id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
146283002|NCT00603304|527550092|FG000|Overall Study|Lost to Follow-up|5|||
146283003|NCT00603304|527550093|FG001|Overall Study|Lost to Follow-up|7|||
146283004|NCT00603304|527550092|FG000|Overall Study|Withdrawal by Subject|8|||
146283005|NCT00603304|527550093|FG001|Overall Study|Withdrawal by Subject|5|||
146283006|NCT00603304|527550092|FG000|Overall Study|Protocol Violation|1|||
146283007|NCT00603304|527550093|FG001|Overall Study|Protocol Violation|0|||
146283008|NCT00603304|527550092|FG000|Overall Study|Adverse Event|4|||
146283009|NCT00603304|527550093|FG001|Overall Study|Adverse Event|2|||
146283010|NCT00603304|527550092|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
146283011|NCT00603304|527550093|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
146283012|NCT00603304|527550092|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
146283013|NCT00603304|527550093|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
146283014|NCT00603304|527550092|FG000|Overall Study|Exclusionary Medication|2|||
146283015|NCT00603304|527550093|FG001|Overall Study|Exclusionary Medication|3|||
146283016|NCT00603304|527550092|FG000|Overall Study|Non-Compliant|0|||
146283017|NCT00603304|527550093|FG001|Overall Study|Non-Compliant|1|||
146283018|NCT00603304|527550092|FG000|Overall Study|Moved Away|0|||
146283019|NCT00603304|527550093|FG001|Overall Study|Moved Away|2|||
146283020|NCT00603304|527550092|FG000|Overall Study|Other|2|||
146283021|NCT00603304|527550093|FG001|Overall Study|Other|0|||
146283022|NCT00603304|527550092|FG000|Overall Study|Patient Decision|2|||
146283023|NCT00603304|527550093|FG001|Overall Study|Patient Decision|0|||
146283024|NCT01076192|527550094|FG000|Overall Study|Other|197|||
146283025|NCT01034176|527550095|FG000|Overall Study|Physician Decision|2|||
146283026|NCT01034176|527550096|FG001|Overall Study|Physician Decision|0|||
146283027|NCT01034176|527550095|FG000|Overall Study|Withdrawal by Subject|0|||
146283028|NCT01034176|527550096|FG001|Overall Study|Withdrawal by Subject|1|||
146283029|NCT01034176|527550095|FG000|Overall Study|Lost to Follow-up|0|||
146283030|NCT01034176|527550096|FG001|Overall Study|Lost to Follow-up|1|||
146283031|NCT05087979|527550099|FG000|Overall Study|Converted to general anesthesia|1|||
146283032|NCT05087979|527550100|FG001|Overall Study|Converted to general anesthesia|0|||
146283033|NCT00616902|527550101|FG000|Overall Study|Termination of study|6|||
146283034|NCT00616902|527550102|FG001|Overall Study|Termination of study|6|||
146283035|NCT02680002|527550104|FG000|Overall Study|Lost to Follow-up|5|||
146283036|NCT02680002|527550105|FG001|Overall Study|Lost to Follow-up|1|||
146056792|NCT01602224|526725450|FG000|Overall Study|Adverse Event|0|||
146056793|NCT01602224|526725451|FG001|Overall Study|Adverse Event|1|||
146056794|NCT01602224|526725452|FG002|Overall Study|Adverse Event|0|||
146056795|NCT01602224|526725450|FG000|Overall Study|Investigator Decison|1|||
146056796|NCT01602224|526725451|FG001|Overall Study|Investigator Decison|0|||
146283037|NCT02680002|527550106|FG002|Overall Study|Lost to Follow-up|4|||
146283038|NCT02680002|527550107|FG003|Overall Study|Lost to Follow-up|2|||
146283039|NCT02680002|527550108|FG004|Overall Study|Lost to Follow-up|0|||
146283040|NCT02680002|527550109|FG005|Overall Study|Lost to Follow-up|2|||
146283041|NCT02680002|527550104|FG000|Overall Study|Physician Decision|5|||
146283042|NCT02680002|527550105|FG001|Overall Study|Physician Decision|1|||
146283043|NCT02680002|527550106|FG002|Overall Study|Physician Decision|1|||
146283044|NCT02680002|527550107|FG003|Overall Study|Physician Decision|1|||
146283045|NCT02680002|527550108|FG004|Overall Study|Physician Decision|1|||
146283046|NCT02680002|527550109|FG005|Overall Study|Physician Decision|1|||
146283047|NCT02680002|527550104|FG000|Overall Study|Protocol Violation|1|||
146283048|NCT02680002|527550105|FG001|Overall Study|Protocol Violation|0|||
146283049|NCT02680002|527550106|FG002|Overall Study|Protocol Violation|1|||
146283050|NCT02680002|527550107|FG003|Overall Study|Protocol Violation|0|||
146283051|NCT02680002|527550108|FG004|Overall Study|Protocol Violation|1|||
146283052|NCT02680002|527550109|FG005|Overall Study|Protocol Violation|2|||
146283053|NCT02680002|527550104|FG000|Overall Study|Withdrawal by Subject|0|||
146283054|NCT02680002|527550105|FG001|Overall Study|Withdrawal by Subject|0|||
146283055|NCT02680002|527550106|FG002|Overall Study|Withdrawal by Subject|1|||
146283056|NCT02680002|527550107|FG003|Overall Study|Withdrawal by Subject|0|||
146283057|NCT02680002|527550108|FG004|Overall Study|Withdrawal by Subject|2|||
146283058|NCT02680002|527550109|FG005|Overall Study|Withdrawal by Subject|2|||
146283059|NCT02680002|527550104|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
146283060|NCT02680002|527550105|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
146283061|NCT02680002|527550106|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
146283062|NCT02680002|527550107|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
146283063|NCT02680002|527550108|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
146283064|NCT02680002|527550109|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
146283065|NCT02680002|527550104|FG000|Overall Study|Other|0|||
146283066|NCT02680002|527550105|FG001|Overall Study|Other|1|||
146283067|NCT02680002|527550106|FG002|Overall Study|Other|0|||
146283068|NCT02680002|527550107|FG003|Overall Study|Other|0|||
146283069|NCT02680002|527550108|FG004|Overall Study|Other|1|||
146283070|NCT02680002|527550109|FG005|Overall Study|Other|0|||
145944093|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
146283071|NCT02680002|527550104|FG000|Overall Study|Adverse Event|0|||
146283072|NCT02680002|527550105|FG001|Overall Study|Adverse Event|0|||
146283073|NCT02680002|527550106|FG002|Overall Study|Adverse Event|0|||
146283074|NCT02680002|527550107|FG003|Overall Study|Adverse Event|0|||
146283075|NCT02680002|527550108|FG004|Overall Study|Adverse Event|1|||
146283076|NCT02680002|527550109|FG005|Overall Study|Adverse Event|2|||
146283077|NCT00705679|527550110|FG000|Overall Study|Adverse Event|1|||
146283078|NCT00705679|527550111|FG001|Overall Study|Adverse Event|1|||
146283079|NCT00705679|527550112|FG002|Overall Study|Adverse Event|0|||
146283080|NCT00705679|527550113|FG003|Overall Study|Adverse Event|0|||
146283081|NCT00705679|527550114|FG004|Overall Study|Adverse Event|0|||
146283082|NCT00705679|527550110|FG000|Overall Study|Death|0|||
146283083|NCT00705679|527550111|FG001|Overall Study|Death|0|||
146283084|NCT00705679|527550112|FG002|Overall Study|Death|3|||
146283085|NCT00705679|527550113|FG003|Overall Study|Death|2|||
146283086|NCT00705679|527550114|FG004|Overall Study|Death|1|||
146283087|NCT00705679|527550110|FG000|Overall Study|Lost to Follow-up|32|||
146283088|NCT00705679|527550111|FG001|Overall Study|Lost to Follow-up|60|||
146283089|NCT00705679|527550112|FG002|Overall Study|Lost to Follow-up|44|||
146283090|NCT00705679|527550113|FG003|Overall Study|Lost to Follow-up|30|||
146283091|NCT00705679|527550114|FG004|Overall Study|Lost to Follow-up|35|||
146283092|NCT00705679|527550110|FG000|Overall Study|Physician Decision|0|||
146283093|NCT00705679|527550111|FG001|Overall Study|Physician Decision|1|||
146283094|NCT00705679|527550112|FG002|Overall Study|Physician Decision|0|||
146283095|NCT00705679|527550113|FG003|Overall Study|Physician Decision|1|||
146283096|NCT00705679|527550114|FG004|Overall Study|Physician Decision|0|||
146283097|NCT00705679|527550110|FG000|Overall Study|Withdrawal by Subject|32|||
146283098|NCT00705679|527550111|FG001|Overall Study|Withdrawal by Subject|77|||
146283099|NCT00705679|527550112|FG002|Overall Study|Withdrawal by Subject|68|||
146283100|NCT00705679|527550113|FG003|Overall Study|Withdrawal by Subject|47|||
146283101|NCT00705679|527550114|FG004|Overall Study|Withdrawal by Subject|33|||
146283102|NCT00759915|527550115|FG000|Overall Study|Withdrawal by Subject|1|||
146283103|NCT00759915|527550116|FG001|Overall Study|Withdrawal by Subject|0|||
146283104|NCT00759915|527550115|FG000|Overall Study|Adverse Event|0|||
146283105|NCT00759915|527550116|FG001|Overall Study|Adverse Event|1|||
146396414|NCT01473602|527956577|FG000|Overall Study|Adverse Event|1|||
146396415|NCT01473602|527956578|FG001|Overall Study|Adverse Event|2|||
146396416|NCT01473602|527956577|FG000|Overall Study|Death|0|||
146396417|NCT01473602|527956578|FG001|Overall Study|Death|1|||
146396418|NCT01473602|527956577|FG000|Overall Study|Lost to Follow-up|1|||
146396419|NCT01473602|527956578|FG001|Overall Study|Lost to Follow-up|1|||
146396420|NCT01473602|527956577|FG000|Overall Study|Withdrawal by Subject|5|||
146396421|NCT01473602|527956578|FG001|Overall Study|Withdrawal by Subject|4|||
146283106|NCT03730480|527550117|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
146396422|NCT01473602|527956577|FG000|Overall Study|Physician Decision|1|||
146396423|NCT01473602|527956578|FG001|Overall Study|Physician Decision|0|||
146396424|NCT00449761|527956579|FG000|Overall Study|Disease progression|12|||
146396425|NCT00449761|527956579|FG000|Overall Study|Death|5|||
146396426|NCT00449761|527956579|FG000|Overall Study|New cancer therapy|1|||
146396427|NCT00726882|527956580|FG000|Overall Study|Withdrawal by Subject|5|||
146396428|NCT00726882|527956580|FG000|Overall Study|Lost to Follow-up|7|||
146396429|NCT00726882|527956580|FG000|Overall Study|Other|10|||
146396430|NCT01339273|527956581|FG000|Overall Study|Lost to Follow-up|8|||
146396431|NCT01339273|527956582|FG001|Overall Study|Lost to Follow-up|8|||
146396432|NCT00560573|527956583|FG000|Overall Study|Death|4|||
146396433|NCT00560573|527956584|FG001|Overall Study|Death|1|||
146396434|NCT00560573|527956585|FG002|Overall Study|Death|4|||
146396435|NCT00560573|527956586|FG003|Overall Study|Death|5|||
146396436|NCT00560573|527956587|FG004|Overall Study|Death|1|||
146396437|NCT00560573|527956588|FG005|Overall Study|Death|10|||
146396438|NCT00560573|527956583|FG000|Overall Study|Lost to Follow-up|0|||
146283107|NCT03245151|527550118|FG000|Overall Study|Withdrawal by Subject|2|||
146283108|NCT03245151|527550119|FG001|Overall Study|Withdrawal by Subject|0|||
146283109|NCT03245151|527550120|FG002|Overall Study|Withdrawal by Subject|0|||
146283110|NCT03245151|527550121|FG003|Overall Study|Withdrawal by Subject|2|||
146283111|NCT03245151|527550122|FG004|Overall Study|Withdrawal by Subject|1|||
146283112|NCT03245151|527550118|FG000|Overall Study|Death|3|||
146283113|NCT03245151|527550119|FG001|Overall Study|Death|14|||
146283114|NCT03245151|527550120|FG002|Overall Study|Death|9|||
146283115|NCT03245151|527550121|FG003|Overall Study|Death|16|||
146283116|NCT03245151|527550122|FG004|Overall Study|Death|7|||
146283117|NCT03245151|527550118|FG000|Overall Study|Sponsor's decision|0|||
146283118|NCT03245151|527550119|FG001|Overall Study|Sponsor's decision|1|||
146283119|NCT03245151|527550120|FG002|Overall Study|Sponsor's decision|0|||
146283120|NCT03245151|527550121|FG003|Overall Study|Sponsor's decision|0|||
146283121|NCT03245151|527550122|FG004|Overall Study|Sponsor's decision|0|||
146283122|NCT04772898|527550127|FG000|Overall Study|Withdrawal by Subject|0|||
146283123|NCT04772898|527550128|FG001|Overall Study|Withdrawal by Subject|1|||
146283124|NCT01004848|527550134|FG000|Overall Study|Lost to Follow-up|55|||
146283125|NCT01004848|527550135|FG001|Overall Study|Lost to Follow-up|45|||
146283126|NCT01631227|527550136|FG000|Overall Study|withdrawn consent|27|||
146283127|NCT01631227|527550137|FG001|Overall Study|withdrawn consent|21|||
146283128|NCT01631227|527550136|FG000|Overall Study|Adverse Event|1|||
146396439|NCT00560573|527956584|FG001|Overall Study|Lost to Follow-up|0|||
146396440|NCT00560573|527956585|FG002|Overall Study|Lost to Follow-up|0|||
146283129|NCT01631227|527550137|FG001|Overall Study|Adverse Event|0|||
146283130|NCT01631227|527550136|FG000|Overall Study|administrative|2|||
146283131|NCT01631227|527550137|FG001|Overall Study|administrative|1|||
146283132|NCT00768079|527550138|FG000|Overall Study|Lost to Follow-up|2|||
146283133|NCT00768079|527550139|FG001|Overall Study|Lost to Follow-up|0|||
146283134|NCT00768079|527550140|FG002|Overall Study|Lost to Follow-up|4|||
146283135|NCT00768079|527550138|FG000|Overall Study|Participant incarcerated|0|||
146283136|NCT00768079|527550139|FG001|Overall Study|Participant incarcerated|1|||
145944094|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
145944095|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
145944096|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
145944097|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
145944098|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
145944099|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
145944100|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
145944101|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
145944102|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
145944103|NCT01777139|526304444|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
145944104|NCT01777139|526304445|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
145944105|NCT01777139|526304444|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
145944106|NCT01777139|526304445|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
145944107|NCT01777139|526304444|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
145944108|NCT01777139|526304445|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
145944109|NCT02542293|526304447|FG000|Overall Study|Death|367|||
145944110|NCT02542293|526304448|FG001|Overall Study|Death|377|||
145944111|NCT02542293|526304447|FG000|Overall Study|Withdrawal by Subject|8|||
145944112|NCT02542293|526304448|FG001|Overall Study|Withdrawal by Subject|19|||
145944113|NCT03030118|526304449|FG000|Overall Study|Achieved SLE Diagnosis|11|||
145944114|NCT03030118|526304450|FG001|Overall Study|Achieved SLE Diagnosis|10|||
145944115|NCT03030118|526304449|FG000|Overall Study|Adverse Event|1|||
145944116|NCT03030118|526304450|FG001|Overall Study|Adverse Event|1|||
145944117|NCT03030118|526304449|FG000|Overall Study|Pregnancy|2|||
145944118|NCT03030118|526304450|FG001|Overall Study|Pregnancy|2|||
145944119|NCT03030118|526304449|FG000|Overall Study|Lost to Follow-up|5|||
145944120|NCT03030118|526304450|FG001|Overall Study|Lost to Follow-up|6|||
145944121|NCT03030118|526304449|FG000|Overall Study|Concomitant Medications|1|||
145944122|NCT03030118|526304450|FG001|Overall Study|Concomitant Medications|1|||
145944123|NCT03030118|526304449|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
145944124|NCT03030118|526304450|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
145944125|NCT03030118|526304449|FG000|Overall Study|Other|2|||
145944126|NCT03030118|526304450|FG001|Overall Study|Other|0|||
145944127|NCT03030118|526304449|FG000|Overall Study|Withdrawal by Subject|26|||
145944128|NCT03030118|526304450|FG001|Overall Study|Withdrawal by Subject|21|||
145944129|NCT03030118|526304449|FG000|Overall Study|Protocol Violation|1|||
145944130|NCT03030118|526304450|FG001|Overall Study|Protocol Violation|6|||
145944131|NCT04529850|526304451|FG000|Overall Study|Death|2|||
145944132|NCT04529850|526304451|FG000|Overall Study|Physician Decision|1|||
145944133|NCT04529850|526304451|FG000|Overall Study|Withdrawal by Subject|2|||
145944134|NCT00593606|526304454|FG000|Overall Study|Adverse Event|13|||
145944135|NCT00593606|526304454|FG000|Overall Study|Withdrawal by Subject|1|||
145944136|NCT00593606|526304454|FG000|Overall Study|Protocol Violation|3|||
145944137|NCT00593606|526304454|FG000|Overall Study|Lost to Follow-up|2|||
145944138|NCT00593606|526304454|FG000|Overall Study|Run-In Failure|5|||
145944139|NCT00593606|526304454|FG000|Overall Study|Screen Failure|3|||
145944140|NCT03309696|526304455|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
145944141|NCT03309696|526304456|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
145944142|NCT03309696|526304457|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
145944143|NCT03309696|526304458|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
145944144|NCT00078949|526304459|FG000|Overall Study|No treated|4|||
145944145|NCT00078949|526304460|FG001|Overall Study|No treated|5|||
145944146|NCT00078949|526304461|FG002|Overall Study|No treated|3|||
145944147|NCT00078949|526304462|FG003|Overall Study|No treated|3|||
145944148|NCT00577005|526304463|FG000|Overall Study|Lost to Follow-up|3|||
145944149|NCT00577005|526304464|FG001|Overall Study|Lost to Follow-up|2|||
145944150|NCT00577005|526304463|FG000|Overall Study|Withdrawal by Subject|2|||
145944151|NCT00577005|526304464|FG001|Overall Study|Withdrawal by Subject|1|||
145944152|NCT01004432|526304465|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
145944153|NCT01004432|526304466|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145944154|NCT01004432|526304467|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
146283137|NCT00768079|527550140|FG002|Overall Study|Participant incarcerated|0|||
146283138|NCT01498679|527550141|FG000|Overall Study|Adverse Event|1|||
146283139|NCT01498679|527550142|FG001|Overall Study|Adverse Event|4|||
146396441|NCT00560573|527956586|FG003|Overall Study|Lost to Follow-up|1|||
146396442|NCT00560573|527956587|FG004|Overall Study|Lost to Follow-up|1|||
145944155|NCT01004432|526304468|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145944156|NCT01004432|526304469|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145944157|NCT01004432|526304465|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
146396443|NCT00560573|527956588|FG005|Overall Study|Lost to Follow-up|0|||
146396444|NCT00560573|527956583|FG000|Overall Study|Withdrawal by Subject|0|||
146396445|NCT00560573|527956584|FG001|Overall Study|Withdrawal by Subject|0|||
146396446|NCT00560573|527956585|FG002|Overall Study|Withdrawal by Subject|0|||
146396447|NCT00560573|527956586|FG003|Overall Study|Withdrawal by Subject|1|||
146396448|NCT00560573|527956587|FG004|Overall Study|Withdrawal by Subject|1|||
146396449|NCT00560573|527956588|FG005|Overall Study|Withdrawal by Subject|0|||
146396450|NCT00560573|527956583|FG000|Overall Study|Other|2|||
146396451|NCT00560573|527956584|FG001|Overall Study|Other|2|||
146396452|NCT00560573|527956585|FG002|Overall Study|Other|2|||
146396453|NCT00560573|527956586|FG003|Overall Study|Other|3|||
146396454|NCT00560573|527956587|FG004|Overall Study|Other|3|||
146396455|NCT00560573|527956588|FG005|Overall Study|Other|3|||
146396456|NCT00560573|527956583|FG000|Overall Study|Enrolled, not treated|0|||
146396457|NCT00560573|527956584|FG001|Overall Study|Enrolled, not treated|0|||
146396458|NCT00560573|527956585|FG002|Overall Study|Enrolled, not treated|0|||
146396459|NCT00560573|527956586|FG003|Overall Study|Enrolled, not treated|0|||
146396460|NCT00560573|527956587|FG004|Overall Study|Enrolled, not treated|1|||
145944158|NCT01004432|526304466|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145944159|NCT01004432|526304467|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145944160|NCT01004432|526304468|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145944161|NCT01004432|526304469|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145944162|NCT01004432|526304465|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
145944163|NCT01004432|526304466|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145944164|NCT01004432|526304467|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145944165|NCT01004432|526304468|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145944166|NCT01004432|526304469|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145944167|NCT01004432|526304465|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
145944168|NCT01004432|526304466|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145944169|NCT01004432|526304467|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145944170|NCT01004432|526304468|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145944171|NCT01004432|526304469|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145944172|NCT01004432|526304465|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
145944173|NCT01004432|526304466|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145944174|NCT01004432|526304467|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145944175|NCT01004432|526304468|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145944176|NCT01004432|526304469|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145944177|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
145944178|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
145944179|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
146283140|NCT01498679|527550141|FG000|Overall Study|Lack of Efficacy|72|||
146283141|NCT01498679|527550142|FG001|Overall Study|Lack of Efficacy|12|||
146283142|NCT01498679|527550141|FG000|Overall Study|Protocol Violation|4|||
146283143|NCT01498679|527550142|FG001|Overall Study|Protocol Violation|0|||
146283144|NCT01498679|527550141|FG000|Overall Study|Physician Decision|0|||
146283145|NCT01498679|527550142|FG001|Overall Study|Physician Decision|2|||
146283146|NCT01498679|527550141|FG000|Overall Study|Withdrawal by Subject|12|||
146283147|NCT01498679|527550142|FG001|Overall Study|Withdrawal by Subject|4|||
146283148|NCT03212989|527550144|FG000|Overall Study|Physician Decision|8|||
146283149|NCT02057523|527550148|FG000|Overall Study|Withdrawal by Subject|1|||
146283150|NCT02057523|527550148|FG000|Overall Study|Lack of Efficacy|1|||
146283151|NCT00158860|527550149|FG000|Overall Study|Adverse Event|3|||
146283152|NCT00158860|527550150|FG001|Overall Study|Adverse Event|6|||
146283153|NCT00158860|527550149|FG000|Overall Study|Lost to Follow-up|11|||
146283154|NCT00158860|527550150|FG001|Overall Study|Lost to Follow-up|17|||
146283155|NCT00158860|527550149|FG000|Overall Study|Protocol Violation|8|||
146283156|NCT00158860|527550150|FG001|Overall Study|Protocol Violation|23|||
146283157|NCT00158860|527550149|FG000|Overall Study|Withdrawal by Subject|7|||
146283158|NCT00158860|527550150|FG001|Overall Study|Withdrawal by Subject|17|||
146283159|NCT00158860|527550149|FG000|Overall Study|MOVING OUT OF STATE|1|||
146283160|NCT00158860|527550150|FG001|Overall Study|MOVING OUT OF STATE|0|||
146283161|NCT00158860|527550149|FG000|Overall Study|Pregnancy|3|||
146283162|NCT00158860|527550150|FG001|Overall Study|Pregnancy|3|||
146283163|NCT00158860|527550149|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
146283164|NCT00158860|527550150|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
145944180|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
146283165|NCT00158860|527550149|FG000|Overall Study|SPONSOR REQUEST|0|||
146283166|NCT00158860|527550150|FG001|Overall Study|SPONSOR REQUEST|1|||
146283167|NCT00158860|527550149|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
146283168|NCT00158860|527550150|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
145944181|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
145944182|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
145944183|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
145944184|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
145944185|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
145944186|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
145944187|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
145944188|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
145944189|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
145944190|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
145944191|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
146396461|NCT00560573|527956588|FG005|Overall Study|Enrolled, not treated|0|||
145944192|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145944193|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145944194|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145944195|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
145944196|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145944197|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
145944198|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
145944199|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
145944200|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
145944201|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
145944202|NCT01004432|526304465|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
145944203|NCT01004432|526304466|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
145944204|NCT01004432|526304467|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
145944205|NCT01004432|526304468|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
145944206|NCT01004432|526304469|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
145944207|NCT01004432|526304465|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145944208|NCT01004432|526304466|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145944209|NCT01004432|526304467|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145944210|NCT01004432|526304468|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145944211|NCT01004432|526304469|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
145944212|NCT01004432|526304465|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145944213|NCT01004432|526304466|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145944214|NCT01004432|526304467|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145944215|NCT01004432|526304468|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145944216|NCT01004432|526304469|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
145944217|NCT01004432|526304465|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145944218|NCT01004432|526304466|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145944219|NCT01004432|526304467|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145944220|NCT01004432|526304468|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145944221|NCT01004432|526304469|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
145944222|NCT01004432|526304465|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145944223|NCT01004432|526304466|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145944224|NCT01004432|526304467|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145944225|NCT01004432|526304468|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145944226|NCT01004432|526304469|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
145944227|NCT04829331|526304470|FG000|Overall Study|Lost to Follow-up|1|||
146056797|NCT01602224|526725452|FG002|Overall Study|Investigator Decison|0|||
146283169|NCT00158860|527550149|FG000|Overall Study|Closed per sponsor|0|||
146283170|NCT00158860|527550150|FG001|Overall Study|Closed per sponsor|1|||
146283171|NCT00964886|527550151|FG000|Overall Study|Lost to Follow-up|2|||
146283172|NCT00964886|527550152|FG001|Overall Study|Lost to Follow-up|2|||
146283173|NCT00964886|527550153|FG002|Overall Study|Lost to Follow-up|6|||
146283174|NCT00964886|527550154|FG003|Overall Study|Lost to Follow-up|4|||
146283175|NCT00964886|527550151|FG000|Overall Study|Withdrawal by Subject|6|||
146283176|NCT00964886|527550152|FG001|Overall Study|Withdrawal by Subject|2|||
146283177|NCT00964886|527550153|FG002|Overall Study|Withdrawal by Subject|5|||
146283178|NCT00964886|527550154|FG003|Overall Study|Withdrawal by Subject|3|||
146283179|NCT00964886|527550151|FG000|Overall Study|Adverse Event|3|||
146283180|NCT00964886|527550152|FG001|Overall Study|Adverse Event|1|||
146283181|NCT00964886|527550153|FG002|Overall Study|Adverse Event|5|||
146283182|NCT00964886|527550154|FG003|Overall Study|Adverse Event|2|||
146283183|NCT00964886|527550151|FG000|Overall Study|Protocol Violation|0|||
146283184|NCT00964886|527550152|FG001|Overall Study|Protocol Violation|2|||
146283185|NCT00964886|527550153|FG002|Overall Study|Protocol Violation|0|||
146283186|NCT00964886|527550154|FG003|Overall Study|Protocol Violation|0|||
146283187|NCT03047395|527550155|FG000|Overall Study|Adverse Event|142|||
146396462|NCT00594568|527956589|FG000|Initial Treatment|Adverse Event|51|||
146283188|NCT03047395|527550155|FG000|Overall Study|Withdrawal by Subject|155|||
145944228|NCT04829331|526304471|FG001|Overall Study|Lost to Follow-up|0|||
145944229|NCT02604550|526304474|FG000|Overall Study|Lost to Follow-up|7|||
145944230|NCT02604550|526304475|FG001|Overall Study|Lost to Follow-up|6|||
145944231|NCT02604550|526304474|FG000|Overall Study|Withdrawal by Subject|0|||
145944232|NCT02604550|526304475|FG001|Overall Study|Withdrawal by Subject|1|||
145944233|NCT02604550|526304474|FG000|Overall Study|Incomplete data using paper journal|18|||
145944234|NCT02604550|526304475|FG001|Overall Study|Incomplete data using paper journal|19|||
145944235|NCT01404208|526304476|FG000|Overall Study|Discontinued|3|||
145944236|NCT01404208|526304477|FG001|Overall Study|Discontinued|0|||
145944237|NCT00908076|526304480|FG000|Overall Study|Lack of Efficacy|1|||
146283189|NCT03047395|527550155|FG000|Overall Study|Lost to Follow-up|144|||
146283190|NCT03047395|527550155|FG000|Overall Study|COVID-19 Infection|2|||
146283191|NCT03047395|527550155|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
146283192|NCT03047395|527550155|FG000|Overall Study|Other, Not Specified|117|||
146283193|NCT01871805|527550160|FG000|Phase I|Death|7|||
146283194|NCT01871805|527550161|FG001|Phase I|Death|4|||
146283195|NCT01871805|527550162|FG002|Phase I|Death|6|||
146283196|NCT01871805|527550163|FG003|Phase I|Death|2|||
146283197|NCT01871805|527550164|FG004|Phase I|Death|9|||
146283198|NCT01871805|527550165|FG005|Phase I|Death|0|||
146283199|NCT01871805|527550160|FG000|Phase I|Alive in Survival Follow-up|0|||
146283200|NCT01871805|527550161|FG001|Phase I|Alive in Survival Follow-up|2|||
146283201|NCT01871805|527550162|FG002|Phase I|Alive in Survival Follow-up|4|||
146283202|NCT01871805|527550163|FG003|Phase I|Alive in Survival Follow-up|5|||
146283203|NCT01871805|527550164|FG004|Phase I|Alive in Survival Follow-up|4|||
146283204|NCT01871805|527550165|FG005|Phase I|Alive in Survival Follow-up|0|||
146283205|NCT01871805|527550160|FG000|Phase I|Lost to Follow-up|0|||
145944238|NCT00908076|526304481|FG001|Overall Study|Lack of Efficacy|1|||
145944239|NCT02382796|526304482|FG000|Overall Study|Global deterioration of health status|1|||
145944240|NCT02382796|526304482|FG000|Overall Study|Objective progression or relapse|3|||
145944241|NCT02382796|526304482|FG000|Overall Study|Commercial dacomitinib became available|3|||
145944242|NCT03769675|526304493|FG000|Overall Study|Lost to Follow-up|1|||
145944243|NCT04068688|526304494|FG000|Overall Study|Lost to Follow-up|1|||
145944244|NCT04068688|526304495|FG001|Overall Study|Lost to Follow-up|1|||
145944245|NCT04068688|526304496|FG002|Overall Study|Lost to Follow-up|0|||
145944246|NCT04068688|526304497|FG003|Overall Study|Lost to Follow-up|0|||
145944247|NCT04068688|526304498|FG004|Overall Study|Lost to Follow-up|5|||
145944248|NCT04068688|526304499|FG005|Overall Study|Lost to Follow-up|5|||
145944249|NCT04068688|526304500|FG006|Overall Study|Lost to Follow-up|0|||
145944250|NCT04068688|526304501|FG007|Overall Study|Lost to Follow-up|0|||
145944251|NCT04068688|526304502|FG008|Overall Study|Lost to Follow-up|1|||
146283206|NCT01871805|527550161|FG001|Phase I|Lost to Follow-up|1|||
145944252|NCT04068688|526304503|FG009|Overall Study|Lost to Follow-up|0|||
145944253|NCT04068688|526304494|FG000|Overall Study|Withdrawal by Subject|1|||
145944254|NCT04068688|526304495|FG001|Overall Study|Withdrawal by Subject|1|||
145944255|NCT04068688|526304496|FG002|Overall Study|Withdrawal by Subject|0|||
145944256|NCT04068688|526304497|FG003|Overall Study|Withdrawal by Subject|0|||
145944257|NCT04068688|526304498|FG004|Overall Study|Withdrawal by Subject|0|||
145944258|NCT04068688|526304499|FG005|Overall Study|Withdrawal by Subject|0|||
145944259|NCT04068688|526304500|FG006|Overall Study|Withdrawal by Subject|0|||
145944260|NCT04068688|526304501|FG007|Overall Study|Withdrawal by Subject|0|||
145944261|NCT04068688|526304502|FG008|Overall Study|Withdrawal by Subject|0|||
145944262|NCT04068688|526304503|FG009|Overall Study|Withdrawal by Subject|0|||
145944263|NCT04068688|526304494|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
145944264|NCT04068688|526304495|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
145944265|NCT04068688|526304496|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944266|NCT04068688|526304497|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944267|NCT04068688|526304498|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944268|NCT04068688|526304499|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944269|NCT04068688|526304500|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944270|NCT04068688|526304501|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944271|NCT04068688|526304502|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944272|NCT04068688|526304503|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145944273|NCT02554318|526304506|FG000|Overall Study|Withdrawal by Subject|10|||
146056798|NCT01602224|526725450|FG000|Overall Study|Lost to Follow-up|0|||
146283207|NCT01871805|527550162|FG002|Phase I|Lost to Follow-up|3|||
145944274|NCT02554318|526304507|FG001|Overall Study|Withdrawal by Subject|8|||
145944275|NCT03436199|526304508|FG000|Overall Study|Adverse Event|15|||
145944276|NCT03436199|526304509|FG001|Overall Study|Adverse Event|40|||
145944277|NCT03436199|526304510|FG002|Overall Study|Adverse Event|7|||
146283208|NCT01871805|527550163|FG003|Phase I|Lost to Follow-up|0|||
146283209|NCT01871805|527550164|FG004|Phase I|Lost to Follow-up|0|||
146283210|NCT01871805|527550165|FG005|Phase I|Lost to Follow-up|0|||
146283211|NCT01871805|527550160|FG000|Phase II|Death|0|||
145944278|NCT03436199|526304508|FG000|Overall Study|Withdrawal by Subject|4|||
145944279|NCT03436199|526304509|FG001|Overall Study|Withdrawal by Subject|10|||
145944280|NCT03436199|526304510|FG002|Overall Study|Withdrawal by Subject|3|||
145944281|NCT03436199|526304508|FG000|Overall Study|Lost to Follow-up|1|||
145944282|NCT03436199|526304509|FG001|Overall Study|Lost to Follow-up|0|||
145944283|NCT03436199|526304510|FG002|Overall Study|Lost to Follow-up|2|||
145944284|NCT03436199|526304508|FG000|Overall Study|Protocol Violation|1|||
145944285|NCT03436199|526304509|FG001|Overall Study|Protocol Violation|1|||
145944286|NCT03436199|526304510|FG002|Overall Study|Protocol Violation|0|||
145944287|NCT03436199|526304508|FG000|Overall Study|Physician Decision|0|||
145944288|NCT03436199|526304509|FG001|Overall Study|Physician Decision|1|||
145944289|NCT03436199|526304510|FG002|Overall Study|Physician Decision|0|||
145944290|NCT03436199|526304508|FG000|Overall Study|Could not return to clinic|1|||
145944291|NCT03436199|526304509|FG001|Overall Study|Could not return to clinic|0|||
145944292|NCT03436199|526304510|FG002|Overall Study|Could not return to clinic|0|||
145944293|NCT03436199|526304508|FG000|Overall Study|Withdrawn per physician|0|||
145944294|NCT03436199|526304509|FG001|Overall Study|Withdrawn per physician|1|||
145944295|NCT03436199|526304510|FG002|Overall Study|Withdrawn per physician|0|||
145944296|NCT02631070|526304511|FG000|Overall Study|Withdrawal by Subject|35|||
145944297|NCT02631070|526304512|FG001|Overall Study|Withdrawal by Subject|13|||
145944298|NCT02631070|526304511|FG000|Overall Study|Death|45|||
145944299|NCT02631070|526304512|FG001|Overall Study|Death|24|||
145944300|NCT02631070|526304511|FG000|Overall Study|Lost to Follow-up|5|||
145944301|NCT02631070|526304512|FG001|Overall Study|Lost to Follow-up|1|||
145944302|NCT02631070|526304511|FG000|Overall Study|Transition to rollover protocol|52|||
145944303|NCT02631070|526304512|FG001|Overall Study|Transition to rollover protocol|21|||
145944304|NCT02631070|526304511|FG000|Overall Study|Other reasons|12|||
145944305|NCT02631070|526304512|FG001|Overall Study|Other reasons|5|||
145944306|NCT00085098|526304518|FG000|Overall Study|Withdrawal by Subject|0|||
145944307|NCT00085098|526304519|FG001|Overall Study|Withdrawal by Subject|1|||
145944308|NCT00085098|526304518|FG000|Overall Study|Ineligible|1|||
145944309|NCT00085098|526304519|FG001|Overall Study|Ineligible|1|||
145944310|NCT01195844|526304522|FG000|Overall Study|Fecal sample not collected|40|||
145944311|NCT00513357|526304523|FG000|Overall Study|did not receive allocated placebo|2|||
145944312|NCT00513357|526304524|FG001|Overall Study|did not receive allocated placebo|3|||
145944313|NCT00513357|526304523|FG000|Overall Study|Adverse Event|4|||
145944314|NCT00513357|526304524|FG001|Overall Study|Adverse Event|2|||
145944315|NCT00513357|526304523|FG000|Overall Study|Death|2|||
145944316|NCT00513357|526304524|FG001|Overall Study|Death|0|||
145944317|NCT00513357|526304523|FG000|Overall Study|Withdrawal by Subject|5|||
145944318|NCT00513357|526304524|FG001|Overall Study|Withdrawal by Subject|4|||
145944319|NCT00513357|526304523|FG000|Overall Study|Disease Progression|2|||
145944320|NCT00513357|526304524|FG001|Overall Study|Disease Progression|1|||
145944321|NCT03301844|526304525|FG000|Overall Study|suspected colon cancer|1|||
145944322|NCT03301844|526304526|FG001|Overall Study|suspected colon cancer|1|||
145944323|NCT00501059|526304527|FG000|Overall Study|Protocol Violation|80|||
145944324|NCT00501059|526304528|FG001|Overall Study|Protocol Violation|69|||
145944325|NCT00501059|526304527|FG000|Overall Study|Death|140|||
145944326|NCT00501059|526304528|FG001|Overall Study|Death|137|||
145944327|NCT00501059|526304527|FG000|Overall Study|Other|236|||
145944328|NCT00501059|526304528|FG001|Overall Study|Other|239|||
145944329|NCT00501059|526304527|FG000|Overall Study|Missing end-of-study page|91|||
145944330|NCT00501059|526304528|FG001|Overall Study|Missing end-of-study page|92|||
145944331|NCT00501059|526304527|FG000|Overall Study|Clinical endpoint reached|110|||
145944332|NCT00501059|526304528|FG001|Overall Study|Clinical endpoint reached|123|||
145944333|NCT00501059|526304527|FG000|Overall Study|Insufficient therapeutic effect|4|||
145944334|NCT00501059|526304528|FG001|Overall Study|Insufficient therapeutic effect|5|||
145944335|NCT00501059|526304527|FG000|Overall Study|Consent withdrawn by subject|817|||
145944336|NCT00501059|526304528|FG001|Overall Study|Consent withdrawn by subject|873|||
145944337|NCT00501059|526304527|FG000|Overall Study|Non-compliant with study treatment|23|||
145944338|NCT00501059|526304528|FG001|Overall Study|Non-compliant with study treatment|16|||
145944339|NCT00501059|526304527|FG000|Overall Study|Reason not given|3|||
146056799|NCT01602224|526725451|FG001|Overall Study|Lost to Follow-up|0|||
145944340|NCT00501059|526304528|FG001|Overall Study|Reason not given|1|||
145944341|NCT00501059|526304527|FG000|Overall Study|Adverse Event|129|||
145944342|NCT00501059|526304528|FG001|Overall Study|Adverse Event|122|||
145944343|NCT00501059|526304527|FG000|Overall Study|Lost to Follow-up|210|||
145944344|NCT00501059|526304528|FG001|Overall Study|Lost to Follow-up|198|||
145944345|NCT00501059|526304527|FG000|Overall Study|Not treated|25|||
145944346|NCT00501059|526304528|FG001|Overall Study|Not treated|17|||
145944347|NCT00637806|526304531|FG000|Double-blind Phase|Study Discontinued|2|||
145944348|NCT00637806|526304532|FG001|Double-blind Phase|Study Discontinued|0|||
145944349|NCT00637806|526304533|FG002|Double-blind Phase|Study Discontinued|1|||
145944350|NCT00637806|526304534|FG003|Double-blind Phase|Study Discontinued|0|||
145944351|NCT00637806|526304531|FG000|Extension Phase|Study Discontinued|0|||
145944352|NCT00637806|526304532|FG001|Extension Phase|Study Discontinued|0|||
145944353|NCT00637806|526304533|FG002|Extension Phase|Study Discontinued|0|||
145944354|NCT00637806|526304534|FG003|Extension Phase|Study Discontinued|1|||
145944355|NCT01592292|526304535|FG000|Overall Study|Follow-up loss|3|||
145944356|NCT01592292|526304536|FG001|Overall Study|Follow-up loss|3|||
145944357|NCT01592292|526304537|FG002|Overall Study|Follow-up loss|1|||
145944358|NCT01592292|526304538|FG003|Overall Study|Follow-up loss|0|||
145944359|NCT01592292|526304535|FG000|Overall Study|Withdrew consent|2|||
145944360|NCT01592292|526304536|FG001|Overall Study|Withdrew consent|1|||
145944361|NCT01592292|526304537|FG002|Overall Study|Withdrew consent|0|||
145944362|NCT01592292|526304538|FG003|Overall Study|Withdrew consent|0|||
145944363|NCT01592292|526304535|FG000|Overall Study|Other|1|||
145944364|NCT01592292|526304536|FG001|Overall Study|Other|1|||
145944365|NCT01592292|526304537|FG002|Overall Study|Other|2|||
145944366|NCT01592292|526304538|FG003|Overall Study|Other|1|||
145944367|NCT00819780|526304539|FG000|Overall Study|Did not receive study drug|3|||
146396463|NCT00594568|527956590|FG001|Initial Treatment|Adverse Event|121|||
146396464|NCT00594568|527956591|FG002|Initial Treatment|Adverse Event|144|||
146396465|NCT00594568|527956589|FG000|Initial Treatment|Death|6|||
146396466|NCT00594568|527956590|FG001|Initial Treatment|Death|11|||
146396467|NCT00594568|527956591|FG002|Initial Treatment|Death|15|||
146396468|NCT00594568|527956589|FG000|Initial Treatment|Lost to Follow-up|4|||
146396469|NCT00594568|527956590|FG001|Initial Treatment|Lost to Follow-up|1|||
146396470|NCT00594568|527956591|FG002|Initial Treatment|Lost to Follow-up|4|||
146396471|NCT00594568|527956589|FG000|Initial Treatment|Physician Decision|3|||
146396472|NCT00594568|527956590|FG001|Initial Treatment|Physician Decision|2|||
146396473|NCT00594568|527956591|FG002|Initial Treatment|Physician Decision|4|||
146396474|NCT00594568|527956589|FG000|Initial Treatment|Protocol Violation|2|||
146396475|NCT00594568|527956590|FG001|Initial Treatment|Protocol Violation|2|||
146396476|NCT00594568|527956591|FG002|Initial Treatment|Protocol Violation|5|||
146396477|NCT00594568|527956589|FG000|Initial Treatment|Withdrawal by Subject|25|||
146396478|NCT00594568|527956590|FG001|Initial Treatment|Withdrawal by Subject|31|||
146396479|NCT00594568|527956591|FG002|Initial Treatment|Withdrawal by Subject|46|||
146396480|NCT00594568|527956589|FG000|Initial Treatment|Sponsor decision|193|||
146396481|NCT00594568|527956590|FG001|Initial Treatment|Sponsor decision|142|||
146396482|NCT00594568|527956591|FG002|Initial Treatment|Sponsor decision|147|||
146396483|NCT00594568|527956589|FG000|Initial Treatment|Caregiver decision|21|||
146396484|NCT00594568|527956590|FG001|Initial Treatment|Caregiver decision|36|||
146396485|NCT00594568|527956591|FG002|Initial Treatment|Caregiver decision|36|||
146396486|NCT00594568|527956589|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
146396487|NCT00594568|527956590|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
145944368|NCT00819780|526304540|FG001|Overall Study|Did not receive study drug|4|||
145944369|NCT00819780|526304539|FG000|Overall Study|Still in treatment|25|||
146396488|NCT00594568|527956591|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
146396489|NCT00594568|527956589|FG000|Initial Treatment|Entry criteria exclusion|0|||
146396490|NCT00594568|527956590|FG001|Initial Treatment|Entry criteria exclusion|1|||
146396491|NCT00594568|527956591|FG002|Initial Treatment|Entry criteria exclusion|1|||
146396492|NCT00594568|527956589|FG000|Delayed Start|Death|0|||
146396493|NCT00594568|527956590|FG001|Delayed Start|Death|0|||
146396494|NCT00594568|527956591|FG002|Delayed Start|Death|1|||
146396495|NCT00594568|527956589|FG000|Delayed Start|Adverse Event|12|||
146396496|NCT00594568|527956590|FG001|Delayed Start|Adverse Event|2|||
146396497|NCT00594568|527956591|FG002|Delayed Start|Adverse Event|2|||
146396498|NCT00594568|527956589|FG000|Delayed Start|Withdrawal by Subject|4|||
146396499|NCT00594568|527956590|FG001|Delayed Start|Withdrawal by Subject|3|||
146396500|NCT00594568|527956591|FG002|Delayed Start|Withdrawal by Subject|0|||
146396501|NCT00594568|527956589|FG000|Delayed Start|Physician Decision|0|||
146396502|NCT00594568|527956590|FG001|Delayed Start|Physician Decision|0|||
145944370|NCT00819780|526304540|FG001|Overall Study|Still in treatment|17|||
145944371|NCT00948506|526304541|FG000|Overall Study|Withdrawal by Subject|3|||
145944372|NCT00948506|526304542|FG001|Overall Study|Withdrawal by Subject|1|||
145944373|NCT00157248|526304543|FG000|Overall Study|Adverse Event|36|||
145944374|NCT00157248|526304544|FG001|Overall Study|Adverse Event|25|||
145944375|NCT00157248|526304545|FG002|Overall Study|Adverse Event|13|||
145944376|NCT00157248|526304546|FG003|Overall Study|Adverse Event|33|||
145944377|NCT00157248|526304543|FG000|Overall Study|Protocol Violation|4|||
145944378|NCT00157248|526304544|FG001|Overall Study|Protocol Violation|0|||
145944379|NCT00157248|526304545|FG002|Overall Study|Protocol Violation|2|||
145944380|NCT00157248|526304546|FG003|Overall Study|Protocol Violation|2|||
145944381|NCT00157248|526304543|FG000|Overall Study|Lost to Follow-up|0|||
145944382|NCT00157248|526304544|FG001|Overall Study|Lost to Follow-up|1|||
145944383|NCT00157248|526304545|FG002|Overall Study|Lost to Follow-up|0|||
145944384|NCT00157248|526304546|FG003|Overall Study|Lost to Follow-up|0|||
145944385|NCT00157248|526304543|FG000|Overall Study|Withdrawal by Subject|1|||
145944386|NCT00157248|526304544|FG001|Overall Study|Withdrawal by Subject|4|||
145944387|NCT00157248|526304545|FG002|Overall Study|Withdrawal by Subject|3|||
145944388|NCT00157248|526304546|FG003|Overall Study|Withdrawal by Subject|3|||
145944389|NCT00157248|526304543|FG000|Overall Study|site closures, subject moving|7|||
145944390|NCT00157248|526304544|FG001|Overall Study|site closures, subject moving|7|||
145944391|NCT00157248|526304545|FG002|Overall Study|site closures, subject moving|3|||
145944392|NCT00157248|526304546|FG003|Overall Study|site closures, subject moving|9|||
145944393|NCT01447927|526304547|FG000|Overall Study|Adverse Event|4|||
145944394|NCT01447927|526304548|FG001|Overall Study|Adverse Event|3|||
145944395|NCT01447927|526304547|FG000|Overall Study|Withdrawal by Subject|1|||
145944396|NCT01447927|526304548|FG001|Overall Study|Withdrawal by Subject|0|||
145944397|NCT02093390|526304553|FG000|Overall Study|Withdrawal by Subject|0|||
145944398|NCT02093390|526304554|FG001|Overall Study|Withdrawal by Subject|1|||
145944399|NCT03334422|526306140|FG000|Overall Study|Adverse Event|1|||
145944400|NCT03334422|526306141|FG001|Overall Study|Adverse Event|3|||
145944401|NCT03334422|526306142|FG002|Overall Study|Adverse Event|2|||
145944402|NCT03334422|526306143|FG003|Overall Study|Adverse Event|2|||
145944403|NCT03334422|526306140|FG000|Overall Study|Lack of Efficacy|10|||
145944404|NCT03334422|526306141|FG001|Overall Study|Lack of Efficacy|2|||
145944405|NCT03334422|526306142|FG002|Overall Study|Lack of Efficacy|7|||
145944406|NCT03334422|526306143|FG003|Overall Study|Lack of Efficacy|3|||
145944407|NCT03334422|526306140|FG000|Overall Study|Withdrawal by Subject|8|||
145944408|NCT03334422|526306141|FG001|Overall Study|Withdrawal by Subject|3|||
145944409|NCT03334422|526306142|FG002|Overall Study|Withdrawal by Subject|1|||
145944410|NCT03334422|526306143|FG003|Overall Study|Withdrawal by Subject|0|||
145944411|NCT03334422|526306140|FG000|Overall Study|Lost to Follow-up|0|||
145944412|NCT03334422|526306141|FG001|Overall Study|Lost to Follow-up|0|||
145944413|NCT03334422|526306142|FG002|Overall Study|Lost to Follow-up|0|||
145944414|NCT03334422|526306143|FG003|Overall Study|Lost to Follow-up|1|||
145944415|NCT03334422|526306140|FG000|Overall Study|Inability to obtain laboratory samples|0|||
145944416|NCT03334422|526306141|FG001|Overall Study|Inability to obtain laboratory samples|1|||
145944417|NCT03334422|526306142|FG002|Overall Study|Inability to obtain laboratory samples|0|||
145944418|NCT03334422|526306143|FG003|Overall Study|Inability to obtain laboratory samples|0|||
145944419|NCT03334422|526306140|FG000|Overall Study|Pregnancy|0|||
145944420|NCT03334422|526306141|FG001|Overall Study|Pregnancy|1|||
145944421|NCT03334422|526306142|FG002|Overall Study|Pregnancy|0|||
145944422|NCT03334422|526306143|FG003|Overall Study|Pregnancy|0|||
145944423|NCT01313221|526306144|FG000|Overall Study|Protocol Violation|0|||
145944424|NCT01313221|526306145|FG001|Overall Study|Protocol Violation|1|||
145944425|NCT01313221|526306146|FG002|Overall Study|Protocol Violation|1|||
145944426|NCT01313221|526306144|FG000|Overall Study|Non-compliance|3|||
145944427|NCT01313221|526306145|FG001|Overall Study|Non-compliance|0|||
145944428|NCT01313221|526306146|FG002|Overall Study|Non-compliance|2|||
145944429|NCT01313221|526306144|FG000|Overall Study|Withdrawal by Subject|2|||
145944430|NCT01313221|526306145|FG001|Overall Study|Withdrawal by Subject|3|||
145944431|NCT01313221|526306146|FG002|Overall Study|Withdrawal by Subject|5|||
145944432|NCT01313221|526306144|FG000|Overall Study|Requirement for alternative therapy|0|||
145944433|NCT01313221|526306145|FG001|Overall Study|Requirement for alternative therapy|1|||
145944434|NCT01313221|526306146|FG002|Overall Study|Requirement for alternative therapy|1|||
145944435|NCT01313221|526306144|FG000|Overall Study|Lost to Follow-up|6|||
145944436|NCT01313221|526306145|FG001|Overall Study|Lost to Follow-up|3|||
145944437|NCT01313221|526306146|FG002|Overall Study|Lost to Follow-up|1|||
145944438|NCT01313221|526306144|FG000|Overall Study|Other|1|||
145944439|NCT01313221|526306145|FG001|Overall Study|Other|0|||
145944440|NCT01313221|526306146|FG002|Overall Study|Other|0|||
145944441|NCT01313221|526306144|FG000|Overall Study|Adverse Event|0|||
145944442|NCT01313221|526306145|FG001|Overall Study|Adverse Event|0|||
145944443|NCT01313221|526306146|FG002|Overall Study|Adverse Event|7|||
145944444|NCT01313221|526306144|FG000|Overall Study|Disease progression|0|||
145944445|NCT01313221|526306145|FG001|Overall Study|Disease progression|0|||
145944446|NCT01313221|526306146|FG002|Overall Study|Disease progression|2|||
145944447|NCT01313221|526306144|FG000|Overall Study|Physician Decision|0|||
145944448|NCT01313221|526306145|FG001|Overall Study|Physician Decision|0|||
145944449|NCT01313221|526306146|FG002|Overall Study|Physician Decision|2|||
145944450|NCT01313221|526306144|FG000|Overall Study|Pregnancy|0|||
145944451|NCT01313221|526306145|FG001|Overall Study|Pregnancy|0|||
145944452|NCT01313221|526306146|FG002|Overall Study|Pregnancy|2|||
145944453|NCT02864316|526306151|FG000|Overall Study|Progressive Disease|2|||
145944454|NCT02864316|526306152|FG001|Overall Study|Progressive Disease|1|||
145944455|NCT02864316|526306151|FG000|Overall Study|Adverse Event|0|||
145944456|NCT02864316|526306152|FG001|Overall Study|Adverse Event|1|||
145944457|NCT05459558|526306153|FG000|Overall Study|Adverse Event|1|||
145944458|NCT05459558|526306154|FG001|Overall Study|Adverse Event|0|||
145944459|NCT05459558|526306155|FG002|Overall Study|Adverse Event|0|||
146056800|NCT01602224|526725452|FG002|Overall Study|Lost to Follow-up|1|||
145944460|NCT05459558|526306153|FG000|Overall Study|Scheduling issue|0|||
145944461|NCT05459558|526306154|FG001|Overall Study|Scheduling issue|1|||
145944462|NCT05459558|526306155|FG002|Overall Study|Scheduling issue|3|||
145944463|NCT05459558|526306153|FG000|Overall Study|Withdrawal by Subject|0|||
145944464|NCT05459558|526306154|FG001|Overall Study|Withdrawal by Subject|0|||
145944465|NCT05459558|526306155|FG002|Overall Study|Withdrawal by Subject|2|||
145944466|NCT01887288|526306160|FG000|Overall Study|The study was terminated and the PI has|16|||
145944467|NCT01092637|526306161|FG000|Overall Study|Death|47|||
145944468|NCT01092637|526306162|FG001|Overall Study|Death|49|||
145944469|NCT02921750|526306163|FG000|Overall Study|Adverse Event|1|||
145944470|NCT02921750|526306164|FG001|Overall Study|Adverse Event|2|||
145944471|NCT02921750|526306163|FG000|Overall Study|Withdrawal by Subject|1|||
145944472|NCT02921750|526306164|FG001|Overall Study|Withdrawal by Subject|1|||
145944473|NCT02921750|526306163|FG000|Overall Study|Lost to Follow-up|3|||
145944474|NCT02921750|526306164|FG001|Overall Study|Lost to Follow-up|3|||
145944475|NCT02921750|526306163|FG000|Overall Study|Wound healed|3|||
145944476|NCT02921750|526306164|FG001|Overall Study|Wound healed|3|||
145944477|NCT02921750|526306163|FG000|Overall Study|Serious Adverse Event|1|||
145944478|NCT02921750|526306164|FG001|Overall Study|Serious Adverse Event|2|||
145944479|NCT03292458|526306165|FG000|Period 1|Adverse Event|2|||
145944480|NCT03292458|526306166|FG001|Period 1|Adverse Event|0|||
145944481|NCT02278367|526306167|FG000|Overall Study|Physician Decision|5|||
145944482|NCT02278367|526306168|FG001|Overall Study|Physician Decision|0|||
145944483|NCT02278367|526306167|FG000|Overall Study|Withdrawal by Subject|5|||
145944484|NCT02278367|526306168|FG001|Overall Study|Withdrawal by Subject|0|||
145944485|NCT04643964|526306170|FG000|Overall Study|Lost to Follow-up|55|||
145944486|NCT04643964|526306171|FG001|Overall Study|Lost to Follow-up|59|||
145944487|NCT04643964|526306172|FG002|Overall Study|Lost to Follow-up|54|||
145944488|NCT04643964|526306173|FG003|Overall Study|Lost to Follow-up|129|||
145944489|NCT04643964|526306174|FG004|Overall Study|Lost to Follow-up|48|||
145944490|NCT04643964|526306170|FG000|Overall Study|Failed attention check|1|||
145944491|NCT04643964|526306171|FG001|Overall Study|Failed attention check|8|||
145944492|NCT04643964|526306172|FG002|Overall Study|Failed attention check|2|||
145944493|NCT04643964|526306173|FG003|Overall Study|Failed attention check|14|||
145944494|NCT04643964|526306174|FG004|Overall Study|Failed attention check|11|||
145944495|NCT02638129|526306175|FG000|Overall Study|Study terminated|28|||
145944496|NCT02638129|526306176|FG001|Overall Study|Study terminated|30|||
145944497|NCT00869557|526306179|FG000|Randomized Phase|Lost to Follow-up|2|||
145944498|NCT00869557|526306180|FG001|Randomized Phase|Lost to Follow-up|1|||
145944499|NCT00869557|526306179|FG000|Randomized Phase|Investigator's Discretion|1|||
145944500|NCT00869557|526306180|FG001|Randomized Phase|Investigator's Discretion|0|||
145944501|NCT00869557|526306179|FG000|Randomized Phase|Withdrew Consent|0|||
145944502|NCT00869557|526306180|FG001|Randomized Phase|Withdrew Consent|1|||
145944503|NCT00869557|526306179|FG000|Extension Phase|Adverse Event|2|||
145944504|NCT00869557|526306180|FG001|Extension Phase|Adverse Event|2|||
145944505|NCT00869557|526306179|FG000|Extension Phase|Lack of Efficacy|1|||
145944506|NCT00869557|526306180|FG001|Extension Phase|Lack of Efficacy|0|||
145944507|NCT00869557|526306179|FG000|Extension Phase|Lost to Follow-up|3|||
145944508|NCT00869557|526306180|FG001|Extension Phase|Lost to Follow-up|1|||
145944509|NCT00869557|526306179|FG000|Extension Phase|Investigator's Discretion|2|||
145944510|NCT00869557|526306180|FG001|Extension Phase|Investigator's Discretion|0|||
145944511|NCT00869557|526306179|FG000|Extension Phase|Withdrew Consent|2|||
145944512|NCT00869557|526306180|FG001|Extension Phase|Withdrew Consent|0|||
145944513|NCT01472939|526306181|FG000|Overall Study|Adverse Event|3|||
145944514|NCT01472939|526306182|FG001|Overall Study|Adverse Event|7|||
146396503|NCT00594568|527956591|FG002|Delayed Start|Physician Decision|1|||
146396504|NCT00594568|527956589|FG000|Delayed Start|Lost to Follow-up|0|||
146396505|NCT00594568|527956590|FG001|Delayed Start|Lost to Follow-up|0|||
146396506|NCT00594568|527956591|FG002|Delayed Start|Lost to Follow-up|1|||
146396507|NCT00594568|527956589|FG000|Delayed Start|Caregiver Decision|5|||
146396508|NCT00594568|527956590|FG001|Delayed Start|Caregiver Decision|6|||
146396509|NCT00594568|527956591|FG002|Delayed Start|Caregiver Decision|2|||
146396510|NCT00594568|527956589|FG000|Delayed Start|Sponsor Decision|77|||
146396511|NCT00594568|527956590|FG001|Delayed Start|Sponsor Decision|66|||
146396512|NCT00594568|527956591|FG002|Delayed Start|Sponsor Decision|59|||
146396513|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
146396514|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
145944515|NCT01472939|526306183|FG002|Overall Study|Adverse Event|7|||
145944516|NCT01472939|526306184|FG003|Overall Study|Adverse Event|14|||
145944517|NCT01472939|526306181|FG000|Overall Study|Lack of Efficacy|1|||
145944518|NCT01472939|526306182|FG001|Overall Study|Lack of Efficacy|0|||
145944519|NCT01472939|526306183|FG002|Overall Study|Lack of Efficacy|0|||
145944520|NCT01472939|526306184|FG003|Overall Study|Lack of Efficacy|1|||
145944521|NCT01472939|526306181|FG000|Overall Study|Lost to Follow-up|3|||
145944522|NCT01472939|526306182|FG001|Overall Study|Lost to Follow-up|0|||
145944523|NCT01472939|526306183|FG002|Overall Study|Lost to Follow-up|2|||
145944524|NCT01472939|526306184|FG003|Overall Study|Lost to Follow-up|0|||
146056801|NCT01602224|526725450|FG000|Overall Study|Protocol Violation|0|||
146056802|NCT01602224|526725451|FG001|Overall Study|Protocol Violation|1|||
145944525|NCT01472939|526306181|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145944526|NCT01472939|526306182|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145944527|NCT01472939|526306183|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
145944528|NCT01472939|526306184|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145944529|NCT01472939|526306181|FG000|Overall Study|Prohibited Medication|0|||
145944530|NCT01472939|526306182|FG001|Overall Study|Prohibited Medication|1|||
145944531|NCT01472939|526306183|FG002|Overall Study|Prohibited Medication|0|||
146056803|NCT01602224|526725452|FG002|Overall Study|Protocol Violation|0|||
145944532|NCT01472939|526306184|FG003|Overall Study|Prohibited Medication|0|||
145944533|NCT01472939|526306181|FG000|Overall Study|Withdrawal By PI|1|||
145944534|NCT01472939|526306182|FG001|Overall Study|Withdrawal By PI|0|||
145944535|NCT01472939|526306183|FG002|Overall Study|Withdrawal By PI|0|||
145944536|NCT01472939|526306184|FG003|Overall Study|Withdrawal By PI|0|||
145944537|NCT01472939|526306181|FG000|Overall Study|Protocol Violation|3|||
145944538|NCT01472939|526306182|FG001|Overall Study|Protocol Violation|3|||
145944539|NCT01472939|526306183|FG002|Overall Study|Protocol Violation|0|||
145944540|NCT01472939|526306184|FG003|Overall Study|Protocol Violation|1|||
145944541|NCT01472939|526306181|FG000|Overall Study|Withdrawal by Subject|9|||
145944542|NCT01472939|526306182|FG001|Overall Study|Withdrawal by Subject|3|||
145944543|NCT01472939|526306183|FG002|Overall Study|Withdrawal by Subject|1|||
145944544|NCT01472939|526306184|FG003|Overall Study|Withdrawal by Subject|4|||
145944545|NCT00114738|526306185|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
145944546|NCT00114738|526306186|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
145944547|NCT00114738|526306187|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
145944548|NCT00114738|526306185|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
145944549|NCT00114738|526306186|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
145944550|NCT00114738|526306187|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
145944551|NCT00114738|526306185|FG000|Screening for Randomization|Neuropathy|17|||
145944552|NCT00114738|526306186|FG001|Screening for Randomization|Neuropathy|0|||
145944553|NCT00114738|526306187|FG002|Screening for Randomization|Neuropathy|0|||
145944554|NCT00114738|526306185|FG000|Screening for Randomization|Progressive disease|2|||
145944555|NCT00114738|526306186|FG001|Screening for Randomization|Progressive disease|0|||
145944556|NCT00114738|526306187|FG002|Screening for Randomization|Progressive disease|0|||
145944557|NCT00114738|526306185|FG000|Screening for Randomization|CNS Hemorrhage|1|||
145944558|NCT00114738|526306186|FG001|Screening for Randomization|CNS Hemorrhage|0|||
145944559|NCT00114738|526306187|FG002|Screening for Randomization|CNS Hemorrhage|0|||
145944560|NCT00114738|526306185|FG000|Screening for Randomization|Other|1|||
145944561|NCT00114738|526306186|FG001|Screening for Randomization|Other|0|||
145944562|NCT00114738|526306187|FG002|Screening for Randomization|Other|0|||
145944563|NCT02368210|526306188|FG000|Overall Study|Withdrawal by Subject|1|||
145944564|NCT02368210|526306189|FG001|Overall Study|Withdrawal by Subject|0|||
145944565|NCT02368210|526306188|FG000|Overall Study|Adverse Event|0|||
145944566|NCT02368210|526306189|FG001|Overall Study|Adverse Event|1|||
145944567|NCT01492101|526306190|FG000|Overall Study|Death|323|||
145944568|NCT01492101|526306191|FG001|Overall Study|Death|322|||
145944569|NCT01492101|526306190|FG000|Overall Study|Withdrawal by Subject|14|||
145944570|NCT01492101|526306191|FG001|Overall Study|Withdrawal by Subject|18|||
145944571|NCT01492101|526306190|FG000|Overall Study|Lost to Follow-up|0|||
145944572|NCT01492101|526306191|FG001|Overall Study|Lost to Follow-up|2|||
145944573|NCT00316914|526306192|FG000|Overall Study|Withdrawal by Subject|5|||
145944574|NCT00316914|526306193|FG001|Overall Study|Withdrawal by Subject|3|||
145944575|NCT00316914|526306192|FG000|Overall Study|Adverse Event|8|||
145944576|NCT00316914|526306193|FG001|Overall Study|Adverse Event|7|||
145944577|NCT00316914|526306192|FG000|Overall Study|Other Problems|6|||
145944578|NCT00316914|526306193|FG001|Overall Study|Other Problems|11|||
145944579|NCT00316914|526306192|FG000|Overall Study|Missing end of treatment documentation|14|||
145944580|NCT00316914|526306193|FG001|Overall Study|Missing end of treatment documentation|15|||
145944581|NCT01675154|526306194|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145944582|NCT01675154|526306195|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
145944583|NCT01675154|526306196|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145944584|NCT01675154|526306197|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145944585|NCT02971800|526306198|FG000|Overall Study|Protocol Violation|1|||
145944586|NCT02971800|526306198|FG000|Overall Study|Withdrawal by Subject|1|||
145944587|NCT02971800|526306198|FG000|Overall Study|Exclusion criteria prior intervention|1|||
145944588|NCT02971800|526306198|FG000|Overall Study|Number evaluable participant already reached|4|||
145944589|NCT01149421|526306202|FG000|Overall Study|Adverse Event|22|||
145944590|NCT01149421|526306203|FG001|Overall Study|Adverse Event|6|||
145944591|NCT01149421|526306204|FG002|Overall Study|Adverse Event|11|||
145944592|NCT01149421|526306202|FG000|Overall Study|Withdrawal by Subject|20|||
145944593|NCT01149421|526306203|FG001|Overall Study|Withdrawal by Subject|12|||
145944594|NCT01149421|526306204|FG002|Overall Study|Withdrawal by Subject|13|||
145944595|NCT01149421|526306202|FG000|Overall Study|Sponsor Decision|0|||
145944596|NCT01149421|526306203|FG001|Overall Study|Sponsor Decision|1|||
145944597|NCT01149421|526306204|FG002|Overall Study|Sponsor Decision|1|||
145944598|NCT01149421|526306202|FG000|Overall Study|Lost to Follow-up|2|||
145944599|NCT01149421|526306203|FG001|Overall Study|Lost to Follow-up|4|||
145944600|NCT01149421|526306204|FG002|Overall Study|Lost to Follow-up|5|||
145944601|NCT01149421|526306202|FG000|Overall Study|Physician Decision|5|||
145944602|NCT01149421|526306203|FG001|Overall Study|Physician Decision|3|||
145944603|NCT01149421|526306204|FG002|Overall Study|Physician Decision|6|||
145944604|NCT01149421|526306202|FG000|Overall Study|Entry Criteria Not Met|1|||
145944605|NCT01149421|526306203|FG001|Overall Study|Entry Criteria Not Met|1|||
145944606|NCT01149421|526306204|FG002|Overall Study|Entry Criteria Not Met|2|||
145944607|NCT01149421|526306202|FG000|Overall Study|Protocol Violation|2|||
145944608|NCT01149421|526306203|FG001|Overall Study|Protocol Violation|2|||
145944609|NCT01149421|526306204|FG002|Overall Study|Protocol Violation|6|||
145944610|NCT00616603|526306205|FG000|Overall Study|Physician Decision|2|||
145944611|NCT00616603|526306206|FG001|Overall Study|Physician Decision|0|||
145944612|NCT00616603|526306207|FG002|Overall Study|Physician Decision|2|||
145944613|NCT03738800|526306213|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
145944614|NCT03738800|526306214|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145944615|NCT03738800|526306215|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145944616|NCT03738800|526306213|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
145944617|NCT03738800|526306214|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
145944618|NCT03738800|526306215|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
145944619|NCT03738800|526306213|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
145944620|NCT03738800|526306214|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145944621|NCT03738800|526306215|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
145944622|NCT02223819|526306221|FG000|Overall Study|Lost to Follow-up|2|||
145944623|NCT01917344|526306223|FG000|Overall Study|Withdrawal by Subject|1|||
145944624|NCT02956057|526306224|FG000|Overall Study|Discontinued intervention|14|||
145944625|NCT02956057|526306225|FG001|Overall Study|Discontinued intervention|10|||
145944626|NCT02956057|526306226|FG002|Overall Study|Discontinued intervention|7|||
145944627|NCT02956057|526306227|FG003|Overall Study|Discontinued intervention|14|||
145944628|NCT02956057|526306228|FG004|Overall Study|Discontinued intervention|4|||
145944629|NCT02956057|526306229|FG005|Overall Study|Discontinued intervention|17|||
145944630|NCT02956057|526306224|FG000|Overall Study|Lost to Follow-up|0|||
145944631|NCT02956057|526306225|FG001|Overall Study|Lost to Follow-up|2|||
145944632|NCT02956057|526306226|FG002|Overall Study|Lost to Follow-up|1|||
145944633|NCT02956057|526306227|FG003|Overall Study|Lost to Follow-up|1|||
145944634|NCT02956057|526306228|FG004|Overall Study|Lost to Follow-up|1|||
145944635|NCT02956057|526306229|FG005|Overall Study|Lost to Follow-up|0|||
145944636|NCT03435224|526306232|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
145944637|NCT00367484|526306233|FG000|Overall Study|Adverse Event|7|||
145944638|NCT00367484|526306233|FG000|Overall Study|Withdrew informed consent|5|||
145944639|NCT00367484|526306233|FG000|Overall Study|Travel to USA|1|||
145944640|NCT00367484|526306233|FG000|Overall Study|Lost to Follow-up|1|||
145944641|NCT00367484|526306233|FG000|Overall Study|Protocol Violation|1|||
145944642|NCT00367484|526306233|FG000|Overall Study|The choice of the patient|1|||
145944643|NCT00367484|526306233|FG000|Overall Study|Lack of Efficacy|1|||
145944644|NCT04007107|526306234|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145944645|NCT04007107|526306235|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
145944646|NCT04007107|526306236|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145944647|NCT04007107|526306237|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145944648|NCT04526574|526306238|FG000|Overall Study|Protocol Violation|3|||
145944649|NCT04526574|526306239|FG001|Overall Study|Protocol Violation|1|||
145944650|NCT04526574|526306238|FG000|Overall Study|Withdrawal by Subject|12|||
145944651|NCT04526574|526306239|FG001|Overall Study|Withdrawal by Subject|9|||
145944652|NCT04526574|526306238|FG000|Overall Study|Other|1|||
145944653|NCT04526574|526306239|FG001|Overall Study|Other|2|||
145944654|NCT04526574|526306238|FG000|Overall Study|Adverse Event|1|||
145944655|NCT04526574|526306239|FG001|Overall Study|Adverse Event|1|||
145944656|NCT04526574|526306238|FG000|Overall Study|Death|2|||
145944657|NCT04526574|526306239|FG001|Overall Study|Death|3|||
145944658|NCT04526574|526306238|FG000|Overall Study|Lost to Follow-up|9|||
145944659|NCT04526574|526306239|FG001|Overall Study|Lost to Follow-up|9|||
145944660|NCT04526574|526306238|FG000|Overall Study|No longer meets eligibility criteria|8|||
145944661|NCT04526574|526306239|FG001|Overall Study|No longer meets eligibility criteria|8|||
145944662|NCT04679051|526306245|FG000|Overall Study|felt tired after restricted time in bed|3|||
145944663|NCT04679051|526306246|FG001|Overall Study|felt tired after restricted time in bed|0|||
145944664|NCT04679051|526306245|FG000|Overall Study|discomfort with blood pressure cuff|2|||
145944665|NCT04679051|526306246|FG001|Overall Study|discomfort with blood pressure cuff|0|||
145944666|NCT04679051|526306245|FG000|Overall Study|scheduling conflict|1|||
145944667|NCT04679051|526306246|FG001|Overall Study|scheduling conflict|1|||
145944668|NCT04679051|526306245|FG000|Overall Study|Protocol Violation|0|||
145944669|NCT04679051|526306246|FG001|Overall Study|Protocol Violation|4|||
145944670|NCT00426660|526306247|FG000|Overall Study|Death|14|||
145944671|NCT00426660|526306247|FG000|Overall Study|Adverse Event|23|||
145944672|NCT00426660|526306247|FG000|Overall Study|Insufficient Clinical Response|22|||
145944673|NCT00426660|526306247|FG000|Overall Study|Lost to Follow-up|15|||
145944674|NCT00426660|526306247|FG000|Overall Study|Other|23|||
145944675|NCT00426660|526306247|FG000|Overall Study|Withdrawal by Subject|18|||
145944676|NCT00426660|526306247|FG000|Overall Study|Protocol Violation|1|||
145944677|NCT00426660|526306247|FG000|Overall Study|Enrolled Not Treated|15|||
146056804|NCT01602224|526725450|FG000|Overall Study|Sponsor Decision|2|||
145944678|NCT00980174|526306248|FG000|Overall Study|Withdrawal by Subject|1|||
145944679|NCT00980174|526306249|FG001|Overall Study|Withdrawal by Subject|4|||
145944680|NCT00980174|526306248|FG000|Overall Study|Adverse Event|0|||
145944681|NCT00980174|526306249|FG001|Overall Study|Adverse Event|3|||
145944682|NCT00980174|526306248|FG000|Overall Study|Ineligibility determined|2|||
145944683|NCT00980174|526306249|FG001|Overall Study|Ineligibility determined|1|||
145944684|NCT00980174|526306248|FG000|Overall Study|Death|1|||
146056805|NCT01602224|526725451|FG001|Overall Study|Sponsor Decision|3|||
145944685|NCT00980174|526306249|FG001|Overall Study|Death|1|||
145944686|NCT00980174|526306248|FG000|Overall Study|Other|0|||
145944687|NCT00980174|526306249|FG001|Overall Study|Other|1|||
145944688|NCT00329641|526306251|FG000|Overall Study|Did not start treatment|1|||
145944689|NCT00329641|526306251|FG000|Overall Study|Not eligible|1|||
145944690|NCT00329641|526306251|FG000|Overall Study|Adverse Event|3|||
145944691|NCT00329641|526306251|FG000|Overall Study|Other reason, not protocol specified|1|||
145944692|NCT00396877|526306253|FG000|Overall Study|Lost to Follow-up|2|||
145944693|NCT00396877|526306254|FG001|Overall Study|Lost to Follow-up|1|||
145944694|NCT00396877|526306253|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
145944695|NCT00396877|526306254|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
145944696|NCT02945254|526306255|FG000|Overall Study|Lost to Follow-up|1|||
145944697|NCT02945254|526306256|FG001|Overall Study|Lost to Follow-up|0|||
145944698|NCT02945254|526306255|FG000|Overall Study|Withdrawal by Subject|1|||
145944699|NCT02945254|526306256|FG001|Overall Study|Withdrawal by Subject|0|||
145944700|NCT00334802|526306257|FG000|Overall Study|Progressive Disease|2|||
145944701|NCT00334802|526306258|FG001|Overall Study|Progressive Disease|24|||
145944702|NCT00334802|526306257|FG000|Overall Study|Toxicity|1|||
145944703|NCT00334802|526306258|FG001|Overall Study|Toxicity|5|||
145944704|NCT00334802|526306257|FG000|Overall Study|Lack of Efficacy|1|||
145944705|NCT00334802|526306258|FG001|Overall Study|Lack of Efficacy|3|||
145944706|NCT00334802|526306257|FG000|Overall Study|Patient Condition Aggrevated|1|||
145944707|NCT00334802|526306258|FG001|Overall Study|Patient Condition Aggrevated|0|||
145944708|NCT00334802|526306257|FG000|Overall Study|Physician Decision|1|||
145944709|NCT00334802|526306258|FG001|Overall Study|Physician Decision|0|||
145944710|NCT00334802|526306257|FG000|Overall Study|Withdrawal by Subject|0|||
145944711|NCT00334802|526306258|FG001|Overall Study|Withdrawal by Subject|4|||
145944712|NCT00334802|526306257|FG000|Overall Study|Adverse Event|0|||
145944713|NCT00334802|526306258|FG001|Overall Study|Adverse Event|3|||
145944714|NCT00334802|526306257|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
145944715|NCT00334802|526306258|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
145944716|NCT02470403|526306259|FG000|Overall Study|Adverse Event|1|||
145944717|NCT02470403|526306260|FG001|Overall Study|Adverse Event|0|||
145944718|NCT02470403|526306261|FG002|Overall Study|Adverse Event|0|||
145944719|NCT02470403|526306262|FG003|Overall Study|Adverse Event|0|||
145944720|NCT02470403|526306263|FG004|Overall Study|Adverse Event|0|||
145944721|NCT02470403|526306259|FG000|Overall Study|Lost to Follow-up|0|||
145944722|NCT02470403|526306260|FG001|Overall Study|Lost to Follow-up|1|||
145944723|NCT02470403|526306261|FG002|Overall Study|Lost to Follow-up|0|||
145944724|NCT02470403|526306262|FG003|Overall Study|Lost to Follow-up|0|||
145944725|NCT02470403|526306263|FG004|Overall Study|Lost to Follow-up|0|||
145944726|NCT02470403|526306259|FG000|Overall Study|Subject/guardian decision|1|||
145944727|NCT02470403|526306260|FG001|Overall Study|Subject/guardian decision|0|||
145944728|NCT02470403|526306261|FG002|Overall Study|Subject/guardian decision|0|||
145944729|NCT02470403|526306262|FG003|Overall Study|Subject/guardian decision|4|||
145944730|NCT02470403|526306263|FG004|Overall Study|Subject/guardian decision|0|||
145944731|NCT03422159|526306264|FG000|Overall Study|Exclusion due to terminal disease|2|||
145944732|NCT03422159|526306265|FG001|Overall Study|Exclusion due to terminal disease|1|||
145944733|NCT03329248|526306266|FG000|Overall Study|Progressive Disease|6|||
145944734|NCT01886781|526306267|FG000|Overall Study|Protocol Violation|5|||
145944735|NCT01886781|526306268|FG001|Overall Study|Protocol Violation|0|||
145944736|NCT01886781|526306267|FG000|Overall Study|Adverse Event|1|||
145944737|NCT01886781|526306268|FG001|Overall Study|Adverse Event|0|||
145944738|NCT01886781|526306267|FG000|Overall Study|Lost to Follow-up|5|||
145944739|NCT01886781|526306268|FG001|Overall Study|Lost to Follow-up|0|||
145944740|NCT01886781|526306267|FG000|Overall Study|Withdrawal by Subject|2|||
145944741|NCT01886781|526306268|FG001|Overall Study|Withdrawal by Subject|1|||
145944742|NCT01886781|526306267|FG000|Overall Study|Worsening of symptoms|1|||
145944743|NCT01886781|526306268|FG001|Overall Study|Worsening of symptoms|1|||
145944744|NCT01522235|526306269|FG000|Overall Study|Physician Decision|1|||
145944745|NCT01522235|526306270|FG001|Overall Study|Physician Decision|1|||
145944746|NCT00987402|526306271|FG000|Overall Study|Insufficient data entry|86|||
145944747|NCT00987402|526306272|FG001|Overall Study|Insufficient data entry|98|||
145944748|NCT03000530|526306273|FG000|Overall Study|Adverse Event|0|||
145944749|NCT03000530|526306274|FG001|Overall Study|Adverse Event|0|||
145944750|NCT03000530|526306275|FG002|Overall Study|Adverse Event|2|||
145944751|NCT03000530|526306273|FG000|Overall Study|Lost to Follow-up|0|||
145944752|NCT03000530|526306274|FG001|Overall Study|Lost to Follow-up|3|||
145944753|NCT03000530|526306275|FG002|Overall Study|Lost to Follow-up|1|||
145944754|NCT03000530|526306273|FG000|Overall Study|Withdrawal by Subject|0|||
145944755|NCT03000530|526306274|FG001|Overall Study|Withdrawal by Subject|2|||
145944756|NCT03000530|526306275|FG002|Overall Study|Withdrawal by Subject|1|||
145944757|NCT01430624|526306279|FG000|Overall Study|Lost to Follow-up|23|||
145944758|NCT01430624|526306280|FG001|Overall Study|Lost to Follow-up|29|||
145944759|NCT01430624|526306281|FG002|Overall Study|Lost to Follow-up|27|||
145944760|NCT01430624|526306279|FG000|Overall Study|technical or eligibility|5|||
145944761|NCT01430624|526306280|FG001|Overall Study|technical or eligibility|5|||
145944762|NCT01430624|526306281|FG002|Overall Study|technical or eligibility|2|||
145944763|NCT01362517|526306282|FG000|Overall Study|Protocol Violation|1|||
145944764|NCT01362517|526306282|FG000|Overall Study|Lost to Follow-up|1|||
145944765|NCT00195494|526306287|FG000|Year 1|Adverse Event|0|||
145944766|NCT00195494|526306288|FG001|Year 1|Adverse Event|0|||
145944767|NCT00195494|526306289|FG002|Year 1|Adverse Event|0|||
145944768|NCT00195494|526306290|FG003|Year 1|Adverse Event|0|||
145944769|NCT00195494|526306291|FG004|Year 1|Adverse Event|34|||
145944770|NCT00195494|526306292|FG005|Year 1|Adverse Event|27|||
145944771|NCT00195494|526306287|FG000|Year 1|System Toxicity|0|||
145944772|NCT00195494|526306288|FG001|Year 1|System Toxicity|0|||
145944773|NCT00195494|526306289|FG002|Year 1|System Toxicity|0|||
145944774|NCT00195494|526306290|FG003|Year 1|System Toxicity|0|||
145944775|NCT00195494|526306291|FG004|Year 1|System Toxicity|0|||
145944776|NCT00195494|526306292|FG005|Year 1|System Toxicity|1|||
145944777|NCT00195494|526306287|FG000|Year 1|Lack of Efficacy|0|||
145944778|NCT00195494|526306288|FG001|Year 1|Lack of Efficacy|0|||
145944779|NCT00195494|526306289|FG002|Year 1|Lack of Efficacy|0|||
145944780|NCT00195494|526306290|FG003|Year 1|Lack of Efficacy|0|||
145944781|NCT00195494|526306291|FG004|Year 1|Lack of Efficacy|24|||
145944782|NCT00195494|526306292|FG005|Year 1|Lack of Efficacy|9|||
145944783|NCT00195494|526306287|FG000|Year 1|Compliance|0|||
145944784|NCT00195494|526306288|FG001|Year 1|Compliance|0|||
145944785|NCT00195494|526306289|FG002|Year 1|Compliance|0|||
145944786|NCT00195494|526306290|FG003|Year 1|Compliance|0|||
145944787|NCT00195494|526306291|FG004|Year 1|Compliance|5|||
145944788|NCT00195494|526306292|FG005|Year 1|Compliance|1|||
145944789|NCT00195494|526306287|FG000|Year 1|Lost to Follow-up|0|||
145944790|NCT00195494|526306288|FG001|Year 1|Lost to Follow-up|0|||
145944791|NCT00195494|526306289|FG002|Year 1|Lost to Follow-up|0|||
145944792|NCT00195494|526306290|FG003|Year 1|Lost to Follow-up|0|||
145944793|NCT00195494|526306291|FG004|Year 1|Lost to Follow-up|1|||
145944794|NCT00195494|526306292|FG005|Year 1|Lost to Follow-up|0|||
145944795|NCT00195494|526306287|FG000|Year 1|Missed >4 consecutive doses|0|||
145944796|NCT00195494|526306288|FG001|Year 1|Missed >4 consecutive doses|0|||
145944797|NCT00195494|526306289|FG002|Year 1|Missed >4 consecutive doses|0|||
145944798|NCT00195494|526306290|FG003|Year 1|Missed >4 consecutive doses|0|||
145944799|NCT00195494|526306291|FG004|Year 1|Missed >4 consecutive doses|3|||
145944800|NCT00195494|526306292|FG005|Year 1|Missed >4 consecutive doses|2|||
145944801|NCT00195494|526306287|FG000|Year 1|Protocol deviation|0|||
145944802|NCT00195494|526306288|FG001|Year 1|Protocol deviation|0|||
145944803|NCT00195494|526306289|FG002|Year 1|Protocol deviation|0|||
145944804|NCT00195494|526306290|FG003|Year 1|Protocol deviation|0|||
145944805|NCT00195494|526306291|FG004|Year 1|Protocol deviation|2|||
145944806|NCT00195494|526306292|FG005|Year 1|Protocol deviation|3|||
145944807|NCT00195494|526306287|FG000|Year 1|Physician Decision|0|||
145944808|NCT00195494|526306288|FG001|Year 1|Physician Decision|0|||
145944809|NCT00195494|526306289|FG002|Year 1|Physician Decision|0|||
145944810|NCT00195494|526306290|FG003|Year 1|Physician Decision|0|||
145944811|NCT00195494|526306291|FG004|Year 1|Physician Decision|1|||
145944812|NCT00195494|526306292|FG005|Year 1|Physician Decision|0|||
145944813|NCT00195494|526306287|FG000|Year 1|Withdrawal by Subject|0|||
145944814|NCT00195494|526306288|FG001|Year 1|Withdrawal by Subject|0|||
145944815|NCT00195494|526306289|FG002|Year 1|Withdrawal by Subject|0|||
145944816|NCT00195494|526306290|FG003|Year 1|Withdrawal by Subject|0|||
145944817|NCT00195494|526306291|FG004|Year 1|Withdrawal by Subject|8|||
145944818|NCT00195494|526306292|FG005|Year 1|Withdrawal by Subject|9|||
145944819|NCT00195494|526306287|FG000|Year 1|Protocol Violation|0|||
145944820|NCT00195494|526306288|FG001|Year 1|Protocol Violation|0|||
145944821|NCT00195494|526306289|FG002|Year 1|Protocol Violation|0|||
145944822|NCT00195494|526306290|FG003|Year 1|Protocol Violation|0|||
145944823|NCT00195494|526306291|FG004|Year 1|Protocol Violation|1|||
145944824|NCT00195494|526306292|FG005|Year 1|Protocol Violation|1|||
146056806|NCT01602224|526725452|FG002|Overall Study|Sponsor Decision|2|||
145944825|NCT00195494|526306287|FG000|Year 2|Adverse Event|3|||
145944826|NCT00195494|526306288|FG001|Year 2|Adverse Event|7|||
145944827|NCT00195494|526306289|FG002|Year 2|Adverse Event|5|||
146056807|NCT01602224|526725450|FG000|Overall Study|Withdrawal by Subject|5|||
145944828|NCT00195494|526306290|FG003|Year 2|Adverse Event|9|||
145944829|NCT00195494|526306291|FG004|Year 2|Adverse Event|0|||
145944830|NCT00195494|526306292|FG005|Year 2|Adverse Event|0|||
145944831|NCT00195494|526306287|FG000|Year 2|Lack of Efficacy|0|||
145944832|NCT00195494|526306288|FG001|Year 2|Lack of Efficacy|1|||
145944833|NCT00195494|526306289|FG002|Year 2|Lack of Efficacy|7|||
146056808|NCT01602224|526725451|FG001|Overall Study|Withdrawal by Subject|3|||
145944834|NCT00195494|526306290|FG003|Year 2|Lack of Efficacy|7|||
145944835|NCT00195494|526306291|FG004|Year 2|Lack of Efficacy|0|||
145944836|NCT00195494|526306292|FG005|Year 2|Lack of Efficacy|0|||
145944837|NCT00195494|526306287|FG000|Year 2|Compliance|1|||
145944838|NCT00195494|526306288|FG001|Year 2|Compliance|0|||
145944839|NCT00195494|526306289|FG002|Year 2|Compliance|0|||
145944840|NCT00195494|526306290|FG003|Year 2|Compliance|2|||
145944841|NCT00195494|526306291|FG004|Year 2|Compliance|0|||
145944842|NCT00195494|526306292|FG005|Year 2|Compliance|0|||
145944843|NCT00195494|526306287|FG000|Year 2|Lost to Follow-up|0|||
145944844|NCT00195494|526306288|FG001|Year 2|Lost to Follow-up|0|||
145944845|NCT00195494|526306289|FG002|Year 2|Lost to Follow-up|1|||
145944846|NCT00195494|526306290|FG003|Year 2|Lost to Follow-up|1|||
145944847|NCT00195494|526306291|FG004|Year 2|Lost to Follow-up|0|||
145944848|NCT00195494|526306292|FG005|Year 2|Lost to Follow-up|0|||
145944849|NCT00195494|526306287|FG000|Year 2|Missed >4 consecutive doses|1|||
145944850|NCT00195494|526306288|FG001|Year 2|Missed >4 consecutive doses|1|||
145944851|NCT00195494|526306289|FG002|Year 2|Missed >4 consecutive doses|1|||
145944852|NCT00195494|526306290|FG003|Year 2|Missed >4 consecutive doses|0|||
145944853|NCT00195494|526306291|FG004|Year 2|Missed >4 consecutive doses|0|||
145944854|NCT00195494|526306292|FG005|Year 2|Missed >4 consecutive doses|0|||
145944855|NCT00195494|526306287|FG000|Year 2|Protocol deviation|0|||
145944856|NCT00195494|526306288|FG001|Year 2|Protocol deviation|1|||
145944857|NCT00195494|526306289|FG002|Year 2|Protocol deviation|0|||
145944858|NCT00195494|526306290|FG003|Year 2|Protocol deviation|0|||
145944859|NCT00195494|526306291|FG004|Year 2|Protocol deviation|0|||
145944860|NCT00195494|526306292|FG005|Year 2|Protocol deviation|0|||
145944861|NCT00195494|526306287|FG000|Year 2|Physician Decision|1|||
145944862|NCT00195494|526306288|FG001|Year 2|Physician Decision|1|||
145944863|NCT00195494|526306289|FG002|Year 2|Physician Decision|0|||
145944864|NCT00195494|526306290|FG003|Year 2|Physician Decision|0|||
145944865|NCT00195494|526306291|FG004|Year 2|Physician Decision|0|||
145944866|NCT00195494|526306292|FG005|Year 2|Physician Decision|0|||
145944867|NCT00195494|526306287|FG000|Year 2|Withdrawal by Subject|1|||
145944868|NCT00195494|526306288|FG001|Year 2|Withdrawal by Subject|5|||
145944869|NCT00195494|526306289|FG002|Year 2|Withdrawal by Subject|4|||
145944870|NCT00195494|526306290|FG003|Year 2|Withdrawal by Subject|3|||
145944871|NCT00195494|526306291|FG004|Year 2|Withdrawal by Subject|0|||
145944872|NCT00195494|526306292|FG005|Year 2|Withdrawal by Subject|0|||
145944873|NCT00195494|526306287|FG000|Year 2|System toxicity|0|||
145944874|NCT00195494|526306288|FG001|Year 2|System toxicity|0|||
145944875|NCT00195494|526306289|FG002|Year 2|System toxicity|0|||
145944876|NCT00195494|526306290|FG003|Year 2|System toxicity|1|||
145944877|NCT00195494|526306291|FG004|Year 2|System toxicity|0|||
145944878|NCT00195494|526306292|FG005|Year 2|System toxicity|0|||
145944879|NCT02020512|526306293|FG000|Overall Study|Adverse Event|1|||
145944880|NCT02020512|526306293|FG000|Overall Study|Lost to Follow-up|3|||
145944881|NCT02020512|526306293|FG000|Overall Study|Protocol Violation|4|||
145944882|NCT04249622|526306294|FG000|Overall Study|Withdrawal by Subject|1|||
145944883|NCT04249622|526306295|FG001|Overall Study|Withdrawal by Subject|1|||
145944884|NCT04249622|526306294|FG000|Overall Study|Alternative therapy|1|||
145944885|NCT04249622|526306295|FG001|Overall Study|Alternative therapy|0|||
145944886|NCT04249622|526306294|FG000|Overall Study|Discontinuation of pertuzumab|1|||
145944887|NCT04249622|526306295|FG001|Overall Study|Discontinuation of pertuzumab|0|||
145944888|NCT04438499|526306304|FG000|Overall Study|Lack of Efficacy|3|||
145970776|NCT04889040|526407258|FG000|Overall Study|Withdrawal by Subject|3|||
145970777|NCT04889040|526407259|FG001|Overall Study|Withdrawal by Subject|3|||
145970778|NCT04889040|526407258|FG000|Overall Study|Lost to Follow-up|0|||
145970779|NCT04889040|526407259|FG001|Overall Study|Lost to Follow-up|1|||
145970780|NCT04889040|526407258|FG000|Overall Study|Adverse Event|2|||
145970781|NCT04889040|526407259|FG001|Overall Study|Adverse Event|1|||
145970782|NCT03183908|526407260|FG000|Overall Study|Missing Symptom Diary Data|0|||
145970783|NCT03183908|526407261|FG001|Overall Study|Missing Symptom Diary Data|2|||
146056809|NCT01602224|526725452|FG002|Overall Study|Withdrawal by Subject|3|||
146056810|NCT00633477|526725453|FG000|Overall Study|Death|1|||
146056811|NCT00633477|526725454|FG001|Overall Study|Death|0|||
146056812|NCT00633477|526725453|FG000|Overall Study|Randomized but not treated|1|||
146056813|NCT00633477|526725454|FG001|Overall Study|Randomized but not treated|0|||
146056814|NCT00770653|526725458|FG000|Overall Study|Adverse Event|13|||
146056815|NCT00770653|526725459|FG001|Overall Study|Adverse Event|5|||
146056816|NCT00770653|526725458|FG000|Overall Study|Protocol Violation|8|||
146056817|NCT00770653|526725459|FG001|Overall Study|Protocol Violation|6|||
146056818|NCT00770653|526725458|FG000|Overall Study|Withdrawal by Subject|4|||
146056819|NCT00770653|526725459|FG001|Overall Study|Withdrawal by Subject|7|||
146056820|NCT00770653|526725458|FG000|Overall Study|Lack of Compliance|1|||
146056821|NCT00770653|526725459|FG001|Overall Study|Lack of Compliance|4|||
146056822|NCT00770653|526725458|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
146056823|NCT00770653|526725459|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
146056824|NCT00770653|526725458|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
146056825|NCT00770653|526725459|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
146056826|NCT00770653|526725458|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
146056827|NCT00770653|526725459|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
146056828|NCT00770653|526725458|FG000|Overall Study|Lost to Follow-up|1|||
146056829|NCT00770653|526725459|FG001|Overall Study|Lost to Follow-up|2|||
146056830|NCT00770653|526725458|FG000|Overall Study|Physician Decision|1|||
146056831|NCT00770653|526725459|FG001|Overall Study|Physician Decision|0|||
145970784|NCT03738696|526407262|FG000|Overall Study|Withdrawal by Subject|0|||
145970785|NCT03738696|526407263|FG001|Overall Study|Withdrawal by Subject|1|||
145970786|NCT03738696|526407262|FG000|Overall Study|Lost to Follow-up|8|||
145970787|NCT03738696|526407263|FG001|Overall Study|Lost to Follow-up|14|||
145970788|NCT00726453|526407269|FG000|Primary Enrollment Group|Death|18|||
145970789|NCT00726453|526407270|FG001|Primary Enrollment Group|Death|0|||
146056832|NCT04906499|526725461|FG000|Overall Study|Lack of time|1|||
146056833|NCT00179621|526725462|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
146056834|NCT00179621|526725463|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
146056835|NCT00179621|526725464|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
146056836|NCT00179621|526725465|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
146056837|NCT00179621|526725462|FG000|Double-Blind Period|Adverse Event|2|||
146056838|NCT00179621|526725463|FG001|Double-Blind Period|Adverse Event|7|||
146056839|NCT00179621|526725464|FG002|Double-Blind Period|Adverse Event|4|||
146056840|NCT00179621|526725465|FG003|Double-Blind Period|Adverse Event|0|||
146056841|NCT00179621|526725462|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146056842|NCT00179621|526725463|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146056843|NCT00179621|526725464|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146056844|NCT00179621|526725465|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146056845|NCT00179621|526725462|FG000|Double-Blind Period|Death|0|||
146056846|NCT00179621|526725463|FG001|Double-Blind Period|Death|1|||
146056847|NCT00179621|526725464|FG002|Double-Blind Period|Death|2|||
146056848|NCT00179621|526725465|FG003|Double-Blind Period|Death|0|||
146056849|NCT00179621|526725462|FG000|Double-Blind Period|Protocol Violation|1|||
146056850|NCT00179621|526725463|FG001|Double-Blind Period|Protocol Violation|0|||
146056851|NCT00179621|526725464|FG002|Double-Blind Period|Protocol Violation|0|||
146056852|NCT00179621|526725465|FG003|Double-Blind Period|Protocol Violation|0|||
146056853|NCT00179621|526725462|FG000|Double-Blind Period|Other|0|||
146056854|NCT00179621|526725463|FG001|Double-Blind Period|Other|2|||
146056855|NCT00179621|526725464|FG002|Double-Blind Period|Other|2|||
146056856|NCT00179621|526725465|FG003|Double-Blind Period|Other|0|||
146056857|NCT00179621|526725462|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
146056858|NCT00179621|526725463|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
146056859|NCT00179621|526725464|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
146056860|NCT00179621|526725465|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
146056861|NCT00179621|526725462|FG000|Open-Label Period|Adverse Event|0|||
146056862|NCT00179621|526725463|FG001|Open-Label Period|Adverse Event|6|||
146056863|NCT00179621|526725464|FG002|Open-Label Period|Adverse Event|5|||
146056864|NCT00179621|526725465|FG003|Open-Label Period|Adverse Event|6|||
146056865|NCT00179621|526725462|FG000|Open-Label Period|Withdrawal by Subject|0|||
146056866|NCT00179621|526725463|FG001|Open-Label Period|Withdrawal by Subject|2|||
146056867|NCT00179621|526725464|FG002|Open-Label Period|Withdrawal by Subject|2|||
146056868|NCT00179621|526725465|FG003|Open-Label Period|Withdrawal by Subject|2|||
146056869|NCT00179621|526725462|FG000|Open-Label Period|Death|0|||
146056870|NCT00179621|526725463|FG001|Open-Label Period|Death|0|||
146056871|NCT00179621|526725464|FG002|Open-Label Period|Death|1|||
146056872|NCT00179621|526725465|FG003|Open-Label Period|Death|2|||
146056873|NCT00179621|526725462|FG000|Open-Label Period|Other|0|||
146056874|NCT00179621|526725463|FG001|Open-Label Period|Other|1|||
146056875|NCT00179621|526725464|FG002|Open-Label Period|Other|1|||
146056876|NCT00179621|526725465|FG003|Open-Label Period|Other|2|||
146056877|NCT03525444|526725470|FG000|Overall Study|Adverse Event|0|||
146056878|NCT03525444|526725471|FG001|Overall Study|Adverse Event|1|||
146056879|NCT03525444|526725470|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146056880|NCT03525444|526725471|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
146056881|NCT03525444|526725470|FG000|Overall Study|Other|0|||
146056882|NCT03525444|526725471|FG001|Overall Study|Other|1|||
146056883|NCT00262860|526725472|FG000|Overall Study|Adverse Event|2|||
146056884|NCT02741128|526725473|FG000|Overall Study|Protocol Violation|4|||
146056885|NCT02741128|526725474|FG001|Overall Study|Protocol Violation|1|||
146056886|NCT02741128|526725473|FG000|Overall Study|Withdrawal by Subject|2|||
146056887|NCT02741128|526725474|FG001|Overall Study|Withdrawal by Subject|0|||
146056888|NCT02741128|526725473|FG000|Overall Study|Lost to Follow-up|1|||
146056889|NCT02741128|526725474|FG001|Overall Study|Lost to Follow-up|0|||
146056890|NCT02973100|526725475|FG000|Overall Study|Adverse Event|1|||
146056891|NCT02973100|526725476|FG001|Overall Study|Adverse Event|2|||
146056892|NCT02973100|526725477|FG002|Overall Study|Adverse Event|1|||
146056893|NCT02973100|526725478|FG003|Overall Study|Adverse Event|2|||
146056894|NCT02973100|526725475|FG000|Overall Study|Lost to Follow-up|3|||
146056895|NCT02973100|526725476|FG001|Overall Study|Lost to Follow-up|1|||
146056896|NCT02973100|526725477|FG002|Overall Study|Lost to Follow-up|1|||
146056897|NCT02973100|526725478|FG003|Overall Study|Lost to Follow-up|0|||
146056898|NCT02973100|526725475|FG000|Overall Study|Withdrawal by Subject|3|||
146056899|NCT02973100|526725476|FG001|Overall Study|Withdrawal by Subject|5|||
146056900|NCT02973100|526725477|FG002|Overall Study|Withdrawal by Subject|1|||
146056901|NCT02973100|526725478|FG003|Overall Study|Withdrawal by Subject|4|||
146056902|NCT02973100|526725475|FG000|Overall Study|Notification of change in address|0|||
146056903|NCT02973100|526725476|FG001|Overall Study|Notification of change in address|0|||
146056904|NCT02973100|526725477|FG002|Overall Study|Notification of change in address|0|||
146056905|NCT02973100|526725478|FG003|Overall Study|Notification of change in address|1|||
146056906|NCT02973100|526725475|FG000|Overall Study|Failed to attend Safety followup period|0|||
146056907|NCT02973100|526725476|FG001|Overall Study|Failed to attend Safety followup period|0|||
146056908|NCT02973100|526725477|FG002|Overall Study|Failed to attend Safety followup period|1|||
146056909|NCT02973100|526725478|FG003|Overall Study|Failed to attend Safety followup period|0|||
146056910|NCT01419769|526725479|FG000|Overall Study|Did not receive the AXIOS stent|3|||
146056911|NCT01419769|526725479|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
146056912|NCT00878501|526725480|FG000|Overall Study|Adverse Event|11|||
146056913|NCT00878501|526725481|FG001|Overall Study|Adverse Event|3|||
146056914|NCT00878501|526725482|FG002|Overall Study|Adverse Event|3|||
146056915|NCT00878501|526725480|FG000|Overall Study|Lack of Efficacy|2|||
146056916|NCT00878501|526725481|FG001|Overall Study|Lack of Efficacy|1|||
146056917|NCT00878501|526725482|FG002|Overall Study|Lack of Efficacy|0|||
146056918|NCT00878501|526725480|FG000|Overall Study|Withdrawal by Subject|2|||
146056919|NCT00878501|526725481|FG001|Overall Study|Withdrawal by Subject|1|||
145944889|NCT01709864|526308058|FG000|Overall Study|Physician Decision|0|||
145944890|NCT01709864|526308059|FG001|Overall Study|Physician Decision|1|||
145944891|NCT01709864|526308058|FG000|Overall Study|subject/guardian decision|5|||
145944892|NCT01709864|526308059|FG001|Overall Study|subject/guardian decision|6|||
145944893|NCT01709864|526308058|FG000|Overall Study|Lost to Follow-up|1|||
145944894|NCT01709864|526308059|FG001|Overall Study|Lost to Follow-up|0|||
145944895|NCT01709864|526308058|FG000|Overall Study|non-compliance with study treatment|1|||
145944896|NCT01709864|526308059|FG001|Overall Study|non-compliance with study treatment|1|||
145944897|NCT01709864|526308058|FG000|Overall Study|Adverse Event|0|||
145944898|NCT01709864|526308059|FG001|Overall Study|Adverse Event|2|||
145944899|NCT01709864|526308058|FG000|Overall Study|Death|0|||
145944900|NCT01709864|526308059|FG001|Overall Study|Death|1|||
145944901|NCT01066793|526308066|FG000|Overall Study|Death|4|||
145944902|NCT01066793|526308067|FG001|Overall Study|Death|1|||
145944903|NCT01066793|526308068|FG002|Overall Study|Death|1|||
145944904|NCT01066793|526308069|FG003|Overall Study|Death|0|||
145944905|NCT01066793|526308070|FG004|Overall Study|Death|0|||
145944906|NCT01066793|526308071|FG005|Overall Study|Death|0|||
145944907|NCT01066793|526308066|FG000|Overall Study|Lack of Efficacy|2|||
145944908|NCT01066793|526308067|FG001|Overall Study|Lack of Efficacy|1|||
145944909|NCT01066793|526308068|FG002|Overall Study|Lack of Efficacy|0|||
145944910|NCT01066793|526308069|FG003|Overall Study|Lack of Efficacy|0|||
145944911|NCT01066793|526308070|FG004|Overall Study|Lack of Efficacy|0|||
145944912|NCT01066793|526308071|FG005|Overall Study|Lack of Efficacy|0|||
145944913|NCT01066793|526308066|FG000|Overall Study|Lost to Follow-up|180|||
145944914|NCT01066793|526308067|FG001|Overall Study|Lost to Follow-up|39|||
145944915|NCT01066793|526308068|FG002|Overall Study|Lost to Follow-up|82|||
145944916|NCT01066793|526308069|FG003|Overall Study|Lost to Follow-up|16|||
145944917|NCT01066793|526308070|FG004|Overall Study|Lost to Follow-up|0|||
145944918|NCT01066793|526308071|FG005|Overall Study|Lost to Follow-up|1|||
145944919|NCT01066793|526308066|FG000|Overall Study|Physician Decision|3|||
145944920|NCT01066793|526308067|FG001|Overall Study|Physician Decision|0|||
145944921|NCT01066793|526308068|FG002|Overall Study|Physician Decision|0|||
145944922|NCT01066793|526308069|FG003|Overall Study|Physician Decision|0|||
146056920|NCT00878501|526725482|FG002|Overall Study|Withdrawal by Subject|2|||
146056921|NCT00878501|526725480|FG000|Overall Study|Protocol Violation|0|||
146056922|NCT00878501|526725481|FG001|Overall Study|Protocol Violation|0|||
146056923|NCT00878501|526725482|FG002|Overall Study|Protocol Violation|1|||
146056924|NCT00878501|526725480|FG000|Overall Study|Incorrect enrolment|1|||
146056925|NCT00878501|526725481|FG001|Overall Study|Incorrect enrolment|2|||
146056926|NCT00878501|526725482|FG002|Overall Study|Incorrect enrolment|0|||
146056927|NCT00878501|526725480|FG000|Overall Study|Intake of prohibited concom. medication|0|||
146056928|NCT00878501|526725481|FG001|Overall Study|Intake of prohibited concom. medication|0|||
146056929|NCT00878501|526725482|FG002|Overall Study|Intake of prohibited concom. medication|1|||
146056930|NCT00878501|526725480|FG000|Overall Study|Mis-randomisation of patient|1|||
145944923|NCT01066793|526308070|FG004|Overall Study|Physician Decision|0|||
145944924|NCT01066793|526308071|FG005|Overall Study|Physician Decision|0|||
145944925|NCT01066793|526308066|FG000|Overall Study|Protocol Violation|3|||
145944926|NCT01066793|526308067|FG001|Overall Study|Protocol Violation|2|||
145944927|NCT01066793|526308068|FG002|Overall Study|Protocol Violation|2|||
145944928|NCT01066793|526308069|FG003|Overall Study|Protocol Violation|0|||
145944929|NCT01066793|526308070|FG004|Overall Study|Protocol Violation|0|||
145944930|NCT01066793|526308071|FG005|Overall Study|Protocol Violation|0|||
145944931|NCT01066793|526308066|FG000|Overall Study|Withdrawal by Subject|7|||
145944932|NCT01066793|526308067|FG001|Overall Study|Withdrawal by Subject|4|||
146056931|NCT00878501|526725481|FG001|Overall Study|Mis-randomisation of patient|0|||
146056932|NCT00878501|526725482|FG002|Overall Study|Mis-randomisation of patient|0|||
146056933|NCT00878501|526725480|FG000|Overall Study|Administrative|0|||
146056934|NCT00878501|526725481|FG001|Overall Study|Administrative|0|||
145944933|NCT01066793|526308068|FG002|Overall Study|Withdrawal by Subject|1|||
145944934|NCT01066793|526308069|FG003|Overall Study|Withdrawal by Subject|0|||
145944935|NCT01066793|526308070|FG004|Overall Study|Withdrawal by Subject|0|||
145944936|NCT01066793|526308071|FG005|Overall Study|Withdrawal by Subject|0|||
145944937|NCT01066793|526308066|FG000|Overall Study|Early Termination|3|||
145944938|NCT01066793|526308067|FG001|Overall Study|Early Termination|0|||
145944939|NCT01066793|526308068|FG002|Overall Study|Early Termination|0|||
145944940|NCT01066793|526308069|FG003|Overall Study|Early Termination|0|||
145944941|NCT01066793|526308070|FG004|Overall Study|Early Termination|0|||
145944942|NCT01066793|526308071|FG005|Overall Study|Early Termination|0|||
145944943|NCT01066793|526308066|FG000|Overall Study|Lab test not done|7|||
145944944|NCT01066793|526308067|FG001|Overall Study|Lab test not done|0|||
145944945|NCT01066793|526308068|FG002|Overall Study|Lab test not done|0|||
145944946|NCT01066793|526308069|FG003|Overall Study|Lab test not done|1|||
145944947|NCT01066793|526308070|FG004|Overall Study|Lab test not done|0|||
145944948|NCT01066793|526308071|FG005|Overall Study|Lab test not done|0|||
145944949|NCT01066793|526308066|FG000|Overall Study|Miscellaneous|4|||
145944950|NCT01066793|526308067|FG001|Overall Study|Miscellaneous|5|||
145944951|NCT01066793|526308068|FG002|Overall Study|Miscellaneous|6|||
145944952|NCT01066793|526308069|FG003|Overall Study|Miscellaneous|0|||
145944953|NCT01066793|526308070|FG004|Overall Study|Miscellaneous|0|||
145944954|NCT01066793|526308071|FG005|Overall Study|Miscellaneous|0|||
145944955|NCT01066793|526308066|FG000|Overall Study|Non-responders|104|||
145944956|NCT01066793|526308067|FG001|Overall Study|Non-responders|5|||
145944957|NCT01066793|526308068|FG002|Overall Study|Non-responders|11|||
145944958|NCT01066793|526308069|FG003|Overall Study|Non-responders|25|||
145944959|NCT01066793|526308070|FG004|Overall Study|Non-responders|0|||
145944960|NCT01066793|526308071|FG005|Overall Study|Non-responders|0|||
145944961|NCT01066793|526308066|FG000|Overall Study|Other|15|||
145944962|NCT01066793|526308067|FG001|Overall Study|Other|5|||
145944963|NCT01066793|526308068|FG002|Overall Study|Other|6|||
145944964|NCT01066793|526308069|FG003|Overall Study|Other|2|||
145944965|NCT01066793|526308070|FG004|Overall Study|Other|0|||
145944966|NCT01066793|526308071|FG005|Overall Study|Other|0|||
145944967|NCT01066793|526308066|FG000|Overall Study|Relapse|20|||
145944968|NCT01066793|526308067|FG001|Overall Study|Relapse|8|||
145944969|NCT01066793|526308068|FG002|Overall Study|Relapse|2|||
145944970|NCT01066793|526308069|FG003|Overall Study|Relapse|3|||
145944971|NCT01066793|526308070|FG004|Overall Study|Relapse|0|||
145944972|NCT01066793|526308071|FG005|Overall Study|Relapse|0|||
145944973|NCT01066793|526308066|FG000|Overall Study|Result Not Available|1|||
145944974|NCT01066793|526308067|FG001|Overall Study|Result Not Available|0|||
145944975|NCT01066793|526308068|FG002|Overall Study|Result Not Available|0|||
145944976|NCT01066793|526308069|FG003|Overall Study|Result Not Available|0|||
145944977|NCT01066793|526308070|FG004|Overall Study|Result Not Available|0|||
145944978|NCT01066793|526308071|FG005|Overall Study|Result Not Available|0|||
145944979|NCT01066793|526308066|FG000|Overall Study|Treatment Interrupted|1|||
145944980|NCT01066793|526308067|FG001|Overall Study|Treatment Interrupted|1|||
145944981|NCT01066793|526308068|FG002|Overall Study|Treatment Interrupted|0|||
145944982|NCT01066793|526308069|FG003|Overall Study|Treatment Interrupted|0|||
145944983|NCT01066793|526308070|FG004|Overall Study|Treatment Interrupted|0|||
145944984|NCT01066793|526308071|FG005|Overall Study|Treatment Interrupted|0|||
145944985|NCT01066793|526308066|FG000|Overall Study|Treatment Never Started|18|||
145944986|NCT01066793|526308067|FG001|Overall Study|Treatment Never Started|5|||
145944987|NCT01066793|526308068|FG002|Overall Study|Treatment Never Started|4|||
145944988|NCT01066793|526308069|FG003|Overall Study|Treatment Never Started|1|||
145944989|NCT01066793|526308070|FG004|Overall Study|Treatment Never Started|0|||
145944990|NCT01066793|526308071|FG005|Overall Study|Treatment Never Started|0|||
145944991|NCT01066793|526308066|FG000|Overall Study|Treatment Stopped|2|||
145944992|NCT01066793|526308067|FG001|Overall Study|Treatment Stopped|1|||
145944993|NCT01066793|526308068|FG002|Overall Study|Treatment Stopped|0|||
145944994|NCT01066793|526308069|FG003|Overall Study|Treatment Stopped|1|||
145944995|NCT01066793|526308070|FG004|Overall Study|Treatment Stopped|0|||
145944996|NCT01066793|526308071|FG005|Overall Study|Treatment Stopped|0|||
145944997|NCT01911793|526308073|FG000|Overall Study|Physician Decision|1|||
145944998|NCT01911793|526308074|FG001|Overall Study|Physician Decision|5|||
146056935|NCT00878501|526725482|FG002|Overall Study|Administrative|1|||
146056936|NCT01959503|526725483|FG000|Overall Study|Death|2|||
146056937|NCT01959503|526725484|FG001|Overall Study|Death|1|||
146056938|NCT01959503|526725483|FG000|Overall Study|Randomized but not treated|1|||
146056939|NCT01959503|526725484|FG001|Overall Study|Randomized but not treated|1|||
146056940|NCT01419236|526725485|FG000|Overall Study|Adverse Event|1|||
145944999|NCT02697916|526308075|FG000|Overall Study|Death|357|||
145945000|NCT02697916|526308076|FG001|Overall Study|Death|315|||
145945001|NCT02697916|526308075|FG000|Overall Study|Withdrawal by Subject|221|||
145945002|NCT02697916|526308076|FG001|Overall Study|Withdrawal by Subject|393|||
146056941|NCT01419236|526725486|FG001|Overall Study|Adverse Event|0|||
146056942|NCT01419236|526725485|FG000|Overall Study|Lack of Efficacy|0|||
145945003|NCT03246061|526308077|FG000|Overall Study|Still in follow-up|15|||
145945004|NCT03246061|526308078|FG001|Overall Study|Still in follow-up|21|||
145945005|NCT04710368|526308079|FG000|Overall Study|Withdrawal by Subject|9|||
145945006|NCT04710368|526308079|FG000|Overall Study|Lost to Follow-up|4|||
145945007|NCT04710368|526308079|FG000|Overall Study|Death|2|||
145945008|NCT04710368|526308079|FG000|Overall Study|Patient preference|11|||
145945009|NCT04710368|526308079|FG000|Overall Study|Treatment discontinuation|1|||
145945010|NCT02667587|526308087|FG000|Pre-Treatment|Not reported|1|||
145945011|NCT02667587|526308088|FG001|Pre-Treatment|Not reported|0|||
145945012|NCT02667587|526308087|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
145945013|NCT02667587|526308088|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
145945014|NCT02667587|526308087|FG000|Pre-Treatment|Participant withdrew consent|0|||
146056943|NCT01419236|526725486|FG001|Overall Study|Lack of Efficacy|1|||
146056944|NCT01419236|526725485|FG000|Overall Study|Lost to Follow-up|1|||
146056945|NCT01419236|526725486|FG001|Overall Study|Lost to Follow-up|0|||
146056946|NCT01419236|526725485|FG000|Overall Study|Physician Decision|1|||
146056947|NCT01419236|526725486|FG001|Overall Study|Physician Decision|0|||
146056948|NCT01419236|526725485|FG000|Overall Study|Withdrawal by Subject|1|||
146056949|NCT01419236|526725486|FG001|Overall Study|Withdrawal by Subject|4|||
146056950|NCT01419236|526725485|FG000|Overall Study|Entry Criteria Not Met|1|||
146056951|NCT01419236|526725486|FG001|Overall Study|Entry Criteria Not Met|0|||
146056952|NCT03598036|526725490|FG000|Overall Study|Withdrawal by Subject|1|||
146056953|NCT03598036|526725491|FG001|Overall Study|Withdrawal by Subject|0|||
146056954|NCT04124939|526725494|FG000|Overall Study|Lost to Follow-up|1|||
146056955|NCT04124939|526725495|FG001|Overall Study|Lost to Follow-up|3|||
146056956|NCT04607668|526725502|FG000|Overall Study|Death|49|||
146056957|NCT04607668|526725503|FG001|Overall Study|Death|26|||
146056958|NCT04607668|526725502|FG000|Overall Study|Lost to Follow-up|3|||
145945015|NCT02667587|526308088|FG001|Pre-Treatment|Participant withdrew consent|1|||
145945016|NCT02667587|526308087|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
145945017|NCT02667587|526308088|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
145945018|NCT02667587|526308087|FG000|End of Treatment|Disease Progression|193|||
145945019|NCT02667587|526308088|FG001|End of Treatment|Disease Progression|226|||
145945020|NCT02667587|526308087|FG000|End of Treatment|Study Drug Toxicity|75|||
145945021|NCT02667587|526308088|FG001|End of Treatment|Study Drug Toxicity|19|||
145945022|NCT02667587|526308087|FG000|End of Treatment|Death|2|||
145945023|NCT02667587|526308088|FG001|End of Treatment|Death|1|||
145945024|NCT02667587|526308087|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
145945025|NCT02667587|526308088|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
145945026|NCT02667587|526308087|FG000|End of Treatment|participant request to discontinue treatment|33|||
145945027|NCT02667587|526308088|FG001|End of Treatment|participant request to discontinue treatment|35|||
145945028|NCT02667587|526308087|FG000|End of Treatment|participant withdrew consent|5|||
145945029|NCT02667587|526308088|FG001|End of Treatment|participant withdrew consent|6|||
145945030|NCT02667587|526308087|FG000|End of Treatment|Lost to Follow-up|1|||
145945031|NCT02667587|526308088|FG001|End of Treatment|Lost to Follow-up|2|||
145945032|NCT02667587|526308087|FG000|End of Treatment|maximum clinical benefit|4|||
145945033|NCT02667587|526308088|FG001|End of Treatment|maximum clinical benefit|4|||
145945034|NCT02667587|526308087|FG000|End of Treatment|poor or non compliant|0|||
145945035|NCT02667587|526308088|FG001|End of Treatment|poor or non compliant|1|||
145945036|NCT02667587|526308087|FG000|End of Treatment|participant no longer meets study criteria|1|||
145945037|NCT02667587|526308088|FG001|End of Treatment|participant no longer meets study criteria|1|||
145945038|NCT02667587|526308087|FG000|End of Treatment|administrative reason by sponsor|1|||
145945039|NCT02667587|526308088|FG001|End of Treatment|administrative reason by sponsor|29|||
145945040|NCT02667587|526308087|FG000|End of Treatment|other reasonse|21|||
145945041|NCT02667587|526308088|FG001|End of Treatment|other reasonse|10|||
145945042|NCT02696434|526308089|FG000|Overall Study|Adverse Event|3|||
145945043|NCT02696434|526308090|FG001|Overall Study|Adverse Event|1|||
145945044|NCT02696434|526308089|FG000|Overall Study|Lost to Follow-up|5|||
145945045|NCT02696434|526308090|FG001|Overall Study|Lost to Follow-up|4|||
145945046|NCT02696434|526308089|FG000|Overall Study|Withdrawal by Subject|14|||
145945047|NCT02696434|526308090|FG001|Overall Study|Withdrawal by Subject|12|||
145945048|NCT02696434|526308089|FG000|Overall Study|Physician Decision|0|||
145945049|NCT02696434|526308090|FG001|Overall Study|Physician Decision|1|||
145945050|NCT00427999|526308112|FG000|Overall Study|Adverse Event|6|||
145945051|NCT00427999|526308112|FG000|Overall Study|Abnormal laboratory values|1|||
145945052|NCT00427999|526308112|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
145945053|NCT00427999|526308112|FG000|Overall Study|Protocol Violation|2|||
145945054|NCT00427999|526308112|FG000|Overall Study|Withdrawal by Subject|9|||
145945055|NCT00427999|526308112|FG000|Overall Study|Death|1|||
145945056|NCT05323994|526308113|FG000|Overall Study|Protocol Violation|1|||
145945057|NCT00766467|526308114|FG000|Overall Study|Withdrawal by Subject|7|||
145945058|NCT00766467|526308115|FG001|Overall Study|Withdrawal by Subject|2|||
145945059|NCT00766467|526308114|FG000|Overall Study|Adverse Event|1|||
145945060|NCT00766467|526308115|FG001|Overall Study|Adverse Event|1|||
145945061|NCT00766467|526308114|FG000|Overall Study|Protocol Violation|2|||
145945062|NCT00766467|526308115|FG001|Overall Study|Protocol Violation|4|||
145945063|NCT00766467|526308114|FG000|Overall Study|Tumor Progression on Study|0|||
145945064|NCT00766467|526308115|FG001|Overall Study|Tumor Progression on Study|1|||
145945065|NCT00766467|526308114|FG000|Overall Study|Physician Decision|1|||
145945066|NCT00766467|526308115|FG001|Overall Study|Physician Decision|0|||
145945067|NCT01420679|526308121|FG000|Overall Study|Disease Progression|3|||
145945068|NCT01420679|526308122|FG001|Overall Study|Disease Progression|2|||
145945069|NCT01420679|526308121|FG000|Overall Study|Adverse Event|4|||
145945070|NCT01420679|526308122|FG001|Overall Study|Adverse Event|0|||
146056959|NCT04607668|526725503|FG001|Overall Study|Lost to Follow-up|4|||
146056960|NCT04607668|526725502|FG000|Overall Study|Study terminated by Sponsor|92|||
146056961|NCT04607668|526725503|FG001|Overall Study|Study terminated by Sponsor|114|||
146056962|NCT04607668|526725502|FG000|Overall Study|Withdrawal by Subject|12|||
146056963|NCT04607668|526725503|FG001|Overall Study|Withdrawal by Subject|11|||
145945071|NCT01420679|526308121|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
145945072|NCT01420679|526308122|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
145945073|NCT01420679|526308121|FG000|Overall Study|Patient Decision|1|||
145945074|NCT01420679|526308122|FG001|Overall Study|Patient Decision|0|||
145945075|NCT01420679|526308121|FG000|Overall Study|Investigator Decision|1|||
145945076|NCT01420679|526308122|FG001|Overall Study|Investigator Decision|2|||
145945077|NCT01420679|526308121|FG000|Overall Study|Sponsor Decision|3|||
145945078|NCT01420679|526308122|FG001|Overall Study|Sponsor Decision|3|||
145945079|NCT01420679|526308121|FG000|Overall Study|Other|1|||
145945080|NCT01420679|526308122|FG001|Overall Study|Other|0|||
146056964|NCT04607668|526725502|FG000|Overall Study|Other, unspecified|8|||
146056965|NCT04607668|526725503|FG001|Overall Study|Other, unspecified|7|||
146056966|NCT02250326|526725504|FG000|Treatment|Death|1|||
146056967|NCT02250326|526725505|FG001|Treatment|Death|13|||
146056968|NCT02250326|526725506|FG002|Treatment|Death|2|||
146056969|NCT02250326|526725504|FG000|Treatment|Adverse Event|8|||
146056970|NCT02250326|526725505|FG001|Treatment|Adverse Event|8|||
146056971|NCT02250326|526725506|FG002|Treatment|Adverse Event|9|||
146056972|NCT02250326|526725504|FG000|Treatment|Progressive Disease|42|||
146056973|NCT02250326|526725505|FG001|Treatment|Progressive Disease|40|||
146056974|NCT02250326|526725506|FG002|Treatment|Progressive Disease|47|||
146056975|NCT02250326|526725504|FG000|Treatment|Symptomatic Deterioration|9|||
146056976|NCT02250326|526725505|FG001|Treatment|Symptomatic Deterioration|4|||
146056977|NCT02250326|526725506|FG002|Treatment|Symptomatic Deterioration|10|||
145945081|NCT00943670|526308123|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
145945082|NCT00943670|526308123|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
145945083|NCT00943670|526308123|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
145945084|NCT00943670|526308123|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
145945085|NCT00943670|526308123|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
146056978|NCT02250326|526725504|FG000|Treatment|Withdrawal by Subject|11|||
146056979|NCT02250326|526725505|FG001|Treatment|Withdrawal by Subject|6|||
146056980|NCT02250326|526725506|FG002|Treatment|Withdrawal by Subject|4|||
146056981|NCT02250326|526725504|FG000|Treatment|Other reasons|8|||
146056982|NCT02250326|526725505|FG001|Treatment|Other reasons|7|||
146056983|NCT02250326|526725506|FG002|Treatment|Other reasons|7|||
146056984|NCT02250326|526725504|FG000|Extension Period|Progressive Disease|0|||
146056985|NCT02250326|526725505|FG001|Extension Period|Progressive Disease|2|||
145945086|NCT00943670|526308123|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
145945087|NCT00943670|526308123|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
145945088|NCT00943670|526308123|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
145945089|NCT00943670|526308123|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
145945090|NCT00943670|526308123|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
145945091|NCT04472026|526308124|FG000|Overall Study|Lost to Follow-up|5|||
145945092|NCT01777295|526308125|FG000|Overall Study|Withdrawal by Subject|2|||
145945093|NCT01777295|526308126|FG001|Overall Study|Withdrawal by Subject|2|||
145945094|NCT01777295|526308125|FG000|Overall Study|Pregnancy|0|||
145945095|NCT01777295|526308126|FG001|Overall Study|Pregnancy|1|||
145945096|NCT01777295|526308125|FG000|Overall Study|Personal problem|1|||
145945097|NCT01777295|526308126|FG001|Overall Study|Personal problem|0|||
145945098|NCT01777295|526308125|FG000|Overall Study|Investigator call for AEs check|1|||
145945099|NCT01777295|526308126|FG001|Overall Study|Investigator call for AEs check|0|||
145945100|NCT01546038|526308128|FG000|Overall Study|Death|15|||
145945101|NCT01546038|526308129|FG001|Overall Study|Death|6|||
145945102|NCT01546038|526308130|FG002|Overall Study|Death|4|||
145945103|NCT01546038|526308131|FG003|Overall Study|Death|2|||
145945104|NCT01546038|526308132|FG004|Overall Study|Death|9|||
145945105|NCT01546038|526308133|FG005|Overall Study|Death|3|||
145945106|NCT01546038|526308134|FG006|Overall Study|Death|46|||
145945107|NCT01546038|526308135|FG007|Overall Study|Death|76|||
145945108|NCT01546038|526308136|FG008|Overall Study|Death|39|||
145945109|NCT01546038|526308128|FG000|Overall Study|Lost to Follow-up|0|||
145945110|NCT01546038|526308129|FG001|Overall Study|Lost to Follow-up|0|||
145945111|NCT01546038|526308130|FG002|Overall Study|Lost to Follow-up|0|||
145945112|NCT01546038|526308131|FG003|Overall Study|Lost to Follow-up|0|||
145945113|NCT01546038|526308132|FG004|Overall Study|Lost to Follow-up|1|||
145945114|NCT01546038|526308133|FG005|Overall Study|Lost to Follow-up|0|||
145945115|NCT01546038|526308134|FG006|Overall Study|Lost to Follow-up|2|||
146056986|NCT02250326|526725506|FG002|Extension Period|Progressive Disease|0|||
146056987|NCT02250326|526725504|FG000|Extension Period|Withdrawal by Subject|0|||
146056988|NCT02250326|526725505|FG001|Extension Period|Withdrawal by Subject|1|||
145945116|NCT01546038|526308135|FG007|Overall Study|Lost to Follow-up|1|||
145945117|NCT01546038|526308136|FG008|Overall Study|Lost to Follow-up|0|||
145945118|NCT01546038|526308128|FG000|Overall Study|Withdrawal by Subject|1|||
145945119|NCT01546038|526308129|FG001|Overall Study|Withdrawal by Subject|0|||
145945120|NCT01546038|526308130|FG002|Overall Study|Withdrawal by Subject|0|||
145945121|NCT01546038|526308131|FG003|Overall Study|Withdrawal by Subject|1|||
146056989|NCT02250326|526725506|FG002|Extension Period|Withdrawal by Subject|0|||
146056990|NCT02250326|526725504|FG000|Extension Period|Withdrawal by investigator|0|||
146056991|NCT02250326|526725505|FG001|Extension Period|Withdrawal by investigator|1|||
146056992|NCT02250326|526725506|FG002|Extension Period|Withdrawal by investigator|0|||
146056993|NCT01838694|526725507|FG000|Overall Study|Adverse Event|0|||
146056994|NCT01838694|526725508|FG001|Overall Study|Adverse Event|1|||
145945122|NCT01546038|526308132|FG004|Overall Study|Withdrawal by Subject|0|||
145945123|NCT01546038|526308133|FG005|Overall Study|Withdrawal by Subject|1|||
146056995|NCT00672555|526725510|FG000|Overall Study|Lost to Follow-up|4|||
146056996|NCT00672555|526725510|FG000|Overall Study|Did not want to answer questionnaire|2|||
146056997|NCT01751061|526725516|FG000|Overall Study|Death|1|||
146056998|NCT01751061|526725517|FG001|Overall Study|Death|0|||
146056999|NCT01751061|526725516|FG000|Overall Study|patient death|5|||
146057000|NCT01751061|526725517|FG001|Overall Study|patient death|0|||
146057001|NCT01751061|526725516|FG000|Overall Study|Lost to Follow-up|40|||
146057002|NCT01751061|526725517|FG001|Overall Study|Lost to Follow-up|25|||
146057003|NCT01751061|526725516|FG000|Overall Study|patient regained decisional capacity|4|||
146057004|NCT01751061|526725517|FG001|Overall Study|patient regained decisional capacity|8|||
146057005|NCT01751061|526725516|FG000|Overall Study|Withdrawal by Subject|4|||
146057006|NCT01751061|526725517|FG001|Overall Study|Withdrawal by Subject|1|||
146057007|NCT01751061|526725516|FG000|Overall Study|Physician Decision|2|||
146057008|NCT01751061|526725517|FG001|Overall Study|Physician Decision|0|||
146057009|NCT02153086|526725521|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
146057010|NCT02153086|526725521|FG000|Overall Study|Other|2|||
146057011|NCT00446849|526725522|FG000|Acute Phase|Lack of Efficacy|64|||
146057012|NCT00446849|526725522|FG000|Acute Phase|Protocol Violation|10|||
146057013|NCT00446849|526725522|FG000|Acute Phase|Consent withdrawn|4|||
146057014|NCT00446849|526725522|FG000|Acute Phase|Lost to Follow-up|2|||
146057015|NCT00446849|526725522|FG000|Acute Phase|Physician Decision|1|||
146057016|NCT00446849|526725522|FG000|Acute Phase|noncompliance|1|||
146057017|NCT00446849|526725522|FG000|Maintenance Phase|Lack of Efficacy|40|||
146057018|NCT00446849|526725522|FG000|Maintenance Phase|Protocol Violation|7|||
146057019|NCT00446849|526725522|FG000|Maintenance Phase|Adverse Event|6|||
146057020|NCT00446849|526725522|FG000|Maintenance Phase|Consent withdrawn|5|||
146057021|NCT00446849|526725522|FG000|Maintenance Phase|Lost to Follow-up|3|||
146057022|NCT00446849|526725522|FG000|Maintenance Phase|Pregnancy|1|||
146057023|NCT00446849|526725522|FG000|Maintenance Phase|noncompliance|2|||
146057024|NCT00446849|526725522|FG000|Maintenance Phase|prohibited medication use|2|||
146057025|NCT00446849|526725522|FG000|Maintenance Phase|antibiotic use|1|||
146057026|NCT00446849|526725522|FG000|Maintenance Phase|study closure|1|||
146057027|NCT00446849|526725522|FG000|Maintenance Phase|hydrocodone use|1|||
146057028|NCT00446849|526725522|FG000|Maintenance Phase|concomitant medication use|1|||
146057029|NCT01194830|526725523|FG000|Overall Study|Adverse Event|3|||
146057030|NCT01194830|526725524|FG001|Overall Study|Adverse Event|2|||
146057031|NCT01194830|526725523|FG000|Overall Study|Protocol Violation|5|||
146057032|NCT01194830|526725524|FG001|Overall Study|Protocol Violation|4|||
146057033|NCT01194830|526725523|FG000|Overall Study|Lost to Follow-up|9|||
146057034|NCT01194830|526725524|FG001|Overall Study|Lost to Follow-up|7|||
146057035|NCT01194830|526725523|FG000|Overall Study|Withdrawal by Subject|2|||
146057036|NCT01194830|526725524|FG001|Overall Study|Withdrawal by Subject|1|||
146057037|NCT01194830|526725523|FG000|Overall Study|Lack of Efficacy|1|||
146057038|NCT01194830|526725524|FG001|Overall Study|Lack of Efficacy|1|||
146057039|NCT01194830|526725523|FG000|Overall Study|Non-compliance issues|4|||
146057040|NCT01194830|526725524|FG001|Overall Study|Non-compliance issues|4|||
146057041|NCT01194830|526725523|FG000|Overall Study|Other Reason|12|||
146057042|NCT01194830|526725524|FG001|Overall Study|Other Reason|8|||
146057043|NCT03115359|526725525|FG000|Overall Study|Withdrawal by Subject|29|||
146057044|NCT03115359|526725526|FG001|Overall Study|Withdrawal by Subject|39|||
146057045|NCT03115359|526725525|FG000|Overall Study|Scheduling conflict|25|||
146057046|NCT03115359|526725526|FG001|Overall Study|Scheduling conflict|23|||
146057047|NCT03115359|526725525|FG000|Overall Study|Personal reasons including health|12|||
146057048|NCT03115359|526725526|FG001|Overall Study|Personal reasons including health|9|||
146057049|NCT03115359|526725525|FG000|Overall Study|Transportation barriers|3|||
146057050|NCT03115359|526725526|FG001|Overall Study|Transportation barriers|0|||
146057051|NCT03115359|526725525|FG000|Overall Study|No longer interested|5|||
146057052|NCT03115359|526725526|FG001|Overall Study|No longer interested|4|||
146057053|NCT03115359|526725525|FG000|Overall Study|No reason provided|45|||
145945124|NCT01546038|526308134|FG006|Overall Study|Withdrawal by Subject|3|||
145945125|NCT01546038|526308135|FG007|Overall Study|Withdrawal by Subject|3|||
145945126|NCT01546038|526308136|FG008|Overall Study|Withdrawal by Subject|1|||
145945127|NCT01546038|526308128|FG000|Overall Study|: Randomized, not treated|0|||
145945128|NCT01546038|526308129|FG001|Overall Study|: Randomized, not treated|0|||
146057054|NCT03115359|526725526|FG001|Overall Study|No reason provided|47|||
146057055|NCT01317472|526725529|FG000|Overall Study|Withdrawal by Subject|1|||
146057056|NCT01317472|526725530|FG001|Overall Study|Withdrawal by Subject|0|||
145945129|NCT01546038|526308130|FG002|Overall Study|: Randomized, not treated|0|||
146057057|NCT01317472|526725529|FG000|Overall Study|Unrelated hospitalization|1|||
146057058|NCT01317472|526725530|FG001|Overall Study|Unrelated hospitalization|0|||
146057059|NCT01815918|526725531|FG000|Overall Study|Patient samples not analyzable|3|||
146057060|NCT01815918|526725532|FG001|Overall Study|Patient samples not analyzable|4|||
146057061|NCT01815918|526725531|FG000|Overall Study|Lack of Efficacy|15|||
146057062|NCT01815918|526725532|FG001|Overall Study|Lack of Efficacy|15|||
146057063|NCT03284710|526725535|FG000|Overall Study|Withdrawal by Subject|1|||
146057064|NCT03284710|526725536|FG001|Overall Study|Withdrawal by Subject|0|||
146057065|NCT03284710|526725537|FG002|Overall Study|Withdrawal by Subject|1|||
146057066|NCT03284710|526725538|FG003|Overall Study|Withdrawal by Subject|6|||
146057067|NCT03284710|526725535|FG000|Overall Study|Lost to Follow-up|3|||
146057068|NCT03284710|526725536|FG001|Overall Study|Lost to Follow-up|3|||
146057069|NCT03284710|526725537|FG002|Overall Study|Lost to Follow-up|1|||
146057070|NCT03284710|526725538|FG003|Overall Study|Lost to Follow-up|0|||
146057071|NCT03284710|526725535|FG000|Overall Study|Physician Decision|1|||
146057072|NCT03284710|526725536|FG001|Overall Study|Physician Decision|0|||
146057073|NCT03284710|526725537|FG002|Overall Study|Physician Decision|0|||
146057074|NCT03284710|526725538|FG003|Overall Study|Physician Decision|0|||
146057075|NCT03284710|526725535|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146057076|NCT03284710|526725536|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146057077|NCT03284710|526725537|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146057078|NCT03284710|526725538|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146057079|NCT03284710|526725535|FG000|Overall Study|HIV Infection|0|||
146057080|NCT03284710|526725536|FG001|Overall Study|HIV Infection|2|||
146057081|NCT03284710|526725537|FG002|Overall Study|HIV Infection|2|||
146057082|NCT03284710|526725538|FG003|Overall Study|HIV Infection|1|||
146057083|NCT02412306|526725541|FG000|Overall Study|Lost to Follow-up|0|||
146057084|NCT02412306|526725542|FG001|Overall Study|Lost to Follow-up|1|||
146057085|NCT02412306|526725543|FG002|Overall Study|Lost to Follow-up|0|||
146057086|NCT02412306|526725544|FG003|Overall Study|Lost to Follow-up|0|||
146057087|NCT02412306|526725545|FG004|Overall Study|Lost to Follow-up|0|||
146057088|NCT02412306|526725541|FG000|Overall Study|Withdrawal by Subject|0|||
146057089|NCT02412306|526725542|FG001|Overall Study|Withdrawal by Subject|0|||
146057090|NCT02412306|526725543|FG002|Overall Study|Withdrawal by Subject|1|||
146057091|NCT02412306|526725544|FG003|Overall Study|Withdrawal by Subject|0|||
146057092|NCT02412306|526725545|FG004|Overall Study|Withdrawal by Subject|0|||
146057093|NCT02412306|526725541|FG000|Overall Study|Death|5|||
146057094|NCT02412306|526725542|FG001|Overall Study|Death|7|||
146057095|NCT02412306|526725543|FG002|Overall Study|Death|15|||
146057096|NCT02412306|526725544|FG003|Overall Study|Death|0|||
146057097|NCT02412306|526725545|FG004|Overall Study|Death|2|||
146057098|NCT03760029|526725555|FG000|Overall Study|Death|1|||
146057099|NCT03760029|526725556|FG001|Overall Study|Death|0|||
146057100|NCT03760029|526725557|FG002|Overall Study|Death|0|||
146057101|NCT03760029|526725555|FG000|Overall Study|Lost to Follow-up|0|||
146057102|NCT03760029|526725556|FG001|Overall Study|Lost to Follow-up|2|||
146057103|NCT03760029|526725557|FG002|Overall Study|Lost to Follow-up|1|||
146057104|NCT03760029|526725555|FG000|Overall Study|Withdrawal by Subject|1|||
146057105|NCT03760029|526725556|FG001|Overall Study|Withdrawal by Subject|4|||
146057106|NCT03760029|526725557|FG002|Overall Study|Withdrawal by Subject|1|||
146057107|NCT03760029|526725555|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146057108|NCT03760029|526725556|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146057109|NCT03760029|526725557|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146057110|NCT03760029|526725555|FG000|Overall Study|Other|2|||
146057111|NCT03760029|526725556|FG001|Overall Study|Other|1|||
146057112|NCT03760029|526725557|FG002|Overall Study|Other|0|||
146057113|NCT03532542|526725558|FG000|Overall Study|Death|1|||
146057114|NCT03532542|526725559|FG001|Overall Study|Death|0|||
146057115|NCT03532542|526725558|FG000|Overall Study|Study Terminated by Sponsor|41|||
146057116|NCT03532542|526725559|FG001|Overall Study|Study Terminated by Sponsor|65|||
146057117|NCT03532542|526725558|FG000|Overall Study|Withdrawal by Subject|6|||
146057118|NCT03532542|526725559|FG001|Overall Study|Withdrawal by Subject|5|||
146057119|NCT00436332|526725560|FG000|Overall Study|Adverse Event|9|||
146057120|NCT00436332|526725560|FG000|Overall Study|Withdrawal by Subject|2|||
146057121|NCT00436332|526725560|FG000|Overall Study|Progression|59|||
146057122|NCT00436332|526725560|FG000|Overall Study|Death|2|||
146057123|NCT00436332|526725560|FG000|Overall Study|Not Protocol Specified|6|||
146057124|NCT00436332|526725560|FG000|Overall Study|Ineligible|2|||
146057125|NCT00436332|526725560|FG000|Overall Study|Never Received Treatment|3|||
146057126|NCT04698343|526725561|FG000|Overall Study|Withdrawal by Subject|6|||
146057127|NCT04698343|526725561|FG000|Overall Study|Physician Decision|2|||
146057128|NCT04698343|526725561|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
146057129|NCT04698343|526725561|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
146057130|NCT04698343|526725561|FG000|Overall Study|Personal reasons|3|||
146057131|NCT04698343|526725561|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
146057132|NCT00286442|526725562|FG000|Overall Study|Hyperglycemic Rescue|19|||
146057133|NCT00286442|526725563|FG001|Overall Study|Hyperglycemic Rescue|17|||
146057134|NCT00286442|526725564|FG002|Overall Study|Hyperglycemic Rescue|25|||
146057135|NCT00286442|526725562|FG000|Overall Study|Adverse Event|7|||
146057136|NCT00286442|526725563|FG001|Overall Study|Adverse Event|6|||
146057137|NCT00286442|526725564|FG002|Overall Study|Adverse Event|1|||
146057138|NCT00286442|526725562|FG000|Overall Study|Protocol Violation|2|||
146057139|NCT00286442|526725563|FG001|Overall Study|Protocol Violation|4|||
146057140|NCT00286442|526725564|FG002|Overall Study|Protocol Violation|2|||
146057141|NCT00286442|526725562|FG000|Overall Study|Lost to Follow-up|5|||
146057142|NCT00286442|526725563|FG001|Overall Study|Lost to Follow-up|2|||
146057143|NCT00286442|526725564|FG002|Overall Study|Lost to Follow-up|1|||
146057144|NCT00286442|526725562|FG000|Overall Study|Physician Decision|1|||
146057145|NCT00286442|526725563|FG001|Overall Study|Physician Decision|1|||
146057146|NCT00286442|526725564|FG002|Overall Study|Physician Decision|1|||
146057147|NCT00286442|526725562|FG000|Overall Study|Administrative Error|1|||
146057148|NCT00286442|526725563|FG001|Overall Study|Administrative Error|1|||
146057149|NCT00286442|526725564|FG002|Overall Study|Administrative Error|0|||
146057150|NCT00286442|526725562|FG000|Overall Study|Withdrawal by Subject|2|||
146057151|NCT00286442|526725563|FG001|Overall Study|Withdrawal by Subject|14|||
146057152|NCT00286442|526725564|FG002|Overall Study|Withdrawal by Subject|2|||
146057153|NCT02756338|526725565|FG000|Overall Study|Withdrawn by Investigator|1|||
146057154|NCT02756338|526725565|FG000|Overall Study|Device Replaced with Pacemaker|4|||
146057155|NCT01339689|526725566|FG000|Overall Study|Adverse Event|1|||
146057156|NCT01339689|526725567|FG001|Overall Study|Adverse Event|2|||
146057157|NCT01339689|526725566|FG000|Overall Study|Lost to Follow-up|9|||
146057158|NCT01339689|526725567|FG001|Overall Study|Lost to Follow-up|3|||
146057159|NCT01339689|526725566|FG000|Overall Study|Withdrawal by Subject|3|||
146057160|NCT01339689|526725567|FG001|Overall Study|Withdrawal by Subject|0|||
146057161|NCT01339689|526725566|FG000|Overall Study|Noncompliance|1|||
146057162|NCT01339689|526725567|FG001|Overall Study|Noncompliance|0|||
146057163|NCT01339689|526725566|FG000|Overall Study|Relocated out of area|0|||
146057164|NCT01339689|526725567|FG001|Overall Study|Relocated out of area|1|||
146057165|NCT01339689|526725566|FG000|Overall Study|Other|2|||
146057166|NCT01339689|526725567|FG001|Overall Study|Other|2|||
146057167|NCT01339689|526725566|FG000|Overall Study|multiple reasons|1|||
146057168|NCT01339689|526725567|FG001|Overall Study|multiple reasons|1|||
146057169|NCT00467740|526725568|FG000|Overall Study|Adverse Event|0|||
146057170|NCT00467740|526725569|FG001|Overall Study|Adverse Event|0|||
146057171|NCT00467740|526725570|FG002|Overall Study|Adverse Event|1|||
146057172|NCT00467740|526725571|FG003|Overall Study|Adverse Event|0|||
146057173|NCT00467740|526725572|FG004|Overall Study|Adverse Event|0|||
146057174|NCT00467740|526725568|FG000|Overall Study|Protocol Violation|0|||
146057175|NCT00467740|526725569|FG001|Overall Study|Protocol Violation|0|||
146057176|NCT00467740|526725570|FG002|Overall Study|Protocol Violation|1|||
146057177|NCT00467740|526725571|FG003|Overall Study|Protocol Violation|0|||
146057178|NCT00467740|526725572|FG004|Overall Study|Protocol Violation|0|||
146057179|NCT00467740|526725568|FG000|Overall Study|Lost to Follow-up|0|||
146057180|NCT00467740|526725569|FG001|Overall Study|Lost to Follow-up|1|||
146057181|NCT00467740|526725570|FG002|Overall Study|Lost to Follow-up|0|||
146057182|NCT00467740|526725571|FG003|Overall Study|Lost to Follow-up|0|||
146057183|NCT00467740|526725572|FG004|Overall Study|Lost to Follow-up|0|||
146057184|NCT00467740|526725568|FG000|Overall Study|Withdrawal by Subject|1|||
146057185|NCT00467740|526725569|FG001|Overall Study|Withdrawal by Subject|1|||
146057186|NCT00467740|526725570|FG002|Overall Study|Withdrawal by Subject|0|||
146057187|NCT00467740|526725571|FG003|Overall Study|Withdrawal by Subject|1|||
146057188|NCT00467740|526725572|FG004|Overall Study|Withdrawal by Subject|0|||
146057189|NCT00467740|526725568|FG000|Overall Study|Lack of Efficacy|0|||
146057190|NCT00467740|526725569|FG001|Overall Study|Lack of Efficacy|1|||
146057191|NCT00467740|526725570|FG002|Overall Study|Lack of Efficacy|0|||
146057192|NCT00467740|526725571|FG003|Overall Study|Lack of Efficacy|0|||
146057193|NCT00467740|526725572|FG004|Overall Study|Lack of Efficacy|0|||
146057194|NCT00730158|526725573|FG000|Overall Study|Withdrawal by Subject|1|||
146057195|NCT00730158|526725574|FG001|Overall Study|Withdrawal by Subject|1|||
146057196|NCT04999839|526725575|FG000|Overall Study|Adverse Event|1|||
146057197|NCT04999839|526725576|FG001|Overall Study|Adverse Event|1|||
146057198|NCT04999839|526725577|FG002|Overall Study|Adverse Event|1|||
146057199|NCT04999839|526725578|FG003|Overall Study|Adverse Event|1|||
146057200|NCT04999839|526725579|FG004|Overall Study|Adverse Event|1|||
146057201|NCT04999839|526725575|FG000|Overall Study|Lost to Follow-up|2|||
146057202|NCT04999839|526725576|FG001|Overall Study|Lost to Follow-up|0|||
146057203|NCT04999839|526725577|FG002|Overall Study|Lost to Follow-up|2|||
146057204|NCT04999839|526725578|FG003|Overall Study|Lost to Follow-up|4|||
146057205|NCT04999839|526725579|FG004|Overall Study|Lost to Follow-up|1|||
146057206|NCT04999839|526725575|FG000|Overall Study|Withdrawal by Subject|6|||
146057207|NCT04999839|526725576|FG001|Overall Study|Withdrawal by Subject|5|||
146057208|NCT04999839|526725577|FG002|Overall Study|Withdrawal by Subject|3|||
146057209|NCT04999839|526725578|FG003|Overall Study|Withdrawal by Subject|2|||
146057210|NCT04999839|526725579|FG004|Overall Study|Withdrawal by Subject|2|||
146057211|NCT04999839|526725575|FG000|Overall Study|Lack of Efficacy|0|||
146057212|NCT04999839|526725576|FG001|Overall Study|Lack of Efficacy|1|||
146057213|NCT04999839|526725577|FG002|Overall Study|Lack of Efficacy|0|||
146057214|NCT04999839|526725578|FG003|Overall Study|Lack of Efficacy|0|||
146057215|NCT04999839|526725579|FG004|Overall Study|Lack of Efficacy|0|||
146057216|NCT04999839|526725575|FG000|Overall Study|Physician Decision|0|||
146057217|NCT04999839|526725576|FG001|Overall Study|Physician Decision|0|||
146057218|NCT04999839|526725577|FG002|Overall Study|Physician Decision|0|||
146057219|NCT04999839|526725578|FG003|Overall Study|Physician Decision|0|||
146057220|NCT04999839|526725579|FG004|Overall Study|Physician Decision|1|||
146057221|NCT04999839|526725575|FG000|Overall Study|Sponsor request|0|||
146057222|NCT04999839|526725576|FG001|Overall Study|Sponsor request|1|||
146057223|NCT04999839|526725577|FG002|Overall Study|Sponsor request|0|||
146057224|NCT04999839|526725578|FG003|Overall Study|Sponsor request|0|||
146057225|NCT04999839|526725579|FG004|Overall Study|Sponsor request|0|||
146057226|NCT04999839|526725575|FG000|Overall Study|Other|0|||
146057227|NCT04999839|526725576|FG001|Overall Study|Other|0|||
146057228|NCT04999839|526725577|FG002|Overall Study|Other|1|||
146057229|NCT04999839|526725578|FG003|Overall Study|Other|0|||
146057230|NCT04999839|526725579|FG004|Overall Study|Other|0|||
146057231|NCT03740048|526725580|FG000|Overall Study|Withdrawal by Subject|1|||
146057232|NCT03740048|526725581|FG001|Overall Study|Withdrawal by Subject|1|||
146057233|NCT03740048|526725580|FG000|Overall Study|Death|1|||
146057234|NCT03740048|526725581|FG001|Overall Study|Death|6|||
146057235|NCT03740048|526725580|FG000|Overall Study|Switched to thrice-weekly HD|2|||
146057236|NCT03740048|526725581|FG001|Overall Study|Switched to thrice-weekly HD|0|||
146057237|NCT03740048|526725580|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
146057238|NCT03740048|526725581|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
146057239|NCT03740048|526725580|FG000|Overall Study|Lost to Follow-up|0|||
146057240|NCT03740048|526725581|FG001|Overall Study|Lost to Follow-up|1|||
146057241|NCT03740048|526725580|FG000|Overall Study|Non-compliance with HD|0|||
146057242|NCT03740048|526725581|FG001|Overall Study|Non-compliance with HD|1|||
146057243|NCT01476722|526725582|FG000|Overall Study|Adverse Event|1|||
146057244|NCT00528957|526725584|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
146057245|NCT00528957|526725585|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
146057246|NCT00528957|526725584|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
146057247|NCT00528957|526725585|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
146057248|NCT00528957|526725584|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
146057249|NCT00528957|526725585|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
146057250|NCT00528957|526725584|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
146057251|NCT00528957|526725585|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
146057252|NCT00528957|526725584|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
146057253|NCT00528957|526725585|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
146057254|NCT00528957|526725584|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
146057255|NCT00528957|526725585|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
146057256|NCT00528957|526725584|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
146057257|NCT00528957|526725585|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
146057258|NCT00528957|526725584|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
146057259|NCT00528957|526725585|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
146057260|NCT00528957|526725584|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
146057261|NCT00528957|526725585|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
146057262|NCT00528957|526725584|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
146057263|NCT00528957|526725585|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
146057264|NCT00528957|526725584|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
146057265|NCT00528957|526725585|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
146057266|NCT00528957|526725584|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
146057267|NCT00528957|526725585|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
146057268|NCT00528957|526725584|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
146057269|NCT00528957|526725585|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
146057270|NCT00528957|526725584|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
146057271|NCT00528957|526725585|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
146057272|NCT00528957|526725584|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
146057273|NCT00528957|526725585|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
146057274|NCT00528957|526725584|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
146057275|NCT00528957|526725585|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
146057276|NCT00539981|526725586|FG000|Overall Study|Adverse events (AE)|3|||
146057277|NCT00539981|526725587|FG001|Overall Study|Adverse events (AE)|3|||
146057278|NCT00539981|526725586|FG000|Overall Study|Lost to Follow-up|260|||
146283212|NCT01871805|527550161|FG001|Phase II|Death|0|||
146057279|NCT00539981|526725587|FG001|Overall Study|Lost to Follow-up|251|||
146057280|NCT00539981|526725586|FG000|Overall Study|Withdrew consent|22|||
146057281|NCT00539981|526725587|FG001|Overall Study|Withdrew consent|14|||
146057282|NCT00539981|526725586|FG000|Overall Study|Death|1|||
146283213|NCT01871805|527550162|FG002|Phase II|Death|0|||
146057283|NCT00539981|526725587|FG001|Overall Study|Death|1|||
146057284|NCT00539981|526725586|FG000|Overall Study|Other reason-unspecified|9|||
146057285|NCT00539981|526725587|FG001|Overall Study|Other reason-unspecified|13|||
146057286|NCT01323582|526725588|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
146057287|NCT01323582|526725589|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
146057288|NCT01323582|526725588|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
146057289|NCT01323582|526725589|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
146057290|NCT01323582|526725588|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
146057291|NCT01323582|526725589|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
146057292|NCT03473236|526725591|FG000|Overall Study|Withdrawal by Subject|0|||
146057293|NCT03473236|526725592|FG001|Overall Study|Withdrawal by Subject|0|||
146057294|NCT03473236|526725593|FG002|Overall Study|Withdrawal by Subject|0|||
146057295|NCT03473236|526725594|FG003|Overall Study|Withdrawal by Subject|0|||
146057296|NCT03473236|526725595|FG004|Overall Study|Withdrawal by Subject|0|||
146057297|NCT03473236|526725596|FG005|Overall Study|Withdrawal by Subject|1|||
146057298|NCT03473236|526725597|FG006|Overall Study|Withdrawal by Subject|0|||
146057299|NCT03473236|526725598|FG007|Overall Study|Withdrawal by Subject|0|||
146057300|NCT03473236|526725599|FG008|Overall Study|Withdrawal by Subject|1|||
146057301|NCT03473236|526725600|FG009|Overall Study|Withdrawal by Subject|0|||
146057302|NCT03155724|526725602|FG000|Overall Study|Death|3|||
146057303|NCT03155724|526725602|FG000|Overall Study|Physician Decision|1|||
146057304|NCT03155724|526725602|FG000|Overall Study|Study closure|7|||
146057305|NCT00525512|526725603|FG000|Double-Blind Phase|Adverse Event|48|||
146057306|NCT00525512|526725604|FG001|Double-Blind Phase|Adverse Event|28|||
146057307|NCT00525512|526725605|FG002|Double-Blind Phase|Adverse Event|0|||
146057308|NCT00525512|526725606|FG003|Double-Blind Phase|Adverse Event|0|||
146057309|NCT00525512|526725603|FG000|Double-Blind Phase|Protocol Violation|3|||
146057310|NCT00525512|526725604|FG001|Double-Blind Phase|Protocol Violation|1|||
146057311|NCT00525512|526725605|FG002|Double-Blind Phase|Protocol Violation|0|||
146057312|NCT00525512|526725606|FG003|Double-Blind Phase|Protocol Violation|0|||
146057313|NCT00525512|526725603|FG000|Double-Blind Phase|Lost to Follow-up|3|||
146057314|NCT00525512|526725604|FG001|Double-Blind Phase|Lost to Follow-up|7|||
146057315|NCT00525512|526725605|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146057316|NCT00525512|526725606|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146057317|NCT00525512|526725603|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
146057318|NCT00525512|526725604|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
146057319|NCT00525512|526725605|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146057320|NCT00525512|526725606|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146057321|NCT00525512|526725603|FG000|Double-Blind Phase|Lack of Efficacy|13|||
146057322|NCT00525512|526725604|FG001|Double-Blind Phase|Lack of Efficacy|5|||
146057323|NCT00525512|526725605|FG002|Double-Blind Phase|Lack of Efficacy|0|||
146057324|NCT00525512|526725606|FG003|Double-Blind Phase|Lack of Efficacy|0|||
146057325|NCT00525512|526725603|FG000|Double-Blind Phase|Other reason (not specified)|12|||
146057326|NCT00525512|526725604|FG001|Double-Blind Phase|Other reason (not specified)|13|||
146057327|NCT00525512|526725605|FG002|Double-Blind Phase|Other reason (not specified)|0|||
146057328|NCT00525512|526725606|FG003|Double-Blind Phase|Other reason (not specified)|0|||
146057329|NCT00525512|526725603|FG000|Open-Label Phase|Adverse Event|0|||
146057330|NCT00525512|526725604|FG001|Open-Label Phase|Adverse Event|0|||
146057331|NCT00525512|526725605|FG002|Open-Label Phase|Adverse Event|1|||
146057332|NCT00525512|526725606|FG003|Open-Label Phase|Adverse Event|0|||
146057333|NCT00525512|526725603|FG000|Open-Label Phase|Lost to Follow-up|0|||
146057334|NCT00525512|526725604|FG001|Open-Label Phase|Lost to Follow-up|0|||
146057335|NCT00525512|526725605|FG002|Open-Label Phase|Lost to Follow-up|1|||
146057336|NCT00525512|526725606|FG003|Open-Label Phase|Lost to Follow-up|0|||
146057337|NCT00525512|526725603|FG000|Open-Label Phase|Other reason (not specified)|0|||
146057338|NCT00525512|526725604|FG001|Open-Label Phase|Other reason (not specified)|0|||
146057339|NCT00525512|526725605|FG002|Open-Label Phase|Other reason (not specified)|4|||
146057340|NCT00525512|526725606|FG003|Open-Label Phase|Other reason (not specified)|5|||
146057341|NCT05893862|526725611|FG000|Overall Study|Physician Decision|0|||
146057342|NCT05893862|526725612|FG001|Overall Study|Physician Decision|1|||
146057343|NCT05893862|526725613|FG002|Overall Study|Physician Decision|0|||
146057344|NCT05893862|526725614|FG003|Overall Study|Physician Decision|0|||
146057345|NCT05893862|526725615|FG004|Overall Study|Physician Decision|1|||
146057346|NCT05893862|526725616|FG005|Overall Study|Physician Decision|0|||
146057347|NCT05893862|526725611|FG000|Overall Study|Withdrawal by Subject|1|||
146057348|NCT05893862|526725612|FG001|Overall Study|Withdrawal by Subject|7|||
146057349|NCT05893862|526725613|FG002|Overall Study|Withdrawal by Subject|1|||
146057350|NCT05893862|526725614|FG003|Overall Study|Withdrawal by Subject|3|||
146283214|NCT01871805|527550163|FG003|Phase II|Death|0|||
146057351|NCT05893862|526725615|FG004|Overall Study|Withdrawal by Subject|3|||
146057352|NCT05893862|526725616|FG005|Overall Study|Withdrawal by Subject|2|||
146057353|NCT05893862|526725611|FG000|Overall Study|Adverse Event|1|||
146057354|NCT05893862|526725612|FG001|Overall Study|Adverse Event|4|||
146057355|NCT05893862|526725613|FG002|Overall Study|Adverse Event|2|||
146057356|NCT05893862|526725614|FG003|Overall Study|Adverse Event|2|||
146057357|NCT05893862|526725615|FG004|Overall Study|Adverse Event|1|||
146283215|NCT01871805|527550164|FG004|Phase II|Death|0|||
146057358|NCT05893862|526725616|FG005|Overall Study|Adverse Event|0|||
146057359|NCT02919761|526725617|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
146057360|NCT02919761|526725618|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
146057361|NCT02919761|526725619|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
146057362|NCT02919761|526725617|FG000|Part 1: Open Label|Adverse Event|1|||
146057363|NCT02919761|526725618|FG001|Part 1: Open Label|Adverse Event|0|||
146057364|NCT02919761|526725619|FG002|Part 1: Open Label|Adverse Event|0|||
146057365|NCT02919761|526725617|FG000|Part 1: Open Label|Lost to Follow-up|1|||
146057366|NCT02919761|526725618|FG001|Part 1: Open Label|Lost to Follow-up|0|||
146057367|NCT02919761|526725619|FG002|Part 1: Open Label|Lost to Follow-up|0|||
146057368|NCT02919761|526725617|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
146057369|NCT02919761|526725618|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
146057370|NCT02919761|526725619|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
146057371|NCT02919761|526725617|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
146057372|NCT02919761|526725618|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
146057373|NCT02919761|526725619|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
146057374|NCT02919761|526725617|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
146057375|NCT02919761|526725618|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
146057376|NCT02919761|526725619|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
146057377|NCT02919761|526725617|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
146057378|NCT02919761|526725618|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
146057379|NCT02919761|526725619|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
146057380|NCT02919761|526725617|FG000|Part 1: Open Label|Termination by Sponsor|1|||
146057381|NCT02919761|526725618|FG001|Part 1: Open Label|Termination by Sponsor|0|||
146057382|NCT02919761|526725619|FG002|Part 1: Open Label|Termination by Sponsor|0|||
146057383|NCT02919761|526725617|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
146057384|NCT02919761|526725618|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
146057385|NCT02919761|526725619|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
146057386|NCT02919761|526725617|FG000|Part 2: Double-blind|Adverse Event|0|||
146057387|NCT02919761|526725618|FG001|Part 2: Double-blind|Adverse Event|1|||
146057388|NCT02919761|526725619|FG002|Part 2: Double-blind|Adverse Event|0|||
146057389|NCT02919761|526725617|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
146057390|NCT02919761|526725618|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
146057391|NCT02919761|526725619|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
146057392|NCT02919761|526725617|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
146057393|NCT02919761|526725618|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
146057394|NCT02919761|526725619|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
146057395|NCT02919761|526725617|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
146057396|NCT02919761|526725618|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
146057397|NCT02919761|526725619|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
146057398|NCT02919761|526725617|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
146057399|NCT02919761|526725618|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
146057400|NCT02919761|526725619|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
146057401|NCT02919761|526725617|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
146057402|NCT02919761|526725618|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
146057403|NCT02919761|526725619|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
146057404|NCT02919761|526725617|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
146057405|NCT02919761|526725618|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
146057406|NCT02919761|526725619|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
146057407|NCT05546476|526727217|FG000|Period 1: Part A|Adverse Event|2|||
146057408|NCT05546476|526727218|FG001|Period 1: Part A|Adverse Event|0|||
146057409|NCT05546476|526727219|FG002|Period 1: Part A|Adverse Event|0|||
146057410|NCT05546476|526727220|FG003|Period 1: Part A|Adverse Event|1|||
146057411|NCT05546476|526727217|FG000|Period 1: Part A|Death|4|||
146057412|NCT05546476|526727218|FG001|Period 1: Part A|Death|4|||
146057413|NCT05546476|526727219|FG002|Period 1: Part A|Death|5|||
146057414|NCT05546476|526727220|FG003|Period 1: Part A|Death|6|||
146057415|NCT05546476|526727217|FG000|Period 1: Part A|Lack of Efficacy|0|||
146057416|NCT05546476|526727218|FG001|Period 1: Part A|Lack of Efficacy|0|||
146057417|NCT05546476|526727219|FG002|Period 1: Part A|Lack of Efficacy|0|||
146057418|NCT05546476|526727220|FG003|Period 1: Part A|Lack of Efficacy|1|||
146057419|NCT05546476|526727217|FG000|Period 1: Part A|Lost to Follow-up|0|||
146057420|NCT05546476|526727218|FG001|Period 1: Part A|Lost to Follow-up|0|||
146057421|NCT05546476|526727219|FG002|Period 1: Part A|Lost to Follow-up|0|||
146283216|NCT01871805|527550165|FG005|Phase II|Death|45|||
146057422|NCT05546476|526727220|FG003|Period 1: Part A|Lost to Follow-up|1|||
146057423|NCT05546476|526727217|FG000|Period 1: Part A|Physician Decision|1|||
146057424|NCT05546476|526727218|FG001|Period 1: Part A|Physician Decision|0|||
146057425|NCT05546476|526727219|FG002|Period 1: Part A|Physician Decision|0|||
146057426|NCT05546476|526727220|FG003|Period 1: Part A|Physician Decision|0|||
146057427|NCT05546476|526727217|FG000|Period 1: Part A|Progressive disease|3|||
146057428|NCT05546476|526727218|FG001|Period 1: Part A|Progressive disease|5|||
146057429|NCT05546476|526727219|FG002|Period 1: Part A|Progressive disease|0|||
146283217|NCT01871805|527550160|FG000|Phase II|Alive in Survival Follow-up|0|||
146057430|NCT05546476|526727220|FG003|Period 1: Part A|Progressive disease|1|||
146057431|NCT05546476|526727217|FG000|Period 1: Part A|Withdrawal by Subject|1|||
146057432|NCT05546476|526727218|FG001|Period 1: Part A|Withdrawal by Subject|1|||
146057433|NCT05546476|526727219|FG002|Period 1: Part A|Withdrawal by Subject|1|||
146057434|NCT05546476|526727220|FG003|Period 1: Part A|Withdrawal by Subject|2|||
146057435|NCT05546476|526727217|FG000|Period 1: Part A|Global deterioration of health status|2|||
146057436|NCT05546476|526727218|FG001|Period 1: Part A|Global deterioration of health status|2|||
146057437|NCT05546476|526727219|FG002|Period 1: Part A|Global deterioration of health status|1|||
146057438|NCT05546476|526727220|FG003|Period 1: Part A|Global deterioration of health status|4|||
146057439|NCT05546476|526727217|FG000|Period 1: Part A|Other: Unspecified|0|||
146057440|NCT05546476|526727218|FG001|Period 1: Part A|Other: Unspecified|2|||
146057441|NCT05546476|526727219|FG002|Period 1: Part A|Other: Unspecified|0|||
146057442|NCT05546476|526727220|FG003|Period 1: Part A|Other: Unspecified|0|||
146057443|NCT05546476|526727217|FG000|Period 2: Part B|Ongoing|26|||
146057444|NCT05546476|526727218|FG001|Period 2: Part B|Ongoing|27|||
146057445|NCT05546476|526727219|FG002|Period 2: Part B|Ongoing|35|||
146057446|NCT05546476|526727220|FG003|Period 2: Part B|Ongoing|29|||
146057447|NCT04890652|526727230|FG000|Overall Study|Withdrawal by Subject|2|||
146057448|NCT04750824|526727235|FG000|Overall Study|Toxicity/intolerability|3|||
146057449|NCT04750824|526727236|FG001|Overall Study|Toxicity/intolerability|1|||
146057450|NCT04750824|526727235|FG000|Overall Study|Death|1|||
146057451|NCT04750824|526727236|FG001|Overall Study|Death|3|||
146057452|NCT04750824|526727235|FG000|Overall Study|Scheduled duration of therapy complete|1|||
146057453|NCT04750824|526727236|FG001|Overall Study|Scheduled duration of therapy complete|9|||
146057454|NCT04750824|526727235|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
146057455|NCT04750824|526727236|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
146057456|NCT00807911|526727237|FG000|Overall Study|Withdrawal by Subject|12|||
146057457|NCT00807911|526727238|FG001|Overall Study|Withdrawal by Subject|10|||
146057458|NCT00807911|526727237|FG000|Overall Study|Ineligible|0|||
146057459|NCT00807911|526727238|FG001|Overall Study|Ineligible|4|||
146057460|NCT04349891|526727241|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
146057461|NCT04349891|526727242|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
146057462|NCT04349891|526727241|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
146057463|NCT04349891|526727242|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
146057464|NCT04349891|526727241|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
146057465|NCT04349891|526727242|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
146057466|NCT04349891|526727241|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
146057467|NCT04349891|526727242|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
146169825|NCT01108458|527134717|FG000|Overall Study|Withdrawal by Subject|1|||
146169826|NCT05044325|527134725|FG000|Part A:Treatment Period 1|Adverse Event|0|||
146169827|NCT05044325|527134726|FG001|Part A:Treatment Period 1|Adverse Event|0|||
146283218|NCT01871805|527550161|FG001|Phase II|Alive in Survival Follow-up|0|||
146057472|NCT00836589|526727249|FG000|Overall Study|Lost to Follow-up|246|||
146057473|NCT00836589|526727249|FG000|Overall Study|Death|429|||
146057474|NCT00836589|526727249|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
146057475|NCT02914639|526727252|FG000|Overall Study|Withdrawal by Subject|0|||
146057476|NCT02914639|526727253|FG001|Overall Study|Withdrawal by Subject|2|||
146057477|NCT01018030|526727254|FG000|Overall Study|Adverse Event|10|||
146057478|NCT01018030|526727255|FG001|Overall Study|Adverse Event|5|||
146057479|NCT01018030|526727256|FG002|Overall Study|Adverse Event|5|||
146057480|NCT01018030|526727254|FG000|Overall Study|Withdrawal by Subject|2|||
146057481|NCT01018030|526727255|FG001|Overall Study|Withdrawal by Subject|2|||
146057482|NCT01018030|526727256|FG002|Overall Study|Withdrawal by Subject|4|||
146057483|NCT01018030|526727254|FG000|Overall Study|Lost to Follow-up|2|||
146057484|NCT01018030|526727255|FG001|Overall Study|Lost to Follow-up|0|||
146057485|NCT01018030|526727256|FG002|Overall Study|Lost to Follow-up|3|||
146057486|NCT01018030|526727254|FG000|Overall Study|Protocol Violation|2|||
146057487|NCT01018030|526727255|FG001|Overall Study|Protocol Violation|1|||
146057488|NCT01018030|526727256|FG002|Overall Study|Protocol Violation|0|||
146057489|NCT01018030|526727254|FG000|Overall Study|Physician Decision|1|||
146057490|NCT01018030|526727255|FG001|Overall Study|Physician Decision|0|||
146057491|NCT01018030|526727256|FG002|Overall Study|Physician Decision|1|||
146057492|NCT01018030|526727254|FG000|Overall Study|Lack of Efficacy|1|||
146057493|NCT01018030|526727255|FG001|Overall Study|Lack of Efficacy|0|||
146057494|NCT01018030|526727256|FG002|Overall Study|Lack of Efficacy|0|||
146057495|NCT01018030|526727254|FG000|Overall Study|Did Not Receive Study Drug|1|||
146057496|NCT01018030|526727255|FG001|Overall Study|Did Not Receive Study Drug|3|||
146057497|NCT01018030|526727256|FG002|Overall Study|Did Not Receive Study Drug|0|||
146057498|NCT01089504|526727257|FG000|Overall Study|Lost to Follow-up|1|||
146057499|NCT01089504|526727258|FG001|Overall Study|Lost to Follow-up|1|||
146057500|NCT01089504|526727257|FG000|Overall Study|Withdrawal by Subject|2|||
146057501|NCT01089504|526727258|FG001|Overall Study|Withdrawal by Subject|0|||
146057502|NCT00062439|526727259|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
146057503|NCT00062439|526727259|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
146057504|NCT00062439|526727259|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
146057505|NCT00062439|526727259|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
146057506|NCT00062439|526727259|FG000|Post Chemoradiation Assessment|Death|1|||
146057507|NCT00062439|526727259|FG000|Post Chemoradiation Assessment|Disease progression|2|||
146057508|NCT00062439|526727259|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
146057509|NCT00062439|526727259|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
146057510|NCT00062439|526727259|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
146057511|NCT00062439|526727259|FG000|Surgery|Physician Decision|4|||
146057512|NCT00062439|526727259|FG000|Surgery|Death|1|||
146057513|NCT00062439|526727259|FG000|Surgery|Adverse Event|2|||
146057514|NCT00062439|526727259|FG000|Consolidation Chemotherapy|Adverse Event|2|||
146057515|NCT01924845|526727260|FG000|Overall Study|Adverse Event|3|||
146057516|NCT01924845|526727260|FG000|Overall Study|Withdrawal by Subject|2|||
146057517|NCT01924845|526727260|FG000|Overall Study|Protocol Violation|1|||
146057518|NCT04529083|526727261|FG000|Overall Study|Withdrawal by Subject|3|||
146057519|NCT04196686|526727266|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
146057520|NCT04196686|526727267|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
146057521|NCT05106959|526727268|FG000|Overall Study|Lost to Follow-up|1|||
146057522|NCT00265564|526727275|FG000|Overall Study|Lost to Follow-up|5|||
146057523|NCT00265564|526727276|FG001|Overall Study|Lost to Follow-up|7|||
146057524|NCT00265564|526727275|FG000|Overall Study|met exclusion criteria|5|||
146057525|NCT00265564|526727276|FG001|Overall Study|met exclusion criteria|2|||
146057526|NCT01553084|526727277|FG000|Overall Study|Withdrawal by Subject|15|||
146057527|NCT01553084|526727278|FG001|Overall Study|Withdrawal by Subject|13|||
146057528|NCT01553084|526727279|FG002|Overall Study|Withdrawal by Subject|35|||
146057529|NCT00659061|526727282|FG000|Overall Study|Migration due to political unrest|21|||
146057530|NCT00659061|526727283|FG001|Overall Study|Migration due to political unrest|15|||
146057531|NCT01277744|526727284|FG000|Overall Study|Physician Decision|2|||
146057532|NCT00475670|526727290|FG000|Overall Study|Death|0|||
146057533|NCT00475670|526727291|FG001|Overall Study|Death|1|||
146057534|NCT00475670|526727290|FG000|Overall Study|Lack of Efficacy|3|||
146057535|NCT00475670|526727291|FG001|Overall Study|Lack of Efficacy|34|||
146057536|NCT00475670|526727290|FG000|Overall Study|Refused treatment|0|||
146057537|NCT00475670|526727291|FG001|Overall Study|Refused treatment|2|||
146057538|NCT00475670|526727290|FG000|Overall Study|Failure to Return|0|||
146057539|NCT00475670|526727291|FG001|Overall Study|Failure to Return|1|||
146057540|NCT00475670|526727290|FG000|Overall Study|Other|0|||
146057541|NCT00475670|526727291|FG001|Overall Study|Other|3|||
146057542|NCT04949191|526727292|FG000|Overall Study|Non-compliance with Study Drug|1|||
146057543|NCT04949191|526727293|FG001|Overall Study|Non-compliance with Study Drug|0|||
146057544|NCT04949191|526727294|FG002|Overall Study|Non-compliance with Study Drug|0|||
146057545|NCT04949191|526727295|FG003|Overall Study|Non-compliance with Study Drug|0|||
146057546|NCT04949191|526727292|FG000|Overall Study|Progressive Disease|0|||
146057547|NCT04949191|526727293|FG001|Overall Study|Progressive Disease|1|||
146057548|NCT04949191|526727294|FG002|Overall Study|Progressive Disease|0|||
146057549|NCT04949191|526727295|FG003|Overall Study|Progressive Disease|0|||
146057550|NCT04949191|526727292|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146057551|NCT04949191|526727293|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
146057552|NCT04949191|526727294|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146057553|NCT04949191|526727295|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
146057554|NCT04949191|526727292|FG000|Overall Study|Sponsor Terminated Study|0|||
146057555|NCT04949191|526727293|FG001|Overall Study|Sponsor Terminated Study|0|||
146057556|NCT04949191|526727294|FG002|Overall Study|Sponsor Terminated Study|1|||
146057557|NCT04949191|526727295|FG003|Overall Study|Sponsor Terminated Study|1|||
146057558|NCT01168349|526727296|FG000|Overall Study|Death|157|||
146057559|NCT01168349|526727296|FG000|Overall Study|Lost to Follow-up|34|||
146057560|NCT01168349|526727296|FG000|Overall Study|Withdrawal by Subject|9|||
146057561|NCT01168349|526727296|FG000|Overall Study|Kidney transplantation|3|||
146057562|NCT01168349|526727296|FG000|Overall Study|Other|22|||
146057563|NCT01168349|526727296|FG000|Overall Study|Protocol Violation|76|||
146057564|NCT02678351|526727297|FG000|Overall Study|Withdrawal by Subject|1|||
146057565|NCT01632020|526727298|FG000|Overall Study|Withdrawal by Subject|1|||
146057566|NCT01632020|526727299|FG001|Overall Study|Withdrawal by Subject|0|||
146057567|NCT01632020|526727298|FG000|Overall Study|Adverse Event|1|||
146057568|NCT01632020|526727299|FG001|Overall Study|Adverse Event|0|||
146057569|NCT01046565|526727300|FG000|Overall Study|Adverse Event|2|||
146057570|NCT01046565|526727300|FG000|Overall Study|Withdrawal by Subject|7|||
146057571|NCT02978417|526727304|FG000|Overall Study|Lost to Follow-up|2|||
146057572|NCT02978417|526727305|FG001|Overall Study|Lost to Follow-up|2|||
146057573|NCT05083351|526727310|FG000|Overall Study|Adverse Event|3|||
146057574|NCT05083351|526727310|FG000|Overall Study|Did not meet data inclusion criteria|8|||
146057575|NCT05083351|526727310|FG000|Overall Study|Did not meet eligibility criteria|19|||
146057576|NCT05083351|526727310|FG000|Overall Study|Study Staff Decision|19|||
146057577|NCT03416868|526727316|FG000|Overall Study|Withdrawal by Subject|2|||
146057578|NCT03416868|526727316|FG000|Overall Study|Lost to Follow-up|1|||
146057579|NCT00960375|526727321|FG000|Overall Study|Lost to Follow-up|20|||
146057580|NCT00960375|526727322|FG001|Overall Study|Lost to Follow-up|22|||
146057581|NCT03353675|526727339|FG000|Overall Study|Adverse Event|4|||
146057582|NCT03309020|526727340|FG000|Overall Study|Death|1|||
146057583|NCT03309020|526727341|FG001|Overall Study|Death|0|||
146057584|NCT03309020|526727340|FG000|Overall Study|Did not undergo surgery|2|||
146057585|NCT03309020|526727341|FG001|Overall Study|Did not undergo surgery|1|||
146057586|NCT00402168|526727342|FG000|Randomized|Lost to Follow-up|1|||
146057587|NCT00402168|526727343|FG001|Randomized|Lost to Follow-up|0|||
146057588|NCT00402168|526727342|FG000|Randomized|Withdrawal by Subject|0|||
146057589|NCT00402168|526727343|FG001|Randomized|Withdrawal by Subject|1|||
146057590|NCT00402168|526727342|FG000|Treatment (up to 12 Months)|Death|0|||
146057591|NCT00402168|526727343|FG001|Treatment (up to 12 Months)|Death|1|||
146057592|NCT00402168|526727342|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
146057593|NCT00402168|526727343|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
146057594|NCT00402168|526727342|FG000|Treatment (up to 12 Months)|non-specified|0|||
146057595|NCT00402168|526727343|FG001|Treatment (up to 12 Months)|non-specified|1|||
146057596|NCT00402168|526727342|FG000|Long Term (LT)|Adverse Event|1|||
146057597|NCT00402168|526727343|FG001|Long Term (LT)|Adverse Event|5|||
146057598|NCT00402168|526727342|FG000|Long Term (LT)|Withdrawal by Subject|4|||
146057599|NCT00402168|526727343|FG001|Long Term (LT)|Withdrawal by Subject|7|||
146057600|NCT00402168|526727342|FG000|Long Term (LT)|Pregnancy|0|||
146057601|NCT00402168|526727343|FG001|Long Term (LT)|Pregnancy|1|||
146057602|NCT00402168|526727342|FG000|Long Term (LT)|Lost to Follow-up|1|||
146057603|NCT00402168|526727343|FG001|Long Term (LT)|Lost to Follow-up|0|||
146057604|NCT00402168|526727342|FG000|Long Term (LT)|Death|4|||
146057605|NCT00402168|526727343|FG001|Long Term (LT)|Death|0|||
146057606|NCT00402168|526727342|FG000|Long Term (LT)|Lack of Efficacy|0|||
146057607|NCT00402168|526727343|FG001|Long Term (LT)|Lack of Efficacy|2|||
146057608|NCT00402168|526727342|FG000|Long Term (LT)|non-specified|1|||
146057609|NCT00402168|526727343|FG001|Long Term (LT)|non-specified|2|||
146057610|NCT00402168|526727342|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
146057611|NCT00402168|526727343|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
146057612|NCT00402168|526727342|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
146057613|NCT00402168|526727343|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
146057614|NCT00601835|526727347|FG000|Overall Study|Withdrawal by Subject|9|||
146057615|NCT00601835|526727348|FG001|Overall Study|Withdrawal by Subject|6|||
146057616|NCT00601835|526727347|FG000|Overall Study|Physician Decision|1|||
146057617|NCT00601835|526727348|FG001|Overall Study|Physician Decision|0|||
146057618|NCT00601835|526727347|FG000|Overall Study|Lost to Follow-up|37|||
146057619|NCT00601835|526727348|FG001|Overall Study|Lost to Follow-up|5|||
146057620|NCT00601835|526727347|FG000|Overall Study|Adverse Event|1|||
146057621|NCT00601835|526727348|FG001|Overall Study|Adverse Event|1|||
146057622|NCT00601835|526727347|FG000|Overall Study|Relocate|12|||
146057623|NCT00601835|526727348|FG001|Overall Study|Relocate|2|||
146057624|NCT02370420|526727351|FG000|Overall Study|Physician Decision|3|||
146057625|NCT02370420|526727352|FG001|Overall Study|Physician Decision|3|||
146057626|NCT02370420|526727351|FG000|Overall Study|Lost to Follow-up|11|||
146057627|NCT02370420|526727352|FG001|Overall Study|Lost to Follow-up|9|||
146057628|NCT00880620|526727353|FG000|Overall Study|Adverse Event|4|||
146057629|NCT00880620|526727354|FG001|Overall Study|Adverse Event|5|||
146057630|NCT00880620|526727355|FG002|Overall Study|Adverse Event|15|||
146057631|NCT00880620|526727356|FG003|Overall Study|Adverse Event|15|||
146057632|NCT00880620|526727353|FG000|Overall Study|Death|0|||
146057633|NCT00880620|526727354|FG001|Overall Study|Death|0|||
146057634|NCT00880620|526727355|FG002|Overall Study|Death|1|||
146057635|NCT00880620|526727356|FG003|Overall Study|Death|0|||
146283219|NCT01871805|527550162|FG002|Phase II|Alive in Survival Follow-up|0|||
146283220|NCT01871805|527550163|FG003|Phase II|Alive in Survival Follow-up|0|||
146057636|NCT00880620|526727353|FG000|Overall Study|Lack of Efficacy|12|||
146057637|NCT00880620|526727354|FG001|Overall Study|Lack of Efficacy|4|||
146057638|NCT00880620|526727355|FG002|Overall Study|Lack of Efficacy|0|||
146057639|NCT00880620|526727356|FG003|Overall Study|Lack of Efficacy|1|||
146057640|NCT00880620|526727353|FG000|Overall Study|Lost to Follow-up|0|||
146057641|NCT00880620|526727354|FG001|Overall Study|Lost to Follow-up|1|||
146283221|NCT01871805|527550164|FG004|Phase II|Alive in Survival Follow-up|0|||
146057642|NCT00880620|526727355|FG002|Overall Study|Lost to Follow-up|1|||
146057643|NCT00880620|526727356|FG003|Overall Study|Lost to Follow-up|0|||
146057644|NCT00880620|526727353|FG000|Overall Study|Protocol Violation|0|||
146057645|NCT00880620|526727354|FG001|Overall Study|Protocol Violation|1|||
146057646|NCT00880620|526727355|FG002|Overall Study|Protocol Violation|0|||
146057647|NCT00880620|526727356|FG003|Overall Study|Protocol Violation|2|||
146057648|NCT00880620|526727353|FG000|Overall Study|Withdrawal by Subject|4|||
146057649|NCT00880620|526727354|FG001|Overall Study|Withdrawal by Subject|3|||
146057650|NCT00880620|526727355|FG002|Overall Study|Withdrawal by Subject|1|||
146057651|NCT00880620|526727356|FG003|Overall Study|Withdrawal by Subject|3|||
146057652|NCT00880620|526727353|FG000|Overall Study|Noncompliance|0|||
146057653|NCT00880620|526727354|FG001|Overall Study|Noncompliance|0|||
146057654|NCT00880620|526727355|FG002|Overall Study|Noncompliance|1|||
146057655|NCT00880620|526727356|FG003|Overall Study|Noncompliance|1|||
146057656|NCT00880620|526727353|FG000|Overall Study|Other|1|||
146057657|NCT00880620|526727354|FG001|Overall Study|Other|1|||
146057658|NCT00880620|526727355|FG002|Overall Study|Other|2|||
146057659|NCT00880620|526727356|FG003|Overall Study|Other|2|||
146057660|NCT01400698|526727357|FG000|Overall Study|Lost to Follow-up|2|||
146057661|NCT01400698|526727358|FG001|Overall Study|Lost to Follow-up|5|||
146057662|NCT01400698|526727359|FG002|Overall Study|Lost to Follow-up|2|||
146057663|NCT01400698|526727360|FG003|Overall Study|Lost to Follow-up|1|||
146057664|NCT01400698|526727361|FG004|Overall Study|Lost to Follow-up|4|||
146057665|NCT01400698|526727362|FG005|Overall Study|Lost to Follow-up|3|||
146057666|NCT01400698|526727357|FG000|Overall Study|Withdrawal by Subject|8|||
146057667|NCT01400698|526727358|FG001|Overall Study|Withdrawal by Subject|2|||
146057668|NCT01400698|526727359|FG002|Overall Study|Withdrawal by Subject|0|||
146057669|NCT01400698|526727360|FG003|Overall Study|Withdrawal by Subject|4|||
146057670|NCT01400698|526727361|FG004|Overall Study|Withdrawal by Subject|1|||
146057671|NCT01400698|526727362|FG005|Overall Study|Withdrawal by Subject|3|||
146057672|NCT01400698|526727357|FG000|Overall Study|Protocol Violation|0|||
146057673|NCT01400698|526727358|FG001|Overall Study|Protocol Violation|1|||
146057674|NCT01400698|526727359|FG002|Overall Study|Protocol Violation|0|||
146057675|NCT01400698|526727360|FG003|Overall Study|Protocol Violation|0|||
146057676|NCT01400698|526727361|FG004|Overall Study|Protocol Violation|1|||
146057677|NCT01400698|526727362|FG005|Overall Study|Protocol Violation|0|||
146057678|NCT01400698|526727357|FG000|Overall Study|Non-compliance|0|||
146057679|NCT01400698|526727358|FG001|Overall Study|Non-compliance|1|||
146057680|NCT01400698|526727359|FG002|Overall Study|Non-compliance|0|||
146057681|NCT01400698|526727360|FG003|Overall Study|Non-compliance|1|||
146057682|NCT01400698|526727361|FG004|Overall Study|Non-compliance|0|||
146057683|NCT01400698|526727362|FG005|Overall Study|Non-compliance|0|||
146057684|NCT01400698|526727357|FG000|Overall Study|Adverse Event|1|||
146057685|NCT01400698|526727358|FG001|Overall Study|Adverse Event|0|||
146057686|NCT01400698|526727359|FG002|Overall Study|Adverse Event|0|||
146057687|NCT01400698|526727360|FG003|Overall Study|Adverse Event|0|||
146057688|NCT01400698|526727361|FG004|Overall Study|Adverse Event|0|||
146057689|NCT01400698|526727362|FG005|Overall Study|Adverse Event|0|||
146057690|NCT01400698|526727357|FG000|Overall Study|Other|4|||
146057691|NCT01400698|526727358|FG001|Overall Study|Other|2|||
146057692|NCT01400698|526727359|FG002|Overall Study|Other|0|||
146057693|NCT01400698|526727360|FG003|Overall Study|Other|2|||
146057694|NCT01400698|526727361|FG004|Overall Study|Other|1|||
146057695|NCT01400698|526727362|FG005|Overall Study|Other|0|||
146057696|NCT02814916|526729371|FG000|Overall Study|Withdrawal of consent|0|||
146057697|NCT02814916|526729372|FG001|Overall Study|Withdrawal of consent|2|||
146057698|NCT02814916|526729373|FG002|Overall Study|Withdrawal of consent|0|||
146057699|NCT02814916|526729371|FG000|Overall Study|Lost to Follow-up|0|||
146057700|NCT02814916|526729372|FG001|Overall Study|Lost to Follow-up|1|||
146057701|NCT02814916|526729373|FG002|Overall Study|Lost to Follow-up|0|||
146057702|NCT02814916|526729371|FG000|Overall Study|Other, not specified|0|||
146057703|NCT02814916|526729372|FG001|Overall Study|Other, not specified|1|||
146057704|NCT02814916|526729373|FG002|Overall Study|Other, not specified|0|||
146057705|NCT05543265|526729374|FG000|Overall Study|Lost to Follow-up|3|||
146057706|NCT05543265|526729375|FG001|Overall Study|Lost to Follow-up|3|||
146057707|NCT05543265|526729374|FG000|Overall Study|Withdrawal by Subject|0|||
146057708|NCT05543265|526729375|FG001|Overall Study|Withdrawal by Subject|1|||
146057709|NCT05316597|526729376|FG000|First Session|Withdrawal by Subject|0|||
146057710|NCT05316597|526729377|FG001|First Session|Withdrawal by Subject|1|||
146057711|NCT05316597|526729376|FG000|Washout Period|Lost to Follow-up|1|||
146057712|NCT05316597|526729377|FG001|Washout Period|Lost to Follow-up|2|||
146057713|NCT05316597|526729376|FG000|Washout Period|Physician Decision|1|||
146057714|NCT05316597|526729377|FG001|Washout Period|Physician Decision|1|||
146057715|NCT05316597|526729376|FG000|Washout Period|Excluded before second session|1|||
146057716|NCT05316597|526729377|FG001|Washout Period|Excluded before second session|1|||
146057717|NCT05316597|526729376|FG000|Washout Period|Withdrawal by Subject|0|||
146057718|NCT05316597|526729377|FG001|Washout Period|Withdrawal by Subject|4|||
146057719|NCT01706458|526729380|FG000|Overall Study|Physician Decision|3|||
146057720|NCT01706458|526729381|FG001|Overall Study|Physician Decision|4|||
146057721|NCT03547518|526729385|FG000|Overall Study|Lost to Follow-up|2|||
146057722|NCT03547518|526729386|FG001|Overall Study|Lost to Follow-up|0|||
146057723|NCT02953652|526729390|FG000|Overall Study|Adverse Event|18|||
146057724|NCT02953652|526729390|FG000|Overall Study|Withdrawal by Subject|6|||
146057725|NCT02953652|526729390|FG000|Overall Study|Protocol Violation|1|||
146057726|NCT02953652|526729390|FG000|Overall Study|Disease Progression|27|||
146057727|NCT03192176|526729392|FG000|Overall Study|Adverse Event|1|||
146057728|NCT03192176|526729393|FG001|Overall Study|Adverse Event|0|||
146057729|NCT03192176|526729394|FG002|Overall Study|Adverse Event|4|||
146057730|NCT03192176|526729395|FG003|Overall Study|Adverse Event|5|||
146057731|NCT03192176|526729396|FG004|Overall Study|Adverse Event|3|||
146057732|NCT03192176|526729397|FG005|Overall Study|Adverse Event|2|||
146057733|NCT03192176|526729398|FG006|Overall Study|Adverse Event|3|||
146057734|NCT03192176|526729399|FG007|Overall Study|Adverse Event|3|||
146057735|NCT03192176|526729392|FG000|Overall Study|Lost to Follow-up|0|||
146057736|NCT03192176|526729393|FG001|Overall Study|Lost to Follow-up|0|||
146057737|NCT03192176|526729394|FG002|Overall Study|Lost to Follow-up|1|||
146057738|NCT03192176|526729395|FG003|Overall Study|Lost to Follow-up|2|||
146057739|NCT03192176|526729396|FG004|Overall Study|Lost to Follow-up|3|||
146057740|NCT03192176|526729397|FG005|Overall Study|Lost to Follow-up|1|||
146057741|NCT03192176|526729398|FG006|Overall Study|Lost to Follow-up|1|||
146057742|NCT03192176|526729399|FG007|Overall Study|Lost to Follow-up|1|||
146057743|NCT03192176|526729392|FG000|Overall Study|Physician Decision|1|||
146057744|NCT03192176|526729393|FG001|Overall Study|Physician Decision|0|||
146057745|NCT03192176|526729394|FG002|Overall Study|Physician Decision|0|||
146057746|NCT03192176|526729395|FG003|Overall Study|Physician Decision|0|||
146057747|NCT03192176|526729396|FG004|Overall Study|Physician Decision|0|||
146057748|NCT03192176|526729397|FG005|Overall Study|Physician Decision|2|||
146057749|NCT03192176|526729398|FG006|Overall Study|Physician Decision|1|||
146057750|NCT03192176|526729399|FG007|Overall Study|Physician Decision|0|||
146057751|NCT03192176|526729392|FG000|Overall Study|Protocol Deviation|1|||
146057752|NCT03192176|526729393|FG001|Overall Study|Protocol Deviation|1|||
146057753|NCT03192176|526729394|FG002|Overall Study|Protocol Deviation|0|||
146057754|NCT03192176|526729395|FG003|Overall Study|Protocol Deviation|0|||
146057755|NCT03192176|526729396|FG004|Overall Study|Protocol Deviation|2|||
146057756|NCT03192176|526729397|FG005|Overall Study|Protocol Deviation|0|||
146057757|NCT03192176|526729398|FG006|Overall Study|Protocol Deviation|0|||
146057758|NCT03192176|526729399|FG007|Overall Study|Protocol Deviation|0|||
146057759|NCT03192176|526729392|FG000|Overall Study|Withdrawal by Subject|3|||
146057760|NCT03192176|526729393|FG001|Overall Study|Withdrawal by Subject|4|||
146057761|NCT03192176|526729394|FG002|Overall Study|Withdrawal by Subject|0|||
146057762|NCT03192176|526729395|FG003|Overall Study|Withdrawal by Subject|4|||
146057763|NCT03192176|526729396|FG004|Overall Study|Withdrawal by Subject|3|||
146057764|NCT03192176|526729397|FG005|Overall Study|Withdrawal by Subject|4|||
146057765|NCT03192176|526729398|FG006|Overall Study|Withdrawal by Subject|4|||
146057766|NCT03192176|526729399|FG007|Overall Study|Withdrawal by Subject|2|||
146057767|NCT03192176|526729392|FG000|Overall Study|Miscellaneous|1|||
146057768|NCT03192176|526729393|FG001|Overall Study|Miscellaneous|0|||
146057769|NCT03192176|526729394|FG002|Overall Study|Miscellaneous|1|||
146057770|NCT03192176|526729395|FG003|Overall Study|Miscellaneous|1|||
146057771|NCT03192176|526729396|FG004|Overall Study|Miscellaneous|1|||
146057772|NCT03192176|526729397|FG005|Overall Study|Miscellaneous|2|||
146057773|NCT03192176|526729398|FG006|Overall Study|Miscellaneous|0|||
146057774|NCT03192176|526729399|FG007|Overall Study|Miscellaneous|1|||
146057775|NCT02384551|526729402|FG000|Overall Study|Lost to Follow-up|13|||
146057776|NCT02384551|526729403|FG001|Overall Study|Lost to Follow-up|14|||
146057777|NCT02384551|526729404|FG002|Overall Study|Lost to Follow-up|14|||
146057778|NCT02384551|526729405|FG003|Overall Study|Lost to Follow-up|14|||
146057779|NCT02927301|526729408|FG000|Overall Study|Death|39|||
146057780|NCT02927301|526729408|FG000|Overall Study|Lost to Follow-up|8|||
146057781|NCT02927301|526729408|FG000|Overall Study|Physician Decision|2|||
146057782|NCT02927301|526729408|FG000|Overall Study|Withdrawal by Subject|12|||
146057783|NCT02927301|526729408|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
146057784|NCT04247347|526729411|FG000|Overall Study|Withdrawal by Subject|2|||
146057785|NCT04247347|526729412|FG001|Overall Study|Withdrawal by Subject|3|||
146057786|NCT04247347|526729413|FG002|Overall Study|Withdrawal by Subject|3|||
146057787|NCT04247347|526729411|FG000|Overall Study|Lost to Follow-up|1|||
146057788|NCT04247347|526729412|FG001|Overall Study|Lost to Follow-up|1|||
146057789|NCT04247347|526729413|FG002|Overall Study|Lost to Follow-up|1|||
146057790|NCT03035032|526729414|FG000|Overall Study|Adverse Event|2|||
146057791|NCT03035032|526729414|FG000|Overall Study|Death|9|||
146283222|NCT01871805|527550165|FG005|Phase II|Alive in Survival Follow-up|29|||
146283223|NCT01871805|527550160|FG000|Phase II|Lost to Follow-up|0|||
146283224|NCT01871805|527550161|FG001|Phase II|Lost to Follow-up|0|||
146057792|NCT03035032|526729414|FG000|Overall Study|Lost to Follow-up|1|||
146057793|NCT03035032|526729414|FG000|Overall Study|Progressive Disease|22|||
146057794|NCT03035032|526729414|FG000|Overall Study|Protocol Violation|2|||
146057795|NCT03035032|526729414|FG000|Overall Study|Withdrawal by Subject|2|||
146057796|NCT03035032|526729414|FG000|Overall Study|Physician Decision|5|||
146057797|NCT02399215|526729429|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
146057798|NCT02399215|526729429|FG000|Overall Study|Withdrawal by Subject|1|||
146057799|NCT00772538|526729430|FG000|Overall Study|Adverse Event|6|||
146057800|NCT00772538|526729431|FG001|Overall Study|Adverse Event|6|||
146057801|NCT00772538|526729430|FG000|Overall Study|Protocol Violation|3|||
146057802|NCT00772538|526729431|FG001|Overall Study|Protocol Violation|3|||
146057803|NCT00772538|526729430|FG000|Overall Study|Lost to Follow-up|1|||
146057804|NCT00772538|526729431|FG001|Overall Study|Lost to Follow-up|1|||
146057805|NCT00772538|526729430|FG000|Overall Study|Withdrawal by Subject|3|||
146057806|NCT00772538|526729431|FG001|Overall Study|Withdrawal by Subject|8|||
146057807|NCT00772538|526729430|FG000|Overall Study|Lack of Efficacy|0|||
146057808|NCT00772538|526729431|FG001|Overall Study|Lack of Efficacy|1|||
146057809|NCT00772538|526729430|FG000|Overall Study|Other|7|||
146057810|NCT00772538|526729431|FG001|Overall Study|Other|7|||
146057811|NCT00189540|526729432|FG000|Overall Study|Withdrawal by Subject|3|||
146057812|NCT00189540|526729433|FG001|Overall Study|Withdrawal by Subject|0|||
146057813|NCT00189540|526729432|FG000|Overall Study|Death|4|||
146283225|NCT01871805|527550162|FG002|Phase II|Lost to Follow-up|0|||
146057814|NCT00189540|526729433|FG001|Overall Study|Death|1|||
146057815|NCT00001832|526729434|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
146057816|NCT00001832|526729435|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
146057817|NCT00001832|526729436|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
146057818|NCT00001832|526729437|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
146057819|NCT00001832|526729438|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
146057820|NCT00001832|526729439|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
146057821|NCT00001832|526729440|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
146057822|NCT00001832|526729441|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
146057823|NCT00001832|526729442|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
146057824|NCT00001832|526729443|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
146057825|NCT00001832|526729444|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
146057826|NCT00001832|526729445|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
146057827|NCT00001832|526729446|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
146057828|NCT00001832|526729447|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
146057829|NCT00001832|526729448|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
146057830|NCT00001832|526729434|FG000|Treatment Period|Death during treatment|0|||
146057831|NCT00001832|526729435|FG001|Treatment Period|Death during treatment|0|||
146057832|NCT00001832|526729436|FG002|Treatment Period|Death during treatment|0|||
146057833|NCT00001832|526729437|FG003|Treatment Period|Death during treatment|0|||
146057834|NCT00001832|526729438|FG004|Treatment Period|Death during treatment|0|||
146057835|NCT00001832|526729439|FG005|Treatment Period|Death during treatment|1|||
146057836|NCT00001832|526729440|FG006|Treatment Period|Death during treatment|0|||
146057837|NCT00001832|526729441|FG007|Treatment Period|Death during treatment|0|||
146057838|NCT00001832|526729442|FG008|Treatment Period|Death during treatment|0|||
146057839|NCT00001832|526729443|FG009|Treatment Period|Death during treatment|0|||
146057840|NCT00001832|526729444|FG010|Treatment Period|Death during treatment|0|||
146057841|NCT00001832|526729445|FG011|Treatment Period|Death during treatment|0|||
146057842|NCT00001832|526729446|FG012|Treatment Period|Death during treatment|0|||
146057843|NCT00001832|526729447|FG013|Treatment Period|Death during treatment|0|||
146057844|NCT00001832|526729448|FG014|Treatment Period|Death during treatment|0|||
146057845|NCT00001832|526729434|FG000|Treatment Period|Not treated|0|||
146057846|NCT00001832|526729435|FG001|Treatment Period|Not treated|0|||
146057847|NCT00001832|526729436|FG002|Treatment Period|Not treated|0|||
146057848|NCT00001832|526729437|FG003|Treatment Period|Not treated|0|||
146057849|NCT00001832|526729438|FG004|Treatment Period|Not treated|0|||
146057850|NCT00001832|526729439|FG005|Treatment Period|Not treated|0|||
146057851|NCT00001832|526729440|FG006|Treatment Period|Not treated|0|||
146057852|NCT00001832|526729441|FG007|Treatment Period|Not treated|1|||
146057853|NCT00001832|526729442|FG008|Treatment Period|Not treated|0|||
146057854|NCT00001832|526729443|FG009|Treatment Period|Not treated|0|||
146057855|NCT00001832|526729444|FG010|Treatment Period|Not treated|0|||
146057856|NCT00001832|526729445|FG011|Treatment Period|Not treated|0|||
146057857|NCT00001832|526729446|FG012|Treatment Period|Not treated|0|||
146057858|NCT00001832|526729447|FG013|Treatment Period|Not treated|0|||
146057859|NCT00001832|526729448|FG014|Treatment Period|Not treated|0|||
146057860|NCT01903356|526729449|FG000|Overall Study|Lost to Follow-up|7|||
146057861|NCT01903356|526729449|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
146057862|NCT01903356|526729449|FG000|Overall Study|Violated the dosage and administration|3|||
146057863|NCT00713609|526729450|FG000|Overall Study|Adverse Event|2|||
146057864|NCT00713609|526729451|FG001|Overall Study|Adverse Event|0|||
146057865|NCT00713609|526729452|FG002|Overall Study|Adverse Event|2|||
146057866|NCT00713609|526729453|FG003|Overall Study|Adverse Event|2|||
146057867|NCT00713609|526729454|FG004|Overall Study|Adverse Event|3|||
146057868|NCT00713609|526729455|FG005|Overall Study|Adverse Event|1|||
146057869|NCT00713609|526729450|FG000|Overall Study|Lost to Follow-up|5|||
146057870|NCT00713609|526729451|FG001|Overall Study|Lost to Follow-up|7|||
146057871|NCT00713609|526729452|FG002|Overall Study|Lost to Follow-up|5|||
146057872|NCT00713609|526729453|FG003|Overall Study|Lost to Follow-up|5|||
146057873|NCT00713609|526729454|FG004|Overall Study|Lost to Follow-up|7|||
146057874|NCT00713609|526729455|FG005|Overall Study|Lost to Follow-up|0|||
146057875|NCT00713609|526729450|FG000|Overall Study|Lack of Efficacy|1|||
146057876|NCT00713609|526729451|FG001|Overall Study|Lack of Efficacy|3|||
146057877|NCT00713609|526729452|FG002|Overall Study|Lack of Efficacy|0|||
146057878|NCT00713609|526729453|FG003|Overall Study|Lack of Efficacy|0|||
146057879|NCT00713609|526729454|FG004|Overall Study|Lack of Efficacy|1|||
146057880|NCT00713609|526729455|FG005|Overall Study|Lack of Efficacy|0|||
146057881|NCT00713609|526729450|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
146057882|NCT00713609|526729451|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
146057883|NCT00713609|526729452|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
146057884|NCT00713609|526729453|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
146057885|NCT00713609|526729454|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
146057886|NCT00713609|526729455|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
146057887|NCT00713609|526729450|FG000|Overall Study|Withdrawal by Subject|6|||
146057888|NCT00713609|526729451|FG001|Overall Study|Withdrawal by Subject|1|||
146057889|NCT00713609|526729452|FG002|Overall Study|Withdrawal by Subject|5|||
146057890|NCT00713609|526729453|FG003|Overall Study|Withdrawal by Subject|1|||
146057891|NCT00713609|526729454|FG004|Overall Study|Withdrawal by Subject|5|||
146057892|NCT00713609|526729455|FG005|Overall Study|Withdrawal by Subject|7|||
146057893|NCT00713609|526729450|FG000|Overall Study|Protocol Violation|6|||
146057894|NCT00713609|526729451|FG001|Overall Study|Protocol Violation|3|||
146057895|NCT00713609|526729452|FG002|Overall Study|Protocol Violation|1|||
146057896|NCT00713609|526729453|FG003|Overall Study|Protocol Violation|1|||
146057897|NCT00713609|526729454|FG004|Overall Study|Protocol Violation|2|||
146057898|NCT00713609|526729455|FG005|Overall Study|Protocol Violation|0|||
146057899|NCT03988400|526729461|FG000|Overall Study|Adverse Event|1|||
146057900|NCT03988400|526729462|FG001|Overall Study|Adverse Event|0|||
146057901|NCT03988400|526729461|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
146057902|NCT03988400|526729462|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
146057903|NCT03988400|526729461|FG000|Overall Study|Lost to Follow-up|0|||
146057904|NCT03988400|526729462|FG001|Overall Study|Lost to Follow-up|1|||
146057905|NCT02542865|526729464|FG000|Overall Study|Identified as screen failure|1|||
146057906|NCT02542865|526729465|FG001|Overall Study|Identified as screen failure|0|||
146057907|NCT02542865|526729464|FG000|Overall Study|Withdrawal by Subject|16|||
146057908|NCT02542865|526729465|FG001|Overall Study|Withdrawal by Subject|0|||
146057909|NCT03582215|526729466|FG000|Overall Study|Adverse Event|1|||
146057910|NCT03582215|526729467|FG001|Overall Study|Adverse Event|0|||
146283226|NCT01871805|527550163|FG003|Phase II|Lost to Follow-up|0|||
146283227|NCT01871805|527550164|FG004|Phase II|Lost to Follow-up|0|||
146283228|NCT01871805|527550165|FG005|Phase II|Lost to Follow-up|13|||
146283229|NCT00635427|527550166|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146283230|NCT00635427|527550167|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146283231|NCT00635427|527550168|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
146283232|NCT00635427|527550169|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146283233|NCT00635427|527550170|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
146283234|NCT00635427|527550166|FG000|Overall Study|Death|0|||
146283235|NCT00635427|527550167|FG001|Overall Study|Death|0|||
146283236|NCT00635427|527550168|FG002|Overall Study|Death|0|||
146283237|NCT00635427|527550169|FG003|Overall Study|Death|1|||
146396515|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
146057911|NCT03582215|526729468|FG002|Overall Study|Adverse Event|0|||
146057912|NCT03582215|526729469|FG003|Overall Study|Adverse Event|0|||
146057913|NCT03582215|526729470|FG004|Overall Study|Adverse Event|0|||
146057914|NCT03582215|526729471|FG005|Overall Study|Adverse Event|0|||
146057915|NCT03582215|526729472|FG006|Overall Study|Adverse Event|2|||
146057916|NCT03582215|526729473|FG007|Overall Study|Adverse Event|2|||
146057917|NCT04913610|526729474|FG000|Randomized Participants|Did Not Receive Treatment|0|||
146057918|NCT04913610|526729475|FG001|Randomized Participants|Did Not Receive Treatment|0|||
146057919|NCT04913610|526729476|FG002|Randomized Participants|Did Not Receive Treatment|1|||
146057920|NCT04913610|526729477|FG003|Randomized Participants|Did Not Receive Treatment|1|||
146057921|NCT04913610|526729478|FG004|Randomized Participants|Did Not Receive Treatment|0|||
146057922|NCT04913610|526729474|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
146057923|NCT04913610|526729475|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146057924|NCT04913610|526729476|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146057925|NCT04913610|526729477|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
146057926|NCT04913610|526729478|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
146057927|NCT03186209|526729481|FG000|Overall Study|Withdrawal by Subject|11|||
146057928|NCT03186209|526729482|FG001|Overall Study|Withdrawal by Subject|22|||
146057929|NCT03186209|526729481|FG000|Overall Study|Pregnancy|1|||
146057930|NCT03186209|526729482|FG001|Overall Study|Pregnancy|0|||
146057931|NCT03186209|526729481|FG000|Overall Study|Adverse Event|4|||
146057932|NCT03186209|526729482|FG001|Overall Study|Adverse Event|0|||
146057933|NCT03186209|526729481|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
146057934|NCT03186209|526729482|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
146057935|NCT03186209|526729481|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
146057936|NCT03186209|526729482|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
146057937|NCT03186209|526729481|FG000|Overall Study|Fail to meet randomization criteria|0|||
146057938|NCT03186209|526729482|FG001|Overall Study|Fail to meet randomization criteria|1|||
146057939|NCT03186209|526729481|FG000|Overall Study|Lost to Follow-up|0|||
146057940|NCT03186209|526729482|FG001|Overall Study|Lost to Follow-up|1|||
146057941|NCT01791244|526729483|FG000|Overall Study|Adverse Event|5|||
146057942|NCT01791244|526729484|FG001|Overall Study|Adverse Event|7|||
146057943|NCT01791244|526729483|FG000|Overall Study|Insufficient clinical response|10|||
146057944|NCT01791244|526729484|FG001|Overall Study|Insufficient clinical response|10|||
146057945|NCT01791244|526729483|FG000|Overall Study|Laboratory Abnormality|0|||
146057946|NCT01791244|526729484|FG001|Overall Study|Laboratory Abnormality|1|||
146057947|NCT02240485|526729489|FG000|3 Months Post-admission|Lost to Follow-up|1|||
146057948|NCT02240485|526729490|FG001|3 Months Post-admission|Lost to Follow-up|5|||
146057949|NCT02240485|526729489|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
146057950|NCT02240485|526729490|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
146057951|NCT02240485|526729489|FG000|9 Months Post-admission|Lost to Follow-up|3|||
146057952|NCT02240485|526729490|FG001|9 Months Post-admission|Lost to Follow-up|1|||
146057953|NCT02240485|526729489|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
146057954|NCT02240485|526729490|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
146057955|NCT02240485|526729489|FG000|18 Months Post-admission|Lost to Follow-up|1|||
146057956|NCT02240485|526729490|FG001|18 Months Post-admission|Lost to Follow-up|1|||
146057957|NCT02240485|526729489|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
146057958|NCT02240485|526729490|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
146057959|NCT00953667|526729491|FG000|Overall Study|Lost to Follow-up|11|||
146057960|NCT00953667|526729491|FG000|Overall Study|Physician Decision|35|||
146057961|NCT00953667|526729491|FG000|Overall Study|Withdrawal by Subject|63|||
146057962|NCT00953667|526729491|FG000|Overall Study|Adverse Event|10|||
146057963|NCT00953667|526729491|FG000|Overall Study|poor venous access,unable to draw blood|4|||
146057964|NCT04038359|526729492|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
146057965|NCT04038359|526729493|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
146057966|NCT04038359|526729492|FG000|Overall Study|Death|8|||
146057967|NCT04038359|526729493|FG001|Overall Study|Death|7|||
146057968|NCT04038359|526729492|FG000|Overall Study|Lost to Follow-up|3|||
146057969|NCT04038359|526729493|FG001|Overall Study|Lost to Follow-up|0|||
146283238|NCT00635427|527550170|FG004|Overall Study|Death|0|||
146283239|NCT00635427|527550166|FG000|Overall Study|Termination Of Study By Sponsor|12|||
146283240|NCT00635427|527550167|FG001|Overall Study|Termination Of Study By Sponsor|6|||
146283241|NCT00635427|527550168|FG002|Overall Study|Termination Of Study By Sponsor|10|||
146283242|NCT00635427|527550169|FG003|Overall Study|Termination Of Study By Sponsor|6|||
146283243|NCT00635427|527550170|FG004|Overall Study|Termination Of Study By Sponsor|6|||
146283244|NCT00635427|527550166|FG000|Overall Study|Withdrawal Of Consent|0|||
146283245|NCT00635427|527550167|FG001|Overall Study|Withdrawal Of Consent|0|||
146283246|NCT00635427|527550168|FG002|Overall Study|Withdrawal Of Consent|0|||
146283247|NCT00635427|527550169|FG003|Overall Study|Withdrawal Of Consent|2|||
146283248|NCT00635427|527550170|FG004|Overall Study|Withdrawal Of Consent|2|||
146283249|NCT00564889|527550171|FG000|Overall Study|Death|7|||
146283250|NCT00564889|527550171|FG000|Overall Study|Adverse Event|12|||
146283251|NCT00564889|527550171|FG000|Overall Study|Alternative treatment|3|||
146283252|NCT00564889|527550171|FG000|Overall Study|Disease progression|3|||
146283253|NCT00564889|527550171|FG000|Overall Study|Other, not specified|4|||
146283254|NCT00468104|527550177|FG000|First Intervention|Protocol Violation|2|||
146283255|NCT00468104|527550178|FG001|First Intervention|Protocol Violation|1|||
146283256|NCT00468104|527550177|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
146283257|NCT00468104|527550178|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
146283258|NCT00468104|527550177|FG000|First Intervention|died within 3 weeks|1|||
146283259|NCT00468104|527550178|FG001|First Intervention|died within 3 weeks|0|||
146283260|NCT00468104|527550177|FG000|First Intervention|malposition/blocked chest tube tube|2|||
146283261|NCT00468104|527550178|FG001|First Intervention|malposition/blocked chest tube tube|0|||
146283262|NCT00468104|527550177|FG000|First Intervention|large lung mass with minimal effusion|1|||
146283263|NCT00468104|527550178|FG001|First Intervention|large lung mass with minimal effusion|0|||
146283264|NCT00468104|527550177|FG000|First Intervention|associated prolonged pneumothorax|1|||
146283265|NCT00468104|527550178|FG001|First Intervention|associated prolonged pneumothorax|0|||
146283266|NCT00468104|527550177|FG000|First Intervention|trapped lung|1|||
146283267|NCT00468104|527550178|FG001|First Intervention|trapped lung|0|||
146283268|NCT00468104|527550177|FG000|Second Intervention|Withdrawal by Subject|5|||
146283269|NCT00468104|527550178|FG001|Second Intervention|Withdrawal by Subject|2|||
146283270|NCT00468104|527550177|FG000|Second Intervention|discarded for malposition of chest tube|0|||
146283271|NCT00468104|527550178|FG001|Second Intervention|discarded for malposition of chest tube|2|||
146283272|NCT02706899|527550179|FG000|Overall Study|Withdrawal by Subject|1|||
146283273|NCT02706899|527550180|FG001|Overall Study|Withdrawal by Subject|0|||
146283274|NCT02706899|527550179|FG000|Overall Study|Death|8|||
146283275|NCT02706899|527550180|FG001|Overall Study|Death|0|||
146283276|NCT02706899|527550179|FG000|Overall Study|Study Termination by Sponsor|4|||
146283277|NCT02706899|527550180|FG001|Overall Study|Study Termination by Sponsor|6|||
146283278|NCT00324675|527550181|FG000|Overall Study|Adverse Event|1|||
146283279|NCT00324675|527550182|FG001|Overall Study|Adverse Event|0|||
146283280|NCT00381615|527550183|FG000|Overall Study|Withdrawal by Subject|1|||
146283281|NCT00381615|527550184|FG001|Overall Study|Withdrawal by Subject|3|||
146283282|NCT00381615|527550185|FG002|Overall Study|Withdrawal by Subject|0|||
146283283|NCT00381615|527550186|FG003|Overall Study|Withdrawal by Subject|1|||
146283284|NCT00381615|527550183|FG000|Overall Study|Lost to Follow-up|3|||
146283285|NCT00381615|527550184|FG001|Overall Study|Lost to Follow-up|2|||
146283286|NCT00381615|527550185|FG002|Overall Study|Lost to Follow-up|0|||
146283287|NCT00381615|527550186|FG003|Overall Study|Lost to Follow-up|1|||
146283288|NCT00381615|527550183|FG000|Overall Study|Protocol Violation|0|||
146283289|NCT00381615|527550184|FG001|Overall Study|Protocol Violation|0|||
146283290|NCT00381615|527550185|FG002|Overall Study|Protocol Violation|1|||
146283291|NCT00381615|527550186|FG003|Overall Study|Protocol Violation|0|||
146283292|NCT01435616|527550190|FG000|Overall Study|Adverse Event|39|||
146283293|NCT01435616|527550191|FG001|Overall Study|Adverse Event|21|||
146283294|NCT01435616|527550190|FG000|Overall Study|Death|7|||
146283295|NCT01435616|527550191|FG001|Overall Study|Death|2|||
146283296|NCT01435616|527550190|FG000|Overall Study|Lost to Follow-up|22|||
146283297|NCT01435616|527550191|FG001|Overall Study|Lost to Follow-up|13|||
146283298|NCT01435616|527550190|FG000|Overall Study|Protocol Violation|16|||
146283299|NCT01435616|527550191|FG001|Overall Study|Protocol Violation|13|||
146283300|NCT01435616|527550190|FG000|Overall Study|Withdrawal by Subject|66|||
146283301|NCT01435616|527550191|FG001|Overall Study|Withdrawal by Subject|24|||
146283302|NCT01435616|527550190|FG000|Overall Study|Physician Decision|20|||
146283303|NCT01435616|527550191|FG001|Overall Study|Physician Decision|7|||
146283304|NCT01435616|527550190|FG000|Overall Study|Sponsor Decision|1|||
146283305|NCT01435616|527550191|FG001|Overall Study|Sponsor Decision|0|||
146283306|NCT04860297|527550192|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
146283307|NCT04860297|527550193|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
146283308|NCT04860297|527550194|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
146283309|NCT04860297|527550195|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
146283310|NCT04860297|527550196|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
146283311|NCT04860297|527550197|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
146283312|NCT04860297|527550198|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
146283313|NCT04860297|527550199|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
146283314|NCT04860297|527550192|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
146283315|NCT04860297|527550193|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
146283316|NCT04860297|527550194|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
146283317|NCT04860297|527550195|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
146283318|NCT04860297|527550196|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
146283319|NCT04860297|527550197|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
146283320|NCT04860297|527550198|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
146283321|NCT04860297|527550199|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
146283322|NCT04860297|527550192|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
146283323|NCT04860297|527550193|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
146283324|NCT04860297|527550194|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
146283325|NCT04860297|527550195|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
146283326|NCT04860297|527550196|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
146283327|NCT04860297|527550197|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
146283328|NCT04860297|527550198|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
146283329|NCT04860297|527550199|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
146283330|NCT04860297|527550192|FG000|Part B (Booster Dose)|Other Than Specified|0|||
146057970|NCT04038359|526729492|FG000|Overall Study|Participant Moved|1|||
146057971|NCT04038359|526729493|FG001|Overall Study|Participant Moved|0|||
146057972|NCT04038359|526729492|FG000|Overall Study|Withdrawal by Subject|4|||
146057973|NCT04038359|526729493|FG001|Overall Study|Withdrawal by Subject|3|||
146057974|NCT04038359|526729492|FG000|Overall Study|Physician Decision|3|||
146057975|NCT04038359|526729493|FG001|Overall Study|Physician Decision|2|||
146057976|NCT04038359|526729492|FG000|Overall Study|Adverse Event|0|||
146057977|NCT04038359|526729493|FG001|Overall Study|Adverse Event|2|||
146057978|NCT04038359|526729492|FG000|Overall Study|Progressive Disease|0|||
146057979|NCT04038359|526729493|FG001|Overall Study|Progressive Disease|1|||
146057980|NCT05468814|526729494|FG000|Overall Study|Lost to Follow-up|5|||
146057981|NCT05468814|526729495|FG001|Overall Study|Lost to Follow-up|6|||
146057982|NCT04716426|526729499|FG000|Overall Study|Vaccination|1|||
146057983|NCT04716426|526729500|FG001|Overall Study|Vaccination|1|||
146057984|NCT04716426|526729499|FG000|Overall Study|Contamination|1|||
146057985|NCT04716426|526729500|FG001|Overall Study|Contamination|0|||
146057986|NCT01650558|526729503|FG000|Overall Study|Migration out of study area|61|||
146057987|NCT01650558|526729504|FG001|Overall Study|Migration out of study area|71|||
146057988|NCT01650558|526729505|FG002|Overall Study|Migration out of study area|56|||
146057989|NCT01650558|526729503|FG000|Overall Study|Lost to Follow-up|10|||
146057990|NCT01650558|526729504|FG001|Overall Study|Lost to Follow-up|13|||
146057991|NCT01650558|526729505|FG002|Overall Study|Lost to Follow-up|6|||
146057992|NCT01650558|526729503|FG000|Overall Study|Death|10|||
146057993|NCT01650558|526729504|FG001|Overall Study|Death|6|||
146057994|NCT01650558|526729505|FG002|Overall Study|Death|8|||
146057995|NCT01650558|526729503|FG000|Overall Study|Withdrawal by Subject|1|||
146057996|NCT01650558|526729504|FG001|Overall Study|Withdrawal by Subject|1|||
146057997|NCT01650558|526729505|FG002|Overall Study|Withdrawal by Subject|3|||
146057998|NCT01650558|526729503|FG000|Overall Study|Non-compliant participant|1|||
146057999|NCT01650558|526729504|FG001|Overall Study|Non-compliant participant|0|||
146058000|NCT01650558|526729505|FG002|Overall Study|Non-compliant participant|2|||
146058001|NCT01650558|526729503|FG000|Overall Study|Physician Decision|0|||
146058002|NCT01650558|526729504|FG001|Overall Study|Physician Decision|1|||
146283331|NCT04860297|527550193|FG001|Part B (Booster Dose)|Other Than Specified|0|||
146283332|NCT04860297|527550194|FG002|Part B (Booster Dose)|Other Than Specified|0|||
146283333|NCT04860297|527550195|FG003|Part B (Booster Dose)|Other Than Specified|0|||
146058003|NCT01650558|526729505|FG002|Overall Study|Physician Decision|0|||
146058004|NCT02960217|526729506|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
146283334|NCT04860297|527550196|FG004|Part B (Booster Dose)|Other Than Specified|0|||
146283335|NCT04860297|527550197|FG005|Part B (Booster Dose)|Other Than Specified|1|||
146283336|NCT04860297|527550198|FG006|Part B (Booster Dose)|Other Than Specified|1|||
146283337|NCT04860297|527550199|FG007|Part B (Booster Dose)|Other Than Specified|0|||
146283338|NCT04860297|527550192|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
146283339|NCT04860297|527550193|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
146283340|NCT04860297|527550194|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
146283341|NCT04860297|527550195|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
146396516|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
146058005|NCT02960217|526729507|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
146058006|NCT02960217|526729506|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
146058007|NCT02960217|526729507|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
146058008|NCT02960217|526729506|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
146058009|NCT02960217|526729507|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
146058010|NCT02960217|526729506|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
146058011|NCT02960217|526729507|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
146058012|NCT02960217|526729506|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
146058013|NCT02960217|526729507|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
146058014|NCT02960217|526729506|FG000|Open-Label Extension Phase|Adverse Event|1|||
146058015|NCT02960217|526729507|FG001|Open-Label Extension Phase|Adverse Event|0|||
146058016|NCT02960217|526729506|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
146058017|NCT02960217|526729507|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
146058018|NCT02960217|526729506|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
146058019|NCT02960217|526729507|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
146058020|NCT02960217|526729506|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
146058021|NCT02960217|526729507|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
146058022|NCT01069484|526729508|FG000|Overall Study|Death-in-near-family|1|||
146058023|NCT01069484|526729509|FG001|Overall Study|Death-in-near-family|0|||
146058024|NCT01069484|526729508|FG000|Overall Study|No specific reason|8|||
146058025|NCT01069484|526729509|FG001|Overall Study|No specific reason|2|||
146058026|NCT01069484|526729508|FG000|Overall Study|Illness mother or child|3|||
146058027|NCT01069484|526729509|FG001|Overall Study|Illness mother or child|1|||
146058028|NCT00083889|526729514|FG000|Overall Study|Adverse Event|76|||
146058029|NCT00083889|526729515|FG001|Overall Study|Adverse Event|86|||
146058030|NCT00083889|526729514|FG000|Overall Study|Protocol Violation|2|||
146058031|NCT00083889|526729515|FG001|Overall Study|Protocol Violation|2|||
146058032|NCT00083889|526729514|FG000|Overall Study|Withdrawal by Subject|22|||
146058033|NCT00083889|526729515|FG001|Overall Study|Withdrawal by Subject|24|||
146058034|NCT00083889|526729514|FG000|Overall Study|Lack of Efficacy|240|||
146058035|NCT00083889|526729515|FG001|Overall Study|Lack of Efficacy|219|||
146058036|NCT00083889|526729514|FG000|Overall Study|Decision of sponsor|32|||
146058037|NCT00083889|526729515|FG001|Overall Study|Decision of sponsor|4|||
146058038|NCT00083889|526729514|FG000|Overall Study|Randomized: did not take study drug|0|||
146058039|NCT00083889|526729515|FG001|Overall Study|Randomized: did not take study drug|15|||
146058040|NCT00083889|526729514|FG000|Overall Study|Completed on marketed sunitinub|3|||
146058041|NCT00083889|526729515|FG001|Overall Study|Completed on marketed sunitinub|0|||
146058042|NCT00083889|526729514|FG000|Overall Study|Crossover to SU011248|0|||
146058043|NCT00083889|526729515|FG001|Overall Study|Crossover to SU011248|25|||
146058044|NCT03624881|526729516|FG000|Overall Study|Screen Failure|14|||
146058045|NCT03624881|526729517|FG001|Overall Study|Screen Failure|0|||
146058046|NCT03624881|526729516|FG000|Overall Study|No Catheter Inserted|6|||
146058047|NCT03624881|526729517|FG001|Overall Study|No Catheter Inserted|1|||
146058048|NCT03624881|526729516|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
146058049|NCT03624881|526729517|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
146058050|NCT03624881|526729516|FG000|Overall Study|Death|2|||
146058051|NCT03624881|526729517|FG001|Overall Study|Death|0|||
146058052|NCT03624881|526729516|FG000|Overall Study|Lost to Follow-up|10|||
146058053|NCT03624881|526729517|FG001|Overall Study|Lost to Follow-up|4|||
146058054|NCT03624881|526729516|FG000|Overall Study|Withdrawal by Subject|12|||
146058055|NCT03624881|526729517|FG001|Overall Study|Withdrawal by Subject|1|||
146058056|NCT03019406|526729518|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
146058057|NCT03019406|526729519|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
146058058|NCT03019406|526729520|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
146058059|NCT03019406|526729521|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
146058060|NCT03668873|526729522|FG000|Overall Study|Lost to Follow-up|6|||
146058061|NCT03668873|526729523|FG001|Overall Study|Lost to Follow-up|3|||
146058062|NCT00849940|526729533|FG000|Overall Study|Physician Decision|4|||
146058063|NCT04258423|526729534|FG000|Overall Study|Study Closure|2|||
146058064|NCT04258423|526729535|FG001|Overall Study|Study Closure|2|||
146058065|NCT01601535|526729538|FG000|Phase 1|Adverse Event|1|||
146058066|NCT01601535|526729539|FG001|Phase 1|Adverse Event|0|||
146058067|NCT01601535|526729540|FG002|Phase 1|Adverse Event|2|||
146058068|NCT01601535|526729541|FG003|Phase 1|Adverse Event|1|||
146058069|NCT01601535|526729542|FG004|Phase 1|Adverse Event|0|||
146058070|NCT01601535|526729543|FG005|Phase 1|Adverse Event|0|||
146058071|NCT01601535|526729538|FG000|Phase 1|Withdrawal by Subject|2|||
146058072|NCT01601535|526729539|FG001|Phase 1|Withdrawal by Subject|1|||
146058073|NCT01601535|526729540|FG002|Phase 1|Withdrawal by Subject|1|||
146058074|NCT01601535|526729541|FG003|Phase 1|Withdrawal by Subject|2|||
146058075|NCT01601535|526729542|FG004|Phase 1|Withdrawal by Subject|0|||
146058076|NCT01601535|526729543|FG005|Phase 1|Withdrawal by Subject|0|||
146058077|NCT01601535|526729538|FG000|Phase 1|Progressive Disease|2|||
146058078|NCT01601535|526729539|FG001|Phase 1|Progressive Disease|3|||
146058079|NCT01601535|526729540|FG002|Phase 1|Progressive Disease|2|||
146058080|NCT01601535|526729541|FG003|Phase 1|Progressive Disease|1|||
146058081|NCT01601535|526729542|FG004|Phase 1|Progressive Disease|0|||
146058082|NCT01601535|526729543|FG005|Phase 1|Progressive Disease|0|||
146058083|NCT01601535|526729538|FG000|Phase 1|Started Another Treatment|1|||
146058084|NCT01601535|526729539|FG001|Phase 1|Started Another Treatment|2|||
146058085|NCT01601535|526729540|FG002|Phase 1|Started Another Treatment|0|||
146058086|NCT01601535|526729541|FG003|Phase 1|Started Another Treatment|0|||
146058087|NCT01601535|526729542|FG004|Phase 1|Started Another Treatment|0|||
146058088|NCT01601535|526729543|FG005|Phase 1|Started Another Treatment|0|||
146058089|NCT01601535|526729538|FG000|Phase 2|Adverse Event|0|||
146058090|NCT01601535|526729539|FG001|Phase 2|Adverse Event|0|||
146058091|NCT01601535|526729540|FG002|Phase 2|Adverse Event|0|||
146058092|NCT01601535|526729541|FG003|Phase 2|Adverse Event|0|||
146058093|NCT01601535|526729542|FG004|Phase 2|Adverse Event|5|||
146058094|NCT01601535|526729543|FG005|Phase 2|Adverse Event|1|||
146058095|NCT01601535|526729538|FG000|Phase 2|Withdrawal by Subject|0|||
146058096|NCT01601535|526729539|FG001|Phase 2|Withdrawal by Subject|0|||
146058097|NCT01601535|526729540|FG002|Phase 2|Withdrawal by Subject|0|||
146058098|NCT01601535|526729541|FG003|Phase 2|Withdrawal by Subject|0|||
146058099|NCT01601535|526729542|FG004|Phase 2|Withdrawal by Subject|8|||
146058100|NCT01601535|526729543|FG005|Phase 2|Withdrawal by Subject|2|||
146058101|NCT01601535|526729538|FG000|Phase 2|Progressive Disease|0|||
146058102|NCT01601535|526729539|FG001|Phase 2|Progressive Disease|0|||
146058103|NCT01601535|526729540|FG002|Phase 2|Progressive Disease|0|||
146058104|NCT01601535|526729541|FG003|Phase 2|Progressive Disease|0|||
146058105|NCT01601535|526729542|FG004|Phase 2|Progressive Disease|5|||
146058106|NCT01601535|526729543|FG005|Phase 2|Progressive Disease|7|||
146058107|NCT01601535|526729538|FG000|Phase 2|Started Another Treatment|0|||
146058108|NCT01601535|526729539|FG001|Phase 2|Started Another Treatment|0|||
146058109|NCT01601535|526729540|FG002|Phase 2|Started Another Treatment|0|||
146058110|NCT01601535|526729541|FG003|Phase 2|Started Another Treatment|0|||
146058111|NCT01601535|526729542|FG004|Phase 2|Started Another Treatment|1|||
146058112|NCT01601535|526729543|FG005|Phase 2|Started Another Treatment|2|||
146087697|NCT04393298|526841822|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
146087698|NCT04393298|526841823|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
146087699|NCT04393298|526841824|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
146087700|NCT04393298|526841810|FG000|Overall Study|Patient Passed Away|0|||
146087701|NCT04393298|526841811|FG001|Overall Study|Patient Passed Away|0|||
146087702|NCT04393298|526841812|FG002|Overall Study|Patient Passed Away|0|||
146087703|NCT04393298|526841813|FG003|Overall Study|Patient Passed Away|0|||
146087704|NCT04393298|526841814|FG004|Overall Study|Patient Passed Away|0|||
146087705|NCT04393298|526841815|FG005|Overall Study|Patient Passed Away|0|||
146087706|NCT04393298|526841816|FG006|Overall Study|Patient Passed Away|0|||
146087707|NCT04393298|526841817|FG007|Overall Study|Patient Passed Away|1|||
146087708|NCT04393298|526841818|FG008|Overall Study|Patient Passed Away|0|||
146087709|NCT04393298|526841819|FG009|Overall Study|Patient Passed Away|0|||
146087710|NCT04393298|526841820|FG010|Overall Study|Patient Passed Away|0|||
146087711|NCT04393298|526841821|FG011|Overall Study|Patient Passed Away|0|||
146087712|NCT04393298|526841822|FG012|Overall Study|Patient Passed Away|0|||
146087713|NCT04393298|526841823|FG013|Overall Study|Patient Passed Away|0|||
146087714|NCT04393298|526841824|FG014|Overall Study|Patient Passed Away|0|||
146087715|NCT04393298|526841810|FG000|Overall Study|Patient Deceased|0|||
146087716|NCT04393298|526841811|FG001|Overall Study|Patient Deceased|0|||
146087717|NCT04393298|526841812|FG002|Overall Study|Patient Deceased|0|||
146087718|NCT04393298|526841813|FG003|Overall Study|Patient Deceased|0|||
146087719|NCT04393298|526841814|FG004|Overall Study|Patient Deceased|0|||
146087720|NCT04393298|526841815|FG005|Overall Study|Patient Deceased|0|||
146087721|NCT04393298|526841816|FG006|Overall Study|Patient Deceased|0|||
146087722|NCT04393298|526841817|FG007|Overall Study|Patient Deceased|1|||
146087723|NCT04393298|526841818|FG008|Overall Study|Patient Deceased|0|||
146087724|NCT04393298|526841819|FG009|Overall Study|Patient Deceased|0|||
146087725|NCT04393298|526841820|FG010|Overall Study|Patient Deceased|0|||
146087726|NCT04393298|526841821|FG011|Overall Study|Patient Deceased|0|||
146087727|NCT04393298|526841822|FG012|Overall Study|Patient Deceased|0|||
146087728|NCT04393298|526841823|FG013|Overall Study|Patient Deceased|0|||
146087729|NCT04393298|526841824|FG014|Overall Study|Patient Deceased|0|||
146087730|NCT04393298|526841810|FG000|Overall Study|Patient Discharged to Hospice|0|||
146087731|NCT04393298|526841811|FG001|Overall Study|Patient Discharged to Hospice|0|||
146087732|NCT04393298|526841812|FG002|Overall Study|Patient Discharged to Hospice|0|||
146087733|NCT04393298|526841813|FG003|Overall Study|Patient Discharged to Hospice|0|||
146058113|NCT04199351|526731404|FG000|Overall Study|Decision by sponsor|0|||
146058114|NCT04199351|526731405|FG001|Overall Study|Decision by sponsor|0|||
146058115|NCT04199351|526731406|FG002|Overall Study|Decision by sponsor|0|||
146058116|NCT04199351|526731407|FG003|Overall Study|Decision by sponsor|2|||
146058117|NCT04199351|526731408|FG004|Overall Study|Decision by sponsor|0|||
146058118|NCT04199351|526731409|FG005|Overall Study|Decision by sponsor|0|||
146058119|NCT04199351|526731410|FG006|Overall Study|Decision by sponsor|0|||
146058120|NCT04199351|526731411|FG007|Overall Study|Decision by sponsor|0|||
146058121|NCT04199351|526731412|FG008|Overall Study|Decision by sponsor|0|||
146058122|NCT04199351|526731413|FG009|Overall Study|Decision by sponsor|6|||
146058123|NCT04199351|526731404|FG000|Overall Study|Lost to Follow-up|0|||
146058124|NCT04199351|526731405|FG001|Overall Study|Lost to Follow-up|0|||
146058125|NCT04199351|526731406|FG002|Overall Study|Lost to Follow-up|1|||
146058126|NCT04199351|526731407|FG003|Overall Study|Lost to Follow-up|0|||
146058127|NCT04199351|526731408|FG004|Overall Study|Lost to Follow-up|0|||
146058128|NCT04199351|526731409|FG005|Overall Study|Lost to Follow-up|1|||
146058129|NCT04199351|526731410|FG006|Overall Study|Lost to Follow-up|0|||
146058130|NCT04199351|526731411|FG007|Overall Study|Lost to Follow-up|0|||
146058131|NCT04199351|526731412|FG008|Overall Study|Lost to Follow-up|0|||
146058132|NCT04199351|526731413|FG009|Overall Study|Lost to Follow-up|0|||
146058133|NCT04199351|526731404|FG000|Overall Study|Withdrawal by Subject|0|||
146058134|NCT04199351|526731405|FG001|Overall Study|Withdrawal by Subject|1|||
146058135|NCT04199351|526731406|FG002|Overall Study|Withdrawal by Subject|0|||
146058136|NCT04199351|526731407|FG003|Overall Study|Withdrawal by Subject|0|||
146058137|NCT04199351|526731408|FG004|Overall Study|Withdrawal by Subject|1|||
146058138|NCT04199351|526731409|FG005|Overall Study|Withdrawal by Subject|4|||
146058139|NCT04199351|526731410|FG006|Overall Study|Withdrawal by Subject|2|||
146058140|NCT04199351|526731411|FG007|Overall Study|Withdrawal by Subject|0|||
146058141|NCT04199351|526731412|FG008|Overall Study|Withdrawal by Subject|3|||
146058142|NCT04199351|526731413|FG009|Overall Study|Withdrawal by Subject|0|||
146058143|NCT03623243|526731414|FG000|Overall Study|Adverse Event|15|||
146058144|NCT03623243|526731414|FG000|Overall Study|Guardian Decision|1|||
146058145|NCT03623243|526731414|FG000|Overall Study|New Therapy for Study Indication|1|||
146058146|NCT03623243|526731414|FG000|Overall Study|Protocol Deviation|3|||
146058147|NCT03623243|526731414|FG000|Overall Study|Physician Decision|4|||
146058148|NCT03623243|526731414|FG000|Overall Study|Patient Decision|15|||
146058149|NCT03007966|526731415|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
146058150|NCT03007966|526731416|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
146058151|NCT00474487|526731420|FG000|Overall Study|Withdrawal by Subject|6|||
146058152|NCT00474487|526731421|FG001|Overall Study|Withdrawal by Subject|0|||
146058153|NCT00474487|526731422|FG002|Overall Study|Withdrawal by Subject|0|||
146058154|NCT00474487|526731423|FG003|Overall Study|Withdrawal by Subject|0|||
146058155|NCT00474487|526731420|FG000|Overall Study|Lost to Follow-up|20|||
146058156|NCT00474487|526731421|FG001|Overall Study|Lost to Follow-up|1|||
146058157|NCT00474487|526731422|FG002|Overall Study|Lost to Follow-up|7|||
146058158|NCT00474487|526731423|FG003|Overall Study|Lost to Follow-up|0|||
146058159|NCT00474487|526731420|FG000|Overall Study|Inappropriate enrollment|4|||
146058160|NCT00474487|526731421|FG001|Overall Study|Inappropriate enrollment|0|||
146058161|NCT00474487|526731422|FG002|Overall Study|Inappropriate enrollment|7|||
146058162|NCT00474487|526731423|FG003|Overall Study|Inappropriate enrollment|0|||
146058163|NCT00474487|526731420|FG000|Overall Study|Death|0|||
146058164|NCT00474487|526731421|FG001|Overall Study|Death|1|||
146058165|NCT00474487|526731422|FG002|Overall Study|Death|0|||
146058166|NCT00474487|526731423|FG003|Overall Study|Death|0|||
146058167|NCT01428258|526731424|FG000|Intervention 1|Withdrawal by Subject|2|||
146058168|NCT01428258|526731425|FG001|Intervention 1|Withdrawal by Subject|0|||
146058169|NCT00419393|526731426|FG000|Overall Study|Adverse Event|5|||
146058170|NCT00419393|526731426|FG000|Overall Study|Protocol Violation|5|||
146058171|NCT00419393|526731426|FG000|Overall Study|Withdrawal by Subject|7|||
146058172|NCT00419393|526731426|FG000|Overall Study|Other: Sponsor request|3|||
146058173|NCT00419393|526731426|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
146058174|NCT00419393|526731426|FG000|Overall Study|Other: Site closure|1|||
146058175|NCT00419393|526731426|FG000|Overall Study|Other: Other health problems|1|||
146058176|NCT00419393|526731426|FG000|Overall Study|Other: Investigator decision|1|||
146058177|NCT00979901|526731427|FG000|Overall Study|Adverse Event|1|||
146058178|NCT00979901|526731428|FG001|Overall Study|Adverse Event|3|||
146058179|NCT00979901|526731429|FG002|Overall Study|Adverse Event|9|||
146058180|NCT00979901|526731430|FG003|Overall Study|Adverse Event|2|||
146058181|NCT00979901|526731427|FG000|Overall Study|Lack of Efficacy|8|||
146058182|NCT00979901|526731428|FG001|Overall Study|Lack of Efficacy|4|||
146058183|NCT00979901|526731429|FG002|Overall Study|Lack of Efficacy|9|||
146058184|NCT00979901|526731430|FG003|Overall Study|Lack of Efficacy|0|||
146058185|NCT00979901|526731427|FG000|Overall Study|Lost to Follow-up|1|||
146058186|NCT00979901|526731428|FG001|Overall Study|Lost to Follow-up|1|||
146058187|NCT00979901|526731429|FG002|Overall Study|Lost to Follow-up|2|||
146058188|NCT00979901|526731430|FG003|Overall Study|Lost to Follow-up|0|||
146058189|NCT00979901|526731427|FG000|Overall Study|Protocol Violation|2|||
146058190|NCT00979901|526731428|FG001|Overall Study|Protocol Violation|2|||
146058191|NCT00979901|526731429|FG002|Overall Study|Protocol Violation|7|||
146058192|NCT00979901|526731430|FG003|Overall Study|Protocol Violation|1|||
146058193|NCT00979901|526731427|FG000|Overall Study|Withdrawal by Subject|2|||
146058194|NCT00979901|526731428|FG001|Overall Study|Withdrawal by Subject|1|||
146058195|NCT00979901|526731429|FG002|Overall Study|Withdrawal by Subject|1|||
146058196|NCT00979901|526731430|FG003|Overall Study|Withdrawal by Subject|1|||
146058197|NCT00979901|526731427|FG000|Overall Study|Noncompliance|1|||
146058198|NCT00979901|526731428|FG001|Overall Study|Noncompliance|0|||
146058199|NCT00979901|526731429|FG002|Overall Study|Noncompliance|0|||
146058200|NCT00979901|526731430|FG003|Overall Study|Noncompliance|0|||
146058201|NCT00979901|526731427|FG000|Overall Study|out-of-state|1|||
146058202|NCT00979901|526731428|FG001|Overall Study|out-of-state|0|||
146058203|NCT00979901|526731429|FG002|Overall Study|out-of-state|0|||
146058204|NCT00979901|526731430|FG003|Overall Study|out-of-state|0|||
146058205|NCT00979901|526731427|FG000|Overall Study|vacation|1|||
146058206|NCT00979901|526731428|FG001|Overall Study|vacation|0|||
146058207|NCT00979901|526731429|FG002|Overall Study|vacation|0|||
146058208|NCT00979901|526731430|FG003|Overall Study|vacation|0|||
146058209|NCT00979901|526731427|FG000|Overall Study|elevated lab values pre-randomization|1|||
146058210|NCT00979901|526731428|FG001|Overall Study|elevated lab values pre-randomization|0|||
146058211|NCT00979901|526731429|FG002|Overall Study|elevated lab values pre-randomization|0|||
146058212|NCT00979901|526731430|FG003|Overall Study|elevated lab values pre-randomization|0|||
146058213|NCT00979901|526731427|FG000|Overall Study|Discontinued in Error|0|||
146058214|NCT00979901|526731428|FG001|Overall Study|Discontinued in Error|1|||
146058215|NCT00979901|526731429|FG002|Overall Study|Discontinued in Error|0|||
146058216|NCT00979901|526731430|FG003|Overall Study|Discontinued in Error|0|||
146058217|NCT00979901|526731427|FG000|Overall Study|Left Country|0|||
146058218|NCT00979901|526731428|FG001|Overall Study|Left Country|0|||
146058219|NCT00979901|526731429|FG002|Overall Study|Left Country|1|||
146058220|NCT00979901|526731430|FG003|Overall Study|Left Country|0|||
146058221|NCT00979901|526731427|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
146058222|NCT00979901|526731428|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
146058223|NCT00979901|526731429|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
146058224|NCT00979901|526731430|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
146058225|NCT04742556|526731435|FG000|Overall Study|Withdrawal by Subject|0|||
146058226|NCT04742556|526731436|FG001|Overall Study|Withdrawal by Subject|1|||
146058227|NCT04742556|526731437|FG002|Overall Study|Withdrawal by Subject|0|||
146058228|NCT04742556|526731435|FG000|Overall Study|Adverse Event|0|||
146058229|NCT04742556|526731436|FG001|Overall Study|Adverse Event|0|||
146058230|NCT04742556|526731437|FG002|Overall Study|Adverse Event|2|||
146058231|NCT04742556|526731435|FG000|Overall Study|Clinical disease progression|0|||
146058232|NCT04742556|526731436|FG001|Overall Study|Clinical disease progression|1|||
146058233|NCT04742556|526731437|FG002|Overall Study|Clinical disease progression|2|||
146058234|NCT04742556|526731435|FG000|Overall Study|Objective disease progression|3|||
146058235|NCT04742556|526731436|FG001|Overall Study|Objective disease progression|2|||
146058236|NCT04742556|526731437|FG002|Overall Study|Objective disease progression|4|||
146058237|NCT03305666|526731438|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
146058238|NCT03305666|526731439|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
146058239|NCT02546609|526731441|FG000|Overall Study|Withdrawal by Subject|0|||
146058240|NCT02546609|526731442|FG001|Overall Study|Withdrawal by Subject|1|||
146058241|NCT02546609|526731443|FG002|Overall Study|Withdrawal by Subject|2|||
146058242|NCT02546609|526731441|FG000|Overall Study|Adverse Event|0|||
146058243|NCT02546609|526731442|FG001|Overall Study|Adverse Event|6|||
146058244|NCT02546609|526731443|FG002|Overall Study|Adverse Event|1|||
146058245|NCT02546609|526731441|FG000|Overall Study|Protocol Violation|0|||
146058246|NCT02546609|526731442|FG001|Overall Study|Protocol Violation|1|||
146058247|NCT02546609|526731443|FG002|Overall Study|Protocol Violation|1|||
146058248|NCT02546609|526731441|FG000|Overall Study|Lost to Follow-up|2|||
146058249|NCT02546609|526731442|FG001|Overall Study|Lost to Follow-up|3|||
146058250|NCT02546609|526731443|FG002|Overall Study|Lost to Follow-up|1|||
146058251|NCT02546609|526731441|FG000|Overall Study|travel or work schedule restriction|0|||
146058252|NCT02546609|526731442|FG001|Overall Study|travel or work schedule restriction|0|||
146058253|NCT02546609|526731443|FG002|Overall Study|travel or work schedule restriction|2|||
146058254|NCT03780452|526731448|FG000|Overall Study|Screening failure|2|||
146058255|NCT00914849|526731449|FG000|Overall Study|Withdrawal by Subject|1|||
146058256|NCT00914849|526731450|FG001|Overall Study|Withdrawal by Subject|0|||
146058257|NCT00914849|526731449|FG000|Overall Study|Not eligible|0|||
146058258|NCT00914849|526731450|FG001|Overall Study|Not eligible|1|||
146058259|NCT01001221|526731453|FG000|Overall Study|Adverse Event|1|||
146058260|NCT01001221|526731454|FG001|Overall Study|Adverse Event|2|||
146058261|NCT01001221|526731455|FG002|Overall Study|Adverse Event|0|||
146058262|NCT01001221|526731456|FG003|Overall Study|Adverse Event|2|||
146058263|NCT01001221|526731457|FG004|Overall Study|Adverse Event|0|||
146058264|NCT01001221|526731453|FG000|Overall Study|Disease progression|3|||
146058265|NCT01001221|526731454|FG001|Overall Study|Disease progression|2|||
146058266|NCT01001221|526731455|FG002|Overall Study|Disease progression|2|||
146058267|NCT01001221|526731456|FG003|Overall Study|Disease progression|4|||
146058268|NCT01001221|526731457|FG004|Overall Study|Disease progression|0|||
146058269|NCT01001221|526731453|FG000|Overall Study|Other|1|||
146058270|NCT01001221|526731454|FG001|Overall Study|Other|1|||
146058271|NCT01001221|526731455|FG002|Overall Study|Other|0|||
146058272|NCT01001221|526731456|FG003|Overall Study|Other|0|||
146058273|NCT01001221|526731457|FG004|Overall Study|Other|0|||
146058274|NCT01001221|526731453|FG000|Overall Study|Not treated; protocol exclusion|0|||
146058275|NCT01001221|526731454|FG001|Overall Study|Not treated; protocol exclusion|0|||
146058276|NCT01001221|526731455|FG002|Overall Study|Not treated; protocol exclusion|1|||
146058277|NCT01001221|526731456|FG003|Overall Study|Not treated; protocol exclusion|0|||
146058278|NCT01001221|526731457|FG004|Overall Study|Not treated; protocol exclusion|0|||
146058279|NCT02388269|526731458|FG000|Overall Study|Adverse Event|2|||
146058280|NCT02388269|526731459|FG001|Overall Study|Adverse Event|0|||
146058281|NCT02388269|526731460|FG002|Overall Study|Adverse Event|0|||
146058282|NCT02388269|526731458|FG000|Overall Study|Withdrawal by Subject|1|||
146058283|NCT02388269|526731459|FG001|Overall Study|Withdrawal by Subject|2|||
146058284|NCT02388269|526731460|FG002|Overall Study|Withdrawal by Subject|0|||
146058285|NCT02388269|526731458|FG000|Overall Study|less than 50% stimulations|1|||
146058286|NCT02388269|526731459|FG001|Overall Study|less than 50% stimulations|0|||
146058287|NCT02388269|526731460|FG002|Overall Study|less than 50% stimulations|0|||
146058288|NCT02388269|526731458|FG000|Overall Study|no diary data|3|||
146058289|NCT02388269|526731459|FG001|Overall Study|no diary data|0|||
146058290|NCT02388269|526731460|FG002|Overall Study|no diary data|0|||
146058291|NCT02388269|526731458|FG000|Overall Study|Protocol Violation|2|||
146058292|NCT02388269|526731459|FG001|Overall Study|Protocol Violation|0|||
146058293|NCT02388269|526731460|FG002|Overall Study|Protocol Violation|0|||
146058294|NCT02388269|526731458|FG000|Overall Study|Screen Failure|0|||
146058295|NCT02388269|526731459|FG001|Overall Study|Screen Failure|0|||
146058296|NCT02388269|526731460|FG002|Overall Study|Screen Failure|10|||
146058297|NCT03448406|526731461|FG000|Overall Study|Noncompliance of scheduled visits|1|||
146058298|NCT03448406|526731462|FG001|Overall Study|Noncompliance of scheduled visits|2|||
146058299|NCT03448406|526731461|FG000|Overall Study|Withdrawal by Subject|1|||
146058300|NCT03448406|526731462|FG001|Overall Study|Withdrawal by Subject|2|||
146058301|NCT03448406|526731461|FG000|Overall Study|Protocol Violation|1|||
146058302|NCT03448406|526731462|FG001|Overall Study|Protocol Violation|0|||
146058303|NCT03448406|526731461|FG000|Overall Study|Adverse Event|8|||
146058304|NCT03448406|526731462|FG001|Overall Study|Adverse Event|9|||
146058305|NCT01292486|526731463|FG000|Overall Study|Protocol Violation|2|||
146058306|NCT01292486|526731463|FG000|Overall Study|Did not meet screening criteria|2|||
146058307|NCT01292486|526731463|FG000|Overall Study|Adverse Event|1|||
146058308|NCT01292486|526731463|FG000|Overall Study|Physician Decision|1|||
146058309|NCT00087152|526731464|FG000|Overall Study|Ineligible|6|||
146058310|NCT04602390|526731465|FG000|Overall Study|Withdrawal by Subject|0|||
146058311|NCT04602390|526731466|FG001|Overall Study|Withdrawal by Subject|0|||
146058312|NCT04602390|526731467|FG002|Overall Study|Withdrawal by Subject|0|||
146058313|NCT04602390|526731468|FG003|Overall Study|Withdrawal by Subject|0|||
146058314|NCT04602390|526731469|FG004|Overall Study|Withdrawal by Subject|1|||
146058315|NCT04602390|526731470|FG005|Overall Study|Withdrawal by Subject|0|||
146058316|NCT04602390|526731465|FG000|Overall Study|Adverse Event|0|||
146058317|NCT04602390|526731466|FG001|Overall Study|Adverse Event|0|||
146058318|NCT04602390|526731467|FG002|Overall Study|Adverse Event|0|||
146058319|NCT04602390|526731468|FG003|Overall Study|Adverse Event|0|||
146058320|NCT04602390|526731469|FG004|Overall Study|Adverse Event|0|||
146058321|NCT04602390|526731470|FG005|Overall Study|Adverse Event|1|||
146058322|NCT03882021|526731471|FG000|Enrollment|Procedure aborted/cancelled|2|||
146058323|NCT03882021|526731471|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
146058324|NCT03882021|526731471|FG000|Enrollment to 3-Month|Death|1|||
146058325|NCT03882021|526731471|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
146058326|NCT03882021|526731471|FG000|Enrollment to 3-Month|Missed Visit|4|||
146058327|NCT03882021|526731471|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
146058328|NCT03882021|526731471|FG000|6-Month to 12-Month Visit|Death|1|||
146058329|NCT03882021|526731471|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
146058330|NCT01546857|526731472|FG000|Overall Study|Withdrawal by Subject|2|||
146058331|NCT01546857|526731473|FG001|Overall Study|Withdrawal by Subject|3|||
146058332|NCT05121766|526731481|FG000|Overall Study|Covid reinfection|3|||
146058333|NCT05121766|526731482|FG001|Overall Study|Covid reinfection|0|||
146058334|NCT05121766|526731481|FG000|Overall Study|Withdrawal by Subject|3|||
146058335|NCT05121766|526731482|FG001|Overall Study|Withdrawal by Subject|1|||
146058336|NCT05121766|526731481|FG000|Overall Study|Adverse Event|2|||
146058337|NCT05121766|526731482|FG001|Overall Study|Adverse Event|4|||
146058338|NCT05121766|526731481|FG000|Overall Study|Lost to Follow-up|0|||
146058339|NCT05121766|526731482|FG001|Overall Study|Lost to Follow-up|1|||
146058340|NCT03259230|526731484|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
146058341|NCT03259230|526731485|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
146058342|NCT01033240|526731486|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
146058343|NCT01033240|526731487|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
146058344|NCT01033240|526731488|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
146058345|NCT01033240|526731486|FG000|Overall Study|Death|2|||
146058346|NCT01033240|526731487|FG001|Overall Study|Death|0|||
146058347|NCT01033240|526731488|FG002|Overall Study|Death|0|||
146058348|NCT01033240|526731486|FG000|Overall Study|Withdrew Consent|2|||
146058349|NCT01033240|526731487|FG001|Overall Study|Withdrew Consent|9|||
146058350|NCT01033240|526731488|FG002|Overall Study|Withdrew Consent|2|||
146058351|NCT01033240|526731486|FG000|Overall Study|Disease Progression|35|||
146058352|NCT01033240|526731487|FG001|Overall Study|Disease Progression|32|||
146058353|NCT01033240|526731488|FG002|Overall Study|Disease Progression|41|||
146058354|NCT01033240|526731486|FG000|Overall Study|Investigator Discretion|0|||
146058355|NCT01033240|526731487|FG001|Overall Study|Investigator Discretion|0|||
146058356|NCT01033240|526731488|FG002|Overall Study|Investigator Discretion|2|||
146058357|NCT01033240|526731486|FG000|Overall Study|Other|0|||
146058358|NCT01033240|526731487|FG001|Overall Study|Other|1|||
146058359|NCT01033240|526731488|FG002|Overall Study|Other|2|||
146058360|NCT02913482|526731489|FG000|Overall Study|Death|0|||
146058361|NCT02913482|526731490|FG001|Overall Study|Death|2|||
146058362|NCT02913482|526731491|FG002|Overall Study|Death|2|||
146058363|NCT02913482|526731489|FG000|Overall Study|Progressive Disease|1|||
146058364|NCT02913482|526731490|FG001|Overall Study|Progressive Disease|1|||
146058365|NCT02913482|526731491|FG002|Overall Study|Progressive Disease|1|||
146058366|NCT02913482|526731489|FG000|Overall Study|Reason not specified|0|||
146058367|NCT02913482|526731490|FG001|Overall Study|Reason not specified|0|||
146058368|NCT02913482|526731491|FG002|Overall Study|Reason not specified|1|||
146058369|NCT02913482|526731489|FG000|Overall Study|Withdrawal by Subject|0|||
146058370|NCT02913482|526731490|FG001|Overall Study|Withdrawal by Subject|1|||
146058371|NCT02913482|526731491|FG002|Overall Study|Withdrawal by Subject|1|||
146058372|NCT00918385|526731492|FG000|Monotherapy|Adverse Event|1|||
146058373|NCT00918385|526731493|FG001|Monotherapy|Adverse Event|6|||
146058374|NCT00918385|526731492|FG000|Monotherapy|Complicating illness|1|||
146058375|NCT00918385|526731493|FG001|Monotherapy|Complicating illness|0|||
146058376|NCT00918385|526731492|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
146058377|NCT00918385|526731493|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
146058378|NCT00918385|526731492|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
146058379|NCT00918385|526731493|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
146058380|NCT00918385|526731492|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
146058381|NCT00918385|526731493|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
146058382|NCT00918385|526731492|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
146058383|NCT00918385|526731493|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
146058384|NCT00625131|526731497|FG000|Overall Study|Lost to Follow-up|3|||
146058385|NCT00625131|526731498|FG001|Overall Study|Lost to Follow-up|2|||
146058386|NCT00625131|526731499|FG002|Overall Study|Lost to Follow-up|0|||
146058387|NCT00625131|526731497|FG000|Overall Study|Withdrawal by Subject|1|||
146058388|NCT00625131|526731498|FG001|Overall Study|Withdrawal by Subject|0|||
146058389|NCT00625131|526731499|FG002|Overall Study|Withdrawal by Subject|5|||
146058390|NCT00168844|526731502|FG000|Overall Study|Adverse Event|31|||
146058391|NCT00168844|526731503|FG001|Overall Study|Adverse Event|32|||
146058392|NCT00168844|526731504|FG002|Overall Study|Adverse Event|48|||
146058393|NCT00168844|526731502|FG000|Overall Study|Lost to Follow-up|4|||
146058394|NCT00168844|526731503|FG001|Overall Study|Lost to Follow-up|5|||
146058395|NCT00168844|526731504|FG002|Overall Study|Lost to Follow-up|11|||
146058396|NCT00168844|526731502|FG000|Overall Study|Withdrawal by Subject|12|||
146058397|NCT00168844|526731503|FG001|Overall Study|Withdrawal by Subject|9|||
146058398|NCT00168844|526731504|FG002|Overall Study|Withdrawal by Subject|19|||
146058399|NCT00168844|526731502|FG000|Overall Study|Protocol Violation|2|||
146058400|NCT00168844|526731503|FG001|Overall Study|Protocol Violation|2|||
146058401|NCT00168844|526731504|FG002|Overall Study|Protocol Violation|4|||
146058402|NCT00168844|526731502|FG000|Overall Study|Other|6|||
146058403|NCT00168844|526731503|FG001|Overall Study|Other|7|||
146058404|NCT00168844|526731504|FG002|Overall Study|Other|9|||
146058405|NCT03557970|526731507|FG000|Overall Study|Study closure|1|||
146058406|NCT03557970|526731508|FG001|Overall Study|Study closure|0|||
146058407|NCT03557970|526731507|FG000|Overall Study|Physician Decision|0|||
146058408|NCT03557970|526731508|FG001|Overall Study|Physician Decision|1|||
146058409|NCT03557970|526731507|FG000|Overall Study|Death|0|||
146058410|NCT03557970|526731508|FG001|Overall Study|Death|1|||
146058411|NCT00112736|526731511|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
146058412|NCT00112736|526731512|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
146058413|NCT02138890|526731513|FG000|Overall Study|Adverse Event|1|||
146058414|NCT02138890|526731514|FG001|Overall Study|Adverse Event|0|||
146058415|NCT05435339|526731515|FG000|Overall Study|Death|1|||
146058416|NCT05435339|526731516|FG001|Overall Study|Death|0|||
146058417|NCT05435339|526731517|FG002|Overall Study|Death|3|||
146058418|NCT05435339|526731518|FG003|Overall Study|Death|1|||
146058419|NCT05435339|526731519|FG004|Overall Study|Death|3|||
146058420|NCT05435339|526731520|FG005|Overall Study|Death|2|||
146058421|NCT05435339|526731521|FG006|Overall Study|Death|4|||
146058422|NCT05435339|526731522|FG007|Overall Study|Death|6|||
146058423|NCT05435339|526731515|FG000|Overall Study|Sponsor Decision|0|||
146058424|NCT05435339|526731516|FG001|Overall Study|Sponsor Decision|1|||
146058425|NCT05435339|526731517|FG002|Overall Study|Sponsor Decision|0|||
146058426|NCT05435339|526731518|FG003|Overall Study|Sponsor Decision|0|||
146058427|NCT05435339|526731519|FG004|Overall Study|Sponsor Decision|2|||
146058428|NCT05435339|526731520|FG005|Overall Study|Sponsor Decision|1|||
146058429|NCT05435339|526731521|FG006|Overall Study|Sponsor Decision|2|||
146058430|NCT05435339|526731522|FG007|Overall Study|Sponsor Decision|2|||
146058431|NCT05435339|526731515|FG000|Overall Study|Withdrawal by Subject|0|||
146058432|NCT05435339|526731516|FG001|Overall Study|Withdrawal by Subject|0|||
146058433|NCT05435339|526731517|FG002|Overall Study|Withdrawal by Subject|0|||
146058434|NCT05435339|526731518|FG003|Overall Study|Withdrawal by Subject|0|||
146058435|NCT05435339|526731519|FG004|Overall Study|Withdrawal by Subject|1|||
146058436|NCT05435339|526731520|FG005|Overall Study|Withdrawal by Subject|0|||
146058437|NCT05435339|526731521|FG006|Overall Study|Withdrawal by Subject|1|||
146058438|NCT05435339|526731522|FG007|Overall Study|Withdrawal by Subject|1|||
146058439|NCT00537394|526731523|FG000|First Year of Follow-up|Death|7|||
146058440|NCT00537394|526731524|FG001|First Year of Follow-up|Death|0|||
146058441|NCT00537394|526731525|FG002|First Year of Follow-up|Death|0|||
146058442|NCT00537394|526731523|FG000|First Year of Follow-up|Severe debilitation|1|||
146058443|NCT00537394|526731524|FG001|First Year of Follow-up|Severe debilitation|0|||
146058444|NCT00537394|526731525|FG002|First Year of Follow-up|Severe debilitation|1|||
146058445|NCT00537394|526731523|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
146058446|NCT00537394|526731524|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
146058447|NCT00537394|526731525|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
146058448|NCT00537394|526731523|FG000|First Year of Follow-up|Lost to Follow-up|1|||
146058449|NCT00537394|526731524|FG001|First Year of Follow-up|Lost to Follow-up|5|||
146058450|NCT00537394|526731525|FG002|First Year of Follow-up|Lost to Follow-up|1|||
146058451|NCT00537394|526731523|FG000|2nd Year of Follow-up|Death|4|||
146058452|NCT00537394|526731524|FG001|2nd Year of Follow-up|Death|1|||
146058453|NCT00537394|526731525|FG002|2nd Year of Follow-up|Death|2|||
146058454|NCT00537394|526731523|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
146058455|NCT00537394|526731524|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
146058456|NCT00537394|526731525|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
146058457|NCT00537394|526731523|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
146058458|NCT00537394|526731524|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
146058459|NCT00537394|526731525|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
146058460|NCT00537394|526731523|FG000|2nd Year of Follow-up|Clinic site closure|1|||
146058461|NCT00537394|526731524|FG001|2nd Year of Follow-up|Clinic site closure|0|||
146058462|NCT00537394|526731525|FG002|2nd Year of Follow-up|Clinic site closure|0|||
146058463|NCT02362724|526731528|FG000|Overall Study|Withdrawal by Subject|3|||
146058464|NCT02362724|526731529|FG001|Overall Study|Withdrawal by Subject|1|||
146058465|NCT02362724|526731528|FG000|Overall Study|Adverse Event|3|||
146058466|NCT02362724|526731529|FG001|Overall Study|Adverse Event|0|||
146058467|NCT02025179|526731530|FG000|Overall Study|Lost to Follow-up|0|||
146058468|NCT02025179|526731531|FG001|Overall Study|Lost to Follow-up|0|||
146058469|NCT02025179|526731532|FG002|Overall Study|Lost to Follow-up|1|||
146058470|NCT04764162|526731535|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
146058471|NCT04764162|526731536|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
146058472|NCT05556265|526731537|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146058473|NCT05556265|526731538|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
146058474|NCT05556265|526731539|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146058475|NCT05556265|526731540|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146058476|NCT05556265|526731541|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
146058477|NCT05556265|526731537|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146058478|NCT05556265|526731538|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
146058479|NCT05556265|526731539|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146058480|NCT05556265|526731540|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146058481|NCT05556265|526731541|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
146058482|NCT05556265|526731537|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146058483|NCT05556265|526731538|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
146058484|NCT05556265|526731539|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146058485|NCT05556265|526731540|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146058486|NCT05556265|526731541|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
146058487|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
146058488|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
146058489|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
146058490|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
146294392|NCT00300781|527594061|FG000|Overall Study|Adverse Event|5|||
146058491|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
146058492|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
146058493|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
146058494|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
146058495|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
146058496|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
146058497|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
146058498|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
146058499|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
146058500|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
146283342|NCT04860297|527550196|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
146283343|NCT04860297|527550197|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
146283344|NCT04860297|527550198|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
146283345|NCT04860297|527550199|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
146283346|NCT04860297|527550192|FG000|Part B (Booster Dose)|Death|0|||
146283347|NCT04860297|527550193|FG001|Part B (Booster Dose)|Death|0|||
146283348|NCT04860297|527550194|FG002|Part B (Booster Dose)|Death|0|||
146283349|NCT04860297|527550195|FG003|Part B (Booster Dose)|Death|0|||
146283350|NCT04860297|527550196|FG004|Part B (Booster Dose)|Death|1|||
146283351|NCT04860297|527550197|FG005|Part B (Booster Dose)|Death|2|||
146283352|NCT04860297|527550198|FG006|Part B (Booster Dose)|Death|1|||
146283353|NCT04860297|527550199|FG007|Part B (Booster Dose)|Death|0|||
146283354|NCT04860297|527550192|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
146283355|NCT04860297|527550193|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
146283356|NCT04860297|527550194|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
146283357|NCT04860297|527550195|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
146283358|NCT04860297|527550196|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
146283359|NCT04860297|527550197|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
146283360|NCT04860297|527550198|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
146283361|NCT04860297|527550199|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
146283362|NCT04811131|527550202|FG000|Overall Study|Adverse Event|0|||
146283363|NCT04811131|527550203|FG001|Overall Study|Adverse Event|0|||
146283364|NCT04811131|527550204|FG002|Overall Study|Adverse Event|1|||
146283365|NCT04811131|527550205|FG003|Overall Study|Adverse Event|0|||
146283366|NCT04811131|527550202|FG000|Overall Study|Lack of Efficacy|0|||
146283367|NCT04811131|527550203|FG001|Overall Study|Lack of Efficacy|0|||
146283368|NCT04811131|527550204|FG002|Overall Study|Lack of Efficacy|0|||
146283369|NCT04811131|527550205|FG003|Overall Study|Lack of Efficacy|1|||
146283370|NCT04811131|527550202|FG000|Overall Study|Lost to Follow-up|0|||
146283371|NCT04811131|527550203|FG001|Overall Study|Lost to Follow-up|1|||
146283372|NCT04811131|527550204|FG002|Overall Study|Lost to Follow-up|0|||
146283373|NCT04811131|527550205|FG003|Overall Study|Lost to Follow-up|0|||
146283374|NCT04811131|527550202|FG000|Overall Study|Sponsor request|31|||
146283375|NCT04811131|527550203|FG001|Overall Study|Sponsor request|35|||
146283376|NCT04811131|527550204|FG002|Overall Study|Sponsor request|27|||
146283377|NCT04811131|527550205|FG003|Overall Study|Sponsor request|10|||
146283378|NCT04811131|527550202|FG000|Overall Study|Withdrawal by Subject|3|||
146283379|NCT04811131|527550203|FG001|Overall Study|Withdrawal by Subject|1|||
146283380|NCT04811131|527550204|FG002|Overall Study|Withdrawal by Subject|3|||
146283381|NCT04811131|527550205|FG003|Overall Study|Withdrawal by Subject|1|||
146283382|NCT00620282|527550210|FG000|Overall Study|Adverse Event|0|||
146283383|NCT00620282|527550211|FG001|Overall Study|Adverse Event|1|||
146283384|NCT00620282|527550212|FG002|Overall Study|Adverse Event|0|||
146283385|NCT00620282|527550210|FG000|Overall Study|Arterial line unable to be placed|0|||
146283386|NCT00620282|527550211|FG001|Overall Study|Arterial line unable to be placed|0|||
146283387|NCT00620282|527550212|FG002|Overall Study|Arterial line unable to be placed|1|||
146283388|NCT00620282|527550210|FG000|Overall Study|Withdrawal by Subject|0|||
146283389|NCT00620282|527550211|FG001|Overall Study|Withdrawal by Subject|1|||
146283390|NCT00620282|527550212|FG002|Overall Study|Withdrawal by Subject|0|||
146283391|NCT02703259|527550213|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
146283392|NCT02703259|527550214|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
146283393|NCT02703259|527550213|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
146283394|NCT02703259|527550214|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
146283395|NCT02703259|527550213|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
146283396|NCT02703259|527550214|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
146283397|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|Death|1|||
146283398|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|Death|1|||
146283399|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
146283400|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
146283401|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
146283402|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
146058501|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
146058502|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146058503|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
146058504|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146058505|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
146058506|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
146058507|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146058508|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146058509|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
146058510|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
146058511|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
146058512|NCT05556265|526731537|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146058513|NCT05556265|526731538|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146058514|NCT05556265|526731539|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
146058515|NCT05556265|526731540|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
146058516|NCT05556265|526731541|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
146058517|NCT03077542|526731542|FG000|Overall Study|Death|4|||
146058518|NCT03077542|526731543|FG001|Overall Study|Death|0|||
146058519|NCT03077542|526731542|FG000|Overall Study|Physician Decision|6|||
146058520|NCT03077542|526731543|FG001|Overall Study|Physician Decision|1|||
146058521|NCT03077542|526731542|FG000|Overall Study|Withdrawal by Subject|0|||
146058522|NCT03077542|526731543|FG001|Overall Study|Withdrawal by Subject|1|||
146058523|NCT03980730|526731544|FG000|Overall Study|Study Terminated by Sponsor|0|||
146058524|NCT03980730|526731545|FG001|Overall Study|Study Terminated by Sponsor|3|||
146058525|NCT03980730|526731544|FG000|Overall Study|Adverse Event|2|||
146058526|NCT03980730|526731545|FG001|Overall Study|Adverse Event|0|||
146058527|NCT03980730|526731544|FG000|Overall Study|Sponsor Request|0|||
146058528|NCT03980730|526731545|FG001|Overall Study|Sponsor Request|1|||
146058529|NCT01300728|526731546|FG000|Overall Study|Withdrawal by Subject|1|||
146058530|NCT01300728|526731547|FG001|Overall Study|Withdrawal by Subject|1|||
146058531|NCT01300728|526731546|FG000|Overall Study|Physician Decision|1|||
146058532|NCT01300728|526731547|FG001|Overall Study|Physician Decision|0|||
146058533|NCT00301808|526731553|FG000|Overall Study|Adverse Event|5|||
146058534|NCT00301808|526731553|FG000|Overall Study|Death|3|||
146058535|NCT00301808|526731553|FG000|Overall Study|Lack of Efficacy|4|||
146058536|NCT03724942|526731558|FG000|Overall Study|Adverse Event|20|||
146058537|NCT03724942|526731559|FG001|Overall Study|Adverse Event|14|||
146058538|NCT03724942|526731558|FG000|Overall Study|Lack of Efficacy|0|||
146058539|NCT03724942|526731559|FG001|Overall Study|Lack of Efficacy|1|||
146058540|NCT03724942|526731558|FG000|Overall Study|Physician Decision|5|||
146058541|NCT03724942|526731559|FG001|Overall Study|Physician Decision|2|||
146058542|NCT03724942|526731558|FG000|Overall Study|Protocol Violation|1|||
146058543|NCT03724942|526731559|FG001|Overall Study|Protocol Violation|0|||
146058544|NCT03724942|526731558|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
146058545|NCT03724942|526731559|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
146058546|NCT03724942|526731558|FG000|Overall Study|Withdrawal by Legal Representative|3|||
146058547|NCT03724942|526731559|FG001|Overall Study|Withdrawal by Legal Representative|0|||
146058548|NCT02429830|526731560|FG000|Overall Study|Lost to Follow-up|1|||
146058549|NCT02429830|526731560|FG000|Overall Study|Device Explant|2|||
146058550|NCT01352117|526733680|FG000|Overall Study|Death|15|||
146058551|NCT01352117|526733681|FG001|Overall Study|Death|16|||
146058552|NCT01352117|526733680|FG000|Overall Study|Withdrawal by Subject|1|||
146058553|NCT01352117|526733681|FG001|Overall Study|Withdrawal by Subject|0|||
146058554|NCT01352117|526733680|FG000|Overall Study|Lost to Follow-up|2|||
146058555|NCT01352117|526733681|FG001|Overall Study|Lost to Follow-up|7|||
146058556|NCT01352117|526733680|FG000|Overall Study|Non-adherent to study requirements|1|||
146058557|NCT01352117|526733681|FG001|Overall Study|Non-adherent to study requirements|1|||
146058558|NCT01352117|526733680|FG000|Overall Study|Did not initiate study treatment|1|||
146058559|NCT01352117|526733681|FG001|Overall Study|Did not initiate study treatment|0|||
146058560|NCT01352117|526733680|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
146058561|NCT01352117|526733681|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
146058562|NCT01766050|526733682|FG000|Overall Study|Adverse Event|1|||
146058563|NCT01766050|526733682|FG000|Overall Study|Lost to Follow-up|1|||
146058564|NCT01766050|526733682|FG000|Overall Study|Withdrawal by Subject|2|||
146058565|NCT02081677|526733684|FG000|Overall Study|Adverse Event|0|||
146058566|NCT02081677|526733685|FG001|Overall Study|Adverse Event|0|||
146058567|NCT02081677|526733686|FG002|Overall Study|Adverse Event|1|||
146058568|NCT02081677|526733687|FG003|Overall Study|Adverse Event|0|||
146058569|NCT02081677|526733684|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146058570|NCT02081677|526733685|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146058571|NCT02081677|526733686|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
146058572|NCT02081677|526733687|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146058573|NCT02081677|526733684|FG000|Overall Study|Not comfortable with lens care system|1|||
146058574|NCT02081677|526733685|FG001|Overall Study|Not comfortable with lens care system|0|||
146058575|NCT02081677|526733686|FG002|Overall Study|Not comfortable with lens care system|0|||
146058576|NCT02081677|526733687|FG003|Overall Study|Not comfortable with lens care system|0|||
146058577|NCT02081677|526733684|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146058578|NCT02081677|526733685|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146058579|NCT02081677|526733686|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
146058580|NCT02081677|526733687|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
146058581|NCT00089297|526733688|FG000|Overall Study|Adverse Event|9|||
146058582|NCT00089297|526733688|FG000|Overall Study|Death|1|||
146058583|NCT00089297|526733688|FG000|Overall Study|Withdrawal by Subject|12|||
146058584|NCT00089297|526733688|FG000|Overall Study|Disease progression|2|||
146058585|NCT00089297|526733688|FG000|Overall Study|Ineligible|11|||
146058586|NCT00089297|526733688|FG000|Overall Study|Secondary malignancy|1|||
146058587|NCT00089297|526733688|FG000|Overall Study|IRB approval not ready|1|||
146058588|NCT00089297|526733688|FG000|Overall Study|Non-compliance|1|||
146058589|NCT01097668|526733689|FG000|Overall Study|Withdrawal by Subject|1|||
146058590|NCT01097668|526733690|FG001|Overall Study|Withdrawal by Subject|2|||
146058591|NCT01097668|526733689|FG000|Overall Study|Lost to Follow-up|1|||
146058592|NCT01097668|526733690|FG001|Overall Study|Lost to Follow-up|0|||
146058593|NCT00385671|526733691|FG000|Overall Study|Adverse Event|14|||
146058594|NCT00385671|526733692|FG001|Overall Study|Adverse Event|27|||
146058595|NCT00385671|526733693|FG002|Overall Study|Adverse Event|18|||
146058596|NCT00385671|526733691|FG000|Overall Study|Lack of Efficacy|5|||
146058597|NCT00385671|526733692|FG001|Overall Study|Lack of Efficacy|9|||
146058598|NCT00385671|526733693|FG002|Overall Study|Lack of Efficacy|5|||
146058599|NCT00385671|526733691|FG000|Overall Study|Lost to Follow-up|6|||
146058600|NCT00385671|526733692|FG001|Overall Study|Lost to Follow-up|6|||
146058601|NCT00385671|526733693|FG002|Overall Study|Lost to Follow-up|5|||
146058602|NCT00385671|526733691|FG000|Overall Study|Physician Decision|2|||
146058603|NCT00385671|526733692|FG001|Overall Study|Physician Decision|1|||
146058604|NCT00385671|526733693|FG002|Overall Study|Physician Decision|2|||
146058605|NCT00385671|526733691|FG000|Overall Study|Protocol Violation|5|||
146058606|NCT00385671|526733692|FG001|Overall Study|Protocol Violation|2|||
146058607|NCT00385671|526733693|FG002|Overall Study|Protocol Violation|1|||
146058608|NCT00385671|526733691|FG000|Overall Study|Sponsor Decision|2|||
146058609|NCT00385671|526733692|FG001|Overall Study|Sponsor Decision|2|||
146058610|NCT00385671|526733693|FG002|Overall Study|Sponsor Decision|1|||
146058611|NCT00385671|526733691|FG000|Overall Study|Withdrawal by Subject|4|||
146058612|NCT00385671|526733692|FG001|Overall Study|Withdrawal by Subject|4|||
146058613|NCT00385671|526733693|FG002|Overall Study|Withdrawal by Subject|4|||
146058614|NCT01910298|526733694|FG000|Overall Study|Adverse Event|1|||
146058615|NCT01910298|526733695|FG001|Overall Study|Adverse Event|0|||
146058616|NCT01910298|526733694|FG000|Overall Study|Withdrawal by Subject|2|||
146058617|NCT01910298|526733695|FG001|Overall Study|Withdrawal by Subject|7|||
146058618|NCT01910298|526733694|FG000|Overall Study|Protocol Deviation|0|||
146058619|NCT01910298|526733695|FG001|Overall Study|Protocol Deviation|5|||
146058620|NCT01910298|526733694|FG000|Overall Study|Lost to Follow-up|1|||
146058621|NCT01910298|526733695|FG001|Overall Study|Lost to Follow-up|1|||
146058622|NCT01910298|526733694|FG000|Overall Study|Study Terminated by Sponsor|1|||
146058623|NCT01910298|526733695|FG001|Overall Study|Study Terminated by Sponsor|17|||
146058624|NCT01910298|526733694|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146058625|NCT01910298|526733695|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146058626|NCT03037385|526733698|FG000|Overall Study|Adverse Event|0|||
146058627|NCT03037385|526733699|FG001|Overall Study|Adverse Event|0|||
146058628|NCT03037385|526733700|FG002|Overall Study|Adverse Event|1|||
146058629|NCT03037385|526733701|FG003|Overall Study|Adverse Event|0|||
146058630|NCT03037385|526733702|FG004|Overall Study|Adverse Event|0|||
146058631|NCT03037385|526733703|FG005|Overall Study|Adverse Event|0|||
146058632|NCT03037385|526733704|FG006|Overall Study|Adverse Event|0|||
146058633|NCT03037385|526733705|FG007|Overall Study|Adverse Event|0|||
146058634|NCT03037385|526733706|FG008|Overall Study|Adverse Event|0|||
146058635|NCT03037385|526733707|FG009|Overall Study|Adverse Event|6|||
146058636|NCT03037385|526733698|FG000|Overall Study|Death|1|||
146058637|NCT03037385|526733699|FG001|Overall Study|Death|4|||
146058638|NCT03037385|526733700|FG002|Overall Study|Death|2|||
146058639|NCT03037385|526733701|FG003|Overall Study|Death|2|||
146058640|NCT03037385|526733702|FG004|Overall Study|Death|5|||
146058641|NCT03037385|526733703|FG005|Overall Study|Death|2|||
146058642|NCT03037385|526733704|FG006|Overall Study|Death|1|||
146058643|NCT03037385|526733705|FG007|Overall Study|Death|4|||
146058644|NCT03037385|526733706|FG008|Overall Study|Death|3|||
146058645|NCT03037385|526733707|FG009|Overall Study|Death|240|||
146283403|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
146058646|NCT03037385|526733698|FG000|Overall Study|Initiation of Another Therapy|1|||
146058647|NCT03037385|526733699|FG001|Overall Study|Initiation of Another Therapy|0|||
146058648|NCT03037385|526733700|FG002|Overall Study|Initiation of Another Therapy|0|||
146058649|NCT03037385|526733701|FG003|Overall Study|Initiation of Another Therapy|0|||
146058650|NCT03037385|526733702|FG004|Overall Study|Initiation of Another Therapy|0|||
146058651|NCT03037385|526733703|FG005|Overall Study|Initiation of Another Therapy|0|||
146058652|NCT03037385|526733704|FG006|Overall Study|Initiation of Another Therapy|0|||
146058653|NCT03037385|526733705|FG007|Overall Study|Initiation of Another Therapy|1|||
146058654|NCT03037385|526733706|FG008|Overall Study|Initiation of Another Therapy|0|||
146058655|NCT03037385|526733707|FG009|Overall Study|Initiation of Another Therapy|2|||
146058656|NCT03037385|526733698|FG000|Overall Study|Lost to Follow-up|0|||
146058657|NCT03037385|526733699|FG001|Overall Study|Lost to Follow-up|0|||
146058658|NCT03037385|526733700|FG002|Overall Study|Lost to Follow-up|0|||
146058659|NCT03037385|526733701|FG003|Overall Study|Lost to Follow-up|0|||
146058660|NCT03037385|526733702|FG004|Overall Study|Lost to Follow-up|0|||
146058661|NCT03037385|526733703|FG005|Overall Study|Lost to Follow-up|1|||
146058662|NCT03037385|526733704|FG006|Overall Study|Lost to Follow-up|0|||
146058663|NCT03037385|526733705|FG007|Overall Study|Lost to Follow-up|0|||
146058664|NCT03037385|526733706|FG008|Overall Study|Lost to Follow-up|0|||
146058665|NCT03037385|526733707|FG009|Overall Study|Lost to Follow-up|16|||
146058666|NCT03037385|526733698|FG000|Overall Study|Physician Decision|0|||
146058667|NCT03037385|526733699|FG001|Overall Study|Physician Decision|0|||
146058668|NCT03037385|526733700|FG002|Overall Study|Physician Decision|0|||
146058669|NCT03037385|526733701|FG003|Overall Study|Physician Decision|0|||
146058670|NCT03037385|526733702|FG004|Overall Study|Physician Decision|0|||
146058671|NCT03037385|526733703|FG005|Overall Study|Physician Decision|0|||
146058672|NCT03037385|526733704|FG006|Overall Study|Physician Decision|0|||
146058673|NCT03037385|526733705|FG007|Overall Study|Physician Decision|0|||
146058674|NCT03037385|526733706|FG008|Overall Study|Physician Decision|0|||
146058675|NCT03037385|526733707|FG009|Overall Study|Physician Decision|1|||
146058676|NCT03037385|526733698|FG000|Overall Study|Progressive Disease|0|||
146058677|NCT03037385|526733699|FG001|Overall Study|Progressive Disease|1|||
146058678|NCT03037385|526733700|FG002|Overall Study|Progressive Disease|1|||
146058679|NCT03037385|526733701|FG003|Overall Study|Progressive Disease|5|||
146058680|NCT03037385|526733702|FG004|Overall Study|Progressive Disease|2|||
146058681|NCT03037385|526733703|FG005|Overall Study|Progressive Disease|0|||
146058682|NCT03037385|526733704|FG006|Overall Study|Progressive Disease|1|||
146058683|NCT03037385|526733705|FG007|Overall Study|Progressive Disease|0|||
146058684|NCT03037385|526733706|FG008|Overall Study|Progressive Disease|0|||
146058685|NCT03037385|526733707|FG009|Overall Study|Progressive Disease|30|||
146058686|NCT03037385|526733698|FG000|Overall Study|Withdrawal by Subject|0|||
146058687|NCT03037385|526733699|FG001|Overall Study|Withdrawal by Subject|0|||
146058688|NCT03037385|526733700|FG002|Overall Study|Withdrawal by Subject|1|||
146058689|NCT03037385|526733701|FG003|Overall Study|Withdrawal by Subject|2|||
146058690|NCT03037385|526733702|FG004|Overall Study|Withdrawal by Subject|1|||
146058691|NCT03037385|526733703|FG005|Overall Study|Withdrawal by Subject|3|||
146058692|NCT03037385|526733704|FG006|Overall Study|Withdrawal by Subject|0|||
146058693|NCT03037385|526733705|FG007|Overall Study|Withdrawal by Subject|0|||
146058694|NCT03037385|526733706|FG008|Overall Study|Withdrawal by Subject|0|||
146058695|NCT03037385|526733707|FG009|Overall Study|Withdrawal by Subject|52|||
146058696|NCT03037385|526733698|FG000|Overall Study|Reason Not Specified|0|||
146058697|NCT03037385|526733699|FG001|Overall Study|Reason Not Specified|1|||
146058698|NCT03037385|526733700|FG002|Overall Study|Reason Not Specified|0|||
146058699|NCT03037385|526733701|FG003|Overall Study|Reason Not Specified|4|||
146058700|NCT03037385|526733702|FG004|Overall Study|Reason Not Specified|3|||
146058701|NCT03037385|526733703|FG005|Overall Study|Reason Not Specified|6|||
146058702|NCT03037385|526733704|FG006|Overall Study|Reason Not Specified|2|||
146058703|NCT03037385|526733705|FG007|Overall Study|Reason Not Specified|0|||
146058704|NCT03037385|526733706|FG008|Overall Study|Reason Not Specified|1|||
146058705|NCT03037385|526733707|FG009|Overall Study|Reason Not Specified|181|||
146058706|NCT04515771|526733708|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
146058707|NCT04515771|526733709|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
146058708|NCT04515771|526733708|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
146058709|NCT04515771|526733709|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
146058710|NCT04515771|526733708|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
146058711|NCT04515771|526733709|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
146058712|NCT01021020|526733711|FG000|Period I|Protocol Violation|1|||
146058713|NCT01021020|526733711|FG000|Period I|Withdrawal by Subject|1|||
146058714|NCT01021020|526733711|FG000|14 Day Washout Period A|Physician Decision|1|||
146058715|NCT00948246|526733714|FG000|Overall Study|Lost to Follow-up|11|||
146058716|NCT00948246|526733714|FG000|Overall Study|Adverse Event|11|||
146058717|NCT00948246|526733714|FG000|Overall Study|Death|1|||
146058718|NCT00948246|526733714|FG000|Overall Study|Withdrawal by Subject|1|||
146058719|NCT00148317|526733715|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
146058720|NCT00148317|526733715|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
146058721|NCT00148317|526733715|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
146058722|NCT03924622|526733716|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
146058723|NCT03924622|526733717|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146058724|NCT03924622|526733718|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146058725|NCT03924622|526733719|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
146294393|NCT00300781|527594062|FG001|Overall Study|Adverse Event|6|||
146058726|NCT03924622|526733720|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146058727|NCT03924622|526733721|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
146058728|NCT02766023|526733722|FG000|Overall Study|Lost to Follow-up|23|||
146058729|NCT02766023|526733723|FG001|Overall Study|Lost to Follow-up|11|||
146058730|NCT02766023|526733722|FG000|Overall Study|Pregnancy|1|||
146058731|NCT02766023|526733723|FG001|Overall Study|Pregnancy|0|||
146058732|NCT02766023|526733722|FG000|Overall Study|Adverse Event|1|||
146058733|NCT02766023|526733723|FG001|Overall Study|Adverse Event|0|||
146058734|NCT02766023|526733722|FG000|Overall Study|Withdrawal by Subject|4|||
146058735|NCT02766023|526733723|FG001|Overall Study|Withdrawal by Subject|5|||
146058736|NCT02766023|526733722|FG000|Overall Study|Physician Decision|1|||
146058737|NCT02766023|526733723|FG001|Overall Study|Physician Decision|0|||
146058738|NCT02766023|526733722|FG000|Overall Study|Not Eligible at Enrollment|0|||
146058739|NCT02766023|526733723|FG001|Overall Study|Not Eligible at Enrollment|1|||
146058740|NCT00286468|526733724|FG000|Overall Study|Hyperglycemic Rescue|28|||
146058741|NCT00286468|526733725|FG001|Overall Study|Hyperglycemic Rescue|30|||
146058742|NCT00286468|526733726|FG002|Overall Study|Hyperglycemic Rescue|31|||
146058743|NCT00286468|526733724|FG000|Overall Study|Adverse Event|2|||
146058744|NCT00286468|526733725|FG001|Overall Study|Adverse Event|6|||
146058745|NCT00286468|526733726|FG002|Overall Study|Adverse Event|4|||
146058746|NCT00286468|526733724|FG000|Overall Study|Protocol Violation|0|||
146058747|NCT00286468|526733725|FG001|Overall Study|Protocol Violation|3|||
146058748|NCT00286468|526733726|FG002|Overall Study|Protocol Violation|1|||
146058749|NCT00286468|526733724|FG000|Overall Study|Lost to Follow-up|1|||
146058750|NCT00286468|526733725|FG001|Overall Study|Lost to Follow-up|1|||
146058751|NCT00286468|526733726|FG002|Overall Study|Lost to Follow-up|2|||
146058752|NCT00286468|526733724|FG000|Overall Study|Withdrawal by Subject|3|||
146058753|NCT00286468|526733725|FG001|Overall Study|Withdrawal by Subject|8|||
146058754|NCT00286468|526733726|FG002|Overall Study|Withdrawal by Subject|11|||
146058755|NCT00286468|526733724|FG000|Overall Study|Physician Decision|3|||
146058756|NCT00286468|526733725|FG001|Overall Study|Physician Decision|2|||
146058757|NCT00286468|526733726|FG002|Overall Study|Physician Decision|1|||
146058758|NCT02923726|526733728|FG000|Overall Study|Death|196|||
146058759|NCT02923726|526733729|FG001|Overall Study|Death|175|||
146058760|NCT02923726|526733728|FG000|Overall Study|Withdrawal by Subject|337|||
146058761|NCT02923726|526733729|FG001|Overall Study|Withdrawal by Subject|307|||
146058762|NCT03617172|526733741|FG000|Overall Study|Lost to Follow-up|1|||
146058763|NCT03617172|526733742|FG001|Overall Study|Lost to Follow-up|0|||
146058764|NCT02587221|526733745|FG000|Overall Study|Adverse Event|3|||
146058765|NCT02587221|526733746|FG001|Overall Study|Adverse Event|3|||
146058766|NCT02587221|526733745|FG000|Overall Study|Death|33|||
146058767|NCT02587221|526733746|FG001|Overall Study|Death|34|||
146058768|NCT02587221|526733745|FG000|Overall Study|Withdrawal by Subject|66|||
146058769|NCT02587221|526733746|FG001|Overall Study|Withdrawal by Subject|61|||
146058770|NCT02587221|526733745|FG000|Overall Study|Lost to Follow-up|21|||
146058771|NCT02587221|526733746|FG001|Overall Study|Lost to Follow-up|19|||
146058772|NCT02587221|526733745|FG000|Overall Study|Protocol Violation|6|||
146058773|NCT02587221|526733746|FG001|Overall Study|Protocol Violation|5|||
146058774|NCT02587221|526733745|FG000|Overall Study|Other Reason or Unspecified|2|||
146058775|NCT02587221|526733746|FG001|Overall Study|Other Reason or Unspecified|1|||
146058776|NCT01176032|526733750|FG000|Overall Study|Adverse Event|1|||
146283404|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
146283405|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
146283406|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
146283407|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
146283408|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
146283409|NCT00371683|527550215|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
146283410|NCT00371683|527550216|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
146283411|NCT00371683|527550215|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
146058777|NCT01176032|526733751|FG001|Overall Study|Adverse Event|0|||
146058778|NCT01176032|526733750|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146058779|NCT01176032|526733751|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146058780|NCT01176032|526733750|FG000|Overall Study|Protocol Violation|1|||
146058781|NCT01176032|526733751|FG001|Overall Study|Protocol Violation|0|||
146058782|NCT01176032|526733750|FG000|Overall Study|Informed consent withdrawn|3|||
146058783|NCT01176032|526733751|FG001|Overall Study|Informed consent withdrawn|0|||
146058784|NCT01176032|526733750|FG000|Overall Study|Other|1|||
146058785|NCT01176032|526733751|FG001|Overall Study|Other|0|||
146058786|NCT01469221|526733752|FG000|Double Blind Phase|Protocol Violation|1|||
146058787|NCT01469221|526733753|FG001|Double Blind Phase|Protocol Violation|0|||
146058788|NCT01469221|526733754|FG002|Double Blind Phase|Protocol Violation|0|||
146058789|NCT01469221|526733752|FG000|Double Blind Phase|Physician Decision|1|||
146058790|NCT01469221|526733753|FG001|Double Blind Phase|Physician Decision|1|||
146058791|NCT01469221|526733754|FG002|Double Blind Phase|Physician Decision|0|||
146058792|NCT01469221|526733752|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
146058793|NCT01469221|526733753|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
146058794|NCT01469221|526733754|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
146058795|NCT01149096|526733757|FG000|Overall Study|Lost to Follow-up|0|||
146058796|NCT01149096|526733758|FG001|Overall Study|Lost to Follow-up|1|||
146058797|NCT04914364|526733759|FG000|Overall Study|No longer eligible for study|1|||
146058798|NCT04914364|526733759|FG000|Overall Study|Lost to Follow-up|2|||
146058799|NCT02358473|526733760|FG000|Overall Study|Disease Progession|6|||
146058800|NCT02358473|526733760|FG000|Overall Study|Adverse Event|3|||
146058801|NCT02358473|526733760|FG000|Overall Study|Withdrawal by Subject|2|||
146058802|NCT02358473|526733760|FG000|Overall Study|Physician Decision|2|||
146058803|NCT01263769|526733763|FG000|Overall Study|Non-Compliant with treatment|1|||
146058804|NCT04819945|526733776|FG000|Overall Study|Lost to Follow-up|1|||
146058805|NCT00703014|526733777|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
146058806|NCT00703014|526733778|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
146058807|NCT00703014|526733779|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146058808|NCT00703014|526733780|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146058809|NCT00703014|526733777|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146058810|NCT00703014|526733778|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
146058811|NCT00703014|526733779|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
146058812|NCT00703014|526733780|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
146058813|NCT02004236|526733781|FG000|Overall Study|Lack of Efficacy|0|||
146058814|NCT02004236|526733782|FG001|Overall Study|Lack of Efficacy|0|||
146058815|NCT02004236|526733783|FG002|Overall Study|Lack of Efficacy|16|||
146058816|NCT00918281|526733788|FG000|Overall Study|Physician Decision|29|||
146058817|NCT01446159|526733789|FG000|Overall Study|Withdrawal by Subject|1|||
146058818|NCT01446159|526733790|FG001|Overall Study|Withdrawal by Subject|0|||
146058819|NCT01446159|526733791|FG002|Overall Study|Withdrawal by Subject|14|||
146058820|NCT01446159|526733792|FG003|Overall Study|Withdrawal by Subject|11|||
146058821|NCT01446159|526733789|FG000|Overall Study|Lost to Follow-up|0|||
146058822|NCT01446159|526733790|FG001|Overall Study|Lost to Follow-up|0|||
146058823|NCT01446159|526733791|FG002|Overall Study|Lost to Follow-up|1|||
146058824|NCT01446159|526733792|FG003|Overall Study|Lost to Follow-up|2|||
146058825|NCT01446159|526733789|FG000|Overall Study|Death|2|||
146058826|NCT01446159|526733790|FG001|Overall Study|Death|3|||
146058827|NCT01446159|526733791|FG002|Overall Study|Death|43|||
146058828|NCT01446159|526733792|FG003|Overall Study|Death|36|||
146058829|NCT01446159|526733789|FG000|Overall Study|Other|0|||
146058830|NCT01446159|526733790|FG001|Overall Study|Other|0|||
146058831|NCT01446159|526733791|FG002|Overall Study|Other|13|||
146058832|NCT01446159|526733792|FG003|Overall Study|Other|13|||
146058833|NCT01283139|526733793|FG000|Overall Study|Lost to Follow-up|5|||
146058834|NCT01283139|526733794|FG001|Overall Study|Lost to Follow-up|2|||
146058835|NCT01283139|526733795|FG002|Overall Study|Lost to Follow-up|3|||
146058836|NCT01283139|526733796|FG003|Overall Study|Lost to Follow-up|1|||
146058837|NCT01283139|526733793|FG000|Overall Study|Withdrawal by Subject|8|||
146058838|NCT01283139|526733794|FG001|Overall Study|Withdrawal by Subject|8|||
146058839|NCT01283139|526733795|FG002|Overall Study|Withdrawal by Subject|6|||
146058840|NCT01283139|526733796|FG003|Overall Study|Withdrawal by Subject|8|||
146058841|NCT01283139|526733793|FG000|Overall Study|Death|2|||
146058842|NCT01283139|526733794|FG001|Overall Study|Death|0|||
146058843|NCT01283139|526733795|FG002|Overall Study|Death|2|||
146058844|NCT01283139|526733796|FG003|Overall Study|Death|2|||
146058845|NCT01283139|526733793|FG000|Overall Study|Lack of Efficacy|1|||
146058846|NCT01283139|526733794|FG001|Overall Study|Lack of Efficacy|2|||
146058847|NCT01283139|526733795|FG002|Overall Study|Lack of Efficacy|2|||
146058848|NCT01283139|526733796|FG003|Overall Study|Lack of Efficacy|1|||
146058849|NCT01283139|526733793|FG000|Overall Study|Early termination due to AE/SAE|1|||
146058850|NCT01283139|526733794|FG001|Overall Study|Early termination due to AE/SAE|1|||
146283412|NCT00371683|527550216|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
146283413|NCT00371683|527550215|FG000|Follow-Up Period - Randomized Patients|Death|0|||
146283414|NCT00371683|527550216|FG001|Follow-Up Period - Randomized Patients|Death|2|||
146283415|NCT00371683|527550215|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
146283416|NCT00371683|527550216|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
146283417|NCT00371683|527550215|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
146283418|NCT00371683|527550216|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
146283419|NCT03181789|527550217|FG000|Overall Study|Withdrawal by Subject|0|||
146283420|NCT03181789|527550218|FG001|Overall Study|Withdrawal by Subject|1|||
146283421|NCT03181789|527550219|FG002|Overall Study|Withdrawal by Subject|1|||
146058851|NCT01283139|526733795|FG002|Overall Study|Early termination due to AE/SAE|0|||
146058852|NCT01283139|526733796|FG003|Overall Study|Early termination due to AE/SAE|0|||
146058853|NCT01283139|526733793|FG000|Overall Study|Participant's refusal to continue|0|||
146058854|NCT01283139|526733794|FG001|Overall Study|Participant's refusal to continue|3|||
146058855|NCT01283139|526733795|FG002|Overall Study|Participant's refusal to continue|1|||
146058856|NCT01283139|526733796|FG003|Overall Study|Participant's refusal to continue|1|||
146058857|NCT01283139|526733793|FG000|Overall Study|Pregnancy|0|||
146058858|NCT01283139|526733794|FG001|Overall Study|Pregnancy|1|||
146058859|NCT01283139|526733795|FG002|Overall Study|Pregnancy|1|||
146058860|NCT01283139|526733796|FG003|Overall Study|Pregnancy|0|||
146058861|NCT01283139|526733793|FG000|Overall Study|Missed follow-up visit|0|||
146058862|NCT01283139|526733794|FG001|Overall Study|Missed follow-up visit|1|||
146058863|NCT01283139|526733795|FG002|Overall Study|Missed follow-up visit|2|||
146058864|NCT01283139|526733796|FG003|Overall Study|Missed follow-up visit|2|||
146058865|NCT01283139|526733793|FG000|Overall Study|Participant randomized in error|0|||
146058866|NCT01283139|526733794|FG001|Overall Study|Participant randomized in error|0|||
146058867|NCT01283139|526733795|FG002|Overall Study|Participant randomized in error|1|||
146058868|NCT01283139|526733796|FG003|Overall Study|Participant randomized in error|0|||
146058869|NCT00004563|526733797|FG000|Overall Study|Withdrawal by Subject|20|||
146058870|NCT00004563|526733798|FG001|Overall Study|Withdrawal by Subject|16|||
146058871|NCT00004563|526733797|FG000|Overall Study|Lack of Efficacy|3|||
146058872|NCT00004563|526733798|FG001|Overall Study|Lack of Efficacy|5|||
146058873|NCT00004563|526733797|FG000|Overall Study|Death|2|||
146058874|NCT00004563|526733798|FG001|Overall Study|Death|3|||
146058875|NCT00762164|526733800|FG000|Overall Study|Lost to Follow-up|1|||
146058876|NCT00762164|526733801|FG001|Overall Study|Lost to Follow-up|1|||
146058877|NCT00762164|526733800|FG000|Overall Study|Discontinued medication|2|||
146058878|NCT00762164|526733801|FG001|Overall Study|Discontinued medication|0|||
146058879|NCT00762164|526733800|FG000|Overall Study|Withdrawal by Subject|0|||
146058880|NCT00762164|526733801|FG001|Overall Study|Withdrawal by Subject|1|||
146058881|NCT00321789|526733805|FG000|Overall Study|Lost to Follow-up|4|||
146058882|NCT00321789|526733806|FG001|Overall Study|Lost to Follow-up|7|||
146058883|NCT00321789|526733805|FG000|Overall Study|Withdrawal by Subject|6|||
146058884|NCT00321789|526733806|FG001|Overall Study|Withdrawal by Subject|6|||
146058885|NCT00321789|526733805|FG000|Overall Study|Protocol Violation|5|||
146058886|NCT00321789|526733806|FG001|Overall Study|Protocol Violation|3|||
146058887|NCT01927497|526733807|FG000|Overall Study|Death|0|||
146058888|NCT01927497|526733808|FG001|Overall Study|Death|1|||
146058889|NCT01927497|526733807|FG000|Overall Study|Protocol Violation|2|||
146058890|NCT01927497|526733808|FG001|Overall Study|Protocol Violation|0|||
146058891|NCT00517296|526733809|FG000|Overall Study|Withdrawal by Subject|1|||
146058892|NCT00517296|526733810|FG001|Overall Study|Withdrawal by Subject|0|||
146058893|NCT03137992|526733813|FG000|Washout Period 1|Adverse Event|1|||
146058894|NCT03137992|526733814|FG001|Washout Period 1|Adverse Event|1|||
146058895|NCT03137992|526733815|FG002|Washout Period 1|Adverse Event|0|||
146058896|NCT03137992|526733816|FG003|Washout Period 1|Adverse Event|0|||
146058897|NCT03137992|526733817|FG004|Washout Period 1|Adverse Event|0|||
146058898|NCT03137992|526733818|FG005|Washout Period 1|Adverse Event|1|||
146058899|NCT03137992|526733813|FG000|Washout Period 1|Withdrawal by Subject|0|||
146058900|NCT03137992|526733814|FG001|Washout Period 1|Withdrawal by Subject|1|||
146058901|NCT03137992|526733815|FG002|Washout Period 1|Withdrawal by Subject|1|||
146058902|NCT03137992|526733816|FG003|Washout Period 1|Withdrawal by Subject|0|||
146058903|NCT03137992|526733817|FG004|Washout Period 1|Withdrawal by Subject|0|||
146058904|NCT03137992|526733818|FG005|Washout Period 1|Withdrawal by Subject|0|||
146058905|NCT03137992|526733813|FG000|Washout Period 1|Principal Investigator Discretion|0|||
146058906|NCT03137992|526733814|FG001|Washout Period 1|Principal Investigator Discretion|1|||
146058907|NCT03137992|526733815|FG002|Washout Period 1|Principal Investigator Discretion|0|||
146058908|NCT03137992|526733816|FG003|Washout Period 1|Principal Investigator Discretion|0|||
146058909|NCT03137992|526733817|FG004|Washout Period 1|Principal Investigator Discretion|0|||
146058910|NCT03137992|526733818|FG005|Washout Period 1|Principal Investigator Discretion|0|||
146058911|NCT03137992|526733813|FG000|Washout Period 1|COPD Exacerbation|1|||
146058912|NCT03137992|526733814|FG001|Washout Period 1|COPD Exacerbation|1|||
146058913|NCT03137992|526733815|FG002|Washout Period 1|COPD Exacerbation|1|||
146058914|NCT03137992|526733816|FG003|Washout Period 1|COPD Exacerbation|0|||
146058915|NCT03137992|526733817|FG004|Washout Period 1|COPD Exacerbation|1|||
146058916|NCT03137992|526733818|FG005|Washout Period 1|COPD Exacerbation|1|||
146058917|NCT03137992|526733813|FG000|Washout Period 1|Subject Noncompliance|1|||
146058918|NCT03137992|526733814|FG001|Washout Period 1|Subject Noncompliance|0|||
146058919|NCT03137992|526733815|FG002|Washout Period 1|Subject Noncompliance|0|||
146058920|NCT03137992|526733816|FG003|Washout Period 1|Subject Noncompliance|0|||
146058921|NCT03137992|526733817|FG004|Washout Period 1|Subject Noncompliance|1|||
146058922|NCT03137992|526733818|FG005|Washout Period 1|Subject Noncompliance|0|||
146058923|NCT03137992|526733813|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
146058924|NCT03137992|526733814|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
146058925|NCT03137992|526733815|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
146058926|NCT03137992|526733816|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
146058927|NCT03137992|526733817|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
146058928|NCT03137992|526733818|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
146058929|NCT03137992|526733813|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
146058930|NCT03137992|526733814|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146058931|NCT03137992|526733815|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146058932|NCT03137992|526733816|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
146058933|NCT03137992|526733817|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
146058934|NCT03137992|526733818|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
146058935|NCT03137992|526733813|FG000|Period 2 (Visit 3)|Adverse Event|0|||
146058936|NCT03137992|526733814|FG001|Period 2 (Visit 3)|Adverse Event|1|||
146058937|NCT03137992|526733815|FG002|Period 2 (Visit 3)|Adverse Event|0|||
146058938|NCT03137992|526733816|FG003|Period 2 (Visit 3)|Adverse Event|0|||
146058939|NCT03137992|526733817|FG004|Period 2 (Visit 3)|Adverse Event|0|||
146058940|NCT03137992|526733818|FG005|Period 2 (Visit 3)|Adverse Event|0|||
146058941|NCT03137992|526733813|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
146058942|NCT03137992|526733814|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
146058943|NCT03137992|526733815|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
146058944|NCT03137992|526733816|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
146058945|NCT03137992|526733817|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
146058946|NCT03137992|526733818|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
146058947|NCT03137992|526733813|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146058948|NCT03137992|526733814|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
146058949|NCT03137992|526733815|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146058950|NCT03137992|526733816|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146058951|NCT03137992|526733817|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
146058952|NCT03137992|526733818|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
146058953|NCT03137992|526733813|FG000|Washout Period 2|COPD Exacerbation|1|||
146058954|NCT03137992|526733814|FG001|Washout Period 2|COPD Exacerbation|1|||
146058955|NCT03137992|526733815|FG002|Washout Period 2|COPD Exacerbation|0|||
146058956|NCT03137992|526733816|FG003|Washout Period 2|COPD Exacerbation|0|||
146058957|NCT03137992|526733817|FG004|Washout Period 2|COPD Exacerbation|1|||
146058958|NCT03137992|526733818|FG005|Washout Period 2|COPD Exacerbation|0|||
146058959|NCT03137992|526733813|FG000|Washout Period 2|Subject Non-compliance|0|||
146058960|NCT03137992|526733814|FG001|Washout Period 2|Subject Non-compliance|1|||
146058961|NCT03137992|526733815|FG002|Washout Period 2|Subject Non-compliance|0|||
146058962|NCT03137992|526733816|FG003|Washout Period 2|Subject Non-compliance|0|||
146058963|NCT03137992|526733817|FG004|Washout Period 2|Subject Non-compliance|0|||
146058964|NCT03137992|526733818|FG005|Washout Period 2|Subject Non-compliance|0|||
146058965|NCT03137992|526733813|FG000|Washout Period 2|Adverse Event|0|||
146058966|NCT03137992|526733814|FG001|Washout Period 2|Adverse Event|0|||
146058967|NCT03137992|526733815|FG002|Washout Period 2|Adverse Event|0|||
146058968|NCT03137992|526733816|FG003|Washout Period 2|Adverse Event|1|||
146058969|NCT03137992|526733817|FG004|Washout Period 2|Adverse Event|1|||
146058970|NCT03137992|526733818|FG005|Washout Period 2|Adverse Event|0|||
146058971|NCT03137992|526733813|FG000|Washout Period 2|Withdrawal by Subject|1|||
146058972|NCT03137992|526733814|FG001|Washout Period 2|Withdrawal by Subject|0|||
146058973|NCT03137992|526733815|FG002|Washout Period 2|Withdrawal by Subject|0|||
146058974|NCT03137992|526733816|FG003|Washout Period 2|Withdrawal by Subject|0|||
146058975|NCT03137992|526733817|FG004|Washout Period 2|Withdrawal by Subject|1|||
146058976|NCT03137992|526733818|FG005|Washout Period 2|Withdrawal by Subject|0|||
146058977|NCT03137992|526733813|FG000|Washout Period 2|Sponsor Decision|0|||
146058978|NCT03137992|526733814|FG001|Washout Period 2|Sponsor Decision|0|||
146058979|NCT03137992|526733815|FG002|Washout Period 2|Sponsor Decision|0|||
146058980|NCT03137992|526733816|FG003|Washout Period 2|Sponsor Decision|0|||
146058981|NCT03137992|526733817|FG004|Washout Period 2|Sponsor Decision|0|||
146058982|NCT03137992|526733818|FG005|Washout Period 2|Sponsor Decision|1|||
146058983|NCT03137992|526733813|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
146058984|NCT03137992|526733814|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
146283422|NCT03181789|527550220|FG003|Overall Study|Withdrawal by Subject|0|||
146283423|NCT03181789|527550217|FG000|Overall Study|Lost to Follow-up|7|||
146283424|NCT03181789|527550218|FG001|Overall Study|Lost to Follow-up|1|||
146283425|NCT03181789|527550219|FG002|Overall Study|Lost to Follow-up|0|||
146283426|NCT03181789|527550220|FG003|Overall Study|Lost to Follow-up|0|||
146283427|NCT03181789|527550217|FG000|Overall Study|Participant unable to adhere to visit|0|||
146283428|NCT03181789|527550218|FG001|Overall Study|Participant unable to adhere to visit|1|||
146283429|NCT03181789|527550219|FG002|Overall Study|Participant unable to adhere to visit|0|||
146283430|NCT03181789|527550220|FG003|Overall Study|Participant unable to adhere to visit|0|||
146283431|NCT01131182|527550221|FG000|Overall Study|Withdrawal by Subject|1|||
146283432|NCT01131182|527550222|FG001|Overall Study|Withdrawal by Subject|1|||
146283433|NCT01131182|527550221|FG000|Overall Study|Lost to Follow-up|14|||
146283434|NCT01131182|527550222|FG001|Overall Study|Lost to Follow-up|15|||
146283435|NCT01131182|527550221|FG000|Overall Study|Other Reason|1|||
146283436|NCT01131182|527550222|FG001|Overall Study|Other Reason|0|||
146283437|NCT02442336|527550225|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
146058985|NCT03137992|526733815|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
146058986|NCT03137992|526733816|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
146058987|NCT03137992|526733817|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
146283438|NCT02442336|527550225|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
146283439|NCT02442336|527550225|FG000|Overall Study|Lost to Follow-up|11|||
146283440|NCT00998790|527550226|FG000|Overall Study|Withdrawal by Subject|21|||
146283441|NCT01080716|527550227|FG000|Part 1|Physician Decision|1|||
146283442|NCT01080716|527550228|FG001|Part 1|Physician Decision|0|||
146283443|NCT01080716|527550229|FG002|Part 1|Physician Decision|0|||
146283444|NCT01080716|527550230|FG003|Part 1|Physician Decision|0|||
146283445|NCT01011387|527550231|FG000|Overall Study|Withdrawal by Subject|3|||
146283446|NCT01011387|527550231|FG000|Overall Study|Adverse Event|2|||
146283447|NCT01011387|527550231|FG000|Overall Study|Protocol Violation|1|||
146283448|NCT01142115|527550232|FG000|First Intervention|Lack of Efficacy|1|||
146283449|NCT01142115|527550233|FG001|First Intervention|Lack of Efficacy|1|||
146283450|NCT01142115|527550232|FG000|First Intervention|Adverse Event|1|||
146283451|NCT01142115|527550233|FG001|First Intervention|Adverse Event|0|||
146283452|NCT03208036|527550234|FG000|Baseline Assessment|Withdrawal by Subject|1|||
146283453|NCT03208036|527550235|FG001|Baseline Assessment|Withdrawal by Subject|1|||
146283454|NCT03208036|527550234|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
146283455|NCT03208036|527550235|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
146283456|NCT03208036|527550234|FG000|Intervention|Withdrawal by Subject|3|||
146283457|NCT03208036|527550235|FG001|Intervention|Withdrawal by Subject|2|||
146283458|NCT03208036|527550234|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
146283459|NCT03208036|527550235|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
146283460|NCT03406078|527550236|FG000|Overall Study|Death|1|||
146283461|NCT03406078|527550237|FG001|Overall Study|Death|0|||
146283462|NCT03406078|527550236|FG000|Overall Study|Lost to Follow-up|0|||
146283463|NCT03406078|527550237|FG001|Overall Study|Lost to Follow-up|1|||
146283464|NCT03406078|527550236|FG000|Overall Study|Withdrawal by Subject|5|||
146283465|NCT03406078|527550237|FG001|Overall Study|Withdrawal by Subject|2|||
146283466|NCT00700778|527550238|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
146283467|NCT01879553|527550241|FG000|Overall Study|Withdrawal by Subject|1|||
146283468|NCT01879553|527550242|FG001|Overall Study|Withdrawal by Subject|0|||
146283469|NCT00591851|527550243|FG000|Overall Study|Withdrawal by Subject|3|||
146283470|NCT00591851|527550243|FG000|Overall Study|Adverse Event|2|||
146283471|NCT00591851|527550243|FG000|Overall Study|Progressive Disease|1|||
146283472|NCT00438672|527550244|FG000|Overall Study|Lost to Follow-up|7|||
146283473|NCT00438672|527550245|FG001|Overall Study|Lost to Follow-up|9|||
146283474|NCT00320528|527550246|FG000|Study Period II|Adverse Event|3|||
146283475|NCT00320528|527550247|FG001|Study Period II|Adverse Event|4|||
146283476|NCT00320528|527550248|FG002|Study Period II|Adverse Event|8|||
146283477|NCT00320528|527550246|FG000|Study Period II|Parent/Caregiver Decision|8|||
146283478|NCT00320528|527550247|FG001|Study Period II|Parent/Caregiver Decision|3|||
146283479|NCT00320528|527550248|FG002|Study Period II|Parent/Caregiver Decision|11|||
146283480|NCT00320528|527550246|FG000|Study Period II|Withdrawal by Subject|0|||
146283481|NCT00320528|527550247|FG001|Study Period II|Withdrawal by Subject|1|||
146283482|NCT00320528|527550248|FG002|Study Period II|Withdrawal by Subject|1|||
146283483|NCT00320528|527550246|FG000|Study Period II|Entry Criteria Exclusion|0|||
146283484|NCT00320528|527550247|FG001|Study Period II|Entry Criteria Exclusion|2|||
146283485|NCT00320528|527550248|FG002|Study Period II|Entry Criteria Exclusion|2|||
146283486|NCT00320528|527550246|FG000|Study Period III|Adverse Event|1|||
146283487|NCT00320528|527550247|FG001|Study Period III|Adverse Event|0|||
146283488|NCT00320528|527550248|FG002|Study Period III|Adverse Event|0|||
146283489|NCT00320528|527550246|FG000|Study Period III|Lost to Follow-up|1|||
146283490|NCT00320528|527550247|FG001|Study Period III|Lost to Follow-up|0|||
146283491|NCT00320528|527550248|FG002|Study Period III|Lost to Follow-up|0|||
146283492|NCT00320528|527550246|FG000|Study Period III|Withdrawal by Subject|1|||
146283493|NCT00320528|527550247|FG001|Study Period III|Withdrawal by Subject|1|||
146283494|NCT00320528|527550248|FG002|Study Period III|Withdrawal by Subject|2|||
146283495|NCT00320528|527550246|FG000|Study Period III|Lack of Efficacy|2|||
146283496|NCT00320528|527550247|FG001|Study Period III|Lack of Efficacy|0|||
146283497|NCT00320528|527550248|FG002|Study Period III|Lack of Efficacy|0|||
146283498|NCT00320528|527550246|FG000|Study Period III|Parent/Caregiver Decision|14|||
146283499|NCT00320528|527550247|FG001|Study Period III|Parent/Caregiver Decision|3|||
146283500|NCT00320528|527550248|FG002|Study Period III|Parent/Caregiver Decision|11|||
146283501|NCT00320528|527550246|FG000|Study Period III|Protocol Violation|0|||
146283502|NCT00320528|527550247|FG001|Study Period III|Protocol Violation|1|||
146283503|NCT00320528|527550248|FG002|Study Period III|Protocol Violation|0|||
146283504|NCT00320528|527550246|FG000|Study Period III|Physician Decision|0|||
146283505|NCT00320528|527550247|FG001|Study Period III|Physician Decision|1|||
146283506|NCT00320528|527550248|FG002|Study Period III|Physician Decision|2|||
146283507|NCT00320528|527550246|FG000|Study Period III|Sponsor Decision|0|||
146283508|NCT00320528|527550247|FG001|Study Period III|Sponsor Decision|0|||
146283509|NCT00320528|527550248|FG002|Study Period III|Sponsor Decision|1|||
146283510|NCT00320528|527550246|FG000|Study Period III|Atomoxetine Commercially Available|68|||
146283511|NCT00320528|527550247|FG001|Study Period III|Atomoxetine Commercially Available|25|||
146283512|NCT00320528|527550248|FG002|Study Period III|Atomoxetine Commercially Available|90|||
146283513|NCT04540887|527550256|FG000|Overall Study|Withdrawal by Subject|2|||
146283514|NCT01942785|527550260|FG000|Overall Study|Adverse Event|2|||
146283515|NCT01942785|527550260|FG000|Overall Study|Withdrawal by Subject|1|||
146283516|NCT01942785|527550260|FG000|Overall Study|Protocol Violation|1|||
146283517|NCT05038163|527550264|FG000|Stage 1|Did not complete survey|374|||
146283518|NCT05038163|527550265|FG001|Stage 1|Did not complete survey|0|||
146283519|NCT05038163|527550266|FG002|Stage 1|Did not complete survey|0|||
146283520|NCT05038163|527550267|FG003|Stage 1|Did not complete survey|0|||
146283521|NCT05038163|527550268|FG004|Stage 1|Did not complete survey|0|||
146283522|NCT05038163|527550269|FG005|Stage 1|Did not complete survey|0|||
146283523|NCT05038163|527550264|FG000|Stage 2|Did not complete Stage 2 survey|0|||
146283524|NCT05038163|527550265|FG001|Stage 2|Did not complete Stage 2 survey|29|||
146283525|NCT05038163|527550266|FG002|Stage 2|Did not complete Stage 2 survey|30|||
146283526|NCT05038163|527550267|FG003|Stage 2|Did not complete Stage 2 survey|24|||
146283527|NCT05038163|527550268|FG004|Stage 2|Did not complete Stage 2 survey|21|||
146283528|NCT05038163|527550269|FG005|Stage 2|Did not complete Stage 2 survey|100|||
146283529|NCT00552929|527550272|FG000|Overall Study|Lost to Follow-up|0|||
146283530|NCT00552929|527550273|FG001|Overall Study|Lost to Follow-up|0|||
146283531|NCT00552929|527550274|FG002|Overall Study|Lost to Follow-up|0|||
146283532|NCT00552929|527550275|FG003|Overall Study|Lost to Follow-up|0|||
146283533|NCT00552929|527550276|FG004|Overall Study|Lost to Follow-up|0|||
146283534|NCT00552929|527550277|FG005|Overall Study|Lost to Follow-up|0|||
146283535|NCT00552929|527550278|FG006|Overall Study|Lost to Follow-up|0|||
146283536|NCT00552929|527550279|FG007|Overall Study|Lost to Follow-up|0|||
146283537|NCT00552929|527550280|FG008|Overall Study|Lost to Follow-up|1|||
146283538|NCT00552929|527550281|FG009|Overall Study|Lost to Follow-up|0|||
146283539|NCT00552929|527550272|FG000|Overall Study|Not Eligible|0|||
146283540|NCT00552929|527550273|FG001|Overall Study|Not Eligible|0|||
146283541|NCT00552929|527550274|FG002|Overall Study|Not Eligible|0|||
146283542|NCT00552929|527550275|FG003|Overall Study|Not Eligible|0|||
146283543|NCT00552929|527550276|FG004|Overall Study|Not Eligible|0|||
146283544|NCT00552929|527550277|FG005|Overall Study|Not Eligible|1|||
146283545|NCT00552929|527550278|FG006|Overall Study|Not Eligible|0|||
146283546|NCT00552929|527550279|FG007|Overall Study|Not Eligible|0|||
146283547|NCT00552929|527550280|FG008|Overall Study|Not Eligible|0|||
146283548|NCT00552929|527550281|FG009|Overall Study|Not Eligible|0|||
146283549|NCT00432666|527551798|FG000|Main Period|Adverse Event|1|||
146283550|NCT00432666|527551799|FG001|Main Period|Adverse Event|1|||
146283551|NCT00432666|527551798|FG000|Main Period|Consent Withdrawn|1|||
146283552|NCT00432666|527551799|FG001|Main Period|Consent Withdrawn|0|||
146283553|NCT00432666|527551798|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
146283554|NCT00432666|527551799|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
146283555|NCT00432666|527551798|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
146283556|NCT00432666|527551799|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146283557|NCT00432666|527551798|FG000|Open-Label Extension Period|Adverse Event|5|||
146283558|NCT00432666|527551799|FG001|Open-Label Extension Period|Adverse Event|0|||
146283559|NCT00432666|527551798|FG000|Open-Label Extension Period|Consent withdrawn|10|||
146283560|NCT00432666|527551799|FG001|Open-Label Extension Period|Consent withdrawn|0|||
146283561|NCT00432666|527551798|FG000|Open-Label Extension Period|Physician Decision|3|||
146283562|NCT00432666|527551799|FG001|Open-Label Extension Period|Physician Decision|0|||
146283563|NCT00978627|527551800|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
146283564|NCT00978627|527551801|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
146283565|NCT00978627|527551800|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
146283566|NCT00978627|527551801|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
146283567|NCT00978627|527551800|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
146283568|NCT00978627|527551801|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
146283569|NCT00978627|527551800|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
146283570|NCT00978627|527551801|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
146283571|NCT00978627|527551800|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
146283572|NCT00978627|527551801|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
146283573|NCT00978627|527551800|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
146283574|NCT00978627|527551801|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
146283575|NCT00978627|527551800|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
146283576|NCT00978627|527551801|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
146283577|NCT00978627|527551800|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
146283578|NCT00978627|527551801|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
146283579|NCT00978627|527551800|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
146283580|NCT00978627|527551801|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
146283581|NCT00565851|527551802|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
146283582|NCT00565851|527551803|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
146283583|NCT00565851|527551804|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
146283584|NCT00565851|527551805|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
146283585|NCT00565851|527551806|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
146283586|NCT00565851|527551807|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
146283587|NCT00565851|527551808|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
146283588|NCT00565851|527551809|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
146283589|NCT00565851|527551802|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
146283590|NCT00565851|527551803|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
146283591|NCT00565851|527551804|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
146283592|NCT00565851|527551805|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
146283593|NCT00565851|527551806|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
146283594|NCT00565851|527551807|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
146283595|NCT00565851|527551808|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
146283596|NCT00565851|527551809|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
146283597|NCT04058366|527551810|FG000|Overall Study|Adverse Event|14|||
146283598|NCT04058366|527551810|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
146283599|NCT04058366|527551810|FG000|Overall Study|Commercial drug is available for participants|6|||
146283600|NCT04058366|527551810|FG000|Overall Study|Death|1|||
146283601|NCT04058366|527551810|FG000|Overall Study|Other non-compliance|2|||
146283602|NCT04058366|527551810|FG000|Overall Study|Other|6|||
146283603|NCT02594163|527551811|FG000|Treatment Period|Progressive disease|2|||
146283604|NCT02594163|527551812|FG001|Treatment Period|Progressive disease|3|||
146283605|NCT02594163|527551811|FG000|Treatment Period|Adverse Event|1|||
146283606|NCT02594163|527551812|FG001|Treatment Period|Adverse Event|5|||
146283607|NCT02594163|527551811|FG000|Treatment Period|Physician Decision|1|||
146283608|NCT02594163|527551812|FG001|Treatment Period|Physician Decision|3|||
146283609|NCT02594163|527551811|FG000|Treatment Period|Study termination by sponsor|2|||
146283610|NCT02594163|527551812|FG001|Treatment Period|Study termination by sponsor|1|||
146283611|NCT02594163|527551811|FG000|Treatment Period|Other, Non-AE|1|||
146283612|NCT02594163|527551812|FG001|Treatment Period|Other, Non-AE|0|||
146283613|NCT02594163|527551811|FG000|Follow-up Period|Withdrawal by Subject|0|||
146283614|NCT02594163|527551812|FG001|Follow-up Period|Withdrawal by Subject|1|||
146283615|NCT02594163|527551811|FG000|Follow-up Period|Study Termination by Sponsor|6|||
146283616|NCT02594163|527551812|FG001|Follow-up Period|Study Termination by Sponsor|4|||
146283617|NCT02594163|527551811|FG000|Follow-up Period|Lost to Follow-up|1|||
146283618|NCT02594163|527551812|FG001|Follow-up Period|Lost to Follow-up|0|||
146283619|NCT02594163|527551811|FG000|Follow-up Period|Death|2|||
146283620|NCT02594163|527551812|FG001|Follow-up Period|Death|5|||
146283621|NCT02594163|527551811|FG000|Follow-up Period|Adverse Event|0|||
146283622|NCT02594163|527551812|FG001|Follow-up Period|Adverse Event|1|||
146283623|NCT02594163|527551811|FG000|Follow-up Period|Progressive Disease|2|||
146283624|NCT02594163|527551812|FG001|Follow-up Period|Progressive Disease|0|||
146283625|NCT02594163|527551811|FG000|Follow-up Period|Physician Decision|0|||
146283626|NCT02594163|527551812|FG001|Follow-up Period|Physician Decision|1|||
146283627|NCT02233543|527551815|FG000|Period 1|Withdrawal by Subject|1|||
146283628|NCT02233543|527551816|FG001|Period 1|Withdrawal by Subject|0|||
146283629|NCT02233543|527551815|FG000|Period 1|Participants required other treatment.|2|||
146283630|NCT02233543|527551816|FG001|Period 1|Participants required other treatment.|3|||
146283631|NCT02233543|527551815|FG000|Period 2|Adverse Event|1|||
146283632|NCT02233543|527551816|FG001|Period 2|Adverse Event|0|||
146283633|NCT02233543|527551815|FG000|Period 2|Participant required other treatment.|0|||
146283634|NCT02233543|527551816|FG001|Period 2|Participant required other treatment.|1|||
146283635|NCT02233543|527551815|FG000|Period 2|COPD exacerbation|1|||
146283636|NCT02233543|527551816|FG001|Period 2|COPD exacerbation|0|||
146283637|NCT03527173|527551817|FG000|Overall Study|Lost to Follow-up|4|||
146283638|NCT03527173|527551818|FG001|Overall Study|Lost to Follow-up|2|||
146283639|NCT03527173|527551817|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
146283640|NCT03527173|527551818|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
146283641|NCT03527173|527551817|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
146283642|NCT03527173|527551818|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
146283643|NCT03527173|527551817|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146283644|NCT03527173|527551818|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146283645|NCT01248780|527551821|FG000|Overall Study|Lack of Efficacy|2|||
146283646|NCT01248780|527551822|FG001|Overall Study|Lack of Efficacy|0|||
146283647|NCT01248780|527551821|FG000|Overall Study|Lost to Follow-up|0|||
146283648|NCT01248780|527551822|FG001|Overall Study|Lost to Follow-up|1|||
146283649|NCT01248780|527551821|FG000|Overall Study|Death|0|||
146283650|NCT01248780|527551822|FG001|Overall Study|Death|1|||
146283651|NCT01248780|527551821|FG000|Overall Study|Adverse Event|2|||
146283652|NCT01248780|527551822|FG001|Overall Study|Adverse Event|7|||
146283653|NCT01248780|527551821|FG000|Overall Study|Protocol Violation|1|||
146283654|NCT01248780|527551822|FG001|Overall Study|Protocol Violation|1|||
146283655|NCT01248780|527551821|FG000|Overall Study|Withdrawal by Subject|4|||
146283656|NCT01248780|527551822|FG001|Overall Study|Withdrawal by Subject|4|||
146283657|NCT01248780|527551821|FG000|Overall Study|Not treated|0|||
146283658|NCT01248780|527551822|FG001|Overall Study|Not treated|1|||
146283659|NCT04097301|527551823|FG000|Overall Study|Death|1|||
146283660|NCT04097301|527551823|FG000|Overall Study|Withdrawal by Subject|1|||
146283661|NCT04097301|527551823|FG000|Overall Study|Screening Failure|5|||
146283662|NCT01227577|527551824|FG000|Overall Study|Protocol deviation|3|||
146283663|NCT01227577|527551824|FG000|Overall Study|Death|3|||
146283664|NCT01227577|527551824|FG000|Overall Study|Administrative problems|2|||
146283665|NCT01227577|527551824|FG000|Overall Study|Lost to Follow-up|1|||
146283666|NCT01227577|527551824|FG000|Overall Study|Withdrawal by Subject|4|||
146283667|NCT01227577|527551824|FG000|Overall Study|Lack of Efficacy|5|||
146283668|NCT01227577|527551824|FG000|Overall Study|Adverse Event|17|||
146283669|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
146283670|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
146283671|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
146283672|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
146283673|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
146283674|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
146283675|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
146283676|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
146283677|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
146283678|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
146283679|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
146283680|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
146283681|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
146283682|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
146283683|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
146283684|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
146283685|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
146283686|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
146283687|NCT02480153|527551825|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
146283688|NCT02480153|527551826|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
146283689|NCT02480153|527551827|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
146283690|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
146283691|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
146283692|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
146283693|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
146283694|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
146283695|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
146283696|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
146283697|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
146283698|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
146283699|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
146283700|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
146283701|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
146283702|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
146283703|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
146283704|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
146283705|NCT02480153|527551825|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
146396517|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
146396518|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
146396519|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
146396520|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
146396521|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
146396522|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
146396523|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
146396524|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
146396525|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
146396526|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
146396527|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
146396528|NCT00594568|527956589|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
146396529|NCT00594568|527956590|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
146396530|NCT00594568|527956591|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
146396531|NCT01422876|527956593|FG000|Week 24|Lost to Follow-up|1|||
146396532|NCT01422876|527956594|FG001|Week 24|Lost to Follow-up|1|||
146396533|NCT01422876|527956595|FG002|Week 24|Lost to Follow-up|2|||
146396534|NCT01422876|527956596|FG003|Week 24|Lost to Follow-up|4|||
146396535|NCT01422876|527956597|FG004|Week 24|Lost to Follow-up|2|||
146396536|NCT01422876|527956598|FG005|Week 24|Lost to Follow-up|0|||
146396537|NCT01422876|527956599|FG006|Week 24|Lost to Follow-up|1|||
146396538|NCT01422876|527956600|FG007|Week 24|Lost to Follow-up|3|||
146396539|NCT01422876|527956601|FG008|Week 24|Lost to Follow-up|3|||
146396540|NCT01422876|527956602|FG009|Week 24|Lost to Follow-up|4|||
146396541|NCT01422876|527956593|FG000|Week 24|Consent withdrawn|5|||
146396542|NCT01422876|527956594|FG001|Week 24|Consent withdrawn|1|||
146396543|NCT01422876|527956595|FG002|Week 24|Consent withdrawn|3|||
146396544|NCT01422876|527956596|FG003|Week 24|Consent withdrawn|4|||
146396545|NCT01422876|527956597|FG004|Week 24|Consent withdrawn|5|||
146396546|NCT01422876|527956598|FG005|Week 24|Consent withdrawn|6|||
146396547|NCT01422876|527956599|FG006|Week 24|Consent withdrawn|5|||
146396548|NCT01422876|527956600|FG007|Week 24|Consent withdrawn|4|||
146396549|NCT01422876|527956601|FG008|Week 24|Consent withdrawn|3|||
146396550|NCT01422876|527956602|FG009|Week 24|Consent withdrawn|6|||
146396551|NCT01422876|527956593|FG000|Week 24|Death|0|||
146396552|NCT01422876|527956594|FG001|Week 24|Death|1|||
146396553|NCT01422876|527956595|FG002|Week 24|Death|0|||
146396554|NCT01422876|527956596|FG003|Week 24|Death|0|||
146396555|NCT01422876|527956597|FG004|Week 24|Death|0|||
146396556|NCT01422876|527956598|FG005|Week 24|Death|0|||
146396557|NCT01422876|527956599|FG006|Week 24|Death|0|||
146396558|NCT01422876|527956600|FG007|Week 24|Death|0|||
146396559|NCT01422876|527956601|FG008|Week 24|Death|0|||
146396560|NCT01422876|527956602|FG009|Week 24|Death|0|||
146396561|NCT01422876|527956593|FG000|Week 52|Lost to Follow-up|3|||
146396562|NCT01422876|527956594|FG001|Week 52|Lost to Follow-up|5|||
146396563|NCT01422876|527956595|FG002|Week 52|Lost to Follow-up|7|||
146396564|NCT01422876|527956596|FG003|Week 52|Lost to Follow-up|5|||
146396565|NCT01422876|527956597|FG004|Week 52|Lost to Follow-up|8|||
146396566|NCT01422876|527956598|FG005|Week 52|Lost to Follow-up|5|||
146396567|NCT01422876|527956599|FG006|Week 52|Lost to Follow-up|5|||
146396568|NCT01422876|527956600|FG007|Week 52|Lost to Follow-up|8|||
146396569|NCT01422876|527956601|FG008|Week 52|Lost to Follow-up|7|||
146396570|NCT01422876|527956602|FG009|Week 52|Lost to Follow-up|8|||
146396571|NCT01422876|527956593|FG000|Week 52|Consent withdrawn|9|||
146396572|NCT01422876|527956594|FG001|Week 52|Consent withdrawn|4|||
146396573|NCT01422876|527956595|FG002|Week 52|Consent withdrawn|6|||
146396574|NCT01422876|527956596|FG003|Week 52|Consent withdrawn|12|||
146396575|NCT01422876|527956597|FG004|Week 52|Consent withdrawn|7|||
146396576|NCT01422876|527956598|FG005|Week 52|Consent withdrawn|12|||
146396577|NCT01422876|527956599|FG006|Week 52|Consent withdrawn|10|||
146396578|NCT01422876|527956600|FG007|Week 52|Consent withdrawn|12|||
146396579|NCT01422876|527956601|FG008|Week 52|Consent withdrawn|13|||
146396580|NCT01422876|527956602|FG009|Week 52|Consent withdrawn|9|||
146396581|NCT01422876|527956593|FG000|Week 52|Death|0|||
146396582|NCT01422876|527956594|FG001|Week 52|Death|1|||
146396583|NCT01422876|527956595|FG002|Week 52|Death|0|||
146396584|NCT01422876|527956596|FG003|Week 52|Death|1|||
146396585|NCT01422876|527956597|FG004|Week 52|Death|0|||
146396586|NCT01422876|527956598|FG005|Week 52|Death|0|||
146283706|NCT02480153|527551826|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
146283707|NCT02480153|527551827|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
146283708|NCT02480153|527551825|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
146283709|NCT02480153|527551826|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
146283710|NCT02480153|527551827|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
146283711|NCT02480153|527551825|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
146396587|NCT01422876|527956599|FG006|Week 52|Death|1|||
146396588|NCT01422876|527956600|FG007|Week 52|Death|3|||
146396589|NCT01422876|527956601|FG008|Week 52|Death|1|||
146283712|NCT02480153|527551826|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
146283713|NCT02480153|527551827|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
146283714|NCT02480153|527551825|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
146283715|NCT02480153|527551826|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
146283716|NCT02480153|527551827|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
146283717|NCT02480153|527551825|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
146283718|NCT02480153|527551826|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
146283719|NCT02480153|527551827|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
146283720|NCT02480153|527551825|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
146283721|NCT02480153|527551826|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
146283722|NCT02480153|527551827|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
146283723|NCT00107120|527551828|FG000|Overall Study|Adverse Event|4|||
146283724|NCT00107120|527551829|FG001|Overall Study|Adverse Event|1|||
146283725|NCT00107120|527551828|FG000|Overall Study|Lack of Efficacy|5|||
146283726|NCT00107120|527551829|FG001|Overall Study|Lack of Efficacy|5|||
146283727|NCT00107120|527551828|FG000|Overall Study|Protocol Violation|3|||
146283728|NCT00107120|527551829|FG001|Overall Study|Protocol Violation|0|||
146283729|NCT00107120|527551828|FG000|Overall Study|Withdrawal by Subject|8|||
146283730|NCT00107120|527551829|FG001|Overall Study|Withdrawal by Subject|9|||
146283731|NCT00107120|527551828|FG000|Overall Study|Lost to Follow-up|8|||
146283732|NCT00107120|527551829|FG001|Overall Study|Lost to Follow-up|6|||
146283733|NCT00107120|527551828|FG000|Overall Study|Pregnancy|0|||
146283734|NCT00107120|527551829|FG001|Overall Study|Pregnancy|1|||
146283735|NCT00107120|527551828|FG000|Overall Study|moving away from site|1|||
146396590|NCT01422876|527956602|FG009|Week 52|Death|0|||
146396591|NCT02526017|527956603|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396592|NCT02526017|527956604|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396593|NCT02526017|527956605|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396594|NCT02526017|527956606|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396595|NCT02526017|527956607|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
146396596|NCT02526017|527956608|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396597|NCT02526017|527956609|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396598|NCT02526017|527956610|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396599|NCT02526017|527956611|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
146396600|NCT00536991|527956613|FG000|Overall Study|Withdrawal by Subject|10|||
146396601|NCT00536991|527956613|FG000|Overall Study|Physician Decision|1|||
146396602|NCT00536991|527956613|FG000|Overall Study|patient ineligible|2|||
146396603|NCT00054639|527956614|FG000|Overall Study|Lack of Efficacy|1|||
146396604|NCT00054639|527956614|FG000|Overall Study|Physician Decision|1|||
146396605|NCT01600755|527956615|FG000|Overall Study|Withdrawal by Subject|6|||
146396606|NCT01366846|527956620|FG000|Overall Study|Withdrawal by Subject|2|||
146396607|NCT01366846|527956621|FG001|Overall Study|Withdrawal by Subject|0|||
146396608|NCT01366846|527956622|FG002|Overall Study|Withdrawal by Subject|0|||
146396609|NCT01366846|527956623|FG003|Overall Study|Withdrawal by Subject|0|||
146396610|NCT01366846|527956620|FG000|Overall Study|Communication Difficulties|1|||
146396611|NCT01366846|527956621|FG001|Overall Study|Communication Difficulties|4|||
146396612|NCT01366846|527956622|FG002|Overall Study|Communication Difficulties|0|||
146396613|NCT01366846|527956623|FG003|Overall Study|Communication Difficulties|1|||
146396614|NCT01366846|527956620|FG000|Overall Study|Scheduling Conflicts|0|||
146396615|NCT01366846|527956621|FG001|Overall Study|Scheduling Conflicts|0|||
146396616|NCT01366846|527956622|FG002|Overall Study|Scheduling Conflicts|1|||
146396617|NCT01366846|527956623|FG003|Overall Study|Scheduling Conflicts|0|||
146396618|NCT05299359|527956626|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
146396619|NCT05299359|527956627|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
146396620|NCT05299359|527956626|FG000|Main Part: Day 1 up to Day 366|Other|2|||
146396621|NCT05299359|527956627|FG001|Main Part: Day 1 up to Day 366|Other|0|||
146396622|NCT05299359|527956626|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
146396623|NCT05299359|527956627|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
146396624|NCT05299359|527956626|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
146396625|NCT05299359|527956627|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
146396626|NCT05299359|527956626|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
146396627|NCT05299359|527956627|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
146396628|NCT05299359|527956626|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
146396629|NCT05299359|527956627|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
146396630|NCT05299359|527956626|FG000|Extension Part: Day 1 to Day 366|Other|0|||
146396631|NCT05299359|527956627|FG001|Extension Part: Day 1 to Day 366|Other|1|||
146396632|NCT04780776|527956632|FG000|Titration Week 1-5|Lost to Follow-up|2|||
146396633|NCT04780776|527956633|FG001|Titration Week 1-5|Lost to Follow-up|8|||
146396634|NCT04780776|527956632|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
146396635|NCT04780776|527956633|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
146396636|NCT04780776|527956632|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
146396637|NCT04780776|527956633|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
146396638|NCT03113760|527956634|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
146396639|NCT03113760|527956635|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146396640|NCT03113760|527956636|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146396641|NCT03113760|527956637|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
146396642|NCT03113760|527956634|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
146396643|NCT03113760|527956635|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146396644|NCT03113760|527956636|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146396645|NCT03113760|527956637|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
146396646|NCT03113760|527956634|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
146396647|NCT03113760|527956635|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
146396648|NCT03113760|527956636|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
146396649|NCT03113760|527956637|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
146396650|NCT02506101|527956638|FG000|Overall Study|Transportation issues|1|||
146396651|NCT02506101|527956639|FG001|Overall Study|Transportation issues|0|||
146396652|NCT02506101|527956638|FG000|Overall Study|No enrollment and staff unavailability|1|||
146396653|NCT02506101|527956639|FG001|Overall Study|No enrollment and staff unavailability|0|||
146396654|NCT01308476|527956640|FG000|Overall Study|Lost to Follow-up|2|||
146396655|NCT01308476|527956641|FG001|Overall Study|Lost to Follow-up|2|||
146396656|NCT01308476|527956640|FG000|Overall Study|Other|1|||
146396657|NCT01308476|527956641|FG001|Overall Study|Other|0|||
146396658|NCT02696382|527956642|FG000|Overall Study|Death|7|||
146396659|NCT02696382|527956643|FG001|Overall Study|Death|2|||
146396660|NCT02696382|527956642|FG000|Overall Study|Withdrawal by Subject|5|||
146396661|NCT02696382|527956643|FG001|Overall Study|Withdrawal by Subject|12|||
146396662|NCT02696382|527956642|FG000|Overall Study|Lost to Follow-up|4|||
146396663|NCT02696382|527956643|FG001|Overall Study|Lost to Follow-up|7|||
146396664|NCT00423137|527956647|FG000|Overall Study|Lost to Follow-up|0|||
146396665|NCT00423137|527956648|FG001|Overall Study|Lost to Follow-up|0|||
146396666|NCT00423137|527956649|FG002|Overall Study|Lost to Follow-up|1|||
146396667|NCT00423137|527956650|FG003|Overall Study|Lost to Follow-up|0|||
146396668|NCT00423137|527956647|FG000|Overall Study|Protocol Violation|0|||
146396669|NCT00423137|527956648|FG001|Overall Study|Protocol Violation|0|||
146396670|NCT00423137|527956649|FG002|Overall Study|Protocol Violation|0|||
146396671|NCT00423137|527956650|FG003|Overall Study|Protocol Violation|1|||
146396672|NCT00423137|527956647|FG000|Overall Study|Adverse Event Study disease worse|1|||
146396673|NCT00423137|527956648|FG001|Overall Study|Adverse Event Study disease worse|0|||
146396674|NCT00423137|527956649|FG002|Overall Study|Adverse Event Study disease worse|3|||
146396675|NCT00423137|527956650|FG003|Overall Study|Adverse Event Study disease worse|1|||
146396676|NCT00423137|527956647|FG000|Overall Study|Adverse Event Other|0|||
146396677|NCT00423137|527956648|FG001|Overall Study|Adverse Event Other|0|||
146396678|NCT00423137|527956649|FG002|Overall Study|Adverse Event Other|2|||
146396679|NCT00423137|527956650|FG003|Overall Study|Adverse Event Other|0|||
146396680|NCT03246152|527956651|FG000|Overall Study|Lost to Follow-up|2|||
146396681|NCT03246152|527956651|FG000|Overall Study|Protocol Violation|1|||
146396682|NCT01243762|527956653|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146396683|NCT01243762|527956654|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
146396684|NCT01243762|527956655|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146396685|NCT01243762|527956656|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146396686|NCT01243762|527956657|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
146396687|NCT01243762|527956658|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
146396688|NCT01243762|527956659|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
146396689|NCT01243762|527956653|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146396690|NCT01243762|527956654|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
146396691|NCT01243762|527956655|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146396692|NCT01243762|527956656|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
146396693|NCT01243762|527956657|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146396694|NCT01243762|527956658|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146396695|NCT01243762|527956659|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
146396696|NCT01243762|527956653|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
146396697|NCT01243762|527956654|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
146396698|NCT01243762|527956655|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
146396699|NCT01243762|527956656|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
146396700|NCT01243762|527956657|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
146396701|NCT01243762|527956658|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
146396702|NCT01243762|527956659|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
146396703|NCT01243762|527956653|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396704|NCT01243762|527956654|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
146396705|NCT01243762|527956655|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396706|NCT01243762|527956656|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396707|NCT01243762|527956657|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396708|NCT01243762|527956658|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396709|NCT01243762|527956659|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
146396710|NCT01243762|527956653|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146396711|NCT01243762|527956654|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
146396712|NCT01243762|527956655|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146396713|NCT01243762|527956656|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146396714|NCT01243762|527956657|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146396715|NCT01243762|527956658|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
146396716|NCT01243762|527956659|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
146396717|NCT01243762|527956653|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
146396718|NCT01243762|527956654|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
146396719|NCT01243762|527956655|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
146396720|NCT01243762|527956656|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
146396721|NCT01243762|527956657|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
146396722|NCT01243762|527956658|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
146396723|NCT01243762|527956659|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
146396724|NCT01243762|527956653|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146396725|NCT01243762|527956654|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
146396726|NCT01243762|527956655|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146396727|NCT01243762|527956656|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146396728|NCT01243762|527956657|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
146396729|NCT01243762|527956658|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146396730|NCT01243762|527956659|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
146396731|NCT01243762|527956653|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146396732|NCT01243762|527956654|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146396733|NCT01243762|527956655|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146396734|NCT01243762|527956656|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
146396735|NCT01243762|527956657|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
146396736|NCT01243762|527956658|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146396737|NCT01243762|527956659|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
146396738|NCT00003526|527956660|FG000|Overall Study|Not evaluable|6|||
146396739|NCT02059265|527956661|FG000|Overall Study|Ineligible|4|||
146396740|NCT04196023|527956662|FG000|Overall Study|Withdrawal by Subject|0|||
146396741|NCT04196023|527956663|FG001|Overall Study|Withdrawal by Subject|1|||
146396742|NCT04196023|527956662|FG000|Overall Study|Adverse Event|3|||
146396743|NCT04196023|527956663|FG001|Overall Study|Adverse Event|1|||
146396744|NCT04196023|527956662|FG000|Overall Study|Lost to Follow-up|0|||
146396745|NCT04196023|527956663|FG001|Overall Study|Lost to Follow-up|1|||
146396746|NCT03358407|527956668|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396747|NCT03358407|527956669|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396748|NCT03358407|527956670|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
146396749|NCT03358407|527956671|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396750|NCT03358407|527956672|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396751|NCT03358407|527956673|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396752|NCT03358407|527956674|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396753|NCT03358407|527956675|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396754|NCT03358407|527956676|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396755|NCT03358407|527956677|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
146396756|NCT03358407|527956668|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396757|NCT03358407|527956669|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396758|NCT03358407|527956670|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396759|NCT03358407|527956671|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396760|NCT03358407|527956672|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146396761|NCT03358407|527956673|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396762|NCT03358407|527956674|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396763|NCT03358407|527956675|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396764|NCT03358407|527956676|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396765|NCT03358407|527956677|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396766|NCT03358407|527956668|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396767|NCT03358407|527956669|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396768|NCT03358407|527956670|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396769|NCT03358407|527956671|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396770|NCT03358407|527956672|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396771|NCT03358407|527956673|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
146396772|NCT03358407|527956674|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396773|NCT03358407|527956675|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
146396774|NCT03358407|527956676|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396775|NCT03358407|527956677|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
146396776|NCT03358407|527956668|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396777|NCT03358407|527956669|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396778|NCT03358407|527956670|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396779|NCT03358407|527956671|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396780|NCT03358407|527956672|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396781|NCT03358407|527956673|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
146396782|NCT03358407|527956674|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396783|NCT03358407|527956675|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
146396784|NCT03358407|527956676|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396785|NCT03358407|527956677|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
146396786|NCT03358407|527956668|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396787|NCT03358407|527956669|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396788|NCT03358407|527956670|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396789|NCT03358407|527956671|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396790|NCT03358407|527956672|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396791|NCT03358407|527956673|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146396792|NCT03358407|527956674|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
146396793|NCT03358407|527956675|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396794|NCT03358407|527956676|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396795|NCT03358407|527956677|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
146396796|NCT03358407|527956668|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396797|NCT03358407|527956669|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396798|NCT03358407|527956670|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396799|NCT03358407|527956671|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396800|NCT03358407|527956672|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396801|NCT03358407|527956673|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
146058988|NCT03137992|526733818|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
146058989|NCT03137992|526733813|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146396802|NCT03358407|527956674|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
146396803|NCT03358407|527956675|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
146396804|NCT03358407|527956676|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396805|NCT03358407|527956677|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
146396806|NCT00483574|527956678|FG000|Overall Study|Adverse Event|6|||
146396807|NCT00483574|527956679|FG001|Overall Study|Adverse Event|0|||
146396808|NCT00483574|527956678|FG000|Overall Study|Protocol Violation|28|||
146396809|NCT00483574|527956679|FG001|Overall Study|Protocol Violation|9|||
146396810|NCT00483574|527956678|FG000|Overall Study|Lost to Follow-up|16|||
146396811|NCT00483574|527956679|FG001|Overall Study|Lost to Follow-up|4|||
146396812|NCT00483574|527956678|FG000|Overall Study|Withdrawal by Subject|52|||
146396813|NCT00483574|527956679|FG001|Overall Study|Withdrawal by Subject|0|||
146396814|NCT03605758|527956680|FG000|Overall Study|Lost to Follow-up|2|||
146396815|NCT03605758|527956681|FG001|Overall Study|Lost to Follow-up|1|||
146396816|NCT03605758|527956680|FG000|Overall Study|Illness|0|||
146396817|NCT03605758|527956681|FG001|Overall Study|Illness|1|||
146396818|NCT03605758|527956680|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
146396819|NCT03605758|527956681|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
146396820|NCT04366258|527956684|FG000|Baseline Assessments|Screen Failure|21|||
146396821|NCT04366258|527956684|FG000|Baseline Assessments|Early Termination|3|||
146396822|NCT03205046|527956690|FG000|Overall Study|Death|10|||
146396823|NCT03205046|527956691|FG001|Overall Study|Death|6|||
146396824|NCT03205046|527956690|FG000|Overall Study|Withdrawal by Subject|1|||
146396825|NCT03205046|527956691|FG001|Overall Study|Withdrawal by Subject|2|||
146396826|NCT03205046|527956690|FG000|Overall Study|Lost to Follow-up|0|||
146396827|NCT03205046|527956691|FG001|Overall Study|Lost to Follow-up|1|||
146396828|NCT03205046|527956690|FG000|Overall Study|Study terminated by sponsor|2|||
146396829|NCT03205046|527956691|FG001|Overall Study|Study terminated by sponsor|1|||
146396830|NCT01023815|527956692|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
146396831|NCT01023815|527956693|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146396832|NCT01023815|527956694|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146396833|NCT01023815|527956695|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
146396834|NCT01023815|527956692|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
146396835|NCT01023815|527956693|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
146396836|NCT01023815|527956694|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
146396837|NCT01023815|527956695|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
146396838|NCT01023815|527956692|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
146396839|NCT01023815|527956693|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
146396840|NCT01023815|527956694|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
146396841|NCT01023815|527956695|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
146396842|NCT01023815|527956692|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
146396843|NCT01023815|527956693|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
146396844|NCT01023815|527956694|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
146396845|NCT01023815|527956695|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
146396846|NCT01023815|527956692|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146396847|NCT01023815|527956693|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
146396848|NCT01023815|527956694|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146396849|NCT01023815|527956695|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
146396850|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
146396851|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
146396852|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
146396853|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
146396854|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
146396855|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Death|1|||
146396856|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Death|0|||
146396857|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Death|0|||
146396858|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Death|0|||
146396859|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Death|0|||
146396860|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
146396861|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
146396862|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
146396863|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
146396864|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
146396865|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
146396866|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
146396867|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
146396868|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
146396869|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
146396870|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146058990|NCT03137992|526733814|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
146283736|NCT00107120|527551829|FG001|Overall Study|moving away from site|1|||
146396871|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
146396872|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
146396873|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146396874|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
146396875|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146396876|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
146396877|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
146396878|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146396879|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
146396880|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
146396881|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
146396882|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146396883|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146396884|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
146396885|NCT00634933|527956706|FG000|Part A: Baseline to Week 24|Other|1|||
146396886|NCT00634933|527956707|FG001|Part A: Baseline to Week 24|Other|8|||
146396887|NCT00634933|527956708|FG002|Part A: Baseline to Week 24|Other|5|||
146396888|NCT00634933|527956709|FG003|Part A: Baseline to Week 24|Other|0|||
146396889|NCT00634933|527956710|FG004|Part A: Baseline to Week 24|Other|0|||
146396890|NCT00634933|527956706|FG000|Between Part A and Part B|Physician Decision|0|||
146396891|NCT00634933|527956707|FG001|Between Part A and Part B|Physician Decision|1|||
146396892|NCT00634933|527956708|FG002|Between Part A and Part B|Physician Decision|0|||
146396893|NCT00634933|527956709|FG003|Between Part A and Part B|Physician Decision|0|||
146396894|NCT00634933|527956710|FG004|Between Part A and Part B|Physician Decision|0|||
146396895|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
146396896|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
146396897|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
146396898|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
146396899|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
146396900|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
146396901|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
146396902|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
146396903|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
146396904|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
146396905|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
146396906|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
146396907|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
146396908|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
146396909|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
146396910|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
146396911|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
146396912|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
146396913|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
146396914|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
146396915|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146396916|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146396917|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
146396918|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
146396919|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
146396920|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146396921|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
146396922|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
146396923|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146396924|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
146396925|NCT00634933|527956706|FG000|Part B: Week 24 to Week 52|Other|0|||
146396926|NCT00634933|527956707|FG001|Part B: Week 24 to Week 52|Other|0|||
146396927|NCT00634933|527956708|FG002|Part B: Week 24 to Week 52|Other|5|||
146396928|NCT00634933|527956709|FG003|Part B: Week 24 to Week 52|Other|0|||
146396929|NCT00634933|527956710|FG004|Part B: Week 24 to Week 52|Other|1|||
146396930|NCT02058849|527956711|FG000|Overall Study|Hospitalization|1|||
146396931|NCT02058849|527956712|FG001|Overall Study|Hospitalization|1|||
146396932|NCT02058849|527956711|FG000|Overall Study|Death|1|||
146396933|NCT02058849|527956712|FG001|Overall Study|Death|0|||
146396934|NCT02058849|527956711|FG000|Overall Study|Lost to Follow-up|1|||
146396935|NCT02058849|527956712|FG001|Overall Study|Lost to Follow-up|0|||
146396936|NCT02058849|527956711|FG000|Overall Study|Withdrawal by Subject|4|||
146396937|NCT02058849|527956712|FG001|Overall Study|Withdrawal by Subject|0|||
146396938|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
146396939|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
146396940|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
146396941|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
146396942|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
146396943|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
146396944|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
146396945|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
146396946|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
146396947|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
146396948|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
146396949|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
146396950|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
146396951|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
146396952|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
146396953|NCT01694849|527956713|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
146396954|NCT01694849|527956714|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
146396955|NCT01694849|527956715|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
146396956|NCT01694849|527956713|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
146396957|NCT01694849|527956714|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
146396958|NCT01694849|527956715|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
146396959|NCT01694849|527956713|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
146396960|NCT01694849|527956714|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
146396961|NCT01694849|527956715|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
146396962|NCT01250418|527956717|FG000|Overall Study|monitor data failure|1|||
146396963|NCT01250418|527956718|FG001|Overall Study|monitor data failure|1|||
146396964|NCT01761565|527956719|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
146396965|NCT04409262|527956721|FG000|Overall Study|Adverse Event|0|||
146396966|NCT04409262|527956722|FG001|Overall Study|Adverse Event|2|||
146396967|NCT04409262|527956721|FG000|Overall Study|Death|55|||
146396968|NCT04409262|527956722|FG001|Overall Study|Death|97|||
146396969|NCT04409262|527956721|FG000|Overall Study|Lost to Follow-up|12|||
146396970|NCT04409262|527956722|FG001|Overall Study|Lost to Follow-up|23|||
146396971|NCT04409262|527956721|FG000|Overall Study|Lack of Staff|0|||
146396972|NCT04409262|527956722|FG001|Overall Study|Lack of Staff|1|||
146396973|NCT04409262|527956721|FG000|Overall Study|Protocol Violation|3|||
146396974|NCT04409262|527956722|FG001|Overall Study|Protocol Violation|1|||
146396975|NCT04409262|527956721|FG000|Overall Study|Withdrawal by Subject|5|||
146396976|NCT04409262|527956722|FG001|Overall Study|Withdrawal by Subject|10|||
146396977|NCT02500732|527956723|FG000|Overall Study|Physician Decision|0|||
146396978|NCT02500732|527956724|FG001|Overall Study|Physician Decision|1|||
146396979|NCT03205605|527956725|FG000|Overall Study|Withdrawal by Subject|1|||
146396980|NCT02396849|527956726|FG000|Overall Study|Lost to Follow-up|1|||
146396981|NCT02396849|527956727|FG001|Overall Study|Lost to Follow-up|1|||
146396982|NCT02396849|527956726|FG000|Overall Study|Did not tolerate intervention|1|||
146396983|NCT02396849|527956727|FG001|Overall Study|Did not tolerate intervention|1|||
146396984|NCT03328325|527956730|FG000|Overall Study|Lost to Follow-up|4|||
146396985|NCT03328325|527956730|FG000|Overall Study|Physician Decision|1|||
146396986|NCT03328325|527956730|FG000|Overall Study|Withdrawal by Subject|3|||
146396987|NCT03328325|527956730|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
146396988|NCT01869959|527956733|FG000|Randomization Period|Physician Decision|0|||
146396989|NCT01869959|527956734|FG001|Randomization Period|Physician Decision|0|||
146396990|NCT01869959|527956735|FG002|Randomization Period|Physician Decision|0|||
146396991|NCT01869959|527956736|FG003|Randomization Period|Physician Decision|0|||
146396992|NCT01869959|527956737|FG004|Randomization Period|Physician Decision|1|||
146396993|NCT01869959|527956733|FG000|Treatment Period|Adverse Event|1|||
146396994|NCT01869959|527956734|FG001|Treatment Period|Adverse Event|0|||
146396995|NCT01869959|527956735|FG002|Treatment Period|Adverse Event|3|||
146396996|NCT01869959|527956736|FG003|Treatment Period|Adverse Event|1|||
146396997|NCT01869959|527956737|FG004|Treatment Period|Adverse Event|0|||
146396998|NCT01869959|527956733|FG000|Treatment Period|Sponsor decision|0|||
146396999|NCT01869959|527956734|FG001|Treatment Period|Sponsor decision|1|||
146397000|NCT01869959|527956735|FG002|Treatment Period|Sponsor decision|0|||
146397001|NCT01869959|527956736|FG003|Treatment Period|Sponsor decision|1|||
146397002|NCT01869959|527956737|FG004|Treatment Period|Sponsor decision|0|||
146397003|NCT01869959|527956733|FG000|Treatment Period|Withdrawal by Subject|0|||
146397004|NCT01869959|527956734|FG001|Treatment Period|Withdrawal by Subject|1|||
146397005|NCT01869959|527956735|FG002|Treatment Period|Withdrawal by Subject|0|||
146397006|NCT01869959|527956736|FG003|Treatment Period|Withdrawal by Subject|0|||
146397007|NCT01869959|527956737|FG004|Treatment Period|Withdrawal by Subject|0|||
146397008|NCT01965600|527956738|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
146397009|NCT01965600|527956739|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
146397010|NCT01965600|527956740|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
146397011|NCT01965600|527956741|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
146397012|NCT01965600|527956738|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146397013|NCT01965600|527956739|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
146397014|NCT01965600|527956740|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146397015|NCT01965600|527956741|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
146397016|NCT01965600|527956738|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
146397017|NCT01965600|527956739|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146397018|NCT01965600|527956740|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146397019|NCT01965600|527956741|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
146397020|NCT01965600|527956738|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
146397021|NCT01965600|527956739|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
146397022|NCT01965600|527956740|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
146397023|NCT01965600|527956741|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
146397024|NCT01965600|527956738|FG000|Second Intervention|Study terminated by Sponsor|0|||
146397025|NCT01965600|527956739|FG001|Second Intervention|Study terminated by Sponsor|0|||
146397026|NCT01965600|527956740|FG002|Second Intervention|Study terminated by Sponsor|2|||
146397027|NCT01965600|527956741|FG003|Second Intervention|Study terminated by Sponsor|2|||
146397028|NCT00509223|527958220|FG000|Overall Study|Lost to Follow-up|1|||
146397029|NCT00509223|527958221|FG001|Overall Study|Lost to Follow-up|1|||
146397030|NCT00509223|527958220|FG000|Overall Study|Adverse Event|1|||
146397031|NCT00509223|527958221|FG001|Overall Study|Adverse Event|1|||
146397032|NCT00509223|527958220|FG000|Overall Study|Withdrawal by Subject|25|||
146397033|NCT00509223|527958221|FG001|Overall Study|Withdrawal by Subject|6|||
146397034|NCT00509223|527958220|FG000|Overall Study|Including: subject change of address|5|||
146397035|NCT00509223|527958221|FG001|Overall Study|Including: subject change of address|2|||
146397036|NCT00509223|527958220|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
146397037|NCT00509223|527958221|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
146397038|NCT00437294|527958227|FG000|Overall Study|Adverse Event|5|||
146397039|NCT00437294|527958228|FG001|Overall Study|Adverse Event|4|||
146397040|NCT00437294|527958227|FG000|Overall Study|Death|5|||
146397041|NCT00437294|527958228|FG001|Overall Study|Death|2|||
146397042|NCT00437294|527958227|FG000|Overall Study|Physician Decision|0|||
146397043|NCT00437294|527958228|FG001|Overall Study|Physician Decision|3|||
146397044|NCT00437294|527958227|FG000|Overall Study|Withdrawal by Subject|5|||
146397045|NCT00437294|527958228|FG001|Overall Study|Withdrawal by Subject|0|||
146397046|NCT00437294|527958227|FG000|Overall Study|Progressive Disease|19|||
146397047|NCT00437294|527958228|FG001|Overall Study|Progressive Disease|23|||
146397048|NCT00437294|527958227|FG000|Overall Study|Sponsor Decision|8|||
146397049|NCT00437294|527958228|FG001|Overall Study|Sponsor Decision|9|||
146397050|NCT00437294|527958227|FG000|Overall Study|Protocol Violation|0|||
146397051|NCT00437294|527958228|FG001|Overall Study|Protocol Violation|1|||
146397052|NCT00437294|527958227|FG000|Overall Study|Entry criteria not met|1|||
146397053|NCT00437294|527958228|FG001|Overall Study|Entry criteria not met|1|||
146397054|NCT00518531|527958238|FG000|Treatment Period 1|Adverse Event|5|||
146397055|NCT00518531|527958239|FG001|Treatment Period 1|Adverse Event|0|||
146397056|NCT00518531|527958238|FG000|Treatment Period 1|Lost to Follow-up|5|||
146397057|NCT00518531|527958239|FG001|Treatment Period 1|Lost to Follow-up|3|||
146397058|NCT00518531|527958238|FG000|Treatment Period 1|Physician Decision|1|||
146397059|NCT00518531|527958239|FG001|Treatment Period 1|Physician Decision|0|||
146397060|NCT00518531|527958238|FG000|Treatment Period 1|Protocol Violation|2|||
146397061|NCT00518531|527958239|FG001|Treatment Period 1|Protocol Violation|0|||
146397062|NCT00518531|527958238|FG000|Treatment Period 1|Withdrawal by Subject|4|||
146397063|NCT00518531|527958239|FG001|Treatment Period 1|Withdrawal by Subject|6|||
146397064|NCT00518531|527958238|FG000|Treatment Period 1|Early crossover|1|||
146397065|NCT00518531|527958239|FG001|Treatment Period 1|Early crossover|3|||
146397066|NCT00518531|527958238|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146397067|NCT00518531|527958239|FG001|Treatment Period 2|Withdrawal by Subject|8|||
146397068|NCT00518531|527958238|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
146397069|NCT00518531|527958239|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
146397070|NCT00518531|527958238|FG000|Treatment Period 2|Adverse Event|1|||
146397071|NCT00518531|527958239|FG001|Treatment Period 2|Adverse Event|7|||
146397072|NCT00518531|527958238|FG000|Treatment Period 2|Protocol-specified criteria|0|||
146397073|NCT00518531|527958239|FG001|Treatment Period 2|Protocol-specified criteria|1|||
146397074|NCT00518531|527958238|FG000|Treatment Period 2|Non-compliance|1|||
146397075|NCT00518531|527958239|FG001|Treatment Period 2|Non-compliance|2|||
146397076|NCT04621227|527958242|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
146397077|NCT04621227|527958242|FG000|Period 3 (29 Days)|Adverse Event|1|||
146397078|NCT04621227|527958242|FG000|Period 8 (2 Days)|Adverse Event|1|||
146397079|NCT01728376|527958243|FG000|Overall Study|Adverse Event|1|||
146397080|NCT01728376|527958244|FG001|Overall Study|Adverse Event|1|||
146397081|NCT01728376|527958245|FG002|Overall Study|Adverse Event|1|||
146397082|NCT01728376|527958246|FG003|Overall Study|Adverse Event|1|||
146397083|NCT01728376|527958247|FG004|Overall Study|Adverse Event|1|||
146397084|NCT01728376|527958248|FG005|Overall Study|Adverse Event|0|||
146397085|NCT01728376|527958243|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
145945130|NCT01546038|526308131|FG003|Overall Study|: Randomized, not treated|0|||
146058991|NCT03137992|526733815|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
146397086|NCT01728376|527958244|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
146397087|NCT01728376|527958245|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
146397088|NCT01728376|527958246|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
146397089|NCT01728376|527958247|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
146397090|NCT01728376|527958248|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
146397091|NCT01728376|527958243|FG000|Overall Study|No relevant bacteria|2|||
146397092|NCT01728376|527958244|FG001|Overall Study|No relevant bacteria|0|||
146397093|NCT01728376|527958245|FG002|Overall Study|No relevant bacteria|0|||
146397094|NCT01728376|527958246|FG003|Overall Study|No relevant bacteria|0|||
146397095|NCT01728376|527958247|FG004|Overall Study|No relevant bacteria|1|||
146397096|NCT01728376|527958248|FG005|Overall Study|No relevant bacteria|1|||
146397097|NCT01728376|527958243|FG000|Overall Study|Did not receive treatment|0|||
146397098|NCT01728376|527958244|FG001|Overall Study|Did not receive treatment|1|||
146397099|NCT01728376|527958245|FG002|Overall Study|Did not receive treatment|0|||
146397100|NCT01728376|527958246|FG003|Overall Study|Did not receive treatment|0|||
146397101|NCT01728376|527958247|FG004|Overall Study|Did not receive treatment|0|||
146397102|NCT01728376|527958248|FG005|Overall Study|Did not receive treatment|0|||
146397103|NCT01728376|527958243|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146397104|NCT01728376|527958244|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146397105|NCT01728376|527958245|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146397106|NCT01728376|527958246|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
146397107|NCT01728376|527958247|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
146397108|NCT01728376|527958248|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
146397109|NCT02856282|527958254|FG000|Overall Study|Withdrawal by Subject|1|||
146397110|NCT00057330|527958255|FG000|Overall Study|Adverse Event|9|||
146397111|NCT00057330|527958256|FG001|Overall Study|Adverse Event|12|||
146397112|NCT00057330|527958255|FG000|Overall Study|Death|1|||
146397113|NCT00057330|527958256|FG001|Overall Study|Death|0|||
146397114|NCT00057330|527958255|FG000|Overall Study|Protocol Violation|1|||
146397115|NCT00057330|527958256|FG001|Overall Study|Protocol Violation|1|||
146397116|NCT00057330|527958255|FG000|Overall Study|Withdrawal by Subject|115|||
146397117|NCT00057330|527958256|FG001|Overall Study|Withdrawal by Subject|84|||
146397118|NCT00057330|527958255|FG000|Overall Study|Lost to Follow-up|745|||
146397119|NCT00057330|527958256|FG001|Overall Study|Lost to Follow-up|617|||
146397120|NCT00057330|527958255|FG000|Overall Study|Physician Decision|1|||
146397121|NCT00057330|527958256|FG001|Overall Study|Physician Decision|0|||
146397122|NCT00057330|527958255|FG000|Overall Study|Other|260|||
146397123|NCT00057330|527958256|FG001|Overall Study|Other|206|||
146397124|NCT04888377|527958262|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
146397125|NCT04888377|527958263|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
146397126|NCT04888377|527958262|FG000|Overall Study|Physician Decision|6|||
146397127|NCT04888377|527958263|FG001|Overall Study|Physician Decision|6|||
146397128|NCT04888377|527958262|FG000|Overall Study|Withdrawal by Subject|7|||
146397129|NCT04888377|527958263|FG001|Overall Study|Withdrawal by Subject|3|||
146397130|NCT00494234|527958265|FG000|Overall Study|Withdrawal by Subject|1|||
146397131|NCT00494234|527958266|FG001|Overall Study|Withdrawal by Subject|0|||
146397132|NCT00494234|527958265|FG000|Overall Study|Disease progression|11|||
146397133|NCT00494234|527958266|FG001|Overall Study|Disease progression|8|||
146397134|NCT00494234|527958265|FG000|Overall Study|Death|2|||
146397135|NCT00494234|527958266|FG001|Overall Study|Death|1|||
146397136|NCT04359758|527958273|FG000|Overall Study|Protocol Violation|3|||
146397137|NCT04359758|527958274|FG001|Overall Study|Protocol Violation|2|||
146397138|NCT04753606|527958275|FG000|Overall Study|Adverse Event|1|||
146397139|NCT04753606|527958276|FG001|Overall Study|Adverse Event|0|||
146397140|NCT04753606|527958277|FG002|Overall Study|Adverse Event|0|||
146397141|NCT01012609|527958280|FG000|Overall Study|Withdrawal by Subject|1|||
146397142|NCT01012609|527958281|FG001|Overall Study|Withdrawal by Subject|1|||
146397143|NCT03253809|527958282|FG000|Overall Study|Unable to obtain study related data|14|||
146397144|NCT05147311|527958285|FG000|Overall Study|Did not complete survey|2|||
146397145|NCT05147311|527958286|FG001|Overall Study|Did not complete survey|1|||
146397146|NCT05147311|527958285|FG000|Overall Study|Patient too sick|1|||
146397147|NCT05147311|527958286|FG001|Overall Study|Patient too sick|2|||
146397148|NCT05147311|527958285|FG000|Overall Study|Death|0|||
146397149|NCT05147311|527958286|FG001|Overall Study|Death|1|||
146397150|NCT05147311|527958285|FG000|Overall Study|Declined survey|1|||
146397151|NCT05147311|527958286|FG001|Overall Study|Declined survey|0|||
146397152|NCT02279888|527958288|FG000|Overall Study|Death|326|||
146397153|NCT02279888|527958288|FG000|Overall Study|Withdrawal by Subject|38|||
146397154|NCT02279888|527958288|FG000|Overall Study|Lost to Follow-up|21|||
146397155|NCT02279888|527958288|FG000|Overall Study|Physician Decision|62|||
146397156|NCT02279888|527958288|FG000|Overall Study|Subject Non-compliance|43|||
146397157|NCT02279888|527958288|FG000|Overall Study|Not implanted|14|||
146283737|NCT00107120|527551828|FG000|Overall Study|death of parent|0|||
146397158|NCT02279888|527958288|FG000|Overall Study|Visit not performed|26|||
146397159|NCT04505592|527958289|FG000|Overall Study|Death|2|||
146397160|NCT04505592|527958290|FG001|Overall Study|Death|1|||
146397161|NCT00262119|527958297|FG000|Overall Study|Lost to Follow-up|38|||
146397162|NCT00262119|527958298|FG001|Overall Study|Lost to Follow-up|51|||
146397163|NCT00262119|527958299|FG002|Overall Study|Lost to Follow-up|42|||
145945131|NCT01546038|526308132|FG004|Overall Study|: Randomized, not treated|0|||
146058992|NCT03137992|526733816|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146058993|NCT03137992|526733817|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
146058994|NCT03137992|526733818|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
146058995|NCT03137992|526733813|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
146058996|NCT03137992|526733814|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146058997|NCT03137992|526733815|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
146058998|NCT03137992|526733816|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146058999|NCT03137992|526733817|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146059000|NCT03137992|526733818|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
146059001|NCT03137992|526733813|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146059002|NCT03137992|526733814|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146059003|NCT03137992|526733815|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146283738|NCT00107120|527551829|FG001|Overall Study|death of parent|1|||
146283739|NCT03241225|527551830|FG000|Overall Study|Lost to Follow-up|2|||
146283740|NCT03241225|527551831|FG001|Overall Study|Lost to Follow-up|1|||
146283741|NCT03241225|527551830|FG000|Overall Study|Protocol Violation|4|||
146283742|NCT03241225|527551831|FG001|Overall Study|Protocol Violation|1|||
146283743|NCT03241225|527551830|FG000|Overall Study|Withdrawal by Subject|1|||
146283744|NCT03241225|527551831|FG001|Overall Study|Withdrawal by Subject|0|||
146283745|NCT00852540|527551832|FG000|Overall Study|Adverse Event|10|||
146283746|NCT00852540|527551833|FG001|Overall Study|Adverse Event|3|||
146283747|NCT00852540|527551832|FG000|Overall Study|Lack of Efficacy|15|||
146283748|NCT00852540|527551833|FG001|Overall Study|Lack of Efficacy|3|||
146283749|NCT00852540|527551832|FG000|Overall Study|Protocol Violation|1|||
146283750|NCT00852540|527551833|FG001|Overall Study|Protocol Violation|2|||
146283751|NCT00852540|527551832|FG000|Overall Study|Lost to Follow-up|2|||
146283752|NCT00852540|527551833|FG001|Overall Study|Lost to Follow-up|3|||
146283753|NCT00852540|527551832|FG000|Overall Study|Investigator Discretion|2|||
146283754|NCT00852540|527551833|FG001|Overall Study|Investigator Discretion|3|||
146283755|NCT00852540|527551832|FG000|Overall Study|Withdrawal by Subject|3|||
146283756|NCT00852540|527551833|FG001|Overall Study|Withdrawal by Subject|1|||
146283757|NCT00852540|527551832|FG000|Overall Study|Did Not Receive Study Drug|3|||
146283758|NCT00852540|527551833|FG001|Overall Study|Did Not Receive Study Drug|3|||
146283759|NCT01639495|527551834|FG000|Overall Study|Lost to Follow-up|6|||
146283760|NCT01639495|527551834|FG000|Overall Study|Consented but didn't have study catheter|4|||
146283761|NCT01639495|527551834|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
146283762|NCT01639495|527551834|FG000|Overall Study|No radiofrequency energy applied|2|||
146283763|NCT01119105|527551835|FG000|Overall Study|Withdrawal by Subject|1|||
146283764|NCT01119105|527551836|FG001|Overall Study|Withdrawal by Subject|1|||
146283765|NCT01119105|527551837|FG002|Overall Study|Withdrawal by Subject|1|||
146283766|NCT01119105|527551835|FG000|Overall Study|Lost to Follow-up|0|||
146283767|NCT01119105|527551836|FG001|Overall Study|Lost to Follow-up|2|||
146283768|NCT01119105|527551837|FG002|Overall Study|Lost to Follow-up|5|||
146283769|NCT01119105|527551835|FG000|Overall Study|Adverse Event|1|||
146283770|NCT01119105|527551836|FG001|Overall Study|Adverse Event|0|||
146283771|NCT01119105|527551837|FG002|Overall Study|Adverse Event|1|||
146283772|NCT01119105|527551835|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
146283773|NCT01119105|527551836|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
146283774|NCT01119105|527551837|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
146283775|NCT01119105|527551835|FG000|Overall Study|Other|1|||
146283776|NCT01119105|527551836|FG001|Overall Study|Other|1|||
146283777|NCT01119105|527551837|FG002|Overall Study|Other|0|||
146283778|NCT04214600|527551840|FG000|Overall Study|Lost to Follow-up|9|||
146283779|NCT04214600|527551841|FG001|Overall Study|Lost to Follow-up|14|||
146283780|NCT01635920|527551849|FG000|Overall Study|Adverse Event|1|||
146283781|NCT01635920|527551850|FG001|Overall Study|Adverse Event|0|||
146283782|NCT01635920|527551849|FG000|Overall Study|Lost to Follow-up|0|||
146283783|NCT01635920|527551850|FG001|Overall Study|Lost to Follow-up|1|||
146283784|NCT01635920|527551849|FG000|Overall Study|Subject decision|2|||
146283785|NCT01635920|527551850|FG001|Overall Study|Subject decision|0|||
146283786|NCT01664598|527551851|FG000|Overall Study|Sponsor Decision|1|||
146283787|NCT01664598|527551851|FG000|Overall Study|Withdrawal of Informed Consent|4|||
146283788|NCT01664598|527551851|FG000|Overall Study|Adverse Event|1|||
146283789|NCT00686725|527551852|FG000|Overall Study|Adverse Event|1|||
146283790|NCT00686725|527551853|FG001|Overall Study|Adverse Event|1|||
146283791|NCT00686725|527551852|FG000|Overall Study|Progressive Disease|17|||
146283792|NCT00686725|527551853|FG001|Overall Study|Progressive Disease|23|||
145945132|NCT01546038|526308133|FG005|Overall Study|: Randomized, not treated|0|||
146059004|NCT03137992|526733816|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
146283793|NCT00686725|527551852|FG000|Overall Study|Lost to Follow-up|7|||
146283794|NCT00686725|527551853|FG001|Overall Study|Lost to Follow-up|5|||
146283795|NCT00686725|527551852|FG000|Overall Study|Death|6|||
146283796|NCT00686725|527551853|FG001|Overall Study|Death|3|||
146283797|NCT00686725|527551852|FG000|Overall Study|Withdrawal by Subject|13|||
146397164|NCT00262119|527958297|FG000|Overall Study|Death|20|||
146059005|NCT03137992|526733817|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146059006|NCT03137992|526733818|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
146059007|NCT03137992|526733813|FG000|Part 2 (Open-label Extension)|Per study team|1|||
146059008|NCT03137992|526733814|FG001|Part 2 (Open-label Extension)|Per study team|0|||
146059009|NCT03137992|526733815|FG002|Part 2 (Open-label Extension)|Per study team|0|||
146059010|NCT03137992|526733816|FG003|Part 2 (Open-label Extension)|Per study team|0|||
146059011|NCT03137992|526733817|FG004|Part 2 (Open-label Extension)|Per study team|0|||
146059012|NCT03137992|526733818|FG005|Part 2 (Open-label Extension)|Per study team|0|||
146059013|NCT03137992|526733813|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146059014|NCT03137992|526733814|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146059015|NCT03137992|526733815|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146059016|NCT03137992|526733816|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146059017|NCT03137992|526733817|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
146059018|NCT03137992|526733818|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
146059019|NCT00795704|526733823|FG000|Overall Study|Withdrawal by Subject|3|||
146059020|NCT00795704|526733824|FG001|Overall Study|Withdrawal by Subject|2|||
146059021|NCT00795704|526733823|FG000|Overall Study|Adverse Event|1|||
146059022|NCT00795704|526733824|FG001|Overall Study|Adverse Event|1|||
146059023|NCT01247324|526733825|FG000|Overall Study|Death|6|||
146059024|NCT01247324|526733826|FG001|Overall Study|Death|10|||
146059025|NCT01247324|526733825|FG000|Overall Study|Physician Decision|2|||
146059026|NCT01247324|526733826|FG001|Overall Study|Physician Decision|3|||
146059027|NCT01247324|526733825|FG000|Overall Study|Non-compliance with study drug|3|||
146059028|NCT01247324|526733826|FG001|Overall Study|Non-compliance with study drug|0|||
146059029|NCT01247324|526733825|FG000|Overall Study|Lack of Efficacy|24|||
146059030|NCT01247324|526733826|FG001|Overall Study|Lack of Efficacy|14|||
146059031|NCT01247324|526733825|FG000|Overall Study|Non-compliance|3|||
146059032|NCT01247324|526733826|FG001|Overall Study|Non-compliance|2|||
146059033|NCT01247324|526733825|FG000|Overall Study|Pregnancy|5|||
146059034|NCT01247324|526733826|FG001|Overall Study|Pregnancy|10|||
146059035|NCT01247324|526733825|FG000|Overall Study|Protocol Violation|1|||
146059036|NCT01247324|526733826|FG001|Overall Study|Protocol Violation|1|||
146059037|NCT01247324|526733825|FG000|Overall Study|Reason not specified|42|||
146059038|NCT01247324|526733826|FG001|Overall Study|Reason not specified|32|||
146059039|NCT01247324|526733825|FG000|Overall Study|Consent withdrawn by participant|41|||
146059040|NCT01247324|526733826|FG001|Overall Study|Consent withdrawn by participant|56|||
146059041|NCT01247324|526733825|FG000|Overall Study|Adverse Event|49|||
146059042|NCT01247324|526733826|FG001|Overall Study|Adverse Event|35|||
146059043|NCT01247324|526733825|FG000|Overall Study|Lost to Follow-up|3|||
146059044|NCT01247324|526733826|FG001|Overall Study|Lost to Follow-up|6|||
146059045|NCT01247324|526733825|FG000|Overall Study|Study Terminated by Sponsor|4|||
146059046|NCT01247324|526733826|FG001|Overall Study|Study Terminated by Sponsor|1|||
146059047|NCT01247324|526733825|FG000|Overall Study|Missing|2|||
146059048|NCT01247324|526733826|FG001|Overall Study|Missing|1|||
146059049|NCT01607957|526733827|FG000|Overall Study|Not treated|1|||
146059050|NCT01607957|526733828|FG001|Overall Study|Not treated|1|||
146059051|NCT01607957|526733827|FG000|Overall Study|Death|367|||
146059052|NCT01607957|526733828|FG001|Overall Study|Death|211|||
146059053|NCT01607957|526733827|FG000|Overall Study|Lost to Follow-up|3|||
146059054|NCT01607957|526733828|FG001|Overall Study|Lost to Follow-up|3|||
146059055|NCT01607957|526733827|FG000|Overall Study|Participant refusal|1|||
146059056|NCT01607957|526733828|FG001|Overall Study|Participant refusal|0|||
146059057|NCT04972786|526733829|FG000|First Intervention (1 Day)|Adverse Event|1|||
146059058|NCT04972786|526733830|FG001|First Intervention (1 Day)|Adverse Event|0|||
146059059|NCT03905096|526733831|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
146059060|NCT03905096|526733832|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
146059061|NCT02016781|526733834|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
146059062|NCT02016781|526733835|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
146059063|NCT02016781|526733834|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
146059064|NCT02016781|526733835|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
146059065|NCT02016781|526733834|FG000|Final Database Lock|Withdrawal by Subject|2|||
146059066|NCT02016781|526733835|FG001|Final Database Lock|Withdrawal by Subject|1|||
146059067|NCT02016781|526733834|FG000|Final Database Lock|Lost to Follow-up|11|||
146059068|NCT02016781|526733835|FG001|Final Database Lock|Lost to Follow-up|4|||
146059069|NCT02016781|526733834|FG000|Final Database Lock|Missing data|0|||
146059070|NCT02016781|526733835|FG001|Final Database Lock|Missing data|3|||
146059071|NCT02994108|526735893|FG000|Intervention Messages|Withdrawal by Subject|2|||
146059072|NCT02994108|526735894|FG001|Intervention Messages|Withdrawal by Subject|0|||
146059073|NCT02994108|526735893|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
146059074|NCT02994108|526735894|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
146059075|NCT02994108|526735893|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
146397165|NCT00262119|527958298|FG001|Overall Study|Death|19|||
146059076|NCT02994108|526735894|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
146059077|NCT02994108|526735893|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
146059078|NCT02994108|526735894|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
146397166|NCT00262119|527958299|FG002|Overall Study|Death|16|||
146059079|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
146059080|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
146059081|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
146059082|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Death|9|||
146059083|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Death|0|||
146059084|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Death|0|||
146059085|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
146059086|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146059087|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146059088|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
146059089|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
146059090|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
146059091|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Other|135|||
146059092|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Other|0|||
146059093|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Other|0|||
146059094|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
146059095|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
146059096|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
146059097|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
146059098|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
146059099|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
146059100|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
146059101|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
146059102|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
146059103|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Other|3|||
146059104|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Other|0|||
146059105|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Other|0|||
146059106|NCT02118584|526735903|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
146059107|NCT02118584|526735904|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146059108|NCT02118584|526735905|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146059109|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146059110|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
146059111|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146059112|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
146059113|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
146059114|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
146059115|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
146059116|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
146059117|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
146059118|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146059119|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146059120|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
146059121|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146059122|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
146059123|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146059124|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
146059125|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
146059126|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
146059127|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146059128|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
146059129|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146059130|NCT02118584|526735903|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
146059131|NCT02118584|526735904|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
146059132|NCT02118584|526735905|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
146059133|NCT00671658|526735910|FG000|Overall Study|Physician Decision|5|||
146059134|NCT01680341|526735914|FG000|Overall Study|Adverse Event|3|||
146059135|NCT01680341|526735915|FG001|Overall Study|Adverse Event|2|||
146059136|NCT01680341|526735914|FG000|Overall Study|Unclassified|18|||
146059137|NCT01680341|526735915|FG001|Overall Study|Unclassified|15|||
146059138|NCT00499486|526735916|FG000|Overall Study|Withdrawal by Subject|16|||
146059139|NCT03796728|526735918|FG000|Overall Study|Lost to Follow-up|8|||
146059140|NCT03796728|526735918|FG000|Overall Study|Reason not Specified|16|||
146059141|NCT02476617|526735920|FG000|Overall Study|Adverse Event|1|||
146059142|NCT02476617|526735920|FG000|Overall Study|Lost to Follow-up|1|||
146059143|NCT01383928|526735921|FG000|Overall Study|Initiation of ASCT|2|||
146059144|NCT01383928|526735922|FG001|Overall Study|Initiation of ASCT|1|||
146059145|NCT01383928|526735923|FG002|Overall Study|Initiation of ASCT|18|||
146059146|NCT01383928|526735921|FG000|Overall Study|Adverse Event|1|||
146059147|NCT01383928|526735922|FG001|Overall Study|Adverse Event|2|||
146059148|NCT01383928|526735923|FG002|Overall Study|Adverse Event|8|||
146059149|NCT01383928|526735921|FG000|Overall Study|Other|1|||
146059150|NCT01383928|526735922|FG001|Overall Study|Other|3|||
146059151|NCT01383928|526735923|FG002|Overall Study|Other|4|||
146059152|NCT01383928|526735921|FG000|Overall Study|Progressive Disease|1|||
146059153|NCT01383928|526735922|FG001|Overall Study|Progressive Disease|1|||
146059154|NCT01383928|526735923|FG002|Overall Study|Progressive Disease|5|||
146059155|NCT01383928|526735921|FG000|Overall Study|Withdrawal by Subject|0|||
146059156|NCT01383928|526735922|FG001|Overall Study|Withdrawal by Subject|0|||
146059157|NCT01383928|526735923|FG002|Overall Study|Withdrawal by Subject|4|||
146059158|NCT01383928|526735921|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
146059159|NCT01383928|526735922|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146059160|NCT01383928|526735923|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
146059161|NCT02491684|526735924|FG000|Treatment Phase|Adverse Event|2|||
146059162|NCT02491684|526735925|FG001|Treatment Phase|Adverse Event|2|||
146059163|NCT02491684|526735924|FG000|Treatment Phase|Incorrect randomisation|1|||
146059164|NCT02491684|526735925|FG001|Treatment Phase|Incorrect randomisation|0|||
146059165|NCT02491684|526735924|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
146059166|NCT02491684|526735925|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
146059167|NCT01346358|526735929|FG000|Overall Study|Withdrawal by Subject|1|||
146059168|NCT01346358|526735930|FG001|Overall Study|Withdrawal by Subject|0|||
146059169|NCT01346358|526735931|FG002|Overall Study|Withdrawal by Subject|1|||
146059170|NCT01346358|526735932|FG003|Overall Study|Withdrawal by Subject|1|||
146059171|NCT01346358|526735933|FG004|Overall Study|Withdrawal by Subject|0|||
146397167|NCT00071006|527958300|FG000|Overall Study|Lack of Efficacy|7|||
146397168|NCT00071006|527958300|FG000|Overall Study|Adverse Event|1|||
146397169|NCT00071006|527958300|FG000|Overall Study|Withdrawal by Subject|1|||
146397170|NCT00071006|527958300|FG000|Overall Study|Other|3|||
146397171|NCT05261126|527958305|FG000|Overall Study|Death|0|||
146397172|NCT05261126|527958306|FG001|Overall Study|Death|0|||
146397173|NCT05261126|527958307|FG002|Overall Study|Death|1|||
146397174|NCT05261126|527958308|FG003|Overall Study|Death|0|||
146397175|NCT05261126|527958309|FG004|Overall Study|Death|0|||
146397176|NCT05261126|527958305|FG000|Overall Study|Lost to Follow-up|0|||
146397177|NCT05261126|527958306|FG001|Overall Study|Lost to Follow-up|0|||
146397178|NCT05261126|527958307|FG002|Overall Study|Lost to Follow-up|0|||
146397179|NCT05261126|527958308|FG003|Overall Study|Lost to Follow-up|0|||
146397180|NCT05261126|527958309|FG004|Overall Study|Lost to Follow-up|1|||
146397181|NCT05261126|527958305|FG000|Overall Study|Physician Decision|1|||
146397182|NCT05261126|527958306|FG001|Overall Study|Physician Decision|0|||
146397183|NCT05261126|527958307|FG002|Overall Study|Physician Decision|0|||
146397184|NCT05261126|527958308|FG003|Overall Study|Physician Decision|0|||
146397185|NCT05261126|527958309|FG004|Overall Study|Physician Decision|0|||
146397186|NCT05261126|527958305|FG000|Overall Study|Screen Failure|0|||
146397187|NCT05261126|527958306|FG001|Overall Study|Screen Failure|0|||
146397188|NCT05261126|527958307|FG002|Overall Study|Screen Failure|0|||
146397189|NCT05261126|527958308|FG003|Overall Study|Screen Failure|0|||
146397190|NCT05261126|527958309|FG004|Overall Study|Screen Failure|1|||
146397191|NCT05261126|527958305|FG000|Overall Study|Withdrawal by Subject|1|||
146397192|NCT05261126|527958306|FG001|Overall Study|Withdrawal by Subject|0|||
146397193|NCT05261126|527958307|FG002|Overall Study|Withdrawal by Subject|1|||
146397194|NCT05261126|527958308|FG003|Overall Study|Withdrawal by Subject|1|||
146397195|NCT05261126|527958309|FG004|Overall Study|Withdrawal by Subject|0|||
146397196|NCT05261126|527958305|FG000|Overall Study|Not Recorded|0|||
146397197|NCT05261126|527958306|FG001|Overall Study|Not Recorded|0|||
146397198|NCT05261126|527958307|FG002|Overall Study|Not Recorded|0|||
146397199|NCT05261126|527958308|FG003|Overall Study|Not Recorded|1|||
146397200|NCT05261126|527958309|FG004|Overall Study|Not Recorded|0|||
146397201|NCT03901274|527958310|FG000|Overall Study|Lost to Follow-up|120|||
146397202|NCT03901274|527958311|FG001|Overall Study|Lost to Follow-up|124|||
146059172|NCT01346358|526735934|FG005|Overall Study|Withdrawal by Subject|2|||
146059173|NCT01346358|526735935|FG006|Overall Study|Withdrawal by Subject|1|||
146059174|NCT01346358|526735936|FG007|Overall Study|Withdrawal by Subject|1|||
146059175|NCT01346358|526735937|FG008|Overall Study|Withdrawal by Subject|1|||
146397203|NCT03901274|527958310|FG000|Overall Study|Withdrawal by Subject|0|||
146397204|NCT03901274|527958311|FG001|Overall Study|Withdrawal by Subject|6|||
146397205|NCT05570604|527958312|FG000|Overall Study|Lost to Follow-up|1|||
146059176|NCT01346358|526735929|FG000|Overall Study|Adverse Event|1|||
146059177|NCT01346358|526735930|FG001|Overall Study|Adverse Event|0|||
146059178|NCT01346358|526735931|FG002|Overall Study|Adverse Event|0|||
146059179|NCT01346358|526735932|FG003|Overall Study|Adverse Event|0|||
146059180|NCT01346358|526735933|FG004|Overall Study|Adverse Event|1|||
146397206|NCT05570604|527958313|FG001|Overall Study|Lost to Follow-up|5|||
146397207|NCT05570604|527958312|FG000|Overall Study|Illness|2|||
146397208|NCT05570604|527958313|FG001|Overall Study|Illness|2|||
146397209|NCT05643573|527958320|FG000|Overall Study|Adverse Event|117|||
146397210|NCT05643573|527958321|FG001|Overall Study|Adverse Event|90|||
146397211|NCT05643573|527958320|FG000|Overall Study|Death|53|||
146397212|NCT05643573|527958321|FG001|Overall Study|Death|57|||
146397213|NCT05643573|527958320|FG000|Overall Study|Lost to Follow-up|6|||
146397214|NCT05643573|527958321|FG001|Overall Study|Lost to Follow-up|3|||
146397215|NCT05643573|527958320|FG000|Overall Study|Other|18|||
146397216|NCT05643573|527958321|FG001|Overall Study|Other|15|||
146397217|NCT05643573|527958320|FG000|Overall Study|Outcome event|64|||
146397218|NCT05643573|527958321|FG001|Overall Study|Outcome event|36|||
146397219|NCT05643573|527958320|FG000|Overall Study|Physician Decision|33|||
146397220|NCT05643573|527958321|FG001|Overall Study|Physician Decision|19|||
146397221|NCT05643573|527958320|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
146397222|NCT05643573|527958321|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
146397223|NCT05643573|527958320|FG000|Overall Study|Site terminated by sponsor|10|||
146397224|NCT05643573|527958321|FG001|Overall Study|Site terminated by sponsor|10|||
146397225|NCT05643573|527958320|FG000|Overall Study|Study terminated by sponsor|1|||
146397226|NCT05643573|527958321|FG001|Overall Study|Study terminated by sponsor|0|||
146397227|NCT05643573|527958320|FG000|Overall Study|Withdrawal by Subject|178|||
146397228|NCT05643573|527958321|FG001|Overall Study|Withdrawal by Subject|130|||
146397229|NCT05182840|527958322|FG000|Run-in Period|Not treated|0|||
146397230|NCT05182840|527958323|FG001|Run-in Period|Not treated|1|||
146397231|NCT05182840|527958324|FG002|Run-in Period|Not treated|0|||
146397232|NCT05182840|527958325|FG003|Run-in Period|Not treated|0|||
146397233|NCT05182840|527958326|FG004|Run-in Period|Not treated|0|||
146397234|NCT05182840|527958327|FG005|Run-in Period|Not treated|0|||
146397235|NCT05182840|527958328|FG006|Run-in Period|Not treated|0|||
146397236|NCT05182840|527958329|FG007|Run-in Period|Not treated|0|||
146397237|NCT05182840|527958330|FG008|Run-in Period|Not treated|0|||
146397238|NCT05182840|527958331|FG009|Run-in Period|Not treated|0|||
146397239|NCT05182840|527958322|FG000|Run-in Period|Other reason but not sponsor termination|14|||
146397240|NCT05182840|527958323|FG001|Run-in Period|Other reason but not sponsor termination|18|||
146397241|NCT05182840|527958324|FG002|Run-in Period|Other reason but not sponsor termination|0|||
146397242|NCT05182840|527958325|FG003|Run-in Period|Other reason but not sponsor termination|0|||
146397243|NCT05182840|527958326|FG004|Run-in Period|Other reason but not sponsor termination|0|||
146397244|NCT05182840|527958327|FG005|Run-in Period|Other reason but not sponsor termination|0|||
146397245|NCT05182840|527958328|FG006|Run-in Period|Other reason but not sponsor termination|0|||
146397246|NCT05182840|527958329|FG007|Run-in Period|Other reason but not sponsor termination|0|||
146397247|NCT05182840|527958330|FG008|Run-in Period|Other reason but not sponsor termination|0|||
146397248|NCT05182840|527958331|FG009|Run-in Period|Other reason but not sponsor termination|0|||
146397249|NCT05182840|527958322|FG000|Run-in Period|No reason available|2|||
146397250|NCT05182840|527958323|FG001|Run-in Period|No reason available|2|||
146397251|NCT05182840|527958324|FG002|Run-in Period|No reason available|0|||
146397252|NCT05182840|527958325|FG003|Run-in Period|No reason available|0|||
146397253|NCT05182840|527958326|FG004|Run-in Period|No reason available|0|||
146397254|NCT05182840|527958327|FG005|Run-in Period|No reason available|0|||
146397255|NCT05182840|527958328|FG006|Run-in Period|No reason available|0|||
146397256|NCT05182840|527958329|FG007|Run-in Period|No reason available|0|||
146397257|NCT05182840|527958330|FG008|Run-in Period|No reason available|0|||
146397258|NCT05182840|527958331|FG009|Run-in Period|No reason available|0|||
146397259|NCT05182840|527958322|FG000|Run-in Period|Burden of study procedures|2|||
146397260|NCT05182840|527958323|FG001|Run-in Period|Burden of study procedures|2|||
146397261|NCT05182840|527958324|FG002|Run-in Period|Burden of study procedures|0|||
146397262|NCT05182840|527958325|FG003|Run-in Period|Burden of study procedures|0|||
146397263|NCT05182840|527958326|FG004|Run-in Period|Burden of study procedures|0|||
146397264|NCT05182840|527958327|FG005|Run-in Period|Burden of study procedures|0|||
146397265|NCT05182840|527958328|FG006|Run-in Period|Burden of study procedures|0|||
146397266|NCT05182840|527958329|FG007|Run-in Period|Burden of study procedures|0|||
146397267|NCT05182840|527958330|FG008|Run-in Period|Burden of study procedures|0|||
146397268|NCT05182840|527958331|FG009|Run-in Period|Burden of study procedures|0|||
146397269|NCT05182840|527958322|FG000|Run-in Period|Change of residence|1|||
146397270|NCT05182840|527958323|FG001|Run-in Period|Change of residence|0|||
146397271|NCT05182840|527958324|FG002|Run-in Period|Change of residence|0|||
146397272|NCT05182840|527958325|FG003|Run-in Period|Change of residence|0|||
146397273|NCT05182840|527958326|FG004|Run-in Period|Change of residence|0|||
146397274|NCT05182840|527958327|FG005|Run-in Period|Change of residence|0|||
146397275|NCT05182840|527958328|FG006|Run-in Period|Change of residence|0|||
146397276|NCT05182840|527958329|FG007|Run-in Period|Change of residence|0|||
146397277|NCT05182840|527958330|FG008|Run-in Period|Change of residence|0|||
146397278|NCT05182840|527958331|FG009|Run-in Period|Change of residence|0|||
146397279|NCT05182840|527958322|FG000|Run-in Period|Adverse Event|5|||
146397280|NCT05182840|527958323|FG001|Run-in Period|Adverse Event|5|||
146397281|NCT05182840|527958324|FG002|Run-in Period|Adverse Event|0|||
146397282|NCT05182840|527958325|FG003|Run-in Period|Adverse Event|0|||
146397283|NCT05182840|527958326|FG004|Run-in Period|Adverse Event|0|||
146397284|NCT05182840|527958327|FG005|Run-in Period|Adverse Event|0|||
146397285|NCT05182840|527958328|FG006|Run-in Period|Adverse Event|0|||
146397286|NCT05182840|527958329|FG007|Run-in Period|Adverse Event|0|||
146397287|NCT05182840|527958330|FG008|Run-in Period|Adverse Event|0|||
146397288|NCT05182840|527958331|FG009|Run-in Period|Adverse Event|0|||
146397289|NCT05182840|527958322|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
146397290|NCT05182840|527958323|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
146397291|NCT05182840|527958324|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397292|NCT05182840|527958325|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397293|NCT05182840|527958326|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397294|NCT05182840|527958327|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397295|NCT05182840|527958328|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397296|NCT05182840|527958329|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397297|NCT05182840|527958330|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397298|NCT05182840|527958331|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
146397299|NCT05182840|527958322|FG000|Treatment Period|Reason missing|0|||
146397300|NCT05182840|527958323|FG001|Treatment Period|Reason missing|0|||
146397301|NCT05182840|527958324|FG002|Treatment Period|Reason missing|1|||
146397302|NCT05182840|527958325|FG003|Treatment Period|Reason missing|0|||
146397303|NCT05182840|527958326|FG004|Treatment Period|Reason missing|0|||
146397304|NCT05182840|527958327|FG005|Treatment Period|Reason missing|0|||
146397305|NCT05182840|527958328|FG006|Treatment Period|Reason missing|0|||
146397306|NCT05182840|527958329|FG007|Treatment Period|Reason missing|0|||
146397307|NCT05182840|527958330|FG008|Treatment Period|Reason missing|0|||
146397308|NCT05182840|527958331|FG009|Treatment Period|Reason missing|0|||
146397309|NCT05182840|527958322|FG000|Treatment Period|Other but not sponsor termination|0|||
146397310|NCT05182840|527958323|FG001|Treatment Period|Other but not sponsor termination|0|||
146397311|NCT05182840|527958324|FG002|Treatment Period|Other but not sponsor termination|8|||
146397312|NCT05182840|527958325|FG003|Treatment Period|Other but not sponsor termination|6|||
146397313|NCT05182840|527958326|FG004|Treatment Period|Other but not sponsor termination|6|||
146397314|NCT05182840|527958327|FG005|Treatment Period|Other but not sponsor termination|7|||
146397315|NCT05182840|527958328|FG006|Treatment Period|Other but not sponsor termination|5|||
146397316|NCT05182840|527958329|FG007|Treatment Period|Other but not sponsor termination|8|||
146397317|NCT05182840|527958330|FG008|Treatment Period|Other but not sponsor termination|7|||
146397318|NCT05182840|527958331|FG009|Treatment Period|Other but not sponsor termination|2|||
146397319|NCT05182840|527958322|FG000|Treatment Period|Protocol deviation|0|||
146397320|NCT05182840|527958323|FG001|Treatment Period|Protocol deviation|0|||
146397321|NCT05182840|527958324|FG002|Treatment Period|Protocol deviation|0|||
146397322|NCT05182840|527958325|FG003|Treatment Period|Protocol deviation|0|||
146397323|NCT05182840|527958326|FG004|Treatment Period|Protocol deviation|0|||
146397324|NCT05182840|527958327|FG005|Treatment Period|Protocol deviation|0|||
146397325|NCT05182840|527958328|FG006|Treatment Period|Protocol deviation|0|||
146397326|NCT05182840|527958329|FG007|Treatment Period|Protocol deviation|0|||
146397327|NCT05182840|527958330|FG008|Treatment Period|Protocol deviation|1|||
146397328|NCT05182840|527958331|FG009|Treatment Period|Protocol deviation|0|||
146397329|NCT05182840|527958322|FG000|Treatment Period|No reason available|0|||
146397330|NCT05182840|527958323|FG001|Treatment Period|No reason available|0|||
146397331|NCT05182840|527958324|FG002|Treatment Period|No reason available|0|||
146397332|NCT05182840|527958325|FG003|Treatment Period|No reason available|1|||
146397333|NCT05182840|527958326|FG004|Treatment Period|No reason available|0|||
146397334|NCT05182840|527958327|FG005|Treatment Period|No reason available|2|||
146397335|NCT05182840|527958328|FG006|Treatment Period|No reason available|0|||
146397336|NCT05182840|527958329|FG007|Treatment Period|No reason available|1|||
146397337|NCT05182840|527958330|FG008|Treatment Period|No reason available|0|||
146397338|NCT05182840|527958331|FG009|Treatment Period|No reason available|0|||
146397339|NCT05182840|527958322|FG000|Treatment Period|Burden of study procedures|0|||
146397340|NCT05182840|527958323|FG001|Treatment Period|Burden of study procedures|0|||
146397341|NCT05182840|527958324|FG002|Treatment Period|Burden of study procedures|0|||
146397342|NCT05182840|527958325|FG003|Treatment Period|Burden of study procedures|0|||
146397343|NCT05182840|527958326|FG004|Treatment Period|Burden of study procedures|1|||
146397344|NCT05182840|527958327|FG005|Treatment Period|Burden of study procedures|0|||
146397345|NCT05182840|527958328|FG006|Treatment Period|Burden of study procedures|0|||
146397346|NCT05182840|527958329|FG007|Treatment Period|Burden of study procedures|0|||
146397347|NCT05182840|527958330|FG008|Treatment Period|Burden of study procedures|0|||
146397348|NCT05182840|527958331|FG009|Treatment Period|Burden of study procedures|0|||
146397349|NCT05182840|527958322|FG000|Treatment Period|Change of residence|0|||
146397350|NCT05182840|527958323|FG001|Treatment Period|Change of residence|0|||
146397351|NCT05182840|527958324|FG002|Treatment Period|Change of residence|0|||
146397352|NCT05182840|527958325|FG003|Treatment Period|Change of residence|0|||
146397353|NCT05182840|527958326|FG004|Treatment Period|Change of residence|0|||
146397354|NCT05182840|527958327|FG005|Treatment Period|Change of residence|1|||
146397355|NCT05182840|527958328|FG006|Treatment Period|Change of residence|0|||
146397356|NCT05182840|527958329|FG007|Treatment Period|Change of residence|0|||
146397357|NCT05182840|527958330|FG008|Treatment Period|Change of residence|0|||
146397358|NCT05182840|527958331|FG009|Treatment Period|Change of residence|0|||
146397359|NCT05182840|527958322|FG000|Treatment Period|Adverse Event|0|||
146397360|NCT05182840|527958323|FG001|Treatment Period|Adverse Event|0|||
146397361|NCT05182840|527958324|FG002|Treatment Period|Adverse Event|4|||
146397362|NCT05182840|527958325|FG003|Treatment Period|Adverse Event|16|||
146397363|NCT05182840|527958326|FG004|Treatment Period|Adverse Event|12|||
146397364|NCT05182840|527958327|FG005|Treatment Period|Adverse Event|6|||
146397365|NCT05182840|527958328|FG006|Treatment Period|Adverse Event|4|||
146397366|NCT05182840|527958329|FG007|Treatment Period|Adverse Event|8|||
146397367|NCT05182840|527958330|FG008|Treatment Period|Adverse Event|16|||
146397368|NCT05182840|527958331|FG009|Treatment Period|Adverse Event|5|||
146397369|NCT05182840|527958322|FG000|Treatment Period|Not treated with study drug|0|||
146397370|NCT05182840|527958323|FG001|Treatment Period|Not treated with study drug|0|||
146397371|NCT05182840|527958324|FG002|Treatment Period|Not treated with study drug|0|||
146397372|NCT05182840|527958325|FG003|Treatment Period|Not treated with study drug|1|||
146397373|NCT05182840|527958326|FG004|Treatment Period|Not treated with study drug|0|||
146397374|NCT05182840|527958327|FG005|Treatment Period|Not treated with study drug|0|||
146397375|NCT05182840|527958328|FG006|Treatment Period|Not treated with study drug|1|||
146397376|NCT05182840|527958329|FG007|Treatment Period|Not treated with study drug|1|||
146397377|NCT05182840|527958330|FG008|Treatment Period|Not treated with study drug|0|||
146397378|NCT05182840|527958331|FG009|Treatment Period|Not treated with study drug|0|||
146397379|NCT02161380|527958332|FG000|Overall Study|Lost to Follow-up|0|||
146397380|NCT02161380|527958333|FG001|Overall Study|Lost to Follow-up|1|||
146059181|NCT01346358|526735934|FG005|Overall Study|Adverse Event|0|||
146059182|NCT01346358|526735935|FG006|Overall Study|Adverse Event|0|||
146059183|NCT01346358|526735936|FG007|Overall Study|Adverse Event|0|||
146059184|NCT01346358|526735937|FG008|Overall Study|Adverse Event|1|||
146059185|NCT01346358|526735929|FG000|Overall Study|Non-Compliance|0|||
146059186|NCT01346358|526735930|FG001|Overall Study|Non-Compliance|0|||
146059187|NCT01346358|526735931|FG002|Overall Study|Non-Compliance|0|||
146059188|NCT01346358|526735932|FG003|Overall Study|Non-Compliance|0|||
146059189|NCT01346358|526735933|FG004|Overall Study|Non-Compliance|0|||
146059190|NCT01346358|526735934|FG005|Overall Study|Non-Compliance|0|||
146059191|NCT01346358|526735935|FG006|Overall Study|Non-Compliance|0|||
146059192|NCT01346358|526735936|FG007|Overall Study|Non-Compliance|2|||
146059193|NCT01346358|526735937|FG008|Overall Study|Non-Compliance|0|||
146059194|NCT01346358|526735929|FG000|Overall Study|Physician Decision|0|||
146059195|NCT01346358|526735930|FG001|Overall Study|Physician Decision|1|||
146059196|NCT01346358|526735931|FG002|Overall Study|Physician Decision|0|||
146059197|NCT01346358|526735932|FG003|Overall Study|Physician Decision|0|||
146059198|NCT01346358|526735933|FG004|Overall Study|Physician Decision|0|||
146059199|NCT01346358|526735934|FG005|Overall Study|Physician Decision|0|||
146059200|NCT01346358|526735935|FG006|Overall Study|Physician Decision|0|||
146059201|NCT01346358|526735936|FG007|Overall Study|Physician Decision|1|||
146059202|NCT01346358|526735937|FG008|Overall Study|Physician Decision|1|||
146059203|NCT05058365|526735940|FG000|Overall Study|Migration|1|||
146059204|NCT05058365|526735941|FG001|Overall Study|Migration|1|||
146059205|NCT00702702|526735944|FG000|Overall Study|Study prematurely terminated|56|||
146059206|NCT00551759|526735947|FG000|Overall Study|Adverse Event|7|||
146059207|NCT00551759|526735947|FG000|Overall Study|Death|5|||
146059208|NCT00551759|526735947|FG000|Overall Study|Ineligible|1|||
146059209|NCT00771914|526735948|FG000|Overall Study|Physician Decision|0|||
146059210|NCT00771914|526735949|FG001|Overall Study|Physician Decision|0|||
146059211|NCT00771914|526735950|FG002|Overall Study|Physician Decision|0|||
146059212|NCT00771914|526735951|FG003|Overall Study|Physician Decision|1|||
146059213|NCT00771914|526735948|FG000|Overall Study|Lost to Follow-up|0|||
146059214|NCT00771914|526735949|FG001|Overall Study|Lost to Follow-up|0|||
146059215|NCT00771914|526735950|FG002|Overall Study|Lost to Follow-up|0|||
146059216|NCT00771914|526735951|FG003|Overall Study|Lost to Follow-up|1|||
146397381|NCT02161380|527958334|FG002|Overall Study|Lost to Follow-up|0|||
146397382|NCT02161380|527958335|FG003|Overall Study|Lost to Follow-up|0|||
146397383|NCT00948896|527958337|FG000|Randomization to 24 Months of Age|Death|1|||
146397384|NCT00948896|527958338|FG001|Randomization to 24 Months of Age|Death|0|||
146059217|NCT01667900|526735952|FG000|Part B|Death|0|||
146059218|NCT01667900|526735953|FG001|Part B|Death|0|||
146059219|NCT01667900|526735954|FG002|Part B|Death|0|||
146059220|NCT01667900|526735955|FG003|Part B|Death|0|||
146059221|NCT01667900|526735956|FG004|Part B|Death|0|||
146059222|NCT01667900|526735957|FG005|Part B|Death|0|||
146059223|NCT01667900|526735958|FG006|Part B|Death|0|||
146059224|NCT01667900|526735959|FG007|Part B|Death|0|||
146059225|NCT01667900|526735960|FG008|Part B|Death|0|||
146059226|NCT01667900|526735961|FG009|Part B|Death|0|||
146059227|NCT01667900|526735962|FG010|Part B|Death|0|||
146397385|NCT00948896|527958339|FG002|Randomization to 24 Months of Age|Death|0|||
146397386|NCT00948896|527958340|FG003|Randomization to 24 Months of Age|Death|0|||
146397387|NCT00948896|527958341|FG004|Randomization to 24 Months of Age|Death|2|||
146059228|NCT01667900|526735963|FG011|Part B|Death|0|||
146059229|NCT01667900|526735964|FG012|Part B|Death|0|||
146059230|NCT01667900|526735965|FG013|Part B|Death|0|||
146059231|NCT01667900|526735966|FG014|Part B|Death|0|||
146059232|NCT01667900|526735967|FG015|Part B|Death|0|||
146059233|NCT01667900|526735968|FG016|Part B|Death|1|||
146059234|NCT01667900|526735969|FG017|Part B|Death|0|||
146059235|NCT01667900|526735970|FG018|Part B|Death|0|||
146059236|NCT01667900|526735971|FG019|Part B|Death|0|||
146059237|NCT02954536|526735974|FG000|Overall Study|Adverse Event|2|||
146059238|NCT02954536|526735974|FG000|Overall Study|Death|12|||
146059239|NCT00685165|526735979|FG000|Washout Period of 14 Days|Adverse Event|1|||
146059240|NCT00685165|526735980|FG001|Washout Period of 14 Days|Adverse Event|0|||
146059241|NCT04576988|526735987|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
146059242|NCT04576988|526735988|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
146059243|NCT04576988|526735987|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
146059244|NCT04576988|526735988|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
146059245|NCT04576988|526735987|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
146059246|NCT04576988|526735988|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
146059247|NCT04576988|526735987|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
146059248|NCT04576988|526735988|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
146059249|NCT04576988|526735987|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
146059250|NCT04576988|526735988|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
146059251|NCT04576988|526735987|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
146059252|NCT04576988|526735988|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
146059253|NCT04576988|526735987|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
146059254|NCT04576988|526735988|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
146059255|NCT04576988|526735987|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
146059256|NCT04576988|526735988|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
146059257|NCT04576988|526735987|FG000|Long Term Double Blind (LTDB)|Death|2|||
146059258|NCT04576988|526735988|FG001|Long Term Double Blind (LTDB)|Death|1|||
146059259|NCT04576988|526735987|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
146059260|NCT04576988|526735988|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
146059261|NCT01576341|526735991|FG000|Overall Study|Withdrawal by Subject|24|||
146059262|NCT01576341|526735991|FG000|Overall Study|Adverse Event|10|||
146059263|NCT01576341|526735991|FG000|Overall Study|Death|21|||
146059264|NCT01576341|526735991|FG000|Overall Study|Physician Decision|2|||
146059265|NCT01576341|526735991|FG000|Overall Study|Lost to Follow-up|2|||
146059266|NCT01576341|526735991|FG000|Overall Study|Kidney transplantation|10|||
146059267|NCT01576341|526735991|FG000|Overall Study|Protocol Violation|12|||
146059268|NCT01576341|526735991|FG000|Overall Study|Other|12|||
146059269|NCT01844765|526735992|FG000|Overall Study|Adverse Event|6|||
146059270|NCT01844765|526735993|FG001|Overall Study|Adverse Event|8|||
146059271|NCT01844765|526735992|FG000|Overall Study|Withdrawal by Subject|2|||
146059272|NCT01844765|526735993|FG001|Overall Study|Withdrawal by Subject|3|||
146059273|NCT01844765|526735992|FG000|Overall Study|Disease progression|1|||
146059274|NCT01844765|526735993|FG001|Overall Study|Disease progression|0|||
146059275|NCT01844765|526735992|FG000|Overall Study|Administrative problems|3|||
146059276|NCT01844765|526735993|FG001|Overall Study|Administrative problems|4|||
146059277|NCT01844765|526735992|FG000|Overall Study|Protocol deviation|2|||
146059278|NCT01844765|526735993|FG001|Overall Study|Protocol deviation|0|||
146059279|NCT01844765|526735992|FG000|Overall Study|Untreated|1|||
146059280|NCT01844765|526735993|FG001|Overall Study|Untreated|0|||
146059281|NCT00556075|526736002|FG000|Overall Study|Lost to Follow-up|3|||
146059282|NCT00556075|526736003|FG001|Overall Study|Lost to Follow-up|0|||
146059283|NCT00556075|526736004|FG002|Overall Study|Lost to Follow-up|3|||
146059284|NCT00556075|526736002|FG000|Overall Study|Withdrawal by Subject|3|||
146059285|NCT00556075|526736003|FG001|Overall Study|Withdrawal by Subject|3|||
146059286|NCT00556075|526736004|FG002|Overall Study|Withdrawal by Subject|0|||
146059287|NCT00556075|526736002|FG000|Overall Study|Protocol Violation|1|||
146397388|NCT00948896|527958342|FG005|Randomization to 24 Months of Age|Death|1|||
146397389|NCT00948896|527958343|FG006|Randomization to 24 Months of Age|Death|2|||
146397390|NCT00948896|527958344|FG007|Randomization to 24 Months of Age|Death|1|||
146397391|NCT00948896|527958337|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
146059288|NCT00556075|526736003|FG001|Overall Study|Protocol Violation|1|||
146059289|NCT00556075|526736004|FG002|Overall Study|Protocol Violation|3|||
146059290|NCT00556075|526736002|FG000|Overall Study|Not eligible|1|||
146059291|NCT00556075|526736003|FG001|Overall Study|Not eligible|1|||
146059292|NCT00556075|526736004|FG002|Overall Study|Not eligible|2|||
146059293|NCT00556075|526736002|FG000|Overall Study|Adverse Event|1|||
146059294|NCT00556075|526736003|FG001|Overall Study|Adverse Event|2|||
146059295|NCT00556075|526736004|FG002|Overall Study|Adverse Event|0|||
146059296|NCT00556075|526736002|FG000|Overall Study|Personal issues|4|||
146059297|NCT00556075|526736003|FG001|Overall Study|Personal issues|1|||
146059298|NCT00556075|526736004|FG002|Overall Study|Personal issues|0|||
146059299|NCT00556075|526736002|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
146059300|NCT00556075|526736003|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
146059301|NCT00556075|526736004|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
146059302|NCT00395746|526736005|FG000|Overall Study|Adverse Event|5|||
146059303|NCT00395746|526736006|FG001|Overall Study|Adverse Event|2|||
146059304|NCT00395746|526736007|FG002|Overall Study|Adverse Event|2|||
146059305|NCT00395746|526736005|FG000|Overall Study|Protocol Violation|0|||
146059306|NCT00395746|526736006|FG001|Overall Study|Protocol Violation|1|||
146059307|NCT00395746|526736007|FG002|Overall Study|Protocol Violation|0|||
146059308|NCT00395746|526736005|FG000|Overall Study|Lack of Efficacy|2|||
146059309|NCT00395746|526736006|FG001|Overall Study|Lack of Efficacy|0|||
146059310|NCT00395746|526736007|FG002|Overall Study|Lack of Efficacy|17|||
146397392|NCT00948896|527958338|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
146397393|NCT00948896|527958339|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
146397394|NCT00948896|527958340|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
146397395|NCT00948896|527958341|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146397396|NCT00948896|527958342|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
146397397|NCT00948896|527958343|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146059311|NCT00395746|526736005|FG000|Overall Study|Hypoglycaemia|2|||
146059312|NCT00395746|526736006|FG001|Overall Study|Hypoglycaemia|1|||
146059313|NCT00395746|526736007|FG002|Overall Study|Hypoglycaemia|0|||
146059314|NCT00395746|526736005|FG000|Overall Study|Subject decision|0|||
146059315|NCT00395746|526736006|FG001|Overall Study|Subject decision|0|||
146059316|NCT00395746|526736007|FG002|Overall Study|Subject decision|1|||
146059317|NCT00395746|526736005|FG000|Overall Study|Withdrawal of consent|0|||
146059318|NCT00395746|526736006|FG001|Overall Study|Withdrawal of consent|0|||
146059319|NCT00395746|526736007|FG002|Overall Study|Withdrawal of consent|1|||
146059320|NCT00395746|526736005|FG000|Overall Study|Difficultulty in use of device|0|||
146059321|NCT00395746|526736006|FG001|Overall Study|Difficultulty in use of device|0|||
146059322|NCT00395746|526736007|FG002|Overall Study|Difficultulty in use of device|1|||
146059323|NCT00395746|526736005|FG000|Overall Study|Unable to visit site on schedule|1|||
146059324|NCT00395746|526736006|FG001|Overall Study|Unable to visit site on schedule|0|||
146059325|NCT00395746|526736007|FG002|Overall Study|Unable to visit site on schedule|0|||
146059326|NCT04528641|526736008|FG000|Overall Study|Withdrawal by Subject|0|||
146059327|NCT04528641|526736009|FG001|Overall Study|Withdrawal by Subject|0|||
146059328|NCT04528641|526736010|FG002|Overall Study|Withdrawal by Subject|0|||
146059329|NCT04528641|526736011|FG003|Overall Study|Withdrawal by Subject|1|||
146059330|NCT04528641|526736012|FG004|Overall Study|Withdrawal by Subject|0|||
146059331|NCT04528641|526736013|FG005|Overall Study|Withdrawal by Subject|1|||
146059332|NCT03914417|526736014|FG000|Overall Study|Withdrawal by Subject|2|||
146059333|NCT03836625|526736015|FG000|Overall Study|Lost to Follow-up|9|||
146059334|NCT03836625|526736016|FG001|Overall Study|Lost to Follow-up|9|||
146059335|NCT03836625|526736015|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
146059336|NCT03836625|526736016|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
146059337|NCT03836625|526736015|FG000|Overall Study|Death|0|||
146059338|NCT03836625|526736016|FG001|Overall Study|Death|1|||
146059339|NCT03836625|526736015|FG000|Overall Study|Refused follow-up|0|||
146059340|NCT03836625|526736016|FG001|Overall Study|Refused follow-up|1|||
146059341|NCT03361137|526736021|FG000|Overall Study|Reason not specified|1|||
146059342|NCT03361137|526736022|FG001|Overall Study|Reason not specified|0|||
146059343|NCT03361137|526736023|FG002|Overall Study|Reason not specified|0|||
146059344|NCT03361137|526736024|FG003|Overall Study|Reason not specified|0|||
146059345|NCT03361137|526736025|FG004|Overall Study|Reason not specified|0|||
146059346|NCT00791934|526736026|FG000|Overall Study|Withdrawal by Subject|2|||
146059347|NCT00791934|526736026|FG000|Overall Study|Did not consent for extended follow-up|13|||
146059348|NCT03413891|526736028|FG000|Overall Study|Lost to Follow-up|2|||
146059349|NCT03413891|526736029|FG001|Overall Study|Lost to Follow-up|1|||
146059350|NCT03413891|526736028|FG000|Overall Study|Protocol Violation|0|||
146059351|NCT03413891|526736029|FG001|Overall Study|Protocol Violation|1|||
146059352|NCT04905134|526736030|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
146059353|NCT04905134|526736030|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
146059354|NCT03009058|526736031|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
146059355|NCT03221556|526736032|FG000|Allocation|post-randomization exclusion|0|||
146059356|NCT03221556|526736033|FG001|Allocation|post-randomization exclusion|1|||
146059357|NCT03221556|526736032|FG000|Follow-Up|Withdrawal by Subject|0|||
146059358|NCT03221556|526736033|FG001|Follow-Up|Withdrawal by Subject|1|||
146059359|NCT02783690|526736034|FG000|Overall Study|Withdrawal by Subject|3|||
146397398|NCT00948896|527958344|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
146397399|NCT00948896|527958337|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
146397400|NCT00948896|527958338|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
146397401|NCT00948896|527958339|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
146397402|NCT00948896|527958340|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
146397403|NCT00948896|527958341|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146397404|NCT00948896|527958342|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146397405|NCT00948896|527958343|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
146397406|NCT00948896|527958344|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
146397407|NCT00948896|527958337|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
146397408|NCT00948896|527958338|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
146397409|NCT00948896|527958339|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
146059360|NCT02783690|526736035|FG001|Overall Study|Withdrawal by Subject|3|||
146059361|NCT01486966|526736038|FG000|Overall Study|Adverse Event|0|||
146059362|NCT01486966|526736039|FG001|Overall Study|Adverse Event|1|||
146059363|NCT01486966|526736038|FG000|Overall Study|Withdrawal by Subject|0|||
146059364|NCT01486966|526736039|FG001|Overall Study|Withdrawal by Subject|1|||
146059365|NCT02234843|526736040|FG000|Overall Study|Death|1|||
146059366|NCT02234843|526736041|FG001|Overall Study|Death|0|||
146059367|NCT02234843|526736042|FG002|Overall Study|Death|0|||
146059368|NCT02234843|526736043|FG003|Overall Study|Death|0|||
146059369|NCT02234843|526736044|FG004|Overall Study|Death|0|||
146059370|NCT02234843|526736045|FG005|Overall Study|Death|0|||
146059371|NCT02234843|526736046|FG006|Overall Study|Death|0|||
146059372|NCT02234843|526736047|FG007|Overall Study|Death|0|||
146059373|NCT02234843|526736048|FG008|Overall Study|Death|0|||
146397410|NCT00948896|527958340|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
146397411|NCT00948896|527958341|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
146397412|NCT00948896|527958342|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
146397413|NCT00948896|527958343|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
146397414|NCT00948896|527958344|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
146397415|NCT00948896|527958337|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146397416|NCT00948896|527958338|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
146397417|NCT00948896|527958339|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
146397418|NCT00948896|527958340|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
146397419|NCT00948896|527958341|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146397420|NCT00948896|527958342|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
146397421|NCT00948896|527958343|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146397422|NCT00948896|527958344|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
146397423|NCT00948896|527958337|FG000|24 Months of Age to 36 Months of Age|Death|0|||
146397424|NCT00948896|527958338|FG001|24 Months of Age to 36 Months of Age|Death|2|||
146397425|NCT00948896|527958339|FG002|24 Months of Age to 36 Months of Age|Death|2|||
146397426|NCT00948896|527958340|FG003|24 Months of Age to 36 Months of Age|Death|0|||
146397427|NCT00948896|527958341|FG004|24 Months of Age to 36 Months of Age|Death|0|||
146397428|NCT00948896|527958342|FG005|24 Months of Age to 36 Months of Age|Death|1|||
146397429|NCT00948896|527958343|FG006|24 Months of Age to 36 Months of Age|Death|0|||
146397430|NCT00948896|527958344|FG007|24 Months of Age to 36 Months of Age|Death|0|||
146397431|NCT00948896|527958337|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146397432|NCT00948896|527958338|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146397433|NCT00948896|527958339|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146397434|NCT00948896|527958340|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
146397435|NCT00948896|527958341|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146059374|NCT02234843|526736049|FG009|Overall Study|Death|0|||
146059375|NCT02234843|526736040|FG000|Overall Study|Protocol Violation|1|||
146059376|NCT02234843|526736041|FG001|Overall Study|Protocol Violation|0|||
146059377|NCT02234843|526736042|FG002|Overall Study|Protocol Violation|1|||
146059378|NCT02234843|526736043|FG003|Overall Study|Protocol Violation|0|||
146059379|NCT02234843|526736044|FG004|Overall Study|Protocol Violation|0|||
146059380|NCT02234843|526736045|FG005|Overall Study|Protocol Violation|0|||
146059381|NCT02234843|526736046|FG006|Overall Study|Protocol Violation|0|||
146059382|NCT02234843|526736047|FG007|Overall Study|Protocol Violation|0|||
146059383|NCT02234843|526736048|FG008|Overall Study|Protocol Violation|0|||
146059384|NCT02234843|526736049|FG009|Overall Study|Protocol Violation|0|||
146059385|NCT02234843|526736040|FG000|Overall Study|Efficacy outcome reached|2|||
146059386|NCT02234843|526736041|FG001|Overall Study|Efficacy outcome reached|0|||
146059387|NCT02234843|526736042|FG002|Overall Study|Efficacy outcome reached|0|||
146059388|NCT02234843|526736043|FG003|Overall Study|Efficacy outcome reached|0|||
146059389|NCT02234843|526736044|FG004|Overall Study|Efficacy outcome reached|0|||
146059390|NCT02234843|526736045|FG005|Overall Study|Efficacy outcome reached|2|||
146059391|NCT02234843|526736046|FG006|Overall Study|Efficacy outcome reached|0|||
146059392|NCT02234843|526736047|FG007|Overall Study|Efficacy outcome reached|0|||
146059393|NCT02234843|526736048|FG008|Overall Study|Efficacy outcome reached|0|||
146059394|NCT02234843|526736049|FG009|Overall Study|Efficacy outcome reached|0|||
146059395|NCT02234843|526736040|FG000|Overall Study|Patient convenience|2|||
146059396|NCT02234843|526736041|FG001|Overall Study|Patient convenience|0|||
146059397|NCT02234843|526736042|FG002|Overall Study|Patient convenience|0|||
146059398|NCT02234843|526736043|FG003|Overall Study|Patient convenience|0|||
146059399|NCT02234843|526736044|FG004|Overall Study|Patient convenience|0|||
146059400|NCT02234843|526736045|FG005|Overall Study|Patient convenience|1|||
146059401|NCT02234843|526736046|FG006|Overall Study|Patient convenience|0|||
146059402|NCT02234843|526736047|FG007|Overall Study|Patient convenience|0|||
146059403|NCT02234843|526736048|FG008|Overall Study|Patient convenience|0|||
146059404|NCT02234843|526736049|FG009|Overall Study|Patient convenience|0|||
146059405|NCT02234843|526736040|FG000|Overall Study|Withdrawal by Subject|5|||
146059406|NCT02234843|526736041|FG001|Overall Study|Withdrawal by Subject|1|||
146059407|NCT02234843|526736042|FG002|Overall Study|Withdrawal by Subject|1|||
146397436|NCT00948896|527958342|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146397437|NCT00948896|527958343|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146397438|NCT00948896|527958344|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
146397439|NCT00948896|527958337|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
146397440|NCT00948896|527958338|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146397441|NCT00948896|527958339|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
146397442|NCT00948896|527958340|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146397443|NCT00948896|527958341|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
146397444|NCT00948896|527958342|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146397445|NCT00948896|527958343|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146397446|NCT00948896|527958344|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
146397447|NCT00948896|527958337|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397448|NCT00948896|527958338|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397449|NCT00948896|527958339|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
146397450|NCT00948896|527958340|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397451|NCT00948896|527958341|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397452|NCT00948896|527958342|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
146397453|NCT00948896|527958343|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397454|NCT00948896|527958344|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
146397455|NCT00948896|527958337|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397456|NCT00948896|527958338|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397457|NCT00948896|527958339|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397458|NCT00948896|527958340|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
146397459|NCT00948896|527958341|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146059408|NCT02234843|526736043|FG003|Overall Study|Withdrawal by Subject|0|||
146059409|NCT02234843|526736044|FG004|Overall Study|Withdrawal by Subject|0|||
146059410|NCT02234843|526736045|FG005|Overall Study|Withdrawal by Subject|7|||
146059411|NCT02234843|526736046|FG006|Overall Study|Withdrawal by Subject|0|||
146059412|NCT02234843|526736047|FG007|Overall Study|Withdrawal by Subject|0|||
146059413|NCT02234843|526736048|FG008|Overall Study|Withdrawal by Subject|0|||
146059414|NCT02234843|526736049|FG009|Overall Study|Withdrawal by Subject|0|||
146059415|NCT02234843|526736040|FG000|Overall Study|Recovery|1|||
146059416|NCT02234843|526736041|FG001|Overall Study|Recovery|0|||
146059417|NCT02234843|526736042|FG002|Overall Study|Recovery|0|||
146059418|NCT02234843|526736043|FG003|Overall Study|Recovery|0|||
146059419|NCT02234843|526736044|FG004|Overall Study|Recovery|0|||
146059420|NCT02234843|526736045|FG005|Overall Study|Recovery|0|||
146059421|NCT02234843|526736046|FG006|Overall Study|Recovery|0|||
146059422|NCT02234843|526736047|FG007|Overall Study|Recovery|0|||
146059423|NCT02234843|526736048|FG008|Overall Study|Recovery|0|||
146059424|NCT02234843|526736049|FG009|Overall Study|Recovery|0|||
146059425|NCT02234843|526736040|FG000|Overall Study|Other|0|||
146059426|NCT02234843|526736041|FG001|Overall Study|Other|2|||
146059427|NCT02234843|526736042|FG002|Overall Study|Other|0|||
146059428|NCT02234843|526736043|FG003|Overall Study|Other|1|||
146059429|NCT02234843|526736044|FG004|Overall Study|Other|0|||
146059430|NCT02234843|526736045|FG005|Overall Study|Other|1|||
146059431|NCT02234843|526736046|FG006|Overall Study|Other|0|||
146059432|NCT02234843|526736047|FG007|Overall Study|Other|1|||
146059433|NCT02234843|526736048|FG008|Overall Study|Other|0|||
146059434|NCT02234843|526736049|FG009|Overall Study|Other|0|||
146059435|NCT02234843|526736040|FG000|Overall Study|Physician Decision|4|||
146059436|NCT02234843|526736041|FG001|Overall Study|Physician Decision|1|||
146059437|NCT02234843|526736042|FG002|Overall Study|Physician Decision|0|||
146059438|NCT02234843|526736043|FG003|Overall Study|Physician Decision|1|||
146059439|NCT02234843|526736044|FG004|Overall Study|Physician Decision|0|||
146059440|NCT02234843|526736045|FG005|Overall Study|Physician Decision|0|||
146059441|NCT02234843|526736046|FG006|Overall Study|Physician Decision|0|||
146059442|NCT02234843|526736047|FG007|Overall Study|Physician Decision|1|||
146059443|NCT02234843|526736048|FG008|Overall Study|Physician Decision|0|||
146059444|NCT02234843|526736049|FG009|Overall Study|Physician Decision|0|||
146059445|NCT02234843|526736040|FG000|Overall Study|Adverse Event|5|||
146059446|NCT02234843|526736041|FG001|Overall Study|Adverse Event|1|||
146059447|NCT02234843|526736042|FG002|Overall Study|Adverse Event|1|||
146059448|NCT02234843|526736043|FG003|Overall Study|Adverse Event|3|||
146059449|NCT02234843|526736044|FG004|Overall Study|Adverse Event|2|||
146059450|NCT02234843|526736045|FG005|Overall Study|Adverse Event|1|||
146059451|NCT02234843|526736046|FG006|Overall Study|Adverse Event|0|||
146059452|NCT02234843|526736047|FG007|Overall Study|Adverse Event|0|||
146059453|NCT02234843|526736048|FG008|Overall Study|Adverse Event|1|||
146059454|NCT02234843|526736049|FG009|Overall Study|Adverse Event|0|||
146059455|NCT02234843|526736040|FG000|Overall Study|Non-compliance with study drug|1|||
146059456|NCT02234843|526736041|FG001|Overall Study|Non-compliance with study drug|0|||
146059457|NCT02234843|526736042|FG002|Overall Study|Non-compliance with study drug|0|||
146059458|NCT02234843|526736043|FG003|Overall Study|Non-compliance with study drug|0|||
146059459|NCT02234843|526736044|FG004|Overall Study|Non-compliance with study drug|0|||
146059460|NCT02234843|526736045|FG005|Overall Study|Non-compliance with study drug|1|||
146059461|NCT02234843|526736046|FG006|Overall Study|Non-compliance with study drug|1|||
146059462|NCT02234843|526736047|FG007|Overall Study|Non-compliance with study drug|0|||
146059463|NCT02234843|526736048|FG008|Overall Study|Non-compliance with study drug|0|||
146059464|NCT02234843|526736049|FG009|Overall Study|Non-compliance with study drug|0|||
146059465|NCT02234843|526736040|FG000|Overall Study|Lost to Follow-up|0|||
146059466|NCT02234843|526736041|FG001|Overall Study|Lost to Follow-up|1|||
146059467|NCT02234843|526736042|FG002|Overall Study|Lost to Follow-up|0|||
146059468|NCT02234843|526736043|FG003|Overall Study|Lost to Follow-up|0|||
146397460|NCT00948896|527958342|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397461|NCT00948896|527958343|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397462|NCT00948896|527958344|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
146397463|NCT04678557|527958346|FG000|Overall Study|Withdrawal by Subject|1|||
146397464|NCT04678557|527958347|FG001|Overall Study|Withdrawal by Subject|0|||
146397465|NCT04678557|527958346|FG000|Overall Study|Lack of Efficacy|0|||
146397466|NCT04678557|527958347|FG001|Overall Study|Lack of Efficacy|13|||
146397467|NCT04678557|527958346|FG000|Overall Study|Safety Evaluation|0|||
146397468|NCT04678557|527958347|FG001|Overall Study|Safety Evaluation|1|||
146397469|NCT00157157|527958348|FG000|Overall Study|Withdrawal by Subject|6|||
146397470|NCT00157157|527958348|FG000|Overall Study|Physician Decision|1|||
146397471|NCT00157157|527958348|FG000|Overall Study|Lost to Follow-up|1|||
146397472|NCT00157157|527958348|FG000|Overall Study|Enrolled in another study|1|||
146397473|NCT00157157|527958348|FG000|Overall Study|Met exclusion criteria|1|||
146397474|NCT00157157|527958348|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
146397475|NCT02260804|527958353|FG000|Induction Study Period|Protocol Violation|2|||
146397476|NCT02260804|527958354|FG001|Induction Study Period|Protocol Violation|0|||
146397477|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
146059469|NCT02234843|526736044|FG004|Overall Study|Lost to Follow-up|0|||
146059470|NCT02234843|526736045|FG005|Overall Study|Lost to Follow-up|0|||
146059471|NCT02234843|526736046|FG006|Overall Study|Lost to Follow-up|1|||
146059472|NCT02234843|526736047|FG007|Overall Study|Lost to Follow-up|0|||
146059473|NCT02234843|526736048|FG008|Overall Study|Lost to Follow-up|0|||
146059474|NCT02234843|526736049|FG009|Overall Study|Lost to Follow-up|0|||
146059475|NCT00506350|526736052|FG000|Overall Study|Serious Adverse Event|1|||
146059476|NCT00506350|526736053|FG001|Overall Study|Serious Adverse Event|0|||
146059477|NCT00506350|526736054|FG002|Overall Study|Serious Adverse Event|0|||
146059478|NCT00506350|526736055|FG003|Overall Study|Serious Adverse Event|0|||
146059479|NCT00506350|526736056|FG004|Overall Study|Serious Adverse Event|0|||
146059480|NCT00506350|526736057|FG005|Overall Study|Serious Adverse Event|0|||
146397478|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
146397479|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
146397480|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
146397481|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
146397482|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
146397483|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
146397484|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
146059481|NCT00506350|526736058|FG006|Overall Study|Serious Adverse Event|0|||
146059482|NCT00506350|526736059|FG007|Overall Study|Serious Adverse Event|0|||
146059483|NCT00506350|526736060|FG008|Overall Study|Serious Adverse Event|0|||
146059484|NCT00506350|526736052|FG000|Overall Study|Adverse Event|0|||
146059485|NCT00506350|526736053|FG001|Overall Study|Adverse Event|0|||
146059486|NCT00506350|526736054|FG002|Overall Study|Adverse Event|0|||
146059487|NCT00506350|526736055|FG003|Overall Study|Adverse Event|0|||
146059488|NCT00506350|526736056|FG004|Overall Study|Adverse Event|0|||
146059489|NCT00506350|526736057|FG005|Overall Study|Adverse Event|0|||
146059490|NCT00506350|526736058|FG006|Overall Study|Adverse Event|0|||
146059491|NCT00506350|526736059|FG007|Overall Study|Adverse Event|1|||
146059492|NCT00506350|526736060|FG008|Overall Study|Adverse Event|1|||
146059493|NCT00506350|526736052|FG000|Overall Study|Protocol Violation|0|||
146059494|NCT00506350|526736053|FG001|Overall Study|Protocol Violation|0|||
146059495|NCT00506350|526736054|FG002|Overall Study|Protocol Violation|1|||
146059496|NCT00506350|526736055|FG003|Overall Study|Protocol Violation|0|||
146059497|NCT00506350|526736056|FG004|Overall Study|Protocol Violation|0|||
146059498|NCT00506350|526736057|FG005|Overall Study|Protocol Violation|0|||
146059499|NCT00506350|526736058|FG006|Overall Study|Protocol Violation|1|||
146059500|NCT00506350|526736059|FG007|Overall Study|Protocol Violation|0|||
146059501|NCT00506350|526736060|FG008|Overall Study|Protocol Violation|0|||
146059502|NCT00506350|526736052|FG000|Overall Study|Withdrawal by Subject|0|||
146059503|NCT00506350|526736053|FG001|Overall Study|Withdrawal by Subject|1|||
146059504|NCT00506350|526736054|FG002|Overall Study|Withdrawal by Subject|1|||
146397485|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
146059505|NCT00506350|526736055|FG003|Overall Study|Withdrawal by Subject|1|||
146059506|NCT00506350|526736056|FG004|Overall Study|Withdrawal by Subject|4|||
146059507|NCT00506350|526736057|FG005|Overall Study|Withdrawal by Subject|1|||
146059508|NCT00506350|526736058|FG006|Overall Study|Withdrawal by Subject|1|||
146059509|NCT00506350|526736059|FG007|Overall Study|Withdrawal by Subject|2|||
146059510|NCT00506350|526736060|FG008|Overall Study|Withdrawal by Subject|0|||
146059511|NCT00506350|526736052|FG000|Overall Study|Lost to Follow-up|1|||
146059512|NCT00506350|526736053|FG001|Overall Study|Lost to Follow-up|1|||
146059513|NCT00506350|526736054|FG002|Overall Study|Lost to Follow-up|1|||
146059514|NCT00506350|526736055|FG003|Overall Study|Lost to Follow-up|1|||
146059515|NCT00506350|526736056|FG004|Overall Study|Lost to Follow-up|2|||
146059516|NCT00506350|526736057|FG005|Overall Study|Lost to Follow-up|1|||
146059517|NCT00506350|526736058|FG006|Overall Study|Lost to Follow-up|0|||
146059518|NCT00506350|526736059|FG007|Overall Study|Lost to Follow-up|0|||
146059519|NCT00506350|526736060|FG008|Overall Study|Lost to Follow-up|2|||
146059520|NCT00506350|526736052|FG000|Overall Study|Medical Reason|0|||
146059521|NCT00506350|526736053|FG001|Overall Study|Medical Reason|0|||
146059522|NCT00506350|526736054|FG002|Overall Study|Medical Reason|0|||
146059523|NCT00506350|526736055|FG003|Overall Study|Medical Reason|0|||
146059524|NCT00506350|526736056|FG004|Overall Study|Medical Reason|1|||
146059525|NCT00506350|526736057|FG005|Overall Study|Medical Reason|0|||
146059526|NCT00506350|526736058|FG006|Overall Study|Medical Reason|0|||
146059527|NCT00506350|526736059|FG007|Overall Study|Medical Reason|0|||
146059528|NCT00506350|526736060|FG008|Overall Study|Medical Reason|0|||
146059529|NCT00506350|526736052|FG000|Overall Study|Other|1|||
146059530|NCT00506350|526736053|FG001|Overall Study|Other|1|||
146059531|NCT00506350|526736054|FG002|Overall Study|Other|3|||
146059532|NCT00506350|526736055|FG003|Overall Study|Other|0|||
146059533|NCT00506350|526736056|FG004|Overall Study|Other|3|||
146059534|NCT00506350|526736057|FG005|Overall Study|Other|0|||
146059535|NCT00506350|526736058|FG006|Overall Study|Other|0|||
146059536|NCT00506350|526736059|FG007|Overall Study|Other|2|||
146059537|NCT00506350|526736060|FG008|Overall Study|Other|2|||
146059538|NCT03474588|526736061|FG000|Overall Study|Withdrawal by Subject|4|||
146059539|NCT03474588|526736062|FG001|Overall Study|Withdrawal by Subject|3|||
146059540|NCT03474588|526736061|FG000|Overall Study|Death|0|||
146059541|NCT03474588|526736062|FG001|Overall Study|Death|1|||
146059542|NCT01691794|526736064|FG000|Overall Study|Poor/Non-Compliance|1|||
146059543|NCT01691794|526736065|FG001|Overall Study|Poor/Non-Compliance|4|||
146059544|NCT01691794|526736066|FG002|Overall Study|Poor/Non-Compliance|1|||
146059545|NCT01691794|526736064|FG000|Overall Study|Death|0|||
146059546|NCT01691794|526736065|FG001|Overall Study|Death|0|||
146059547|NCT01691794|526736066|FG002|Overall Study|Death|1|||
146059548|NCT01691794|526736064|FG000|Overall Study|Lack of Efficacy|0|||
146059549|NCT01691794|526736065|FG001|Overall Study|Lack of Efficacy|7|||
146059550|NCT01691794|526736066|FG002|Overall Study|Lack of Efficacy|1|||
146059551|NCT01691794|526736064|FG000|Overall Study|Participant request to discontinue|0|||
146059552|NCT01691794|526736065|FG001|Overall Study|Participant request to discontinue|1|||
146059553|NCT01691794|526736066|FG002|Overall Study|Participant request to discontinue|0|||
146059554|NCT01691794|526736064|FG000|Overall Study|Adverse Event|0|||
146059555|NCT01691794|526736065|FG001|Overall Study|Adverse Event|1|||
146059556|NCT01691794|526736066|FG002|Overall Study|Adverse Event|1|||
146059557|NCT01691794|526736064|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
146283798|NCT00686725|527551853|FG001|Overall Study|Withdrawal by Subject|4|||
146283799|NCT00686725|527551852|FG000|Overall Study|Protocol Violation|1|||
146283800|NCT00686725|527551853|FG001|Overall Study|Protocol Violation|3|||
146283801|NCT00686725|527551852|FG000|Overall Study|Other|1|||
146283802|NCT00686725|527551853|FG001|Overall Study|Other|3|||
146283803|NCT00092495|527551854|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
146283804|NCT00092495|527551855|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
146283805|NCT00092495|527551856|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146283806|NCT00092495|527551857|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
146283807|NCT00092495|527551858|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146283808|NCT00092495|527551854|FG000|Base Study Vaccination Period|Extended|0|||
146283809|NCT00092495|527551855|FG001|Base Study Vaccination Period|Extended|0|||
146283810|NCT00092495|527551856|FG002|Base Study Vaccination Period|Extended|0|||
146283811|NCT00092495|527551857|FG003|Base Study Vaccination Period|Extended|1|||
146283812|NCT00092495|527551858|FG004|Base Study Vaccination Period|Extended|0|||
146283813|NCT00092495|527551854|FG000|Base Study Vaccination Period|*Clinical AE|1|||
146283814|NCT00092495|527551855|FG001|Base Study Vaccination Period|*Clinical AE|0|||
146283815|NCT00092495|527551856|FG002|Base Study Vaccination Period|*Clinical AE|1|||
146283816|NCT00092495|527551857|FG003|Base Study Vaccination Period|*Clinical AE|2|||
146283817|NCT00092495|527551858|FG004|Base Study Vaccination Period|*Clinical AE|0|||
146283818|NCT00092495|527551854|FG000|Base Study Vaccination Period|*Other reasons|1|||
146283819|NCT00092495|527551855|FG001|Base Study Vaccination Period|*Other reasons|0|||
146283820|NCT00092495|527551856|FG002|Base Study Vaccination Period|*Other reasons|0|||
146283821|NCT00092495|527551857|FG003|Base Study Vaccination Period|*Other reasons|1|||
146283822|NCT00092495|527551858|FG004|Base Study Vaccination Period|*Other reasons|0|||
146283823|NCT00092495|527551854|FG000|Base Study Vaccination Period|*Pregnancy|0|||
146283824|NCT00092495|527551855|FG001|Base Study Vaccination Period|*Pregnancy|2|||
146283825|NCT00092495|527551856|FG002|Base Study Vaccination Period|*Pregnancy|5|||
146059558|NCT01691794|526736065|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
146059559|NCT01691794|526736066|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
146059560|NCT01691794|526736064|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
146059561|NCT01691794|526736065|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
146059562|NCT01691794|526736066|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
146059563|NCT00844844|526736069|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
146059564|NCT00844844|526736069|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
146059565|NCT00844844|526736069|FG000|Extension Treatment Period|Adverse Event|2|||
146059566|NCT00844844|526736069|FG000|Post Treatment Period|Withdrawal by Subject|1|||
146059567|NCT00945009|526736070|FG000|Overall Study|Lack of Efficacy|10|||
146059568|NCT00945009|526736071|FG001|Overall Study|Lack of Efficacy|0|||
146059569|NCT00945009|526736072|FG002|Overall Study|Lack of Efficacy|0|||
146059570|NCT00945009|526736070|FG000|Overall Study|Physician Decision|21|||
146059571|NCT00945009|526736071|FG001|Overall Study|Physician Decision|4|||
146059572|NCT00945009|526736072|FG002|Overall Study|Physician Decision|3|||
146059573|NCT00945009|526736070|FG000|Overall Study|Protocol Violation|6|||
146059574|NCT00945009|526736071|FG001|Overall Study|Protocol Violation|1|||
146059575|NCT00945009|526736072|FG002|Overall Study|Protocol Violation|0|||
146059576|NCT00945009|526736070|FG000|Overall Study|Withdrawal by Subject|1|||
146059577|NCT00945009|526736071|FG001|Overall Study|Withdrawal by Subject|0|||
146059578|NCT00945009|526736072|FG002|Overall Study|Withdrawal by Subject|0|||
146059579|NCT00945009|526736070|FG000|Overall Study|Ineligible|6|||
146059580|NCT00945009|526736071|FG001|Overall Study|Ineligible|1|||
146059581|NCT00945009|526736072|FG002|Overall Study|Ineligible|0|||
146059582|NCT00945009|526736070|FG000|Overall Study|Inevaluable|0|||
146059583|NCT00945009|526736071|FG001|Overall Study|Inevaluable|1|||
146059584|NCT00945009|526736072|FG002|Overall Study|Inevaluable|0|||
146059585|NCT00945009|526736070|FG000|Overall Study|Refusal of further protocol|1|||
146059586|NCT00945009|526736071|FG001|Overall Study|Refusal of further protocol|0|||
146059587|NCT00945009|526736072|FG002|Overall Study|Refusal of further protocol|0|||
146059588|NCT04886154|526736073|FG000|Overall Study|Adverse Event|0|||
146059589|NCT04886154|526736074|FG001|Overall Study|Adverse Event|0|||
146059590|NCT04886154|526736075|FG002|Overall Study|Adverse Event|0|||
146059591|NCT04886154|526736076|FG003|Overall Study|Adverse Event|0|||
146059592|NCT04886154|526736077|FG004|Overall Study|Adverse Event|1|||
146059593|NCT04886154|526736078|FG005|Overall Study|Adverse Event|0|||
146059594|NCT04886154|526736079|FG006|Overall Study|Adverse Event|0|||
146059595|NCT04886154|526736080|FG007|Overall Study|Adverse Event|1|||
146059596|NCT04886154|526736081|FG008|Overall Study|Adverse Event|1|||
146059597|NCT04886154|526736082|FG009|Overall Study|Adverse Event|0|||
146059598|NCT04886154|526736083|FG010|Overall Study|Adverse Event|0|||
146059599|NCT04886154|526736084|FG011|Overall Study|Adverse Event|1|||
146059600|NCT04886154|526736085|FG012|Overall Study|Adverse Event|0|||
146059601|NCT04886154|526736086|FG013|Overall Study|Adverse Event|0|||
146059602|NCT04886154|526736087|FG014|Overall Study|Adverse Event|3|||
146059603|NCT04886154|526736073|FG000|Overall Study|Lost to Follow-up|1|||
146059604|NCT04886154|526736074|FG001|Overall Study|Lost to Follow-up|0|||
146059605|NCT04886154|526736075|FG002|Overall Study|Lost to Follow-up|2|||
146059606|NCT04886154|526736076|FG003|Overall Study|Lost to Follow-up|0|||
146059607|NCT04886154|526736077|FG004|Overall Study|Lost to Follow-up|17|||
146059608|NCT04886154|526736078|FG005|Overall Study|Lost to Follow-up|7|||
146059609|NCT04886154|526736079|FG006|Overall Study|Lost to Follow-up|8|||
146059610|NCT04886154|526736080|FG007|Overall Study|Lost to Follow-up|7|||
146059611|NCT04886154|526736081|FG008|Overall Study|Lost to Follow-up|8|||
146059612|NCT04886154|526736082|FG009|Overall Study|Lost to Follow-up|0|||
146059613|NCT04886154|526736083|FG010|Overall Study|Lost to Follow-up|2|||
146059614|NCT04886154|526736084|FG011|Overall Study|Lost to Follow-up|0|||
146059615|NCT04886154|526736085|FG012|Overall Study|Lost to Follow-up|0|||
146059616|NCT04886154|526736086|FG013|Overall Study|Lost to Follow-up|0|||
146059617|NCT04886154|526736087|FG014|Overall Study|Lost to Follow-up|0|||
146059618|NCT04886154|526736073|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059619|NCT04886154|526736074|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059620|NCT04886154|526736075|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059621|NCT04886154|526736076|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059622|NCT04886154|526736077|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059623|NCT04886154|526736078|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059624|NCT04886154|526736079|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
146059625|NCT04886154|526736080|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059626|NCT04886154|526736081|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059627|NCT04886154|526736082|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059628|NCT04886154|526736083|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059629|NCT04886154|526736084|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059630|NCT04886154|526736085|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059631|NCT04886154|526736086|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059632|NCT04886154|526736087|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
146059633|NCT04886154|526736073|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146397486|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
146397487|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
146397488|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
146397489|NCT02260804|527958353|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
146397490|NCT02260804|527958354|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
146397491|NCT02260804|527958353|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
146397492|NCT02260804|527958354|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
146397493|NCT02260804|527958353|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
146397494|NCT02260804|527958354|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
146397495|NCT02260804|527958353|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
146397496|NCT02260804|527958354|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
146397497|NCT02983305|527960016|FG000|Overall Study|incomplete data|2|||
146397498|NCT02983305|527960017|FG001|Overall Study|incomplete data|0|||
146397499|NCT00822237|527960018|FG000|Dose 1 Vaccination|Not vaccinated|3|||
146397500|NCT00822237|527960019|FG001|Dose 1 Vaccination|Not vaccinated|0|||
146397501|NCT00822237|527960018|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
146397502|NCT00822237|527960019|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
146397503|NCT00822237|527960018|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
146397504|NCT00822237|527960019|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
146397505|NCT00822237|527960018|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
146397506|NCT00822237|527960019|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
146397507|NCT00822237|527960018|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
146397508|NCT00822237|527960019|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
146397509|NCT01519635|527960020|FG000|Overall Study|Withdrawal by Subject|0|||
146397510|NCT01519635|527960021|FG001|Overall Study|Withdrawal by Subject|1|||
146397511|NCT01519635|527960020|FG000|Overall Study|No possibility to put a catheter|1|||
146397512|NCT01519635|527960021|FG001|Overall Study|No possibility to put a catheter|2|||
146397513|NCT00812968|527960022|FG000|Overall Study|Relapse after erythroid response|6|||
146397514|NCT00812968|527960022|FG000|Overall Study|Disease progression|1|||
146397515|NCT00812968|527960022|FG000|Overall Study|No further treatment required|1|||
146397516|NCT00812968|527960022|FG000|Overall Study|Study closed due to marketing approval|3|||
146397517|NCT01298362|527960026|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
146397518|NCT01298362|527960027|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
146397519|NCT00505765|527960034|FG000|Overall Study|Withdrawal by Subject|1|||
146397520|NCT00505765|527960035|FG001|Overall Study|Withdrawal by Subject|0|||
146397521|NCT00505765|527960036|FG002|Overall Study|Withdrawal by Subject|0|||
146397522|NCT00505765|527960034|FG000|Overall Study|Adverse Event|1|||
146397523|NCT00505765|527960035|FG001|Overall Study|Adverse Event|2|||
146397524|NCT00505765|527960036|FG002|Overall Study|Adverse Event|0|||
146397525|NCT00505765|527960034|FG000|Overall Study|Noncompliance|0|||
146397526|NCT00505765|527960035|FG001|Overall Study|Noncompliance|1|||
146397527|NCT00505765|527960036|FG002|Overall Study|Noncompliance|3|||
146397528|NCT01207219|527960038|FG000|Overall Study|changed diagnosis during study period|5|||
146397529|NCT01207219|527960039|FG001|Overall Study|changed diagnosis during study period|3|||
146397530|NCT01207219|527960040|FG002|Overall Study|changed diagnosis during study period|1|||
146397531|NCT01207219|527960038|FG000|Overall Study|Lost to Follow-up|6|||
146397532|NCT01207219|527960039|FG001|Overall Study|Lost to Follow-up|8|||
146397533|NCT01207219|527960040|FG002|Overall Study|Lost to Follow-up|6|||
146397534|NCT00620776|527960041|FG000|Overall Study|Did not receive treatment|3|||
146397535|NCT00620776|527960042|FG001|Overall Study|Did not receive treatment|5|||
146397536|NCT00620776|527960041|FG000|Overall Study|Adverse Event|2|||
146397537|NCT00620776|527960042|FG001|Overall Study|Adverse Event|3|||
146397538|NCT00620776|527960041|FG000|Overall Study|Lack of Efficacy|2|||
146397539|NCT00620776|527960042|FG001|Overall Study|Lack of Efficacy|1|||
146397540|NCT00620776|527960041|FG000|Overall Study|Lost to Follow-up|2|||
146397541|NCT00620776|527960042|FG001|Overall Study|Lost to Follow-up|5|||
146397542|NCT00620776|527960041|FG000|Overall Study|Withdrawal by Subject|3|||
146397543|NCT00620776|527960042|FG001|Overall Study|Withdrawal by Subject|2|||
146397544|NCT00183170|527960045|FG000|First Intervention|Did not complete study|1|||
146397545|NCT00183170|527960046|FG001|First Intervention|Did not complete study|0|||
146397546|NCT00183170|527960045|FG000|First Intervention|Did not meet targeted BrAC|1|||
146397547|NCT00183170|527960046|FG001|First Intervention|Did not meet targeted BrAC|0|||
146397548|NCT00183170|527960045|FG000|Washout 1 Week|Did not complete study|6|||
146397549|NCT00183170|527960046|FG001|Washout 1 Week|Did not complete study|8|||
146397550|NCT00183170|527960045|FG000|Second Intervention|Did not complete study|1|||
146397551|NCT00183170|527960046|FG001|Second Intervention|Did not complete study|0|||
146397552|NCT00183170|527960045|FG000|Second Intervention|Did not meet targeted BrAC|0|||
146397553|NCT00183170|527960046|FG001|Second Intervention|Did not meet targeted BrAC|2|||
146397554|NCT00924820|527960047|FG000|Overall Study|Death|2|||
146397555|NCT00924820|527960047|FG000|Overall Study|Ineligible, Screen Failure|5|||
146397556|NCT00761969|527960048|FG000|Overall Study|Death|112|||
146397557|NCT00761969|527960049|FG001|Overall Study|Death|47|||
146397558|NCT00761969|527960048|FG000|Overall Study|Lost to Follow-up|88|||
146397559|NCT00761969|527960049|FG001|Overall Study|Lost to Follow-up|93|||
146397560|NCT01725217|527960050|FG000|Overall Study|Withdrawal by Subject|1|||
146397561|NCT01725217|527960051|FG001|Overall Study|Withdrawal by Subject|0|||
146397562|NCT01725217|527960052|FG002|Overall Study|Withdrawal by Subject|0|||
146397563|NCT03992456|527960055|FG000|Overall Study|Withdrawal by Subject|1|||
146397564|NCT03992456|527960056|FG001|Overall Study|Withdrawal by Subject|0|||
146397565|NCT03992456|527960055|FG000|Overall Study|Disease progression|4|||
146397566|NCT03992456|527960056|FG001|Overall Study|Disease progression|5|||
146397567|NCT03992456|527960055|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
146397568|NCT03992456|527960056|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
146397569|NCT01068418|527960057|FG000|Overall Study|Physician Decision|12|||
146397570|NCT00910000|527960058|FG000|Overall Study|Adverse Event|0|||
146397571|NCT00910000|527960059|FG001|Overall Study|Adverse Event|3|||
146397572|NCT00910000|527960060|FG002|Overall Study|Adverse Event|2|||
146397573|NCT00910000|527960061|FG003|Overall Study|Adverse Event|2|||
146397574|NCT00910000|527960062|FG004|Overall Study|Adverse Event|0|||
146397575|NCT00910000|527960063|FG005|Overall Study|Adverse Event|1|||
146397576|NCT00910000|527960058|FG000|Overall Study|Withdrawal by Subject|0|||
146397577|NCT00910000|527960059|FG001|Overall Study|Withdrawal by Subject|0|||
146397578|NCT00910000|527960060|FG002|Overall Study|Withdrawal by Subject|1|||
146397579|NCT00910000|527960061|FG003|Overall Study|Withdrawal by Subject|0|||
146397580|NCT00910000|527960062|FG004|Overall Study|Withdrawal by Subject|1|||
146397581|NCT00910000|527960063|FG005|Overall Study|Withdrawal by Subject|0|||
146397582|NCT04637815|527960064|FG000|Overall Study|Death|1|||
146397583|NCT04637815|527960065|FG001|Overall Study|Death|0|||
146397584|NCT04637815|527960064|FG000|Overall Study|Lost to Follow-up|5|||
146397585|NCT04637815|527960065|FG001|Overall Study|Lost to Follow-up|2|||
146397586|NCT01977625|527960066|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
146397587|NCT01977625|527960067|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146397588|NCT01977625|527960066|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146397589|NCT01977625|527960067|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146397590|NCT02594384|527960068|FG000|Overall Study|Disease Progression|3|||
146397591|NCT02594384|527960069|FG001|Overall Study|Disease Progression|7|||
146397592|NCT02594384|527960070|FG002|Overall Study|Disease Progression|0|||
146397593|NCT02594384|527960071|FG003|Overall Study|Disease Progression|2|||
146397594|NCT02594384|527960072|FG004|Overall Study|Disease Progression|2|||
146397595|NCT02594384|527960073|FG005|Overall Study|Disease Progression|12|||
146397596|NCT02594384|527960074|FG006|Overall Study|Disease Progression|5|||
146397597|NCT02594384|527960075|FG007|Overall Study|Disease Progression|5|||
146397598|NCT02594384|527960068|FG000|Overall Study|Adverse Event|0|||
146397599|NCT02594384|527960069|FG001|Overall Study|Adverse Event|1|||
146397600|NCT02594384|527960070|FG002|Overall Study|Adverse Event|4|||
146397601|NCT02594384|527960071|FG003|Overall Study|Adverse Event|1|||
146397602|NCT02594384|527960072|FG004|Overall Study|Adverse Event|0|||
146397603|NCT02594384|527960073|FG005|Overall Study|Adverse Event|6|||
146397604|NCT02594384|527960074|FG006|Overall Study|Adverse Event|1|||
146397605|NCT02594384|527960075|FG007|Overall Study|Adverse Event|1|||
146397606|NCT02594384|527960068|FG000|Overall Study|Withdrawal by Subject|0|||
146397607|NCT02594384|527960069|FG001|Overall Study|Withdrawal by Subject|0|||
146397608|NCT02594384|527960070|FG002|Overall Study|Withdrawal by Subject|0|||
146397609|NCT02594384|527960071|FG003|Overall Study|Withdrawal by Subject|1|||
146397610|NCT02594384|527960072|FG004|Overall Study|Withdrawal by Subject|0|||
146397611|NCT02594384|527960073|FG005|Overall Study|Withdrawal by Subject|0|||
146397612|NCT02594384|527960074|FG006|Overall Study|Withdrawal by Subject|0|||
146397613|NCT02594384|527960075|FG007|Overall Study|Withdrawal by Subject|1|||
146397614|NCT02594384|527960068|FG000|Overall Study|Physician Decision|0|||
146397615|NCT02594384|527960069|FG001|Overall Study|Physician Decision|0|||
146397616|NCT02594384|527960070|FG002|Overall Study|Physician Decision|0|||
146397617|NCT02594384|527960071|FG003|Overall Study|Physician Decision|0|||
146397618|NCT02594384|527960072|FG004|Overall Study|Physician Decision|0|||
146397619|NCT02594384|527960073|FG005|Overall Study|Physician Decision|1|||
146397620|NCT02594384|527960074|FG006|Overall Study|Physician Decision|2|||
146397621|NCT02594384|527960075|FG007|Overall Study|Physician Decision|0|||
146397622|NCT02594384|527960068|FG000|Overall Study|Progressive Leukocytosis|0|||
146397623|NCT02594384|527960069|FG001|Overall Study|Progressive Leukocytosis|0|||
146397624|NCT02594384|527960070|FG002|Overall Study|Progressive Leukocytosis|1|||
146397625|NCT02594384|527960071|FG003|Overall Study|Progressive Leukocytosis|0|||
146397626|NCT02594384|527960072|FG004|Overall Study|Progressive Leukocytosis|0|||
146397627|NCT02594384|527960073|FG005|Overall Study|Progressive Leukocytosis|0|||
146397628|NCT02594384|527960074|FG006|Overall Study|Progressive Leukocytosis|0|||
146397629|NCT02594384|527960075|FG007|Overall Study|Progressive Leukocytosis|0|||
146397630|NCT02594384|527960068|FG000|Overall Study|Lack of Efficacy|0|||
146397631|NCT02594384|527960069|FG001|Overall Study|Lack of Efficacy|0|||
146397632|NCT02594384|527960070|FG002|Overall Study|Lack of Efficacy|0|||
146397633|NCT02594384|527960071|FG003|Overall Study|Lack of Efficacy|0|||
146397634|NCT02594384|527960072|FG004|Overall Study|Lack of Efficacy|1|||
146397635|NCT02594384|527960073|FG005|Overall Study|Lack of Efficacy|0|||
146397636|NCT02594384|527960074|FG006|Overall Study|Lack of Efficacy|0|||
146397637|NCT02594384|527960075|FG007|Overall Study|Lack of Efficacy|0|||
146059634|NCT04886154|526736074|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059635|NCT04886154|526736075|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059636|NCT04886154|526736076|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059637|NCT04886154|526736077|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146059638|NCT04886154|526736078|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059639|NCT04886154|526736079|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
146059640|NCT04886154|526736080|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146059641|NCT04886154|526736081|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059642|NCT04886154|526736082|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059643|NCT04886154|526736083|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059644|NCT04886154|526736084|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059645|NCT04886154|526736085|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059646|NCT04886154|526736086|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146059647|NCT04886154|526736087|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146059648|NCT04886154|526736073|FG000|Overall Study|Other, Not Specified|0|||
146059649|NCT04886154|526736074|FG001|Overall Study|Other, Not Specified|0|||
146059650|NCT04886154|526736075|FG002|Overall Study|Other, Not Specified|0|||
146059651|NCT04886154|526736076|FG003|Overall Study|Other, Not Specified|0|||
146059652|NCT04886154|526736077|FG004|Overall Study|Other, Not Specified|11|||
146059653|NCT04886154|526736078|FG005|Overall Study|Other, Not Specified|8|||
146059654|NCT04886154|526736079|FG006|Overall Study|Other, Not Specified|9|||
146059655|NCT04886154|526736080|FG007|Overall Study|Other, Not Specified|10|||
146059656|NCT04886154|526736081|FG008|Overall Study|Other, Not Specified|6|||
146059657|NCT04886154|526736082|FG009|Overall Study|Other, Not Specified|1|||
146059658|NCT04886154|526736083|FG010|Overall Study|Other, Not Specified|1|||
146059659|NCT04886154|526736084|FG011|Overall Study|Other, Not Specified|2|||
146059660|NCT04886154|526736085|FG012|Overall Study|Other, Not Specified|1|||
146059661|NCT04886154|526736086|FG013|Overall Study|Other, Not Specified|2|||
146059662|NCT04886154|526736087|FG014|Overall Study|Other, Not Specified|3|||
146059663|NCT03919773|526736096|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
146059664|NCT03919773|526736097|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
146059665|NCT03919773|526736096|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
146059666|NCT03919773|526736097|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
146059667|NCT04659044|526736098|FG000|Induction|Physician Decision|1|||
146059668|NCT04659044|526736098|FG000|Induction|Adverse Event|2|||
146059669|NCT04966013|526736099|FG000|Overall Study|Withdrawal by Subject|0|||
146059670|NCT04966013|526736100|FG001|Overall Study|Withdrawal by Subject|2|||
146059671|NCT04966013|526736101|FG002|Overall Study|Withdrawal by Subject|1|||
146059672|NCT04966013|526736099|FG000|Overall Study|Adverse Event|2|||
146059673|NCT04966013|526736100|FG001|Overall Study|Adverse Event|1|||
146059674|NCT04966013|526736101|FG002|Overall Study|Adverse Event|1|||
146059675|NCT02336282|526736105|FG000|Overall Study|Unrelated illness|1|||
146059676|NCT02336282|526736105|FG000|Overall Study|Uncomfortable with technology|1|||
146059677|NCT02336282|526736105|FG000|Overall Study|Lost to Follow-up|1|||
146059678|NCT02336282|526736105|FG000|Overall Study|Not enough time to complete sessions|2|||
146059679|NCT04875975|526736121|FG000|Overall Study|Adverse Event|1|||
146059680|NCT04875975|526736122|FG001|Overall Study|Adverse Event|2|||
146059681|NCT04875975|526736121|FG000|Overall Study|Lack of Efficacy|2|||
146059682|NCT04875975|526736122|FG001|Overall Study|Lack of Efficacy|2|||
146059683|NCT04875975|526736121|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
146059684|NCT04875975|526736122|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
146059685|NCT04875975|526736121|FG000|Overall Study|Relapse With Insults|0|||
146059686|NCT04875975|526736122|FG001|Overall Study|Relapse With Insults|1|||
146059687|NCT04875975|526736121|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
146059688|NCT04875975|526736122|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
146283826|NCT00092495|527551857|FG003|Base Study Vaccination Period|*Pregnancy|7|||
146283827|NCT00092495|527551858|FG004|Base Study Vaccination Period|*Pregnancy|0|||
146283828|NCT00092495|527551854|FG000|Base Study Vaccination Period|Adverse Event|1|||
146283829|NCT00092495|527551855|FG001|Base Study Vaccination Period|Adverse Event|0|||
146283830|NCT00092495|527551856|FG002|Base Study Vaccination Period|Adverse Event|0|||
146283831|NCT00092495|527551857|FG003|Base Study Vaccination Period|Adverse Event|3|||
146283832|NCT00092495|527551858|FG004|Base Study Vaccination Period|Adverse Event|0|||
146283833|NCT00092495|527551854|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
146283834|NCT00092495|527551855|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
146283835|NCT00092495|527551856|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
146283836|NCT00092495|527551857|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
146283837|NCT00092495|527551858|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146283838|NCT00092495|527551854|FG000|Base Study Vaccination Period|Moved|3|||
146283839|NCT00092495|527551855|FG001|Base Study Vaccination Period|Moved|1|||
146283840|NCT00092495|527551856|FG002|Base Study Vaccination Period|Moved|2|||
146283841|NCT00092495|527551857|FG003|Base Study Vaccination Period|Moved|2|||
146283842|NCT00092495|527551858|FG004|Base Study Vaccination Period|Moved|0|||
146059689|NCT00904969|526737439|FG000|Overall Study|Lost to Follow-up|4|||
146059690|NCT00904969|526737439|FG000|Overall Study|Withdrawal by Subject|3|||
146059691|NCT00904969|526737439|FG000|Overall Study|Additional Treatments|11|||
146059692|NCT00904969|526737439|FG000|Overall Study|Case Aborted; Subject Exited|1|||
146059693|NCT00755183|526737447|FG000|Overall Study|Adverse Event|5|||
146059694|NCT00755183|526737448|FG001|Overall Study|Adverse Event|2|||
146059695|NCT00755183|526737447|FG000|Overall Study|Protocol Violation|0|||
146059696|NCT00755183|526737448|FG001|Overall Study|Protocol Violation|1|||
146059697|NCT00755183|526737447|FG000|Overall Study|Withdrawal by Subject|0|||
146059698|NCT00755183|526737448|FG001|Overall Study|Withdrawal by Subject|2|||
146059699|NCT00755183|526737447|FG000|Overall Study|Administrative|2|||
146059700|NCT00755183|526737448|FG001|Overall Study|Administrative|1|||
146059701|NCT00804908|526737450|FG000|Overall Study|Other|115|||
146059702|NCT00804908|526737451|FG001|Overall Study|Other|116|||
146059703|NCT00804908|526737452|FG002|Overall Study|Other|114|||
146059704|NCT02177695|526737453|FG000|ITT Analysis|Ineligible|5|||
146059705|NCT02177695|526737454|FG001|ITT Analysis|Ineligible|5|||
146059706|NCT02177695|526737453|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
146059707|NCT02177695|526737454|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
146059708|NCT02177695|526737453|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
146059709|NCT02177695|526737454|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
146059710|NCT02177695|526737453|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
146059711|NCT02177695|526737454|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
146059712|NCT00248625|526737457|FG000|Overall Study|Withdrawal by Subject|0|||
146059713|NCT00248625|526737458|FG001|Overall Study|Withdrawal by Subject|2|||
146059714|NCT05176314|526737465|FG000|Overall Study|Lost to Follow-up|2|||
146059715|NCT05176314|526737465|FG000|Overall Study|Physician Decision|1|||
146059716|NCT05176314|526737465|FG000|Overall Study|Adverse Event|1|||
146059717|NCT03103542|526737470|FG000|Overall Study|Physician Decision|2|||
146059718|NCT03103542|526737470|FG000|Overall Study|Adverse Event|2|||
146059719|NCT03103542|526737470|FG000|Overall Study|Other|2|||
146059720|NCT03103542|526737470|FG000|Overall Study|Withdrawal by Subject|1|||
146059721|NCT02939287|526737474|FG000|Overall Study|met exclusion criteria|1|||
146059722|NCT02939287|526737475|FG001|Overall Study|met exclusion criteria|1|||
146059723|NCT02939287|526737476|FG002|Overall Study|met exclusion criteria|1|||
146059724|NCT02939287|526737474|FG000|Overall Study|Did not complete survey|2|||
146059725|NCT02939287|526737475|FG001|Overall Study|Did not complete survey|2|||
146059726|NCT02939287|526737476|FG002|Overall Study|Did not complete survey|0|||
146059727|NCT02939287|526737474|FG000|Overall Study|Withdrawal by Subject|1|||
146059728|NCT02939287|526737475|FG001|Overall Study|Withdrawal by Subject|1|||
146059729|NCT02939287|526737476|FG002|Overall Study|Withdrawal by Subject|0|||
146059730|NCT00333775|526737479|FG000|Overall Study|Death|144|||
146059731|NCT00333775|526737480|FG001|Overall Study|Death|149|||
146059732|NCT00333775|526737481|FG002|Overall Study|Death|143|||
146059733|NCT00333775|526737479|FG000|Overall Study|In Follow-up When Study Stopped|87|||
146059734|NCT00333775|526737480|FG001|Overall Study|In Follow-up When Study Stopped|92|||
146059735|NCT00333775|526737481|FG002|Overall Study|In Follow-up When Study Stopped|96|||
146059736|NCT00333775|526737479|FG000|Overall Study|Lost to Follow-up|10|||
146059737|NCT00333775|526737480|FG001|Overall Study|Lost to Follow-up|7|||
146059738|NCT00333775|526737481|FG002|Overall Study|Lost to Follow-up|8|||
146059739|NCT04739982|526737486|FG000|Overall Study|Lost to Follow-up|176|||
146059740|NCT04739982|526737487|FG001|Overall Study|Lost to Follow-up|65|||
146059741|NCT04739982|526737486|FG000|Overall Study|Withdrawal by Subject|19|||
146059742|NCT04739982|526737487|FG001|Overall Study|Withdrawal by Subject|0|||
146059743|NCT04739982|526737486|FG000|Overall Study|Protocol Violation|0|||
146059744|NCT04739982|526737487|FG001|Overall Study|Protocol Violation|5|||
146059745|NCT03651765|526737488|FG000|Overall Study|Adverse Event|6|||
146059746|NCT03651765|526737488|FG000|Overall Study|Lack of Efficacy|18|||
146059747|NCT03651765|526737488|FG000|Overall Study|Lost to Follow-up|5|||
146059748|NCT03651765|526737488|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146059749|NCT03651765|526737488|FG000|Overall Study|Physician Decision|6|||
146059750|NCT03651765|526737488|FG000|Overall Study|Pregnancy|1|||
146059751|NCT03651765|526737488|FG000|Overall Study|Discontinued by Sponsor|40|||
146059752|NCT03651765|526737488|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
146059753|NCT03651765|526737488|FG000|Overall Study|Withdrawal by Subject|24|||
146059754|NCT03651765|526737488|FG000|Overall Study|Miscellaneous|6|||
146059755|NCT03521570|526737489|FG000|Overall Study|Not eligible|11|||
146059756|NCT03279081|526737490|FG000|Overall Study|Withdrawal by Subject|12|||
146059757|NCT03279081|526737491|FG001|Overall Study|Withdrawal by Subject|20|||
146059758|NCT03279081|526737490|FG000|Overall Study|Physician Decision|4|||
146059759|NCT03279081|526737491|FG001|Overall Study|Physician Decision|1|||
146059760|NCT03279081|526737490|FG000|Overall Study|Lost to Follow-up|8|||
146059761|NCT03279081|526737491|FG001|Overall Study|Lost to Follow-up|8|||
146059762|NCT03279081|526737490|FG000|Overall Study|Death|0|||
146059763|NCT03279081|526737491|FG001|Overall Study|Death|1|||
146397638|NCT02594384|527960068|FG000|Overall Study|Substantial noncompliance|0|||
146059764|NCT03279081|526737490|FG000|Overall Study|Adverse Event|1|||
146397639|NCT02594384|527960069|FG001|Overall Study|Substantial noncompliance|0|||
146059765|NCT03279081|526737491|FG001|Overall Study|Adverse Event|0|||
146059766|NCT03279081|526737490|FG000|Overall Study|Reason not Specified|14|||
146059767|NCT03279081|526737491|FG001|Overall Study|Reason not Specified|4|||
146059768|NCT00322881|526737492|FG000|Overall Study|Death|2|||
146059769|NCT00322881|526737492|FG000|Overall Study|Adverse Event|1|||
146059770|NCT00322881|526737492|FG000|Overall Study|Disease Progression|2|||
146059771|NCT00468169|526737497|FG000|Overall Study|Withdrawal by Subject|1|||
146059772|NCT00468169|526737498|FG001|Overall Study|Withdrawal by Subject|0|||
146059773|NCT01521117|526737503|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
146059774|NCT01521117|526737504|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146059775|NCT01521117|526737503|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
146059776|NCT01521117|526737504|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
146059777|NCT01521117|526737503|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146059778|NCT01521117|526737504|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
146059779|NCT00784563|526737505|FG000|Years 1 & 2|Withdrawal by Subject|3|||
146059780|NCT00784563|526737506|FG001|Years 1 & 2|Withdrawal by Subject|2|||
146059781|NCT00784563|526737507|FG002|Years 1 & 2|Withdrawal by Subject|0|||
146059782|NCT00784563|526737505|FG000|Years 1 & 2|Adverse Event|0|||
146059783|NCT00784563|526737506|FG001|Years 1 & 2|Adverse Event|3|||
146059784|NCT00784563|526737507|FG002|Years 1 & 2|Adverse Event|0|||
146059785|NCT00784563|526737505|FG000|Year 3|Withdrawal by Subject|0|||
146059786|NCT00784563|526737506|FG001|Year 3|Withdrawal by Subject|0|||
146059787|NCT00784563|526737507|FG002|Year 3|Withdrawal by Subject|2|||
146059788|NCT00784563|526737505|FG000|Year 3|Adverse Event|0|||
146059789|NCT00784563|526737506|FG001|Year 3|Adverse Event|0|||
146059790|NCT00784563|526737507|FG002|Year 3|Adverse Event|1|||
146059791|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
146059792|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
146059793|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
146059794|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
146059795|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
146059796|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
146059797|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
146059798|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
146059799|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
146059800|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
146059801|NCT01668784|526737508|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
146059802|NCT01668784|526737509|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
146059803|NCT01668784|526737508|FG000|Treatment Period|Disease Progression|316|||
146059804|NCT01668784|526737509|FG001|Treatment Period|Disease Progression|293|||
146059805|NCT01668784|526737508|FG000|Treatment Period|Study Drug Toxicity|46|||
146059806|NCT01668784|526737509|FG001|Treatment Period|Study Drug Toxicity|53|||
146059807|NCT01668784|526737508|FG000|Treatment Period|Death|1|||
146059808|NCT01668784|526737509|FG001|Treatment Period|Death|1|||
146059809|NCT01668784|526737508|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
146059810|NCT01668784|526737509|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
146059811|NCT01668784|526737508|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
146059812|NCT01668784|526737509|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
146059813|NCT01668784|526737508|FG000|Treatment Period|Withdrawal by Subject|5|||
146059814|NCT01668784|526737509|FG001|Treatment Period|Withdrawal by Subject|3|||
146059815|NCT01668784|526737508|FG000|Treatment Period|Maximal Clinical Benefit|3|||
146059816|NCT01668784|526737509|FG001|Treatment Period|Maximal Clinical Benefit|3|||
146059817|NCT01668784|526737508|FG000|Treatment Period|Other|2|||
146059818|NCT01668784|526737509|FG001|Treatment Period|Other|8|||
146059819|NCT01668784|526737508|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
146059820|NCT01668784|526737509|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
146059821|NCT05135871|526737512|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
146059822|NCT05135871|526737513|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146059823|NCT05135871|526737514|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146059824|NCT05135871|526737515|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
146059825|NCT00374140|526737520|FG000|Overall Study|Lost to Follow-up|1|||
146059826|NCT00374140|526737520|FG000|Overall Study|Protocol Violation|1|||
146059827|NCT00617734|526737521|FG000|Overall Study|Withdrew Consent|2|||
146059828|NCT00617734|526737522|FG001|Overall Study|Withdrew Consent|0|||
146059829|NCT00617734|526737521|FG000|Overall Study|Adverse Event|4|||
146059830|NCT00617734|526737522|FG001|Overall Study|Adverse Event|1|||
146059831|NCT00617734|526737521|FG000|Overall Study|Protocol Violation|1|||
146059832|NCT00617734|526737522|FG001|Overall Study|Protocol Violation|0|||
146059833|NCT00617734|526737521|FG000|Overall Study|Found Ineligible After Randomization|1|||
146059834|NCT00617734|526737522|FG001|Overall Study|Found Ineligible After Randomization|4|||
146059835|NCT00617734|526737521|FG000|Overall Study|Lost to Follow-up|0|||
146059836|NCT00617734|526737522|FG001|Overall Study|Lost to Follow-up|1|||
146059837|NCT02485691|526737523|FG000|Overall Study|Adverse Event|25|||
146059838|NCT02485691|526737524|FG001|Overall Study|Adverse Event|11|||
146059839|NCT02485691|526737523|FG000|Overall Study|Poor compliance to protocol|0|||
146059840|NCT02485691|526737524|FG001|Overall Study|Poor compliance to protocol|1|||
146059841|NCT02485691|526737523|FG000|Overall Study|Disease progression|57|||
146059842|NCT02485691|526737524|FG001|Overall Study|Disease progression|92|||
146059843|NCT02485691|526737523|FG000|Overall Study|Investigator's decision|23|||
146059844|NCT02485691|526737524|FG001|Overall Study|Investigator's decision|5|||
146059845|NCT02485691|526737523|FG000|Overall Study|Participant's request|13|||
146059846|NCT02485691|526737524|FG001|Overall Study|Participant's request|6|||
146059847|NCT02485691|526737523|FG000|Overall Study|Other reason|8|||
146059848|NCT02485691|526737524|FG001|Overall Study|Other reason|9|||
146059849|NCT02485691|526737523|FG000|Overall Study|Randomized and not treated|3|||
146059850|NCT02485691|526737524|FG001|Overall Study|Randomized and not treated|2|||
146059851|NCT00604565|526737525|FG000|Overall Study|Study terminated|0|||
146059852|NCT00604565|526737526|FG001|Overall Study|Study terminated|3|||
146059853|NCT04292535|526737528|FG000|Overall Study|Withdrawal by Subject|0|||
146059854|NCT04292535|526737529|FG001|Overall Study|Withdrawal by Subject|0|||
146059855|NCT04292535|526737530|FG002|Overall Study|Withdrawal by Subject|0|||
146059856|NCT04292535|526737531|FG003|Overall Study|Withdrawal by Subject|0|||
146059857|NCT04292535|526737532|FG004|Overall Study|Withdrawal by Subject|0|||
146059858|NCT04292535|526737533|FG005|Overall Study|Withdrawal by Subject|0|||
146059859|NCT04292535|526737534|FG006|Overall Study|Withdrawal by Subject|0|||
146059860|NCT04292535|526737535|FG007|Overall Study|Withdrawal by Subject|1|||
146059861|NCT04292535|526737536|FG008|Overall Study|Withdrawal by Subject|0|||
146059862|NCT04292535|526737537|FG009|Overall Study|Withdrawal by Subject|0|||
146059863|NCT04292535|526737538|FG010|Overall Study|Withdrawal by Subject|0|||
146059864|NCT04292535|526737539|FG011|Overall Study|Withdrawal by Subject|0|||
146059865|NCT04292535|526737540|FG012|Overall Study|Withdrawal by Subject|0|||
146059866|NCT04292535|526737541|FG013|Overall Study|Withdrawal by Subject|0|||
146059867|NCT04292535|526737528|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059868|NCT04292535|526737529|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059869|NCT04292535|526737530|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059870|NCT04292535|526737531|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059871|NCT04292535|526737532|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059872|NCT04292535|526737533|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059873|NCT04292535|526737534|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059874|NCT04292535|526737535|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146059875|NCT04292535|526737536|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059876|NCT04292535|526737537|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059877|NCT04292535|526737538|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059878|NCT04292535|526737539|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
146059879|NCT04292535|526737540|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146059880|NCT04292535|526737541|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
146059881|NCT04292535|526737528|FG000|Overall Study|Report of Dizziness|0|||
146059882|NCT04292535|526737529|FG001|Overall Study|Report of Dizziness|0|||
146059883|NCT04292535|526737530|FG002|Overall Study|Report of Dizziness|0|||
146059884|NCT04292535|526737531|FG003|Overall Study|Report of Dizziness|0|||
146059885|NCT04292535|526737532|FG004|Overall Study|Report of Dizziness|0|||
146059886|NCT04292535|526737533|FG005|Overall Study|Report of Dizziness|0|||
146059887|NCT04292535|526737534|FG006|Overall Study|Report of Dizziness|0|||
146059888|NCT04292535|526737535|FG007|Overall Study|Report of Dizziness|0|||
146059889|NCT04292535|526737536|FG008|Overall Study|Report of Dizziness|0|||
146059890|NCT04292535|526737537|FG009|Overall Study|Report of Dizziness|0|||
146059891|NCT04292535|526737538|FG010|Overall Study|Report of Dizziness|0|||
146059892|NCT04292535|526737539|FG011|Overall Study|Report of Dizziness|0|||
146059893|NCT04292535|526737540|FG012|Overall Study|Report of Dizziness|0|||
146059894|NCT04292535|526737541|FG013|Overall Study|Report of Dizziness|1|||
146059895|NCT04292535|526737528|FG000|Overall Study|Equipment Failure|0|||
146059896|NCT04292535|526737529|FG001|Overall Study|Equipment Failure|0|||
146059897|NCT04292535|526737530|FG002|Overall Study|Equipment Failure|0|||
146059898|NCT04292535|526737531|FG003|Overall Study|Equipment Failure|0|||
146059899|NCT04292535|526737532|FG004|Overall Study|Equipment Failure|0|||
146059900|NCT04292535|526737533|FG005|Overall Study|Equipment Failure|0|||
146059901|NCT04292535|526737534|FG006|Overall Study|Equipment Failure|0|||
146059902|NCT04292535|526737535|FG007|Overall Study|Equipment Failure|0|||
146059903|NCT04292535|526737536|FG008|Overall Study|Equipment Failure|0|||
146059904|NCT04292535|526737537|FG009|Overall Study|Equipment Failure|0|||
146059905|NCT04292535|526737538|FG010|Overall Study|Equipment Failure|0|||
146059906|NCT04292535|526737539|FG011|Overall Study|Equipment Failure|1|||
146059907|NCT04292535|526737540|FG012|Overall Study|Equipment Failure|0|||
146059908|NCT04292535|526737541|FG013|Overall Study|Equipment Failure|0|||
146059909|NCT01420861|526737546|FG000|Overall Study|Adverse Event|2|||
146059910|NCT01420861|526737546|FG000|Overall Study|Study terminated by Sponsor|7|||
146059911|NCT01420861|526737546|FG000|Overall Study|Screen failure|7|||
146059912|NCT01420861|526737546|FG000|Overall Study|Randomized not Treated|2|||
146059913|NCT05472090|526737559|FG000|Overall Study|Adverse Event|2|||
146059914|NCT05472090|526737560|FG001|Overall Study|Adverse Event|3|||
146059915|NCT05472090|526737559|FG000|Overall Study|Lack of Efficacy|1|||
146059916|NCT05472090|526737560|FG001|Overall Study|Lack of Efficacy|0|||
146059917|NCT05472090|526737559|FG000|Overall Study|Physician Decision|1|||
146059918|NCT05472090|526737560|FG001|Overall Study|Physician Decision|0|||
146059919|NCT05472090|526737559|FG000|Overall Study|Withdrawal by Subject|2|||
146059920|NCT05472090|526737560|FG001|Overall Study|Withdrawal by Subject|0|||
146059921|NCT05472090|526737559|FG000|Overall Study|Lost to Follow-up|0|||
146059922|NCT05472090|526737560|FG001|Overall Study|Lost to Follow-up|3|||
146059923|NCT03414983|526739433|FG000|Pre-Treatment|Other reasons|1|||
146059924|NCT03414983|526739434|FG001|Pre-Treatment|Other reasons|0|||
146059925|NCT03414983|526739433|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146059926|NCT03414983|526739434|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
146059927|NCT03414983|526739433|FG000|Pre-Treatment|Participant withdrew consent|1|||
146059928|NCT03414983|526739434|FG001|Pre-Treatment|Participant withdrew consent|3|||
146059929|NCT03414983|526739433|FG000|Treatment|Participant withdrew consent|4|||
146059930|NCT03414983|526739434|FG001|Treatment|Participant withdrew consent|3|||
146059931|NCT03414983|526739433|FG000|Treatment|Participant request to discontinue study treatment|8|||
146059932|NCT03414983|526739434|FG001|Treatment|Participant request to discontinue study treatment|10|||
146059933|NCT03414983|526739433|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
146059934|NCT03414983|526739434|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
146059935|NCT03414983|526739433|FG000|Treatment|Death|0|||
146059936|NCT03414983|526739434|FG001|Treatment|Death|1|||
146059937|NCT03414983|526739433|FG000|Treatment|Study Drug Toxicity|10|||
146059938|NCT03414983|526739434|FG001|Treatment|Study Drug Toxicity|5|||
146059939|NCT03414983|526739433|FG000|Treatment|Disease Progression|75|||
146059940|NCT03414983|526739434|FG001|Treatment|Disease Progression|29|||
146059941|NCT03414983|526739433|FG000|Treatment|Not reported|1|||
146059942|NCT03414983|526739434|FG001|Treatment|Not reported|0|||
146059943|NCT03414983|526739433|FG000|Treatment|Other reasons|3|||
146059944|NCT03414983|526739434|FG001|Treatment|Other reasons|2|||
146059945|NCT03414983|526739433|FG000|Treatment|Poor/non-compliance|2|||
146059946|NCT03414983|526739434|FG001|Treatment|Poor/non-compliance|0|||
146059947|NCT03414983|526739433|FG000|Treatment|Maximum clinical benefit|5|||
146059948|NCT03414983|526739434|FG001|Treatment|Maximum clinical benefit|9|||
146059949|NCT03414983|526739433|FG000|Treatment|Lost to Follow-up|0|||
146059950|NCT03414983|526739434|FG001|Treatment|Lost to Follow-up|1|||
146059951|NCT03414983|526739433|FG000|Treatment|Administrative reasons by sponsor|1|||
146059952|NCT03414983|526739434|FG001|Treatment|Administrative reasons by sponsor|0|||
146059953|NCT02608684|526739435|FG000|Overall Study|Physician Decision|2|||
146059954|NCT02608684|526739435|FG000|Overall Study|Withdrawal by Subject|1|||
146059955|NCT00751296|526739436|FG000|Overall Study|Adverse Event|2|||
146059956|NCT01775501|526739441|FG000|Overall Study|Discontinued prior to treatment|1|||
146059957|NCT02318706|526739442|FG000|Double-blind Phase|Adverse Event|7|||
146059958|NCT02318706|526739443|FG001|Double-blind Phase|Adverse Event|4|||
146059959|NCT02318706|526739444|FG002|Double-blind Phase|Adverse Event|3|||
146059960|NCT02318706|526739445|FG003|Double-blind Phase|Adverse Event|10|||
146059961|NCT02318706|526739446|FG004|Double-blind Phase|Adverse Event|0|||
146059962|NCT02318706|526739442|FG000|Double-blind Phase|Lost to Follow-up|1|||
146059963|NCT02318706|526739443|FG001|Double-blind Phase|Lost to Follow-up|0|||
146059964|NCT02318706|526739444|FG002|Double-blind Phase|Lost to Follow-up|0|||
146059965|NCT02318706|526739445|FG003|Double-blind Phase|Lost to Follow-up|0|||
146059966|NCT02318706|526739446|FG004|Double-blind Phase|Lost to Follow-up|0|||
146059967|NCT02318706|526739442|FG000|Double-blind Phase|Protocol Violation|4|||
146059968|NCT02318706|526739443|FG001|Double-blind Phase|Protocol Violation|2|||
146059969|NCT02318706|526739444|FG002|Double-blind Phase|Protocol Violation|4|||
146059970|NCT02318706|526739445|FG003|Double-blind Phase|Protocol Violation|3|||
146059971|NCT02318706|526739446|FG004|Double-blind Phase|Protocol Violation|0|||
146059972|NCT02318706|526739442|FG000|Double-blind Phase|Withdrawal by Subject|9|||
146059973|NCT02318706|526739443|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146059974|NCT02318706|526739444|FG002|Double-blind Phase|Withdrawal by Subject|7|||
146059975|NCT02318706|526739445|FG003|Double-blind Phase|Withdrawal by Subject|10|||
146059976|NCT02318706|526739446|FG004|Double-blind Phase|Withdrawal by Subject|0|||
146059977|NCT02318706|526739442|FG000|Double-blind Phase|Other|4|||
146059978|NCT02318706|526739443|FG001|Double-blind Phase|Other|1|||
146059979|NCT02318706|526739444|FG002|Double-blind Phase|Other|2|||
146059980|NCT02318706|526739445|FG003|Double-blind Phase|Other|1|||
146059981|NCT02318706|526739446|FG004|Double-blind Phase|Other|0|||
146059982|NCT02318706|526739442|FG000|Double-blind Phase|Death|0|||
146059983|NCT02318706|526739443|FG001|Double-blind Phase|Death|0|||
146059984|NCT02318706|526739444|FG002|Double-blind Phase|Death|2|||
146059985|NCT02318706|526739445|FG003|Double-blind Phase|Death|0|||
146059986|NCT02318706|526739446|FG004|Double-blind Phase|Death|0|||
146059987|NCT02318706|526739442|FG000|Open-label Extension Phase|Adverse Event|0|||
146059988|NCT02318706|526739443|FG001|Open-label Extension Phase|Adverse Event|0|||
146059989|NCT02318706|526739444|FG002|Open-label Extension Phase|Adverse Event|0|||
146059990|NCT02318706|526739445|FG003|Open-label Extension Phase|Adverse Event|0|||
146059991|NCT02318706|526739446|FG004|Open-label Extension Phase|Adverse Event|21|||
146059992|NCT02318706|526739442|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
146059993|NCT02318706|526739443|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146059994|NCT02318706|526739444|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
146059995|NCT02318706|526739445|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
146059996|NCT02318706|526739446|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
146059997|NCT02318706|526739442|FG000|Open-label Extension Phase|Death|0|||
146059998|NCT02318706|526739443|FG001|Open-label Extension Phase|Death|0|||
146059999|NCT02318706|526739444|FG002|Open-label Extension Phase|Death|0|||
146060000|NCT02318706|526739445|FG003|Open-label Extension Phase|Death|0|||
146060001|NCT02318706|526739446|FG004|Open-label Extension Phase|Death|1|||
146060002|NCT02318706|526739442|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
146060003|NCT02318706|526739443|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146060004|NCT02318706|526739444|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
146060005|NCT02318706|526739445|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
146060006|NCT02318706|526739446|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
146060007|NCT01702311|526739447|FG000|Overall Study|Withdrawal by Subject|3|||
146060008|NCT01702311|526739448|FG001|Overall Study|Withdrawal by Subject|2|||
146060009|NCT01702311|526739447|FG000|Overall Study|Discharge less than 24 hours|10|||
146060010|NCT01702311|526739448|FG001|Overall Study|Discharge less than 24 hours|7|||
146060011|NCT01702311|526739447|FG000|Overall Study|Physician Decision|3|||
146060012|NCT01702311|526739448|FG001|Overall Study|Physician Decision|4|||
146060013|NCT04106557|526739454|FG000|Overall Study|Physician Decision|0|||
146060014|NCT04106557|526739455|FG001|Overall Study|Physician Decision|1|||
146060015|NCT04106557|526739456|FG002|Overall Study|Physician Decision|0|||
146060016|NCT04106557|526739454|FG000|Overall Study|Protocol Violation|0|||
146060017|NCT04106557|526739455|FG001|Overall Study|Protocol Violation|1|||
146060018|NCT04106557|526739456|FG002|Overall Study|Protocol Violation|0|||
146060019|NCT02326155|526739457|FG000|Overall Study|Adverse Event|21|||
146060020|NCT02326155|526739458|FG001|Overall Study|Adverse Event|5|||
146060021|NCT02326155|526739457|FG000|Overall Study|Death|3|||
146060022|NCT02326155|526739458|FG001|Overall Study|Death|0|||
146060023|NCT02326155|526739457|FG000|Overall Study|Lack of Efficacy|49|||
146060024|NCT02326155|526739458|FG001|Overall Study|Lack of Efficacy|5|||
146060025|NCT02326155|526739457|FG000|Overall Study|Lost to Follow-up|14|||
146060026|NCT02326155|526739458|FG001|Overall Study|Lost to Follow-up|3|||
146060027|NCT02326155|526739457|FG000|Overall Study|Protocol Violation|2|||
146060028|NCT02326155|526739458|FG001|Overall Study|Protocol Violation|0|||
146060029|NCT02326155|526739457|FG000|Overall Study|Withdrawal by Subject|34|||
146060030|NCT02326155|526739458|FG001|Overall Study|Withdrawal by Subject|11|||
146060031|NCT02326155|526739457|FG000|Overall Study|Disease progression|37|||
146060032|NCT02326155|526739458|FG001|Overall Study|Disease progression|4|||
146060033|NCT02326155|526739457|FG000|Overall Study|Study close|188|||
146060034|NCT02326155|526739458|FG001|Overall Study|Study close|21|||
146060035|NCT02326155|526739457|FG000|Overall Study|except for study close|46|||
146060036|NCT02326155|526739458|FG001|Overall Study|except for study close|13|||
146060037|NCT05024032|526739461|FG000|Overall Study|Withdrawal by Subject|0|||
146060038|NCT05024032|526739462|FG001|Overall Study|Withdrawal by Subject|3|||
146060039|NCT05024032|526739463|FG002|Overall Study|Withdrawal by Subject|4|||
146060040|NCT05024032|526739461|FG000|Overall Study|Adverse Event|0|||
146060041|NCT05024032|526739462|FG001|Overall Study|Adverse Event|1|||
146060042|NCT05024032|526739463|FG002|Overall Study|Adverse Event|0|||
146060043|NCT05024032|526739461|FG000|Overall Study|Protocol Deviation|1|||
146060044|NCT05024032|526739462|FG001|Overall Study|Protocol Deviation|0|||
146060045|NCT05024032|526739463|FG002|Overall Study|Protocol Deviation|0|||
146060046|NCT01209689|526739464|FG000|Overall Study|Insufficient Therapeutic Response|7|||
146060047|NCT01209689|526739465|FG001|Overall Study|Insufficient Therapeutic Response|2|||
146060048|NCT01209689|526739464|FG000|Overall Study|Refused Treatment|8|||
146060049|NCT01209689|526739465|FG001|Overall Study|Refused Treatment|3|||
146060050|NCT01209689|526739464|FG000|Overall Study|Adverse Event|4|||
146060051|NCT01209689|526739465|FG001|Overall Study|Adverse Event|0|||
146060052|NCT01209689|526739464|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146060053|NCT01209689|526739465|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146060054|NCT01209689|526739464|FG000|Overall Study|Failure to Return|3|||
146060055|NCT01209689|526739465|FG001|Overall Study|Failure to Return|0|||
146060056|NCT01209689|526739464|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
146060057|NCT01209689|526739465|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
146060058|NCT03780244|526739466|FG000|Overall Study|Lost to Follow-up|1|||
146060059|NCT03780244|526739467|FG001|Overall Study|Lost to Follow-up|0|||
146060060|NCT03175367|526739468|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146060061|NCT03175367|526739469|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146060062|NCT03175367|526739470|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
146060063|NCT03175367|526739471|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
146060064|NCT03175367|526739472|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146060065|NCT03175367|526739473|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
146060066|NCT03175367|526739474|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
146060067|NCT03175367|526739468|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146060068|NCT03175367|526739469|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146060069|NCT03175367|526739470|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146060070|NCT03175367|526739471|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146060071|NCT03175367|526739472|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
146060072|NCT03175367|526739473|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146060073|NCT03175367|526739474|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146060074|NCT03175367|526739468|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146060075|NCT03175367|526739469|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146060076|NCT03175367|526739470|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
146060077|NCT03175367|526739471|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
146060078|NCT03175367|526739472|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146060079|NCT03175367|526739473|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146060080|NCT03175367|526739474|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146060081|NCT03175367|526739468|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
146060082|NCT03175367|526739469|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
146060083|NCT03175367|526739470|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
146060084|NCT03175367|526739471|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
146060085|NCT03175367|526739472|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146060086|NCT03175367|526739473|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146060087|NCT03175367|526739474|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146060088|NCT03175367|526739468|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146060089|NCT03175367|526739469|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146060090|NCT03175367|526739470|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146060091|NCT03175367|526739471|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146060092|NCT03175367|526739472|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146060093|NCT03175367|526739473|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146060094|NCT03175367|526739474|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146060095|NCT03175367|526739468|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060096|NCT03175367|526739469|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060097|NCT03175367|526739470|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060098|NCT03175367|526739471|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060099|NCT03175367|526739472|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060100|NCT03175367|526739473|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
146060101|NCT03175367|526739474|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
146060102|NCT03175367|526739468|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060103|NCT03175367|526739469|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060104|NCT03175367|526739470|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060105|NCT03175367|526739471|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060106|NCT03175367|526739472|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060107|NCT03175367|526739473|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
146060108|NCT03175367|526739474|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
146060109|NCT03714672|526739479|FG000|Overall Study|Adverse Event|0|||
146060110|NCT03714672|526739480|FG001|Overall Study|Adverse Event|0|||
146060111|NCT03714672|526739481|FG002|Overall Study|Adverse Event|3|||
146060112|NCT03714672|526739482|FG003|Overall Study|Adverse Event|0|||
146060113|NCT03714672|526739479|FG000|Overall Study|Physician Decision|0|||
146060114|NCT03714672|526739480|FG001|Overall Study|Physician Decision|1|||
146060115|NCT03714672|526739481|FG002|Overall Study|Physician Decision|0|||
146060116|NCT03714672|526739482|FG003|Overall Study|Physician Decision|0|||
146060117|NCT03714672|526739479|FG000|Overall Study|Other Reason|1|||
146060118|NCT03714672|526739480|FG001|Overall Study|Other Reason|2|||
146060119|NCT03714672|526739481|FG002|Overall Study|Other Reason|1|||
146060120|NCT03714672|526739482|FG003|Overall Study|Other Reason|1|||
146060121|NCT03714672|526739479|FG000|Overall Study|Lost to Follow-up|1|||
146060122|NCT03714672|526739480|FG001|Overall Study|Lost to Follow-up|1|||
146060123|NCT03714672|526739481|FG002|Overall Study|Lost to Follow-up|0|||
146060124|NCT03714672|526739482|FG003|Overall Study|Lost to Follow-up|0|||
146060125|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
146060126|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060127|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060128|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060129|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060130|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060131|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146060132|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
146060133|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060134|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060135|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060136|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060137|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060138|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
146060139|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
146060140|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060141|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060142|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060143|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060144|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060145|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146060146|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
146060147|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060148|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060149|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060150|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060151|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060152|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146060153|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
146060154|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060155|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060156|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060157|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060158|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060159|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
146060160|NCT01054885|526739485|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
146060161|NCT01054885|526739486|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060162|NCT01054885|526739487|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060163|NCT01054885|526739488|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060164|NCT01054885|526739489|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060165|NCT01054885|526739490|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060166|NCT01054885|526739491|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146060167|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146060168|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
146060169|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
146060170|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
146060171|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
146060172|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
146060173|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
146060174|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146060175|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146060176|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146060177|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
146060178|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146060179|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
146060180|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146060181|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146060182|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
146060183|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
146060184|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
146060185|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
146060186|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
146060187|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
146060188|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146060189|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
146060190|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
146060191|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146060192|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146060193|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
146060194|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146060195|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
146060196|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146060197|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
146060198|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146060199|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
146060200|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
146060201|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
146060202|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146060203|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146060204|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
146060205|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146060206|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146060207|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
146060208|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
146060209|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146060210|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146060211|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146060212|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146060213|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146060214|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146060215|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146060216|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146060217|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
146060218|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146060219|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
146060220|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
146060221|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
146060222|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
146060223|NCT01054885|526739485|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146060224|NCT01054885|526739486|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
146060225|NCT01054885|526739487|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146060226|NCT01054885|526739488|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146060227|NCT01054885|526739489|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
146060228|NCT01054885|526739490|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146060229|NCT01054885|526739491|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
146060230|NCT01280903|526739492|FG000|Overall Study|Lost to Follow-up|23|||
146060231|NCT01280903|526739493|FG001|Overall Study|Lost to Follow-up|16|||
146060232|NCT03453164|526739494|FG000|Overall Study|Lack of Efficacy|16|||
146060233|NCT03453164|526739494|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
146060234|NCT01074502|526739497|FG000|Overall Study|Withdrawal by Subject|1|||
146060235|NCT02220920|526739505|FG000|Overall Study|Adverse Event|1|||
146060236|NCT02220920|526739506|FG001|Overall Study|Adverse Event|0|||
146060237|NCT02220920|526739505|FG000|Overall Study|Lack of Efficacy|0|||
146060238|NCT02220920|526739506|FG001|Overall Study|Lack of Efficacy|1|||
146060239|NCT02220920|526739505|FG000|Overall Study|Withdrawal by Subject|1|||
146060240|NCT02220920|526739506|FG001|Overall Study|Withdrawal by Subject|0|||
146060241|NCT02220920|526739505|FG000|Overall Study|Conflict with the stopping criteria|1|||
146060242|NCT02220920|526739506|FG001|Overall Study|Conflict with the stopping criteria|2|||
146060243|NCT04945733|526739507|FG000|Overall Study|Physician Decision|1|||
146060244|NCT04945733|526739508|FG001|Overall Study|Physician Decision|3|||
146060245|NCT04945733|526739509|FG002|Overall Study|Physician Decision|0|||
146060246|NCT04945733|526739507|FG000|Overall Study|Withdrawal by Subject|3|||
146060247|NCT04945733|526739508|FG001|Overall Study|Withdrawal by Subject|3|||
146060248|NCT04945733|526739509|FG002|Overall Study|Withdrawal by Subject|0|||
146060249|NCT00726063|526739510|FG000|Overall Study|Adverse Event|9|||
146060250|NCT00726063|526739511|FG001|Overall Study|Adverse Event|7|||
146060251|NCT02007096|526739512|FG000|Overall Study|medication not available|2|||
146060252|NCT02007096|526739513|FG001|Overall Study|medication not available|0|||
146060253|NCT02007096|526739512|FG000|Overall Study|did not inject saline|0|||
146060254|NCT02007096|526739513|FG001|Overall Study|did not inject saline|3|||
146060255|NCT02007096|526739512|FG000|Overall Study|did not follow postoperative protocol|8|||
146060256|NCT02007096|526739513|FG001|Overall Study|did not follow postoperative protocol|11|||
146060257|NCT02007096|526739512|FG000|Overall Study|converted to open surgery|1|||
146060258|NCT02007096|526739513|FG001|Overall Study|converted to open surgery|1|||
146060259|NCT02007096|526739512|FG000|Overall Study|no mesh placed|0|||
146060260|NCT02007096|526739513|FG001|Overall Study|no mesh placed|1|||
146060261|NCT01231984|526739514|FG000|Study Period 1|Withdrawal by Subject|0|||
146060262|NCT01231984|526739515|FG001|Study Period 1|Withdrawal by Subject|0|||
145945133|NCT01546038|526308134|FG006|Overall Study|: Randomized, not treated|2|||
146060263|NCT01231984|526739516|FG002|Study Period 1|Withdrawal by Subject|0|||
146060264|NCT01231984|526739517|FG003|Study Period 1|Withdrawal by Subject|1|||
146060265|NCT01231984|526739514|FG000|Study Period 1|Lost to Follow-up|1|||
146060266|NCT01231984|526739515|FG001|Study Period 1|Lost to Follow-up|1|||
146060267|NCT01231984|526739516|FG002|Study Period 1|Lost to Follow-up|1|||
146060268|NCT01231984|526739517|FG003|Study Period 1|Lost to Follow-up|0|||
146060269|NCT01231984|526739514|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
146060270|NCT01231984|526739515|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
146060271|NCT01231984|526739516|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
146060272|NCT01231984|526739517|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
146060273|NCT01231984|526739514|FG000|Study Period 1|Screen Failure|0|||
146060274|NCT01231984|526739515|FG001|Study Period 1|Screen Failure|0|||
146060275|NCT01231984|526739516|FG002|Study Period 1|Screen Failure|0|||
146060276|NCT01231984|526739517|FG003|Study Period 1|Screen Failure|1|||
146060277|NCT01231984|526739514|FG000|Study Period 1|Non-compliance with study requirements|5|||
146060278|NCT01231984|526739515|FG001|Study Period 1|Non-compliance with study requirements|0|||
146060279|NCT01231984|526739516|FG002|Study Period 1|Non-compliance with study requirements|2|||
146060280|NCT01231984|526739517|FG003|Study Period 1|Non-compliance with study requirements|1|||
146060281|NCT01231984|526739514|FG000|Study Period 1|Protocol Violation|3|||
146060282|NCT01231984|526739515|FG001|Study Period 1|Protocol Violation|4|||
146060283|NCT01231984|526739516|FG002|Study Period 1|Protocol Violation|2|||
146060284|NCT01231984|526739517|FG003|Study Period 1|Protocol Violation|3|||
146060285|NCT01231984|526739514|FG000|Study Period 1|Adverse Event|1|||
146060286|NCT01231984|526739515|FG001|Study Period 1|Adverse Event|0|||
146060287|NCT01231984|526739516|FG002|Study Period 1|Adverse Event|0|||
146060288|NCT01231984|526739517|FG003|Study Period 1|Adverse Event|0|||
146060289|NCT01231984|526739514|FG000|Study Period 1|Other|0|||
146060290|NCT01231984|526739515|FG001|Study Period 1|Other|0|||
146060291|NCT01231984|526739516|FG002|Study Period 1|Other|0|||
146060292|NCT01231984|526739517|FG003|Study Period 1|Other|1|||
146060293|NCT01231984|526739514|FG000|Study Period 2|Withdrawal by Subject|1|||
146060294|NCT01231984|526739515|FG001|Study Period 2|Withdrawal by Subject|1|||
146060295|NCT01231984|526739516|FG002|Study Period 2|Withdrawal by Subject|0|||
146060296|NCT01231984|526739517|FG003|Study Period 2|Withdrawal by Subject|0|||
146060297|NCT01231984|526739514|FG000|Study Period 2|Lost to Follow-up|1|||
146060298|NCT01231984|526739515|FG001|Study Period 2|Lost to Follow-up|0|||
146060299|NCT01231984|526739516|FG002|Study Period 2|Lost to Follow-up|0|||
146060300|NCT01231984|526739517|FG003|Study Period 2|Lost to Follow-up|3|||
146060301|NCT01231984|526739514|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
146060302|NCT01231984|526739515|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
146060303|NCT01231984|526739516|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
146060304|NCT01231984|526739517|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
146060305|NCT02182895|526739520|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
146060306|NCT02182895|526739521|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
146060307|NCT03566511|526739523|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
146060308|NCT03566511|526739524|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
146060309|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146060310|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
146060311|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146060312|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146060313|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146060314|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146060315|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146060316|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146060317|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
146060318|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146060319|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146060320|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146060321|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146060322|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146060323|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
146060324|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
146060325|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
146060326|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
146060327|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
146060328|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
146060329|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146060330|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146060331|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146060332|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146060333|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146060334|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
146060335|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146060336|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
146060337|NCT04026113|526739525|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146060338|NCT04026113|526739526|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
146060339|NCT04026113|526739527|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146060340|NCT04026113|526739528|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146060341|NCT04026113|526739525|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
146060342|NCT04026113|526739526|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
146060343|NCT04026113|526739527|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
146060344|NCT04026113|526739528|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
146060345|NCT04613362|526739529|FG000|3 Month Follow-up|Lost to Follow-up|1|||
146060346|NCT04613362|526739530|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146060347|NCT04613362|526739529|FG000|6 Month Follow-up|Lost to Follow-up|0|||
146060348|NCT04613362|526739530|FG001|6 Month Follow-up|Lost to Follow-up|1|||
146060349|NCT02218372|526739531|FG000|Overall Study|Adverse Event|1|||
146060350|NCT02218372|526739532|FG001|Overall Study|Adverse Event|1|||
146060351|NCT02218372|526739531|FG000|Overall Study|Miscellaneous|2|||
146060352|NCT02218372|526739532|FG001|Overall Study|Miscellaneous|1|||
146060353|NCT02218372|526739531|FG000|Overall Study|Randomized but did not receive treatment|2|||
146060354|NCT02218372|526739532|FG001|Overall Study|Randomized but did not receive treatment|3|||
146060355|NCT02218372|526739531|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146060356|NCT02218372|526739532|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146060357|NCT03406780|526739533|FG000|Overall Study|Withdrawal by Subject|1|||
146060358|NCT03406780|526739534|FG001|Overall Study|Withdrawal by Subject|1|||
146060359|NCT03406780|526739533|FG000|Overall Study|Other|0|||
146060360|NCT03406780|526739534|FG001|Overall Study|Other|2|||
146060361|NCT01488045|526739536|FG000|Overall Study|Withdrawal by Subject|6|||
146060362|NCT01488045|526739537|FG001|Overall Study|Withdrawal by Subject|11|||
146060363|NCT01488045|526739536|FG000|Overall Study|Failure to present for colonoscopy|3|||
146060364|NCT01488045|526739537|FG001|Overall Study|Failure to present for colonoscopy|6|||
146060365|NCT01488045|526739536|FG000|Overall Study|Failure to report exclusion criteria|0|||
146060366|NCT01488045|526739537|FG001|Overall Study|Failure to report exclusion criteria|1|||
146060367|NCT05365217|526739539|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146060368|NCT05365217|526739540|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146060369|NCT01527149|526739541|FG000|Overall Study|Death|2|||
146060370|NCT02230410|526739542|FG000|Overall Study|Screen Failure|3|||
146060371|NCT04558125|526739546|FG000|Overall Study|Death|1|||
146060372|NCT03199976|526739547|FG000|Overall Study|Lack of Efficacy|3|||
146060373|NCT03199976|526739548|FG001|Overall Study|Lack of Efficacy|6|||
146060374|NCT03199976|526739549|FG002|Overall Study|Lack of Efficacy|13|||
146060375|NCT03199976|526739547|FG000|Overall Study|Withdrawal by Subject|1|||
146060376|NCT03199976|526739548|FG001|Overall Study|Withdrawal by Subject|0|||
146060377|NCT03199976|526739549|FG002|Overall Study|Withdrawal by Subject|0|||
146060378|NCT03199976|526739547|FG000|Overall Study|Lost to Follow-up|0|||
146060379|NCT03199976|526739548|FG001|Overall Study|Lost to Follow-up|1|||
146060380|NCT03199976|526739549|FG002|Overall Study|Lost to Follow-up|1|||
146060381|NCT01761877|526739550|FG000|Overall Study|Adverse Event|7|||
146060382|NCT01761877|526739551|FG001|Overall Study|Adverse Event|0|||
146060383|NCT01761877|526739550|FG000|Overall Study|Withdrawal by Subject|6|||
146060384|NCT01761877|526739551|FG001|Overall Study|Withdrawal by Subject|4|||
146060385|NCT01761877|526739550|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
146060386|NCT01761877|526739551|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
146060387|NCT01761877|526739550|FG000|Overall Study|Death|0|||
146060388|NCT01761877|526739551|FG001|Overall Study|Death|1|||
146060389|NCT01761877|526739550|FG000|Overall Study|MRI intolerant|1|||
146060390|NCT01761877|526739551|FG001|Overall Study|MRI intolerant|6|||
146060391|NCT04842747|526739553|FG000|Overall Study|Withdrawal by Subject|6|||
146060392|NCT04842747|526739554|FG001|Overall Study|Withdrawal by Subject|2|||
146060393|NCT04842747|526739553|FG000|Overall Study|Lost to Follow-up|1|||
146060394|NCT04842747|526739554|FG001|Overall Study|Lost to Follow-up|2|||
146060395|NCT04842747|526739553|FG000|Overall Study|Physician Decision|1|||
146060396|NCT04842747|526739554|FG001|Overall Study|Physician Decision|0|||
146060397|NCT04842747|526739553|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
146060398|NCT04842747|526739554|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
146060399|NCT01126749|526739557|FG000|Phase 1b|Other|0|||
146060400|NCT01126749|526739558|FG001|Phase 1b|Other|1|||
146060401|NCT01126749|526739559|FG002|Phase 1b|Other|0|||
146060402|NCT01126749|526739560|FG003|Phase 1b|Other|0|||
146060403|NCT01126749|526739557|FG000|Phase 1b|Withdrawal by Subject|0|||
146060404|NCT01126749|526739558|FG001|Phase 1b|Withdrawal by Subject|1|||
146060405|NCT01126749|526739559|FG002|Phase 1b|Withdrawal by Subject|0|||
146060406|NCT01126749|526739560|FG003|Phase 1b|Withdrawal by Subject|0|||
146060407|NCT01126749|526739557|FG000|Phase 1b|Death|3|||
146060408|NCT01126749|526739558|FG001|Phase 1b|Death|4|||
146060409|NCT01126749|526739559|FG002|Phase 1b|Death|0|||
146060410|NCT01126749|526739560|FG003|Phase 1b|Death|0|||
146060411|NCT01126749|526739557|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
146060412|NCT01126749|526739558|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
146060413|NCT01126749|526739559|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
146060414|NCT01126749|526739560|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
146060415|NCT01126749|526739557|FG000|Phase 2|Study Termination by Sponsor|0|||
146060416|NCT01126749|526739558|FG001|Phase 2|Study Termination by Sponsor|0|||
146060417|NCT01126749|526739559|FG002|Phase 2|Study Termination by Sponsor|12|||
146060418|NCT01126749|526739560|FG003|Phase 2|Study Termination by Sponsor|6|||
146060419|NCT01126749|526739557|FG000|Phase 2|Other|0|||
146060420|NCT01126749|526739558|FG001|Phase 2|Other|0|||
146060421|NCT01126749|526739559|FG002|Phase 2|Other|4|||
146060422|NCT01126749|526739560|FG003|Phase 2|Other|2|||
146060423|NCT01126749|526739557|FG000|Phase 2|Withdrawal by Subject|0|||
146060424|NCT01126749|526739558|FG001|Phase 2|Withdrawal by Subject|0|||
146060425|NCT01126749|526739559|FG002|Phase 2|Withdrawal by Subject|0|||
146060426|NCT01126749|526739560|FG003|Phase 2|Withdrawal by Subject|2|||
146060427|NCT01126749|526739557|FG000|Phase 2|Lost to Follow-up|0|||
146060428|NCT01126749|526739558|FG001|Phase 2|Lost to Follow-up|0|||
146060429|NCT01126749|526739559|FG002|Phase 2|Lost to Follow-up|0|||
146060430|NCT01126749|526739560|FG003|Phase 2|Lost to Follow-up|1|||
146060431|NCT01126749|526739557|FG000|Phase 2|Death|0|||
146060432|NCT01126749|526739558|FG001|Phase 2|Death|0|||
146060433|NCT01126749|526739559|FG002|Phase 2|Death|22|||
146060434|NCT01126749|526739560|FG003|Phase 2|Death|22|||
146060435|NCT01126749|526739557|FG000|Phase 2|Adverse Event|0|||
146060436|NCT01126749|526739558|FG001|Phase 2|Adverse Event|0|||
146060437|NCT01126749|526739559|FG002|Phase 2|Adverse Event|0|||
146060438|NCT01126749|526739560|FG003|Phase 2|Adverse Event|1|||
146060439|NCT00976274|526739562|FG000|Overall Study|Lost to Follow-up|5|||
146060440|NCT00976274|526739563|FG001|Overall Study|Lost to Follow-up|5|||
146060441|NCT00976274|526739562|FG000|Overall Study|Withdrawal by Subject|1|||
146060442|NCT00976274|526739563|FG001|Overall Study|Withdrawal by Subject|1|||
146060443|NCT00976274|526739562|FG000|Overall Study|Physician Decision|1|||
146060444|NCT00976274|526739563|FG001|Overall Study|Physician Decision|2|||
146397640|NCT02594384|527960070|FG002|Overall Study|Substantial noncompliance|0|||
146397641|NCT02594384|527960071|FG003|Overall Study|Substantial noncompliance|0|||
146060445|NCT02183675|526739564|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
146060446|NCT02183675|526739565|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
146060447|NCT02183675|526739566|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
146060448|NCT02183675|526739567|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
146060449|NCT02183675|526739568|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
146060450|NCT02183675|526739569|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
146060451|NCT00627393|526739570|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
146060452|NCT00627393|526739571|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
146060453|NCT00627393|526739570|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
146060454|NCT00627393|526739571|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
146060455|NCT00627393|526739570|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
146060456|NCT00627393|526739571|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
146060457|NCT00627393|526739570|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
146060458|NCT00627393|526739571|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
146060459|NCT03337308|526739572|FG000|Overall Study|Adverse Event|2|||
146060460|NCT03337308|526739573|FG001|Overall Study|Adverse Event|3|||
146060461|NCT03337308|526739574|FG002|Overall Study|Adverse Event|3|||
146060462|NCT03337308|526739575|FG003|Overall Study|Adverse Event|1|||
146060463|NCT03337308|526739572|FG000|Overall Study|Lost to Follow-up|1|||
146397642|NCT02594384|527960072|FG004|Overall Study|Substantial noncompliance|0|||
146397643|NCT02594384|527960073|FG005|Overall Study|Substantial noncompliance|0|||
146397644|NCT02594384|527960074|FG006|Overall Study|Substantial noncompliance|1|||
146397645|NCT02594384|527960075|FG007|Overall Study|Substantial noncompliance|0|||
146397646|NCT03919669|527960079|FG000|Overall Study|Withdrawal by Subject|1|||
146397647|NCT03919669|527960080|FG001|Overall Study|Withdrawal by Subject|0|||
146060464|NCT03337308|526739573|FG001|Overall Study|Lost to Follow-up|2|||
146060465|NCT03337308|526739574|FG002|Overall Study|Lost to Follow-up|0|||
146060466|NCT03337308|526739575|FG003|Overall Study|Lost to Follow-up|0|||
146060467|NCT03337308|526739572|FG000|Overall Study|Withdrawal by Subject|2|||
146060468|NCT03337308|526739573|FG001|Overall Study|Withdrawal by Subject|1|||
146060469|NCT03337308|526739574|FG002|Overall Study|Withdrawal by Subject|2|||
146060470|NCT03337308|526739575|FG003|Overall Study|Withdrawal by Subject|1|||
146060471|NCT03337308|526739572|FG000|Overall Study|Protocol Violation|0|||
146060472|NCT03337308|526739573|FG001|Overall Study|Protocol Violation|1|||
146060473|NCT03337308|526739574|FG002|Overall Study|Protocol Violation|0|||
146060474|NCT03337308|526739575|FG003|Overall Study|Protocol Violation|0|||
146397648|NCT03919669|527960081|FG002|Overall Study|Withdrawal by Subject|0|||
146060475|NCT01056822|526739576|FG000|Overall Study|Adverse Event|0|||
146060476|NCT01056822|526739577|FG001|Overall Study|Adverse Event|1|||
146060477|NCT01056822|526739576|FG000|Overall Study|Protocol Violation|6|||
146060478|NCT01056822|526739577|FG001|Overall Study|Protocol Violation|5|||
146060479|NCT01056822|526739576|FG000|Overall Study|Withdrawal by Subject|1|||
146060480|NCT01056822|526739577|FG001|Overall Study|Withdrawal by Subject|1|||
146060481|NCT01056822|526739576|FG000|Overall Study|Lost to Follow-up|1|||
146060482|NCT01056822|526739577|FG001|Overall Study|Lost to Follow-up|0|||
146060483|NCT01614249|526739581|FG000|Overall Study|Lost to Follow-up|11|||
146060484|NCT01614249|526739582|FG001|Overall Study|Lost to Follow-up|23|||
146060485|NCT02946580|526739594|FG000|Overall Study|Withdrawal by Subject|1|||
146060486|NCT02946580|526739595|FG001|Overall Study|Withdrawal by Subject|2|||
146060487|NCT02946580|526739594|FG000|Overall Study|Adverse Event|0|||
146060488|NCT02946580|526739595|FG001|Overall Study|Adverse Event|2|||
146060489|NCT02946580|526739594|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
146060490|NCT02946580|526739595|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
146060491|NCT02761330|526739596|FG000|Treatment Week 1|Withdrawal by Subject|0|||
146060492|NCT02761330|526739597|FG001|Treatment Week 1|Withdrawal by Subject|0|||
146060493|NCT02761330|526739598|FG002|Treatment Week 1|Withdrawal by Subject|0|||
146060494|NCT02761330|526739599|FG003|Treatment Week 1|Withdrawal by Subject|1|||
146060495|NCT02761330|526739600|FG004|Treatment Week 1|Withdrawal by Subject|0|||
146060496|NCT02761330|526739601|FG005|Treatment Week 1|Withdrawal by Subject|1|||
146060497|NCT00888134|526739602|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
146060498|NCT00888134|526739602|FG000|Follow-up|being followed for long-term survival|1|||
146060499|NCT03043313|526739603|FG000|Overall Study|Withdrawal by Subject|5|||
146060500|NCT03043313|526739604|FG001|Overall Study|Withdrawal by Subject|1|||
146060501|NCT03043313|526739605|FG002|Overall Study|Withdrawal by Subject|1|||
146060502|NCT03043313|526739603|FG000|Overall Study|Lost to Follow-up|1|||
146060503|NCT03043313|526739604|FG001|Overall Study|Lost to Follow-up|1|||
146060504|NCT03043313|526739605|FG002|Overall Study|Lost to Follow-up|0|||
146060505|NCT03043313|526739603|FG000|Overall Study|Death|28|||
146060506|NCT03043313|526739604|FG001|Overall Study|Death|26|||
146060507|NCT03043313|526739605|FG002|Overall Study|Death|17|||
146060508|NCT03043313|526739603|FG000|Overall Study|Participation terminated by sponsor|11|||
146060509|NCT03043313|526739604|FG001|Overall Study|Participation terminated by sponsor|13|||
146060510|NCT03043313|526739605|FG002|Overall Study|Participation terminated by sponsor|13|||
146060511|NCT02657889|526739606|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
146060512|NCT02657889|526739607|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
146060513|NCT02657889|526739608|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
146060514|NCT02657889|526739609|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
146060515|NCT02657889|526739606|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
146060516|NCT02657889|526739607|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146060517|NCT02657889|526739608|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146060518|NCT02657889|526739609|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
146060519|NCT02657889|526739606|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146060520|NCT02657889|526739607|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
146060521|NCT02657889|526739608|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146397649|NCT02319642|527960082|FG000|Overall Study|Adverse Event|2|||
146397650|NCT02319642|527960083|FG001|Overall Study|Adverse Event|4|||
146397651|NCT02319642|527960082|FG000|Overall Study|Lack of Efficacy|1|||
146397652|NCT02319642|527960083|FG001|Overall Study|Lack of Efficacy|1|||
146397653|NCT02319642|527960082|FG000|Overall Study|Withdrawal by Subject|1|||
146397654|NCT02319642|527960083|FG001|Overall Study|Withdrawal by Subject|1|||
146397655|NCT01265875|527960084|FG000|Overall Study|Uncooperative/unreliable|1|||
146397656|NCT00483119|527960085|FG000|Overall Study|Adverse Event|0|||
146397657|NCT00483119|527960086|FG001|Overall Study|Adverse Event|1|||
146397658|NCT00483119|527960085|FG000|Overall Study|Physician Decision|1|||
146397659|NCT00483119|527960086|FG001|Overall Study|Physician Decision|0|||
146397660|NCT04409509|527960087|FG000|Overall Study|Failure to meet randomization requirement|1|||
146397661|NCT04409509|527960088|FG001|Overall Study|Failure to meet randomization requirement|0|||
146397662|NCT04409509|527960087|FG000|Overall Study|Adverse Event|0|||
146397663|NCT04409509|527960088|FG001|Overall Study|Adverse Event|1|||
146397664|NCT04409509|527960087|FG000|Overall Study|Death|11|||
146397665|NCT04409509|527960088|FG001|Overall Study|Death|10|||
146397666|NCT04409509|527960087|FG000|Overall Study|Non-compliance with study drug|0|||
146397667|NCT04409509|527960088|FG001|Overall Study|Non-compliance with study drug|1|||
146397668|NCT04409509|527960087|FG000|Overall Study|Lost to Follow-up|0|||
146060522|NCT02657889|526739609|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
146060523|NCT02657889|526739606|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146060524|NCT02657889|526739607|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
146060525|NCT02657889|526739608|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146060526|NCT02657889|526739609|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
146060527|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
146397669|NCT04409509|527960088|FG001|Overall Study|Lost to Follow-up|3|||
146397670|NCT04409509|527960087|FG000|Overall Study|Withdrawal by Subject|0|||
146397671|NCT04409509|527960088|FG001|Overall Study|Withdrawal by Subject|3|||
146397672|NCT04409509|527960087|FG000|Overall Study|Randomized by mistake|0|||
146397673|NCT04409509|527960088|FG001|Overall Study|Randomized by mistake|1|||
146397674|NCT04409509|527960087|FG000|Overall Study|Other|1|||
146397675|NCT04409509|527960088|FG001|Overall Study|Other|1|||
146397676|NCT04668066|527960091|FG000|Part 1: Treatment Phase|Adverse Event|0|||
146397677|NCT04668066|527960092|FG001|Part 1: Treatment Phase|Adverse Event|0|||
146397678|NCT04668066|527960093|FG002|Part 1: Treatment Phase|Adverse Event|0|||
146397679|NCT04668066|527960094|FG003|Part 1: Treatment Phase|Adverse Event|0|||
146397680|NCT04668066|527960095|FG004|Part 1: Treatment Phase|Adverse Event|0|||
146397681|NCT04668066|527960096|FG005|Part 1: Treatment Phase|Adverse Event|0|||
146397682|NCT04668066|527960097|FG006|Part 1: Treatment Phase|Adverse Event|0|||
146397683|NCT04668066|527960098|FG007|Part 1: Treatment Phase|Adverse Event|0|||
146397684|NCT04668066|527960099|FG008|Part 1: Treatment Phase|Adverse Event|0|||
146397685|NCT04668066|527960100|FG009|Part 1: Treatment Phase|Adverse Event|0|||
146397686|NCT04668066|527960101|FG010|Part 1: Treatment Phase|Adverse Event|0|||
146397687|NCT04668066|527960102|FG011|Part 1: Treatment Phase|Adverse Event|1|||
146397688|NCT04668066|527960103|FG012|Part 1: Treatment Phase|Adverse Event|1|||
146397689|NCT04668066|527960104|FG013|Part 1: Treatment Phase|Adverse Event|0|||
146397690|NCT04668066|527960105|FG014|Part 1: Treatment Phase|Adverse Event|0|||
146397691|NCT04668066|527960106|FG015|Part 1: Treatment Phase|Adverse Event|0|||
146397692|NCT04668066|527960107|FG016|Part 1: Treatment Phase|Adverse Event|0|||
146397693|NCT04668066|527960108|FG017|Part 1: Treatment Phase|Adverse Event|0|||
146397694|NCT04668066|527960109|FG018|Part 1: Treatment Phase|Adverse Event|0|||
146397695|NCT04668066|527960091|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397696|NCT04668066|527960092|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397697|NCT04668066|527960093|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
146397698|NCT04668066|527960094|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397699|NCT04668066|527960095|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397700|NCT04668066|527960096|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397701|NCT04668066|527960097|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397702|NCT04668066|527960098|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397703|NCT04668066|527960099|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397704|NCT04668066|527960100|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397705|NCT04668066|527960101|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397706|NCT04668066|527960102|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397707|NCT04668066|527960103|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397708|NCT04668066|527960104|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397709|NCT04668066|527960105|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397710|NCT04668066|527960106|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397711|NCT04668066|527960107|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397712|NCT04668066|527960108|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397713|NCT04668066|527960109|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
146397714|NCT04668066|527960091|FG000|Part 1: Treatment Phase|Other|0|||
146397715|NCT04668066|527960092|FG001|Part 1: Treatment Phase|Other|0|||
146397716|NCT04668066|527960093|FG002|Part 1: Treatment Phase|Other|0|||
146397717|NCT04668066|527960094|FG003|Part 1: Treatment Phase|Other|0|||
146397718|NCT04668066|527960095|FG004|Part 1: Treatment Phase|Other|0|||
146397719|NCT04668066|527960096|FG005|Part 1: Treatment Phase|Other|0|||
146397720|NCT04668066|527960097|FG006|Part 1: Treatment Phase|Other|0|||
146397721|NCT04668066|527960098|FG007|Part 1: Treatment Phase|Other|0|||
146397722|NCT04668066|527960099|FG008|Part 1: Treatment Phase|Other|0|||
146397723|NCT04668066|527960100|FG009|Part 1: Treatment Phase|Other|0|||
146397724|NCT04668066|527960101|FG010|Part 1: Treatment Phase|Other|0|||
146397725|NCT04668066|527960102|FG011|Part 1: Treatment Phase|Other|1|||
146397726|NCT04668066|527960103|FG012|Part 1: Treatment Phase|Other|0|||
146397727|NCT04668066|527960104|FG013|Part 1: Treatment Phase|Other|0|||
146397728|NCT04668066|527960105|FG014|Part 1: Treatment Phase|Other|0|||
146397729|NCT04668066|527960106|FG015|Part 1: Treatment Phase|Other|0|||
146397730|NCT04668066|527960107|FG016|Part 1: Treatment Phase|Other|0|||
146397731|NCT04668066|527960108|FG017|Part 1: Treatment Phase|Other|0|||
146397732|NCT04668066|527960109|FG018|Part 1: Treatment Phase|Other|0|||
146397733|NCT04668066|527960091|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397734|NCT04668066|527960092|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397735|NCT04668066|527960093|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397736|NCT04668066|527960094|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397737|NCT04668066|527960095|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397738|NCT04668066|527960096|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397739|NCT04668066|527960097|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397740|NCT04668066|527960098|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397741|NCT04668066|527960099|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397742|NCT04668066|527960100|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397743|NCT04668066|527960101|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397744|NCT04668066|527960102|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397745|NCT04668066|527960103|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
146397746|NCT04668066|527960104|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397747|NCT04668066|527960105|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397748|NCT04668066|527960106|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
146397749|NCT04668066|527960107|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397750|NCT04668066|527960108|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397751|NCT04668066|527960109|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
146397752|NCT04668066|527960091|FG000|Part 1: Follow-Up|Adverse Event|0|||
146397753|NCT04668066|527960092|FG001|Part 1: Follow-Up|Adverse Event|0|||
146397754|NCT04668066|527960093|FG002|Part 1: Follow-Up|Adverse Event|0|||
146397755|NCT04668066|527960094|FG003|Part 1: Follow-Up|Adverse Event|0|||
146397756|NCT04668066|527960095|FG004|Part 1: Follow-Up|Adverse Event|0|||
146397757|NCT04668066|527960096|FG005|Part 1: Follow-Up|Adverse Event|0|||
146397758|NCT04668066|527960097|FG006|Part 1: Follow-Up|Adverse Event|0|||
146397759|NCT04668066|527960098|FG007|Part 1: Follow-Up|Adverse Event|0|||
146397760|NCT04668066|527960099|FG008|Part 1: Follow-Up|Adverse Event|0|||
146397761|NCT04668066|527960100|FG009|Part 1: Follow-Up|Adverse Event|0|||
146397762|NCT04668066|527960101|FG010|Part 1: Follow-Up|Adverse Event|0|||
146397763|NCT04668066|527960102|FG011|Part 1: Follow-Up|Adverse Event|1|||
146397764|NCT04668066|527960103|FG012|Part 1: Follow-Up|Adverse Event|0|||
146397765|NCT04668066|527960104|FG013|Part 1: Follow-Up|Adverse Event|0|||
146397766|NCT04668066|527960105|FG014|Part 1: Follow-Up|Adverse Event|0|||
146397767|NCT04668066|527960106|FG015|Part 1: Follow-Up|Adverse Event|0|||
146397768|NCT04668066|527960107|FG016|Part 1: Follow-Up|Adverse Event|0|||
146397769|NCT04668066|527960108|FG017|Part 1: Follow-Up|Adverse Event|0|||
146397770|NCT04668066|527960109|FG018|Part 1: Follow-Up|Adverse Event|0|||
146397771|NCT04668066|527960091|FG000|Part 1: Follow-Up|Other|0|||
146397772|NCT04668066|527960092|FG001|Part 1: Follow-Up|Other|0|||
146397773|NCT04668066|527960093|FG002|Part 1: Follow-Up|Other|0|||
146397774|NCT04668066|527960094|FG003|Part 1: Follow-Up|Other|0|||
146397775|NCT04668066|527960095|FG004|Part 1: Follow-Up|Other|0|||
146397776|NCT04668066|527960096|FG005|Part 1: Follow-Up|Other|0|||
146397777|NCT04668066|527960097|FG006|Part 1: Follow-Up|Other|0|||
146397778|NCT04668066|527960098|FG007|Part 1: Follow-Up|Other|0|||
146397779|NCT04668066|527960099|FG008|Part 1: Follow-Up|Other|0|||
146397780|NCT04668066|527960100|FG009|Part 1: Follow-Up|Other|0|||
146397781|NCT04668066|527960101|FG010|Part 1: Follow-Up|Other|0|||
146397782|NCT04668066|527960102|FG011|Part 1: Follow-Up|Other|1|||
146397783|NCT04668066|527960103|FG012|Part 1: Follow-Up|Other|1|||
146397784|NCT04668066|527960104|FG013|Part 1: Follow-Up|Other|0|||
146397785|NCT04668066|527960105|FG014|Part 1: Follow-Up|Other|0|||
146397786|NCT04668066|527960106|FG015|Part 1: Follow-Up|Other|0|||
146397787|NCT04668066|527960107|FG016|Part 1: Follow-Up|Other|0|||
146397788|NCT04668066|527960108|FG017|Part 1: Follow-Up|Other|0|||
146397789|NCT04668066|527960109|FG018|Part 1: Follow-Up|Other|0|||
146397790|NCT04668066|527960091|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397791|NCT04668066|527960092|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397792|NCT04668066|527960093|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397793|NCT04668066|527960094|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397794|NCT04668066|527960095|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397795|NCT04668066|527960096|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
146060528|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
146060529|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
146060530|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
146060531|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
146060532|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
146060533|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
146060534|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
146060535|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
146397796|NCT04668066|527960097|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397797|NCT04668066|527960098|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397798|NCT04668066|527960099|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
146060536|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
146397799|NCT04668066|527960100|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397800|NCT04668066|527960101|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397801|NCT04668066|527960102|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397802|NCT04668066|527960103|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
146397803|NCT04668066|527960104|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397804|NCT04668066|527960105|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397805|NCT04668066|527960106|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
146397806|NCT04668066|527960107|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397807|NCT04668066|527960108|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397808|NCT04668066|527960109|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
146397809|NCT04668066|527960091|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397810|NCT04668066|527960092|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397811|NCT04668066|527960093|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397812|NCT04668066|527960094|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397813|NCT04668066|527960095|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146060537|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
146060538|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
146060539|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
146060540|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
146397814|NCT04668066|527960096|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397815|NCT04668066|527960097|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397816|NCT04668066|527960098|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146060541|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
146060542|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
146060543|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
146060544|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
146060545|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
146060546|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
146060547|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146060548|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146060549|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
146060550|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
146060551|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
146060552|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
146060553|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
146060554|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
146060555|NCT02657889|526739606|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146060556|NCT02657889|526739607|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146060557|NCT02657889|526739608|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
146060558|NCT02657889|526739609|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
146060559|NCT00795535|526739610|FG000|Overall Study|incomplete data and technical problems|20|||
146060560|NCT03341299|526739611|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146060561|NCT03341299|526739612|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146060562|NCT03341299|526739613|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
146060563|NCT03341299|526739614|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
146060564|NCT02702492|526739615|FG000|Overall Study|Disease progression|3|||
146060565|NCT02702492|526739616|FG001|Overall Study|Disease progression|3|||
146060566|NCT02702492|526739617|FG002|Overall Study|Disease progression|2|||
146060567|NCT02702492|526739618|FG003|Overall Study|Disease progression|4|||
146060568|NCT02702492|526739619|FG004|Overall Study|Disease progression|4|||
146060569|NCT02702492|526739620|FG005|Overall Study|Disease progression|1|||
146060570|NCT02702492|526739621|FG006|Overall Study|Disease progression|2|||
146060571|NCT02702492|526739622|FG007|Overall Study|Disease progression|8|||
146060572|NCT02702492|526739623|FG008|Overall Study|Disease progression|5|||
146060573|NCT02702492|526739624|FG009|Overall Study|Disease progression|1|||
146060574|NCT02702492|526739625|FG010|Overall Study|Disease progression|0|||
146060575|NCT02702492|526739626|FG011|Overall Study|Disease progression|3|||
146060576|NCT02702492|526739627|FG012|Overall Study|Disease progression|2|||
146060577|NCT02702492|526739615|FG000|Overall Study|Clinical progression|0|||
146060578|NCT02702492|526739616|FG001|Overall Study|Clinical progression|0|||
146060579|NCT02702492|526739617|FG002|Overall Study|Clinical progression|2|||
146060580|NCT02702492|526739618|FG003|Overall Study|Clinical progression|1|||
146060581|NCT02702492|526739619|FG004|Overall Study|Clinical progression|0|||
146060582|NCT02702492|526739620|FG005|Overall Study|Clinical progression|2|||
146060583|NCT02702492|526739621|FG006|Overall Study|Clinical progression|1|||
146060584|NCT02702492|526739622|FG007|Overall Study|Clinical progression|4|||
146397817|NCT04668066|527960099|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397818|NCT04668066|527960100|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397819|NCT04668066|527960101|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397820|NCT04668066|527960102|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397821|NCT04668066|527960103|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397822|NCT04668066|527960104|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397823|NCT04668066|527960105|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397824|NCT04668066|527960106|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397825|NCT04668066|527960107|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397826|NCT04668066|527960108|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
146397827|NCT04668066|527960109|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
146397828|NCT04668066|527960091|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397829|NCT04668066|527960092|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397830|NCT04668066|527960093|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397831|NCT04668066|527960094|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397832|NCT04668066|527960095|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397833|NCT04668066|527960096|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397834|NCT04668066|527960097|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397835|NCT04668066|527960098|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397836|NCT04668066|527960099|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397837|NCT04668066|527960100|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397838|NCT04668066|527960101|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397839|NCT04668066|527960102|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397840|NCT04668066|527960103|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397841|NCT04668066|527960104|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397842|NCT04668066|527960105|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397843|NCT04668066|527960106|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397844|NCT04668066|527960107|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397845|NCT04668066|527960108|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
146397846|NCT04668066|527960109|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
146397847|NCT04668066|527960091|FG000|Part 2: Treatment Phase|Other|0|||
146397848|NCT04668066|527960092|FG001|Part 2: Treatment Phase|Other|0|||
146397849|NCT04668066|527960093|FG002|Part 2: Treatment Phase|Other|0|||
146397850|NCT04668066|527960094|FG003|Part 2: Treatment Phase|Other|0|||
146397851|NCT04668066|527960095|FG004|Part 2: Treatment Phase|Other|0|||
146397852|NCT04668066|527960096|FG005|Part 2: Treatment Phase|Other|0|||
146397853|NCT04668066|527960097|FG006|Part 2: Treatment Phase|Other|0|||
146397854|NCT04668066|527960098|FG007|Part 2: Treatment Phase|Other|0|||
146397855|NCT04668066|527960099|FG008|Part 2: Treatment Phase|Other|0|||
146397856|NCT04668066|527960100|FG009|Part 2: Treatment Phase|Other|0|||
146397857|NCT04668066|527960101|FG010|Part 2: Treatment Phase|Other|0|||
146397858|NCT04668066|527960102|FG011|Part 2: Treatment Phase|Other|0|||
146397859|NCT04668066|527960103|FG012|Part 2: Treatment Phase|Other|0|||
146397860|NCT04668066|527960104|FG013|Part 2: Treatment Phase|Other|0|||
146397861|NCT04668066|527960105|FG014|Part 2: Treatment Phase|Other|0|||
146397862|NCT04668066|527960106|FG015|Part 2: Treatment Phase|Other|0|||
146397863|NCT04668066|527960107|FG016|Part 2: Treatment Phase|Other|0|||
146397864|NCT04668066|527960108|FG017|Part 2: Treatment Phase|Other|0|||
146397865|NCT04668066|527960109|FG018|Part 2: Treatment Phase|Other|1|||
146397866|NCT04668066|527960091|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397867|NCT04668066|527960092|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397868|NCT04668066|527960093|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397869|NCT04668066|527960094|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397870|NCT04668066|527960095|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397871|NCT04668066|527960096|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397872|NCT04668066|527960097|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397873|NCT04668066|527960098|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397874|NCT04668066|527960099|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397875|NCT04668066|527960100|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397876|NCT04668066|527960101|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
146060585|NCT02702492|526739623|FG008|Overall Study|Clinical progression|0|||
146060586|NCT02702492|526739624|FG009|Overall Study|Clinical progression|0|||
146060587|NCT02702492|526739625|FG010|Overall Study|Clinical progression|1|||
146060588|NCT02702492|526739626|FG011|Overall Study|Clinical progression|2|||
146060589|NCT02702492|526739627|FG012|Overall Study|Clinical progression|0|||
146060590|NCT02702492|526739615|FG000|Overall Study|Adverse Event|0|||
146060591|NCT02702492|526739616|FG001|Overall Study|Adverse Event|0|||
146060592|NCT02702492|526739617|FG002|Overall Study|Adverse Event|1|||
146060593|NCT02702492|526739618|FG003|Overall Study|Adverse Event|2|||
146060594|NCT02702492|526739619|FG004|Overall Study|Adverse Event|1|||
146060595|NCT02702492|526739620|FG005|Overall Study|Adverse Event|0|||
146060596|NCT02702492|526739621|FG006|Overall Study|Adverse Event|1|||
146060597|NCT02702492|526739622|FG007|Overall Study|Adverse Event|0|||
146060598|NCT02702492|526739623|FG008|Overall Study|Adverse Event|2|||
146060599|NCT02702492|526739624|FG009|Overall Study|Adverse Event|0|||
146060600|NCT02702492|526739625|FG010|Overall Study|Adverse Event|0|||
146060601|NCT02702492|526739626|FG011|Overall Study|Adverse Event|0|||
146060602|NCT02702492|526739627|FG012|Overall Study|Adverse Event|1|||
146060603|NCT02702492|526739615|FG000|Overall Study|Other|0|||
146060604|NCT02702492|526739616|FG001|Overall Study|Other|0|||
146060605|NCT02702492|526739617|FG002|Overall Study|Other|0|||
146060606|NCT02702492|526739618|FG003|Overall Study|Other|0|||
146060607|NCT02702492|526739619|FG004|Overall Study|Other|0|||
146060608|NCT02702492|526739620|FG005|Overall Study|Other|0|||
146060609|NCT02702492|526739621|FG006|Overall Study|Other|0|||
146060610|NCT02702492|526739622|FG007|Overall Study|Other|0|||
146060611|NCT02702492|526739623|FG008|Overall Study|Other|0|||
146397877|NCT04668066|527960102|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397878|NCT04668066|527960103|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
146060612|NCT02702492|526739624|FG009|Overall Study|Other|0|||
146060613|NCT02702492|526739625|FG010|Overall Study|Other|0|||
146060614|NCT02702492|526739626|FG011|Overall Study|Other|0|||
146060615|NCT02702492|526739627|FG012|Overall Study|Other|1|||
146397879|NCT04668066|527960104|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397880|NCT04668066|527960105|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397881|NCT04668066|527960106|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397882|NCT04668066|527960107|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
146060616|NCT00781768|526741617|FG000|Overall Study|Not transplanted.|0|||
146060617|NCT00781768|526741618|FG001|Overall Study|Not transplanted.|2|||
146060618|NCT02458313|526741627|FG000|Overall Study|Withdrawal by Subject|6|||
146060619|NCT02458313|526741628|FG001|Overall Study|Withdrawal by Subject|8|||
146060620|NCT02458313|526741627|FG000|Overall Study|Excluded for motion during MRI|1|||
146060621|NCT02458313|526741628|FG001|Overall Study|Excluded for motion during MRI|2|||
146060622|NCT00199381|526741629|FG000|Overall Study|Withdrawal by Subject|38|||
146060623|NCT00199381|526741629|FG000|Overall Study|Adverse Event|73|||
146060624|NCT00199381|526741629|FG000|Overall Study|Protocol Violation|6|||
146060625|NCT00199381|526741629|FG000|Overall Study|Lack of Efficacy|27|||
146060626|NCT00199381|526741629|FG000|Overall Study|Not including due to early termination|37|||
146060627|NCT00199381|526741629|FG000|Overall Study|Study termination by Sponsor|323|||
146060628|NCT02892344|526741631|FG000|Overall Study|Protocol deviation|3|||
146060629|NCT02892344|526741632|FG001|Overall Study|Protocol deviation|4|||
146060630|NCT02892344|526741631|FG000|Overall Study|Adverse Event|1|||
146060631|NCT02892344|526741632|FG001|Overall Study|Adverse Event|8|||
146060632|NCT02892344|526741631|FG000|Overall Study|Lost to Follow-up|0|||
146060633|NCT02892344|526741632|FG001|Overall Study|Lost to Follow-up|1|||
146060634|NCT02892344|526741631|FG000|Overall Study|Non-compliance with study treatment|0|||
146060635|NCT02892344|526741632|FG001|Overall Study|Non-compliance with study treatment|1|||
146060636|NCT02892344|526741631|FG000|Overall Study|Physician Decision|0|||
146060637|NCT02892344|526741632|FG001|Overall Study|Physician Decision|2|||
146060638|NCT02892344|526741631|FG000|Overall Study|Subject/guardian decision|0|||
146060639|NCT02892344|526741632|FG001|Overall Study|Subject/guardian decision|4|||
146060640|NCT02892344|526741631|FG000|Overall Study|Technical problems|0|||
146060641|NCT02892344|526741632|FG001|Overall Study|Technical problems|1|||
146060642|NCT01295814|526741633|FG000|Overall Study|Lack of Efficacy|0|||
146060643|NCT01295814|526741634|FG001|Overall Study|Lack of Efficacy|2|||
146060644|NCT01295814|526741633|FG000|Overall Study|Withdrawal by Subject|2|||
146060645|NCT01295814|526741634|FG001|Overall Study|Withdrawal by Subject|0|||
146060646|NCT03085095|526741636|FG000|Overall Study|Adverse Event|23|||
146060647|NCT03085095|526741637|FG001|Overall Study|Adverse Event|8|||
146060648|NCT03085095|526741636|FG000|Overall Study|Protocol Violation|0|||
146060649|NCT03085095|526741637|FG001|Overall Study|Protocol Violation|1|||
146060650|NCT03085095|526741636|FG000|Overall Study|Lost to Follow-up|2|||
146060651|NCT03085095|526741637|FG001|Overall Study|Lost to Follow-up|1|||
146060652|NCT03085095|526741636|FG000|Overall Study|Withdrawal by Subject|17|||
146060653|NCT03085095|526741637|FG001|Overall Study|Withdrawal by Subject|6|||
146060654|NCT03085095|526741636|FG000|Overall Study|Physician Decision|9|||
146060655|NCT03085095|526741637|FG001|Overall Study|Physician Decision|3|||
146060656|NCT03085095|526741636|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
146060657|NCT03085095|526741637|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
146060658|NCT03085095|526741636|FG000|Overall Study|Did not Receive Study Drug|2|||
146060659|NCT03085095|526741637|FG001|Overall Study|Did not Receive Study Drug|2|||
146060660|NCT03085095|526741636|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
146060661|NCT03085095|526741637|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
146060662|NCT03459079|526741639|FG000|Overall Study|Adverse Event|4|||
146060663|NCT03459079|526741640|FG001|Overall Study|Adverse Event|2|||
146060664|NCT03459079|526741641|FG002|Overall Study|Adverse Event|0|||
146060665|NCT03459079|526741639|FG000|Overall Study|Withdrawal by Subject|2|||
146060666|NCT03459079|526741640|FG001|Overall Study|Withdrawal by Subject|2|||
146060667|NCT03459079|526741641|FG002|Overall Study|Withdrawal by Subject|0|||
146060668|NCT00674817|526741642|FG000|Period 1|Withdrawal by Subject|2|||
146060669|NCT00674817|526741642|FG000|Period 1|Protocol Violation|1|||
146060670|NCT00674817|526741642|FG000|Period 3|Adverse Event|1|||
146060671|NCT00674817|526741642|FG000|Period 3|Protocol Violation|1|||
146060672|NCT00674817|526741642|FG000|Period 4|Adverse Event|1|||
146060673|NCT02379728|526741643|FG000|Overall Study|Lost to Follow-up|1|||
146060674|NCT02379728|526741644|FG001|Overall Study|Lost to Follow-up|0|||
146060675|NCT02379728|526741645|FG002|Overall Study|Lost to Follow-up|3|||
146060676|NCT02379728|526741646|FG003|Overall Study|Lost to Follow-up|0|||
146060677|NCT02379728|526741643|FG000|Overall Study|Withdrawal by Subject|5|||
146060678|NCT02379728|526741644|FG001|Overall Study|Withdrawal by Subject|0|||
146060679|NCT02379728|526741645|FG002|Overall Study|Withdrawal by Subject|5|||
146060680|NCT02379728|526741646|FG003|Overall Study|Withdrawal by Subject|3|||
146060681|NCT02379728|526741643|FG000|Overall Study|Protocol Violation|0|||
146060682|NCT02379728|526741644|FG001|Overall Study|Protocol Violation|0|||
146060683|NCT02379728|526741645|FG002|Overall Study|Protocol Violation|2|||
146060684|NCT02379728|526741646|FG003|Overall Study|Protocol Violation|0|||
146060685|NCT01112917|526741647|FG000|Overall Study|Death|2|||
146060686|NCT01112917|526741648|FG001|Overall Study|Death|11|||
146060687|NCT01112917|526741647|FG000|Overall Study|Lost to Follow-up|1|||
146060688|NCT01112917|526741648|FG001|Overall Study|Lost to Follow-up|1|||
146060689|NCT01112917|526741647|FG000|Overall Study|Withdrawal by Subject|1|||
146060690|NCT01112917|526741648|FG001|Overall Study|Withdrawal by Subject|3|||
146060691|NCT01112917|526741647|FG000|Overall Study|Unable to Convert Filter|3|||
146060692|NCT01112917|526741648|FG001|Overall Study|Unable to Convert Filter|0|||
146060693|NCT05101122|526741649|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
146060694|NCT05101122|526741649|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
146060695|NCT05101122|526741649|FG000|AD313 80/5|Withdrawal by Subject|1|||
146060696|NCT05101122|526741649|FG000|AD313 80/10|Physician Decision|1|||
146060697|NCT03363841|526741650|FG000|Overall Study|Adverse Event|1|||
146060698|NCT03363841|526741650|FG000|Overall Study|Withdrawal by Subject|1|||
146060699|NCT03363841|526741650|FG000|Overall Study|Death|7|||
146060700|NCT03363841|526741650|FG000|Overall Study|Physician Decision|1|||
146060701|NCT02156076|526741653|FG000|Treatment Period|no longer meets study criteria|0|||
146060702|NCT02156076|526741654|FG001|Treatment Period|no longer meets study criteria|0|||
146060703|NCT02156076|526741655|FG002|Treatment Period|no longer meets study criteria|1|||
146060704|NCT02156076|526741656|FG003|Treatment Period|no longer meets study criteria|0|||
146060705|NCT02156076|526741653|FG000|Treatment Period|Poor/non-compliance|0|||
146060706|NCT02156076|526741654|FG001|Treatment Period|Poor/non-compliance|1|||
146060707|NCT02156076|526741655|FG002|Treatment Period|Poor/non-compliance|0|||
146060708|NCT02156076|526741656|FG003|Treatment Period|Poor/non-compliance|0|||
146060709|NCT02156076|526741653|FG000|Treatment Period|Lost to Follow-up|0|||
146060710|NCT02156076|526741654|FG001|Treatment Period|Lost to Follow-up|0|||
146060711|NCT02156076|526741655|FG002|Treatment Period|Lost to Follow-up|0|||
146060712|NCT02156076|526741656|FG003|Treatment Period|Lost to Follow-up|1|||
146060713|NCT02156076|526741653|FG000|Treatment Period|Withdrawal by Subject|0|||
146060714|NCT02156076|526741654|FG001|Treatment Period|Withdrawal by Subject|0|||
146060715|NCT02156076|526741655|FG002|Treatment Period|Withdrawal by Subject|1|||
146060716|NCT02156076|526741656|FG003|Treatment Period|Withdrawal by Subject|0|||
146060717|NCT02156076|526741653|FG000|Treatment Period|Subject request to discontinue treatment|0|||
146060718|NCT02156076|526741654|FG001|Treatment Period|Subject request to discontinue treatment|1|||
146060719|NCT02156076|526741655|FG002|Treatment Period|Subject request to discontinue treatment|0|||
146060720|NCT02156076|526741656|FG003|Treatment Period|Subject request to discontinue treatment|0|||
146060721|NCT02156076|526741653|FG000|Treatment Period|Adverse Event|0|||
146060722|NCT02156076|526741654|FG001|Treatment Period|Adverse Event|0|||
146060723|NCT02156076|526741655|FG002|Treatment Period|Adverse Event|0|||
146060724|NCT02156076|526741656|FG003|Treatment Period|Adverse Event|1|||
146060725|NCT02156076|526741653|FG000|Follow-up Period|Withdrawal by Subject|1|||
146169828|NCT05044325|527134727|FG002|Part A:Treatment Period 1|Adverse Event|0|||
146169829|NCT05044325|527134728|FG003|Part A:Treatment Period 1|Adverse Event|0|||
146169830|NCT05044325|527134729|FG004|Part A:Treatment Period 1|Adverse Event|0|||
146169831|NCT05044325|527134730|FG005|Part A:Treatment Period 1|Adverse Event|1|||
146169832|NCT05044325|527134731|FG006|Part A:Treatment Period 1|Adverse Event|0|||
146169833|NCT05044325|527134732|FG007|Part A:Treatment Period 1|Adverse Event|1|||
146169834|NCT05044325|527134733|FG008|Part A:Treatment Period 1|Adverse Event|0|||
146169835|NCT05044325|527134734|FG009|Part A:Treatment Period 1|Adverse Event|0|||
146169836|NCT05044325|527134725|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169837|NCT05044325|527134726|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169838|NCT05044325|527134727|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169839|NCT05044325|527134728|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146169840|NCT05044325|527134729|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146169841|NCT05044325|527134730|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
146169842|NCT05044325|527134731|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169843|NCT05044325|527134732|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169844|NCT05044325|527134733|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169845|NCT05044325|527134734|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
146169846|NCT05044325|527134725|FG000|Part A:Treatment Period 1|Physician Decision|0|||
146169847|NCT05044325|527134726|FG001|Part A:Treatment Period 1|Physician Decision|0|||
146169848|NCT05044325|527134727|FG002|Part A:Treatment Period 1|Physician Decision|0|||
146169849|NCT05044325|527134728|FG003|Part A:Treatment Period 1|Physician Decision|0|||
146169850|NCT05044325|527134729|FG004|Part A:Treatment Period 1|Physician Decision|0|||
146169851|NCT05044325|527134730|FG005|Part A:Treatment Period 1|Physician Decision|0|||
146169852|NCT05044325|527134731|FG006|Part A:Treatment Period 1|Physician Decision|1|||
146169853|NCT05044325|527134732|FG007|Part A:Treatment Period 1|Physician Decision|0|||
146169854|NCT05044325|527134733|FG008|Part A:Treatment Period 1|Physician Decision|0|||
146169855|NCT05044325|527134734|FG009|Part A:Treatment Period 1|Physician Decision|0|||
146169856|NCT05044325|527134725|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169857|NCT05044325|527134726|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169858|NCT05044325|527134727|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
146169859|NCT05044325|527134728|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169860|NCT05044325|527134729|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169861|NCT05044325|527134730|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169862|NCT05044325|527134731|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169863|NCT05044325|527134732|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169864|NCT05044325|527134733|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169865|NCT05044325|527134734|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
146169866|NCT05044325|527134725|FG000|Part A:Treatment Period 2|Adverse Event|0|||
146169867|NCT05044325|527134726|FG001|Part A:Treatment Period 2|Adverse Event|1|||
146169868|NCT05044325|527134727|FG002|Part A:Treatment Period 2|Adverse Event|0|||
146169869|NCT05044325|527134728|FG003|Part A:Treatment Period 2|Adverse Event|0|||
146169870|NCT05044325|527134729|FG004|Part A:Treatment Period 2|Adverse Event|1|||
146169871|NCT05044325|527134730|FG005|Part A:Treatment Period 2|Adverse Event|1|||
146169872|NCT05044325|527134731|FG006|Part A:Treatment Period 2|Adverse Event|0|||
146169873|NCT05044325|527134732|FG007|Part A:Treatment Period 2|Adverse Event|0|||
146169874|NCT05044325|527134733|FG008|Part A:Treatment Period 2|Adverse Event|0|||
146169875|NCT05044325|527134734|FG009|Part A:Treatment Period 2|Adverse Event|0|||
146169876|NCT05044325|527134725|FG000|Part A:Treatment Period 2|Physician Decision|0|||
146169877|NCT05044325|527134726|FG001|Part A:Treatment Period 2|Physician Decision|0|||
146397883|NCT04668066|527960108|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
146397884|NCT04668066|527960109|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
146397885|NCT02369874|527960110|FG000|Overall Study|Lost to Follow-up|2|||
146397886|NCT02369874|527960111|FG001|Overall Study|Lost to Follow-up|2|||
146397887|NCT02369874|527960112|FG002|Overall Study|Lost to Follow-up|2|||
146397888|NCT02369874|527960110|FG000|Overall Study|Withdrawal by Subject|7|||
146397889|NCT02369874|527960111|FG001|Overall Study|Withdrawal by Subject|9|||
146397890|NCT02369874|527960112|FG002|Overall Study|Withdrawal by Subject|27|||
146397891|NCT02369874|527960110|FG000|Overall Study|Miscellaneous|1|||
146397892|NCT02369874|527960111|FG001|Overall Study|Miscellaneous|1|||
146397893|NCT02369874|527960112|FG002|Overall Study|Miscellaneous|0|||
146397894|NCT02369874|527960110|FG000|Overall Study|On Treatment/Off Study|34|||
146397895|NCT02369874|527960111|FG001|Overall Study|On Treatment/Off Study|45|||
146397896|NCT02369874|527960112|FG002|Overall Study|On Treatment/Off Study|32|||
146397897|NCT02331680|527960113|FG000|Overall Study|Adverse Event|3|||
146397898|NCT02331680|527960114|FG001|Overall Study|Adverse Event|0|||
146397899|NCT02331680|527960115|FG002|Overall Study|Adverse Event|2|||
146397900|NCT02331680|527960113|FG000|Overall Study|Physician Decision|1|||
146397901|NCT02331680|527960114|FG001|Overall Study|Physician Decision|1|||
146397902|NCT02331680|527960115|FG002|Overall Study|Physician Decision|2|||
146397903|NCT02331680|527960113|FG000|Overall Study|Withdrawal by Subject|0|||
146397904|NCT02331680|527960114|FG001|Overall Study|Withdrawal by Subject|1|||
146397905|NCT02331680|527960115|FG002|Overall Study|Withdrawal by Subject|2|||
146397906|NCT02331680|527960113|FG000|Overall Study|Met withdrawal criteria|2|||
146397907|NCT02331680|527960114|FG001|Overall Study|Met withdrawal criteria|2|||
146397908|NCT02331680|527960115|FG002|Overall Study|Met withdrawal criteria|5|||
146397909|NCT02331680|527960113|FG000|Overall Study|Non-compliance with study drug|0|||
146397910|NCT02331680|527960114|FG001|Overall Study|Non-compliance with study drug|0|||
146397911|NCT02331680|527960115|FG002|Overall Study|Non-compliance with study drug|1|||
146397912|NCT02331680|527960113|FG000|Overall Study|Protocol Violation|0|||
146397913|NCT02331680|527960114|FG001|Overall Study|Protocol Violation|0|||
146397914|NCT02331680|527960115|FG002|Overall Study|Protocol Violation|3|||
146397915|NCT00596466|527960116|FG000|Overall Study|Lack of Efficacy|5|||
146397916|NCT00596466|527960116|FG000|Overall Study|Adverse Event|4|||
146397917|NCT00596466|527960116|FG000|Overall Study|Withdrawal by Subject|2|||
146397918|NCT00596466|527960116|FG000|Overall Study|Protocol Violation|2|||
146397919|NCT00596466|527960116|FG000|Overall Study|Unpecified|2|||
146397920|NCT00596466|527960116|FG000|Overall Study|Enrolled, not treated|2|||
146397921|NCT00145795|527960117|FG000|Overall Study|Adverse Event|1|||
146397922|NCT00145795|527960118|FG001|Overall Study|Adverse Event|0|||
146397923|NCT01891669|527960119|FG000|Overall Study|Death|0|||
146397924|NCT01891669|527960120|FG001|Overall Study|Death|0|||
146397925|NCT01891669|527960121|FG002|Overall Study|Death|0|||
146397926|NCT01891669|527960122|FG003|Overall Study|Death|0|||
146397927|NCT01891669|527960123|FG004|Overall Study|Death|0|||
146397928|NCT01891669|527960124|FG005|Overall Study|Death|0|||
146397929|NCT01891669|527960125|FG006|Overall Study|Death|0|||
146397930|NCT01891669|527960126|FG007|Overall Study|Death|1|||
146397931|NCT01891669|527960127|FG008|Overall Study|Death|0|||
146397932|NCT01891669|527960128|FG009|Overall Study|Death|1|||
146397933|NCT01891669|527960119|FG000|Overall Study|Withdrawal by Subject|1|||
146397934|NCT01891669|527960120|FG001|Overall Study|Withdrawal by Subject|1|||
146397935|NCT01891669|527960121|FG002|Overall Study|Withdrawal by Subject|0|||
146397936|NCT01891669|527960122|FG003|Overall Study|Withdrawal by Subject|0|||
146397937|NCT01891669|527960123|FG004|Overall Study|Withdrawal by Subject|0|||
146397938|NCT01891669|527960124|FG005|Overall Study|Withdrawal by Subject|0|||
146397939|NCT01891669|527960125|FG006|Overall Study|Withdrawal by Subject|1|||
146169878|NCT05044325|527134727|FG002|Part A:Treatment Period 2|Physician Decision|0|||
146169879|NCT05044325|527134728|FG003|Part A:Treatment Period 2|Physician Decision|0|||
146169880|NCT05044325|527134729|FG004|Part A:Treatment Period 2|Physician Decision|0|||
146169881|NCT05044325|527134730|FG005|Part A:Treatment Period 2|Physician Decision|1|||
146397940|NCT01891669|527960126|FG007|Overall Study|Withdrawal by Subject|2|||
146397941|NCT01891669|527960127|FG008|Overall Study|Withdrawal by Subject|1|||
146397942|NCT01891669|527960128|FG009|Overall Study|Withdrawal by Subject|1|||
146397943|NCT01891669|527960119|FG000|Overall Study|Other|1|||
146397944|NCT01891669|527960120|FG001|Overall Study|Other|0|||
146397945|NCT01891669|527960121|FG002|Overall Study|Other|0|||
146397946|NCT01891669|527960122|FG003|Overall Study|Other|0|||
146397947|NCT01891669|527960123|FG004|Overall Study|Other|0|||
146397948|NCT01891669|527960124|FG005|Overall Study|Other|0|||
146397949|NCT01891669|527960125|FG006|Overall Study|Other|0|||
146397950|NCT01891669|527960126|FG007|Overall Study|Other|1|||
146397951|NCT01891669|527960127|FG008|Overall Study|Other|0|||
146397952|NCT01891669|527960128|FG009|Overall Study|Other|0|||
146397953|NCT01015118|527960129|FG000|Overall Study|Protocol Violation|5|||
146397954|NCT01015118|527960130|FG001|Overall Study|Protocol Violation|6|||
146397955|NCT01015118|527960129|FG000|Overall Study|Withdrawal by Subject|103|||
146397956|NCT01015118|527960130|FG001|Overall Study|Withdrawal by Subject|27|||
146397957|NCT01015118|527960129|FG000|Overall Study|Other Adverse Event (AE)|141|||
146397958|NCT01015118|527960130|FG001|Overall Study|Other Adverse Event (AE)|33|||
146397959|NCT01015118|527960129|FG000|Overall Study|Worsening or AE of underlying disease|5|||
146397960|NCT01015118|527960130|FG001|Overall Study|Worsening or AE of underlying disease|4|||
146397961|NCT01015118|527960129|FG000|Overall Study|Progressive disease|364|||
146397962|NCT01015118|527960130|FG001|Overall Study|Progressive disease|229|||
146397963|NCT01015118|527960129|FG000|Overall Study|Not treated|9|||
146397964|NCT01015118|527960130|FG001|Overall Study|Not treated|5|||
146397965|NCT01015118|527960129|FG000|Overall Study|Other than stated above|42|||
146397966|NCT01015118|527960130|FG001|Overall Study|Other than stated above|23|||
146397967|NCT03522506|527960131|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146397968|NCT03522506|527960132|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146397969|NCT03522506|527960133|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146397970|NCT03522506|527960134|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146397971|NCT03522506|527960131|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146397972|NCT03522506|527960132|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146397973|NCT03522506|527960133|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146397974|NCT03522506|527960134|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
146397975|NCT03480243|527960135|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
146397976|NCT03480243|527960135|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
146397977|NCT02388906|527960144|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146397978|NCT02388906|527960145|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146397979|NCT02388906|527960144|FG000|Treatment Period|Disease progression|121|||
146397980|NCT02388906|527960145|FG001|Treatment Period|Disease progression|100|||
146397981|NCT02388906|527960144|FG000|Treatment Period|Study drug toxicity|41|||
146397982|NCT02388906|527960145|FG001|Treatment Period|Study drug toxicity|208|||
146397983|NCT02388906|527960144|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
146397984|NCT02388906|527960145|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
146397985|NCT02388906|527960144|FG000|Treatment Period|Participant request to stop treatment|5|||
146397986|NCT02388906|527960145|FG001|Treatment Period|Participant request to stop treatment|9|||
146397987|NCT02388906|527960144|FG000|Treatment Period|Participant withdrew consent|2|||
146397988|NCT02388906|527960145|FG001|Treatment Period|Participant withdrew consent|3|||
146397989|NCT02388906|527960144|FG000|Treatment Period|Poor/non-compliance|0|||
146397990|NCT02388906|527960145|FG001|Treatment Period|Poor/non-compliance|1|||
146397991|NCT02388906|527960144|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146397992|NCT02388906|527960145|FG001|Treatment Period|Participant no longer meets study criteria|1|||
146397993|NCT02388906|527960144|FG000|Treatment Period|Other reasons|3|||
146397994|NCT02388906|527960145|FG001|Treatment Period|Other reasons|3|||
146397995|NCT04365387|527960146|FG000|Overall Study|Adverse Event|4|||
146397996|NCT04365387|527960147|FG001|Overall Study|Adverse Event|2|||
146397997|NCT04365387|527960146|FG000|Overall Study|Participants request|14|||
146397998|NCT04365387|527960147|FG001|Overall Study|Participants request|14|||
146397999|NCT04365387|527960146|FG000|Overall Study|Lost to Follow-up|8|||
146398000|NCT04365387|527960147|FG001|Overall Study|Lost to Follow-up|5|||
146398001|NCT04365387|527960146|FG000|Overall Study|Protocol deviation|3|||
146398002|NCT04365387|527960147|FG001|Overall Study|Protocol deviation|4|||
146398003|NCT04365387|527960146|FG000|Overall Study|Participant compliance with visit schedule|1|||
146398004|NCT04365387|527960147|FG001|Overall Study|Participant compliance with visit schedule|0|||
146398005|NCT04365387|527960146|FG000|Overall Study|Participant incarcerated|1|||
146398006|NCT04365387|527960147|FG001|Overall Study|Participant incarcerated|0|||
146398007|NCT04365387|527960146|FG000|Overall Study|Participant moved out of town (relocated)|0|||
146398008|NCT04365387|527960147|FG001|Overall Study|Participant moved out of town (relocated)|1|||
146398009|NCT04365387|527960146|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
146398010|NCT04365387|527960147|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
146398011|NCT04365387|527960146|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
146398012|NCT04365387|527960147|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
146398013|NCT05770401|527960156|FG000|Overall Study|Lost to Follow-up|5|||
146398014|NCT05770401|527960157|FG001|Overall Study|Lost to Follow-up|4|||
146398015|NCT00402298|527960158|FG000|Overall Study|Withdrawal by Subject|1|||
146398016|NCT00402298|527960159|FG001|Overall Study|Withdrawal by Subject|0|||
146169882|NCT05044325|527134731|FG006|Part A:Treatment Period 2|Physician Decision|0|||
145945134|NCT01546038|526308135|FG007|Overall Study|: Randomized, not treated|4|||
146398017|NCT04784455|527960160|FG000|Overall Study|Death|4|||
146398018|NCT04298229|527960161|FG000|Overall Study|Physician Decision|1|||
146398019|NCT04298229|527960162|FG001|Overall Study|Physician Decision|1|||
146398020|NCT04298229|527960161|FG000|Overall Study|Withdrawal by Subject|1|||
146398021|NCT04298229|527960162|FG001|Overall Study|Withdrawal by Subject|1|||
146398022|NCT04298229|527960161|FG000|Overall Study|Did not receive IV loop diuretics|2|||
146398023|NCT04298229|527960162|FG001|Overall Study|Did not receive IV loop diuretics|0|||
146398024|NCT00859313|527960163|FG000|Overall Study|Lack of Efficacy|2|||
146398025|NCT00859313|527960163|FG000|Overall Study|Adverse Event|1|||
146398026|NCT00859313|527960163|FG000|Overall Study|staff error|1|||
146398027|NCT05939388|527960164|FG000|Overall Study|Lost to Follow-up|1|||
146398028|NCT04527380|527960167|FG000|Overall Study|Lack of Efficacy|0|||
146398029|NCT04527380|527960168|FG001|Overall Study|Lack of Efficacy|1|||
146398030|NCT04527380|527960167|FG000|Overall Study|Withdrawal by Subject|1|||
146398031|NCT04527380|527960168|FG001|Overall Study|Withdrawal by Subject|0|||
146398032|NCT01958619|527960171|FG000|Overall Study|Protocol Violation|2|||
146398033|NCT01958619|527960172|FG001|Overall Study|Protocol Violation|0|||
146398034|NCT01958619|527960173|FG002|Overall Study|Protocol Violation|1|||
146398035|NCT01958619|527960174|FG003|Overall Study|Protocol Violation|0|||
146398036|NCT04794491|527960177|FG000|Overall Study|Adverse Event|1|||
146398037|NCT04794491|527960177|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
146398038|NCT04794491|527960177|FG000|Overall Study|Noncompliance With Study Intervention|1|||
146398039|NCT04794491|527960177|FG000|Overall Study|Withdrawal by Subject|2|||
146398040|NCT00931515|527960178|FG000|Overall Study|Lost to Follow-up|2|||
146398041|NCT00931515|527960179|FG001|Overall Study|Lost to Follow-up|5|||
146398042|NCT03759340|527960180|FG000|Overall Study|Adverse Event|2|||
146398043|NCT03759340|527960180|FG000|Overall Study|Lost to Follow-up|1|||
146398044|NCT03759340|527960180|FG000|Overall Study|Withdrawal by Subject|15|||
146398045|NCT03759340|527960180|FG000|Overall Study|Study Terminated by Sponsor|38|||
146398046|NCT02711306|527960186|FG000|Overall Study|Withdrawal by Subject|2|||
146398047|NCT02711306|527960187|FG001|Overall Study|Withdrawal by Subject|2|||
146398048|NCT03145207|527960192|FG000|Overall Study|volunteer started taking allergy shots|1|||
146398049|NCT03145207|527960192|FG000|Overall Study|baseline blood pressure high|1|||
146398050|NCT01396434|527960193|FG000|Overall Study|Lost to Follow-up|1|||
146398051|NCT01396434|527960194|FG001|Overall Study|Lost to Follow-up|0|||
146398052|NCT01396434|527960195|FG002|Overall Study|Lost to Follow-up|0|||
146398053|NCT01396434|527960193|FG000|Overall Study|Other|10|||
146398054|NCT01396434|527960194|FG001|Overall Study|Other|0|||
146398055|NCT01396434|527960195|FG002|Overall Study|Other|0|||
146398056|NCT00563706|527962260|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
146398057|NCT00563706|527962261|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146398058|NCT00563706|527962262|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146398059|NCT00563706|527962263|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146398060|NCT00563706|527962264|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146398061|NCT00563706|527962265|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146398062|NCT00563706|527962266|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
146398063|NCT00563706|527962267|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
146398064|NCT00563706|527962268|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
146398065|NCT00563706|527962260|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146398066|NCT00563706|527962261|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146398067|NCT00563706|527962262|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146398068|NCT00563706|527962263|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
146398069|NCT00563706|527962264|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146398070|NCT00563706|527962265|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146398071|NCT00563706|527962266|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
146398072|NCT00563706|527962267|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
146398073|NCT00563706|527962268|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
146398074|NCT00563706|527962260|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
146398075|NCT00563706|527962261|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146398076|NCT00563706|527962262|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
146398077|NCT00563706|527962263|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
146398078|NCT00563706|527962264|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
146398079|NCT00563706|527962265|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146398080|NCT00563706|527962266|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
146398081|NCT00563706|527962267|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
146398082|NCT00563706|527962268|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
146398083|NCT00563706|527962260|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
146398084|NCT00563706|527962261|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398085|NCT00563706|527962262|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398086|NCT00563706|527962263|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398087|NCT00563706|527962264|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398088|NCT00563706|527962265|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398089|NCT00563706|527962266|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398090|NCT00563706|527962267|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
146398091|NCT00563706|527962268|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
146398092|NCT00563706|527962260|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398093|NCT00563706|527962261|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398094|NCT00563706|527962262|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398095|NCT00563706|527962263|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398096|NCT00563706|527962264|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398097|NCT00563706|527962265|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398098|NCT00563706|527962266|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
146398099|NCT00563706|527962267|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
146398100|NCT00563706|527962268|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
146398101|NCT03280628|527962271|FG000|Overall Study|Lost to Follow-up|8|||
146398102|NCT03280628|527962272|FG001|Overall Study|Lost to Follow-up|6|||
146398103|NCT03280628|527962273|FG002|Overall Study|Lost to Follow-up|11|||
146398104|NCT01361308|527962276|FG000|Overall Study|Withdrawal by Subject|9|||
146398105|NCT01361308|527962277|FG001|Overall Study|Withdrawal by Subject|13|||
146398106|NCT01361308|527962276|FG000|Overall Study|Physician Decision|3|||
146398107|NCT01361308|527962277|FG001|Overall Study|Physician Decision|3|||
146398108|NCT01361308|527962276|FG000|Overall Study|Lack of Efficacy|2|||
146398109|NCT01361308|527962277|FG001|Overall Study|Lack of Efficacy|0|||
146398110|NCT01361308|527962276|FG000|Overall Study|Protocol Violation|1|||
146398111|NCT01361308|527962277|FG001|Overall Study|Protocol Violation|0|||
146398112|NCT01361308|527962276|FG000|Overall Study|Lost to Follow-up|5|||
146398113|NCT01361308|527962277|FG001|Overall Study|Lost to Follow-up|4|||
146398114|NCT01361308|527962276|FG000|Overall Study|Adverse Event|8|||
146398115|NCT01361308|527962277|FG001|Overall Study|Adverse Event|4|||
146398116|NCT01361308|527962276|FG000|Overall Study|Eligibility Criteria Not Met|2|||
146398117|NCT01361308|527962277|FG001|Overall Study|Eligibility Criteria Not Met|3|||
146398118|NCT01361308|527962276|FG000|Overall Study|Failed C-SSRS|5|||
146398119|NCT01361308|527962277|FG001|Overall Study|Failed C-SSRS|2|||
146398120|NCT01361308|527962276|FG000|Overall Study|Other|0|||
146398121|NCT01361308|527962277|FG001|Overall Study|Other|1|||
146398122|NCT03839693|527962282|FG000|Overall Study|Lost to Follow-up|0|||
146398123|NCT03839693|527962283|FG001|Overall Study|Lost to Follow-up|2|||
146398124|NCT03839693|527962284|FG002|Overall Study|Lost to Follow-up|2|||
146398125|NCT03839693|527962282|FG000|Overall Study|Withdrawal by Subject|1|||
146398126|NCT03839693|527962283|FG001|Overall Study|Withdrawal by Subject|0|||
146398127|NCT03839693|527962284|FG002|Overall Study|Withdrawal by Subject|2|||
146398128|NCT03839693|527962282|FG000|Overall Study|subject moved out of the area|1|||
146398129|NCT03839693|527962283|FG001|Overall Study|subject moved out of the area|0|||
146398130|NCT03839693|527962284|FG002|Overall Study|subject moved out of the area|0|||
146398131|NCT00700115|527962293|FG000|Overall Study|Withdrawal by Subject|1|||
146398132|NCT00700115|527962294|FG001|Overall Study|Withdrawal by Subject|0|||
146398133|NCT00700115|527962293|FG000|Overall Study|Lost to Follow-up|0|||
146398134|NCT00700115|527962294|FG001|Overall Study|Lost to Follow-up|1|||
146398135|NCT02503215|527962295|FG000|Overall Study|Unable to wear compression stockings|1|||
146398136|NCT02503215|527962295|FG000|Overall Study|Unable to use positive airway pressure|2|||
146398137|NCT00706901|527962296|FG000|Overall Study|Lost to Follow-up|2|||
146398138|NCT00706901|527962297|FG001|Overall Study|Lost to Follow-up|3|||
146398139|NCT00706901|527962298|FG002|Overall Study|Lost to Follow-up|2|||
146398140|NCT00706901|527962296|FG000|Overall Study|Withdrawal by Subject|4|||
146398141|NCT00706901|527962297|FG001|Overall Study|Withdrawal by Subject|2|||
146398142|NCT00706901|527962298|FG002|Overall Study|Withdrawal by Subject|5|||
146398143|NCT00706901|527962296|FG000|Overall Study|In Jail|1|||
146398144|NCT00706901|527962297|FG001|Overall Study|In Jail|0|||
146398145|NCT00706901|527962298|FG002|Overall Study|In Jail|1|||
146398146|NCT00706901|527962296|FG000|Overall Study|Death|1|||
146398147|NCT00706901|527962297|FG001|Overall Study|Death|0|||
146398148|NCT00706901|527962298|FG002|Overall Study|Death|0|||
146398149|NCT03433482|527962299|FG000|Overall Study|Lost to Follow-up|1|||
146398150|NCT03433482|527962300|FG001|Overall Study|Lost to Follow-up|0|||
146398151|NCT03433482|527962301|FG002|Overall Study|Lost to Follow-up|1|||
146398152|NCT03433482|527962302|FG003|Overall Study|Lost to Follow-up|1|||
146398153|NCT03433482|527962299|FG000|Overall Study|Withdrawal by Subject|0|||
146398154|NCT03433482|527962300|FG001|Overall Study|Withdrawal by Subject|0|||
146398155|NCT03433482|527962301|FG002|Overall Study|Withdrawal by Subject|1|||
146398156|NCT03433482|527962302|FG003|Overall Study|Withdrawal by Subject|0|||
146398157|NCT03433482|527962299|FG000|Overall Study|Unknown reason|0|||
146398158|NCT03433482|527962300|FG001|Overall Study|Unknown reason|0|||
146398159|NCT03433482|527962301|FG002|Overall Study|Unknown reason|2|||
146398160|NCT03433482|527962302|FG003|Overall Study|Unknown reason|0|||
146398161|NCT01646268|527962303|FG000|Overall Study|Adverse Event|6|||
146398162|NCT01646268|527962304|FG001|Overall Study|Adverse Event|7|||
146398163|NCT01646268|527962303|FG000|Overall Study|Lack of Efficacy|1|||
146398164|NCT01646268|527962304|FG001|Overall Study|Lack of Efficacy|3|||
146398165|NCT01646268|527962303|FG000|Overall Study|Protocol Violation|0|||
146398166|NCT01646268|527962304|FG001|Overall Study|Protocol Violation|1|||
146398167|NCT01646268|527962303|FG000|Overall Study|Withdrawal by Subject|2|||
146398168|NCT01646268|527962304|FG001|Overall Study|Withdrawal by Subject|5|||
146398169|NCT01646268|527962303|FG000|Overall Study|Other|2|||
146398170|NCT01646268|527962304|FG001|Overall Study|Other|0|||
146398171|NCT00347776|527962307|FG000|1.5 Month Follow-up|Death|2|||
146398172|NCT00347776|527962308|FG001|1.5 Month Follow-up|Death|0|||
146398173|NCT00347776|527962309|FG002|1.5 Month Follow-up|Death|0|||
146398174|NCT00347776|527962307|FG000|1.5 Month Follow-up|reached the endpoint|12|||
146398175|NCT00347776|527962308|FG001|1.5 Month Follow-up|reached the endpoint|8|||
146398176|NCT00347776|527962309|FG002|1.5 Month Follow-up|reached the endpoint|12|||
146398177|NCT00347776|527962307|FG000|6 Month Follow-up|Death|2|||
146398178|NCT00347776|527962308|FG001|6 Month Follow-up|Death|1|||
146398179|NCT00347776|527962309|FG002|6 Month Follow-up|Death|3|||
146398180|NCT00347776|527962307|FG000|6 Month Follow-up|reached endpont|20|||
146398181|NCT00347776|527962308|FG001|6 Month Follow-up|reached endpont|12|||
146398182|NCT00347776|527962309|FG002|6 Month Follow-up|reached endpont|15|||
146398183|NCT00347776|527962307|FG000|12 Month Follow-up|Lost to Follow-up|7|||
146398184|NCT00347776|527962308|FG001|12 Month Follow-up|Lost to Follow-up|6|||
146398185|NCT00347776|527962309|FG002|12 Month Follow-up|Lost to Follow-up|6|||
146398186|NCT00347776|527962307|FG000|12 Month Follow-up|Death|3|||
146398187|NCT00347776|527962308|FG001|12 Month Follow-up|Death|4|||
146398188|NCT00347776|527962309|FG002|12 Month Follow-up|Death|4|||
146398189|NCT00347776|527962307|FG000|12 Month Follow-up|Reached endpoint|13|||
146398190|NCT00347776|527962308|FG001|12 Month Follow-up|Reached endpoint|6|||
146398191|NCT00347776|527962309|FG002|12 Month Follow-up|Reached endpoint|9|||
146398192|NCT00968539|527962310|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
146398193|NCT00968539|527962311|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146398194|NCT00457249|527962312|FG000|Overall Study|Lost to Follow-up|3|||
146398195|NCT00457249|527962313|FG001|Overall Study|Lost to Follow-up|0|||
146398196|NCT00457249|527962312|FG000|Overall Study|Protocol Violation|4|||
146398197|NCT00457249|527962313|FG001|Overall Study|Protocol Violation|1|||
146398198|NCT00457249|527962312|FG000|Overall Study|Withdrawal by Subject|3|||
146398199|NCT00457249|527962313|FG001|Overall Study|Withdrawal by Subject|1|||
146398200|NCT00457249|527962312|FG000|Overall Study|Serious Adverse Events|2|||
146398201|NCT00457249|527962313|FG001|Overall Study|Serious Adverse Events|0|||
146398202|NCT00326118|527962314|FG000|Active Phase|Withdrawal by Subject|4|||
146398203|NCT00326118|527962315|FG001|Active Phase|Withdrawal by Subject|1|||
146398204|NCT00938392|527962316|FG000|Overall Study|Adverse Event|0|||
146398205|NCT00938392|527962317|FG001|Overall Study|Adverse Event|1|||
146398206|NCT00938392|527962316|FG000|Overall Study|Withdrawal by Subject|0|||
146398207|NCT00938392|527962317|FG001|Overall Study|Withdrawal by Subject|1|||
146398208|NCT00938392|527962316|FG000|Overall Study|Lost to Follow-up|2|||
146398209|NCT00938392|527962317|FG001|Overall Study|Lost to Follow-up|2|||
146398210|NCT02916056|527962318|FG000|Overall Study|Adverse Event|6|||
146398211|NCT02916056|527962318|FG000|Overall Study|Lost to Follow-up|1|||
146398212|NCT02916056|527962318|FG000|Overall Study|Other|12|||
146398213|NCT02916056|527962318|FG000|Overall Study|Protocol Violation|1|||
146398214|NCT02916056|527962318|FG000|Overall Study|Withdrawal by Subject|8|||
146398215|NCT02916056|527962318|FG000|Overall Study|Study Terminated by Sponsor|269|||
146398216|NCT00124709|527962319|FG000|Overall Study|Randomized but did not take medication|3|||
146398217|NCT00124709|527962320|FG001|Overall Study|Randomized but did not take medication|1|||
146398218|NCT00124709|527962319|FG000|Overall Study|Adverse Event|3|||
146398219|NCT00124709|527962320|FG001|Overall Study|Adverse Event|0|||
146398220|NCT00124709|527962319|FG000|Overall Study|Lack of Efficacy|5|||
146398221|NCT00124709|527962320|FG001|Overall Study|Lack of Efficacy|10|||
146398222|NCT00124709|527962319|FG000|Overall Study|Protocol Violation|3|||
146398223|NCT00124709|527962320|FG001|Overall Study|Protocol Violation|5|||
146398224|NCT00124709|527962319|FG000|Overall Study|Withdrawal by Subject|127|||
146398225|NCT00124709|527962320|FG001|Overall Study|Withdrawal by Subject|136|||
146398226|NCT00124709|527962319|FG000|Overall Study|Lost to Follow-up|114|||
146398227|NCT00124709|527962320|FG001|Overall Study|Lost to Follow-up|120|||
146398228|NCT05604521|527962323|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
146398229|NCT05604521|527962324|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
146398230|NCT05604521|527962323|FG000|Overall Study|Adverse Event|1|||
146398231|NCT05604521|527962324|FG001|Overall Study|Adverse Event|0|||
146398232|NCT01491737|527962325|FG000|Overall Study|Withdrawal by Subject|20|||
146398233|NCT01491737|527962326|FG001|Overall Study|Withdrawal by Subject|17|||
146398234|NCT01491737|527962325|FG000|Overall Study|Lost to Follow-up|2|||
146398235|NCT01491737|527962326|FG001|Overall Study|Lost to Follow-up|10|||
146398236|NCT01491737|527962325|FG000|Overall Study|Death|63|||
146398237|NCT01491737|527962326|FG001|Overall Study|Death|57|||
146398238|NCT01491737|527962325|FG000|Overall Study|Study Termination by Sponsor|36|||
146398239|NCT01491737|527962326|FG001|Overall Study|Study Termination by Sponsor|36|||
146398240|NCT01491737|527962325|FG000|Overall Study|Reason Not Specified|8|||
146398241|NCT01491737|527962326|FG001|Overall Study|Reason Not Specified|9|||
146398242|NCT05993299|527962328|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
146398243|NCT05993299|527962328|FG000|Overall Study|Ongoing|4|||
146398244|NCT05644756|527962329|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
146398245|NCT05644756|527962329|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
146398246|NCT03110107|527962330|FG000|Treatment Period|Disease Progression|3|||
146398247|NCT03110107|527962331|FG001|Treatment Period|Disease Progression|9|||
146398248|NCT03110107|527962332|FG002|Treatment Period|Disease Progression|8|||
146398249|NCT03110107|527962333|FG003|Treatment Period|Disease Progression|11|||
146398250|NCT03110107|527962334|FG004|Treatment Period|Disease Progression|8|||
146398251|NCT03110107|527962335|FG005|Treatment Period|Disease Progression|4|||
146398252|NCT03110107|527962336|FG006|Treatment Period|Disease Progression|6|||
146398253|NCT03110107|527962337|FG007|Treatment Period|Disease Progression|7|||
146398254|NCT03110107|527962338|FG008|Treatment Period|Disease Progression|2|||
146398255|NCT03110107|527962339|FG009|Treatment Period|Disease Progression|10|||
146398256|NCT03110107|527962340|FG010|Treatment Period|Disease Progression|5|||
146398257|NCT03110107|527962341|FG011|Treatment Period|Disease Progression|2|||
146398258|NCT03110107|527962342|FG012|Treatment Period|Disease Progression|0|||
146398259|NCT03110107|527962343|FG013|Treatment Period|Disease Progression|5|||
146398260|NCT03110107|527962344|FG014|Treatment Period|Disease Progression|14|||
146398261|NCT03110107|527962345|FG015|Treatment Period|Disease Progression|14|||
146398262|NCT03110107|527962346|FG016|Treatment Period|Disease Progression|4|||
146398263|NCT03110107|527962347|FG017|Treatment Period|Disease Progression|3|||
146398264|NCT03110107|527962348|FG018|Treatment Period|Disease Progression|16|||
146398265|NCT03110107|527962349|FG019|Treatment Period|Disease Progression|14|||
146398266|NCT03110107|527962350|FG020|Treatment Period|Disease Progression|12|||
146398267|NCT03110107|527962351|FG021|Treatment Period|Disease Progression|16|||
146398268|NCT03110107|527962352|FG022|Treatment Period|Disease Progression|18|||
146398269|NCT03110107|527962353|FG023|Treatment Period|Disease Progression|13|||
146398270|NCT03110107|527962354|FG024|Treatment Period|Disease Progression|16|||
146398271|NCT03110107|527962355|FG025|Treatment Period|Disease Progression|31|||
146398272|NCT03110107|527962330|FG000|Treatment Period|Study drug toxicity|1|||
146398273|NCT03110107|527962331|FG001|Treatment Period|Study drug toxicity|0|||
146398274|NCT03110107|527962332|FG002|Treatment Period|Study drug toxicity|1|||
146398275|NCT03110107|527962333|FG003|Treatment Period|Study drug toxicity|2|||
146398276|NCT03110107|527962334|FG004|Treatment Period|Study drug toxicity|0|||
146398277|NCT03110107|527962335|FG005|Treatment Period|Study drug toxicity|3|||
146398278|NCT03110107|527962336|FG006|Treatment Period|Study drug toxicity|1|||
146398279|NCT03110107|527962337|FG007|Treatment Period|Study drug toxicity|1|||
146398280|NCT03110107|527962338|FG008|Treatment Period|Study drug toxicity|3|||
146398281|NCT03110107|527962339|FG009|Treatment Period|Study drug toxicity|2|||
146398282|NCT03110107|527962340|FG010|Treatment Period|Study drug toxicity|0|||
146398283|NCT03110107|527962341|FG011|Treatment Period|Study drug toxicity|2|||
146398284|NCT03110107|527962342|FG012|Treatment Period|Study drug toxicity|0|||
146398285|NCT03110107|527962343|FG013|Treatment Period|Study drug toxicity|0|||
146398286|NCT03110107|527962344|FG014|Treatment Period|Study drug toxicity|2|||
146398287|NCT03110107|527962345|FG015|Treatment Period|Study drug toxicity|3|||
146398288|NCT03110107|527962346|FG016|Treatment Period|Study drug toxicity|3|||
146398289|NCT03110107|527962347|FG017|Treatment Period|Study drug toxicity|3|||
146398290|NCT03110107|527962348|FG018|Treatment Period|Study drug toxicity|1|||
146398291|NCT03110107|527962349|FG019|Treatment Period|Study drug toxicity|2|||
146398292|NCT03110107|527962350|FG020|Treatment Period|Study drug toxicity|2|||
146398293|NCT03110107|527962351|FG021|Treatment Period|Study drug toxicity|0|||
146398294|NCT03110107|527962352|FG022|Treatment Period|Study drug toxicity|2|||
146398295|NCT03110107|527962353|FG023|Treatment Period|Study drug toxicity|6|||
146398296|NCT03110107|527962354|FG024|Treatment Period|Study drug toxicity|7|||
146398297|NCT03110107|527962355|FG025|Treatment Period|Study drug toxicity|6|||
146398298|NCT03110107|527962330|FG000|Treatment Period|Death|0|||
146398299|NCT03110107|527962331|FG001|Treatment Period|Death|0|||
146398300|NCT03110107|527962332|FG002|Treatment Period|Death|0|||
146398301|NCT03110107|527962333|FG003|Treatment Period|Death|0|||
146398302|NCT03110107|527962334|FG004|Treatment Period|Death|0|||
146398303|NCT03110107|527962335|FG005|Treatment Period|Death|0|||
146398304|NCT03110107|527962336|FG006|Treatment Period|Death|0|||
146398305|NCT03110107|527962337|FG007|Treatment Period|Death|0|||
146398306|NCT03110107|527962338|FG008|Treatment Period|Death|0|||
146398307|NCT03110107|527962339|FG009|Treatment Period|Death|0|||
146398308|NCT03110107|527962340|FG010|Treatment Period|Death|0|||
146398309|NCT03110107|527962341|FG011|Treatment Period|Death|0|||
146398310|NCT03110107|527962342|FG012|Treatment Period|Death|1|||
146398311|NCT03110107|527962343|FG013|Treatment Period|Death|0|||
146398312|NCT03110107|527962344|FG014|Treatment Period|Death|0|||
146398313|NCT03110107|527962345|FG015|Treatment Period|Death|0|||
146398314|NCT03110107|527962346|FG016|Treatment Period|Death|0|||
146398315|NCT03110107|527962347|FG017|Treatment Period|Death|0|||
146398316|NCT03110107|527962348|FG018|Treatment Period|Death|0|||
146398317|NCT03110107|527962349|FG019|Treatment Period|Death|0|||
146398318|NCT03110107|527962350|FG020|Treatment Period|Death|0|||
146398319|NCT03110107|527962351|FG021|Treatment Period|Death|0|||
146398320|NCT03110107|527962352|FG022|Treatment Period|Death|0|||
146398321|NCT03110107|527962353|FG023|Treatment Period|Death|0|||
146398322|NCT03110107|527962354|FG024|Treatment Period|Death|0|||
146398323|NCT03110107|527962355|FG025|Treatment Period|Death|0|||
146398324|NCT03110107|527962330|FG000|Treatment Period|Adverse Event|0|||
146398325|NCT03110107|527962331|FG001|Treatment Period|Adverse Event|0|||
146398326|NCT03110107|527962332|FG002|Treatment Period|Adverse Event|1|||
146398327|NCT03110107|527962333|FG003|Treatment Period|Adverse Event|0|||
146398328|NCT03110107|527962334|FG004|Treatment Period|Adverse Event|0|||
146398329|NCT03110107|527962335|FG005|Treatment Period|Adverse Event|2|||
146398330|NCT03110107|527962336|FG006|Treatment Period|Adverse Event|0|||
146398331|NCT03110107|527962337|FG007|Treatment Period|Adverse Event|2|||
146398332|NCT03110107|527962338|FG008|Treatment Period|Adverse Event|0|||
146398333|NCT03110107|527962339|FG009|Treatment Period|Adverse Event|1|||
146398334|NCT03110107|527962340|FG010|Treatment Period|Adverse Event|0|||
146398335|NCT03110107|527962341|FG011|Treatment Period|Adverse Event|0|||
146398336|NCT03110107|527962342|FG012|Treatment Period|Adverse Event|0|||
146398337|NCT03110107|527962343|FG013|Treatment Period|Adverse Event|0|||
146398338|NCT03110107|527962344|FG014|Treatment Period|Adverse Event|0|||
146398339|NCT03110107|527962345|FG015|Treatment Period|Adverse Event|2|||
146398340|NCT03110107|527962346|FG016|Treatment Period|Adverse Event|0|||
146398341|NCT03110107|527962347|FG017|Treatment Period|Adverse Event|1|||
146398342|NCT03110107|527962348|FG018|Treatment Period|Adverse Event|2|||
146398343|NCT03110107|527962349|FG019|Treatment Period|Adverse Event|1|||
146398344|NCT03110107|527962350|FG020|Treatment Period|Adverse Event|4|||
146398345|NCT03110107|527962351|FG021|Treatment Period|Adverse Event|2|||
146398346|NCT03110107|527962352|FG022|Treatment Period|Adverse Event|2|||
146398347|NCT03110107|527962353|FG023|Treatment Period|Adverse Event|2|||
146398348|NCT03110107|527962354|FG024|Treatment Period|Adverse Event|2|||
146398349|NCT03110107|527962355|FG025|Treatment Period|Adverse Event|4|||
146398350|NCT03110107|527962330|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
146398351|NCT03110107|527962331|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
146398352|NCT03110107|527962332|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
146398353|NCT03110107|527962333|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
146398354|NCT03110107|527962334|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
146398355|NCT03110107|527962335|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
146398356|NCT03110107|527962336|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
146398357|NCT03110107|527962337|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
146398358|NCT03110107|527962338|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
146398359|NCT03110107|527962339|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
146398360|NCT03110107|527962340|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
146398361|NCT03110107|527962341|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
146398362|NCT03110107|527962342|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
146398363|NCT03110107|527962343|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
146398364|NCT03110107|527962344|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
146398365|NCT03110107|527962345|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
146398366|NCT03110107|527962346|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
146398367|NCT03110107|527962347|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
146398368|NCT03110107|527962348|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
146398369|NCT03110107|527962349|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
146398370|NCT03110107|527962350|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
146398371|NCT03110107|527962351|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
146398372|NCT03110107|527962352|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
146398373|NCT03110107|527962353|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
146398374|NCT03110107|527962354|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
146398375|NCT03110107|527962355|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
146398376|NCT03110107|527962330|FG000|Treatment Period|Participant withdrew consent|0|||
146398377|NCT03110107|527962331|FG001|Treatment Period|Participant withdrew consent|0|||
146398378|NCT03110107|527962332|FG002|Treatment Period|Participant withdrew consent|1|||
146398379|NCT03110107|527962333|FG003|Treatment Period|Participant withdrew consent|0|||
146398380|NCT03110107|527962334|FG004|Treatment Period|Participant withdrew consent|4|||
146398381|NCT03110107|527962335|FG005|Treatment Period|Participant withdrew consent|3|||
146398382|NCT03110107|527962336|FG006|Treatment Period|Participant withdrew consent|0|||
146398383|NCT03110107|527962337|FG007|Treatment Period|Participant withdrew consent|0|||
146398384|NCT03110107|527962338|FG008|Treatment Period|Participant withdrew consent|0|||
146398385|NCT03110107|527962339|FG009|Treatment Period|Participant withdrew consent|1|||
146398386|NCT03110107|527962340|FG010|Treatment Period|Participant withdrew consent|0|||
146398387|NCT03110107|527962341|FG011|Treatment Period|Participant withdrew consent|0|||
146398388|NCT03110107|527962342|FG012|Treatment Period|Participant withdrew consent|0|||
146398389|NCT03110107|527962343|FG013|Treatment Period|Participant withdrew consent|0|||
146398390|NCT03110107|527962344|FG014|Treatment Period|Participant withdrew consent|0|||
146398391|NCT03110107|527962345|FG015|Treatment Period|Participant withdrew consent|0|||
146398392|NCT03110107|527962346|FG016|Treatment Period|Participant withdrew consent|0|||
146398393|NCT03110107|527962347|FG017|Treatment Period|Participant withdrew consent|0|||
146398394|NCT03110107|527962348|FG018|Treatment Period|Participant withdrew consent|0|||
146398395|NCT03110107|527962349|FG019|Treatment Period|Participant withdrew consent|1|||
146398396|NCT03110107|527962350|FG020|Treatment Period|Participant withdrew consent|0|||
146398397|NCT03110107|527962351|FG021|Treatment Period|Participant withdrew consent|2|||
146398398|NCT03110107|527962352|FG022|Treatment Period|Participant withdrew consent|0|||
146398399|NCT03110107|527962353|FG023|Treatment Period|Participant withdrew consent|0|||
146398400|NCT03110107|527962354|FG024|Treatment Period|Participant withdrew consent|0|||
146398401|NCT03110107|527962355|FG025|Treatment Period|Participant withdrew consent|2|||
146398402|NCT03110107|527962330|FG000|Treatment Period|Participants no longer meets study criteria|0|||
146398403|NCT03110107|527962331|FG001|Treatment Period|Participants no longer meets study criteria|0|||
146398404|NCT03110107|527962332|FG002|Treatment Period|Participants no longer meets study criteria|0|||
146398405|NCT03110107|527962333|FG003|Treatment Period|Participants no longer meets study criteria|0|||
146398406|NCT03110107|527962334|FG004|Treatment Period|Participants no longer meets study criteria|0|||
146398407|NCT03110107|527962335|FG005|Treatment Period|Participants no longer meets study criteria|0|||
146398408|NCT03110107|527962336|FG006|Treatment Period|Participants no longer meets study criteria|0|||
146398409|NCT03110107|527962337|FG007|Treatment Period|Participants no longer meets study criteria|0|||
146398410|NCT03110107|527962338|FG008|Treatment Period|Participants no longer meets study criteria|0|||
146398411|NCT03110107|527962339|FG009|Treatment Period|Participants no longer meets study criteria|0|||
146398412|NCT03110107|527962340|FG010|Treatment Period|Participants no longer meets study criteria|0|||
146398413|NCT03110107|527962341|FG011|Treatment Period|Participants no longer meets study criteria|0|||
146398414|NCT03110107|527962342|FG012|Treatment Period|Participants no longer meets study criteria|0|||
146398415|NCT03110107|527962343|FG013|Treatment Period|Participants no longer meets study criteria|0|||
146398416|NCT03110107|527962344|FG014|Treatment Period|Participants no longer meets study criteria|0|||
146398417|NCT03110107|527962345|FG015|Treatment Period|Participants no longer meets study criteria|0|||
146398418|NCT03110107|527962346|FG016|Treatment Period|Participants no longer meets study criteria|0|||
146398419|NCT03110107|527962347|FG017|Treatment Period|Participants no longer meets study criteria|0|||
146398420|NCT03110107|527962348|FG018|Treatment Period|Participants no longer meets study criteria|0|||
146398421|NCT03110107|527962349|FG019|Treatment Period|Participants no longer meets study criteria|0|||
146398422|NCT03110107|527962350|FG020|Treatment Period|Participants no longer meets study criteria|0|||
146398423|NCT03110107|527962351|FG021|Treatment Period|Participants no longer meets study criteria|0|||
146398424|NCT03110107|527962352|FG022|Treatment Period|Participants no longer meets study criteria|0|||
146398425|NCT03110107|527962353|FG023|Treatment Period|Participants no longer meets study criteria|1|||
146398426|NCT03110107|527962354|FG024|Treatment Period|Participants no longer meets study criteria|0|||
146398427|NCT03110107|527962355|FG025|Treatment Period|Participants no longer meets study criteria|0|||
146398428|NCT03110107|527962330|FG000|Treatment Period|Other Reasons|0|||
146398429|NCT03110107|527962331|FG001|Treatment Period|Other Reasons|0|||
146398430|NCT03110107|527962332|FG002|Treatment Period|Other Reasons|1|||
146398431|NCT03110107|527962333|FG003|Treatment Period|Other Reasons|1|||
146398432|NCT03110107|527962334|FG004|Treatment Period|Other Reasons|0|||
146398433|NCT03110107|527962335|FG005|Treatment Period|Other Reasons|1|||
146398434|NCT03110107|527962336|FG006|Treatment Period|Other Reasons|0|||
146398435|NCT03110107|527962337|FG007|Treatment Period|Other Reasons|0|||
146398436|NCT03110107|527962338|FG008|Treatment Period|Other Reasons|0|||
146398437|NCT03110107|527962339|FG009|Treatment Period|Other Reasons|0|||
146398438|NCT03110107|527962340|FG010|Treatment Period|Other Reasons|0|||
146398439|NCT03110107|527962341|FG011|Treatment Period|Other Reasons|0|||
146398440|NCT03110107|527962342|FG012|Treatment Period|Other Reasons|0|||
146398441|NCT03110107|527962343|FG013|Treatment Period|Other Reasons|0|||
146398442|NCT03110107|527962344|FG014|Treatment Period|Other Reasons|0|||
146398443|NCT03110107|527962345|FG015|Treatment Period|Other Reasons|0|||
146398444|NCT03110107|527962346|FG016|Treatment Period|Other Reasons|0|||
146398445|NCT03110107|527962347|FG017|Treatment Period|Other Reasons|0|||
146398446|NCT03110107|527962348|FG018|Treatment Period|Other Reasons|0|||
146398447|NCT03110107|527962349|FG019|Treatment Period|Other Reasons|0|||
146398448|NCT03110107|527962350|FG020|Treatment Period|Other Reasons|0|||
146398449|NCT03110107|527962351|FG021|Treatment Period|Other Reasons|0|||
146398450|NCT03110107|527962352|FG022|Treatment Period|Other Reasons|0|||
146398451|NCT03110107|527962353|FG023|Treatment Period|Other Reasons|0|||
146398452|NCT03110107|527962354|FG024|Treatment Period|Other Reasons|1|||
146398453|NCT03110107|527962355|FG025|Treatment Period|Other Reasons|0|||
146398454|NCT03985982|527962356|FG000|Double-Blind Phase|Lost to Follow-up|4|||
146398455|NCT03985982|527962357|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146398456|NCT03985982|527962358|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146398457|NCT03985982|527962356|FG000|Double-Blind Phase|Physician Decision|1|||
146398458|NCT03985982|527962357|FG001|Double-Blind Phase|Physician Decision|0|||
146398459|NCT03985982|527962358|FG002|Double-Blind Phase|Physician Decision|0|||
146398460|NCT03985982|527962356|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
146398461|NCT03985982|527962357|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146398462|NCT03985982|527962358|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146398463|NCT03985982|527962356|FG000|Double-Blind Phase|COVID-19|1|||
146398464|NCT03985982|527962357|FG001|Double-Blind Phase|COVID-19|0|||
146398465|NCT03985982|527962358|FG002|Double-Blind Phase|COVID-19|0|||
146398466|NCT03985982|527962356|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
146398467|NCT03985982|527962357|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
146398468|NCT03985982|527962358|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
146398469|NCT03985982|527962356|FG000|Open-Label Phase|Lost to Follow-up|0|||
146398470|NCT03985982|527962357|FG001|Open-Label Phase|Lost to Follow-up|0|||
146398471|NCT03985982|527962358|FG002|Open-Label Phase|Lost to Follow-up|13|||
146398472|NCT03985982|527962356|FG000|Open-Label Phase|Physician Decision|0|||
146398473|NCT03985982|527962357|FG001|Open-Label Phase|Physician Decision|0|||
146398474|NCT03985982|527962358|FG002|Open-Label Phase|Physician Decision|2|||
146398475|NCT03985982|527962356|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146398476|NCT03985982|527962357|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146398477|NCT03985982|527962358|FG002|Open-Label Phase|Withdrawal by Subject|11|||
146398478|NCT01283009|527962364|FG000|Overall Study|Death|83|||
146398479|NCT01283009|527962365|FG001|Overall Study|Death|78|||
146398480|NCT01283009|527962364|FG000|Overall Study|Study ended early|23|||
146398481|NCT01283009|527962365|FG001|Overall Study|Study ended early|26|||
146398482|NCT01283009|527962364|FG000|Overall Study|Withdrawal by Subject|10|||
146398483|NCT01283009|527962365|FG001|Overall Study|Withdrawal by Subject|8|||
146398484|NCT01283009|527962364|FG000|Overall Study|Physician Decision|1|||
146398485|NCT01283009|527962365|FG001|Overall Study|Physician Decision|1|||
146398486|NCT01283009|527962364|FG000|Overall Study|Lost to Follow-up|1|||
146398487|NCT01283009|527962365|FG001|Overall Study|Lost to Follow-up|0|||
146398488|NCT01283009|527962364|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
146398489|NCT01283009|527962365|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
146398490|NCT02743117|527962368|FG000|Overall Study|Lost to Follow-up|0|||
146398491|NCT02743117|527962369|FG001|Overall Study|Lost to Follow-up|1|||
146398492|NCT02743117|527962368|FG000|Overall Study|Other|1|||
146398493|NCT02743117|527962369|FG001|Overall Study|Other|0|||
146398494|NCT01453296|527962370|FG000|Treatment Period 1|Adverse Event|0|||
146398495|NCT01453296|527962371|FG001|Treatment Period 1|Adverse Event|1|||
146398496|NCT01453296|527962370|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
146398497|NCT01453296|527962371|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
146398498|NCT01453296|527962370|FG000|Treatment Period 2|Adverse Event|1|||
146398499|NCT01453296|527962371|FG001|Treatment Period 2|Adverse Event|0|||
146398500|NCT01453296|527962370|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146398501|NCT01453296|527962371|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146398502|NCT04983589|527962374|FG000|Overall Study|Withdrawal by Subject|0|||
146398503|NCT04983589|527962375|FG001|Overall Study|Withdrawal by Subject|3|||
146398504|NCT04983589|527962374|FG000|Overall Study|COVID-19 Infection|1|||
146398505|NCT04983589|527962375|FG001|Overall Study|COVID-19 Infection|0|||
146398506|NCT04983589|527962374|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
146398507|NCT04983589|527962375|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
146398508|NCT00585468|527962376|FG000|First Intervention|Withdrawal by Subject|1|||
146398509|NCT00585468|527962377|FG001|First Intervention|Withdrawal by Subject|1|||
146398510|NCT00978120|527962382|FG000|Overall Study|Death|0|||
146398511|NCT00978120|527962383|FG001|Overall Study|Death|0|||
146398512|NCT00978120|527962384|FG002|Overall Study|Death|0|||
146398513|NCT00978120|527962385|FG003|Overall Study|Death|1|||
146398514|NCT00978120|527962382|FG000|Overall Study|Lost to Follow-up|0|||
146398515|NCT00978120|527962383|FG001|Overall Study|Lost to Follow-up|0|||
146398516|NCT00978120|527962384|FG002|Overall Study|Lost to Follow-up|3|||
146398517|NCT00978120|527962385|FG003|Overall Study|Lost to Follow-up|0|||
146398518|NCT00978120|527962382|FG000|Overall Study|Withdrawal by Subject|2|||
146398519|NCT00978120|527962383|FG001|Overall Study|Withdrawal by Subject|0|||
146398520|NCT00978120|527962384|FG002|Overall Study|Withdrawal by Subject|0|||
146398521|NCT00978120|527962385|FG003|Overall Study|Withdrawal by Subject|0|||
146398522|NCT00978120|527962382|FG000|Overall Study|Moved out of state|0|||
146398523|NCT00978120|527962383|FG001|Overall Study|Moved out of state|0|||
146398524|NCT00978120|527962384|FG002|Overall Study|Moved out of state|0|||
146398525|NCT00978120|527962385|FG003|Overall Study|Moved out of state|1|||
146398526|NCT00762073|527962386|FG000|Overall Study|Lack of Efficacy|1|||
146398527|NCT00762073|527962387|FG001|Overall Study|Lack of Efficacy|1|||
146398528|NCT00762073|527962388|FG002|Overall Study|Lack of Efficacy|0|||
146398529|NCT00762073|527962389|FG003|Overall Study|Lack of Efficacy|0|||
146398530|NCT00762073|527962386|FG000|Overall Study|Adverse Event|1|||
146398531|NCT00762073|527962387|FG001|Overall Study|Adverse Event|0|||
146398532|NCT00762073|527962388|FG002|Overall Study|Adverse Event|1|||
146398533|NCT00762073|527962389|FG003|Overall Study|Adverse Event|1|||
146398534|NCT00762073|527962386|FG000|Overall Study|Significant Subject Noncompliance|0|||
146398535|NCT00762073|527962387|FG001|Overall Study|Significant Subject Noncompliance|1|||
146398536|NCT00762073|527962388|FG002|Overall Study|Significant Subject Noncompliance|0|||
146398537|NCT00762073|527962389|FG003|Overall Study|Significant Subject Noncompliance|1|||
146398538|NCT00762073|527962386|FG000|Overall Study|Withdrawal by Subject|1|||
146398539|NCT00762073|527962387|FG001|Overall Study|Withdrawal by Subject|2|||
146398540|NCT00762073|527962388|FG002|Overall Study|Withdrawal by Subject|1|||
146398541|NCT00762073|527962389|FG003|Overall Study|Withdrawal by Subject|1|||
146398542|NCT00762073|527962386|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
146398543|NCT00762073|527962387|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
146398544|NCT00762073|527962388|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
146398545|NCT00762073|527962389|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
146398546|NCT03155269|527962396|FG000|Overall Study|Withdrawal by Subject|4|||
146398547|NCT03155269|527962397|FG001|Overall Study|Withdrawal by Subject|5|||
146398548|NCT03155269|527962396|FG000|Overall Study|Lost to Follow-up|1|||
146398549|NCT03155269|527962397|FG001|Overall Study|Lost to Follow-up|2|||
146398550|NCT00480077|527962398|FG000|Overall Study|Death|19|||
146398551|NCT00480077|527962399|FG001|Overall Study|Death|15|||
146398552|NCT00480077|527962398|FG000|Overall Study|early exit|12|||
146398553|NCT00480077|527962399|FG001|Overall Study|early exit|11|||
146398554|NCT00938366|527962400|FG000|Overall Study|Withdrawal by Subject|1|||
146398555|NCT00938366|527962401|FG001|Overall Study|Withdrawal by Subject|0|||
146398556|NCT01215968|527962404|FG000|Overall Study|Adverse Event|0|||
146398557|NCT01215968|527962405|FG001|Overall Study|Adverse Event|2|||
146398558|NCT01215968|527962404|FG000|Overall Study|Protocol Violation|2|||
146398559|NCT01215968|527962405|FG001|Overall Study|Protocol Violation|4|||
146398560|NCT01215968|527962404|FG000|Overall Study|Not received study drug|0|||
146398561|NCT01215968|527962405|FG001|Overall Study|Not received study drug|1|||
146398562|NCT03795233|527962406|FG000|Overall Study|Withdrawal by Subject|2|||
146398563|NCT03795233|527962407|FG001|Overall Study|Withdrawal by Subject|1|||
146398564|NCT03795233|527962406|FG000|Overall Study|Lost to Follow-up|1|||
146398565|NCT03795233|527962407|FG001|Overall Study|Lost to Follow-up|0|||
146398566|NCT03795233|527962406|FG000|Overall Study|Death|1|||
146398567|NCT03795233|527962407|FG001|Overall Study|Death|0|||
146398568|NCT01054443|527962408|FG000|Overall Study|Withdrawal by Subject|0|||
146398569|NCT01054443|527962409|FG001|Overall Study|Withdrawal by Subject|0|||
146398570|NCT01054443|527962410|FG002|Overall Study|Withdrawal by Subject|0|||
146398571|NCT01054443|527962411|FG003|Overall Study|Withdrawal by Subject|1|||
146398572|NCT00985114|527962413|FG000|Overall Study|Adverse Event|1|||
146398573|NCT00985114|527962414|FG001|Overall Study|Adverse Event|0|||
146398574|NCT00985114|527962413|FG000|Overall Study|Withdrawal by Subject|0|||
146398575|NCT00985114|527962414|FG001|Overall Study|Withdrawal by Subject|2|||
146398576|NCT02950831|527962415|FG000|Overall Study|Lost to Follow-up|1|||
146398577|NCT02950831|527962415|FG000|Overall Study|Withdrawal by Subject|3|||
146398578|NCT02950831|527962415|FG000|Overall Study|stimulation trail failure|5|||
146398579|NCT01119118|527962416|FG000|Overall Study|Adverse Event|1|||
146398580|NCT01676818|527962420|FG000|Overall Study|Physician Decision|1|||
146398581|NCT01676818|527962420|FG000|Overall Study|Withdrawal by Subject|1|||
146398582|NCT03213704|527962425|FG000|Overall Study|Physician Decision|3|||
146398583|NCT03213704|527962425|FG000|Overall Study|Protocol Violation|1|||
146398584|NCT03213704|527962425|FG000|Overall Study|Progressive disease|4|||
146398585|NCT04075656|527962426|FG000|Overall Study|Withdrawal by Subject|5|||
146398586|NCT04075656|527962427|FG001|Overall Study|Withdrawal by Subject|5|||
146398591|NCT00122954|527964042|FG000|Overall Study|Withdrawal by Subject|2|||
146398592|NCT00122954|527964043|FG001|Overall Study|Withdrawal by Subject|2|||
146398593|NCT00122954|527964042|FG000|Overall Study|Protocol Violation|0|||
146398594|NCT00122954|527964043|FG001|Overall Study|Protocol Violation|1|||
146398595|NCT04341727|527964051|FG000|Overall Study|Withdrawal by Subject|0|||
146398596|NCT04341727|527964052|FG001|Overall Study|Withdrawal by Subject|0|||
146398597|NCT04341727|527964053|FG002|Overall Study|Withdrawal by Subject|1|||
146398598|NCT04341727|527964054|FG003|Overall Study|Withdrawal by Subject|0|||
146398599|NCT04341727|527964051|FG000|Overall Study|Lost to Follow-up|0|||
146398600|NCT04341727|527964052|FG001|Overall Study|Lost to Follow-up|0|||
146398601|NCT04341727|527964053|FG002|Overall Study|Lost to Follow-up|0|||
146398602|NCT04341727|527964054|FG003|Overall Study|Lost to Follow-up|1|||
146398603|NCT02074982|527964055|FG000|Overall Study|Adverse Event|15|||
146398604|NCT02074982|527964056|FG001|Overall Study|Adverse Event|7|||
146398605|NCT02074982|527964055|FG000|Overall Study|Lack of Efficacy|6|||
146398606|NCT02074982|527964056|FG001|Overall Study|Lack of Efficacy|1|||
146398607|NCT02074982|527964055|FG000|Overall Study|Lost to Follow-up|9|||
146398608|NCT02074982|527964056|FG001|Overall Study|Lost to Follow-up|10|||
146398609|NCT02074982|527964055|FG000|Overall Study|Non-compliance with study treatment|0|||
146398610|NCT02074982|527964056|FG001|Overall Study|Non-compliance with study treatment|2|||
146398611|NCT02074982|527964055|FG000|Overall Study|Physician Decision|1|||
146398612|NCT02074982|527964056|FG001|Overall Study|Physician Decision|1|||
146398613|NCT02074982|527964055|FG000|Overall Study|Pregnancy|1|||
146398614|NCT02074982|527964056|FG001|Overall Study|Pregnancy|2|||
146398615|NCT02074982|527964055|FG000|Overall Study|Protocol deviation|4|||
146398616|NCT02074982|527964056|FG001|Overall Study|Protocol deviation|3|||
146398617|NCT02074982|527964055|FG000|Overall Study|Technical problems|0|||
146398618|NCT02074982|527964056|FG001|Overall Study|Technical problems|2|||
146398619|NCT02074982|527964055|FG000|Overall Study|Subject/guardian decision|15|||
146398620|NCT02074982|527964056|FG001|Overall Study|Subject/guardian decision|24|||
146398621|NCT02074982|527964055|FG000|Overall Study|Death|0|||
146398622|NCT02074982|527964056|FG001|Overall Study|Death|2|||
146398623|NCT01817764|527964057|FG000|Overall Study|Adverse Event|7|||
146398624|NCT01817764|527964058|FG001|Overall Study|Adverse Event|10|||
146398625|NCT01817764|527964057|FG000|Overall Study|Lack of Efficacy|9|||
146398626|NCT01817764|527964058|FG001|Overall Study|Lack of Efficacy|7|||
146398627|NCT01817764|527964057|FG000|Overall Study|Protocol Violation|7|||
146398628|NCT01817764|527964058|FG001|Overall Study|Protocol Violation|5|||
146398629|NCT01817764|527964057|FG000|Overall Study|Lost to Follow-up|1|||
146398630|NCT01817764|527964058|FG001|Overall Study|Lost to Follow-up|4|||
146398631|NCT01817764|527964057|FG000|Overall Study|Withdrawal by Subject|10|||
146398632|NCT01817764|527964058|FG001|Overall Study|Withdrawal by Subject|12|||
146398633|NCT05279807|527964063|FG000|Overall Study|Withdrawal by Subject|1|||
146398634|NCT05279807|527964064|FG001|Overall Study|Withdrawal by Subject|0|||
146398635|NCT05279807|527964063|FG000|Overall Study|Adverse Event|0|||
146398636|NCT05279807|527964064|FG001|Overall Study|Adverse Event|1|||
146398637|NCT05279807|527964063|FG000|Overall Study|Laboratory Abnormal Results|1|||
146398638|NCT05279807|527964064|FG001|Overall Study|Laboratory Abnormal Results|0|||
146398639|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146398640|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
146398641|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
146398642|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146398643|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146398644|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146398645|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146398646|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146398647|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
146398648|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
146398649|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146398650|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146398651|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146398652|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146398653|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
146398654|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
146398655|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
146398656|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146398657|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146398658|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146398659|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146398660|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
146398661|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
146398662|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
146398663|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146398664|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146398665|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146398666|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146398667|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
146398668|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398669|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398670|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398671|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398672|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398673|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
146398674|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398675|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398676|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
146398677|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398678|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398679|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398680|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
146398681|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398682|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398683|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
146398684|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398685|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398686|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398687|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
146398688|NCT04242446|527964069|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146398689|NCT04242446|527964070|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
146398690|NCT04242446|527964071|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
146398691|NCT04242446|527964072|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146398692|NCT04242446|527964073|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146398693|NCT04242446|527964074|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146398694|NCT04242446|527964075|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146398695|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146398696|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146398697|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146398698|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
146398699|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
146398700|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
146398701|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
146398702|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146398703|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146398704|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146398705|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
146398706|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
146398707|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
146398708|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
146398709|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146169883|NCT05044325|527134732|FG007|Part A:Treatment Period 2|Physician Decision|0|||
146398710|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146398711|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146398712|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146398713|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146398714|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146398715|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146398716|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146398717|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146398718|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146398719|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146398720|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
146398721|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146398722|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146398723|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146398724|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146398725|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146398726|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
146398727|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
146398728|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
146398729|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
146398730|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398731|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398732|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398733|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
146398734|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398735|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398736|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
146398737|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398738|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398739|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398740|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398741|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
146398742|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398743|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
146398744|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398745|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398746|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398747|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398748|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
146398749|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398750|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
146398751|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398752|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398753|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398754|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398755|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
146398756|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398757|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
146398758|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398759|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398760|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398761|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398762|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
146398763|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398764|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
146398765|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398766|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398767|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398768|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398769|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
146398770|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398771|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
146398772|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398773|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398774|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398775|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398776|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398777|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
146398778|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
146398779|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398780|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398781|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398782|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398783|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398784|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
146398785|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
146398786|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398787|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398788|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398789|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398790|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398791|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
146398792|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
146398793|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398794|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398795|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398796|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398797|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398798|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
146398799|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
146398800|NCT04242446|527964069|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398801|NCT04242446|527964070|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398802|NCT04242446|527964071|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398803|NCT04242446|527964072|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398804|NCT04242446|527964073|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398805|NCT04242446|527964074|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
146398806|NCT04242446|527964075|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
146398807|NCT03587116|527964076|FG000|Overall Study|Lost to Follow-up|0|||
146398808|NCT03587116|527964077|FG001|Overall Study|Lost to Follow-up|1|||
146398809|NCT03587116|527964076|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
146398810|NCT03587116|527964077|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
146398811|NCT03587116|527964076|FG000|Overall Study|Withdrawal by Subject|4|||
146398812|NCT03587116|527964077|FG001|Overall Study|Withdrawal by Subject|0|||
146398813|NCT03526549|527964084|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
146398814|NCT03526549|527964085|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
146398815|NCT03526549|527964084|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
146398816|NCT03526549|527964085|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
146398817|NCT03526549|527964084|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
146398818|NCT03526549|527964085|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
146398819|NCT03526549|527964084|FG000|Open-label Phase|Adverse Event|4|||
146398820|NCT03526549|527964085|FG001|Open-label Phase|Adverse Event|0|||
146398821|NCT03526549|527964084|FG000|Open-label Phase|Withdrawal by Subject|54|||
146398822|NCT03526549|527964085|FG001|Open-label Phase|Withdrawal by Subject|0|||
146398823|NCT03526549|527964084|FG000|Open-label Phase|Lost to Follow-up|35|||
146398824|NCT03526549|527964085|FG001|Open-label Phase|Lost to Follow-up|0|||
146398825|NCT03526549|527964084|FG000|Open-label Phase|Other than Specified|5|||
146398826|NCT03526549|527964085|FG001|Open-label Phase|Other than Specified|0|||
146398827|NCT05981365|527964086|FG000|Period 1|Adverse Event|1|||
146398828|NCT05981365|527964087|FG001|Period 1|Adverse Event|0|||
146398829|NCT03927989|527964091|FG000|Overall Study|Withdrawal by Subject|0|||
146398830|NCT03927989|527964092|FG001|Overall Study|Withdrawal by Subject|1|||
146398831|NCT02593175|527964093|FG000|Overall Study|Adverse Event|5|||
146398832|NCT02593175|527964093|FG000|Overall Study|Disease progression|4|||
146398833|NCT00478933|527964097|FG000|Overall Study|Protocol Violation|22|||
146398834|NCT00478933|527964097|FG000|Overall Study|Informed consent not verified|3|||
146398835|NCT00478933|527964097|FG000|Overall Study|Inadequate data available|53|||
146398836|NCT00643006|527964099|FG000|Overall Study|Lost to Follow-up|5|||
146398837|NCT00643006|527964100|FG001|Overall Study|Lost to Follow-up|4|||
146398838|NCT03772574|527964101|FG000|Overall Study|Protocol Violation|2|||
146398839|NCT03772574|527964102|FG001|Overall Study|Protocol Violation|0|||
146398840|NCT03772574|527964103|FG002|Overall Study|Protocol Violation|0|||
146398841|NCT03772574|527964101|FG000|Overall Study|Discomfort|0|||
146398842|NCT03772574|527964102|FG001|Overall Study|Discomfort|5|||
146398843|NCT03772574|527964103|FG002|Overall Study|Discomfort|4|||
146398844|NCT03586427|527964109|FG000|Overall Study|Lost to Follow-up|0|||
146398845|NCT03586427|527964110|FG001|Overall Study|Lost to Follow-up|3|||
146398846|NCT03586427|527964111|FG002|Overall Study|Lost to Follow-up|1|||
146398847|NCT03586427|527964112|FG003|Overall Study|Lost to Follow-up|3|||
146398848|NCT03586427|527964113|FG004|Overall Study|Lost to Follow-up|3|||
146398849|NCT03586427|527964109|FG000|Overall Study|Withdrawal by Subject|0|||
146398850|NCT03586427|527964110|FG001|Overall Study|Withdrawal by Subject|1|||
146398851|NCT03586427|527964111|FG002|Overall Study|Withdrawal by Subject|2|||
146398852|NCT03586427|527964112|FG003|Overall Study|Withdrawal by Subject|1|||
146398853|NCT03586427|527964113|FG004|Overall Study|Withdrawal by Subject|1|||
146398854|NCT03586427|527964109|FG000|Overall Study|Adverse Event|0|||
146398855|NCT03586427|527964110|FG001|Overall Study|Adverse Event|0|||
146398856|NCT03586427|527964111|FG002|Overall Study|Adverse Event|1|||
146398857|NCT03586427|527964112|FG003|Overall Study|Adverse Event|0|||
146398858|NCT03586427|527964113|FG004|Overall Study|Adverse Event|0|||
146398859|NCT03586427|527964109|FG000|Overall Study|Protocol Violation|0|||
146398860|NCT03586427|527964110|FG001|Overall Study|Protocol Violation|0|||
146398861|NCT03586427|527964111|FG002|Overall Study|Protocol Violation|1|||
146398862|NCT03586427|527964112|FG003|Overall Study|Protocol Violation|0|||
146398863|NCT03586427|527964113|FG004|Overall Study|Protocol Violation|1|||
146398864|NCT03586427|527964109|FG000|Overall Study|Noncompliance with study drug|0|||
146398865|NCT03586427|527964110|FG001|Overall Study|Noncompliance with study drug|0|||
146398866|NCT03586427|527964111|FG002|Overall Study|Noncompliance with study drug|1|||
146398867|NCT03586427|527964112|FG003|Overall Study|Noncompliance with study drug|0|||
146398868|NCT03586427|527964113|FG004|Overall Study|Noncompliance with study drug|0|||
146398869|NCT00593385|527964118|FG000|Overall Study|Death|14|||
146398870|NCT00593385|527964118|FG000|Overall Study|Lost to Follow-up|17|||
146398871|NCT00593385|527964118|FG000|Overall Study|Withdrawal by Subject|9|||
146398872|NCT01471197|527964119|FG000|Overall Study|Disease Progression|4|||
146398873|NCT01471197|527964120|FG001|Overall Study|Disease Progression|2|||
146398874|NCT01471197|527964119|FG000|Overall Study|Death|1|||
146398875|NCT01471197|527964120|FG001|Overall Study|Death|0|||
146398876|NCT01471197|527964119|FG000|Overall Study|Study Drug Toxicity|1|||
146398877|NCT01471197|527964120|FG001|Overall Study|Study Drug Toxicity|0|||
146398878|NCT00924313|527964123|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
146398879|NCT00455923|527964131|FG000|Overall Study|Pregnancy|0|||
146398880|NCT00455923|527964132|FG001|Overall Study|Pregnancy|2|||
146398881|NCT00455923|527964131|FG000|Overall Study|Other|3|||
146398882|NCT00455923|527964132|FG001|Overall Study|Other|1|||
146398883|NCT02686749|527964134|FG000|Overall Study|terminated for poor enrollment|2|||
146398884|NCT02686749|527964135|FG001|Overall Study|terminated for poor enrollment|2|||
146398885|NCT03707145|527964140|FG000|Overall Study|Lost to Follow-up|0|||
146398886|NCT03707145|527964141|FG001|Overall Study|Lost to Follow-up|1|||
146398887|NCT03707145|527964142|FG002|Overall Study|Lost to Follow-up|1|||
146398888|NCT03707145|527964143|FG003|Overall Study|Lost to Follow-up|0|||
146398889|NCT04882085|527964144|FG000|Overall Study|Death|6|||
146398890|NCT04882085|527964145|FG001|Overall Study|Death|9|||
146398891|NCT04882085|527964144|FG000|Overall Study|Withdrawal by Subject|0|||
146398892|NCT04882085|527964145|FG001|Overall Study|Withdrawal by Subject|3|||
146398893|NCT04882085|527964144|FG000|Overall Study|Randomized not treated|1|||
146398894|NCT04882085|527964145|FG001|Overall Study|Randomized not treated|0|||
146398895|NCT00145119|527964146|FG000|Overall Study|Death|45|||
146398896|NCT05403502|527964147|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
146398897|NCT05403502|527964147|FG000|Humalog Lead-In Period|Physician Decision|2|||
146398898|NCT05403502|527964147|FG000|Humalog Lead-In Period|Protocol Violation|1|||
146398899|NCT05403502|527964147|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
146398900|NCT05403502|527964147|FG000|Lyumjev Treatment Period|Physician Decision|2|||
146398901|NCT01003691|527964148|FG000|Overall Study|Adverse Event|0|||
146398902|NCT01003691|527964149|FG001|Overall Study|Adverse Event|0|||
146398903|NCT01003691|527964150|FG002|Overall Study|Adverse Event|0|||
146398904|NCT01003691|527964151|FG003|Overall Study|Adverse Event|1|||
146398905|NCT04814654|527964162|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
146398906|NCT04814654|527964163|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
146398907|NCT04814654|527964164|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
146398908|NCT02207413|527964167|FG000|Overall Study|Withdrawal by Subject|1|||
146398909|NCT02207413|527964168|FG001|Overall Study|Withdrawal by Subject|0|||
146398910|NCT02207413|527964169|FG002|Overall Study|Withdrawal by Subject|0|||
146398911|NCT02207413|527964170|FG003|Overall Study|Withdrawal by Subject|0|||
146398912|NCT02207413|527964171|FG004|Overall Study|Withdrawal by Subject|3|||
146398913|NCT02207413|527964172|FG005|Overall Study|Withdrawal by Subject|7|||
146398914|NCT02207413|527964167|FG000|Overall Study|Lost to Follow-up|0|||
146398915|NCT02207413|527964168|FG001|Overall Study|Lost to Follow-up|0|||
146398916|NCT02207413|527964169|FG002|Overall Study|Lost to Follow-up|0|||
146398917|NCT02207413|527964170|FG003|Overall Study|Lost to Follow-up|1|||
146398918|NCT02207413|527964171|FG004|Overall Study|Lost to Follow-up|1|||
146398919|NCT02207413|527964172|FG005|Overall Study|Lost to Follow-up|5|||
146398920|NCT02207413|527964167|FG000|Overall Study|Adverse Event|0|||
146398921|NCT02207413|527964168|FG001|Overall Study|Adverse Event|0|||
146398922|NCT02207413|527964169|FG002|Overall Study|Adverse Event|0|||
146398923|NCT02207413|527964170|FG003|Overall Study|Adverse Event|0|||
146398924|NCT02207413|527964171|FG004|Overall Study|Adverse Event|2|||
146398925|NCT02207413|527964172|FG005|Overall Study|Adverse Event|1|||
146398926|NCT02207413|527964167|FG000|Overall Study|Migrated/moved from study area|0|||
146398927|NCT02207413|527964168|FG001|Overall Study|Migrated/moved from study area|0|||
146398928|NCT02207413|527964169|FG002|Overall Study|Migrated/moved from study area|0|||
146398929|NCT02207413|527964170|FG003|Overall Study|Migrated/moved from study area|0|||
146398930|NCT02207413|527964171|FG004|Overall Study|Migrated/moved from study area|1|||
146398931|NCT02207413|527964172|FG005|Overall Study|Migrated/moved from study area|0|||
146398932|NCT04478994|527965501|FG000|Overall Study|Withdrawal by Subject|1|||
146398933|NCT04478994|527965502|FG001|Overall Study|Withdrawal by Subject|1|||
146398934|NCT01100073|527965503|FG000|Overall Study|Lack of Efficacy|4|||
146398935|NCT01100073|527965503|FG000|Overall Study|Insufficient Tolerability|21|||
146398936|NCT01100073|527965503|FG000|Overall Study|Withdrawal by Subject|13|||
146398937|NCT01100073|527965503|FG000|Overall Study|Lost to Follow-up|39|||
146398938|NCT01100073|527965503|FG000|Overall Study|Lack of effect + patient's wish|2|||
146398939|NCT01100073|527965503|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
146398940|NCT01100073|527965503|FG000|Overall Study|Other|8|||
146398941|NCT01100073|527965503|FG000|Overall Study|Missing|5|||
146398942|NCT00299546|527965504|FG000|Overall Study|Death|3|||
146398943|NCT00299546|527965505|FG001|Overall Study|Death|2|||
146398944|NCT00299546|527965506|FG002|Overall Study|Death|0|||
146398945|NCT00299546|527965504|FG000|Overall Study|Lost to Follow-up|2|||
146398946|NCT00299546|527965505|FG001|Overall Study|Lost to Follow-up|2|||
146398947|NCT00299546|527965506|FG002|Overall Study|Lost to Follow-up|5|||
146398948|NCT00299546|527965504|FG000|Overall Study|Adverse Event|37|||
146398949|NCT00299546|527965505|FG001|Overall Study|Adverse Event|22|||
146398950|NCT00299546|527965506|FG002|Overall Study|Adverse Event|27|||
146398951|NCT00299546|527965504|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
146398952|NCT00299546|527965505|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
146398953|NCT00299546|527965506|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
146398954|NCT00299546|527965504|FG000|Overall Study|Other|24|||
146398955|NCT00299546|527965505|FG001|Overall Study|Other|26|||
146398956|NCT00299546|527965506|FG002|Overall Study|Other|19|||
146398957|NCT00299546|527965504|FG000|Overall Study|Not treated|0|||
146398958|NCT00299546|527965505|FG001|Overall Study|Not treated|1|||
146398959|NCT00299546|527965506|FG002|Overall Study|Not treated|1|||
146398960|NCT03099265|527965507|FG000|Overall Study|Adverse Event|1|||
146398961|NCT01741259|527965511|FG000|Overall Study|Protocol Violation|6|||
146398962|NCT01741259|527965512|FG001|Overall Study|Protocol Violation|4|||
146398963|NCT01741259|527965511|FG000|Overall Study|Withdrawal by Subject|0|||
146398964|NCT01741259|527965512|FG001|Overall Study|Withdrawal by Subject|2|||
146398965|NCT02094573|527965515|FG000|Overall Study|Adverse Event|4|||
146398966|NCT02094573|527965516|FG001|Overall Study|Adverse Event|14|||
146398967|NCT02094573|527965515|FG000|Overall Study|Clinical Progressive Disease|9|||
146398968|NCT02094573|527965516|FG001|Overall Study|Clinical Progressive Disease|13|||
146398969|NCT02094573|527965515|FG000|Overall Study|Death|11|||
146398970|NCT02094573|527965516|FG001|Overall Study|Death|3|||
146398971|NCT02094573|527965515|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
146398972|NCT02094573|527965516|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
146398973|NCT02094573|527965515|FG000|Overall Study|Non-compliance with Study Drug|1|||
146398974|NCT02094573|527965516|FG001|Overall Study|Non-compliance with Study Drug|1|||
146398975|NCT02094573|527965515|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
146398976|NCT02094573|527965516|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
146398977|NCT02094573|527965515|FG000|Overall Study|Physician Decision|4|||
146398978|NCT02094573|527965516|FG001|Overall Study|Physician Decision|4|||
146398979|NCT02094573|527965515|FG000|Overall Study|Site Terminated by Sponsor|10|||
146398980|NCT02094573|527965516|FG001|Overall Study|Site Terminated by Sponsor|17|||
146398981|NCT02094573|527965515|FG000|Overall Study|Withdrawal by Subject|6|||
146398982|NCT02094573|527965516|FG001|Overall Study|Withdrawal by Subject|8|||
146398983|NCT02094573|527965515|FG000|Overall Study|Randomized but not Treated|3|||
146398984|NCT02094573|527965516|FG001|Overall Study|Randomized but not Treated|0|||
146398985|NCT02411110|527965517|FG000|Treatment Period 1|Adverse Event|4|||
146398986|NCT02411110|527965518|FG001|Treatment Period 1|Adverse Event|2|||
146398987|NCT02411110|527965517|FG000|Treatment Period 1|Lost to Follow-up|1|||
146398988|NCT02411110|527965518|FG001|Treatment Period 1|Lost to Follow-up|0|||
146398989|NCT02411110|527965517|FG000|Treatment Period 1|Personal Reasons|2|||
146398990|NCT02411110|527965518|FG001|Treatment Period 1|Personal Reasons|5|||
146398991|NCT02411110|527965517|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
146398992|NCT02411110|527965518|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
146398993|NCT02411110|527965517|FG000|Treatment Period 2|Adverse Event|1|||
146398994|NCT02411110|527965518|FG001|Treatment Period 2|Adverse Event|0|||
146398995|NCT02411110|527965517|FG000|Treatment Period 2|Lost to Follow-up|0|||
146398996|NCT02411110|527965518|FG001|Treatment Period 2|Lost to Follow-up|2|||
146398997|NCT02411110|527965517|FG000|Treatment Period 2|Personal Reasons|0|||
146398998|NCT02411110|527965518|FG001|Treatment Period 2|Personal Reasons|2|||
146398999|NCT00526162|527965519|FG000|Overall Study|Device not implanted|3|||
146399000|NCT03193996|527965521|FG000|Overall Study|Withdrawal by Subject|4|||
146399001|NCT03193996|527965521|FG000|Overall Study|Lost to Follow-up|4|||
146399002|NCT03193996|527965521|FG000|Overall Study|Physician Decision|2|||
146399003|NCT03193996|527965521|FG000|Overall Study|Pregnancy|1|||
146399004|NCT03193996|527965521|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
146399005|NCT03193996|527965521|FG000|Overall Study|Complicating disease|1|||
146399006|NCT01353586|527965522|FG000|Overall Study|Procedure terminated prior to ablation|3|||
146399007|NCT01353586|527965523|FG001|Overall Study|Procedure terminated prior to ablation|0|||
146399008|NCT01353586|527965522|FG000|Overall Study|Never had insertion of study catheter|4|||
146399009|NCT01353586|527965523|FG001|Overall Study|Never had insertion of study catheter|1|||
146399010|NCT01353586|527965522|FG000|Overall Study|Neurological exam not done|0|||
146399011|NCT01353586|527965523|FG001|Overall Study|Neurological exam not done|1|||
146399012|NCT05027958|527965524|FG000|Overall Study|Lost to Follow-up|1|||
146399013|NCT05027958|527965525|FG001|Overall Study|Lost to Follow-up|1|||
146399014|NCT05027958|527965524|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
146399015|NCT05027958|527965525|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
146399016|NCT05027958|527965524|FG000|Overall Study|Physician Decision|1|||
146399017|NCT05027958|527965525|FG001|Overall Study|Physician Decision|4|||
146399018|NCT05027958|527965524|FG000|Overall Study|Adverse Event|0|||
146399019|NCT05027958|527965525|FG001|Overall Study|Adverse Event|1|||
146399020|NCT00491322|527965527|FG000|Overall Study|Protocol Violation|1|||
146399021|NCT00491322|527965528|FG001|Overall Study|Protocol Violation|0|||
146399022|NCT00491322|527965527|FG000|Overall Study|Pregnancy|0|||
146399023|NCT00491322|527965528|FG001|Overall Study|Pregnancy|1|||
146399024|NCT00807040|527965531|FG000|Overall Study|Death|24|||
146399025|NCT00807040|527965532|FG001|Overall Study|Death|29|||
146399026|NCT00807040|527965531|FG000|Overall Study|Withdrawal by Subject|8|||
146399027|NCT00807040|527965532|FG001|Overall Study|Withdrawal by Subject|6|||
146399028|NCT00807040|527965531|FG000|Overall Study|Lost to Follow-up|4|||
146399029|NCT00807040|527965532|FG001|Overall Study|Lost to Follow-up|6|||
146399030|NCT00890409|527965537|FG000|Overall Study|Lost to Follow-up|20|||
146399031|NCT00890409|527965538|FG001|Overall Study|Lost to Follow-up|21|||
146399032|NCT02353572|527965539|FG000|Overall Study|Withdrawal by Subject|1|||
146399033|NCT02353572|527965539|FG000|Overall Study|Study terminated|2|||
146399034|NCT01870921|527965547|FG000|Overall Study|Subject decision|80|||
146399035|NCT01870921|527965547|FG000|Overall Study|Severe non-compliance to protocol|7|||
146399036|NCT01870921|527965547|FG000|Overall Study|Subject Lost to Follow up|2|||
146399037|NCT01870921|527965547|FG000|Overall Study|Other|1|||
146399038|NCT03075826|527965548|FG000|Overall Study|Withdrawal by Subject|1|||
146399039|NCT03075826|527965548|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
146399040|NCT04221477|527965549|FG000|Overall Study|Adverse Event|1|||
146399041|NCT04221477|527965550|FG001|Overall Study|Adverse Event|1|||
146399042|NCT04221477|527965549|FG000|Overall Study|Death|5|||
146399043|NCT04221477|527965550|FG001|Overall Study|Death|4|||
146399044|NCT04221477|527965549|FG000|Overall Study|Lack of Efficacy|1|||
146399045|NCT04221477|527965550|FG001|Overall Study|Lack of Efficacy|2|||
146399046|NCT04221477|527965549|FG000|Overall Study|Lost to Follow-up|1|||
146399047|NCT04221477|527965550|FG001|Overall Study|Lost to Follow-up|2|||
146399048|NCT04221477|527965549|FG000|Overall Study|Non-compliance with Study Drug|1|||
146399049|NCT04221477|527965550|FG001|Overall Study|Non-compliance with Study Drug|0|||
146399050|NCT04221477|527965549|FG000|Overall Study|Reason not Specified|0|||
146399051|NCT04221477|527965550|FG001|Overall Study|Reason not Specified|5|||
146399052|NCT04221477|527965549|FG000|Overall Study|Physician Decision|0|||
146399053|NCT04221477|527965550|FG001|Overall Study|Physician Decision|6|||
146399054|NCT04221477|527965549|FG000|Overall Study|Withdrawal by Subject|10|||
146399055|NCT04221477|527965550|FG001|Overall Study|Withdrawal by Subject|14|||
146399056|NCT04221477|527965549|FG000|Overall Study|Ongoing in the Study|116|||
146399057|NCT04221477|527965550|FG001|Overall Study|Ongoing in the Study|102|||
146399058|NCT02242942|527965551|FG000|Overall Study|Death|17|||
146399059|NCT02242942|527965552|FG001|Overall Study|Death|20|||
146399060|NCT02242942|527965553|FG002|Overall Study|Death|2|||
146399061|NCT02242942|527965551|FG000|Overall Study|Physician Decision|1|||
146399062|NCT02242942|527965552|FG001|Overall Study|Physician Decision|0|||
146399063|NCT02242942|527965553|FG002|Overall Study|Physician Decision|0|||
146399064|NCT02242942|527965551|FG000|Overall Study|Withdrawal by Subject|8|||
146399065|NCT02242942|527965552|FG001|Overall Study|Withdrawal by Subject|10|||
146399066|NCT02242942|527965553|FG002|Overall Study|Withdrawal by Subject|0|||
146399067|NCT02242942|527965551|FG000|Overall Study|On-going in Study|190|||
146399068|NCT02242942|527965552|FG001|Overall Study|On-going in Study|186|||
146399069|NCT02242942|527965553|FG002|Overall Study|On-going in Study|11|||
146399070|NCT05681715|527965562|FG000|Training Period (6-weeks)|Adverse Event|3|||
146399071|NCT05681715|527965563|FG001|Training Period (6-weeks)|Adverse Event|0|||
146399072|NCT05681715|527965564|FG002|Training Period (6-weeks)|Adverse Event|0|||
146399073|NCT05681715|527965562|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
146399074|NCT05681715|527965563|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
146399075|NCT05681715|527965564|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
146399076|NCT05681715|527965562|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
146399077|NCT05681715|527965563|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
146399078|NCT05681715|527965564|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
146399079|NCT05681715|527965562|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
146399080|NCT05681715|527965563|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
146399081|NCT05681715|527965564|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
146399082|NCT05681715|527965562|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
146399083|NCT05681715|527965563|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
146399084|NCT05681715|527965564|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
146399085|NCT05681715|527965562|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
146399086|NCT05681715|527965563|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
146399087|NCT05681715|527965564|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
146399088|NCT05681715|527965562|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
146399089|NCT05681715|527965563|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
146399090|NCT05681715|527965564|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
146399091|NCT05681715|527965562|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
146399092|NCT05681715|527965563|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
146399093|NCT05681715|527965564|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
146399094|NCT05455684|527965565|FG000|Overall Study|Withdrawal by Subject|7|||
146399095|NCT05455684|527965566|FG001|Overall Study|Withdrawal by Subject|4|||
146399096|NCT05455684|527965565|FG000|Overall Study|Lost to Follow-up|3|||
146399097|NCT05455684|527965566|FG001|Overall Study|Lost to Follow-up|3|||
146399098|NCT05455684|527965565|FG000|Overall Study|Adverse Event|2|||
146399099|NCT05455684|527965566|FG001|Overall Study|Adverse Event|3|||
146399100|NCT05455684|527965565|FG000|Overall Study|Protocol Violation|1|||
146399101|NCT05455684|527965566|FG001|Overall Study|Protocol Violation|1|||
146399102|NCT05455684|527965565|FG000|Overall Study|Non-Compliant with study drug|0|||
146399103|NCT05455684|527965566|FG001|Overall Study|Non-Compliant with study drug|1|||
146399104|NCT05455684|527965565|FG000|Overall Study|Other|1|||
146399105|NCT05455684|527965566|FG001|Overall Study|Other|2|||
146399106|NCT05455684|527965565|FG000|Overall Study|Randomized but not treated|1|||
146399107|NCT05455684|527965566|FG001|Overall Study|Randomized but not treated|0|||
146399108|NCT05116241|527965567|FG000|Study|Withdrawal by Subject|5|||
146399109|NCT05116241|527965568|FG001|Study|Withdrawal by Subject|2|||
146399110|NCT05116241|527965569|FG002|Study|Withdrawal by Subject|1|||
146399111|NCT05116241|527965567|FG000|Study|Lost to Follow-up|0|||
146399112|NCT05116241|527965568|FG001|Study|Lost to Follow-up|2|||
146399113|NCT05116241|527965569|FG002|Study|Lost to Follow-up|2|||
146399114|NCT05204563|527965570|FG000|Overall Study|Other than Specified|2|||
146399115|NCT05204563|527965571|FG001|Overall Study|Other than Specified|1|||
146399116|NCT05204563|527965570|FG000|Overall Study|Death|18|||
146399117|NCT05204563|527965571|FG001|Overall Study|Death|4|||
146399118|NCT05204563|527965570|FG000|Overall Study|Lost to Follow-up|6|||
146399119|NCT05204563|527965571|FG001|Overall Study|Lost to Follow-up|3|||
146399120|NCT05204563|527965570|FG000|Overall Study|Withdrawal by Subject|12|||
146399121|NCT05204563|527965571|FG001|Overall Study|Withdrawal by Subject|3|||
146399122|NCT05204563|527965570|FG000|Overall Study|Enrolled, Not Treated|1|||
146399123|NCT05204563|527965571|FG001|Overall Study|Enrolled, Not Treated|0|||
146399124|NCT04755283|527965574|FG000|Overall Study|Withdrawal by Subject|14|||
146399125|NCT04755283|527965575|FG001|Overall Study|Withdrawal by Subject|3|||
146399126|NCT04755283|527965576|FG002|Overall Study|Withdrawal by Subject|6|||
146399127|NCT04755283|527965574|FG000|Overall Study|Lost to Follow-up|0|||
146399128|NCT04755283|527965575|FG001|Overall Study|Lost to Follow-up|0|||
146399129|NCT04755283|527965576|FG002|Overall Study|Lost to Follow-up|1|||
146399130|NCT04755283|527965574|FG000|Overall Study|Death|31|||
146399131|NCT04755283|527965575|FG001|Overall Study|Death|36|||
146399132|NCT04755283|527965576|FG002|Overall Study|Death|34|||
146399133|NCT02268214|527965577|FG000|Overall Study|Subject no longer meets study criteria|0|||
146399134|NCT02268214|527965578|FG001|Overall Study|Subject no longer meets study criteria|2|||
146399135|NCT02268214|527965579|FG002|Overall Study|Subject no longer meets study criteria|0|||
146399136|NCT02268214|527965577|FG000|Overall Study|Pregnancy|2|||
146399137|NCT02268214|527965578|FG001|Overall Study|Pregnancy|2|||
146399138|NCT02268214|527965579|FG002|Overall Study|Pregnancy|1|||
146399139|NCT02268214|527965577|FG000|Overall Study|Lost to Follow-up|3|||
146399140|NCT02268214|527965578|FG001|Overall Study|Lost to Follow-up|3|||
146399141|NCT02268214|527965579|FG002|Overall Study|Lost to Follow-up|4|||
146399142|NCT02268214|527965577|FG000|Overall Study|Lack of Efficacy|1|||
146399143|NCT02268214|527965578|FG001|Overall Study|Lack of Efficacy|0|||
146399144|NCT02268214|527965579|FG002|Overall Study|Lack of Efficacy|2|||
146399145|NCT02268214|527965577|FG000|Overall Study|Adverse Event|11|||
146399146|NCT02268214|527965578|FG001|Overall Study|Adverse Event|14|||
146399147|NCT02268214|527965579|FG002|Overall Study|Adverse Event|9|||
146399148|NCT02268214|527965577|FG000|Overall Study|Withdrawal by Subject|4|||
146399149|NCT02268214|527965578|FG001|Overall Study|Withdrawal by Subject|5|||
146399150|NCT02268214|527965579|FG002|Overall Study|Withdrawal by Subject|10|||
146399151|NCT02268214|527965577|FG000|Overall Study|Subject request to discontinue treatment|10|||
146399152|NCT02268214|527965578|FG001|Overall Study|Subject request to discontinue treatment|8|||
146399153|NCT02268214|527965579|FG002|Overall Study|Subject request to discontinue treatment|6|||
146399154|NCT02268214|527965577|FG000|Overall Study|Poor/non-compliance|2|||
146399155|NCT02268214|527965578|FG001|Overall Study|Poor/non-compliance|1|||
146399156|NCT02268214|527965579|FG002|Overall Study|Poor/non-compliance|2|||
146399157|NCT02268214|527965577|FG000|Overall Study|Other reasons|7|||
146399158|NCT02268214|527965578|FG001|Overall Study|Other reasons|3|||
146399159|NCT02268214|527965579|FG002|Overall Study|Other reasons|3|||
146399160|NCT02268214|527965577|FG000|Overall Study|Not entering long-term period|2|||
146399161|NCT02268214|527965578|FG001|Overall Study|Not entering long-term period|3|||
146399162|NCT02268214|527965579|FG002|Overall Study|Not entering long-term period|5|||
146399163|NCT04342390|527965580|FG000|Overall Study|Lost to Follow-up|3|||
146399164|NCT04342390|527965581|FG001|Overall Study|Lost to Follow-up|0|||
146399165|NCT02951130|527965585|FG000|Overall Study|Protocol Violation|1|||
146399166|NCT02951130|527965586|FG001|Overall Study|Protocol Violation|1|||
146399167|NCT04584294|527965587|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
146399168|NCT04584294|527965588|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
146399169|NCT04584294|527965587|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
146399170|NCT04584294|527965588|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
146399171|NCT04584294|527965587|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
146399172|NCT04584294|527965588|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
146399173|NCT04584294|527965587|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
146399174|NCT04584294|527965588|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
146399175|NCT04584294|527965587|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
146399176|NCT04584294|527965588|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
146399177|NCT04584294|527965587|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
146399178|NCT04584294|527965588|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
146399179|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146399180|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
146399181|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
146399182|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146399183|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146399184|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146399185|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
146399186|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399187|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399188|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
146399189|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399190|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399191|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399192|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
146399193|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
146399194|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146399195|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
146399196|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146399197|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146399198|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146399199|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
146399200|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
146399201|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146399202|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
146399203|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146399204|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146399205|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146399206|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
146399207|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
146399208|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
146399209|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
146399210|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146399211|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146399212|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146399213|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
146399214|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399215|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399216|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
146399217|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399218|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399219|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399220|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
146399221|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399222|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399223|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
146399224|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399225|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399226|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399227|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
146399228|NCT04242498|527965589|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146399229|NCT04242498|527965590|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
146399230|NCT04242498|527965591|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
146399231|NCT04242498|527965592|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146399232|NCT04242498|527965593|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146399233|NCT04242498|527965594|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146399234|NCT04242498|527965595|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
146399235|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146399236|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146399237|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146399238|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
146399239|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
146399240|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
146399241|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
146399242|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146399243|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146399244|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146399245|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
146399246|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
146399247|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
146399248|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
146399249|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146399250|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146399251|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146399252|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146399253|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
146399254|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
146399255|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
146399256|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146399257|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146399258|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
146399259|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146399260|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
146399261|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
146399262|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
146399263|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146399264|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146399265|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
146399266|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
146399267|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
146399268|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
146399269|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
146399270|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399271|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399272|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399273|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399274|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
146399275|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399276|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
146399277|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399278|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399279|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399280|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399281|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399282|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
146399283|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
146399284|NCT04242498|527965589|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146399285|NCT04242498|527965590|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146399286|NCT04242498|527965591|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146399287|NCT04242498|527965592|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146399288|NCT04242498|527965593|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
146399289|NCT04242498|527965594|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
146399290|NCT04242498|527965595|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
146399291|NCT01083121|527965596|FG000|Overall Study|Use of Humira outside the approved label|81|||
146399292|NCT03743571|527965597|FG000|Overall Study|Withdrawal by Subject|1|||
146399293|NCT03743571|527965598|FG001|Overall Study|Withdrawal by Subject|1|||
146399294|NCT03743571|527965597|FG000|Overall Study|Lost to Follow-up|1|||
146399295|NCT03743571|527965598|FG001|Overall Study|Lost to Follow-up|2|||
146399296|NCT04115488|527965599|FG000|Overall Study|Adverse Event|8|||
146399297|NCT04115488|527965600|FG001|Overall Study|Adverse Event|4|||
146399298|NCT04115488|527965599|FG000|Overall Study|Withdrawal by Subject|3|||
146399299|NCT04115488|527965600|FG001|Overall Study|Withdrawal by Subject|6|||
146399300|NCT04115488|527965599|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
146399301|NCT04115488|527965600|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
146399302|NCT04115488|527965599|FG000|Overall Study|Patient 's location change|1|||
146399303|NCT04115488|527965600|FG001|Overall Study|Patient 's location change|0|||
146399304|NCT04115488|527965599|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
146399305|NCT04115488|527965600|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
146399306|NCT00885677|527965601|FG000|Overall Study|Death|40|||
146399307|NCT00885677|527965602|FG001|Overall Study|Death|34|||
146399308|NCT00885677|527965601|FG000|Overall Study|Lost to Follow-up|15|||
146399309|NCT00885677|527965602|FG001|Overall Study|Lost to Follow-up|13|||
146399310|NCT00885677|527965601|FG000|Overall Study|Protocol Violation|54|||
146399311|NCT00885677|527965602|FG001|Overall Study|Protocol Violation|54|||
146399312|NCT00885677|527965601|FG000|Overall Study|premature study closure|41|||
146399313|NCT00885677|527965602|FG001|Overall Study|premature study closure|44|||
146399314|NCT00885677|527965601|FG000|Overall Study|device/lead revision or replacement|7|||
146399315|NCT00885677|527965602|FG001|Overall Study|device/lead revision or replacement|6|||
146399316|NCT00885677|527965601|FG000|Overall Study|Heart transplantation|1|||
146399317|NCT00885677|527965602|FG001|Overall Study|Heart transplantation|0|||
146399318|NCT00885677|527965601|FG000|Overall Study|Inclusion/exclusion not met|25|||
146399319|NCT00885677|527965602|FG001|Overall Study|Inclusion/exclusion not met|27|||
146399320|NCT01233284|527965614|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146399321|NCT01233284|527965615|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146399322|NCT01233284|527965616|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146399323|NCT01233284|527965617|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146399324|NCT01233284|527965618|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146399325|NCT01233284|527965614|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146399326|NCT01233284|527965615|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
146399327|NCT01233284|527965616|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146399328|NCT01233284|527965617|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146399329|NCT01233284|527965618|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146399330|NCT01233284|527965614|FG000|Period 1 (4 Weeks)|Other|0|||
146399331|NCT01233284|527965615|FG001|Period 1 (4 Weeks)|Other|0|||
146399332|NCT01233284|527965616|FG002|Period 1 (4 Weeks)|Other|1|||
146399333|NCT01233284|527965617|FG003|Period 1 (4 Weeks)|Other|0|||
146399334|NCT01233284|527965618|FG004|Period 1 (4 Weeks)|Other|0|||
146399335|NCT01233284|527965614|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146399336|NCT01233284|527965615|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146399337|NCT01233284|527965616|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
146399338|NCT01233284|527965617|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146399339|NCT01233284|527965618|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146399340|NCT01233284|527965614|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146399341|NCT01233284|527965615|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146399342|NCT01233284|527965616|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
146399343|NCT01233284|527965617|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146399344|NCT01233284|527965618|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
146399345|NCT01233284|527965614|FG000|Period 3 (4 Weeks)|Other|0|||
146399346|NCT01233284|527965615|FG001|Period 3 (4 Weeks)|Other|0|||
146399347|NCT01233284|527965616|FG002|Period 3 (4 Weeks)|Other|0|||
146399348|NCT01233284|527965617|FG003|Period 3 (4 Weeks)|Other|1|||
146399349|NCT01233284|527965618|FG004|Period 3 (4 Weeks)|Other|0|||
146399350|NCT01233284|527965614|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
146399351|NCT01233284|527965615|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
146399352|NCT01233284|527965616|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
146399353|NCT01233284|527965617|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
146399354|NCT01233284|527965618|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
146399355|NCT01233284|527965614|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146399356|NCT01233284|527965615|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146399357|NCT01233284|527965616|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146399358|NCT01233284|527965617|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
146399359|NCT01233284|527965618|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
146399360|NCT02756182|527965620|FG000|Overall Study|StudyTechnical Difficulties|4|||
146399361|NCT00167414|527965622|FG000|Overall Study|Death|10|||
146399362|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
146399363|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
146399364|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
146399365|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
146399366|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
146399367|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
146399368|NCT00828009|527965623|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
146399369|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
146399370|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
146399371|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Death|1|||
146399372|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
146399373|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
146399374|NCT00828009|527965623|FG000|Step 2 - Maintenance Therapy|Other|1|||
146399375|NCT05102162|527967376|FG000|Overall Study|Withdrawal by Subject|3|||
146399376|NCT05102162|527967377|FG001|Overall Study|Withdrawal by Subject|0|||
146399377|NCT05102162|527967376|FG000|Overall Study|Baseline cultures negative|4|||
146399378|NCT05102162|527967377|FG001|Overall Study|Baseline cultures negative|2|||
146399379|NCT05102162|527967376|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
146399380|NCT05102162|527967377|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
146399381|NCT05102162|527967376|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
146399382|NCT05102162|527967377|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
146399383|NCT02871921|527967380|FG000|Overall Study|Withdrawal by Subject|34|||
146399384|NCT02871921|527967381|FG001|Overall Study|Withdrawal by Subject|27|||
146399385|NCT02871921|527967382|FG002|Overall Study|Withdrawal by Subject|27|||
146399386|NCT02871921|527967383|FG003|Overall Study|Withdrawal by Subject|30|||
146399387|NCT00320801|527967384|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
146399388|NCT00320801|527967385|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
146399389|NCT00320801|527967386|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
146399390|NCT00320801|527967387|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
146399391|NCT00320801|527967384|FG000|Open-label Run-in Period|Adverse Event|33|||
146399392|NCT00320801|527967385|FG001|Open-label Run-in Period|Adverse Event|0|||
146399393|NCT00320801|527967386|FG002|Open-label Run-in Period|Adverse Event|0|||
146399394|NCT00320801|527967387|FG003|Open-label Run-in Period|Adverse Event|0|||
146399395|NCT00320801|527967384|FG000|Open-label Run-in Period|Administrative|10|||
146399396|NCT00320801|527967385|FG001|Open-label Run-in Period|Administrative|0|||
146399397|NCT00320801|527967386|FG002|Open-label Run-in Period|Administrative|0|||
146399398|NCT00320801|527967387|FG003|Open-label Run-in Period|Administrative|0|||
146399399|NCT00320801|527967384|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
146399400|NCT00320801|527967385|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
146399401|NCT00320801|527967386|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
146399402|NCT00320801|527967387|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
146399403|NCT00320801|527967384|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
146399404|NCT00320801|527967385|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
146399405|NCT00320801|527967386|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
146399406|NCT00320801|527967387|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
146399407|NCT00320801|527967384|FG000|Open-label Run-in Period|Did not qualify|1|||
146399408|NCT00320801|527967385|FG001|Open-label Run-in Period|Did not qualify|0|||
146399409|NCT00320801|527967386|FG002|Open-label Run-in Period|Did not qualify|0|||
146399410|NCT00320801|527967387|FG003|Open-label Run-in Period|Did not qualify|0|||
146399411|NCT00320801|527967384|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146399412|NCT00320801|527967385|FG001|Double-blind Phase|Withdrawal by Subject|0|||
146399413|NCT00320801|527967386|FG002|Double-blind Phase|Withdrawal by Subject|1|||
146399414|NCT00320801|527967387|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146399415|NCT00320801|527967384|FG000|Double-blind Phase|Adverse Event|0|||
146399416|NCT00320801|527967385|FG001|Double-blind Phase|Adverse Event|2|||
146399417|NCT00320801|527967386|FG002|Double-blind Phase|Adverse Event|8|||
146399418|NCT00320801|527967387|FG003|Double-blind Phase|Adverse Event|0|||
146399419|NCT00320801|527967384|FG000|Double-blind Phase|Administrative|0|||
146399420|NCT00320801|527967385|FG001|Double-blind Phase|Administrative|0|||
146399421|NCT00320801|527967386|FG002|Double-blind Phase|Administrative|4|||
146399422|NCT00320801|527967387|FG003|Double-blind Phase|Administrative|0|||
146399423|NCT00320801|527967384|FG000|Double-blind Phase|Lack of Efficacy|0|||
146399424|NCT00320801|527967385|FG001|Double-blind Phase|Lack of Efficacy|9|||
146399425|NCT00320801|527967386|FG002|Double-blind Phase|Lack of Efficacy|1|||
146399426|NCT00320801|527967387|FG003|Double-blind Phase|Lack of Efficacy|0|||
146399427|NCT00320801|527967384|FG000|Extension Phase|Withdrawal by Subject|0|||
146399428|NCT00320801|527967385|FG001|Extension Phase|Withdrawal by Subject|0|||
146399429|NCT00320801|527967386|FG002|Extension Phase|Withdrawal by Subject|0|||
146399430|NCT00320801|527967387|FG003|Extension Phase|Withdrawal by Subject|6|||
146399431|NCT00320801|527967384|FG000|Extension Phase|Adverse Event|0|||
146399432|NCT00320801|527967385|FG001|Extension Phase|Adverse Event|0|||
146399433|NCT00320801|527967386|FG002|Extension Phase|Adverse Event|0|||
146399434|NCT00320801|527967387|FG003|Extension Phase|Adverse Event|8|||
146399435|NCT00320801|527967384|FG000|Extension Phase|Administrative|0|||
146399436|NCT00320801|527967385|FG001|Extension Phase|Administrative|0|||
146399437|NCT00320801|527967386|FG002|Extension Phase|Administrative|0|||
146399438|NCT00320801|527967387|FG003|Extension Phase|Administrative|29|||
146399439|NCT00320801|527967384|FG000|Extension Phase|Lack of Efficacy|0|||
146399440|NCT00320801|527967385|FG001|Extension Phase|Lack of Efficacy|0|||
146399441|NCT00320801|527967386|FG002|Extension Phase|Lack of Efficacy|0|||
146399442|NCT00320801|527967387|FG003|Extension Phase|Lack of Efficacy|2|||
146399443|NCT00320801|527967384|FG000|Extension Phase|Lost to Follow-up|0|||
146399444|NCT00320801|527967385|FG001|Extension Phase|Lost to Follow-up|0|||
146399445|NCT00320801|527967386|FG002|Extension Phase|Lost to Follow-up|0|||
146399446|NCT00320801|527967387|FG003|Extension Phase|Lost to Follow-up|3|||
146399447|NCT02060188|527967388|FG000|Overall Study|Disease Progression|36|||
146399448|NCT02060188|527967389|FG001|Overall Study|Disease Progression|42|||
146399449|NCT02060188|527967390|FG002|Overall Study|Disease Progression|8|||
146399450|NCT02060188|527967391|FG003|Overall Study|Disease Progression|5|||
146399451|NCT02060188|527967392|FG004|Overall Study|Disease Progression|6|||
146399452|NCT02060188|527967393|FG005|Overall Study|Disease Progression|3|||
146399453|NCT02060188|527967394|FG006|Overall Study|Disease Progression|23|||
146399454|NCT02060188|527967395|FG007|Overall Study|Disease Progression|20|||
146399455|NCT02060188|527967396|FG008|Overall Study|Disease Progression|43|||
146399456|NCT02060188|527967388|FG000|Overall Study|Study Drug Toxicity|10|||
146399457|NCT02060188|527967389|FG001|Overall Study|Study Drug Toxicity|18|||
146399458|NCT02060188|527967390|FG002|Overall Study|Study Drug Toxicity|7|||
146399459|NCT02060188|527967391|FG003|Overall Study|Study Drug Toxicity|4|||
146399460|NCT02060188|527967392|FG004|Overall Study|Study Drug Toxicity|3|||
146399461|NCT02060188|527967393|FG005|Overall Study|Study Drug Toxicity|0|||
146399462|NCT02060188|527967394|FG006|Overall Study|Study Drug Toxicity|2|||
146399463|NCT02060188|527967395|FG007|Overall Study|Study Drug Toxicity|5|||
146399464|NCT02060188|527967396|FG008|Overall Study|Study Drug Toxicity|0|||
146399465|NCT02060188|527967388|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146399466|NCT02060188|527967389|FG001|Overall Study|Adverse event unrelated to study drug|5|||
146399467|NCT02060188|527967390|FG002|Overall Study|Adverse event unrelated to study drug|6|||
146399468|NCT02060188|527967391|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146399469|NCT02060188|527967392|FG004|Overall Study|Adverse event unrelated to study drug|1|||
146399470|NCT02060188|527967393|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146399471|NCT02060188|527967394|FG006|Overall Study|Adverse event unrelated to study drug|4|||
146399472|NCT02060188|527967395|FG007|Overall Study|Adverse event unrelated to study drug|4|||
146399473|NCT02060188|527967396|FG008|Overall Study|Adverse event unrelated to study drug|1|||
146399474|NCT02060188|527967388|FG000|Overall Study|Participant request to discontinue study treatment|7|||
146399475|NCT02060188|527967389|FG001|Overall Study|Participant request to discontinue study treatment|7|||
146399476|NCT02060188|527967390|FG002|Overall Study|Participant request to discontinue study treatment|4|||
146399477|NCT02060188|527967391|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146399478|NCT02060188|527967392|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146399479|NCT02060188|527967393|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146399480|NCT02060188|527967394|FG006|Overall Study|Participant request to discontinue study treatment|1|||
146399481|NCT02060188|527967395|FG007|Overall Study|Participant request to discontinue study treatment|1|||
146399482|NCT02060188|527967396|FG008|Overall Study|Participant request to discontinue study treatment|0|||
146399483|NCT02060188|527967388|FG000|Overall Study|Participant withdrew consent|3|||
146399484|NCT02060188|527967389|FG001|Overall Study|Participant withdrew consent|0|||
146399485|NCT02060188|527967390|FG002|Overall Study|Participant withdrew consent|0|||
146399486|NCT02060188|527967391|FG003|Overall Study|Participant withdrew consent|0|||
146399487|NCT02060188|527967392|FG004|Overall Study|Participant withdrew consent|0|||
146399488|NCT02060188|527967393|FG005|Overall Study|Participant withdrew consent|0|||
146399489|NCT02060188|527967394|FG006|Overall Study|Participant withdrew consent|0|||
146399490|NCT02060188|527967395|FG007|Overall Study|Participant withdrew consent|0|||
146399491|NCT02060188|527967396|FG008|Overall Study|Participant withdrew consent|0|||
146399492|NCT02060188|527967388|FG000|Overall Study|Maximum clinical benefit|13|||
146399493|NCT02060188|527967389|FG001|Overall Study|Maximum clinical benefit|38|||
146399494|NCT02060188|527967390|FG002|Overall Study|Maximum clinical benefit|19|||
146399495|NCT02060188|527967391|FG003|Overall Study|Maximum clinical benefit|0|||
146399496|NCT02060188|527967392|FG004|Overall Study|Maximum clinical benefit|0|||
146399497|NCT02060188|527967393|FG005|Overall Study|Maximum clinical benefit|0|||
146399498|NCT02060188|527967394|FG006|Overall Study|Maximum clinical benefit|0|||
146399499|NCT02060188|527967395|FG007|Overall Study|Maximum clinical benefit|10|||
146399500|NCT02060188|527967396|FG008|Overall Study|Maximum clinical benefit|0|||
146399501|NCT02060188|527967388|FG000|Overall Study|Other reason|3|||
146399502|NCT02060188|527967389|FG001|Overall Study|Other reason|7|||
146399503|NCT02060188|527967390|FG002|Overall Study|Other reason|0|||
146399504|NCT02060188|527967391|FG003|Overall Study|Other reason|1|||
146399505|NCT02060188|527967392|FG004|Overall Study|Other reason|0|||
146399506|NCT02060188|527967393|FG005|Overall Study|Other reason|0|||
146399507|NCT02060188|527967394|FG006|Overall Study|Other reason|0|||
146399508|NCT02060188|527967395|FG007|Overall Study|Other reason|9|||
146399509|NCT02060188|527967396|FG008|Overall Study|Other reason|0|||
146399510|NCT02060188|527967388|FG000|Overall Study|Death|0|||
146399511|NCT02060188|527967389|FG001|Overall Study|Death|1|||
146399512|NCT02060188|527967390|FG002|Overall Study|Death|0|||
146399513|NCT02060188|527967391|FG003|Overall Study|Death|0|||
146399514|NCT02060188|527967392|FG004|Overall Study|Death|0|||
146399515|NCT02060188|527967393|FG005|Overall Study|Death|0|||
146399516|NCT02060188|527967394|FG006|Overall Study|Death|0|||
146399517|NCT02060188|527967395|FG007|Overall Study|Death|1|||
146399518|NCT02060188|527967396|FG008|Overall Study|Death|0|||
146399519|NCT02060188|527967388|FG000|Overall Study|Administrative reasons by sponsor|0|||
146399520|NCT02060188|527967389|FG001|Overall Study|Administrative reasons by sponsor|1|||
146399521|NCT02060188|527967390|FG002|Overall Study|Administrative reasons by sponsor|0|||
146399522|NCT02060188|527967391|FG003|Overall Study|Administrative reasons by sponsor|0|||
146399523|NCT02060188|527967392|FG004|Overall Study|Administrative reasons by sponsor|0|||
146399524|NCT02060188|527967393|FG005|Overall Study|Administrative reasons by sponsor|0|||
146399525|NCT02060188|527967394|FG006|Overall Study|Administrative reasons by sponsor|0|||
146399526|NCT02060188|527967395|FG007|Overall Study|Administrative reasons by sponsor|0|||
146399527|NCT02060188|527967396|FG008|Overall Study|Administrative reasons by sponsor|0|||
146399528|NCT02060188|527967388|FG000|Overall Study|Lost to Follow-up|0|||
146399529|NCT02060188|527967389|FG001|Overall Study|Lost to Follow-up|0|||
146399530|NCT02060188|527967390|FG002|Overall Study|Lost to Follow-up|1|||
146399531|NCT02060188|527967391|FG003|Overall Study|Lost to Follow-up|0|||
146399532|NCT02060188|527967392|FG004|Overall Study|Lost to Follow-up|0|||
146399533|NCT02060188|527967393|FG005|Overall Study|Lost to Follow-up|0|||
146399534|NCT02060188|527967394|FG006|Overall Study|Lost to Follow-up|0|||
146399535|NCT02060188|527967395|FG007|Overall Study|Lost to Follow-up|0|||
146399536|NCT02060188|527967396|FG008|Overall Study|Lost to Follow-up|0|||
146399537|NCT03426995|527967397|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399538|NCT03426995|527967398|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399539|NCT03426995|527967399|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
146399540|NCT03426995|527967400|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399541|NCT03426995|527967401|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399542|NCT03426995|527967402|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399543|NCT03426995|527967403|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399544|NCT03426995|527967404|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399545|NCT03426995|527967405|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399546|NCT03426995|527967406|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399547|NCT03426995|527967407|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399548|NCT03426995|527967408|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399549|NCT03426995|527967409|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399550|NCT03426995|527967410|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399551|NCT03426995|527967411|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399552|NCT03426995|527967412|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399553|NCT03426995|527967413|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399554|NCT03426995|527967414|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399555|NCT03426995|527967415|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
146399556|NCT03426995|527967397|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399557|NCT03426995|527967398|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399558|NCT03426995|527967399|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399559|NCT03426995|527967400|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399560|NCT03426995|527967401|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399561|NCT03426995|527967402|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
146399562|NCT03426995|527967403|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399563|NCT03426995|527967404|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399564|NCT03426995|527967405|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399565|NCT03426995|527967406|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399566|NCT03426995|527967407|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399567|NCT03426995|527967408|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399568|NCT03426995|527967409|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399569|NCT03426995|527967410|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399570|NCT03426995|527967411|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399571|NCT03426995|527967412|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399572|NCT03426995|527967413|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399573|NCT03426995|527967414|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399574|NCT03426995|527967415|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
146399575|NCT03426995|527967397|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399576|NCT03426995|527967398|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399577|NCT03426995|527967399|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399578|NCT03426995|527967400|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399579|NCT03426995|527967401|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
146399580|NCT03426995|527967402|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
146399581|NCT03426995|527967403|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399582|NCT03426995|527967404|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399583|NCT03426995|527967405|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399584|NCT03426995|527967406|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399585|NCT03426995|527967407|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399586|NCT03426995|527967408|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399587|NCT03426995|527967409|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399588|NCT03426995|527967410|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399589|NCT03426995|527967411|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399590|NCT03426995|527967412|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399591|NCT03426995|527967413|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399592|NCT03426995|527967414|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399593|NCT03426995|527967415|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
146399594|NCT03426995|527967397|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399595|NCT03426995|527967398|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399596|NCT03426995|527967399|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399597|NCT03426995|527967400|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399598|NCT03426995|527967401|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399599|NCT03426995|527967402|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399600|NCT03426995|527967403|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399601|NCT03426995|527967404|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399602|NCT03426995|527967405|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399603|NCT03426995|527967406|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399604|NCT03426995|527967407|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
146399605|NCT03426995|527967408|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399606|NCT03426995|527967409|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399607|NCT03426995|527967410|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399608|NCT03426995|527967411|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399609|NCT03426995|527967412|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399610|NCT03426995|527967413|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399611|NCT03426995|527967414|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399612|NCT03426995|527967415|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
146399613|NCT03426995|527967397|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399614|NCT03426995|527967398|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399615|NCT03426995|527967399|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399616|NCT03426995|527967400|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399617|NCT03426995|527967401|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399618|NCT03426995|527967402|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399619|NCT03426995|527967403|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399620|NCT03426995|527967404|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
146399621|NCT03426995|527967405|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399622|NCT03426995|527967406|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399623|NCT03426995|527967407|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399624|NCT03426995|527967408|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399625|NCT03426995|527967409|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399626|NCT03426995|527967410|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399627|NCT03426995|527967411|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399628|NCT03426995|527967412|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399629|NCT03426995|527967413|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399630|NCT03426995|527967414|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399631|NCT03426995|527967415|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
146399632|NCT03426995|527967397|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399633|NCT03426995|527967398|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399634|NCT03426995|527967399|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399635|NCT03426995|527967400|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399636|NCT03426995|527967401|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399637|NCT03426995|527967402|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399638|NCT03426995|527967403|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399639|NCT03426995|527967404|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399640|NCT03426995|527967405|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399641|NCT03426995|527967406|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399642|NCT03426995|527967407|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399643|NCT03426995|527967408|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399644|NCT03426995|527967409|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399645|NCT03426995|527967410|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399646|NCT03426995|527967411|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
146399647|NCT03426995|527967412|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
146399648|NCT03426995|527967413|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399649|NCT03426995|527967414|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399650|NCT03426995|527967415|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
146399651|NCT03426995|527967397|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399652|NCT03426995|527967398|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399653|NCT03426995|527967399|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399654|NCT03426995|527967400|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399655|NCT03426995|527967401|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399656|NCT03426995|527967402|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399657|NCT03426995|527967403|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399658|NCT03426995|527967404|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399659|NCT03426995|527967405|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399660|NCT03426995|527967406|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399661|NCT03426995|527967407|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399662|NCT03426995|527967408|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399663|NCT03426995|527967409|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399664|NCT03426995|527967410|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399665|NCT03426995|527967411|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
146399666|NCT03426995|527967412|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
146399667|NCT03426995|527967413|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399668|NCT03426995|527967414|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399669|NCT03426995|527967415|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
146399670|NCT02335411|527967416|FG000|Overall Study|Death|223|||
146399671|NCT02335411|527967417|FG001|Overall Study|Death|22|||
146399672|NCT02335411|527967418|FG002|Overall Study|Death|26|||
146399673|NCT02335411|527967416|FG000|Overall Study|Physician Decision|3|||
146399674|NCT02335411|527967417|FG001|Overall Study|Physician Decision|0|||
146399675|NCT02335411|527967418|FG002|Overall Study|Physician Decision|0|||
146399676|NCT02335411|527967416|FG000|Overall Study|Protocol Violation|1|||
146399677|NCT02335411|527967417|FG001|Overall Study|Protocol Violation|0|||
146399678|NCT02335411|527967418|FG002|Overall Study|Protocol Violation|0|||
146399679|NCT02335411|527967416|FG000|Overall Study|Withdrawal by Subject|11|||
146399680|NCT02335411|527967417|FG001|Overall Study|Withdrawal by Subject|0|||
146399681|NCT02335411|527967418|FG002|Overall Study|Withdrawal by Subject|3|||
146399682|NCT02335411|527967416|FG000|Overall Study|Sponsor Decision|12|||
146399683|NCT02335411|527967417|FG001|Overall Study|Sponsor Decision|3|||
146399684|NCT02335411|527967418|FG002|Overall Study|Sponsor Decision|2|||
146399685|NCT02335411|527967416|FG000|Overall Study|Adverse Event|9|||
146399686|NCT02335411|527967417|FG001|Overall Study|Adverse Event|0|||
146399687|NCT02335411|527967418|FG002|Overall Study|Adverse Event|0|||
146399688|NCT04150107|527967422|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
146399689|NCT04150107|527967423|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
146399690|NCT04150107|527967422|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
146399691|NCT04150107|527967423|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
146399692|NCT00650806|527967424|FG000|Overall Study|Adverse Event|0|||
146399693|NCT00650806|527967425|FG001|Overall Study|Adverse Event|5|||
146399694|NCT00650806|527967426|FG002|Overall Study|Adverse Event|3|||
146399695|NCT00650806|527967427|FG003|Overall Study|Adverse Event|4|||
146399696|NCT00650806|527967424|FG000|Overall Study|Lost to Follow-up|7|||
146399697|NCT00650806|527967425|FG001|Overall Study|Lost to Follow-up|6|||
146399698|NCT00650806|527967426|FG002|Overall Study|Lost to Follow-up|11|||
146399699|NCT00650806|527967427|FG003|Overall Study|Lost to Follow-up|10|||
146399700|NCT00650806|527967424|FG000|Overall Study|Protocol Violation|0|||
146399701|NCT00650806|527967425|FG001|Overall Study|Protocol Violation|0|||
146399702|NCT00650806|527967426|FG002|Overall Study|Protocol Violation|0|||
146399703|NCT00650806|527967427|FG003|Overall Study|Protocol Violation|1|||
146399704|NCT00650806|527967424|FG000|Overall Study|Pregnancy|0|||
146399705|NCT00650806|527967425|FG001|Overall Study|Pregnancy|0|||
146399706|NCT00650806|527967426|FG002|Overall Study|Pregnancy|0|||
146399707|NCT00650806|527967427|FG003|Overall Study|Pregnancy|1|||
146399708|NCT00650806|527967424|FG000|Overall Study|Withdrawal by Subject|7|||
146399709|NCT00650806|527967425|FG001|Overall Study|Withdrawal by Subject|5|||
146399710|NCT00650806|527967426|FG002|Overall Study|Withdrawal by Subject|8|||
146399711|NCT00650806|527967427|FG003|Overall Study|Withdrawal by Subject|6|||
146399712|NCT00650806|527967424|FG000|Overall Study|Noncompliance with study drug regimen|1|||
146399713|NCT00650806|527967425|FG001|Overall Study|Noncompliance with study drug regimen|1|||
146399714|NCT00650806|527967426|FG002|Overall Study|Noncompliance with study drug regimen|0|||
146399715|NCT00650806|527967427|FG003|Overall Study|Noncompliance with study drug regimen|0|||
146399716|NCT00650806|527967424|FG000|Overall Study|Study terminated by sponsor|2|||
146399717|NCT00650806|527967425|FG001|Overall Study|Study terminated by sponsor|3|||
146399718|NCT00650806|527967426|FG002|Overall Study|Study terminated by sponsor|5|||
146399719|NCT00650806|527967427|FG003|Overall Study|Study terminated by sponsor|4|||
146399720|NCT00650806|527967424|FG000|Overall Study|Other|1|||
146399721|NCT00650806|527967425|FG001|Overall Study|Other|1|||
146399722|NCT00650806|527967426|FG002|Overall Study|Other|2|||
146399723|NCT00650806|527967427|FG003|Overall Study|Other|0|||
146399724|NCT04456998|527967430|FG000|Overall Study|Adverse Event|0|||
146399725|NCT04456998|527967431|FG001|Overall Study|Adverse Event|4|||
146399726|NCT04456998|527967430|FG000|Overall Study|Protocol Deviation|0|||
146399727|NCT04456998|527967431|FG001|Overall Study|Protocol Deviation|1|||
146399728|NCT04456998|527967430|FG000|Overall Study|Withdrawal by Subject|0|||
146399729|NCT04456998|527967431|FG001|Overall Study|Withdrawal by Subject|1|||
146399730|NCT04455620|527967435|FG000|Overall Study|Withdrawal by Subject|0|||
146399731|NCT04455620|527967436|FG001|Overall Study|Withdrawal by Subject|0|||
146399732|NCT04455620|527967437|FG002|Overall Study|Withdrawal by Subject|2|||
146399733|NCT04455620|527967438|FG003|Overall Study|Withdrawal by Subject|0|||
146399734|NCT04455620|527967439|FG004|Overall Study|Withdrawal by Subject|1|||
146399735|NCT04455620|527967435|FG000|Overall Study|Lost to Follow-up|0|||
146399736|NCT04455620|527967436|FG001|Overall Study|Lost to Follow-up|0|||
146399737|NCT04455620|527967437|FG002|Overall Study|Lost to Follow-up|1|||
146399738|NCT04455620|527967438|FG003|Overall Study|Lost to Follow-up|1|||
146399739|NCT04455620|527967439|FG004|Overall Study|Lost to Follow-up|0|||
146399740|NCT04455620|527967435|FG000|Overall Study|Death|1|||
146399741|NCT04455620|527967436|FG001|Overall Study|Death|6|||
146399742|NCT04455620|527967437|FG002|Overall Study|Death|20|||
146399743|NCT04455620|527967438|FG003|Overall Study|Death|1|||
146399744|NCT04455620|527967439|FG004|Overall Study|Death|7|||
146399745|NCT04455620|527967435|FG000|Overall Study|Study Termination|0|||
146399746|NCT04455620|527967436|FG001|Overall Study|Study Termination|2|||
146399747|NCT04455620|527967437|FG002|Overall Study|Study Termination|1|||
146399748|NCT04455620|527967438|FG003|Overall Study|Study Termination|0|||
146399749|NCT04455620|527967439|FG004|Overall Study|Study Termination|6|||
146399750|NCT05012943|527967440|FG000|Overall Study|Adverse Event|2|||
146399751|NCT05012943|527967441|FG001|Overall Study|Adverse Event|1|||
146399752|NCT05012943|527967442|FG002|Overall Study|Adverse Event|0|||
146399753|NCT05012943|527967440|FG000|Overall Study|Withdrawal by Subject|1052|||
146399754|NCT05012943|527967441|FG001|Overall Study|Withdrawal by Subject|1006|||
146399755|NCT05012943|527967442|FG002|Overall Study|Withdrawal by Subject|20|||
146399756|NCT05012943|527967440|FG000|Overall Study|Death|25|||
146399757|NCT05012943|527967441|FG001|Overall Study|Death|17|||
146399758|NCT05012943|527967442|FG002|Overall Study|Death|4|||
146399759|NCT05012943|527967440|FG000|Overall Study|Lost to Follow-up|11|||
146399760|NCT05012943|527967441|FG001|Overall Study|Lost to Follow-up|24|||
146399761|NCT05012943|527967442|FG002|Overall Study|Lost to Follow-up|3|||
146399762|NCT05012943|527967440|FG000|Overall Study|Physician Decision|1|||
146399763|NCT05012943|527967441|FG001|Overall Study|Physician Decision|1|||
146399764|NCT05012943|527967442|FG002|Overall Study|Physician Decision|0|||
146399765|NCT05012943|527967440|FG000|Overall Study|Other than Specified|2|||
146399766|NCT05012943|527967441|FG001|Overall Study|Other than Specified|1|||
146399767|NCT05012943|527967442|FG002|Overall Study|Other than Specified|0|||
146399768|NCT04228107|527967443|FG000|Overall Study|Protocol Violation|1|||
146399769|NCT04228107|527967444|FG001|Overall Study|Protocol Violation|0|||
146399770|NCT04228107|527967443|FG000|Overall Study|Withdrawal by Subject|6|||
146399771|NCT04228107|527967444|FG001|Overall Study|Withdrawal by Subject|0|||
146399772|NCT04228107|527967443|FG000|Overall Study|Lost to Follow-up|18|||
146399773|NCT04228107|527967444|FG001|Overall Study|Lost to Follow-up|0|||
146399774|NCT04228107|527967443|FG000|Overall Study|No controller use data|1|||
146399775|NCT04228107|527967444|FG001|Overall Study|No controller use data|0|||
146399776|NCT04228107|527967443|FG000|Overall Study|No medication data collected|1|||
146399777|NCT04228107|527967444|FG001|Overall Study|No medication data collected|0|||
146399778|NCT00400985|527967445|FG000|Overall Study|Withdrawal by Subject|5|||
146399779|NCT00400985|527967445|FG000|Overall Study|system modification|8|||
146399780|NCT00400985|527967445|FG000|Overall Study|Death|30|||
146399781|NCT00400985|527967445|FG000|Overall Study|Lost to Follow-up|9|||
146399782|NCT00965562|527967446|FG000|Overall Study|Lost to Follow-up|1|||
146399783|NCT00965562|527967447|FG001|Overall Study|Lost to Follow-up|2|||
146399784|NCT00965562|527967448|FG002|Overall Study|Lost to Follow-up|3|||
146399785|NCT00965562|527967446|FG000|Overall Study|Withdrawal by Subject|2|||
146399786|NCT00965562|527967447|FG001|Overall Study|Withdrawal by Subject|2|||
146399787|NCT00965562|527967448|FG002|Overall Study|Withdrawal by Subject|0|||
146399788|NCT03792633|527967449|FG000|Overall Study|Alternative Treatment|17|||
146399789|NCT03792633|527967450|FG001|Overall Study|Alternative Treatment|19|||
146399790|NCT03792633|527967449|FG000|Overall Study|Death|2|||
146399791|NCT03792633|527967450|FG001|Overall Study|Death|0|||
146399792|NCT03792633|527967449|FG000|Overall Study|Disease progression|8|||
146399793|NCT03792633|527967450|FG001|Overall Study|Disease progression|9|||
146399794|NCT03792633|527967449|FG000|Overall Study|Lost to Follow-up|1|||
146399795|NCT03792633|527967450|FG001|Overall Study|Lost to Follow-up|1|||
146399796|NCT03792633|527967449|FG000|Overall Study|Screen fail|1|||
146399797|NCT03792633|527967450|FG001|Overall Study|Screen fail|0|||
146399798|NCT03792633|527967449|FG000|Overall Study|Second malignancy|0|||
146399799|NCT03792633|527967450|FG001|Overall Study|Second malignancy|1|||
146399800|NCT05048875|527967452|FG000|Overall Study|Withdrawal by Subject|1|||
146399801|NCT05048875|527967453|FG001|Overall Study|Withdrawal by Subject|0|||
146399802|NCT05048875|527967454|FG002|Overall Study|Withdrawal by Subject|0|||
146399803|NCT05048875|527967455|FG003|Overall Study|Withdrawal by Subject|0|||
146399804|NCT05048875|527967456|FG004|Overall Study|Withdrawal by Subject|0|||
146399805|NCT05048875|527967457|FG005|Overall Study|Withdrawal by Subject|0|||
146399806|NCT05048875|527967458|FG006|Overall Study|Withdrawal by Subject|0|||
146399807|NCT05048875|527967459|FG007|Overall Study|Withdrawal by Subject|0|||
146399808|NCT05048875|527967452|FG000|Overall Study|Adverse Event|0|||
146399809|NCT05048875|527967453|FG001|Overall Study|Adverse Event|0|||
146399810|NCT05048875|527967454|FG002|Overall Study|Adverse Event|0|||
146399811|NCT05048875|527967455|FG003|Overall Study|Adverse Event|1|||
146399812|NCT05048875|527967456|FG004|Overall Study|Adverse Event|0|||
146399813|NCT05048875|527967457|FG005|Overall Study|Adverse Event|0|||
146399814|NCT05048875|527967458|FG006|Overall Study|Adverse Event|0|||
146399815|NCT05048875|527967459|FG007|Overall Study|Adverse Event|0|||
146399816|NCT02684162|527967470|FG000|Overall Study|Physician Decision|0|||
146399817|NCT02684162|527967471|FG001|Overall Study|Physician Decision|1|||
146399818|NCT02684162|527967472|FG002|Overall Study|Physician Decision|0|||
146399819|NCT05153629|527967474|FG000|Overall Study|Withdrawal by Subject|0|||
146399820|NCT05153629|527967475|FG001|Overall Study|Withdrawal by Subject|2|||
146399821|NCT04089566|527967480|FG000|Overall Study|Death|0|||
146399822|NCT04089566|527967481|FG001|Overall Study|Death|6|||
146399823|NCT04089566|527967482|FG002|Overall Study|Death|10|||
146399824|NCT04089566|527967483|FG003|Overall Study|Death|0|||
146399825|NCT04089566|527967484|FG004|Overall Study|Death|0|||
146399826|NCT04089566|527967485|FG005|Overall Study|Death|0|||
146399827|NCT04089566|527967480|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
146399828|NCT04089566|527967481|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
146399829|NCT04089566|527967482|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
146399830|NCT04089566|527967483|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
146399831|NCT04089566|527967484|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
146399832|NCT04089566|527967485|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
146399833|NCT04089566|527967480|FG000|Overall Study|Reason not Specified|0|||
146399834|NCT04089566|527967481|FG001|Overall Study|Reason not Specified|4|||
146399835|NCT04089566|527967482|FG002|Overall Study|Reason not Specified|4|||
146399836|NCT04089566|527967483|FG003|Overall Study|Reason not Specified|1|||
146399837|NCT04089566|527967484|FG004|Overall Study|Reason not Specified|0|||
146399838|NCT04089566|527967485|FG005|Overall Study|Reason not Specified|0|||
146399839|NCT01489865|527967493|FG000|Overall Study|Progression of Disease|4|||
146399840|NCT01489865|527967494|FG001|Overall Study|Progression of Disease|2|||
146399841|NCT01489865|527967495|FG002|Overall Study|Progression of Disease|2|||
146399842|NCT01489865|527967496|FG003|Overall Study|Progression of Disease|3|||
146399843|NCT01489865|527967497|FG004|Overall Study|Progression of Disease|1|||
146399844|NCT01489865|527967498|FG005|Overall Study|Progression of Disease|6|||
146399845|NCT01489865|527967499|FG006|Overall Study|Progression of Disease|3|||
146399846|NCT01489865|527967500|FG007|Overall Study|Progression of Disease|0|||
146399847|NCT01489865|527967501|FG008|Overall Study|Progression of Disease|23|||
146399848|NCT01489865|527967493|FG000|Overall Study|Adverse Event|2|||
146399849|NCT01489865|527967494|FG001|Overall Study|Adverse Event|0|||
146399850|NCT01489865|527967495|FG002|Overall Study|Adverse Event|0|||
146399851|NCT01489865|527967496|FG003|Overall Study|Adverse Event|0|||
146399852|NCT01489865|527967497|FG004|Overall Study|Adverse Event|1|||
146399853|NCT01489865|527967498|FG005|Overall Study|Adverse Event|0|||
146399854|NCT01489865|527967499|FG006|Overall Study|Adverse Event|2|||
146399855|NCT01489865|527967500|FG007|Overall Study|Adverse Event|0|||
146399856|NCT01489865|527967501|FG008|Overall Study|Adverse Event|5|||
146399857|NCT01489865|527967493|FG000|Overall Study|Death|0|||
146399858|NCT01489865|527967494|FG001|Overall Study|Death|1|||
146399859|NCT01489865|527967495|FG002|Overall Study|Death|0|||
146399860|NCT01489865|527967496|FG003|Overall Study|Death|0|||
146399861|NCT01489865|527967497|FG004|Overall Study|Death|1|||
146399862|NCT01489865|527967498|FG005|Overall Study|Death|0|||
146399863|NCT01489865|527967499|FG006|Overall Study|Death|0|||
146399864|NCT01489865|527967500|FG007|Overall Study|Death|0|||
146399865|NCT01489865|527967501|FG008|Overall Study|Death|2|||
146399866|NCT01489865|527967493|FG000|Overall Study|Withdrawal by Subject|0|||
146399867|NCT01489865|527967494|FG001|Overall Study|Withdrawal by Subject|0|||
146399868|NCT01489865|527967495|FG002|Overall Study|Withdrawal by Subject|0|||
146399869|NCT01489865|527967496|FG003|Overall Study|Withdrawal by Subject|0|||
146399870|NCT01489865|527967497|FG004|Overall Study|Withdrawal by Subject|0|||
146399871|NCT01489865|527967498|FG005|Overall Study|Withdrawal by Subject|1|||
146399872|NCT01489865|527967499|FG006|Overall Study|Withdrawal by Subject|1|||
146399873|NCT01489865|527967500|FG007|Overall Study|Withdrawal by Subject|0|||
146399874|NCT01489865|527967501|FG008|Overall Study|Withdrawal by Subject|2|||
146399875|NCT01489865|527967493|FG000|Overall Study|Shifted|0|||
146399876|NCT01489865|527967494|FG001|Overall Study|Shifted|0|||
146399877|NCT01489865|527967495|FG002|Overall Study|Shifted|1|||
146399878|NCT01489865|527967496|FG003|Overall Study|Shifted|0|||
146399879|NCT01489865|527967497|FG004|Overall Study|Shifted|0|||
146399880|NCT01489865|527967498|FG005|Overall Study|Shifted|0|||
146399881|NCT01489865|527967499|FG006|Overall Study|Shifted|0|||
146399882|NCT01489865|527967500|FG007|Overall Study|Shifted|0|||
146399883|NCT01489865|527967501|FG008|Overall Study|Shifted|0|||
146399884|NCT00972309|527967502|FG000|Overall Study|Switched to alternative treatment|0|||
146399885|NCT00972309|527967503|FG001|Overall Study|Switched to alternative treatment|2|||
146399886|NCT00972309|527967502|FG000|Overall Study|Refused further treatment|0|||
146399887|NCT00972309|527967503|FG001|Overall Study|Refused further treatment|1|||
146399888|NCT00972309|527967502|FG000|Overall Study|Late determination of ineligibility|0|||
146399889|NCT00972309|527967503|FG001|Overall Study|Late determination of ineligibility|1|||
146399890|NCT00972309|527967502|FG000|Overall Study|Second malignancy|1|||
146399891|NCT00972309|527967503|FG001|Overall Study|Second malignancy|1|||
146399892|NCT00972309|527967502|FG000|Overall Study|Visa issues|0|||
146399893|NCT00972309|527967503|FG001|Overall Study|Visa issues|1|||
146399894|NCT00972309|527967502|FG000|Overall Study|Secondary cancer (SCC)|0|||
146399895|NCT00972309|527967503|FG001|Overall Study|Secondary cancer (SCC)|1|||
146399896|NCT00972309|527967502|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
146399897|NCT00972309|527967503|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
146399898|NCT00972309|527967502|FG000|Overall Study|Lost to Follow-up|1|||
146399899|NCT00972309|527967503|FG001|Overall Study|Lost to Follow-up|1|||
146399900|NCT00972309|527967502|FG000|Overall Study|Disease progression on study|10|||
146399901|NCT00972309|527967503|FG001|Overall Study|Disease progression on study|4|||
146399902|NCT01058707|527967507|FG000|Overall Study|Disease Progression|15|||
146399903|NCT01058707|527967508|FG001|Overall Study|Disease Progression|20|||
146399904|NCT01058707|527967509|FG002|Overall Study|Disease Progression|20|||
146399905|NCT01058707|527967510|FG003|Overall Study|Disease Progression|15|||
146399906|NCT01058707|527967511|FG004|Overall Study|Disease Progression|23|||
146399907|NCT01058707|527967512|FG005|Overall Study|Disease Progression|10|||
146399908|NCT01058707|527967513|FG006|Overall Study|Disease Progression|12|||
146399909|NCT01058707|527967507|FG000|Overall Study|Adverse Event|11|||
146399910|NCT01058707|527967508|FG001|Overall Study|Adverse Event|4|||
146399911|NCT01058707|527967509|FG002|Overall Study|Adverse Event|7|||
146399912|NCT01058707|527967510|FG003|Overall Study|Adverse Event|6|||
146399913|NCT01058707|527967511|FG004|Overall Study|Adverse Event|7|||
146399914|NCT01058707|527967512|FG005|Overall Study|Adverse Event|3|||
146399915|NCT01058707|527967513|FG006|Overall Study|Adverse Event|1|||
146399916|NCT01058707|527967507|FG000|Overall Study|Subject Decision|5|||
146399917|NCT01058707|527967508|FG001|Overall Study|Subject Decision|3|||
146399918|NCT01058707|527967509|FG002|Overall Study|Subject Decision|3|||
146399919|NCT01058707|527967510|FG003|Overall Study|Subject Decision|1|||
146399920|NCT01058707|527967511|FG004|Overall Study|Subject Decision|2|||
146399921|NCT01058707|527967512|FG005|Overall Study|Subject Decision|3|||
146399922|NCT01058707|527967513|FG006|Overall Study|Subject Decision|6|||
146399923|NCT01058707|527967507|FG000|Overall Study|Lost to Follow-up|0|||
146169884|NCT05044325|527134733|FG008|Part A:Treatment Period 2|Physician Decision|0|||
146399924|NCT01058707|527967508|FG001|Overall Study|Lost to Follow-up|0|||
146399925|NCT01058707|527967509|FG002|Overall Study|Lost to Follow-up|1|||
146399926|NCT01058707|527967510|FG003|Overall Study|Lost to Follow-up|0|||
146399927|NCT01058707|527967511|FG004|Overall Study|Lost to Follow-up|0|||
146399928|NCT01058707|527967512|FG005|Overall Study|Lost to Follow-up|0|||
146399929|NCT01058707|527967513|FG006|Overall Study|Lost to Follow-up|0|||
146399930|NCT01058707|527967507|FG000|Overall Study|Reason Not Specified|0|||
146399931|NCT01058707|527967508|FG001|Overall Study|Reason Not Specified|3|||
146399932|NCT01058707|527967509|FG002|Overall Study|Reason Not Specified|2|||
146399933|NCT01058707|527967510|FG003|Overall Study|Reason Not Specified|0|||
146399934|NCT01058707|527967511|FG004|Overall Study|Reason Not Specified|7|||
146399935|NCT01058707|527967512|FG005|Overall Study|Reason Not Specified|1|||
146399936|NCT01058707|527967513|FG006|Overall Study|Reason Not Specified|7|||
146399937|NCT01593761|527967515|FG000|Overall Study|Lost to Follow-up|1|||
146399938|NCT01593761|527967515|FG000|Overall Study|culture negative for MRSA at baseline|5|||
146399939|NCT01593761|527967515|FG000|Overall Study|positive for hepatitis C virus|1|||
146399940|NCT01593761|527967515|FG000|Overall Study|secondary cellulitis|1|||
146399941|NCT00795886|527967517|FG000|Overall Study|Death|10|||
146399942|NCT05554471|527967521|FG000|Overall Study|Physician Decision|2|||
146399943|NCT05554471|527967522|FG001|Overall Study|Physician Decision|1|||
146399944|NCT05554471|527967521|FG000|Overall Study|Lost to Follow-up|2|||
146399945|NCT05554471|527967522|FG001|Overall Study|Lost to Follow-up|1|||
146399946|NCT05554471|527967521|FG000|Overall Study|Death|0|||
146399947|NCT05554471|527967522|FG001|Overall Study|Death|1|||
146399948|NCT04880850|527967523|FG000|Overall Study|Death|2|||
146399949|NCT04880850|527967524|FG001|Overall Study|Death|1|||
146399950|NCT04880850|527967523|FG000|Overall Study|Lost to Follow-up|3|||
146399951|NCT04880850|527967524|FG001|Overall Study|Lost to Follow-up|6|||
146399952|NCT04880850|527967523|FG000|Overall Study|Physician Decision|2|||
146399953|NCT04880850|527967524|FG001|Overall Study|Physician Decision|1|||
146399954|NCT04880850|527967523|FG000|Overall Study|Withdrawal by Subject|9|||
146399955|NCT04880850|527967524|FG001|Overall Study|Withdrawal by Subject|10|||
146399956|NCT01875731|527967525|FG000|Overall Study|Fail to obtain lab sample|1|||
146399957|NCT01875731|527967526|FG001|Overall Study|Fail to obtain lab sample|0|||
146399958|NCT02576951|527967527|FG000|Overall Study|Lost to Follow-up|0|||
146399959|NCT02576951|527967528|FG001|Overall Study|Lost to Follow-up|0|||
146399960|NCT02576951|527967529|FG002|Overall Study|Lost to Follow-up|2|||
146399961|NCT02576951|527967530|FG003|Overall Study|Lost to Follow-up|2|||
146399962|NCT02576951|527967527|FG000|Overall Study|Withdrawal by Subject|1|||
146399963|NCT02576951|527967528|FG001|Overall Study|Withdrawal by Subject|0|||
146399964|NCT02576951|527967529|FG002|Overall Study|Withdrawal by Subject|0|||
146399965|NCT02576951|527967530|FG003|Overall Study|Withdrawal by Subject|2|||
146399966|NCT02576951|527967527|FG000|Overall Study|Protocol Violation|0|||
146399967|NCT02576951|527967528|FG001|Overall Study|Protocol Violation|0|||
146399968|NCT02576951|527967529|FG002|Overall Study|Protocol Violation|0|||
146399969|NCT02576951|527967530|FG003|Overall Study|Protocol Violation|1|||
146399970|NCT03417102|527967531|FG000|Overall Study|Adverse Event|0|||
146399971|NCT03417102|527967532|FG001|Overall Study|Adverse Event|1|||
146399972|NCT03417102|527967531|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
146399973|NCT03417102|527967532|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
146399974|NCT03417102|527967531|FG000|Overall Study|Other|0|||
146399975|NCT03417102|527967532|FG001|Overall Study|Other|1|||
146399976|NCT02062385|527967534|FG000|Overall Study|Adverse Event|19|||
146399977|NCT02062385|527967535|FG001|Overall Study|Adverse Event|13|||
146399978|NCT02062385|527967536|FG002|Overall Study|Adverse Event|1|||
146399979|NCT02062385|527967537|FG003|Overall Study|Adverse Event|0|||
146399980|NCT02062385|527967534|FG000|Overall Study|Protocol Violation|1|||
146399981|NCT02062385|527967535|FG001|Overall Study|Protocol Violation|0|||
146399982|NCT02062385|527967536|FG002|Overall Study|Protocol Violation|0|||
146399983|NCT02062385|527967537|FG003|Overall Study|Protocol Violation|0|||
146399984|NCT02062385|527967534|FG000|Overall Study|Incomplete EPI by database lock|2|||
146399985|NCT02062385|527967535|FG001|Overall Study|Incomplete EPI by database lock|0|||
145945135|NCT01546038|526308136|FG008|Overall Study|: Randomized, not treated|3|||
145945136|NCT04245202|526308137|FG000|Overall Study|Lack of Efficacy|10|||
145945137|NCT04245202|526308138|FG001|Overall Study|Lack of Efficacy|1|||
145945138|NCT03515629|526308139|FG000|Overall Study|Death|0|||
145945139|NCT03515629|526308140|FG001|Overall Study|Death|1|||
145945140|NCT03515629|526308141|FG002|Overall Study|Death|1|||
145945141|NCT03515629|526308139|FG000|Overall Study|Progressive disease|0|||
145945142|NCT03515629|526308140|FG001|Overall Study|Progressive disease|1|||
145945143|NCT03515629|526308141|FG002|Overall Study|Progressive disease|0|||
145945144|NCT00312572|526308145|FG000|Overall Study|Adverse Event|10|||
145945145|NCT00312572|526308146|FG001|Overall Study|Adverse Event|16|||
146399986|NCT02062385|527967536|FG002|Overall Study|Incomplete EPI by database lock|0|||
146399987|NCT02062385|527967537|FG003|Overall Study|Incomplete EPI by database lock|0|||
146399988|NCT02062385|527967534|FG000|Overall Study|Moved|10|||
146399989|NCT02062385|527967535|FG001|Overall Study|Moved|11|||
146399990|NCT02062385|527967536|FG002|Overall Study|Moved|1|||
146399991|NCT02062385|527967537|FG003|Overall Study|Moved|0|||
146399992|NCT02062385|527967534|FG000|Overall Study|Withdrawn by parent/guardian|46|||
146399993|NCT02062385|527967535|FG001|Overall Study|Withdrawn by parent/guardian|41|||
146399994|NCT02062385|527967536|FG002|Overall Study|Withdrawn by parent/guardian|9|||
146399995|NCT02062385|527967537|FG003|Overall Study|Withdrawn by parent/guardian|8|||
146399996|NCT02062385|527967534|FG000|Overall Study|Death|0|||
146399997|NCT02062385|527967535|FG001|Overall Study|Death|0|||
146399998|NCT02062385|527967536|FG002|Overall Study|Death|0|||
146399999|NCT02062385|527967537|FG003|Overall Study|Death|1|||
146400000|NCT02062385|527967534|FG000|Overall Study|Lost to Follow-up|0|||
146400001|NCT02062385|527967535|FG001|Overall Study|Lost to Follow-up|0|||
146400002|NCT02062385|527967536|FG002|Overall Study|Lost to Follow-up|1|||
146400003|NCT02062385|527967537|FG003|Overall Study|Lost to Follow-up|0|||
146400004|NCT03188991|527967538|FG000|Overall Study|Withdrawal by Subject|0|||
146400005|NCT03188991|527967539|FG001|Overall Study|Withdrawal by Subject|0|||
146400006|NCT03188991|527967540|FG002|Overall Study|Withdrawal by Subject|0|||
146400007|NCT03188991|527967541|FG003|Overall Study|Withdrawal by Subject|1|||
146400008|NCT01656850|527968591|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
146400009|NCT01656850|527968592|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
146400010|NCT00396318|527968593|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
146400011|NCT03255226|527968599|FG000|Overall Study|Adverse Event|2|||
146400012|NCT03255226|527968599|FG000|Overall Study|Physician Decision|3|||
146400013|NCT03255226|527968599|FG000|Overall Study|Withdrawal by Subject|1|||
146400014|NCT03255226|527968599|FG000|Overall Study|Serum or blood sodium increased|4|||
146400015|NCT03255226|527968599|FG000|Overall Study|Serum or blood potassium increased|4|||
146400016|NCT00602927|527968600|FG000|Period 1: 13 Days|Protocol Violation|2|||
146400017|NCT00602927|527968601|FG001|Period 1: 13 Days|Protocol Violation|4|||
146400018|NCT00602927|527968600|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
146400019|NCT00602927|527968601|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
146400020|NCT00602927|527968600|FG000|Period 1: 13 Days|Time|1|||
146400021|NCT00602927|527968601|FG001|Period 1: 13 Days|Time|0|||
146400022|NCT00602927|527968600|FG000|Period 1: 13 Days|Claustrophobia|0|||
146400023|NCT00602927|527968601|FG001|Period 1: 13 Days|Claustrophobia|1|||
146400024|NCT00602927|527968600|FG000|Period 2: 14 Days|Protocol Violation|0|||
146400025|NCT00602927|527968601|FG001|Period 2: 14 Days|Protocol Violation|2|||
146400026|NCT00602927|527968600|FG000|Period 3: 13 Days|Protocol Violation|0|||
146400027|NCT00602927|527968601|FG001|Period 3: 13 Days|Protocol Violation|1|||
146400028|NCT00602927|527968600|FG000|Period 3: 13 Days|MRI data quality|2|||
146400029|NCT00602927|527968601|FG001|Period 3: 13 Days|MRI data quality|2|||
146400030|NCT00685763|527968608|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
146400031|NCT00685763|527968608|FG000|Overall Study|Protocol Violation|1|||
146400032|NCT02525627|527968609|FG000|Overall Study|Revision|1|||
146400033|NCT02525627|527968610|FG001|Overall Study|Revision|1|||
146400034|NCT02525627|527968609|FG000|Overall Study|Withdrawal by Subject|1|||
146400035|NCT02525627|527968610|FG001|Overall Study|Withdrawal by Subject|2|||
146400036|NCT02525627|527968609|FG000|Overall Study|Death|1|||
146400037|NCT02525627|527968610|FG001|Overall Study|Death|0|||
146400038|NCT02525627|527968609|FG000|Overall Study|Site terminated|11|||
146400039|NCT02525627|527968610|FG001|Overall Study|Site terminated|10|||
146400040|NCT02875340|527968612|FG000|Overall Study|Death|2|||
146400041|NCT02875340|527968612|FG000|Overall Study|Withdrawal by Subject|2|||
146400042|NCT02875340|527968612|FG000|Overall Study|Physician Decision|3|||
146400043|NCT02875340|527968612|FG000|Overall Study|Adverse Event|1|||
146400044|NCT01160770|527968613|FG000|Overall Study|Adverse Event|10|||
146400045|NCT01160770|527968613|FG000|Overall Study|Protocol Violation|2|||
146400046|NCT01160770|527968613|FG000|Overall Study|Subject/parent/caregiver request|33|||
146400047|NCT01160770|527968613|FG000|Overall Study|Physician Decision|1|||
146400048|NCT01160770|527968613|FG000|Overall Study|Lost to Follow-up|7|||
146400049|NCT01160770|527968613|FG000|Overall Study|Study termination or sponsor request|1|||
146400050|NCT01160770|527968613|FG000|Overall Study|Death|9|||
146400051|NCT01160770|527968613|FG000|Overall Study|Lack of Efficacy|15|||
145945146|NCT00312572|526308145|FG000|Overall Study|Lost to Follow-up|1|||
146060726|NCT02156076|526741654|FG001|Follow-up Period|Withdrawal by Subject|0|||
146060727|NCT02156076|526741655|FG002|Follow-up Period|Withdrawal by Subject|0|||
146060728|NCT02156076|526741656|FG003|Follow-up Period|Withdrawal by Subject|0|||
146060729|NCT06271993|526741657|FG000|Overall Study|Not reactive to histamine|5|||
146060730|NCT06271993|526741658|FG001|Overall Study|Not reactive to histamine|5|||
146060731|NCT06271993|526741659|FG002|Overall Study|Not reactive to histamine|5|||
146060732|NCT00687596|526741660|FG000|Overall Study|Adverse Event (AE)|10|||
146060733|NCT00687596|526741661|FG001|Overall Study|Adverse Event (AE)|3|||
146060734|NCT00687596|526741660|FG000|Overall Study|Radiological Disease Progression|6|||
146060735|NCT00687596|526741661|FG001|Overall Study|Radiological Disease Progression|2|||
146060736|NCT00687596|526741660|FG000|Overall Study|Clinical Disease Progression|1|||
146060737|NCT00687596|526741661|FG001|Overall Study|Clinical Disease Progression|3|||
146060738|NCT00687596|526741660|FG000|Overall Study|Investigator Discretion|3|||
146060739|NCT00687596|526741661|FG001|Overall Study|Investigator Discretion|1|||
146060740|NCT00687596|526741660|FG000|Overall Study|Sponsor Terminated Study|6|||
146060741|NCT00687596|526741661|FG001|Overall Study|Sponsor Terminated Study|17|||
146400052|NCT01160770|527968613|FG000|Overall Study|Other Reasons|1|||
146400053|NCT04930536|527968616|FG000|Overall Study|Adverse Event|1|||
146400054|NCT04930536|527968617|FG001|Overall Study|Adverse Event|0|||
146400055|NCT04930536|527968616|FG000|Overall Study|Disease Progression|2|||
146400056|NCT04930536|527968617|FG001|Overall Study|Disease Progression|0|||
146400057|NCT04930536|527968616|FG000|Overall Study|Patient Decision|4|||
146400058|NCT04930536|527968617|FG001|Overall Study|Patient Decision|2|||
146400059|NCT04930536|527968616|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
146400060|NCT04930536|527968617|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
146400061|NCT01432600|527968618|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
146400062|NCT01432600|527968619|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
146400063|NCT01432600|527968620|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
146400064|NCT00848965|527968625|FG000|Overall Study|Adverse Event|1|||
146400065|NCT00848965|527968625|FG000|Overall Study|Withdrawal by Subject|1|||
146400066|NCT00348348|527968630|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
146400067|NCT00348348|527968631|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
146400068|NCT00348348|527968630|FG000|Overall Study|Lack of Efficacy|1|||
146400069|NCT00348348|527968631|FG001|Overall Study|Lack of Efficacy|1|||
146400070|NCT00348348|527968630|FG000|Overall Study|Lost to Follow-up|8|||
146400071|NCT00348348|527968631|FG001|Overall Study|Lost to Follow-up|10|||
146400072|NCT00348348|527968630|FG000|Overall Study|Withdrawal by Subject|4|||
146400073|NCT00348348|527968631|FG001|Overall Study|Withdrawal by Subject|1|||
146400074|NCT00348348|527968630|FG000|Overall Study|Other|7|||
146400075|NCT00348348|527968631|FG001|Overall Study|Other|4|||
146400076|NCT00348348|527968630|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
146400077|NCT00348348|527968631|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
146400078|NCT00348348|527968630|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
146400079|NCT00348348|527968631|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
146400080|NCT00348348|527968630|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
146400081|NCT00348348|527968631|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
146400082|NCT00348348|527968630|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
146400083|NCT00348348|527968631|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
146400084|NCT00348348|527968630|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
146400085|NCT00348348|527968631|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
146400086|NCT00348348|527968630|FG000|Overall Study|Adverse event probably related to study|1|||
146400087|NCT00348348|527968631|FG001|Overall Study|Adverse event probably related to study|0|||
146400088|NCT01605370|527968634|FG000|Overall Study|Adverse Event|1|||
146400089|NCT01605370|527968635|FG001|Overall Study|Adverse Event|0|||
146400090|NCT01976104|527968636|FG000|Overall Study|Adverse Event|0|||
146400091|NCT01976104|527968637|FG001|Overall Study|Adverse Event|0|||
146400092|NCT01976104|527968638|FG002|Overall Study|Adverse Event|1|||
146400093|NCT01976104|527968639|FG003|Overall Study|Adverse Event|0|||
146400094|NCT01976104|527968636|FG000|Overall Study|Lost to Follow-up|3|||
146400095|NCT01976104|527968637|FG001|Overall Study|Lost to Follow-up|0|||
146400096|NCT01976104|527968638|FG002|Overall Study|Lost to Follow-up|1|||
146400097|NCT01976104|527968639|FG003|Overall Study|Lost to Follow-up|1|||
146400098|NCT01976104|527968636|FG000|Overall Study|Subject Choice|0|||
146400099|NCT01976104|527968637|FG001|Overall Study|Subject Choice|1|||
146400100|NCT01976104|527968638|FG002|Overall Study|Subject Choice|0|||
146400101|NCT01976104|527968639|FG003|Overall Study|Subject Choice|1|||
146400102|NCT01976104|527968636|FG000|Overall Study|Withdrawal by Subject|3|||
146400103|NCT01976104|527968637|FG001|Overall Study|Withdrawal by Subject|0|||
146400104|NCT01976104|527968638|FG002|Overall Study|Withdrawal by Subject|0|||
146400105|NCT01976104|527968639|FG003|Overall Study|Withdrawal by Subject|1|||
146400106|NCT01976104|527968636|FG000|Overall Study|Other|0|||
146400107|NCT01976104|527968637|FG001|Overall Study|Other|1|||
146400108|NCT01976104|527968638|FG002|Overall Study|Other|0|||
146400109|NCT01976104|527968639|FG003|Overall Study|Other|0|||
146400110|NCT01353209|527968640|FG000|Overall Study|Adverse Event|1|||
146400111|NCT01353209|527968641|FG001|Overall Study|Adverse Event|1|||
146400112|NCT01165424|527968649|FG000|Overall Study|Clinical adverse experiences|1|||
146400113|NCT01165424|527968649|FG000|Overall Study|Laboratory adverse experiences|1|||
146400114|NCT01165424|527968649|FG000|Overall Study|Did not meet entry criteria|1|||
146400115|NCT01165424|527968649|FG000|Overall Study|Participant moved (relocated)|1|||
146400116|NCT02181673|527968650|FG000|Up to Week 24|Adverse Event|2|||
146060742|NCT03331315|526741669|FG000|Overall Study|Physician Decision|18|||
146060743|NCT03331315|526741670|FG001|Overall Study|Physician Decision|14|||
146060744|NCT02558894|526741673|FG000|Overall Study|Death; any cause, entire study duration|28|||
146060745|NCT02558894|526741674|FG001|Overall Study|Death; any cause, entire study duration|31|||
146060746|NCT02558894|526741673|FG000|Overall Study|Withdrawal by Subject|2|||
146060747|NCT02558894|526741674|FG001|Overall Study|Withdrawal by Subject|1|||
146060748|NCT02558894|526741673|FG000|Overall Study|Closure of Part A|2|||
146060749|NCT02558894|526741674|FG001|Overall Study|Closure of Part A|1|||
146060750|NCT02992288|526741675|FG000|Overall Study|Adverse Event|8|||
146060751|NCT02992288|526741676|FG001|Overall Study|Adverse Event|2|||
146060752|NCT02992288|526741677|FG002|Overall Study|Adverse Event|2|||
146060753|NCT02992288|526741678|FG003|Overall Study|Adverse Event|2|||
146060754|NCT02992288|526741679|FG004|Overall Study|Adverse Event|2|||
146060755|NCT02992288|526741680|FG005|Overall Study|Adverse Event|7|||
146060756|NCT02992288|526741675|FG000|Overall Study|Non-compliance with study drug|0|||
146060757|NCT02992288|526741676|FG001|Overall Study|Non-compliance with study drug|1|||
146060758|NCT02992288|526741677|FG002|Overall Study|Non-compliance with study drug|1|||
146060759|NCT02992288|526741678|FG003|Overall Study|Non-compliance with study drug|0|||
146060760|NCT02992288|526741679|FG004|Overall Study|Non-compliance with study drug|1|||
146060761|NCT02992288|526741680|FG005|Overall Study|Non-compliance with study drug|0|||
146060762|NCT02992288|526741675|FG000|Overall Study|Physician Decision|3|||
146060763|NCT02992288|526741676|FG001|Overall Study|Physician Decision|0|||
146060764|NCT02992288|526741677|FG002|Overall Study|Physician Decision|1|||
146060765|NCT02992288|526741678|FG003|Overall Study|Physician Decision|0|||
146060766|NCT02992288|526741679|FG004|Overall Study|Physician Decision|0|||
146060767|NCT02992288|526741680|FG005|Overall Study|Physician Decision|1|||
146060768|NCT02992288|526741675|FG000|Overall Study|Death|2|||
146060769|NCT02992288|526741676|FG001|Overall Study|Death|0|||
146060770|NCT02992288|526741677|FG002|Overall Study|Death|2|||
146060771|NCT02992288|526741678|FG003|Overall Study|Death|1|||
146060772|NCT02992288|526741679|FG004|Overall Study|Death|2|||
146060773|NCT02992288|526741680|FG005|Overall Study|Death|0|||
146060774|NCT02992288|526741675|FG000|Overall Study|Lost to Follow-up|0|||
146060775|NCT02992288|526741676|FG001|Overall Study|Lost to Follow-up|0|||
146060776|NCT02992288|526741677|FG002|Overall Study|Lost to Follow-up|0|||
146060777|NCT02992288|526741678|FG003|Overall Study|Lost to Follow-up|1|||
146060778|NCT02992288|526741679|FG004|Overall Study|Lost to Follow-up|0|||
146060779|NCT02992288|526741680|FG005|Overall Study|Lost to Follow-up|0|||
146060780|NCT02992288|526741675|FG000|Overall Study|Protocol Violation|0|||
146060781|NCT02992288|526741676|FG001|Overall Study|Protocol Violation|0|||
146060782|NCT02992288|526741677|FG002|Overall Study|Protocol Violation|0|||
146060783|NCT02992288|526741678|FG003|Overall Study|Protocol Violation|0|||
146060784|NCT02992288|526741679|FG004|Overall Study|Protocol Violation|0|||
146060785|NCT02992288|526741680|FG005|Overall Study|Protocol Violation|1|||
146060786|NCT02992288|526741675|FG000|Overall Study|Withdrawal by Subject|4|||
146060787|NCT02992288|526741676|FG001|Overall Study|Withdrawal by Subject|2|||
146060788|NCT02992288|526741677|FG002|Overall Study|Withdrawal by Subject|1|||
146060789|NCT02992288|526741678|FG003|Overall Study|Withdrawal by Subject|5|||
146060790|NCT02992288|526741679|FG004|Overall Study|Withdrawal by Subject|3|||
146060791|NCT02992288|526741680|FG005|Overall Study|Withdrawal by Subject|4|||
146060792|NCT00656513|526741681|FG000|Overall Study|Protocol Violation|1|||
146060793|NCT00656513|526741682|FG001|Overall Study|Protocol Violation|0|||
146060794|NCT00656513|526741683|FG002|Overall Study|Protocol Violation|2|||
146060795|NCT00656513|526741681|FG000|Overall Study|Withdrawal by Subject|0|||
146060796|NCT00656513|526741682|FG001|Overall Study|Withdrawal by Subject|11|||
146400117|NCT02181673|527968651|FG001|Up to Week 24|Adverse Event|0|||
146060797|NCT00656513|526741683|FG002|Overall Study|Withdrawal by Subject|4|||
146060798|NCT00656513|526741681|FG000|Overall Study|Death|0|||
146060799|NCT00656513|526741682|FG001|Overall Study|Death|0|||
146060800|NCT00656513|526741683|FG002|Overall Study|Death|1|||
146060801|NCT00656513|526741681|FG000|Overall Study|Missing data|0|||
146060802|NCT00656513|526741682|FG001|Overall Study|Missing data|11|||
146060803|NCT00656513|526741683|FG002|Overall Study|Missing data|9|||
146060804|NCT00656513|526741681|FG000|Overall Study|Incomplete treatment|3|||
146060805|NCT00656513|526741682|FG001|Overall Study|Incomplete treatment|0|||
146060806|NCT00656513|526741683|FG002|Overall Study|Incomplete treatment|0|||
146060807|NCT00656513|526741681|FG000|Overall Study|Treatment completed outside of timeframe|0|||
146060808|NCT00656513|526741682|FG001|Overall Study|Treatment completed outside of timeframe|3|||
146060809|NCT00656513|526741683|FG002|Overall Study|Treatment completed outside of timeframe|1|||
146060810|NCT00656513|526741681|FG000|Overall Study|Missing baseline form|0|||
146060811|NCT00656513|526741682|FG001|Overall Study|Missing baseline form|5|||
146060812|NCT00656513|526741683|FG002|Overall Study|Missing baseline form|5|||
146400118|NCT02181673|527968652|FG002|Up to Week 24|Adverse Event|3|||
146400119|NCT02181673|527968650|FG000|Up to Week 24|Death|1|||
146400120|NCT02181673|527968651|FG001|Up to Week 24|Death|0|||
146400121|NCT02181673|527968652|FG002|Up to Week 24|Death|0|||
146400122|NCT02181673|527968650|FG000|Up to Week 24|Lack of Efficacy|1|||
146400123|NCT02181673|527968651|FG001|Up to Week 24|Lack of Efficacy|0|||
146400124|NCT02181673|527968652|FG002|Up to Week 24|Lack of Efficacy|0|||
146400125|NCT02181673|527968650|FG000|Up to Week 24|Lost to Follow-up|1|||
146400126|NCT02181673|527968651|FG001|Up to Week 24|Lost to Follow-up|0|||
146400127|NCT02181673|527968652|FG002|Up to Week 24|Lost to Follow-up|0|||
146400128|NCT02181673|527968650|FG000|Up to Week 24|Physician Decision|0|||
146400129|NCT02181673|527968651|FG001|Up to Week 24|Physician Decision|0|||
146400130|NCT02181673|527968652|FG002|Up to Week 24|Physician Decision|3|||
146400131|NCT02181673|527968650|FG000|Up to Week 24|Withdrawal by Subject|10|||
146400132|NCT02181673|527968651|FG001|Up to Week 24|Withdrawal by Subject|0|||
146400133|NCT02181673|527968652|FG002|Up to Week 24|Withdrawal by Subject|1|||
146400134|NCT02181673|527968650|FG000|Up to Week 24|Other|2|||
146400135|NCT02181673|527968651|FG001|Up to Week 24|Other|0|||
146400136|NCT02181673|527968652|FG002|Up to Week 24|Other|3|||
146400137|NCT02181673|527968650|FG000|Up to Week 24|Randomized not Treated|0|||
146400138|NCT02181673|527968651|FG001|Up to Week 24|Randomized not Treated|0|||
146400139|NCT02181673|527968652|FG002|Up to Week 24|Randomized not Treated|1|||
146400140|NCT02181673|527968650|FG000|Week 24-Week 60|Adverse Event|0|||
146400141|NCT02181673|527968651|FG001|Week 24-Week 60|Adverse Event|4|||
146400142|NCT02181673|527968652|FG002|Week 24-Week 60|Adverse Event|10|||
146400143|NCT02181673|527968650|FG000|Week 24-Week 60|Other|0|||
146400144|NCT02181673|527968651|FG001|Week 24-Week 60|Other|2|||
146400145|NCT02181673|527968652|FG002|Week 24-Week 60|Other|1|||
146400146|NCT02181673|527968650|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
146400147|NCT02181673|527968651|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
146400148|NCT02181673|527968652|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
145945147|NCT00312572|526308146|FG001|Overall Study|Lost to Follow-up|1|||
145945148|NCT00312572|526308145|FG000|Overall Study|Administrative|4|||
145945149|NCT00312572|526308146|FG001|Overall Study|Administrative|2|||
145945150|NCT00312572|526308145|FG000|Overall Study|Lack of Efficacy|1|||
145945151|NCT00312572|526308146|FG001|Overall Study|Lack of Efficacy|2|||
145945152|NCT05385224|526308147|FG000|Overall Study|Unable to swallow capsule|2|||
145945153|NCT05385224|526308147|FG000|Overall Study|Withdrawal by Subject|2|||
145945154|NCT05385224|526308147|FG000|Overall Study|Did not meet study criteria|1|||
145945155|NCT01133288|526308154|FG000|Eligibility Assessment|met exclusion criteria|5|||
145945156|NCT01133288|526308154|FG000|Intervention Allocation|study terminated|2|||
145945157|NCT01832818|526308155|FG000|Overall Study|Lost to Follow-up|6|||
145945158|NCT00551161|526308156|FG000|Overall Study|Withdrawal by Subject|1|||
145945159|NCT01672294|526308158|FG000|Overall Study|Withdrawal by Subject|4|||
145945160|NCT01672294|526308159|FG001|Overall Study|Withdrawal by Subject|4|||
145945161|NCT01672294|526308160|FG002|Overall Study|Withdrawal by Subject|4|||
145945162|NCT01672294|526308161|FG003|Overall Study|Withdrawal by Subject|4|||
145945163|NCT01672294|526308158|FG000|Overall Study|Excluded by study|1|||
145945164|NCT01672294|526308159|FG001|Overall Study|Excluded by study|1|||
145945165|NCT01672294|526308160|FG002|Overall Study|Excluded by study|0|||
145945166|NCT01672294|526308161|FG003|Overall Study|Excluded by study|0|||
145945167|NCT01672294|526308158|FG000|Overall Study|Lost to Follow-up|1|||
145945168|NCT01672294|526308159|FG001|Overall Study|Lost to Follow-up|16|||
145945169|NCT01672294|526308160|FG002|Overall Study|Lost to Follow-up|7|||
145945170|NCT01672294|526308161|FG003|Overall Study|Lost to Follow-up|9|||
145945171|NCT03379792|526308162|FG000|Overall Study|Physician Decision|0|||
145945172|NCT03379792|526308163|FG001|Overall Study|Physician Decision|0|||
145945173|NCT03379792|526308164|FG002|Overall Study|Physician Decision|0|||
145945174|NCT03379792|526308165|FG003|Overall Study|Physician Decision|1|||
145945175|NCT03379792|526308166|FG004|Overall Study|Physician Decision|0|||
145945176|NCT03379792|526308167|FG005|Overall Study|Physician Decision|0|||
145945177|NCT03379792|526308162|FG000|Overall Study|Withdrawal by Subject|0|||
145945178|NCT03379792|526308163|FG001|Overall Study|Withdrawal by Subject|0|||
145945179|NCT03379792|526308164|FG002|Overall Study|Withdrawal by Subject|0|||
145945180|NCT03379792|526308165|FG003|Overall Study|Withdrawal by Subject|0|||
145945181|NCT03379792|526308166|FG004|Overall Study|Withdrawal by Subject|1|||
145945182|NCT03379792|526308167|FG005|Overall Study|Withdrawal by Subject|1|||
145945183|NCT01121536|526308168|FG000|Overall Study|Adverse Event|63|||
145945184|NCT01121536|526308168|FG000|Overall Study|Lack of Efficacy|35|||
145945185|NCT01121536|526308168|FG000|Overall Study|Withdrawal by Subject|65|||
145945186|NCT01121536|526308168|FG000|Overall Study|Protocol Violation|20|||
145945187|NCT01121536|526308168|FG000|Overall Study|Noncompliance with study medication|12|||
145945188|NCT01121536|526308168|FG000|Overall Study|Noncompliance with study procedures|9|||
145945189|NCT01121536|526308168|FG000|Overall Study|Lost to Follow-up|39|||
145945190|NCT01121536|526308168|FG000|Overall Study|Other|118|||
145945191|NCT01273155|526308170|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
145945192|NCT01273155|526308171|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
145945193|NCT01273155|526308172|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
146400149|NCT02181673|527968650|FG000|Week 24-Week 60|Pregnancy|0|||
146400150|NCT02181673|527968651|FG001|Week 24-Week 60|Pregnancy|0|||
146400151|NCT02181673|527968652|FG002|Week 24-Week 60|Pregnancy|1|||
146400152|NCT02181673|527968650|FG000|Week 24-Week 60|Lack of Efficacy|0|||
146400153|NCT02181673|527968651|FG001|Week 24-Week 60|Lack of Efficacy|0|||
146400154|NCT02181673|527968652|FG002|Week 24-Week 60|Lack of Efficacy|1|||
146400155|NCT02181673|527968650|FG000|Week 24-Week 60|Lost to Follow-up|0|||
146400156|NCT02181673|527968651|FG001|Week 24-Week 60|Lost to Follow-up|0|||
146400157|NCT02181673|527968652|FG002|Week 24-Week 60|Lost to Follow-up|1|||
146400158|NCT02181673|527968650|FG000|Week 24-Week 60|Physician Decision|0|||
146400159|NCT02181673|527968651|FG001|Week 24-Week 60|Physician Decision|0|||
146400160|NCT02181673|527968652|FG002|Week 24-Week 60|Physician Decision|1|||
146400161|NCT00433771|527968653|FG000|Overall Study|screen fail|14|||
146400162|NCT00433771|527968653|FG000|Overall Study|Treated and later found to be ineligible|2|||
146400163|NCT00433771|527968653|FG000|Overall Study|Death|2|||
146400164|NCT00433771|527968653|FG000|Overall Study|Failure to deploy stent|1|||
146400165|NCT00337727|527968654|FG000|Overall Study|Adverse Event|5|||
146400166|NCT00337727|527968655|FG001|Overall Study|Adverse Event|3|||
146400167|NCT00337727|527968654|FG000|Overall Study|Lost to Follow-up|5|||
146400168|NCT00337727|527968655|FG001|Overall Study|Lost to Follow-up|4|||
146400169|NCT00337727|527968654|FG000|Overall Study|Physician Decision|1|||
146400170|NCT00337727|527968655|FG001|Overall Study|Physician Decision|0|||
146400171|NCT00337727|527968654|FG000|Overall Study|Protocol Violation|4|||
146400172|NCT00337727|527968655|FG001|Overall Study|Protocol Violation|0|||
146400173|NCT00337727|527968654|FG000|Overall Study|Withdrawal by Subject|3|||
146400174|NCT00337727|527968655|FG001|Overall Study|Withdrawal by Subject|5|||
146400175|NCT00943826|527968656|FG000|Concurrent Phase|Adverse Event|50|||
146400176|NCT00943826|527968657|FG001|Concurrent Phase|Adverse Event|27|||
146400177|NCT00943826|527968656|FG000|Concurrent Phase|Withdrew consent|3|||
146400178|NCT00943826|527968657|FG001|Concurrent Phase|Withdrew consent|7|||
146400179|NCT00943826|527968656|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
146400180|NCT00943826|527968657|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
146400181|NCT00943826|527968656|FG000|Concurrent Phase|Administrative reasons|2|||
146400182|NCT00943826|527968657|FG001|Concurrent Phase|Administrative reasons|1|||
146400183|NCT00943826|527968656|FG000|Concurrent Phase|Protocol Violation|1|||
146400184|NCT00943826|527968657|FG001|Concurrent Phase|Protocol Violation|0|||
146400185|NCT00943826|527968656|FG000|Maintenance Phase|Adverse Event|31|||
146400186|NCT00943826|527968657|FG001|Maintenance Phase|Adverse Event|30|||
146400187|NCT00943826|527968656|FG000|Maintenance Phase|Withdrew consent|2|||
146400188|NCT00943826|527968657|FG001|Maintenance Phase|Withdrew consent|4|||
146400189|NCT00943826|527968656|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
146400190|NCT00943826|527968657|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
146400191|NCT00943826|527968656|FG000|Maintenance Phase|Administrative reasons|4|||
146400192|NCT00943826|527968657|FG001|Maintenance Phase|Administrative reasons|1|||
146400193|NCT00943826|527968656|FG000|Maintenance Phase|Failure to return|0|||
146400194|NCT00943826|527968657|FG001|Maintenance Phase|Failure to return|1|||
146400195|NCT00943826|527968656|FG000|Monotherapy Phase|Adverse Event|42|||
146400196|NCT00943826|527968657|FG001|Monotherapy Phase|Adverse Event|5|||
146400197|NCT00943826|527968656|FG000|Monotherapy Phase|Administrative reasons|11|||
146400198|NCT00943826|527968657|FG001|Monotherapy Phase|Administrative reasons|5|||
146400199|NCT00943826|527968656|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
146400200|NCT00943826|527968657|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
146400201|NCT00943826|527968656|FG000|Monotherapy Phase|Withdrew Consent|2|||
146400202|NCT00943826|527968657|FG001|Monotherapy Phase|Withdrew Consent|3|||
146400203|NCT00943826|527968656|FG000|Monotherapy Phase|Failure to return|2|||
146400204|NCT00943826|527968657|FG001|Monotherapy Phase|Failure to return|1|||
146400205|NCT00943826|527968656|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
146400206|NCT00943826|527968657|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
146400207|NCT00943826|527968656|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
146400208|NCT00943826|527968657|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
146400209|NCT00943826|527968656|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
146400210|NCT00943826|527968657|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
146400211|NCT00943826|527968656|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
146400212|NCT00943826|527968657|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
146400213|NCT00326625|527968658|FG000|Overall Study|Adverse Event|20|||
146400214|NCT00326625|527968659|FG001|Overall Study|Adverse Event|9|||
146400215|NCT00326625|527968658|FG000|Overall Study|Withdrawal by Subject|15|||
146400216|NCT00326625|527968659|FG001|Overall Study|Withdrawal by Subject|12|||
146400217|NCT00326625|527968658|FG000|Overall Study|Death|18|||
146400218|NCT00326625|527968659|FG001|Overall Study|Death|16|||
146400219|NCT00326625|527968658|FG000|Overall Study|Lost to Follow-up|1|||
146400220|NCT00326625|527968659|FG001|Overall Study|Lost to Follow-up|0|||
146400221|NCT00326625|527968658|FG000|Overall Study|prescheduled medical intervention|0|||
146400222|NCT00326625|527968659|FG001|Overall Study|prescheduled medical intervention|1|||
146400223|NCT06067191|527968662|FG000|Overall Study|Withdrawal by Subject|0|||
146400224|NCT06067191|527968663|FG001|Overall Study|Withdrawal by Subject|1|||
146400225|NCT04764669|527968665|FG000|Overall Study|Adverse Event|1|||
146400226|NCT04764669|527968666|FG001|Overall Study|Adverse Event|0|||
146400227|NCT04764669|527968667|FG002|Overall Study|Adverse Event|1|||
146400228|NCT04764669|527968668|FG003|Overall Study|Adverse Event|0|||
146400229|NCT04764669|527968665|FG000|Overall Study|Subject Choice|0|||
146400230|NCT04764669|527968666|FG001|Overall Study|Subject Choice|0|||
146400231|NCT04764669|527968667|FG002|Overall Study|Subject Choice|1|||
146400232|NCT04764669|527968668|FG003|Overall Study|Subject Choice|0|||
146400233|NCT04764669|527968665|FG000|Overall Study|Withdrawal by Subject|2|||
146400234|NCT04764669|527968666|FG001|Overall Study|Withdrawal by Subject|0|||
146400235|NCT04764669|527968667|FG002|Overall Study|Withdrawal by Subject|0|||
146400236|NCT04764669|527968668|FG003|Overall Study|Withdrawal by Subject|0|||
146400237|NCT00625846|527968669|FG000|Overall Study|Withdrawal by Subject|2|||
146400238|NCT00625846|527968670|FG001|Overall Study|Withdrawal by Subject|0|||
146400239|NCT00625846|527968671|FG002|Overall Study|Withdrawal by Subject|1|||
146400240|NCT00625846|527968672|FG003|Overall Study|Withdrawal by Subject|2|||
146400241|NCT04411641|527968675|FG000|DB Period|Other|7|||
146400242|NCT04411641|527968676|FG001|DB Period|Other|27|||
146400243|NCT04411641|527968677|FG002|DB Period|Other|0|||
146400244|NCT04411641|527968678|FG003|DB Period|Other|0|||
146400245|NCT04411641|527968675|FG000|DB Period|Withdrawal by Subject|67|||
146400246|NCT04411641|527968676|FG001|DB Period|Withdrawal by Subject|122|||
146400247|NCT04411641|527968677|FG002|DB Period|Withdrawal by Subject|0|||
146400248|NCT04411641|527968678|FG003|DB Period|Withdrawal by Subject|0|||
146400249|NCT04411641|527968675|FG000|DB Period|Progressive disease|76|||
146400250|NCT04411641|527968676|FG001|DB Period|Progressive disease|116|||
146400251|NCT04411641|527968677|FG002|DB Period|Progressive disease|0|||
146400252|NCT04411641|527968678|FG003|DB Period|Progressive disease|0|||
146400253|NCT04411641|527968675|FG000|DB Period|Poor compliance to protocol|1|||
146400254|NCT04411641|527968676|FG001|DB Period|Poor compliance to protocol|5|||
146400255|NCT04411641|527968677|FG002|DB Period|Poor compliance to protocol|0|||
146400256|NCT04411641|527968678|FG003|DB Period|Poor compliance to protocol|0|||
146400257|NCT04411641|527968675|FG000|DB Period|Lack of Efficacy|19|||
146400258|NCT04411641|527968676|FG001|DB Period|Lack of Efficacy|19|||
146400259|NCT04411641|527968677|FG002|DB Period|Lack of Efficacy|0|||
146400260|NCT04411641|527968678|FG003|DB Period|Lack of Efficacy|0|||
146400261|NCT04411641|527968675|FG000|DB Period|Adverse Event|13|||
146400262|NCT04411641|527968676|FG001|DB Period|Adverse Event|29|||
146400263|NCT04411641|527968677|FG002|DB Period|Adverse Event|0|||
146400264|NCT04411641|527968678|FG003|DB Period|Adverse Event|0|||
146400265|NCT04411641|527968675|FG000|DB Period|Randomized and not treated|2|||
146400266|NCT04411641|527968676|FG001|DB Period|Randomized and not treated|2|||
146400267|NCT04411641|527968677|FG002|DB Period|Randomized and not treated|0|||
146400268|NCT04411641|527968678|FG003|DB Period|Randomized and not treated|0|||
146400269|NCT04411641|527968675|FG000|OL|Withdrawal by Subject|0|||
146400270|NCT04411641|527968676|FG001|OL|Withdrawal by Subject|0|||
146400271|NCT04411641|527968677|FG002|OL|Withdrawal by Subject|6|||
146400272|NCT04411641|527968678|FG003|OL|Withdrawal by Subject|17|||
146400273|NCT04411641|527968675|FG000|OL|Progressive disease|0|||
146400274|NCT04411641|527968676|FG001|OL|Progressive disease|0|||
146400275|NCT04411641|527968677|FG002|OL|Progressive disease|1|||
146400276|NCT04411641|527968678|FG003|OL|Progressive disease|2|||
146400277|NCT04411641|527968675|FG000|OL|Poor compliance to protocol|0|||
146400278|NCT04411641|527968676|FG001|OL|Poor compliance to protocol|0|||
146400279|NCT04411641|527968677|FG002|OL|Poor compliance to protocol|1|||
146400280|NCT04411641|527968678|FG003|OL|Poor compliance to protocol|0|||
146400281|NCT04411641|527968675|FG000|OL|Adverse Event|0|||
146400282|NCT04411641|527968676|FG001|OL|Adverse Event|0|||
146400283|NCT04411641|527968677|FG002|OL|Adverse Event|1|||
146400284|NCT04411641|527968678|FG003|OL|Adverse Event|0|||
146400285|NCT04411641|527968675|FG000|OL|Other|0|||
146400286|NCT04411641|527968676|FG001|OL|Other|0|||
146400287|NCT04411641|527968677|FG002|OL|Other|0|||
146400288|NCT04411641|527968678|FG003|OL|Other|6|||
146400289|NCT04410978|527968688|FG000|Overall Study|Poor compliance to protocol|2|||
146400290|NCT04410978|527968689|FG001|Overall Study|Poor compliance to protocol|4|||
146400291|NCT04410978|527968688|FG000|Overall Study|Withdrawal by Subject|64|||
146400292|NCT04410978|527968689|FG001|Overall Study|Withdrawal by Subject|66|||
146400293|NCT04410978|527968688|FG000|Overall Study|Other|6|||
146400294|NCT04410978|527968689|FG001|Overall Study|Other|7|||
146400295|NCT04410978|527968688|FG000|Overall Study|Missing study status|1|||
146400296|NCT04410978|527968689|FG001|Overall Study|Missing study status|0|||
146400297|NCT00157820|527968693|FG000|Randomized|Physician Decision|4|||
146400298|NCT00157820|527968694|FG001|Randomized|Physician Decision|2|||
146400299|NCT00157820|527968695|FG002|Randomized|Physician Decision|3|||
146400300|NCT00157820|527968693|FG000|Randomized|Withdrawal by Subject|1|||
146400301|NCT00157820|527968694|FG001|Randomized|Withdrawal by Subject|2|||
146400302|NCT00157820|527968695|FG002|Randomized|Withdrawal by Subject|3|||
146400303|NCT00157820|527968693|FG000|Randomized|Protocol Violation|2|||
146400304|NCT00157820|527968694|FG001|Randomized|Protocol Violation|1|||
146400305|NCT00157820|527968695|FG002|Randomized|Protocol Violation|2|||
146400306|NCT00157820|527968693|FG000|1st 8 Month|Death|7|||
146400307|NCT00157820|527968694|FG001|1st 8 Month|Death|8|||
146400308|NCT00157820|527968695|FG002|1st 8 Month|Death|3|||
146400309|NCT00157820|527968693|FG000|1st 8 Month|Lost to Follow-up|1|||
146400310|NCT00157820|527968694|FG001|1st 8 Month|Lost to Follow-up|2|||
146400311|NCT00157820|527968695|FG002|1st 8 Month|Lost to Follow-up|1|||
146400312|NCT00157820|527968693|FG000|1st 8 Month|Premature cross-over|0|||
146400313|NCT00157820|527968694|FG001|1st 8 Month|Premature cross-over|2|||
146400314|NCT00157820|527968695|FG002|1st 8 Month|Premature cross-over|2|||
146400315|NCT00157820|527968693|FG000|2nd 8 Months|Death|3|||
146400316|NCT00157820|527968694|FG001|2nd 8 Months|Death|1|||
146400317|NCT00157820|527968695|FG002|2nd 8 Months|Death|3|||
146400318|NCT00157820|527968693|FG000|2nd 8 Months|Lost to Follow-up|1|||
146400319|NCT00157820|527968694|FG001|2nd 8 Months|Lost to Follow-up|5|||
146400320|NCT00157820|527968695|FG002|2nd 8 Months|Lost to Follow-up|2|||
146400321|NCT00157820|527968693|FG000|2nd 8 Months|Premature cross-over|1|||
146400322|NCT00157820|527968694|FG001|2nd 8 Months|Premature cross-over|7|||
146400323|NCT00157820|527968695|FG002|2nd 8 Months|Premature cross-over|9|||
146060813|NCT03379818|526741684|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
146060814|NCT03379818|526741685|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
146060815|NCT03379818|526741684|FG000|Overall Study|Withdrawal by Subject|2|||
146060816|NCT03379818|526741685|FG001|Overall Study|Withdrawal by Subject|3|||
146060817|NCT03379818|526741684|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
146060818|NCT03379818|526741685|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
146060819|NCT01867671|526741689|FG000|Overall Study|Adverse Event|5|||
146060820|NCT01867671|526741690|FG001|Overall Study|Adverse Event|3|||
146060821|NCT01867671|526741689|FG000|Overall Study|Anaphylaxis|0|||
146060822|NCT01867671|526741690|FG001|Overall Study|Anaphylaxis|1|||
146060823|NCT01867671|526741689|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
146060824|NCT01867671|526741690|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
146060825|NCT01867671|526741689|FG000|Overall Study|Lost to Follow-up|0|||
146060826|NCT01867671|526741690|FG001|Overall Study|Lost to Follow-up|1|||
146060827|NCT01867671|526741689|FG000|Overall Study|Non-compliance with Study Drug|1|||
146060828|NCT01867671|526741690|FG001|Overall Study|Non-compliance with Study Drug|2|||
146060829|NCT01867671|526741689|FG000|Overall Study|Withdrawal by Subject|21|||
146060830|NCT01867671|526741690|FG001|Overall Study|Withdrawal by Subject|21|||
146060831|NCT05236270|526741693|FG000|Overall Study|Lost to Follow-up|3|||
146060832|NCT05236270|526741694|FG001|Overall Study|Lost to Follow-up|2|||
146060833|NCT05236270|526741695|FG002|Overall Study|Lost to Follow-up|0|||
146060834|NCT05236270|526741696|FG003|Overall Study|Lost to Follow-up|0|||
146060835|NCT05236270|526741697|FG004|Overall Study|Lost to Follow-up|2|||
146060836|NCT05236270|526741698|FG005|Overall Study|Lost to Follow-up|0|||
146060837|NCT05236270|526741699|FG006|Overall Study|Lost to Follow-up|1|||
146060838|NCT05236270|526741700|FG007|Overall Study|Lost to Follow-up|3|||
146060839|NCT04711850|526741701|FG000|Overall Study|Graft loss|2|||
146060840|NCT04711850|526741702|FG001|Overall Study|Graft loss|1|||
146060841|NCT04711850|526741701|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
146060842|NCT04711850|526741702|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
146060843|NCT04711850|526741701|FG000|Overall Study|Study terminated by sponsor|5|||
146060844|NCT04711850|526741702|FG001|Overall Study|Study terminated by sponsor|3|||
146060845|NCT04711850|526741701|FG000|Overall Study|Sponsor decision|0|||
146060846|NCT04711850|526741702|FG001|Overall Study|Sponsor decision|2|||
146400324|NCT00223990|527968696|FG000|Overall Study|Moved from area|2|||
146400325|NCT00223990|527968697|FG001|Overall Study|Moved from area|1|||
146400326|NCT00223990|527968696|FG000|Overall Study|Withdrawal by Subject|4|||
146400327|NCT00223990|527968697|FG001|Overall Study|Withdrawal by Subject|8|||
146400328|NCT00223990|527968696|FG000|Overall Study|Lost to Follow-up|1|||
146400329|NCT00223990|527968697|FG001|Overall Study|Lost to Follow-up|0|||
146060847|NCT04531176|526741724|FG000|Overall Study|Study was stopped early|24|||
146060848|NCT04531176|526741725|FG001|Overall Study|Study was stopped early|26|||
146169885|NCT05044325|527134734|FG009|Part A:Treatment Period 2|Physician Decision|0|||
146400330|NCT01319994|527970228|FG000|Overall Study|Protocol Violation|7|||
146400331|NCT01319994|527970229|FG001|Overall Study|Protocol Violation|6|||
146400332|NCT01340794|527970230|FG000|Overall Study|Withdrawal by Subject|0|||
146400333|NCT01340794|527970231|FG001|Overall Study|Withdrawal by Subject|1|||
146400334|NCT02674568|527970233|FG000|Overall Study|Withdrawal by Subject|5|||
146400335|NCT02674568|527970233|FG000|Overall Study|Death|303|||
146400336|NCT02674568|527970233|FG000|Overall Study|Physician Decision|2|||
146400337|NCT02674568|527970233|FG000|Overall Study|Lost to Follow-up|9|||
146400338|NCT02674568|527970233|FG000|Overall Study|Other, Not Specified|20|||
146060849|NCT04531176|526741726|FG002|Overall Study|Study was stopped early|24|||
146060850|NCT00561652|526741727|FG000|Overall Study|Withdrawal by Subject|0|||
146060851|NCT00561652|526741728|FG001|Overall Study|Withdrawal by Subject|1|||
146060852|NCT01743469|526741729|FG000|Active Treatment Phase|Adverse Event|10|||
146060853|NCT01743469|526741730|FG001|Active Treatment Phase|Adverse Event|5|||
146060854|NCT01743469|526741731|FG002|Active Treatment Phase|Adverse Event|8|||
146060855|NCT01743469|526741732|FG003|Active Treatment Phase|Adverse Event|1|||
146060856|NCT01743469|526741729|FG000|Active Treatment Phase|Disease Progression|40|||
146400339|NCT01118949|527970236|FG000|Overall Study|Adverse Event|5|||
146400340|NCT01118949|527970236|FG000|Overall Study|Withdrawal by Subject|4|||
146400341|NCT00698009|527970238|FG000|Overall Study|Withdrawal by Subject|1|||
146400342|NCT00798707|527970246|FG000|Overall Study|Adverse Event|6|||
146400343|NCT00798707|527970247|FG001|Overall Study|Adverse Event|8|||
146400344|NCT00798707|527970248|FG002|Overall Study|Adverse Event|8|||
146400345|NCT00798707|527970246|FG000|Overall Study|Failed to return|2|||
146400346|NCT00798707|527970247|FG001|Overall Study|Failed to return|2|||
146400347|NCT00798707|527970248|FG002|Overall Study|Failed to return|0|||
146400348|NCT00798707|527970246|FG000|Overall Study|Investigator|0|||
146400349|NCT00798707|527970247|FG001|Overall Study|Investigator|1|||
146400350|NCT00798707|527970248|FG002|Overall Study|Investigator|2|||
146400351|NCT00798707|527970246|FG000|Overall Study|Lack of Efficacy|2|||
146400352|NCT00798707|527970247|FG001|Overall Study|Lack of Efficacy|2|||
146400353|NCT00798707|527970248|FG002|Overall Study|Lack of Efficacy|1|||
146400354|NCT00798707|527970246|FG000|Overall Study|Lost to Follow-up|5|||
146400355|NCT00798707|527970247|FG001|Overall Study|Lost to Follow-up|6|||
146400356|NCT00798707|527970248|FG002|Overall Study|Lost to Follow-up|6|||
146400357|NCT00798707|527970246|FG000|Overall Study|Other|0|||
146400358|NCT00798707|527970247|FG001|Overall Study|Other|1|||
146400359|NCT00798707|527970248|FG002|Overall Study|Other|0|||
146400360|NCT00798707|527970246|FG000|Overall Study|Protocol Violation|4|||
146400361|NCT00798707|527970247|FG001|Overall Study|Protocol Violation|0|||
146400362|NCT00798707|527970248|FG002|Overall Study|Protocol Violation|2|||
146400363|NCT00798707|527970246|FG000|Overall Study|Withdrawal by Subject|3|||
146400364|NCT00798707|527970247|FG001|Overall Study|Withdrawal by Subject|8|||
146400365|NCT00798707|527970248|FG002|Overall Study|Withdrawal by Subject|2|||
146400366|NCT00798707|527970246|FG000|Overall Study|Randomized not treated|4|||
146400367|NCT00798707|527970247|FG001|Overall Study|Randomized not treated|5|||
146400368|NCT00798707|527970248|FG002|Overall Study|Randomized not treated|1|||
146400369|NCT01473589|527970251|FG000|Overall Study|Adverse Event|1|||
146400370|NCT01473589|527970252|FG001|Overall Study|Adverse Event|1|||
146400371|NCT01473589|527970251|FG000|Overall Study|Death|2|||
146400372|NCT01473589|527970252|FG001|Overall Study|Death|0|||
146400373|NCT01473589|527970251|FG000|Overall Study|Lost to Follow-up|2|||
146400374|NCT01473589|527970252|FG001|Overall Study|Lost to Follow-up|2|||
146400375|NCT01473589|527970251|FG000|Overall Study|Protocol Violation|1|||
146400376|NCT01473589|527970252|FG001|Overall Study|Protocol Violation|0|||
146400377|NCT01473589|527970251|FG000|Overall Study|Withdrawal by Subject|5|||
146400378|NCT01473589|527970252|FG001|Overall Study|Withdrawal by Subject|11|||
146400379|NCT01473589|527970251|FG000|Overall Study|Physician Decision|0|||
146400380|NCT01473589|527970252|FG001|Overall Study|Physician Decision|1|||
146400381|NCT01473589|527970251|FG000|Overall Study|Entry criteria not met|0|||
146400382|NCT01473589|527970252|FG001|Overall Study|Entry criteria not met|1|||
146400383|NCT03457727|527970253|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146400384|NCT03457727|527970254|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146400385|NCT03457727|527970255|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
146400386|NCT03457727|527970256|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
146400387|NCT00929201|527970257|FG000|Period 1|Withdrawal by Subject|0|||
146400388|NCT00929201|527970258|FG001|Period 1|Withdrawal by Subject|1|||
146400389|NCT00242567|527970262|FG000|Overall Study|Adverse Event|70|||
146400390|NCT00242567|527970263|FG001|Overall Study|Adverse Event|43|||
146400391|NCT00242567|527970262|FG000|Overall Study|Disease Progression|17|||
146400392|NCT00242567|527970263|FG001|Overall Study|Disease Progression|22|||
146400393|NCT00242567|527970262|FG000|Overall Study|Symptomatic deterioration|9|||
146400394|NCT00242567|527970263|FG001|Overall Study|Symptomatic deterioration|3|||
146400395|NCT00242567|527970262|FG000|Overall Study|Lack of Efficacy|2|||
146400396|NCT00242567|527970263|FG001|Overall Study|Lack of Efficacy|2|||
146400397|NCT00242567|527970262|FG000|Overall Study|Lost to Follow-up|9|||
146400398|NCT00242567|527970263|FG001|Overall Study|Lost to Follow-up|19|||
146400399|NCT00242567|527970262|FG000|Overall Study|Withdrawal by Subject|33|||
146400400|NCT00242567|527970263|FG001|Overall Study|Withdrawal by Subject|28|||
146400401|NCT00242567|527970262|FG000|Overall Study|Protocol Violation|12|||
146400402|NCT00242567|527970263|FG001|Overall Study|Protocol Violation|12|||
146400403|NCT00242567|527970262|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
146400404|NCT00242567|527970263|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
146400405|NCT00242567|527970262|FG000|Overall Study|Other|14|||
146400406|NCT00242567|527970263|FG001|Overall Study|Other|9|||
146400407|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
146400408|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146400409|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146400410|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
146400411|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
146400412|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
146400413|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
146400414|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
146400415|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
146400416|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146400417|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146400418|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
146400419|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
146400420|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
146400421|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
146400422|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
146400423|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
146400424|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146400425|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146400426|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
146400427|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
146400428|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
146400429|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
146400430|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
146400431|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
146400432|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146400433|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146400434|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
146400435|NCT01299272|527970264|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
146400436|NCT01299272|527970265|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
146400437|NCT01299272|527970266|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
146400438|NCT01299272|527970267|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
146400439|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146400440|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
145945194|NCT01273155|526308173|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
145945195|NCT01273155|526308174|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
145945196|NCT01273155|526308175|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
145945197|NCT01273155|526308176|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
145945198|NCT01273155|526308170|FG000|Overall Study|Change in liver function/no longer eval.|0|||
145945199|NCT01273155|526308171|FG001|Overall Study|Change in liver function/no longer eval.|1|||
145945200|NCT01273155|526308172|FG002|Overall Study|Change in liver function/no longer eval.|0|||
145945201|NCT01273155|526308173|FG003|Overall Study|Change in liver function/no longer eval.|0|||
145945202|NCT01273155|526308174|FG004|Overall Study|Change in liver function/no longer eval.|1|||
145945203|NCT01273155|526308175|FG005|Overall Study|Change in liver function/no longer eval.|0|||
145945204|NCT01273155|526308176|FG006|Overall Study|Change in liver function/no longer eval.|0|||
145945205|NCT01273155|526308170|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
145945206|NCT01273155|526308171|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
145945207|NCT01273155|526308172|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
145945208|NCT01273155|526308173|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
145945209|NCT01273155|526308174|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
145945210|NCT01273155|526308175|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
145945211|NCT01273155|526308176|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
145945212|NCT01273155|526308170|FG000|Overall Study|Died during Cycle 1|0|||
145945213|NCT01273155|526308171|FG001|Overall Study|Died during Cycle 1|0|||
145945214|NCT01273155|526308172|FG002|Overall Study|Died during Cycle 1|1|||
145945215|NCT01273155|526308173|FG003|Overall Study|Died during Cycle 1|1|||
145945216|NCT01273155|526308174|FG004|Overall Study|Died during Cycle 1|0|||
145945217|NCT01273155|526308175|FG005|Overall Study|Died during Cycle 1|2|||
145945218|NCT01273155|526308176|FG006|Overall Study|Died during Cycle 1|2|||
145945219|NCT01273155|526308170|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
145945220|NCT01273155|526308171|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
145945221|NCT01273155|526308172|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
145945222|NCT01273155|526308173|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
145945223|NCT01273155|526308174|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
145945224|NCT01273155|526308175|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
145945225|NCT01273155|526308176|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
145945226|NCT01256385|526308177|FG000|Overall Study|Physician Decision|1|||
145945227|NCT01256385|526308178|FG001|Overall Study|Physician Decision|1|||
145945228|NCT01256385|526308177|FG000|Overall Study|Withdrawal by Subject|2|||
145945229|NCT01256385|526308178|FG001|Overall Study|Withdrawal by Subject|2|||
145945230|NCT00401960|526308179|FG000|Overall Study|Lost to Follow-up|3|||
145945231|NCT00401960|526308180|FG001|Overall Study|Lost to Follow-up|0|||
145945232|NCT00401960|526308179|FG000|Overall Study|Death|2|||
145945233|NCT00401960|526308180|FG001|Overall Study|Death|0|||
145945234|NCT02649426|526308181|FG000|Overall Study|Follow-up on going|1|||
145945235|NCT02649426|526308182|FG001|Overall Study|Follow-up on going|26|||
145945236|NCT02649426|526308183|FG002|Overall Study|Follow-up on going|28|||
145945237|NCT02649426|526308184|FG003|Overall Study|Follow-up on going|31|||
145945238|NCT01606202|526308185|FG000|Overall Study|Adverse Event|5|||
145945239|NCT01606202|526308186|FG001|Overall Study|Adverse Event|0|||
145945240|NCT01606202|526308185|FG000|Overall Study|Withdrawal by Subject|2|||
146400441|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146400442|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
146400443|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146400444|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
146400445|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146400446|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
146400447|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
146400448|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
146400449|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
146400450|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
146400451|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146400452|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
146400453|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146060857|NCT01743469|526741730|FG001|Active Treatment Phase|Disease Progression|47|||
146060858|NCT01743469|526741731|FG002|Active Treatment Phase|Disease Progression|30|||
146060859|NCT01743469|526741732|FG003|Active Treatment Phase|Disease Progression|20|||
146060860|NCT01743469|526741729|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
146060861|NCT01743469|526741730|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
146060862|NCT01743469|526741731|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
146060863|NCT01743469|526741732|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
146400454|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
146400455|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146400456|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
146400457|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146400458|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
146400459|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146400460|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
146400461|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146400462|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
146400463|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146400464|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
146400465|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146400466|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
146400467|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146400468|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
146400469|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146400470|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
146400471|NCT01299272|527970264|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
146400472|NCT01299272|527970265|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
146400473|NCT01299272|527970266|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
146400474|NCT01299272|527970267|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
146400475|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
146400476|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
146400477|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
146400478|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
146400479|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
146400480|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
146400481|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
146400482|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
146400483|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
146400484|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
146400485|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
146400486|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
146400487|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
146400488|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
146400489|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
146400490|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
146400491|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
146400492|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
146400493|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
146400494|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
146400495|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
146400496|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
146400497|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
146400498|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
146400499|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
146400500|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
146400501|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
146400502|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
146400503|NCT01299272|527970264|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
146400504|NCT01299272|527970265|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
146400505|NCT01299272|527970266|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
146400506|NCT01299272|527970267|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
146400507|NCT00464308|527970268|FG000|Overall Study|Adverse Event|22|||
146400508|NCT00464308|527970269|FG001|Overall Study|Adverse Event|27|||
146400509|NCT00464308|527970270|FG002|Overall Study|Adverse Event|16|||
146400510|NCT00464308|527970268|FG000|Overall Study|Lost to Follow-up|29|||
146400511|NCT00464308|527970269|FG001|Overall Study|Lost to Follow-up|19|||
146400512|NCT00464308|527970270|FG002|Overall Study|Lost to Follow-up|20|||
146400513|NCT00464308|527970268|FG000|Overall Study|Patient discontinued and other reasons|17|||
146400514|NCT00464308|527970269|FG001|Overall Study|Patient discontinued and other reasons|17|||
146400515|NCT00464308|527970270|FG002|Overall Study|Patient discontinued and other reasons|23|||
146400516|NCT00464308|527970268|FG000|Overall Study|Physician Decision|1|||
146400517|NCT00464308|527970269|FG001|Overall Study|Physician Decision|0|||
146400518|NCT00464308|527970270|FG002|Overall Study|Physician Decision|0|||
146400519|NCT01721200|527970271|FG000|Overall Study|Lost to Follow-up|3|||
146400520|NCT01721200|527970272|FG001|Overall Study|Lost to Follow-up|5|||
146400521|NCT00630994|527970277|FG000|Overall Study|Adverse Event|1|||
146400522|NCT00630994|527970277|FG000|Overall Study|Disease Progression|1|||
146400523|NCT00630994|527970277|FG000|Overall Study|Lack of Efficacy|1|||
146400524|NCT00630994|527970277|FG000|Overall Study|Other|1|||
146400525|NCT03722849|527970280|FG000|Overall Study|Withdrawal by Subject|1|||
146400526|NCT03722849|527970281|FG001|Overall Study|Withdrawal by Subject|1|||
146400527|NCT03533608|527970282|FG000|Overall Study|Withdrawal by Subject|3|||
146400528|NCT03533608|527970282|FG000|Overall Study|Physician Decision|2|||
146400529|NCT03286426|527970283|FG000|Overall Study|Physician Decision|3|||
146400530|NCT03514121|527970284|FG000|Overall Study|Withdrawal by Subject|0|||
146400531|NCT03514121|527970285|FG001|Overall Study|Withdrawal by Subject|0|||
146400532|NCT03514121|527970286|FG002|Overall Study|Withdrawal by Subject|0|||
146400533|NCT03514121|527970287|FG003|Overall Study|Withdrawal by Subject|0|||
146400534|NCT03514121|527970288|FG004|Overall Study|Withdrawal by Subject|1|||
146400535|NCT03514121|527970289|FG005|Overall Study|Withdrawal by Subject|2|||
146400536|NCT03514121|527970290|FG006|Overall Study|Withdrawal by Subject|1|||
146400537|NCT03514121|527970291|FG007|Overall Study|Withdrawal by Subject|1|||
146400538|NCT03514121|527970292|FG008|Overall Study|Withdrawal by Subject|7|||
146060864|NCT01743469|526741729|FG000|Active Treatment Phase|Missing|1|||
146060865|NCT01743469|526741730|FG001|Active Treatment Phase|Missing|0|||
146060866|NCT01743469|526741731|FG002|Active Treatment Phase|Missing|0|||
146060867|NCT01743469|526741732|FG003|Active Treatment Phase|Missing|0|||
146060868|NCT01743469|526741729|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
146060869|NCT01743469|526741730|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
146060870|NCT01743469|526741731|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
146060871|NCT01743469|526741732|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
146060872|NCT01743469|526741729|FG000|Follow-up Period - Post-Treatment|Death|43|||
146060873|NCT01743469|526741730|FG001|Follow-up Period - Post-Treatment|Death|47|||
146060874|NCT01743469|526741731|FG002|Follow-up Period - Post-Treatment|Death|22|||
146060875|NCT01743469|526741732|FG003|Follow-up Period - Post-Treatment|Death|16|||
146060876|NCT01743469|526741729|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
146060877|NCT01743469|526741730|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
146060878|NCT01743469|526741731|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
146060879|NCT01743469|526741732|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
146060880|NCT00317473|526741733|FG000|Overall Study|Withdrawal by Subject|2|||
146060881|NCT00317473|526741734|FG001|Overall Study|Withdrawal by Subject|1|||
146060882|NCT00317473|526741735|FG002|Overall Study|Withdrawal by Subject|2|||
146060883|NCT00317473|526741736|FG003|Overall Study|Withdrawal by Subject|1|||
146060884|NCT00317473|526741737|FG004|Overall Study|Withdrawal by Subject|3|||
146400539|NCT03514121|527970293|FG009|Overall Study|Withdrawal by Subject|2|||
146400540|NCT03514121|527970284|FG000|Overall Study|Death|0|||
146060885|NCT00317473|526741738|FG005|Overall Study|Withdrawal by Subject|1|||
146060886|NCT00317473|526741733|FG000|Overall Study|Relocation|1|||
146060887|NCT00317473|526741734|FG001|Overall Study|Relocation|0|||
146060888|NCT00317473|526741735|FG002|Overall Study|Relocation|1|||
146060889|NCT00317473|526741736|FG003|Overall Study|Relocation|1|||
146400541|NCT03514121|527970285|FG001|Overall Study|Death|0|||
146400542|NCT03514121|527970286|FG002|Overall Study|Death|0|||
146400543|NCT03514121|527970287|FG003|Overall Study|Death|0|||
146400544|NCT03514121|527970288|FG004|Overall Study|Death|0|||
146400545|NCT03514121|527970289|FG005|Overall Study|Death|3|||
146400546|NCT03514121|527970290|FG006|Overall Study|Death|2|||
146060890|NCT00317473|526741737|FG004|Overall Study|Relocation|5|||
146060891|NCT00317473|526741738|FG005|Overall Study|Relocation|2|||
146060892|NCT00317473|526741733|FG000|Overall Study|Death|1|||
146060893|NCT00317473|526741734|FG001|Overall Study|Death|0|||
146060894|NCT00317473|526741735|FG002|Overall Study|Death|0|||
146060895|NCT00317473|526741736|FG003|Overall Study|Death|0|||
146060896|NCT00317473|526741737|FG004|Overall Study|Death|0|||
146060897|NCT00317473|526741738|FG005|Overall Study|Death|0|||
146060898|NCT00317473|526741733|FG000|Overall Study|Other|0|||
146060899|NCT00317473|526741734|FG001|Overall Study|Other|2|||
146060900|NCT00317473|526741735|FG002|Overall Study|Other|0|||
146060901|NCT00317473|526741736|FG003|Overall Study|Other|0|||
146060902|NCT00317473|526741737|FG004|Overall Study|Other|0|||
146060903|NCT00317473|526741738|FG005|Overall Study|Other|0|||
146060904|NCT02285855|526741739|FG000|Overall Study|Withdrawal by Subject|2|||
146060905|NCT02285855|526741740|FG001|Overall Study|Withdrawal by Subject|1|||
146060906|NCT00528112|526741741|FG000|Treatment up to 3 Years|Adverse Event|313|||
146060907|NCT00528112|526741742|FG001|Treatment up to 3 Years|Adverse Event|278|||
146060908|NCT00528112|526741741|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
146060909|NCT00528112|526741742|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
146060910|NCT00528112|526741741|FG000|Treatment up to 3 Years|Protocol Violation|16|||
146060911|NCT00528112|526741742|FG001|Treatment up to 3 Years|Protocol Violation|16|||
146060912|NCT00528112|526741741|FG000|Treatment up to 3 Years|Death|0|||
146060913|NCT00528112|526741742|FG001|Treatment up to 3 Years|Death|1|||
146060914|NCT00528112|526741741|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
146060915|NCT00528112|526741742|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
146060916|NCT00528112|526741741|FG000|Treatment up to 3 Years|Pregnancy|9|||
146060917|NCT00528112|526741742|FG001|Treatment up to 3 Years|Pregnancy|10|||
146060918|NCT00528112|526741741|FG000|Treatment up to 3 Years|Other reasons|186|||
146060919|NCT00528112|526741742|FG001|Treatment up to 3 Years|Other reasons|186|||
146060920|NCT00528112|526741741|FG000|Extension Phase|Withdrawal by Subject|0|||
146060921|NCT00528112|526741742|FG001|Extension Phase|Withdrawal by Subject|3|||
146060922|NCT00528112|526741741|FG000|Extension Phase|Other reasons|0|||
146060923|NCT00528112|526741742|FG001|Extension Phase|Other reasons|100|||
146060924|NCT00528112|526741741|FG000|Extension Phase|Pregnancy|0|||
146060925|NCT00528112|526741742|FG001|Extension Phase|Pregnancy|3|||
146060926|NCT00528112|526741741|FG000|Extension Phase|Lost to Follow-up|0|||
146060927|NCT00528112|526741742|FG001|Extension Phase|Lost to Follow-up|12|||
146060928|NCT00528112|526741741|FG000|Extension Phase|Death|0|||
146060929|NCT00528112|526741742|FG001|Extension Phase|Death|1|||
146060930|NCT00528112|526741741|FG000|Extension Phase|Adverse Event|0|||
146060931|NCT00528112|526741742|FG001|Extension Phase|Adverse Event|36|||
146060932|NCT00528112|526741741|FG000|Extension Phase|Protocol Violation|0|||
146060933|NCT00528112|526741742|FG001|Extension Phase|Protocol Violation|2|||
146060934|NCT02718898|526741747|FG000|Blinded Treatment Period|Adverse Event|5|||
146060935|NCT02718898|526741748|FG001|Blinded Treatment Period|Adverse Event|1|||
146060936|NCT02718898|526741749|FG002|Blinded Treatment Period|Adverse Event|0|||
146060937|NCT02718898|526741750|FG003|Blinded Treatment Period|Adverse Event|0|||
146060938|NCT02718898|526741751|FG004|Blinded Treatment Period|Adverse Event|0|||
146060939|NCT02718898|526741752|FG005|Blinded Treatment Period|Adverse Event|0|||
146060940|NCT02718898|526741753|FG006|Blinded Treatment Period|Adverse Event|0|||
146060941|NCT02718898|526741747|FG000|Blinded Treatment Period|Physician Decision|1|||
146060942|NCT02718898|526741748|FG001|Blinded Treatment Period|Physician Decision|0|||
146060943|NCT02718898|526741749|FG002|Blinded Treatment Period|Physician Decision|0|||
146060944|NCT02718898|526741750|FG003|Blinded Treatment Period|Physician Decision|0|||
146060945|NCT02718898|526741751|FG004|Blinded Treatment Period|Physician Decision|0|||
146060946|NCT02718898|526741752|FG005|Blinded Treatment Period|Physician Decision|0|||
146060947|NCT02718898|526741753|FG006|Blinded Treatment Period|Physician Decision|0|||
146060948|NCT02718898|526741747|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
146060949|NCT02718898|526741748|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
146060950|NCT02718898|526741749|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
146060951|NCT02718898|526741750|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
146060952|NCT02718898|526741751|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
146060953|NCT02718898|526741752|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
146060954|NCT02718898|526741753|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
146060955|NCT02718898|526741747|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
146060956|NCT02718898|526741748|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
146060957|NCT02718898|526741749|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
146060958|NCT02718898|526741750|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
146060959|NCT02718898|526741751|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
146060960|NCT02718898|526741752|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
146060961|NCT02718898|526741753|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
146060962|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146060963|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146060964|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
146060965|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
146060966|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146400547|NCT03514121|527970291|FG007|Overall Study|Death|1|||
146060967|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146060968|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
146060969|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146060970|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146400548|NCT03514121|527970292|FG008|Overall Study|Death|26|||
146400549|NCT03514121|527970293|FG009|Overall Study|Death|3|||
146400550|NCT03514121|527970284|FG000|Overall Study|Lost to Follow-up|0|||
146060971|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146060972|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
146060973|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146060974|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146060975|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
146060976|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060977|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060978|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
146060979|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
146060980|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060981|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060982|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
146060983|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146060984|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146060985|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
146060986|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
146060987|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146060988|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146060989|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
146060990|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060991|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060992|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060993|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
146060994|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060995|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060996|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
146060997|NCT02718898|526741747|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146060998|NCT02718898|526741748|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146060999|NCT02718898|526741749|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146061000|NCT02718898|526741750|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
146061001|NCT02718898|526741751|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146061002|NCT02718898|526741752|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146061003|NCT02718898|526741753|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
146061004|NCT02718898|526741747|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
146061005|NCT02718898|526741748|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
146061006|NCT02718898|526741749|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
146400551|NCT03514121|527970285|FG001|Overall Study|Lost to Follow-up|0|||
146400552|NCT03514121|527970286|FG002|Overall Study|Lost to Follow-up|1|||
146400553|NCT03514121|527970287|FG003|Overall Study|Lost to Follow-up|0|||
146400554|NCT03514121|527970288|FG004|Overall Study|Lost to Follow-up|0|||
146400555|NCT03514121|527970289|FG005|Overall Study|Lost to Follow-up|0|||
146400556|NCT03514121|527970290|FG006|Overall Study|Lost to Follow-up|0|||
146400557|NCT03514121|527970291|FG007|Overall Study|Lost to Follow-up|0|||
146400558|NCT03514121|527970292|FG008|Overall Study|Lost to Follow-up|1|||
146400559|NCT03514121|527970293|FG009|Overall Study|Lost to Follow-up|0|||
146400560|NCT03514121|527970284|FG000|Overall Study|Adverse Event|0|||
146400561|NCT03514121|527970285|FG001|Overall Study|Adverse Event|0|||
146400562|NCT03514121|527970286|FG002|Overall Study|Adverse Event|0|||
146400563|NCT03514121|527970287|FG003|Overall Study|Adverse Event|0|||
146400564|NCT03514121|527970288|FG004|Overall Study|Adverse Event|0|||
146400565|NCT03514121|527970289|FG005|Overall Study|Adverse Event|0|||
146400566|NCT03514121|527970290|FG006|Overall Study|Adverse Event|1|||
146400567|NCT03514121|527970291|FG007|Overall Study|Adverse Event|0|||
146400568|NCT03514121|527970292|FG008|Overall Study|Adverse Event|0|||
146400569|NCT03514121|527970293|FG009|Overall Study|Adverse Event|0|||
146400570|NCT03514121|527970284|FG000|Overall Study|Other|0|||
146400571|NCT03514121|527970285|FG001|Overall Study|Other|1|||
146400572|NCT03514121|527970286|FG002|Overall Study|Other|1|||
146400573|NCT03514121|527970287|FG003|Overall Study|Other|0|||
146400574|NCT03514121|527970288|FG004|Overall Study|Other|1|||
146400575|NCT03514121|527970289|FG005|Overall Study|Other|2|||
146400576|NCT03514121|527970290|FG006|Overall Study|Other|3|||
146400577|NCT03514121|527970291|FG007|Overall Study|Other|2|||
146400578|NCT03514121|527970292|FG008|Overall Study|Other|7|||
146400579|NCT03514121|527970293|FG009|Overall Study|Other|3|||
146400580|NCT03514121|527970284|FG000|Overall Study|Study termination by Sponsor|0|||
146400581|NCT03514121|527970285|FG001|Overall Study|Study termination by Sponsor|0|||
146400582|NCT03514121|527970286|FG002|Overall Study|Study termination by Sponsor|0|||
146400583|NCT03514121|527970287|FG003|Overall Study|Study termination by Sponsor|0|||
146400584|NCT03514121|527970288|FG004|Overall Study|Study termination by Sponsor|0|||
146400585|NCT03514121|527970289|FG005|Overall Study|Study termination by Sponsor|0|||
146400586|NCT03514121|527970290|FG006|Overall Study|Study termination by Sponsor|0|||
146400587|NCT03514121|527970291|FG007|Overall Study|Study termination by Sponsor|0|||
146400588|NCT03514121|527970292|FG008|Overall Study|Study termination by Sponsor|11|||
146400589|NCT03514121|527970293|FG009|Overall Study|Study termination by Sponsor|3|||
146400590|NCT03514121|527970284|FG000|Overall Study|Investigator decision|0|||
146400591|NCT03514121|527970285|FG001|Overall Study|Investigator decision|0|||
146400592|NCT03514121|527970286|FG002|Overall Study|Investigator decision|0|||
146400593|NCT03514121|527970287|FG003|Overall Study|Investigator decision|0|||
146400594|NCT03514121|527970288|FG004|Overall Study|Investigator decision|0|||
146400595|NCT03514121|527970289|FG005|Overall Study|Investigator decision|0|||
146400596|NCT03514121|527970290|FG006|Overall Study|Investigator decision|0|||
146400597|NCT03514121|527970291|FG007|Overall Study|Investigator decision|0|||
146400598|NCT03514121|527970292|FG008|Overall Study|Investigator decision|1|||
146400599|NCT03514121|527970293|FG009|Overall Study|Investigator decision|0|||
146400600|NCT05553600|527970294|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
146400601|NCT05553600|527970295|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
146400602|NCT05553600|527970296|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
146400603|NCT05553600|527970297|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
146400604|NCT05553600|527970294|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
146061007|NCT02718898|526741750|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
146061008|NCT02718898|526741751|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
146061009|NCT02718898|526741752|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
146061010|NCT02718898|526741753|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
146061011|NCT02718898|526741747|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146061012|NCT02718898|526741748|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146061013|NCT02718898|526741749|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146061014|NCT02718898|526741750|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
146061015|NCT02718898|526741751|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
146061016|NCT02718898|526741752|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
146061017|NCT02718898|526741753|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
146061018|NCT02718898|526741747|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146061019|NCT02718898|526741748|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146061020|NCT02718898|526741749|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146061021|NCT02718898|526741750|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146061022|NCT02718898|526741751|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146061023|NCT02718898|526741752|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
146061024|NCT02718898|526741753|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
146061025|NCT01451606|526741754|FG000|Overall Study|Withdrawal by Subject|4|||
146061026|NCT01451606|526741755|FG001|Overall Study|Withdrawal by Subject|3|||
146061027|NCT02559622|526741759|FG000|Overall Study|Progressive disease|0|||
146061028|NCT02559622|526741760|FG001|Overall Study|Progressive disease|1|||
146061029|NCT02559622|526741761|FG002|Overall Study|Progressive disease|0|||
146061030|NCT02559622|526741762|FG003|Overall Study|Progressive disease|0|||
146061031|NCT02559622|526741759|FG000|Overall Study|Adverse Event|0|||
146061032|NCT02559622|526741760|FG001|Overall Study|Adverse Event|2|||
146061033|NCT02559622|526741761|FG002|Overall Study|Adverse Event|2|||
146061034|NCT02559622|526741762|FG003|Overall Study|Adverse Event|2|||
146061035|NCT02559622|526741759|FG000|Overall Study|Patient/guardian decision|1|||
146061036|NCT02559622|526741760|FG001|Overall Study|Patient/guardian decision|2|||
146061037|NCT02559622|526741761|FG002|Overall Study|Patient/guardian decision|0|||
146061038|NCT02559622|526741762|FG003|Overall Study|Patient/guardian decision|1|||
146061039|NCT02163538|526741763|FG000|Overall Study|Protocol Violation|1|||
146061040|NCT02163538|526741764|FG001|Overall Study|Protocol Violation|0|||
146061041|NCT02163538|526741763|FG000|Overall Study|Physician Decision|0|||
146061042|NCT02163538|526741764|FG001|Overall Study|Physician Decision|1|||
146061043|NCT04484961|526741767|FG000|Overall Study|Lost to Follow-up|9|||
146061044|NCT04484961|526741768|FG001|Overall Study|Lost to Follow-up|9|||
146400605|NCT05553600|527970295|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
146400606|NCT05553600|527970296|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
146400607|NCT05553600|527970297|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
146400608|NCT05553600|527970294|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146400609|NCT05553600|527970295|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146061045|NCT00388349|526741769|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
146400610|NCT05553600|527970296|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
146400611|NCT05553600|527970297|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
146400612|NCT05553600|527970294|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
146400613|NCT05553600|527970295|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
146400614|NCT05553600|527970296|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
146400615|NCT05553600|527970297|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
146400616|NCT05553600|527970294|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
146400617|NCT05553600|527970295|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
146400618|NCT05553600|527970296|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
146400619|NCT05553600|527970297|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
146400620|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146400621|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146400622|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
146400623|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
146400624|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
146400625|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
146400626|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
146400627|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
146400628|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
146400629|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
146400630|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
146400631|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
146400632|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
146400633|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
146400634|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
146400635|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
146400636|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
146400637|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
146400638|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
146400639|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
146400640|NCT05553600|527970294|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
146400641|NCT05553600|527970295|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
146400642|NCT05553600|527970296|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
146400643|NCT05553600|527970297|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
146400644|NCT05553600|527970294|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
146400645|NCT05553600|527970295|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
146400646|NCT05553600|527970296|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
146400647|NCT05553600|527970297|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
146400648|NCT00366678|527970298|FG000|Infant Series|Withdrawal by Subject|8|||
146400649|NCT00366678|527970299|FG001|Infant Series|Withdrawal by Subject|6|||
146400650|NCT00366678|527970300|FG002|Infant Series|Withdrawal by Subject|0|||
146400651|NCT00366678|527970298|FG000|Infant Series|Protocol Violation|4|||
146400652|NCT00366678|527970299|FG001|Infant Series|Protocol Violation|3|||
146400653|NCT00366678|527970300|FG002|Infant Series|Protocol Violation|0|||
146400654|NCT00366678|527970298|FG000|Infant Series|Failed to return|1|||
146400655|NCT00366678|527970299|FG001|Infant Series|Failed to return|1|||
146400656|NCT00366678|527970300|FG002|Infant Series|Failed to return|0|||
146400657|NCT00366678|527970298|FG000|Infant Series|Adverse Event|1|||
146400658|NCT00366678|527970299|FG001|Infant Series|Adverse Event|0|||
146400659|NCT00366678|527970300|FG002|Infant Series|Adverse Event|0|||
146400660|NCT00366678|527970298|FG000|After Infant|Withdrawal by Subject|8|||
146400661|NCT00366678|527970299|FG001|After Infant|Withdrawal by Subject|4|||
146400662|NCT00366678|527970300|FG002|After Infant|Withdrawal by Subject|0|||
146400663|NCT00366678|527970298|FG000|After Infant|Lost to Follow-up|2|||
146400664|NCT00366678|527970299|FG001|After Infant|Lost to Follow-up|1|||
146400665|NCT00366678|527970300|FG002|After Infant|Lost to Follow-up|0|||
146400666|NCT00366678|527970298|FG000|After Infant|Failed to return|5|||
146400667|NCT00366678|527970299|FG001|After Infant|Failed to return|5|||
146400668|NCT00366678|527970300|FG002|After Infant|Failed to return|0|||
146400669|NCT00366678|527970298|FG000|After Infant|Adverse Event|1|||
146400670|NCT00366678|527970299|FG001|After Infant|Adverse Event|0|||
146400671|NCT00366678|527970300|FG002|After Infant|Adverse Event|0|||
146400672|NCT00366678|527970298|FG000|After Infant|Protocol Violation|1|||
146400673|NCT00366678|527970299|FG001|After Infant|Protocol Violation|0|||
146400674|NCT00366678|527970300|FG002|After Infant|Protocol Violation|0|||
146400675|NCT00366678|527970298|FG000|Toddler Dose|Protocol Violation|2|||
146400676|NCT00366678|527970299|FG001|Toddler Dose|Protocol Violation|1|||
146400677|NCT00366678|527970300|FG002|Toddler Dose|Protocol Violation|0|||
146400678|NCT00366678|527970298|FG000|Toddler Dose|Failed to return|1|||
146400679|NCT00366678|527970299|FG001|Toddler Dose|Failed to return|0|||
146400680|NCT00366678|527970300|FG002|Toddler Dose|Failed to return|0|||
146400681|NCT00366678|527970298|FG000|Toddler Dose|Withdrawal by Subject|1|||
146400682|NCT00366678|527970299|FG001|Toddler Dose|Withdrawal by Subject|0|||
146400683|NCT00366678|527970300|FG002|Toddler Dose|Withdrawal by Subject|0|||
146400684|NCT00366678|527970298|FG000|Toddler Dose|protocol deviation|1|||
146400685|NCT00366678|527970299|FG001|Toddler Dose|protocol deviation|0|||
146400686|NCT00366678|527970300|FG002|Toddler Dose|protocol deviation|0|||
146400687|NCT04292171|527970301|FG000|Overall Study|Pharmacy error|2|||
146400688|NCT04292171|527970302|FG001|Overall Study|Pharmacy error|0|||
146400689|NCT04292171|527970301|FG000|Overall Study|Delivered prior to procedure|0|||
146400690|NCT04292171|527970302|FG001|Overall Study|Delivered prior to procedure|1|||
146400691|NCT03079869|527970303|FG000|Overall Study|Adverse Event|6|||
146400692|NCT03079869|527970304|FG001|Overall Study|Adverse Event|8|||
146400693|NCT03079869|527970303|FG000|Overall Study|Withdrawal by Subject|4|||
146400694|NCT03079869|527970304|FG001|Overall Study|Withdrawal by Subject|1|||
146400695|NCT03079869|527970303|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
146400696|NCT03079869|527970304|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
146400697|NCT04633434|527970305|FG000|Overall Study|Lost to Follow-up|32|||
146400698|NCT04633434|527970306|FG001|Overall Study|Lost to Follow-up|32|||
146400699|NCT00297882|527970311|FG000|Day 14|Lack of Efficacy|12|||
146400700|NCT00297882|527970312|FG001|Day 14|Lack of Efficacy|49|||
146400701|NCT00297882|527970311|FG000|Day 28|Lost to Follow-up|13|||
146400702|NCT00297882|527970312|FG001|Day 28|Lost to Follow-up|23|||
146400703|NCT00297882|527970311|FG000|Day 28|Lack of Efficacy|3|||
146400704|NCT00297882|527970312|FG001|Day 28|Lack of Efficacy|0|||
146400705|NCT01301625|527970315|FG000|Overall Study|Death|5|||
146400706|NCT01301625|527970315|FG000|Overall Study|Not Due|21|||
146400707|NCT01301625|527970315|FG000|Overall Study|Expected|8|||
146400708|NCT01301625|527970315|FG000|Overall Study|Lost to Follow-up|1|||
146400709|NCT03237325|527970318|FG000|Overall Study|Lost to Follow-up|3|||
146400710|NCT03237325|527970319|FG001|Overall Study|Lost to Follow-up|5|||
146400711|NCT03237325|527970318|FG000|Overall Study|Physician Decision|2|||
146400712|NCT03237325|527970319|FG001|Overall Study|Physician Decision|4|||
146400713|NCT03237325|527970318|FG000|Overall Study|Withdrawal by Subject|9|||
146400714|NCT03237325|527970319|FG001|Overall Study|Withdrawal by Subject|12|||
146400715|NCT03237325|527970318|FG000|Overall Study|Noncompliance with Study Procedures|1|||
146400716|NCT03237325|527970319|FG001|Overall Study|Noncompliance with Study Procedures|1|||
146400717|NCT03237325|527970318|FG000|Overall Study|Termination by Sponsor|0|||
146400718|NCT03237325|527970319|FG001|Overall Study|Termination by Sponsor|1|||
146400719|NCT03237325|527970318|FG000|Overall Study|Reason other than described|0|||
146400720|NCT03237325|527970319|FG001|Overall Study|Reason other than described|2|||
146400721|NCT02684370|527970320|FG000|Part A|Adverse Event|2|||
146400722|NCT02684370|527970321|FG001|Part A|Adverse Event|0|||
146400723|NCT02684370|527970322|FG002|Part A|Adverse Event|1|||
146400724|NCT02684370|527970323|FG003|Part A|Adverse Event|0|||
146400725|NCT02684370|527970324|FG004|Part A|Adverse Event|0|||
146400726|NCT02684370|527970325|FG005|Part A|Adverse Event|0|||
146400727|NCT02684370|527970320|FG000|Part A|Lost to Follow-up|1|||
146400728|NCT02684370|527970321|FG001|Part A|Lost to Follow-up|1|||
146400729|NCT02684370|527970322|FG002|Part A|Lost to Follow-up|0|||
146400730|NCT02684370|527970323|FG003|Part A|Lost to Follow-up|0|||
146400731|NCT02684370|527970324|FG004|Part A|Lost to Follow-up|0|||
146400732|NCT02684370|527970325|FG005|Part A|Lost to Follow-up|0|||
146400733|NCT02684370|527970320|FG000|Part A|Subject Withdrawal|1|||
146400734|NCT02684370|527970321|FG001|Part A|Subject Withdrawal|0|||
146400735|NCT02684370|527970322|FG002|Part A|Subject Withdrawal|3|||
146400736|NCT02684370|527970323|FG003|Part A|Subject Withdrawal|0|||
146400737|NCT02684370|527970324|FG004|Part A|Subject Withdrawal|0|||
146400738|NCT02684370|527970325|FG005|Part A|Subject Withdrawal|0|||
146400739|NCT02684370|527970320|FG000|Part A|Other|0|||
146400740|NCT02684370|527970321|FG001|Part A|Other|0|||
146400741|NCT02684370|527970322|FG002|Part A|Other|1|||
146400742|NCT02684370|527970323|FG003|Part A|Other|0|||
146400743|NCT02684370|527970324|FG004|Part A|Other|0|||
146400744|NCT02684370|527970325|FG005|Part A|Other|0|||
146400745|NCT02684370|527970320|FG000|Part B|Adverse Event|0|||
146400746|NCT02684370|527970321|FG001|Part B|Adverse Event|0|||
146400747|NCT02684370|527970322|FG002|Part B|Adverse Event|0|||
146400748|NCT02684370|527970323|FG003|Part B|Adverse Event|0|||
146400749|NCT02684370|527970324|FG004|Part B|Adverse Event|2|||
146400750|NCT02684370|527970325|FG005|Part B|Adverse Event|1|||
146400751|NCT02684370|527970320|FG000|Part B|Lost to Follow-up|0|||
146400752|NCT02684370|527970321|FG001|Part B|Lost to Follow-up|0|||
146400753|NCT02684370|527970322|FG002|Part B|Lost to Follow-up|0|||
146400754|NCT02684370|527970323|FG003|Part B|Lost to Follow-up|1|||
146400755|NCT02684370|527970324|FG004|Part B|Lost to Follow-up|2|||
146400756|NCT02684370|527970325|FG005|Part B|Lost to Follow-up|5|||
146400757|NCT02684370|527970320|FG000|Part B|Subject Withdrawal|0|||
146400758|NCT02684370|527970321|FG001|Part B|Subject Withdrawal|0|||
146400759|NCT02684370|527970322|FG002|Part B|Subject Withdrawal|0|||
146400760|NCT02684370|527970323|FG003|Part B|Subject Withdrawal|1|||
146400761|NCT02684370|527970324|FG004|Part B|Subject Withdrawal|1|||
146400762|NCT02684370|527970325|FG005|Part B|Subject Withdrawal|2|||
146400763|NCT01833897|527970336|FG000|Overall Study|Lack of Efficacy|1|||
146400764|NCT02860039|527970337|FG000|Overall Study|Death|4|||
146400765|NCT02860039|527970338|FG001|Overall Study|Death|0|||
146400766|NCT02860039|527970337|FG000|Overall Study|Lost to Follow-up|2|||
146400767|NCT02860039|527970338|FG001|Overall Study|Lost to Follow-up|2|||
146400768|NCT02860039|527970337|FG000|Overall Study|Protocol Violation|3|||
146400769|NCT02860039|527970338|FG001|Overall Study|Protocol Violation|1|||
146400770|NCT02860039|527970337|FG000|Overall Study|Withdrawal by Subject|1|||
146400771|NCT02860039|527970338|FG001|Overall Study|Withdrawal by Subject|0|||
146400772|NCT02860039|527970337|FG000|Overall Study|Not otherwise eligible|1|||
146400773|NCT02860039|527970338|FG001|Overall Study|Not otherwise eligible|1|||
146400774|NCT00669110|527970339|FG000|Overall Study|Adverse Event|4|||
146400775|NCT00669110|527970340|FG001|Overall Study|Adverse Event|3|||
146400776|NCT00669110|527970339|FG000|Overall Study|Caregiver request|3|||
146400777|NCT00669110|527970340|FG001|Overall Study|Caregiver request|2|||
146400778|NCT00669110|527970339|FG000|Overall Study|Physician Decision|0|||
146400779|NCT00669110|527970340|FG001|Overall Study|Physician Decision|1|||
146400780|NCT00669110|527970339|FG000|Overall Study|Lost to Follow-up|1|||
146400781|NCT00669110|527970340|FG001|Overall Study|Lost to Follow-up|0|||
146400782|NCT00669110|527970339|FG000|Overall Study|Protocol Violation|0|||
146400783|NCT00669110|527970340|FG001|Overall Study|Protocol Violation|5|||
146400784|NCT00669110|527970339|FG000|Overall Study|Withdrawal by Subject|0|||
146400785|NCT00669110|527970340|FG001|Overall Study|Withdrawal by Subject|2|||
146400786|NCT01244516|527970341|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
146400787|NCT01244516|527970342|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
146400788|NCT01244516|527970343|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
146400789|NCT01244516|527970341|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
146400790|NCT01244516|527970342|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
146400791|NCT01244516|527970343|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
146400792|NCT01244516|527970341|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
146400793|NCT01244516|527970342|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
146400794|NCT01244516|527970343|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
146400795|NCT01244516|527970341|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
146400796|NCT01244516|527970342|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
146400797|NCT01244516|527970343|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
146400798|NCT01244516|527970341|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
146400799|NCT01244516|527970342|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
146400800|NCT01244516|527970343|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
146400801|NCT01244516|527970341|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
146400802|NCT01244516|527970342|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
146400803|NCT01244516|527970343|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
146400804|NCT01244516|527970341|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
146400805|NCT01244516|527970342|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
146400806|NCT01244516|527970343|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
146400807|NCT00077766|527970349|FG000|Overall Study|Adverse Event|1|||
146400808|NCT00077766|527970350|FG001|Overall Study|Adverse Event|1|||
146400809|NCT00077766|527970349|FG000|Overall Study|Withdrawal by Subject|4|||
146400810|NCT00077766|527970350|FG001|Overall Study|Withdrawal by Subject|3|||
146400811|NCT00077766|527970349|FG000|Overall Study|Death|12|||
146400812|NCT00077766|527970350|FG001|Overall Study|Death|10|||
146400813|NCT00077766|527970349|FG000|Overall Study|Lost to Follow-up|2|||
146400814|NCT00077766|527970350|FG001|Overall Study|Lost to Follow-up|0|||
146400815|NCT00077766|527970349|FG000|Overall Study|Protocol Violation|1|||
146400816|NCT00077766|527970350|FG001|Overall Study|Protocol Violation|0|||
146400817|NCT00077766|527970349|FG000|Overall Study|Kidney Transplantation|9|||
146400818|NCT00077766|527970350|FG001|Overall Study|Kidney Transplantation|5|||
146400819|NCT00077766|527970349|FG000|Overall Study|Transplantation|5|||
146400820|NCT00077766|527970350|FG001|Overall Study|Transplantation|1|||
146400821|NCT00077766|527970349|FG000|Overall Study|Investigators Discretion|1|||
146400822|NCT00077766|527970350|FG001|Overall Study|Investigators Discretion|0|||
146061046|NCT00388349|526741770|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
146061047|NCT01345240|526741774|FG000|Overall Study|Adverse Event|3|||
146400823|NCT00077766|527970349|FG000|Overall Study|Participant's decision|1|||
146400824|NCT00077766|527970350|FG001|Overall Study|Participant's decision|0|||
146400825|NCT00077766|527970349|FG000|Overall Study|Dialysis Discontinued|1|||
146400826|NCT00077766|527970350|FG001|Overall Study|Dialysis Discontinued|0|||
146400827|NCT00077766|527970349|FG000|Overall Study|Dialysis|0|||
146400828|NCT00077766|527970350|FG001|Overall Study|Dialysis|1|||
146400829|NCT00077766|527970349|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
146400830|NCT00077766|527970350|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
146400831|NCT00077766|527970349|FG000|Overall Study|Started Nocturnal Dialysis|0|||
146400832|NCT00077766|527970350|FG001|Overall Study|Started Nocturnal Dialysis|1|||
146400833|NCT00077766|527970349|FG000|Overall Study|Stop Dialysis|0|||
146400834|NCT00077766|527970350|FG001|Overall Study|Stop Dialysis|1|||
146400835|NCT00077766|527970349|FG000|Overall Study|Participants Vacation|2|||
146400836|NCT00077766|527970350|FG001|Overall Study|Participants Vacation|1|||
146400837|NCT00352664|527970352|FG000|Overall Study|Withdrawal by Subject|7|||
146400838|NCT00352664|527970353|FG001|Overall Study|Withdrawal by Subject|0|||
146400839|NCT01808508|527972568|FG000|Overall Study|Lost to Follow-up|1|||
146400840|NCT01808508|527972569|FG001|Overall Study|Lost to Follow-up|0|||
146400841|NCT01808508|527972570|FG002|Overall Study|Lost to Follow-up|0|||
146400842|NCT01035229|527972571|FG000|Overall Study|Adverse Event|61|||
146400843|NCT01035229|527972572|FG001|Overall Study|Adverse Event|14|||
146400844|NCT01035229|527972571|FG000|Overall Study|Withdrawal by Subject|20|||
146400845|NCT01035229|527972572|FG001|Overall Study|Withdrawal by Subject|7|||
146400846|NCT01035229|527972571|FG000|Overall Study|Lost to Follow-up|1|||
146400847|NCT01035229|527972572|FG001|Overall Study|Lost to Follow-up|0|||
146400848|NCT01035229|527972571|FG000|Overall Study|Administrative problems|1|||
146400849|NCT01035229|527972572|FG001|Overall Study|Administrative problems|1|||
146400850|NCT01035229|527972571|FG000|Overall Study|Death|13|||
146400851|NCT01035229|527972572|FG001|Overall Study|Death|5|||
146400852|NCT01035229|527972571|FG000|Overall Study|New cancer therapy|2|||
146400853|NCT01035229|527972572|FG001|Overall Study|New cancer therapy|0|||
146400854|NCT01035229|527972571|FG000|Overall Study|Protocol Violation|0|||
146400855|NCT01035229|527972572|FG001|Overall Study|Protocol Violation|2|||
146400856|NCT01035229|527972571|FG000|Overall Study|Sponsor's decision to end study|3|||
146400857|NCT01035229|527972572|FG001|Overall Study|Sponsor's decision to end study|3|||
146400858|NCT01035229|527972571|FG000|Overall Study|Disease Progression|261|||
146400859|NCT01035229|527972572|FG001|Overall Study|Disease Progression|152|||
146400860|NCT00648739|527972573|FG000|Overall Study|Adverse Event|1|||
146400861|NCT00648739|527972574|FG001|Overall Study|Adverse Event|0|||
146061048|NCT01345240|526741775|FG001|Overall Study|Adverse Event|5|||
146061049|NCT01345240|526741776|FG002|Overall Study|Adverse Event|4|||
146061050|NCT01345240|526741777|FG003|Overall Study|Adverse Event|2|||
146061051|NCT01345240|526741778|FG004|Overall Study|Adverse Event|1|||
146061052|NCT01345240|526741774|FG000|Overall Study|Lost to Follow-up|8|||
146061053|NCT01345240|526741775|FG001|Overall Study|Lost to Follow-up|9|||
146061054|NCT01345240|526741776|FG002|Overall Study|Lost to Follow-up|14|||
146061055|NCT01345240|526741777|FG003|Overall Study|Lost to Follow-up|7|||
146061056|NCT01345240|526741778|FG004|Overall Study|Lost to Follow-up|9|||
146061057|NCT04011540|526741779|FG000|Overall Study|Lost to Follow-up|9|||
146061058|NCT04011540|526741780|FG001|Overall Study|Lost to Follow-up|6|||
146061059|NCT01502293|526741784|FG000|Overall Study|Progressive Disease|20|||
146061060|NCT01502293|526741785|FG001|Overall Study|Progressive Disease|12|||
146061061|NCT01502293|526741786|FG002|Overall Study|Progressive Disease|2|||
146061062|NCT01502293|526741784|FG000|Overall Study|Withdrawal by Subject|3|||
146061063|NCT01502293|526741785|FG001|Overall Study|Withdrawal by Subject|3|||
146061064|NCT01502293|526741786|FG002|Overall Study|Withdrawal by Subject|1|||
146061065|NCT01502293|526741784|FG000|Overall Study|Adverse Event|0|||
146061066|NCT01502293|526741785|FG001|Overall Study|Adverse Event|2|||
146061067|NCT01502293|526741786|FG002|Overall Study|Adverse Event|0|||
146061068|NCT01502293|526741784|FG000|Overall Study|Reason Not Specified|2|||
146061069|NCT01502293|526741785|FG001|Overall Study|Reason Not Specified|0|||
146061070|NCT01502293|526741786|FG002|Overall Study|Reason Not Specified|0|||
146061071|NCT01502293|526741784|FG000|Overall Study|Physician Decision|0|||
146061072|NCT01502293|526741785|FG001|Overall Study|Physician Decision|0|||
146061073|NCT01502293|526741786|FG002|Overall Study|Physician Decision|1|||
146061074|NCT01339832|526741789|FG000|Overall Study|Lost to Follow-up|3|||
146061075|NCT01339832|526741789|FG000|Overall Study|Death|11|||
146061076|NCT00231816|526741790|FG000|Overall Study|Adverse Event|1|||
146061077|NCT00231816|526741791|FG001|Overall Study|Adverse Event|0|||
146061078|NCT00231816|526741790|FG000|Overall Study|Lost to Follow-up|8|||
146061079|NCT00231816|526741791|FG001|Overall Study|Lost to Follow-up|5|||
146061080|NCT00231816|526741790|FG000|Overall Study|Protocol Violation|2|||
146061081|NCT00231816|526741791|FG001|Overall Study|Protocol Violation|3|||
146061082|NCT00231816|526741790|FG000|Overall Study|Withdrawal by Subject|3|||
146061083|NCT00231816|526741791|FG001|Overall Study|Withdrawal by Subject|3|||
146061084|NCT00231816|526741790|FG000|Overall Study|Other|2|||
146061085|NCT00231816|526741791|FG001|Overall Study|Other|1|||
146061086|NCT00774046|526741792|FG000|Screening|Not eligible|56|||
146061087|NCT00774046|526741792|FG000|Enrollment|Desired other therapy/refused|28|||
146061088|NCT00774046|526741792|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
146061089|NCT05498649|526741793|FG000|Overall Study|Lost to Follow-up|1|||
146061090|NCT04609319|526741794|FG000|Overall Study|Death|64|||
146061091|NCT04609319|526741795|FG001|Overall Study|Death|49|||
146061092|NCT04609319|526741796|FG002|Overall Study|Death|1|||
146061093|NCT04609319|526741794|FG000|Overall Study|Withdrawal of consent|15|||
146061094|NCT04609319|526741795|FG001|Overall Study|Withdrawal of consent|3|||
146400862|NCT00648739|527972575|FG002|Overall Study|Adverse Event|1|||
146400863|NCT00648739|527972576|FG003|Overall Study|Adverse Event|2|||
146400864|NCT00648739|527972577|FG004|Overall Study|Adverse Event|1|||
146400865|NCT00648739|527972578|FG005|Overall Study|Adverse Event|0|||
146400866|NCT00648739|527972579|FG006|Overall Study|Adverse Event|0|||
146061095|NCT04609319|526741796|FG002|Overall Study|Withdrawal of consent|0|||
146061096|NCT04609319|526741794|FG000|Overall Study|Lost to Follow-up|20|||
146400867|NCT00648739|527972573|FG000|Overall Study|Withdrawal by Subject|1|||
146400868|NCT00648739|527972574|FG001|Overall Study|Withdrawal by Subject|0|||
146400869|NCT00648739|527972575|FG002|Overall Study|Withdrawal by Subject|1|||
146400870|NCT00648739|527972576|FG003|Overall Study|Withdrawal by Subject|0|||
146400871|NCT00648739|527972577|FG004|Overall Study|Withdrawal by Subject|0|||
146400872|NCT00648739|527972578|FG005|Overall Study|Withdrawal by Subject|2|||
146400873|NCT00648739|527972579|FG006|Overall Study|Withdrawal by Subject|0|||
146400874|NCT00648739|527972573|FG000|Overall Study|Lack of Efficacy|0|||
146400875|NCT00648739|527972574|FG001|Overall Study|Lack of Efficacy|0|||
146400876|NCT00648739|527972575|FG002|Overall Study|Lack of Efficacy|0|||
146400877|NCT00648739|527972576|FG003|Overall Study|Lack of Efficacy|0|||
146400878|NCT00648739|527972577|FG004|Overall Study|Lack of Efficacy|1|||
146400879|NCT00648739|527972578|FG005|Overall Study|Lack of Efficacy|2|||
146400880|NCT00648739|527972579|FG006|Overall Study|Lack of Efficacy|0|||
146400881|NCT00648739|527972573|FG000|Overall Study|Investigator Considered it Advisable|0|||
146400882|NCT00648739|527972574|FG001|Overall Study|Investigator Considered it Advisable|0|||
146400883|NCT00648739|527972575|FG002|Overall Study|Investigator Considered it Advisable|0|||
146400884|NCT00648739|527972576|FG003|Overall Study|Investigator Considered it Advisable|0|||
146400885|NCT00648739|527972577|FG004|Overall Study|Investigator Considered it Advisable|0|||
146400886|NCT00648739|527972578|FG005|Overall Study|Investigator Considered it Advisable|1|||
146400887|NCT00648739|527972579|FG006|Overall Study|Investigator Considered it Advisable|1|||
146400888|NCT00648739|527972573|FG000|Overall Study|Death|0|||
146400889|NCT00648739|527972574|FG001|Overall Study|Death|1|||
146400890|NCT00648739|527972575|FG002|Overall Study|Death|0|||
146400891|NCT00648739|527972576|FG003|Overall Study|Death|0|||
146400892|NCT00648739|527972577|FG004|Overall Study|Death|0|||
146400893|NCT00648739|527972578|FG005|Overall Study|Death|0|||
146400894|NCT00648739|527972579|FG006|Overall Study|Death|0|||
146400895|NCT00648739|527972573|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
146400896|NCT00648739|527972574|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
146400897|NCT00648739|527972575|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
146400898|NCT00648739|527972576|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
146400899|NCT00648739|527972577|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
146400900|NCT00648739|527972578|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
146400901|NCT00648739|527972579|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
146400902|NCT00648739|527972573|FG000|Overall Study|Follow-up Visits Not Completed|0|||
146400903|NCT00648739|527972574|FG001|Overall Study|Follow-up Visits Not Completed|1|||
146400904|NCT00648739|527972575|FG002|Overall Study|Follow-up Visits Not Completed|0|||
146400905|NCT00648739|527972576|FG003|Overall Study|Follow-up Visits Not Completed|0|||
146400906|NCT00648739|527972577|FG004|Overall Study|Follow-up Visits Not Completed|0|||
146400907|NCT00648739|527972578|FG005|Overall Study|Follow-up Visits Not Completed|0|||
146400908|NCT00648739|527972579|FG006|Overall Study|Follow-up Visits Not Completed|0|||
146400909|NCT03387423|527972584|FG000|Overall Study|Lost to Follow-up|16|||
146400910|NCT03387423|527972585|FG001|Overall Study|Lost to Follow-up|12|||
146400911|NCT03387423|527972586|FG002|Overall Study|Lost to Follow-up|1|||
146400912|NCT03387423|527972587|FG003|Overall Study|Lost to Follow-up|0|||
146400913|NCT03387423|527972584|FG000|Overall Study|Other|0|||
146400914|NCT03387423|527972585|FG001|Overall Study|Other|3|||
146400915|NCT03387423|527972586|FG002|Overall Study|Other|0|||
146400916|NCT03387423|527972587|FG003|Overall Study|Other|0|||
146400917|NCT03387423|527972584|FG000|Overall Study|Administrative Reason|166|||
146400918|NCT03387423|527972585|FG001|Overall Study|Administrative Reason|89|||
146400919|NCT03387423|527972586|FG002|Overall Study|Administrative Reason|17|||
146400920|NCT03387423|527972587|FG003|Overall Study|Administrative Reason|19|||
146400921|NCT03387423|527972584|FG000|Overall Study|Revocation Consent|76|||
146400922|NCT03387423|527972585|FG001|Overall Study|Revocation Consent|32|||
146400923|NCT03387423|527972586|FG002|Overall Study|Revocation Consent|3|||
146400924|NCT03387423|527972587|FG003|Overall Study|Revocation Consent|5|||
146400925|NCT03862807|527972588|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
146400926|NCT01513759|527972593|FG000|Overall Study|Protocol Violation|4|||
146400927|NCT01513759|527972593|FG000|Overall Study|Death during catheter placement|1|||
146400928|NCT03606109|527972594|FG000|Overall Study|Lost to Follow-up|2|||
146400929|NCT03606109|527972595|FG001|Overall Study|Lost to Follow-up|1|||
146400930|NCT03669640|527972596|FG000|Overall Study|Study Terminated by Sponsor|0|||
146400931|NCT03669640|527972597|FG001|Overall Study|Study Terminated by Sponsor|0|||
146400932|NCT03669640|527972598|FG002|Overall Study|Study Terminated by Sponsor|0|||
146400933|NCT03669640|527972599|FG003|Overall Study|Study Terminated by Sponsor|0|||
146400934|NCT03669640|527972600|FG004|Overall Study|Study Terminated by Sponsor|1|||
146400935|NCT03669640|527972601|FG005|Overall Study|Study Terminated by Sponsor|0|||
146400936|NCT03669640|527972596|FG000|Overall Study|Lost to Follow-up|0|||
146400937|NCT03669640|527972597|FG001|Overall Study|Lost to Follow-up|0|||
146400938|NCT03669640|527972598|FG002|Overall Study|Lost to Follow-up|2|||
146400939|NCT03669640|527972599|FG003|Overall Study|Lost to Follow-up|0|||
146400940|NCT03669640|527972600|FG004|Overall Study|Lost to Follow-up|0|||
146400941|NCT03669640|527972601|FG005|Overall Study|Lost to Follow-up|0|||
146400942|NCT03669640|527972596|FG000|Overall Study|Death|0|||
146400943|NCT03669640|527972597|FG001|Overall Study|Death|0|||
146400944|NCT03669640|527972598|FG002|Overall Study|Death|1|||
146061097|NCT04609319|526741795|FG001|Overall Study|Lost to Follow-up|33|||
146061098|NCT04609319|526741796|FG002|Overall Study|Lost to Follow-up|0|||
146061099|NCT04609319|526741794|FG000|Overall Study|Alive until end of follow-up|60|||
146061100|NCT04609319|526741795|FG001|Overall Study|Alive until end of follow-up|53|||
146400945|NCT03669640|527972599|FG003|Overall Study|Death|0|||
146400946|NCT03669640|527972600|FG004|Overall Study|Death|0|||
146400947|NCT03669640|527972601|FG005|Overall Study|Death|0|||
146061101|NCT04609319|526741796|FG002|Overall Study|Alive until end of follow-up|1|||
146061102|NCT03804528|526741797|FG000|Overall Study|Time Commitment|18|||
146061103|NCT03804528|526741797|FG000|Overall Study|Health Reasons|5|||
146061104|NCT04607005|526741800|FG000|Overall Study|Adverse Event|0|||
146061105|NCT04607005|526741801|FG001|Overall Study|Adverse Event|1|||
146061106|NCT04607005|526741800|FG000|Overall Study|Lack of Efficacy|1|||
146061107|NCT04607005|526741801|FG001|Overall Study|Lack of Efficacy|6|||
146061108|NCT04607005|526741800|FG000|Overall Study|Withdrawal by Subject|4|||
146061109|NCT04607005|526741801|FG001|Overall Study|Withdrawal by Subject|9|||
146061110|NCT04607005|526741800|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
146061111|NCT04607005|526741801|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
146061112|NCT00668148|526741802|FG000|Overall Study|Adverse Event|5|||
146061113|NCT00668148|526741802|FG000|Overall Study|Subject Non-compliance|1|||
146061114|NCT00668148|526741802|FG000|Overall Study|Progressive Disease Before Treatment|2|||
146061115|NCT00668148|526741802|FG000|Overall Study|Withdrawal of Consent|2|||
146061116|NCT04944992|526743321|FG000|Overall Study|Lost to Follow-up|1|||
146061117|NCT04944992|526743322|FG001|Overall Study|Lost to Follow-up|1|||
146061118|NCT04944992|526743321|FG000|Overall Study|Physician Decision|1|||
146061119|NCT04944992|526743322|FG001|Overall Study|Physician Decision|0|||
146061120|NCT04944992|526743321|FG000|Overall Study|Withdrawal by Subject|6|||
146061121|NCT04944992|526743322|FG001|Overall Study|Withdrawal by Subject|1|||
146061122|NCT00303069|526743323|FG000|Overall Study|Lost to Follow-up|1|||
146061123|NCT00303069|526743324|FG001|Overall Study|Lost to Follow-up|0|||
146061124|NCT00303069|526743325|FG002|Overall Study|Lost to Follow-up|0|||
146061125|NCT00303069|526743326|FG003|Overall Study|Lost to Follow-up|2|||
146061126|NCT00303069|526743323|FG000|Overall Study|subject moved|1|||
146061127|NCT00303069|526743324|FG001|Overall Study|subject moved|0|||
146061128|NCT00303069|526743325|FG002|Overall Study|subject moved|0|||
146061129|NCT00303069|526743326|FG003|Overall Study|subject moved|0|||
146061130|NCT00303069|526743323|FG000|Overall Study|Recruitment into Army Reserves|0|||
146061131|NCT00303069|526743324|FG001|Overall Study|Recruitment into Army Reserves|0|||
146061132|NCT00303069|526743325|FG002|Overall Study|Recruitment into Army Reserves|1|||
146061133|NCT00303069|526743326|FG003|Overall Study|Recruitment into Army Reserves|0|||
146061134|NCT01972217|526743329|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146061135|NCT01972217|526743330|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
146061136|NCT01972217|526743331|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146061137|NCT01972217|526743332|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
146061138|NCT01972217|526743329|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
146061139|NCT01972217|526743330|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
146061140|NCT01972217|526743331|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
146061141|NCT01972217|526743332|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
146061142|NCT01972217|526743329|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146061143|NCT01972217|526743330|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
146061144|NCT01972217|526743331|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146061145|NCT01972217|526743332|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
146061146|NCT01972217|526743329|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
146061147|NCT01972217|526743330|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
146400948|NCT03669640|527972596|FG000|Overall Study|Withdrawal by Subject|1|||
146400949|NCT03669640|527972597|FG001|Overall Study|Withdrawal by Subject|2|||
146400950|NCT03669640|527972598|FG002|Overall Study|Withdrawal by Subject|1|||
146400951|NCT03669640|527972599|FG003|Overall Study|Withdrawal by Subject|0|||
146400952|NCT03669640|527972600|FG004|Overall Study|Withdrawal by Subject|1|||
146400953|NCT03669640|527972601|FG005|Overall Study|Withdrawal by Subject|3|||
146400954|NCT03669640|527972596|FG000|Overall Study|Protocol Violation|1|||
146400955|NCT03669640|527972597|FG001|Overall Study|Protocol Violation|0|||
146400956|NCT03669640|527972598|FG002|Overall Study|Protocol Violation|0|||
146400957|NCT03669640|527972599|FG003|Overall Study|Protocol Violation|0|||
146400958|NCT03669640|527972600|FG004|Overall Study|Protocol Violation|0|||
146400959|NCT03669640|527972601|FG005|Overall Study|Protocol Violation|0|||
146400960|NCT03669640|527972596|FG000|Overall Study|Physician Decision|0|||
146400961|NCT03669640|527972597|FG001|Overall Study|Physician Decision|2|||
146400962|NCT03669640|527972598|FG002|Overall Study|Physician Decision|0|||
146400963|NCT03669640|527972599|FG003|Overall Study|Physician Decision|0|||
146400964|NCT03669640|527972600|FG004|Overall Study|Physician Decision|0|||
146400965|NCT03669640|527972601|FG005|Overall Study|Physician Decision|0|||
146400966|NCT03669640|527972596|FG000|Overall Study|Disease Relapse|1|||
146400967|NCT03669640|527972597|FG001|Overall Study|Disease Relapse|0|||
146400968|NCT03669640|527972598|FG002|Overall Study|Disease Relapse|0|||
146400969|NCT03669640|527972599|FG003|Overall Study|Disease Relapse|0|||
146400970|NCT03669640|527972600|FG004|Overall Study|Disease Relapse|0|||
146400971|NCT03669640|527972601|FG005|Overall Study|Disease Relapse|0|||
146400972|NCT03669640|527972596|FG000|Overall Study|Adverse Event|2|||
146400973|NCT03669640|527972597|FG001|Overall Study|Adverse Event|1|||
146400974|NCT03669640|527972598|FG002|Overall Study|Adverse Event|0|||
146400975|NCT03669640|527972599|FG003|Overall Study|Adverse Event|0|||
146400976|NCT03669640|527972600|FG004|Overall Study|Adverse Event|1|||
146400977|NCT03669640|527972601|FG005|Overall Study|Adverse Event|0|||
146400978|NCT00826176|527972608|FG000|Overall Study|Lost to Follow-up|1|||
146400979|NCT00826176|527972609|FG001|Overall Study|Lost to Follow-up|0|||
146400980|NCT00826176|527972608|FG000|Overall Study|Subject Withdrew Consent|3|||
146400981|NCT00826176|527972609|FG001|Overall Study|Subject Withdrew Consent|0|||
146400982|NCT00826176|527972608|FG000|Overall Study|Administrative|9|||
146400983|NCT00826176|527972609|FG001|Overall Study|Administrative|0|||
146400984|NCT00388674|527972612|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
146400985|NCT00388674|527972613|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
146400986|NCT00388674|527972612|FG000|Initial Treatment|Adverse Event|22|||
146400987|NCT00388674|527972613|FG001|Initial Treatment|Adverse Event|87|||
146400988|NCT00388674|527972612|FG000|Initial Treatment|Death|215|||
146400989|NCT00388674|527972613|FG001|Initial Treatment|Death|216|||
146400990|NCT00388674|527972612|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
146400991|NCT00388674|527972613|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
146400992|NCT00388674|527972612|FG000|Initial Treatment|HCC|12|||
146400993|NCT00388674|527972613|FG001|Initial Treatment|HCC|20|||
146400994|NCT00388674|527972612|FG000|Initial Treatment|Lost to Follow-up|526|||
146400995|NCT00388674|527972613|FG001|Initial Treatment|Lost to Follow-up|624|||
146400996|NCT00388674|527972612|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
146400997|NCT00388674|527972613|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
146400998|NCT00388674|527972612|FG000|Initial Treatment|Never Treated with Study Medication|1|||
146400999|NCT00388674|527972613|FG001|Initial Treatment|Never Treated with Study Medication|7|||
146401000|NCT00388674|527972612|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
146401001|NCT00388674|527972613|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
146401002|NCT00388674|527972612|FG000|Initial Treatment|Not Defined|125|||
146401003|NCT00388674|527972613|FG001|Initial Treatment|Not Defined|172|||
146401004|NCT00388674|527972612|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
146401005|NCT00388674|527972613|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
146401006|NCT00388674|527972612|FG000|Initial Treatment|Pregnancy|26|||
146401007|NCT00388674|527972613|FG001|Initial Treatment|Pregnancy|16|||
146401008|NCT00388674|527972612|FG000|Initial Treatment|Study Drug Toxicity|5|||
146401009|NCT00388674|527972613|FG001|Initial Treatment|Study Drug Toxicity|92|||
146401010|NCT00388674|527972612|FG000|Initial Treatment|Participant Request|501|||
146401011|NCT00388674|527972613|FG001|Initial Treatment|Participant Request|673|||
146401012|NCT00388674|527972612|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
146401013|NCT00388674|527972613|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
146401014|NCT00388674|527972612|FG000|Initial Treatment|Not Reported|10|||
146401015|NCT00388674|527972613|FG001|Initial Treatment|Not Reported|12|||
146401016|NCT00388674|527972612|FG000|End of Study|Administrative Reason By Sponsor|299|||
146401017|NCT00388674|527972613|FG001|End of Study|Administrative Reason By Sponsor|253|||
146401018|NCT00388674|527972612|FG000|End of Study|Death|239|||
146401019|NCT00388674|527972613|FG001|End of Study|Death|262|||
146401020|NCT00388674|527972612|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
146401021|NCT00388674|527972613|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
146401022|NCT00388674|527972612|FG000|End of Study|HCC|8|||
146401023|NCT00388674|527972613|FG001|End of Study|HCC|7|||
146401024|NCT00388674|527972612|FG000|End of Study|Lost to Follow-up|587|||
146401025|NCT00388674|527972613|FG001|End of Study|Lost to Follow-up|715|||
146401026|NCT00388674|527972612|FG000|End of Study|Malignancy (Non-HCC)|1|||
146401027|NCT00388674|527972613|FG001|End of Study|Malignancy (Non-HCC)|1|||
146401028|NCT00388674|527972612|FG000|End of Study|Non-Study Related Comorbidities|3|||
146401029|NCT00388674|527972613|FG001|End of Study|Non-Study Related Comorbidities|4|||
146401030|NCT00388674|527972612|FG000|End of Study|Not Defined|135|||
146401031|NCT00388674|527972613|FG001|End of Study|Not Defined|214|||
146401032|NCT00388674|527972612|FG000|End of Study|Participant Withdrew Consent|437|||
146401033|NCT00388674|527972613|FG001|End of Study|Participant Withdrew Consent|673|||
146401034|NCT00388674|527972612|FG000|End of Study|No Off-Treatment Status Data|22|||
146401035|NCT00388674|527972613|FG001|End of Study|No Off-Treatment Status Data|30|||
146401036|NCT00388674|527972612|FG000|End of Study|Not Reported|0|||
146401037|NCT00388674|527972613|FG001|End of Study|Not Reported|1|||
146401038|NCT04484805|527972616|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
146401039|NCT04484805|527972617|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
146401040|NCT04484805|527972616|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
146401041|NCT04484805|527972617|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
146401042|NCT02118896|527972618|FG000|Overall Study|Death|4|||
146401043|NCT02118896|527972619|FG001|Overall Study|Death|0|||
146401044|NCT02118896|527972620|FG002|Overall Study|Death|4|||
146401045|NCT02118896|527972621|FG003|Overall Study|Death|6|||
146401046|NCT02118896|527972622|FG004|Overall Study|Death|3|||
146401047|NCT02118896|527972623|FG005|Overall Study|Death|1|||
146401048|NCT02118896|527972624|FG006|Overall Study|Death|0|||
146401049|NCT02118896|527972625|FG007|Overall Study|Death|0|||
146401050|NCT02118896|527972626|FG008|Overall Study|Death|0|||
146401051|NCT02118896|527972627|FG009|Overall Study|Death|0|||
146401052|NCT02118896|527972618|FG000|Overall Study|Adverse Event|5|||
146401053|NCT02118896|527972619|FG001|Overall Study|Adverse Event|4|||
146401054|NCT02118896|527972620|FG002|Overall Study|Adverse Event|4|||
146401055|NCT02118896|527972621|FG003|Overall Study|Adverse Event|5|||
146401056|NCT02118896|527972622|FG004|Overall Study|Adverse Event|5|||
146401057|NCT02118896|527972623|FG005|Overall Study|Adverse Event|9|||
146401058|NCT02118896|527972624|FG006|Overall Study|Adverse Event|1|||
146401059|NCT02118896|527972625|FG007|Overall Study|Adverse Event|1|||
146401060|NCT02118896|527972626|FG008|Overall Study|Adverse Event|4|||
146401061|NCT02118896|527972627|FG009|Overall Study|Adverse Event|0|||
146401062|NCT02118896|527972618|FG000|Overall Study|Consent withdrawn|2|||
146401063|NCT02118896|527972619|FG001|Overall Study|Consent withdrawn|0|||
146401064|NCT02118896|527972620|FG002|Overall Study|Consent withdrawn|3|||
146401065|NCT02118896|527972621|FG003|Overall Study|Consent withdrawn|4|||
146401066|NCT02118896|527972622|FG004|Overall Study|Consent withdrawn|1|||
146401067|NCT02118896|527972623|FG005|Overall Study|Consent withdrawn|4|||
146401068|NCT02118896|527972624|FG006|Overall Study|Consent withdrawn|0|||
146401069|NCT02118896|527972625|FG007|Overall Study|Consent withdrawn|0|||
146401070|NCT02118896|527972626|FG008|Overall Study|Consent withdrawn|0|||
146401071|NCT02118896|527972627|FG009|Overall Study|Consent withdrawn|0|||
146401072|NCT02118896|527972618|FG000|Overall Study|Non-compliance|2|||
146401073|NCT02118896|527972619|FG001|Overall Study|Non-compliance|1|||
146401074|NCT02118896|527972620|FG002|Overall Study|Non-compliance|1|||
146401075|NCT02118896|527972621|FG003|Overall Study|Non-compliance|5|||
146401076|NCT02118896|527972622|FG004|Overall Study|Non-compliance|0|||
146401077|NCT02118896|527972623|FG005|Overall Study|Non-compliance|1|||
146401078|NCT02118896|527972624|FG006|Overall Study|Non-compliance|0|||
146401079|NCT02118896|527972625|FG007|Overall Study|Non-compliance|1|||
146401080|NCT02118896|527972626|FG008|Overall Study|Non-compliance|0|||
146401081|NCT02118896|527972627|FG009|Overall Study|Non-compliance|0|||
146401082|NCT02118896|527972618|FG000|Overall Study|Pregnancy|1|||
146401083|NCT02118896|527972619|FG001|Overall Study|Pregnancy|1|||
146401084|NCT02118896|527972620|FG002|Overall Study|Pregnancy|0|||
146401085|NCT02118896|527972621|FG003|Overall Study|Pregnancy|0|||
146401086|NCT02118896|527972622|FG004|Overall Study|Pregnancy|1|||
146401087|NCT02118896|527972623|FG005|Overall Study|Pregnancy|3|||
146401088|NCT02118896|527972624|FG006|Overall Study|Pregnancy|1|||
146401089|NCT02118896|527972625|FG007|Overall Study|Pregnancy|0|||
146401090|NCT02118896|527972626|FG008|Overall Study|Pregnancy|0|||
146401091|NCT02118896|527972627|FG009|Overall Study|Pregnancy|0|||
146401092|NCT02118896|527972618|FG000|Overall Study|Lost to Follow-up|1|||
146401093|NCT02118896|527972619|FG001|Overall Study|Lost to Follow-up|2|||
146401094|NCT02118896|527972620|FG002|Overall Study|Lost to Follow-up|1|||
146401095|NCT02118896|527972621|FG003|Overall Study|Lost to Follow-up|0|||
146401096|NCT02118896|527972622|FG004|Overall Study|Lost to Follow-up|2|||
146401097|NCT02118896|527972623|FG005|Overall Study|Lost to Follow-up|1|||
146401098|NCT02118896|527972624|FG006|Overall Study|Lost to Follow-up|0|||
146401099|NCT02118896|527972625|FG007|Overall Study|Lost to Follow-up|0|||
146401100|NCT02118896|527972626|FG008|Overall Study|Lost to Follow-up|0|||
146401101|NCT02118896|527972627|FG009|Overall Study|Lost to Follow-up|0|||
146401102|NCT02118896|527972618|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
146401103|NCT02118896|527972619|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
146401104|NCT02118896|527972620|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
146401105|NCT02118896|527972621|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146401106|NCT02118896|527972622|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
146401107|NCT02118896|527972623|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146401108|NCT02118896|527972624|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146401109|NCT02118896|527972625|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146401110|NCT02118896|527972626|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
146401111|NCT02118896|527972627|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
146401112|NCT02118896|527972618|FG000|Overall Study|Prohibited medication|0|||
146401113|NCT02118896|527972619|FG001|Overall Study|Prohibited medication|0|||
146401114|NCT02118896|527972620|FG002|Overall Study|Prohibited medication|0|||
146401115|NCT02118896|527972621|FG003|Overall Study|Prohibited medication|0|||
146401116|NCT02118896|527972622|FG004|Overall Study|Prohibited medication|1|||
146401117|NCT02118896|527972623|FG005|Overall Study|Prohibited medication|3|||
146401118|NCT02118896|527972624|FG006|Overall Study|Prohibited medication|0|||
146401119|NCT02118896|527972625|FG007|Overall Study|Prohibited medication|0|||
146401120|NCT02118896|527972626|FG008|Overall Study|Prohibited medication|0|||
146401121|NCT02118896|527972627|FG009|Overall Study|Prohibited medication|0|||
146401122|NCT02118896|527972618|FG000|Overall Study|Miscellaneous|1|||
146061148|NCT01972217|526743331|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
146061149|NCT01972217|526743332|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
146061150|NCT01972217|526743329|FG000|Part B Double-blind, Randomised Period|Death|0|||
146061151|NCT01972217|526743330|FG001|Part B Double-blind, Randomised Period|Death|0|||
146061152|NCT01972217|526743331|FG002|Part B Double-blind, Randomised Period|Death|43|||
146061153|NCT01972217|526743332|FG003|Part B Double-blind, Randomised Period|Death|44|||
146061154|NCT01972217|526743329|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146061155|NCT01972217|526743330|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146061156|NCT01972217|526743331|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
146401123|NCT02118896|527972619|FG001|Overall Study|Miscellaneous|2|||
146061157|NCT01972217|526743332|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
146061158|NCT01972217|526743329|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
146061159|NCT01972217|526743330|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
146061160|NCT01972217|526743331|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
146061161|NCT01972217|526743332|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
146061162|NCT01972217|526743329|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
146061163|NCT01972217|526743330|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
146061164|NCT01972217|526743331|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
146061165|NCT01972217|526743332|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
146061166|NCT01972217|526743329|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146061167|NCT01972217|526743330|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146061168|NCT01972217|526743331|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
146061169|NCT01972217|526743332|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
146061170|NCT04328077|526743334|FG000|Overall Study|Lost to Follow-up|0|||
146061171|NCT04328077|526743335|FG001|Overall Study|Lost to Follow-up|1|||
146401124|NCT02118896|527972620|FG002|Overall Study|Miscellaneous|0|||
146401125|NCT02118896|527972621|FG003|Overall Study|Miscellaneous|2|||
146401126|NCT02118896|527972622|FG004|Overall Study|Miscellaneous|0|||
146401127|NCT02118896|527972623|FG005|Overall Study|Miscellaneous|4|||
146401128|NCT02118896|527972624|FG006|Overall Study|Miscellaneous|0|||
146401129|NCT02118896|527972625|FG007|Overall Study|Miscellaneous|0|||
146401130|NCT02118896|527972626|FG008|Overall Study|Miscellaneous|0|||
146401131|NCT02118896|527972627|FG009|Overall Study|Miscellaneous|0|||
146401132|NCT04242264|527972628|FG000|Overall Study|Lost to Follow-up|2|||
146401133|NCT04242264|527972629|FG001|Overall Study|Lost to Follow-up|2|||
146401134|NCT04242264|527972630|FG002|Overall Study|Lost to Follow-up|1|||
146401135|NCT04242264|527972631|FG003|Overall Study|Lost to Follow-up|1|||
146401136|NCT04242264|527972628|FG000|Overall Study|Withdrawal by Subject|1|||
146061172|NCT04328077|526743336|FG002|Overall Study|Lost to Follow-up|0|||
146061173|NCT04328077|526743337|FG003|Overall Study|Lost to Follow-up|0|||
146061174|NCT04328077|526743334|FG000|Overall Study|Withdrawal by Subject|0|||
146061175|NCT04328077|526743335|FG001|Overall Study|Withdrawal by Subject|1|||
146061176|NCT04328077|526743336|FG002|Overall Study|Withdrawal by Subject|1|||
146061177|NCT04328077|526743337|FG003|Overall Study|Withdrawal by Subject|3|||
146061178|NCT01456039|526743338|FG000|Phase 1 (First Step)|Disease Progression|1|||
146401137|NCT04242264|527972629|FG001|Overall Study|Withdrawal by Subject|0|||
146401138|NCT04242264|527972630|FG002|Overall Study|Withdrawal by Subject|0|||
146401139|NCT04242264|527972631|FG003|Overall Study|Withdrawal by Subject|0|||
146401140|NCT02116309|527972633|FG000|Overall Study|Lost to Follow-up|0|||
146401141|NCT02116309|527972634|FG001|Overall Study|Lost to Follow-up|1|||
146401142|NCT03292731|527972635|FG000|Overall Study|Protocol Violation|4|||
146401143|NCT03292731|527972636|FG001|Overall Study|Protocol Violation|11|||
146401144|NCT03292731|527972637|FG002|Overall Study|Protocol Violation|1|||
146401145|NCT00471237|527972638|FG000|Overall Study|Adverse Event|6|||
146401146|NCT00471237|527972639|FG001|Overall Study|Adverse Event|5|||
146401147|NCT00471237|527972640|FG002|Overall Study|Adverse Event|4|||
146401148|NCT00471237|527972641|FG003|Overall Study|Adverse Event|8|||
146401149|NCT00471237|527972642|FG004|Overall Study|Adverse Event|7|||
146401150|NCT00471237|527972643|FG005|Overall Study|Adverse Event|5|||
146401151|NCT00471237|527972644|FG006|Overall Study|Adverse Event|0|||
146401152|NCT00471237|527972638|FG000|Overall Study|Lost to Follow-up|1|||
146401153|NCT00471237|527972639|FG001|Overall Study|Lost to Follow-up|1|||
146401154|NCT00471237|527972640|FG002|Overall Study|Lost to Follow-up|0|||
146401155|NCT00471237|527972641|FG003|Overall Study|Lost to Follow-up|2|||
146401156|NCT00471237|527972642|FG004|Overall Study|Lost to Follow-up|3|||
146401157|NCT00471237|527972643|FG005|Overall Study|Lost to Follow-up|0|||
146401158|NCT00471237|527972644|FG006|Overall Study|Lost to Follow-up|0|||
146401159|NCT00471237|527972638|FG000|Overall Study|Protocol Violation|3|||
146401160|NCT00471237|527972639|FG001|Overall Study|Protocol Violation|6|||
146401161|NCT00471237|527972640|FG002|Overall Study|Protocol Violation|3|||
146401162|NCT00471237|527972641|FG003|Overall Study|Protocol Violation|2|||
146401163|NCT00471237|527972642|FG004|Overall Study|Protocol Violation|2|||
146401164|NCT00471237|527972643|FG005|Overall Study|Protocol Violation|4|||
146401165|NCT00471237|527972644|FG006|Overall Study|Protocol Violation|1|||
146401166|NCT00471237|527972638|FG000|Overall Study|Withdrawal by Subject|8|||
146401167|NCT00471237|527972639|FG001|Overall Study|Withdrawal by Subject|6|||
146401168|NCT00471237|527972640|FG002|Overall Study|Withdrawal by Subject|5|||
146401169|NCT00471237|527972641|FG003|Overall Study|Withdrawal by Subject|8|||
146401170|NCT00471237|527972642|FG004|Overall Study|Withdrawal by Subject|7|||
146401171|NCT00471237|527972643|FG005|Overall Study|Withdrawal by Subject|4|||
146401172|NCT00471237|527972644|FG006|Overall Study|Withdrawal by Subject|2|||
146401173|NCT00471237|527972638|FG000|Overall Study|Sponsor terminated study|20|||
146401174|NCT00471237|527972639|FG001|Overall Study|Sponsor terminated study|23|||
146401175|NCT00471237|527972640|FG002|Overall Study|Sponsor terminated study|19|||
146401176|NCT00471237|527972641|FG003|Overall Study|Sponsor terminated study|22|||
146401177|NCT00471237|527972642|FG004|Overall Study|Sponsor terminated study|18|||
146401178|NCT00471237|527972643|FG005|Overall Study|Sponsor terminated study|24|||
146401179|NCT00471237|527972644|FG006|Overall Study|Sponsor terminated study|0|||
146401180|NCT00471237|527972638|FG000|Overall Study|Non-compliance|0|||
146401181|NCT00471237|527972639|FG001|Overall Study|Non-compliance|1|||
146401182|NCT00471237|527972640|FG002|Overall Study|Non-compliance|0|||
146401183|NCT00471237|527972641|FG003|Overall Study|Non-compliance|1|||
146401184|NCT00471237|527972642|FG004|Overall Study|Non-compliance|0|||
146401185|NCT00471237|527972643|FG005|Overall Study|Non-compliance|0|||
146401186|NCT00471237|527972644|FG006|Overall Study|Non-compliance|0|||
146401187|NCT00471237|527972638|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
146401188|NCT00471237|527972639|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
146401189|NCT00471237|527972640|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
146401190|NCT00471237|527972641|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
146401191|NCT00471237|527972642|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
146401192|NCT00471237|527972643|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
146401193|NCT00471237|527972644|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
146401194|NCT00471237|527972638|FG000|Overall Study|Early stopping due to non-efficacy|1|||
146401195|NCT00471237|527972639|FG001|Overall Study|Early stopping due to non-efficacy|0|||
146401196|NCT00471237|527972640|FG002|Overall Study|Early stopping due to non-efficacy|0|||
146401197|NCT00471237|527972641|FG003|Overall Study|Early stopping due to non-efficacy|0|||
146401198|NCT00471237|527972642|FG004|Overall Study|Early stopping due to non-efficacy|1|||
146401199|NCT00471237|527972643|FG005|Overall Study|Early stopping due to non-efficacy|0|||
146401200|NCT00471237|527972644|FG006|Overall Study|Early stopping due to non-efficacy|0|||
146401201|NCT00471237|527972638|FG000|Overall Study|Participant planned to travel to abraod|1|||
146401202|NCT00471237|527972639|FG001|Overall Study|Participant planned to travel to abraod|0|||
146401203|NCT00471237|527972640|FG002|Overall Study|Participant planned to travel to abraod|0|||
146401204|NCT00471237|527972641|FG003|Overall Study|Participant planned to travel to abraod|0|||
146401205|NCT00471237|527972642|FG004|Overall Study|Participant planned to travel to abraod|0|||
146401206|NCT00471237|527972643|FG005|Overall Study|Participant planned to travel to abraod|1|||
146401207|NCT00471237|527972644|FG006|Overall Study|Participant planned to travel to abraod|0|||
146401208|NCT00471237|527972638|FG000|Overall Study|High parathyroid hormone|0|||
146401209|NCT00471237|527972639|FG001|Overall Study|High parathyroid hormone|0|||
146401210|NCT00471237|527972640|FG002|Overall Study|High parathyroid hormone|1|||
146401211|NCT00471237|527972641|FG003|Overall Study|High parathyroid hormone|0|||
146401212|NCT00471237|527972642|FG004|Overall Study|High parathyroid hormone|0|||
146401213|NCT00471237|527972643|FG005|Overall Study|High parathyroid hormone|0|||
146401214|NCT00471237|527972644|FG006|Overall Study|High parathyroid hormone|0|||
146401215|NCT00471237|527972638|FG000|Overall Study|Participant lost medication|0|||
146401216|NCT00471237|527972639|FG001|Overall Study|Participant lost medication|0|||
146401217|NCT00471237|527972640|FG002|Overall Study|Participant lost medication|0|||
146401218|NCT00471237|527972641|FG003|Overall Study|Participant lost medication|0|||
146401219|NCT00471237|527972642|FG004|Overall Study|Participant lost medication|1|||
146401220|NCT00471237|527972643|FG005|Overall Study|Participant lost medication|0|||
146401221|NCT00471237|527972644|FG006|Overall Study|Participant lost medication|0|||
146401222|NCT00471237|527972638|FG000|Overall Study|Administration of prohibited medicine|0|||
146401223|NCT00471237|527972639|FG001|Overall Study|Administration of prohibited medicine|0|||
146401224|NCT00471237|527972640|FG002|Overall Study|Administration of prohibited medicine|0|||
146401225|NCT00471237|527972641|FG003|Overall Study|Administration of prohibited medicine|0|||
146401226|NCT00471237|527972642|FG004|Overall Study|Administration of prohibited medicine|1|||
146401227|NCT00471237|527972643|FG005|Overall Study|Administration of prohibited medicine|0|||
146401228|NCT00471237|527972644|FG006|Overall Study|Administration of prohibited medicine|0|||
146401229|NCT00471237|527972638|FG000|Overall Study|Participant shifted residence|0|||
146401230|NCT00471237|527972639|FG001|Overall Study|Participant shifted residence|0|||
146401231|NCT00471237|527972640|FG002|Overall Study|Participant shifted residence|0|||
146401232|NCT00471237|527972641|FG003|Overall Study|Participant shifted residence|0|||
146401233|NCT00471237|527972642|FG004|Overall Study|Participant shifted residence|1|||
146401234|NCT00471237|527972643|FG005|Overall Study|Participant shifted residence|0|||
146401235|NCT00471237|527972644|FG006|Overall Study|Participant shifted residence|0|||
146401236|NCT00471237|527972638|FG000|Overall Study|Participant's decision|0|||
146401237|NCT00471237|527972639|FG001|Overall Study|Participant's decision|0|||
146401238|NCT00471237|527972640|FG002|Overall Study|Participant's decision|0|||
146061179|NCT01456039|526743339|FG001|Phase 1 (First Step)|Disease Progression|1|||
146061180|NCT01456039|526743340|FG002|Phase 1 (First Step)|Disease Progression|0|||
146061181|NCT01456039|526743338|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
146061182|NCT01456039|526743339|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
146061183|NCT01456039|526743340|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
146061184|NCT01456039|526743338|FG000|Phase 1 (First Step)|Adverse Event|0|||
146061185|NCT01456039|526743339|FG001|Phase 1 (First Step)|Adverse Event|3|||
146061186|NCT01456039|526743340|FG002|Phase 1 (First Step)|Adverse Event|0|||
146061187|NCT01456039|526743338|FG000|Phase 1 (First Step)|Other|0|||
146061188|NCT01456039|526743339|FG001|Phase 1 (First Step)|Other|1|||
146061189|NCT01456039|526743340|FG002|Phase 1 (First Step)|Other|0|||
146061190|NCT01456039|526743338|FG000|Phase 2 (Second Step)|Disease Progression|0|||
146061191|NCT01456039|526743339|FG001|Phase 2 (Second Step)|Disease Progression|0|||
146061192|NCT01456039|526743340|FG002|Phase 2 (Second Step)|Disease Progression|17|||
146061193|NCT01456039|526743338|FG000|Phase 2 (Second Step)|Adverse Event|0|||
146061194|NCT01456039|526743339|FG001|Phase 2 (Second Step)|Adverse Event|0|||
146061195|NCT01456039|526743340|FG002|Phase 2 (Second Step)|Adverse Event|10|||
146061196|NCT01456039|526743338|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
146061197|NCT01456039|526743339|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
146061198|NCT01456039|526743340|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
146061199|NCT01456039|526743338|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
146061200|NCT01456039|526743339|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
146061201|NCT01456039|526743340|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
146061202|NCT01456039|526743338|FG000|Phase 2 (Second Step)|Other|0|||
146061203|NCT01456039|526743339|FG001|Phase 2 (Second Step)|Other|0|||
146061204|NCT01456039|526743340|FG002|Phase 2 (Second Step)|Other|1|||
146061205|NCT00335777|526743343|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
146061206|NCT00335777|526743343|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
146061207|NCT00335777|526743343|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
146061208|NCT00335777|526743343|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
146061209|NCT00335777|526743343|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
146061210|NCT00939393|526743351|FG000|Overall Study|Withdrawal by Subject|1|||
146061211|NCT00939393|526743352|FG001|Overall Study|Withdrawal by Subject|0|||
146061212|NCT00939393|526743351|FG000|Overall Study|Lost to Follow-up|3|||
146061213|NCT00939393|526743352|FG001|Overall Study|Lost to Follow-up|0|||
146061214|NCT02851615|526743353|FG000|Overall Study|Cognitive Issue|1|||
146061215|NCT02851615|526743354|FG001|Overall Study|Cognitive Issue|0|||
146061216|NCT02851615|526743353|FG000|Overall Study|Lost to Follow-up|0|||
146061217|NCT02851615|526743354|FG001|Overall Study|Lost to Follow-up|4|||
146061218|NCT00313014|526743355|FG000|Overall Study|Withdrawal by Subject|11|||
146061219|NCT00313014|526743356|FG001|Overall Study|Withdrawal by Subject|7|||
146061220|NCT00313014|526743357|FG002|Overall Study|Withdrawal by Subject|5|||
146061221|NCT00313014|526743355|FG000|Overall Study|Adverse Event|14|||
146061222|NCT00313014|526743356|FG001|Overall Study|Adverse Event|29|||
146061223|NCT00313014|526743357|FG002|Overall Study|Adverse Event|16|||
146061224|NCT00313014|526743355|FG000|Overall Study|Lost to Follow-up|7|||
146061225|NCT00313014|526743356|FG001|Overall Study|Lost to Follow-up|6|||
146061226|NCT00313014|526743357|FG002|Overall Study|Lost to Follow-up|10|||
146061227|NCT00313014|526743355|FG000|Overall Study|Administrative|9|||
146061228|NCT00313014|526743356|FG001|Overall Study|Administrative|6|||
146061229|NCT00313014|526743357|FG002|Overall Study|Administrative|14|||
146061230|NCT00313014|526743355|FG000|Overall Study|Lack of Efficacy|52|||
146061231|NCT00313014|526743356|FG001|Overall Study|Lack of Efficacy|25|||
146401239|NCT00471237|527972641|FG003|Overall Study|Participant's decision|0|||
146401240|NCT00471237|527972642|FG004|Overall Study|Participant's decision|0|||
146061232|NCT00313014|526743357|FG002|Overall Study|Lack of Efficacy|16|||
146061233|NCT00371150|526743359|FG000|Overall Study|Lost to Follow-up|3|||
146061234|NCT00371150|526743360|FG001|Overall Study|Lost to Follow-up|2|||
146061235|NCT02345070|526743362|FG000|Overall Study|Adverse Event|12|||
146061236|NCT02345070|526743363|FG001|Overall Study|Adverse Event|8|||
146061237|NCT02345070|526743364|FG002|Overall Study|Adverse Event|16|||
146061238|NCT02345070|526743362|FG000|Overall Study|Poor compliance to protocol|2|||
146061239|NCT02345070|526743363|FG001|Overall Study|Poor compliance to protocol|0|||
146401241|NCT00471237|527972643|FG005|Overall Study|Participant's decision|1|||
146401242|NCT00471237|527972644|FG006|Overall Study|Participant's decision|0|||
146401243|NCT03710824|527972645|FG000|Overall Study|Withdrawal by Subject|1|||
146401244|NCT03710824|527972645|FG000|Overall Study|Lost to Follow-up|3|||
146401245|NCT03710824|527972645|FG000|Overall Study|Adverse Event|25|||
146401246|NCT03710824|527972645|FG000|Overall Study|Treatment discontinuation|2|||
146401247|NCT02329834|527972646|FG000|Overall Study|Physician Decision|1|||
146401248|NCT02329834|527972647|FG001|Overall Study|Physician Decision|0|||
146401249|NCT01317199|527972648|FG000|Dose-escalation Phase 1|Physician Decision|5|||
146061240|NCT02345070|526743364|FG002|Overall Study|Poor compliance to protocol|0|||
146061241|NCT02345070|526743362|FG000|Overall Study|Other than specified above|6|||
146061242|NCT02345070|526743363|FG001|Overall Study|Other than specified above|3|||
146061243|NCT02345070|526743364|FG002|Overall Study|Other than specified above|7|||
146401250|NCT01317199|527972649|FG001|Dose-escalation Phase 1|Physician Decision|0|||
146401251|NCT01317199|527972650|FG002|Dose-escalation Phase 1|Physician Decision|0|||
146401252|NCT01317199|527972651|FG003|Dose-escalation Phase 1|Physician Decision|0|||
146401253|NCT01317199|527972648|FG000|Dose-escalation Phase 1|Disease progression|1|||
146401254|NCT01317199|527972649|FG001|Dose-escalation Phase 1|Disease progression|0|||
146401255|NCT01317199|527972650|FG002|Dose-escalation Phase 1|Disease progression|0|||
146401256|NCT01317199|527972651|FG003|Dose-escalation Phase 1|Disease progression|0|||
146401257|NCT01317199|527972648|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
146401258|NCT01317199|527972649|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146401259|NCT01317199|527972650|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146401260|NCT01317199|527972651|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
146401261|NCT01317199|527972648|FG000|Randomized Phase 2|Disease progression|0|||
146401262|NCT01317199|527972649|FG001|Randomized Phase 2|Disease progression|3|||
146401263|NCT01317199|527972650|FG002|Randomized Phase 2|Disease progression|7|||
146401264|NCT01317199|527972651|FG003|Randomized Phase 2|Disease progression|5|||
146401265|NCT01317199|527972648|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
146401266|NCT01317199|527972649|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
146401267|NCT01317199|527972650|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
146401268|NCT01317199|527972651|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
146401269|NCT01317199|527972648|FG000|Randomized Phase 2|Adverse Event|0|||
146401270|NCT01317199|527972649|FG001|Randomized Phase 2|Adverse Event|0|||
146401271|NCT01317199|527972650|FG002|Randomized Phase 2|Adverse Event|0|||
146401272|NCT01317199|527972651|FG003|Randomized Phase 2|Adverse Event|1|||
146401273|NCT01317199|527972648|FG000|Randomized Phase 2|Comorbidities|0|||
146401274|NCT01317199|527972649|FG001|Randomized Phase 2|Comorbidities|2|||
146401275|NCT01317199|527972650|FG002|Randomized Phase 2|Comorbidities|2|||
146401276|NCT01317199|527972651|FG003|Randomized Phase 2|Comorbidities|2|||
146401277|NCT01317199|527972648|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
146401278|NCT01317199|527972649|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
146401279|NCT01317199|527972650|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
146401280|NCT01317199|527972651|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
146401281|NCT01317199|527972648|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
146401282|NCT01317199|527972649|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
146401283|NCT01317199|527972650|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
146401284|NCT01317199|527972651|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
146401285|NCT01317199|527972648|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
146401286|NCT01317199|527972649|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
146401287|NCT01317199|527972650|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
146401288|NCT01317199|527972651|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
146401289|NCT01317199|527972648|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
146401290|NCT01317199|527972649|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
146401291|NCT01317199|527972650|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
146401292|NCT01317199|527972651|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
146401293|NCT04139642|527972661|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
146401294|NCT04139642|527972662|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
146401295|NCT00138658|527972667|FG000|Overall Study|Adverse Event|23|||
146401296|NCT00138658|527972667|FG000|Overall Study|Death|1|||
146401297|NCT00138658|527972667|FG000|Overall Study|Disease Progression|21|||
146401298|NCT00138658|527972667|FG000|Overall Study|Physician Decision|11|||
146401299|NCT00138658|527972667|FG000|Overall Study|Withdrawal by Subject|5|||
146401300|NCT03733301|527972668|FG000|Overall Study|Screen Fail|1|||
146401301|NCT03733301|527972669|FG001|Overall Study|Screen Fail|0|||
146401302|NCT03733301|527972670|FG002|Overall Study|Screen Fail|0|||
146401303|NCT03733301|527972668|FG000|Overall Study|Non-compliance|1|||
146401304|NCT03733301|527972669|FG001|Overall Study|Non-compliance|0|||
146401305|NCT03733301|527972670|FG002|Overall Study|Non-compliance|0|||
146401306|NCT03733301|527972668|FG000|Overall Study|Lack of Efficacy|2|||
146401307|NCT03733301|527972669|FG001|Overall Study|Lack of Efficacy|3|||
146401308|NCT03733301|527972670|FG002|Overall Study|Lack of Efficacy|0|||
146401309|NCT03733301|527972668|FG000|Overall Study|Adverse Event|0|||
146401310|NCT03733301|527972669|FG001|Overall Study|Adverse Event|1|||
146401311|NCT03733301|527972670|FG002|Overall Study|Adverse Event|3|||
146401312|NCT03733301|527972668|FG000|Overall Study|Withdrawal by Subject|3|||
146401313|NCT03733301|527972669|FG001|Overall Study|Withdrawal by Subject|5|||
146401314|NCT03733301|527972670|FG002|Overall Study|Withdrawal by Subject|1|||
146401315|NCT02050373|527972671|FG000|Overall Study|Adverse Event|4|||
146061244|NCT03829228|526743367|FG000|Overall Study|Protocol Violation|1|||
146061245|NCT00408317|526743368|FG000|First Intervention Period|Adverse Event|0|||
146401316|NCT02050373|527972672|FG001|Overall Study|Adverse Event|7|||
146401317|NCT02050373|527972671|FG000|Overall Study|Death|3|||
146401318|NCT02050373|527972672|FG001|Overall Study|Death|3|||
146401319|NCT00557830|527972676|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
146401320|NCT00557830|527972677|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
146061246|NCT00408317|526743369|FG001|First Intervention Period|Adverse Event|1|||
146061247|NCT00408317|526743368|FG000|Second Intervention Period|Adverse Event|2|||
146401321|NCT00557830|527972678|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
146401322|NCT00557830|527972676|FG000|Screening Treatment Phase|Adverse Event|2|||
146401323|NCT00557830|527972677|FG001|Screening Treatment Phase|Adverse Event|0|||
146401324|NCT00557830|527972678|FG002|Screening Treatment Phase|Adverse Event|0|||
146401325|NCT00557830|527972676|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
146401326|NCT00557830|527972677|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
146401327|NCT00557830|527972678|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
146401328|NCT01803464|527972682|FG000|Overall Study|Incomplete data|0|||
146401329|NCT01803464|527972683|FG001|Overall Study|Incomplete data|0|||
146401330|NCT01803464|527972684|FG002|Overall Study|Incomplete data|4|||
146401331|NCT01803464|527972685|FG003|Overall Study|Incomplete data|0|||
146401332|NCT01803464|527972682|FG000|Overall Study|Withdrawal by Subject|1|||
146401333|NCT01803464|527972683|FG001|Overall Study|Withdrawal by Subject|0|||
146401334|NCT01803464|527972684|FG002|Overall Study|Withdrawal by Subject|0|||
146401335|NCT01803464|527972685|FG003|Overall Study|Withdrawal by Subject|0|||
146401336|NCT01856257|527972688|FG000|Overall Study|Death|2|||
146401337|NCT01856257|527972689|FG001|Overall Study|Death|0|||
146401338|NCT01856257|527972690|FG002|Overall Study|Death|0|||
146401339|NCT01856257|527972691|FG003|Overall Study|Death|0|||
146401340|NCT01856257|527972688|FG000|Overall Study|Physician Decision|0|||
146061248|NCT00408317|526743369|FG001|Second Intervention Period|Adverse Event|0|||
146061249|NCT00408317|526743368|FG000|Second Intervention Period|Protocol Violation|0|||
146061250|NCT00408317|526743369|FG001|Second Intervention Period|Protocol Violation|1|||
146061251|NCT00408317|526743368|FG000|Second Intervention Period|Withdrawal of consent|0|||
146061252|NCT00408317|526743369|FG001|Second Intervention Period|Withdrawal of consent|1|||
146061253|NCT00473564|526743370|FG000|Overall Study|robot surgery aborted in OR|23|||
146061254|NCT03131219|526743372|FG000|Initial Evaluation Period|Adverse Event|2|||
146061255|NCT03131219|526743373|FG001|Initial Evaluation Period|Adverse Event|0|||
146061256|NCT03131219|526743372|FG000|Initial Evaluation Period|Protocol Violation|1|||
146061257|NCT03131219|526743373|FG001|Initial Evaluation Period|Protocol Violation|0|||
146061258|NCT03131219|526743372|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
146061259|NCT03131219|526743373|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
146061260|NCT03131219|526743372|FG000|Initial Evaluation Period|Physician Decision|1|||
146061261|NCT03131219|526743373|FG001|Initial Evaluation Period|Physician Decision|0|||
146061262|NCT03131219|526743372|FG000|Extension Period|Physician Decision|1|||
146061263|NCT03131219|526743373|FG001|Extension Period|Physician Decision|0|||
146061264|NCT00616759|526743374|FG000|Overall Study|Physician Decision|2|||
146061265|NCT00616759|526743375|FG001|Overall Study|Physician Decision|0|||
146061266|NCT00616759|526743374|FG000|Overall Study|Withdrawal by Subject|1|||
146061267|NCT00616759|526743375|FG001|Overall Study|Withdrawal by Subject|2|||
146061268|NCT00981656|526743389|FG000|Overall Study|Protocol Violation|1|||
146061269|NCT00981656|526743389|FG000|Overall Study|Did not start protocol treatment|2|||
146061270|NCT02903771|526743390|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
146061271|NCT02903771|526743391|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
146061272|NCT02903771|526743392|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
146061273|NCT02903771|526743393|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
146061274|NCT02903771|526743394|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
146061275|NCT02903771|526743395|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
146061276|NCT02903771|526743396|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
146061277|NCT02903771|526743390|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061278|NCT02903771|526743391|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
146061279|NCT02903771|526743392|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061280|NCT02903771|526743393|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061281|NCT02903771|526743394|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061282|NCT02903771|526743395|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061283|NCT02903771|526743396|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
146061284|NCT02903771|526743390|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146061285|NCT02903771|526743391|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146401341|NCT01856257|527972689|FG001|Overall Study|Physician Decision|0|||
146401342|NCT01856257|527972690|FG002|Overall Study|Physician Decision|0|||
146401343|NCT01856257|527972691|FG003|Overall Study|Physician Decision|1|||
146401344|NCT01856257|527972688|FG000|Overall Study|Withdrawal by Subject|1|||
146061286|NCT02903771|526743392|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
146061287|NCT02903771|526743393|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146061288|NCT02903771|526743394|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146401345|NCT01856257|527972689|FG001|Overall Study|Withdrawal by Subject|1|||
146401346|NCT01856257|527972690|FG002|Overall Study|Withdrawal by Subject|0|||
146401347|NCT01856257|527972691|FG003|Overall Study|Withdrawal by Subject|0|||
146401348|NCT01856257|527972688|FG000|Overall Study|Donor complication|0|||
146401349|NCT01856257|527972689|FG001|Overall Study|Donor complication|0|||
146401350|NCT01856257|527972690|FG002|Overall Study|Donor complication|0|||
146401351|NCT01856257|527972691|FG003|Overall Study|Donor complication|1|||
146401352|NCT03664024|527972695|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
146401353|NCT03664024|527972695|FG000|Overall Study|Lost to Follow-up|2|||
146401354|NCT03664024|527972695|FG000|Overall Study|Withdrawal by Subject|2|||
146401355|NCT03664024|527972695|FG000|Overall Study|Death|80|||
146401356|NCT01157065|527972696|FG000|Overall Study|Death|0|||
146401357|NCT01157065|527972697|FG001|Overall Study|Death|1|||
146401358|NCT05275673|527972700|FG000|Overall Study|Study Termination by Sponsor|2|||
146401359|NCT05275673|527972701|FG001|Overall Study|Study Termination by Sponsor|3|||
146401360|NCT05275673|527972700|FG000|Overall Study|Death|1|||
146401361|NCT05275673|527972701|FG001|Overall Study|Death|0|||
146401362|NCT05275673|527972700|FG000|Overall Study|Withdrawal by Subject|1|||
146401363|NCT05275673|527972701|FG001|Overall Study|Withdrawal by Subject|0|||
146401364|NCT02325739|527972702|FG000|Phase I Part|Adverse Event|1|||
146401365|NCT02325739|527972703|FG001|Phase I Part|Adverse Event|0|||
146401366|NCT02325739|527972704|FG002|Phase I Part|Adverse Event|1|||
146401367|NCT02325739|527972705|FG003|Phase I Part|Adverse Event|2|||
146401368|NCT02325739|527972706|FG004|Phase I Part|Adverse Event|3|||
146401369|NCT02325739|527972707|FG005|Phase I Part|Adverse Event|1|||
146401370|NCT02325739|527972708|FG006|Phase I Part|Adverse Event|0|||
146401371|NCT02325739|527972709|FG007|Phase I Part|Adverse Event|2|||
146401372|NCT02325739|527972710|FG008|Phase I Part|Adverse Event|0|||
146401373|NCT02325739|527972711|FG009|Phase I Part|Adverse Event|0|||
146401374|NCT02325739|527972712|FG010|Phase I Part|Adverse Event|0|||
146401375|NCT02325739|527972702|FG000|Phase I Part|Progressive disease|9|||
146401376|NCT02325739|527972703|FG001|Phase I Part|Progressive disease|6|||
146401377|NCT02325739|527972704|FG002|Phase I Part|Progressive disease|3|||
146401378|NCT02325739|527972705|FG003|Phase I Part|Progressive disease|23|||
146401379|NCT02325739|527972706|FG004|Phase I Part|Progressive disease|14|||
146401380|NCT02325739|527972707|FG005|Phase I Part|Progressive disease|6|||
146169886|NCT05044325|527134725|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169887|NCT05044325|527134726|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169888|NCT05044325|527134727|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146401381|NCT02325739|527972708|FG006|Phase I Part|Progressive disease|6|||
146401382|NCT02325739|527972709|FG007|Phase I Part|Progressive disease|3|||
146401383|NCT02325739|527972710|FG008|Phase I Part|Progressive disease|0|||
146401384|NCT02325739|527972711|FG009|Phase I Part|Progressive disease|0|||
146401385|NCT02325739|527972712|FG010|Phase I Part|Progressive disease|0|||
146401386|NCT02325739|527972702|FG000|Phase I Part|Subject/guardian decision|1|||
146401387|NCT02325739|527972703|FG001|Phase I Part|Subject/guardian decision|0|||
146401388|NCT02325739|527972704|FG002|Phase I Part|Subject/guardian decision|1|||
146401389|NCT02325739|527972705|FG003|Phase I Part|Subject/guardian decision|1|||
146401390|NCT02325739|527972706|FG004|Phase I Part|Subject/guardian decision|0|||
146401391|NCT02325739|527972707|FG005|Phase I Part|Subject/guardian decision|0|||
146401392|NCT02325739|527972708|FG006|Phase I Part|Subject/guardian decision|0|||
146401393|NCT02325739|527972709|FG007|Phase I Part|Subject/guardian decision|1|||
146401394|NCT02325739|527972710|FG008|Phase I Part|Subject/guardian decision|0|||
146401395|NCT02325739|527972711|FG009|Phase I Part|Subject/guardian decision|0|||
146401396|NCT02325739|527972712|FG010|Phase I Part|Subject/guardian decision|0|||
146401397|NCT02325739|527972702|FG000|Phase I Part|Death|0|||
146401398|NCT02325739|527972703|FG001|Phase I Part|Death|0|||
146401399|NCT02325739|527972704|FG002|Phase I Part|Death|0|||
146401400|NCT02325739|527972705|FG003|Phase I Part|Death|0|||
146401401|NCT02325739|527972706|FG004|Phase I Part|Death|2|||
146401402|NCT02325739|527972707|FG005|Phase I Part|Death|0|||
146401403|NCT02325739|527972708|FG006|Phase I Part|Death|0|||
146401404|NCT02325739|527972709|FG007|Phase I Part|Death|0|||
146401405|NCT02325739|527972710|FG008|Phase I Part|Death|0|||
146401406|NCT02325739|527972711|FG009|Phase I Part|Death|0|||
146401407|NCT02325739|527972712|FG010|Phase I Part|Death|0|||
146401408|NCT02325739|527972702|FG000|Phase II Part|Adverse Event|0|||
146401409|NCT02325739|527972703|FG001|Phase II Part|Adverse Event|0|||
146401410|NCT02325739|527972704|FG002|Phase II Part|Adverse Event|0|||
146401411|NCT02325739|527972705|FG003|Phase II Part|Adverse Event|0|||
146401412|NCT02325739|527972706|FG004|Phase II Part|Adverse Event|0|||
146401413|NCT02325739|527972707|FG005|Phase II Part|Adverse Event|0|||
146401414|NCT02325739|527972708|FG006|Phase II Part|Adverse Event|0|||
146401415|NCT02325739|527972709|FG007|Phase II Part|Adverse Event|0|||
146401416|NCT02325739|527972710|FG008|Phase II Part|Adverse Event|4|||
146401417|NCT02325739|527972711|FG009|Phase II Part|Adverse Event|5|||
146401418|NCT02325739|527972712|FG010|Phase II Part|Adverse Event|1|||
146401419|NCT02325739|527972702|FG000|Phase II Part|Physician Decision|0|||
146401420|NCT02325739|527972703|FG001|Phase II Part|Physician Decision|0|||
146401421|NCT02325739|527972704|FG002|Phase II Part|Physician Decision|0|||
146401422|NCT02325739|527972705|FG003|Phase II Part|Physician Decision|0|||
146401423|NCT02325739|527972706|FG004|Phase II Part|Physician Decision|0|||
146401424|NCT02325739|527972707|FG005|Phase II Part|Physician Decision|0|||
146401425|NCT02325739|527972708|FG006|Phase II Part|Physician Decision|0|||
146401426|NCT02325739|527972709|FG007|Phase II Part|Physician Decision|0|||
146401427|NCT02325739|527972710|FG008|Phase II Part|Physician Decision|0|||
146061289|NCT02903771|526743395|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
146061290|NCT02903771|526743396|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
146061291|NCT02903771|526743390|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061292|NCT02903771|526743391|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061293|NCT02903771|526743392|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061294|NCT02903771|526743393|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061295|NCT02903771|526743394|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
146061296|NCT02903771|526743395|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061297|NCT02903771|526743396|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
146061298|NCT02903771|526743390|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061299|NCT02903771|526743391|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061300|NCT02903771|526743392|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061301|NCT02903771|526743393|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061302|NCT02903771|526743394|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061303|NCT02903771|526743395|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
146061304|NCT02903771|526743396|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
146061305|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061306|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061307|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061308|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061309|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
146061310|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061311|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
146061312|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061313|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061314|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061315|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061316|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
146061317|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061318|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
146061319|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061320|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061321|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061322|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061323|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
146061324|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061325|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
146061326|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146061327|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146061328|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146061329|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146061330|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
146061331|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146061332|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
146401428|NCT02325739|527972711|FG009|Phase II Part|Physician Decision|1|||
146401429|NCT02325739|527972712|FG010|Phase II Part|Physician Decision|0|||
146401430|NCT02325739|527972702|FG000|Phase II Part|Progressive disease|0|||
146401431|NCT02325739|527972703|FG001|Phase II Part|Progressive disease|0|||
146401432|NCT02325739|527972704|FG002|Phase II Part|Progressive disease|0|||
146401433|NCT02325739|527972705|FG003|Phase II Part|Progressive disease|0|||
146401434|NCT02325739|527972706|FG004|Phase II Part|Progressive disease|0|||
146401435|NCT02325739|527972707|FG005|Phase II Part|Progressive disease|0|||
146401436|NCT02325739|527972708|FG006|Phase II Part|Progressive disease|0|||
146401437|NCT02325739|527972709|FG007|Phase II Part|Progressive disease|0|||
146401438|NCT02325739|527972710|FG008|Phase II Part|Progressive disease|22|||
146401439|NCT02325739|527972711|FG009|Phase II Part|Progressive disease|29|||
146401440|NCT02325739|527972712|FG010|Phase II Part|Progressive disease|18|||
146401441|NCT02325739|527972702|FG000|Phase II Part|Subject/guardian decision|0|||
146401442|NCT02325739|527972703|FG001|Phase II Part|Subject/guardian decision|0|||
146401443|NCT02325739|527972704|FG002|Phase II Part|Subject/guardian decision|0|||
146401444|NCT02325739|527972705|FG003|Phase II Part|Subject/guardian decision|0|||
146401445|NCT02325739|527972706|FG004|Phase II Part|Subject/guardian decision|0|||
146401446|NCT02325739|527972707|FG005|Phase II Part|Subject/guardian decision|0|||
146401447|NCT02325739|527972708|FG006|Phase II Part|Subject/guardian decision|0|||
146401448|NCT02325739|527972709|FG007|Phase II Part|Subject/guardian decision|0|||
146401449|NCT02325739|527972710|FG008|Phase II Part|Subject/guardian decision|4|||
146401450|NCT02325739|527972711|FG009|Phase II Part|Subject/guardian decision|1|||
146401451|NCT02325739|527972712|FG010|Phase II Part|Subject/guardian decision|1|||
146401452|NCT00227591|527972713|FG000|Overall Study|Withdrawal by Subject|1|||
146401453|NCT01886105|527972714|FG000|Overall Study|Lack of Efficacy|3|||
146401454|NCT02057549|527972716|FG000|Overall Study|Lost to Follow-up|1|||
146401455|NCT02057549|527972717|FG001|Overall Study|Lost to Follow-up|0|||
146401456|NCT02057549|527972716|FG000|Overall Study|Physician Decision|1|||
146401457|NCT02057549|527972717|FG001|Overall Study|Physician Decision|0|||
146401458|NCT02057549|527972716|FG000|Overall Study|Withdrawal by Subject|1|||
146401459|NCT02057549|527972717|FG001|Overall Study|Withdrawal by Subject|0|||
146401460|NCT03843775|527972720|FG000|Overall Study|Adverse Event|1|||
146401461|NCT03843775|527972721|FG001|Overall Study|Adverse Event|1|||
146401462|NCT03843775|527972720|FG000|Overall Study|Lack of Efficacy|2|||
146401463|NCT03843775|527972721|FG001|Overall Study|Lack of Efficacy|6|||
146401464|NCT03843775|527972720|FG000|Overall Study|Withdrawal by Subject|0|||
146401465|NCT03843775|527972721|FG001|Overall Study|Withdrawal by Subject|1|||
146401466|NCT00530621|527972725|FG000|Overall Study|Adverse Event|11|||
146401467|NCT00530621|527972726|FG001|Overall Study|Adverse Event|8|||
146401468|NCT00530621|527972725|FG000|Overall Study|Physician Decision|2|||
146401469|NCT00530621|527972726|FG001|Overall Study|Physician Decision|4|||
146401470|NCT00530621|527972725|FG000|Overall Study|Progressive Disease (PD)|47|||
146401471|NCT00530621|527972726|FG001|Overall Study|Progressive Disease (PD)|40|||
146401472|NCT00530621|527972725|FG000|Overall Study|Sponsor Decision|12|||
146401473|NCT00530621|527972726|FG001|Overall Study|Sponsor Decision|15|||
146401474|NCT00530621|527972725|FG000|Overall Study|Subject Decision|4|||
146401475|NCT00530621|527972726|FG001|Overall Study|Subject Decision|7|||
146401476|NCT00530621|527972725|FG000|Overall Study|Death|3|||
146401477|NCT00530621|527972726|FG001|Overall Study|Death|6|||
146401478|NCT00530621|527972725|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
146401479|NCT00530621|527972726|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
146401480|NCT04611152|527972727|FG000|Overall Study|Adverse Event|9|||
146401481|NCT04611152|527972728|FG001|Overall Study|Adverse Event|8|||
146401482|NCT04611152|527972727|FG000|Overall Study|Non-compliance with study schedule|1|||
146401483|NCT04611152|527972728|FG001|Overall Study|Non-compliance with study schedule|3|||
146401484|NCT04611152|527972727|FG000|Overall Study|Withdrawal by Subject|5|||
146401485|NCT04611152|527972728|FG001|Overall Study|Withdrawal by Subject|6|||
146401486|NCT04611152|527972727|FG000|Overall Study|Lost to Follow-up|11|||
146401487|NCT04611152|527972728|FG001|Overall Study|Lost to Follow-up|2|||
146401488|NCT00605839|527972736|FG000|Overall Study|Protocol Violation|1|||
146401489|NCT00605839|527972737|FG001|Overall Study|Protocol Violation|0|||
146401490|NCT00605839|527972738|FG002|Overall Study|Protocol Violation|0|||
146401491|NCT03917654|527972739|FG000|Year 1|Withdrawal by Subject|1|||
146401492|NCT03917654|527972740|FG001|Year 1|Withdrawal by Subject|0|||
146401493|NCT03917654|527972741|FG002|Year 1|Withdrawal by Subject|0|||
146401494|NCT03917654|527972742|FG003|Year 1|Withdrawal by Subject|0|||
146401495|NCT03917654|527972743|FG004|Year 1|Withdrawal by Subject|0|||
146401496|NCT03917654|527972744|FG005|Year 1|Withdrawal by Subject|1|||
146401497|NCT03917654|527972745|FG006|Year 1|Withdrawal by Subject|6|||
146401498|NCT03917654|527972746|FG007|Year 1|Withdrawal by Subject|2|||
146401499|NCT03917654|527972747|FG008|Year 1|Withdrawal by Subject|5|||
146401500|NCT03917654|527972748|FG009|Year 1|Withdrawal by Subject|3|||
146401501|NCT03917654|527972749|FG010|Year 1|Withdrawal by Subject|1|||
146401502|NCT03917654|527972750|FG011|Year 1|Withdrawal by Subject|0|||
146401503|NCT03917654|527972739|FG000|Year 1|Travel|0|||
146401504|NCT03917654|527972740|FG001|Year 1|Travel|1|||
146401505|NCT03917654|527972741|FG002|Year 1|Travel|1|||
146401506|NCT03917654|527972742|FG003|Year 1|Travel|0|||
146061333|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061334|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061335|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061336|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061337|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
146061338|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061339|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
146061340|NCT02903771|526743390|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061341|NCT02903771|526743391|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061342|NCT02903771|526743392|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061343|NCT02903771|526743393|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061344|NCT02903771|526743394|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
146061345|NCT02903771|526743395|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061346|NCT02903771|526743396|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
146061347|NCT01709721|526743397|FG000|Open Label Phase|Withdrawal by Subject|0|||
146061348|NCT01709721|526743398|FG001|Open Label Phase|Withdrawal by Subject|0|||
146061349|NCT01709721|526743399|FG002|Open Label Phase|Withdrawal by Subject|5|||
146061350|NCT01709721|526743397|FG000|Open Label Phase|Adverse Event|0|||
146401507|NCT03917654|527972743|FG004|Year 1|Travel|4|||
146401508|NCT03917654|527972744|FG005|Year 1|Travel|4|||
146401509|NCT03917654|527972745|FG006|Year 1|Travel|10|||
146401510|NCT03917654|527972746|FG007|Year 1|Travel|8|||
146401511|NCT03917654|527972747|FG008|Year 1|Travel|2|||
146401512|NCT03917654|527972748|FG009|Year 1|Travel|5|||
146401513|NCT03917654|527972749|FG010|Year 1|Travel|3|||
146061351|NCT01709721|526743398|FG001|Open Label Phase|Adverse Event|0|||
146061352|NCT01709721|526743399|FG002|Open Label Phase|Adverse Event|8|||
146061353|NCT01709721|526743397|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
146061354|NCT01709721|526743398|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
146061355|NCT01709721|526743399|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
146061356|NCT01709721|526743397|FG000|Open Label Phase|Investigator Decision|0|||
146061357|NCT01709721|526743398|FG001|Open Label Phase|Investigator Decision|0|||
146061358|NCT01709721|526743399|FG002|Open Label Phase|Investigator Decision|1|||
146061359|NCT01709721|526743397|FG000|Open Label Phase|Sponsor Decision|0|||
146061360|NCT01709721|526743398|FG001|Open Label Phase|Sponsor Decision|0|||
146061361|NCT01709721|526743399|FG002|Open Label Phase|Sponsor Decision|2|||
146061362|NCT01709721|526743397|FG000|Open Label Phase|Protocol Violation|0|||
146061363|NCT01709721|526743398|FG001|Open Label Phase|Protocol Violation|0|||
146061364|NCT01709721|526743399|FG002|Open Label Phase|Protocol Violation|1|||
146061365|NCT01709721|526743397|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
146401514|NCT03917654|527972750|FG011|Year 1|Travel|3|||
146401515|NCT03917654|527972739|FG000|Year 1|Subject moved away from site|0|||
146401516|NCT03917654|527972740|FG001|Year 1|Subject moved away from site|1|||
146401517|NCT03917654|527972741|FG002|Year 1|Subject moved away from site|0|||
146401518|NCT03917654|527972742|FG003|Year 1|Subject moved away from site|0|||
146401519|NCT03917654|527972743|FG004|Year 1|Subject moved away from site|0|||
146401520|NCT03917654|527972744|FG005|Year 1|Subject moved away from site|0|||
146401521|NCT03917654|527972745|FG006|Year 1|Subject moved away from site|1|||
146401522|NCT03917654|527972746|FG007|Year 1|Subject moved away from site|2|||
146401523|NCT03917654|527972747|FG008|Year 1|Subject moved away from site|1|||
146401524|NCT03917654|527972748|FG009|Year 1|Subject moved away from site|0|||
146401525|NCT03917654|527972749|FG010|Year 1|Subject moved away from site|0|||
146401526|NCT03917654|527972750|FG011|Year 1|Subject moved away from site|3|||
146401527|NCT03917654|527972739|FG000|Year 1|Spouse/Family member request|0|||
146401528|NCT03917654|527972740|FG001|Year 1|Spouse/Family member request|0|||
146401529|NCT03917654|527972741|FG002|Year 1|Spouse/Family member request|1|||
146401530|NCT03917654|527972742|FG003|Year 1|Spouse/Family member request|0|||
146401531|NCT03917654|527972743|FG004|Year 1|Spouse/Family member request|1|||
146401532|NCT03917654|527972744|FG005|Year 1|Spouse/Family member request|0|||
146401533|NCT03917654|527972745|FG006|Year 1|Spouse/Family member request|0|||
146401534|NCT03917654|527972746|FG007|Year 1|Spouse/Family member request|2|||
146401535|NCT03917654|527972747|FG008|Year 1|Spouse/Family member request|0|||
146401536|NCT03917654|527972748|FG009|Year 1|Spouse/Family member request|0|||
146401537|NCT03917654|527972749|FG010|Year 1|Spouse/Family member request|0|||
146401538|NCT03917654|527972750|FG011|Year 1|Spouse/Family member request|1|||
146401539|NCT03917654|527972739|FG000|Year 1|Death|0|||
146401540|NCT03917654|527972740|FG001|Year 1|Death|0|||
146401541|NCT03917654|527972741|FG002|Year 1|Death|0|||
146401542|NCT03917654|527972742|FG003|Year 1|Death|0|||
146401543|NCT03917654|527972743|FG004|Year 1|Death|0|||
146401544|NCT03917654|527972744|FG005|Year 1|Death|0|||
146401545|NCT03917654|527972745|FG006|Year 1|Death|0|||
146401546|NCT03917654|527972746|FG007|Year 1|Death|0|||
146401547|NCT03917654|527972747|FG008|Year 1|Death|1|||
146401548|NCT03917654|527972748|FG009|Year 1|Death|1|||
146401549|NCT03917654|527972749|FG010|Year 1|Death|0|||
146401550|NCT03917654|527972750|FG011|Year 1|Death|0|||
146401551|NCT03917654|527972739|FG000|Year 1|Lost to Follow-up|0|||
146401552|NCT03917654|527972740|FG001|Year 1|Lost to Follow-up|0|||
146401553|NCT03917654|527972741|FG002|Year 1|Lost to Follow-up|0|||
146401554|NCT03917654|527972742|FG003|Year 1|Lost to Follow-up|0|||
146401555|NCT03917654|527972743|FG004|Year 1|Lost to Follow-up|0|||
146401556|NCT03917654|527972744|FG005|Year 1|Lost to Follow-up|0|||
146401557|NCT03917654|527972745|FG006|Year 1|Lost to Follow-up|2|||
146401558|NCT03917654|527972746|FG007|Year 1|Lost to Follow-up|0|||
146401559|NCT03917654|527972747|FG008|Year 1|Lost to Follow-up|0|||
146401560|NCT03917654|527972748|FG009|Year 1|Lost to Follow-up|0|||
146401561|NCT03917654|527972749|FG010|Year 1|Lost to Follow-up|0|||
146401562|NCT03917654|527972750|FG011|Year 1|Lost to Follow-up|0|||
146401563|NCT03917654|527972739|FG000|Year 1|Missed visits|0|||
146401564|NCT03917654|527972740|FG001|Year 1|Missed visits|0|||
146401565|NCT03917654|527972741|FG002|Year 1|Missed visits|0|||
146401566|NCT03917654|527972742|FG003|Year 1|Missed visits|0|||
146401567|NCT03917654|527972743|FG004|Year 1|Missed visits|0|||
146401568|NCT03917654|527972744|FG005|Year 1|Missed visits|0|||
146087734|NCT04393298|526841814|FG004|Overall Study|Patient Discharged to Hospice|0|||
146087735|NCT04393298|526841815|FG005|Overall Study|Patient Discharged to Hospice|0|||
146401569|NCT03917654|527972745|FG006|Year 1|Missed visits|0|||
146401570|NCT03917654|527972746|FG007|Year 1|Missed visits|0|||
146401571|NCT03917654|527972747|FG008|Year 1|Missed visits|0|||
146401572|NCT03917654|527972748|FG009|Year 1|Missed visits|0|||
146401573|NCT03917654|527972749|FG010|Year 1|Missed visits|1|||
146401574|NCT03917654|527972750|FG011|Year 1|Missed visits|1|||
146087736|NCT04393298|526841816|FG006|Overall Study|Patient Discharged to Hospice|0|||
146401575|NCT03917654|527972739|FG000|Year 1|Pregnancy|0|||
146401576|NCT03917654|527972740|FG001|Year 1|Pregnancy|0|||
146401577|NCT03917654|527972741|FG002|Year 1|Pregnancy|0|||
146401578|NCT03917654|527972742|FG003|Year 1|Pregnancy|0|||
146401579|NCT03917654|527972743|FG004|Year 1|Pregnancy|0|||
146401580|NCT03917654|527972744|FG005|Year 1|Pregnancy|0|||
146401581|NCT03917654|527972745|FG006|Year 1|Pregnancy|0|||
146401582|NCT03917654|527972746|FG007|Year 1|Pregnancy|1|||
146401583|NCT03917654|527972747|FG008|Year 1|Pregnancy|0|||
146401584|NCT03917654|527972748|FG009|Year 1|Pregnancy|1|||
146401585|NCT03917654|527972749|FG010|Year 1|Pregnancy|0|||
146401586|NCT03917654|527972750|FG011|Year 1|Pregnancy|0|||
146401587|NCT03917654|527972739|FG000|Year 2|Travel|1|||
146401588|NCT03917654|527972740|FG001|Year 2|Travel|0|||
146401589|NCT03917654|527972741|FG002|Year 2|Travel|0|||
146401590|NCT03917654|527972742|FG003|Year 2|Travel|0|||
146401591|NCT03917654|527972743|FG004|Year 2|Travel|1|||
146401592|NCT03917654|527972744|FG005|Year 2|Travel|1|||
146401593|NCT03917654|527972745|FG006|Year 2|Travel|2|||
146401594|NCT03917654|527972746|FG007|Year 2|Travel|1|||
146401595|NCT03917654|527972747|FG008|Year 2|Travel|0|||
146401596|NCT03917654|527972748|FG009|Year 2|Travel|1|||
146401597|NCT03917654|527972749|FG010|Year 2|Travel|0|||
146401598|NCT03917654|527972750|FG011|Year 2|Travel|1|||
146401599|NCT03917654|527972739|FG000|Year 2|Married|1|||
146401600|NCT03917654|527972740|FG001|Year 2|Married|0|||
146401601|NCT03917654|527972741|FG002|Year 2|Married|0|||
146401602|NCT03917654|527972742|FG003|Year 2|Married|0|||
146401603|NCT03917654|527972743|FG004|Year 2|Married|0|||
146401604|NCT03917654|527972744|FG005|Year 2|Married|0|||
146401605|NCT03917654|527972745|FG006|Year 2|Married|1|||
146401606|NCT03917654|527972746|FG007|Year 2|Married|1|||
146401607|NCT03917654|527972747|FG008|Year 2|Married|0|||
146401608|NCT03917654|527972748|FG009|Year 2|Married|0|||
146401609|NCT03917654|527972749|FG010|Year 2|Married|0|||
146401610|NCT03917654|527972750|FG011|Year 2|Married|0|||
146401611|NCT03917654|527972739|FG000|Year 2|Subject moved away from site|1|||
146401612|NCT03917654|527972740|FG001|Year 2|Subject moved away from site|0|||
146401613|NCT03917654|527972741|FG002|Year 2|Subject moved away from site|0|||
146401614|NCT03917654|527972742|FG003|Year 2|Subject moved away from site|0|||
146401615|NCT03917654|527972743|FG004|Year 2|Subject moved away from site|1|||
146401616|NCT03917654|527972744|FG005|Year 2|Subject moved away from site|0|||
146401617|NCT03917654|527972745|FG006|Year 2|Subject moved away from site|2|||
146401618|NCT03917654|527972746|FG007|Year 2|Subject moved away from site|3|||
146401619|NCT03917654|527972747|FG008|Year 2|Subject moved away from site|0|||
146401620|NCT03917654|527972748|FG009|Year 2|Subject moved away from site|2|||
146401621|NCT03917654|527972749|FG010|Year 2|Subject moved away from site|0|||
146401622|NCT03917654|527972750|FG011|Year 2|Subject moved away from site|1|||
146401623|NCT03917654|527972739|FG000|Year 2|Year 2 Screening failure|0|||
146401624|NCT03917654|527972740|FG001|Year 2|Year 2 Screening failure|1|||
146401625|NCT03917654|527972741|FG002|Year 2|Year 2 Screening failure|0|||
146401626|NCT03917654|527972742|FG003|Year 2|Year 2 Screening failure|0|||
146401627|NCT03917654|527972743|FG004|Year 2|Year 2 Screening failure|2|||
146401628|NCT03917654|527972744|FG005|Year 2|Year 2 Screening failure|0|||
146401629|NCT03917654|527972745|FG006|Year 2|Year 2 Screening failure|4|||
146401630|NCT03917654|527972746|FG007|Year 2|Year 2 Screening failure|3|||
146401631|NCT03917654|527972747|FG008|Year 2|Year 2 Screening failure|10|||
146401632|NCT03917654|527972748|FG009|Year 2|Year 2 Screening failure|2|||
146401633|NCT03917654|527972749|FG010|Year 2|Year 2 Screening failure|1|||
146401634|NCT03917654|527972750|FG011|Year 2|Year 2 Screening failure|1|||
146401635|NCT03917654|527972739|FG000|Year 2|Death|0|||
146401636|NCT03917654|527972740|FG001|Year 2|Death|0|||
146401637|NCT03917654|527972741|FG002|Year 2|Death|0|||
146401638|NCT03917654|527972742|FG003|Year 2|Death|0|||
146401639|NCT03917654|527972743|FG004|Year 2|Death|0|||
146401640|NCT03917654|527972744|FG005|Year 2|Death|1|||
146401641|NCT03917654|527972745|FG006|Year 2|Death|0|||
146401642|NCT03917654|527972746|FG007|Year 2|Death|0|||
146401643|NCT03917654|527972747|FG008|Year 2|Death|1|||
146401644|NCT03917654|527972748|FG009|Year 2|Death|1|||
146401645|NCT03917654|527972749|FG010|Year 2|Death|0|||
146401646|NCT03917654|527972750|FG011|Year 2|Death|0|||
146401647|NCT03917654|527972739|FG000|Year 2|Withdrawal by Subject|0|||
146401648|NCT03917654|527972740|FG001|Year 2|Withdrawal by Subject|0|||
146401649|NCT03917654|527972741|FG002|Year 2|Withdrawal by Subject|0|||
146401650|NCT03917654|527972742|FG003|Year 2|Withdrawal by Subject|0|||
146401651|NCT03917654|527972743|FG004|Year 2|Withdrawal by Subject|0|||
146401652|NCT03917654|527972744|FG005|Year 2|Withdrawal by Subject|0|||
146401653|NCT03917654|527972745|FG006|Year 2|Withdrawal by Subject|3|||
146401654|NCT03917654|527972746|FG007|Year 2|Withdrawal by Subject|0|||
146401655|NCT03917654|527972747|FG008|Year 2|Withdrawal by Subject|2|||
146401656|NCT03917654|527972748|FG009|Year 2|Withdrawal by Subject|5|||
146401657|NCT03917654|527972749|FG010|Year 2|Withdrawal by Subject|0|||
146401658|NCT03917654|527972750|FG011|Year 2|Withdrawal by Subject|0|||
146401659|NCT03917654|527972739|FG000|Year 2|Spouse/family member request|0|||
146401660|NCT03917654|527972740|FG001|Year 2|Spouse/family member request|0|||
146401661|NCT03917654|527972741|FG002|Year 2|Spouse/family member request|0|||
146401662|NCT03917654|527972742|FG003|Year 2|Spouse/family member request|0|||
146401663|NCT03917654|527972743|FG004|Year 2|Spouse/family member request|0|||
146401664|NCT03917654|527972744|FG005|Year 2|Spouse/family member request|0|||
146169889|NCT05044325|527134728|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
146169890|NCT05044325|527134729|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
146169891|NCT05044325|527134730|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169892|NCT05044325|527134731|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169893|NCT05044325|527134732|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169894|NCT05044325|527134733|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169895|NCT05044325|527134734|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
146169896|NCT00755222|527134735|FG000|Overall Study|Withdrawal by Subject|4|||
146169897|NCT00755222|527134736|FG001|Overall Study|Withdrawal by Subject|2|||
146169898|NCT00755222|527134735|FG000|Overall Study|Adverse Event|2|||
146169899|NCT00755222|527134736|FG001|Overall Study|Adverse Event|0|||
146169900|NCT00755222|527134735|FG000|Overall Study|Protocol Violation|2|||
146169901|NCT00755222|527134736|FG001|Overall Study|Protocol Violation|0|||
146169902|NCT02243202|527134737|FG000|Overall Study|Adverse Event|5|||
146169903|NCT02243202|527134738|FG001|Overall Study|Adverse Event|6|||
146169904|NCT02243202|527134739|FG002|Overall Study|Adverse Event|10|||
146169905|NCT02243202|527134740|FG003|Overall Study|Adverse Event|4|||
146169906|NCT02243202|527134737|FG000|Overall Study|Lost to Follow-up|9|||
146169907|NCT02243202|527134738|FG001|Overall Study|Lost to Follow-up|9|||
146169908|NCT02243202|527134739|FG002|Overall Study|Lost to Follow-up|14|||
146169909|NCT02243202|527134740|FG003|Overall Study|Lost to Follow-up|11|||
146169910|NCT02243202|527134737|FG000|Overall Study|Protocol Violation|3|||
146169911|NCT02243202|527134738|FG001|Overall Study|Protocol Violation|1|||
146169912|NCT02243202|527134739|FG002|Overall Study|Protocol Violation|2|||
146169913|NCT02243202|527134740|FG003|Overall Study|Protocol Violation|1|||
146169914|NCT02243202|527134737|FG000|Overall Study|Withdrawal by Subject|7|||
146169915|NCT02243202|527134738|FG001|Overall Study|Withdrawal by Subject|6|||
146169916|NCT02243202|527134739|FG002|Overall Study|Withdrawal by Subject|4|||
146169917|NCT02243202|527134740|FG003|Overall Study|Withdrawal by Subject|4|||
146169918|NCT02243202|527134737|FG000|Overall Study|Other|1|||
146169919|NCT02243202|527134738|FG001|Overall Study|Other|3|||
146169920|NCT02243202|527134739|FG002|Overall Study|Other|1|||
146169921|NCT02243202|527134740|FG003|Overall Study|Other|2|||
146169922|NCT02243202|527134737|FG000|Overall Study|Randomized but not received treatment|0|||
146169923|NCT02243202|527134738|FG001|Overall Study|Randomized but not received treatment|0|||
146169924|NCT02243202|527134739|FG002|Overall Study|Randomized but not received treatment|0|||
146169925|NCT02243202|527134740|FG003|Overall Study|Randomized but not received treatment|1|||
146401665|NCT03917654|527972745|FG006|Year 2|Spouse/family member request|1|||
146401666|NCT03917654|527972746|FG007|Year 2|Spouse/family member request|0|||
146401667|NCT03917654|527972747|FG008|Year 2|Spouse/family member request|0|||
146401668|NCT03917654|527972748|FG009|Year 2|Spouse/family member request|0|||
146401669|NCT03917654|527972749|FG010|Year 2|Spouse/family member request|0|||
146401670|NCT03917654|527972750|FG011|Year 2|Spouse/family member request|0|||
146401671|NCT03917654|527972739|FG000|Year 2|Lost to Follow-up|0|||
146401672|NCT03917654|527972740|FG001|Year 2|Lost to Follow-up|0|||
146401673|NCT03917654|527972741|FG002|Year 2|Lost to Follow-up|0|||
146401674|NCT03917654|527972742|FG003|Year 2|Lost to Follow-up|0|||
146401675|NCT03917654|527972743|FG004|Year 2|Lost to Follow-up|0|||
146401676|NCT03917654|527972744|FG005|Year 2|Lost to Follow-up|0|||
146401677|NCT03917654|527972745|FG006|Year 2|Lost to Follow-up|1|||
146401678|NCT03917654|527972746|FG007|Year 2|Lost to Follow-up|0|||
146401679|NCT03917654|527972747|FG008|Year 2|Lost to Follow-up|1|||
146401680|NCT03917654|527972748|FG009|Year 2|Lost to Follow-up|0|||
146401681|NCT03917654|527972749|FG010|Year 2|Lost to Follow-up|0|||
146401682|NCT03917654|527972750|FG011|Year 2|Lost to Follow-up|1|||
146401683|NCT03917654|527972739|FG000|Year 2|Adverse Event|0|||
146401684|NCT03917654|527972740|FG001|Year 2|Adverse Event|0|||
146401685|NCT03917654|527972741|FG002|Year 2|Adverse Event|0|||
146401686|NCT03917654|527972742|FG003|Year 2|Adverse Event|0|||
146401687|NCT03917654|527972743|FG004|Year 2|Adverse Event|0|||
146401688|NCT03917654|527972744|FG005|Year 2|Adverse Event|0|||
146401689|NCT03917654|527972745|FG006|Year 2|Adverse Event|0|||
146169926|NCT04382924|527134741|FG000|Overall Study|Death|2|||
146401690|NCT03917654|527972746|FG007|Year 2|Adverse Event|0|||
146169927|NCT04382924|527134742|FG001|Overall Study|Death|5|||
146169928|NCT04382924|527134743|FG002|Overall Study|Death|4|||
146169929|NCT04382924|527134741|FG000|Overall Study|Protocol Violation|0|||
146169930|NCT04382924|527134742|FG001|Overall Study|Protocol Violation|1|||
146169931|NCT04382924|527134743|FG002|Overall Study|Protocol Violation|1|||
146169932|NCT04382924|527134741|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
146401691|NCT03917654|527972747|FG008|Year 2|Adverse Event|0|||
146401692|NCT03917654|527972748|FG009|Year 2|Adverse Event|1|||
146401693|NCT03917654|527972749|FG010|Year 2|Adverse Event|0|||
146401694|NCT03917654|527972750|FG011|Year 2|Adverse Event|0|||
146401695|NCT02255422|527972751|FG000|Overall Study|Withdrawal by Subject|0|||
146401696|NCT02255422|527972752|FG001|Overall Study|Withdrawal by Subject|0|||
146401697|NCT02255422|527972753|FG002|Overall Study|Withdrawal by Subject|0|||
146401698|NCT02255422|527972754|FG003|Overall Study|Withdrawal by Subject|0|||
146401699|NCT02255422|527972755|FG004|Overall Study|Withdrawal by Subject|0|||
146061366|NCT01709721|526743398|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
146061367|NCT01709721|526743399|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
146061368|NCT01709721|526743397|FG000|Open Label Phase|Inadequate Pain Control|0|||
146061369|NCT01709721|526743398|FG001|Open Label Phase|Inadequate Pain Control|0|||
146061370|NCT01709721|526743399|FG002|Open Label Phase|Inadequate Pain Control|37|||
146061371|NCT01709721|526743397|FG000|Open Label Phase|Other, Specify in text field in database|0|||
146061372|NCT01709721|526743398|FG001|Open Label Phase|Other, Specify in text field in database|0|||
146061373|NCT01709721|526743399|FG002|Open Label Phase|Other, Specify in text field in database|14|||
146061374|NCT01709721|526743397|FG000|Randomized Phase|Adverse Event|0|||
146061375|NCT01709721|526743398|FG001|Randomized Phase|Adverse Event|1|||
146061376|NCT01709721|526743399|FG002|Randomized Phase|Adverse Event|0|||
146061377|NCT01709721|526743397|FG000|Randomized Phase|Lost to Follow-up|1|||
146061378|NCT01709721|526743398|FG001|Randomized Phase|Lost to Follow-up|0|||
146061379|NCT01709721|526743399|FG002|Randomized Phase|Lost to Follow-up|0|||
146061380|NCT01709721|526743397|FG000|Randomized Phase|Inadequate Pain Control|1|||
146061381|NCT01709721|526743398|FG001|Randomized Phase|Inadequate Pain Control|2|||
146061382|NCT01709721|526743399|FG002|Randomized Phase|Inadequate Pain Control|0|||
146061383|NCT01709721|526743397|FG000|Randomized Phase|Other, Specify text field in database|1|||
146061384|NCT01709721|526743398|FG001|Randomized Phase|Other, Specify text field in database|3|||
146061385|NCT01709721|526743399|FG002|Randomized Phase|Other, Specify text field in database|0|||
146061386|NCT01435382|526743402|FG000|Overall Study|Lost to Follow-up|1|||
146061387|NCT01435382|526743403|FG001|Overall Study|Lost to Follow-up|0|||
146061388|NCT01435382|526743404|FG002|Overall Study|Lost to Follow-up|1|||
146061389|NCT01435382|526743405|FG003|Overall Study|Lost to Follow-up|0|||
146061390|NCT01435382|526743402|FG000|Overall Study|Withdrawal by Subject|0|||
146061391|NCT01435382|526743403|FG001|Overall Study|Withdrawal by Subject|2|||
146061392|NCT01435382|526743404|FG002|Overall Study|Withdrawal by Subject|0|||
146061393|NCT01435382|526743405|FG003|Overall Study|Withdrawal by Subject|1|||
146061394|NCT00423579|526743407|FG000|Overall Study|Lost to Follow-up|3|||
146061395|NCT00423579|526743408|FG001|Overall Study|Lost to Follow-up|0|||
146061396|NCT00423579|526743407|FG000|Overall Study|Protocol Violation|1|||
146061397|NCT00423579|526743408|FG001|Overall Study|Protocol Violation|3|||
146061398|NCT00423579|526743407|FG000|Overall Study|Diagnosis of diabetes|0|||
146061399|NCT00423579|526743408|FG001|Overall Study|Diagnosis of diabetes|1|||
146061400|NCT01310777|526743413|FG000|Overall Study|Adverse Event|23|||
146061401|NCT01310777|526743414|FG001|Overall Study|Adverse Event|1|||
146061402|NCT01310777|526743415|FG002|Overall Study|Adverse Event|15|||
146061403|NCT01310777|526743413|FG000|Overall Study|Lost to Follow-up|0|||
146061404|NCT01310777|526743414|FG001|Overall Study|Lost to Follow-up|4|||
146061405|NCT01310777|526743415|FG002|Overall Study|Lost to Follow-up|1|||
146061406|NCT01310777|526743413|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
146061407|NCT01310777|526743414|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
146061408|NCT01310777|526743415|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
146061409|NCT01310777|526743413|FG000|Overall Study|Inadequate Control of IOP|5|||
146061410|NCT01310777|526743414|FG001|Overall Study|Inadequate Control of IOP|7|||
146061411|NCT01310777|526743415|FG002|Overall Study|Inadequate Control of IOP|10|||
146061412|NCT01310777|526743413|FG000|Overall Study|Other|4|||
146061413|NCT01310777|526743414|FG001|Overall Study|Other|1|||
146061414|NCT01310777|526743415|FG002|Overall Study|Other|2|||
146061415|NCT03962491|526743416|FG000|Overall Study|Lost to Follow-up|4|||
146061416|NCT03962491|526743417|FG001|Overall Study|Lost to Follow-up|5|||
146061417|NCT03697252|526743424|FG000|Overall Study|Adverse Event|3|||
146061418|NCT03697252|526743425|FG001|Overall Study|Adverse Event|2|||
146061419|NCT03697252|526743424|FG000|Overall Study|Withdrawal by Subject|14|||
146061420|NCT03697252|526743425|FG001|Overall Study|Withdrawal by Subject|14|||
146061421|NCT03697252|526743424|FG000|Overall Study|Lost to Follow-up|0|||
146061422|NCT03697252|526743425|FG001|Overall Study|Lost to Follow-up|1|||
146061423|NCT03697252|526743424|FG000|Overall Study|Physician Decision|1|||
146061424|NCT03697252|526743425|FG001|Overall Study|Physician Decision|1|||
146061425|NCT03697252|526743424|FG000|Overall Study|Other|0|||
146061426|NCT03697252|526743425|FG001|Overall Study|Other|1|||
146061427|NCT03125395|526743426|FG000|Overall Study|Adverse Event|2|||
146061428|NCT03125395|526743426|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146061429|NCT03125395|526743426|FG000|Overall Study|Physician Decision|2|||
146061430|NCT03125395|526743426|FG000|Overall Study|Commercial drug is available|5|||
146401700|NCT02255422|527972756|FG005|Overall Study|Withdrawal by Subject|0|||
146061431|NCT00106704|526743427|FG000|Overall Study|Adverse Event|10|||
146061432|NCT00106704|526743428|FG001|Overall Study|Adverse Event|7|||
146061433|NCT00106704|526743427|FG000|Overall Study|Death|2|||
146061434|NCT00106704|526743428|FG001|Overall Study|Death|1|||
146061435|NCT00106704|526743427|FG000|Overall Study|Lack of Efficacy|67|||
146061436|NCT00106704|526743428|FG001|Overall Study|Lack of Efficacy|69|||
146061437|NCT00106704|526743427|FG000|Overall Study|Lost to Follow-up|7|||
146061438|NCT00106704|526743428|FG001|Overall Study|Lost to Follow-up|3|||
146061439|NCT00106704|526743427|FG000|Overall Study|Pregnancy|1|||
146061440|NCT00106704|526743428|FG001|Overall Study|Pregnancy|0|||
146401701|NCT02255422|527972757|FG006|Overall Study|Withdrawal by Subject|2|||
146401702|NCT02255422|527972751|FG000|Overall Study|Lost to Follow-up|0|||
146401703|NCT02255422|527972752|FG001|Overall Study|Lost to Follow-up|0|||
146401704|NCT02255422|527972753|FG002|Overall Study|Lost to Follow-up|1|||
146401705|NCT02255422|527972754|FG003|Overall Study|Lost to Follow-up|0|||
146401706|NCT02255422|527972755|FG004|Overall Study|Lost to Follow-up|0|||
146401707|NCT02255422|527972756|FG005|Overall Study|Lost to Follow-up|0|||
146401708|NCT02255422|527972757|FG006|Overall Study|Lost to Follow-up|0|||
146401709|NCT00602667|527972758|FG000|Overall Study|Still on Therapy|0|||
146401710|NCT00602667|527972759|FG001|Overall Study|Still on Therapy|2|||
146401711|NCT00602667|527972760|FG002|Overall Study|Still on Therapy|2|||
146401712|NCT00602667|527972758|FG000|Overall Study|Death|0|||
146401713|NCT00602667|527972759|FG001|Overall Study|Death|1|||
146401714|NCT00602667|527972760|FG002|Overall Study|Death|1|||
146401715|NCT00602667|527972758|FG000|Overall Study|Family request|3|||
146401716|NCT00602667|527972759|FG001|Overall Study|Family request|25|||
146401717|NCT00602667|527972760|FG002|Overall Study|Family request|6|||
146401718|NCT00602667|527972758|FG000|Overall Study|Excessive toxicity|1|||
146401719|NCT00602667|527972759|FG001|Overall Study|Excessive toxicity|1|||
146401720|NCT00602667|527972760|FG002|Overall Study|Excessive toxicity|0|||
146401721|NCT00602667|527972758|FG000|Overall Study|Second malignancy|0|||
146401722|NCT00602667|527972759|FG001|Overall Study|Second malignancy|1|||
146401723|NCT00602667|527972760|FG002|Overall Study|Second malignancy|0|||
146401724|NCT00602667|527972758|FG000|Overall Study|Physician Decision|2|||
146401725|NCT00602667|527972759|FG001|Overall Study|Physician Decision|3|||
146401726|NCT00602667|527972760|FG002|Overall Study|Physician Decision|8|||
146401727|NCT00602667|527972758|FG000|Overall Study|Progressive disease|13|||
146401728|NCT00602667|527972759|FG001|Overall Study|Progressive disease|48|||
146401729|NCT00602667|527972760|FG002|Overall Study|Progressive disease|45|||
146401730|NCT00602667|527972758|FG000|Overall Study|Progressive disease prior to therapy|0|||
146401731|NCT00602667|527972759|FG001|Overall Study|Progressive disease prior to therapy|0|||
146401732|NCT00602667|527972760|FG002|Overall Study|Progressive disease prior to therapy|1|||
146401733|NCT03179462|527972766|FG000|Overall Study|screening failure|1|||
146401734|NCT03179462|527972767|FG001|Overall Study|screening failure|2|||
146401735|NCT03179462|527972768|FG002|Overall Study|screening failure|0|||
146401736|NCT04636437|527972769|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
146401737|NCT04636437|527972770|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
146401738|NCT04636437|527972771|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
146401739|NCT04636437|527972769|FG000|Overall Study|Started weight loss drug/program|2|||
146401740|NCT04636437|527972770|FG001|Overall Study|Started weight loss drug/program|1|||
146401741|NCT04636437|527972771|FG002|Overall Study|Started weight loss drug/program|1|||
146401742|NCT04636437|527972769|FG000|Overall Study|Lost to Follow-up|3|||
146401743|NCT04636437|527972770|FG001|Overall Study|Lost to Follow-up|1|||
146401744|NCT04636437|527972771|FG002|Overall Study|Lost to Follow-up|4|||
146401745|NCT04636437|527972769|FG000|Overall Study|Participant or physician decision|3|||
146401746|NCT04636437|527972770|FG001|Overall Study|Participant or physician decision|1|||
146401747|NCT04636437|527972771|FG002|Overall Study|Participant or physician decision|1|||
146401748|NCT00816166|527972775|FG000|Overall Study|Lost to Follow-up|6|||
146401749|NCT00816166|527972776|FG001|Overall Study|Lost to Follow-up|10|||
146401750|NCT00816166|527972775|FG000|Overall Study|Death|4|||
146401751|NCT00816166|527972776|FG001|Overall Study|Death|2|||
146401752|NCT02851069|527972777|FG000|Overall Study|Failure to Return|3|||
146401753|NCT02851069|527972777|FG000|Overall Study|Other|3|||
146401754|NCT02146365|527972778|FG000|Overall Study|Lost to Follow-up|2|||
146401755|NCT02146365|527972779|FG001|Overall Study|Lost to Follow-up|1|||
146401756|NCT02146365|527972780|FG002|Overall Study|Lost to Follow-up|3|||
146401757|NCT02146365|527972781|FG003|Overall Study|Lost to Follow-up|3|||
146401758|NCT02146365|527972782|FG004|Overall Study|Lost to Follow-up|1|||
146401759|NCT02146365|527972783|FG005|Overall Study|Lost to Follow-up|1|||
146401760|NCT02146365|527972784|FG006|Overall Study|Lost to Follow-up|0|||
146401761|NCT02146365|527972785|FG007|Overall Study|Lost to Follow-up|1|||
146401762|NCT02146365|527972778|FG000|Overall Study|Withdrawal by Subject|1|||
146401763|NCT02146365|527972779|FG001|Overall Study|Withdrawal by Subject|2|||
146401764|NCT02146365|527972780|FG002|Overall Study|Withdrawal by Subject|1|||
146401765|NCT02146365|527972781|FG003|Overall Study|Withdrawal by Subject|5|||
146401766|NCT02146365|527972782|FG004|Overall Study|Withdrawal by Subject|1|||
146401767|NCT02146365|527972783|FG005|Overall Study|Withdrawal by Subject|0|||
146401768|NCT02146365|527972784|FG006|Overall Study|Withdrawal by Subject|0|||
146401769|NCT02146365|527972785|FG007|Overall Study|Withdrawal by Subject|0|||
146401770|NCT02146365|527972778|FG000|Overall Study|Unable to Comply with Protocol|0|||
146401771|NCT02146365|527972779|FG001|Overall Study|Unable to Comply with Protocol|1|||
146401772|NCT02146365|527972780|FG002|Overall Study|Unable to Comply with Protocol|1|||
146401773|NCT02146365|527972781|FG003|Overall Study|Unable to Comply with Protocol|0|||
146401774|NCT02146365|527972782|FG004|Overall Study|Unable to Comply with Protocol|0|||
146401775|NCT02146365|527972783|FG005|Overall Study|Unable to Comply with Protocol|0|||
146401776|NCT02146365|527972784|FG006|Overall Study|Unable to Comply with Protocol|0|||
146401777|NCT02146365|527972785|FG007|Overall Study|Unable to Comply with Protocol|0|||
146061441|NCT00106704|526743427|FG000|Overall Study|Protocol Violation|4|||
146061442|NCT00106704|526743428|FG001|Overall Study|Protocol Violation|7|||
146061443|NCT00106704|526743427|FG000|Overall Study|Withdrawal by Subject|14|||
146061444|NCT00106704|526743428|FG001|Overall Study|Withdrawal by Subject|21|||
146061445|NCT00106704|526743427|FG000|Overall Study|Patient moved|1|||
146061446|NCT00106704|526743428|FG001|Overall Study|Patient moved|0|||
146061447|NCT00106704|526743427|FG000|Overall Study|Site terminated|0|||
146061448|NCT00106704|526743428|FG001|Overall Study|Site terminated|1|||
146061449|NCT00106704|526743427|FG000|Overall Study|Planned major surgery|1|||
146061450|NCT00106704|526743428|FG001|Overall Study|Planned major surgery|0|||
146061451|NCT00106704|526743427|FG000|Overall Study|Patient Received Glycemic Medication|22|||
146061452|NCT00106704|526743428|FG001|Overall Study|Patient Received Glycemic Medication|41|||
146061453|NCT00106704|526743427|FG000|Overall Study|Unable to re-enter US|1|||
146061454|NCT00106704|526743428|FG001|Overall Study|Unable to re-enter US|0|||
146061455|NCT00106704|526743427|FG000|Overall Study|Laboratory test|1|||
146061456|NCT00106704|526743428|FG001|Overall Study|Laboratory test|1|||
146061457|NCT01780506|526743429|FG000|Double-Blind Phase|Randomized but not Treated|3|||
146061458|NCT01780506|526743430|FG001|Double-Blind Phase|Randomized but not Treated|2|||
146061459|NCT01780506|526743429|FG000|Double-Blind Phase|Adverse Event|4|||
146061460|NCT01780506|526743430|FG001|Double-Blind Phase|Adverse Event|14|||
146061461|NCT01780506|526743429|FG000|Double-Blind Phase|Death|1|||
146061462|NCT01780506|526743430|FG001|Double-Blind Phase|Death|2|||
146061463|NCT01780506|526743429|FG000|Double-Blind Phase|Pregnancy|2|||
146061464|NCT01780506|526743430|FG001|Double-Blind Phase|Pregnancy|1|||
146061465|NCT01780506|526743429|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146061466|NCT01780506|526743430|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146061467|NCT01780506|526743429|FG000|Double-Blind Phase|Investigator's Discretion|5|||
146061468|NCT01780506|526743430|FG001|Double-Blind Phase|Investigator's Discretion|2|||
146061469|NCT01780506|526743429|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
146061470|NCT01780506|526743430|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
146061471|NCT01780506|526743429|FG000|Double-Blind Phase|Protocol Violation|4|||
146061472|NCT01780506|526743430|FG001|Double-Blind Phase|Protocol Violation|3|||
146061473|NCT01780506|526743429|FG000|Double-Blind Phase|Withdrew Consent|23|||
146061474|NCT01780506|526743430|FG001|Double-Blind Phase|Withdrew Consent|24|||
146061475|NCT01780506|526743429|FG000|Double-Blind Phase|Lost to Follow-up|23|||
146061476|NCT01780506|526743430|FG001|Double-Blind Phase|Lost to Follow-up|26|||
146061477|NCT01780506|526743429|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
146061478|NCT01780506|526743430|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
146061479|NCT03486912|526743434|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146061480|NCT03486912|526743435|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
146061481|NCT03486912|526743436|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146061482|NCT03486912|526743437|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
146061483|NCT03486912|526743434|FG000|Treatment Period|Withdrawal by Subject|3|||
146061484|NCT03486912|526743435|FG001|Treatment Period|Withdrawal by Subject|3|||
146061485|NCT03486912|526743436|FG002|Treatment Period|Withdrawal by Subject|3|||
146061486|NCT03486912|526743437|FG003|Treatment Period|Withdrawal by Subject|2|||
146061487|NCT03486912|526743434|FG000|Treatment Period|Other Reasons|0|||
146061488|NCT03486912|526743435|FG001|Treatment Period|Other Reasons|2|||
146061489|NCT03486912|526743436|FG002|Treatment Period|Other Reasons|1|||
146061490|NCT03486912|526743437|FG003|Treatment Period|Other Reasons|1|||
146061491|NCT03486912|526743434|FG000|Treatment Period|Adverse Event|0|||
146061492|NCT03486912|526743435|FG001|Treatment Period|Adverse Event|1|||
146061493|NCT03486912|526743436|FG002|Treatment Period|Adverse Event|1|||
146061494|NCT03486912|526743437|FG003|Treatment Period|Adverse Event|0|||
146061495|NCT03486912|526743434|FG000|Treatment Period|Lost to Follow-up|1|||
146061496|NCT03486912|526743435|FG001|Treatment Period|Lost to Follow-up|0|||
146061497|NCT03486912|526743436|FG002|Treatment Period|Lost to Follow-up|0|||
146061498|NCT03486912|526743437|FG003|Treatment Period|Lost to Follow-up|2|||
146061499|NCT01499940|526743438|FG000|Overall Study|Study was withdrawn before completion.|9|||
146061500|NCT00412984|526743439|FG000|Overall Study|Death|331|||
146061501|NCT00412984|526743440|FG001|Overall Study|Death|349|||
146061502|NCT00412984|526743439|FG000|Overall Study|Adverse Event|679|||
146061503|NCT00412984|526743440|FG001|Overall Study|Adverse Event|738|||
146061504|NCT00412984|526743439|FG000|Overall Study|Withdrawal by Subject|921|||
146061505|NCT00412984|526743440|FG001|Overall Study|Withdrawal by Subject|989|||
146061506|NCT00412984|526743439|FG000|Overall Study|Lost to Follow-up|51|||
146061507|NCT00412984|526743440|FG001|Overall Study|Lost to Follow-up|39|||
146061508|NCT00412984|526743439|FG000|Overall Study|Poor/Noncompliance|57|||
146061509|NCT00412984|526743440|FG001|Overall Study|Poor/Noncompliance|77|||
146061510|NCT00412984|526743439|FG000|Overall Study|Pregnancy|1|||
146061511|NCT00412984|526743440|FG001|Overall Study|Pregnancy|0|||
146061512|NCT00412984|526743439|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
146061513|NCT00412984|526743440|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
146061514|NCT00412984|526743439|FG000|Overall Study|Administrative Reason by Sponsor|11|||
146061515|NCT00412984|526743440|FG001|Overall Study|Administrative Reason by Sponsor|8|||
146061516|NCT00412984|526743439|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
146401778|NCT02146365|527972778|FG000|Overall Study|Other|1|||
146401779|NCT02146365|527972779|FG001|Overall Study|Other|0|||
146401780|NCT02146365|527972780|FG002|Overall Study|Other|2|||
146401781|NCT02146365|527972781|FG003|Overall Study|Other|1|||
146401782|NCT02146365|527972782|FG004|Overall Study|Other|0|||
146401783|NCT02146365|527972783|FG005|Overall Study|Other|0|||
146061517|NCT00412984|526743440|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
146061518|NCT00412984|526743439|FG000|Overall Study|Other Reason|80|||
146061519|NCT00412984|526743440|FG001|Overall Study|Other Reason|92|||
146061520|NCT00412984|526743439|FG000|Overall Study|Not Reported|11|||
146061521|NCT00412984|526743440|FG001|Overall Study|Not Reported|12|||
146061522|NCT02383576|526743442|FG000|Overall Study|Death|53|||
146061523|NCT02383576|526743443|FG001|Overall Study|Death|33|||
146061524|NCT02383576|526743442|FG000|Overall Study|Lost to Follow-up|7|||
146061525|NCT02383576|526743443|FG001|Overall Study|Lost to Follow-up|1|||
146061526|NCT02383576|526743442|FG000|Overall Study|Withdrew Consent|1|||
146061527|NCT02383576|526743443|FG001|Overall Study|Withdrew Consent|6|||
146061528|NCT02383576|526743442|FG000|Overall Study|Investigator's Decision|0|||
146061529|NCT02383576|526743443|FG001|Overall Study|Investigator's Decision|1|||
146061530|NCT02383576|526743442|FG000|Overall Study|Administrative/Other|2|||
146061531|NCT02383576|526743443|FG001|Overall Study|Administrative/Other|4|||
146061532|NCT04097678|526743444|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
146061533|NCT04097678|526743445|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
146061534|NCT03694678|526743446|FG000|Overall Study|Withdrawal by Subject|2|||
146061535|NCT03694678|526743447|FG001|Overall Study|Withdrawal by Subject|0|||
146061536|NCT03694678|526743446|FG000|Overall Study|Lost to Follow-up|2|||
146061537|NCT03694678|526743447|FG001|Overall Study|Lost to Follow-up|3|||
146061538|NCT02435212|526743448|FG000|Core Phase|Adverse Event|8|||
146061539|NCT02435212|526743449|FG001|Core Phase|Adverse Event|5|||
146061540|NCT02435212|526743448|FG000|Core Phase|Withdrawal by Subject|3|||
146061541|NCT02435212|526743449|FG001|Core Phase|Withdrawal by Subject|0|||
146061542|NCT02435212|526743448|FG000|Core Phase|Withdrawal by parent/guardian|9|||
146169933|NCT04382924|527134742|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
146169934|NCT04382924|527134743|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
146169935|NCT04382924|527134741|FG000|Overall Study|Withdrawal by Subject|6|||
146169936|NCT04382924|527134742|FG001|Overall Study|Withdrawal by Subject|3|||
146169937|NCT04382924|527134743|FG002|Overall Study|Withdrawal by Subject|6|||
146169938|NCT04207840|527134747|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
146169939|NCT04207840|527134748|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
146401784|NCT02146365|527972784|FG006|Overall Study|Other|0|||
146401785|NCT02146365|527972785|FG007|Overall Study|Other|0|||
146401786|NCT03222856|527972786|FG000|Overall Study|Adverse Event|6|||
146401787|NCT03222856|527972786|FG000|Overall Study|Death|1|||
146401788|NCT03505606|527974133|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
146401789|NCT03505606|527974134|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
146401790|NCT03505606|527974135|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
146401791|NCT03505606|527974133|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
146401792|NCT03505606|527974134|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
146401793|NCT03505606|527974135|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
146401794|NCT03505606|527974133|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
146401795|NCT03505606|527974134|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
146401796|NCT03505606|527974135|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
146401797|NCT03505606|527974133|FG000|Overall Study|Poor compliance with refractive correction|0|||
146401798|NCT03505606|527974134|FG001|Overall Study|Poor compliance with refractive correction|0|||
146401799|NCT03505606|527974135|FG002|Overall Study|Poor compliance with refractive correction|1|||
146401800|NCT03505606|527974133|FG000|Overall Study|Insufficient anisometropia|0|||
146401801|NCT03505606|527974134|FG001|Overall Study|Insufficient anisometropia|0|||
146401802|NCT03505606|527974135|FG002|Overall Study|Insufficient anisometropia|2|||
146401803|NCT03505606|527974133|FG000|Overall Study|Ectopia Lentis|0|||
146401804|NCT03505606|527974134|FG001|Overall Study|Ectopia Lentis|0|||
146401805|NCT03505606|527974135|FG002|Overall Study|Ectopia Lentis|1|||
146401806|NCT03505606|527974133|FG000|Overall Study|alternation of amblyopic eye|0|||
146401807|NCT03505606|527974134|FG001|Overall Study|alternation of amblyopic eye|1|||
146401808|NCT03505606|527974135|FG002|Overall Study|alternation of amblyopic eye|0|||
146401809|NCT02087865|527974137|FG000|Overall Study|Withdrawal by Subject|6|||
146401810|NCT02087865|527974138|FG001|Overall Study|Withdrawal by Subject|0|||
146401811|NCT02087865|527974139|FG002|Overall Study|Withdrawal by Subject|1|||
146401812|NCT02087865|527974137|FG000|Overall Study|Lost to Follow-up|0|||
146401813|NCT02087865|527974138|FG001|Overall Study|Lost to Follow-up|0|||
146061543|NCT02435212|526743449|FG001|Core Phase|Withdrawal by parent/guardian|4|||
146061544|NCT02435212|526743448|FG000|Core Phase|Protocol Violation|1|||
146061545|NCT02435212|526743449|FG001|Core Phase|Protocol Violation|2|||
146061546|NCT02435212|526743448|FG000|Core Phase|Physician Decision|3|||
146061547|NCT02435212|526743449|FG001|Core Phase|Physician Decision|0|||
146401814|NCT02087865|527974139|FG002|Overall Study|Lost to Follow-up|1|||
146401815|NCT02087865|527974137|FG000|Overall Study|Drug Non-compliance|0|||
146401816|NCT02087865|527974138|FG001|Overall Study|Drug Non-compliance|2|||
146401817|NCT02087865|527974139|FG002|Overall Study|Drug Non-compliance|0|||
146401818|NCT02087865|527974137|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
146401819|NCT02087865|527974138|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
146401820|NCT02087865|527974139|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
146401821|NCT01392469|527974142|FG000|Overall Study|Adverse Event|2|||
146401822|NCT01392469|527974142|FG000|Overall Study|Withdrawal by Subject|1|||
146401823|NCT01392469|527974142|FG000|Overall Study|Protocol Violation|1|||
146401824|NCT01017731|527974144|FG000|Overall Study|Lost to Follow-up|2|||
146401825|NCT01017731|527974144|FG000|Overall Study|Withdrawal by Subject|3|||
146401826|NCT01017731|527974144|FG000|Overall Study|Physician Decision|2|||
146061548|NCT02435212|526743448|FG000|Core Phase|Lost to Follow-up|0|||
146061549|NCT02435212|526743449|FG001|Core Phase|Lost to Follow-up|1|||
146061550|NCT02435212|526743448|FG000|Core Phase|Lack of Efficacy|0|||
146061551|NCT02435212|526743449|FG001|Core Phase|Lack of Efficacy|1|||
146061552|NCT02435212|526743448|FG000|Core Phase|Recovery|1|||
146061553|NCT02435212|526743449|FG001|Core Phase|Recovery|0|||
146061554|NCT02435212|526743448|FG000|Optional Extension Phase|Adverse Event|3|||
146061555|NCT02435212|526743449|FG001|Optional Extension Phase|Adverse Event|9|||
146061556|NCT02435212|526743448|FG000|Optional Extension Phase|Physician Decision|6|||
146061557|NCT02435212|526743449|FG001|Optional Extension Phase|Physician Decision|8|||
146061558|NCT02435212|526743448|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
146061559|NCT02435212|526743449|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
146061560|NCT02435212|526743448|FG000|Optional Extension Phase|Lack of Efficacy|2|||
146061561|NCT02435212|526743449|FG001|Optional Extension Phase|Lack of Efficacy|3|||
146061562|NCT02435212|526743448|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
146061563|NCT02435212|526743449|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
146061564|NCT02435212|526743448|FG000|Optional Extension Phase|Protocol Violation|0|||
146061565|NCT02435212|526743449|FG001|Optional Extension Phase|Protocol Violation|1|||
146061566|NCT02435212|526743448|FG000|Optional Extension Phase|Recovery|1|||
146061567|NCT02435212|526743449|FG001|Optional Extension Phase|Recovery|1|||
146061568|NCT02435212|526743448|FG000|Optional Extension Phase|Death|1|||
146061569|NCT02435212|526743449|FG001|Optional Extension Phase|Death|0|||
146061570|NCT02435212|526743448|FG000|Optional Extension Phase|Technical problems|2|||
146061571|NCT02435212|526743449|FG001|Optional Extension Phase|Technical problems|0|||
146061572|NCT03050801|526743452|FG000|Experiment 1|Lost to Follow-up|0|||
146061573|NCT03050801|526743453|FG001|Experiment 1|Lost to Follow-up|1|||
146061574|NCT03050801|526743454|FG002|Experiment 1|Lost to Follow-up|0|||
146061575|NCT03050801|526743455|FG003|Experiment 1|Lost to Follow-up|0|||
146061576|NCT03050801|526743456|FG004|Experiment 1|Lost to Follow-up|0|||
146061577|NCT03050801|526743457|FG005|Experiment 1|Lost to Follow-up|0|||
146061578|NCT03050801|526743452|FG000|Experiment 1|Physician Decision|0|||
146061579|NCT03050801|526743453|FG001|Experiment 1|Physician Decision|3|||
146061580|NCT03050801|526743454|FG002|Experiment 1|Physician Decision|0|||
146061581|NCT03050801|526743455|FG003|Experiment 1|Physician Decision|0|||
146061582|NCT03050801|526743456|FG004|Experiment 1|Physician Decision|0|||
146061583|NCT03050801|526743457|FG005|Experiment 1|Physician Decision|0|||
146061584|NCT03050801|526743452|FG000|Experiment 1|Change of experimental design|0|||
146061585|NCT03050801|526743453|FG001|Experiment 1|Change of experimental design|3|||
146061586|NCT03050801|526743454|FG002|Experiment 1|Change of experimental design|0|||
146061587|NCT03050801|526743455|FG003|Experiment 1|Change of experimental design|0|||
146061588|NCT03050801|526743456|FG004|Experiment 1|Change of experimental design|0|||
146061589|NCT03050801|526743457|FG005|Experiment 1|Change of experimental design|0|||
146061590|NCT03050801|526743452|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
146061591|NCT03050801|526743453|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
146061592|NCT03050801|526743454|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
146061593|NCT03050801|526743455|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
146061594|NCT03050801|526743456|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
146061595|NCT03050801|526743457|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
146061596|NCT03050801|526743452|FG000|Experiment 2|Lost to Follow-up|0|||
146061597|NCT03050801|526743453|FG001|Experiment 2|Lost to Follow-up|0|||
146061598|NCT03050801|526743454|FG002|Experiment 2|Lost to Follow-up|0|||
146061599|NCT03050801|526743455|FG003|Experiment 2|Lost to Follow-up|1|||
146061600|NCT03050801|526743456|FG004|Experiment 2|Lost to Follow-up|1|||
146061601|NCT03050801|526743457|FG005|Experiment 2|Lost to Follow-up|0|||
146061602|NCT03050801|526743452|FG000|Experiment 2|Physician Decision|0|||
146061603|NCT03050801|526743453|FG001|Experiment 2|Physician Decision|0|||
146061604|NCT03050801|526743454|FG002|Experiment 2|Physician Decision|0|||
146061605|NCT03050801|526743455|FG003|Experiment 2|Physician Decision|0|||
146061606|NCT03050801|526743456|FG004|Experiment 2|Physician Decision|1|||
146061607|NCT03050801|526743457|FG005|Experiment 2|Physician Decision|0|||
146061608|NCT03050801|526743452|FG000|Experiment 2|Pregnancy|0|||
146061609|NCT03050801|526743453|FG001|Experiment 2|Pregnancy|0|||
146061610|NCT03050801|526743454|FG002|Experiment 2|Pregnancy|0|||
146401827|NCT01017731|527974144|FG000|Overall Study|Adverse Event|1|||
146401828|NCT00564486|527974148|FG000|Overall Study|Adverse Event|0|||
146401829|NCT00564486|527974149|FG001|Overall Study|Adverse Event|1|||
146401830|NCT00564486|527974150|FG002|Overall Study|Adverse Event|0|||
146401831|NCT00564486|527974151|FG003|Overall Study|Adverse Event|0|||
146401832|NCT00564486|527974148|FG000|Overall Study|Withdrawal by Subject|4|||
146401833|NCT00564486|527974149|FG001|Overall Study|Withdrawal by Subject|0|||
146401834|NCT00564486|527974150|FG002|Overall Study|Withdrawal by Subject|0|||
146169940|NCT04207840|527134749|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
146169941|NCT04207840|527134747|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
146169942|NCT04207840|527134748|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
146169943|NCT04207840|527134749|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
146401835|NCT00564486|527974151|FG003|Overall Study|Withdrawal by Subject|5|||
146401836|NCT00564486|527974148|FG000|Overall Study|Subject refused to have blood drawn|0|||
146401837|NCT00564486|527974149|FG001|Overall Study|Subject refused to have blood drawn|0|||
146401838|NCT00564486|527974150|FG002|Overall Study|Subject refused to have blood drawn|1|||
146401839|NCT00564486|527974151|FG003|Overall Study|Subject refused to have blood drawn|0|||
146401840|NCT00564486|527974148|FG000|Overall Study|Lost to Follow-up|3|||
146401841|NCT00564486|527974149|FG001|Overall Study|Lost to Follow-up|0|||
146401842|NCT00564486|527974150|FG002|Overall Study|Lost to Follow-up|2|||
146401843|NCT00564486|527974151|FG003|Overall Study|Lost to Follow-up|2|||
146401844|NCT04362761|527974156|FG000|Part A (48 Weeks)|Adverse Event|2|||
146401845|NCT04362761|527974156|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
146401846|NCT04362761|527974156|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
146401847|NCT04362761|527974156|FG000|Part A (48 Weeks)|Other|5|||
146401848|NCT04362761|527974156|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
146401849|NCT04362761|527974156|FG000|Part B (86 Weeks)|Other|4|||
146401850|NCT03286400|527974157|FG000|Overall Study|Death|10|||
146401851|NCT03286400|527974157|FG000|Overall Study|Lost to Follow-up|10|||
146401852|NCT03286400|527974157|FG000|Overall Study|Physician Decision|1|||
146401853|NCT03286400|527974157|FG000|Overall Study|Scheduling difficulty|4|||
146401854|NCT03576131|527974160|FG000|Overall Study|Investigator decision|0|||
146401855|NCT03576131|527974161|FG001|Overall Study|Investigator decision|0|||
146169944|NCT02173054|527134750|FG000|Overall Study|lack of compliance|1|||
146169945|NCT02173054|527134751|FG001|Overall Study|lack of compliance|0|||
146401856|NCT03576131|527974162|FG002|Overall Study|Investigator decision|0|||
146401857|NCT03576131|527974163|FG003|Overall Study|Investigator decision|1|||
146401858|NCT03576131|527974164|FG004|Overall Study|Investigator decision|0|||
146401859|NCT03576131|527974165|FG005|Overall Study|Investigator decision|1|||
146401860|NCT03576131|527974166|FG006|Overall Study|Investigator decision|0|||
146401861|NCT03576131|527974167|FG007|Overall Study|Investigator decision|0|||
146401862|NCT03576131|527974160|FG000|Overall Study|Withdrawal by Subject|1|||
146401863|NCT03576131|527974161|FG001|Overall Study|Withdrawal by Subject|1|||
146401864|NCT03576131|527974162|FG002|Overall Study|Withdrawal by Subject|0|||
146401865|NCT03576131|527974163|FG003|Overall Study|Withdrawal by Subject|1|||
146401866|NCT03576131|527974164|FG004|Overall Study|Withdrawal by Subject|2|||
146401867|NCT03576131|527974165|FG005|Overall Study|Withdrawal by Subject|3|||
146401868|NCT03576131|527974166|FG006|Overall Study|Withdrawal by Subject|1|||
146401869|NCT03576131|527974167|FG007|Overall Study|Withdrawal by Subject|0|||
146401870|NCT03576131|527974160|FG000|Overall Study|Death|3|||
146401871|NCT03576131|527974161|FG001|Overall Study|Death|3|||
146401872|NCT03576131|527974162|FG002|Overall Study|Death|1|||
146401873|NCT03576131|527974163|FG003|Overall Study|Death|5|||
146401874|NCT03576131|527974164|FG004|Overall Study|Death|4|||
146401875|NCT03576131|527974165|FG005|Overall Study|Death|1|||
146401876|NCT03576131|527974166|FG006|Overall Study|Death|0|||
146401877|NCT03576131|527974167|FG007|Overall Study|Death|1|||
146401878|NCT03576131|527974160|FG000|Overall Study|New anti-cancer treatment|5|||
146401879|NCT03576131|527974161|FG001|Overall Study|New anti-cancer treatment|1|||
146401880|NCT03576131|527974162|FG002|Overall Study|New anti-cancer treatment|2|||
146401881|NCT03576131|527974163|FG003|Overall Study|New anti-cancer treatment|3|||
146401882|NCT03576131|527974164|FG004|Overall Study|New anti-cancer treatment|0|||
146401883|NCT03576131|527974165|FG005|Overall Study|New anti-cancer treatment|0|||
146401884|NCT03576131|527974166|FG006|Overall Study|New anti-cancer treatment|0|||
146401885|NCT03576131|527974167|FG007|Overall Study|New anti-cancer treatment|0|||
146401886|NCT03576131|527974160|FG000|Overall Study|Unspecified reason|0|||
146401887|NCT03576131|527974161|FG001|Overall Study|Unspecified reason|0|||
146401888|NCT03576131|527974162|FG002|Overall Study|Unspecified reason|1|||
146401889|NCT03576131|527974163|FG003|Overall Study|Unspecified reason|1|||
146401890|NCT03576131|527974164|FG004|Overall Study|Unspecified reason|1|||
146401891|NCT03576131|527974165|FG005|Overall Study|Unspecified reason|1|||
146401892|NCT03576131|527974166|FG006|Overall Study|Unspecified reason|0|||
146401893|NCT03576131|527974167|FG007|Overall Study|Unspecified reason|0|||
146401894|NCT03576131|527974160|FG000|Overall Study|Subject non-compliance|0|||
146169946|NCT02173054|527134752|FG002|Overall Study|lack of compliance|0|||
146401895|NCT03576131|527974161|FG001|Overall Study|Subject non-compliance|0|||
146401896|NCT03576131|527974162|FG002|Overall Study|Subject non-compliance|0|||
146061611|NCT03050801|526743455|FG003|Experiment 2|Pregnancy|0|||
146061612|NCT03050801|526743456|FG004|Experiment 2|Pregnancy|1|||
146061613|NCT03050801|526743457|FG005|Experiment 2|Pregnancy|0|||
146061614|NCT03050801|526743452|FG000|Experiment 2|Withdrawal by Subject|0|||
146061615|NCT03050801|526743453|FG001|Experiment 2|Withdrawal by Subject|0|||
146061616|NCT03050801|526743454|FG002|Experiment 2|Withdrawal by Subject|0|||
146061617|NCT03050801|526743455|FG003|Experiment 2|Withdrawal by Subject|1|||
146061618|NCT03050801|526743456|FG004|Experiment 2|Withdrawal by Subject|0|||
146061619|NCT03050801|526743457|FG005|Experiment 2|Withdrawal by Subject|0|||
146061620|NCT03050801|526743452|FG000|Experiment 2|Poor data quality|0|||
146061621|NCT03050801|526743453|FG001|Experiment 2|Poor data quality|0|||
146061622|NCT03050801|526743454|FG002|Experiment 2|Poor data quality|0|||
146061623|NCT03050801|526743455|FG003|Experiment 2|Poor data quality|4|||
146061624|NCT03050801|526743456|FG004|Experiment 2|Poor data quality|1|||
146061625|NCT03050801|526743457|FG005|Experiment 2|Poor data quality|0|||
146061626|NCT03050801|526743452|FG000|Experiment 2|Discomfort during stimulation|0|||
146061627|NCT03050801|526743453|FG001|Experiment 2|Discomfort during stimulation|0|||
146061628|NCT03050801|526743454|FG002|Experiment 2|Discomfort during stimulation|0|||
146061629|NCT03050801|526743455|FG003|Experiment 2|Discomfort during stimulation|0|||
146061630|NCT03050801|526743456|FG004|Experiment 2|Discomfort during stimulation|0|||
146061631|NCT03050801|526743457|FG005|Experiment 2|Discomfort during stimulation|2|||
146061632|NCT02331134|526743458|FG000|Overall Study|Withdrawal by Subject|1|||
146061633|NCT04825574|526743459|FG000|Overall Study|Commercial treatment became available|1|||
146061634|NCT04825574|526743459|FG000|Overall Study|Disease progression|1|||
146061635|NCT03518086|526743460|FG000|Overall Study|Adverse Event|23|||
146061636|NCT03518086|526743461|FG001|Overall Study|Adverse Event|15|||
146061637|NCT03518086|526743462|FG002|Overall Study|Adverse Event|3|||
146061638|NCT03518086|526743463|FG003|Overall Study|Adverse Event|2|||
146061639|NCT03518086|526743460|FG000|Overall Study|Withdrawal by Subject|8|||
146061640|NCT03518086|526743461|FG001|Overall Study|Withdrawal by Subject|5|||
146061641|NCT03518086|526743462|FG002|Overall Study|Withdrawal by Subject|1|||
146061642|NCT03518086|526743463|FG003|Overall Study|Withdrawal by Subject|0|||
146061643|NCT03518086|526743460|FG000|Overall Study|Lack of Efficacy|5|||
146061644|NCT03518086|526743461|FG001|Overall Study|Lack of Efficacy|5|||
146061645|NCT03518086|526743462|FG002|Overall Study|Lack of Efficacy|0|||
146061646|NCT03518086|526743463|FG003|Overall Study|Lack of Efficacy|2|||
146061647|NCT03518086|526743460|FG000|Overall Study|Protocol Violation|1|||
146061648|NCT03518086|526743461|FG001|Overall Study|Protocol Violation|5|||
146061649|NCT03518086|526743462|FG002|Overall Study|Protocol Violation|1|||
146061650|NCT03518086|526743463|FG003|Overall Study|Protocol Violation|3|||
146061651|NCT03518086|526743460|FG000|Overall Study|Lost to Follow-up|0|||
146061652|NCT03518086|526743461|FG001|Overall Study|Lost to Follow-up|3|||
146061653|NCT03518086|526743462|FG002|Overall Study|Lost to Follow-up|0|||
146061654|NCT03518086|526743463|FG003|Overall Study|Lost to Follow-up|0|||
146061655|NCT03518086|526743460|FG000|Overall Study|Insufficient Diary Data|0|||
146061656|NCT03518086|526743461|FG001|Overall Study|Insufficient Diary Data|2|||
146061657|NCT03518086|526743462|FG002|Overall Study|Insufficient Diary Data|0|||
146061658|NCT03518086|526743463|FG003|Overall Study|Insufficient Diary Data|0|||
146061659|NCT03518086|526743460|FG000|Overall Study|Non- compliance to Protocol|0|||
146401897|NCT03576131|527974163|FG003|Overall Study|Subject non-compliance|0|||
146401898|NCT03576131|527974164|FG004|Overall Study|Subject non-compliance|0|||
146401899|NCT03576131|527974165|FG005|Overall Study|Subject non-compliance|1|||
146401900|NCT03576131|527974166|FG006|Overall Study|Subject non-compliance|0|||
146401901|NCT03576131|527974167|FG007|Overall Study|Subject non-compliance|0|||
146401902|NCT00996632|527974172|FG000|Overall Study|Physician Decision|0|||
146401903|NCT00996632|527974173|FG001|Overall Study|Physician Decision|0|||
146401904|NCT00578448|527974184|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
146401905|NCT00578448|527974184|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
146401906|NCT00578448|527974184|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
146061660|NCT03518086|526743461|FG001|Overall Study|Non- compliance to Protocol|1|||
146061661|NCT03518086|526743462|FG002|Overall Study|Non- compliance to Protocol|0|||
146061662|NCT03518086|526743463|FG003|Overall Study|Non- compliance to Protocol|0|||
146061663|NCT03518086|526743460|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
146061664|NCT03518086|526743461|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
146061665|NCT03518086|526743462|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
146061666|NCT03518086|526743463|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
146401907|NCT00578448|527974184|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
146401908|NCT04221373|527974185|FG000|Overall Study|Physician Decision|4|||
146061667|NCT03518086|526743460|FG000|Overall Study|Site Terminated by Sponsor|0|||
146061668|NCT03518086|526743461|FG001|Overall Study|Site Terminated by Sponsor|1|||
146061669|NCT03518086|526743462|FG002|Overall Study|Site Terminated by Sponsor|0|||
146061670|NCT03518086|526743463|FG003|Overall Study|Site Terminated by Sponsor|0|||
146061671|NCT03518086|526743460|FG000|Overall Study|Pregnancy|0|||
146061672|NCT03518086|526743461|FG001|Overall Study|Pregnancy|0|||
146061673|NCT03518086|526743462|FG002|Overall Study|Pregnancy|0|||
146061674|NCT03518086|526743463|FG003|Overall Study|Pregnancy|2|||
146061675|NCT02151058|526745346|FG000|Overall Study|Withdrawal by Subject|1|||
146401909|NCT04221373|527974186|FG001|Overall Study|Physician Decision|0|||
146401910|NCT00627094|527974187|FG000|Overall Study|Adverse Event|8|||
146401911|NCT00627094|527974188|FG001|Overall Study|Adverse Event|7|||
146401912|NCT00627094|527974187|FG000|Overall Study|Lost to Follow-up|1|||
146401913|NCT00627094|527974188|FG001|Overall Study|Lost to Follow-up|0|||
146401914|NCT00627094|527974187|FG000|Overall Study|Withdrawal by Subject|1|||
146401915|NCT00627094|527974188|FG001|Overall Study|Withdrawal by Subject|1|||
146401916|NCT00627094|527974187|FG000|Overall Study|ulcer healed|1|||
146401917|NCT00627094|527974188|FG001|Overall Study|ulcer healed|7|||
146401918|NCT00627094|527974187|FG000|Overall Study|Other reason|1|||
146401919|NCT00627094|527974188|FG001|Overall Study|Other reason|0|||
146401920|NCT00539006|527974194|FG000|Pre-treatment|Other|0|||
146401921|NCT00539006|527974195|FG001|Pre-treatment|Other|1|||
146401922|NCT00539006|527974196|FG002|Pre-treatment|Other|0|||
146401923|NCT00539006|527974197|FG003|Pre-treatment|Other|0|||
146401924|NCT00539006|527974194|FG000|Treatment Period 1|Lost to Follow-up|0|||
146401925|NCT00539006|527974195|FG001|Treatment Period 1|Lost to Follow-up|0|||
146401926|NCT00539006|527974196|FG002|Treatment Period 1|Lost to Follow-up|1|||
146401927|NCT00539006|527974197|FG003|Treatment Period 1|Lost to Follow-up|0|||
146401928|NCT00539006|527974194|FG000|Treatment Period 1|Protocol Violation|0|||
146401929|NCT00539006|527974195|FG001|Treatment Period 1|Protocol Violation|0|||
146401930|NCT00539006|527974196|FG002|Treatment Period 1|Protocol Violation|1|||
146401931|NCT00539006|527974197|FG003|Treatment Period 1|Protocol Violation|0|||
146401932|NCT00539006|527974194|FG000|Treatment Period 1|Lack of Efficacy|0|||
146401933|NCT00539006|527974195|FG001|Treatment Period 1|Lack of Efficacy|0|||
146401934|NCT00539006|527974196|FG002|Treatment Period 1|Lack of Efficacy|0|||
146401935|NCT00539006|527974197|FG003|Treatment Period 1|Lack of Efficacy|1|||
146401936|NCT00539006|527974194|FG000|Washout|Adverse Event|2|||
146401937|NCT00539006|527974195|FG001|Washout|Adverse Event|1|||
146401938|NCT00539006|527974196|FG002|Washout|Adverse Event|0|||
146401939|NCT00539006|527974197|FG003|Washout|Adverse Event|0|||
146401940|NCT00539006|527974194|FG000|Washout|Protocol Violation|1|||
146401941|NCT00539006|527974195|FG001|Washout|Protocol Violation|1|||
146401942|NCT00539006|527974196|FG002|Washout|Protocol Violation|0|||
146401943|NCT00539006|527974197|FG003|Washout|Protocol Violation|0|||
146401944|NCT00539006|527974194|FG000|Washout|Withdrawal by Subject|0|||
146401945|NCT00539006|527974195|FG001|Washout|Withdrawal by Subject|2|||
146401946|NCT00539006|527974196|FG002|Washout|Withdrawal by Subject|0|||
146401947|NCT00539006|527974197|FG003|Washout|Withdrawal by Subject|0|||
146401948|NCT00539006|527974194|FG000|Washout|Failed to meet continuation criteria|16|||
146401949|NCT00539006|527974195|FG001|Washout|Failed to meet continuation criteria|5|||
146401950|NCT00539006|527974196|FG002|Washout|Failed to meet continuation criteria|14|||
146401951|NCT00539006|527974197|FG003|Washout|Failed to meet continuation criteria|6|||
146401952|NCT00539006|527974194|FG000|Washout|Other|1|||
146401953|NCT00539006|527974195|FG001|Washout|Other|1|||
146401954|NCT00539006|527974196|FG002|Washout|Other|2|||
146401955|NCT00539006|527974197|FG003|Washout|Other|3|||
146401956|NCT00539006|527974194|FG000|Treatment Period 2|Protocol Violation|1|||
146401957|NCT00539006|527974195|FG001|Treatment Period 2|Protocol Violation|0|||
146401958|NCT00539006|527974196|FG002|Treatment Period 2|Protocol Violation|0|||
146401959|NCT00539006|527974197|FG003|Treatment Period 2|Protocol Violation|0|||
146401960|NCT00539006|527974194|FG000|Treatment Period 2|Other|0|||
146401961|NCT00539006|527974195|FG001|Treatment Period 2|Other|1|||
146401962|NCT00539006|527974196|FG002|Treatment Period 2|Other|0|||
146401963|NCT00539006|527974197|FG003|Treatment Period 2|Other|0|||
146401964|NCT01965431|527974200|FG000|Overall Study|Adverse Event|0|||
146401965|NCT01965431|527974201|FG001|Overall Study|Adverse Event|1|||
146401966|NCT01965431|527974202|FG002|Overall Study|Adverse Event|0|||
146401967|NCT01965431|527974203|FG003|Overall Study|Adverse Event|0|||
146401968|NCT01965431|527974204|FG004|Overall Study|Adverse Event|0|||
146401969|NCT01965431|527974205|FG005|Overall Study|Adverse Event|0|||
146401970|NCT01965431|527974200|FG000|Overall Study|Other than stated above|6|||
146169947|NCT02173054|527134750|FG000|Overall Study|Withdrawal by Subject|0|||
146401971|NCT01965431|527974201|FG001|Overall Study|Other than stated above|5|||
146401972|NCT01965431|527974202|FG002|Overall Study|Other than stated above|6|||
146401973|NCT01965431|527974203|FG003|Overall Study|Other than stated above|6|||
146401974|NCT01965431|527974204|FG004|Overall Study|Other than stated above|6|||
146401975|NCT01965431|527974205|FG005|Overall Study|Other than stated above|6|||
146401976|NCT00577031|527974206|FG000|Overall Study|Adverse Event|52|||
146401977|NCT00577031|527974206|FG000|Overall Study|Progression of disease|93|||
146401978|NCT00577031|527974206|FG000|Overall Study|Protocol Violation|5|||
146401979|NCT00577031|527974206|FG000|Overall Study|Participant withdrew consent|13|||
146401980|NCT00577031|527974206|FG000|Overall Study|Participant non-compliance|5|||
146169948|NCT02173054|527134751|FG001|Overall Study|Withdrawal by Subject|0|||
146401981|NCT00577031|527974206|FG000|Overall Study|Need for surgery|17|||
146401982|NCT00577031|527974206|FG000|Overall Study|Medical decision|14|||
146401983|NCT00577031|527974206|FG000|Overall Study|Death|6|||
146401984|NCT04635631|527974207|FG000|Overall Study|Adverse Event|1|||
146401985|NCT04635631|527974207|FG000|Overall Study|Progressive disease|13|||
146401986|NCT04635631|527974207|FG000|Overall Study|Withdrawal by Subject|1|||
146401987|NCT01067339|527974210|FG000|Overall Study|Withdrawal by Subject|6|||
146401988|NCT01067339|527974211|FG001|Overall Study|Withdrawal by Subject|5|||
146401989|NCT00769132|527974212|FG000|Period 1|Adverse Event|1|||
146401990|NCT00769132|527974213|FG001|Period 1|Adverse Event|0|||
146401991|NCT00769132|527974214|FG002|Period 1|Adverse Event|0|||
146401992|NCT00769132|527974215|FG003|Period 1|Adverse Event|1|||
146401993|NCT00769132|527974212|FG000|Period 2|Withdrawal by Subject|0|||
146401994|NCT00769132|527974213|FG001|Period 2|Withdrawal by Subject|0|||
146401995|NCT00769132|527974214|FG002|Period 2|Withdrawal by Subject|0|||
146401996|NCT00769132|527974215|FG003|Period 2|Withdrawal by Subject|1|||
146401997|NCT00769132|527974212|FG000|Period 3|Withdrawal by Subject|1|||
146401998|NCT00769132|527974213|FG001|Period 3|Withdrawal by Subject|0|||
146401999|NCT00769132|527974214|FG002|Period 3|Withdrawal by Subject|0|||
146402000|NCT00769132|527974215|FG003|Period 3|Withdrawal by Subject|0|||
146402001|NCT00769132|527974212|FG000|Period 4|Withdrawal by Subject|0|||
146402002|NCT00769132|527974213|FG001|Period 4|Withdrawal by Subject|1|||
146402003|NCT00769132|527974214|FG002|Period 4|Withdrawal by Subject|0|||
146402004|NCT00769132|527974215|FG003|Period 4|Withdrawal by Subject|0|||
146402005|NCT00877799|527974217|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
146402006|NCT00877799|527974218|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
146402007|NCT00877799|527974219|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
146402008|NCT00877799|527974220|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
146402009|NCT00877799|527974221|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
146402010|NCT00877799|527974217|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
146402011|NCT00877799|527974218|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
146402012|NCT00877799|527974219|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
146402013|NCT00877799|527974220|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
146402014|NCT00877799|527974221|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
146402015|NCT00877799|527974217|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146402016|NCT00877799|527974218|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
146402017|NCT00877799|527974219|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146402018|NCT00877799|527974220|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146402019|NCT00877799|527974221|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
146402020|NCT00877799|527974217|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146402021|NCT00877799|527974218|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146402022|NCT00877799|527974219|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146402023|NCT00877799|527974220|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
146402024|NCT00877799|527974221|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
146402025|NCT00877799|527974217|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146402026|NCT00877799|527974218|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146402027|NCT00877799|527974219|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
146402028|NCT00877799|527974220|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
146402029|NCT00877799|527974221|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
146402030|NCT01360021|527974222|FG000|Overall Study|Eligibility criteria + other|2|||
146402031|NCT01360021|527974223|FG001|Overall Study|Eligibility criteria + other|1|||
146402032|NCT01360021|527974224|FG002|Overall Study|Eligibility criteria + other|1|||
146402033|NCT01360021|527974222|FG000|Overall Study|Protocol Violation|0|||
146402034|NCT01360021|527974223|FG001|Overall Study|Protocol Violation|0|||
146402035|NCT01360021|527974224|FG002|Overall Study|Protocol Violation|1|||
146402036|NCT01360021|527974222|FG000|Overall Study|Withdrawal by Subject|4|||
146402037|NCT01360021|527974223|FG001|Overall Study|Withdrawal by Subject|0|||
146402038|NCT01360021|527974224|FG002|Overall Study|Withdrawal by Subject|2|||
146402039|NCT01360021|527974222|FG000|Overall Study|Adverse Event|2|||
146402040|NCT01360021|527974223|FG001|Overall Study|Adverse Event|3|||
146402041|NCT01360021|527974224|FG002|Overall Study|Adverse Event|3|||
146402042|NCT00127192|527974225|FG000|Overall Study|Adverse Event|0|||
146402043|NCT00127192|527974226|FG001|Overall Study|Adverse Event|1|||
146402044|NCT00127192|527974227|FG002|Overall Study|Adverse Event|1|||
146169949|NCT02173054|527134752|FG002|Overall Study|Withdrawal by Subject|1|||
146169950|NCT01114204|527134753|FG000|Overall Study|Adverse Event|3|||
146402045|NCT00127192|527974228|FG003|Overall Study|Adverse Event|1|||
146402046|NCT00127192|527974229|FG004|Overall Study|Adverse Event|0|||
146402047|NCT00127192|527974225|FG000|Overall Study|Lack of Efficacy|2|||
146402048|NCT00127192|527974226|FG001|Overall Study|Lack of Efficacy|0|||
146402049|NCT00127192|527974227|FG002|Overall Study|Lack of Efficacy|0|||
146402050|NCT00127192|527974228|FG003|Overall Study|Lack of Efficacy|0|||
146402051|NCT00127192|527974229|FG004|Overall Study|Lack of Efficacy|2|||
146402052|NCT00127192|527974225|FG000|Overall Study|Withdrawal by Subject|0|||
146402053|NCT00127192|527974226|FG001|Overall Study|Withdrawal by Subject|0|||
146402054|NCT00127192|527974227|FG002|Overall Study|Withdrawal by Subject|1|||
146402055|NCT00127192|527974228|FG003|Overall Study|Withdrawal by Subject|0|||
146169951|NCT01114204|527134754|FG001|Overall Study|Adverse Event|2|||
146169952|NCT01114204|527134753|FG000|Overall Study|Lost to Follow-up|1|||
146402056|NCT00127192|527974229|FG004|Overall Study|Withdrawal by Subject|3|||
146402057|NCT00127192|527974225|FG000|Overall Study|Adverse event in pre-treatment period|1|||
146402058|NCT00127192|527974226|FG001|Overall Study|Adverse event in pre-treatment period|0|||
146402059|NCT00127192|527974227|FG002|Overall Study|Adverse event in pre-treatment period|0|||
146402060|NCT00127192|527974228|FG003|Overall Study|Adverse event in pre-treatment period|0|||
146402061|NCT00127192|527974229|FG004|Overall Study|Adverse event in pre-treatment period|0|||
146402062|NCT00203892|527974230|FG000|Overall Study|Physician Decision|1|||
146402063|NCT00203892|527974231|FG001|Overall Study|Physician Decision|2|||
146402064|NCT00203892|527974232|FG002|Overall Study|Physician Decision|0|||
146402065|NCT00203892|527974230|FG000|Overall Study|Death|1|||
146402066|NCT00203892|527974231|FG001|Overall Study|Death|0|||
146402067|NCT00203892|527974232|FG002|Overall Study|Death|0|||
146402068|NCT00806416|527974235|FG000|Period 1 - Part I|Adverse Event|0|||
146402069|NCT00806416|527974236|FG001|Period 1 - Part I|Adverse Event|1|||
146402070|NCT00806416|527974237|FG002|Period 1 - Part I|Adverse Event|0|||
146402071|NCT00806416|527974238|FG003|Period 1 - Part I|Adverse Event|0|||
146402072|NCT00806416|527974235|FG000|Period 1 - Part I|Lost to Follow-up|0|||
146402073|NCT00806416|527974236|FG001|Period 1 - Part I|Lost to Follow-up|2|||
146402074|NCT00806416|527974237|FG002|Period 1 - Part I|Lost to Follow-up|0|||
146402075|NCT00806416|527974238|FG003|Period 1 - Part I|Lost to Follow-up|0|||
146402076|NCT00806416|527974235|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
146402077|NCT00806416|527974236|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
146402078|NCT00806416|527974237|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
146402079|NCT00806416|527974238|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
146402080|NCT00806416|527974235|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
146402081|NCT00806416|527974236|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
146402082|NCT00806416|527974237|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
146402083|NCT00806416|527974238|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
146402084|NCT01102972|527974243|FG000|Overall Study|Adverse Event|8|||
146402085|NCT01102972|527974244|FG001|Overall Study|Adverse Event|2|||
146402086|NCT01102972|527974243|FG000|Overall Study|Lack of Efficacy|2|||
146402087|NCT01102972|527974244|FG001|Overall Study|Lack of Efficacy|1|||
146402088|NCT01102972|527974243|FG000|Overall Study|Protocol Violation|1|||
146402089|NCT01102972|527974244|FG001|Overall Study|Protocol Violation|0|||
146402090|NCT01102972|527974243|FG000|Overall Study|Lost to Follow-up|10|||
146402091|NCT01102972|527974244|FG001|Overall Study|Lost to Follow-up|5|||
146402092|NCT01102972|527974243|FG000|Overall Study|Investigator Discretion|2|||
146402093|NCT01102972|527974244|FG001|Overall Study|Investigator Discretion|0|||
146402094|NCT01102972|527974243|FG000|Overall Study|Withdrawal by Subject|6|||
146402095|NCT01102972|527974244|FG001|Overall Study|Withdrawal by Subject|6|||
146402096|NCT04935931|527974245|FG000|Overall Study|Withdrawal by Subject|1|||
146402097|NCT02596009|527974248|FG000|Overall Study|Administrative problems|0|||
146402098|NCT02596009|527974249|FG001|Overall Study|Administrative problems|1|||
146402099|NCT02596009|527974250|FG002|Overall Study|Administrative problems|0|||
146402100|NCT02596009|527974251|FG003|Overall Study|Administrative problems|0|||
146402101|NCT02596009|527974252|FG004|Overall Study|Administrative problems|0|||
146402102|NCT02596009|527974253|FG005|Overall Study|Administrative problems|0|||
146402103|NCT01071278|527974254|FG000|Overall Study|Premature Discontinuation|254|||
146402104|NCT01071278|527974254|FG000|Overall Study|Completion Status Unknown|459|||
146402105|NCT00903409|527974255|FG000|Overall Study|Adverse Event|11|||
146402106|NCT00903409|527974256|FG001|Overall Study|Adverse Event|9|||
146402107|NCT00903409|527974255|FG000|Overall Study|Non-compliance with Protocol|1|||
146402108|NCT00903409|527974256|FG001|Overall Study|Non-compliance with Protocol|1|||
146402109|NCT00903409|527974255|FG000|Overall Study|Laboratory Abnormality|2|||
146402110|NCT00903409|527974256|FG001|Overall Study|Laboratory Abnormality|0|||
146402111|NCT00903409|527974255|FG000|Overall Study|Withdrawal by Subject|8|||
146402112|NCT00903409|527974256|FG001|Overall Study|Withdrawal by Subject|8|||
146402113|NCT00903409|527974255|FG000|Overall Study|Other|2|||
146402114|NCT00903409|527974256|FG001|Overall Study|Other|3|||
146402115|NCT00903409|527974255|FG000|Overall Study|Lost to Follow-up|2|||
146402116|NCT00903409|527974256|FG001|Overall Study|Lost to Follow-up|6|||
146402117|NCT03539952|527974258|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
146402118|NCT03539952|527974259|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
146402119|NCT03539952|527974258|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
146402120|NCT03539952|527974259|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
146402121|NCT03539952|527974258|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
146402122|NCT03539952|527974259|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
146402123|NCT03539952|527974258|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
146402124|NCT03539952|527974259|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
146402125|NCT03539952|527974258|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
146402126|NCT03539952|527974259|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
146402127|NCT03539952|527974258|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
146402128|NCT03539952|527974259|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
146402129|NCT03539952|527974258|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
146061676|NCT02151058|526745347|FG001|Overall Study|Withdrawal by Subject|1|||
146061677|NCT02151058|526745348|FG002|Overall Study|Withdrawal by Subject|3|||
146061678|NCT02151058|526745346|FG000|Overall Study|Lost to Follow-up|1|||
146061679|NCT02151058|526745347|FG001|Overall Study|Lost to Follow-up|0|||
146061680|NCT02151058|526745348|FG002|Overall Study|Lost to Follow-up|2|||
146061681|NCT00124943|526745349|FG000|Phase II|Adverse Event|0|||
146061682|NCT00124943|526745350|FG001|Phase II|Adverse Event|2|||
146061683|NCT00124943|526745351|FG002|Phase II|Adverse Event|0|||
146061684|NCT00124943|526745352|FG003|Phase II|Adverse Event|1|||
146061685|NCT00124943|526745349|FG000|Phase II|Protocol Violation|0|||
146061686|NCT00124943|526745350|FG001|Phase II|Protocol Violation|0|||
146061687|NCT00124943|526745351|FG002|Phase II|Protocol Violation|0|||
146061688|NCT00124943|526745352|FG003|Phase II|Protocol Violation|1|||
146061689|NCT00124943|526745349|FG000|Phase II|Lost to Follow-up|0|||
146061690|NCT00124943|526745350|FG001|Phase II|Lost to Follow-up|0|||
146061691|NCT00124943|526745351|FG002|Phase II|Lost to Follow-up|0|||
146061692|NCT00124943|526745352|FG003|Phase II|Lost to Follow-up|1|||
146061693|NCT00124943|526745349|FG000|Phase II|Withdrawal by Subject|0|||
146061694|NCT00124943|526745350|FG001|Phase II|Withdrawal by Subject|0|||
146061695|NCT00124943|526745351|FG002|Phase II|Withdrawal by Subject|0|||
146061696|NCT00124943|526745352|FG003|Phase II|Withdrawal by Subject|2|||
146061697|NCT03337477|526745353|FG000|Overall Study|not categorized into the listed ones|11|||
146061698|NCT03337477|526745354|FG001|Overall Study|not categorized into the listed ones|9|||
146061699|NCT03337477|526745353|FG000|Overall Study|Withdrawal by Subject|0|||
146061700|NCT03337477|526745354|FG001|Overall Study|Withdrawal by Subject|1|||
146061701|NCT03337477|526745353|FG000|Overall Study|Death|0|||
146061702|NCT03337477|526745354|FG001|Overall Study|Death|1|||
146061703|NCT03337477|526745353|FG000|Overall Study|Lost to Follow-up|0|||
146061704|NCT03337477|526745354|FG001|Overall Study|Lost to Follow-up|2|||
146061705|NCT02443688|526745357|FG000|Overall Study|Adverse Event|2|||
146061706|NCT02443688|526745358|FG001|Overall Study|Adverse Event|3|||
146061707|NCT02443688|526745359|FG002|Overall Study|Adverse Event|2|||
146061708|NCT02443688|526745357|FG000|Overall Study|Lost to Follow-up|1|||
146061709|NCT02443688|526745358|FG001|Overall Study|Lost to Follow-up|0|||
146061710|NCT02443688|526745359|FG002|Overall Study|Lost to Follow-up|0|||
146061711|NCT02443688|526745357|FG000|Overall Study|Physician Decision|3|||
146061712|NCT02443688|526745358|FG001|Overall Study|Physician Decision|0|||
146061713|NCT02443688|526745359|FG002|Overall Study|Physician Decision|1|||
146061714|NCT02443688|526745357|FG000|Overall Study|Pregnancy|0|||
146061715|NCT02443688|526745358|FG001|Overall Study|Pregnancy|0|||
146061716|NCT02443688|526745359|FG002|Overall Study|Pregnancy|1|||
146061717|NCT02443688|526745357|FG000|Overall Study|Withdrawal by Subject|3|||
146061718|NCT02443688|526745358|FG001|Overall Study|Withdrawal by Subject|3|||
146061719|NCT02443688|526745359|FG002|Overall Study|Withdrawal by Subject|4|||
146061720|NCT02443688|526745357|FG000|Overall Study|Non-compliance with study drug|1|||
146061721|NCT02443688|526745358|FG001|Overall Study|Non-compliance with study drug|2|||
146061722|NCT02443688|526745359|FG002|Overall Study|Non-compliance with study drug|4|||
146061723|NCT02443688|526745357|FG000|Overall Study|Sponsor Request|2|||
146061724|NCT02443688|526745358|FG001|Overall Study|Sponsor Request|1|||
146061725|NCT02443688|526745359|FG002|Overall Study|Sponsor Request|0|||
146061726|NCT02177123|526745367|FG000|Overall Study|Lost to Follow-up|6|||
146061727|NCT02177123|526745367|FG000|Overall Study|Withdrawal by Subject|4|||
146061728|NCT02177123|526745367|FG000|Overall Study|Adverse Event|4|||
146061729|NCT02177123|526745367|FG000|Overall Study|Physician Decision|3|||
146061730|NCT02177123|526745367|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
146061731|NCT02177123|526745367|FG000|Overall Study|Excluded for medical reasons|2|||
146061732|NCT02177123|526745367|FG000|Overall Study|Death|1|||
146061733|NCT02177123|526745367|FG000|Overall Study|Other|1|||
146061734|NCT02177123|526745367|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
146061735|NCT05660577|526745368|FG000|Overall Study|Discontinued|9|||
146061736|NCT00481832|526745373|FG000|Enrollment|Physician Decision|8|||
146061737|NCT00481832|526745373|FG000|Enrollment|Unable to collect enough stem cells|2|||
146061738|NCT00481832|526745373|FG000|Inter-transplant Period|Adverse Event|4|||
146061739|NCT00481832|526745373|FG000|Inter-transplant Period|Death|3|||
146061740|NCT00481832|526745373|FG000|Inter-transplant Period|Physician Decision|4|||
146061741|NCT00481832|526745373|FG000|Inter-transplant Period|Disease relapse|11|||
146061742|NCT00481832|526745373|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
146061743|NCT00581308|526745374|FG000|Pre Discharge|Lost to Follow-up|1|||
146061744|NCT00581308|526745374|FG000|Pre Discharge|Device Removed|1|||
146061745|NCT00581308|526745374|FG000|Month 1|Lost to Follow-up|3|||
146061746|NCT00581308|526745374|FG000|Month 1|Withdrawal by Subject|2|||
146061747|NCT00581308|526745374|FG000|Month 1|Device Removed|2|||
146061748|NCT00581308|526745374|FG000|Month 1|Uknown|1|||
146061749|NCT00581308|526745374|FG000|Month 6|Lost to Follow-up|1|||
146061750|NCT00581308|526745374|FG000|Month 6|Withdrawal by Subject|2|||
146061751|NCT00581308|526745374|FG000|Month 12|Death|1|||
146061752|NCT00581308|526745374|FG000|Month 12|Lost to Follow-up|14|||
146061753|NCT00581308|526745374|FG000|Month 12|Withdrawal by Subject|3|||
146061754|NCT00581308|526745374|FG000|Month 12|Device Removed|1|||
146061755|NCT00581308|526745374|FG000|Month 12|Other|1|||
146061756|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
146061757|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
146061758|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
146061759|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
146061760|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
146061761|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146061762|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146061763|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
146061764|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146061765|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
146061766|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
146061767|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
146061768|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
146061769|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
146061770|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
146061771|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Other|1|||
146061772|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Other|5|||
146061773|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Other|0|||
146061774|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Other|2|||
146061775|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Other|3|||
146061776|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
146061777|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
146061778|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
146061779|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
146061780|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
146061781|NCT02006472|526745378|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146061782|NCT02006472|526745379|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
146061783|NCT02006472|526745380|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146061784|NCT02006472|526745381|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
146061785|NCT02006472|526745382|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
146061786|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146061787|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
146061788|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
146061789|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146061790|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
146061791|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
146061792|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
146061793|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
146061794|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
146061795|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
146061796|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
146061797|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
146061798|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
146061799|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
146061800|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
146061801|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Other|0|||
146061802|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Other|1|||
146061803|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Other|0|||
146061804|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Other|1|||
146061805|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Other|0|||
146061806|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Not treated|0|||
146061807|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Not treated|0|||
146061808|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Not treated|2|||
146061809|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Not treated|0|||
146061810|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Not treated|0|||
146061811|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
146061812|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
146061813|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
146061814|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
146061815|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
146061816|NCT02006472|526745378|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
146061817|NCT02006472|526745379|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
146061818|NCT02006472|526745380|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
146061819|NCT02006472|526745381|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
146061820|NCT02006472|526745382|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
146061821|NCT00886379|526745383|FG000|Overall Study|Transferred Schools|0|||
146061822|NCT00886379|526745384|FG001|Overall Study|Transferred Schools|0|||
146061823|NCT00886379|526745385|FG002|Overall Study|Transferred Schools|2|||
146061824|NCT00886379|526745386|FG003|Overall Study|Transferred Schools|1|||
146061825|NCT00886379|526745387|FG004|Overall Study|Transferred Schools|1|||
146061826|NCT00886379|526745383|FG000|Overall Study|Final blood draw not obtained|3|||
146061827|NCT00886379|526745384|FG001|Overall Study|Final blood draw not obtained|3|||
146061828|NCT00886379|526745385|FG002|Overall Study|Final blood draw not obtained|4|||
146169953|NCT01114204|527134754|FG001|Overall Study|Lost to Follow-up|0|||
146169954|NCT01114204|527134753|FG000|Overall Study|Withdrawal by Subject|10|||
146402130|NCT03539952|527974259|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
146402131|NCT02184988|527974260|FG000|Overall Study|Pregnancy|2|||
146402132|NCT02184988|527974260|FG000|Overall Study|Adverse Event|2|||
146402133|NCT02184988|527974260|FG000|Overall Study|moving away/travelling/unable to complet|6|||
146402134|NCT02184988|527974260|FG000|Overall Study|work scheduling issues|4|||
146402135|NCT02184988|527974260|FG000|Overall Study|various other reasons|9|||
146402136|NCT02184988|527974260|FG000|Overall Study|Lost to Follow-up|32|||
146402137|NCT01821391|527974261|FG000|Overall Study|Adverse Event|1|||
146402138|NCT01821391|527974262|FG001|Overall Study|Adverse Event|0|||
146402139|NCT01843660|527974263|FG000|Overall Study|Other|30|||
146402140|NCT01977482|527974264|FG000|Overall Study|Adverse Event|0|||
146402141|NCT01977482|527974265|FG001|Overall Study|Adverse Event|1|||
146402142|NCT01977482|527974266|FG002|Overall Study|Adverse Event|1|||
146402143|NCT01977482|527974267|FG003|Overall Study|Adverse Event|0|||
146402144|NCT01977482|527974268|FG004|Overall Study|Adverse Event|2|||
146402145|NCT01977482|527974269|FG005|Overall Study|Adverse Event|0|||
146402146|NCT01977482|527974264|FG000|Overall Study|Lost to Follow-up|1|||
146402147|NCT01977482|527974265|FG001|Overall Study|Lost to Follow-up|0|||
146402148|NCT01977482|527974266|FG002|Overall Study|Lost to Follow-up|0|||
146402149|NCT01977482|527974267|FG003|Overall Study|Lost to Follow-up|0|||
146402150|NCT01977482|527974268|FG004|Overall Study|Lost to Follow-up|0|||
146402151|NCT01977482|527974269|FG005|Overall Study|Lost to Follow-up|0|||
146402152|NCT01977482|527974264|FG000|Overall Study|Physician Decision|0|||
146402153|NCT01977482|527974265|FG001|Overall Study|Physician Decision|1|||
146402154|NCT01977482|527974266|FG002|Overall Study|Physician Decision|0|||
146402155|NCT01977482|527974267|FG003|Overall Study|Physician Decision|0|||
146402156|NCT01977482|527974268|FG004|Overall Study|Physician Decision|0|||
146402157|NCT01977482|527974269|FG005|Overall Study|Physician Decision|0|||
146402158|NCT01977482|527974264|FG000|Overall Study|Protocol Violation|0|||
146402159|NCT01977482|527974265|FG001|Overall Study|Protocol Violation|0|||
146402160|NCT01977482|527974266|FG002|Overall Study|Protocol Violation|1|||
146402161|NCT01977482|527974267|FG003|Overall Study|Protocol Violation|0|||
146402162|NCT01977482|527974268|FG004|Overall Study|Protocol Violation|0|||
146402163|NCT01977482|527974269|FG005|Overall Study|Protocol Violation|0|||
146402164|NCT01977482|527974264|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146402165|NCT01977482|527974265|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
146402166|NCT01977482|527974266|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
146402167|NCT01977482|527974267|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
146402168|NCT01977482|527974268|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146402169|NCT01977482|527974269|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
146402170|NCT01977482|527974264|FG000|Overall Study|Withdrawal by Subject|2|||
146402171|NCT01977482|527974265|FG001|Overall Study|Withdrawal by Subject|4|||
146402172|NCT01977482|527974266|FG002|Overall Study|Withdrawal by Subject|1|||
146402173|NCT01977482|527974267|FG003|Overall Study|Withdrawal by Subject|3|||
146402174|NCT01977482|527974268|FG004|Overall Study|Withdrawal by Subject|1|||
146402175|NCT01977482|527974269|FG005|Overall Study|Withdrawal by Subject|5|||
146402176|NCT00209560|527974270|FG000|Overall Study|Lack of Efficacy|1|||
146402177|NCT00209560|527974271|FG001|Overall Study|Lack of Efficacy|0|||
146402178|NCT01608321|527974278|FG000|Overall Study|Withdrawal by Subject|1|||
146402179|NCT01608321|527974279|FG001|Overall Study|Withdrawal by Subject|0|||
146402180|NCT01721369|527974280|FG000|Overall Study|Not initial etiological diagnosis|12|||
146402181|NCT01819467|527975897|FG000|Overall Study|Physician Decision|20|||
146402182|NCT01819467|527975898|FG001|Overall Study|Physician Decision|9|||
146402183|NCT03926728|527975901|FG000|Overall Study|Withdrawal by Subject|0|||
146402184|NCT03926728|527975902|FG001|Overall Study|Withdrawal by Subject|1|||
146402185|NCT03926728|527975903|FG002|Overall Study|Withdrawal by Subject|1|||
146402186|NCT03926728|527975904|FG003|Overall Study|Withdrawal by Subject|0|||
146402187|NCT03926728|527975905|FG004|Overall Study|Withdrawal by Subject|0|||
146402188|NCT03926728|527975906|FG005|Overall Study|Withdrawal by Subject|1|||
146402189|NCT03926728|527975907|FG006|Overall Study|Withdrawal by Subject|1|||
146402190|NCT03926728|527975908|FG007|Overall Study|Withdrawal by Subject|0|||
146169955|NCT01114204|527134754|FG001|Overall Study|Withdrawal by Subject|6|||
146169956|NCT01114204|527134753|FG000|Overall Study|Death|1|||
146402191|NCT03926728|527975909|FG008|Overall Study|Withdrawal by Subject|0|||
146402192|NCT03926728|527975910|FG009|Overall Study|Withdrawal by Subject|1|||
146402193|NCT03926728|527975911|FG010|Overall Study|Withdrawal by Subject|0|||
146402194|NCT03926728|527975912|FG011|Overall Study|Withdrawal by Subject|0|||
146402195|NCT03993288|527975913|FG000|Overall Study|Lost to Follow-up|2|||
146402196|NCT03993288|527975914|FG001|Overall Study|Lost to Follow-up|1|||
146402197|NCT03993288|527975913|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
146402198|NCT03993288|527975914|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
146169957|NCT01114204|527134754|FG001|Overall Study|Death|0|||
146402199|NCT03993288|527975913|FG000|Overall Study|wrong randomization|0|||
146402200|NCT03993288|527975914|FG001|Overall Study|wrong randomization|1|||
146402201|NCT03993288|527975913|FG000|Overall Study|improper enrollment|0|||
146169958|NCT01114204|527134753|FG000|Overall Study|Other-Personal reasons|2|||
146169959|NCT01114204|527134754|FG001|Overall Study|Other-Personal reasons|0|||
146169960|NCT01114204|527134753|FG000|Overall Study|Other-Medical monitor request|1|||
146169961|NCT01114204|527134754|FG001|Overall Study|Other-Medical monitor request|0|||
146169962|NCT01114204|527134753|FG000|Overall Study|Other-Participant request|2|||
146169963|NCT01114204|527134754|FG001|Overall Study|Other-Participant request|0|||
146169964|NCT01114204|527134753|FG000|Overall Study|Other-Protocol Violation|1|||
146169965|NCT01114204|527134754|FG001|Overall Study|Other-Protocol Violation|0|||
146169966|NCT00991341|527134762|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
146169967|NCT00991341|527134763|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
146169968|NCT00991341|527134762|FG000|Overall Study|Death|3|||
146169969|NCT00991341|527134763|FG001|Overall Study|Death|0|||
146169970|NCT00991341|527134762|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
146169971|NCT00991341|527134763|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
146169972|NCT00991341|527134762|FG000|Overall Study|Physician Decision|1|||
146169973|NCT00991341|527134763|FG001|Overall Study|Physician Decision|2|||
146169974|NCT00991341|527134762|FG000|Overall Study|Withdrawal by Subject|3|||
146169975|NCT00991341|527134763|FG001|Overall Study|Withdrawal by Subject|4|||
146169976|NCT03010462|527134778|FG000|Overall Study|Withdrawal by Subject|3|||
146169977|NCT03010462|527134779|FG001|Overall Study|Withdrawal by Subject|1|||
146169978|NCT02799472|527134782|FG000|Overall Study|Withdrawal by Subject|2|||
146169979|NCT02799472|527134783|FG001|Overall Study|Withdrawal by Subject|4|||
146169980|NCT02799472|527134782|FG000|Overall Study|Lack of Efficacy|2|||
146169981|NCT02799472|527134783|FG001|Overall Study|Lack of Efficacy|0|||
146169982|NCT02799472|527134782|FG000|Overall Study|Lost to Follow-up|0|||
146169983|NCT02799472|527134783|FG001|Overall Study|Lost to Follow-up|1|||
146169984|NCT02287584|527134784|FG000|the Double-blind Phase|Adverse Event|17|||
146169985|NCT02287584|527134785|FG001|the Double-blind Phase|Adverse Event|17|||
146169986|NCT02287584|527134786|FG002|the Double-blind Phase|Adverse Event|12|||
146169987|NCT02287584|527134787|FG003|the Double-blind Phase|Adverse Event|0|||
146169988|NCT02287584|527134788|FG004|the Double-blind Phase|Adverse Event|0|||
146169989|NCT02287584|527134789|FG005|the Double-blind Phase|Adverse Event|0|||
146169990|NCT02287584|527134784|FG000|the Double-blind Phase|Lack of Efficacy|18|||
146169991|NCT02287584|527134785|FG001|the Double-blind Phase|Lack of Efficacy|8|||
146169992|NCT02287584|527134786|FG002|the Double-blind Phase|Lack of Efficacy|8|||
146169993|NCT02287584|527134787|FG003|the Double-blind Phase|Lack of Efficacy|0|||
146169994|NCT02287584|527134788|FG004|the Double-blind Phase|Lack of Efficacy|0|||
146169995|NCT02287584|527134789|FG005|the Double-blind Phase|Lack of Efficacy|0|||
146169996|NCT02287584|527134784|FG000|the Double-blind Phase|Lost to Follow-up|0|||
146169997|NCT02287584|527134785|FG001|the Double-blind Phase|Lost to Follow-up|1|||
146169998|NCT02287584|527134786|FG002|the Double-blind Phase|Lost to Follow-up|1|||
146169999|NCT02287584|527134787|FG003|the Double-blind Phase|Lost to Follow-up|0|||
146170000|NCT02287584|527134788|FG004|the Double-blind Phase|Lost to Follow-up|0|||
146170001|NCT02287584|527134789|FG005|the Double-blind Phase|Lost to Follow-up|0|||
146170002|NCT02287584|527134784|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
146170003|NCT02287584|527134785|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
146170004|NCT02287584|527134786|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
146170005|NCT02287584|527134787|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
146170006|NCT02287584|527134788|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
146170007|NCT02287584|527134789|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
146170008|NCT02287584|527134784|FG000|the Double-blind Phase|Pregnancy|0|||
146170009|NCT02287584|527134785|FG001|the Double-blind Phase|Pregnancy|1|||
146170010|NCT02287584|527134786|FG002|the Double-blind Phase|Pregnancy|0|||
146170011|NCT02287584|527134787|FG003|the Double-blind Phase|Pregnancy|0|||
146170012|NCT02287584|527134788|FG004|the Double-blind Phase|Pregnancy|0|||
146170013|NCT02287584|527134789|FG005|the Double-blind Phase|Pregnancy|0|||
146170014|NCT02287584|527134784|FG000|the Double-blind Phase|Protocol Violation|0|||
146170015|NCT02287584|527134785|FG001|the Double-blind Phase|Protocol Violation|3|||
146170016|NCT02287584|527134786|FG002|the Double-blind Phase|Protocol Violation|0|||
146170017|NCT02287584|527134787|FG003|the Double-blind Phase|Protocol Violation|0|||
146170018|NCT02287584|527134788|FG004|the Double-blind Phase|Protocol Violation|0|||
146170019|NCT02287584|527134789|FG005|the Double-blind Phase|Protocol Violation|0|||
146170020|NCT02287584|527134784|FG000|the Double-blind Phase|other reasons|0|||
146170021|NCT02287584|527134785|FG001|the Double-blind Phase|other reasons|0|||
146170022|NCT02287584|527134786|FG002|the Double-blind Phase|other reasons|1|||
146170023|NCT02287584|527134787|FG003|the Double-blind Phase|other reasons|0|||
146170024|NCT02287584|527134788|FG004|the Double-blind Phase|other reasons|0|||
146170025|NCT02287584|527134789|FG005|the Double-blind Phase|other reasons|0|||
146170026|NCT02287584|527134784|FG000|the Open-label Phase|Did not receive drug|0|||
146170027|NCT02287584|527134785|FG001|the Open-label Phase|Did not receive drug|0|||
146170028|NCT02287584|527134786|FG002|the Open-label Phase|Did not receive drug|0|||
146170029|NCT02287584|527134787|FG003|the Open-label Phase|Did not receive drug|7|||
146170030|NCT02287584|527134788|FG004|the Open-label Phase|Did not receive drug|6|||
146170031|NCT02287584|527134789|FG005|the Open-label Phase|Did not receive drug|4|||
146170032|NCT02287584|527134784|FG000|the Open-label Phase|Adverse Event|0|||
146061829|NCT00886379|526745386|FG003|Overall Study|Final blood draw not obtained|2|||
146061830|NCT00886379|526745387|FG004|Overall Study|Final blood draw not obtained|2|||
146061831|NCT03219723|526745388|FG000|Overall Study|Case Report Forms Uncollected|6|||
146061832|NCT03219723|526745388|FG000|Overall Study|Protocol Deviation|4|||
146061833|NCT03137381|526745389|FG000|Overall Study|Adverse Event|3|||
146061834|NCT03137381|526745390|FG001|Overall Study|Adverse Event|0|||
146061835|NCT03137381|526745391|FG002|Overall Study|Adverse Event|2|||
146061836|NCT03137381|526745392|FG003|Overall Study|Adverse Event|0|||
146061837|NCT03137381|526745389|FG000|Overall Study|Lost to Follow-up|2|||
146061838|NCT03137381|526745390|FG001|Overall Study|Lost to Follow-up|1|||
146061839|NCT03137381|526745391|FG002|Overall Study|Lost to Follow-up|1|||
146061840|NCT03137381|526745392|FG003|Overall Study|Lost to Follow-up|0|||
146061841|NCT03137381|526745389|FG000|Overall Study|Protocol deviation|1|||
146061842|NCT03137381|526745390|FG001|Overall Study|Protocol deviation|1|||
146061843|NCT03137381|526745391|FG002|Overall Study|Protocol deviation|0|||
146061844|NCT03137381|526745392|FG003|Overall Study|Protocol deviation|1|||
146061845|NCT03137381|526745389|FG000|Overall Study|Withdrawal by Investigator|0|||
146061846|NCT03137381|526745390|FG001|Overall Study|Withdrawal by Investigator|1|||
146061847|NCT03137381|526745391|FG002|Overall Study|Withdrawal by Investigator|1|||
146061848|NCT03137381|526745392|FG003|Overall Study|Withdrawal by Investigator|0|||
146061849|NCT03137381|526745389|FG000|Overall Study|Withdrawal by Subject|3|||
146061850|NCT03137381|526745390|FG001|Overall Study|Withdrawal by Subject|4|||
146061851|NCT03137381|526745391|FG002|Overall Study|Withdrawal by Subject|3|||
146061852|NCT03137381|526745392|FG003|Overall Study|Withdrawal by Subject|0|||
146061853|NCT03137381|526745389|FG000|Overall Study|Pregnancy|0|||
146061854|NCT03137381|526745390|FG001|Overall Study|Pregnancy|0|||
146061855|NCT03137381|526745391|FG002|Overall Study|Pregnancy|1|||
146061856|NCT03137381|526745392|FG003|Overall Study|Pregnancy|0|||
146061857|NCT00459316|526745397|FG000|Steps 1 & 2|Other eligibility failure|1|||
146061858|NCT00459316|526745398|FG001|Steps 1 & 2|Other eligibility failure|1|||
146061859|NCT00459316|526745399|FG002|Steps 1 & 2|Other eligibility failure|0|||
146061860|NCT00459316|526745397|FG000|Steps 1 & 2|Death|1|||
146061861|NCT00459316|526745398|FG001|Steps 1 & 2|Death|1|||
146061862|NCT00459316|526745399|FG002|Steps 1 & 2|Death|0|||
146061863|NCT00459316|526745397|FG000|Steps 1 & 2|Not able to get to clinic|7|||
146061864|NCT00459316|526745398|FG001|Steps 1 & 2|Not able to get to clinic|4|||
146061865|NCT00459316|526745399|FG002|Steps 1 & 2|Not able to get to clinic|0|||
146061866|NCT00459316|526745397|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
146061867|NCT00459316|526745398|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
146061868|NCT00459316|526745399|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
146061869|NCT00459316|526745397|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
146061870|NCT00459316|526745398|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
146061871|NCT00459316|526745399|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
146061872|NCT00459316|526745397|FG000|Steps 1 & 2|Lost to Follow-up|5|||
146061873|NCT00459316|526745398|FG001|Steps 1 & 2|Lost to Follow-up|0|||
146061874|NCT00459316|526745399|FG002|Steps 1 & 2|Lost to Follow-up|2|||
146061875|NCT00459316|526745397|FG000|Step 3|Withdrawal by Subject|3|||
146061876|NCT00459316|526745398|FG001|Step 3|Withdrawal by Subject|0|||
146061877|NCT00459316|526745399|FG002|Step 3|Withdrawal by Subject|1|||
146061878|NCT01980017|526745400|FG000|Overall Study|Lost to Follow-up|30|||
146061879|NCT01980017|526745401|FG001|Overall Study|Lost to Follow-up|21|||
146061880|NCT01980017|526745400|FG000|Overall Study|Death|0|||
146061881|NCT01980017|526745401|FG001|Overall Study|Death|1|||
146061882|NCT03044106|526745403|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
146061883|NCT03044106|526745404|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
146061884|NCT01207414|526745405|FG000|Overall Study|Adverse Event|25|||
146061885|NCT01207414|526745406|FG001|Overall Study|Adverse Event|39|||
146061886|NCT01207414|526745405|FG000|Overall Study|Abnormal test procedure results|0|||
146061887|NCT01207414|526745406|FG001|Overall Study|Abnormal test procedure results|1|||
146061888|NCT01207414|526745405|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146170033|NCT02287584|527134785|FG001|the Open-label Phase|Adverse Event|0|||
146170034|NCT02287584|527134786|FG002|the Open-label Phase|Adverse Event|0|||
146061889|NCT01207414|526745406|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146061890|NCT01207414|526745405|FG000|Overall Study|Patient withdrew consent|14|||
146061891|NCT01207414|526745406|FG001|Overall Study|Patient withdrew consent|11|||
146061892|NCT01207414|526745405|FG000|Overall Study|Lost to Follow-up|15|||
146061893|NCT01207414|526745406|FG001|Overall Study|Lost to Follow-up|17|||
146061894|NCT01207414|526745405|FG000|Overall Study|Administrative problems|1|||
146061895|NCT01207414|526745406|FG001|Overall Study|Administrative problems|1|||
146170035|NCT02287584|527134787|FG003|the Open-label Phase|Adverse Event|15|||
146170036|NCT02287584|527134788|FG004|the Open-label Phase|Adverse Event|12|||
146061896|NCT01207414|526745405|FG000|Overall Study|Protocol deviation|12|||
146061897|NCT01207414|526745406|FG001|Overall Study|Protocol deviation|9|||
146061898|NCT01207414|526745405|FG000|Overall Study|Randomized in error|1|||
146061899|NCT01207414|526745406|FG001|Overall Study|Randomized in error|0|||
146061900|NCT01748292|526745407|FG000|Overall Study|Adverse Event|2|||
146170037|NCT02287584|527134789|FG005|the Open-label Phase|Adverse Event|16|||
146061901|NCT01748292|526745408|FG001|Overall Study|Adverse Event|4|||
146061902|NCT01748292|526745407|FG000|Overall Study|Lost to Follow-up|0|||
146061903|NCT01748292|526745408|FG001|Overall Study|Lost to Follow-up|3|||
146061904|NCT01748292|526745407|FG000|Overall Study|Death|0|||
146061905|NCT01748292|526745408|FG001|Overall Study|Death|3|||
146061906|NCT01748292|526745407|FG000|Overall Study|Withdrawal by Subject|0|||
146061907|NCT01748292|526745408|FG001|Overall Study|Withdrawal by Subject|2|||
146061908|NCT02057250|526745409|FG000|AID Assessment Phase|Adverse Event|3|||
146061909|NCT02057250|526745410|FG001|AID Assessment Phase|Adverse Event|2|||
146061910|NCT02057250|526745411|FG002|AID Assessment Phase|Adverse Event|6|||
146061911|NCT02057250|526745412|FG003|AID Assessment Phase|Adverse Event|1|||
146061912|NCT02057250|526745413|FG004|AID Assessment Phase|Adverse Event|0|||
146061913|NCT02057250|526745409|FG000|AID Assessment Phase|Other than specified above|1|||
146061914|NCT02057250|526745410|FG001|AID Assessment Phase|Other than specified above|1|||
146061915|NCT02057250|526745411|FG002|AID Assessment Phase|Other than specified above|1|||
146061916|NCT02057250|526745412|FG003|AID Assessment Phase|Other than specified above|1|||
146061917|NCT02057250|526745413|FG004|AID Assessment Phase|Other than specified above|0|||
146061918|NCT02057250|526745409|FG000|Extension Phase|Adverse Event|0|||
146061919|NCT02057250|526745410|FG001|Extension Phase|Adverse Event|0|||
146061920|NCT02057250|526745411|FG002|Extension Phase|Adverse Event|0|||
146061921|NCT02057250|526745412|FG003|Extension Phase|Adverse Event|0|||
146061922|NCT02057250|526745413|FG004|Extension Phase|Adverse Event|15|||
146061923|NCT02057250|526745409|FG000|Extension Phase|Lack of Efficacy|0|||
146061924|NCT02057250|526745410|FG001|Extension Phase|Lack of Efficacy|0|||
146061925|NCT02057250|526745411|FG002|Extension Phase|Lack of Efficacy|0|||
146061926|NCT02057250|526745412|FG003|Extension Phase|Lack of Efficacy|0|||
146061927|NCT02057250|526745413|FG004|Extension Phase|Lack of Efficacy|10|||
146061928|NCT02057250|526745409|FG000|Extension Phase|Entered in this period but not treated|0|||
146061929|NCT02057250|526745410|FG001|Extension Phase|Entered in this period but not treated|0|||
146061930|NCT02057250|526745411|FG002|Extension Phase|Entered in this period but not treated|0|||
146061931|NCT02057250|526745412|FG003|Extension Phase|Entered in this period but not treated|0|||
146061932|NCT02057250|526745413|FG004|Extension Phase|Entered in this period but not treated|4|||
146061933|NCT02057250|526745409|FG000|Extension Phase|Other than specified above|0|||
146061934|NCT02057250|526745410|FG001|Extension Phase|Other than specified above|0|||
146061935|NCT02057250|526745411|FG002|Extension Phase|Other than specified above|0|||
146061936|NCT02057250|526745412|FG003|Extension Phase|Other than specified above|0|||
146061937|NCT02057250|526745413|FG004|Extension Phase|Other than specified above|7|||
146061938|NCT04852302|526745425|FG000|Overall Study|Withdrawal by Subject|2|||
146061939|NCT04852302|526745425|FG000|Overall Study|Did not complete CALM therapy.|2|||
146061940|NCT05249582|526745426|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
146061941|NCT05249582|526745427|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
146061942|NCT05249582|526745426|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
146061943|NCT05249582|526745427|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
146061944|NCT05249582|526745426|FG000|Overall Study|Declined to use virtual reality headset|1|||
146061945|NCT05249582|526745427|FG001|Overall Study|Declined to use virtual reality headset|0|||
146061946|NCT03267277|526745428|FG000|Overall Study|Withdrawal by Subject|1|||
146061947|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
146061948|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
146061949|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
146061950|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
146061951|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
146061952|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
146061953|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
146061954|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146061955|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146061956|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
146061957|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146061958|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
146061959|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
146061960|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146061961|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146061962|NCT01436149|526745429|FG000|Antidepressant Lead-in Phase|Other|119|||
146402202|NCT03993288|527975914|FG001|Overall Study|improper enrollment|1|||
146402203|NCT03993288|527975913|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
146402204|NCT03993288|527975914|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
146402205|NCT03993288|527975913|FG000|Overall Study|developed SAE|2|||
146402206|NCT03993288|527975914|FG001|Overall Study|developed SAE|0|||
146402207|NCT03993288|527975913|FG000|Overall Study|consent withdrawal|1|||
146402208|NCT03993288|527975914|FG001|Overall Study|consent withdrawal|0|||
146402209|NCT03993288|527975913|FG000|Overall Study|did not follow the treatment schedule|1|||
146402210|NCT03993288|527975914|FG001|Overall Study|did not follow the treatment schedule|0|||
146402211|NCT03993288|527975913|FG000|Overall Study|did not follow the treatment regimen|1|||
146402212|NCT03993288|527975914|FG001|Overall Study|did not follow the treatment regimen|0|||
146170038|NCT02287584|527134784|FG000|the Open-label Phase|Lack of Efficacy|0|||
146170039|NCT02287584|527134785|FG001|the Open-label Phase|Lack of Efficacy|0|||
146402213|NCT03993288|527975913|FG000|Overall Study|Adverse Event|1|||
146402214|NCT03993288|527975914|FG001|Overall Study|Adverse Event|0|||
146402215|NCT03993288|527975913|FG000|Overall Study|Withdrawal by Subject|1|||
146402216|NCT03993288|527975914|FG001|Overall Study|Withdrawal by Subject|1|||
146402217|NCT02729545|527975915|FG000|Overall Study|Pregnancy|1|||
146402218|NCT02729545|527975916|FG001|Overall Study|Pregnancy|1|||
146402219|NCT02729545|527975915|FG000|Overall Study|Lost to Follow-up|0|||
146402220|NCT02729545|527975916|FG001|Overall Study|Lost to Follow-up|1|||
146402221|NCT02729545|527975915|FG000|Overall Study|Withdrawal by Subject|2|||
146402222|NCT02729545|527975916|FG001|Overall Study|Withdrawal by Subject|3|||
146402223|NCT00915473|527975917|FG000|Screening|Withdrawal by Subject|1|||
146402224|NCT00915473|527975918|FG001|Screening|Withdrawal by Subject|0|||
146402225|NCT00915473|527975917|FG000|4-week Follow Up|Lost to Follow-up|1|||
146402226|NCT00915473|527975918|FG001|4-week Follow Up|Lost to Follow-up|5|||
146402227|NCT01389024|527975919|FG000|Overall Study|Withdrawal by Subject|0|||
146402228|NCT01389024|527975920|FG001|Overall Study|Withdrawal by Subject|1|||
146402229|NCT01389024|527975919|FG000|Overall Study|Lost to Follow-up|1|||
146402230|NCT01389024|527975920|FG001|Overall Study|Lost to Follow-up|0|||
146402231|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
146402232|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
146402233|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
146402234|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Death|1|||
146402235|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
146402236|NCT00529802|527975924|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
146402237|NCT00529802|527975924|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
146402238|NCT00740480|527975932|FG000|Overall Study|Adverse Event|1|||
146402239|NCT00740480|527975932|FG000|Overall Study|Physician Decision|1|||
146402240|NCT01325701|527975937|FG000|Overall Study|Adverse Event|12|||
146402241|NCT01325701|527975938|FG001|Overall Study|Adverse Event|0|||
146402242|NCT01325701|527975937|FG000|Overall Study|Protocol Violation|1|||
146402243|NCT01325701|527975938|FG001|Overall Study|Protocol Violation|0|||
146402244|NCT01325701|527975937|FG000|Overall Study|Physician Decision|2|||
146402245|NCT01325701|527975938|FG001|Overall Study|Physician Decision|2|||
146402246|NCT01325701|527975937|FG000|Overall Study|Withdrawal by Subject|2|||
146402247|NCT01325701|527975938|FG001|Overall Study|Withdrawal by Subject|1|||
146402248|NCT01325701|527975937|FG000|Overall Study|Rollerover Extension Study|4|||
146402249|NCT01325701|527975938|FG001|Overall Study|Rollerover Extension Study|0|||
146402250|NCT00568776|527975940|FG000|Overall Study|Adverse Event|8|||
146402251|NCT00568776|527975941|FG001|Overall Study|Adverse Event|8|||
146402252|NCT00568776|527975942|FG002|Overall Study|Adverse Event|10|||
146402253|NCT00568776|527975943|FG003|Overall Study|Adverse Event|8|||
146402254|NCT00568776|527975940|FG000|Overall Study|Death|0|||
146402255|NCT00568776|527975941|FG001|Overall Study|Death|1|||
146402256|NCT00568776|527975942|FG002|Overall Study|Death|4|||
146402257|NCT00568776|527975943|FG003|Overall Study|Death|3|||
146402258|NCT00568776|527975940|FG000|Overall Study|Physician Decision|0|||
146402259|NCT00568776|527975941|FG001|Overall Study|Physician Decision|2|||
146402260|NCT00568776|527975942|FG002|Overall Study|Physician Decision|0|||
146402261|NCT00568776|527975943|FG003|Overall Study|Physician Decision|0|||
146402262|NCT00568776|527975940|FG000|Overall Study|Lack of Efficacy|2|||
146402263|NCT00568776|527975941|FG001|Overall Study|Lack of Efficacy|2|||
146402264|NCT00568776|527975942|FG002|Overall Study|Lack of Efficacy|2|||
146402265|NCT00568776|527975943|FG003|Overall Study|Lack of Efficacy|4|||
146402266|NCT00568776|527975940|FG000|Overall Study|Lost to Follow-up|1|||
146402267|NCT00568776|527975941|FG001|Overall Study|Lost to Follow-up|1|||
146402268|NCT00568776|527975942|FG002|Overall Study|Lost to Follow-up|1|||
146402269|NCT00568776|527975943|FG003|Overall Study|Lost to Follow-up|1|||
146402270|NCT00568776|527975940|FG000|Overall Study|Protocol Violation|1|||
146402271|NCT00568776|527975941|FG001|Overall Study|Protocol Violation|0|||
146402272|NCT00568776|527975942|FG002|Overall Study|Protocol Violation|1|||
146402273|NCT00568776|527975943|FG003|Overall Study|Protocol Violation|1|||
146402274|NCT00568776|527975940|FG000|Overall Study|Withdrawal by Subject|13|||
146402275|NCT00568776|527975941|FG001|Overall Study|Withdrawal by Subject|15|||
146170040|NCT02287584|527134786|FG002|the Open-label Phase|Lack of Efficacy|0|||
146170041|NCT02287584|527134787|FG003|the Open-label Phase|Lack of Efficacy|8|||
146402276|NCT00568776|527975942|FG002|Overall Study|Withdrawal by Subject|13|||
146402277|NCT00568776|527975943|FG003|Overall Study|Withdrawal by Subject|7|||
146402278|NCT00568776|527975940|FG000|Overall Study|Loss of Caregiver|0|||
146402279|NCT00568776|527975941|FG001|Overall Study|Loss of Caregiver|2|||
146402280|NCT00568776|527975942|FG002|Overall Study|Loss of Caregiver|1|||
146402281|NCT00568776|527975943|FG003|Overall Study|Loss of Caregiver|2|||
146402282|NCT00568776|527975940|FG000|Overall Study|Sponsor Decision|2|||
146402283|NCT00568776|527975941|FG001|Overall Study|Sponsor Decision|2|||
146402284|NCT00568776|527975942|FG002|Overall Study|Sponsor Decision|41|||
146402285|NCT00568776|527975943|FG003|Overall Study|Sponsor Decision|42|||
146402286|NCT00568776|527975940|FG000|Overall Study|Miscellaeneous|3|||
146402287|NCT00568776|527975941|FG001|Overall Study|Miscellaeneous|3|||
146402288|NCT00568776|527975942|FG002|Overall Study|Miscellaeneous|1|||
146402289|NCT00568776|527975943|FG003|Overall Study|Miscellaeneous|4|||
146402290|NCT01005680|527975944|FG000|Overall Study|Lost to Follow-up|4|||
146402291|NCT01005680|527975945|FG001|Overall Study|Lost to Follow-up|6|||
146402292|NCT01005680|527975944|FG000|Overall Study|Withdrawal by Subject|1|||
146402293|NCT01005680|527975945|FG001|Overall Study|Withdrawal by Subject|4|||
146402294|NCT01005680|527975944|FG000|Overall Study|Physician Decision|1|||
146402295|NCT01005680|527975945|FG001|Overall Study|Physician Decision|1|||
146402296|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
146402297|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
146402298|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
146402299|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
146402300|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
146402301|NCT01179191|527975958|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
146402302|NCT01179191|527975958|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
146402303|NCT01179191|527975958|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
146402304|NCT01179191|527975958|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
146402305|NCT01179191|527975958|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
146402306|NCT01179191|527975958|FG000|Maintenance Phase (8 Weeks)|Other|66|||
146402307|NCT00572910|527975959|FG000|Overall Study|Adverse Event|1|||
146402308|NCT00572910|527975960|FG001|Overall Study|Adverse Event|2|||
146402309|NCT00572910|527975961|FG002|Overall Study|Adverse Event|0|||
146402310|NCT00572910|527975962|FG003|Overall Study|Adverse Event|2|||
146402311|NCT00572910|527975963|FG004|Overall Study|Adverse Event|0|||
146402312|NCT00572910|527975964|FG005|Overall Study|Adverse Event|0|||
146402313|NCT00572910|527975965|FG006|Overall Study|Adverse Event|4|||
146402314|NCT00572910|527975966|FG007|Overall Study|Adverse Event|2|||
146402315|NCT00572910|527975967|FG008|Overall Study|Adverse Event|1|||
146402316|NCT00572910|527975968|FG009|Overall Study|Adverse Event|3|||
146402317|NCT00572910|527975969|FG010|Overall Study|Adverse Event|2|||
146402318|NCT00572910|527975959|FG000|Overall Study|Lost to Follow-up|0|||
146402319|NCT00572910|527975960|FG001|Overall Study|Lost to Follow-up|1|||
146402320|NCT00572910|527975961|FG002|Overall Study|Lost to Follow-up|1|||
146402321|NCT00572910|527975962|FG003|Overall Study|Lost to Follow-up|2|||
146402322|NCT00572910|527975963|FG004|Overall Study|Lost to Follow-up|1|||
146402323|NCT00572910|527975964|FG005|Overall Study|Lost to Follow-up|0|||
146402324|NCT00572910|527975965|FG006|Overall Study|Lost to Follow-up|0|||
146402325|NCT00572910|527975966|FG007|Overall Study|Lost to Follow-up|0|||
146402326|NCT00572910|527975967|FG008|Overall Study|Lost to Follow-up|0|||
146402327|NCT00572910|527975968|FG009|Overall Study|Lost to Follow-up|1|||
146402328|NCT00572910|527975969|FG010|Overall Study|Lost to Follow-up|0|||
146402329|NCT00572910|527975959|FG000|Overall Study|Withdrawal by Subject|3|||
146402330|NCT00572910|527975960|FG001|Overall Study|Withdrawal by Subject|0|||
146402331|NCT00572910|527975961|FG002|Overall Study|Withdrawal by Subject|1|||
146402332|NCT00572910|527975962|FG003|Overall Study|Withdrawal by Subject|0|||
146402333|NCT00572910|527975963|FG004|Overall Study|Withdrawal by Subject|1|||
146402334|NCT00572910|527975964|FG005|Overall Study|Withdrawal by Subject|3|||
146402335|NCT00572910|527975965|FG006|Overall Study|Withdrawal by Subject|0|||
146402336|NCT00572910|527975966|FG007|Overall Study|Withdrawal by Subject|2|||
146402337|NCT00572910|527975967|FG008|Overall Study|Withdrawal by Subject|2|||
146402338|NCT00572910|527975968|FG009|Overall Study|Withdrawal by Subject|2|||
146402339|NCT00572910|527975969|FG010|Overall Study|Withdrawal by Subject|1|||
146402340|NCT02230332|527975970|FG000|Overall Study|Adverse Event|2|||
146402341|NCT02230332|527975971|FG001|Overall Study|Adverse Event|1|||
146402342|NCT02230332|527975970|FG000|Overall Study|Lost to Follow-up|1|||
146402343|NCT02230332|527975971|FG001|Overall Study|Lost to Follow-up|0|||
146402344|NCT02230332|527975970|FG000|Overall Study|Protocol Violation|1|||
146402345|NCT02230332|527975971|FG001|Overall Study|Protocol Violation|0|||
146402346|NCT01260194|527975972|FG000|Overall Study|Withdrawal of Consent|1|||
146402347|NCT00592007|527975973|FG000|Overall Study|Withdrawal by Subject|1|||
146402348|NCT00592007|527975973|FG000|Overall Study|patient ineligible (out of lab range)|1|||
146402349|NCT04054011|527975974|FG000|Overall Study|COVID|3|||
146402350|NCT00595127|527975975|FG000|Overall Study|Death|6|||
146402351|NCT00595127|527975975|FG000|Overall Study|Relapsed|3|||
146402352|NCT00595127|527975975|FG000|Overall Study|joined another trial|1|||
146402353|NCT00538473|527975976|FG000|Overall Study|Adverse Event|1|||
146402354|NCT00538473|527975977|FG001|Overall Study|Adverse Event|0|||
146402355|NCT01569074|527975978|FG000|Overall Study|Study stopped|6|||
146402356|NCT01569074|527975979|FG001|Overall Study|Study stopped|6|||
146402357|NCT01569074|527975980|FG002|Overall Study|Study stopped|8|||
146402358|NCT01569074|527975981|FG003|Overall Study|Study stopped|7|||
146402359|NCT01569074|527975982|FG004|Overall Study|Study stopped|7|||
146402360|NCT01569074|527975978|FG000|Overall Study|Study-specific discontinuation criteria|0|||
146402361|NCT01569074|527975979|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146402362|NCT01569074|527975980|FG002|Overall Study|Study-specific discontinuation criteria|0|||
146402363|NCT01569074|527975981|FG003|Overall Study|Study-specific discontinuation criteria|0|||
146402364|NCT01569074|527975982|FG004|Overall Study|Study-specific discontinuation criteria|0|||
146061963|NCT01436149|526745430|FG001|Antidepressant Lead-in Phase|Other|0|||
146061964|NCT01436149|526745431|FG002|Antidepressant Lead-in Phase|Other|0|||
146061965|NCT01436149|526745429|FG000|Randomized Phase|Adverse Event|9|||
146061966|NCT01436149|526745430|FG001|Randomized Phase|Adverse Event|10|||
146061967|NCT01436149|526745431|FG002|Randomized Phase|Adverse Event|11|||
146061968|NCT01436149|526745429|FG000|Randomized Phase|Protocol Violation|4|||
146061969|NCT01436149|526745430|FG001|Randomized Phase|Protocol Violation|5|||
146061970|NCT01436149|526745431|FG002|Randomized Phase|Protocol Violation|0|||
146061971|NCT01436149|526745429|FG000|Randomized Phase|Withdrawal by Subject|16|||
146061972|NCT01436149|526745430|FG001|Randomized Phase|Withdrawal by Subject|10|||
146061973|NCT01436149|526745431|FG002|Randomized Phase|Withdrawal by Subject|10|||
146061974|NCT01436149|526745429|FG000|Randomized Phase|Lost to Follow-up|34|||
146061975|NCT01436149|526745430|FG001|Randomized Phase|Lost to Follow-up|5|||
146061976|NCT01436149|526745431|FG002|Randomized Phase|Lost to Follow-up|6|||
146061977|NCT01436149|526745429|FG000|Randomized Phase|Lack of Efficacy|0|||
146061978|NCT01436149|526745430|FG001|Randomized Phase|Lack of Efficacy|0|||
146061979|NCT01436149|526745431|FG002|Randomized Phase|Lack of Efficacy|1|||
146061980|NCT01436149|526745429|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
146061981|NCT01436149|526745430|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
146061982|NCT01436149|526745431|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
146061983|NCT01436149|526745429|FG000|Randomized Phase|Other|12|||
146061984|NCT01436149|526745430|FG001|Randomized Phase|Other|5|||
146061985|NCT01436149|526745431|FG002|Randomized Phase|Other|11|||
146061986|NCT04849364|526745433|FG000|Overall Study|Eligibility criteria not meet|0|||
146061987|NCT04849364|526745434|FG001|Overall Study|Eligibility criteria not meet|1|||
146061988|NCT04849364|526745435|FG002|Overall Study|Eligibility criteria not meet|0|||
146061989|NCT02738801|526745444|FG000|Overall Study|Adverse Event|1|||
146061990|NCT02738801|526745445|FG001|Overall Study|Adverse Event|1|||
146061991|NCT02738801|526745444|FG000|Overall Study|Withdrawal by Subject|0|||
146061992|NCT02738801|526745445|FG001|Overall Study|Withdrawal by Subject|1|||
146061993|NCT01643668|526745446|FG000|Overall Study|Death|1|||
146061994|NCT03253796|526745457|FG000|Period 1: Run-In|Adverse Event|4|||
146061995|NCT03253796|526745458|FG001|Period 1: Run-In|Adverse Event|0|||
146061996|NCT03253796|526745459|FG002|Period 1: Run-In|Adverse Event|0|||
146061997|NCT03253796|526745460|FG003|Period 1: Run-In|Adverse Event|0|||
146061998|NCT03253796|526745461|FG004|Period 1: Run-In|Adverse Event|0|||
146061999|NCT03253796|526745457|FG000|Period 1: Run-In|Lack of Efficacy|1|||
146062000|NCT03253796|526745458|FG001|Period 1: Run-In|Lack of Efficacy|0|||
146062001|NCT03253796|526745459|FG002|Period 1: Run-In|Lack of Efficacy|0|||
146062002|NCT03253796|526745460|FG003|Period 1: Run-In|Lack of Efficacy|0|||
146062003|NCT03253796|526745461|FG004|Period 1: Run-In|Lack of Efficacy|0|||
146062004|NCT03253796|526745457|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
146062005|NCT03253796|526745458|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
146062006|NCT03253796|526745459|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
146062007|NCT03253796|526745460|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
146062008|NCT03253796|526745461|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
146062009|NCT03253796|526745457|FG000|Period 1: Run-In|Protocol Violation|5|||
146062010|NCT03253796|526745458|FG001|Period 1: Run-In|Protocol Violation|0|||
146062011|NCT03253796|526745459|FG002|Period 1: Run-In|Protocol Violation|0|||
146062012|NCT03253796|526745460|FG003|Period 1: Run-In|Protocol Violation|0|||
146062013|NCT03253796|526745461|FG004|Period 1: Run-In|Protocol Violation|0|||
146062014|NCT03253796|526745457|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
146062015|NCT03253796|526745458|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
146062016|NCT03253796|526745459|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
146062017|NCT03253796|526745460|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
146062018|NCT03253796|526745461|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
146062019|NCT03253796|526745457|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146062020|NCT03253796|526745458|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146062021|NCT03253796|526745459|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
146062022|NCT03253796|526745460|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146062023|NCT03253796|526745461|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
146062024|NCT03253796|526745457|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146062025|NCT03253796|526745458|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146170042|NCT02287584|527134788|FG004|the Open-label Phase|Lack of Efficacy|3|||
146170043|NCT02287584|527134789|FG005|the Open-label Phase|Lack of Efficacy|7|||
146170044|NCT02287584|527134784|FG000|the Open-label Phase|Lost to Follow-up|0|||
146062026|NCT03253796|526745459|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
146062027|NCT03253796|526745460|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146062028|NCT03253796|526745461|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
146062029|NCT03253796|526745457|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146062030|NCT03253796|526745458|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146062031|NCT03253796|526745459|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
146170045|NCT02287584|527134785|FG001|the Open-label Phase|Lost to Follow-up|0|||
146170046|NCT02287584|527134786|FG002|the Open-label Phase|Lost to Follow-up|0|||
146170047|NCT02287584|527134787|FG003|the Open-label Phase|Lost to Follow-up|4|||
146402365|NCT01569074|527975978|FG000|Overall Study|Severe non-compliance to protocol|0|||
146402366|NCT01569074|527975979|FG001|Overall Study|Severe non-compliance to protocol|0|||
146402367|NCT01569074|527975980|FG002|Overall Study|Severe non-compliance to protocol|1|||
146402368|NCT01569074|527975981|FG003|Overall Study|Severe non-compliance to protocol|0|||
146402369|NCT01569074|527975982|FG004|Overall Study|Severe non-compliance to protocol|0|||
146402370|NCT01569074|527975978|FG000|Overall Study|eg change in circumstances|0|||
146402371|NCT01569074|527975979|FG001|Overall Study|eg change in circumstances|2|||
146402372|NCT01569074|527975980|FG002|Overall Study|eg change in circumstances|0|||
146402373|NCT01569074|527975981|FG003|Overall Study|eg change in circumstances|1|||
146402374|NCT01569074|527975982|FG004|Overall Study|eg change in circumstances|1|||
146402375|NCT01569074|527975978|FG000|Overall Study|Adverse Event|1|||
146402376|NCT01569074|527975979|FG001|Overall Study|Adverse Event|0|||
146402377|NCT01569074|527975980|FG002|Overall Study|Adverse Event|3|||
146402378|NCT01569074|527975981|FG003|Overall Study|Adverse Event|0|||
146402379|NCT01569074|527975982|FG004|Overall Study|Adverse Event|0|||
146402380|NCT01036594|527975988|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
146402381|NCT01036594|527975989|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
146402382|NCT01036594|527975988|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
146402383|NCT01036594|527975989|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
146402384|NCT01036594|527975988|FG000|Week 12 Evaluation|Adverse Event|5|||
146402385|NCT01036594|527975989|FG001|Week 12 Evaluation|Adverse Event|0|||
146402386|NCT01036594|527975988|FG000|Week 12 Evaluation|Physician Decision|1|||
146402387|NCT01036594|527975989|FG001|Week 12 Evaluation|Physician Decision|0|||
146402388|NCT01036594|527975988|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
146402389|NCT01036594|527975989|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
146402390|NCT01036594|527975988|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
146402391|NCT01036594|527975989|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
146402392|NCT01036594|527975988|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
146402393|NCT01036594|527975989|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
146402394|NCT01036594|527975988|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
146402395|NCT01036594|527975989|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
146402396|NCT01036594|527975988|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
146402397|NCT01036594|527975989|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
146402398|NCT00244881|527975990|FG000|Overall Study|Withdrawal by Subject|3|||
146402399|NCT03345485|527975991|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
146402400|NCT03345485|527975992|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
146402401|NCT03345485|527975993|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
146402402|NCT03345485|527975994|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
146402403|NCT03345485|527975995|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
146402404|NCT03345485|527975996|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
146402405|NCT03345485|527975997|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
146402406|NCT03345485|527975998|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
146402407|NCT03345485|527975999|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
146402408|NCT03345485|527976000|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
146402409|NCT03345485|527976001|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
146402410|NCT03345485|527976002|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
146402411|NCT03345485|527976003|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
146402412|NCT01610284|527976004|FG000|Randomization Phase|Adverse Event|1|||
146402413|NCT01610284|527976005|FG001|Randomization Phase|Adverse Event|0|||
146402414|NCT01610284|527976004|FG000|Randomization Phase|Physician Decision|1|||
146402415|NCT01610284|527976005|FG001|Randomization Phase|Physician Decision|1|||
146402416|NCT01610284|527976004|FG000|Randomization Phase|Death|0|||
146402417|NCT01610284|527976005|FG001|Randomization Phase|Death|1|||
146402418|NCT01610284|527976004|FG000|Treatment Phase|Adverse Event|80|||
146402419|NCT01610284|527976005|FG001|Treatment Phase|Adverse Event|12|||
146402420|NCT01610284|527976004|FG000|Treatment Phase|Lost to Follow-up|1|||
146402421|NCT01610284|527976005|FG001|Treatment Phase|Lost to Follow-up|0|||
146402422|NCT01610284|527976004|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
146402423|NCT01610284|527976005|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
146402424|NCT01610284|527976004|FG000|Treatment Phase|Physician Decision|27|||
146402425|NCT01610284|527976005|FG001|Treatment Phase|Physician Decision|24|||
146402426|NCT01610284|527976004|FG000|Treatment Phase|Progressive Disease|377|||
146402427|NCT01610284|527976005|FG001|Treatment Phase|Progressive Disease|486|||
146402428|NCT01610284|527976004|FG000|Treatment Phase|Protocol Deviation|2|||
146402429|NCT01610284|527976005|FG001|Treatment Phase|Protocol Deviation|3|||
146402430|NCT01610284|527976004|FG000|Treatment Phase|Study terminated by Sponsor|18|||
146402431|NCT01610284|527976005|FG001|Treatment Phase|Study terminated by Sponsor|15|||
146402432|NCT01610284|527976004|FG000|Treatment Phase|Subject/Guardian Decision|55|||
146402433|NCT01610284|527976005|FG001|Treatment Phase|Subject/Guardian Decision|23|||
146402434|NCT01610284|527976004|FG000|Treatment Phase|Death|6|||
146402435|NCT01610284|527976005|FG001|Treatment Phase|Death|5|||
146062032|NCT03253796|526745460|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
146062033|NCT03253796|526745461|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
146062034|NCT03253796|526745457|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146062035|NCT03253796|526745458|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146062036|NCT03253796|526745459|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
146062037|NCT03253796|526745460|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146062038|NCT03253796|526745461|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
146062039|NCT03253796|526745457|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
146062040|NCT03253796|526745458|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
146062041|NCT03253796|526745459|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
146062042|NCT03253796|526745460|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
146062043|NCT03253796|526745461|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
146062044|NCT03253796|526745457|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146062045|NCT03253796|526745458|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146062046|NCT03253796|526745459|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146062047|NCT03253796|526745460|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
146062048|NCT03253796|526745461|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
146062049|NCT00894803|526745462|FG000|Overall Study|Death|20|||
146062050|NCT00894803|526745463|FG001|Overall Study|Death|4|||
146062051|NCT00894803|526745462|FG000|Overall Study|Lost to Follow-up|0|||
146062052|NCT00894803|526745463|FG001|Overall Study|Lost to Follow-up|1|||
146062053|NCT01075243|526745465|FG000|Overall Study|Lost to Follow-up|5|||
146062054|NCT01075243|526745466|FG001|Overall Study|Lost to Follow-up|2|||
146062055|NCT01075243|526745467|FG002|Overall Study|Lost to Follow-up|0|||
146062056|NCT01075243|526745465|FG000|Overall Study|Withdrawal by Subject|1|||
146062057|NCT01075243|526745466|FG001|Overall Study|Withdrawal by Subject|1|||
146062058|NCT01075243|526745467|FG002|Overall Study|Withdrawal by Subject|0|||
146062059|NCT03094416|526745473|FG000|Run-in|Screening failure|8|||
146062060|NCT03094416|526745473|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
146402436|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
146402437|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146402438|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
146402439|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
146402440|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
146402441|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
146402442|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
146402443|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146402444|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
146402445|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
146402446|NCT01610284|527976004|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
146402447|NCT01610284|527976005|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
146402448|NCT01125358|527976009|FG000|Overall Study|Adverse Event|3|||
146402449|NCT01125358|527976010|FG001|Overall Study|Adverse Event|0|||
146402450|NCT01125358|527976011|FG002|Overall Study|Adverse Event|0|||
146402451|NCT01125358|527976012|FG003|Overall Study|Adverse Event|2|||
146402452|NCT01125358|527976009|FG000|Overall Study|Perceived Lack of Efficacy|6|||
146402453|NCT01125358|527976010|FG001|Overall Study|Perceived Lack of Efficacy|3|||
146402454|NCT01125358|527976011|FG002|Overall Study|Perceived Lack of Efficacy|7|||
146402455|NCT01125358|527976012|FG003|Overall Study|Perceived Lack of Efficacy|4|||
146402456|NCT01125358|527976009|FG000|Overall Study|Protocol Violation|1|||
146402457|NCT01125358|527976010|FG001|Overall Study|Protocol Violation|0|||
146402458|NCT01125358|527976011|FG002|Overall Study|Protocol Violation|0|||
146402459|NCT01125358|527976012|FG003|Overall Study|Protocol Violation|0|||
146402460|NCT01125358|527976009|FG000|Overall Study|Sponsor Decision|0|||
146402461|NCT01125358|527976010|FG001|Overall Study|Sponsor Decision|0|||
146402462|NCT01125358|527976011|FG002|Overall Study|Sponsor Decision|1|||
146402463|NCT01125358|527976012|FG003|Overall Study|Sponsor Decision|1|||
146402464|NCT01125358|527976009|FG000|Overall Study|Withdrawal by Subject|2|||
146402465|NCT01125358|527976010|FG001|Overall Study|Withdrawal by Subject|1|||
146402466|NCT01125358|527976011|FG002|Overall Study|Withdrawal by Subject|1|||
146402467|NCT01125358|527976012|FG003|Overall Study|Withdrawal by Subject|1|||
146402468|NCT01060007|527976013|FG000|Overall Study|Withdrawal by Subject|1|||
146402469|NCT01060007|527976013|FG000|Overall Study|Inevaluable for response at surgery|3|||
146402470|NCT05168657|527976014|FG000|Overall Study|Adverse Event|0|||
146062061|NCT03094416|526745473|FG000|Run-in|Withdrawal by Subject|3|||
146402471|NCT05168657|527976015|FG001|Overall Study|Adverse Event|0|||
146402472|NCT05168657|527976016|FG002|Overall Study|Adverse Event|1|||
146402473|NCT05168657|527976017|FG003|Overall Study|Adverse Event|0|||
146062062|NCT03094416|526745473|FG000|Treatment Period|Withdrawal by Subject|2|||
146062063|NCT05386329|526745474|FG000|Overall Study|Lost to Follow-up|3|||
146062064|NCT03600909|526745477|FG000|Overall Study|Not treated|0|||
146062065|NCT03600909|526745478|FG001|Overall Study|Not treated|3|||
146062066|NCT03600909|526745479|FG002|Overall Study|Not treated|0|||
146062067|NCT02246530|526745480|FG000|Overall Study|Lost to Follow-up|4|||
146062068|NCT02246530|526745481|FG001|Overall Study|Lost to Follow-up|0|||
146062069|NCT01506596|526745482|FG000|Overall Study|ineligible pathology|1|||
146062070|NCT01488890|526745485|FG000|Overall Study|Serious adverse event|2|||
146062071|NCT01488890|526745486|FG001|Overall Study|Serious adverse event|0|||
146062072|NCT01488890|526745487|FG002|Overall Study|Serious adverse event|0|||
146062073|NCT01488890|526745488|FG003|Overall Study|Serious adverse event|0|||
146062074|NCT01488890|526745485|FG000|Overall Study|Protocol Violation|3|||
146062075|NCT01488890|526745486|FG001|Overall Study|Protocol Violation|0|||
146062076|NCT01488890|526745487|FG002|Overall Study|Protocol Violation|4|||
146062077|NCT01488890|526745488|FG003|Overall Study|Protocol Violation|0|||
146062078|NCT01488890|526745485|FG000|Overall Study|Lost to Follow-up|13|||
146062079|NCT01488890|526745486|FG001|Overall Study|Lost to Follow-up|10|||
146062080|NCT01488890|526745487|FG002|Overall Study|Lost to Follow-up|20|||
146062081|NCT01488890|526745488|FG003|Overall Study|Lost to Follow-up|3|||
146062082|NCT01488890|526745485|FG000|Overall Study|Withdrawal by Subject|14|||
146062083|NCT01488890|526745486|FG001|Overall Study|Withdrawal by Subject|10|||
146062084|NCT01488890|526745487|FG002|Overall Study|Withdrawal by Subject|11|||
146062085|NCT01488890|526745488|FG003|Overall Study|Withdrawal by Subject|2|||
146062086|NCT05712460|526745489|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062087|NCT05712460|526745490|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062088|NCT05712460|526745491|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062089|NCT05712460|526745492|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062090|NCT05712460|526745493|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062091|NCT05712460|526745494|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062092|NCT05712460|526745495|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062093|NCT05712460|526745496|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
146062094|NCT05712460|526745497|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062095|NCT05712460|526745498|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062096|NCT05712460|526745499|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062097|NCT05712460|526745500|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
146062098|NCT04366349|526745503|FG000|Overall Study|Withdrawal by Subject|1|||
146062099|NCT04366349|526745504|FG001|Overall Study|Withdrawal by Subject|0|||
146062100|NCT04366349|526745505|FG002|Overall Study|Withdrawal by Subject|0|||
146062101|NCT04366349|526745506|FG003|Overall Study|Withdrawal by Subject|0|||
146062102|NCT04366349|526745507|FG004|Overall Study|Withdrawal by Subject|0|||
146062103|NCT04366349|526745508|FG005|Overall Study|Withdrawal by Subject|0|||
146062104|NCT02532517|526745515|FG000|Overall Study|Did not complete 24-Month visit|4|||
146062105|NCT02532517|526745515|FG000|Overall Study|Failed Angiographic eligibility|1|||
146062106|NCT02532517|526745515|FG000|Overall Study|Lost to Follow-up|4|||
146062107|NCT02532517|526745515|FG000|Overall Study|Withdrawal by Subject|4|||
146062108|NCT02532517|526745515|FG000|Overall Study|Death|4|||
146062109|NCT05138653|526745518|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
146062110|NCT05138653|526745519|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062111|NCT05138653|526745520|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062112|NCT05138653|526745521|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062113|NCT05138653|526745522|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062114|NCT05138653|526745523|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062115|NCT05138653|526745524|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062116|NCT05138653|526745525|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062117|NCT05138653|526745526|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062118|NCT05138653|526745527|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062119|NCT05138653|526745528|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062120|NCT05138653|526745529|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062121|NCT05138653|526745530|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062122|NCT05138653|526745531|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062123|NCT05138653|526745532|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062124|NCT05138653|526745533|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
146062125|NCT05138653|526745518|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062126|NCT05138653|526745519|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
146170048|NCT02287584|527134788|FG004|the Open-label Phase|Lost to Follow-up|1|||
146170049|NCT02287584|527134789|FG005|the Open-label Phase|Lost to Follow-up|2|||
146402474|NCT05168657|527976018|FG004|Overall Study|Adverse Event|0|||
146062127|NCT05138653|526745520|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062128|NCT05138653|526745521|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062129|NCT05138653|526745522|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062130|NCT05138653|526745523|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062131|NCT05138653|526745524|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062132|NCT05138653|526745525|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062133|NCT05138653|526745526|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
146062134|NCT05138653|526745527|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062135|NCT05138653|526745528|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062136|NCT05138653|526745529|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062137|NCT05138653|526745530|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062138|NCT05138653|526745531|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062139|NCT05138653|526745532|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062140|NCT05138653|526745533|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
146062141|NCT05138653|526745518|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062142|NCT05138653|526745519|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
146062143|NCT05138653|526745520|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062144|NCT05138653|526745521|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062145|NCT05138653|526745522|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
146062146|NCT05138653|526745523|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062147|NCT05138653|526745524|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062148|NCT05138653|526745525|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062149|NCT05138653|526745526|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062150|NCT05138653|526745527|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062151|NCT05138653|526745528|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062152|NCT05138653|526745529|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062153|NCT05138653|526745530|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062154|NCT05138653|526745531|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062155|NCT05138653|526745532|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062156|NCT05138653|526745533|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
146062157|NCT05138653|526745518|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062158|NCT05138653|526745519|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062159|NCT05138653|526745520|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146170050|NCT02287584|527134784|FG000|the Open-label Phase|Withdrawal by Subject|0|||
146170051|NCT02287584|527134785|FG001|the Open-label Phase|Withdrawal by Subject|0|||
146402475|NCT05168657|527976019|FG005|Overall Study|Adverse Event|0|||
146402476|NCT05168657|527976020|FG006|Overall Study|Adverse Event|0|||
146402477|NCT05168657|527976021|FG007|Overall Study|Adverse Event|0|||
146402478|NCT03159611|527976024|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
146402479|NCT03159611|527976025|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
146402480|NCT03159611|527976024|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
146402481|NCT03159611|527976025|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
146402482|NCT03159611|527976024|FG000|Overall Study|Protocol Violation|7|||
146402483|NCT03159611|527976025|FG001|Overall Study|Protocol Violation|4|||
146402484|NCT03159611|527976024|FG000|Overall Study|Adverse Event|1|||
146402485|NCT03159611|527976025|FG001|Overall Study|Adverse Event|0|||
146402486|NCT03159611|527976024|FG000|Overall Study|Withdrawal by Subject|1|||
146402487|NCT03159611|527976025|FG001|Overall Study|Withdrawal by Subject|1|||
146402488|NCT03159611|527976024|FG000|Overall Study|Non-compliance with protocol requirement|3|||
146402489|NCT03159611|527976025|FG001|Overall Study|Non-compliance with protocol requirement|2|||
146402490|NCT03159611|527976024|FG000|Overall Study|Inability to perform procedures|1|||
146402491|NCT03159611|527976025|FG001|Overall Study|Inability to perform procedures|0|||
146402492|NCT01984229|527976026|FG000|Safety Follow-up Period|Adverse Event|1|||
146402493|NCT01984229|527976027|FG001|Safety Follow-up Period|Adverse Event|1|||
146402494|NCT01984229|527976026|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
146402495|NCT01984229|527976027|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146402496|NCT02072174|527976028|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
146402497|NCT02072174|527976029|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
146402498|NCT02072174|527976028|FG000|Overall Study|Protocol Violation|16|||
146402499|NCT02072174|527976029|FG001|Overall Study|Protocol Violation|23|||
146402500|NCT02072174|527976028|FG000|Overall Study|Physician Decision|0|||
146402501|NCT02072174|527976029|FG001|Overall Study|Physician Decision|1|||
146402502|NCT02072174|527976028|FG000|Overall Study|Non-compliance with protocol requirement|2|||
146402503|NCT02072174|527976029|FG001|Overall Study|Non-compliance with protocol requirement|0|||
146402504|NCT01418365|527976034|FG000|First Intervention|Withdrawal by Subject|0|||
146402505|NCT01418365|527976035|FG001|First Intervention|Withdrawal by Subject|1|||
146402506|NCT01418365|527976034|FG000|First Intervention|Non-compliance|1|||
146402507|NCT01418365|527976035|FG001|First Intervention|Non-compliance|0|||
146402508|NCT01418365|527976034|FG000|Second Intervention|Withdrawal by Subject|0|||
146402509|NCT01418365|527976035|FG001|Second Intervention|Withdrawal by Subject|1|||
146402510|NCT03319368|527976040|FG000|Overall Study|Discharge swabs not collected from resident|57|||
146062160|NCT05138653|526745521|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062161|NCT05138653|526745522|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062162|NCT05138653|526745523|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062163|NCT05138653|526745524|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
146170052|NCT02287584|527134786|FG002|the Open-label Phase|Withdrawal by Subject|0|||
146170053|NCT02287584|527134787|FG003|the Open-label Phase|Withdrawal by Subject|18|||
146170054|NCT02287584|527134788|FG004|the Open-label Phase|Withdrawal by Subject|29|||
146170055|NCT02287584|527134789|FG005|the Open-label Phase|Withdrawal by Subject|21|||
146170056|NCT02287584|527134784|FG000|the Open-label Phase|non-compliance|0|||
146170057|NCT02287584|527134785|FG001|the Open-label Phase|non-compliance|0|||
146170058|NCT02287584|527134786|FG002|the Open-label Phase|non-compliance|0|||
146170059|NCT02287584|527134787|FG003|the Open-label Phase|non-compliance|2|||
146170060|NCT02287584|527134788|FG004|the Open-label Phase|non-compliance|5|||
146170061|NCT02287584|527134789|FG005|the Open-label Phase|non-compliance|1|||
146170062|NCT02287584|527134784|FG000|the Open-label Phase|other reasons|0|||
146170063|NCT02287584|527134785|FG001|the Open-label Phase|other reasons|0|||
146062164|NCT05138653|526745525|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062165|NCT05138653|526745526|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062166|NCT05138653|526745527|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062167|NCT05138653|526745528|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062168|NCT05138653|526745529|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062169|NCT05138653|526745530|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062170|NCT05138653|526745531|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062171|NCT05138653|526745532|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062172|NCT05138653|526745533|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
146062173|NCT05138653|526745518|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062174|NCT05138653|526745519|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062175|NCT05138653|526745520|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062176|NCT05138653|526745521|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062177|NCT05138653|526745522|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062178|NCT05138653|526745523|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062179|NCT05138653|526745524|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062180|NCT05138653|526745525|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062181|NCT05138653|526745526|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062182|NCT05138653|526745527|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062183|NCT05138653|526745528|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146062184|NCT05138653|526745529|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062185|NCT05138653|526745530|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146062186|NCT05138653|526745531|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062187|NCT05138653|526745532|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
146062188|NCT05138653|526745533|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
146062189|NCT05138653|526745518|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062190|NCT05138653|526745519|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062191|NCT05138653|526745520|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062192|NCT05138653|526745521|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062193|NCT05138653|526745522|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062194|NCT05138653|526745523|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062195|NCT05138653|526745524|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062196|NCT05138653|526745525|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062197|NCT05138653|526745526|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062198|NCT05138653|526745527|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062199|NCT05138653|526745528|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062200|NCT05138653|526745529|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062201|NCT05138653|526745530|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062202|NCT05138653|526745531|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062203|NCT05138653|526745532|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
146062204|NCT05138653|526745533|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
146062205|NCT05138653|526745518|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062206|NCT05138653|526745519|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062207|NCT05138653|526745520|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062208|NCT05138653|526745521|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062209|NCT05138653|526745522|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062210|NCT05138653|526745523|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062211|NCT05138653|526745524|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062212|NCT05138653|526745525|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146170064|NCT02287584|527134786|FG002|the Open-label Phase|other reasons|0|||
146402511|NCT03319368|527976041|FG001|Overall Study|Discharge swabs not collected from resident|46|||
146402512|NCT00824993|527976046|FG000|Overall Study|Withdrawal by Subject|1|||
146402513|NCT00824993|527976047|FG001|Overall Study|Withdrawal by Subject|1|||
146402514|NCT00824993|527976046|FG000|Overall Study|Malignancy Relapse|9|||
146402515|NCT00824993|527976047|FG001|Overall Study|Malignancy Relapse|10|||
146402516|NCT00824993|527976046|FG000|Overall Study|Rapid Bone Loss|0|||
146402517|NCT00824993|527976047|FG001|Overall Study|Rapid Bone Loss|1|||
146402518|NCT00824993|527976046|FG000|Overall Study|Non-Compliant|2|||
146402519|NCT00824993|527976047|FG001|Overall Study|Non-Compliant|1|||
146402520|NCT00824993|527976046|FG000|Overall Study|Insurance Issue|2|||
146402521|NCT00824993|527976047|FG001|Overall Study|Insurance Issue|1|||
146402522|NCT00824993|527976046|FG000|Overall Study|Death|0|||
146402523|NCT00824993|527976047|FG001|Overall Study|Death|3|||
146402524|NCT00518011|527976048|FG000|Overall Study|Death|1|||
146402525|NCT00518011|527976049|FG001|Overall Study|Death|1|||
146402526|NCT00518011|527976048|FG000|Overall Study|Adverse Event|2|||
146402527|NCT00518011|527976049|FG001|Overall Study|Adverse Event|3|||
146402528|NCT00518011|527976048|FG000|Overall Study|Disease Progression|2|||
146402529|NCT00518011|527976049|FG001|Overall Study|Disease Progression|2|||
146402530|NCT00518011|527976048|FG000|Overall Study|Other Reasons|3|||
146402531|NCT00518011|527976049|FG001|Overall Study|Other Reasons|2|||
146402532|NCT00518011|527976048|FG000|Overall Study|Withdrawal by Subject|1|||
146402533|NCT00518011|527976049|FG001|Overall Study|Withdrawal by Subject|0|||
146402534|NCT03409328|527976050|FG000|Overall Study|Lost to Follow-up|6|||
146402535|NCT03409328|527976051|FG001|Overall Study|Lost to Follow-up|3|||
146402536|NCT02998645|527976052|FG000|Treatment Period 1|Adverse Event|6|||
146402537|NCT02998645|527976052|FG000|Treatment Period 1|Death|5|||
146402538|NCT02998645|527976052|FG000|Treatment Period 1|Technical Problems|4|||
146402539|NCT02998645|527976052|FG000|Treatment Period 1|Lack of Efficacy|2|||
146402540|NCT02998645|527976052|FG000|Treatment Period 1|Progressive disease|1|||
146402541|NCT02998645|527976052|FG000|Treatment Period 1|Subject/guardian decision|1|||
146402542|NCT02998645|527976052|FG000|Treatment Period 2|Lack of Efficacy|5|||
146402543|NCT02998645|527976052|FG000|Treatment Period 2|Adverse Event|2|||
146402544|NCT02998645|527976052|FG000|Treatment Period 2|Progressive disease|2|||
146402545|NCT02998645|527976052|FG000|Treatment Period 2|Physician Decision|1|||
146402546|NCT03930615|527976054|FG000|Overall Study|Death|9|||
146402547|NCT03930615|527976055|FG001|Overall Study|Death|3|||
146402548|NCT03930615|527976054|FG000|Overall Study|Lost to Follow-up|1|||
146402549|NCT03930615|527976055|FG001|Overall Study|Lost to Follow-up|2|||
146402550|NCT03930615|527976054|FG000|Overall Study|Physician Decision|3|||
146402551|NCT03930615|527976055|FG001|Overall Study|Physician Decision|4|||
146402552|NCT03930615|527976054|FG000|Overall Study|Withdrawal by Subject|13|||
146402553|NCT03930615|527976055|FG001|Overall Study|Withdrawal by Subject|2|||
146402554|NCT03930615|527976054|FG000|Overall Study|Not treated|1|||
146402555|NCT03930615|527976055|FG001|Overall Study|Not treated|1|||
146402556|NCT00358670|527976056|FG000|Overall Study|Adverse Event|26|||
146402557|NCT00358670|527976057|FG001|Overall Study|Adverse Event|29|||
146402558|NCT00358670|527976056|FG000|Overall Study|Lack of Efficacy|20|||
146402559|NCT00358670|527976057|FG001|Overall Study|Lack of Efficacy|23|||
146402560|NCT00358670|527976056|FG000|Overall Study|Protocol Violation|6|||
146402561|NCT00358670|527976057|FG001|Overall Study|Protocol Violation|9|||
146402562|NCT00358670|527976056|FG000|Overall Study|Lost to Follow-up|4|||
146402563|NCT00358670|527976057|FG001|Overall Study|Lost to Follow-up|5|||
146402564|NCT00358670|527976056|FG000|Overall Study|Withdrawal by Subject|13|||
146402565|NCT00358670|527976057|FG001|Overall Study|Withdrawal by Subject|24|||
146402566|NCT00358670|527976056|FG000|Overall Study|Protocol Defined Clinical Event|0|||
146402567|NCT00358670|527976057|FG001|Overall Study|Protocol Defined Clinical Event|1|||
146402568|NCT00358670|527976056|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146402569|NCT00358670|527976057|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
146402570|NCT00358670|527976056|FG000|Overall Study|Administrative|153|||
146402571|NCT00358670|527976057|FG001|Overall Study|Administrative|125|||
146402572|NCT00905437|527976060|FG000|Overall Study|Adverse Event|3|||
146402573|NCT00905437|527976061|FG001|Overall Study|Adverse Event|2|||
146402574|NCT00905437|527976060|FG000|Overall Study|Lost to Follow-up|0|||
146402575|NCT00905437|527976061|FG001|Overall Study|Lost to Follow-up|1|||
146402576|NCT00905437|527976060|FG000|Overall Study|Withdrawal by Subject|0|||
146402577|NCT00905437|527976061|FG001|Overall Study|Withdrawal by Subject|1|||
146402578|NCT00905437|527976060|FG000|Overall Study|Other|5|||
146402579|NCT00905437|527976061|FG001|Overall Study|Other|6|||
146402580|NCT03128931|527976064|FG000|Overall Study|Physician Decision|1|||
146402581|NCT03128931|527976064|FG000|Overall Study|Equipment Issues|3|||
146402582|NCT03252015|527976065|FG000|Overall Study|Withdrawal by Subject|0|||
146402583|NCT03252015|527976066|FG001|Overall Study|Withdrawal by Subject|1|||
146402584|NCT03252015|527976067|FG002|Overall Study|Withdrawal by Subject|1|||
146402585|NCT03252015|527976068|FG003|Overall Study|Withdrawal by Subject|0|||
146402586|NCT03252015|527976065|FG000|Overall Study|Adverse Event|1|||
146402587|NCT03252015|527976066|FG001|Overall Study|Adverse Event|0|||
146402588|NCT03252015|527976067|FG002|Overall Study|Adverse Event|0|||
146402589|NCT03252015|527976068|FG003|Overall Study|Adverse Event|1|||
146062213|NCT05138653|526745526|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062214|NCT05138653|526745527|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062215|NCT05138653|526745528|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062216|NCT05138653|526745529|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062217|NCT05138653|526745530|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062218|NCT05138653|526745531|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
146062219|NCT05138653|526745532|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062220|NCT05138653|526745533|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
146062221|NCT05967260|526745534|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
146062222|NCT05967260|526745535|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
146062223|NCT03204188|526745538|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
146062224|NCT03204188|526745538|FG000|Immunotherapy Phase (1 Year)|Death|1|||
146062225|NCT03204188|526745538|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
146062226|NCT03204188|526745538|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
146062227|NCT01350999|526745539|FG000|Overall Study|Adverse Event|4|||
146062228|NCT01350999|526745540|FG001|Overall Study|Adverse Event|9|||
146062229|NCT01350999|526745541|FG002|Overall Study|Adverse Event|10|||
146062230|NCT01350999|526745539|FG000|Overall Study|Voluntary withdrawal|3|||
146062231|NCT01350999|526745540|FG001|Overall Study|Voluntary withdrawal|4|||
146062232|NCT01350999|526745541|FG002|Overall Study|Voluntary withdrawal|6|||
146062233|NCT01350999|526745539|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
146170065|NCT02287584|527134787|FG003|the Open-label Phase|other reasons|3|||
146170066|NCT02287584|527134788|FG004|the Open-label Phase|other reasons|6|||
146170067|NCT02287584|527134789|FG005|the Open-label Phase|other reasons|6|||
146170068|NCT01492686|527134792|FG000|Double-blind Phase|Adverse Event|0|||
146170069|NCT01492686|527134793|FG001|Double-blind Phase|Adverse Event|2|||
146170070|NCT01492686|527134792|FG000|Double-blind Phase|Physician Decision|0|||
146170071|NCT01492686|527134793|FG001|Double-blind Phase|Physician Decision|1|||
146170072|NCT01492686|527134792|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146170073|NCT01492686|527134793|FG001|Double-blind Phase|Withdrawal by Subject|2|||
146170074|NCT01492686|527134792|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
146170075|NCT01492686|527134793|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
146170076|NCT01492686|527134792|FG000|Open-label Phase|Adverse Event|1|||
146170077|NCT01492686|527134793|FG001|Open-label Phase|Adverse Event|2|||
146170078|NCT01492686|527134792|FG000|Open-label Phase|Physician Decision|1|||
146170079|NCT01492686|527134793|FG001|Open-label Phase|Physician Decision|0|||
146170080|NCT01492686|527134792|FG000|Open-label Phase|Withdrawal by Subject|6|||
146170081|NCT01492686|527134793|FG001|Open-label Phase|Withdrawal by Subject|7|||
146170082|NCT01492686|527134792|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
146170083|NCT01492686|527134793|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
146170084|NCT03430063|527134795|FG000|Overall Study|Adverse Event|0|||
146170085|NCT03430063|527134796|FG001|Overall Study|Adverse Event|1|||
146170086|NCT03430063|527134797|FG002|Overall Study|Adverse Event|0|||
146170087|NCT03430063|527134795|FG000|Overall Study|Death|3|||
146170088|NCT03430063|527134796|FG001|Overall Study|Death|2|||
146170089|NCT03430063|527134797|FG002|Overall Study|Death|3|||
146170090|NCT03430063|527134795|FG000|Overall Study|Lost to Follow-up|0|||
146170091|NCT03430063|527134796|FG001|Overall Study|Lost to Follow-up|1|||
146170092|NCT03430063|527134797|FG002|Overall Study|Lost to Follow-up|0|||
146170093|NCT03430063|527134795|FG000|Overall Study|Withdrawal by Subject|0|||
146170094|NCT03430063|527134796|FG001|Overall Study|Withdrawal by Subject|0|||
146170095|NCT03430063|527134797|FG002|Overall Study|Withdrawal by Subject|1|||
146170096|NCT03430063|527134795|FG000|Overall Study|Withdrawal of consent|3|||
146170097|NCT03430063|527134796|FG001|Overall Study|Withdrawal of consent|1|||
146170098|NCT03430063|527134797|FG002|Overall Study|Withdrawal of consent|2|||
146170099|NCT03430063|527134795|FG000|Overall Study|Progressive disease|1|||
146170100|NCT03430063|527134796|FG001|Overall Study|Progressive disease|2|||
146170101|NCT03430063|527134797|FG002|Overall Study|Progressive disease|1|||
146170102|NCT03430063|527134795|FG000|Overall Study|Other un-specified|1|||
146170103|NCT03430063|527134796|FG001|Overall Study|Other un-specified|1|||
146170104|NCT03430063|527134797|FG002|Overall Study|Other un-specified|0|||
146170105|NCT03430063|527134795|FG000|Overall Study|Randomized, but never treated|0|||
146170106|NCT03430063|527134796|FG001|Overall Study|Randomized, but never treated|0|||
146170107|NCT03430063|527134797|FG002|Overall Study|Randomized, but never treated|1|||
146170108|NCT02748694|527134798|FG000|Overall Study|Voluntary Withdrawal|0|||
146170109|NCT02748694|527134799|FG001|Overall Study|Voluntary Withdrawal|0|||
146170110|NCT02748694|527134800|FG002|Overall Study|Voluntary Withdrawal|0|||
146170111|NCT02748694|527134801|FG003|Overall Study|Voluntary Withdrawal|0|||
146170112|NCT02748694|527134802|FG004|Overall Study|Voluntary Withdrawal|0|||
146170113|NCT02748694|527134803|FG005|Overall Study|Voluntary Withdrawal|0|||
146170114|NCT02748694|527134804|FG006|Overall Study|Voluntary Withdrawal|0|||
146170115|NCT02748694|527134805|FG007|Overall Study|Voluntary Withdrawal|0|||
146062234|NCT01350999|526745540|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
146062235|NCT01350999|526745541|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
146062236|NCT00079417|526748130|FG000|Overall Study|Physician Decision|2|||
146062237|NCT00079417|526748130|FG000|Overall Study|Ineligible|7|||
146062238|NCT01615939|526748131|FG000|Overall Study|Lost to Follow-up|5|||
146062239|NCT01615939|526748132|FG001|Overall Study|Lost to Follow-up|0|||
146062240|NCT02121535|526748136|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
146062241|NCT02121535|526748137|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
146062242|NCT02121535|526748136|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
146062243|NCT02121535|526748137|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
146062244|NCT00092417|526748138|FG000|Overall Study|Lost to Follow-up|2|||
146062245|NCT00092417|526748139|FG001|Overall Study|Lost to Follow-up|0|||
146062246|NCT00092417|526748138|FG000|Overall Study|Withdrawal by Subject|2|||
146062247|NCT00092417|526748139|FG001|Overall Study|Withdrawal by Subject|1|||
146062248|NCT00092417|526748138|FG000|Overall Study|Other|1|||
146062249|NCT00092417|526748139|FG001|Overall Study|Other|0|||
146062250|NCT01520506|526748140|FG000|Overall Study|Missed Visit|4|||
146062251|NCT01520506|526748140|FG000|Overall Study|Lost to Follow-up|1|||
146062252|NCT01520506|526748140|FG000|Overall Study|Withdrawal by Subject|1|||
146062253|NCT00425269|526748141|FG000|Overall Study|Pregnancy|5|||
146062254|NCT00425269|526748142|FG001|Overall Study|Pregnancy|7|||
146062255|NCT00425269|526748141|FG000|Overall Study|Lost to Follow-up|9|||
146062256|NCT00425269|526748142|FG001|Overall Study|Lost to Follow-up|9|||
146062257|NCT00425269|526748141|FG000|Overall Study|moved or medical reason|5|||
146062258|NCT00425269|526748142|FG001|Overall Study|moved or medical reason|4|||
146062259|NCT01084655|526748143|FG000|Overall Study|Radiographic disease progression|3|||
146062260|NCT01084655|526748144|FG001|Overall Study|Radiographic disease progression|2|||
146402590|NCT04993339|527976069|FG000|Overall Study|Lost to Follow-up|0|||
146402591|NCT04993339|527976070|FG001|Overall Study|Lost to Follow-up|1|||
146402592|NCT04993339|527976069|FG000|Overall Study|no MRI scan|3|||
146402593|NCT04993339|527976070|FG001|Overall Study|no MRI scan|1|||
146402594|NCT03075215|527976073|FG000|12-Month Primary Endpoint|Death|152|||
146402595|NCT03075215|527976073|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
146402596|NCT03075215|527976073|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
146402597|NCT03075215|527976073|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
146402598|NCT01525407|527976080|FG000|Overall Study|Change in recipient treatment plan|2|||
146402599|NCT01525407|527976081|FG001|Overall Study|Change in recipient treatment plan|2|||
146402600|NCT01525407|527976080|FG000|Overall Study|Withdrawal by Subject|0|||
146402601|NCT01525407|527976081|FG001|Overall Study|Withdrawal by Subject|1|||
146402602|NCT01525407|527976080|FG000|Overall Study|Transplant was delayed|0|||
146402603|NCT01525407|527976081|FG001|Overall Study|Transplant was delayed|1|||
146402604|NCT01525407|527976080|FG000|Overall Study|Delay in Transplant|1|||
146402605|NCT01525407|527976081|FG001|Overall Study|Delay in Transplant|0|||
146402606|NCT03256526|527977526|FG000|Overall Study|Adverse Event|1|||
146402607|NCT03256526|527977527|FG001|Overall Study|Adverse Event|0|||
146402608|NCT03256526|527977528|FG002|Overall Study|Adverse Event|1|||
146402609|NCT03256526|527977526|FG000|Overall Study|Lost to Follow-up|1|||
146402610|NCT03256526|527977527|FG001|Overall Study|Lost to Follow-up|0|||
146402611|NCT03256526|527977528|FG002|Overall Study|Lost to Follow-up|2|||
146402612|NCT01607398|527977529|FG000|Overall Study|Adverse Event|0|||
146402613|NCT01607398|527977530|FG001|Overall Study|Adverse Event|2|||
146402614|NCT01607398|527977529|FG000|Overall Study|Severe COPD|2|||
146402615|NCT01607398|527977530|FG001|Overall Study|Severe COPD|0|||
146402616|NCT03526679|527977534|FG000|Overall Study|still under treatment|2|||
146402617|NCT03443973|527977535|FG000|Double-blind Treatment Period|Adverse Event|5|||
146402618|NCT03443973|527977536|FG001|Double-blind Treatment Period|Adverse Event|19|||
146402619|NCT03443973|527977537|FG002|Double-blind Treatment Period|Adverse Event|0|||
146402620|NCT03443973|527977538|FG003|Double-blind Treatment Period|Adverse Event|0|||
146402621|NCT03443973|527977535|FG000|Double-blind Treatment Period|Death|5|||
146402622|NCT03443973|527977536|FG001|Double-blind Treatment Period|Death|7|||
146402623|NCT03443973|527977537|FG002|Double-blind Treatment Period|Death|0|||
146402624|NCT03443973|527977538|FG003|Double-blind Treatment Period|Death|0|||
146402625|NCT03443973|527977535|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146402626|NCT03443973|527977536|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146402627|NCT03443973|527977537|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146402628|NCT03443973|527977538|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146402629|NCT03443973|527977535|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146402630|NCT03443973|527977536|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146062261|NCT01084655|526748145|FG002|Overall Study|Radiographic disease progression|8|||
146062262|NCT01084655|526748143|FG000|Overall Study|Withdrawal by Subject|1|||
146062263|NCT01084655|526748144|FG001|Overall Study|Withdrawal by Subject|0|||
146062264|NCT01084655|526748145|FG002|Overall Study|Withdrawal by Subject|4|||
146062265|NCT01084655|526748143|FG000|Overall Study|Adverse Event|2|||
146062266|NCT01084655|526748144|FG001|Overall Study|Adverse Event|1|||
146062267|NCT01084655|526748145|FG002|Overall Study|Adverse Event|2|||
146062268|NCT01084655|526748143|FG000|Overall Study|Other|0|||
146402631|NCT03443973|527977537|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146402632|NCT03443973|527977538|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146402633|NCT03443973|527977535|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
146402634|NCT03443973|527977536|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
146402635|NCT03443973|527977537|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
146402636|NCT03443973|527977538|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
146402637|NCT03443973|527977535|FG000|Double-blind Treatment Period|Physician Decision|5|||
146402638|NCT03443973|527977536|FG001|Double-blind Treatment Period|Physician Decision|6|||
146402639|NCT03443973|527977537|FG002|Double-blind Treatment Period|Physician Decision|0|||
146402640|NCT03443973|527977538|FG003|Double-blind Treatment Period|Physician Decision|0|||
146402641|NCT03443973|527977535|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
146402642|NCT03443973|527977536|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
146402643|NCT03443973|527977537|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
146402644|NCT03443973|527977538|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
146402645|NCT03443973|527977535|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
146402646|NCT03443973|527977536|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
146402647|NCT03443973|527977537|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146402648|NCT03443973|527977538|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
146402649|NCT03443973|527977535|FG000|Open-label Extension Period|Reason Not Specified|0|||
146402650|NCT03443973|527977536|FG001|Open-label Extension Period|Reason Not Specified|0|||
146402651|NCT03443973|527977537|FG002|Open-label Extension Period|Reason Not Specified|3|||
146402652|NCT03443973|527977538|FG003|Open-label Extension Period|Reason Not Specified|0|||
146402653|NCT03443973|527977535|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146402654|NCT03443973|527977536|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
146402655|NCT03443973|527977537|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
146402656|NCT03443973|527977538|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
146402657|NCT00398632|527977541|FG000|Overall Study|Withdrawal by Subject|1|||
146062269|NCT01084655|526748144|FG001|Overall Study|Other|3|||
146062270|NCT01084655|526748145|FG002|Overall Study|Other|2|||
146062271|NCT01084655|526748143|FG000|Overall Study|Symptomatic deterioration|0|||
146062272|NCT01084655|526748144|FG001|Overall Study|Symptomatic deterioration|0|||
146062273|NCT01084655|526748145|FG002|Overall Study|Symptomatic deterioration|2|||
146062274|NCT01084655|526748143|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
146062275|NCT01084655|526748144|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
146062276|NCT01084655|526748145|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
146062277|NCT01256788|526748146|FG000|Overall Study|Lost to Follow-up|5|||
146062278|NCT01256788|526748147|FG001|Overall Study|Lost to Follow-up|8|||
146062279|NCT01256788|526748148|FG002|Overall Study|Lost to Follow-up|3|||
146062280|NCT00906204|526748149|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
146062281|NCT00906204|526748150|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
146062282|NCT00906204|526748149|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
146062283|NCT00906204|526748150|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
146062284|NCT00906204|526748149|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
146062285|NCT00906204|526748150|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
146062286|NCT00906204|526748149|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
146062287|NCT00906204|526748150|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
146062288|NCT00906204|526748149|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
146062289|NCT00906204|526748150|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
146062290|NCT03181932|526748155|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
146062291|NCT03181932|526748156|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
146062292|NCT03181932|526748155|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
146062293|NCT03181932|526748156|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
146062294|NCT03181932|526748155|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
146062295|NCT03181932|526748156|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
146062296|NCT03181932|526748155|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
146062297|NCT03181932|526748156|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
146062298|NCT03181932|526748155|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
146062299|NCT03181932|526748156|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
146062300|NCT03181932|526748155|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
146062301|NCT03181932|526748156|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
146062302|NCT03181932|526748155|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
146062303|NCT03181932|526748156|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
146062304|NCT03181932|526748155|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
146062305|NCT03181932|526748156|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
146062306|NCT03181932|526748155|FG000|Period 2 (Open-label Period)|Reason missing|2|||
146062307|NCT03181932|526748156|FG001|Period 2 (Open-label Period)|Reason missing|0|||
146062308|NCT03304626|526748157|FG000|Overall Study|Adverse Event|1|||
146062309|NCT03304626|526748158|FG001|Overall Study|Adverse Event|0|||
146062310|NCT03304626|526748157|FG000|Overall Study|Lack of Efficacy|1|||
146062311|NCT03304626|526748158|FG001|Overall Study|Lack of Efficacy|1|||
146062312|NCT00744497|526748159|FG000|Overall Study|Withdrawal by Subject|21|||
146062313|NCT00744497|526748160|FG001|Overall Study|Withdrawal by Subject|18|||
146062314|NCT00744497|526748159|FG000|Overall Study|Death|11|||
146062315|NCT00744497|526748160|FG001|Overall Study|Death|9|||
146062316|NCT00744497|526748159|FG000|Overall Study|Lost to Follow-up|4|||
146062317|NCT00744497|526748160|FG001|Overall Study|Lost to Follow-up|2|||
146062318|NCT00744497|526748159|FG000|Overall Study|Poor compliance/noncompliance|9|||
146062319|NCT00744497|526748160|FG001|Overall Study|Poor compliance/noncompliance|5|||
146062320|NCT00744497|526748159|FG000|Overall Study|No longer meets study criteria|7|||
146062321|NCT00744497|526748160|FG001|Overall Study|No longer meets study criteria|3|||
146062322|NCT00744497|526748159|FG000|Overall Study|Administrative Reason By Sponsor|25|||
146062323|NCT00744497|526748160|FG001|Overall Study|Administrative Reason By Sponsor|8|||
146062324|NCT00744497|526748159|FG000|Overall Study|Disease progression|312|||
146062325|NCT00744497|526748160|FG001|Overall Study|Disease progression|219|||
146062326|NCT00744497|526748159|FG000|Overall Study|Study drug toxicity|68|||
146062327|NCT00744497|526748160|FG001|Overall Study|Study drug toxicity|141|||
146062328|NCT00744497|526748159|FG000|Overall Study|Adverse event unrelated to study drug|78|||
146062329|NCT00744497|526748160|FG001|Overall Study|Adverse event unrelated to study drug|122|||
146062330|NCT00744497|526748159|FG000|Overall Study|Patient requested to stop study drug|65|||
146062331|NCT00744497|526748160|FG001|Overall Study|Patient requested to stop study drug|80|||
146062332|NCT00744497|526748159|FG000|Overall Study|Maximum clinical benefit|141|||
146170116|NCT02748694|527134806|FG008|Overall Study|Voluntary Withdrawal|0|||
146170117|NCT02748694|527134807|FG009|Overall Study|Voluntary Withdrawal|0|||
146062333|NCT00744497|526748160|FG001|Overall Study|Maximum clinical benefit|142|||
146062334|NCT00744497|526748159|FG000|Overall Study|Not defined|19|||
146062335|NCT00744497|526748160|FG001|Overall Study|Not defined|13|||
146062336|NCT03182374|526748165|FG000|Overall Study|Lost to Follow-up|3|||
146062337|NCT03182374|526748166|FG001|Overall Study|Lost to Follow-up|2|||
146062338|NCT03182374|526748165|FG000|Overall Study|Lack of Efficacy|8|||
146062339|NCT03182374|526748166|FG001|Overall Study|Lack of Efficacy|14|||
146170118|NCT02748694|527134808|FG010|Overall Study|Voluntary Withdrawal|0|||
146170119|NCT02748694|527134809|FG011|Overall Study|Voluntary Withdrawal|0|||
146170120|NCT02748694|527134810|FG012|Overall Study|Voluntary Withdrawal|0|||
146170121|NCT02748694|527134811|FG013|Overall Study|Voluntary Withdrawal|0|||
146170122|NCT02748694|527134812|FG014|Overall Study|Voluntary Withdrawal|2|||
146170123|NCT00659984|527134815|FG000|Overall Study|Adverse Event|1|||
146170124|NCT02007434|527134818|FG000|Overall Study|Lost to Follow-up|0|||
146170125|NCT02007434|527134819|FG001|Overall Study|Lost to Follow-up|1|||
146170126|NCT02007434|527134820|FG002|Overall Study|Lost to Follow-up|0|||
146170127|NCT02007434|527134821|FG003|Overall Study|Lost to Follow-up|0|||
146170128|NCT02007434|527134822|FG004|Overall Study|Lost to Follow-up|0|||
146062340|NCT03182374|526748165|FG000|Overall Study|Withdrawal by Subject|1|||
146062341|NCT03182374|526748166|FG001|Overall Study|Withdrawal by Subject|1|||
146062342|NCT03182374|526748165|FG000|Overall Study|exit for non-compliance|1|||
146062343|NCT03182374|526748166|FG001|Overall Study|exit for non-compliance|1|||
146062344|NCT03182374|526748165|FG000|Overall Study|one subject was randomized but not treated|1|||
146062345|NCT03182374|526748166|FG001|Overall Study|one subject was randomized but not treated|0|||
146062346|NCT03182374|526748165|FG000|Overall Study|Other reasons|0|||
146062347|NCT03182374|526748166|FG001|Overall Study|Other reasons|3|||
146062348|NCT03198715|526748167|FG000|Overall Study|Death|0|||
146062349|NCT03198715|526748168|FG001|Overall Study|Death|0|||
146062350|NCT03198715|526748169|FG002|Overall Study|Death|1|||
146062351|NCT03198715|526748170|FG003|Overall Study|Death|0|||
146062352|NCT03198715|526748171|FG004|Overall Study|Death|2|||
146062353|NCT03198715|526748167|FG000|Overall Study|Other|0|||
146062354|NCT03198715|526748168|FG001|Overall Study|Other|1|||
146062355|NCT03198715|526748169|FG002|Overall Study|Other|1|||
146062356|NCT03198715|526748170|FG003|Overall Study|Other|0|||
146062357|NCT03198715|526748171|FG004|Overall Study|Other|0|||
146062358|NCT00914316|526748174|FG000|Phase 1|Physician Decision|4|||
146062359|NCT00914316|526748175|FG001|Phase 1|Physician Decision|0|||
146062360|NCT00914316|526748176|FG002|Phase 1|Physician Decision|1|||
146062361|NCT00914316|526748177|FG003|Phase 1|Physician Decision|2|||
146062362|NCT00914316|526748174|FG000|Phase 1|Withdrawal by Subject|0|||
146062363|NCT00914316|526748175|FG001|Phase 1|Withdrawal by Subject|2|||
146062364|NCT00914316|526748176|FG002|Phase 1|Withdrawal by Subject|4|||
146062365|NCT00914316|526748177|FG003|Phase 1|Withdrawal by Subject|0|||
146062366|NCT00914316|526748174|FG000|Phase 1|Adverse Event|1|||
146062367|NCT00914316|526748175|FG001|Phase 1|Adverse Event|0|||
146062368|NCT00914316|526748176|FG002|Phase 1|Adverse Event|0|||
146062369|NCT00914316|526748177|FG003|Phase 1|Adverse Event|0|||
146062370|NCT00914316|526748174|FG000|Phase 2|Withdrawal by Subject|1|||
146062371|NCT00914316|526748175|FG001|Phase 2|Withdrawal by Subject|0|||
146062372|NCT00914316|526748176|FG002|Phase 2|Withdrawal by Subject|1|||
146062373|NCT00914316|526748177|FG003|Phase 2|Withdrawal by Subject|0|||
146062374|NCT02399163|526748180|FG000|Overall Study|Adverse Event|2|||
146062375|NCT02399163|526748180|FG000|Overall Study|Protocol Deviation|2|||
146062376|NCT02399163|526748180|FG000|Overall Study|Withdrawal by Participant|5|||
146062377|NCT01391546|526748186|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
146062378|NCT01391546|526748187|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
146062379|NCT04225897|526748193|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062380|NCT04225897|526748194|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
146062381|NCT04225897|526748195|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062382|NCT04225897|526748196|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062383|NCT04225897|526748197|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062384|NCT04225897|526748198|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062385|NCT04225897|526748199|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062386|NCT04225897|526748200|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062387|NCT04225897|526748201|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062388|NCT04225897|526748202|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062389|NCT04225897|526748203|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062390|NCT04225897|526748204|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
146062391|NCT04225897|526748193|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062392|NCT04225897|526748194|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062393|NCT04225897|526748195|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
146062394|NCT04225897|526748196|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062395|NCT04225897|526748197|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062396|NCT04225897|526748198|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062397|NCT04225897|526748199|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062398|NCT04225897|526748200|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062399|NCT04225897|526748201|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062400|NCT04225897|526748202|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062401|NCT04225897|526748203|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062402|NCT04225897|526748204|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
146062403|NCT04225897|526748193|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062404|NCT04225897|526748194|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062405|NCT04225897|526748195|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
146062406|NCT04225897|526748196|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062407|NCT04225897|526748197|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062408|NCT04225897|526748198|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062409|NCT04225897|526748199|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062410|NCT04225897|526748200|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062411|NCT04225897|526748201|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062412|NCT04225897|526748202|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062413|NCT04225897|526748203|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062414|NCT04225897|526748204|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
146062415|NCT04225897|526748193|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062416|NCT04225897|526748194|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062417|NCT04225897|526748195|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062418|NCT04225897|526748196|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062419|NCT04225897|526748197|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062420|NCT04225897|526748198|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062421|NCT04225897|526748199|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062422|NCT04225897|526748200|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
146062423|NCT04225897|526748201|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062424|NCT04225897|526748202|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062425|NCT04225897|526748203|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062426|NCT04225897|526748204|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
146062427|NCT00074711|526748206|FG000|Overall Study|Withdrawal by Subject|1|||
146062428|NCT00074711|526748207|FG001|Overall Study|Withdrawal by Subject|1|||
146062429|NCT00074711|526748206|FG000|Overall Study|Lost to Follow-up|10|||
146062430|NCT00074711|526748207|FG001|Overall Study|Lost to Follow-up|8|||
146062431|NCT00074711|526748206|FG000|Overall Study|Participant stopped study drug|4|||
146062432|NCT00074711|526748207|FG001|Overall Study|Participant stopped study drug|6|||
146062433|NCT03466658|526748208|FG000|Overall Study|Withdrawal by Subject|3|||
146062434|NCT00837434|526748209|FG000|Overall Study|Physician Decision|3|||
146062435|NCT00837434|526748210|FG001|Overall Study|Physician Decision|0|||
146062436|NCT00837434|526748209|FG000|Overall Study|Lost to Follow-up|1|||
146062437|NCT00837434|526748210|FG001|Overall Study|Lost to Follow-up|1|||
146062438|NCT00837434|526748209|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
146062439|NCT00837434|526748210|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
146062440|NCT00837434|526748209|FG000|Overall Study|Noncompliant|2|||
146062441|NCT00837434|526748210|FG001|Overall Study|Noncompliant|0|||
146062442|NCT00837434|526748209|FG000|Overall Study|Baseline assessments not done in time|1|||
146062443|NCT00837434|526748210|FG001|Overall Study|Baseline assessments not done in time|0|||
146062444|NCT00837434|526748209|FG000|Overall Study|Unable to obtain study drug|1|||
146062445|NCT00837434|526748210|FG001|Overall Study|Unable to obtain study drug|0|||
146062446|NCT01921205|526748211|FG000|Overall Study|Adverse Event|12|||
146062447|NCT01921205|526748212|FG001|Overall Study|Adverse Event|7|||
146062448|NCT01921205|526748211|FG000|Overall Study|Lack of Efficacy|1|||
146062449|NCT01921205|526748212|FG001|Overall Study|Lack of Efficacy|0|||
146062450|NCT01921205|526748211|FG000|Overall Study|Protocol Violation|1|||
146062451|NCT01921205|526748212|FG001|Overall Study|Protocol Violation|3|||
146062452|NCT01921205|526748211|FG000|Overall Study|Lost to Follow-up|1|||
146062453|NCT01921205|526748212|FG001|Overall Study|Lost to Follow-up|1|||
146062454|NCT01921205|526748211|FG000|Overall Study|Withdrawal by Subject|6|||
146062455|NCT01921205|526748212|FG001|Overall Study|Withdrawal by Subject|5|||
146062456|NCT01921205|526748211|FG000|Overall Study|Use Of Prohibited Medication|0|||
146062457|NCT01921205|526748212|FG001|Overall Study|Use Of Prohibited Medication|1|||
146062458|NCT01921205|526748211|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
146062459|NCT01921205|526748212|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
146062460|NCT01921205|526748211|FG000|Overall Study|Non Compliance Of The Parent|0|||
146062461|NCT01921205|526748212|FG001|Overall Study|Non Compliance Of The Parent|1|||
146062462|NCT01921205|526748211|FG000|Overall Study|Non Compliance Of Child|0|||
146062463|NCT01921205|526748212|FG001|Overall Study|Non Compliance Of Child|1|||
146062464|NCT00360230|526748213|FG000|Overall Study|Withdrawal by Subject|1|||
146062465|NCT00360230|526748214|FG001|Overall Study|Withdrawal by Subject|1|||
146062466|NCT00360230|526748215|FG002|Overall Study|Withdrawal by Subject|0|||
146062467|NCT00360230|526748216|FG003|Overall Study|Withdrawal by Subject|1|||
146062468|NCT00360230|526748217|FG004|Overall Study|Withdrawal by Subject|1|||
146062469|NCT00360230|526748218|FG005|Overall Study|Withdrawal by Subject|1|||
146062470|NCT00360230|526748219|FG006|Overall Study|Withdrawal by Subject|0|||
146062471|NCT00360230|526748213|FG000|Overall Study|Migrated|4|||
146062472|NCT00360230|526748214|FG001|Overall Study|Migrated|1|||
146062473|NCT00360230|526748215|FG002|Overall Study|Migrated|3|||
146062474|NCT00360230|526748216|FG003|Overall Study|Migrated|1|||
146062475|NCT00360230|526748217|FG004|Overall Study|Migrated|4|||
146062476|NCT00360230|526748218|FG005|Overall Study|Migrated|1|||
146062477|NCT00360230|526748219|FG006|Overall Study|Migrated|1|||
146062478|NCT00360230|526748213|FG000|Overall Study|Other|1|||
146062479|NCT00360230|526748214|FG001|Overall Study|Other|0|||
146062480|NCT00360230|526748215|FG002|Overall Study|Other|0|||
146062481|NCT00360230|526748216|FG003|Overall Study|Other|0|||
146062482|NCT00360230|526748217|FG004|Overall Study|Other|0|||
146062483|NCT00360230|526748218|FG005|Overall Study|Other|0|||
146170129|NCT02007434|527134823|FG005|Overall Study|Lost to Follow-up|0|||
146170130|NCT02007434|527134824|FG006|Overall Study|Lost to Follow-up|0|||
146170131|NCT02007434|527134825|FG007|Overall Study|Lost to Follow-up|0|||
146170132|NCT02007434|527134818|FG000|Overall Study|Non-compliance|1|||
146170133|NCT02007434|527134819|FG001|Overall Study|Non-compliance|0|||
146170134|NCT02007434|527134820|FG002|Overall Study|Non-compliance|1|||
146170135|NCT02007434|527134821|FG003|Overall Study|Non-compliance|0|||
146170136|NCT02007434|527134822|FG004|Overall Study|Non-compliance|0|||
146170137|NCT02007434|527134823|FG005|Overall Study|Non-compliance|0|||
146170138|NCT02007434|527134824|FG006|Overall Study|Non-compliance|0|||
146170139|NCT02007434|527134825|FG007|Overall Study|Non-compliance|0|||
146170140|NCT04074590|527134828|FG000|Overall Study|Adverse Event|1|||
146170141|NCT04074590|527134829|FG001|Overall Study|Adverse Event|0|||
146170142|NCT04074590|527134828|FG000|Overall Study|Physician Decision|1|||
146170143|NCT04074590|527134829|FG001|Overall Study|Physician Decision|0|||
146170144|NCT04074590|527134828|FG000|Overall Study|Withdrawal by Subject|2|||
146170145|NCT04074590|527134829|FG001|Overall Study|Withdrawal by Subject|0|||
146170146|NCT00792103|527134842|FG000|Overall Study|Enrolled, not treated|15|||
146170147|NCT00792103|527134842|FG000|Overall Study|Lost to Follow-up|17|||
146170148|NCT00792103|527134842|FG000|Overall Study|Adverse Event|25|||
146170149|NCT00792103|527134842|FG000|Overall Study|Withdrawal by Subject|52|||
146170150|NCT00792103|527134842|FG000|Overall Study|Protocol Violation|10|||
146170151|NCT00792103|527134842|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
146170152|NCT03745222|527134843|FG000|Overall Study|Withdrawal by Subject|0|||
146170153|NCT03745222|527134844|FG001|Overall Study|Withdrawal by Subject|1|||
146170154|NCT03745222|527134845|FG002|Overall Study|Withdrawal by Subject|0|||
146170155|NCT02535364|527134846|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
146170156|NCT02535364|527134846|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
146170157|NCT02535364|527134846|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
146170158|NCT02535364|527134846|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
146170159|NCT02535364|527134846|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
146170160|NCT02535364|527134846|FG000|Part B Screening|Death|2|||
146170161|NCT02535364|527134846|FG000|Part B Screening|Physician Decision|1|||
146170162|NCT02535364|527134846|FG000|Part B Screening|Withdrawal by Subject|1|||
146170163|NCT02535364|527134846|FG000|Part B Screening|Adverse Event|1|||
146170164|NCT02535364|527134846|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
146170165|NCT02535364|527134846|FG000|Study Treatment|Death|1|||
146170166|NCT02535364|527134846|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
146170167|NCT02535364|527134846|FG000|12-Month Follow-up Period|Disease progression|22|||
146170168|NCT02535364|527134846|FG000|12-Month Follow-up Period|Death|5|||
146170169|NCT02535364|527134846|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
146170170|NCT02535364|527134846|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
146170171|NCT02535364|527134846|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
146170172|NCT00571701|527134847|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
146170173|NCT00571701|527134848|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
146170174|NCT00571701|527134847|FG000|First Intervention 12 Months|Death|1|||
146170175|NCT00571701|527134848|FG001|First Intervention 12 Months|Death|0|||
146170176|NCT00571701|527134847|FG000|Second Intervention 12 Months|Adverse Event|0|||
146170177|NCT00571701|527134848|FG001|Second Intervention 12 Months|Adverse Event|1|||
146170178|NCT00571701|527134847|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
146062484|NCT00360230|526748219|FG006|Overall Study|Other|0|||
146062485|NCT00360230|526748213|FG000|Overall Study|Protocol Violation|0|||
146062486|NCT00360230|526748214|FG001|Overall Study|Protocol Violation|0|||
146062487|NCT00360230|526748215|FG002|Overall Study|Protocol Violation|0|||
146062488|NCT00360230|526748216|FG003|Overall Study|Protocol Violation|0|||
146170179|NCT00571701|527134848|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
146170180|NCT04766086|527134851|FG000|Overall Study|Lost to Follow-up|3|||
146170181|NCT04766086|527134852|FG001|Overall Study|Lost to Follow-up|5|||
146170182|NCT04766086|527134853|FG002|Overall Study|Lost to Follow-up|3|||
146170183|NCT04766086|527134851|FG000|Overall Study|Withdrawal by Subject|1|||
146062489|NCT00360230|526748217|FG004|Overall Study|Protocol Violation|0|||
146062490|NCT00360230|526748218|FG005|Overall Study|Protocol Violation|1|||
146062491|NCT00360230|526748219|FG006|Overall Study|Protocol Violation|0|||
146170184|NCT04766086|527134852|FG001|Overall Study|Withdrawal by Subject|1|||
146170185|NCT04766086|527134853|FG002|Overall Study|Withdrawal by Subject|2|||
146170186|NCT04766086|527134851|FG000|Overall Study|Other|0|||
146170187|NCT04766086|527134852|FG001|Overall Study|Other|0|||
146170188|NCT04766086|527134853|FG002|Overall Study|Other|1|||
146170189|NCT01959347|527134856|FG000|Overall Study|Protocol Violation|9|||
146170190|NCT01959347|527134857|FG001|Overall Study|Protocol Violation|7|||
146170191|NCT03541044|527134858|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
146170192|NCT03541044|527134859|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
146170193|NCT03541044|527134858|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
146170194|NCT03541044|527134859|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
146170195|NCT04581200|527134860|FG000|Overall Study|Lost to Follow-up|6|||
146170196|NCT04581200|527134861|FG001|Overall Study|Lost to Follow-up|5|||
146170197|NCT03131960|527134862|FG000|Overall Study|Adverse Event|0|||
146170198|NCT03131960|527134863|FG001|Overall Study|Adverse Event|1|||
146170199|NCT03485911|527134867|FG000|Part 1|Perceived lack of efficacy|1|||
146170200|NCT03485911|527134868|FG001|Part 1|Perceived lack of efficacy|1|||
146170201|NCT03485911|527134869|FG002|Part 1|Perceived lack of efficacy|2|||
146170202|NCT03485911|527134870|FG003|Part 1|Perceived lack of efficacy|0|||
146170203|NCT03485911|527134867|FG000|Part 1|Subject withdrew consent|0|||
146170204|NCT03485911|527134868|FG001|Part 1|Subject withdrew consent|1|||
146170205|NCT03485911|527134869|FG002|Part 1|Subject withdrew consent|0|||
146170206|NCT03485911|527134870|FG003|Part 1|Subject withdrew consent|1|||
146170207|NCT03485911|527134867|FG000|Part 1|Lab abnormalities/AEs|3|||
146170208|NCT03485911|527134868|FG001|Part 1|Lab abnormalities/AEs|1|||
146170209|NCT03485911|527134869|FG002|Part 1|Lab abnormalities/AEs|1|||
146170210|NCT03485911|527134870|FG003|Part 1|Lab abnormalities/AEs|0|||
146170211|NCT03485911|527134867|FG000|Part 1|Withdrew Consent prior to dosing|0|||
146170212|NCT03485911|527134868|FG001|Part 1|Withdrew Consent prior to dosing|0|||
146170213|NCT03485911|527134869|FG002|Part 1|Withdrew Consent prior to dosing|0|||
146170214|NCT03485911|527134870|FG003|Part 1|Withdrew Consent prior to dosing|1|||
146170215|NCT03485911|527134867|FG000|Part 1|Other NOS|0|||
146170216|NCT03485911|527134868|FG001|Part 1|Other NOS|0|||
146170217|NCT03485911|527134869|FG002|Part 1|Other NOS|0|||
146170218|NCT03485911|527134870|FG003|Part 1|Other NOS|1|||
146170219|NCT03485911|527134867|FG000|Part 2|Perceived lack of efficacy|5|||
146170220|NCT03485911|527134868|FG001|Part 2|Perceived lack of efficacy|3|||
146170221|NCT03485911|527134869|FG002|Part 2|Perceived lack of efficacy|0|||
146170222|NCT03485911|527134870|FG003|Part 2|Perceived lack of efficacy|2|||
146170223|NCT03485911|527134867|FG000|Part 2|Subject withdrew consent|1|||
146170224|NCT03485911|527134868|FG001|Part 2|Subject withdrew consent|0|||
146170225|NCT03485911|527134869|FG002|Part 2|Subject withdrew consent|2|||
146170226|NCT03485911|527134870|FG003|Part 2|Subject withdrew consent|1|||
146170227|NCT03485911|527134867|FG000|Part 2|Lab abnormalities/AEs|1|||
146170228|NCT03485911|527134868|FG001|Part 2|Lab abnormalities/AEs|2|||
146170229|NCT03485911|527134869|FG002|Part 2|Lab abnormalities/AEs|0|||
146170230|NCT03485911|527134870|FG003|Part 2|Lab abnormalities/AEs|0|||
146170231|NCT03485911|527134867|FG000|Part 2|Other NOS|0|||
146170232|NCT03485911|527134868|FG001|Part 2|Other NOS|1|||
146170233|NCT03485911|527134869|FG002|Part 2|Other NOS|0|||
146170234|NCT03485911|527134870|FG003|Part 2|Other NOS|0|||
146170235|NCT03485911|527134867|FG000|Part 2|Intercurrent illness/new medical condition|1|||
146170236|NCT03485911|527134868|FG001|Part 2|Intercurrent illness/new medical condition|0|||
146170237|NCT03485911|527134869|FG002|Part 2|Intercurrent illness/new medical condition|0|||
146170238|NCT03485911|527134870|FG003|Part 2|Intercurrent illness/new medical condition|0|||
146170239|NCT03485911|527134867|FG000|Part 2|Investigator judgement|1|||
146170240|NCT03485911|527134868|FG001|Part 2|Investigator judgement|0|||
146170241|NCT03485911|527134869|FG002|Part 2|Investigator judgement|0|||
146170242|NCT03485911|527134870|FG003|Part 2|Investigator judgement|0|||
146170243|NCT03485911|527134867|FG000|Part 3|Perceived lack of efficacy|2|||
146170244|NCT03485911|527134868|FG001|Part 3|Perceived lack of efficacy|2|||
146170245|NCT03485911|527134869|FG002|Part 3|Perceived lack of efficacy|2|||
146170246|NCT03485911|527134870|FG003|Part 3|Perceived lack of efficacy|0|||
146170247|NCT03485911|527134867|FG000|Part 3|Subject withdrew consent|1|||
146170248|NCT03485911|527134868|FG001|Part 3|Subject withdrew consent|4|||
146170249|NCT03485911|527134869|FG002|Part 3|Subject withdrew consent|0|||
146170250|NCT03485911|527134870|FG003|Part 3|Subject withdrew consent|1|||
146170251|NCT03485911|527134867|FG000|Part 3|Lab abnormalities/AEs|1|||
146170252|NCT03485911|527134868|FG001|Part 3|Lab abnormalities/AEs|1|||
146170253|NCT03485911|527134869|FG002|Part 3|Lab abnormalities/AEs|0|||
146170254|NCT03485911|527134870|FG003|Part 3|Lab abnormalities/AEs|2|||
146170255|NCT03485911|527134867|FG000|Part 3|Other NOS|1|||
146170256|NCT03485911|527134868|FG001|Part 3|Other NOS|1|||
146170257|NCT03485911|527134869|FG002|Part 3|Other NOS|0|||
146170258|NCT03485911|527134870|FG003|Part 3|Other NOS|0|||
146170259|NCT03485911|527134867|FG000|Part 3|Intercurrent illness/new medical condition|0|||
146170260|NCT03485911|527134868|FG001|Part 3|Intercurrent illness/new medical condition|1|||
146170261|NCT03485911|527134869|FG002|Part 3|Intercurrent illness/new medical condition|1|||
146170262|NCT03485911|527134870|FG003|Part 3|Intercurrent illness/new medical condition|0|||
146170263|NCT03485911|527134867|FG000|Part 3|Sponsor discontinuation|1|||
146170264|NCT03485911|527134868|FG001|Part 3|Sponsor discontinuation|0|||
146170265|NCT03485911|527134869|FG002|Part 3|Sponsor discontinuation|0|||
146170266|NCT03485911|527134870|FG003|Part 3|Sponsor discontinuation|0|||
146170267|NCT03485911|527134867|FG000|Part 3|Berotralstat provided by alternative means|13|||
146170268|NCT03485911|527134868|FG001|Part 3|Berotralstat provided by alternative means|13|||
146170269|NCT03485911|527134869|FG002|Part 3|Berotralstat provided by alternative means|7|||
146170270|NCT03485911|527134870|FG003|Part 3|Berotralstat provided by alternative means|7|||
146170271|NCT02036645|527134871|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170272|NCT02036645|527134872|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170273|NCT02036645|527134873|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170274|NCT02036645|527134874|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170275|NCT02036645|527134875|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170276|NCT02036645|527134876|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170277|NCT02036645|527134877|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
146170278|NCT02036645|527134878|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170279|NCT02036645|527134879|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170280|NCT02036645|527134880|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170281|NCT02036645|527134881|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170282|NCT02036645|527134882|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
146170283|NCT02036645|527134871|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170284|NCT02036645|527134872|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170285|NCT02036645|527134873|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170286|NCT02036645|527134874|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
146170287|NCT02036645|527134875|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170288|NCT02036645|527134876|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170289|NCT02036645|527134877|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170290|NCT02036645|527134878|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170291|NCT02036645|527134879|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170292|NCT02036645|527134880|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170293|NCT02036645|527134881|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170294|NCT02036645|527134882|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
146170295|NCT03750006|527134887|FG000|Overall Study|Withdrawal by Subject|8|||
146170296|NCT03750006|527134887|FG000|Overall Study|COVID PANDEMIC|11|||
146170297|NCT02202434|527137123|FG000|Overall Study|Death|70|||
146170298|NCT02202434|527137124|FG001|Overall Study|Death|39|||
146170299|NCT02202434|527137125|FG002|Overall Study|Death|13|||
146170300|NCT02202434|527137126|FG003|Overall Study|Death|27|||
146170301|NCT02202434|527137123|FG000|Overall Study|Lost to Follow-up|1|||
146170302|NCT02202434|527137124|FG001|Overall Study|Lost to Follow-up|1|||
146170303|NCT02202434|527137125|FG002|Overall Study|Lost to Follow-up|1|||
146170304|NCT02202434|527137126|FG003|Overall Study|Lost to Follow-up|0|||
146170305|NCT02202434|527137123|FG000|Overall Study|Physician Decision|2|||
146170306|NCT02202434|527137124|FG001|Overall Study|Physician Decision|3|||
146170307|NCT02202434|527137125|FG002|Overall Study|Physician Decision|0|||
146170308|NCT02202434|527137126|FG003|Overall Study|Physician Decision|0|||
146170309|NCT02202434|527137123|FG000|Overall Study|Withdrawal by Subject|13|||
146170310|NCT02202434|527137124|FG001|Overall Study|Withdrawal by Subject|14|||
146170311|NCT02202434|527137125|FG002|Overall Study|Withdrawal by Subject|1|||
146170312|NCT02202434|527137126|FG003|Overall Study|Withdrawal by Subject|4|||
146170313|NCT02202434|527137123|FG000|Overall Study|Completed Study|1|||
146170314|NCT02202434|527137124|FG001|Overall Study|Completed Study|0|||
146170315|NCT02202434|527137125|FG002|Overall Study|Completed Study|0|||
146170316|NCT02202434|527137126|FG003|Overall Study|Completed Study|0|||
146170317|NCT02202434|527137123|FG000|Overall Study|Visit Missed|21|||
146170318|NCT02202434|527137124|FG001|Overall Study|Visit Missed|12|||
146170319|NCT02202434|527137125|FG002|Overall Study|Visit Missed|0|||
146170320|NCT02202434|527137126|FG003|Overall Study|Visit Missed|5|||
146170321|NCT02202434|527137123|FG000|Overall Study|Other|1|||
146170322|NCT02202434|527137124|FG001|Overall Study|Other|0|||
146170323|NCT02202434|527137125|FG002|Overall Study|Other|0|||
146170324|NCT02202434|527137126|FG003|Overall Study|Other|1|||
146170325|NCT03237858|527137127|FG000|Overall Study|Death|19|||
146170326|NCT03237858|527137127|FG000|Overall Study|Withdrawal by Subject|37|||
146170327|NCT04858802|527137130|FG000|Overall Study|Lost to Follow-up|1|||
146170328|NCT04858802|527137131|FG001|Overall Study|Lost to Follow-up|1|||
146170329|NCT04858802|527137130|FG000|Overall Study|Withdrawal by Subject|1|||
146170330|NCT04858802|527137131|FG001|Overall Study|Withdrawal by Subject|1|||
146170331|NCT03610737|527137134|FG000|Overall Study|Withdrawal by Subject|1|||
146170332|NCT03610737|527137135|FG001|Overall Study|Withdrawal by Subject|5|||
146170333|NCT03610737|527137134|FG000|Overall Study|Death|1|||
146170334|NCT03610737|527137135|FG001|Overall Study|Death|0|||
146170335|NCT03610737|527137134|FG000|Overall Study|Not treated|5|||
146170336|NCT03610737|527137135|FG001|Overall Study|Not treated|2|||
146170337|NCT03610737|527137134|FG000|Overall Study|Missed Visit|1|||
146170338|NCT03610737|527137135|FG001|Overall Study|Missed Visit|2|||
146170339|NCT02013388|527137138|FG000|Overall Study|work emergency|1|||
146170340|NCT02013388|527137139|FG001|Overall Study|work emergency|0|||
146170341|NCT02013388|527137140|FG002|Overall Study|work emergency|0|||
146062492|NCT00360230|526748213|FG000|Overall Study|Death|0|||
146062493|NCT00360230|526748214|FG001|Overall Study|Death|1|||
146062494|NCT00360230|526748215|FG002|Overall Study|Death|0|||
146062495|NCT00360230|526748216|FG003|Overall Study|Death|0|||
146062496|NCT00360230|526748217|FG004|Overall Study|Death|0|||
146062497|NCT00360230|526748218|FG005|Overall Study|Death|1|||
146062498|NCT00360230|526748219|FG006|Overall Study|Death|1|||
146062499|NCT00456846|526748220|FG000|Overall Study|Adverse Event|2|||
146062500|NCT00456846|526748221|FG001|Overall Study|Adverse Event|15|||
146062501|NCT00456846|526748220|FG000|Overall Study|Physician Decision|11|||
146062502|NCT00456846|526748221|FG001|Overall Study|Physician Decision|6|||
146062503|NCT00456846|526748220|FG000|Overall Study|Protocol Deviation|2|||
146062504|NCT00456846|526748221|FG001|Overall Study|Protocol Deviation|0|||
146062505|NCT00456846|526748220|FG000|Overall Study|Participant Discretion|1|||
146062506|NCT00456846|526748221|FG001|Overall Study|Participant Discretion|5|||
146062507|NCT00456846|526748220|FG000|Overall Study|Other|0|||
146062508|NCT00456846|526748221|FG001|Overall Study|Other|2|||
146062509|NCT00910650|526748222|FG000|Overall Study|Death|2|||
146062510|NCT03367793|526748223|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146062511|NCT03367793|526748224|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146062512|NCT03367793|526748225|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
146062513|NCT03367793|526748226|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146062514|NCT03367793|526748227|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146062515|NCT03367793|526748228|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
146062516|NCT00260533|526748229|FG000|Overall Study|Other|3|||
146062517|NCT00260533|526748230|FG001|Overall Study|Other|3|||
146062518|NCT00003475|526748231|FG000|Overall Study|Not evaluable|13|||
146062519|NCT04682366|526748232|FG000|Overall Study|Lost to Follow-up|1|||
146062520|NCT04682366|526748233|FG001|Overall Study|Lost to Follow-up|1|||
146062521|NCT02224560|526748238|FG000|Overall Study|Protocol Deviation|1|||
146062522|NCT02224560|526748239|FG001|Overall Study|Protocol Deviation|0|||
146062523|NCT02224560|526748240|FG002|Overall Study|Protocol Deviation|0|||
146062524|NCT02224560|526748238|FG000|Overall Study|Withdrawal by Subject|2|||
146062525|NCT02224560|526748239|FG001|Overall Study|Withdrawal by Subject|0|||
146062526|NCT02224560|526748240|FG002|Overall Study|Withdrawal by Subject|1|||
146062527|NCT02224560|526748238|FG000|Overall Study|Met Withdrawal Criteria|1|||
146062528|NCT02224560|526748239|FG001|Overall Study|Met Withdrawal Criteria|0|||
146062529|NCT02224560|526748240|FG002|Overall Study|Met Withdrawal Criteria|0|||
146062530|NCT02224560|526748238|FG000|Overall Study|Adverse Event|4|||
146062531|NCT02224560|526748239|FG001|Overall Study|Adverse Event|1|||
146062532|NCT02224560|526748240|FG002|Overall Study|Adverse Event|1|||
146062533|NCT02224560|526748238|FG000|Overall Study|Withdrawn by Investigator|1|||
146062534|NCT02224560|526748239|FG001|Overall Study|Withdrawn by Investigator|1|||
146062535|NCT02224560|526748240|FG002|Overall Study|Withdrawn by Investigator|0|||
146062536|NCT04543279|526748241|FG000|Overall Study|Withdrawal by Subject|1|||
146062537|NCT04543279|526748242|FG001|Overall Study|Withdrawal by Subject|0|||
146062538|NCT04543279|526748241|FG000|Overall Study|Adverse Event|1|||
146062539|NCT04543279|526748242|FG001|Overall Study|Adverse Event|0|||
146062540|NCT04543279|526748241|FG000|Overall Study|Physician Decision|1|||
146062541|NCT04543279|526748242|FG001|Overall Study|Physician Decision|0|||
146062542|NCT00929695|526748244|FG000|Overall Study|Death|2|||
146062543|NCT00929695|526748245|FG001|Overall Study|Death|1|||
146062544|NCT00929695|526748244|FG000|Overall Study|Withdrawal by Subject|0|||
146062545|NCT00929695|526748245|FG001|Overall Study|Withdrawal by Subject|2|||
146062546|NCT00929695|526748244|FG000|Overall Study|discharge home|4|||
146062547|NCT00929695|526748245|FG001|Overall Study|discharge home|3|||
146062548|NCT00929695|526748244|FG000|Overall Study|incorrect stratification|2|||
146062549|NCT00929695|526748245|FG001|Overall Study|incorrect stratification|0|||
146062550|NCT04030143|526748246|FG000|Overall Study|Adverse Event|5|||
146062551|NCT04030143|526748247|FG001|Overall Study|Adverse Event|10|||
146062552|NCT04030143|526748246|FG000|Overall Study|Lost to Follow-up|3|||
146062553|NCT04030143|526748247|FG001|Overall Study|Lost to Follow-up|7|||
146062554|NCT04030143|526748246|FG000|Overall Study|Protocol Deviation|2|||
146062555|NCT04030143|526748247|FG001|Overall Study|Protocol Deviation|2|||
146062556|NCT04030143|526748246|FG000|Overall Study|Withdrawal by Subject|16|||
146062557|NCT04030143|526748247|FG001|Overall Study|Withdrawal by Subject|18|||
146062558|NCT04030143|526748246|FG000|Overall Study|Physician Decision|1|||
146062559|NCT04030143|526748247|FG001|Overall Study|Physician Decision|1|||
146062560|NCT04030143|526748246|FG000|Overall Study|Due to Covid-19|2|||
146062561|NCT04030143|526748247|FG001|Overall Study|Due to Covid-19|3|||
146062562|NCT04030143|526748246|FG000|Overall Study|Not Due to Covid-19|1|||
146062563|NCT04030143|526748247|FG001|Overall Study|Not Due to Covid-19|1|||
146062564|NCT03216226|526748248|FG000|Overall Study|Adverse Event|3|||
146062565|NCT03216226|526748249|FG001|Overall Study|Adverse Event|0|||
146062566|NCT03216226|526748248|FG000|Overall Study|Protocol Violation|1|||
146062567|NCT03216226|526748249|FG001|Overall Study|Protocol Violation|3|||
146062568|NCT03216226|526748248|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
146087737|NCT04393298|526841817|FG007|Overall Study|Patient Discharged to Hospice|0|||
146170342|NCT02013388|527137141|FG003|Overall Study|work emergency|0|||
146170343|NCT02013388|527137142|FG004|Overall Study|work emergency|1|||
146170344|NCT02013388|527137143|FG005|Overall Study|work emergency|0|||
146170345|NCT02013388|527137144|FG006|Overall Study|work emergency|0|||
146170346|NCT02013388|527137145|FG007|Overall Study|work emergency|0|||
146170347|NCT03243422|527137146|FG000|Overall Study|Death|20|||
146170348|NCT03243422|527137147|FG001|Overall Study|Death|21|||
146170349|NCT03243422|527137146|FG000|Overall Study|Lost to Follow-up|9|||
146170350|NCT03243422|527137147|FG001|Overall Study|Lost to Follow-up|21|||
146170351|NCT03243422|527137146|FG000|Overall Study|Withdrawal by Subject|22|||
146170352|NCT03243422|527137147|FG001|Overall Study|Withdrawal by Subject|8|||
146170353|NCT00215540|527137151|FG000|Overall Study|Withdrew from study medication|1|||
146170354|NCT00215540|527137152|FG001|Overall Study|Withdrew from study medication|0|||
146170355|NCT00215540|527137153|FG002|Overall Study|Withdrew from study medication|0|||
146170356|NCT03145766|527137154|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146170357|NCT03145766|527137155|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146170358|NCT03145766|527137156|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
146170359|NCT03145766|527137157|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
146170360|NCT03145766|527137158|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
146170361|NCT03145766|527137154|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
146170362|NCT03145766|527137155|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
146170363|NCT03145766|527137156|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
146170364|NCT03145766|527137157|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
146170365|NCT03145766|527137158|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
146170366|NCT03145766|527137154|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
146170367|NCT03145766|527137155|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
146170368|NCT03145766|527137156|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
146170369|NCT03145766|527137157|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
146170370|NCT03145766|527137158|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
146170371|NCT03145766|527137154|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
146170372|NCT03145766|527137155|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146170373|NCT03145766|527137156|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146170374|NCT03145766|527137157|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
146170375|NCT03145766|527137158|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
146170376|NCT03145766|527137154|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
146170377|NCT03145766|527137155|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146170378|NCT03145766|527137156|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146170379|NCT03145766|527137157|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
146170380|NCT03145766|527137158|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
146170381|NCT03145766|527137154|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
146170382|NCT03145766|527137155|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
146170383|NCT03145766|527137156|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
146170384|NCT03145766|527137157|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
146170385|NCT03145766|527137158|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
146170386|NCT03145766|527137154|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146170387|NCT03145766|527137155|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146170388|NCT03145766|527137156|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
146170389|NCT03145766|527137157|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
146170390|NCT03145766|527137158|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
146170391|NCT02801669|527137160|FG000|Overall Study|Death|66|||
146170392|NCT02801669|527137161|FG001|Overall Study|Death|69|||
146170393|NCT02801669|527137160|FG000|Overall Study|Withdrawal by Subject|81|||
146170394|NCT02801669|527137161|FG001|Overall Study|Withdrawal by Subject|77|||
146170395|NCT02801669|527137160|FG000|Overall Study|Other|4|||
146170396|NCT02801669|527137161|FG001|Overall Study|Other|6|||
146170397|NCT04461795|527137163|FG000|Overall Study|Lost to Follow-up|2|||
146170398|NCT04461795|527137163|FG000|Overall Study|Withdrawal by Subject|2|||
146170399|NCT04461795|527137163|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
146170400|NCT00615264|527137164|FG000|Overall Study|Withdrawal by Subject|17|||
146170401|NCT00615264|527137165|FG001|Overall Study|Withdrawal by Subject|19|||
146170402|NCT00615264|527137164|FG000|Overall Study|Lost to Follow-up|6|||
146170403|NCT00615264|527137165|FG001|Overall Study|Lost to Follow-up|13|||
146170404|NCT00615264|527137164|FG000|Overall Study|Adverse Event|8|||
146170405|NCT00615264|527137165|FG001|Overall Study|Adverse Event|5|||
146170406|NCT00615264|527137164|FG000|Overall Study|Death|1|||
146170407|NCT00615264|527137165|FG001|Overall Study|Death|1|||
146170408|NCT00615264|527137164|FG000|Overall Study|Protocol Violation|11|||
146170409|NCT00615264|527137165|FG001|Overall Study|Protocol Violation|7|||
146170410|NCT00615264|527137164|FG000|Overall Study|Not defined|7|||
146170411|NCT00615264|527137165|FG001|Overall Study|Not defined|4|||
146170412|NCT00615264|527137164|FG000|Overall Study|Dermal Hypersensitivity|0|||
146170413|NCT00615264|527137165|FG001|Overall Study|Dermal Hypersensitivity|3|||
146170414|NCT00185640|527137166|FG000|Overall Study|Not Eligible|4|||
146170415|NCT00185640|527137166|FG000|Overall Study|Withdrawal by Subject|3|||
146170416|NCT00185640|527137166|FG000|Overall Study|Death|138|||
146170417|NCT00058422|527137167|FG000|Overall Study|Not treated|2|||
146170418|NCT02396537|527137176|FG000|Overall Study|Protocol Violation|0|||
146170419|NCT02396537|527137177|FG001|Overall Study|Protocol Violation|1|||
146170420|NCT01982435|527137178|FG000|Overall Study|Adverse Event|1|||
146170421|NCT01982435|527137179|FG001|Overall Study|Adverse Event|0|||
146170422|NCT00871403|527137180|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
146170423|NCT00871403|527137181|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
146170424|NCT00871403|527137182|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
146170425|NCT00871403|527137180|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
146170426|NCT00871403|527137181|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
146170427|NCT00871403|527137182|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
146170428|NCT00871403|527137180|FG000|Combination Treatment Phase|Adverse Event|0|||
146170429|NCT00871403|527137181|FG001|Combination Treatment Phase|Adverse Event|17|||
146170430|NCT00871403|527137182|FG002|Combination Treatment Phase|Adverse Event|2|||
146170431|NCT00871403|527137180|FG000|Combination Treatment Phase|Disease Progression|0|||
146170432|NCT00871403|527137181|FG001|Combination Treatment Phase|Disease Progression|8|||
146170433|NCT00871403|527137182|FG002|Combination Treatment Phase|Disease Progression|5|||
146170434|NCT00871403|527137180|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
146170435|NCT00871403|527137181|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
146170436|NCT00871403|527137182|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
146170437|NCT00871403|527137180|FG000|Combination Treatment Phase|Physician Decision|0|||
146170438|NCT00871403|527137181|FG001|Combination Treatment Phase|Physician Decision|1|||
146170439|NCT00871403|527137182|FG002|Combination Treatment Phase|Physician Decision|3|||
146170440|NCT00871403|527137180|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
146170441|NCT00871403|527137181|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
146170442|NCT00871403|527137182|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
146170443|NCT00871403|527137180|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
146170444|NCT00871403|527137181|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
146170445|NCT00871403|527137182|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
146170446|NCT01781390|527137188|FG000|Overall Study|Withdrawal of Consent|0|||
146170447|NCT01781390|527137189|FG001|Overall Study|Withdrawal of Consent|3|||
146170448|NCT01781390|527137190|FG002|Overall Study|Withdrawal of Consent|1|||
146170449|NCT01781390|527137188|FG000|Overall Study|Lost to Follow-up|1|||
146170450|NCT01781390|527137189|FG001|Overall Study|Lost to Follow-up|1|||
146170451|NCT01781390|527137190|FG002|Overall Study|Lost to Follow-up|1|||
146170452|NCT01781390|527137188|FG000|Overall Study|Adverse Event|1|||
146170453|NCT01781390|527137189|FG001|Overall Study|Adverse Event|2|||
146170454|NCT01781390|527137190|FG002|Overall Study|Adverse Event|1|||
146170455|NCT01781390|527137188|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
146170456|NCT01781390|527137189|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
146170457|NCT01781390|527137190|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
146170458|NCT00622713|527137191|FG000|Overall Study|Adverse Event|35|||
146170459|NCT00622713|527137191|FG000|Overall Study|Administrative problems|4|||
146170460|NCT00622713|527137191|FG000|Overall Study|Withdrawal by Subject|11|||
146170461|NCT00622713|527137191|FG000|Overall Study|Lost to Follow-up|5|||
146170462|NCT00622713|527137191|FG000|Overall Study|Death|2|||
146170463|NCT00622713|527137191|FG000|Overall Study|Subject no longer required study drug|1|||
146170464|NCT00622713|527137191|FG000|Overall Study|Did not meet eligibility criteria|1|||
146170465|NCT01215357|527137192|FG000|Overall Study|Withdrawal by Subject|3|||
146170466|NCT01215357|527137192|FG000|Overall Study|Protocol Violation|9|||
146170467|NCT01719237|527137193|FG000|Overall Study|Physician Decision|0|||
146170468|NCT01719237|527137194|FG001|Overall Study|Physician Decision|1|||
146170469|NCT02914314|527137198|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146170470|NCT02914314|527137199|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146170471|NCT02914314|527137200|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
146170472|NCT02914314|527137201|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
146170473|NCT02914314|527137198|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146170474|NCT02914314|527137199|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146170475|NCT02914314|527137200|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
146170476|NCT02914314|527137201|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
146170477|NCT02914314|527137198|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146170478|NCT02914314|527137199|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146170479|NCT02914314|527137200|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
146170480|NCT02914314|527137201|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
146170481|NCT02914314|527137198|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146170482|NCT02914314|527137199|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146402658|NCT00398632|527977541|FG000|Overall Study|Lack of Efficacy|1|||
146170483|NCT02914314|527137200|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
146170484|NCT02914314|527137201|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
146170485|NCT02914314|527137198|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146170486|NCT02914314|527137199|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146170487|NCT02914314|527137200|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
146170488|NCT02914314|527137201|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
146170489|NCT01859793|527137204|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
146170490|NCT01859793|527137205|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
146170491|NCT01859793|527137204|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
146170492|NCT01859793|527137205|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
146170493|NCT01859793|527137204|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146170494|NCT01859793|527137205|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146170495|NCT01859793|527137204|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
146170496|NCT01859793|527137205|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
146170497|NCT01597505|527137215|FG000|Overall Study|Physician Decision|5|||
146170498|NCT01597505|527137216|FG001|Overall Study|Physician Decision|0|||
146170499|NCT01597505|527137215|FG000|Overall Study|Adverse Event|19|||
146170500|NCT01597505|527137216|FG001|Overall Study|Adverse Event|7|||
146170501|NCT01597505|527137215|FG000|Overall Study|Lost to Follow-up|4|||
146170502|NCT01597505|527137216|FG001|Overall Study|Lost to Follow-up|2|||
146170503|NCT01597505|527137215|FG000|Overall Study|Withdrawal by Subject|10|||
146170504|NCT01597505|527137216|FG001|Overall Study|Withdrawal by Subject|18|||
146170505|NCT01597505|527137215|FG000|Overall Study|Other|5|||
146170506|NCT01597505|527137216|FG001|Overall Study|Other|6|||
146170507|NCT01597505|527137215|FG000|Overall Study|Missing|1|||
146170508|NCT01597505|527137216|FG001|Overall Study|Missing|0|||
146170509|NCT03728972|527137217|FG000|Overall Study|Death|1|||
146170510|NCT03728972|527137218|FG001|Overall Study|Death|0|||
146170511|NCT03728972|527137217|FG000|Overall Study|Lack of Efficacy|1|||
146170512|NCT03728972|527137218|FG001|Overall Study|Lack of Efficacy|0|||
146170513|NCT03728972|527137217|FG000|Overall Study|Physician Decision|3|||
146170514|NCT03728972|527137218|FG001|Overall Study|Physician Decision|0|||
146170515|NCT03728972|527137217|FG000|Overall Study|Disease progression|4|||
146170516|NCT03728972|527137218|FG001|Overall Study|Disease progression|3|||
146170517|NCT04543188|527137219|FG000|Phase 1a|Adverse Event|0|||
146170518|NCT04543188|527137220|FG001|Phase 1a|Adverse Event|0|||
146170519|NCT04543188|527137221|FG002|Phase 1a|Adverse Event|0|||
146170520|NCT04543188|527137222|FG003|Phase 1a|Adverse Event|1|||
146170521|NCT04543188|527137223|FG004|Phase 1a|Adverse Event|0|||
146170522|NCT04543188|527137224|FG005|Phase 1a|Adverse Event|0|||
146170523|NCT04543188|527137225|FG006|Phase 1a|Adverse Event|1|||
146170524|NCT04543188|527137226|FG007|Phase 1a|Adverse Event|0|||
146170525|NCT04543188|527137227|FG008|Phase 1a|Adverse Event|0|||
146170526|NCT04543188|527137228|FG009|Phase 1a|Adverse Event|0|||
146170527|NCT04543188|527137229|FG010|Phase 1a|Adverse Event|0|||
146170528|NCT04543188|527137230|FG011|Phase 1a|Adverse Event|0|||
146170529|NCT04543188|527137231|FG012|Phase 1a|Adverse Event|0|||
146170530|NCT04543188|527137232|FG013|Phase 1a|Adverse Event|0|||
146170531|NCT04543188|527137233|FG014|Phase 1a|Adverse Event|0|||
146170532|NCT04543188|527137219|FG000|Phase 1a|Other (Death)|0|||
146170533|NCT04543188|527137220|FG001|Phase 1a|Other (Death)|1|||
146170534|NCT04543188|527137221|FG002|Phase 1a|Other (Death)|0|||
146170535|NCT04543188|527137222|FG003|Phase 1a|Other (Death)|0|||
146170536|NCT04543188|527137223|FG004|Phase 1a|Other (Death)|1|||
146170537|NCT04543188|527137224|FG005|Phase 1a|Other (Death)|0|||
146170538|NCT04543188|527137225|FG006|Phase 1a|Other (Death)|0|||
146170539|NCT04543188|527137226|FG007|Phase 1a|Other (Death)|0|||
146170540|NCT04543188|527137227|FG008|Phase 1a|Other (Death)|0|||
146170541|NCT04543188|527137228|FG009|Phase 1a|Other (Death)|1|||
146170542|NCT04543188|527137229|FG010|Phase 1a|Other (Death)|0|||
146170543|NCT04543188|527137230|FG011|Phase 1a|Other (Death)|0|||
146170544|NCT04543188|527137231|FG012|Phase 1a|Other (Death)|0|||
146170545|NCT04543188|527137232|FG013|Phase 1a|Other (Death)|0|||
146170546|NCT04543188|527137233|FG014|Phase 1a|Other (Death)|0|||
146170547|NCT04543188|527137219|FG000|Phase 1a|Lost to Follow-up|0|||
146170548|NCT04543188|527137220|FG001|Phase 1a|Lost to Follow-up|0|||
146170549|NCT04543188|527137221|FG002|Phase 1a|Lost to Follow-up|0|||
146170550|NCT04543188|527137222|FG003|Phase 1a|Lost to Follow-up|0|||
146170551|NCT04543188|527137223|FG004|Phase 1a|Lost to Follow-up|0|||
146170552|NCT04543188|527137224|FG005|Phase 1a|Lost to Follow-up|0|||
146170553|NCT04543188|527137225|FG006|Phase 1a|Lost to Follow-up|0|||
146170554|NCT04543188|527137226|FG007|Phase 1a|Lost to Follow-up|0|||
146170555|NCT04543188|527137227|FG008|Phase 1a|Lost to Follow-up|0|||
146402659|NCT00267020|527977542|FG000|Overall Study|Adverse Event|22|||
146402660|NCT00267020|527977543|FG001|Overall Study|Adverse Event|5|||
146170556|NCT04543188|527137228|FG009|Phase 1a|Lost to Follow-up|0|||
146170557|NCT04543188|527137229|FG010|Phase 1a|Lost to Follow-up|1|||
146170558|NCT04543188|527137230|FG011|Phase 1a|Lost to Follow-up|0|||
146170559|NCT04543188|527137231|FG012|Phase 1a|Lost to Follow-up|0|||
146170560|NCT04543188|527137232|FG013|Phase 1a|Lost to Follow-up|0|||
146170561|NCT04543188|527137233|FG014|Phase 1a|Lost to Follow-up|0|||
146062569|NCT03216226|526748249|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
146062570|NCT03216226|526748248|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
146062571|NCT03216226|526748249|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
146062572|NCT03216226|526748248|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
146062573|NCT03216226|526748249|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
146062574|NCT04218240|526748250|FG000|Overall Study|Withdrawal by Subject|6|||
146062575|NCT04218240|526748251|FG001|Overall Study|Withdrawal by Subject|0|||
146062576|NCT04218240|526748250|FG000|Overall Study|Lack of Efficacy|24|||
146062577|NCT04218240|526748251|FG001|Overall Study|Lack of Efficacy|19|||
146062578|NCT04218240|526748250|FG000|Overall Study|Physician Decision|0|||
146062579|NCT04218240|526748251|FG001|Overall Study|Physician Decision|1|||
146062580|NCT04218240|526748250|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
146062581|NCT04218240|526748251|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
146062582|NCT05966142|526748255|FG000|Overall Study|Death|3|||
146062583|NCT05966142|526748256|FG001|Overall Study|Death|3|||
146062584|NCT05966142|526748255|FG000|Overall Study|Lost to Follow-up|55|||
146062585|NCT05966142|526748256|FG001|Overall Study|Lost to Follow-up|52|||
146062586|NCT05966142|526748255|FG000|Overall Study|Physician Decision|1|||
146062587|NCT05966142|526748256|FG001|Overall Study|Physician Decision|0|||
146062588|NCT05966142|526748255|FG000|Overall Study|Withdrawal by Subject|9|||
146062589|NCT05966142|526748256|FG001|Overall Study|Withdrawal by Subject|8|||
146062590|NCT05966142|526748255|FG000|Overall Study|Duplicate Enrollment|1|||
146062591|NCT05966142|526748256|FG001|Overall Study|Duplicate Enrollment|0|||
146062592|NCT05966142|526748255|FG000|Overall Study|Study Logistical Reason|1|||
146062593|NCT05966142|526748256|FG001|Overall Study|Study Logistical Reason|0|||
146062594|NCT05966142|526748255|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
146062595|NCT05966142|526748256|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
146062596|NCT02158442|526748262|FG000|Overall Study|Withdrawal by Subject|1|||
146062597|NCT02158442|526748263|FG001|Overall Study|Withdrawal by Subject|0|||
146062598|NCT02158442|526748262|FG000|Overall Study|Perfusion staff not available|1|||
146062599|NCT02158442|526748263|FG001|Overall Study|Perfusion staff not available|0|||
146062600|NCT01409707|526748264|FG000|Overall Study|Withdrawal by Subject|5|||
146062601|NCT01409707|526748265|FG001|Overall Study|Withdrawal by Subject|17|||
146062602|NCT01409707|526748266|FG002|Overall Study|Withdrawal by Subject|16|||
146062603|NCT01217229|526748267|FG000|Overall Study|Adverse Event|1|||
146062604|NCT01217229|526748267|FG000|Overall Study|Disease progression, deterioration|2|||
146062605|NCT01217229|526748267|FG000|Overall Study|Disease progression, Cheson criteria|14|||
146062606|NCT01217229|526748267|FG000|Overall Study|Protocol Violation|1|||
146062607|NCT01217229|526748267|FG000|Overall Study|Disease progression not confirmed|2|||
146062608|NCT00521079|526748270|FG000|Overall Study|Adverse Event|7|||
146062609|NCT00521079|526748271|FG001|Overall Study|Adverse Event|1|||
146062610|NCT00521079|526748270|FG000|Overall Study|Lost to Follow-up|2|||
146062611|NCT00521079|526748271|FG001|Overall Study|Lost to Follow-up|1|||
146062612|NCT00521079|526748270|FG000|Overall Study|Withdrawal by Subject|5|||
146062613|NCT00521079|526748271|FG001|Overall Study|Withdrawal by Subject|3|||
146062614|NCT02651675|526748272|FG000|Overall Study|Death|0|||
146062615|NCT02651675|526748273|FG001|Overall Study|Death|0|||
146062616|NCT02651675|526748274|FG002|Overall Study|Death|1|||
146062617|NCT04408989|526748276|FG000|Overall Study|Lost to Follow-up|0|||
146062618|NCT04408989|526748277|FG001|Overall Study|Lost to Follow-up|0|||
146062619|NCT04408989|526748278|FG002|Overall Study|Lost to Follow-up|1|||
146062620|NCT04408989|526748276|FG000|Overall Study|Withdrawal by Subject|0|||
146062621|NCT04408989|526748277|FG001|Overall Study|Withdrawal by Subject|0|||
146062622|NCT04408989|526748278|FG002|Overall Study|Withdrawal by Subject|2|||
146062623|NCT05135767|526748279|FG000|Baseline|Lost to Follow-up|1|||
146062624|NCT05135767|526748280|FG001|Baseline|Lost to Follow-up|1|||
146062625|NCT05135767|526748279|FG000|Baseline|Withdrawal by Subject|0|||
146062626|NCT05135767|526748280|FG001|Baseline|Withdrawal by Subject|2|||
146062627|NCT05135767|526748279|FG000|Active Study Phase|Lost to Follow-up|2|||
146062628|NCT05135767|526748280|FG001|Active Study Phase|Lost to Follow-up|0|||
146062629|NCT02694185|526748281|FG000|Overall Study|Withdrawal by Subject|45|||
146062630|NCT02694185|526748282|FG001|Overall Study|Withdrawal by Subject|0|||
146062631|NCT05082857|526748283|FG000|Overall Study|participants relocated and could not continue|2|||
146062632|NCT05082857|526748284|FG001|Overall Study|participants relocated and could not continue|1|||
146062633|NCT05082857|526748283|FG000|Overall Study|Lost to Follow-up|1|||
146062634|NCT05082857|526748284|FG001|Overall Study|Lost to Follow-up|3|||
146062635|NCT04363320|526748285|FG000|Overall Study|Lost to Follow-up|43|||
146062636|NCT04363320|526748286|FG001|Overall Study|Lost to Follow-up|42|||
146062637|NCT04363320|526748287|FG002|Overall Study|Lost to Follow-up|24|||
146062638|NCT04363320|526748288|FG003|Overall Study|Lost to Follow-up|29|||
146062639|NCT04363320|526748285|FG000|Overall Study|Death|0|||
146062640|NCT04363320|526748286|FG001|Overall Study|Death|0|||
146062641|NCT04363320|526748287|FG002|Overall Study|Death|1|||
146170562|NCT04543188|527137219|FG000|Phase 1a|Progressive Disease|2|||
146170563|NCT04543188|527137220|FG001|Phase 1a|Progressive Disease|2|||
146170564|NCT04543188|527137221|FG002|Phase 1a|Progressive Disease|3|||
146170565|NCT04543188|527137222|FG003|Phase 1a|Progressive Disease|1|||
146170566|NCT04543188|527137223|FG004|Phase 1a|Progressive Disease|4|||
146170567|NCT04543188|527137224|FG005|Phase 1a|Progressive Disease|2|||
146170568|NCT04543188|527137225|FG006|Phase 1a|Progressive Disease|3|||
146170569|NCT04543188|527137226|FG007|Phase 1a|Progressive Disease|4|||
146170570|NCT04543188|527137227|FG008|Phase 1a|Progressive Disease|1|||
146170571|NCT04543188|527137228|FG009|Phase 1a|Progressive Disease|0|||
146170572|NCT04543188|527137229|FG010|Phase 1a|Progressive Disease|4|||
146170573|NCT04543188|527137230|FG011|Phase 1a|Progressive Disease|0|||
146170574|NCT04543188|527137231|FG012|Phase 1a|Progressive Disease|0|||
146170575|NCT04543188|527137232|FG013|Phase 1a|Progressive Disease|0|||
146170576|NCT04543188|527137233|FG014|Phase 1a|Progressive Disease|0|||
146170577|NCT04543188|527137219|FG000|Phase 1a|Study terminated by sponsor|0|||
146170578|NCT04543188|527137220|FG001|Phase 1a|Study terminated by sponsor|0|||
146170579|NCT04543188|527137221|FG002|Phase 1a|Study terminated by sponsor|0|||
146170580|NCT04543188|527137222|FG003|Phase 1a|Study terminated by sponsor|0|||
146170581|NCT04543188|527137223|FG004|Phase 1a|Study terminated by sponsor|1|||
146170582|NCT04543188|527137224|FG005|Phase 1a|Study terminated by sponsor|0|||
146170583|NCT04543188|527137225|FG006|Phase 1a|Study terminated by sponsor|0|||
146170584|NCT04543188|527137226|FG007|Phase 1a|Study terminated by sponsor|0|||
146170585|NCT04543188|527137227|FG008|Phase 1a|Study terminated by sponsor|0|||
146170586|NCT04543188|527137228|FG009|Phase 1a|Study terminated by sponsor|0|||
146170587|NCT04543188|527137229|FG010|Phase 1a|Study terminated by sponsor|1|||
146170588|NCT04543188|527137230|FG011|Phase 1a|Study terminated by sponsor|0|||
146170589|NCT04543188|527137231|FG012|Phase 1a|Study terminated by sponsor|0|||
146170590|NCT04543188|527137232|FG013|Phase 1a|Study terminated by sponsor|0|||
146170591|NCT04543188|527137233|FG014|Phase 1a|Study terminated by sponsor|0|||
146170592|NCT04543188|527137219|FG000|Phase 1a|Withdrawal by Subject|0|||
146170593|NCT04543188|527137220|FG001|Phase 1a|Withdrawal by Subject|0|||
146170594|NCT04543188|527137221|FG002|Phase 1a|Withdrawal by Subject|0|||
146170595|NCT04543188|527137222|FG003|Phase 1a|Withdrawal by Subject|0|||
146170596|NCT04543188|527137223|FG004|Phase 1a|Withdrawal by Subject|3|||
146170597|NCT04543188|527137224|FG005|Phase 1a|Withdrawal by Subject|0|||
146170598|NCT04543188|527137225|FG006|Phase 1a|Withdrawal by Subject|0|||
146170599|NCT04543188|527137226|FG007|Phase 1a|Withdrawal by Subject|0|||
146170600|NCT04543188|527137227|FG008|Phase 1a|Withdrawal by Subject|1|||
146170601|NCT04543188|527137228|FG009|Phase 1a|Withdrawal by Subject|1|||
146170602|NCT04543188|527137229|FG010|Phase 1a|Withdrawal by Subject|2|||
146170603|NCT04543188|527137230|FG011|Phase 1a|Withdrawal by Subject|0|||
146170604|NCT04543188|527137231|FG012|Phase 1a|Withdrawal by Subject|0|||
146170605|NCT04543188|527137232|FG013|Phase 1a|Withdrawal by Subject|0|||
146170606|NCT04543188|527137233|FG014|Phase 1a|Withdrawal by Subject|0|||
146170607|NCT04543188|527137219|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
146170608|NCT04543188|527137220|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
146170609|NCT04543188|527137221|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
146170610|NCT04543188|527137222|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
146170611|NCT04543188|527137223|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
146170612|NCT04543188|527137224|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
146170613|NCT04543188|527137225|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
146170614|NCT04543188|527137226|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
146170615|NCT04543188|527137227|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
146170616|NCT04543188|527137228|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
146170617|NCT04543188|527137229|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
146170618|NCT04543188|527137230|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
146170619|NCT04543188|527137231|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
146170620|NCT04543188|527137232|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
146170621|NCT04543188|527137233|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
146170622|NCT04543188|527137219|FG000|Phase 1a|Other|0|||
146170623|NCT04543188|527137220|FG001|Phase 1a|Other|0|||
146170624|NCT04543188|527137221|FG002|Phase 1a|Other|0|||
146170625|NCT04543188|527137222|FG003|Phase 1a|Other|0|||
146170626|NCT04543188|527137223|FG004|Phase 1a|Other|0|||
146170627|NCT04543188|527137224|FG005|Phase 1a|Other|0|||
146170628|NCT04543188|527137225|FG006|Phase 1a|Other|0|||
146170629|NCT04543188|527137226|FG007|Phase 1a|Other|0|||
146170630|NCT04543188|527137227|FG008|Phase 1a|Other|0|||
146170631|NCT04543188|527137228|FG009|Phase 1a|Other|1|||
146170632|NCT04543188|527137229|FG010|Phase 1a|Other|0|||
146170633|NCT04543188|527137230|FG011|Phase 1a|Other|0|||
146170634|NCT04543188|527137231|FG012|Phase 1a|Other|0|||
146170635|NCT04543188|527137232|FG013|Phase 1a|Other|0|||
146170636|NCT04543188|527137233|FG014|Phase 1a|Other|0|||
146170637|NCT04543188|527137219|FG000|Phase 1b|Adverse Event|0|||
146170638|NCT04543188|527137220|FG001|Phase 1b|Adverse Event|0|||
146170639|NCT04543188|527137221|FG002|Phase 1b|Adverse Event|0|||
146170640|NCT04543188|527137222|FG003|Phase 1b|Adverse Event|0|||
146170641|NCT04543188|527137223|FG004|Phase 1b|Adverse Event|0|||
146170642|NCT04543188|527137224|FG005|Phase 1b|Adverse Event|0|||
146170643|NCT04543188|527137225|FG006|Phase 1b|Adverse Event|0|||
146170644|NCT04543188|527137226|FG007|Phase 1b|Adverse Event|0|||
146170645|NCT04543188|527137227|FG008|Phase 1b|Adverse Event|0|||
146170646|NCT04543188|527137228|FG009|Phase 1b|Adverse Event|0|||
146170647|NCT04543188|527137229|FG010|Phase 1b|Adverse Event|0|||
146170648|NCT04543188|527137230|FG011|Phase 1b|Adverse Event|0|||
146170649|NCT04543188|527137231|FG012|Phase 1b|Adverse Event|0|||
146170650|NCT04543188|527137232|FG013|Phase 1b|Adverse Event|0|||
146170651|NCT04543188|527137233|FG014|Phase 1b|Adverse Event|2|||
146170652|NCT04543188|527137219|FG000|Phase 1b|Other (Death)|0|||
146170653|NCT04543188|527137220|FG001|Phase 1b|Other (Death)|0|||
146170654|NCT04543188|527137221|FG002|Phase 1b|Other (Death)|0|||
146170655|NCT04543188|527137222|FG003|Phase 1b|Other (Death)|0|||
146170656|NCT04543188|527137223|FG004|Phase 1b|Other (Death)|0|||
146170657|NCT04543188|527137224|FG005|Phase 1b|Other (Death)|0|||
146170658|NCT04543188|527137225|FG006|Phase 1b|Other (Death)|0|||
146170659|NCT04543188|527137226|FG007|Phase 1b|Other (Death)|0|||
146170660|NCT04543188|527137227|FG008|Phase 1b|Other (Death)|0|||
146170661|NCT04543188|527137228|FG009|Phase 1b|Other (Death)|0|||
146170662|NCT04543188|527137229|FG010|Phase 1b|Other (Death)|0|||
146170663|NCT04543188|527137230|FG011|Phase 1b|Other (Death)|0|||
146170664|NCT04543188|527137231|FG012|Phase 1b|Other (Death)|1|||
146170665|NCT04543188|527137232|FG013|Phase 1b|Other (Death)|0|||
146170666|NCT04543188|527137233|FG014|Phase 1b|Other (Death)|1|||
146170667|NCT04543188|527137219|FG000|Phase 1b|Progressive Disease|0|||
146170668|NCT04543188|527137220|FG001|Phase 1b|Progressive Disease|0|||
146170669|NCT04543188|527137221|FG002|Phase 1b|Progressive Disease|0|||
146170670|NCT04543188|527137222|FG003|Phase 1b|Progressive Disease|0|||
146170671|NCT04543188|527137223|FG004|Phase 1b|Progressive Disease|0|||
146170672|NCT04543188|527137224|FG005|Phase 1b|Progressive Disease|0|||
146170673|NCT04543188|527137225|FG006|Phase 1b|Progressive Disease|0|||
146170674|NCT04543188|527137226|FG007|Phase 1b|Progressive Disease|0|||
146170675|NCT04543188|527137227|FG008|Phase 1b|Progressive Disease|0|||
146170676|NCT04543188|527137228|FG009|Phase 1b|Progressive Disease|0|||
146170677|NCT04543188|527137229|FG010|Phase 1b|Progressive Disease|0|||
146170678|NCT04543188|527137230|FG011|Phase 1b|Progressive Disease|0|||
146170679|NCT04543188|527137231|FG012|Phase 1b|Progressive Disease|2|||
146170680|NCT04543188|527137232|FG013|Phase 1b|Progressive Disease|1|||
146170681|NCT04543188|527137233|FG014|Phase 1b|Progressive Disease|5|||
146170682|NCT04543188|527137219|FG000|Phase 1b|Study Terminated By Sponsor|0|||
146170683|NCT04543188|527137220|FG001|Phase 1b|Study Terminated By Sponsor|0|||
146170684|NCT04543188|527137221|FG002|Phase 1b|Study Terminated By Sponsor|0|||
146170685|NCT04543188|527137222|FG003|Phase 1b|Study Terminated By Sponsor|0|||
146170686|NCT04543188|527137223|FG004|Phase 1b|Study Terminated By Sponsor|0|||
146170687|NCT04543188|527137224|FG005|Phase 1b|Study Terminated By Sponsor|0|||
146170688|NCT04543188|527137225|FG006|Phase 1b|Study Terminated By Sponsor|0|||
146170689|NCT04543188|527137226|FG007|Phase 1b|Study Terminated By Sponsor|0|||
146170690|NCT04543188|527137227|FG008|Phase 1b|Study Terminated By Sponsor|0|||
146170691|NCT04543188|527137228|FG009|Phase 1b|Study Terminated By Sponsor|0|||
146170692|NCT04543188|527137229|FG010|Phase 1b|Study Terminated By Sponsor|0|||
146170693|NCT04543188|527137230|FG011|Phase 1b|Study Terminated By Sponsor|1|||
146170694|NCT04543188|527137231|FG012|Phase 1b|Study Terminated By Sponsor|1|||
146170695|NCT04543188|527137232|FG013|Phase 1b|Study Terminated By Sponsor|0|||
146170696|NCT04543188|527137233|FG014|Phase 1b|Study Terminated By Sponsor|1|||
146170697|NCT04543188|527137219|FG000|Phase 1b|Withdrawal by Subject|0|||
146170698|NCT04543188|527137220|FG001|Phase 1b|Withdrawal by Subject|0|||
146170699|NCT04543188|527137221|FG002|Phase 1b|Withdrawal by Subject|0|||
146170700|NCT04543188|527137222|FG003|Phase 1b|Withdrawal by Subject|0|||
146170701|NCT04543188|527137223|FG004|Phase 1b|Withdrawal by Subject|0|||
146170702|NCT04543188|527137224|FG005|Phase 1b|Withdrawal by Subject|0|||
146170703|NCT04543188|527137225|FG006|Phase 1b|Withdrawal by Subject|0|||
146170704|NCT04543188|527137226|FG007|Phase 1b|Withdrawal by Subject|0|||
146170705|NCT04543188|527137227|FG008|Phase 1b|Withdrawal by Subject|0|||
146170706|NCT04543188|527137228|FG009|Phase 1b|Withdrawal by Subject|0|||
146170707|NCT04543188|527137229|FG010|Phase 1b|Withdrawal by Subject|0|||
146170708|NCT04543188|527137230|FG011|Phase 1b|Withdrawal by Subject|0|||
146170709|NCT04543188|527137231|FG012|Phase 1b|Withdrawal by Subject|0|||
146170710|NCT04543188|527137232|FG013|Phase 1b|Withdrawal by Subject|0|||
146170711|NCT04543188|527137233|FG014|Phase 1b|Withdrawal by Subject|2|||
146170712|NCT02487472|527137234|FG000|Overall Study|Did not complete telephonic interviews|9|||
146170713|NCT02487472|527137234|FG000|Overall Study|Other|2|||
146170714|NCT01313286|527137239|FG000|Period 1|Withdrawal by Subject|2|||
146170715|NCT01313286|527137240|FG001|Period 1|Withdrawal by Subject|0|||
146170716|NCT02034708|527137241|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
146170717|NCT02034708|527137242|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
146170718|NCT02034708|527137241|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
146170719|NCT02034708|527137242|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
146170720|NCT02034708|527137241|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
146170721|NCT02034708|527137242|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
146170722|NCT02034708|527137241|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
146170723|NCT02034708|527137242|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
146170724|NCT00654901|527137243|FG000|Overall Study|Lost to Follow-up|1|||
146170725|NCT00654901|527137244|FG001|Overall Study|Lost to Follow-up|0|||
146170726|NCT00654901|527137245|FG002|Overall Study|Lost to Follow-up|1|||
146170727|NCT00654901|527137246|FG003|Overall Study|Lost to Follow-up|0|||
146170728|NCT00654901|527137243|FG000|Overall Study|Withdrawal by Subject|3|||
146170729|NCT00654901|527137244|FG001|Overall Study|Withdrawal by Subject|0|||
146170730|NCT00654901|527137245|FG002|Overall Study|Withdrawal by Subject|1|||
146170731|NCT00654901|527137246|FG003|Overall Study|Withdrawal by Subject|0|||
146170732|NCT04843930|527137247|FG000|Randomization|Withdrawal by Subject|6|||
146170733|NCT04843930|527137248|FG001|Randomization|Withdrawal by Subject|6|||
146170734|NCT04843930|527137249|FG002|Randomization|Withdrawal by Subject|0|||
146170735|NCT04843930|527137250|FG003|Randomization|Withdrawal by Subject|0|||
146170736|NCT04843930|527137247|FG000|Week 6 Assessment|Adverse Event|3|||
146170737|NCT04843930|527137248|FG001|Week 6 Assessment|Adverse Event|0|||
146170738|NCT04843930|527137249|FG002|Week 6 Assessment|Adverse Event|0|||
146170739|NCT04843930|527137250|FG003|Week 6 Assessment|Adverse Event|0|||
146170740|NCT04843930|527137247|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
146170741|NCT04843930|527137248|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
146170742|NCT04843930|527137249|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
146170743|NCT04843930|527137250|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
146170744|NCT04843930|527137247|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
146170745|NCT04843930|527137248|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
146170746|NCT04843930|527137249|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
146170747|NCT04843930|527137250|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
146170748|NCT02552238|527137253|FG000|Overall Study|Withdrawal by Subject|2|||
146170749|NCT02552238|527137253|FG000|Overall Study|Adverse Event|2|||
146170750|NCT04770779|527137254|FG000|Overall Study|Randomized, never treated|0|||
146170751|NCT04770779|527137255|FG001|Overall Study|Randomized, never treated|1|||
146170752|NCT04770779|527137254|FG000|Overall Study|Adverse Event|9|||
146170753|NCT04770779|527137255|FG001|Overall Study|Adverse Event|1|||
146170754|NCT04770779|527137254|FG000|Overall Study|Withdrawal by Subject|7|||
146170755|NCT04770779|527137255|FG001|Overall Study|Withdrawal by Subject|1|||
146170756|NCT04770779|527137254|FG000|Overall Study|Pregnancy|0|||
146170757|NCT04770779|527137255|FG001|Overall Study|Pregnancy|1|||
146170758|NCT03692052|527137256|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
146170759|NCT03692052|527137256|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
146170760|NCT03692052|527137256|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
146170761|NCT03692052|527137256|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
146170762|NCT04241094|527137257|FG000|Overall Study|Dropped out of treatment|4|||
146170763|NCT04241094|527137257|FG000|Overall Study|Ineligible after clinical assessment|2|||
146170764|NCT04241094|527137257|FG000|Overall Study|Lost to Follow-up|2|||
146170765|NCT01669798|527137258|FG000|Overall Study|Physician Decision|5|||
146170766|NCT05918978|527137262|FG000|Overall Study|Study Terminated by Sponsor|17|||
146170767|NCT05918978|527137263|FG001|Overall Study|Study Terminated by Sponsor|11|||
146170768|NCT05918978|527137262|FG000|Overall Study|Withdrawal by Subject|1|||
146170769|NCT05918978|527137263|FG001|Overall Study|Withdrawal by Subject|1|||
146170770|NCT05918978|527137262|FG000|Overall Study|Adverse Event|1|||
146170771|NCT05918978|527137263|FG001|Overall Study|Adverse Event|0|||
146170772|NCT05918978|527137262|FG000|Overall Study|Other|0|||
146170773|NCT05918978|527137263|FG001|Overall Study|Other|1|||
146170774|NCT00622180|527137264|FG000|Overall Study|Lost to Follow-up|1|||
146170775|NCT00622180|527137265|FG001|Overall Study|Lost to Follow-up|2|||
146170776|NCT06387472|527137268|FG000|Overall Study|Withdrawal by Subject|1|||
146170777|NCT06387472|527137268|FG000|Overall Study|Lost to Follow-up|2|||
146170778|NCT06387472|527137268|FG000|Overall Study|Physician Decision|1|||
146170779|NCT02332590|527137271|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
146170780|NCT02332590|527137272|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
146170781|NCT02332590|527137271|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
146170782|NCT02332590|527137272|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
146170783|NCT02332590|527137271|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
146170784|NCT02332590|527137272|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
146170785|NCT02332590|527137271|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
146170786|NCT02332590|527137272|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
146170787|NCT02332590|527137271|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
146170788|NCT02332590|527137272|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
146170789|NCT02332590|527137271|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
146170790|NCT02332590|527137272|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
146170791|NCT02332590|527137271|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
146170792|NCT02332590|527137272|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
146170793|NCT02332590|527137271|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
146170794|NCT02332590|527137272|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
146170795|NCT02332590|527137271|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
146170796|NCT02332590|527137272|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
146170797|NCT00279201|527137273|FG000|Initiation|Death|1|||
146170798|NCT00279201|527137274|FG001|Initiation|Death|5|||
146170799|NCT00279201|527137275|FG002|Initiation|Death|0|||
146170800|NCT00279201|527137276|FG003|Initiation|Death|0|||
146170801|NCT00279201|527137277|FG004|Initiation|Death|0|||
146170802|NCT00279201|527137278|FG005|Initiation|Death|0|||
146170803|NCT00279201|527137273|FG000|Initiation|Adverse Event|6|||
146170804|NCT00279201|527137274|FG001|Initiation|Adverse Event|15|||
146170805|NCT00279201|527137275|FG002|Initiation|Adverse Event|0|||
146170806|NCT00279201|527137276|FG003|Initiation|Adverse Event|0|||
146170807|NCT00279201|527137277|FG004|Initiation|Adverse Event|0|||
146170808|NCT00279201|527137278|FG005|Initiation|Adverse Event|0|||
146170809|NCT00279201|527137273|FG000|Initiation|Lost to Follow-up|42|||
146170810|NCT00279201|527137274|FG001|Initiation|Lost to Follow-up|41|||
146170811|NCT00279201|527137275|FG002|Initiation|Lost to Follow-up|0|||
146170812|NCT00279201|527137276|FG003|Initiation|Lost to Follow-up|0|||
146170813|NCT00279201|527137277|FG004|Initiation|Lost to Follow-up|0|||
146170814|NCT00279201|527137278|FG005|Initiation|Lost to Follow-up|0|||
146170815|NCT00279201|527137273|FG000|Initiation|Entry Criteria Exclusion|7|||
146170816|NCT00279201|527137274|FG001|Initiation|Entry Criteria Exclusion|9|||
146170817|NCT00279201|527137275|FG002|Initiation|Entry Criteria Exclusion|0|||
146170818|NCT00279201|527137276|FG003|Initiation|Entry Criteria Exclusion|0|||
146170819|NCT00279201|527137277|FG004|Initiation|Entry Criteria Exclusion|0|||
146170820|NCT00279201|527137278|FG005|Initiation|Entry Criteria Exclusion|0|||
146170821|NCT00279201|527137273|FG000|Initiation|Protocol Violation|9|||
146170822|NCT00279201|527137274|FG001|Initiation|Protocol Violation|10|||
146170823|NCT00279201|527137275|FG002|Initiation|Protocol Violation|0|||
146170824|NCT00279201|527137276|FG003|Initiation|Protocol Violation|0|||
146170825|NCT00279201|527137277|FG004|Initiation|Protocol Violation|0|||
146170826|NCT00279201|527137278|FG005|Initiation|Protocol Violation|0|||
146170827|NCT00279201|527137273|FG000|Initiation|Withdrawal by Subject|35|||
146170828|NCT00279201|527137274|FG001|Initiation|Withdrawal by Subject|41|||
146170829|NCT00279201|527137275|FG002|Initiation|Withdrawal by Subject|0|||
146170830|NCT00279201|527137276|FG003|Initiation|Withdrawal by Subject|0|||
146170831|NCT00279201|527137277|FG004|Initiation|Withdrawal by Subject|0|||
146170832|NCT00279201|527137278|FG005|Initiation|Withdrawal by Subject|0|||
146170833|NCT00279201|527137273|FG000|Initiation|Physician Decision|15|||
146170834|NCT00279201|527137274|FG001|Initiation|Physician Decision|18|||
146170835|NCT00279201|527137275|FG002|Initiation|Physician Decision|0|||
146170836|NCT00279201|527137276|FG003|Initiation|Physician Decision|0|||
146170837|NCT00279201|527137277|FG004|Initiation|Physician Decision|0|||
146170838|NCT00279201|527137278|FG005|Initiation|Physician Decision|0|||
146170839|NCT00279201|527137273|FG000|Initiation|Sponsor Decision|13|||
146170840|NCT00279201|527137274|FG001|Initiation|Sponsor Decision|5|||
146170841|NCT00279201|527137275|FG002|Initiation|Sponsor Decision|0|||
146170842|NCT00279201|527137276|FG003|Initiation|Sponsor Decision|0|||
146170843|NCT00279201|527137277|FG004|Initiation|Sponsor Decision|0|||
146170844|NCT00279201|527137278|FG005|Initiation|Sponsor Decision|0|||
146170845|NCT00279201|527137273|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146170846|NCT00279201|527137274|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
146170847|NCT00279201|527137275|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146170848|NCT00279201|527137276|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146170849|NCT00279201|527137277|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146170850|NCT00279201|527137278|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
146170851|NCT00279201|527137273|FG000|Maintenance|Lack of Efficacy|32|||
146170852|NCT00279201|527137274|FG001|Maintenance|Lack of Efficacy|30|||
146170853|NCT00279201|527137275|FG002|Maintenance|Lack of Efficacy|0|||
146170854|NCT00279201|527137276|FG003|Maintenance|Lack of Efficacy|0|||
146170855|NCT00279201|527137277|FG004|Maintenance|Lack of Efficacy|0|||
146170856|NCT00279201|527137278|FG005|Maintenance|Lack of Efficacy|0|||
146170857|NCT00279201|527137273|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
146170858|NCT00279201|527137274|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
146170859|NCT00279201|527137275|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146170860|NCT00279201|527137276|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146170861|NCT00279201|527137277|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146170862|NCT00279201|527137278|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
146170863|NCT00279201|527137273|FG000|Maintenance|Adverse Event|4|||
146170864|NCT00279201|527137274|FG001|Maintenance|Adverse Event|4|||
146170865|NCT00279201|527137275|FG002|Maintenance|Adverse Event|0|||
146170866|NCT00279201|527137276|FG003|Maintenance|Adverse Event|0|||
146283843|NCT00092495|527551854|FG000|Base Study Vaccination Period|Other|1|||
146283844|NCT00092495|527551855|FG001|Base Study Vaccination Period|Other|1|||
146170867|NCT00279201|527137277|FG004|Maintenance|Adverse Event|0|||
146170868|NCT00279201|527137278|FG005|Maintenance|Adverse Event|0|||
146170869|NCT00279201|527137273|FG000|Maintenance|Death|4|||
146170870|NCT00279201|527137274|FG001|Maintenance|Death|4|||
146170871|NCT00279201|527137275|FG002|Maintenance|Death|0|||
146170872|NCT00279201|527137276|FG003|Maintenance|Death|0|||
146170873|NCT00279201|527137277|FG004|Maintenance|Death|0|||
146170874|NCT00279201|527137278|FG005|Maintenance|Death|0|||
146170875|NCT00279201|527137273|FG000|Maintenance|Lost to Follow-up|17|||
146170876|NCT00279201|527137274|FG001|Maintenance|Lost to Follow-up|13|||
146170877|NCT00279201|527137275|FG002|Maintenance|Lost to Follow-up|0|||
146170878|NCT00279201|527137276|FG003|Maintenance|Lost to Follow-up|0|||
146170879|NCT00279201|527137277|FG004|Maintenance|Lost to Follow-up|0|||
146170880|NCT00279201|527137278|FG005|Maintenance|Lost to Follow-up|0|||
146170881|NCT00279201|527137273|FG000|Maintenance|Entry Criteria Exclusion|1|||
146170882|NCT00279201|527137274|FG001|Maintenance|Entry Criteria Exclusion|4|||
146170883|NCT00279201|527137275|FG002|Maintenance|Entry Criteria Exclusion|0|||
146170884|NCT00279201|527137276|FG003|Maintenance|Entry Criteria Exclusion|0|||
146170885|NCT00279201|527137277|FG004|Maintenance|Entry Criteria Exclusion|0|||
146170886|NCT00279201|527137278|FG005|Maintenance|Entry Criteria Exclusion|0|||
146170887|NCT00279201|527137273|FG000|Maintenance|Protocol Violation|16|||
146170888|NCT00279201|527137274|FG001|Maintenance|Protocol Violation|24|||
146170889|NCT00279201|527137275|FG002|Maintenance|Protocol Violation|0|||
146170890|NCT00279201|527137276|FG003|Maintenance|Protocol Violation|0|||
146170891|NCT00279201|527137277|FG004|Maintenance|Protocol Violation|0|||
146170892|NCT00279201|527137278|FG005|Maintenance|Protocol Violation|0|||
146170893|NCT00279201|527137273|FG000|Maintenance|Withdrawal by Subject|18|||
146170894|NCT00279201|527137274|FG001|Maintenance|Withdrawal by Subject|18|||
146170895|NCT00279201|527137275|FG002|Maintenance|Withdrawal by Subject|0|||
146170896|NCT00279201|527137276|FG003|Maintenance|Withdrawal by Subject|0|||
146170897|NCT00279201|527137277|FG004|Maintenance|Withdrawal by Subject|0|||
146170898|NCT00279201|527137278|FG005|Maintenance|Withdrawal by Subject|0|||
146170899|NCT00279201|527137273|FG000|Maintenance|Physician Decision|9|||
146170900|NCT00279201|527137274|FG001|Maintenance|Physician Decision|9|||
146170901|NCT00279201|527137275|FG002|Maintenance|Physician Decision|0|||
146170902|NCT00279201|527137276|FG003|Maintenance|Physician Decision|0|||
146170903|NCT00279201|527137277|FG004|Maintenance|Physician Decision|0|||
146170904|NCT00279201|527137278|FG005|Maintenance|Physician Decision|0|||
146170905|NCT00279201|527137273|FG000|Maintenance|Sponsor Decision|4|||
146170906|NCT00279201|527137274|FG001|Maintenance|Sponsor Decision|0|||
146170907|NCT00279201|527137275|FG002|Maintenance|Sponsor Decision|0|||
146170908|NCT00279201|527137276|FG003|Maintenance|Sponsor Decision|0|||
146170909|NCT00279201|527137277|FG004|Maintenance|Sponsor Decision|0|||
146170910|NCT00279201|527137278|FG005|Maintenance|Sponsor Decision|0|||
146170911|NCT00279201|527137273|FG000|Maintenance|HbA1c>7.5%|123|||
146170912|NCT00279201|527137274|FG001|Maintenance|HbA1c>7.5%|126|||
146170913|NCT00279201|527137275|FG002|Maintenance|HbA1c>7.5%|0|||
146170914|NCT00279201|527137276|FG003|Maintenance|HbA1c>7.5%|0|||
146170915|NCT00279201|527137277|FG004|Maintenance|HbA1c>7.5%|0|||
146170916|NCT00279201|527137278|FG005|Maintenance|HbA1c>7.5%|0|||
146170917|NCT00279201|527137273|FG000|Intensification Addendum|Withdrawal by Subject|0|||
146170918|NCT00279201|527137274|FG001|Intensification Addendum|Withdrawal by Subject|0|||
146170919|NCT00279201|527137275|FG002|Intensification Addendum|Withdrawal by Subject|12|||
146170920|NCT00279201|527137276|FG003|Intensification Addendum|Withdrawal by Subject|14|||
146170921|NCT00279201|527137277|FG004|Intensification Addendum|Withdrawal by Subject|9|||
146170922|NCT00279201|527137278|FG005|Intensification Addendum|Withdrawal by Subject|18|||
146170923|NCT00279201|527137273|FG000|Intensification Addendum|Lost to Follow-up|0|||
146170924|NCT00279201|527137274|FG001|Intensification Addendum|Lost to Follow-up|0|||
146170925|NCT00279201|527137275|FG002|Intensification Addendum|Lost to Follow-up|4|||
146170926|NCT00279201|527137276|FG003|Intensification Addendum|Lost to Follow-up|6|||
146170927|NCT00279201|527137277|FG004|Intensification Addendum|Lost to Follow-up|7|||
146170928|NCT00279201|527137278|FG005|Intensification Addendum|Lost to Follow-up|7|||
146170929|NCT00279201|527137273|FG000|Intensification Addendum|Protocol Violation|0|||
146170930|NCT00279201|527137274|FG001|Intensification Addendum|Protocol Violation|0|||
146170931|NCT00279201|527137275|FG002|Intensification Addendum|Protocol Violation|2|||
146170932|NCT00279201|527137276|FG003|Intensification Addendum|Protocol Violation|2|||
146170933|NCT00279201|527137277|FG004|Intensification Addendum|Protocol Violation|6|||
146170934|NCT00279201|527137278|FG005|Intensification Addendum|Protocol Violation|6|||
146170935|NCT00279201|527137273|FG000|Intensification Addendum|Adverse Event|0|||
146170936|NCT00279201|527137274|FG001|Intensification Addendum|Adverse Event|0|||
146170937|NCT00279201|527137275|FG002|Intensification Addendum|Adverse Event|0|||
146170938|NCT00279201|527137276|FG003|Intensification Addendum|Adverse Event|4|||
146170939|NCT00279201|527137277|FG004|Intensification Addendum|Adverse Event|1|||
146170940|NCT00279201|527137278|FG005|Intensification Addendum|Adverse Event|3|||
146170941|NCT00279201|527137273|FG000|Intensification Addendum|Physician Decision|0|||
146170942|NCT00279201|527137274|FG001|Intensification Addendum|Physician Decision|0|||
146170943|NCT00279201|527137275|FG002|Intensification Addendum|Physician Decision|4|||
146170944|NCT00279201|527137276|FG003|Intensification Addendum|Physician Decision|1|||
146170945|NCT00279201|527137277|FG004|Intensification Addendum|Physician Decision|3|||
146170946|NCT00279201|527137278|FG005|Intensification Addendum|Physician Decision|2|||
146170947|NCT00279201|527137273|FG000|Intensification Addendum|Sponsor Decision|0|||
146170948|NCT00279201|527137274|FG001|Intensification Addendum|Sponsor Decision|0|||
146170949|NCT00279201|527137275|FG002|Intensification Addendum|Sponsor Decision|0|||
146170950|NCT00279201|527137276|FG003|Intensification Addendum|Sponsor Decision|0|||
146170951|NCT00279201|527137277|FG004|Intensification Addendum|Sponsor Decision|1|||
146170952|NCT00279201|527137278|FG005|Intensification Addendum|Sponsor Decision|1|||
146170953|NCT00279201|527137273|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
146170954|NCT00279201|527137274|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
146170955|NCT00279201|527137275|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
146170956|NCT00279201|527137276|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
146170957|NCT00279201|527137277|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
146170958|NCT00279201|527137278|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
146170959|NCT00279201|527137273|FG000|Intensification Addendum|Lack of Efficacy|0|||
146170960|NCT00279201|527137274|FG001|Intensification Addendum|Lack of Efficacy|0|||
146170961|NCT00279201|527137275|FG002|Intensification Addendum|Lack of Efficacy|0|||
146170962|NCT00279201|527137276|FG003|Intensification Addendum|Lack of Efficacy|1|||
146170963|NCT00279201|527137277|FG004|Intensification Addendum|Lack of Efficacy|1|||
146170964|NCT00279201|527137278|FG005|Intensification Addendum|Lack of Efficacy|0|||
146170965|NCT00279201|527137273|FG000|Intensification Addendum|Death|0|||
146170966|NCT00279201|527137274|FG001|Intensification Addendum|Death|0|||
146170967|NCT00279201|527137275|FG002|Intensification Addendum|Death|0|||
146170968|NCT00279201|527137276|FG003|Intensification Addendum|Death|0|||
146170969|NCT00279201|527137277|FG004|Intensification Addendum|Death|1|||
146170970|NCT00279201|527137278|FG005|Intensification Addendum|Death|0|||
146170971|NCT03881696|527137287|FG000|Overall Study|Adverse Event|2|||
146170972|NCT03881696|527137288|FG001|Overall Study|Adverse Event|0|||
146170973|NCT03881696|527137287|FG000|Overall Study|Withdrawal by Subject|2|||
146170974|NCT03881696|527137288|FG001|Overall Study|Withdrawal by Subject|0|||
146170975|NCT03881696|527137287|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
146170976|NCT03881696|527137288|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
146170977|NCT03881696|527137287|FG000|Overall Study|Failure to meet continuation criteria|1|||
146170978|NCT03881696|527137288|FG001|Overall Study|Failure to meet continuation criteria|0|||
146170979|NCT01061333|527137289|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
146170980|NCT01061333|527137290|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
146170981|NCT01966003|527138640|FG000|Overall Study|Death|43|||
146170982|NCT01966003|527138641|FG001|Overall Study|Death|36|||
146170983|NCT01966003|527138640|FG000|Overall Study|Protocol Violation|6|||
146170984|NCT01966003|527138641|FG001|Overall Study|Protocol Violation|4|||
146170985|NCT01966003|527138640|FG000|Overall Study|Lost to Follow-up|4|||
146170986|NCT01966003|527138641|FG001|Overall Study|Lost to Follow-up|3|||
146170987|NCT01966003|527138640|FG000|Overall Study|Physician Decision|12|||
146170988|NCT01966003|527138641|FG001|Overall Study|Physician Decision|13|||
146170989|NCT01966003|527138640|FG000|Overall Study|Withdrawal by Subject|29|||
146170990|NCT01966003|527138641|FG001|Overall Study|Withdrawal by Subject|19|||
146170991|NCT01966003|527138640|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
146170992|NCT01966003|527138641|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
146170993|NCT01966003|527138640|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
146170994|NCT01966003|527138641|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
146170995|NCT01966003|527138640|FG000|Overall Study|Other|1|||
146170996|NCT01966003|527138641|FG001|Overall Study|Other|1|||
146170997|NCT00674570|527138642|FG000|Overall Study|Withdrawal by Subject|0|||
146170998|NCT00674570|527138643|FG001|Overall Study|Withdrawal by Subject|2|||
146170999|NCT00674570|527138644|FG002|Overall Study|Withdrawal by Subject|0|||
146171000|NCT00633932|527138646|FG000|Overall Study|Adverse Event|1|||
146171001|NCT00633932|527138647|FG001|Overall Study|Adverse Event|3|||
146171002|NCT00633932|527138648|FG002|Overall Study|Adverse Event|4|||
146171003|NCT00633932|527138646|FG000|Overall Study|Withdrawal by Subject|3|||
146171004|NCT00633932|527138647|FG001|Overall Study|Withdrawal by Subject|9|||
146171005|NCT00633932|527138648|FG002|Overall Study|Withdrawal by Subject|1|||
146171006|NCT00633932|527138646|FG000|Overall Study|Lost to Follow-up|1|||
146171007|NCT00633932|527138647|FG001|Overall Study|Lost to Follow-up|0|||
146171008|NCT00633932|527138648|FG002|Overall Study|Lost to Follow-up|2|||
146171009|NCT00633932|527138646|FG000|Overall Study|Protocol Violation|5|||
146171010|NCT00633932|527138647|FG001|Overall Study|Protocol Violation|2|||
146171011|NCT00633932|527138648|FG002|Overall Study|Protocol Violation|3|||
146171012|NCT00633932|527138646|FG000|Overall Study|Physician Decision|0|||
146171013|NCT00633932|527138647|FG001|Overall Study|Physician Decision|0|||
146171014|NCT00633932|527138648|FG002|Overall Study|Physician Decision|1|||
146062642|NCT04363320|526748288|FG003|Overall Study|Death|0|||
146062643|NCT02260934|526748298|FG000|Overall Study|Lost to Follow-up|2|||
146062644|NCT02260934|526748299|FG001|Overall Study|Lost to Follow-up|1|||
146062645|NCT02260934|526748298|FG000|Overall Study|Withdrawal by Subject|0|||
146062646|NCT02260934|526748299|FG001|Overall Study|Withdrawal by Subject|2|||
146062647|NCT02260934|526748298|FG000|Overall Study|Participant Relocated|1|||
146062648|NCT02260934|526748299|FG001|Overall Study|Participant Relocated|0|||
146062649|NCT02260934|526748298|FG000|Overall Study|Site error|0|||
146062650|NCT02260934|526748299|FG001|Overall Study|Site error|1|||
146171015|NCT00633932|527138646|FG000|Overall Study|Doctor's judgement|1|||
146171016|NCT00633932|527138647|FG001|Overall Study|Doctor's judgement|0|||
146171017|NCT00633932|527138648|FG002|Overall Study|Doctor's judgement|0|||
146171018|NCT00633932|527138646|FG000|Overall Study|Moved Away|1|||
146171019|NCT00633932|527138647|FG001|Overall Study|Moved Away|0|||
146171020|NCT00633932|527138648|FG002|Overall Study|Moved Away|0|||
146171021|NCT00482274|527138649|FG000|Overall Study|Adverse Event|1|||
146171022|NCT04836858|527138650|FG000|Overall Study|Adverse Event|0|||
146171023|NCT04836858|527138651|FG001|Overall Study|Adverse Event|0|||
146171024|NCT04836858|527138652|FG002|Overall Study|Adverse Event|0|||
146171025|NCT04836858|527138653|FG003|Overall Study|Adverse Event|1|||
146171026|NCT04836858|527138650|FG000|Overall Study|Lost to Follow-up|1|||
146171027|NCT04836858|527138651|FG001|Overall Study|Lost to Follow-up|0|||
146171028|NCT04836858|527138652|FG002|Overall Study|Lost to Follow-up|0|||
146171029|NCT04836858|527138653|FG003|Overall Study|Lost to Follow-up|0|||
146171030|NCT04836858|527138650|FG000|Overall Study|Subject/Guardian decision|3|||
146171031|NCT04836858|527138651|FG001|Overall Study|Subject/Guardian decision|0|||
146171032|NCT04836858|527138652|FG002|Overall Study|Subject/Guardian decision|0|||
146171033|NCT04836858|527138653|FG003|Overall Study|Subject/Guardian decision|1|||
146171034|NCT04836858|527138650|FG000|Overall Study|Randomized but not treated|4|||
146171035|NCT04836858|527138651|FG001|Overall Study|Randomized but not treated|0|||
146171036|NCT04836858|527138652|FG002|Overall Study|Randomized but not treated|0|||
146171037|NCT04836858|527138653|FG003|Overall Study|Randomized but not treated|0|||
146171038|NCT04887948|527138657|FG000|Overall Study|Death|1|||
146171039|NCT04887948|527138658|FG001|Overall Study|Death|0|||
146171040|NCT04887948|527138659|FG002|Overall Study|Death|0|||
146171041|NCT04887948|527138657|FG000|Overall Study|Lost to Follow-up|1|||
146171042|NCT04887948|527138658|FG001|Overall Study|Lost to Follow-up|0|||
146171043|NCT04887948|527138659|FG002|Overall Study|Lost to Follow-up|3|||
146171044|NCT04887948|527138657|FG000|Overall Study|Physician Decision|0|||
146171045|NCT04887948|527138658|FG001|Overall Study|Physician Decision|4|||
146171046|NCT04887948|527138659|FG002|Overall Study|Physician Decision|1|||
146171047|NCT04887948|527138657|FG000|Overall Study|Protocol Violation|1|||
146171048|NCT04887948|527138658|FG001|Overall Study|Protocol Violation|1|||
146171049|NCT04887948|527138659|FG002|Overall Study|Protocol Violation|0|||
146171050|NCT04887948|527138657|FG000|Overall Study|Withdrawal by Subject|0|||
146171051|NCT04887948|527138658|FG001|Overall Study|Withdrawal by Subject|6|||
146171052|NCT04887948|527138659|FG002|Overall Study|Withdrawal by Subject|1|||
146171053|NCT04887948|527138657|FG000|Overall Study|No longer met eligibility criteria|1|||
146171054|NCT04887948|527138658|FG001|Overall Study|No longer met eligibility criteria|2|||
146171055|NCT04887948|527138659|FG002|Overall Study|No longer met eligibility criteria|1|||
146171056|NCT04887948|527138657|FG000|Overall Study|Other|2|||
146171057|NCT04887948|527138658|FG001|Overall Study|Other|1|||
146171058|NCT04887948|527138659|FG002|Overall Study|Other|1|||
146171059|NCT00787319|527138660|FG000|Overall Study|Lost to Follow-up|2|||
146171060|NCT00787319|527138660|FG000|Overall Study|Withdrawal by Subject|15|||
146171061|NCT00787319|527138660|FG000|Overall Study|Adverse Event|3|||
146171062|NCT00787319|527138660|FG000|Overall Study|Objective progression or relapse|30|||
146171063|NCT00787319|527138660|FG000|Overall Study|Lack of Efficacy|1|||
146171064|NCT00787319|527138660|FG000|Overall Study|Budget exhausted/exceeded|1|||
146171065|NCT00787319|527138660|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
146171066|NCT00787319|527138660|FG000|Overall Study|No health insurance reimbursement|2|||
146171067|NCT00787319|527138660|FG000|Overall Study|Stabilized disease findings|3|||
146171068|NCT00787319|527138660|FG000|Overall Study|Inactive disease|5|||
146171069|NCT03075904|527138661|FG000|Overall Study|Physician Decision|3|||
146171070|NCT03075904|527138661|FG000|Overall Study|Need for Medication not Permitted|1|||
146171071|NCT00985985|527138664|FG000|Overall Study|Adverse Event|4|||
146171072|NCT00985985|527138665|FG001|Overall Study|Adverse Event|2|||
146171073|NCT00985985|527138666|FG002|Overall Study|Adverse Event|2|||
146171074|NCT00985985|527138667|FG003|Overall Study|Adverse Event|2|||
146171075|NCT00985985|527138664|FG000|Overall Study|Lost to Follow-up|4|||
146171076|NCT00985985|527138665|FG001|Overall Study|Lost to Follow-up|11|||
146171077|NCT00985985|527138666|FG002|Overall Study|Lost to Follow-up|2|||
146171078|NCT00985985|527138667|FG003|Overall Study|Lost to Follow-up|3|||
146171079|NCT00985985|527138664|FG000|Overall Study|Protocol Violation|1|||
146171080|NCT00985985|527138665|FG001|Overall Study|Protocol Violation|2|||
146171081|NCT00985985|527138666|FG002|Overall Study|Protocol Violation|0|||
146171082|NCT00985985|527138667|FG003|Overall Study|Protocol Violation|1|||
146171083|NCT00985985|527138664|FG000|Overall Study|Lack of Efficacy|5|||
146171084|NCT00985985|527138665|FG001|Overall Study|Lack of Efficacy|6|||
146171085|NCT00985985|527138666|FG002|Overall Study|Lack of Efficacy|1|||
146171086|NCT00985985|527138667|FG003|Overall Study|Lack of Efficacy|3|||
146171087|NCT00985985|527138664|FG000|Overall Study|Withdrawal by Subject|4|||
146171088|NCT00985985|527138665|FG001|Overall Study|Withdrawal by Subject|2|||
146171089|NCT00985985|527138666|FG002|Overall Study|Withdrawal by Subject|2|||
146171090|NCT00985985|527138667|FG003|Overall Study|Withdrawal by Subject|2|||
146171091|NCT00985985|527138664|FG000|Overall Study|Other Reason|6|||
146171092|NCT00985985|527138665|FG001|Overall Study|Other Reason|1|||
146171093|NCT00985985|527138666|FG002|Overall Study|Other Reason|4|||
146171094|NCT00985985|527138667|FG003|Overall Study|Other Reason|2|||
146171095|NCT00509236|527138670|FG000|Overall Study|Adverse Event|7|||
146171096|NCT00509236|527138671|FG001|Overall Study|Adverse Event|9|||
146171097|NCT00509236|527138670|FG000|Overall Study|Withdrawal by Subject|5|||
146171098|NCT00509236|527138671|FG001|Overall Study|Withdrawal by Subject|10|||
146171099|NCT00509236|527138670|FG000|Overall Study|Protocol Violation|3|||
146402661|NCT00267020|527977542|FG000|Overall Study|Death|2|||
146402662|NCT00267020|527977543|FG001|Overall Study|Death|1|||
146402663|NCT00267020|527977542|FG000|Overall Study|Withdrawal by Subject|17|||
146402664|NCT00267020|527977543|FG001|Overall Study|Withdrawal by Subject|7|||
146402665|NCT00267020|527977542|FG000|Overall Study|Physician Decision|3|||
146402666|NCT00267020|527977543|FG001|Overall Study|Physician Decision|2|||
146402667|NCT00267020|527977542|FG000|Overall Study|Disease Progression|39|||
146402668|NCT00267020|527977543|FG001|Overall Study|Disease Progression|25|||
146402669|NCT00267020|527977542|FG000|Overall Study|Unrelated Complication|1|||
146402670|NCT00267020|527977543|FG001|Overall Study|Unrelated Complication|1|||
146402671|NCT00267020|527977542|FG000|Overall Study|Sponsor Request|1|||
146402672|NCT00267020|527977543|FG001|Overall Study|Sponsor Request|0|||
146402673|NCT00267020|527977542|FG000|Overall Study|Other|1|||
146402674|NCT00267020|527977543|FG001|Overall Study|Other|2|||
146402675|NCT00640614|527977544|FG000|Overall Study|Lost to Follow-up|1|||
146402676|NCT00640614|527977545|FG001|Overall Study|Lost to Follow-up|0|||
146402677|NCT02209454|527977548|FG000|Second Period|Adverse Event|1|||
146402678|NCT02209454|527977549|FG001|Second Period|Adverse Event|0|||
146402679|NCT02545868|527977550|FG000|Overall Study|Lack of Efficacy|1|||
146402680|NCT02545868|527977551|FG001|Overall Study|Lack of Efficacy|1|||
146402681|NCT02545868|527977552|FG002|Overall Study|Lack of Efficacy|0|||
146402682|NCT02545868|527977550|FG000|Overall Study|Lost to Follow-up|1|||
146402683|NCT02545868|527977551|FG001|Overall Study|Lost to Follow-up|5|||
146402684|NCT02545868|527977552|FG002|Overall Study|Lost to Follow-up|1|||
146402685|NCT02545868|527977550|FG000|Overall Study|Non-compliance|1|||
146402686|NCT02545868|527977551|FG001|Overall Study|Non-compliance|1|||
146402687|NCT02545868|527977552|FG002|Overall Study|Non-compliance|1|||
146402688|NCT02545868|527977550|FG000|Overall Study|Treatment change|21|||
146402689|NCT02545868|527977551|FG001|Overall Study|Treatment change|19|||
146402690|NCT02545868|527977552|FG002|Overall Study|Treatment change|22|||
146402691|NCT02545868|527977550|FG000|Overall Study|Physician Decision|1|||
146402692|NCT02545868|527977551|FG001|Overall Study|Physician Decision|1|||
146402693|NCT02545868|527977552|FG002|Overall Study|Physician Decision|1|||
146402694|NCT02545868|527977550|FG000|Overall Study|Withdrawal by Subject|6|||
146402695|NCT02545868|527977551|FG001|Overall Study|Withdrawal by Subject|7|||
146402696|NCT02545868|527977552|FG002|Overall Study|Withdrawal by Subject|9|||
146402697|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
146402698|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
146402699|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
146402700|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
146402701|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
146402702|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
146402703|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
146402704|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
146402705|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
146402706|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
146402707|NCT01777191|527977553|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
146402708|NCT01777191|527977554|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
146402709|NCT01777191|527977553|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
146402710|NCT01777191|527977554|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
146402711|NCT01777191|527977553|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
146402712|NCT01777191|527977554|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
146402713|NCT01777191|527977553|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
146402714|NCT01777191|527977554|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
146402715|NCT01777191|527977553|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
146402716|NCT01777191|527977554|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
146402717|NCT01777191|527977553|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
146402718|NCT01777191|527977554|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
146402719|NCT04465916|527977559|FG000|Overall Study|Withdrawal by Subject|0|||
146402720|NCT04465916|527977560|FG001|Overall Study|Withdrawal by Subject|1|||
146171100|NCT00509236|527138671|FG001|Overall Study|Protocol Violation|0|||
146171101|NCT00509236|527138670|FG000|Overall Study|Excluded Medication|1|||
146402721|NCT01856686|527977561|FG000|Overall Study|Lost to Follow-up|5|||
146171102|NCT00509236|527138671|FG001|Overall Study|Excluded Medication|1|||
146171103|NCT00509236|527138670|FG000|Overall Study|Scheduled Kidney Transplant|1|||
146171104|NCT00509236|527138671|FG001|Overall Study|Scheduled Kidney Transplant|0|||
146171105|NCT00927355|527138672|FG000|Overall Study|Adverse Event|1|||
146171106|NCT00927355|527138673|FG001|Overall Study|Adverse Event|1|||
146171107|NCT01572389|527138674|FG000|Overall Study|Death|1|||
146171108|NCT01572389|527138675|FG001|Overall Study|Death|3|||
146171109|NCT01572389|527138674|FG000|Overall Study|Withdrawal by Subject|14|||
146171110|NCT01572389|527138675|FG001|Overall Study|Withdrawal by Subject|2|||
146171111|NCT01572389|527138674|FG000|Overall Study|Lost to Follow-up|25|||
146171112|NCT01572389|527138675|FG001|Overall Study|Lost to Follow-up|14|||
146171113|NCT01572389|527138674|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
146171114|NCT01572389|527138675|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
146171115|NCT03954743|527138676|FG000|Overall Study|Adverse Event|1|||
146171116|NCT03954743|527138677|FG001|Overall Study|Adverse Event|0|||
146171117|NCT03954743|527138676|FG000|Overall Study|Lost to Follow-up|6|||
146171118|NCT03954743|527138677|FG001|Overall Study|Lost to Follow-up|4|||
146171119|NCT03954743|527138676|FG000|Overall Study|Protocol Violation|1|||
146171120|NCT03954743|527138677|FG001|Overall Study|Protocol Violation|0|||
146171121|NCT03954743|527138676|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
146171122|NCT03954743|527138677|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
146171123|NCT03954743|527138676|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
146171124|NCT03954743|527138677|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146171125|NCT01446796|527138688|FG000|Overall Study|Withdrawal by Subject|1|||
146171126|NCT01446796|527138689|FG001|Overall Study|Withdrawal by Subject|0|||
146171127|NCT03579290|527138697|FG000|Overall Study|Lost to Follow-up|9|||
146171128|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
146171129|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
146171130|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
146171131|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
146171132|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
146171133|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
146171134|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
146171135|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Physician Decision|4|||
146171136|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Physician Decision|1|||
146171137|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Physician Decision|3|||
146171138|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Physician Decision|0|||
146171139|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Physician Decision|0|||
146171140|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Physician Decision|1|||
146171141|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Physician Decision|0|||
146171142|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Other|0|||
146171143|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Other|1|||
146171144|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Other|0|||
146171145|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Other|0|||
146171146|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Other|0|||
146171147|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Other|0|||
146171148|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Other|0|||
146171149|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171150|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171151|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171152|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171153|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171154|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
146171155|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
146171156|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
146171157|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
146171158|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
146171159|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
146171160|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
146171161|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
146171162|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
146171163|NCT05375955|527138698|FG000|Treatment (12 Weeks)|Pregnancy|0|||
146171164|NCT05375955|527138699|FG001|Treatment (12 Weeks)|Pregnancy|0|||
146171165|NCT05375955|527138700|FG002|Treatment (12 Weeks)|Pregnancy|1|||
146171166|NCT05375955|527138701|FG003|Treatment (12 Weeks)|Pregnancy|0|||
146171167|NCT05375955|527138702|FG004|Treatment (12 Weeks)|Pregnancy|0|||
146171168|NCT05375955|527138703|FG005|Treatment (12 Weeks)|Pregnancy|0|||
146171169|NCT05375955|527138704|FG006|Treatment (12 Weeks)|Pregnancy|0|||
146171170|NCT05375955|527138698|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171171|NCT05375955|527138699|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171172|NCT05375955|527138700|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
146171173|NCT05375955|527138701|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171174|NCT05375955|527138702|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171175|NCT05375955|527138703|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171176|NCT05375955|527138704|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
146171177|NCT05375955|527138698|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146171178|NCT05375955|527138699|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146171179|NCT05375955|527138700|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146171180|NCT05375955|527138701|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146171181|NCT05375955|527138702|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146171182|NCT05375955|527138703|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
146171183|NCT05375955|527138704|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
146171184|NCT05375955|527138698|FG000|Follow-up (up to 5 Weeks)|Other|0|||
146171185|NCT05375955|527138699|FG001|Follow-up (up to 5 Weeks)|Other|1|||
146171186|NCT05375955|527138700|FG002|Follow-up (up to 5 Weeks)|Other|0|||
146171187|NCT05375955|527138701|FG003|Follow-up (up to 5 Weeks)|Other|0|||
146171188|NCT05375955|527138702|FG004|Follow-up (up to 5 Weeks)|Other|0|||
146171189|NCT05375955|527138703|FG005|Follow-up (up to 5 Weeks)|Other|0|||
146171190|NCT05375955|527138704|FG006|Follow-up (up to 5 Weeks)|Other|0|||
146171191|NCT05375955|527138698|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
146171192|NCT05375955|527138699|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146171193|NCT05375955|527138700|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
146171194|NCT05375955|527138701|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146171195|NCT05375955|527138702|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146171196|NCT05375955|527138703|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146171197|NCT05375955|527138704|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
146171198|NCT05375955|527138698|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146171199|NCT05375955|527138699|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
146171200|NCT05375955|527138700|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146171201|NCT05375955|527138701|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
146171202|NCT05375955|527138702|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146171203|NCT05375955|527138703|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
146171204|NCT05375955|527138704|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
146171205|NCT05454410|527138705|FG000|Overall Study|Withdrawal by Subject|0|||
146171206|NCT05454410|527138706|FG001|Overall Study|Withdrawal by Subject|0|||
146171207|NCT05454410|527138707|FG002|Overall Study|Withdrawal by Subject|1|||
146171208|NCT05454410|527138708|FG003|Overall Study|Withdrawal by Subject|1|||
146171209|NCT05004688|527138718|FG000|Overall Study|Protocol Violation|7|||
146171210|NCT05004688|527138718|FG000|Overall Study|Physician Decision|2|||
146171211|NCT05004688|527138718|FG000|Overall Study|Withdrawal by Subject|2|||
146171212|NCT00895622|527138719|FG000|Overall Study|Protocol Violation|5|||
146171213|NCT00895622|527138720|FG001|Overall Study|Protocol Violation|4|||
146171214|NCT00895622|527138721|FG002|Overall Study|Protocol Violation|4|||
146171215|NCT03879408|527138722|FG000|Overall Study|Lost to Follow-up|0|||
146171216|NCT03879408|527138723|FG001|Overall Study|Lost to Follow-up|3|||
146171217|NCT03879408|527138724|FG002|Overall Study|Lost to Follow-up|2|||
146171218|NCT03879408|527138725|FG003|Overall Study|Lost to Follow-up|1|||
146171219|NCT03879408|527138726|FG004|Overall Study|Lost to Follow-up|0|||
146171220|NCT03879408|527138722|FG000|Overall Study|Withdrawal by Subject|2|||
146171221|NCT03879408|527138723|FG001|Overall Study|Withdrawal by Subject|1|||
146171222|NCT03879408|527138724|FG002|Overall Study|Withdrawal by Subject|1|||
146171223|NCT03879408|527138725|FG003|Overall Study|Withdrawal by Subject|0|||
146171224|NCT03879408|527138726|FG004|Overall Study|Withdrawal by Subject|1|||
146171225|NCT01320943|527138727|FG000|Overall Study|Lost to Follow-up|1|||
146171226|NCT01320943|527138728|FG001|Overall Study|Lost to Follow-up|0|||
146171227|NCT01320943|527138727|FG000|Overall Study|Physician Decision|0|||
146171228|NCT01320943|527138728|FG001|Overall Study|Physician Decision|1|||
146171229|NCT01320943|527138727|FG000|Overall Study|Randomized but not Treated|0|||
146171230|NCT01320943|527138728|FG001|Overall Study|Randomized but not Treated|1|||
146171231|NCT03489057|527138737|FG000|Overall Study|Lost to Follow-up|16|||
146171232|NCT03489057|527138738|FG001|Overall Study|Lost to Follow-up|16|||
146171233|NCT03489057|527138739|FG002|Overall Study|Lost to Follow-up|14|||
146171234|NCT03489057|527138740|FG003|Overall Study|Lost to Follow-up|14|||
146171235|NCT03489057|527138737|FG000|Overall Study|Withdrawal by Subject|12|||
146171236|NCT03489057|527138738|FG001|Overall Study|Withdrawal by Subject|12|||
146171237|NCT03489057|527138739|FG002|Overall Study|Withdrawal by Subject|8|||
146171238|NCT03489057|527138740|FG003|Overall Study|Withdrawal by Subject|8|||
146171239|NCT03489057|527138737|FG000|Overall Study|Protocol Violation|7|||
146171240|NCT03489057|527138738|FG001|Overall Study|Protocol Violation|7|||
146171241|NCT03489057|527138739|FG002|Overall Study|Protocol Violation|2|||
146171242|NCT03489057|527138740|FG003|Overall Study|Protocol Violation|2|||
146171243|NCT05158296|527138741|FG000|Overall Study|Sponsor Decision|2|||
146171244|NCT05158296|527138742|FG001|Overall Study|Sponsor Decision|3|||
146171245|NCT05158296|527138743|FG002|Overall Study|Sponsor Decision|2|||
146171246|NCT02010632|527138744|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
146171247|NCT02010632|527138745|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
146171248|NCT03324880|527138746|FG000|Overall Study|Adverse Event|0|||
146171249|NCT03324880|527138747|FG001|Overall Study|Adverse Event|2|||
146171250|NCT03324880|527138746|FG000|Overall Study|Withdrawal by Subject|2|||
146171251|NCT03324880|527138747|FG001|Overall Study|Withdrawal by Subject|2|||
146171252|NCT03324880|527138746|FG000|Overall Study|Lost to Follow-up|0|||
146171253|NCT03324880|527138747|FG001|Overall Study|Lost to Follow-up|1|||
146171254|NCT03324880|527138746|FG000|Overall Study|Product Recall|0|||
146171255|NCT03324880|527138747|FG001|Overall Study|Product Recall|1|||
146171256|NCT01412801|527138748|FG000|Overall Study|Death|0|||
146171257|NCT01412801|527138749|FG001|Overall Study|Death|1|||
146171258|NCT01412801|527138750|FG002|Overall Study|Death|0|||
146171259|NCT01412801|527138751|FG003|Overall Study|Death|4|||
146171260|NCT01412801|527138752|FG004|Overall Study|Death|2|||
146171261|NCT01412801|527138753|FG005|Overall Study|Death|2|||
146171262|NCT01412801|527138748|FG000|Overall Study|Lost to Follow-up|1|||
146171263|NCT01412801|527138749|FG001|Overall Study|Lost to Follow-up|2|||
146171264|NCT01412801|527138750|FG002|Overall Study|Lost to Follow-up|4|||
146171265|NCT01412801|527138751|FG003|Overall Study|Lost to Follow-up|0|||
146171266|NCT01412801|527138752|FG004|Overall Study|Lost to Follow-up|1|||
146171267|NCT01412801|527138753|FG005|Overall Study|Lost to Follow-up|1|||
146171268|NCT01412801|527138748|FG000|Overall Study|Withdrawal by Subject|3|||
146171269|NCT01412801|527138749|FG001|Overall Study|Withdrawal by Subject|2|||
146171270|NCT01412801|527138750|FG002|Overall Study|Withdrawal by Subject|1|||
146171271|NCT01412801|527138751|FG003|Overall Study|Withdrawal by Subject|0|||
146171272|NCT01412801|527138752|FG004|Overall Study|Withdrawal by Subject|0|||
146171273|NCT01412801|527138753|FG005|Overall Study|Withdrawal by Subject|0|||
146171274|NCT01412801|527138748|FG000|Overall Study|Relocated to another area|0|||
146171275|NCT01412801|527138749|FG001|Overall Study|Relocated to another area|0|||
146171276|NCT01412801|527138750|FG002|Overall Study|Relocated to another area|2|||
146171277|NCT01412801|527138751|FG003|Overall Study|Relocated to another area|0|||
146171278|NCT01412801|527138752|FG004|Overall Study|Relocated to another area|0|||
146171279|NCT01412801|527138753|FG005|Overall Study|Relocated to another area|0|||
146171280|NCT01547299|527138754|FG000|Overall Study|Withdrawal by Subject|2|||
146171281|NCT01547299|527138755|FG001|Overall Study|Withdrawal by Subject|2|||
146171282|NCT02272725|527138756|FG000|Overall Study|equipment malfunction|2|||
146171283|NCT02272725|527138757|FG001|Overall Study|equipment malfunction|0|||
146171284|NCT04739761|527138758|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
146171285|NCT04739761|527138759|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
146171286|NCT04739761|527138758|FG000|Overall Study|By complete response from the participant|1|||
146171287|NCT04739761|527138759|FG001|Overall Study|By complete response from the participant|0|||
146171288|NCT04739761|527138758|FG000|Overall Study|Lost to Follow-up|3|||
146171289|NCT04739761|527138759|FG001|Overall Study|Lost to Follow-up|3|||
146171290|NCT04739761|527138758|FG000|Overall Study|Death|13|||
146171291|NCT04739761|527138759|FG001|Overall Study|Death|13|||
146171292|NCT04739761|527138758|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
146171293|NCT04739761|527138759|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
146171294|NCT04739761|527138758|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
146171295|NCT04739761|527138759|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
146171296|NCT04739761|527138758|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
146171297|NCT04739761|527138759|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
146402722|NCT01856686|527977562|FG001|Overall Study|Lost to Follow-up|11|||
146402723|NCT00602979|527977563|FG000|Overall Study|Lost to Follow-up|3|||
146402724|NCT00602979|527977564|FG001|Overall Study|Lost to Follow-up|2|||
146402725|NCT00602979|527977565|FG002|Overall Study|Lost to Follow-up|3|||
146402726|NCT00602979|527977566|FG003|Overall Study|Lost to Follow-up|2|||
146402727|NCT00602979|527977567|FG004|Overall Study|Lost to Follow-up|3|||
146062651|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
146062652|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
146062653|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
146062654|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
146062655|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
146062656|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
146062657|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
146062658|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
146062659|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
146062660|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
146062661|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
146062662|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
146062663|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
146062664|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
146062665|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
146062666|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
146062667|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
146062668|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
146062669|NCT03605667|526748302|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
146062670|NCT03605667|526748303|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
146062671|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
146062672|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
146062673|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Other|6|||
146062674|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Other|8|||
146062675|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
146062676|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
146062677|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
146062678|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
146062679|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
146062680|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
146062681|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
146062682|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
146062683|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
146062684|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
146062685|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
146062686|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
146062687|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Death|0|||
146062688|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Death|2|||
146062689|NCT03605667|526748302|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
146062690|NCT03605667|526748303|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
146062691|NCT05632211|526748304|FG000|Overall Study|Withdrawal by Subject|2|||
146062692|NCT05632211|526748305|FG001|Overall Study|Withdrawal by Subject|0|||
146062693|NCT05632211|526748306|FG002|Overall Study|Withdrawal by Subject|2|||
146062694|NCT05632211|526748304|FG000|Overall Study|Other reasons|1|||
146062695|NCT05632211|526748305|FG001|Overall Study|Other reasons|1|||
146062696|NCT05632211|526748306|FG002|Overall Study|Other reasons|1|||
146062697|NCT05194124|526748309|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062698|NCT05194124|526748310|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062699|NCT05194124|526748311|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062700|NCT05194124|526748312|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
146062701|NCT05194124|526748313|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062702|NCT05194124|526748314|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
146062703|NCT05194124|526748315|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062704|NCT05194124|526748316|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062705|NCT05194124|526748317|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062706|NCT05194124|526748318|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
146062707|NCT05194124|526748309|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146062708|NCT05194124|526748310|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146062709|NCT05194124|526748311|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146062710|NCT05194124|526748312|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146062711|NCT05194124|526748313|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146062712|NCT05194124|526748314|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146171298|NCT04739761|527138758|FG000|Overall Study|Adverse Event|0|||
146171299|NCT04739761|527138759|FG001|Overall Study|Adverse Event|3|||
146171300|NCT04739761|527138758|FG000|Overall Study|Participant decision|1|||
146171301|NCT04739761|527138759|FG001|Overall Study|Participant decision|0|||
146171302|NCT04739761|527138758|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
146171303|NCT04739761|527138759|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
146171304|NCT04739761|527138758|FG000|Overall Study|Participant immediately started next line of treatment|1|||
146171305|NCT04739761|527138759|FG001|Overall Study|Participant immediately started next line of treatment|0|||
146171306|NCT04739761|527138758|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
146171307|NCT04739761|527138759|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
146171308|NCT04739761|527138758|FG000|Overall Study|Lack of clinical benefit|1|||
146171309|NCT04739761|527138759|FG001|Overall Study|Lack of clinical benefit|0|||
146171310|NCT04739761|527138758|FG000|Overall Study|Disease progression|5|||
146171311|NCT04739761|527138759|FG001|Overall Study|Disease progression|5|||
146171312|NCT04739761|527138758|FG000|Overall Study|Withdrawal by Subject|14|||
146171313|NCT04739761|527138759|FG001|Overall Study|Withdrawal by Subject|13|||
146171314|NCT04739761|527138758|FG000|Overall Study|Protocol Violation|1|||
146171315|NCT04739761|527138759|FG001|Overall Study|Protocol Violation|0|||
146171316|NCT04739761|527138758|FG000|Overall Study|Physician Decision|2|||
146171317|NCT04739761|527138759|FG001|Overall Study|Physician Decision|0|||
146171318|NCT00605319|527140959|FG000|Overall Study|Adverse Event|6|||
146171319|NCT02670538|527140960|FG000|Overall Study|Withdrawal of Consent|8|||
146171320|NCT02670538|527140961|FG001|Overall Study|Withdrawal of Consent|6|||
146171321|NCT02670538|527140962|FG002|Overall Study|Withdrawal of Consent|5|||
146171322|NCT02670538|527140960|FG000|Overall Study|Lost to Follow-up|8|||
146171323|NCT02670538|527140961|FG001|Overall Study|Lost to Follow-up|12|||
146171324|NCT02670538|527140962|FG002|Overall Study|Lost to Follow-up|7|||
146171325|NCT02670538|527140960|FG000|Overall Study|Adverse Event|5|||
146171326|NCT02670538|527140961|FG001|Overall Study|Adverse Event|5|||
146171327|NCT02670538|527140962|FG002|Overall Study|Adverse Event|11|||
146171328|NCT02670538|527140960|FG000|Overall Study|Lack of Efficacy|7|||
146171329|NCT02670538|527140961|FG001|Overall Study|Lack of Efficacy|1|||
146171330|NCT02670538|527140962|FG002|Overall Study|Lack of Efficacy|2|||
146171331|NCT02670538|527140960|FG000|Overall Study|Protocol Violation|3|||
146171332|NCT02670538|527140961|FG001|Overall Study|Protocol Violation|4|||
146171333|NCT02670538|527140962|FG002|Overall Study|Protocol Violation|1|||
146171334|NCT02670538|527140960|FG000|Overall Study|Noncompliance with Study Drug|1|||
146171335|NCT02670538|527140961|FG001|Overall Study|Noncompliance with Study Drug|3|||
146171336|NCT02670538|527140962|FG002|Overall Study|Noncompliance with Study Drug|2|||
146171337|NCT02670538|527140960|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146402728|NCT00602979|527977563|FG000|Overall Study|Failed Intubation|0|||
146402729|NCT00602979|527977564|FG001|Overall Study|Failed Intubation|1|||
146402730|NCT00602979|527977565|FG002|Overall Study|Failed Intubation|0|||
146402731|NCT00602979|527977566|FG003|Overall Study|Failed Intubation|1|||
146402732|NCT00602979|527977567|FG004|Overall Study|Failed Intubation|0|||
146402733|NCT00468312|527977568|FG000|Overall Study|Adverse Event|2|||
146171338|NCT02670538|527140961|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146171339|NCT02670538|527140962|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146171340|NCT02312856|527140966|FG000|Overall Study|Death|1|||
146171341|NCT02312856|527140966|FG000|Overall Study|Lost to Follow-up|3|||
146171342|NCT01932294|527140967|FG000|Overall Study|Death|43|||
146171343|NCT01932294|527140967|FG000|Overall Study|Lost to Follow-up|8|||
146171344|NCT01932294|527140967|FG000|Overall Study|VAD Implantation|20|||
146171345|NCT01932294|527140967|FG000|Overall Study|Heart Transplantation|16|||
146171346|NCT01932294|527140967|FG000|Overall Study|Transferred to other hospitals|12|||
146171347|NCT04415151|527140968|FG000|Overall Study|Death|1|||
146171348|NCT04415151|527140969|FG001|Overall Study|Death|1|||
146171349|NCT04415151|527140968|FG000|Overall Study|Withdrawal by Subject|1|||
146171350|NCT04415151|527140969|FG001|Overall Study|Withdrawal by Subject|0|||
146171351|NCT00638235|527140973|FG000|Overall Study|Lost to Follow-up|31|||
146171352|NCT00638235|527140974|FG001|Overall Study|Lost to Follow-up|3|||
146171353|NCT00638235|527140975|FG002|Overall Study|Lost to Follow-up|18|||
146171354|NCT00638235|527140976|FG003|Overall Study|Lost to Follow-up|10|||
146171355|NCT00638235|527140977|FG004|Overall Study|Lost to Follow-up|13|||
146171356|NCT00638235|527140978|FG005|Overall Study|Lost to Follow-up|26|||
146171357|NCT00638235|527140979|FG006|Overall Study|Lost to Follow-up|0|||
146171358|NCT00638235|527140980|FG007|Overall Study|Lost to Follow-up|1|||
146402734|NCT00468312|527977569|FG001|Overall Study|Adverse Event|1|||
146402735|NCT00468312|527977568|FG000|Overall Study|Lack of Efficacy|0|||
146171359|NCT00638235|527140981|FG008|Overall Study|Lost to Follow-up|18|||
146171360|NCT01473381|527140988|FG000|Overall Study|Adverse Event|8|||
146171361|NCT01473381|527140989|FG001|Overall Study|Adverse Event|20|||
146171362|NCT01473381|527140990|FG002|Overall Study|Adverse Event|25|||
146171363|NCT01473381|527140991|FG003|Overall Study|Adverse Event|17|||
146171364|NCT01473381|527140988|FG000|Overall Study|Insufficient Therapeutic Response|10|||
146171365|NCT01473381|527140989|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146171366|NCT01473381|527140990|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146402736|NCT00468312|527977569|FG001|Overall Study|Lack of Efficacy|1|||
146171367|NCT01473381|527140991|FG003|Overall Study|Insufficient Therapeutic Response|3|||
146171368|NCT01473381|527140988|FG000|Overall Study|Protocol Violation|17|||
146171369|NCT01473381|527140989|FG001|Overall Study|Protocol Violation|23|||
146171370|NCT01473381|527140990|FG002|Overall Study|Protocol Violation|19|||
146171371|NCT01473381|527140991|FG003|Overall Study|Protocol Violation|17|||
146171372|NCT01473381|527140988|FG000|Overall Study|Withdrawal of Consent|20|||
146171373|NCT01473381|527140989|FG001|Overall Study|Withdrawal of Consent|21|||
146171374|NCT01473381|527140990|FG002|Overall Study|Withdrawal of Consent|20|||
146171375|NCT01473381|527140991|FG003|Overall Study|Withdrawal of Consent|26|||
146171376|NCT01473381|527140988|FG000|Overall Study|Lost to Follow-up|25|||
146171377|NCT01473381|527140989|FG001|Overall Study|Lost to Follow-up|28|||
146171378|NCT01473381|527140990|FG002|Overall Study|Lost to Follow-up|35|||
146171379|NCT01473381|527140991|FG003|Overall Study|Lost to Follow-up|23|||
146171380|NCT01473381|527140988|FG000|Overall Study|Other Reasons|0|||
146171381|NCT01473381|527140989|FG001|Overall Study|Other Reasons|0|||
146171382|NCT01473381|527140990|FG002|Overall Study|Other Reasons|1|||
146171383|NCT01473381|527140991|FG003|Overall Study|Other Reasons|3|||
146171384|NCT00539643|527140992|FG000|Overall Study|Adverse Event|1|||
146171385|NCT00539643|527140993|FG001|Overall Study|Adverse Event|0|||
146171386|NCT00539643|527140992|FG000|Overall Study|Death|2|||
146171387|NCT00539643|527140993|FG001|Overall Study|Death|1|||
146171388|NCT00539643|527140992|FG000|Overall Study|Physician Decision|3|||
146171389|NCT00539643|527140993|FG001|Overall Study|Physician Decision|1|||
146171390|NCT00539643|527140992|FG000|Overall Study|Withdrawal by Subject|0|||
146171391|NCT00539643|527140993|FG001|Overall Study|Withdrawal by Subject|1|||
146171392|NCT02228395|527140994|FG000|First Intervention Period|No longer willing to participate|1|||
146171393|NCT02228395|527140995|FG001|First Intervention Period|No longer willing to participate|0|||
146171394|NCT02228395|527140996|FG002|First Intervention Period|No longer willing to participate|0|||
146171395|NCT02228395|527140994|FG000|First Intervention Period|Unable to comply with study dates|0|||
146171396|NCT02228395|527140995|FG001|First Intervention Period|Unable to comply with study dates|1|||
146171397|NCT02228395|527140996|FG002|First Intervention Period|Unable to comply with study dates|1|||
146171398|NCT02569437|527141000|FG000|Overall Study|Lost to Follow-up|12|||
146171399|NCT02569437|527141001|FG001|Overall Study|Lost to Follow-up|14|||
146171400|NCT02255357|527141002|FG000|Overall Study|Physician Decision|10|||
146171401|NCT02255357|527141003|FG001|Overall Study|Physician Decision|24|||
146171402|NCT01641926|527141004|FG000|Overall Study|Adverse Event|5|||
146171403|NCT01641926|527141005|FG001|Overall Study|Adverse Event|2|||
146171404|NCT01641926|527141006|FG002|Overall Study|Adverse Event|3|||
146171405|NCT01641926|527141007|FG003|Overall Study|Adverse Event|1|||
146171406|NCT01641926|527141004|FG000|Overall Study|Lost to Follow-up|2|||
146171407|NCT01641926|527141005|FG001|Overall Study|Lost to Follow-up|2|||
146171408|NCT01641926|527141006|FG002|Overall Study|Lost to Follow-up|1|||
146171409|NCT01641926|527141007|FG003|Overall Study|Lost to Follow-up|0|||
146171410|NCT01641926|527141004|FG000|Overall Study|Physician Decision|6|||
146171411|NCT01641926|527141005|FG001|Overall Study|Physician Decision|5|||
146171412|NCT01641926|527141006|FG002|Overall Study|Physician Decision|0|||
146171413|NCT01641926|527141007|FG003|Overall Study|Physician Decision|1|||
146171414|NCT01641926|527141004|FG000|Overall Study|Protocol Violation|1|||
146171415|NCT01641926|527141005|FG001|Overall Study|Protocol Violation|0|||
146171416|NCT01641926|527141006|FG002|Overall Study|Protocol Violation|0|||
146171417|NCT01641926|527141007|FG003|Overall Study|Protocol Violation|1|||
146171418|NCT01641926|527141004|FG000|Overall Study|Withdrawal by Subject|13|||
146171419|NCT01641926|527141005|FG001|Overall Study|Withdrawal by Subject|5|||
146171420|NCT01641926|527141006|FG002|Overall Study|Withdrawal by Subject|6|||
146171421|NCT01641926|527141007|FG003|Overall Study|Withdrawal by Subject|1|||
146171422|NCT01641926|527141004|FG000|Overall Study|Not Treated|1|||
146171423|NCT01641926|527141005|FG001|Overall Study|Not Treated|1|||
146171424|NCT01641926|527141006|FG002|Overall Study|Not Treated|1|||
146171425|NCT01641926|527141007|FG003|Overall Study|Not Treated|0|||
146171426|NCT01287520|527141008|FG000|Overall Study|Adverse Event|2|||
146171427|NCT01287520|527141009|FG001|Overall Study|Adverse Event|2|||
146171428|NCT01287520|527141010|FG002|Overall Study|Adverse Event|2|||
146171429|NCT01287520|527141011|FG003|Overall Study|Adverse Event|1|||
146171430|NCT01287520|527141012|FG004|Overall Study|Adverse Event|1|||
146171431|NCT01287520|527141013|FG005|Overall Study|Adverse Event|2|||
146171432|NCT01287520|527141014|FG006|Overall Study|Adverse Event|0|||
146171433|NCT01287520|527141015|FG007|Overall Study|Adverse Event|2|||
146171434|NCT01287520|527141016|FG008|Overall Study|Adverse Event|0|||
146171435|NCT01287520|527141008|FG000|Overall Study|Physician Decision|1|||
146171436|NCT01287520|527141009|FG001|Overall Study|Physician Decision|1|||
146171437|NCT01287520|527141010|FG002|Overall Study|Physician Decision|2|||
146171438|NCT01287520|527141011|FG003|Overall Study|Physician Decision|0|||
146171439|NCT01287520|527141012|FG004|Overall Study|Physician Decision|1|||
146171440|NCT01287520|527141013|FG005|Overall Study|Physician Decision|1|||
146171441|NCT01287520|527141014|FG006|Overall Study|Physician Decision|0|||
146171442|NCT01287520|527141015|FG007|Overall Study|Physician Decision|1|||
146171443|NCT01287520|527141016|FG008|Overall Study|Physician Decision|0|||
146171444|NCT01287520|527141008|FG000|Overall Study|Progressive disease|0|||
146171445|NCT01287520|527141009|FG001|Overall Study|Progressive disease|4|||
146171446|NCT01287520|527141010|FG002|Overall Study|Progressive disease|1|||
146171447|NCT01287520|527141011|FG003|Overall Study|Progressive disease|6|||
146171448|NCT01287520|527141012|FG004|Overall Study|Progressive disease|1|||
146171449|NCT01287520|527141013|FG005|Overall Study|Progressive disease|0|||
146171450|NCT01287520|527141014|FG006|Overall Study|Progressive disease|2|||
146171451|NCT01287520|527141015|FG007|Overall Study|Progressive disease|2|||
146171452|NCT01287520|527141016|FG008|Overall Study|Progressive disease|4|||
146171453|NCT01287520|527141008|FG000|Overall Study|Withdrawal by Subject|0|||
146171454|NCT01287520|527141009|FG001|Overall Study|Withdrawal by Subject|0|||
146171455|NCT01287520|527141010|FG002|Overall Study|Withdrawal by Subject|0|||
146171456|NCT01287520|527141011|FG003|Overall Study|Withdrawal by Subject|0|||
146171457|NCT01287520|527141012|FG004|Overall Study|Withdrawal by Subject|0|||
146171458|NCT01287520|527141013|FG005|Overall Study|Withdrawal by Subject|1|||
146171459|NCT01287520|527141014|FG006|Overall Study|Withdrawal by Subject|0|||
146171460|NCT01287520|527141015|FG007|Overall Study|Withdrawal by Subject|0|||
146171461|NCT01287520|527141016|FG008|Overall Study|Withdrawal by Subject|1|||
146402737|NCT00468312|527977568|FG000|Overall Study|Withdrawal by Subject|0|||
146402738|NCT00468312|527977569|FG001|Overall Study|Withdrawal by Subject|1|||
146402739|NCT00468312|527977568|FG000|Overall Study|Protocol Violation|2|||
146402740|NCT00468312|527977569|FG001|Overall Study|Protocol Violation|1|||
146402741|NCT00468312|527977568|FG000|Overall Study|Did not meet protocol eligibility|0|||
146402742|NCT00468312|527977569|FG001|Overall Study|Did not meet protocol eligibility|1|||
146402743|NCT00916617|527977580|FG000|Overall Study|Adverse Event|3|||
146402744|NCT00916617|527977581|FG001|Overall Study|Adverse Event|2|||
146402745|NCT00916617|527977582|FG002|Overall Study|Adverse Event|6|||
146402746|NCT00916617|527977583|FG003|Overall Study|Adverse Event|3|||
146402747|NCT00916617|527977580|FG000|Overall Study|Withdrawal by Subject|3|||
146402748|NCT00916617|527977581|FG001|Overall Study|Withdrawal by Subject|2|||
146402749|NCT00916617|527977582|FG002|Overall Study|Withdrawal by Subject|0|||
146402750|NCT00916617|527977583|FG003|Overall Study|Withdrawal by Subject|1|||
146402751|NCT00916617|527977580|FG000|Overall Study|Caregiver Request|3|||
146402752|NCT00916617|527977581|FG001|Overall Study|Caregiver Request|2|||
146402753|NCT00916617|527977582|FG002|Overall Study|Caregiver Request|1|||
146402754|NCT00916617|527977583|FG003|Overall Study|Caregiver Request|0|||
146402755|NCT00916617|527977580|FG000|Overall Study|Physician Decision|1|||
146402756|NCT00916617|527977581|FG001|Overall Study|Physician Decision|1|||
146402757|NCT00916617|527977582|FG002|Overall Study|Physician Decision|0|||
146402758|NCT00916617|527977583|FG003|Overall Study|Physician Decision|0|||
146402759|NCT00916617|527977580|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
146402760|NCT00916617|527977581|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
146402761|NCT00916617|527977582|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
146402762|NCT00916617|527977583|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
146402763|NCT00916617|527977580|FG000|Overall Study|Lost to Follow-up|2|||
146402764|NCT00916617|527977581|FG001|Overall Study|Lost to Follow-up|1|||
146402765|NCT00916617|527977582|FG002|Overall Study|Lost to Follow-up|0|||
146402766|NCT00916617|527977583|FG003|Overall Study|Lost to Follow-up|0|||
146402767|NCT00916617|527977580|FG000|Overall Study|Lack of Efficacy|1|||
146402768|NCT00916617|527977581|FG001|Overall Study|Lack of Efficacy|0|||
146402769|NCT00916617|527977582|FG002|Overall Study|Lack of Efficacy|0|||
146402770|NCT00916617|527977583|FG003|Overall Study|Lack of Efficacy|0|||
146402771|NCT00916617|527977580|FG000|Overall Study|Other|2|||
146402772|NCT00916617|527977581|FG001|Overall Study|Other|0|||
146402773|NCT00916617|527977582|FG002|Overall Study|Other|0|||
146171462|NCT03587142|527141017|FG000|Overall Study|Lost to Follow-up|5|||
146171463|NCT03587142|527141018|FG001|Overall Study|Lost to Follow-up|3|||
146283845|NCT00092495|527551856|FG002|Base Study Vaccination Period|Other|0|||
146402774|NCT00916617|527977583|FG003|Overall Study|Other|2|||
146402775|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
146171464|NCT03587142|527141017|FG000|Overall Study|Did not complete the f4 visit|3|||
146171465|NCT03587142|527141018|FG001|Overall Study|Did not complete the f4 visit|7|||
146171466|NCT03673462|527141019|FG000|Overall Study|Adverse Event|11|||
146171467|NCT03673462|527141020|FG001|Overall Study|Adverse Event|1|||
146402776|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
146402777|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
146402778|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
146402779|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
146402780|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
146402781|NCT00566631|527977585|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
146402782|NCT00566631|527977585|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
146402783|NCT00566631|527977585|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
146402784|NCT00566631|527977585|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
146402785|NCT00566631|527977585|FG000|Part 2: Extension Phase|Adverse Event|11|||
146402786|NCT00566631|527977585|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
146402787|NCT00566631|527977585|FG000|Part 2: Extension Phase|Death|1|||
146402788|NCT00566631|527977585|FG000|Part 2: Extension Phase|Other|5|||
146402789|NCT02723786|527977587|FG000|Overall Study|Lost to Follow-up|1|||
146402790|NCT03170271|527977592|FG000|Overall Study|Adverse Event|7|||
146402791|NCT03170271|527977593|FG001|Overall Study|Adverse Event|2|||
146402792|NCT03170271|527977592|FG000|Overall Study|Lost to Follow-up|0|||
146402793|NCT03170271|527977593|FG001|Overall Study|Lost to Follow-up|1|||
146402794|NCT03170271|527977592|FG000|Overall Study|Physician Decision|1|||
146402795|NCT03170271|527977593|FG001|Overall Study|Physician Decision|0|||
146402796|NCT03170271|527977592|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
146402797|NCT03170271|527977593|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
146402798|NCT03170271|527977592|FG000|Overall Study|Withdrawal by Subject|17|||
146402799|NCT03170271|527977593|FG001|Overall Study|Withdrawal by Subject|5|||
146402800|NCT03170271|527977592|FG000|Overall Study|Other|2|||
146402801|NCT03170271|527977593|FG001|Overall Study|Other|2|||
146402802|NCT03170271|527977592|FG000|Overall Study|Randomized in error|4|||
146402803|NCT03170271|527977593|FG001|Overall Study|Randomized in error|0|||
146402804|NCT03466060|527977609|FG000|Period 1|Test Lens Damage|0|||
146402805|NCT03466060|527977610|FG001|Period 1|Test Lens Damage|2|||
146402806|NCT03466060|527977611|FG002|Period 1|Test Lens Damage|0|||
146402807|NCT03466060|527977612|FG003|Period 1|Test Lens Damage|0|||
146402808|NCT03466060|527977613|FG004|Period 1|Test Lens Damage|0|||
146402809|NCT03466060|527977614|FG005|Period 1|Test Lens Damage|0|||
146402810|NCT03466060|527977609|FG000|Period 1|Withdrawal by Subject|0|||
146402811|NCT03466060|527977610|FG001|Period 1|Withdrawal by Subject|0|||
146402812|NCT03466060|527977611|FG002|Period 1|Withdrawal by Subject|2|||
146402813|NCT03466060|527977612|FG003|Period 1|Withdrawal by Subject|0|||
146402814|NCT03466060|527977613|FG004|Period 1|Withdrawal by Subject|0|||
146402815|NCT03466060|527977614|FG005|Period 1|Withdrawal by Subject|0|||
146402816|NCT03466060|527977609|FG000|Period 1|Lost to Follow-up|0|||
146402817|NCT03466060|527977610|FG001|Period 1|Lost to Follow-up|0|||
146402818|NCT03466060|527977611|FG002|Period 1|Lost to Follow-up|0|||
146402819|NCT03466060|527977612|FG003|Period 1|Lost to Follow-up|1|||
146402820|NCT03466060|527977613|FG004|Period 1|Lost to Follow-up|0|||
146402821|NCT03466060|527977614|FG005|Period 1|Lost to Follow-up|0|||
146402822|NCT03466060|527977609|FG000|Period 1|Grade 2 Conjunctivitis|0|||
146402823|NCT03466060|527977610|FG001|Period 1|Grade 2 Conjunctivitis|0|||
146402824|NCT03466060|527977611|FG002|Period 1|Grade 2 Conjunctivitis|1|||
146402825|NCT03466060|527977612|FG003|Period 1|Grade 2 Conjunctivitis|0|||
146402826|NCT03466060|527977613|FG004|Period 1|Grade 2 Conjunctivitis|0|||
146402827|NCT03466060|527977614|FG005|Period 1|Grade 2 Conjunctivitis|0|||
146402828|NCT03466060|527977609|FG000|Period 2|Lens Handling Difficulties|0|||
146402829|NCT03466060|527977610|FG001|Period 2|Lens Handling Difficulties|0|||
145945241|NCT01606202|526308186|FG001|Overall Study|Withdrawal by Subject|1|||
146062713|NCT05194124|526748315|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146402830|NCT03466060|527977611|FG002|Period 2|Lens Handling Difficulties|1|||
146402831|NCT03466060|527977612|FG003|Period 2|Lens Handling Difficulties|0|||
146402832|NCT03466060|527977613|FG004|Period 2|Lens Handling Difficulties|0|||
146402833|NCT03466060|527977614|FG005|Period 2|Lens Handling Difficulties|0|||
146402834|NCT03701516|527977615|FG000|Period 1|Lost to Follow-up|0|||
146402835|NCT03701516|527977616|FG001|Period 1|Lost to Follow-up|1|||
146402836|NCT03701516|527977615|FG000|Period 1|Adverse Event|0|||
146402837|NCT03701516|527977616|FG001|Period 1|Adverse Event|2|||
146402838|NCT03701516|527977615|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
146402839|NCT03701516|527977616|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146402840|NCT03701516|527977615|FG000|Period 1|Non Compliance to Protocol|2|||
146402841|NCT03701516|527977616|FG001|Period 1|Non Compliance to Protocol|1|||
146402842|NCT03701516|527977615|FG000|Period 1|Withdrawal by Subject|0|||
146402843|NCT03701516|527977616|FG001|Period 1|Withdrawal by Subject|1|||
146402844|NCT03701516|527977615|FG000|Period 2|failed to meet all eligibility creiteria|1|||
146402845|NCT03701516|527977616|FG001|Period 2|failed to meet all eligibility creiteria|0|||
146402846|NCT03701516|527977615|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
146402847|NCT03701516|527977616|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
146402848|NCT03644927|527977621|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
146402849|NCT03644927|527977622|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
146402850|NCT00956813|527977623|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
146402851|NCT00956813|527977624|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
146402852|NCT00956813|527977623|FG000|Flaxseed and Placebo|Ineligible|3|||
146402853|NCT00956813|527977624|FG001|Flaxseed and Placebo|Ineligible|1|||
146402854|NCT04797637|527977625|FG000|Overall Study|Lost to Follow-up|23|||
146402855|NCT04797637|527977626|FG001|Overall Study|Lost to Follow-up|32|||
146402856|NCT04797637|527977625|FG000|Overall Study|Withdrawal by Subject|0|||
146402857|NCT04797637|527977626|FG001|Overall Study|Withdrawal by Subject|1|||
146402858|NCT02864953|527977629|FG000|Overall Study|Adverse Event|22|||
146402859|NCT02864953|527977630|FG001|Overall Study|Adverse Event|19|||
146402860|NCT02864953|527977629|FG000|Overall Study|Withdrawal by Subject|1|||
146402861|NCT02864953|527977630|FG001|Overall Study|Withdrawal by Subject|0|||
146402862|NCT02864953|527977629|FG000|Overall Study|Physician Decision|4|||
146402863|NCT02864953|527977630|FG001|Overall Study|Physician Decision|2|||
146402864|NCT02864953|527977629|FG000|Overall Study|Death|3|||
146402865|NCT02864953|527977630|FG001|Overall Study|Death|13|||
146402866|NCT02864953|527977629|FG000|Overall Study|Reason not specified|14|||
146402867|NCT02864953|527977630|FG001|Overall Study|Reason not specified|12|||
146402868|NCT02864953|527977629|FG000|Overall Study|Withdrew Prior to Dosing|9|||
146402869|NCT02864953|527977630|FG001|Overall Study|Withdrew Prior to Dosing|8|||
146402870|NCT00981019|527977631|FG000|Overall Study|Did not respond|65|||
146402871|NCT00981019|527977631|FG000|Overall Study|Did not match target population|94|||
146402872|NCT00981019|527977631|FG000|Overall Study|Inadvertent exclusion|239|||
146402873|NCT00981019|527977631|FG000|Overall Study|Hit the survey after closure|79|||
146402874|NCT05083559|527977632|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
146402875|NCT05083559|527977633|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
146402876|NCT05083559|527977632|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
146402877|NCT05083559|527977633|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
146402878|NCT05083559|527977632|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
146402879|NCT05083559|527977633|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
146402880|NCT00690573|527977641|FG000|Overall Study|Lack of Efficacy|8|||
146402881|NCT00690573|527977641|FG000|Overall Study|Withdrawal by Subject|1|||
146402882|NCT02392377|527977642|FG000|Overall Study|Withdrawal by Subject|0|||
146402883|NCT02392377|527977643|FG001|Overall Study|Withdrawal by Subject|1|||
146402884|NCT01126359|527977646|FG000|First Intervention (20-minutes)|Physician Decision|0|||
146402885|NCT01126359|527977647|FG001|First Intervention (20-minutes)|Physician Decision|1|||
146402886|NCT00902486|527977648|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146402887|NCT00902486|527977649|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
146402888|NCT00902486|527977650|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
146402889|NCT00902486|527977651|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146402890|NCT00902486|527977652|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
146402891|NCT00902486|527977653|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
146402892|NCT00902486|527977648|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
146402893|NCT00902486|527977649|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146402894|NCT00902486|527977650|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146402895|NCT00902486|527977651|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146402896|NCT00902486|527977652|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
146402897|NCT00902486|527977653|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
146402898|NCT00902486|527977648|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146402899|NCT00902486|527977649|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146402900|NCT00902486|527977650|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146402901|NCT00902486|527977651|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
146402902|NCT00902486|527977652|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
146402903|NCT00902486|527977653|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
146402904|NCT00902486|527977648|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146402905|NCT00902486|527977649|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146402906|NCT00902486|527977650|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146402907|NCT00902486|527977651|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
146402908|NCT00902486|527977652|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146402909|NCT00902486|527977653|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
146402910|NCT00902486|527977648|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146402911|NCT00902486|527977649|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146402912|NCT00902486|527977650|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146402913|NCT00902486|527977651|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
146402914|NCT00902486|527977652|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146402915|NCT00902486|527977653|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
146402916|NCT00902486|527977648|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146402917|NCT00902486|527977649|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146402918|NCT00902486|527977650|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146402919|NCT00902486|527977651|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
146402920|NCT00902486|527977652|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
146402921|NCT00902486|527977653|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
146402922|NCT00902486|527977648|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146402923|NCT00902486|527977649|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146402924|NCT00902486|527977650|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
146402925|NCT00902486|527977651|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
146402926|NCT00902486|527977652|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146402927|NCT00902486|527977653|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
146402928|NCT00902486|527977648|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146402929|NCT00902486|527977649|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146402930|NCT00902486|527977650|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146402931|NCT00902486|527977651|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146402932|NCT00902486|527977652|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
146402933|NCT00902486|527977653|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
146402934|NCT00902486|527977648|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146402935|NCT00902486|527977649|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146402936|NCT00902486|527977650|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146402937|NCT00902486|527977651|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
146402938|NCT00902486|527977652|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146402939|NCT00902486|527977653|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
146402940|NCT00902486|527977648|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146402941|NCT00902486|527977649|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146402942|NCT00902486|527977650|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
146402943|NCT00902486|527977651|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146402944|NCT00902486|527977652|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146402945|NCT00902486|527977653|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
146402946|NCT00902486|527977648|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
146402947|NCT00902486|527977649|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
146402948|NCT00902486|527977650|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
146402949|NCT00902486|527977651|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
146402950|NCT00902486|527977652|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
146402951|NCT00902486|527977653|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
146402952|NCT02332655|527977654|FG000|Overall Study|Lack of Efficacy|1|||
146402953|NCT01298661|527977655|FG000|Overall Study|Withdrawal by Subject|2|||
146402954|NCT01298661|527977656|FG001|Overall Study|Withdrawal by Subject|0|||
146402955|NCT01298661|527977657|FG002|Overall Study|Withdrawal by Subject|2|||
146402956|NCT00526227|527977658|FG000|Overall Study|Device not implanted|1|||
146402957|NCT00526227|527977658|FG000|Overall Study|Death|1|||
146402958|NCT05378269|527979376|FG000|Overall Study|Protocol Violation|1|||
146402959|NCT05378269|527979377|FG001|Overall Study|Protocol Violation|0|||
146402960|NCT05378269|527979378|FG002|Overall Study|Protocol Violation|2|||
146402961|NCT05378269|527979379|FG003|Overall Study|Protocol Violation|0|||
146402962|NCT05378269|527979380|FG004|Overall Study|Protocol Violation|0|||
146402963|NCT00684645|527979381|FG000|Overall Study|Death|2|||
146402964|NCT00684645|527979381|FG000|Overall Study|Progressive disease|67|||
146402965|NCT00684645|527979381|FG000|Overall Study|Adverse Event|27|||
146402966|NCT00684645|527979381|FG000|Overall Study|Lost to Follow-up|3|||
146402967|NCT00684645|527979381|FG000|Overall Study|Other|15|||
146402968|NCT01186744|527979382|FG000|Overall Study|Lack of Efficacy|156|||
146402969|NCT01186744|527979383|FG001|Overall Study|Lack of Efficacy|99|||
146402970|NCT01186744|527979384|FG002|Overall Study|Lack of Efficacy|0|||
146402971|NCT01186744|527979385|FG003|Overall Study|Lack of Efficacy|2|||
146402972|NCT01186744|527979386|FG004|Overall Study|Lack of Efficacy|2|||
146402973|NCT01186744|527979387|FG005|Overall Study|Lack of Efficacy|5|||
146402974|NCT01186744|527979382|FG000|Overall Study|Protocol Violation|1|||
146402975|NCT01186744|527979383|FG001|Overall Study|Protocol Violation|2|||
146402976|NCT01186744|527979384|FG002|Overall Study|Protocol Violation|0|||
146402977|NCT01186744|527979385|FG003|Overall Study|Protocol Violation|1|||
146402978|NCT01186744|527979386|FG004|Overall Study|Protocol Violation|1|||
146402979|NCT01186744|527979387|FG005|Overall Study|Protocol Violation|2|||
146402980|NCT01186744|527979382|FG000|Overall Study|Lost to Follow-up|15|||
146402981|NCT01186744|527979383|FG001|Overall Study|Lost to Follow-up|16|||
146402982|NCT01186744|527979384|FG002|Overall Study|Lost to Follow-up|2|||
146402983|NCT01186744|527979385|FG003|Overall Study|Lost to Follow-up|1|||
146402984|NCT01186744|527979386|FG004|Overall Study|Lost to Follow-up|1|||
146402985|NCT01186744|527979387|FG005|Overall Study|Lost to Follow-up|4|||
146402986|NCT01186744|527979382|FG000|Overall Study|Screen failure|1|||
146402987|NCT01186744|527979383|FG001|Overall Study|Screen failure|1|||
146402988|NCT01186744|527979384|FG002|Overall Study|Screen failure|0|||
146402989|NCT01186744|527979385|FG003|Overall Study|Screen failure|1|||
146402990|NCT01186744|527979386|FG004|Overall Study|Screen failure|0|||
146402991|NCT01186744|527979387|FG005|Overall Study|Screen failure|0|||
146402992|NCT01186744|527979382|FG000|Overall Study|Withdrawal by Subject|14|||
146402993|NCT01186744|527979383|FG001|Overall Study|Withdrawal by Subject|10|||
146402994|NCT01186744|527979384|FG002|Overall Study|Withdrawal by Subject|2|||
146402995|NCT01186744|527979385|FG003|Overall Study|Withdrawal by Subject|5|||
146402996|NCT01186744|527979386|FG004|Overall Study|Withdrawal by Subject|0|||
146402997|NCT01186744|527979387|FG005|Overall Study|Withdrawal by Subject|6|||
146402998|NCT01186744|527979382|FG000|Overall Study|Study terminated by Sponsor|1|||
146402999|NCT01186744|527979383|FG001|Overall Study|Study terminated by Sponsor|0|||
146403000|NCT01186744|527979384|FG002|Overall Study|Study terminated by Sponsor|0|||
146403001|NCT01186744|527979385|FG003|Overall Study|Study terminated by Sponsor|0|||
146403002|NCT01186744|527979386|FG004|Overall Study|Study terminated by Sponsor|0|||
146403003|NCT01186744|527979387|FG005|Overall Study|Study terminated by Sponsor|0|||
146403004|NCT01186744|527979382|FG000|Overall Study|Other|9|||
146403005|NCT01186744|527979383|FG001|Overall Study|Other|10|||
146403006|NCT01186744|527979384|FG002|Overall Study|Other|1|||
146403007|NCT01186744|527979385|FG003|Overall Study|Other|2|||
146403008|NCT01186744|527979386|FG004|Overall Study|Other|1|||
146403009|NCT01186744|527979387|FG005|Overall Study|Other|5|||
146403010|NCT01186744|527979382|FG000|Overall Study|Adverse Event|10|||
146403011|NCT01186744|527979383|FG001|Overall Study|Adverse Event|14|||
146403012|NCT01186744|527979384|FG002|Overall Study|Adverse Event|1|||
146403013|NCT01186744|527979385|FG003|Overall Study|Adverse Event|0|||
146403014|NCT01186744|527979386|FG004|Overall Study|Adverse Event|1|||
146403015|NCT01186744|527979387|FG005|Overall Study|Adverse Event|4|||
146403016|NCT01186744|527979382|FG000|Overall Study|Death|1|||
146403017|NCT01186744|527979383|FG001|Overall Study|Death|0|||
146403018|NCT01186744|527979384|FG002|Overall Study|Death|0|||
146403019|NCT01186744|527979385|FG003|Overall Study|Death|0|||
146403020|NCT01186744|527979386|FG004|Overall Study|Death|0|||
146403021|NCT01186744|527979387|FG005|Overall Study|Death|0|||
146403022|NCT02325401|527979390|FG000|Overall Study|Withdrawal by Subject|0|||
146403023|NCT02325401|527979391|FG001|Overall Study|Withdrawal by Subject|1|||
146403024|NCT02325401|527979392|FG002|Overall Study|Withdrawal by Subject|1|||
146403025|NCT01956123|527979393|FG000|COS Cycle 2|Protocol Violation|8|||
146403026|NCT01956123|527979394|FG001|COS Cycle 2|Protocol Violation|3|||
146403027|NCT01956123|527979395|FG002|COS Cycle 2|Protocol Violation|0|||
146403028|NCT01956123|527979396|FG003|COS Cycle 2|Protocol Violation|0|||
146403029|NCT01956123|527979393|FG000|COS Cycle 2|Adverse Event|3|||
146403030|NCT01956123|527979394|FG001|COS Cycle 2|Adverse Event|4|||
146403031|NCT01956123|527979395|FG002|COS Cycle 2|Adverse Event|0|||
146403032|NCT01956123|527979396|FG003|COS Cycle 2|Adverse Event|0|||
146403033|NCT01956123|527979393|FG000|COS Cycle 2|Personal Reasons|2|||
146403034|NCT01956123|527979394|FG001|COS Cycle 2|Personal Reasons|0|||
146403035|NCT01956123|527979395|FG002|COS Cycle 2|Personal Reasons|0|||
146403036|NCT01956123|527979396|FG003|COS Cycle 2|Personal Reasons|0|||
146403037|NCT01956123|527979393|FG000|COS Cycle 2|Withdrawal by Subject|1|||
146403038|NCT01956123|527979394|FG001|COS Cycle 2|Withdrawal by Subject|0|||
146403039|NCT01956123|527979395|FG002|COS Cycle 2|Withdrawal by Subject|0|||
146403040|NCT01956123|527979396|FG003|COS Cycle 2|Withdrawal by Subject|0|||
146403041|NCT01956123|527979393|FG000|COS Cycle 3|Protocol Violation|0|||
146403042|NCT01956123|527979394|FG001|COS Cycle 3|Protocol Violation|0|||
146403043|NCT01956123|527979395|FG002|COS Cycle 3|Protocol Violation|2|||
146403044|NCT01956123|527979396|FG003|COS Cycle 3|Protocol Violation|1|||
146403045|NCT01956123|527979393|FG000|COS Cycle 3|Adverse Event|0|||
146403046|NCT01956123|527979394|FG001|COS Cycle 3|Adverse Event|0|||
146403047|NCT01956123|527979395|FG002|COS Cycle 3|Adverse Event|3|||
146403048|NCT01956123|527979396|FG003|COS Cycle 3|Adverse Event|0|||
146403049|NCT01956123|527979393|FG000|COS Cycle 3|Personal Reasons|0|||
146403050|NCT01956123|527979394|FG001|COS Cycle 3|Personal Reasons|0|||
146403051|NCT01956123|527979395|FG002|COS Cycle 3|Personal Reasons|1|||
146403052|NCT01956123|527979396|FG003|COS Cycle 3|Personal Reasons|0|||
146403053|NCT01956123|527979393|FG000|COS Cycle 3|Withdrawal by Subject|0|||
146403054|NCT01956123|527979394|FG001|COS Cycle 3|Withdrawal by Subject|0|||
146403055|NCT01956123|527979395|FG002|COS Cycle 3|Withdrawal by Subject|0|||
146403056|NCT01956123|527979396|FG003|COS Cycle 3|Withdrawal by Subject|1|||
146403057|NCT01461369|527979397|FG000|Overall Study|Lack of Efficacy|2|||
146403058|NCT01461369|527979398|FG001|Overall Study|Lack of Efficacy|0|||
146403059|NCT01461369|527979399|FG002|Overall Study|Lack of Efficacy|6|||
146403060|NCT01461369|527979397|FG000|Overall Study|Lost to Follow-up|0|||
146403061|NCT01461369|527979398|FG001|Overall Study|Lost to Follow-up|0|||
146403062|NCT01461369|527979399|FG002|Overall Study|Lost to Follow-up|3|||
146403063|NCT01461369|527979397|FG000|Overall Study|Adverse Event|9|||
146403064|NCT01461369|527979398|FG001|Overall Study|Adverse Event|12|||
146403065|NCT01461369|527979399|FG002|Overall Study|Adverse Event|4|||
146403066|NCT01461369|527979397|FG000|Overall Study|Protocol Violation|1|||
146403067|NCT01461369|527979398|FG001|Overall Study|Protocol Violation|2|||
146403068|NCT01461369|527979399|FG002|Overall Study|Protocol Violation|2|||
146403069|NCT01461369|527979397|FG000|Overall Study|Withdrawal by Subject|1|||
146403070|NCT01461369|527979398|FG001|Overall Study|Withdrawal by Subject|3|||
146403071|NCT01461369|527979399|FG002|Overall Study|Withdrawal by Subject|2|||
146403072|NCT02886494|527979406|FG000|Overall Study|Adverse Event|1|||
146403073|NCT02886494|527979407|FG001|Overall Study|Adverse Event|0|||
146403074|NCT02886494|527979406|FG000|Overall Study|Withdrawal by Subject|12|||
146403075|NCT02886494|527979407|FG001|Overall Study|Withdrawal by Subject|3|||
146403076|NCT02886494|527979406|FG000|Overall Study|Protocol Violation|4|||
146403077|NCT02886494|527979407|FG001|Overall Study|Protocol Violation|1|||
146403078|NCT00499252|527979413|FG000|Overall Study|Adverse Event|3|||
146403079|NCT00499252|527979413|FG000|Overall Study|Refused further treatment|2|||
146403080|NCT00499252|527979413|FG000|Overall Study|Ineligible|4|||
146403081|NCT00499252|527979413|FG000|Overall Study|<no further label>|3|||
146403082|NCT00556166|527979420|FG000|Overall Study|Withdrawal by Subject|1|||
146403083|NCT01612780|527979421|FG000|Overall Study|Treatment not completed|1|||
146403084|NCT01612780|527979421|FG000|Overall Study|Withdrawal by Subject|5|||
146403085|NCT02985515|527979424|FG000|Olfaction Testing|Lost to Follow-up|0|||
146403086|NCT02985515|527979425|FG001|Olfaction Testing|Lost to Follow-up|5|||
146403087|NCT02985515|527979424|FG000|Olfaction Testing|Protocol Violation|0|||
146403088|NCT02985515|527979425|FG001|Olfaction Testing|Protocol Violation|3|||
146403089|NCT03359473|527979426|FG000|Overall Study|Adverse Event|0|||
146403090|NCT03359473|527979427|FG001|Overall Study|Adverse Event|2|||
146403091|NCT03359473|527979428|FG002|Overall Study|Adverse Event|5|||
146403092|NCT03359473|527979429|FG003|Overall Study|Adverse Event|3|||
146403093|NCT03359473|527979426|FG000|Overall Study|Lost to Follow-up|0|||
146403094|NCT03359473|527979427|FG001|Overall Study|Lost to Follow-up|1|||
146403095|NCT03359473|527979428|FG002|Overall Study|Lost to Follow-up|0|||
146403096|NCT03359473|527979429|FG003|Overall Study|Lost to Follow-up|0|||
146403097|NCT03359473|527979426|FG000|Overall Study|Physician Decision|0|||
146403098|NCT03359473|527979427|FG001|Overall Study|Physician Decision|1|||
146403099|NCT03359473|527979428|FG002|Overall Study|Physician Decision|0|||
146403100|NCT03359473|527979429|FG003|Overall Study|Physician Decision|1|||
146403101|NCT03359473|527979426|FG000|Overall Study|Withdrawal by Subject|1|||
146403102|NCT03359473|527979427|FG001|Overall Study|Withdrawal by Subject|2|||
146403103|NCT03359473|527979428|FG002|Overall Study|Withdrawal by Subject|1|||
146403104|NCT03359473|527979429|FG003|Overall Study|Withdrawal by Subject|0|||
146403105|NCT03359473|527979426|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146403106|NCT03359473|527979427|FG001|Overall Study|Protocol-defined stopping criteria|0|||
146403107|NCT03359473|527979428|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146403108|NCT03359473|527979429|FG003|Overall Study|Protocol-defined stopping criteria|1|||
146403109|NCT05302414|527979430|FG000|Pretest to Posttest|Lost to Follow-up|12|||
146403110|NCT05302414|527979431|FG001|Pretest to Posttest|Lost to Follow-up|8|||
146403111|NCT05302414|527979432|FG002|Pretest to Posttest|Lost to Follow-up|8|||
146403112|NCT05302414|527979430|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146403113|NCT05302414|527979431|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146403114|NCT05302414|527979432|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
146403115|NCT00424632|527979435|FG000|Overall Study|Death|0|||
146403116|NCT00424632|527979436|FG001|Overall Study|Death|0|||
146403117|NCT00424632|527979437|FG002|Overall Study|Death|0|||
146403118|NCT00424632|527979438|FG003|Overall Study|Death|0|||
146403119|NCT00424632|527979439|FG004|Overall Study|Death|0|||
146403120|NCT00424632|527979440|FG005|Overall Study|Death|2|||
146403121|NCT00424632|527979441|FG006|Overall Study|Death|0|||
146403122|NCT00424632|527979442|FG007|Overall Study|Death|0|||
146403123|NCT00424632|527979443|FG008|Overall Study|Death|0|||
146403124|NCT00424632|527979444|FG009|Overall Study|Death|0|||
146403125|NCT00424632|527979435|FG000|Overall Study|Adverse Event|0|||
146403126|NCT00424632|527979436|FG001|Overall Study|Adverse Event|0|||
146403127|NCT00424632|527979437|FG002|Overall Study|Adverse Event|0|||
146403128|NCT00424632|527979438|FG003|Overall Study|Adverse Event|0|||
146403129|NCT00424632|527979439|FG004|Overall Study|Adverse Event|0|||
146403130|NCT00424632|527979440|FG005|Overall Study|Adverse Event|0|||
146403131|NCT00424632|527979441|FG006|Overall Study|Adverse Event|0|||
146403132|NCT00424632|527979442|FG007|Overall Study|Adverse Event|0|||
146403133|NCT00424632|527979443|FG008|Overall Study|Adverse Event|3|||
146403134|NCT00424632|527979444|FG009|Overall Study|Adverse Event|2|||
146403135|NCT00424632|527979435|FG000|Overall Study|Global deterioration of health status|0|||
146403136|NCT00424632|527979436|FG001|Overall Study|Global deterioration of health status|0|||
146403137|NCT00424632|527979437|FG002|Overall Study|Global deterioration of health status|0|||
146403138|NCT00424632|527979438|FG003|Overall Study|Global deterioration of health status|1|||
146403139|NCT00424632|527979439|FG004|Overall Study|Global deterioration of health status|1|||
146403140|NCT00424632|527979440|FG005|Overall Study|Global deterioration of health status|0|||
146403141|NCT00424632|527979441|FG006|Overall Study|Global deterioration of health status|0|||
146403142|NCT00424632|527979442|FG007|Overall Study|Global deterioration of health status|0|||
146403143|NCT00424632|527979443|FG008|Overall Study|Global deterioration of health status|0|||
146403144|NCT00424632|527979444|FG009|Overall Study|Global deterioration of health status|0|||
146403145|NCT00424632|527979435|FG000|Overall Study|Objective progression or relapse|1|||
146403146|NCT00424632|527979436|FG001|Overall Study|Objective progression or relapse|1|||
146403147|NCT00424632|527979437|FG002|Overall Study|Objective progression or relapse|1|||
146403148|NCT00424632|527979438|FG003|Overall Study|Objective progression or relapse|2|||
146403149|NCT00424632|527979439|FG004|Overall Study|Objective progression or relapse|2|||
146403150|NCT00424632|527979440|FG005|Overall Study|Objective progression or relapse|13|||
146403151|NCT00424632|527979441|FG006|Overall Study|Objective progression or relapse|7|||
146403152|NCT00424632|527979442|FG007|Overall Study|Objective progression or relapse|3|||
146403153|NCT00424632|527979443|FG008|Overall Study|Objective progression or relapse|12|||
146403154|NCT00424632|527979444|FG009|Overall Study|Objective progression or relapse|4|||
146403155|NCT00424632|527979435|FG000|Overall Study|Other|0|||
146403156|NCT00424632|527979436|FG001|Overall Study|Other|0|||
146403157|NCT00424632|527979437|FG002|Overall Study|Other|0|||
146403158|NCT00424632|527979438|FG003|Overall Study|Other|1|||
146403159|NCT00424632|527979439|FG004|Overall Study|Other|0|||
146403160|NCT00424632|527979440|FG005|Overall Study|Other|0|||
146403161|NCT00424632|527979441|FG006|Overall Study|Other|0|||
146403162|NCT00424632|527979442|FG007|Overall Study|Other|0|||
146403163|NCT00424632|527979443|FG008|Overall Study|Other|1|||
146403164|NCT00424632|527979444|FG009|Overall Study|Other|0|||
146403165|NCT02628418|527979445|FG000|Overall Study|Lost to Follow-up|1|||
146403166|NCT02628418|527979446|FG001|Overall Study|Lost to Follow-up|2|||
146403167|NCT01071083|527979450|FG000|Overall Study|Adverse Event|1|||
146403168|NCT01071083|527979451|FG001|Overall Study|Adverse Event|0|||
146403169|NCT01071083|527979452|FG002|Overall Study|Adverse Event|1|||
146403170|NCT01071083|527979453|FG003|Overall Study|Adverse Event|0|||
146403171|NCT01071083|527979454|FG004|Overall Study|Adverse Event|1|||
146403172|NCT01071083|527979450|FG000|Overall Study|Withdrawal by Subject|3|||
146403173|NCT01071083|527979451|FG001|Overall Study|Withdrawal by Subject|0|||
146403174|NCT01071083|527979452|FG002|Overall Study|Withdrawal by Subject|2|||
146403175|NCT01071083|527979453|FG003|Overall Study|Withdrawal by Subject|0|||
146403176|NCT01071083|527979454|FG004|Overall Study|Withdrawal by Subject|3|||
146403177|NCT01071083|527979450|FG000|Overall Study|Physician Decision|1|||
146403178|NCT01071083|527979451|FG001|Overall Study|Physician Decision|0|||
146403179|NCT01071083|527979452|FG002|Overall Study|Physician Decision|0|||
146403180|NCT01071083|527979453|FG003|Overall Study|Physician Decision|1|||
146403181|NCT01071083|527979454|FG004|Overall Study|Physician Decision|1|||
146403182|NCT01071083|527979450|FG000|Overall Study|Early Rescue|1|||
146403183|NCT01071083|527979451|FG001|Overall Study|Early Rescue|0|||
146403184|NCT01071083|527979452|FG002|Overall Study|Early Rescue|0|||
146403185|NCT01071083|527979453|FG003|Overall Study|Early Rescue|0|||
146403186|NCT01071083|527979454|FG004|Overall Study|Early Rescue|1|||
146403187|NCT01071083|527979450|FG000|Overall Study|Subject Moved|0|||
146403188|NCT01071083|527979451|FG001|Overall Study|Subject Moved|1|||
146403189|NCT01071083|527979452|FG002|Overall Study|Subject Moved|0|||
146403190|NCT01071083|527979453|FG003|Overall Study|Subject Moved|0|||
146403191|NCT01071083|527979454|FG004|Overall Study|Subject Moved|0|||
146403192|NCT01071083|527979450|FG000|Overall Study|Images Not Usable (Motion)|0|||
146403193|NCT01071083|527979451|FG001|Overall Study|Images Not Usable (Motion)|1|||
146403194|NCT01071083|527979452|FG002|Overall Study|Images Not Usable (Motion)|0|||
146403195|NCT01071083|527979453|FG003|Overall Study|Images Not Usable (Motion)|0|||
146403196|NCT01071083|527979454|FG004|Overall Study|Images Not Usable (Motion)|0|||
146403197|NCT01071083|527979450|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146403198|NCT01071083|527979451|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146403199|NCT01071083|527979452|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
146403200|NCT01071083|527979453|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
146403201|NCT01071083|527979454|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
146403202|NCT01071083|527979450|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
146403203|NCT01071083|527979451|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
146403204|NCT01071083|527979452|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
146403205|NCT01071083|527979453|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
146403206|NCT01071083|527979454|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
146403207|NCT01071083|527979450|FG000|Overall Study|Subject Refused to Continue|1|||
146403208|NCT01071083|527979451|FG001|Overall Study|Subject Refused to Continue|0|||
146403209|NCT01071083|527979452|FG002|Overall Study|Subject Refused to Continue|0|||
146403210|NCT01071083|527979453|FG003|Overall Study|Subject Refused to Continue|0|||
146403211|NCT01071083|527979454|FG004|Overall Study|Subject Refused to Continue|0|||
146403212|NCT01523301|527979455|FG000|Overall Study|Adverse Event|25|||
146403213|NCT01523301|527979456|FG001|Overall Study|Adverse Event|16|||
146403214|NCT01523301|527979455|FG000|Overall Study|Lack of Efficacy|0|||
146403215|NCT01523301|527979456|FG001|Overall Study|Lack of Efficacy|2|||
146403216|NCT01523301|527979455|FG000|Overall Study|Protocol Violation|3|||
146403217|NCT01523301|527979456|FG001|Overall Study|Protocol Violation|4|||
146403218|NCT01523301|527979455|FG000|Overall Study|Lost to Follow-up|1|||
146403219|NCT01523301|527979456|FG001|Overall Study|Lost to Follow-up|0|||
146403220|NCT01523301|527979455|FG000|Overall Study|Withdrawal by Subject|6|||
146403221|NCT01523301|527979456|FG001|Overall Study|Withdrawal by Subject|8|||
146403222|NCT01523301|527979455|FG000|Overall Study|Other Reason|0|||
146403223|NCT01523301|527979456|FG001|Overall Study|Other Reason|2|||
146403224|NCT01339000|527979457|FG000|Overall Study|study closed due to lack of drug supply|1|||
146403225|NCT01339000|527979458|FG001|Overall Study|study closed due to lack of drug supply|0|||
146403226|NCT00728988|527979459|FG000|Overall Study|Not Treated|2|||
146403227|NCT00728988|527979460|FG001|Overall Study|Not Treated|2|||
146403228|NCT00728988|527979459|FG000|Overall Study|Death|1|||
146403229|NCT00728988|527979460|FG001|Overall Study|Death|1|||
146403230|NCT00728988|527979459|FG000|Overall Study|Adverse Event|3|||
146403231|NCT00728988|527979460|FG001|Overall Study|Adverse Event|2|||
146403232|NCT00728988|527979459|FG000|Overall Study|Other|85|||
146403233|NCT00728988|527979460|FG001|Overall Study|Other|77|||
146403234|NCT00728988|527979459|FG000|Overall Study|Withdrawal by Subject|2|||
146403235|NCT00728988|527979460|FG001|Overall Study|Withdrawal by Subject|6|||
146403236|NCT05674721|527979463|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
146403237|NCT05674721|527979464|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
146403238|NCT05674721|527979463|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
146403239|NCT05674721|527979464|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
146403240|NCT05013749|527979472|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
146403241|NCT05013749|527979473|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
146403242|NCT05013749|527979472|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
146403243|NCT05013749|527979473|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
146403244|NCT02017535|527979474|FG000|Overall Study|Withdrawal by Subject|1|||
146403245|NCT02017535|527979475|FG001|Overall Study|Withdrawal by Subject|0|||
146403246|NCT02017535|527979476|FG002|Overall Study|Withdrawal by Subject|0|||
146403247|NCT02017535|527979477|FG003|Overall Study|Withdrawal by Subject|0|||
146403248|NCT03506425|527979478|FG000|Overall Study|Adverse Event|1|||
146403249|NCT03506425|527979479|FG001|Overall Study|Adverse Event|3|||
146403250|NCT03506425|527979480|FG002|Overall Study|Adverse Event|0|||
146403251|NCT03506425|527979478|FG000|Overall Study|Death|1|||
146403252|NCT03506425|527979479|FG001|Overall Study|Death|0|||
146403253|NCT03506425|527979480|FG002|Overall Study|Death|0|||
146403254|NCT03506425|527979478|FG000|Overall Study|Withdrawal by Subject|0|||
146403255|NCT03506425|527979479|FG001|Overall Study|Withdrawal by Subject|0|||
146403256|NCT03506425|527979480|FG002|Overall Study|Withdrawal by Subject|1|||
146403257|NCT02380248|527979481|FG000|Overall Study|Lost to Follow-up|11|||
146403258|NCT02380248|527979481|FG000|Overall Study|Withdrawal by Subject|3|||
146403259|NCT02666768|527979482|FG000|Overall Study|Withdrawal by Subject|4|||
146403260|NCT01023022|527979483|FG000|Overall Study|Death|5|||
146403261|NCT01023022|527979483|FG000|Overall Study|Lost to Follow-up|7|||
146403262|NCT01023022|527979483|FG000|Overall Study|due to technical issues|2|||
146403263|NCT00621309|527979485|FG000|Overall Study|Withdrawal by Subject|2|||
146403264|NCT00621309|527979486|FG001|Overall Study|Withdrawal by Subject|0|||
146403265|NCT00621309|527979487|FG002|Overall Study|Withdrawal by Subject|1|||
146403266|NCT00621309|527979488|FG003|Overall Study|Withdrawal by Subject|1|||
146403267|NCT00621309|527979489|FG004|Overall Study|Withdrawal by Subject|1|||
146403268|NCT00621309|527979490|FG005|Overall Study|Withdrawal by Subject|1|||
146403269|NCT01306968|527979491|FG000|Overall Study|Lost to Follow-up|1|||
146403270|NCT01306968|527979492|FG001|Overall Study|Lost to Follow-up|1|||
146403271|NCT01306968|527979493|FG002|Overall Study|Lost to Follow-up|0|||
146403272|NCT01306968|527979494|FG003|Overall Study|Lost to Follow-up|0|||
146403273|NCT01306968|527979491|FG000|Overall Study|Physician Decision|0|||
146403274|NCT01306968|527979492|FG001|Overall Study|Physician Decision|1|||
146403275|NCT01306968|527979493|FG002|Overall Study|Physician Decision|0|||
146403276|NCT01306968|527979494|FG003|Overall Study|Physician Decision|0|||
146403277|NCT01306968|527979491|FG000|Overall Study|Relocated and left active duty|0|||
146403278|NCT01306968|527979492|FG001|Overall Study|Relocated and left active duty|1|||
146403279|NCT01306968|527979493|FG002|Overall Study|Relocated and left active duty|1|||
146403280|NCT01306968|527979494|FG003|Overall Study|Relocated and left active duty|1|||
146403281|NCT01306968|527979491|FG000|Overall Study|Withdrew - time commitment|0|||
146403282|NCT01306968|527979492|FG001|Overall Study|Withdrew - time commitment|0|||
146403283|NCT01306968|527979493|FG002|Overall Study|Withdrew - time commitment|0|||
146403284|NCT01306968|527979494|FG003|Overall Study|Withdrew - time commitment|2|||
146403285|NCT01306968|527979491|FG000|Overall Study|Withdrew over privacy concerns|0|||
146403286|NCT01306968|527979492|FG001|Overall Study|Withdrew over privacy concerns|0|||
146403287|NCT01306968|527979493|FG002|Overall Study|Withdrew over privacy concerns|0|||
146403288|NCT01306968|527979494|FG003|Overall Study|Withdrew over privacy concerns|1|||
146403289|NCT01329562|527979495|FG000|Overall Study|Protocol Violation|5|||
146403290|NCT01329562|527979496|FG001|Overall Study|Protocol Violation|3|||
146403291|NCT01329562|527979495|FG000|Overall Study|Lost to Follow-up|1|||
146403292|NCT01329562|527979496|FG001|Overall Study|Lost to Follow-up|1|||
146403293|NCT01329562|527979495|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
146403294|NCT01329562|527979496|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
146403295|NCT01329562|527979495|FG000|Overall Study|Physician Decision|0|||
146403296|NCT01329562|527979496|FG001|Overall Study|Physician Decision|1|||
146403297|NCT00061568|527979497|FG000|Overall Study|Lost to Follow-up|12|||
146403298|NCT00061568|527979498|FG001|Overall Study|Lost to Follow-up|0|||
146403299|NCT00061568|527979497|FG000|Overall Study|Death|6|||
146403300|NCT00061568|527979498|FG001|Overall Study|Death|0|||
146403301|NCT00061568|527979497|FG000|Overall Study|Withdrawal by Subject|1|||
146403302|NCT00061568|527979498|FG001|Overall Study|Withdrawal by Subject|0|||
146403303|NCT01381068|527979499|FG000|Overall Study|Death|1|||
146403304|NCT01381068|527979500|FG001|Overall Study|Death|0|||
146403305|NCT00797316|527979501|FG000|Overall Study|Administrative problems|1|||
146403306|NCT00797316|527979502|FG001|Overall Study|Administrative problems|0|||
146403307|NCT00797316|527979501|FG000|Overall Study|Adverse Event|5|||
146403308|NCT00797316|527979502|FG001|Overall Study|Adverse Event|3|||
146403309|NCT00797316|527979501|FG000|Overall Study|Lost to Follow-up|4|||
146403310|NCT00797316|527979502|FG001|Overall Study|Lost to Follow-up|8|||
146403311|NCT00797316|527979501|FG000|Overall Study|Protocol Deviation|1|||
146403312|NCT00797316|527979502|FG001|Overall Study|Protocol Deviation|2|||
146403313|NCT00797316|527979501|FG000|Overall Study|Patient withdrew consent|12|||
146403314|NCT00797316|527979502|FG001|Overall Study|Patient withdrew consent|6|||
146403315|NCT00797316|527979501|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146403316|NCT00797316|527979502|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
146403317|NCT03239340|527979509|FG000|Overall Study|Other|26|||
146403318|NCT03239340|527979509|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
146403319|NCT03239340|527979509|FG000|Overall Study|Death|40|||
146403320|NCT03239340|527979509|FG000|Overall Study|Lost to Follow-up|2|||
146403321|NCT03239340|527979509|FG000|Overall Study|Physician Decision|16|||
146403322|NCT03239340|527979509|FG000|Overall Study|Withdrawal by Subject|27|||
146403323|NCT02061293|527979515|FG000|Overall Study|Elevated Blood Pressure|1|||
146403324|NCT02061293|527979516|FG001|Overall Study|Elevated Blood Pressure|1|||
146403325|NCT00734617|527981195|FG000|Overall Study|Adverse Event|4|||
146403326|NCT00734617|527981196|FG001|Overall Study|Adverse Event|7|||
146403327|NCT00734617|527981195|FG000|Overall Study|Withdrawal by Subject|103|||
146403328|NCT00734617|527981196|FG001|Overall Study|Withdrawal by Subject|95|||
146403329|NCT01988337|527981197|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
146403330|NCT02742818|527981198|FG000|Overall Study|Adverse Event|0|||
146403331|NCT02742818|527981199|FG001|Overall Study|Adverse Event|1|||
146403332|NCT02742818|527981198|FG000|Overall Study|Protocol Violation|0|||
146403333|NCT02742818|527981199|FG001|Overall Study|Protocol Violation|1|||
146403334|NCT00457418|527981200|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
146403335|NCT00457418|527981200|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
146403336|NCT00457418|527981200|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
146403337|NCT00457418|527981200|FG000|Post PK Maintenance|Adverse Event|10|||
146403338|NCT00457418|527981200|FG000|Post PK Maintenance|Progression of Disease|6|||
146403339|NCT00457418|527981200|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
146062714|NCT05194124|526748316|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146403340|NCT00457418|527981200|FG000|Post PK Maintenance|Lost to Follow-up|1|||
146403341|NCT01785472|527981201|FG000|Overall Study|Adverse Event|5|||
146403342|NCT01785472|527981202|FG001|Overall Study|Adverse Event|4|||
146403343|NCT01785472|527981203|FG002|Overall Study|Adverse Event|6|||
146403344|NCT01785472|527981201|FG000|Overall Study|Lack of Efficacy|2|||
146403345|NCT01785472|527981202|FG001|Overall Study|Lack of Efficacy|0|||
146403346|NCT01785472|527981203|FG002|Overall Study|Lack of Efficacy|1|||
146403347|NCT01785472|527981201|FG000|Overall Study|Lost to Follow-up|1|||
146403348|NCT01785472|527981202|FG001|Overall Study|Lost to Follow-up|2|||
146403349|NCT01785472|527981203|FG002|Overall Study|Lost to Follow-up|0|||
146403350|NCT01785472|527981201|FG000|Overall Study|Physician Decision|1|||
146403351|NCT01785472|527981202|FG001|Overall Study|Physician Decision|1|||
146403352|NCT01785472|527981203|FG002|Overall Study|Physician Decision|1|||
146403353|NCT01785472|527981201|FG000|Overall Study|Protocol deviation|0|||
146403354|NCT01785472|527981202|FG001|Overall Study|Protocol deviation|2|||
146403355|NCT01785472|527981203|FG002|Overall Study|Protocol deviation|2|||
146403356|NCT01785472|527981201|FG000|Overall Study|Subject/guardian decision|15|||
146403357|NCT01785472|527981202|FG001|Overall Study|Subject/guardian decision|10|||
146403358|NCT01785472|527981203|FG002|Overall Study|Subject/guardian decision|11|||
146403359|NCT01785472|527981201|FG000|Overall Study|Technical problems|0|||
146403360|NCT01785472|527981202|FG001|Overall Study|Technical problems|0|||
146403361|NCT01785472|527981203|FG002|Overall Study|Technical problems|1|||
146403362|NCT02086968|527981205|FG000|Overall Study|Adverse Event|1|||
146403363|NCT02086968|527981206|FG001|Overall Study|Adverse Event|5|||
146403364|NCT02086968|527981205|FG000|Overall Study|Lost to Follow-up|2|||
146403365|NCT02086968|527981206|FG001|Overall Study|Lost to Follow-up|3|||
146403366|NCT02086968|527981205|FG000|Overall Study|Study drug received outside protocol|0|||
146403367|NCT02086968|527981206|FG001|Overall Study|Study drug received outside protocol|1|||
146403368|NCT02086968|527981205|FG000|Overall Study|Physician Decision|4|||
146403369|NCT02086968|527981206|FG001|Overall Study|Physician Decision|0|||
146403370|NCT02086968|527981205|FG000|Overall Study|Withdrawal by Subject|1|||
146403371|NCT02086968|527981206|FG001|Overall Study|Withdrawal by Subject|4|||
146403372|NCT03387735|527981210|FG000|Overall Study|Lost to Follow-up|4|||
146403373|NCT03387735|527981211|FG001|Overall Study|Lost to Follow-up|8|||
146403374|NCT03387735|527981210|FG000|Overall Study|Death|4|||
146403375|NCT03387735|527981211|FG001|Overall Study|Death|8|||
146403376|NCT03099161|527981212|FG000|Overall Study|Adverse Event|0|||
146403377|NCT03099161|527981213|FG001|Overall Study|Adverse Event|0|||
146403378|NCT03099161|527981214|FG002|Overall Study|Adverse Event|2|||
146403379|NCT03099161|527981212|FG000|Overall Study|Physician Decision|2|||
146403380|NCT03099161|527981213|FG001|Overall Study|Physician Decision|0|||
146403381|NCT03099161|527981214|FG002|Overall Study|Physician Decision|0|||
146403382|NCT03099161|527981212|FG000|Overall Study|Progressive Disease|1|||
146403383|NCT03099161|527981213|FG001|Overall Study|Progressive Disease|4|||
146403384|NCT03099161|527981214|FG002|Overall Study|Progressive Disease|1|||
146403385|NCT00110084|527981215|FG000|Overall Study|Adverse Event|9|||
146403386|NCT00110084|527981215|FG000|Overall Study|Death|1|||
146403387|NCT00110084|527981215|FG000|Overall Study|Patient Refusal|10|||
146403388|NCT00110084|527981215|FG000|Overall Study|Alternate Therapy|5|||
146403389|NCT00110084|527981215|FG000|Overall Study|Intercurrent Illness|1|||
146403390|NCT00110084|527981215|FG000|Overall Study|Other|2|||
146403391|NCT04854707|527981217|FG000|Overall Study|Lack of Efficacy|78|||
146403392|NCT04854707|527981218|FG001|Overall Study|Lack of Efficacy|59|||
146403393|NCT04854707|527981219|FG002|Overall Study|Lack of Efficacy|30|||
146403394|NCT00537056|527981220|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
146403395|NCT01257737|527981222|FG000|Overall Study|Lost to Follow-up|1|||
146403396|NCT01257737|527981223|FG001|Overall Study|Lost to Follow-up|2|||
146403397|NCT01257737|527981222|FG000|Overall Study|Liver transplant|1|||
146403398|NCT01257737|527981223|FG001|Overall Study|Liver transplant|0|||
146403399|NCT01257737|527981222|FG000|Overall Study|Relocation out of the country|0|||
146403400|NCT01257737|527981223|FG001|Overall Study|Relocation out of the country|1|||
146403401|NCT01257737|527981222|FG000|Overall Study|Withdrew from study|0|||
146403402|NCT01257737|527981223|FG001|Overall Study|Withdrew from study|1|||
146403403|NCT03020966|527981226|FG000|Overall Study|Withdrawal by Subject|2|||
146403404|NCT03020966|527981227|FG001|Overall Study|Withdrawal by Subject|0|||
146403405|NCT00962013|527981235|FG000|Overall Study|Did not have surgery|1|||
146403406|NCT00962013|527981235|FG000|Overall Study|Death|8|||
146403407|NCT00962013|527981235|FG000|Overall Study|Lost to Follow-up|12|||
146403408|NCT00962013|527981235|FG000|Overall Study|Unable/Unwilling to return|6|||
146403409|NCT00962013|527981235|FG000|Overall Study|Withdrawal by Subject|8|||
146403410|NCT00962013|527981235|FG000|Overall Study|Removal of study device|3|||
146403411|NCT00962013|527981235|FG000|Overall Study|Site Termination|24|||
146403412|NCT00962013|527981235|FG000|Overall Study|No 5 year evaluation|6|||
146403413|NCT00445458|527981240|FG000|Overall Study|Disease Progression|3|||
146403414|NCT00445458|527981241|FG001|Overall Study|Disease Progression|4|||
146403415|NCT00445458|527981242|FG002|Overall Study|Disease Progression|54|||
146403416|NCT00445458|527981243|FG003|Overall Study|Disease Progression|27|||
146403417|NCT00445458|527981240|FG000|Overall Study|Withdrawal by Subject|0|||
146403418|NCT00445458|527981241|FG001|Overall Study|Withdrawal by Subject|0|||
146403419|NCT00445458|527981242|FG002|Overall Study|Withdrawal by Subject|7|||
146403420|NCT00445458|527981243|FG003|Overall Study|Withdrawal by Subject|0|||
146403421|NCT00445458|527981240|FG000|Overall Study|Adverse Event|0|||
146403422|NCT00445458|527981241|FG001|Overall Study|Adverse Event|0|||
146403423|NCT00445458|527981242|FG002|Overall Study|Adverse Event|3|||
146403424|NCT00445458|527981243|FG003|Overall Study|Adverse Event|0|||
146403425|NCT00445458|527981240|FG000|Overall Study|Death|0|||
146403426|NCT00445458|527981241|FG001|Overall Study|Death|1|||
146403427|NCT00445458|527981242|FG002|Overall Study|Death|2|||
146403428|NCT00445458|527981243|FG003|Overall Study|Death|0|||
146403429|NCT00445458|527981240|FG000|Overall Study|Physician Decision|0|||
146403430|NCT00445458|527981241|FG001|Overall Study|Physician Decision|0|||
146403431|NCT00445458|527981242|FG002|Overall Study|Physician Decision|1|||
146403432|NCT00445458|527981243|FG003|Overall Study|Physician Decision|1|||
146403433|NCT00445458|527981240|FG000|Overall Study|Surgery|0|||
146403434|NCT00445458|527981241|FG001|Overall Study|Surgery|0|||
146403435|NCT00445458|527981242|FG002|Overall Study|Surgery|1|||
146403436|NCT00445458|527981243|FG003|Overall Study|Surgery|0|||
146403437|NCT03972709|527981246|FG000|Overall Study|Withdrawal by Subject|18|||
146403438|NCT03972709|527981247|FG001|Overall Study|Withdrawal by Subject|7|||
146403439|NCT03972709|527981248|FG002|Overall Study|Withdrawal by Subject|14|||
146403440|NCT03972709|527981246|FG000|Overall Study|Study Terminated by Sponsor|48|||
146403441|NCT03972709|527981247|FG001|Overall Study|Study Terminated by Sponsor|25|||
146403442|NCT03972709|527981248|FG002|Overall Study|Study Terminated by Sponsor|50|||
146403443|NCT03972709|527981246|FG000|Overall Study|Physician Decision|1|||
146403444|NCT03972709|527981247|FG001|Overall Study|Physician Decision|0|||
146403445|NCT03972709|527981248|FG002|Overall Study|Physician Decision|0|||
146403446|NCT03972709|527981246|FG000|Overall Study|COVID-19|0|||
146403447|NCT03972709|527981247|FG001|Overall Study|COVID-19|1|||
146403448|NCT03972709|527981248|FG002|Overall Study|COVID-19|1|||
146403449|NCT03972709|527981246|FG000|Overall Study|Lost to Follow-up|6|||
146403450|NCT03972709|527981247|FG001|Overall Study|Lost to Follow-up|1|||
146403451|NCT03972709|527981248|FG002|Overall Study|Lost to Follow-up|2|||
146403452|NCT03972709|527981246|FG000|Overall Study|Death|5|||
146403453|NCT03972709|527981247|FG001|Overall Study|Death|1|||
146403454|NCT03972709|527981248|FG002|Overall Study|Death|4|||
146403455|NCT03972709|527981246|FG000|Overall Study|Adverse Event|3|||
146403456|NCT03972709|527981247|FG001|Overall Study|Adverse Event|1|||
146403457|NCT03972709|527981248|FG002|Overall Study|Adverse Event|4|||
146403458|NCT03972709|527981246|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
146403459|NCT03972709|527981247|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
146403460|NCT03972709|527981248|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
146403461|NCT03972709|527981246|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
146403462|NCT03972709|527981247|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
146403463|NCT03972709|527981248|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
146403464|NCT03972709|527981246|FG000|Overall Study|Subject Unable to be Contacted|0|||
146403465|NCT03972709|527981247|FG001|Overall Study|Subject Unable to be Contacted|1|||
146403466|NCT03972709|527981248|FG002|Overall Study|Subject Unable to be Contacted|0|||
146403467|NCT03972709|527981246|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
146403468|NCT03972709|527981247|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
146403469|NCT03972709|527981248|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
146403470|NCT03972709|527981246|FG000|Overall Study|Subject Moved|0|||
146403471|NCT03972709|527981247|FG001|Overall Study|Subject Moved|1|||
146403472|NCT03972709|527981248|FG002|Overall Study|Subject Moved|0|||
146403473|NCT03972709|527981246|FG000|Overall Study|Missed Study Visits|1|||
146403474|NCT03972709|527981247|FG001|Overall Study|Missed Study Visits|0|||
146403475|NCT03972709|527981248|FG002|Overall Study|Missed Study Visits|0|||
146403476|NCT04732728|527981249|FG000|Overall Study|Death|12|||
146403477|NCT04732728|527981249|FG000|Overall Study|Withdrawn|136|||
146403478|NCT01393626|527981258|FG000|Overall Study|Adverse Event|2|||
146403479|NCT01393626|527981259|FG001|Overall Study|Adverse Event|1|||
146403480|NCT01393626|527981260|FG002|Overall Study|Adverse Event|5|||
146403481|NCT01393626|527981261|FG003|Overall Study|Adverse Event|0|||
146403482|NCT01393626|527981258|FG000|Overall Study|Did not meet entrance criteria|1|||
146403483|NCT01393626|527981259|FG001|Overall Study|Did not meet entrance criteria|0|||
146403484|NCT01393626|527981260|FG002|Overall Study|Did not meet entrance criteria|0|||
146403485|NCT01393626|527981261|FG003|Overall Study|Did not meet entrance criteria|0|||
146403486|NCT01393626|527981258|FG000|Overall Study|Lack of Efficacy|6|||
146403487|NCT01393626|527981259|FG001|Overall Study|Lack of Efficacy|6|||
146403488|NCT01393626|527981260|FG002|Overall Study|Lack of Efficacy|4|||
146403489|NCT01393626|527981261|FG003|Overall Study|Lack of Efficacy|1|||
146403490|NCT01393626|527981258|FG000|Overall Study|Lost to Follow-up|1|||
146403491|NCT01393626|527981259|FG001|Overall Study|Lost to Follow-up|1|||
146403492|NCT01393626|527981260|FG002|Overall Study|Lost to Follow-up|1|||
146403493|NCT01393626|527981261|FG003|Overall Study|Lost to Follow-up|0|||
146403494|NCT01393626|527981258|FG000|Overall Study|Withdrawal by Subject|6|||
146403495|NCT01393626|527981259|FG001|Overall Study|Withdrawal by Subject|4|||
146403496|NCT01393626|527981260|FG002|Overall Study|Withdrawal by Subject|0|||
146403497|NCT01393626|527981261|FG003|Overall Study|Withdrawal by Subject|0|||
146403498|NCT01393626|527981258|FG000|Overall Study|Other|1|||
146403499|NCT01393626|527981259|FG001|Overall Study|Other|0|||
146403500|NCT01393626|527981260|FG002|Overall Study|Other|0|||
146403501|NCT01393626|527981261|FG003|Overall Study|Other|0|||
146403502|NCT01393626|527981258|FG000|Overall Study|Protocol Violation|1|||
146403503|NCT01393626|527981259|FG001|Overall Study|Protocol Violation|0|||
146403504|NCT01393626|527981260|FG002|Overall Study|Protocol Violation|2|||
146403505|NCT01393626|527981261|FG003|Overall Study|Protocol Violation|0|||
146403506|NCT02426125|527981262|FG000|Overall Study|Lost to Follow-up|14|||
146403507|NCT02426125|527981263|FG001|Overall Study|Lost to Follow-up|12|||
146403508|NCT02426125|527981262|FG000|Overall Study|Withdrawal by Subject|13|||
146403509|NCT02426125|527981263|FG001|Overall Study|Withdrawal by Subject|14|||
146403510|NCT02426125|527981262|FG000|Overall Study|Death|185|||
146403511|NCT02426125|527981263|FG001|Overall Study|Death|200|||
146403512|NCT02426125|527981262|FG000|Overall Study|Randomized, But Never Treated|5|||
146403513|NCT02426125|527981263|FG001|Overall Study|Randomized, But Never Treated|2|||
146403514|NCT02858076|527981264|FG000|Overall Study|Death|6|||
146403515|NCT02858076|527981265|FG001|Overall Study|Death|3|||
146403516|NCT02858076|527981264|FG000|Overall Study|Withdrawal by Subject|1|||
146403517|NCT02858076|527981265|FG001|Overall Study|Withdrawal by Subject|5|||
146403518|NCT02858076|527981264|FG000|Overall Study|Lost to Follow-up|2|||
146403519|NCT02858076|527981265|FG001|Overall Study|Lost to Follow-up|7|||
146403520|NCT02858076|527981264|FG000|Overall Study|Completed Out of Window|1|||
146403521|NCT02858076|527981265|FG001|Overall Study|Completed Out of Window|3|||
146403522|NCT00938015|527981273|FG000|Overall Study|Death|2|||
146403523|NCT00938015|527981273|FG000|Overall Study|Lost to Follow-up|32|||
146403524|NCT00938015|527981273|FG000|Overall Study|Adverse Event|32|||
146403525|NCT00938015|527981273|FG000|Overall Study|Non-responder|52|||
146403526|NCT00938015|527981273|FG000|Overall Study|Reason not related to Etanercept|29|||
146403527|NCT02341482|527981274|FG000|Overall Study|Adverse Event|1|||
146403528|NCT03186794|527981275|FG000|Overall Study|Physician Decision|2|||
146403529|NCT03186794|527981275|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
146403530|NCT00664066|527981279|FG000|Overall Study|Study terminated|3|||
146403531|NCT02180659|527981283|FG000|Overall Study|Adverse Event|1|||
146403532|NCT02180659|527981284|FG001|Overall Study|Adverse Event|0|||
146403533|NCT02180659|527981283|FG000|Overall Study|Lost to Follow-up|4|||
146403534|NCT02180659|527981284|FG001|Overall Study|Lost to Follow-up|2|||
146403535|NCT02180659|527981283|FG000|Overall Study|Subject incarcerated during conduct|1|||
146403536|NCT02180659|527981284|FG001|Overall Study|Subject incarcerated during conduct|0|||
146403537|NCT02180659|527981283|FG000|Overall Study|Withdrawal by Subject|0|||
146403538|NCT02180659|527981284|FG001|Overall Study|Withdrawal by Subject|2|||
146403539|NCT02180659|527981283|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
146403540|NCT02180659|527981284|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
146403541|NCT03000075|527981285|FG000|Part A|Adverse Event|4|||
146403542|NCT03000075|527981286|FG001|Part A|Adverse Event|0|||
146403543|NCT03000075|527981287|FG002|Part A|Adverse Event|0|||
146403544|NCT03000075|527981288|FG003|Part A|Adverse Event|0|||
146403545|NCT03000075|527981289|FG004|Part A|Adverse Event|0|||
146403546|NCT03000075|527981290|FG005|Part A|Adverse Event|0|||
146403547|NCT03000075|527981291|FG006|Part A|Adverse Event|0|||
146403548|NCT03000075|527981285|FG000|Part B|Not dosed due to AE|0|||
146403549|NCT03000075|527981286|FG001|Part B|Not dosed due to AE|0|||
146403550|NCT03000075|527981287|FG002|Part B|Not dosed due to AE|0|||
146403551|NCT03000075|527981288|FG003|Part B|Not dosed due to AE|0|||
146403552|NCT03000075|527981289|FG004|Part B|Not dosed due to AE|0|||
146403553|NCT03000075|527981290|FG005|Part B|Not dosed due to AE|2|||
146403554|NCT03000075|527981291|FG006|Part B|Not dosed due to AE|1|||
146403555|NCT03000075|527981285|FG000|Part B|Adverse Event|0|||
146403556|NCT03000075|527981286|FG001|Part B|Adverse Event|0|||
146403557|NCT03000075|527981287|FG002|Part B|Adverse Event|0|||
146403558|NCT03000075|527981288|FG003|Part B|Adverse Event|0|||
146403559|NCT03000075|527981289|FG004|Part B|Adverse Event|1|||
146403560|NCT03000075|527981290|FG005|Part B|Adverse Event|0|||
146403561|NCT03000075|527981291|FG006|Part B|Adverse Event|0|||
146403562|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
146403563|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
146403564|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Death|5|||
146403565|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Death|2|||
146403566|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
146403567|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
146403568|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
146403569|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
146403570|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
146403571|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
146403572|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Relapse|1|||
146403573|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Relapse|0|||
146403574|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
146403575|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
146403576|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
146403577|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
146403578|NCT00111007|527981292|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
146403579|NCT00111007|527981293|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
146403580|NCT00111007|527981292|FG000|Active Follow-up|Adverse Event|1|||
146403581|NCT00111007|527981293|FG001|Active Follow-up|Adverse Event|0|||
146403582|NCT00111007|527981292|FG000|Active Follow-up|Death|2|||
146403583|NCT00111007|527981293|FG001|Active Follow-up|Death|0|||
146403584|NCT00111007|527981292|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
146403585|NCT00111007|527981293|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
146403586|NCT00111007|527981292|FG000|Long Term Follow-up|Death|34|||
146403587|NCT00111007|527981293|FG001|Long Term Follow-up|Death|39|||
146403588|NCT00111007|527981292|FG000|Long Term Follow-up|Lost to Follow-up|1|||
146403589|NCT00111007|527981293|FG001|Long Term Follow-up|Lost to Follow-up|1|||
146403590|NCT00111007|527981292|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
146403591|NCT00111007|527981293|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
146403592|NCT00111007|527981292|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
146403593|NCT00111007|527981293|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
146403594|NCT00111007|527981292|FG000|Long Term Follow-up|Missing|10|||
146403595|NCT00111007|527981293|FG001|Long Term Follow-up|Missing|3|||
146403596|NCT01495793|527981294|FG000|Overall Study|Lost to Follow-up|1|||
146403597|NCT01495793|527981294|FG000|Overall Study|Violation of inclusion criteria|1|||
146403598|NCT00440193|527981295|FG000|Treatment Period|Adverse Event|74|||
146403599|NCT00440193|527981296|FG001|Treatment Period|Adverse Event|67|||
146403600|NCT00440193|527981295|FG000|Treatment Period|Death|19|||
146403601|NCT00440193|527981296|FG001|Treatment Period|Death|22|||
146403602|NCT00440193|527981295|FG000|Treatment Period|Lack of Efficacy|0|||
146403603|NCT00440193|527981296|FG001|Treatment Period|Lack of Efficacy|1|||
146403604|NCT00440193|527981295|FG000|Treatment Period|Lost to Follow-up|12|||
146403605|NCT00440193|527981296|FG001|Treatment Period|Lost to Follow-up|18|||
146403606|NCT00440193|527981295|FG000|Treatment Period|Physician Decision|3|||
146403607|NCT00440193|527981296|FG001|Treatment Period|Physician Decision|6|||
146403608|NCT00440193|527981295|FG000|Treatment Period|Protocol Violation|16|||
146403609|NCT00440193|527981296|FG001|Treatment Period|Protocol Violation|19|||
146403610|NCT00440193|527981295|FG000|Treatment Period|Withdrawal by Subject|36|||
146403611|NCT00440193|527981296|FG001|Treatment Period|Withdrawal by Subject|77|||
146403612|NCT00440193|527981295|FG000|Treatment Period|Clinical endpoint reached|28|||
146403613|NCT00440193|527981296|FG001|Treatment Period|Clinical endpoint reached|25|||
146403614|NCT00440193|527981295|FG000|Treatment Period|Study terminated by sponsor|102|||
146403615|NCT00440193|527981296|FG001|Treatment Period|Study terminated by sponsor|94|||
146403616|NCT00440193|527981295|FG000|Treatment Period|Protocol driven decision point|2|||
146403617|NCT00440193|527981296|FG001|Treatment Period|Protocol driven decision point|2|||
146403618|NCT00440193|527981295|FG000|Treatment Period|Switch to commercial drug|0|||
146403619|NCT00440193|527981296|FG001|Treatment Period|Switch to commercial drug|2|||
146403620|NCT00440193|527981295|FG000|Treatment Period|Technical problems|1|||
146403621|NCT00440193|527981296|FG001|Treatment Period|Technical problems|1|||
146403622|NCT00440193|527981295|FG000|Treatment Period|Participant convenience|5|||
146403623|NCT00440193|527981296|FG001|Treatment Period|Participant convenience|2|||
146403624|NCT00440193|527981295|FG000|Treatment Period|Participant did not receive treatment|7|||
146403625|NCT00440193|527981296|FG001|Treatment Period|Participant did not receive treatment|13|||
146403626|NCT00440193|527981295|FG000|Treatment Period|Site closed by investigator|0|||
146403627|NCT00440193|527981296|FG001|Treatment Period|Site closed by investigator|2|||
146403628|NCT00440193|527981295|FG000|Observational Period|Adverse Event|2|||
146403629|NCT00440193|527981296|FG001|Observational Period|Adverse Event|2|||
146403630|NCT00440193|527981295|FG000|Observational Period|Death|15|||
146403631|NCT00440193|527981296|FG001|Observational Period|Death|20|||
146403632|NCT00440193|527981295|FG000|Observational Period|Lost to Follow-up|12|||
146403633|NCT00440193|527981296|FG001|Observational Period|Lost to Follow-up|8|||
146403634|NCT00440193|527981295|FG000|Observational Period|Protocol Violation|1|||
146403635|NCT00440193|527981296|FG001|Observational Period|Protocol Violation|0|||
146403636|NCT00440193|527981295|FG000|Observational Period|Withdrawal by Subject|11|||
146403637|NCT00440193|527981296|FG001|Observational Period|Withdrawal by Subject|8|||
146403638|NCT00440193|527981295|FG000|Observational Period|Physician Decision|1|||
146403639|NCT00440193|527981296|FG001|Observational Period|Physician Decision|0|||
146403640|NCT00440193|527981295|FG000|Observational Period|Clinical endpoint reached|1|||
146403641|NCT00440193|527981296|FG001|Observational Period|Clinical endpoint reached|0|||
146403642|NCT00440193|527981295|FG000|Observational Period|Participant convenience|2|||
146403643|NCT00440193|527981296|FG001|Observational Period|Participant convenience|0|||
146403644|NCT00834366|527981297|FG000|Treatment Period 1|Adverse Event|1|||
146403645|NCT00834366|527981298|FG001|Treatment Period 1|Adverse Event|1|||
146403646|NCT03014570|527981299|FG000|Overall Study|COVID-19 Restrictions|38|||
146403647|NCT03014570|527981300|FG001|Overall Study|COVID-19 Restrictions|24|||
146403648|NCT03014570|527981299|FG000|Overall Study|Death|70|||
146403649|NCT03014570|527981300|FG001|Overall Study|Death|79|||
146403650|NCT03014570|527981299|FG000|Overall Study|Transfer from facility|11|||
146403651|NCT03014570|527981300|FG001|Overall Study|Transfer from facility|14|||
146403652|NCT03014570|527981299|FG000|Overall Study|Hospitalized|5|||
146403653|NCT03014570|527981300|FG001|Overall Study|Hospitalized|3|||
146403654|NCT03014570|527981299|FG000|Overall Study|Transfer within facility|1|||
146403655|NCT03014570|527981300|FG001|Overall Study|Transfer within facility|0|||
146403656|NCT03014570|527981299|FG000|Overall Study|Site refusal|0|||
146403657|NCT03014570|527981300|FG001|Overall Study|Site refusal|11|||
146403658|NCT01154673|527981301|FG000|Overall Study|Lost to Follow-up|1|||
146403659|NCT01154673|527981302|FG001|Overall Study|Lost to Follow-up|0|||
146403660|NCT01154673|527981301|FG000|Overall Study|moved out of province|1|||
146403661|NCT01154673|527981302|FG001|Overall Study|moved out of province|0|||
146403662|NCT00090259|527981303|FG000|Overall Study|Lost to Follow-up|30|||
146403663|NCT00090259|527981304|FG001|Overall Study|Lost to Follow-up|26|||
146403664|NCT00090259|527981303|FG000|Overall Study|Withdrawal by Subject|21|||
146403665|NCT00090259|527981304|FG001|Overall Study|Withdrawal by Subject|15|||
146403666|NCT00090259|527981303|FG000|Overall Study|Investigator site closed|11|||
146403667|NCT00090259|527981304|FG001|Overall Study|Investigator site closed|7|||
146403668|NCT03083639|527981308|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
146403669|NCT03083639|527981309|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
146403670|NCT03083639|527981308|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
146403671|NCT03083639|527981309|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
146403672|NCT01275170|527981310|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
146403673|NCT01275170|527981311|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403674|NCT01275170|527981312|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403675|NCT01275170|527981313|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403676|NCT01275170|527981314|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403677|NCT01275170|527981315|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403678|NCT01275170|527981316|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403679|NCT01275170|527981317|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
146403680|NCT00960687|527981318|FG000|Washout Period of 7 Days|Adverse Event|3|||
146403681|NCT00960687|527981319|FG001|Washout Period of 7 Days|Adverse Event|2|||
146403682|NCT00960687|527981318|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146403683|NCT00960687|527981319|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146403684|NCT02362646|527981320|FG000|Overall Study|Death|15|||
146403685|NCT02362646|527981321|FG001|Overall Study|Death|8|||
146403686|NCT02362646|527981320|FG000|Overall Study|Withdrawal by Subject|2|||
146403687|NCT02362646|527981321|FG001|Overall Study|Withdrawal by Subject|2|||
146403688|NCT02362646|527981320|FG000|Overall Study|received transplant|21|||
146403689|NCT02362646|527981321|FG001|Overall Study|received transplant|14|||
146403690|NCT00865306|527981322|FG000|Controlled Trial|Lost to Follow-up|1|||
146403691|NCT00865306|527981323|FG001|Controlled Trial|Lost to Follow-up|1|||
146403692|NCT00865306|527981322|FG000|Controlled Trial|Difficulty commuting|2|||
146403693|NCT00865306|527981323|FG001|Controlled Trial|Difficulty commuting|0|||
146403694|NCT00865306|527981322|FG000|Controlled Trial|Improved btw baseline and first session|1|||
146403695|NCT00865306|527981323|FG001|Controlled Trial|Improved btw baseline and first session|0|||
146403696|NCT00865306|527981322|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
146403697|NCT00865306|527981323|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
146403698|NCT00865306|527981322|FG000|Controlled Trial|Withdrawal by Subject|0|||
146403699|NCT00865306|527981323|FG001|Controlled Trial|Withdrawal by Subject|1|||
146403700|NCT02704130|527981327|FG000|Overall Study|Physician Decision|5|||
146403701|NCT02704130|527981328|FG001|Overall Study|Physician Decision|3|||
146403702|NCT01216319|527981332|FG000|Overall Study|Lost to Follow-up|2|||
146403703|NCT01216319|527981332|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
146403704|NCT03611751|527981336|FG000|Pre-treatment|Randomized but not treated|1|||
146403705|NCT03611751|527981337|FG001|Pre-treatment|Randomized but not treated|1|||
146403706|NCT03611751|527981338|FG002|Pre-treatment|Randomized but not treated|0|||
146403707|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
146403708|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
146403709|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
146403710|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
146403711|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
146403712|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
146403713|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
146403714|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
146403715|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
146403716|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
146403717|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
146403718|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
146403719|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
146403720|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
146403721|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
146403722|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
146403723|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
146403724|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
146403725|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
146403726|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
146403727|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
146403728|NCT03611751|527981336|FG000|Treatment Week 0 - Week 16|Death|0|||
146403729|NCT03611751|527981337|FG001|Treatment Week 0 - Week 16|Death|0|||
146403730|NCT03611751|527981338|FG002|Treatment Week 0 - Week 16|Death|1|||
146403731|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
146403732|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
146403733|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
146403734|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
146403735|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146403736|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
146403737|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
146403738|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146403739|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146403740|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
146403741|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
146403742|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
146403743|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
146403744|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
146403745|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
146403746|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
146403747|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
146403748|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
146403749|NCT03611751|527981336|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
146403750|NCT03611751|527981337|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
146403751|NCT03611751|527981338|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
146403752|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
146403753|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
146403754|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
146403755|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
146403756|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
146403757|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146403758|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
146403759|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
146403760|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
146403761|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
146403762|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
146403763|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
146403764|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
146403765|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
146403766|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146403767|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
146403768|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
146403769|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
146403770|NCT03611751|527981336|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
146403771|NCT03611751|527981337|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
146403772|NCT03611751|527981338|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
146403773|NCT00929864|527981339|FG000|Overall Study|Death|1|||
146403774|NCT00929864|527981340|FG001|Overall Study|Death|1|||
146403775|NCT00929864|527981339|FG000|Overall Study|Adverse Event|11|||
146403776|NCT00929864|527981340|FG001|Overall Study|Adverse Event|30|||
146403777|NCT00929864|527981339|FG000|Overall Study|Lack of Efficacy|19|||
146403778|NCT00929864|527981340|FG001|Overall Study|Lack of Efficacy|16|||
146403779|NCT00929864|527981339|FG000|Overall Study|Lost to Follow-up|7|||
146403780|NCT00929864|527981340|FG001|Overall Study|Lost to Follow-up|12|||
146403781|NCT00929864|527981339|FG000|Overall Study|Withdrawal by Subject|20|||
146403782|NCT00929864|527981340|FG001|Overall Study|Withdrawal by Subject|9|||
146403783|NCT00929864|527981339|FG000|Overall Study|No longer met criteria|2|||
146403784|NCT00929864|527981340|FG001|Overall Study|No longer met criteria|1|||
146403785|NCT00929864|527981339|FG000|Overall Study|Poor or non-compliance|3|||
146403786|NCT00929864|527981340|FG001|Overall Study|Poor or non-compliance|3|||
146403787|NCT00929864|527981339|FG000|Overall Study|Pregnancy|0|||
146403788|NCT00929864|527981340|FG001|Overall Study|Pregnancy|3|||
146403789|NCT00929864|527981339|FG000|Overall Study|Administrative reason by Sponsor|1|||
146403790|NCT00929864|527981340|FG001|Overall Study|Administrative reason by Sponsor|1|||
146403791|NCT00929864|527981339|FG000|Overall Study|Non-specified|2|||
146403792|NCT00929864|527981340|FG001|Overall Study|Non-specified|7|||
146403793|NCT03728257|527981341|FG000|Overall Study|Death|3|||
146403794|NCT03728257|527981342|FG001|Overall Study|Death|0|||
146062715|NCT05194124|526748317|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
146403795|NCT03868059|527981347|FG000|Overall Study|Adverse Event|3|||
146403796|NCT03868059|527981347|FG000|Overall Study|Lost to Follow-up|3|||
146403797|NCT03868059|527981347|FG000|Overall Study|Withdrawal by Subject|6|||
146403798|NCT03205163|527981348|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
146403799|NCT03205163|527981349|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
146403800|NCT04502862|527981350|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
146403801|NCT04502862|527981351|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
146403802|NCT04502862|527981350|FG000|Overall Study|Withdrawal by Subject|1|||
146403803|NCT04502862|527981351|FG001|Overall Study|Withdrawal by Subject|0|||
146403804|NCT04502862|527981350|FG000|Overall Study|Adverse Event|1|||
146403805|NCT04502862|527981351|FG001|Overall Study|Adverse Event|1|||
146403806|NCT03284424|527983009|FG000|Overall Study|Death|70|||
146403807|NCT03284424|527983010|FG001|Overall Study|Death|24|||
146403808|NCT03284424|527983009|FG000|Overall Study|Lost to Follow-up|3|||
146403809|NCT03284424|527983010|FG001|Overall Study|Lost to Follow-up|1|||
146403810|NCT03284424|527983009|FG000|Overall Study|Physician Decision|1|||
146403811|NCT03284424|527983010|FG001|Overall Study|Physician Decision|2|||
146403812|NCT03284424|527983009|FG000|Overall Study|Withdrawal by Subject|4|||
146403813|NCT03284424|527983010|FG001|Overall Study|Withdrawal by Subject|5|||
146403814|NCT03284424|527983009|FG000|Overall Study|Sponsor's decision|27|||
146403815|NCT03284424|527983010|FG001|Overall Study|Sponsor's decision|22|||
146403816|NCT01563029|527983013|FG000|Overall Study|Adverse Event|1|||
146403817|NCT01563029|527983014|FG001|Overall Study|Adverse Event|0|||
146403818|NCT01563029|527983015|FG002|Overall Study|Adverse Event|1|||
146403819|NCT01563029|527983016|FG003|Overall Study|Adverse Event|2|||
146403820|NCT01563029|527983017|FG004|Overall Study|Adverse Event|1|||
146403821|NCT01563029|527983013|FG000|Overall Study|Lack of Efficacy|42|||
146403822|NCT01563029|527983014|FG001|Overall Study|Lack of Efficacy|16|||
146403823|NCT01563029|527983015|FG002|Overall Study|Lack of Efficacy|23|||
146403824|NCT01563029|527983016|FG003|Overall Study|Lack of Efficacy|21|||
146403825|NCT01563029|527983017|FG004|Overall Study|Lack of Efficacy|19|||
146403826|NCT01563029|527983013|FG000|Overall Study|Protocol Violation|1|||
146403827|NCT01563029|527983014|FG001|Overall Study|Protocol Violation|2|||
146403828|NCT01563029|527983015|FG002|Overall Study|Protocol Violation|3|||
146403829|NCT01563029|527983016|FG003|Overall Study|Protocol Violation|1|||
146403830|NCT01563029|527983017|FG004|Overall Study|Protocol Violation|3|||
146403831|NCT01563029|527983013|FG000|Overall Study|Protocol defined stopping criteria|1|||
146403832|NCT01563029|527983014|FG001|Overall Study|Protocol defined stopping criteria|0|||
146403833|NCT01563029|527983015|FG002|Overall Study|Protocol defined stopping criteria|0|||
146403834|NCT01563029|527983016|FG003|Overall Study|Protocol defined stopping criteria|0|||
146403835|NCT01563029|527983017|FG004|Overall Study|Protocol defined stopping criteria|0|||
146403836|NCT01563029|527983013|FG000|Overall Study|Lost to Follow-up|1|||
146403837|NCT01563029|527983014|FG001|Overall Study|Lost to Follow-up|0|||
146403838|NCT01563029|527983015|FG002|Overall Study|Lost to Follow-up|1|||
146403839|NCT01563029|527983016|FG003|Overall Study|Lost to Follow-up|1|||
146403840|NCT01563029|527983017|FG004|Overall Study|Lost to Follow-up|1|||
146403841|NCT01563029|527983013|FG000|Overall Study|Physician Decision|3|||
146403842|NCT01563029|527983014|FG001|Overall Study|Physician Decision|5|||
146403843|NCT01563029|527983015|FG002|Overall Study|Physician Decision|2|||
146403844|NCT01563029|527983016|FG003|Overall Study|Physician Decision|4|||
146403845|NCT01563029|527983017|FG004|Overall Study|Physician Decision|2|||
146403846|NCT01563029|527983013|FG000|Overall Study|Withdrawal by Subject|4|||
146403847|NCT01563029|527983014|FG001|Overall Study|Withdrawal by Subject|1|||
146403848|NCT01563029|527983015|FG002|Overall Study|Withdrawal by Subject|3|||
146403849|NCT01563029|527983016|FG003|Overall Study|Withdrawal by Subject|4|||
146403850|NCT01563029|527983017|FG004|Overall Study|Withdrawal by Subject|3|||
146403851|NCT01569594|527983018|FG000|Overall Study|Physician Decision|4|||
146403852|NCT01569594|527983018|FG000|Overall Study|Death|13|||
146403853|NCT01569594|527983018|FG000|Overall Study|Lost to Follow-up|22|||
146403854|NCT01569594|527983018|FG000|Overall Study|Adverse Event|2|||
146403855|NCT01569594|527983018|FG000|Overall Study|Withdrawal by Subject|13|||
146403856|NCT01569594|527983018|FG000|Overall Study|Other|4|||
146403857|NCT01569594|527983018|FG000|Overall Study|No ECM used|9|||
146403858|NCT03069365|527983019|FG000|Overall Study|Adverse Event|1|||
146403859|NCT02861534|527983020|FG000|Overall Study|Death|541|||
146403860|NCT02861534|527983021|FG001|Overall Study|Death|552|||
146403861|NCT02861534|527983020|FG000|Overall Study|Lost to Follow-up|14|||
146403862|NCT02861534|527983021|FG001|Overall Study|Lost to Follow-up|14|||
146403863|NCT02861534|527983020|FG000|Overall Study|Site Terminated by Sponsor|4|||
146403864|NCT02861534|527983021|FG001|Overall Study|Site Terminated by Sponsor|3|||
146403865|NCT02861534|527983020|FG000|Overall Study|Withdrawal by Subject|15|||
146403866|NCT02861534|527983021|FG001|Overall Study|Withdrawal by Subject|18|||
146403867|NCT02780115|527983022|FG000|Overall Study|Withdrawal by Subject|0|||
146403868|NCT02780115|527983023|FG001|Overall Study|Withdrawal by Subject|1|||
146403869|NCT02780115|527983024|FG002|Overall Study|Withdrawal by Subject|1|||
146403870|NCT02780115|527983025|FG003|Overall Study|Withdrawal by Subject|0|||
146403871|NCT02780115|527983026|FG004|Overall Study|Withdrawal by Subject|0|||
146403872|NCT02780115|527983022|FG000|Overall Study|Adverse Event|0|||
146403873|NCT02780115|527983023|FG001|Overall Study|Adverse Event|0|||
146403874|NCT02780115|527983024|FG002|Overall Study|Adverse Event|0|||
146403875|NCT02780115|527983025|FG003|Overall Study|Adverse Event|1|||
146403876|NCT02780115|527983026|FG004|Overall Study|Adverse Event|1|||
146403877|NCT00742859|527983035|FG000|Overall Study|Adverse Event|5|||
146403878|NCT00742859|527983036|FG001|Overall Study|Adverse Event|6|||
146403879|NCT00742859|527983037|FG002|Overall Study|Adverse Event|3|||
146403880|NCT00742859|527983038|FG003|Overall Study|Adverse Event|1|||
146403881|NCT00742859|527983035|FG000|Overall Study|Death|1|||
146403882|NCT00742859|527983036|FG001|Overall Study|Death|0|||
146403883|NCT00742859|527983037|FG002|Overall Study|Death|0|||
146403884|NCT00742859|527983038|FG003|Overall Study|Death|1|||
146171468|NCT03673462|527141019|FG000|Overall Study|Protocol Violation|25|||
146171469|NCT03673462|527141020|FG001|Overall Study|Protocol Violation|11|||
146171470|NCT03673462|527141019|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
146171471|NCT03673462|527141020|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
146171472|NCT03673462|527141019|FG000|Overall Study|Lost to Follow-up|102|||
146171473|NCT03673462|527141020|FG001|Overall Study|Lost to Follow-up|19|||
146171474|NCT02768662|527141021|FG000|Overall Study|Adverse Event|1|||
146171475|NCT02768662|527141021|FG000|Overall Study|Lost to Follow-up|4|||
146171476|NCT02768662|527141021|FG000|Overall Study|Withdrawal by Subject|3|||
146171477|NCT02768662|527141021|FG000|Overall Study|Study terminated by Sponsor|78|||
146171478|NCT01800201|527141022|FG000|Overall Study|Withdrawal by Subject|2|||
146171479|NCT01800201|527141023|FG001|Overall Study|Withdrawal by Subject|0|||
146171480|NCT01800201|527141022|FG000|Overall Study|patient privacy concerns|1|||
146171481|NCT01800201|527141023|FG001|Overall Study|patient privacy concerns|1|||
146171482|NCT01800201|527141022|FG000|Overall Study|did not want to use device|0|||
146171483|NCT01800201|527141023|FG001|Overall Study|did not want to use device|1|||
146171484|NCT01800201|527141022|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
146171485|NCT01800201|527141023|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
146171486|NCT00708435|527141024|FG000|Overall Study|Death / Serious Adverse Event|10|||
146171487|NCT00708435|527141025|FG001|Overall Study|Death / Serious Adverse Event|5|||
146171488|NCT00708435|527141024|FG000|Overall Study|Lost to Follow-up|9|||
146171489|NCT00708435|527141025|FG001|Overall Study|Lost to Follow-up|4|||
146171490|NCT00708435|527141024|FG000|Overall Study|Withdrawal by Subject|3|||
146171491|NCT00708435|527141025|FG001|Overall Study|Withdrawal by Subject|7|||
146171492|NCT00708435|527141024|FG000|Overall Study|Adverse Event|1|||
146171493|NCT00708435|527141025|FG001|Overall Study|Adverse Event|0|||
146171494|NCT00708435|527141024|FG000|Overall Study|Protocol Violation|0|||
146171495|NCT00708435|527141025|FG001|Overall Study|Protocol Violation|1|||
146171496|NCT00708435|527141024|FG000|Overall Study|Intervention by primary care physician|1|||
146171497|NCT00708435|527141025|FG001|Overall Study|Intervention by primary care physician|0|||
146171498|NCT00708435|527141024|FG000|Overall Study|Refused hospitalization|1|||
146171499|NCT00708435|527141025|FG001|Overall Study|Refused hospitalization|0|||
146171500|NCT05061537|527141031|FG000|Treatment Phase|Progressive disease|0|||
146171501|NCT05061537|527141032|FG001|Treatment Phase|Progressive disease|1|||
146171502|NCT05061537|527141033|FG002|Treatment Phase|Progressive disease|2|||
146171503|NCT05061537|527141034|FG003|Treatment Phase|Progressive disease|0|||
146171504|NCT05061537|527141035|FG004|Treatment Phase|Progressive disease|0|||
146171505|NCT05061537|527141031|FG000|Treatment Phase|Adverse Event|0|||
146171506|NCT05061537|527141032|FG001|Treatment Phase|Adverse Event|0|||
146171507|NCT05061537|527141033|FG002|Treatment Phase|Adverse Event|2|||
146171508|NCT05061537|527141034|FG003|Treatment Phase|Adverse Event|0|||
146171509|NCT05061537|527141035|FG004|Treatment Phase|Adverse Event|0|||
146171510|NCT05061537|527141031|FG000|Treatment Phase|Global deterioration of health status|0|||
146171511|NCT05061537|527141032|FG001|Treatment Phase|Global deterioration of health status|1|||
146171512|NCT05061537|527141033|FG002|Treatment Phase|Global deterioration of health status|0|||
146171513|NCT05061537|527141034|FG003|Treatment Phase|Global deterioration of health status|0|||
146171514|NCT05061537|527141035|FG004|Treatment Phase|Global deterioration of health status|0|||
146171515|NCT05061537|527141031|FG000|Follow up|Other|2|||
146171516|NCT05061537|527141032|FG001|Follow up|Other|0|||
146171517|NCT05061537|527141033|FG002|Follow up|Other|2|||
146171518|NCT05061537|527141034|FG003|Follow up|Other|0|||
146171519|NCT05061537|527141035|FG004|Follow up|Other|0|||
146171520|NCT05061537|527141031|FG000|Follow up|Study terminated by sponsor|0|||
146171521|NCT05061537|527141032|FG001|Follow up|Study terminated by sponsor|0|||
146171522|NCT05061537|527141033|FG002|Follow up|Study terminated by sponsor|2|||
146171523|NCT05061537|527141034|FG003|Follow up|Study terminated by sponsor|0|||
146171524|NCT05061537|527141035|FG004|Follow up|Study terminated by sponsor|0|||
146171525|NCT05061537|527141031|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
146171526|NCT05061537|527141032|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
146171527|NCT05061537|527141033|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
146171528|NCT05061537|527141034|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
146171529|NCT05061537|527141035|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
146171530|NCT05061537|527141031|FG000|Long-term Follow-up|Death|0|||
146171531|NCT05061537|527141032|FG001|Long-term Follow-up|Death|1|||
146171532|NCT05061537|527141033|FG002|Long-term Follow-up|Death|0|||
146171533|NCT05061537|527141034|FG003|Long-term Follow-up|Death|0|||
146171534|NCT05061537|527141035|FG004|Long-term Follow-up|Death|0|||
146171535|NCT01691521|527141038|FG000|Overall Study|Adverse Event|4|||
146171536|NCT01691521|527141039|FG001|Overall Study|Adverse Event|0|||
146171537|NCT01691521|527141040|FG002|Overall Study|Adverse Event|1|||
146171538|NCT01691521|527141038|FG000|Overall Study|Lack of Efficacy|1|||
146171539|NCT01691521|527141039|FG001|Overall Study|Lack of Efficacy|1|||
146171540|NCT01691521|527141040|FG002|Overall Study|Lack of Efficacy|2|||
146171541|NCT01691521|527141038|FG000|Overall Study|Protocol Violation|0|||
146171542|NCT01691521|527141039|FG001|Overall Study|Protocol Violation|3|||
146171543|NCT01691521|527141040|FG002|Overall Study|Protocol Violation|0|||
146171544|NCT01691521|527141038|FG000|Overall Study|Lost to Follow-up|0|||
146403885|NCT00742859|527983035|FG000|Overall Study|Physician Decision|1|||
146403886|NCT00742859|527983036|FG001|Overall Study|Physician Decision|2|||
146403887|NCT00742859|527983037|FG002|Overall Study|Physician Decision|0|||
146403888|NCT00742859|527983038|FG003|Overall Study|Physician Decision|0|||
146403889|NCT00742859|527983035|FG000|Overall Study|Withdrawal by Subject|4|||
146403890|NCT00742859|527983036|FG001|Overall Study|Withdrawal by Subject|2|||
146403891|NCT00742859|527983037|FG002|Overall Study|Withdrawal by Subject|4|||
146403892|NCT00742859|527983038|FG003|Overall Study|Withdrawal by Subject|1|||
146403893|NCT00742859|527983035|FG000|Overall Study|Endpoint|0|||
146403894|NCT00742859|527983036|FG001|Overall Study|Endpoint|1|||
146403895|NCT00742859|527983037|FG002|Overall Study|Endpoint|1|||
146403896|NCT00742859|527983038|FG003|Overall Study|Endpoint|2|||
146403897|NCT00742859|527983035|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
146403898|NCT00742859|527983036|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
146403899|NCT00742859|527983037|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
146403900|NCT00742859|527983038|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
146403901|NCT00742859|527983035|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
146403902|NCT00742859|527983036|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
146403903|NCT00742859|527983037|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
146403904|NCT00742859|527983038|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
146403905|NCT00742859|527983035|FG000|Overall Study|Sponsor request patient out of town|0|||
146403906|NCT00742859|527983036|FG001|Overall Study|Sponsor request patient out of town|0|||
146403907|NCT00742859|527983037|FG002|Overall Study|Sponsor request patient out of town|1|||
146403908|NCT00742859|527983038|FG003|Overall Study|Sponsor request patient out of town|1|||
146403909|NCT00742859|527983035|FG000|Overall Study|Site error|0|||
146403910|NCT00742859|527983036|FG001|Overall Study|Site error|0|||
146403911|NCT00742859|527983037|FG002|Overall Study|Site error|1|||
146403912|NCT00742859|527983038|FG003|Overall Study|Site error|1|||
146403913|NCT00943384|527983048|FG000|Overall Study|Dispositioned prior to treatment|23|||
146403914|NCT00943384|527983048|FG000|Overall Study|Treated off protocol-protocol violation|5|||
146403915|NCT00943384|527983048|FG000|Overall Study|Lost to Follow-up|16|||
146403916|NCT00943384|527983048|FG000|Overall Study|Withdrawal by Subject|5|||
146403917|NCT02575807|527983049|FG000|Overall Study|Death|8|||
146403918|NCT02575807|527983050|FG001|Overall Study|Death|3|||
146403919|NCT02575807|527983051|FG002|Overall Study|Death|7|||
146403920|NCT02575807|527983052|FG003|Overall Study|Death|0|||
146403921|NCT02575807|527983053|FG004|Overall Study|Death|1|||
146403922|NCT02575807|527983049|FG000|Overall Study|Study terminated by Sponsor|0|||
146403923|NCT02575807|527983050|FG001|Overall Study|Study terminated by Sponsor|1|||
146403924|NCT02575807|527983051|FG002|Overall Study|Study terminated by Sponsor|7|||
146403925|NCT02575807|527983052|FG003|Overall Study|Study terminated by Sponsor|0|||
146403926|NCT02575807|527983053|FG004|Overall Study|Study terminated by Sponsor|1|||
146403927|NCT02575807|527983049|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
146403928|NCT02575807|527983050|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
146403929|NCT02575807|527983051|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
146403930|NCT02575807|527983052|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
146403931|NCT02575807|527983053|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
146403932|NCT02575807|527983049|FG000|Overall Study|Terminated due to physician decision|0|||
146403933|NCT02575807|527983050|FG001|Overall Study|Terminated due to physician decision|0|||
146403934|NCT02575807|527983051|FG002|Overall Study|Terminated due to physician decision|1|||
146403935|NCT02575807|527983052|FG003|Overall Study|Terminated due to physician decision|0|||
146403936|NCT02575807|527983053|FG004|Overall Study|Terminated due to physician decision|0|||
146403937|NCT02575807|527983049|FG000|Overall Study|Subject ineligible - medical implant|0|||
146403938|NCT02575807|527983050|FG001|Overall Study|Subject ineligible - medical implant|0|||
146403939|NCT02575807|527983051|FG002|Overall Study|Subject ineligible - medical implant|0|||
146403940|NCT02575807|527983052|FG003|Overall Study|Subject ineligible - medical implant|1|||
146403941|NCT02575807|527983053|FG004|Overall Study|Subject ineligible - medical implant|0|||
146403942|NCT02575807|527983049|FG000|Overall Study|Withdrawal by Subject|0|||
146403943|NCT02575807|527983050|FG001|Overall Study|Withdrawal by Subject|0|||
146403944|NCT02575807|527983051|FG002|Overall Study|Withdrawal by Subject|1|||
146403945|NCT02575807|527983052|FG003|Overall Study|Withdrawal by Subject|1|||
146403946|NCT02575807|527983053|FG004|Overall Study|Withdrawal by Subject|2|||
146403947|NCT00478673|527983061|FG000|30-Days Post-Procedure|Death|2|||
146403948|NCT00478673|527983061|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
146403949|NCT00478673|527983061|FG000|30-Days Post-Procedure|Missed Visit|7|||
146403950|NCT00478673|527983061|FG000|12-Months Post-Procedure|Death|23|||
146403951|NCT00478673|527983061|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
146403952|NCT00478673|527983061|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
146403953|NCT00478673|527983061|FG000|12-Months Post-Procedure|Missed Visit|25|||
146403954|NCT00478673|527983061|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
146403955|NCT03940742|527983069|FG000|Overall Study|Lost to Follow-up|0|||
146403956|NCT03940742|527983070|FG001|Overall Study|Lost to Follow-up|0|||
146403957|NCT03940742|527983071|FG002|Overall Study|Lost to Follow-up|0|||
145945242|NCT01606202|526308185|FG000|Overall Study|Personal problems|0|||
146403958|NCT03940742|527983072|FG003|Overall Study|Lost to Follow-up|1|||
146403959|NCT02032823|527983073|FG000|Overall Study|Death|75|||
146403960|NCT02032823|527983074|FG001|Overall Study|Death|109|||
146403961|NCT02032823|527983073|FG000|Overall Study|Lost to Follow-up|18|||
146403962|NCT02032823|527983074|FG001|Overall Study|Lost to Follow-up|17|||
146403963|NCT02032823|527983073|FG000|Overall Study|Withdrawal by Subject|70|||
146403964|NCT02032823|527983074|FG001|Overall Study|Withdrawal by Subject|53|||
146403965|NCT02032823|527983073|FG000|Overall Study|Ongoing study at data cut-off|755|||
146403966|NCT02032823|527983074|FG001|Overall Study|Ongoing study at data cut-off|731|||
146403967|NCT02032823|527983073|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
146403968|NCT02032823|527983074|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
146403969|NCT03428217|527983075|FG000|Overall Study|Death|89|||
146403970|NCT03428217|527983076|FG001|Overall Study|Death|93|||
146403971|NCT03428217|527983075|FG000|Overall Study|Withdrawal by Subject|8|||
146403972|NCT03428217|527983076|FG001|Overall Study|Withdrawal by Subject|7|||
146403973|NCT03428217|527983075|FG000|Overall Study|Lost to Follow-up|1|||
146403974|NCT03428217|527983076|FG001|Overall Study|Lost to Follow-up|3|||
146403975|NCT03428217|527983075|FG000|Overall Study|Study terminated by sponsor|124|||
146403976|NCT03428217|527983076|FG001|Overall Study|Study terminated by sponsor|118|||
146403977|NCT03428217|527983075|FG000|Overall Study|Other, Not Specified|1|||
146403978|NCT03428217|527983076|FG001|Overall Study|Other, Not Specified|0|||
146403979|NCT03889197|527983077|FG000|Overall Study|Withdrawal by Subject|1|||
146403980|NCT03889197|527983078|FG001|Overall Study|Withdrawal by Subject|0|||
146403981|NCT03889197|527983077|FG000|Overall Study|Physician Decision|0|||
146403982|NCT03889197|527983078|FG001|Overall Study|Physician Decision|1|||
146403983|NCT03889197|527983077|FG000|Overall Study|met exclusion criteria|0|||
146403984|NCT03889197|527983078|FG001|Overall Study|met exclusion criteria|1|||
146403985|NCT03889197|527983077|FG000|Overall Study|Protocol Violation|1|||
146403986|NCT03889197|527983078|FG001|Overall Study|Protocol Violation|0|||
146403987|NCT05246111|527983079|FG000|Period 01|NOT ELIGIBLE IC5|1|||
146403988|NCT05246111|527983080|FG001|Period 01|NOT ELIGIBLE IC5|0|||
146403989|NCT03151226|527983081|FG000|Overall Study|Withdrawal by Subject|2|||
146403990|NCT03151226|527983081|FG000|Overall Study|not wear device correctly|1|||
146403991|NCT00402779|527983082|FG000|Overall Study|Screen Failure|77|||
146403992|NCT00402779|527983083|FG001|Overall Study|Screen Failure|76|||
146403993|NCT05004181|527983087|FG000|Overall Study|Withdrawal of consent|0|||
146403994|NCT05004181|527983088|FG001|Overall Study|Withdrawal of consent|0|||
146403995|NCT05004181|527983089|FG002|Overall Study|Withdrawal of consent|1|||
146403996|NCT05004181|527983090|FG003|Overall Study|Withdrawal of consent|3|||
146403997|NCT05004181|527983091|FG004|Overall Study|Withdrawal of consent|3|||
146403998|NCT05004181|527983092|FG005|Overall Study|Withdrawal of consent|0|||
146403999|NCT05004181|527983093|FG006|Overall Study|Withdrawal of consent|30|||
146404000|NCT05004181|527983094|FG007|Overall Study|Withdrawal of consent|9|||
146404001|NCT05004181|527983095|FG008|Overall Study|Withdrawal of consent|3|||
146404002|NCT05004181|527983096|FG009|Overall Study|Withdrawal of consent|2|||
146404003|NCT05004181|527983097|FG010|Overall Study|Withdrawal of consent|5|||
146404004|NCT05004181|527983098|FG011|Overall Study|Withdrawal of consent|1|||
146404005|NCT05004181|527983087|FG000|Overall Study|Lost to Follow-up|2|||
146404006|NCT05004181|527983088|FG001|Overall Study|Lost to Follow-up|4|||
146404007|NCT05004181|527983089|FG002|Overall Study|Lost to Follow-up|2|||
146404008|NCT05004181|527983090|FG003|Overall Study|Lost to Follow-up|3|||
146404009|NCT05004181|527983091|FG004|Overall Study|Lost to Follow-up|5|||
146404010|NCT05004181|527983092|FG005|Overall Study|Lost to Follow-up|2|||
146404011|NCT05004181|527983093|FG006|Overall Study|Lost to Follow-up|15|||
146404012|NCT05004181|527983094|FG007|Overall Study|Lost to Follow-up|12|||
146404013|NCT05004181|527983095|FG008|Overall Study|Lost to Follow-up|38|||
146404014|NCT05004181|527983096|FG009|Overall Study|Lost to Follow-up|6|||
146404015|NCT05004181|527983097|FG010|Overall Study|Lost to Follow-up|6|||
146171545|NCT01691521|527141039|FG001|Overall Study|Lost to Follow-up|2|||
146404016|NCT05004181|527983098|FG011|Overall Study|Lost to Follow-up|0|||
146404017|NCT05004181|527983087|FG000|Overall Study|Death|0|||
146404018|NCT05004181|527983088|FG001|Overall Study|Death|0|||
146404019|NCT05004181|527983089|FG002|Overall Study|Death|0|||
146404020|NCT05004181|527983090|FG003|Overall Study|Death|0|||
146404021|NCT05004181|527983091|FG004|Overall Study|Death|0|||
146404022|NCT05004181|527983092|FG005|Overall Study|Death|0|||
146404023|NCT05004181|527983093|FG006|Overall Study|Death|1|||
146404024|NCT05004181|527983094|FG007|Overall Study|Death|0|||
146404025|NCT05004181|527983095|FG008|Overall Study|Death|2|||
146404026|NCT05004181|527983096|FG009|Overall Study|Death|0|||
146404027|NCT05004181|527983097|FG010|Overall Study|Death|0|||
146404028|NCT05004181|527983098|FG011|Overall Study|Death|0|||
146404029|NCT05004181|527983087|FG000|Overall Study|Physician Decision|0|||
146404030|NCT05004181|527983088|FG001|Overall Study|Physician Decision|0|||
146404031|NCT05004181|527983089|FG002|Overall Study|Physician Decision|0|||
146404032|NCT05004181|527983090|FG003|Overall Study|Physician Decision|0|||
146404033|NCT05004181|527983091|FG004|Overall Study|Physician Decision|0|||
146404034|NCT05004181|527983092|FG005|Overall Study|Physician Decision|0|||
146404035|NCT05004181|527983093|FG006|Overall Study|Physician Decision|2|||
146404036|NCT05004181|527983094|FG007|Overall Study|Physician Decision|0|||
146404037|NCT05004181|527983095|FG008|Overall Study|Physician Decision|7|||
146404038|NCT05004181|527983096|FG009|Overall Study|Physician Decision|0|||
146404039|NCT05004181|527983097|FG010|Overall Study|Physician Decision|0|||
146404040|NCT05004181|527983098|FG011|Overall Study|Physician Decision|0|||
146404041|NCT05004181|527983087|FG000|Overall Study|Withdrawal by Subject|2|||
146404042|NCT05004181|527983088|FG001|Overall Study|Withdrawal by Subject|3|||
146404043|NCT05004181|527983089|FG002|Overall Study|Withdrawal by Subject|2|||
146404044|NCT05004181|527983090|FG003|Overall Study|Withdrawal by Subject|2|||
146404045|NCT05004181|527983091|FG004|Overall Study|Withdrawal by Subject|4|||
146404046|NCT05004181|527983092|FG005|Overall Study|Withdrawal by Subject|2|||
146404047|NCT05004181|527983093|FG006|Overall Study|Withdrawal by Subject|4|||
146404048|NCT05004181|527983094|FG007|Overall Study|Withdrawal by Subject|22|||
146404049|NCT05004181|527983095|FG008|Overall Study|Withdrawal by Subject|8|||
146404050|NCT05004181|527983096|FG009|Overall Study|Withdrawal by Subject|1|||
146404051|NCT05004181|527983097|FG010|Overall Study|Withdrawal by Subject|3|||
146404052|NCT05004181|527983098|FG011|Overall Study|Withdrawal by Subject|2|||
146404053|NCT05004181|527983087|FG000|Overall Study|Protocol Violation|2|||
146404054|NCT05004181|527983088|FG001|Overall Study|Protocol Violation|3|||
146404055|NCT05004181|527983089|FG002|Overall Study|Protocol Violation|0|||
146404056|NCT05004181|527983090|FG003|Overall Study|Protocol Violation|0|||
146404057|NCT05004181|527983091|FG004|Overall Study|Protocol Violation|1|||
146404058|NCT05004181|527983092|FG005|Overall Study|Protocol Violation|0|||
146404059|NCT05004181|527983093|FG006|Overall Study|Protocol Violation|16|||
146404060|NCT05004181|527983094|FG007|Overall Study|Protocol Violation|18|||
146404061|NCT05004181|527983095|FG008|Overall Study|Protocol Violation|2|||
146404062|NCT05004181|527983096|FG009|Overall Study|Protocol Violation|2|||
146404063|NCT05004181|527983097|FG010|Overall Study|Protocol Violation|2|||
146404064|NCT05004181|527983098|FG011|Overall Study|Protocol Violation|1|||
146404065|NCT05004181|527983087|FG000|Overall Study|Not further specified|1|||
146404066|NCT05004181|527983088|FG001|Overall Study|Not further specified|0|||
146404067|NCT05004181|527983089|FG002|Overall Study|Not further specified|0|||
146404068|NCT05004181|527983090|FG003|Overall Study|Not further specified|0|||
146404069|NCT05004181|527983091|FG004|Overall Study|Not further specified|0|||
146404070|NCT05004181|527983092|FG005|Overall Study|Not further specified|0|||
146404071|NCT05004181|527983093|FG006|Overall Study|Not further specified|1|||
146404072|NCT05004181|527983094|FG007|Overall Study|Not further specified|0|||
146404073|NCT05004181|527983095|FG008|Overall Study|Not further specified|2|||
146404074|NCT05004181|527983096|FG009|Overall Study|Not further specified|1|||
146404075|NCT05004181|527983097|FG010|Overall Study|Not further specified|0|||
146404076|NCT05004181|527983098|FG011|Overall Study|Not further specified|1|||
146404077|NCT04066894|527983099|FG000|Overall Study|Lack of Efficacy|1|||
146404078|NCT04066894|527983099|FG000|Overall Study|Screen Failure|1|||
146404079|NCT02949219|527983100|FG000|Overall Study|Withdrawal by Subject|1|||
146404080|NCT04278872|527983101|FG000|Overall Study|Adverse Event|1|||
146404081|NCT04278872|527983102|FG001|Overall Study|Adverse Event|0|||
146404082|NCT04278872|527983101|FG000|Overall Study|Protocol Violation|0|||
146404083|NCT04278872|527983102|FG001|Overall Study|Protocol Violation|1|||
146404084|NCT04278872|527983101|FG000|Overall Study|Study Termination|2|||
146404085|NCT04278872|527983102|FG001|Overall Study|Study Termination|0|||
146404086|NCT03494816|527983103|FG000|Overall Study|Protocol Violation|2|||
146404087|NCT03494816|527983103|FG000|Overall Study|Physician Decision|2|||
146404088|NCT03494816|527983103|FG000|Overall Study|Did not start trial treatment|1|||
146404089|NCT03494816|527983103|FG000|Overall Study|Adverse Event|1|||
146404090|NCT01283282|527983108|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
146404091|NCT01283282|527983109|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
146404092|NCT01283282|527983108|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
146404093|NCT01283282|527983109|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
146404094|NCT01283282|527983108|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
146404095|NCT01283282|527983109|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
146404096|NCT00096031|527983110|FG000|Overall Study|Adverse Event|3|||
146404097|NCT00096031|527983110|FG000|Overall Study|Lack of Efficacy|42|||
146404098|NCT00096031|527983110|FG000|Overall Study|Death|4|||
146404099|NCT00096031|527983110|FG000|Overall Study|Withdrawal by Subject|1|||
146404100|NCT00096031|527983110|FG000|Overall Study|Ineligible|8|||
146404101|NCT00096031|527983110|FG000|Overall Study|Not protocol specified|5|||
146404102|NCT00777920|527983111|FG000|Overall Study|Adverse Event|39|||
146404103|NCT00777920|527983111|FG000|Overall Study|Withdrawal of Consent|4|||
146404104|NCT00777920|527983111|FG000|Overall Study|Lost to Follow-up|1|||
146404105|NCT00777920|527983111|FG000|Overall Study|Investigator's discretion|1|||
146404106|NCT00777920|527983111|FG000|Overall Study|Clinical status did not improve|1|||
146404107|NCT00777920|527983111|FG000|Overall Study|Other, not specified|4|||
146404108|NCT00483717|527983112|FG000|Overall Study|Protocol Violation|5|||
146404109|NCT00483717|527983113|FG001|Overall Study|Protocol Violation|7|||
145945243|NCT01606202|526308186|FG001|Overall Study|Personal problems|1|||
146404110|NCT00483717|527983112|FG000|Overall Study|Time of dosing missing|1|||
146404111|NCT00483717|527983113|FG001|Overall Study|Time of dosing missing|1|||
146404112|NCT00483717|527983112|FG000|Overall Study|No treatment for migraine|16|||
146404113|NCT00483717|527983113|FG001|Overall Study|No treatment for migraine|13|||
146404114|NCT00483717|527983112|FG000|Overall Study|Lost to Follow-up|1|||
146404115|NCT00483717|527983113|FG001|Overall Study|Lost to Follow-up|0|||
146404116|NCT00483717|527983112|FG000|Overall Study|Withdrawal by Subject|1|||
146404117|NCT00483717|527983113|FG001|Overall Study|Withdrawal by Subject|0|||
146404118|NCT00083226|527983114|FG000|Overall Study|Lack of Efficacy|19|||
146404119|NCT00083226|527983114|FG000|Overall Study|Adverse Event|9|||
146404120|NCT00083226|527983114|FG000|Overall Study|Death|4|||
146404121|NCT00083226|527983114|FG000|Overall Study|Withdrawal by Subject|4|||
146404122|NCT00083226|527983114|FG000|Overall Study|Other|2|||
146404123|NCT00083226|527983114|FG000|Overall Study|ineligible or not receiving treatment|4|||
146404124|NCT00909857|527983115|FG000|Overall Study|Withdrawal by Subject|6|||
146404125|NCT00909857|527983116|FG001|Overall Study|Withdrawal by Subject|10|||
146404126|NCT00909857|527983115|FG000|Overall Study|Adverse Event|5|||
146404127|NCT00909857|527983116|FG001|Overall Study|Adverse Event|5|||
146404128|NCT00909857|527983115|FG000|Overall Study|Lost to Follow-up|2|||
146404129|NCT00909857|527983116|FG001|Overall Study|Lost to Follow-up|5|||
146404130|NCT00909857|527983115|FG000|Overall Study|Protocol Violation|2|||
146404131|NCT00909857|527983116|FG001|Overall Study|Protocol Violation|1|||
146404132|NCT00909857|527983115|FG000|Overall Study|Pregnancy|1|||
146404133|NCT00909857|527983116|FG001|Overall Study|Pregnancy|0|||
146404134|NCT00909857|527983115|FG000|Overall Study|Other|1|||
146404135|NCT00909857|527983116|FG001|Overall Study|Other|0|||
146404136|NCT00909857|527983115|FG000|Overall Study|Did not receive study medication|19|||
146404137|NCT00909857|527983116|FG001|Overall Study|Did not receive study medication|24|||
146404138|NCT03878108|527983117|FG000|Overall Study|Adverse Event|1|||
146404139|NCT03878108|527983118|FG001|Overall Study|Adverse Event|0|||
146404140|NCT00604175|527983125|FG000|Entry Through Week 28|Death|2|||
146404141|NCT00604175|527983126|FG001|Entry Through Week 28|Death|0|||
146404142|NCT00604175|527983127|FG002|Entry Through Week 28|Death|0|||
146404143|NCT00604175|527983125|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
146404144|NCT00604175|527983126|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
146404145|NCT00604175|527983127|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
146404146|NCT00604175|527983125|FG000|Entry Through Week 28|Lost to Follow-up|4|||
146404147|NCT00604175|527983126|FG001|Entry Through Week 28|Lost to Follow-up|3|||
146404148|NCT00604175|527983127|FG002|Entry Through Week 28|Lost to Follow-up|0|||
146404149|NCT00604175|527983125|FG000|Entry Through Week 28|Ineligible|1|||
146404150|NCT00604175|527983126|FG001|Entry Through Week 28|Ineligible|0|||
146404151|NCT00604175|527983127|FG002|Entry Through Week 28|Ineligible|0|||
146404152|NCT00604175|527983125|FG000|Entry Through Week 28|Did not start intervention|2|||
146404153|NCT00604175|527983126|FG001|Entry Through Week 28|Did not start intervention|0|||
146404154|NCT00604175|527983127|FG002|Entry Through Week 28|Did not start intervention|1|||
146404155|NCT00604175|527983125|FG000|Week 29 Through Week 72|Death|0|||
146404156|NCT00604175|527983126|FG001|Week 29 Through Week 72|Death|0|||
146404157|NCT00604175|527983127|FG002|Week 29 Through Week 72|Death|1|||
146404158|NCT00604175|527983125|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
146404159|NCT00604175|527983126|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
146404160|NCT00604175|527983127|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
146404161|NCT00604175|527983125|FG000|Week 29 Through Week 72|Site closure|0|||
146404162|NCT00604175|527983126|FG001|Week 29 Through Week 72|Site closure|1|||
146404163|NCT00604175|527983127|FG002|Week 29 Through Week 72|Site closure|0|||
146404164|NCT00604175|527983125|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
146404165|NCT00604175|527983126|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
146404166|NCT00604175|527983127|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
146404167|NCT01682681|527983128|FG000|Overall Study|Lack of Efficacy|62|||
146404168|NCT01682681|527983128|FG000|Overall Study|Withdrawal by Subject|1|||
146404169|NCT01682681|527983128|FG000|Overall Study|Moved to other hospital|10|||
146404170|NCT01682681|527983128|FG000|Overall Study|Lost to Follow-up|174|||
146404171|NCT01682681|527983128|FG000|Overall Study|Adverse Event|46|||
146404172|NCT01682681|527983128|FG000|Overall Study|tapering of topiramate|5|||
146404173|NCT01682681|527983128|FG000|Overall Study|Other|21|||
146404174|NCT01682681|527983128|FG000|Overall Study|Low compliance|13|||
146404175|NCT02044094|527983129|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
146404176|NCT02044094|527983129|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
146404177|NCT02044094|527983129|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
146404178|NCT02044094|527983129|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
146404179|NCT02044094|527983129|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
146404180|NCT02044094|527983129|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
146404181|NCT02044094|527983129|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
146404182|NCT02044094|527983129|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
146404183|NCT03353415|527983132|FG000|Masked CGM Wear|Lost to Follow-up|2|||
146404184|NCT03353415|527983132|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
146404185|NCT00975000|527983133|FG000|Overall Study|Other|1|||
146404186|NCT00975000|527983134|FG001|Overall Study|Other|0|||
146404187|NCT00975000|527983133|FG000|Overall Study|Adverse Event|1|||
146404188|NCT00975000|527983134|FG001|Overall Study|Adverse Event|1|||
146404189|NCT00975000|527983133|FG000|Overall Study|Withdrawal by Subject|2|||
146404190|NCT00975000|527983134|FG001|Overall Study|Withdrawal by Subject|2|||
146404191|NCT00975000|527983133|FG000|Overall Study|Lost to Follow-up|0|||
146404192|NCT00975000|527983134|FG001|Overall Study|Lost to Follow-up|1|||
146404193|NCT00975000|527983133|FG000|Overall Study|Protocol-specified Criteria|1|||
146404194|NCT00975000|527983134|FG001|Overall Study|Protocol-specified Criteria|0|||
146404195|NCT00975000|527983133|FG000|Overall Study|Non-compliance|0|||
146404196|NCT00975000|527983134|FG001|Overall Study|Non-compliance|1|||
146404197|NCT00359073|527984748|FG000|Overall Study|Withdrawal by Subject|1|||
146404198|NCT00359073|527984749|FG001|Overall Study|Withdrawal by Subject|1|||
146404199|NCT00359073|527984748|FG000|Overall Study|Eligibility criteria no longer met|3|||
146404200|NCT00359073|527984749|FG001|Overall Study|Eligibility criteria no longer met|0|||
146404201|NCT00359073|527984748|FG000|Overall Study|developed RV16 antibody|0|||
146404202|NCT00359073|527984749|FG001|Overall Study|developed RV16 antibody|1|||
146404203|NCT01371006|527984750|FG000|Overall Study|Adverse Event|1|||
146404204|NCT01371006|527984751|FG001|Overall Study|Adverse Event|0|||
146404205|NCT00891527|527984752|FG000|Overall Study|Withdrawal by Subject|2|||
146404206|NCT03515837|527984754|FG000|Overall Study|Death|219|||
146404207|NCT03515837|527984755|FG001|Overall Study|Death|227|||
146404208|NCT03515837|527984754|FG000|Overall Study|Lost to Follow-up|0|||
146404209|NCT03515837|527984755|FG001|Overall Study|Lost to Follow-up|1|||
146404210|NCT03515837|527984754|FG000|Overall Study|Withdrawal by Subject|0|||
146404211|NCT03515837|527984755|FG001|Overall Study|Withdrawal by Subject|4|||
146404212|NCT03515837|527984754|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
146404213|NCT03515837|527984755|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
146404214|NCT01964898|527984756|FG000|Overall Study|ineligible post-randomization|1|||
146404215|NCT01964898|527984757|FG001|Overall Study|ineligible post-randomization|1|||
146404216|NCT01964898|527984756|FG000|Overall Study|did not receive the allocated interventi|2|||
146404217|NCT01964898|527984757|FG001|Overall Study|did not receive the allocated interventi|1|||
146404218|NCT01964898|527984756|FG000|Overall Study|Lost to Follow-up|3|||
146404219|NCT01964898|527984757|FG001|Overall Study|Lost to Follow-up|5|||
146404220|NCT01964898|527984756|FG000|Overall Study|Withdrawal by Subject|1|||
146404221|NCT01964898|527984757|FG001|Overall Study|Withdrawal by Subject|0|||
146404222|NCT02957682|527984760|FG000|Overall Study|Adverse Event|64|||
146171546|NCT01691521|527141040|FG002|Overall Study|Lost to Follow-up|2|||
146171547|NCT01691521|527141038|FG000|Overall Study|Physician Decision|2|||
146171548|NCT01691521|527141039|FG001|Overall Study|Physician Decision|1|||
146171549|NCT01691521|527141040|FG002|Overall Study|Physician Decision|0|||
146171550|NCT01691521|527141038|FG000|Overall Study|Withdrawal by Subject|5|||
146171551|NCT01691521|527141039|FG001|Overall Study|Withdrawal by Subject|9|||
146171552|NCT01691521|527141040|FG002|Overall Study|Withdrawal by Subject|4|||
146171553|NCT02343003|527141041|FG000|Overall Study|Withdrawal by Subject|9|||
146171554|NCT02343003|527141042|FG001|Overall Study|Withdrawal by Subject|4|||
146171555|NCT02343003|527141041|FG000|Overall Study|Lost to Follow-up|5|||
146171556|NCT02343003|527141042|FG001|Overall Study|Lost to Follow-up|1|||
146171557|NCT02343003|527141041|FG000|Overall Study|Protocol Violation|1|||
146171558|NCT02343003|527141042|FG001|Overall Study|Protocol Violation|0|||
146171559|NCT02343003|527141041|FG000|Overall Study|Death|0|||
146171560|NCT02343003|527141042|FG001|Overall Study|Death|1|||
146171561|NCT02343003|527141041|FG000|Overall Study|exclusion criteria met|1|||
146171562|NCT02343003|527141042|FG001|Overall Study|exclusion criteria met|1|||
146171563|NCT02343003|527141041|FG000|Overall Study|terminated by sponsor|2|||
146171564|NCT02343003|527141042|FG001|Overall Study|terminated by sponsor|0|||
146171565|NCT01153269|527141043|FG000|Overall Study|Withdrawal by Subject|1|||
146171566|NCT01153269|527141043|FG000|Overall Study|Antiretroviral therapy break|1|||
146171567|NCT02281760|527141044|FG000|Overall Study|Withdrawal by Subject|1|||
146171568|NCT02635724|527141045|FG000|Overall Study|Withdrawal by Subject|0|||
146171569|NCT02635724|527141046|FG001|Overall Study|Withdrawal by Subject|1|||
146404223|NCT02957682|527984761|FG001|Overall Study|Adverse Event|67|||
146404224|NCT02957682|527984760|FG000|Overall Study|Poor Compliance to Protocol|30|||
146171570|NCT02635724|527141047|FG002|Overall Study|Withdrawal by Subject|0|||
146171571|NCT00100932|527141054|FG000|Overall Study|Adverse Event|11|||
146171572|NCT00100932|527141055|FG001|Overall Study|Adverse Event|2|||
146171573|NCT00100932|527141054|FG000|Overall Study|Withdrawal by Subject|6|||
146171574|NCT00100932|527141055|FG001|Overall Study|Withdrawal by Subject|0|||
146171575|NCT00100932|527141054|FG000|Overall Study|Progressive Disease|44|||
146171576|NCT00100932|527141055|FG001|Overall Study|Progressive Disease|18|||
146171577|NCT00100932|527141054|FG000|Overall Study|Physician Decision|7|||
146171578|NCT00100932|527141055|FG001|Overall Study|Physician Decision|5|||
146171579|NCT00100932|527141054|FG000|Overall Study|Other|5|||
146171580|NCT00100932|527141055|FG001|Overall Study|Other|2|||
146171581|NCT02387996|527141058|FG000|Overall Study|Disease Progression|167|||
146171582|NCT02387996|527141058|FG000|Overall Study|Study Drug Toxicity|31|||
146171583|NCT02387996|527141058|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
146404225|NCT02957682|527984761|FG001|Overall Study|Poor Compliance to Protocol|26|||
146404226|NCT02957682|527984760|FG000|Overall Study|Physician Decision|4|||
146404227|NCT02957682|527984761|FG001|Overall Study|Physician Decision|4|||
146404228|NCT02957682|527984760|FG000|Overall Study|Study Terminated by Sponsor|4|||
146404229|NCT02957682|527984761|FG001|Overall Study|Study Terminated by Sponsor|3|||
146404230|NCT02957682|527984760|FG000|Overall Study|Subject Moved|10|||
146404231|NCT02957682|527984761|FG001|Overall Study|Subject Moved|16|||
146404232|NCT02957682|527984760|FG000|Overall Study|Withdrawal by Subject|64|||
146404233|NCT02957682|527984761|FG001|Overall Study|Withdrawal by Subject|33|||
146404234|NCT02957682|527984760|FG000|Overall Study|Related to IMP Administration|3|||
146404235|NCT02957682|527984761|FG001|Overall Study|Related to IMP Administration|6|||
146404236|NCT02957682|527984760|FG000|Overall Study|Non-disclosed|16|||
146404237|NCT02957682|527984761|FG001|Overall Study|Non-disclosed|12|||
146404238|NCT02957682|527984760|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
146404239|NCT02957682|527984761|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
146404240|NCT02953262|527984769|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
146404241|NCT02953262|527984770|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
146404242|NCT02953262|527984771|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
146404243|NCT02953262|527984772|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
146404244|NCT00934622|527984773|FG000|Overall Study|Lost to Follow-up|7|||
146404245|NCT00934622|527984773|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
146404246|NCT03349437|527984774|FG000|Screening|Screen Fail|4|||
146404247|NCT03349437|527984775|FG001|Screening|Screen Fail|0|||
146404248|NCT03349437|527984776|FG002|Screening|Screen Fail|0|||
146404249|NCT03349437|527984774|FG000|Screening|Withdrawn|1|||
146404250|NCT03349437|527984775|FG001|Screening|Withdrawn|0|||
146404251|NCT03349437|527984776|FG002|Screening|Withdrawn|0|||
146404252|NCT02406742|527984777|FG000|Overall Study|Progression of Disease|5|||
146404253|NCT02406742|527984778|FG001|Overall Study|Progression of Disease|1|||
146404254|NCT02406742|527984779|FG002|Overall Study|Progression of Disease|6|||
146404255|NCT02406742|527984777|FG000|Overall Study|Adverse Event|3|||
146404256|NCT02406742|527984778|FG001|Overall Study|Adverse Event|0|||
146404257|NCT02406742|527984779|FG002|Overall Study|Adverse Event|2|||
146404258|NCT02406742|527984777|FG000|Overall Study|Death|1|||
146404259|NCT02406742|527984778|FG001|Overall Study|Death|0|||
146404260|NCT02406742|527984779|FG002|Overall Study|Death|0|||
146404261|NCT02406742|527984777|FG000|Overall Study|Lack of Efficacy|0|||
146404262|NCT02406742|527984778|FG001|Overall Study|Lack of Efficacy|0|||
146404263|NCT02406742|527984779|FG002|Overall Study|Lack of Efficacy|1|||
146404264|NCT02406742|527984777|FG000|Overall Study|Withdrawal by Participant|1|||
146404265|NCT02406742|527984778|FG001|Overall Study|Withdrawal by Participant|2|||
146404266|NCT02406742|527984779|FG002|Overall Study|Withdrawal by Participant|0|||
146404267|NCT02406742|527984777|FG000|Overall Study|Physician Decision|1|||
146404268|NCT02406742|527984778|FG001|Overall Study|Physician Decision|2|||
146404269|NCT02406742|527984779|FG002|Overall Study|Physician Decision|1|||
146404270|NCT02406742|527984777|FG000|Overall Study|Transition to other treatment|2|||
146404271|NCT02406742|527984778|FG001|Overall Study|Transition to other treatment|0|||
146404272|NCT02406742|527984779|FG002|Overall Study|Transition to other treatment|1|||
146404273|NCT02406742|527984777|FG000|Overall Study|Other Reasons|1|||
146404274|NCT02406742|527984778|FG001|Overall Study|Other Reasons|11|||
146404275|NCT02406742|527984779|FG002|Overall Study|Other Reasons|5|||
146404276|NCT00765999|527984780|FG000|Overall Study|Adverse Event|203|||
146404277|NCT00765999|527984780|FG000|Overall Study|Insufficient Therapeutic Response|100|||
146404278|NCT00765999|527984780|FG000|Overall Study|Protocol Violation|95|||
146404279|NCT00765999|527984780|FG000|Overall Study|Consent Withdrawn|202|||
146404280|NCT00765999|527984780|FG000|Overall Study|Lost to Follow-up|131|||
146404281|NCT00765999|527984780|FG000|Overall Study|Study Terminated by Sponsor|2|||
146404282|NCT00765999|527984780|FG000|Overall Study|Other Miscellaneous Reasons|51|||
146404283|NCT02367729|527984781|FG000|Overall Study|Organic disorder diagnosed|2|||
146404284|NCT02367729|527984782|FG001|Overall Study|Organic disorder diagnosed|1|||
146404285|NCT02367729|527984781|FG000|Overall Study|Adverse Event|1|||
146404286|NCT02367729|527984782|FG001|Overall Study|Adverse Event|2|||
146404287|NCT02367729|527984781|FG000|Overall Study|Withdrawal by Subject|0|||
146404288|NCT02367729|527984782|FG001|Overall Study|Withdrawal by Subject|5|||
146404289|NCT00759174|527984787|FG000|Overall Study|Other|0|||
146404290|NCT00759174|527984788|FG001|Overall Study|Other|2|||
146404291|NCT01890109|527984789|FG000|Overall Study|Withdrawal by Subject|0|||
146404292|NCT01890109|527984790|FG001|Overall Study|Withdrawal by Subject|3|||
146404293|NCT01890109|527984789|FG000|Overall Study|Lost to Follow-up|1|||
146404294|NCT01890109|527984790|FG001|Overall Study|Lost to Follow-up|2|||
146062716|NCT05194124|526748318|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
146404295|NCT01643928|527984791|FG000|Overall Study|Lost to Follow-up|1|||
146404296|NCT01643928|527984792|FG001|Overall Study|Lost to Follow-up|0|||
146404297|NCT01643928|527984793|FG002|Overall Study|Lost to Follow-up|2|||
146404298|NCT01643928|527984794|FG003|Overall Study|Lost to Follow-up|0|||
146404299|NCT01643928|527984795|FG004|Overall Study|Lost to Follow-up|0|||
146404300|NCT01643928|527984791|FG000|Overall Study|Withdrawal by Subject|2|||
146404301|NCT01643928|527984792|FG001|Overall Study|Withdrawal by Subject|0|||
146404302|NCT01643928|527984793|FG002|Overall Study|Withdrawal by Subject|0|||
146404303|NCT01643928|527984794|FG003|Overall Study|Withdrawal by Subject|1|||
146404304|NCT01643928|527984795|FG004|Overall Study|Withdrawal by Subject|0|||
146404305|NCT01643928|527984791|FG000|Overall Study|Pregnancy|0|||
146404306|NCT01643928|527984792|FG001|Overall Study|Pregnancy|0|||
146404307|NCT01643928|527984793|FG002|Overall Study|Pregnancy|0|||
146404308|NCT01643928|527984794|FG003|Overall Study|Pregnancy|1|||
146404309|NCT01643928|527984795|FG004|Overall Study|Pregnancy|0|||
146404310|NCT01643928|527984791|FG000|Overall Study|Other|5|||
146404311|NCT01643928|527984792|FG001|Overall Study|Other|1|||
146404312|NCT01643928|527984793|FG002|Overall Study|Other|1|||
146404313|NCT01643928|527984794|FG003|Overall Study|Other|0|||
146404314|NCT01643928|527984795|FG004|Overall Study|Other|0|||
146404315|NCT01643928|527984791|FG000|Overall Study|Adverse Event|2|||
146404316|NCT01643928|527984792|FG001|Overall Study|Adverse Event|1|||
146404317|NCT01643928|527984793|FG002|Overall Study|Adverse Event|0|||
146404318|NCT01643928|527984794|FG003|Overall Study|Adverse Event|1|||
146404319|NCT01643928|527984795|FG004|Overall Study|Adverse Event|2|||
146404320|NCT03692078|527984797|FG000|Overall Study|Adverse Event|0|||
146404321|NCT03692078|527984798|FG001|Overall Study|Adverse Event|0|||
146404322|NCT03692078|527984799|FG002|Overall Study|Adverse Event|0|||
146404323|NCT03692078|527984800|FG003|Overall Study|Adverse Event|0|||
146404324|NCT03692078|527984801|FG004|Overall Study|Adverse Event|0|||
146404325|NCT03692078|527984802|FG005|Overall Study|Adverse Event|1|||
146404326|NCT03692078|527984803|FG006|Overall Study|Adverse Event|0|||
146404327|NCT03692078|527984797|FG000|Overall Study|Enrollment Closed|5|||
146404328|NCT03692078|527984798|FG001|Overall Study|Enrollment Closed|0|||
146404329|NCT03692078|527984799|FG002|Overall Study|Enrollment Closed|0|||
146404330|NCT03692078|527984800|FG003|Overall Study|Enrollment Closed|0|||
146404331|NCT03692078|527984801|FG004|Overall Study|Enrollment Closed|0|||
146404332|NCT03692078|527984802|FG005|Overall Study|Enrollment Closed|0|||
146404333|NCT03692078|527984803|FG006|Overall Study|Enrollment Closed|0|||
146404334|NCT03692078|527984797|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
146404335|NCT03692078|527984798|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
146404336|NCT03692078|527984799|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
146404337|NCT03692078|527984800|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
146404338|NCT03692078|527984801|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
146404339|NCT03692078|527984802|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
146404340|NCT03692078|527984803|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
146404341|NCT03692078|527984797|FG000|Overall Study|Withdrawal by Subject|0|||
146404342|NCT03692078|527984798|FG001|Overall Study|Withdrawal by Subject|2|||
146404343|NCT03692078|527984799|FG002|Overall Study|Withdrawal by Subject|0|||
146404344|NCT03692078|527984800|FG003|Overall Study|Withdrawal by Subject|1|||
146404345|NCT03692078|527984801|FG004|Overall Study|Withdrawal by Subject|5|||
146404346|NCT03692078|527984802|FG005|Overall Study|Withdrawal by Subject|3|||
146404347|NCT03692078|527984803|FG006|Overall Study|Withdrawal by Subject|3|||
146404348|NCT05723835|527984806|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
146404349|NCT05723835|527984807|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
146404350|NCT05723835|527984808|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
146404351|NCT05723835|527984809|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
146404352|NCT05723835|527984810|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
146404353|NCT05723835|527984811|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
146404354|NCT05723835|527984812|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
146404355|NCT05723835|527984813|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
146404356|NCT05226286|527984814|FG000|Overall Study|Screen failures prior to implant|62|||
146404357|NCT05226286|527984814|FG000|Overall Study|Withdrawal by Subject|13|||
146404358|NCT05226286|527984814|FG000|Overall Study|Lost to Follow-up|3|||
146404359|NCT05226286|527984814|FG000|Overall Study|Physician Decision|1|||
146404360|NCT05226286|527984814|FG000|Overall Study|Adverse Event|1|||
146404361|NCT05226286|527984814|FG000|Overall Study|Death|1|||
146404362|NCT05226286|527984814|FG000|Overall Study|Device explant with no planned replacement|1|||
146404363|NCT05226286|527984814|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
146404364|NCT05226286|527984814|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
146404365|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146404366|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146404367|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146404368|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
146404369|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146404370|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
146404371|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146404372|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146404373|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
146404374|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
146404375|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146404376|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
146404377|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146404378|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146404379|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
146404380|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146404381|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146404382|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
146404383|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146404384|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146404385|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
146404386|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
146404387|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146404388|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
146404389|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146404390|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146404391|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
146404392|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
146404393|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146404394|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
146404395|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
146404396|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
146404397|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
146404398|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
146404399|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
146404400|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
146404401|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
146404402|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
146404403|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
146404404|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
146404405|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
146404406|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
146404407|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146404408|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
146404409|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
146404410|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
146404411|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146404412|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
146404413|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
146404414|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146404415|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
146404416|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
146404417|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146404418|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
146404419|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
146404420|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
146404421|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
146404422|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
146404423|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
146404424|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
146404425|NCT03395197|527984815|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
146404426|NCT03395197|527984816|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146404427|NCT03395197|527984817|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
146404428|NCT03395197|527984818|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
146404429|NCT03395197|527984819|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146404430|NCT03395197|527984820|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
146404431|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Death|0|||
146404432|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Death|0|||
146404433|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Death|0|||
146404434|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Death|0|||
146404435|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Death|1|||
146404436|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Death|4|||
146404437|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146404438|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146404439|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146404440|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
146404441|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
146404442|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
146404443|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146404444|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146404445|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146404446|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146404447|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
146404448|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
146404449|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146404450|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146404451|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146404452|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
146404453|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
146404454|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
146404455|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146404456|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146404457|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146404458|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
146404459|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
146404460|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
146404461|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146404462|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146404463|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146404464|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
146404465|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
146404466|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
146404467|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146404468|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146404469|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146404470|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
146404471|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
146404472|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
146404473|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Other|0|||
146404474|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Other|0|||
146404475|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Other|0|||
146404476|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Other|0|||
146404477|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Other|3|||
146404478|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Other|3|||
146404479|NCT03395197|527984815|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
146404480|NCT03395197|527984816|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
146404481|NCT03395197|527984817|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
146404482|NCT03395197|527984818|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
146404483|NCT03395197|527984819|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
146404484|NCT03395197|527984820|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
146404485|NCT04701658|527984821|FG000|Overall Study|Lost to Follow-up|6|||
146404486|NCT01346501|527984823|FG000|Overall Study|Initiated Other Biological Agents|3|||
146404487|NCT01346501|527984824|FG001|Overall Study|Initiated Other Biological Agents|1|||
146404488|NCT01346501|527984823|FG000|Overall Study|Other|8|||
146404489|NCT01346501|527984824|FG001|Overall Study|Other|12|||
146404490|NCT04101721|527984825|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
146404491|NCT04101721|527984826|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146404492|NCT04101721|527984825|FG000|Overall Study|Death|0|||
146404493|NCT04101721|527984826|FG001|Overall Study|Death|1|||
146404494|NCT04101721|527984825|FG000|Overall Study|Lost to Follow-up|0|||
146404495|NCT04101721|527984826|FG001|Overall Study|Lost to Follow-up|3|||
146404496|NCT00756652|527984827|FG000|Original Phase|Withdrawal by Subject|864|||
146404497|NCT00756652|527984828|FG001|Original Phase|Withdrawal by Subject|23|||
146404498|NCT00756652|527984827|FG000|Original Phase|Lost to Follow-up|601|||
146404499|NCT00756652|527984828|FG001|Original Phase|Lost to Follow-up|0|||
146404500|NCT00756652|527984827|FG000|Original Phase|Other Discontinuation|797|||
146404501|NCT00756652|527984828|FG001|Original Phase|Other Discontinuation|5|||
146404502|NCT00756652|527984827|FG000|Original Phase|Participant Noncompliance|18622|||
146404503|NCT00756652|527984828|FG001|Original Phase|Participant Noncompliance|424|||
146404504|NCT00756652|527984827|FG000|Original Phase|Unknown Discontinuation Reason|2|||
146404505|NCT00756652|527984828|FG001|Original Phase|Unknown Discontinuation Reason|0|||
146404506|NCT00756652|527984827|FG000|Original Phase|Participants without data|3259|||
146404507|NCT00756652|527984828|FG001|Original Phase|Participants without data|466|||
146404508|NCT00756652|527984827|FG000|Original Phase|Death|168|||
146404509|NCT00756652|527984828|FG001|Original Phase|Death|1|||
146404510|NCT00756652|527984827|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
146404511|NCT00756652|527984828|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
146404512|NCT00756652|527984827|FG000|Re-Op Phase|Withdrawal by Subject|62|||
146404513|NCT00756652|527984828|FG001|Re-Op Phase|Withdrawal by Subject|0|||
146404514|NCT00756652|527984827|FG000|Re-Op Phase|Death|6|||
146404515|NCT00756652|527984828|FG001|Re-Op Phase|Death|0|||
146404516|NCT00756652|527984827|FG000|Re-Op Phase|Lost to Follow-up|340|||
146404517|NCT00756652|527984828|FG001|Re-Op Phase|Lost to Follow-up|0|||
146404518|NCT00756652|527984827|FG000|Re-Op Phase|Site Closed|2454|||
146404519|NCT00756652|527984828|FG001|Re-Op Phase|Site Closed|0|||
146404520|NCT00756652|527984827|FG000|Re-Op Phase|Withdrawn after explant|14|||
146404521|NCT00756652|527984828|FG001|Re-Op Phase|Withdrawn after explant|0|||
146404522|NCT02564952|527984829|FG000|Overall Study|Adverse Event|6|||
146404523|NCT02564952|527984829|FG000|Overall Study|Lost to Follow-up|1|||
146404524|NCT02564952|527984829|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
146404525|NCT02564952|527984829|FG000|Overall Study|Withdrawal by Subject|1|||
146404526|NCT02564952|527984829|FG000|Overall Study|Low Efficacy|1|||
146404527|NCT02564952|527984829|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146404528|NCT01215955|527984830|FG000|Overall Study|Adverse Event|1|||
146404529|NCT01215955|527984831|FG001|Overall Study|Adverse Event|4|||
146404530|NCT01215955|527984832|FG002|Overall Study|Adverse Event|2|||
146404531|NCT01215955|527984833|FG003|Overall Study|Adverse Event|3|||
146404532|NCT01215955|527984830|FG000|Overall Study|Death|2|||
146404533|NCT01215955|527984831|FG001|Overall Study|Death|0|||
146404534|NCT01215955|527984832|FG002|Overall Study|Death|1|||
146404535|NCT01215955|527984833|FG003|Overall Study|Death|3|||
146404536|NCT01215955|527984830|FG000|Overall Study|Entry Criteria Not Met|1|||
146404537|NCT01215955|527984831|FG001|Overall Study|Entry Criteria Not Met|3|||
146404538|NCT01215955|527984832|FG002|Overall Study|Entry Criteria Not Met|4|||
146404539|NCT01215955|527984833|FG003|Overall Study|Entry Criteria Not Met|7|||
146404540|NCT01215955|527984830|FG000|Overall Study|Lack of Efficacy|1|||
146404541|NCT01215955|527984831|FG001|Overall Study|Lack of Efficacy|2|||
146404542|NCT01215955|527984832|FG002|Overall Study|Lack of Efficacy|1|||
146404543|NCT01215955|527984833|FG003|Overall Study|Lack of Efficacy|0|||
146404544|NCT01215955|527984830|FG000|Overall Study|Lost to Follow-up|4|||
146404545|NCT01215955|527984831|FG001|Overall Study|Lost to Follow-up|4|||
146404546|NCT01215955|527984832|FG002|Overall Study|Lost to Follow-up|8|||
146404547|NCT01215955|527984833|FG003|Overall Study|Lost to Follow-up|9|||
146404548|NCT01215955|527984830|FG000|Overall Study|Physician Decision|4|||
146404549|NCT01215955|527984831|FG001|Overall Study|Physician Decision|10|||
146404550|NCT01215955|527984832|FG002|Overall Study|Physician Decision|8|||
146404551|NCT01215955|527984833|FG003|Overall Study|Physician Decision|11|||
146404552|NCT01215955|527984830|FG000|Overall Study|Protocol Violation|17|||
146404553|NCT01215955|527984831|FG001|Overall Study|Protocol Violation|13|||
146404554|NCT01215955|527984832|FG002|Overall Study|Protocol Violation|8|||
146404555|NCT01215955|527984833|FG003|Overall Study|Protocol Violation|8|||
146404556|NCT01215955|527984830|FG000|Overall Study|Sponsor Decision|1|||
146404557|NCT01215955|527984831|FG001|Overall Study|Sponsor Decision|2|||
146404558|NCT01215955|527984832|FG002|Overall Study|Sponsor Decision|0|||
146404559|NCT01215955|527984833|FG003|Overall Study|Sponsor Decision|1|||
146404560|NCT01215955|527984830|FG000|Overall Study|Withdrawal by Subject|14|||
146404561|NCT01215955|527984831|FG001|Overall Study|Withdrawal by Subject|15|||
146404562|NCT01215955|527984832|FG002|Overall Study|Withdrawal by Subject|13|||
146404563|NCT01215955|527984833|FG003|Overall Study|Withdrawal by Subject|9|||
146404564|NCT01215955|527984830|FG000|Overall Study|Quality Issues|0|||
146404565|NCT01215955|527984831|FG001|Overall Study|Quality Issues|0|||
146404566|NCT01215955|527984832|FG002|Overall Study|Quality Issues|3|||
146404567|NCT01215955|527984833|FG003|Overall Study|Quality Issues|2|||
146404568|NCT00038467|527984834|FG000|Overall Study|Adverse Event|170|||
146404569|NCT00038467|527984835|FG001|Overall Study|Adverse Event|145|||
146404570|NCT00038467|527984834|FG000|Overall Study|Withdrawal by Subject|150|||
146404571|NCT00038467|527984835|FG001|Overall Study|Withdrawal by Subject|107|||
146404572|NCT00038467|527984834|FG000|Overall Study|Protocol Violation|19|||
146404573|NCT00038467|527984835|FG001|Overall Study|Protocol Violation|22|||
146404574|NCT00038467|527984834|FG000|Overall Study|Death|22|||
146404575|NCT00038467|527984835|FG001|Overall Study|Death|16|||
146404576|NCT00038467|527984834|FG000|Overall Study|Lost to Follow-up|15|||
146404577|NCT00038467|527984835|FG001|Overall Study|Lost to Follow-up|10|||
146404578|NCT00038467|527984834|FG000|Overall Study|Recurrence|109|||
146404579|NCT00038467|527984835|FG001|Overall Study|Recurrence|179|||
146404580|NCT00038467|527984834|FG000|Overall Study|Randomized, but not treated|31|||
146404581|NCT00038467|527984835|FG001|Overall Study|Randomized, but not treated|35|||
146404582|NCT00038467|527984834|FG000|Overall Study|Other|26|||
146404583|NCT00038467|527984835|FG001|Overall Study|Other|28|||
146404584|NCT01787188|527984836|FG000|Overall Study|Adverse Event|2|||
146404585|NCT01787188|527984837|FG001|Overall Study|Adverse Event|4|||
146404586|NCT01787188|527984838|FG002|Overall Study|Adverse Event|6|||
146404587|NCT01787188|527984836|FG000|Overall Study|Lack of Efficacy|7|||
146404588|NCT01787188|527984837|FG001|Overall Study|Lack of Efficacy|3|||
146404589|NCT01787188|527984838|FG002|Overall Study|Lack of Efficacy|5|||
146404590|NCT01787188|527984836|FG000|Overall Study|Non-compliance with Study Drug|0|||
146404591|NCT01787188|527984837|FG001|Overall Study|Non-compliance with Study Drug|1|||
146404592|NCT01787188|527984838|FG002|Overall Study|Non-compliance with Study Drug|0|||
146404593|NCT01787188|527984836|FG000|Overall Study|Withdrawal by Subject|4|||
146404594|NCT01787188|527984837|FG001|Overall Study|Withdrawal by Subject|3|||
146404595|NCT01787188|527984838|FG002|Overall Study|Withdrawal by Subject|2|||
146404596|NCT01787188|527984836|FG000|Overall Study|Protocol Violation|3|||
146404597|NCT01787188|527984837|FG001|Overall Study|Protocol Violation|2|||
146404598|NCT01787188|527984838|FG002|Overall Study|Protocol Violation|3|||
146404599|NCT01787188|527984836|FG000|Overall Study|Lost to Follow-up|1|||
146404600|NCT01787188|527984837|FG001|Overall Study|Lost to Follow-up|2|||
146404601|NCT01787188|527984838|FG002|Overall Study|Lost to Follow-up|2|||
146404602|NCT01787188|527984836|FG000|Overall Study|Other, including patient moved|0|||
146404603|NCT01787188|527984837|FG001|Overall Study|Other, including patient moved|3|||
146404604|NCT01787188|527984838|FG002|Overall Study|Other, including patient moved|0|||
146404605|NCT05511428|527984839|FG000|Overall Study|Withdrawal by Subject|1|||
146404606|NCT05511428|527984839|FG000|Overall Study|Adverse Event|1|||
146404607|NCT02643394|527984840|FG000|Overall Study|Protocol Violation|4|||
146404608|NCT02643394|527984841|FG001|Overall Study|Protocol Violation|5|||
146404609|NCT04088734|527984842|FG000|Overall Study|Other, Not Specified|5|||
146404610|NCT00096200|527984843|FG000|Overall Study|Adverse Event|0|||
146404611|NCT00096200|527984844|FG001|Overall Study|Adverse Event|4|||
146404612|NCT00096200|527984845|FG002|Overall Study|Adverse Event|0|||
146404613|NCT00096200|527984843|FG000|Overall Study|Withdrawal by Subject|1|||
146404614|NCT00096200|527984844|FG001|Overall Study|Withdrawal by Subject|2|||
146404615|NCT00096200|527984845|FG002|Overall Study|Withdrawal by Subject|0|||
146404616|NCT00096200|527984843|FG000|Overall Study|Ineligible pathology|0|||
146404617|NCT00096200|527984844|FG001|Overall Study|Ineligible pathology|1|||
146404618|NCT00096200|527984845|FG002|Overall Study|Ineligible pathology|0|||
146404619|NCT00835068|527984846|FG000|Overall Study|Death|1|||
146404620|NCT00835068|527984847|FG001|Overall Study|Death|0|||
146404621|NCT00835068|527984846|FG000|Overall Study|Adverse Event|0|||
146404622|NCT00835068|527984847|FG001|Overall Study|Adverse Event|1|||
146404623|NCT00835068|527984846|FG000|Overall Study|Other|8|||
146404624|NCT00835068|527984847|FG001|Overall Study|Other|0|||
146404625|NCT00835068|527984846|FG000|Overall Study|Withdrawal by Subject|1|||
146404626|NCT00835068|527984847|FG001|Overall Study|Withdrawal by Subject|0|||
146404627|NCT05264506|527984848|FG000|Overall Study|Adverse Event|59|||
146404628|NCT05264506|527984848|FG000|Overall Study|Lost to Follow-up|204|||
146404629|NCT05264506|527984848|FG000|Overall Study|Protocol Violation|185|||
146404630|NCT05264506|527984848|FG000|Overall Study|Pregnancy|60|||
146404631|NCT05264506|527984848|FG000|Overall Study|Physician Decision|6|||
146404632|NCT05264506|527984848|FG000|Overall Study|Non-compliance with Study Drug|29|||
146404633|NCT05264506|527984848|FG000|Overall Study|Study termination|677|||
146404634|NCT05264506|527984848|FG000|Overall Study|Withdrawal by Subject|208|||
146404635|NCT05264506|527984848|FG000|Overall Study|Discontinued prior treatment|89|||
146404636|NCT00005879|527984850|FG000|Overall Study|Withdrawal by Subject|8|||
146404637|NCT00005879|527984851|FG001|Overall Study|Withdrawal by Subject|10|||
146404638|NCT01238172|527984852|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
146404639|NCT01238172|527984853|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
146404640|NCT01238172|527984852|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
146404641|NCT01238172|527984853|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
146404642|NCT05022121|527984854|FG000|Overall Study|Lack of Efficacy|1|||
146404643|NCT05022121|527984855|FG001|Overall Study|Lack of Efficacy|0|||
146404644|NCT05022121|527984854|FG000|Overall Study|Lost to Follow-up|0|||
146404645|NCT05022121|527984855|FG001|Overall Study|Lost to Follow-up|2|||
146404646|NCT05257109|527984860|FG000|Overall Study|Withdrawal by Subject|1|||
146404647|NCT05257109|527984861|FG001|Overall Study|Withdrawal by Subject|0|||
146404648|NCT05257109|527984862|FG002|Overall Study|Withdrawal by Subject|0|||
146404649|NCT05257109|527984863|FG003|Overall Study|Withdrawal by Subject|0|||
146404650|NCT03978117|527985644|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
146404651|NCT03978117|527985645|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
146404652|NCT03978117|527985644|FG000|Overall Study|Lost to Follow-up|4|||
146404653|NCT03978117|527985645|FG001|Overall Study|Lost to Follow-up|4|||
146404654|NCT00791154|527985646|FG000|Overall Study|Noncompliance|0|||
146404655|NCT00791154|527985647|FG001|Overall Study|Noncompliance|1|||
146404656|NCT00791154|527985648|FG002|Overall Study|Noncompliance|0|||
146404657|NCT00791154|527985649|FG003|Overall Study|Noncompliance|0|||
146404658|NCT00791154|527985650|FG004|Overall Study|Noncompliance|1|||
146404659|NCT00791154|527985651|FG005|Overall Study|Noncompliance|1|||
146404660|NCT00791154|527985652|FG006|Overall Study|Noncompliance|1|||
146404661|NCT00791154|527985646|FG000|Overall Study|Adverse Event|0|||
146404662|NCT00791154|527985647|FG001|Overall Study|Adverse Event|0|||
146404663|NCT00791154|527985648|FG002|Overall Study|Adverse Event|0|||
146404664|NCT00791154|527985649|FG003|Overall Study|Adverse Event|0|||
146404665|NCT00791154|527985650|FG004|Overall Study|Adverse Event|2|||
146404666|NCT00791154|527985651|FG005|Overall Study|Adverse Event|0|||
146404667|NCT00791154|527985652|FG006|Overall Study|Adverse Event|1|||
146404668|NCT00791154|527985646|FG000|Overall Study|Full Consent withdrawn|1|||
146404669|NCT00791154|527985647|FG001|Overall Study|Full Consent withdrawn|3|||
146404670|NCT00791154|527985648|FG002|Overall Study|Full Consent withdrawn|0|||
146404671|NCT00791154|527985649|FG003|Overall Study|Full Consent withdrawn|0|||
146404672|NCT00791154|527985650|FG004|Overall Study|Full Consent withdrawn|1|||
146404673|NCT00791154|527985651|FG005|Overall Study|Full Consent withdrawn|3|||
146404674|NCT00791154|527985652|FG006|Overall Study|Full Consent withdrawn|1|||
146404675|NCT00791154|527985646|FG000|Overall Study|Lost to Follow-up|0|||
146404676|NCT00791154|527985647|FG001|Overall Study|Lost to Follow-up|0|||
146404677|NCT00791154|527985648|FG002|Overall Study|Lost to Follow-up|0|||
146404678|NCT00791154|527985649|FG003|Overall Study|Lost to Follow-up|1|||
146404679|NCT00791154|527985650|FG004|Overall Study|Lost to Follow-up|2|||
146404680|NCT00791154|527985651|FG005|Overall Study|Lost to Follow-up|0|||
146404681|NCT00791154|527985652|FG006|Overall Study|Lost to Follow-up|4|||
146404682|NCT00791154|527985646|FG000|Overall Study|Death|5|||
146404683|NCT00791154|527985647|FG001|Overall Study|Death|4|||
146404684|NCT00791154|527985648|FG002|Overall Study|Death|4|||
146404685|NCT00791154|527985649|FG003|Overall Study|Death|7|||
146404686|NCT00791154|527985650|FG004|Overall Study|Death|54|||
146404687|NCT00791154|527985651|FG005|Overall Study|Death|54|||
146404688|NCT00791154|527985652|FG006|Overall Study|Death|52|||
146404689|NCT00791154|527985646|FG000|Overall Study|Other event|0|||
146404690|NCT00791154|527985647|FG001|Overall Study|Other event|0|||
146404691|NCT00791154|527985648|FG002|Overall Study|Other event|2|||
146404692|NCT00791154|527985649|FG003|Overall Study|Other event|0|||
146404693|NCT00791154|527985650|FG004|Overall Study|Other event|2|||
146404694|NCT00791154|527985651|FG005|Overall Study|Other event|4|||
146404695|NCT00791154|527985652|FG006|Overall Study|Other event|2|||
146404696|NCT01652573|527985653|FG000|Overall Study|Adverse Event|0|||
146404697|NCT01652573|527985654|FG001|Overall Study|Adverse Event|1|||
146404698|NCT01052038|527985658|FG000|Overall Study|Lost to Follow-up|2|||
146404699|NCT01052038|527985659|FG001|Overall Study|Lost to Follow-up|3|||
146404700|NCT01052038|527985660|FG002|Overall Study|Lost to Follow-up|1|||
146404701|NCT01052038|527985658|FG000|Overall Study|Protocol Violation|2|||
146404702|NCT01052038|527985659|FG001|Overall Study|Protocol Violation|3|||
146404703|NCT01052038|527985660|FG002|Overall Study|Protocol Violation|3|||
146404704|NCT03976076|527985661|FG000|Overall Study|Withdrawal by Subject|2|||
146404705|NCT00602641|527985663|FG000|Overall Study|Never started protocol therapy|6|||
146404706|NCT00602641|527985664|FG001|Overall Study|Never started protocol therapy|2|||
146404707|NCT00602641|527985663|FG000|Overall Study|Still on treatment at time of analysis|8|||
146404708|NCT00602641|527985664|FG001|Overall Study|Still on treatment at time of analysis|15|||
146404709|NCT00602641|527985663|FG000|Overall Study|Adverse Event|62|||
146404710|NCT00602641|527985664|FG001|Overall Study|Adverse Event|53|||
146404711|NCT00602641|527985663|FG000|Overall Study|Disease progression|38|||
146404712|NCT00602641|527985664|FG001|Overall Study|Disease progression|55|||
146404713|NCT00602641|527985663|FG000|Overall Study|Death|6|||
146404714|NCT00602641|527985664|FG001|Overall Study|Death|5|||
146404715|NCT00602641|527985663|FG000|Overall Study|Withdrawal by Subject|15|||
146404716|NCT00602641|527985664|FG001|Overall Study|Withdrawal by Subject|12|||
146404717|NCT00602641|527985663|FG000|Overall Study|Alternative therapy|5|||
146404718|NCT00602641|527985664|FG001|Overall Study|Alternative therapy|2|||
146404719|NCT00602641|527985663|FG000|Overall Study|Other Complicating Disease|5|||
146404720|NCT00602641|527985664|FG001|Overall Study|Other Complicating Disease|2|||
146404721|NCT00602641|527985663|FG000|Overall Study|Physician Decision|5|||
146404722|NCT00602641|527985664|FG001|Overall Study|Physician Decision|4|||
146404723|NCT00602641|527985663|FG000|Overall Study|Administrative Closure|1|||
146404724|NCT00602641|527985664|FG001|Overall Study|Administrative Closure|1|||
146404725|NCT00602641|527985663|FG000|Overall Study|Other|3|||
146404726|NCT00602641|527985664|FG001|Overall Study|Other|1|||
146404727|NCT03901352|527985666|FG000|Double-blind Phase|Adverse Event|6|||
146404728|NCT03901352|527985667|FG001|Double-blind Phase|Adverse Event|4|||
146404729|NCT03901352|527985666|FG000|Double-blind Phase|Death|1|||
146404730|NCT03901352|527985667|FG001|Double-blind Phase|Death|0|||
146404731|NCT03901352|527985666|FG000|Double-blind Phase|Lack of Efficacy|0|||
146404732|NCT03901352|527985667|FG001|Double-blind Phase|Lack of Efficacy|1|||
146404733|NCT03901352|527985666|FG000|Double-blind Phase|Protocol Violation|0|||
146404734|NCT03901352|527985667|FG001|Double-blind Phase|Protocol Violation|1|||
146404735|NCT03901352|527985666|FG000|Double-blind Phase|Withdrawal by Subject|10|||
146404736|NCT03901352|527985667|FG001|Double-blind Phase|Withdrawal by Subject|8|||
146404737|NCT03901352|527985666|FG000|Open-label Extension Phase|Adverse Event|24|||
146404738|NCT03901352|527985667|FG001|Open-label Extension Phase|Adverse Event|0|||
146404739|NCT03901352|527985666|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
146404740|NCT03901352|527985667|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146404741|NCT03901352|527985666|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
146404742|NCT03901352|527985667|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146404743|NCT03901352|527985666|FG000|Open-label Extension Phase|Other|1|||
146404744|NCT03901352|527985667|FG001|Open-label Extension Phase|Other|0|||
146404745|NCT01826201|527985670|FG000|Overall Study|Non compliance with protocol|4|||
146404746|NCT01615822|527985671|FG000|Period 1|Withdrawal by Subject|0|||
146404747|NCT01615822|527985672|FG001|Period 1|Withdrawal by Subject|1|||
146404748|NCT01615822|527985673|FG002|Period 1|Withdrawal by Subject|0|||
146404749|NCT01615822|527985671|FG000|Period 1|Adverse Event|1|||
146404750|NCT01615822|527985672|FG001|Period 1|Adverse Event|1|||
146404751|NCT01615822|527985673|FG002|Period 1|Adverse Event|0|||
146404752|NCT01615822|527985671|FG000|Period 2|Lost to Follow-up|0|||
146404753|NCT01615822|527985672|FG001|Period 2|Lost to Follow-up|1|||
146404754|NCT01615822|527985673|FG002|Period 2|Lost to Follow-up|2|||
146404755|NCT03901339|527985674|FG000|Overall Study|Death|220|||
146404756|NCT03901339|527985675|FG001|Overall Study|Death|192|||
146404757|NCT03901339|527985674|FG000|Overall Study|Informed consent withdrawn|13|||
146404758|NCT03901339|527985675|FG001|Overall Study|Informed consent withdrawn|40|||
146404759|NCT03901339|527985674|FG000|Overall Study|Sponsor request|30|||
146404760|NCT03901339|527985675|FG001|Overall Study|Sponsor request|23|||
146404761|NCT03901339|527985674|FG000|Overall Study|Reason not specified|5|||
146404762|NCT03901339|527985675|FG001|Overall Study|Reason not specified|7|||
146404763|NCT03901339|527985674|FG000|Overall Study|Lost to Follow-up|4|||
146404764|NCT03901339|527985675|FG001|Overall Study|Lost to Follow-up|7|||
146404765|NCT03901339|527985674|FG000|Overall Study|Covid19|0|||
146404766|NCT03901339|527985675|FG001|Overall Study|Covid19|2|||
146404767|NCT03981614|527985676|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
146404768|NCT03981614|527985677|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
146404769|NCT03981614|527985678|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
146404770|NCT04971226|527985681|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146404771|NCT04971226|527985682|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146404772|NCT04971226|527985683|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
146404773|NCT04971226|527985684|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
146404774|NCT04971226|527985681|FG000|Overall Study|Adverse Event|6|||
146404775|NCT04971226|527985682|FG001|Overall Study|Adverse Event|5|||
146404776|NCT04971226|527985683|FG002|Overall Study|Adverse Event|11|||
146404777|NCT04971226|527985684|FG003|Overall Study|Adverse Event|10|||
146404778|NCT04971226|527985681|FG000|Overall Study|Progressive disease|2|||
146404779|NCT04971226|527985682|FG001|Overall Study|Progressive disease|0|||
146404780|NCT04971226|527985683|FG002|Overall Study|Progressive disease|3|||
146404781|NCT04971226|527985684|FG003|Overall Study|Progressive disease|1|||
146404782|NCT04971226|527985681|FG000|Overall Study|Protocol Deviation|1|||
146404783|NCT04971226|527985682|FG001|Overall Study|Protocol Deviation|0|||
146404784|NCT04971226|527985683|FG002|Overall Study|Protocol Deviation|1|||
146404785|NCT04971226|527985684|FG003|Overall Study|Protocol Deviation|1|||
146404786|NCT04971226|527985681|FG000|Overall Study|Subject Decision|0|||
146404787|NCT04971226|527985682|FG001|Overall Study|Subject Decision|1|||
146404788|NCT04971226|527985683|FG002|Overall Study|Subject Decision|1|||
146404789|NCT04971226|527985684|FG003|Overall Study|Subject Decision|1|||
146404790|NCT04971226|527985681|FG000|Overall Study|Pregnancy|0|||
146404791|NCT04971226|527985682|FG001|Overall Study|Pregnancy|0|||
146404792|NCT04971226|527985683|FG002|Overall Study|Pregnancy|0|||
146404793|NCT04971226|527985684|FG003|Overall Study|Pregnancy|1|||
146404794|NCT04971226|527985681|FG000|Overall Study|Participants not treated|1|||
146404795|NCT04971226|527985682|FG001|Overall Study|Participants not treated|0|||
146404796|NCT04971226|527985683|FG002|Overall Study|Participants not treated|2|||
146404797|NCT04971226|527985684|FG003|Overall Study|Participants not treated|1|||
146404798|NCT04439149|527985685|FG000|Overall Study|Ineligible|1|||
146404799|NCT04439149|527985685|FG000|Overall Study|Never start protocol therapy|1|||
146404800|NCT04439149|527985685|FG000|Overall Study|Adverse Event|4|||
146404801|NCT04439149|527985685|FG000|Overall Study|Disease Progression|14|||
146404802|NCT04439149|527985685|FG000|Overall Study|Complicating disease|1|||
146404803|NCT04439149|527985685|FG000|Overall Study|Withdrawal by Subject|3|||
146404804|NCT05919823|527985692|FG000|Pre-Treatment Period|Screen failure|1|||
146404805|NCT05919823|527985693|FG001|Pre-Treatment Period|Screen failure|0|||
146404806|NCT05919823|527985694|FG002|Pre-Treatment Period|Screen failure|0|||
146404807|NCT05919823|527985695|FG003|Pre-Treatment Period|Screen failure|0|||
146404808|NCT05919823|527985692|FG000|Pre-Treatment Period|Protocol Violation|0|||
146404809|NCT05919823|527985693|FG001|Pre-Treatment Period|Protocol Violation|1|||
146404810|NCT05919823|527985694|FG002|Pre-Treatment Period|Protocol Violation|0|||
146404811|NCT05919823|527985695|FG003|Pre-Treatment Period|Protocol Violation|0|||
146404812|NCT05919823|527985692|FG000|Double-Blind Period|Adverse Event|8|||
146404813|NCT05919823|527985693|FG001|Double-Blind Period|Adverse Event|9|||
146404814|NCT05919823|527985694|FG002|Double-Blind Period|Adverse Event|0|||
146404815|NCT05919823|527985695|FG003|Double-Blind Period|Adverse Event|0|||
146404816|NCT05919823|527985692|FG000|Double-Blind Period|Protocol Violation|2|||
146404817|NCT05919823|527985693|FG001|Double-Blind Period|Protocol Violation|1|||
146404818|NCT05919823|527985694|FG002|Double-Blind Period|Protocol Violation|0|||
146404819|NCT05919823|527985695|FG003|Double-Blind Period|Protocol Violation|0|||
146404820|NCT05919823|527985692|FG000|Double-Blind Period|Participant withdrew consent|11|||
146404821|NCT05919823|527985693|FG001|Double-Blind Period|Participant withdrew consent|7|||
146404822|NCT05919823|527985694|FG002|Double-Blind Period|Participant withdrew consent|0|||
146404823|NCT05919823|527985695|FG003|Double-Blind Period|Participant withdrew consent|0|||
146404824|NCT05919823|527985692|FG000|Double-Blind Period|Other reasons|2|||
146404825|NCT05919823|527985693|FG001|Double-Blind Period|Other reasons|3|||
146404826|NCT05919823|527985694|FG002|Double-Blind Period|Other reasons|0|||
146404827|NCT05919823|527985695|FG003|Double-Blind Period|Other reasons|0|||
146404828|NCT05919823|527985692|FG000|Open Label Period|Adverse Event|0|||
146404829|NCT05919823|527985693|FG001|Open Label Period|Adverse Event|0|||
146404830|NCT05919823|527985694|FG002|Open Label Period|Adverse Event|2|||
146404831|NCT05919823|527985695|FG003|Open Label Period|Adverse Event|4|||
146404832|NCT05919823|527985692|FG000|Open Label Period|Lost to Follow-up|0|||
146404833|NCT05919823|527985693|FG001|Open Label Period|Lost to Follow-up|0|||
146404834|NCT05919823|527985694|FG002|Open Label Period|Lost to Follow-up|1|||
146404835|NCT05919823|527985695|FG003|Open Label Period|Lost to Follow-up|0|||
146404836|NCT05919823|527985692|FG000|Open Label Period|Protocol Violation|0|||
146404837|NCT05919823|527985693|FG001|Open Label Period|Protocol Violation|0|||
146404838|NCT05919823|527985694|FG002|Open Label Period|Protocol Violation|0|||
146404839|NCT05919823|527985695|FG003|Open Label Period|Protocol Violation|1|||
146404840|NCT05919823|527985692|FG000|Open Label Period|Participant withdrew consent|0|||
146404841|NCT05919823|527985693|FG001|Open Label Period|Participant withdrew consent|0|||
146404842|NCT05919823|527985694|FG002|Open Label Period|Participant withdrew consent|8|||
146404843|NCT05919823|527985695|FG003|Open Label Period|Participant withdrew consent|6|||
146404844|NCT05919823|527985692|FG000|Open Label Period|Death|0|||
146404845|NCT05919823|527985693|FG001|Open Label Period|Death|0|||
146404846|NCT05919823|527985694|FG002|Open Label Period|Death|0|||
146404847|NCT05919823|527985695|FG003|Open Label Period|Death|1|||
146404848|NCT05919823|527985692|FG000|Open Label Period|Other reasons|0|||
146404849|NCT05919823|527985693|FG001|Open Label Period|Other reasons|0|||
146404850|NCT05919823|527985694|FG002|Open Label Period|Other reasons|9|||
146404851|NCT05919823|527985695|FG003|Open Label Period|Other reasons|5|||
146404852|NCT06065176|527985696|FG000|Overall Study|Lost to Follow-up|11|||
146404853|NCT06065176|527985697|FG001|Overall Study|Lost to Follow-up|11|||
146404854|NCT06065176|527985698|FG002|Overall Study|Lost to Follow-up|10|||
146404855|NCT06065176|527985696|FG000|Overall Study|Withdrawal by Subject|1|||
146404856|NCT06065176|527985697|FG001|Overall Study|Withdrawal by Subject|1|||
146404857|NCT06065176|527985698|FG002|Overall Study|Withdrawal by Subject|2|||
146404858|NCT06065176|527985696|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
146404859|NCT06065176|527985697|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
146404860|NCT06065176|527985698|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
146404861|NCT04521608|527985699|FG000|Overall Study|Death|8|||
146404862|NCT04521608|527985700|FG001|Overall Study|Death|9|||
146404863|NCT04521608|527985699|FG000|Overall Study|Withdrawal by Subject|25|||
146404864|NCT04521608|527985700|FG001|Overall Study|Withdrawal by Subject|18|||
146404865|NCT04521608|527985699|FG000|Overall Study|Disease Progression|3|||
145945244|NCT01606202|526308185|FG000|Overall Study|Problems with administration|0|||
146404866|NCT04521608|527985700|FG001|Overall Study|Disease Progression|10|||
146404867|NCT04521608|527985699|FG000|Overall Study|Complicating Disease|6|||
146404868|NCT04521608|527985700|FG001|Overall Study|Complicating Disease|3|||
146404869|NCT04521608|527985699|FG000|Overall Study|Lost Contact|25|||
146404870|NCT04521608|527985700|FG001|Overall Study|Lost Contact|27|||
146404871|NCT04521608|527985699|FG000|Overall Study|Ineligible|1|||
146404872|NCT04521608|527985700|FG001|Overall Study|Ineligible|0|||
146404873|NCT04521608|527985699|FG000|Overall Study|Refused Further Study Participation|13|||
146404874|NCT04521608|527985700|FG001|Overall Study|Refused Further Study Participation|7|||
146404875|NCT02588651|527985701|FG000|Overall Study|Adverse Event|1|||
146404876|NCT02588651|527985701|FG000|Overall Study|Withdrawal by Subject|2|||
146404877|NCT02588651|527985701|FG000|Overall Study|Death|1|||
146404878|NCT02588651|527985701|FG000|Overall Study|Lack of Efficacy|13|||
146404879|NCT02588651|527985701|FG000|Overall Study|Lost to Follow-up|1|||
146404880|NCT02588651|527985701|FG000|Overall Study|Physician Decision|1|||
146404881|NCT02588651|527985701|FG000|Overall Study|Disease progression|2|||
146404882|NCT04083378|527985704|FG000|Overall Study|Death|18|||
146404883|NCT04083378|527985705|FG001|Overall Study|Death|4|||
146404884|NCT04083378|527985704|FG000|Overall Study|Lost to Follow-up|4|||
146404885|NCT04083378|527985705|FG001|Overall Study|Lost to Follow-up|0|||
146404886|NCT00285012|527985706|FG000|Assigned to Study Treatment (Tx)|Other|2|||
146404887|NCT00285012|527985707|FG001|Assigned to Study Treatment (Tx)|Other|3|||
146404888|NCT00285012|527985706|FG000|Received Study Tx|Death|2|||
146404889|NCT00285012|527985707|FG001|Received Study Tx|Death|1|||
146404890|NCT00285012|527985706|FG000|Received Study Tx|Adverse Event|5|||
146404891|NCT00285012|527985707|FG001|Received Study Tx|Adverse Event|11|||
146404892|NCT00285012|527985706|FG000|Received Study Tx|Lack of Efficacy|0|||
146404893|NCT00285012|527985707|FG001|Received Study Tx|Lack of Efficacy|3|||
146404894|NCT00285012|527985706|FG000|Received Study Tx|Lost to Follow-up|29|||
146404895|NCT00285012|527985707|FG001|Received Study Tx|Lost to Follow-up|31|||
146404896|NCT00285012|527985706|FG000|Received Study Tx|Withdrawal by Subject|31|||
146404897|NCT00285012|527985707|FG001|Received Study Tx|Withdrawal by Subject|43|||
146404898|NCT00285012|527985706|FG000|Received Study Tx|Other|5|||
146404899|NCT00285012|527985707|FG001|Received Study Tx|Other|5|||
146404900|NCT04050293|527985711|FG000|Overall Study|Lost to Follow-up|1|||
146404901|NCT04050293|527985712|FG001|Overall Study|Lost to Follow-up|2|||
146404902|NCT04050293|527985711|FG000|Overall Study|Withdrawal by Subject|2|||
146404903|NCT04050293|527985712|FG001|Overall Study|Withdrawal by Subject|0|||
146404904|NCT05631093|527985715|FG000|Overall Study|Death|0|||
146404905|NCT05631093|527985716|FG001|Overall Study|Death|1|||
146404906|NCT05631093|527985715|FG000|Overall Study|Lost to Follow-up|1|||
146404907|NCT05631093|527985716|FG001|Overall Study|Lost to Follow-up|2|||
146404908|NCT05631093|527985715|FG000|Overall Study|Physician Decision|1|||
146404909|NCT05631093|527985716|FG001|Overall Study|Physician Decision|0|||
146404910|NCT05631093|527985715|FG000|Overall Study|Withdrawal by Subject|4|||
146404911|NCT05631093|527985716|FG001|Overall Study|Withdrawal by Subject|1|||
146404912|NCT05631093|527985715|FG000|Overall Study|Ongoing|353|||
146404913|NCT05631093|527985716|FG001|Overall Study|Ongoing|177|||
146404914|NCT05631093|527985715|FG000|Overall Study|Adverse Event|0|||
146404915|NCT05631093|527985716|FG001|Overall Study|Adverse Event|1|||
146404916|NCT00391092|527986900|FG000|Overall Study|Death|78|||
146404917|NCT00391092|527986901|FG001|Overall Study|Death|81|||
146404918|NCT00391092|527986900|FG000|Overall Study|Lost to Follow-up|13|||
146404919|NCT00391092|527986901|FG001|Overall Study|Lost to Follow-up|18|||
146404920|NCT00391092|527986900|FG000|Overall Study|Alive on treatment|29|||
146404921|NCT00391092|527986901|FG001|Overall Study|Alive on treatment|33|||
146404922|NCT00391092|527986900|FG000|Overall Study|Alive in follow-up|88|||
146404923|NCT00391092|527986901|FG001|Overall Study|Alive in follow-up|84|||
146404924|NCT00424515|527986904|FG000|Overall Study|Progressive Disease|10|||
146404925|NCT00424515|527986905|FG001|Overall Study|Progressive Disease|11|||
146404926|NCT00424515|527986904|FG000|Overall Study|Adverse Event|0|||
146404927|NCT00424515|527986905|FG001|Overall Study|Adverse Event|1|||
146404928|NCT00424515|527986904|FG000|Overall Study|Intercurrent Illness|0|||
146404929|NCT00424515|527986905|FG001|Overall Study|Intercurrent Illness|1|||
146404930|NCT00424515|527986904|FG000|Overall Study|Withdrawal by Subject|1|||
146404931|NCT00424515|527986905|FG001|Overall Study|Withdrawal by Subject|0|||
146404932|NCT04071366|527986906|FG000|Part 1: Open-label (29 Days)|Death|4|||
146404933|NCT04071366|527986907|FG001|Part 1: Open-label (29 Days)|Death|2|||
146404934|NCT04071366|527986908|FG002|Part 1: Open-label (29 Days)|Death|8|||
146404935|NCT04071366|527986909|FG003|Part 1: Open-label (29 Days)|Death|0|||
146404936|NCT04071366|527986910|FG004|Part 1: Open-label (29 Days)|Death|0|||
146404937|NCT04071366|527986906|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146404938|NCT04071366|527986907|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146404939|NCT04071366|527986908|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
146404940|NCT04071366|527986909|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146404941|NCT04071366|527986910|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
146404942|NCT04071366|527986906|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
146404943|NCT04071366|527986907|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146404944|NCT04071366|527986908|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
146404945|NCT04071366|527986909|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146404946|NCT04071366|527986910|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
146404947|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Death|0|||
146404948|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Death|0|||
146404949|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Death|0|||
146404950|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Death|2|||
146404951|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Death|2|||
146404952|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146404953|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146404954|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146404955|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
146404956|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
146404957|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
146404958|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
146404959|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
146404960|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
146404961|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
146404962|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146404963|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146404964|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
146404965|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
146404966|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
146404967|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146404968|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146404969|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146404970|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
146404971|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
146404972|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146404973|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146404974|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146404975|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
146404976|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
146404977|NCT04071366|527986906|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146404978|NCT04071366|527986907|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146404979|NCT04071366|527986908|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146404980|NCT04071366|527986909|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
146404981|NCT04071366|527986910|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
146404982|NCT02239692|527986911|FG000|Overall Study|Incomplete colonoscopy|1|||
146404983|NCT02239692|527986912|FG001|Overall Study|Incomplete colonoscopy|2|||
146404984|NCT02239692|527986911|FG000|Overall Study|Adverse Event|0|||
146404985|NCT02239692|527986912|FG001|Overall Study|Adverse Event|1|||
146404986|NCT02239692|527986911|FG000|Overall Study|Physician Decision|0|||
146404987|NCT02239692|527986912|FG001|Overall Study|Physician Decision|1|||
146404988|NCT02239692|527986911|FG000|Overall Study|Lost to Follow-up|1|||
146404989|NCT02239692|527986912|FG001|Overall Study|Lost to Follow-up|4|||
146404990|NCT02239692|527986911|FG000|Overall Study|Withdrawal by Subject|3|||
146404991|NCT02239692|527986912|FG001|Overall Study|Withdrawal by Subject|5|||
146404992|NCT02239692|527986911|FG000|Overall Study|Other reason|1|||
146404993|NCT02239692|527986912|FG001|Overall Study|Other reason|0|||
146404994|NCT00858234|527986913|FG000|Overall Study|Adverse Event|6|||
146404995|NCT00858234|527986913|FG000|Overall Study|Progressive disease|2|||
146404996|NCT00858234|527986913|FG000|Overall Study|Status unknown|1|||
146404997|NCT01678924|527986915|FG000|Overall Study|Adverse Event|1|||
146404998|NCT01678924|527986916|FG001|Overall Study|Adverse Event|1|||
146404999|NCT01678924|527986917|FG002|Overall Study|Adverse Event|0|||
146405000|NCT01678924|527986918|FG003|Overall Study|Adverse Event|1|||
146405001|NCT01678924|527986915|FG000|Overall Study|Lack of Efficacy|7|||
146405002|NCT01678924|527986916|FG001|Overall Study|Lack of Efficacy|2|||
146405003|NCT01678924|527986917|FG002|Overall Study|Lack of Efficacy|0|||
146405004|NCT01678924|527986918|FG003|Overall Study|Lack of Efficacy|5|||
146405005|NCT01678924|527986915|FG000|Overall Study|Lost to Follow-up|0|||
146405006|NCT01678924|527986916|FG001|Overall Study|Lost to Follow-up|4|||
146405007|NCT01678924|527986917|FG002|Overall Study|Lost to Follow-up|0|||
146405008|NCT01678924|527986918|FG003|Overall Study|Lost to Follow-up|2|||
146405009|NCT01678924|527986915|FG000|Overall Study|Personal Reasons|2|||
146405010|NCT01678924|527986916|FG001|Overall Study|Personal Reasons|2|||
146405011|NCT01678924|527986917|FG002|Overall Study|Personal Reasons|2|||
146405012|NCT01678924|527986918|FG003|Overall Study|Personal Reasons|7|||
146405013|NCT01678924|527986915|FG000|Overall Study|Withdrawal by Subject|0|||
146405014|NCT01678924|527986916|FG001|Overall Study|Withdrawal by Subject|3|||
146405015|NCT01678924|527986917|FG002|Overall Study|Withdrawal by Subject|0|||
146405016|NCT01678924|527986918|FG003|Overall Study|Withdrawal by Subject|2|||
146405017|NCT01678924|527986915|FG000|Overall Study|Unable to attend scheduled visits|0|||
146405018|NCT01678924|527986916|FG001|Overall Study|Unable to attend scheduled visits|0|||
146405019|NCT01678924|527986917|FG002|Overall Study|Unable to attend scheduled visits|0|||
146405020|NCT01678924|527986918|FG003|Overall Study|Unable to attend scheduled visits|1|||
146405021|NCT02428231|527986922|FG000|Overall Study|Other|10|||
146405022|NCT02428231|527986923|FG001|Overall Study|Other|16|||
146405023|NCT02428231|527986922|FG000|Overall Study|Required Symptomatic Therapy|0|||
146171584|NCT02387996|527141058|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
146171585|NCT02387996|527141058|FG000|Overall Study|Subject Withdrew Consent|5|||
146171586|NCT02387996|527141058|FG000|Overall Study|Lost to Follow-up|1|||
146171587|NCT02387996|527141058|FG000|Overall Study|Poor/Non-Compliance|1|||
146171588|NCT02387996|527141058|FG000|Overall Study|Other Reasons|5|||
146171589|NCT02387996|527141058|FG000|Overall Study|Death|1|||
146171590|NCT02424591|527141059|FG000|Overall Study|Protocol Violation|2|||
146171591|NCT02424591|527141060|FG001|Overall Study|Protocol Violation|3|||
146171592|NCT00770432|527141061|FG000|Overall Study|Other|4|||
146171593|NCT00770432|527141062|FG001|Overall Study|Other|6|||
146171594|NCT00770432|527141061|FG000|Overall Study|Non-compliance|0|||
146171595|NCT00770432|527141062|FG001|Overall Study|Non-compliance|1|||
146171596|NCT00312702|527141063|FG000|Immunization Phase|Lost to Follow-up|0|||
146171597|NCT00312702|527141064|FG001|Immunization Phase|Lost to Follow-up|1|||
146171598|NCT00312702|527141065|FG002|Immunization Phase|Lost to Follow-up|0|||
146171599|NCT01453348|527141068|FG000|Overall Study|Death|0|||
146171600|NCT01453348|527141069|FG001|Overall Study|Death|0|||
146171601|NCT01453348|527141070|FG002|Overall Study|Death|1|||
146171602|NCT01453348|527141068|FG000|Overall Study|Withdrawal by Subject|0|||
146171603|NCT01453348|527141069|FG001|Overall Study|Withdrawal by Subject|1|||
146171604|NCT01453348|527141070|FG002|Overall Study|Withdrawal by Subject|0|||
146171605|NCT01453348|527141068|FG000|Overall Study|Protocol Violation|1|||
146171606|NCT01453348|527141069|FG001|Overall Study|Protocol Violation|0|||
146171607|NCT01453348|527141070|FG002|Overall Study|Protocol Violation|0|||
146171608|NCT02756832|527141074|FG000|Overall Study|Lost for Observation after Baseline|6|||
146171609|NCT02756832|527141074|FG000|Overall Study|Lost for Observation|13|||
146171610|NCT02756832|527141074|FG000|Overall Study|Patient's Unwillingness|12|||
146171611|NCT02756832|527141074|FG000|Overall Study|Insufficient Efficacy|2|||
146171612|NCT02756832|527141074|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
146171613|NCT02756832|527141074|FG000|Overall Study|Reason not Specified|9|||
146171614|NCT02756832|527141074|FG000|Overall Study|Protocol Deviation|10|||
146171615|NCT03592277|527141078|FG000|Overall Study|Withdrawal by Subject|6|||
146171616|NCT03592277|527141079|FG001|Overall Study|Withdrawal by Subject|8|||
146171617|NCT00954733|527141080|FG000|Overall Study|blood gas machine did not work|1|||
146171618|NCT01346514|527141087|FG000|Overall Study|Lost to Follow-up|19|||
146171619|NCT01346514|527141088|FG001|Overall Study|Lost to Follow-up|30|||
146171620|NCT01346514|527141087|FG000|Overall Study|Withdrawal by Subject|7|||
146171621|NCT01346514|527141088|FG001|Overall Study|Withdrawal by Subject|3|||
146171622|NCT01346514|527141087|FG000|Overall Study|Death|3|||
146171623|NCT01346514|527141088|FG001|Overall Study|Death|4|||
146171624|NCT00909480|527141092|FG000|Overall Study|Adverse Event|5|||
146171625|NCT00909480|527141093|FG001|Overall Study|Adverse Event|3|||
146171626|NCT00909480|527141092|FG000|Overall Study|Protocol Violation|6|||
146171627|NCT00909480|527141093|FG001|Overall Study|Protocol Violation|8|||
146171628|NCT00909480|527141092|FG000|Overall Study|Withdrawal criteria|9|||
146171629|NCT00909480|527141093|FG001|Overall Study|Withdrawal criteria|11|||
146171630|NCT00909480|527141092|FG000|Overall Study|Unclassified|18|||
146171631|NCT00909480|527141093|FG001|Overall Study|Unclassified|19|||
146171632|NCT01725386|527141096|FG000|Overall Study|Death|84|||
146171633|NCT01725386|527141097|FG001|Overall Study|Death|40|||
146171634|NCT01725386|527141096|FG000|Overall Study|Lost to Follow-up|81|||
146171635|NCT01725386|527141097|FG001|Overall Study|Lost to Follow-up|6|||
146171636|NCT01725386|527141096|FG000|Overall Study|Withdrawal by Subject|10|||
146171637|NCT01725386|527141097|FG001|Overall Study|Withdrawal by Subject|0|||
146171638|NCT00879996|527141098|FG000|Overall Study|Lost to Follow-up|7|||
146171639|NCT00879996|527141099|FG001|Overall Study|Lost to Follow-up|6|||
146171640|NCT00879996|527141098|FG000|Overall Study|non-compliance|6|||
146171641|NCT00879996|527141099|FG001|Overall Study|non-compliance|4|||
146171642|NCT00879996|527141098|FG000|Overall Study|Physician Decision|1|||
146171643|NCT00879996|527141099|FG001|Overall Study|Physician Decision|2|||
146171644|NCT00879996|527141098|FG000|Overall Study|psychiatric problem|0|||
146171645|NCT00879996|527141099|FG001|Overall Study|psychiatric problem|1|||
146171646|NCT00879996|527141098|FG000|Overall Study|put on parole|1|||
146171647|NCT00879996|527141099|FG001|Overall Study|put on parole|0|||
146171648|NCT04772053|527141111|FG000|Overall Study|Physician Decision|2|||
146171649|NCT04772053|527141111|FG000|Overall Study|Withdrawal by Subject|3|||
146171650|NCT04772053|527141111|FG000|Overall Study|Study Terminated by Sponsor|1|||
146171651|NCT04146896|527141112|FG000|Overall Study|Adverse Event|5|||
146171652|NCT04146896|527141113|FG001|Overall Study|Adverse Event|8|||
146171653|NCT04146896|527141112|FG000|Overall Study|Lack of Efficacy|3|||
146171654|NCT04146896|527141113|FG001|Overall Study|Lack of Efficacy|2|||
146171655|NCT04146896|527141112|FG000|Overall Study|Lost to Follow-up|0|||
146171656|NCT04146896|527141113|FG001|Overall Study|Lost to Follow-up|1|||
146171657|NCT04146896|527141112|FG000|Overall Study|Non-compliance|5|||
146171658|NCT04146896|527141113|FG001|Overall Study|Non-compliance|4|||
146171659|NCT04146896|527141112|FG000|Overall Study|Withdrawal by Subject|3|||
146171660|NCT04146896|527141113|FG001|Overall Study|Withdrawal by Subject|5|||
146171661|NCT04146896|527141112|FG000|Overall Study|Randomized in error|1|||
146171662|NCT04146896|527141113|FG001|Overall Study|Randomized in error|2|||
146171663|NCT02118337|527141114|FG000|Overall Study|Other|1|||
146405024|NCT02428231|527986923|FG001|Overall Study|Required Symptomatic Therapy|1|||
146405025|NCT02428231|527986922|FG000|Overall Study|Adverse Event|3|||
146405026|NCT02428231|527986923|FG001|Overall Study|Adverse Event|0|||
146405027|NCT00817778|527986925|FG000|Overall Study|Adverse Event|1|||
146405028|NCT00817778|527986926|FG001|Overall Study|Adverse Event|0|||
146405029|NCT00817778|527986925|FG000|Overall Study|Withdrawal by Subject|1|||
146405030|NCT00817778|527986926|FG001|Overall Study|Withdrawal by Subject|1|||
146405031|NCT00817778|527986925|FG000|Overall Study|Protocol Violation|0|||
146405032|NCT00817778|527986926|FG001|Overall Study|Protocol Violation|1|||
146405033|NCT00817778|527986925|FG000|Overall Study|Study-specific discontinuation criteria|0|||
146405034|NCT00817778|527986926|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146405035|NCT00817778|527986925|FG000|Overall Study|Poor venous access|1|||
146405036|NCT00817778|527986926|FG001|Overall Study|Poor venous access|0|||
146405037|NCT03343054|527986927|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
146405038|NCT03343054|527986928|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
146405039|NCT03343054|527986929|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
146405040|NCT03343054|527986927|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
146405041|NCT03343054|527986928|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
146405042|NCT03343054|527986929|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
146405043|NCT03343054|527986927|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
146405044|NCT03343054|527986928|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
146405045|NCT03343054|527986929|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
146405046|NCT03343054|527986927|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
146405047|NCT03343054|527986928|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
146405048|NCT03343054|527986929|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
146405049|NCT04256759|527986930|FG000|Overall Study|Physician Decision|1|||
146405050|NCT04256759|527986930|FG000|Overall Study|Lack of Efficacy|1|||
146405051|NCT04075292|527986937|FG000|Overall Study|Withdrawal by Subject|1|||
146405052|NCT04075292|527986938|FG001|Overall Study|Withdrawal by Subject|9|||
146405053|NCT04075292|527986937|FG000|Overall Study|Death|2|||
146405054|NCT04075292|527986938|FG001|Overall Study|Death|5|||
146405055|NCT04075292|527986937|FG000|Overall Study|Remained on study at time of DCO|74|||
146405056|NCT04075292|527986938|FG001|Overall Study|Remained on study at time of DCO|64|||
146405057|NCT03829462|527986940|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
146405058|NCT03829462|527986941|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
146405059|NCT03829462|527986940|FG000|Overall Study|No treatment due to progression disease|0|||
146405060|NCT03829462|527986941|FG001|Overall Study|No treatment due to progression disease|1|||
146405061|NCT00481871|527986944|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
146405062|NCT00481871|527986945|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
146405063|NCT00481871|527986946|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
146405064|NCT00481871|527986947|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
146405065|NCT00481871|527986948|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
146405066|NCT00569127|527986953|FG000|Overall Study|Adverse Event|57|||
146405067|NCT00569127|527986954|FG001|Overall Study|Adverse Event|47|||
146405068|NCT00569127|527986953|FG000|Overall Study|Withdrawal by Subject|13|||
146405069|NCT00569127|527986954|FG001|Overall Study|Withdrawal by Subject|27|||
146405070|NCT00569127|527986953|FG000|Overall Study|Progression|99|||
146405071|NCT00569127|527986954|FG001|Overall Study|Progression|100|||
146405072|NCT00569127|527986953|FG000|Overall Study|Death|4|||
146405073|NCT00569127|527986954|FG001|Overall Study|Death|3|||
146405074|NCT00569127|527986953|FG000|Overall Study|Other|20|||
146405075|NCT00569127|527986954|FG001|Overall Study|Other|19|||
146405076|NCT00569127|527986953|FG000|Overall Study|Lost to Follow-up|0|||
146405077|NCT00569127|527986954|FG001|Overall Study|Lost to Follow-up|3|||
146405078|NCT00569127|527986953|FG000|Overall Study|Not Eligible|14|||
146171664|NCT02118337|527141115|FG001|Overall Study|Other|0|||
146171665|NCT02118337|527141116|FG002|Overall Study|Other|0|||
146171666|NCT02118337|527141117|FG003|Overall Study|Other|0|||
146171667|NCT02118337|527141118|FG004|Overall Study|Other|2|||
146171668|NCT02118337|527141119|FG005|Overall Study|Other|3|||
146171669|NCT02118337|527141120|FG006|Overall Study|Other|1|||
146171670|NCT02118337|527141121|FG007|Overall Study|Other|28|||
146171671|NCT02118337|527141122|FG008|Overall Study|Other|15|||
146171672|NCT02118337|527141114|FG000|Overall Study|Lost to Follow-up|0|||
146171673|NCT02118337|527141115|FG001|Overall Study|Lost to Follow-up|0|||
146171674|NCT02118337|527141116|FG002|Overall Study|Lost to Follow-up|0|||
146405079|NCT00569127|527986954|FG001|Overall Study|Not Eligible|11|||
146171675|NCT02118337|527141117|FG003|Overall Study|Lost to Follow-up|0|||
146405080|NCT00569127|527986953|FG000|Overall Study|Still on Treatment|7|||
146171676|NCT02118337|527141118|FG004|Overall Study|Lost to Follow-up|0|||
146171677|NCT02118337|527141119|FG005|Overall Study|Lost to Follow-up|0|||
146405081|NCT00569127|527986954|FG001|Overall Study|Still on Treatment|3|||
146405082|NCT04803214|527986955|FG000|Overall Study|Adverse Event|1|||
146405083|NCT04803214|527986956|FG001|Overall Study|Adverse Event|0|||
146405084|NCT04803214|527986955|FG000|Overall Study|Withdrawal by Subject|1|||
146405085|NCT04803214|527986956|FG001|Overall Study|Withdrawal by Subject|2|||
146405086|NCT04803214|527986955|FG000|Overall Study|Lost to Follow-up|2|||
146405087|NCT04803214|527986956|FG001|Overall Study|Lost to Follow-up|4|||
146405088|NCT04803214|527986955|FG000|Overall Study|Physician Decision|1|||
146405089|NCT04803214|527986956|FG001|Overall Study|Physician Decision|1|||
146405090|NCT04803214|527986955|FG000|Overall Study|Missed 12 month visit|0|||
146405091|NCT04803214|527986956|FG001|Overall Study|Missed 12 month visit|3|||
146405092|NCT00644228|527986957|FG000|Randomization & Eligibility|Ineligible|31|||
146405093|NCT00644228|527986958|FG001|Randomization & Eligibility|Ineligible|21|||
146405094|NCT00644228|527986957|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
146405095|NCT00644228|527986958|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
146405096|NCT00644228|527986957|FG000|Randomization & Eligibility|Invalid Consent|0|||
146405097|NCT00644228|527986958|FG001|Randomization & Eligibility|Invalid Consent|1|||
146405098|NCT00644228|527986957|FG000|Induction Therapy|Adverse Event|22|||
146405099|NCT00644228|527986958|FG001|Induction Therapy|Adverse Event|55|||
146405100|NCT00644228|527986957|FG000|Induction Therapy|Withdrawal by Subject|10|||
146405101|NCT00644228|527986958|FG001|Induction Therapy|Withdrawal by Subject|3|||
146405102|NCT00644228|527986957|FG000|Induction Therapy|Progression/Relapse|24|||
146405103|NCT00644228|527986958|FG001|Induction Therapy|Progression/Relapse|12|||
146405104|NCT00644228|527986957|FG000|Induction Therapy|Death|3|||
146405105|NCT00644228|527986958|FG001|Induction Therapy|Death|7|||
146405106|NCT00644228|527986957|FG000|Induction Therapy|Not Protocol-Specified|24|||
146405107|NCT00644228|527986958|FG001|Induction Therapy|Not Protocol-Specified|28|||
146405108|NCT00644228|527986957|FG000|Maintenance|Adverse Event|27|||
146405109|NCT00644228|527986958|FG001|Maintenance|Adverse Event|31|||
146405110|NCT00644228|527986957|FG000|Maintenance|Withdrawal by Subject|6|||
146405111|NCT00644228|527986958|FG001|Maintenance|Withdrawal by Subject|4|||
146405112|NCT00644228|527986957|FG000|Maintenance|Progression/Relapse|67|||
146405113|NCT00644228|527986958|FG001|Maintenance|Progression/Relapse|42|||
146405114|NCT00644228|527986957|FG000|Maintenance|Death|3|||
146405115|NCT00644228|527986958|FG001|Maintenance|Death|3|||
146405116|NCT00644228|527986957|FG000|Maintenance|Not Protocol-Specified|14|||
146405117|NCT00644228|527986958|FG001|Maintenance|Not Protocol-Specified|15|||
146405118|NCT00644228|527986957|FG000|Maintenance|On Treatment|26|||
146405119|NCT00644228|527986958|FG001|Maintenance|On Treatment|40|||
146405120|NCT06078124|527986959|FG000|Overall Study|Lost to Follow-up|14|||
146405121|NCT06078124|527986960|FG001|Overall Study|Lost to Follow-up|14|||
146405122|NCT05824273|527986961|FG000|Overall Study|Lost to Follow-up|16|||
146405123|NCT05824273|527986962|FG001|Overall Study|Lost to Follow-up|13|||
146405124|NCT02736695|527986963|FG000|Overall Study|Ineligible|6|||
146405125|NCT02736695|527986964|FG001|Overall Study|Ineligible|0|||
146405126|NCT04223193|527986965|FG000|Overall Study|Adverse Event|6|||
146405127|NCT04223193|527986966|FG001|Overall Study|Adverse Event|36|||
146405128|NCT04223193|527986965|FG000|Overall Study|Lack of Efficacy|2|||
146405129|NCT04223193|527986966|FG001|Overall Study|Lack of Efficacy|2|||
146405130|NCT04223193|527986965|FG000|Overall Study|Lost to Follow-up|1|||
146405131|NCT04223193|527986966|FG001|Overall Study|Lost to Follow-up|1|||
146405132|NCT04223193|527986965|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
146405133|NCT04223193|527986966|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146405134|NCT04223193|527986965|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
146405135|NCT04223193|527986966|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146405136|NCT04223193|527986965|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146405137|NCT04223193|527986966|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146405138|NCT04223193|527986965|FG000|Overall Study|Physician Decision|0|||
146405139|NCT04223193|527986966|FG001|Overall Study|Physician Decision|1|||
146405140|NCT04223193|527986965|FG000|Overall Study|Protocol Violation|1|||
146405141|NCT04223193|527986966|FG001|Overall Study|Protocol Violation|1|||
146405142|NCT04223193|527986965|FG000|Overall Study|Site Terminated by Sponsor|1|||
146405143|NCT04223193|527986966|FG001|Overall Study|Site Terminated by Sponsor|3|||
146405144|NCT04223193|527986965|FG000|Overall Study|Withdrawal by Subject|5|||
146405145|NCT04223193|527986966|FG001|Overall Study|Withdrawal by Subject|6|||
146405146|NCT04223193|527986965|FG000|Overall Study|Other|3|||
146405147|NCT04223193|527986966|FG001|Overall Study|Other|6|||
146405148|NCT03193190|527986969|FG000|Stage 1|Arm Terminated by Sponsor|0|||
146405149|NCT03193190|527986970|FG001|Stage 1|Arm Terminated by Sponsor|0|||
146405150|NCT03193190|527986971|FG002|Stage 1|Arm Terminated by Sponsor|0|||
146405151|NCT03193190|527986972|FG003|Stage 1|Arm Terminated by Sponsor|1|||
146405152|NCT03193190|527986973|FG004|Stage 1|Arm Terminated by Sponsor|0|||
146405153|NCT03193190|527986974|FG005|Stage 1|Arm Terminated by Sponsor|2|||
146405154|NCT03193190|527986975|FG006|Stage 1|Arm Terminated by Sponsor|0|||
146405155|NCT03193190|527986976|FG007|Stage 1|Arm Terminated by Sponsor|0|||
146405156|NCT03193190|527986977|FG008|Stage 1|Arm Terminated by Sponsor|0|||
146405157|NCT03193190|527986978|FG009|Stage 1|Arm Terminated by Sponsor|0|||
146405158|NCT03193190|527986979|FG010|Stage 1|Arm Terminated by Sponsor|0|||
146405159|NCT03193190|527986980|FG011|Stage 1|Arm Terminated by Sponsor|0|||
146405160|NCT03193190|527986981|FG012|Stage 1|Arm Terminated by Sponsor|0|||
146405161|NCT03193190|527986982|FG013|Stage 1|Arm Terminated by Sponsor|0|||
146405162|NCT03193190|527986983|FG014|Stage 1|Arm Terminated by Sponsor|0|||
146405163|NCT03193190|527986984|FG015|Stage 1|Arm Terminated by Sponsor|0|||
146405164|NCT03193190|527986969|FG000|Stage 1|Death|22|||
146405165|NCT03193190|527986970|FG001|Stage 1|Death|8|||
146405166|NCT03193190|527986971|FG002|Stage 1|Death|23|||
146405167|NCT03193190|527986972|FG003|Stage 1|Death|14|||
146405168|NCT03193190|527986973|FG004|Stage 1|Death|34|||
146405169|NCT03193190|527986974|FG005|Stage 1|Death|28|||
146405170|NCT03193190|527986975|FG006|Stage 1|Death|19|||
146062717|NCT03642873|526748319|FG000|Third Intervention (1 Day)|Screen failure|0|||
146062718|NCT03642873|526748320|FG001|Third Intervention (1 Day)|Screen failure|0|||
146405171|NCT03193190|527986976|FG007|Stage 1|Death|21|||
146405172|NCT03193190|527986977|FG008|Stage 1|Death|14|||
146405173|NCT03193190|527986978|FG009|Stage 1|Death|10|||
146405174|NCT03193190|527986979|FG010|Stage 1|Death|59|||
146405175|NCT03193190|527986980|FG011|Stage 1|Death|14|||
146405176|NCT03193190|527986981|FG012|Stage 1|Death|14|||
146405177|NCT03193190|527986982|FG013|Stage 1|Death|0|||
146405178|NCT03193190|527986983|FG014|Stage 1|Death|0|||
146405179|NCT03193190|527986984|FG015|Stage 1|Death|0|||
146405180|NCT03193190|527986969|FG000|Stage 1|Lost to Follow-up|2|||
146405181|NCT03193190|527986970|FG001|Stage 1|Lost to Follow-up|1|||
146405182|NCT03193190|527986971|FG002|Stage 1|Lost to Follow-up|1|||
146405183|NCT03193190|527986972|FG003|Stage 1|Lost to Follow-up|0|||
146405184|NCT03193190|527986973|FG004|Stage 1|Lost to Follow-up|0|||
146405185|NCT03193190|527986974|FG005|Stage 1|Lost to Follow-up|0|||
146405186|NCT03193190|527986975|FG006|Stage 1|Lost to Follow-up|1|||
146405187|NCT03193190|527986976|FG007|Stage 1|Lost to Follow-up|0|||
146405188|NCT03193190|527986977|FG008|Stage 1|Lost to Follow-up|0|||
146405189|NCT03193190|527986978|FG009|Stage 1|Lost to Follow-up|0|||
146405190|NCT03193190|527986979|FG010|Stage 1|Lost to Follow-up|0|||
146405191|NCT03193190|527986980|FG011|Stage 1|Lost to Follow-up|0|||
146405192|NCT03193190|527986981|FG012|Stage 1|Lost to Follow-up|0|||
146405193|NCT03193190|527986982|FG013|Stage 1|Lost to Follow-up|0|||
146405194|NCT03193190|527986983|FG014|Stage 1|Lost to Follow-up|0|||
146405195|NCT03193190|527986984|FG015|Stage 1|Lost to Follow-up|0|||
146405196|NCT03193190|527986969|FG000|Stage 1|Reason not Specified|1|||
146405197|NCT03193190|527986970|FG001|Stage 1|Reason not Specified|0|||
146405198|NCT03193190|527986971|FG002|Stage 1|Reason not Specified|0|||
146405199|NCT03193190|527986972|FG003|Stage 1|Reason not Specified|1|||
146405200|NCT03193190|527986973|FG004|Stage 1|Reason not Specified|0|||
146405201|NCT03193190|527986974|FG005|Stage 1|Reason not Specified|1|||
146405202|NCT03193190|527986975|FG006|Stage 1|Reason not Specified|2|||
146405203|NCT03193190|527986976|FG007|Stage 1|Reason not Specified|2|||
146405204|NCT03193190|527986977|FG008|Stage 1|Reason not Specified|0|||
146405205|NCT03193190|527986978|FG009|Stage 1|Reason not Specified|1|||
146405206|NCT03193190|527986979|FG010|Stage 1|Reason not Specified|3|||
146405207|NCT03193190|527986980|FG011|Stage 1|Reason not Specified|0|||
146405208|NCT03193190|527986981|FG012|Stage 1|Reason not Specified|1|||
146405209|NCT03193190|527986982|FG013|Stage 1|Reason not Specified|0|||
146405210|NCT03193190|527986983|FG014|Stage 1|Reason not Specified|0|||
146405211|NCT03193190|527986984|FG015|Stage 1|Reason not Specified|0|||
146405212|NCT03193190|527986969|FG000|Stage 1|Physician Decision|0|||
146405213|NCT03193190|527986970|FG001|Stage 1|Physician Decision|0|||
146171678|NCT02118337|527141120|FG006|Overall Study|Lost to Follow-up|0|||
146171679|NCT02118337|527141121|FG007|Overall Study|Lost to Follow-up|1|||
146171680|NCT02118337|527141122|FG008|Overall Study|Lost to Follow-up|0|||
146171681|NCT02118337|527141114|FG000|Overall Study|Withdrawal by Subject|1|||
146171682|NCT02118337|527141115|FG001|Overall Study|Withdrawal by Subject|3|||
146405214|NCT03193190|527986971|FG002|Stage 1|Physician Decision|0|||
146405215|NCT03193190|527986972|FG003|Stage 1|Physician Decision|0|||
146405216|NCT03193190|527986973|FG004|Stage 1|Physician Decision|0|||
146405217|NCT03193190|527986974|FG005|Stage 1|Physician Decision|0|||
146405218|NCT03193190|527986975|FG006|Stage 1|Physician Decision|0|||
146405219|NCT03193190|527986976|FG007|Stage 1|Physician Decision|0|||
146405220|NCT03193190|527986977|FG008|Stage 1|Physician Decision|0|||
146405221|NCT03193190|527986978|FG009|Stage 1|Physician Decision|0|||
146405222|NCT03193190|527986979|FG010|Stage 1|Physician Decision|0|||
146405223|NCT03193190|527986980|FG011|Stage 1|Physician Decision|1|||
146405224|NCT03193190|527986981|FG012|Stage 1|Physician Decision|0|||
146405225|NCT03193190|527986982|FG013|Stage 1|Physician Decision|0|||
146405226|NCT03193190|527986983|FG014|Stage 1|Physician Decision|0|||
146405227|NCT03193190|527986984|FG015|Stage 1|Physician Decision|0|||
146405228|NCT03193190|527986969|FG000|Stage 1|Progressive Disease|1|||
146405229|NCT03193190|527986970|FG001|Stage 1|Progressive Disease|0|||
146405230|NCT03193190|527986971|FG002|Stage 1|Progressive Disease|0|||
146405231|NCT03193190|527986972|FG003|Stage 1|Progressive Disease|0|||
146405232|NCT03193190|527986973|FG004|Stage 1|Progressive Disease|0|||
146405233|NCT03193190|527986974|FG005|Stage 1|Progressive Disease|0|||
146405234|NCT03193190|527986975|FG006|Stage 1|Progressive Disease|0|||
146405235|NCT03193190|527986976|FG007|Stage 1|Progressive Disease|0|||
146405236|NCT03193190|527986977|FG008|Stage 1|Progressive Disease|0|||
146405237|NCT03193190|527986978|FG009|Stage 1|Progressive Disease|0|||
146405238|NCT03193190|527986979|FG010|Stage 1|Progressive Disease|0|||
146405239|NCT03193190|527986980|FG011|Stage 1|Progressive Disease|0|||
146405240|NCT03193190|527986981|FG012|Stage 1|Progressive Disease|0|||
146405241|NCT03193190|527986982|FG013|Stage 1|Progressive Disease|0|||
146405242|NCT03193190|527986983|FG014|Stage 1|Progressive Disease|0|||
146405243|NCT03193190|527986984|FG015|Stage 1|Progressive Disease|0|||
146405244|NCT03193190|527986969|FG000|Stage 1|Study Terminated By Sponsor|3|||
146405245|NCT03193190|527986970|FG001|Stage 1|Study Terminated By Sponsor|0|||
146405246|NCT03193190|527986971|FG002|Stage 1|Study Terminated By Sponsor|0|||
146405247|NCT03193190|527986972|FG003|Stage 1|Study Terminated By Sponsor|0|||
146405248|NCT03193190|527986973|FG004|Stage 1|Study Terminated By Sponsor|6|||
146405249|NCT03193190|527986974|FG005|Stage 1|Study Terminated By Sponsor|0|||
146405250|NCT03193190|527986975|FG006|Stage 1|Study Terminated By Sponsor|0|||
146405251|NCT03193190|527986976|FG007|Stage 1|Study Terminated By Sponsor|0|||
146405252|NCT03193190|527986977|FG008|Stage 1|Study Terminated By Sponsor|0|||
146405253|NCT03193190|527986978|FG009|Stage 1|Study Terminated By Sponsor|0|||
146405254|NCT03193190|527986979|FG010|Stage 1|Study Terminated By Sponsor|0|||
146405255|NCT03193190|527986980|FG011|Stage 1|Study Terminated By Sponsor|0|||
146405256|NCT03193190|527986981|FG012|Stage 1|Study Terminated By Sponsor|0|||
146405257|NCT03193190|527986982|FG013|Stage 1|Study Terminated By Sponsor|0|||
146405258|NCT03193190|527986983|FG014|Stage 1|Study Terminated By Sponsor|0|||
146405259|NCT03193190|527986984|FG015|Stage 1|Study Terminated By Sponsor|0|||
146405260|NCT03193190|527986969|FG000|Stage 1|Withdrawal by Subject|6|||
146405261|NCT03193190|527986970|FG001|Stage 1|Withdrawal by Subject|0|||
146405262|NCT03193190|527986971|FG002|Stage 1|Withdrawal by Subject|1|||
146405263|NCT03193190|527986972|FG003|Stage 1|Withdrawal by Subject|0|||
146405264|NCT03193190|527986973|FG004|Stage 1|Withdrawal by Subject|2|||
146405265|NCT03193190|527986974|FG005|Stage 1|Withdrawal by Subject|0|||
146405266|NCT03193190|527986975|FG006|Stage 1|Withdrawal by Subject|3|||
146405267|NCT03193190|527986976|FG007|Stage 1|Withdrawal by Subject|2|||
146405268|NCT03193190|527986977|FG008|Stage 1|Withdrawal by Subject|2|||
146405269|NCT03193190|527986978|FG009|Stage 1|Withdrawal by Subject|4|||
146405270|NCT03193190|527986979|FG010|Stage 1|Withdrawal by Subject|9|||
146405271|NCT03193190|527986980|FG011|Stage 1|Withdrawal by Subject|1|||
146405272|NCT03193190|527986981|FG012|Stage 1|Withdrawal by Subject|0|||
146405273|NCT03193190|527986982|FG013|Stage 1|Withdrawal by Subject|0|||
146405274|NCT03193190|527986983|FG014|Stage 1|Withdrawal by Subject|0|||
146405275|NCT03193190|527986984|FG015|Stage 1|Withdrawal by Subject|0|||
146405276|NCT03193190|527986969|FG000|Stage 2|Death|0|||
146405277|NCT03193190|527986970|FG001|Stage 2|Death|0|||
146405278|NCT03193190|527986971|FG002|Stage 2|Death|0|||
146062719|NCT03642873|526748321|FG002|Third Intervention (1 Day)|Screen failure|0|||
146405279|NCT03193190|527986972|FG003|Stage 2|Death|0|||
146405280|NCT03193190|527986973|FG004|Stage 2|Death|0|||
146405281|NCT03193190|527986974|FG005|Stage 2|Death|0|||
146405282|NCT03193190|527986975|FG006|Stage 2|Death|0|||
146405283|NCT03193190|527986976|FG007|Stage 2|Death|0|||
146405284|NCT03193190|527986977|FG008|Stage 2|Death|0|||
146405285|NCT03193190|527986978|FG009|Stage 2|Death|0|||
146405286|NCT03193190|527986979|FG010|Stage 2|Death|0|||
146405287|NCT03193190|527986980|FG011|Stage 2|Death|0|||
146405288|NCT03193190|527986981|FG012|Stage 2|Death|0|||
146405289|NCT03193190|527986982|FG013|Stage 2|Death|14|||
146405290|NCT03193190|527986983|FG014|Stage 2|Death|4|||
146405291|NCT03193190|527986984|FG015|Stage 2|Death|1|||
146405292|NCT03193190|527986969|FG000|Stage 2|Lost to Follow-up|0|||
146405293|NCT03193190|527986970|FG001|Stage 2|Lost to Follow-up|0|||
146405294|NCT03193190|527986971|FG002|Stage 2|Lost to Follow-up|0|||
146405295|NCT03193190|527986972|FG003|Stage 2|Lost to Follow-up|0|||
146405296|NCT03193190|527986973|FG004|Stage 2|Lost to Follow-up|0|||
146405297|NCT03193190|527986974|FG005|Stage 2|Lost to Follow-up|0|||
146405298|NCT03193190|527986975|FG006|Stage 2|Lost to Follow-up|0|||
146405299|NCT03193190|527986976|FG007|Stage 2|Lost to Follow-up|0|||
146405300|NCT03193190|527986977|FG008|Stage 2|Lost to Follow-up|0|||
146405301|NCT03193190|527986978|FG009|Stage 2|Lost to Follow-up|0|||
146405302|NCT03193190|527986979|FG010|Stage 2|Lost to Follow-up|0|||
146405303|NCT03193190|527986980|FG011|Stage 2|Lost to Follow-up|0|||
146405304|NCT03193190|527986981|FG012|Stage 2|Lost to Follow-up|0|||
146405305|NCT03193190|527986982|FG013|Stage 2|Lost to Follow-up|0|||
146405306|NCT03193190|527986983|FG014|Stage 2|Lost to Follow-up|1|||
146405307|NCT03193190|527986984|FG015|Stage 2|Lost to Follow-up|0|||
146405308|NCT03193190|527986969|FG000|Stage 2|Withdrawal by Subject|0|||
146405309|NCT03193190|527986970|FG001|Stage 2|Withdrawal by Subject|0|||
146405310|NCT03193190|527986971|FG002|Stage 2|Withdrawal by Subject|0|||
146405311|NCT03193190|527986972|FG003|Stage 2|Withdrawal by Subject|0|||
146405312|NCT03193190|527986973|FG004|Stage 2|Withdrawal by Subject|0|||
146405313|NCT03193190|527986974|FG005|Stage 2|Withdrawal by Subject|0|||
146405314|NCT03193190|527986975|FG006|Stage 2|Withdrawal by Subject|0|||
146405315|NCT03193190|527986976|FG007|Stage 2|Withdrawal by Subject|0|||
146405316|NCT03193190|527986977|FG008|Stage 2|Withdrawal by Subject|0|||
146405317|NCT03193190|527986978|FG009|Stage 2|Withdrawal by Subject|0|||
146405318|NCT03193190|527986979|FG010|Stage 2|Withdrawal by Subject|0|||
146405319|NCT03193190|527986980|FG011|Stage 2|Withdrawal by Subject|0|||
146405320|NCT03193190|527986981|FG012|Stage 2|Withdrawal by Subject|0|||
146405321|NCT03193190|527986982|FG013|Stage 2|Withdrawal by Subject|1|||
146405322|NCT03193190|527986983|FG014|Stage 2|Withdrawal by Subject|1|||
146405323|NCT03193190|527986984|FG015|Stage 2|Withdrawal by Subject|0|||
146405324|NCT03532295|527986985|FG000|Overall Study|Did not start treatment|0|||
146405325|NCT03532295|527986986|FG001|Overall Study|Did not start treatment|2|||
146405326|NCT03732677|527986990|FG000|Overall Study|Terminated the study|154|||
146405327|NCT03732677|527986991|FG001|Overall Study|Terminated the study|197|||
146405328|NCT03732677|527986990|FG000|Overall Study|Continuing study off treatment|379|||
146405329|NCT03732677|527986991|FG001|Overall Study|Continuing study off treatment|333|||
146405330|NCT04644237|527986992|FG000|Overall Study|Death|4|||
146405331|NCT04644237|527986993|FG001|Overall Study|Death|2|||
146405332|NCT04644237|527986992|FG000|Overall Study|Adverse Event|18|||
146405333|NCT04644237|527986993|FG001|Overall Study|Adverse Event|19|||
146405334|NCT04644237|527986992|FG000|Overall Study|Progressive Disease|61|||
146405335|NCT04644237|527986993|FG001|Overall Study|Progressive Disease|23|||
146405336|NCT04644237|527986992|FG000|Overall Study|Clinical Progression|4|||
146405337|NCT04644237|527986993|FG001|Overall Study|Clinical Progression|1|||
146405338|NCT04644237|527986992|FG000|Overall Study|Withdrawal by Subject|4|||
146405339|NCT04644237|527986993|FG001|Overall Study|Withdrawal by Subject|2|||
146405340|NCT04644237|527986992|FG000|Overall Study|Physician Decision|4|||
146405341|NCT04644237|527986993|FG001|Overall Study|Physician Decision|0|||
146405342|NCT04644237|527986992|FG000|Overall Study|Other|6|||
146405343|NCT04644237|527986993|FG001|Overall Study|Other|3|||
146405344|NCT04644237|527986992|FG000|Overall Study|Randomized but not Treated|1|||
146405345|NCT04644237|527986993|FG001|Overall Study|Randomized but not Treated|0|||
146405346|NCT03131817|527986994|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
146405347|NCT05838755|527986995|FG000|Overall Study|Adverse Event|1|||
146405348|NCT05838755|527986996|FG001|Overall Study|Adverse Event|0|||
146405349|NCT05838755|527986997|FG002|Overall Study|Adverse Event|0|||
146405350|NCT05838755|527986995|FG000|Overall Study|Lack of Efficacy|1|||
146405351|NCT05838755|527986996|FG001|Overall Study|Lack of Efficacy|0|||
146405352|NCT05838755|527986997|FG002|Overall Study|Lack of Efficacy|1|||
146405353|NCT05838755|527986995|FG000|Overall Study|Lost to Follow-up|0|||
146405354|NCT05838755|527986996|FG001|Overall Study|Lost to Follow-up|1|||
146405355|NCT05838755|527986997|FG002|Overall Study|Lost to Follow-up|4|||
146405356|NCT05838755|527986995|FG000|Overall Study|Withdrawal by Subject|0|||
146405357|NCT05838755|527986996|FG001|Overall Study|Withdrawal by Subject|2|||
146405358|NCT05838755|527986997|FG002|Overall Study|Withdrawal by Subject|0|||
146405359|NCT05838755|527986995|FG000|Overall Study|Study terminated by sponsor|26|||
146405360|NCT05838755|527986996|FG001|Overall Study|Study terminated by sponsor|27|||
146405361|NCT05838755|527986997|FG002|Overall Study|Study terminated by sponsor|26|||
146405362|NCT05838755|527986995|FG000|Overall Study|Randomized, not treated|2|||
146405363|NCT05838755|527986996|FG001|Overall Study|Randomized, not treated|0|||
146405364|NCT05838755|527986997|FG002|Overall Study|Randomized, not treated|1|||
146405365|NCT05838755|527986995|FG000|Overall Study|Pregnancy|0|||
146405366|NCT05838755|527986996|FG001|Overall Study|Pregnancy|1|||
146405367|NCT05838755|527986997|FG002|Overall Study|Pregnancy|0|||
146405368|NCT04439110|527986998|FG000|Overall Study|Ineligible|2|||
146405369|NCT04439110|527986998|FG000|Overall Study|Adverse Event|4|||
146405370|NCT04439110|527986998|FG000|Overall Study|Death|2|||
146171683|NCT02118337|527141116|FG002|Overall Study|Withdrawal by Subject|2|||
146171684|NCT02118337|527141117|FG003|Overall Study|Withdrawal by Subject|1|||
146171685|NCT02118337|527141118|FG004|Overall Study|Withdrawal by Subject|2|||
146171686|NCT02118337|527141119|FG005|Overall Study|Withdrawal by Subject|2|||
146171687|NCT02118337|527141120|FG006|Overall Study|Withdrawal by Subject|1|||
146171688|NCT02118337|527141121|FG007|Overall Study|Withdrawal by Subject|4|||
146171689|NCT02118337|527141122|FG008|Overall Study|Withdrawal by Subject|2|||
146171690|NCT02118337|527141114|FG000|Overall Study|Death|2|||
146171691|NCT02118337|527141115|FG001|Overall Study|Death|2|||
146171692|NCT02118337|527141116|FG002|Overall Study|Death|1|||
146171693|NCT02118337|527141117|FG003|Overall Study|Death|2|||
146171694|NCT02118337|527141118|FG004|Overall Study|Death|5|||
146171695|NCT02118337|527141119|FG005|Overall Study|Death|1|||
146171696|NCT02118337|527141120|FG006|Overall Study|Death|2|||
146171697|NCT02118337|527141121|FG007|Overall Study|Death|9|||
146171698|NCT02118337|527141122|FG008|Overall Study|Death|4|||
146171699|NCT04296890|527141123|FG000|Overall Study|Withdrawal by Subject|1|||
146171700|NCT04296890|527141123|FG000|Overall Study|Death|62|||
146171701|NCT04296890|527141123|FG000|Overall Study|Lost to Follow-up|3|||
146171702|NCT04296890|527141123|FG000|Overall Study|Other than specified|2|||
146171703|NCT00652938|527141129|FG000|Overall Study|Adverse Event|1|||
146171704|NCT00652938|527141130|FG001|Overall Study|Adverse Event|0|||
146171705|NCT00652938|527141131|FG002|Overall Study|Adverse Event|2|||
146171706|NCT00652938|527141129|FG000|Overall Study|Withdrawal by Subject|0|||
146171707|NCT00652938|527141130|FG001|Overall Study|Withdrawal by Subject|6|||
146171708|NCT00652938|527141131|FG002|Overall Study|Withdrawal by Subject|1|||
146171709|NCT00652938|527141129|FG000|Overall Study|Lost to Follow-up|0|||
146171710|NCT00652938|527141130|FG001|Overall Study|Lost to Follow-up|0|||
146171711|NCT00652938|527141131|FG002|Overall Study|Lost to Follow-up|2|||
146171712|NCT00652938|527141129|FG000|Overall Study|fear of blood sampling|0|||
146171713|NCT00652938|527141130|FG001|Overall Study|fear of blood sampling|1|||
146171714|NCT00652938|527141131|FG002|Overall Study|fear of blood sampling|0|||
146234899|NCT03801148|527378401|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
146234900|NCT03801148|527378402|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
146234901|NCT03801148|527378403|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
146234902|NCT00609869|527378404|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
146234903|NCT00609869|527378404|FG000|Overall Study|Severe hematologic toxicity|1|||
146234904|NCT00609869|527378404|FG000|Overall Study|Withdrawal by Subject|1|||
146234905|NCT00609869|527378404|FG000|Overall Study|Seizures|1|||
146234906|NCT00609869|527378404|FG000|Overall Study|Severe tumor flare reaction|1|||
146234907|NCT00609869|527378404|FG000|Overall Study|Hepatitis B infection|1|||
146234908|NCT00609869|527378404|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
146234909|NCT00609869|527378404|FG000|Overall Study|Mantle cell: not evaluable|4|||
146234910|NCT00890591|527378412|FG000|Overall Study|Lack of Efficacy|20|||
146234911|NCT01436175|527378415|FG000|Overall Study|Adverse Event|111|||
146234912|NCT01436175|527378415|FG000|Overall Study|Protocol Violation|49|||
146234913|NCT01436175|527378415|FG000|Overall Study|Withdrawal by Subject|108|||
146234914|NCT01436175|527378415|FG000|Overall Study|Lost to Follow-up|89|||
146234915|NCT01436175|527378415|FG000|Overall Study|Lack of Efficacy|24|||
146234916|NCT01436175|527378415|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
146234917|NCT01436175|527378415|FG000|Overall Study|Other|826|||
146234918|NCT05405244|527378416|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
146234919|NCT05405244|527378417|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
146234920|NCT05405244|527378416|FG000|Washout (2 Weeks)|Adverse Event|2|||
146234921|NCT05405244|527378417|FG001|Washout (2 Weeks)|Adverse Event|0|||
146234922|NCT05405244|527378416|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
146234923|NCT05405244|527378417|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146234924|NCT03418922|527378418|FG000|Overall Study|Withdrawal by Subject|0|||
146234925|NCT03418922|527378419|FG001|Overall Study|Withdrawal by Subject|2|||
146234926|NCT03418922|527378418|FG000|Overall Study|Adverse Event|2|||
146234927|NCT03418922|527378419|FG001|Overall Study|Adverse Event|2|||
146234928|NCT03418922|527378418|FG000|Overall Study|Death|0|||
146234929|NCT03418922|527378419|FG001|Overall Study|Death|1|||
146234930|NCT03418922|527378418|FG000|Overall Study|Physician Decision|0|||
146234931|NCT03418922|527378419|FG001|Overall Study|Physician Decision|1|||
146234932|NCT03577106|527378420|FG000|Overall Study|Withdrawal by Subject|3|||
146234933|NCT03601715|527378423|FG000|Second Intervention|Lost to Follow-up|1|||
146234934|NCT03601715|527378424|FG001|Second Intervention|Lost to Follow-up|1|||
146234935|NCT03601715|527378425|FG002|Second Intervention|Lost to Follow-up|0|||
146234936|NCT02347332|527378426|FG000|Overall Study|Not treated|5|||
146234937|NCT02347332|527378427|FG001|Overall Study|Not treated|2|||
146234938|NCT02347332|527378426|FG000|Overall Study|Progressive disease|141|||
146405371|NCT04439110|527986998|FG000|Overall Study|Disease proression|25|||
146405372|NCT04439110|527986998|FG000|Overall Study|Withdrawal by Subject|1|||
146234939|NCT02347332|527378427|FG001|Overall Study|Progressive disease|159|||
146234940|NCT02347332|527378426|FG000|Overall Study|Adverse Event|50|||
146234941|NCT02347332|527378427|FG001|Overall Study|Adverse Event|41|||
145890881|NCT00952276|526105922|FG000|Overall Study|Withdrawal by Subject|1|||
145890882|NCT00952276|526105923|FG001|Overall Study|Withdrawal by Subject|0|||
145890883|NCT00952276|526105924|FG002|Overall Study|Withdrawal by Subject|0|||
145890884|NCT00952276|526105925|FG003|Overall Study|Withdrawal by Subject|1|||
145890885|NCT00952276|526105926|FG004|Overall Study|Withdrawal by Subject|0|||
145890886|NCT02427984|526105927|FG000|Overall Study|Lost to Follow-up|13|||
145890887|NCT02427984|526105928|FG001|Overall Study|Lost to Follow-up|5|||
145890888|NCT02427984|526105929|FG002|Overall Study|Lost to Follow-up|18|||
145890889|NCT01010126|526107545|FG000|Overall Study|Withdrawal by Subject|1|||
145890890|NCT01010126|526107546|FG001|Overall Study|Withdrawal by Subject|0|||
145890891|NCT01010126|526107547|FG002|Overall Study|Withdrawal by Subject|1|||
145890892|NCT01010126|526107548|FG003|Overall Study|Withdrawal by Subject|0|||
145890893|NCT01010126|526107549|FG004|Overall Study|Withdrawal by Subject|3|||
145890894|NCT01010126|526107550|FG005|Overall Study|Withdrawal by Subject|0|||
145890895|NCT01131299|526107553|FG000|Overall Study|Withdrawal by Subject|4|||
145890896|NCT01131299|526107554|FG001|Overall Study|Withdrawal by Subject|7|||
145890897|NCT01885182|526107562|FG000|Overall Study|Adverse Event|11|||
145890898|NCT01885182|526107563|FG001|Overall Study|Adverse Event|13|||
145890899|NCT01885182|526107562|FG000|Overall Study|Withdrawal by Subject|13|||
145890900|NCT01885182|526107563|FG001|Overall Study|Withdrawal by Subject|6|||
145890901|NCT01885182|526107562|FG000|Overall Study|Lost to Follow-up|2|||
145890902|NCT01885182|526107563|FG001|Overall Study|Lost to Follow-up|2|||
145890903|NCT01885182|526107562|FG000|Overall Study|Lack of Efficacy|8|||
145890904|NCT01885182|526107563|FG001|Overall Study|Lack of Efficacy|1|||
145890905|NCT01207440|526107570|FG000|Overall Study|Adverse Event|46|||
145890906|NCT01207440|526107571|FG001|Overall Study|Adverse Event|11|||
145890907|NCT01207440|526107572|FG002|Overall Study|Adverse Event|7|||
145890908|NCT01207440|526107573|FG003|Overall Study|Adverse Event|2|||
145890909|NCT01207440|526107574|FG004|Overall Study|Adverse Event|6|||
145890910|NCT01207440|526107575|FG005|Overall Study|Adverse Event|6|||
145890911|NCT01207440|526107576|FG006|Overall Study|Adverse Event|2|||
145890912|NCT01207440|526107570|FG000|Overall Study|Death|6|||
145890913|NCT01207440|526107571|FG001|Overall Study|Death|3|||
145890914|NCT01207440|526107572|FG002|Overall Study|Death|2|||
145890915|NCT01207440|526107573|FG003|Overall Study|Death|2|||
145890916|NCT01207440|526107574|FG004|Overall Study|Death|7|||
145890917|NCT01207440|526107575|FG005|Overall Study|Death|5|||
145890918|NCT01207440|526107576|FG006|Overall Study|Death|1|||
145890919|NCT01207440|526107570|FG000|Overall Study|Lack of Efficacy|13|||
145890920|NCT01207440|526107571|FG001|Overall Study|Lack of Efficacy|2|||
145890921|NCT01207440|526107572|FG002|Overall Study|Lack of Efficacy|5|||
146405373|NCT04439110|527986998|FG000|Overall Study|Alternative therapy|1|||
146405374|NCT04439110|527986998|FG000|Overall Study|Other complicating disease|1|||
146405375|NCT04439110|527986998|FG000|Overall Study|Personal reasons|1|||
146405376|NCT04439110|527986998|FG000|Overall Study|Still on treatment|1|||
146405377|NCT04647253|527987005|FG000|Overall Study|Death ≤ 365 Days|16|||
146405378|NCT04647253|527987006|FG001|Overall Study|Death ≤ 365 Days|7|||
146405379|NCT04647253|527987005|FG000|Overall Study|Physician Decision|0|||
146405380|NCT04647253|527987006|FG001|Overall Study|Physician Decision|1|||
146405381|NCT04647253|527987005|FG000|Overall Study|Withdrawal by Subject|7|||
146405382|NCT04647253|527987006|FG001|Overall Study|Withdrawal by Subject|2|||
146405383|NCT04647253|527987005|FG000|Overall Study|Missed 12-Month Visit|9|||
146405384|NCT04647253|527987006|FG001|Overall Study|Missed 12-Month Visit|7|||
146405385|NCT04647253|527987005|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
146405386|NCT04647253|527987006|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
146405387|NCT02706353|527987007|FG000|Dose Level 1|Disease Progression|1|||
146405388|NCT02706353|527987008|FG001|Dose Level 1|Disease Progression|0|||
146405389|NCT02706353|527987009|FG002|Dose Level 1|Disease Progression|0|||
146405390|NCT02706353|527987010|FG003|Dose Level 1|Disease Progression|0|||
146405391|NCT02706353|527987011|FG004|Dose Level 1|Disease Progression|0|||
146405392|NCT02706353|527987012|FG005|Dose Level 1|Disease Progression|0|||
146405393|NCT02706353|527987007|FG000|Dose Level 3|Disease Progression|0|||
146405394|NCT02706353|527987008|FG001|Dose Level 3|Disease Progression|0|||
146405395|NCT02706353|527987009|FG002|Dose Level 3|Disease Progression|2|||
146405396|NCT02706353|527987010|FG003|Dose Level 3|Disease Progression|0|||
146405397|NCT02706353|527987011|FG004|Dose Level 3|Disease Progression|0|||
146405398|NCT02706353|527987012|FG005|Dose Level 3|Disease Progression|0|||
146405399|NCT02706353|527987007|FG000|Dose Level 4|Disease Progression|0|||
146405400|NCT02706353|527987008|FG001|Dose Level 4|Disease Progression|0|||
146405401|NCT02706353|527987009|FG002|Dose Level 4|Disease Progression|0|||
146405402|NCT02706353|527987010|FG003|Dose Level 4|Disease Progression|1|||
146405403|NCT02706353|527987011|FG004|Dose Level 4|Disease Progression|0|||
146405404|NCT02706353|527987012|FG005|Dose Level 4|Disease Progression|0|||
146405405|NCT02706353|527987007|FG000|Dose Level 4|Toxicity|0|||
146405406|NCT02706353|527987008|FG001|Dose Level 4|Toxicity|0|||
146405407|NCT02706353|527987009|FG002|Dose Level 4|Toxicity|0|||
146405408|NCT02706353|527987010|FG003|Dose Level 4|Toxicity|1|||
146405409|NCT02706353|527987011|FG004|Dose Level 4|Toxicity|0|||
146405410|NCT02706353|527987012|FG005|Dose Level 4|Toxicity|0|||
146405411|NCT02706353|527987007|FG000|Dose Level 4|Death|0|||
146405412|NCT02706353|527987008|FG001|Dose Level 4|Death|0|||
146405413|NCT02706353|527987009|FG002|Dose Level 4|Death|0|||
146405414|NCT02706353|527987010|FG003|Dose Level 4|Death|1|||
146405415|NCT02706353|527987011|FG004|Dose Level 4|Death|0|||
146405416|NCT02706353|527987012|FG005|Dose Level 4|Death|0|||
146405417|NCT02706353|527987007|FG000|Dose Level 5|Toxicity|0|||
146405418|NCT02706353|527987008|FG001|Dose Level 5|Toxicity|0|||
146405419|NCT02706353|527987009|FG002|Dose Level 5|Toxicity|0|||
146405420|NCT02706353|527987010|FG003|Dose Level 5|Toxicity|0|||
146405421|NCT02706353|527987011|FG004|Dose Level 5|Toxicity|1|||
146405422|NCT02706353|527987012|FG005|Dose Level 5|Toxicity|0|||
146405423|NCT02706353|527987007|FG000|Dose Level 5|Disease Progression|0|||
146405424|NCT02706353|527987008|FG001|Dose Level 5|Disease Progression|0|||
146405425|NCT02706353|527987009|FG002|Dose Level 5|Disease Progression|0|||
146405426|NCT02706353|527987010|FG003|Dose Level 5|Disease Progression|0|||
146405427|NCT02706353|527987011|FG004|Dose Level 5|Disease Progression|3|||
146405428|NCT02706353|527987012|FG005|Dose Level 5|Disease Progression|2|||
146405429|NCT02706353|527987007|FG000|Dose Level 5|Death|0|||
146405430|NCT02706353|527987008|FG001|Dose Level 5|Death|0|||
146405431|NCT02706353|527987009|FG002|Dose Level 5|Death|0|||
146405432|NCT02706353|527987010|FG003|Dose Level 5|Death|0|||
146405433|NCT02706353|527987011|FG004|Dose Level 5|Death|1|||
146405434|NCT02706353|527987012|FG005|Dose Level 5|Death|6|||
146405435|NCT02706353|527987007|FG000|Dose Level 5|Withdrawal by Subject|0|||
146405436|NCT02706353|527987008|FG001|Dose Level 5|Withdrawal by Subject|0|||
146405437|NCT02706353|527987009|FG002|Dose Level 5|Withdrawal by Subject|0|||
146405438|NCT02706353|527987010|FG003|Dose Level 5|Withdrawal by Subject|0|||
146405439|NCT02706353|527987011|FG004|Dose Level 5|Withdrawal by Subject|0|||
146405440|NCT02706353|527987012|FG005|Dose Level 5|Withdrawal by Subject|2|||
146405441|NCT03560466|527987013|FG000|Overall Study|Adverse Event|1|||
146405442|NCT03560466|527987014|FG001|Overall Study|Adverse Event|2|||
146405443|NCT03560466|527987015|FG002|Overall Study|Adverse Event|0|||
146405444|NCT03560466|527987013|FG000|Overall Study|Poor Compliance to Protocol|0|||
146405445|NCT03560466|527987014|FG001|Overall Study|Poor Compliance to Protocol|2|||
146405446|NCT03560466|527987015|FG002|Overall Study|Poor Compliance to Protocol|0|||
146405447|NCT03560466|527987013|FG000|Overall Study|Other|6|||
146405448|NCT03560466|527987014|FG001|Overall Study|Other|8|||
146405449|NCT03560466|527987015|FG002|Overall Study|Other|1|||
146405450|NCT03703297|527987016|FG000|Overall Study|Death|115|||
146405451|NCT03703297|527987017|FG001|Overall Study|Death|0|||
146405452|NCT03703297|527987018|FG002|Overall Study|Death|144|||
146405453|NCT03703297|527987016|FG000|Overall Study|Withdrawal by Subject|9|||
146405454|NCT03703297|527987017|FG001|Overall Study|Withdrawal by Subject|0|||
146405455|NCT03703297|527987018|FG002|Overall Study|Withdrawal by Subject|11|||
146405456|NCT03703297|527987016|FG000|Overall Study|Ongoing at the time of DCO|140|||
146405457|NCT03703297|527987017|FG001|Overall Study|Ongoing at the time of DCO|200|||
146405458|NCT03703297|527987018|FG002|Overall Study|Ongoing at the time of DCO|111|||
146405459|NCT02038959|527988134|FG000|Overall Study|Withdrawal by Subject|6|||
146405460|NCT02038959|527988135|FG001|Overall Study|Withdrawal by Subject|8|||
146405461|NCT00819091|527988141|FG000|Overall Study|Adverse Event|3|||
146405462|NCT00819091|527988142|FG001|Overall Study|Adverse Event|5|||
146405463|NCT00819091|527988141|FG000|Overall Study|Protocol Violation|0|||
146405464|NCT00819091|527988142|FG001|Overall Study|Protocol Violation|1|||
146405465|NCT00819091|527988141|FG000|Overall Study|Lost to Follow-up|2|||
146405466|NCT00819091|527988142|FG001|Overall Study|Lost to Follow-up|0|||
146405467|NCT00819091|527988141|FG000|Overall Study|Withdrawal by Subject|1|||
146405468|NCT00819091|527988142|FG001|Overall Study|Withdrawal by Subject|2|||
146405469|NCT00819091|527988141|FG000|Overall Study|Other|1|||
146405470|NCT00819091|527988142|FG001|Overall Study|Other|2|||
146405471|NCT03911960|527988144|FG000|Overall Study|Lost to Follow-up|5|||
146405472|NCT03911960|527988145|FG001|Overall Study|Lost to Follow-up|3|||
146405473|NCT04318535|527988146|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
146405474|NCT04318535|527988147|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
146405475|NCT04318535|527988148|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
146405476|NCT02675426|527988151|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
146405477|NCT02675426|527988152|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
146405478|NCT02675426|527988153|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
146405479|NCT02675426|527988154|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
146405480|NCT02675426|527988151|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
146405481|NCT02675426|527988152|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
146405482|NCT02675426|527988153|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
146405483|NCT02675426|527988154|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
146405484|NCT02675426|527988151|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
146405485|NCT02675426|527988152|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
146062720|NCT03642873|526748322|FG003|Third Intervention (1 Day)|Screen failure|0|||
146062721|NCT03642873|526748323|FG004|Third Intervention (1 Day)|Screen failure|1|||
146062722|NCT03642873|526748324|FG005|Third Intervention (1 Day)|Screen failure|0|||
146062723|NCT03312231|526748325|FG000|Overall Study|Lost to Follow-up|2|||
146062724|NCT03312231|526748326|FG001|Overall Study|Lost to Follow-up|6|||
146062725|NCT03312231|526748327|FG002|Overall Study|Lost to Follow-up|1|||
146062726|NCT03312231|526748328|FG003|Overall Study|Lost to Follow-up|3|||
146062727|NCT03312231|526748329|FG004|Overall Study|Lost to Follow-up|1|||
146062728|NCT03312231|526748325|FG000|Overall Study|Withdrawal by Subject|0|||
146062729|NCT03312231|526748326|FG001|Overall Study|Withdrawal by Subject|3|||
146062730|NCT03312231|526748327|FG002|Overall Study|Withdrawal by Subject|1|||
146062731|NCT03312231|526748328|FG003|Overall Study|Withdrawal by Subject|0|||
146062732|NCT03312231|526748329|FG004|Overall Study|Withdrawal by Subject|0|||
146062733|NCT03312231|526748325|FG000|Overall Study|Death|0|||
146062734|NCT03312231|526748326|FG001|Overall Study|Death|1|||
146062735|NCT03312231|526748327|FG002|Overall Study|Death|1|||
146062736|NCT03312231|526748328|FG003|Overall Study|Death|0|||
146062737|NCT03312231|526748329|FG004|Overall Study|Death|0|||
146062738|NCT03312231|526748325|FG000|Overall Study|Study Vaccination not Received|1|||
146062739|NCT03312231|526748326|FG001|Overall Study|Study Vaccination not Received|1|||
146062740|NCT03312231|526748327|FG002|Overall Study|Study Vaccination not Received|1|||
146062741|NCT03312231|526748328|FG003|Overall Study|Study Vaccination not Received|0|||
146062742|NCT03312231|526748329|FG004|Overall Study|Study Vaccination not Received|0|||
146062743|NCT03157830|526748334|FG000|Overall Study|Lost to Follow-up|1|||
146062744|NCT03157830|526748334|FG000|Overall Study|Withdrawal by Subject|1|||
146062745|NCT00400179|526748335|FG000|Overall Study|Adverse Event|2|||
145890922|NCT01207440|526107573|FG003|Overall Study|Lack of Efficacy|1|||
146405486|NCT02675426|527988153|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
146405487|NCT02675426|527988154|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
146405488|NCT02675426|527988151|FG000|Period 1: Week 1 to Week 12|Other|2|||
146405489|NCT02675426|527988152|FG001|Period 1: Week 1 to Week 12|Other|1|||
146405490|NCT02675426|527988153|FG002|Period 1: Week 1 to Week 12|Other|0|||
146405491|NCT02675426|527988154|FG003|Period 1: Week 1 to Week 12|Other|2|||
146405492|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
146405493|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
146405494|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
146405495|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
146405496|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
146405497|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
146405498|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
146405499|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
146405500|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
146405501|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
146405502|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
146405503|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
146405504|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
146405505|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
146405506|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
146405507|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
146405508|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
146405509|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
146405510|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
146405511|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
146405512|NCT02675426|527988151|FG000|Period 2: Week 12 to Week 260|Other|8|||
146405513|NCT02675426|527988152|FG001|Period 2: Week 12 to Week 260|Other|12|||
146405514|NCT02675426|527988153|FG002|Period 2: Week 12 to Week 260|Other|23|||
146405515|NCT02675426|527988154|FG003|Period 2: Week 12 to Week 260|Other|15|||
146405516|NCT02156466|527988157|FG000|Overall Study|Adverse Event|0|||
146405517|NCT02156466|527988158|FG001|Overall Study|Adverse Event|0|||
145890923|NCT01207440|526107574|FG004|Overall Study|Lack of Efficacy|2|||
146062746|NCT00400179|526748336|FG001|Overall Study|Adverse Event|2|||
145890924|NCT01207440|526107575|FG005|Overall Study|Lack of Efficacy|3|||
146405518|NCT02156466|527988159|FG002|Overall Study|Adverse Event|1|||
146405519|NCT02156466|527988160|FG003|Overall Study|Adverse Event|1|||
146405520|NCT02156466|527988161|FG004|Overall Study|Adverse Event|0|||
146405521|NCT02156466|527988157|FG000|Overall Study|Quantiferon Positivity|0|||
146405522|NCT02156466|527988158|FG001|Overall Study|Quantiferon Positivity|0|||
146405523|NCT02156466|527988159|FG002|Overall Study|Quantiferon Positivity|0|||
146405524|NCT02156466|527988160|FG003|Overall Study|Quantiferon Positivity|1|||
146405525|NCT02156466|527988161|FG004|Overall Study|Quantiferon Positivity|0|||
146405526|NCT02237118|527988162|FG000|Overall Study|Protocol Violation|0|||
146405527|NCT02237118|527988163|FG001|Overall Study|Protocol Violation|1|||
146405528|NCT02237118|527988162|FG000|Overall Study|consent withdrawn|1|||
146405529|NCT02237118|527988163|FG001|Overall Study|consent withdrawn|0|||
146405530|NCT00080288|527988164|FG000|Overall Study|Adverse Event|7|||
146405531|NCT00080288|527988165|FG001|Overall Study|Adverse Event|4|||
146405532|NCT00080288|527988164|FG000|Overall Study|Lost to Follow-up|3|||
146405533|NCT00080288|527988165|FG001|Overall Study|Lost to Follow-up|5|||
146405534|NCT00080288|527988164|FG000|Overall Study|Physician Decision|6|||
146405535|NCT00080288|527988165|FG001|Overall Study|Physician Decision|2|||
146405536|NCT00080288|527988164|FG000|Overall Study|Withdrawal by Subject|3|||
146405537|NCT00080288|527988165|FG001|Overall Study|Withdrawal by Subject|16|||
146405538|NCT00080288|527988164|FG000|Overall Study|Miscellaneous|11|||
146405539|NCT00080288|527988165|FG001|Overall Study|Miscellaneous|11|||
146405540|NCT02253654|527988166|FG000|Overall Study|Withdrawal by Subject|12|||
146405541|NCT02253654|527988167|FG001|Overall Study|Withdrawal by Subject|4|||
146405542|NCT02253654|527988166|FG000|Overall Study|Decision by Sponsor|1|||
146405543|NCT02253654|527988167|FG001|Overall Study|Decision by Sponsor|1|||
146405544|NCT02253654|527988166|FG000|Overall Study|Lost to Follow-up|2|||
146405545|NCT02253654|527988167|FG001|Overall Study|Lost to Follow-up|5|||
146405546|NCT02253654|527988166|FG000|Overall Study|Death|4|||
146405547|NCT02253654|527988167|FG001|Overall Study|Death|7|||
146405548|NCT02253654|527988166|FG000|Overall Study|Did Not Receive Study Treatment|4|||
146405549|NCT02253654|527988167|FG001|Overall Study|Did Not Receive Study Treatment|1|||
146405550|NCT03044431|527988170|FG000|Overall Study|Lost to Follow-up|59|||
146405551|NCT03456726|527988171|FG000|Overall Study|Disease Progression|6|||
146405552|NCT03456726|527988172|FG001|Overall Study|Disease Progression|1|||
146405553|NCT03456726|527988171|FG000|Overall Study|Adverse Event|4|||
146405554|NCT03456726|527988172|FG001|Overall Study|Adverse Event|2|||
146405555|NCT03456726|527988171|FG000|Overall Study|Withdrawal by Subject|1|||
146405556|NCT03456726|527988172|FG001|Overall Study|Withdrawal by Subject|0|||
146405557|NCT03456726|527988171|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
146405558|NCT03456726|527988172|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
146405559|NCT04470622|527988173|FG000|Overall Study|Withdrawal by Subject|0|||
146405560|NCT04470622|527988174|FG001|Overall Study|Withdrawal by Subject|1|||
146405561|NCT04470622|527988173|FG000|Overall Study|Screen Failure|0|||
146405562|NCT04470622|527988174|FG001|Overall Study|Screen Failure|1|||
146405563|NCT04470622|527988173|FG000|Overall Study|Death|0|||
146405564|NCT04470622|527988174|FG001|Overall Study|Death|1|||
146405565|NCT00399490|527988175|FG000|Overall Study|Adverse Event|19|||
146405566|NCT00399490|527988175|FG000|Overall Study|Lack of Efficacy|31|||
146405567|NCT00399490|527988175|FG000|Overall Study|Lost to Follow-up|5|||
146405568|NCT00399490|527988175|FG000|Overall Study|Withdrawal by Subject|18|||
146405569|NCT00399490|527988175|FG000|Overall Study|Other|25|||
146405570|NCT02328547|527988176|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
146405571|NCT02328547|527988177|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
146405572|NCT02328547|527988176|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146405573|NCT02328547|527988177|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
146405574|NCT02576054|527988181|FG000|Overall Study|Withdrawal by Subject|1|||
146405575|NCT01586624|527988183|FG000|Overall Study|Adverse Event|3|||
146405576|NCT01586624|527988184|FG001|Overall Study|Adverse Event|0|||
146405577|NCT01586624|527988185|FG002|Overall Study|Adverse Event|2|||
146405578|NCT01586624|527988186|FG003|Overall Study|Adverse Event|1|||
146405579|NCT01586624|527988187|FG004|Overall Study|Adverse Event|3|||
146405580|NCT01586624|527988188|FG005|Overall Study|Adverse Event|3|||
146405581|NCT01586624|527988189|FG006|Overall Study|Adverse Event|2|||
146405582|NCT01586624|527988190|FG007|Overall Study|Adverse Event|3|||
146405583|NCT01586624|527988183|FG000|Overall Study|Physician Decision|0|||
146405584|NCT01586624|527988184|FG001|Overall Study|Physician Decision|1|||
146405585|NCT01586624|527988185|FG002|Overall Study|Physician Decision|1|||
146405586|NCT01586624|527988186|FG003|Overall Study|Physician Decision|0|||
146405587|NCT01586624|527988187|FG004|Overall Study|Physician Decision|2|||
146062747|NCT00400179|526748335|FG000|Overall Study|Death|1|||
146062748|NCT00400179|526748336|FG001|Overall Study|Death|2|||
146062749|NCT00400179|526748335|FG000|Overall Study|Withdrew Consent|1|||
146062750|NCT00400179|526748336|FG001|Overall Study|Withdrew Consent|5|||
146062751|NCT00400179|526748335|FG000|Overall Study|Disease progression|1|||
146062752|NCT00400179|526748336|FG001|Overall Study|Disease progression|1|||
146062753|NCT00400179|526748335|FG000|Overall Study|Intercurrent illness|0|||
146062754|NCT00400179|526748336|FG001|Overall Study|Intercurrent illness|1|||
146062755|NCT00400179|526748335|FG000|Overall Study|Investigator judgment|0|||
146062756|NCT00400179|526748336|FG001|Overall Study|Investigator judgment|1|||
146062757|NCT00400179|526748335|FG000|Overall Study|Randomization error/patient ineligible|1|||
146062758|NCT00400179|526748336|FG001|Overall Study|Randomization error/patient ineligible|6|||
146062759|NCT04780061|526748337|FG000|Overall Study|Withdrawal by Subject|5|||
146062760|NCT04780061|526748338|FG001|Overall Study|Withdrawal by Subject|8|||
146062761|NCT04780061|526748337|FG000|Overall Study|Adverse Event|2|||
146062762|NCT04780061|526748338|FG001|Overall Study|Adverse Event|2|||
146062763|NCT04780061|526748337|FG000|Overall Study|Lost to Follow-up|1|||
146062764|NCT04780061|526748338|FG001|Overall Study|Lost to Follow-up|5|||
146062765|NCT00734149|526748339|FG000|Overall Study|Withdrawal by Subject|1|||
146062766|NCT00626106|526748340|FG000|Overall Study|Withdrawal by Subject|2|||
146405588|NCT01586624|527988188|FG005|Overall Study|Physician Decision|0|||
146405589|NCT01586624|527988189|FG006|Overall Study|Physician Decision|1|||
146405590|NCT01586624|527988190|FG007|Overall Study|Physician Decision|1|||
146405591|NCT01586624|527988183|FG000|Overall Study|Withdrawal by Subject|0|||
146405592|NCT01586624|527988184|FG001|Overall Study|Withdrawal by Subject|0|||
146405593|NCT01586624|527988185|FG002|Overall Study|Withdrawal by Subject|0|||
146405594|NCT01586624|527988186|FG003|Overall Study|Withdrawal by Subject|1|||
146405595|NCT01586624|527988187|FG004|Overall Study|Withdrawal by Subject|0|||
146405596|NCT01586624|527988188|FG005|Overall Study|Withdrawal by Subject|0|||
146405597|NCT01586624|527988189|FG006|Overall Study|Withdrawal by Subject|0|||
146405598|NCT01586624|527988190|FG007|Overall Study|Withdrawal by Subject|0|||
146405599|NCT01586624|527988183|FG000|Overall Study|Evidence of disease progression|1|||
146405600|NCT01586624|527988184|FG001|Overall Study|Evidence of disease progression|3|||
146405601|NCT01586624|527988185|FG002|Overall Study|Evidence of disease progression|2|||
146405602|NCT01586624|527988186|FG003|Overall Study|Evidence of disease progression|5|||
146405603|NCT01586624|527988187|FG004|Overall Study|Evidence of disease progression|3|||
146405604|NCT01586624|527988188|FG005|Overall Study|Evidence of disease progression|5|||
146405605|NCT01586624|527988189|FG006|Overall Study|Evidence of disease progression|4|||
146405606|NCT01586624|527988190|FG007|Overall Study|Evidence of disease progression|6|||
146405607|NCT01586624|527988183|FG000|Overall Study|Screen failure (no treatment received)|0|||
146405608|NCT01586624|527988184|FG001|Overall Study|Screen failure (no treatment received)|0|||
146405609|NCT01586624|527988185|FG002|Overall Study|Screen failure (no treatment received)|0|||
146405610|NCT01586624|527988186|FG003|Overall Study|Screen failure (no treatment received)|0|||
146405611|NCT01586624|527988187|FG004|Overall Study|Screen failure (no treatment received)|0|||
146405612|NCT01586624|527988188|FG005|Overall Study|Screen failure (no treatment received)|0|||
146405613|NCT01586624|527988189|FG006|Overall Study|Screen failure (no treatment received)|1|||
146405614|NCT01586624|527988190|FG007|Overall Study|Screen failure (no treatment received)|0|||
146405615|NCT00953927|527988191|FG000|Overall Study|Lost to Follow-up|61|||
146405616|NCT00953927|527988192|FG001|Overall Study|Lost to Follow-up|65|||
146405617|NCT00953927|527988191|FG000|Overall Study|Withdrawal by Subject|36|||
146405618|NCT00953927|527988192|FG001|Overall Study|Withdrawal by Subject|25|||
146405619|NCT00953927|527988191|FG000|Overall Study|Death|7|||
146405620|NCT00953927|527988192|FG001|Overall Study|Death|4|||
146405621|NCT00953927|527988191|FG000|Overall Study|Other study discontinuation|1|||
146405622|NCT00953927|527988192|FG001|Overall Study|Other study discontinuation|1|||
146405623|NCT01396161|527988193|FG000|Overall Study|Withdrawal by Subject|0|||
146405624|NCT01396161|527988194|FG001|Overall Study|Withdrawal by Subject|0|||
146405625|NCT01396161|527988195|FG002|Overall Study|Withdrawal by Subject|0|||
146405626|NCT01396161|527988196|FG003|Overall Study|Withdrawal by Subject|0|||
146405627|NCT01396161|527988197|FG004|Overall Study|Withdrawal by Subject|1|||
146405628|NCT01396161|527988198|FG005|Overall Study|Withdrawal by Subject|0|||
146405629|NCT01396161|527988199|FG006|Overall Study|Withdrawal by Subject|0|||
146405630|NCT01396161|527988193|FG000|Overall Study|Other|0|||
146405631|NCT01396161|527988194|FG001|Overall Study|Other|0|||
146405632|NCT01396161|527988195|FG002|Overall Study|Other|0|||
146405633|NCT01396161|527988196|FG003|Overall Study|Other|0|||
146405634|NCT01396161|527988197|FG004|Overall Study|Other|0|||
146405635|NCT01396161|527988198|FG005|Overall Study|Other|0|||
146405636|NCT01396161|527988199|FG006|Overall Study|Other|1|||
146405637|NCT02962739|527988204|FG000|Overall Study|Withdrawal by Subject|0|||
146405638|NCT02962739|527988205|FG001|Overall Study|Withdrawal by Subject|1|||
146405639|NCT02962739|527988206|FG002|Overall Study|Withdrawal by Subject|0|||
146405640|NCT02962739|527988207|FG003|Overall Study|Withdrawal by Subject|0|||
146405641|NCT02962739|527988208|FG004|Overall Study|Withdrawal by Subject|0|||
146405642|NCT02962739|527988209|FG005|Overall Study|Withdrawal by Subject|0|||
146405643|NCT02962739|527988204|FG000|Overall Study|Protocol Violation|0|||
146405644|NCT02962739|527988205|FG001|Overall Study|Protocol Violation|0|||
146405645|NCT02962739|527988206|FG002|Overall Study|Protocol Violation|1|||
146405646|NCT02962739|527988207|FG003|Overall Study|Protocol Violation|0|||
146405647|NCT02962739|527988208|FG004|Overall Study|Protocol Violation|1|||
146405648|NCT02962739|527988209|FG005|Overall Study|Protocol Violation|0|||
146405649|NCT00414011|527988210|FG000|Overall Study|Physician Decision|3|||
146405650|NCT00414011|527988210|FG000|Overall Study|Withdrawal by Subject|2|||
146405651|NCT02360397|527988217|FG000|Overall Study|Incomplete screening|3|||
146405652|NCT02360397|527988217|FG000|Overall Study|Adverse Event|1|||
146405653|NCT01537549|527988218|FG000|Overall Study|Lost to Follow-up|1|||
146405654|NCT01537549|527988218|FG000|Overall Study|Withdrawal by Subject|2|||
146405655|NCT05349188|527988225|FG000|Overall Study|Withdrawal by Subject|1|||
146405656|NCT05349188|527988226|FG001|Overall Study|Withdrawal by Subject|0|||
146405657|NCT02756078|527988227|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
146405658|NCT02756078|527988228|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
146405659|NCT02756078|527988227|FG000|Period 1|Lost to Follow-up|0|||
146405660|NCT02756078|527988228|FG001|Period 1|Lost to Follow-up|2|||
146405661|NCT02756078|527988227|FG000|Period 1|Protocol Violation|0|||
146405662|NCT02756078|527988228|FG001|Period 1|Protocol Violation|1|||
146062767|NCT00626106|526748341|FG001|Overall Study|Withdrawal by Subject|1|||
146062768|NCT00626106|526748340|FG000|Overall Study|Lost to Follow-up|1|||
146062769|NCT00626106|526748341|FG001|Overall Study|Lost to Follow-up|4|||
146062770|NCT00626106|526748340|FG000|Overall Study|Death|64|||
146062771|NCT00626106|526748341|FG001|Overall Study|Death|19|||
146062772|NCT03253393|526748342|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
146062773|NCT03253393|526748343|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
146062774|NCT03253393|526748344|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
146062775|NCT01586364|526749593|FG000|Overall Study|Withdrawal by Subject|40|||
146062776|NCT01586364|526749593|FG000|Overall Study|Adverse Event|37|||
146062777|NCT01586364|526749593|FG000|Overall Study|Lost to Follow-up|17|||
146062778|NCT01586364|526749593|FG000|Overall Study|Protocol Violation|16|||
146062779|NCT01586364|526749593|FG000|Overall Study|Lack of Efficacy|1|||
146062780|NCT01586364|526749593|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
146062781|NCT01586364|526749593|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
146062782|NCT01586364|526749593|FG000|Overall Study|Other-Site closure due to PI illness|1|||
146062783|NCT01586364|526749593|FG000|Overall Study|Other-PI discretion, site closing|2|||
146062784|NCT01586364|526749593|FG000|Overall Study|Other-Not specified|1|||
146062785|NCT00091949|526749594|FG000|Overall Study|Withdrawal by Subject|117|||
146062786|NCT00091949|526749595|FG001|Overall Study|Withdrawal by Subject|110|||
146062787|NCT00091949|526749594|FG000|Overall Study|Lost to Follow-up|58|||
146062788|NCT00091949|526749595|FG001|Overall Study|Lost to Follow-up|41|||
146062789|NCT05366738|526749596|FG000|Overall Study|Adverse Event|0|||
146062790|NCT05366738|526749597|FG001|Overall Study|Adverse Event|1|||
146062791|NCT05366738|526749598|FG002|Overall Study|Adverse Event|0|||
146062792|NCT05291520|526749599|FG000|Overall Study|Lost to Follow-up|0|||
146062793|NCT05291520|526749600|FG001|Overall Study|Lost to Follow-up|0|||
146062794|NCT05291520|526749601|FG002|Overall Study|Lost to Follow-up|1|||
146062795|NCT01347112|526749602|FG000|Overall Study|Withdrawal by Subject|1|||
146062796|NCT01347112|526749603|FG001|Overall Study|Withdrawal by Subject|7|||
146062797|NCT01347112|526749602|FG000|Overall Study|Lost to Follow-up|3|||
146062798|NCT01347112|526749603|FG001|Overall Study|Lost to Follow-up|5|||
146062799|NCT00696072|526749604|FG000|Overall Study|continuing active treatment|10|||
146062800|NCT00696072|526749605|FG001|Overall Study|continuing active treatment|13|||
146062801|NCT00696072|526749604|FG000|Overall Study|Adverse Event|10|||
146062802|NCT00696072|526749605|FG001|Overall Study|Adverse Event|6|||
146062803|NCT00696072|526749604|FG000|Overall Study|Patient Request|3|||
146062804|NCT00696072|526749605|FG001|Overall Study|Patient Request|7|||
146062805|NCT00696072|526749604|FG000|Overall Study|Investigator Request|1|||
146062806|NCT00696072|526749605|FG001|Overall Study|Investigator Request|4|||
146062807|NCT00696072|526749604|FG000|Overall Study|Sponsor Request|0|||
146062808|NCT00696072|526749605|FG001|Overall Study|Sponsor Request|1|||
146062809|NCT00696072|526749604|FG000|Overall Study|Disease Progression|32|||
146062810|NCT00696072|526749605|FG001|Overall Study|Disease Progression|30|||
146062811|NCT00696072|526749604|FG000|Overall Study|Non-specified|1|||
146062812|NCT00696072|526749605|FG001|Overall Study|Non-specified|2|||
146062813|NCT01597596|526749606|FG000|Overall Study|Study terminated by sponsor|1|||
146062814|NCT01597596|526749607|FG001|Overall Study|Study terminated by sponsor|0|||
146062815|NCT01597596|526749606|FG000|Overall Study|Physician Decision|0|||
146062816|NCT01597596|526749607|FG001|Overall Study|Physician Decision|1|||
146062817|NCT00992108|526749614|FG000|Overall Study|Lost to Follow-up|0|||
146062818|NCT00992108|526749615|FG001|Overall Study|Lost to Follow-up|1|||
146062819|NCT04639245|526749616|FG000|Overall Study|Death|1|||
146062820|NCT02419001|526749619|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
146062821|NCT02419001|526749620|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
146062822|NCT00535496|526749621|FG000|Overall Study|Lost to Follow-up|0|||
146062823|NCT00535496|526749622|FG001|Overall Study|Lost to Follow-up|1|||
146062824|NCT00535496|526749623|FG002|Overall Study|Lost to Follow-up|0|||
146062825|NCT00535496|526749624|FG003|Overall Study|Lost to Follow-up|0|||
146062826|NCT00535496|526749621|FG000|Overall Study|Not treated with sugammadex|0|||
146062827|NCT00535496|526749622|FG001|Overall Study|Not treated with sugammadex|1|||
146062828|NCT00535496|526749623|FG002|Overall Study|Not treated with sugammadex|0|||
146062829|NCT00535496|526749624|FG003|Overall Study|Not treated with sugammadex|0|||
146062830|NCT03591406|526749626|FG000|Overall Study|Adverse Event|5|||
146062831|NCT03591406|526749627|FG001|Overall Study|Adverse Event|3|||
146062832|NCT03591406|526749626|FG000|Overall Study|Protocol Violation|2|||
146062833|NCT03591406|526749627|FG001|Overall Study|Protocol Violation|1|||
146062834|NCT03591406|526749626|FG000|Overall Study|Withdrawal by Subject|0|||
146062835|NCT03591406|526749627|FG001|Overall Study|Withdrawal by Subject|5|||
146062836|NCT01083771|526749628|FG000|Overall Study|non-compliant|2|||
146062837|NCT01083771|526749628|FG000|Overall Study|Withdrawal by Subject|3|||
146062838|NCT00321620|526749629|FG000|Overall Study|Death|269|||
146062839|NCT00321620|526749630|FG001|Overall Study|Death|294|||
146062840|NCT00321620|526749629|FG000|Overall Study|Withdrawal by Subject|164|||
146062841|NCT00321620|526749630|FG001|Overall Study|Withdrawal by Subject|147|||
146062842|NCT00321620|526749629|FG000|Overall Study|Disease progression|113|||
146062843|NCT00321620|526749630|FG001|Overall Study|Disease progression|117|||
146062844|NCT00321620|526749629|FG000|Overall Study|Adverse Event|43|||
146062845|NCT00321620|526749630|FG001|Overall Study|Adverse Event|56|||
146062846|NCT00321620|526749629|FG000|Overall Study|Lost to Follow-up|13|||
146062847|NCT00321620|526749630|FG001|Overall Study|Lost to Follow-up|9|||
146062848|NCT00321620|526749629|FG000|Overall Study|Physician Decision|4|||
146062849|NCT00321620|526749630|FG001|Overall Study|Physician Decision|1|||
146062850|NCT00321620|526749629|FG000|Overall Study|Noncompliance|14|||
146062851|NCT00321620|526749630|FG001|Overall Study|Noncompliance|7|||
146062852|NCT00321620|526749629|FG000|Overall Study|Protocol deviation|4|||
146062853|NCT00321620|526749630|FG001|Overall Study|Protocol deviation|3|||
146062854|NCT00321620|526749629|FG000|Overall Study|Ineligibility determined|2|||
146062855|NCT00321620|526749630|FG001|Overall Study|Ineligibility determined|3|||
146062856|NCT00321620|526749629|FG000|Overall Study|Participant request|75|||
146062857|NCT00321620|526749630|FG001|Overall Study|Participant request|52|||
146062858|NCT00321620|526749629|FG000|Overall Study|Other|42|||
146062859|NCT00321620|526749630|FG001|Overall Study|Other|33|||
146062860|NCT01462370|526749634|FG000|Overall Study|Lack of Qualifying Event|1|||
146062861|NCT01462370|526749635|FG001|Overall Study|Lack of Qualifying Event|1|||
146062862|NCT01462370|526749634|FG000|Overall Study|Physician Decision|0|||
146062863|NCT01462370|526749635|FG001|Overall Study|Physician Decision|1|||
146062864|NCT01462370|526749634|FG000|Overall Study|Withdrawal by Subject|0|||
146062865|NCT01462370|526749635|FG001|Overall Study|Withdrawal by Subject|3|||
146062866|NCT01747876|526749636|FG000|Overall Study|Adverse Event|1|||
146062867|NCT01747876|526749637|FG001|Overall Study|Adverse Event|0|||
146062868|NCT01747876|526749638|FG002|Overall Study|Adverse Event|2|||
146062869|NCT01747876|526749636|FG000|Overall Study|Withdrawal by Subject|0|||
146062870|NCT01747876|526749637|FG001|Overall Study|Withdrawal by Subject|1|||
146062871|NCT01747876|526749638|FG002|Overall Study|Withdrawal by Subject|1|||
146062872|NCT01747876|526749636|FG000|Overall Study|Disease progression|4|||
146062873|NCT01747876|526749637|FG001|Overall Study|Disease progression|13|||
146062874|NCT01747876|526749638|FG002|Overall Study|Disease progression|8|||
146062875|NCT01747876|526749636|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
146062876|NCT01747876|526749637|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
146062877|NCT01747876|526749638|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
146062878|NCT00853307|526749639|FG000|Overall Study|Adverse Event|1|||
146062879|NCT00853307|526749640|FG001|Overall Study|Adverse Event|2|||
146062880|NCT00853307|526749639|FG000|Overall Study|Withdrawal by Subject|1|||
146062881|NCT00853307|526749640|FG001|Overall Study|Withdrawal by Subject|2|||
146062882|NCT00853307|526749639|FG000|Overall Study|Reason Not Specified|0|||
146062883|NCT00853307|526749640|FG001|Overall Study|Reason Not Specified|1|||
146062884|NCT02703597|526749665|FG000|Assignment to Baseline|Lost to Follow-up|17|||
146062885|NCT02703597|526749666|FG001|Assignment to Baseline|Lost to Follow-up|16|||
146062886|NCT02703597|526749665|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
146062887|NCT02703597|526749666|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
146062888|NCT02703597|526749665|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
146062889|NCT02703597|526749666|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
146062890|NCT02703597|526749665|FG000|First Post-test to First Follow-up|Site drop out|0|||
146062891|NCT02703597|526749666|FG001|First Post-test to First Follow-up|Site drop out|58|||
146062892|NCT02703597|526749665|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
146062893|NCT02703597|526749666|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
146062894|NCT02703597|526749665|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
146062895|NCT02703597|526749666|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
146062896|NCT02703597|526749665|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
146062897|NCT02703597|526749666|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
146062898|NCT01614886|526749667|FG000|Overall Study|Adverse Event|15|||
146062899|NCT01614886|526749668|FG001|Overall Study|Adverse Event|20|||
146062900|NCT01614886|526749667|FG000|Overall Study|Withdrawal by Subject|4|||
146062901|NCT01614886|526749668|FG001|Overall Study|Withdrawal by Subject|4|||
146062902|NCT01614886|526749667|FG000|Overall Study|Death|1|||
146062903|NCT01614886|526749668|FG001|Overall Study|Death|0|||
146062904|NCT01614886|526749667|FG000|Overall Study|Protocol deviation|0|||
146062905|NCT01614886|526749668|FG001|Overall Study|Protocol deviation|2|||
146062906|NCT01523366|526749669|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146062907|NCT01523366|526749670|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146062908|NCT01523366|526749669|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
146062909|NCT01523366|526749670|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
146062910|NCT02461758|526749671|FG000|Overall Study|Lost to Follow-up|0|||
146062911|NCT02461758|526749672|FG001|Overall Study|Lost to Follow-up|1|||
146062912|NCT02461758|526749673|FG002|Overall Study|Lost to Follow-up|1|||
146062913|NCT02461758|526749674|FG003|Overall Study|Lost to Follow-up|0|||
146062914|NCT00449696|526749676|FG000|Overall Study|Other Treatment Required|6|||
146062915|NCT00449696|526749677|FG001|Overall Study|Other Treatment Required|1|||
146062916|NCT00449696|526749676|FG000|Overall Study|Withdrawal by Subject|5|||
146062917|NCT00449696|526749677|FG001|Overall Study|Withdrawal by Subject|5|||
146062918|NCT00449696|526749676|FG000|Overall Study|Lost to Follow-up|2|||
146062919|NCT00449696|526749677|FG001|Overall Study|Lost to Follow-up|3|||
146062920|NCT00449696|526749676|FG000|Overall Study|Others|7|||
146062921|NCT00449696|526749677|FG001|Overall Study|Others|0|||
146062922|NCT01033019|526749678|FG000|Overall Study|Withdrawal by Subject|1|||
146062923|NCT01033019|526749679|FG001|Overall Study|Withdrawal by Subject|0|||
146062924|NCT00551642|526749684|FG000|Treatment Period|Protocol Deviation|6|||
146062925|NCT00551642|526749685|FG001|Treatment Period|Protocol Deviation|11|||
146062926|NCT00551642|526749684|FG000|Treatment Period|Delivery device failure|1|||
146062927|NCT00551642|526749685|FG001|Treatment Period|Delivery device failure|3|||
146062928|NCT00551642|526749684|FG000|Treatment Period|Physician Decision|0|||
146062929|NCT00551642|526749685|FG001|Treatment Period|Physician Decision|1|||
146062930|NCT00551642|526749684|FG000|Treatment Period|Death|33|||
146062931|NCT00551642|526749685|FG001|Treatment Period|Death|31|||
146062932|NCT00551642|526749684|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
146062933|NCT00551642|526749685|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
146062934|NCT00551642|526749684|FG000|Treatment Period|Adverse Event|15|||
146062935|NCT00551642|526749685|FG001|Treatment Period|Adverse Event|12|||
146062936|NCT00551642|526749684|FG000|Treatment Period|Withdrawal by Subject|2|||
146062937|NCT00551642|526749685|FG001|Treatment Period|Withdrawal by Subject|1|||
146062938|NCT03011099|526749686|FG000|Overall Study|Withdrawal by Subject|0|||
146062939|NCT03011099|526749687|FG001|Overall Study|Withdrawal by Subject|2|||
146062940|NCT00283296|526749691|FG000|Overall Study|in-home trial not completed|5|||
146062941|NCT01353898|526749692|FG000|Overall Study|Study site terminated|0|||
146062942|NCT01353898|526749693|FG001|Overall Study|Study site terminated|0|||
146062943|NCT01353898|526749694|FG002|Overall Study|Study site terminated|0|||
146062944|NCT01353898|526749695|FG003|Overall Study|Study site terminated|0|||
146062945|NCT01353898|526749696|FG004|Overall Study|Study site terminated|0|||
146062946|NCT01353898|526749697|FG005|Overall Study|Study site terminated|1|||
146062947|NCT01903460|526749700|FG000|Overall Study|Adverse Event|0|||
146062948|NCT01903460|526749701|FG001|Overall Study|Adverse Event|0|||
146062949|NCT01903460|526749702|FG002|Overall Study|Adverse Event|0|||
146062950|NCT01903460|526749703|FG003|Overall Study|Adverse Event|1|||
146062951|NCT03104868|526749704|FG000|6 Week Follow up|Lost to Follow-up|5|||
146062952|NCT03104868|526749705|FG001|6 Week Follow up|Lost to Follow-up|8|||
146062953|NCT03104868|526749704|FG000|6 Week Follow up|Death|1|||
146062954|NCT03104868|526749705|FG001|6 Week Follow up|Death|1|||
146062955|NCT03104868|526749704|FG000|6 Week Follow up|Withdrawal by Subject|7|||
146062956|NCT03104868|526749705|FG001|6 Week Follow up|Withdrawal by Subject|6|||
146062957|NCT03104868|526749704|FG000|6 Week Follow up|Completed Later Timepoint|24|||
146062958|NCT03104868|526749705|FG001|6 Week Follow up|Completed Later Timepoint|22|||
146062959|NCT03104868|526749704|FG000|6 Month Follow up|Lost to Follow-up|2|||
146062960|NCT03104868|526749705|FG001|6 Month Follow up|Lost to Follow-up|2|||
146062961|NCT03104868|526749704|FG000|6 Month Follow up|Death|0|||
146062962|NCT03104868|526749705|FG001|6 Month Follow up|Death|1|||
146062963|NCT03104868|526749704|FG000|6 Month Follow up|Completed Later Timepoint|22|||
146062964|NCT03104868|526749705|FG001|6 Month Follow up|Completed Later Timepoint|32|||
146062965|NCT03104868|526749704|FG000|12 Month Follow up|Lost to Follow-up|1|||
146062966|NCT03104868|526749705|FG001|12 Month Follow up|Lost to Follow-up|2|||
146062967|NCT03104868|526749704|FG000|12 Month Follow up|Death|0|||
146062968|NCT03104868|526749705|FG001|12 Month Follow up|Death|1|||
146062969|NCT03104868|526749704|FG000|12 Month Follow up|Withdrawal by Subject|0|||
146062970|NCT03104868|526749705|FG001|12 Month Follow up|Withdrawal by Subject|3|||
146062971|NCT03104868|526749704|FG000|12 Month Follow up|Completed Later Timepoint|32|||
146062972|NCT03104868|526749705|FG001|12 Month Follow up|Completed Later Timepoint|29|||
146062973|NCT03104868|526749704|FG000|18 Month Follow up|Lost to Follow-up|7|||
146062974|NCT03104868|526749705|FG001|18 Month Follow up|Lost to Follow-up|11|||
146062975|NCT03104868|526749704|FG000|18 Month Follow up|Death|2|||
146062976|NCT03104868|526749705|FG001|18 Month Follow up|Death|1|||
146062977|NCT03104868|526749704|FG000|18 Month Follow up|Withdrawal by Subject|1|||
146405663|NCT02756078|527988227|FG000|Period 1|Adverse Event|1|||
146062978|NCT03104868|526749705|FG001|18 Month Follow up|Withdrawal by Subject|2|||
146062979|NCT03104868|526749704|FG000|18 Month Follow up|Graft Loss|1|||
146062980|NCT03104868|526749705|FG001|18 Month Follow up|Graft Loss|1|||
146062981|NCT03104868|526749704|FG000|18 Month Follow up|Completed Later Timepoint|19|||
146062982|NCT03104868|526749705|FG001|18 Month Follow up|Completed Later Timepoint|20|||
146405664|NCT02756078|527988228|FG001|Period 1|Adverse Event|10|||
146062983|NCT03104868|526749704|FG000|24 Month Follow up|Lost to Follow-up|15|||
146062984|NCT03104868|526749705|FG001|24 Month Follow up|Lost to Follow-up|16|||
146405665|NCT02756078|527988227|FG000|Period 1|Withdrawal by Subject|6|||
146062985|NCT03104868|526749704|FG000|24 Month Follow up|Death|3|||
146062986|NCT03104868|526749705|FG001|24 Month Follow up|Death|2|||
146062987|NCT03104868|526749704|FG000|24 Month Follow up|Withdrawal by Subject|1|||
146062988|NCT03104868|526749705|FG001|24 Month Follow up|Withdrawal by Subject|0|||
146062989|NCT03104868|526749704|FG000|24 Month Follow up|Graft Loss|2|||
146405666|NCT02756078|527988228|FG001|Period 1|Withdrawal by Subject|6|||
146062990|NCT03104868|526749705|FG001|24 Month Follow up|Graft Loss|0|||
146062991|NCT01253291|526749706|FG000|Overall Study|Withdrawal by Subject|1|||
146062992|NCT01253291|526749707|FG001|Overall Study|Withdrawal by Subject|1|||
146062993|NCT01253291|526749708|FG002|Overall Study|Withdrawal by Subject|0|||
146062994|NCT01253291|526749709|FG003|Overall Study|Withdrawal by Subject|0|||
146062995|NCT01253291|526749710|FG004|Overall Study|Withdrawal by Subject|0|||
146062996|NCT01253291|526749706|FG000|Overall Study|Adverse Event|0|||
146062997|NCT01253291|526749707|FG001|Overall Study|Adverse Event|1|||
146062998|NCT01253291|526749708|FG002|Overall Study|Adverse Event|0|||
146062999|NCT01253291|526749709|FG003|Overall Study|Adverse Event|0|||
146063000|NCT01253291|526749710|FG004|Overall Study|Adverse Event|0|||
146063001|NCT01253291|526749706|FG000|Overall Study|Lack of Efficacy|1|||
146063002|NCT01253291|526749707|FG001|Overall Study|Lack of Efficacy|0|||
146063003|NCT01253291|526749708|FG002|Overall Study|Lack of Efficacy|0|||
146063004|NCT01253291|526749709|FG003|Overall Study|Lack of Efficacy|0|||
146063005|NCT01253291|526749710|FG004|Overall Study|Lack of Efficacy|0|||
146063006|NCT01253291|526749706|FG000|Overall Study|Physician Decision|2|||
146063007|NCT01253291|526749707|FG001|Overall Study|Physician Decision|0|||
146063008|NCT01253291|526749708|FG002|Overall Study|Physician Decision|0|||
146063009|NCT01253291|526749709|FG003|Overall Study|Physician Decision|0|||
146063010|NCT01253291|526749710|FG004|Overall Study|Physician Decision|2|||
146063011|NCT01838395|526749714|FG000|Overall Study|Withdrawal by Subject|0|||
146063012|NCT01838395|526749715|FG001|Overall Study|Withdrawal by Subject|0|||
146063013|NCT01838395|526749716|FG002|Overall Study|Withdrawal by Subject|0|||
146063014|NCT01838395|526749717|FG003|Overall Study|Withdrawal by Subject|0|||
146063015|NCT01838395|526749718|FG004|Overall Study|Withdrawal by Subject|1|||
146063016|NCT01838395|526749719|FG005|Overall Study|Withdrawal by Subject|0|||
146063017|NCT01838395|526749714|FG000|Overall Study|Death|0|||
146063018|NCT01838395|526749715|FG001|Overall Study|Death|0|||
146063019|NCT01838395|526749716|FG002|Overall Study|Death|1|||
146063020|NCT01838395|526749717|FG003|Overall Study|Death|0|||
146063021|NCT01838395|526749718|FG004|Overall Study|Death|0|||
146063022|NCT01838395|526749719|FG005|Overall Study|Death|0|||
146063023|NCT01838395|526749714|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146063024|NCT01838395|526749715|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
146063025|NCT01838395|526749716|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146063026|NCT01838395|526749717|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146063027|NCT01838395|526749718|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146063028|NCT01838395|526749719|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
146063029|NCT03694353|526749723|FG000|Overall Study|Withdrawal by Subject|1|||
146063030|NCT03694353|526749723|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
146063031|NCT05720897|526749725|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
146063032|NCT05720897|526749726|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
146063033|NCT05565742|526749732|FG000|Overall Study|Withdrawal by Subject|0|||
146063034|NCT05565742|526749733|FG001|Overall Study|Withdrawal by Subject|0|||
146063035|NCT05565742|526749734|FG002|Overall Study|Withdrawal by Subject|2|||
146063036|NCT05565742|526749735|FG003|Overall Study|Withdrawal by Subject|2|||
146063037|NCT05565742|526749736|FG004|Overall Study|Withdrawal by Subject|2|||
146063038|NCT05565742|526749732|FG000|Overall Study|Death|1|||
146063039|NCT05565742|526749733|FG001|Overall Study|Death|0|||
146063040|NCT05565742|526749734|FG002|Overall Study|Death|0|||
146063041|NCT05565742|526749735|FG003|Overall Study|Death|0|||
146063042|NCT05565742|526749736|FG004|Overall Study|Death|0|||
146063043|NCT05565742|526749732|FG000|Overall Study|Participant Travelled Abroad|0|||
146063044|NCT05565742|526749733|FG001|Overall Study|Participant Travelled Abroad|0|||
146063045|NCT05565742|526749734|FG002|Overall Study|Participant Travelled Abroad|0|||
146405667|NCT02756078|527988227|FG000|Period 1|Lens Discomfort|2|||
146405668|NCT02756078|527988228|FG001|Period 1|Lens Discomfort|2|||
146405669|NCT02756078|527988227|FG000|Period 2|Adverse Event|3|||
146405670|NCT02756078|527988228|FG001|Period 2|Adverse Event|5|||
146405671|NCT02756078|527988227|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
146405672|NCT02756078|527988228|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
146405673|NCT02756078|527988227|FG000|Period 2|Withdrawal by Subject|3|||
146063046|NCT05565742|526749735|FG003|Overall Study|Participant Travelled Abroad|0|||
146063047|NCT05565742|526749736|FG004|Overall Study|Participant Travelled Abroad|1|||
146063048|NCT04163341|526749737|FG000|Overall Study|Withdrawal by Subject|2|||
146063049|NCT04163341|526749738|FG001|Overall Study|Withdrawal by Subject|0|||
146063050|NCT04163341|526749737|FG000|Overall Study|Lost to Follow-up|3|||
146063051|NCT04163341|526749738|FG001|Overall Study|Lost to Follow-up|4|||
146063052|NCT05417438|526749739|FG000|Overall Study|Withdrawal by Subject|3|||
146063053|NCT04272242|526749740|FG000|Overall Study|Withdrawal by Subject|3|||
146063054|NCT04272242|526749740|FG000|Overall Study|Lost to Follow-up|1|||
146405674|NCT02756078|527988228|FG001|Period 2|Withdrawal by Subject|1|||
146405675|NCT02268045|527988229|FG000|Overall Study|Death|4|||
146063055|NCT04272242|526749740|FG000|Overall Study|Adverse Event|1|||
146063056|NCT02681523|526749743|FG000|Overall Study|Adverse Event|1|||
146063057|NCT02681523|526749743|FG000|Overall Study|Patient Non-compliance|1|||
146063058|NCT00129402|526751224|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146063059|NCT00129402|526751225|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146063060|NCT00129402|526751226|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146063061|NCT00129402|526751227|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146063062|NCT00129402|526751228|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146063063|NCT00129402|526751229|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
146063064|NCT00129402|526751230|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
146063065|NCT00129402|526751224|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063066|NCT00129402|526751225|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063067|NCT00129402|526751226|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063068|NCT00129402|526751227|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063069|NCT00129402|526751228|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063070|NCT00129402|526751229|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
146063071|NCT00129402|526751230|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
146063072|NCT00129402|526751224|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063073|NCT00129402|526751225|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063074|NCT00129402|526751226|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063075|NCT00129402|526751227|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
146063076|NCT00129402|526751228|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063077|NCT00129402|526751229|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063078|NCT00129402|526751230|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
146063079|NCT00129402|526751224|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146063080|NCT00129402|526751225|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146063081|NCT00129402|526751226|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
146063082|NCT00129402|526751227|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146063083|NCT00129402|526751228|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
146063084|NCT00129402|526751229|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146063085|NCT00129402|526751230|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
146063086|NCT00129402|526751224|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063087|NCT00129402|526751225|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063088|NCT00129402|526751226|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
146063089|NCT00129402|526751227|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063090|NCT00129402|526751228|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063091|NCT00129402|526751229|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063092|NCT00129402|526751230|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
146063093|NCT00129402|526751224|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146063094|NCT00129402|526751225|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146063095|NCT00129402|526751226|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
146063096|NCT00129402|526751227|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146063097|NCT00129402|526751228|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146063098|NCT00129402|526751229|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
146063099|NCT00129402|526751230|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
146063100|NCT00129402|526751224|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063101|NCT00129402|526751225|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063102|NCT00129402|526751226|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
146063103|NCT00129402|526751227|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063104|NCT00129402|526751228|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063105|NCT00129402|526751229|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063106|NCT00129402|526751230|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
146063107|NCT00129402|526751224|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146063108|NCT00129402|526751225|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146063109|NCT00129402|526751226|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
146063110|NCT00129402|526751227|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146063111|NCT00129402|526751228|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146063112|NCT00129402|526751229|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
146063113|NCT00129402|526751230|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
146063114|NCT00129402|526751224|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146063115|NCT00129402|526751225|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146063116|NCT00129402|526751226|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
146063117|NCT00129402|526751227|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146405676|NCT02268045|527988230|FG001|Overall Study|Death|4|||
146405677|NCT02268045|527988229|FG000|Overall Study|Disease Progression|2|||
146405678|NCT02268045|527988230|FG001|Overall Study|Disease Progression|1|||
146405679|NCT02268045|527988229|FG000|Overall Study|Adverse Event|7|||
146405680|NCT02268045|527988230|FG001|Overall Study|Adverse Event|7|||
146405681|NCT02268045|527988229|FG000|Overall Study|Withdrawal by Subject|2|||
146405682|NCT02268045|527988230|FG001|Overall Study|Withdrawal by Subject|6|||
146405683|NCT02268045|527988229|FG000|Overall Study|Physician Decision|0|||
146405684|NCT02268045|527988230|FG001|Overall Study|Physician Decision|1|||
146405685|NCT02268045|527988229|FG000|Overall Study|Protocol Violation|1|||
146405686|NCT02268045|527988230|FG001|Overall Study|Protocol Violation|1|||
146405687|NCT03107715|527988233|FG000|Overall Study|did not deliver at the home hospital|4|||
146405688|NCT03107715|527988234|FG001|Overall Study|did not deliver at the home hospital|6|||
146405689|NCT03107715|527988233|FG000|Overall Study|infant stillborn|0|||
146405690|NCT03107715|527988234|FG001|Overall Study|infant stillborn|1|||
146405691|NCT01907516|527988235|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
146405692|NCT01907516|527988236|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
146405693|NCT01907516|527988235|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
146405694|NCT01907516|527988236|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
146405695|NCT01907516|527988235|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
146405696|NCT01907516|527988236|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
146405697|NCT01907516|527988235|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
146405698|NCT01907516|527988236|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
146405699|NCT00131937|527988238|FG000|Overall Study|Adverse Event|3|||
146405700|NCT00131937|527988238|FG000|Overall Study|Withdrawal by Subject|2|||
146405701|NCT00131937|527988238|FG000|Overall Study|Physician Decision|1|||
146405702|NCT00131937|527988238|FG000|Overall Study|Disease Progression|7|||
146405703|NCT00131937|527988238|FG000|Overall Study|Alternative therapy|1|||
146405704|NCT01211613|527990453|FG000|Overall Study|Lost to Follow-up|2|||
146405705|NCT01211613|527990454|FG001|Overall Study|Lost to Follow-up|2|||
146405706|NCT01211613|527990455|FG002|Overall Study|Lost to Follow-up|2|||
146405707|NCT01211613|527990453|FG000|Overall Study|Withdrawal by Subject|1|||
146405708|NCT01211613|527990454|FG001|Overall Study|Withdrawal by Subject|0|||
146405709|NCT01211613|527990455|FG002|Overall Study|Withdrawal by Subject|0|||
146405710|NCT01020773|527990456|FG000|Overall Study|Withdrawal by Subject|4|||
146405711|NCT01020773|527990457|FG001|Overall Study|Withdrawal by Subject|3|||
146405712|NCT03853213|527990458|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
146405713|NCT03853213|527990459|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
146405714|NCT03853213|527990458|FG000|Overall Study|Other (e.g., too busy)|0|||
146405715|NCT03853213|527990459|FG001|Overall Study|Other (e.g., too busy)|2|||
146405716|NCT03302299|527990460|FG000|Overall Study|Protocol Violation|1|||
146405717|NCT01458132|527990461|FG000|Overall Study|Other|15|||
146405718|NCT01458132|527990462|FG001|Overall Study|Other|3|||
146405719|NCT01788163|527990463|FG000|Overall Study|Other|53|||
146405720|NCT01788163|527990464|FG001|Overall Study|Other|0|||
146405721|NCT01788163|527990465|FG002|Overall Study|Other|0|||
146405722|NCT01788163|527990466|FG003|Overall Study|Other|0|||
146405723|NCT01788163|527990467|FG004|Overall Study|Other|0|||
146405724|NCT01788163|527990468|FG005|Overall Study|Other|7|||
146405725|NCT01788163|527990469|FG006|Overall Study|Other|1|||
146405726|NCT01788163|527990470|FG007|Overall Study|Other|48|||
146405727|NCT01788163|527990471|FG008|Overall Study|Other|15|||
146405728|NCT01788163|527990463|FG000|Overall Study|Withdrawal by Subject|2|||
146405729|NCT01788163|527990464|FG001|Overall Study|Withdrawal by Subject|0|||
146405730|NCT01788163|527990465|FG002|Overall Study|Withdrawal by Subject|0|||
146405731|NCT01788163|527990466|FG003|Overall Study|Withdrawal by Subject|0|||
146405732|NCT01788163|527990467|FG004|Overall Study|Withdrawal by Subject|0|||
146405733|NCT01788163|527990468|FG005|Overall Study|Withdrawal by Subject|0|||
146405734|NCT01788163|527990469|FG006|Overall Study|Withdrawal by Subject|0|||
146405735|NCT01788163|527990470|FG007|Overall Study|Withdrawal by Subject|0|||
146405736|NCT01788163|527990471|FG008|Overall Study|Withdrawal by Subject|1|||
146405737|NCT00545441|527990472|FG000|Overall Study|Fistula draining at 6 months|2|||
146405738|NCT00545441|527990473|FG001|Overall Study|Fistula draining at 6 months|4|||
146063118|NCT00129402|526751228|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146405739|NCT00545441|527990472|FG000|Overall Study|Lost to Follow-up|9|||
146063119|NCT00129402|526751229|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
146405740|NCT00545441|527990473|FG001|Overall Study|Lost to Follow-up|5|||
146405741|NCT00545441|527990472|FG000|Overall Study|Technical failure|0|||
146405742|NCT00545441|527990473|FG001|Overall Study|Technical failure|1|||
146405743|NCT00545441|527990472|FG000|Overall Study|Withdrawal by Subject|1|||
146405744|NCT00545441|527990473|FG001|Overall Study|Withdrawal by Subject|1|||
146405745|NCT00545441|527990472|FG000|Overall Study|Persistence or recurrence of fistula|5|||
146405746|NCT00545441|527990473|FG001|Overall Study|Persistence or recurrence of fistula|2|||
146405747|NCT00545441|527990472|FG000|Overall Study|Patients were not treated|1|||
146405748|NCT00545441|527990473|FG001|Overall Study|Patients were not treated|3|||
146063120|NCT00129402|526751230|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
146405749|NCT00265239|527990474|FG000|Overall Study|Adverse Event|2|||
146405750|NCT00265239|527990475|FG001|Overall Study|Adverse Event|1|||
146405751|NCT02803138|527990476|FG000|Overall Study|Failure to return|38|||
146405752|NCT02803138|527990476|FG000|Overall Study|Insufficient virological response|2|||
146405753|NCT02803138|527990476|FG000|Overall Study|Withdrawn consent|1|||
146405754|NCT02803138|527990476|FG000|Overall Study|Death|1|||
146405755|NCT02803138|527990476|FG000|Overall Study|Other, not specified|28|||
146405756|NCT00021229|527990477|FG000|Overall Study|Adverse Event|10|||
146405757|NCT00021229|527990478|FG001|Overall Study|Adverse Event|5|||
146405758|NCT00021229|527990479|FG002|Overall Study|Adverse Event|2|||
146405759|NCT00021229|527990477|FG000|Overall Study|Death|0|||
146405760|NCT00021229|527990478|FG001|Overall Study|Death|1|||
146405761|NCT00021229|527990479|FG002|Overall Study|Death|0|||
146405762|NCT00021229|527990477|FG000|Overall Study|Withdrawal by Subject|7|||
146405763|NCT00021229|527990478|FG001|Overall Study|Withdrawal by Subject|7|||
146405764|NCT00021229|527990479|FG002|Overall Study|Withdrawal by Subject|1|||
146405765|NCT00021229|527990477|FG000|Overall Study|Progressive Disease|15|||
146405766|NCT00021229|527990478|FG001|Overall Study|Progressive Disease|19|||
146405767|NCT00021229|527990479|FG002|Overall Study|Progressive Disease|12|||
146405768|NCT00021229|527990477|FG000|Overall Study|Protocol Violation|1|||
146405769|NCT00021229|527990478|FG001|Overall Study|Protocol Violation|1|||
146405770|NCT00021229|527990479|FG002|Overall Study|Protocol Violation|0|||
146405771|NCT00021229|527990477|FG000|Overall Study|Physician Decision|0|||
146405772|NCT00021229|527990478|FG001|Overall Study|Physician Decision|0|||
146405773|NCT00021229|527990479|FG002|Overall Study|Physician Decision|1|||
146405774|NCT00021229|527990477|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
146405775|NCT00021229|527990478|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
146405776|NCT00021229|527990479|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
146405777|NCT01858558|527990483|FG000|Overall Study|Death|1|||
146405778|NCT01858558|527990484|FG001|Overall Study|Death|1|||
146405779|NCT01858558|527990483|FG000|Overall Study|Lost to Follow-up|1|||
146405780|NCT01858558|527990484|FG001|Overall Study|Lost to Follow-up|0|||
146405781|NCT01858558|527990483|FG000|Overall Study|Disease progression|3|||
146405782|NCT01858558|527990484|FG001|Overall Study|Disease progression|1|||
146405783|NCT01858558|527990483|FG000|Overall Study|Product contamination|2|||
146405784|NCT01858558|527990484|FG001|Overall Study|Product contamination|0|||
146405785|NCT01858558|527990483|FG000|Overall Study|Failed expansion of cell product|2|||
146405786|NCT01858558|527990484|FG001|Overall Study|Failed expansion of cell product|0|||
146405787|NCT01784419|527990485|FG000|Overall Study|Adverse Event|3|||
146405788|NCT00306852|527990486|FG000|Overall Study|Death|14|||
146405789|NCT00306852|527990487|FG001|Overall Study|Death|14|||
146405790|NCT00306852|527990486|FG000|Overall Study|Lost to Follow-up|15|||
146405791|NCT00306852|527990487|FG001|Overall Study|Lost to Follow-up|24|||
146405792|NCT03578276|527990488|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
146405793|NCT03578276|527990489|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
146405794|NCT00883740|527990490|FG000|First Intervention|Lost to Follow-up|1|||
146405795|NCT00883740|527990491|FG001|First Intervention|Lost to Follow-up|0|||
146405796|NCT00883740|527990490|FG000|First Intervention|No longer willing to participate|2|||
146405797|NCT00883740|527990491|FG001|First Intervention|No longer willing to participate|0|||
146405798|NCT00883740|527990490|FG000|First Intervention|Protocol Violation|3|||
146405799|NCT00883740|527990491|FG001|First Intervention|Protocol Violation|6|||
146405800|NCT00883740|527990490|FG000|First Intervention|Adverse Event|1|||
146405801|NCT00883740|527990491|FG001|First Intervention|Adverse Event|2|||
146405802|NCT00883740|527990490|FG000|Second Intervention|Protocol Violation|1|||
146405803|NCT00883740|527990491|FG001|Second Intervention|Protocol Violation|0|||
146405804|NCT00883740|527990490|FG000|Second Intervention|No longer willing to participate|0|||
146405805|NCT00883740|527990491|FG001|Second Intervention|No longer willing to participate|1|||
146405806|NCT01286207|527990494|FG000|Overall Study|Adverse Event|27|||
146405807|NCT01286207|527990495|FG001|Overall Study|Adverse Event|41|||
146405808|NCT01286207|527990496|FG002|Overall Study|Adverse Event|8|||
146405809|NCT01286207|527990494|FG000|Overall Study|Lost to Follow-up|49|||
146405810|NCT01286207|527990495|FG001|Overall Study|Lost to Follow-up|43|||
146405811|NCT01286207|527990496|FG002|Overall Study|Lost to Follow-up|20|||
146405812|NCT01286207|527990494|FG000|Overall Study|Withdrawal by Subject|93|||
146405813|NCT01286207|527990495|FG001|Overall Study|Withdrawal by Subject|79|||
146405814|NCT01286207|527990496|FG002|Overall Study|Withdrawal by Subject|41|||
146405815|NCT01286207|527990494|FG000|Overall Study|Lack of Response|92|||
146405816|NCT01286207|527990495|FG001|Overall Study|Lack of Response|38|||
146405817|NCT01286207|527990496|FG002|Overall Study|Lack of Response|8|||
146405818|NCT01286207|527990494|FG000|Overall Study|Other|37|||
146405819|NCT01286207|527990495|FG001|Overall Study|Other|47|||
146405820|NCT01286207|527990496|FG002|Overall Study|Other|13|||
146405821|NCT00981409|527990497|FG000|Overall Study|Adverse Event|4|||
146405822|NCT00981409|527990498|FG001|Overall Study|Adverse Event|0|||
146405823|NCT00981409|527990497|FG000|Overall Study|Protocol Violation|0|||
146405824|NCT00981409|527990498|FG001|Overall Study|Protocol Violation|1|||
146405825|NCT00981409|527990497|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
146405826|NCT00981409|527990498|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
146405827|NCT00450177|527990499|FG000|Overall Study|Adverse Event|7|||
146405828|NCT00450177|527990500|FG001|Overall Study|Adverse Event|4|||
146405829|NCT00450177|527990499|FG000|Overall Study|Withdrawal by Subject|1|||
146405830|NCT00450177|527990500|FG001|Overall Study|Withdrawal by Subject|6|||
146405831|NCT00450177|527990499|FG000|Overall Study|Withdrawal by Primary Team|1|||
146405832|NCT00450177|527990500|FG001|Overall Study|Withdrawal by Primary Team|1|||
146405833|NCT02923115|527990501|FG000|Overall Study|Lost to Follow-up|0|||
146405834|NCT02923115|527990502|FG001|Overall Study|Lost to Follow-up|0|||
146405835|NCT02923115|527990503|FG002|Overall Study|Lost to Follow-up|0|||
146405836|NCT02923115|527990504|FG003|Overall Study|Lost to Follow-up|1|||
146405837|NCT02923115|527990505|FG004|Overall Study|Lost to Follow-up|0|||
146405838|NCT02923115|527990506|FG005|Overall Study|Lost to Follow-up|0|||
146405839|NCT02923115|527990501|FG000|Overall Study|Withdrawal by Subject|0|||
146405840|NCT02923115|527990502|FG001|Overall Study|Withdrawal by Subject|1|||
146405841|NCT02923115|527990503|FG002|Overall Study|Withdrawal by Subject|0|||
146405842|NCT02923115|527990504|FG003|Overall Study|Withdrawal by Subject|0|||
146405843|NCT02923115|527990505|FG004|Overall Study|Withdrawal by Subject|0|||
146405844|NCT02923115|527990506|FG005|Overall Study|Withdrawal by Subject|0|||
146405845|NCT02923115|527990501|FG000|Overall Study|Randomized, but not dosed|0|||
146405846|NCT02923115|527990502|FG001|Overall Study|Randomized, but not dosed|0|||
146405847|NCT02923115|527990503|FG002|Overall Study|Randomized, but not dosed|3|||
146405848|NCT02923115|527990504|FG003|Overall Study|Randomized, but not dosed|1|||
146405849|NCT02923115|527990505|FG004|Overall Study|Randomized, but not dosed|5|||
146405850|NCT02923115|527990506|FG005|Overall Study|Randomized, but not dosed|0|||
146405851|NCT03869684|527990509|FG000|Overall Study|Adverse Event|0|||
146405852|NCT03869684|527990510|FG001|Overall Study|Adverse Event|3|||
146405853|NCT03869684|527990511|FG002|Overall Study|Adverse Event|1|||
146405854|NCT03869684|527990509|FG000|Overall Study|Withdrawal by Subject|1|||
146405855|NCT03869684|527990510|FG001|Overall Study|Withdrawal by Subject|0|||
146405856|NCT03869684|527990511|FG002|Overall Study|Withdrawal by Subject|0|||
146405857|NCT03869684|527990509|FG000|Overall Study|Lost to Follow-up|1|||
146405858|NCT03869684|527990510|FG001|Overall Study|Lost to Follow-up|0|||
146405859|NCT03869684|527990511|FG002|Overall Study|Lost to Follow-up|0|||
146405860|NCT03869684|527990509|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
146405861|NCT03869684|527990510|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
146405862|NCT03869684|527990511|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
146405863|NCT04056299|527990512|FG000|Overall Study|Sponsor discontinued study|3|||
146405864|NCT04056299|527990513|FG001|Overall Study|Sponsor discontinued study|3|||
146405865|NCT01296152|527990520|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146405866|NCT04840901|527990521|FG000|Overall Study|Lost to Follow-up|3|||
146405867|NCT04840901|527990522|FG001|Overall Study|Lost to Follow-up|1|||
146405868|NCT04840901|527990521|FG000|Overall Study|Moved|1|||
146405869|NCT04840901|527990522|FG001|Overall Study|Moved|0|||
146405870|NCT04840901|527990521|FG000|Overall Study|Unable to comply with study schedule|0|||
146405871|NCT04840901|527990522|FG001|Overall Study|Unable to comply with study schedule|1|||
146405872|NCT04840901|527990521|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
146405873|NCT04840901|527990522|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
146405874|NCT01268683|527990523|FG000|Overall Study|Lost to Follow-up|1|||
146405875|NCT01268683|527990523|FG000|Overall Study|Death|1|||
146405876|NCT00103259|527990526|FG000|Overall Study|Death|3|||
146405877|NCT00103259|527990527|FG001|Overall Study|Death|2|||
146405878|NCT00103259|527990526|FG000|Overall Study|Withdrawal by Subject|2|||
146405879|NCT00103259|527990527|FG001|Overall Study|Withdrawal by Subject|3|||
146405880|NCT00103259|527990526|FG000|Overall Study|alternative therapy|1|||
146405881|NCT00103259|527990527|FG001|Overall Study|alternative therapy|0|||
146405882|NCT00103259|527990526|FG000|Overall Study|other (reasons were not specified)|2|||
146405883|NCT00103259|527990527|FG001|Overall Study|other (reasons were not specified)|1|||
146063121|NCT00129402|526751224|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146063122|NCT00129402|526751225|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146063123|NCT00129402|526751226|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146063124|NCT00129402|526751227|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146063125|NCT00129402|526751228|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146063126|NCT00129402|526751229|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
146405884|NCT00103259|527990526|FG000|Overall Study|ineligible/no protocol therapy|4|||
146405885|NCT00103259|527990527|FG001|Overall Study|ineligible/no protocol therapy|6|||
146405886|NCT03224234|527990530|FG000|Main Study|Lost to Follow-up|5|||
146405887|NCT03224234|527990531|FG001|Main Study|Lost to Follow-up|5|||
146405888|NCT02610842|527990532|FG000|Overall Study|Lost to Follow-up|5|||
146405889|NCT01988493|527990533|FG000|Overall Study|Randomized but not treated|0|||
146405890|NCT01988493|527990534|FG001|Overall Study|Randomized but not treated|0|||
146405891|NCT01988493|527990535|FG002|Overall Study|Randomized but not treated|0|||
146405892|NCT01988493|527990536|FG003|Overall Study|Randomized but not treated|0|||
146405893|NCT01988493|527990537|FG004|Overall Study|Randomized but not treated|1|||
146405894|NCT02494583|527990538|FG000|Overall Study|Death|224|||
146405895|NCT02494583|527990539|FG001|Overall Study|Death|214|||
146405896|NCT02494583|527990540|FG002|Overall Study|Death|225|||
146405897|NCT02494583|527990538|FG000|Overall Study|Lost to Follow-up|1|||
146405898|NCT02494583|527990539|FG001|Overall Study|Lost to Follow-up|0|||
146405899|NCT02494583|527990540|FG002|Overall Study|Lost to Follow-up|0|||
146405900|NCT02494583|527990538|FG000|Overall Study|Protocol Violation|1|||
146405901|NCT02494583|527990539|FG001|Overall Study|Protocol Violation|2|||
146405902|NCT02494583|527990540|FG002|Overall Study|Protocol Violation|0|||
146405903|NCT02494583|527990538|FG000|Overall Study|Screen Failure|0|||
146405904|NCT02494583|527990539|FG001|Overall Study|Screen Failure|1|||
146405905|NCT02494583|527990540|FG002|Overall Study|Screen Failure|0|||
146405906|NCT02494583|527990538|FG000|Overall Study|Transferred to Extension Study|15|||
146405907|NCT02494583|527990539|FG001|Overall Study|Transferred to Extension Study|15|||
146405908|NCT02494583|527990540|FG002|Overall Study|Transferred to Extension Study|6|||
146405909|NCT02494583|527990538|FG000|Overall Study|Did Not Continue on Extension Study|8|||
146405910|NCT02494583|527990539|FG001|Overall Study|Did Not Continue on Extension Study|10|||
146405911|NCT02494583|527990540|FG002|Overall Study|Did Not Continue on Extension Study|4|||
146405912|NCT02494583|527990538|FG000|Overall Study|Withdrawal by Subject|7|||
146405913|NCT02494583|527990539|FG001|Overall Study|Withdrawal by Subject|15|||
146405914|NCT02494583|527990540|FG002|Overall Study|Withdrawal by Subject|15|||
146405915|NCT00627458|527990545|FG000|Overall Study|Migrated from study area|1|||
146405916|NCT00627458|527990546|FG001|Overall Study|Migrated from study area|0|||
146405917|NCT00627458|527990547|FG002|Overall Study|Migrated from study area|1|||
146405918|NCT00627458|527990545|FG000|Overall Study|Withdrawal by Subject|2|||
146405919|NCT00627458|527990546|FG001|Overall Study|Withdrawal by Subject|6|||
146405920|NCT00627458|527990547|FG002|Overall Study|Withdrawal by Subject|5|||
146405921|NCT00627458|527990545|FG000|Overall Study|Lost to Follow-up|1|||
146405922|NCT00627458|527990546|FG001|Overall Study|Lost to Follow-up|1|||
146405923|NCT00627458|527990547|FG002|Overall Study|Lost to Follow-up|0|||
146405924|NCT03891875|527990548|FG000|Overall Study|Withdrawal by Subject|20|||
146405925|NCT03891875|527990549|FG001|Overall Study|Withdrawal by Subject|3|||
146405926|NCT03891875|527990548|FG000|Overall Study|Adverse Event|10|||
146405927|NCT03891875|527990549|FG001|Overall Study|Adverse Event|4|||
146405928|NCT03891875|527990548|FG000|Overall Study|Physician Decision|1|||
146405929|NCT03891875|527990549|FG001|Overall Study|Physician Decision|1|||
146405930|NCT03891875|527990548|FG000|Overall Study|Protocol Violation|1|||
146405931|NCT03891875|527990549|FG001|Overall Study|Protocol Violation|0|||
146405932|NCT03891875|527990548|FG000|Overall Study|Lost to Follow-up|1|||
146405933|NCT03891875|527990549|FG001|Overall Study|Lost to Follow-up|0|||
146405934|NCT03891875|527990548|FG000|Overall Study|COVID-19 infection|1|||
146405935|NCT03891875|527990549|FG001|Overall Study|COVID-19 infection|0|||
146405936|NCT03332212|527990552|FG000|Overall Study|Not treated|0|||
146405937|NCT03332212|527990553|FG001|Overall Study|Not treated|1|||
146405938|NCT03332212|527990554|FG002|Overall Study|Not treated|0|||
146405939|NCT03332212|527990555|FG003|Overall Study|Not treated|0|||
146405940|NCT03332212|527990552|FG000|Overall Study|Adverse Event|0|||
146405941|NCT03332212|527990553|FG001|Overall Study|Adverse Event|0|||
146405942|NCT03332212|527990554|FG002|Overall Study|Adverse Event|0|||
146405943|NCT03332212|527990555|FG003|Overall Study|Adverse Event|1|||
146405944|NCT03332212|527990552|FG000|Overall Study|worsening of disease under study|1|||
146405945|NCT03332212|527990553|FG001|Overall Study|worsening of disease under study|1|||
146405946|NCT03332212|527990554|FG002|Overall Study|worsening of disease under study|0|||
146405947|NCT03332212|527990555|FG003|Overall Study|worsening of disease under study|0|||
146405948|NCT02125734|527990559|FG000|Period 2|Adverse Event|0|||
146405949|NCT02125734|527990560|FG001|Period 2|Adverse Event|1|||
146405950|NCT01308762|527990561|FG000|Overall Study|Protocol Violation|0|||
146405951|NCT01308762|527990562|FG001|Overall Study|Protocol Violation|1|||
146405952|NCT01308762|527990563|FG002|Overall Study|Protocol Violation|0|||
146405953|NCT02617446|527990564|FG000|Overall Study|Withdrawal by Subject|0|||
146405954|NCT02617446|527990565|FG001|Overall Study|Withdrawal by Subject|2|||
146405955|NCT02617446|527990566|FG002|Overall Study|Withdrawal by Subject|0|||
146405956|NCT02617446|527990564|FG000|Overall Study|Adverse Event|1|||
146405957|NCT02617446|527990565|FG001|Overall Study|Adverse Event|0|||
146171715|NCT00975221|527143206|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
146405958|NCT02617446|527990566|FG002|Overall Study|Adverse Event|5|||
146405959|NCT02617446|527990564|FG000|Overall Study|Lost to Follow-up|3|||
146405960|NCT02617446|527990565|FG001|Overall Study|Lost to Follow-up|0|||
146405961|NCT02617446|527990566|FG002|Overall Study|Lost to Follow-up|0|||
146405962|NCT02617446|527990564|FG000|Overall Study|Death|0|||
146405963|NCT02617446|527990565|FG001|Overall Study|Death|0|||
146405964|NCT02617446|527990566|FG002|Overall Study|Death|2|||
146405965|NCT01556490|527990575|FG000|Randomized Patients Summary|Protocol Violation|22|||
146405966|NCT01556490|527990576|FG001|Randomized Patients Summary|Protocol Violation|23|||
146405967|NCT01556490|527990575|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
146405968|NCT01556490|527990576|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
146405969|NCT02058368|527990577|FG000|Overall Study|Adverse Event|15|||
146405970|NCT02058368|527990578|FG001|Overall Study|Adverse Event|20|||
146405971|NCT02058368|527990577|FG000|Overall Study|Lack of Efficacy|0|||
146405972|NCT02058368|527990578|FG001|Overall Study|Lack of Efficacy|1|||
146405973|NCT02058368|527990577|FG000|Overall Study|Protocol Violation|0|||
146405974|NCT02058368|527990578|FG001|Overall Study|Protocol Violation|4|||
146405975|NCT02058368|527990577|FG000|Overall Study|Lost to Follow-up|2|||
146405976|NCT02058368|527990578|FG001|Overall Study|Lost to Follow-up|0|||
146405977|NCT02058368|527990577|FG000|Overall Study|Physician Decision|2|||
146405978|NCT02058368|527990578|FG001|Overall Study|Physician Decision|3|||
146405979|NCT02058368|527990577|FG000|Overall Study|Withdrawal by Subject|22|||
146405980|NCT02058368|527990578|FG001|Overall Study|Withdrawal by Subject|26|||
146405981|NCT01652872|527990579|FG000|Overall Study|Death|36|||
146405982|NCT01652872|527990580|FG001|Overall Study|Death|39|||
146405983|NCT01652872|527990579|FG000|Overall Study|Lost to Follow-up|28|||
146405984|NCT01652872|527990580|FG001|Overall Study|Lost to Follow-up|23|||
146405985|NCT01652872|527990579|FG000|Overall Study|Decision by sponsor|5|||
146405986|NCT01652872|527990580|FG001|Overall Study|Decision by sponsor|7|||
146405987|NCT01652872|527990579|FG000|Overall Study|Withdrawal by Subject|76|||
146405988|NCT01652872|527990580|FG001|Overall Study|Withdrawal by Subject|84|||
146405989|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
146405990|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
146405991|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
146405992|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
146405993|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
146405994|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
146405995|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
146405996|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146405997|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
146405998|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146405999|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
146406000|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
146406001|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146406002|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146406003|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146406004|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
146406005|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146406006|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
146406007|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
146406008|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
146406009|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
146406010|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
146406011|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
146406012|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
146406013|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
146406014|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
146406015|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146406016|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146406017|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
146406018|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
146406019|NCT03985293|527990583|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
146406020|NCT03985293|527990584|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
146406021|NCT03985293|527990585|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
146406022|NCT03985293|527990586|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
146406023|NCT03985293|527990587|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
146406024|NCT03985293|527990588|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
146406025|NCT03985293|527990583|FG000|FOLLOW-UP|Lost to Follow-up|0|||
146406026|NCT03985293|527990584|FG001|FOLLOW-UP|Lost to Follow-up|0|||
146406027|NCT03985293|527990585|FG002|FOLLOW-UP|Lost to Follow-up|1|||
146406028|NCT03985293|527990586|FG003|FOLLOW-UP|Lost to Follow-up|0|||
146406029|NCT03985293|527990587|FG004|FOLLOW-UP|Lost to Follow-up|0|||
146406030|NCT03985293|527990588|FG005|FOLLOW-UP|Lost to Follow-up|0|||
146406031|NCT01488071|527990589|FG000|Overall Study|Adverse Event|15|||
146406032|NCT01488071|527990590|FG001|Overall Study|Adverse Event|23|||
146406033|NCT01488071|527990589|FG000|Overall Study|Lack of Efficacy|11|||
146406034|NCT01488071|527990590|FG001|Overall Study|Lack of Efficacy|17|||
146406035|NCT01488071|527990589|FG000|Overall Study|Non-compliance with study drug|2|||
146406036|NCT01488071|527990590|FG001|Overall Study|Non-compliance with study drug|0|||
146406037|NCT01488071|527990589|FG000|Overall Study|Protocol Violation|5|||
146406038|NCT01488071|527990590|FG001|Overall Study|Protocol Violation|7|||
146406039|NCT01488071|527990589|FG000|Overall Study|Withdrawal of Consent|14|||
146406040|NCT01488071|527990590|FG001|Overall Study|Withdrawal of Consent|12|||
146406041|NCT01488071|527990589|FG000|Overall Study|Lost to Follow-up|1|||
146406042|NCT01488071|527990590|FG001|Overall Study|Lost to Follow-up|0|||
146406043|NCT01488071|527990589|FG000|Overall Study|Administrative or Other Reason(s)|5|||
146406044|NCT01488071|527990590|FG001|Overall Study|Administrative or Other Reason(s)|4|||
146406045|NCT05899218|527990591|FG000|Overall Study|Lost to Follow-up|2|||
146406046|NCT05899218|527990592|FG001|Overall Study|Lost to Follow-up|2|||
146406047|NCT05899218|527990591|FG000|Overall Study|deemed ineligible out of country|1|||
146063127|NCT00129402|526751230|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
146063128|NCT00129402|526751224|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063129|NCT00129402|526751225|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063130|NCT00129402|526751226|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063131|NCT00129402|526751227|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063132|NCT00129402|526751228|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063133|NCT00129402|526751229|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
146063134|NCT00129402|526751230|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
146063135|NCT00129402|526751224|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146171716|NCT00975221|527143207|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
146406048|NCT05899218|527990592|FG001|Overall Study|deemed ineligible out of country|0|||
146406049|NCT02587325|527990593|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
146406050|NCT02587325|527990594|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
146406051|NCT02587325|527990595|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
146406052|NCT02587325|527990596|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
146406053|NCT02587325|527990597|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
146406054|NCT02587325|527990593|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146406055|NCT02587325|527990594|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146406056|NCT02587325|527990595|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146406057|NCT02587325|527990596|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
146406058|NCT02587325|527990597|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
146406059|NCT02587325|527990593|FG000|32-Week Optional Extension Part|Adverse Event|0|||
146406060|NCT02587325|527990594|FG001|32-Week Optional Extension Part|Adverse Event|0|||
146406061|NCT02587325|527990595|FG002|32-Week Optional Extension Part|Adverse Event|1|||
146406062|NCT02587325|527990596|FG003|32-Week Optional Extension Part|Adverse Event|0|||
146406063|NCT02587325|527990597|FG004|32-Week Optional Extension Part|Adverse Event|0|||
146406064|NCT02587325|527990593|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
146406065|NCT02587325|527990594|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
146406066|NCT02587325|527990595|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
146406067|NCT02587325|527990596|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
146406068|NCT02587325|527990597|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
146406069|NCT00390572|527990598|FG000|Overall Study|Lost to Follow-up|8|||
146406070|NCT00390572|527990599|FG001|Overall Study|Lost to Follow-up|4|||
146406071|NCT00390572|527990598|FG000|Overall Study|health condition|0|||
146406072|NCT00390572|527990599|FG001|Overall Study|health condition|1|||
146406073|NCT02913261|527990606|FG000|Overall Study|Technical problems|0|||
146406074|NCT02913261|527990607|FG001|Overall Study|Technical problems|1|||
146406075|NCT02913261|527990606|FG000|Overall Study|Lack of Efficacy|32|||
146406076|NCT02913261|527990607|FG001|Overall Study|Lack of Efficacy|69|||
146406077|NCT02913261|527990606|FG000|Overall Study|Adverse Event|27|||
146406078|NCT02913261|527990607|FG001|Overall Study|Adverse Event|5|||
146406079|NCT02913261|527990606|FG000|Overall Study|Death|25|||
146406080|NCT02913261|527990607|FG001|Overall Study|Death|22|||
146406081|NCT02913261|527990606|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
146406082|NCT02913261|527990607|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
146406083|NCT02913261|527990606|FG000|Overall Study|Disease relapse|8|||
146406084|NCT02913261|527990607|FG001|Overall Study|Disease relapse|13|||
146406085|NCT02913261|527990606|FG000|Overall Study|Physician Decision|8|||
146406086|NCT02913261|527990607|FG001|Overall Study|Physician Decision|9|||
146406087|NCT02913261|527990606|FG000|Overall Study|Subject/guardian decision|4|||
146406088|NCT02913261|527990607|FG001|Overall Study|Subject/guardian decision|6|||
146406089|NCT02913261|527990606|FG000|Overall Study|Graft loss|2|||
146406090|NCT02913261|527990607|FG001|Overall Study|Graft loss|0|||
146406091|NCT03594175|527990608|FG000|Overall Study|Not treated|8|||
146406092|NCT03594175|527990609|FG001|Overall Study|Not treated|1|||
146406093|NCT03594175|527990610|FG002|Overall Study|Not treated|5|||
146406094|NCT03594175|527990608|FG000|Overall Study|Adverse Event|3|||
146406095|NCT03594175|527990609|FG001|Overall Study|Adverse Event|0|||
146406096|NCT03594175|527990610|FG002|Overall Study|Adverse Event|0|||
146406097|NCT03594175|527990608|FG000|Overall Study|Withdrawal by Subject|3|||
146406098|NCT03594175|527990609|FG001|Overall Study|Withdrawal by Subject|0|||
146406099|NCT03594175|527990610|FG002|Overall Study|Withdrawal by Subject|0|||
146406100|NCT03594175|527990608|FG000|Overall Study|Protocol Violation|2|||
146406101|NCT03594175|527990609|FG001|Overall Study|Protocol Violation|2|||
146406102|NCT03594175|527990610|FG002|Overall Study|Protocol Violation|2|||
146406103|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406104|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406105|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406106|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146406107|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146063136|NCT00129402|526751225|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146063137|NCT00129402|526751226|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146063138|NCT00129402|526751227|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146063139|NCT00129402|526751228|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146063140|NCT00129402|526751229|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
146063141|NCT00129402|526751230|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
146063142|NCT00129402|526751224|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146063143|NCT00129402|526751225|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146406108|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406109|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406110|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406111|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406112|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146406113|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406114|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406115|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146406116|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
146063144|NCT00129402|526751226|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146063145|NCT00129402|526751227|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146063146|NCT00129402|526751228|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146063147|NCT00129402|526751229|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
146406117|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
146406118|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
146406119|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
146406120|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
146406121|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
146406122|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406123|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406124|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406125|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406126|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406127|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146406128|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406129|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406130|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406131|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146406132|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406133|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406134|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406135|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146406136|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146406137|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
146406138|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146406139|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
146406140|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
146406141|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
146406142|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406143|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406144|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406145|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406146|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
145945245|NCT01606202|526308186|FG001|Overall Study|Problems with administration|1|||
146063148|NCT00129402|526751230|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
146063149|NCT03041038|526751231|FG000|Overall Study|Withdrawal by Subject|4|||
146063150|NCT03041038|526751232|FG001|Overall Study|Withdrawal by Subject|0|||
146063151|NCT03041038|526751231|FG000|Overall Study|Lost to Follow-up|1|||
146063152|NCT03041038|526751232|FG001|Overall Study|Lost to Follow-up|1|||
146406147|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406148|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406149|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406150|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406151|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406152|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406153|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406154|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406155|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
146406156|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406157|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406158|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
146406159|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
146406160|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406161|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406162|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406163|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406164|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406165|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406166|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406167|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406168|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406169|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406170|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146406171|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406172|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406173|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146406174|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406175|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406176|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146406177|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
146406178|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
146406179|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146406180|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146406181|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406182|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146406183|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406184|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406185|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146406186|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406187|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406188|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406189|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146406190|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406191|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
146406192|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
146406193|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
146406194|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146406195|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
146406196|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
146406197|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
146406198|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406199|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406200|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
146406201|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406202|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406203|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406204|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406205|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406206|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406207|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406208|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406209|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406210|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406211|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146063153|NCT03041038|526751231|FG000|Overall Study|Protocol Violation|1|||
145945246|NCT03008278|526308187|FG000|Overall Study|Progressive Disease|0|||
146406212|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406213|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
146406214|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
146406215|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
146406216|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
146406217|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406218|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406219|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406220|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406221|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
146406222|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406223|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406224|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406225|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406226|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
146406227|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406228|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406229|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406230|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406231|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406232|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406233|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406234|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406235|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
146406236|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146406237|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406238|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406239|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406240|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406241|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146406242|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406243|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406244|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406245|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406246|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
146406247|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406248|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406249|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
146406250|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
146406251|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
146406252|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
146406253|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
146406254|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
146406255|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406256|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406257|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406258|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406259|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406260|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406261|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406262|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406263|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406264|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406265|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
146406266|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406267|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406268|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406269|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406270|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406271|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406272|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146063154|NCT03041038|526751232|FG001|Overall Study|Protocol Violation|1|||
146406273|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
146406274|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146406275|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146406276|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146063155|NCT02131259|526751233|FG000|Overall Study|Progressive disease|751|||
146406277|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406278|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146406279|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146406280|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406281|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146406282|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406283|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146406284|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406285|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406286|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146406287|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146406288|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
146406289|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
146406290|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
146406291|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
146406292|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
146406293|NCT01915498|527990611|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
146406294|NCT01915498|527990612|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146406295|NCT01915498|527990613|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146406296|NCT01915498|527990614|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
146406297|NCT01915498|527990615|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
146406298|NCT01915498|527990616|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
146406299|NCT01915498|527990617|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
146406300|NCT01915498|527990618|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
146406301|NCT01915498|527990619|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
146406302|NCT01915498|527990620|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
146406303|NCT01915498|527990621|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146406304|NCT01915498|527990622|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
146406305|NCT01915498|527990623|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
146406306|NCT01915498|527990624|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
146406307|NCT01915498|527990625|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
146406308|NCT01915498|527990626|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
146406309|NCT01915498|527990627|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
146406310|NCT01915498|527990628|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
146406311|NCT01915498|527990629|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
146406312|NCT01915498|527990611|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406313|NCT01915498|527990612|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406314|NCT01915498|527990613|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406315|NCT01915498|527990614|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406316|NCT01915498|527990615|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406317|NCT01915498|527990616|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406318|NCT01915498|527990617|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406319|NCT01915498|527990618|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406320|NCT01915498|527990619|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406321|NCT01915498|527990620|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406322|NCT01915498|527990621|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406323|NCT01915498|527990622|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406324|NCT01915498|527990623|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406325|NCT01915498|527990624|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406326|NCT01915498|527990625|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406327|NCT01915498|527990626|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406328|NCT01915498|527990627|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406329|NCT01915498|527990628|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
146406330|NCT01915498|527990629|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
146406331|NCT01915498|527990611|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406332|NCT01915498|527990612|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406333|NCT01915498|527990613|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406334|NCT01915498|527990614|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406335|NCT01915498|527990615|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406336|NCT01915498|527990616|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406337|NCT01915498|527990617|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146063156|NCT02131259|526751233|FG000|Overall Study|Adverse Event|341|||
146063157|NCT02131259|526751233|FG000|Overall Study|Lost to Follow-up|7|||
146063158|NCT02131259|526751233|FG000|Overall Study|Relocation|32|||
146063159|NCT02131259|526751233|FG000|Overall Study|Other|63|||
146406338|NCT01915498|527990618|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406339|NCT01915498|527990619|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406340|NCT01915498|527990620|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406341|NCT01915498|527990621|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406342|NCT01915498|527990622|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406343|NCT01915498|527990623|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406344|NCT01915498|527990624|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406345|NCT01915498|527990625|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406346|NCT01915498|527990626|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406347|NCT01915498|527990627|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406348|NCT01915498|527990628|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
146406349|NCT01915498|527990629|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
146406350|NCT01915498|527990611|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406351|NCT01915498|527990612|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406352|NCT01915498|527990613|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406353|NCT01915498|527990614|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406354|NCT01915498|527990615|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406355|NCT01915498|527990616|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406356|NCT01915498|527990617|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406357|NCT01915498|527990618|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406358|NCT01915498|527990619|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406359|NCT01915498|527990620|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406360|NCT01915498|527990621|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406361|NCT01915498|527990622|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406362|NCT01915498|527990623|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406363|NCT01915498|527990624|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406364|NCT01915498|527990625|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406365|NCT01915498|527990626|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406366|NCT01915498|527990627|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406367|NCT01915498|527990628|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
146406368|NCT01915498|527990629|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
146406369|NCT01901146|527992394|FG000|Neoadjuvant Phase|Death|1|||
146406370|NCT01901146|527992395|FG001|Neoadjuvant Phase|Death|2|||
146406371|NCT01901146|527992396|FG002|Neoadjuvant Phase|Death|0|||
146406372|NCT01901146|527992397|FG003|Neoadjuvant Phase|Death|0|||
146406373|NCT01901146|527992398|FG004|Neoadjuvant Phase|Death|0|||
146406374|NCT01901146|527992394|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
146406375|NCT01901146|527992395|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
146406376|NCT01901146|527992396|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146406377|NCT01901146|527992397|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146406378|NCT01901146|527992398|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
146406379|NCT01901146|527992394|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
146406380|NCT01901146|527992395|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
146406381|NCT01901146|527992396|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
146406382|NCT01901146|527992397|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
146406383|NCT01901146|527992398|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
146406384|NCT01901146|527992394|FG000|Neoadjuvant Phase|Physician Decision|1|||
146406385|NCT01901146|527992395|FG001|Neoadjuvant Phase|Physician Decision|2|||
146406386|NCT01901146|527992396|FG002|Neoadjuvant Phase|Physician Decision|0|||
146406387|NCT01901146|527992397|FG003|Neoadjuvant Phase|Physician Decision|0|||
146406388|NCT01901146|527992398|FG004|Neoadjuvant Phase|Physician Decision|0|||
146406389|NCT01901146|527992394|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
146406390|NCT01901146|527992395|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
146406391|NCT01901146|527992396|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
146406392|NCT01901146|527992397|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
146406393|NCT01901146|527992398|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
146406394|NCT01901146|527992394|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146406395|NCT01901146|527992395|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
146406396|NCT01901146|527992396|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146406397|NCT01901146|527992397|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146406398|NCT01901146|527992398|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
146406399|NCT01901146|527992394|FG000|Adjuvant Phase|Other|0|||
146406400|NCT01901146|527992395|FG001|Adjuvant Phase|Other|0|||
146063160|NCT02131259|526751233|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
146063161|NCT02131259|526751233|FG000|Overall Study|Progressive disease/relocation|1|||
146406401|NCT01901146|527992396|FG002|Adjuvant Phase|Other|1|||
146063162|NCT02131259|526751233|FG000|Overall Study|Progressive disease/other|2|||
146063163|NCT02131259|526751233|FG000|Overall Study|AE/lost to follow-up|1|||
146063164|NCT02131259|526751233|FG000|Overall Study|AE/other|1|||
146406402|NCT01901146|527992397|FG003|Adjuvant Phase|Other|0|||
146406403|NCT01901146|527992398|FG004|Adjuvant Phase|Other|0|||
146406404|NCT01901146|527992394|FG000|Adjuvant Phase|Death|0|||
146406405|NCT01901146|527992395|FG001|Adjuvant Phase|Death|0|||
146406406|NCT01901146|527992396|FG002|Adjuvant Phase|Death|0|||
146406407|NCT01901146|527992397|FG003|Adjuvant Phase|Death|0|||
146406408|NCT01901146|527992398|FG004|Adjuvant Phase|Death|3|||
146406409|NCT01901146|527992394|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
146406410|NCT01901146|527992395|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
146406411|NCT01901146|527992396|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
146406412|NCT01901146|527992397|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
146406413|NCT01901146|527992398|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
146406414|NCT01901146|527992394|FG000|Adjuvant Phase|Physician Decision|0|||
146406415|NCT01901146|527992395|FG001|Adjuvant Phase|Physician Decision|0|||
146406416|NCT01901146|527992396|FG002|Adjuvant Phase|Physician Decision|9|||
146406417|NCT01901146|527992397|FG003|Adjuvant Phase|Physician Decision|2|||
146406418|NCT01901146|527992398|FG004|Adjuvant Phase|Physician Decision|4|||
146406419|NCT01901146|527992394|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
146406420|NCT01901146|527992395|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
146406421|NCT01901146|527992396|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
146406422|NCT01901146|527992397|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
146406423|NCT01901146|527992398|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
146406424|NCT00297492|527992399|FG000|Set Quit Date|Lost to Follow-up|7|||
146406425|NCT00297492|527992400|FG001|Set Quit Date|Lost to Follow-up|13|||
146406426|NCT00297492|527992401|FG002|Set Quit Date|Lost to Follow-up|5|||
146406427|NCT00297492|527992399|FG000|6 Month Follow-up|Lost to Follow-up|63|||
146406428|NCT00297492|527992400|FG001|6 Month Follow-up|Lost to Follow-up|49|||
146406429|NCT00297492|527992401|FG002|6 Month Follow-up|Lost to Follow-up|27|||
146406430|NCT03724968|527992402|FG000|Overall Study|Insurance issues|0|||
146406431|NCT03724968|527992403|FG001|Overall Study|Insurance issues|1|||
146406432|NCT03724968|527992402|FG000|Overall Study|Study closed|0|||
146406433|NCT03724968|527992403|FG001|Overall Study|Study closed|1|||
146406434|NCT00569231|527992406|FG000|Overall Study|Study unrelated surgery|1|||
146406435|NCT00569231|527992406|FG000|Overall Study|Airfare expense|2|||
146406436|NCT00569231|527992406|FG000|Overall Study|Withdrawal by Subject|1|||
146406437|NCT00569231|527992406|FG000|Overall Study|Car accident injury|1|||
146406438|NCT00569231|527992406|FG000|Overall Study|Non-compliance|2|||
146406439|NCT01614925|527992407|FG000|Overall Study|Withdrawal by Subject|1|||
146406440|NCT01614925|527992408|FG001|Overall Study|Withdrawal by Subject|0|||
146406441|NCT01614925|527992407|FG000|Overall Study|Protocol Violation|3|||
146406442|NCT01614925|527992408|FG001|Overall Study|Protocol Violation|2|||
146406443|NCT02437890|527992413|FG000|Overall Study|Non-compliance to study drug|0|||
146406444|NCT02437890|527992414|FG001|Overall Study|Non-compliance to study drug|1|||
146406445|NCT02437890|527992415|FG002|Overall Study|Non-compliance to study drug|0|||
146406446|NCT02437890|527992416|FG003|Overall Study|Non-compliance to study drug|0|||
146406447|NCT02437890|527992417|FG004|Overall Study|Non-compliance to study drug|1|||
146406448|NCT02437890|527992413|FG000|Overall Study|Sponsor's decision|1|||
146406449|NCT02437890|527992414|FG001|Overall Study|Sponsor's decision|1|||
146406450|NCT02437890|527992415|FG002|Overall Study|Sponsor's decision|4|||
146406451|NCT02437890|527992416|FG003|Overall Study|Sponsor's decision|0|||
146406452|NCT02437890|527992417|FG004|Overall Study|Sponsor's decision|2|||
146406453|NCT02437890|527992413|FG000|Overall Study|Physician Decision|0|||
146406454|NCT02437890|527992414|FG001|Overall Study|Physician Decision|0|||
146406455|NCT02437890|527992415|FG002|Overall Study|Physician Decision|0|||
146406456|NCT02437890|527992416|FG003|Overall Study|Physician Decision|1|||
146406457|NCT02437890|527992417|FG004|Overall Study|Physician Decision|0|||
146406458|NCT02437890|527992413|FG000|Overall Study|Unable to attend visit(s)|1|||
146406459|NCT02437890|527992414|FG001|Overall Study|Unable to attend visit(s)|0|||
146406460|NCT02437890|527992415|FG002|Overall Study|Unable to attend visit(s)|0|||
146406461|NCT02437890|527992416|FG003|Overall Study|Unable to attend visit(s)|0|||
146406462|NCT02437890|527992417|FG004|Overall Study|Unable to attend visit(s)|0|||
146406463|NCT02437890|527992413|FG000|Overall Study|Lack of Efficacy|1|||
146406464|NCT02437890|527992414|FG001|Overall Study|Lack of Efficacy|3|||
146406465|NCT02437890|527992415|FG002|Overall Study|Lack of Efficacy|0|||
146063165|NCT02131259|526751233|FG000|Overall Study|Progressive disease/AE/other|1|||
146406466|NCT02437890|527992416|FG003|Overall Study|Lack of Efficacy|3|||
146406467|NCT02437890|527992417|FG004|Overall Study|Lack of Efficacy|1|||
146406468|NCT02437890|527992413|FG000|Overall Study|Adverse Event|4|||
146406469|NCT02437890|527992414|FG001|Overall Study|Adverse Event|9|||
146406470|NCT02437890|527992415|FG002|Overall Study|Adverse Event|5|||
146406471|NCT02437890|527992416|FG003|Overall Study|Adverse Event|11|||
146406472|NCT02437890|527992417|FG004|Overall Study|Adverse Event|7|||
146406473|NCT02437890|527992413|FG000|Overall Study|Withdrawal by Subject|1|||
146406474|NCT02437890|527992414|FG001|Overall Study|Withdrawal by Subject|2|||
146406475|NCT02437890|527992415|FG002|Overall Study|Withdrawal by Subject|6|||
146406476|NCT02437890|527992416|FG003|Overall Study|Withdrawal by Subject|5|||
146406477|NCT02437890|527992417|FG004|Overall Study|Withdrawal by Subject|5|||
146406478|NCT02437890|527992413|FG000|Overall Study|Death|0|||
146406479|NCT02437890|527992414|FG001|Overall Study|Death|0|||
146406480|NCT02437890|527992415|FG002|Overall Study|Death|0|||
146406481|NCT02437890|527992416|FG003|Overall Study|Death|2|||
146406482|NCT02437890|527992417|FG004|Overall Study|Death|0|||
146406483|NCT00344305|527992418|FG000|Overall Study|Lost to Follow-up|2|||
146406484|NCT00344305|527992419|FG001|Overall Study|Lost to Follow-up|0|||
146406485|NCT00344305|527992418|FG000|Overall Study|Participant was not contacted in window|0|||
146406486|NCT00344305|527992419|FG001|Overall Study|Participant was not contacted in window|1|||
146406487|NCT01190098|527992420|FG000|Overall Study|Adverse Event|2|||
146406488|NCT01190098|527992421|FG001|Overall Study|Adverse Event|0|||
146406489|NCT01190098|527992420|FG000|Overall Study|Patient coomorbidity|0|||
146406490|NCT01190098|527992421|FG001|Overall Study|Patient coomorbidity|1|||
146406491|NCT01190098|527992420|FG000|Overall Study|Lack of transportation|1|||
146406492|NCT01190098|527992421|FG001|Overall Study|Lack of transportation|0|||
146406493|NCT01190098|527992420|FG000|Overall Study|Other|0|||
146406494|NCT01190098|527992421|FG001|Overall Study|Other|1|||
146406495|NCT01227954|527992435|FG000|Overall Study|Protocol Violation|6|||
146406496|NCT01227954|527992435|FG000|Overall Study|No protocol treatment|7|||
146406497|NCT00078312|527992441|FG000|Overall Study|Adverse Event|43|||
146406498|NCT00078312|527992441|FG000|Overall Study|Lack of Efficacy|15|||
146406499|NCT00078312|527992441|FG000|Overall Study|Lost to Follow-up|41|||
146406500|NCT00078312|527992441|FG000|Overall Study|Physician Decision|9|||
146406501|NCT00078312|527992441|FG000|Overall Study|Protocol Violation|3|||
146406502|NCT00078312|527992441|FG000|Overall Study|Withdrawal by Subject|33|||
146406503|NCT00078312|527992441|FG000|Overall Study|Miscellaneous|33|||
146406504|NCT01875991|527992445|FG000|Overall Study|Withdrawal by Subject|6|||
146406505|NCT01875991|527992446|FG001|Overall Study|Withdrawal by Subject|6|||
146406506|NCT01875991|527992445|FG000|Overall Study|Sponsor Decision|1|||
146406507|NCT01875991|527992446|FG001|Overall Study|Sponsor Decision|0|||
146406508|NCT02216214|527992447|FG000|Overall Study|Randomized Never Received Study Drug|1|||
146406509|NCT02216214|527992448|FG001|Overall Study|Randomized Never Received Study Drug|0|||
146406510|NCT02216214|527992447|FG000|Overall Study|Adverse Event|10|||
146406511|NCT02216214|527992448|FG001|Overall Study|Adverse Event|8|||
146406512|NCT02216214|527992447|FG000|Overall Study|Lack of Efficacy|2|||
146406513|NCT02216214|527992448|FG001|Overall Study|Lack of Efficacy|2|||
146406514|NCT02216214|527992447|FG000|Overall Study|Lost to Follow-up|3|||
146406515|NCT02216214|527992448|FG001|Overall Study|Lost to Follow-up|2|||
146406516|NCT02216214|527992447|FG000|Overall Study|Protocol Violation|4|||
146406517|NCT02216214|527992448|FG001|Overall Study|Protocol Violation|2|||
146406518|NCT02216214|527992447|FG000|Overall Study|Withdrawal by Subject|22|||
146406519|NCT02216214|527992448|FG001|Overall Study|Withdrawal by Subject|20|||
146406520|NCT02216214|527992447|FG000|Overall Study|Study Terminated By Sponsor|0|||
146406521|NCT02216214|527992448|FG001|Overall Study|Study Terminated By Sponsor|1|||
146406522|NCT02216214|527992447|FG000|Overall Study|Miscellaneous|1|||
146406523|NCT02216214|527992448|FG001|Overall Study|Miscellaneous|1|||
146406524|NCT05354206|527992449|FG000|Overall Study|Withdrawal by Subject|1|||
146406525|NCT05354206|527992450|FG001|Overall Study|Withdrawal by Subject|0|||
146406526|NCT01414062|527992451|FG000|Overall Study|Lost to Follow-up|3|||
146406527|NCT01414062|527992452|FG001|Overall Study|Lost to Follow-up|2|||
146406528|NCT01414062|527992451|FG000|Overall Study|Left Country|1|||
146406529|NCT01414062|527992452|FG001|Overall Study|Left Country|1|||
146406530|NCT01414062|527992451|FG000|Overall Study|Family Disapproval|1|||
146406531|NCT01414062|527992452|FG001|Overall Study|Family Disapproval|0|||
146406532|NCT01414062|527992451|FG000|Overall Study|Withdrawal by Subject|0|||
146406533|NCT01414062|527992452|FG001|Overall Study|Withdrawal by Subject|1|||
146406534|NCT04285983|527992453|FG000|Overall Study|Protocol Violation|6|||
146406535|NCT04936334|527992454|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
146406536|NCT00902265|527992457|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
146406537|NCT00902265|527992457|FG000|Overall Study|Adverse Event|2|||
146406538|NCT00902265|527992457|FG000|Overall Study|Lack of Efficacy|2|||
146406539|NCT00902265|527992457|FG000|Overall Study|Protocol Violation|1|||
146406540|NCT02866695|527992460|FG000|Overall Study|Adverse Event|1|||
146406541|NCT02866695|527992460|FG000|Overall Study|Lost to Follow-up|1|||
146406542|NCT05016765|527992461|FG000|Overall Study|Lost to Follow-up|4|||
146406543|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146406544|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
146406545|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146406546|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
146406547|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
146406548|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
146406549|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
146406550|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
146406551|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146406552|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
146406553|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146406554|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
146406555|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
146406556|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
146406557|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
146406558|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
146406559|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
146406560|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
146406561|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
146406562|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
146406563|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146406564|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
146406565|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146406566|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
146406567|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
146406568|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146406569|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146406570|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
146406571|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
146406572|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
146406573|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
146406574|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
146406575|NCT03747939|527992462|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146406576|NCT03747939|527992463|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
146406577|NCT03747939|527992464|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146406578|NCT03747939|527992465|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
146406579|NCT03747939|527992462|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
146406580|NCT03747939|527992463|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
146406581|NCT03747939|527992464|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
146406582|NCT03747939|527992465|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
146406583|NCT03747939|527992462|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
146406584|NCT03747939|527992463|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
146406585|NCT03747939|527992464|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
146406586|NCT03747939|527992465|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
146406587|NCT03747939|527992462|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
146406588|NCT03747939|527992463|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
146406589|NCT03747939|527992464|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
146406590|NCT03747939|527992465|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
146406591|NCT03747939|527992462|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
146406592|NCT03747939|527992463|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
146406593|NCT03747939|527992464|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
146406594|NCT03747939|527992465|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
146406595|NCT03747939|527992462|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146406596|NCT03747939|527992463|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146406597|NCT03747939|527992464|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
146406598|NCT03747939|527992465|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
146406599|NCT01447628|527992468|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146406600|NCT01447628|527992469|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146406601|NCT01447628|527992470|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
146406602|NCT01447628|527992471|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
146406603|NCT00185731|527992472|FG000|Overall Study|Withdrawal by Subject|1|||
146406604|NCT00185731|527992472|FG000|Overall Study|Not Eligible|1|||
146406605|NCT03087773|527992473|FG000|Overall Study|Withdrawal by Subject|8|||
146406606|NCT03087773|527992474|FG001|Overall Study|Withdrawal by Subject|4|||
146406607|NCT03087773|527992473|FG000|Overall Study|Lost to Follow-up|12|||
146406608|NCT03087773|527992474|FG001|Overall Study|Lost to Follow-up|8|||
146406609|NCT05144477|527992477|FG000|Overall Study|Withdrawal by Subject|1|||
146406610|NCT05144477|527992478|FG001|Overall Study|Withdrawal by Subject|1|||
146406611|NCT02181842|527992479|FG000|Overall Study|Case Report Forms Uncollected|2|||
146406612|NCT04529096|527992480|FG000|Overall Study|Adverse Event|6|||
146406613|NCT04529096|527992481|FG001|Overall Study|Adverse Event|1|||
146406614|NCT04529096|527992480|FG000|Overall Study|Lack of Efficacy|1|||
146406615|NCT04529096|527992481|FG001|Overall Study|Lack of Efficacy|0|||
146406616|NCT04529096|527992480|FG000|Overall Study|Lost to Follow-up|1|||
146171717|NCT00975221|527143206|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
146171718|NCT00975221|527143207|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
146406617|NCT04529096|527992481|FG001|Overall Study|Lost to Follow-up|1|||
146406618|NCT04529096|527992480|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146406619|NCT04529096|527992481|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146406620|NCT04529096|527992480|FG000|Overall Study|Physician Decision|1|||
146406621|NCT04529096|527992481|FG001|Overall Study|Physician Decision|3|||
146406622|NCT04529096|527992480|FG000|Overall Study|Withdrawal by Subject|5|||
146406623|NCT04529096|527992481|FG001|Overall Study|Withdrawal by Subject|0|||
146406624|NCT00758706|527992482|FG000|Overall Study|Adverse Event|4|||
146406625|NCT00758706|527992483|FG001|Overall Study|Adverse Event|4|||
146406626|NCT03454672|527992493|FG000|Overall Study|Adverse Event|1|||
146406627|NCT03454672|527992494|FG001|Overall Study|Adverse Event|1|||
146406628|NCT03454672|527992493|FG000|Overall Study|Lost to Follow-up|1|||
146406629|NCT03454672|527992494|FG001|Overall Study|Lost to Follow-up|3|||
146406630|NCT03454672|527992493|FG000|Overall Study|painful|1|||
146406631|NCT03454672|527992494|FG001|Overall Study|painful|2|||
146406632|NCT03454672|527992493|FG000|Overall Study|Non-compliance|2|||
146406633|NCT03454672|527992494|FG001|Overall Study|Non-compliance|4|||
146406634|NCT03454672|527992493|FG000|Overall Study|personal reasons|3|||
146406635|NCT03454672|527992494|FG001|Overall Study|personal reasons|2|||
146406636|NCT03454672|527992493|FG000|Overall Study|Withdrawal by Subject|1|||
146406637|NCT03454672|527992494|FG001|Overall Study|Withdrawal by Subject|0|||
146406638|NCT02139306|527992498|FG000|Overall Study|Withdrawal by Subject|4|||
146406639|NCT02139306|527992499|FG001|Overall Study|Withdrawal by Subject|6|||
146406640|NCT02139306|527992498|FG000|Overall Study|Adverse Event|3|||
146406641|NCT02139306|527992499|FG001|Overall Study|Adverse Event|4|||
146406642|NCT02139306|527992498|FG000|Overall Study|Physician Decision|0|||
146406643|NCT02139306|527992499|FG001|Overall Study|Physician Decision|1|||
146406644|NCT02139306|527992498|FG000|Overall Study|Other Unspecified|2|||
146406645|NCT02139306|527992499|FG001|Overall Study|Other Unspecified|3|||
146063166|NCT02131259|526751233|FG000|Overall Study|Missing|3|||
146063167|NCT02796170|526751234|FG000|Overall Study|Lost to Follow-up|3|||
146063168|NCT02796170|526751235|FG001|Overall Study|Lost to Follow-up|0|||
146063169|NCT01527370|526751236|FG000|Overall Study|Withdrawal by Subject|4|||
146063170|NCT01527370|526751236|FG000|Overall Study|Physician Decision|1|||
146063171|NCT01527370|526751236|FG000|Overall Study|Death|1|||
146063172|NCT01352715|526751240|FG000|Overall Study|Death|3|||
146063173|NCT01352715|526751241|FG001|Overall Study|Death|3|||
146063174|NCT01352715|526751240|FG000|Overall Study|Lost to Follow-up|5|||
146063175|NCT01352715|526751241|FG001|Overall Study|Lost to Follow-up|7|||
146063176|NCT01352715|526751240|FG000|Overall Study|Withdrawal by Subject|4|||
146063177|NCT01352715|526751241|FG001|Overall Study|Withdrawal by Subject|8|||
146171719|NCT00975221|527143206|FG000|Titration Phase (Weeks 1-12)|Other|0|||
146171720|NCT00975221|527143207|FG001|Titration Phase (Weeks 1-12)|Other|1|||
146171721|NCT00975221|527143206|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
146171722|NCT00975221|527143207|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
146171723|NCT00975221|527143206|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
146171724|NCT00975221|527143207|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
146171725|NCT00975221|527143206|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
146171726|NCT00975221|527143207|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
146171727|NCT01862991|527143208|FG000|Overall Study|Lost to Follow-up|2|||
146171728|NCT01862991|527143209|FG001|Overall Study|Lost to Follow-up|1|||
146171729|NCT01862991|527143210|FG002|Overall Study|Lost to Follow-up|1|||
146171730|NCT01862991|527143208|FG000|Overall Study|Protocol Violation|1|||
146171731|NCT01862991|527143209|FG001|Overall Study|Protocol Violation|0|||
146171732|NCT01862991|527143210|FG002|Overall Study|Protocol Violation|0|||
146171733|NCT02026232|527143211|FG000|Overall Study|incomplete visit/missing data|3|||
146171734|NCT02026232|527143212|FG001|Overall Study|incomplete visit/missing data|2|||
146171735|NCT02110732|527143214|FG000|Overall Study|Physician Decision|5|||
146171736|NCT02110732|527143215|FG001|Overall Study|Physician Decision|2|||
146171737|NCT02110732|527143214|FG000|Overall Study|Lost to Follow-up|1|||
146171738|NCT02110732|527143215|FG001|Overall Study|Lost to Follow-up|1|||
146171739|NCT01480596|527143216|FG000|Overall Study|Adverse Event|3|||
146171740|NCT01480596|527143217|FG001|Overall Study|Adverse Event|0|||
146171741|NCT01480596|527143216|FG000|Overall Study|MG exacerbation or change in medication|2|||
146171742|NCT01480596|527143217|FG001|Overall Study|MG exacerbation or change in medication|2|||
146406646|NCT02139306|527992498|FG000|Overall Study|Protocol Violation|4|||
146063178|NCT01352715|526751240|FG000|Overall Study|site closure|16|||
146171743|NCT04503096|527143218|FG000|Overall Study|Withdrawal by Subject|3|||
146406647|NCT02139306|527992499|FG001|Overall Study|Protocol Violation|0|||
146406648|NCT04449354|527992500|FG000|Overall Study|Withdrawal by Subject|1|||
146406649|NCT02304302|527992503|FG000|Overall Study|Adverse Event|2|||
146406650|NCT02304302|527992504|FG001|Overall Study|Adverse Event|3|||
146406651|NCT02304302|527992503|FG000|Overall Study|Lost to Follow-up|1|||
146171744|NCT01576367|527143221|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146171745|NCT01576367|527143221|FG000|Overall Study|Moved to commercial use after 6 months|1|||
146406652|NCT02304302|527992504|FG001|Overall Study|Lost to Follow-up|4|||
146406653|NCT02304302|527992503|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
146063179|NCT01352715|526751241|FG001|Overall Study|site closure|15|||
146063180|NCT01352715|526751240|FG000|Overall Study|no final visit in closeout period|15|||
146063181|NCT01352715|526751241|FG001|Overall Study|no final visit in closeout period|12|||
146406654|NCT02304302|527992504|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
146406655|NCT00391118|527992505|FG000|Overall Study|Adverse Event|3|||
146406656|NCT00391118|527992506|FG001|Overall Study|Adverse Event|10|||
146406657|NCT00391118|527992507|FG002|Overall Study|Adverse Event|7|||
146406658|NCT00391118|527992505|FG000|Overall Study|Lost to Follow-up|0|||
146406659|NCT00391118|527992506|FG001|Overall Study|Lost to Follow-up|2|||
146406660|NCT00391118|527992507|FG002|Overall Study|Lost to Follow-up|3|||
146406661|NCT00391118|527992505|FG000|Overall Study|Withdrawal by Subject|0|||
146406662|NCT00391118|527992506|FG001|Overall Study|Withdrawal by Subject|9|||
146406663|NCT00391118|527992507|FG002|Overall Study|Withdrawal by Subject|1|||
146406664|NCT00391118|527992505|FG000|Overall Study|Death|0|||
146406665|NCT00391118|527992506|FG001|Overall Study|Death|1|||
146406666|NCT00391118|527992507|FG002|Overall Study|Death|0|||
146406667|NCT00391118|527992505|FG000|Overall Study|Physician Decision|0|||
146406668|NCT00391118|527992506|FG001|Overall Study|Physician Decision|3|||
146406669|NCT00391118|527992507|FG002|Overall Study|Physician Decision|0|||
146406670|NCT00391118|527992505|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
146406671|NCT00391118|527992506|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
146406672|NCT00391118|527992507|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
146406673|NCT00391118|527992505|FG000|Overall Study|Progressive Disease|7|||
146406674|NCT00391118|527992506|FG001|Overall Study|Progressive Disease|26|||
146406675|NCT00391118|527992507|FG002|Overall Study|Progressive Disease|43|||
146406676|NCT00391118|527992505|FG000|Overall Study|Sponsor Decision|0|||
146406677|NCT00391118|527992506|FG001|Overall Study|Sponsor Decision|1|||
146406678|NCT00391118|527992507|FG002|Overall Study|Sponsor Decision|3|||
146406679|NCT00391118|527992505|FG000|Overall Study|Protocol Violation|1|||
146406680|NCT00391118|527992506|FG001|Overall Study|Protocol Violation|0|||
146406681|NCT00391118|527992507|FG002|Overall Study|Protocol Violation|0|||
146406682|NCT01892020|527992508|FG000|Period 1|Adverse Event|1|||
146406683|NCT01892020|527992509|FG001|Period 1|Adverse Event|1|||
146406684|NCT01892020|527992508|FG000|Period 1|Protocol Violation|2|||
146406685|NCT01892020|527992509|FG001|Period 1|Protocol Violation|4|||
146406686|NCT01892020|527992508|FG000|Period 1|Unclassified|0|||
146406687|NCT01892020|527992509|FG001|Period 1|Unclassified|1|||
146406688|NCT01892020|527992508|FG000|Period 2|Protocol Violation|1|||
146406689|NCT01892020|527992509|FG001|Period 2|Protocol Violation|0|||
146406690|NCT03078192|527992514|FG000|Overall Study|Withdrawal by Subject|2|||
146406691|NCT03078192|527992515|FG001|Overall Study|Withdrawal by Subject|1|||
146406692|NCT03078192|527992514|FG000|Overall Study|screen failure|0|||
146406693|NCT03078192|527992515|FG001|Overall Study|screen failure|3|||
146406694|NCT02873195|527992516|FG000|Overall Study|Ineligible|5|||
146406695|NCT02873195|527992517|FG001|Overall Study|Ineligible|0|||
146406696|NCT02508649|527992518|FG000|Overall Study|Withdrawal by Subject|4|||
146406697|NCT02508649|527992519|FG001|Overall Study|Withdrawal by Subject|6|||
146406698|NCT02508649|527992520|FG002|Overall Study|Withdrawal by Subject|5|||
146406699|NCT02508649|527992521|FG003|Overall Study|Withdrawal by Subject|6|||
146406700|NCT02508649|527992518|FG000|Overall Study|Investigator withdrew the subject|1|||
146406701|NCT02508649|527992519|FG001|Overall Study|Investigator withdrew the subject|2|||
146406702|NCT02508649|527992520|FG002|Overall Study|Investigator withdrew the subject|1|||
146406703|NCT02508649|527992521|FG003|Overall Study|Investigator withdrew the subject|0|||
146406704|NCT02508649|527992518|FG000|Overall Study|Post randomization screening failure|12|||
146406705|NCT02508649|527992519|FG001|Overall Study|Post randomization screening failure|4|||
146406706|NCT02508649|527992520|FG002|Overall Study|Post randomization screening failure|9|||
146406707|NCT02508649|527992521|FG003|Overall Study|Post randomization screening failure|3|||
146406708|NCT02508649|527992518|FG000|Overall Study|Lost to Follow-up|1|||
146406709|NCT02508649|527992519|FG001|Overall Study|Lost to Follow-up|1|||
146406710|NCT02508649|527992520|FG002|Overall Study|Lost to Follow-up|0|||
146406711|NCT02508649|527992521|FG003|Overall Study|Lost to Follow-up|1|||
146063182|NCT01352715|526751240|FG000|Overall Study|major ineligibility|2|||
146063183|NCT01352715|526751241|FG001|Overall Study|major ineligibility|1|||
146063184|NCT04596267|526751242|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
146063185|NCT04596267|526751243|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
146063186|NCT04596267|526751242|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
146063187|NCT04596267|526751243|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
146406712|NCT03252756|527992524|FG000|Overall Study|Protocol Violation|2|||
146406713|NCT03252756|527992525|FG001|Overall Study|Protocol Violation|4|||
146406714|NCT03252756|527992524|FG000|Overall Study|COVID-19 Pandemic|1|||
146406715|NCT03252756|527992525|FG001|Overall Study|COVID-19 Pandemic|1|||
146406716|NCT03252756|527992524|FG000|Overall Study|Study Drug Expiration|0|||
146406717|NCT03252756|527992525|FG001|Overall Study|Study Drug Expiration|1|||
146406718|NCT01966107|527992526|FG000|Overall Study|excluded from FAS|21|||
146406719|NCT01966107|527992527|FG001|Overall Study|excluded from FAS|20|||
146406720|NCT01966107|527992526|FG000|Overall Study|discontinued treatment|345|||
146406721|NCT01966107|527992527|FG001|Overall Study|discontinued treatment|372|||
146063188|NCT00071058|526751244|FG000|Overall Study|brain tumor-removed from study|1|||
146406722|NCT01966107|527992526|FG000|Overall Study|due to study closure|164|||
146406723|NCT01966107|527992527|FG001|Overall Study|due to study closure|186|||
146406724|NCT01966107|527992526|FG000|Overall Study|withdrew from the study|272|||
146406725|NCT01966107|527992527|FG001|Overall Study|withdrew from the study|303|||
146406726|NCT00689273|527992528|FG000|Overall Study|Adverse Event|3|||
146406727|NCT00689273|527992529|FG001|Overall Study|Adverse Event|1|||
146406728|NCT00689273|527992528|FG000|Overall Study|Lack of Efficacy|3|||
146406729|NCT00689273|527992529|FG001|Overall Study|Lack of Efficacy|0|||
146406730|NCT00689273|527992528|FG000|Overall Study|Lost to Follow-up|0|||
146406731|NCT00689273|527992529|FG001|Overall Study|Lost to Follow-up|2|||
146406732|NCT00689273|527992528|FG000|Overall Study|Other|6|||
146406733|NCT00689273|527992529|FG001|Overall Study|Other|2|||
146406734|NCT00689273|527992528|FG000|Overall Study|Randomized but not Treated|1|||
146406735|NCT00689273|527992529|FG001|Overall Study|Randomized but not Treated|0|||
146406736|NCT01336608|527994391|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
146406737|NCT01336608|527994392|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146406738|NCT01336608|527994393|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146406739|NCT01336608|527994394|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146406740|NCT01336608|527994391|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
146406741|NCT01336608|527994392|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146406742|NCT01336608|527994393|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146406743|NCT01336608|527994394|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146406744|NCT01336608|527994391|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
146406745|NCT01336608|527994392|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146406746|NCT01336608|527994393|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146406747|NCT01336608|527994394|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146406748|NCT01336608|527994391|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
146406749|NCT01336608|527994392|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146406750|NCT01336608|527994393|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146406751|NCT01336608|527994394|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146406752|NCT01336608|527994391|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
146406753|NCT01336608|527994392|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146406754|NCT01336608|527994393|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146406755|NCT01336608|527994394|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146406756|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146406757|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
146406758|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
146406759|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
146406760|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146406761|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146406762|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146406763|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146406764|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146406765|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146406766|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146406767|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
146406768|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146406769|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146406770|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146406771|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146406772|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
146406773|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
146406774|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
146406775|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
146406776|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146406777|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146406778|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146406779|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146406780|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146406781|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
146406782|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146406783|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
146406784|NCT01336608|527994391|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146406785|NCT01336608|527994392|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146406786|NCT01336608|527994393|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
146406787|NCT01336608|527994394|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
146406788|NCT04723173|527994397|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
146406789|NCT02996448|527994398|FG000|Overall Study|Study terminated due to adverse effects|3|||
146063189|NCT02000440|526751249|FG000|Overall Study|Adverse Event|3|||
146063190|NCT02000440|526751249|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
146063191|NCT01690143|526751251|FG000|Overall Study|Withdrawal by Subject|1|||
146063192|NCT01210313|526751255|FG000|Overall Study|Withdrawal by Subject|3|||
146063193|NCT01210313|526751255|FG000|Overall Study|Adverse Event|2|||
146063194|NCT01210313|526751255|FG000|Overall Study|Distant recurrence|4|||
146063195|NCT01210313|526751255|FG000|Overall Study|Non-compliance|7|||
146063196|NCT00870740|526751258|FG000|Overall Study|Adverse Event|2|||
146063197|NCT00870740|526751259|FG001|Overall Study|Adverse Event|1|||
146063198|NCT00870740|526751260|FG002|Overall Study|Adverse Event|3|||
146063199|NCT00870740|526751261|FG003|Overall Study|Adverse Event|2|||
146063200|NCT00870740|526751262|FG004|Overall Study|Adverse Event|1|||
146063201|NCT00870740|526751263|FG005|Overall Study|Adverse Event|6|||
146063202|NCT00870740|526751258|FG000|Overall Study|Consent Withdrawn|6|||
146063203|NCT00870740|526751259|FG001|Overall Study|Consent Withdrawn|3|||
146063204|NCT00870740|526751260|FG002|Overall Study|Consent Withdrawn|4|||
146063205|NCT00870740|526751261|FG003|Overall Study|Consent Withdrawn|6|||
146063206|NCT00870740|526751262|FG004|Overall Study|Consent Withdrawn|6|||
146063207|NCT00870740|526751263|FG005|Overall Study|Consent Withdrawn|5|||
146063208|NCT00870740|526751258|FG000|Overall Study|Investigator Decision|2|||
146063209|NCT00870740|526751259|FG001|Overall Study|Investigator Decision|0|||
146063210|NCT00870740|526751260|FG002|Overall Study|Investigator Decision|1|||
146063211|NCT00870740|526751261|FG003|Overall Study|Investigator Decision|0|||
146063212|NCT00870740|526751262|FG004|Overall Study|Investigator Decision|0|||
146063213|NCT00870740|526751263|FG005|Overall Study|Investigator Decision|0|||
146063214|NCT00870740|526751258|FG000|Overall Study|Subject Non-compliance|0|||
146063215|NCT00870740|526751259|FG001|Overall Study|Subject Non-compliance|0|||
146063216|NCT00870740|526751260|FG002|Overall Study|Subject Non-compliance|0|||
146406790|NCT00303316|527994401|FG000|Overall Study|Protocol Violation|1|||
146406791|NCT00303316|527994402|FG001|Overall Study|Protocol Violation|0|||
146406792|NCT00303316|527994401|FG000|Overall Study|Lost to Follow-up|0|||
146406793|NCT00303316|527994402|FG001|Overall Study|Lost to Follow-up|1|||
146406794|NCT00303316|527994401|FG000|Overall Study|Withdrawal by Subject|1|||
146406795|NCT00303316|527994402|FG001|Overall Study|Withdrawal by Subject|2|||
146406796|NCT01160198|527994406|FG000|Overall Study|Withdrawal by Subject|2|||
146406797|NCT01160198|527994407|FG001|Overall Study|Withdrawal by Subject|1|||
146406798|NCT01160198|527994408|FG002|Overall Study|Withdrawal by Subject|0|||
146406799|NCT01160198|527994406|FG000|Overall Study|Adverse Event|0|||
146406800|NCT01160198|527994407|FG001|Overall Study|Adverse Event|1|||
146406801|NCT01160198|527994408|FG002|Overall Study|Adverse Event|0|||
146406802|NCT01160198|527994406|FG000|Overall Study|Lost to Follow-up|0|||
146063217|NCT00870740|526751261|FG003|Overall Study|Subject Non-compliance|0|||
146063218|NCT00870740|526751262|FG004|Overall Study|Subject Non-compliance|0|||
146063219|NCT00870740|526751263|FG005|Overall Study|Subject Non-compliance|1|||
146063220|NCT00870740|526751258|FG000|Overall Study|Death|0|||
146063221|NCT00870740|526751259|FG001|Overall Study|Death|0|||
146063222|NCT00870740|526751260|FG002|Overall Study|Death|0|||
146063223|NCT00870740|526751261|FG003|Overall Study|Death|0|||
146063224|NCT00870740|526751262|FG004|Overall Study|Death|1|||
146063225|NCT00870740|526751263|FG005|Overall Study|Death|0|||
146406803|NCT01160198|527994407|FG001|Overall Study|Lost to Follow-up|1|||
146063226|NCT00870740|526751258|FG000|Overall Study|Other|2|||
146063227|NCT00870740|526751259|FG001|Overall Study|Other|5|||
146063228|NCT00870740|526751260|FG002|Overall Study|Other|2|||
146063229|NCT00870740|526751261|FG003|Overall Study|Other|4|||
146063230|NCT00870740|526751262|FG004|Overall Study|Other|3|||
146063231|NCT00870740|526751263|FG005|Overall Study|Other|5|||
146406804|NCT01160198|527994408|FG002|Overall Study|Lost to Follow-up|0|||
146406805|NCT01160198|527994406|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
146406806|NCT01160198|527994407|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
146406807|NCT01160198|527994408|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
146406808|NCT01796860|527994410|FG000|Overall Study|Withdrawal by Subject|3|||
146406809|NCT02016755|527994411|FG000|Overall Study|Major amputation of index limb|2|||
146406810|NCT02016755|527994411|FG000|Overall Study|Adverse Event|2|||
146406811|NCT02016755|527994411|FG000|Overall Study|Physician Decision|1|||
146406812|NCT02016755|527994411|FG000|Overall Study|Death|2|||
146406813|NCT00563524|527994421|FG000|Overall Study|Adverse Event|0|||
146406814|NCT00563524|527994422|FG001|Overall Study|Adverse Event|1|||
146406815|NCT00563524|527994423|FG002|Overall Study|Adverse Event|0|||
146406816|NCT00563524|527994424|FG003|Overall Study|Adverse Event|0|||
146406817|NCT00563524|527994425|FG004|Overall Study|Adverse Event|2|||
146406818|NCT00563524|527994426|FG005|Overall Study|Adverse Event|0|||
146406819|NCT00563524|527994421|FG000|Overall Study|Lost to Follow-up|1|||
146406820|NCT00563524|527994422|FG001|Overall Study|Lost to Follow-up|0|||
146406821|NCT00563524|527994423|FG002|Overall Study|Lost to Follow-up|0|||
146406822|NCT00563524|527994424|FG003|Overall Study|Lost to Follow-up|0|||
146406823|NCT00563524|527994425|FG004|Overall Study|Lost to Follow-up|0|||
146406824|NCT00563524|527994426|FG005|Overall Study|Lost to Follow-up|0|||
146406825|NCT00563524|527994421|FG000|Overall Study|Protocol Violation|0|||
146406826|NCT00563524|527994422|FG001|Overall Study|Protocol Violation|1|||
146406827|NCT00563524|527994423|FG002|Overall Study|Protocol Violation|0|||
146406828|NCT00563524|527994424|FG003|Overall Study|Protocol Violation|0|||
146406829|NCT00563524|527994425|FG004|Overall Study|Protocol Violation|0|||
146406830|NCT00563524|527994426|FG005|Overall Study|Protocol Violation|0|||
146406831|NCT00563524|527994421|FG000|Overall Study|Withdrawal by Subject|1|||
146406832|NCT00563524|527994422|FG001|Overall Study|Withdrawal by Subject|1|||
146406833|NCT00563524|527994423|FG002|Overall Study|Withdrawal by Subject|3|||
146406834|NCT00563524|527994424|FG003|Overall Study|Withdrawal by Subject|0|||
146406835|NCT00563524|527994425|FG004|Overall Study|Withdrawal by Subject|0|||
146406836|NCT00563524|527994426|FG005|Overall Study|Withdrawal by Subject|1|||
146406837|NCT03543046|527994432|FG000|Overall Study|Adverse Event|1|||
146406838|NCT03543046|527994433|FG001|Overall Study|Adverse Event|1|||
146406839|NCT03543046|527994432|FG000|Overall Study|Physician Decision|1|||
146406840|NCT03543046|527994433|FG001|Overall Study|Physician Decision|1|||
146406841|NCT03543046|527994432|FG000|Overall Study|Protocol Violation|1|||
146406842|NCT03543046|527994433|FG001|Overall Study|Protocol Violation|0|||
146406843|NCT00520494|527994443|FG000|Overall Study|Withdrawal by Subject|1|||
146406844|NCT04247594|527994444|FG000|Overall Study|Withdrawal by Subject|4|||
146406845|NCT02748616|527994445|FG000|Overall Study|Lost to Follow-up|1|||
146406846|NCT02748616|527994445|FG000|Overall Study|Withdrawal by Subject|2|||
146406847|NCT02748616|527994445|FG000|Overall Study|Physician Decision|2|||
146406848|NCT02748616|527994445|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
146406849|NCT00422058|527994446|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
146406850|NCT00422058|527994447|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
146406851|NCT00422058|527994448|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
146406852|NCT00422058|527994449|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
146406853|NCT00422058|527994450|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
146406854|NCT00422058|527994451|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
146406855|NCT00422058|527994446|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
146406856|NCT00422058|527994447|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
146406857|NCT00422058|527994448|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
146406858|NCT00422058|527994449|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
146406859|NCT00422058|527994450|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
146406860|NCT00422058|527994451|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
146406861|NCT00422058|527994446|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
146063232|NCT01710345|526751270|FG000|Overall Study|Adverse Event|0|||
146063233|NCT01710345|526751271|FG001|Overall Study|Adverse Event|2|||
146406862|NCT00422058|527994447|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146406863|NCT00422058|527994448|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146406864|NCT00422058|527994449|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
146406865|NCT00422058|527994450|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
146406866|NCT00422058|527994451|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
146406867|NCT00422058|527994446|FG000|Double-Blind, Week 0-20|Other|11|||
146406868|NCT00422058|527994447|FG001|Double-Blind, Week 0-20|Other|3|||
146406869|NCT00422058|527994448|FG002|Double-Blind, Week 0-20|Other|8|||
146063234|NCT01710345|526751272|FG002|Overall Study|Adverse Event|0|||
146063235|NCT01710345|526751270|FG000|Overall Study|Lack of Efficacy|2|||
146063236|NCT01710345|526751271|FG001|Overall Study|Lack of Efficacy|3|||
146406870|NCT00422058|527994449|FG003|Double-Blind, Week 0-20|Other|8|||
146406871|NCT00422058|527994450|FG004|Double-Blind, Week 0-20|Other|4|||
146406872|NCT00422058|527994451|FG005|Double-Blind, Week 0-20|Other|10|||
146406873|NCT00422058|527994446|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
146406874|NCT00422058|527994447|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
146406875|NCT00422058|527994448|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
146406876|NCT00422058|527994449|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
146406877|NCT00422058|527994450|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
146406878|NCT00422058|527994451|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
146406879|NCT00422058|527994446|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
146406880|NCT00422058|527994447|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
146406881|NCT00422058|527994448|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
146406882|NCT00422058|527994449|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
146406883|NCT00422058|527994450|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
146406884|NCT00422058|527994451|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
146406885|NCT00422058|527994446|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
146406886|NCT00422058|527994447|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
146406887|NCT00422058|527994448|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
146406888|NCT00422058|527994449|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
146406889|NCT00422058|527994450|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
146406890|NCT00422058|527994451|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
146406891|NCT00422058|527994446|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
146406892|NCT00422058|527994447|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
146406893|NCT00422058|527994448|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
146406894|NCT00422058|527994449|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
146406895|NCT00422058|527994450|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
146406896|NCT00422058|527994451|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
146406897|NCT00422058|527994446|FG000|Open-Label Extension, Week 20-104|Other|13|||
146406898|NCT00422058|527994447|FG001|Open-Label Extension, Week 20-104|Other|14|||
146406899|NCT00422058|527994448|FG002|Open-Label Extension, Week 20-104|Other|6|||
146406900|NCT00422058|527994449|FG003|Open-Label Extension, Week 20-104|Other|13|||
146406901|NCT00422058|527994450|FG004|Open-Label Extension, Week 20-104|Other|16|||
146406902|NCT00422058|527994451|FG005|Open-Label Extension, Week 20-104|Other|18|||
146406903|NCT00713830|527994452|FG000|Overall Study|Adverse Event|23|||
146406904|NCT00713830|527994453|FG001|Overall Study|Adverse Event|71|||
146406905|NCT00713830|527994452|FG000|Overall Study|Lack of Efficacy|24|||
146406906|NCT00713830|527994453|FG001|Overall Study|Lack of Efficacy|16|||
146406907|NCT00713830|527994452|FG000|Overall Study|Lost to Follow-up|2|||
146406908|NCT00713830|527994453|FG001|Overall Study|Lost to Follow-up|9|||
146406909|NCT00713830|527994452|FG000|Overall Study|Withdrawal by Subject|13|||
146406910|NCT00713830|527994453|FG001|Overall Study|Withdrawal by Subject|23|||
146406911|NCT00713830|527994452|FG000|Overall Study|Poor Compliance to Protocol|7|||
146406912|NCT00713830|527994453|FG001|Overall Study|Poor Compliance to Protocol|14|||
146406913|NCT00713830|527994452|FG000|Overall Study|Familial and Personal Reasons|9|||
146406914|NCT00713830|527994453|FG001|Overall Study|Familial and Personal Reasons|34|||
146063237|NCT01710345|526751272|FG002|Overall Study|Lack of Efficacy|1|||
146063238|NCT01710345|526751270|FG000|Overall Study|Drug Dosing Error|1|||
146063239|NCT01710345|526751271|FG001|Overall Study|Drug Dosing Error|0|||
146063240|NCT01710345|526751272|FG002|Overall Study|Drug Dosing Error|0|||
146063241|NCT02668653|526751274|FG000|Overall Study|Refractory disease|41|||
146063242|NCT02668653|526751275|FG001|Overall Study|Refractory disease|70|||
146063243|NCT02668653|526751274|FG000|Overall Study|Relapse|44|||
146063244|NCT02668653|526751275|FG001|Overall Study|Relapse|65|||
146063245|NCT02668653|526751274|FG000|Overall Study|Adverse Event|58|||
146063246|NCT02668653|526751275|FG001|Overall Study|Adverse Event|23|||
146063247|NCT02668653|526751274|FG000|Overall Study|Subject decision to stop study drug|25|||
146063248|NCT02668653|526751275|FG001|Overall Study|Subject decision to stop study drug|23|||
146063249|NCT02668653|526751274|FG000|Overall Study|Other reasons not specified|16|||
146063250|NCT02668653|526751275|FG001|Overall Study|Other reasons not specified|11|||
146406915|NCT00713830|527994452|FG000|Overall Study|Sponsor Decision|4|||
146406916|NCT00713830|527994453|FG001|Overall Study|Sponsor Decision|10|||
146406917|NCT02787785|527994456|FG000|Overall Study|Death|3|||
146063251|NCT02668653|526751274|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
146063252|NCT02668653|526751275|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
146063253|NCT02668653|526751274|FG000|Overall Study|Investigator decision|10|||
146406918|NCT02787785|527994457|FG001|Overall Study|Death|4|||
146406919|NCT02787785|527994456|FG000|Overall Study|Lost to Follow-up|1|||
146406920|NCT02787785|527994457|FG001|Overall Study|Lost to Follow-up|1|||
146406921|NCT02787785|527994456|FG000|Overall Study|Withdrawal by Subject|0|||
146406922|NCT02787785|527994457|FG001|Overall Study|Withdrawal by Subject|5|||
146406923|NCT02030834|527994458|FG000|Overall Study|Death|4|||
146063254|NCT02668653|526751275|FG001|Overall Study|Investigator decision|7|||
146063255|NCT02668653|526751274|FG000|Overall Study|Failure to meet continuation criteria|5|||
146063256|NCT02668653|526751275|FG001|Overall Study|Failure to meet continuation criteria|12|||
146406924|NCT02030834|527994459|FG001|Overall Study|Death|0|||
146406925|NCT02030834|527994460|FG002|Overall Study|Death|0|||
146406926|NCT02030834|527994458|FG000|Overall Study|Manufacturing failure|2|||
146406927|NCT02030834|527994459|FG001|Overall Study|Manufacturing failure|0|||
146406928|NCT02030834|527994460|FG002|Overall Study|Manufacturing failure|1|||
146406929|NCT02030834|527994458|FG000|Overall Study|Disease progression|2|||
146406930|NCT02030834|527994459|FG001|Overall Study|Disease progression|0|||
146406931|NCT02030834|527994460|FG002|Overall Study|Disease progression|2|||
146406932|NCT02030834|527994458|FG000|Overall Study|Lost to Follow-up|1|||
146406933|NCT02030834|527994459|FG001|Overall Study|Lost to Follow-up|0|||
146406934|NCT02030834|527994460|FG002|Overall Study|Lost to Follow-up|0|||
146406935|NCT02030834|527994458|FG000|Overall Study|Withdrawal by Subject|1|||
146406936|NCT02030834|527994459|FG001|Overall Study|Withdrawal by Subject|0|||
146406937|NCT02030834|527994460|FG002|Overall Study|Withdrawal by Subject|0|||
146406938|NCT02030834|527994458|FG000|Overall Study|Lack of funding|1|||
146406939|NCT02030834|527994459|FG001|Overall Study|Lack of funding|0|||
146406940|NCT02030834|527994460|FG002|Overall Study|Lack of funding|0|||
146406941|NCT00854607|527994464|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
146406942|NCT00965263|527994472|FG000|Overall Study|Physician Decision|2|||
146406943|NCT00965263|527994473|FG001|Overall Study|Physician Decision|0|||
146406944|NCT00965263|527994472|FG000|Overall Study|Family emergency|0|||
146406945|NCT00965263|527994473|FG001|Overall Study|Family emergency|1|||
146406946|NCT00965263|527994472|FG000|Overall Study|Protocol Violation|0|||
146406947|NCT00965263|527994473|FG001|Overall Study|Protocol Violation|2|||
146406948|NCT01766310|527994474|FG000|Overall Study|Lost to Follow-up|1|||
145890925|NCT01207440|526107576|FG006|Overall Study|Lack of Efficacy|0|||
146063257|NCT02668653|526751274|FG000|Overall Study|Lost to Follow-up|1|||
146063258|NCT02668653|526751275|FG001|Overall Study|Lost to Follow-up|0|||
146063259|NCT02668653|526751274|FG000|Overall Study|Pregnancy|0|||
146063260|NCT02668653|526751275|FG001|Overall Study|Pregnancy|1|||
146063261|NCT02668653|526751274|FG000|Overall Study|Death|0|||
146063262|NCT02668653|526751275|FG001|Overall Study|Death|1|||
146063263|NCT03558737|526751276|FG000|Overall Study|Death|1|||
146063264|NCT03558737|526751277|FG001|Overall Study|Death|1|||
146063265|NCT01294553|526751278|FG000|Overall Study|Duplicated Participants|1|||
146063266|NCT01294553|526751278|FG000|Overall Study|Protocol Violation|268|||
146063267|NCT03041181|526751281|FG000|Overall Study|Disease Progression|1|||
146063268|NCT03041181|526751282|FG001|Overall Study|Disease Progression|2|||
146406949|NCT01766310|527994475|FG001|Overall Study|Lost to Follow-up|3|||
146406950|NCT03151707|527994476|FG000|Overall Study|Lost to Follow-up|6|||
146406951|NCT01591499|527994478|FG000|Baseline Visit|Withdrawal by Subject|0|||
146406952|NCT01591499|527994479|FG001|Baseline Visit|Withdrawal by Subject|2|||
146406953|NCT01591499|527994480|FG002|Baseline Visit|Withdrawal by Subject|0|||
146406954|NCT01591499|527994481|FG003|Baseline Visit|Withdrawal by Subject|2|||
146406955|NCT01591499|527994478|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
146406956|NCT01591499|527994479|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
146406957|NCT01591499|527994480|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
146063269|NCT03224819|526751283|FG000|Overall Study|Withdrawal by Subject|0|||
146063270|NCT03224819|526751284|FG001|Overall Study|Withdrawal by Subject|0|||
146406958|NCT01591499|527994481|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
146063271|NCT03224819|526751285|FG002|Overall Study|Withdrawal by Subject|0|||
146063272|NCT03224819|526751286|FG003|Overall Study|Withdrawal by Subject|0|||
146406959|NCT01591499|527994478|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
146406960|NCT01591499|527994479|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
146406961|NCT01591499|527994480|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
146406962|NCT01591499|527994481|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
146406963|NCT00646282|527994482|FG000|Overall Study|Protocol terminated|4|||
146406964|NCT00646282|527994483|FG001|Overall Study|Protocol terminated|4|||
146406965|NCT00530088|527994484|FG000|Overall Study|Disease Progression|4|||
146406966|NCT00530088|527994484|FG000|Overall Study|Physician Decision|4|||
146406967|NCT00530088|527994484|FG000|Overall Study|Other Not Specified|2|||
146406968|NCT00902278|527994485|FG000|Overall Study|Physician Decision|1|||
146406969|NCT00902278|527994486|FG001|Overall Study|Physician Decision|0|||
146406970|NCT00902278|527994487|FG002|Overall Study|Physician Decision|2|||
146406971|NCT00902278|527994488|FG003|Overall Study|Physician Decision|0|||
146406972|NCT00902278|527994489|FG004|Overall Study|Physician Decision|1|||
146406973|NCT00902278|527994485|FG000|Overall Study|Lost to Follow-up|3|||
146406974|NCT00902278|527994486|FG001|Overall Study|Lost to Follow-up|2|||
146063273|NCT03224819|526751287|FG004|Overall Study|Withdrawal by Subject|0|||
146063274|NCT03224819|526751288|FG005|Overall Study|Withdrawal by Subject|0|||
146063275|NCT03224819|526751289|FG006|Overall Study|Withdrawal by Subject|0|||
146063276|NCT03224819|526751290|FG007|Overall Study|Withdrawal by Subject|0|||
146406975|NCT00902278|527994487|FG002|Overall Study|Lost to Follow-up|3|||
146406976|NCT00902278|527994488|FG003|Overall Study|Lost to Follow-up|0|||
146406977|NCT00902278|527994489|FG004|Overall Study|Lost to Follow-up|1|||
146406978|NCT00995488|527994496|FG000|Overall Study|Withdrawal by Subject|1|||
146406979|NCT01289990|527994497|FG000|Overall Study|Death|0|||
146406980|NCT01289990|527994498|FG001|Overall Study|Death|0|||
146063277|NCT03224819|526751291|FG008|Overall Study|Withdrawal by Subject|0|||
146063278|NCT03224819|526751292|FG009|Overall Study|Withdrawal by Subject|0|||
146063279|NCT03224819|526751293|FG010|Overall Study|Withdrawal by Subject|0|||
146063280|NCT03224819|526751294|FG011|Overall Study|Withdrawal by Subject|0|||
146063281|NCT03224819|526751295|FG012|Overall Study|Withdrawal by Subject|1|||
146063282|NCT03224819|526751296|FG013|Overall Study|Withdrawal by Subject|0|||
146063283|NCT03224819|526751283|FG000|Overall Study|Sponsor Decision|0|||
146406981|NCT01289990|527994499|FG002|Overall Study|Death|0|||
146406982|NCT01289990|527994500|FG003|Overall Study|Death|1|||
146406983|NCT01289990|527994501|FG004|Overall Study|Death|2|||
146406984|NCT01289990|527994502|FG005|Overall Study|Death|1|||
146406985|NCT01289990|527994503|FG006|Overall Study|Death|0|||
146406986|NCT01289990|527994504|FG007|Overall Study|Death|0|||
146063284|NCT03224819|526751284|FG001|Overall Study|Sponsor Decision|0|||
146063285|NCT03224819|526751285|FG002|Overall Study|Sponsor Decision|0|||
146063286|NCT03224819|526751286|FG003|Overall Study|Sponsor Decision|1|||
146063287|NCT03224819|526751287|FG004|Overall Study|Sponsor Decision|1|||
146063288|NCT03224819|526751288|FG005|Overall Study|Sponsor Decision|2|||
146063289|NCT03224819|526751289|FG006|Overall Study|Sponsor Decision|1|||
146063290|NCT03224819|526751290|FG007|Overall Study|Sponsor Decision|1|||
146063291|NCT03224819|526751291|FG008|Overall Study|Sponsor Decision|1|||
146406987|NCT01289990|527994505|FG008|Overall Study|Death|0|||
146406988|NCT01289990|527994506|FG009|Overall Study|Death|0|||
146406989|NCT01289990|527994507|FG010|Overall Study|Death|0|||
146406990|NCT01289990|527994508|FG011|Overall Study|Death|1|||
146406991|NCT01289990|527994509|FG012|Overall Study|Death|0|||
146406992|NCT01289990|527994497|FG000|Overall Study|Lost to Follow-up|3|||
146063292|NCT03224819|526751292|FG009|Overall Study|Sponsor Decision|2|||
146063293|NCT03224819|526751293|FG010|Overall Study|Sponsor Decision|1|||
146063294|NCT03224819|526751294|FG011|Overall Study|Sponsor Decision|1|||
146063295|NCT03224819|526751295|FG012|Overall Study|Sponsor Decision|1|||
146063296|NCT03224819|526751296|FG013|Overall Study|Sponsor Decision|0|||
146063297|NCT03224819|526751283|FG000|Overall Study|Lost to Follow-up|0|||
146406993|NCT01289990|527994498|FG001|Overall Study|Lost to Follow-up|2|||
146406994|NCT01289990|527994499|FG002|Overall Study|Lost to Follow-up|5|||
146063298|NCT03224819|526751284|FG001|Overall Study|Lost to Follow-up|0|||
146063299|NCT03224819|526751285|FG002|Overall Study|Lost to Follow-up|0|||
146063300|NCT03224819|526751286|FG003|Overall Study|Lost to Follow-up|0|||
146063301|NCT03224819|526751287|FG004|Overall Study|Lost to Follow-up|0|||
146406995|NCT01289990|527994500|FG003|Overall Study|Lost to Follow-up|5|||
146406996|NCT01289990|527994501|FG004|Overall Study|Lost to Follow-up|3|||
146406997|NCT01289990|527994502|FG005|Overall Study|Lost to Follow-up|4|||
146406998|NCT01289990|527994503|FG006|Overall Study|Lost to Follow-up|2|||
146406999|NCT01289990|527994504|FG007|Overall Study|Lost to Follow-up|2|||
146407000|NCT01289990|527994505|FG008|Overall Study|Lost to Follow-up|1|||
146407001|NCT01289990|527994506|FG009|Overall Study|Lost to Follow-up|4|||
146407002|NCT01289990|527994507|FG010|Overall Study|Lost to Follow-up|2|||
146407003|NCT01289990|527994508|FG011|Overall Study|Lost to Follow-up|1|||
146407004|NCT01289990|527994509|FG012|Overall Study|Lost to Follow-up|2|||
146407005|NCT01289990|527994497|FG000|Overall Study|Withdrawal by Subject|15|||
146407006|NCT01289990|527994498|FG001|Overall Study|Withdrawal by Subject|14|||
146407007|NCT01289990|527994499|FG002|Overall Study|Withdrawal by Subject|12|||
146407008|NCT01289990|527994500|FG003|Overall Study|Withdrawal by Subject|13|||
146407009|NCT01289990|527994501|FG004|Overall Study|Withdrawal by Subject|8|||
146407010|NCT01289990|527994502|FG005|Overall Study|Withdrawal by Subject|7|||
146407011|NCT01289990|527994503|FG006|Overall Study|Withdrawal by Subject|13|||
146407012|NCT01289990|527994504|FG007|Overall Study|Withdrawal by Subject|9|||
146407013|NCT01289990|527994505|FG008|Overall Study|Withdrawal by Subject|12|||
146407014|NCT01289990|527994506|FG009|Overall Study|Withdrawal by Subject|13|||
146407015|NCT01289990|527994507|FG010|Overall Study|Withdrawal by Subject|11|||
146407016|NCT01289990|527994508|FG011|Overall Study|Withdrawal by Subject|13|||
146407017|NCT01289990|527994509|FG012|Overall Study|Withdrawal by Subject|16|||
146063302|NCT03224819|526751288|FG005|Overall Study|Lost to Follow-up|0|||
146063303|NCT03224819|526751289|FG006|Overall Study|Lost to Follow-up|0|||
146063304|NCT03224819|526751290|FG007|Overall Study|Lost to Follow-up|0|||
146063305|NCT03224819|526751291|FG008|Overall Study|Lost to Follow-up|1|||
146063306|NCT03224819|526751292|FG009|Overall Study|Lost to Follow-up|0|||
146063307|NCT03224819|526751293|FG010|Overall Study|Lost to Follow-up|0|||
146063308|NCT03224819|526751294|FG011|Overall Study|Lost to Follow-up|0|||
146063309|NCT03224819|526751295|FG012|Overall Study|Lost to Follow-up|0|||
146063310|NCT03224819|526751296|FG013|Overall Study|Lost to Follow-up|0|||
146063311|NCT03224819|526751283|FG000|Overall Study|Death|0|||
146063312|NCT03224819|526751284|FG001|Overall Study|Death|1|||
146063313|NCT03224819|526751285|FG002|Overall Study|Death|0|||
146063314|NCT03224819|526751286|FG003|Overall Study|Death|0|||
146063315|NCT03224819|526751287|FG004|Overall Study|Death|0|||
146063316|NCT03224819|526751288|FG005|Overall Study|Death|0|||
146063317|NCT03224819|526751289|FG006|Overall Study|Death|0|||
146063318|NCT03224819|526751290|FG007|Overall Study|Death|1|||
146063319|NCT03224819|526751291|FG008|Overall Study|Death|0|||
146063320|NCT03224819|526751292|FG009|Overall Study|Death|0|||
146063321|NCT03224819|526751293|FG010|Overall Study|Death|0|||
146407018|NCT01289990|527994497|FG000|Overall Study|discontinued in preceding trial|18|||
146407019|NCT01289990|527994498|FG001|Overall Study|discontinued in preceding trial|20|||
146407020|NCT01289990|527994499|FG002|Overall Study|discontinued in preceding trial|41|||
146063322|NCT03224819|526751294|FG011|Overall Study|Death|1|||
146407021|NCT01289990|527994500|FG003|Overall Study|discontinued in preceding trial|17|||
146407022|NCT01289990|527994501|FG004|Overall Study|discontinued in preceding trial|11|||
146407023|NCT01289990|527994502|FG005|Overall Study|discontinued in preceding trial|12|||
146407024|NCT01289990|527994503|FG006|Overall Study|discontinued in preceding trial|18|||
146407025|NCT01289990|527994504|FG007|Overall Study|discontinued in preceding trial|8|||
146407026|NCT01289990|527994505|FG008|Overall Study|discontinued in preceding trial|17|||
146407027|NCT01289990|527994506|FG009|Overall Study|discontinued in preceding trial|21|||
146063323|NCT03224819|526751295|FG012|Overall Study|Death|0|||
146063324|NCT03224819|526751296|FG013|Overall Study|Death|0|||
146063325|NCT00005780|526751297|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
146063326|NCT04973449|526751298|FG000|Overall Study|Withdrawal by Subject|3|||
146063327|NCT04973449|526751299|FG001|Overall Study|Withdrawal by Subject|3|||
146063328|NCT04973449|526751300|FG002|Overall Study|Withdrawal by Subject|2|||
146063329|NCT04973449|526751301|FG003|Overall Study|Withdrawal by Subject|5|||
146063330|NCT04973449|526751302|FG004|Overall Study|Withdrawal by Subject|5|||
146407028|NCT01289990|527994507|FG010|Overall Study|discontinued in preceding trial|17|||
146063331|NCT04973449|526751303|FG005|Overall Study|Withdrawal by Subject|4|||
146063332|NCT04973449|526751304|FG006|Overall Study|Withdrawal by Subject|7|||
146407029|NCT01289990|527994508|FG011|Overall Study|discontinued in preceding trial|17|||
146407030|NCT01289990|527994509|FG012|Overall Study|discontinued in preceding trial|24|||
146407031|NCT01289990|527994497|FG000|Overall Study|did not continue in extension|41|||
146407032|NCT01289990|527994498|FG001|Overall Study|did not continue in extension|45|||
146407033|NCT01289990|527994499|FG002|Overall Study|did not continue in extension|51|||
146407034|NCT01289990|527994500|FG003|Overall Study|did not continue in extension|51|||
146407035|NCT01289990|527994501|FG004|Overall Study|did not continue in extension|48|||
146407036|NCT01289990|527994502|FG005|Overall Study|did not continue in extension|50|||
146407037|NCT01289990|527994503|FG006|Overall Study|did not continue in extension|54|||
146407038|NCT01289990|527994504|FG007|Overall Study|did not continue in extension|36|||
146407039|NCT01289990|527994505|FG008|Overall Study|did not continue in extension|44|||
146407040|NCT01289990|527994506|FG009|Overall Study|did not continue in extension|48|||
146407041|NCT01289990|527994507|FG010|Overall Study|did not continue in extension|45|||
146407042|NCT01289990|527994508|FG011|Overall Study|did not continue in extension|34|||
146407043|NCT01289990|527994509|FG012|Overall Study|did not continue in extension|56|||
146407044|NCT01289990|527994497|FG000|Overall Study|Not treated|0|||
146407045|NCT01289990|527994498|FG001|Overall Study|Not treated|0|||
146407046|NCT01289990|527994499|FG002|Overall Study|Not treated|0|||
146407047|NCT01289990|527994500|FG003|Overall Study|Not treated|0|||
146407048|NCT01289990|527994501|FG004|Overall Study|Not treated|0|||
146407049|NCT01289990|527994502|FG005|Overall Study|Not treated|0|||
146407050|NCT01289990|527994503|FG006|Overall Study|Not treated|1|||
146407051|NCT01289990|527994504|FG007|Overall Study|Not treated|0|||
146407052|NCT01289990|527994505|FG008|Overall Study|Not treated|1|||
146407053|NCT01289990|527994506|FG009|Overall Study|Not treated|0|||
146407054|NCT01289990|527994507|FG010|Overall Study|Not treated|1|||
146407055|NCT01289990|527994508|FG011|Overall Study|Not treated|2|||
146407056|NCT01289990|527994509|FG012|Overall Study|Not treated|0|||
146407057|NCT02149199|527994536|FG000|Overall Study|Study specific withdrawal criteria|4|||
146407058|NCT02149199|527994537|FG001|Overall Study|Study specific withdrawal criteria|21|||
146407059|NCT02149199|527994538|FG002|Overall Study|Study specific withdrawal criteria|6|||
146407060|NCT02149199|527994536|FG000|Overall Study|Other|20|||
146407061|NCT02149199|527994537|FG001|Overall Study|Other|25|||
146407062|NCT02149199|527994538|FG002|Overall Study|Other|20|||
146407063|NCT02149199|527994536|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
146407064|NCT02149199|527994537|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
146407065|NCT02149199|527994538|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
146407066|NCT02149199|527994536|FG000|Overall Study|Withdrawal by Subject|75|||
146407067|NCT02149199|527994537|FG001|Overall Study|Withdrawal by Subject|93|||
146407068|NCT02149199|527994538|FG002|Overall Study|Withdrawal by Subject|77|||
146407069|NCT02149199|527994536|FG000|Overall Study|Protocol Violation|16|||
146407070|NCT02149199|527994537|FG001|Overall Study|Protocol Violation|13|||
146407071|NCT02149199|527994538|FG002|Overall Study|Protocol Violation|15|||
146407072|NCT02149199|527994536|FG000|Overall Study|Lost to Follow-up|3|||
146407073|NCT02149199|527994537|FG001|Overall Study|Lost to Follow-up|12|||
146407074|NCT02149199|527994538|FG002|Overall Study|Lost to Follow-up|11|||
146407075|NCT02149199|527994536|FG000|Overall Study|Death|0|||
146407076|NCT02149199|527994537|FG001|Overall Study|Death|0|||
146407077|NCT02149199|527994538|FG002|Overall Study|Death|1|||
146407078|NCT02149199|527994536|FG000|Overall Study|Adverse Event|6|||
146407079|NCT02149199|527994537|FG001|Overall Study|Adverse Event|15|||
146407080|NCT02149199|527994538|FG002|Overall Study|Adverse Event|9|||
146407081|NCT01500434|527994541|FG000|Overall Study|Death|1|||
146407082|NCT01500434|527994541|FG000|Overall Study|Withdrawal by Subject|1|||
146407083|NCT01500434|527994541|FG000|Overall Study|Missed 12-month follow-up|5|||
146407084|NCT00752895|527994542|FG000|Overall Study|Withdrawal by Subject|8|||
146407085|NCT00752895|527994543|FG001|Overall Study|Withdrawal by Subject|3|||
146407086|NCT00633217|527994544|FG000|Overall Study|Adverse Event|5|||
146407087|NCT00633217|527994545|FG001|Overall Study|Adverse Event|9|||
146407088|NCT00633217|527994544|FG000|Overall Study|Lack of Efficacy|0|||
146407089|NCT00633217|527994545|FG001|Overall Study|Lack of Efficacy|2|||
146407090|NCT00633217|527994544|FG000|Overall Study|Protocol Violation|3|||
146407091|NCT00633217|527994545|FG001|Overall Study|Protocol Violation|7|||
146407092|NCT00633217|527994544|FG000|Overall Study|Lost to Follow-up|2|||
146407093|NCT00633217|527994545|FG001|Overall Study|Lost to Follow-up|2|||
146407094|NCT00633217|527994544|FG000|Overall Study|Investigator Discretion|2|||
146407095|NCT00633217|527994545|FG001|Overall Study|Investigator Discretion|0|||
146407096|NCT00633217|527994544|FG000|Overall Study|Withdrew Consent|3|||
146063333|NCT04973449|526751305|FG007|Overall Study|Withdrawal by Subject|5|||
146407097|NCT00633217|527994545|FG001|Overall Study|Withdrew Consent|3|||
146407098|NCT04881448|527994546|FG000|Overall Study|Study cancelled by sponsor|220|||
146407099|NCT04881448|527994546|FG000|Overall Study|Withdrawal by Subject|2|||
146407100|NCT04881448|527994546|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
146407101|NCT00532779|527994547|FG000|Overall Study|Adverse Event|122|||
146407102|NCT00532779|527994548|FG001|Overall Study|Adverse Event|112|||
146407103|NCT00532779|527994549|FG002|Overall Study|Adverse Event|56|||
146407104|NCT00532779|527994547|FG000|Overall Study|Lost to Follow-up|76|||
146407105|NCT00532779|527994548|FG001|Overall Study|Lost to Follow-up|65|||
146407106|NCT00532779|527994549|FG002|Overall Study|Lost to Follow-up|66|||
146407107|NCT00532779|527994547|FG000|Overall Study|Withdrawal by Subject|63|||
146407108|NCT00532779|527994548|FG001|Overall Study|Withdrawal by Subject|60|||
146407109|NCT00532779|527994549|FG002|Overall Study|Withdrawal by Subject|90|||
146407110|NCT00532779|527994547|FG000|Overall Study|Lack of Efficacy|12|||
146407111|NCT00532779|527994548|FG001|Overall Study|Lack of Efficacy|12|||
146407112|NCT00532779|527994549|FG002|Overall Study|Lack of Efficacy|40|||
146407113|NCT00532779|527994547|FG000|Overall Study|Protocol Violation|5|||
146407114|NCT00532779|527994548|FG001|Overall Study|Protocol Violation|9|||
146407115|NCT00532779|527994549|FG002|Overall Study|Protocol Violation|7|||
146407116|NCT00532779|527994547|FG000|Overall Study|Pregnancy|2|||
146407117|NCT00532779|527994548|FG001|Overall Study|Pregnancy|5|||
146407118|NCT00532779|527994549|FG002|Overall Study|Pregnancy|3|||
146407119|NCT00532779|527994547|FG000|Overall Study|Death|0|||
146407120|NCT00532779|527994548|FG001|Overall Study|Death|1|||
146407121|NCT00532779|527994549|FG002|Overall Study|Death|0|||
146407122|NCT00532779|527994547|FG000|Overall Study|Drug noncompliance, moved, other|14|||
146407123|NCT00532779|527994548|FG001|Overall Study|Drug noncompliance, moved, other|23|||
146407124|NCT00532779|527994549|FG002|Overall Study|Drug noncompliance, moved, other|29|||
146407125|NCT02662556|527994550|FG000|Overall Study|Adverse Event|4|||
146407126|NCT02662556|527994550|FG000|Overall Study|Lack of Efficacy|4|||
146407127|NCT02531698|527994558|FG000|Overall Study|Adverse Event|2|||
146407128|NCT02531698|527994559|FG001|Overall Study|Adverse Event|1|||
146407129|NCT02531698|527994558|FG000|Overall Study|Withdrawal by Subject|6|||
146407130|NCT02531698|527994559|FG001|Overall Study|Withdrawal by Subject|1|||
146407131|NCT02531698|527994558|FG000|Overall Study|Protocol Violation|2|||
146407132|NCT02531698|527994559|FG001|Overall Study|Protocol Violation|0|||
146407133|NCT02531698|527994558|FG000|Overall Study|Lost to Follow-up|1|||
146407134|NCT02531698|527994559|FG001|Overall Study|Lost to Follow-up|0|||
146407135|NCT02395536|527994560|FG000|Overall Study|Lost to Follow-up|4|||
146407136|NCT02395536|527994561|FG001|Overall Study|Lost to Follow-up|4|||
146407137|NCT02395536|527994560|FG000|Overall Study|Death|2|||
146407138|NCT02395536|527994561|FG001|Overall Study|Death|0|||
146407139|NCT02395536|527994560|FG000|Overall Study|Physician Decision|4|||
146407140|NCT02395536|527994561|FG001|Overall Study|Physician Decision|6|||
146407141|NCT02395536|527994560|FG000|Overall Study|Withdrawal by Subject|9|||
146407142|NCT02395536|527994561|FG001|Overall Study|Withdrawal by Subject|17|||
146407143|NCT02395536|527994560|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
146407144|NCT02395536|527994561|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
146407145|NCT02395536|527994560|FG000|Overall Study|Insurance issue|0|||
146407146|NCT02395536|527994561|FG001|Overall Study|Insurance issue|1|||
146407147|NCT00701558|527994562|FG000|Overall Study|Death|7|||
146407148|NCT00701558|527994562|FG000|Overall Study|Lost to Follow-up|8|||
146407149|NCT00700310|527995994|FG000|Overall Study|Adverse Event|6|||
146407150|NCT00700310|527995995|FG001|Overall Study|Adverse Event|10|||
146407151|NCT00700310|527995996|FG002|Overall Study|Adverse Event|5|||
146407152|NCT00700310|527995997|FG003|Overall Study|Adverse Event|11|||
146407153|NCT00700310|527995994|FG000|Overall Study|Lost to Follow-up|4|||
146407154|NCT00700310|527995995|FG001|Overall Study|Lost to Follow-up|1|||
146407155|NCT00700310|527995996|FG002|Overall Study|Lost to Follow-up|0|||
146407156|NCT00700310|527995997|FG003|Overall Study|Lost to Follow-up|1|||
146407157|NCT00700310|527995994|FG000|Overall Study|Withdrawal by Subject|8|||
146407158|NCT00700310|527995995|FG001|Overall Study|Withdrawal by Subject|9|||
146407159|NCT00700310|527995996|FG002|Overall Study|Withdrawal by Subject|8|||
146407160|NCT00700310|527995997|FG003|Overall Study|Withdrawal by Subject|8|||
146407161|NCT00700310|527995994|FG000|Overall Study|Lack of Efficacy|0|||
146407162|NCT00700310|527995995|FG001|Overall Study|Lack of Efficacy|3|||
146407163|NCT00700310|527995996|FG002|Overall Study|Lack of Efficacy|0|||
146407164|NCT00700310|527995997|FG003|Overall Study|Lack of Efficacy|1|||
146407165|NCT00700310|527995994|FG000|Overall Study|Administrative/Other|1|||
146407166|NCT00700310|527995995|FG001|Overall Study|Administrative/Other|3|||
146407167|NCT00700310|527995996|FG002|Overall Study|Administrative/Other|1|||
146407168|NCT00700310|527995997|FG003|Overall Study|Administrative/Other|3|||
146407169|NCT00700310|527995994|FG000|Overall Study|Randomized, Not Treated|2|||
146063334|NCT04973449|526751298|FG000|Overall Study|Lost to Follow-up|15|||
146407170|NCT00700310|527995995|FG001|Overall Study|Randomized, Not Treated|0|||
146407171|NCT00700310|527995996|FG002|Overall Study|Randomized, Not Treated|2|||
146407172|NCT00700310|527995997|FG003|Overall Study|Randomized, Not Treated|2|||
146407173|NCT01422720|527995998|FG000|Overall Study|Adverse Event|16|||
146407174|NCT01422720|527995998|FG000|Overall Study|Lack of Efficacy|1|||
146407175|NCT01422720|527995998|FG000|Overall Study|Withdrawal by Subject|4|||
146407176|NCT01422720|527995998|FG000|Overall Study|Ineligibility|1|||
146407177|NCT00606801|527995999|FG000|Intervention|Protocol Violation|3|||
146407178|NCT00606801|527996000|FG001|Intervention|Protocol Violation|3|||
146407179|NCT02082262|527996001|FG000|Overall Study|Withdrawal by Subject|3|||
146407180|NCT02082262|527996001|FG000|Overall Study|Adverse Event|48|||
146407181|NCT01726335|527996004|FG000|Overall Study|Lost to Follow-up|2|||
146407182|NCT01726335|527996004|FG000|Overall Study|Withdrawal by Subject|15|||
146407183|NCT01726335|527996004|FG000|Overall Study|Adverse Event|4|||
146407184|NCT01726335|527996004|FG000|Overall Study|Lost to Follow-up|2|||
146407185|NCT01726335|527996004|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
146407186|NCT01074307|527996006|FG000|Overall Study|No primary endpoint evaluation|14|||
146407187|NCT01074307|527996007|FG001|Overall Study|No primary endpoint evaluation|6|||
146407188|NCT01074307|527996006|FG000|Overall Study|Exclusion criterion|0|||
146407189|NCT01074307|527996007|FG001|Overall Study|Exclusion criterion|1|||
146407190|NCT01074307|527996006|FG000|Overall Study|Protocol Violation|8|||
146407191|NCT01074307|527996007|FG001|Overall Study|Protocol Violation|5|||
146407192|NCT02162511|527996013|FG000|Overall Study|Lack of Efficacy|0|||
146407193|NCT02162511|527996014|FG001|Overall Study|Lack of Efficacy|0|||
146407194|NCT02162511|527996015|FG002|Overall Study|Lack of Efficacy|2|||
146407195|NCT02703454|527996020|FG000|Overall Study|Not treated|1|||
146407196|NCT02703454|527996021|FG001|Overall Study|Not treated|3|||
146407197|NCT02703454|527996020|FG000|Overall Study|Withdrawal by Subject|4|||
146407198|NCT02703454|527996021|FG001|Overall Study|Withdrawal by Subject|3|||
146407199|NCT02703454|527996020|FG000|Overall Study|Lost to Follow-up|1|||
146407200|NCT02703454|527996021|FG001|Overall Study|Lost to Follow-up|2|||
146407201|NCT02703454|527996020|FG000|Overall Study|Study discontinuation|5|||
146407202|NCT02703454|527996021|FG001|Overall Study|Study discontinuation|8|||
146407203|NCT02284373|527996022|FG000|Overall Study|Withdrawal by Subject|0|||
146407204|NCT02284373|527996023|FG001|Overall Study|Withdrawal by Subject|1|||
146407205|NCT02284373|527996024|FG002|Overall Study|Withdrawal by Subject|0|||
146407206|NCT02284373|527996022|FG000|Overall Study|Other|0|||
146407207|NCT02284373|527996023|FG001|Overall Study|Other|1|||
146407208|NCT02284373|527996024|FG002|Overall Study|Other|0|||
146407209|NCT02284373|527996022|FG000|Overall Study|Lost to Follow-up|0|||
146407210|NCT02284373|527996023|FG001|Overall Study|Lost to Follow-up|1|||
146407211|NCT02284373|527996024|FG002|Overall Study|Lost to Follow-up|0|||
146407212|NCT02499406|527996027|FG000|Overall Study|missed 3 treatment sessions|4|||
146407213|NCT00552617|527996031|FG000|Overall Study|Not Treated|0|||
146407214|NCT00552617|527996032|FG001|Overall Study|Not Treated|0|||
146407215|NCT00552617|527996033|FG002|Overall Study|Not Treated|1|||
146407216|NCT00552617|527996034|FG003|Overall Study|Not Treated|0|||
146407217|NCT00552617|527996035|FG004|Overall Study|Not Treated|0|||
146407218|NCT00552617|527996036|FG005|Overall Study|Not Treated|0|||
146407219|NCT00552617|527996037|FG006|Overall Study|Not Treated|0|||
146407220|NCT00552617|527996038|FG007|Overall Study|Not Treated|0|||
146407221|NCT00552617|527996039|FG008|Overall Study|Not Treated|0|||
146407222|NCT00552617|527996040|FG009|Overall Study|Not Treated|1|||
146407223|NCT00552617|527996031|FG000|Overall Study|Lost to Follow-up|0|||
146407224|NCT00552617|527996032|FG001|Overall Study|Lost to Follow-up|0|||
146407225|NCT00552617|527996033|FG002|Overall Study|Lost to Follow-up|0|||
146407226|NCT00552617|527996034|FG003|Overall Study|Lost to Follow-up|1|||
146407227|NCT00552617|527996035|FG004|Overall Study|Lost to Follow-up|0|||
146407228|NCT00552617|527996036|FG005|Overall Study|Lost to Follow-up|2|||
146407229|NCT00552617|527996037|FG006|Overall Study|Lost to Follow-up|0|||
146407230|NCT00552617|527996038|FG007|Overall Study|Lost to Follow-up|0|||
146407231|NCT00552617|527996039|FG008|Overall Study|Lost to Follow-up|2|||
146407232|NCT00552617|527996040|FG009|Overall Study|Lost to Follow-up|0|||
146407233|NCT04651218|527996041|FG000|Overall Study|Withdrawal by Subject|0|||
146407234|NCT04651218|527996042|FG001|Overall Study|Withdrawal by Subject|2|||
146407235|NCT02476851|527996043|FG000|Overall Study|Protocol Violation|1|||
146407236|NCT02476851|527996044|FG001|Overall Study|Protocol Violation|1|||
146407237|NCT01399125|527996047|FG000|Overall Study|Adverse Event|32|||
146407238|NCT01399125|527996048|FG001|Overall Study|Adverse Event|30|||
146407239|NCT01399125|527996047|FG000|Overall Study|Abnormal Lab values|0|||
146407240|NCT01399125|527996048|FG001|Overall Study|Abnormal Lab values|1|||
146407241|NCT01399125|527996047|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146407242|NCT01399125|527996048|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146407243|NCT01399125|527996047|FG000|Overall Study|Withdrawal by Subject|5|||
146407244|NCT01399125|527996048|FG001|Overall Study|Withdrawal by Subject|8|||
146407245|NCT01399125|527996047|FG000|Overall Study|Lost to Follow-up|2|||
146407246|NCT01399125|527996048|FG001|Overall Study|Lost to Follow-up|3|||
146407247|NCT01399125|527996047|FG000|Overall Study|Administrative Problems|7|||
146407248|NCT01399125|527996048|FG001|Overall Study|Administrative Problems|11|||
146407249|NCT01399125|527996047|FG000|Overall Study|Death|0|||
146407250|NCT01399125|527996048|FG001|Overall Study|Death|1|||
146407251|NCT01399125|527996047|FG000|Overall Study|Protocol Deviation|5|||
146407252|NCT01399125|527996048|FG001|Overall Study|Protocol Deviation|2|||
146407253|NCT03836729|527996063|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
146407254|NCT00948025|527996064|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
146407255|NCT00948025|527996065|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
146407256|NCT00948025|527996064|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
146407257|NCT00948025|527996065|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
146407258|NCT00948025|527996064|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
146407259|NCT00948025|527996065|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
146407260|NCT00763269|527996066|FG000|Overall Study|Lost to Follow-up|12|||
146407261|NCT00763269|527996067|FG001|Overall Study|Lost to Follow-up|13|||
146407262|NCT03959137|527996071|FG000|Overall Study|Protocol Violation|6|||
146407263|NCT00683904|527996073|FG000|Dose Level 1|Disease progression|2|||
146407264|NCT00683904|527996074|FG001|Dose Level 1|Disease progression|0|||
146407265|NCT00683904|527996073|FG000|Dose Level 1|Adverse Event|1|||
146063335|NCT04973449|526751299|FG001|Overall Study|Lost to Follow-up|16|||
146063336|NCT04973449|526751300|FG002|Overall Study|Lost to Follow-up|16|||
146063337|NCT04973449|526751301|FG003|Overall Study|Lost to Follow-up|13|||
146063338|NCT04973449|526751302|FG004|Overall Study|Lost to Follow-up|5|||
146063339|NCT04973449|526751303|FG005|Overall Study|Lost to Follow-up|6|||
146063340|NCT04973449|526751304|FG006|Overall Study|Lost to Follow-up|10|||
146063341|NCT04973449|526751305|FG007|Overall Study|Lost to Follow-up|6|||
146063342|NCT04973449|526751298|FG000|Overall Study|Death|1|||
146063343|NCT04973449|526751299|FG001|Overall Study|Death|0|||
146063344|NCT04973449|526751300|FG002|Overall Study|Death|0|||
146063345|NCT04973449|526751301|FG003|Overall Study|Death|0|||
146063346|NCT04973449|526751302|FG004|Overall Study|Death|0|||
146063347|NCT04973449|526751303|FG005|Overall Study|Death|1|||
146063348|NCT04973449|526751304|FG006|Overall Study|Death|0|||
146407266|NCT00683904|527996074|FG001|Dose Level 1|Adverse Event|0|||
146407267|NCT00683904|527996073|FG000|Dose Level 2|Adverse Event|0|||
146407268|NCT00683904|527996074|FG001|Dose Level 2|Adverse Event|2|||
146407269|NCT01220128|527996075|FG000|Overall Study|Progressive disease|0|||
146407270|NCT01220128|527996076|FG001|Overall Study|Progressive disease|0|||
146407271|NCT01220128|527996077|FG002|Overall Study|Progressive disease|2|||
146407272|NCT01220128|527996078|FG003|Overall Study|Progressive disease|0|||
146407273|NCT01220128|527996079|FG004|Overall Study|Progressive disease|0|||
146407274|NCT01220128|527996080|FG005|Overall Study|Progressive disease|0|||
146407275|NCT01220128|527996081|FG006|Overall Study|Progressive disease|0|||
146407276|NCT01220128|527996075|FG000|Overall Study|Sponsor study termination|0|||
146407277|NCT01220128|527996076|FG001|Overall Study|Sponsor study termination|1|||
146407278|NCT01220128|527996077|FG002|Overall Study|Sponsor study termination|0|||
146407279|NCT01220128|527996078|FG003|Overall Study|Sponsor study termination|0|||
146407280|NCT01220128|527996079|FG004|Overall Study|Sponsor study termination|0|||
146407281|NCT01220128|527996080|FG005|Overall Study|Sponsor study termination|0|||
146407282|NCT01220128|527996081|FG006|Overall Study|Sponsor study termination|1|||
146407283|NCT01220128|527996075|FG000|Overall Study|Adverse event, serious fatal|2|||
146407284|NCT01220128|527996076|FG001|Overall Study|Adverse event, serious fatal|0|||
146407285|NCT01220128|527996077|FG002|Overall Study|Adverse event, serious fatal|0|||
146407286|NCT01220128|527996078|FG003|Overall Study|Adverse event, serious fatal|0|||
146407287|NCT01220128|527996079|FG004|Overall Study|Adverse event, serious fatal|0|||
146407288|NCT01220128|527996080|FG005|Overall Study|Adverse event, serious fatal|0|||
146407289|NCT01220128|527996081|FG006|Overall Study|Adverse event, serious fatal|1|||
146407290|NCT01220128|527996075|FG000|Overall Study|Adverse event, non-fatal|1|||
146407291|NCT01220128|527996076|FG001|Overall Study|Adverse event, non-fatal|0|||
146407292|NCT01220128|527996077|FG002|Overall Study|Adverse event, non-fatal|0|||
146407293|NCT01220128|527996078|FG003|Overall Study|Adverse event, non-fatal|0|||
146407294|NCT01220128|527996079|FG004|Overall Study|Adverse event, non-fatal|0|||
146407295|NCT01220128|527996080|FG005|Overall Study|Adverse event, non-fatal|0|||
146407296|NCT01220128|527996081|FG006|Overall Study|Adverse event, non-fatal|3|||
146407297|NCT01220128|527996075|FG000|Overall Study|Other|0|||
146063349|NCT04973449|526751305|FG007|Overall Study|Death|0|||
146063350|NCT04973449|526751298|FG000|Overall Study|Other|1|||
146063351|NCT04973449|526751299|FG001|Overall Study|Other|1|||
146063352|NCT04973449|526751300|FG002|Overall Study|Other|2|||
146063353|NCT04973449|526751301|FG003|Overall Study|Other|1|||
146063354|NCT04973449|526751302|FG004|Overall Study|Other|4|||
146063355|NCT04973449|526751303|FG005|Overall Study|Other|0|||
146063356|NCT04973449|526751304|FG006|Overall Study|Other|2|||
146063357|NCT04973449|526751305|FG007|Overall Study|Other|2|||
146063358|NCT00829426|526751306|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146063359|NCT00829426|526751307|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146063360|NCT03597347|526751311|FG000|Overall Study|Withdrawal by Subject|1|||
146063361|NCT03597347|526751312|FG001|Overall Study|Withdrawal by Subject|1|||
146063362|NCT03597347|526751313|FG002|Overall Study|Withdrawal by Subject|0|||
146063363|NCT03597347|526751311|FG000|Overall Study|Withdrawal due to Covid-19|3|||
146063364|NCT03597347|526751312|FG001|Overall Study|Withdrawal due to Covid-19|0|||
146063365|NCT03597347|526751313|FG002|Overall Study|Withdrawal due to Covid-19|0|||
146063366|NCT03597347|526751311|FG000|Overall Study|Sponsor decision to terminate study|3|||
146063367|NCT03597347|526751312|FG001|Overall Study|Sponsor decision to terminate study|2|||
146063368|NCT03597347|526751313|FG002|Overall Study|Sponsor decision to terminate study|4|||
146063369|NCT04606134|526751314|FG000|Overall Study|Adverse Event|0|||
146063370|NCT04606134|526751315|FG001|Overall Study|Adverse Event|1|||
146407298|NCT01220128|527996076|FG001|Overall Study|Other|0|||
146407299|NCT01220128|527996077|FG002|Overall Study|Other|1|||
146407300|NCT01220128|527996078|FG003|Overall Study|Other|0|||
146407301|NCT01220128|527996079|FG004|Overall Study|Other|0|||
146407302|NCT01220128|527996080|FG005|Overall Study|Other|0|||
146407303|NCT01220128|527996081|FG006|Overall Study|Other|0|||
146407304|NCT01220128|527996075|FG000|Overall Study|Consent withdrawn by subject|1|||
146407305|NCT01220128|527996076|FG001|Overall Study|Consent withdrawn by subject|0|||
146407306|NCT01220128|527996077|FG002|Overall Study|Consent withdrawn by subject|0|||
146407307|NCT01220128|527996078|FG003|Overall Study|Consent withdrawn by subject|0|||
146407308|NCT01220128|527996079|FG004|Overall Study|Consent withdrawn by subject|0|||
146407309|NCT01220128|527996080|FG005|Overall Study|Consent withdrawn by subject|0|||
146407310|NCT01220128|527996081|FG006|Overall Study|Consent withdrawn by subject|0|||
146407311|NCT02392559|527996082|FG000|Overall Study|Withdrawal by Subject|0|||
146407312|NCT02392559|527996083|FG001|Overall Study|Withdrawal by Subject|1|||
146407313|NCT00314262|527996088|FG000|Overall Study|Adverse Event|2|||
146407314|NCT00314262|527996088|FG000|Overall Study|Withdrawal by Subject|2|||
146407315|NCT00314262|527996088|FG000|Overall Study|Physician Decision|1|||
146407316|NCT00828516|527996095|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
146407317|NCT01556165|527996096|FG000|Overall Study|Adverse Event|5|||
146407318|NCT01556165|527996097|FG001|Overall Study|Adverse Event|3|||
146407319|NCT01556165|527996096|FG000|Overall Study|Protocol Violation|0|||
146407320|NCT01556165|527996097|FG001|Overall Study|Protocol Violation|3|||
146407321|NCT01556165|527996096|FG000|Overall Study|Withdrawal of Consent|7|||
146407322|NCT01556165|527996097|FG001|Overall Study|Withdrawal of Consent|1|||
146407323|NCT01640964|527996103|FG000|Overall Study|Lost to Follow-up|0|||
146407324|NCT01640964|527996104|FG001|Overall Study|Lost to Follow-up|0|||
146407325|NCT01640964|527996105|FG002|Overall Study|Lost to Follow-up|1|||
146407326|NCT01640964|527996103|FG000|Overall Study|Protocol Deviation|1|||
146407327|NCT01640964|527996104|FG001|Overall Study|Protocol Deviation|1|||
146407328|NCT01640964|527996105|FG002|Overall Study|Protocol Deviation|2|||
146407329|NCT02787746|527996106|FG000|Overall Study|Adverse Event|42|||
146407330|NCT02787746|527996106|FG000|Overall Study|Withdrawal by Subject|65|||
146407331|NCT02787746|527996106|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
146407332|NCT04822701|527996109|FG000|Overall Study|Not treated|2|||
146407333|NCT04822701|527996110|FG001|Overall Study|Not treated|0|||
146407334|NCT04822701|527996109|FG000|Overall Study|Lost to Follow-up|1|||
146407335|NCT04822701|527996110|FG001|Overall Study|Lost to Follow-up|0|||
146407336|NCT04822701|527996109|FG000|Overall Study|Withdrawal by Subject|1|||
146407337|NCT04822701|527996110|FG001|Overall Study|Withdrawal by Subject|0|||
146407338|NCT01408576|527997948|FG000|Overall Study|Lack of Efficacy|17|||
146407339|NCT01408576|527997949|FG001|Overall Study|Lack of Efficacy|30|||
146407340|NCT01408576|527997950|FG002|Overall Study|Lack of Efficacy|48|||
146407341|NCT01408576|527997948|FG000|Overall Study|Protocol Violation|1|||
146407342|NCT01408576|527997949|FG001|Overall Study|Protocol Violation|2|||
146407343|NCT01408576|527997950|FG002|Overall Study|Protocol Violation|2|||
146407344|NCT01408576|527997948|FG000|Overall Study|Lost to Follow-up|10|||
146407345|NCT01408576|527997949|FG001|Overall Study|Lost to Follow-up|9|||
146407346|NCT01408576|527997950|FG002|Overall Study|Lost to Follow-up|17|||
146407347|NCT01408576|527997948|FG000|Overall Study|Withdrawal by Subject|34|||
146407348|NCT01408576|527997949|FG001|Overall Study|Withdrawal by Subject|60|||
146407349|NCT01408576|527997950|FG002|Overall Study|Withdrawal by Subject|66|||
146407350|NCT01408576|527997948|FG000|Overall Study|Sponsor terminated study|89|||
146407351|NCT01408576|527997949|FG001|Overall Study|Sponsor terminated study|333|||
146407352|NCT01408576|527997950|FG002|Overall Study|Sponsor terminated study|330|||
146407353|NCT01408576|527997948|FG000|Overall Study|AE, serious fatal|4|||
146407354|NCT01408576|527997949|FG001|Overall Study|AE, serious fatal|4|||
146407355|NCT01408576|527997950|FG002|Overall Study|AE, serious fatal|1|||
146407356|NCT01408576|527997948|FG000|Overall Study|SAE, non-fatal|11|||
146407357|NCT01408576|527997949|FG001|Overall Study|SAE, non-fatal|23|||
146407358|NCT01408576|527997950|FG002|Overall Study|SAE, non-fatal|14|||
146407359|NCT01408576|527997948|FG000|Overall Study|AE, non-serious non-fatal|12|||
146407360|NCT01408576|527997949|FG001|Overall Study|AE, non-serious non-fatal|19|||
146407361|NCT01408576|527997950|FG002|Overall Study|AE, non-serious non-fatal|11|||
146407362|NCT01408576|527997948|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146407363|NCT01408576|527997949|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146407364|NCT01408576|527997950|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146407365|NCT01408576|527997948|FG000|Overall Study|AE, unknown type|0|||
146407366|NCT01408576|527997949|FG001|Overall Study|AE, unknown type|1|||
146063371|NCT00107653|526751316|FG000|Overall Study|Adverse Event|24|||
146063372|NCT00107653|526751317|FG001|Overall Study|Adverse Event|43|||
146063373|NCT00107653|526751316|FG000|Overall Study|Insufficient Therapeutic Response|25|||
146063374|NCT00107653|526751317|FG001|Overall Study|Insufficient Therapeutic Response|11|||
146407367|NCT01408576|527997950|FG002|Overall Study|AE, unknown type|0|||
146407368|NCT01408576|527997948|FG000|Overall Study|Other|10|||
146407369|NCT01408576|527997949|FG001|Overall Study|Other|16|||
146407370|NCT01408576|527997950|FG002|Overall Study|Other|18|||
146407371|NCT00802529|527997951|FG000|Overall Study|Lost to Follow-up|0|||
146407372|NCT00802529|527997952|FG001|Overall Study|Lost to Follow-up|1|||
146407373|NCT00337129|527997953|FG000|Overall Study|Adverse Event|4|||
146407374|NCT00337129|527997953|FG000|Overall Study|Withdrawal by Subject|1|||
146407375|NCT00337129|527997953|FG000|Overall Study|Lack of Efficacy|32|||
146063375|NCT00107653|526751316|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146171746|NCT00988221|527143222|FG000|Part I|Adverse Event|0|||
146407376|NCT00337129|527997953|FG000|Overall Study|Death|2|||
146407377|NCT00337129|527997953|FG000|Overall Study|not protocol specified|1|||
146407378|NCT00647426|527997954|FG000|Overall Study|Withdrawal by Subject|2|||
146407379|NCT01467570|527997956|FG000|Overall Study|Lost to Follow-up|8|||
146407380|NCT01467570|527997957|FG001|Overall Study|Lost to Follow-up|9|||
146407381|NCT02626182|527997958|FG000|Overall Study|Adverse Event|2|||
146407382|NCT02626182|527997959|FG001|Overall Study|Adverse Event|0|||
146407383|NCT01084603|527997962|FG000|Baseline|Withdrawal by Subject|2|||
146407384|NCT01084603|527997962|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
146407385|NCT01084603|527997962|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
146407386|NCT01084603|527997962|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
146407387|NCT01084603|527997962|FG000|Washout Period 4|Adverse Event|1|||
146407388|NCT03372369|527997968|FG000|Qualification Period|Withdrawal by Subject|16|||
146407389|NCT03372369|527997969|FG001|Qualification Period|Withdrawal by Subject|13|||
146407390|NCT03372369|527997968|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
146407391|NCT03372369|527997969|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
146407392|NCT03372369|527997968|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
146407393|NCT03372369|527997969|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
146407394|NCT02239601|527997970|FG000|Overall Study|Withdrawal by Subject|3|||
146407395|NCT02239601|527997971|FG001|Overall Study|Withdrawal by Subject|4|||
146407396|NCT02239601|527997970|FG000|Overall Study|Protocol Violation|4|||
146407397|NCT02239601|527997971|FG001|Overall Study|Protocol Violation|2|||
146407398|NCT01508325|527997972|FG000|Overall Study|Withdrawal by Subject|8|||
146407399|NCT01508325|527997973|FG001|Overall Study|Withdrawal by Subject|9|||
146407400|NCT01508325|527997972|FG000|Overall Study|Protocol Violation|0|||
146407401|NCT01508325|527997973|FG001|Overall Study|Protocol Violation|3|||
146407402|NCT01508325|527997972|FG000|Overall Study|Physician Decision|2|||
146407403|NCT01508325|527997973|FG001|Overall Study|Physician Decision|1|||
146407404|NCT01508325|527997972|FG000|Overall Study|Adverse Event|1|||
146407405|NCT01508325|527997973|FG001|Overall Study|Adverse Event|0|||
146407406|NCT01508325|527997972|FG000|Overall Study|Lost to Follow-up|5|||
146407407|NCT01508325|527997973|FG001|Overall Study|Lost to Follow-up|6|||
146407408|NCT01508325|527997972|FG000|Overall Study|Other|2|||
146407409|NCT01508325|527997973|FG001|Overall Study|Other|2|||
146407410|NCT01392170|527997974|FG000|Overall Study|Withdrawal by Subject|1|||
146407411|NCT01392170|527997974|FG000|Overall Study|Ineligible|1|||
146407412|NCT03174925|527997982|FG000|Overall Study|Elastographic images not retrievable|2|||
146407413|NCT03174925|527997982|FG000|Overall Study|Elastography image not interpretable|1|||
146407414|NCT01791127|527997985|FG000|Overall Study|Death|356|||
146407415|NCT01791127|527997985|FG000|Overall Study|Patient has withdrawn from study|293|||
146407416|NCT01791127|527997985|FG000|Overall Study|Lost to Follow-up|42|||
146407417|NCT01791127|527997985|FG000|Overall Study|All Siello leads are explanted|31|||
146407418|NCT01791127|527997985|FG000|Overall Study|Completion of 30 day safety registry|1|||
146407419|NCT01791127|527997985|FG000|Overall Study|Study terminated for EP Passion|749|||
146407420|NCT00589693|527997991|FG000|Overall Study|randomized in error|12|||
146407421|NCT00589693|527997992|FG001|Overall Study|randomized in error|6|||
146407422|NCT00589693|527997991|FG000|Overall Study|Adverse Event|4|||
146407423|NCT00589693|527997992|FG001|Overall Study|Adverse Event|4|||
146407424|NCT00589693|527997991|FG000|Overall Study|Death|26|||
146407425|NCT00589693|527997992|FG001|Overall Study|Death|16|||
146407426|NCT00589693|527997991|FG000|Overall Study|Lack of Efficacy|0|||
146407427|NCT00589693|527997992|FG001|Overall Study|Lack of Efficacy|1|||
146407428|NCT00589693|527997991|FG000|Overall Study|Lost to Follow-up|1|||
146407429|NCT00589693|527997992|FG001|Overall Study|Lost to Follow-up|0|||
146407430|NCT00589693|527997991|FG000|Overall Study|Physician Decision|0|||
146407431|NCT00589693|527997992|FG001|Overall Study|Physician Decision|1|||
146407432|NCT00589693|527997991|FG000|Overall Study|Protocol Violation|1|||
146407433|NCT00589693|527997992|FG001|Overall Study|Protocol Violation|1|||
146407434|NCT03231709|527997993|FG000|Treatment Period 1|Reason not Specified|0|||
146407435|NCT03231709|527997994|FG001|Treatment Period 1|Reason not Specified|1|||
146407436|NCT03231709|527997993|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
146407437|NCT03231709|527997994|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
146407438|NCT02609178|527997995|FG000|First Crown|Withdrawal by Subject|0|||
146407439|NCT02609178|527997996|FG001|First Crown|Withdrawal by Subject|0|||
146407440|NCT02609178|527997997|FG002|First Crown|Withdrawal by Subject|1|||
146407441|NCT02609178|527997998|FG003|First Crown|Withdrawal by Subject|1|||
146407442|NCT02609178|527997999|FG004|First Crown|Withdrawal by Subject|0|||
146407443|NCT02609178|527998000|FG005|First Crown|Withdrawal by Subject|0|||
146407444|NCT01128153|527998001|FG000|Overall Study|Adverse Event|1|||
146407445|NCT01128153|527998002|FG001|Overall Study|Adverse Event|3|||
146407446|NCT01128153|527998001|FG000|Overall Study|Condition under investigation worsened|8|||
146407447|NCT01128153|527998002|FG001|Overall Study|Condition under investigation worsened|7|||
146407448|NCT01128153|527998001|FG000|Overall Study|Withdrawal by Subject|2|||
146407449|NCT01128153|527998002|FG001|Overall Study|Withdrawal by Subject|3|||
146407450|NCT01128153|527998001|FG000|Overall Study|Incorrect enrolment to study|2|||
146407451|NCT01128153|527998002|FG001|Overall Study|Incorrect enrolment to study|1|||
146407452|NCT01128153|527998001|FG000|Overall Study|Protocol Violation|2|||
146407453|NCT01128153|527998002|FG001|Overall Study|Protocol Violation|0|||
146407454|NCT01128153|527998001|FG000|Overall Study|Developed discontinuation criteria|1|||
145890926|NCT01207440|526107570|FG000|Overall Study|Lost to Follow-up|0|||
146407455|NCT01128153|527998002|FG001|Overall Study|Developed discontinuation criteria|1|||
146407456|NCT01954082|527998003|FG000|Overall Study|Study Suspension|42|||
146407457|NCT01954082|527998004|FG001|Overall Study|Study Suspension|36|||
146407458|NCT01954082|527998003|FG000|Overall Study|Adverse Event|10|||
146063376|NCT00107653|526751317|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146063377|NCT00107653|526751316|FG000|Overall Study|Protocol Violation|1|||
146063378|NCT00107653|526751317|FG001|Overall Study|Protocol Violation|0|||
146063379|NCT00107653|526751316|FG000|Overall Study|Withdrawal by Subject|12|||
146063380|NCT00107653|526751317|FG001|Overall Study|Withdrawal by Subject|13|||
146063381|NCT00107653|526751316|FG000|Overall Study|Lost to Follow-up|13|||
146063382|NCT00107653|526751317|FG001|Overall Study|Lost to Follow-up|5|||
146063383|NCT00107653|526751316|FG000|Overall Study|Administrative Reasons|3|||
146063384|NCT00107653|526751317|FG001|Overall Study|Administrative Reasons|3|||
146063385|NCT02018562|526751323|FG000|Overall Study|Withdrawal by Subject|2|||
146063386|NCT02018562|526751324|FG001|Overall Study|Withdrawal by Subject|0|||
146063387|NCT02018562|526751323|FG000|Overall Study|Discharged prior to study completion|1|||
146407459|NCT01954082|527998004|FG001|Overall Study|Adverse Event|4|||
146407460|NCT01954082|527998003|FG000|Overall Study|Intolerance|0|||
146407461|NCT01954082|527998004|FG001|Overall Study|Intolerance|1|||
146407462|NCT01954082|527998003|FG000|Overall Study|Non-compliance|6|||
146407463|NCT01954082|527998004|FG001|Overall Study|Non-compliance|4|||
146407464|NCT01954082|527998003|FG000|Overall Study|Physician Decision|2|||
146407465|NCT01954082|527998004|FG001|Overall Study|Physician Decision|0|||
146407466|NCT01954082|527998003|FG000|Overall Study|Parent Decision|1|||
146407467|NCT01954082|527998004|FG001|Overall Study|Parent Decision|0|||
146407468|NCT01954082|527998003|FG000|Overall Study|Withdrawal by Subject|0|||
146407469|NCT01954082|527998004|FG001|Overall Study|Withdrawal by Subject|1|||
146407470|NCT01954082|527998003|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
146407471|NCT01954082|527998004|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
146407472|NCT01954082|527998003|FG000|Overall Study|Redirection of Care|0|||
146407473|NCT01954082|527998004|FG001|Overall Study|Redirection of Care|2|||
146407474|NCT01954082|527998003|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
146407475|NCT01954082|527998004|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
146407476|NCT01954082|527998003|FG000|Overall Study|Comfort Care|0|||
146407477|NCT01954082|527998004|FG001|Overall Study|Comfort Care|1|||
146407478|NCT01954082|527998003|FG000|Overall Study|Infant Moved|0|||
146407479|NCT01954082|527998004|FG001|Overall Study|Infant Moved|1|||
146407480|NCT01954082|527998003|FG000|Overall Study|Randomized not Treated|4|||
146407481|NCT01954082|527998004|FG001|Overall Study|Randomized not Treated|2|||
146407482|NCT02419469|527998005|FG000|Overall Study|Withdrawal by Subject|1|||
146407483|NCT01682512|527998006|FG000|Overall Study|Adverse Event|6|||
146407484|NCT01682512|527998007|FG001|Overall Study|Adverse Event|5|||
146407485|NCT01682512|527998008|FG002|Overall Study|Adverse Event|2|||
146407486|NCT01682512|527998006|FG000|Overall Study|Withdrawal by Subject|2|||
146407487|NCT01682512|527998007|FG001|Overall Study|Withdrawal by Subject|6|||
146407488|NCT01682512|527998008|FG002|Overall Study|Withdrawal by Subject|3|||
146407489|NCT01682512|527998006|FG000|Overall Study|Physician Decision|0|||
146407490|NCT01682512|527998007|FG001|Overall Study|Physician Decision|2|||
146407491|NCT01682512|527998008|FG002|Overall Study|Physician Decision|0|||
146407492|NCT01682512|527998006|FG000|Overall Study|Study terminated by sponsor|46|||
146407493|NCT01682512|527998007|FG001|Overall Study|Study terminated by sponsor|43|||
146407494|NCT01682512|527998008|FG002|Overall Study|Study terminated by sponsor|0|||
146407495|NCT01682512|527998006|FG000|Overall Study|Lost to Follow-up|3|||
146407496|NCT01682512|527998007|FG001|Overall Study|Lost to Follow-up|0|||
146407497|NCT01682512|527998008|FG002|Overall Study|Lost to Follow-up|2|||
146407498|NCT01682512|527998006|FG000|Overall Study|Protocol Violation|2|||
146407499|NCT01682512|527998007|FG001|Overall Study|Protocol Violation|3|||
146407500|NCT01682512|527998008|FG002|Overall Study|Protocol Violation|2|||
146407501|NCT01682512|527998006|FG000|Overall Study|Primary lack of efficacy|10|||
146063388|NCT02018562|526751324|FG001|Overall Study|Discharged prior to study completion|0|||
146407502|NCT01682512|527998007|FG001|Overall Study|Primary lack of efficacy|7|||
146063389|NCT04050553|526751334|FG000|Period 1|Physician Decision|2|||
146407503|NCT01682512|527998008|FG002|Overall Study|Primary lack of efficacy|7|||
146407504|NCT01682512|527998006|FG000|Overall Study|Secondary lack of efficacy|1|||
146407505|NCT01682512|527998007|FG001|Overall Study|Secondary lack of efficacy|1|||
146063390|NCT04050553|526751335|FG001|Period 1|Physician Decision|2|||
146407506|NCT01682512|527998008|FG002|Overall Study|Secondary lack of efficacy|0|||
146407507|NCT01682512|527998006|FG000|Overall Study|Other than stated above|2|||
146407508|NCT01682512|527998007|FG001|Overall Study|Other than stated above|4|||
146407509|NCT01682512|527998008|FG002|Overall Study|Other than stated above|2|||
146407510|NCT01377233|527998009|FG000|Open-label|Adverse Event|1|||
146407511|NCT01377233|527998010|FG001|Open-label|Adverse Event|0|||
146407512|NCT01377233|527998011|FG002|Open-label|Adverse Event|0|||
146407513|NCT01377233|527998012|FG003|Open-label|Adverse Event|0|||
146407514|NCT01377233|527998013|FG004|Open-label|Adverse Event|0|||
146063391|NCT04050553|526751334|FG000|Period 1|Adverse Event|1|||
146407515|NCT01377233|527998009|FG000|Open-label|Withdrawal by Subject|3|||
146407516|NCT01377233|527998010|FG001|Open-label|Withdrawal by Subject|0|||
146407517|NCT01377233|527998011|FG002|Open-label|Withdrawal by Subject|0|||
146407518|NCT01377233|527998012|FG003|Open-label|Withdrawal by Subject|0|||
146407519|NCT01377233|527998013|FG004|Open-label|Withdrawal by Subject|0|||
146407520|NCT01377233|527998009|FG000|Double-blind|Adverse Event|0|||
146407521|NCT01377233|527998010|FG001|Double-blind|Adverse Event|1|||
146407522|NCT01377233|527998011|FG002|Double-blind|Adverse Event|2|||
146407523|NCT01377233|527998012|FG003|Double-blind|Adverse Event|2|||
146407524|NCT01377233|527998013|FG004|Double-blind|Adverse Event|0|||
146407525|NCT01377233|527998009|FG000|Double-blind|Protocol Violation|0|||
146407526|NCT01377233|527998010|FG001|Double-blind|Protocol Violation|0|||
146407527|NCT01377233|527998011|FG002|Double-blind|Protocol Violation|0|||
146407528|NCT01377233|527998012|FG003|Double-blind|Protocol Violation|0|||
146407529|NCT01377233|527998013|FG004|Double-blind|Protocol Violation|1|||
146407530|NCT01377233|527998009|FG000|Double-blind|Withdrawal by Subject|0|||
146407531|NCT01377233|527998010|FG001|Double-blind|Withdrawal by Subject|0|||
146407532|NCT01377233|527998011|FG002|Double-blind|Withdrawal by Subject|0|||
146407533|NCT01377233|527998012|FG003|Double-blind|Withdrawal by Subject|1|||
146407534|NCT01377233|527998013|FG004|Double-blind|Withdrawal by Subject|0|||
146407535|NCT01377233|527998009|FG000|Double-blind|Administrative or other|0|||
146407536|NCT01377233|527998010|FG001|Double-blind|Administrative or other|0|||
146407537|NCT01377233|527998011|FG002|Double-blind|Administrative or other|0|||
146407538|NCT01377233|527998012|FG003|Double-blind|Administrative or other|1|||
146407539|NCT01377233|527998013|FG004|Double-blind|Administrative or other|1|||
146407540|NCT01785875|527998014|FG000|Overall Study|Withdrawal by Subject|41|||
146407541|NCT01785875|527998015|FG001|Overall Study|Withdrawal by Subject|34|||
146407542|NCT01785875|527998016|FG002|Overall Study|Withdrawal by Subject|36|||
146407543|NCT01785875|527998014|FG000|Overall Study|Lost to Follow-up|19|||
146407544|NCT01785875|527998015|FG001|Overall Study|Lost to Follow-up|22|||
146407545|NCT01785875|527998016|FG002|Overall Study|Lost to Follow-up|6|||
146407546|NCT01785875|527998014|FG000|Overall Study|Death|27|||
146407547|NCT01785875|527998015|FG001|Overall Study|Death|16|||
146407548|NCT01785875|527998016|FG002|Overall Study|Death|7|||
146407549|NCT01785875|527998014|FG000|Overall Study|Sponsor Decision|0|||
146407550|NCT01785875|527998015|FG001|Overall Study|Sponsor Decision|2|||
146407551|NCT01785875|527998016|FG002|Overall Study|Sponsor Decision|0|||
146407552|NCT01785875|527998014|FG000|Overall Study|Protocol Specified Criteria|207|||
146407553|NCT01785875|527998015|FG001|Overall Study|Protocol Specified Criteria|214|||
146407554|NCT01785875|527998016|FG002|Overall Study|Protocol Specified Criteria|55|||
146407555|NCT01785875|527998014|FG000|Overall Study|Missing|0|||
146407556|NCT01785875|527998015|FG001|Overall Study|Missing|1|||
146407557|NCT01785875|527998016|FG002|Overall Study|Missing|3|||
146407558|NCT00417027|527998019|FG000|Overall Study|Protocol Violation|0|||
146407559|NCT00417027|527998020|FG001|Overall Study|Protocol Violation|5|||
146407560|NCT00417027|527998021|FG002|Overall Study|Protocol Violation|5|||
146407561|NCT03137082|527998022|FG000|Overall Study|Withdrawal by Subject|1|||
146407562|NCT03137082|527998023|FG001|Overall Study|Withdrawal by Subject|1|||
146407563|NCT03137082|527998022|FG000|Overall Study|Lost to Follow-up|1|||
146407564|NCT03137082|527998023|FG001|Overall Study|Lost to Follow-up|0|||
146407565|NCT00707174|527998024|FG000|Overall Study|Adverse Event|1|||
146407566|NCT00707174|527998025|FG001|Overall Study|Adverse Event|6|||
146407567|NCT00707174|527998024|FG000|Overall Study|Withdrawal by Subject|4|||
146407568|NCT00707174|527998025|FG001|Overall Study|Withdrawal by Subject|1|||
146407569|NCT00544557|527998026|FG000|Overall Study|Adverse Event|140|||
146407570|NCT00544557|527998026|FG000|Overall Study|Lack of Efficacy|196|||
146407571|NCT00544557|527998026|FG000|Overall Study|Other|98|||
146407572|NCT04057118|527998027|FG000|Overall Study|Adverse Event|1|||
146407573|NCT04057118|527998028|FG001|Overall Study|Adverse Event|0|||
146407574|NCT04057118|527998029|FG002|Overall Study|Adverse Event|1|||
146407575|NCT04057118|527998030|FG003|Overall Study|Adverse Event|1|||
146407576|NCT04057118|527998027|FG000|Overall Study|Physician Decision|0|||
146407577|NCT04057118|527998028|FG001|Overall Study|Physician Decision|0|||
146407578|NCT04057118|527998029|FG002|Overall Study|Physician Decision|1|||
146407579|NCT04057118|527998030|FG003|Overall Study|Physician Decision|1|||
146407580|NCT04057118|527998027|FG000|Overall Study|Withdrawal by Subject|2|||
146407581|NCT04057118|527998028|FG001|Overall Study|Withdrawal by Subject|2|||
146407582|NCT04057118|527998029|FG002|Overall Study|Withdrawal by Subject|0|||
146407583|NCT04057118|527998030|FG003|Overall Study|Withdrawal by Subject|2|||
146407584|NCT04057118|527998027|FG000|Overall Study|Not Specific|0|||
146407585|NCT04057118|527998028|FG001|Overall Study|Not Specific|0|||
146407586|NCT04057118|527998029|FG002|Overall Study|Not Specific|1|||
146407587|NCT04057118|527998030|FG003|Overall Study|Not Specific|1|||
146407588|NCT04333199|527998038|FG000|Evaluated Patients|Lost to Follow-up|0|||
146407589|NCT04333199|527998039|FG001|Evaluated Patients|Lost to Follow-up|1|||
146407590|NCT04333199|527998040|FG002|Evaluated Patients|Lost to Follow-up|2|||
146407591|NCT00810615|527998046|FG000|Overall Study|Withdrawal by Subject|1|||
146407592|NCT00810615|527998047|FG001|Overall Study|Withdrawal by Subject|1|||
146407593|NCT02567266|527998048|FG000|Overall Study|Withdrawal by Subject|10|||
146407594|NCT02567266|527998049|FG001|Overall Study|Withdrawal by Subject|7|||
146407595|NCT02567266|527998050|FG002|Overall Study|Withdrawal by Subject|6|||
146407596|NCT02567266|527998048|FG000|Overall Study|Lost to Follow-up|13|||
146407597|NCT02567266|527998049|FG001|Overall Study|Lost to Follow-up|8|||
146407598|NCT02567266|527998050|FG002|Overall Study|Lost to Follow-up|10|||
146407599|NCT02702271|527998054|FG000|Overall Study|Death|36|||
146407600|NCT02702271|527998055|FG001|Overall Study|Death|7|||
146407601|NCT02702271|527998054|FG000|Overall Study|Lost to Follow-up|12|||
146407602|NCT02702271|527998055|FG001|Overall Study|Lost to Follow-up|0|||
146407603|NCT02702271|527998054|FG000|Overall Study|Withdrawal by Subject|8|||
146407604|NCT02702271|527998055|FG001|Overall Study|Withdrawal by Subject|1|||
146407605|NCT02702271|527998054|FG000|Overall Study|Physician Decision|2|||
146407606|NCT02702271|527998055|FG001|Overall Study|Physician Decision|0|||
146407607|NCT02702271|527998054|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
146407608|NCT02702271|527998055|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
146407609|NCT03091400|527998056|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
146407610|NCT03091400|527998057|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
146407611|NCT05789420|527998058|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
146407612|NCT05789420|527998058|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
146407613|NCT05473247|527998059|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
146407614|NCT02340078|527998065|FG000|Overall Study|Protocol Violation|1|||
146407615|NCT01831596|527998066|FG000|Overall Study|Other|8|||
146407616|NCT00446134|527998067|FG000|Overall Study|Adverse Event|7|||
146407617|NCT00446134|527998068|FG001|Overall Study|Adverse Event|17|||
146407618|NCT00446134|527998069|FG002|Overall Study|Adverse Event|13|||
146407619|NCT00446134|527998070|FG003|Overall Study|Adverse Event|18|||
146407620|NCT00446134|527998067|FG000|Overall Study|Lack of Efficacy|19|||
146407621|NCT00446134|527998068|FG001|Overall Study|Lack of Efficacy|19|||
146407622|NCT00446134|527998069|FG002|Overall Study|Lack of Efficacy|24|||
146407623|NCT00446134|527998070|FG003|Overall Study|Lack of Efficacy|19|||
146407624|NCT00446134|527998067|FG000|Overall Study|Protocol Violation|0|||
146407625|NCT00446134|527998068|FG001|Overall Study|Protocol Violation|2|||
146063392|NCT04050553|526751335|FG001|Period 1|Adverse Event|1|||
146063393|NCT04050553|526751334|FG000|Period 1|Withdrawal by Subject|0|||
146063394|NCT04050553|526751335|FG001|Period 1|Withdrawal by Subject|1|||
146063395|NCT04050553|526751334|FG000|Wash-out|Adverse Event|0|||
146063396|NCT04050553|526751335|FG001|Wash-out|Adverse Event|1|||
146063397|NCT04050553|526751334|FG000|Wash-out|Withdrawal by Subject|0|||
146063398|NCT04050553|526751335|FG001|Wash-out|Withdrawal by Subject|1|||
146063399|NCT05430854|526751336|FG000|Overall Study|Trial terminated by Sponsor|39|||
146063400|NCT05430854|526751337|FG001|Overall Study|Trial terminated by Sponsor|50|||
146063401|NCT05430854|526751338|FG002|Overall Study|Trial terminated by Sponsor|46|||
146063402|NCT05430854|526751336|FG000|Overall Study|Withdrawal by Subject|0|||
146063403|NCT05430854|526751337|FG001|Overall Study|Withdrawal by Subject|3|||
146063404|NCT05430854|526751338|FG002|Overall Study|Withdrawal by Subject|0|||
146063405|NCT04314284|526751339|FG000|Overall Study|Withdrawal by Subject|4|||
146063406|NCT04314284|526751340|FG001|Overall Study|Withdrawal by Subject|7|||
146063407|NCT04314284|526751339|FG000|Overall Study|Consented but did not complete survey|0|||
146063408|NCT04314284|526751340|FG001|Overall Study|Consented but did not complete survey|6|||
146063409|NCT01652235|526751344|FG000|Overall Study|Death|9|||
146063410|NCT01652235|526751344|FG000|Overall Study|Lost to Follow-up|5|||
146063411|NCT01652235|526751344|FG000|Overall Study|Withdrawal by Subject|2|||
146063412|NCT02023086|526751345|FG000|Overall Study|Withdrawal by Subject|2|||
146063413|NCT02023086|526751346|FG001|Overall Study|Withdrawal by Subject|0|||
146063414|NCT03589859|526751349|FG000|Overall Study|Withdrawal by Subject|0|||
146063415|NCT03589859|526751350|FG001|Overall Study|Withdrawal by Subject|6|||
146063416|NCT03472885|526751352|FG000|24-Week Treatment Period|Adverse Event|1|||
146063417|NCT02201953|526751353|FG000|Overall Study|Randomized but Never Treated|1|||
146063418|NCT02201953|526751354|FG001|Overall Study|Randomized but Never Treated|5|||
146063419|NCT02201953|526751353|FG000|Overall Study|Lack of Efficacy|9|||
146063420|NCT02201953|526751354|FG001|Overall Study|Lack of Efficacy|30|||
146063421|NCT02201953|526751353|FG000|Overall Study|Lost to Follow-up|8|||
146063422|NCT02201953|526751354|FG001|Overall Study|Lost to Follow-up|8|||
146407626|NCT00446134|527998069|FG002|Overall Study|Protocol Violation|1|||
146407627|NCT00446134|527998070|FG003|Overall Study|Protocol Violation|0|||
146407628|NCT00446134|527998067|FG000|Overall Study|Lost to Follow-up|1|||
146407629|NCT00446134|527998068|FG001|Overall Study|Lost to Follow-up|3|||
146407630|NCT00446134|527998069|FG002|Overall Study|Lost to Follow-up|1|||
146407631|NCT00446134|527998070|FG003|Overall Study|Lost to Follow-up|1|||
146407632|NCT00446134|527998067|FG000|Overall Study|Withdrawal by Subject|3|||
146407633|NCT00446134|527998068|FG001|Overall Study|Withdrawal by Subject|3|||
146063423|NCT02201953|526751353|FG000|Overall Study|Withdrew Consent|2|||
146063424|NCT02201953|526751354|FG001|Overall Study|Withdrew Consent|5|||
146063425|NCT02201953|526751353|FG000|Overall Study|Adverse Event|0|||
146407634|NCT00446134|527998069|FG002|Overall Study|Withdrawal by Subject|1|||
146407635|NCT00446134|527998070|FG003|Overall Study|Withdrawal by Subject|3|||
146407636|NCT00446134|527998067|FG000|Overall Study|Physician Decision|0|||
146063426|NCT02201953|526751354|FG001|Overall Study|Adverse Event|5|||
146063427|NCT02201953|526751353|FG000|Overall Study|Death|0|||
146063428|NCT02201953|526751354|FG001|Overall Study|Death|3|||
146063429|NCT02638220|526751355|FG000|Overall Study|Lost to Follow-up|6|||
146063430|NCT02638220|526751355|FG000|Overall Study|Withdrawal by Subject|3|||
146063431|NCT02638220|526751355|FG000|Overall Study|Physician Decision|1|||
146063432|NCT02638220|526751355|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
146063433|NCT01198795|526753827|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
146063434|NCT01198795|526753827|FG000|Overall Study|Withdrawal by Subject|17|||
146063435|NCT01198795|526753827|FG000|Overall Study|Lost to Follow-up|15|||
146063436|NCT01198795|526753827|FG000|Overall Study|Adverse Event|9|||
146063437|NCT01198795|526753827|FG000|Overall Study|Lack of Efficacy|5|||
146063438|NCT01198795|526753827|FG000|Overall Study|Protocol Violation|2|||
146063439|NCT01198795|526753827|FG000|Overall Study|Other Reason|4|||
146063440|NCT01472289|526753828|FG000|Overall Study|Death|2|||
146063441|NCT02435992|526753829|FG000|Overall Study|non compliance with protocol|2|||
146063442|NCT02435992|526753830|FG001|Overall Study|non compliance with protocol|0|||
146063443|NCT02435992|526753831|FG002|Overall Study|non compliance with protocol|1|||
146063444|NCT02435992|526753832|FG003|Overall Study|non compliance with protocol|0|||
146063445|NCT02435992|526753833|FG004|Overall Study|non compliance with protocol|0|||
146063446|NCT02435992|526753829|FG000|Overall Study|Adverse Event|11|||
146063447|NCT02435992|526753830|FG001|Overall Study|Adverse Event|6|||
146063448|NCT02435992|526753831|FG002|Overall Study|Adverse Event|12|||
146063449|NCT02435992|526753832|FG003|Overall Study|Adverse Event|0|||
146063450|NCT02435992|526753833|FG004|Overall Study|Adverse Event|0|||
146063451|NCT02435992|526753829|FG000|Overall Study|Lack of Efficacy|4|||
146063452|NCT02435992|526753830|FG001|Overall Study|Lack of Efficacy|10|||
146063453|NCT02435992|526753831|FG002|Overall Study|Lack of Efficacy|9|||
146063454|NCT02435992|526753832|FG003|Overall Study|Lack of Efficacy|0|||
146063455|NCT02435992|526753833|FG004|Overall Study|Lack of Efficacy|0|||
146063456|NCT02435992|526753829|FG000|Overall Study|Withdrawal by Subject|10|||
146063457|NCT02435992|526753830|FG001|Overall Study|Withdrawal by Subject|8|||
146063458|NCT02435992|526753831|FG002|Overall Study|Withdrawal by Subject|20|||
146063459|NCT02435992|526753832|FG003|Overall Study|Withdrawal by Subject|0|||
146063460|NCT02435992|526753833|FG004|Overall Study|Withdrawal by Subject|0|||
146063461|NCT02435992|526753829|FG000|Overall Study|Other Reason|1|||
146407637|NCT00446134|527998068|FG001|Overall Study|Physician Decision|0|||
146407638|NCT00446134|527998069|FG002|Overall Study|Physician Decision|0|||
146407639|NCT00446134|527998070|FG003|Overall Study|Physician Decision|2|||
146407640|NCT00446134|527998067|FG000|Overall Study|Adverse Event-Diarrhea|1|||
146407641|NCT00446134|527998068|FG001|Overall Study|Adverse Event-Diarrhea|1|||
146407642|NCT00446134|527998069|FG002|Overall Study|Adverse Event-Diarrhea|2|||
146407643|NCT00446134|527998070|FG003|Overall Study|Adverse Event-Diarrhea|0|||
146407644|NCT00446134|527998067|FG000|Overall Study|Reason Not Completed|3|||
146407645|NCT00446134|527998068|FG001|Overall Study|Reason Not Completed|0|||
146407646|NCT00446134|527998069|FG002|Overall Study|Reason Not Completed|1|||
146407647|NCT00446134|527998070|FG003|Overall Study|Reason Not Completed|2|||
146407648|NCT01311505|527998071|FG000|First Intervention Period|Protocol Violation|0|||
146407649|NCT01311505|527998072|FG001|First Intervention Period|Protocol Violation|1|||
146407650|NCT00567996|527998076|FG000|Overall Study|Adverse Event|18|||
146407651|NCT00567996|527998077|FG001|Overall Study|Adverse Event|16|||
146407652|NCT00567996|527998078|FG002|Overall Study|Adverse Event|13|||
146407653|NCT00567996|527998076|FG000|Overall Study|Protocol Deviation|9|||
146407654|NCT00567996|527998077|FG001|Overall Study|Protocol Deviation|11|||
146407655|NCT00567996|527998078|FG002|Overall Study|Protocol Deviation|13|||
146407656|NCT00567996|527998076|FG000|Overall Study|Withdrawal by Subject|8|||
146407657|NCT00567996|527998077|FG001|Overall Study|Withdrawal by Subject|12|||
146407658|NCT00567996|527998078|FG002|Overall Study|Withdrawal by Subject|22|||
146407659|NCT00567996|527998076|FG000|Overall Study|Abnormal Lab value(s)|2|||
146407660|NCT00567996|527998077|FG001|Overall Study|Abnormal Lab value(s)|1|||
146407661|NCT00567996|527998078|FG002|Overall Study|Abnormal Lab value(s)|2|||
146407662|NCT00567996|527998076|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146407663|NCT00567996|527998077|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146407664|NCT00567996|527998078|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146407665|NCT00567996|527998076|FG000|Overall Study|Lost to Follow-up|2|||
146407666|NCT00567996|527998077|FG001|Overall Study|Lost to Follow-up|5|||
146407667|NCT00567996|527998078|FG002|Overall Study|Lost to Follow-up|2|||
146407668|NCT00567996|527998076|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146407669|NCT00567996|527998077|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146407670|NCT00567996|527998078|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
146063462|NCT02435992|526753830|FG001|Overall Study|Other Reason|0|||
146407671|NCT00567996|527998076|FG000|Overall Study|Administrative problems|1|||
146407672|NCT00567996|527998077|FG001|Overall Study|Administrative problems|1|||
146063463|NCT02435992|526753831|FG002|Overall Study|Other Reason|0|||
146063464|NCT02435992|526753832|FG003|Overall Study|Other Reason|0|||
146063465|NCT02435992|526753833|FG004|Overall Study|Other Reason|0|||
146407673|NCT00567996|527998078|FG002|Overall Study|Administrative problems|0|||
146407674|NCT00567996|527998076|FG000|Overall Study|Death|1|||
146407675|NCT00567996|527998077|FG001|Overall Study|Death|0|||
146407676|NCT00567996|527998078|FG002|Overall Study|Death|2|||
146407677|NCT00567996|527998076|FG000|Overall Study|Patient's inability to use the device|0|||
146407678|NCT00567996|527998077|FG001|Overall Study|Patient's inability to use the device|1|||
146407679|NCT00567996|527998078|FG002|Overall Study|Patient's inability to use the device|0|||
146407680|NCT02956005|527998079|FG000|Overall Study|Not eligible|1|||
146407681|NCT02956005|527998079|FG000|Overall Study|Withdrawal by Subject|3|||
146407682|NCT02956005|527998079|FG000|Overall Study|Physician Decision|12|||
146407683|NCT02524665|527998082|FG000|Overall Study|Lost to Follow-up|1|||
146407684|NCT02602080|527998085|FG000|Overall Study|Protocol Violation|6|||
146407685|NCT02602080|527998086|FG001|Overall Study|Protocol Violation|1|||
146407686|NCT02602080|527998087|FG002|Overall Study|Protocol Violation|3|||
146407687|NCT01066039|527998093|FG000|Overall Study|Adverse Event|6|||
146407688|NCT01066039|527998093|FG000|Overall Study|Withdrawal by Subject|17|||
146063466|NCT02435992|526753829|FG000|Overall Study|Physician Decision|0|||
146407689|NCT01066039|527998093|FG000|Overall Study|Protocol Violation|2|||
146407690|NCT01066039|527998093|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
146407691|NCT01066039|527998093|FG000|Overall Study|Investigator's Request|1|||
146407692|NCT01066039|527998093|FG000|Overall Study|Dropout due to Insulin Administration|1|||
146407693|NCT01066039|527998093|FG000|Overall Study|Additional Antihypertensive Required|4|||
146407694|NCT01066039|527998093|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
146407695|NCT01066039|527998093|FG000|Overall Study|Failure to Control Blood Pressure|1|||
146407696|NCT01066039|527998093|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
146407697|NCT02574260|527998095|FG000|Overall Study|Disease Progression|1|||
146407698|NCT03022799|527998098|FG000|Overall Study|Adverse Event|0|||
146407699|NCT03022799|527998099|FG001|Overall Study|Adverse Event|0|||
146407700|NCT03022799|527998100|FG002|Overall Study|Adverse Event|0|||
146407701|NCT03022799|527998101|FG003|Overall Study|Adverse Event|0|||
146407702|NCT03022799|527998102|FG004|Overall Study|Adverse Event|0|||
146407703|NCT03022799|527998103|FG005|Overall Study|Adverse Event|0|||
146407704|NCT03022799|527998104|FG006|Overall Study|Adverse Event|0|||
146407705|NCT03022799|527998105|FG007|Overall Study|Adverse Event|0|||
146407706|NCT03022799|527998106|FG008|Overall Study|Adverse Event|0|||
146407707|NCT03022799|527998107|FG009|Overall Study|Adverse Event|1|||
146407708|NCT03022799|527998108|FG010|Overall Study|Adverse Event|1|||
146407709|NCT03022799|527998109|FG011|Overall Study|Adverse Event|0|||
146407710|NCT03022799|527998110|FG012|Overall Study|Adverse Event|0|||
146407711|NCT00883129|527998114|FG000|Overall Study|Adverse Event|7|||
146407712|NCT00883129|527998115|FG001|Overall Study|Adverse Event|15|||
146407713|NCT00883129|527998114|FG000|Overall Study|Withdrawal by Subject|8|||
146407714|NCT00883129|527998115|FG001|Overall Study|Withdrawal by Subject|9|||
146407715|NCT00883129|527998114|FG000|Overall Study|Non-compliance|3|||
146407716|NCT00883129|527998115|FG001|Overall Study|Non-compliance|6|||
146407717|NCT00883129|527998114|FG000|Overall Study|Lost to Follow-up|1|||
146407718|NCT00883129|527998115|FG001|Overall Study|Lost to Follow-up|2|||
146407719|NCT00883129|527998114|FG000|Overall Study|Death|1|||
146407720|NCT00883129|527998115|FG001|Overall Study|Death|2|||
146407721|NCT00883129|527998114|FG000|Overall Study|Defined Treatment Failure|0|||
146407722|NCT00883129|527998115|FG001|Overall Study|Defined Treatment Failure|2|||
146407723|NCT03273257|527998116|FG000|Overall Study|Death|0|||
146407724|NCT03273257|527998117|FG001|Overall Study|Death|1|||
146407725|NCT03273257|527998116|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
146407726|NCT03273257|527998117|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
146407727|NCT03273257|527998116|FG000|Overall Study|Study terminated|3|||
146407728|NCT03273257|527998117|FG001|Overall Study|Study terminated|2|||
146407729|NCT01185639|527998119|FG000|Overall Study|Progressed and didn't receive therapy|2|||
146407730|NCT02200614|527998120|FG000|Double Blind Treatment|Adverse Event|86|||
146407731|NCT02200614|527998121|FG001|Double Blind Treatment|Adverse Event|48|||
146407732|NCT02200614|527998120|FG000|Double Blind Treatment|Confirmed metastasis|120|||
146407733|NCT02200614|527998121|FG001|Double Blind Treatment|Confirmed metastasis|140|||
146407734|NCT02200614|527998120|FG000|Double Blind Treatment|Judgment of the investigator|59|||
146407735|NCT02200614|527998121|FG001|Double Blind Treatment|Judgment of the investigator|99|||
146407736|NCT02200614|527998120|FG000|Double Blind Treatment|Metastasis by local reading|1|||
146407737|NCT02200614|527998121|FG001|Double Blind Treatment|Metastasis by local reading|3|||
146407738|NCT02200614|527998120|FG000|Double Blind Treatment|Other reason|6|||
146407739|NCT02200614|527998121|FG001|Double Blind Treatment|Other reason|2|||
146407740|NCT02200614|527998120|FG000|Double Blind Treatment|Personal reason|77|||
146407741|NCT02200614|527998121|FG001|Double Blind Treatment|Personal reason|85|||
146407742|NCT02200614|527998120|FG000|Double Blind Treatment|Protocol deviation|14|||
146407743|NCT02200614|527998121|FG001|Double Blind Treatment|Protocol deviation|7|||
146407744|NCT02200614|527998120|FG000|Double Blind Treatment|Not treated|1|||
146407745|NCT02200614|527998121|FG001|Double Blind Treatment|Not treated|0|||
146407746|NCT02200614|527998120|FG000|Open Label|Adverse Event|41|||
146407747|NCT02200614|527998121|FG001|Open Label|Adverse Event|11|||
146407748|NCT02200614|527998120|FG000|Open Label|Confirmed metastasis|1|||
146407749|NCT02200614|527998121|FG001|Open Label|Confirmed metastasis|0|||
146407750|NCT02200614|527998120|FG000|Open Label|Judgment of the investigator|29|||
146407751|NCT02200614|527998121|FG001|Open Label|Judgment of the investigator|2|||
146407752|NCT02200614|527998120|FG000|Open Label|Metastasis by local reading|138|||
146407753|NCT02200614|527998121|FG001|Open Label|Metastasis by local reading|27|||
146407754|NCT02200614|527998120|FG000|Open Label|Other reason|22|||
146407755|NCT02200614|527998121|FG001|Open Label|Other reason|4|||
146407756|NCT02200614|527998120|FG000|Open Label|Personal reason|60|||
146407757|NCT02200614|527998121|FG001|Open Label|Personal reason|8|||
146407758|NCT02200614|527998120|FG000|Open Label|Protocol deviation|3|||
146407759|NCT02200614|527998121|FG001|Open Label|Protocol deviation|2|||
146407760|NCT02200614|527998120|FG000|Open Label|Missing|2|||
146407761|NCT02200614|527998121|FG001|Open Label|Missing|2|||
146407762|NCT01898884|527998122|FG000|Multiple Dose Period|Adverse Event|0|||
146407763|NCT01898884|527998123|FG001|Multiple Dose Period|Adverse Event|0|||
146407764|NCT01898884|527998124|FG002|Multiple Dose Period|Adverse Event|0|||
146407765|NCT01898884|527998125|FG003|Multiple Dose Period|Adverse Event|0|||
146407766|NCT01898884|527998126|FG004|Multiple Dose Period|Adverse Event|0|||
146407767|NCT01898884|527998127|FG005|Multiple Dose Period|Adverse Event|0|||
146407768|NCT01898884|527998128|FG006|Multiple Dose Period|Adverse Event|1|||
146407769|NCT01898884|527998129|FG007|Multiple Dose Period|Adverse Event|0|||
146407770|NCT01898884|527998130|FG008|Multiple Dose Period|Adverse Event|0|||
146407771|NCT01898884|527998122|FG000|Multiple Dose Period|Randomized Not Treated|0|||
146407772|NCT01898884|527998123|FG001|Multiple Dose Period|Randomized Not Treated|0|||
146407773|NCT01898884|527998124|FG002|Multiple Dose Period|Randomized Not Treated|0|||
146407774|NCT01898884|527998125|FG003|Multiple Dose Period|Randomized Not Treated|0|||
146407775|NCT01898884|527998126|FG004|Multiple Dose Period|Randomized Not Treated|0|||
146407776|NCT01898884|527998127|FG005|Multiple Dose Period|Randomized Not Treated|0|||
146407777|NCT01898884|527998128|FG006|Multiple Dose Period|Randomized Not Treated|0|||
146407778|NCT01898884|527998129|FG007|Multiple Dose Period|Randomized Not Treated|0|||
146407779|NCT01898884|527998130|FG008|Multiple Dose Period|Randomized Not Treated|1|||
146407780|NCT00434148|527998131|FG000|Overall Study|Adverse Event|18|||
146407781|NCT00434148|527998132|FG001|Overall Study|Adverse Event|18|||
146407782|NCT00434148|527998131|FG000|Overall Study|Lack of Efficacy|25|||
146407783|NCT00434148|527998132|FG001|Overall Study|Lack of Efficacy|28|||
146407784|NCT00434148|527998131|FG000|Overall Study|Withdrawal by Subject|15|||
146407785|NCT00434148|527998132|FG001|Overall Study|Withdrawal by Subject|15|||
146407786|NCT00434148|527998131|FG000|Overall Study|Protocol Violation|4|||
146407787|NCT00434148|527998132|FG001|Overall Study|Protocol Violation|0|||
146407788|NCT00434148|527998131|FG000|Overall Study|Administrative problems|6|||
146407789|NCT00434148|527998132|FG001|Overall Study|Administrative problems|10|||
146407790|NCT00434148|527998131|FG000|Overall Study|Lost to Follow-up|0|||
146407791|NCT00434148|527998132|FG001|Overall Study|Lost to Follow-up|1|||
146407792|NCT00434148|527998131|FG000|Overall Study|Condition no longer requires study drug|1|||
146407793|NCT00434148|527998132|FG001|Overall Study|Condition no longer requires study drug|0|||
146407794|NCT00434148|527998131|FG000|Overall Study|Abnormal test procedure result|0|||
146407795|NCT00434148|527998132|FG001|Overall Study|Abnormal test procedure result|1|||
146407796|NCT00759759|527998133|FG000|Overall Study|didn't return for period 2|1|||
146407797|NCT00759759|527998134|FG001|Overall Study|didn't return for period 2|0|||
146407798|NCT00759759|527998133|FG000|Overall Study|Didn't receive drug in period 2|1|||
146407799|NCT00759759|527998134|FG001|Overall Study|Didn't receive drug in period 2|0|||
146407800|NCT00759759|527998133|FG000|Overall Study|Withdrawal by Subject|2|||
146407801|NCT00759759|527998134|FG001|Overall Study|Withdrawal by Subject|1|||
146407802|NCT01861717|527998138|FG000|Overall Study|Lost to Follow-up|1|||
146407803|NCT01861717|527998138|FG000|Overall Study|Withdrawal by Subject|1|||
146407804|NCT01142466|528000018|FG000|Overall Study|Adverse Event|2|||
146407805|NCT01142466|528000019|FG001|Overall Study|Adverse Event|1|||
146407806|NCT01142466|528000018|FG000|Overall Study|Withdrawal by Subject|1|||
146407807|NCT01142466|528000019|FG001|Overall Study|Withdrawal by Subject|1|||
146407808|NCT02414854|528000024|FG000|Overall Study|Adverse Event|9|||
146407809|NCT02414854|528000025|FG001|Overall Study|Adverse Event|7|||
146407810|NCT02414854|528000026|FG002|Overall Study|Adverse Event|1|||
146407811|NCT02414854|528000027|FG003|Overall Study|Adverse Event|12|||
146407812|NCT02414854|528000024|FG000|Overall Study|Poor compliance to protocol|1|||
146407813|NCT02414854|528000025|FG001|Overall Study|Poor compliance to protocol|1|||
146407814|NCT02414854|528000026|FG002|Overall Study|Poor compliance to protocol|2|||
146407815|NCT02414854|528000027|FG003|Overall Study|Poor compliance to protocol|2|||
146407816|NCT02414854|528000024|FG000|Overall Study|Other than specified above|12|||
146407817|NCT02414854|528000025|FG001|Overall Study|Other than specified above|37|||
146407818|NCT02414854|528000026|FG002|Overall Study|Other than specified above|17|||
146407819|NCT02414854|528000027|FG003|Overall Study|Other than specified above|37|||
146407820|NCT04575038|528000028|FG000|Overall Study|Withdrawal by Subject|1|||
146407821|NCT04575038|528000029|FG001|Overall Study|Withdrawal by Subject|1|||
146407822|NCT01355523|528000030|FG000|Overall Study|Withdrawal by Subject|1|||
146407823|NCT01355523|528000031|FG001|Overall Study|Withdrawal by Subject|4|||
146407824|NCT01355523|528000030|FG000|Overall Study|Lost to Follow-up|0|||
146407825|NCT01355523|528000031|FG001|Overall Study|Lost to Follow-up|2|||
146407826|NCT01355523|528000030|FG000|Overall Study|Protocol Violation|0|||
146407827|NCT01355523|528000031|FG001|Overall Study|Protocol Violation|2|||
146407828|NCT01355523|528000030|FG000|Overall Study|Adverse Event|0|||
146407829|NCT01355523|528000031|FG001|Overall Study|Adverse Event|2|||
146407830|NCT02766088|528000032|FG000|Overall Study|Sponsor study termination|498|||
146407831|NCT02766088|528000032|FG000|Overall Study|Migrated/moved from the study area|1|||
146063467|NCT02435992|526753830|FG001|Overall Study|Physician Decision|0|||
146063468|NCT02435992|526753831|FG002|Overall Study|Physician Decision|1|||
146063469|NCT02435992|526753832|FG003|Overall Study|Physician Decision|0|||
146063470|NCT02435992|526753833|FG004|Overall Study|Physician Decision|0|||
146063471|NCT04004988|526753834|FG000|Period 1|Physician Decision|2|||
146063472|NCT04004988|526753835|FG001|Period 1|Physician Decision|0|||
146063473|NCT04004988|526753834|FG000|Period 1|Withdrawal by Subject|0|||
146063474|NCT04004988|526753835|FG001|Period 1|Withdrawal by Subject|1|||
146063475|NCT04004988|526753834|FG000|Period 1|Adverse Event|1|||
146063476|NCT04004988|526753835|FG001|Period 1|Adverse Event|2|||
146063477|NCT03873116|526753836|FG000|Part 1|Study drug discontinuation due to rash|0|||
146063478|NCT03873116|526753837|FG001|Part 1|Study drug discontinuation due to rash|0|||
146063479|NCT03873116|526753838|FG002|Part 1|Study drug discontinuation due to rash|0|||
146063480|NCT03873116|526753839|FG003|Part 1|Study drug discontinuation due to rash|0|||
146063481|NCT03873116|526753840|FG004|Part 1|Study drug discontinuation due to rash|0|||
146063482|NCT03873116|526753841|FG005|Part 1|Study drug discontinuation due to rash|1|||
146063483|NCT03873116|526753836|FG000|Part 2|Withdrawal by Subject|0|||
146063484|NCT03873116|526753837|FG001|Part 2|Withdrawal by Subject|0|||
146063485|NCT03873116|526753838|FG002|Part 2|Withdrawal by Subject|1|||
146063486|NCT03873116|526753839|FG003|Part 2|Withdrawal by Subject|0|||
146063487|NCT03873116|526753840|FG004|Part 2|Withdrawal by Subject|0|||
146063488|NCT03873116|526753841|FG005|Part 2|Withdrawal by Subject|0|||
146063489|NCT03873116|526753836|FG000|Part 2|Lab abnormality or AE|0|||
146063490|NCT03873116|526753837|FG001|Part 2|Lab abnormality or AE|0|||
146063491|NCT03873116|526753838|FG002|Part 2|Lab abnormality or AE|0|||
146063492|NCT03873116|526753839|FG003|Part 2|Lab abnormality or AE|0|||
146063493|NCT03873116|526753840|FG004|Part 2|Lab abnormality or AE|1|||
146063494|NCT03873116|526753841|FG005|Part 2|Lab abnormality or AE|0|||
146063495|NCT03873116|526753836|FG000|Part 3|Withdrawal by Subject|0|||
146063496|NCT03873116|526753837|FG001|Part 3|Withdrawal by Subject|0|||
146063497|NCT03873116|526753838|FG002|Part 3|Withdrawal by Subject|0|||
146063498|NCT03873116|526753839|FG003|Part 3|Withdrawal by Subject|0|||
146063499|NCT03873116|526753840|FG004|Part 3|Withdrawal by Subject|1|||
146063500|NCT03873116|526753841|FG005|Part 3|Withdrawal by Subject|0|||
146063501|NCT02531802|526753844|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
146063502|NCT02531802|526753845|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
146063503|NCT02531802|526753846|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
146063504|NCT02531802|526753847|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
146063505|NCT02531802|526753848|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
146063506|NCT02531802|526753849|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
146063507|NCT02531802|526753850|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
146063508|NCT02531802|526753851|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
146063509|NCT02531802|526753852|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
146063510|NCT02531802|526753853|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
146063511|NCT02531802|526753854|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
146063512|NCT02531802|526753855|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
146063513|NCT02531802|526753856|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
146063514|NCT02531802|526753857|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
146063515|NCT02531802|526753858|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
146063516|NCT02531802|526753859|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
146063517|NCT02531802|526753860|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
146063518|NCT02531802|526753861|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
146063519|NCT02531802|526753862|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
146063520|NCT02531802|526753863|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
146063521|NCT02531802|526753864|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
146063522|NCT02531802|526753844|FG000|Received Vaccination 2|Physician Decision|0|||
146063523|NCT02531802|526753845|FG001|Received Vaccination 2|Physician Decision|0|||
146063524|NCT02531802|526753846|FG002|Received Vaccination 2|Physician Decision|0|||
146063525|NCT02531802|526753847|FG003|Received Vaccination 2|Physician Decision|0|||
146063526|NCT02531802|526753848|FG004|Received Vaccination 2|Physician Decision|0|||
146063527|NCT02531802|526753849|FG005|Received Vaccination 2|Physician Decision|1|||
146063528|NCT02531802|526753850|FG006|Received Vaccination 2|Physician Decision|0|||
146407832|NCT02766088|528000032|FG000|Overall Study|Lost to Follow-up|5|||
146407833|NCT02766088|528000032|FG000|Overall Study|Other|1|||
146063529|NCT02531802|526753851|FG007|Received Vaccination 2|Physician Decision|0|||
146407834|NCT02766088|528000032|FG000|Overall Study|Death|1|||
146063530|NCT02531802|526753852|FG008|Received Vaccination 2|Physician Decision|0|||
146063531|NCT02531802|526753853|FG009|Received Vaccination 2|Physician Decision|2|||
146407835|NCT01222715|528000033|FG000|Overall Study|Adverse Event|0|||
146407836|NCT01222715|528000034|FG001|Overall Study|Adverse Event|4|||
146407837|NCT01222715|528000033|FG000|Overall Study|Death|0|||
146063532|NCT02531802|526753854|FG010|Received Vaccination 2|Physician Decision|0|||
146063533|NCT02531802|526753855|FG011|Received Vaccination 2|Physician Decision|0|||
146063534|NCT02531802|526753856|FG012|Received Vaccination 2|Physician Decision|0|||
146063535|NCT02531802|526753857|FG013|Received Vaccination 2|Physician Decision|1|||
146063536|NCT02531802|526753858|FG014|Received Vaccination 2|Physician Decision|0|||
146063537|NCT02531802|526753859|FG015|Received Vaccination 2|Physician Decision|0|||
146063538|NCT02531802|526753860|FG016|Received Vaccination 2|Physician Decision|0|||
146063539|NCT02531802|526753861|FG017|Received Vaccination 2|Physician Decision|1|||
146063540|NCT02531802|526753862|FG018|Received Vaccination 2|Physician Decision|0|||
146063541|NCT02531802|526753863|FG019|Received Vaccination 2|Physician Decision|0|||
146063542|NCT02531802|526753864|FG020|Received Vaccination 2|Physician Decision|0|||
146063543|NCT02531802|526753844|FG000|Received Vaccination 2|Adverse Event|0|||
146063544|NCT02531802|526753845|FG001|Received Vaccination 2|Adverse Event|0|||
146063545|NCT02531802|526753846|FG002|Received Vaccination 2|Adverse Event|0|||
146063546|NCT02531802|526753847|FG003|Received Vaccination 2|Adverse Event|0|||
146063547|NCT02531802|526753848|FG004|Received Vaccination 2|Adverse Event|0|||
146063548|NCT02531802|526753849|FG005|Received Vaccination 2|Adverse Event|2|||
146063549|NCT02531802|526753850|FG006|Received Vaccination 2|Adverse Event|0|||
146063550|NCT02531802|526753851|FG007|Received Vaccination 2|Adverse Event|0|||
146063551|NCT02531802|526753852|FG008|Received Vaccination 2|Adverse Event|0|||
146063552|NCT02531802|526753853|FG009|Received Vaccination 2|Adverse Event|0|||
146063553|NCT02531802|526753854|FG010|Received Vaccination 2|Adverse Event|0|||
146063554|NCT02531802|526753855|FG011|Received Vaccination 2|Adverse Event|0|||
146063555|NCT02531802|526753856|FG012|Received Vaccination 2|Adverse Event|0|||
146063556|NCT02531802|526753857|FG013|Received Vaccination 2|Adverse Event|0|||
146063557|NCT02531802|526753858|FG014|Received Vaccination 2|Adverse Event|0|||
146063558|NCT02531802|526753859|FG015|Received Vaccination 2|Adverse Event|0|||
146063559|NCT02531802|526753860|FG016|Received Vaccination 2|Adverse Event|0|||
146063560|NCT02531802|526753861|FG017|Received Vaccination 2|Adverse Event|2|||
146063561|NCT02531802|526753862|FG018|Received Vaccination 2|Adverse Event|1|||
146063562|NCT02531802|526753863|FG019|Received Vaccination 2|Adverse Event|0|||
146063563|NCT02531802|526753864|FG020|Received Vaccination 2|Adverse Event|1|||
146063564|NCT02531802|526753844|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146063565|NCT02531802|526753845|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146063566|NCT02531802|526753846|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
146063567|NCT02531802|526753847|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
146063568|NCT02531802|526753848|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
146063569|NCT02531802|526753849|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
146063570|NCT02531802|526753850|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
146063571|NCT02531802|526753851|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
146063572|NCT02531802|526753852|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
146063573|NCT02531802|526753853|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
146063574|NCT02531802|526753854|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
146063575|NCT02531802|526753855|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
146063576|NCT02531802|526753856|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
146063577|NCT02531802|526753857|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
146063578|NCT02531802|526753858|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
146063579|NCT02531802|526753859|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
146063580|NCT02531802|526753860|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
146063581|NCT02531802|526753861|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
146063582|NCT02531802|526753862|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
146063583|NCT02531802|526753863|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
146063584|NCT02531802|526753864|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
146063585|NCT00538902|526753874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
146063586|NCT00538902|526753875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
146063587|NCT00538902|526753876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
146063588|NCT00538902|526753874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
146063589|NCT00538902|526753875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
146063590|NCT00538902|526753876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
146063591|NCT00538902|526753874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
146407838|NCT01222715|528000034|FG001|Overall Study|Death|1|||
146407839|NCT01222715|528000033|FG000|Overall Study|Lack of Efficacy|22|||
146407840|NCT01222715|528000034|FG001|Overall Study|Lack of Efficacy|14|||
146407841|NCT01222715|528000033|FG000|Overall Study|Physician Decision|12|||
146407842|NCT01222715|528000034|FG001|Overall Study|Physician Decision|2|||
146063592|NCT00538902|526753875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
146063593|NCT00538902|526753876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
146063594|NCT00538902|526753874|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146063595|NCT00538902|526753875|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146063596|NCT00538902|526753876|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
146063597|NCT00538902|526753874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
146063598|NCT00538902|526753875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
146171747|NCT00988221|527143223|FG001|Part I|Adverse Event|1|||
146407843|NCT01222715|528000033|FG000|Overall Study|Refusal of further protocol therapy|0|||
146063599|NCT00538902|526753876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
146063600|NCT00538902|526753874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
146063601|NCT00538902|526753875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
146063602|NCT00538902|526753876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
146063603|NCT00538902|526753874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
146063604|NCT00538902|526753875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
146063605|NCT00538902|526753876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
146063606|NCT00538902|526753874|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
146063607|NCT00538902|526753875|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
146063608|NCT00538902|526753876|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
146063609|NCT03131570|526753878|FG000|Overall Study|Adverse Event|1|||
146063610|NCT03131570|526753879|FG001|Overall Study|Adverse Event|0|||
146063611|NCT04109547|526753884|FG000|Overall Study|Withdrawal by Subject|3|||
146063612|NCT04109547|526753885|FG001|Overall Study|Withdrawal by Subject|2|||
146063613|NCT04109547|526753886|FG002|Overall Study|Withdrawal by Subject|6|||
146063614|NCT04109547|526753887|FG003|Overall Study|Withdrawal by Subject|6|||
146063615|NCT04109547|526753884|FG000|Overall Study|Lost to Follow-up|0|||
146063616|NCT04109547|526753885|FG001|Overall Study|Lost to Follow-up|0|||
146063617|NCT04109547|526753886|FG002|Overall Study|Lost to Follow-up|0|||
146063618|NCT04109547|526753887|FG003|Overall Study|Lost to Follow-up|1|||
146063619|NCT04109547|526753884|FG000|Overall Study|Physician Decision|1|||
146063620|NCT04109547|526753885|FG001|Overall Study|Physician Decision|2|||
146063621|NCT04109547|526753886|FG002|Overall Study|Physician Decision|0|||
146063622|NCT04109547|526753887|FG003|Overall Study|Physician Decision|0|||
146063623|NCT00871975|526753888|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
146063624|NCT00871975|526753888|FG000|Overall Study|Catheters could not be inserted|1|||
146063625|NCT00871975|526753888|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
146063626|NCT00871975|526753888|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
146063627|NCT03113487|526753891|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
146063628|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
146063629|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
146063630|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
146063631|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
146063632|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
146063633|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
146063634|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
146063635|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
146063636|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
146063637|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
146063638|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
146063639|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
146063640|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
146063641|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
146063642|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
146063643|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
146063644|NCT03773978|526753892|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
146063645|NCT03773978|526753893|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
146063646|NCT03773978|526753892|FG000|DBW Period|Adverse Event|2|||
146063647|NCT03773978|526753893|FG001|DBW Period|Adverse Event|2|||
146063648|NCT03773978|526753892|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
146063649|NCT03773978|526753893|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
146063650|NCT03773978|526753892|FG000|DBW Period|Withdrawal by Subject|2|||
146063651|NCT03773978|526753893|FG001|DBW Period|Withdrawal by Subject|1|||
146063652|NCT03773978|526753892|FG000|DBW Period|Due to epidemic or pandemic|5|||
146063653|NCT03773978|526753893|FG001|DBW Period|Due to epidemic or pandemic|6|||
146063654|NCT03773978|526753892|FG000|DBW Period|Study team decision|1|||
146063655|NCT03773978|526753893|FG001|DBW Period|Study team decision|0|||
146063656|NCT03777982|526753894|FG000|Overall Study|Physician Decision|0|||
146063657|NCT03777982|526753895|FG001|Overall Study|Physician Decision|1|||
146283846|NCT00092495|527551857|FG003|Base Study Vaccination Period|Other|2|||
146407844|NCT01222715|528000034|FG001|Overall Study|Refusal of further protocol therapy|4|||
146407845|NCT01222715|528000033|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
146407846|NCT01222715|528000034|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
146407847|NCT01222715|528000033|FG000|Overall Study|Ineligible|0|||
146407848|NCT01222715|528000034|FG001|Overall Study|Ineligible|1|||
146407849|NCT01222715|528000033|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
146407850|NCT01222715|528000034|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
146407851|NCT03555890|528000041|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146407852|NCT03555890|528000042|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146063658|NCT04189952|526753898|FG000|Follow-up Period|Death|1|||
146063659|NCT04189952|526753898|FG000|Follow-up Period|Withdrawal by Subject|1|||
146063660|NCT04298697|526753899|FG000|Overall Study|Lost to Follow-up|5|||
146063661|NCT04298697|526753900|FG001|Overall Study|Lost to Follow-up|5|||
146063662|NCT04298697|526753901|FG002|Overall Study|Lost to Follow-up|1|||
146063663|NCT04298697|526753902|FG003|Overall Study|Lost to Follow-up|0|||
146063664|NCT04298697|526753899|FG000|Overall Study|Withdrawal by Subject|0|||
146063665|NCT04298697|526753900|FG001|Overall Study|Withdrawal by Subject|3|||
146063666|NCT04298697|526753901|FG002|Overall Study|Withdrawal by Subject|2|||
146063667|NCT04298697|526753902|FG003|Overall Study|Withdrawal by Subject|3|||
146063668|NCT03755934|526753903|FG000|Overall Study|Adverse Event|4|||
146063669|NCT03755934|526753904|FG001|Overall Study|Adverse Event|1|||
146063670|NCT03755934|526753905|FG002|Overall Study|Adverse Event|1|||
146063671|NCT03755934|526753906|FG003|Overall Study|Adverse Event|3|||
146063672|NCT03755934|526753903|FG000|Overall Study|Physician Decision|2|||
146063673|NCT03755934|526753904|FG001|Overall Study|Physician Decision|0|||
146063674|NCT03755934|526753905|FG002|Overall Study|Physician Decision|0|||
146063675|NCT03755934|526753906|FG003|Overall Study|Physician Decision|1|||
146063676|NCT03755934|526753903|FG000|Overall Study|Withdrawal by Subject|5|||
146063677|NCT03755934|526753904|FG001|Overall Study|Withdrawal by Subject|0|||
146063678|NCT03755934|526753905|FG002|Overall Study|Withdrawal by Subject|0|||
146063679|NCT03755934|526753906|FG003|Overall Study|Withdrawal by Subject|1|||
146063680|NCT03755934|526753903|FG000|Overall Study|Other|3|||
146063681|NCT03755934|526753904|FG001|Overall Study|Other|1|||
146063682|NCT03755934|526753905|FG002|Overall Study|Other|3|||
146063683|NCT03755934|526753906|FG003|Overall Study|Other|1|||
146063684|NCT01498068|526753909|FG000|Overall Study|Withdrawal by Subject|1|||
146063685|NCT01498068|526753910|FG001|Overall Study|Withdrawal by Subject|1|||
146063686|NCT03944577|526753911|FG000|Overall Study|Adverse Event|3|||
146063687|NCT00198822|526753912|FG000|Overall Study|Lost to Follow-up|14|||
146063688|NCT00198822|526753913|FG001|Overall Study|Lost to Follow-up|20|||
146063689|NCT00198822|526753914|FG002|Overall Study|Lost to Follow-up|21|||
146063690|NCT01467960|526753917|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146063691|NCT01467960|526753918|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146063692|NCT01467960|526753919|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
146063693|NCT01467960|526753920|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146063694|NCT01467960|526753921|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146063695|NCT01467960|526753922|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
146063696|NCT00888173|526753923|FG000|Overall Study|Wrong Primary|1|||
146063697|NCT00888173|526753923|FG000|Overall Study|Ineligible: required test not done|1|||
146063698|NCT00737672|526753930|FG000|Overall Study|Graft Abandonment|48|||
146063699|NCT00737672|526753931|FG001|Overall Study|Graft Abandonment|56|||
146063700|NCT00737672|526753930|FG000|Overall Study|Death|23|||
146063701|NCT00737672|526753931|FG001|Overall Study|Death|22|||
146063702|NCT00737672|526753930|FG000|Overall Study|Withdrawal by Subject|1|||
146063703|NCT00737672|526753931|FG001|Overall Study|Withdrawal by Subject|2|||
146063704|NCT00737672|526753930|FG000|Overall Study|Lost to Follow-up|1|||
146063705|NCT00737672|526753931|FG001|Overall Study|Lost to Follow-up|0|||
146063706|NCT00737672|526753930|FG000|Overall Study|Miscellaneous|7|||
146063707|NCT00737672|526753931|FG001|Overall Study|Miscellaneous|1|||
146063708|NCT00737672|526753930|FG000|Overall Study|Physician Decision|0|||
146063709|NCT00737672|526753931|FG001|Overall Study|Physician Decision|2|||
146063710|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
146063711|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
146063712|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
146063713|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
146063714|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Adverse Event|2|||
146063715|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Adverse Event|5|||
146063716|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Adverse Event|1|||
146063717|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Adverse Event|2|||
146063718|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Death|13|||
146063719|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Death|17|||
146063720|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Death|1|||
146063721|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Death|0|||
146063722|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
146063723|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
146063724|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
146063725|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
146063726|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Disease Progression|2|||
146063727|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Disease Progression|0|||
146063728|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Disease Progression|0|||
146063729|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Disease Progression|0|||
146063730|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
146063731|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
146063732|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
146063733|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
146063734|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
146063735|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
146063736|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
146063737|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
146063738|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
146063739|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
146063740|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
146063741|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
146063742|NCT03955146|526753937|FG000|DB Period (48 Weeks)|Participant Decision|9|||
146063743|NCT03955146|526753938|FG001|DB Period (48 Weeks)|Participant Decision|12|||
146063744|NCT03955146|526753939|FG002|DB Period (48 Weeks)|Participant Decision|1|||
146063745|NCT03955146|526753940|FG003|DB Period (48 Weeks)|Participant Decision|1|||
146063746|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
146063747|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
146063748|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
146063749|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
146063750|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
146063751|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
146063752|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
146063753|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
146063754|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146063755|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
146063756|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146063757|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
146063758|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
146063759|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
146063760|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
146063761|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
146063762|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
146063763|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
146063764|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
146063765|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
146063766|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
146063767|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146063768|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146063769|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
146063770|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
146063771|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
146063772|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
146063773|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
146063774|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
146063775|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
146063776|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
146063777|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
146063778|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
146063779|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146063780|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146063781|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
146063782|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
146063783|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
146063784|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
146063785|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
146063786|NCT03955146|526753937|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
146063787|NCT03955146|526753938|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146063788|NCT03955146|526753939|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146063789|NCT03955146|526753940|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
146063790|NCT02002598|526753945|FG000|Dose Level 1|Withdrawal by Subject|1|||
146063791|NCT02002598|526753946|FG001|Dose Level 1|Withdrawal by Subject|0|||
146063792|NCT02002598|526753947|FG002|Dose Level 1|Withdrawal by Subject|0|||
146063793|NCT02002598|526753948|FG003|Dose Level 1|Withdrawal by Subject|0|||
146063794|NCT02002598|526753949|FG004|Dose Level 1|Withdrawal by Subject|0|||
146063795|NCT02628873|526753950|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
146063796|NCT02628873|526753951|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
146063797|NCT02628873|526753950|FG000|Second Test (1 Hour)|Physician Decision|1|||
146063798|NCT02628873|526753951|FG001|Second Test (1 Hour)|Physician Decision|0|||
146063799|NCT04672239|526753952|FG000|Week 2 Survey|Failed survey check items|1|||
146063800|NCT04672239|526753953|FG001|Week 2 Survey|Failed survey check items|2|||
146063801|NCT04672239|526753954|FG002|Week 2 Survey|Failed survey check items|3|||
146407853|NCT03555890|528000043|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145890927|NCT01207440|526107571|FG001|Overall Study|Lost to Follow-up|0|||
146063802|NCT04672239|526753952|FG000|Week 2 Survey|Partially completed survey|7|||
146063803|NCT04672239|526753953|FG001|Week 2 Survey|Partially completed survey|1|||
146063804|NCT04672239|526753954|FG002|Week 2 Survey|Partially completed survey|4|||
146063805|NCT04672239|526753952|FG000|Week 2 Survey|Withdrawal by Subject|0|||
146063806|NCT04672239|526753953|FG001|Week 2 Survey|Withdrawal by Subject|1|||
146063807|NCT04672239|526753954|FG002|Week 2 Survey|Withdrawal by Subject|0|||
146063808|NCT04672239|526753952|FG000|Week 2 Survey|Lost to Follow-up|3|||
146063809|NCT04672239|526753953|FG001|Week 2 Survey|Lost to Follow-up|2|||
146063810|NCT04672239|526753954|FG002|Week 2 Survey|Lost to Follow-up|5|||
146063811|NCT04672239|526753952|FG000|Week 6 Survey|Failed survey check items|2|||
146063812|NCT04672239|526753953|FG001|Week 6 Survey|Failed survey check items|2|||
146063813|NCT04672239|526753954|FG002|Week 6 Survey|Failed survey check items|2|||
146063814|NCT04672239|526753952|FG000|Week 6 Survey|Partially completed survey|3|||
146063815|NCT04672239|526753953|FG001|Week 6 Survey|Partially completed survey|3|||
146063816|NCT04672239|526753954|FG002|Week 6 Survey|Partially completed survey|2|||
146063817|NCT04672239|526753952|FG000|Week 6 Survey|Withdrawal by Subject|1|||
146063818|NCT04672239|526753953|FG001|Week 6 Survey|Withdrawal by Subject|1|||
146063819|NCT04672239|526753954|FG002|Week 6 Survey|Withdrawal by Subject|1|||
146063820|NCT04672239|526753952|FG000|Week 6 Survey|Withdrawn by PI|0|||
146063821|NCT04672239|526753953|FG001|Week 6 Survey|Withdrawn by PI|1|||
146063822|NCT04672239|526753954|FG002|Week 6 Survey|Withdrawn by PI|0|||
146063823|NCT04672239|526753952|FG000|Week 6 Survey|Lost to Follow-up|12|||
146063824|NCT04672239|526753953|FG001|Week 6 Survey|Lost to Follow-up|2|||
146063825|NCT04672239|526753954|FG002|Week 6 Survey|Lost to Follow-up|5|||
146063826|NCT04672239|526753952|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
146063827|NCT04672239|526753953|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
146063828|NCT04672239|526753954|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
146063829|NCT04672239|526753952|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
146063830|NCT04672239|526753953|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
146063831|NCT04672239|526753954|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
146063832|NCT04672239|526753952|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
146063833|NCT04672239|526753953|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
146063834|NCT04672239|526753954|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
146063835|NCT04672239|526753952|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
146063836|NCT04672239|526753953|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
146063837|NCT04672239|526753954|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
146063838|NCT04672239|526753952|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
146063839|NCT04672239|526753953|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
146063840|NCT04672239|526753954|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
146063841|NCT04672239|526753952|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
146063842|NCT04672239|526753953|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
146063843|NCT04672239|526753954|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
146063844|NCT04672239|526753952|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
146063845|NCT04672239|526753953|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
146063846|NCT04672239|526753954|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
146063847|NCT00541658|526753955|FG000|Overall Study|Adverse Event|28|||
146063848|NCT00541658|526753956|FG001|Overall Study|Adverse Event|37|||
146063849|NCT00541658|526753957|FG002|Overall Study|Adverse Event|25|||
146063850|NCT00541658|526753955|FG000|Overall Study|Physician Decision|0|||
146063851|NCT00541658|526753956|FG001|Overall Study|Physician Decision|0|||
146063852|NCT00541658|526753957|FG002|Overall Study|Physician Decision|4|||
146063853|NCT00541658|526753955|FG000|Overall Study|Lost to Follow-up|3|||
146063854|NCT00541658|526753956|FG001|Overall Study|Lost to Follow-up|3|||
146063855|NCT00541658|526753957|FG002|Overall Study|Lost to Follow-up|6|||
146063856|NCT00541658|526753955|FG000|Overall Study|Protocol Violation|0|||
146063857|NCT00541658|526753956|FG001|Overall Study|Protocol Violation|1|||
146063858|NCT00541658|526753957|FG002|Overall Study|Protocol Violation|1|||
146063859|NCT00541658|526753955|FG000|Overall Study|Withdrawal by Subject|28|||
146063860|NCT00541658|526753956|FG001|Overall Study|Withdrawal by Subject|32|||
146063861|NCT00541658|526753957|FG002|Overall Study|Withdrawal by Subject|32|||
146063862|NCT00541658|526753955|FG000|Overall Study|Took No Study Drug|1|||
146063863|NCT00541658|526753956|FG001|Overall Study|Took No Study Drug|0|||
146063864|NCT00541658|526753957|FG002|Overall Study|Took No Study Drug|0|||
146063865|NCT01099267|526753958|FG000|MDS-003 Study|Adverse Event|37|||
146171748|NCT00988221|527143224|FG002|Part I|Adverse Event|2|||
146171749|NCT00988221|527143225|FG003|Part I|Adverse Event|0|||
146171750|NCT00988221|527143222|FG000|Part I|Insufficient Therapeutic Response|4|||
146171751|NCT00988221|527143223|FG001|Part I|Insufficient Therapeutic Response|6|||
146171752|NCT00988221|527143224|FG002|Part I|Insufficient Therapeutic Response|5|||
146063866|NCT01099267|526753958|FG000|MDS-003 Study|Lack of Efficacy|52|||
146063867|NCT01099267|526753958|FG000|MDS-003 Study|Withdrawal by Subject|8|||
146063868|NCT01099267|526753958|FG000|MDS-003 Study|Lost to Follow-up|1|||
146063869|NCT01099267|526753958|FG000|MDS-003 Study|Death|11|||
146063870|NCT01099267|526753958|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
146063871|NCT01099267|526753958|FG000|MDS-003 Study|Disease Progression|7|||
146063872|NCT01099267|526753958|FG000|MDS-003 Study|Investigator Decision|2|||
146063873|NCT01099267|526753958|FG000|MDS-003 Study|Non-Compliance|2|||
146063874|NCT01099267|526753958|FG000|MDS-003 Study|Loss of Response|1|||
146063875|NCT01099267|526753958|FG000|MDS-003 Study|Secondary Malign Disease|1|||
146063876|NCT04986904|526753959|FG000|Overall Study|Lost to Follow-up|11|||
146063877|NCT04986904|526753959|FG000|Overall Study|Withdrawal by Subject|1|||
146063878|NCT04123470|526753962|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
146063879|NCT04123470|526753963|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
146063880|NCT04123470|526753962|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
146063881|NCT04123470|526753963|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
146063882|NCT04123470|526753962|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
146063883|NCT04123470|526753963|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
146063884|NCT04123470|526753962|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
146063885|NCT04123470|526753963|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
146063886|NCT05972993|526753969|FG000|Overall Study|Lost to Follow-up|2|||
146063887|NCT05972993|526753970|FG001|Overall Study|Lost to Follow-up|0|||
146063888|NCT05972993|526753971|FG002|Overall Study|Lost to Follow-up|1|||
146063889|NCT05972993|526753972|FG003|Overall Study|Lost to Follow-up|0|||
146063890|NCT05972993|526753973|FG004|Overall Study|Lost to Follow-up|0|||
146063891|NCT05972993|526753974|FG005|Overall Study|Lost to Follow-up|0|||
146063892|NCT05972993|526753975|FG006|Overall Study|Lost to Follow-up|0|||
146063893|NCT05972993|526753976|FG007|Overall Study|Lost to Follow-up|2|||
146063894|NCT05972993|526753977|FG008|Overall Study|Lost to Follow-up|0|||
146063895|NCT03866577|526753980|FG000|Overall Study|Protocol Violation|0|||
146063896|NCT03866577|526753981|FG001|Overall Study|Protocol Violation|0|||
146063897|NCT03866577|526753982|FG002|Overall Study|Protocol Violation|0|||
146063898|NCT03866577|526753983|FG003|Overall Study|Protocol Violation|0|||
146063899|NCT03866577|526753984|FG004|Overall Study|Protocol Violation|0|||
146063900|NCT03866577|526753985|FG005|Overall Study|Protocol Violation|0|||
146063901|NCT03866577|526753986|FG006|Overall Study|Protocol Violation|0|||
146063902|NCT03866577|526753987|FG007|Overall Study|Protocol Violation|0|||
146063903|NCT03866577|526753988|FG008|Overall Study|Protocol Violation|0|||
146063904|NCT03866577|526753989|FG009|Overall Study|Protocol Violation|0|||
146063905|NCT03866577|526753990|FG010|Overall Study|Protocol Violation|0|||
146063906|NCT03866577|526753991|FG011|Overall Study|Protocol Violation|1|||
146063907|NCT03866577|526753992|FG012|Overall Study|Protocol Violation|0|||
146063908|NCT03866577|526753980|FG000|Overall Study|Withdrawal by Subject|0|||
146063909|NCT03866577|526753981|FG001|Overall Study|Withdrawal by Subject|0|||
146063910|NCT03866577|526753982|FG002|Overall Study|Withdrawal by Subject|0|||
146063911|NCT03866577|526753983|FG003|Overall Study|Withdrawal by Subject|0|||
146063912|NCT03866577|526753984|FG004|Overall Study|Withdrawal by Subject|0|||
146063913|NCT03866577|526753985|FG005|Overall Study|Withdrawal by Subject|0|||
146063914|NCT03866577|526753986|FG006|Overall Study|Withdrawal by Subject|0|||
146063915|NCT03866577|526753987|FG007|Overall Study|Withdrawal by Subject|0|||
146063916|NCT03866577|526753988|FG008|Overall Study|Withdrawal by Subject|1|||
146063917|NCT03866577|526753989|FG009|Overall Study|Withdrawal by Subject|1|||
146063918|NCT03866577|526753990|FG010|Overall Study|Withdrawal by Subject|0|||
146063919|NCT03866577|526753991|FG011|Overall Study|Withdrawal by Subject|0|||
146063920|NCT03866577|526753992|FG012|Overall Study|Withdrawal by Subject|0|||
146063921|NCT03866577|526753980|FG000|Overall Study|Not qualified for IVIg infusion|0|||
146063922|NCT03866577|526753981|FG001|Overall Study|Not qualified for IVIg infusion|0|||
146063923|NCT03866577|526753982|FG002|Overall Study|Not qualified for IVIg infusion|0|||
146063924|NCT03866577|526753983|FG003|Overall Study|Not qualified for IVIg infusion|0|||
146063925|NCT03866577|526753984|FG004|Overall Study|Not qualified for IVIg infusion|0|||
146063926|NCT03866577|526753985|FG005|Overall Study|Not qualified for IVIg infusion|0|||
146063927|NCT03866577|526753986|FG006|Overall Study|Not qualified for IVIg infusion|0|||
146063928|NCT03866577|526753987|FG007|Overall Study|Not qualified for IVIg infusion|0|||
146063929|NCT03866577|526753988|FG008|Overall Study|Not qualified for IVIg infusion|0|||
146063930|NCT03866577|526753989|FG009|Overall Study|Not qualified for IVIg infusion|1|||
146063931|NCT03866577|526753990|FG010|Overall Study|Not qualified for IVIg infusion|0|||
146063932|NCT03866577|526753991|FG011|Overall Study|Not qualified for IVIg infusion|0|||
146063933|NCT03866577|526753992|FG012|Overall Study|Not qualified for IVIg infusion|0|||
146063934|NCT05530252|526753993|FG000|Overall Study|Lost to Follow-up|1|||
146063935|NCT05530252|526753994|FG001|Overall Study|Lost to Follow-up|1|||
146063936|NCT05530252|526753995|FG002|Overall Study|Lost to Follow-up|1|||
146063937|NCT00651742|526754000|FG000|Overall Study|Objective Disease Progression|22|||
146063938|NCT00651742|526754000|FG000|Overall Study|Toxicity|3|||
146063939|NCT00651742|526754000|FG000|Overall Study|Investigator Judgment|1|||
146171753|NCT00988221|527143225|FG003|Part I|Insufficient Therapeutic Response|0|||
146063940|NCT00651742|526754000|FG000|Overall Study|Withdrawal of Consent|1|||
146063941|NCT00651742|526754000|FG000|Overall Study|Enrolled but not treated|1|||
146063942|NCT01535040|526754002|FG000|Overall Study|Physician Decision|0|||
146063943|NCT01535040|526754003|FG001|Overall Study|Physician Decision|1|||
146063944|NCT01535040|526754002|FG000|Overall Study|Withdrawal by Subject|13|||
146063945|NCT01535040|526754003|FG001|Overall Study|Withdrawal by Subject|10|||
146063946|NCT01535040|526754002|FG000|Overall Study|Never Started|9|||
146063947|NCT01535040|526754003|FG001|Overall Study|Never Started|4|||
146063948|NCT01535040|526754002|FG000|Overall Study|Toxicity|7|||
146063949|NCT01535040|526754003|FG001|Overall Study|Toxicity|5|||
146063950|NCT01535040|526754002|FG000|Overall Study|Multiple Reasons|1|||
146063951|NCT01535040|526754003|FG001|Overall Study|Multiple Reasons|1|||
146063952|NCT01074970|526754004|FG000|Overall Study|Never Treated|0|||
146063953|NCT01074970|526754005|FG001|Overall Study|Never Treated|0|||
146063954|NCT01074970|526754006|FG002|Overall Study|Never Treated|8|||
146063955|NCT01074970|526754007|FG003|Overall Study|Never Treated|1|||
146063956|NCT01074970|526754004|FG000|Overall Study|Adverse Event|1|||
146063957|NCT01074970|526754005|FG001|Overall Study|Adverse Event|0|||
146063958|NCT01074970|526754006|FG002|Overall Study|Adverse Event|4|||
146063959|NCT01074970|526754007|FG003|Overall Study|Adverse Event|3|||
146063960|NCT01074970|526754004|FG000|Overall Study|Disease progression during treatment|3|||
146063961|NCT01074970|526754005|FG001|Overall Study|Disease progression during treatment|1|||
146063962|NCT01074970|526754006|FG002|Overall Study|Disease progression during treatment|2|||
146063963|NCT01074970|526754007|FG003|Overall Study|Disease progression during treatment|9|||
146063964|NCT01074970|526754004|FG000|Overall Study|Lost to Follow-up|0|||
146063965|NCT01074970|526754005|FG001|Overall Study|Lost to Follow-up|0|||
146063966|NCT01074970|526754006|FG002|Overall Study|Lost to Follow-up|1|||
146063967|NCT01074970|526754007|FG003|Overall Study|Lost to Follow-up|0|||
146063968|NCT01074970|526754004|FG000|Overall Study|Withdrawal by Subject|0|||
146063969|NCT01074970|526754005|FG001|Overall Study|Withdrawal by Subject|0|||
146063970|NCT01074970|526754006|FG002|Overall Study|Withdrawal by Subject|6|||
146063971|NCT01074970|526754007|FG003|Overall Study|Withdrawal by Subject|4|||
146063972|NCT05523089|526754011|FG000|Overall Study|Withdrawal by Subject|1|||
146063973|NCT05523089|526754012|FG001|Overall Study|Withdrawal by Subject|0|||
146063974|NCT05523089|526754013|FG002|Overall Study|Withdrawal by Subject|0|||
146063975|NCT05523089|526754011|FG000|Overall Study|Lost to Follow-up|1|||
146063976|NCT05523089|526754012|FG001|Overall Study|Lost to Follow-up|0|||
146063977|NCT05523089|526754013|FG002|Overall Study|Lost to Follow-up|0|||
146063978|NCT02514083|526754014|FG000|Overall Study|Adverse Event|1|||
146063979|NCT01899040|526754015|FG000|Overall Study|Randomized in error|0|||
146063980|NCT01899040|526754016|FG001|Overall Study|Randomized in error|1|||
146063981|NCT01899040|526754017|FG002|Overall Study|Randomized in error|1|||
146063982|NCT01899040|526754015|FG000|Overall Study|Adverse Event|3|||
146063983|NCT01899040|526754016|FG001|Overall Study|Adverse Event|1|||
146063984|NCT01899040|526754017|FG002|Overall Study|Adverse Event|2|||
146063985|NCT01899040|526754015|FG000|Overall Study|Unspecified reasons|4|||
146063986|NCT01899040|526754016|FG001|Overall Study|Unspecified reasons|4|||
146063987|NCT01899040|526754017|FG002|Overall Study|Unspecified reasons|0|||
146063988|NCT01899040|526754015|FG000|Overall Study|Compliance issues|1|||
146063989|NCT01899040|526754016|FG001|Overall Study|Compliance issues|2|||
146063990|NCT01899040|526754017|FG002|Overall Study|Compliance issues|0|||
146063991|NCT01710501|526755922|FG000|Overall Study|Lost to Follow-up|2|||
146063992|NCT01710501|526755923|FG001|Overall Study|Lost to Follow-up|0|||
146063993|NCT01710501|526755924|FG002|Overall Study|Lost to Follow-up|0|||
146063994|NCT02536976|526755925|FG000|Overall Study|Physician Decision|0|||
146063995|NCT02536976|526755926|FG001|Overall Study|Physician Decision|1|||
146063996|NCT02144610|526755929|FG000|Overall Study|Physician Decision|1|||
146063997|NCT02144610|526755930|FG001|Overall Study|Physician Decision|0|||
146063998|NCT02144610|526755929|FG000|Overall Study|Withdrawal by Subject|1|||
146063999|NCT02144610|526755930|FG001|Overall Study|Withdrawal by Subject|5|||
146064000|NCT02144610|526755929|FG000|Overall Study|Death|2|||
146064001|NCT02144610|526755930|FG001|Overall Study|Death|2|||
146064002|NCT02144610|526755929|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
146064003|NCT02144610|526755930|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
146064004|NCT02144610|526755929|FG000|Overall Study|Other|0|||
146064005|NCT02144610|526755930|FG001|Overall Study|Other|1|||
146064006|NCT01432730|526755932|FG000|Period 1|Adverse Event|2|||
146064007|NCT01432730|526755933|FG001|Period 1|Adverse Event|0|||
146064008|NCT01432730|526755932|FG000|Period 2|Adverse Event|0|||
146064009|NCT01432730|526755933|FG001|Period 2|Adverse Event|4|||
146064010|NCT03038100|526755947|FG000|Overall Study|Death|289|||
146064011|NCT03038100|526755948|FG001|Overall Study|Death|272|||
146064012|NCT03038100|526755947|FG000|Overall Study|Lost to Follow-up|9|||
146064013|NCT03038100|526755948|FG001|Overall Study|Lost to Follow-up|10|||
146064014|NCT03038100|526755947|FG000|Overall Study|Protocol Deviation|1|||
146064015|NCT03038100|526755948|FG001|Overall Study|Protocol Deviation|4|||
146064016|NCT03038100|526755947|FG000|Overall Study|Withdrawal by Subject|45|||
146064017|NCT03038100|526755948|FG001|Overall Study|Withdrawal by Subject|51|||
146064018|NCT03038100|526755947|FG000|Overall Study|Study Terminated By Sponsor|305|||
146064019|NCT03038100|526755948|FG001|Overall Study|Study Terminated By Sponsor|311|||
146064020|NCT03038100|526755947|FG000|Overall Study|Physician Decision|1|||
146064021|NCT03038100|526755948|FG001|Overall Study|Physician Decision|3|||
146064022|NCT03250273|526755981|FG000|Overall Study|Disease Progression|2|||
146064023|NCT03250273|526755982|FG001|Overall Study|Disease Progression|11|||
146064024|NCT03250273|526755981|FG000|Overall Study|Death|0|||
146064025|NCT03250273|526755982|FG001|Overall Study|Death|1|||
146064026|NCT04154904|526755983|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
146064027|NCT04154904|526755984|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
146064028|NCT04154904|526755985|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
146064029|NCT02392624|526755986|FG000|Overall Study|Withdrawal by Subject|15|||
146064030|NCT02392624|526755987|FG001|Overall Study|Withdrawal by Subject|12|||
146064031|NCT02392624|526755988|FG002|Overall Study|Withdrawal by Subject|9|||
146064032|NCT02392624|526755986|FG000|Overall Study|Adverse Event|4|||
146064033|NCT02392624|526755987|FG001|Overall Study|Adverse Event|1|||
146064034|NCT02392624|526755988|FG002|Overall Study|Adverse Event|2|||
146064035|NCT02392624|526755986|FG000|Overall Study|Pregnancy|1|||
146064036|NCT02392624|526755987|FG001|Overall Study|Pregnancy|0|||
146064037|NCT02392624|526755988|FG002|Overall Study|Pregnancy|0|||
146064038|NCT02392624|526755986|FG000|Overall Study|Protocol Violation|0|||
146064039|NCT02392624|526755987|FG001|Overall Study|Protocol Violation|0|||
146064040|NCT02392624|526755988|FG002|Overall Study|Protocol Violation|1|||
146064041|NCT02392624|526755986|FG000|Overall Study|Sponsor/Investigator Decision|2|||
146064042|NCT02392624|526755987|FG001|Overall Study|Sponsor/Investigator Decision|1|||
146064043|NCT02392624|526755988|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146064044|NCT02392624|526755986|FG000|Overall Study|Other|49|||
146064045|NCT02392624|526755987|FG001|Overall Study|Other|1|||
146064046|NCT02392624|526755988|FG002|Overall Study|Other|1|||
146064047|NCT00936715|526755989|FG000|Overall Study|Investigators Discretion|1|||
146064048|NCT00936715|526755989|FG000|Overall Study|Protocol Violation|1|||
146064049|NCT00936715|526755989|FG000|Overall Study|Safety or Tolerability Reasons|4|||
146064050|NCT03841604|526755990|FG000|Overall Study|Withdrawal by Subject|3|||
146064051|NCT03841604|526755991|FG001|Overall Study|Withdrawal by Subject|1|||
146064052|NCT03841604|526755990|FG000|Overall Study|Adverse Event|4|||
146064053|NCT03841604|526755991|FG001|Overall Study|Adverse Event|2|||
146064054|NCT03841604|526755990|FG000|Overall Study|Physician Decision|1|||
146064055|NCT03841604|526755991|FG001|Overall Study|Physician Decision|0|||
146064056|NCT02492763|526755992|FG000|Overall Study|Withdrawal by Subject|0|||
146064057|NCT02492763|526755993|FG001|Overall Study|Withdrawal by Subject|2|||
146064058|NCT02492763|526755994|FG002|Overall Study|Withdrawal by Subject|1|||
146064059|NCT02492763|526755995|FG003|Overall Study|Withdrawal by Subject|0|||
146064060|NCT02492763|526755992|FG000|Overall Study|Adverse Event|3|||
146064061|NCT02492763|526755993|FG001|Overall Study|Adverse Event|1|||
146064062|NCT02492763|526755994|FG002|Overall Study|Adverse Event|1|||
146064063|NCT02492763|526755995|FG003|Overall Study|Adverse Event|2|||
146064064|NCT02492763|526755992|FG000|Overall Study|Death|0|||
146064065|NCT02492763|526755993|FG001|Overall Study|Death|0|||
146064066|NCT02492763|526755994|FG002|Overall Study|Death|1|||
146064067|NCT02492763|526755995|FG003|Overall Study|Death|0|||
146064068|NCT02492763|526755992|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146064069|NCT02492763|526755993|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
146064070|NCT02492763|526755994|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146064071|NCT02492763|526755995|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
146064072|NCT02492763|526755992|FG000|Overall Study|Lost to Follow-up|0|||
146064073|NCT02492763|526755993|FG001|Overall Study|Lost to Follow-up|0|||
146064074|NCT02492763|526755994|FG002|Overall Study|Lost to Follow-up|1|||
146064075|NCT02492763|526755995|FG003|Overall Study|Lost to Follow-up|0|||
146064076|NCT02492763|526755992|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146064077|NCT02492763|526755993|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146064078|NCT02492763|526755994|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146064079|NCT02492763|526755995|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146407854|NCT03555890|528000044|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
146407855|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
146407856|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146407857|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
146407858|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146407859|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
146407860|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146407861|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146407862|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146407863|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146407864|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146407865|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
146064080|NCT02492763|526755992|FG000|Overall Study|Screen Failure|0|||
146064081|NCT02492763|526755993|FG001|Overall Study|Screen Failure|0|||
146064082|NCT02492763|526755994|FG002|Overall Study|Screen Failure|0|||
146064083|NCT02492763|526755995|FG003|Overall Study|Screen Failure|1|||
146407866|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146407867|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146064084|NCT02492763|526755992|FG000|Overall Study|Study Terminated by Sponsor|13|||
146064085|NCT02492763|526755993|FG001|Overall Study|Study Terminated by Sponsor|10|||
146064086|NCT02492763|526755994|FG002|Overall Study|Study Terminated by Sponsor|6|||
146064087|NCT02492763|526755995|FG003|Overall Study|Study Terminated by Sponsor|10|||
146064088|NCT03877510|526755996|FG000|Overall Study|Death|6|||
146064089|NCT03877510|526755996|FG000|Overall Study|Lost to Follow-up|2|||
146064090|NCT03877510|526755996|FG000|Overall Study|Non-compliance with study drug|2|||
146064091|NCT03877510|526755996|FG000|Overall Study|Lack of Efficacy|14|||
146064092|NCT03877510|526755996|FG000|Overall Study|Adverse Event|20|||
146064093|NCT03877510|526755996|FG000|Overall Study|Withdrawal by Subject|22|||
146064094|NCT03877510|526755996|FG000|Overall Study|Miscellaneous|1|||
146064095|NCT01337960|526755997|FG000|Overall Study|Lost to Follow-up|1|||
146064096|NCT01337960|526755998|FG001|Overall Study|Lost to Follow-up|0|||
146064097|NCT01337960|526755999|FG002|Overall Study|Lost to Follow-up|0|||
146064098|NCT01337960|526755997|FG000|Overall Study|Withdrawal by Subject|1|||
146064099|NCT01337960|526755998|FG001|Overall Study|Withdrawal by Subject|0|||
146064100|NCT01337960|526755999|FG002|Overall Study|Withdrawal by Subject|0|||
146064101|NCT02085161|526756001|FG000|Overall Study|Not Treated|1|||
146064102|NCT02085161|526756002|FG001|Overall Study|Not Treated|0|||
146064103|NCT02085161|526756003|FG002|Overall Study|Not Treated|0|||
146064104|NCT02085161|526756004|FG003|Overall Study|Not Treated|0|||
146064105|NCT02085161|526756001|FG000|Overall Study|Adverse Event|8|||
146064106|NCT02085161|526756002|FG001|Overall Study|Adverse Event|5|||
146064107|NCT02085161|526756003|FG002|Overall Study|Adverse Event|4|||
146064108|NCT02085161|526756004|FG003|Overall Study|Adverse Event|5|||
146064109|NCT02085161|526756001|FG000|Overall Study|Protocol Violation|0|||
146064110|NCT02085161|526756002|FG001|Overall Study|Protocol Violation|1|||
146064111|NCT02085161|526756003|FG002|Overall Study|Protocol Violation|0|||
146064112|NCT02085161|526756004|FG003|Overall Study|Protocol Violation|1|||
146064113|NCT02085161|526756001|FG000|Overall Study|Withdrawal by Subject|2|||
146064114|NCT02085161|526756002|FG001|Overall Study|Withdrawal by Subject|4|||
146064115|NCT02085161|526756003|FG002|Overall Study|Withdrawal by Subject|0|||
146064116|NCT02085161|526756004|FG003|Overall Study|Withdrawal by Subject|3|||
146064117|NCT02085161|526756001|FG000|Overall Study|Other Reason|1|||
146064118|NCT02085161|526756002|FG001|Overall Study|Other Reason|0|||
146064119|NCT02085161|526756003|FG002|Overall Study|Other Reason|1|||
146064120|NCT02085161|526756004|FG003|Overall Study|Other Reason|1|||
146064121|NCT01936870|526756009|FG000|Overall Study|No Visit After Treatment|176|||
146064122|NCT01936870|526756009|FG000|Overall Study|Protocol Violation|12|||
146064123|NCT01936870|526756009|FG000|Overall Study|No Drug Administration|1|||
146064124|NCT00628108|526756015|FG000|Overall Study|Adverse Event|0|||
146064125|NCT00628108|526756016|FG001|Overall Study|Adverse Event|3|||
146064126|NCT00628108|526756015|FG000|Overall Study|Withdrawal by Subject|1|||
146064127|NCT00628108|526756016|FG001|Overall Study|Withdrawal by Subject|0|||
146064128|NCT03848832|526756017|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
146064129|NCT03848832|526756018|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
146064130|NCT03848832|526756019|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
146064131|NCT03848832|526756017|FG000|Overall Study|Withdrawal by Subject|0|||
146064132|NCT03848832|526756018|FG001|Overall Study|Withdrawal by Subject|0|||
146064133|NCT03848832|526756019|FG002|Overall Study|Withdrawal by Subject|1|||
146064134|NCT03848832|526756017|FG000|Overall Study|Withdrawal (Covid-19)|0|||
146064135|NCT03848832|526756018|FG001|Overall Study|Withdrawal (Covid-19)|2|||
146064136|NCT03848832|526756019|FG002|Overall Study|Withdrawal (Covid-19)|0|||
146064137|NCT03848832|526756017|FG000|Overall Study|Physician Decision|2|||
146064138|NCT03848832|526756018|FG001|Overall Study|Physician Decision|1|||
146064139|NCT03848832|526756019|FG002|Overall Study|Physician Decision|3|||
146064140|NCT03848832|526756017|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
146064141|NCT03848832|526756018|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
146064142|NCT03848832|526756019|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
146064143|NCT03848832|526756017|FG000|Overall Study|Adverse Event|1|||
146064144|NCT03848832|526756018|FG001|Overall Study|Adverse Event|0|||
146064145|NCT03848832|526756019|FG002|Overall Study|Adverse Event|0|||
146064146|NCT00719472|526756021|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
146064147|NCT00719472|526756021|FG000|Enrolled in Study|Subject decision to withdraw|8|||
146064148|NCT00719472|526756021|FG000|Enrolled in Study|Various Reasons|17|||
146171754|NCT00988221|527143222|FG000|Part I|Refused Treatment|0|||
146171755|NCT00988221|527143223|FG001|Part I|Refused Treatment|2|||
146171756|NCT00988221|527143224|FG002|Part I|Refused Treatment|1|||
146064149|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
146064150|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Death|5|||
146064151|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
146064152|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
146064153|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
146064154|NCT00719472|526756021|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
146171757|NCT00988221|527143225|FG003|Part I|Refused Treatment|0|||
146064155|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
146064156|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Death|6|||
146064157|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Disease progression|3|||
146064158|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
146064159|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
146064160|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
146171758|NCT00988221|527143222|FG000|Part I|Lost to Follow-up|0|||
146064161|NCT00719472|526756021|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
146064162|NCT00711191|526756024|FG000|Overall Study|Adverse Event|1|||
146064163|NCT00711191|526756025|FG001|Overall Study|Adverse Event|1|||
146064164|NCT00711191|526756026|FG002|Overall Study|Adverse Event|2|||
146064165|NCT00711191|526756024|FG000|Overall Study|Objective progression or relapse|2|||
146064166|NCT00711191|526756025|FG001|Overall Study|Objective progression or relapse|3|||
146064167|NCT00711191|526756026|FG002|Overall Study|Objective progression or relapse|7|||
146064168|NCT00711191|526756024|FG000|Overall Study|Withdrawal by Subject|0|||
146064169|NCT00711191|526756025|FG001|Overall Study|Withdrawal by Subject|1|||
146064170|NCT00711191|526756026|FG002|Overall Study|Withdrawal by Subject|3|||
146064171|NCT01744977|526756027|FG000|Overall Study|Withdrawal by Subject|1|||
146064172|NCT01744977|526756028|FG001|Overall Study|Withdrawal by Subject|2|||
146064173|NCT01744977|526756027|FG000|Overall Study|Death|2|||
146064174|NCT01744977|526756028|FG001|Overall Study|Death|3|||
146064175|NCT01744977|526756027|FG000|Overall Study|Lost to Follow-up|2|||
146064176|NCT01744977|526756028|FG001|Overall Study|Lost to Follow-up|0|||
146064177|NCT01744977|526756027|FG000|Overall Study|No longer meets inclusion|6|||
146064178|NCT01744977|526756028|FG001|Overall Study|No longer meets inclusion|0|||
146064179|NCT00912808|526756031|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
146064180|NCT00912808|526756032|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146064181|NCT00912808|526756031|FG000|Washout|Withdrawal by Subject|0|||
146064182|NCT00912808|526756032|FG001|Washout|Withdrawal by Subject|1|||
146064183|NCT00912808|526756031|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146064184|NCT00912808|526756032|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
146064185|NCT00912808|526756031|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
146064186|NCT00912808|526756032|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
146064187|NCT03345784|526756035|FG000|Overall Study|Withdrawal by Subject|2|||
146064188|NCT03345784|526756036|FG001|Overall Study|Withdrawal by Subject|1|||
146064189|NCT00482053|526756041|FG000|Inter-treatment Period|Disease progression|1|||
146064190|NCT00728689|526756042|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
146064191|NCT00728689|526756043|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
146064192|NCT01055197|526756046|FG000|Overall Study|Protocol Violation|7|||
146064193|NCT01055197|526756047|FG001|Overall Study|Protocol Violation|2|||
146064194|NCT01055197|526756046|FG000|Overall Study|Withdrawal by Subject|2|||
146064195|NCT01055197|526756047|FG001|Overall Study|Withdrawal by Subject|0|||
146064196|NCT00389610|526756048|FG000|Overall Study|Disease Progression|0|||
146064197|NCT00389610|526756049|FG001|Overall Study|Disease Progression|19|||
146064198|NCT00389610|526756048|FG000|Overall Study|Death|0|||
146064199|NCT00389610|526756049|FG001|Overall Study|Death|1|||
146064200|NCT00389610|526756048|FG000|Overall Study|Physician Decision|0|||
146064201|NCT00389610|526756049|FG001|Overall Study|Physician Decision|1|||
146064202|NCT00389610|526756048|FG000|Overall Study|Withdrawal by Subject|0|||
146064203|NCT00389610|526756049|FG001|Overall Study|Withdrawal by Subject|1|||
146064204|NCT00887809|526756050|FG000|Overall Study|Patient Not Treated|3|||
146064205|NCT00887809|526756051|FG001|Overall Study|Patient Not Treated|0|||
146064206|NCT00887809|526756050|FG000|Overall Study|Death|1|||
146064207|NCT00887809|526756051|FG001|Overall Study|Death|0|||
146064208|NCT01550003|526756052|FG000|Overall Study|Adverse Event|0|||
146064209|NCT01550003|526756053|FG001|Overall Study|Adverse Event|9|||
146064210|NCT01550003|526756054|FG002|Overall Study|Adverse Event|15|||
146407868|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146407869|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146064211|NCT01550003|526756052|FG000|Overall Study|Lack of Efficacy|4|||
146064212|NCT01550003|526756053|FG001|Overall Study|Lack of Efficacy|11|||
146064213|NCT01550003|526756054|FG002|Overall Study|Lack of Efficacy|15|||
146064214|NCT01550003|526756052|FG000|Overall Study|Protocol Violation|0|||
146064215|NCT01550003|526756053|FG001|Overall Study|Protocol Violation|3|||
146064216|NCT01550003|526756054|FG002|Overall Study|Protocol Violation|2|||
146064217|NCT01550003|526756052|FG000|Overall Study|Lost to Follow-up|1|||
146064218|NCT01550003|526756053|FG001|Overall Study|Lost to Follow-up|4|||
146407870|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146407871|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
146407872|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146407873|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146407874|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
146407875|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
146407876|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146407877|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146064219|NCT01550003|526756054|FG002|Overall Study|Lost to Follow-up|8|||
146064220|NCT01550003|526756052|FG000|Overall Study|Consent withdrawn|2|||
146064221|NCT01550003|526756053|FG001|Overall Study|Consent withdrawn|11|||
146064222|NCT01550003|526756054|FG002|Overall Study|Consent withdrawn|23|||
146064223|NCT01550003|526756052|FG000|Overall Study|Missing|1|||
146064224|NCT01550003|526756053|FG001|Overall Study|Missing|0|||
146064225|NCT01550003|526756054|FG002|Overall Study|Missing|2|||
146064226|NCT01550003|526756052|FG000|Overall Study|Study closure as announced by sponsor|7|||
146064227|NCT01550003|526756053|FG001|Overall Study|Study closure as announced by sponsor|6|||
146064228|NCT01550003|526756054|FG002|Overall Study|Study closure as announced by sponsor|24|||
146064229|NCT01550003|526756052|FG000|Overall Study|Protocol Noncompliance|1|||
146064230|NCT01550003|526756053|FG001|Overall Study|Protocol Noncompliance|0|||
146064231|NCT01550003|526756054|FG002|Overall Study|Protocol Noncompliance|0|||
146064232|NCT01550003|526756052|FG000|Overall Study|Study closure|0|||
146064233|NCT01550003|526756053|FG001|Overall Study|Study closure|1|||
146064234|NCT01550003|526756054|FG002|Overall Study|Study closure|1|||
146064235|NCT01550003|526756052|FG000|Overall Study|Patient reached adulthood|0|||
146064236|NCT01550003|526756053|FG001|Overall Study|Patient reached adulthood|1|||
146064237|NCT01550003|526756054|FG002|Overall Study|Patient reached adulthood|0|||
146064238|NCT01550003|526756052|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
146064239|NCT01550003|526756053|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
146064240|NCT01550003|526756054|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
146064241|NCT01550003|526756052|FG000|Overall Study|Sponsor's order|0|||
146064242|NCT01550003|526756053|FG001|Overall Study|Sponsor's order|3|||
146064243|NCT01550003|526756054|FG002|Overall Study|Sponsor's order|3|||
146064244|NCT01550003|526756052|FG000|Overall Study|Sponsor's decision|1|||
146064245|NCT01550003|526756053|FG001|Overall Study|Sponsor's decision|5|||
146064246|NCT01550003|526756054|FG002|Overall Study|Sponsor's decision|4|||
146064247|NCT01550003|526756052|FG000|Overall Study|Subject mother passed away|0|||
146064248|NCT01550003|526756053|FG001|Overall Study|Subject mother passed away|1|||
146064249|NCT01550003|526756054|FG002|Overall Study|Subject mother passed away|0|||
146064250|NCT01550003|526756052|FG000|Overall Study|Discontinuation|0|||
146064251|NCT01550003|526756053|FG001|Overall Study|Discontinuation|1|||
146064252|NCT01550003|526756054|FG002|Overall Study|Discontinuation|0|||
146064253|NCT01550003|526756052|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
146064254|NCT01550003|526756053|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
146064255|NCT01550003|526756054|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
146064256|NCT01550003|526756052|FG000|Overall Study|Site closure|0|||
146064257|NCT01550003|526756053|FG001|Overall Study|Site closure|2|||
146064258|NCT01550003|526756054|FG002|Overall Study|Site closure|0|||
146064259|NCT01550003|526756052|FG000|Overall Study|Pregnancy|0|||
146064260|NCT01550003|526756053|FG001|Overall Study|Pregnancy|1|||
146064261|NCT01550003|526756054|FG002|Overall Study|Pregnancy|0|||
146064262|NCT01550003|526756052|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
146064263|NCT01550003|526756053|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
146064264|NCT01550003|526756054|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
146064265|NCT01550003|526756052|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
146064266|NCT01550003|526756053|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
146064267|NCT01550003|526756054|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
146064268|NCT01550003|526756052|FG000|Overall Study|Switching to adult rheumatologist|0|||
146064269|NCT01550003|526756053|FG001|Overall Study|Switching to adult rheumatologist|0|||
146064270|NCT01550003|526756054|FG002|Overall Study|Switching to adult rheumatologist|1|||
146064271|NCT01550003|526756052|FG000|Overall Study|Patient transition to adult care|0|||
146064272|NCT01550003|526756053|FG001|Overall Study|Patient transition to adult care|0|||
146064273|NCT01550003|526756054|FG002|Overall Study|Patient transition to adult care|1|||
146064274|NCT01550003|526756052|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
146064275|NCT01550003|526756053|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
146064276|NCT01550003|526756054|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
146064277|NCT01550003|526756052|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
146064278|NCT01550003|526756053|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
146064279|NCT01550003|526756054|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
146064280|NCT01550003|526756052|FG000|Overall Study|Per Sponsor request|1|||
146064281|NCT01550003|526756053|FG001|Overall Study|Per Sponsor request|0|||
146064282|NCT01550003|526756054|FG002|Overall Study|Per Sponsor request|1|||
146064283|NCT01550003|526756052|FG000|Overall Study|Patient not compliance|0|||
146064284|NCT01550003|526756053|FG001|Overall Study|Patient not compliance|0|||
146064285|NCT01550003|526756054|FG002|Overall Study|Patient not compliance|1|||
146064286|NCT01550003|526756052|FG000|Overall Study|Non-compliance|0|||
146064287|NCT01550003|526756053|FG001|Overall Study|Non-compliance|0|||
146064288|NCT01550003|526756054|FG002|Overall Study|Non-compliance|1|||
145890928|NCT01207440|526107572|FG002|Overall Study|Lost to Follow-up|2|||
146064289|NCT01550003|526756052|FG000|Overall Study|Study closed|0|||
146064290|NCT01550003|526756053|FG001|Overall Study|Study closed|1|||
146064291|NCT01550003|526756054|FG002|Overall Study|Study closed|0|||
146064292|NCT01550003|526756052|FG000|Overall Study|Transitioned to adult rheumatology|0|||
146064293|NCT01550003|526756053|FG001|Overall Study|Transitioned to adult rheumatology|0|||
146064294|NCT01550003|526756054|FG002|Overall Study|Transitioned to adult rheumatology|1|||
146064295|NCT05567783|526756055|FG000|Overall Study|Death|2|||
146064296|NCT05567783|526756056|FG001|Overall Study|Death|3|||
146064297|NCT05567783|526756057|FG002|Overall Study|Death|0|||
146064298|NCT05567783|526756055|FG000|Overall Study|Lost to Follow-up|25|||
146064299|NCT05567783|526756056|FG001|Overall Study|Lost to Follow-up|19|||
146064300|NCT05567783|526756057|FG002|Overall Study|Lost to Follow-up|17|||
146064301|NCT05567783|526756055|FG000|Overall Study|Physician Decision|10|||
146064302|NCT05567783|526756056|FG001|Overall Study|Physician Decision|7|||
146064303|NCT05567783|526756057|FG002|Overall Study|Physician Decision|9|||
146064304|NCT05567783|526756055|FG000|Overall Study|Study Terminated by Sponsor|924|||
146064305|NCT05567783|526756056|FG001|Overall Study|Study Terminated by Sponsor|937|||
146064306|NCT05567783|526756057|FG002|Overall Study|Study Terminated by Sponsor|941|||
146064307|NCT05567783|526756055|FG000|Overall Study|Withdrawal by Subject|23|||
146064308|NCT05567783|526756056|FG001|Overall Study|Withdrawal by Subject|27|||
146064309|NCT05567783|526756057|FG002|Overall Study|Withdrawal by Subject|24|||
146064310|NCT05567783|526756055|FG000|Overall Study|Incarcerated|1|||
146064311|NCT05567783|526756056|FG001|Overall Study|Incarcerated|0|||
146064312|NCT05567783|526756057|FG002|Overall Study|Incarcerated|0|||
146064313|NCT05567783|526756055|FG000|Overall Study|Participant randomized in error|4|||
146064314|NCT05567783|526756056|FG001|Overall Study|Participant randomized in error|2|||
146064315|NCT05567783|526756057|FG002|Overall Study|Participant randomized in error|2|||
146064316|NCT03675126|526756060|FG000|Overall Study|Study Terminated by Sponsor|9|||
146064317|NCT03675126|526756060|FG000|Overall Study|Death|2|||
146064318|NCT03675126|526756060|FG000|Overall Study|Withdrawal by Subject|4|||
146064319|NCT00001959|526756061|FG000|Overall Study|newly diagnosed colon cancer|1|||
146064320|NCT00001959|526756061|FG000|Overall Study|disabling sedation|1|||
146064321|NCT00001959|526756061|FG000|Overall Study|non-compliance|1|||
146064322|NCT03995368|526756064|FG000|Overall Study|Lost to Follow-up|1|||
146064323|NCT03995368|526756065|FG001|Overall Study|Lost to Follow-up|4|||
146064324|NCT03995368|526756066|FG002|Overall Study|Lost to Follow-up|1|||
146064325|NCT03995368|526756064|FG000|Overall Study|Did not meet inclusion criteria|1|||
146064326|NCT03995368|526756065|FG001|Overall Study|Did not meet inclusion criteria|6|||
146064327|NCT03995368|526756066|FG002|Overall Study|Did not meet inclusion criteria|3|||
146064328|NCT03995368|526756064|FG000|Overall Study|Withdrawal by Subject|0|||
146064329|NCT03995368|526756065|FG001|Overall Study|Withdrawal by Subject|1|||
146064330|NCT03995368|526756066|FG002|Overall Study|Withdrawal by Subject|1|||
146064331|NCT03592186|526756067|FG000|Overall Study|Withdrawal by Subject|1|||
146064332|NCT03592186|526756068|FG001|Overall Study|Withdrawal by Subject|0|||
146064333|NCT03592186|526756067|FG000|Overall Study|Lost to Follow-up|16|||
146064334|NCT03592186|526756068|FG001|Overall Study|Lost to Follow-up|11|||
146064335|NCT01052493|526756069|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
146064336|NCT01052493|526756070|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
146064337|NCT01052493|526756071|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
146064338|NCT00307801|526756072|FG000|Overall Study|Adverse Event|12|||
146064339|NCT00307801|526756073|FG001|Overall Study|Adverse Event|4|||
146064340|NCT00307801|526756072|FG000|Overall Study|Withdrawal by Subject|9|||
146064341|NCT00307801|526756073|FG001|Overall Study|Withdrawal by Subject|4|||
146064342|NCT00307801|526756072|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
146064343|NCT00307801|526756073|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
146064344|NCT00307801|526756072|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
146064345|NCT00307801|526756073|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
146064346|NCT00307801|526756072|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
146064347|NCT00307801|526756073|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
146064348|NCT00307801|526756072|FG000|Overall Study|Wrong Randomization|1|||
146064349|NCT00307801|526756073|FG001|Overall Study|Wrong Randomization|0|||
146064350|NCT00307801|526756072|FG000|Overall Study|Lack of Efficacy|0|||
146064351|NCT00307801|526756073|FG001|Overall Study|Lack of Efficacy|2|||
146064352|NCT00307801|526756072|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
146064353|NCT00307801|526756073|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
146064354|NCT00307801|526756072|FG000|Overall Study|Frustration with e-diary|1|||
146064355|NCT00307801|526756073|FG001|Overall Study|Frustration with e-diary|0|||
146064356|NCT00307801|526756072|FG000|Overall Study|Protocol Violation|3|||
146064357|NCT00307801|526756073|FG001|Overall Study|Protocol Violation|2|||
146064358|NCT00307801|526756072|FG000|Overall Study|No reason specified|2|||
146064359|NCT00307801|526756073|FG001|Overall Study|No reason specified|0|||
146064360|NCT00307801|526756072|FG000|Overall Study|Pregnancy|0|||
146064361|NCT00307801|526756073|FG001|Overall Study|Pregnancy|1|||
146064362|NCT00391586|526756077|FG000|Overall Study|Progressive disease|13|||
146064363|NCT00391586|526756077|FG000|Overall Study|Adverse Event|5|||
146064364|NCT00391586|526756077|FG000|Overall Study|Physician Decision|2|||
146407878|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146407879|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
146407880|NCT04682639|528000045|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146407881|NCT04682639|528000046|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146407882|NCT04682639|528000047|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
146407883|NCT04682639|528000048|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146407884|NCT04682639|528000049|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146407885|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
146407886|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
146407887|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
146407888|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
146407889|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
146407890|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Other|1|||
146407891|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Other|2|||
146407892|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Other|0|||
146407893|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Other|0|||
146407894|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Other|1|||
146407895|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
146407896|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
146407897|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146407898|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146407899|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
146407900|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
146407901|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
146407902|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146407903|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146407904|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146407905|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
146407906|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
146407907|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146407908|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146407909|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146407910|NCT04682639|528000045|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
146407911|NCT04682639|528000046|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
146407912|NCT04682639|528000047|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
146407913|NCT04682639|528000048|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
146407914|NCT04682639|528000049|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
146407915|NCT01383954|528000050|FG000|Overall Study|Lack of Efficacy|2|||
146407916|NCT01383954|528000050|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
146407917|NCT01383954|528000050|FG000|Overall Study|Adverse Event|1|||
146407918|NCT01383954|528000050|FG000|Overall Study|Reason Not Specified|9|||
146064365|NCT00391586|526756077|FG000|Overall Study|Death|4|||
146064366|NCT00453206|526756078|FG000|Overall Study|Death|1|||
146064367|NCT03058146|526756084|FG000|Overall Study|Withdrawal by Subject|4|||
146064368|NCT03058146|526756085|FG001|Overall Study|Withdrawal by Subject|1|||
146064369|NCT03058146|526756084|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
146064370|NCT03058146|526756085|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
146064371|NCT00632229|526756086|FG000|Overall Study|Adverse Event|6|||
146064372|NCT00632229|526756087|FG001|Overall Study|Adverse Event|0|||
146064373|NCT00632229|526756086|FG000|Overall Study|Lost to Follow-up|0|||
146064374|NCT00632229|526756087|FG001|Overall Study|Lost to Follow-up|3|||
146064375|NCT00632229|526756086|FG000|Overall Study|Lack of Efficacy|0|||
146064376|NCT00632229|526756087|FG001|Overall Study|Lack of Efficacy|2|||
146064377|NCT00632229|526756086|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
146064378|NCT00632229|526756087|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
146064379|NCT00577889|526756089|FG000|Overall Study|Withdrawal by Subject|1|||
146064380|NCT00577889|526756090|FG001|Overall Study|Withdrawal by Subject|0|||
146064381|NCT00577889|526756091|FG002|Overall Study|Withdrawal by Subject|0|||
146064382|NCT00993967|526756095|FG000|Overall Study|Adverse Event|8|||
146064383|NCT00993967|526756095|FG000|Overall Study|Death|1|||
146064384|NCT00993967|526756095|FG000|Overall Study|Lost to Follow-up|14|||
146064385|NCT00993967|526756095|FG000|Overall Study|Withdrawal by Subject|36|||
146064386|NCT00993967|526756095|FG000|Overall Study|Protocol Violation|2|||
146064387|NCT04825678|526756098|FG000|Overall Study|Decision by Sponsor|2|||
146064388|NCT04825678|526756099|FG001|Overall Study|Decision by Sponsor|3|||
146064389|NCT04825678|526756098|FG000|Overall Study|Withdrawal of Consent From Study|7|||
146064390|NCT04825678|526756099|FG001|Overall Study|Withdrawal of Consent From Study|9|||
146064391|NCT04825678|526756098|FG000|Overall Study|Lost to Follow-up|3|||
146064392|NCT04825678|526756099|FG001|Overall Study|Lost to Follow-up|4|||
146064393|NCT04825678|526756098|FG000|Overall Study|Never Received Investigational Product|1|||
146064394|NCT04825678|526756099|FG001|Overall Study|Never Received Investigational Product|1|||
146064395|NCT00911170|526756100|FG000|Treatment Period|Randomized in error|1|||
146064396|NCT00911170|526756101|FG001|Treatment Period|Randomized in error|1|||
146064397|NCT00911170|526756100|FG000|Treatment Period|Ineligibility determined|1|||
146064398|NCT00911170|526756101|FG001|Treatment Period|Ineligibility determined|3|||
146064399|NCT00911170|526756100|FG000|Treatment Period|Protocol deviation|1|||
146064400|NCT00911170|526756101|FG001|Treatment Period|Protocol deviation|2|||
146064401|NCT00911170|526756100|FG000|Treatment Period|Adverse Event|9|||
146064402|NCT00911170|526756101|FG001|Treatment Period|Adverse Event|10|||
146064403|NCT00911170|526756100|FG000|Treatment Period|Withdrawal by Subject|4|||
146064404|NCT00911170|526756101|FG001|Treatment Period|Withdrawal by Subject|4|||
146064405|NCT00911170|526756100|FG000|Treatment Period|Disease progression|0|||
146064406|NCT00911170|526756101|FG001|Treatment Period|Disease progression|2|||
146064407|NCT00911170|526756100|FG000|Treatment Period|Physician Decision|5|||
146064408|NCT00911170|526756101|FG001|Treatment Period|Physician Decision|5|||
146064409|NCT00911170|526756100|FG000|Treatment Period|Lost to Follow-up|0|||
146064410|NCT00911170|526756101|FG001|Treatment Period|Lost to Follow-up|1|||
146064411|NCT00911170|526756100|FG000|Treatment Period|Death|6|||
146064412|NCT00911170|526756101|FG001|Treatment Period|Death|9|||
146064413|NCT00911170|526756100|FG000|Long Term Follow-Up|Continuing in study|274|||
146064414|NCT00911170|526756101|FG001|Long Term Follow-Up|Continuing in study|269|||
146064415|NCT00911170|526756100|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
146064416|NCT00911170|526756101|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
146064417|NCT00911170|526756100|FG000|Long Term Follow-Up|Physician Decision|5|||
146064418|NCT00911170|526756101|FG001|Long Term Follow-Up|Physician Decision|4|||
146064419|NCT00911170|526756100|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
146064420|NCT00911170|526756101|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
146064421|NCT00911170|526756100|FG000|Long Term Follow-Up|Death|116|||
146064422|NCT00911170|526756101|FG001|Long Term Follow-Up|Death|121|||
146064423|NCT02594124|526756102|FG000|Overall Study|Adverse Event|0|||
146064424|NCT02594124|526756103|FG001|Overall Study|Adverse Event|5|||
146064425|NCT02594124|526756104|FG002|Overall Study|Adverse Event|8|||
146064426|NCT02594124|526756105|FG003|Overall Study|Adverse Event|1|||
146407919|NCT03471182|528000051|FG000|Overall Study|Withdrawal by Subject|1|||
146064427|NCT02594124|526756106|FG004|Overall Study|Adverse Event|0|||
146064428|NCT02594124|526756107|FG005|Overall Study|Adverse Event|0|||
146064429|NCT02594124|526756108|FG006|Overall Study|Adverse Event|2|||
146064430|NCT02594124|526756109|FG007|Overall Study|Adverse Event|2|||
146064431|NCT02594124|526756110|FG008|Overall Study|Adverse Event|0|||
146064432|NCT02594124|526756102|FG000|Overall Study|Withdrawal by Subject|2|||
146064433|NCT02594124|526756103|FG001|Overall Study|Withdrawal by Subject|3|||
146064434|NCT02594124|526756104|FG002|Overall Study|Withdrawal by Subject|5|||
146064435|NCT02594124|526756105|FG003|Overall Study|Withdrawal by Subject|1|||
146064436|NCT02594124|526756106|FG004|Overall Study|Withdrawal by Subject|8|||
146064437|NCT02594124|526756107|FG005|Overall Study|Withdrawal by Subject|4|||
146064438|NCT02594124|526756108|FG006|Overall Study|Withdrawal by Subject|13|||
146064439|NCT02594124|526756109|FG007|Overall Study|Withdrawal by Subject|19|||
146064440|NCT02594124|526756110|FG008|Overall Study|Withdrawal by Subject|0|||
146064441|NCT02594124|526756102|FG000|Overall Study|Physician Decision|0|||
146064442|NCT02594124|526756103|FG001|Overall Study|Physician Decision|2|||
146064443|NCT02594124|526756104|FG002|Overall Study|Physician Decision|0|||
146064444|NCT02594124|526756105|FG003|Overall Study|Physician Decision|0|||
146064445|NCT02594124|526756106|FG004|Overall Study|Physician Decision|0|||
146064446|NCT02594124|526756107|FG005|Overall Study|Physician Decision|0|||
146064447|NCT02594124|526756108|FG006|Overall Study|Physician Decision|0|||
146064448|NCT02594124|526756109|FG007|Overall Study|Physician Decision|1|||
146064449|NCT02594124|526756110|FG008|Overall Study|Physician Decision|0|||
146064450|NCT02594124|526756102|FG000|Overall Study|Commercial drug|0|||
146064451|NCT02594124|526756103|FG001|Overall Study|Commercial drug|1|||
146064452|NCT02594124|526756104|FG002|Overall Study|Commercial drug|6|||
146064453|NCT02594124|526756105|FG003|Overall Study|Commercial drug|3|||
146064454|NCT02594124|526756106|FG004|Overall Study|Commercial drug|0|||
146064455|NCT02594124|526756107|FG005|Overall Study|Commercial drug|0|||
146064456|NCT02594124|526756108|FG006|Overall Study|Commercial drug|7|||
146064457|NCT02594124|526756109|FG007|Overall Study|Commercial drug|11|||
146064458|NCT02594124|526756110|FG008|Overall Study|Commercial drug|2|||
146064459|NCT02594124|526756102|FG000|Overall Study|Reason Not Specified|1|||
146064460|NCT02594124|526756103|FG001|Overall Study|Reason Not Specified|3|||
146064461|NCT02594124|526756104|FG002|Overall Study|Reason Not Specified|4|||
146064462|NCT02594124|526756105|FG003|Overall Study|Reason Not Specified|0|||
146064463|NCT02594124|526756106|FG004|Overall Study|Reason Not Specified|0|||
146064464|NCT02594124|526756107|FG005|Overall Study|Reason Not Specified|1|||
146064465|NCT02594124|526756108|FG006|Overall Study|Reason Not Specified|1|||
146064466|NCT02594124|526756109|FG007|Overall Study|Reason Not Specified|6|||
146064467|NCT02594124|526756110|FG008|Overall Study|Reason Not Specified|1|||
146064468|NCT01824836|526756111|FG000|Overall Study|Adverse Event|48|||
146064469|NCT01824836|526756111|FG000|Overall Study|Withdrawal by Subject|63|||
146064470|NCT01824836|526756111|FG000|Overall Study|Other complicating disease|116|||
146064471|NCT01824836|526756111|FG000|Overall Study|Disease progression|5|||
146064472|NCT01824836|526756111|FG000|Overall Study|Alternative therapy|2|||
146064473|NCT01824836|526756111|FG000|Overall Study|Depression|1|||
146064474|NCT01824836|526756111|FG000|Overall Study|Non-compliance|3|||
146064475|NCT01824836|526756111|FG000|Overall Study|Patient regained ovarian function|3|||
146064476|NCT01824836|526756111|FG000|Overall Study|Lost to Follow-up|8|||
146064477|NCT01824836|526756111|FG000|Overall Study|Physician Decision|2|||
146064478|NCT01824836|526756111|FG000|Overall Study|Research office was closed|3|||
146064479|NCT01824836|526756111|FG000|Overall Study|Relocation|3|||
146064480|NCT01824836|526756111|FG000|Overall Study|Insurance-related issue|1|||
146064481|NCT01824836|526756111|FG000|Overall Study|Transportation issue|1|||
146064482|NCT01824836|526756111|FG000|Overall Study|Patient transferred care|1|||
146064483|NCT01824836|526756111|FG000|Overall Study|Unknown reasons|4|||
146064484|NCT01824836|526756111|FG000|Overall Study|Never started treatment|16|||
146064485|NCT04323124|526756114|FG000|Overall Study|Adverse Event|0|||
146064486|NCT04323124|526756115|FG001|Overall Study|Adverse Event|0|||
146064487|NCT04323124|526756116|FG002|Overall Study|Adverse Event|0|||
146064488|NCT04323124|526756117|FG003|Overall Study|Adverse Event|0|||
146064489|NCT04323124|526756118|FG004|Overall Study|Adverse Event|0|||
146064490|NCT04323124|526756119|FG005|Overall Study|Adverse Event|1|||
146064491|NCT04323124|526756120|FG006|Overall Study|Adverse Event|0|||
146064492|NCT04323124|526756121|FG007|Overall Study|Adverse Event|1|||
146064493|NCT04323124|526756122|FG008|Overall Study|Adverse Event|1|||
146064494|NCT04323124|526756123|FG009|Overall Study|Adverse Event|0|||
146064495|NCT04323124|526756124|FG010|Overall Study|Adverse Event|0|||
146064496|NCT04323124|526756125|FG011|Overall Study|Adverse Event|0|||
146064497|NCT04323124|526756126|FG012|Overall Study|Adverse Event|0|||
146064498|NCT04323124|526756127|FG013|Overall Study|Adverse Event|0|||
146064499|NCT04323124|526756128|FG014|Overall Study|Adverse Event|0|||
146064500|NCT04323124|526756114|FG000|Overall Study|Other|0|||
146064501|NCT04323124|526756115|FG001|Overall Study|Other|0|||
146064502|NCT04323124|526756116|FG002|Overall Study|Other|0|||
146064503|NCT04323124|526756117|FG003|Overall Study|Other|0|||
146064504|NCT04323124|526756118|FG004|Overall Study|Other|1|||
146064505|NCT04323124|526756119|FG005|Overall Study|Other|0|||
146064506|NCT04323124|526756120|FG006|Overall Study|Other|0|||
146064507|NCT04323124|526756121|FG007|Overall Study|Other|0|||
146064508|NCT04323124|526756122|FG008|Overall Study|Other|1|||
146064509|NCT04323124|526756123|FG009|Overall Study|Other|0|||
146064510|NCT04323124|526756124|FG010|Overall Study|Other|0|||
146064511|NCT04323124|526756125|FG011|Overall Study|Other|0|||
146064512|NCT04323124|526756126|FG012|Overall Study|Other|0|||
146064513|NCT04323124|526756127|FG013|Overall Study|Other|0|||
146064514|NCT04323124|526756128|FG014|Overall Study|Other|0|||
146064515|NCT04323124|526756114|FG000|Overall Study|Coming from a red zone (COVID)|0|||
146064516|NCT04323124|526756115|FG001|Overall Study|Coming from a red zone (COVID)|0|||
146064517|NCT04323124|526756116|FG002|Overall Study|Coming from a red zone (COVID)|0|||
146064518|NCT04323124|526756117|FG003|Overall Study|Coming from a red zone (COVID)|0|||
146064519|NCT04323124|526756118|FG004|Overall Study|Coming from a red zone (COVID)|1|||
146064520|NCT04323124|526756119|FG005|Overall Study|Coming from a red zone (COVID)|1|||
146064521|NCT04323124|526756120|FG006|Overall Study|Coming from a red zone (COVID)|0|||
146064522|NCT04323124|526756121|FG007|Overall Study|Coming from a red zone (COVID)|0|||
146064523|NCT04323124|526756122|FG008|Overall Study|Coming from a red zone (COVID)|0|||
146064524|NCT04323124|526756123|FG009|Overall Study|Coming from a red zone (COVID)|0|||
146064525|NCT04323124|526756124|FG010|Overall Study|Coming from a red zone (COVID)|0|||
146064526|NCT04323124|526756125|FG011|Overall Study|Coming from a red zone (COVID)|0|||
146064527|NCT04323124|526756126|FG012|Overall Study|Coming from a red zone (COVID)|0|||
146064528|NCT04323124|526756127|FG013|Overall Study|Coming from a red zone (COVID)|0|||
146064529|NCT04323124|526756128|FG014|Overall Study|Coming from a red zone (COVID)|0|||
146064530|NCT04323124|526756114|FG000|Overall Study|No longer meets eligibility criteria|0|||
146064531|NCT04323124|526756115|FG001|Overall Study|No longer meets eligibility criteria|0|||
146064532|NCT04323124|526756116|FG002|Overall Study|No longer meets eligibility criteria|0|||
146064533|NCT04323124|526756117|FG003|Overall Study|No longer meets eligibility criteria|0|||
146064534|NCT04323124|526756118|FG004|Overall Study|No longer meets eligibility criteria|0|||
146064535|NCT04323124|526756119|FG005|Overall Study|No longer meets eligibility criteria|0|||
146064536|NCT04323124|526756120|FG006|Overall Study|No longer meets eligibility criteria|0|||
146064537|NCT04323124|526756121|FG007|Overall Study|No longer meets eligibility criteria|1|||
146064538|NCT04323124|526756122|FG008|Overall Study|No longer meets eligibility criteria|0|||
146064539|NCT04323124|526756123|FG009|Overall Study|No longer meets eligibility criteria|0|||
146064540|NCT04323124|526756124|FG010|Overall Study|No longer meets eligibility criteria|0|||
146064541|NCT04323124|526756125|FG011|Overall Study|No longer meets eligibility criteria|0|||
146064542|NCT04323124|526756126|FG012|Overall Study|No longer meets eligibility criteria|0|||
146064543|NCT04323124|526756127|FG013|Overall Study|No longer meets eligibility criteria|1|||
146064544|NCT04323124|526756128|FG014|Overall Study|No longer meets eligibility criteria|1|||
146064545|NCT04323124|526756114|FG000|Overall Study|Study terminated by sponsor|0|||
146064546|NCT04323124|526756115|FG001|Overall Study|Study terminated by sponsor|0|||
146064547|NCT04323124|526756116|FG002|Overall Study|Study terminated by sponsor|0|||
146064548|NCT04323124|526756117|FG003|Overall Study|Study terminated by sponsor|0|||
146064549|NCT04323124|526756118|FG004|Overall Study|Study terminated by sponsor|0|||
146064550|NCT04323124|526756119|FG005|Overall Study|Study terminated by sponsor|0|||
146064551|NCT04323124|526756120|FG006|Overall Study|Study terminated by sponsor|0|||
146064552|NCT04323124|526756121|FG007|Overall Study|Study terminated by sponsor|0|||
146064553|NCT04323124|526756122|FG008|Overall Study|Study terminated by sponsor|0|||
146064554|NCT04323124|526756123|FG009|Overall Study|Study terminated by sponsor|0|||
146064555|NCT04323124|526756124|FG010|Overall Study|Study terminated by sponsor|0|||
146064556|NCT04323124|526756125|FG011|Overall Study|Study terminated by sponsor|2|||
146064557|NCT04323124|526756126|FG012|Overall Study|Study terminated by sponsor|1|||
146064558|NCT04323124|526756127|FG013|Overall Study|Study terminated by sponsor|0|||
146064559|NCT04323124|526756128|FG014|Overall Study|Study terminated by sponsor|0|||
146064560|NCT02083354|526758169|FG000|Overall Study|Withdrawal by Subject|9|||
146064561|NCT02083354|526758169|FG000|Overall Study|Lost to Follow-up|1|||
146064562|NCT02083354|526758169|FG000|Overall Study|Adverse Event|3|||
146064563|NCT02083354|526758169|FG000|Overall Study|Disease progression|46|||
146064564|NCT02083354|526758169|FG000|Overall Study|Study closed/terminated|5|||
146064565|NCT02066181|526758184|FG000|Overall Study|Withdrawal by Subject|1|||
146064566|NCT02066181|526758185|FG001|Overall Study|Withdrawal by Subject|1|||
146064567|NCT02141295|526758189|FG000|Overall Study|Adverse Event|1|||
146064568|NCT02141295|526758190|FG001|Overall Study|Adverse Event|18|||
146064569|NCT02141295|526758191|FG002|Overall Study|Adverse Event|11|||
146064570|NCT02141295|526758189|FG000|Overall Study|Physician Decision|2|||
146064571|NCT02141295|526758190|FG001|Overall Study|Physician Decision|19|||
146064572|NCT02141295|526758191|FG002|Overall Study|Physician Decision|14|||
146064573|NCT02141295|526758189|FG000|Overall Study|Study terminated by sponsor|0|||
146064574|NCT02141295|526758190|FG001|Overall Study|Study terminated by sponsor|6|||
146064575|NCT02141295|526758191|FG002|Overall Study|Study terminated by sponsor|6|||
146064576|NCT02141295|526758189|FG000|Overall Study|Non-compliance|0|||
146064577|NCT02141295|526758190|FG001|Overall Study|Non-compliance|1|||
146064578|NCT02141295|526758191|FG002|Overall Study|Non-compliance|0|||
146064579|NCT02141295|526758189|FG000|Overall Study|Progressive disease|3|||
146407920|NCT03471182|528000052|FG001|Overall Study|Withdrawal by Subject|1|||
146407921|NCT03471182|528000053|FG002|Overall Study|Withdrawal by Subject|0|||
146407922|NCT03471182|528000051|FG000|Overall Study|Technical failure|2|||
146407923|NCT03471182|528000052|FG001|Overall Study|Technical failure|0|||
146407924|NCT03471182|528000053|FG002|Overall Study|Technical failure|0|||
146407925|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
146407926|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
146407927|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
146064580|NCT02141295|526758190|FG001|Overall Study|Progressive disease|32|||
146064581|NCT02141295|526758191|FG002|Overall Study|Progressive disease|50|||
146064582|NCT02141295|526758189|FG000|Overall Study|Reason not specified|0|||
146064583|NCT02141295|526758190|FG001|Overall Study|Reason not specified|9|||
146407928|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
146407929|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
146064584|NCT02141295|526758191|FG002|Overall Study|Reason not specified|10|||
146064585|NCT02141295|526758189|FG000|Overall Study|Withdrawal by Subject|0|||
146064586|NCT02141295|526758190|FG001|Overall Study|Withdrawal by Subject|9|||
146064587|NCT02141295|526758191|FG002|Overall Study|Withdrawal by Subject|4|||
146064588|NCT01671319|526758192|FG000|Overall Study|Withdrawal by Subject|1|||
146064589|NCT01389596|526758193|FG000|Overall Study|Protocol Violation|3|||
146064590|NCT01389596|526758194|FG001|Overall Study|Protocol Violation|4|||
146064591|NCT01389596|526758195|FG002|Overall Study|Protocol Violation|3|||
146064592|NCT01389596|526758193|FG000|Overall Study|Withdrawal by Subject|1|||
146064593|NCT01389596|526758194|FG001|Overall Study|Withdrawal by Subject|2|||
146064594|NCT01389596|526758195|FG002|Overall Study|Withdrawal by Subject|2|||
146064595|NCT01389596|526758193|FG000|Overall Study|Insufficient Clinical Response|3|||
146064596|NCT01389596|526758194|FG001|Overall Study|Insufficient Clinical Response|4|||
146064597|NCT01389596|526758195|FG002|Overall Study|Insufficient Clinical Response|5|||
146064598|NCT01389596|526758193|FG000|Overall Study|Adverse Event|1|||
146064599|NCT01389596|526758194|FG001|Overall Study|Adverse Event|4|||
146064600|NCT01389596|526758195|FG002|Overall Study|Adverse Event|0|||
146064601|NCT01389596|526758193|FG000|Overall Study|Death|0|||
146064602|NCT01389596|526758194|FG001|Overall Study|Death|1|||
146064603|NCT01389596|526758195|FG002|Overall Study|Death|0|||
146064604|NCT01389596|526758193|FG000|Overall Study|Other Unspecified|2|||
146064605|NCT01389596|526758194|FG001|Overall Study|Other Unspecified|1|||
146064606|NCT01389596|526758195|FG002|Overall Study|Other Unspecified|0|||
146064607|NCT00214201|526758196|FG000|Overall Study|Withdrawal by Subject|2|||
146064608|NCT00214201|526758197|FG001|Overall Study|Withdrawal by Subject|0|||
146064609|NCT00214201|526758196|FG000|Overall Study|Death|0|||
146064610|NCT00214201|526758197|FG001|Overall Study|Death|2|||
146064611|NCT01354899|526758198|FG000|Overall Study|discharge from the hospital|2|||
146064612|NCT01354899|526758198|FG000|Overall Study|Protocol Violation|1|||
146064613|NCT00463567|526758199|FG000|Overall Study|Adverse Event|29|||
146064614|NCT00463567|526758200|FG001|Overall Study|Adverse Event|26|||
146064615|NCT00463567|526758201|FG002|Overall Study|Adverse Event|17|||
146064616|NCT00463567|526758202|FG003|Overall Study|Adverse Event|46|||
146064617|NCT00463567|526758203|FG004|Overall Study|Adverse Event|10|||
146064618|NCT00463567|526758204|FG005|Overall Study|Adverse Event|10|||
146064619|NCT00463567|526758205|FG006|Overall Study|Adverse Event|4|||
146064620|NCT00463567|526758199|FG000|Overall Study|Withdrawal by Subject|29|||
146064621|NCT00463567|526758200|FG001|Overall Study|Withdrawal by Subject|22|||
146064622|NCT00463567|526758201|FG002|Overall Study|Withdrawal by Subject|20|||
146064623|NCT00463567|526758202|FG003|Overall Study|Withdrawal by Subject|37|||
146064624|NCT00463567|526758203|FG004|Overall Study|Withdrawal by Subject|6|||
146064625|NCT00463567|526758204|FG005|Overall Study|Withdrawal by Subject|5|||
146064626|NCT00463567|526758205|FG006|Overall Study|Withdrawal by Subject|1|||
146064627|NCT00463567|526758199|FG000|Overall Study|Protocol Deviation|13|||
146064628|NCT00463567|526758200|FG001|Overall Study|Protocol Deviation|9|||
146064629|NCT00463567|526758201|FG002|Overall Study|Protocol Deviation|14|||
146064630|NCT00463567|526758202|FG003|Overall Study|Protocol Deviation|11|||
146064631|NCT00463567|526758203|FG004|Overall Study|Protocol Deviation|1|||
146064632|NCT00463567|526758204|FG005|Overall Study|Protocol Deviation|1|||
146064633|NCT00463567|526758205|FG006|Overall Study|Protocol Deviation|2|||
146064634|NCT00463567|526758199|FG000|Overall Study|Lost to Follow-up|12|||
146064635|NCT00463567|526758200|FG001|Overall Study|Lost to Follow-up|6|||
146064636|NCT00463567|526758201|FG002|Overall Study|Lost to Follow-up|13|||
146064637|NCT00463567|526758202|FG003|Overall Study|Lost to Follow-up|8|||
146064638|NCT00463567|526758203|FG004|Overall Study|Lost to Follow-up|1|||
146064639|NCT00463567|526758204|FG005|Overall Study|Lost to Follow-up|1|||
146064640|NCT00463567|526758205|FG006|Overall Study|Lost to Follow-up|1|||
146064641|NCT00463567|526758199|FG000|Overall Study|Administrative problems|5|||
146064642|NCT00463567|526758200|FG001|Overall Study|Administrative problems|3|||
146064643|NCT00463567|526758201|FG002|Overall Study|Administrative problems|6|||
146064644|NCT00463567|526758202|FG003|Overall Study|Administrative problems|9|||
146064645|NCT00463567|526758203|FG004|Overall Study|Administrative problems|3|||
146064646|NCT00463567|526758204|FG005|Overall Study|Administrative problems|2|||
146064647|NCT00463567|526758205|FG006|Overall Study|Administrative problems|2|||
146064648|NCT00463567|526758199|FG000|Overall Study|Lack of Efficacy|4|||
146064649|NCT00463567|526758200|FG001|Overall Study|Lack of Efficacy|9|||
146064650|NCT00463567|526758201|FG002|Overall Study|Lack of Efficacy|9|||
146064651|NCT00463567|526758202|FG003|Overall Study|Lack of Efficacy|17|||
146064652|NCT00463567|526758203|FG004|Overall Study|Lack of Efficacy|1|||
146064653|NCT00463567|526758204|FG005|Overall Study|Lack of Efficacy|0|||
146064654|NCT00463567|526758205|FG006|Overall Study|Lack of Efficacy|1|||
146064655|NCT00463567|526758199|FG000|Overall Study|Abnormal lab value(s)|1|||
146064656|NCT00463567|526758200|FG001|Overall Study|Abnormal lab value(s)|1|||
146064657|NCT00463567|526758201|FG002|Overall Study|Abnormal lab value(s)|2|||
146064658|NCT00463567|526758202|FG003|Overall Study|Abnormal lab value(s)|1|||
146064659|NCT00463567|526758203|FG004|Overall Study|Abnormal lab value(s)|1|||
146064660|NCT00463567|526758204|FG005|Overall Study|Abnormal lab value(s)|0|||
146064661|NCT00463567|526758205|FG006|Overall Study|Abnormal lab value(s)|0|||
146171759|NCT00988221|527143223|FG001|Part I|Lost to Follow-up|1|||
146064662|NCT00463567|526758199|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146064663|NCT00463567|526758200|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146064664|NCT00463567|526758201|FG002|Overall Study|Abnormal test procedure result(s)|6|||
146064665|NCT00463567|526758202|FG003|Overall Study|Abnormal test procedure result(s)|2|||
146064666|NCT00463567|526758203|FG004|Overall Study|Abnormal test procedure result(s)|0|||
146064667|NCT00463567|526758204|FG005|Overall Study|Abnormal test procedure result(s)|2|||
146064668|NCT00463567|526758205|FG006|Overall Study|Abnormal test procedure result(s)|0|||
146064669|NCT00463567|526758199|FG000|Overall Study|Death|1|||
146064670|NCT00463567|526758200|FG001|Overall Study|Death|0|||
146064671|NCT00463567|526758201|FG002|Overall Study|Death|2|||
146064672|NCT00463567|526758202|FG003|Overall Study|Death|0|||
146064673|NCT00463567|526758203|FG004|Overall Study|Death|0|||
146064674|NCT00463567|526758204|FG005|Overall Study|Death|0|||
146064675|NCT00463567|526758205|FG006|Overall Study|Death|0|||
146064676|NCT01124006|526758206|FG000|Overall Study|Withdrawal by Subject|2|||
146064677|NCT01124006|526758207|FG001|Overall Study|Withdrawal by Subject|2|||
146064678|NCT01124006|526758208|FG002|Overall Study|Withdrawal by Subject|0|||
146064679|NCT01124006|526758206|FG000|Overall Study|Lost to Follow-up|1|||
146064680|NCT01124006|526758207|FG001|Overall Study|Lost to Follow-up|0|||
146064681|NCT01124006|526758208|FG002|Overall Study|Lost to Follow-up|1|||
146064682|NCT01124006|526758206|FG000|Overall Study|Other|0|||
146064683|NCT01124006|526758207|FG001|Overall Study|Other|0|||
146064684|NCT01124006|526758208|FG002|Overall Study|Other|1|||
146064685|NCT01803607|526758210|FG000|Overall Study|Adverse Event|5|||
146064686|NCT01803607|526758211|FG001|Overall Study|Adverse Event|3|||
146064687|NCT01803607|526758210|FG000|Overall Study|Lack of Efficacy|0|||
146064688|NCT01803607|526758211|FG001|Overall Study|Lack of Efficacy|1|||
146064689|NCT01803607|526758210|FG000|Overall Study|Protocol Violation|3|||
146064690|NCT01803607|526758211|FG001|Overall Study|Protocol Violation|2|||
146064691|NCT01803607|526758210|FG000|Overall Study|Study terminated by sponsor|54|||
146064692|NCT01803607|526758211|FG001|Overall Study|Study terminated by sponsor|56|||
146064693|NCT01803607|526758210|FG000|Overall Study|Withdrawal by Subject|6|||
146064694|NCT01803607|526758211|FG001|Overall Study|Withdrawal by Subject|5|||
146064695|NCT00706238|526758218|FG000|Overall Study|Disease progression|4|||
146064696|NCT00706238|526758218|FG000|Overall Study|Other|1|||
146064697|NCT03819114|526758219|FG000|Overall Study|Protocol Violation|0|||
146064698|NCT03819114|526758220|FG001|Overall Study|Protocol Violation|1|||
146064699|NCT03819114|526758221|FG002|Overall Study|Protocol Violation|1|||
146064700|NCT03819114|526758222|FG003|Overall Study|Protocol Violation|0|||
146064701|NCT03819114|526758219|FG000|Overall Study|Lost to Follow-up|0|||
146064702|NCT03819114|526758220|FG001|Overall Study|Lost to Follow-up|0|||
146064703|NCT03819114|526758221|FG002|Overall Study|Lost to Follow-up|1|||
146064704|NCT03819114|526758222|FG003|Overall Study|Lost to Follow-up|0|||
146064705|NCT04646044|526758224|FG000|Overall Study|Lost to Follow-up|0|||
146064706|NCT04646044|526758225|FG001|Overall Study|Lost to Follow-up|0|||
146064707|NCT04646044|526758226|FG002|Overall Study|Lost to Follow-up|1|||
146064708|NCT04646044|526758227|FG003|Overall Study|Lost to Follow-up|0|||
146064709|NCT04646044|526758224|FG000|Overall Study|Withdrawal by Subject|0|||
146064710|NCT04646044|526758225|FG001|Overall Study|Withdrawal by Subject|1|||
146064711|NCT04646044|526758226|FG002|Overall Study|Withdrawal by Subject|0|||
146064712|NCT04646044|526758227|FG003|Overall Study|Withdrawal by Subject|0|||
146064713|NCT03038880|526758233|FG000|Overall Study|Death|1|||
146064714|NCT03038880|526758234|FG001|Overall Study|Death|2|||
146064715|NCT03038880|526758235|FG002|Overall Study|Death|0|||
146064716|NCT03038880|526758233|FG000|Overall Study|Physician Decision|2|||
146064717|NCT03038880|526758234|FG001|Overall Study|Physician Decision|1|||
146064718|NCT03038880|526758235|FG002|Overall Study|Physician Decision|0|||
146064719|NCT02803580|526758236|FG000|Overall Study|Death|13|||
146064720|NCT02803580|526758236|FG000|Overall Study|Lost to Follow-up|19|||
146064721|NCT02803580|526758236|FG000|Overall Study|Withdrawal by Subject|3|||
146064722|NCT02803580|526758236|FG000|Overall Study|Inclusion in clinical trial|1|||
146064723|NCT02633306|526758237|FG000|Overall Study|Withdrawal by Subject|3|||
146064724|NCT03910244|526758238|FG000|Overall Study|Adverse Event|14|||
146064725|NCT03910244|526758239|FG001|Overall Study|Adverse Event|0|||
146064726|NCT03910244|526758238|FG000|Overall Study|Death|1|||
146407930|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
146064727|NCT03910244|526758239|FG001|Overall Study|Death|0|||
146064728|NCT03910244|526758238|FG000|Overall Study|Lost to Follow-up|0|||
146064729|NCT03910244|526758239|FG001|Overall Study|Lost to Follow-up|2|||
146064730|NCT03910244|526758238|FG000|Overall Study|Joint withdrawal decision|1|||
146064731|NCT03910244|526758239|FG001|Overall Study|Joint withdrawal decision|0|||
146064732|NCT03910244|526758238|FG000|Overall Study|Study Terminated by Sponsor|7|||
146064733|NCT03910244|526758239|FG001|Overall Study|Study Terminated by Sponsor|4|||
146064734|NCT03910244|526758238|FG000|Overall Study|Physician Decision|1|||
146064735|NCT03910244|526758239|FG001|Overall Study|Physician Decision|0|||
146064736|NCT03910244|526758238|FG000|Overall Study|Protocol Violation|1|||
146064737|NCT03910244|526758239|FG001|Overall Study|Protocol Violation|0|||
146064738|NCT03910244|526758238|FG000|Overall Study|Withdrawal by Subject|7|||
146064739|NCT03910244|526758239|FG001|Overall Study|Withdrawal by Subject|2|||
146064740|NCT01213472|526758242|FG000|Overall Study|Recurrence/Progressive disease|25|||
146064741|NCT01213472|526758242|FG000|Overall Study|Withdrawal by Subject|1|||
146064742|NCT01213472|526758242|FG000|Overall Study|Physician Decision|1|||
146064743|NCT03774576|526758243|FG000|Period 2|Adverse Event|1|||
146064744|NCT01746901|526758244|FG000|Naloxone Challenge Phase|Adverse Event|2|||
146064745|NCT01746901|526758245|FG001|Naloxone Challenge Phase|Adverse Event|0|||
146064746|NCT01746901|526758246|FG002|Naloxone Challenge Phase|Adverse Event|0|||
146064747|NCT01746901|526758247|FG003|Naloxone Challenge Phase|Adverse Event|0|||
146064748|NCT01746901|526758248|FG004|Naloxone Challenge Phase|Adverse Event|0|||
146064749|NCT01746901|526758249|FG005|Naloxone Challenge Phase|Adverse Event|0|||
146064750|NCT01746901|526758250|FG006|Naloxone Challenge Phase|Adverse Event|0|||
146064751|NCT01746901|526758251|FG007|Naloxone Challenge Phase|Adverse Event|0|||
146064752|NCT01746901|526758252|FG008|Naloxone Challenge Phase|Adverse Event|0|||
146064753|NCT01746901|526758244|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
146064754|NCT01746901|526758245|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064755|NCT01746901|526758246|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064756|NCT01746901|526758247|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064757|NCT01746901|526758248|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064758|NCT01746901|526758249|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064759|NCT01746901|526758250|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064760|NCT01746901|526758251|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064761|NCT01746901|526758252|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
146064762|NCT01746901|526758244|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064763|NCT01746901|526758245|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
146064764|NCT01746901|526758246|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064765|NCT01746901|526758247|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064766|NCT01746901|526758248|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064767|NCT01746901|526758249|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064768|NCT01746901|526758250|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064769|NCT01746901|526758251|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064770|NCT01746901|526758252|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
146064771|NCT01746901|526758244|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064772|NCT01746901|526758245|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
146064773|NCT01746901|526758246|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
146064774|NCT01746901|526758247|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064775|NCT01746901|526758248|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064776|NCT01746901|526758249|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064777|NCT01746901|526758250|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064778|NCT01746901|526758251|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064779|NCT01746901|526758252|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
146064780|NCT01746901|526758244|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064781|NCT01746901|526758245|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
146064782|NCT01746901|526758246|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
146064783|NCT01746901|526758247|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064784|NCT01746901|526758248|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064785|NCT01746901|526758249|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064786|NCT01746901|526758250|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064787|NCT01746901|526758251|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064788|NCT01746901|526758252|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
146064789|NCT01746901|526758244|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064790|NCT01746901|526758245|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
146064791|NCT01746901|526758246|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
146064792|NCT01746901|526758247|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064793|NCT01746901|526758248|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064794|NCT01746901|526758249|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064795|NCT01746901|526758250|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064796|NCT01746901|526758251|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064797|NCT01746901|526758252|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
146064798|NCT01746901|526758244|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
146064799|NCT01746901|526758245|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
146064800|NCT01746901|526758246|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
146064801|NCT01746901|526758247|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
146064802|NCT01746901|526758248|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
146064803|NCT01746901|526758249|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
146064804|NCT01746901|526758250|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
146064805|NCT01746901|526758251|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
146064806|NCT01746901|526758252|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
146064807|NCT01746901|526758244|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064808|NCT01746901|526758245|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064809|NCT01746901|526758246|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064810|NCT01746901|526758247|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064811|NCT01746901|526758248|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064812|NCT01746901|526758249|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064813|NCT01746901|526758250|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064814|NCT01746901|526758251|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
146064815|NCT01746901|526758252|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
146064816|NCT01746901|526758244|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064817|NCT01746901|526758245|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064818|NCT01746901|526758246|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064819|NCT01746901|526758247|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064820|NCT01746901|526758248|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064821|NCT01746901|526758249|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
146064822|NCT01746901|526758250|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
146064823|NCT01746901|526758251|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064824|NCT01746901|526758252|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
146064825|NCT01746901|526758244|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146407931|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
146407932|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
146407933|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146064826|NCT01746901|526758245|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064827|NCT01746901|526758246|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064828|NCT01746901|526758247|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
146064829|NCT01746901|526758248|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064830|NCT01746901|526758249|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064831|NCT01746901|526758250|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064832|NCT01746901|526758251|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064833|NCT01746901|526758252|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
146064834|NCT01746901|526758244|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064835|NCT01746901|526758245|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064836|NCT01746901|526758246|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064837|NCT01746901|526758247|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064838|NCT01746901|526758248|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064839|NCT01746901|526758249|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
146064840|NCT01746901|526758250|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064841|NCT01746901|526758251|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
146064842|NCT01746901|526758252|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
146064843|NCT01746901|526758244|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064844|NCT01746901|526758245|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064845|NCT01746901|526758246|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064846|NCT01746901|526758247|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064847|NCT01746901|526758248|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064848|NCT01746901|526758249|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064849|NCT01746901|526758250|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
146064850|NCT01746901|526758251|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
146064851|NCT01746901|526758252|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
146064852|NCT03594110|526758256|FG000|Interventional Part|Participant concerned about study treatment|23|||
146064853|NCT03594110|526758257|FG001|Interventional Part|Participant concerned about study treatment|28|||
146064854|NCT03594110|526758256|FG000|Interventional Part|Doctor advice|38|||
146064855|NCT03594110|526758257|FG001|Interventional Part|Doctor advice|40|||
146064856|NCT03594110|526758256|FG000|Interventional Part|Participants' wish|89|||
146064857|NCT03594110|526758257|FG001|Interventional Part|Participants' wish|68|||
146064858|NCT03594110|526758256|FG000|Interventional Part|Adverse event-non-fatal events|119|||
146064859|NCT03594110|526758257|FG001|Interventional Part|Adverse event-non-fatal events|116|||
146407934|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146407935|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146407936|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
146407937|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
146407938|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146407939|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146407940|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
146407941|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
146064860|NCT03594110|526758256|FG000|Interventional Part|Study drug stopped, reason missing|336|||
146064861|NCT03594110|526758257|FG001|Interventional Part|Study drug stopped, reason missing|294|||
146064862|NCT03594110|526758256|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
146064863|NCT03594110|526758257|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
146064864|NCT03594110|526758256|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
146064865|NCT03594110|526758257|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
146064866|NCT03594110|526758256|FG000|Interventional Part|Contraindicated drug started|32|||
146064867|NCT03594110|526758257|FG001|Interventional Part|Contraindicated drug started|18|||
146064868|NCT03594110|526758256|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
146064869|NCT03594110|526758257|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
146064870|NCT03594110|526758256|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
146064871|NCT03594110|526758257|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
146064872|NCT03594110|526758256|FG000|Non-interventional Part|Withdrawal by Subject|3|||
146064873|NCT03594110|526758257|FG001|Non-interventional Part|Withdrawal by Subject|4|||
146064874|NCT03594110|526758256|FG000|Non-interventional Part|Lost to Follow-up|45|||
146064875|NCT03594110|526758257|FG001|Non-interventional Part|Lost to Follow-up|41|||
146064876|NCT02085460|526758259|FG000|Overall Study|Adverse Event|2|||
146064877|NCT02085460|526758260|FG001|Overall Study|Adverse Event|2|||
146064878|NCT02085460|526758261|FG002|Overall Study|Adverse Event|1|||
146064879|NCT02085460|526758259|FG000|Overall Study|Physician Decision|1|||
146064880|NCT02085460|526758260|FG001|Overall Study|Physician Decision|1|||
146064881|NCT02085460|526758261|FG002|Overall Study|Physician Decision|2|||
146064882|NCT02085460|526758259|FG000|Overall Study|Withdrawal by Subject|11|||
146064883|NCT02085460|526758260|FG001|Overall Study|Withdrawal by Subject|5|||
146064884|NCT02085460|526758261|FG002|Overall Study|Withdrawal by Subject|7|||
146064885|NCT00907335|526758264|FG000|Overall Study|Withdrawal by Subject|2|||
146064886|NCT00907335|526758265|FG001|Overall Study|Withdrawal by Subject|0|||
146064887|NCT00907335|526758264|FG000|Overall Study|Adverse Event|4|||
146064888|NCT00907335|526758265|FG001|Overall Study|Adverse Event|1|||
146064889|NCT00907335|526758264|FG000|Overall Study|Lost to Follow-up|2|||
146064890|NCT00907335|526758265|FG001|Overall Study|Lost to Follow-up|0|||
146064891|NCT03879772|526758266|FG000|Overall Study|Adverse Event|2|||
146064892|NCT03879772|526758267|FG001|Overall Study|Adverse Event|2|||
146064893|NCT03879772|526758268|FG002|Overall Study|Adverse Event|3|||
146064894|NCT03879772|526758269|FG003|Overall Study|Adverse Event|4|||
146064895|NCT03879772|526758270|FG004|Overall Study|Adverse Event|3|||
146064896|NCT03879772|526758266|FG000|Overall Study|Treatment Failure|1|||
146407942|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
146407943|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
146407944|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
146407945|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
146407946|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
146407947|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
146407948|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
146064897|NCT03879772|526758267|FG001|Overall Study|Treatment Failure|0|||
146064898|NCT03879772|526758268|FG002|Overall Study|Treatment Failure|0|||
146064899|NCT03879772|526758269|FG003|Overall Study|Treatment Failure|2|||
146064900|NCT03879772|526758270|FG004|Overall Study|Treatment Failure|1|||
146064901|NCT03879772|526758266|FG000|Overall Study|Lost to Follow-up|0|||
146064902|NCT03879772|526758267|FG001|Overall Study|Lost to Follow-up|0|||
146064903|NCT03879772|526758268|FG002|Overall Study|Lost to Follow-up|0|||
146064904|NCT03879772|526758269|FG003|Overall Study|Lost to Follow-up|0|||
146064905|NCT03879772|526758270|FG004|Overall Study|Lost to Follow-up|1|||
146064906|NCT03879772|526758266|FG000|Overall Study|Withdrawal by Subject|0|||
146064907|NCT03879772|526758267|FG001|Overall Study|Withdrawal by Subject|1|||
146064908|NCT03879772|526758268|FG002|Overall Study|Withdrawal by Subject|3|||
146171760|NCT00988221|527143224|FG002|Part I|Lost to Follow-up|0|||
146407949|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
146407950|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146407951|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
146407952|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146407953|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
146407954|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146407955|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146407956|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
146407957|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
146407958|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146407959|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
146407960|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
146407961|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146064909|NCT03879772|526758269|FG003|Overall Study|Withdrawal by Subject|1|||
146064910|NCT03879772|526758270|FG004|Overall Study|Withdrawal by Subject|1|||
146064911|NCT03879772|526758266|FG000|Overall Study|Protocol Violation|0|||
146064912|NCT03879772|526758267|FG001|Overall Study|Protocol Violation|0|||
146064913|NCT03879772|526758268|FG002|Overall Study|Protocol Violation|3|||
146064914|NCT03879772|526758269|FG003|Overall Study|Protocol Violation|1|||
146064915|NCT03879772|526758270|FG004|Overall Study|Protocol Violation|2|||
146064916|NCT03879772|526758266|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
146064917|NCT03879772|526758267|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
146064918|NCT03879772|526758268|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
146064919|NCT03879772|526758269|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
146064920|NCT03879772|526758270|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
146064921|NCT00930046|526758271|FG000|Overall Study|Wound catheter malfunctioned|1|||
146064922|NCT00930046|526758272|FG001|Overall Study|Wound catheter malfunctioned|2|||
146064923|NCT01598532|526758273|FG000|Overall Study|Lost to Follow-up|3|||
146064924|NCT01598532|526758273|FG000|Overall Study|Did not meet inclusion criteria|8|||
146064925|NCT00702221|526758274|FG000|Overall Study|Adverse Event|4|||
146064926|NCT00702221|526758275|FG001|Overall Study|Adverse Event|3|||
146064927|NCT04798196|526758279|FG000|Overall Study|Lost to Follow-up|3|||
146064928|NCT04798196|526758280|FG001|Overall Study|Lost to Follow-up|1|||
146064929|NCT04798196|526758281|FG002|Overall Study|Lost to Follow-up|3|||
146064930|NCT01249261|526758282|FG000|Overall Study|Withdrawal by Subject|1|||
146064931|NCT01249261|526758283|FG001|Overall Study|Withdrawal by Subject|0|||
146064932|NCT01967940|526758285|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
146064933|NCT01967940|526758286|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
146064934|NCT01967940|526758287|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
146064935|NCT01967940|526758288|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
146064936|NCT01967940|526758285|FG000|Part 2|Adverse Event|0|||
146064937|NCT01967940|526758286|FG001|Part 2|Adverse Event|0|||
146064938|NCT01967940|526758287|FG002|Part 2|Adverse Event|0|||
146064939|NCT01967940|526758288|FG003|Part 2|Adverse Event|1|||
146064940|NCT01967940|526758285|FG000|Part 2|Unknown Reason|0|||
146064941|NCT01967940|526758286|FG001|Part 2|Unknown Reason|0|||
146064942|NCT01967940|526758287|FG002|Part 2|Unknown Reason|0|||
146064943|NCT01967940|526758288|FG003|Part 2|Unknown Reason|1|||
146064944|NCT00361296|526758289|FG000|Overall Study|Physician Decision|1|||
146064945|NCT00361296|526758289|FG000|Overall Study|Lack of Efficacy|2|||
146064946|NCT00904982|526758292|FG000|Overall Study|Withdrawal by Subject|2|||
146064947|NCT00904982|526758293|FG001|Overall Study|Withdrawal by Subject|0|||
146064948|NCT00904982|526758294|FG002|Overall Study|Withdrawal by Subject|0|||
146064949|NCT00904982|526758295|FG003|Overall Study|Withdrawal by Subject|0|||
146064950|NCT02072668|526758300|FG000|Second Intervention|Lost to Follow-up|1|||
146064951|NCT02072668|526758301|FG001|Second Intervention|Lost to Follow-up|0|||
146064952|NCT01352793|526758307|FG000|Overall Study|Lost to Follow-up|289|||
146064953|NCT01352793|526758308|FG001|Overall Study|Lost to Follow-up|125|||
146064954|NCT01352793|526758307|FG000|Overall Study|Withdrawal by Subject|120|||
146064955|NCT01352793|526758308|FG001|Overall Study|Withdrawal by Subject|55|||
146064956|NCT01352793|526758307|FG000|Overall Study|Protocol Violation|44|||
146064957|NCT01352793|526758308|FG001|Overall Study|Protocol Violation|23|||
146064958|NCT01352793|526758307|FG000|Overall Study|Adverse Event|44|||
146064959|NCT01352793|526758308|FG001|Overall Study|Adverse Event|10|||
146064960|NCT01352793|526758307|FG000|Overall Study|Physician Decision|1|||
146064961|NCT01352793|526758308|FG001|Overall Study|Physician Decision|0|||
146064962|NCT01352793|526758307|FG000|Overall Study|Pregnancy|26|||
146064963|NCT01352793|526758308|FG001|Overall Study|Pregnancy|8|||
146064964|NCT01352793|526758307|FG000|Overall Study|Other|25|||
146064965|NCT01352793|526758308|FG001|Overall Study|Other|7|||
146064966|NCT01352793|526758307|FG000|Overall Study|Medication error|2|||
146064967|NCT01352793|526758308|FG001|Overall Study|Medication error|2|||
146064968|NCT01352793|526758307|FG000|Overall Study|Death|1|||
146064969|NCT01352793|526758308|FG001|Overall Study|Death|0|||
146064970|NCT01352793|526758307|FG000|Overall Study|Randomized but not vaccinated|8|||
146064971|NCT01352793|526758308|FG001|Overall Study|Randomized but not vaccinated|0|||
146064972|NCT01352793|526758307|FG000|Overall Study|No longer meets eligibility criteria|25|||
146407962|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146064973|NCT01352793|526758308|FG001|Overall Study|No longer meets eligibility criteria|15|||
146064974|NCT01929317|526758311|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
146064975|NCT01929317|526758312|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
146064976|NCT01929317|526758311|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
146064977|NCT01929317|526758312|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
146064978|NCT01929317|526758311|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
146064979|NCT01929317|526758312|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
146064980|NCT01929317|526758311|FG000|Long-term Phase|Adverse Event|5|||
146064981|NCT01929317|526758312|FG001|Long-term Phase|Adverse Event|1|||
146064982|NCT01929317|526758311|FG000|Long-term Phase|Physician Decision|3|||
146064983|NCT01929317|526758312|FG001|Long-term Phase|Physician Decision|0|||
146064984|NCT01929317|526758311|FG000|Long-term Phase|Withdrawal by Subject|4|||
146064985|NCT01929317|526758312|FG001|Long-term Phase|Withdrawal by Subject|0|||
146064986|NCT01929317|526758311|FG000|Long-term Phase|Protocol Violation|1|||
146064987|NCT01929317|526758312|FG001|Long-term Phase|Protocol Violation|0|||
146064988|NCT01929317|526758311|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
146064989|NCT01929317|526758312|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
146064990|NCT01929317|526758311|FG000|Long-term Phase|Study Closed/Terminated|5|||
146064991|NCT01929317|526758312|FG001|Long-term Phase|Study Closed/Terminated|3|||
146064992|NCT02667119|526758313|FG000|Overall Study|Lost to Follow-up|3|||
146064993|NCT02667119|526758314|FG001|Overall Study|Lost to Follow-up|0|||
146064994|NCT03783078|526758315|FG000|Overall Study|Death|31|||
146064995|NCT03783078|526758315|FG000|Overall Study|Sponsor Decision|23|||
146064996|NCT03783078|526758315|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146064997|NCT02059278|526758316|FG000|Overall Study|Adverse Event|1|||
146064998|NCT02059278|526758317|FG001|Overall Study|Adverse Event|1|||
146064999|NCT02059278|526758316|FG000|Overall Study|Lost to Follow-up|1|||
146065000|NCT02059278|526758317|FG001|Overall Study|Lost to Follow-up|0|||
146065001|NCT02059278|526758316|FG000|Overall Study|Withdrawal by Subject|0|||
146065002|NCT02059278|526758317|FG001|Overall Study|Withdrawal by Subject|3|||
146065003|NCT02059278|526758316|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
146065004|NCT02059278|526758317|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
146065005|NCT03043794|526758320|FG000|Overall Study|Lost to Follow-up|1|||
146065006|NCT03205423|526758323|FG000|Overall Study|Personal|1|||
146065007|NCT03205423|526758324|FG001|Overall Study|Personal|1|||
146065008|NCT03205423|526758323|FG000|Overall Study|Physician Decision|0|||
146065009|NCT03205423|526758324|FG001|Overall Study|Physician Decision|2|||
146065010|NCT04467905|526758325|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
146065011|NCT04467905|526758326|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
146065012|NCT04467905|526758327|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
146065013|NCT04467905|526758325|FG000|Overall Study|Conversion to SR|0|||
146065014|NCT04467905|526758326|FG001|Overall Study|Conversion to SR|0|||
146065015|NCT04467905|526758327|FG002|Overall Study|Conversion to SR|3|||
146065016|NCT04467905|526758325|FG000|Overall Study|Technical issue with Holter ECG|0|||
146065017|NCT04467905|526758326|FG001|Overall Study|Technical issue with Holter ECG|0|||
146065018|NCT04467905|526758327|FG002|Overall Study|Technical issue with Holter ECG|3|||
146065019|NCT04467905|526758325|FG000|Overall Study|Hemodynamic instability|0|||
146065020|NCT04467905|526758326|FG001|Overall Study|Hemodynamic instability|0|||
146065021|NCT04467905|526758327|FG002|Overall Study|Hemodynamic instability|1|||
146065022|NCT04467905|526758325|FG000|Overall Study|Site misinterpretation of protocol|0|||
146065023|NCT04467905|526758326|FG001|Overall Study|Site misinterpretation of protocol|0|||
146065024|NCT04467905|526758327|FG002|Overall Study|Site misinterpretation of protocol|1|||
146065025|NCT04145349|526759889|FG000|Overall Study|Withdrawal by Subject|3|||
146065026|NCT04145349|526759890|FG001|Overall Study|Withdrawal by Subject|0|||
146065027|NCT04145349|526759889|FG000|Overall Study|Lost to Follow-up|0|||
146065028|NCT04145349|526759890|FG001|Overall Study|Lost to Follow-up|1|||
146065029|NCT04145349|526759889|FG000|Overall Study|On study treatment (Ongoing)|0|||
146065030|NCT04145349|526759890|FG001|Overall Study|On study treatment (Ongoing)|1|||
146065031|NCT03312634|526759891|FG000|Overall Study|Adverse Event|11|||
146065032|NCT03312634|526759892|FG001|Overall Study|Adverse Event|0|||
146065033|NCT03312634|526759891|FG000|Overall Study|Sponsor request|2|||
146065034|NCT03312634|526759892|FG001|Overall Study|Sponsor request|0|||
146065035|NCT03312634|526759891|FG000|Overall Study|Withdrawal by Subject|31|||
146065036|NCT03312634|526759892|FG001|Overall Study|Withdrawal by Subject|9|||
146065037|NCT03312634|526759891|FG000|Overall Study|Enrolled in an interventional study|0|||
146065038|NCT03312634|526759892|FG001|Overall Study|Enrolled in an interventional study|52|||
146065039|NCT03312634|526759891|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
146065040|NCT03312634|526759892|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
146065041|NCT03312634|526759891|FG000|Overall Study|Death|0|||
146065042|NCT03312634|526759892|FG001|Overall Study|Death|1|||
146065043|NCT03312634|526759891|FG000|Overall Study|Non-compliance|0|||
146065044|NCT03312634|526759892|FG001|Overall Study|Non-compliance|2|||
146065045|NCT03312634|526759891|FG000|Overall Study|Lost to Follow-up|0|||
146065046|NCT03312634|526759892|FG001|Overall Study|Lost to Follow-up|1|||
146065047|NCT03312634|526759891|FG000|Overall Study|Enrolled into non-interventional study|0|||
146065048|NCT03312634|526759892|FG001|Overall Study|Enrolled into non-interventional study|5|||
146065049|NCT03312634|526759891|FG000|Overall Study|Worsening clinical condition|0|||
146065050|NCT03312634|526759892|FG001|Overall Study|Worsening clinical condition|1|||
146065051|NCT03312634|526759891|FG000|Overall Study|Participant did not want to travel|0|||
146065052|NCT03312634|526759892|FG001|Overall Study|Participant did not want to travel|1|||
146065053|NCT03312634|526759891|FG000|Overall Study|Physician Decision|1|||
146065054|NCT03312634|526759892|FG001|Overall Study|Physician Decision|0|||
146065055|NCT03312634|526759891|FG000|Overall Study|Other|13|||
146065056|NCT03312634|526759892|FG001|Overall Study|Other|0|||
146065057|NCT01148979|526759901|FG000|Overall Study|Lost to Follow-up|0|||
146065058|NCT01148979|526759902|FG001|Overall Study|Lost to Follow-up|1|||
146065059|NCT00777153|526759903|FG000|Overall Study|Lost to Follow-up|1|||
146065060|NCT00777153|526759904|FG001|Overall Study|Lost to Follow-up|1|||
146065061|NCT00777153|526759905|FG002|Overall Study|Lost to Follow-up|0|||
146065062|NCT00777153|526759903|FG000|Overall Study|Death|85|||
146065063|NCT00777153|526759904|FG001|Overall Study|Death|73|||
146065064|NCT00777153|526759905|FG002|Overall Study|Death|33|||
146065065|NCT00777153|526759903|FG000|Overall Study|Withdrawal by Subject|3|||
146065066|NCT00777153|526759904|FG001|Overall Study|Withdrawal by Subject|4|||
146065067|NCT00777153|526759905|FG002|Overall Study|Withdrawal by Subject|3|||
146065068|NCT00777153|526759903|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
146065069|NCT00777153|526759904|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
146065070|NCT00777153|526759905|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
146065071|NCT00554216|526759906|FG000|Overall Study|Lost to Follow-up|92|||
146065072|NCT00554216|526759907|FG001|Overall Study|Lost to Follow-up|31|||
146065073|NCT00554216|526759908|FG002|Overall Study|Lost to Follow-up|63|||
146065074|NCT00554216|526759906|FG000|Overall Study|Adverse Event|16|||
146065075|NCT00554216|526759907|FG001|Overall Study|Adverse Event|16|||
146065076|NCT00554216|526759908|FG002|Overall Study|Adverse Event|36|||
146065077|NCT00554216|526759906|FG000|Overall Study|Withdrawal by Subject|92|||
146065078|NCT00554216|526759907|FG001|Overall Study|Withdrawal by Subject|31|||
146065079|NCT00554216|526759908|FG002|Overall Study|Withdrawal by Subject|43|||
146065080|NCT00554216|526759906|FG000|Overall Study|Non compliance|10|||
146065081|NCT00554216|526759907|FG001|Overall Study|Non compliance|4|||
146065082|NCT00554216|526759908|FG002|Overall Study|Non compliance|5|||
146065083|NCT00554216|526759906|FG000|Overall Study|Pregnancy|2|||
146065084|NCT00554216|526759907|FG001|Overall Study|Pregnancy|1|||
146065085|NCT00554216|526759908|FG002|Overall Study|Pregnancy|14|||
146065086|NCT00554216|526759906|FG000|Overall Study|Restricted med|3|||
146065087|NCT00554216|526759907|FG001|Overall Study|Restricted med|1|||
146065088|NCT00554216|526759908|FG002|Overall Study|Restricted med|1|||
146065089|NCT00554216|526759906|FG000|Overall Study|Other|12|||
146065090|NCT00554216|526759907|FG001|Overall Study|Other|7|||
146065091|NCT00554216|526759908|FG002|Overall Study|Other|10|||
146065092|NCT00554216|526759906|FG000|Overall Study|Lack of Efficacy|15|||
146065093|NCT00554216|526759907|FG001|Overall Study|Lack of Efficacy|3|||
146065094|NCT00554216|526759908|FG002|Overall Study|Lack of Efficacy|0|||
146065095|NCT05462756|526759911|FG000|Treatment Period|Adverse Event|3|||
146065096|NCT05462756|526759912|FG001|Treatment Period|Adverse Event|0|||
146065097|NCT05462756|526759911|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
146065098|NCT05462756|526759912|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
146065099|NCT05462756|526759911|FG000|Treatment Period|Death|0|||
146065100|NCT05462756|526759912|FG001|Treatment Period|Death|1|||
146065101|NCT05462756|526759911|FG000|Treatment Period|Lost to Follow-up|2|||
146065102|NCT05462756|526759912|FG001|Treatment Period|Lost to Follow-up|1|||
146065103|NCT05462756|526759911|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
146065104|NCT05462756|526759912|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
146065105|NCT05462756|526759911|FG000|Treatment Period|Physician Decision|2|||
146065106|NCT05462756|526759912|FG001|Treatment Period|Physician Decision|0|||
146065107|NCT05462756|526759911|FG000|Treatment Period|Protocol Violation|0|||
146065108|NCT05462756|526759912|FG001|Treatment Period|Protocol Violation|1|||
146065109|NCT05462756|526759911|FG000|Treatment Period|Withdrawal by Subject|5|||
146065110|NCT05462756|526759912|FG001|Treatment Period|Withdrawal by Subject|12|||
146065111|NCT05462756|526759911|FG000|Follow-Up Period|Adverse Event|1|||
146065112|NCT05462756|526759912|FG001|Follow-Up Period|Adverse Event|0|||
146065113|NCT05462756|526759911|FG000|Follow-Up Period|Death|1|||
146065114|NCT05462756|526759912|FG001|Follow-Up Period|Death|0|||
146065115|NCT05462756|526759911|FG000|Follow-Up Period|Lost to Follow-up|3|||
146065116|NCT05462756|526759912|FG001|Follow-Up Period|Lost to Follow-up|1|||
146065117|NCT05462756|526759911|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146065118|NCT05462756|526759912|FG001|Follow-Up Period|Withdrawal by Subject|4|||
146065119|NCT02079246|526759913|FG000|OLEX|Withdrawal before treatment|1|||
146065120|NCT02079246|526759914|FG001|OLEX|Withdrawal before treatment|0|||
146065121|NCT02079246|526759913|FG000|OLEX|Death|11|||
146065122|NCT02079246|526759914|FG001|OLEX|Death|0|||
146065123|NCT02079246|526759913|FG000|OLEX|Adverse Event|66|||
146065124|NCT02079246|526759914|FG001|OLEX|Adverse Event|0|||
146065125|NCT02079246|526759913|FG000|OLEX|Withdrawal by Subject|60|||
146065126|NCT02079246|526759914|FG001|OLEX|Withdrawal by Subject|0|||
146065127|NCT02079246|526759913|FG000|OLEX|Lost to Follow-up|6|||
146065128|NCT02079246|526759914|FG001|OLEX|Lost to Follow-up|0|||
146065129|NCT02079246|526759913|FG000|OLEX|Protocol Violation|6|||
146065130|NCT02079246|526759914|FG001|OLEX|Protocol Violation|0|||
146065131|NCT02079246|526759913|FG000|OLEX|Lack of Efficacy|3|||
146065132|NCT02079246|526759914|FG001|OLEX|Lack of Efficacy|0|||
146065133|NCT02079246|526759913|FG000|OLEX|Results of the lead-in studies|58|||
146065134|NCT02079246|526759914|FG001|OLEX|Results of the lead-in studies|0|||
146065135|NCT02079246|526759913|FG000|OLEX|Other: Disallowed medication|8|||
146065136|NCT02079246|526759914|FG001|OLEX|Other: Disallowed medication|0|||
146065137|NCT02079246|526759913|FG000|OLEX|Other: Insufficient compliance|2|||
146065138|NCT02079246|526759914|FG001|OLEX|Other: Insufficient compliance|0|||
146065139|NCT02079246|526759913|FG000|OLEX|Other: Caregiver unavailable|3|||
146065140|NCT02079246|526759914|FG001|OLEX|Other: Caregiver unavailable|0|||
146065141|NCT02079246|526759913|FG000|OLEX|Other: Coordinator decision|1|||
146065142|NCT02079246|526759914|FG001|OLEX|Other: Coordinator decision|0|||
146065143|NCT02079246|526759913|FG000|OLEX|Other: Worsening of condition|1|||
146065144|NCT02079246|526759914|FG001|OLEX|Other: Worsening of condition|0|||
146065145|NCT02079246|526759913|FG000|OLEX|Other: Moved to nursing home|1|||
146065146|NCT02079246|526759914|FG001|OLEX|Other: Moved to nursing home|0|||
146065147|NCT02079246|526759913|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
146065148|NCT02079246|526759914|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
146065149|NCT02079246|526759913|FG000|OLEX-MEM|Adverse Event|0|||
146065150|NCT02079246|526759914|FG001|OLEX-MEM|Adverse Event|6|||
146065151|NCT02079246|526759913|FG000|OLEX-MEM|Withdrawal by Subject|0|||
146065152|NCT02079246|526759914|FG001|OLEX-MEM|Withdrawal by Subject|7|||
146065153|NCT02079246|526759913|FG000|OLEX-MEM|Protocol Violation|0|||
146065154|NCT02079246|526759914|FG001|OLEX-MEM|Protocol Violation|2|||
146065155|NCT02079246|526759913|FG000|OLEX-MEM|Lost to Follow-up|0|||
146065156|NCT02079246|526759914|FG001|OLEX-MEM|Lost to Follow-up|1|||
146065157|NCT02079246|526759913|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
146065158|NCT02079246|526759914|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
146065159|NCT04040933|526759919|FG000|Overall Study|Protocol Violation|1|||
146065160|NCT04040933|526759919|FG000|Overall Study|Withdrawal by Subject|2|||
146065161|NCT00775190|526759920|FG000|Overall Study|Lost to Follow-up|2|||
146065162|NCT00775190|526759921|FG001|Overall Study|Lost to Follow-up|3|||
146065163|NCT00775190|526759920|FG000|Overall Study|Withdrawal by Subject|1|||
146065164|NCT00775190|526759921|FG001|Overall Study|Withdrawal by Subject|2|||
146065165|NCT00775190|526759920|FG000|Overall Study|Protocol Violation|1|||
146065166|NCT00775190|526759921|FG001|Overall Study|Protocol Violation|0|||
146065167|NCT01709084|526759922|FG000|Overall Study|Lost to Follow-up|4|||
146065168|NCT01709084|526759923|FG001|Overall Study|Lost to Follow-up|7|||
146065169|NCT01709084|526759922|FG000|Overall Study|Withdrawal by Subject|2|||
146065170|NCT01709084|526759923|FG001|Overall Study|Withdrawal by Subject|2|||
146065171|NCT01709084|526759922|FG000|Overall Study|Adverse Event|5|||
146065172|NCT01709084|526759923|FG001|Overall Study|Adverse Event|0|||
146065173|NCT01709084|526759922|FG000|Overall Study|Other|5|||
146065174|NCT01709084|526759923|FG001|Overall Study|Other|3|||
146065175|NCT01709084|526759922|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
146065176|NCT01709084|526759923|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
146065177|NCT01709084|526759922|FG000|Overall Study|Not Treated|0|||
146065178|NCT01709084|526759923|FG001|Overall Study|Not Treated|2|||
146065179|NCT00641667|526759929|FG000|Overall Study|Withdrawal by Subject|1|||
146065180|NCT00641667|526759929|FG000|Overall Study|Adverse Event|1|||
146065181|NCT00641667|526759929|FG000|Overall Study|Physician Decision|1|||
146065182|NCT00641667|526759929|FG000|Overall Study|Worsening of underlying disease|3|||
146065183|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
146065184|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
146065185|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
146065186|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
146065187|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
146065188|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
146065189|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
146065190|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
146065191|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
146065192|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
146065193|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
146065194|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
146065195|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
146065196|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
146065197|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
146065198|NCT01235741|526759930|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
146065199|NCT01235741|526759931|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
146065200|NCT01235741|526759932|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
146065201|NCT01235741|526759930|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
146065202|NCT01235741|526759931|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
146065203|NCT01235741|526759932|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
146065204|NCT01235741|526759930|FG000|Randomized to Treatment|Adverse Event|0|||
146065205|NCT01235741|526759931|FG001|Randomized to Treatment|Adverse Event|1|||
146065206|NCT01235741|526759932|FG002|Randomized to Treatment|Adverse Event|1|||
146065207|NCT01235741|526759930|FG000|Randomized to Treatment|Sponsor terminated study|0|||
146065208|NCT01235741|526759931|FG001|Randomized to Treatment|Sponsor terminated study|35|||
146065209|NCT01235741|526759932|FG002|Randomized to Treatment|Sponsor terminated study|34|||
146171761|NCT00988221|527143225|FG003|Part I|Lost to Follow-up|0|||
146065210|NCT01235741|526759930|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
146065211|NCT01235741|526759931|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
146065212|NCT01235741|526759932|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
146065213|NCT01235741|526759930|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
146065214|NCT01235741|526759931|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
146065215|NCT01235741|526759932|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
146065216|NCT01235741|526759930|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
146065217|NCT01235741|526759931|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
146065218|NCT01235741|526759932|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
146065219|NCT01421719|526759933|FG000|Overall Study|Withdrawal by Subject|4|||
146065220|NCT01712399|526759937|FG000|Overall Study|Lost to Follow-up|1|||
146065221|NCT01712399|526759937|FG000|Overall Study|Withdrawal by Subject|39|||
146065222|NCT01712399|526759937|FG000|Overall Study|Death|1|||
146065223|NCT01712399|526759937|FG000|Overall Study|Adverse Event|11|||
146065224|NCT01712399|526759937|FG000|Overall Study|Study closure|345|||
146065225|NCT01357850|526759942|FG000|Overall Study|Lost to Follow-up|1|||
146065226|NCT01357850|526759943|FG001|Overall Study|Lost to Follow-up|0|||
146065227|NCT01357850|526759944|FG002|Overall Study|Lost to Follow-up|0|||
146065228|NCT01357850|526759945|FG003|Overall Study|Lost to Follow-up|0|||
146065229|NCT04610281|526759946|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
146065230|NCT04610281|526759947|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
146065231|NCT01772316|526759948|FG000|Overall Study|Serious adverse event|1|||
146065232|NCT01772316|526759948|FG000|Overall Study|Inform consent withdrawn|1|||
146065233|NCT01772316|526759948|FG000|Overall Study|Withdrawn by sponsor decision|5|||
146065234|NCT01774721|526759950|FG000|Overall Study|Death|133|||
146065235|NCT01774721|526759951|FG001|Overall Study|Death|152|||
146065236|NCT01774721|526759950|FG000|Overall Study|Withdrawal by Subject|20|||
146065237|NCT01774721|526759951|FG001|Overall Study|Withdrawal by Subject|14|||
146065238|NCT01774721|526759950|FG000|Overall Study|Lost to Follow-up|6|||
146065239|NCT01774721|526759951|FG001|Overall Study|Lost to Follow-up|7|||
146065240|NCT01774721|526759950|FG000|Overall Study|Did not meet eligibility criteria|0|||
146065241|NCT01774721|526759951|FG001|Overall Study|Did not meet eligibility criteria|3|||
146065242|NCT01774721|526759950|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
146065243|NCT01774721|526759951|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
146065244|NCT01774721|526759950|FG000|Overall Study|Study terminated by sponsor|5|||
146065245|NCT01774721|526759951|FG001|Overall Study|Study terminated by sponsor|0|||
146065246|NCT01774721|526759950|FG000|Overall Study|Disease progression|5|||
146065247|NCT01774721|526759951|FG001|Overall Study|Disease progression|0|||
146065248|NCT02453321|526759955|FG000|Overall Study|Weakness|1|||
146065249|NCT02453321|526759956|FG001|Overall Study|Weakness|1|||
146065250|NCT02453321|526759957|FG002|Overall Study|Weakness|2|||
146065251|NCT02453321|526759955|FG000|Overall Study|Deep Venous Thrombosis|0|||
146065252|NCT02453321|526759956|FG001|Overall Study|Deep Venous Thrombosis|1|||
146065253|NCT02453321|526759957|FG002|Overall Study|Deep Venous Thrombosis|0|||
146065254|NCT02054104|526759959|FG000|Overall Study|Did not want to continue due to college classes|1|||
146065255|NCT02054104|526759960|FG001|Overall Study|Did not want to continue due to college classes|0|||
146065256|NCT02054104|526759959|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
146065257|NCT02054104|526759960|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
146065258|NCT02054104|526759959|FG000|Overall Study|No evidence of immunologic response|2|||
146065259|NCT02054104|526759960|FG001|Overall Study|No evidence of immunologic response|2|||
146065260|NCT02054104|526759959|FG000|Overall Study|Disease Progression On Study|4|||
146065261|NCT02054104|526759960|FG001|Overall Study|Disease Progression On Study|5|||
146065262|NCT02054104|526759959|FG000|Overall Study|Diagnosis of lymphoma|0|||
146065263|NCT02054104|526759960|FG001|Overall Study|Diagnosis of lymphoma|1|||
146065264|NCT02054104|526759959|FG000|Overall Study|Inconclusive response|0|||
146065265|NCT02054104|526759960|FG001|Overall Study|Inconclusive response|1|||
146065266|NCT00763035|526759964|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
146065267|NCT00763035|526759965|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
146065268|NCT00763035|526759964|FG000|First Intervention|Adverse Event|0|||
146065269|NCT00763035|526759965|FG001|First Intervention|Adverse Event|1|||
146065270|NCT00763035|526759964|FG000|Second Intervention|Adverse Event|1|||
146065271|NCT00763035|526759965|FG001|Second Intervention|Adverse Event|0|||
146065272|NCT00763035|526759964|FG000|Second Intervention|Physician Decision|2|||
146407963|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
146407964|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
146065273|NCT00763035|526759965|FG001|Second Intervention|Physician Decision|0|||
146065274|NCT02420821|526759976|FG000|Overall Study|Lost to Follow-up|6|||
146065275|NCT02420821|526759977|FG001|Overall Study|Lost to Follow-up|6|||
146065276|NCT02420821|526759976|FG000|Overall Study|Non-compliance|0|||
146065277|NCT02420821|526759977|FG001|Overall Study|Non-compliance|2|||
146065278|NCT02420821|526759976|FG000|Overall Study|Physician Decision|6|||
146065279|NCT02420821|526759977|FG001|Overall Study|Physician Decision|2|||
146065280|NCT02420821|526759976|FG000|Overall Study|Withdrawal by Subject|32|||
146065281|NCT02420821|526759977|FG001|Overall Study|Withdrawal by Subject|25|||
146065282|NCT02420821|526759976|FG000|Overall Study|Death|270|||
146065283|NCT02420821|526759977|FG001|Overall Study|Death|263|||
146065284|NCT02420821|526759976|FG000|Overall Study|Study Terminated By Sponsor|145|||
146065285|NCT02420821|526759977|FG001|Overall Study|Study Terminated By Sponsor|149|||
146065286|NCT02420821|526759976|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
146065287|NCT02420821|526759977|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
146065288|NCT02420821|526759976|FG000|Overall Study|Adverse Event|0|||
146065289|NCT02420821|526759977|FG001|Overall Study|Adverse Event|1|||
146065290|NCT02420821|526759976|FG000|Overall Study|Protinuria|0|||
146065291|NCT02420821|526759977|FG001|Overall Study|Protinuria|1|||
146065292|NCT02420821|526759976|FG000|Overall Study|Progressive Disease|1|||
146065293|NCT02420821|526759977|FG001|Overall Study|Progressive Disease|1|||
146065294|NCT02420821|526759976|FG000|Overall Study|Disease Progression|0|||
146065295|NCT02420821|526759977|FG001|Overall Study|Disease Progression|1|||
146065296|NCT02420821|526759976|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
146065297|NCT02420821|526759977|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
146065298|NCT01658436|526759978|FG000|Overall Study|Adverse Event|6|||
146065299|NCT01658436|526759979|FG001|Overall Study|Adverse Event|5|||
146065300|NCT01658436|526759978|FG000|Overall Study|Physician Decision|1|||
146065301|NCT01658436|526759979|FG001|Overall Study|Physician Decision|0|||
146065302|NCT01658436|526759978|FG000|Overall Study|Progressive disease|12|||
146065303|NCT01658436|526759979|FG001|Overall Study|Progressive disease|4|||
146065304|NCT01658436|526759978|FG000|Overall Study|Study terminated by sponsor|0|||
146065305|NCT01658436|526759979|FG001|Overall Study|Study terminated by sponsor|1|||
146065306|NCT01658436|526759978|FG000|Overall Study|Subject/guardian decision|0|||
146065307|NCT01658436|526759979|FG001|Overall Study|Subject/guardian decision|1|||
146065308|NCT01658436|526759978|FG000|Overall Study|Death|1|||
146065309|NCT01658436|526759979|FG001|Overall Study|Death|0|||
146065310|NCT00686712|526759980|FG000|Overall Study|Protocol Violation|8|||
146065311|NCT00686712|526759981|FG001|Overall Study|Protocol Violation|8|||
146065312|NCT00686712|526759982|FG002|Overall Study|Protocol Violation|10|||
146065313|NCT00686712|526759980|FG000|Overall Study|Lost to Follow-up|1|||
146065314|NCT00686712|526759981|FG001|Overall Study|Lost to Follow-up|2|||
146065315|NCT00686712|526759982|FG002|Overall Study|Lost to Follow-up|3|||
146065316|NCT00686712|526759980|FG000|Overall Study|Adverse Event|1|||
146065317|NCT00686712|526759981|FG001|Overall Study|Adverse Event|1|||
146065318|NCT00686712|526759982|FG002|Overall Study|Adverse Event|0|||
146065319|NCT01318915|526759985|FG000|Overall Study|Lost to Follow-up|1|||
146065320|NCT00926237|526759986|FG000|Overall Study|Withdrawal by Subject|2|||
146065321|NCT00926237|526759987|FG001|Overall Study|Withdrawal by Subject|1|||
146065322|NCT04119414|526759988|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
146065323|NCT04322526|526759990|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
146065324|NCT04322526|526759991|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146065325|NCT04322526|526759990|FG000|Washout (1 Week)|Lost to Follow-up|1|||
146065326|NCT04322526|526759991|FG001|Washout (1 Week)|Lost to Follow-up|2|||
146065327|NCT01716234|526759992|FG000|Overall Study|Protocol Violation|0|||
146065328|NCT01716234|526759993|FG001|Overall Study|Protocol Violation|0|||
146065329|NCT01716234|526759994|FG002|Overall Study|Protocol Violation|0|||
146065330|NCT01716234|526759995|FG003|Overall Study|Protocol Violation|1|||
146065331|NCT01716234|526759996|FG004|Overall Study|Protocol Violation|1|||
146065332|NCT01716234|526759997|FG005|Overall Study|Protocol Violation|1|||
146065333|NCT01716234|526759998|FG006|Overall Study|Protocol Violation|0|||
146065334|NCT01716234|526759992|FG000|Overall Study|Lack of Efficacy|0|||
146065335|NCT01716234|526759993|FG001|Overall Study|Lack of Efficacy|0|||
146065336|NCT01716234|526759994|FG002|Overall Study|Lack of Efficacy|0|||
146065337|NCT01716234|526759995|FG003|Overall Study|Lack of Efficacy|1|||
146065338|NCT01716234|526759996|FG004|Overall Study|Lack of Efficacy|0|||
146065339|NCT01716234|526759997|FG005|Overall Study|Lack of Efficacy|0|||
146065340|NCT01716234|526759998|FG006|Overall Study|Lack of Efficacy|0|||
146065341|NCT01716234|526759992|FG000|Overall Study|Did not meet protocol eligibility|0|||
146065342|NCT01716234|526759993|FG001|Overall Study|Did not meet protocol eligibility|0|||
146171762|NCT00988221|527143222|FG000|Part II|Adverse Event|1|||
146171763|NCT00988221|527143223|FG001|Part II|Adverse Event|0|||
146065343|NCT01716234|526759994|FG002|Overall Study|Did not meet protocol eligibility|1|||
146065344|NCT01716234|526759995|FG003|Overall Study|Did not meet protocol eligibility|0|||
146065345|NCT01716234|526759996|FG004|Overall Study|Did not meet protocol eligibility|0|||
146065346|NCT01716234|526759997|FG005|Overall Study|Did not meet protocol eligibility|4|||
146065347|NCT01716234|526759998|FG006|Overall Study|Did not meet protocol eligibility|0|||
146171764|NCT00988221|527143224|FG002|Part II|Adverse Event|0|||
146171765|NCT00988221|527143225|FG003|Part II|Adverse Event|1|||
146171766|NCT00988221|527143222|FG000|Part II|Withdrawal by Subject|0|||
146065348|NCT01716234|526759992|FG000|Overall Study|Adverse Event|7|||
146065349|NCT01716234|526759993|FG001|Overall Study|Adverse Event|10|||
146065350|NCT01716234|526759994|FG002|Overall Study|Adverse Event|2|||
146065351|NCT01716234|526759995|FG003|Overall Study|Adverse Event|8|||
146065352|NCT01716234|526759996|FG004|Overall Study|Adverse Event|3|||
146065353|NCT01716234|526759997|FG005|Overall Study|Adverse Event|6|||
146065354|NCT01716234|526759998|FG006|Overall Study|Adverse Event|0|||
146065355|NCT01716234|526759992|FG000|Overall Study|Withdrawal by Subject|3|||
146065356|NCT01716234|526759993|FG001|Overall Study|Withdrawal by Subject|0|||
146065357|NCT01716234|526759994|FG002|Overall Study|Withdrawal by Subject|2|||
146065358|NCT01716234|526759995|FG003|Overall Study|Withdrawal by Subject|2|||
146065359|NCT01716234|526759996|FG004|Overall Study|Withdrawal by Subject|1|||
146065360|NCT01716234|526759997|FG005|Overall Study|Withdrawal by Subject|3|||
146065361|NCT01716234|526759998|FG006|Overall Study|Withdrawal by Subject|0|||
146065362|NCT01523756|526759999|FG000|Baseline Period|Adverse Event|0|||
146065363|NCT01523756|526760000|FG001|Baseline Period|Adverse Event|1|||
146065364|NCT01523756|526759999|FG000|Test Period 1|Adverse Event|1|||
146065365|NCT01523756|526760000|FG001|Test Period 1|Adverse Event|0|||
146065366|NCT01523756|526759999|FG000|Test Period 2|Withdrawal by Subject|0|||
146065367|NCT01523756|526760000|FG001|Test Period 2|Withdrawal by Subject|1|||
146065368|NCT00474812|526760006|FG000|Overall Study|Withdrawal by Subject|5|||
146065369|NCT00474812|526760006|FG000|Overall Study|No Initiation of treatment|2|||
146065370|NCT05408429|526760009|FG000|Overall Study|Lost to Follow-up|1|||
146065371|NCT05408429|526760010|FG001|Overall Study|Lost to Follow-up|1|||
146065372|NCT05408429|526760011|FG002|Overall Study|Lost to Follow-up|0|||
146065373|NCT05408429|526760009|FG000|Overall Study|Withdrawal by Subject|5|||
146065374|NCT05408429|526760010|FG001|Overall Study|Withdrawal by Subject|0|||
146065375|NCT05408429|526760011|FG002|Overall Study|Withdrawal by Subject|1|||
146065376|NCT03435211|526760012|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
146065377|NCT02195518|526760013|FG000|Overall Study|Adverse Event|1|||
146065378|NCT02195518|526760013|FG000|Overall Study|Protocol Violation|4|||
146065379|NCT02195518|526760013|FG000|Overall Study|Pregnancy|2|||
146065380|NCT02195518|526760013|FG000|Overall Study|Withdrawal by Subject|1|||
146065381|NCT02195518|526760013|FG000|Overall Study|Lost to Follow-up|1|||
146065382|NCT03818256|526760014|FG000|Overall Study|Withdrawal by Subject|2|||
146065383|NCT03818256|526760015|FG001|Overall Study|Withdrawal by Subject|2|||
146065384|NCT03818256|526760014|FG000|Overall Study|Adverse Event|3|||
146065385|NCT03818256|526760015|FG001|Overall Study|Adverse Event|1|||
146065386|NCT03818256|526760014|FG000|Overall Study|Lost to Follow-up|0|||
146065387|NCT03818256|526760015|FG001|Overall Study|Lost to Follow-up|5|||
146065388|NCT03818256|526760014|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
146065389|NCT03818256|526760015|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
146065390|NCT03818256|526760014|FG000|Overall Study|Not reporting for scheduled visits|1|||
146065391|NCT03818256|526760015|FG001|Overall Study|Not reporting for scheduled visits|0|||
146065392|NCT03818256|526760014|FG000|Overall Study|Non-compliant with investigational product|1|||
146065393|NCT03818256|526760015|FG001|Overall Study|Non-compliant with investigational product|0|||
146065394|NCT01342211|526760016|FG000|Overall Study|Lost to Follow-up|0|||
146065395|NCT01342211|526760017|FG001|Overall Study|Lost to Follow-up|0|||
146065396|NCT01342211|526760018|FG002|Overall Study|Lost to Follow-up|0|||
146065397|NCT01342211|526760019|FG003|Overall Study|Lost to Follow-up|1|||
146065398|NCT01342211|526760020|FG004|Overall Study|Lost to Follow-up|0|||
146065399|NCT01342211|526760016|FG000|Overall Study|Adverse Event|0|||
146065400|NCT01342211|526760017|FG001|Overall Study|Adverse Event|0|||
146065401|NCT01342211|526760018|FG002|Overall Study|Adverse Event|0|||
146065402|NCT01342211|526760019|FG003|Overall Study|Adverse Event|0|||
146065403|NCT01342211|526760020|FG004|Overall Study|Adverse Event|1|||
146065404|NCT01342211|526760016|FG000|Overall Study|Withdrawal by Subject|0|||
146065405|NCT01342211|526760017|FG001|Overall Study|Withdrawal by Subject|0|||
146065406|NCT01342211|526760018|FG002|Overall Study|Withdrawal by Subject|0|||
146065407|NCT01342211|526760019|FG003|Overall Study|Withdrawal by Subject|1|||
146065408|NCT01342211|526760020|FG004|Overall Study|Withdrawal by Subject|0|||
146065409|NCT01342211|526760016|FG000|Overall Study|Randomized, but not Treated|0|||
146065410|NCT01342211|526760017|FG001|Overall Study|Randomized, but not Treated|2|||
146065411|NCT01342211|526760018|FG002|Overall Study|Randomized, but not Treated|0|||
146065412|NCT01342211|526760019|FG003|Overall Study|Randomized, but not Treated|0|||
146065413|NCT01342211|526760020|FG004|Overall Study|Randomized, but not Treated|1|||
146065414|NCT01588522|526760023|FG000|Overall Study|Withdrawal by Subject|1|||
146065415|NCT01588522|526760024|FG001|Overall Study|Withdrawal by Subject|5|||
146065416|NCT01588522|526760025|FG002|Overall Study|Withdrawal by Subject|3|||
146065417|NCT01588522|526760026|FG003|Overall Study|Withdrawal by Subject|1|||
146065418|NCT01588522|526760027|FG004|Overall Study|Withdrawal by Subject|2|||
146065419|NCT01588522|526760028|FG005|Overall Study|Withdrawal by Subject|0|||
146065420|NCT01588522|526760023|FG000|Overall Study|Lack of Efficacy|0|||
146065421|NCT01588522|526760024|FG001|Overall Study|Lack of Efficacy|0|||
146065422|NCT01588522|526760025|FG002|Overall Study|Lack of Efficacy|0|||
146065423|NCT01588522|526760026|FG003|Overall Study|Lack of Efficacy|0|||
146065424|NCT01588522|526760027|FG004|Overall Study|Lack of Efficacy|1|||
146065425|NCT01588522|526760028|FG005|Overall Study|Lack of Efficacy|0|||
146065426|NCT01588522|526760023|FG000|Overall Study|Adverse Event|0|||
146065427|NCT01588522|526760024|FG001|Overall Study|Adverse Event|0|||
146065428|NCT01588522|526760025|FG002|Overall Study|Adverse Event|0|||
146065429|NCT01588522|526760026|FG003|Overall Study|Adverse Event|1|||
146065430|NCT01588522|526760027|FG004|Overall Study|Adverse Event|0|||
146065431|NCT01588522|526760028|FG005|Overall Study|Adverse Event|0|||
146065432|NCT01588522|526760023|FG000|Overall Study|Grade 2 alopecia|1|||
146065433|NCT01588522|526760024|FG001|Overall Study|Grade 2 alopecia|0|||
146065434|NCT01588522|526760025|FG002|Overall Study|Grade 2 alopecia|0|||
146065435|NCT01588522|526760026|FG003|Overall Study|Grade 2 alopecia|0|||
146065436|NCT01588522|526760027|FG004|Overall Study|Grade 2 alopecia|0|||
146065437|NCT01588522|526760028|FG005|Overall Study|Grade 2 alopecia|0|||
146065438|NCT01588522|526760023|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
146065439|NCT01588522|526760024|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
146065440|NCT01588522|526760025|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
146065441|NCT01588522|526760026|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
146065442|NCT01588522|526760027|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
146065443|NCT01588522|526760028|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
146065444|NCT01588522|526760023|FG000|Overall Study|Taken off taxane-based regimen|0|||
146065445|NCT01588522|526760024|FG001|Overall Study|Taken off taxane-based regimen|0|||
146065446|NCT01588522|526760025|FG002|Overall Study|Taken off taxane-based regimen|0|||
146065447|NCT01588522|526760026|FG003|Overall Study|Taken off taxane-based regimen|1|||
146065448|NCT01588522|526760027|FG004|Overall Study|Taken off taxane-based regimen|0|||
146065449|NCT01588522|526760028|FG005|Overall Study|Taken off taxane-based regimen|0|||
146065450|NCT01588522|526760023|FG000|Overall Study|Did not initiate chemotherapy|0|||
146065451|NCT01588522|526760024|FG001|Overall Study|Did not initiate chemotherapy|0|||
146065452|NCT01588522|526760025|FG002|Overall Study|Did not initiate chemotherapy|0|||
146065453|NCT01588522|526760026|FG003|Overall Study|Did not initiate chemotherapy|0|||
146065454|NCT01588522|526760027|FG004|Overall Study|Did not initiate chemotherapy|1|||
146065455|NCT01588522|526760028|FG005|Overall Study|Did not initiate chemotherapy|0|||
146065456|NCT02749422|526760033|FG000|Overall Study|Lost to Follow-up|0|||
146065457|NCT02749422|526760034|FG001|Overall Study|Lost to Follow-up|2|||
146065458|NCT02749422|526760033|FG000|Overall Study|Ineligible|0|||
146065459|NCT02749422|526760034|FG001|Overall Study|Ineligible|1|||
146065460|NCT05786651|526760035|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
146065461|NCT02855125|526760036|FG000|Overall Study|Withdrawal by Subject|2|||
146065462|NCT02855125|526760037|FG001|Overall Study|Withdrawal by Subject|2|||
146065463|NCT02855125|526760036|FG000|Overall Study|Clinical Disease Progression|5|||
146065464|NCT02855125|526760037|FG001|Overall Study|Clinical Disease Progression|4|||
146065465|NCT02855125|526760036|FG000|Overall Study|Radiologic Disease Progression|36|||
146065466|NCT02855125|526760037|FG001|Overall Study|Radiologic Disease Progression|39|||
146065467|NCT02855125|526760036|FG000|Overall Study|Adverse Event|11|||
146065468|NCT02855125|526760037|FG001|Overall Study|Adverse Event|7|||
146065469|NCT02855125|526760036|FG000|Overall Study|Physician Decision|1|||
146065470|NCT02855125|526760037|FG001|Overall Study|Physician Decision|0|||
146065471|NCT02855125|526760036|FG000|Overall Study|On Treatment|9|||
146065472|NCT02855125|526760037|FG001|Overall Study|On Treatment|11|||
146065473|NCT02855125|526760036|FG000|Overall Study|Randomized but not treated|0|||
146065474|NCT02855125|526760037|FG001|Overall Study|Randomized but not treated|1|||
146065475|NCT04586205|526760047|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
146065476|NCT04586205|526760048|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
146065477|NCT01646125|526761524|FG000|Overall Study|Untreated|2|||
146065478|NCT01646125|526761525|FG001|Overall Study|Untreated|5|||
146065479|NCT01646125|526761524|FG000|Overall Study|Adverse Event|2|||
146065480|NCT01646125|526761525|FG001|Overall Study|Adverse Event|1|||
146065481|NCT01646125|526761524|FG000|Overall Study|Death|1|||
146065482|NCT01646125|526761525|FG001|Overall Study|Death|1|||
146065483|NCT01646125|526761524|FG000|Overall Study|Physician Decision|1|||
146065484|NCT01646125|526761525|FG001|Overall Study|Physician Decision|3|||
146065485|NCT01646125|526761524|FG000|Overall Study|Progressive disease|22|||
146065486|NCT01646125|526761525|FG001|Overall Study|Progressive disease|16|||
146065487|NCT01646125|526761524|FG000|Overall Study|Study terminated by sponsor|2|||
146065488|NCT01646125|526761525|FG001|Overall Study|Study terminated by sponsor|1|||
146065489|NCT01646125|526761524|FG000|Overall Study|Subject/Guardian decision|1|||
146065490|NCT01646125|526761525|FG001|Overall Study|Subject/Guardian decision|1|||
146065491|NCT01942837|526761534|FG000|Overall Study|Death|1|||
146065492|NCT01942837|526761534|FG000|Overall Study|Symptomatic or radiographic progression|49|||
146065493|NCT01942837|526761534|FG000|Overall Study|Adverse Event|6|||
146407965|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
146407966|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
146065494|NCT01942837|526761534|FG000|Overall Study|Physician Decision|3|||
146065495|NCT01942837|526761534|FG000|Overall Study|Withdrawal by Subject|2|||
146065496|NCT01942837|526761534|FG000|Overall Study|Intercurrent Illness|1|||
146065497|NCT01942837|526761534|FG000|Overall Study|On treatment|3|||
146065498|NCT01942837|526761534|FG000|Overall Study|Never initiate the treatment|2|||
146065499|NCT01298648|526761535|FG000|Overall Study|Withdrawal by Subject|2|||
146407967|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
146065500|NCT01298648|526761535|FG000|Overall Study|Lost to Follow-up|21|||
146065501|NCT03077412|526761539|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
146065502|NCT03077412|526761540|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
146065503|NCT03077412|526761541|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
146065504|NCT03077412|526761539|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
146065505|NCT03077412|526761540|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
146065506|NCT03077412|526761541|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
146065507|NCT03077412|526761539|FG000|Overall Study|Adverse Event|1|||
146065508|NCT03077412|526761540|FG001|Overall Study|Adverse Event|2|||
146065509|NCT03077412|526761541|FG002|Overall Study|Adverse Event|2|||
146065510|NCT03077412|526761539|FG000|Overall Study|Investigator's Discretion|0|||
146065511|NCT03077412|526761540|FG001|Overall Study|Investigator's Discretion|1|||
146065512|NCT03077412|526761541|FG002|Overall Study|Investigator's Discretion|1|||
146065513|NCT03077412|526761539|FG000|Overall Study|Withdrew Consent|0|||
146065514|NCT03077412|526761540|FG001|Overall Study|Withdrew Consent|2|||
146065515|NCT03077412|526761541|FG002|Overall Study|Withdrew Consent|0|||
146065516|NCT02266888|526761543|FG000|Overall Study|Death|2|||
146065517|NCT02266888|526761544|FG001|Overall Study|Death|2|||
146065518|NCT02266888|526761545|FG002|Overall Study|Death|4|||
146065519|NCT02266888|526761546|FG003|Overall Study|Death|2|||
146065520|NCT02266888|526761543|FG000|Overall Study|Physician Decision|0|||
146065521|NCT02266888|526761544|FG001|Overall Study|Physician Decision|1|||
146065522|NCT02266888|526761545|FG002|Overall Study|Physician Decision|2|||
146065523|NCT02266888|526761546|FG003|Overall Study|Physician Decision|2|||
146065524|NCT02266888|526761543|FG000|Overall Study|Study Terminated|5|||
146065525|NCT02266888|526761544|FG001|Overall Study|Study Terminated|1|||
146065526|NCT02266888|526761545|FG002|Overall Study|Study Terminated|0|||
146065527|NCT02266888|526761546|FG003|Overall Study|Study Terminated|0|||
146065528|NCT02266888|526761543|FG000|Overall Study|No Longer Eligible|0|||
146065529|NCT02266888|526761544|FG001|Overall Study|No Longer Eligible|0|||
146065530|NCT02266888|526761545|FG002|Overall Study|No Longer Eligible|0|||
146065531|NCT02266888|526761546|FG003|Overall Study|No Longer Eligible|2|||
146065532|NCT02266888|526761543|FG000|Overall Study|Randomization Closed|0|||
146065533|NCT02266888|526761544|FG001|Overall Study|Randomization Closed|0|||
146065534|NCT02266888|526761545|FG002|Overall Study|Randomization Closed|4|||
146065535|NCT02266888|526761546|FG003|Overall Study|Randomization Closed|0|||
146065536|NCT02266888|526761543|FG000|Overall Study|Personnel unavailable at transplant|0|||
146065537|NCT02266888|526761544|FG001|Overall Study|Personnel unavailable at transplant|0|||
146065538|NCT02266888|526761545|FG002|Overall Study|Personnel unavailable at transplant|0|||
146065539|NCT02266888|526761546|FG003|Overall Study|Personnel unavailable at transplant|1|||
146065540|NCT02266888|526761543|FG000|Overall Study|Transfer of care|0|||
146065541|NCT02266888|526761544|FG001|Overall Study|Transfer of care|0|||
146065542|NCT02266888|526761545|FG002|Overall Study|Transfer of care|1|||
146065543|NCT02266888|526761546|FG003|Overall Study|Transfer of care|0|||
146065544|NCT02351856|526761547|FG000|Overall Study|Adverse Event|2|||
146065545|NCT02351856|526761547|FG000|Overall Study|Physician Decision|5|||
146065546|NCT02351856|526761547|FG000|Overall Study|Study terminated by sponsor|1|||
146065547|NCT01458392|526761550|FG000|Overall Study|Death|2|||
146065548|NCT01458392|526761551|FG001|Overall Study|Death|11|||
146065549|NCT01458392|526761552|FG002|Overall Study|Death|22|||
146065550|NCT01458392|526761550|FG000|Overall Study|At the discretion of the sponsor|0|||
146065551|NCT01458392|526761551|FG001|Overall Study|At the discretion of the sponsor|2|||
146065552|NCT01458392|526761552|FG002|Overall Study|At the discretion of the sponsor|7|||
146065553|NCT01458392|526761550|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
146065554|NCT01458392|526761551|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
146065555|NCT01458392|526761552|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
146065556|NCT01281124|526761555|FG000|Overall Study|Death|1|||
146065557|NCT00918255|526761556|FG000|Overall Study|Adverse Event|1|||
146065558|NCT00918255|526761557|FG001|Overall Study|Adverse Event|0|||
146065559|NCT00918255|526761558|FG002|Overall Study|Adverse Event|0|||
146065560|NCT00918255|526761556|FG000|Overall Study|Withdrawal by Subject|1|||
146065561|NCT00918255|526761557|FG001|Overall Study|Withdrawal by Subject|0|||
146065562|NCT00918255|526761558|FG002|Overall Study|Withdrawal by Subject|2|||
146065563|NCT00918255|526761556|FG000|Overall Study|Lack of Efficacy|1|||
146065564|NCT00918255|526761557|FG001|Overall Study|Lack of Efficacy|0|||
146065565|NCT00918255|526761558|FG002|Overall Study|Lack of Efficacy|0|||
146065566|NCT00918255|526761556|FG000|Overall Study|Lost to Follow-up|1|||
146065567|NCT00918255|526761557|FG001|Overall Study|Lost to Follow-up|0|||
146065568|NCT00918255|526761558|FG002|Overall Study|Lost to Follow-up|2|||
146065569|NCT00918255|526761556|FG000|Overall Study|Exceeded allowed number of interventions|0|||
146065570|NCT00918255|526761557|FG001|Overall Study|Exceeded allowed number of interventions|0|||
146065571|NCT00918255|526761558|FG002|Overall Study|Exceeded allowed number of interventions|1|||
146065572|NCT00918255|526761556|FG000|Overall Study|Non-compliance|1|||
146065573|NCT00918255|526761557|FG001|Overall Study|Non-compliance|0|||
146065574|NCT00918255|526761558|FG002|Overall Study|Non-compliance|0|||
146065575|NCT00918255|526761556|FG000|Overall Study|Investigator discretion|1|||
146065576|NCT00918255|526761557|FG001|Overall Study|Investigator discretion|0|||
146065577|NCT00918255|526761558|FG002|Overall Study|Investigator discretion|0|||
146065578|NCT02038933|526761559|FG000|Overall Study|Disease progression|104|||
146065579|NCT02038933|526761559|FG000|Overall Study|Study drug toxicity|6|||
146065580|NCT02038933|526761559|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146065581|NCT02038933|526761559|FG000|Overall Study|Participant request to discontinue treatment|2|||
146065582|NCT02038933|526761559|FG000|Overall Study|Lost to Follow-up|1|||
146065583|NCT02038933|526761559|FG000|Overall Study|Other reasons|2|||
146065584|NCT00753506|526761560|FG000|Overall Study|Withdrawal by Subject|4|||
146065585|NCT00753506|526761561|FG001|Overall Study|Withdrawal by Subject|1|||
146065586|NCT00753506|526761560|FG000|Overall Study|Lost to Follow-up|2|||
146065587|NCT00753506|526761561|FG001|Overall Study|Lost to Follow-up|0|||
146065588|NCT00753506|526761560|FG000|Overall Study|Other reason|1|||
146065589|NCT00753506|526761561|FG001|Overall Study|Other reason|1|||
146065590|NCT04226742|526761564|FG000|Overall Study|Lost to Follow-up|16|||
146065591|NCT04226742|526761565|FG001|Overall Study|Lost to Follow-up|13|||
146065592|NCT04226742|526761564|FG000|Overall Study|Withdrawal by Subject|5|||
146065593|NCT04226742|526761565|FG001|Overall Study|Withdrawal by Subject|3|||
146065594|NCT01193244|526761568|FG000|Overall Study|Withdrawal by Subject|79|||
146065595|NCT01193244|526761569|FG001|Overall Study|Withdrawal by Subject|97|||
146065596|NCT01193244|526761568|FG000|Overall Study|Other|303|||
146065597|NCT01193244|526761569|FG001|Overall Study|Other|278|||
146065598|NCT01193244|526761568|FG000|Overall Study|Lost to Follow-up|6|||
146065599|NCT01193244|526761569|FG001|Overall Study|Lost to Follow-up|15|||
146065600|NCT01417377|526761570|FG000|Overall Study|Lost to Follow-up|12|||
146065601|NCT01417377|526761570|FG000|Overall Study|Enrolled, but not treated|1|||
146065602|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
146065603|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
146065604|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
146065605|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
146065606|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
146065607|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
146065608|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
146065609|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
146065610|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
146065611|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
146065612|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
146065613|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
146065614|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
146065615|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
146065616|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
146065617|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
146065618|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
146065619|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
146065620|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
146065621|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
146065622|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
146065623|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
146065624|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
146065625|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
146065626|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
146065627|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
146065628|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
146065629|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
146065630|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065631|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065632|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065633|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065634|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146407968|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
146407969|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
146407970|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
146407971|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
146407972|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
146407973|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
146407974|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
146065635|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065636|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
146065637|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065638|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065639|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065640|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146171767|NCT00988221|527143223|FG001|Part II|Withdrawal by Subject|0|||
146065641|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065642|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065643|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
146065644|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Transplant|0|||
146065645|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Transplant|1|||
146065646|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Transplant|0|||
146065647|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Transplant|0|||
146065648|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Transplant|0|||
146065649|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Transplant|1|||
146065650|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Transplant|0|||
146065651|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Transplant|0|||
146065652|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Transplant|0|||
146065653|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Transplant|0|||
146065654|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Transplant|0|||
146065655|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Transplant|0|||
146065656|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Transplant|0|||
146065657|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Transplant|0|||
146065658|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
146065659|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
146065660|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
146065661|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
146065662|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
146065663|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
146065664|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
146065665|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
146065666|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
146065667|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
146065668|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
146065669|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
146065670|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
146065671|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
146065672|NCT02113982|526761571|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
146065673|NCT02113982|526761572|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
146065674|NCT02113982|526761573|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
146065675|NCT02113982|526761574|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
146065676|NCT02113982|526761575|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
146065677|NCT02113982|526761576|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
146065678|NCT02113982|526761577|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
146065679|NCT02113982|526761578|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
146065680|NCT02113982|526761579|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
146065681|NCT02113982|526761580|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
146065682|NCT02113982|526761581|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
146065683|NCT02113982|526761582|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
146065684|NCT02113982|526761583|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
146065685|NCT02113982|526761584|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
146065686|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
146065687|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
146065688|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
146065689|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
146065690|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
146065691|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
146065692|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
146065693|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
146065694|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
146065695|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
146065696|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
146065697|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
146065698|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
146065699|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
146065700|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
146065701|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
146065702|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
146171768|NCT00988221|527143224|FG002|Part II|Withdrawal by Subject|2|||
146065703|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
146065704|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
146065705|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
146065706|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
146065707|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
146065708|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
146065709|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
146171769|NCT00988221|527143225|FG003|Part II|Withdrawal by Subject|2|||
146171770|NCT00988221|527143222|FG000|Part II|Reason not Specified|0|||
146171771|NCT00988221|527143223|FG001|Part II|Reason not Specified|0|||
146171772|NCT00988221|527143224|FG002|Part II|Reason not Specified|1|||
146065710|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
146065711|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
146065712|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
146065713|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
146065714|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065715|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065716|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065717|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065718|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065719|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065720|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065721|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
146065722|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065723|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
146065724|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
146065725|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065726|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065727|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
146065728|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065729|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065730|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065731|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065732|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065733|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065734|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065735|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
146065736|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065737|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
146065738|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065739|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065740|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065741|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
146065742|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065743|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065744|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065745|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065746|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065747|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065748|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065749|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
146065750|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065751|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065752|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065753|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065754|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065755|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
146065756|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Transplant|0|||
146065757|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Transplant|0|||
146065758|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Transplant|0|||
146065759|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Transplant|0|||
146065760|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Transplant|0|||
146065761|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Transplant|0|||
146065762|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Transplant|0|||
146065763|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Transplant|0|||
146065764|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Transplant|0|||
146065765|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Transplant|4|||
146065766|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Transplant|2|||
146065767|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Transplant|0|||
146065768|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Transplant|0|||
146065769|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Transplant|0|||
146065770|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
146065771|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
146065772|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
146065773|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
146065774|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
146065775|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
146065776|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
146065777|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
146065778|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
146065779|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
146065780|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
146065781|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
146065782|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
146065783|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
146065784|NCT02113982|526761571|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
146065785|NCT02113982|526761572|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
146065786|NCT02113982|526761573|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
146065787|NCT02113982|526761574|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
146065788|NCT02113982|526761575|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
146065789|NCT02113982|526761576|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
146065790|NCT02113982|526761577|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
146065791|NCT02113982|526761578|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
146065792|NCT02113982|526761579|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
146065793|NCT02113982|526761580|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
146065794|NCT02113982|526761581|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
146065795|NCT02113982|526761582|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
146065796|NCT02113982|526761583|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
146065797|NCT02113982|526761584|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
146065798|NCT02113982|526761571|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065799|NCT02113982|526761572|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065800|NCT02113982|526761573|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065801|NCT02113982|526761574|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065802|NCT02113982|526761575|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065803|NCT02113982|526761576|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065804|NCT02113982|526761577|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065805|NCT02113982|526761578|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065806|NCT02113982|526761579|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065807|NCT02113982|526761580|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065808|NCT02113982|526761581|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065809|NCT02113982|526761582|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
146065810|NCT02113982|526761583|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065811|NCT02113982|526761584|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
146065812|NCT02113982|526761571|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065813|NCT02113982|526761572|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065814|NCT02113982|526761573|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065815|NCT02113982|526761574|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065816|NCT02113982|526761575|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065817|NCT02113982|526761576|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065818|NCT02113982|526761577|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065819|NCT02113982|526761578|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065820|NCT02113982|526761579|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065821|NCT02113982|526761580|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065822|NCT02113982|526761581|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065823|NCT02113982|526761582|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
146065824|NCT02113982|526761583|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065825|NCT02113982|526761584|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
146065826|NCT02113982|526761571|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065827|NCT02113982|526761572|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065828|NCT02113982|526761573|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065829|NCT02113982|526761574|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065830|NCT02113982|526761575|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065831|NCT02113982|526761576|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065832|NCT02113982|526761577|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065833|NCT02113982|526761578|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065834|NCT02113982|526761579|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065835|NCT02113982|526761580|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065836|NCT02113982|526761581|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065837|NCT02113982|526761582|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
146065838|NCT02113982|526761583|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065839|NCT02113982|526761584|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
146065840|NCT02113982|526761571|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
146065841|NCT02113982|526761572|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
146065842|NCT02113982|526761573|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
146065843|NCT02113982|526761574|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
146065844|NCT02113982|526761575|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
146065845|NCT02113982|526761576|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
146065846|NCT02113982|526761577|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
146065847|NCT02113982|526761578|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
146065848|NCT02113982|526761579|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
146065849|NCT02113982|526761580|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
146065850|NCT02113982|526761581|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
146065851|NCT02113982|526761582|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
146065852|NCT02113982|526761583|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
146065853|NCT02113982|526761584|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
146065854|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065855|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065856|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065857|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065858|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065859|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065860|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065861|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065862|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065863|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065864|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065865|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065866|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
146065867|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
146065868|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065869|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065870|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065871|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065872|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065873|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065874|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065875|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065876|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065877|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065878|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065879|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
146065880|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
146065881|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
146065882|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065883|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065884|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065885|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065886|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065887|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065888|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065889|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065890|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065891|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065892|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065893|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
146065894|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
146065895|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
146065896|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065897|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065898|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065899|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065900|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065901|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065902|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065903|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065904|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065905|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065906|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065907|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
146065908|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
146065909|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
146065910|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065911|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065912|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065913|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065914|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065915|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065916|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065917|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065918|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146171773|NCT00988221|527143225|FG003|Part II|Reason not Specified|0|||
146065919|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065920|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065921|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065922|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
146065923|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
146065924|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065925|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065926|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065927|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065928|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065929|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065930|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065931|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065932|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065933|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065934|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065935|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065936|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
146065937|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
146065938|NCT02113982|526761571|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065939|NCT02113982|526761572|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065940|NCT02113982|526761573|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065941|NCT02113982|526761574|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065942|NCT02113982|526761575|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065943|NCT02113982|526761576|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065944|NCT02113982|526761577|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065945|NCT02113982|526761578|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065946|NCT02113982|526761579|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065947|NCT02113982|526761580|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065948|NCT02113982|526761581|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065949|NCT02113982|526761582|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065950|NCT02113982|526761583|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
146065951|NCT02113982|526761584|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
146065952|NCT03763877|526761594|FG000|Overall Study|Withdrawal by Subject|3|||
146065953|NCT03763877|526761595|FG001|Overall Study|Withdrawal by Subject|1|||
146065954|NCT03763877|526761596|FG002|Overall Study|Withdrawal by Subject|3|||
146065955|NCT03763877|526761597|FG003|Overall Study|Withdrawal by Subject|4|||
146065956|NCT03763877|526761594|FG000|Overall Study|Adverse Event|1|||
146065957|NCT03763877|526761595|FG001|Overall Study|Adverse Event|1|||
146065958|NCT03763877|526761596|FG002|Overall Study|Adverse Event|3|||
146065959|NCT03763877|526761597|FG003|Overall Study|Adverse Event|1|||
146065960|NCT03763877|526761594|FG000|Overall Study|Protocol Violation|1|||
146065961|NCT03763877|526761595|FG001|Overall Study|Protocol Violation|1|||
146065962|NCT03763877|526761596|FG002|Overall Study|Protocol Violation|0|||
146065963|NCT03763877|526761597|FG003|Overall Study|Protocol Violation|0|||
146065964|NCT03763877|526761594|FG000|Overall Study|Lost to Follow-up|0|||
146065965|NCT03763877|526761595|FG001|Overall Study|Lost to Follow-up|1|||
146065966|NCT03763877|526761596|FG002|Overall Study|Lost to Follow-up|1|||
146065967|NCT03763877|526761597|FG003|Overall Study|Lost to Follow-up|0|||
146065968|NCT03040336|526761598|FG000|Overall Study|Death|1|||
146065969|NCT03040336|526761599|FG001|Overall Study|Death|0|||
146065970|NCT03040336|526761598|FG000|Overall Study|Withdrawal by Subject|2|||
146065971|NCT03040336|526761599|FG001|Overall Study|Withdrawal by Subject|3|||
146065972|NCT00068692|526761604|FG000|Step 1: Registration|Disese progression/relapse|5|||
146065973|NCT00068692|526761605|FG001|Step 1: Registration|Disese progression/relapse|0|||
146065974|NCT00068692|526761606|FG002|Step 1: Registration|Disese progression/relapse|0|||
146065975|NCT00068692|526761607|FG003|Step 1: Registration|Disese progression/relapse|0|||
146065976|NCT00068692|526761608|FG004|Step 1: Registration|Disese progression/relapse|0|||
146065977|NCT00068692|526761609|FG005|Step 1: Registration|Disese progression/relapse|0|||
146065978|NCT00068692|526761610|FG006|Step 1: Registration|Disese progression/relapse|0|||
146065979|NCT00068692|526761611|FG007|Step 1: Registration|Disese progression/relapse|0|||
146065980|NCT00068692|526761604|FG000|Step 1: Registration|Adverse Event|7|||
146065981|NCT00068692|526761605|FG001|Step 1: Registration|Adverse Event|0|||
146065982|NCT00068692|526761606|FG002|Step 1: Registration|Adverse Event|0|||
146065983|NCT00068692|526761607|FG003|Step 1: Registration|Adverse Event|0|||
146065984|NCT00068692|526761608|FG004|Step 1: Registration|Adverse Event|0|||
146065985|NCT00068692|526761609|FG005|Step 1: Registration|Adverse Event|0|||
146065986|NCT00068692|526761610|FG006|Step 1: Registration|Adverse Event|0|||
146065987|NCT00068692|526761611|FG007|Step 1: Registration|Adverse Event|0|||
146065988|NCT00068692|526761604|FG000|Step 1: Registration|Death|1|||
146065989|NCT00068692|526761605|FG001|Step 1: Registration|Death|0|||
146065990|NCT00068692|526761606|FG002|Step 1: Registration|Death|0|||
146065991|NCT00068692|526761607|FG003|Step 1: Registration|Death|0|||
146065992|NCT00068692|526761608|FG004|Step 1: Registration|Death|0|||
146065993|NCT00068692|526761609|FG005|Step 1: Registration|Death|0|||
146065994|NCT00068692|526761610|FG006|Step 1: Registration|Death|0|||
146065995|NCT00068692|526761611|FG007|Step 1: Registration|Death|0|||
146065996|NCT00068692|526761604|FG000|Step 1: Registration|Withdrawal by Subject|11|||
146065997|NCT00068692|526761605|FG001|Step 1: Registration|Withdrawal by Subject|0|||
146065998|NCT00068692|526761606|FG002|Step 1: Registration|Withdrawal by Subject|0|||
146065999|NCT00068692|526761607|FG003|Step 1: Registration|Withdrawal by Subject|0|||
146066000|NCT00068692|526761608|FG004|Step 1: Registration|Withdrawal by Subject|0|||
146066001|NCT00068692|526761609|FG005|Step 1: Registration|Withdrawal by Subject|0|||
146066002|NCT00068692|526761610|FG006|Step 1: Registration|Withdrawal by Subject|0|||
146066003|NCT00068692|526761611|FG007|Step 1: Registration|Withdrawal by Subject|0|||
146066004|NCT00068692|526761604|FG000|Step 1: Registration|Alternative therapy|2|||
146066005|NCT00068692|526761605|FG001|Step 1: Registration|Alternative therapy|0|||
146066006|NCT00068692|526761606|FG002|Step 1: Registration|Alternative therapy|0|||
146066007|NCT00068692|526761607|FG003|Step 1: Registration|Alternative therapy|0|||
146066008|NCT00068692|526761608|FG004|Step 1: Registration|Alternative therapy|0|||
146066009|NCT00068692|526761609|FG005|Step 1: Registration|Alternative therapy|0|||
146066010|NCT00068692|526761610|FG006|Step 1: Registration|Alternative therapy|0|||
146066011|NCT00068692|526761611|FG007|Step 1: Registration|Alternative therapy|0|||
146066012|NCT00068692|526761604|FG000|Step 1: Registration|Complicating disease|2|||
146066013|NCT00068692|526761605|FG001|Step 1: Registration|Complicating disease|0|||
146066014|NCT00068692|526761606|FG002|Step 1: Registration|Complicating disease|0|||
146066015|NCT00068692|526761607|FG003|Step 1: Registration|Complicating disease|0|||
146066016|NCT00068692|526761608|FG004|Step 1: Registration|Complicating disease|0|||
146066017|NCT00068692|526761609|FG005|Step 1: Registration|Complicating disease|0|||
146066018|NCT00068692|526761610|FG006|Step 1: Registration|Complicating disease|0|||
146066019|NCT00068692|526761611|FG007|Step 1: Registration|Complicating disease|0|||
146066020|NCT00068692|526761604|FG000|Step 1: Registration|Protocol Violation|1|||
146066021|NCT00068692|526761605|FG001|Step 1: Registration|Protocol Violation|0|||
146066022|NCT00068692|526761606|FG002|Step 1: Registration|Protocol Violation|0|||
146066023|NCT00068692|526761607|FG003|Step 1: Registration|Protocol Violation|0|||
146066024|NCT00068692|526761608|FG004|Step 1: Registration|Protocol Violation|0|||
146066025|NCT00068692|526761609|FG005|Step 1: Registration|Protocol Violation|0|||
146066026|NCT00068692|526761610|FG006|Step 1: Registration|Protocol Violation|0|||
146066027|NCT00068692|526761611|FG007|Step 1: Registration|Protocol Violation|0|||
146066028|NCT00068692|526761604|FG000|Step 1: Registration|Not eligible|6|||
146066029|NCT00068692|526761605|FG001|Step 1: Registration|Not eligible|0|||
146066030|NCT00068692|526761606|FG002|Step 1: Registration|Not eligible|0|||
146066031|NCT00068692|526761607|FG003|Step 1: Registration|Not eligible|0|||
146066032|NCT00068692|526761608|FG004|Step 1: Registration|Not eligible|0|||
146066033|NCT00068692|526761609|FG005|Step 1: Registration|Not eligible|0|||
146066034|NCT00068692|526761610|FG006|Step 1: Registration|Not eligible|0|||
146066035|NCT00068692|526761611|FG007|Step 1: Registration|Not eligible|0|||
146066036|NCT00068692|526761604|FG000|Step 1: Registration|Other|2|||
146066037|NCT00068692|526761605|FG001|Step 1: Registration|Other|0|||
146066038|NCT00068692|526761606|FG002|Step 1: Registration|Other|0|||
146066039|NCT00068692|526761607|FG003|Step 1: Registration|Other|0|||
146066040|NCT00068692|526761608|FG004|Step 1: Registration|Other|0|||
146066041|NCT00068692|526761609|FG005|Step 1: Registration|Other|0|||
146066042|NCT00068692|526761610|FG006|Step 1: Registration|Other|0|||
146066043|NCT00068692|526761611|FG007|Step 1: Registration|Other|0|||
146066044|NCT00068692|526761604|FG000|Step 1: Registration|Not start protocol therapy|3|||
146066045|NCT00068692|526761605|FG001|Step 1: Registration|Not start protocol therapy|0|||
146066046|NCT00068692|526761606|FG002|Step 1: Registration|Not start protocol therapy|0|||
146066047|NCT00068692|526761607|FG003|Step 1: Registration|Not start protocol therapy|0|||
146066048|NCT00068692|526761608|FG004|Step 1: Registration|Not start protocol therapy|0|||
146066049|NCT00068692|526761609|FG005|Step 1: Registration|Not start protocol therapy|0|||
146066050|NCT00068692|526761610|FG006|Step 1: Registration|Not start protocol therapy|0|||
146407975|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146066051|NCT00068692|526761611|FG007|Step 1: Registration|Not start protocol therapy|0|||
146066052|NCT00068692|526761604|FG000|Step 1: Registration|Registered but not randomized|0|||
146066053|NCT00068692|526761605|FG001|Step 1: Registration|Registered but not randomized|1|||
146066054|NCT00068692|526761606|FG002|Step 1: Registration|Registered but not randomized|0|||
146066055|NCT00068692|526761607|FG003|Step 1: Registration|Registered but not randomized|0|||
146407976|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
146066056|NCT00068692|526761608|FG004|Step 1: Registration|Registered but not randomized|0|||
146066057|NCT00068692|526761609|FG005|Step 1: Registration|Registered but not randomized|0|||
146066058|NCT00068692|526761610|FG006|Step 1: Registration|Registered but not randomized|0|||
146066059|NCT00068692|526761611|FG007|Step 1: Registration|Registered but not randomized|0|||
146066060|NCT00068692|526761604|FG000|Step 2: Randomization|Disesae progression/replase|0|||
146171774|NCT00988221|527143222|FG000|Part III|Adverse Event|1|||
146066061|NCT00068692|526761605|FG001|Step 2: Randomization|Disesae progression/replase|0|||
146066062|NCT00068692|526761606|FG002|Step 2: Randomization|Disesae progression/replase|1|||
146066063|NCT00068692|526761607|FG003|Step 2: Randomization|Disesae progression/replase|1|||
146066064|NCT00068692|526761608|FG004|Step 2: Randomization|Disesae progression/replase|0|||
146066065|NCT00068692|526761609|FG005|Step 2: Randomization|Disesae progression/replase|0|||
146066066|NCT00068692|526761610|FG006|Step 2: Randomization|Disesae progression/replase|0|||
146066067|NCT00068692|526761611|FG007|Step 2: Randomization|Disesae progression/replase|0|||
146066068|NCT00068692|526761604|FG000|Step 2: Randomization|Adverse Event|0|||
146066069|NCT00068692|526761605|FG001|Step 2: Randomization|Adverse Event|0|||
146066070|NCT00068692|526761606|FG002|Step 2: Randomization|Adverse Event|4|||
146066071|NCT00068692|526761607|FG003|Step 2: Randomization|Adverse Event|2|||
146066072|NCT00068692|526761608|FG004|Step 2: Randomization|Adverse Event|2|||
146066073|NCT00068692|526761609|FG005|Step 2: Randomization|Adverse Event|3|||
146066074|NCT00068692|526761610|FG006|Step 2: Randomization|Adverse Event|4|||
146066075|NCT00068692|526761611|FG007|Step 2: Randomization|Adverse Event|4|||
146066076|NCT00068692|526761604|FG000|Step 2: Randomization|Death|0|||
146066077|NCT00068692|526761605|FG001|Step 2: Randomization|Death|0|||
146066078|NCT00068692|526761606|FG002|Step 2: Randomization|Death|0|||
146066079|NCT00068692|526761607|FG003|Step 2: Randomization|Death|0|||
146066080|NCT00068692|526761608|FG004|Step 2: Randomization|Death|1|||
146066081|NCT00068692|526761609|FG005|Step 2: Randomization|Death|0|||
146066082|NCT00068692|526761610|FG006|Step 2: Randomization|Death|0|||
146066083|NCT00068692|526761611|FG007|Step 2: Randomization|Death|1|||
146066084|NCT00068692|526761604|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
146066085|NCT00068692|526761605|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
146066086|NCT00068692|526761606|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
146066087|NCT00068692|526761607|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
146066088|NCT00068692|526761608|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
146066089|NCT00068692|526761609|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
146066090|NCT00068692|526761610|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
146066091|NCT00068692|526761611|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
146066092|NCT00068692|526761604|FG000|Step 2: Randomization|alternative therapy|0|||
146066093|NCT00068692|526761605|FG001|Step 2: Randomization|alternative therapy|0|||
146066094|NCT00068692|526761606|FG002|Step 2: Randomization|alternative therapy|0|||
146066095|NCT00068692|526761607|FG003|Step 2: Randomization|alternative therapy|1|||
146066096|NCT00068692|526761608|FG004|Step 2: Randomization|alternative therapy|1|||
146066097|NCT00068692|526761609|FG005|Step 2: Randomization|alternative therapy|0|||
146066098|NCT00068692|526761610|FG006|Step 2: Randomization|alternative therapy|0|||
146066099|NCT00068692|526761611|FG007|Step 2: Randomization|alternative therapy|0|||
146066100|NCT00068692|526761604|FG000|Step 2: Randomization|Physician Decision|0|||
146066101|NCT00068692|526761605|FG001|Step 2: Randomization|Physician Decision|0|||
146066102|NCT00068692|526761606|FG002|Step 2: Randomization|Physician Decision|0|||
146066103|NCT00068692|526761607|FG003|Step 2: Randomization|Physician Decision|1|||
146066104|NCT00068692|526761608|FG004|Step 2: Randomization|Physician Decision|1|||
146066105|NCT00068692|526761609|FG005|Step 2: Randomization|Physician Decision|0|||
146066106|NCT00068692|526761610|FG006|Step 2: Randomization|Physician Decision|0|||
146066107|NCT00068692|526761611|FG007|Step 2: Randomization|Physician Decision|0|||
146066108|NCT00068692|526761604|FG000|Step 2: Randomization|Other|0|||
146066109|NCT00068692|526761605|FG001|Step 2: Randomization|Other|0|||
146066110|NCT00068692|526761606|FG002|Step 2: Randomization|Other|0|||
146066111|NCT00068692|526761607|FG003|Step 2: Randomization|Other|1|||
146066112|NCT00068692|526761608|FG004|Step 2: Randomization|Other|0|||
146066113|NCT00068692|526761609|FG005|Step 2: Randomization|Other|1|||
146066114|NCT00068692|526761610|FG006|Step 2: Randomization|Other|0|||
146066115|NCT00068692|526761611|FG007|Step 2: Randomization|Other|0|||
146066116|NCT00068692|526761604|FG000|Step 2: Randomization|never start protocol therapy|0|||
146066117|NCT00068692|526761605|FG001|Step 2: Randomization|never start protocol therapy|0|||
146066118|NCT00068692|526761606|FG002|Step 2: Randomization|never start protocol therapy|1|||
146066119|NCT00068692|526761607|FG003|Step 2: Randomization|never start protocol therapy|0|||
146066120|NCT00068692|526761608|FG004|Step 2: Randomization|never start protocol therapy|1|||
146066121|NCT00068692|526761609|FG005|Step 2: Randomization|never start protocol therapy|0|||
146066122|NCT00068692|526761610|FG006|Step 2: Randomization|never start protocol therapy|0|||
146066123|NCT00068692|526761611|FG007|Step 2: Randomization|never start protocol therapy|0|||
146066124|NCT01600716|526761613|FG000|Overall Study|Other Reasons|3|||
146066125|NCT01600716|526761614|FG001|Overall Study|Other Reasons|1|||
146066126|NCT01600716|526761613|FG000|Overall Study|Personal Reasons|0|||
146066127|NCT01600716|526761614|FG001|Overall Study|Personal Reasons|2|||
146066128|NCT01600716|526761613|FG000|Overall Study|Lost to Follow-up|0|||
146066129|NCT01600716|526761614|FG001|Overall Study|Lost to Follow-up|2|||
146066130|NCT01600716|526761613|FG000|Overall Study|Pregnancy|1|||
146066131|NCT01600716|526761614|FG001|Overall Study|Pregnancy|0|||
146066132|NCT01600716|526761613|FG000|Overall Study|Lack of Efficacy|2|||
146066133|NCT01600716|526761614|FG001|Overall Study|Lack of Efficacy|1|||
146066134|NCT01600716|526761613|FG000|Overall Study|Adverse Event|1|||
146066135|NCT01600716|526761614|FG001|Overall Study|Adverse Event|1|||
146066136|NCT00248040|526761615|FG000|Overall Study|transplantectomy|2|||
146066137|NCT00248040|526761616|FG001|Overall Study|transplantectomy|1|||
146066138|NCT00248040|526761617|FG002|Overall Study|transplantectomy|3|||
146066139|NCT00248040|526761615|FG000|Overall Study|transplant cancelled post treat start|1|||
146066140|NCT00248040|526761616|FG001|Overall Study|transplant cancelled post treat start|0|||
146066141|NCT00248040|526761617|FG002|Overall Study|transplant cancelled post treat start|0|||
146066142|NCT00248040|526761615|FG000|Overall Study|Death|0|||
146066143|NCT00248040|526761616|FG001|Overall Study|Death|0|||
146066144|NCT00248040|526761617|FG002|Overall Study|Death|1|||
146066145|NCT03557034|526761622|FG000|Overall Study|Withdrawal by Subject|1|||
146066146|NCT03557034|526761623|FG001|Overall Study|Withdrawal by Subject|0|||
146066147|NCT01759446|526761626|FG000|Overall Study|Protocol Violation|1|||
146066148|NCT01759446|526761627|FG001|Overall Study|Protocol Violation|0|||
146066149|NCT01759446|526761628|FG002|Overall Study|Protocol Violation|1|||
146066150|NCT01759446|526761629|FG003|Overall Study|Protocol Violation|0|||
146066151|NCT01759446|526761630|FG004|Overall Study|Protocol Violation|0|||
146066152|NCT01759446|526761626|FG000|Overall Study|Withdrawal by Subject|0|||
146066153|NCT01759446|526761627|FG001|Overall Study|Withdrawal by Subject|1|||
146066154|NCT01759446|526761628|FG002|Overall Study|Withdrawal by Subject|0|||
146066155|NCT01759446|526761629|FG003|Overall Study|Withdrawal by Subject|1|||
146066156|NCT01759446|526761630|FG004|Overall Study|Withdrawal by Subject|0|||
146066157|NCT01760733|526761631|FG000|Waiting List|Death|18|||
146066158|NCT01760733|526761631|FG000|Waiting List|Removed from waiting list|41|||
146066159|NCT01760733|526761631|FG000|Waiting List|Not received a transplant yet|13|||
146066160|NCT01760733|526761631|FG000|Transplanted|Not reached 10 years post transplant|184|||
146066161|NCT01760733|526761631|FG000|Transplanted|Death|26|||
146066162|NCT01760733|526761631|FG000|Transplanted|Graft loss|7|||
146066163|NCT00815659|526761632|FG000|Overall Study|Adverse Event|9|||
146066164|NCT00815659|526761632|FG000|Overall Study|Withdrawal by Subject|9|||
146066165|NCT00815659|526761632|FG000|Overall Study|Lost to Follow-up|4|||
146066166|NCT00815659|526761632|FG000|Overall Study|Protocol Violation|1|||
146066167|NCT03847896|526761633|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146066168|NCT03847896|526761634|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146066169|NCT03847896|526761635|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
146066170|NCT03847896|526761636|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146066171|NCT03847896|526761637|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
146066172|NCT03847896|526761633|FG000|Overall Study|Withdrawal by Subject|2|||
146066173|NCT03847896|526761634|FG001|Overall Study|Withdrawal by Subject|10|||
146066174|NCT03847896|526761635|FG002|Overall Study|Withdrawal by Subject|5|||
146066175|NCT03847896|526761636|FG003|Overall Study|Withdrawal by Subject|9|||
146066176|NCT03847896|526761637|FG004|Overall Study|Withdrawal by Subject|8|||
146066177|NCT03847896|526761633|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146066178|NCT03847896|526761634|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146066179|NCT03847896|526761635|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146066180|NCT03847896|526761636|FG003|Overall Study|Withdrawal by parent/guardian|0|||
146066181|NCT03847896|526761637|FG004|Overall Study|Withdrawal by parent/guardian|0|||
146066182|NCT03847896|526761633|FG000|Overall Study|Adverse Event|2|||
146066183|NCT03847896|526761634|FG001|Overall Study|Adverse Event|1|||
146066184|NCT03847896|526761635|FG002|Overall Study|Adverse Event|3|||
146066185|NCT03847896|526761636|FG003|Overall Study|Adverse Event|2|||
146066186|NCT03847896|526761637|FG004|Overall Study|Adverse Event|4|||
146066187|NCT03847896|526761633|FG000|Overall Study|A severe exacerbation event|0|||
146066188|NCT03847896|526761634|FG001|Overall Study|A severe exacerbation event|0|||
146066189|NCT03847896|526761635|FG002|Overall Study|A severe exacerbation event|0|||
146066190|NCT03847896|526761636|FG003|Overall Study|A severe exacerbation event|0|||
146066191|NCT03847896|526761637|FG004|Overall Study|A severe exacerbation event|3|||
146066192|NCT03847896|526761633|FG000|Overall Study|Protocol Violation|0|||
146066193|NCT03847896|526761634|FG001|Overall Study|Protocol Violation|2|||
146066194|NCT03847896|526761635|FG002|Overall Study|Protocol Violation|1|||
146066195|NCT03847896|526761636|FG003|Overall Study|Protocol Violation|0|||
146066196|NCT03847896|526761637|FG004|Overall Study|Protocol Violation|2|||
146066197|NCT03847896|526761633|FG000|Overall Study|Lost to Follow-up|0|||
146066198|NCT03847896|526761634|FG001|Overall Study|Lost to Follow-up|0|||
146066199|NCT03847896|526761635|FG002|Overall Study|Lost to Follow-up|0|||
146066200|NCT03847896|526761636|FG003|Overall Study|Lost to Follow-up|1|||
146066201|NCT03847896|526761637|FG004|Overall Study|Lost to Follow-up|0|||
146066202|NCT03847896|526761633|FG000|Overall Study|Condition under investigation worsened|0|||
146066203|NCT03847896|526761634|FG001|Overall Study|Condition under investigation worsened|0|||
146066204|NCT03847896|526761635|FG002|Overall Study|Condition under investigation worsened|0|||
146066205|NCT03847896|526761636|FG003|Overall Study|Condition under investigation worsened|1|||
146066206|NCT03847896|526761637|FG004|Overall Study|Condition under investigation worsened|1|||
146066207|NCT03847896|526761633|FG000|Overall Study|Lack of Efficacy|0|||
146066208|NCT03847896|526761634|FG001|Overall Study|Lack of Efficacy|0|||
146066209|NCT03847896|526761635|FG002|Overall Study|Lack of Efficacy|0|||
146066210|NCT03847896|526761636|FG003|Overall Study|Lack of Efficacy|2|||
146066211|NCT03847896|526761637|FG004|Overall Study|Lack of Efficacy|2|||
146066212|NCT03847896|526761633|FG000|Overall Study|Other reasons|3|||
146066213|NCT03847896|526761634|FG001|Overall Study|Other reasons|3|||
146066214|NCT03847896|526761635|FG002|Overall Study|Other reasons|1|||
146066215|NCT03847896|526761636|FG003|Overall Study|Other reasons|2|||
146066216|NCT03847896|526761637|FG004|Overall Study|Other reasons|1|||
146066217|NCT02395471|526761638|FG000|Overall Study|Lost to Follow-up|2|||
146066218|NCT02395471|526761639|FG001|Overall Study|Lost to Follow-up|0|||
146066219|NCT02395471|526761638|FG000|Overall Study|Withdrawal by Subject|2|||
146066220|NCT02395471|526761639|FG001|Overall Study|Withdrawal by Subject|1|||
146066221|NCT02395471|526761638|FG000|Overall Study|Physician Decision|1|||
146066222|NCT02395471|526761639|FG001|Overall Study|Physician Decision|0|||
146066223|NCT02395471|526761638|FG000|Overall Study|Protocol Violation|0|||
146066224|NCT02395471|526761639|FG001|Overall Study|Protocol Violation|1|||
146066225|NCT02395471|526761638|FG000|Overall Study|Failure to swollow sponge twice|1|||
146066226|NCT02395471|526761639|FG001|Overall Study|Failure to swollow sponge twice|0|||
146066227|NCT02395471|526761638|FG000|Overall Study|Patient did not return for procedure|0|||
146066228|NCT02395471|526761639|FG001|Overall Study|Patient did not return for procedure|1|||
146066229|NCT02395471|526761638|FG000|Overall Study|Subject not eligible|1|||
146066230|NCT02395471|526761639|FG001|Overall Study|Subject not eligible|0|||
146066231|NCT00118417|526761640|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
146066232|NCT00118417|526761641|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
146066233|NCT00118417|526761640|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
146066234|NCT00118417|526761641|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
146066235|NCT00118417|526761640|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
146066236|NCT00118417|526761641|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
146407977|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146407978|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146407979|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146407980|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
146407981|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
146407982|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
146066237|NCT00118417|526761640|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
146066238|NCT00118417|526761641|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
146066239|NCT00118417|526761640|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
146066240|NCT00118417|526761641|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
146066241|NCT02978781|526761642|FG000|Part A|Adverse Event|1|||
146066242|NCT02978781|526761643|FG001|Part A|Adverse Event|1|||
146066243|NCT02978781|526761644|FG002|Part A|Adverse Event|0|||
146066244|NCT02978781|526761645|FG003|Part A|Adverse Event|0|||
146066245|NCT02978781|526761646|FG004|Part A|Adverse Event|0|||
146066246|NCT02978781|526761642|FG000|Part A|Withdrawal by Subject|0|||
146066247|NCT02978781|526761643|FG001|Part A|Withdrawal by Subject|1|||
146066248|NCT02978781|526761644|FG002|Part A|Withdrawal by Subject|0|||
146066249|NCT02978781|526761645|FG003|Part A|Withdrawal by Subject|0|||
146066250|NCT02978781|526761646|FG004|Part A|Withdrawal by Subject|0|||
146066251|NCT02978781|526761642|FG000|Part B|Withdrawal by Subject|0|||
146066252|NCT02978781|526761643|FG001|Part B|Withdrawal by Subject|0|||
146066253|NCT02978781|526761644|FG002|Part B|Withdrawal by Subject|0|||
146066254|NCT02978781|526761645|FG003|Part B|Withdrawal by Subject|1|||
146066255|NCT02978781|526761646|FG004|Part B|Withdrawal by Subject|0|||
146066256|NCT02978781|526761642|FG000|Part C|Adverse Event|0|||
146066257|NCT02978781|526761643|FG001|Part C|Adverse Event|0|||
146066258|NCT02978781|526761644|FG002|Part C|Adverse Event|0|||
146066259|NCT02978781|526761645|FG003|Part C|Adverse Event|0|||
146407983|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
146407984|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
146407985|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
146407986|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
146407987|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
146407988|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
146066260|NCT02978781|526761646|FG004|Part C|Adverse Event|2|||
146066261|NCT02978781|526761642|FG000|Part C|Withdrawal by Subject|0|||
146066262|NCT02978781|526761643|FG001|Part C|Withdrawal by Subject|0|||
146066263|NCT02978781|526761644|FG002|Part C|Withdrawal by Subject|0|||
146066264|NCT02978781|526761645|FG003|Part C|Withdrawal by Subject|0|||
146066265|NCT02978781|526761646|FG004|Part C|Withdrawal by Subject|1|||
146171775|NCT00988221|527143223|FG001|Part III|Adverse Event|0|||
146066266|NCT02978781|526761642|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
146066267|NCT02978781|526761643|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
146066268|NCT02978781|526761644|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
146066269|NCT02978781|526761645|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
146066270|NCT02978781|526761646|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
146066271|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
146066272|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
146066273|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Adverse Event|31|||
146066274|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Adverse Event|21|||
146066275|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
146066276|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
146066277|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
146066278|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
146066279|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
146066280|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
146066281|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
146066282|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
146066283|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Administrative problems|3|||
146066284|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Administrative problems|3|||
146066285|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Death|5|||
146066286|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Death|8|||
146066287|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Disease progression|139|||
146066288|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Disease progression|119|||
146066289|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
146066290|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
146066291|NCT00785785|526761647|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
146066292|NCT00785785|526761648|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
146066293|NCT00785785|526761647|FG000|Optional Extension Phase|Adverse Event|4|||
146066294|NCT00785785|526761648|FG001|Optional Extension Phase|Adverse Event|5|||
146066295|NCT00785785|526761647|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
146066296|NCT00785785|526761648|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
146066297|NCT00785785|526761647|FG000|Optional Extension Phase|Lost to Follow-up|1|||
146066298|NCT00785785|526761648|FG001|Optional Extension Phase|Lost to Follow-up|0|||
146066299|NCT00785785|526761647|FG000|Optional Extension Phase|Administrative problems|2|||
146066300|NCT00785785|526761648|FG001|Optional Extension Phase|Administrative problems|0|||
146066301|NCT00785785|526761647|FG000|Optional Extension Phase|Death|1|||
146066302|NCT00785785|526761648|FG001|Optional Extension Phase|Death|5|||
146066303|NCT00785785|526761647|FG000|Optional Extension Phase|Disease progression|22|||
146066304|NCT00785785|526761648|FG001|Optional Extension Phase|Disease progression|70|||
146066305|NCT00785785|526761647|FG000|Optional Extension Phase|Protocol deviation|0|||
146066306|NCT00785785|526761648|FG001|Optional Extension Phase|Protocol deviation|2|||
146066307|NCT00785785|526761647|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
146066308|NCT00785785|526761648|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
146066309|NCT01244893|526761649|FG000|Baseline|Protocol Violation|0|||
146066310|NCT01244893|526761650|FG001|Baseline|Protocol Violation|1|||
146066311|NCT01244893|526761649|FG000|1-Week Follow Up|Lost to Follow-up|1|||
146066312|NCT01244893|526761650|FG001|1-Week Follow Up|Lost to Follow-up|0|||
146066313|NCT00357552|526761651|FG000|Screening|Did not meet eligibility criteria|84|||
146066314|NCT00357552|526761651|FG000|Weeks 0 to 24|Death|1|||
146066315|NCT00357552|526761651|FG000|Weeks 24 to 104|Death|3|||
146066316|NCT00357552|526761651|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
146066317|NCT00882557|526761659|FG000|Overall Study|Withdrawal by Subject|1|||
146066318|NCT00882557|526761660|FG001|Overall Study|Withdrawal by Subject|0|||
146066319|NCT00882557|526761659|FG000|Overall Study|Trouble with Vein Access|1|||
146066320|NCT00882557|526761660|FG001|Overall Study|Trouble with Vein Access|0|||
146066321|NCT00882557|526761659|FG000|Overall Study|Randomized Not Treated|0|||
146066322|NCT00882557|526761660|FG001|Overall Study|Randomized Not Treated|1|||
146066323|NCT01528969|526761661|FG000|Overall Study|absent from the school at baseline|2|||
146066324|NCT01528969|526761662|FG001|Overall Study|absent from the school at baseline|0|||
146066325|NCT02282605|526761665|FG000|Overall Study|negative SA result on Day -1|3|||
146066326|NCT02282605|526761666|FG001|Overall Study|negative SA result on Day -1|0|||
146066327|NCT02282605|526761667|FG002|Overall Study|negative SA result on Day -1|0|||
146066328|NCT03584789|526761670|FG000|Overall Study|refused EHR permission|19|||
146066329|NCT03584789|526761671|FG001|Overall Study|refused EHR permission|28|||
146066330|NCT03584789|526761672|FG002|Overall Study|refused EHR permission|23|||
146066331|NCT03584789|526761670|FG000|Overall Study|patients tied to a provider who retired|0|||
146066332|NCT03584789|526761671|FG001|Overall Study|patients tied to a provider who retired|0|||
146066333|NCT03584789|526761672|FG002|Overall Study|patients tied to a provider who retired|3|||
146066334|NCT02035267|526761673|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
146066335|NCT02035267|526761674|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
146066336|NCT02035267|526761675|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
146066337|NCT02035267|526761676|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
146066338|NCT02035267|526761673|FG000|Overall Study|Adverse Event|0|||
146066339|NCT02035267|526761674|FG001|Overall Study|Adverse Event|0|||
146066340|NCT02035267|526761675|FG002|Overall Study|Adverse Event|1|||
146066341|NCT02035267|526761676|FG003|Overall Study|Adverse Event|0|||
146066342|NCT02035267|526761673|FG000|Overall Study|Lost to Follow-up|0|||
146066343|NCT02035267|526761674|FG001|Overall Study|Lost to Follow-up|0|||
146066344|NCT02035267|526761675|FG002|Overall Study|Lost to Follow-up|0|||
146066345|NCT02035267|526761676|FG003|Overall Study|Lost to Follow-up|1|||
146066346|NCT02035267|526761673|FG000|Overall Study|Other unspecified|0|||
146066347|NCT02035267|526761674|FG001|Overall Study|Other unspecified|1|||
146066348|NCT02035267|526761675|FG002|Overall Study|Other unspecified|0|||
146066349|NCT02035267|526761676|FG003|Overall Study|Other unspecified|0|||
146066350|NCT02404025|526761678|FG000|Overall Study|Adverse Event|1|||
146066351|NCT02404025|526761678|FG000|Overall Study|Lack of Efficacy|3|||
146066352|NCT00823615|526761679|FG000|Period 2|Lost to Follow-up|2|||
146066353|NCT00823615|526761680|FG001|Period 2|Lost to Follow-up|0|||
146066354|NCT00823615|526761679|FG000|Period 2|Time/Job Conflict|1|||
146066355|NCT00823615|526761680|FG001|Period 2|Time/Job Conflict|2|||
146066356|NCT00084136|526761684|FG000|PI Comparison|Death|10|||
146066357|NCT00084136|526761685|FG001|PI Comparison|Death|9|||
146066358|NCT00084136|526761686|FG002|PI Comparison|Death|0|||
146066359|NCT00084136|526761684|FG000|PI Comparison|Lost to Follow-up|11|||
146066360|NCT00084136|526761685|FG001|PI Comparison|Lost to Follow-up|8|||
146066361|NCT00084136|526761686|FG002|PI Comparison|Lost to Follow-up|0|||
146066362|NCT00084136|526761684|FG000|PI Comparison|Withdrawal by Subject|33|||
146066363|NCT00084136|526761685|FG001|PI Comparison|Withdrawal by Subject|30|||
146066364|NCT00084136|526761686|FG002|PI Comparison|Withdrawal by Subject|0|||
146066365|NCT00084136|526761684|FG000|PI Comparison|Clinic site closed|1|||
146066366|NCT00084136|526761685|FG001|PI Comparison|Clinic site closed|0|||
146066367|NCT00084136|526761686|FG002|PI Comparison|Clinic site closed|0|||
146066368|NCT00084136|526761684|FG000|NRTI Comparison|Death|20|||
146066369|NCT00084136|526761685|FG001|NRTI Comparison|Death|0|||
146066370|NCT00084136|526761686|FG002|NRTI Comparison|Death|18|||
146066371|NCT00084136|526761684|FG000|NRTI Comparison|Lost to Follow-up|14|||
146066372|NCT00084136|526761685|FG001|NRTI Comparison|Lost to Follow-up|0|||
146066373|NCT00084136|526761686|FG002|NRTI Comparison|Lost to Follow-up|12|||
146066374|NCT00084136|526761684|FG000|NRTI Comparison|Withdrawal by Subject|54|||
146066375|NCT00084136|526761685|FG001|NRTI Comparison|Withdrawal by Subject|0|||
146066376|NCT00084136|526761686|FG002|NRTI Comparison|Withdrawal by Subject|38|||
146066377|NCT00084136|526761684|FG000|NRTI Comparison|Clinic site closed|12|||
146066378|NCT00084136|526761685|FG001|NRTI Comparison|Clinic site closed|0|||
146066379|NCT00084136|526761686|FG002|NRTI Comparison|Clinic site closed|14|||
146066380|NCT00084136|526761684|FG000|NRTI Comparison|Not reason above|1|||
146066381|NCT00084136|526761685|FG001|NRTI Comparison|Not reason above|0|||
146066382|NCT00084136|526761686|FG002|NRTI Comparison|Not reason above|0|||
146066383|NCT00905164|526761689|FG000|Period 1|Protocol Violation|0|||
146066384|NCT00905164|526761690|FG001|Period 1|Protocol Violation|1|||
146066385|NCT00904033|526763850|FG000|Overall Study|Withdrawal by Subject|1|||
146066386|NCT00904033|526763851|FG001|Overall Study|Withdrawal by Subject|1|||
146066387|NCT00904033|526763852|FG002|Overall Study|Withdrawal by Subject|0|||
146066388|NCT00904033|526763853|FG003|Overall Study|Withdrawal by Subject|0|||
146066389|NCT00904033|526763850|FG000|Overall Study|Physician Decision|0|||
146066390|NCT00904033|526763851|FG001|Overall Study|Physician Decision|0|||
146066391|NCT00904033|526763852|FG002|Overall Study|Physician Decision|1|||
146066392|NCT00904033|526763853|FG003|Overall Study|Physician Decision|0|||
146066393|NCT00904033|526763850|FG000|Overall Study|Unable to obtain final blood draw|0|||
146066394|NCT00904033|526763851|FG001|Overall Study|Unable to obtain final blood draw|0|||
146066395|NCT00904033|526763852|FG002|Overall Study|Unable to obtain final blood draw|0|||
146066396|NCT00904033|526763853|FG003|Overall Study|Unable to obtain final blood draw|2|||
146066397|NCT00865566|526763854|FG000|Overall Study|Death|1|||
146066398|NCT00865566|526763855|FG001|Overall Study|Death|11|||
146066399|NCT00865566|526763854|FG000|Overall Study|Lost to Follow-up|314|||
146066400|NCT00865566|526763855|FG001|Overall Study|Lost to Follow-up|315|||
146066401|NCT00865566|526763854|FG000|Overall Study|Withdrawal by Subject|45|||
146066402|NCT00865566|526763855|FG001|Overall Study|Withdrawal by Subject|65|||
146066403|NCT00865566|526763854|FG000|Overall Study|Physician Decision|0|||
146066404|NCT00865566|526763855|FG001|Overall Study|Physician Decision|1|||
146066405|NCT00865566|526763854|FG000|Overall Study|Participant relocated|78|||
146066406|NCT00865566|526763855|FG001|Overall Study|Participant relocated|107|||
146066407|NCT00865566|526763854|FG000|Overall Study|Participant unable to adhere|27|||
145890929|NCT01207440|526107573|FG003|Overall Study|Lost to Follow-up|1|||
146066408|NCT00865566|526763855|FG001|Overall Study|Participant unable to adhere|42|||
146066409|NCT00865566|526763854|FG000|Overall Study|Other; N=245 due to early study closure|154|||
146066410|NCT00865566|526763855|FG001|Overall Study|Other; N=245 due to early study closure|139|||
146066411|NCT00865566|526763854|FG000|Overall Study|HIV infection|5|||
146066412|NCT00865566|526763855|FG001|Overall Study|HIV infection|7|||
146066413|NCT03252925|526763858|FG000|Overall Study|Withdrawal by Subject|1|||
146066414|NCT03252925|526763859|FG001|Overall Study|Withdrawal by Subject|0|||
146066415|NCT03252925|526763858|FG000|Overall Study|Protocol Violation|6|||
146066416|NCT03252925|526763859|FG001|Overall Study|Protocol Violation|0|||
146066417|NCT03252925|526763858|FG000|Overall Study|Adverse Event|1|||
146066418|NCT03252925|526763859|FG001|Overall Study|Adverse Event|0|||
146066419|NCT03252925|526763858|FG000|Overall Study|Lost to Follow-up|6|||
146066420|NCT03252925|526763859|FG001|Overall Study|Lost to Follow-up|6|||
146066421|NCT00521404|526763860|FG000|Overall Study|Adverse Event|13|||
146066422|NCT00521404|526763860|FG000|Overall Study|Disease Progression|33|||
146066423|NCT00521404|526763860|FG000|Overall Study|Investigator decision|5|||
146066424|NCT00521404|526763860|FG000|Overall Study|Withdrawal of consent|3|||
146066425|NCT00521404|526763860|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
146066426|NCT00521404|526763860|FG000|Overall Study|Other|7|||
146066427|NCT01383356|526763861|FG000|Period 1|Adverse Event|5|||
146066428|NCT01383356|526763862|FG001|Period 1|Adverse Event|3|||
146066429|NCT01383356|526763861|FG000|Period 1|Non-compliance|3|||
146066430|NCT01383356|526763862|FG001|Period 1|Non-compliance|0|||
146066431|NCT01383356|526763861|FG000|Period 1|Out of Range Mid-study-Test|0|||
146066432|NCT01383356|526763862|FG001|Period 1|Out of Range Mid-study-Test|1|||
146066433|NCT01383356|526763861|FG000|Period 1|Personal|0|||
146066434|NCT01383356|526763862|FG001|Period 1|Personal|2|||
146066435|NCT00602472|526763863|FG000|Overall Study|Adverse Event|5|||
146066436|NCT00602472|526763864|FG001|Overall Study|Adverse Event|23|||
146066437|NCT00602472|526763863|FG000|Overall Study|Protocol Violation|4|||
146066438|NCT00602472|526763864|FG001|Overall Study|Protocol Violation|19|||
146066439|NCT00602472|526763863|FG000|Overall Study|Withdrawal by Subject|8|||
146066440|NCT00602472|526763864|FG001|Overall Study|Withdrawal by Subject|14|||
146066441|NCT00602472|526763863|FG000|Overall Study|Other incl. lack of efficacy|4|||
146066442|NCT00602472|526763864|FG001|Overall Study|Other incl. lack of efficacy|2|||
146066443|NCT01908803|526763871|FG000|Overall Study|Adverse Event|1|||
146066444|NCT01908803|526763872|FG001|Overall Study|Adverse Event|0|||
146066445|NCT01908803|526763871|FG000|Overall Study|Physician Decision|0|||
146066446|NCT01908803|526763872|FG001|Overall Study|Physician Decision|1|||
146066447|NCT01908803|526763871|FG000|Overall Study|Withdrawal by Subject|1|||
146066448|NCT01908803|526763872|FG001|Overall Study|Withdrawal by Subject|0|||
146066449|NCT01908803|526763871|FG000|Overall Study|Randomization Error|1|||
146066450|NCT01908803|526763872|FG001|Overall Study|Randomization Error|0|||
146066451|NCT01908803|526763871|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
146066452|NCT01908803|526763872|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
146066453|NCT00098813|526763873|FG000|Overall Study|Death|8|||
146066454|NCT00098813|526763873|FG000|Overall Study|Protocol Violation|1|||
146066455|NCT00098813|526763873|FG000|Overall Study|Withdrawal by Subject|7|||
146066456|NCT00098813|526763873|FG000|Overall Study|Progression of Disease|1|||
146066457|NCT00098813|526763873|FG000|Overall Study|Other complicating disease|1|||
146066458|NCT00098813|526763873|FG000|Overall Study|Reversal of RAI resistance|1|||
146066459|NCT03926611|526763874|FG000|Overall Study|Adverse Event|0|||
146066460|NCT03926611|526763875|FG001|Overall Study|Adverse Event|0|||
146066461|NCT03926611|526763876|FG002|Overall Study|Adverse Event|0|||
146066462|NCT03926611|526763877|FG003|Overall Study|Adverse Event|3|||
146066463|NCT03926611|526763878|FG004|Overall Study|Adverse Event|1|||
146066464|NCT03926611|526763879|FG005|Overall Study|Adverse Event|3|||
146066465|NCT03926611|526763880|FG006|Overall Study|Adverse Event|0|||
146066466|NCT03926611|526763874|FG000|Overall Study|Lack of Efficacy|1|||
146066467|NCT03926611|526763875|FG001|Overall Study|Lack of Efficacy|2|||
146066468|NCT03926611|526763876|FG002|Overall Study|Lack of Efficacy|0|||
146066469|NCT03926611|526763877|FG003|Overall Study|Lack of Efficacy|0|||
146066470|NCT03926611|526763878|FG004|Overall Study|Lack of Efficacy|1|||
146066471|NCT03926611|526763879|FG005|Overall Study|Lack of Efficacy|0|||
146066472|NCT03926611|526763880|FG006|Overall Study|Lack of Efficacy|1|||
146066473|NCT03926611|526763874|FG000|Overall Study|Physician Decision|0|||
146066474|NCT03926611|526763875|FG001|Overall Study|Physician Decision|0|||
146066475|NCT03926611|526763876|FG002|Overall Study|Physician Decision|0|||
146066476|NCT03926611|526763877|FG003|Overall Study|Physician Decision|0|||
146066477|NCT03926611|526763878|FG004|Overall Study|Physician Decision|0|||
146066478|NCT03926611|526763879|FG005|Overall Study|Physician Decision|1|||
146066479|NCT03926611|526763880|FG006|Overall Study|Physician Decision|0|||
146066480|NCT03926611|526763874|FG000|Overall Study|Protocol Violation|1|||
146066481|NCT03926611|526763875|FG001|Overall Study|Protocol Violation|0|||
146066482|NCT03926611|526763876|FG002|Overall Study|Protocol Violation|0|||
146066483|NCT03926611|526763877|FG003|Overall Study|Protocol Violation|1|||
146066484|NCT03926611|526763878|FG004|Overall Study|Protocol Violation|1|||
146066485|NCT03926611|526763879|FG005|Overall Study|Protocol Violation|1|||
146066486|NCT03926611|526763880|FG006|Overall Study|Protocol Violation|1|||
146066487|NCT03926611|526763874|FG000|Overall Study|Technical problems|0|||
146066488|NCT03926611|526763875|FG001|Overall Study|Technical problems|0|||
146066489|NCT03926611|526763876|FG002|Overall Study|Technical problems|0|||
146066490|NCT03926611|526763877|FG003|Overall Study|Technical problems|0|||
146066491|NCT03926611|526763878|FG004|Overall Study|Technical problems|0|||
146066492|NCT03926611|526763879|FG005|Overall Study|Technical problems|1|||
146066493|NCT03926611|526763880|FG006|Overall Study|Technical problems|0|||
146066494|NCT03926611|526763874|FG000|Overall Study|Withdrawal by Subject|1|||
146066495|NCT03926611|526763875|FG001|Overall Study|Withdrawal by Subject|1|||
146066496|NCT03926611|526763876|FG002|Overall Study|Withdrawal by Subject|1|||
146066497|NCT03926611|526763877|FG003|Overall Study|Withdrawal by Subject|0|||
146066498|NCT03926611|526763878|FG004|Overall Study|Withdrawal by Subject|0|||
146066499|NCT03926611|526763879|FG005|Overall Study|Withdrawal by Subject|1|||
146066500|NCT03926611|526763880|FG006|Overall Study|Withdrawal by Subject|3|||
146066501|NCT03926611|526763874|FG000|Overall Study|Covid-19 pandemic|0|||
146066502|NCT03926611|526763875|FG001|Overall Study|Covid-19 pandemic|0|||
146066503|NCT03926611|526763876|FG002|Overall Study|Covid-19 pandemic|1|||
146066504|NCT03926611|526763877|FG003|Overall Study|Covid-19 pandemic|0|||
146066505|NCT03926611|526763878|FG004|Overall Study|Covid-19 pandemic|1|||
146066506|NCT03926611|526763879|FG005|Overall Study|Covid-19 pandemic|2|||
146066507|NCT03926611|526763880|FG006|Overall Study|Covid-19 pandemic|0|||
146066508|NCT02230670|526763881|FG000|Overall Study|Adverse Event|1|||
146066509|NCT02230670|526763882|FG001|Overall Study|Adverse Event|2|||
146066510|NCT02230670|526763881|FG000|Overall Study|Withdrawal by Subject|2|||
146066511|NCT02230670|526763882|FG001|Overall Study|Withdrawal by Subject|2|||
146066512|NCT02230670|526763881|FG000|Overall Study|Physician Decision|0|||
146066513|NCT02230670|526763882|FG001|Overall Study|Physician Decision|1|||
146066514|NCT02230670|526763881|FG000|Overall Study|Protocol Violation|0|||
146066515|NCT02230670|526763882|FG001|Overall Study|Protocol Violation|1|||
146066516|NCT02230670|526763881|FG000|Overall Study|Progression to Child-Pugh C|1|||
146066517|NCT02230670|526763882|FG001|Overall Study|Progression to Child-Pugh C|2|||
146066518|NCT01524796|526763883|FG000|Overall Study|Adverse Event|13|||
146066519|NCT01524796|526763883|FG000|Overall Study|Lack of Efficacy|3|||
146066520|NCT01524796|526763883|FG000|Overall Study|Lost to Follow-up|1|||
146066521|NCT01524796|526763883|FG000|Overall Study|The price|1|||
146066522|NCT01524796|526763883|FG000|Overall Study|Withdrawal by Subject|4|||
146066523|NCT01524796|526763883|FG000|Overall Study|Move|1|||
146066524|NCT01524796|526763883|FG000|Overall Study|Deterioration of pains|1|||
146066525|NCT01524796|526763883|FG000|Overall Study|Gall stone surgery|1|||
146066526|NCT01524796|526763883|FG000|Overall Study|Nervous about confidentiality|1|||
146066527|NCT01524796|526763883|FG000|Overall Study|Switch to carbamazapine|1|||
146066528|NCT01524796|526763883|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
146066529|NCT03938259|526763888|FG000|Overall Study|unable to establish baseline for ventilation|1|||
146066530|NCT03938259|526763889|FG001|Overall Study|unable to establish baseline for ventilation|1|||
146066531|NCT00836693|526763890|FG000|Overall Study|Adverse Event|4|||
146066532|NCT00836693|526763891|FG001|Overall Study|Adverse Event|1|||
146066533|NCT00836693|526763890|FG000|Overall Study|Sponsor Decision|0|||
146066534|NCT00836693|526763891|FG001|Overall Study|Sponsor Decision|1|||
146066535|NCT00836693|526763890|FG000|Overall Study|Physician Decision|2|||
146066536|NCT00836693|526763891|FG001|Overall Study|Physician Decision|0|||
146066537|NCT00836693|526763890|FG000|Overall Study|Withdrawal by Subject|9|||
146066538|NCT00836693|526763891|FG001|Overall Study|Withdrawal by Subject|4|||
146066539|NCT00836693|526763890|FG000|Overall Study|Protocol Violation|1|||
146066540|NCT00836693|526763891|FG001|Overall Study|Protocol Violation|0|||
146066541|NCT00836693|526763890|FG000|Overall Study|Lost to Follow-up|1|||
146066542|NCT00836693|526763891|FG001|Overall Study|Lost to Follow-up|0|||
146066543|NCT02612779|526763892|FG000|Overall Study|Administrative reason by sponsor|4|||
146066544|NCT02612779|526763893|FG001|Overall Study|Administrative reason by sponsor|1|||
146066545|NCT02612779|526763892|FG000|Overall Study|No longer meet study criteria|0|||
146066546|NCT02612779|526763893|FG001|Overall Study|No longer meet study criteria|1|||
146066547|NCT02612779|526763892|FG000|Overall Study|Disease progression|29|||
146066548|NCT02612779|526763893|FG001|Overall Study|Disease progression|2|||
146066549|NCT02612779|526763892|FG000|Overall Study|Study drug toxicity|10|||
146066550|NCT02612779|526763893|FG001|Overall Study|Study drug toxicity|1|||
146066551|NCT02612779|526763892|FG000|Overall Study|Death|1|||
146066552|NCT02612779|526763893|FG001|Overall Study|Death|0|||
146066553|NCT02612779|526763892|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146066554|NCT02612779|526763893|FG001|Overall Study|Adverse event unrelated to study drug|0|||
146066555|NCT02612779|526763892|FG000|Overall Study|Participant withdrew consent|4|||
146066556|NCT02612779|526763893|FG001|Overall Study|Participant withdrew consent|0|||
146066557|NCT02612779|526763892|FG000|Overall Study|Lost to Follow-up|1|||
146066558|NCT02612779|526763893|FG001|Overall Study|Lost to Follow-up|0|||
146066559|NCT02612779|526763892|FG000|Overall Study|Maximum clinical benefit|10|||
146066560|NCT02612779|526763893|FG001|Overall Study|Maximum clinical benefit|1|||
146066561|NCT02612779|526763892|FG000|Overall Study|Other reasons|4|||
146066562|NCT02612779|526763893|FG001|Overall Study|Other reasons|0|||
146066563|NCT01002339|526763894|FG000|Overall Study|Withdrawal by Subject|0|||
146066564|NCT01002339|526763895|FG001|Overall Study|Withdrawal by Subject|1|||
146066565|NCT01002339|526763896|FG002|Overall Study|Withdrawal by Subject|0|||
146066566|NCT01002339|526763894|FG000|Overall Study|Incorrect treatment assignment|0|||
146066567|NCT01002339|526763895|FG001|Overall Study|Incorrect treatment assignment|0|||
146066568|NCT01002339|526763896|FG002|Overall Study|Incorrect treatment assignment|1|||
146066569|NCT01002339|526763894|FG000|Overall Study|Protocol Violation|0|||
146066570|NCT01002339|526763895|FG001|Overall Study|Protocol Violation|0|||
146066571|NCT01002339|526763896|FG002|Overall Study|Protocol Violation|2|||
146066572|NCT01002339|526763894|FG000|Overall Study|Lung cancer detected before transplant|0|||
146066573|NCT01002339|526763895|FG001|Overall Study|Lung cancer detected before transplant|0|||
146066574|NCT01002339|526763896|FG002|Overall Study|Lung cancer detected before transplant|1|||
146066575|NCT01002339|526763894|FG000|Overall Study|Randomized. Not transplanted|0|||
146066576|NCT01002339|526763895|FG001|Overall Study|Randomized. Not transplanted|0|||
146066577|NCT01002339|526763896|FG002|Overall Study|Randomized. Not transplanted|1|||
146066578|NCT01907854|526763897|FG000|Overall Study|Protocol Violation|1|||
146066579|NCT01907854|526763898|FG001|Overall Study|Protocol Violation|1|||
146066580|NCT01907854|526763897|FG000|Overall Study|Withdrawal by Subject|9|||
146066581|NCT01907854|526763898|FG001|Overall Study|Withdrawal by Subject|7|||
146066582|NCT01907854|526763897|FG000|Overall Study|Lost to Follow-up|2|||
146066583|NCT01907854|526763898|FG001|Overall Study|Lost to Follow-up|2|||
146066584|NCT01907854|526763897|FG000|Overall Study|Unclassified|4|||
146066585|NCT01907854|526763898|FG001|Overall Study|Unclassified|3|||
146066586|NCT02215252|526763899|FG000|Overall Study|Adverse Event|1|||
146066587|NCT02215252|526763900|FG001|Overall Study|Adverse Event|5|||
146066588|NCT02215252|526763901|FG002|Overall Study|Adverse Event|2|||
146066589|NCT02215252|526763899|FG000|Overall Study|Lost to Follow-up|0|||
146066590|NCT02215252|526763900|FG001|Overall Study|Lost to Follow-up|0|||
146066591|NCT02215252|526763901|FG002|Overall Study|Lost to Follow-up|1|||
146066592|NCT02215252|526763899|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
146066593|NCT02215252|526763900|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
146066594|NCT02215252|526763901|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
146066595|NCT02215252|526763899|FG000|Overall Study|Protocol Violation|0|||
146066596|NCT02215252|526763900|FG001|Overall Study|Protocol Violation|1|||
146066597|NCT02215252|526763901|FG002|Overall Study|Protocol Violation|0|||
146066598|NCT02215252|526763899|FG000|Overall Study|Withdrawal by Subject|1|||
146066599|NCT02215252|526763900|FG001|Overall Study|Withdrawal by Subject|0|||
146066600|NCT02215252|526763901|FG002|Overall Study|Withdrawal by Subject|0|||
146066601|NCT02215252|526763899|FG000|Overall Study|Other|0|||
146066602|NCT02215252|526763900|FG001|Overall Study|Other|1|||
146066603|NCT02215252|526763901|FG002|Overall Study|Other|1|||
146066604|NCT00892099|526763902|FG000|Overall Study|Death|1|||
146066605|NCT00892099|526763903|FG001|Overall Study|Death|0|||
146066606|NCT00892099|526763904|FG002|Overall Study|Death|1|||
146066607|NCT00892099|526763902|FG000|Overall Study|Adverse Event|1|||
146066608|NCT00892099|526763903|FG001|Overall Study|Adverse Event|0|||
146066609|NCT00892099|526763904|FG002|Overall Study|Adverse Event|0|||
146066610|NCT00892099|526763902|FG000|Overall Study|replocated|1|||
146066611|NCT00892099|526763903|FG001|Overall Study|replocated|0|||
146066612|NCT00892099|526763904|FG002|Overall Study|replocated|2|||
146066613|NCT00892099|526763902|FG000|Overall Study|Prolonged hospitalization|1|||
146066614|NCT00892099|526763903|FG001|Overall Study|Prolonged hospitalization|0|||
146066615|NCT00892099|526763904|FG002|Overall Study|Prolonged hospitalization|1|||
146066616|NCT00892099|526763902|FG000|Overall Study|no further details|1|||
146066617|NCT00892099|526763903|FG001|Overall Study|no further details|0|||
146066618|NCT00892099|526763904|FG002|Overall Study|no further details|1|||
146066619|NCT00892099|526763902|FG000|Overall Study|kidney function recovered|0|||
146066620|NCT00892099|526763903|FG001|Overall Study|kidney function recovered|1|||
146066621|NCT00892099|526763904|FG002|Overall Study|kidney function recovered|0|||
146066622|NCT00892099|526763902|FG000|Overall Study|investigator decision|0|||
146066623|NCT00892099|526763903|FG001|Overall Study|investigator decision|0|||
146066624|NCT00892099|526763904|FG002|Overall Study|investigator decision|1|||
146066625|NCT00892099|526763902|FG000|Overall Study|Lost to Follow-up|0|||
146066626|NCT00892099|526763903|FG001|Overall Study|Lost to Follow-up|0|||
146066627|NCT00892099|526763904|FG002|Overall Study|Lost to Follow-up|1|||
146066628|NCT01657019|526763905|FG000|Overall Study|Withdrawal by Subject|65|||
146066629|NCT01657019|526763905|FG000|Overall Study|Adverse Event|55|||
146066630|NCT01657019|526763905|FG000|Overall Study|Lost to Follow-up|48|||
146066631|NCT01657019|526763905|FG000|Overall Study|Protocol Violation|6|||
146066632|NCT01657019|526763905|FG000|Overall Study|Lack of Efficacy|3|||
146066633|NCT01657019|526763905|FG000|Overall Study|Other|58|||
146066634|NCT00956007|526763906|FG000|Overall Study|Protocol Violation|27|||
146066635|NCT00956007|526763907|FG001|Overall Study|Protocol Violation|23|||
146066636|NCT01750229|526763908|FG000|Randomized Crossover Phase|Adverse Event|1|||
146066637|NCT01750229|526763908|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
146066638|NCT01750229|526763908|FG000|Long-term Follow-up Phase|Adverse Event|2|||
146066639|NCT01750229|526763908|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
146066640|NCT02346721|526763909|FG000|Overall Study|Withdrew Consent|3|||
146066641|NCT02346721|526763909|FG000|Overall Study|Lack of Efficacy|1|||
146066642|NCT01285323|526763912|FG000|Overall Study|Adverse Event|9|||
146066643|NCT01285323|526763913|FG001|Overall Study|Adverse Event|8|||
146066644|NCT01285323|526763912|FG000|Overall Study|Lack of Efficacy|4|||
146066645|NCT01285323|526763913|FG001|Overall Study|Lack of Efficacy|2|||
146066646|NCT01285323|526763912|FG000|Overall Study|Withdrawal by Subject|15|||
146066647|NCT01285323|526763913|FG001|Overall Study|Withdrawal by Subject|11|||
146066648|NCT01285323|526763912|FG000|Overall Study|Protocol Violation|1|||
146066649|NCT01285323|526763913|FG001|Overall Study|Protocol Violation|2|||
146066650|NCT01285323|526763912|FG000|Overall Study|Non-compliance with study procedures|2|||
146066651|NCT01285323|526763913|FG001|Overall Study|Non-compliance with study procedures|3|||
146066652|NCT01285323|526763912|FG000|Overall Study|Lost to Follow-up|1|||
146407989|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
146066653|NCT01285323|526763913|FG001|Overall Study|Lost to Follow-up|1|||
146066654|NCT01285323|526763912|FG000|Overall Study|Other|1|||
146066655|NCT01285323|526763913|FG001|Overall Study|Other|3|||
146407990|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
146407991|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
146407992|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
146407993|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
146407994|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
146407995|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
146407996|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
146407997|NCT04440163|528000056|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
146407998|NCT04440163|528000057|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
146407999|NCT04440163|528000058|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
146066656|NCT02606643|526763914|FG000|Overall Study|did not meet inclusion criteria|1|||
146408000|NCT04440163|528000059|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
146408001|NCT04440163|528000060|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
146408002|NCT04440163|528000061|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
146408003|NCT04440163|528000062|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
146408004|NCT04440163|528000063|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
146408005|NCT04440163|528000056|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
146408006|NCT04440163|528000057|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
146408007|NCT04440163|528000058|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146408008|NCT04440163|528000059|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146408009|NCT04440163|528000060|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
146408010|NCT04440163|528000061|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
146408011|NCT04440163|528000062|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
146408012|NCT04440163|528000063|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
146408013|NCT04440163|528000056|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408014|NCT04440163|528000057|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408015|NCT04440163|528000058|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408016|NCT04440163|528000059|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
146408017|NCT04440163|528000060|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408018|NCT04440163|528000061|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408019|NCT04440163|528000062|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408020|NCT04440163|528000063|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
146408021|NCT00068406|528000066|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
146408022|NCT00068406|528000066|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
146408023|NCT02018042|528000067|FG000|Overall Study|Withdrawal by Subject|1|||
146408024|NCT01850108|528000071|FG000|Overall Study|Lost to Follow-up|4|||
146408025|NCT01850108|528000071|FG000|Overall Study|Not eligible|1|||
146408026|NCT01850108|528000071|FG000|Overall Study|Failed engraftment|2|||
146408027|NCT01850108|528000071|FG000|Overall Study|Physician Decision|1|||
146408028|NCT03273712|528000075|FG000|Overall Study|Death|5|||
146408029|NCT03273712|528000075|FG000|Overall Study|Adverse Event|1|||
146408030|NCT03273712|528000075|FG000|Overall Study|Disease Progression|1|||
146408031|NCT00666718|528000077|FG000|Overall Study|Adverse Event|0|||
146408032|NCT00666718|528000078|FG001|Overall Study|Adverse Event|1|||
146408033|NCT00666718|528000077|FG000|Overall Study|Death|1|||
146408034|NCT00666718|528000078|FG001|Overall Study|Death|0|||
146408035|NCT00666718|528000077|FG000|Overall Study|Lost to Follow-up|1|||
146408036|NCT00666718|528000078|FG001|Overall Study|Lost to Follow-up|0|||
146408037|NCT00666718|528000077|FG000|Overall Study|Entry Criteria Not Met|2|||
146408038|NCT00666718|528000078|FG001|Overall Study|Entry Criteria Not Met|0|||
146408039|NCT00666718|528000077|FG000|Overall Study|Protocol Violation|1|||
146408040|NCT00666718|528000078|FG001|Overall Study|Protocol Violation|3|||
146408041|NCT00666718|528000077|FG000|Overall Study|Withdrawal by Subject|7|||
146408042|NCT00666718|528000078|FG001|Overall Study|Withdrawal by Subject|12|||
146066657|NCT02606643|526763915|FG001|Overall Study|did not meet inclusion criteria|3|||
146066658|NCT00803569|526763918|FG000|Overall Study|Progressive Disease|3|||
146066659|NCT00803569|526763918|FG000|Overall Study|Noncompliance|1|||
146066660|NCT02900378|526763926|FG000|Randomization (Visit 2)|Adverse Event|14|||
146066661|NCT02900378|526763927|FG001|Randomization (Visit 2)|Adverse Event|11|||
146066662|NCT02900378|526763926|FG000|Randomization (Visit 2)|Death|1|||
146066663|NCT02900378|526763927|FG001|Randomization (Visit 2)|Death|4|||
146066664|NCT02900378|526763926|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
146066665|NCT02900378|526763927|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
146066666|NCT02900378|526763926|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
146066667|NCT02900378|526763927|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
146066668|NCT02900378|526763926|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
146408043|NCT00666718|528000077|FG000|Overall Study|Physician Decision|0|||
146408044|NCT00666718|528000078|FG001|Overall Study|Physician Decision|2|||
146408045|NCT00963599|528000079|FG000|Overall Study|Adverse Event|2|||
146066669|NCT02900378|526763927|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
146066670|NCT02900378|526763926|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
146066671|NCT02900378|526763927|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
146066672|NCT02900378|526763926|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
146066673|NCT02900378|526763927|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
146066674|NCT03818321|526763928|FG000|Overall Study|Withdrawal by Subject|1|||
146066675|NCT03818321|526763929|FG001|Overall Study|Withdrawal by Subject|2|||
146066676|NCT01134055|526763930|FG000|Overall Study|Adverse Event|5|||
146066677|NCT01134055|526763931|FG001|Overall Study|Adverse Event|2|||
146066678|NCT01134055|526763932|FG002|Overall Study|Adverse Event|2|||
146066679|NCT01134055|526763933|FG003|Overall Study|Adverse Event|2|||
146066680|NCT01134055|526763934|FG004|Overall Study|Adverse Event|5|||
146066681|NCT01134055|526763935|FG005|Overall Study|Adverse Event|7|||
146066682|NCT01134055|526763936|FG006|Overall Study|Adverse Event|2|||
146066683|NCT01134055|526763930|FG000|Overall Study|Lost to Follow-up|0|||
146066684|NCT01134055|526763931|FG001|Overall Study|Lost to Follow-up|1|||
146066685|NCT01134055|526763932|FG002|Overall Study|Lost to Follow-up|0|||
146066686|NCT01134055|526763933|FG003|Overall Study|Lost to Follow-up|1|||
146066687|NCT01134055|526763934|FG004|Overall Study|Lost to Follow-up|0|||
146066688|NCT01134055|526763935|FG005|Overall Study|Lost to Follow-up|0|||
146066689|NCT01134055|526763936|FG006|Overall Study|Lost to Follow-up|0|||
146066690|NCT01134055|526763930|FG000|Overall Study|Withdrawal by Subject|3|||
146066691|NCT01134055|526763931|FG001|Overall Study|Withdrawal by Subject|3|||
146066692|NCT01134055|526763932|FG002|Overall Study|Withdrawal by Subject|1|||
146066693|NCT01134055|526763933|FG003|Overall Study|Withdrawal by Subject|2|||
146066694|NCT01134055|526763934|FG004|Overall Study|Withdrawal by Subject|0|||
146066695|NCT01134055|526763935|FG005|Overall Study|Withdrawal by Subject|0|||
146066696|NCT01134055|526763936|FG006|Overall Study|Withdrawal by Subject|8|||
146066697|NCT01134055|526763930|FG000|Overall Study|Protocol Violation|0|||
146066698|NCT01134055|526763931|FG001|Overall Study|Protocol Violation|0|||
146066699|NCT01134055|526763932|FG002|Overall Study|Protocol Violation|0|||
146066700|NCT01134055|526763933|FG003|Overall Study|Protocol Violation|1|||
146066701|NCT01134055|526763934|FG004|Overall Study|Protocol Violation|1|||
146066702|NCT01134055|526763935|FG005|Overall Study|Protocol Violation|0|||
146066703|NCT01134055|526763936|FG006|Overall Study|Protocol Violation|0|||
146066704|NCT01134055|526763930|FG000|Overall Study|Physician Decision|0|||
146066705|NCT01134055|526763931|FG001|Overall Study|Physician Decision|0|||
146066706|NCT01134055|526763932|FG002|Overall Study|Physician Decision|0|||
146066707|NCT01134055|526763933|FG003|Overall Study|Physician Decision|0|||
146066708|NCT01134055|526763934|FG004|Overall Study|Physician Decision|0|||
146066709|NCT01134055|526763935|FG005|Overall Study|Physician Decision|0|||
146066710|NCT01134055|526763936|FG006|Overall Study|Physician Decision|1|||
146066711|NCT05038982|526763937|FG000|Overall Study|Withdrawal by Subject|0|||
146066712|NCT05038982|526763938|FG001|Overall Study|Withdrawal by Subject|2|||
146066713|NCT01454102|526763940|FG000|Overall Study|Continuing in the treatment period|0|||
146066714|NCT01454102|526763941|FG001|Overall Study|Continuing in the treatment period|0|||
146066715|NCT01454102|526763942|FG002|Overall Study|Continuing in the treatment period|0|||
146066716|NCT01454102|526763943|FG003|Overall Study|Continuing in the treatment period|0|||
146066717|NCT01454102|526763944|FG004|Overall Study|Continuing in the treatment period|3|||
146066718|NCT01454102|526763945|FG005|Overall Study|Continuing in the treatment period|3|||
146066719|NCT01454102|526763946|FG006|Overall Study|Continuing in the treatment period|2|||
146066720|NCT01454102|526763947|FG007|Overall Study|Continuing in the treatment period|0|||
146066721|NCT01454102|526763948|FG008|Overall Study|Continuing in the treatment period|1|||
146066722|NCT01454102|526763949|FG009|Overall Study|Continuing in the treatment period|0|||
146066723|NCT01454102|526763950|FG010|Overall Study|Continuing in the treatment period|0|||
146066724|NCT01454102|526763951|FG011|Overall Study|Continuing in the treatment period|4|||
146066725|NCT01454102|526763952|FG012|Overall Study|Continuing in the treatment period|7|||
146066726|NCT01454102|526763953|FG013|Overall Study|Continuing in the treatment period|4|||
146066727|NCT01454102|526763954|FG014|Overall Study|Continuing in the treatment period|3|||
146066728|NCT01454102|526763955|FG015|Overall Study|Continuing in the treatment period|1|||
146066729|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
146066730|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
146066731|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
146066732|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146066733|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146066734|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146066735|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146066736|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146066737|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
146066738|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146066739|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146066740|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
146171776|NCT00988221|527143224|FG002|Part III|Adverse Event|1|||
146171777|NCT00988221|527143225|FG003|Part III|Adverse Event|0|||
146066741|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
146066742|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
146066743|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
146066744|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
146066745|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
146066746|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
146066747|NCT03739203|526763956|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
146066748|NCT03739203|526763957|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
146408046|NCT00963599|528000080|FG001|Overall Study|Adverse Event|0|||
146408047|NCT00963599|528000081|FG002|Overall Study|Adverse Event|1|||
146408048|NCT00963599|528000082|FG003|Overall Study|Adverse Event|2|||
146408049|NCT00963599|528000079|FG000|Overall Study|Lack of Efficacy|0|||
146408050|NCT00963599|528000080|FG001|Overall Study|Lack of Efficacy|2|||
146408051|NCT00963599|528000081|FG002|Overall Study|Lack of Efficacy|1|||
146408052|NCT00963599|528000082|FG003|Overall Study|Lack of Efficacy|4|||
146408053|NCT00963599|528000079|FG000|Overall Study|Lost to Follow-up|0|||
146408054|NCT00963599|528000080|FG001|Overall Study|Lost to Follow-up|1|||
146408055|NCT00963599|528000081|FG002|Overall Study|Lost to Follow-up|1|||
146408056|NCT00963599|528000082|FG003|Overall Study|Lost to Follow-up|1|||
146408057|NCT00963599|528000079|FG000|Overall Study|Protocol Violation|2|||
146408058|NCT00963599|528000080|FG001|Overall Study|Protocol Violation|2|||
146408059|NCT00963599|528000081|FG002|Overall Study|Protocol Violation|3|||
146408060|NCT00963599|528000082|FG003|Overall Study|Protocol Violation|4|||
146408061|NCT00963599|528000079|FG000|Overall Study|Withdrawal by Subject|2|||
146408062|NCT00963599|528000080|FG001|Overall Study|Withdrawal by Subject|1|||
146408063|NCT00963599|528000081|FG002|Overall Study|Withdrawal by Subject|3|||
146408064|NCT00963599|528000082|FG003|Overall Study|Withdrawal by Subject|3|||
146408065|NCT00190684|528000090|FG000|Overall Study|Adverse Event|86|||
146408066|NCT00190684|528000090|FG000|Overall Study|Satisfactory response|80|||
146408067|NCT00190684|528000090|FG000|Overall Study|Lack of efficacy|204|||
146408068|NCT00190684|528000090|FG000|Overall Study|Lost to Follow-up|232|||
146408069|NCT00190684|528000090|FG000|Overall Study|Patient moved|60|||
146408070|NCT00190684|528000090|FG000|Overall Study|Patient Decision|432|||
146408071|NCT00190684|528000090|FG000|Overall Study|Clinical relapse|67|||
146408072|NCT00190684|528000090|FG000|Overall Study|Sponsor's decision|17|||
146408073|NCT00190684|528000090|FG000|Overall Study|Physician Decision|84|||
146408074|NCT00190684|528000090|FG000|Overall Study|Protocol Violation|123|||
146408075|NCT00190684|528000090|FG000|Overall Study|Study Period III Completed|103|||
146408076|NCT00190684|528000090|FG000|Overall Study|Study Period V Completed|1|||
146408077|NCT03496207|528000091|FG000|Base Study|Adverse Event|0|||
146408078|NCT03496207|528000092|FG001|Base Study|Adverse Event|0|||
146408079|NCT03496207|528000093|FG002|Base Study|Adverse Event|1|||
146408080|NCT03496207|528000094|FG003|Base Study|Adverse Event|1|||
146408081|NCT03496207|528000095|FG004|Base Study|Adverse Event|4|||
146408082|NCT03496207|528000091|FG000|Base Study|Death|0|||
146408083|NCT03496207|528000092|FG001|Base Study|Death|0|||
146408084|NCT03496207|528000093|FG002|Base Study|Death|0|||
146408085|NCT03496207|528000094|FG003|Base Study|Death|0|||
146408086|NCT03496207|528000095|FG004|Base Study|Death|1|||
146408087|NCT03496207|528000091|FG000|Base Study|Withdrawal by Subject|0|||
146408088|NCT03496207|528000092|FG001|Base Study|Withdrawal by Subject|0|||
146066749|NCT03739203|526763958|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
146066750|NCT03739203|526763956|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
146066751|NCT03739203|526763957|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
146066752|NCT03739203|526763958|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
146066753|NCT03739203|526763956|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
146066754|NCT03739203|526763957|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
146066755|NCT03739203|526763958|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
146066756|NCT03739203|526763956|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
146408089|NCT03496207|528000093|FG002|Base Study|Withdrawal by Subject|1|||
146408090|NCT03496207|528000094|FG003|Base Study|Withdrawal by Subject|0|||
146408091|NCT03496207|528000095|FG004|Base Study|Withdrawal by Subject|1|||
146408092|NCT03496207|528000091|FG000|Extension Period|Adverse Event|0|||
146408093|NCT03496207|528000092|FG001|Extension Period|Adverse Event|0|||
146408094|NCT03496207|528000093|FG002|Extension Period|Adverse Event|0|||
146408095|NCT03496207|528000094|FG003|Extension Period|Adverse Event|1|||
146408096|NCT03496207|528000095|FG004|Extension Period|Adverse Event|1|||
146408097|NCT03496207|528000091|FG000|Extension Period|Death|1|||
146408098|NCT03496207|528000092|FG001|Extension Period|Death|0|||
146408099|NCT03496207|528000093|FG002|Extension Period|Death|0|||
146408100|NCT03496207|528000094|FG003|Extension Period|Death|1|||
146408101|NCT03496207|528000095|FG004|Extension Period|Death|2|||
146408102|NCT03496207|528000091|FG000|Extension Period|Withdrawal by Subject|1|||
146408103|NCT03496207|528000092|FG001|Extension Period|Withdrawal by Subject|0|||
146408104|NCT03496207|528000093|FG002|Extension Period|Withdrawal by Subject|0|||
146408105|NCT03496207|528000094|FG003|Extension Period|Withdrawal by Subject|1|||
146408106|NCT03496207|528000095|FG004|Extension Period|Withdrawal by Subject|1|||
146066757|NCT03739203|526763957|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
146066758|NCT03739203|526763958|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
146066759|NCT03739203|526763956|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
146066760|NCT03739203|526763957|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
146066761|NCT03739203|526763958|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
146066762|NCT01782378|526763959|FG000|First Series|Lost to Follow-up|7|||
146066763|NCT01782378|526763960|FG001|First Series|Lost to Follow-up|8|||
146066764|NCT01782378|526763959|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
146066765|NCT01782378|526763960|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
146066766|NCT01782378|526763959|FG000|Second Series|Lost to Follow-up|8|||
146066767|NCT01782378|526763960|FG001|Second Series|Lost to Follow-up|7|||
146066768|NCT01782378|526763959|FG000|Second Series|Did not choose to complete S2 Optional|18|||
146066769|NCT01782378|526763960|FG001|Second Series|Did not choose to complete S2 Optional|0|||
146066770|NCT01663103|526763963|FG000|Overall Study|Withdrawal by Subject|1|||
146066771|NCT01663103|526763964|FG001|Overall Study|Withdrawal by Subject|2|||
146066772|NCT01663103|526763963|FG000|Overall Study|Adverse Event|1|||
146066773|NCT01663103|526763964|FG001|Overall Study|Adverse Event|0|||
146066774|NCT01663103|526763963|FG000|Overall Study|dog bite|1|||
146066775|NCT01663103|526763964|FG001|Overall Study|dog bite|0|||
146066776|NCT01656408|526763965|FG000|Overall Study|Adverse Event|0|||
146066777|NCT01656408|526763966|FG001|Overall Study|Adverse Event|0|||
146066778|NCT01656408|526763967|FG002|Overall Study|Adverse Event|1|||
146066779|NCT01656408|526763968|FG003|Overall Study|Adverse Event|0|||
146066780|NCT01656408|526763969|FG004|Overall Study|Adverse Event|0|||
146066781|NCT01656408|526763970|FG005|Overall Study|Adverse Event|1|||
146066782|NCT01656408|526763971|FG006|Overall Study|Adverse Event|1|||
146066783|NCT01656408|526763972|FG007|Overall Study|Adverse Event|0|||
146066784|NCT01656408|526763973|FG008|Overall Study|Adverse Event|1|||
146066785|NCT01656408|526763974|FG009|Overall Study|Adverse Event|0|||
146066786|NCT01656408|526763965|FG000|Overall Study|Physician Decision|1|||
146066787|NCT01656408|526763966|FG001|Overall Study|Physician Decision|0|||
146066788|NCT01656408|526763967|FG002|Overall Study|Physician Decision|1|||
146066789|NCT01656408|526763968|FG003|Overall Study|Physician Decision|0|||
146066790|NCT01656408|526763969|FG004|Overall Study|Physician Decision|1|||
146066791|NCT01656408|526763970|FG005|Overall Study|Physician Decision|1|||
146066792|NCT01656408|526763971|FG006|Overall Study|Physician Decision|0|||
146066793|NCT01656408|526763972|FG007|Overall Study|Physician Decision|1|||
146066794|NCT01656408|526763973|FG008|Overall Study|Physician Decision|1|||
146066795|NCT01656408|526763974|FG009|Overall Study|Physician Decision|3|||
146066796|NCT00888940|526763985|FG000|Overall Study|Adverse Event|12|||
146066797|NCT00888940|526763986|FG001|Overall Study|Adverse Event|3|||
146066798|NCT00888940|526763985|FG000|Overall Study|Lost to Follow-up|5|||
146066799|NCT00888940|526763986|FG001|Overall Study|Lost to Follow-up|5|||
146066800|NCT00888940|526763985|FG000|Overall Study|Randomized Not Treated|11|||
146066801|NCT00888940|526763986|FG001|Overall Study|Randomized Not Treated|13|||
146066802|NCT03815929|526763991|FG000|Overall Study|Lost to Follow-up|2|||
146066803|NCT03815929|526763992|FG001|Overall Study|Lost to Follow-up|1|||
146066804|NCT03815929|526763993|FG002|Overall Study|Lost to Follow-up|0|||
146066805|NCT03815929|526763991|FG000|Overall Study|Physician Decision|2|||
146066806|NCT03815929|526763992|FG001|Overall Study|Physician Decision|2|||
146066807|NCT03815929|526763993|FG002|Overall Study|Physician Decision|0|||
146066808|NCT03815929|526763991|FG000|Overall Study|Withdrawal by Subject|0|||
146066809|NCT03815929|526763992|FG001|Overall Study|Withdrawal by Subject|0|||
146066810|NCT03815929|526763993|FG002|Overall Study|Withdrawal by Subject|1|||
146066811|NCT03313037|526763994|FG000|Overall Study|Protocol Violation|4|||
146066812|NCT03313037|526763995|FG001|Overall Study|Protocol Violation|1|||
146066813|NCT03313037|526763994|FG000|Overall Study|Other|1|||
146066814|NCT03313037|526763995|FG001|Overall Study|Other|1|||
146066815|NCT03313037|526763994|FG000|Overall Study|Withdrawal by Subject|4|||
146066816|NCT03313037|526763995|FG001|Overall Study|Withdrawal by Subject|3|||
146066817|NCT03313037|526763994|FG000|Overall Study|No longer meets eligibility criteria|1|||
146066818|NCT03313037|526763995|FG001|Overall Study|No longer meets eligibility criteria|7|||
146066819|NCT03313037|526763994|FG000|Overall Study|Lost to Follow-up|9|||
146066820|NCT03313037|526763995|FG001|Overall Study|Lost to Follow-up|8|||
146066821|NCT03313037|526763994|FG000|Overall Study|Randomized but not treated|1|||
146066822|NCT03313037|526763995|FG001|Overall Study|Randomized but not treated|0|||
146066823|NCT02760498|526763996|FG000|Overall Study|Adverse Event|3|||
146066824|NCT02760498|526763997|FG001|Overall Study|Adverse Event|3|||
146066825|NCT02760498|526763998|FG002|Overall Study|Adverse Event|1|||
146066826|NCT02760498|526763999|FG003|Overall Study|Adverse Event|1|||
146066827|NCT02760498|526764000|FG004|Overall Study|Adverse Event|0|||
146066828|NCT02760498|526764001|FG005|Overall Study|Adverse Event|6|||
146066829|NCT02760498|526763996|FG000|Overall Study|Death|7|||
146066830|NCT02760498|526763997|FG001|Overall Study|Death|5|||
146066831|NCT02760498|526763998|FG002|Overall Study|Death|5|||
146066832|NCT02760498|526763999|FG003|Overall Study|Death|7|||
146066833|NCT02760498|526764000|FG004|Overall Study|Death|0|||
146066834|NCT02760498|526764001|FG005|Overall Study|Death|23|||
146066835|NCT02760498|526763996|FG000|Overall Study|Lost to Follow-up|0|||
146066836|NCT02760498|526763997|FG001|Overall Study|Lost to Follow-up|0|||
146066837|NCT02760498|526763998|FG002|Overall Study|Lost to Follow-up|0|||
146066838|NCT02760498|526763999|FG003|Overall Study|Lost to Follow-up|0|||
146066839|NCT02760498|526764000|FG004|Overall Study|Lost to Follow-up|0|||
146066840|NCT02760498|526764001|FG005|Overall Study|Lost to Follow-up|3|||
146066841|NCT02760498|526763996|FG000|Overall Study|Non-compliance with study drug|0|||
146066842|NCT02760498|526763997|FG001|Overall Study|Non-compliance with study drug|2|||
146066843|NCT02760498|526763998|FG002|Overall Study|Non-compliance with study drug|0|||
146066844|NCT02760498|526763999|FG003|Overall Study|Non-compliance with study drug|0|||
146066845|NCT02760498|526764000|FG004|Overall Study|Non-compliance with study drug|0|||
146066846|NCT02760498|526764001|FG005|Overall Study|Non-compliance with study drug|0|||
146066847|NCT02760498|526763996|FG000|Overall Study|Participant decision|1|||
146066848|NCT02760498|526763997|FG001|Overall Study|Participant decision|4|||
146066849|NCT02760498|526763998|FG002|Overall Study|Participant decision|2|||
146066850|NCT02760498|526763999|FG003|Overall Study|Participant decision|2|||
146066851|NCT02760498|526764000|FG004|Overall Study|Participant decision|1|||
146066852|NCT02760498|526764001|FG005|Overall Study|Participant decision|6|||
146066853|NCT02760498|526763996|FG000|Overall Study|Sponsor decision|0|||
146066854|NCT02760498|526763997|FG001|Overall Study|Sponsor decision|0|||
146066855|NCT02760498|526763998|FG002|Overall Study|Sponsor decision|0|||
146066856|NCT02760498|526763999|FG003|Overall Study|Sponsor decision|3|||
146066857|NCT02760498|526764000|FG004|Overall Study|Sponsor decision|0|||
146066858|NCT02760498|526764001|FG005|Overall Study|Sponsor decision|0|||
146066859|NCT02760498|526763996|FG000|Overall Study|Physician Decision|3|||
146066860|NCT02760498|526763997|FG001|Overall Study|Physician Decision|4|||
146066861|NCT02760498|526763998|FG002|Overall Study|Physician Decision|1|||
146066862|NCT02760498|526763999|FG003|Overall Study|Physician Decision|4|||
146066863|NCT02760498|526764000|FG004|Overall Study|Physician Decision|0|||
146066864|NCT02760498|526764001|FG005|Overall Study|Physician Decision|2|||
146066865|NCT02760498|526763996|FG000|Overall Study|Disease progression|21|||
146066866|NCT02760498|526763997|FG001|Overall Study|Disease progression|19|||
146066867|NCT02760498|526763998|FG002|Overall Study|Disease progression|20|||
146066868|NCT02760498|526763999|FG003|Overall Study|Disease progression|18|||
146066869|NCT02760498|526764000|FG004|Overall Study|Disease progression|4|||
146066870|NCT02760498|526764001|FG005|Overall Study|Disease progression|55|||
146066871|NCT02760498|526763996|FG000|Overall Study|Withdrawal by Subject|4|||
146066872|NCT02760498|526763997|FG001|Overall Study|Withdrawal by Subject|7|||
146066873|NCT02760498|526763998|FG002|Overall Study|Withdrawal by Subject|5|||
146066874|NCT02760498|526763999|FG003|Overall Study|Withdrawal by Subject|1|||
146066875|NCT02760498|526764000|FG004|Overall Study|Withdrawal by Subject|0|||
146066876|NCT02760498|526764001|FG005|Overall Study|Withdrawal by Subject|6|||
146066877|NCT02760498|526763996|FG000|Overall Study|Other than specified|1|||
146066878|NCT02760498|526763997|FG001|Overall Study|Other than specified|6|||
146066879|NCT02760498|526763998|FG002|Overall Study|Other than specified|0|||
146066880|NCT02760498|526763999|FG003|Overall Study|Other than specified|3|||
146066881|NCT02760498|526764000|FG004|Overall Study|Other than specified|1|||
146066882|NCT02760498|526764001|FG005|Overall Study|Other than specified|0|||
146066883|NCT02760498|526763996|FG000|Overall Study|Not treated|0|||
146066884|NCT02760498|526763997|FG001|Overall Study|Not treated|0|||
146066885|NCT02760498|526763998|FG002|Overall Study|Not treated|0|||
146066886|NCT02760498|526763999|FG003|Overall Study|Not treated|0|||
146066887|NCT02760498|526764000|FG004|Overall Study|Not treated|0|||
146066888|NCT02760498|526764001|FG005|Overall Study|Not treated|2|||
146066889|NCT02205736|526764002|FG000|Overall Study|Lost to Follow-up|106|||
146066890|NCT03326713|526764003|FG000|Overall Study|Death|2|||
146066891|NCT03326713|526764004|FG001|Overall Study|Death|1|||
146066892|NCT03326713|526764005|FG002|Overall Study|Death|0|||
146066893|NCT03326713|526764003|FG000|Overall Study|Lost to Follow-up|20|||
146066894|NCT03326713|526764004|FG001|Overall Study|Lost to Follow-up|21|||
146066895|NCT03326713|526764005|FG002|Overall Study|Lost to Follow-up|33|||
146066896|NCT03326713|526764003|FG000|Overall Study|Withdrawal by Subject|1|||
146066897|NCT03326713|526764004|FG001|Overall Study|Withdrawal by Subject|2|||
146066898|NCT03326713|526764005|FG002|Overall Study|Withdrawal by Subject|11|||
146066899|NCT03326713|526764003|FG000|Overall Study|Found Ineligible|11|||
146066900|NCT03326713|526764004|FG001|Overall Study|Found Ineligible|11|||
146066901|NCT03326713|526764005|FG002|Overall Study|Found Ineligible|8|||
146066902|NCT00771758|526764006|FG000|Overall Study|Adverse Event|2|||
146066903|NCT00771758|526764007|FG001|Overall Study|Adverse Event|8|||
146066904|NCT00771758|526764008|FG002|Overall Study|Adverse Event|1|||
146066905|NCT00771758|526764006|FG000|Overall Study|Lack of Efficacy|0|||
146066906|NCT00771758|526764007|FG001|Overall Study|Lack of Efficacy|2|||
146066907|NCT00771758|526764008|FG002|Overall Study|Lack of Efficacy|1|||
146066908|NCT00771758|526764006|FG000|Overall Study|Lost to Follow-up|1|||
146066909|NCT00771758|526764007|FG001|Overall Study|Lost to Follow-up|0|||
146171778|NCT00988221|527143222|FG000|Part III|Insufficient Therapeutic Response|0|||
146066910|NCT00771758|526764008|FG002|Overall Study|Lost to Follow-up|0|||
146066911|NCT00771758|526764006|FG000|Overall Study|Protocol Violation|1|||
146066912|NCT00771758|526764007|FG001|Overall Study|Protocol Violation|0|||
146066913|NCT00771758|526764008|FG002|Overall Study|Protocol Violation|0|||
146066914|NCT00771758|526764006|FG000|Overall Study|Withdrawal by Subject|1|||
146066915|NCT00771758|526764007|FG001|Overall Study|Withdrawal by Subject|0|||
146066916|NCT00771758|526764008|FG002|Overall Study|Withdrawal by Subject|0|||
146066917|NCT00771758|526764006|FG000|Overall Study|Other|3|||
146066918|NCT00771758|526764007|FG001|Overall Study|Other|2|||
146066919|NCT00771758|526764008|FG002|Overall Study|Other|0|||
146066920|NCT03067077|526764009|FG000|Overall Study|Did not receive surgery|4|||
146066921|NCT03067077|526764010|FG001|Overall Study|Did not receive surgery|5|||
146066922|NCT03067077|526764009|FG000|Overall Study|Lost to Follow-up|3|||
146066923|NCT03067077|526764010|FG001|Overall Study|Lost to Follow-up|2|||
146066924|NCT00935584|526764013|FG000|Overall Study|Withdrawal by Subject|9|||
146066925|NCT00935584|526764014|FG001|Overall Study|Withdrawal by Subject|0|||
146066926|NCT00935584|526764013|FG000|Overall Study|Death|3|||
146066927|NCT00935584|526764014|FG001|Overall Study|Death|0|||
146066928|NCT00935584|526764013|FG000|Overall Study|Lost to Follow-up|8|||
146066929|NCT00935584|526764014|FG001|Overall Study|Lost to Follow-up|0|||
146066930|NCT00935584|526764013|FG000|Overall Study|No show|9|||
146066931|NCT00935584|526764014|FG001|Overall Study|No show|0|||
146066932|NCT00935584|526764013|FG000|Overall Study|Relocated|3|||
146066933|NCT00935584|526764014|FG001|Overall Study|Relocated|0|||
146066934|NCT00935584|526764013|FG000|Overall Study|Patient changed provider|3|||
146066935|NCT00935584|526764014|FG001|Overall Study|Patient changed provider|0|||
146066936|NCT00935584|526764013|FG000|Overall Study|Provider dropped out of study|14|||
146066937|NCT00935584|526764014|FG001|Overall Study|Provider dropped out of study|4|||
146066938|NCT00174187|526764021|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
146066939|NCT00174187|526764022|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
146066940|NCT00174187|526764023|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
146066941|NCT00174187|526764021|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
146066942|NCT00174187|526764022|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
146066943|NCT00174187|526764023|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
146066944|NCT00174187|526764021|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
146066945|NCT00174187|526764022|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
146066946|NCT00174187|526764023|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
146066947|NCT00174187|526764021|FG000|Period 1 (up to 3 Years)|Other|0|||
146066948|NCT00174187|526764022|FG001|Period 1 (up to 3 Years)|Other|1|||
146066949|NCT00174187|526764023|FG002|Period 1 (up to 3 Years)|Other|0|||
146066950|NCT00174187|526764021|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
146066951|NCT00174187|526764022|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
146066952|NCT00174187|526764023|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
146066953|NCT00174187|526764021|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
146066954|NCT00174187|526764022|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
146066955|NCT00174187|526764023|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
146066956|NCT00174187|526764021|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
146066957|NCT00174187|526764022|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
146066958|NCT00174187|526764023|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
146066959|NCT00174187|526764021|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
146066960|NCT00174187|526764022|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
146066961|NCT00174187|526764023|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
146066962|NCT00174187|526764021|FG000|Period 2 (After 3 Years)|Other|0|||
146066963|NCT00174187|526764022|FG001|Period 2 (After 3 Years)|Other|0|||
146066964|NCT00174187|526764023|FG002|Period 2 (After 3 Years)|Other|5|||
146066965|NCT01198977|526764025|FG000|Overall Study|Lost to Follow-up|1|||
146066966|NCT01198977|526764026|FG001|Overall Study|Lost to Follow-up|0|||
146066967|NCT01285557|526764027|FG000|Overall Study|Death|173|||
146066968|NCT01285557|526764028|FG001|Overall Study|Death|90|||
146066969|NCT01285557|526764027|FG000|Overall Study|Lost to Follow-up|6|||
146066970|NCT01285557|526764028|FG001|Overall Study|Lost to Follow-up|2|||
146066971|NCT01285557|526764027|FG000|Overall Study|Withdrew Consent|6|||
146066972|NCT01285557|526764028|FG001|Overall Study|Withdrew Consent|1|||
146066973|NCT01285557|526764027|FG000|Overall Study|Sponsor Study Termination|23|||
146066974|NCT01285557|526764028|FG001|Overall Study|Sponsor Study Termination|13|||
146066975|NCT01285557|526764027|FG000|Overall Study|Randomized but not treated|1|||
146066976|NCT01285557|526764028|FG001|Overall Study|Randomized but not treated|1|||
146066977|NCT01285557|526764027|FG000|Overall Study|Study follow-up ongoing|28|||
146066978|NCT01285557|526764028|FG001|Overall Study|Study follow-up ongoing|14|||
146066979|NCT01285557|526764027|FG000|Overall Study|Sponsor Decision|2|||
146066980|NCT01285557|526764028|FG001|Overall Study|Sponsor Decision|1|||
146066981|NCT01648751|526764035|FG000|Overall Study|Withdrawal by Subject|2|||
146066982|NCT01648751|526764036|FG001|Overall Study|Withdrawal by Subject|3|||
146066983|NCT02484391|526764041|FG000|Overall Study|Lack of Efficacy|15|||
146066984|NCT02484391|526764042|FG001|Overall Study|Lack of Efficacy|14|||
146066985|NCT02484391|526764043|FG002|Overall Study|Lack of Efficacy|3|||
146066986|NCT02484391|526764041|FG000|Overall Study|Lost to Follow-up|0|||
146066987|NCT02484391|526764042|FG001|Overall Study|Lost to Follow-up|0|||
146066988|NCT02484391|526764043|FG002|Overall Study|Lost to Follow-up|2|||
146066989|NCT02484391|526764041|FG000|Overall Study|Physician Decision|1|||
146408107|NCT03496207|528000091|FG000|Extension Period|Elevated hemoglobin levels|0|||
146408108|NCT03496207|528000092|FG001|Extension Period|Elevated hemoglobin levels|0|||
146408109|NCT03496207|528000093|FG002|Extension Period|Elevated hemoglobin levels|0|||
146408110|NCT03496207|528000094|FG003|Extension Period|Elevated hemoglobin levels|0|||
146066990|NCT02484391|526764042|FG001|Overall Study|Physician Decision|3|||
146066991|NCT02484391|526764043|FG002|Overall Study|Physician Decision|0|||
146066992|NCT02484391|526764041|FG000|Overall Study|Went to Transplant|5|||
146408111|NCT03496207|528000095|FG004|Extension Period|Elevated hemoglobin levels|1|||
146408112|NCT00068445|528000096|FG000|Randomization|Cancel|1|||
146408113|NCT00068445|528000097|FG001|Randomization|Cancel|3|||
146408114|NCT00068445|528000096|FG000|Randomization|Ineligible|1|||
146408115|NCT00068445|528000097|FG001|Randomization|Ineligible|1|||
146408116|NCT00068445|528000096|FG000|Treatment|Refused Further Treatment|13|||
146408117|NCT00068445|528000097|FG001|Treatment|Refused Further Treatment|10|||
146408118|NCT00068445|528000096|FG000|Treatment|Adverse Event|7|||
146408119|NCT00068445|528000097|FG001|Treatment|Adverse Event|1|||
146408120|NCT00068445|528000096|FG000|Treatment|Other (Specifics not available)|9|||
146408121|NCT00068445|528000097|FG001|Treatment|Other (Specifics not available)|5|||
146408122|NCT01155284|528000098|FG000|Overall Study|Withdrawal by Subject|4|||
146408123|NCT01155284|528000099|FG001|Overall Study|Withdrawal by Subject|3|||
146408124|NCT01155284|528000098|FG000|Overall Study|Lost to Follow-up|1|||
146408125|NCT01155284|528000099|FG001|Overall Study|Lost to Follow-up|2|||
146408126|NCT01155284|528000098|FG000|Overall Study|Physician Decision|1|||
146408127|NCT01155284|528000099|FG001|Overall Study|Physician Decision|0|||
146408128|NCT01155284|528000098|FG000|Overall Study|Adverse Event|1|||
146408129|NCT01155284|528000099|FG001|Overall Study|Adverse Event|0|||
146408130|NCT01896700|528000100|FG000|Overall Study|Adverse Event|4|||
146408131|NCT01896700|528000101|FG001|Overall Study|Adverse Event|5|||
146408132|NCT01896700|528000100|FG000|Overall Study|Withdrawal by Subject|0|||
146408133|NCT01896700|528000101|FG001|Overall Study|Withdrawal by Subject|1|||
146408134|NCT00123487|528000102|FG000|Randomized|Death prior to starting treatment|0|||
146408135|NCT00123487|528000103|FG001|Randomized|Death prior to starting treatment|1|||
146408136|NCT00123487|528000102|FG000|Randomized|SAE prior to starting treatment|1|||
146408137|NCT00123487|528000103|FG001|Randomized|SAE prior to starting treatment|0|||
146408138|NCT00123487|528000102|FG000|Treated With Study Drug|Adverse Event|23|||
146408139|NCT00123487|528000103|FG001|Treated With Study Drug|Adverse Event|22|||
146408140|NCT00123487|528000102|FG000|Treated With Study Drug|Disease Progression|141|||
146408141|NCT00123487|528000103|FG001|Treated With Study Drug|Disease Progression|122|||
146408142|NCT00123487|528000102|FG000|Treated With Study Drug|Physician Decision|8|||
146408143|NCT00123487|528000103|FG001|Treated With Study Drug|Physician Decision|9|||
146408144|NCT00123487|528000102|FG000|Treated With Study Drug|Other|59|||
146408145|NCT00123487|528000103|FG001|Treated With Study Drug|Other|58|||
146408146|NCT00123487|528000102|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
146408147|NCT00123487|528000103|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
146408148|NCT00123487|528000102|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
146408149|NCT00123487|528000103|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
146408150|NCT00123487|528000102|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
146066993|NCT02484391|526764042|FG001|Overall Study|Went to Transplant|3|||
146066994|NCT02484391|526764043|FG002|Overall Study|Went to Transplant|2|||
146408151|NCT00123487|528000103|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
146408152|NCT00423488|528000106|FG000|Overall Study|No evidence of study drug intake|2|||
146408153|NCT00423488|528000107|FG001|Overall Study|No evidence of study drug intake|1|||
146408154|NCT00423488|528000106|FG000|Overall Study|No post baseline data|3|||
146408155|NCT00423488|528000107|FG001|Overall Study|No post baseline data|0|||
146408156|NCT00886782|528000108|FG000|Overall Study|Disease progression|3|||
146408157|NCT00886782|528000109|FG001|Overall Study|Disease progression|3|||
146408158|NCT00886782|528000110|FG002|Overall Study|Disease progression|3|||
146408159|NCT00886782|528000108|FG000|Overall Study|Study drug toxicity|0|||
146066995|NCT02202759|526765690|FG000|Overall Study|Study Terminated by Sponsor|3|||
146066996|NCT02202759|526765691|FG001|Overall Study|Study Terminated by Sponsor|3|||
146066997|NCT02202759|526765692|FG002|Overall Study|Study Terminated by Sponsor|3|||
146066998|NCT02202759|526765690|FG000|Overall Study|Withdrawal by Subject|2|||
146066999|NCT02202759|526765691|FG001|Overall Study|Withdrawal by Subject|1|||
146067000|NCT02202759|526765692|FG002|Overall Study|Withdrawal by Subject|1|||
146067001|NCT02202759|526765690|FG000|Overall Study|Reason not Specified|4|||
146067002|NCT02202759|526765691|FG001|Overall Study|Reason not Specified|11|||
146067003|NCT02202759|526765692|FG002|Overall Study|Reason not Specified|10|||
146067004|NCT00790842|526765696|FG000|Dose Level 1|Adverse Event|1|||
146067005|NCT00790842|526765697|FG001|Dose Level 1|Adverse Event|0|||
146067006|NCT00790842|526765698|FG002|Dose Level 1|Adverse Event|0|||
146067007|NCT00790842|526765699|FG003|Dose Level 1|Adverse Event|2|||
146067008|NCT00790842|526765700|FG004|Dose Level 1|Adverse Event|0|||
146067009|NCT00790842|526765701|FG005|Dose Level 1|Adverse Event|0|||
146067010|NCT00790842|526765702|FG006|Dose Level 1|Adverse Event|0|||
146067011|NCT00790842|526765703|FG007|Dose Level 1|Adverse Event|1|||
146067012|NCT00790842|526765704|FG008|Dose Level 1|Adverse Event|0|||
146067013|NCT00790842|526765705|FG009|Dose Level 1|Adverse Event|0|||
146067014|NCT00790842|526765706|FG010|Dose Level 1|Adverse Event|0|||
146067015|NCT00790842|526765696|FG000|Dose Level 1|Physician Decision|1|||
146067016|NCT00790842|526765697|FG001|Dose Level 1|Physician Decision|0|||
146067017|NCT00790842|526765698|FG002|Dose Level 1|Physician Decision|0|||
146067018|NCT00790842|526765699|FG003|Dose Level 1|Physician Decision|0|||
146067019|NCT00790842|526765700|FG004|Dose Level 1|Physician Decision|0|||
146171779|NCT00988221|527143223|FG001|Part III|Insufficient Therapeutic Response|1|||
146067020|NCT00790842|526765701|FG005|Dose Level 1|Physician Decision|0|||
146067021|NCT00790842|526765702|FG006|Dose Level 1|Physician Decision|0|||
146067022|NCT00790842|526765703|FG007|Dose Level 1|Physician Decision|1|||
146067023|NCT00790842|526765704|FG008|Dose Level 1|Physician Decision|0|||
146067024|NCT00790842|526765705|FG009|Dose Level 1|Physician Decision|0|||
146067025|NCT00790842|526765706|FG010|Dose Level 1|Physician Decision|0|||
146067026|NCT00790842|526765696|FG000|Dose Level 1|Withdrawal by Subject|1|||
146067027|NCT00790842|526765697|FG001|Dose Level 1|Withdrawal by Subject|0|||
146067028|NCT00790842|526765698|FG002|Dose Level 1|Withdrawal by Subject|0|||
146067029|NCT00790842|526765699|FG003|Dose Level 1|Withdrawal by Subject|0|||
146067030|NCT00790842|526765700|FG004|Dose Level 1|Withdrawal by Subject|0|||
146067031|NCT00790842|526765701|FG005|Dose Level 1|Withdrawal by Subject|0|||
146067032|NCT00790842|526765702|FG006|Dose Level 1|Withdrawal by Subject|0|||
146067033|NCT00790842|526765703|FG007|Dose Level 1|Withdrawal by Subject|0|||
146067034|NCT00790842|526765704|FG008|Dose Level 1|Withdrawal by Subject|0|||
146067035|NCT00790842|526765705|FG009|Dose Level 1|Withdrawal by Subject|0|||
146067036|NCT00790842|526765706|FG010|Dose Level 1|Withdrawal by Subject|0|||
146067037|NCT00790842|526765696|FG000|Dose Level 2|Death|0|||
146067038|NCT00790842|526765697|FG001|Dose Level 2|Death|1|||
146067039|NCT00790842|526765698|FG002|Dose Level 2|Death|0|||
146067040|NCT00790842|526765699|FG003|Dose Level 2|Death|0|||
146067041|NCT00790842|526765700|FG004|Dose Level 2|Death|1|||
146067042|NCT00790842|526765701|FG005|Dose Level 2|Death|0|||
146067043|NCT00790842|526765702|FG006|Dose Level 2|Death|0|||
146067044|NCT00790842|526765703|FG007|Dose Level 2|Death|0|||
146067045|NCT00790842|526765704|FG008|Dose Level 2|Death|0|||
146067046|NCT00790842|526765705|FG009|Dose Level 2|Death|0|||
146067047|NCT00790842|526765706|FG010|Dose Level 2|Death|0|||
146067048|NCT00790842|526765696|FG000|Dose Level 2|Physician Decision|0|||
146067049|NCT00790842|526765697|FG001|Dose Level 2|Physician Decision|1|||
146067050|NCT00790842|526765698|FG002|Dose Level 2|Physician Decision|0|||
146067051|NCT00790842|526765699|FG003|Dose Level 2|Physician Decision|0|||
146067052|NCT00790842|526765700|FG004|Dose Level 2|Physician Decision|0|||
146067053|NCT00790842|526765701|FG005|Dose Level 2|Physician Decision|0|||
145890930|NCT01207440|526107574|FG004|Overall Study|Lost to Follow-up|0|||
146067054|NCT00790842|526765702|FG006|Dose Level 2|Physician Decision|0|||
146067055|NCT00790842|526765703|FG007|Dose Level 2|Physician Decision|0|||
146067056|NCT00790842|526765704|FG008|Dose Level 2|Physician Decision|0|||
146067057|NCT00790842|526765705|FG009|Dose Level 2|Physician Decision|0|||
146067058|NCT00790842|526765706|FG010|Dose Level 2|Physician Decision|0|||
146067059|NCT00790842|526765696|FG000|Dose Level 2|Withdrawal by Subject|0|||
146067060|NCT00790842|526765697|FG001|Dose Level 2|Withdrawal by Subject|1|||
146067061|NCT00790842|526765698|FG002|Dose Level 2|Withdrawal by Subject|0|||
146067062|NCT00790842|526765699|FG003|Dose Level 2|Withdrawal by Subject|0|||
146067063|NCT00790842|526765700|FG004|Dose Level 2|Withdrawal by Subject|0|||
146067064|NCT00790842|526765701|FG005|Dose Level 2|Withdrawal by Subject|0|||
146067065|NCT00790842|526765702|FG006|Dose Level 2|Withdrawal by Subject|0|||
146067066|NCT00790842|526765703|FG007|Dose Level 2|Withdrawal by Subject|0|||
146067067|NCT00790842|526765704|FG008|Dose Level 2|Withdrawal by Subject|0|||
146171780|NCT00988221|527143224|FG002|Part III|Insufficient Therapeutic Response|1|||
146171781|NCT00988221|527143225|FG003|Part III|Insufficient Therapeutic Response|0|||
146171782|NCT00988221|527143222|FG000|Part III|Refused Treatment|0|||
146171783|NCT00988221|527143223|FG001|Part III|Refused Treatment|0|||
146067068|NCT00790842|526765705|FG009|Dose Level 2|Withdrawal by Subject|0|||
146067069|NCT00790842|526765706|FG010|Dose Level 2|Withdrawal by Subject|0|||
146067070|NCT00790842|526765696|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067071|NCT00790842|526765697|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067072|NCT00790842|526765698|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067073|NCT00790842|526765699|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067074|NCT00790842|526765700|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067075|NCT00790842|526765701|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067076|NCT00790842|526765702|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067077|NCT00790842|526765703|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067078|NCT00790842|526765704|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
146067079|NCT00790842|526765705|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067080|NCT00790842|526765706|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
146067081|NCT00790842|526765696|FG000|Dose Level 3|Adverse Event|0|||
146067082|NCT00790842|526765697|FG001|Dose Level 3|Adverse Event|0|||
146067083|NCT00790842|526765698|FG002|Dose Level 3|Adverse Event|1|||
146067084|NCT00790842|526765699|FG003|Dose Level 3|Adverse Event|0|||
146067085|NCT00790842|526765700|FG004|Dose Level 3|Adverse Event|0|||
146067086|NCT00790842|526765701|FG005|Dose Level 3|Adverse Event|0|||
146067087|NCT00790842|526765702|FG006|Dose Level 3|Adverse Event|0|||
146067088|NCT00790842|526765703|FG007|Dose Level 3|Adverse Event|0|||
146067089|NCT00790842|526765704|FG008|Dose Level 3|Adverse Event|0|||
146067090|NCT00790842|526765705|FG009|Dose Level 3|Adverse Event|0|||
146067091|NCT00790842|526765706|FG010|Dose Level 3|Adverse Event|0|||
146067092|NCT00790842|526765696|FG000|Dose Level 3|Withdrawal by Subject|0|||
146067093|NCT00790842|526765697|FG001|Dose Level 3|Withdrawal by Subject|0|||
146067094|NCT00790842|526765698|FG002|Dose Level 3|Withdrawal by Subject|3|||
146067095|NCT00790842|526765699|FG003|Dose Level 3|Withdrawal by Subject|0|||
146067096|NCT00790842|526765700|FG004|Dose Level 3|Withdrawal by Subject|0|||
146067097|NCT00790842|526765701|FG005|Dose Level 3|Withdrawal by Subject|0|||
146067098|NCT00790842|526765702|FG006|Dose Level 3|Withdrawal by Subject|0|||
146067099|NCT00790842|526765703|FG007|Dose Level 3|Withdrawal by Subject|0|||
146067100|NCT00790842|526765704|FG008|Dose Level 3|Withdrawal by Subject|0|||
146067101|NCT00790842|526765705|FG009|Dose Level 3|Withdrawal by Subject|2|||
146067102|NCT00790842|526765706|FG010|Dose Level 3|Withdrawal by Subject|0|||
146067103|NCT00790842|526765696|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067104|NCT00790842|526765697|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067105|NCT00790842|526765698|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067106|NCT00790842|526765699|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067107|NCT00790842|526765700|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067108|NCT00790842|526765701|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
146067109|NCT00790842|526765702|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067110|NCT00790842|526765703|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067111|NCT00790842|526765704|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067112|NCT00790842|526765705|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067113|NCT00790842|526765706|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
146067114|NCT00790842|526765696|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067115|NCT00790842|526765697|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067116|NCT00790842|526765698|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
146067117|NCT00790842|526765699|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067118|NCT00790842|526765700|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067119|NCT00790842|526765701|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067120|NCT00790842|526765702|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067121|NCT00790842|526765703|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067122|NCT00790842|526765704|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067123|NCT00790842|526765705|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067124|NCT00790842|526765706|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
146067125|NCT00790842|526765696|FG000|Dose Level 4|Adverse Event|0|||
146171784|NCT00988221|527143224|FG002|Part III|Refused Treatment|1|||
146171785|NCT00988221|527143225|FG003|Part III|Refused Treatment|0|||
146171786|NCT03528174|527143233|FG000|Overall Study|Adverse Event|1|||
146171787|NCT03528174|527143233|FG000|Overall Study|sensors dislodged|1|||
146067126|NCT00790842|526765697|FG001|Dose Level 4|Adverse Event|0|||
146067127|NCT00790842|526765698|FG002|Dose Level 4|Adverse Event|0|||
146067128|NCT00790842|526765699|FG003|Dose Level 4|Adverse Event|0|||
146067129|NCT00790842|526765700|FG004|Dose Level 4|Adverse Event|0|||
146067130|NCT00790842|526765701|FG005|Dose Level 4|Adverse Event|0|||
146067131|NCT00790842|526765702|FG006|Dose Level 4|Adverse Event|1|||
146067132|NCT00790842|526765703|FG007|Dose Level 4|Adverse Event|0|||
146067133|NCT00790842|526765704|FG008|Dose Level 4|Adverse Event|0|||
146171788|NCT03002038|527143234|FG000|Overall Study|Adverse Event|3|||
146171789|NCT03002038|527143235|FG001|Overall Study|Adverse Event|1|||
146067134|NCT00790842|526765705|FG009|Dose Level 4|Adverse Event|0|||
146067135|NCT00790842|526765706|FG010|Dose Level 4|Adverse Event|0|||
146067136|NCT00790842|526765696|FG000|Dose Level 4|Physician Decision|0|||
146067137|NCT00790842|526765697|FG001|Dose Level 4|Physician Decision|0|||
146067138|NCT00790842|526765698|FG002|Dose Level 4|Physician Decision|0|||
146067139|NCT00790842|526765699|FG003|Dose Level 4|Physician Decision|0|||
146067140|NCT00790842|526765700|FG004|Dose Level 4|Physician Decision|0|||
146067141|NCT00790842|526765701|FG005|Dose Level 4|Physician Decision|0|||
146067142|NCT00790842|526765702|FG006|Dose Level 4|Physician Decision|1|||
146067143|NCT00790842|526765703|FG007|Dose Level 4|Physician Decision|0|||
146067144|NCT00790842|526765704|FG008|Dose Level 4|Physician Decision|0|||
146067145|NCT00790842|526765705|FG009|Dose Level 4|Physician Decision|0|||
146067146|NCT00790842|526765706|FG010|Dose Level 4|Physician Decision|1|||
146067147|NCT00790842|526765696|FG000|Dose Level 4|Withdrawal by Subject|0|||
146067148|NCT00790842|526765697|FG001|Dose Level 4|Withdrawal by Subject|0|||
146067149|NCT00790842|526765698|FG002|Dose Level 4|Withdrawal by Subject|0|||
146067150|NCT00790842|526765699|FG003|Dose Level 4|Withdrawal by Subject|0|||
146067151|NCT00790842|526765700|FG004|Dose Level 4|Withdrawal by Subject|0|||
146067152|NCT00790842|526765701|FG005|Dose Level 4|Withdrawal by Subject|0|||
146067153|NCT00790842|526765702|FG006|Dose Level 4|Withdrawal by Subject|0|||
146067154|NCT00790842|526765703|FG007|Dose Level 4|Withdrawal by Subject|0|||
146067155|NCT00790842|526765704|FG008|Dose Level 4|Withdrawal by Subject|0|||
146067156|NCT00790842|526765705|FG009|Dose Level 4|Withdrawal by Subject|0|||
146067157|NCT00790842|526765706|FG010|Dose Level 4|Withdrawal by Subject|1|||
146067158|NCT00790842|526765696|FG000|Expansion Cohort|Adverse Event|0|||
146067159|NCT00790842|526765697|FG001|Expansion Cohort|Adverse Event|0|||
146067160|NCT00790842|526765698|FG002|Expansion Cohort|Adverse Event|0|||
146067161|NCT00790842|526765699|FG003|Expansion Cohort|Adverse Event|0|||
146067162|NCT00790842|526765700|FG004|Expansion Cohort|Adverse Event|0|||
146067163|NCT00790842|526765701|FG005|Expansion Cohort|Adverse Event|0|||
146067164|NCT00790842|526765702|FG006|Expansion Cohort|Adverse Event|1|||
146067165|NCT00790842|526765703|FG007|Expansion Cohort|Adverse Event|0|||
146067166|NCT00790842|526765704|FG008|Expansion Cohort|Adverse Event|0|||
146067167|NCT00790842|526765705|FG009|Expansion Cohort|Adverse Event|0|||
146067168|NCT00790842|526765706|FG010|Expansion Cohort|Adverse Event|0|||
146067169|NCT00790842|526765696|FG000|Expansion Cohort|Death|0|||
146067170|NCT00790842|526765697|FG001|Expansion Cohort|Death|0|||
146067171|NCT00790842|526765698|FG002|Expansion Cohort|Death|2|||
146067172|NCT00790842|526765699|FG003|Expansion Cohort|Death|0|||
146067173|NCT00790842|526765700|FG004|Expansion Cohort|Death|0|||
146067174|NCT00790842|526765701|FG005|Expansion Cohort|Death|0|||
146067175|NCT00790842|526765702|FG006|Expansion Cohort|Death|0|||
146067176|NCT00790842|526765703|FG007|Expansion Cohort|Death|0|||
146067177|NCT00790842|526765704|FG008|Expansion Cohort|Death|0|||
146067178|NCT00790842|526765705|FG009|Expansion Cohort|Death|0|||
146067179|NCT00790842|526765706|FG010|Expansion Cohort|Death|0|||
146067180|NCT00790842|526765696|FG000|Expansion Cohort|Physician Decision|0|||
146067181|NCT00790842|526765697|FG001|Expansion Cohort|Physician Decision|0|||
146067182|NCT00790842|526765698|FG002|Expansion Cohort|Physician Decision|1|||
146067183|NCT00790842|526765699|FG003|Expansion Cohort|Physician Decision|0|||
146067184|NCT00790842|526765700|FG004|Expansion Cohort|Physician Decision|0|||
146067185|NCT00790842|526765701|FG005|Expansion Cohort|Physician Decision|0|||
146067186|NCT00790842|526765702|FG006|Expansion Cohort|Physician Decision|0|||
146067187|NCT00790842|526765703|FG007|Expansion Cohort|Physician Decision|0|||
146067188|NCT00790842|526765704|FG008|Expansion Cohort|Physician Decision|0|||
146067189|NCT00790842|526765705|FG009|Expansion Cohort|Physician Decision|0|||
146067190|NCT00790842|526765706|FG010|Expansion Cohort|Physician Decision|0|||
146067191|NCT00790842|526765696|FG000|Expansion Cohort|Withdrawal by Subject|0|||
146067192|NCT00790842|526765697|FG001|Expansion Cohort|Withdrawal by Subject|0|||
146067193|NCT00790842|526765698|FG002|Expansion Cohort|Withdrawal by Subject|3|||
146067194|NCT00790842|526765699|FG003|Expansion Cohort|Withdrawal by Subject|0|||
146067195|NCT00790842|526765700|FG004|Expansion Cohort|Withdrawal by Subject|0|||
146067196|NCT00790842|526765701|FG005|Expansion Cohort|Withdrawal by Subject|0|||
146067197|NCT00790842|526765702|FG006|Expansion Cohort|Withdrawal by Subject|0|||
146067198|NCT00790842|526765703|FG007|Expansion Cohort|Withdrawal by Subject|0|||
146067199|NCT00790842|526765704|FG008|Expansion Cohort|Withdrawal by Subject|0|||
146067200|NCT00790842|526765705|FG009|Expansion Cohort|Withdrawal by Subject|0|||
146067201|NCT00790842|526765706|FG010|Expansion Cohort|Withdrawal by Subject|0|||
146171790|NCT03002038|527143234|FG000|Overall Study|Withdrawal by Subject|8|||
146067202|NCT00790842|526765696|FG000|Expansion Cohort|Study Closure|0|||
146067203|NCT00790842|526765697|FG001|Expansion Cohort|Study Closure|0|||
146067204|NCT00790842|526765698|FG002|Expansion Cohort|Study Closure|1|||
146067205|NCT00790842|526765699|FG003|Expansion Cohort|Study Closure|0|||
146067206|NCT00790842|526765700|FG004|Expansion Cohort|Study Closure|0|||
146067207|NCT00790842|526765701|FG005|Expansion Cohort|Study Closure|0|||
146067208|NCT00790842|526765702|FG006|Expansion Cohort|Study Closure|0|||
146067209|NCT00790842|526765703|FG007|Expansion Cohort|Study Closure|0|||
146067210|NCT00790842|526765704|FG008|Expansion Cohort|Study Closure|0|||
146067211|NCT00790842|526765705|FG009|Expansion Cohort|Study Closure|0|||
146067212|NCT00790842|526765706|FG010|Expansion Cohort|Study Closure|0|||
146067213|NCT02968004|526765707|FG000|Main Study Phase|Adverse Event|1|||
146171791|NCT03002038|527143235|FG001|Overall Study|Withdrawal by Subject|4|||
146171792|NCT03002038|527143234|FG000|Overall Study|Immigration to another region|0|||
146171793|NCT03002038|527143235|FG001|Overall Study|Immigration to another region|2|||
146171794|NCT00979602|527143244|FG000|Overall Study|Serious Adverse Event|5|||
146171795|NCT00979602|527143245|FG001|Overall Study|Serious Adverse Event|3|||
146171796|NCT00979602|527143244|FG000|Overall Study|Protocol Violation|3|||
146067214|NCT02968004|526765708|FG001|Main Study Phase|Adverse Event|0|||
146067215|NCT02968004|526765707|FG000|Main Study Phase|Withdrawal by Subject|0|||
146067216|NCT02968004|526765708|FG001|Main Study Phase|Withdrawal by Subject|1|||
146067217|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
146067218|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
146067219|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
146067220|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
146067221|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
146067222|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
146067223|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
146067224|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
146067225|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
146067226|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
146067227|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
146067228|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
146067229|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
146067230|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
146067231|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
146067232|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
146067233|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
146067234|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
146067235|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
146067236|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
146067237|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
146067238|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
146067239|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
146067240|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
146067241|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
146067242|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
146067243|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
146067244|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
146067245|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
146067246|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
146067247|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
146067248|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
146067249|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
146067250|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
146067251|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
146067252|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
146067253|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
146067254|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
146067255|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
146067256|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
146067257|NCT02968004|526765707|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
146067258|NCT02968004|526765708|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
146067259|NCT05029362|526765709|FG000|Overall Study|Lost to Follow-up|9|||
146067260|NCT00419952|526765710|FG000|Overall Study|Adverse Event|8|||
146067261|NCT00419952|526765711|FG001|Overall Study|Adverse Event|10|||
146067262|NCT00419952|526765710|FG000|Overall Study|Withdrawal by Subject|44|||
146067263|NCT00419952|526765711|FG001|Overall Study|Withdrawal by Subject|43|||
146067264|NCT00419952|526765710|FG000|Overall Study|Lost to Follow-up|43|||
146067265|NCT00419952|526765711|FG001|Overall Study|Lost to Follow-up|34|||
146067266|NCT00419952|526765710|FG000|Overall Study|Protocol Violation|32|||
146171797|NCT00979602|527143245|FG001|Overall Study|Protocol Violation|0|||
146171798|NCT00979602|527143244|FG000|Overall Study|Withdrawal by Subject|31|||
146171799|NCT00979602|527143245|FG001|Overall Study|Withdrawal by Subject|25|||
146067267|NCT00419952|526765711|FG001|Overall Study|Protocol Violation|24|||
146067268|NCT00419952|526765710|FG000|Overall Study|Pregnancy|4|||
146067269|NCT00419952|526765711|FG001|Overall Study|Pregnancy|2|||
146067270|NCT00419952|526765710|FG000|Overall Study|Physician Decision|1|||
146171800|NCT00979602|527143244|FG000|Overall Study|Lost to Follow-up|100|||
146171801|NCT00979602|527143245|FG001|Overall Study|Lost to Follow-up|96|||
146171802|NCT00979602|527143244|FG000|Overall Study|Migrated/moved from study area|3|||
146408160|NCT00886782|528000109|FG001|Overall Study|Study drug toxicity|0|||
146067271|NCT00419952|526765711|FG001|Overall Study|Physician Decision|3|||
146171803|NCT00979602|527143245|FG001|Overall Study|Migrated/moved from study area|6|||
146171804|NCT00979602|527143244|FG000|Overall Study|Others|3|||
146067272|NCT00419952|526765710|FG000|Overall Study|Incorrectly enrolled|10|||
146067273|NCT00419952|526765711|FG001|Overall Study|Incorrectly enrolled|3|||
146067274|NCT00419952|526765710|FG000|Overall Study|Intake of prohibited medication|2|||
146067275|NCT00419952|526765711|FG001|Overall Study|Intake of prohibited medication|2|||
146067276|NCT00419952|526765710|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
146067277|NCT00419952|526765711|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
146067278|NCT00419952|526765710|FG000|Overall Study|Diary or medication non-compliance|2|||
146067279|NCT00419952|526765711|FG001|Overall Study|Diary or medication non-compliance|4|||
146067280|NCT00419952|526765710|FG000|Overall Study|Abnormal ECG|1|||
146067281|NCT00419952|526765711|FG001|Overall Study|Abnormal ECG|0|||
146067282|NCT03126591|526765712|FG000|Overall Study|Death|6|||
146067283|NCT03126591|526765713|FG001|Overall Study|Death|3|||
146067284|NCT03126591|526765714|FG002|Overall Study|Death|17|||
146067285|NCT03126591|526765712|FG000|Overall Study|Progressive Disease|0|||
146067286|NCT03126591|526765713|FG001|Overall Study|Progressive Disease|1|||
146067287|NCT03126591|526765714|FG002|Overall Study|Progressive Disease|2|||
146067288|NCT03126591|526765712|FG000|Overall Study|Terminated by Sponsor|0|||
146067289|NCT03126591|526765713|FG001|Overall Study|Terminated by Sponsor|1|||
146067290|NCT03126591|526765714|FG002|Overall Study|Terminated by Sponsor|4|||
146067291|NCT03126591|526765712|FG000|Overall Study|Withdrawal by Subject|1|||
146067292|NCT03126591|526765713|FG001|Overall Study|Withdrawal by Subject|1|||
146067293|NCT03126591|526765714|FG002|Overall Study|Withdrawal by Subject|4|||
146067294|NCT02158546|526765721|FG000|Overall Study|Physician Decision|0|||
146067295|NCT02158546|526765722|FG001|Overall Study|Physician Decision|1|||
146067296|NCT02158546|526765723|FG002|Overall Study|Physician Decision|0|||
146067297|NCT02158546|526765724|FG003|Overall Study|Physician Decision|0|||
146067298|NCT02158546|526765721|FG000|Overall Study|Non-compliance|0|||
146067299|NCT02158546|526765722|FG001|Overall Study|Non-compliance|1|||
146067300|NCT02158546|526765723|FG002|Overall Study|Non-compliance|0|||
146067301|NCT02158546|526765724|FG003|Overall Study|Non-compliance|1|||
146067302|NCT02158546|526765721|FG000|Overall Study|Failure to meet eligibility criteria|0|||
146067303|NCT02158546|526765722|FG001|Overall Study|Failure to meet eligibility criteria|1|||
146067304|NCT02158546|526765723|FG002|Overall Study|Failure to meet eligibility criteria|0|||
146067305|NCT02158546|526765724|FG003|Overall Study|Failure to meet eligibility criteria|0|||
146067306|NCT02158546|526765721|FG000|Overall Study|Lack of Efficacy|1|||
146067307|NCT02158546|526765722|FG001|Overall Study|Lack of Efficacy|1|||
145890931|NCT01207440|526107575|FG005|Overall Study|Lost to Follow-up|0|||
146067308|NCT02158546|526765723|FG002|Overall Study|Lack of Efficacy|0|||
146067309|NCT02158546|526765724|FG003|Overall Study|Lack of Efficacy|0|||
146067310|NCT02158546|526765721|FG000|Overall Study|Adverse Event|2|||
146067311|NCT02158546|526765722|FG001|Overall Study|Adverse Event|2|||
146067312|NCT02158546|526765723|FG002|Overall Study|Adverse Event|0|||
146067313|NCT02158546|526765724|FG003|Overall Study|Adverse Event|0|||
146067314|NCT02158546|526765721|FG000|Overall Study|Withdrawal by Subject|6|||
146067315|NCT02158546|526765722|FG001|Overall Study|Withdrawal by Subject|2|||
146067316|NCT02158546|526765723|FG002|Overall Study|Withdrawal by Subject|1|||
146067317|NCT02158546|526765724|FG003|Overall Study|Withdrawal by Subject|0|||
146067318|NCT02158546|526765721|FG000|Overall Study|Lost to Follow-up|5|||
146067319|NCT02158546|526765722|FG001|Overall Study|Lost to Follow-up|4|||
146067320|NCT02158546|526765723|FG002|Overall Study|Lost to Follow-up|0|||
146067321|NCT02158546|526765724|FG003|Overall Study|Lost to Follow-up|1|||
146067322|NCT02158546|526765721|FG000|Overall Study|Site Excluded|5|||
146067323|NCT02158546|526765722|FG001|Overall Study|Site Excluded|5|||
146067324|NCT02158546|526765723|FG002|Overall Study|Site Excluded|3|||
146171805|NCT00979602|527143245|FG001|Overall Study|Others|3|||
146171806|NCT02904902|527143246|FG000|Overall Study|Withdrawal by Subject|1|||
146067325|NCT02158546|526765724|FG003|Overall Study|Site Excluded|4|||
146067326|NCT02351817|526765725|FG000|Period 1|Adverse Event|1|||
146067327|NCT02351817|526765726|FG001|Period 1|Adverse Event|2|||
146067328|NCT02351817|526765725|FG000|Period 1|Lack of Efficacy|0|||
146067329|NCT02351817|526765726|FG001|Period 1|Lack of Efficacy|1|||
146067330|NCT02351817|526765725|FG000|Period 2|Adverse Event|0|||
146067331|NCT02351817|526765726|FG001|Period 2|Adverse Event|2|||
146067332|NCT02351817|526765725|FG000|Period 2|Protocol Violation|1|||
146067333|NCT02351817|526765726|FG001|Period 2|Protocol Violation|0|||
146067334|NCT02488915|526765729|FG000|Overall Study|Death|21|||
146067335|NCT02488915|526765729|FG000|Overall Study|Lost to Follow-up|4|||
146067336|NCT02488915|526765729|FG000|Overall Study|Withdrawal by Subject|1|||
146171807|NCT02712398|527143250|FG000|Overall Study|Withdrawal by Subject|6|||
146067337|NCT00885170|526765732|FG000|Overall Study|Adverse Event|12|||
146067338|NCT00885170|526765733|FG001|Overall Study|Adverse Event|4|||
146067339|NCT00885170|526765732|FG000|Overall Study|Excessive bone loss|6|||
146067340|NCT00885170|526765733|FG001|Overall Study|Excessive bone loss|3|||
146067341|NCT00885170|526765732|FG000|Overall Study|Lost to Follow-up|2|||
146067342|NCT00885170|526765733|FG001|Overall Study|Lost to Follow-up|1|||
146067343|NCT00885170|526765732|FG000|Overall Study|Physician Decision|2|||
146067344|NCT00885170|526765733|FG001|Overall Study|Physician Decision|1|||
146067345|NCT00885170|526765732|FG000|Overall Study|Protocol Violation|3|||
146067346|NCT00885170|526765733|FG001|Overall Study|Protocol Violation|1|||
146067347|NCT00885170|526765732|FG000|Overall Study|Withdrawal by Subject|13|||
146067348|NCT00885170|526765733|FG001|Overall Study|Withdrawal by Subject|13|||
146067349|NCT03771664|526765734|FG000|Overall Study|Adverse Event|1|||
146067350|NCT03771664|526765735|FG001|Overall Study|Adverse Event|0|||
146067351|NCT03771664|526765734|FG000|Overall Study|Lost to Follow-up|1|||
146067352|NCT03771664|526765735|FG001|Overall Study|Lost to Follow-up|0|||
146067353|NCT03771664|526765734|FG000|Overall Study|Withdrawal by Participant|1|||
146067354|NCT03771664|526765735|FG001|Overall Study|Withdrawal by Participant|4|||
146067355|NCT03771664|526765734|FG000|Overall Study|Randomized but not Treated|0|||
146067356|NCT03771664|526765735|FG001|Overall Study|Randomized but not Treated|1|||
146067357|NCT01208207|526765738|FG000|Part I|Adverse Event|19|||
146067358|NCT01208207|526765739|FG001|Part I|Adverse Event|2|||
146067359|NCT01208207|526765740|FG002|Part I|Adverse Event|6|||
146067360|NCT01208207|526765741|FG003|Part I|Adverse Event|0|||
146067361|NCT01208207|526765742|FG004|Part I|Adverse Event|0|||
146067362|NCT01208207|526765743|FG005|Part I|Adverse Event|0|||
146067363|NCT01208207|526765744|FG006|Part I|Adverse Event|0|||
146171808|NCT02712398|527143250|FG000|Overall Study|Lost to Follow-up|6|||
146408161|NCT00886782|528000110|FG002|Overall Study|Study drug toxicity|1|||
146408162|NCT00886782|528000108|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
146408163|NCT00886782|528000109|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
146408164|NCT00886782|528000110|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
146408165|NCT01255722|528000111|FG000|Overall Study|Adverse Event|0|||
146408166|NCT01255722|528000112|FG001|Overall Study|Adverse Event|1|||
146408167|NCT01255722|528000113|FG002|Overall Study|Adverse Event|1|||
146408168|NCT01255722|528000111|FG000|Overall Study|asymptomatic patient|1|||
146408169|NCT01255722|528000112|FG001|Overall Study|asymptomatic patient|0|||
146408170|NCT01255722|528000113|FG002|Overall Study|asymptomatic patient|0|||
146408171|NCT01255722|528000111|FG000|Overall Study|beta-blocker contraindicated|2|||
146408172|NCT01255722|528000112|FG001|Overall Study|beta-blocker contraindicated|0|||
146408173|NCT01255722|528000113|FG002|Overall Study|beta-blocker contraindicated|0|||
146408174|NCT03835975|528000116|FG000|Overall Study|Lost to Follow-up|1|||
146067364|NCT01208207|526765738|FG000|Part I|Lack of Efficacy|21|||
146171809|NCT02712398|527143250|FG000|Overall Study|Sponsor Decision|1|||
146171810|NCT02712398|527143250|FG000|Overall Study|Physician Decision|1|||
146171811|NCT02712398|527143250|FG000|Overall Study|Death|2|||
146171812|NCT02712398|527143250|FG000|Overall Study|Re-operation|21|||
146171813|NCT02002182|527143260|FG000|Overall Study|Withdraw from study|3|||
146171814|NCT02002182|527143261|FG001|Overall Study|Withdraw from study|1|||
146171815|NCT02002182|527143260|FG000|Overall Study|Health Reasons|1|||
146171816|NCT02002182|527143261|FG001|Overall Study|Health Reasons|0|||
146171817|NCT02002182|527143260|FG000|Overall Study|Death|1|||
146171818|NCT02002182|527143261|FG001|Overall Study|Death|0|||
146171819|NCT03787680|527143263|FG000|Overall Study|Physician Decision|2|||
146171820|NCT03787680|527143264|FG001|Overall Study|Physician Decision|3|||
146171821|NCT03787680|527143263|FG000|Overall Study|Adverse Event|7|||
146171822|NCT03787680|527143264|FG001|Overall Study|Adverse Event|3|||
146171823|NCT03787680|527143263|FG000|Overall Study|Withdrawal by Subject|2|||
146171824|NCT03787680|527143264|FG001|Overall Study|Withdrawal by Subject|1|||
146171825|NCT05400746|527143265|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
146171826|NCT05400746|527143266|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
146171827|NCT05400746|527143267|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
146171828|NCT03724396|527143268|FG000|Overall Study|Lost to Follow-up|1|||
146408175|NCT03835975|528000117|FG001|Overall Study|Lost to Follow-up|1|||
146067365|NCT01208207|526765739|FG001|Part I|Lack of Efficacy|3|||
146067366|NCT01208207|526765740|FG002|Part I|Lack of Efficacy|2|||
146171829|NCT03724396|527143269|FG001|Overall Study|Lost to Follow-up|1|||
146171830|NCT03724396|527143268|FG000|Overall Study|Withdrawal by Subject|1|||
146171831|NCT03724396|527143269|FG001|Overall Study|Withdrawal by Subject|0|||
146171832|NCT01490125|527143270|FG000|Period I|Adverse Event|4|||
146171833|NCT01490125|527143271|FG001|Period I|Adverse Event|1|||
146067367|NCT01208207|526765741|FG003|Part I|Lack of Efficacy|0|||
146067368|NCT01208207|526765742|FG004|Part I|Lack of Efficacy|0|||
146067369|NCT01208207|526765743|FG005|Part I|Lack of Efficacy|0|||
146067370|NCT01208207|526765744|FG006|Part I|Lack of Efficacy|0|||
146067371|NCT01208207|526765738|FG000|Part I|Lost to Follow-up|6|||
146067372|NCT01208207|526765739|FG001|Part I|Lost to Follow-up|1|||
146067373|NCT01208207|526765740|FG002|Part I|Lost to Follow-up|0|||
146067374|NCT01208207|526765741|FG003|Part I|Lost to Follow-up|0|||
146067375|NCT01208207|526765742|FG004|Part I|Lost to Follow-up|0|||
146067376|NCT01208207|526765743|FG005|Part I|Lost to Follow-up|0|||
146067377|NCT01208207|526765744|FG006|Part I|Lost to Follow-up|0|||
146067378|NCT01208207|526765738|FG000|Part I|Non-Compliance With Study Drug|1|||
146067379|NCT01208207|526765739|FG001|Part I|Non-Compliance With Study Drug|0|||
146067380|NCT01208207|526765740|FG002|Part I|Non-Compliance With Study Drug|1|||
146067381|NCT01208207|526765741|FG003|Part I|Non-Compliance With Study Drug|0|||
146067382|NCT01208207|526765742|FG004|Part I|Non-Compliance With Study Drug|0|||
146067383|NCT01208207|526765743|FG005|Part I|Non-Compliance With Study Drug|0|||
146067384|NCT01208207|526765744|FG006|Part I|Non-Compliance With Study Drug|0|||
146067385|NCT01208207|526765738|FG000|Part I|Physician Decision|0|||
146067386|NCT01208207|526765739|FG001|Part I|Physician Decision|1|||
146067387|NCT01208207|526765740|FG002|Part I|Physician Decision|0|||
146067388|NCT01208207|526765741|FG003|Part I|Physician Decision|0|||
146067389|NCT01208207|526765742|FG004|Part I|Physician Decision|0|||
146067390|NCT01208207|526765743|FG005|Part I|Physician Decision|0|||
146067391|NCT01208207|526765744|FG006|Part I|Physician Decision|0|||
146067392|NCT01208207|526765738|FG000|Part I|Progressive Disease|1|||
146067393|NCT01208207|526765739|FG001|Part I|Progressive Disease|0|||
146067394|NCT01208207|526765740|FG002|Part I|Progressive Disease|0|||
146067395|NCT01208207|526765741|FG003|Part I|Progressive Disease|0|||
146067396|NCT01208207|526765742|FG004|Part I|Progressive Disease|0|||
146067397|NCT01208207|526765743|FG005|Part I|Progressive Disease|0|||
146067398|NCT01208207|526765744|FG006|Part I|Progressive Disease|0|||
146067399|NCT01208207|526765738|FG000|Part I|Protocol Violation|8|||
146067400|NCT01208207|526765739|FG001|Part I|Protocol Violation|0|||
146067401|NCT01208207|526765740|FG002|Part I|Protocol Violation|2|||
146067402|NCT01208207|526765741|FG003|Part I|Protocol Violation|0|||
146067403|NCT01208207|526765742|FG004|Part I|Protocol Violation|0|||
146067404|NCT01208207|526765743|FG005|Part I|Protocol Violation|0|||
146067405|NCT01208207|526765744|FG006|Part I|Protocol Violation|0|||
146067406|NCT01208207|526765738|FG000|Part I|Withdrawal by Subject|14|||
146067407|NCT01208207|526765739|FG001|Part I|Withdrawal by Subject|4|||
146067408|NCT01208207|526765740|FG002|Part I|Withdrawal by Subject|4|||
146067409|NCT01208207|526765741|FG003|Part I|Withdrawal by Subject|0|||
146067410|NCT01208207|526765742|FG004|Part I|Withdrawal by Subject|0|||
146067411|NCT01208207|526765743|FG005|Part I|Withdrawal by Subject|0|||
146067412|NCT01208207|526765744|FG006|Part I|Withdrawal by Subject|0|||
146067413|NCT01208207|526765738|FG000|Part II|Withdrawal by Subject|0|||
146067414|NCT01208207|526765739|FG001|Part II|Withdrawal by Subject|0|||
146067415|NCT01208207|526765740|FG002|Part II|Withdrawal by Subject|0|||
146067416|NCT01208207|526765741|FG003|Part II|Withdrawal by Subject|10|||
146067417|NCT01208207|526765742|FG004|Part II|Withdrawal by Subject|9|||
146067418|NCT01208207|526765743|FG005|Part II|Withdrawal by Subject|3|||
146067419|NCT01208207|526765744|FG006|Part II|Withdrawal by Subject|5|||
146067420|NCT01208207|526765738|FG000|Part II|Adverse Event|0|||
146067421|NCT01208207|526765739|FG001|Part II|Adverse Event|0|||
146067422|NCT01208207|526765740|FG002|Part II|Adverse Event|0|||
146067423|NCT01208207|526765741|FG003|Part II|Adverse Event|5|||
146067424|NCT01208207|526765742|FG004|Part II|Adverse Event|9|||
146067425|NCT01208207|526765743|FG005|Part II|Adverse Event|4|||
146067426|NCT01208207|526765744|FG006|Part II|Adverse Event|2|||
146067427|NCT01208207|526765738|FG000|Part II|Lack of Efficacy|0|||
146067428|NCT01208207|526765739|FG001|Part II|Lack of Efficacy|0|||
146067429|NCT01208207|526765740|FG002|Part II|Lack of Efficacy|0|||
146067430|NCT01208207|526765741|FG003|Part II|Lack of Efficacy|6|||
146067431|NCT01208207|526765742|FG004|Part II|Lack of Efficacy|4|||
146067432|NCT01208207|526765743|FG005|Part II|Lack of Efficacy|3|||
146067433|NCT01208207|526765744|FG006|Part II|Lack of Efficacy|3|||
146067434|NCT01208207|526765738|FG000|Part II|Lost to Follow-up|0|||
146067435|NCT01208207|526765739|FG001|Part II|Lost to Follow-up|0|||
146067436|NCT01208207|526765740|FG002|Part II|Lost to Follow-up|0|||
146067437|NCT01208207|526765741|FG003|Part II|Lost to Follow-up|4|||
146067438|NCT01208207|526765742|FG004|Part II|Lost to Follow-up|0|||
146067439|NCT01208207|526765743|FG005|Part II|Lost to Follow-up|2|||
146067440|NCT01208207|526765744|FG006|Part II|Lost to Follow-up|1|||
146067441|NCT01208207|526765738|FG000|Part II|Non-Compliance With Study Drug|0|||
146067442|NCT01208207|526765739|FG001|Part II|Non-Compliance With Study Drug|0|||
146067443|NCT01208207|526765740|FG002|Part II|Non-Compliance With Study Drug|0|||
146067444|NCT01208207|526765741|FG003|Part II|Non-Compliance With Study Drug|4|||
146067445|NCT01208207|526765742|FG004|Part II|Non-Compliance With Study Drug|1|||
146067446|NCT01208207|526765743|FG005|Part II|Non-Compliance With Study Drug|1|||
146067447|NCT01208207|526765744|FG006|Part II|Non-Compliance With Study Drug|0|||
146067448|NCT01208207|526765738|FG000|Part II|Physician Decision|0|||
146171834|NCT01490125|527143272|FG002|Period I|Adverse Event|1|||
146067449|NCT01208207|526765739|FG001|Part II|Physician Decision|0|||
146067450|NCT01208207|526765740|FG002|Part II|Physician Decision|0|||
146067451|NCT01208207|526765741|FG003|Part II|Physician Decision|1|||
146067452|NCT01208207|526765742|FG004|Part II|Physician Decision|0|||
146067453|NCT01208207|526765743|FG005|Part II|Physician Decision|2|||
146067454|NCT01208207|526765744|FG006|Part II|Physician Decision|0|||
146067455|NCT01208207|526765738|FG000|Part II|Protocol Violation|0|||
146067456|NCT01208207|526765739|FG001|Part II|Protocol Violation|0|||
146067457|NCT01208207|526765740|FG002|Part II|Protocol Violation|0|||
146067458|NCT01208207|526765741|FG003|Part II|Protocol Violation|1|||
146067459|NCT01208207|526765742|FG004|Part II|Protocol Violation|0|||
146067460|NCT01208207|526765743|FG005|Part II|Protocol Violation|0|||
146067461|NCT01208207|526765744|FG006|Part II|Protocol Violation|0|||
146067462|NCT01208207|526765738|FG000|Part II|Technical Problems|0|||
146067463|NCT01208207|526765739|FG001|Part II|Technical Problems|0|||
146067464|NCT01208207|526765740|FG002|Part II|Technical Problems|0|||
146067465|NCT01208207|526765741|FG003|Part II|Technical Problems|1|||
146067466|NCT01208207|526765742|FG004|Part II|Technical Problems|0|||
146067467|NCT01208207|526765743|FG005|Part II|Technical Problems|1|||
146067468|NCT01208207|526765744|FG006|Part II|Technical Problems|0|||
146067469|NCT04041414|526765747|FG000|Overall Study|Lost to Follow-up|1|||
146067470|NCT04041414|526765748|FG001|Overall Study|Lost to Follow-up|2|||
146067471|NCT00665652|526765749|FG000|Overall Study|Adverse Event|4|||
146067472|NCT00665652|526765749|FG000|Overall Study|Death|1|||
146067473|NCT00665652|526765749|FG000|Overall Study|No longer met inclusion criteria.|1|||
146067474|NCT02161016|526765750|FG000|Overall Study|withdrawn by IRB|1|||
146067475|NCT00380367|526765766|FG000|Overall Study|Lost to Follow-up|1|||
146067476|NCT00380367|526765766|FG000|Overall Study|Withdrawal by Subject|1|||
146067477|NCT01605799|526765767|FG000|Overall Study|Withdrawal by Subject|2|||
146067478|NCT01605799|526765768|FG001|Overall Study|Withdrawal by Subject|1|||
146067479|NCT00830440|526765779|FG000|Overall Study|Protocol Violation|1|||
146067480|NCT00830440|526765780|FG001|Overall Study|Protocol Violation|0|||
146067481|NCT00830440|526765779|FG000|Overall Study|Withdrawal by Subject|1|||
146067482|NCT00830440|526765780|FG001|Overall Study|Withdrawal by Subject|0|||
146067483|NCT00830440|526765779|FG000|Overall Study|unsuccessful procedure|4|||
146067484|NCT00830440|526765780|FG001|Overall Study|unsuccessful procedure|0|||
146067485|NCT00830440|526765779|FG000|Overall Study|Adverse Event|2|||
146067486|NCT00830440|526765780|FG001|Overall Study|Adverse Event|0|||
146067487|NCT02592798|526765781|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
146067488|NCT02592798|526765782|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
146067489|NCT02592798|526765781|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
146067490|NCT02592798|526765782|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
146067491|NCT02592798|526765781|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
146067492|NCT02592798|526765782|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
146067493|NCT02592798|526765781|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
146067494|NCT02592798|526765782|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
146067495|NCT02592798|526765781|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
146067496|NCT02592798|526765782|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
146067497|NCT02592798|526765781|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
146067498|NCT02592798|526765782|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
146067499|NCT02592798|526765781|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
146067500|NCT02592798|526765782|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
146067501|NCT02592798|526765781|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
146067502|NCT02592798|526765782|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
146067503|NCT02592798|526765781|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
146067504|NCT02592798|526765782|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
146067505|NCT02592798|526765781|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
146067506|NCT02592798|526765782|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
146067507|NCT02592798|526765781|FG000|Transition From DB2 to OLE|Other reasons|1|||
146067508|NCT02592798|526765782|FG001|Transition From DB2 to OLE|Other reasons|0|||
146067509|NCT02592798|526765781|FG000|Open Label Period (OLE)|Other reasons|0|||
146067510|NCT02592798|526765782|FG001|Open Label Period (OLE)|Other reasons|2|||
146067511|NCT02592798|526765781|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
146067512|NCT02592798|526765782|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
146067513|NCT02592798|526765781|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
146067514|NCT02592798|526765782|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
146067515|NCT02592798|526765781|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
146067516|NCT02592798|526765782|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
146067517|NCT02592798|526765781|FG000|Open Label Period (OLE)|Adverse Event|0|||
146067518|NCT02592798|526765782|FG001|Open Label Period (OLE)|Adverse Event|1|||
146067519|NCT00942604|526765783|FG000|Overall Study|Protocol Violation|1|||
146067520|NCT00942604|526765784|FG001|Overall Study|Protocol Violation|1|||
146067521|NCT00942604|526765783|FG000|Overall Study|Adverse Event|0|||
146067522|NCT00942604|526765784|FG001|Overall Study|Adverse Event|1|||
146067523|NCT00942604|526765783|FG000|Overall Study|Withdrawal by Subject|0|||
146067524|NCT00942604|526765784|FG001|Overall Study|Withdrawal by Subject|1|||
146067525|NCT00942604|526765783|FG000|Overall Study|Patient relocation|1|||
146067526|NCT00942604|526765784|FG001|Overall Study|Patient relocation|1|||
146067527|NCT01143246|526765785|FG000|Overall Study|Adverse Event|24|||
146067528|NCT01143246|526765786|FG001|Overall Study|Adverse Event|28|||
146067529|NCT01143246|526765785|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
146067530|NCT01143246|526765786|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
146067531|NCT01143246|526765785|FG000|Overall Study|Lost to Follow-up|0|||
146067532|NCT01143246|526765786|FG001|Overall Study|Lost to Follow-up|1|||
146067533|NCT01143246|526765785|FG000|Overall Study|Death|16|||
146067534|NCT01143246|526765786|FG001|Overall Study|Death|15|||
146067535|NCT01143246|526765785|FG000|Overall Study|Reason not Specified|3|||
146067536|NCT01143246|526765786|FG001|Overall Study|Reason not Specified|5|||
146067537|NCT03987503|526765788|FG000|Overall Study|Lost to Follow-up|20|||
146067538|NCT03987503|526765788|FG000|Overall Study|Withdrawal by Subject|2|||
146067539|NCT03486834|526765790|FG000|Overall Study|Withdrawal by Subject|46|||
146067540|NCT03486834|526765791|FG001|Overall Study|Withdrawal by Subject|46|||
146067541|NCT03486834|526765792|FG002|Overall Study|Withdrawal by Subject|52|||
146067542|NCT03486834|526765790|FG000|Overall Study|Adverse Event|8|||
146067543|NCT03486834|526765791|FG001|Overall Study|Adverse Event|7|||
146067544|NCT03486834|526765792|FG002|Overall Study|Adverse Event|0|||
146067545|NCT03486834|526765790|FG000|Overall Study|Lost to Follow-up|41|||
146067546|NCT03486834|526765791|FG001|Overall Study|Lost to Follow-up|24|||
146067547|NCT03486834|526765792|FG002|Overall Study|Lost to Follow-up|39|||
146067548|NCT03486834|526765790|FG000|Overall Study|Non-compliance with Study Drug|2|||
146067549|NCT03486834|526765791|FG001|Overall Study|Non-compliance with Study Drug|2|||
146067550|NCT03486834|526765792|FG002|Overall Study|Non-compliance with Study Drug|0|||
146067551|NCT03486834|526765790|FG000|Overall Study|Physician Decision|5|||
146067552|NCT03486834|526765791|FG001|Overall Study|Physician Decision|2|||
146067553|NCT03486834|526765792|FG002|Overall Study|Physician Decision|3|||
146067554|NCT03486834|526765790|FG000|Overall Study|Pregnancy|10|||
146067555|NCT03486834|526765791|FG001|Overall Study|Pregnancy|12|||
146067556|NCT03486834|526765792|FG002|Overall Study|Pregnancy|12|||
146067557|NCT03486834|526765790|FG000|Overall Study|Protocol Deviation|2|||
146067558|NCT03486834|526765791|FG001|Overall Study|Protocol Deviation|3|||
146067559|NCT03486834|526765792|FG002|Overall Study|Protocol Deviation|3|||
146067560|NCT03486834|526765790|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146067561|NCT03486834|526765791|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146067562|NCT03486834|526765792|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146067563|NCT03486834|526765790|FG000|Overall Study|Randomized but not treated|4|||
146067564|NCT03486834|526765791|FG001|Overall Study|Randomized but not treated|4|||
146067565|NCT03486834|526765792|FG002|Overall Study|Randomized but not treated|1|||
146067566|NCT02745119|526765794|FG000|Overall Study|Adverse Event|1|||
146067567|NCT02745119|526765795|FG001|Overall Study|Adverse Event|0|||
146067568|NCT02745119|526765796|FG002|Overall Study|Adverse Event|1|||
146067569|NCT02745119|526765797|FG003|Overall Study|Adverse Event|3|||
146067570|NCT02745119|526765794|FG000|Overall Study|Death|3|||
146067571|NCT02745119|526765795|FG001|Overall Study|Death|3|||
146067572|NCT02745119|526765796|FG002|Overall Study|Death|0|||
146067573|NCT02745119|526765797|FG003|Overall Study|Death|4|||
146067574|NCT02745119|526765794|FG000|Overall Study|Lost to Follow-up|0|||
146067575|NCT02745119|526765795|FG001|Overall Study|Lost to Follow-up|0|||
146067576|NCT02745119|526765796|FG002|Overall Study|Lost to Follow-up|0|||
146067577|NCT02745119|526765797|FG003|Overall Study|Lost to Follow-up|1|||
146067578|NCT02745119|526765794|FG000|Overall Study|Protocol Deviation|0|||
146067579|NCT02745119|526765795|FG001|Overall Study|Protocol Deviation|0|||
146067580|NCT02745119|526765796|FG002|Overall Study|Protocol Deviation|0|||
146067581|NCT02745119|526765797|FG003|Overall Study|Protocol Deviation|1|||
146067582|NCT02745119|526765794|FG000|Overall Study|Withdrawal by Subject|7|||
146067583|NCT02745119|526765795|FG001|Overall Study|Withdrawal by Subject|15|||
146067584|NCT02745119|526765796|FG002|Overall Study|Withdrawal by Subject|8|||
146067585|NCT02745119|526765797|FG003|Overall Study|Withdrawal by Subject|14|||
146067586|NCT02745119|526765794|FG000|Overall Study|Study Terminated by Sponsor|134|||
146067587|NCT02745119|526765795|FG001|Overall Study|Study Terminated by Sponsor|252|||
146067588|NCT02745119|526765796|FG002|Overall Study|Study Terminated by Sponsor|135|||
146067589|NCT02745119|526765797|FG003|Overall Study|Study Terminated by Sponsor|251|||
146067590|NCT02745119|526765794|FG000|Overall Study|Physician Decision|0|||
146067591|NCT02745119|526765795|FG001|Overall Study|Physician Decision|2|||
146067592|NCT02745119|526765796|FG002|Overall Study|Physician Decision|2|||
146067593|NCT02745119|526765797|FG003|Overall Study|Physician Decision|2|||
146067594|NCT02745119|526765794|FG000|Overall Study|Reason Not Specified|0|||
146067595|NCT02745119|526765795|FG001|Overall Study|Reason Not Specified|2|||
146067596|NCT02745119|526765796|FG002|Overall Study|Reason Not Specified|0|||
146067597|NCT02745119|526765797|FG003|Overall Study|Reason Not Specified|1|||
146067598|NCT00687193|526765801|FG000|Overall Study|Adverse Event|0|||
146067599|NCT00687193|526765802|FG001|Overall Study|Adverse Event|1|||
146067600|NCT00687193|526765803|FG002|Overall Study|Adverse Event|2|||
146067601|NCT00687193|526765804|FG003|Overall Study|Adverse Event|3|||
146067602|NCT00687193|526765805|FG004|Overall Study|Adverse Event|0|||
146067603|NCT00687193|526765806|FG005|Overall Study|Adverse Event|2|||
146067604|NCT00687193|526765801|FG000|Overall Study|Lack of Efficacy|1|||
146067605|NCT00687193|526765802|FG001|Overall Study|Lack of Efficacy|1|||
146067606|NCT00687193|526765803|FG002|Overall Study|Lack of Efficacy|0|||
146067607|NCT00687193|526765804|FG003|Overall Study|Lack of Efficacy|0|||
146067608|NCT00687193|526765805|FG004|Overall Study|Lack of Efficacy|0|||
146067609|NCT00687193|526765806|FG005|Overall Study|Lack of Efficacy|2|||
146067610|NCT00687193|526765801|FG000|Overall Study|Protocol Violation|1|||
146067611|NCT00687193|526765802|FG001|Overall Study|Protocol Violation|2|||
146067612|NCT00687193|526765803|FG002|Overall Study|Protocol Violation|0|||
146067613|NCT00687193|526765804|FG003|Overall Study|Protocol Violation|1|||
146171835|NCT01490125|527143273|FG003|Period I|Adverse Event|3|||
146171836|NCT01490125|527143274|FG004|Period I|Adverse Event|2|||
146171837|NCT01490125|527143275|FG005|Period I|Adverse Event|4|||
146171838|NCT01490125|527143270|FG000|Period I|Protocol Violation|1|||
146171839|NCT01490125|527143271|FG001|Period I|Protocol Violation|1|||
146171840|NCT01490125|527143272|FG002|Period I|Protocol Violation|1|||
146171841|NCT01490125|527143273|FG003|Period I|Protocol Violation|1|||
146171842|NCT01490125|527143274|FG004|Period I|Protocol Violation|0|||
146171843|NCT01490125|527143275|FG005|Period I|Protocol Violation|0|||
146171844|NCT01490125|527143270|FG000|Period I|Withdrawal by Subject|1|||
146171845|NCT01490125|527143271|FG001|Period I|Withdrawal by Subject|3|||
146171846|NCT01490125|527143272|FG002|Period I|Withdrawal by Subject|2|||
146171847|NCT01490125|527143273|FG003|Period I|Withdrawal by Subject|1|||
146171848|NCT01490125|527143274|FG004|Period I|Withdrawal by Subject|2|||
146171849|NCT01490125|527143275|FG005|Period I|Withdrawal by Subject|1|||
146171850|NCT01490125|527143270|FG000|Period II|Adverse Event|2|||
146171851|NCT01490125|527143271|FG001|Period II|Adverse Event|3|||
146171852|NCT01490125|527143272|FG002|Period II|Adverse Event|2|||
146171853|NCT01490125|527143273|FG003|Period II|Adverse Event|2|||
146171854|NCT01490125|527143274|FG004|Period II|Adverse Event|4|||
146171855|NCT01490125|527143275|FG005|Period II|Adverse Event|2|||
146171856|NCT01490125|527143270|FG000|Period II|Protocol Violation|0|||
146171857|NCT01490125|527143271|FG001|Period II|Protocol Violation|0|||
146171858|NCT01490125|527143272|FG002|Period II|Protocol Violation|1|||
146171859|NCT01490125|527143273|FG003|Period II|Protocol Violation|1|||
146171860|NCT01490125|527143274|FG004|Period II|Protocol Violation|0|||
146171861|NCT01490125|527143275|FG005|Period II|Protocol Violation|0|||
146171862|NCT01490125|527143270|FG000|Period II|Lost to Follow-up|0|||
146171863|NCT01490125|527143271|FG001|Period II|Lost to Follow-up|1|||
146171864|NCT01490125|527143272|FG002|Period II|Lost to Follow-up|0|||
146171865|NCT01490125|527143273|FG003|Period II|Lost to Follow-up|0|||
146171866|NCT01490125|527143274|FG004|Period II|Lost to Follow-up|0|||
146171867|NCT01490125|527143275|FG005|Period II|Lost to Follow-up|0|||
146171868|NCT01490125|527143270|FG000|Period II|Withdrawal by Subject|1|||
146171869|NCT01490125|527143271|FG001|Period II|Withdrawal by Subject|0|||
146171870|NCT01490125|527143272|FG002|Period II|Withdrawal by Subject|0|||
146171871|NCT01490125|527143273|FG003|Period II|Withdrawal by Subject|0|||
146171872|NCT01490125|527143274|FG004|Period II|Withdrawal by Subject|0|||
146171873|NCT01490125|527143275|FG005|Period II|Withdrawal by Subject|0|||
146171874|NCT01490125|527143270|FG000|Period III|Adverse Event|3|||
146171875|NCT01490125|527143271|FG001|Period III|Adverse Event|1|||
146171876|NCT01490125|527143272|FG002|Period III|Adverse Event|0|||
146171877|NCT01490125|527143273|FG003|Period III|Adverse Event|1|||
146171878|NCT01490125|527143274|FG004|Period III|Adverse Event|0|||
146171879|NCT01490125|527143275|FG005|Period III|Adverse Event|0|||
146171880|NCT01490125|527143270|FG000|Period III|Death|0|||
146171881|NCT01490125|527143271|FG001|Period III|Death|0|||
146171882|NCT01490125|527143272|FG002|Period III|Death|0|||
146171883|NCT01490125|527143273|FG003|Period III|Death|1|||
146171884|NCT01490125|527143274|FG004|Period III|Death|0|||
145890932|NCT01207440|526107576|FG006|Overall Study|Lost to Follow-up|0|||
146067614|NCT00687193|526765805|FG004|Overall Study|Protocol Violation|2|||
146171885|NCT01490125|527143275|FG005|Period III|Death|0|||
146171886|NCT01490125|527143270|FG000|Period III|Lack of Efficacy|0|||
146171887|NCT01490125|527143271|FG001|Period III|Lack of Efficacy|0|||
146171888|NCT01490125|527143272|FG002|Period III|Lack of Efficacy|0|||
146171889|NCT01490125|527143273|FG003|Period III|Lack of Efficacy|0|||
146171890|NCT01490125|527143274|FG004|Period III|Lack of Efficacy|1|||
146171891|NCT01490125|527143275|FG005|Period III|Lack of Efficacy|0|||
146171892|NCT04522180|527143276|FG000|Overall Study|Investigator judgement|3|||
146171893|NCT04522180|527143277|FG001|Overall Study|Investigator judgement|4|||
146171894|NCT04522180|527143276|FG000|Overall Study|Voluntary withdrawal|1|||
146171895|NCT04522180|527143277|FG001|Overall Study|Voluntary withdrawal|0|||
146171896|NCT04522180|527143276|FG000|Overall Study|Pregnancy|0|||
146171897|NCT04522180|527143277|FG001|Overall Study|Pregnancy|1|||
146171898|NCT04522180|527143276|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
146171899|NCT04522180|527143277|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
146067615|NCT00687193|526765806|FG005|Overall Study|Protocol Violation|0|||
146067616|NCT02447003|526765807|FG000|Overall Study|Other|0|||
146067617|NCT02447003|526765808|FG001|Overall Study|Other|4|||
146067618|NCT02447003|526765807|FG000|Overall Study|Site discontinued|0|||
146067619|NCT02447003|526765808|FG001|Overall Study|Site discontinued|2|||
146067620|NCT02447003|526765807|FG000|Overall Study|Physician Decision|0|||
146067621|NCT02447003|526765808|FG001|Overall Study|Physician Decision|1|||
146067622|NCT02447003|526765807|FG000|Overall Study|Withdrawal by Subject|4|||
146067623|NCT02447003|526765808|FG001|Overall Study|Withdrawal by Subject|3|||
146067624|NCT02447003|526765807|FG000|Overall Study|Sponsor Decision|6|||
146067625|NCT02447003|526765808|FG001|Overall Study|Sponsor Decision|11|||
146067626|NCT02447003|526765807|FG000|Overall Study|Progressive Disease|1|||
146067627|NCT02447003|526765808|FG001|Overall Study|Progressive Disease|0|||
146067628|NCT02447003|526765807|FG000|Overall Study|Lost to Follow-up|5|||
146067629|NCT02447003|526765808|FG001|Overall Study|Lost to Follow-up|0|||
146067630|NCT02447003|526765807|FG000|Overall Study|Death|154|||
146067631|NCT02447003|526765808|FG001|Overall Study|Death|63|||
146067632|NCT01394016|526765809|FG000|Overall Study|Progressive Disease|2|||
146067633|NCT01394016|526765810|FG001|Overall Study|Progressive Disease|0|||
146067634|NCT01394016|526765811|FG002|Overall Study|Progressive Disease|0|||
146067635|NCT01394016|526765812|FG003|Overall Study|Progressive Disease|0|||
146067636|NCT01394016|526765813|FG004|Overall Study|Progressive Disease|0|||
146067637|NCT01394016|526765814|FG005|Overall Study|Progressive Disease|0|||
146067638|NCT01394016|526765815|FG006|Overall Study|Progressive Disease|0|||
146067639|NCT01394016|526765816|FG007|Overall Study|Progressive Disease|0|||
146067640|NCT01394016|526765817|FG008|Overall Study|Progressive Disease|0|||
146067641|NCT01394016|526765818|FG009|Overall Study|Progressive Disease|0|||
146067642|NCT01394016|526765819|FG010|Overall Study|Progressive Disease|0|||
146067643|NCT01394016|526765820|FG011|Overall Study|Progressive Disease|0|||
146067644|NCT01394016|526765821|FG012|Overall Study|Progressive Disease|0|||
146067645|NCT01394016|526765822|FG013|Overall Study|Progressive Disease|0|||
146067646|NCT01394016|526765823|FG014|Overall Study|Progressive Disease|0|||
146067647|NCT01394016|526765824|FG015|Overall Study|Progressive Disease|0|||
146067648|NCT01394016|526765825|FG016|Overall Study|Progressive Disease|0|||
146067649|NCT01394016|526765826|FG017|Overall Study|Progressive Disease|0|||
146067650|NCT01394016|526765827|FG018|Overall Study|Progressive Disease|0|||
146067651|NCT01394016|526765809|FG000|Overall Study|Withdrawal by Subject|0|||
146067652|NCT01394016|526765810|FG001|Overall Study|Withdrawal by Subject|0|||
146067653|NCT01394016|526765811|FG002|Overall Study|Withdrawal by Subject|0|||
146067654|NCT01394016|526765812|FG003|Overall Study|Withdrawal by Subject|0|||
146067655|NCT01394016|526765813|FG004|Overall Study|Withdrawal by Subject|0|||
146067656|NCT01394016|526765814|FG005|Overall Study|Withdrawal by Subject|0|||
146067657|NCT01394016|526765815|FG006|Overall Study|Withdrawal by Subject|0|||
146067658|NCT01394016|526765816|FG007|Overall Study|Withdrawal by Subject|1|||
146067659|NCT01394016|526765817|FG008|Overall Study|Withdrawal by Subject|1|||
146067660|NCT01394016|526765818|FG009|Overall Study|Withdrawal by Subject|1|||
146067661|NCT01394016|526765819|FG010|Overall Study|Withdrawal by Subject|4|||
146067662|NCT01394016|526765820|FG011|Overall Study|Withdrawal by Subject|0|||
146067663|NCT01394016|526765821|FG012|Overall Study|Withdrawal by Subject|0|||
146067664|NCT01394016|526765822|FG013|Overall Study|Withdrawal by Subject|3|||
146067665|NCT01394016|526765823|FG014|Overall Study|Withdrawal by Subject|1|||
146067666|NCT01394016|526765824|FG015|Overall Study|Withdrawal by Subject|3|||
146067667|NCT01394016|526765825|FG016|Overall Study|Withdrawal by Subject|1|||
146067668|NCT01394016|526765826|FG017|Overall Study|Withdrawal by Subject|1|||
146067669|NCT01394016|526765827|FG018|Overall Study|Withdrawal by Subject|2|||
146067670|NCT01394016|526765809|FG000|Overall Study|Adverse Event|0|||
146067671|NCT01394016|526765810|FG001|Overall Study|Adverse Event|0|||
146067672|NCT01394016|526765811|FG002|Overall Study|Adverse Event|0|||
146067673|NCT01394016|526765812|FG003|Overall Study|Adverse Event|0|||
146067674|NCT01394016|526765813|FG004|Overall Study|Adverse Event|0|||
146067675|NCT01394016|526765814|FG005|Overall Study|Adverse Event|0|||
146067676|NCT01394016|526765815|FG006|Overall Study|Adverse Event|0|||
146067677|NCT01394016|526765816|FG007|Overall Study|Adverse Event|0|||
146067678|NCT01394016|526765817|FG008|Overall Study|Adverse Event|0|||
146067679|NCT01394016|526765818|FG009|Overall Study|Adverse Event|1|||
146067680|NCT01394016|526765819|FG010|Overall Study|Adverse Event|0|||
146067681|NCT01394016|526765820|FG011|Overall Study|Adverse Event|0|||
146067682|NCT01394016|526765821|FG012|Overall Study|Adverse Event|0|||
146067683|NCT01394016|526765822|FG013|Overall Study|Adverse Event|0|||
146067684|NCT01394016|526765823|FG014|Overall Study|Adverse Event|0|||
146067685|NCT01394016|526765824|FG015|Overall Study|Adverse Event|0|||
146067686|NCT01394016|526765825|FG016|Overall Study|Adverse Event|1|||
146067687|NCT01394016|526765826|FG017|Overall Study|Adverse Event|1|||
146067688|NCT01394016|526765827|FG018|Overall Study|Adverse Event|0|||
146067689|NCT01394016|526765809|FG000|Overall Study|Sponsor Decision|0|||
146067690|NCT01394016|526765810|FG001|Overall Study|Sponsor Decision|0|||
146067691|NCT01394016|526765811|FG002|Overall Study|Sponsor Decision|0|||
146067692|NCT01394016|526765812|FG003|Overall Study|Sponsor Decision|0|||
146067693|NCT01394016|526765813|FG004|Overall Study|Sponsor Decision|0|||
146067694|NCT01394016|526765814|FG005|Overall Study|Sponsor Decision|0|||
146067695|NCT01394016|526765815|FG006|Overall Study|Sponsor Decision|0|||
146067696|NCT01394016|526765816|FG007|Overall Study|Sponsor Decision|0|||
146067697|NCT01394016|526765817|FG008|Overall Study|Sponsor Decision|0|||
146067698|NCT01394016|526765818|FG009|Overall Study|Sponsor Decision|0|||
146067699|NCT01394016|526765819|FG010|Overall Study|Sponsor Decision|0|||
146067700|NCT01394016|526765820|FG011|Overall Study|Sponsor Decision|0|||
146067701|NCT01394016|526765821|FG012|Overall Study|Sponsor Decision|1|||
146067702|NCT01394016|526765822|FG013|Overall Study|Sponsor Decision|0|||
146067703|NCT01394016|526765823|FG014|Overall Study|Sponsor Decision|0|||
146067704|NCT01394016|526765824|FG015|Overall Study|Sponsor Decision|0|||
146067705|NCT01394016|526765825|FG016|Overall Study|Sponsor Decision|0|||
146067706|NCT01394016|526765826|FG017|Overall Study|Sponsor Decision|0|||
146067707|NCT01394016|526765827|FG018|Overall Study|Sponsor Decision|0|||
146067708|NCT01394016|526765809|FG000|Overall Study|Lost to Follow-up|0|||
146067709|NCT01394016|526765810|FG001|Overall Study|Lost to Follow-up|0|||
146067710|NCT01394016|526765811|FG002|Overall Study|Lost to Follow-up|0|||
146067711|NCT01394016|526765812|FG003|Overall Study|Lost to Follow-up|0|||
146067712|NCT01394016|526765813|FG004|Overall Study|Lost to Follow-up|0|||
146067713|NCT01394016|526765814|FG005|Overall Study|Lost to Follow-up|0|||
146067714|NCT01394016|526765815|FG006|Overall Study|Lost to Follow-up|0|||
146067715|NCT01394016|526765816|FG007|Overall Study|Lost to Follow-up|0|||
146067716|NCT01394016|526765817|FG008|Overall Study|Lost to Follow-up|0|||
146067717|NCT01394016|526765818|FG009|Overall Study|Lost to Follow-up|0|||
146067718|NCT01394016|526765819|FG010|Overall Study|Lost to Follow-up|0|||
146067719|NCT01394016|526765820|FG011|Overall Study|Lost to Follow-up|0|||
146067720|NCT01394016|526765821|FG012|Overall Study|Lost to Follow-up|0|||
146067721|NCT01394016|526765822|FG013|Overall Study|Lost to Follow-up|0|||
146067722|NCT01394016|526765823|FG014|Overall Study|Lost to Follow-up|0|||
146067723|NCT01394016|526765824|FG015|Overall Study|Lost to Follow-up|0|||
146067724|NCT01394016|526765825|FG016|Overall Study|Lost to Follow-up|0|||
146067725|NCT01394016|526765826|FG017|Overall Study|Lost to Follow-up|0|||
146067726|NCT01394016|526765827|FG018|Overall Study|Lost to Follow-up|1|||
146067727|NCT03534804|526765828|FG000|Overall Study|Withdrawal by Subject|1|||
146067728|NCT04161157|526765829|FG000|Overall Study|Lost to Follow-up|4|||
146067729|NCT04161157|526765829|FG000|Overall Study|Death|3|||
146067730|NCT04161157|526765829|FG000|Overall Study|Ineligible|2|||
146067731|NCT04161157|526765829|FG000|Overall Study|Withdrawal by Subject|4|||
146067732|NCT04922216|526765837|FG000|Overall Study|Withdrawal by Subject|0|||
146067733|NCT04922216|526765838|FG001|Overall Study|Withdrawal by Subject|1|||
146067734|NCT04922216|526765839|FG002|Overall Study|Withdrawal by Subject|0|||
146067735|NCT04922216|526765840|FG003|Overall Study|Withdrawal by Subject|0|||
146067736|NCT04922216|526765841|FG004|Overall Study|Withdrawal by Subject|0|||
146067737|NCT04922216|526765842|FG005|Overall Study|Withdrawal by Subject|0|||
146067738|NCT04922216|526765843|FG006|Overall Study|Withdrawal by Subject|0|||
146067739|NCT04922216|526765844|FG007|Overall Study|Withdrawal by Subject|2|||
146067740|NCT04922216|526765845|FG008|Overall Study|Withdrawal by Subject|0|||
146067741|NCT04922216|526765846|FG009|Overall Study|Withdrawal by Subject|0|||
146067742|NCT04922216|526765847|FG010|Overall Study|Withdrawal by Subject|0|||
146067743|NCT04922216|526765848|FG011|Overall Study|Withdrawal by Subject|0|||
146067744|NCT04922216|526765849|FG012|Overall Study|Withdrawal by Subject|1|||
146067745|NCT04922216|526765850|FG013|Overall Study|Withdrawal by Subject|1|||
146067746|NCT04922216|526765851|FG014|Overall Study|Withdrawal by Subject|1|||
146067747|NCT04922216|526765852|FG015|Overall Study|Withdrawal by Subject|0|||
146067748|NCT04922216|526765853|FG016|Overall Study|Withdrawal by Subject|0|||
146067749|NCT04922216|526765854|FG017|Overall Study|Withdrawal by Subject|1|||
146067750|NCT04922216|526765855|FG018|Overall Study|Withdrawal by Subject|1|||
146067751|NCT04922216|526765856|FG019|Overall Study|Withdrawal by Subject|1|||
146067752|NCT04922216|526765857|FG020|Overall Study|Withdrawal by Subject|1|||
146067753|NCT04922216|526765858|FG021|Overall Study|Withdrawal by Subject|0|||
146067754|NCT04922216|526765859|FG022|Overall Study|Withdrawal by Subject|0|||
146067755|NCT04922216|526765860|FG023|Overall Study|Withdrawal by Subject|2|||
146067756|NCT04922216|526765861|FG024|Overall Study|Withdrawal by Subject|0|||
146067757|NCT04922216|526765862|FG025|Overall Study|Withdrawal by Subject|0|||
146067758|NCT04922216|526765863|FG026|Overall Study|Withdrawal by Subject|1|||
146067759|NCT04922216|526765864|FG027|Overall Study|Withdrawal by Subject|0|||
146067760|NCT04922216|526765865|FG028|Overall Study|Withdrawal by Subject|0|||
146067761|NCT04922216|526765866|FG029|Overall Study|Withdrawal by Subject|0|||
146067762|NCT04922216|526765867|FG030|Overall Study|Withdrawal by Subject|1|||
146067763|NCT04922216|526765868|FG031|Overall Study|Withdrawal by Subject|0|||
146067764|NCT04922216|526765837|FG000|Overall Study|Lost to Follow-up|1|||
146067765|NCT04922216|526765838|FG001|Overall Study|Lost to Follow-up|0|||
146067766|NCT04922216|526765839|FG002|Overall Study|Lost to Follow-up|2|||
146067767|NCT04922216|526765840|FG003|Overall Study|Lost to Follow-up|0|||
146067768|NCT04922216|526765841|FG004|Overall Study|Lost to Follow-up|0|||
146067769|NCT04922216|526765842|FG005|Overall Study|Lost to Follow-up|2|||
146067770|NCT04922216|526765843|FG006|Overall Study|Lost to Follow-up|0|||
146067771|NCT04922216|526765844|FG007|Overall Study|Lost to Follow-up|1|||
146067772|NCT04922216|526765845|FG008|Overall Study|Lost to Follow-up|1|||
146067773|NCT04922216|526765846|FG009|Overall Study|Lost to Follow-up|2|||
146067774|NCT04922216|526765847|FG010|Overall Study|Lost to Follow-up|2|||
146067775|NCT04922216|526765848|FG011|Overall Study|Lost to Follow-up|1|||
146067776|NCT04922216|526765849|FG012|Overall Study|Lost to Follow-up|1|||
146067777|NCT04922216|526765850|FG013|Overall Study|Lost to Follow-up|0|||
146067778|NCT04922216|526765851|FG014|Overall Study|Lost to Follow-up|1|||
146067779|NCT04922216|526765852|FG015|Overall Study|Lost to Follow-up|0|||
146067780|NCT04922216|526765853|FG016|Overall Study|Lost to Follow-up|0|||
146067781|NCT04922216|526765854|FG017|Overall Study|Lost to Follow-up|2|||
146067782|NCT04922216|526765855|FG018|Overall Study|Lost to Follow-up|1|||
146067783|NCT04922216|526765856|FG019|Overall Study|Lost to Follow-up|0|||
146067784|NCT04922216|526765857|FG020|Overall Study|Lost to Follow-up|1|||
146067785|NCT04922216|526765858|FG021|Overall Study|Lost to Follow-up|0|||
146067786|NCT04922216|526765859|FG022|Overall Study|Lost to Follow-up|2|||
146067787|NCT04922216|526765860|FG023|Overall Study|Lost to Follow-up|1|||
146067788|NCT04922216|526765861|FG024|Overall Study|Lost to Follow-up|0|||
146067789|NCT04922216|526765862|FG025|Overall Study|Lost to Follow-up|2|||
146067790|NCT04922216|526765863|FG026|Overall Study|Lost to Follow-up|0|||
146067791|NCT04922216|526765864|FG027|Overall Study|Lost to Follow-up|0|||
146067792|NCT04922216|526765865|FG028|Overall Study|Lost to Follow-up|1|||
146067793|NCT04922216|526765866|FG029|Overall Study|Lost to Follow-up|0|||
146067794|NCT04922216|526765867|FG030|Overall Study|Lost to Follow-up|2|||
146067795|NCT04922216|526765868|FG031|Overall Study|Lost to Follow-up|1|||
146067796|NCT04721977|526765869|FG000|Overall Study|Death|15|||
146067797|NCT04721977|526765869|FG000|Overall Study|Ongoing|51|||
146067798|NCT03278249|526765870|FG000|Overall Study|Withdrawal by Subject|2|||
146067799|NCT03278249|526765870|FG000|Overall Study|Lost to Follow-up|1|||
146067800|NCT02017405|526765871|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146067801|NCT02017405|526765872|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146067802|NCT02017405|526765873|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146067803|NCT02017405|526765874|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146067804|NCT02017405|526765875|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
146067805|NCT02017405|526765876|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
146067806|NCT02017405|526765871|FG000|Open-label Phase|Adverse Event|1|||
146067807|NCT02017405|526765872|FG001|Open-label Phase|Adverse Event|1|||
146067808|NCT02017405|526765873|FG002|Open-label Phase|Adverse Event|0|||
146067809|NCT02017405|526765874|FG003|Open-label Phase|Adverse Event|0|||
146067810|NCT02017405|526765875|FG004|Open-label Phase|Adverse Event|0|||
146067811|NCT02017405|526765876|FG005|Open-label Phase|Adverse Event|0|||
146067812|NCT02864394|526765878|FG000|Overall Study|Death|184|||
146067813|NCT02864394|526765879|FG001|Overall Study|Death|189|||
146067814|NCT02864394|526765878|FG000|Overall Study|Lost to Follow-up|0|||
146067815|NCT02864394|526765879|FG001|Overall Study|Lost to Follow-up|2|||
146067816|NCT02864394|526765878|FG000|Overall Study|Sponsor Decision|26|||
146067817|NCT02864394|526765879|FG001|Overall Study|Sponsor Decision|11|||
146067818|NCT02864394|526765878|FG000|Overall Study|Withdrawal by Subject|3|||
146067819|NCT02864394|526765879|FG001|Overall Study|Withdrawal by Subject|10|||
146067820|NCT02374450|526765880|FG000|Overall Study|Protocol Violation|0|||
146067821|NCT02374450|526765881|FG001|Overall Study|Protocol Violation|1|||
146067822|NCT02374450|526765882|FG002|Overall Study|Protocol Violation|0|||
146067823|NCT02374450|526765880|FG000|Overall Study|Withdrawal by Subject|91|||
146067824|NCT02374450|526765881|FG001|Overall Study|Withdrawal by Subject|110|||
146067825|NCT02374450|526765882|FG002|Overall Study|Withdrawal by Subject|4|||
146067826|NCT02374450|526765880|FG000|Overall Study|Lost to Follow-up|168|||
146067827|NCT02374450|526765881|FG001|Overall Study|Lost to Follow-up|194|||
146067828|NCT02374450|526765882|FG002|Overall Study|Lost to Follow-up|138|||
146067829|NCT02374450|526765880|FG000|Overall Study|Death|173|||
146067830|NCT02374450|526765881|FG001|Overall Study|Death|185|||
146067831|NCT02374450|526765882|FG002|Overall Study|Death|81|||
146067832|NCT02374450|526765880|FG000|Overall Study|Migrated from the study area|538|||
146067833|NCT02374450|526765881|FG001|Overall Study|Migrated from the study area|648|||
146067834|NCT02374450|526765882|FG002|Overall Study|Migrated from the study area|181|||
146067835|NCT02374450|526765880|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
146067836|NCT02374450|526765881|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
146067837|NCT02374450|526765882|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
146067838|NCT02374450|526765880|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
146067839|NCT02374450|526765881|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
146067840|NCT02374450|526765882|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
146067841|NCT02374450|526765880|FG000|Overall Study|Other|0|||
146067842|NCT02374450|526765881|FG001|Overall Study|Other|21|||
146067843|NCT02374450|526765882|FG002|Overall Study|Other|79|||
146067844|NCT04730804|526765883|FG000|Overall Study|Physician Decision|0|||
146067845|NCT04730804|526765884|FG001|Overall Study|Physician Decision|0|||
146067846|NCT04730804|526765885|FG002|Overall Study|Physician Decision|0|||
146067847|NCT04730804|526765886|FG003|Overall Study|Physician Decision|0|||
146067848|NCT04730804|526765887|FG004|Overall Study|Physician Decision|0|||
146067849|NCT04730804|526765888|FG005|Overall Study|Physician Decision|1|||
146067850|NCT04730804|526765883|FG000|Overall Study|Withdrawal by Subject|0|||
146067851|NCT04730804|526765884|FG001|Overall Study|Withdrawal by Subject|0|||
146067852|NCT04730804|526765885|FG002|Overall Study|Withdrawal by Subject|0|||
146067853|NCT04730804|526765886|FG003|Overall Study|Withdrawal by Subject|0|||
146067854|NCT04730804|526765887|FG004|Overall Study|Withdrawal by Subject|1|||
146067855|NCT04730804|526765888|FG005|Overall Study|Withdrawal by Subject|2|||
146067856|NCT03722238|526767058|FG000|Overall Study|Protocol Violation|1|||
146067857|NCT03722238|526767059|FG001|Overall Study|Protocol Violation|0|||
146067858|NCT03722238|526767058|FG000|Overall Study|Physician Decision|1|||
146067859|NCT03722238|526767059|FG001|Overall Study|Physician Decision|0|||
146067860|NCT03722238|526767058|FG000|Overall Study|Death|1|||
146067861|NCT03722238|526767059|FG001|Overall Study|Death|0|||
146067862|NCT03722238|526767058|FG000|Overall Study|Lost to Follow-up|6|||
146067863|NCT03722238|526767059|FG001|Overall Study|Lost to Follow-up|0|||
146067864|NCT03722238|526767058|FG000|Overall Study|Partial missing data|44|||
146171900|NCT04522180|527143276|FG000|Overall Study|Reason not specified|8|||
146171901|NCT04522180|527143277|FG001|Overall Study|Reason not specified|5|||
146171902|NCT05807919|527143278|FG000|Overall Study|Received antibiotics - excluded|0|||
146171903|NCT05807919|527143279|FG001|Overall Study|Received antibiotics - excluded|1|||
146067865|NCT03722238|526767059|FG001|Overall Study|Partial missing data|1|||
146067866|NCT03722238|526767058|FG000|Overall Study|Withdrawal by Subject|2|||
146067867|NCT03722238|526767059|FG001|Overall Study|Withdrawal by Subject|0|||
146171904|NCT05807919|527143278|FG000|Overall Study|Withdrawal by Subject|0|||
146408176|NCT03835975|528000118|FG002|Overall Study|Lost to Follow-up|0|||
146408177|NCT03835975|528000119|FG003|Overall Study|Lost to Follow-up|0|||
146408178|NCT03835975|528000120|FG004|Overall Study|Lost to Follow-up|0|||
146408179|NCT03835975|528000116|FG000|Overall Study|No longer met eligibility criteria|0|||
146408180|NCT03835975|528000117|FG001|Overall Study|No longer met eligibility criteria|1|||
146408181|NCT03835975|528000118|FG002|Overall Study|No longer met eligibility criteria|0|||
146408182|NCT03835975|528000119|FG003|Overall Study|No longer met eligibility criteria|0|||
146408183|NCT03835975|528000120|FG004|Overall Study|No longer met eligibility criteria|0|||
146408184|NCT03835975|528000116|FG000|Overall Study|Protocol Violation|1|||
146408185|NCT03835975|528000117|FG001|Overall Study|Protocol Violation|1|||
146408186|NCT03835975|528000118|FG002|Overall Study|Protocol Violation|2|||
146408187|NCT03835975|528000119|FG003|Overall Study|Protocol Violation|0|||
146408188|NCT03835975|528000120|FG004|Overall Study|Protocol Violation|0|||
146408189|NCT03835975|528000116|FG000|Overall Study|Withdrawal by Subject|1|||
146408190|NCT03835975|528000117|FG001|Overall Study|Withdrawal by Subject|0|||
146408191|NCT03835975|528000118|FG002|Overall Study|Withdrawal by Subject|1|||
146408192|NCT03835975|528000119|FG003|Overall Study|Withdrawal by Subject|1|||
146408193|NCT03835975|528000120|FG004|Overall Study|Withdrawal by Subject|0|||
146408194|NCT00370396|528000126|FG000|Overall Study|Withdrawal by Subject|0|||
146408195|NCT00370396|528000127|FG001|Overall Study|Withdrawal by Subject|0|||
146408196|NCT00370396|528000128|FG002|Overall Study|Withdrawal by Subject|1|||
146408197|NCT00370396|528000126|FG000|Overall Study|Lost to Follow-up|11|||
146408198|NCT00370396|528000127|FG001|Overall Study|Lost to Follow-up|1|||
146408199|NCT00370396|528000128|FG002|Overall Study|Lost to Follow-up|0|||
146408200|NCT04529499|528000129|FG000|Overall Study|Withdrawal by Subject|9|||
146408201|NCT04529499|528000130|FG001|Overall Study|Withdrawal by Subject|11|||
146408202|NCT04529499|528000129|FG000|Overall Study|Physician Decision|1|||
146408203|NCT04529499|528000130|FG001|Overall Study|Physician Decision|2|||
146408204|NCT04529499|528000129|FG000|Overall Study|Adverse Event|4|||
146408205|NCT04529499|528000130|FG001|Overall Study|Adverse Event|4|||
146408206|NCT04529499|528000129|FG000|Overall Study|Death|14|||
146408207|NCT04529499|528000130|FG001|Overall Study|Death|11|||
146408208|NCT04529499|528000129|FG000|Overall Study|Lost to Follow-up|1|||
146067868|NCT03722238|526767058|FG000|Overall Study|Other|4|||
146067869|NCT03722238|526767059|FG001|Overall Study|Other|0|||
146067870|NCT03722238|526767058|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
146067871|NCT03722238|526767059|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
146067872|NCT03722238|526767058|FG000|Overall Study|Did not meet risk classification group criteria|90|||
146067873|NCT03722238|526767059|FG001|Overall Study|Did not meet risk classification group criteria|0|||
146171905|NCT05807919|527143279|FG001|Overall Study|Withdrawal by Subject|3|||
146408209|NCT04529499|528000130|FG001|Overall Study|Lost to Follow-up|1|||
146067874|NCT03722238|526767058|FG000|Overall Study|Did not sign consent|17|||
146067875|NCT03722238|526767059|FG001|Overall Study|Did not sign consent|0|||
146067876|NCT03722238|526767058|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
146067877|NCT03722238|526767059|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
146067878|NCT03722238|526767058|FG000|Overall Study|Not willing to purchase study medication|142|||
146067879|NCT03722238|526767059|FG001|Overall Study|Not willing to purchase study medication|0|||
146067880|NCT03722238|526767058|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
146067881|NCT03722238|526767059|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
146067882|NCT00561925|526767060|FG000|14 Day Lead-In Period|Adverse Event|38|||
146067883|NCT00561925|526767061|FG001|14 Day Lead-In Period|Adverse Event|0|||
146067884|NCT00561925|526767062|FG002|14 Day Lead-In Period|Adverse Event|0|||
146067885|NCT00561925|526767063|FG003|14 Day Lead-In Period|Adverse Event|0|||
146067886|NCT00561925|526767064|FG004|14 Day Lead-In Period|Adverse Event|0|||
146067887|NCT00561925|526767060|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
146067888|NCT00561925|526767061|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
146067889|NCT00561925|526767062|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
146067890|NCT00561925|526767063|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
146067891|NCT00561925|526767064|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
146067892|NCT00561925|526767060|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
146067893|NCT00561925|526767061|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
146067894|NCT00561925|526767062|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
146067895|NCT00561925|526767063|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
146067896|NCT00561925|526767064|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
146067897|NCT00561925|526767060|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
146067898|NCT00561925|526767061|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
146067899|NCT00561925|526767062|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
146067900|NCT00561925|526767063|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
146067901|NCT00561925|526767064|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
146067902|NCT00561925|526767060|FG000|14 Day Lead-In Period|Other|5|||
146067903|NCT00561925|526767061|FG001|14 Day Lead-In Period|Other|0|||
146067904|NCT00561925|526767062|FG002|14 Day Lead-In Period|Other|0|||
146067905|NCT00561925|526767063|FG003|14 Day Lead-In Period|Other|0|||
146067906|NCT00561925|526767064|FG004|14 Day Lead-In Period|Other|0|||
146067907|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
146067908|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
146067909|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
146067910|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
146067911|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
146067912|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146067913|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
146067914|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
146067915|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146067916|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
146067917|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146067918|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
146067919|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
146067920|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146067921|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
146067922|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146067923|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
146067924|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
146067925|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146067926|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
146067927|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146067928|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
146067929|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
146067930|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146067931|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
146067932|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
146067933|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
146067934|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
146067935|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
146067936|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
146067937|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Death|0|||
146067938|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Death|6|||
146067939|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Death|3|||
146067940|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Death|0|||
146067941|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Death|0|||
146067942|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146171906|NCT05807919|527143278|FG000|Overall Study|Adverse Event|1|||
146067943|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
146067944|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146067945|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146067946|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
146067947|NCT00561925|526767060|FG000|144-week Double-blind, Double-dummy|Other|0|||
146067948|NCT00561925|526767061|FG001|144-week Double-blind, Double-dummy|Other|8|||
146067949|NCT00561925|526767062|FG002|144-week Double-blind, Double-dummy|Other|11|||
146067950|NCT00561925|526767063|FG003|144-week Double-blind, Double-dummy|Other|0|||
146067951|NCT00561925|526767064|FG004|144-week Double-blind, Double-dummy|Other|0|||
146067952|NCT00561925|526767060|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
146067953|NCT00561925|526767061|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
146067954|NCT00561925|526767062|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
146067955|NCT00561925|526767063|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
146067956|NCT00561925|526767064|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
146067957|NCT00684021|526767067|FG000|Overall Study|MRI Contraindicated|1|||
146067958|NCT00684021|526767068|FG001|Overall Study|MRI Contraindicated|1|||
146067959|NCT00684021|526767069|FG002|Overall Study|MRI Contraindicated|1|||
146067960|NCT00684021|526767070|FG003|Overall Study|MRI Contraindicated|0|||
146067961|NCT00684021|526767067|FG000|Overall Study|MRI not performed|0|||
146067962|NCT00684021|526767068|FG001|Overall Study|MRI not performed|1|||
146067963|NCT00684021|526767069|FG002|Overall Study|MRI not performed|1|||
146067964|NCT00684021|526767070|FG003|Overall Study|MRI not performed|2|||
146067965|NCT00684021|526767067|FG000|Overall Study|Death|1|||
146067966|NCT00684021|526767068|FG001|Overall Study|Death|0|||
146067967|NCT00684021|526767069|FG002|Overall Study|Death|0|||
146067968|NCT00684021|526767070|FG003|Overall Study|Death|0|||
146067969|NCT00891904|526767071|FG000|Overall Study|Death|1|||
146067970|NCT00891904|526767071|FG000|Overall Study|Adverse Event|1|||
146067971|NCT02976038|526767072|FG000|Overall Study|Physician Decision|22|||
146067972|NCT02976038|526767072|FG000|Overall Study|Withdrawal by Subject|3|||
146067973|NCT02976038|526767072|FG000|Overall Study|Lost to Follow-up|2|||
146067974|NCT02976038|526767072|FG000|Overall Study|Adverse Event|1|||
146067975|NCT01046396|526767073|FG000|Overall Study|Withdrawal by Subject|5|||
146067976|NCT00724698|526767074|FG000|Overall Study|Adverse Event|9|||
146067977|NCT00724698|526767074|FG000|Overall Study|Failure of Therapy|4|||
146067978|NCT00724698|526767074|FG000|Overall Study|Poor Compliance|16|||
146067979|NCT00724698|526767074|FG000|Overall Study|Lost to Follow-up|36|||
146067980|NCT00724698|526767074|FG000|Overall Study|No Info|25|||
146067981|NCT02177032|526767075|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
146067982|NCT02177032|526767076|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
146067983|NCT02177032|526767077|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
146067984|NCT02177032|526767078|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
146067985|NCT02177032|526767075|FG000|Overall Study|Lost to Follow-up|0|||
146067986|NCT02177032|526767076|FG001|Overall Study|Lost to Follow-up|2|||
146067987|NCT02177032|526767077|FG002|Overall Study|Lost to Follow-up|0|||
146067988|NCT02177032|526767078|FG003|Overall Study|Lost to Follow-up|0|||
146067989|NCT02177032|526767075|FG000|Overall Study|OTHER|2|||
146067990|NCT02177032|526767076|FG001|Overall Study|OTHER|0|||
146067991|NCT02177032|526767077|FG002|Overall Study|OTHER|1|||
146067992|NCT02177032|526767078|FG003|Overall Study|OTHER|0|||
146067993|NCT02177032|526767075|FG000|Overall Study|Withdrawal by Subject|1|||
146067994|NCT02177032|526767076|FG001|Overall Study|Withdrawal by Subject|0|||
146067995|NCT02177032|526767077|FG002|Overall Study|Withdrawal by Subject|1|||
146067996|NCT02177032|526767078|FG003|Overall Study|Withdrawal by Subject|0|||
146067997|NCT02556177|526767080|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
146067998|NCT02556177|526767081|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
146067999|NCT00658359|526767082|FG000|Overall Study|Death|3|||
146068000|NCT00658359|526767083|FG001|Overall Study|Death|1|||
146068001|NCT00658359|526767084|FG002|Overall Study|Death|2|||
146068002|NCT00658359|526767082|FG000|Overall Study|Adverse Event|13|||
146068003|NCT00658359|526767083|FG001|Overall Study|Adverse Event|6|||
146068004|NCT00658359|526767084|FG002|Overall Study|Adverse Event|9|||
146068005|NCT00658359|526767082|FG000|Overall Study|Protocol Violation|1|||
146068006|NCT00658359|526767083|FG001|Overall Study|Protocol Violation|0|||
146068007|NCT00658359|526767084|FG002|Overall Study|Protocol Violation|0|||
146068008|NCT00658359|526767082|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
146068009|NCT00658359|526767083|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
146068010|NCT00658359|526767084|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
146068011|NCT00658359|526767082|FG000|Overall Study|Withdrawal by Subject|7|||
146068012|NCT00658359|526767083|FG001|Overall Study|Withdrawal by Subject|4|||
146068013|NCT00658359|526767084|FG002|Overall Study|Withdrawal by Subject|2|||
146068014|NCT00658359|526767082|FG000|Overall Study|Lost to Follow-up|2|||
146068015|NCT00658359|526767083|FG001|Overall Study|Lost to Follow-up|2|||
146068016|NCT00658359|526767084|FG002|Overall Study|Lost to Follow-up|4|||
146068017|NCT00658359|526767082|FG000|Overall Study|Lack of Efficacy|0|||
146068018|NCT00658359|526767083|FG001|Overall Study|Lack of Efficacy|1|||
146068019|NCT00658359|526767084|FG002|Overall Study|Lack of Efficacy|0|||
146068020|NCT00734539|526767085|FG000|Main Study|Death|33|||
146068021|NCT00734539|526767086|FG001|Main Study|Death|32|||
146068022|NCT00734539|526767085|FG000|Main Study|Physician Decision|2|||
146068023|NCT00734539|526767086|FG001|Main Study|Physician Decision|0|||
146068024|NCT00734539|526767085|FG000|Main Study|Withdrawal by Subject|1|||
146068025|NCT00734539|526767086|FG001|Main Study|Withdrawal by Subject|3|||
146068026|NCT00734539|526767085|FG000|Main Study|Enrolled in error; ineligible|1|||
146068027|NCT00734539|526767086|FG001|Main Study|Enrolled in error; ineligible|0|||
146068028|NCT02504151|526767089|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
146068029|NCT02504151|526767090|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
146068030|NCT02504151|526767089|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146068031|NCT02504151|526767090|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146068032|NCT02504151|526767089|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146068033|NCT02504151|526767090|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146068034|NCT02504151|526767089|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
146068035|NCT02504151|526767090|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
146068036|NCT00705016|526767091|FG000|Overall Study|Adverse Event|6|||
146068037|NCT00705016|526767092|FG001|Overall Study|Adverse Event|11|||
146068038|NCT00705016|526767093|FG002|Overall Study|Adverse Event|10|||
146068039|NCT00705016|526767091|FG000|Overall Study|Death|5|||
146068040|NCT00705016|526767092|FG001|Overall Study|Death|7|||
146068041|NCT00705016|526767093|FG002|Overall Study|Death|5|||
146068042|NCT00705016|526767091|FG000|Overall Study|Protocol Violation|0|||
146068043|NCT00705016|526767092|FG001|Overall Study|Protocol Violation|1|||
146068044|NCT00705016|526767093|FG002|Overall Study|Protocol Violation|1|||
146068045|NCT00705016|526767091|FG000|Overall Study|Withdrawal by Subject|4|||
146068046|NCT00705016|526767092|FG001|Overall Study|Withdrawal by Subject|3|||
146068047|NCT00705016|526767093|FG002|Overall Study|Withdrawal by Subject|2|||
146068048|NCT00705016|526767091|FG000|Overall Study|Progressive Disease|33|||
146068049|NCT00705016|526767092|FG001|Overall Study|Progressive Disease|29|||
146068050|NCT00705016|526767093|FG002|Overall Study|Progressive Disease|33|||
146068051|NCT00705016|526767091|FG000|Overall Study|Symptomatic Deterioration|3|||
146068052|NCT00705016|526767092|FG001|Overall Study|Symptomatic Deterioration|1|||
146068053|NCT00705016|526767093|FG002|Overall Study|Symptomatic Deterioration|1|||
146068054|NCT00705016|526767091|FG000|Overall Study|Other|9|||
146068055|NCT00705016|526767092|FG001|Overall Study|Other|6|||
146068056|NCT00705016|526767093|FG002|Overall Study|Other|6|||
146068057|NCT01188343|526767094|FG000|Overall Study|Not vaccinated|0|||
146068058|NCT01188343|526767095|FG001|Overall Study|Not vaccinated|2|||
146068059|NCT01188343|526767096|FG002|Overall Study|Not vaccinated|1|||
146068060|NCT01188343|526767094|FG000|Overall Study|Withdrawal by Subject|1|||
146068061|NCT01188343|526767095|FG001|Overall Study|Withdrawal by Subject|24|||
146068062|NCT01188343|526767096|FG002|Overall Study|Withdrawal by Subject|0|||
146068063|NCT01457703|526767099|FG000|Overall Study|Screen Failure|5|||
146068064|NCT01457703|526767100|FG001|Overall Study|Screen Failure|7|||
146068065|NCT01457703|526767099|FG000|Overall Study|Withdrawal by Subject|1|||
146068066|NCT01457703|526767100|FG001|Overall Study|Withdrawal by Subject|4|||
146068067|NCT03133793|526767105|FG000|Overall Study|Withdrawal by Subject|0|||
146068068|NCT03133793|526767106|FG001|Overall Study|Withdrawal by Subject|4|||
146068069|NCT03133793|526767107|FG002|Overall Study|Withdrawal by Subject|2|||
146068070|NCT03133793|526767108|FG003|Overall Study|Withdrawal by Subject|4|||
146068071|NCT03133793|526767105|FG000|Overall Study|Lost to Follow-up|1|||
146068072|NCT03133793|526767106|FG001|Overall Study|Lost to Follow-up|0|||
146068073|NCT03133793|526767107|FG002|Overall Study|Lost to Follow-up|2|||
146068074|NCT03133793|526767108|FG003|Overall Study|Lost to Follow-up|0|||
146068075|NCT03133793|526767105|FG000|Overall Study|Death|0|||
146068076|NCT03133793|526767106|FG001|Overall Study|Death|0|||
146068077|NCT03133793|526767107|FG002|Overall Study|Death|0|||
146068078|NCT03133793|526767108|FG003|Overall Study|Death|1|||
146068079|NCT02536963|526767110|FG000|Overall Study|Withdrawal by Subject|18|||
146068080|NCT00515619|526767115|FG000|Overall Study|Adverse Event|34|||
146068081|NCT00515619|526767115|FG000|Overall Study|Lack of Efficacy|92|||
146068082|NCT00515619|526767115|FG000|Overall Study|Withdrawal by Subject|66|||
146068083|NCT00515619|526767115|FG000|Overall Study|Protocol Violation|3|||
146068084|NCT00515619|526767115|FG000|Overall Study|Lost to Follow-up|4|||
146068085|NCT00515619|526767115|FG000|Overall Study|Unsatisfactory compliance|6|||
146068086|NCT00515619|526767115|FG000|Overall Study|Other: Site discontinuing trials|2|||
146068087|NCT00515619|526767115|FG000|Overall Study|Other: Subject cannot attend visits|2|||
146068088|NCT00515619|526767115|FG000|Overall Study|Other: Subject required surgery|1|||
146068089|NCT00515619|526767115|FG000|Overall Study|Other: Subject moved to another country|1|||
146068090|NCT00515619|526767115|FG000|Overall Study|Other: Investigator decision|1|||
146068091|NCT00515619|526767115|FG000|Overall Study|Other: Subject became pregnant|1|||
146068092|NCT00515619|526767115|FG000|Overall Study|Other: Request from sponsor|1|||
146068093|NCT00515619|526767115|FG000|Overall Study|Other: Drug available on license|1|||
146068094|NCT00515619|526767115|FG000|Overall Study|Other: Subject interested in other AED|1|||
146068095|NCT02379091|526767116|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146068096|NCT02379091|526767117|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146068097|NCT02379091|526767118|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146068098|NCT02379091|526767119|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146068099|NCT02379091|526767116|FG000|Overall Study|Principal Investigator Discretion|0|||
146068100|NCT02379091|526767117|FG001|Overall Study|Principal Investigator Discretion|1|||
146068101|NCT02379091|526767118|FG002|Overall Study|Principal Investigator Discretion|0|||
146068102|NCT02379091|526767119|FG003|Overall Study|Principal Investigator Discretion|0|||
146068103|NCT02379091|526767116|FG000|Overall Study|Lost to Follow-up|0|||
146068104|NCT02379091|526767117|FG001|Overall Study|Lost to Follow-up|0|||
146068105|NCT02379091|526767118|FG002|Overall Study|Lost to Follow-up|0|||
146068106|NCT02379091|526767119|FG003|Overall Study|Lost to Follow-up|1|||
146068107|NCT02379091|526767116|FG000|Overall Study|Voluntary Withdrawal|2|||
146068108|NCT02379091|526767117|FG001|Overall Study|Voluntary Withdrawal|5|||
146068109|NCT02379091|526767118|FG002|Overall Study|Voluntary Withdrawal|2|||
146068110|NCT02379091|526767119|FG003|Overall Study|Voluntary Withdrawal|4|||
146068111|NCT02379091|526767116|FG000|Overall Study|Study Termination|7|||
146068112|NCT02379091|526767117|FG001|Overall Study|Study Termination|2|||
146068113|NCT02379091|526767118|FG002|Overall Study|Study Termination|5|||
146068114|NCT02379091|526767119|FG003|Overall Study|Study Termination|8|||
146068115|NCT02379091|526767116|FG000|Overall Study|Lack of Efficacy|3|||
146068116|NCT02379091|526767117|FG001|Overall Study|Lack of Efficacy|0|||
146068117|NCT02379091|526767118|FG002|Overall Study|Lack of Efficacy|0|||
146068118|NCT02379091|526767119|FG003|Overall Study|Lack of Efficacy|0|||
146068119|NCT02129699|526767121|FG000|Overall Study|Did not start treatment|3|||
146068120|NCT02129699|526767122|FG001|Overall Study|Did not start treatment|2|||
146068121|NCT00670748|526767127|FG000|Overall Study|Death during treatment|1|||
146068122|NCT00670748|526767128|FG001|Overall Study|Death during treatment|1|||
146068123|NCT00670748|526767129|FG002|Overall Study|Death during treatment|1|||
146068124|NCT00670748|526767130|FG003|Overall Study|Death during treatment|0|||
146068125|NCT00670748|526767127|FG000|Overall Study|Not off study|2|||
146408210|NCT04529499|528000129|FG000|Overall Study|Others|7|||
146408211|NCT04529499|528000130|FG001|Overall Study|Others|11|||
146408212|NCT02441179|528000132|FG000|Overall Study|Withdrawal by Subject|1|||
146408213|NCT02441179|528000133|FG001|Overall Study|Withdrawal by Subject|1|||
146408214|NCT01494649|528000134|FG000|Overall Study|Lost to Follow-up|0|||
146408215|NCT01494649|528000135|FG001|Overall Study|Lost to Follow-up|1|||
146408216|NCT03467971|528000136|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146408217|NCT03467971|528000137|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146408218|NCT01656967|528000138|FG000|Overall Study|faulty monitor|1|||
146408219|NCT01656967|528000139|FG001|Overall Study|faulty monitor|0|||
146408220|NCT01656967|528000138|FG000|Overall Study|unsuccessful ETT insertion|3|||
146408221|NCT01656967|528000139|FG001|Overall Study|unsuccessful ETT insertion|2|||
146408222|NCT00479765|528000140|FG000|Overall Study|study terminated|4|||
146408223|NCT05166512|528000141|FG000|Randomized|Lost to Follow-up|2|||
146408224|NCT05166512|528000142|FG001|Randomized|Lost to Follow-up|0|||
146408225|NCT05166512|528000141|FG000|Randomized|Withdrawal by Subject|1|||
146408226|NCT05166512|528000142|FG001|Randomized|Withdrawal by Subject|0|||
146408227|NCT05166512|528000141|FG000|Baseline Data Collection|Lost to Follow-up|0|||
146408228|NCT05166512|528000142|FG001|Baseline Data Collection|Lost to Follow-up|3|||
146408229|NCT05166512|528000141|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
146408230|NCT05166512|528000142|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
146408231|NCT05166512|528000141|FG000|Baseline Data Collection|Protocol Violation|2|||
146408232|NCT05166512|528000142|FG001|Baseline Data Collection|Protocol Violation|0|||
146408233|NCT05166512|528000141|FG000|4 Month Data Collection|Lost to Follow-up|1|||
146408234|NCT05166512|528000142|FG001|4 Month Data Collection|Lost to Follow-up|0|||
146408235|NCT05166512|528000141|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
146408236|NCT05166512|528000142|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
146408237|NCT05166512|528000141|FG000|12 Month Data Collection|Lost to Follow-up|3|||
146408238|NCT05166512|528000142|FG001|12 Month Data Collection|Lost to Follow-up|1|||
146408239|NCT05166512|528000141|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
146408240|NCT05166512|528000142|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
146408241|NCT00420849|528000143|FG000|Overall Study|Lack of Efficacy|154|||
146408242|NCT00420849|528000143|FG000|Overall Study|Adverse Event|107|||
146408243|NCT00420849|528000143|FG000|Overall Study|Withdrawal by Subject|28|||
146408244|NCT00420849|528000143|FG000|Overall Study|Death|18|||
146408245|NCT00420849|528000143|FG000|Overall Study|Other|14|||
146408246|NCT00420849|528000143|FG000|Overall Study|Transplant|8|||
146408247|NCT00420849|528000143|FG000|Overall Study|Protocol Violation|1|||
146408248|NCT00420849|528000143|FG000|Overall Study|Lost to Follow-up|1|||
146408249|NCT00725725|528000144|FG000|Overall Study|Adverse Event|1|||
146408250|NCT00725725|528000145|FG001|Overall Study|Adverse Event|3|||
146408251|NCT00725725|528000146|FG002|Overall Study|Adverse Event|2|||
146408252|NCT00725725|528000144|FG000|Overall Study|Lost to Follow-up|2|||
146408253|NCT00725725|528000145|FG001|Overall Study|Lost to Follow-up|0|||
146408254|NCT00725725|528000146|FG002|Overall Study|Lost to Follow-up|2|||
146408255|NCT00725725|528000144|FG000|Overall Study|Withdrawal by Subject|1|||
146408256|NCT00725725|528000145|FG001|Overall Study|Withdrawal by Subject|0|||
146408257|NCT00725725|528000146|FG002|Overall Study|Withdrawal by Subject|1|||
146408258|NCT00725725|528000144|FG000|Overall Study|Protocol Violation|0|||
146408259|NCT00725725|528000145|FG001|Overall Study|Protocol Violation|1|||
146408260|NCT00725725|528000146|FG002|Overall Study|Protocol Violation|0|||
146408261|NCT01619085|528000147|FG000|Overall Study|Adverse Event|231|||
146408262|NCT01619085|528000147|FG000|Overall Study|Protocol Violation|4|||
146408263|NCT01619085|528000147|FG000|Overall Study|Lost to Follow-up|3|||
146408264|NCT01619085|528000147|FG000|Overall Study|Withdrawal by Subject|45|||
146408265|NCT01619085|528000147|FG000|Overall Study|Other than specified|96|||
146408266|NCT01619085|528000147|FG000|Overall Study|Not treated|1|||
146408267|NCT01619085|528000147|FG000|Overall Study|Death|145|||
146408268|NCT01345058|528000148|FG000|Overall Study|Withdrawal by Subject|1|||
146408269|NCT01345058|528000149|FG001|Overall Study|Withdrawal by Subject|0|||
146408270|NCT01345058|528000148|FG000|Overall Study|Participant Reported Increase in Events|1|||
146408271|NCT01345058|528000149|FG001|Overall Study|Participant Reported Increase in Events|0|||
146408272|NCT01345058|528000148|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
146408273|NCT01345058|528000149|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
146408274|NCT01345058|528000148|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
146408275|NCT01345058|528000149|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
146408276|NCT01345058|528000148|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
146408277|NCT01345058|528000149|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
146408278|NCT00000135|528000150|FG000|Overall Study|Death|27|||
146408279|NCT00000135|528000151|FG001|Overall Study|Death|14|||
146408280|NCT00944125|528000154|FG000|3 to 6 Months|Withdrawal by Subject|0|||
146408281|NCT00944125|528000155|FG001|3 to 6 Months|Withdrawal by Subject|2|||
146408282|NCT00944125|528000154|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
146408283|NCT00944125|528000155|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
146408284|NCT03125629|528000156|FG000|Overall Study|Withdrawal by Subject|2|||
146408285|NCT03125629|528000156|FG000|Overall Study|Equipment malfunction|1|||
146068126|NCT00670748|526767128|FG001|Overall Study|Not off study|1|||
146068127|NCT00670748|526767129|FG002|Overall Study|Not off study|1|||
146068128|NCT00670748|526767130|FG003|Overall Study|Not off study|1|||
146068129|NCT03863080|526767135|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146068130|NCT03863080|526767136|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146068131|NCT03863080|526767137|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
146068132|NCT03863080|526767138|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
146068133|NCT03863080|526767135|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146068134|NCT03863080|526767136|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146068135|NCT03863080|526767137|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
146068136|NCT03863080|526767138|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
146068137|NCT03863080|526767135|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146068138|NCT03863080|526767136|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146068139|NCT03863080|526767137|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
146068140|NCT03863080|526767138|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
146068141|NCT02991768|526767148|FG000|Overall Study|Physician Decision|4|||
146068142|NCT03467750|526767149|FG000|Overall Study|Surgery canceled|1|||
146068143|NCT03467750|526767150|FG001|Overall Study|Surgery canceled|0|||
146068144|NCT03467750|526767149|FG000|Overall Study|Protocol Violation|1|||
146068145|NCT03467750|526767150|FG001|Overall Study|Protocol Violation|1|||
146068146|NCT03467750|526767149|FG000|Overall Study|Withdrawal by Subject|0|||
146068147|NCT03467750|526767150|FG001|Overall Study|Withdrawal by Subject|1|||
146068148|NCT05673876|526767151|FG000|Overall Study|Death|3|||
146068149|NCT05673876|526767152|FG001|Overall Study|Death|1|||
146068150|NCT05673876|526767151|FG000|Overall Study|Study Terminated by Sponsor|0|||
146068151|NCT05673876|526767152|FG001|Overall Study|Study Terminated by Sponsor|1|||
146068152|NCT05673876|526767151|FG000|Overall Study|Physician Decision|0|||
146068153|NCT05673876|526767152|FG001|Overall Study|Physician Decision|1|||
146068154|NCT03529422|526767153|FG000|Overall Study|Withdrawal by Subject|1|||
146068155|NCT03529422|526767153|FG000|Overall Study|Protocol Violation|1|||
146068156|NCT03529422|526767153|FG000|Overall Study|Disease progression|2|||
146068157|NCT02000115|526767156|FG000|Overall Study|Death|56|||
146068158|NCT02000115|526767157|FG001|Overall Study|Death|45|||
146068159|NCT02000115|526767158|FG002|Overall Study|Death|0|||
146068160|NCT02000115|526767159|FG003|Overall Study|Death|0|||
146068161|NCT02000115|526767156|FG000|Overall Study|Missed Visit|6|||
146068162|NCT02000115|526767157|FG001|Overall Study|Missed Visit|8|||
146068163|NCT02000115|526767158|FG002|Overall Study|Missed Visit|1|||
146068164|NCT02000115|526767159|FG003|Overall Study|Missed Visit|0|||
146068165|NCT02000115|526767156|FG000|Overall Study|Protocol Violation|2|||
146068166|NCT02000115|526767157|FG001|Overall Study|Protocol Violation|1|||
146068167|NCT02000115|526767158|FG002|Overall Study|Protocol Violation|0|||
146068168|NCT02000115|526767159|FG003|Overall Study|Protocol Violation|0|||
146068169|NCT02000115|526767156|FG000|Overall Study|Physician Decision|2|||
146068170|NCT02000115|526767157|FG001|Overall Study|Physician Decision|0|||
146408286|NCT00743119|528000157|FG000|Overall Study|unreliable|3|||
146408287|NCT00743119|528000157|FG000|Overall Study|Withdrawal by Subject|1|||
146408288|NCT04816877|528000158|FG000|Overall Study|Withdrawal by Subject|1|||
146408289|NCT04816877|528000159|FG001|Overall Study|Withdrawal by Subject|0|||
146408290|NCT02989610|528000160|FG000|Overall Study|Withdrawal by Subject|20|||
146408291|NCT02989610|528000160|FG000|Overall Study|Departure of PI from Site|8|||
146408292|NCT02989610|528000160|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
146408293|NCT02989610|528000160|FG000|Overall Study|Lost to Follow-up|3|||
146408294|NCT02989610|528000160|FG000|Overall Study|Death|3|||
146408295|NCT02989610|528000160|FG000|Overall Study|System Explant|3|||
146408296|NCT02989610|528000160|FG000|Overall Study|Subject Non-Compliance|2|||
146408297|NCT02989610|528000160|FG000|Overall Study|System Revision|2|||
146408298|NCT02989610|528000160|FG000|Overall Study|PI Left, Study Closing|1|||
146408299|NCT02989610|528000160|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
146408300|NCT02989610|528000160|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
146068171|NCT02000115|526767158|FG002|Overall Study|Physician Decision|0|||
146068172|NCT02000115|526767159|FG003|Overall Study|Physician Decision|0|||
146068173|NCT02000115|526767156|FG000|Overall Study|Withdrawal by Subject|11|||
146171907|NCT05807919|527143279|FG001|Overall Study|Adverse Event|1|||
146408301|NCT04508621|528000163|FG000|Overall Study|Adverse Event|39|||
145945247|NCT03008278|526308188|FG001|Overall Study|Progressive Disease|0|||
146068174|NCT02000115|526767157|FG001|Overall Study|Withdrawal by Subject|11|||
146068175|NCT02000115|526767158|FG002|Overall Study|Withdrawal by Subject|0|||
146068176|NCT02000115|526767159|FG003|Overall Study|Withdrawal by Subject|0|||
146068177|NCT02000115|526767156|FG000|Overall Study|Lost to Follow-up|0|||
146068178|NCT02000115|526767157|FG001|Overall Study|Lost to Follow-up|1|||
146068179|NCT02000115|526767158|FG002|Overall Study|Lost to Follow-up|0|||
146068180|NCT02000115|526767159|FG003|Overall Study|Lost to Follow-up|0|||
146068181|NCT02000115|526767156|FG000|Overall Study|Non-compliance|2|||
146068182|NCT02000115|526767157|FG001|Overall Study|Non-compliance|1|||
146068183|NCT02000115|526767158|FG002|Overall Study|Non-compliance|0|||
146068184|NCT02000115|526767159|FG003|Overall Study|Non-compliance|0|||
146068185|NCT02000115|526767156|FG000|Overall Study|Withdrawn on day of randomization|0|||
146068186|NCT02000115|526767157|FG001|Overall Study|Withdrawn on day of randomization|1|||
146068187|NCT02000115|526767158|FG002|Overall Study|Withdrawn on day of randomization|0|||
146068188|NCT02000115|526767159|FG003|Overall Study|Withdrawn on day of randomization|0|||
146068189|NCT02000115|526767156|FG000|Overall Study|Still on Study|0|||
146068190|NCT02000115|526767157|FG001|Overall Study|Still on Study|0|||
146068191|NCT02000115|526767158|FG002|Overall Study|Still on Study|0|||
146068192|NCT02000115|526767159|FG003|Overall Study|Still on Study|53|||
146068193|NCT05006573|526767162|FG000|Double-blind Treatment Period|Physician Decision|2|||
146068194|NCT05006573|526767163|FG001|Double-blind Treatment Period|Physician Decision|0|||
146068195|NCT05006573|526767162|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
146068196|NCT05006573|526767163|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
146068197|NCT05006573|526767162|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146068198|NCT05006573|526767163|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146068199|NCT05006573|526767162|FG000|Double-blind Treatment Period|Protocol Violation|2|||
146068200|NCT05006573|526767163|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146068201|NCT05006573|526767162|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
146068202|NCT05006573|526767163|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
146068203|NCT05006573|526767162|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
146068204|NCT05006573|526767163|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
146068205|NCT04949490|526767164|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146068206|NCT04949490|526767165|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146068207|NCT04949490|526767166|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146068208|NCT04949490|526767167|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
146068209|NCT04949490|526767168|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146068210|NCT04949490|526767169|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
146068211|NCT04949490|526767164|FG000|Group A and Group B|Withdrawal by Subject|0|||
146068212|NCT04949490|526767165|FG001|Group A and Group B|Withdrawal by Subject|0|||
146068213|NCT04949490|526767166|FG002|Group A and Group B|Withdrawal by Subject|1|||
146068214|NCT04949490|526767167|FG003|Group A and Group B|Withdrawal by Subject|0|||
146068215|NCT04949490|526767168|FG004|Group A and Group B|Withdrawal by Subject|0|||
146068216|NCT04949490|526767169|FG005|Group A and Group B|Withdrawal by Subject|0|||
146068217|NCT04949490|526767164|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146068218|NCT04949490|526767165|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146068219|NCT04949490|526767166|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146068220|NCT04949490|526767167|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146068221|NCT04949490|526767168|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
146068222|NCT04949490|526767169|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
146068223|NCT04949490|526767164|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146068224|NCT04949490|526767165|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146068225|NCT04949490|526767166|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146068226|NCT04949490|526767167|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146068227|NCT04949490|526767168|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
146068228|NCT04949490|526767169|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
146068229|NCT04988477|526767172|FG000|Overall Study|Death|1|||
146068230|NCT04988477|526767173|FG001|Overall Study|Death|0|||
146068231|NCT04988477|526767174|FG002|Overall Study|Death|0|||
146068232|NCT04988477|526767172|FG000|Overall Study|Lost to Follow-up|5|||
146068233|NCT04988477|526767173|FG001|Overall Study|Lost to Follow-up|2|||
146068234|NCT04988477|526767174|FG002|Overall Study|Lost to Follow-up|0|||
146068235|NCT04988477|526767172|FG000|Overall Study|Withdrawal by Subject|2|||
146068236|NCT04988477|526767173|FG001|Overall Study|Withdrawal by Subject|0|||
146068237|NCT04988477|526767174|FG002|Overall Study|Withdrawal by Subject|0|||
146068238|NCT01987453|526768648|FG000|Overall Study|Death|0|||
146068239|NCT01987453|526768649|FG001|Overall Study|Death|0|||
146068240|NCT01987453|526768650|FG002|Overall Study|Death|1|||
146068241|NCT01987453|526768648|FG000|Overall Study|Lack of Efficacy|1|||
146068242|NCT01987453|526768649|FG001|Overall Study|Lack of Efficacy|12|||
146068243|NCT01987453|526768650|FG002|Overall Study|Lack of Efficacy|0|||
146068244|NCT01590888|526768651|FG000|Overall Study|Adverse Event|3|||
146068245|NCT01590888|526768652|FG001|Overall Study|Adverse Event|0|||
146068246|NCT01590888|526768653|FG002|Overall Study|Adverse Event|1|||
146068247|NCT01590888|526768651|FG000|Overall Study|Lost to Follow-up|1|||
146068248|NCT01590888|526768652|FG001|Overall Study|Lost to Follow-up|0|||
146068249|NCT01590888|526768653|FG002|Overall Study|Lost to Follow-up|0|||
146068250|NCT04953728|526768654|FG000|Overall Study|Withdrawal by Subject|3|||
146068251|NCT04953728|526768654|FG000|Overall Study|Physician Decision|1|||
146068252|NCT02105662|526768655|FG000|Overall Study|Lost to Follow-up|5|||
146068253|NCT02105662|526768655|FG000|Overall Study|Withdrawal by Subject|1|||
146068254|NCT02331277|526768656|FG000|Overall Study|Withdrawal by Subject|1|||
146068255|NCT02331277|526768657|FG001|Overall Study|Withdrawal by Subject|0|||
146068256|NCT00990704|526768660|FG000|Overall Study|Adverse Event|1|||
146068257|NCT00990704|526768661|FG001|Overall Study|Adverse Event|1|||
146068258|NCT00990704|526768660|FG000|Overall Study|Physician Decision|0|||
146068259|NCT00990704|526768661|FG001|Overall Study|Physician Decision|1|||
146068260|NCT01399372|526768662|FG000|Overall Study|Protocol Violation|3|||
146408302|NCT04508621|528000164|FG001|Overall Study|Adverse Event|16|||
146408303|NCT04508621|528000163|FG000|Overall Study|Lack of Efficacy|2|||
146408304|NCT04508621|528000164|FG001|Overall Study|Lack of Efficacy|8|||
146408305|NCT04508621|528000163|FG000|Overall Study|Physician Decision|0|||
146408306|NCT04508621|528000164|FG001|Overall Study|Physician Decision|1|||
146408307|NCT04508621|528000163|FG000|Overall Study|Withdrawal by Subject|10|||
146408308|NCT04508621|528000164|FG001|Overall Study|Withdrawal by Subject|14|||
146408309|NCT04508621|528000163|FG000|Overall Study|Lost to Follow-up|12|||
146408310|NCT04508621|528000164|FG001|Overall Study|Lost to Follow-up|9|||
146408311|NCT04508621|528000163|FG000|Overall Study|COVID-19 related crisis|3|||
146408312|NCT04508621|528000164|FG001|Overall Study|COVID-19 related crisis|0|||
146408313|NCT04508621|528000163|FG000|Overall Study|Subject non-compliance|1|||
146408314|NCT04508621|528000164|FG001|Overall Study|Subject non-compliance|0|||
146408315|NCT04355767|528000165|FG000|Overall Study|Withdrawal by Subject|2|||
146408316|NCT04355767|528000166|FG001|Overall Study|Withdrawal by Subject|2|||
146068261|NCT01399372|526768663|FG001|Overall Study|Protocol Violation|1|||
146068262|NCT01376804|526768664|FG000|Treatment Period|Withdrawal by Subject|1|||
146068263|NCT01376804|526768664|FG000|Treatment Period|Adverse Event|6|||
146408317|NCT04355767|528000165|FG000|Overall Study|Death|5|||
146068264|NCT01376804|526768664|FG000|Treatment Period|Patient did not receive study drug|1|||
146068265|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
146068266|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
146068267|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Patient requirement|20|||
146068268|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Death|5|||
146068269|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Change of therapy|6|||
146068270|NCT01071798|526768665|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
146068271|NCT01071798|526768665|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
146068272|NCT01071798|526768665|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
146068273|NCT01071798|526768665|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
146068274|NCT01071798|526768665|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
146068275|NCT01705509|526768672|FG000|Inclusion CPET|Screen Failure|5|||
146068276|NCT01705509|526768672|FG000|Inclusion CPET|Withdrawal by Subject|2|||
146068277|NCT01705509|526768672|FG000|CPET w/ Ranexa|Screen Failure|2|||
146068278|NCT02736890|526768673|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
146068279|NCT02736890|526768674|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
146068280|NCT02736890|526768673|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
146068281|NCT02736890|526768674|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
146068282|NCT02904954|526768675|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
146068283|NCT02904954|526768676|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
146068284|NCT02904954|526768675|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
146068285|NCT02904954|526768676|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
146068286|NCT02904954|526768675|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
146068287|NCT02904954|526768676|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
146068288|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Recurrence|2|||
146068289|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Recurrence|0|||
146068290|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Adverse Event|2|||
146068291|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Adverse Event|6|||
146068292|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Participant wishes|12|||
146068293|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Participant wishes|7|||
146068294|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Physician Decision|2|||
146068295|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Physician Decision|1|||
146068296|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
146068297|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
146068298|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Death|0|||
146068299|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Death|1|||
146068300|NCT02904954|526768675|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
146068301|NCT02904954|526768676|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
146068302|NCT05097963|526768677|FG000|Overall Study|Protocol Violation|13|||
146068303|NCT05097963|526768677|FG000|Overall Study|Withdrawal by Subject|21|||
146068304|NCT03349034|526768680|FG000|Overall Study|catheters dislodged during transport|2|||
146068305|NCT03349034|526768681|FG001|Overall Study|catheters dislodged during transport|0|||
146068306|NCT03349034|526768680|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
146068307|NCT03349034|526768681|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
146068308|NCT03349034|526768680|FG000|Overall Study|soft tissue flap used|1|||
146068309|NCT03349034|526768681|FG001|Overall Study|soft tissue flap used|0|||
146068310|NCT03349034|526768680|FG000|Overall Study|Other|0|||
146068311|NCT03349034|526768681|FG001|Overall Study|Other|1|||
146068312|NCT01039376|526768682|FG000|Overall Study|Lost to Follow-up|5|||
146068313|NCT01039376|526768683|FG001|Overall Study|Lost to Follow-up|12|||
146068314|NCT01039376|526768682|FG000|Overall Study|Physician Decision|15|||
146068315|NCT01039376|526768683|FG001|Overall Study|Physician Decision|10|||
146068316|NCT01039376|526768682|FG000|Overall Study|Withdrawal by Subject|20|||
146068317|NCT01039376|526768683|FG001|Overall Study|Withdrawal by Subject|32|||
146068318|NCT01039376|526768682|FG000|Overall Study|Study terminated by Sponsor|90|||
146068319|NCT01039376|526768683|FG001|Overall Study|Study terminated by Sponsor|72|||
146068320|NCT00123422|526768684|FG000|Overall Study|Physician Decision|2|||
146068321|NCT00123422|526768685|FG001|Overall Study|Physician Decision|2|||
146068322|NCT00123422|526768686|FG002|Overall Study|Physician Decision|6|||
146068323|NCT00123422|526768684|FG000|Overall Study|Withdrawal by Subject|1|||
146068324|NCT00123422|526768685|FG001|Overall Study|Withdrawal by Subject|2|||
146068325|NCT00123422|526768686|FG002|Overall Study|Withdrawal by Subject|2|||
146068326|NCT00123422|526768684|FG000|Overall Study|Lost to Follow-up|1|||
146068327|NCT00123422|526768685|FG001|Overall Study|Lost to Follow-up|2|||
146068328|NCT00123422|526768686|FG002|Overall Study|Lost to Follow-up|2|||
146068329|NCT01554241|526768687|FG000|Overall Study|Death|3|||
146068330|NCT01554241|526768688|FG001|Overall Study|Death|1|||
146283847|NCT00092495|527551858|FG004|Base Study Vaccination Period|Other|0|||
146068331|NCT01554241|526768689|FG002|Overall Study|Death|1|||
146068332|NCT01554241|526768690|FG003|Overall Study|Death|0|||
146068333|NCT01554241|526768687|FG000|Overall Study|protocol specified renal stone|0|||
146068334|NCT01554241|526768688|FG001|Overall Study|protocol specified renal stone|0|||
146068335|NCT01554241|526768689|FG002|Overall Study|protocol specified renal stone|0|||
146068336|NCT01554241|526768690|FG003|Overall Study|protocol specified renal stone|1|||
146068337|NCT01554241|526768687|FG000|Overall Study|protocol specified change in eGFR|0|||
146068338|NCT01554241|526768688|FG001|Overall Study|protocol specified change in eGFR|0|||
146068339|NCT01554241|526768689|FG002|Overall Study|protocol specified change in eGFR|1|||
146068340|NCT01554241|526768690|FG003|Overall Study|protocol specified change in eGFR|0|||
146068341|NCT01554241|526768687|FG000|Overall Study|Withdrawal by Subject|0|||
146068342|NCT01554241|526768688|FG001|Overall Study|Withdrawal by Subject|0|||
146068343|NCT01554241|526768689|FG002|Overall Study|Withdrawal by Subject|2|||
146068344|NCT01554241|526768690|FG003|Overall Study|Withdrawal by Subject|0|||
146068345|NCT02118961|526768691|FG000|Overall Study|Withdrawal by Subject|1|||
146068346|NCT02118961|526768692|FG001|Overall Study|Withdrawal by Subject|0|||
146068347|NCT03809104|526768695|FG000|Overall Study|Withdrawal by Subject|3|||
146068348|NCT01532986|526768696|FG000|Overall Study|Death|9|||
146068349|NCT01532986|526768697|FG001|Overall Study|Death|9|||
146068350|NCT01532986|526768696|FG000|Overall Study|Withdrawal by Subject|7|||
146068351|NCT01532986|526768697|FG001|Overall Study|Withdrawal by Subject|10|||
146068352|NCT01532986|526768696|FG000|Overall Study|Physician Decision|7|||
146068353|NCT01532986|526768697|FG001|Overall Study|Physician Decision|5|||
146068354|NCT02120898|526768698|FG000|Overall Study|Withdrawal by Subject|4|||
146068355|NCT02120898|526768699|FG001|Overall Study|Withdrawal by Subject|2|||
146068356|NCT02120898|526768700|FG002|Overall Study|Withdrawal by Subject|2|||
146068357|NCT02120898|526768698|FG000|Overall Study|Non-compliance with study drug|3|||
146068358|NCT02120898|526768699|FG001|Overall Study|Non-compliance with study drug|0|||
146068359|NCT02120898|526768700|FG002|Overall Study|Non-compliance with study drug|0|||
146068360|NCT02120898|526768698|FG000|Overall Study|Adverse Event|1|||
146068361|NCT02120898|526768699|FG001|Overall Study|Adverse Event|2|||
146068362|NCT02120898|526768700|FG002|Overall Study|Adverse Event|1|||
146068363|NCT02120898|526768698|FG000|Overall Study|Protocol Violation|1|||
146068364|NCT02120898|526768699|FG001|Overall Study|Protocol Violation|2|||
146068365|NCT02120898|526768700|FG002|Overall Study|Protocol Violation|0|||
146068366|NCT02120898|526768698|FG000|Overall Study|Lost to Follow-up|0|||
146068367|NCT02120898|526768699|FG001|Overall Study|Lost to Follow-up|0|||
146068368|NCT02120898|526768700|FG002|Overall Study|Lost to Follow-up|1|||
146068369|NCT04313244|526768701|FG000|Overall Study|Withdrawal of Consent|3|||
146068370|NCT04313244|526768702|FG001|Overall Study|Withdrawal of Consent|3|||
146068371|NCT04313244|526768701|FG000|Overall Study|Met Exclusion Criteria|1|||
146068372|NCT04313244|526768702|FG001|Overall Study|Met Exclusion Criteria|0|||
146068373|NCT04313244|526768701|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
146068374|NCT04313244|526768702|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
146068375|NCT00927953|526768703|FG000|Overall Study|Death|2|||
146068376|NCT00927953|526768704|FG001|Overall Study|Death|1|||
146068377|NCT05021978|526768705|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
146068378|NCT05021978|526768706|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146068379|NCT05021978|526768707|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146068380|NCT05021978|526768708|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
146068381|NCT05021978|526768705|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146068382|NCT05021978|526768706|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
146068383|NCT05021978|526768707|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146068384|NCT05021978|526768708|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
146068385|NCT00043979|526768709|FG000|Period 1|recipient with progressive disease|7|||
146068386|NCT00043979|526768710|FG001|Period 1|recipient with progressive disease|4|||
146068387|NCT00043979|526768711|FG002|Period 1|recipient with progressive disease|3|||
146068388|NCT01411891|526768716|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
146068389|NCT01411891|526768717|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
146068390|NCT02004093|526768718|FG000|Overall Study|Death|2|||
146068391|NCT02004093|526768719|FG001|Overall Study|Death|1|||
146068392|NCT02004093|526768718|FG000|Overall Study|Lack of Efficacy|66|||
146068393|NCT02004093|526768719|FG001|Overall Study|Lack of Efficacy|62|||
146408318|NCT04355767|528000166|FG001|Overall Study|Death|1|||
146408319|NCT01999322|528000167|FG000|Overall Study|Adverse Event|1|||
146408320|NCT01999322|528000168|FG001|Overall Study|Adverse Event|0|||
146408321|NCT00833976|528002085|FG000|Overall Study|Withdrawal by Subject|5|||
146408322|NCT00833976|528002085|FG000|Overall Study|Lost to Follow-up|4|||
146408323|NCT00833976|528002085|FG000|Overall Study|Did not meet eligibility criteria|41|||
146408324|NCT00833976|528002085|FG000|Overall Study|Physician Decision|1|||
146408325|NCT03724916|528002088|FG000|Overall Study|Withdrawal by Subject|0|||
146408326|NCT03724916|528002089|FG001|Overall Study|Withdrawal by Subject|1|||
146408327|NCT03724916|528002090|FG002|Overall Study|Withdrawal by Subject|1|||
146408328|NCT03724916|528002091|FG003|Overall Study|Withdrawal by Subject|2|||
146408329|NCT03724916|528002088|FG000|Overall Study|Randomized but not Treated|1|||
146408330|NCT03724916|528002089|FG001|Overall Study|Randomized but not Treated|0|||
146408331|NCT03724916|528002090|FG002|Overall Study|Randomized but not Treated|0|||
146408332|NCT03724916|528002091|FG003|Overall Study|Randomized but not Treated|0|||
146408333|NCT02464059|528002096|FG000|Overall Study|Lost to Follow-up|6|||
146408334|NCT01272193|528002097|FG000|Overall Study|Adverse Event|1|||
146408335|NCT01272193|528002098|FG001|Overall Study|Adverse Event|1|||
146408336|NCT01272193|528002097|FG000|Overall Study|Lack of Efficacy|0|||
146408337|NCT01272193|528002098|FG001|Overall Study|Lack of Efficacy|3|||
146408338|NCT01272193|528002097|FG000|Overall Study|Withdrawal Criteria|1|||
146068394|NCT02004093|526768718|FG000|Overall Study|Protocol Violation|0|||
146068395|NCT02004093|526768719|FG001|Overall Study|Protocol Violation|1|||
146408339|NCT01272193|528002098|FG001|Overall Study|Withdrawal Criteria|1|||
146068396|NCT02004093|526768718|FG000|Overall Study|Lost to Follow-up|0|||
146068397|NCT02004093|526768719|FG001|Overall Study|Lost to Follow-up|1|||
146068398|NCT02004093|526768718|FG000|Overall Study|Withdrawal by Subject|3|||
146068399|NCT02004093|526768719|FG001|Overall Study|Withdrawal by Subject|7|||
146068400|NCT02004093|526768718|FG000|Overall Study|Other|3|||
146068401|NCT02004093|526768719|FG001|Overall Study|Other|1|||
146068402|NCT04085289|526768720|FG000|Overall Study|Withdrawal by Subject|0|||
146408340|NCT01272193|528002097|FG000|Overall Study|Unclassified|8|||
146408341|NCT01272193|528002098|FG001|Overall Study|Unclassified|7|||
146408342|NCT00350519|528002107|FG000|Overall Study|Death|0|||
146408343|NCT00350519|528002108|FG001|Overall Study|Death|1|||
146068403|NCT04085289|526768721|FG001|Overall Study|Withdrawal by Subject|0|||
146068404|NCT04085289|526768722|FG002|Overall Study|Withdrawal by Subject|1|||
146068405|NCT04639258|526768723|FG000|Overall Study|Screen failure|5|||
146068406|NCT04639258|526768723|FG000|Overall Study|Physician Decision|2|||
146068407|NCT04639258|526768723|FG000|Overall Study|Early study termination|3|||
146068408|NCT04639258|526768723|FG000|Overall Study|Withdrawal by Subject|1|||
146068409|NCT00414596|526768724|FG000|Overall Study|Protocol Violation|2|||
146068410|NCT04614974|526768726|FG000|Overall Study|Lost to Follow-up|14|||
146068411|NCT04614974|526768727|FG001|Overall Study|Lost to Follow-up|11|||
146068412|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Adverse Event|9|||
146068413|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Adverse Event|3|||
146068414|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Death|7|||
146068415|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Death|7|||
146068416|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
146068417|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
146068418|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Physician Decision|1|||
146068419|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Physician Decision|0|||
146068420|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
146068421|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
146068422|NCT02558296|526768729|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
146068423|NCT02558296|526768730|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
146171908|NCT03635489|527143284|FG000|Overall Study|Death|19|||
146171909|NCT03635489|527143285|FG001|Overall Study|Death|13|||
146171910|NCT03635489|527143284|FG000|Overall Study|Lost to Follow-up|1|||
146068424|NCT02558296|526768729|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
146068425|NCT02558296|526768730|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
146068426|NCT02558296|526768729|FG000|Completed the Study|Adverse Event|14|||
146068427|NCT02558296|526768730|FG001|Completed the Study|Adverse Event|5|||
146068428|NCT02558296|526768729|FG000|Completed the Study|Death|39|||
146068429|NCT02558296|526768730|FG001|Completed the Study|Death|25|||
146068430|NCT02558296|526768729|FG000|Completed the Study|Lost to Follow-up|31|||
146068431|NCT02558296|526768730|FG001|Completed the Study|Lost to Follow-up|23|||
146068432|NCT02558296|526768729|FG000|Completed the Study|Physician Decision|6|||
146068433|NCT02558296|526768730|FG001|Completed the Study|Physician Decision|0|||
146068434|NCT02558296|526768729|FG000|Completed the Study|Protocol Violation|2|||
146068435|NCT02558296|526768730|FG001|Completed the Study|Protocol Violation|1|||
146068436|NCT02558296|526768729|FG000|Completed the Study|Withdrawal by Subject|53|||
146068437|NCT02558296|526768730|FG001|Completed the Study|Withdrawal by Subject|31|||
146068438|NCT02558296|526768729|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
146068439|NCT02558296|526768730|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
146068440|NCT02754440|526768731|FG000|Overall Study|Protocol Violation|3|||
146068441|NCT02754440|526768732|FG001|Overall Study|Protocol Violation|2|||
146068442|NCT02754440|526768733|FG002|Overall Study|Protocol Violation|2|||
146068443|NCT02754440|526768734|FG003|Overall Study|Protocol Violation|6|||
146068444|NCT02754440|526768731|FG000|Overall Study|Adverse Event|3|||
146068445|NCT02754440|526768732|FG001|Overall Study|Adverse Event|1|||
146068446|NCT02754440|526768733|FG002|Overall Study|Adverse Event|0|||
146068447|NCT02754440|526768734|FG003|Overall Study|Adverse Event|9|||
146068448|NCT02754440|526768731|FG000|Overall Study|Withdrawal by Subject|0|||
146068449|NCT02754440|526768732|FG001|Overall Study|Withdrawal by Subject|0|||
146068450|NCT02754440|526768733|FG002|Overall Study|Withdrawal by Subject|0|||
146068451|NCT02754440|526768734|FG003|Overall Study|Withdrawal by Subject|1|||
146068452|NCT02754440|526768731|FG000|Overall Study|Equipment failure|0|||
146068453|NCT02754440|526768732|FG001|Overall Study|Equipment failure|5|||
146068454|NCT02754440|526768733|FG002|Overall Study|Equipment failure|5|||
146068455|NCT02754440|526768734|FG003|Overall Study|Equipment failure|7|||
146068456|NCT02754440|526768731|FG000|Overall Study|Subject issues not resulting in AE|0|||
146068457|NCT02754440|526768732|FG001|Overall Study|Subject issues not resulting in AE|0|||
146068458|NCT02754440|526768733|FG002|Overall Study|Subject issues not resulting in AE|0|||
146068459|NCT02754440|526768734|FG003|Overall Study|Subject issues not resulting in AE|12|||
146068460|NCT02919995|526768738|FG000|Overall Study|Adverse Event|0|||
146068461|NCT02919995|526768739|FG001|Overall Study|Adverse Event|0|||
146068462|NCT02919995|526768740|FG002|Overall Study|Adverse Event|0|||
146068463|NCT02919995|526768741|FG003|Overall Study|Adverse Event|0|||
146068464|NCT02919995|526768742|FG004|Overall Study|Adverse Event|0|||
146068465|NCT02919995|526768743|FG005|Overall Study|Adverse Event|1|||
146068466|NCT02560558|526768744|FG000|Overall Study|Adverse Event|1|||
146068467|NCT02560558|526768745|FG001|Overall Study|Adverse Event|0|||
146068468|NCT02560558|526768744|FG000|Overall Study|Death|0|||
146068469|NCT02560558|526768745|FG001|Overall Study|Death|2|||
146068470|NCT02560558|526768744|FG000|Overall Study|Lost to Follow-up|0|||
146068471|NCT02560558|526768745|FG001|Overall Study|Lost to Follow-up|4|||
146068472|NCT02560558|526768744|FG000|Overall Study|Protocol Violation|3|||
146068473|NCT02560558|526768745|FG001|Overall Study|Protocol Violation|0|||
146068474|NCT02560558|526768744|FG000|Overall Study|Withdrawal by Subject|3|||
146068475|NCT02560558|526768745|FG001|Overall Study|Withdrawal by Subject|0|||
146068476|NCT01263197|526768747|FG000|First Intervention (Period 1)|Adverse Event|0|||
146068477|NCT01263197|526768748|FG001|First Intervention (Period 1)|Adverse Event|0|||
146068478|NCT01263197|526768749|FG002|First Intervention (Period 1)|Adverse Event|0|||
146068479|NCT01263197|526768750|FG003|First Intervention (Period 1)|Adverse Event|0|||
146068480|NCT01263197|526768751|FG004|First Intervention (Period 1)|Adverse Event|0|||
146068481|NCT01263197|526768752|FG005|First Intervention (Period 1)|Adverse Event|1|||
146068482|NCT01263197|526768747|FG000|Washout Period 1|Protocol Violation|0|||
146068483|NCT01263197|526768748|FG001|Washout Period 1|Protocol Violation|0|||
146068484|NCT01263197|526768749|FG002|Washout Period 1|Protocol Violation|0|||
146068485|NCT01263197|526768750|FG003|Washout Period 1|Protocol Violation|0|||
146068486|NCT01263197|526768751|FG004|Washout Period 1|Protocol Violation|1|||
146068487|NCT01263197|526768752|FG005|Washout Period 1|Protocol Violation|0|||
146068488|NCT01263197|526768747|FG000|Washout Period 2|Physician Decision|0|||
146068489|NCT01263197|526768748|FG001|Washout Period 2|Physician Decision|0|||
146068490|NCT01263197|526768749|FG002|Washout Period 2|Physician Decision|0|||
146068491|NCT01263197|526768750|FG003|Washout Period 2|Physician Decision|0|||
146068492|NCT01263197|526768751|FG004|Washout Period 2|Physician Decision|0|||
146068493|NCT01263197|526768752|FG005|Washout Period 2|Physician Decision|1|||
146068494|NCT01263197|526768747|FG000|Washout Period 2|Protocol Violation|0|||
146068495|NCT01263197|526768748|FG001|Washout Period 2|Protocol Violation|0|||
146068496|NCT01263197|526768749|FG002|Washout Period 2|Protocol Violation|0|||
146068497|NCT01263197|526768750|FG003|Washout Period 2|Protocol Violation|1|||
146408344|NCT00350519|528002107|FG000|Overall Study|Physician Decision|0|||
146408345|NCT00350519|528002108|FG001|Overall Study|Physician Decision|1|||
146408346|NCT00350519|528002107|FG000|Overall Study|Protocol Violation|1|||
146408347|NCT00350519|528002108|FG001|Overall Study|Protocol Violation|2|||
146408348|NCT00350519|528002107|FG000|Overall Study|Withdrawal by Subject|3|||
146408349|NCT00350519|528002108|FG001|Overall Study|Withdrawal by Subject|2|||
146408350|NCT04388527|528002109|FG000|Overall Study|Death|14|||
146408351|NCT04388527|528002109|FG000|Overall Study|Withdrawal by Subject|2|||
146408352|NCT04388527|528002109|FG000|Overall Study|Lost to Follow-up|1|||
146408353|NCT00289731|528002113|FG000|Overall Study|Adverse Event|1|||
146408354|NCT00289731|528002114|FG001|Overall Study|Adverse Event|2|||
146408355|NCT00289731|528002115|FG002|Overall Study|Adverse Event|2|||
146408356|NCT00289731|528002113|FG000|Overall Study|Other|1|||
146408357|NCT00289731|528002114|FG001|Overall Study|Other|0|||
146408358|NCT00289731|528002115|FG002|Overall Study|Other|0|||
146408359|NCT01830920|528002118|FG000|Overall Study|Adverse Event|1|||
146408360|NCT01830920|528002119|FG001|Overall Study|Adverse Event|0|||
146408361|NCT01830920|528002120|FG002|Overall Study|Adverse Event|1|||
146408362|NCT01830920|528002121|FG003|Overall Study|Adverse Event|0|||
146408363|NCT01830920|528002122|FG004|Overall Study|Adverse Event|0|||
146408364|NCT01830920|528002118|FG000|Overall Study|Withdrawal by Subject|2|||
146408365|NCT01830920|528002119|FG001|Overall Study|Withdrawal by Subject|2|||
146408366|NCT01830920|528002120|FG002|Overall Study|Withdrawal by Subject|1|||
146408367|NCT01830920|528002121|FG003|Overall Study|Withdrawal by Subject|7|||
146408368|NCT01830920|528002122|FG004|Overall Study|Withdrawal by Subject|1|||
146408369|NCT01830920|528002118|FG000|Overall Study|Death|3|||
146408370|NCT01830920|528002119|FG001|Overall Study|Death|3|||
146408371|NCT01830920|528002120|FG002|Overall Study|Death|5|||
146408372|NCT01830920|528002121|FG003|Overall Study|Death|4|||
146408373|NCT01830920|528002122|FG004|Overall Study|Death|4|||
146408374|NCT01830920|528002118|FG000|Overall Study|Other|15|||
146408375|NCT01830920|528002119|FG001|Overall Study|Other|1|||
146408376|NCT01830920|528002120|FG002|Overall Study|Other|1|||
146408377|NCT01830920|528002121|FG003|Overall Study|Other|5|||
146408378|NCT01830920|528002122|FG004|Overall Study|Other|3|||
146408379|NCT01313728|528002123|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
146408380|NCT00736333|528002124|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
146408381|NCT00736333|528002124|FG000|Overall Study|Data Missing|2|||
146408382|NCT00736333|528002124|FG000|Overall Study|Tumor Progression|75|||
146408383|NCT00736333|528002124|FG000|Overall Study|Toxicity|6|||
146408384|NCT00736333|528002124|FG000|Overall Study|Withdrawal by Subject|10|||
146408385|NCT00736333|528002124|FG000|Overall Study|Death|7|||
146408386|NCT00736333|528002124|FG000|Overall Study|Other|4|||
146408387|NCT00572156|528002132|FG000|Overall Study|Adverse Event|3|||
146408388|NCT00572156|528002133|FG001|Overall Study|Adverse Event|1|||
146408389|NCT00572156|528002134|FG002|Overall Study|Adverse Event|5|||
146408390|NCT00572156|528002135|FG003|Overall Study|Adverse Event|1|||
146408391|NCT00572156|528002132|FG000|Overall Study|Lost to Follow-up|1|||
146408392|NCT00572156|528002133|FG001|Overall Study|Lost to Follow-up|1|||
146408393|NCT00572156|528002134|FG002|Overall Study|Lost to Follow-up|1|||
146408394|NCT00572156|528002135|FG003|Overall Study|Lost to Follow-up|0|||
146408395|NCT00572156|528002132|FG000|Overall Study|Protocol Violation|1|||
146408396|NCT00572156|528002133|FG001|Overall Study|Protocol Violation|2|||
146408397|NCT00572156|528002134|FG002|Overall Study|Protocol Violation|0|||
146408398|NCT00572156|528002135|FG003|Overall Study|Protocol Violation|2|||
146408399|NCT00572156|528002132|FG000|Overall Study|Patient/Parent Decision|1|||
146408400|NCT00572156|528002133|FG001|Overall Study|Patient/Parent Decision|6|||
146408401|NCT00572156|528002134|FG002|Overall Study|Patient/Parent Decision|4|||
146408402|NCT00572156|528002135|FG003|Overall Study|Patient/Parent Decision|3|||
146408403|NCT00572156|528002132|FG000|Overall Study|Sponsor Decision|20|||
146408404|NCT00572156|528002133|FG001|Overall Study|Sponsor Decision|16|||
146408405|NCT00572156|528002134|FG002|Overall Study|Sponsor Decision|17|||
146408406|NCT00572156|528002135|FG003|Overall Study|Sponsor Decision|19|||
146408407|NCT02261974|528002136|FG000|Overall Study|Withdrawal by Subject|3|||
146408408|NCT02261974|528002137|FG001|Overall Study|Withdrawal by Subject|2|||
146408409|NCT02261974|528002136|FG000|Overall Study|Pregnancy|0|||
146408410|NCT02261974|528002137|FG001|Overall Study|Pregnancy|1|||
146408411|NCT02261974|528002136|FG000|Overall Study|Missed treatment cut-off date|6|||
146408412|NCT02261974|528002137|FG001|Overall Study|Missed treatment cut-off date|3|||
146408413|NCT02261974|528002136|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
146408414|NCT02261974|528002137|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
146408415|NCT02261974|528002136|FG000|Overall Study|Lost to Follow-up|2|||
146408416|NCT02261974|528002137|FG001|Overall Study|Lost to Follow-up|0|||
146408417|NCT02261974|528002136|FG000|Overall Study|Adverse Event|1|||
146408418|NCT02261974|528002137|FG001|Overall Study|Adverse Event|0|||
146408419|NCT01440595|528002138|FG000|Overall Study|Lost to Follow-up|0|||
146408420|NCT01440595|528002139|FG001|Overall Study|Lost to Follow-up|1|||
146408421|NCT01440595|528002140|FG002|Overall Study|Lost to Follow-up|0|||
146408422|NCT01440595|528002138|FG000|Overall Study|Study terminated by sponsor.|1|||
146408423|NCT01440595|528002139|FG001|Overall Study|Study terminated by sponsor.|2|||
146408424|NCT01440595|528002140|FG002|Overall Study|Study terminated by sponsor.|1|||
146408425|NCT01347879|528002141|FG000|Overall Study|Adverse Event|0|||
146408426|NCT01347879|528002142|FG001|Overall Study|Adverse Event|12|||
146408427|NCT01347879|528002141|FG000|Overall Study|Lost to Follow-up|2|||
146408428|NCT01347879|528002142|FG001|Overall Study|Lost to Follow-up|0|||
146408429|NCT01347879|528002141|FG000|Overall Study|Withdrawal by Subject|3|||
146408430|NCT01347879|528002142|FG001|Overall Study|Withdrawal by Subject|2|||
146408431|NCT01347879|528002141|FG000|Overall Study|Other|2|||
146408432|NCT01347879|528002142|FG001|Overall Study|Other|3|||
146408433|NCT04736576|528002145|FG000|Overall Study|Progressive disease|3|||
146408434|NCT04736576|528002146|FG001|Overall Study|Progressive disease|1|||
146408435|NCT04736576|528002145|FG000|Overall Study|Death|1|||
146408436|NCT04736576|528002146|FG001|Overall Study|Death|0|||
146408437|NCT00720304|528002149|FG000|Overall Study|Withdrawal by Subject|14|||
146408438|NCT00720304|528002150|FG001|Overall Study|Withdrawal by Subject|1|||
146408439|NCT00720304|528002149|FG000|Overall Study|Death|1|||
146408440|NCT00720304|528002150|FG001|Overall Study|Death|0|||
146408441|NCT00720304|528002149|FG000|Overall Study|Physician Decision|5|||
146408442|NCT00720304|528002150|FG001|Overall Study|Physician Decision|2|||
146408443|NCT00720304|528002149|FG000|Overall Study|Adverse Event|3|||
146408444|NCT00720304|528002150|FG001|Overall Study|Adverse Event|1|||
146408445|NCT00720304|528002149|FG000|Overall Study|Disease progression|6|||
146408446|NCT00720304|528002150|FG001|Overall Study|Disease progression|1|||
146408447|NCT04330482|528002153|FG000|Overall Study|Lost to Follow-up|2|||
146408448|NCT04330482|528002154|FG001|Overall Study|Lost to Follow-up|1|||
146408449|NCT04330482|528002153|FG000|Overall Study|Withdrawal by Subject|0|||
146408450|NCT04330482|528002154|FG001|Overall Study|Withdrawal by Subject|3|||
146408451|NCT00996918|528002155|FG000|Overall Study|Lack of Efficacy|1|||
146408452|NCT00996918|528002156|FG001|Overall Study|Lack of Efficacy|1|||
146408453|NCT00996918|528002157|FG002|Overall Study|Lack of Efficacy|2|||
146408454|NCT00996918|528002158|FG003|Overall Study|Lack of Efficacy|2|||
146408455|NCT00996918|528002159|FG004|Overall Study|Lack of Efficacy|0|||
146408456|NCT00996918|528002155|FG000|Overall Study|Adverse Event|2|||
146408457|NCT00996918|528002156|FG001|Overall Study|Adverse Event|5|||
146408458|NCT00996918|528002157|FG002|Overall Study|Adverse Event|2|||
146408459|NCT00996918|528002158|FG003|Overall Study|Adverse Event|6|||
146408460|NCT00996918|528002159|FG004|Overall Study|Adverse Event|0|||
146068498|NCT01263197|526768751|FG004|Washout Period 2|Protocol Violation|0|||
146068499|NCT01263197|526768752|FG005|Washout Period 2|Protocol Violation|0|||
146068500|NCT01263197|526768747|FG000|Third Intervention (Period 3)|Adverse Event|0|||
146068501|NCT01263197|526768748|FG001|Third Intervention (Period 3)|Adverse Event|1|||
146068502|NCT01263197|526768749|FG002|Third Intervention (Period 3)|Adverse Event|0|||
146068503|NCT01263197|526768750|FG003|Third Intervention (Period 3)|Adverse Event|0|||
146068504|NCT01263197|526768751|FG004|Third Intervention (Period 3)|Adverse Event|0|||
146068505|NCT01263197|526768752|FG005|Third Intervention (Period 3)|Adverse Event|0|||
146068506|NCT01967576|526768753|FG000|Overall Study|Withdrawal by Subject|3|||
146068507|NCT01967576|526768753|FG000|Overall Study|Progressed/Removed from treatment|1|||
146068508|NCT01967576|526768753|FG000|Overall Study|Study closing at site|1|||
146068509|NCT01967576|526768753|FG000|Overall Study|Adverse Event|1|||
146068510|NCT01967576|526768753|FG000|Overall Study|Refused further treatment|1|||
146068511|NCT01821118|526768761|FG000|Overall Study|Death|0|||
146068512|NCT01821118|526768762|FG001|Overall Study|Death|1|||
146068513|NCT00345358|526768763|FG000|Primary Vaccination Phase|Other|0|||
146068514|NCT00345358|526768764|FG001|Primary Vaccination Phase|Other|1|||
146068515|NCT00345358|526768765|FG002|Primary Vaccination Phase|Other|1|||
146068516|NCT00345358|526768766|FG003|Primary Vaccination Phase|Other|0|||
146068517|NCT00345358|526768763|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
146068518|NCT00345358|526768764|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
146068519|NCT00345358|526768765|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
146068520|NCT00345358|526768766|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
146068521|NCT00345358|526768763|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
146068522|NCT00345358|526768764|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
146068523|NCT00345358|526768765|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
146068524|NCT00345358|526768766|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
146068525|NCT00345358|526768763|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
146068526|NCT00345358|526768764|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
146068527|NCT00345358|526768765|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
146068528|NCT00345358|526768766|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
146068529|NCT00345358|526768763|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
146068530|NCT00345358|526768764|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146068531|NCT00345358|526768765|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
146068532|NCT00345358|526768766|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
146068533|NCT00345358|526768763|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
146068534|NCT00345358|526768764|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
146068535|NCT00345358|526768765|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
146068536|NCT00345358|526768766|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
146068537|NCT00346697|526768768|FG000|Overall Study|Lost to Follow-up|0|||
146068538|NCT00346697|526768769|FG001|Overall Study|Lost to Follow-up|1|||
146068539|NCT00499083|526768770|FG000|Overall Study|Not evaluable|3|||
146068540|NCT00318643|526768773|FG000|Overall Study|Adverse Event|0|||
146068541|NCT00318643|526768774|FG001|Overall Study|Adverse Event|0|||
146068542|NCT00318643|526768775|FG002|Overall Study|Adverse Event|0|||
146068543|NCT00318643|526768776|FG003|Overall Study|Adverse Event|0|||
146171911|NCT03635489|527143285|FG001|Overall Study|Lost to Follow-up|2|||
146068544|NCT00318643|526768777|FG004|Overall Study|Adverse Event|1|||
146068545|NCT00318643|526768773|FG000|Overall Study|Participant's Decision|0|||
146068546|NCT00318643|526768774|FG001|Overall Study|Participant's Decision|0|||
146068547|NCT00318643|526768775|FG002|Overall Study|Participant's Decision|0|||
146068548|NCT00318643|526768776|FG003|Overall Study|Participant's Decision|0|||
146068549|NCT00318643|526768777|FG004|Overall Study|Participant's Decision|1|||
146068550|NCT00318643|526768773|FG000|Overall Study|Investigator's Decision|0|||
146068551|NCT00318643|526768774|FG001|Overall Study|Investigator's Decision|0|||
146068552|NCT00318643|526768775|FG002|Overall Study|Investigator's Decision|0|||
146068553|NCT00318643|526768776|FG003|Overall Study|Investigator's Decision|0|||
146068554|NCT00318643|526768777|FG004|Overall Study|Investigator's Decision|1|||
146068555|NCT01812252|526768780|FG000|Overall Study|Persistent Disease|1|||
146068556|NCT01812252|526768781|FG001|Overall Study|Persistent Disease|0|||
146068557|NCT01812252|526768780|FG000|Overall Study|Not transplanted|11|||
146068558|NCT01812252|526768781|FG001|Overall Study|Not transplanted|11|||
146068559|NCT01812252|526768780|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
146068560|NCT01812252|526768781|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
146068561|NCT01812252|526768780|FG000|Overall Study|Withdrawal by Subject|1|||
146068562|NCT01812252|526768781|FG001|Overall Study|Withdrawal by Subject|1|||
146068563|NCT01812252|526768780|FG000|Overall Study|Screen Failure|1|||
146068564|NCT01812252|526768781|FG001|Overall Study|Screen Failure|0|||
146068565|NCT02557139|526768782|FG000|Overall Study|Significant liver elevation|1|||
146068566|NCT02557139|526768783|FG001|Overall Study|Significant liver elevation|0|||
146068567|NCT02557139|526768784|FG002|Overall Study|Significant liver elevation|1|||
146068568|NCT02557139|526768782|FG000|Overall Study|Withdrawal by Subject|1|||
146068569|NCT02557139|526768783|FG001|Overall Study|Withdrawal by Subject|0|||
146068570|NCT02557139|526768784|FG002|Overall Study|Withdrawal by Subject|0|||
146068571|NCT02557139|526768782|FG000|Overall Study|Illness of prohibited medication|0|||
146068572|NCT02557139|526768783|FG001|Overall Study|Illness of prohibited medication|0|||
146068573|NCT02557139|526768784|FG002|Overall Study|Illness of prohibited medication|1|||
146068574|NCT01146795|526768786|FG000|Overall Study|Withdrawal by Subject|4|||
146068575|NCT01146795|526768786|FG000|Overall Study|Adverse Event|6|||
146068576|NCT01146795|526768786|FG000|Overall Study|Still in treatment at study closure|10|||
146068577|NCT05375760|526768787|FG000|Overall Study|Adverse Event|1|||
146068578|NCT05375760|526768788|FG001|Overall Study|Adverse Event|0|||
146068579|NCT05375760|526768787|FG000|Overall Study|Death|0|||
146068580|NCT05375760|526768788|FG001|Overall Study|Death|1|||
146068581|NCT05375760|526768787|FG000|Overall Study|Lost to Follow-up|6|||
146068582|NCT05375760|526768788|FG001|Overall Study|Lost to Follow-up|6|||
146068583|NCT05375760|526768787|FG000|Overall Study|Withdrawal by Subject|17|||
146068584|NCT05375760|526768788|FG001|Overall Study|Withdrawal by Subject|19|||
146068585|NCT05375760|526768787|FG000|Overall Study|Dosing halted by FDA|96|||
146068586|NCT05375760|526768788|FG001|Overall Study|Dosing halted by FDA|100|||
146068587|NCT05375760|526768787|FG000|Overall Study|Not compliant with study visit|2|||
146068588|NCT05375760|526768788|FG001|Overall Study|Not compliant with study visit|0|||
146068589|NCT05375760|526768787|FG000|Overall Study|Physician Decision|1|||
146068590|NCT05375760|526768788|FG001|Overall Study|Physician Decision|0|||
146068591|NCT05375760|526768787|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
146068592|NCT05375760|526768788|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
146068593|NCT05375760|526768787|FG000|Overall Study|Participant moved|1|||
146068594|NCT05375760|526768788|FG001|Overall Study|Participant moved|0|||
146068595|NCT00363480|526768789|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
146068596|NCT00363480|526768789|FG000|Overall Study|Adverse Event|4|||
146068597|NCT00363480|526768789|FG000|Overall Study|Lost to Follow-up|5|||
146068598|NCT00363480|526768789|FG000|Overall Study|Withdrawal by Subject|5|||
146068599|NCT00363480|526768789|FG000|Overall Study|Non-compliance of subject|1|||
146068600|NCT00363480|526768789|FG000|Overall Study|Participant discontinued on its own|1|||
146068601|NCT03853109|526768790|FG000|Overall Study|Withdrawal by Subject|0|||
146068602|NCT03853109|526768791|FG001|Overall Study|Withdrawal by Subject|0|||
146068603|NCT03853109|526768792|FG002|Overall Study|Withdrawal by Subject|1|||
146068604|NCT03853109|526768793|FG003|Overall Study|Withdrawal by Subject|2|||
146068605|NCT03853109|526768794|FG004|Overall Study|Withdrawal by Subject|1|||
146068606|NCT03853109|526768795|FG005|Overall Study|Withdrawal by Subject|4|||
146068607|NCT03853109|526768796|FG006|Overall Study|Withdrawal by Subject|5|||
146068608|NCT03853109|526768797|FG007|Overall Study|Withdrawal by Subject|3|||
146068609|NCT03853109|526768790|FG000|Overall Study|Decision by Sponsor|0|||
146068610|NCT03853109|526768791|FG001|Overall Study|Decision by Sponsor|0|||
146068611|NCT03853109|526768792|FG002|Overall Study|Decision by Sponsor|1|||
146068612|NCT03853109|526768793|FG003|Overall Study|Decision by Sponsor|0|||
146068613|NCT03853109|526768794|FG004|Overall Study|Decision by Sponsor|1|||
146068614|NCT03853109|526768795|FG005|Overall Study|Decision by Sponsor|1|||
146068615|NCT03853109|526768796|FG006|Overall Study|Decision by Sponsor|10|||
146068616|NCT03853109|526768797|FG007|Overall Study|Decision by Sponsor|2|||
146068617|NCT03853109|526768790|FG000|Overall Study|Lost to Follow-up|0|||
146068618|NCT03853109|526768791|FG001|Overall Study|Lost to Follow-up|0|||
146068619|NCT03853109|526768792|FG002|Overall Study|Lost to Follow-up|0|||
146068620|NCT03853109|526768793|FG003|Overall Study|Lost to Follow-up|0|||
146068621|NCT03853109|526768794|FG004|Overall Study|Lost to Follow-up|1|||
146068622|NCT03853109|526768795|FG005|Overall Study|Lost to Follow-up|3|||
146068623|NCT03853109|526768796|FG006|Overall Study|Lost to Follow-up|0|||
146068624|NCT03853109|526768797|FG007|Overall Study|Lost to Follow-up|0|||
146068625|NCT03853109|526768790|FG000|Overall Study|Death|2|||
146068626|NCT03853109|526768791|FG001|Overall Study|Death|5|||
146068627|NCT03853109|526768792|FG002|Overall Study|Death|8|||
146068628|NCT03853109|526768793|FG003|Overall Study|Death|10|||
146068629|NCT03853109|526768794|FG004|Overall Study|Death|3|||
146068630|NCT03853109|526768795|FG005|Overall Study|Death|20|||
146068631|NCT03853109|526768796|FG006|Overall Study|Death|10|||
146068632|NCT03853109|526768797|FG007|Overall Study|Death|5|||
146068633|NCT04634253|526768798|FG000|Overall Study|Adverse Event|1|||
146068634|NCT04634253|526768799|FG001|Overall Study|Adverse Event|1|||
146068635|NCT04634253|526768800|FG002|Overall Study|Adverse Event|0|||
146068636|NCT04634253|526768798|FG000|Overall Study|Physician Decision|0|||
146068637|NCT04634253|526768799|FG001|Overall Study|Physician Decision|1|||
146068638|NCT04634253|526768800|FG002|Overall Study|Physician Decision|0|||
146068639|NCT04634253|526768798|FG000|Overall Study|Withdrawal by Subject|1|||
146068640|NCT04634253|526768799|FG001|Overall Study|Withdrawal by Subject|0|||
146068641|NCT04634253|526768800|FG002|Overall Study|Withdrawal by Subject|3|||
146068642|NCT01499355|526768801|FG000|Run-In Period|Study Termination|15|||
146068643|NCT01499355|526768802|FG001|Run-In Period|Study Termination|0|||
146068644|NCT01499355|526768803|FG002|Run-In Period|Study Termination|0|||
146068645|NCT01499355|526768804|FG003|Run-In Period|Study Termination|0|||
146068646|NCT01499355|526768801|FG000|Run-In Period|Other|3|||
146068647|NCT01499355|526768802|FG001|Run-In Period|Other|0|||
146068648|NCT01499355|526768803|FG002|Run-In Period|Other|0|||
146068649|NCT01499355|526768804|FG003|Run-In Period|Other|0|||
146068650|NCT01499355|526768801|FG000|Run-In Period|Death|2|||
146068651|NCT01499355|526768802|FG001|Run-In Period|Death|0|||
146068652|NCT01499355|526768803|FG002|Run-In Period|Death|0|||
146068653|NCT01499355|526768804|FG003|Run-In Period|Death|0|||
146068654|NCT01499355|526768801|FG000|Run-In Period|Investigator Decision|2|||
146068655|NCT01499355|526768802|FG001|Run-In Period|Investigator Decision|0|||
146068656|NCT01499355|526768803|FG002|Run-In Period|Investigator Decision|0|||
146068657|NCT01499355|526768804|FG003|Run-In Period|Investigator Decision|0|||
146068658|NCT01499355|526768801|FG000|Run-In Period|Consent Withdrawn|1|||
146068659|NCT01499355|526768802|FG001|Run-In Period|Consent Withdrawn|0|||
146068660|NCT01499355|526768803|FG002|Run-In Period|Consent Withdrawn|0|||
146068661|NCT01499355|526768804|FG003|Run-In Period|Consent Withdrawn|0|||
146068662|NCT01499355|526768801|FG000|Run-In Period|Adverse Event|8|||
146068663|NCT01499355|526768802|FG001|Run-In Period|Adverse Event|0|||
146068664|NCT01499355|526768803|FG002|Run-In Period|Adverse Event|0|||
146068665|NCT01499355|526768804|FG003|Run-In Period|Adverse Event|0|||
146068666|NCT01499355|526768801|FG000|Double-Blind Period|Adverse Event|0|||
146068667|NCT01499355|526768802|FG001|Double-Blind Period|Adverse Event|2|||
146068668|NCT01499355|526768803|FG002|Double-Blind Period|Adverse Event|3|||
146068669|NCT01499355|526768804|FG003|Double-Blind Period|Adverse Event|2|||
146068670|NCT01499355|526768801|FG000|Double-Blind Period|Study Termination|0|||
146068671|NCT01499355|526768802|FG001|Double-Blind Period|Study Termination|18|||
146068672|NCT01499355|526768803|FG002|Double-Blind Period|Study Termination|16|||
146408461|NCT00996918|528002155|FG000|Overall Study|Withdrawal by Subject|1|||
146408462|NCT00996918|528002156|FG001|Overall Study|Withdrawal by Subject|4|||
146408463|NCT00996918|528002157|FG002|Overall Study|Withdrawal by Subject|3|||
146408464|NCT00996918|528002158|FG003|Overall Study|Withdrawal by Subject|3|||
146408465|NCT00996918|528002159|FG004|Overall Study|Withdrawal by Subject|2|||
146408466|NCT00996918|528002155|FG000|Overall Study|Physician Decision|1|||
146408467|NCT00996918|528002156|FG001|Overall Study|Physician Decision|0|||
146408468|NCT00996918|528002157|FG002|Overall Study|Physician Decision|0|||
146408469|NCT00996918|528002158|FG003|Overall Study|Physician Decision|0|||
146408470|NCT00996918|528002159|FG004|Overall Study|Physician Decision|0|||
146408471|NCT00996918|528002155|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
146408472|NCT00996918|528002156|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
146408473|NCT00996918|528002157|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
146408474|NCT00996918|528002158|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
146408475|NCT00996918|528002159|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
146068673|NCT01499355|526768804|FG003|Double-Blind Period|Study Termination|14|||
146068674|NCT01499355|526768801|FG000|Double-Blind Period|Other|0|||
146068675|NCT01499355|526768802|FG001|Double-Blind Period|Other|1|||
146068676|NCT01499355|526768803|FG002|Double-Blind Period|Other|2|||
146408476|NCT00996918|528002155|FG000|Overall Study|Loss of Caregiver|0|||
146408477|NCT00996918|528002156|FG001|Overall Study|Loss of Caregiver|1|||
146408478|NCT00996918|528002157|FG002|Overall Study|Loss of Caregiver|0|||
146408479|NCT00996918|528002158|FG003|Overall Study|Loss of Caregiver|0|||
146068677|NCT01499355|526768804|FG003|Double-Blind Period|Other|2|||
146068678|NCT01499355|526768801|FG000|Double-Blind Period|Death|0|||
146283848|NCT00092495|527551854|FG000|Base Study Vaccination Period|Pregnancy|2|||
146068679|NCT01499355|526768802|FG001|Double-Blind Period|Death|1|||
146068680|NCT01499355|526768803|FG002|Double-Blind Period|Death|0|||
146068681|NCT01499355|526768804|FG003|Double-Blind Period|Death|0|||
146068682|NCT01499355|526768801|FG000|Double-Blind Period|Investigator Decision|0|||
146068683|NCT01499355|526768802|FG001|Double-Blind Period|Investigator Decision|0|||
146068684|NCT01499355|526768803|FG002|Double-Blind Period|Investigator Decision|3|||
146068685|NCT01499355|526768804|FG003|Double-Blind Period|Investigator Decision|3|||
146068686|NCT01499355|526768801|FG000|Double-Blind Period|Consent Withdrawn|0|||
146068687|NCT01499355|526768802|FG001|Double-Blind Period|Consent Withdrawn|0|||
146068688|NCT01499355|526768803|FG002|Double-Blind Period|Consent Withdrawn|1|||
146068689|NCT01499355|526768804|FG003|Double-Blind Period|Consent Withdrawn|2|||
146068690|NCT01499355|526768801|FG000|Double-Blind Period|Lost to Follow-up|0|||
146068691|NCT01499355|526768802|FG001|Double-Blind Period|Lost to Follow-up|1|||
146068692|NCT01499355|526768803|FG002|Double-Blind Period|Lost to Follow-up|0|||
146068693|NCT01499355|526768804|FG003|Double-Blind Period|Lost to Follow-up|0|||
146068694|NCT00432172|526768807|FG000|Overall Study|Physician Decision|0|||
146068695|NCT00432172|526768808|FG001|Overall Study|Physician Decision|0|||
146068696|NCT00432172|526768809|FG002|Overall Study|Physician Decision|2|||
146068697|NCT00432172|526768810|FG003|Overall Study|Physician Decision|0|||
146068698|NCT00432172|526768807|FG000|Overall Study|Adverse Event|4|||
146068699|NCT00432172|526768808|FG001|Overall Study|Adverse Event|2|||
146068700|NCT00432172|526768809|FG002|Overall Study|Adverse Event|4|||
146068701|NCT00432172|526768810|FG003|Overall Study|Adverse Event|3|||
146068702|NCT00432172|526768807|FG000|Overall Study|Disease progression|0|||
146068703|NCT00432172|526768808|FG001|Overall Study|Disease progression|2|||
146068704|NCT00432172|526768809|FG002|Overall Study|Disease progression|5|||
146068705|NCT00432172|526768810|FG003|Overall Study|Disease progression|1|||
146068706|NCT00432172|526768807|FG000|Overall Study|Withdrawal by Subject|0|||
146068707|NCT00432172|526768808|FG001|Overall Study|Withdrawal by Subject|1|||
146068708|NCT00432172|526768809|FG002|Overall Study|Withdrawal by Subject|0|||
146068709|NCT00432172|526768810|FG003|Overall Study|Withdrawal by Subject|2|||
146068710|NCT00432172|526768807|FG000|Overall Study|No treatment received|2|||
146068711|NCT00432172|526768808|FG001|Overall Study|No treatment received|2|||
146068712|NCT00432172|526768809|FG002|Overall Study|No treatment received|0|||
146068713|NCT00432172|526768810|FG003|Overall Study|No treatment received|1|||
146068714|NCT02141204|526768811|FG000|Overall Study|Lost to Follow-up|2|||
146068715|NCT02141204|526768812|FG001|Overall Study|Lost to Follow-up|1|||
146068716|NCT02141204|526768811|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
146068717|NCT02141204|526768812|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
146068718|NCT02141204|526768811|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
146068719|NCT02141204|526768812|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
146068720|NCT02141204|526768811|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
146068721|NCT02141204|526768812|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
146068722|NCT01177397|526770734|FG000|Overall Study|Protocol Violation|0|||
146068723|NCT01177397|526770735|FG001|Overall Study|Protocol Violation|0|||
146068724|NCT01177397|526770736|FG002|Overall Study|Protocol Violation|0|||
146068725|NCT01177397|526770737|FG003|Overall Study|Protocol Violation|0|||
146068726|NCT01177397|526770738|FG004|Overall Study|Protocol Violation|0|||
146068727|NCT01177397|526770739|FG005|Overall Study|Protocol Violation|1|||
146068728|NCT01177397|526770740|FG006|Overall Study|Protocol Violation|0|||
146068729|NCT01177397|526770741|FG007|Overall Study|Protocol Violation|0|||
146068730|NCT01177397|526770742|FG008|Overall Study|Protocol Violation|0|||
146068731|NCT01177397|526770743|FG009|Overall Study|Protocol Violation|0|||
146068732|NCT01177397|526770744|FG010|Overall Study|Protocol Violation|0|||
146068733|NCT01177397|526770745|FG011|Overall Study|Protocol Violation|0|||
146068734|NCT01177397|526770734|FG000|Overall Study|Lost to Follow-up|0|||
146068735|NCT01177397|526770735|FG001|Overall Study|Lost to Follow-up|0|||
146408480|NCT00996918|528002159|FG004|Overall Study|Loss of Caregiver|0|||
146408481|NCT00996918|528002155|FG000|Overall Study|Other|3|||
146408482|NCT00996918|528002156|FG001|Overall Study|Other|1|||
146408483|NCT00996918|528002157|FG002|Overall Study|Other|0|||
146408484|NCT00996918|528002158|FG003|Overall Study|Other|0|||
146408485|NCT00996918|528002159|FG004|Overall Study|Other|0|||
146408486|NCT01333475|528002162|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
146408487|NCT01333475|528002163|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
146068736|NCT01177397|526770736|FG002|Overall Study|Lost to Follow-up|0|||
146068737|NCT01177397|526770737|FG003|Overall Study|Lost to Follow-up|0|||
146068738|NCT01177397|526770738|FG004|Overall Study|Lost to Follow-up|1|||
146068739|NCT01177397|526770739|FG005|Overall Study|Lost to Follow-up|0|||
146408488|NCT01333475|528002162|FG000|Overall Study|Toxicity|1|||
146068740|NCT01177397|526770740|FG006|Overall Study|Lost to Follow-up|0|||
146068741|NCT01177397|526770741|FG007|Overall Study|Lost to Follow-up|2|||
146068742|NCT01177397|526770742|FG008|Overall Study|Lost to Follow-up|0|||
146068743|NCT01177397|526770743|FG009|Overall Study|Lost to Follow-up|0|||
146068744|NCT01177397|526770744|FG010|Overall Study|Lost to Follow-up|0|||
146068745|NCT01177397|526770745|FG011|Overall Study|Lost to Follow-up|0|||
146068746|NCT01177397|526770734|FG000|Overall Study|Death|0|||
146068747|NCT01177397|526770735|FG001|Overall Study|Death|0|||
146068748|NCT01177397|526770736|FG002|Overall Study|Death|1|||
146068749|NCT01177397|526770737|FG003|Overall Study|Death|1|||
146068750|NCT01177397|526770738|FG004|Overall Study|Death|0|||
146408489|NCT01333475|528002163|FG001|Overall Study|Toxicity|3|||
146068751|NCT01177397|526770739|FG005|Overall Study|Death|0|||
146068752|NCT01177397|526770740|FG006|Overall Study|Death|0|||
146068753|NCT01177397|526770741|FG007|Overall Study|Death|5|||
146068754|NCT01177397|526770742|FG008|Overall Study|Death|2|||
146068755|NCT01177397|526770743|FG009|Overall Study|Death|1|||
146068756|NCT01177397|526770744|FG010|Overall Study|Death|0|||
146068757|NCT01177397|526770745|FG011|Overall Study|Death|0|||
146068758|NCT01177397|526770734|FG000|Overall Study|Withdrawal by Subject|0|||
146068759|NCT01177397|526770735|FG001|Overall Study|Withdrawal by Subject|0|||
146068760|NCT01177397|526770736|FG002|Overall Study|Withdrawal by Subject|1|||
146068761|NCT01177397|526770737|FG003|Overall Study|Withdrawal by Subject|1|||
146068762|NCT01177397|526770738|FG004|Overall Study|Withdrawal by Subject|1|||
146068763|NCT01177397|526770739|FG005|Overall Study|Withdrawal by Subject|2|||
146068764|NCT01177397|526770740|FG006|Overall Study|Withdrawal by Subject|0|||
146068765|NCT01177397|526770741|FG007|Overall Study|Withdrawal by Subject|5|||
146068766|NCT01177397|526770742|FG008|Overall Study|Withdrawal by Subject|9|||
146068767|NCT01177397|526770743|FG009|Overall Study|Withdrawal by Subject|1|||
146068768|NCT01177397|526770744|FG010|Overall Study|Withdrawal by Subject|1|||
146068769|NCT01177397|526770745|FG011|Overall Study|Withdrawal by Subject|0|||
146068770|NCT01177397|526770734|FG000|Overall Study|Adverse Event|0|||
146068771|NCT01177397|526770735|FG001|Overall Study|Adverse Event|0|||
146068772|NCT01177397|526770736|FG002|Overall Study|Adverse Event|1|||
146068773|NCT01177397|526770737|FG003|Overall Study|Adverse Event|2|||
146068774|NCT01177397|526770738|FG004|Overall Study|Adverse Event|0|||
146068775|NCT01177397|526770739|FG005|Overall Study|Adverse Event|12|||
146068776|NCT01177397|526770740|FG006|Overall Study|Adverse Event|1|||
146068777|NCT01177397|526770741|FG007|Overall Study|Adverse Event|14|||
146068778|NCT01177397|526770742|FG008|Overall Study|Adverse Event|8|||
146068779|NCT01177397|526770743|FG009|Overall Study|Adverse Event|6|||
146068780|NCT01177397|526770744|FG010|Overall Study|Adverse Event|3|||
146068781|NCT01177397|526770745|FG011|Overall Study|Adverse Event|7|||
146068782|NCT01177397|526770734|FG000|Overall Study|Disease progression|1|||
146068783|NCT01177397|526770735|FG001|Overall Study|Disease progression|2|||
146068784|NCT01177397|526770736|FG002|Overall Study|Disease progression|5|||
146068785|NCT01177397|526770737|FG003|Overall Study|Disease progression|5|||
146068786|NCT01177397|526770738|FG004|Overall Study|Disease progression|4|||
146068787|NCT01177397|526770739|FG005|Overall Study|Disease progression|10|||
146068788|NCT01177397|526770740|FG006|Overall Study|Disease progression|10|||
146068789|NCT01177397|526770741|FG007|Overall Study|Disease progression|21|||
146068790|NCT01177397|526770742|FG008|Overall Study|Disease progression|18|||
146068791|NCT01177397|526770743|FG009|Overall Study|Disease progression|12|||
146068792|NCT01177397|526770744|FG010|Overall Study|Disease progression|10|||
146068793|NCT01177397|526770745|FG011|Overall Study|Disease progression|8|||
146068794|NCT01177397|526770734|FG000|Overall Study|Other reasons|0|||
146068795|NCT01177397|526770735|FG001|Overall Study|Other reasons|0|||
146068796|NCT01177397|526770736|FG002|Overall Study|Other reasons|1|||
146068797|NCT01177397|526770737|FG003|Overall Study|Other reasons|0|||
146068798|NCT01177397|526770738|FG004|Overall Study|Other reasons|1|||
146068799|NCT01177397|526770739|FG005|Overall Study|Other reasons|1|||
146068800|NCT01177397|526770740|FG006|Overall Study|Other reasons|2|||
146068801|NCT01177397|526770741|FG007|Overall Study|Other reasons|6|||
146068802|NCT01177397|526770742|FG008|Overall Study|Other reasons|10|||
146068803|NCT01177397|526770743|FG009|Overall Study|Other reasons|8|||
146068804|NCT01177397|526770744|FG010|Overall Study|Other reasons|0|||
146068805|NCT01177397|526770745|FG011|Overall Study|Other reasons|2|||
146068806|NCT04555616|526770746|FG000|Overall Study|Death|1|||
146068807|NCT04555616|526770747|FG001|Overall Study|Death|0|||
146068808|NCT04555616|526770748|FG002|Overall Study|Death|1|||
146068809|NCT04555616|526770746|FG000|Overall Study|Withdrawal by Subject|2|||
146068810|NCT04555616|526770747|FG001|Overall Study|Withdrawal by Subject|1|||
146068811|NCT04555616|526770748|FG002|Overall Study|Withdrawal by Subject|0|||
146068812|NCT02446899|526770749|FG000|Overall Study|Adverse Event|4|||
146068813|NCT02446899|526770750|FG001|Overall Study|Adverse Event|7|||
146068814|NCT02446899|526770749|FG000|Overall Study|Condition Under Investigation Worsened|1|||
146068815|NCT02446899|526770750|FG001|Overall Study|Condition Under Investigation Worsened|4|||
146068816|NCT02446899|526770749|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
146068817|NCT02446899|526770750|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
146068818|NCT02446899|526770749|FG000|Overall Study|Lack of Efficacy|2|||
146068819|NCT02446899|526770750|FG001|Overall Study|Lack of Efficacy|8|||
146068820|NCT02446899|526770749|FG000|Overall Study|Lost to Follow-up|1|||
146068821|NCT02446899|526770750|FG001|Overall Study|Lost to Follow-up|3|||
146068822|NCT02446899|526770749|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
146068823|NCT02446899|526770750|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
146068824|NCT02446899|526770749|FG000|Overall Study|Withdrawal by Subject|11|||
146068825|NCT02446899|526770750|FG001|Overall Study|Withdrawal by Subject|19|||
146068826|NCT02446899|526770749|FG000|Overall Study|Miscellaneous|5|||
146068827|NCT02446899|526770750|FG001|Overall Study|Miscellaneous|4|||
146068828|NCT02446899|526770749|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
146068829|NCT02446899|526770750|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
146068830|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
146068831|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
146068832|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
146068833|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
146068834|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
146068835|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
146068836|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
146068837|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
146068838|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
146068839|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
146068840|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
146068841|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
146068842|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
146068843|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
146068844|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
146068845|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146068846|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146068847|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146068848|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
146068849|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146068850|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146068851|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
146068852|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
146068853|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
146068854|NCT01106690|526770756|FG000|Core Period: Baseline to Week 26|Other|10|||
146068855|NCT01106690|526770757|FG001|Core Period: Baseline to Week 26|Other|2|||
146068856|NCT01106690|526770758|FG002|Core Period: Baseline to Week 26|Other|6|||
146068857|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146068858|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
146068859|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
146068860|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146068861|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
146068862|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
146068863|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146068864|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146068865|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146068866|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146068867|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
146068868|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
146068869|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
146068870|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
146068871|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
146068872|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Other|8|||
146068873|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Other|3|||
146068874|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Other|4|||
146068875|NCT01106690|526770756|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
146068876|NCT01106690|526770757|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146068877|NCT01106690|526770758|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
146068878|NCT00998296|526770759|FG000|Overall Study|Progressive disease|0|||
146068879|NCT00998296|526770760|FG001|Overall Study|Progressive disease|1|||
146068880|NCT00998296|526770761|FG002|Overall Study|Progressive disease|0|||
146171912|NCT03635489|527143284|FG000|Overall Study|Withdrawal by Subject|1|||
146171913|NCT03635489|527143285|FG001|Overall Study|Withdrawal by Subject|2|||
146171914|NCT03635489|527143284|FG000|Overall Study|Study Ended by Sponsor|28|||
146171915|NCT03635489|527143285|FG001|Overall Study|Study Ended by Sponsor|34|||
146171916|NCT01368900|527143286|FG000|Overall Study|Lost to Follow-up|7|||
146171917|NCT02277743|527143293|FG000|Overall Study|Protocol Violation|1|||
146171918|NCT02277743|527143294|FG001|Overall Study|Protocol Violation|1|||
146171919|NCT02277743|527143295|FG002|Overall Study|Protocol Violation|1|||
146171920|NCT02277743|527143293|FG000|Overall Study|Adverse Event|10|||
146171921|NCT02277743|527143294|FG001|Overall Study|Adverse Event|6|||
146171922|NCT02277743|527143295|FG002|Overall Study|Adverse Event|6|||
146171923|NCT02277743|527143293|FG000|Overall Study|Lack of Efficacy|11|||
146283849|NCT00092495|527551855|FG001|Base Study Vaccination Period|Pregnancy|0|||
146408490|NCT04440007|528002164|FG000|Overall Study|Adverse Event|0|||
146408491|NCT04440007|528002165|FG001|Overall Study|Adverse Event|1|||
145945248|NCT03008278|526308189|FG002|Overall Study|Progressive Disease|32|||
146068881|NCT00998296|526770762|FG003|Overall Study|Progressive disease|0|||
146068882|NCT00998296|526770763|FG004|Overall Study|Progressive disease|0|||
146068883|NCT00998296|526770764|FG005|Overall Study|Progressive disease|0|||
146068884|NCT00998296|526770765|FG006|Overall Study|Progressive disease|1|||
146068885|NCT00998296|526770766|FG007|Overall Study|Progressive disease|0|||
146068886|NCT00998296|526770767|FG008|Overall Study|Progressive disease|0|||
146068887|NCT00998296|526770768|FG009|Overall Study|Progressive disease|14|||
146068888|NCT00998296|526770769|FG010|Overall Study|Progressive disease|5|||
146068889|NCT00998296|526770759|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068890|NCT00998296|526770760|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068891|NCT00998296|526770761|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068892|NCT00998296|526770762|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068893|NCT00998296|526770763|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
146068894|NCT00998296|526770764|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068895|NCT00998296|526770765|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068896|NCT00998296|526770766|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
146068897|NCT00998296|526770767|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
146068898|NCT00998296|526770768|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068899|NCT00998296|526770769|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
146068900|NCT00998296|526770759|FG000|Overall Study|Other adverse event|0|||
146068901|NCT00998296|526770760|FG001|Overall Study|Other adverse event|0|||
146068902|NCT00998296|526770761|FG002|Overall Study|Other adverse event|0|||
146068903|NCT00998296|526770762|FG003|Overall Study|Other adverse event|0|||
146068904|NCT00998296|526770763|FG004|Overall Study|Other adverse event|1|||
146068905|NCT00998296|526770764|FG005|Overall Study|Other adverse event|0|||
146068906|NCT00998296|526770765|FG006|Overall Study|Other adverse event|0|||
146068907|NCT00998296|526770766|FG007|Overall Study|Other adverse event|0|||
146068908|NCT00998296|526770767|FG008|Overall Study|Other adverse event|0|||
146068909|NCT00998296|526770768|FG009|Overall Study|Other adverse event|1|||
146068910|NCT00998296|526770769|FG010|Overall Study|Other adverse event|2|||
146068911|NCT00998296|526770759|FG000|Overall Study|Refused to continue taking trial med.|0|||
146068912|NCT00998296|526770760|FG001|Overall Study|Refused to continue taking trial med.|0|||
146068913|NCT00998296|526770761|FG002|Overall Study|Refused to continue taking trial med.|0|||
146068914|NCT00998296|526770762|FG003|Overall Study|Refused to continue taking trial med.|0|||
146068915|NCT00998296|526770763|FG004|Overall Study|Refused to continue taking trial med.|0|||
146068916|NCT00998296|526770764|FG005|Overall Study|Refused to continue taking trial med.|0|||
146068917|NCT00998296|526770765|FG006|Overall Study|Refused to continue taking trial med.|0|||
146068918|NCT00998296|526770766|FG007|Overall Study|Refused to continue taking trial med.|0|||
146068919|NCT00998296|526770767|FG008|Overall Study|Refused to continue taking trial med.|0|||
146068920|NCT00998296|526770768|FG009|Overall Study|Refused to continue taking trial med.|2|||
146068921|NCT00998296|526770769|FG010|Overall Study|Refused to continue taking trial med.|0|||
146068922|NCT00998296|526770759|FG000|Overall Study|Reason other than those specified above|0|||
146068923|NCT00998296|526770760|FG001|Overall Study|Reason other than those specified above|0|||
146068924|NCT00998296|526770761|FG002|Overall Study|Reason other than those specified above|0|||
146068925|NCT00998296|526770762|FG003|Overall Study|Reason other than those specified above|0|||
146068926|NCT00998296|526770763|FG004|Overall Study|Reason other than those specified above|0|||
146068927|NCT00998296|526770764|FG005|Overall Study|Reason other than those specified above|0|||
146068928|NCT00998296|526770765|FG006|Overall Study|Reason other than those specified above|0|||
146068929|NCT00998296|526770766|FG007|Overall Study|Reason other than those specified above|0|||
146068930|NCT00998296|526770767|FG008|Overall Study|Reason other than those specified above|0|||
146068931|NCT00998296|526770768|FG009|Overall Study|Reason other than those specified above|1|||
146068932|NCT00998296|526770769|FG010|Overall Study|Reason other than those specified above|0|||
146068933|NCT04396639|526770770|FG000|Overall Study|Withdrawal by Subject|1|||
146068934|NCT04396639|526770770|FG000|Overall Study|Other|1|||
146068935|NCT01544335|526770771|FG000|Overall Study|Lost to Follow-up|27|||
146068936|NCT01544335|526770771|FG000|Overall Study|Death|4|||
146068937|NCT01544335|526770771|FG000|Overall Study|Disease progression|3|||
146068938|NCT01544335|526770771|FG000|Overall Study|Baseline Measurements not Available|19|||
146068939|NCT03219528|526770778|FG000|Overall Study|Lost to Follow-up|5|||
146068940|NCT03219528|526770779|FG001|Overall Study|Lost to Follow-up|4|||
146068941|NCT03219528|526770778|FG000|Overall Study|Withdrawal by Subject|4|||
146068942|NCT03219528|526770779|FG001|Overall Study|Withdrawal by Subject|4|||
146068943|NCT00241839|526770780|FG000|Overall Study|Withdrawal by Subject|18|||
146068944|NCT00241839|526770781|FG001|Overall Study|Withdrawal by Subject|17|||
146068945|NCT00241839|526770780|FG000|Overall Study|Adverse Event|1|||
146068946|NCT00241839|526770781|FG001|Overall Study|Adverse Event|1|||
146068947|NCT00196313|526770786|FG000|Overall Study|Protocol Violation|2|||
146068948|NCT00196313|526770787|FG001|Overall Study|Protocol Violation|3|||
146068949|NCT00196313|526770786|FG000|Overall Study|Withdrawal by Subject|3|||
146408492|NCT04440007|528002164|FG000|Overall Study|Lost to Follow-up|1|||
146068950|NCT00196313|526770787|FG001|Overall Study|Withdrawal by Subject|1|||
146068951|NCT00196313|526770786|FG000|Overall Study|Adverse Event|3|||
146068952|NCT00196313|526770787|FG001|Overall Study|Adverse Event|1|||
146068953|NCT00196313|526770786|FG000|Overall Study|Subject Pregnant|1|||
146068954|NCT00196313|526770787|FG001|Overall Study|Subject Pregnant|1|||
146068955|NCT00196313|526770786|FG000|Overall Study|Lost to Follow-up|2|||
146068956|NCT00196313|526770787|FG001|Overall Study|Lost to Follow-up|2|||
146068957|NCT03096288|526770788|FG000|Overall Study|Withdrawal by Subject|0|||
146068958|NCT03096288|526770789|FG001|Overall Study|Withdrawal by Subject|1|||
146068959|NCT03096288|526770790|FG002|Overall Study|Withdrawal by Subject|0|||
146068960|NCT03096288|526770791|FG003|Overall Study|Withdrawal by Subject|1|||
146068961|NCT01635153|526770794|FG000|Overall Study|Lost to Follow-up|40|||
146068962|NCT01635153|526770795|FG001|Overall Study|Lost to Follow-up|43|||
146068963|NCT00297258|526770806|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
146068964|NCT00297258|526770806|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
146068965|NCT00297258|526770806|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
146068966|NCT00297258|526770806|FG000|Overall Study|Intercurrent Illness|3|||
146068967|NCT00297258|526770806|FG000|Overall Study|Intercurrent Death|2|||
146068968|NCT00297258|526770806|FG000|Overall Study|Deteriorization of General Condition|1|||
146068969|NCT00297258|526770806|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
146068970|NCT00297258|526770806|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
146068971|NCT00297258|526770806|FG000|Overall Study|Switch to Commercial Treatment|1|||
146068972|NCT00297258|526770806|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
146068973|NCT01470326|526770807|FG000|Overall Study|Protocol Violation|32|||
146068974|NCT01470326|526770807|FG000|Overall Study|No Drug Administration Information|2|||
146068975|NCT01470326|526770807|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
146068976|NCT03967444|526770808|FG000|Overall Study|Lost to Follow-up|1|||
146068977|NCT03967444|526770809|FG001|Overall Study|Lost to Follow-up|2|||
146068978|NCT02892448|526770810|FG000|Overall Study|Screening failure|2|||
146068979|NCT02892448|526770811|FG001|Overall Study|Screening failure|2|||
146068980|NCT02892448|526770812|FG002|Overall Study|Screening failure|1|||
146068981|NCT01519921|526770816|FG000|Overall Study|Adverse Event|10|||
146068982|NCT01519921|526770817|FG001|Overall Study|Adverse Event|9|||
146068983|NCT01519921|526770816|FG000|Overall Study|Lack of Efficacy|4|||
146068984|NCT01519921|526770817|FG001|Overall Study|Lack of Efficacy|3|||
146408493|NCT04440007|528002165|FG001|Overall Study|Lost to Follow-up|3|||
146408494|NCT04440007|528002164|FG000|Overall Study|Death|7|||
146408495|NCT04440007|528002165|FG001|Overall Study|Death|2|||
146408496|NCT04440007|528002164|FG000|Overall Study|Physician Decision|1|||
146408497|NCT04440007|528002165|FG001|Overall Study|Physician Decision|1|||
146408498|NCT04440007|528002164|FG000|Overall Study|Withdrawal by Subject|2|||
146408499|NCT04440007|528002165|FG001|Overall Study|Withdrawal by Subject|1|||
146408500|NCT04440007|528002164|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
146408501|NCT04440007|528002165|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
146408502|NCT04440007|528002164|FG000|Overall Study|Discontinued prior to dosing|0|||
146408503|NCT04440007|528002165|FG001|Overall Study|Discontinued prior to dosing|2|||
146408504|NCT01466673|528002166|FG000|Overall Study|Non-compliance with study treatment|2|||
146408505|NCT01466673|528002167|FG001|Overall Study|Non-compliance with study treatment|0|||
146408506|NCT01466673|528002166|FG000|Overall Study|Lost to Follow-up|3|||
146408507|NCT01466673|528002167|FG001|Overall Study|Lost to Follow-up|5|||
146408508|NCT01466673|528002166|FG000|Overall Study|Adverse Event|2|||
146408509|NCT01466673|528002167|FG001|Overall Study|Adverse Event|1|||
146408510|NCT02981602|528002168|FG000|Overall Study|Adverse Event|0|||
146408511|NCT02981602|528002169|FG001|Overall Study|Adverse Event|0|||
146408512|NCT02981602|528002170|FG002|Overall Study|Adverse Event|0|||
146408513|NCT02981602|528002171|FG003|Overall Study|Adverse Event|1|||
146408514|NCT02981602|528002172|FG004|Overall Study|Adverse Event|0|||
146408515|NCT02725671|528002173|FG000|Overall Study|Lost to Follow-up|1|||
146408516|NCT02525562|528002175|FG000|Overall Study|Death|9|||
146408517|NCT02525562|528002176|FG001|Overall Study|Death|0|||
146408518|NCT02525562|528002177|FG002|Overall Study|Death|0|||
146408519|NCT02525562|528002175|FG000|Overall Study|Lost to Follow-up|19|||
146408520|NCT02525562|528002176|FG001|Overall Study|Lost to Follow-up|0|||
146068985|NCT01519921|526770816|FG000|Overall Study|Withdrawal by Subject|3|||
146408521|NCT02525562|528002177|FG002|Overall Study|Lost to Follow-up|0|||
146408522|NCT02525562|528002175|FG000|Overall Study|Withdrawal by Subject|37|||
146068986|NCT01519921|526770817|FG001|Overall Study|Withdrawal by Subject|0|||
146171924|NCT02277743|527143294|FG001|Overall Study|Lack of Efficacy|4|||
146408523|NCT02525562|528002176|FG001|Overall Study|Withdrawal by Subject|0|||
146068987|NCT01519921|526770816|FG000|Overall Study|Lost to Follow-up|2|||
146068988|NCT01519921|526770817|FG001|Overall Study|Lost to Follow-up|1|||
146068989|NCT01519921|526770816|FG000|Overall Study|Treatment refusal|2|||
146068990|NCT01519921|526770817|FG001|Overall Study|Treatment refusal|1|||
146068991|NCT01519921|526770816|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
146068992|NCT01519921|526770817|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
146171925|NCT02277743|527143295|FG002|Overall Study|Lack of Efficacy|3|||
146068993|NCT01216189|526770819|FG000|Overall Study|Lost to Follow-up|21|||
146068994|NCT01216189|526770820|FG001|Overall Study|Lost to Follow-up|3|||
146068995|NCT01216189|526770819|FG000|Overall Study|Death|4|||
146068996|NCT01216189|526770820|FG001|Overall Study|Death|2|||
146068997|NCT00541385|526770821|FG000|Overall Study|Adverse Event|6|||
146068998|NCT00541385|526770822|FG001|Overall Study|Adverse Event|3|||
146068999|NCT00541385|526770821|FG000|Overall Study|Withdrawal by Subject|2|||
146069000|NCT00541385|526770822|FG001|Overall Study|Withdrawal by Subject|2|||
146069001|NCT00541385|526770821|FG000|Overall Study|Lost to Follow-up|6|||
146069002|NCT00541385|526770822|FG001|Overall Study|Lost to Follow-up|1|||
146069003|NCT00541385|526770821|FG000|Overall Study|Parasite reappearance/malaria|67|||
146069004|NCT00541385|526770822|FG001|Overall Study|Parasite reappearance/malaria|32|||
146069005|NCT01733680|526770823|FG000|Overall Study|Withdrawal by Subject|0|||
146069006|NCT01733680|526770824|FG001|Overall Study|Withdrawal by Subject|1|||
146069007|NCT04269889|526770826|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
146069008|NCT01721044|526770829|FG000|Treatment Period|Adverse Event|7|||
146069009|NCT01721044|526770830|FG001|Treatment Period|Adverse Event|7|||
146069010|NCT01721044|526770831|FG002|Treatment Period|Adverse Event|10|||
146069011|NCT01721044|526770829|FG000|Treatment Period|Death|0|||
146069012|NCT01721044|526770830|FG001|Treatment Period|Death|0|||
146069013|NCT01721044|526770831|FG002|Treatment Period|Death|1|||
146069014|NCT01721044|526770829|FG000|Treatment Period|Lack of Efficacy|16|||
146069015|NCT01721044|526770830|FG001|Treatment Period|Lack of Efficacy|4|||
146069016|NCT01721044|526770831|FG002|Treatment Period|Lack of Efficacy|4|||
146069017|NCT01721044|526770829|FG000|Treatment Period|Lost to Follow-up|0|||
146069018|NCT01721044|526770830|FG001|Treatment Period|Lost to Follow-up|0|||
146069019|NCT01721044|526770831|FG002|Treatment Period|Lost to Follow-up|1|||
146069020|NCT01721044|526770829|FG000|Treatment Period|Physician Decision|1|||
146069021|NCT01721044|526770830|FG001|Treatment Period|Physician Decision|0|||
146069022|NCT01721044|526770831|FG002|Treatment Period|Physician Decision|2|||
146069023|NCT01721044|526770829|FG000|Treatment Period|Protocol Violation|1|||
146069024|NCT01721044|526770830|FG001|Treatment Period|Protocol Violation|0|||
146069025|NCT01721044|526770831|FG002|Treatment Period|Protocol Violation|0|||
146069026|NCT01721044|526770829|FG000|Treatment Period|Withdrawal by Subject|7|||
146069027|NCT01721044|526770830|FG001|Treatment Period|Withdrawal by Subject|6|||
146069028|NCT01721044|526770831|FG002|Treatment Period|Withdrawal by Subject|1|||
146069029|NCT03155841|526770832|FG000|Overall Study|Protocol Violation|3|||
146069030|NCT03155841|526770833|FG001|Overall Study|Protocol Violation|4|||
146069031|NCT01526733|526770834|FG000|Phase 1|Protocol Violation|1|||
146069032|NCT01526733|526770835|FG001|Phase 1|Protocol Violation|0|||
146069033|NCT01526733|526770834|FG000|Phase 1|Withdrawal by Subject|1|||
146069034|NCT01526733|526770835|FG001|Phase 1|Withdrawal by Subject|1|||
146069035|NCT04032093|526770836|FG000|Overall Study|Lost to Follow-up|7|||
146069036|NCT04032093|526770837|FG001|Overall Study|Lost to Follow-up|7|||
146069037|NCT04032093|526770838|FG002|Overall Study|Lost to Follow-up|6|||
146069038|NCT04032093|526770839|FG003|Overall Study|Lost to Follow-up|10|||
146069039|NCT04032093|526770840|FG004|Overall Study|Lost to Follow-up|13|||
146069040|NCT04032093|526770841|FG005|Overall Study|Lost to Follow-up|7|||
146069041|NCT04032093|526770842|FG006|Overall Study|Lost to Follow-up|7|||
146069042|NCT04032093|526770843|FG007|Overall Study|Lost to Follow-up|5|||
146069043|NCT04032093|526770844|FG008|Overall Study|Lost to Follow-up|9|||
146069044|NCT04032093|526770845|FG009|Overall Study|Lost to Follow-up|12|||
146069045|NCT04032093|526770836|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069046|NCT04032093|526770837|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069047|NCT04032093|526770838|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069048|NCT04032093|526770839|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
146069049|NCT04032093|526770840|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
146069050|NCT04032093|526770841|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069051|NCT04032093|526770842|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069052|NCT04032093|526770843|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146069053|NCT04032093|526770844|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
146069054|NCT04032093|526770845|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
146069055|NCT04032093|526770836|FG000|Overall Study|Other|1|||
146069056|NCT04032093|526770837|FG001|Overall Study|Other|0|||
146069057|NCT04032093|526770838|FG002|Overall Study|Other|0|||
146069058|NCT04032093|526770839|FG003|Overall Study|Other|1|||
146069059|NCT04032093|526770840|FG004|Overall Study|Other|1|||
146069060|NCT04032093|526770841|FG005|Overall Study|Other|0|||
146069061|NCT04032093|526770842|FG006|Overall Study|Other|0|||
146069062|NCT04032093|526770843|FG007|Overall Study|Other|0|||
146069063|NCT04032093|526770844|FG008|Overall Study|Other|0|||
146069064|NCT04032093|526770845|FG009|Overall Study|Other|1|||
146069065|NCT04032093|526770836|FG000|Overall Study|Withdrawal by Subject|1|||
146069066|NCT04032093|526770837|FG001|Overall Study|Withdrawal by Subject|3|||
146069067|NCT04032093|526770838|FG002|Overall Study|Withdrawal by Subject|2|||
146069068|NCT04032093|526770839|FG003|Overall Study|Withdrawal by Subject|2|||
146069069|NCT04032093|526770840|FG004|Overall Study|Withdrawal by Subject|3|||
146069070|NCT04032093|526770841|FG005|Overall Study|Withdrawal by Subject|0|||
146069071|NCT04032093|526770842|FG006|Overall Study|Withdrawal by Subject|0|||
146069072|NCT04032093|526770843|FG007|Overall Study|Withdrawal by Subject|0|||
146069073|NCT04032093|526770844|FG008|Overall Study|Withdrawal by Subject|0|||
146069074|NCT04032093|526770845|FG009|Overall Study|Withdrawal by Subject|0|||
146069075|NCT04032093|526770836|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146069076|NCT04032093|526770837|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146069077|NCT04032093|526770838|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146069078|NCT04032093|526770839|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146069079|NCT04032093|526770840|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146069080|NCT04032093|526770841|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146069081|NCT04032093|526770842|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
146069082|NCT04032093|526770843|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
146069083|NCT04032093|526770844|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
146069084|NCT04032093|526770845|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
146069085|NCT04032093|526770836|FG000|Overall Study|Adverse Event|0|||
146069086|NCT04032093|526770837|FG001|Overall Study|Adverse Event|0|||
146069087|NCT04032093|526770838|FG002|Overall Study|Adverse Event|0|||
146069088|NCT04032093|526770839|FG003|Overall Study|Adverse Event|0|||
146069089|NCT04032093|526770840|FG004|Overall Study|Adverse Event|0|||
146069090|NCT04032093|526770841|FG005|Overall Study|Adverse Event|0|||
146069091|NCT04032093|526770842|FG006|Overall Study|Adverse Event|0|||
146069092|NCT04032093|526770843|FG007|Overall Study|Adverse Event|0|||
146069093|NCT04032093|526770844|FG008|Overall Study|Adverse Event|0|||
146069094|NCT04032093|526770845|FG009|Overall Study|Adverse Event|1|||
146069095|NCT04032093|526770836|FG000|Overall Study|Physician Decision|0|||
146069096|NCT04032093|526770837|FG001|Overall Study|Physician Decision|0|||
146069097|NCT04032093|526770838|FG002|Overall Study|Physician Decision|0|||
146069098|NCT04032093|526770839|FG003|Overall Study|Physician Decision|0|||
146069099|NCT04032093|526770840|FG004|Overall Study|Physician Decision|0|||
146069100|NCT04032093|526770841|FG005|Overall Study|Physician Decision|1|||
146069101|NCT04032093|526770842|FG006|Overall Study|Physician Decision|0|||
146069102|NCT04032093|526770843|FG007|Overall Study|Physician Decision|0|||
146069103|NCT04032093|526770844|FG008|Overall Study|Physician Decision|0|||
146069104|NCT04032093|526770845|FG009|Overall Study|Physician Decision|0|||
146069105|NCT00949702|526770851|FG000|Overall Study|Death|40|||
146069106|NCT00949702|526770851|FG000|Overall Study|Disease progression|7|||
146069107|NCT00949702|526770851|FG000|Overall Study|Withdrawal of consent|1|||
146069108|NCT01654302|526770852|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
146069109|NCT01654302|526770853|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
146069110|NCT02699749|526770861|FG000|Overall Study|Other|0|||
146069111|NCT02699749|526770862|FG001|Overall Study|Other|0|||
146069112|NCT02699749|526770863|FG002|Overall Study|Other|2|||
146069113|NCT02699749|526770864|FG003|Overall Study|Other|0|||
146069114|NCT02699749|526770865|FG004|Overall Study|Other|0|||
146069115|NCT02699749|526770866|FG005|Overall Study|Other|1|||
146069116|NCT02699749|526770867|FG006|Overall Study|Other|1|||
146069117|NCT02699749|526770868|FG007|Overall Study|Other|0|||
146069118|NCT02699749|526770869|FG008|Overall Study|Other|0|||
146069119|NCT02699749|526770870|FG009|Overall Study|Other|0|||
146069120|NCT02699749|526770871|FG010|Overall Study|Other|1|||
146069121|NCT02699749|526770872|FG011|Overall Study|Other|0|||
146069122|NCT02699749|526770873|FG012|Overall Study|Other|0|||
146069123|NCT02699749|526770874|FG013|Overall Study|Other|0|||
146069124|NCT02699749|526770861|FG000|Overall Study|Progressive Disease|3|||
146069125|NCT02699749|526770862|FG001|Overall Study|Progressive Disease|3|||
146069126|NCT02699749|526770863|FG002|Overall Study|Progressive Disease|14|||
146069127|NCT02699749|526770864|FG003|Overall Study|Progressive Disease|3|||
146069128|NCT02699749|526770865|FG004|Overall Study|Progressive Disease|3|||
146069129|NCT02699749|526770866|FG005|Overall Study|Progressive Disease|7|||
146069130|NCT02699749|526770867|FG006|Overall Study|Progressive Disease|5|||
146069131|NCT02699749|526770868|FG007|Overall Study|Progressive Disease|5|||
146069132|NCT02699749|526770869|FG008|Overall Study|Progressive Disease|6|||
146069133|NCT02699749|526770870|FG009|Overall Study|Progressive Disease|6|||
146069134|NCT02699749|526770871|FG010|Overall Study|Progressive Disease|5|||
146069135|NCT02699749|526770872|FG011|Overall Study|Progressive Disease|4|||
146069136|NCT02699749|526770873|FG012|Overall Study|Progressive Disease|3|||
146069137|NCT02699749|526770874|FG013|Overall Study|Progressive Disease|5|||
146069138|NCT02699749|526770861|FG000|Overall Study|Death|0|||
146408524|NCT02525562|528002177|FG002|Overall Study|Withdrawal by Subject|0|||
146069139|NCT02699749|526770862|FG001|Overall Study|Death|0|||
146069140|NCT02699749|526770863|FG002|Overall Study|Death|0|||
146069141|NCT02699749|526770864|FG003|Overall Study|Death|0|||
146069142|NCT02699749|526770865|FG004|Overall Study|Death|0|||
146069143|NCT02699749|526770866|FG005|Overall Study|Death|0|||
146069144|NCT02699749|526770867|FG006|Overall Study|Death|0|||
146069145|NCT02699749|526770868|FG007|Overall Study|Death|0|||
146069146|NCT02699749|526770869|FG008|Overall Study|Death|0|||
146069147|NCT02699749|526770870|FG009|Overall Study|Death|0|||
146069148|NCT02699749|526770871|FG010|Overall Study|Death|0|||
146408525|NCT02525562|528002175|FG000|Overall Study|Revision/Removal of Study Device|4|||
146069149|NCT02699749|526770872|FG011|Overall Study|Death|0|||
146069150|NCT02699749|526770873|FG012|Overall Study|Death|0|||
146069151|NCT02699749|526770874|FG013|Overall Study|Death|1|||
146069152|NCT02699749|526770861|FG000|Overall Study|Lost to Follow-up|0|||
146069153|NCT02699749|526770862|FG001|Overall Study|Lost to Follow-up|0|||
146069154|NCT02699749|526770863|FG002|Overall Study|Lost to Follow-up|0|||
146069155|NCT02699749|526770864|FG003|Overall Study|Lost to Follow-up|0|||
146069156|NCT02699749|526770865|FG004|Overall Study|Lost to Follow-up|0|||
146171926|NCT02277743|527143293|FG000|Overall Study|Other than specified above|18|||
146171927|NCT02277743|527143294|FG001|Overall Study|Other than specified above|5|||
146171928|NCT02277743|527143295|FG002|Overall Study|Other than specified above|16|||
146171929|NCT01224158|527143299|FG000|Overall Study|Withdrawal by Subject|1|||
146171930|NCT01224158|527143300|FG001|Overall Study|Withdrawal by Subject|0|||
146171931|NCT03976466|527143303|FG000|Overall Study|Lost to Follow-up|1|||
146171932|NCT03976466|527143304|FG001|Overall Study|Lost to Follow-up|3|||
146171933|NCT02055157|527143305|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146171934|NCT02055157|527143306|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
146171935|NCT02055157|527143307|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146171936|NCT02055157|527143308|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
146171937|NCT02055157|527143305|FG000|Initial 6 Months|Adverse Event|0|||
146171938|NCT02055157|527143306|FG001|Initial 6 Months|Adverse Event|0|||
146171939|NCT02055157|527143307|FG002|Initial 6 Months|Adverse Event|0|||
146171940|NCT02055157|527143308|FG003|Initial 6 Months|Adverse Event|1|||
146171941|NCT02055157|527143305|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
146171942|NCT02055157|527143306|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
146171943|NCT02055157|527143307|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
146171944|NCT02055157|527143308|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
146171945|NCT02055157|527143305|FG000|18-month Extension|Investigator decision|0|||
146171946|NCT02055157|527143306|FG001|18-month Extension|Investigator decision|1|||
146171947|NCT02055157|527143307|FG002|18-month Extension|Investigator decision|0|||
146171948|NCT02055157|527143308|FG003|18-month Extension|Investigator decision|0|||
146171949|NCT02055157|527143305|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
146171950|NCT02055157|527143306|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146171951|NCT02055157|527143307|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146171952|NCT02055157|527143308|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
146171953|NCT00943306|527143313|FG000|Overall Study|Physician Decision|1|||
146171954|NCT00943306|527143313|FG000|Overall Study|Death|1|||
146171955|NCT00943306|527143313|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
146171956|NCT00733499|527143314|FG000|Pre-operative|Protocol Violation|0|||
146171957|NCT00733499|527143315|FG001|Pre-operative|Protocol Violation|1|||
146171958|NCT00733499|527143314|FG000|3 Months Follow-up|Death|1|||
146171959|NCT00733499|527143315|FG001|3 Months Follow-up|Death|2|||
146171960|NCT00733499|527143314|FG000|6 Months Follow-up|Death|0|||
146171961|NCT00733499|527143315|FG001|6 Months Follow-up|Death|2|||
146171962|NCT00733499|527143314|FG000|6 Months Follow-up|Adverse Event|0|||
146171963|NCT00733499|527143315|FG001|6 Months Follow-up|Adverse Event|1|||
146171964|NCT00733499|527143314|FG000|12 Months Follow-up|Death|2|||
146171965|NCT00733499|527143315|FG001|12 Months Follow-up|Death|1|||
146171966|NCT00733499|527143314|FG000|24 Months Follow-up|Death|0|||
146171967|NCT00733499|527143315|FG001|24 Months Follow-up|Death|1|||
146171968|NCT00733499|527143314|FG000|5 Year Followup|Adverse Event|2|||
146171969|NCT00733499|527143315|FG001|5 Year Followup|Adverse Event|2|||
146171970|NCT00733499|527143314|FG000|5 Year Followup|Non device related AE|0|||
146171971|NCT00733499|527143315|FG001|5 Year Followup|Non device related AE|1|||
146171972|NCT00733499|527143314|FG000|5 Year Followup|Revision of Study Implant|0|||
146171973|NCT00733499|527143315|FG001|5 Year Followup|Revision of Study Implant|1|||
146171974|NCT00733499|527143314|FG000|5 Year Followup|Lost to Follow-up|2|||
146171975|NCT00733499|527143315|FG001|5 Year Followup|Lost to Follow-up|0|||
146171976|NCT00733499|527143314|FG000|5 Year Followup|Death|13|||
146171977|NCT00733499|527143315|FG001|5 Year Followup|Death|19|||
146171978|NCT00733499|527143314|FG000|5 Year Followup|missing, unable to locate|0|||
146171979|NCT00733499|527143315|FG001|5 Year Followup|missing, unable to locate|1|||
146171980|NCT00733499|527143314|FG000|5 Year Followup|Withdrawal by Subject|4|||
146171981|NCT00733499|527143315|FG001|5 Year Followup|Withdrawal by Subject|1|||
146171982|NCT00733499|527143314|FG000|10 Year Followup|Death|9|||
146171983|NCT00733499|527143315|FG001|10 Year Followup|Death|7|||
146171984|NCT00733499|527143314|FG000|10 Year Followup|Adverse Event|3|||
146171985|NCT00733499|527143315|FG001|10 Year Followup|Adverse Event|3|||
146171986|NCT00733499|527143314|FG000|10 Year Followup|Lost to Follow-up|3|||
146171987|NCT00733499|527143315|FG001|10 Year Followup|Lost to Follow-up|2|||
146171988|NCT00733499|527143314|FG000|10 Year Followup|Withdrawal by Subject|5|||
146069157|NCT02699749|526770866|FG005|Overall Study|Lost to Follow-up|1|||
146171989|NCT00733499|527143315|FG001|10 Year Followup|Withdrawal by Subject|5|||
146171990|NCT00733499|527143314|FG000|10 Year Followup|missing, unable to locate|0|||
146283850|NCT00092495|527551856|FG002|Base Study Vaccination Period|Pregnancy|0|||
146069158|NCT02699749|526770867|FG006|Overall Study|Lost to Follow-up|0|||
146069159|NCT02699749|526770868|FG007|Overall Study|Lost to Follow-up|1|||
146171991|NCT00733499|527143315|FG001|10 Year Followup|missing, unable to locate|2|||
146069160|NCT02699749|526770869|FG008|Overall Study|Lost to Follow-up|0|||
146069161|NCT02699749|526770870|FG009|Overall Study|Lost to Follow-up|0|||
146069162|NCT02699749|526770871|FG010|Overall Study|Lost to Follow-up|0|||
146069163|NCT02699749|526770872|FG011|Overall Study|Lost to Follow-up|0|||
146069164|NCT02699749|526770873|FG012|Overall Study|Lost to Follow-up|0|||
146069165|NCT02699749|526770874|FG013|Overall Study|Lost to Follow-up|0|||
146069166|NCT02377817|526770875|FG000|Overall Study|Transportation/childcare barriers.|2|||
146069167|NCT02377817|526770876|FG001|Overall Study|Transportation/childcare barriers.|0|||
146069168|NCT02377817|526770875|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
146069169|NCT02377817|526770876|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
146069170|NCT02839200|526770877|FG000|Overall Study|Withdrawal by Subject|2|||
146069171|NCT02839200|526770878|FG001|Overall Study|Withdrawal by Subject|0|||
146069172|NCT02839200|526770879|FG002|Overall Study|Withdrawal by Subject|1|||
146069173|NCT02839200|526770880|FG003|Overall Study|Withdrawal by Subject|0|||
146069174|NCT02839200|526770881|FG004|Overall Study|Withdrawal by Subject|0|||
146069175|NCT02839200|526770882|FG005|Overall Study|Withdrawal by Subject|1|||
146069176|NCT02839200|526770877|FG000|Overall Study|Lost to Follow-up|2|||
146069177|NCT02839200|526770878|FG001|Overall Study|Lost to Follow-up|0|||
146069178|NCT02839200|526770879|FG002|Overall Study|Lost to Follow-up|0|||
146069179|NCT02839200|526770880|FG003|Overall Study|Lost to Follow-up|0|||
146069180|NCT02839200|526770881|FG004|Overall Study|Lost to Follow-up|1|||
146069181|NCT02839200|526770882|FG005|Overall Study|Lost to Follow-up|0|||
146069182|NCT02839200|526770877|FG000|Overall Study|Adverse Event|0|||
146069183|NCT02839200|526770878|FG001|Overall Study|Adverse Event|0|||
146408526|NCT02525562|528002176|FG001|Overall Study|Revision/Removal of Study Device|0|||
146408527|NCT02525562|528002177|FG002|Overall Study|Revision/Removal of Study Device|0|||
146408528|NCT02525562|528002175|FG000|Overall Study|Study Closed by Sponsor|154|||
146408529|NCT02525562|528002176|FG001|Overall Study|Study Closed by Sponsor|0|||
146408530|NCT02525562|528002177|FG002|Overall Study|Study Closed by Sponsor|0|||
146408531|NCT02983227|528002178|FG000|Overall Study|Adverse Event|21|||
146408532|NCT02983227|528002179|FG001|Overall Study|Adverse Event|3|||
146408533|NCT02983227|528002178|FG000|Overall Study|Death|3|||
146408534|NCT02983227|528002179|FG001|Overall Study|Death|0|||
146408535|NCT02983227|528002178|FG000|Overall Study|Lack of Efficacy|8|||
146408536|NCT02983227|528002179|FG001|Overall Study|Lack of Efficacy|1|||
146408537|NCT02983227|528002178|FG000|Overall Study|Lost to Follow-up|3|||
146408538|NCT02983227|528002179|FG001|Overall Study|Lost to Follow-up|0|||
146408539|NCT02983227|528002178|FG000|Overall Study|Multiple Reasons|2|||
146408540|NCT02983227|528002179|FG001|Overall Study|Multiple Reasons|1|||
146408541|NCT02983227|528002178|FG000|Overall Study|Physician Decision|3|||
146408542|NCT02983227|528002179|FG001|Overall Study|Physician Decision|1|||
146408543|NCT02983227|528002178|FG000|Overall Study|Withdrawal by Subject|19|||
146408544|NCT02983227|528002179|FG001|Overall Study|Withdrawal by Subject|8|||
146408545|NCT01706770|528002180|FG000|Overall Study|Lost to Follow-up|1|||
146408546|NCT01706770|528002181|FG001|Overall Study|Lost to Follow-up|0|||
146408547|NCT01706770|528002180|FG000|Overall Study|Physician Decision|1|||
146408548|NCT01706770|528002181|FG001|Overall Study|Physician Decision|0|||
146408549|NCT02164539|528002182|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
146408550|NCT02164539|528002183|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
146408551|NCT02164539|528002184|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
146408552|NCT02164539|528002185|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
146408553|NCT02164539|528002186|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
146408554|NCT02164539|528002187|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
146408555|NCT02164539|528002188|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
146408556|NCT02164539|528002182|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
146408557|NCT02164539|528002183|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
146408558|NCT02164539|528002184|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
146408559|NCT02164539|528002185|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
146408560|NCT02164539|528002186|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
146408561|NCT02164539|528002187|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
146408562|NCT02164539|528002188|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
146408563|NCT02164539|528002182|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
146408564|NCT02164539|528002183|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
146408565|NCT02164539|528002184|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
146408566|NCT02164539|528002185|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
146408567|NCT02164539|528002186|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
146408568|NCT02164539|528002187|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
146408569|NCT02164539|528002188|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
146408570|NCT02164539|528002182|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
145945249|NCT03008278|526308187|FG000|Overall Study|Adverse Event|0|||
146069184|NCT02839200|526770879|FG002|Overall Study|Adverse Event|0|||
146069185|NCT02839200|526770880|FG003|Overall Study|Adverse Event|0|||
146069186|NCT02839200|526770881|FG004|Overall Study|Adverse Event|1|||
146069187|NCT02839200|526770882|FG005|Overall Study|Adverse Event|0|||
146069188|NCT02839200|526770877|FG000|Overall Study|Randomized in error|0|||
146069189|NCT02839200|526770878|FG001|Overall Study|Randomized in error|1|||
146069190|NCT02839200|526770879|FG002|Overall Study|Randomized in error|0|||
146069191|NCT02839200|526770880|FG003|Overall Study|Randomized in error|0|||
146069192|NCT02839200|526770881|FG004|Overall Study|Randomized in error|0|||
146069193|NCT02839200|526770882|FG005|Overall Study|Randomized in error|0|||
146069194|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
146069195|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
146069196|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
146069197|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
146069198|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
146069199|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
146069200|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
146069201|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
146069202|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
146069203|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
146069204|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
146069205|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
146069206|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
146069207|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
146069208|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
146069209|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
146069210|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
146069211|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
146069212|NCT02952820|526770883|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146069213|NCT02952820|526770884|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146069214|NCT02952820|526770885|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
146069215|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
146069216|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
146069217|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
146069218|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
146069219|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
146069220|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
146069221|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
146069222|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
146069223|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
146069224|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
146069225|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
146069226|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
146069227|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
146069228|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
146069229|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
146069230|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
146069231|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
146069232|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
146069233|NCT02952820|526770883|FG000|Active Treatment Period (6 Months)|Not treated|0|||
146069234|NCT02952820|526770884|FG001|Active Treatment Period (6 Months)|Not treated|0|||
146069235|NCT02952820|526770885|FG002|Active Treatment Period (6 Months)|Not treated|1|||
146069236|NCT04139018|526770886|FG000|Overall Study|Screen fail|1|||
146069237|NCT04139018|526770887|FG001|Overall Study|Screen fail|0|||
146069238|NCT04139018|526770886|FG000|Overall Study|Withdrawal by Subject|2|||
146069239|NCT04139018|526770887|FG001|Overall Study|Withdrawal by Subject|0|||
146408571|NCT02164539|528002183|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408572|NCT02164539|528002184|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408573|NCT02164539|528002185|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408574|NCT02164539|528002186|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408575|NCT02164539|528002187|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408576|NCT02164539|528002188|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
146408577|NCT02164539|528002182|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
146408578|NCT02164539|528002183|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
146408579|NCT02164539|528002184|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
146408580|NCT02164539|528002185|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
146408581|NCT02164539|528002186|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
146408582|NCT02164539|528002187|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
146408583|NCT02164539|528002188|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
146069240|NCT04139018|526770886|FG000|Overall Study|Lost to Follow-up|0|||
146408584|NCT02164539|528002182|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
146408585|NCT02164539|528002183|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
146069241|NCT04139018|526770887|FG001|Overall Study|Lost to Follow-up|1|||
146069242|NCT02565108|526770888|FG000|Overall Study|Adverse Event|1|||
146069243|NCT02565108|526770889|FG001|Overall Study|Adverse Event|0|||
146069244|NCT02565108|526770888|FG000|Overall Study|Withdrew Consent|1|||
146069245|NCT02565108|526770889|FG001|Overall Study|Withdrew Consent|0|||
146069246|NCT01310075|526770906|FG000|Overall Study|Lost to Follow-up|1|||
146069247|NCT01310075|526770907|FG001|Overall Study|Lost to Follow-up|0|||
146069248|NCT01310075|526770906|FG000|Overall Study|Physician Decision|10|||
146069249|NCT01310075|526770907|FG001|Overall Study|Physician Decision|7|||
146069250|NCT01310075|526770906|FG000|Overall Study|Protocol Violation|2|||
146069251|NCT01310075|526770907|FG001|Overall Study|Protocol Violation|2|||
146069252|NCT01310075|526770906|FG000|Overall Study|Withdrawal by Subject|1|||
146069253|NCT01310075|526770907|FG001|Overall Study|Withdrawal by Subject|1|||
146069254|NCT03614156|526770908|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
146069255|NCT03614156|526770909|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146069256|NCT03614156|526770910|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146069257|NCT03614156|526770911|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
146069258|NCT03614156|526770908|FG000|Open-Label Treatment Period|Adverse Event|7|||
146069259|NCT03614156|526770909|FG001|Open-Label Treatment Period|Adverse Event|0|||
146069260|NCT03614156|526770910|FG002|Open-Label Treatment Period|Adverse Event|0|||
146069261|NCT03614156|526770911|FG003|Open-Label Treatment Period|Adverse Event|0|||
146069262|NCT03614156|526770908|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
146069263|NCT03614156|526770909|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146069264|NCT03614156|526770910|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146069265|NCT03614156|526770911|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146069266|NCT03614156|526770908|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
146069267|NCT03614156|526770909|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146069268|NCT03614156|526770910|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146069269|NCT03614156|526770911|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146069270|NCT03614156|526770908|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
146069271|NCT03614156|526770909|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146069272|NCT03614156|526770910|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146069273|NCT03614156|526770911|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146069274|NCT03614156|526770908|FG000|Open-Label Treatment Period|Protocol Violation|2|||
146069275|NCT03614156|526770909|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146069276|NCT03614156|526770910|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146069277|NCT03614156|526770911|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146069278|NCT03614156|526770908|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
146069279|NCT03614156|526770909|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
146069280|NCT03614156|526770910|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
146069281|NCT03614156|526770911|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
146069282|NCT03614156|526770908|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
146069283|NCT03614156|526770909|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
146069284|NCT03614156|526770910|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
146069285|NCT03614156|526770911|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
146069286|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
146069287|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
146069288|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
146069289|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
146069290|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146069291|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
146408586|NCT02164539|528002184|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
146408587|NCT02164539|528002185|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
146408588|NCT02164539|528002186|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
146408589|NCT02164539|528002187|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
146408590|NCT02164539|528002188|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
146069292|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146069293|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146069294|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146069295|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146069296|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
146069297|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
146069298|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
146069299|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146408591|NCT02643966|528002189|FG000|First Screening Round|ineligible|1|||
146069300|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146069301|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
146069302|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
146408592|NCT02643966|528002189|FG000|First Screening Round|excluded from analysis|2|||
146069303|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
146069304|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
146069305|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
146069306|NCT03614156|526770908|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146069307|NCT03614156|526770909|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
146069308|NCT03614156|526770910|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146069309|NCT03614156|526770911|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
146069310|NCT03614156|526770908|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
146069311|NCT03614156|526770909|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146069312|NCT03614156|526770910|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146069313|NCT03614156|526770911|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
146069314|NCT03614156|526770908|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
146069315|NCT03614156|526770909|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
146069316|NCT03614156|526770910|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
146069317|NCT03614156|526770911|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
146069318|NCT03614156|526770908|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
146069319|NCT03614156|526770909|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
146069320|NCT03614156|526770910|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
146069321|NCT03614156|526770911|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
146069322|NCT01094119|526770913|FG000|Overall Study|Lack of Efficacy|2|||
146069323|NCT01094119|526770914|FG001|Overall Study|Lack of Efficacy|4|||
146069324|NCT00960999|526770915|FG000|Overall Study|Withdrawal by Subject|1|||
146069325|NCT00960999|526770916|FG001|Overall Study|Withdrawal by Subject|0|||
146069326|NCT00960999|526770915|FG000|Overall Study|Protocol Violation|5|||
146069327|NCT00960999|526770916|FG001|Overall Study|Protocol Violation|2|||
146069328|NCT00960999|526770915|FG000|Overall Study|RT dose constraints not met|2|||
146069329|NCT00960999|526770916|FG001|Overall Study|RT dose constraints not met|0|||
146069330|NCT04774094|526770922|FG000|Overall Study|Other|2|||
146069331|NCT04774094|526770922|FG000|Overall Study|Withdrawal by Subject|9|||
146069332|NCT04774094|526770922|FG000|Overall Study|Lost to Follow-up|7|||
146069333|NCT04774094|526770922|FG000|Overall Study|Lack of Efficacy|5|||
146069334|NCT04774094|526770922|FG000|Overall Study|Death|17|||
146069335|NCT04774094|526770922|FG000|Overall Study|Adverse Event|4|||
146069336|NCT05232682|526770925|FG000|Overall Study|Lost to Follow-up|2|||
146069337|NCT03207763|526772430|FG000|Overall Study|Lost to Follow-up|1|||
146069338|NCT03207763|526772431|FG001|Overall Study|Lost to Follow-up|0|||
146069339|NCT03751657|526772432|FG000|Overall Study|Physician Decision|0|||
146069340|NCT03751657|526772433|FG001|Overall Study|Physician Decision|1|||
146069341|NCT03751657|526772432|FG000|Overall Study|Withdrawal by Subject|1|||
146069342|NCT03751657|526772433|FG001|Overall Study|Withdrawal by Subject|1|||
146069343|NCT03751657|526772432|FG000|Overall Study|Lost to Follow-up|2|||
146069344|NCT03751657|526772433|FG001|Overall Study|Lost to Follow-up|1|||
146069345|NCT01938716|526772438|FG000|Overall Study|Physician Decision|2|||
146069346|NCT01938716|526772438|FG000|Overall Study|Withdrawal by Subject|2|||
146069347|NCT01358721|526772439|FG000|Overall Study|Withdrawal by Subject|0|||
146069348|NCT01358721|526772440|FG001|Overall Study|Withdrawal by Subject|0|||
146069349|NCT01358721|526772441|FG002|Overall Study|Withdrawal by Subject|0|||
146069350|NCT01358721|526772442|FG003|Overall Study|Withdrawal by Subject|1|||
146069351|NCT01358721|526772439|FG000|Overall Study|Death|0|||
146069352|NCT01358721|526772440|FG001|Overall Study|Death|2|||
146069353|NCT01358721|526772441|FG002|Overall Study|Death|0|||
146069354|NCT01358721|526772442|FG003|Overall Study|Death|0|||
146069355|NCT01358721|526772439|FG000|Overall Study|Study Drug Toxicity|1|||
146069356|NCT01358721|526772440|FG001|Overall Study|Study Drug Toxicity|3|||
146069357|NCT01358721|526772441|FG002|Overall Study|Study Drug Toxicity|4|||
146069358|NCT01358721|526772442|FG003|Overall Study|Study Drug Toxicity|5|||
146069359|NCT01358721|526772439|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
146069360|NCT01358721|526772440|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
146069361|NCT01358721|526772441|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
146069362|NCT01358721|526772442|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
146069363|NCT01358721|526772439|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146069364|NCT01358721|526772440|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146069365|NCT01358721|526772441|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146069366|NCT01358721|526772442|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
146069367|NCT01358721|526772439|FG000|Overall Study|Adverse Event related to study drug|1|||
146069368|NCT01358721|526772440|FG001|Overall Study|Adverse Event related to study drug|0|||
146408593|NCT02643966|528002189|FG000|First Screening Round|Lost to Follow-up|56|||
146408594|NCT02643966|528002189|FG000|First Screening Round|Withdrawal by Subject|28|||
146069369|NCT01358721|526772441|FG002|Overall Study|Adverse Event related to study drug|0|||
146069370|NCT01358721|526772442|FG003|Overall Study|Adverse Event related to study drug|1|||
146069371|NCT01358721|526772439|FG000|Overall Study|Disease Progression|19|||
146069372|NCT01358721|526772440|FG001|Overall Study|Disease Progression|15|||
146069373|NCT01358721|526772441|FG002|Overall Study|Disease Progression|17|||
146069374|NCT01358721|526772442|FG003|Overall Study|Disease Progression|15|||
146069375|NCT01358721|526772439|FG000|Overall Study|Out of State/Unmet Criteria|0|||
146069376|NCT01358721|526772440|FG001|Overall Study|Out of State/Unmet Criteria|0|||
146069377|NCT01358721|526772441|FG002|Overall Study|Out of State/Unmet Criteria|1|||
146069378|NCT01358721|526772442|FG003|Overall Study|Out of State/Unmet Criteria|0|||
146069379|NCT04730271|526772448|FG000|Overall Study|Adverse Event|0|||
146069380|NCT04730271|526772449|FG001|Overall Study|Adverse Event|2|||
146069381|NCT04730271|526772448|FG000|Overall Study|Withdrawal by Subject|1|||
146069382|NCT04730271|526772449|FG001|Overall Study|Withdrawal by Subject|1|||
146069383|NCT04730271|526772448|FG000|Overall Study|Protocol Violation|7|||
146069384|NCT04730271|526772449|FG001|Overall Study|Protocol Violation|13|||
146069385|NCT04730271|526772448|FG000|Overall Study|Lost to Follow-up|3|||
146069386|NCT04730271|526772449|FG001|Overall Study|Lost to Follow-up|3|||
146069387|NCT04730271|526772448|FG000|Overall Study|Death|1|||
146069388|NCT04730271|526772449|FG001|Overall Study|Death|0|||
146069389|NCT02223858|526772454|FG000|Overall Study|Death|1|||
146069390|NCT02223858|526772455|FG001|Overall Study|Death|1|||
146069391|NCT02223858|526772454|FG000|Overall Study|Lost to Follow-up|6|||
146069392|NCT02223858|526772455|FG001|Overall Study|Lost to Follow-up|11|||
146069393|NCT02223858|526772454|FG000|Overall Study|Withdrawal by Subject|8|||
146069394|NCT02223858|526772455|FG001|Overall Study|Withdrawal by Subject|5|||
146069395|NCT02223858|526772454|FG000|Overall Study|Refused|9|||
146069396|NCT02223858|526772455|FG001|Overall Study|Refused|9|||
146069397|NCT04455815|526772456|FG000|Randomisation Phase|Adverse Event|1|||
146069398|NCT04455815|526772457|FG001|Randomisation Phase|Adverse Event|0|||
146069399|NCT04455815|526772456|FG000|Treatment Phase|Adverse Event|0|||
146069400|NCT04455815|526772457|FG001|Treatment Phase|Adverse Event|1|||
146069401|NCT04455815|526772456|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
146069402|NCT04455815|526772457|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
146069403|NCT04455815|526772456|FG000|Treatment Phase|Withdrawal by Subject|1|||
146069404|NCT04455815|526772457|FG001|Treatment Phase|Withdrawal by Subject|1|||
146069405|NCT02106390|526772458|FG000|Overall Study|Withdrawal by Subject|15|||
146069406|NCT02106390|526772459|FG001|Overall Study|Withdrawal by Subject|16|||
146069407|NCT02106390|526772460|FG002|Overall Study|Withdrawal by Subject|15|||
146069408|NCT02106390|526772458|FG000|Overall Study|Lost to Follow-up|25|||
146069409|NCT02106390|526772459|FG001|Overall Study|Lost to Follow-up|20|||
146069410|NCT02106390|526772460|FG002|Overall Study|Lost to Follow-up|13|||
146069411|NCT02106390|526772458|FG000|Overall Study|Other: Administrative Reason|8|||
146069412|NCT02106390|526772459|FG001|Overall Study|Other: Administrative Reason|5|||
146069413|NCT02106390|526772460|FG002|Overall Study|Other: Administrative Reason|12|||
146069414|NCT02106390|526772458|FG000|Overall Study|Other: Unspecified|1|||
146171992|NCT00733980|527143316|FG000|Overall Study|Adverse Event|5|||
146069415|NCT02106390|526772459|FG001|Overall Study|Other: Unspecified|4|||
146069416|NCT02106390|526772460|FG002|Overall Study|Other: Unspecified|2|||
146069417|NCT02106390|526772458|FG000|Overall Study|Adverse Event|0|||
146069418|NCT02106390|526772459|FG001|Overall Study|Adverse Event|2|||
146069419|NCT02106390|526772460|FG002|Overall Study|Adverse Event|1|||
146069420|NCT02106390|526772458|FG000|Overall Study|Protocol Violation|0|||
146069421|NCT02106390|526772459|FG001|Overall Study|Protocol Violation|1|||
146069422|NCT02106390|526772460|FG002|Overall Study|Protocol Violation|0|||
146069423|NCT00473382|526772461|FG000|Core Study|Adverse Event|3|||
146069424|NCT00473382|526772462|FG001|Core Study|Adverse Event|1|||
146069425|NCT00473382|526772463|FG002|Core Study|Adverse Event|1|||
146069426|NCT00473382|526772461|FG000|Core Study|Death|3|||
146069427|NCT00473382|526772462|FG001|Core Study|Death|5|||
146069428|NCT00473382|526772463|FG002|Core Study|Death|10|||
146069429|NCT00473382|526772461|FG000|Core Study|Lost to Follow-up|3|||
146069430|NCT00473382|526772462|FG001|Core Study|Lost to Follow-up|3|||
146069431|NCT00473382|526772463|FG002|Core Study|Lost to Follow-up|3|||
146069432|NCT00473382|526772461|FG000|Core Study|Physician Decision|1|||
146069433|NCT00473382|526772462|FG001|Core Study|Physician Decision|2|||
146069434|NCT00473382|526772463|FG002|Core Study|Physician Decision|2|||
146069435|NCT00473382|526772461|FG000|Core Study|Subject non-compliance|5|||
146069436|NCT00473382|526772462|FG001|Core Study|Subject non-compliance|2|||
146069437|NCT00473382|526772463|FG002|Core Study|Subject non-compliance|1|||
146069438|NCT00473382|526772461|FG000|Core Study|Subject needed other treatment|1|||
146069439|NCT00473382|526772462|FG001|Core Study|Subject needed other treatment|3|||
146069440|NCT00473382|526772463|FG002|Core Study|Subject needed other treatment|2|||
146069441|NCT00473382|526772461|FG000|Core Study|Subject's decision|12|||
146069442|NCT00473382|526772462|FG001|Core Study|Subject's decision|11|||
146069443|NCT00473382|526772463|FG002|Core Study|Subject's decision|10|||
146069444|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
146069445|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
146069446|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
146069447|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Death|1|||
146069448|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Death|3|||
146069449|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Death|3|||
146069450|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146069451|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
146069452|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146069453|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
146069454|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
146069455|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
146069456|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
146069457|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
146069458|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
146069459|NCT00473382|526772461|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
146069460|NCT00473382|526772462|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
146069461|NCT00473382|526772463|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
146069462|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
146069463|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
146069464|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
146069465|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Death|1|||
146069466|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Death|7|||
146069467|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Death|4|||
146069468|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
146069469|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
146069470|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
146069471|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
146069472|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
146069473|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
146069474|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
146069475|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
146069476|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
146069477|NCT00473382|526772461|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
146069478|NCT00473382|526772462|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
146069479|NCT00473382|526772463|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
146069480|NCT01189032|526772464|FG000|Overall Study|Adverse Event|1|||
146069481|NCT01189032|526772465|FG001|Overall Study|Adverse Event|3|||
146069482|NCT01189032|526772466|FG002|Overall Study|Adverse Event|4|||
146069483|NCT01189032|526772464|FG000|Overall Study|Lack of Efficacy|2|||
146069484|NCT01189032|526772465|FG001|Overall Study|Lack of Efficacy|3|||
146069485|NCT01189032|526772466|FG002|Overall Study|Lack of Efficacy|0|||
146069486|NCT01189032|526772464|FG000|Overall Study|Withdrawal by Subject|1|||
146069487|NCT01189032|526772465|FG001|Overall Study|Withdrawal by Subject|0|||
146069488|NCT01189032|526772466|FG002|Overall Study|Withdrawal by Subject|1|||
146069489|NCT01189032|526772464|FG000|Overall Study|Protocol Violation|1|||
146069490|NCT01189032|526772465|FG001|Overall Study|Protocol Violation|1|||
146069491|NCT01189032|526772466|FG002|Overall Study|Protocol Violation|1|||
146069492|NCT01166282|526772467|FG000|Open-label Period|Adverse Event|0|||
146069493|NCT01166282|526772468|FG001|Open-label Period|Adverse Event|0|||
146069494|NCT01166282|526772469|FG002|Open-label Period|Adverse Event|6|||
146069495|NCT01166282|526772467|FG000|Open-label Period|Withdrawal by Subject|0|||
146069496|NCT01166282|526772468|FG001|Open-label Period|Withdrawal by Subject|0|||
146069497|NCT01166282|526772469|FG002|Open-label Period|Withdrawal by Subject|4|||
146069498|NCT01166282|526772467|FG000|Open-label Period|Lack of Efficacy|0|||
146069499|NCT01166282|526772468|FG001|Open-label Period|Lack of Efficacy|0|||
146069500|NCT01166282|526772469|FG002|Open-label Period|Lack of Efficacy|2|||
146069501|NCT01166282|526772467|FG000|Open-label Period|Remission|0|||
146069502|NCT01166282|526772468|FG001|Open-label Period|Remission|0|||
146069503|NCT01166282|526772469|FG002|Open-label Period|Remission|4|||
146069504|NCT01166282|526772467|FG000|Open-label Period|Irregular Compliance|0|||
146069505|NCT01166282|526772468|FG001|Open-label Period|Irregular Compliance|0|||
146069506|NCT01166282|526772469|FG002|Open-label Period|Irregular Compliance|1|||
146069507|NCT02577718|526772470|FG000|Overall Study|Death|6|||
146069508|NCT02577718|526772470|FG000|Overall Study|Withdrawal by Subject|2|||
146069509|NCT01995838|526772475|FG000|Overall Study|Lost to Follow-up|0|||
146069510|NCT01995838|526772476|FG001|Overall Study|Lost to Follow-up|1|||
146069511|NCT01995838|526772477|FG002|Overall Study|Lost to Follow-up|0|||
146069512|NCT01995838|526772478|FG003|Overall Study|Lost to Follow-up|0|||
146069513|NCT01995838|526772479|FG004|Overall Study|Lost to Follow-up|0|||
146069514|NCT01995838|526772480|FG005|Overall Study|Lost to Follow-up|0|||
146069515|NCT01995838|526772481|FG006|Overall Study|Lost to Follow-up|1|||
146069516|NCT01995838|526772475|FG000|Overall Study|Participant choice|2|||
146069517|NCT01995838|526772476|FG001|Overall Study|Participant choice|0|||
146069518|NCT01995838|526772477|FG002|Overall Study|Participant choice|0|||
146069519|NCT01995838|526772478|FG003|Overall Study|Participant choice|0|||
146069520|NCT01995838|526772479|FG004|Overall Study|Participant choice|0|||
146069521|NCT01995838|526772480|FG005|Overall Study|Participant choice|1|||
146069522|NCT01995838|526772481|FG006|Overall Study|Participant choice|1|||
146069523|NCT01995838|526772475|FG000|Overall Study|Adverse Event|0|||
146069524|NCT01995838|526772476|FG001|Overall Study|Adverse Event|0|||
146069525|NCT01995838|526772477|FG002|Overall Study|Adverse Event|0|||
146069526|NCT01995838|526772478|FG003|Overall Study|Adverse Event|0|||
146069527|NCT01995838|526772479|FG004|Overall Study|Adverse Event|0|||
146069528|NCT01995838|526772480|FG005|Overall Study|Adverse Event|0|||
146069529|NCT01995838|526772481|FG006|Overall Study|Adverse Event|1|||
146069530|NCT01995838|526772475|FG000|Overall Study|Withdrawal by Subject|0|||
146069531|NCT01995838|526772476|FG001|Overall Study|Withdrawal by Subject|0|||
146069532|NCT01995838|526772477|FG002|Overall Study|Withdrawal by Subject|0|||
146069533|NCT01995838|526772478|FG003|Overall Study|Withdrawal by Subject|0|||
146069534|NCT01995838|526772479|FG004|Overall Study|Withdrawal by Subject|1|||
146069535|NCT01995838|526772480|FG005|Overall Study|Withdrawal by Subject|0|||
146069536|NCT01995838|526772481|FG006|Overall Study|Withdrawal by Subject|0|||
146069537|NCT01995838|526772475|FG000|Overall Study|Other|3|||
146069538|NCT01995838|526772476|FG001|Overall Study|Other|1|||
146069539|NCT01995838|526772477|FG002|Overall Study|Other|0|||
146408595|NCT02643966|528002189|FG000|First Screening Round|Death|1|||
146408596|NCT02643966|528002189|FG000|Between First and Second Screening|Lost to Follow-up|65|||
146408597|NCT02643966|528002189|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
146408598|NCT02643966|528002189|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
146408599|NCT02643966|528002189|FG000|Second Screening Round|Withdrawal by Subject|20|||
146408600|NCT02643966|528002189|FG000|Second Screening Round|Lost to Follow-up|57|||
146408601|NCT02643966|528002189|FG000|Second Screening Round|Physician Decision|2|||
146408602|NCT02643966|528002189|FG000|Second Screening Round|Death|4|||
146408603|NCT02643966|528002189|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
146408604|NCT02643966|528002189|FG000|Between Second and Third Screening|Death|1|||
146408605|NCT02643966|528002189|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
146408606|NCT02643966|528002189|FG000|Third Screening Round|PI excluded|2|||
146408607|NCT02643966|528002189|FG000|Third Screening Round|Lost to Follow-up|241|||
146069540|NCT01995838|526772478|FG003|Overall Study|Other|2|||
146069541|NCT01995838|526772479|FG004|Overall Study|Other|1|||
146069542|NCT01995838|526772480|FG005|Overall Study|Other|1|||
146069543|NCT01995838|526772481|FG006|Overall Study|Other|2|||
146069544|NCT00275509|526772482|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
146069545|NCT00275509|526772483|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
146069546|NCT03196349|526772484|FG000|Overall Study|Did not receive study drug|0|||
146069547|NCT03196349|526772485|FG001|Overall Study|Did not receive study drug|1|||
146069548|NCT03196349|526772486|FG002|Overall Study|Did not receive study drug|2|||
146069549|NCT03196349|526772484|FG000|Overall Study|No data entered|2|||
146069550|NCT03196349|526772485|FG001|Overall Study|No data entered|4|||
146069551|NCT03196349|526772486|FG002|Overall Study|No data entered|0|||
146069552|NCT03196349|526772484|FG000|Overall Study|Study Terminated early|15|||
146408608|NCT03070431|528002192|FG000|Overall Study|Withdrawal by Subject|2|||
146408609|NCT03070431|528002192|FG000|Overall Study|Lost to Follow-up|2|||
146069553|NCT03196349|526772485|FG001|Overall Study|Study Terminated early|9|||
146069554|NCT03196349|526772486|FG002|Overall Study|Study Terminated early|11|||
146069555|NCT02819804|526772487|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
146069556|NCT03388164|526772492|FG000|Overall Study|Withdrawal by Subject|3|||
146069557|NCT03388164|526772493|FG001|Overall Study|Withdrawal by Subject|1|||
146069558|NCT00686686|526772495|FG000|Overall Study|Non-compliance|1|||
146069559|NCT00686686|526772495|FG000|Overall Study|Adverse Event|2|||
146069560|NCT00686686|526772495|FG000|Overall Study|Lost to Follow-up|3|||
146069561|NCT01012440|526772496|FG000|Overall Study|Withdrawal by Subject|2|||
146069562|NCT00131248|526772498|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
146069563|NCT00131248|526772499|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
146408610|NCT01542736|528002195|FG000|Overall Study|Death|1|||
146408611|NCT01783483|528002196|FG000|Overall Study|Death|3|||
146408612|NCT01783483|528002197|FG001|Overall Study|Death|3|||
146408613|NCT01783483|528002196|FG000|Overall Study|Lost to Follow-up|14|||
146408614|NCT01783483|528002197|FG001|Overall Study|Lost to Follow-up|10|||
146408615|NCT01783483|528002196|FG000|Overall Study|Withdrawal by Subject|2|||
146408616|NCT01783483|528002197|FG001|Overall Study|Withdrawal by Subject|1|||
146408617|NCT01783483|528002196|FG000|Overall Study|Physician Decision|1|||
146408618|NCT01783483|528002197|FG001|Overall Study|Physician Decision|1|||
146408619|NCT02065791|528002198|FG000|Overall Study|Closed Site|1|||
146408620|NCT02065791|528002199|FG001|Overall Study|Closed Site|1|||
146408621|NCT02065791|528002198|FG000|Overall Study|Withdrawal by Subject|11|||
146408622|NCT02065791|528002199|FG001|Overall Study|Withdrawal by Subject|5|||
146408623|NCT02065791|528002198|FG000|Overall Study|Lost to Follow-up|13|||
146408624|NCT02065791|528002199|FG001|Overall Study|Lost to Follow-up|9|||
146408625|NCT00975884|528002200|FG000|Overall Study|Adverse Event|1|||
146408626|NCT00975884|528002201|FG001|Overall Study|Adverse Event|0|||
146408627|NCT00975884|528002200|FG000|Overall Study|Lost to Follow-up|5|||
146408628|NCT00975884|528002201|FG001|Overall Study|Lost to Follow-up|3|||
146408629|NCT00975884|528002200|FG000|Overall Study|Withdrawal by Subject|9|||
146408630|NCT00975884|528002201|FG001|Overall Study|Withdrawal by Subject|9|||
146408631|NCT00975884|528002200|FG000|Overall Study|Other|1|||
146408632|NCT00975884|528002201|FG001|Overall Study|Other|3|||
146408633|NCT00051636|528002202|FG000|Period 1 - Core|Adverse Event|2|||
146408634|NCT00051636|528002203|FG001|Period 1 - Core|Adverse Event|2|||
146408635|NCT00051636|528002202|FG000|Period 1 - Core|Protocol Violation|1|||
146408636|NCT00051636|528002203|FG001|Period 1 - Core|Protocol Violation|0|||
146408637|NCT00051636|528002202|FG000|Period 1 - Core|Withdrawal by Subject|1|||
146408638|NCT00051636|528002203|FG001|Period 1 - Core|Withdrawal by Subject|2|||
146408639|NCT00051636|528002202|FG000|Period 1 - Core|Lost to Follow-up|0|||
146408640|NCT00051636|528002203|FG001|Period 1 - Core|Lost to Follow-up|2|||
146408641|NCT00051636|528002202|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
146408642|NCT00051636|528002203|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
146408643|NCT00051636|528002202|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
146408644|NCT00051636|528002203|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
146408645|NCT00051636|528002202|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
146408646|NCT00051636|528002203|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
146408647|NCT00051636|528002202|FG000|Period 2- Extended Observation Period|Death|4|||
146408648|NCT00051636|528002203|FG001|Period 2- Extended Observation Period|Death|5|||
146408649|NCT00051636|528002202|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
146408650|NCT00051636|528002203|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
146408651|NCT01174368|528002204|FG000|Overall Study|Withdrawal by Subject|1|||
146408652|NCT00363129|528002209|FG000|Overall Study|Withdrawal by Subject|11|||
146408653|NCT00363129|528002210|FG001|Overall Study|Withdrawal by Subject|18|||
146408654|NCT00363129|528002209|FG000|Overall Study|Adverse Event|8|||
146408655|NCT00363129|528002210|FG001|Overall Study|Adverse Event|3|||
146408656|NCT00363129|528002209|FG000|Overall Study|Alternate Treatment|2|||
146408657|NCT00363129|528002210|FG001|Overall Study|Alternate Treatment|4|||
146408658|NCT00363129|528002209|FG000|Overall Study|Other Medical Problems|2|||
146408659|NCT00363129|528002210|FG001|Overall Study|Other Medical Problems|4|||
146408660|NCT00363129|528002209|FG000|Overall Study|Death|0|||
146069564|NCT00477386|526772507|FG000|Overall Study|Adverse Event|4|||
146408661|NCT00363129|528002210|FG001|Overall Study|Death|1|||
146408662|NCT00363129|528002209|FG000|Overall Study|Other Reasons|6|||
146408663|NCT00363129|528002210|FG001|Overall Study|Other Reasons|3|||
146408664|NCT03707522|528002211|FG000|Overall Study|Lost to Follow-up|24|||
146408665|NCT03707522|528002212|FG001|Overall Study|Lost to Follow-up|27|||
146408666|NCT03707522|528002213|FG002|Overall Study|Lost to Follow-up|41|||
146408667|NCT03707522|528002214|FG003|Overall Study|Lost to Follow-up|36|||
146408668|NCT00383019|528002215|FG000|Overall Study|Adverse Event|5|||
146069565|NCT00477386|526772508|FG001|Overall Study|Adverse Event|8|||
146069566|NCT00477386|526772507|FG000|Overall Study|Disease progression, relapse|3|||
146069567|NCT00477386|526772508|FG001|Overall Study|Disease progression, relapse|4|||
146171993|NCT00733980|527143317|FG001|Overall Study|Adverse Event|2|||
146408669|NCT00383019|528002216|FG001|Overall Study|Adverse Event|1|||
146069568|NCT00477386|526772507|FG000|Overall Study|Disease progression, refractory|1|||
146069569|NCT00477386|526772508|FG001|Overall Study|Disease progression, refractory|3|||
146069570|NCT00477386|526772507|FG000|Overall Study|Other|1|||
146069571|NCT00477386|526772508|FG001|Overall Study|Other|2|||
146069572|NCT00477386|526772507|FG000|Overall Study|Physician Decision|1|||
146069573|NCT00477386|526772508|FG001|Overall Study|Physician Decision|0|||
146069574|NCT00477386|526772507|FG000|Overall Study|Withdrawal by Subject|1|||
146069575|NCT00477386|526772508|FG001|Overall Study|Withdrawal by Subject|0|||
146069576|NCT01254422|526772509|FG000|Overall Study|Protocol Violation|1|||
146069577|NCT01254422|526772510|FG001|Overall Study|Protocol Violation|0|||
146069578|NCT01254422|526772509|FG000|Overall Study|Adverse Event|1|||
146069579|NCT01254422|526772510|FG001|Overall Study|Adverse Event|0|||
146069580|NCT01254422|526772509|FG000|Overall Study|Serious adverse event|0|||
146069581|NCT01254422|526772510|FG001|Overall Study|Serious adverse event|1|||
146069582|NCT01254422|526772509|FG000|Overall Study|Lost to Follow-up|1|||
146408670|NCT00383019|528002215|FG000|Overall Study|Withdrawal by Subject|0|||
146408671|NCT00383019|528002216|FG001|Overall Study|Withdrawal by Subject|1|||
146408672|NCT02278952|528002217|FG000|Overall Study|Insufficient Sample|6|||
146408673|NCT00659581|528002218|FG000|Overall Study|Adverse Event|1006|||
146408674|NCT00659581|528002218|FG000|Overall Study|Lack of Efficacy|1183|||
146408675|NCT00659581|528002218|FG000|Overall Study|Other|6393|||
146408676|NCT02176642|528002225|FG000|Overall Study|Withdrawal by Subject|0|||
146408677|NCT02176642|528002226|FG001|Overall Study|Withdrawal by Subject|1|||
146408678|NCT00295620|528002227|FG000|Overall Study|Lost to Follow-up|9|||
146408679|NCT00295620|528002228|FG001|Overall Study|Lost to Follow-up|5|||
146408680|NCT00295620|528002227|FG000|Overall Study|Withdrawal by Subject|37|||
146408681|NCT00295620|528002228|FG001|Overall Study|Withdrawal by Subject|50|||
146408682|NCT00295620|528002227|FG000|Overall Study|Death|206|||
146408683|NCT00295620|528002228|FG001|Overall Study|Death|207|||
146408684|NCT00295620|528002227|FG000|Overall Study|Other reasons|10|||
146408685|NCT00295620|528002228|FG001|Overall Study|Other reasons|9|||
146408686|NCT00295620|528002227|FG000|Overall Study|Discontinuation by sponsor|580|||
146408687|NCT00295620|528002228|FG001|Overall Study|Discontinuation by sponsor|593|||
146408688|NCT00295620|528002227|FG000|Overall Study|Protocol Violation|30|||
146408689|NCT00295620|528002228|FG001|Overall Study|Protocol Violation|32|||
146408690|NCT00084617|528002240|FG000|Overall Study|Withdrawal by Subject|7|||
146408691|NCT00084617|528002240|FG000|Overall Study|Lack of Efficacy|1|||
146408692|NCT00084617|528002240|FG000|Overall Study|Protocol Violation|1|||
146408693|NCT01625286|528002241|FG000|Overall Study|Adverse Event|0|||
146408694|NCT01625286|528002242|FG001|Overall Study|Adverse Event|0|||
146408695|NCT01625286|528002243|FG002|Overall Study|Adverse Event|0|||
146408696|NCT01625286|528002244|FG003|Overall Study|Adverse Event|0|||
146408697|NCT01625286|528002245|FG004|Overall Study|Adverse Event|1|||
146408698|NCT01625286|528002246|FG005|Overall Study|Adverse Event|2|||
146408699|NCT01625286|528002247|FG006|Overall Study|Adverse Event|1|||
146408700|NCT01625286|528002241|FG000|Overall Study|Death|0|||
146408701|NCT01625286|528002242|FG001|Overall Study|Death|0|||
146408702|NCT01625286|528002243|FG002|Overall Study|Death|1|||
146408703|NCT01625286|528002244|FG003|Overall Study|Death|1|||
146408704|NCT01625286|528002245|FG004|Overall Study|Death|0|||
146408705|NCT01625286|528002246|FG005|Overall Study|Death|11|||
146408706|NCT01625286|528002247|FG006|Overall Study|Death|16|||
146408707|NCT01625286|528002241|FG000|Overall Study|Withdrawal by Subject|0|||
146408708|NCT01625286|528002242|FG001|Overall Study|Withdrawal by Subject|1|||
146408709|NCT01625286|528002243|FG002|Overall Study|Withdrawal by Subject|0|||
146408710|NCT01625286|528002244|FG003|Overall Study|Withdrawal by Subject|1|||
146408711|NCT01625286|528002245|FG004|Overall Study|Withdrawal by Subject|0|||
146408712|NCT01625286|528002246|FG005|Overall Study|Withdrawal by Subject|0|||
146408713|NCT01625286|528002247|FG006|Overall Study|Withdrawal by Subject|1|||
146408714|NCT01625286|528002241|FG000|Overall Study|Any reason not specifically recorded|0|||
146408715|NCT01625286|528002242|FG001|Overall Study|Any reason not specifically recorded|0|||
146408716|NCT01625286|528002243|FG002|Overall Study|Any reason not specifically recorded|0|||
146069583|NCT01254422|526772510|FG001|Overall Study|Lost to Follow-up|0|||
146069584|NCT02207088|526772511|FG000|Overall Study|Adverse Event|2|||
146069585|NCT00643162|526772512|FG000|Overall Study|Withdrawal by Subject|1|||
146408717|NCT01625286|528002244|FG003|Overall Study|Any reason not specifically recorded|0|||
146408718|NCT01625286|528002245|FG004|Overall Study|Any reason not specifically recorded|0|||
146408719|NCT01625286|528002246|FG005|Overall Study|Any reason not specifically recorded|1|||
146408720|NCT01625286|528002247|FG006|Overall Study|Any reason not specifically recorded|0|||
146408721|NCT01625286|528002241|FG000|Overall Study|Progressive disease|6|||
146408722|NCT01625286|528002242|FG001|Overall Study|Progressive disease|3|||
146069586|NCT00643162|526772513|FG001|Overall Study|Withdrawal by Subject|1|||
146408723|NCT01625286|528002243|FG002|Overall Study|Progressive disease|4|||
146408724|NCT01625286|528002244|FG003|Overall Study|Progressive disease|5|||
146408725|NCT01625286|528002245|FG004|Overall Study|Progressive disease|5|||
146408726|NCT01625286|528002246|FG005|Overall Study|Progressive disease|0|||
146069587|NCT02691507|526772514|FG000|Overall Study|Missed Visit 3|0|||
146069588|NCT02691507|526772515|FG001|Overall Study|Missed Visit 3|1|||
146069589|NCT03023397|526772516|FG000|Run-In|Failed screening allergen challenge|1|||
146069590|NCT03023397|526772517|FG001|Run-In|Failed screening allergen challenge|0|||
146069591|NCT03023397|526772518|FG002|Run-In|Failed screening allergen challenge|0|||
146069592|NCT03023397|526772516|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
146069593|NCT03023397|526772517|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
146069594|NCT03023397|526772518|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
146069595|NCT01587924|526772519|FG000|Overall Study|Adverse Event|0|||
146069596|NCT01587924|526772520|FG001|Overall Study|Adverse Event|2|||
146069597|NCT01587924|526772521|FG002|Overall Study|Adverse Event|0|||
146069598|NCT01587924|526772522|FG003|Overall Study|Adverse Event|0|||
146069599|NCT01587924|526772519|FG000|Overall Study|Protocol Violation|2|||
146069600|NCT01587924|526772520|FG001|Overall Study|Protocol Violation|1|||
146069601|NCT01587924|526772521|FG002|Overall Study|Protocol Violation|2|||
146069602|NCT01587924|526772522|FG003|Overall Study|Protocol Violation|1|||
146069603|NCT01587924|526772519|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
146069604|NCT01587924|526772520|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
146069605|NCT01587924|526772521|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
146069606|NCT01587924|526772522|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
146069607|NCT01587924|526772519|FG000|Overall Study|Withdrawal by Subject|0|||
146069608|NCT01587924|526772520|FG001|Overall Study|Withdrawal by Subject|1|||
146069609|NCT01587924|526772521|FG002|Overall Study|Withdrawal by Subject|1|||
146069610|NCT01587924|526772522|FG003|Overall Study|Withdrawal by Subject|0|||
146069611|NCT01696188|526772523|FG000|Overall Study|Protocol Violation|1|||
146069612|NCT01696188|526772524|FG001|Overall Study|Protocol Violation|1|||
146069613|NCT02668393|526772525|FG000|Overall Study|Progressive disease|6|||
146069614|NCT02668393|526772526|FG001|Overall Study|Progressive disease|3|||
146069615|NCT02668393|526772525|FG000|Overall Study|Adverse Event|0|||
146069616|NCT02668393|526772526|FG001|Overall Study|Adverse Event|2|||
146069617|NCT02668393|526772525|FG000|Overall Study|Withdrawal from the trial|0|||
146069618|NCT02668393|526772526|FG001|Overall Study|Withdrawal from the trial|1|||
146069619|NCT02668393|526772525|FG000|Overall Study|Lack of benefit and side effects|1|||
146069620|NCT02668393|526772526|FG001|Overall Study|Lack of benefit and side effects|0|||
146069621|NCT00606593|526772527|FG000|Overall Study|Adverse Event|0|||
146069622|NCT00606593|526772528|FG001|Overall Study|Adverse Event|0|||
146069623|NCT00606593|526772529|FG002|Overall Study|Adverse Event|0|||
146069624|NCT00606593|526772530|FG003|Overall Study|Adverse Event|1|||
146069625|NCT00606593|526772531|FG004|Overall Study|Adverse Event|1|||
146069626|NCT00606593|526772532|FG005|Overall Study|Adverse Event|0|||
146069627|NCT00606593|526772533|FG006|Overall Study|Adverse Event|1|||
146069628|NCT00606593|526772534|FG007|Overall Study|Adverse Event|2|||
146069629|NCT00606593|526772535|FG008|Overall Study|Adverse Event|1|||
146069630|NCT00606593|526772536|FG009|Overall Study|Adverse Event|0|||
146069631|NCT00606593|526772527|FG000|Overall Study|Withdrawal of consent|1|||
146069632|NCT00606593|526772528|FG001|Overall Study|Withdrawal of consent|0|||
146069633|NCT00606593|526772529|FG002|Overall Study|Withdrawal of consent|1|||
146069634|NCT00606593|526772530|FG003|Overall Study|Withdrawal of consent|0|||
146069635|NCT00606593|526772531|FG004|Overall Study|Withdrawal of consent|0|||
146069636|NCT00606593|526772532|FG005|Overall Study|Withdrawal of consent|0|||
146069637|NCT00606593|526772533|FG006|Overall Study|Withdrawal of consent|0|||
146069638|NCT00606593|526772534|FG007|Overall Study|Withdrawal of consent|0|||
146069639|NCT00606593|526772535|FG008|Overall Study|Withdrawal of consent|0|||
146171994|NCT00733980|527143316|FG000|Overall Study|Lack of Efficacy|0|||
146171995|NCT00733980|527143317|FG001|Overall Study|Lack of Efficacy|1|||
146171996|NCT00733980|527143316|FG000|Overall Study|Protocol Violation|2|||
146171997|NCT00733980|527143317|FG001|Overall Study|Protocol Violation|1|||
146171998|NCT00733980|527143316|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
146171999|NCT00733980|527143317|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
146172000|NCT00733980|527143316|FG000|Overall Study|Lost to Follow-up|6|||
146172001|NCT00733980|527143317|FG001|Overall Study|Lost to Follow-up|11|||
146172002|NCT00733980|527143316|FG000|Overall Study|Physician Decision|2|||
146172003|NCT00733980|527143317|FG001|Overall Study|Physician Decision|3|||
146172004|NCT00733980|527143316|FG000|Overall Study|Withdrawal by Subject|6|||
146172005|NCT00733980|527143317|FG001|Overall Study|Withdrawal by Subject|2|||
146069640|NCT00606593|526772536|FG009|Overall Study|Withdrawal of consent|0|||
146069641|NCT00606593|526772527|FG000|Overall Study|Administrative/Other|0|||
146172006|NCT02739347|527143318|FG000|Overall Study|Adverse Event|3|||
146172007|NCT02739347|527143319|FG001|Overall Study|Adverse Event|0|||
146172008|NCT02739347|527143318|FG000|Overall Study|Protocol Violation|0|||
146069642|NCT00606593|526772528|FG001|Overall Study|Administrative/Other|0|||
146172009|NCT02739347|527143319|FG001|Overall Study|Protocol Violation|1|||
146172010|NCT02739347|527143318|FG000|Overall Study|Lost to Follow-up|0|||
146069643|NCT00606593|526772529|FG002|Overall Study|Administrative/Other|1|||
146172011|NCT02739347|527143319|FG001|Overall Study|Lost to Follow-up|2|||
146172012|NCT01552954|527143320|FG000|Overall Study|Adverse Event|1|||
146069644|NCT00606593|526772530|FG003|Overall Study|Administrative/Other|0|||
146069645|NCT00606593|526772531|FG004|Overall Study|Administrative/Other|0|||
146069646|NCT00606593|526772532|FG005|Overall Study|Administrative/Other|0|||
146069647|NCT00606593|526772533|FG006|Overall Study|Administrative/Other|0|||
146069648|NCT00606593|526772534|FG007|Overall Study|Administrative/Other|0|||
146069649|NCT00606593|526772535|FG008|Overall Study|Administrative/Other|0|||
146069650|NCT00606593|526772536|FG009|Overall Study|Administrative/Other|0|||
146069651|NCT03181529|526772537|FG000|Overall Study|Withdrawal by Subject|1|||
146069652|NCT03181529|526772538|FG001|Overall Study|Withdrawal by Subject|1|||
146069653|NCT03181529|526772537|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
146069654|NCT03181529|526772538|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
146069655|NCT00787644|526772539|FG000|Overall Study|Lost to Follow-up|1|||
146069656|NCT00787644|526772540|FG001|Overall Study|Lost to Follow-up|1|||
146069657|NCT00787644|526772539|FG000|Overall Study|Withdrawal by Subject|1|||
146069658|NCT00787644|526772540|FG001|Overall Study|Withdrawal by Subject|1|||
146069659|NCT00536744|526772541|FG000|Overall Study|Adverse Event|13|||
146069660|NCT00536744|526772542|FG001|Overall Study|Adverse Event|10|||
146069661|NCT00536744|526772541|FG000|Overall Study|Death|2|||
146069662|NCT00536744|526772542|FG001|Overall Study|Death|1|||
146069663|NCT00536744|526772541|FG000|Overall Study|Physician Decision|3|||
146069664|NCT00536744|526772542|FG001|Overall Study|Physician Decision|1|||
146069665|NCT00536744|526772541|FG000|Overall Study|Lost to Follow-up|3|||
146069666|NCT00536744|526772542|FG001|Overall Study|Lost to Follow-up|5|||
146069667|NCT00536744|526772541|FG000|Overall Study|Withdrawal by Subject|7|||
146069668|NCT00536744|526772542|FG001|Overall Study|Withdrawal by Subject|8|||
146069669|NCT00536744|526772541|FG000|Overall Study|PI tried alternative treatment|1|||
146069670|NCT00536744|526772542|FG001|Overall Study|PI tried alternative treatment|3|||
146069671|NCT01642589|526772546|FG000|Overall Study|Withdrawal by Subject|1|||
146069672|NCT01642589|526772547|FG001|Overall Study|Withdrawal by Subject|1|||
146069673|NCT01108185|526772548|FG000|Overall Study|Non-compliance|15|||
146069674|NCT01108185|526772548|FG000|Overall Study|Lost to Follow-up|12|||
146069675|NCT02581410|526772553|FG000|Vaccination Phase|Adverse Event|2|||
146069676|NCT02581410|526772554|FG001|Vaccination Phase|Adverse Event|1|||
146069677|NCT02581410|526772553|FG000|Vaccination Phase|Withdrawal by Subject|0|||
146069678|NCT02581410|526772554|FG001|Vaccination Phase|Withdrawal by Subject|1|||
146069679|NCT02581410|526772553|FG000|Vaccination Phase|Migrated/moved from study area|0|||
146069680|NCT02581410|526772554|FG001|Vaccination Phase|Migrated/moved from study area|1|||
146069681|NCT02581410|526772553|FG000|End of Study Phase|Adverse Event|4|||
146069682|NCT02581410|526772554|FG001|End of Study Phase|Adverse Event|3|||
146069683|NCT02581410|526772553|FG000|End of Study Phase|Withdrawal by Subject|1|||
146069684|NCT02581410|526772554|FG001|End of Study Phase|Withdrawal by Subject|2|||
146069685|NCT02581410|526772553|FG000|End of Study Phase|Migrated/moved from study area|0|||
146069686|NCT02581410|526772554|FG001|End of Study Phase|Migrated/moved from study area|3|||
146408727|NCT01625286|528002247|FG006|Overall Study|Progressive disease|0|||
146069687|NCT02581410|526772553|FG000|End of Study Phase|Lost to Follow-up|0|||
146069688|NCT02581410|526772554|FG001|End of Study Phase|Lost to Follow-up|2|||
146069689|NCT02581410|526772553|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
146069690|NCT02581410|526772554|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
146069691|NCT02908672|526772557|FG000|Run-in Period|Death|12|||
146069692|NCT02908672|526772558|FG001|Run-in Period|Death|10|||
146069693|NCT02908672|526772559|FG002|Run-in Period|Death|0|||
146069694|NCT02908672|526772560|FG003|Run-in Period|Death|0|||
146069695|NCT02908672|526772557|FG000|Run-in Period|Lost to Follow-up|1|||
146408728|NCT01625286|528002241|FG000|Overall Study|Lost to Follow-up|0|||
146408729|NCT01625286|528002242|FG001|Overall Study|Lost to Follow-up|0|||
146408730|NCT01625286|528002243|FG002|Overall Study|Lost to Follow-up|0|||
146408731|NCT01625286|528002244|FG003|Overall Study|Lost to Follow-up|0|||
146408732|NCT01625286|528002245|FG004|Overall Study|Lost to Follow-up|0|||
146408733|NCT01625286|528002246|FG005|Overall Study|Lost to Follow-up|0|||
146408734|NCT01625286|528002247|FG006|Overall Study|Lost to Follow-up|1|||
146408735|NCT03053622|528004199|FG000|Overall Study|Lost to Follow-up|0|||
145945250|NCT03008278|526308188|FG001|Overall Study|Adverse Event|0|||
146069696|NCT02908672|526772558|FG001|Run-in Period|Lost to Follow-up|1|||
146069697|NCT02908672|526772559|FG002|Run-in Period|Lost to Follow-up|0|||
146069698|NCT02908672|526772560|FG003|Run-in Period|Lost to Follow-up|0|||
146069699|NCT02908672|526772557|FG000|Run-in Period|Reason Not Specified|2|||
146069700|NCT02908672|526772558|FG001|Run-in Period|Reason Not Specified|0|||
146069701|NCT02908672|526772559|FG002|Run-in Period|Reason Not Specified|0|||
146069702|NCT02908672|526772560|FG003|Run-in Period|Reason Not Specified|0|||
146069703|NCT02908672|526772557|FG000|Run-in Period|Protocol Violation|1|||
146069704|NCT02908672|526772558|FG001|Run-in Period|Protocol Violation|1|||
146408736|NCT03053622|528004200|FG001|Overall Study|Lost to Follow-up|0|||
146069705|NCT02908672|526772559|FG002|Run-in Period|Protocol Violation|0|||
146069706|NCT02908672|526772560|FG003|Run-in Period|Protocol Violation|0|||
146408737|NCT03053622|528004201|FG002|Overall Study|Lost to Follow-up|0|||
146408738|NCT03053622|528004202|FG003|Overall Study|Lost to Follow-up|1|||
146069707|NCT02908672|526772557|FG000|Run-in Period|Study Ended by Sponsor|5|||
146069708|NCT02908672|526772558|FG001|Run-in Period|Study Ended by Sponsor|1|||
146069709|NCT02908672|526772559|FG002|Run-in Period|Study Ended by Sponsor|0|||
146069710|NCT02908672|526772560|FG003|Run-in Period|Study Ended by Sponsor|0|||
146069711|NCT02908672|526772557|FG000|Run-in Period|Withdrawal by Subject|3|||
146069712|NCT02908672|526772558|FG001|Run-in Period|Withdrawal by Subject|9|||
146069713|NCT02908672|526772559|FG002|Run-in Period|Withdrawal by Subject|0|||
146069714|NCT02908672|526772560|FG003|Run-in Period|Withdrawal by Subject|0|||
146069715|NCT02908672|526772557|FG000|Triple Combination Period|Death|0|||
146069716|NCT02908672|526772558|FG001|Triple Combination Period|Death|0|||
146069717|NCT02908672|526772559|FG002|Triple Combination Period|Death|150|||
146069718|NCT02908672|526772560|FG003|Triple Combination Period|Death|127|||
146069719|NCT02908672|526772557|FG000|Triple Combination Period|Lost to Follow-up|0|||
146069720|NCT02908672|526772558|FG001|Triple Combination Period|Lost to Follow-up|0|||
146069721|NCT02908672|526772559|FG002|Triple Combination Period|Lost to Follow-up|6|||
146069722|NCT02908672|526772560|FG003|Triple Combination Period|Lost to Follow-up|8|||
146069723|NCT02908672|526772557|FG000|Triple Combination Period|Reason Not Specified|0|||
146069724|NCT02908672|526772558|FG001|Triple Combination Period|Reason Not Specified|0|||
146069725|NCT02908672|526772559|FG002|Triple Combination Period|Reason Not Specified|0|||
146069726|NCT02908672|526772560|FG003|Triple Combination Period|Reason Not Specified|1|||
146069727|NCT02908672|526772557|FG000|Triple Combination Period|Physician Decision|0|||
146069728|NCT02908672|526772558|FG001|Triple Combination Period|Physician Decision|0|||
146069729|NCT02908672|526772559|FG002|Triple Combination Period|Physician Decision|1|||
146069730|NCT02908672|526772560|FG003|Triple Combination Period|Physician Decision|1|||
146069731|NCT02908672|526772557|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
146069732|NCT02908672|526772558|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
146069733|NCT02908672|526772559|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
146069734|NCT02908672|526772560|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
146069735|NCT02908672|526772557|FG000|Triple Combination Period|Withdrawal by Subject|0|||
146069736|NCT02908672|526772558|FG001|Triple Combination Period|Withdrawal by Subject|0|||
146069737|NCT02908672|526772559|FG002|Triple Combination Period|Withdrawal by Subject|13|||
146069738|NCT02908672|526772560|FG003|Triple Combination Period|Withdrawal by Subject|16|||
146069739|NCT01185080|526772564|FG000|Overall Study|Adverse Event|1|||
146069740|NCT01185080|526772565|FG001|Overall Study|Adverse Event|1|||
146069741|NCT01185080|526772566|FG002|Overall Study|Adverse Event|0|||
146069742|NCT01185080|526772564|FG000|Overall Study|Personal reasons|0|||
146069743|NCT01185080|526772565|FG001|Overall Study|Personal reasons|0|||
146069744|NCT01185080|526772566|FG002|Overall Study|Personal reasons|1|||
146069745|NCT02876601|526772567|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146069746|NCT02876601|526772568|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146069747|NCT02876601|526772569|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
146069748|NCT02876601|526772570|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
146069749|NCT00759941|526772571|FG000|Overall Study|Use of medication|1|||
146069750|NCT00759941|526772572|FG001|Overall Study|Use of medication|0|||
146069751|NCT00759941|526772571|FG000|Overall Study|Adverse Event|1|||
146069752|NCT00759941|526772572|FG001|Overall Study|Adverse Event|0|||
146069753|NCT00759941|526772571|FG000|Overall Study|Exited in error by site|1|||
146069754|NCT00759941|526772572|FG001|Overall Study|Exited in error by site|1|||
146069755|NCT05615922|526772576|FG000|Overall Study|Lost to Follow-up|1|||
146069756|NCT06083506|526772577|FG000|Overall Study|Physician Decision|2|||
146069757|NCT06083506|526772577|FG000|Overall Study|Lack of Efficacy|1|||
146408739|NCT02598622|528004203|FG000|Overall Study|Withdrawal by Subject|3|||
146408740|NCT02598622|528004204|FG001|Overall Study|Withdrawal by Subject|0|||
146408741|NCT02598622|528004203|FG000|Overall Study|Physician Decision|3|||
146408742|NCT02598622|528004204|FG001|Overall Study|Physician Decision|0|||
146408743|NCT00681824|528004208|FG000|Overall Study|withdrawn by investigator|0|||
146408744|NCT00681824|528004209|FG001|Overall Study|withdrawn by investigator|0|||
146408745|NCT00681824|528004210|FG002|Overall Study|withdrawn by investigator|1|||
146408746|NCT00681824|528004208|FG000|Overall Study|scheduling conflict|1|||
146408747|NCT00681824|528004209|FG001|Overall Study|scheduling conflict|0|||
146408748|NCT00681824|528004210|FG002|Overall Study|scheduling conflict|0|||
146408749|NCT00681824|528004208|FG000|Overall Study|Death|0|||
146408750|NCT00681824|528004209|FG001|Overall Study|Death|1|||
146408751|NCT00681824|528004210|FG002|Overall Study|Death|0|||
146408752|NCT03591107|528004213|FG000|Overall Study|Same patient in both arms|1|||
146408753|NCT03591107|528004214|FG001|Overall Study|Same patient in both arms|1|||
146408754|NCT03591107|528004213|FG000|Overall Study|Sought care at other clinics|0|||
146408755|NCT03591107|528004214|FG001|Overall Study|Sought care at other clinics|2|||
146408756|NCT03591107|528004213|FG000|Overall Study|Discharged from clinic|0|||
146408757|NCT03591107|528004214|FG001|Overall Study|Discharged from clinic|1|||
146408758|NCT03591107|528004213|FG000|Overall Study|Withdrawal by Subject|0|||
146408759|NCT03591107|528004214|FG001|Overall Study|Withdrawal by Subject|1|||
146408760|NCT01902134|528004215|FG000|Overall Study|Adverse Event|3|||
146408761|NCT01902134|528004216|FG001|Overall Study|Adverse Event|1|||
146408762|NCT01902134|528004217|FG002|Overall Study|Adverse Event|2|||
146408763|NCT01902134|528004218|FG003|Overall Study|Adverse Event|1|||
146408764|NCT01902134|528004219|FG004|Overall Study|Adverse Event|1|||
146408765|NCT01902134|528004220|FG005|Overall Study|Adverse Event|3|||
146408766|NCT01902134|528004215|FG000|Overall Study|Lack of Efficacy|0|||
146408767|NCT01902134|528004216|FG001|Overall Study|Lack of Efficacy|0|||
146408768|NCT01902134|528004217|FG002|Overall Study|Lack of Efficacy|2|||
146408769|NCT01902134|528004218|FG003|Overall Study|Lack of Efficacy|0|||
146408770|NCT01902134|528004219|FG004|Overall Study|Lack of Efficacy|0|||
146408771|NCT01902134|528004220|FG005|Overall Study|Lack of Efficacy|1|||
146408772|NCT01902134|528004215|FG000|Overall Study|Physician Decision|0|||
146408773|NCT01902134|528004216|FG001|Overall Study|Physician Decision|1|||
146408774|NCT01902134|528004217|FG002|Overall Study|Physician Decision|0|||
146408775|NCT01902134|528004218|FG003|Overall Study|Physician Decision|0|||
146408776|NCT01902134|528004219|FG004|Overall Study|Physician Decision|0|||
146408777|NCT01902134|528004220|FG005|Overall Study|Physician Decision|0|||
146408778|NCT01902134|528004215|FG000|Overall Study|Protocol Violation|0|||
146408779|NCT01902134|528004216|FG001|Overall Study|Protocol Violation|0|||
146408780|NCT01902134|528004217|FG002|Overall Study|Protocol Violation|0|||
146408781|NCT01902134|528004218|FG003|Overall Study|Protocol Violation|0|||
146408782|NCT01902134|528004219|FG004|Overall Study|Protocol Violation|0|||
146408783|NCT01902134|528004220|FG005|Overall Study|Protocol Violation|1|||
146408784|NCT01902134|528004215|FG000|Overall Study|Withdrawal by Subject|4|||
146408785|NCT01902134|528004216|FG001|Overall Study|Withdrawal by Subject|8|||
146408786|NCT01902134|528004217|FG002|Overall Study|Withdrawal by Subject|9|||
146408787|NCT01902134|528004218|FG003|Overall Study|Withdrawal by Subject|1|||
146408788|NCT01902134|528004219|FG004|Overall Study|Withdrawal by Subject|5|||
146408789|NCT01902134|528004220|FG005|Overall Study|Withdrawal by Subject|4|||
146408790|NCT01902134|528004215|FG000|Overall Study|no compliance|1|||
146408791|NCT01902134|528004216|FG001|Overall Study|no compliance|0|||
146408792|NCT01902134|528004217|FG002|Overall Study|no compliance|0|||
146408793|NCT01902134|528004218|FG003|Overall Study|no compliance|0|||
146408794|NCT01902134|528004219|FG004|Overall Study|no compliance|0|||
146408795|NCT01902134|528004220|FG005|Overall Study|no compliance|0|||
146408796|NCT01902134|528004215|FG000|Overall Study|Other|0|||
146408797|NCT01902134|528004216|FG001|Overall Study|Other|1|||
146408798|NCT01902134|528004217|FG002|Overall Study|Other|2|||
146408799|NCT01902134|528004218|FG003|Overall Study|Other|0|||
146408800|NCT01902134|528004219|FG004|Overall Study|Other|1|||
146069758|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146069759|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
146069760|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146069761|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
146172013|NCT01552954|527143321|FG001|Overall Study|Adverse Event|2|||
146408801|NCT01902134|528004220|FG005|Overall Study|Other|0|||
146408802|NCT00305110|528004221|FG000|Overall Study|Missing data|29|||
146408803|NCT01440647|528004226|FG000|Overall Study|Death|2|||
146408804|NCT01440647|528004227|FG001|Overall Study|Death|3|||
146408805|NCT04335110|528004241|FG000|Overall Study|Withdrawal by Subject|1|||
146408806|NCT04335110|528004242|FG001|Overall Study|Withdrawal by Subject|1|||
146408807|NCT04335110|528004241|FG000|Overall Study|Death|0|||
146408808|NCT04335110|528004242|FG001|Overall Study|Death|1|||
146408809|NCT00736099|528004243|FG000|Overall Study|Adverse Event|61|||
146408810|NCT00736099|528004244|FG001|Overall Study|Adverse Event|18|||
146408811|NCT00736099|528004243|FG000|Overall Study|Protocol Violation|10|||
146408812|NCT00736099|528004244|FG001|Overall Study|Protocol Violation|4|||
146069762|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146069763|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
146069764|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146069765|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
146069766|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
146069767|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
146069768|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
146069769|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
146069770|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
146069771|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
146069772|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
146069773|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
146172014|NCT01552954|527143320|FG000|Overall Study|Lost to Follow-up|1|||
146172015|NCT01552954|527143321|FG001|Overall Study|Lost to Follow-up|1|||
146069774|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146069775|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
146069776|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146069777|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
146069778|NCT05307692|526772579|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
146069779|NCT05307692|526772580|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
146069780|NCT05307692|526772581|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
146069781|NCT05307692|526772582|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
146069782|NCT05307692|526772579|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146069783|NCT05307692|526772580|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146069784|NCT05307692|526772581|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
146069785|NCT05307692|526772582|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
146069786|NCT05307692|526772579|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146069787|NCT05307692|526772580|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146069788|NCT05307692|526772581|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
146069789|NCT05307692|526772582|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
146069790|NCT04500158|526772583|FG000|Overall Study|Physician Decision|17|||
146069791|NCT04500158|526772584|FG001|Overall Study|Physician Decision|11|||
146069792|NCT01967238|526772585|FG000|Overall Study|Adverse Event|1|||
146069793|NCT01967238|526772586|FG001|Overall Study|Adverse Event|1|||
146069794|NCT01967238|526772587|FG002|Overall Study|Adverse Event|0|||
146069795|NCT01967238|526772585|FG000|Overall Study|Lost to Follow-up|1|||
146069796|NCT01967238|526772586|FG001|Overall Study|Lost to Follow-up|0|||
146069797|NCT01967238|526772587|FG002|Overall Study|Lost to Follow-up|1|||
146069798|NCT01967238|526772585|FG000|Overall Study|Withdrawal by Subject|0|||
146069799|NCT01967238|526772586|FG001|Overall Study|Withdrawal by Subject|0|||
146069800|NCT01967238|526772587|FG002|Overall Study|Withdrawal by Subject|1|||
146069801|NCT03493464|526772594|FG000|Overall Study|Surgery not performed|1|||
146069802|NCT01442103|526773668|FG000|Overall Study|Lost to Follow-up|2|||
146069803|NCT02605122|526773671|FG000|Overall Study|Withdrawal by Subject|4|||
146069804|NCT02605122|526773672|FG001|Overall Study|Withdrawal by Subject|1|||
146069805|NCT02605122|526773671|FG000|Overall Study|Lost to Follow-up|1|||
146069806|NCT02605122|526773672|FG001|Overall Study|Lost to Follow-up|1|||
146069807|NCT03894813|526773679|FG000|Overall Study|Adverse Event|1|||
146069808|NCT03894813|526773680|FG001|Overall Study|Adverse Event|1|||
146069809|NCT03894813|526773679|FG000|Overall Study|Lack of Efficacy|3|||
146069810|NCT03894813|526773680|FG001|Overall Study|Lack of Efficacy|3|||
146069811|NCT03894813|526773679|FG000|Overall Study|Lost to Follow-up|1|||
146069812|NCT03894813|526773680|FG001|Overall Study|Lost to Follow-up|0|||
146069813|NCT03894813|526773679|FG000|Overall Study|Pregnancy|2|||
146069814|NCT03894813|526773680|FG001|Overall Study|Pregnancy|1|||
146069815|NCT03894813|526773679|FG000|Overall Study|Protocol Violation|3|||
146069816|NCT03894813|526773680|FG001|Overall Study|Protocol Violation|7|||
146069817|NCT03894813|526773679|FG000|Overall Study|Withdrawal by Subject|1|||
146069818|NCT03894813|526773680|FG001|Overall Study|Withdrawal by Subject|3|||
146069819|NCT03894813|526773679|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
146069820|NCT03894813|526773680|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
146069821|NCT00831181|526773686|FG000|Overall Study|Adverse Event|12|||
146069822|NCT02863419|526773687|FG000|Overall Study|Lost to Follow-up|0|||
146069823|NCT02863419|526773688|FG001|Overall Study|Lost to Follow-up|1|||
146069824|NCT02863419|526773689|FG002|Overall Study|Lost to Follow-up|4|||
146069825|NCT02863419|526773687|FG000|Overall Study|Withdrawal by Subject|5|||
146069826|NCT02863419|526773688|FG001|Overall Study|Withdrawal by Subject|5|||
146069827|NCT02863419|526773689|FG002|Overall Study|Withdrawal by Subject|3|||
146069828|NCT02863419|526773687|FG000|Overall Study|Died|3|||
146069829|NCT02863419|526773688|FG001|Overall Study|Died|4|||
146069830|NCT02863419|526773689|FG002|Overall Study|Died|1|||
146069831|NCT02362282|526773690|FG000|Overall Study|Withdrawal by Subject|1|||
146069832|NCT02362282|526773691|FG001|Overall Study|Withdrawal by Subject|0|||
146069833|NCT02284243|526773698|FG000|Overall Study|Lack of Efficacy|3|||
146069834|NCT02284243|526773699|FG001|Overall Study|Lack of Efficacy|3|||
146069835|NCT02284243|526773698|FG000|Overall Study|Adverse Event|1|||
146069836|NCT02284243|526773699|FG001|Overall Study|Adverse Event|0|||
146069837|NCT01932437|526773700|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146069838|NCT01932437|526773701|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146069839|NCT01932437|526773702|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146069840|NCT01932437|526773703|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146069841|NCT01932437|526773704|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
146069842|NCT01932437|526773705|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
146069843|NCT00074490|526773706|FG000|Overall Study|Progressive malignancy|0|||
146069844|NCT00074490|526773707|FG001|Overall Study|Progressive malignancy|7|||
146069845|NCT00074490|526773708|FG002|Overall Study|Progressive malignancy|0|||
146069846|NCT00074490|526773709|FG003|Overall Study|Progressive malignancy|0|||
146069847|NCT00074490|526773710|FG004|Overall Study|Progressive malignancy|3|||
146069848|NCT00074490|526773711|FG005|Overall Study|Progressive malignancy|0|||
146069849|NCT04411667|526773714|FG000|Overall Study|Physician Decision|1|||
146069850|NCT04411667|526773715|FG001|Overall Study|Physician Decision|0|||
146069851|NCT04287517|526773721|FG000|Overall Study|Withdrawal by Subject|1|||
146069852|NCT04287517|526773722|FG001|Overall Study|Withdrawal by Subject|1|||
146069853|NCT03857867|526773723|FG000|Overall Study|Physician Decision|1|||
146069854|NCT01869764|526773724|FG000|Overall Study|Withdrawal by Subject|0|||
146069855|NCT01869764|526773725|FG001|Overall Study|Withdrawal by Subject|2|||
146069856|NCT01626872|526773726|FG000|Overall Study|Physician Decision|13|||
146069857|NCT01626872|526773727|FG001|Overall Study|Physician Decision|9|||
146069858|NCT01626872|526773728|FG002|Overall Study|Physician Decision|6|||
146069859|NCT01626872|526773726|FG000|Overall Study|Withdrawal by Subject|19|||
146069860|NCT01626872|526773727|FG001|Overall Study|Withdrawal by Subject|27|||
146069861|NCT01626872|526773728|FG002|Overall Study|Withdrawal by Subject|8|||
146069862|NCT01626872|526773726|FG000|Overall Study|Adverse Event (including Death)|20|||
146069863|NCT01626872|526773727|FG001|Overall Study|Adverse Event (including Death)|28|||
146069864|NCT01626872|526773728|FG002|Overall Study|Adverse Event (including Death)|8|||
146069865|NCT01626872|526773726|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
146069866|NCT01626872|526773727|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
146069867|NCT01626872|526773728|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
146069868|NCT01578486|526773729|FG000|Overall Study|Physician Decision|3|||
146069869|NCT01578486|526773729|FG000|Overall Study|Withdrawal by Subject|2|||
146069870|NCT02425943|526773730|FG000|Overall Study|Adverse Event|3|||
146069871|NCT02425943|526773731|FG001|Overall Study|Adverse Event|1|||
146069872|NCT02425943|526773730|FG000|Overall Study|Lost to Follow-up|59|||
146069873|NCT02425943|526773731|FG001|Overall Study|Lost to Follow-up|37|||
146069874|NCT02425943|526773730|FG000|Overall Study|Protocol Violation|4|||
146069875|NCT02425943|526773731|FG001|Overall Study|Protocol Violation|1|||
146069876|NCT02425943|526773730|FG000|Overall Study|Withdrawal by Subject|64|||
146069877|NCT02425943|526773731|FG001|Overall Study|Withdrawal by Subject|31|||
146069878|NCT02425943|526773730|FG000|Overall Study|Other|6|||
146069879|NCT02425943|526773731|FG001|Overall Study|Other|0|||
146069880|NCT01106248|526773734|FG000|Overall Study|Adverse Event|1|||
146069881|NCT01106248|526773734|FG000|Overall Study|Administrative|2|||
146069882|NCT00357903|526773735|FG000|Overall Study|Adverse Event|87|||
146069883|NCT00357903|526773736|FG001|Overall Study|Adverse Event|4|||
146069884|NCT00357903|526773735|FG000|Overall Study|Death|33|||
146069885|NCT00357903|526773736|FG001|Overall Study|Death|0|||
146069886|NCT00357903|526773735|FG000|Overall Study|Lost to Follow-up|23|||
146069887|NCT00357903|526773736|FG001|Overall Study|Lost to Follow-up|4|||
146069888|NCT00357903|526773735|FG000|Overall Study|Physician Decision|39|||
146069889|NCT00357903|526773736|FG001|Overall Study|Physician Decision|5|||
146069890|NCT00357903|526773735|FG000|Overall Study|Withdrawal by Subject|57|||
146069891|NCT00357903|526773736|FG001|Overall Study|Withdrawal by Subject|7|||
146069892|NCT00357903|526773735|FG000|Overall Study|Completed month 12 only|0|||
146069893|NCT00357903|526773736|FG001|Overall Study|Completed month 12 only|1|||
146069894|NCT00357903|526773735|FG000|Overall Study|Protocol issues|14|||
146069895|NCT00357903|526773736|FG001|Overall Study|Protocol issues|3|||
146069896|NCT00357903|526773735|FG000|Overall Study|Response status|61|||
146069897|NCT00357903|526773736|FG001|Overall Study|Response status|9|||
146069898|NCT00357903|526773735|FG000|Overall Study|Other|49|||
146069899|NCT00357903|526773736|FG001|Overall Study|Other|10|||
146069900|NCT02506244|526773739|FG000|Overall Study|Did not undergo active monitoring|458|||
146069901|NCT02506244|526773740|FG001|Overall Study|Did not undergo active monitoring|459|||
146069902|NCT02506244|526773741|FG002|Overall Study|Did not undergo active monitoring|0|||
146069903|NCT00314795|526773743|FG000|Overall Study|Adverse Event|8|||
146069904|NCT00314795|526773743|FG000|Overall Study|Death|4|||
146069905|NCT00314795|526773743|FG000|Overall Study|Reason not Specified|3|||
146069906|NCT00314795|526773743|FG000|Overall Study|Renal Transplant|3|||
146069907|NCT00314795|526773743|FG000|Overall Study|Participants Withdrew Consent|2|||
146069908|NCT04717336|526773744|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
146069909|NCT04717336|526773745|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
146069910|NCT04717336|526773744|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
146069911|NCT04717336|526773745|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
146069912|NCT02039843|526773750|FG000|Randomization and Observation Period|Adverse Event|2|||
146069913|NCT02039843|526773751|FG001|Randomization and Observation Period|Adverse Event|0|||
146069914|NCT02039843|526773750|FG000|Randomization and Observation Period|Death|1|||
146069915|NCT02039843|526773751|FG001|Randomization and Observation Period|Death|0|||
146069916|NCT02039843|526773750|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
146069917|NCT02039843|526773751|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
146069918|NCT02039843|526773750|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
146069919|NCT02039843|526773751|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
146069920|NCT02039843|526773750|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
146069921|NCT02039843|526773751|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
146069922|NCT02039843|526773750|FG000|Pairing With a Study Dog|Death|1|||
146069923|NCT02039843|526773751|FG001|Pairing With a Study Dog|Death|0|||
146069924|NCT02039843|526773750|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
146069925|NCT02039843|526773751|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
146069926|NCT02039843|526773750|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
146069927|NCT02039843|526773751|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
146172016|NCT01552954|527143320|FG000|Overall Study|Withdrawal by Subject|1|||
146172017|NCT01552954|527143321|FG001|Overall Study|Withdrawal by Subject|1|||
146172018|NCT01552954|527143320|FG000|Overall Study|Protocol Violation|1|||
146172019|NCT01552954|527143321|FG001|Overall Study|Protocol Violation|2|||
146172020|NCT01552954|527143320|FG000|Overall Study|diagnosed DM|1|||
146172021|NCT01552954|527143321|FG001|Overall Study|diagnosed DM|0|||
146172022|NCT01931735|527143323|FG000|Randomized Phase|Lost to Follow-up|2|||
146172023|NCT01931735|527143324|FG001|Randomized Phase|Lost to Follow-up|2|||
146172024|NCT01931735|527143325|FG002|Randomized Phase|Lost to Follow-up|5|||
146172025|NCT01931735|527143326|FG003|Randomized Phase|Lost to Follow-up|0|||
146172026|NCT01931735|527143323|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
146069928|NCT02039843|526773750|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
146069929|NCT02039843|526773751|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
146172027|NCT01931735|527143324|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
146172028|NCT01931735|527143325|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
146172029|NCT01931735|527143326|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
146069930|NCT01958164|526773754|FG000|Overall Study|Adverse Event|0|||
146069931|NCT01958164|526773755|FG001|Overall Study|Adverse Event|2|||
146069932|NCT01958164|526773754|FG000|Overall Study|Lost to Follow-up|2|||
146069933|NCT01958164|526773755|FG001|Overall Study|Lost to Follow-up|3|||
146069934|NCT01780974|526773758|FG000|Overall Study|Death|1|||
146069935|NCT01780974|526773759|FG001|Overall Study|Death|0|||
146069936|NCT01780974|526773758|FG000|Overall Study|Adverse Event|1|||
146069937|NCT01780974|526773759|FG001|Overall Study|Adverse Event|3|||
146069938|NCT01724346|526773760|FG000|Overall Study|Death|42|||
146069939|NCT01724346|526773761|FG001|Overall Study|Death|42|||
146069940|NCT01724346|526773760|FG000|Overall Study|Lost to Follow-up|5|||
146069941|NCT01724346|526773761|FG001|Overall Study|Lost to Follow-up|1|||
146172030|NCT01931735|527143323|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146408813|NCT00736099|528004243|FG000|Overall Study|Lost to Follow-up|12|||
146408814|NCT00736099|528004244|FG001|Overall Study|Lost to Follow-up|5|||
146408815|NCT00736099|528004243|FG000|Overall Study|Withdrawal by Subject|42|||
146408816|NCT00736099|528004244|FG001|Overall Study|Withdrawal by Subject|13|||
146408817|NCT00736099|528004243|FG000|Overall Study|Lack of Efficacy|15|||
146172031|NCT01931735|527143324|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146408818|NCT00736099|528004244|FG001|Overall Study|Lack of Efficacy|8|||
146408819|NCT00736099|528004243|FG000|Overall Study|Other reason|43|||
146069942|NCT01724346|526773760|FG000|Overall Study|Withdrawal by Subject|27|||
146069943|NCT01724346|526773761|FG001|Overall Study|Withdrawal by Subject|19|||
146069944|NCT01724346|526773760|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
146069945|NCT01724346|526773761|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
146069946|NCT00525161|526773764|FG000|Overall Study|Adverse Event|1|||
146069947|NCT01076361|526773765|FG000|Overall Study|22 leads were excluded from analysis|21|||
146069948|NCT03848728|526773766|FG000|Overall Study|Death|16|||
146069949|NCT03848728|526773767|FG001|Overall Study|Death|13|||
146069950|NCT03848728|526773766|FG000|Overall Study|Outmigrated to non-study community|98|||
146069951|NCT03848728|526773767|FG001|Overall Study|Outmigrated to non-study community|106|||
146069952|NCT03848728|526773766|FG000|Overall Study|Transfered to non-study clinic|32|||
146069953|NCT03848728|526773767|FG001|Overall Study|Transfered to non-study clinic|48|||
146069954|NCT03848728|526773766|FG000|Overall Study|Withdrawal by Subject|1|||
146069955|NCT03848728|526773767|FG001|Overall Study|Withdrawal by Subject|0|||
146069956|NCT02807402|526773772|FG000|Overall Study|Failure to Return|1|||
146069957|NCT02807402|526773772|FG000|Overall Study|Death|3|||
146069958|NCT02807402|526773772|FG000|Overall Study|Other|2|||
146069959|NCT00807001|526775294|FG000|Overall Study|Non-compliance|0|||
146069960|NCT00807001|526775295|FG001|Overall Study|Non-compliance|1|||
146069961|NCT00807001|526775296|FG002|Overall Study|Non-compliance|0|||
146069962|NCT00807001|526775297|FG003|Overall Study|Non-compliance|0|||
146069963|NCT00807001|526775298|FG004|Overall Study|Non-compliance|0|||
146069964|NCT02139592|526775312|FG000|Overall Study|Case Report Forms Uncollected|8|||
146069965|NCT02873702|526775317|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
146069966|NCT02873702|526775318|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
146069967|NCT02873702|526775319|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
146069968|NCT02873702|526775320|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
146069969|NCT02873702|526775317|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146069970|NCT02873702|526775318|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
146069971|NCT02873702|526775319|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146069972|NCT02873702|526775320|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
146069973|NCT02873702|526775317|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
146069974|NCT02873702|526775318|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
146069975|NCT02873702|526775319|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
146069976|NCT02873702|526775320|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
146069977|NCT02873702|526775317|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
146069978|NCT02873702|526775318|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
146069979|NCT02873702|526775319|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
146069980|NCT02873702|526775320|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
146069981|NCT02873702|526775317|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
146069982|NCT02873702|526775318|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
146069983|NCT02873702|526775319|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
146069984|NCT02873702|526775320|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
146069985|NCT01255436|526775330|FG000|Overall Study|Lost to Follow-up|178|||
146069986|NCT01255436|526775331|FG001|Overall Study|Lost to Follow-up|191|||
146069987|NCT01255436|526775330|FG000|Overall Study|Death, stroke, or MI|4|||
146069988|NCT01255436|526775331|FG001|Overall Study|Death, stroke, or MI|3|||
146069989|NCT04816669|526775332|FG000|Part 1|Adverse Event|1|||
146408820|NCT00736099|528004244|FG001|Overall Study|Other reason|10|||
146408821|NCT01637961|528004245|FG000|Overall Study|Ineligible: wrong primary|1|||
146408822|NCT01637961|528004245|FG000|Overall Study|Ineligible: inadequate pathology|1|||
146408823|NCT03101293|528004246|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
146408824|NCT03101293|528004247|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
146408825|NCT03451331|528004259|FG000|Overall Study|Withdrawal by Subject|1|||
146408826|NCT03451331|528004260|FG001|Overall Study|Withdrawal by Subject|0|||
146408827|NCT03451331|528004259|FG000|Overall Study|Unable to start treatment.|1|||
146408828|NCT03451331|528004260|FG001|Overall Study|Unable to start treatment.|1|||
146408829|NCT02773446|528004261|FG000|First Admission|Withdrawal by Subject|0|||
146408830|NCT02773446|528004262|FG001|First Admission|Withdrawal by Subject|0|||
146408831|NCT02773446|528004263|FG002|First Admission|Withdrawal by Subject|0|||
146408832|NCT02773446|528004264|FG003|First Admission|Withdrawal by Subject|1|||
146408833|NCT02773446|528004265|FG004|First Admission|Withdrawal by Subject|0|||
146408834|NCT02773446|528004266|FG005|First Admission|Withdrawal by Subject|0|||
146408835|NCT02773446|528004261|FG000|First Admission|Lost to Follow-up|1|||
146408836|NCT02773446|528004262|FG001|First Admission|Lost to Follow-up|0|||
146408837|NCT02773446|528004263|FG002|First Admission|Lost to Follow-up|0|||
146408838|NCT02773446|528004264|FG003|First Admission|Lost to Follow-up|0|||
146408839|NCT02773446|528004265|FG004|First Admission|Lost to Follow-up|0|||
146408840|NCT02773446|528004266|FG005|First Admission|Lost to Follow-up|0|||
146408841|NCT04023994|528004267|FG000|Overall Study|Lost to Follow-up|0|||
146408842|NCT04023994|528004268|FG001|Overall Study|Lost to Follow-up|1|||
146408843|NCT04023994|528004269|FG002|Overall Study|Lost to Follow-up|2|||
146408844|NCT04023994|528004270|FG003|Overall Study|Lost to Follow-up|0|||
146408845|NCT04023994|528004271|FG004|Overall Study|Lost to Follow-up|0|||
146408846|NCT04023994|528004272|FG005|Overall Study|Lost to Follow-up|0|||
146408847|NCT04023994|528004267|FG000|Overall Study|Withdrawal by Subject|0|||
146408848|NCT04023994|528004268|FG001|Overall Study|Withdrawal by Subject|0|||
146069990|NCT04816669|526775333|FG001|Part 1|Adverse Event|1|||
146069991|NCT04816669|526775334|FG002|Part 1|Adverse Event|0|||
146069992|NCT04816669|526775335|FG003|Part 1|Adverse Event|0|||
146172032|NCT01931735|527143325|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
146069993|NCT04816669|526775332|FG000|Part 1|Lost to Follow-up|2|||
146069994|NCT04816669|526775333|FG001|Part 1|Lost to Follow-up|2|||
146069995|NCT04816669|526775334|FG002|Part 1|Lost to Follow-up|0|||
146069996|NCT04816669|526775335|FG003|Part 1|Lost to Follow-up|0|||
146069997|NCT04816669|526775332|FG000|Part 1|Protocol Violation|0|||
146069998|NCT04816669|526775333|FG001|Part 1|Protocol Violation|1|||
146069999|NCT04816669|526775334|FG002|Part 1|Protocol Violation|0|||
146070000|NCT04816669|526775335|FG003|Part 1|Protocol Violation|0|||
146172033|NCT01931735|527143326|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
146408849|NCT04023994|528004269|FG002|Overall Study|Withdrawal by Subject|0|||
146408850|NCT04023994|528004270|FG003|Overall Study|Withdrawal by Subject|1|||
146070001|NCT04816669|526775332|FG000|Part 1|Withdrawal by Subject|1|||
146070002|NCT04816669|526775333|FG001|Part 1|Withdrawal by Subject|2|||
146070003|NCT04816669|526775334|FG002|Part 1|Withdrawal by Subject|0|||
146070004|NCT04816669|526775335|FG003|Part 1|Withdrawal by Subject|0|||
146070005|NCT04816669|526775332|FG000|Part 2|Other|0|||
146070006|NCT04816669|526775333|FG001|Part 2|Other|0|||
146070007|NCT04816669|526775334|FG002|Part 2|Other|1|||
146070008|NCT04816669|526775335|FG003|Part 2|Other|0|||
146070009|NCT04816669|526775332|FG000|Part 2|Withdrawal by Subject|0|||
146070010|NCT04816669|526775333|FG001|Part 2|Withdrawal by Subject|0|||
146070011|NCT04816669|526775334|FG002|Part 2|Withdrawal by Subject|0|||
146070012|NCT04816669|526775335|FG003|Part 2|Withdrawal by Subject|1|||
146070013|NCT04816669|526775332|FG000|Part 2|Lost to Follow-up|0|||
146070014|NCT04816669|526775333|FG001|Part 2|Lost to Follow-up|0|||
146070015|NCT04816669|526775334|FG002|Part 2|Lost to Follow-up|1|||
146070016|NCT04816669|526775335|FG003|Part 2|Lost to Follow-up|0|||
146070017|NCT01229267|526775336|FG000|Overall Study|Adverse Event|4|||
146070018|NCT01229267|526775337|FG001|Overall Study|Adverse Event|6|||
146070019|NCT01229267|526775338|FG002|Overall Study|Adverse Event|3|||
146070020|NCT01229267|526775339|FG003|Overall Study|Adverse Event|2|||
146070021|NCT01229267|526775340|FG004|Overall Study|Adverse Event|10|||
146070022|NCT01229267|526775336|FG000|Overall Study|Death|40|||
146070023|NCT01229267|526775337|FG001|Overall Study|Death|37|||
146070024|NCT01229267|526775338|FG002|Overall Study|Death|35|||
146070025|NCT01229267|526775339|FG003|Overall Study|Death|13|||
146070026|NCT01229267|526775340|FG004|Overall Study|Death|103|||
146070027|NCT01229267|526775336|FG000|Overall Study|Withdrawal by Subject|23|||
146070028|NCT01229267|526775337|FG001|Overall Study|Withdrawal by Subject|22|||
146070029|NCT01229267|526775338|FG002|Overall Study|Withdrawal by Subject|32|||
146172034|NCT00779779|527143327|FG000|Overall Study|Adverse Event|1|||
146172035|NCT00779779|527143327|FG000|Overall Study|Protocol Violation|14|||
146070030|NCT01229267|526775339|FG003|Overall Study|Withdrawal by Subject|14|||
146070031|NCT01229267|526775340|FG004|Overall Study|Withdrawal by Subject|59|||
146070032|NCT01229267|526775336|FG000|Overall Study|Protocol Violation|0|||
146070033|NCT01229267|526775337|FG001|Overall Study|Protocol Violation|1|||
146070034|NCT01229267|526775338|FG002|Overall Study|Protocol Violation|0|||
146070035|NCT01229267|526775339|FG003|Overall Study|Protocol Violation|0|||
146070036|NCT01229267|526775340|FG004|Overall Study|Protocol Violation|0|||
146070037|NCT01229267|526775336|FG000|Overall Study|Progressive disease|0|||
146070038|NCT01229267|526775337|FG001|Overall Study|Progressive disease|0|||
146070039|NCT01229267|526775338|FG002|Overall Study|Progressive disease|0|||
146070040|NCT01229267|526775339|FG003|Overall Study|Progressive disease|0|||
146070041|NCT01229267|526775340|FG004|Overall Study|Progressive disease|1|||
146070042|NCT01229267|526775336|FG000|Overall Study|Physician Decision|8|||
146070043|NCT01229267|526775337|FG001|Overall Study|Physician Decision|11|||
146070044|NCT01229267|526775338|FG002|Overall Study|Physician Decision|8|||
146070045|NCT01229267|526775339|FG003|Overall Study|Physician Decision|3|||
146070046|NCT01229267|526775340|FG004|Overall Study|Physician Decision|25|||
146070047|NCT01229267|526775336|FG000|Overall Study|Lost to Follow-up|6|||
146070048|NCT01229267|526775337|FG001|Overall Study|Lost to Follow-up|5|||
146070049|NCT01229267|526775338|FG002|Overall Study|Lost to Follow-up|8|||
146070050|NCT01229267|526775339|FG003|Overall Study|Lost to Follow-up|3|||
146070051|NCT01229267|526775340|FG004|Overall Study|Lost to Follow-up|22|||
146070052|NCT00867815|526775346|FG000|Overall Study|Lost to Follow-up|1|||
146070053|NCT04050202|526775347|FG000|Overall Study|Lost to Follow-up|2|||
146070054|NCT00001213|526775348|FG000|Overall Study|Death|18|||
146070055|NCT01499277|526775351|FG000|Overall Study|Adverse Event|3|||
146070056|NCT01499277|526775352|FG001|Overall Study|Adverse Event|6|||
146070057|NCT01499277|526775351|FG000|Overall Study|Death|3|||
146070058|NCT01499277|526775352|FG001|Overall Study|Death|2|||
146070059|NCT01499277|526775351|FG000|Overall Study|Lost to Follow-up|15|||
146070060|NCT01499277|526775352|FG001|Overall Study|Lost to Follow-up|8|||
146070061|NCT01499277|526775351|FG000|Overall Study|Protocol Violation|2|||
146070062|NCT01499277|526775352|FG001|Overall Study|Protocol Violation|3|||
146070063|NCT01499277|526775351|FG000|Overall Study|Withdrawal by Subject|16|||
146070064|NCT01499277|526775352|FG001|Overall Study|Withdrawal by Subject|6|||
146070065|NCT01499277|526775351|FG000|Overall Study|Lack of therapeutic response and other|8|||
146070066|NCT01499277|526775352|FG001|Overall Study|Lack of therapeutic response and other|7|||
146070067|NCT00372593|526775355|FG000|Overall Study|Adverse Event|43|||
146070068|NCT00372593|526775356|FG001|Overall Study|Adverse Event|45|||
146070069|NCT00372593|526775357|FG002|Overall Study|Adverse Event|0|||
146070070|NCT00372593|526775355|FG000|Overall Study|Death|16|||
146070071|NCT00372593|526775356|FG001|Overall Study|Death|20|||
146070072|NCT00372593|526775357|FG002|Overall Study|Death|1|||
146070073|NCT00372593|526775355|FG000|Overall Study|Lack of Efficacy|82|||
146070074|NCT00372593|526775356|FG001|Overall Study|Lack of Efficacy|71|||
146070075|NCT00372593|526775357|FG002|Overall Study|Lack of Efficacy|2|||
146070076|NCT00372593|526775355|FG000|Overall Study|Lost to Follow-up|1|||
146070077|NCT00372593|526775356|FG001|Overall Study|Lost to Follow-up|0|||
146070078|NCT00372593|526775357|FG002|Overall Study|Lost to Follow-up|0|||
146070079|NCT00372593|526775355|FG000|Overall Study|Physician Decision|42|||
146070080|NCT00372593|526775356|FG001|Overall Study|Physician Decision|41|||
146070081|NCT00372593|526775357|FG002|Overall Study|Physician Decision|0|||
146070082|NCT00372593|526775355|FG000|Overall Study|Ineligible|20|||
146070083|NCT00372593|526775356|FG001|Overall Study|Ineligible|21|||
146070084|NCT00372593|526775357|FG002|Overall Study|Ineligible|1|||
146070085|NCT02974543|526775358|FG000|Overall Study|Withdrawal by Subject|1|||
146070086|NCT02974543|526775359|FG001|Overall Study|Withdrawal by Subject|0|||
146070087|NCT00742235|526775360|FG000|Overall Study|Lost to Follow-up|0|||
146070088|NCT00742235|526775361|FG001|Overall Study|Lost to Follow-up|31|||
146070089|NCT00433004|526775362|FG000|Overall Study|Lost to Follow-up|5|||
146070090|NCT00433004|526775363|FG001|Overall Study|Lost to Follow-up|7|||
146070091|NCT03534180|526775364|FG000|Overall Study|Withdrawal by Subject|1|||
146070092|NCT00220636|526775365|FG000|Overall Study|Withdrawal by Subject|4|||
146070093|NCT01237899|526775368|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
146070094|NCT01237899|526775369|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
146070095|NCT01237899|526775370|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
146172036|NCT00779779|527143327|FG000|Overall Study|Withdrawal by Subject|4|||
146172037|NCT00779779|527143327|FG000|Overall Study|Lost to Follow-up|5|||
146070096|NCT01237899|526775371|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
146070097|NCT01237899|526775372|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
146070098|NCT01237899|526775373|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
146070099|NCT01237899|526775374|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
146070100|NCT01237899|526775375|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
146070101|NCT01237899|526775376|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
146070102|NCT01237899|526775377|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
146070103|NCT01237899|526775378|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
146070104|NCT00790088|526775379|FG000|Overall Study|Protocol Violation|11|||
146070105|NCT00790088|526775379|FG000|Overall Study|Withdrawal by Subject|17|||
146070106|NCT00790088|526775379|FG000|Overall Study|Lost to Follow-up|7|||
146070107|NCT00790088|526775379|FG000|Overall Study|Physician Decision|4|||
146070108|NCT05661409|526775380|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
146070109|NCT05661409|526775381|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
146070110|NCT05661409|526775382|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
146070111|NCT05661409|526775383|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
146070112|NCT05661409|526775384|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
146070113|NCT05661409|526775385|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
146070114|NCT05661409|526775380|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
146070115|NCT05661409|526775381|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
146070116|NCT05661409|526775382|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
146070117|NCT05661409|526775383|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
146070118|NCT05661409|526775384|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
146070119|NCT05661409|526775385|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
146070120|NCT05661409|526775380|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146070121|NCT05661409|526775381|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146070122|NCT05661409|526775382|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
146070123|NCT05661409|526775383|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
146070124|NCT05661409|526775384|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
146070125|NCT05661409|526775385|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
146070126|NCT05661409|526775380|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
146070127|NCT05661409|526775381|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
146070128|NCT05661409|526775382|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
146070129|NCT05661409|526775383|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
146070130|NCT05661409|526775384|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
146070131|NCT05661409|526775385|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
146070132|NCT05661409|526775380|FG000|Overall Study|Miscommu-nication about administration|0|||
146070133|NCT05661409|526775381|FG001|Overall Study|Miscommu-nication about administration|0|||
146070134|NCT05661409|526775382|FG002|Overall Study|Miscommu-nication about administration|0|||
146070135|NCT05661409|526775383|FG003|Overall Study|Miscommu-nication about administration|0|||
146070136|NCT05661409|526775384|FG004|Overall Study|Miscommu-nication about administration|0|||
146070137|NCT05661409|526775385|FG005|Overall Study|Miscommu-nication about administration|1|||
146070138|NCT02636595|526775386|FG000|Overall Study|Lost to Follow-up|1|||
146070139|NCT02636595|526775386|FG000|Overall Study|Other|1|||
146070140|NCT02015637|526775391|FG000|Overall Study|Lost to Follow-up|3|||
146070141|NCT02015637|526775392|FG001|Overall Study|Lost to Follow-up|5|||
146070142|NCT02015637|526775391|FG000|Overall Study|Adverse Event|3|||
146070143|NCT02015637|526775392|FG001|Overall Study|Adverse Event|0|||
146070144|NCT02015637|526775391|FG000|Overall Study|Did not take study drug|2|||
146070145|NCT02015637|526775392|FG001|Overall Study|Did not take study drug|0|||
146070146|NCT03198507|526775395|FG000|Overall Study|Withdrawal by Subject|1|||
146070147|NCT03198507|526775396|FG001|Overall Study|Withdrawal by Subject|0|||
146070148|NCT02454517|526775397|FG000|Overall Study|Withdrawal by Subject|3|||
146070149|NCT02454517|526775398|FG001|Overall Study|Withdrawal by Subject|0|||
146070150|NCT02454517|526775397|FG000|Overall Study|Lost to Follow-up|4|||
146070151|NCT02454517|526775398|FG001|Overall Study|Lost to Follow-up|7|||
146070152|NCT02454517|526775397|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
146070153|NCT02454517|526775398|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
146070154|NCT02194985|526775399|FG000|Overall Study|Adverse Event|1|||
146070155|NCT02194985|526775399|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
146070156|NCT02194985|526775399|FG000|Overall Study|Physician Decision|4|||
146070157|NCT02194985|526775399|FG000|Overall Study|Lost to Follow-up|1|||
146070158|NCT02194985|526775399|FG000|Overall Study|Withdrawal by Subject|2|||
146070159|NCT02304367|526775406|FG000|Overall Study|Lack of Response to Bruosumab|1|||
146070160|NCT02304367|526775406|FG000|Overall Study|Sponsor Decision|3|||
146070161|NCT02304367|526775406|FG000|Overall Study|Death|2|||
146070162|NCT02304367|526775406|FG000|Overall Study|Physician Decision|1|||
146070163|NCT02304367|526775406|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
146070164|NCT04139798|526775411|FG000|Overall Study|Withdrawal by Subject|6|||
146070165|NCT04139798|526775412|FG001|Overall Study|Withdrawal by Subject|5|||
146070166|NCT04139798|526775411|FG000|Overall Study|Lost to Follow-up|2|||
146070167|NCT04139798|526775412|FG001|Overall Study|Lost to Follow-up|5|||
146070168|NCT04139798|526775411|FG000|Overall Study|Discontinued|4|||
146070169|NCT04139798|526775412|FG001|Overall Study|Discontinued|2|||
146070170|NCT04139798|526775411|FG000|Overall Study|Adverse Event|1|||
146070171|NCT04139798|526775412|FG001|Overall Study|Adverse Event|3|||
146070172|NCT04139798|526775411|FG000|Overall Study|Protocol Violation|1|||
146070173|NCT04139798|526775412|FG001|Overall Study|Protocol Violation|0|||
146070174|NCT03895840|526775415|FG000|Overall Study|Withdrawal by Subject|21|||
146070175|NCT01931566|526775416|FG000|Overall Study|Randomized But Not Treated|6|||
146070176|NCT01931566|526775417|FG001|Overall Study|Randomized But Not Treated|9|||
146070177|NCT01931566|526775418|FG002|Overall Study|Randomized But Not Treated|14|||
146070178|NCT01931566|526775416|FG000|Overall Study|Adverse Event|37|||
146070179|NCT01931566|526775417|FG001|Overall Study|Adverse Event|167|||
146070180|NCT01931566|526775418|FG002|Overall Study|Adverse Event|132|||
146070181|NCT01931566|526775416|FG000|Overall Study|Major Protocol Deviation|5|||
146070182|NCT01931566|526775417|FG001|Overall Study|Major Protocol Deviation|14|||
146070183|NCT01931566|526775418|FG002|Overall Study|Major Protocol Deviation|21|||
146070184|NCT01931566|526775416|FG000|Overall Study|Lost to Follow-up|3|||
146070185|NCT01931566|526775417|FG001|Overall Study|Lost to Follow-up|26|||
146070186|NCT01931566|526775418|FG002|Overall Study|Lost to Follow-up|23|||
146070187|NCT01931566|526775416|FG000|Overall Study|Voluntary Withdrawal|78|||
146070188|NCT01931566|526775417|FG001|Overall Study|Voluntary Withdrawal|245|||
146070189|NCT01931566|526775418|FG002|Overall Study|Voluntary Withdrawal|225|||
146070190|NCT01931566|526775416|FG000|Overall Study|Study Termination|289|||
146070191|NCT01931566|526775417|FG001|Overall Study|Study Termination|968|||
146070192|NCT01931566|526775418|FG002|Overall Study|Study Termination|1037|||
146070193|NCT01931566|526775416|FG000|Overall Study|Reason Not Specified|11|||
146070194|NCT01931566|526775417|FG001|Overall Study|Reason Not Specified|47|||
146070195|NCT01931566|526775418|FG002|Overall Study|Reason Not Specified|53|||
146070196|NCT01931566|526775416|FG000|Overall Study|Missing|0|||
146070197|NCT01931566|526775417|FG001|Overall Study|Missing|0|||
146070198|NCT01931566|526775418|FG002|Overall Study|Missing|1|||
146070199|NCT01599637|526775419|FG000|Overall Study|administrative problems|0|||
146070200|NCT01599637|526775420|FG001|Overall Study|administrative problems|2|||
146070201|NCT01599637|526775421|FG002|Overall Study|administrative problems|0|||
146070202|NCT01599637|526775419|FG000|Overall Study|Adverse Event|1|||
146070203|NCT01599637|526775420|FG001|Overall Study|Adverse Event|0|||
146070204|NCT01599637|526775421|FG002|Overall Study|Adverse Event|0|||
146070205|NCT00760617|526775423|FG000|Overall Study|Adverse Event|5|||
146070206|NCT00760617|526775424|FG001|Overall Study|Adverse Event|2|||
146070207|NCT00760617|526775425|FG002|Overall Study|Adverse Event|0|||
146070208|NCT00760617|526775423|FG000|Overall Study|Lost to Follow-up|0|||
146070209|NCT00760617|526775424|FG001|Overall Study|Lost to Follow-up|0|||
146070210|NCT00760617|526775425|FG002|Overall Study|Lost to Follow-up|5|||
146070211|NCT04476797|526775426|FG000|Overall Study|Withdrawal by Subject|1|||
146070212|NCT04476797|526775427|FG001|Overall Study|Withdrawal by Subject|0|||
146070213|NCT04476797|526775428|FG002|Overall Study|Withdrawal by Subject|0|||
146070214|NCT04476797|526775426|FG000|Overall Study|Death|0|||
146070215|NCT04476797|526775427|FG001|Overall Study|Death|1|||
146070216|NCT04476797|526775428|FG002|Overall Study|Death|2|||
146070217|NCT04476797|526775426|FG000|Overall Study|Sponsor Terminated Study|0|||
146070218|NCT04476797|526775427|FG001|Overall Study|Sponsor Terminated Study|18|||
146070219|NCT04476797|526775428|FG002|Overall Study|Sponsor Terminated Study|17|||
146070220|NCT02395081|526775429|FG000|Overall Study|Withdrawal by Subject|1|||
146070221|NCT02395081|526775430|FG001|Overall Study|Withdrawal by Subject|1|||
146070222|NCT02395081|526775431|FG002|Overall Study|Withdrawal by Subject|0|||
146070223|NCT02395081|526775429|FG000|Overall Study|Moved where blood couldn't be collected|4|||
146070224|NCT02395081|526775430|FG001|Overall Study|Moved where blood couldn't be collected|1|||
146070225|NCT02395081|526775431|FG002|Overall Study|Moved where blood couldn't be collected|3|||
146070226|NCT02395081|526775429|FG000|Overall Study|Fetal Loss|2|||
146070227|NCT02395081|526775430|FG001|Overall Study|Fetal Loss|3|||
146070228|NCT02395081|526775431|FG002|Overall Study|Fetal Loss|1|||
146070229|NCT04625101|526775432|FG000|Overall Study|Withdrawal by Subject|0|||
146070230|NCT04625101|526775433|FG001|Overall Study|Withdrawal by Subject|1|||
146070231|NCT04625101|526775432|FG000|Overall Study|Protocol Deviation|1|||
146172038|NCT01395823|527143328|FG000|Overall Study|Death|4|||
146070232|NCT04625101|526775433|FG001|Overall Study|Protocol Deviation|0|||
146070233|NCT02991040|526775434|FG000|Overall Study|Withdrawal by Subject|2|||
146070234|NCT02991040|526775434|FG000|Overall Study|Lost to Follow-up|2|||
146070235|NCT02721966|526775435|FG000|Overall Study|Protocol Violation|1|||
146070236|NCT02721966|526775436|FG001|Overall Study|Protocol Violation|0|||
146070237|NCT02721966|526775437|FG002|Overall Study|Protocol Violation|0|||
146070238|NCT02721966|526775438|FG003|Overall Study|Protocol Violation|0|||
146070239|NCT02721966|526775439|FG004|Overall Study|Protocol Violation|0|||
146070240|NCT02721966|526775435|FG000|Overall Study|Withdrawal by Subject|9|||
146070241|NCT02721966|526775436|FG001|Overall Study|Withdrawal by Subject|2|||
146070242|NCT02721966|526775437|FG002|Overall Study|Withdrawal by Subject|3|||
146070243|NCT02721966|526775438|FG003|Overall Study|Withdrawal by Subject|7|||
146172039|NCT01395823|527143329|FG001|Overall Study|Death|4|||
146070244|NCT02721966|526775439|FG004|Overall Study|Withdrawal by Subject|0|||
146070245|NCT02721966|526775435|FG000|Overall Study|Adverse Event|4|||
146070246|NCT02721966|526775436|FG001|Overall Study|Adverse Event|4|||
145945251|NCT03008278|526308189|FG002|Overall Study|Adverse Event|4|||
146070247|NCT02721966|526775437|FG002|Overall Study|Adverse Event|3|||
146070248|NCT02721966|526775438|FG003|Overall Study|Adverse Event|0|||
146070249|NCT02721966|526775439|FG004|Overall Study|Adverse Event|0|||
146070250|NCT02721966|526775435|FG000|Overall Study|Death|1|||
146070251|NCT02721966|526775436|FG001|Overall Study|Death|0|||
146070252|NCT02721966|526775437|FG002|Overall Study|Death|0|||
146070253|NCT02721966|526775438|FG003|Overall Study|Death|0|||
146070254|NCT02721966|526775439|FG004|Overall Study|Death|0|||
146070255|NCT02721966|526775435|FG000|Overall Study|Lack of Efficacy|7|||
146070256|NCT02721966|526775436|FG001|Overall Study|Lack of Efficacy|4|||
146070257|NCT02721966|526775437|FG002|Overall Study|Lack of Efficacy|0|||
146070258|NCT02721966|526775438|FG003|Overall Study|Lack of Efficacy|0|||
146070259|NCT02721966|526775439|FG004|Overall Study|Lack of Efficacy|0|||
146070260|NCT02721966|526775435|FG000|Overall Study|Lost to Follow-up|0|||
146070261|NCT02721966|526775436|FG001|Overall Study|Lost to Follow-up|0|||
146070262|NCT02721966|526775437|FG002|Overall Study|Lost to Follow-up|3|||
146070263|NCT02721966|526775438|FG003|Overall Study|Lost to Follow-up|0|||
146070264|NCT02721966|526775439|FG004|Overall Study|Lost to Follow-up|0|||
146070265|NCT02721966|526775435|FG000|Overall Study|Physician Decision|1|||
146070266|NCT02721966|526775436|FG001|Overall Study|Physician Decision|1|||
146070267|NCT02721966|526775437|FG002|Overall Study|Physician Decision|0|||
146070268|NCT02721966|526775438|FG003|Overall Study|Physician Decision|0|||
146070269|NCT02721966|526775439|FG004|Overall Study|Physician Decision|0|||
146070270|NCT02721966|526775435|FG000|Overall Study|Pregnancy|1|||
146070271|NCT02721966|526775436|FG001|Overall Study|Pregnancy|0|||
146070272|NCT02721966|526775437|FG002|Overall Study|Pregnancy|0|||
146070273|NCT02721966|526775438|FG003|Overall Study|Pregnancy|0|||
146070274|NCT02721966|526775439|FG004|Overall Study|Pregnancy|0|||
146070275|NCT02721966|526775435|FG000|Overall Study|Did not continue to period 2|5|||
146070276|NCT02721966|526775436|FG001|Overall Study|Did not continue to period 2|12|||
146070277|NCT02721966|526775437|FG002|Overall Study|Did not continue to period 2|0|||
146070278|NCT02721966|526775438|FG003|Overall Study|Did not continue to period 2|0|||
146070279|NCT02721966|526775439|FG004|Overall Study|Did not continue to period 2|5|||
146070280|NCT03070964|526775440|FG000|Overall Study|Progressive disease|8|||
146070281|NCT03070964|526775440|FG000|Overall Study|Treatment-unrelated adverse event|2|||
146070282|NCT03070964|526775440|FG000|Overall Study|Never treated|1|||
146070283|NCT03070964|526775440|FG000|Overall Study|Physician Decision|1|||
146070284|NCT03070964|526775440|FG000|Overall Study|Withdrawal by Subject|1|||
146070285|NCT03070964|526775440|FG000|Overall Study|Adverse Event|1|||
146070286|NCT01286480|526775441|FG000|Overall Study|Withdrawal by Subject|5|||
146070287|NCT01286480|526775442|FG001|Overall Study|Withdrawal by Subject|3|||
146070288|NCT00834093|526775443|FG000|Overall Study|Progressive Disease|3|||
146070289|NCT00834093|526775443|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
146070290|NCT01209325|526775444|FG000|Overall Study|Lost to Follow-up|24|||
146070291|NCT01209325|526775444|FG000|Overall Study|Adverse Event|1|||
146070292|NCT01209325|526775444|FG000|Overall Study|Relocated|3|||
146070293|NCT01209325|526775444|FG000|Overall Study|Refusal after starting therapy|8|||
146070294|NCT01209325|526775444|FG000|Overall Study|Protocol Violation|4|||
146070295|NCT01209325|526775444|FG000|Overall Study|Refusal prior to therapy|1|||
146070296|NCT01209325|526775444|FG000|Overall Study|Incarceration|2|||
146070297|NCT00607373|526775445|FG000|Treatment Period|Adverse Event|0|||
146070298|NCT00607373|526775446|FG001|Treatment Period|Adverse Event|4|||
146070299|NCT00607373|526775445|FG000|Treatment Period|Physician Decision|0|||
146070300|NCT00607373|526775446|FG001|Treatment Period|Physician Decision|1|||
146070301|NCT00607373|526775445|FG000|Treatment Period|Withdrawal by Subject|0|||
146070302|NCT00607373|526775446|FG001|Treatment Period|Withdrawal by Subject|1|||
146070303|NCT00607373|526775445|FG000|Follow-up Period|Other|0|||
146070304|NCT00607373|526775446|FG001|Follow-up Period|Other|1|||
146070305|NCT00607373|526775445|FG000|Follow-up Period|Protocol Violation|0|||
146070306|NCT00607373|526775446|FG001|Follow-up Period|Protocol Violation|1|||
146070307|NCT00607373|526775445|FG000|Follow-up Period|Withdrawal by Subject|1|||
146070308|NCT00607373|526775446|FG001|Follow-up Period|Withdrawal by Subject|3|||
146070309|NCT01918306|526775447|FG000|Overall Study|progresive disease|4|||
146070310|NCT01918306|526775448|FG001|Overall Study|progresive disease|0|||
146070311|NCT01918306|526775449|FG002|Overall Study|progresive disease|1|||
146070312|NCT01918306|526775450|FG003|Overall Study|progresive disease|1|||
146408851|NCT04023994|528004271|FG004|Overall Study|Withdrawal by Subject|0|||
146070313|NCT01918306|526775447|FG000|Overall Study|Withdrawal by Subject|0|||
146070314|NCT01918306|526775448|FG001|Overall Study|Withdrawal by Subject|0|||
146070315|NCT01918306|526775449|FG002|Overall Study|Withdrawal by Subject|0|||
146070316|NCT01918306|526775450|FG003|Overall Study|Withdrawal by Subject|2|||
146070317|NCT01918306|526775447|FG000|Overall Study|neutropenia|1|||
146070318|NCT01918306|526775448|FG001|Overall Study|neutropenia|0|||
146070319|NCT01918306|526775449|FG002|Overall Study|neutropenia|0|||
146070320|NCT01918306|526775450|FG003|Overall Study|neutropenia|0|||
146070321|NCT01918306|526775447|FG000|Overall Study|Lack of Efficacy|1|||
146070322|NCT01918306|526775448|FG001|Overall Study|Lack of Efficacy|0|||
146070323|NCT01918306|526775449|FG002|Overall Study|Lack of Efficacy|0|||
146070324|NCT01918306|526775450|FG003|Overall Study|Lack of Efficacy|0|||
146070325|NCT01918306|526775447|FG000|Overall Study|progress disease, crossover|0|||
146070326|NCT01918306|526775448|FG001|Overall Study|progress disease, crossover|0|||
146070327|NCT01918306|526775449|FG002|Overall Study|progress disease, crossover|1|||
146070328|NCT01918306|526775450|FG003|Overall Study|progress disease, crossover|0|||
146070329|NCT01160822|526775455|FG000|Overall Study|Adverse Event|0|||
146070330|NCT01160822|526775456|FG001|Overall Study|Adverse Event|0|||
146070331|NCT01160822|526775457|FG002|Overall Study|Adverse Event|0|||
146070332|NCT01160822|526775458|FG003|Overall Study|Adverse Event|0|||
146070333|NCT01160822|526775459|FG004|Overall Study|Adverse Event|1|||
146070334|NCT01160822|526775460|FG005|Overall Study|Adverse Event|2|||
146070335|NCT01160822|526775461|FG006|Overall Study|Adverse Event|5|||
146070336|NCT01160822|526775455|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146070337|NCT01160822|526775456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146070338|NCT01160822|526775457|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146070339|NCT01160822|526775458|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146070340|NCT01160822|526775459|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
146070341|NCT01160822|526775460|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
146070342|NCT01160822|526775461|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
146070343|NCT01160822|526775455|FG000|Overall Study|Withdrawal by Subject|0|||
146070344|NCT01160822|526775456|FG001|Overall Study|Withdrawal by Subject|0|||
146070345|NCT01160822|526775457|FG002|Overall Study|Withdrawal by Subject|0|||
146070346|NCT01160822|526775458|FG003|Overall Study|Withdrawal by Subject|0|||
146070347|NCT01160822|526775459|FG004|Overall Study|Withdrawal by Subject|0|||
146070348|NCT01160822|526775460|FG005|Overall Study|Withdrawal by Subject|0|||
146070349|NCT01160822|526775461|FG006|Overall Study|Withdrawal by Subject|1|||
146070350|NCT01160822|526775455|FG000|Overall Study|Lost to Follow-up|0|||
146070351|NCT01160822|526775456|FG001|Overall Study|Lost to Follow-up|0|||
146070352|NCT01160822|526775457|FG002|Overall Study|Lost to Follow-up|0|||
146070353|NCT01160822|526775458|FG003|Overall Study|Lost to Follow-up|0|||
146070354|NCT01160822|526775459|FG004|Overall Study|Lost to Follow-up|1|||
146070355|NCT01160822|526775460|FG005|Overall Study|Lost to Follow-up|0|||
146070356|NCT01160822|526775461|FG006|Overall Study|Lost to Follow-up|0|||
146070357|NCT01160822|526775455|FG000|Overall Study|Administrative problems|0|||
146070358|NCT01160822|526775456|FG001|Overall Study|Administrative problems|0|||
146070359|NCT01160822|526775457|FG002|Overall Study|Administrative problems|0|||
146070360|NCT01160822|526775458|FG003|Overall Study|Administrative problems|0|||
146070361|NCT01160822|526775459|FG004|Overall Study|Administrative problems|1|||
146070362|NCT01160822|526775460|FG005|Overall Study|Administrative problems|0|||
146070363|NCT01160822|526775461|FG006|Overall Study|Administrative problems|0|||
146070364|NCT01160822|526775455|FG000|Overall Study|Protocol deviation|0|||
146070365|NCT01160822|526775456|FG001|Overall Study|Protocol deviation|0|||
146070366|NCT01160822|526775457|FG002|Overall Study|Protocol deviation|0|||
146070367|NCT01160822|526775458|FG003|Overall Study|Protocol deviation|0|||
146070368|NCT01160822|526775459|FG004|Overall Study|Protocol deviation|2|||
146070369|NCT01160822|526775460|FG005|Overall Study|Protocol deviation|0|||
146070370|NCT01160822|526775461|FG006|Overall Study|Protocol deviation|0|||
146070371|NCT02170077|526775464|FG000|Overall Study|Withdrawal by Subject|3|||
146070372|NCT02170077|526775465|FG001|Overall Study|Withdrawal by Subject|4|||
146070373|NCT02170077|526775466|FG002|Overall Study|Withdrawal by Subject|2|||
146070374|NCT02170077|526775464|FG000|Overall Study|Adverse Event|4|||
146070375|NCT02170077|526775465|FG001|Overall Study|Adverse Event|4|||
146070376|NCT02170077|526775466|FG002|Overall Study|Adverse Event|4|||
146070377|NCT02170077|526775464|FG000|Overall Study|Lost to Follow-up|0|||
146070378|NCT02170077|526775465|FG001|Overall Study|Lost to Follow-up|1|||
146070379|NCT02170077|526775466|FG002|Overall Study|Lost to Follow-up|0|||
146070380|NCT02170077|526775464|FG000|Overall Study|Exclusion criteria|2|||
146070381|NCT02170077|526775465|FG001|Overall Study|Exclusion criteria|2|||
146070382|NCT02170077|526775466|FG002|Overall Study|Exclusion criteria|5|||
146070383|NCT02170077|526775464|FG000|Overall Study|Exacerbation of seizures|0|||
146070384|NCT02170077|526775465|FG001|Overall Study|Exacerbation of seizures|2|||
146070385|NCT02170077|526775466|FG002|Overall Study|Exacerbation of seizures|1|||
146070386|NCT00750438|526775471|FG000|Overall Study|Protocol Violation|4|||
146070387|NCT00750438|526775472|FG001|Overall Study|Protocol Violation|1|||
146070388|NCT00750438|526775471|FG000|Overall Study|Physician Decision|2|||
146070389|NCT00750438|526775472|FG001|Overall Study|Physician Decision|2|||
146070390|NCT00750438|526775471|FG000|Overall Study|Withdrawal by Subject|1|||
146070391|NCT00750438|526775472|FG001|Overall Study|Withdrawal by Subject|1|||
146070392|NCT00256997|526775475|FG000|Overall Study|Protocol Violation|1|||
146070393|NCT00256997|526775476|FG001|Overall Study|Protocol Violation|4|||
146070394|NCT00256997|526775475|FG000|Overall Study|Lack of Efficacy|1|||
146070395|NCT00256997|526775476|FG001|Overall Study|Lack of Efficacy|4|||
146070396|NCT00256997|526775475|FG000|Overall Study|Death|2|||
146070397|NCT00256997|526775476|FG001|Overall Study|Death|0|||
146070398|NCT00256997|526775475|FG000|Overall Study|Adverse Event|4|||
146070399|NCT00256997|526775476|FG001|Overall Study|Adverse Event|0|||
146070400|NCT00256997|526775475|FG000|Overall Study|Lost to Follow-up|3|||
146070401|NCT00256997|526775476|FG001|Overall Study|Lost to Follow-up|5|||
146070402|NCT00256997|526775475|FG000|Overall Study|Withdrawal by Subject|13|||
146070403|NCT00256997|526775476|FG001|Overall Study|Withdrawal by Subject|3|||
146070404|NCT00256997|526775475|FG000|Overall Study|Started but not treated|2|||
146070405|NCT00256997|526775476|FG001|Overall Study|Started but not treated|0|||
146070406|NCT00256997|526775475|FG000|Overall Study|Other|5|||
146070407|NCT00256997|526775476|FG001|Overall Study|Other|8|||
146070408|NCT00256997|526775475|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
146070409|NCT00256997|526775476|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
146070410|NCT00256997|526775475|FG000|Overall Study|Participant Non-compliant|3|||
146070411|NCT00256997|526775476|FG001|Overall Study|Participant Non-compliant|6|||
146070412|NCT00256997|526775475|FG000|Overall Study|Investigator Withdrew Participant|2|||
146070413|NCT00256997|526775476|FG001|Overall Study|Investigator Withdrew Participant|1|||
146070414|NCT02736578|526775477|FG000|Overall Study|Adverse Event|1|||
146070415|NCT02736578|526775478|FG001|Overall Study|Adverse Event|0|||
146070416|NCT00354432|526775479|FG000|Overall Study|Adverse Event|3|||
146070417|NCT00354432|526775480|FG001|Overall Study|Adverse Event|1|||
146070418|NCT00354432|526775481|FG002|Overall Study|Adverse Event|5|||
146070419|NCT00354432|526775482|FG003|Overall Study|Adverse Event|5|||
146070420|NCT00354432|526775479|FG000|Overall Study|Off/Toxicity|3|||
146070421|NCT00354432|526775480|FG001|Overall Study|Off/Toxicity|7|||
146070422|NCT00354432|526775481|FG002|Overall Study|Off/Toxicity|5|||
146070423|NCT00354432|526775482|FG003|Overall Study|Off/Toxicity|5|||
146070424|NCT00802945|526775483|FG000|Overall Study|Death|27|||
146070425|NCT00802945|526775484|FG001|Overall Study|Death|23|||
146070426|NCT00802945|526775483|FG000|Overall Study|Terminated by sponsor|8|||
146070427|NCT00802945|526775484|FG001|Overall Study|Terminated by sponsor|12|||
146070428|NCT01104311|526775485|FG000|Overall Study|Withdrawal by Subject|6|||
146070429|NCT01104311|526775486|FG001|Overall Study|Withdrawal by Subject|6|||
146070430|NCT01104311|526775485|FG000|Overall Study|Protocol Violation|0|||
146172040|NCT01395823|527143328|FG000|Overall Study|Physician Decision|3|||
146408852|NCT04023994|528004272|FG005|Overall Study|Withdrawal by Subject|0|||
146408853|NCT01613131|528004273|FG000|Overall Study|Withdrawal by Subject|3|||
146408854|NCT01613131|528004274|FG001|Overall Study|Withdrawal by Subject|5|||
146408855|NCT01020305|528004275|FG000|Overall Study|Adverse Event|2|||
146408856|NCT00467818|528004276|FG000|Overall Study|Adverse Event|1|||
146408857|NCT00467818|528004277|FG001|Overall Study|Adverse Event|0|||
146408858|NCT00467818|528004276|FG000|Overall Study|Lost to Follow-up|2|||
146408859|NCT00467818|528004277|FG001|Overall Study|Lost to Follow-up|2|||
146408860|NCT01017029|528004278|FG000|Overall Study|Lost to Follow-up|1|||
146408861|NCT01017029|528004279|FG001|Overall Study|Lost to Follow-up|0|||
146408862|NCT01017029|528004278|FG000|Overall Study|Administrative problem|0|||
146408863|NCT01017029|528004279|FG001|Overall Study|Administrative problem|1|||
146408864|NCT01017029|528004278|FG000|Overall Study|Death|3|||
146408865|NCT01017029|528004279|FG001|Overall Study|Death|1|||
146408866|NCT00618774|528004282|FG000|Overall Study|Adverse Event|5|||
146408867|NCT00618774|528004283|FG001|Overall Study|Adverse Event|3|||
146408868|NCT00618774|528004282|FG000|Overall Study|Withdrawal by Subject|1|||
146408869|NCT00618774|528004283|FG001|Overall Study|Withdrawal by Subject|0|||
146408870|NCT02770716|528004284|FG000|Overall Study|Death|101|||
146408871|NCT02770716|528004285|FG001|Overall Study|Death|45|||
146408872|NCT02770716|528004284|FG000|Overall Study|Withdrawal by Subject|4|||
146070431|NCT01104311|526775486|FG001|Overall Study|Protocol Violation|1|||
146408873|NCT02770716|528004285|FG001|Overall Study|Withdrawal by Subject|2|||
146070432|NCT01104311|526775485|FG000|Overall Study|Physician Decision|2|||
146070433|NCT01104311|526775486|FG001|Overall Study|Physician Decision|2|||
146070434|NCT01104311|526775485|FG000|Overall Study|low compliance|1|||
146172041|NCT01395823|527143329|FG001|Overall Study|Physician Decision|1|||
146408874|NCT02770716|528004284|FG000|Overall Study|Lost to Follow-up|1|||
146070435|NCT01104311|526775486|FG001|Overall Study|low compliance|1|||
146070436|NCT01104311|526775485|FG000|Overall Study|Adverse Event|1|||
146070437|NCT01104311|526775486|FG001|Overall Study|Adverse Event|2|||
146070438|NCT02102204|526777069|FG000|Overall Study|Withdrawal by Subject|137|||
146070439|NCT02102204|526777069|FG000|Overall Study|Death|92|||
146070440|NCT02102204|526777069|FG000|Overall Study|Lost to Follow-up|65|||
146070441|NCT02102204|526777069|FG000|Overall Study|Sponsor Decision|5|||
146070442|NCT02102204|526777069|FG000|Overall Study|Ongoing|5|||
146070443|NCT02656693|526777071|FG000|Overall Study|Pregnancy|1|||
146070444|NCT02656693|526777072|FG001|Overall Study|Pregnancy|1|||
146070445|NCT02656693|526777073|FG002|Overall Study|Pregnancy|1|||
146070446|NCT02656693|526777071|FG000|Overall Study|Bariatric surgery|0|||
146070447|NCT02656693|526777072|FG001|Overall Study|Bariatric surgery|1|||
146070448|NCT02656693|526777073|FG002|Overall Study|Bariatric surgery|2|||
146070449|NCT02269267|526777075|FG000|Overall Study|Death|5|||
146070450|NCT03773796|526777076|FG000|Overall Study|Adverse Event|1|||
146070451|NCT03773796|526777076|FG000|Overall Study|Withdrawal by Subject|1|||
146070452|NCT03773796|526777076|FG000|Overall Study|Lack of Efficacy|1|||
146070453|NCT03805659|526777078|FG000|Overall Study|Withdrawal by Subject|0|||
146070454|NCT03805659|526777079|FG001|Overall Study|Withdrawal by Subject|1|||
146070455|NCT02273596|526777082|FG000|24-Week Treatment Period|Adverse Event|3|||
146070456|NCT02273596|526777082|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
146070457|NCT02273596|526777082|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
146070458|NCT02273596|526777082|FG000|24-Week Treatment Period|Physician Decision|1|||
146070459|NCT02273596|526777082|FG000|24-Week Treatment Period|Protocol Deviation|1|||
146070460|NCT02273596|526777082|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
146070461|NCT02273596|526777082|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
146070462|NCT02273596|526777082|FG000|Extension Period|Lost to Follow-up|1|||
146070463|NCT02273596|526777082|FG000|Extension Period|Protocol Deviation|1|||
146070464|NCT02604160|526777084|FG000|Overall Study|Protocol Violation|0|||
146070465|NCT02604160|526777085|FG001|Overall Study|Protocol Violation|1|||
146070466|NCT02604160|526777084|FG000|Overall Study|Physician Decision|0|||
146070467|NCT02604160|526777085|FG001|Overall Study|Physician Decision|1|||
146070468|NCT01596062|526777086|FG000|Overall Study|Adverse Event|1|||
146070469|NCT01596062|526777087|FG001|Overall Study|Adverse Event|0|||
146070470|NCT01596062|526777088|FG002|Overall Study|Adverse Event|2|||
146070471|NCT01596062|526777086|FG000|Overall Study|Lack of Efficacy|0|||
146070472|NCT01596062|526777087|FG001|Overall Study|Lack of Efficacy|0|||
146070473|NCT01596062|526777088|FG002|Overall Study|Lack of Efficacy|1|||
146070474|NCT01413204|526777089|FG000|Overall Study|Adverse Event|1|||
146070475|NCT01413204|526777090|FG001|Overall Study|Adverse Event|2|||
146070476|NCT01413204|526777091|FG002|Overall Study|Adverse Event|2|||
146070477|NCT01413204|526777089|FG000|Overall Study|Physician Decision|3|||
146070478|NCT01413204|526777090|FG001|Overall Study|Physician Decision|0|||
146070479|NCT01413204|526777091|FG002|Overall Study|Physician Decision|2|||
146070480|NCT01413204|526777089|FG000|Overall Study|Withdrawal by Subject|1|||
146070481|NCT01413204|526777090|FG001|Overall Study|Withdrawal by Subject|4|||
146070482|NCT01413204|526777091|FG002|Overall Study|Withdrawal by Subject|4|||
146070483|NCT01413204|526777089|FG000|Overall Study|Clearly not eligible for the study|0|||
146070484|NCT01413204|526777090|FG001|Overall Study|Clearly not eligible for the study|0|||
146070485|NCT01413204|526777091|FG002|Overall Study|Clearly not eligible for the study|1|||
146070486|NCT01413204|526777089|FG000|Overall Study|Fasting plasma glucose level increased|1|||
146070487|NCT01413204|526777090|FG001|Overall Study|Fasting plasma glucose level increased|0|||
146070488|NCT01413204|526777091|FG002|Overall Study|Fasting plasma glucose level increased|10|||
146070489|NCT03085797|526777092|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
146070490|NCT03085797|526777093|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
146070491|NCT03085797|526777092|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
146070492|NCT03085797|526777093|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
146172042|NCT01395823|527143328|FG000|Overall Study|Lost to Follow-up|1|||
146172043|NCT01395823|527143329|FG001|Overall Study|Lost to Follow-up|0|||
146172044|NCT01395823|527143328|FG000|Overall Study|Transplant|1|||
146172045|NCT01395823|527143329|FG001|Overall Study|Transplant|0|||
146172046|NCT01395823|527143328|FG000|Overall Study|GI symptoms|1|||
146172047|NCT01395823|527143329|FG001|Overall Study|GI symptoms|0|||
146172048|NCT01395823|527143328|FG000|Overall Study|Withdrawal by Subject|5|||
146172049|NCT01395823|527143329|FG001|Overall Study|Withdrawal by Subject|4|||
146408875|NCT02770716|528004285|FG001|Overall Study|Lost to Follow-up|0|||
146070493|NCT03085797|526777092|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
146070494|NCT03085797|526777093|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
146070495|NCT00859456|526777094|FG000|Overall Study|Adverse Event|3|||
146070496|NCT00859456|526777094|FG000|Overall Study|Progressive disease|2|||
146070497|NCT00859456|526777094|FG000|Overall Study|Non-compliance|3|||
146070498|NCT05782179|526777096|FG000|Overall Study|Adverse Event|0|||
146070499|NCT05782179|526777097|FG001|Overall Study|Adverse Event|0|||
146070500|NCT05782179|526777098|FG002|Overall Study|Adverse Event|2|||
146172050|NCT02719990|527143330|FG000|Overall Study|Physician Decision|2|||
146408876|NCT02770716|528004284|FG000|Overall Study|Various reasons|6|||
146172051|NCT02719990|527143330|FG000|Overall Study|Withdrawal by Subject|2|||
146172052|NCT02719990|527143330|FG000|Overall Study|Study Terminated By Sponsor|32|||
146172053|NCT02404389|527143331|FG000|Overall Study|Adverse Event|1|||
146172054|NCT02404389|527143332|FG001|Overall Study|Adverse Event|0|||
146172055|NCT02404389|527143333|FG002|Overall Study|Adverse Event|1|||
146172056|NCT02404389|527143334|FG003|Overall Study|Adverse Event|0|||
146172057|NCT02404389|527143335|FG004|Overall Study|Adverse Event|2|||
146172058|NCT02404389|527143331|FG000|Overall Study|Subject/guardian decision|1|||
146070501|NCT05782179|526777099|FG003|Overall Study|Adverse Event|0|||
146070502|NCT05782179|526777100|FG004|Overall Study|Adverse Event|0|||
146070503|NCT05782179|526777101|FG005|Overall Study|Adverse Event|0|||
146172059|NCT02404389|527143332|FG001|Overall Study|Subject/guardian decision|0|||
146172060|NCT02404389|527143333|FG002|Overall Study|Subject/guardian decision|0|||
146172061|NCT02404389|527143334|FG003|Overall Study|Subject/guardian decision|1|||
146172062|NCT02404389|527143335|FG004|Overall Study|Subject/guardian decision|1|||
146172063|NCT03300570|527143340|FG000|Overall Study|Adverse Event|0|||
146172064|NCT03300570|527143341|FG001|Overall Study|Adverse Event|1|||
146172065|NCT03300570|527143340|FG000|Overall Study|Withdrawal by Subject|1|||
146172066|NCT03300570|527143341|FG001|Overall Study|Withdrawal by Subject|0|||
146172067|NCT03300570|527143340|FG000|Overall Study|Inadequate bowel prep|1|||
146172068|NCT03300570|527143341|FG001|Overall Study|Inadequate bowel prep|0|||
146172069|NCT05076149|527143345|FG000|Overall Study|Adverse Event|3|||
146172070|NCT05076149|527143346|FG001|Overall Study|Adverse Event|9|||
146172071|NCT05076149|527143345|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146172072|NCT05076149|527143346|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
146172073|NCT05076149|527143345|FG000|Overall Study|Lost to Follow-up|0|||
146070504|NCT06170242|526777102|FG000|Overall Study|Lost to Follow-up|0|||
146070505|NCT06170242|526777103|FG001|Overall Study|Lost to Follow-up|0|||
146070506|NCT06170242|526777104|FG002|Overall Study|Lost to Follow-up|1|||
146070507|NCT06170242|526777105|FG003|Overall Study|Lost to Follow-up|1|||
146070508|NCT03682770|526777115|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070509|NCT03682770|526777116|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
146070510|NCT03682770|526777117|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070511|NCT03682770|526777118|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070512|NCT03682770|526777119|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070513|NCT03682770|526777120|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070514|NCT03682770|526777121|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
146070515|NCT03682770|526777115|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
146070516|NCT03682770|526777116|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
146070517|NCT03682770|526777117|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146070518|NCT03682770|526777118|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146070519|NCT03682770|526777119|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146070520|NCT03682770|526777120|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146070521|NCT03682770|526777121|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
146070522|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146070523|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146070524|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
146070525|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
146070526|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146172074|NCT05076149|527143346|FG001|Overall Study|Lost to Follow-up|1|||
146172075|NCT05076149|527143345|FG000|Overall Study|Commercial drug is available for participant|0|||
146172076|NCT05076149|527143346|FG001|Overall Study|Commercial drug is available for participant|1|||
146172077|NCT05076149|527143345|FG000|Overall Study|Other non compliance|1|||
146172078|NCT05076149|527143346|FG001|Overall Study|Other non compliance|1|||
146172079|NCT05076149|527143345|FG000|Overall Study|Physician Decision|0|||
146172080|NCT05076149|527143346|FG001|Overall Study|Physician Decision|1|||
146172081|NCT05076149|527143345|FG000|Overall Study|Other|5|||
146172082|NCT05076149|527143346|FG001|Overall Study|Other|4|||
146172083|NCT00717314|527143347|FG000|Overall Study|Adverse Event|3|||
146172084|NCT00717314|527143348|FG001|Overall Study|Adverse Event|2|||
146172085|NCT00717314|527143347|FG000|Overall Study|Protocol Violation|1|||
146070527|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146070528|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
146070529|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070530|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070531|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070532|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
146070533|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070534|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070535|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
146070536|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146070537|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146070538|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
146070539|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
146070540|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146070541|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146070542|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
146070543|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070544|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070545|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
146070546|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070547|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070548|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070549|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
146070550|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070551|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070552|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
146070553|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070554|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070555|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070556|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
146070557|NCT03682770|526777115|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070558|NCT03682770|526777116|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070559|NCT03682770|526777117|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070560|NCT03682770|526777118|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
146070561|NCT03682770|526777119|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070562|NCT03682770|526777120|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070563|NCT03682770|526777121|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
146070564|NCT03682770|526777115|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146070565|NCT03682770|526777116|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146070566|NCT03682770|526777117|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146070567|NCT03682770|526777118|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
146070568|NCT03682770|526777119|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
146070569|NCT03682770|526777120|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
146070570|NCT03682770|526777121|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
146070571|NCT03682770|526777115|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070572|NCT03682770|526777116|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070573|NCT03682770|526777117|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070574|NCT03682770|526777118|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070575|NCT03682770|526777119|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
146070576|NCT03682770|526777120|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070577|NCT03682770|526777121|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
146070578|NCT03682770|526777115|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070579|NCT03682770|526777116|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070580|NCT03682770|526777117|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070581|NCT03682770|526777118|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070582|NCT03682770|526777119|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070583|NCT03682770|526777120|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
146070584|NCT03682770|526777121|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
146070585|NCT03682770|526777115|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146070586|NCT03682770|526777116|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146070587|NCT03682770|526777117|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146070588|NCT03682770|526777118|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146172086|NCT00717314|527143348|FG001|Overall Study|Protocol Violation|0|||
146172087|NCT00717314|527143347|FG000|Overall Study|Lost to Follow-up|1|||
146172088|NCT00717314|527143348|FG001|Overall Study|Lost to Follow-up|5|||
146070589|NCT03682770|526777119|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
146070590|NCT03682770|526777120|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
146070591|NCT03682770|526777121|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
146070592|NCT01491607|526777122|FG000|Overall Study|Lost to Follow-up|7|||
146070593|NCT01491607|526777122|FG000|Overall Study|Withdrawal by Subject|3|||
146070594|NCT01317277|526777123|FG000|Overall Study|Lost to Follow-up|3|||
146070595|NCT01317277|526777124|FG001|Overall Study|Lost to Follow-up|1|||
146070596|NCT01317277|526777123|FG000|Overall Study|Lost MEMS|1|||
146070597|NCT01317277|526777124|FG001|Overall Study|Lost MEMS|1|||
146070598|NCT01317277|526777123|FG000|Overall Study|Unable to comply with intervention|1|||
146070599|NCT01317277|526777124|FG001|Overall Study|Unable to comply with intervention|0|||
146070600|NCT01317277|526777123|FG000|Overall Study|Withdrawal by Subject|1|||
146070601|NCT01317277|526777124|FG001|Overall Study|Withdrawal by Subject|0|||
146070602|NCT01317277|526777123|FG000|Overall Study|Adverse Event|1|||
146070603|NCT01317277|526777124|FG001|Overall Study|Adverse Event|0|||
146070604|NCT00774566|526777125|FG000|Overall Study|Protocol Violation|18|||
146070605|NCT00774566|526777126|FG001|Overall Study|Protocol Violation|15|||
146070606|NCT04896073|526777133|FG000|Overall Study|Screen failure|0|||
146070607|NCT04896073|526777134|FG001|Overall Study|Screen failure|2|||
146070608|NCT04896073|526777133|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
146070609|NCT04896073|526777134|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
146070610|NCT02999672|526777136|FG000|Overall Study|Death|0|||
146070611|NCT02999672|526777137|FG001|Overall Study|Death|1|||
146070612|NCT02999672|526777136|FG000|Overall Study|Study Terminated by Sponsor|0|||
146070613|NCT02999672|526777137|FG001|Overall Study|Study Terminated by Sponsor|1|||
146070614|NCT02999672|526777136|FG000|Overall Study|Progressive Disease|9|||
146070615|NCT02999672|526777137|FG001|Overall Study|Progressive Disease|5|||
146070616|NCT02999672|526777136|FG000|Overall Study|Adverse Event|4|||
146070617|NCT02999672|526777137|FG001|Overall Study|Adverse Event|0|||
146070618|NCT03565497|526777138|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
146070619|NCT03565497|526777139|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
146070620|NCT03565497|526777140|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
146070621|NCT03565497|526777138|FG000|Overall Study|Lost to Follow-up|1|||
146070622|NCT03565497|526777139|FG001|Overall Study|Lost to Follow-up|1|||
146070623|NCT03565497|526777140|FG002|Overall Study|Lost to Follow-up|2|||
146070624|NCT03565497|526777138|FG000|Overall Study|Withdrawal by Subject|1|||
146070625|NCT03565497|526777139|FG001|Overall Study|Withdrawal by Subject|1|||
146070626|NCT03565497|526777140|FG002|Overall Study|Withdrawal by Subject|1|||
146070627|NCT01385176|526777141|FG000|Randomization Phase|Death|1|||
146070628|NCT01385176|526777142|FG001|Randomization Phase|Death|2|||
146070629|NCT01385176|526777141|FG000|6-18 Month All VNS Active|Death|1|||
146070630|NCT01385176|526777142|FG001|6-18 Month All VNS Active|Death|2|||
146070631|NCT01385176|526777141|FG000|6-18 Month All VNS Active|Physician Decision|0|||
146070632|NCT01385176|526777142|FG001|6-18 Month All VNS Active|Physician Decision|1|||
146070633|NCT01385176|526777141|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
146070634|NCT01385176|526777142|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
146070635|NCT01385176|526777141|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
146070636|NCT01385176|526777142|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
146070637|NCT01075685|526777143|FG000|Overall Study|Protocol Violation|9|||
146070638|NCT01075685|526777144|FG001|Overall Study|Protocol Violation|1|||
146070639|NCT01075685|526777143|FG000|Overall Study|Withdrawal by Subject|20|||
146070640|NCT01075685|526777144|FG001|Overall Study|Withdrawal by Subject|5|||
146070641|NCT01075685|526777143|FG000|Overall Study|Lost to Follow-up|563|||
146070642|NCT01075685|526777144|FG001|Overall Study|Lost to Follow-up|220|||
146070643|NCT02858362|526777147|FG000|Overall Study|Protocol Violation|0|||
146070644|NCT02858362|526777148|FG001|Overall Study|Protocol Violation|1|||
146070645|NCT02858362|526777149|FG002|Overall Study|Protocol Violation|0|||
146070646|NCT02858362|526777147|FG000|Overall Study|Withdrawal by Subject|1|||
146070647|NCT02858362|526777148|FG001|Overall Study|Withdrawal by Subject|0|||
146070648|NCT02858362|526777149|FG002|Overall Study|Withdrawal by Subject|0|||
146070649|NCT02858362|526777147|FG000|Overall Study|Early Study Termination|0|||
146070650|NCT02858362|526777148|FG001|Overall Study|Early Study Termination|0|||
146070651|NCT02858362|526777149|FG002|Overall Study|Early Study Termination|3|||
146070652|NCT02858362|526777147|FG000|Overall Study|Lost to Follow-up|1|||
146070653|NCT02858362|526777148|FG001|Overall Study|Lost to Follow-up|0|||
146070654|NCT02858362|526777149|FG002|Overall Study|Lost to Follow-up|0|||
146070655|NCT00392769|526777153|FG000|Overall Study|Clinical Deterioration|9|||
146070656|NCT00392769|526777153|FG000|Overall Study|Adverse Event|1|||
146070657|NCT02561832|526777154|FG000|Overall Study|Withdrawal by Subject|1|||
146070658|NCT02561832|526777155|FG001|Overall Study|Withdrawal by Subject|1|||
146070659|NCT02561832|526777154|FG000|Overall Study|Adverse Event|3|||
146070660|NCT02561832|526777155|FG001|Overall Study|Adverse Event|0|||
146070661|NCT02561832|526777154|FG000|Overall Study|Disease progression|3|||
146070662|NCT02561832|526777155|FG001|Overall Study|Disease progression|3|||
146070663|NCT00439517|526777157|FG000|Overall Study|Subject on treatment|1|||
146070664|NCT00439517|526777158|FG001|Overall Study|Subject on treatment|0|||
146070665|NCT00439517|526777157|FG000|Overall Study|Subject in survival follow-up|1|||
146070666|NCT00439517|526777158|FG001|Overall Study|Subject in survival follow-up|0|||
146070667|NCT00594815|526777161|FG000|Overall Study|Never Treated|3|||
146070668|NCT00594815|526777161|FG000|Overall Study|Withdrawal by Subject|2|||
146070669|NCT00594815|526777161|FG000|Overall Study|Toxicity|4|||
146070670|NCT03599089|526777162|FG000|Overall Study|Lost to Follow-up|1|||
146070671|NCT03599089|526777163|FG001|Overall Study|Lost to Follow-up|0|||
146070672|NCT03599089|526777164|FG002|Overall Study|Lost to Follow-up|0|||
146070673|NCT03599089|526777165|FG003|Overall Study|Lost to Follow-up|0|||
146070674|NCT03599089|526777162|FG000|Overall Study|Withdrawal by Subject|2|||
146070675|NCT03599089|526777163|FG001|Overall Study|Withdrawal by Subject|1|||
146070676|NCT03599089|526777164|FG002|Overall Study|Withdrawal by Subject|0|||
146070677|NCT03599089|526777165|FG003|Overall Study|Withdrawal by Subject|0|||
146070678|NCT03599089|526777162|FG000|Overall Study|Lack of Efficacy|0|||
146070679|NCT03599089|526777163|FG001|Overall Study|Lack of Efficacy|0|||
146070680|NCT03599089|526777164|FG002|Overall Study|Lack of Efficacy|1|||
146070681|NCT03599089|526777165|FG003|Overall Study|Lack of Efficacy|2|||
146070682|NCT03214666|526777166|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146070683|NCT03214666|526777167|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146070684|NCT03214666|526777168|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146070685|NCT03214666|526777169|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146070686|NCT03214666|526777170|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
146070687|NCT03214666|526777171|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
146070688|NCT02500797|526777174|FG000|Overall Study|Cancel (rapid disease progression)|0|||
146070689|NCT02500797|526777175|FG001|Overall Study|Cancel (rapid disease progression)|0|||
146070690|NCT02500797|526777176|FG002|Overall Study|Cancel (rapid disease progression)|0|||
146070691|NCT02500797|526777177|FG003|Overall Study|Cancel (rapid disease progression)|0|||
146070692|NCT02500797|526777178|FG004|Overall Study|Cancel (rapid disease progression)|1|||
146070693|NCT02500797|526777179|FG005|Overall Study|Cancel (rapid disease progression)|1|||
146070694|NCT02500797|526777180|FG006|Overall Study|Cancel (rapid disease progression)|0|||
146070695|NCT02500797|526777181|FG007|Overall Study|Cancel (rapid disease progression)|0|||
146070696|NCT02500797|526777174|FG000|Overall Study|Withdrawal by Subject|1|||
146070697|NCT02500797|526777175|FG001|Overall Study|Withdrawal by Subject|0|||
146070698|NCT02500797|526777176|FG002|Overall Study|Withdrawal by Subject|0|||
146070699|NCT02500797|526777177|FG003|Overall Study|Withdrawal by Subject|0|||
146070700|NCT02500797|526777178|FG004|Overall Study|Withdrawal by Subject|0|||
146070701|NCT02500797|526777179|FG005|Overall Study|Withdrawal by Subject|0|||
146070702|NCT02500797|526777180|FG006|Overall Study|Withdrawal by Subject|0|||
146070703|NCT02500797|526777181|FG007|Overall Study|Withdrawal by Subject|0|||
146070704|NCT00060840|526777182|FG000|Overall Study|Change in surgical plan|2|||
146070705|NCT00060840|526777183|FG001|Overall Study|Change in surgical plan|6|||
146070706|NCT00060840|526777182|FG000|Overall Study|Death|0|||
146070707|NCT00060840|526777183|FG001|Overall Study|Death|1|||
146070708|NCT00060840|526777182|FG000|Overall Study|Withdrawal by Subject|0|||
146070709|NCT00060840|526777183|FG001|Overall Study|Withdrawal by Subject|1|||
146070710|NCT00060840|526777182|FG000|Overall Study|Subinvestigator unavailable|0|||
146070711|NCT00060840|526777183|FG001|Overall Study|Subinvestigator unavailable|1|||
146070712|NCT00060840|526777182|FG000|Overall Study|Physician Decision|1|||
146070713|NCT00060840|526777183|FG001|Overall Study|Physician Decision|0|||
146070714|NCT00060840|526777182|FG000|Overall Study|Other|1|||
146070715|NCT00060840|526777183|FG001|Overall Study|Other|0|||
146070716|NCT00357006|526777184|FG000|Overall Study|Lost to Follow-up|1|||
146070717|NCT00357006|526777185|FG001|Overall Study|Lost to Follow-up|2|||
146070718|NCT00357006|526777186|FG002|Overall Study|Lost to Follow-up|1|||
146070719|NCT00357006|526777184|FG000|Overall Study|Withdrawal by Subject|1|||
146070720|NCT00357006|526777185|FG001|Overall Study|Withdrawal by Subject|3|||
146070721|NCT00357006|526777186|FG002|Overall Study|Withdrawal by Subject|2|||
146070722|NCT00976560|526777187|FG000|Overall Study|Adverse Event|5|||
146070723|NCT00976560|526777188|FG001|Overall Study|Adverse Event|5|||
146070724|NCT00976560|526777187|FG000|Overall Study|Lack of Efficacy|3|||
146070725|NCT00976560|526777188|FG001|Overall Study|Lack of Efficacy|5|||
146070726|NCT00976560|526777187|FG000|Overall Study|Protocol Violation|1|||
146070727|NCT00976560|526777188|FG001|Overall Study|Protocol Violation|0|||
146070728|NCT00976560|526777187|FG000|Overall Study|Lost to Follow-up|1|||
146070729|NCT00976560|526777188|FG001|Overall Study|Lost to Follow-up|0|||
146070730|NCT00976560|526777187|FG000|Overall Study|Physician Decision|2|||
146070731|NCT00976560|526777188|FG001|Overall Study|Physician Decision|0|||
146172089|NCT00717314|527143347|FG000|Overall Study|Withdrawal by Subject|1|||
146172090|NCT00717314|527143348|FG001|Overall Study|Withdrawal by Subject|3|||
146070732|NCT00976560|526777187|FG000|Overall Study|Withdrawal by Subject|2|||
146070733|NCT00976560|526777188|FG001|Overall Study|Withdrawal by Subject|3|||
146070734|NCT03710161|526777189|FG000|Overall Study|Study halted due to COVID pandemic|3|||
146070735|NCT03710161|526777190|FG001|Overall Study|Study halted due to COVID pandemic|2|||
146070736|NCT05340478|526777193|FG000|Overall Study|Scheduling Issues|10|||
146070737|NCT05340478|526777194|FG001|Overall Study|Scheduling Issues|4|||
146070738|NCT05340478|526777193|FG000|Overall Study|Neither member of dyad started treatment|2|||
146070739|NCT05340478|526777194|FG001|Overall Study|Neither member of dyad started treatment|2|||
146070740|NCT05340478|526777193|FG000|Overall Study|Withdrawn from study|2|||
146070741|NCT05340478|526777194|FG001|Overall Study|Withdrawn from study|2|||
146070742|NCT05340478|526777193|FG000|Overall Study|Lost to Follow-up|1|||
146070743|NCT05340478|526777194|FG001|Overall Study|Lost to Follow-up|4|||
146070744|NCT00092443|526777197|FG000|Overall Study|Adverse Event|9|||
146070745|NCT00092443|526777198|FG001|Overall Study|Adverse Event|13|||
146070746|NCT00092443|526777197|FG000|Overall Study|Lost to Follow-up|7|||
146070747|NCT00092443|526777198|FG001|Overall Study|Lost to Follow-up|3|||
146070748|NCT00092443|526777197|FG000|Overall Study|Protocol Violation|11|||
146070749|NCT00092443|526777198|FG001|Overall Study|Protocol Violation|9|||
146070750|NCT00092443|526777197|FG000|Overall Study|Withdrawal by Subject|9|||
146070751|NCT00092443|526777198|FG001|Overall Study|Withdrawal by Subject|11|||
146070752|NCT00092443|526777197|FG000|Overall Study|Moved|5|||
146070753|NCT00092443|526777198|FG001|Overall Study|Moved|5|||
146070754|NCT00092443|526777197|FG000|Overall Study|Other|17|||
146070755|NCT00092443|526777198|FG001|Overall Study|Other|13|||
146070756|NCT02963506|526777200|FG000|Double-Blind Period|Adverse Event|0|||
146070757|NCT02963506|526777201|FG001|Double-Blind Period|Adverse Event|0|||
146070758|NCT02963506|526777202|FG002|Double-Blind Period|Adverse Event|1|||
146070759|NCT02963506|526777203|FG003|Double-Blind Period|Adverse Event|0|||
146070760|NCT02963506|526777204|FG004|Double-Blind Period|Adverse Event|0|||
146070761|NCT02963506|526777205|FG005|Double-Blind Period|Adverse Event|0|||
146070762|NCT02963506|526777206|FG006|Double-Blind Period|Adverse Event|0|||
146070763|NCT02963506|526777207|FG007|Double-Blind Period|Adverse Event|0|||
146070764|NCT02963506|526777208|FG008|Double-Blind Period|Adverse Event|0|||
146070765|NCT02963506|526777209|FG009|Double-Blind Period|Adverse Event|0|||
146070766|NCT02963506|526777210|FG010|Double-Blind Period|Adverse Event|0|||
146070767|NCT02963506|526777211|FG011|Double-Blind Period|Adverse Event|0|||
146070768|NCT02963506|526777212|FG012|Double-Blind Period|Adverse Event|0|||
146070769|NCT02963506|526777200|FG000|Double-Blind Period|Death|0|||
146070770|NCT02963506|526777201|FG001|Double-Blind Period|Death|0|||
146070771|NCT02963506|526777202|FG002|Double-Blind Period|Death|0|||
146070772|NCT02963506|526777203|FG003|Double-Blind Period|Death|1|||
146070773|NCT02963506|526777204|FG004|Double-Blind Period|Death|0|||
146070774|NCT02963506|526777205|FG005|Double-Blind Period|Death|0|||
146070775|NCT02963506|526777206|FG006|Double-Blind Period|Death|0|||
146070776|NCT02963506|526777207|FG007|Double-Blind Period|Death|0|||
146070777|NCT02963506|526777208|FG008|Double-Blind Period|Death|0|||
146070778|NCT02963506|526777209|FG009|Double-Blind Period|Death|0|||
146070779|NCT02963506|526777210|FG010|Double-Blind Period|Death|0|||
146070780|NCT02963506|526777211|FG011|Double-Blind Period|Death|0|||
146070781|NCT02963506|526777212|FG012|Double-Blind Period|Death|0|||
146070782|NCT02963506|526777200|FG000|Double-Blind Period|Lost to Follow-up|0|||
146070783|NCT02963506|526777201|FG001|Double-Blind Period|Lost to Follow-up|1|||
146070784|NCT02963506|526777202|FG002|Double-Blind Period|Lost to Follow-up|0|||
146070785|NCT02963506|526777203|FG003|Double-Blind Period|Lost to Follow-up|0|||
146070786|NCT02963506|526777204|FG004|Double-Blind Period|Lost to Follow-up|0|||
146070787|NCT02963506|526777205|FG005|Double-Blind Period|Lost to Follow-up|0|||
146070788|NCT02963506|526777206|FG006|Double-Blind Period|Lost to Follow-up|0|||
146070789|NCT02963506|526777207|FG007|Double-Blind Period|Lost to Follow-up|0|||
146070790|NCT02963506|526777208|FG008|Double-Blind Period|Lost to Follow-up|0|||
146070791|NCT02963506|526777209|FG009|Double-Blind Period|Lost to Follow-up|0|||
146070792|NCT02963506|526777210|FG010|Double-Blind Period|Lost to Follow-up|0|||
146070793|NCT02963506|526777211|FG011|Double-Blind Period|Lost to Follow-up|0|||
146070794|NCT02963506|526777212|FG012|Double-Blind Period|Lost to Follow-up|0|||
146070795|NCT02963506|526777200|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146070796|NCT02963506|526777201|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146070797|NCT02963506|526777202|FG002|Double-Blind Period|Withdrawal by Subject|1|||
146070798|NCT02963506|526777203|FG003|Double-Blind Period|Withdrawal by Subject|1|||
146070799|NCT02963506|526777204|FG004|Double-Blind Period|Withdrawal by Subject|0|||
146070800|NCT02963506|526777205|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146070801|NCT02963506|526777206|FG006|Double-Blind Period|Withdrawal by Subject|0|||
146070802|NCT02963506|526777207|FG007|Double-Blind Period|Withdrawal by Subject|0|||
146070803|NCT02963506|526777208|FG008|Double-Blind Period|Withdrawal by Subject|0|||
146070804|NCT02963506|526777209|FG009|Double-Blind Period|Withdrawal by Subject|0|||
146070805|NCT02963506|526777210|FG010|Double-Blind Period|Withdrawal by Subject|0|||
146070806|NCT02963506|526777211|FG011|Double-Blind Period|Withdrawal by Subject|0|||
146070807|NCT02963506|526777212|FG012|Double-Blind Period|Withdrawal by Subject|0|||
146070808|NCT02963506|526777200|FG000|Double-Blind Period|No compliance|0|||
146070809|NCT02963506|526777201|FG001|Double-Blind Period|No compliance|1|||
146070810|NCT02963506|526777202|FG002|Double-Blind Period|No compliance|0|||
146070811|NCT02963506|526777203|FG003|Double-Blind Period|No compliance|0|||
146070812|NCT02963506|526777204|FG004|Double-Blind Period|No compliance|0|||
146070813|NCT02963506|526777205|FG005|Double-Blind Period|No compliance|0|||
146070814|NCT02963506|526777206|FG006|Double-Blind Period|No compliance|0|||
146070815|NCT02963506|526777207|FG007|Double-Blind Period|No compliance|0|||
146070816|NCT02963506|526777208|FG008|Double-Blind Period|No compliance|0|||
146070817|NCT02963506|526777209|FG009|Double-Blind Period|No compliance|0|||
146070818|NCT02963506|526777210|FG010|Double-Blind Period|No compliance|0|||
146070819|NCT02963506|526777211|FG011|Double-Blind Period|No compliance|0|||
146070820|NCT02963506|526777212|FG012|Double-Blind Period|No compliance|0|||
146070821|NCT02963506|526777200|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070822|NCT02963506|526777201|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
146070823|NCT02963506|526777202|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070824|NCT02963506|526777203|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070825|NCT02963506|526777204|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070826|NCT02963506|526777205|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070827|NCT02963506|526777206|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070828|NCT02963506|526777207|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070829|NCT02963506|526777208|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070830|NCT02963506|526777209|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070831|NCT02963506|526777210|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070832|NCT02963506|526777211|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070833|NCT02963506|526777212|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
146070834|NCT02963506|526777200|FG000|Dose-Blind Period|Adverse Event|0|||
146070835|NCT02963506|526777201|FG001|Dose-Blind Period|Adverse Event|0|||
146070836|NCT02963506|526777202|FG002|Dose-Blind Period|Adverse Event|0|||
146070837|NCT02963506|526777203|FG003|Dose-Blind Period|Adverse Event|0|||
146070838|NCT02963506|526777204|FG004|Dose-Blind Period|Adverse Event|0|||
146070839|NCT02963506|526777205|FG005|Dose-Blind Period|Adverse Event|1|||
146070840|NCT02963506|526777206|FG006|Dose-Blind Period|Adverse Event|3|||
146070841|NCT02963506|526777207|FG007|Dose-Blind Period|Adverse Event|2|||
146070842|NCT02963506|526777208|FG008|Dose-Blind Period|Adverse Event|2|||
146070843|NCT02963506|526777209|FG009|Dose-Blind Period|Adverse Event|2|||
146070844|NCT02963506|526777210|FG010|Dose-Blind Period|Adverse Event|1|||
146070845|NCT02963506|526777211|FG011|Dose-Blind Period|Adverse Event|1|||
146070846|NCT02963506|526777212|FG012|Dose-Blind Period|Adverse Event|6|||
146070847|NCT02963506|526777200|FG000|Dose-Blind Period|Lack of Efficacy|0|||
146070848|NCT02963506|526777201|FG001|Dose-Blind Period|Lack of Efficacy|0|||
146070849|NCT02963506|526777202|FG002|Dose-Blind Period|Lack of Efficacy|0|||
146070850|NCT02963506|526777203|FG003|Dose-Blind Period|Lack of Efficacy|0|||
146070851|NCT02963506|526777204|FG004|Dose-Blind Period|Lack of Efficacy|0|||
146070852|NCT02963506|526777205|FG005|Dose-Blind Period|Lack of Efficacy|0|||
146070853|NCT02963506|526777206|FG006|Dose-Blind Period|Lack of Efficacy|0|||
146070854|NCT02963506|526777207|FG007|Dose-Blind Period|Lack of Efficacy|1|||
146070855|NCT02963506|526777208|FG008|Dose-Blind Period|Lack of Efficacy|0|||
146070856|NCT02963506|526777209|FG009|Dose-Blind Period|Lack of Efficacy|1|||
146070857|NCT02963506|526777210|FG010|Dose-Blind Period|Lack of Efficacy|0|||
146070858|NCT02963506|526777211|FG011|Dose-Blind Period|Lack of Efficacy|0|||
146070859|NCT02963506|526777212|FG012|Dose-Blind Period|Lack of Efficacy|0|||
146070860|NCT02963506|526777200|FG000|Dose-Blind Period|Lost to Follow-up|0|||
146070861|NCT02963506|526777201|FG001|Dose-Blind Period|Lost to Follow-up|0|||
146070862|NCT02963506|526777202|FG002|Dose-Blind Period|Lost to Follow-up|0|||
146070863|NCT02963506|526777203|FG003|Dose-Blind Period|Lost to Follow-up|0|||
146070864|NCT02963506|526777204|FG004|Dose-Blind Period|Lost to Follow-up|0|||
146070865|NCT02963506|526777205|FG005|Dose-Blind Period|Lost to Follow-up|1|||
146070866|NCT02963506|526777206|FG006|Dose-Blind Period|Lost to Follow-up|0|||
146070867|NCT02963506|526777207|FG007|Dose-Blind Period|Lost to Follow-up|0|||
146070868|NCT02963506|526777208|FG008|Dose-Blind Period|Lost to Follow-up|1|||
146070869|NCT02963506|526777209|FG009|Dose-Blind Period|Lost to Follow-up|0|||
146070870|NCT02963506|526777210|FG010|Dose-Blind Period|Lost to Follow-up|0|||
146070871|NCT02963506|526777211|FG011|Dose-Blind Period|Lost to Follow-up|1|||
146070872|NCT02963506|526777212|FG012|Dose-Blind Period|Lost to Follow-up|0|||
146070873|NCT02963506|526777200|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
146070874|NCT02963506|526777201|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
146070875|NCT02963506|526777202|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
146070876|NCT02963506|526777203|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
146070877|NCT02963506|526777204|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
146070878|NCT02963506|526777205|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
146070879|NCT02963506|526777206|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
146070880|NCT02963506|526777207|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
146070881|NCT02963506|526777208|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
146070882|NCT02963506|526777209|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
146070883|NCT02963506|526777210|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
146070884|NCT02963506|526777211|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
146070885|NCT02963506|526777212|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
146070886|NCT02963506|526777200|FG000|Dose-Blind Period|Sponsor decision|0|||
146070887|NCT02963506|526777201|FG001|Dose-Blind Period|Sponsor decision|0|||
146070888|NCT02963506|526777202|FG002|Dose-Blind Period|Sponsor decision|0|||
146070889|NCT02963506|526777203|FG003|Dose-Blind Period|Sponsor decision|0|||
146070890|NCT02963506|526777204|FG004|Dose-Blind Period|Sponsor decision|0|||
146070891|NCT02963506|526777205|FG005|Dose-Blind Period|Sponsor decision|1|||
146070892|NCT02963506|526777206|FG006|Dose-Blind Period|Sponsor decision|0|||
146070893|NCT02963506|526777207|FG007|Dose-Blind Period|Sponsor decision|0|||
146070894|NCT02963506|526777208|FG008|Dose-Blind Period|Sponsor decision|0|||
146070895|NCT02963506|526777209|FG009|Dose-Blind Period|Sponsor decision|0|||
146070896|NCT02963506|526777210|FG010|Dose-Blind Period|Sponsor decision|0|||
146070897|NCT02963506|526777211|FG011|Dose-Blind Period|Sponsor decision|0|||
146070898|NCT02963506|526777212|FG012|Dose-Blind Period|Sponsor decision|0|||
146070899|NCT02963506|526777200|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070900|NCT02963506|526777201|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070901|NCT02963506|526777202|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070902|NCT02963506|526777203|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070903|NCT02963506|526777204|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070904|NCT02963506|526777205|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070905|NCT02963506|526777206|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070906|NCT02963506|526777207|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070907|NCT02963506|526777208|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070908|NCT02963506|526777209|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070909|NCT02963506|526777210|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070910|NCT02963506|526777211|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
146070911|NCT02963506|526777212|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
146070912|NCT00630838|526777215|FG000|Overall Study|Death|0|||
146070913|NCT00630838|526777216|FG001|Overall Study|Death|1|||
146070914|NCT00630838|526777215|FG000|Overall Study|Lost to Follow-up|0|||
146070915|NCT00630838|526777216|FG001|Overall Study|Lost to Follow-up|1|||
146070916|NCT00928408|526777217|FG000|Overall Study|Other|2|||
146070917|NCT00928408|526777217|FG000|Overall Study|Withdrawal by Subject|4|||
146070918|NCT00928408|526777217|FG000|Overall Study|Death|5|||
146070919|NCT00928408|526777217|FG000|Overall Study|Lost to Follow-up|12|||
146070920|NCT03843541|526777218|FG000|Overall Study|Adverse Event|4|||
146070921|NCT03843541|526777219|FG001|Overall Study|Adverse Event|2|||
146070922|NCT03843541|526777220|FG002|Overall Study|Adverse Event|3|||
146070923|NCT03843541|526777218|FG000|Overall Study|Death|1|||
146070924|NCT03843541|526777219|FG001|Overall Study|Death|0|||
146070925|NCT03843541|526777220|FG002|Overall Study|Death|0|||
146070926|NCT03843541|526777218|FG000|Overall Study|Lack of adherence to study medication|0|||
146070927|NCT03843541|526777219|FG001|Overall Study|Lack of adherence to study medication|0|||
146070928|NCT03843541|526777220|FG002|Overall Study|Lack of adherence to study medication|1|||
146070929|NCT03843541|526777218|FG000|Overall Study|Physician Decision|1|||
146070930|NCT03843541|526777219|FG001|Overall Study|Physician Decision|2|||
146070931|NCT03843541|526777220|FG002|Overall Study|Physician Decision|2|||
146070932|NCT03843541|526777218|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
146070933|NCT03843541|526777219|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
146070934|NCT03843541|526777220|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
146070935|NCT03843541|526777218|FG000|Overall Study|Withdrawal by Subject|6|||
146070936|NCT03843541|526777219|FG001|Overall Study|Withdrawal by Subject|9|||
146070937|NCT03843541|526777220|FG002|Overall Study|Withdrawal by Subject|7|||
146070938|NCT03843541|526777218|FG000|Overall Study|Administration of rescue mucolytic|0|||
146070939|NCT03843541|526777219|FG001|Overall Study|Administration of rescue mucolytic|0|||
146070940|NCT03843541|526777220|FG002|Overall Study|Administration of rescue mucolytic|1|||
146070941|NCT03843541|526777218|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
146070942|NCT03843541|526777219|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
146070943|NCT03843541|526777220|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
146070944|NCT04163016|526777222|FG000|Enrollment|Adverse Event|1|||
146070945|NCT04163016|526777223|FG001|Enrollment|Adverse Event|0|||
146070946|NCT04163016|526777224|FG002|Enrollment|Adverse Event|0|||
146070947|NCT04163016|526777225|FG003|Enrollment|Adverse Event|0|||
146070948|NCT04163016|526777222|FG000|Treatment|Adverse Event|0|||
146070949|NCT04163016|526777223|FG001|Treatment|Adverse Event|1|||
146070950|NCT04163016|526777224|FG002|Treatment|Adverse Event|0|||
146070951|NCT04163016|526777225|FG003|Treatment|Adverse Event|0|||
146070952|NCT04163016|526777222|FG000|Treatment|Withdrawal by Subject|0|||
146070953|NCT04163016|526777223|FG001|Treatment|Withdrawal by Subject|2|||
146070954|NCT04163016|526777224|FG002|Treatment|Withdrawal by Subject|0|||
146070955|NCT04163016|526777225|FG003|Treatment|Withdrawal by Subject|0|||
146070956|NCT04163016|526777222|FG000|Treatment|Indeterminate TB-test|0|||
146070957|NCT04163016|526777223|FG001|Treatment|Indeterminate TB-test|0|||
146070958|NCT04163016|526777224|FG002|Treatment|Indeterminate TB-test|0|||
146070959|NCT04163016|526777225|FG003|Treatment|Indeterminate TB-test|1|||
146070960|NCT04163016|526777222|FG000|Treatment|Participant did not want to continue in study|0|||
146070961|NCT04163016|526777223|FG001|Treatment|Participant did not want to continue in study|0|||
146070962|NCT04163016|526777224|FG002|Treatment|Participant did not want to continue in study|0|||
146070963|NCT04163016|526777225|FG003|Treatment|Participant did not want to continue in study|1|||
146070964|NCT02930018|526777229|FG000|Overall Study|Lost to Follow-up|1|||
146070965|NCT02930018|526777230|FG001|Overall Study|Lost to Follow-up|1|||
146070966|NCT02930018|526777229|FG000|Overall Study|Withdrawal by Subject|5|||
146070967|NCT02930018|526777230|FG001|Overall Study|Withdrawal by Subject|2|||
146070968|NCT02255435|526778847|FG000|Overall Study|Patient's Limited Time Availability|0|||
146070969|NCT02255435|526778848|FG001|Overall Study|Patient's Limited Time Availability|0|||
146070970|NCT02255435|526778849|FG002|Overall Study|Patient's Limited Time Availability|0|||
146070971|NCT02255435|526778850|FG003|Overall Study|Patient's Limited Time Availability|0|||
146070972|NCT02255435|526778851|FG004|Overall Study|Patient's Limited Time Availability|0|||
146070973|NCT02255435|526778852|FG005|Overall Study|Patient's Limited Time Availability|0|||
146070974|NCT02255435|526778853|FG006|Overall Study|Patient's Limited Time Availability|0|||
146070975|NCT02255435|526778854|FG007|Overall Study|Patient's Limited Time Availability|1|||
146070976|NCT02255435|526778855|FG008|Overall Study|Patient's Limited Time Availability|0|||
146070977|NCT02255435|526778856|FG009|Overall Study|Patient's Limited Time Availability|0|||
146070978|NCT02255435|526778847|FG000|Overall Study|Withdrawal by Subject|0|||
146070979|NCT02255435|526778848|FG001|Overall Study|Withdrawal by Subject|0|||
146070980|NCT02255435|526778849|FG002|Overall Study|Withdrawal by Subject|0|||
146070981|NCT02255435|526778850|FG003|Overall Study|Withdrawal by Subject|0|||
146070982|NCT02255435|526778851|FG004|Overall Study|Withdrawal by Subject|0|||
146070983|NCT02255435|526778852|FG005|Overall Study|Withdrawal by Subject|0|||
146070984|NCT02255435|526778853|FG006|Overall Study|Withdrawal by Subject|0|||
146070985|NCT02255435|526778854|FG007|Overall Study|Withdrawal by Subject|0|||
146070986|NCT02255435|526778855|FG008|Overall Study|Withdrawal by Subject|1|||
146070987|NCT02255435|526778856|FG009|Overall Study|Withdrawal by Subject|4|||
146070988|NCT02255435|526778847|FG000|Overall Study|Administrative reasons|0|||
146070989|NCT02255435|526778848|FG001|Overall Study|Administrative reasons|0|||
146070990|NCT02255435|526778849|FG002|Overall Study|Administrative reasons|0|||
146070991|NCT02255435|526778850|FG003|Overall Study|Administrative reasons|0|||
146070992|NCT02255435|526778851|FG004|Overall Study|Administrative reasons|0|||
146070993|NCT02255435|526778852|FG005|Overall Study|Administrative reasons|0|||
146070994|NCT02255435|526778853|FG006|Overall Study|Administrative reasons|0|||
146070995|NCT02255435|526778854|FG007|Overall Study|Administrative reasons|0|||
146070996|NCT02255435|526778855|FG008|Overall Study|Administrative reasons|0|||
146070997|NCT02255435|526778856|FG009|Overall Study|Administrative reasons|2|||
146070998|NCT01069900|526778859|FG000|Overall Study|Technical problems|0|||
146070999|NCT01069900|526778860|FG001|Overall Study|Technical problems|1|||
146071000|NCT01069900|526778859|FG000|Overall Study|Lost to Follow-up|7|||
146071001|NCT01069900|526778860|FG001|Overall Study|Lost to Follow-up|1|||
146071002|NCT01069900|526778859|FG000|Overall Study|Withdrawal by Subject|6|||
146071003|NCT01069900|526778860|FG001|Overall Study|Withdrawal by Subject|1|||
146071004|NCT01069900|526778859|FG000|Overall Study|Protocol Violation|4|||
146071005|NCT01069900|526778860|FG001|Overall Study|Protocol Violation|1|||
146071006|NCT01069900|526778859|FG000|Overall Study|Insufficient Therapeutic effect|1|||
146071007|NCT01069900|526778860|FG001|Overall Study|Insufficient Therapeutic effect|0|||
146071008|NCT00145158|526778861|FG000|Overall Study|premature withdrawal|2|||
146071009|NCT00145158|526778862|FG001|Overall Study|premature withdrawal|3|||
146071010|NCT02687191|526778863|FG000|Overall Study|Death|0|||
146071011|NCT02687191|526778864|FG001|Overall Study|Death|1|||
146071012|NCT02687191|526778865|FG002|Overall Study|Death|1|||
146071013|NCT02687191|526778866|FG003|Overall Study|Death|0|||
146071014|NCT02687191|526778867|FG004|Overall Study|Death|1|||
146071015|NCT02687191|526778868|FG005|Overall Study|Death|1|||
146071016|NCT02687191|526778863|FG000|Overall Study|Withdrawal by Subject|0|||
146071017|NCT02687191|526778864|FG001|Overall Study|Withdrawal by Subject|0|||
146408877|NCT02770716|528004285|FG001|Overall Study|Various reasons|2|||
146408878|NCT02753400|528004287|FG000|Overall Study|Adverse Event|3|||
146408879|NCT02753400|528004288|FG001|Overall Study|Adverse Event|0|||
146408880|NCT02753400|528004287|FG000|Overall Study|Withdrawal by Subject|2|||
146408881|NCT02753400|528004288|FG001|Overall Study|Withdrawal by Subject|1|||
146408882|NCT03989115|528004289|FG000|Overall Study|Withdrawal by Subject|2|||
146408883|NCT03989115|528004290|FG001|Overall Study|Withdrawal by Subject|1|||
146408884|NCT03989115|528004291|FG002|Overall Study|Withdrawal by Subject|3|||
146408885|NCT03989115|528004292|FG003|Overall Study|Withdrawal by Subject|0|||
146408886|NCT03989115|528004293|FG004|Overall Study|Withdrawal by Subject|17|||
146408887|NCT03989115|528004294|FG005|Overall Study|Withdrawal by Subject|1|||
146071018|NCT02687191|526778865|FG002|Overall Study|Withdrawal by Subject|0|||
146071019|NCT02687191|526778866|FG003|Overall Study|Withdrawal by Subject|1|||
146071020|NCT02687191|526778867|FG004|Overall Study|Withdrawal by Subject|0|||
146071021|NCT02687191|526778868|FG005|Overall Study|Withdrawal by Subject|0|||
146071022|NCT00476008|526778869|FG000|Overall Study|Adverse Event|4|||
146071023|NCT00476008|526778870|FG001|Overall Study|Adverse Event|4|||
146071024|NCT00476008|526778869|FG000|Overall Study|Placebo concerns|2|||
146071025|NCT00476008|526778870|FG001|Overall Study|Placebo concerns|2|||
146071026|NCT00476008|526778869|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
146071027|NCT00476008|526778870|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
146071028|NCT00476008|526778869|FG000|Overall Study|Withdrawal by Subject|0|||
146408888|NCT03989115|528004295|FG006|Overall Study|Withdrawal by Subject|0|||
146408889|NCT03989115|528004296|FG007|Overall Study|Withdrawal by Subject|0|||
146408890|NCT03989115|528004289|FG000|Overall Study|Sponsor decision to terminate the study|1|||
146408891|NCT03989115|528004290|FG001|Overall Study|Sponsor decision to terminate the study|1|||
146408892|NCT03989115|528004291|FG002|Overall Study|Sponsor decision to terminate the study|0|||
146408893|NCT03989115|528004292|FG003|Overall Study|Sponsor decision to terminate the study|1|||
146408894|NCT03989115|528004293|FG004|Overall Study|Sponsor decision to terminate the study|11|||
146408895|NCT03989115|528004294|FG005|Overall Study|Sponsor decision to terminate the study|0|||
146408896|NCT03989115|528004295|FG006|Overall Study|Sponsor decision to terminate the study|2|||
146408897|NCT03989115|528004296|FG007|Overall Study|Sponsor decision to terminate the study|1|||
146408898|NCT03989115|528004289|FG000|Overall Study|Lost to Follow-up|2|||
146408899|NCT03989115|528004290|FG001|Overall Study|Lost to Follow-up|0|||
146408900|NCT03989115|528004291|FG002|Overall Study|Lost to Follow-up|0|||
146408901|NCT03989115|528004292|FG003|Overall Study|Lost to Follow-up|0|||
146408902|NCT03989115|528004293|FG004|Overall Study|Lost to Follow-up|1|||
146408903|NCT03989115|528004294|FG005|Overall Study|Lost to Follow-up|0|||
146408904|NCT03989115|528004295|FG006|Overall Study|Lost to Follow-up|0|||
146408905|NCT03989115|528004296|FG007|Overall Study|Lost to Follow-up|0|||
146408906|NCT03989115|528004289|FG000|Overall Study|Death|2|||
146408907|NCT03989115|528004290|FG001|Overall Study|Death|2|||
146408908|NCT03989115|528004291|FG002|Overall Study|Death|9|||
146408909|NCT03989115|528004292|FG003|Overall Study|Death|6|||
146408910|NCT03989115|528004293|FG004|Overall Study|Death|31|||
146408911|NCT03989115|528004294|FG005|Overall Study|Death|6|||
146408912|NCT03989115|528004295|FG006|Overall Study|Death|2|||
146408913|NCT03989115|528004296|FG007|Overall Study|Death|3|||
146408914|NCT03989115|528004289|FG000|Overall Study|Other|1|||
146408915|NCT03989115|528004290|FG001|Overall Study|Other|2|||
146408916|NCT03989115|528004291|FG002|Overall Study|Other|0|||
146408917|NCT03989115|528004292|FG003|Overall Study|Other|0|||
146408918|NCT03989115|528004293|FG004|Overall Study|Other|5|||
146408919|NCT03989115|528004294|FG005|Overall Study|Other|0|||
146408920|NCT03989115|528004295|FG006|Overall Study|Other|0|||
146408921|NCT03989115|528004296|FG007|Overall Study|Other|0|||
146408922|NCT02354976|528004307|FG000|Overall Study|Other - reason not specified|1|||
146408923|NCT02354976|528004308|FG001|Overall Study|Other - reason not specified|0|||
146408924|NCT02354976|528004309|FG002|Overall Study|Other - reason not specified|1|||
146408925|NCT02354976|528004307|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
146408926|NCT02354976|528004308|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
146408927|NCT02354976|528004309|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
146408928|NCT02354976|528004307|FG000|Overall Study|Adverse Event|1|||
146408929|NCT02354976|528004308|FG001|Overall Study|Adverse Event|0|||
146408930|NCT02354976|528004309|FG002|Overall Study|Adverse Event|2|||
146408931|NCT03118765|528004310|FG000|Overall Study|Withdrawal by Subject|0|||
146408932|NCT03118765|528004311|FG001|Overall Study|Withdrawal by Subject|0|||
146408933|NCT03118765|528004312|FG002|Overall Study|Withdrawal by Subject|1|||
146408934|NCT03118765|528004313|FG003|Overall Study|Withdrawal by Subject|0|||
146408935|NCT03118765|528004314|FG004|Overall Study|Withdrawal by Subject|0|||
146408936|NCT03118765|528004310|FG000|Overall Study|Adverse Event|1|||
146408937|NCT03118765|528004311|FG001|Overall Study|Adverse Event|1|||
146408938|NCT03118765|528004312|FG002|Overall Study|Adverse Event|1|||
146408939|NCT03118765|528004313|FG003|Overall Study|Adverse Event|1|||
146408940|NCT03118765|528004314|FG004|Overall Study|Adverse Event|1|||
146408941|NCT03118765|528004310|FG000|Overall Study|Non compliance with Study Procedures|0|||
146408942|NCT03118765|528004311|FG001|Overall Study|Non compliance with Study Procedures|0|||
146172091|NCT05096208|527143349|FG000|Overall Study|Lost to Follow-up|3|||
146172092|NCT05096208|527143350|FG001|Overall Study|Lost to Follow-up|5|||
146172093|NCT05096208|527143351|FG002|Overall Study|Lost to Follow-up|5|||
146172094|NCT05096208|527143352|FG003|Overall Study|Lost to Follow-up|2|||
146172095|NCT05096208|527143349|FG000|Overall Study|Withdrawal by Subject|0|||
146172096|NCT05096208|527143350|FG001|Overall Study|Withdrawal by Subject|1|||
146172097|NCT05096208|527143351|FG002|Overall Study|Withdrawal by Subject|2|||
146172098|NCT05096208|527143352|FG003|Overall Study|Withdrawal by Subject|3|||
146172099|NCT05096208|527143349|FG000|Overall Study|No longer met eligibility criteria|1|||
146172100|NCT05096208|527143350|FG001|Overall Study|No longer met eligibility criteria|0|||
146172101|NCT05096208|527143351|FG002|Overall Study|No longer met eligibility criteria|0|||
146172102|NCT05096208|527143352|FG003|Overall Study|No longer met eligibility criteria|0|||
146172103|NCT05096208|527143349|FG000|Overall Study|Other|0|||
146408943|NCT03118765|528004312|FG002|Overall Study|Non compliance with Study Procedures|0|||
146408944|NCT03118765|528004313|FG003|Overall Study|Non compliance with Study Procedures|1|||
146408945|NCT03118765|528004314|FG004|Overall Study|Non compliance with Study Procedures|0|||
146408946|NCT03118765|528004310|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146408947|NCT03118765|528004311|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
146408948|NCT03118765|528004312|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
146172104|NCT05096208|527143350|FG001|Overall Study|Other|0|||
146071029|NCT00476008|526778870|FG001|Overall Study|Withdrawal by Subject|1|||
146071030|NCT00476008|526778869|FG000|Overall Study|Death|1|||
146071031|NCT00476008|526778870|FG001|Overall Study|Death|0|||
146071032|NCT01227018|526778871|FG000|Overall Study|Disease progression|9|||
146071033|NCT01227018|526778871|FG000|Overall Study|Toxicity|2|||
146071034|NCT01227018|526778871|FG000|Overall Study|Withdrew after beginning treatment|4|||
146071035|NCT02948634|526778872|FG000|Overall Study|Lack of efficacy and study suspended|10|||
146071036|NCT02948634|526778873|FG001|Overall Study|Lack of efficacy and study suspended|2|||
146071037|NCT00753649|526778876|FG000|Overall Study|Migrated/moved from study area|1|||
146071038|NCT00753649|526778877|FG001|Overall Study|Migrated/moved from study area|0|||
146071039|NCT00753649|526778876|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
146071040|NCT00753649|526778877|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
146071041|NCT00753649|526778876|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
146071042|NCT00753649|526778877|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
146071043|NCT00753649|526778876|FG000|Overall Study|Protocol Violation|2|||
146071044|NCT00753649|526778877|FG001|Overall Study|Protocol Violation|0|||
146071045|NCT00499616|526778878|FG000|Overall Study|Death|1|||
146071046|NCT00499616|526778879|FG001|Overall Study|Death|5|||
146071047|NCT00499616|526778880|FG002|Overall Study|Death|3|||
146071048|NCT00499616|526778881|FG003|Overall Study|Death|1|||
146071049|NCT00499616|526778878|FG000|Overall Study|Lack of Efficacy|5|||
146071050|NCT00499616|526778879|FG001|Overall Study|Lack of Efficacy|0|||
146071051|NCT00499616|526778880|FG002|Overall Study|Lack of Efficacy|19|||
146071052|NCT00499616|526778881|FG003|Overall Study|Lack of Efficacy|0|||
146071053|NCT00499616|526778878|FG000|Overall Study|Lost to Follow-up|0|||
146071054|NCT00499616|526778879|FG001|Overall Study|Lost to Follow-up|0|||
146071055|NCT00499616|526778880|FG002|Overall Study|Lost to Follow-up|1|||
146071056|NCT00499616|526778881|FG003|Overall Study|Lost to Follow-up|0|||
146071057|NCT00499616|526778878|FG000|Overall Study|Physician Decision|6|||
146071058|NCT00499616|526778879|FG001|Overall Study|Physician Decision|16|||
146071059|NCT00499616|526778880|FG002|Overall Study|Physician Decision|9|||
146071060|NCT00499616|526778881|FG003|Overall Study|Physician Decision|0|||
146071061|NCT00499616|526778878|FG000|Overall Study|Withdrawal by Subject|1|||
146071062|NCT00499616|526778879|FG001|Overall Study|Withdrawal by Subject|0|||
146071063|NCT00499616|526778880|FG002|Overall Study|Withdrawal by Subject|1|||
146071064|NCT00499616|526778881|FG003|Overall Study|Withdrawal by Subject|0|||
146071065|NCT00499616|526778878|FG000|Overall Study|Ineligible|1|||
146071066|NCT00499616|526778879|FG001|Overall Study|Ineligible|2|||
146071067|NCT00499616|526778880|FG002|Overall Study|Ineligible|0|||
146071068|NCT00499616|526778881|FG003|Overall Study|Ineligible|15|||
146071069|NCT00499616|526778878|FG000|Overall Study|Not evaluable|0|||
146071070|NCT00499616|526778879|FG001|Overall Study|Not evaluable|0|||
146071071|NCT00499616|526778880|FG002|Overall Study|Not evaluable|0|||
146071072|NCT00499616|526778881|FG003|Overall Study|Not evaluable|41|||
146071073|NCT00499616|526778878|FG000|Overall Study|Patient/Parent Refusal|1|||
146071074|NCT00499616|526778879|FG001|Overall Study|Patient/Parent Refusal|5|||
146071075|NCT00499616|526778880|FG002|Overall Study|Patient/Parent Refusal|3|||
146071076|NCT00499616|526778881|FG003|Overall Study|Patient/Parent Refusal|0|||
146071077|NCT01864603|526778883|FG000|Stage 2|DSMB design modification|86056|||
146071078|NCT01864603|526778884|FG001|Stage 2|DSMB design modification|92558|||
146071079|NCT03830892|526778887|FG000|Overall Study|Physician Decision|2|||
146071080|NCT03830892|526778888|FG001|Overall Study|Physician Decision|3|||
146071081|NCT03830892|526778887|FG000|Overall Study|Study terminated due to COVID|4|||
146071082|NCT03830892|526778888|FG001|Overall Study|Study terminated due to COVID|0|||
146071083|NCT03830892|526778887|FG000|Overall Study|Protocol Violation|0|||
146071084|NCT03830892|526778888|FG001|Overall Study|Protocol Violation|1|||
146071085|NCT03830892|526778887|FG000|Overall Study|Withdrawal by Subject|0|||
146071086|NCT03830892|526778888|FG001|Overall Study|Withdrawal by Subject|2|||
146071087|NCT00330967|526778889|FG000|Overall Study|Withdrawal by Subject|0|||
146071088|NCT00330967|526778890|FG001|Overall Study|Withdrawal by Subject|5|||
146071089|NCT00330967|526778889|FG000|Overall Study|Physician Decision|0|||
146071090|NCT00330967|526778890|FG001|Overall Study|Physician Decision|9|||
146071091|NCT00337675|526778891|FG000|Overall Study|Adverse Event|10|||
146071092|NCT00337675|526778892|FG001|Overall Study|Adverse Event|9|||
146071093|NCT00337675|526778893|FG002|Overall Study|Adverse Event|19|||
146071094|NCT00337675|526778891|FG000|Overall Study|Lack of Efficacy|10|||
146071095|NCT00337675|526778892|FG001|Overall Study|Lack of Efficacy|7|||
146071096|NCT00337675|526778893|FG002|Overall Study|Lack of Efficacy|9|||
146071097|NCT00337675|526778891|FG000|Overall Study|Lost to Follow-up|22|||
146071098|NCT00337675|526778892|FG001|Overall Study|Lost to Follow-up|19|||
146071099|NCT00337675|526778893|FG002|Overall Study|Lost to Follow-up|17|||
146071100|NCT00337675|526778891|FG000|Overall Study|Physician Decision|9|||
146071101|NCT00337675|526778892|FG001|Overall Study|Physician Decision|17|||
146071102|NCT00337675|526778893|FG002|Overall Study|Physician Decision|14|||
146071103|NCT00337675|526778891|FG000|Overall Study|Protocol Violation|21|||
146071104|NCT00337675|526778892|FG001|Overall Study|Protocol Violation|24|||
146071105|NCT00337675|526778893|FG002|Overall Study|Protocol Violation|19|||
146071106|NCT00337675|526778891|FG000|Overall Study|Withdrawal by Subject|25|||
146071107|NCT00337675|526778892|FG001|Overall Study|Withdrawal by Subject|25|||
146071108|NCT00337675|526778893|FG002|Overall Study|Withdrawal by Subject|19|||
146071109|NCT00337675|526778891|FG000|Overall Study|Progressive Disease|0|||
146071110|NCT00337675|526778892|FG001|Overall Study|Progressive Disease|2|||
146071111|NCT00337675|526778893|FG002|Overall Study|Progressive Disease|0|||
146071112|NCT00337675|526778891|FG000|Overall Study|Trial Terminated|0|||
146071113|NCT00337675|526778892|FG001|Overall Study|Trial Terminated|0|||
146071114|NCT00337675|526778893|FG002|Overall Study|Trial Terminated|2|||
146071115|NCT04269265|526778894|FG000|Overall Study|Physician Decision|1|||
146071116|NCT04269265|526778894|FG000|Overall Study|Withdrawal by Subject|1|||
146071117|NCT04269265|526778894|FG000|Overall Study|Overenrolled (sample size reached)|4|||
146071118|NCT04439136|526778895|FG000|Overall Study|Ineligible|1|||
146071119|NCT04439136|526778895|FG000|Overall Study|Never Started Treatment|2|||
146071120|NCT04439136|526778895|FG000|Overall Study|Adverse Event|4|||
146071121|NCT04439136|526778895|FG000|Overall Study|Death|3|||
146071122|NCT04439136|526778895|FG000|Overall Study|Disease Progression|27|||
146071123|NCT04439136|526778895|FG000|Overall Study|Alternative Therapy|1|||
146071124|NCT04439136|526778895|FG000|Overall Study|Increased Tumor Burden|1|||
146071125|NCT04439136|526778895|FG000|Overall Study|Symptomatic Detrioration|1|||
146071126|NCT02578706|526778898|FG000|Overall Study|Withdrawal by Subject|1|||
146071127|NCT02578706|526778899|FG001|Overall Study|Withdrawal by Subject|0|||
146071128|NCT02578706|526778900|FG002|Overall Study|Withdrawal by Subject|0|||
146071129|NCT02578706|526778898|FG000|Overall Study|Lost to Follow-up|0|||
146071130|NCT02578706|526778899|FG001|Overall Study|Lost to Follow-up|4|||
146071131|NCT02578706|526778900|FG002|Overall Study|Lost to Follow-up|0|||
146071132|NCT02578706|526778898|FG000|Overall Study|Physician Decision|0|||
146071133|NCT02578706|526778899|FG001|Overall Study|Physician Decision|1|||
146071134|NCT02578706|526778900|FG002|Overall Study|Physician Decision|0|||
146071135|NCT04849559|526778903|FG000|Overall Study|Withdrawal by Subject|2|||
146071136|NCT04849559|526778904|FG001|Overall Study|Withdrawal by Subject|1|||
146071137|NCT02910986|526778910|FG000|Overall Study|non-Latina|14|||
146071138|NCT02910986|526778911|FG001|Overall Study|non-Latina|13|||
146071139|NCT02910986|526778912|FG002|Overall Study|non-Latina|12|||
146071140|NCT02910986|526778910|FG000|Overall Study|Failure to return T! survey|72|||
146071141|NCT02910986|526778911|FG001|Overall Study|Failure to return T! survey|84|||
146071142|NCT02910986|526778912|FG002|Overall Study|Failure to return T! survey|72|||
146071143|NCT02910986|526778910|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
146071144|NCT02910986|526778911|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
146071145|NCT02910986|526778912|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
146071146|NCT02910986|526778910|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
146071147|NCT02910986|526778911|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
146071148|NCT02910986|526778912|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
146071149|NCT01662102|526778919|FG000|Overall Study|Sponsor's decision|1|||
146071150|NCT01662102|526778920|FG001|Overall Study|Sponsor's decision|0|||
146071151|NCT02586207|526778921|FG000|Overall Study|Physician Decision|1|||
146071152|NCT02586207|526778921|FG000|Overall Study|Withdrawal by Subject|1|||
146071153|NCT03527732|526778922|FG000|Overall Study|Lost to Follow-up|21|||
146071154|NCT03527732|526778923|FG001|Overall Study|Lost to Follow-up|23|||
146071155|NCT03527732|526778924|FG002|Overall Study|Lost to Follow-up|80|||
146071156|NCT03527732|526778925|FG003|Overall Study|Lost to Follow-up|62|||
146071157|NCT03527732|526778926|FG004|Overall Study|Lost to Follow-up|12|||
146071158|NCT03527732|526778927|FG005|Overall Study|Lost to Follow-up|20|||
146071159|NCT01262989|526778928|FG000|Period 1|Lost to Follow-up|1|||
146071160|NCT01262989|526778929|FG001|Period 1|Lost to Follow-up|1|||
146071161|NCT01262989|526778928|FG000|Period 1|Intercurrent disease|0|||
146071162|NCT01262989|526778929|FG001|Period 1|Intercurrent disease|1|||
146071163|NCT01262989|526778928|FG000|Period 1|Positive answer for exclusion criteria|0|||
146071164|NCT01262989|526778929|FG001|Period 1|Positive answer for exclusion criteria|1|||
146071165|NCT01262989|526778928|FG000|Period 2|Intercurrent disease|0|||
146071166|NCT01262989|526778929|FG001|Period 2|Intercurrent disease|1|||
146172105|NCT05096208|527143351|FG002|Overall Study|Other|1|||
146172106|NCT05096208|527143352|FG003|Overall Study|Other|0|||
146172107|NCT00782496|527143353|FG000|Overall Study|Lost to Follow-up|14|||
146172108|NCT00782496|527143354|FG001|Overall Study|Lost to Follow-up|15|||
146172109|NCT00117156|527143358|FG000|Overall Study|Adverse Event|9|||
146172110|NCT00117156|527143358|FG000|Overall Study|Physician Decision|1|||
146172111|NCT00117156|527143358|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
146172112|NCT01919970|527143359|FG000|Overall Study|Withdrawal by Subject|3|||
146172113|NCT01919970|527143360|FG001|Overall Study|Withdrawal by Subject|0|||
146172114|NCT04043962|527143361|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
146172115|NCT04043962|527143361|FG000|Post-Treatment|Withdrawal by Subject|5|||
146071177|NCT00470275|526778932|FG000|Overall Study|Death|1|||
146071178|NCT00470275|526778932|FG000|Overall Study|Lack of Efficacy|7|||
146071179|NCT00470275|526778932|FG000|Overall Study|Withdrawal by Subject|2|||
146071180|NCT03048578|526778933|FG000|Overall Study|Withdrawal by Subject|5|||
146071181|NCT03048578|526778934|FG001|Overall Study|Withdrawal by Subject|6|||
146071182|NCT03048578|526778933|FG000|Overall Study|Lost to Follow-up|22|||
146071183|NCT03048578|526778934|FG001|Overall Study|Lost to Follow-up|10|||
146071184|NCT03048578|526778933|FG000|Overall Study|Adverse Event|1|||
146071185|NCT03048578|526778934|FG001|Overall Study|Adverse Event|2|||
146071186|NCT03048578|526778933|FG000|Overall Study|Terminated|3|||
146071187|NCT03048578|526778934|FG001|Overall Study|Terminated|2|||
146071188|NCT00526071|526778935|FG000|Overall Study|Adverse Event|1|||
146071189|NCT00526071|526778935|FG000|Overall Study|Withdrawal by Subject|1|||
146071190|NCT00526071|526778935|FG000|Overall Study|Lack of Response to Study Drug|4|||
146071191|NCT03306173|526778938|FG000|Overall Study|Lost to Follow-up|16|||
146071192|NCT03306173|526778939|FG001|Overall Study|Lost to Follow-up|23|||
146071193|NCT03306173|526778938|FG000|Overall Study|Withdrawal by Subject|4|||
146071194|NCT03306173|526778939|FG001|Overall Study|Withdrawal by Subject|3|||
146071195|NCT03306173|526778938|FG000|Overall Study|Discontinued|4|||
146071196|NCT03306173|526778939|FG001|Overall Study|Discontinued|4|||
146071197|NCT01339052|526778946|FG000|Overall Study|Disease progression|13|||
146071198|NCT01339052|526778947|FG001|Overall Study|Disease progression|46|||
146071199|NCT01339052|526778946|FG000|Overall Study|Adverse Event|1|||
146071200|NCT01339052|526778947|FG001|Overall Study|Adverse Event|1|||
146071201|NCT01339052|526778946|FG000|Overall Study|Withdrawal by Subject|0|||
146071202|NCT01339052|526778947|FG001|Overall Study|Withdrawal by Subject|3|||
146071203|NCT01339052|526778946|FG000|Overall Study|Physician Decision|1|||
146071204|NCT01339052|526778947|FG001|Overall Study|Physician Decision|0|||
146071205|NCT02637037|526778948|FG000|Overall Study|Positive drug screen at admission|1|||
146071206|NCT02637037|526778949|FG001|Overall Study|Positive drug screen at admission|0|||
146071207|NCT02637037|526778948|FG000|Overall Study|Withdrawal by Subject|2|||
146071208|NCT02637037|526778949|FG001|Overall Study|Withdrawal by Subject|1|||
146071209|NCT02637037|526778948|FG000|Overall Study|Adverse Event|1|||
146071210|NCT02637037|526778949|FG001|Overall Study|Adverse Event|0|||
146071211|NCT02023697|526778952|FG000|Treatment Period|Radiological progression|13|||
146071212|NCT02023697|526778953|FG001|Treatment Period|Radiological progression|17|||
146071213|NCT02023697|526778954|FG002|Treatment Period|Radiological progression|26|||
146071214|NCT02023697|526778952|FG000|Treatment Period|Never Treated|5|||
146071215|NCT02023697|526778953|FG001|Treatment Period|Never Treated|6|||
146071216|NCT02023697|526778954|FG002|Treatment Period|Never Treated|10|||
146071217|NCT02023697|526778952|FG000|Treatment Period|Adverse Event|13|||
146071218|NCT02023697|526778953|FG001|Treatment Period|Adverse Event|25|||
146071219|NCT02023697|526778954|FG002|Treatment Period|Adverse Event|23|||
146071220|NCT02023697|526778952|FG000|Treatment Period|Logistical difficulties|1|||
146071221|NCT02023697|526778953|FG001|Treatment Period|Logistical difficulties|1|||
146071222|NCT02023697|526778954|FG002|Treatment Period|Logistical difficulties|1|||
146071223|NCT02023697|526778952|FG000|Treatment Period|Clinical progression|10|||
146071224|NCT02023697|526778953|FG001|Treatment Period|Clinical progression|8|||
146071225|NCT02023697|526778954|FG002|Treatment Period|Clinical progression|28|||
146071226|NCT02023697|526778952|FG000|Treatment Period|Withdrawal by Subject|4|||
146071227|NCT02023697|526778953|FG001|Treatment Period|Withdrawal by Subject|5|||
146071228|NCT02023697|526778954|FG002|Treatment Period|Withdrawal by Subject|13|||
146071229|NCT02023697|526778952|FG000|Treatment Period|Safety outcome reached|0|||
146071230|NCT02023697|526778953|FG001|Treatment Period|Safety outcome reached|1|||
146071231|NCT02023697|526778954|FG002|Treatment Period|Safety outcome reached|0|||
146071232|NCT02023697|526778952|FG000|Treatment Period|Physician Decision|0|||
146071233|NCT02023697|526778953|FG001|Treatment Period|Physician Decision|0|||
146071234|NCT02023697|526778954|FG002|Treatment Period|Physician Decision|1|||
146071235|NCT02023697|526778952|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
146071236|NCT02023697|526778953|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
146408949|NCT03118765|528004313|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146408950|NCT03118765|528004314|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
146408951|NCT03118765|528004310|FG000|Overall Study|COPD Exacerbation|1|||
146408952|NCT03118765|528004311|FG001|Overall Study|COPD Exacerbation|0|||
146408953|NCT03118765|528004312|FG002|Overall Study|COPD Exacerbation|0|||
146408954|NCT03118765|528004313|FG003|Overall Study|COPD Exacerbation|1|||
146408955|NCT03118765|528004314|FG004|Overall Study|COPD Exacerbation|0|||
146408956|NCT03118765|528004310|FG000|Overall Study|Lost to Follow-up|1|||
146408957|NCT03118765|528004311|FG001|Overall Study|Lost to Follow-up|0|||
146408958|NCT03118765|528004312|FG002|Overall Study|Lost to Follow-up|1|||
146408959|NCT03118765|528004313|FG003|Overall Study|Lost to Follow-up|0|||
146408960|NCT03118765|528004314|FG004|Overall Study|Lost to Follow-up|0|||
146408961|NCT03118765|528004310|FG000|Overall Study|Sponsor Decision|1|||
146408962|NCT03118765|528004311|FG001|Overall Study|Sponsor Decision|0|||
146071237|NCT02023697|526778954|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
146071238|NCT02023697|526778952|FG000|Active Follow-up Period|Lost to Follow-up|1|||
146071239|NCT02023697|526778953|FG001|Active Follow-up Period|Lost to Follow-up|1|||
146071240|NCT02023697|526778954|FG002|Active Follow-up Period|Lost to Follow-up|1|||
146071241|NCT02023697|526778952|FG000|Active Follow-up Period|Deterioration of general condition|1|||
146408963|NCT03118765|528004312|FG002|Overall Study|Sponsor Decision|1|||
146071242|NCT02023697|526778953|FG001|Active Follow-up Period|Deterioration of general condition|1|||
146071243|NCT02023697|526778954|FG002|Active Follow-up Period|Deterioration of general condition|1|||
146071244|NCT02023697|526778952|FG000|Active Follow-up Period|Other unspecified|2|||
146408964|NCT03118765|528004313|FG003|Overall Study|Sponsor Decision|0|||
146071245|NCT02023697|526778953|FG001|Active Follow-up Period|Other unspecified|0|||
146071246|NCT02023697|526778954|FG002|Active Follow-up Period|Other unspecified|1|||
146071247|NCT02023697|526778952|FG000|Active Follow-up Period|Clinical progression|0|||
146071248|NCT02023697|526778953|FG001|Active Follow-up Period|Clinical progression|2|||
146071249|NCT02023697|526778954|FG002|Active Follow-up Period|Clinical progression|1|||
146071250|NCT02023697|526778952|FG000|Active Follow-up Period|Radiological progression|0|||
146071251|NCT02023697|526778953|FG001|Active Follow-up Period|Radiological progression|0|||
146071252|NCT02023697|526778954|FG002|Active Follow-up Period|Radiological progression|1|||
146071253|NCT02023697|526778952|FG000|Active Follow-up Period|Death|83|||
146071254|NCT02023697|526778953|FG001|Active Follow-up Period|Death|82|||
146071255|NCT02023697|526778954|FG002|Active Follow-up Period|Death|87|||
146071256|NCT02023697|526778952|FG000|Long-term Follow-up Period|Death|9|||
146071257|NCT02023697|526778953|FG001|Long-term Follow-up Period|Death|6|||
146071258|NCT02023697|526778954|FG002|Long-term Follow-up Period|Death|4|||
146071259|NCT02023697|526778952|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
146071260|NCT02023697|526778953|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
146071261|NCT02023697|526778954|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
146071262|NCT02023697|526778952|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
146071263|NCT02023697|526778953|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
146071264|NCT02023697|526778954|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
146071265|NCT02023697|526778952|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
146071266|NCT02023697|526778953|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
146071267|NCT02023697|526778954|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
146071268|NCT02023697|526778952|FG000|Long-term Follow-up Period|Technical problems|0|||
146071269|NCT02023697|526778953|FG001|Long-term Follow-up Period|Technical problems|0|||
146071270|NCT02023697|526778954|FG002|Long-term Follow-up Period|Technical problems|1|||
146071271|NCT02023697|526778952|FG000|Long-term Follow-up Period|Other unspecified|6|||
146071272|NCT02023697|526778953|FG001|Long-term Follow-up Period|Other unspecified|3|||
146071273|NCT02023697|526778954|FG002|Long-term Follow-up Period|Other unspecified|5|||
146071274|NCT01469377|526778960|FG000|Overall Study|Protocol Deviation|7|||
146071275|NCT01469377|526778961|FG001|Overall Study|Protocol Deviation|10|||
146071276|NCT01469377|526778962|FG002|Overall Study|Protocol Deviation|10|||
146071277|NCT01469377|526778960|FG000|Overall Study|Lost to Follow-up|3|||
146071278|NCT01469377|526778961|FG001|Overall Study|Lost to Follow-up|2|||
146071279|NCT01469377|526778962|FG002|Overall Study|Lost to Follow-up|5|||
146071280|NCT01469377|526778960|FG000|Overall Study|Withdrawal of Consent|12|||
146071281|NCT01469377|526778961|FG001|Overall Study|Withdrawal of Consent|14|||
146071282|NCT01469377|526778962|FG002|Overall Study|Withdrawal of Consent|15|||
146071283|NCT01469377|526778960|FG000|Overall Study|Adverse Event|8|||
146071284|NCT01469377|526778961|FG001|Overall Study|Adverse Event|18|||
146071285|NCT01469377|526778962|FG002|Overall Study|Adverse Event|36|||
146071286|NCT01469377|526778960|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146071287|NCT01469377|526778961|FG001|Overall Study|Insufficient Therapeutic Response|4|||
146071288|NCT01469377|526778962|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146071289|NCT01469377|526778960|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146071290|NCT01469377|526778961|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146071291|NCT01469377|526778962|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146071292|NCT00714870|526778964|FG000|Overall Study|Lost to Follow-up|22|||
146071293|NCT00714870|526778965|FG001|Overall Study|Lost to Follow-up|5|||
146071294|NCT00714870|526778964|FG000|Overall Study|patient unable to come b/c back pain|1|||
146071295|NCT00714870|526778965|FG001|Overall Study|patient unable to come b/c back pain|0|||
146071296|NCT00714870|526778964|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
146071297|NCT00714870|526778965|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
146071298|NCT03399552|526778966|FG000|Overall Study|No evidence of disease|1|||
146071299|NCT03399552|526778966|FG000|Overall Study|Unevaluable|1|||
146071300|NCT02357368|526778967|FG000|Overall Study|Lost to Follow-up|0|||
146071301|NCT02357368|526778968|FG001|Overall Study|Lost to Follow-up|0|||
146071302|NCT02357368|526778969|FG002|Overall Study|Lost to Follow-up|0|||
146071303|NCT02357368|526778970|FG003|Overall Study|Lost to Follow-up|1|||
146071304|NCT02357368|526778967|FG000|Overall Study|Pregnancy|3|||
146071305|NCT02357368|526778968|FG001|Overall Study|Pregnancy|2|||
146071306|NCT02357368|526778969|FG002|Overall Study|Pregnancy|0|||
146172116|NCT04043962|527143361|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
146172117|NCT01987817|527143363|FG000|Overall Study|Adverse Event|4|||
146071307|NCT02357368|526778970|FG003|Overall Study|Pregnancy|0|||
146071308|NCT02357368|526778967|FG000|Overall Study|Withdrawal by Subject|3|||
146071309|NCT02357368|526778968|FG001|Overall Study|Withdrawal by Subject|1|||
146071310|NCT02357368|526778969|FG002|Overall Study|Withdrawal by Subject|1|||
146071311|NCT02357368|526778970|FG003|Overall Study|Withdrawal by Subject|2|||
146071312|NCT00611026|526778973|FG000|Randomized to Double-blind Treatment|Not treated|2|||
146071313|NCT00611026|526778974|FG001|Randomized to Double-blind Treatment|Not treated|1|||
146071314|NCT00611026|526778975|FG002|Randomized to Double-blind Treatment|Not treated|3|||
146071315|NCT00611026|526778973|FG000|Double-blind Treatment Period|Death|1|||
146408965|NCT03118765|528004314|FG004|Overall Study|Sponsor Decision|1|||
146071316|NCT00611026|526778974|FG001|Double-blind Treatment Period|Death|0|||
146071317|NCT00611026|526778975|FG002|Double-blind Treatment Period|Death|0|||
146071318|NCT00611026|526778973|FG000|Double-blind Treatment Period|Adverse Event|9|||
146071319|NCT00611026|526778974|FG001|Double-blind Treatment Period|Adverse Event|28|||
146071320|NCT00611026|526778975|FG002|Double-blind Treatment Period|Adverse Event|46|||
146071321|NCT00611026|526778973|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
146071322|NCT00611026|526778974|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
146071323|NCT00611026|526778975|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
146071324|NCT00611026|526778973|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
146071325|NCT00611026|526778974|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
146071326|NCT00611026|526778975|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
146071327|NCT00611026|526778973|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146071328|NCT00611026|526778974|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
146071329|NCT00611026|526778975|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
146071330|NCT00611026|526778973|FG000|Double-blind Treatment Period|Other|13|||
146071331|NCT00611026|526778974|FG001|Double-blind Treatment Period|Other|20|||
146071332|NCT00611026|526778975|FG002|Double-blind Treatment Period|Other|18|||
146071333|NCT01147874|526778977|FG000|Overall Study|Adverse Event|5|||
146071334|NCT01147874|526778977|FG000|Overall Study|Investigator's Request|1|||
146071335|NCT01147874|526778977|FG000|Overall Study|Lost to Follow-up|25|||
146071336|NCT01147874|526778977|FG000|Overall Study|Other|5|||
146071337|NCT01147874|526778977|FG000|Overall Study|Protocol Violation|5|||
146071338|NCT01147874|526778977|FG000|Overall Study|Sponsor's Decision|2|||
146071339|NCT01147874|526778977|FG000|Overall Study|Withdrawal by Subject|24|||
146071340|NCT02175030|526778985|FG000|Overall Study|Failed screen after consent|7|||
146071341|NCT02175030|526778986|FG001|Overall Study|Failed screen after consent|6|||
146071342|NCT02175030|526778985|FG000|Overall Study|Failed IUD Insertion|20|||
146071343|NCT02175030|526778986|FG001|Overall Study|Failed IUD Insertion|21|||
146071344|NCT02175030|526778985|FG000|Overall Study|Physician Decision|1|||
146071345|NCT02175030|526778986|FG001|Overall Study|Physician Decision|1|||
146071346|NCT02175030|526778985|FG000|Overall Study|Lost to Follow-up|6|||
146071347|NCT02175030|526778986|FG001|Overall Study|Lost to Follow-up|6|||
146071348|NCT02175030|526778985|FG000|Overall Study|Withdrawal by Subject|1|||
146071349|NCT02175030|526778986|FG001|Overall Study|Withdrawal by Subject|4|||
146071350|NCT02533453|526778987|FG000|Overall Study|Adverse Event|6|||
146071351|NCT02533453|526778987|FG000|Overall Study|Protocol Violation|1|||
146071352|NCT02533453|526778987|FG000|Overall Study|Withdrawal by Subject|2|||
146071353|NCT03892967|526778994|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
146071354|NCT03892967|526778995|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
146071355|NCT03892967|526778996|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
146071356|NCT03892967|526778997|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
146071357|NCT03892967|526778998|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
146071358|NCT03892967|526778994|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
146071359|NCT03892967|526778995|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
146071360|NCT03892967|526778996|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
146071361|NCT03892967|526778997|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
146071362|NCT03892967|526778998|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
146071363|NCT03892967|526778994|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
146071364|NCT03892967|526778995|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
146071365|NCT03892967|526778996|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
146071366|NCT03892967|526778997|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
146071367|NCT03892967|526778998|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
146071368|NCT03892967|526778994|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
146071369|NCT03892967|526778995|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
146071370|NCT03892967|526778996|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
146071371|NCT03892967|526778997|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
146071372|NCT03892967|526778998|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
146071373|NCT03892967|526778994|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
146071374|NCT03892967|526778995|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
146071375|NCT03892967|526778996|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
146071376|NCT03892967|526778997|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
146071377|NCT03892967|526778998|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
146071378|NCT03892967|526778994|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
146071379|NCT03892967|526778995|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
146071380|NCT03892967|526778996|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
146071381|NCT03892967|526778997|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
146071382|NCT03892967|526778998|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
146071383|NCT04434937|526778999|FG000|Overall Study|Death|4|||
146071384|NCT04434937|526778999|FG000|Overall Study|Withdrawal by Subject|1|||
146071385|NCT04434937|526778999|FG000|Overall Study|Transitioned to Rollover Study|19|||
146071386|NCT04434937|526778999|FG000|Overall Study|Progressive Disease|18|||
146071387|NCT03387085|526779004|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
146408966|NCT01612702|528004315|FG000|Overall Study|Protocol Violation|11|||
146408967|NCT01612702|528004316|FG001|Overall Study|Protocol Violation|11|||
146408968|NCT03674827|528004317|FG000|Treatment Phase|Adverse Event|0|||
146408969|NCT03674827|528004318|FG001|Treatment Phase|Adverse Event|0|||
146408970|NCT03674827|528004319|FG002|Treatment Phase|Adverse Event|0|||
146408971|NCT03674827|528004320|FG003|Treatment Phase|Adverse Event|0|||
146408972|NCT03674827|528004321|FG004|Treatment Phase|Adverse Event|0|||
146408973|NCT03674827|528004322|FG005|Treatment Phase|Adverse Event|2|||
146408974|NCT03674827|528004317|FG000|Treatment Phase|Death|2|||
146408975|NCT03674827|528004318|FG001|Treatment Phase|Death|0|||
146408976|NCT03674827|528004319|FG002|Treatment Phase|Death|0|||
146408977|NCT03674827|528004320|FG003|Treatment Phase|Death|0|||
146408978|NCT03674827|528004321|FG004|Treatment Phase|Death|1|||
146408979|NCT03674827|528004322|FG005|Treatment Phase|Death|0|||
146408980|NCT03674827|528004317|FG000|Treatment Phase|Progressive Disease|0|||
146408981|NCT03674827|528004318|FG001|Treatment Phase|Progressive Disease|4|||
146408982|NCT03674827|528004319|FG002|Treatment Phase|Progressive Disease|3|||
146408983|NCT03674827|528004320|FG003|Treatment Phase|Progressive Disease|4|||
146408984|NCT03674827|528004321|FG004|Treatment Phase|Progressive Disease|4|||
146408985|NCT03674827|528004322|FG005|Treatment Phase|Progressive Disease|9|||
146408986|NCT03674827|528004317|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
146408987|NCT03674827|528004318|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
146408988|NCT03674827|528004319|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
146408989|NCT03674827|528004320|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
146408990|NCT03674827|528004321|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
146408991|NCT03674827|528004322|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
146408992|NCT03674827|528004317|FG000|Treatment Phase|Withdrawal by Subject|0|||
146408993|NCT03674827|528004318|FG001|Treatment Phase|Withdrawal by Subject|0|||
146408994|NCT03674827|528004319|FG002|Treatment Phase|Withdrawal by Subject|0|||
146408995|NCT03674827|528004320|FG003|Treatment Phase|Withdrawal by Subject|0|||
146408996|NCT03674827|528004321|FG004|Treatment Phase|Withdrawal by Subject|0|||
146408997|NCT03674827|528004322|FG005|Treatment Phase|Withdrawal by Subject|1|||
146408998|NCT03674827|528004317|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
146408999|NCT03674827|528004318|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
146409000|NCT03674827|528004319|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
146409001|NCT03674827|528004320|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
146409002|NCT03674827|528004321|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
146409003|NCT03674827|528004322|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
146409004|NCT03674827|528004317|FG000|Treatment Phase|Other|0|||
146409005|NCT03674827|528004318|FG001|Treatment Phase|Other|1|||
146409006|NCT03674827|528004319|FG002|Treatment Phase|Other|0|||
146409007|NCT03674827|528004320|FG003|Treatment Phase|Other|0|||
146409008|NCT03674827|528004321|FG004|Treatment Phase|Other|0|||
146409009|NCT03674827|528004322|FG005|Treatment Phase|Other|1|||
146409010|NCT03674827|528004317|FG000|Long-Term Follow-up Phase|Death|2|||
146409011|NCT03674827|528004318|FG001|Long-Term Follow-up Phase|Death|4|||
146409012|NCT03674827|528004319|FG002|Long-Term Follow-up Phase|Death|2|||
146409013|NCT03674827|528004320|FG003|Long-Term Follow-up Phase|Death|3|||
146409014|NCT03674827|528004321|FG004|Long-Term Follow-up Phase|Death|2|||
146409015|NCT03674827|528004322|FG005|Long-Term Follow-up Phase|Death|6|||
146409016|NCT03674827|528004317|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
146409017|NCT03674827|528004318|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
146409018|NCT03674827|528004319|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
146409019|NCT03674827|528004320|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
146409020|NCT03674827|528004321|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
146409021|NCT03674827|528004322|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
146409022|NCT03674827|528004317|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146172118|NCT01987817|527143364|FG001|Overall Study|Adverse Event|0|||
146172119|NCT01987817|527143363|FG000|Overall Study|Withdrawal by Subject|1|||
146172120|NCT01987817|527143364|FG001|Overall Study|Withdrawal by Subject|1|||
146172121|NCT01987817|527143363|FG000|Overall Study|Physician Decision|1|||
146172122|NCT01987817|527143364|FG001|Overall Study|Physician Decision|0|||
146172123|NCT01576718|527143367|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
146172124|NCT01576718|527143368|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172125|NCT01576718|527143369|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172126|NCT01576718|527143370|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172127|NCT01576718|527143371|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172128|NCT01576718|527143372|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172129|NCT01576718|527143373|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146172130|NCT01576718|527143367|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
146172131|NCT01576718|527143368|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172132|NCT01576718|527143369|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172133|NCT01576718|527143370|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172134|NCT01576718|527143371|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172135|NCT01576718|527143372|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172136|NCT01576718|527143373|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146172137|NCT01576718|527143367|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
146172138|NCT01576718|527143368|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146172139|NCT01576718|527143369|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146172140|NCT01576718|527143370|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146172141|NCT01576718|527143371|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146071388|NCT04193189|526779005|FG000|Overall Study|Lost to Follow-up|9|||
146071389|NCT04193189|526779006|FG001|Overall Study|Lost to Follow-up|7|||
146071390|NCT04193189|526779007|FG002|Overall Study|Lost to Follow-up|9|||
146071391|NCT04193189|526779008|FG003|Overall Study|Lost to Follow-up|0|||
146071392|NCT04193189|526779005|FG000|Overall Study|Withdrawal by Subject|1|||
146071393|NCT04193189|526779006|FG001|Overall Study|Withdrawal by Subject|2|||
146071394|NCT04193189|526779007|FG002|Overall Study|Withdrawal by Subject|2|||
146071395|NCT04193189|526779008|FG003|Overall Study|Withdrawal by Subject|0|||
146071396|NCT04193189|526779005|FG000|Overall Study|Death|1|||
146071397|NCT04193189|526779006|FG001|Overall Study|Death|1|||
146071398|NCT04193189|526779007|FG002|Overall Study|Death|0|||
146071399|NCT04193189|526779008|FG003|Overall Study|Death|0|||
146071400|NCT04193189|526779005|FG000|Overall Study|Protocol Violation|0|||
146071401|NCT04193189|526779006|FG001|Overall Study|Protocol Violation|0|||
146071402|NCT04193189|526779007|FG002|Overall Study|Protocol Violation|0|||
146071403|NCT04193189|526779008|FG003|Overall Study|Protocol Violation|1|||
146071404|NCT01077050|526780828|FG000|Overall Study|Subjects signed ICF could not be located|1|||
146071405|NCT01077050|526780828|FG000|Overall Study|Screen failure|8|||
146071406|NCT01006291|526780834|FG000|Overall Study|Adverse Event|2|||
146071407|NCT01006291|526780835|FG001|Overall Study|Adverse Event|1|||
146071408|NCT01006291|526780836|FG002|Overall Study|Adverse Event|2|||
146071409|NCT01006291|526780834|FG000|Overall Study|Lack of Efficacy|2|||
146071410|NCT01006291|526780835|FG001|Overall Study|Lack of Efficacy|2|||
146071411|NCT01006291|526780836|FG002|Overall Study|Lack of Efficacy|1|||
146071412|NCT01006291|526780834|FG000|Overall Study|Protocol Violation|3|||
146071413|NCT01006291|526780835|FG001|Overall Study|Protocol Violation|3|||
146071414|NCT01006291|526780836|FG002|Overall Study|Protocol Violation|3|||
146071415|NCT01006291|526780834|FG000|Overall Study|Withdrawal criteria|5|||
146071416|NCT01006291|526780835|FG001|Overall Study|Withdrawal criteria|4|||
146071417|NCT01006291|526780836|FG002|Overall Study|Withdrawal criteria|4|||
146071418|NCT01006291|526780834|FG000|Overall Study|Other|14|||
146071419|NCT01006291|526780835|FG001|Overall Study|Other|14|||
146071420|NCT01006291|526780836|FG002|Overall Study|Other|17|||
146071421|NCT00684060|526780837|FG000|Overall Study|Lost to Follow-up|1|||
146071422|NCT00684060|526780838|FG001|Overall Study|Lost to Follow-up|0|||
146071423|NCT00684060|526780837|FG000|Overall Study|New stenosis identified|1|||
146071424|NCT00684060|526780838|FG001|Overall Study|New stenosis identified|0|||
146071425|NCT00684060|526780837|FG000|Overall Study|Unable to collect MRI|1|||
146071426|NCT00684060|526780838|FG001|Overall Study|Unable to collect MRI|2|||
146071427|NCT00684060|526780837|FG000|Overall Study|Death|0|||
146071428|NCT00684060|526780838|FG001|Overall Study|Death|1|||
146071429|NCT00702715|526780839|FG000|Overall Study|Lost to Follow-up|1|||
146071430|NCT00702715|526780840|FG001|Overall Study|Lost to Follow-up|0|||
146071431|NCT01865552|526780841|FG000|Period 1|Adverse Event|1|||
146071432|NCT01865552|526780842|FG001|Period 1|Adverse Event|0|||
146071433|NCT01865552|526780843|FG002|Period 1|Adverse Event|0|||
146071434|NCT01865552|526780844|FG003|Period 1|Adverse Event|1|||
146071435|NCT01865552|526780845|FG004|Period 1|Adverse Event|1|||
146071436|NCT01865552|526780846|FG005|Period 1|Adverse Event|1|||
146071437|NCT01865552|526780841|FG000|Period 1|Pathological lab|0|||
146071438|NCT01865552|526780842|FG001|Period 1|Pathological lab|0|||
146071439|NCT01865552|526780843|FG002|Period 1|Pathological lab|0|||
146071440|NCT01865552|526780844|FG003|Period 1|Pathological lab|0|||
146071441|NCT01865552|526780845|FG004|Period 1|Pathological lab|1|||
146071442|NCT01865552|526780846|FG005|Period 1|Pathological lab|0|||
146071443|NCT01865552|526780841|FG000|Period 1|Other|0|||
146071444|NCT01865552|526780842|FG001|Period 1|Other|0|||
146071445|NCT01865552|526780843|FG002|Period 1|Other|0|||
146071446|NCT01865552|526780844|FG003|Period 1|Other|0|||
146071447|NCT01865552|526780845|FG004|Period 1|Other|1|||
146071448|NCT01865552|526780846|FG005|Period 1|Other|0|||
146071449|NCT03079102|526780847|FG000|Overall Study|Physician Decision|0|||
146071450|NCT03079102|526780848|FG001|Overall Study|Physician Decision|1|||
146071451|NCT02923921|526780849|FG000|Overall Study|Sponsor Decision|39|||
146071452|NCT02923921|526780850|FG001|Overall Study|Sponsor Decision|38|||
146071453|NCT02923921|526780849|FG000|Overall Study|Lost to Follow-up|1|||
146071454|NCT02923921|526780850|FG001|Overall Study|Lost to Follow-up|0|||
146071455|NCT02923921|526780849|FG000|Overall Study|Withdrawal by Subject|6|||
146071456|NCT02923921|526780850|FG001|Overall Study|Withdrawal by Subject|13|||
146071457|NCT02923921|526780849|FG000|Overall Study|Unknown, Not Collected|7|||
146071458|NCT02923921|526780850|FG001|Overall Study|Unknown, Not Collected|6|||
146071459|NCT00854113|526780851|FG000|Overall Study|Adverse Event|0|||
146071460|NCT00854113|526780852|FG001|Overall Study|Adverse Event|0|||
146071461|NCT00854113|526780853|FG002|Overall Study|Adverse Event|0|||
146071462|NCT00854113|526780854|FG003|Overall Study|Adverse Event|0|||
146071463|NCT00854113|526780855|FG004|Overall Study|Adverse Event|0|||
146071464|NCT00854113|526780856|FG005|Overall Study|Adverse Event|0|||
146071465|NCT00854113|526780857|FG006|Overall Study|Adverse Event|0|||
146071466|NCT00854113|526780858|FG007|Overall Study|Adverse Event|2|||
146071467|NCT00854113|526780859|FG008|Overall Study|Adverse Event|0|||
146071468|NCT00854113|526780860|FG009|Overall Study|Adverse Event|0|||
146071469|NCT00854113|526780861|FG010|Overall Study|Adverse Event|0|||
146071470|NCT00854113|526780851|FG000|Overall Study|Withdrawal by Subject|0|||
146071471|NCT00854113|526780852|FG001|Overall Study|Withdrawal by Subject|0|||
146071472|NCT00854113|526780853|FG002|Overall Study|Withdrawal by Subject|0|||
146071473|NCT00854113|526780854|FG003|Overall Study|Withdrawal by Subject|0|||
146071474|NCT00854113|526780855|FG004|Overall Study|Withdrawal by Subject|0|||
146071475|NCT00854113|526780856|FG005|Overall Study|Withdrawal by Subject|0|||
146071476|NCT00854113|526780857|FG006|Overall Study|Withdrawal by Subject|0|||
146071477|NCT00854113|526780858|FG007|Overall Study|Withdrawal by Subject|1|||
146071478|NCT00854113|526780859|FG008|Overall Study|Withdrawal by Subject|1|||
146071479|NCT00854113|526780860|FG009|Overall Study|Withdrawal by Subject|0|||
146071480|NCT00854113|526780861|FG010|Overall Study|Withdrawal by Subject|0|||
146071481|NCT01250145|526780864|FG000|Overall Study|Adverse Event|2|||
146071482|NCT01250145|526780865|FG001|Overall Study|Adverse Event|1|||
146071483|NCT01250145|526780864|FG000|Overall Study|Withdrawal by Subject|0|||
146071484|NCT01250145|526780865|FG001|Overall Study|Withdrawal by Subject|4|||
146071485|NCT02741518|526780866|FG000|Overall Study|Withdrawal by Subject|1|||
146071486|NCT02741518|526780867|FG001|Overall Study|Withdrawal by Subject|1|||
146071487|NCT03180840|526780868|FG000|Overall Study|Withdrawal by Subject|1|||
146071488|NCT01788358|526780874|FG000|Overall Study|Other|11|||
146071489|NCT01788358|526780874|FG000|Overall Study|Logistical difficulties|1|||
146071490|NCT01788358|526780874|FG000|Overall Study|Lost to Follow-up|5|||
146071491|NCT01788358|526780874|FG000|Overall Study|Protocol Violation|3|||
146071492|NCT01788358|526780874|FG000|Overall Study|Withdrawal by Subject|26|||
146071493|NCT01788358|526780874|FG000|Overall Study|Lack of Efficacy|1|||
146071494|NCT01788358|526780874|FG000|Overall Study|Adverse Event|51|||
146071495|NCT01168219|526780875|FG000|Overall Study|off study before starting treatment|2|||
146071496|NCT01168219|526780875|FG000|Overall Study|withdrew before transplant|1|||
146071497|NCT01168219|526780875|FG000|Overall Study|ineligible due to CML|2|||
146071498|NCT02563067|526780878|FG000|Overall Study|Subject/guardian decision|14|||
146071499|NCT02563067|526780879|FG001|Overall Study|Subject/guardian decision|20|||
146071500|NCT02563067|526780880|FG002|Overall Study|Subject/guardian decision|16|||
146071501|NCT02563067|526780878|FG000|Overall Study|Physician Decision|0|||
146071502|NCT02563067|526780879|FG001|Overall Study|Physician Decision|1|||
146071503|NCT02563067|526780880|FG002|Overall Study|Physician Decision|3|||
146071504|NCT02563067|526780878|FG000|Overall Study|Lost to Follow-up|1|||
146071505|NCT02563067|526780879|FG001|Overall Study|Lost to Follow-up|2|||
146071506|NCT02563067|526780880|FG002|Overall Study|Lost to Follow-up|0|||
146071507|NCT02563067|526780878|FG000|Overall Study|Technical problems|0|||
146071508|NCT02563067|526780879|FG001|Overall Study|Technical problems|1|||
146071509|NCT02563067|526780880|FG002|Overall Study|Technical problems|0|||
146071510|NCT02563067|526780878|FG000|Overall Study|Lack of Efficacy|1|||
146071511|NCT02563067|526780879|FG001|Overall Study|Lack of Efficacy|0|||
146071512|NCT02563067|526780880|FG002|Overall Study|Lack of Efficacy|0|||
146071513|NCT02563067|526780878|FG000|Overall Study|Death|0|||
146071514|NCT02563067|526780879|FG001|Overall Study|Death|1|||
146071515|NCT02563067|526780880|FG002|Overall Study|Death|1|||
146071516|NCT02563067|526780878|FG000|Overall Study|Adverse Event|2|||
146071517|NCT02563067|526780879|FG001|Overall Study|Adverse Event|1|||
146071518|NCT02563067|526780880|FG002|Overall Study|Adverse Event|0|||
146172142|NCT01576718|527143372|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146172143|NCT01576718|527143373|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146172144|NCT01576718|527143367|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
146172145|NCT01576718|527143368|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172146|NCT01576718|527143369|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172147|NCT01576718|527143370|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172148|NCT01576718|527143371|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172149|NCT01576718|527143372|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172150|NCT01576718|527143373|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146172151|NCT01576718|527143367|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
146172152|NCT01576718|527143368|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172153|NCT01576718|527143369|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172154|NCT01576718|527143370|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172155|NCT01576718|527143371|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172156|NCT01576718|527143372|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172157|NCT01576718|527143373|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146172158|NCT01576718|527143367|FG000|Treatment Period|Adverse Event|0|||
146172159|NCT01576718|527143368|FG001|Treatment Period|Adverse Event|1|||
146172160|NCT01576718|527143369|FG002|Treatment Period|Adverse Event|1|||
146172161|NCT01576718|527143370|FG003|Treatment Period|Adverse Event|1|||
146172162|NCT01576718|527143371|FG004|Treatment Period|Adverse Event|1|||
146172163|NCT01576718|527143372|FG005|Treatment Period|Adverse Event|1|||
146172164|NCT01576718|527143373|FG006|Treatment Period|Adverse Event|0|||
146172165|NCT01576718|527143367|FG000|Treatment Period|Withdrawal by Subject|0|||
146071519|NCT02563067|526780878|FG000|Overall Study|Death post Treatment/safety period|1|||
146071520|NCT02563067|526780879|FG001|Overall Study|Death post Treatment/safety period|0|||
146071521|NCT02563067|526780880|FG002|Overall Study|Death post Treatment/safety period|0|||
146071522|NCT01039519|526780888|FG000|Treatment|Progressive disease|20|||
146071523|NCT01039519|526780888|FG000|Treatment|Treatment failure|2|||
146071524|NCT01039519|526780888|FG000|Treatment|Adverse Event|3|||
146071525|NCT01039519|526780888|FG000|Treatment|Physician Decision|2|||
146071526|NCT01039519|526780888|FG000|Survival Follow-up|Death|23|||
146071527|NCT01039519|526780888|FG000|Survival Follow-up|Sponsor decision|4|||
146071528|NCT00808080|526780889|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
146071529|NCT00423917|526780892|FG000|Overall Study|Cancel|2|||
146071530|NCT00423917|526780892|FG000|Overall Study|Ineligible|1|||
146071531|NCT00243269|526780893|FG000|Overall Study|Protocol Violation|2|||
146071532|NCT00243269|526780894|FG001|Overall Study|Protocol Violation|1|||
146071533|NCT00243269|526780895|FG002|Overall Study|Protocol Violation|0|||
146071534|NCT00243269|526780896|FG003|Overall Study|Protocol Violation|1|||
146071535|NCT00243269|526780893|FG000|Overall Study|Lost to Follow-up|1|||
146071536|NCT00243269|526780894|FG001|Overall Study|Lost to Follow-up|0|||
146071537|NCT00243269|526780895|FG002|Overall Study|Lost to Follow-up|1|||
146071538|NCT00243269|526780896|FG003|Overall Study|Lost to Follow-up|3|||
146071539|NCT01837823|526780897|FG000|Overall Study|Lost to Follow-up|6|||
146071540|NCT03052400|526780898|FG000|Overall Study|Lost to Follow-up|1|||
146071541|NCT03052400|526780899|FG001|Overall Study|Lost to Follow-up|0|||
146071542|NCT03052400|526780898|FG000|Overall Study|Withdrawal by Subject|0|||
146071543|NCT03052400|526780899|FG001|Overall Study|Withdrawal by Subject|1|||
146071544|NCT00555061|526780900|FG000|Overall Study|Adverse Event|3|||
146071545|NCT00555061|526780900|FG000|Overall Study|Protocol Violation|1|||
146071546|NCT00555061|526780900|FG000|Overall Study|Lost to Follow-up|2|||
146071547|NCT00555061|526780900|FG000|Overall Study|Withdrawal by Subject|2|||
146071548|NCT00555061|526780900|FG000|Overall Study|Participant enrolled, but never treated|1|||
146071549|NCT04995419|526780902|FG000|Overall Study|Withdrawal by Subject|3|||
146071550|NCT04995419|526780902|FG000|Overall Study|Progressive Disease|19|||
146071551|NCT04995419|526780902|FG000|Overall Study|Adverse Event|2|||
146071552|NCT04995419|526780902|FG000|Overall Study|Ongoing|16|||
146071553|NCT00573144|526780905|FG000|Overall Study|Withdrawal by Subject|2|||
146071554|NCT00573144|526780906|FG001|Overall Study|Withdrawal by Subject|3|||
146071555|NCT00125164|526780907|FG000|Overall Study|Adverse Event|0|||
146071556|NCT00125164|526780908|FG001|Overall Study|Adverse Event|0|||
146071557|NCT00125164|526780909|FG002|Overall Study|Adverse Event|2|||
146071558|NCT00125164|526780910|FG003|Overall Study|Adverse Event|4|||
146071559|NCT00125164|526780907|FG000|Overall Study|Lost to Follow-up|0|||
146071560|NCT00125164|526780908|FG001|Overall Study|Lost to Follow-up|0|||
146172166|NCT01576718|527143368|FG001|Treatment Period|Withdrawal by Subject|1|||
146172167|NCT01576718|527143369|FG002|Treatment Period|Withdrawal by Subject|1|||
146071561|NCT00125164|526780909|FG002|Overall Study|Lost to Follow-up|1|||
146071562|NCT00125164|526780910|FG003|Overall Study|Lost to Follow-up|1|||
146172168|NCT01576718|527143370|FG003|Treatment Period|Withdrawal by Subject|0|||
146071563|NCT00125164|526780907|FG000|Overall Study|Withdrawal by Subject|2|||
146071564|NCT00125164|526780908|FG001|Overall Study|Withdrawal by Subject|0|||
146071565|NCT00125164|526780909|FG002|Overall Study|Withdrawal by Subject|1|||
146071566|NCT00125164|526780910|FG003|Overall Study|Withdrawal by Subject|1|||
146172169|NCT01576718|527143371|FG004|Treatment Period|Withdrawal by Subject|2|||
146172170|NCT01576718|527143372|FG005|Treatment Period|Withdrawal by Subject|4|||
146172171|NCT01576718|527143373|FG006|Treatment Period|Withdrawal by Subject|2|||
146172172|NCT01576718|527143367|FG000|Treatment Period|Physician Decision|0|||
146172173|NCT01576718|527143368|FG001|Treatment Period|Physician Decision|1|||
146172174|NCT01576718|527143369|FG002|Treatment Period|Physician Decision|1|||
146172175|NCT01576718|527143370|FG003|Treatment Period|Physician Decision|1|||
146172176|NCT01576718|527143371|FG004|Treatment Period|Physician Decision|1|||
146172177|NCT01576718|527143372|FG005|Treatment Period|Physician Decision|0|||
146172178|NCT01576718|527143373|FG006|Treatment Period|Physician Decision|0|||
146172179|NCT01576718|527143367|FG000|Treatment Period|Protocol Violation|0|||
146172180|NCT01576718|527143368|FG001|Treatment Period|Protocol Violation|5|||
146172181|NCT01576718|527143369|FG002|Treatment Period|Protocol Violation|4|||
146172182|NCT01576718|527143370|FG003|Treatment Period|Protocol Violation|10|||
146172183|NCT01576718|527143371|FG004|Treatment Period|Protocol Violation|6|||
146172184|NCT01576718|527143372|FG005|Treatment Period|Protocol Violation|8|||
146172185|NCT01576718|527143373|FG006|Treatment Period|Protocol Violation|12|||
146172186|NCT01576718|527143367|FG000|Treatment Period|Sponsor request|0|||
146172187|NCT01576718|527143368|FG001|Treatment Period|Sponsor request|1|||
146172188|NCT01576718|527143369|FG002|Treatment Period|Sponsor request|0|||
146172189|NCT01576718|527143370|FG003|Treatment Period|Sponsor request|0|||
146172190|NCT01576718|527143371|FG004|Treatment Period|Sponsor request|0|||
146172191|NCT01576718|527143372|FG005|Treatment Period|Sponsor request|1|||
146172192|NCT01576718|527143373|FG006|Treatment Period|Sponsor request|0|||
146071567|NCT04939415|526780917|FG000|Overall Study|Withdrawal by Subject|1|||
146071568|NCT04939415|526780918|FG001|Overall Study|Withdrawal by Subject|3|||
146071569|NCT04939415|526780917|FG000|Overall Study|Lost to Follow-up|0|||
146071570|NCT04939415|526780918|FG001|Overall Study|Lost to Follow-up|2|||
146071571|NCT04308291|526780919|FG000|Run-In Phase|Withdrawal by Subject|4|||
146071572|NCT04308291|526780919|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
146071573|NCT04308291|526780919|FG000|Study Phase 6-M|Physician Decision|2|||
146071574|NCT04308291|526780919|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
146071575|NCT04308291|526780919|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
146071576|NCT04308291|526780919|FG000|Study Phase 12-M|Physician Decision|2|||
146071577|NCT04308291|526780919|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
146071578|NCT03610269|526780921|FG000|Overall Study|Physician Decision|10|||
146071579|NCT03610269|526780921|FG000|Overall Study|Protocol Violation|1|||
146071580|NCT03610269|526780921|FG000|Overall Study|Unable to draw blood|1|||
146071581|NCT03610269|526780921|FG000|Overall Study|Screen fail|4|||
146071582|NCT00067002|526780924|FG000|Overall Study|Early Death|1|||
146071583|NCT00067002|526780925|FG001|Overall Study|Early Death|2|||
146071584|NCT00067002|526780924|FG000|Overall Study|Delayed|1|||
146071585|NCT00067002|526780925|FG001|Overall Study|Delayed|1|||
146071586|NCT00067002|526780924|FG000|Overall Study|Graft Failure|5|||
146071587|NCT00067002|526780925|FG001|Overall Study|Graft Failure|6|||
146071588|NCT01354314|526780926|FG000|Overall Study|Lost to Follow-up|1|||
146071589|NCT01354314|526780927|FG001|Overall Study|Lost to Follow-up|0|||
146071590|NCT01354314|526780928|FG002|Overall Study|Lost to Follow-up|1|||
146071591|NCT01354314|526780929|FG003|Overall Study|Lost to Follow-up|1|||
146071592|NCT01354314|526780926|FG000|Overall Study|Withdrawal by Subject|0|||
146071593|NCT01354314|526780927|FG001|Overall Study|Withdrawal by Subject|0|||
146071594|NCT01354314|526780928|FG002|Overall Study|Withdrawal by Subject|1|||
146071595|NCT01354314|526780929|FG003|Overall Study|Withdrawal by Subject|0|||
146071596|NCT01354314|526780926|FG000|Overall Study|Adverse Event|0|||
146071597|NCT01354314|526780927|FG001|Overall Study|Adverse Event|0|||
146071598|NCT01354314|526780928|FG002|Overall Study|Adverse Event|0|||
146071599|NCT01354314|526780929|FG003|Overall Study|Adverse Event|1|||
146172193|NCT01576718|527143367|FG000|Treatment Period|Met stopping criteria|0|||
146172194|NCT01576718|527143368|FG001|Treatment Period|Met stopping criteria|16|||
146071600|NCT01354314|526780926|FG000|Overall Study|Protocol Violation|1|||
146071601|NCT01354314|526780927|FG001|Overall Study|Protocol Violation|1|||
146071602|NCT01354314|526780928|FG002|Overall Study|Protocol Violation|0|||
146172195|NCT01576718|527143369|FG002|Treatment Period|Met stopping criteria|13|||
146172196|NCT01576718|527143370|FG003|Treatment Period|Met stopping criteria|19|||
146071603|NCT01354314|526780929|FG003|Overall Study|Protocol Violation|0|||
146071604|NCT01354314|526780926|FG000|Overall Study|Less than 90% Adherence|4|||
146071605|NCT01354314|526780927|FG001|Overall Study|Less than 90% Adherence|2|||
146071606|NCT01354314|526780928|FG002|Overall Study|Less than 90% Adherence|6|||
146071607|NCT01354314|526780929|FG003|Overall Study|Less than 90% Adherence|4|||
146071608|NCT00478023|526780930|FG000|Overall Study|Adverse Event|11|||
146071609|NCT00478023|526780931|FG001|Overall Study|Adverse Event|7|||
146172197|NCT01576718|527143371|FG004|Treatment Period|Met stopping criteria|16|||
146172198|NCT01576718|527143372|FG005|Treatment Period|Met stopping criteria|33|||
146172199|NCT01576718|527143373|FG006|Treatment Period|Met stopping criteria|15|||
146172200|NCT01576718|527143367|FG000|Treatment Period|Lost to Follow-up|0|||
146172201|NCT01576718|527143368|FG001|Treatment Period|Lost to Follow-up|0|||
146172202|NCT01576718|527143369|FG002|Treatment Period|Lost to Follow-up|0|||
146172203|NCT01576718|527143370|FG003|Treatment Period|Lost to Follow-up|0|||
146172204|NCT01576718|527143371|FG004|Treatment Period|Lost to Follow-up|1|||
146172205|NCT01576718|527143372|FG005|Treatment Period|Lost to Follow-up|0|||
146172206|NCT01576718|527143373|FG006|Treatment Period|Lost to Follow-up|0|||
146172207|NCT01576718|527143367|FG000|Treatment Period|Noncompliance to study medication|0|||
146172208|NCT01576718|527143368|FG001|Treatment Period|Noncompliance to study medication|0|||
146172209|NCT01576718|527143369|FG002|Treatment Period|Noncompliance to study medication|0|||
146172210|NCT01576718|527143370|FG003|Treatment Period|Noncompliance to study medication|0|||
146172211|NCT01576718|527143371|FG004|Treatment Period|Noncompliance to study medication|0|||
146172212|NCT01576718|527143372|FG005|Treatment Period|Noncompliance to study medication|1|||
146172213|NCT01576718|527143373|FG006|Treatment Period|Noncompliance to study medication|1|||
146172214|NCT01874145|527143374|FG000|Core Period|Non-compliance|1|||
146172215|NCT01874145|527143375|FG001|Core Period|Non-compliance|0|||
146172216|NCT01874145|527143374|FG000|Core Period|Protocol Violation|1|||
146172217|NCT01874145|527143375|FG001|Core Period|Protocol Violation|1|||
146172218|NCT01874145|527143374|FG000|Core Period|Physician Decision|1|||
146172219|NCT01874145|527143375|FG001|Core Period|Physician Decision|1|||
146172220|NCT01874145|527143374|FG000|Core Period|Adverse Event|0|||
146172221|NCT01874145|527143375|FG001|Core Period|Adverse Event|1|||
146172222|NCT01874145|527143374|FG000|Core Period|Withdrawal by Subject|0|||
146172223|NCT01874145|527143375|FG001|Core Period|Withdrawal by Subject|4|||
146172224|NCT01874145|527143374|FG000|Extension Period|Adverse Event|3|||
146172225|NCT01874145|527143375|FG001|Extension Period|Adverse Event|2|||
146172226|NCT01874145|527143374|FG000|Extension Period|Withdrawal by Subject|2|||
146172227|NCT01874145|527143375|FG001|Extension Period|Withdrawal by Subject|1|||
146172228|NCT01874145|527143374|FG000|Extension Period|Lost to Follow-up|1|||
146172229|NCT01874145|527143375|FG001|Extension Period|Lost to Follow-up|1|||
146172230|NCT04631705|527143376|FG000|Overall Study|Withdrawal by Subject|0|||
146172231|NCT04631705|527143377|FG001|Overall Study|Withdrawal by Subject|0|||
146172232|NCT04631705|527143378|FG002|Overall Study|Withdrawal by Subject|0|||
146172233|NCT04631705|527143379|FG003|Overall Study|Withdrawal by Subject|0|||
146172234|NCT04631705|527143380|FG004|Overall Study|Withdrawal by Subject|0|||
146172235|NCT04631705|527143381|FG005|Overall Study|Withdrawal by Subject|0|||
146172236|NCT04631705|527143382|FG006|Overall Study|Withdrawal by Subject|1|||
146172237|NCT04631705|527143383|FG007|Overall Study|Withdrawal by Subject|0|||
146172238|NCT04631705|527143384|FG008|Overall Study|Withdrawal by Subject|0|||
146172239|NCT02070484|527143386|FG000|Overall Study|Withdrawal by Subject|1|||
146172240|NCT02070484|527143387|FG001|Overall Study|Withdrawal by Subject|0|||
146172241|NCT02658630|527143388|FG000|Overall Study|Withdrawal by Subject|4|||
146172242|NCT02821819|527143389|FG000|Overall Study|Protocol Violation|1|||
146172243|NCT01353222|527143396|FG000|Overall Study|Death|30|||
146172244|NCT01353222|527143397|FG001|Overall Study|Death|30|||
146172245|NCT01353222|527143396|FG000|Overall Study|Withdrawal by Subject|8|||
146071610|NCT00478023|526780932|FG002|Overall Study|Adverse Event|8|||
146071611|NCT00478023|526780933|FG003|Overall Study|Adverse Event|14|||
146071612|NCT00478023|526780934|FG004|Overall Study|Adverse Event|6|||
146071613|NCT00478023|526780930|FG000|Overall Study|Death|1|||
146071614|NCT00478023|526780931|FG001|Overall Study|Death|0|||
146071615|NCT00478023|526780932|FG002|Overall Study|Death|0|||
146071616|NCT00478023|526780933|FG003|Overall Study|Death|0|||
146071617|NCT00478023|526780934|FG004|Overall Study|Death|0|||
146071618|NCT00478023|526780930|FG000|Overall Study|Lack of Efficacy|11|||
146071619|NCT00478023|526780931|FG001|Overall Study|Lack of Efficacy|10|||
146071620|NCT00478023|526780932|FG002|Overall Study|Lack of Efficacy|4|||
146071621|NCT00478023|526780933|FG003|Overall Study|Lack of Efficacy|5|||
146071622|NCT00478023|526780934|FG004|Overall Study|Lack of Efficacy|41|||
146071623|NCT00478023|526780930|FG000|Overall Study|Lost to Follow-up|3|||
146071624|NCT00478023|526780931|FG001|Overall Study|Lost to Follow-up|1|||
146071625|NCT00478023|526780932|FG002|Overall Study|Lost to Follow-up|1|||
146071626|NCT00478023|526780933|FG003|Overall Study|Lost to Follow-up|1|||
146071627|NCT00478023|526780934|FG004|Overall Study|Lost to Follow-up|0|||
146071628|NCT00478023|526780930|FG000|Overall Study|Withdrawal by Subject|2|||
146071629|NCT00478023|526780931|FG001|Overall Study|Withdrawal by Subject|3|||
146071630|NCT00478023|526780932|FG002|Overall Study|Withdrawal by Subject|2|||
146071631|NCT00478023|526780933|FG003|Overall Study|Withdrawal by Subject|4|||
146071632|NCT00478023|526780934|FG004|Overall Study|Withdrawal by Subject|5|||
146071633|NCT00478023|526780930|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
146071634|NCT00478023|526780931|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
146071635|NCT00478023|526780932|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
146071636|NCT00478023|526780933|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
146071637|NCT00478023|526780934|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
146071638|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
146071639|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
146172246|NCT01353222|527143397|FG001|Overall Study|Withdrawal by Subject|5|||
146172247|NCT01353222|527143396|FG000|Overall Study|Study Terminated|31|||
146172248|NCT01353222|527143397|FG001|Overall Study|Study Terminated|37|||
146172249|NCT01353222|527143396|FG000|Overall Study|Site closed research department|1|||
146172250|NCT01353222|527143397|FG001|Overall Study|Site closed research department|0|||
146172251|NCT01654601|527143398|FG000|1st Administration|Withdrawal by Subject|2|||
146172252|NCT01654601|527143399|FG001|1st Administration|Withdrawal by Subject|0|||
146172253|NCT01654601|527143398|FG000|1st Administration|Protocol Violation|0|||
146172254|NCT01654601|527143399|FG001|1st Administration|Protocol Violation|2|||
146172255|NCT01654601|527143398|FG000|2nd Administration|Adverse Event|1|||
146172256|NCT01654601|527143399|FG001|2nd Administration|Adverse Event|0|||
146172257|NCT01654601|527143398|FG000|2nd Administration|Protocol Violation|0|||
146172258|NCT01654601|527143399|FG001|2nd Administration|Protocol Violation|1|||
146172259|NCT02636270|527143400|FG000|Overall Study|Adverse Event|1|||
146172260|NCT02636270|527143401|FG001|Overall Study|Adverse Event|0|||
146172261|NCT02636270|527143402|FG002|Overall Study|Adverse Event|0|||
146172262|NCT02636270|527143400|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
146172263|NCT02636270|527143401|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
146172264|NCT02636270|527143402|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
146172265|NCT01833143|527143403|FG000|Overall Study|Not Treated|1|||
146172266|NCT03021668|527143404|FG000|Overall Study|Physician Decision|0|||
146172267|NCT03021668|527143405|FG001|Overall Study|Physician Decision|1|||
146172268|NCT02217280|527143406|FG000|Overall Study|Withdrawal by Subject|2|||
146172269|NCT02217280|527143406|FG000|Overall Study|Post-consent sceen fail|2|||
146172270|NCT01816763|527145037|FG000|Overall Study|The main reason for an incomplete survey|4|||
146172271|NCT01816763|527145038|FG001|Overall Study|The main reason for an incomplete survey|15|||
146172272|NCT01816763|527145039|FG002|Overall Study|The main reason for an incomplete survey|11|||
146172273|NCT00429494|527145040|FG000|Overall Study|Withdrawal by Subject|9|||
146172274|NCT00429494|527145040|FG000|Overall Study|Death|6|||
146172275|NCT00976703|527145041|FG000|Overall Study|Physician Decision|1|||
146172276|NCT00976703|527145042|FG001|Overall Study|Physician Decision|1|||
146172277|NCT00976703|527145041|FG000|Overall Study|ineligible for study|2|||
146172278|NCT00976703|527145042|FG001|Overall Study|ineligible for study|2|||
146172279|NCT01900054|527145054|FG000|Overall Study|Physician Decision|1|||
146172280|NCT01900054|527145054|FG000|Overall Study|Withdrawal by Subject|1|||
146172281|NCT01186328|527145055|FG000|Overall Study|Death|1|||
146172282|NCT01186328|527145056|FG001|Overall Study|Death|0|||
146172283|NCT01186328|527145057|FG002|Overall Study|Death|0|||
146172284|NCT03075501|527145058|FG000|Overall Study|Scheduling difficulties|15|||
146172285|NCT03075501|527145059|FG001|Overall Study|Scheduling difficulties|9|||
146172286|NCT02762981|527145060|FG000|Overall Study|Adverse Event|2|||
146172287|NCT02762981|527145061|FG001|Overall Study|Adverse Event|3|||
146172288|NCT02762981|527145062|FG002|Overall Study|Adverse Event|1|||
146172289|NCT02762981|527145063|FG003|Overall Study|Adverse Event|1|||
146172290|NCT02762981|527145064|FG004|Overall Study|Adverse Event|3|||
146172291|NCT02762981|527145060|FG000|Overall Study|Physician Decision|0|||
146172292|NCT02762981|527145061|FG001|Overall Study|Physician Decision|1|||
146172293|NCT02762981|527145062|FG002|Overall Study|Physician Decision|0|||
146172294|NCT02762981|527145063|FG003|Overall Study|Physician Decision|0|||
146172295|NCT02762981|527145064|FG004|Overall Study|Physician Decision|1|||
146172296|NCT02762981|527145060|FG000|Overall Study|Disease progression|11|||
146172297|NCT02762981|527145061|FG001|Overall Study|Disease progression|23|||
146172298|NCT02762981|527145062|FG002|Overall Study|Disease progression|4|||
146172299|NCT02762981|527145063|FG003|Overall Study|Disease progression|10|||
146172300|NCT02762981|527145064|FG004|Overall Study|Disease progression|1|||
146071640|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
146071641|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
146071642|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071643|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071644|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071645|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146071646|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146071647|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146172301|NCT02762981|527145060|FG000|Overall Study|Enrolled not treated|1|||
146172302|NCT02762981|527145061|FG001|Overall Study|Enrolled not treated|5|||
146172303|NCT02762981|527145062|FG002|Overall Study|Enrolled not treated|0|||
146172304|NCT02762981|527145063|FG003|Overall Study|Enrolled not treated|2|||
146172305|NCT02762981|527145064|FG004|Overall Study|Enrolled not treated|0|||
146172306|NCT02762981|527145060|FG000|Overall Study|Other|2|||
146172307|NCT02762981|527145061|FG001|Overall Study|Other|3|||
146172308|NCT02762981|527145062|FG002|Overall Study|Other|1|||
146172309|NCT02762981|527145063|FG003|Overall Study|Other|0|||
146172310|NCT02762981|527145064|FG004|Overall Study|Other|0|||
146172311|NCT02762981|527145060|FG000|Overall Study|Missing|1|||
146172312|NCT02762981|527145061|FG001|Overall Study|Missing|0|||
146071648|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
146071649|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071650|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071651|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071652|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
146071653|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
146071654|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
146071655|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
146071656|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071657|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071658|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071659|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
146071660|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146071661|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
146071662|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146071663|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146071664|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146071665|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
146071666|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
146071667|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
146071668|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
146071669|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
146071670|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
146071671|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
146071672|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
146071673|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
146071674|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071675|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071676|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071677|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071678|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071679|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071680|NCT05019521|526780938|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146071681|NCT05019521|526780939|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071682|NCT05019521|526780940|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146071683|NCT05019521|526780941|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
146071684|NCT05019521|526780942|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071685|NCT05019521|526780943|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071686|NCT05019521|526780944|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071687|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
146071688|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
146071689|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
146071690|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071691|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071692|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
146071693|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
146071694|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146071695|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
146071696|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146071697|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071698|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071699|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
146071700|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
146071701|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
146071702|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071703|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071704|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
146071705|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
146071706|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
146071707|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
146071708|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146071709|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
146172313|NCT02762981|527145062|FG002|Overall Study|Missing|0|||
146071710|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
146071711|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146071712|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146071713|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146071714|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
146071715|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
146071716|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
146071717|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
146172314|NCT02762981|527145063|FG003|Overall Study|Missing|0|||
146409023|NCT03674827|528004318|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146409024|NCT03674827|528004319|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
146409025|NCT03674827|528004320|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
146409026|NCT03674827|528004321|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
146409027|NCT03674827|528004322|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
146409028|NCT00527397|528004323|FG000|Overall Study|Adverse Event|3|||
146409029|NCT00527397|528004323|FG000|Overall Study|Lack of Efficacy|1|||
146409030|NCT00527397|528004323|FG000|Overall Study|Protocol Violation|1|||
146409031|NCT00527397|528004323|FG000|Overall Study|Withdrawal by Subject|6|||
146409032|NCT00527397|528004323|FG000|Overall Study|Study terminated by sponsor|13|||
146409033|NCT04130919|528004326|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
146409034|NCT04130919|528004327|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
146409035|NCT04130919|528004328|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
146409036|NCT04130919|528004329|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
146409037|NCT04130919|528004330|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
146409038|NCT04130919|528004331|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
146409039|NCT04130919|528004326|FG000|Blinded Treatment Phase|Adverse Event|0|||
146409040|NCT04130919|528004327|FG001|Blinded Treatment Phase|Adverse Event|0|||
146409041|NCT04130919|528004328|FG002|Blinded Treatment Phase|Adverse Event|1|||
146409042|NCT04130919|528004329|FG003|Blinded Treatment Phase|Adverse Event|0|||
146409043|NCT04130919|528004330|FG004|Blinded Treatment Phase|Adverse Event|0|||
146409044|NCT04130919|528004331|FG005|Blinded Treatment Phase|Adverse Event|0|||
146409045|NCT04130919|528004326|FG000|Blinded Treatment Phase|Disease worsening|0|||
146409046|NCT04130919|528004327|FG001|Blinded Treatment Phase|Disease worsening|0|||
146409047|NCT04130919|528004328|FG002|Blinded Treatment Phase|Disease worsening|1|||
146409048|NCT04130919|528004329|FG003|Blinded Treatment Phase|Disease worsening|0|||
146409049|NCT04130919|528004330|FG004|Blinded Treatment Phase|Disease worsening|0|||
146409050|NCT04130919|528004331|FG005|Blinded Treatment Phase|Disease worsening|0|||
146409051|NCT04130919|528004326|FG000|Blinded Treatment Phase|Investigator's decision|0|||
146409052|NCT04130919|528004327|FG001|Blinded Treatment Phase|Investigator's decision|1|||
146409053|NCT04130919|528004328|FG002|Blinded Treatment Phase|Investigator's decision|0|||
146409054|NCT04130919|528004329|FG003|Blinded Treatment Phase|Investigator's decision|0|||
146409055|NCT04130919|528004330|FG004|Blinded Treatment Phase|Investigator's decision|0|||
146409056|NCT04130919|528004331|FG005|Blinded Treatment Phase|Investigator's decision|0|||
146409057|NCT04130919|528004326|FG000|Blinded Treatment Phase|Withdrew consent|1|||
146409058|NCT04130919|528004327|FG001|Blinded Treatment Phase|Withdrew consent|0|||
146409059|NCT04130919|528004328|FG002|Blinded Treatment Phase|Withdrew consent|0|||
146409060|NCT04130919|528004329|FG003|Blinded Treatment Phase|Withdrew consent|0|||
146409061|NCT04130919|528004330|FG004|Blinded Treatment Phase|Withdrew consent|0|||
146409062|NCT04130919|528004331|FG005|Blinded Treatment Phase|Withdrew consent|0|||
146409063|NCT04130919|528004326|FG000|Open-label Treatment Phase|Withdrew consent|0|||
146409064|NCT04130919|528004327|FG001|Open-label Treatment Phase|Withdrew consent|0|||
146409065|NCT04130919|528004328|FG002|Open-label Treatment Phase|Withdrew consent|0|||
146409066|NCT04130919|528004329|FG003|Open-label Treatment Phase|Withdrew consent|1|||
146409067|NCT04130919|528004330|FG004|Open-label Treatment Phase|Withdrew consent|1|||
146409068|NCT04130919|528004331|FG005|Open-label Treatment Phase|Withdrew consent|1|||
146409069|NCT04130919|528004326|FG000|Open-label Treatment Phase|Disease worsening|0|||
146409070|NCT04130919|528004327|FG001|Open-label Treatment Phase|Disease worsening|0|||
146409071|NCT04130919|528004328|FG002|Open-label Treatment Phase|Disease worsening|0|||
146409072|NCT04130919|528004329|FG003|Open-label Treatment Phase|Disease worsening|1|||
146409073|NCT04130919|528004330|FG004|Open-label Treatment Phase|Disease worsening|0|||
146409074|NCT04130919|528004331|FG005|Open-label Treatment Phase|Disease worsening|1|||
146409075|NCT04130919|528004326|FG000|Open-label Treatment Phase|Investigator's decision|0|||
146409076|NCT04130919|528004327|FG001|Open-label Treatment Phase|Investigator's decision|0|||
146409077|NCT04130919|528004328|FG002|Open-label Treatment Phase|Investigator's decision|0|||
146409078|NCT04130919|528004329|FG003|Open-label Treatment Phase|Investigator's decision|1|||
146409079|NCT04130919|528004330|FG004|Open-label Treatment Phase|Investigator's decision|0|||
146409080|NCT04130919|528004331|FG005|Open-label Treatment Phase|Investigator's decision|0|||
146409081|NCT04130919|528004326|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146409082|NCT04130919|528004327|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
146409083|NCT04130919|528004328|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
145945252|NCT03008278|526308187|FG000|Overall Study|Withdrawal by Subject|0|||
146172315|NCT02762981|527145064|FG004|Overall Study|Missing|0|||
146172316|NCT02762981|527145060|FG000|Overall Study|Withdrawal by Subject|0|||
146172317|NCT02762981|527145061|FG001|Overall Study|Withdrawal by Subject|5|||
146172318|NCT02762981|527145062|FG002|Overall Study|Withdrawal by Subject|1|||
146172319|NCT02762981|527145063|FG003|Overall Study|Withdrawal by Subject|3|||
146172320|NCT02762981|527145064|FG004|Overall Study|Withdrawal by Subject|0|||
146172321|NCT00957931|527145067|FG000|Overall Study|Death|4|||
146172322|NCT00857805|527145068|FG000|Overall Study|Withdrawal by Subject|1|||
146172323|NCT00857805|527145069|FG001|Overall Study|Withdrawal by Subject|1|||
146172324|NCT01062763|527145070|FG000|Overall Study|Adverse Event|3|||
146172325|NCT01062763|527145071|FG001|Overall Study|Adverse Event|4|||
146172326|NCT02392611|527145077|FG000|Overall Study|Adverse Event|0|||
146172327|NCT02392611|527145078|FG001|Overall Study|Adverse Event|0|||
146172328|NCT02392611|527145079|FG002|Overall Study|Adverse Event|0|||
146172329|NCT02392611|527145080|FG003|Overall Study|Adverse Event|1|||
146172330|NCT02392611|527145081|FG004|Overall Study|Adverse Event|0|||
146172331|NCT02392611|527145082|FG005|Overall Study|Adverse Event|0|||
146172332|NCT02392611|527145083|FG006|Overall Study|Adverse Event|0|||
146172333|NCT02392611|527145084|FG007|Overall Study|Adverse Event|0|||
146172334|NCT02392611|527145085|FG008|Overall Study|Adverse Event|0|||
146172335|NCT02392611|527145077|FG000|Overall Study|Progressive disease|0|||
146172336|NCT02392611|527145078|FG001|Overall Study|Progressive disease|0|||
146172337|NCT02392611|527145079|FG002|Overall Study|Progressive disease|0|||
146172338|NCT02392611|527145080|FG003|Overall Study|Progressive disease|2|||
146172339|NCT02392611|527145081|FG004|Overall Study|Progressive disease|1|||
146172340|NCT02392611|527145082|FG005|Overall Study|Progressive disease|0|||
146172341|NCT02392611|527145083|FG006|Overall Study|Progressive disease|0|||
146172342|NCT02392611|527145084|FG007|Overall Study|Progressive disease|0|||
146172343|NCT02392611|527145085|FG008|Overall Study|Progressive disease|0|||
146172344|NCT02392611|527145077|FG000|Overall Study|Death|1|||
146172345|NCT02392611|527145078|FG001|Overall Study|Death|0|||
146172346|NCT02392611|527145079|FG002|Overall Study|Death|0|||
146172347|NCT02392611|527145080|FG003|Overall Study|Death|0|||
146172348|NCT02392611|527145081|FG004|Overall Study|Death|0|||
146172349|NCT02392611|527145082|FG005|Overall Study|Death|1|||
146172350|NCT02392611|527145083|FG006|Overall Study|Death|0|||
146172351|NCT02392611|527145084|FG007|Overall Study|Death|0|||
146172352|NCT02392611|527145085|FG008|Overall Study|Death|0|||
146172353|NCT02392611|527145077|FG000|Overall Study|Withdrawal by Subject|0|||
146172354|NCT02392611|527145078|FG001|Overall Study|Withdrawal by Subject|0|||
146172355|NCT02392611|527145079|FG002|Overall Study|Withdrawal by Subject|0|||
146172356|NCT02392611|527145080|FG003|Overall Study|Withdrawal by Subject|1|||
146172357|NCT02392611|527145081|FG004|Overall Study|Withdrawal by Subject|0|||
146172358|NCT02392611|527145082|FG005|Overall Study|Withdrawal by Subject|0|||
146172359|NCT02392611|527145083|FG006|Overall Study|Withdrawal by Subject|0|||
146172360|NCT02392611|527145084|FG007|Overall Study|Withdrawal by Subject|0|||
146172361|NCT02392611|527145085|FG008|Overall Study|Withdrawal by Subject|0|||
146172362|NCT02392611|527145077|FG000|Overall Study|Lost to Follow-up|0|||
146172363|NCT02392611|527145078|FG001|Overall Study|Lost to Follow-up|0|||
146172364|NCT02392611|527145079|FG002|Overall Study|Lost to Follow-up|0|||
146172365|NCT02392611|527145080|FG003|Overall Study|Lost to Follow-up|0|||
146172366|NCT02392611|527145081|FG004|Overall Study|Lost to Follow-up|0|||
146172367|NCT02392611|527145082|FG005|Overall Study|Lost to Follow-up|0|||
146172368|NCT02392611|527145083|FG006|Overall Study|Lost to Follow-up|1|||
146172369|NCT02392611|527145084|FG007|Overall Study|Lost to Follow-up|0|||
146172370|NCT02392611|527145085|FG008|Overall Study|Lost to Follow-up|0|||
146071718|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
146071719|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
146071720|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
146071721|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
146071722|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071723|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071724|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071725|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146172371|NCT02392611|527145077|FG000|Overall Study|Enrolled, not treated|0|||
146172372|NCT02392611|527145078|FG001|Overall Study|Enrolled, not treated|0|||
146172373|NCT02392611|527145079|FG002|Overall Study|Enrolled, not treated|0|||
146172374|NCT02392611|527145080|FG003|Overall Study|Enrolled, not treated|2|||
146172375|NCT02392611|527145081|FG004|Overall Study|Enrolled, not treated|0|||
146172376|NCT02392611|527145082|FG005|Overall Study|Enrolled, not treated|0|||
146172377|NCT02392611|527145083|FG006|Overall Study|Enrolled, not treated|0|||
146172378|NCT02392611|527145084|FG007|Overall Study|Enrolled, not treated|0|||
146172379|NCT02392611|527145085|FG008|Overall Study|Enrolled, not treated|0|||
146172380|NCT00369681|527145087|FG000|Overall Study|Death|1|||
146172381|NCT02991482|527145089|FG000|Overall Study|Disease progression|56|||
146172382|NCT02991482|527145090|FG001|Overall Study|Disease progression|47|||
146172383|NCT02991482|527145089|FG000|Overall Study|Death|4|||
146071726|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071727|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
146071728|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
146071729|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146071730|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
146071731|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
146071732|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071733|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071734|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
146071735|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
146071736|NCT05019521|526780938|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
146071737|NCT05019521|526780939|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
146071738|NCT05019521|526780940|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
146071739|NCT05019521|526780941|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
146071740|NCT05019521|526780942|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
146071741|NCT05019521|526780943|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
146071742|NCT05019521|526780944|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
146071743|NCT02453711|526780945|FG000|Overall Study|Withdrawal by Subject|5|||
146071744|NCT02453711|526780946|FG001|Overall Study|Withdrawal by Subject|4|||
146071745|NCT02453711|526780947|FG002|Overall Study|Withdrawal by Subject|6|||
146071746|NCT02453711|526780948|FG003|Overall Study|Withdrawal by Subject|4|||
146071747|NCT02453711|526780949|FG004|Overall Study|Withdrawal by Subject|1|||
146071748|NCT02453711|526780950|FG005|Overall Study|Withdrawal by Subject|1|||
146071749|NCT02453711|526780951|FG006|Overall Study|Withdrawal by Subject|0|||
146071750|NCT02453711|526780952|FG007|Overall Study|Withdrawal by Subject|1|||
146071751|NCT02453711|526780953|FG008|Overall Study|Withdrawal by Subject|7|||
146071752|NCT02453711|526780945|FG000|Overall Study|Lost to Follow-up|5|||
146071753|NCT02453711|526780946|FG001|Overall Study|Lost to Follow-up|3|||
146071754|NCT02453711|526780947|FG002|Overall Study|Lost to Follow-up|2|||
146071755|NCT02453711|526780948|FG003|Overall Study|Lost to Follow-up|3|||
146071756|NCT02453711|526780949|FG004|Overall Study|Lost to Follow-up|1|||
146071757|NCT02453711|526780950|FG005|Overall Study|Lost to Follow-up|5|||
146071758|NCT02453711|526780951|FG006|Overall Study|Lost to Follow-up|2|||
146071759|NCT02453711|526780952|FG007|Overall Study|Lost to Follow-up|6|||
146409084|NCT04130919|528004329|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
146409085|NCT04130919|528004330|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
146409086|NCT04130919|528004331|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
146409087|NCT04130919|528004326|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146409088|NCT04130919|528004327|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146409089|NCT04130919|528004328|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146409090|NCT04130919|528004329|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146409091|NCT04130919|528004330|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
146409092|NCT04130919|528004331|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
146409093|NCT02400905|528004332|FG000|Overall Study|Death|24|||
146409094|NCT02400905|528004332|FG000|Overall Study|Lost to Follow-up|18|||
146409095|NCT02400905|528004332|FG000|Overall Study|Withdrawal by Subject|16|||
146409096|NCT02400905|528004332|FG000|Overall Study|Physician Decision|4|||
146409097|NCT02400905|528004332|FG000|Overall Study|Other|1|||
146409098|NCT00061945|528004335|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
146409099|NCT00061945|528004336|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
146409100|NCT00061945|528004335|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
146409101|NCT00061945|528004336|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
146409102|NCT00061945|528004335|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
146409103|NCT00061945|528004336|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
146409104|NCT00061945|528004335|FG000|Course IV: Alemtuzumab|Early exits|6|||
146409105|NCT00061945|528004336|FG001|Course IV: Alemtuzumab|Early exits|15|||
146409106|NCT01039584|528004337|FG000|Overall Study|Withdrawal by Subject|4|||
146409107|NCT01039584|528004338|FG001|Overall Study|Withdrawal by Subject|2|||
146409108|NCT01039584|528004339|FG002|Overall Study|Withdrawal by Subject|1|||
146409109|NCT01039584|528004337|FG000|Overall Study|Protocol Violation|10|||
146409110|NCT01039584|528004338|FG001|Overall Study|Protocol Violation|4|||
146409111|NCT01039584|528004339|FG002|Overall Study|Protocol Violation|6|||
146409112|NCT01039584|528004337|FG000|Overall Study|Lost to Follow-up|5|||
146409113|NCT01039584|528004338|FG001|Overall Study|Lost to Follow-up|3|||
146409114|NCT01039584|528004339|FG002|Overall Study|Lost to Follow-up|4|||
146071760|NCT02453711|526780953|FG008|Overall Study|Lost to Follow-up|6|||
146172384|NCT02991482|527145090|FG001|Overall Study|Death|4|||
146409115|NCT01039584|528004337|FG000|Overall Study|Negative Baseline culture for Candida|59|||
145945253|NCT03008278|526308188|FG001|Overall Study|Withdrawal by Subject|0|||
146071761|NCT02453711|526780945|FG000|Overall Study|Death|0|||
146071762|NCT02453711|526780946|FG001|Overall Study|Death|0|||
146071763|NCT02453711|526780947|FG002|Overall Study|Death|0|||
146071764|NCT02453711|526780948|FG003|Overall Study|Death|0|||
146071765|NCT02453711|526780949|FG004|Overall Study|Death|0|||
146071766|NCT02453711|526780950|FG005|Overall Study|Death|0|||
146071767|NCT02453711|526780951|FG006|Overall Study|Death|1|||
146071768|NCT02453711|526780952|FG007|Overall Study|Death|0|||
146071769|NCT02453711|526780953|FG008|Overall Study|Death|0|||
146071770|NCT02453711|526780945|FG000|Overall Study|Unclassified|1|||
146071771|NCT02453711|526780946|FG001|Overall Study|Unclassified|0|||
146071772|NCT02453711|526780947|FG002|Overall Study|Unclassified|1|||
146071773|NCT02453711|526780948|FG003|Overall Study|Unclassified|0|||
146071774|NCT02453711|526780949|FG004|Overall Study|Unclassified|0|||
146071775|NCT02453711|526780950|FG005|Overall Study|Unclassified|0|||
146071776|NCT02453711|526780951|FG006|Overall Study|Unclassified|0|||
146071777|NCT02453711|526780952|FG007|Overall Study|Unclassified|0|||
146071778|NCT02453711|526780953|FG008|Overall Study|Unclassified|0|||
146071779|NCT03695367|526780955|FG000|Overall Study|Missed the Day 28 visit.|1|||
146071780|NCT03695367|526780956|FG001|Overall Study|Missed the Day 28 visit.|0|||
146071781|NCT03695367|526780955|FG000|Overall Study|Lost to Follow-up|0|||
146071782|NCT03695367|526780956|FG001|Overall Study|Lost to Follow-up|1|||
146071783|NCT03695367|526780955|FG000|Overall Study|Withdrawal by Subject|0|||
146071784|NCT03695367|526780956|FG001|Overall Study|Withdrawal by Subject|1|||
146071785|NCT03695367|526780955|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
146071786|NCT03695367|526780956|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
146071787|NCT00068419|526780957|FG000|Overall Study|Adverse Event|3|||
146071788|NCT00068419|526780957|FG000|Overall Study|Lack of Efficacy|24|||
146071789|NCT00068419|526780957|FG000|Overall Study|Lost to Follow-up|1|||
146071790|NCT00068419|526780957|FG000|Overall Study|Physician Decision|7|||
146071791|NCT00068419|526780957|FG000|Overall Study|Withdrawal by Subject|14|||
146071792|NCT00068419|526780957|FG000|Overall Study|Ineligible|11|||
146071793|NCT00396253|526780966|FG000|Overall Study|Protocol Violation|1|||
146071794|NCT00396253|526780966|FG000|Overall Study|Withdrawal by Subject|7|||
146071795|NCT00396253|526780966|FG000|Overall Study|Death|3|||
146071796|NCT00396253|526780966|FG000|Overall Study|Physician Decision|1|||
146071797|NCT00396253|526780966|FG000|Overall Study|Change in eligibility status|1|||
146071798|NCT04672655|526780977|FG000|Overall Study|Lost to Follow-up|12|||
146071799|NCT04672655|526780978|FG001|Overall Study|Lost to Follow-up|17|||
146071800|NCT04672655|526780977|FG000|Overall Study|Withdrawal by Subject|1|||
146071801|NCT04672655|526780978|FG001|Overall Study|Withdrawal by Subject|0|||
146071802|NCT04672655|526780977|FG000|Overall Study|Withdrawal by Study|1|||
146071803|NCT04672655|526780978|FG001|Overall Study|Withdrawal by Study|0|||
146071804|NCT00796419|526782647|FG000|Overall Study|Death|0|||
146071805|NCT00796419|526782648|FG001|Overall Study|Death|1|||
146071806|NCT02840799|526782649|FG000|Phase 1|Physician Decision|1|||
146071807|NCT02840799|526782650|FG001|Phase 1|Physician Decision|3|||
146071808|NCT02840799|526782649|FG000|Phase 1|Withdrawal by Subject|4|||
146071809|NCT02840799|526782650|FG001|Phase 1|Withdrawal by Subject|0|||
146071810|NCT02840799|526782649|FG000|Phase 2 (Crossover)|Adverse Event|0|||
146071811|NCT02840799|526782650|FG001|Phase 2 (Crossover)|Adverse Event|1|||
146071812|NCT02840799|526782649|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
146071813|NCT02840799|526782650|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
146071814|NCT02565784|526782651|FG000|First Treatment|Adverse Event|1|||
146071815|NCT02565784|526782651|FG000|First Treatment|Withdrawal by Subject|1|||
146071816|NCT02565784|526782651|FG000|Second Treatment|Withdrawal by Subject|2|||
146071817|NCT01349049|526782655|FG000|Overall Study|Disease progression|3|||
146071818|NCT01349049|526782656|FG001|Overall Study|Disease progression|5|||
146071819|NCT01349049|526782657|FG002|Overall Study|Disease progression|3|||
146071820|NCT01349049|526782658|FG003|Overall Study|Disease progression|2|||
146071821|NCT01349049|526782659|FG004|Overall Study|Disease progression|2|||
146071822|NCT01349049|526782660|FG005|Overall Study|Disease progression|2|||
146071823|NCT01349049|526782661|FG006|Overall Study|Disease progression|3|||
146071824|NCT01349049|526782662|FG007|Overall Study|Disease progression|2|||
146071825|NCT01349049|526782663|FG008|Overall Study|Disease progression|33|||
146071826|NCT01349049|526782655|FG000|Overall Study|Adverse Event|0|||
146071827|NCT01349049|526782656|FG001|Overall Study|Adverse Event|1|||
146071828|NCT01349049|526782657|FG002|Overall Study|Adverse Event|0|||
146071829|NCT01349049|526782658|FG003|Overall Study|Adverse Event|0|||
146071830|NCT01349049|526782659|FG004|Overall Study|Adverse Event|0|||
146071831|NCT01349049|526782660|FG005|Overall Study|Adverse Event|3|||
146071832|NCT01349049|526782661|FG006|Overall Study|Adverse Event|1|||
146071833|NCT01349049|526782662|FG007|Overall Study|Adverse Event|0|||
146071834|NCT01349049|526782663|FG008|Overall Study|Adverse Event|4|||
146071835|NCT01349049|526782655|FG000|Overall Study|Physician Decision|0|||
146071836|NCT01349049|526782656|FG001|Overall Study|Physician Decision|1|||
146071837|NCT01349049|526782657|FG002|Overall Study|Physician Decision|0|||
146071838|NCT01349049|526782658|FG003|Overall Study|Physician Decision|0|||
146172385|NCT02991482|527145089|FG000|Overall Study|Adverse Event|1|||
146172386|NCT02991482|527145090|FG001|Overall Study|Adverse Event|6|||
146172387|NCT02991482|527145089|FG000|Overall Study|Patient decision|1|||
146172388|NCT02991482|527145090|FG001|Overall Study|Patient decision|1|||
146172389|NCT02991482|527145089|FG000|Overall Study|Physician Decision|0|||
146172390|NCT02991482|527145090|FG001|Overall Study|Physician Decision|6|||
146172391|NCT02991482|527145089|FG000|Overall Study|Clinical deterioration|1|||
146172392|NCT02991482|527145090|FG001|Overall Study|Clinical deterioration|0|||
146172393|NCT02991482|527145089|FG000|Overall Study|Patient feeling too unwell|1|||
146172394|NCT02991482|527145090|FG001|Overall Study|Patient feeling too unwell|0|||
146172395|NCT02991482|527145089|FG000|Overall Study|Worsening of performance status|0|||
146172396|NCT02991482|527145090|FG001|Overall Study|Worsening of performance status|1|||
146172397|NCT02991482|527145089|FG000|Overall Study|Death prior to study drug initiation|1|||
146172398|NCT02991482|527145090|FG001|Overall Study|Death prior to study drug initiation|0|||
146172399|NCT02991482|527145089|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
146172400|NCT02991482|527145090|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
146172401|NCT01250119|527145091|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
146172402|NCT01250119|527145092|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
146172403|NCT01250119|527145091|FG000|Diagnostic Phase|Participants Not Tested|44|||
146172404|NCT01250119|527145092|FG001|Diagnostic Phase|Participants Not Tested|0|||
146172405|NCT01250119|527145091|FG000|Treatment Phase|Progressive Disease|0|||
146172406|NCT01250119|527145092|FG001|Treatment Phase|Progressive Disease|32|||
146172407|NCT01250119|527145091|FG000|Treatment Phase|Death|0|||
146172408|NCT01250119|527145092|FG001|Treatment Phase|Death|2|||
146172409|NCT01250119|527145091|FG000|Treatment Phase|Withdrawal by Subject|0|||
146172410|NCT01250119|527145092|FG001|Treatment Phase|Withdrawal by Subject|1|||
146172411|NCT01250119|527145091|FG000|Treatment Phase|Adverse Event|0|||
146172412|NCT01250119|527145092|FG001|Treatment Phase|Adverse Event|2|||
146172413|NCT01250119|527145091|FG000|Treatment Phase|Unknown reason|0|||
146172414|NCT01250119|527145092|FG001|Treatment Phase|Unknown reason|4|||
146172415|NCT02887989|527145095|FG000|Overall Study|Withdrawal by Subject|8|||
146172416|NCT02887989|527145096|FG001|Overall Study|Withdrawal by Subject|11|||
146172417|NCT02887989|527145095|FG000|Overall Study|Death|1|||
146172418|NCT02887989|527145096|FG001|Overall Study|Death|0|||
146172419|NCT05648357|527145100|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
146172420|NCT00255346|527145101|FG000|Overall Study|Adverse Event|1|||
146172421|NCT00255346|527145102|FG001|Overall Study|Adverse Event|0|||
146172422|NCT00255346|527145103|FG002|Overall Study|Adverse Event|0|||
146172423|NCT00255346|527145104|FG003|Overall Study|Adverse Event|0|||
146172424|NCT00255346|527145105|FG004|Overall Study|Adverse Event|0|||
146172425|NCT00674323|527145106|FG000|Overall Study|Adverse Event|0|||
146172426|NCT00674323|527145107|FG001|Overall Study|Adverse Event|1|||
146172427|NCT00674323|527145108|FG002|Overall Study|Adverse Event|0|||
146172428|NCT00674323|527145106|FG000|Overall Study|Protocol Violation|1|||
146172429|NCT00674323|527145107|FG001|Overall Study|Protocol Violation|0|||
146172430|NCT00674323|527145108|FG002|Overall Study|Protocol Violation|0|||
146172431|NCT02045433|527145114|FG000|Overall Study|Withdrawal by Subject|1|||
146172432|NCT01559454|527145115|FG000|Overall Study|Lost to Follow-up|3|||
146172433|NCT01559454|527145116|FG001|Overall Study|Lost to Follow-up|2|||
146172434|NCT01559454|527145115|FG000|Overall Study|Withdrawal by Subject|0|||
146172435|NCT01559454|527145116|FG001|Overall Study|Withdrawal by Subject|1|||
146172436|NCT01559454|527145115|FG000|Overall Study|Physician Decision|0|||
146172437|NCT01559454|527145116|FG001|Overall Study|Physician Decision|1|||
146172438|NCT01559454|527145115|FG000|Overall Study|Protocol Violation|0|||
146172439|NCT01559454|527145116|FG001|Overall Study|Protocol Violation|1|||
146172440|NCT01559454|527145115|FG000|Overall Study|Lack of Efficacy|0|||
146071839|NCT01349049|526782659|FG004|Overall Study|Physician Decision|0|||
146071840|NCT01349049|526782660|FG005|Overall Study|Physician Decision|0|||
146071841|NCT01349049|526782661|FG006|Overall Study|Physician Decision|0|||
146071842|NCT01349049|526782662|FG007|Overall Study|Physician Decision|0|||
146071843|NCT01349049|526782663|FG008|Overall Study|Physician Decision|2|||
146071844|NCT01349049|526782655|FG000|Overall Study|Protocol Violation|0|||
146071845|NCT01349049|526782656|FG001|Overall Study|Protocol Violation|0|||
146071846|NCT01349049|526782657|FG002|Overall Study|Protocol Violation|0|||
146071847|NCT01349049|526782658|FG003|Overall Study|Protocol Violation|0|||
146071848|NCT01349049|526782659|FG004|Overall Study|Protocol Violation|0|||
146172441|NCT01559454|527145116|FG001|Overall Study|Lack of Efficacy|1|||
146172442|NCT02207725|527145117|FG000|Overall Study|Did Not Receive Treatment|0|||
146172443|NCT02207725|527145118|FG001|Overall Study|Did Not Receive Treatment|1|||
146172444|NCT02207725|527145119|FG002|Overall Study|Did Not Receive Treatment|1|||
146172445|NCT02207725|527145120|FG003|Overall Study|Did Not Receive Treatment|1|||
146172446|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
146172447|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
146172448|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Adverse Event|2|||
146172449|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Adverse Event|5|||
146071849|NCT01349049|526782660|FG005|Overall Study|Protocol Violation|0|||
146172450|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
146172451|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
146172452|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
146172453|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
146172454|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Randomized by error|0|||
146172455|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Randomized by error|5|||
146172456|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
146172457|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
146172458|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
146172459|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
146172460|NCT02948959|527145122|FG000|52 Weeks Treatment Period|Change of residence location|0|||
146172461|NCT02948959|527145123|FG001|52 Weeks Treatment Period|Change of residence location|1|||
146172462|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
146172463|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
146172464|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
146172465|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
146172466|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
146172467|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
146071850|NCT01349049|526782661|FG006|Overall Study|Protocol Violation|0|||
146071851|NCT01349049|526782662|FG007|Overall Study|Protocol Violation|0|||
146071852|NCT01349049|526782663|FG008|Overall Study|Protocol Violation|1|||
146071853|NCT01349049|526782655|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
146071854|NCT01349049|526782656|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
146071855|NCT01349049|526782657|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
146071856|NCT01349049|526782658|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
146071857|NCT01349049|526782659|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
146071858|NCT01349049|526782660|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
146071859|NCT01349049|526782661|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
146071860|NCT01349049|526782662|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
146071861|NCT01349049|526782663|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
146071862|NCT01349049|526782655|FG000|Overall Study|Other|0|||
146071863|NCT01349049|526782656|FG001|Overall Study|Other|0|||
146071864|NCT01349049|526782657|FG002|Overall Study|Other|0|||
146071865|NCT01349049|526782658|FG003|Overall Study|Other|0|||
146071866|NCT01349049|526782659|FG004|Overall Study|Other|0|||
146071867|NCT01349049|526782660|FG005|Overall Study|Other|1|||
146071868|NCT01349049|526782661|FG006|Overall Study|Other|0|||
146071869|NCT01349049|526782662|FG007|Overall Study|Other|0|||
146071870|NCT01349049|526782663|FG008|Overall Study|Other|4|||
146071871|NCT01349049|526782655|FG000|Overall Study|Death|0|||
146071872|NCT01349049|526782656|FG001|Overall Study|Death|0|||
146071873|NCT01349049|526782657|FG002|Overall Study|Death|0|||
146071874|NCT01349049|526782658|FG003|Overall Study|Death|0|||
146071875|NCT01349049|526782659|FG004|Overall Study|Death|0|||
146071876|NCT01349049|526782660|FG005|Overall Study|Death|0|||
146071877|NCT01349049|526782661|FG006|Overall Study|Death|0|||
146071878|NCT01349049|526782662|FG007|Overall Study|Death|1|||
146071879|NCT01349049|526782663|FG008|Overall Study|Death|5|||
146071880|NCT01349049|526782655|FG000|Overall Study|Non-compliance|0|||
146071881|NCT01349049|526782656|FG001|Overall Study|Non-compliance|0|||
146071882|NCT01349049|526782657|FG002|Overall Study|Non-compliance|0|||
146071883|NCT01349049|526782658|FG003|Overall Study|Non-compliance|1|||
146071884|NCT01349049|526782659|FG004|Overall Study|Non-compliance|0|||
146071885|NCT01349049|526782660|FG005|Overall Study|Non-compliance|0|||
146071886|NCT01349049|526782661|FG006|Overall Study|Non-compliance|0|||
146071887|NCT01349049|526782662|FG007|Overall Study|Non-compliance|0|||
146071888|NCT01349049|526782663|FG008|Overall Study|Non-compliance|0|||
146071889|NCT01349049|526782655|FG000|Overall Study|Withdrawal by Subject|0|||
146071890|NCT01349049|526782656|FG001|Overall Study|Withdrawal by Subject|0|||
146071891|NCT01349049|526782657|FG002|Overall Study|Withdrawal by Subject|0|||
146071892|NCT01349049|526782658|FG003|Overall Study|Withdrawal by Subject|0|||
146071893|NCT01349049|526782659|FG004|Overall Study|Withdrawal by Subject|0|||
146071894|NCT01349049|526782660|FG005|Overall Study|Withdrawal by Subject|0|||
146071895|NCT01349049|526782661|FG006|Overall Study|Withdrawal by Subject|0|||
146071896|NCT01349049|526782662|FG007|Overall Study|Withdrawal by Subject|0|||
146071897|NCT01349049|526782663|FG008|Overall Study|Withdrawal by Subject|6|||
146071898|NCT00552188|526782666|FG000|Overall Study|Adverse Event|0|||
146172468|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
146172469|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
146071899|NCT00552188|526782667|FG001|Overall Study|Adverse Event|2|||
146071900|NCT00552188|526782666|FG000|Overall Study|Lost to Follow-up|2|||
146071901|NCT00552188|526782667|FG001|Overall Study|Lost to Follow-up|1|||
146071902|NCT00552188|526782666|FG000|Overall Study|Withdrawal of consent|0|||
146071903|NCT00552188|526782667|FG001|Overall Study|Withdrawal of consent|1|||
146071904|NCT00552188|526782666|FG000|Overall Study|Subject returned to home country|0|||
146071905|NCT00552188|526782667|FG001|Overall Study|Subject returned to home country|1|||
146071906|NCT03887702|526782668|FG000|Overall Study|Study terminated|0|||
146172470|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
146172471|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
146172472|NCT02948959|527145122|FG000|12 Weeks Follow-up Period|Study site closure|1|||
146172473|NCT02948959|527145123|FG001|12 Weeks Follow-up Period|Study site closure|0|||
146172474|NCT00409786|527145124|FG000|Overall Study|Withdrawal by Subject|3|||
146172475|NCT00597714|527145125|FG000|Overall Study|Death|56|||
146172476|NCT00597714|527145126|FG001|Overall Study|Death|46|||
146172477|NCT00597714|527145127|FG002|Overall Study|Death|0|||
146172478|NCT00597714|527145125|FG000|Overall Study|Recipient death|0|||
146172479|NCT00597714|527145126|FG001|Overall Study|Recipient death|0|||
146172480|NCT00597714|527145127|FG002|Overall Study|Recipient death|10|||
146172481|NCT01350141|527145128|FG000|Overall Study|Lost to Follow-up|1|||
146172482|NCT01350141|527145129|FG001|Overall Study|Lost to Follow-up|0|||
146172483|NCT01350141|527145130|FG002|Overall Study|Lost to Follow-up|1|||
146172484|NCT01350141|527145128|FG000|Overall Study|Withdrawal by Subject|1|||
146172485|NCT01350141|527145129|FG001|Overall Study|Withdrawal by Subject|0|||
146172486|NCT01350141|527145130|FG002|Overall Study|Withdrawal by Subject|0|||
146172487|NCT01350141|527145128|FG000|Overall Study|Randomized but not treated|1|||
146172488|NCT01350141|527145129|FG001|Overall Study|Randomized but not treated|0|||
146172489|NCT01350141|527145130|FG002|Overall Study|Randomized but not treated|0|||
146172490|NCT00810082|527145131|FG000|Overall Study|Lost to Follow-up|0|||
146172491|NCT00810082|527145132|FG001|Overall Study|Lost to Follow-up|4|||
146172492|NCT01588990|527145133|FG000|Phase A|Withdrawal by Subject|5|||
146172493|NCT01588990|527145133|FG000|Phase A|Physician Decision|11|||
146172494|NCT01588990|527145133|FG000|Phase A|Other|14|||
146172495|NCT01588990|527145133|FG000|Phase A|Lost to Follow-up|1|||
146172496|NCT01588990|527145133|FG000|Phase A|Death|5|||
146172497|NCT01588990|527145133|FG000|Phase A|Adverse Event|28|||
146172498|NCT01588990|527145133|FG000|Phase A|Still on therapy at end of study|6|||
146172499|NCT01588990|527145133|FG000|Phase B|Adverse Event|2|||
146172500|NCT01588990|527145133|FG000|Phase B|Still on therapy at end of study|5|||
146172501|NCT01588990|527145133|FG000|Phase B|Withdrawal by Subject|3|||
146172502|NCT01588990|527145133|FG000|Phase B|Physician Decision|4|||
146172503|NCT01588990|527145133|FG000|Phase B|Other|2|||
146172504|NCT02367716|527145134|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
146172505|NCT02341456|527145135|FG000|Overall Study|Disease progression|2|||
146172506|NCT02341456|527145136|FG001|Overall Study|Disease progression|3|||
146172507|NCT02341456|527145137|FG002|Overall Study|Disease progression|1|||
146172508|NCT02341456|527145135|FG000|Overall Study|Death|1|||
146172509|NCT02341456|527145136|FG001|Overall Study|Death|1|||
146172510|NCT02341456|527145137|FG002|Overall Study|Death|1|||
146172511|NCT02341456|527145135|FG000|Overall Study|Withdrawal by Subject|0|||
146172512|NCT02341456|527145136|FG001|Overall Study|Withdrawal by Subject|1|||
146172513|NCT02341456|527145137|FG002|Overall Study|Withdrawal by Subject|1|||
146172514|NCT02341456|527145135|FG000|Overall Study|Moved to local access programme.|0|||
146172515|NCT02341456|527145136|FG001|Overall Study|Moved to local access programme.|1|||
146172516|NCT02341456|527145137|FG002|Overall Study|Moved to local access programme.|1|||
146172517|NCT02341456|527145135|FG000|Overall Study|Physician Decision|1|||
146172518|NCT02341456|527145136|FG001|Overall Study|Physician Decision|0|||
146172519|NCT02341456|527145137|FG002|Overall Study|Physician Decision|0|||
146172520|NCT02508532|527145140|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172521|NCT02508532|527145141|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172522|NCT02508532|527145142|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172523|NCT02508532|527145143|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172524|NCT02508532|527145144|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172525|NCT02508532|527145145|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172526|NCT02508532|527145146|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
146172527|NCT02508532|527145147|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172528|NCT02508532|527145148|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
146172529|NCT02508532|527145140|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172530|NCT02508532|527145141|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172531|NCT02508532|527145142|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172532|NCT02508532|527145143|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172533|NCT02508532|527145144|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172534|NCT02508532|527145145|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172535|NCT02508532|527145146|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
146172536|NCT02508532|527145147|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
146172537|NCT02508532|527145148|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
145945254|NCT03008278|526308189|FG002|Overall Study|Withdrawal by Subject|3|||
145945255|NCT03008278|526308187|FG000|Overall Study|Physician Decision|0|||
146172538|NCT02508532|527145140|FG000|Part 2 - Treatment|Disease Progression|0|||
146172539|NCT02508532|527145141|FG001|Part 2 - Treatment|Disease Progression|0|||
146172540|NCT02508532|527145142|FG002|Part 2 - Treatment|Disease Progression|0|||
146172541|NCT02508532|527145143|FG003|Part 2 - Treatment|Disease Progression|0|||
146071907|NCT03887702|526782669|FG001|Overall Study|Study terminated|0|||
146409116|NCT01039584|528004338|FG001|Overall Study|Negative Baseline culture for Candida|59|||
146409117|NCT01039584|528004339|FG002|Overall Study|Negative Baseline culture for Candida|24|||
146409118|NCT01039584|528004337|FG000|Overall Study|Lack of Efficacy|7|||
146409119|NCT01039584|528004338|FG001|Overall Study|Lack of Efficacy|6|||
146409120|NCT01039584|528004339|FG002|Overall Study|Lack of Efficacy|10|||
146409121|NCT01039584|528004337|FG000|Overall Study|other|1|||
146409122|NCT01039584|528004338|FG001|Overall Study|other|3|||
146409123|NCT01039584|528004339|FG002|Overall Study|other|1|||
146409124|NCT01039584|528004337|FG000|Overall Study|Pap smear with significant pathology|10|||
146409125|NCT01039584|528004338|FG001|Overall Study|Pap smear with significant pathology|10|||
146409126|NCT01039584|528004339|FG002|Overall Study|Pap smear with significant pathology|3|||
146409127|NCT01039584|528004337|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
146409128|NCT01039584|528004338|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
146409129|NCT01039584|528004339|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
146409130|NCT03672396|528004342|FG000|Overall Study|Withdrawal by Subject|4|||
146409131|NCT03672396|528004342|FG000|Overall Study|Physician Decision|1|||
146409132|NCT03672396|528004342|FG000|Overall Study|Adverse Event|1|||
146409133|NCT04380701|528004345|FG000|Overall Study|Pregnancy|0|||
146409134|NCT04380701|528004346|FG001|Overall Study|Pregnancy|0|||
146409135|NCT04380701|528004347|FG002|Overall Study|Pregnancy|0|||
146409136|NCT04380701|528004348|FG003|Overall Study|Pregnancy|0|||
146409137|NCT04380701|528004349|FG004|Overall Study|Pregnancy|0|||
146409138|NCT04380701|528004350|FG005|Overall Study|Pregnancy|0|||
146409139|NCT04380701|528004351|FG006|Overall Study|Pregnancy|0|||
146409140|NCT04380701|528004352|FG007|Overall Study|Pregnancy|0|||
146409141|NCT04380701|528004353|FG008|Overall Study|Pregnancy|0|||
146409142|NCT04380701|528004354|FG009|Overall Study|Pregnancy|0|||
146409143|NCT04380701|528004355|FG010|Overall Study|Pregnancy|0|||
146409144|NCT04380701|528004356|FG011|Overall Study|Pregnancy|0|||
146409145|NCT04380701|528004357|FG012|Overall Study|Pregnancy|0|||
146409146|NCT04380701|528004358|FG013|Overall Study|Pregnancy|0|||
146409147|NCT04380701|528004359|FG014|Overall Study|Pregnancy|0|||
146409148|NCT04380701|528004360|FG015|Overall Study|Pregnancy|0|||
146409149|NCT04380701|528004361|FG016|Overall Study|Pregnancy|0|||
146409150|NCT04380701|528004362|FG017|Overall Study|Pregnancy|0|||
146409151|NCT04380701|528004363|FG018|Overall Study|Pregnancy|0|||
146409152|NCT04380701|528004364|FG019|Overall Study|Pregnancy|0|||
146409153|NCT04380701|528004365|FG020|Overall Study|Pregnancy|0|||
146409154|NCT04380701|528004366|FG021|Overall Study|Pregnancy|0|||
146409155|NCT04380701|528004367|FG022|Overall Study|Pregnancy|0|||
146409156|NCT04380701|528004368|FG023|Overall Study|Pregnancy|0|||
146409157|NCT04380701|528004369|FG024|Overall Study|Pregnancy|0|||
146409158|NCT04380701|528004370|FG025|Overall Study|Pregnancy|0|||
146409159|NCT04380701|528004371|FG026|Overall Study|Pregnancy|0|||
146409160|NCT04380701|528004372|FG027|Overall Study|Pregnancy|0|||
146409161|NCT04380701|528004373|FG028|Overall Study|Pregnancy|0|||
146409162|NCT04380701|528004374|FG029|Overall Study|Pregnancy|0|||
146409163|NCT04380701|528004375|FG030|Overall Study|Pregnancy|0|||
146409164|NCT04380701|528004376|FG031|Overall Study|Pregnancy|0|||
146409165|NCT04380701|528004377|FG032|Overall Study|Pregnancy|1|||
146409166|NCT04380701|528004378|FG033|Overall Study|Pregnancy|0|||
146409167|NCT04380701|528004345|FG000|Overall Study|Lost to Follow-up|0|||
146409168|NCT04380701|528004346|FG001|Overall Study|Lost to Follow-up|0|||
146409169|NCT04380701|528004347|FG002|Overall Study|Lost to Follow-up|0|||
146409170|NCT04380701|528004348|FG003|Overall Study|Lost to Follow-up|0|||
146409171|NCT04380701|528004349|FG004|Overall Study|Lost to Follow-up|0|||
146409172|NCT04380701|528004350|FG005|Overall Study|Lost to Follow-up|0|||
146409173|NCT04380701|528004351|FG006|Overall Study|Lost to Follow-up|0|||
146409174|NCT04380701|528004352|FG007|Overall Study|Lost to Follow-up|0|||
146409175|NCT04380701|528004353|FG008|Overall Study|Lost to Follow-up|0|||
146409176|NCT04380701|528004354|FG009|Overall Study|Lost to Follow-up|0|||
146409177|NCT04380701|528004355|FG010|Overall Study|Lost to Follow-up|0|||
146409178|NCT04380701|528004356|FG011|Overall Study|Lost to Follow-up|0|||
146409179|NCT04380701|528004357|FG012|Overall Study|Lost to Follow-up|0|||
146409180|NCT04380701|528004358|FG013|Overall Study|Lost to Follow-up|0|||
146409181|NCT04380701|528004359|FG014|Overall Study|Lost to Follow-up|0|||
146409182|NCT04380701|528004360|FG015|Overall Study|Lost to Follow-up|0|||
146409183|NCT04380701|528004361|FG016|Overall Study|Lost to Follow-up|0|||
146409184|NCT04380701|528004362|FG017|Overall Study|Lost to Follow-up|0|||
146409185|NCT04380701|528004363|FG018|Overall Study|Lost to Follow-up|0|||
146409186|NCT04380701|528004364|FG019|Overall Study|Lost to Follow-up|0|||
146409187|NCT04380701|528004365|FG020|Overall Study|Lost to Follow-up|1|||
146409188|NCT04380701|528004366|FG021|Overall Study|Lost to Follow-up|0|||
146409189|NCT04380701|528004367|FG022|Overall Study|Lost to Follow-up|0|||
146283851|NCT00092495|527551857|FG003|Base Study Vaccination Period|Pregnancy|0|||
146409190|NCT04380701|528004368|FG023|Overall Study|Lost to Follow-up|1|||
146409191|NCT04380701|528004369|FG024|Overall Study|Lost to Follow-up|0|||
146409192|NCT04380701|528004370|FG025|Overall Study|Lost to Follow-up|0|||
146409193|NCT04380701|528004371|FG026|Overall Study|Lost to Follow-up|0|||
146409194|NCT04380701|528004372|FG027|Overall Study|Lost to Follow-up|0|||
146409195|NCT04380701|528004373|FG028|Overall Study|Lost to Follow-up|0|||
146172542|NCT02508532|527145144|FG004|Part 2 - Treatment|Disease Progression|0|||
146071908|NCT03887702|526782670|FG002|Overall Study|Study terminated|2|||
146071909|NCT03887702|526782671|FG003|Overall Study|Study terminated|2|||
146071910|NCT01193257|526782677|FG000|Overall Study|Death|202|||
146071911|NCT01193257|526782678|FG001|Overall Study|Death|391|||
146071912|NCT01193257|526782677|FG000|Overall Study|Study termination by sponsor|0|||
146071913|NCT01193257|526782678|FG001|Overall Study|Study termination by sponsor|3|||
146071914|NCT01193257|526782677|FG000|Overall Study|Withdrawal by Subject|26|||
146071915|NCT01193257|526782678|FG001|Overall Study|Withdrawal by Subject|86|||
146071916|NCT01193257|526782677|FG000|Overall Study|Lost to Follow-up|2|||
146071917|NCT01193257|526782678|FG001|Overall Study|Lost to Follow-up|3|||
146071918|NCT01193257|526782677|FG000|Overall Study|Unblinded due to futility|135|||
146071919|NCT01193257|526782678|FG001|Overall Study|Unblinded due to futility|251|||
146071920|NCT01675544|526782686|FG000|Overall Study|Withdrawal by Subject|2|||
146071921|NCT03544333|526782687|FG000|Overall Study|Withdrawal by Subject|1|||
146409196|NCT04380701|528004374|FG029|Overall Study|Lost to Follow-up|1|||
146409197|NCT04380701|528004375|FG030|Overall Study|Lost to Follow-up|0|||
146409198|NCT04380701|528004376|FG031|Overall Study|Lost to Follow-up|0|||
146409199|NCT04380701|528004377|FG032|Overall Study|Lost to Follow-up|0|||
146409200|NCT04380701|528004378|FG033|Overall Study|Lost to Follow-up|1|||
146409201|NCT04380701|528004345|FG000|Overall Study|Private reason(s)|0|||
146409202|NCT04380701|528004346|FG001|Overall Study|Private reason(s)|0|||
146409203|NCT04380701|528004347|FG002|Overall Study|Private reason(s)|0|||
146409204|NCT04380701|528004348|FG003|Overall Study|Private reason(s)|0|||
146409205|NCT04380701|528004349|FG004|Overall Study|Private reason(s)|0|||
146409206|NCT04380701|528004350|FG005|Overall Study|Private reason(s)|0|||
146409207|NCT04380701|528004351|FG006|Overall Study|Private reason(s)|1|||
146409208|NCT04380701|528004352|FG007|Overall Study|Private reason(s)|0|||
146409209|NCT04380701|528004353|FG008|Overall Study|Private reason(s)|1|||
146409210|NCT04380701|528004354|FG009|Overall Study|Private reason(s)|1|||
146409211|NCT04380701|528004355|FG010|Overall Study|Private reason(s)|0|||
146409212|NCT04380701|528004356|FG011|Overall Study|Private reason(s)|0|||
146409213|NCT04380701|528004357|FG012|Overall Study|Private reason(s)|0|||
146409214|NCT04380701|528004358|FG013|Overall Study|Private reason(s)|0|||
146409215|NCT04380701|528004359|FG014|Overall Study|Private reason(s)|0|||
146409216|NCT04380701|528004360|FG015|Overall Study|Private reason(s)|0|||
146409217|NCT04380701|528004361|FG016|Overall Study|Private reason(s)|0|||
146409218|NCT04380701|528004362|FG017|Overall Study|Private reason(s)|0|||
146409219|NCT04380701|528004363|FG018|Overall Study|Private reason(s)|0|||
146409220|NCT04380701|528004364|FG019|Overall Study|Private reason(s)|0|||
146409221|NCT04380701|528004365|FG020|Overall Study|Private reason(s)|0|||
146409222|NCT04380701|528004366|FG021|Overall Study|Private reason(s)|0|||
146409223|NCT04380701|528004367|FG022|Overall Study|Private reason(s)|0|||
146409224|NCT04380701|528004368|FG023|Overall Study|Private reason(s)|1|||
146409225|NCT04380701|528004369|FG024|Overall Study|Private reason(s)|0|||
146409226|NCT04380701|528004370|FG025|Overall Study|Private reason(s)|0|||
146409227|NCT04380701|528004371|FG026|Overall Study|Private reason(s)|0|||
146409228|NCT04380701|528004372|FG027|Overall Study|Private reason(s)|0|||
146409229|NCT04380701|528004373|FG028|Overall Study|Private reason(s)|0|||
146409230|NCT04380701|528004374|FG029|Overall Study|Private reason(s)|1|||
146409231|NCT04380701|528004375|FG030|Overall Study|Private reason(s)|0|||
146409232|NCT04380701|528004376|FG031|Overall Study|Private reason(s)|0|||
146409233|NCT04380701|528004377|FG032|Overall Study|Private reason(s)|0|||
146409234|NCT04380701|528004378|FG033|Overall Study|Private reason(s)|0|||
146409235|NCT04380701|528004345|FG000|Overall Study|Withdrawal by Subject|0|||
146409236|NCT04380701|528004346|FG001|Overall Study|Withdrawal by Subject|0|||
146409237|NCT04380701|528004347|FG002|Overall Study|Withdrawal by Subject|0|||
146409238|NCT04380701|528004348|FG003|Overall Study|Withdrawal by Subject|0|||
146409239|NCT04380701|528004349|FG004|Overall Study|Withdrawal by Subject|0|||
146409240|NCT04380701|528004350|FG005|Overall Study|Withdrawal by Subject|0|||
146409241|NCT04380701|528004351|FG006|Overall Study|Withdrawal by Subject|1|||
146409242|NCT04380701|528004352|FG007|Overall Study|Withdrawal by Subject|1|||
146409243|NCT04380701|528004353|FG008|Overall Study|Withdrawal by Subject|0|||
146409244|NCT04380701|528004354|FG009|Overall Study|Withdrawal by Subject|0|||
146071922|NCT03544333|526782688|FG001|Overall Study|Withdrawal by Subject|0|||
146172543|NCT02508532|527145145|FG005|Part 2 - Treatment|Disease Progression|0|||
146409245|NCT04380701|528004355|FG010|Overall Study|Withdrawal by Subject|0|||
146409246|NCT04380701|528004356|FG011|Overall Study|Withdrawal by Subject|1|||
146409247|NCT04380701|528004357|FG012|Overall Study|Withdrawal by Subject|0|||
146409248|NCT04380701|528004358|FG013|Overall Study|Withdrawal by Subject|1|||
146409249|NCT04380701|528004359|FG014|Overall Study|Withdrawal by Subject|0|||
146409250|NCT04380701|528004360|FG015|Overall Study|Withdrawal by Subject|0|||
146071923|NCT03656562|526782690|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
146172544|NCT02508532|527145146|FG006|Part 2 - Treatment|Disease Progression|0|||
146172545|NCT02508532|527145147|FG007|Part 2 - Treatment|Disease Progression|0|||
146409251|NCT04380701|528004361|FG016|Overall Study|Withdrawal by Subject|1|||
146409252|NCT04380701|528004362|FG017|Overall Study|Withdrawal by Subject|0|||
146409253|NCT04380701|528004363|FG018|Overall Study|Withdrawal by Subject|0|||
146172546|NCT02508532|527145148|FG008|Part 2 - Treatment|Disease Progression|118|||
146172547|NCT02508532|527145140|FG000|Part 2 - Treatment|Adverse Event|0|||
146172548|NCT02508532|527145141|FG001|Part 2 - Treatment|Adverse Event|0|||
146172549|NCT02508532|527145142|FG002|Part 2 - Treatment|Adverse Event|0|||
146172550|NCT02508532|527145143|FG003|Part 2 - Treatment|Adverse Event|0|||
146172551|NCT02508532|527145144|FG004|Part 2 - Treatment|Adverse Event|0|||
146172552|NCT02508532|527145145|FG005|Part 2 - Treatment|Adverse Event|0|||
146172553|NCT02508532|527145146|FG006|Part 2 - Treatment|Adverse Event|0|||
146172554|NCT02508532|527145147|FG007|Part 2 - Treatment|Adverse Event|0|||
146172555|NCT02508532|527145148|FG008|Part 2 - Treatment|Adverse Event|49|||
146172556|NCT02508532|527145140|FG000|Part 2 - Treatment|Physician Decision|0|||
146172557|NCT02508532|527145141|FG001|Part 2 - Treatment|Physician Decision|0|||
146172558|NCT02508532|527145142|FG002|Part 2 - Treatment|Physician Decision|0|||
146172559|NCT02508532|527145143|FG003|Part 2 - Treatment|Physician Decision|0|||
146172560|NCT02508532|527145144|FG004|Part 2 - Treatment|Physician Decision|0|||
146172561|NCT02508532|527145145|FG005|Part 2 - Treatment|Physician Decision|0|||
146172562|NCT02508532|527145146|FG006|Part 2 - Treatment|Physician Decision|0|||
146172563|NCT02508532|527145147|FG007|Part 2 - Treatment|Physician Decision|0|||
146172564|NCT02508532|527145148|FG008|Part 2 - Treatment|Physician Decision|12|||
146172565|NCT02508532|527145140|FG000|Part 2 - Treatment|Administrative|0|||
146172566|NCT02508532|527145141|FG001|Part 2 - Treatment|Administrative|0|||
146172567|NCT02508532|527145142|FG002|Part 2 - Treatment|Administrative|0|||
146172568|NCT02508532|527145143|FG003|Part 2 - Treatment|Administrative|0|||
146172569|NCT02508532|527145144|FG004|Part 2 - Treatment|Administrative|0|||
146172570|NCT02508532|527145145|FG005|Part 2 - Treatment|Administrative|0|||
146172571|NCT02508532|527145146|FG006|Part 2 - Treatment|Administrative|0|||
146172572|NCT02508532|527145147|FG007|Part 2 - Treatment|Administrative|0|||
146172573|NCT02508532|527145148|FG008|Part 2 - Treatment|Administrative|3|||
146172574|NCT02508532|527145140|FG000|Part 2 - Treatment|Sponsor Decision|0|||
146172575|NCT02508532|527145141|FG001|Part 2 - Treatment|Sponsor Decision|0|||
146172576|NCT02508532|527145142|FG002|Part 2 - Treatment|Sponsor Decision|0|||
146172577|NCT02508532|527145143|FG003|Part 2 - Treatment|Sponsor Decision|0|||
146172578|NCT02508532|527145144|FG004|Part 2 - Treatment|Sponsor Decision|0|||
146172579|NCT02508532|527145145|FG005|Part 2 - Treatment|Sponsor Decision|0|||
146172580|NCT02508532|527145146|FG006|Part 2 - Treatment|Sponsor Decision|0|||
146172581|NCT02508532|527145147|FG007|Part 2 - Treatment|Sponsor Decision|0|||
146172582|NCT02508532|527145148|FG008|Part 2 - Treatment|Sponsor Decision|28|||
146172583|NCT02508532|527145140|FG000|Part 2 - Treatment|Death|0|||
146172584|NCT02508532|527145141|FG001|Part 2 - Treatment|Death|0|||
146172585|NCT02508532|527145142|FG002|Part 2 - Treatment|Death|0|||
146172586|NCT02508532|527145143|FG003|Part 2 - Treatment|Death|0|||
146172587|NCT02508532|527145144|FG004|Part 2 - Treatment|Death|0|||
146172588|NCT02508532|527145145|FG005|Part 2 - Treatment|Death|0|||
146172589|NCT02508532|527145146|FG006|Part 2 - Treatment|Death|0|||
146172590|NCT02508532|527145147|FG007|Part 2 - Treatment|Death|0|||
146172591|NCT02508532|527145148|FG008|Part 2 - Treatment|Death|1|||
146172592|NCT02508532|527145140|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
146172593|NCT02508532|527145141|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
146172594|NCT02508532|527145142|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
146172595|NCT02508532|527145143|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
146172596|NCT02508532|527145144|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
146172597|NCT02508532|527145145|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
146172598|NCT02508532|527145146|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
146071924|NCT03656562|526782691|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
146071925|NCT03656562|526782692|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
146071926|NCT03656562|526782693|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
146071927|NCT03656562|526782690|FG000|Overall Study|Physician Decision|1|||
146071928|NCT03656562|526782691|FG001|Overall Study|Physician Decision|2|||
146071929|NCT03656562|526782692|FG002|Overall Study|Physician Decision|0|||
146071930|NCT03656562|526782693|FG003|Overall Study|Physician Decision|0|||
146409254|NCT04380701|528004364|FG019|Overall Study|Withdrawal by Subject|0|||
146409255|NCT04380701|528004365|FG020|Overall Study|Withdrawal by Subject|0|||
146071931|NCT03656562|526782690|FG000|Overall Study|Subject Decision|3|||
146409256|NCT04380701|528004366|FG021|Overall Study|Withdrawal by Subject|0|||
146409257|NCT04380701|528004367|FG022|Overall Study|Withdrawal by Subject|2|||
146409258|NCT04380701|528004368|FG023|Overall Study|Withdrawal by Subject|2|||
146409259|NCT04380701|528004369|FG024|Overall Study|Withdrawal by Subject|1|||
146409260|NCT04380701|528004370|FG025|Overall Study|Withdrawal by Subject|1|||
146409261|NCT04380701|528004371|FG026|Overall Study|Withdrawal by Subject|0|||
146409262|NCT04380701|528004372|FG027|Overall Study|Withdrawal by Subject|0|||
146071932|NCT03656562|526782691|FG001|Overall Study|Subject Decision|5|||
146172599|NCT02508532|527145147|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
146172600|NCT02508532|527145148|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
146071933|NCT03656562|526782692|FG002|Overall Study|Subject Decision|0|||
146172601|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
146172602|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
146409263|NCT04380701|528004373|FG028|Overall Study|Withdrawal by Subject|0|||
146409264|NCT04380701|528004374|FG029|Overall Study|Withdrawal by Subject|0|||
146409265|NCT04380701|528004375|FG030|Overall Study|Withdrawal by Subject|0|||
146409266|NCT04380701|528004376|FG031|Overall Study|Withdrawal by Subject|0|||
146409267|NCT04380701|528004377|FG032|Overall Study|Withdrawal by Subject|0|||
146409268|NCT04380701|528004378|FG033|Overall Study|Withdrawal by Subject|0|||
146409269|NCT04380701|528004345|FG000|Overall Study|Adverse Event|0|||
146409270|NCT04380701|528004346|FG001|Overall Study|Adverse Event|0|||
146409271|NCT04380701|528004347|FG002|Overall Study|Adverse Event|0|||
146409272|NCT04380701|528004348|FG003|Overall Study|Adverse Event|0|||
146409273|NCT04380701|528004349|FG004|Overall Study|Adverse Event|0|||
146409274|NCT04380701|528004350|FG005|Overall Study|Adverse Event|1|||
146409275|NCT04380701|528004351|FG006|Overall Study|Adverse Event|0|||
146409276|NCT04380701|528004352|FG007|Overall Study|Adverse Event|0|||
146409277|NCT04380701|528004353|FG008|Overall Study|Adverse Event|0|||
146409278|NCT04380701|528004354|FG009|Overall Study|Adverse Event|0|||
146409279|NCT04380701|528004355|FG010|Overall Study|Adverse Event|0|||
146409280|NCT04380701|528004356|FG011|Overall Study|Adverse Event|0|||
146409281|NCT04380701|528004357|FG012|Overall Study|Adverse Event|0|||
146409282|NCT04380701|528004358|FG013|Overall Study|Adverse Event|0|||
146409283|NCT04380701|528004359|FG014|Overall Study|Adverse Event|0|||
146409284|NCT04380701|528004360|FG015|Overall Study|Adverse Event|1|||
146409285|NCT04380701|528004361|FG016|Overall Study|Adverse Event|0|||
146409286|NCT04380701|528004362|FG017|Overall Study|Adverse Event|0|||
146409287|NCT04380701|528004363|FG018|Overall Study|Adverse Event|0|||
146409288|NCT04380701|528004364|FG019|Overall Study|Adverse Event|1|||
146409289|NCT04380701|528004365|FG020|Overall Study|Adverse Event|0|||
146409290|NCT04380701|528004366|FG021|Overall Study|Adverse Event|0|||
146409291|NCT04380701|528004367|FG022|Overall Study|Adverse Event|0|||
146409292|NCT04380701|528004368|FG023|Overall Study|Adverse Event|0|||
146409293|NCT04380701|528004369|FG024|Overall Study|Adverse Event|0|||
146409294|NCT04380701|528004370|FG025|Overall Study|Adverse Event|0|||
146409295|NCT04380701|528004371|FG026|Overall Study|Adverse Event|0|||
146409296|NCT04380701|528004372|FG027|Overall Study|Adverse Event|0|||
146409297|NCT04380701|528004373|FG028|Overall Study|Adverse Event|0|||
146409298|NCT04380701|528004374|FG029|Overall Study|Adverse Event|0|||
146409299|NCT04380701|528004375|FG030|Overall Study|Adverse Event|0|||
146409300|NCT04380701|528004376|FG031|Overall Study|Adverse Event|0|||
146409301|NCT04380701|528004377|FG032|Overall Study|Adverse Event|0|||
146409302|NCT04380701|528004378|FG033|Overall Study|Adverse Event|0|||
146409303|NCT04380701|528004345|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
146071934|NCT03656562|526782693|FG003|Overall Study|Subject Decision|2|||
146071935|NCT02136069|526782694|FG000|Overall Study|UC flare-up|1|||
146071936|NCT02136069|526782695|FG001|Overall Study|UC flare-up|0|||
146071937|NCT02136069|526782694|FG000|Overall Study|Adverse Event|6|||
146071938|NCT02136069|526782695|FG001|Overall Study|Adverse Event|8|||
146071939|NCT02136069|526782694|FG000|Overall Study|Death|0|||
146071940|NCT02136069|526782695|FG001|Overall Study|Death|1|||
146071941|NCT02136069|526782694|FG000|Overall Study|Lack of Efficacy|10|||
146071942|NCT02136069|526782695|FG001|Overall Study|Lack of Efficacy|4|||
146071943|NCT02136069|526782694|FG000|Overall Study|Lost to Follow-up|1|||
146071944|NCT02136069|526782695|FG001|Overall Study|Lost to Follow-up|0|||
146071945|NCT02136069|526782694|FG000|Overall Study|Non-Compliance|1|||
146071946|NCT02136069|526782695|FG001|Overall Study|Non-Compliance|0|||
146071947|NCT02136069|526782694|FG000|Overall Study|Physician Decision|5|||
146071948|NCT02136069|526782695|FG001|Overall Study|Physician Decision|4|||
146071949|NCT02136069|526782694|FG000|Overall Study|Withdrawal by Subject|10|||
146071950|NCT02136069|526782695|FG001|Overall Study|Withdrawal by Subject|11|||
146071951|NCT04693234|526782696|FG000|Overall Study|Death|79|||
146071952|NCT04693234|526782697|FG001|Overall Study|Death|19|||
146071953|NCT04693234|526782696|FG000|Overall Study|Sponsor Ended Study|47|||
146071954|NCT04693234|526782697|FG001|Overall Study|Sponsor Ended Study|18|||
146071955|NCT04693234|526782696|FG000|Overall Study|Withdrawal by Subject|10|||
146409304|NCT04380701|528004346|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
146409305|NCT04380701|528004347|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
146409306|NCT04380701|528004348|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
146409307|NCT04380701|528004349|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
146409308|NCT04380701|528004350|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
146409309|NCT04380701|528004351|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
146071956|NCT04693234|526782697|FG001|Overall Study|Withdrawal by Subject|2|||
146071957|NCT04693234|526782696|FG000|Overall Study|Lost to Follow-up|2|||
146071958|NCT04693234|526782697|FG001|Overall Study|Lost to Follow-up|1|||
146071959|NCT00459186|526782698|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
146071960|NCT00459186|526782698|FG000|PET Imaging and Assessment|Adverse Event|3|||
146409310|NCT04380701|528004352|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
146409311|NCT04380701|528004353|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
146409312|NCT04380701|528004354|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
146409313|NCT04380701|528004355|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
146409314|NCT04380701|528004356|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
146409315|NCT04380701|528004357|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
146071961|NCT02920242|526782699|FG000|Overall Study|Withdrawal by Subject|1|||
146071962|NCT02920242|526782700|FG001|Overall Study|Withdrawal by Subject|0|||
146071963|NCT02920242|526782701|FG002|Overall Study|Withdrawal by Subject|1|||
146071964|NCT02920242|526782699|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
146071965|NCT02920242|526782700|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
146071966|NCT02920242|526782701|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
146071967|NCT00441064|526782702|FG000|Overall Study|Adverse Event|1|||
146071968|NCT00441064|526782703|FG001|Overall Study|Adverse Event|0|||
146071969|NCT00441064|526782702|FG000|Overall Study|Abnormal laboratory values|0|||
146071970|NCT00441064|526782703|FG001|Overall Study|Abnormal laboratory values|2|||
146071971|NCT00441064|526782702|FG000|Overall Study|Abnormal test procedure results|0|||
146071972|NCT00441064|526782703|FG001|Overall Study|Abnormal test procedure results|1|||
146071973|NCT00441064|526782702|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146071974|NCT00441064|526782703|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146071975|NCT00441064|526782702|FG000|Overall Study|Protocol Deviation|3|||
146071976|NCT00441064|526782703|FG001|Overall Study|Protocol Deviation|2|||
146071977|NCT00441064|526782702|FG000|Overall Study|Patient withdrew consent|5|||
146071978|NCT00441064|526782703|FG001|Overall Study|Patient withdrew consent|2|||
146071979|NCT03051178|526782704|FG000|Overall Study|Withdrawal by Subject|5|||
146071980|NCT00953056|526782705|FG000|Overall Study|Withdrew Consent|0|||
146071981|NCT00953056|526782706|FG001|Overall Study|Withdrew Consent|0|||
146071982|NCT00953056|526782707|FG002|Overall Study|Withdrew Consent|0|||
146071983|NCT00953056|526782708|FG003|Overall Study|Withdrew Consent|0|||
146071984|NCT00953056|526782709|FG004|Overall Study|Withdrew Consent|2|||
146071985|NCT00953056|526782710|FG005|Overall Study|Withdrew Consent|3|||
146071986|NCT00953056|526782705|FG000|Overall Study|Serious Adverse Event|0|||
146071987|NCT00953056|526782706|FG001|Overall Study|Serious Adverse Event|0|||
146071988|NCT00953056|526782707|FG002|Overall Study|Serious Adverse Event|0|||
146071989|NCT00953056|526782708|FG003|Overall Study|Serious Adverse Event|0|||
146071990|NCT00953056|526782709|FG004|Overall Study|Serious Adverse Event|0|||
146071991|NCT00953056|526782710|FG005|Overall Study|Serious Adverse Event|1|||
146071992|NCT03962504|526782711|FG000|Overall Study|Other|11|||
146071993|NCT03962504|526782712|FG001|Overall Study|Other|32|||
146071994|NCT02813577|526782713|FG000|Overall Study|Study terminated|4|||
146071995|NCT01388335|526782714|FG000|Period 1|Progressive Disease|1|||
146071996|NCT01388335|526782714|FG000|Period 2|Progressive Disease|2|||
146071997|NCT01388335|526782714|FG000|Period 2|Sponsor Decision|1|||
146071998|NCT01388335|526782714|FG000|Safety Extension|Progressive Disease|7|||
146071999|NCT03339219|526782715|FG000|Overall Study|Death|12|||
146072000|NCT03339219|526782715|FG000|Overall Study|Site Terminated by Sponsor|22|||
146072001|NCT03339219|526782715|FG000|Overall Study|Withdrawal by Subject|1|||
146072002|NCT00885534|526782719|FG000|Overall Study|Patient deemed ineligible|1|||
146072003|NCT01032889|526782720|FG000|Overall Study|Adverse Event|2|||
146072004|NCT01032889|526782721|FG001|Overall Study|Adverse Event|2|||
146072005|NCT01032889|526782722|FG002|Overall Study|Adverse Event|0|||
146072006|NCT01032889|526782720|FG000|Overall Study|Withdrawal of Consent|1|||
146072007|NCT01032889|526782721|FG001|Overall Study|Withdrawal of Consent|2|||
146072008|NCT01032889|526782722|FG002|Overall Study|Withdrawal of Consent|1|||
146072009|NCT01032889|526782720|FG000|Overall Study|Patient Request|0|||
146072010|NCT01032889|526782721|FG001|Overall Study|Patient Request|1|||
146072011|NCT01032889|526782722|FG002|Overall Study|Patient Request|0|||
146072012|NCT01032889|526782720|FG000|Overall Study|Lost to Follow-up|1|||
146072013|NCT01032889|526782721|FG001|Overall Study|Lost to Follow-up|1|||
146072014|NCT01032889|526782722|FG002|Overall Study|Lost to Follow-up|0|||
146072015|NCT01032889|526782720|FG000|Overall Study|Lack of Submental Fat|2|||
146072016|NCT01032889|526782721|FG001|Overall Study|Lack of Submental Fat|8|||
146072017|NCT01032889|526782722|FG002|Overall Study|Lack of Submental Fat|1|||
146072018|NCT01032889|526782720|FG000|Overall Study|Miscellaneous Reasons|2|||
146072019|NCT01032889|526782721|FG001|Overall Study|Miscellaneous Reasons|1|||
146072020|NCT01032889|526782722|FG002|Overall Study|Miscellaneous Reasons|1|||
146072021|NCT01500720|526782724|FG000|Overall Study|Randomized But Not Treated|1|||
146072022|NCT01500720|526782725|FG001|Overall Study|Randomized But Not Treated|1|||
146072023|NCT01500720|526782724|FG000|Overall Study|Other|4|||
146072024|NCT01500720|526782725|FG001|Overall Study|Other|8|||
146072025|NCT00740857|526782726|FG000|Overall Study|Withdrawal by Subject|1|||
146072026|NCT00740857|526782727|FG001|Overall Study|Withdrawal by Subject|0|||
146072027|NCT00740857|526782728|FG002|Overall Study|Withdrawal by Subject|0|||
146072028|NCT03532451|526782729|FG000|Overall Study|Withdrawal by Subject|0|||
146072029|NCT03532451|526782730|FG001|Overall Study|Withdrawal by Subject|1|||
146072030|NCT03532451|526782729|FG000|Overall Study|Did not undergo surgery|1|||
146072031|NCT03532451|526782730|FG001|Overall Study|Did not undergo surgery|1|||
146072032|NCT02527421|526782731|FG000|Overall Study|Withdrawal by Subject|1|||
146072033|NCT02527421|526782732|FG001|Overall Study|Withdrawal by Subject|0|||
146072034|NCT02541604|526782733|FG000|Overall Study|Death|6|||
146072035|NCT02541604|526782734|FG001|Overall Study|Death|5|||
146072036|NCT02541604|526782735|FG002|Overall Study|Death|7|||
146072037|NCT02541604|526782736|FG003|Overall Study|Death|2|||
146072038|NCT02541604|526782737|FG004|Overall Study|Death|9|||
146172603|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
146172604|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
146172605|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
146172606|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
146172607|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
146172608|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
146172609|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
146172610|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
146172611|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172612|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
146172613|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172614|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172615|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172616|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172617|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
146172618|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
146172619|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Death|0|||
146172620|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Death|4|||
146172621|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Death|2|||
146172622|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Death|4|||
146172623|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Death|3|||
146172624|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Death|0|||
146172625|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Death|0|||
146172626|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Death|1|||
146172627|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Death|111|||
146172628|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146172629|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146172630|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
146172631|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146172632|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146172633|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146172634|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146172635|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
146172636|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
146172637|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172638|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172639|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172640|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172641|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172642|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172643|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146172644|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
146072039|NCT02541604|526782738|FG005|Overall Study|Death|8|||
146072040|NCT02541604|526782739|FG006|Overall Study|Death|9|||
146072041|NCT02541604|526782740|FG007|Overall Study|Death|9|||
146072042|NCT02541604|526782741|FG008|Overall Study|Death|3|||
146072043|NCT02541604|526782742|FG009|Overall Study|Death|4|||
146072044|NCT02541604|526782743|FG010|Overall Study|Death|2|||
146072045|NCT02541604|526782744|FG011|Overall Study|Death|3|||
146072046|NCT02541604|526782733|FG000|Overall Study|Lost to Follow-up|2|||
146072047|NCT02541604|526782734|FG001|Overall Study|Lost to Follow-up|0|||
146072048|NCT02541604|526782735|FG002|Overall Study|Lost to Follow-up|1|||
146072049|NCT02541604|526782736|FG003|Overall Study|Lost to Follow-up|0|||
146172645|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
146172646|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172647|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172648|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
146172649|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172650|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
146172651|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172652|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172653|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
146172654|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
146172655|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172656|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172657|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172658|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172659|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172660|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146072050|NCT02541604|526782737|FG004|Overall Study|Lost to Follow-up|0|||
146172661|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172662|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
146172663|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
146172664|NCT02508532|527145140|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146172665|NCT02508532|527145141|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146172666|NCT02508532|527145142|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146172667|NCT02508532|527145143|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146172668|NCT02508532|527145144|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
146172669|NCT02508532|527145145|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
146172670|NCT02508532|527145146|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
146172671|NCT02508532|527145147|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
146172672|NCT02508532|527145148|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
146172673|NCT00301080|527145149|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
146172674|NCT00301080|527145150|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146172675|NCT00301080|527145151|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146172676|NCT00301080|527145152|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146172677|NCT00301080|527145153|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
146172678|NCT03502616|527145154|FG000|Up to Week 16|Withdrawal by Subject|1|||
146172679|NCT03502616|527145155|FG001|Up to Week 16|Withdrawal by Subject|2|||
146172680|NCT03502616|527145154|FG000|Up to Week 16|Lost to Follow-up|0|||
146172681|NCT03502616|527145155|FG001|Up to Week 16|Lost to Follow-up|1|||
146172682|NCT03502616|527145154|FG000|Up to Week 16|Randomized, but not treated|1|||
146172683|NCT03502616|527145155|FG001|Up to Week 16|Randomized, but not treated|0|||
146172684|NCT03502616|527145154|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
146172685|NCT03502616|527145155|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
146172686|NCT03502616|527145154|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
146172687|NCT03502616|527145155|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
146172688|NCT04359771|527145157|FG000|Overall Study|Lack of Efficacy|2|||
146172689|NCT04359771|527145158|FG001|Overall Study|Lack of Efficacy|2|||
146172690|NCT02917265|527145159|FG000|Overall Study|Physician Decision|1|||
146172691|NCT02917265|527145160|FG001|Overall Study|Physician Decision|0|||
146172692|NCT02917265|527145159|FG000|Overall Study|Withdrawal by Subject|1|||
146172693|NCT02917265|527145160|FG001|Overall Study|Withdrawal by Subject|0|||
146172694|NCT01216163|527145161|FG000|Overall Study|Withdrawal by Subject|1|||
146172695|NCT01216163|527145162|FG001|Overall Study|Withdrawal by Subject|1|||
146172696|NCT01216163|527145163|FG002|Overall Study|Withdrawal by Subject|0|||
146172697|NCT02237508|527145165|FG000|Overall Study|Withdrawal by Subject|0|||
146172698|NCT02237508|527145166|FG001|Overall Study|Withdrawal by Subject|2|||
146172699|NCT02237508|527145167|FG002|Overall Study|Withdrawal by Subject|0|||
146172700|NCT02237508|527145168|FG003|Overall Study|Withdrawal by Subject|1|||
146172701|NCT02237508|527145169|FG004|Overall Study|Withdrawal by Subject|0|||
146172702|NCT02237508|527145170|FG005|Overall Study|Withdrawal by Subject|1|||
146172703|NCT02237508|527145171|FG006|Overall Study|Withdrawal by Subject|1|||
146172704|NCT02237508|527145172|FG007|Overall Study|Withdrawal by Subject|0|||
146172705|NCT02237508|527145173|FG008|Overall Study|Withdrawal by Subject|1|||
146172706|NCT02237508|527145174|FG009|Overall Study|Withdrawal by Subject|0|||
146172707|NCT02237508|527145165|FG000|Overall Study|Physician Decision|0|||
146172708|NCT02237508|527145166|FG001|Overall Study|Physician Decision|1|||
146172709|NCT02237508|527145167|FG002|Overall Study|Physician Decision|0|||
146172710|NCT02237508|527145168|FG003|Overall Study|Physician Decision|0|||
146172711|NCT02237508|527145169|FG004|Overall Study|Physician Decision|0|||
146172712|NCT02237508|527145170|FG005|Overall Study|Physician Decision|0|||
146172713|NCT02237508|527145171|FG006|Overall Study|Physician Decision|0|||
146172714|NCT02237508|527145172|FG007|Overall Study|Physician Decision|0|||
146172715|NCT02237508|527145173|FG008|Overall Study|Physician Decision|0|||
146172716|NCT02237508|527145174|FG009|Overall Study|Physician Decision|0|||
146172717|NCT02237508|527145165|FG000|Overall Study|Protocol Violation|0|||
146172718|NCT02237508|527145166|FG001|Overall Study|Protocol Violation|0|||
146172719|NCT02237508|527145167|FG002|Overall Study|Protocol Violation|1|||
146172720|NCT02237508|527145168|FG003|Overall Study|Protocol Violation|0|||
146172721|NCT02237508|527145169|FG004|Overall Study|Protocol Violation|0|||
146172722|NCT02237508|527145170|FG005|Overall Study|Protocol Violation|0|||
146172723|NCT02237508|527145171|FG006|Overall Study|Protocol Violation|0|||
146172724|NCT02237508|527145172|FG007|Overall Study|Protocol Violation|0|||
146172725|NCT02237508|527145173|FG008|Overall Study|Protocol Violation|0|||
146172726|NCT02237508|527145174|FG009|Overall Study|Protocol Violation|0|||
146172727|NCT04000594|527145175|FG000|Overall Study|Withdrawal by Subject|1|||
146172728|NCT04000594|527145176|FG001|Overall Study|Withdrawal by Subject|0|||
146172729|NCT04000594|527145177|FG002|Overall Study|Withdrawal by Subject|0|||
146172730|NCT01905046|527145178|FG000|Months 13-24|Withdrawal by Subject|10|||
146172731|NCT01905046|527145179|FG001|Months 13-24|Withdrawal by Subject|10|||
146172732|NCT01905046|527145178|FG000|Months 13-24|Adverse Event|3|||
146172733|NCT01905046|527145179|FG001|Months 13-24|Adverse Event|2|||
146172734|NCT01905046|527145178|FG000|Months 13-24|Protocol Violation|3|||
146172735|NCT01905046|527145179|FG001|Months 13-24|Protocol Violation|3|||
146172736|NCT01905046|527145178|FG000|Months 13-24|Physician Decision|1|||
146172737|NCT01905046|527145179|FG001|Months 13-24|Physician Decision|0|||
146172738|NCT05672680|527145180|FG000|Overall Study|Patient Did Not Complete the Form|5|||
146172739|NCT05672680|527145181|FG001|Overall Study|Patient Did Not Complete the Form|4|||
146172740|NCT05672680|527145180|FG000|Overall Study|Procedure Aborted|1|||
146172741|NCT05672680|527145181|FG001|Overall Study|Procedure Aborted|0|||
146172742|NCT00116272|527145182|FG000|Overall Study|Lost to Follow-up|11|||
146172743|NCT00116272|527145183|FG001|Overall Study|Lost to Follow-up|6|||
146172744|NCT03188120|527145185|FG000|Overall Study|Adverse Event|4|||
146172745|NCT03188120|527145185|FG000|Overall Study|Insufficient Effectiveness|8|||
146172746|NCT03188120|527145185|FG000|Overall Study|Improved|12|||
146172747|NCT03188120|527145185|FG000|Overall Study|Lost to Follow-up|7|||
146172748|NCT03188120|527145185|FG000|Overall Study|Other than specified|3|||
146172749|NCT03188120|527145185|FG000|Overall Study|No visit after the first visit|13|||
146172750|NCT00576732|527145186|FG000|DOUBLE BLIND|Adverse Event|0|||
146172751|NCT00576732|527145187|FG001|DOUBLE BLIND|Adverse Event|0|||
146172752|NCT00576732|527145188|FG002|DOUBLE BLIND|Adverse Event|1|||
146172753|NCT00576732|527145189|FG003|DOUBLE BLIND|Adverse Event|0|||
146172754|NCT00576732|527145190|FG004|DOUBLE BLIND|Adverse Event|0|||
146172755|NCT00576732|527145191|FG005|DOUBLE BLIND|Adverse Event|0|||
146172756|NCT00576732|527145186|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
146172757|NCT00576732|527145187|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
146172758|NCT00576732|527145188|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
146172759|NCT00576732|527145189|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
146172760|NCT00576732|527145190|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
146172761|NCT00576732|527145191|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
146172762|NCT00576732|527145186|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
146172763|NCT00576732|527145187|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
146172764|NCT00576732|527145188|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
146172765|NCT00576732|527145189|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
146172766|NCT00576732|527145190|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
146172767|NCT00576732|527145191|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
146172768|NCT00576732|527145186|FG000|DOUBLE BLIND|OTHER|0|||
146172769|NCT00576732|527145187|FG001|DOUBLE BLIND|OTHER|2|||
146172770|NCT00576732|527145188|FG002|DOUBLE BLIND|OTHER|1|||
146172771|NCT00576732|527145189|FG003|DOUBLE BLIND|OTHER|0|||
146172772|NCT00576732|527145190|FG004|DOUBLE BLIND|OTHER|0|||
146172773|NCT00576732|527145191|FG005|DOUBLE BLIND|OTHER|0|||
146172774|NCT00576732|527145186|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
146172775|NCT00576732|527145187|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
146172776|NCT00576732|527145188|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
146172777|NCT00576732|527145189|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
146172778|NCT00576732|527145190|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
146172779|NCT00576732|527145191|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
146172780|NCT00576732|527145186|FG000|DOUBLE BLIND|Protocol Violation|1|||
146172781|NCT00576732|527145187|FG001|DOUBLE BLIND|Protocol Violation|0|||
146172782|NCT00576732|527145188|FG002|DOUBLE BLIND|Protocol Violation|0|||
146172783|NCT00576732|527145189|FG003|DOUBLE BLIND|Protocol Violation|0|||
146172784|NCT00576732|527145190|FG004|DOUBLE BLIND|Protocol Violation|0|||
146172785|NCT00576732|527145191|FG005|DOUBLE BLIND|Protocol Violation|0|||
146172786|NCT00576732|527145186|FG000|OPEN LABEL|Adverse Event|0|||
146172787|NCT00576732|527145187|FG001|OPEN LABEL|Adverse Event|0|||
146172788|NCT00576732|527145188|FG002|OPEN LABEL|Adverse Event|0|||
146172789|NCT00576732|527145189|FG003|OPEN LABEL|Adverse Event|4|||
146172790|NCT00576732|527145190|FG004|OPEN LABEL|Adverse Event|0|||
146172791|NCT00576732|527145191|FG005|OPEN LABEL|Adverse Event|1|||
146172792|NCT00576732|527145186|FG000|OPEN LABEL|Lost to Follow-up|0|||
146172793|NCT00576732|527145187|FG001|OPEN LABEL|Lost to Follow-up|0|||
146172794|NCT00576732|527145188|FG002|OPEN LABEL|Lost to Follow-up|0|||
146172795|NCT00576732|527145189|FG003|OPEN LABEL|Lost to Follow-up|2|||
146172796|NCT00576732|527145190|FG004|OPEN LABEL|Lost to Follow-up|1|||
146172797|NCT00576732|527145191|FG005|OPEN LABEL|Lost to Follow-up|1|||
146172798|NCT00576732|527145186|FG000|OPEN LABEL|Withdrawal by Subject|0|||
146172799|NCT00576732|527145187|FG001|OPEN LABEL|Withdrawal by Subject|0|||
146172800|NCT00576732|527145188|FG002|OPEN LABEL|Withdrawal by Subject|0|||
146172801|NCT00576732|527145189|FG003|OPEN LABEL|Withdrawal by Subject|1|||
146172802|NCT00576732|527145190|FG004|OPEN LABEL|Withdrawal by Subject|0|||
146172803|NCT00576732|527145191|FG005|OPEN LABEL|Withdrawal by Subject|1|||
146172804|NCT00576732|527145186|FG000|OPEN LABEL|OTHER|0|||
146172805|NCT00576732|527145187|FG001|OPEN LABEL|OTHER|0|||
146172806|NCT00576732|527145188|FG002|OPEN LABEL|OTHER|0|||
146172807|NCT00576732|527145189|FG003|OPEN LABEL|OTHER|0|||
146172808|NCT00576732|527145190|FG004|OPEN LABEL|OTHER|0|||
146172809|NCT00576732|527145191|FG005|OPEN LABEL|OTHER|2|||
146172810|NCT00576732|527145186|FG000|OPEN LABEL|Lack of Efficacy|0|||
146172811|NCT00576732|527145187|FG001|OPEN LABEL|Lack of Efficacy|0|||
146172812|NCT00576732|527145188|FG002|OPEN LABEL|Lack of Efficacy|0|||
146172813|NCT00576732|527145189|FG003|OPEN LABEL|Lack of Efficacy|2|||
146172814|NCT00576732|527145190|FG004|OPEN LABEL|Lack of Efficacy|2|||
146172815|NCT00576732|527145191|FG005|OPEN LABEL|Lack of Efficacy|3|||
146172816|NCT00576732|527145186|FG000|OPEN LABEL|Protocol Violation|0|||
146172817|NCT00576732|527145187|FG001|OPEN LABEL|Protocol Violation|0|||
146172818|NCT00576732|527145188|FG002|OPEN LABEL|Protocol Violation|0|||
146172819|NCT00576732|527145189|FG003|OPEN LABEL|Protocol Violation|2|||
146172820|NCT00576732|527145190|FG004|OPEN LABEL|Protocol Violation|1|||
146172821|NCT00576732|527145191|FG005|OPEN LABEL|Protocol Violation|0|||
146172822|NCT01235403|527145192|FG000|Overall Study|Adverse Event|14|||
146072051|NCT02541604|526782738|FG005|Overall Study|Lost to Follow-up|1|||
146072052|NCT02541604|526782739|FG006|Overall Study|Lost to Follow-up|1|||
146072053|NCT02541604|526782740|FG007|Overall Study|Lost to Follow-up|0|||
146072054|NCT02541604|526782741|FG008|Overall Study|Lost to Follow-up|0|||
146172823|NCT01235403|527145192|FG000|Overall Study|Lost to Follow-up|2|||
146172824|NCT01235403|527145192|FG000|Overall Study|Withdrawal by Subject|4|||
146172825|NCT01235403|527145192|FG000|Overall Study|Lack of Efficacy|2|||
146172826|NCT01235403|527145192|FG000|Overall Study|Other reasons for premature termination|4|||
146172827|NCT00990340|527145193|FG000|First 14-day Treatment|Not Compliant|2|||
146172828|NCT00990340|527145194|FG001|First 14-day Treatment|Not Compliant|1|||
146172829|NCT00990340|527145193|FG000|First 14-day Treatment|Lost to Follow-up|2|||
146172830|NCT00990340|527145194|FG001|First 14-day Treatment|Lost to Follow-up|1|||
146172831|NCT00990340|527145193|FG000|First 14-day Treatment|Protocol Violation|2|||
146172832|NCT00990340|527145194|FG001|First 14-day Treatment|Protocol Violation|2|||
146172833|NCT04615182|527145195|FG000|Overall Study|Re-transplanted|2|||
146172834|NCT04615182|527145195|FG000|Overall Study|Protocol Violation|6|||
146172835|NCT04615182|527145195|FG000|Overall Study|Death|6|||
146172836|NCT04615182|527145195|FG000|Overall Study|Death and protocol violation|1|||
146172837|NCT02130284|527145199|FG000|Overall Study|Withdrawal by Subject|3|||
146172838|NCT02130284|527145199|FG000|Overall Study|Subject Withdrew Consent|1|||
146172839|NCT02130284|527145199|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
146172840|NCT02130284|527145199|FG000|Overall Study|Subject was screened as backup for study|3|||
146172841|NCT02130284|527145199|FG000|Overall Study|Screen Failure|1|||
146172842|NCT01119898|527145202|FG000|Overall Study|Adverse Event|4|||
146172843|NCT01119898|527145203|FG001|Overall Study|Adverse Event|5|||
146172844|NCT01119898|527145202|FG000|Overall Study|Withdrawal by Subject|1|||
146172845|NCT01119898|527145203|FG001|Overall Study|Withdrawal by Subject|4|||
146172846|NCT01119898|527145202|FG000|Overall Study|Lack of Efficacy|0|||
146172847|NCT01119898|527145203|FG001|Overall Study|Lack of Efficacy|2|||
146172848|NCT01119898|527145202|FG000|Overall Study|Protocol Violation|1|||
146172849|NCT01119898|527145203|FG001|Overall Study|Protocol Violation|1|||
146172850|NCT01119898|527145202|FG000|Overall Study|Medical procedure|1|||
146172851|NCT01119898|527145203|FG001|Overall Study|Medical procedure|0|||
146172852|NCT01119898|527145202|FG000|Overall Study|Randomized in error did not participate|1|||
146172853|NCT01119898|527145203|FG001|Overall Study|Randomized in error did not participate|0|||
146172854|NCT00116844|527145204|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
146172855|NCT00116844|527145205|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
146172856|NCT00116844|527145204|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
146172857|NCT00116844|527145205|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
146172858|NCT00116844|527145204|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
146172859|NCT00116844|527145205|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
146172860|NCT00116844|527145204|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
146172861|NCT00116844|527145205|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
146172862|NCT00116844|527145204|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
146172863|NCT00116844|527145205|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
146172864|NCT00116844|527145204|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
146172865|NCT00116844|527145205|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
146072055|NCT02541604|526782742|FG009|Overall Study|Lost to Follow-up|0|||
146072056|NCT02541604|526782743|FG010|Overall Study|Lost to Follow-up|0|||
146072057|NCT02541604|526782744|FG011|Overall Study|Lost to Follow-up|0|||
146072058|NCT02541604|526782733|FG000|Overall Study|Withdrawal by Subject|2|||
146072059|NCT02541604|526782734|FG001|Overall Study|Withdrawal by Subject|0|||
146072060|NCT02541604|526782735|FG002|Overall Study|Withdrawal by Subject|1|||
146072061|NCT02541604|526782736|FG003|Overall Study|Withdrawal by Subject|0|||
146072062|NCT02541604|526782737|FG004|Overall Study|Withdrawal by Subject|1|||
146072063|NCT02541604|526782738|FG005|Overall Study|Withdrawal by Subject|1|||
146072064|NCT02541604|526782739|FG006|Overall Study|Withdrawal by Subject|0|||
146072065|NCT02541604|526782740|FG007|Overall Study|Withdrawal by Subject|0|||
146072066|NCT02541604|526782741|FG008|Overall Study|Withdrawal by Subject|1|||
146072067|NCT02541604|526782742|FG009|Overall Study|Withdrawal by Subject|0|||
146072068|NCT02541604|526782743|FG010|Overall Study|Withdrawal by Subject|0|||
146072069|NCT02541604|526782744|FG011|Overall Study|Withdrawal by Subject|0|||
146072070|NCT02541604|526782733|FG000|Overall Study|Study Terminated by Sponsor|1|||
146072071|NCT02541604|526782734|FG001|Overall Study|Study Terminated by Sponsor|4|||
146072072|NCT02541604|526782735|FG002|Overall Study|Study Terminated by Sponsor|2|||
146172866|NCT00116844|527145204|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
146172867|NCT00116844|527145205|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
146172868|NCT00116844|527145204|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
146172869|NCT00116844|527145205|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
146072073|NCT02541604|526782736|FG003|Overall Study|Study Terminated by Sponsor|1|||
146072074|NCT02541604|526782737|FG004|Overall Study|Study Terminated by Sponsor|0|||
146072075|NCT02541604|526782738|FG005|Overall Study|Study Terminated by Sponsor|0|||
146072076|NCT02541604|526782739|FG006|Overall Study|Study Terminated by Sponsor|0|||
146072077|NCT02541604|526782740|FG007|Overall Study|Study Terminated by Sponsor|0|||
146072078|NCT02541604|526782741|FG008|Overall Study|Study Terminated by Sponsor|0|||
146072079|NCT02541604|526782742|FG009|Overall Study|Study Terminated by Sponsor|0|||
146072080|NCT02541604|526782743|FG010|Overall Study|Study Terminated by Sponsor|0|||
146072081|NCT02541604|526782744|FG011|Overall Study|Study Terminated by Sponsor|0|||
146072082|NCT02541604|526782733|FG000|Overall Study|Medical condition may jeopardize safety|0|||
146072083|NCT02541604|526782734|FG001|Overall Study|Medical condition may jeopardize safety|0|||
146072084|NCT02541604|526782735|FG002|Overall Study|Medical condition may jeopardize safety|0|||
146072085|NCT02541604|526782736|FG003|Overall Study|Medical condition may jeopardize safety|0|||
146072086|NCT02541604|526782737|FG004|Overall Study|Medical condition may jeopardize safety|0|||
146072087|NCT02541604|526782738|FG005|Overall Study|Medical condition may jeopardize safety|0|||
146072088|NCT02541604|526782739|FG006|Overall Study|Medical condition may jeopardize safety|0|||
146072089|NCT02541604|526782740|FG007|Overall Study|Medical condition may jeopardize safety|1|||
146072090|NCT02541604|526782741|FG008|Overall Study|Medical condition may jeopardize safety|0|||
146072091|NCT02541604|526782742|FG009|Overall Study|Medical condition may jeopardize safety|0|||
146072092|NCT02541604|526782743|FG010|Overall Study|Medical condition may jeopardize safety|0|||
146072093|NCT02541604|526782744|FG011|Overall Study|Medical condition may jeopardize safety|0|||
146072094|NCT01615029|526782745|FG000|Overall Study|Adverse Event|0|||
146072095|NCT01615029|526782746|FG001|Overall Study|Adverse Event|0|||
146072096|NCT01615029|526782747|FG002|Overall Study|Adverse Event|0|||
146072097|NCT01615029|526782748|FG003|Overall Study|Adverse Event|0|||
146072098|NCT01615029|526782749|FG004|Overall Study|Adverse Event|1|||
146072099|NCT01615029|526782745|FG000|Overall Study|Death|0|||
146072100|NCT01615029|526782746|FG001|Overall Study|Death|0|||
146072101|NCT01615029|526782747|FG002|Overall Study|Death|0|||
146072102|NCT01615029|526782748|FG003|Overall Study|Death|0|||
146072103|NCT01615029|526782749|FG004|Overall Study|Death|1|||
146072104|NCT01615029|526782745|FG000|Overall Study|Lost to Follow-up|0|||
146072105|NCT01615029|526782746|FG001|Overall Study|Lost to Follow-up|0|||
146072106|NCT01615029|526782747|FG002|Overall Study|Lost to Follow-up|0|||
146072107|NCT01615029|526782748|FG003|Overall Study|Lost to Follow-up|0|||
146072108|NCT01615029|526782749|FG004|Overall Study|Lost to Follow-up|1|||
146072109|NCT01615029|526782745|FG000|Overall Study|Progressive disease|2|||
146072110|NCT01615029|526782746|FG001|Overall Study|Progressive disease|1|||
146072111|NCT01615029|526782747|FG002|Overall Study|Progressive disease|1|||
146072112|NCT01615029|526782748|FG003|Overall Study|Progressive disease|1|||
146072113|NCT01615029|526782749|FG004|Overall Study|Progressive disease|5|||
146072114|NCT01615029|526782745|FG000|Overall Study|Physician Decision|0|||
146072115|NCT01615029|526782746|FG001|Overall Study|Physician Decision|0|||
146072116|NCT01615029|526782747|FG002|Overall Study|Physician Decision|0|||
146072117|NCT01615029|526782748|FG003|Overall Study|Physician Decision|0|||
146072118|NCT01615029|526782749|FG004|Overall Study|Physician Decision|1|||
146072119|NCT01615029|526782745|FG000|Overall Study|Ongoing|1|||
146072120|NCT01615029|526782746|FG001|Overall Study|Ongoing|2|||
146072121|NCT01615029|526782747|FG002|Overall Study|Ongoing|3|||
146072122|NCT01615029|526782748|FG003|Overall Study|Ongoing|2|||
146072123|NCT01615029|526782749|FG004|Overall Study|Ongoing|23|||
146072124|NCT05064358|526782750|FG000|Overall Study|Death|23|||
146072125|NCT05064358|526782751|FG001|Overall Study|Death|23|||
146072126|NCT05064358|526782752|FG002|Overall Study|Death|25|||
146072127|NCT05064358|526782753|FG003|Overall Study|Death|21|||
146072128|NCT05064358|526782754|FG004|Overall Study|Death|5|||
146072129|NCT05064358|526782750|FG000|Overall Study|Lost to Follow-up|1|||
146072130|NCT05064358|526782751|FG001|Overall Study|Lost to Follow-up|2|||
146072131|NCT05064358|526782752|FG002|Overall Study|Lost to Follow-up|0|||
146072132|NCT05064358|526782753|FG003|Overall Study|Lost to Follow-up|2|||
146072133|NCT05064358|526782754|FG004|Overall Study|Lost to Follow-up|0|||
146072134|NCT05064358|526782750|FG000|Overall Study|Physician Decision|1|||
146072135|NCT05064358|526782751|FG001|Overall Study|Physician Decision|1|||
146072136|NCT05064358|526782752|FG002|Overall Study|Physician Decision|2|||
146072137|NCT05064358|526782753|FG003|Overall Study|Physician Decision|0|||
146072138|NCT05064358|526782754|FG004|Overall Study|Physician Decision|0|||
146072139|NCT05064358|526782750|FG000|Overall Study|Withdrawal by Subject|4|||
146072140|NCT05064358|526782751|FG001|Overall Study|Withdrawal by Subject|5|||
146072141|NCT05064358|526782752|FG002|Overall Study|Withdrawal by Subject|3|||
146072142|NCT05064358|526782753|FG003|Overall Study|Withdrawal by Subject|6|||
146072143|NCT05064358|526782754|FG004|Overall Study|Withdrawal by Subject|3|||
146072144|NCT05064358|526782750|FG000|Overall Study|Ongoing at the time of analysis|1|||
146072145|NCT05064358|526782751|FG001|Overall Study|Ongoing at the time of analysis|2|||
146072146|NCT05064358|526782752|FG002|Overall Study|Ongoing at the time of analysis|2|||
146072147|NCT05064358|526782753|FG003|Overall Study|Ongoing at the time of analysis|2|||
146072148|NCT05064358|526782754|FG004|Overall Study|Ongoing at the time of analysis|2|||
146072149|NCT01287741|526782755|FG000|Overall Study|Withdrawal by Subject|35|||
146072150|NCT01287741|526782756|FG001|Overall Study|Withdrawal by Subject|38|||
146072151|NCT01287741|526782755|FG000|Overall Study|Protocol Violation|2|||
146072152|NCT01287741|526782756|FG001|Overall Study|Protocol Violation|0|||
146072153|NCT01287741|526782755|FG000|Overall Study|Physician Decision|15|||
146072154|NCT01287741|526782756|FG001|Overall Study|Physician Decision|23|||
146072155|NCT01287741|526782755|FG000|Overall Study|Non-compliance|8|||
146072156|NCT01287741|526782756|FG001|Overall Study|Non-compliance|6|||
146072157|NCT01287741|526782755|FG000|Overall Study|Lost to Follow-up|10|||
146072158|NCT01287741|526782756|FG001|Overall Study|Lost to Follow-up|8|||
146072159|NCT01287741|526782755|FG000|Overall Study|Death|32|||
146072160|NCT01287741|526782756|FG001|Overall Study|Death|44|||
146072161|NCT01287741|526782755|FG000|Overall Study|Adverse Event|4|||
146072162|NCT01287741|526782756|FG001|Overall Study|Adverse Event|6|||
146072163|NCT01287741|526782755|FG000|Overall Study|Study terminated by Sponsor|307|||
146072164|NCT01287741|526782756|FG001|Overall Study|Study terminated by Sponsor|315|||
146072165|NCT01287741|526782755|FG000|Overall Study|Progressive disease|190|||
146072166|NCT01287741|526782756|FG001|Overall Study|Progressive disease|166|||
146072167|NCT01287741|526782755|FG000|Overall Study|Reason not specified|23|||
146072168|NCT01287741|526782756|FG001|Overall Study|Reason not specified|9|||
146072169|NCT04421027|526782757|FG000|Treatment Period|Adverse Event|5|||
146072170|NCT04421027|526782758|FG001|Treatment Period|Adverse Event|3|||
146072171|NCT04421027|526782759|FG002|Treatment Period|Adverse Event|0|||
146072172|NCT04421027|526782760|FG003|Treatment Period|Adverse Event|0|||
146072173|NCT04421027|526782757|FG000|Treatment Period|Death|98|||
146072174|NCT04421027|526782758|FG001|Treatment Period|Death|61|||
146072175|NCT04421027|526782759|FG002|Treatment Period|Death|0|||
146072176|NCT04421027|526782760|FG003|Treatment Period|Death|0|||
146072177|NCT04421027|526782757|FG000|Treatment Period|Lost to Follow-up|22|||
146072178|NCT04421027|526782758|FG001|Treatment Period|Lost to Follow-up|20|||
146072179|NCT04421027|526782759|FG002|Treatment Period|Lost to Follow-up|0|||
146072180|NCT04421027|526782760|FG003|Treatment Period|Lost to Follow-up|0|||
146072181|NCT04421027|526782757|FG000|Treatment Period|Other-Unknown|15|||
146072182|NCT04421027|526782758|FG001|Treatment Period|Other-Unknown|9|||
146072183|NCT04421027|526782759|FG002|Treatment Period|Other-Unknown|0|||
146072184|NCT04421027|526782760|FG003|Treatment Period|Other-Unknown|0|||
146072185|NCT04421027|526782757|FG000|Treatment Period|Physician Decision|1|||
146072186|NCT04421027|526782758|FG001|Treatment Period|Physician Decision|1|||
146072187|NCT04421027|526782759|FG002|Treatment Period|Physician Decision|0|||
146072188|NCT04421027|526782760|FG003|Treatment Period|Physician Decision|0|||
146072189|NCT04421027|526782757|FG000|Treatment Period|Withdrawal by Subject|7|||
146072190|NCT04421027|526782758|FG001|Treatment Period|Withdrawal by Subject|12|||
146072191|NCT04421027|526782759|FG002|Treatment Period|Withdrawal by Subject|0|||
146072192|NCT04421027|526782760|FG003|Treatment Period|Withdrawal by Subject|0|||
146072193|NCT04421027|526782757|FG000|Treatment Period|Randomized Not Dosed|9|||
146072194|NCT04421027|526782758|FG001|Treatment Period|Randomized Not Dosed|14|||
146072195|NCT04421027|526782759|FG002|Treatment Period|Randomized Not Dosed|0|||
146072196|NCT04421027|526782760|FG003|Treatment Period|Randomized Not Dosed|0|||
146072197|NCT04421027|526782757|FG000|Follow-Up Period|Adverse Event|0|||
146072198|NCT04421027|526782758|FG001|Follow-Up Period|Adverse Event|0|||
146072199|NCT04421027|526782759|FG002|Follow-Up Period|Adverse Event|0|||
146072200|NCT04421027|526782760|FG003|Follow-Up Period|Adverse Event|3|||
146409316|NCT04380701|528004358|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
146409317|NCT04380701|528004359|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
146409318|NCT04380701|528004360|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
146409319|NCT04380701|528004361|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
146409320|NCT04380701|528004362|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
146409321|NCT04380701|528004363|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
146072201|NCT04421027|526782757|FG000|Follow-Up Period|Death|0|||
146072202|NCT04421027|526782758|FG001|Follow-Up Period|Death|0|||
146072203|NCT04421027|526782759|FG002|Follow-Up Period|Death|16|||
146072204|NCT04421027|526782760|FG003|Follow-Up Period|Death|17|||
146072205|NCT04421027|526782757|FG000|Follow-Up Period|Lost to Follow-up|0|||
146072206|NCT04421027|526782758|FG001|Follow-Up Period|Lost to Follow-up|0|||
146409322|NCT04380701|528004364|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
146409323|NCT04380701|528004365|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
146409324|NCT04380701|528004366|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
146072207|NCT04421027|526782759|FG002|Follow-Up Period|Lost to Follow-up|7|||
146072208|NCT04421027|526782760|FG003|Follow-Up Period|Lost to Follow-up|7|||
146072209|NCT04421027|526782757|FG000|Follow-Up Period|Protocol Deviation|0|||
146072210|NCT04421027|526782758|FG001|Follow-Up Period|Protocol Deviation|0|||
146072211|NCT04421027|526782759|FG002|Follow-Up Period|Protocol Deviation|1|||
146072212|NCT04421027|526782760|FG003|Follow-Up Period|Protocol Deviation|0|||
146072213|NCT04421027|526782757|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146072214|NCT04421027|526782758|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146409325|NCT04380701|528004367|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
146072215|NCT04421027|526782759|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
146072216|NCT04421027|526782760|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
146172870|NCT00116844|527145204|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
146172871|NCT00116844|527145205|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
146172872|NCT03995784|527145206|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
146172873|NCT01786330|527145210|FG000|Overall Study|Withdrawal by Subject|0|||
146172874|NCT01786330|527145211|FG001|Overall Study|Withdrawal by Subject|1|||
146172875|NCT01786330|527145210|FG000|Overall Study|Lost to Follow-up|0|||
146172876|NCT01786330|527145211|FG001|Overall Study|Lost to Follow-up|1|||
146172877|NCT01786330|527145210|FG000|Overall Study|Excluded intraoperatively|0|||
146172878|NCT01786330|527145211|FG001|Overall Study|Excluded intraoperatively|1|||
146172879|NCT01786330|527145210|FG000|Overall Study|Protocol Violation|1|||
146172880|NCT01786330|527145211|FG001|Overall Study|Protocol Violation|0|||
146172881|NCT02172625|527145212|FG000|Overall Study|Adverse Event|0|||
146172882|NCT02172625|527145213|FG001|Overall Study|Adverse Event|1|||
146172883|NCT02172625|527145212|FG000|Overall Study|Pregnancy|0|||
146172884|NCT02172625|527145213|FG001|Overall Study|Pregnancy|1|||
146172885|NCT02172625|527145212|FG000|Overall Study|car accident|0|||
146172886|NCT02172625|527145213|FG001|Overall Study|car accident|1|||
146172887|NCT03285295|527147122|FG000|Alinity s HBsAg|Protocol Violation|11|||
146172888|NCT03285295|527147123|FG001|Alinity s HBsAg|Protocol Violation|0|||
146172889|NCT03285295|527147124|FG002|Alinity s HBsAg|Protocol Violation|0|||
146172890|NCT03285295|527147125|FG003|Alinity s HBsAg|Protocol Violation|0|||
146172891|NCT03285295|527147126|FG004|Alinity s HBsAg|Protocol Violation|0|||
146172892|NCT03285295|527147122|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
146172893|NCT03285295|527147123|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
146172894|NCT03285295|527147124|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
146172895|NCT03285295|527147125|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
146172896|NCT03285295|527147126|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
146172897|NCT03285295|527147122|FG000|Alinity s HBsAg|No Results Generated|74|||
146172898|NCT03285295|527147123|FG001|Alinity s HBsAg|No Results Generated|6|||
146172899|NCT03285295|527147124|FG002|Alinity s HBsAg|No Results Generated|0|||
146172900|NCT03285295|527147125|FG003|Alinity s HBsAg|No Results Generated|0|||
146172901|NCT03285295|527147126|FG004|Alinity s HBsAg|No Results Generated|0|||
146172902|NCT03285295|527147122|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
146172903|NCT03285295|527147123|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
146172904|NCT03285295|527147124|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
146172905|NCT03285295|527147125|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
146172906|NCT03285295|527147126|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
146172907|NCT03285295|527147122|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
146172908|NCT03285295|527147123|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146172909|NCT03285295|527147124|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146172910|NCT03285295|527147125|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146172911|NCT03285295|527147126|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
146172912|NCT03285295|527147122|FG000|Alinity s HTLV I/II|No Results Generated|70|||
146172913|NCT03285295|527147123|FG001|Alinity s HTLV I/II|No Results Generated|0|||
146172914|NCT03285295|527147124|FG002|Alinity s HTLV I/II|No Results Generated|0|||
146172915|NCT03285295|527147125|FG003|Alinity s HTLV I/II|No Results Generated|0|||
146172916|NCT03285295|527147126|FG004|Alinity s HTLV I/II|No Results Generated|0|||
146172917|NCT03285295|527147122|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
146172918|NCT03285295|527147123|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146172919|NCT03285295|527147124|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146172920|NCT03285295|527147125|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146172921|NCT03285295|527147126|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
146172922|NCT03285295|527147122|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
146172923|NCT03285295|527147123|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
146172924|NCT03285295|527147124|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
146172925|NCT03285295|527147125|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
146172926|NCT03285295|527147126|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
146172927|NCT03285295|527147122|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
146172928|NCT03285295|527147123|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146172929|NCT03285295|527147124|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146172930|NCT03285295|527147125|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146172931|NCT03285295|527147126|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
146172932|NCT03285295|527147122|FG000|Alinity s Anti-HCV|No Results Generated|71|||
146172933|NCT03285295|527147123|FG001|Alinity s Anti-HCV|No Results Generated|0|||
146172934|NCT03285295|527147124|FG002|Alinity s Anti-HCV|No Results Generated|0|||
146172935|NCT03285295|527147125|FG003|Alinity s Anti-HCV|No Results Generated|0|||
146172936|NCT03285295|527147126|FG004|Alinity s Anti-HCV|No Results Generated|0|||
146172937|NCT03285295|527147122|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
146172938|NCT03285295|527147123|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146172939|NCT03285295|527147124|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146283852|NCT00092495|527551858|FG004|Base Study Vaccination Period|Pregnancy|0|||
146172940|NCT03285295|527147125|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146172941|NCT03285295|527147126|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
146072217|NCT04421027|526782757|FG000|Follow-Up Period|Left message, participant did not call back|0|||
146072218|NCT04421027|526782758|FG001|Follow-Up Period|Left message, participant did not call back|0|||
146072219|NCT04421027|526782759|FG002|Follow-Up Period|Left message, participant did not call back|0|||
146072220|NCT04421027|526782760|FG003|Follow-Up Period|Left message, participant did not call back|1|||
146072221|NCT04421027|526782757|FG000|Follow-Up Period|Participant died|0|||
146072222|NCT04421027|526782758|FG001|Follow-Up Period|Participant died|0|||
146072223|NCT04421027|526782759|FG002|Follow-Up Period|Participant died|0|||
146072224|NCT04421027|526782760|FG003|Follow-Up Period|Participant died|1|||
146072225|NCT04421027|526782757|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146072226|NCT04421027|526782758|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146072227|NCT04421027|526782759|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
146072228|NCT04421027|526782760|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
146072229|NCT05767749|526782770|FG000|Overall Study|Withdrawal by Subject|0|||
146072230|NCT05767749|526782771|FG001|Overall Study|Withdrawal by Subject|0|||
146072231|NCT05767749|526782772|FG002|Overall Study|Withdrawal by Subject|2|||
146072232|NCT05767749|526782773|FG003|Overall Study|Withdrawal by Subject|2|||
146072233|NCT05767749|526782774|FG004|Overall Study|Withdrawal by Subject|2|||
146072234|NCT05767749|526782775|FG005|Overall Study|Withdrawal by Subject|2|||
146072235|NCT03083873|526784574|FG000|Overall Study|Death|6|||
146072236|NCT03083873|526784575|FG001|Overall Study|Death|15|||
146072237|NCT03083873|526784576|FG002|Overall Study|Death|13|||
146072238|NCT03083873|526784577|FG003|Overall Study|Death|9|||
146072239|NCT03083873|526784578|FG004|Overall Study|Death|0|||
146072240|NCT03083873|526784574|FG000|Overall Study|Sponsor Terminated Study|0|||
146072241|NCT03083873|526784575|FG001|Overall Study|Sponsor Terminated Study|1|||
146072242|NCT03083873|526784576|FG002|Overall Study|Sponsor Terminated Study|2|||
146072243|NCT03083873|526784577|FG003|Overall Study|Sponsor Terminated Study|3|||
146072244|NCT03083873|526784578|FG004|Overall Study|Sponsor Terminated Study|0|||
146072245|NCT03083873|526784574|FG000|Overall Study|Lost to Follow-up|0|||
146072246|NCT03083873|526784575|FG001|Overall Study|Lost to Follow-up|1|||
146072247|NCT03083873|526784576|FG002|Overall Study|Lost to Follow-up|1|||
146072248|NCT03083873|526784577|FG003|Overall Study|Lost to Follow-up|0|||
146072249|NCT03083873|526784578|FG004|Overall Study|Lost to Follow-up|0|||
146072250|NCT03083873|526784574|FG000|Overall Study|Withdrawal by Subject|2|||
146072251|NCT03083873|526784575|FG001|Overall Study|Withdrawal by Subject|0|||
146072252|NCT03083873|526784576|FG002|Overall Study|Withdrawal by Subject|0|||
146072253|NCT03083873|526784577|FG003|Overall Study|Withdrawal by Subject|0|||
146072254|NCT03083873|526784578|FG004|Overall Study|Withdrawal by Subject|0|||
146072255|NCT03083873|526784574|FG000|Overall Study|Did Not Receive TIL|2|||
146072256|NCT03083873|526784575|FG001|Overall Study|Did Not Receive TIL|5|||
146072257|NCT03083873|526784576|FG002|Overall Study|Did Not Receive TIL|3|||
146072258|NCT03083873|526784577|FG003|Overall Study|Did Not Receive TIL|1|||
146072259|NCT03083873|526784578|FG004|Overall Study|Did Not Receive TIL|0|||
146072260|NCT01677377|526784579|FG000|Overall Study|Protocol Violation|1|||
146072261|NCT01677377|526784580|FG001|Overall Study|Protocol Violation|0|||
146072262|NCT01677377|526784581|FG002|Overall Study|Protocol Violation|0|||
146072263|NCT01677377|526784579|FG000|Overall Study|Lost to Follow-up|0|||
146072264|NCT01677377|526784580|FG001|Overall Study|Lost to Follow-up|1|||
146072265|NCT01677377|526784581|FG002|Overall Study|Lost to Follow-up|1|||
146072266|NCT01677377|526784579|FG000|Overall Study|Withdrawal by Subject|0|||
146072267|NCT01677377|526784580|FG001|Overall Study|Withdrawal by Subject|0|||
146072268|NCT01677377|526784581|FG002|Overall Study|Withdrawal by Subject|3|||
146072269|NCT01677377|526784579|FG000|Overall Study|Lack of Efficacy|0|||
146072270|NCT01677377|526784580|FG001|Overall Study|Lack of Efficacy|0|||
146072271|NCT01677377|526784581|FG002|Overall Study|Lack of Efficacy|1|||
146072272|NCT01677377|526784579|FG000|Overall Study|Pregnancy|0|||
146072273|NCT01677377|526784580|FG001|Overall Study|Pregnancy|0|||
146072274|NCT01677377|526784581|FG002|Overall Study|Pregnancy|1|||
146172942|NCT03285295|527147122|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
146172943|NCT03285295|527147123|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146172944|NCT03285295|527147124|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146072275|NCT00479687|526784582|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
146072276|NCT00479687|526784583|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
146072277|NCT00479687|526784584|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
146072278|NCT00479687|526784582|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
146072279|NCT00479687|526784583|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
146072280|NCT00479687|526784584|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
146072281|NCT00479687|526784582|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
146072282|NCT00479687|526784583|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
146072283|NCT00479687|526784584|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
146072284|NCT00479687|526784582|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
146072285|NCT00479687|526784583|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
146072286|NCT00479687|526784584|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
146172945|NCT03285295|527147125|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146172946|NCT03285295|527147126|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
146172947|NCT03285295|527147122|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
146172948|NCT03285295|527147123|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146172949|NCT03285295|527147124|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146172950|NCT03285295|527147125|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146172951|NCT03285295|527147126|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
146172952|NCT03285295|527147122|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
146172953|NCT03285295|527147123|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146172954|NCT03285295|527147124|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146172955|NCT03285295|527147125|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146172956|NCT03285295|527147126|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
146172957|NCT03285295|527147122|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
146172958|NCT03285295|527147123|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146172959|NCT03285295|527147124|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146172960|NCT03285295|527147125|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146172961|NCT03285295|527147126|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
146172962|NCT03285295|527147122|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
146172963|NCT03285295|527147123|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
146172964|NCT03285295|527147124|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
146172965|NCT03285295|527147125|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
146172966|NCT03285295|527147126|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
146172967|NCT03285295|527147122|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
146172968|NCT03285295|527147123|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
146172969|NCT03285295|527147124|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146172970|NCT03285295|527147125|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146172971|NCT03285295|527147126|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
146172972|NCT03285295|527147122|FG000|Alinity s Anti-HBc|No Results Generated|70|||
146172973|NCT03285295|527147123|FG001|Alinity s Anti-HBc|No Results Generated|0|||
146172974|NCT03285295|527147124|FG002|Alinity s Anti-HBc|No Results Generated|0|||
146072287|NCT00479687|526784582|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
146072288|NCT00479687|526784583|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
146072289|NCT00479687|526784584|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
146172975|NCT03285295|527147125|FG003|Alinity s Anti-HBc|No Results Generated|0|||
146172976|NCT03285295|527147126|FG004|Alinity s Anti-HBc|No Results Generated|0|||
146172977|NCT03285295|527147122|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
146072290|NCT00479687|526784582|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
146072291|NCT00479687|526784583|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
146072292|NCT00479687|526784584|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
146072293|NCT00479687|526784582|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
146072294|NCT00479687|526784583|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
146072295|NCT00479687|526784584|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
146072296|NCT00479687|526784582|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
146072297|NCT00479687|526784583|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
146072298|NCT00479687|526784584|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
146072299|NCT00479687|526784582|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
146072300|NCT00479687|526784583|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
146072301|NCT00479687|526784584|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
146072302|NCT00295880|526784585|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
146072303|NCT00295880|526784585|FG000|Overall Study|Unit randomization did not occur|1|||
146072304|NCT01474239|526784586|FG000|Overall Study|Disease Progression|37|||
146072305|NCT01474239|526784587|FG001|Overall Study|Disease Progression|25|||
146072306|NCT01474239|526784586|FG000|Overall Study|Adverse Event|12|||
146072307|NCT01474239|526784587|FG001|Overall Study|Adverse Event|3|||
146072308|NCT01474239|526784586|FG000|Overall Study|Withdrawal by Subject|1|||
146072309|NCT01474239|526784587|FG001|Overall Study|Withdrawal by Subject|2|||
146072310|NCT01474239|526784586|FG000|Overall Study|Death|1|||
146072311|NCT01474239|526784587|FG001|Overall Study|Death|1|||
146072312|NCT01474239|526784586|FG000|Overall Study|Clinical Disease Progression|7|||
146072313|NCT01474239|526784587|FG001|Overall Study|Clinical Disease Progression|1|||
146072314|NCT01474239|526784586|FG000|Overall Study|Withdrawal for Economic Reason|1|||
146072315|NCT01474239|526784587|FG001|Overall Study|Withdrawal for Economic Reason|0|||
146072316|NCT02260180|526784591|FG000|Overall Study|Adverse Event|2|||
146072317|NCT02260180|526784592|FG001|Overall Study|Adverse Event|0|||
146072318|NCT02260180|526784593|FG002|Overall Study|Adverse Event|1|||
146072319|NCT03126344|526784600|FG000|Overall Study|Lost to Follow-up|0|||
146172978|NCT03285295|527147123|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146172979|NCT03285295|527147124|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146172980|NCT03285295|527147125|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146172981|NCT03285295|527147126|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
146172982|NCT03285295|527147122|FG000|Alinity s Chagas|Protocol Violation|76|||
146072320|NCT03126344|526784601|FG001|Overall Study|Lost to Follow-up|0|||
146072321|NCT03126344|526784602|FG002|Overall Study|Lost to Follow-up|5|||
146072322|NCT01027273|526784603|FG000|Overall Study|Lost to Follow-up|57|||
146072323|NCT01027273|526784604|FG001|Overall Study|Lost to Follow-up|31|||
146072324|NCT01027273|526784603|FG000|Overall Study|Death|2|||
146072325|NCT01027273|526784604|FG001|Overall Study|Death|2|||
146072326|NCT01330108|526784611|FG000|Overall Study|Withdrawal by Subject|4|||
146072327|NCT00485134|526784612|FG000|Overall Study|Lost to Follow-up|1|||
146072328|NCT00485134|526784613|FG001|Overall Study|Lost to Follow-up|0|||
146072329|NCT00485134|526784614|FG002|Overall Study|Lost to Follow-up|0|||
146072330|NCT00485134|526784615|FG003|Overall Study|Lost to Follow-up|0|||
146072331|NCT00485134|526784616|FG004|Overall Study|Lost to Follow-up|0|||
146072332|NCT00485134|526784617|FG005|Overall Study|Lost to Follow-up|0|||
146072333|NCT00485134|526784618|FG006|Overall Study|Lost to Follow-up|0|||
146072334|NCT00485134|526784619|FG007|Overall Study|Lost to Follow-up|0|||
146072335|NCT00485134|526784612|FG000|Overall Study|Withdrawal by Subject|0|||
146072336|NCT00485134|526784613|FG001|Overall Study|Withdrawal by Subject|1|||
146072337|NCT00485134|526784614|FG002|Overall Study|Withdrawal by Subject|0|||
146072338|NCT00485134|526784615|FG003|Overall Study|Withdrawal by Subject|0|||
146072339|NCT00485134|526784616|FG004|Overall Study|Withdrawal by Subject|0|||
146072340|NCT00485134|526784617|FG005|Overall Study|Withdrawal by Subject|0|||
146072341|NCT00485134|526784618|FG006|Overall Study|Withdrawal by Subject|0|||
146072342|NCT00485134|526784619|FG007|Overall Study|Withdrawal by Subject|0|||
146072343|NCT00485134|526784612|FG000|Overall Study|Change in health status|0|||
146072344|NCT00485134|526784613|FG001|Overall Study|Change in health status|1|||
146072345|NCT00485134|526784614|FG002|Overall Study|Change in health status|2|||
146072346|NCT00485134|526784615|FG003|Overall Study|Change in health status|1|||
146072347|NCT00485134|526784616|FG004|Overall Study|Change in health status|0|||
146072348|NCT00485134|526784617|FG005|Overall Study|Change in health status|1|||
146072349|NCT00485134|526784618|FG006|Overall Study|Change in health status|0|||
146072350|NCT00485134|526784619|FG007|Overall Study|Change in health status|0|||
146072351|NCT00485134|526784612|FG000|Overall Study|Withdrew for adverse event|0|||
146072352|NCT00485134|526784613|FG001|Overall Study|Withdrew for adverse event|0|||
146072353|NCT00485134|526784614|FG002|Overall Study|Withdrew for adverse event|1|||
146072354|NCT00485134|526784615|FG003|Overall Study|Withdrew for adverse event|0|||
146072355|NCT00485134|526784616|FG004|Overall Study|Withdrew for adverse event|0|||
146072356|NCT00485134|526784617|FG005|Overall Study|Withdrew for adverse event|0|||
146072357|NCT00485134|526784618|FG006|Overall Study|Withdrew for adverse event|0|||
146072358|NCT00485134|526784619|FG007|Overall Study|Withdrew for adverse event|0|||
146072359|NCT00485134|526784612|FG000|Overall Study|Positive drug test|0|||
146072360|NCT00485134|526784613|FG001|Overall Study|Positive drug test|0|||
146072361|NCT00485134|526784614|FG002|Overall Study|Positive drug test|0|||
146072362|NCT00485134|526784615|FG003|Overall Study|Positive drug test|0|||
146072363|NCT00485134|526784616|FG004|Overall Study|Positive drug test|2|||
146072364|NCT00485134|526784617|FG005|Overall Study|Positive drug test|1|||
146072365|NCT00485134|526784618|FG006|Overall Study|Positive drug test|0|||
146072366|NCT00485134|526784619|FG007|Overall Study|Positive drug test|0|||
146072367|NCT00485134|526784612|FG000|Overall Study|Non-compliance|0|||
146072368|NCT00485134|526784613|FG001|Overall Study|Non-compliance|0|||
146072369|NCT00485134|526784614|FG002|Overall Study|Non-compliance|0|||
146072370|NCT00485134|526784615|FG003|Overall Study|Non-compliance|0|||
146072371|NCT00485134|526784616|FG004|Overall Study|Non-compliance|1|||
146072372|NCT00485134|526784617|FG005|Overall Study|Non-compliance|2|||
146072373|NCT00485134|526784618|FG006|Overall Study|Non-compliance|2|||
146072374|NCT00485134|526784619|FG007|Overall Study|Non-compliance|0|||
146072375|NCT00485134|526784612|FG000|Overall Study|Unable to comply with study schedule|0|||
146072376|NCT00485134|526784613|FG001|Overall Study|Unable to comply with study schedule|0|||
146172983|NCT03285295|527147123|FG001|Alinity s Chagas|Protocol Violation|0|||
146172984|NCT03285295|527147124|FG002|Alinity s Chagas|Protocol Violation|0|||
146172985|NCT03285295|527147125|FG003|Alinity s Chagas|Protocol Violation|0|||
146072377|NCT00485134|526784614|FG002|Overall Study|Unable to comply with study schedule|0|||
146072378|NCT00485134|526784615|FG003|Overall Study|Unable to comply with study schedule|0|||
146072379|NCT00485134|526784616|FG004|Overall Study|Unable to comply with study schedule|0|||
146072380|NCT00485134|526784617|FG005|Overall Study|Unable to comply with study schedule|0|||
146072381|NCT00485134|526784618|FG006|Overall Study|Unable to comply with study schedule|0|||
146072382|NCT00485134|526784619|FG007|Overall Study|Unable to comply with study schedule|1|||
146072383|NCT00485134|526784612|FG000|Overall Study|Pregnancy|0|||
146072384|NCT00485134|526784613|FG001|Overall Study|Pregnancy|0|||
146072385|NCT00485134|526784614|FG002|Overall Study|Pregnancy|0|||
146072386|NCT00485134|526784615|FG003|Overall Study|Pregnancy|0|||
146072387|NCT00485134|526784616|FG004|Overall Study|Pregnancy|0|||
146072388|NCT00485134|526784617|FG005|Overall Study|Pregnancy|0|||
146072389|NCT00485134|526784618|FG006|Overall Study|Pregnancy|1|||
146072390|NCT00485134|526784619|FG007|Overall Study|Pregnancy|0|||
146072391|NCT00970684|526784620|FG000|Overall Study|Lack of Efficacy|5|||
146072392|NCT00970684|526784620|FG000|Overall Study|Adverse Event|4|||
146072393|NCT00970684|526784620|FG000|Overall Study|Withdrawal by Subject|1|||
146172986|NCT03285295|527147126|FG004|Alinity s Chagas|Protocol Violation|0|||
146172987|NCT03285295|527147122|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
146172988|NCT03285295|527147123|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
146172989|NCT03285295|527147124|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
146172990|NCT03285295|527147125|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
146172991|NCT03285295|527147126|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
146172992|NCT03285295|527147122|FG000|Alinity s Chagas|No Results Generated|105|||
146172993|NCT03285295|527147123|FG001|Alinity s Chagas|No Results Generated|0|||
146172994|NCT03285295|527147124|FG002|Alinity s Chagas|No Results Generated|0|||
146172995|NCT03285295|527147125|FG003|Alinity s Chagas|No Results Generated|0|||
146172996|NCT03285295|527147126|FG004|Alinity s Chagas|No Results Generated|0|||
146172997|NCT03285295|527147122|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
146172998|NCT03285295|527147123|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146172999|NCT03285295|527147124|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146173000|NCT03285295|527147125|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146173001|NCT03285295|527147126|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
146173002|NCT01289041|527147128|FG000|Overall Study|Adverse Event|24|||
146173003|NCT01289041|527147128|FG000|Overall Study|Physician Decision|1|||
146173004|NCT01289041|527147128|FG000|Overall Study|Progressive Disease|41|||
146173005|NCT01289041|527147128|FG000|Overall Study|Withdrawal by Subject|3|||
146173006|NCT01289041|527147128|FG000|Overall Study|Death|1|||
146173007|NCT02714868|527147135|FG000|Overall Study|Withdrawal by Subject|3|||
146173008|NCT02714868|527147136|FG001|Overall Study|Withdrawal by Subject|0|||
146173009|NCT02714868|527147135|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
146173010|NCT02714868|527147136|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
146173011|NCT02714868|527147135|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
146173012|NCT02714868|527147136|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
146173013|NCT00519896|527147149|FG000|Overall Study|Protocol Violation|1|||
146173014|NCT00519896|527147149|FG000|Overall Study|Adverse Event|1|||
146173015|NCT02296190|527147156|FG000|Overall Study|Lost to Follow-up|0|||
146173016|NCT02296190|527147157|FG001|Overall Study|Lost to Follow-up|0|||
146173017|NCT02296190|527147158|FG002|Overall Study|Lost to Follow-up|0|||
146173018|NCT02296190|527147159|FG003|Overall Study|Lost to Follow-up|0|||
146173019|NCT02296190|527147160|FG004|Overall Study|Lost to Follow-up|1|||
146173020|NCT02296190|527147161|FG005|Overall Study|Lost to Follow-up|0|||
146173021|NCT02296190|527147156|FG000|Overall Study|Failure to induce PSVT|6|||
146173022|NCT02296190|527147157|FG001|Overall Study|Failure to induce PSVT|10|||
146173023|NCT02296190|527147158|FG002|Overall Study|Failure to induce PSVT|5|||
146173024|NCT02296190|527147159|FG003|Overall Study|Failure to induce PSVT|13|||
146173025|NCT02296190|527147160|FG004|Overall Study|Failure to induce PSVT|8|||
146283853|NCT00092495|527551854|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146283854|NCT00092495|527551855|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146283855|NCT00092495|527551856|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
146283856|NCT00092495|527551857|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
146283857|NCT00092495|527551858|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
146283858|NCT00092495|527551854|FG000|Base Study Vaccination Period|Protocol Violation|1|||
146283859|NCT00092495|527551855|FG001|Base Study Vaccination Period|Protocol Violation|0|||
146283860|NCT00092495|527551856|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146283861|NCT00092495|527551857|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146283862|NCT00092495|527551858|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146283863|NCT00092495|527551854|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
146283864|NCT00092495|527551855|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
146283865|NCT00092495|527551856|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
146283866|NCT00092495|527551857|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
146283867|NCT00092495|527551858|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146283868|NCT00092495|527551854|FG000|Base Study Follow-up Period|Extended|0|||
146283869|NCT00092495|527551855|FG001|Base Study Follow-up Period|Extended|0|||
146283870|NCT00092495|527551856|FG002|Base Study Follow-up Period|Extended|1|||
146283871|NCT00092495|527551857|FG003|Base Study Follow-up Period|Extended|2|||
146283872|NCT00092495|527551858|FG004|Base Study Follow-up Period|Extended|0|||
146283873|NCT00092495|527551854|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
146283874|NCT00092495|527551855|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
146283875|NCT00092495|527551856|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
146283876|NCT00092495|527551857|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
146283877|NCT00092495|527551858|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
146283878|NCT00092495|527551854|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
146283879|NCT00092495|527551855|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
146283880|NCT00092495|527551856|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
146173026|NCT02296190|527147161|FG005|Overall Study|Failure to induce PSVT|0|||
146173027|NCT02296190|527147156|FG000|Overall Study|Physician Decision|1|||
146173028|NCT02296190|527147157|FG001|Overall Study|Physician Decision|1|||
146173029|NCT02296190|527147158|FG002|Overall Study|Physician Decision|0|||
146173030|NCT02296190|527147159|FG003|Overall Study|Physician Decision|1|||
146173031|NCT02296190|527147160|FG004|Overall Study|Physician Decision|2|||
146072394|NCT00905645|526784622|FG000|Overall Study|Death (not device related)|10|||
146072395|NCT00905645|526784623|FG001|Overall Study|Death (not device related)|4|||
146072396|NCT00905645|526784624|FG002|Overall Study|Death (not device related)|15|||
146072397|NCT00905645|526784625|FG003|Overall Study|Death (not device related)|8|||
146072398|NCT00905645|526784622|FG000|Overall Study|Explantation of study device(s)|78|||
146072399|NCT00905645|526784623|FG001|Overall Study|Explantation of study device(s)|47|||
146072400|NCT00905645|526784624|FG002|Overall Study|Explantation of study device(s)|28|||
146072401|NCT00905645|526784625|FG003|Overall Study|Explantation of study device(s)|21|||
146072402|NCT00905645|526784622|FG000|Overall Study|Subject Request|41|||
146072403|NCT00905645|526784623|FG001|Overall Study|Subject Request|17|||
146072404|NCT00905645|526784624|FG002|Overall Study|Subject Request|13|||
146072405|NCT00905645|526784625|FG003|Overall Study|Subject Request|11|||
146072406|NCT00905645|526784622|FG000|Overall Study|Lost to Follow-up|299|||
146072407|NCT00905645|526784623|FG001|Overall Study|Lost to Follow-up|103|||
146072408|NCT00905645|526784624|FG002|Overall Study|Lost to Follow-up|51|||
146072409|NCT00905645|526784625|FG003|Overall Study|Lost to Follow-up|12|||
146072410|NCT04881942|526784626|FG000|Overall Study|Adverse Event|0|||
146072411|NCT04881942|526784627|FG001|Overall Study|Adverse Event|0|||
146072412|NCT04881942|526784628|FG002|Overall Study|Adverse Event|0|||
146072413|NCT04881942|526784629|FG003|Overall Study|Adverse Event|0|||
146072414|NCT04881942|526784630|FG004|Overall Study|Adverse Event|1|||
146072415|NCT04881942|526784626|FG000|Overall Study|Alternates|0|||
146072416|NCT04881942|526784627|FG001|Overall Study|Alternates|0|||
146072417|NCT04881942|526784628|FG002|Overall Study|Alternates|0|||
146072418|NCT04881942|526784629|FG003|Overall Study|Alternates|0|||
146072419|NCT04881942|526784630|FG004|Overall Study|Alternates|2|||
146072420|NCT00578292|526784631|FG000|Overall Study|Death|1|||
146072421|NCT00578292|526784631|FG000|Overall Study|Graft failure|2|||
146072422|NCT01587014|526784632|FG000|Overall Study|Death|2|||
146072423|NCT02948088|526784633|FG000|Overall Study|Lost to Follow-up|8|||
146072424|NCT02948088|526784633|FG000|Overall Study|Death|1|||
146072425|NCT02948088|526784633|FG000|Overall Study|Withdrawal by Subject|4|||
146072426|NCT02948088|526784633|FG000|Overall Study|Other|2|||
146072427|NCT01409811|526784634|FG000|Overall Study|Insurance denial|1|||
146072428|NCT00634101|526784635|FG000|Overall Study|Study Terminated|3|||
146072429|NCT00634101|526784636|FG001|Overall Study|Study Terminated|3|||
146072430|NCT00634101|526784635|FG000|Overall Study|Lost to Follow-up|2|||
146072431|NCT00634101|526784636|FG001|Overall Study|Lost to Follow-up|0|||
146072432|NCT00838513|526784638|FG000|Screening Period|Screen Failure|3|||
146072433|NCT00838513|526784638|FG000|Extension Treatment Period|Death|1|||
146072434|NCT00838513|526784638|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
146072435|NCT00139477|526784642|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
146072436|NCT00139477|526784643|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
146072437|NCT00139477|526784642|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
146072438|NCT00139477|526784643|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
146072439|NCT00139477|526784642|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
146072440|NCT00139477|526784643|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
146072441|NCT00139477|526784642|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
146072442|NCT00139477|526784643|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
146072443|NCT00139477|526784642|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
146072444|NCT00139477|526784643|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
146072445|NCT00139477|526784642|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
146072446|NCT00139477|526784643|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
146072447|NCT00139477|526784642|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
146072448|NCT00139477|526784643|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
146072449|NCT00975780|526784644|FG000|Follow Up|Death|88|||
146072450|NCT00975780|526784645|FG001|Follow Up|Death|122|||
146072451|NCT00975780|526784644|FG000|Follow Up|Facility Withdrawal|7|||
146072452|NCT00975780|526784645|FG001|Follow Up|Facility Withdrawal|23|||
146072453|NCT00975780|526784644|FG000|Follow Up|Discharged from Facility|7|||
146072454|NCT00975780|526784645|FG001|Follow Up|Discharged from Facility|12|||
146072455|NCT01077076|526784646|FG000|First Intervention|Withdrawal by Subject|1|||
146072456|NCT01077076|526784647|FG001|First Intervention|Withdrawal by Subject|0|||
146072457|NCT01077076|526784648|FG002|First Intervention|Withdrawal by Subject|0|||
146072458|NCT01077076|526784649|FG003|First Intervention|Withdrawal by Subject|0|||
146072459|NCT01077076|526784650|FG004|First Intervention|Withdrawal by Subject|0|||
146072460|NCT01077076|526784651|FG005|First Intervention|Withdrawal by Subject|0|||
146072461|NCT01077076|526784646|FG000|Third Intervention|Death in the participant's family|0|||
146072462|NCT01077076|526784647|FG001|Third Intervention|Death in the participant's family|0|||
146072463|NCT01077076|526784648|FG002|Third Intervention|Death in the participant's family|0|||
146072464|NCT01077076|526784649|FG003|Third Intervention|Death in the participant's family|0|||
146072465|NCT01077076|526784650|FG004|Third Intervention|Death in the participant's family|0|||
146072466|NCT01077076|526784651|FG005|Third Intervention|Death in the participant's family|1|||
146072467|NCT01976741|526784652|FG000|Overall Study|Withdrawal by Subject|1|||
146173032|NCT02296190|527147161|FG005|Overall Study|Physician Decision|0|||
146072468|NCT01976741|526784653|FG001|Overall Study|Withdrawal by Subject|0|||
146072469|NCT01976741|526784654|FG002|Overall Study|Withdrawal by Subject|1|||
146072470|NCT01976741|526784655|FG003|Overall Study|Withdrawal by Subject|1|||
146072471|NCT01976741|526784656|FG004|Overall Study|Withdrawal by Subject|0|||
146072472|NCT01976741|526784657|FG005|Overall Study|Withdrawal by Subject|0|||
146072473|NCT01976741|526784658|FG006|Overall Study|Withdrawal by Subject|1|||
146072474|NCT01976741|526784659|FG007|Overall Study|Withdrawal by Subject|4|||
146072475|NCT01976741|526784660|FG008|Overall Study|Withdrawal by Subject|0|||
146072476|NCT01976741|526784661|FG009|Overall Study|Withdrawal by Subject|0|||
146072477|NCT01976741|526784652|FG000|Overall Study|Adverse Event|0|||
146072478|NCT01976741|526784653|FG001|Overall Study|Adverse Event|0|||
146072479|NCT01976741|526784654|FG002|Overall Study|Adverse Event|2|||
146072480|NCT01976741|526784655|FG003|Overall Study|Adverse Event|0|||
146072481|NCT01976741|526784656|FG004|Overall Study|Adverse Event|0|||
146072482|NCT01976741|526784657|FG005|Overall Study|Adverse Event|0|||
146072483|NCT01976741|526784658|FG006|Overall Study|Adverse Event|3|||
146072484|NCT01976741|526784659|FG007|Overall Study|Adverse Event|8|||
146072485|NCT01976741|526784660|FG008|Overall Study|Adverse Event|1|||
146072486|NCT01976741|526784661|FG009|Overall Study|Adverse Event|4|||
146072487|NCT01415882|526784662|FG000|Overall Study|Ineligible|1|||
146072488|NCT01415882|526784663|FG001|Overall Study|Ineligible|0|||
146072489|NCT01415882|526784664|FG002|Overall Study|Ineligible|0|||
146072490|NCT01415882|526784665|FG003|Overall Study|Ineligible|3|||
146072491|NCT01415882|526784666|FG004|Overall Study|Ineligible|0|||
146072492|NCT01415882|526784662|FG000|Overall Study|Withdrawal by Subject|0|||
146072493|NCT01415882|526784663|FG001|Overall Study|Withdrawal by Subject|1|||
146072494|NCT01415882|526784664|FG002|Overall Study|Withdrawal by Subject|0|||
146072495|NCT01415882|526784665|FG003|Overall Study|Withdrawal by Subject|1|||
146072496|NCT01415882|526784666|FG004|Overall Study|Withdrawal by Subject|0|||
146072497|NCT00670306|526784667|FG000|Overall Study|Adverse Event|8|||
146072498|NCT00670306|526784667|FG000|Overall Study|Lack of Efficacy|10|||
146072499|NCT00670306|526784667|FG000|Overall Study|Withdrawal by Subject|9|||
146072500|NCT00670306|526784667|FG000|Overall Study|Physician Decision|1|||
146173033|NCT02296190|527147156|FG000|Overall Study|Withdrawal by Subject|0|||
146173034|NCT02296190|527147157|FG001|Overall Study|Withdrawal by Subject|1|||
146173035|NCT02296190|527147158|FG002|Overall Study|Withdrawal by Subject|0|||
146173036|NCT02296190|527147159|FG003|Overall Study|Withdrawal by Subject|0|||
146173037|NCT02296190|527147160|FG004|Overall Study|Withdrawal by Subject|0|||
146173038|NCT02296190|527147161|FG005|Overall Study|Withdrawal by Subject|0|||
146072501|NCT00670306|526784667|FG000|Overall Study|Lost to Follow-up|8|||
146072502|NCT00670306|526784667|FG000|Overall Study|incl/excl criterias did not meet|19|||
146072503|NCT00845897|526784668|FG000|Overall Study|Lost to Follow-up|1|||
146072504|NCT00845897|526784669|FG001|Overall Study|Lost to Follow-up|1|||
146072505|NCT00845897|526784670|FG002|Overall Study|Lost to Follow-up|0|||
146072506|NCT00845897|526784668|FG000|Overall Study|Withdrawal by Subject|0|||
146072507|NCT00845897|526784669|FG001|Overall Study|Withdrawal by Subject|3|||
146173039|NCT02296190|527147156|FG000|Overall Study|PSVT < 5 minutes|5|||
146173040|NCT02296190|527147157|FG001|Overall Study|PSVT < 5 minutes|6|||
146173041|NCT02296190|527147158|FG002|Overall Study|PSVT < 5 minutes|6|||
146173042|NCT02296190|527147159|FG003|Overall Study|PSVT < 5 minutes|6|||
146173043|NCT02296190|527147160|FG004|Overall Study|PSVT < 5 minutes|5|||
146173044|NCT02296190|527147161|FG005|Overall Study|PSVT < 5 minutes|0|||
146173045|NCT02296190|527147156|FG000|Overall Study|Patient was given Propofol|0|||
146173046|NCT02296190|527147157|FG001|Overall Study|Patient was given Propofol|1|||
146173047|NCT02296190|527147158|FG002|Overall Study|Patient was given Propofol|0|||
146173048|NCT02296190|527147159|FG003|Overall Study|Patient was given Propofol|1|||
146173049|NCT02296190|527147160|FG004|Overall Study|Patient was given Propofol|0|||
146173050|NCT02296190|527147161|FG005|Overall Study|Patient was given Propofol|0|||
146173051|NCT02296190|527147156|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
146173052|NCT02296190|527147157|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
146173053|NCT02296190|527147158|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
146173054|NCT02296190|527147159|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
146173055|NCT02296190|527147160|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
146173056|NCT02296190|527147161|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
146173057|NCT02296190|527147156|FG000|Overall Study|Blood pressure <100 after sedation|0|||
146173058|NCT02296190|527147157|FG001|Overall Study|Blood pressure <100 after sedation|0|||
146173059|NCT02296190|527147158|FG002|Overall Study|Blood pressure <100 after sedation|0|||
146173060|NCT02296190|527147159|FG003|Overall Study|Blood pressure <100 after sedation|1|||
146072508|NCT00845897|526784670|FG002|Overall Study|Withdrawal by Subject|2|||
146072509|NCT00845897|526784668|FG000|Overall Study|Ulcer did not heal|1|||
146072510|NCT00845897|526784669|FG001|Overall Study|Ulcer did not heal|0|||
146072511|NCT00845897|526784670|FG002|Overall Study|Ulcer did not heal|1|||
146072512|NCT00845897|526784668|FG000|Overall Study|Too ill to participate|0|||
146072513|NCT00845897|526784669|FG001|Overall Study|Too ill to participate|1|||
146072514|NCT00845897|526784670|FG002|Overall Study|Too ill to participate|0|||
146072515|NCT02722499|526784671|FG000|Overall Study|Lost to Follow-up|2|||
146072516|NCT02722499|526784672|FG001|Overall Study|Lost to Follow-up|0|||
146173061|NCT02296190|527147160|FG004|Overall Study|Blood pressure <100 after sedation|0|||
146173062|NCT02296190|527147161|FG005|Overall Study|Blood pressure <100 after sedation|0|||
146173063|NCT02296190|527147156|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146173064|NCT02296190|527147157|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
146173065|NCT02296190|527147158|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
146173066|NCT02296190|527147159|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146173067|NCT02296190|527147160|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146173068|NCT02296190|527147161|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
146173069|NCT02296190|527147156|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
146173070|NCT02296190|527147157|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
146173071|NCT02296190|527147158|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
146173072|NCT02296190|527147159|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
146173073|NCT02296190|527147160|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
146173074|NCT02296190|527147161|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
146173075|NCT02296190|527147156|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146173076|NCT02296190|527147157|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
146173077|NCT02296190|527147158|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146173078|NCT02296190|527147159|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146173079|NCT02296190|527147160|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146173080|NCT02296190|527147161|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
146173081|NCT02296190|527147156|FG000|Overall Study|Lab result not available in time|1|||
146173082|NCT02296190|527147157|FG001|Overall Study|Lab result not available in time|0|||
146173083|NCT02296190|527147158|FG002|Overall Study|Lab result not available in time|0|||
146173084|NCT02296190|527147159|FG003|Overall Study|Lab result not available in time|0|||
146173085|NCT02296190|527147160|FG004|Overall Study|Lab result not available in time|0|||
146173086|NCT02296190|527147161|FG005|Overall Study|Lab result not available in time|0|||
146173087|NCT02978443|527147162|FG000|Overall Study|Withdrawal by Subject|1|||
146173088|NCT02978443|527147162|FG000|Overall Study|Adverse Event|3|||
146173089|NCT02978443|527147162|FG000|Overall Study|Disease Progression on study|6|||
146173090|NCT02978443|527147162|FG000|Overall Study|Death|1|||
146173091|NCT02978443|527147162|FG000|Overall Study|Physician Decision|1|||
146173092|NCT02978443|527147162|FG000|Overall Study|Switch to alternative therapy|1|||
146173093|NCT02978443|527147162|FG000|Overall Study|Refused further treatment|1|||
146173094|NCT03682705|527147163|FG000|Overall Study|Adverse Event|1|||
146173095|NCT03682705|527147164|FG001|Overall Study|Adverse Event|1|||
146173096|NCT03682705|527147165|FG002|Overall Study|Adverse Event|1|||
146173097|NCT03682705|527147166|FG003|Overall Study|Adverse Event|0|||
146173098|NCT03682705|527147167|FG004|Overall Study|Adverse Event|1|||
146173099|NCT03682705|527147168|FG005|Overall Study|Adverse Event|1|||
146173100|NCT03682705|527147163|FG000|Overall Study|Withdrawal by Subject|1|||
146173101|NCT03682705|527147164|FG001|Overall Study|Withdrawal by Subject|3|||
146173102|NCT03682705|527147165|FG002|Overall Study|Withdrawal by Subject|2|||
146173103|NCT03682705|527147166|FG003|Overall Study|Withdrawal by Subject|4|||
146173104|NCT03682705|527147167|FG004|Overall Study|Withdrawal by Subject|0|||
146173105|NCT03682705|527147168|FG005|Overall Study|Withdrawal by Subject|1|||
146173106|NCT03682705|527147163|FG000|Overall Study|Other, not specified|0|||
146173107|NCT03682705|527147164|FG001|Overall Study|Other, not specified|0|||
146409326|NCT04380701|528004368|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
146409327|NCT04380701|528004369|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
146072517|NCT02722499|526784673|FG002|Overall Study|Lost to Follow-up|1|||
146072518|NCT00369265|526784683|FG000|Overall Study|Study terminated|4|||
146072519|NCT00369265|526784684|FG001|Overall Study|Study terminated|7|||
146072520|NCT01192191|526784685|FG000|Overall Study|Adverse Event|7|||
146072521|NCT01192191|526784686|FG001|Overall Study|Adverse Event|12|||
146072522|NCT01192191|526784685|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
146072523|NCT01192191|526784686|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
146072524|NCT01192191|526784685|FG000|Overall Study|Lost to Follow-up|0|||
146072525|NCT01192191|526784686|FG001|Overall Study|Lost to Follow-up|1|||
146072526|NCT01192191|526784685|FG000|Overall Study|Withdrawal by Subject|1|||
146072527|NCT01192191|526784686|FG001|Overall Study|Withdrawal by Subject|6|||
146072528|NCT00467753|526784687|FG000|Overall Study|Lost to Follow-up|1|||
146072529|NCT00467753|526784688|FG001|Overall Study|Lost to Follow-up|2|||
146072530|NCT00467753|526784687|FG000|Overall Study|Adverse Event|2|||
146072531|NCT00467753|526784688|FG001|Overall Study|Adverse Event|0|||
146072532|NCT02817464|526784694|FG000|Overall Study|Lost to Follow-up|1|||
146072533|NCT02817464|526784695|FG001|Overall Study|Lost to Follow-up|0|||
146072534|NCT02817464|526784694|FG000|Overall Study|Discontinued early due to personal decision|1|||
146409328|NCT04380701|528004370|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
146409329|NCT04380701|528004371|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
146072535|NCT02817464|526784695|FG001|Overall Study|Discontinued early due to personal decision|1|||
146072536|NCT01273519|526784697|FG000|Overall Study|Adverse Event|3|||
146072537|NCT01273519|526784698|FG001|Overall Study|Adverse Event|0|||
146072538|NCT01273519|526784699|FG002|Overall Study|Adverse Event|0|||
146072539|NCT01273519|526784697|FG000|Overall Study|Lost to Follow-up|2|||
146072540|NCT01273519|526784698|FG001|Overall Study|Lost to Follow-up|1|||
146072541|NCT01273519|526784699|FG002|Overall Study|Lost to Follow-up|3|||
146072542|NCT01273519|526784697|FG000|Overall Study|Lack of Efficacy|8|||
146072543|NCT01273519|526784698|FG001|Overall Study|Lack of Efficacy|3|||
146072544|NCT01273519|526784699|FG002|Overall Study|Lack of Efficacy|4|||
146072545|NCT01273519|526784697|FG000|Overall Study|Other|6|||
146072546|NCT01273519|526784698|FG001|Overall Study|Other|1|||
146072547|NCT01273519|526784699|FG002|Overall Study|Other|1|||
146072548|NCT04292899|526784700|FG000|Overall Study|Death|21|||
146072549|NCT04292899|526784701|FG001|Overall Study|Death|28|||
146072550|NCT04292899|526784702|FG002|Overall Study|Death|188|||
146072551|NCT04292899|526784703|FG003|Overall Study|Death|371|||
146072552|NCT04292899|526784700|FG000|Overall Study|Lost to Follow-up|8|||
146072553|NCT04292899|526784701|FG001|Overall Study|Lost to Follow-up|4|||
146072554|NCT04292899|526784702|FG002|Overall Study|Lost to Follow-up|22|||
146072555|NCT04292899|526784703|FG003|Overall Study|Lost to Follow-up|235|||
146072556|NCT04292899|526784700|FG000|Overall Study|Withdrew consent|1|||
146072557|NCT04292899|526784701|FG001|Overall Study|Withdrew consent|0|||
146072558|NCT04292899|526784702|FG002|Overall Study|Withdrew consent|11|||
146072559|NCT04292899|526784703|FG003|Overall Study|Withdrew consent|32|||
146072560|NCT04292899|526784700|FG000|Overall Study|Adverse Event|2|||
146072561|NCT04292899|526784701|FG001|Overall Study|Adverse Event|1|||
146072562|NCT04292899|526784702|FG002|Overall Study|Adverse Event|2|||
146072563|NCT04292899|526784703|FG003|Overall Study|Adverse Event|2|||
146072564|NCT04292899|526784700|FG000|Overall Study|Investigator's Discretion|0|||
146072565|NCT04292899|526784701|FG001|Overall Study|Investigator's Discretion|0|||
146072566|NCT04292899|526784702|FG002|Overall Study|Investigator's Discretion|0|||
146072567|NCT04292899|526784703|FG003|Overall Study|Investigator's Discretion|3|||
146072568|NCT04292899|526784700|FG000|Overall Study|Non-compliance With Study Drug|0|||
146072569|NCT04292899|526784701|FG001|Overall Study|Non-compliance With Study Drug|0|||
146072570|NCT04292899|526784702|FG002|Overall Study|Non-compliance With Study Drug|0|||
146072571|NCT04292899|526784703|FG003|Overall Study|Non-compliance With Study Drug|1|||
146072572|NCT04292899|526784700|FG000|Overall Study|Protocol Violation|0|||
146072573|NCT04292899|526784701|FG001|Overall Study|Protocol Violation|0|||
146072574|NCT04292899|526784702|FG002|Overall Study|Protocol Violation|0|||
146072575|NCT04292899|526784703|FG003|Overall Study|Protocol Violation|1|||
146072576|NCT00828204|526784708|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
146072577|NCT00828204|526784709|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
146072578|NCT00828204|526784708|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
146072579|NCT00828204|526784709|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
146072580|NCT00828204|526784708|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
146072581|NCT00828204|526784709|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
146072582|NCT00828204|526784708|FG000|Main Study: After Study Restart|Adverse Event|0|||
146072583|NCT00828204|526784709|FG001|Main Study: After Study Restart|Adverse Event|2|||
146072584|NCT00828204|526784708|FG000|Main Study: After Study Restart|Noncompliance|0|||
146072585|NCT00828204|526784709|FG001|Main Study: After Study Restart|Noncompliance|1|||
146072586|NCT00828204|526784708|FG000|Extension Study|Lost to Follow-up|0|||
146072587|NCT00828204|526784709|FG001|Extension Study|Lost to Follow-up|1|||
146072588|NCT00828204|526784708|FG000|Extension Study|Physician Decision|0|||
146072589|NCT00828204|526784709|FG001|Extension Study|Physician Decision|2|||
146072590|NCT01704599|526784716|FG000|Overall Study|Adverse Event|1|||
146072591|NCT02840461|526784717|FG000|Overall Study|Adverse Event|1|||
146072592|NCT02840461|526784718|FG001|Overall Study|Adverse Event|5|||
146072593|NCT02840461|526784719|FG002|Overall Study|Adverse Event|3|||
146072594|NCT02840461|526784717|FG000|Overall Study|Lost to Follow-up|10|||
146072595|NCT02840461|526784718|FG001|Overall Study|Lost to Follow-up|7|||
146072596|NCT02840461|526784719|FG002|Overall Study|Lost to Follow-up|6|||
146072597|NCT02840461|526784717|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
146072598|NCT02840461|526784718|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
146072599|NCT02840461|526784719|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
146072600|NCT02840461|526784717|FG000|Overall Study|Protocol Violation|2|||
146072601|NCT02840461|526784718|FG001|Overall Study|Protocol Violation|3|||
146072602|NCT02840461|526784719|FG002|Overall Study|Protocol Violation|1|||
146072603|NCT02840461|526784717|FG000|Overall Study|Withdrawal by Subject|10|||
146072604|NCT02840461|526784718|FG001|Overall Study|Withdrawal by Subject|6|||
146072605|NCT02840461|526784719|FG002|Overall Study|Withdrawal by Subject|2|||
146072606|NCT02840461|526784717|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
146072607|NCT02840461|526784718|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
146072608|NCT02840461|526784719|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
146072609|NCT01737502|526784722|FG000|Phase I|Disease progression|2|||
146072610|NCT01737502|526784723|FG001|Phase I|Disease progression|3|||
146072611|NCT01737502|526784722|FG000|Phase I|Complicating disease|1|||
146072612|NCT01737502|526784723|FG001|Phase I|Complicating disease|0|||
146072613|NCT01737502|526784722|FG000|Phase II|Adverse Event|0|||
146072614|NCT01737502|526784723|FG001|Phase II|Adverse Event|3|||
146173108|NCT03682705|527147165|FG002|Overall Study|Other, not specified|0|||
146173109|NCT03682705|527147166|FG003|Overall Study|Other, not specified|1|||
146173110|NCT03682705|527147167|FG004|Overall Study|Other, not specified|2|||
146173111|NCT03682705|527147168|FG005|Overall Study|Other, not specified|0|||
146173112|NCT03682705|527147163|FG000|Overall Study|Lost to Follow-up|0|||
146173113|NCT03682705|527147164|FG001|Overall Study|Lost to Follow-up|0|||
146173114|NCT03682705|527147165|FG002|Overall Study|Lost to Follow-up|0|||
146173115|NCT03682705|527147166|FG003|Overall Study|Lost to Follow-up|0|||
146173116|NCT03682705|527147167|FG004|Overall Study|Lost to Follow-up|3|||
146173117|NCT03682705|527147168|FG005|Overall Study|Lost to Follow-up|0|||
146173118|NCT00094328|527147169|FG000|Overall Study|Lost to Follow-up|1|||
146173119|NCT01483937|527147170|FG000|Overall Study|Withdrawal by Subject|4|||
146173120|NCT01483937|527147171|FG001|Overall Study|Withdrawal by Subject|3|||
146173121|NCT02213328|527147172|FG000|Overall Study|Withdrawal by Subject|10|||
146173122|NCT02213328|527147172|FG000|Overall Study|Physician Decision|2|||
146173123|NCT02213328|527147172|FG000|Overall Study|Lost to Follow-up|16|||
146173124|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
146173125|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
146173126|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
146173127|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
146173128|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
146173129|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
146173130|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
146173131|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
146173132|NCT01336621|527147173|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
146173133|NCT01336621|527147173|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
146173134|NCT01336621|527147173|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
146173135|NCT01336621|527147173|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
146173136|NCT01336621|527147173|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
146173137|NCT01336621|527147173|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
146173138|NCT01126060|527147176|FG000|Overall Study|Protocol Violation|0|||
146173139|NCT01126060|527147177|FG001|Overall Study|Protocol Violation|2|||
146173140|NCT00402337|527147182|FG000|Overall Study|Adverse Event|0|||
146173141|NCT00402337|527147183|FG001|Overall Study|Adverse Event|2|||
146173142|NCT00402337|527147184|FG002|Overall Study|Adverse Event|2|||
146173143|NCT00402337|527147185|FG003|Overall Study|Adverse Event|3|||
146173144|NCT00402337|527147186|FG004|Overall Study|Adverse Event|2|||
146173145|NCT00402337|527147182|FG000|Overall Study|Noncompliance|0|||
146173146|NCT00402337|527147183|FG001|Overall Study|Noncompliance|0|||
146173147|NCT00402337|527147184|FG002|Overall Study|Noncompliance|0|||
146173148|NCT00402337|527147185|FG003|Overall Study|Noncompliance|0|||
146173149|NCT00402337|527147186|FG004|Overall Study|Noncompliance|2|||
146173150|NCT00402337|527147182|FG000|Overall Study|Withdrawal by Subject|5|||
146173151|NCT00402337|527147183|FG001|Overall Study|Withdrawal by Subject|3|||
146173152|NCT00402337|527147184|FG002|Overall Study|Withdrawal by Subject|1|||
146173153|NCT00402337|527147185|FG003|Overall Study|Withdrawal by Subject|6|||
146173154|NCT00402337|527147186|FG004|Overall Study|Withdrawal by Subject|4|||
146173155|NCT00402337|527147182|FG000|Overall Study|Lost to Follow-up|0|||
146173156|NCT00402337|527147183|FG001|Overall Study|Lost to Follow-up|0|||
146173157|NCT00402337|527147184|FG002|Overall Study|Lost to Follow-up|1|||
146173158|NCT00402337|527147185|FG003|Overall Study|Lost to Follow-up|2|||
146173159|NCT00402337|527147186|FG004|Overall Study|Lost to Follow-up|0|||
146173160|NCT00402337|527147182|FG000|Overall Study|Physician Decision|0|||
146173161|NCT00402337|527147183|FG001|Overall Study|Physician Decision|0|||
146173162|NCT00402337|527147184|FG002|Overall Study|Physician Decision|0|||
146173163|NCT00402337|527147185|FG003|Overall Study|Physician Decision|1|||
146173164|NCT00402337|527147186|FG004|Overall Study|Physician Decision|0|||
146173165|NCT00402337|527147182|FG000|Overall Study|Other Reason|0|||
146173166|NCT00402337|527147183|FG001|Overall Study|Other Reason|1|||
146173167|NCT00402337|527147184|FG002|Overall Study|Other Reason|0|||
146173168|NCT00402337|527147185|FG003|Overall Study|Other Reason|0|||
146173169|NCT00402337|527147186|FG004|Overall Study|Other Reason|0|||
146173170|NCT02178566|527147187|FG000|Overall Study|patient did not complete due to noncompliance|0|||
146173171|NCT02178566|527147188|FG001|Overall Study|patient did not complete due to noncompliance|1|||
146173172|NCT00682643|527147194|FG000|Overall Study|Adverse Event|12|||
146173173|NCT00682643|527147195|FG001|Overall Study|Adverse Event|23|||
146173174|NCT00682643|527147194|FG000|Overall Study|Lack of Efficacy|2|||
146173175|NCT00682643|527147195|FG001|Overall Study|Lack of Efficacy|0|||
146173176|NCT00682643|527147194|FG000|Overall Study|Protocol Violation|38|||
146173177|NCT00682643|527147195|FG001|Overall Study|Protocol Violation|76|||
146173178|NCT00682643|527147194|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146173179|NCT00682643|527147195|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
146173180|NCT00682643|527147194|FG000|Overall Study|Lost to Follow-up|1|||
146173181|NCT00682643|527147195|FG001|Overall Study|Lost to Follow-up|6|||
146173182|NCT00682643|527147194|FG000|Overall Study|Physician Decision|2|||
146173183|NCT00682643|527147195|FG001|Overall Study|Physician Decision|6|||
146409330|NCT04380701|528004372|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
146409331|NCT04380701|528004373|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
146409332|NCT04380701|528004374|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
146409333|NCT04380701|528004375|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
146409334|NCT04380701|528004376|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
146409335|NCT04380701|528004377|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
146409336|NCT04380701|528004378|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
146409337|NCT04380701|528004345|FG000|Overall Study|Physician Decision|0|||
146409338|NCT04380701|528004346|FG001|Overall Study|Physician Decision|0|||
146409339|NCT04380701|528004347|FG002|Overall Study|Physician Decision|0|||
146409340|NCT04380701|528004348|FG003|Overall Study|Physician Decision|0|||
146409341|NCT04380701|528004349|FG004|Overall Study|Physician Decision|0|||
146409342|NCT04380701|528004350|FG005|Overall Study|Physician Decision|0|||
146409343|NCT04380701|528004351|FG006|Overall Study|Physician Decision|0|||
146409344|NCT04380701|528004352|FG007|Overall Study|Physician Decision|0|||
146409345|NCT04380701|528004353|FG008|Overall Study|Physician Decision|0|||
146409346|NCT04380701|528004354|FG009|Overall Study|Physician Decision|0|||
146409347|NCT04380701|528004355|FG010|Overall Study|Physician Decision|0|||
146409348|NCT04380701|528004356|FG011|Overall Study|Physician Decision|0|||
146409349|NCT04380701|528004357|FG012|Overall Study|Physician Decision|0|||
146409350|NCT04380701|528004358|FG013|Overall Study|Physician Decision|0|||
146409351|NCT04380701|528004359|FG014|Overall Study|Physician Decision|0|||
146409352|NCT04380701|528004360|FG015|Overall Study|Physician Decision|0|||
146409353|NCT04380701|528004361|FG016|Overall Study|Physician Decision|0|||
146409354|NCT04380701|528004362|FG017|Overall Study|Physician Decision|0|||
146409355|NCT04380701|528004363|FG018|Overall Study|Physician Decision|0|||
146409356|NCT04380701|528004364|FG019|Overall Study|Physician Decision|0|||
146409357|NCT04380701|528004365|FG020|Overall Study|Physician Decision|0|||
146409358|NCT04380701|528004366|FG021|Overall Study|Physician Decision|0|||
146409359|NCT04380701|528004367|FG022|Overall Study|Physician Decision|0|||
146409360|NCT04380701|528004368|FG023|Overall Study|Physician Decision|0|||
146409361|NCT04380701|528004369|FG024|Overall Study|Physician Decision|2|||
145945256|NCT03008278|526308188|FG001|Overall Study|Physician Decision|2|||
145945257|NCT03008278|526308189|FG002|Overall Study|Physician Decision|0|||
145945258|NCT01389258|526308190|FG000|Overall Study|Lost to Follow-up|5|||
145945259|NCT01217385|526308191|FG000|Overall Study|Withdrawal by Subject|3|||
145945260|NCT01217385|526308191|FG000|Overall Study|DOSI not performed/not eval|12|||
145945261|NCT01217385|526308191|FG000|Overall Study|Central Path not Available|1|||
145945262|NCT01217385|526308191|FG000|Overall Study|Normal Breast TOI not available|10|||
145945263|NCT02918552|526308192|FG000|Overall Study|Failed Pharmacokinetics|1|||
145945264|NCT02918552|526308193|FG001|Overall Study|Failed Pharmacokinetics|0|||
145945265|NCT02918552|526308192|FG000|Overall Study|Withdrawal by Subject|0|||
145945266|NCT02918552|526308193|FG001|Overall Study|Withdrawal by Subject|1|||
145945267|NCT02918552|526308192|FG000|Overall Study|Lost to Follow-up|0|||
145945268|NCT02918552|526308193|FG001|Overall Study|Lost to Follow-up|1|||
145945269|NCT04395274|526308194|FG000|Overall Study|Lost to Follow-up|20|||
145945270|NCT04395274|526308195|FG001|Overall Study|Lost to Follow-up|11|||
145945271|NCT04395274|526308194|FG000|Overall Study|Withdrawal by Subject|13|||
145945272|NCT04395274|526308195|FG001|Overall Study|Withdrawal by Subject|10|||
145945273|NCT04395274|526308194|FG000|Overall Study|Moved Abroad|0|||
145945274|NCT04395274|526308195|FG001|Overall Study|Moved Abroad|1|||
145945275|NCT03482167|526308196|FG000|Allocated to Intervention|Physician Decision|1|||
145945276|NCT03482167|526308197|FG001|Allocated to Intervention|Physician Decision|2|||
145945277|NCT03482167|526308196|FG000|Received Intervention|Adverse Event|3|||
145945278|NCT03482167|526308197|FG001|Received Intervention|Adverse Event|1|||
145945279|NCT03482167|526308196|FG000|Received Intervention|Physician Decision|1|||
145945280|NCT03482167|526308197|FG001|Received Intervention|Physician Decision|1|||
145945281|NCT03482167|526308196|FG000|Received Intervention|Withdrawal by Subject|1|||
145945282|NCT03482167|526308197|FG001|Received Intervention|Withdrawal by Subject|0|||
145945283|NCT02680834|526308199|FG000|Overall Study|Physician Decision|5|||
145945284|NCT02680834|526308200|FG001|Overall Study|Physician Decision|2|||
145945285|NCT02680834|526308199|FG000|Overall Study|Withdrawal by Subject|6|||
145945286|NCT02680834|526308200|FG001|Overall Study|Withdrawal by Subject|0|||
145945287|NCT02680834|526308199|FG000|Overall Study|Lost to Follow-up|0|||
145945288|NCT02680834|526308200|FG001|Overall Study|Lost to Follow-up|1|||
145945289|NCT01362244|526308201|FG000|Overall Study|Adverse Event|3|||
145945290|NCT01362244|526308202|FG001|Overall Study|Adverse Event|5|||
145945291|NCT01362244|526308201|FG000|Overall Study|Lack of Efficacy|5|||
145945292|NCT01362244|526308202|FG001|Overall Study|Lack of Efficacy|11|||
145945293|NCT01362244|526308201|FG000|Overall Study|Lost to Follow-up|0|||
145945294|NCT01362244|526308202|FG001|Overall Study|Lost to Follow-up|2|||
145945295|NCT01362244|526308201|FG000|Overall Study|Protocol Violation|5|||
145945296|NCT01362244|526308202|FG001|Overall Study|Protocol Violation|1|||
145945297|NCT01362244|526308201|FG000|Overall Study|Withdrawal by Subject|2|||
145945298|NCT01362244|526308202|FG001|Overall Study|Withdrawal by Subject|1|||
145945299|NCT01362244|526308201|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
145945300|NCT01362244|526308202|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
146173184|NCT00682643|527147194|FG000|Overall Study|Withdrawal by Subject|19|||
146173185|NCT00682643|527147195|FG001|Overall Study|Withdrawal by Subject|53|||
146173186|NCT00682643|527147194|FG000|Overall Study|Did Not Receive Study Drug|1|||
146173187|NCT00682643|527147195|FG001|Overall Study|Did Not Receive Study Drug|1|||
146173188|NCT01875185|527147196|FG000|Overall Study|study was terminated|52|||
146173189|NCT01875185|527147197|FG001|Overall Study|study was terminated|48|||
146173190|NCT01521884|527147198|FG000|Overall Study|Non Responders|10|||
146173191|NCT01521884|527147198|FG000|Overall Study|Adverse Event|5|||
146173192|NCT01521884|527147198|FG000|Overall Study|Pregnancy|1|||
146173193|NCT01521884|527147198|FG000|Overall Study|Withdrawal by Subject|1|||
146173194|NCT01521884|527147198|FG000|Overall Study|Physician Decision|2|||
146173195|NCT01521884|527147198|FG000|Overall Study|Protocol Violation|3|||
146173196|NCT01521884|527147198|FG000|Overall Study|Participant non-eligible|1|||
146173197|NCT01521884|527147198|FG000|Overall Study|Lost to Follow-up|4|||
146173198|NCT03565068|527147199|FG000|Overall Study|Protocol Violation|0|||
146173199|NCT03565068|527147200|FG001|Overall Study|Protocol Violation|0|||
146173200|NCT03565068|527147201|FG002|Overall Study|Protocol Violation|0|||
146173201|NCT03565068|527147202|FG003|Overall Study|Protocol Violation|0|||
146173202|NCT03565068|527147203|FG004|Overall Study|Protocol Violation|1|||
146173203|NCT03565068|527147204|FG005|Overall Study|Protocol Violation|0|||
146173204|NCT03565068|527147205|FG006|Overall Study|Protocol Violation|0|||
146173205|NCT03565068|527147206|FG007|Overall Study|Protocol Violation|1|||
146173206|NCT03565068|527147207|FG008|Overall Study|Protocol Violation|0|||
146173207|NCT03565068|527147199|FG000|Overall Study|Sponsor decision|0|||
146173208|NCT03565068|527147200|FG001|Overall Study|Sponsor decision|0|||
146173209|NCT03565068|527147201|FG002|Overall Study|Sponsor decision|0|||
146173210|NCT03565068|527147202|FG003|Overall Study|Sponsor decision|0|||
146173211|NCT03565068|527147203|FG004|Overall Study|Sponsor decision|1|||
146173212|NCT03565068|527147204|FG005|Overall Study|Sponsor decision|1|||
146173213|NCT03565068|527147205|FG006|Overall Study|Sponsor decision|0|||
146173214|NCT03565068|527147206|FG007|Overall Study|Sponsor decision|0|||
146173215|NCT03565068|527147207|FG008|Overall Study|Sponsor decision|0|||
146173216|NCT03565068|527147199|FG000|Overall Study|Withdrawal by Subject|0|||
146173217|NCT03565068|527147200|FG001|Overall Study|Withdrawal by Subject|0|||
146173218|NCT03565068|527147201|FG002|Overall Study|Withdrawal by Subject|1|||
146173219|NCT03565068|527147202|FG003|Overall Study|Withdrawal by Subject|0|||
146173220|NCT03565068|527147203|FG004|Overall Study|Withdrawal by Subject|2|||
146173221|NCT03565068|527147204|FG005|Overall Study|Withdrawal by Subject|0|||
146173222|NCT03565068|527147205|FG006|Overall Study|Withdrawal by Subject|1|||
146173223|NCT03565068|527147206|FG007|Overall Study|Withdrawal by Subject|5|||
146173224|NCT03565068|527147207|FG008|Overall Study|Withdrawal by Subject|1|||
146173225|NCT03565068|527147199|FG000|Overall Study|Physician Decision|0|||
146173226|NCT03565068|527147200|FG001|Overall Study|Physician Decision|0|||
146173227|NCT03565068|527147201|FG002|Overall Study|Physician Decision|0|||
146173228|NCT03565068|527147202|FG003|Overall Study|Physician Decision|0|||
146173229|NCT03565068|527147203|FG004|Overall Study|Physician Decision|0|||
146173230|NCT03565068|527147204|FG005|Overall Study|Physician Decision|0|||
146173231|NCT03565068|527147205|FG006|Overall Study|Physician Decision|0|||
146173232|NCT03565068|527147206|FG007|Overall Study|Physician Decision|1|||
146173233|NCT03565068|527147207|FG008|Overall Study|Physician Decision|0|||
146173234|NCT03565068|527147199|FG000|Overall Study|Lost to Follow-up|0|||
146173235|NCT03565068|527147200|FG001|Overall Study|Lost to Follow-up|0|||
146173236|NCT03565068|527147201|FG002|Overall Study|Lost to Follow-up|0|||
146173237|NCT03565068|527147202|FG003|Overall Study|Lost to Follow-up|0|||
146173238|NCT03565068|527147203|FG004|Overall Study|Lost to Follow-up|0|||
146173239|NCT03565068|527147204|FG005|Overall Study|Lost to Follow-up|0|||
146173240|NCT03565068|527147205|FG006|Overall Study|Lost to Follow-up|0|||
146173241|NCT03565068|527147206|FG007|Overall Study|Lost to Follow-up|1|||
146173242|NCT03565068|527147207|FG008|Overall Study|Lost to Follow-up|0|||
146173243|NCT05778526|527147208|FG000|Overall Study|Lost to Follow-up|0|||
146173244|NCT05778526|527147209|FG001|Overall Study|Lost to Follow-up|1|||
146173245|NCT05778526|527147210|FG002|Overall Study|Lost to Follow-up|3|||
146173246|NCT05778526|527147208|FG000|Overall Study|Protocol Violation|0|||
146173247|NCT05778526|527147209|FG001|Overall Study|Protocol Violation|0|||
146173248|NCT05778526|527147210|FG002|Overall Study|Protocol Violation|8|||
146173249|NCT00085202|527147211|FG000|Overall Study|Still on therapy|2|||
146173250|NCT00085202|527147212|FG001|Overall Study|Still on therapy|0|||
146173251|NCT00085202|527147211|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
146173252|NCT00085202|527147212|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
146173253|NCT00085202|527147211|FG000|Overall Study|Excessive toxicity|6|||
146173254|NCT00085202|527147212|FG001|Overall Study|Excessive toxicity|5|||
146173255|NCT00085202|527147211|FG000|Overall Study|Non-specified|3|||
146173256|NCT00085202|527147212|FG001|Overall Study|Non-specified|5|||
146173257|NCT00085202|527147211|FG000|Overall Study|Withdrawal by Subject|2|||
146173258|NCT00085202|527147212|FG001|Overall Study|Withdrawal by Subject|1|||
146173259|NCT00085202|527147211|FG000|Overall Study|Physician Decision|4|||
146173260|NCT00085202|527147212|FG001|Overall Study|Physician Decision|1|||
146173261|NCT00085202|527147211|FG000|Overall Study|Progressive disease|1|||
146173262|NCT00085202|527147212|FG001|Overall Study|Progressive disease|11|||
146072615|NCT01737502|526784722|FG000|Phase II|Disease progression|0|||
146072616|NCT01737502|526784723|FG001|Phase II|Disease progression|18|||
146072617|NCT01737502|526784722|FG000|Phase II|Death|0|||
146072618|NCT01737502|526784723|FG001|Phase II|Death|1|||
146072619|NCT01737502|526784722|FG000|Phase II|Transition to hospice care|0|||
146072620|NCT01737502|526784723|FG001|Phase II|Transition to hospice care|1|||
146072621|NCT02003924|526784734|FG000|Double-blind Phase|Lost to Follow-up|2|||
146409362|NCT04380701|528004370|FG025|Overall Study|Physician Decision|0|||
146409363|NCT04380701|528004371|FG026|Overall Study|Physician Decision|0|||
146409364|NCT04380701|528004372|FG027|Overall Study|Physician Decision|0|||
146409365|NCT04380701|528004373|FG028|Overall Study|Physician Decision|0|||
146409366|NCT04380701|528004374|FG029|Overall Study|Physician Decision|0|||
146409367|NCT04380701|528004375|FG030|Overall Study|Physician Decision|0|||
146409368|NCT04380701|528004376|FG031|Overall Study|Physician Decision|0|||
146409369|NCT04380701|528004377|FG032|Overall Study|Physician Decision|0|||
146409370|NCT04380701|528004378|FG033|Overall Study|Physician Decision|0|||
146409371|NCT04380701|528004345|FG000|Overall Study|Death|0|||
146409372|NCT04380701|528004346|FG001|Overall Study|Death|0|||
146409373|NCT04380701|528004347|FG002|Overall Study|Death|0|||
146409374|NCT04380701|528004348|FG003|Overall Study|Death|0|||
146409375|NCT04380701|528004349|FG004|Overall Study|Death|0|||
146409376|NCT04380701|528004350|FG005|Overall Study|Death|0|||
146409377|NCT04380701|528004351|FG006|Overall Study|Death|0|||
146409378|NCT04380701|528004352|FG007|Overall Study|Death|0|||
146409379|NCT04380701|528004353|FG008|Overall Study|Death|0|||
146409380|NCT04380701|528004354|FG009|Overall Study|Death|0|||
146409381|NCT04380701|528004355|FG010|Overall Study|Death|0|||
146409382|NCT04380701|528004356|FG011|Overall Study|Death|0|||
146409383|NCT04380701|528004357|FG012|Overall Study|Death|0|||
146409384|NCT04380701|528004358|FG013|Overall Study|Death|0|||
146409385|NCT04380701|528004359|FG014|Overall Study|Death|0|||
146409386|NCT04380701|528004360|FG015|Overall Study|Death|0|||
146409387|NCT04380701|528004361|FG016|Overall Study|Death|0|||
146409388|NCT04380701|528004362|FG017|Overall Study|Death|0|||
146409389|NCT04380701|528004363|FG018|Overall Study|Death|0|||
146409390|NCT04380701|528004364|FG019|Overall Study|Death|0|||
146409391|NCT04380701|528004365|FG020|Overall Study|Death|0|||
146409392|NCT04380701|528004366|FG021|Overall Study|Death|0|||
146409393|NCT04380701|528004367|FG022|Overall Study|Death|0|||
146409394|NCT04380701|528004368|FG023|Overall Study|Death|0|||
146409395|NCT04380701|528004369|FG024|Overall Study|Death|1|||
146409396|NCT04380701|528004370|FG025|Overall Study|Death|0|||
146409397|NCT04380701|528004371|FG026|Overall Study|Death|0|||
146409398|NCT04380701|528004372|FG027|Overall Study|Death|0|||
146409399|NCT04380701|528004373|FG028|Overall Study|Death|0|||
146409400|NCT04380701|528004374|FG029|Overall Study|Death|0|||
146409401|NCT04380701|528004375|FG030|Overall Study|Death|0|||
146409402|NCT04380701|528004376|FG031|Overall Study|Death|0|||
146409403|NCT04380701|528004377|FG032|Overall Study|Death|0|||
146409404|NCT04380701|528004378|FG033|Overall Study|Death|0|||
146409405|NCT04380701|528004345|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409406|NCT04380701|528004346|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409407|NCT04380701|528004347|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409408|NCT04380701|528004348|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409409|NCT04380701|528004349|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409410|NCT04380701|528004350|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409411|NCT04380701|528004351|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409412|NCT04380701|528004352|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409413|NCT04380701|528004353|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409414|NCT04380701|528004354|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409415|NCT04380701|528004355|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409416|NCT04380701|528004356|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409417|NCT04380701|528004357|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409418|NCT04380701|528004358|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409419|NCT04380701|528004359|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409420|NCT04380701|528004360|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409421|NCT04380701|528004361|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409422|NCT04380701|528004362|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409423|NCT04380701|528004363|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409424|NCT04380701|528004364|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409425|NCT04380701|528004365|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409426|NCT04380701|528004366|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
146409427|NCT04380701|528004367|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
146409428|NCT04380701|528004368|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
146072622|NCT02003924|526784735|FG001|Double-blind Phase|Lost to Follow-up|1|||
146409429|NCT04380701|528004369|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
146072623|NCT02003924|526784736|FG002|Double-blind Phase|Lost to Follow-up|0|||
146072624|NCT02003924|526784734|FG000|Double-blind Phase|Protocol Violation|1|||
146072625|NCT02003924|526784735|FG001|Double-blind Phase|Protocol Violation|2|||
146072626|NCT02003924|526784736|FG002|Double-blind Phase|Protocol Violation|0|||
146072627|NCT02003924|526784734|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
146072628|NCT02003924|526784735|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
146072629|NCT02003924|526784736|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
146072630|NCT02003924|526784734|FG000|Double-blind Phase|Disease Progression|229|||
146072631|NCT02003924|526784735|FG001|Double-blind Phase|Disease Progression|247|||
146072632|NCT02003924|526784736|FG002|Double-blind Phase|Disease Progression|0|||
146072633|NCT02003924|526784734|FG000|Double-blind Phase|Adverse Event|120|||
146072634|NCT02003924|526784735|FG001|Double-blind Phase|Adverse Event|31|||
146072635|NCT02003924|526784736|FG002|Double-blind Phase|Adverse Event|0|||
146072636|NCT02003924|526784734|FG000|Double-blind Phase|Randomized But not Treated|3|||
146072637|NCT02003924|526784735|FG001|Double-blind Phase|Randomized But not Treated|3|||
146072638|NCT02003924|526784736|FG002|Double-blind Phase|Randomized But not Treated|0|||
146072639|NCT02003924|526784734|FG000|Double-blind Phase|Other|29|||
146072640|NCT02003924|526784735|FG001|Double-blind Phase|Other|50|||
146072641|NCT02003924|526784736|FG002|Double-blind Phase|Other|0|||
146072642|NCT02003924|526784734|FG000|Open-label Phase|Lost to Follow-up|0|||
146072643|NCT02003924|526784735|FG001|Open-label Phase|Lost to Follow-up|0|||
146072644|NCT02003924|526784736|FG002|Open-label Phase|Lost to Follow-up|1|||
146072645|NCT02003924|526784734|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
146072646|NCT02003924|526784735|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
146072647|NCT02003924|526784736|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
146072648|NCT02003924|526784734|FG000|Open-label Phase|Disease Progression|59|||
146072649|NCT02003924|526784735|FG001|Open-label Phase|Disease Progression|0|||
146072650|NCT02003924|526784736|FG002|Open-label Phase|Disease Progression|5|||
146072651|NCT02003924|526784734|FG000|Open-label Phase|Adverse Event|25|||
146072652|NCT02003924|526784735|FG001|Open-label Phase|Adverse Event|0|||
146072653|NCT02003924|526784736|FG002|Open-label Phase|Adverse Event|10|||
146072654|NCT02003924|526784734|FG000|Open-label Phase|Other|7|||
146072655|NCT02003924|526784735|FG001|Open-label Phase|Other|0|||
146072656|NCT02003924|526784736|FG002|Open-label Phase|Other|0|||
146072657|NCT02003924|526784734|FG000|Long-term Follow-up Phase|Death|288|||
146072658|NCT02003924|526784735|FG001|Long-term Follow-up Phase|Death|174|||
146072659|NCT02003924|526784736|FG002|Long-term Follow-up Phase|Death|4|||
146072660|NCT02003924|526784734|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
146072661|NCT02003924|526784735|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
146072662|NCT02003924|526784736|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
146072663|NCT02003924|526784734|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
146072664|NCT02003924|526784735|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
146072665|NCT02003924|526784736|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
146072666|NCT02003924|526784734|FG000|Long-term Follow-up Phase|Other|5|||
146072667|NCT02003924|526784735|FG001|Long-term Follow-up Phase|Other|2|||
146072668|NCT02003924|526784736|FG002|Long-term Follow-up Phase|Other|1|||
146072669|NCT00124306|526784740|FG000|Overall Study|Adverse Event|7|||
146072670|NCT00124306|526784741|FG001|Overall Study|Adverse Event|2|||
146072671|NCT00124306|526784740|FG000|Overall Study|Lost to Follow-up|10|||
146072672|NCT00124306|526784741|FG001|Overall Study|Lost to Follow-up|6|||
146072673|NCT00124306|526784740|FG000|Overall Study|Lack of Efficacy|3|||
146072674|NCT00124306|526784741|FG001|Overall Study|Lack of Efficacy|6|||
146072675|NCT00124306|526784740|FG000|Overall Study|Personal constraints|0|||
146072676|NCT00124306|526784741|FG001|Overall Study|Personal constraints|2|||
146072677|NCT00124306|526784740|FG000|Overall Study|Use of unacceptable medication|1|||
146072678|NCT00124306|526784741|FG001|Overall Study|Use of unacceptable medication|0|||
146072679|NCT00124306|526784740|FG000|Overall Study|Abnormal lab result|0|||
146072680|NCT00124306|526784741|FG001|Overall Study|Abnormal lab result|1|||
146072681|NCT00124306|526784740|FG000|Overall Study|Other|2|||
146072682|NCT00124306|526784741|FG001|Overall Study|Other|0|||
146072683|NCT00560352|526784743|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146072684|NCT00560352|526784744|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146072685|NCT00560352|526784745|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146072686|NCT00560352|526784743|FG000|Overall Study|Study drug toxicity|3|||
146072687|NCT00560352|526784744|FG001|Overall Study|Study drug toxicity|0|||
146072688|NCT00560352|526784745|FG002|Overall Study|Study drug toxicity|1|||
146072689|NCT00560352|526784743|FG000|Overall Study|Disease progression|0|||
146072690|NCT00560352|526784744|FG001|Overall Study|Disease progression|1|||
146072691|NCT00560352|526784745|FG002|Overall Study|Disease progression|1|||
146072692|NCT00560352|526784743|FG000|Overall Study|Withdrawal by Subject|1|||
146072693|NCT00560352|526784744|FG001|Overall Study|Withdrawal by Subject|1|||
146072694|NCT00560352|526784745|FG002|Overall Study|Withdrawal by Subject|1|||
146072695|NCT00560352|526784743|FG000|Overall Study|Maximum clinical benefit|1|||
146072696|NCT00560352|526784744|FG001|Overall Study|Maximum clinical benefit|0|||
146072697|NCT00560352|526784745|FG002|Overall Study|Maximum clinical benefit|0|||
146072698|NCT00114517|526784746|FG000|Overall Study|Adverse Event|6|||
146173263|NCT03238300|527147216|FG000|Baseline (Before Intervention)|Physician Decision|0|||
146173264|NCT03238300|527147217|FG001|Baseline (Before Intervention)|Physician Decision|1|||
146173265|NCT03238300|527147216|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
146173266|NCT03238300|527147217|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
146173267|NCT03238300|527147216|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
146173268|NCT03238300|527147217|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
146072699|NCT00114517|526784747|FG001|Overall Study|Adverse Event|1|||
146072700|NCT00114517|526784748|FG002|Overall Study|Adverse Event|6|||
146072701|NCT00114517|526784749|FG003|Overall Study|Adverse Event|3|||
146072702|NCT00114517|526784746|FG000|Overall Study|Lost to Follow-up|2|||
146072703|NCT00114517|526784747|FG001|Overall Study|Lost to Follow-up|2|||
146072704|NCT00114517|526784748|FG002|Overall Study|Lost to Follow-up|2|||
146072705|NCT00114517|526784749|FG003|Overall Study|Lost to Follow-up|1|||
146072706|NCT00114517|526784746|FG000|Overall Study|Too busy|3|||
146072707|NCT00114517|526784747|FG001|Overall Study|Too busy|1|||
146072708|NCT00114517|526784748|FG002|Overall Study|Too busy|1|||
146072709|NCT00114517|526784749|FG003|Overall Study|Too busy|2|||
146409430|NCT04380701|528004370|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409431|NCT04380701|528004371|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409432|NCT04380701|528004372|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409433|NCT04380701|528004373|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409434|NCT04380701|528004374|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409435|NCT04380701|528004375|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409436|NCT04380701|528004376|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409437|NCT04380701|528004377|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409438|NCT04380701|528004378|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
146409439|NCT03001011|528004379|FG000|Overall Study|Adverse Event|9|||
146409440|NCT03001011|528004380|FG001|Overall Study|Adverse Event|3|||
146072710|NCT00114517|526784746|FG000|Overall Study|Moved from area|0|||
146173269|NCT03238300|527147216|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
146173270|NCT03238300|527147217|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
146072711|NCT00114517|526784747|FG001|Overall Study|Moved from area|3|||
146072712|NCT00114517|526784748|FG002|Overall Study|Moved from area|2|||
146072713|NCT00114517|526784749|FG003|Overall Study|Moved from area|1|||
146072714|NCT00114517|526784746|FG000|Overall Study|Did not want estradiol|1|||
146072715|NCT00114517|526784747|FG001|Overall Study|Did not want estradiol|1|||
146072716|NCT00114517|526784748|FG002|Overall Study|Did not want estradiol|0|||
146072717|NCT00114517|526784749|FG003|Overall Study|Did not want estradiol|0|||
146072718|NCT00114517|526784746|FG000|Overall Study|Armed-services duty|0|||
146072719|NCT00114517|526784747|FG001|Overall Study|Armed-services duty|1|||
146072720|NCT00114517|526784748|FG002|Overall Study|Armed-services duty|0|||
146072721|NCT00114517|526784749|FG003|Overall Study|Armed-services duty|1|||
146072722|NCT00114517|526784746|FG000|Overall Study|Competing family issue|0|||
146072723|NCT00114517|526784747|FG001|Overall Study|Competing family issue|1|||
146072724|NCT00114517|526784748|FG002|Overall Study|Competing family issue|0|||
146072725|NCT00114517|526784749|FG003|Overall Study|Competing family issue|1|||
146072726|NCT00114517|526784746|FG000|Overall Study|Physician Decision|0|||
146072727|NCT00114517|526784747|FG001|Overall Study|Physician Decision|1|||
146072728|NCT00114517|526784748|FG002|Overall Study|Physician Decision|0|||
146072729|NCT00114517|526784749|FG003|Overall Study|Physician Decision|0|||
146072730|NCT00114517|526784746|FG000|Overall Study|Lost interest|0|||
146072731|NCT00114517|526784747|FG001|Overall Study|Lost interest|0|||
146072732|NCT00114517|526784748|FG002|Overall Study|Lost interest|1|||
146072733|NCT00114517|526784749|FG003|Overall Study|Lost interest|0|||
146072734|NCT00114517|526784746|FG000|Overall Study|Weight increase|0|||
146072735|NCT00114517|526784747|FG001|Overall Study|Weight increase|0|||
146072736|NCT00114517|526784748|FG002|Overall Study|Weight increase|1|||
146072737|NCT00114517|526784749|FG003|Overall Study|Weight increase|0|||
146072738|NCT00114517|526784746|FG000|Overall Study|Concern about blood clots|0|||
146072739|NCT00114517|526784747|FG001|Overall Study|Concern about blood clots|0|||
146072740|NCT00114517|526784748|FG002|Overall Study|Concern about blood clots|1|||
146072741|NCT00114517|526784749|FG003|Overall Study|Concern about blood clots|0|||
146072742|NCT00114517|526784746|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146072743|NCT00114517|526784747|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146072744|NCT00114517|526784748|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
146072745|NCT00114517|526784749|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
146072746|NCT00539864|526786326|FG000|Overall Study|Lost to Follow-up|0|||
146072747|NCT00539864|526786327|FG001|Overall Study|Lost to Follow-up|1|||
146072748|NCT00539864|526786326|FG000|Overall Study|Withdrawal by Subject|1|||
146072749|NCT00539864|526786327|FG001|Overall Study|Withdrawal by Subject|1|||
146072750|NCT00943072|526786333|FG000|Overall Study|Adverse Event|0|||
146072751|NCT00943072|526786334|FG001|Overall Study|Adverse Event|3|||
146072752|NCT00943072|526786333|FG000|Overall Study|Death|0|||
146072753|NCT00943072|526786334|FG001|Overall Study|Death|2|||
146173271|NCT01435655|527147220|FG000|Overall Study|Death|2|||
146173272|NCT01435655|527147220|FG000|Overall Study|Other|1|||
146173273|NCT01436201|527147222|FG000|Overall Study|Adverse Event|2|||
146173274|NCT01436201|527147222|FG000|Overall Study|Withdrawal by Subject|1|||
146173275|NCT01436201|527147222|FG000|Overall Study|Protocol Violation|1|||
146173276|NCT00110890|527147223|FG000|Overall Study|Adverse Event|30|||
146173277|NCT00110890|527147224|FG001|Overall Study|Adverse Event|7|||
146173278|NCT00110890|527147223|FG000|Overall Study|Death|16|||
146173279|NCT00110890|527147224|FG001|Overall Study|Death|9|||
146173280|NCT00110890|527147223|FG000|Overall Study|Lost to Follow-up|3|||
146173281|NCT00110890|527147224|FG001|Overall Study|Lost to Follow-up|1|||
146173282|NCT00110890|527147223|FG000|Overall Study|Physician Decision|4|||
146173283|NCT00110890|527147224|FG001|Overall Study|Physician Decision|5|||
146173284|NCT00110890|527147223|FG000|Overall Study|Withdrawal by Subject|17|||
146173285|NCT00110890|527147224|FG001|Overall Study|Withdrawal by Subject|5|||
146173286|NCT00110890|527147223|FG000|Overall Study|Protocol Deviation|1|||
146173287|NCT00110890|527147224|FG001|Overall Study|Protocol Deviation|0|||
146173288|NCT00110890|527147223|FG000|Overall Study|Noncompliance|10|||
146173289|NCT00110890|527147224|FG001|Overall Study|Noncompliance|0|||
146173290|NCT00110890|527147223|FG000|Overall Study|Kidney Transplant|16|||
146173291|NCT00110890|527147224|FG001|Overall Study|Kidney Transplant|12|||
146173292|NCT00110890|527147223|FG000|Overall Study|Invest. Product Commercially Available|217|||
146173293|NCT00110890|527147224|FG001|Overall Study|Invest. Product Commercially Available|110|||
146173294|NCT00110890|527147223|FG000|Overall Study|Other|34|||
146173295|NCT00110890|527147224|FG001|Overall Study|Other|23|||
146173296|NCT00110890|527147223|FG000|Overall Study|Ineligibility determined|3|||
146173297|NCT00110890|527147224|FG001|Overall Study|Ineligibility determined|0|||
146173298|NCT00110890|527147223|FG000|Overall Study|Requirement for alternative therapy|0|||
146173299|NCT00110890|527147224|FG001|Overall Study|Requirement for alternative therapy|1|||
146173300|NCT00110890|527147223|FG000|Overall Study|Disease progression|0|||
146173301|NCT00110890|527147224|FG001|Overall Study|Disease progression|1|||
146173302|NCT00110890|527147223|FG000|Overall Study|Parathyroidectomy|0|||
146173303|NCT00110890|527147224|FG001|Overall Study|Parathyroidectomy|1|||
146173304|NCT00110890|527147223|FG000|Overall Study|Did not enter follow-up phase|10|||
146173305|NCT00110890|527147224|FG001|Overall Study|Did not enter follow-up phase|4|||
146173306|NCT01686581|527147225|FG000|Overall Study|Side-effects or Health Problems|15|||
146173307|NCT01686581|527147225|FG000|Overall Study|Lack of Efficacy|90|||
146173308|NCT01686581|527147225|FG000|Overall Study|Participant Concerned about Risks|6|||
146173309|NCT01686581|527147225|FG000|Overall Study|Thinks Injections Too Painful|8|||
146173310|NCT01686581|527147225|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
146173311|NCT01686581|527147225|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
146173312|NCT01686581|527147225|FG000|Overall Study|Thinks it is Inconvenient|17|||
146173313|NCT01686581|527147225|FG000|Overall Study|Other Miscellaneous Reasons|36|||
146173314|NCT01686581|527147225|FG000|Overall Study|Reason Missing|1|||
146173315|NCT01975220|527147226|FG000|Test Period 1|Not treated|0|||
146173316|NCT01975220|527147227|FG001|Test Period 1|Not treated|1|||
146173317|NCT01975220|527147228|FG002|Test Period 1|Not treated|0|||
146173318|NCT01975220|527147229|FG003|Test Period 1|Not treated|0|||
146173319|NCT01975220|527147230|FG004|Test Period 1|Not treated|0|||
146173320|NCT01975220|527147231|FG005|Test Period 1|Not treated|0|||
146173321|NCT02839343|527147232|FG000|Overall Study|Withdrawal by Subject|3|||
146173322|NCT02839343|527147233|FG001|Overall Study|Withdrawal by Subject|1|||
146173323|NCT02839343|527147232|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
146173324|NCT02839343|527147233|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
146173325|NCT02839343|527147232|FG000|Overall Study|Adverse Event|1|||
146173326|NCT02839343|527147233|FG001|Overall Study|Adverse Event|0|||
146173327|NCT01852058|527147234|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
146173328|NCT01852058|527147235|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173329|NCT01852058|527147236|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173330|NCT01852058|527147237|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173331|NCT01852058|527147238|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146072754|NCT00943072|526786333|FG000|Overall Study|Withdrawal by Subject|3|||
146409441|NCT03001011|528004379|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
146409442|NCT03001011|528004380|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
146072755|NCT00943072|526786334|FG001|Overall Study|Withdrawal by Subject|1|||
146072756|NCT00943072|526786333|FG000|Overall Study|Protocol Violation|0|||
146072757|NCT00943072|526786334|FG001|Overall Study|Protocol Violation|1|||
146072758|NCT00943072|526786333|FG000|Overall Study|Lost to Follow-up|1|||
146072759|NCT00943072|526786334|FG001|Overall Study|Lost to Follow-up|2|||
146072760|NCT00943072|526786333|FG000|Overall Study|Lack of Efficacy|0|||
146072761|NCT00943072|526786334|FG001|Overall Study|Lack of Efficacy|4|||
146072762|NCT00943072|526786333|FG000|Overall Study|Other|1|||
146072763|NCT00943072|526786334|FG001|Overall Study|Other|1|||
146072764|NCT03860818|526786340|FG000|Overall Study|Death|144|||
146072765|NCT03860818|526786341|FG001|Overall Study|Death|195|||
146072766|NCT03860818|526786340|FG000|Overall Study|Graft Loss|32|||
146072767|NCT03860818|526786341|FG001|Overall Study|Graft Loss|45|||
146072768|NCT00792571|526786342|FG000|Overall Study|Death|1|||
146072769|NCT00792571|526786342|FG000|Overall Study|Adverse Event|4|||
146072770|NCT00792571|526786342|FG000|Overall Study|Withdrawal by Subject|1|||
146072771|NCT00792571|526786342|FG000|Overall Study|Other|4|||
146072772|NCT02600819|526786343|FG000|GEN Phase|Adverse Event|2|||
146072773|NCT02600819|526786344|FG001|GEN Phase|Adverse Event|0|||
146072774|NCT02600819|526786343|FG000|GEN Phase|Death|2|||
146072775|NCT02600819|526786344|FG001|GEN Phase|Death|0|||
146072776|NCT02600819|526786343|FG000|GEN Phase|Investigator's Discretion|4|||
146072777|NCT02600819|526786344|FG001|GEN Phase|Investigator's Discretion|0|||
146072778|NCT02600819|526786343|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
146072779|NCT02600819|526786344|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
146072780|NCT02600819|526786343|FG000|GEN Phase|Withdrew Consent|5|||
146072781|NCT02600819|526786344|FG001|GEN Phase|Withdrew Consent|0|||
146072782|NCT02600819|526786343|FG000|GEN Phase|Lost to Follow-up|2|||
146072783|NCT02600819|526786344|FG001|GEN Phase|Lost to Follow-up|0|||
146072784|NCT01715857|526786345|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
146072785|NCT00505778|526786346|FG000|Overall Study|Adverse Event|2|||
146072786|NCT00505778|526786347|FG001|Overall Study|Adverse Event|7|||
146072787|NCT00505778|526786346|FG000|Overall Study|Physician Decision|8|||
146072788|NCT00505778|526786347|FG001|Overall Study|Physician Decision|14|||
146072789|NCT00505778|526786346|FG000|Overall Study|Lost to Follow-up|17|||
146072790|NCT00505778|526786347|FG001|Overall Study|Lost to Follow-up|23|||
146072791|NCT00505778|526786346|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
146072792|NCT00505778|526786347|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
146072793|NCT00505778|526786346|FG000|Overall Study|Protocol Violation|7|||
146072794|NCT00505778|526786347|FG001|Overall Study|Protocol Violation|9|||
146072795|NCT00505778|526786346|FG000|Overall Study|Withdrawal by Subject|29|||
146072796|NCT00505778|526786347|FG001|Overall Study|Withdrawal by Subject|14|||
146072797|NCT00505778|526786346|FG000|Overall Study|Relapse|65|||
146072798|NCT00505778|526786347|FG001|Overall Study|Relapse|65|||
146072799|NCT00505778|526786346|FG000|Overall Study|Took No Study Drug|2|||
146072800|NCT00505778|526786347|FG001|Overall Study|Took No Study Drug|2|||
146072801|NCT03790696|526786350|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
146072802|NCT03790696|526786351|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
146072803|NCT00481091|526786358|FG000|Overall Study|Withdrawal by Subject|0|||
146173332|NCT01852058|527147239|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173333|NCT01852058|527147240|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146072804|NCT00481091|526786359|FG001|Overall Study|Withdrawal by Subject|1|||
146072805|NCT00481091|526786360|FG002|Overall Study|Withdrawal by Subject|1|||
146072806|NCT00481091|526786361|FG003|Overall Study|Withdrawal by Subject|0|||
146072807|NCT00481091|526786362|FG004|Overall Study|Withdrawal by Subject|0|||
146072808|NCT00481091|526786363|FG005|Overall Study|Withdrawal by Subject|0|||
146072809|NCT00481091|526786364|FG006|Overall Study|Withdrawal by Subject|0|||
146072810|NCT00481091|526786365|FG007|Overall Study|Withdrawal by Subject|0|||
146072811|NCT00481091|526786366|FG008|Overall Study|Withdrawal by Subject|1|||
146072812|NCT00481091|526786367|FG009|Overall Study|Withdrawal by Subject|6|||
146072813|NCT00481091|526786358|FG000|Overall Study|Other, Not Specified|0|||
146072814|NCT00481091|526786359|FG001|Overall Study|Other, Not Specified|1|||
146072815|NCT00481091|526786360|FG002|Overall Study|Other, Not Specified|1|||
146072816|NCT00481091|526786361|FG003|Overall Study|Other, Not Specified|0|||
146072817|NCT00481091|526786362|FG004|Overall Study|Other, Not Specified|0|||
146072818|NCT00481091|526786363|FG005|Overall Study|Other, Not Specified|1|||
146409443|NCT03001011|528004379|FG000|Overall Study|Other than specified above|3|||
146072819|NCT00481091|526786364|FG006|Overall Study|Other, Not Specified|0|||
146072820|NCT00481091|526786365|FG007|Overall Study|Other, Not Specified|0|||
146072821|NCT00481091|526786366|FG008|Overall Study|Other, Not Specified|0|||
146072822|NCT00481091|526786367|FG009|Overall Study|Other, Not Specified|4|||
146072823|NCT00481091|526786358|FG000|Overall Study|Adverse Event|1|||
146072824|NCT00481091|526786359|FG001|Overall Study|Adverse Event|2|||
146072825|NCT00481091|526786360|FG002|Overall Study|Adverse Event|0|||
146072826|NCT00481091|526786361|FG003|Overall Study|Adverse Event|1|||
146072827|NCT00481091|526786362|FG004|Overall Study|Adverse Event|1|||
146072828|NCT00481091|526786363|FG005|Overall Study|Adverse Event|1|||
146072829|NCT00481091|526786364|FG006|Overall Study|Adverse Event|2|||
146072830|NCT00481091|526786365|FG007|Overall Study|Adverse Event|1|||
146072831|NCT00481091|526786366|FG008|Overall Study|Adverse Event|1|||
146072832|NCT00481091|526786367|FG009|Overall Study|Adverse Event|6|||
146072833|NCT00481091|526786358|FG000|Overall Study|Progressive disease clinical|0|||
146072834|NCT00481091|526786359|FG001|Overall Study|Progressive disease clinical|0|||
146072835|NCT00481091|526786360|FG002|Overall Study|Progressive disease clinical|0|||
146072836|NCT00481091|526786361|FG003|Overall Study|Progressive disease clinical|0|||
146072837|NCT00481091|526786362|FG004|Overall Study|Progressive disease clinical|0|||
146072838|NCT00481091|526786363|FG005|Overall Study|Progressive disease clinical|0|||
146072839|NCT00481091|526786364|FG006|Overall Study|Progressive disease clinical|0|||
146072840|NCT00481091|526786365|FG007|Overall Study|Progressive disease clinical|0|||
146409444|NCT03001011|528004380|FG001|Overall Study|Other than specified above|8|||
146409445|NCT01021137|528004381|FG000|Overall Study|Lost to Follow-up|9|||
146409446|NCT01021137|528004382|FG001|Overall Study|Lost to Follow-up|4|||
146409447|NCT01021137|528004383|FG002|Overall Study|Lost to Follow-up|2|||
146409448|NCT01021137|528004384|FG003|Overall Study|Lost to Follow-up|6|||
146409449|NCT01021137|528004381|FG000|Overall Study|Withdrawal by Subject|1|||
146409450|NCT01021137|528004382|FG001|Overall Study|Withdrawal by Subject|0|||
146409451|NCT01021137|528004383|FG002|Overall Study|Withdrawal by Subject|0|||
146409452|NCT01021137|528004384|FG003|Overall Study|Withdrawal by Subject|3|||
146409453|NCT03125915|528004391|FG000|1 Month Follow up|Lost to Follow-up|3|||
146409454|NCT03125915|528004392|FG001|1 Month Follow up|Lost to Follow-up|3|||
146409455|NCT03125915|528004393|FG002|1 Month Follow up|Lost to Follow-up|2|||
146409456|NCT03125915|528004394|FG003|1 Month Follow up|Lost to Follow-up|3|||
146409457|NCT03125915|528004391|FG000|3 Month Follow-up|Lost to Follow-up|6|||
146409458|NCT03125915|528004392|FG001|3 Month Follow-up|Lost to Follow-up|4|||
146409459|NCT03125915|528004393|FG002|3 Month Follow-up|Lost to Follow-up|4|||
146409460|NCT03125915|528004394|FG003|3 Month Follow-up|Lost to Follow-up|2|||
146409461|NCT03125915|528004391|FG000|6 Month Follow-up|Lost to Follow-up|7|||
146409462|NCT03125915|528004392|FG001|6 Month Follow-up|Lost to Follow-up|3|||
146409463|NCT03125915|528004393|FG002|6 Month Follow-up|Lost to Follow-up|6|||
146409464|NCT03125915|528004394|FG003|6 Month Follow-up|Lost to Follow-up|3|||
146409465|NCT01309828|528004397|FG000|Overall Study|Adverse Event|10|||
146409466|NCT01309828|528004398|FG001|Overall Study|Adverse Event|11|||
146409467|NCT01309828|528004397|FG000|Overall Study|Voluntary Withdrawal|5|||
146409468|NCT01309828|528004398|FG001|Overall Study|Voluntary Withdrawal|4|||
146409469|NCT01309828|528004397|FG000|Overall Study|Major Protocol Deviation|0|||
146409470|NCT01309828|528004398|FG001|Overall Study|Major Protocol Deviation|1|||
146409471|NCT01309828|528004397|FG000|Overall Study|Other|1|||
146409472|NCT01309828|528004398|FG001|Overall Study|Other|0|||
146409473|NCT00217971|528004399|FG000|Overall Study|Adverse Event|1|||
146409474|NCT00217971|528004400|FG001|Overall Study|Adverse Event|1|||
146409475|NCT00217971|528004399|FG000|Overall Study|Lost to Follow-up|15|||
146409476|NCT00217971|528004400|FG001|Overall Study|Lost to Follow-up|19|||
146409477|NCT00217971|528004399|FG000|Overall Study|Physician Decision|0|||
146409478|NCT00217971|528004400|FG001|Overall Study|Physician Decision|1|||
146409479|NCT00217971|528004399|FG000|Overall Study|Withdrawal by Subject|7|||
146409480|NCT00217971|528004400|FG001|Overall Study|Withdrawal by Subject|12|||
146409481|NCT00217971|528004399|FG000|Overall Study|non compliant|1|||
146409482|NCT00217971|528004400|FG001|Overall Study|non compliant|0|||
146409483|NCT00928135|528004401|FG000|Overall Study|Withdrawal by Subject|1|||
146409484|NCT00928135|528004402|FG001|Overall Study|Withdrawal by Subject|0|||
146409485|NCT03338673|528004403|FG000|Overall Study|Lost to Follow-up|1|||
146409486|NCT03338673|528004404|FG001|Overall Study|Lost to Follow-up|1|||
146409487|NCT01416142|528005837|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
146409488|NCT01416142|528005838|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
146409489|NCT01416142|528005839|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
146409490|NCT00678379|528005840|FG000|Overall Study|Injection performed after tonsillectomy|2|||
146409491|NCT00678379|528005841|FG001|Overall Study|Injection performed after tonsillectomy|0|||
146409492|NCT00678379|528005842|FG002|Overall Study|Injection performed after tonsillectomy|1|||
146409493|NCT00678379|528005840|FG000|Overall Study|Incomplete Data|4|||
146409494|NCT00678379|528005841|FG001|Overall Study|Incomplete Data|3|||
146409495|NCT00678379|528005842|FG002|Overall Study|Incomplete Data|3|||
146409496|NCT04006847|528005845|FG000|Overall Study|Product issue|1|||
146409497|NCT03333382|528005851|FG000|Overall Study|Lost to Follow-up|1|||
146409498|NCT03333382|528005852|FG001|Overall Study|Lost to Follow-up|0|||
146409499|NCT02454972|528005855|FG000|Overall Study|Progressive disease|17|||
146409500|NCT02454972|528005856|FG001|Overall Study|Progressive disease|16|||
146409501|NCT02454972|528005857|FG002|Overall Study|Progressive disease|59|||
146409502|NCT02454972|528005858|FG003|Overall Study|Progressive disease|23|||
146409503|NCT02454972|528005859|FG004|Overall Study|Progressive disease|16|||
146409504|NCT02454972|528005860|FG005|Overall Study|Progressive disease|12|||
146409505|NCT02454972|528005861|FG006|Overall Study|Progressive disease|19|||
146409506|NCT02454972|528005862|FG007|Overall Study|Progressive disease|27|||
146409507|NCT02454972|528005863|FG008|Overall Study|Progressive disease|0|||
146409508|NCT02454972|528005855|FG000|Overall Study|Death|0|||
146409509|NCT02454972|528005856|FG001|Overall Study|Death|0|||
146409510|NCT02454972|528005857|FG002|Overall Study|Death|5|||
146409511|NCT02454972|528005858|FG003|Overall Study|Death|1|||
146409512|NCT02454972|528005859|FG004|Overall Study|Death|0|||
146072841|NCT00481091|526786366|FG008|Overall Study|Progressive disease clinical|1|||
146072842|NCT00481091|526786367|FG009|Overall Study|Progressive disease clinical|7|||
146409513|NCT02454972|528005860|FG005|Overall Study|Death|0|||
146409514|NCT02454972|528005861|FG006|Overall Study|Death|0|||
146409515|NCT02454972|528005862|FG007|Overall Study|Death|0|||
146409516|NCT02454972|528005863|FG008|Overall Study|Death|95|||
146409517|NCT02454972|528005855|FG000|Overall Study|Physician Decision|0|||
146409518|NCT02454972|528005856|FG001|Overall Study|Physician Decision|1|||
146409519|NCT02454972|528005857|FG002|Overall Study|Physician Decision|2|||
146409520|NCT02454972|528005858|FG003|Overall Study|Physician Decision|1|||
146409521|NCT02454972|528005859|FG004|Overall Study|Physician Decision|2|||
146409522|NCT02454972|528005860|FG005|Overall Study|Physician Decision|0|||
146409523|NCT02454972|528005861|FG006|Overall Study|Physician Decision|0|||
146409524|NCT02454972|528005862|FG007|Overall Study|Physician Decision|1|||
146409525|NCT02454972|528005863|FG008|Overall Study|Physician Decision|0|||
146409526|NCT02454972|528005855|FG000|Overall Study|Non treatment-related adverse event|2|||
146409527|NCT02454972|528005856|FG001|Overall Study|Non treatment-related adverse event|0|||
146409528|NCT02454972|528005857|FG002|Overall Study|Non treatment-related adverse event|1|||
146409529|NCT02454972|528005858|FG003|Overall Study|Non treatment-related adverse event|0|||
146409530|NCT02454972|528005859|FG004|Overall Study|Non treatment-related adverse event|0|||
146409531|NCT02454972|528005860|FG005|Overall Study|Non treatment-related adverse event|1|||
146409532|NCT02454972|528005861|FG006|Overall Study|Non treatment-related adverse event|0|||
146409533|NCT02454972|528005862|FG007|Overall Study|Non treatment-related adverse event|1|||
146409534|NCT02454972|528005863|FG008|Overall Study|Non treatment-related adverse event|0|||
146409535|NCT02454972|528005855|FG000|Overall Study|Treatment-related adverse events|0|||
146409536|NCT02454972|528005856|FG001|Overall Study|Treatment-related adverse events|1|||
146409537|NCT02454972|528005857|FG002|Overall Study|Treatment-related adverse events|1|||
146409538|NCT02454972|528005858|FG003|Overall Study|Treatment-related adverse events|0|||
146409539|NCT02454972|528005859|FG004|Overall Study|Treatment-related adverse events|2|||
146409540|NCT02454972|528005860|FG005|Overall Study|Treatment-related adverse events|0|||
146409541|NCT02454972|528005861|FG006|Overall Study|Treatment-related adverse events|0|||
146409542|NCT02454972|528005862|FG007|Overall Study|Treatment-related adverse events|2|||
146409543|NCT02454972|528005863|FG008|Overall Study|Treatment-related adverse events|0|||
146409544|NCT02454972|528005855|FG000|Overall Study|Patient moves to compassionate use|0|||
146409545|NCT02454972|528005856|FG001|Overall Study|Patient moves to compassionate use|0|||
146409546|NCT02454972|528005857|FG002|Overall Study|Patient moves to compassionate use|0|||
146409547|NCT02454972|528005858|FG003|Overall Study|Patient moves to compassionate use|0|||
146409548|NCT02454972|528005859|FG004|Overall Study|Patient moves to compassionate use|0|||
146409549|NCT02454972|528005860|FG005|Overall Study|Patient moves to compassionate use|0|||
146409550|NCT02454972|528005861|FG006|Overall Study|Patient moves to compassionate use|2|||
146409551|NCT02454972|528005862|FG007|Overall Study|Patient moves to compassionate use|0|||
146409552|NCT02454972|528005863|FG008|Overall Study|Patient moves to compassionate use|0|||
146409553|NCT02454972|528005855|FG000|Overall Study|Withdrawal by Subject|0|||
146409554|NCT02454972|528005856|FG001|Overall Study|Withdrawal by Subject|1|||
146409555|NCT02454972|528005857|FG002|Overall Study|Withdrawal by Subject|5|||
146409556|NCT02454972|528005858|FG003|Overall Study|Withdrawal by Subject|2|||
146072843|NCT00481091|526786358|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146072844|NCT00481091|526786359|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146072845|NCT00481091|526786360|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072846|NCT00481091|526786361|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072847|NCT00481091|526786362|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072848|NCT00481091|526786363|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
146072849|NCT00481091|526786364|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072850|NCT00481091|526786365|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072851|NCT00481091|526786366|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072852|NCT00481091|526786367|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
146072853|NCT00481091|526786358|FG000|Overall Study|Progressive disease other|1|||
146072854|NCT00481091|526786359|FG001|Overall Study|Progressive disease other|1|||
146072855|NCT00481091|526786360|FG002|Overall Study|Progressive disease other|0|||
146072856|NCT00481091|526786361|FG003|Overall Study|Progressive disease other|1|||
146072857|NCT00481091|526786362|FG004|Overall Study|Progressive disease other|1|||
146072858|NCT00481091|526786363|FG005|Overall Study|Progressive disease other|1|||
146072859|NCT00481091|526786364|FG006|Overall Study|Progressive disease other|0|||
146072860|NCT00481091|526786365|FG007|Overall Study|Progressive disease other|2|||
146072861|NCT00481091|526786366|FG008|Overall Study|Progressive disease other|0|||
146072862|NCT00481091|526786367|FG009|Overall Study|Progressive disease other|0|||
146072863|NCT00481091|526786358|FG000|Overall Study|No reason given|0|||
146072864|NCT00481091|526786359|FG001|Overall Study|No reason given|0|||
146072865|NCT00481091|526786360|FG002|Overall Study|No reason given|1|||
146072866|NCT00481091|526786361|FG003|Overall Study|No reason given|1|||
146072867|NCT00481091|526786362|FG004|Overall Study|No reason given|1|||
146173334|NCT01852058|527147241|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146409557|NCT02454972|528005859|FG004|Overall Study|Withdrawal by Subject|3|||
146409558|NCT02454972|528005860|FG005|Overall Study|Withdrawal by Subject|2|||
146409559|NCT02454972|528005861|FG006|Overall Study|Withdrawal by Subject|0|||
146409560|NCT02454972|528005862|FG007|Overall Study|Withdrawal by Subject|1|||
146072868|NCT00481091|526786363|FG005|Overall Study|No reason given|0|||
146072869|NCT00481091|526786364|FG006|Overall Study|No reason given|1|||
146072870|NCT00481091|526786365|FG007|Overall Study|No reason given|1|||
146072871|NCT00481091|526786366|FG008|Overall Study|No reason given|1|||
146072872|NCT00481091|526786367|FG009|Overall Study|No reason given|4|||
146072873|NCT00475306|526786368|FG000|Overall Study|Protocol Violation|1|||
146072874|NCT00475306|526786369|FG001|Overall Study|Protocol Violation|1|||
146072875|NCT00475306|526786370|FG002|Overall Study|Protocol Violation|0|||
146072876|NCT00475306|526786371|FG003|Overall Study|Protocol Violation|1|||
146072877|NCT04294680|526786372|FG000|Overall Study|Withdrawal by Subject|2|||
146072878|NCT04294680|526786373|FG001|Overall Study|Withdrawal by Subject|1|||
146072879|NCT04294680|526786372|FG000|Overall Study|Follow-up visits completed outside of window|1|||
146072880|NCT04294680|526786373|FG001|Overall Study|Follow-up visits completed outside of window|0|||
146409561|NCT02454972|528005863|FG008|Overall Study|Withdrawal by Subject|2|||
146409562|NCT02454972|528005855|FG000|Overall Study|Multiple delay/holds on treatment|0|||
146409563|NCT02454972|528005856|FG001|Overall Study|Multiple delay/holds on treatment|0|||
146409564|NCT02454972|528005857|FG002|Overall Study|Multiple delay/holds on treatment|0|||
146409565|NCT02454972|528005858|FG003|Overall Study|Multiple delay/holds on treatment|1|||
146409566|NCT02454972|528005859|FG004|Overall Study|Multiple delay/holds on treatment|0|||
146409567|NCT02454972|528005860|FG005|Overall Study|Multiple delay/holds on treatment|0|||
146409568|NCT02454972|528005861|FG006|Overall Study|Multiple delay/holds on treatment|0|||
146409569|NCT02454972|528005862|FG007|Overall Study|Multiple delay/holds on treatment|0|||
146409570|NCT02454972|528005863|FG008|Overall Study|Multiple delay/holds on treatment|0|||
146409571|NCT02454972|528005855|FG000|Overall Study|Never treated|0|||
146409572|NCT02454972|528005856|FG001|Overall Study|Never treated|0|||
146409573|NCT02454972|528005857|FG002|Overall Study|Never treated|3|||
146409574|NCT02454972|528005858|FG003|Overall Study|Never treated|1|||
146409575|NCT02454972|528005859|FG004|Overall Study|Never treated|1|||
146409576|NCT02454972|528005860|FG005|Overall Study|Never treated|0|||
146409577|NCT02454972|528005861|FG006|Overall Study|Never treated|0|||
146409578|NCT02454972|528005862|FG007|Overall Study|Never treated|0|||
146409579|NCT02454972|528005863|FG008|Overall Study|Never treated|5|||
146409580|NCT02454972|528005855|FG000|Overall Study|Lost to Follow-up|0|||
146409581|NCT02454972|528005856|FG001|Overall Study|Lost to Follow-up|0|||
146409582|NCT02454972|528005857|FG002|Overall Study|Lost to Follow-up|0|||
146409583|NCT02454972|528005858|FG003|Overall Study|Lost to Follow-up|0|||
146409584|NCT02454972|528005859|FG004|Overall Study|Lost to Follow-up|0|||
146409585|NCT02454972|528005860|FG005|Overall Study|Lost to Follow-up|0|||
146409586|NCT02454972|528005861|FG006|Overall Study|Lost to Follow-up|0|||
146409587|NCT02454972|528005862|FG007|Overall Study|Lost to Follow-up|0|||
146409588|NCT02454972|528005863|FG008|Overall Study|Lost to Follow-up|2|||
146409589|NCT02454972|528005855|FG000|Overall Study|Study termination|0|||
146072881|NCT02881567|526786374|FG000|Overall Study|Adverse Event|1|||
146072882|NCT02881567|526786374|FG000|Overall Study|Lost to Follow-up|3|||
146072883|NCT02881567|526786374|FG000|Overall Study|Consent withdrawn|1|||
146409590|NCT02454972|528005856|FG001|Overall Study|Study termination|0|||
146409591|NCT02454972|528005857|FG002|Overall Study|Study termination|0|||
146072884|NCT02881567|526786374|FG000|Overall Study|Investigator decision|1|||
146072885|NCT02881567|526786374|FG000|Overall Study|Study terminated by sponsor|9|||
146072886|NCT02881567|526786374|FG000|Overall Study|Reason not Specified|3|||
146173335|NCT01852058|527147242|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146072887|NCT02405442|526786375|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
146072888|NCT02405442|526786376|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
146072889|NCT02405442|526786377|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
146072890|NCT02405442|526786378|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
146072891|NCT02405442|526786375|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
146072892|NCT02405442|526786376|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
146072893|NCT02405442|526786377|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
146072894|NCT02405442|526786378|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
146409592|NCT02454972|528005858|FG003|Overall Study|Study termination|0|||
146409593|NCT02454972|528005859|FG004|Overall Study|Study termination|0|||
146409594|NCT02454972|528005860|FG005|Overall Study|Study termination|0|||
146409595|NCT02454972|528005861|FG006|Overall Study|Study termination|0|||
146409596|NCT02454972|528005862|FG007|Overall Study|Study termination|0|||
146409597|NCT02454972|528005863|FG008|Overall Study|Study termination|6|||
146409598|NCT00787566|528005864|FG000|Overall Study|AE related to chemotherapy|0|||
146409599|NCT00787566|528005865|FG001|Overall Study|AE related to chemotherapy|1|||
146409600|NCT00787566|528005866|FG002|Overall Study|AE related to chemotherapy|0|||
146409601|NCT01070966|528005876|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
146409602|NCT01070966|528005876|FG000|Participants for Safety Evaluation|Off-label use|9|||
146409603|NCT01070966|528005876|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
146409604|NCT01070966|528005876|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
146409605|NCT01070966|528005876|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
146409606|NCT01070966|528005876|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
146409607|NCT01070966|528005876|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
146409608|NCT01070966|528005876|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
146409609|NCT01725113|528005878|FG000|Overall Study|Kidney Transplant|1|||
146409610|NCT01725113|528005879|FG001|Overall Study|Kidney Transplant|1|||
146409611|NCT01725113|528005878|FG000|Overall Study|Withdrawal by Subject|0|||
146409612|NCT01725113|528005879|FG001|Overall Study|Withdrawal by Subject|1|||
146409613|NCT01415921|528005881|FG000|Overall Study|Adverse Event|0|||
146409614|NCT01415921|528005882|FG001|Overall Study|Adverse Event|1|||
146409615|NCT01415921|528005881|FG000|Overall Study|Physician Decision|1|||
146409616|NCT01415921|528005882|FG001|Overall Study|Physician Decision|1|||
146409617|NCT01415921|528005881|FG000|Overall Study|Withdrawal by Subject|0|||
146409618|NCT01415921|528005882|FG001|Overall Study|Withdrawal by Subject|1|||
146409619|NCT01415921|528005881|FG000|Overall Study|Other|2|||
146409620|NCT01415921|528005882|FG001|Overall Study|Other|0|||
146409621|NCT03876873|528005887|FG000|Overall Study|Physician Decision|0|||
146409622|NCT03876873|528005888|FG001|Overall Study|Physician Decision|1|||
146409623|NCT02117479|528005890|FG000|Overall Study|Death|13|||
146409624|NCT02117479|528005891|FG001|Overall Study|Death|8|||
146409625|NCT02117479|528005890|FG000|Overall Study|Adverse Event|8|||
146409626|NCT02117479|528005891|FG001|Overall Study|Adverse Event|16|||
146409627|NCT02117479|528005890|FG000|Overall Study|Subject decision|8|||
146409628|NCT02117479|528005891|FG001|Overall Study|Subject decision|9|||
146409629|NCT02117479|528005890|FG000|Overall Study|Disease progression|104|||
146409630|NCT02117479|528005891|FG001|Overall Study|Disease progression|108|||
146409631|NCT02117479|528005890|FG000|Overall Study|Noncompliance with study treatment|1|||
146409632|NCT02117479|528005891|FG001|Overall Study|Noncompliance with study treatment|0|||
146409633|NCT02117479|528005890|FG000|Overall Study|Study terminated by the sponsor|4|||
146409634|NCT02117479|528005891|FG001|Overall Study|Study terminated by the sponsor|6|||
146409635|NCT02117479|528005890|FG000|Overall Study|Physician Decision|7|||
146409636|NCT02117479|528005891|FG001|Overall Study|Physician Decision|2|||
146409637|NCT02117479|528005890|FG000|Overall Study|Other unspecified|11|||
146409638|NCT02117479|528005891|FG001|Overall Study|Other unspecified|7|||
146409639|NCT01453374|528005894|FG000|Overall Study|Adverse Event|7|||
146409640|NCT01453374|528005894|FG000|Overall Study|Lack of Efficacy|1|||
146409641|NCT01453374|528005894|FG000|Overall Study|Lost to Follow-up|3|||
146409642|NCT01453374|528005894|FG000|Overall Study|Withdrawal by Subject|5|||
146409643|NCT01453374|528005894|FG000|Overall Study|Incarcerated|2|||
146409644|NCT02629133|528005896|FG000|Overall Study|Lost to Follow-up|3|||
146409645|NCT02629133|528005897|FG001|Overall Study|Lost to Follow-up|1|||
146409646|NCT02629133|528005896|FG000|Overall Study|Withdrawal by Subject|1|||
146409647|NCT02629133|528005897|FG001|Overall Study|Withdrawal by Subject|1|||
146409648|NCT03216954|528005898|FG000|Overall Study|Adverse Event|0|||
146409649|NCT03216954|528005899|FG001|Overall Study|Adverse Event|0|||
146409650|NCT03216954|528005900|FG002|Overall Study|Adverse Event|1|||
146409651|NCT03216954|528005901|FG003|Overall Study|Adverse Event|0|||
146409652|NCT03216954|528005902|FG004|Overall Study|Adverse Event|1|||
146072895|NCT02405442|526786375|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
146072896|NCT02405442|526786376|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
146173336|NCT01852058|527147243|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173337|NCT01852058|527147244|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146173338|NCT01852058|527147245|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
146072897|NCT02405442|526786377|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
146072898|NCT02405442|526786378|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
146072899|NCT02405442|526786375|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146072900|NCT02405442|526786376|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
146072901|NCT02405442|526786377|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146072902|NCT02405442|526786378|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
146072903|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
146072904|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
146072905|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
146072906|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
146072907|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
146072908|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
146072909|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
146072910|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
146072911|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
146072912|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
146072913|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
146072914|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
146072915|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
146072916|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
146072917|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
146072918|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
146072919|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146072920|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
146072921|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146072922|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
146072923|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146072924|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
146072925|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146072926|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
146072927|NCT02405442|526786375|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146072928|NCT02405442|526786376|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
146072929|NCT02405442|526786377|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146072930|NCT02405442|526786378|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
146072931|NCT02405442|526786375|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146072932|NCT02405442|526786376|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
146072933|NCT02405442|526786377|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146072934|NCT02405442|526786378|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
146072935|NCT02405442|526786375|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146072936|NCT02405442|526786376|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
146072937|NCT02405442|526786377|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146072938|NCT02405442|526786378|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
146072939|NCT02405442|526786375|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
146072940|NCT02405442|526786376|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146072941|NCT02405442|526786377|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146072942|NCT02405442|526786378|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
146072943|NCT00373113|526786379|FG000|Overall Study|Death|1|||
146072944|NCT00373113|526786380|FG001|Overall Study|Death|7|||
146072945|NCT00373113|526786379|FG000|Overall Study|Adverse Event|38|||
146072946|NCT00373113|526786380|FG001|Overall Study|Adverse Event|24|||
146072947|NCT00373113|526786379|FG000|Overall Study|Study terminated by sponsor|9|||
146072948|NCT00373113|526786380|FG001|Overall Study|Study terminated by sponsor|1|||
146072949|NCT00373113|526786379|FG000|Overall Study|Global deterioration of health status|10|||
146173339|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146072950|NCT00373113|526786380|FG001|Overall Study|Global deterioration of health status|7|||
146072951|NCT00373113|526786379|FG000|Overall Study|Lost to Follow-up|1|||
146072952|NCT00373113|526786380|FG001|Overall Study|Lost to Follow-up|3|||
146072953|NCT00373113|526786379|FG000|Overall Study|Objective progression or relapse|150|||
146072954|NCT00373113|526786380|FG001|Overall Study|Objective progression or relapse|169|||
146072955|NCT00373113|526786379|FG000|Overall Study|Other|14|||
146072956|NCT00373113|526786380|FG001|Overall Study|Other|17|||
146072957|NCT00373113|526786379|FG000|Overall Study|Protocol Violation|5|||
146072958|NCT00373113|526786380|FG001|Overall Study|Protocol Violation|1|||
146072959|NCT00373113|526786379|FG000|Overall Study|Withdrawal by Subject|10|||
146072960|NCT00373113|526786380|FG001|Overall Study|Withdrawal by Subject|15|||
146072961|NCT02078960|526786381|FG000|Treatment Period|Other|0|||
146072962|NCT02078960|526786382|FG001|Treatment Period|Other|0|||
146072963|NCT02078960|526786383|FG002|Treatment Period|Other|1|||
146072964|NCT02078960|526786381|FG000|Treatment Period|Lack of Efficacy|0|||
146072965|NCT02078960|526786382|FG001|Treatment Period|Lack of Efficacy|1|||
146072966|NCT02078960|526786383|FG002|Treatment Period|Lack of Efficacy|0|||
146072967|NCT02078960|526786381|FG000|Treatment Period|Disease progression - accelerated phase|0|||
146072968|NCT02078960|526786382|FG001|Treatment Period|Disease progression - accelerated phase|1|||
146072969|NCT02078960|526786383|FG002|Treatment Period|Disease progression - accelerated phase|0|||
146072970|NCT02078960|526786381|FG000|Treatment Period|Disease progression - blast phase|1|||
146072971|NCT02078960|526786382|FG001|Treatment Period|Disease progression - blast phase|0|||
146072972|NCT02078960|526786383|FG002|Treatment Period|Disease progression - blast phase|0|||
146072973|NCT02078960|526786381|FG000|Treatment Period|Withdrawal by Subject|0|||
146072974|NCT02078960|526786382|FG001|Treatment Period|Withdrawal by Subject|1|||
146072975|NCT02078960|526786383|FG002|Treatment Period|Withdrawal by Subject|1|||
146072976|NCT02078960|526786381|FG000|Treatment Period|Adverse Event|1|||
146072977|NCT02078960|526786382|FG001|Treatment Period|Adverse Event|0|||
146072978|NCT02078960|526786383|FG002|Treatment Period|Adverse Event|0|||
146072979|NCT02078960|526786381|FG000|Treatment Period|Death|0|||
146072980|NCT02078960|526786382|FG001|Treatment Period|Death|0|||
146072981|NCT02078960|526786383|FG002|Treatment Period|Death|1|||
146072982|NCT02078960|526786381|FG000|Follow-up Period|Death|2|||
146072983|NCT02078960|526786382|FG001|Follow-up Period|Death|0|||
146072984|NCT02078960|526786383|FG002|Follow-up Period|Death|0|||
146072985|NCT02078960|526786381|FG000|Follow-up Period|Lost to Follow-up|0|||
146072986|NCT02078960|526786382|FG001|Follow-up Period|Lost to Follow-up|1|||
146072987|NCT02078960|526786383|FG002|Follow-up Period|Lost to Follow-up|0|||
146072988|NCT03275350|526786384|FG000|Overall Study|Lost to Follow-up|4|||
146072989|NCT03275350|526786385|FG001|Overall Study|Lost to Follow-up|6|||
146072990|NCT03275350|526786384|FG000|Overall Study|Death|2|||
146072991|NCT03275350|526786385|FG001|Overall Study|Death|1|||
146072992|NCT03275350|526786384|FG000|Overall Study|Physician Decision|1|||
146072993|NCT03275350|526786385|FG001|Overall Study|Physician Decision|0|||
146072994|NCT03275350|526786384|FG000|Overall Study|Incarcerated|1|||
146072995|NCT03275350|526786385|FG001|Overall Study|Incarcerated|1|||
146072996|NCT04661579|526786388|FG000|Overall Study|Lost to Follow-up|19|||
146072997|NCT04661579|526786389|FG001|Overall Study|Lost to Follow-up|10|||
146072998|NCT04661579|526786390|FG002|Overall Study|Lost to Follow-up|2|||
146072999|NCT04661579|526786391|FG003|Overall Study|Lost to Follow-up|7|||
146073000|NCT04661579|526786392|FG004|Overall Study|Lost to Follow-up|11|||
146073001|NCT04661579|526786388|FG000|Overall Study|Physician Decision|2|||
146073002|NCT04661579|526786389|FG001|Overall Study|Physician Decision|0|||
146073003|NCT04661579|526786390|FG002|Overall Study|Physician Decision|0|||
146073004|NCT04661579|526786391|FG003|Overall Study|Physician Decision|1|||
146073005|NCT04661579|526786392|FG004|Overall Study|Physician Decision|0|||
146073006|NCT04661579|526786388|FG000|Overall Study|Withdrawal by Subject|1|||
146073007|NCT04661579|526786389|FG001|Overall Study|Withdrawal by Subject|4|||
146073008|NCT04661579|526786390|FG002|Overall Study|Withdrawal by Subject|0|||
146173340|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146073009|NCT04661579|526786391|FG003|Overall Study|Withdrawal by Subject|2|||
146073010|NCT04661579|526786392|FG004|Overall Study|Withdrawal by Subject|0|||
146073011|NCT04661579|526786388|FG000|Overall Study|Death|1|||
146073012|NCT04661579|526786389|FG001|Overall Study|Death|0|||
146073013|NCT04661579|526786390|FG002|Overall Study|Death|0|||
146073014|NCT04661579|526786391|FG003|Overall Study|Death|0|||
146073015|NCT04661579|526786392|FG004|Overall Study|Death|0|||
146073016|NCT04661579|526786388|FG000|Overall Study|Other|1|||
146073017|NCT04661579|526786389|FG001|Overall Study|Other|2|||
146073018|NCT04661579|526786390|FG002|Overall Study|Other|1|||
146073019|NCT04661579|526786391|FG003|Overall Study|Other|1|||
146073020|NCT04661579|526786392|FG004|Overall Study|Other|1|||
146409653|NCT03216954|528005898|FG000|Overall Study|Withdrawal by Subject|2|||
146409654|NCT03216954|528005899|FG001|Overall Study|Withdrawal by Subject|0|||
146409655|NCT03216954|528005900|FG002|Overall Study|Withdrawal by Subject|0|||
146409656|NCT03216954|528005901|FG003|Overall Study|Withdrawal by Subject|0|||
146409657|NCT03216954|528005902|FG004|Overall Study|Withdrawal by Subject|0|||
146409658|NCT03216954|528005898|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146409659|NCT03216954|528005899|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
146409660|NCT03216954|528005900|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146409661|NCT03216954|528005901|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146409662|NCT03216954|528005902|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
146409663|NCT01238822|528005905|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
146073021|NCT04661579|526786388|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
146073022|NCT04661579|526786389|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
146073023|NCT04661579|526786390|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
146073024|NCT04661579|526786391|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
146073025|NCT04661579|526786392|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
146073026|NCT01396447|526786393|FG000|Overall Study|Did Not Receive Treatment|3|||
146409664|NCT05180630|528005906|FG000|First Intervention|Physician Decision|0|||
146409665|NCT05180630|528005907|FG001|First Intervention|Physician Decision|0|||
146409666|NCT05180630|528005908|FG002|First Intervention|Physician Decision|3|||
146409667|NCT00447694|528005911|FG000|Overall Study|Adverse Event|2|||
146409668|NCT00447694|528005911|FG000|Overall Study|Abnormal laboratory value|1|||
146409669|NCT00447694|528005911|FG000|Overall Study|Abnormal test procedure result|1|||
146409670|NCT00447694|528005911|FG000|Overall Study|Withdrawal by Subject|2|||
146409671|NCT00709735|528005912|FG000|Overall Study|Lost to Follow-up|1|||
146409672|NCT00709735|528005913|FG001|Overall Study|Lost to Follow-up|1|||
146409673|NCT00709735|528005912|FG000|Overall Study|Relapse into Opioid Abuse|0|||
146409674|NCT00709735|528005913|FG001|Overall Study|Relapse into Opioid Abuse|1|||
146409675|NCT00709735|528005912|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
146409676|NCT00709735|528005913|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
146409677|NCT00849524|528005914|FG000|Overall Study|Lack of Efficacy|3|||
146409678|NCT01027884|528005917|FG000|Overall Study|Adverse Event|2|||
146409679|NCT01027884|528005918|FG001|Overall Study|Adverse Event|1|||
146409680|NCT01027884|528005917|FG000|Overall Study|Protocol Violation|1|||
146409681|NCT01027884|528005918|FG001|Overall Study|Protocol Violation|0|||
146409682|NCT01027884|528005917|FG000|Overall Study|Non-compliance|1|||
146409683|NCT01027884|528005918|FG001|Overall Study|Non-compliance|1|||
146409684|NCT01027884|528005917|FG000|Overall Study|Withdrawal by Subject|0|||
146409685|NCT01027884|528005918|FG001|Overall Study|Withdrawal by Subject|1|||
146409686|NCT01027884|528005917|FG000|Overall Study|Lost to Follow-up|0|||
146409687|NCT01027884|528005918|FG001|Overall Study|Lost to Follow-up|1|||
146409688|NCT01027884|528005917|FG000|Overall Study|Spinal fixation surgery|0|||
146409689|NCT01027884|528005918|FG001|Overall Study|Spinal fixation surgery|3|||
146409690|NCT03636542|528005919|FG000|Overall Study|Lost to Follow-up|1|||
146409691|NCT03636542|528005920|FG001|Overall Study|Lost to Follow-up|1|||
146409692|NCT03636542|528005919|FG000|Overall Study|Physician Decision|0|||
146409693|NCT03636542|528005920|FG001|Overall Study|Physician Decision|1|||
146409694|NCT03636542|528005919|FG000|Overall Study|Withdrawal by Subject|1|||
146409695|NCT03636542|528005920|FG001|Overall Study|Withdrawal by Subject|0|||
146409696|NCT02059187|528005921|FG000|Overall Study|Adverse Event|0|||
146409697|NCT02059187|528005922|FG001|Overall Study|Adverse Event|3|||
146409698|NCT02059187|528005921|FG000|Overall Study|Death|1|||
146409699|NCT02059187|528005922|FG001|Overall Study|Death|1|||
146409700|NCT02059187|528005921|FG000|Overall Study|Lost to Follow-up|9|||
146409701|NCT02059187|528005922|FG001|Overall Study|Lost to Follow-up|8|||
146409702|NCT02059187|528005921|FG000|Overall Study|Non-compliance with study drug|1|||
146409703|NCT02059187|528005922|FG001|Overall Study|Non-compliance with study drug|0|||
146409704|NCT02059187|528005921|FG000|Overall Study|Physician Decision|1|||
146409705|NCT02059187|528005922|FG001|Overall Study|Physician Decision|2|||
146409706|NCT02059187|528005921|FG000|Overall Study|Protocol Violation|1|||
146409707|NCT02059187|528005922|FG001|Overall Study|Protocol Violation|0|||
146073027|NCT01396447|526786394|FG001|Overall Study|Did Not Receive Treatment|2|||
146073028|NCT01396447|526786395|FG002|Overall Study|Did Not Receive Treatment|1|||
146073029|NCT01396447|526786396|FG003|Overall Study|Did Not Receive Treatment|0|||
146073030|NCT01396447|526786393|FG000|Overall Study|Adverse Event|15|||
146073031|NCT01396447|526786394|FG001|Overall Study|Adverse Event|12|||
146073032|NCT01396447|526786395|FG002|Overall Study|Adverse Event|12|||
146073033|NCT01396447|526786396|FG003|Overall Study|Adverse Event|17|||
146073034|NCT01396447|526786393|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146073035|NCT01396447|526786394|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146073036|NCT01396447|526786395|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146073037|NCT01396447|526786396|FG003|Overall Study|Insufficient Therapeutic Response|4|||
146073038|NCT01396447|526786393|FG000|Overall Study|Protocol Violation|5|||
146073039|NCT01396447|526786394|FG001|Overall Study|Protocol Violation|2|||
146073040|NCT01396447|526786395|FG002|Overall Study|Protocol Violation|3|||
146073041|NCT01396447|526786396|FG003|Overall Study|Protocol Violation|7|||
146073042|NCT01396447|526786393|FG000|Overall Study|Withdrawal of Consent|11|||
146073043|NCT01396447|526786394|FG001|Overall Study|Withdrawal of Consent|9|||
146073044|NCT01396447|526786395|FG002|Overall Study|Withdrawal of Consent|4|||
146073045|NCT01396447|526786396|FG003|Overall Study|Withdrawal of Consent|15|||
146073046|NCT01396447|526786393|FG000|Overall Study|Lost to Follow-up|4|||
146073047|NCT01396447|526786394|FG001|Overall Study|Lost to Follow-up|8|||
146073048|NCT01396447|526786395|FG002|Overall Study|Lost to Follow-up|7|||
146073049|NCT01396447|526786396|FG003|Overall Study|Lost to Follow-up|9|||
146073050|NCT01396447|526786393|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146073051|NCT01396447|526786394|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146073052|NCT01396447|526786395|FG002|Overall Study|Other Miscellaneous Reasons|1|||
146073053|NCT01396447|526786396|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146073054|NCT01402102|526786398|FG000|Overall Study|Protocol Violation|1|||
146073055|NCT01402102|526786399|FG001|Overall Study|Protocol Violation|0|||
146073056|NCT01402102|526786398|FG000|Overall Study|Insufficiency of compliance|1|||
146073057|NCT01402102|526786399|FG001|Overall Study|Insufficiency of compliance|1|||
146073058|NCT01402102|526786398|FG000|Overall Study|Withdrawal by Subject|0|||
146073059|NCT01402102|526786399|FG001|Overall Study|Withdrawal by Subject|2|||
146073060|NCT01386970|526786400|FG000|Overall Study|Withdrawal by Subject|0|||
146073061|NCT01386970|526786401|FG001|Overall Study|Withdrawal by Subject|1|||
146073062|NCT01386970|526786400|FG000|Overall Study|Adverse Event|4|||
146073063|NCT01386970|526786401|FG001|Overall Study|Adverse Event|1|||
146073064|NCT02423902|526786403|FG000|Overall Study|Disease progression|1|||
146073065|NCT02423902|526786404|FG001|Overall Study|Disease progression|4|||
146073066|NCT04329806|526786405|FG000|Overall Study|Physician Decision|3|||
146073067|NCT04329806|526786406|FG001|Overall Study|Physician Decision|4|||
146073068|NCT04838626|526786407|FG000|Overall Study|Adverse Event|2|||
146073069|NCT04838626|526786407|FG000|Overall Study|Physician Decision|6|||
146073070|NCT04838626|526786407|FG000|Overall Study|Protocol Violation|3|||
146073071|NCT04838626|526786407|FG000|Overall Study|Withdrawal by Subject|9|||
146073072|NCT04838626|526786407|FG000|Overall Study|Technical Problems|2|||
146073073|NCT02867384|526786408|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
146073074|NCT02867384|526786409|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
146073075|NCT02867384|526786410|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
146073076|NCT02867384|526786408|FG000|Overall Study|Progression/ Relapse|15|||
146073077|NCT02867384|526786409|FG001|Overall Study|Progression/ Relapse|19|||
146073078|NCT02867384|526786410|FG002|Overall Study|Progression/ Relapse|0|||
146073079|NCT02867384|526786408|FG000|Overall Study|Adverse Event|13|||
146073080|NCT02867384|526786409|FG001|Overall Study|Adverse Event|1|||
146073081|NCT02867384|526786410|FG002|Overall Study|Adverse Event|0|||
146073082|NCT02867384|526786408|FG000|Overall Study|Withdrawal by Subject|6|||
146073083|NCT02867384|526786409|FG001|Overall Study|Withdrawal by Subject|5|||
146073084|NCT02867384|526786410|FG002|Overall Study|Withdrawal by Subject|0|||
146073085|NCT02867384|526786408|FG000|Overall Study|Physician Decision|1|||
146073086|NCT02867384|526786409|FG001|Overall Study|Physician Decision|2|||
146073087|NCT02867384|526786410|FG002|Overall Study|Physician Decision|0|||
146073088|NCT02867384|526786408|FG000|Overall Study|Patient compliance|1|||
146073089|NCT02867384|526786409|FG001|Overall Study|Patient compliance|0|||
146073090|NCT02867384|526786410|FG002|Overall Study|Patient compliance|0|||
146073091|NCT02867384|526786408|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
146073092|NCT02867384|526786409|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
146073093|NCT02867384|526786410|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
146073094|NCT02867384|526786408|FG000|Overall Study|Never start treatment|3|||
146073095|NCT02867384|526786409|FG001|Overall Study|Never start treatment|0|||
146073096|NCT02867384|526786410|FG002|Overall Study|Never start treatment|0|||
146073097|NCT03901469|526786411|FG000|Overall Study|Radiographic Progression|4|||
146073098|NCT03901469|526786412|FG001|Overall Study|Radiographic Progression|6|||
146073099|NCT03901469|526786413|FG002|Overall Study|Radiographic Progression|3|||
146073100|NCT03901469|526786414|FG003|Overall Study|Radiographic Progression|30|||
146073101|NCT03901469|526786415|FG004|Overall Study|Radiographic Progression|7|||
146073102|NCT03901469|526786416|FG005|Overall Study|Radiographic Progression|2|||
146073103|NCT03901469|526786417|FG006|Overall Study|Radiographic Progression|11|||
146073104|NCT03901469|526786411|FG000|Overall Study|Clinical Progression|0|||
146073105|NCT03901469|526786412|FG001|Overall Study|Clinical Progression|2|||
146073106|NCT03901469|526786413|FG002|Overall Study|Clinical Progression|0|||
146073107|NCT03901469|526786414|FG003|Overall Study|Clinical Progression|7|||
146073108|NCT03901469|526786415|FG004|Overall Study|Clinical Progression|6|||
146073109|NCT03901469|526786416|FG005|Overall Study|Clinical Progression|0|||
146073110|NCT03901469|526786417|FG006|Overall Study|Clinical Progression|2|||
146073111|NCT03901469|526786411|FG000|Overall Study|Adverse Event|1|||
146073112|NCT03901469|526786412|FG001|Overall Study|Adverse Event|0|||
146073113|NCT03901469|526786413|FG002|Overall Study|Adverse Event|0|||
146073114|NCT03901469|526786414|FG003|Overall Study|Adverse Event|0|||
146073115|NCT03901469|526786415|FG004|Overall Study|Adverse Event|0|||
146073116|NCT03901469|526786416|FG005|Overall Study|Adverse Event|0|||
146073117|NCT03901469|526786417|FG006|Overall Study|Adverse Event|9|||
146409708|NCT02059187|528005921|FG000|Overall Study|Withdrawal by Subject|12|||
146409709|NCT02059187|528005922|FG001|Overall Study|Withdrawal by Subject|8|||
146409710|NCT02624518|528005923|FG000|Overall Study|Physician Decision|1|||
146409711|NCT02729194|528005924|FG000|Overall Study|Withdrawal by Subject|3|||
146409712|NCT00845026|528005925|FG000|Study Period III|Adverse Event|23|||
146409713|NCT00845026|528005926|FG001|Study Period III|Adverse Event|19|||
146409714|NCT00845026|528005925|FG000|Study Period III|Perceived lack of efficacy|27|||
146073118|NCT03901469|526786411|FG000|Overall Study|Physician Decision|0|||
146073119|NCT03901469|526786412|FG001|Overall Study|Physician Decision|0|||
146073120|NCT03901469|526786413|FG002|Overall Study|Physician Decision|0|||
146073121|NCT03901469|526786414|FG003|Overall Study|Physician Decision|1|||
146073122|NCT03901469|526786415|FG004|Overall Study|Physician Decision|0|||
146073123|NCT03901469|526786416|FG005|Overall Study|Physician Decision|0|||
146073124|NCT03901469|526786417|FG006|Overall Study|Physician Decision|0|||
146073125|NCT03901469|526786411|FG000|Overall Study|Withdrawal by Subject|0|||
146073126|NCT03901469|526786412|FG001|Overall Study|Withdrawal by Subject|0|||
146073127|NCT03901469|526786413|FG002|Overall Study|Withdrawal by Subject|0|||
146073128|NCT03901469|526786414|FG003|Overall Study|Withdrawal by Subject|0|||
146073129|NCT03901469|526786415|FG004|Overall Study|Withdrawal by Subject|2|||
146073130|NCT03901469|526786416|FG005|Overall Study|Withdrawal by Subject|0|||
146073131|NCT03901469|526786417|FG006|Overall Study|Withdrawal by Subject|8|||
146173341|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173342|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146073132|NCT03901469|526786411|FG000|Overall Study|Death|0|||
146073133|NCT03901469|526786412|FG001|Overall Study|Death|0|||
146173343|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
146173344|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173345|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146409715|NCT00845026|528005926|FG001|Study Period III|Perceived lack of efficacy|15|||
146073134|NCT03901469|526786413|FG002|Overall Study|Death|0|||
146073135|NCT03901469|526786414|FG003|Overall Study|Death|3|||
146073136|NCT03901469|526786415|FG004|Overall Study|Death|5|||
146073137|NCT03901469|526786416|FG005|Overall Study|Death|0|||
146073138|NCT03901469|526786417|FG006|Overall Study|Death|1|||
146073139|NCT03901469|526786411|FG000|Overall Study|Termination of study by sponsor|0|||
146073140|NCT03901469|526786412|FG001|Overall Study|Termination of study by sponsor|0|||
146073141|NCT03901469|526786413|FG002|Overall Study|Termination of study by sponsor|0|||
146409716|NCT00845026|528005925|FG000|Study Period III|Withdrawal by Subject|19|||
146409717|NCT00845026|528005926|FG001|Study Period III|Withdrawal by Subject|15|||
146409718|NCT00845026|528005925|FG000|Study Period III|Entry Criteria not met|8|||
146409719|NCT00845026|528005926|FG001|Study Period III|Entry Criteria not met|11|||
146409720|NCT00845026|528005925|FG000|Study Period III|Lost to Follow-up|4|||
146073142|NCT03901469|526786414|FG003|Overall Study|Termination of study by sponsor|0|||
146073143|NCT03901469|526786415|FG004|Overall Study|Termination of study by sponsor|1|||
146073144|NCT03901469|526786416|FG005|Overall Study|Termination of study by sponsor|1|||
146073145|NCT03901469|526786417|FG006|Overall Study|Termination of study by sponsor|0|||
146073146|NCT03901469|526786411|FG000|Overall Study|Not Reported|1|||
146073147|NCT03901469|526786412|FG001|Overall Study|Not Reported|0|||
146073148|NCT03901469|526786413|FG002|Overall Study|Not Reported|0|||
146073149|NCT03901469|526786414|FG003|Overall Study|Not Reported|1|||
146073150|NCT03901469|526786415|FG004|Overall Study|Not Reported|0|||
146073151|NCT03901469|526786416|FG005|Overall Study|Not Reported|0|||
146073152|NCT03901469|526786417|FG006|Overall Study|Not Reported|1|||
146073153|NCT03710083|526786418|FG000|Overall Study|Withdrawal by Subject|2|||
146073154|NCT03710083|526786418|FG000|Overall Study|Unsuccessful Procedure|1|||
146073155|NCT01727024|526786419|FG000|Period 1|Lost to Follow-up|1|||
146073156|NCT01727024|526786420|FG001|Period 1|Lost to Follow-up|1|||
146073157|NCT01727024|526786419|FG000|Period 1|Withdrawal by Subject|2|||
146073158|NCT01727024|526786420|FG001|Period 1|Withdrawal by Subject|3|||
146173346|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173347|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173348|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173349|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173350|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
146173351|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173352|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173353|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173354|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146073159|NCT01485172|526786421|FG000|Overall Study|Adverse Event|2|||
146073160|NCT01485172|526786422|FG001|Overall Study|Adverse Event|1|||
146073161|NCT01485172|526786423|FG002|Overall Study|Adverse Event|2|||
146073162|NCT01485172|526786424|FG003|Overall Study|Adverse Event|2|||
146073163|NCT01485172|526786425|FG004|Overall Study|Adverse Event|1|||
146073164|NCT01485172|526786426|FG005|Overall Study|Adverse Event|2|||
146073165|NCT01485172|526786421|FG000|Overall Study|Lack of Efficacy|2|||
146073166|NCT01485172|526786422|FG001|Overall Study|Lack of Efficacy|0|||
146073167|NCT01485172|526786423|FG002|Overall Study|Lack of Efficacy|0|||
146073168|NCT01485172|526786424|FG003|Overall Study|Lack of Efficacy|0|||
146073169|NCT01485172|526786425|FG004|Overall Study|Lack of Efficacy|0|||
146073170|NCT01485172|526786426|FG005|Overall Study|Lack of Efficacy|0|||
146073171|NCT01485172|526786421|FG000|Overall Study|Protocol Violation|0|||
146073172|NCT01485172|526786422|FG001|Overall Study|Protocol Violation|0|||
146073173|NCT01485172|526786423|FG002|Overall Study|Protocol Violation|4|||
146073174|NCT01485172|526786424|FG003|Overall Study|Protocol Violation|5|||
146073175|NCT01485172|526786425|FG004|Overall Study|Protocol Violation|1|||
146073176|NCT01485172|526786426|FG005|Overall Study|Protocol Violation|0|||
146073177|NCT01485172|526786421|FG000|Overall Study|Protocol defined stopping criteria|1|||
146073178|NCT01485172|526786422|FG001|Overall Study|Protocol defined stopping criteria|0|||
146073179|NCT01485172|526786423|FG002|Overall Study|Protocol defined stopping criteria|0|||
146073180|NCT01485172|526786424|FG003|Overall Study|Protocol defined stopping criteria|0|||
146073181|NCT01485172|526786425|FG004|Overall Study|Protocol defined stopping criteria|1|||
146073182|NCT01485172|526786426|FG005|Overall Study|Protocol defined stopping criteria|0|||
146073183|NCT01485172|526786421|FG000|Overall Study|Lost to Follow-up|0|||
146073184|NCT01485172|526786422|FG001|Overall Study|Lost to Follow-up|0|||
146073185|NCT01485172|526786423|FG002|Overall Study|Lost to Follow-up|1|||
146073186|NCT01485172|526786424|FG003|Overall Study|Lost to Follow-up|0|||
146073187|NCT01485172|526786425|FG004|Overall Study|Lost to Follow-up|0|||
146073188|NCT01485172|526786426|FG005|Overall Study|Lost to Follow-up|1|||
146073189|NCT01485172|526786421|FG000|Overall Study|Physician Decision|0|||
146073190|NCT01485172|526786422|FG001|Overall Study|Physician Decision|0|||
146073191|NCT01485172|526786423|FG002|Overall Study|Physician Decision|0|||
146073192|NCT01485172|526786424|FG003|Overall Study|Physician Decision|0|||
146073193|NCT01485172|526786425|FG004|Overall Study|Physician Decision|1|||
146073194|NCT01485172|526786426|FG005|Overall Study|Physician Decision|0|||
146173355|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
146283881|NCT00092495|527551857|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
146283882|NCT00092495|527551858|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
146283883|NCT00309959|527551863|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
146283884|NCT02947087|527551864|FG000|Overall Study|Withdrawal by Subject|3|||
146283885|NCT02947087|527551865|FG001|Overall Study|Withdrawal by Subject|2|||
146283886|NCT00895154|527551868|FG000|Overall Study|Lost to Follow-up|1|||
146283887|NCT00895154|527551869|FG001|Overall Study|Lost to Follow-up|1|||
146283888|NCT00895154|527551868|FG000|Overall Study|Withdrawal by Subject|0|||
146283889|NCT00895154|527551869|FG001|Overall Study|Withdrawal by Subject|1|||
146283890|NCT01993927|527551870|FG000|Overall Study|Case Report Forms Uncollected|18|||
146283891|NCT01993927|527551870|FG000|Overall Study|Protocol Violation|11|||
146283892|NCT00287690|527551871|FG000|Overall Study|Protocol Violation|20|||
146283893|NCT00287690|527551872|FG001|Overall Study|Protocol Violation|26|||
146283894|NCT01146782|527551873|FG000|Screening Cohort|Screen Failure|187|||
146073195|NCT01485172|526786421|FG000|Overall Study|Withdrawal by Subject|2|||
146073196|NCT01485172|526786422|FG001|Overall Study|Withdrawal by Subject|0|||
146073197|NCT01485172|526786423|FG002|Overall Study|Withdrawal by Subject|0|||
146073198|NCT01485172|526786424|FG003|Overall Study|Withdrawal by Subject|1|||
146073199|NCT01485172|526786425|FG004|Overall Study|Withdrawal by Subject|1|||
146073200|NCT01485172|526786426|FG005|Overall Study|Withdrawal by Subject|1|||
146073201|NCT01301027|526786434|FG000|Overall Study|Physician Decision|2|||
146073202|NCT01301027|526786435|FG001|Overall Study|Physician Decision|0|||
146173356|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
146173357|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173358|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173359|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173360|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173361|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173362|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
146173363|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173364|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173365|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173366|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173367|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
146173368|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173369|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173370|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173371|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173372|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173373|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146173374|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
146409721|NCT00845026|528005926|FG001|Study Period III|Lost to Follow-up|5|||
146409722|NCT00845026|528005925|FG000|Study Period III|Protocol Violation|8|||
146073203|NCT01301027|526786434|FG000|Overall Study|Withdrawal by Subject|2|||
146073204|NCT01301027|526786435|FG001|Overall Study|Withdrawal by Subject|3|||
146073205|NCT01301027|526786434|FG000|Overall Study|Adverse Event|0|||
146073206|NCT01301027|526786435|FG001|Overall Study|Adverse Event|2|||
146073207|NCT01301027|526786434|FG000|Overall Study|Fracture|1|||
146073208|NCT01301027|526786435|FG001|Overall Study|Fracture|3|||
146073209|NCT01301027|526786434|FG000|Overall Study|Transplant|0|||
146073210|NCT01301027|526786435|FG001|Overall Study|Transplant|2|||
146073211|NCT01301027|526786434|FG000|Overall Study|Volume Overload|3|||
146073212|NCT01301027|526786435|FG001|Overall Study|Volume Overload|0|||
146073213|NCT03566485|526786436|FG000|Overall Study|Disease progression|5|||
146073214|NCT03566485|526786437|FG001|Overall Study|Disease progression|4|||
146073215|NCT03566485|526786436|FG000|Overall Study|Clinical progression|0|||
146073216|NCT03566485|526786437|FG001|Overall Study|Clinical progression|1|||
146073217|NCT03566485|526786436|FG000|Overall Study|Toxicity|0|||
146073218|NCT03566485|526786437|FG001|Overall Study|Toxicity|2|||
146073219|NCT01047553|526786438|FG000|Overall Study|Adverse Event|10|||
146073220|NCT01047553|526786439|FG001|Overall Study|Adverse Event|5|||
146073221|NCT01047553|526786438|FG000|Overall Study|Withdrawal by Subject|4|||
146073222|NCT01047553|526786439|FG001|Overall Study|Withdrawal by Subject|2|||
146073223|NCT01047553|526786438|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
146073224|NCT01047553|526786439|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
146073225|NCT01047553|526786438|FG000|Overall Study|Lost to Follow-up|1|||
146073226|NCT01047553|526786439|FG001|Overall Study|Lost to Follow-up|0|||
146073227|NCT01047553|526786438|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
146073228|NCT01047553|526786439|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
146073229|NCT01047553|526786438|FG000|Overall Study|PI's decision|0|||
146073230|NCT01047553|526786439|FG001|Overall Study|PI's decision|1|||
146073231|NCT00948441|526786440|FG000|Overall Study|no longer meet inclusion criteria|1|||
146073232|NCT00948441|526786441|FG001|Overall Study|no longer meet inclusion criteria|4|||
146073233|NCT00104520|526786443|FG000|Overall Study|Unrelated adverse event|34|||
146073234|NCT00104520|526786444|FG001|Overall Study|Unrelated adverse event|47|||
146073235|NCT00104520|526786443|FG000|Overall Study|Study drug intolerance|0|||
146073236|NCT00104520|526786444|FG001|Overall Study|Study drug intolerance|1|||
146073237|NCT00104520|526786443|FG000|Overall Study|Related adverse event|13|||
146073238|NCT00104520|526786444|FG001|Overall Study|Related adverse event|15|||
146073239|NCT00104520|526786443|FG000|Overall Study|Lost to Follow-up|1|||
146073240|NCT00104520|526786444|FG001|Overall Study|Lost to Follow-up|0|||
146073241|NCT00104520|526786443|FG000|Overall Study|Noncompliance|0|||
146073242|NCT00104520|526786444|FG001|Overall Study|Noncompliance|2|||
146073243|NCT00104520|526786443|FG000|Overall Study|Personal/administrative|1|||
146073244|NCT00104520|526786444|FG001|Overall Study|Personal/administrative|1|||
146073245|NCT00104520|526786443|FG000|Overall Study|Other|1|||
146409723|NCT00845026|528005926|FG001|Study Period III|Protocol Violation|1|||
146073246|NCT00104520|526786444|FG001|Overall Study|Other|5|||
146073247|NCT01026324|526786445|FG000|Follow up/Survival|Withdrawal by Subject|1|||
146073248|NCT01026324|526786446|FG001|Follow up/Survival|Withdrawal by Subject|0|||
146073249|NCT01026324|526786447|FG002|Follow up/Survival|Withdrawal by Subject|0|||
146073250|NCT02442804|526786448|FG000|Overall Study|Withdrawal by Subject|0|||
146073251|NCT02442804|526786449|FG001|Overall Study|Withdrawal by Subject|1|||
146073252|NCT02442804|526786448|FG000|Overall Study|Adverse Event|1|||
146073253|NCT02442804|526786449|FG001|Overall Study|Adverse Event|0|||
146073254|NCT02624986|526786453|FG000|Overall Study|Death|0|||
146073255|NCT02624986|526786454|FG001|Overall Study|Death|1|||
146073256|NCT02624986|526786455|FG002|Overall Study|Death|2|||
146073257|NCT02624986|526786456|FG003|Overall Study|Death|2|||
146073258|NCT02624986|526786457|FG004|Overall Study|Death|2|||
146073259|NCT02624986|526786458|FG005|Overall Study|Death|0|||
146073260|NCT02624986|526786459|FG006|Overall Study|Death|0|||
146073261|NCT02624986|526786460|FG007|Overall Study|Death|1|||
146073262|NCT02624986|526786453|FG000|Overall Study|Study Terminated by Sponsor|1|||
146073263|NCT02624986|526786454|FG001|Overall Study|Study Terminated by Sponsor|1|||
146073264|NCT02624986|526786455|FG002|Overall Study|Study Terminated by Sponsor|0|||
146409724|NCT00845026|528005925|FG000|Study Period III|Scheduled conflict|3|||
146409725|NCT00845026|528005926|FG001|Study Period III|Scheduled conflict|1|||
146409726|NCT00845026|528005925|FG000|Study Period III|Subject is moving or has moved|2|||
146409727|NCT00845026|528005926|FG001|Study Period III|Subject is moving or has moved|4|||
146409728|NCT00845026|528005925|FG000|Study Period III|Transportation issues|1|||
146409729|NCT00845026|528005926|FG001|Study Period III|Transportation issues|1|||
146409730|NCT00845026|528005925|FG000|Study Period IV|Adverse Event|4|||
146409731|NCT00845026|528005926|FG001|Study Period IV|Adverse Event|0|||
146409732|NCT00845026|528005925|FG000|Study Period IV|Perceived lack of efficacy|2|||
146409733|NCT00845026|528005926|FG001|Study Period IV|Perceived lack of efficacy|1|||
146409734|NCT00845026|528005925|FG000|Study Period IV|Protocol Violation|3|||
146409735|NCT00845026|528005926|FG001|Study Period IV|Protocol Violation|1|||
146409736|NCT00845026|528005925|FG000|Study Period IV|Lost to Follow-up|1|||
146409737|NCT00845026|528005926|FG001|Study Period IV|Lost to Follow-up|0|||
146409738|NCT00845026|528005925|FG000|Study Period IV|Withdrawal by Subject|4|||
146409739|NCT00845026|528005926|FG001|Study Period IV|Withdrawal by Subject|1|||
146409740|NCT00845026|528005925|FG000|Study Period IV|Entry Criteria Not Met|1|||
146409741|NCT00845026|528005926|FG001|Study Period IV|Entry Criteria Not Met|0|||
146409742|NCT00845026|528005925|FG000|Study Period IV|Subject is moving or has moved|0|||
146409743|NCT00845026|528005926|FG001|Study Period IV|Subject is moving or has moved|1|||
146409744|NCT00845026|528005925|FG000|Study Period IV|Scheduling conflict|1|||
146409745|NCT00845026|528005926|FG001|Study Period IV|Scheduling conflict|0|||
146409746|NCT03012815|528005927|FG000|Overall Study|Lost to Follow-up|1|||
146409747|NCT03012815|528005928|FG001|Overall Study|Lost to Follow-up|0|||
146409748|NCT03012815|528005927|FG000|Overall Study|Physician Decision|3|||
146409749|NCT03012815|528005928|FG001|Overall Study|Physician Decision|2|||
146409750|NCT03012815|528005927|FG000|Overall Study|Adverse Event|1|||
146409751|NCT03012815|528005928|FG001|Overall Study|Adverse Event|0|||
146409752|NCT01462695|528005929|FG000|Overall Study|Adverse Event|1|||
146409753|NCT01462695|528005930|FG001|Overall Study|Adverse Event|1|||
146409754|NCT01462695|528005929|FG000|Overall Study|Death|2|||
146409755|NCT01462695|528005930|FG001|Overall Study|Death|0|||
146409756|NCT01462695|528005929|FG000|Overall Study|Lack of Efficacy|6|||
146409757|NCT01462695|528005930|FG001|Overall Study|Lack of Efficacy|12|||
146409758|NCT01462695|528005929|FG000|Overall Study|Physician Decision|5|||
146409759|NCT01462695|528005930|FG001|Overall Study|Physician Decision|0|||
146409760|NCT01462695|528005929|FG000|Overall Study|Withdrawal by Subject|2|||
146409761|NCT01462695|528005930|FG001|Overall Study|Withdrawal by Subject|0|||
146409762|NCT01462695|528005929|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
146409763|NCT01462695|528005930|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
146409764|NCT00879970|528005931|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
146409765|NCT00879970|528005932|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
146409766|NCT00879970|528005933|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
146409767|NCT00879970|528005934|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
146409768|NCT00879970|528005935|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
146409769|NCT00879970|528005931|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
146409770|NCT00879970|528005932|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
146409771|NCT00879970|528005933|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
146409772|NCT00879970|528005934|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
146409773|NCT00879970|528005935|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
146073265|NCT02624986|526786456|FG003|Overall Study|Study Terminated by Sponsor|1|||
146409774|NCT00879970|528005931|FG000|Period 1 TZD Randomization|Death|2|||
146409775|NCT00879970|528005932|FG001|Period 1 TZD Randomization|Death|1|||
146409776|NCT00879970|528005933|FG002|Period 1 TZD Randomization|Death|0|||
146409777|NCT00879970|528005934|FG003|Period 1 TZD Randomization|Death|0|||
146409778|NCT00879970|528005935|FG004|Period 1 TZD Randomization|Death|0|||
146409779|NCT00879970|528005931|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
146409780|NCT00879970|528005932|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146073266|NCT02624986|526786457|FG004|Overall Study|Study Terminated by Sponsor|2|||
146073267|NCT02624986|526786458|FG005|Overall Study|Study Terminated by Sponsor|2|||
146073268|NCT02624986|526786459|FG006|Overall Study|Study Terminated by Sponsor|4|||
146073269|NCT02624986|526786460|FG007|Overall Study|Study Terminated by Sponsor|3|||
146173375|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173376|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173377|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173378|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173379|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
146173380|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
146173381|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173382|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173383|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173384|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173385|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173386|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
146173387|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173388|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173389|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173390|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
146173391|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173392|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173393|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173394|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173395|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173396|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173397|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146073270|NCT02624986|526786453|FG000|Overall Study|Progressive Disease|0|||
146073271|NCT02624986|526786454|FG001|Overall Study|Progressive Disease|1|||
146073272|NCT02624986|526786455|FG002|Overall Study|Progressive Disease|0|||
146073273|NCT02624986|526786456|FG003|Overall Study|Progressive Disease|0|||
146073274|NCT02624986|526786457|FG004|Overall Study|Progressive Disease|0|||
146073275|NCT02624986|526786458|FG005|Overall Study|Progressive Disease|0|||
146073276|NCT02624986|526786459|FG006|Overall Study|Progressive Disease|0|||
146073277|NCT02624986|526786460|FG007|Overall Study|Progressive Disease|0|||
146073278|NCT02624986|526786453|FG000|Overall Study|Protocol Violation|1|||
146073279|NCT02624986|526786454|FG001|Overall Study|Protocol Violation|0|||
146073280|NCT02624986|526786455|FG002|Overall Study|Protocol Violation|0|||
146073281|NCT02624986|526786456|FG003|Overall Study|Protocol Violation|0|||
146073282|NCT02624986|526786457|FG004|Overall Study|Protocol Violation|0|||
146073283|NCT02624986|526786458|FG005|Overall Study|Protocol Violation|0|||
146073284|NCT02624986|526786459|FG006|Overall Study|Protocol Violation|0|||
146073285|NCT02624986|526786460|FG007|Overall Study|Protocol Violation|0|||
146073286|NCT02624986|526786453|FG000|Overall Study|Withdrawal by Subject|0|||
146073287|NCT02624986|526786454|FG001|Overall Study|Withdrawal by Subject|0|||
146073288|NCT02624986|526786455|FG002|Overall Study|Withdrawal by Subject|0|||
146073289|NCT02624986|526786456|FG003|Overall Study|Withdrawal by Subject|0|||
146073290|NCT02624986|526786457|FG004|Overall Study|Withdrawal by Subject|0|||
146073291|NCT02624986|526786458|FG005|Overall Study|Withdrawal by Subject|0|||
146073292|NCT02624986|526786459|FG006|Overall Study|Withdrawal by Subject|0|||
146073293|NCT02624986|526786460|FG007|Overall Study|Withdrawal by Subject|1|||
146073294|NCT02116205|526786461|FG000|Overall Study|Withdrawal by Subject|2|||
146073295|NCT02116205|526786462|FG001|Overall Study|Withdrawal by Subject|4|||
146073296|NCT02116205|526786463|FG002|Overall Study|Withdrawal by Subject|1|||
146073297|NCT02116205|526786464|FG003|Overall Study|Withdrawal by Subject|3|||
146073298|NCT02116205|526786461|FG000|Overall Study|Lost to Follow-up|0|||
146073299|NCT02116205|526786462|FG001|Overall Study|Lost to Follow-up|2|||
146073300|NCT02116205|526786463|FG002|Overall Study|Lost to Follow-up|1|||
146073301|NCT02116205|526786464|FG003|Overall Study|Lost to Follow-up|2|||
146073302|NCT02116205|526786461|FG000|Overall Study|Physician Decision|0|||
146073303|NCT02116205|526786462|FG001|Overall Study|Physician Decision|1|||
146073304|NCT02116205|526786463|FG002|Overall Study|Physician Decision|1|||
146073305|NCT02116205|526786464|FG003|Overall Study|Physician Decision|1|||
146073306|NCT02116205|526786461|FG000|Overall Study|Exclusion criteria|0|||
146073307|NCT02116205|526786462|FG001|Overall Study|Exclusion criteria|0|||
146073308|NCT02116205|526786463|FG002|Overall Study|Exclusion criteria|1|||
146073309|NCT02116205|526786464|FG003|Overall Study|Exclusion criteria|0|||
146073310|NCT04200352|526786470|FG000|Overall Study|Death|1|||
146073311|NCT04200352|526786470|FG000|Overall Study|Adverse Event|6|||
146073312|NCT04200352|526786470|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146073313|NCT04200352|526786470|FG000|Overall Study|Lack of Efficacy|1|||
146073314|NCT04200352|526786470|FG000|Overall Study|Other than specified|6|||
146073315|NCT00806819|526786471|FG000|Overall Study|progressive disease (modified RECIST )|217|||
146073316|NCT00806819|526786472|FG001|Overall Study|progressive disease (modified RECIST )|216|||
146073317|NCT00806819|526786471|FG000|Overall Study|Worsening or AE of underlying disease|18|||
146073318|NCT00806819|526786472|FG001|Overall Study|Worsening or AE of underlying disease|25|||
146073319|NCT00806819|526786471|FG000|Overall Study|Other AE|38|||
146073320|NCT00806819|526786472|FG001|Overall Study|Other AE|40|||
146073321|NCT00806819|526786471|FG000|Overall Study|Protocol Violation|9|||
146073322|NCT00806819|526786472|FG001|Overall Study|Protocol Violation|4|||
146073323|NCT00806819|526786471|FG000|Overall Study|Lost to Follow-up|1|||
146073324|NCT00806819|526786472|FG001|Overall Study|Lost to Follow-up|0|||
146073325|NCT00806819|526786471|FG000|Overall Study|Withdrawal by Subject|32|||
146073326|NCT00806819|526786472|FG001|Overall Study|Withdrawal by Subject|29|||
146173398|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
146173399|NCT01852058|527147234|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173400|NCT01852058|527147235|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173401|NCT01852058|527147236|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146409781|NCT00879970|528005933|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
146409782|NCT00879970|528005934|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146409783|NCT00879970|528005935|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
146409784|NCT00879970|528005931|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146409785|NCT00879970|528005932|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146409786|NCT00879970|528005933|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
146409787|NCT00879970|528005934|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
146409788|NCT00879970|528005935|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
146409789|NCT00879970|528005931|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146409790|NCT00879970|528005932|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146409791|NCT00879970|528005933|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146409792|NCT00879970|528005934|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
146409793|NCT00879970|528005935|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
146409794|NCT00879970|528005931|FG000|Period 2 Vitamin D Randomization|Death|0|||
146409795|NCT00879970|528005932|FG001|Period 2 Vitamin D Randomization|Death|0|||
146409796|NCT00879970|528005933|FG002|Period 2 Vitamin D Randomization|Death|0|||
146073327|NCT00806819|526786471|FG000|Overall Study|Not treated|6|||
146073328|NCT00806819|526786472|FG001|Overall Study|Not treated|3|||
146073329|NCT00806819|526786471|FG000|Overall Study|Reasons other than stated above|25|||
146073330|NCT00806819|526786472|FG001|Overall Study|Reasons other than stated above|41|||
146073331|NCT00912197|526786477|FG000|Overall Study|Withdrawal by Subject|3|||
146073332|NCT00912197|526786478|FG001|Overall Study|Withdrawal by Subject|3|||
146073333|NCT01326104|526786486|FG000|Overall Study|progressed prior to vaccine|0|||
146073334|NCT01326104|526786487|FG001|Overall Study|progressed prior to vaccine|2|||
146073335|NCT01326104|526786486|FG000|Overall Study|unable to make vaccine|0|||
146073336|NCT01326104|526786487|FG001|Overall Study|unable to make vaccine|2|||
146073337|NCT00494676|526786490|FG000|Allocation|Withdrawal by Subject|2|||
146073338|NCT00494676|526786491|FG001|Allocation|Withdrawal by Subject|4|||
146073339|NCT00494676|526786490|FG000|First Intervention|Withdrawal by Subject|1|||
146073340|NCT00494676|526786491|FG001|First Intervention|Withdrawal by Subject|3|||
146073341|NCT00494676|526786490|FG000|Second Intervention|Withdrawal by Subject|1|||
146073342|NCT00494676|526786491|FG001|Second Intervention|Withdrawal by Subject|1|||
146073343|NCT00775593|526787679|FG000|Overall Study|Unmet eligibility criteria|6|||
146073344|NCT00775593|526787679|FG000|Overall Study|Death|1|||
146073345|NCT02067676|526787680|FG000|Overall Study|Withdrawal by Subject|1|||
146073346|NCT02067676|526787681|FG001|Overall Study|Withdrawal by Subject|0|||
146073347|NCT02067676|526787682|FG002|Overall Study|Withdrawal by Subject|0|||
146073348|NCT02067676|526787683|FG003|Overall Study|Withdrawal by Subject|0|||
146073349|NCT02067676|526787684|FG004|Overall Study|Withdrawal by Subject|0|||
146073350|NCT02067676|526787685|FG005|Overall Study|Withdrawal by Subject|0|||
146073351|NCT00996333|526787686|FG000|Overall Study|Screen failure|1|||
146073352|NCT00996333|526787686|FG000|Overall Study|Withdrawal by Subject|1|||
146073353|NCT00996333|526787686|FG000|Overall Study|Death|4|||
146073354|NCT00996333|526787686|FG000|Overall Study|Adverse Event|1|||
146073355|NCT00996333|526787686|FG000|Overall Study|Physician Decision|1|||
146073356|NCT00996333|526787686|FG000|Overall Study|Other|5|||
146073357|NCT01327482|526787687|FG000|Overall Study|Adverse Event|1|||
146073358|NCT00476229|526787688|FG000|Overall Study|Progressive shortness of breath|1|||
146073359|NCT02164461|526787689|FG000|Overall Study|Adverse Event|0|||
146073360|NCT02164461|526787690|FG001|Overall Study|Adverse Event|0|||
146073361|NCT02164461|526787691|FG002|Overall Study|Adverse Event|1|||
146073362|NCT02164461|526787689|FG000|Overall Study|Disease Progression|1|||
146073363|NCT02164461|526787690|FG001|Overall Study|Disease Progression|3|||
146073364|NCT02164461|526787691|FG002|Overall Study|Disease Progression|4|||
146073365|NCT02164461|526787689|FG000|Overall Study|Withdrawal by Subject|0|||
146073366|NCT02164461|526787690|FG001|Overall Study|Withdrawal by Subject|3|||
146073367|NCT02164461|526787691|FG002|Overall Study|Withdrawal by Subject|0|||
146073368|NCT02100696|526787693|FG000|Induction Phase|Adverse Event|0|||
146073369|NCT02100696|526787694|FG001|Induction Phase|Adverse Event|0|||
146073370|NCT02100696|526787695|FG002|Induction Phase|Adverse Event|1|||
146073371|NCT02100696|526787696|FG003|Induction Phase|Adverse Event|0|||
146073372|NCT02100696|526787697|FG004|Induction Phase|Adverse Event|0|||
146409797|NCT00879970|528005934|FG003|Period 2 Vitamin D Randomization|Death|2|||
146409798|NCT00879970|528005935|FG004|Period 2 Vitamin D Randomization|Death|0|||
146409799|NCT00558519|528005936|FG000|Overall Study|Ph+|20|||
146409800|NCT00558519|528005936|FG000|Overall Study|Ineligible|1|||
146409801|NCT00558519|528005936|FG000|Overall Study|Insufficient data|1|||
146409802|NCT00558519|528005936|FG000|Overall Study|Never received treatment|1|||
146409803|NCT02556632|528005941|FG000|Overall Study|Lost to Follow-up|1|||
146409804|NCT02556632|528005942|FG001|Overall Study|Lost to Follow-up|0|||
146409805|NCT02556632|528005943|FG002|Overall Study|Lost to Follow-up|0|||
146073373|NCT02100696|526787698|FG005|Induction Phase|Adverse Event|0|||
146073374|NCT02100696|526787693|FG000|Induction Phase|Lost to Follow-up|1|||
146073375|NCT02100696|526787694|FG001|Induction Phase|Lost to Follow-up|0|||
146073376|NCT02100696|526787695|FG002|Induction Phase|Lost to Follow-up|1|||
146073377|NCT02100696|526787696|FG003|Induction Phase|Lost to Follow-up|0|||
146073378|NCT02100696|526787697|FG004|Induction Phase|Lost to Follow-up|0|||
146073379|NCT02100696|526787698|FG005|Induction Phase|Lost to Follow-up|0|||
146073380|NCT02100696|526787693|FG000|Induction Phase|Protocol Violation|0|||
146073381|NCT02100696|526787694|FG001|Induction Phase|Protocol Violation|1|||
146283895|NCT01146782|527551873|FG000|Screening Cohort|Lost to Follow-up|4|||
146409806|NCT02556632|528005941|FG000|Overall Study|Disliked Intervention|1|||
146409807|NCT02556632|528005942|FG001|Overall Study|Disliked Intervention|1|||
146409808|NCT02556632|528005943|FG002|Overall Study|Disliked Intervention|1|||
146409809|NCT02556632|528005941|FG000|Overall Study|No Reason|1|||
146409810|NCT02556632|528005942|FG001|Overall Study|No Reason|0|||
146409811|NCT02556632|528005943|FG002|Overall Study|No Reason|1|||
146409812|NCT02556632|528005941|FG000|Overall Study|Personal Issues|0|||
146409813|NCT02556632|528005942|FG001|Overall Study|Personal Issues|1|||
146409814|NCT02556632|528005943|FG002|Overall Study|Personal Issues|1|||
146409815|NCT02556632|528005941|FG000|Overall Study|Changed Mind|0|||
146409816|NCT02556632|528005942|FG001|Overall Study|Changed Mind|1|||
146409817|NCT02556632|528005943|FG002|Overall Study|Changed Mind|0|||
146409818|NCT02556632|528005941|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
146409819|NCT02556632|528005942|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
146409820|NCT02556632|528005943|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
146409821|NCT02556632|528005941|FG000|Overall Study|Unrelated Adverse Event|1|||
146409822|NCT02556632|528005942|FG001|Overall Study|Unrelated Adverse Event|0|||
146409823|NCT02556632|528005943|FG002|Overall Study|Unrelated Adverse Event|3|||
146409824|NCT02556632|528005941|FG000|Overall Study|Related Adverse Event|0|||
146409825|NCT02556632|528005942|FG001|Overall Study|Related Adverse Event|1|||
146409826|NCT02556632|528005943|FG002|Overall Study|Related Adverse Event|0|||
146409827|NCT02556632|528005941|FG000|Overall Study|Possibly Related Adverse Event|0|||
146409828|NCT02556632|528005942|FG001|Overall Study|Possibly Related Adverse Event|0|||
146409829|NCT02556632|528005943|FG002|Overall Study|Possibly Related Adverse Event|1|||
146409830|NCT02556632|528005941|FG000|Overall Study|Did Not Start RT|0|||
146409831|NCT02556632|528005942|FG001|Overall Study|Did Not Start RT|1|||
146409832|NCT02556632|528005943|FG002|Overall Study|Did Not Start RT|0|||
146409833|NCT02556632|528005941|FG000|Overall Study|Ineligible|0|||
146409834|NCT02556632|528005942|FG001|Overall Study|Ineligible|1|||
146409835|NCT02556632|528005943|FG002|Overall Study|Ineligible|0|||
146409836|NCT02556632|528005941|FG000|Overall Study|Disliked Study Procedures|0|||
146409837|NCT02556632|528005942|FG001|Overall Study|Disliked Study Procedures|0|||
146409838|NCT02556632|528005943|FG002|Overall Study|Disliked Study Procedures|1|||
146409839|NCT02556632|528005941|FG000|Overall Study|Treatment or Change Delay|0|||
146409840|NCT02556632|528005942|FG001|Overall Study|Treatment or Change Delay|0|||
146409841|NCT02556632|528005943|FG002|Overall Study|Treatment or Change Delay|1|||
146409842|NCT00808015|528005944|FG000|Overall Study|Death|1|||
146409843|NCT00808015|528005944|FG000|Overall Study|Lack of Efficacy|58|||
146409844|NCT00808015|528005944|FG000|Overall Study|Lost to Follow-up|76|||
146409845|NCT00808015|528005944|FG000|Overall Study|Participants not willing to participate|158|||
146409846|NCT00808015|528005944|FG000|Overall Study|Adverse Event|22|||
146409847|NCT00808015|528005944|FG000|Overall Study|Other|25|||
146409848|NCT00808015|528005944|FG000|Overall Study|Enrolled but not treated|4|||
146409849|NCT04523831|528005950|FG000|Overall Study|Lost to Follow-up|15|||
146409850|NCT04523831|528005951|FG001|Overall Study|Lost to Follow-up|17|||
146409851|NCT04523831|528005950|FG000|Overall Study|Death|0|||
146409852|NCT04523831|528005951|FG001|Overall Study|Death|3|||
146409853|NCT04523831|528005950|FG000|Overall Study|Adverse Event|2|||
146409854|NCT04523831|528005951|FG001|Overall Study|Adverse Event|0|||
146409855|NCT04556838|528005952|FG000|Overall Study|Withdrawal by Subject|3|||
146409856|NCT04556838|528005953|FG001|Overall Study|Withdrawal by Subject|1|||
146409857|NCT04556838|528005954|FG002|Overall Study|Withdrawal by Subject|2|||
146409858|NCT04556838|528005952|FG000|Overall Study|Adverse Event|0|||
146409859|NCT04556838|528005953|FG001|Overall Study|Adverse Event|1|||
146409860|NCT04556838|528005954|FG002|Overall Study|Adverse Event|1|||
146409861|NCT04556838|528005952|FG000|Overall Study|Lost to Follow-up|0|||
146073382|NCT02100696|526787695|FG002|Induction Phase|Protocol Violation|1|||
146073383|NCT02100696|526787696|FG003|Induction Phase|Protocol Violation|0|||
146073384|NCT02100696|526787697|FG004|Induction Phase|Protocol Violation|0|||
146073385|NCT02100696|526787698|FG005|Induction Phase|Protocol Violation|0|||
146073386|NCT02100696|526787693|FG000|Induction Phase|Withdrawal by Subject|8|||
146073387|NCT02100696|526787694|FG001|Induction Phase|Withdrawal by Subject|2|||
145945301|NCT01362244|526308201|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
145945302|NCT01362244|526308202|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
145945303|NCT02407054|526308205|FG000|Overall Study|Adverse Event|1|||
146073388|NCT02100696|526787695|FG002|Induction Phase|Withdrawal by Subject|13|||
146073389|NCT02100696|526787696|FG003|Induction Phase|Withdrawal by Subject|0|||
146073390|NCT02100696|526787697|FG004|Induction Phase|Withdrawal by Subject|0|||
145945304|NCT02407054|526308206|FG001|Overall Study|Adverse Event|4|||
146073391|NCT02100696|526787698|FG005|Induction Phase|Withdrawal by Subject|0|||
146073392|NCT02100696|526787693|FG000|Induction Phase|Physician Decision|1|||
146409862|NCT04556838|528005953|FG001|Overall Study|Lost to Follow-up|0|||
146409863|NCT04556838|528005954|FG002|Overall Study|Lost to Follow-up|2|||
146409864|NCT04556838|528005952|FG000|Overall Study|Subject travel|0|||
146409865|NCT04556838|528005953|FG001|Overall Study|Subject travel|1|||
146409866|NCT04556838|528005954|FG002|Overall Study|Subject travel|0|||
146409867|NCT04556838|528005952|FG000|Overall Study|Physician Decision|1|||
146409868|NCT04556838|528005953|FG001|Overall Study|Physician Decision|0|||
146409869|NCT04556838|528005954|FG002|Overall Study|Physician Decision|0|||
146409870|NCT00995930|528005955|FG000|Overall Study|Protocol deviation|2|||
146409871|NCT00995930|528005956|FG001|Overall Study|Protocol deviation|5|||
146409872|NCT00995930|528005955|FG000|Overall Study|Death|0|||
146409873|NCT00995930|528005956|FG001|Overall Study|Death|1|||
146409874|NCT00995930|528005955|FG000|Overall Study|Administrative problems|4|||
146409875|NCT00995930|528005956|FG001|Overall Study|Administrative problems|2|||
146409876|NCT00995930|528005955|FG000|Overall Study|Lost to Follow-up|1|||
146409877|NCT00995930|528005956|FG001|Overall Study|Lost to Follow-up|2|||
146409878|NCT00995930|528005955|FG000|Overall Study|Withdrawal by Subject|3|||
146409879|NCT00995930|528005956|FG001|Overall Study|Withdrawal by Subject|4|||
146409880|NCT00995930|528005955|FG000|Overall Study|Adverse Event|11|||
146409881|NCT00995930|528005956|FG001|Overall Study|Adverse Event|14|||
146409882|NCT01458119|528005957|FG000|Overall Study|Physician Decision|4|||
146409883|NCT01458119|528005957|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
146409884|NCT01458119|528005957|FG000|Overall Study|Pregnancy|1|||
146409885|NCT01458119|528005957|FG000|Overall Study|Death|2|||
146409886|NCT01458119|528005957|FG000|Overall Study|Adverse Event|1|||
146409887|NCT01458119|528005957|FG000|Overall Study|Consent Withdrawn by Participant|8|||
146409888|NCT01458119|528005957|FG000|Overall Study|Non-compliance With Study Drug|3|||
146409889|NCT03033069|528005958|FG000|Overall Study|Adverse Event|6|||
146409890|NCT03033069|528005959|FG001|Overall Study|Adverse Event|7|||
146409891|NCT03033069|528005960|FG002|Overall Study|Adverse Event|4|||
146409892|NCT03033069|528005961|FG003|Overall Study|Adverse Event|6|||
146409893|NCT03033069|528005958|FG000|Overall Study|Lack of Efficacy|0|||
146409894|NCT03033069|528005959|FG001|Overall Study|Lack of Efficacy|0|||
146409895|NCT03033069|528005960|FG002|Overall Study|Lack of Efficacy|1|||
146409896|NCT03033069|528005961|FG003|Overall Study|Lack of Efficacy|0|||
146409897|NCT03033069|528005958|FG000|Overall Study|Lost to Follow-up|6|||
146409898|NCT03033069|528005959|FG001|Overall Study|Lost to Follow-up|5|||
146409899|NCT03033069|528005960|FG002|Overall Study|Lost to Follow-up|5|||
146409900|NCT03033069|528005961|FG003|Overall Study|Lost to Follow-up|6|||
146409901|NCT03033069|528005958|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146409902|NCT03033069|528005959|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146409903|NCT03033069|528005960|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146409904|NCT03033069|528005961|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146409905|NCT03033069|528005958|FG000|Overall Study|Protocol Deviation|0|||
146409906|NCT03033069|528005959|FG001|Overall Study|Protocol Deviation|1|||
146409907|NCT03033069|528005960|FG002|Overall Study|Protocol Deviation|0|||
146409908|NCT03033069|528005961|FG003|Overall Study|Protocol Deviation|0|||
146409909|NCT03033069|528005958|FG000|Overall Study|Withdrawal by Subject|10|||
146409910|NCT03033069|528005959|FG001|Overall Study|Withdrawal by Subject|10|||
146409911|NCT03033069|528005960|FG002|Overall Study|Withdrawal by Subject|11|||
146409912|NCT03033069|528005961|FG003|Overall Study|Withdrawal by Subject|6|||
146409913|NCT03033069|528005958|FG000|Overall Study|Withdrawal By Caregiver|1|||
146409914|NCT03033069|528005959|FG001|Overall Study|Withdrawal By Caregiver|0|||
146409915|NCT03033069|528005960|FG002|Overall Study|Withdrawal By Caregiver|0|||
146409916|NCT03033069|528005961|FG003|Overall Study|Withdrawal By Caregiver|0|||
146409917|NCT03033069|528005958|FG000|Overall Study|Reason not Specified|0|||
146409918|NCT03033069|528005959|FG001|Overall Study|Reason not Specified|1|||
146409919|NCT03033069|528005960|FG002|Overall Study|Reason not Specified|0|||
146409920|NCT03033069|528005961|FG003|Overall Study|Reason not Specified|1|||
146409921|NCT02623426|528005966|FG000|Overall Study|Lost to Follow-up|0|||
146409922|NCT02623426|528005967|FG001|Overall Study|Lost to Follow-up|0|||
146409923|NCT02623426|528005968|FG002|Overall Study|Lost to Follow-up|1|||
146409924|NCT02623426|528005966|FG000|Overall Study|Withdrawal by Subject|1|||
146409925|NCT02623426|528005967|FG001|Overall Study|Withdrawal by Subject|2|||
146409926|NCT02623426|528005968|FG002|Overall Study|Withdrawal by Subject|2|||
146409927|NCT02094937|528005969|FG000|8 Weeks in Period 1|Adverse Event|9|||
146409928|NCT02094937|528005970|FG001|8 Weeks in Period 1|Adverse Event|0|||
146409929|NCT02094937|528005971|FG002|8 Weeks in Period 1|Adverse Event|0|||
146409930|NCT02094937|528005972|FG003|8 Weeks in Period 1|Adverse Event|0|||
146409931|NCT02094937|528005969|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
146409932|NCT02094937|528005970|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
146409933|NCT02094937|528005971|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
146409934|NCT02094937|528005972|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
146409935|NCT02094937|528005969|FG000|8 Weeks in Period 1|Protocol Violation|2|||
146409936|NCT02094937|528005970|FG001|8 Weeks in Period 1|Protocol Violation|0|||
146409937|NCT02094937|528005971|FG002|8 Weeks in Period 1|Protocol Violation|0|||
146409938|NCT02094937|528005972|FG003|8 Weeks in Period 1|Protocol Violation|0|||
146409939|NCT02094937|528005969|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
146073393|NCT02100696|526787694|FG001|Induction Phase|Physician Decision|0|||
146283896|NCT01146782|527551873|FG000|Screening Cohort|Physician Decision|1|||
146073394|NCT02100696|526787695|FG002|Induction Phase|Physician Decision|2|||
146073395|NCT02100696|526787696|FG003|Induction Phase|Physician Decision|0|||
146073396|NCT02100696|526787697|FG004|Induction Phase|Physician Decision|0|||
146073397|NCT02100696|526787698|FG005|Induction Phase|Physician Decision|0|||
146073398|NCT02100696|526787693|FG000|Induction Phase|Multiple Reasons|5|||
146073399|NCT02100696|526787694|FG001|Induction Phase|Multiple Reasons|2|||
146073400|NCT02100696|526787695|FG002|Induction Phase|Multiple Reasons|8|||
146073401|NCT02100696|526787696|FG003|Induction Phase|Multiple Reasons|0|||
146073402|NCT02100696|526787697|FG004|Induction Phase|Multiple Reasons|0|||
146073403|NCT02100696|526787698|FG005|Induction Phase|Multiple Reasons|0|||
146073404|NCT02100696|526787693|FG000|Maintenance Phase|Adverse Event|0|||
146073405|NCT02100696|526787694|FG001|Maintenance Phase|Adverse Event|0|||
146073406|NCT02100696|526787695|FG002|Maintenance Phase|Adverse Event|0|||
146073407|NCT02100696|526787696|FG003|Maintenance Phase|Adverse Event|0|||
146073408|NCT02100696|526787697|FG004|Maintenance Phase|Adverse Event|0|||
146073409|NCT02100696|526787698|FG005|Maintenance Phase|Adverse Event|2|||
146073410|NCT02100696|526787693|FG000|Maintenance Phase|Lost to Follow-up|0|||
146283897|NCT01146782|527551873|FG000|Screening Cohort|Withdrawal by Subject|29|||
146073411|NCT02100696|526787694|FG001|Maintenance Phase|Lost to Follow-up|0|||
146073412|NCT02100696|526787695|FG002|Maintenance Phase|Lost to Follow-up|0|||
146073413|NCT02100696|526787696|FG003|Maintenance Phase|Lost to Follow-up|0|||
146073414|NCT02100696|526787697|FG004|Maintenance Phase|Lost to Follow-up|1|||
146073415|NCT02100696|526787698|FG005|Maintenance Phase|Lost to Follow-up|0|||
146073416|NCT02100696|526787693|FG000|Maintenance Phase|Protocol Violation|0|||
146073417|NCT02100696|526787694|FG001|Maintenance Phase|Protocol Violation|0|||
146073418|NCT02100696|526787695|FG002|Maintenance Phase|Protocol Violation|0|||
146073419|NCT02100696|526787696|FG003|Maintenance Phase|Protocol Violation|0|||
146073420|NCT02100696|526787697|FG004|Maintenance Phase|Protocol Violation|1|||
146073421|NCT02100696|526787698|FG005|Maintenance Phase|Protocol Violation|0|||
146073422|NCT02100696|526787693|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146073423|NCT02100696|526787694|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146073424|NCT02100696|526787695|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146073425|NCT02100696|526787696|FG003|Maintenance Phase|Withdrawal by Subject|1|||
146073426|NCT02100696|526787697|FG004|Maintenance Phase|Withdrawal by Subject|4|||
146073427|NCT02100696|526787698|FG005|Maintenance Phase|Withdrawal by Subject|2|||
146073428|NCT02100696|526787693|FG000|Maintenance Phase|Physician Decision|0|||
146073429|NCT02100696|526787694|FG001|Maintenance Phase|Physician Decision|0|||
146073430|NCT02100696|526787695|FG002|Maintenance Phase|Physician Decision|0|||
146073431|NCT02100696|526787696|FG003|Maintenance Phase|Physician Decision|0|||
146073432|NCT02100696|526787697|FG004|Maintenance Phase|Physician Decision|1|||
146073433|NCT02100696|526787698|FG005|Maintenance Phase|Physician Decision|0|||
146073434|NCT02100696|526787693|FG000|Maintenance Phase|Multiple Reasons|0|||
146073435|NCT02100696|526787694|FG001|Maintenance Phase|Multiple Reasons|0|||
146073436|NCT02100696|526787695|FG002|Maintenance Phase|Multiple Reasons|0|||
146073437|NCT02100696|526787696|FG003|Maintenance Phase|Multiple Reasons|0|||
146073438|NCT02100696|526787697|FG004|Maintenance Phase|Multiple Reasons|2|||
146073439|NCT02100696|526787698|FG005|Maintenance Phase|Multiple Reasons|1|||
146173402|NCT01852058|527147237|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146409940|NCT02094937|528005970|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146409941|NCT02094937|528005971|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146409942|NCT02094937|528005972|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
146409943|NCT02094937|528005969|FG000|8 Weeks in Period 1|Physician Decision|1|||
146409944|NCT02094937|528005970|FG001|8 Weeks in Period 1|Physician Decision|0|||
146409945|NCT02094937|528005971|FG002|8 Weeks in Period 1|Physician Decision|0|||
146409946|NCT02094937|528005972|FG003|8 Weeks in Period 1|Physician Decision|0|||
146409947|NCT02094937|528005969|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
146409948|NCT02094937|528005970|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
146409949|NCT02094937|528005971|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
146409950|NCT02094937|528005972|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
146173403|NCT01852058|527147238|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
146173404|NCT01852058|527147239|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
146173405|NCT01852058|527147240|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173406|NCT01852058|527147241|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173407|NCT01852058|527147242|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173408|NCT01852058|527147243|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173409|NCT01852058|527147244|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173410|NCT01852058|527147245|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
146173411|NCT01852058|527147234|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173412|NCT01852058|527147235|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173413|NCT01852058|527147236|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173414|NCT01852058|527147237|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173415|NCT01852058|527147238|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173416|NCT01852058|527147239|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173417|NCT01852058|527147240|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173418|NCT01852058|527147241|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
146173419|NCT01852058|527147242|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146409951|NCT02094937|528005969|FG000|12 Weeks in Period 2|Adverse Event|0|||
146409952|NCT02094937|528005970|FG001|12 Weeks in Period 2|Adverse Event|2|||
146283898|NCT01146782|527551873|FG000|Safety Cohort|Screen Failure|61|||
146409953|NCT02094937|528005971|FG002|12 Weeks in Period 2|Adverse Event|4|||
146409954|NCT02094937|528005972|FG003|12 Weeks in Period 2|Adverse Event|1|||
146409955|NCT02094937|528005969|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
146409956|NCT02094937|528005970|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
146409957|NCT02094937|528005971|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
146409958|NCT02094937|528005972|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
146409959|NCT02094937|528005969|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
146409960|NCT02094937|528005970|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
146409961|NCT02094937|528005971|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
146409962|NCT02094937|528005972|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
146409963|NCT02094937|528005969|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
146409964|NCT02094937|528005970|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
146409965|NCT02094937|528005971|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
146409966|NCT02094937|528005972|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
146409967|NCT02094937|528005969|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
146409968|NCT02094937|528005970|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
146409969|NCT02094937|528005971|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
146409970|NCT02094937|528005972|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
146409971|NCT03751124|528005975|FG000|Overall Study|Adverse Event|4|||
146409972|NCT03751124|528005976|FG001|Overall Study|Adverse Event|3|||
146409973|NCT03751124|528005975|FG000|Overall Study|Protocol Deviation|0|||
146409974|NCT03751124|528005976|FG001|Overall Study|Protocol Deviation|1|||
146409975|NCT03751124|528005975|FG000|Overall Study|Lost to Follow-up|6|||
146409976|NCT03751124|528005976|FG001|Overall Study|Lost to Follow-up|4|||
146409977|NCT03751124|528005975|FG000|Overall Study|Withdrawal by Subject|6|||
146409978|NCT03751124|528005976|FG001|Overall Study|Withdrawal by Subject|8|||
146409979|NCT03751124|528005975|FG000|Overall Study|Lack of Efficacy|1|||
146409980|NCT03751124|528005976|FG001|Overall Study|Lack of Efficacy|1|||
146073440|NCT03865381|526787702|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
146073441|NCT03865381|526787702|FG000|Overall Study|Withdrawal by Subject|2|||
146073442|NCT04999852|526787703|FG000|Overall Study|Withdrawal by Subject|11|||
146073443|NCT04999852|526787704|FG001|Overall Study|Withdrawal by Subject|1|||
146073444|NCT04999852|526787703|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
146073445|NCT04999852|526787704|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
146073446|NCT05626322|526787705|FG000|Overall Study|Death|2|||
146409981|NCT03751124|528005975|FG000|Overall Study|Pregnancy|0|||
146409982|NCT03751124|528005976|FG001|Overall Study|Pregnancy|1|||
146409983|NCT03751124|528005975|FG000|Overall Study|Other|9|||
146409984|NCT03751124|528005976|FG001|Overall Study|Other|9|||
146409985|NCT03751124|528005975|FG000|Overall Study|Participants who did not receive any study drug|0|||
146409986|NCT03751124|528005976|FG001|Overall Study|Participants who did not receive any study drug|1|||
146409987|NCT00555399|528005987|FG000|Overall Study|Withdrawal by Subject|0|||
146409988|NCT00555399|528005988|FG001|Overall Study|Withdrawal by Subject|0|||
146409989|NCT00555399|528005989|FG002|Overall Study|Withdrawal by Subject|1|||
146409990|NCT00555399|528005990|FG003|Overall Study|Withdrawal by Subject|0|||
146409991|NCT00555399|528005991|FG004|Overall Study|Withdrawal by Subject|0|||
146409992|NCT00555399|528005992|FG005|Overall Study|Withdrawal by Subject|0|||
146409993|NCT00555399|528005993|FG006|Overall Study|Withdrawal by Subject|0|||
146409994|NCT00555399|528005994|FG007|Overall Study|Withdrawal by Subject|0|||
146409995|NCT00555399|528005995|FG008|Overall Study|Withdrawal by Subject|0|||
146409996|NCT00555399|528005996|FG009|Overall Study|Withdrawal by Subject|0|||
146409997|NCT00555399|528005997|FG010|Overall Study|Withdrawal by Subject|0|||
146409998|NCT00555399|528005998|FG011|Overall Study|Withdrawal by Subject|1|||
146409999|NCT00555399|528005987|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
146410000|NCT00555399|528005988|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
146410001|NCT00555399|528005989|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
146410002|NCT00555399|528005990|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
146410003|NCT00555399|528005991|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
146410004|NCT00555399|528005992|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
146410005|NCT00555399|528005993|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
146410006|NCT00555399|528005994|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
146410007|NCT00555399|528005995|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
146410008|NCT00555399|528005996|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
146410009|NCT00555399|528005997|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
146410010|NCT00555399|528005998|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
146410011|NCT05458895|528005999|FG000|Overall Study|Withdrawal by Subject|8|||
146410012|NCT05458895|528005999|FG000|Overall Study|Lost to Follow-up|17|||
146410013|NCT05458895|528005999|FG000|Overall Study|Pregnancy|2|||
146410014|NCT05458895|528005999|FG000|Overall Study|Withdrawal by Study Team|1|||
146410015|NCT04639310|528006000|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
146410016|NCT04639310|528006001|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
146410017|NCT01246973|528007721|FG000|Overall Study|Other|38|||
146410018|NCT01246973|528007722|FG001|Overall Study|Other|25|||
146410019|NCT01246973|528007721|FG000|Overall Study|Adverse Event|16|||
146410020|NCT01246973|528007722|FG001|Overall Study|Adverse Event|9|||
146410021|NCT01246973|528007721|FG000|Overall Study|Withdrawal by Subject|7|||
146410022|NCT01246973|528007722|FG001|Overall Study|Withdrawal by Subject|13|||
146410023|NCT01011907|528007723|FG000|Overall Study|Withdrawal by Subject|13|||
146410024|NCT01011907|528007724|FG001|Overall Study|Withdrawal by Subject|11|||
146410025|NCT01011907|528007723|FG000|Overall Study|Adverse Event|1|||
146410026|NCT01011907|528007724|FG001|Overall Study|Adverse Event|4|||
146410027|NCT03862625|528007726|FG000|Overall Study|Lost to Follow-up|0|||
146410028|NCT03862625|528007727|FG001|Overall Study|Lost to Follow-up|1|||
146410029|NCT01326702|528007728|FG000|Overall Study|Other|1|||
146410030|NCT01326702|528007729|FG001|Overall Study|Other|0|||
146410031|NCT01326702|528007730|FG002|Overall Study|Other|0|||
146410032|NCT01326702|528007731|FG003|Overall Study|Other|0|||
146410033|NCT01326702|528007732|FG004|Overall Study|Other|0|||
146410034|NCT01326702|528007733|FG005|Overall Study|Other|1|||
146410035|NCT01326702|528007734|FG006|Overall Study|Other|0|||
146410036|NCT01326702|528007728|FG000|Overall Study|progressive disease|1|||
146073447|NCT05626322|526787706|FG001|Overall Study|Death|0|||
146410037|NCT01326702|528007729|FG001|Overall Study|progressive disease|1|||
146410038|NCT01326702|528007730|FG002|Overall Study|progressive disease|3|||
146410039|NCT01326702|528007731|FG003|Overall Study|progressive disease|1|||
146410040|NCT01326702|528007732|FG004|Overall Study|progressive disease|3|||
146410041|NCT01326702|528007733|FG005|Overall Study|progressive disease|2|||
146410042|NCT01326702|528007734|FG006|Overall Study|progressive disease|3|||
146410043|NCT01326702|528007728|FG000|Overall Study|Death|0|||
146410044|NCT01326702|528007729|FG001|Overall Study|Death|1|||
146410045|NCT01326702|528007730|FG002|Overall Study|Death|0|||
146410046|NCT01326702|528007731|FG003|Overall Study|Death|0|||
146410047|NCT01326702|528007732|FG004|Overall Study|Death|0|||
146410048|NCT01326702|528007733|FG005|Overall Study|Death|0|||
146410049|NCT01326702|528007734|FG006|Overall Study|Death|0|||
146410050|NCT01326702|528007728|FG000|Overall Study|Adverse Event|0|||
146410051|NCT01326702|528007729|FG001|Overall Study|Adverse Event|0|||
146410052|NCT01326702|528007730|FG002|Overall Study|Adverse Event|1|||
146410053|NCT01326702|528007731|FG003|Overall Study|Adverse Event|1|||
146410054|NCT01326702|528007732|FG004|Overall Study|Adverse Event|0|||
146410055|NCT01326702|528007733|FG005|Overall Study|Adverse Event|3|||
146410056|NCT01326702|528007734|FG006|Overall Study|Adverse Event|1|||
146410057|NCT01326702|528007728|FG000|Overall Study|Withdrawal by Subject|0|||
146410058|NCT01326702|528007729|FG001|Overall Study|Withdrawal by Subject|0|||
146410059|NCT01326702|528007730|FG002|Overall Study|Withdrawal by Subject|1|||
146410060|NCT01326702|528007731|FG003|Overall Study|Withdrawal by Subject|0|||
146410061|NCT01326702|528007732|FG004|Overall Study|Withdrawal by Subject|1|||
146410062|NCT01326702|528007733|FG005|Overall Study|Withdrawal by Subject|1|||
146410063|NCT01326702|528007734|FG006|Overall Study|Withdrawal by Subject|3|||
146410064|NCT01326702|528007728|FG000|Overall Study|Not Treated|0|||
146410065|NCT01326702|528007729|FG001|Overall Study|Not Treated|0|||
146410066|NCT01326702|528007730|FG002|Overall Study|Not Treated|0|||
146410067|NCT01326702|528007731|FG003|Overall Study|Not Treated|1|||
146410068|NCT01326702|528007732|FG004|Overall Study|Not Treated|0|||
146410069|NCT01326702|528007733|FG005|Overall Study|Not Treated|1|||
146410070|NCT01326702|528007734|FG006|Overall Study|Not Treated|0|||
146410071|NCT02082912|528007735|FG000|Overall Study|Physician Decision|0|||
146410072|NCT02082912|528007736|FG001|Overall Study|Physician Decision|1|||
146410073|NCT01835132|528007743|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
146410074|NCT00856778|528007744|FG000|Overall Study|Adverse Event|7|||
146410075|NCT00856778|528007744|FG000|Overall Study|Withdrawal by Subject|10|||
146410076|NCT00856778|528007744|FG000|Overall Study|Study deviation|2|||
146410077|NCT00856778|528007744|FG000|Overall Study|Lost to Follow-up|5|||
146410078|NCT00265083|528007745|FG000|Overall Study|Adverse Event|5|||
146410079|NCT00265083|528007746|FG001|Overall Study|Adverse Event|13|||
146410080|NCT00265083|528007747|FG002|Overall Study|Adverse Event|15|||
146410081|NCT00265083|528007745|FG000|Overall Study|Lost to Follow-up|3|||
146410082|NCT00265083|528007746|FG001|Overall Study|Lost to Follow-up|4|||
146410083|NCT00265083|528007747|FG002|Overall Study|Lost to Follow-up|4|||
146410084|NCT00265083|528007745|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
146410085|NCT00265083|528007746|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
146410086|NCT00265083|528007747|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
146173420|NCT01852058|527147243|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173421|NCT01852058|527147244|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173422|NCT01852058|527147245|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
146173423|NCT01852058|527147234|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173424|NCT01852058|527147235|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173425|NCT01852058|527147236|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173426|NCT01852058|527147237|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173427|NCT01852058|527147238|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173428|NCT01852058|527147239|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173429|NCT01852058|527147240|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173430|NCT01852058|527147241|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173431|NCT01852058|527147242|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
146173432|NCT01852058|527147243|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173433|NCT01852058|527147244|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173434|NCT01852058|527147245|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
146173435|NCT00263328|527147247|FG000|Overall Study|Death|0|||
146173436|NCT00263328|527147248|FG001|Overall Study|Death|0|||
146173437|NCT00263328|527147249|FG002|Overall Study|Death|1|||
146173438|NCT00263328|527147247|FG000|Overall Study|Lost to Follow-up|1|||
146173439|NCT00263328|527147248|FG001|Overall Study|Lost to Follow-up|1|||
146173440|NCT00263328|527147249|FG002|Overall Study|Lost to Follow-up|0|||
146173441|NCT00263328|527147247|FG000|Overall Study|Withdrawal by Subject|3|||
146173442|NCT00263328|527147248|FG001|Overall Study|Withdrawal by Subject|0|||
146173443|NCT00263328|527147249|FG002|Overall Study|Withdrawal by Subject|1|||
146173444|NCT00263328|527147247|FG000|Overall Study|Other|3|||
146173445|NCT00263328|527147248|FG001|Overall Study|Other|0|||
146173446|NCT00263328|527147249|FG002|Overall Study|Other|1|||
146173447|NCT00263328|527147247|FG000|Overall Study|Adverse Event|1|||
146173448|NCT00263328|527147248|FG001|Overall Study|Adverse Event|1|||
146173449|NCT00263328|527147249|FG002|Overall Study|Adverse Event|4|||
146173450|NCT02613221|527147252|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
146173451|NCT02613221|527147252|FG000|Overall Study|Adverse Event|2|||
146173452|NCT02613221|527147252|FG000|Overall Study|Voluntary Discontinuation|1|||
146173453|NCT02613221|527147252|FG000|Overall Study|Delayed Treatment|1|||
146173454|NCT02613221|527147252|FG000|Overall Study|Enrolled but Not Treated|1|||
146173455|NCT01301274|527147253|FG000|Overall Study|Physician Decision|2|||
146173456|NCT01301274|527147254|FG001|Overall Study|Physician Decision|1|||
146173457|NCT00661661|527147255|FG000|Overall Study|Adverse Event|99|||
146173458|NCT00661661|527147256|FG001|Overall Study|Adverse Event|24|||
146173459|NCT00661661|527147255|FG000|Overall Study|Lack of Efficacy|3|||
146173460|NCT00661661|527147256|FG001|Overall Study|Lack of Efficacy|2|||
146173461|NCT00661661|527147255|FG000|Overall Study|Lost to Follow-up|0|||
146173462|NCT00661661|527147256|FG001|Overall Study|Lost to Follow-up|1|||
146173463|NCT00661661|527147255|FG000|Overall Study|Withdrawal by Subject|15|||
146173464|NCT00661661|527147256|FG001|Overall Study|Withdrawal by Subject|5|||
146173465|NCT00661661|527147255|FG000|Overall Study|Other|22|||
146173466|NCT00661661|527147256|FG001|Overall Study|Other|7|||
146173467|NCT00661661|527147255|FG000|Overall Study|Not assigned treatment|1|||
146173468|NCT00661661|527147256|FG001|Overall Study|Not assigned treatment|0|||
146173469|NCT01893827|527147257|FG000|Overall Study|Lost to Follow-up|19|||
146173470|NCT01893827|527147258|FG001|Overall Study|Lost to Follow-up|26|||
146173471|NCT02917941|527147259|FG000|Treatment Period|Adverse Event|11|||
146173472|NCT02917941|527147259|FG000|Treatment Period|Progressive Disease|11|||
146173473|NCT02917941|527147259|FG000|Treatment Period|Reason not Specified|2|||
146173474|NCT02917941|527147259|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
146173475|NCT02917941|527147259|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
146173476|NCT00399763|527147260|FG000|Overall Study|Lost to Follow-up|2|||
146173477|NCT00399763|527147261|FG001|Overall Study|Lost to Follow-up|3|||
146173478|NCT04182880|527147264|FG000|Overall Study|Pregnancy|1|||
146173479|NCT04182880|527147265|FG001|Overall Study|Pregnancy|0|||
146173480|NCT03389477|527147266|FG000|Step 1|Withdrawal by Subject|1|||
146173481|NCT03389477|527147267|FG001|Step 1|Withdrawal by Subject|0|||
146173482|NCT03389477|527147266|FG000|Step 2|Withdrawal by Subject|1|||
146173483|NCT03389477|527147267|FG001|Step 2|Withdrawal by Subject|2|||
146173484|NCT03389477|527147266|FG000|Step 2|Disease progression|1|||
146173485|NCT03389477|527147267|FG001|Step 2|Disease progression|0|||
146173486|NCT03389477|527147266|FG000|Step 2|Death|0|||
146173487|NCT03389477|527147267|FG001|Step 2|Death|1|||
146173488|NCT03389477|527147266|FG000|Step 2|Poor performance status and nutrition|0|||
146173489|NCT03389477|527147267|FG001|Step 2|Poor performance status and nutrition|1|||
146173490|NCT03389477|527147266|FG000|Step 3|Withdrawal after 3 cycles|0|||
146173491|NCT03389477|527147267|FG001|Step 3|Withdrawal after 3 cycles|1|||
146173492|NCT03389477|527147266|FG000|Step 3|Still receiving active treatment|4|||
146173493|NCT03389477|527147267|FG001|Step 3|Still receiving active treatment|0|||
146173494|NCT03389477|527147266|FG000|Step 3|Progressive disease after 2 cycles|1|||
146173495|NCT03389477|527147267|FG001|Step 3|Progressive disease after 2 cycles|0|||
146173496|NCT04512066|527147270|FG000|Double-blind Treatment Period|Adverse Event|6|||
146173497|NCT04512066|527147271|FG001|Double-blind Treatment Period|Adverse Event|4|||
146173498|NCT04512066|527147272|FG002|Double-blind Treatment Period|Adverse Event|5|||
146173499|NCT04512066|527147273|FG003|Double-blind Treatment Period|Adverse Event|1|||
146173500|NCT04512066|527147274|FG004|Double-blind Treatment Period|Adverse Event|0|||
146073448|NCT05626322|526787707|FG002|Overall Study|Death|0|||
146073449|NCT05626322|526787705|FG000|Overall Study|Physician Decision|1|||
146073450|NCT05626322|526787706|FG001|Overall Study|Physician Decision|0|||
146073451|NCT05626322|526787707|FG002|Overall Study|Physician Decision|0|||
146073452|NCT05626322|526787705|FG000|Overall Study|Progressive Disease|0|||
146073453|NCT05626322|526787706|FG001|Overall Study|Progressive Disease|1|||
146073454|NCT05626322|526787707|FG002|Overall Study|Progressive Disease|1|||
146073455|NCT05626322|526787705|FG000|Overall Study|Study terminated by sponsor|0|||
146073456|NCT05626322|526787706|FG001|Overall Study|Study terminated by sponsor|1|||
146073457|NCT05626322|526787707|FG002|Overall Study|Study terminated by sponsor|0|||
146073458|NCT03776812|526787708|FG000|Overall Study|Death|53|||
146073459|NCT03776812|526787709|FG001|Overall Study|Death|49|||
146073460|NCT03776812|526787710|FG002|Overall Study|Death|56|||
146073461|NCT03776812|526787708|FG000|Overall Study|Withdrawal by Subject|1|||
146073462|NCT03776812|526787709|FG001|Overall Study|Withdrawal by Subject|7|||
146073463|NCT03776812|526787710|FG002|Overall Study|Withdrawal by Subject|2|||
146073464|NCT03776812|526787708|FG000|Overall Study|Lost to Follow-up|1|||
146073465|NCT03776812|526787709|FG001|Overall Study|Lost to Follow-up|1|||
146073466|NCT03776812|526787710|FG002|Overall Study|Lost to Follow-up|0|||
146073467|NCT03776812|526787708|FG000|Overall Study|Did not enter long-term follow-up|3|||
146073468|NCT03776812|526787709|FG001|Overall Study|Did not enter long-term follow-up|3|||
146073469|NCT03776812|526787710|FG002|Overall Study|Did not enter long-term follow-up|2|||
146073470|NCT04758637|526787713|FG000|Overall Study|Lost to Follow-up|0|||
146073471|NCT04758637|526787714|FG001|Overall Study|Lost to Follow-up|1|||
146073472|NCT04758637|526787715|FG002|Overall Study|Lost to Follow-up|0|||
146073473|NCT04758637|526787716|FG003|Overall Study|Lost to Follow-up|0|||
146073474|NCT03350672|526787722|FG000|Overall Study|Withdrawal by Subject|7|||
146073475|NCT03350672|526787723|FG001|Overall Study|Withdrawal by Subject|0|||
146173501|NCT04512066|527147275|FG005|Double-blind Treatment Period|Adverse Event|0|||
146173502|NCT04512066|527147270|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
146173503|NCT04512066|527147271|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
146173504|NCT04512066|527147272|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
146173505|NCT04512066|527147273|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
146173506|NCT04512066|527147274|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
146173507|NCT04512066|527147275|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
146173508|NCT04512066|527147270|FG000|Double-blind Treatment Period|Physician Decision|1|||
146173509|NCT04512066|527147271|FG001|Double-blind Treatment Period|Physician Decision|0|||
146173510|NCT04512066|527147272|FG002|Double-blind Treatment Period|Physician Decision|1|||
146173511|NCT04512066|527147273|FG003|Double-blind Treatment Period|Physician Decision|0|||
146173512|NCT04512066|527147274|FG004|Double-blind Treatment Period|Physician Decision|0|||
146173513|NCT04512066|527147275|FG005|Double-blind Treatment Period|Physician Decision|0|||
146173514|NCT04512066|527147270|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
146173515|NCT04512066|527147271|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
146173516|NCT04512066|527147272|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
146173517|NCT04512066|527147273|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
146173518|NCT04512066|527147274|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146173519|NCT04512066|527147275|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
146173520|NCT04512066|527147270|FG000|Extension Period|Adverse Event|0|||
146173521|NCT04512066|527147271|FG001|Extension Period|Adverse Event|1|||
146173522|NCT04512066|527147272|FG002|Extension Period|Adverse Event|4|||
146173523|NCT04512066|527147273|FG003|Extension Period|Adverse Event|3|||
146410087|NCT00265083|528007745|FG000|Overall Study|Other|1|||
146173524|NCT04512066|527147274|FG004|Extension Period|Adverse Event|1|||
146173525|NCT04512066|527147275|FG005|Extension Period|Adverse Event|3|||
146173526|NCT04512066|527147270|FG000|Extension Period|Death|0|||
146173527|NCT04512066|527147271|FG001|Extension Period|Death|0|||
146173528|NCT04512066|527147272|FG002|Extension Period|Death|0|||
146410088|NCT00265083|528007746|FG001|Overall Study|Other|12|||
146410089|NCT00265083|528007747|FG002|Overall Study|Other|9|||
146410090|NCT03208933|528007748|FG000|Overall Study|Death|3|||
146410091|NCT03208933|528007748|FG000|Overall Study|Withdrawal by Subject|3|||
146410092|NCT03208933|528007748|FG000|Overall Study|Adverse Event|1|||
146410093|NCT03208933|528007748|FG000|Overall Study|Lost to Follow-up|2|||
146410094|NCT03208933|528007748|FG000|Overall Study|Physician Decision|3|||
146410095|NCT03208933|528007748|FG000|Overall Study|Protocol Violation|1|||
146410096|NCT00550420|528007751|FG000|Overall Study|Adverse Event|28|||
146410097|NCT00550420|528007751|FG000|Overall Study|Lost to Follow-up|8|||
146410098|NCT00550420|528007751|FG000|Overall Study|Protocol Violation|11|||
146410099|NCT00550420|528007751|FG000|Overall Study|Withdrawal by Subject|30|||
146410100|NCT00550420|528007751|FG000|Overall Study|Still in study at termination|206|||
146410101|NCT00550420|528007751|FG000|Overall Study|Missing|2|||
146410102|NCT00550420|528007751|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
146410103|NCT00550420|528007751|FG000|Overall Study|Investigators opinion|1|||
146410104|NCT00550420|528007751|FG000|Overall Study|Lack of curative effect|1|||
146410105|NCT00550420|528007751|FG000|Overall Study|Unethical stop of enrollment|2|||
146410106|NCT00550420|528007751|FG000|Overall Study|Caregiver's decision to withdraw|1|||
146410107|NCT00550420|528007751|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
146410108|NCT00550420|528007751|FG000|Overall Study|Exclusion criteria|1|||
146410109|NCT00550420|528007751|FG000|Overall Study|Prohibited medicine|1|||
146410110|NCT00782275|528007752|FG000|Overall Study|Adverse Event|11|||
146410111|NCT00782275|528007752|FG000|Overall Study|Withdrawal by Subject|1|||
146410112|NCT00782275|528007752|FG000|Overall Study|Progressive Disease|21|||
146410113|NCT00782275|528007752|FG000|Overall Study|Physician Decision|4|||
146410114|NCT00782275|528007752|FG000|Overall Study|Not started treatment|1|||
146410115|NCT00782275|528007752|FG000|Overall Study|Other|3|||
146410116|NCT04378010|528007753|FG000|Overall Study|Adverse Event|8|||
146410117|NCT04378010|528007754|FG001|Overall Study|Adverse Event|14|||
146410118|NCT04378010|528007755|FG002|Overall Study|Adverse Event|4|||
146410119|NCT04378010|528007753|FG000|Overall Study|Withdrawal by Subject|0|||
146410120|NCT04378010|528007754|FG001|Overall Study|Withdrawal by Subject|2|||
146410121|NCT04378010|528007755|FG002|Overall Study|Withdrawal by Subject|1|||
146410122|NCT04378010|528007753|FG000|Overall Study|Protocol Violation|2|||
146410123|NCT04378010|528007754|FG001|Overall Study|Protocol Violation|1|||
146410124|NCT04378010|528007755|FG002|Overall Study|Protocol Violation|4|||
146410125|NCT04378010|528007753|FG000|Overall Study|Study terminated by Sponsor|22|||
146410126|NCT04378010|528007754|FG001|Overall Study|Study terminated by Sponsor|16|||
146410127|NCT04378010|528007755|FG002|Overall Study|Study terminated by Sponsor|22|||
146410128|NCT04378010|528007753|FG000|Overall Study|Subject inability to complete study visit|0|||
146410129|NCT04378010|528007754|FG001|Overall Study|Subject inability to complete study visit|0|||
146410130|NCT04378010|528007755|FG002|Overall Study|Subject inability to complete study visit|1|||
146410131|NCT04378010|528007753|FG000|Overall Study|Subject never dosed|0|||
146410132|NCT04378010|528007754|FG001|Overall Study|Subject never dosed|1|||
146410133|NCT04378010|528007755|FG002|Overall Study|Subject never dosed|0|||
146410134|NCT02019979|528007756|FG000|Overall Study|study terminated|14|||
146073476|NCT03350672|526787724|FG002|Overall Study|Withdrawal by Subject|0|||
146073477|NCT00048074|526787727|FG000|Overall Study|Adverse Event|46|||
146073478|NCT00048074|526787728|FG001|Overall Study|Adverse Event|41|||
146073479|NCT00048074|526787729|FG002|Overall Study|Adverse Event|53|||
146073480|NCT00048074|526787727|FG000|Overall Study|Death|3|||
146173529|NCT04512066|527147273|FG003|Extension Period|Death|0|||
146173530|NCT04512066|527147274|FG004|Extension Period|Death|0|||
146173531|NCT04512066|527147275|FG005|Extension Period|Death|1|||
146173532|NCT04512066|527147270|FG000|Extension Period|Lack of Efficacy|0|||
146173533|NCT04512066|527147271|FG001|Extension Period|Lack of Efficacy|4|||
146173534|NCT04512066|527147272|FG002|Extension Period|Lack of Efficacy|4|||
146173535|NCT04512066|527147273|FG003|Extension Period|Lack of Efficacy|1|||
146173536|NCT04512066|527147274|FG004|Extension Period|Lack of Efficacy|3|||
146173537|NCT04512066|527147275|FG005|Extension Period|Lack of Efficacy|3|||
146173538|NCT04512066|527147270|FG000|Extension Period|Lost to Follow-up|0|||
146173539|NCT04512066|527147271|FG001|Extension Period|Lost to Follow-up|1|||
146173540|NCT04512066|527147272|FG002|Extension Period|Lost to Follow-up|5|||
146173541|NCT04512066|527147273|FG003|Extension Period|Lost to Follow-up|2|||
146173542|NCT04512066|527147274|FG004|Extension Period|Lost to Follow-up|3|||
146173543|NCT04512066|527147275|FG005|Extension Period|Lost to Follow-up|2|||
146173544|NCT04512066|527147270|FG000|Extension Period|Non-compliance with study drug|0|||
146173545|NCT04512066|527147271|FG001|Extension Period|Non-compliance with study drug|1|||
146173546|NCT04512066|527147272|FG002|Extension Period|Non-compliance with study drug|0|||
146173547|NCT04512066|527147273|FG003|Extension Period|Non-compliance with study drug|0|||
146173548|NCT04512066|527147274|FG004|Extension Period|Non-compliance with study drug|0|||
146173549|NCT04512066|527147275|FG005|Extension Period|Non-compliance with study drug|1|||
146173550|NCT04512066|527147270|FG000|Extension Period|Other|0|||
146173551|NCT04512066|527147271|FG001|Extension Period|Other|2|||
146173552|NCT04512066|527147272|FG002|Extension Period|Other|0|||
146173553|NCT04512066|527147273|FG003|Extension Period|Other|0|||
146173554|NCT04512066|527147274|FG004|Extension Period|Other|0|||
146173555|NCT04512066|527147275|FG005|Extension Period|Other|0|||
146173556|NCT04512066|527147270|FG000|Extension Period|Physician Decision|0|||
146173557|NCT04512066|527147271|FG001|Extension Period|Physician Decision|2|||
146173558|NCT04512066|527147272|FG002|Extension Period|Physician Decision|0|||
146173559|NCT04512066|527147273|FG003|Extension Period|Physician Decision|1|||
146410135|NCT02513459|528007757|FG000|Overall Study|Adverse Event|7|||
146410136|NCT02513459|528007757|FG000|Overall Study|Withdrew consent|5|||
146410137|NCT02513459|528007757|FG000|Overall Study|Loss of efficacy|2|||
146410138|NCT02513459|528007757|FG000|Overall Study|Pregnancy|2|||
146173560|NCT04512066|527147274|FG004|Extension Period|Physician Decision|1|||
146173561|NCT04512066|527147275|FG005|Extension Period|Physician Decision|0|||
146173562|NCT04512066|527147270|FG000|Extension Period|Withdrawal by Subject|0|||
146173563|NCT04512066|527147271|FG001|Extension Period|Withdrawal by Subject|3|||
146173564|NCT04512066|527147272|FG002|Extension Period|Withdrawal by Subject|7|||
146173565|NCT04512066|527147273|FG003|Extension Period|Withdrawal by Subject|11|||
146173566|NCT04512066|527147274|FG004|Extension Period|Withdrawal by Subject|8|||
146173567|NCT04512066|527147275|FG005|Extension Period|Withdrawal by Subject|4|||
146173568|NCT00445679|527147278|FG000|Overall Study|Adverse Event|22|||
146173569|NCT00445679|527147279|FG001|Overall Study|Adverse Event|12|||
146173570|NCT00445679|527147280|FG002|Overall Study|Adverse Event|30|||
146173571|NCT00445679|527147281|FG003|Overall Study|Adverse Event|19|||
146173572|NCT00445679|527147278|FG000|Overall Study|Failed to return|1|||
146173573|NCT00445679|527147279|FG001|Overall Study|Failed to return|3|||
146173574|NCT00445679|527147280|FG002|Overall Study|Failed to return|2|||
146173575|NCT00445679|527147281|FG003|Overall Study|Failed to return|2|||
146173576|NCT00445679|527147278|FG000|Overall Study|Physician Decision|0|||
146173577|NCT00445679|527147279|FG001|Overall Study|Physician Decision|0|||
146173578|NCT00445679|527147280|FG002|Overall Study|Physician Decision|1|||
146173579|NCT00445679|527147281|FG003|Overall Study|Physician Decision|0|||
146173580|NCT00445679|527147278|FG000|Overall Study|Lost to Follow-up|10|||
146173581|NCT00445679|527147279|FG001|Overall Study|Lost to Follow-up|6|||
146283899|NCT01146782|527551873|FG000|Safety Cohort|Withdrawal by Subject|4|||
146173582|NCT00445679|527147280|FG002|Overall Study|Lost to Follow-up|6|||
146173583|NCT00445679|527147281|FG003|Overall Study|Lost to Follow-up|5|||
146173584|NCT00445679|527147278|FG000|Overall Study|Compliance|3|||
146173585|NCT00445679|527147279|FG001|Overall Study|Compliance|2|||
146173586|NCT00445679|527147280|FG002|Overall Study|Compliance|1|||
146410139|NCT02513459|528007757|FG000|Overall Study|Subject decision|2|||
146410140|NCT02513459|528007757|FG000|Overall Study|Lack of response|1|||
146410141|NCT02513459|528007757|FG000|Overall Study|Reproductive plans|1|||
146410142|NCT02513459|528007757|FG000|Overall Study|Surgery planned-- not done|1|||
146410143|NCT03237611|528007758|FG000|Overall Study|Withdrawal by Subject|1|||
146410144|NCT03237611|528007758|FG000|Overall Study|Ineligible|1|||
146410145|NCT00923195|528007762|FG000|Overall Study|Death|0|||
146410146|NCT00923195|528007763|FG001|Overall Study|Death|1|||
146173587|NCT00445679|527147281|FG003|Overall Study|Compliance|2|||
146173588|NCT00445679|527147278|FG000|Overall Study|Withdrawal of Informed Consent|0|||
146173589|NCT00445679|527147279|FG001|Overall Study|Withdrawal of Informed Consent|0|||
146173590|NCT00445679|527147280|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146173591|NCT00445679|527147281|FG003|Overall Study|Withdrawal of Informed Consent|0|||
146173592|NCT00445679|527147278|FG000|Overall Study|Protocol Violation|2|||
146173593|NCT00445679|527147279|FG001|Overall Study|Protocol Violation|3|||
146173594|NCT00445679|527147280|FG002|Overall Study|Protocol Violation|3|||
146073481|NCT00048074|526787728|FG001|Overall Study|Death|3|||
146073482|NCT00048074|526787729|FG002|Overall Study|Death|2|||
146073483|NCT00048074|526787727|FG000|Overall Study|Lost to Follow-up|2|||
146073484|NCT00048074|526787728|FG001|Overall Study|Lost to Follow-up|6|||
146073485|NCT00048074|526787729|FG002|Overall Study|Lost to Follow-up|6|||
146073486|NCT00048074|526787727|FG000|Overall Study|Withdrawal by Subject|28|||
146073487|NCT00048074|526787728|FG001|Overall Study|Withdrawal by Subject|30|||
146073488|NCT00048074|526787729|FG002|Overall Study|Withdrawal by Subject|35|||
146073489|NCT00048074|526787727|FG000|Overall Study|Protocol Violation|1|||
146073490|NCT00048074|526787728|FG001|Overall Study|Protocol Violation|3|||
146073491|NCT00048074|526787729|FG002|Overall Study|Protocol Violation|0|||
146073492|NCT00048074|526787727|FG000|Overall Study|Study participation was terminated|0|||
146073493|NCT00048074|526787728|FG001|Overall Study|Study participation was terminated|1|||
146073494|NCT00048074|526787729|FG002|Overall Study|Study participation was terminated|0|||
146073495|NCT00048074|526787727|FG000|Overall Study|Husband ill|0|||
146073496|NCT00048074|526787728|FG001|Overall Study|Husband ill|1|||
146073497|NCT00048074|526787729|FG002|Overall Study|Husband ill|0|||
146073498|NCT00048074|526787727|FG000|Overall Study|Poor compliance|0|||
146073499|NCT00048074|526787728|FG001|Overall Study|Poor compliance|1|||
146073500|NCT00048074|526787729|FG002|Overall Study|Poor compliance|0|||
146073501|NCT00048074|526787727|FG000|Overall Study|Out of station|0|||
146073502|NCT00048074|526787728|FG001|Overall Study|Out of station|1|||
146073503|NCT00048074|526787729|FG002|Overall Study|Out of station|1|||
146073504|NCT00048074|526787727|FG000|Overall Study|Social reasons|1|||
146073505|NCT00048074|526787728|FG001|Overall Study|Social reasons|0|||
146073506|NCT00048074|526787729|FG002|Overall Study|Social reasons|0|||
146073507|NCT02873377|526787730|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
146073508|NCT02873377|526787731|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
146073509|NCT02873377|526787730|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
146073510|NCT02873377|526787731|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
146073511|NCT01583296|526787734|FG000|Overall Study|Withdrawal by Subject|11|||
146073512|NCT01583296|526787735|FG001|Overall Study|Withdrawal by Subject|10|||
146073513|NCT01063283|526787736|FG000|Cycle 1|Adverse Event|2|||
146073514|NCT01063283|526787737|FG001|Cycle 1|Adverse Event|0|||
146073515|NCT01063283|526787738|FG002|Cycle 1|Adverse Event|0|||
146073516|NCT01063283|526787736|FG000|Cycle 1|Technical failure in data collection|1|||
146073517|NCT01063283|526787737|FG001|Cycle 1|Technical failure in data collection|0|||
146073518|NCT01063283|526787738|FG002|Cycle 1|Technical failure in data collection|0|||
146073519|NCT03237286|526787741|FG000|Overall Study|Withdrawal by Subject|1|||
146073520|NCT03237286|526787742|FG001|Overall Study|Withdrawal by Subject|0|||
146073521|NCT03237286|526787743|FG002|Overall Study|Withdrawal by Subject|2|||
146073522|NCT03237286|526787741|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
146073523|NCT03237286|526787742|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
146173595|NCT00445679|527147281|FG003|Overall Study|Protocol Violation|1|||
146283900|NCT01146782|527551873|FG000|Safety Cohort|Control AHI <5|4|||
146410147|NCT00525031|528007764|FG000|Overall Study|Disease Progression|1|||
146410148|NCT00525031|528007765|FG001|Overall Study|Disease Progression|1|||
146410149|NCT00830063|528007768|FG000|Overall Study|Adverse Event|7|||
146410150|NCT00830063|528007769|FG001|Overall Study|Adverse Event|13|||
146410151|NCT00830063|528007770|FG002|Overall Study|Adverse Event|16|||
146410152|NCT00830063|528007771|FG003|Overall Study|Adverse Event|13|||
146410153|NCT00830063|528007768|FG000|Overall Study|Death|1|||
146410154|NCT00830063|528007769|FG001|Overall Study|Death|0|||
146410155|NCT00830063|528007770|FG002|Overall Study|Death|0|||
146410156|NCT00830063|528007771|FG003|Overall Study|Death|0|||
146410157|NCT00830063|528007768|FG000|Overall Study|Lost to Follow-up|0|||
146410158|NCT00830063|528007769|FG001|Overall Study|Lost to Follow-up|0|||
146410159|NCT00830063|528007770|FG002|Overall Study|Lost to Follow-up|3|||
146410160|NCT00830063|528007771|FG003|Overall Study|Lost to Follow-up|1|||
146410161|NCT00830063|528007768|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
146410162|NCT00830063|528007769|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
146410163|NCT00830063|528007770|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
146410164|NCT00830063|528007771|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
146410165|NCT00830063|528007768|FG000|Overall Study|Lack of Efficacy|51|||
146283901|NCT01146782|527551873|FG000|Safety Cohort|TST <4 hrs|14|||
146410166|NCT00830063|528007769|FG001|Overall Study|Lack of Efficacy|23|||
146073524|NCT03237286|526787743|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
146073525|NCT02792829|526787744|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073526|NCT02792829|526787745|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
146073527|NCT02792829|526787746|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073528|NCT02792829|526787747|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073529|NCT02792829|526787748|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073530|NCT02792829|526787749|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073531|NCT02792829|526787750|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073532|NCT02792829|526787751|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
146073533|NCT02792829|526787744|FG000|Treatment Period 2|Adverse Event|0|||
146073534|NCT02792829|526787745|FG001|Treatment Period 2|Adverse Event|0|||
146073535|NCT02792829|526787746|FG002|Treatment Period 2|Adverse Event|0|||
146073536|NCT02792829|526787747|FG003|Treatment Period 2|Adverse Event|0|||
146073537|NCT02792829|526787748|FG004|Treatment Period 2|Adverse Event|1|||
146073538|NCT02792829|526787749|FG005|Treatment Period 2|Adverse Event|0|||
146073539|NCT02792829|526787750|FG006|Treatment Period 2|Adverse Event|1|||
146073540|NCT02792829|526787751|FG007|Treatment Period 2|Adverse Event|1|||
146073541|NCT02792829|526787744|FG000|Treatment Period 2|Use of proscribed medications|0|||
146073542|NCT02792829|526787745|FG001|Treatment Period 2|Use of proscribed medications|0|||
146073543|NCT02792829|526787746|FG002|Treatment Period 2|Use of proscribed medications|0|||
146073544|NCT02792829|526787747|FG003|Treatment Period 2|Use of proscribed medications|0|||
146073545|NCT02792829|526787748|FG004|Treatment Period 2|Use of proscribed medications|0|||
146073546|NCT02792829|526787749|FG005|Treatment Period 2|Use of proscribed medications|0|||
146073547|NCT02792829|526787750|FG006|Treatment Period 2|Use of proscribed medications|0|||
146073548|NCT02792829|526787751|FG007|Treatment Period 2|Use of proscribed medications|1|||
146073549|NCT01668589|526787757|FG000|Overall Study|Lost to Follow-up|29|||
146073550|NCT01668589|526787758|FG001|Overall Study|Lost to Follow-up|37|||
146073551|NCT01668589|526787759|FG002|Overall Study|Lost to Follow-up|15|||
146073552|NCT01668589|526787760|FG003|Overall Study|Lost to Follow-up|5|||
146073553|NCT01668589|526787757|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
146073554|NCT01668589|526787758|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
146073555|NCT01668589|526787759|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
146073556|NCT01668589|526787760|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
146073557|NCT01668589|526787757|FG000|Overall Study|Death|12|||
146073558|NCT01668589|526787758|FG001|Overall Study|Death|3|||
146073559|NCT01668589|526787759|FG002|Overall Study|Death|2|||
146073560|NCT01668589|526787760|FG003|Overall Study|Death|11|||
146073561|NCT01668589|526787757|FG000|Overall Study|Other|44|||
146073562|NCT01668589|526787758|FG001|Overall Study|Other|10|||
146410167|NCT00830063|528007770|FG002|Overall Study|Lack of Efficacy|25|||
146173596|NCT00445679|527147278|FG000|Overall Study|Withdrawal by Subject|8|||
146173597|NCT00445679|527147279|FG001|Overall Study|Withdrawal by Subject|14|||
146173598|NCT00445679|527147280|FG002|Overall Study|Withdrawal by Subject|20|||
146173599|NCT00445679|527147281|FG003|Overall Study|Withdrawal by Subject|18|||
146173600|NCT00445679|527147278|FG000|Overall Study|Lack of Efficacy|2|||
146173601|NCT00445679|527147279|FG001|Overall Study|Lack of Efficacy|6|||
146173602|NCT00445679|527147280|FG002|Overall Study|Lack of Efficacy|2|||
146173603|NCT00445679|527147281|FG003|Overall Study|Lack of Efficacy|0|||
146173604|NCT01806584|527147282|FG000|Overall Study|Adverse Event|2|||
146173605|NCT01806584|527147283|FG001|Overall Study|Adverse Event|1|||
146173606|NCT01806584|527147282|FG000|Overall Study|Death|1|||
146173607|NCT01806584|527147283|FG001|Overall Study|Death|0|||
146173608|NCT01806584|527147282|FG000|Overall Study|Lost to Follow-up|0|||
146173609|NCT01806584|527147283|FG001|Overall Study|Lost to Follow-up|2|||
146173610|NCT01806584|527147282|FG000|Overall Study|Study terminated by sponsor|9|||
146173611|NCT01806584|527147283|FG001|Overall Study|Study terminated by sponsor|14|||
146173612|NCT01806584|527147282|FG000|Overall Study|Withdrawal by Subject|1|||
146173613|NCT01806584|527147283|FG001|Overall Study|Withdrawal by Subject|1|||
146173614|NCT01806584|527147282|FG000|Overall Study|Other unspecified|1|||
146173615|NCT01806584|527147283|FG001|Overall Study|Other unspecified|0|||
146173616|NCT00909428|527147284|FG000|Overall Study|Lost to Follow-up|13|||
146173617|NCT00909428|527147285|FG001|Overall Study|Lost to Follow-up|10|||
146173618|NCT00909428|527147286|FG002|Overall Study|Lost to Follow-up|9|||
146173619|NCT03535337|527147290|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
146173620|NCT03535337|527147291|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
146173621|NCT03535337|527147292|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
146173622|NCT03535337|527147293|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
146173623|NCT03535337|527147294|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
146173624|NCT03535337|527147295|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
146173625|NCT03535337|527147296|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
146173626|NCT03535337|527147297|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
146173627|NCT03535337|527147298|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
146173628|NCT03535337|527147299|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
146173629|NCT00311155|527148975|FG000|Overall Study|Adverse Event|21|||
146173630|NCT00311155|527148975|FG000|Overall Study|Withdrawal by Subject|17|||
146173631|NCT00311155|527148975|FG000|Overall Study|Did not meet entry criteria|55|||
146173632|NCT02764775|527148977|FG000|Overall Study|Death|1|||
146173633|NCT02764775|527148977|FG000|Overall Study|Lost to Follow-up|2|||
146173634|NCT02764775|527148977|FG000|Overall Study|Withdrawal by Subject|3|||
146173635|NCT01992549|527148979|FG000|Overall Study|Lost to Follow-up|2|||
146173636|NCT01992549|527148979|FG000|Overall Study|Serious Adverse Event|1|||
146410168|NCT00830063|528007771|FG003|Overall Study|Lack of Efficacy|32|||
146410169|NCT00830063|528007768|FG000|Overall Study|Other|5|||
146410170|NCT00830063|528007769|FG001|Overall Study|Other|5|||
146410171|NCT00830063|528007770|FG002|Overall Study|Other|8|||
146410172|NCT00830063|528007771|FG003|Overall Study|Other|6|||
146410173|NCT00830063|528007768|FG000|Overall Study|Withdrawal by Subject|16|||
146410174|NCT00830063|528007769|FG001|Overall Study|Withdrawal by Subject|10|||
146410175|NCT00830063|528007770|FG002|Overall Study|Withdrawal by Subject|16|||
146410176|NCT00830063|528007771|FG003|Overall Study|Withdrawal by Subject|13|||
146410177|NCT00830063|528007768|FG000|Overall Study|Protocol Violation|1|||
146410178|NCT00830063|528007769|FG001|Overall Study|Protocol Violation|0|||
146410179|NCT00830063|528007770|FG002|Overall Study|Protocol Violation|3|||
146410180|NCT00830063|528007771|FG003|Overall Study|Protocol Violation|2|||
146410181|NCT00830063|528007768|FG000|Overall Study|Randomized But Not Treated|0|||
146410182|NCT00830063|528007769|FG001|Overall Study|Randomized But Not Treated|2|||
146410183|NCT00830063|528007770|FG002|Overall Study|Randomized But Not Treated|0|||
146410184|NCT00830063|528007771|FG003|Overall Study|Randomized But Not Treated|2|||
146410185|NCT02140164|528007774|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
146410186|NCT01814761|528007775|FG000|Overall Study|Other Reasons|1|||
146410187|NCT01814761|528007776|FG001|Overall Study|Other Reasons|10|||
146410188|NCT01814761|528007775|FG000|Overall Study|Ocular Adverse Event|6|||
146410189|NCT01814761|528007776|FG001|Overall Study|Ocular Adverse Event|15|||
146410190|NCT01814761|528007775|FG000|Overall Study|Lost to Follow-up|1|||
146073563|NCT01668589|526787759|FG002|Overall Study|Other|7|||
146410191|NCT01814761|528007776|FG001|Overall Study|Lost to Follow-up|5|||
146410192|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146410193|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
146410194|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146410195|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
146410196|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
146410197|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
146410198|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
146410199|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
146410200|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
146410201|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
146410202|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
146410203|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
146410204|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
146410205|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
146410206|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
146410207|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
146410208|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
146410209|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
146410210|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
146073564|NCT01668589|526787760|FG003|Overall Study|Other|15|||
146073565|NCT00993148|526787761|FG000|Overall Study|Lost to Follow-up|2|||
146073566|NCT00993148|526787761|FG000|Overall Study|never initiated treatment|1|||
146073567|NCT02302339|526787762|FG000|Overall Study|Lost to Follow-up|1|||
146073568|NCT02302339|526787763|FG001|Overall Study|Lost to Follow-up|0|||
146073569|NCT02302339|526787764|FG002|Overall Study|Lost to Follow-up|0|||
146073570|NCT02302339|526787765|FG003|Overall Study|Lost to Follow-up|0|||
146073571|NCT02302339|526787762|FG000|Overall Study|Withdrawal by Subject|0|||
146073572|NCT02302339|526787763|FG001|Overall Study|Withdrawal by Subject|2|||
146073573|NCT02302339|526787764|FG002|Overall Study|Withdrawal by Subject|1|||
146073574|NCT02302339|526787765|FG003|Overall Study|Withdrawal by Subject|0|||
146073575|NCT02752165|526787766|FG000|Overall Study|Withdrawal by Subject|6|||
146073576|NCT02752165|526787767|FG001|Overall Study|Withdrawal by Subject|6|||
146073577|NCT02752165|526787766|FG000|Overall Study|Protocol Violation|6|||
146073578|NCT02752165|526787767|FG001|Overall Study|Protocol Violation|5|||
146073579|NCT02752165|526787766|FG000|Overall Study|Lost to Follow-up|33|||
146073580|NCT02752165|526787767|FG001|Overall Study|Lost to Follow-up|38|||
146073581|NCT04073225|526787771|FG000|Overall Study|Lost to Follow-up|4|||
146073582|NCT04073225|526787772|FG001|Overall Study|Lost to Follow-up|3|||
146073583|NCT03568461|526787777|FG000|Overall Study|Death|7|||
146073584|NCT03568461|526787777|FG000|Overall Study|Physician Decision|5|||
146073585|NCT03568461|526787777|FG000|Overall Study|Subject decision|5|||
146073586|NCT03568461|526787777|FG000|Overall Study|Lost to Follow-up|1|||
146073587|NCT04695977|526787778|FG000|Overall Study|Sponsor Decision|9|||
146073588|NCT04695977|526787779|FG001|Overall Study|Sponsor Decision|4|||
146073589|NCT04695977|526787778|FG000|Overall Study|Death|2|||
146073590|NCT04695977|526787779|FG001|Overall Study|Death|5|||
146073591|NCT02175199|526789026|FG000|Overall Study|Withdrawal by Subject|1|||
146073592|NCT02175199|526789027|FG001|Overall Study|Withdrawal by Subject|5|||
146073593|NCT02175199|526789026|FG000|Overall Study|Randomized in Error|1|||
146073594|NCT02175199|526789027|FG001|Overall Study|Randomized in Error|0|||
146073595|NCT02175199|526789026|FG000|Overall Study|Sponsor Decision|1|||
146073596|NCT02175199|526789027|FG001|Overall Study|Sponsor Decision|0|||
146073597|NCT03983317|526789030|FG000|Overall Study|Physician Decision|5|||
146073598|NCT01761162|526789031|FG000|Overall Study|Withdrawal by Subject|3|||
146073599|NCT04681352|526789032|FG000|Overall Study|Lost to Follow-up|2|||
146073600|NCT04681352|526789032|FG000|Overall Study|Withdrawal by Subject|22|||
146073601|NCT01643772|526789033|FG000|Overall Study|Protocol Violation|0|||
146073602|NCT01643772|526789034|FG001|Overall Study|Protocol Violation|0|||
146073603|NCT01643772|526789035|FG002|Overall Study|Protocol Violation|0|||
146073604|NCT01643772|526789036|FG003|Overall Study|Protocol Violation|1|||
146073605|NCT01643772|526789033|FG000|Overall Study|Adverse Event|0|||
146073606|NCT01643772|526789034|FG001|Overall Study|Adverse Event|0|||
146073607|NCT01643772|526789035|FG002|Overall Study|Adverse Event|0|||
146073608|NCT01643772|526789036|FG003|Overall Study|Adverse Event|1|||
146073609|NCT01296672|526789037|FG000|Overall Study|Lost to Follow-up|73|||
146073610|NCT01296672|526789038|FG001|Overall Study|Lost to Follow-up|18|||
146073611|NCT01716052|526789039|FG000|Overall Study|Withdrawal of funding|1|||
146073612|NCT01716052|526789040|FG001|Overall Study|Withdrawal of funding|1|||
146073613|NCT04335136|526789043|FG000|Overall Study|Death|8|||
146073614|NCT04335136|526789044|FG001|Overall Study|Death|4|||
146073615|NCT04335136|526789043|FG000|Overall Study|Lost to Follow-up|2|||
146073616|NCT04335136|526789044|FG001|Overall Study|Lost to Follow-up|0|||
146073617|NCT04335136|526789043|FG000|Overall Study|Protocol Violation|1|||
146073618|NCT04335136|526789044|FG001|Overall Study|Protocol Violation|0|||
146283902|NCT01146782|527551873|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
146410211|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
146073619|NCT04335136|526789043|FG000|Overall Study|Withdrawal by Subject|1|||
146073620|NCT04335136|526789044|FG001|Overall Study|Withdrawal by Subject|1|||
146073621|NCT04335136|526789043|FG000|Overall Study|Health-threatening condition|0|||
146073622|NCT04335136|526789044|FG001|Overall Study|Health-threatening condition|1|||
146073623|NCT04335136|526789043|FG000|Overall Study|Adverse Event|0|||
146073624|NCT04335136|526789044|FG001|Overall Study|Adverse Event|1|||
146073625|NCT04335136|526789043|FG000|Overall Study|Erroneously randomized|2|||
146073626|NCT04335136|526789044|FG001|Overall Study|Erroneously randomized|0|||
146073627|NCT00975689|526789045|FG000|Overall Study|Adverse Event|0|||
146073628|NCT00975689|526789046|FG001|Overall Study|Adverse Event|3|||
146073629|NCT00975689|526789045|FG000|Overall Study|Withdrawal by Subject|1|||
146073630|NCT00975689|526789046|FG001|Overall Study|Withdrawal by Subject|0|||
146073631|NCT00975689|526789045|FG000|Overall Study|Physician Decision|1|||
146073632|NCT00975689|526789046|FG001|Overall Study|Physician Decision|0|||
146073633|NCT01305577|526789050|FG000|Overall Study|Adverse Event|2|||
146073634|NCT01305577|526789051|FG001|Overall Study|Adverse Event|2|||
146073635|NCT01305577|526789052|FG002|Overall Study|Adverse Event|1|||
146073636|NCT01305577|526789050|FG000|Overall Study|Withdrawal by Subject|7|||
146073637|NCT01305577|526789051|FG001|Overall Study|Withdrawal by Subject|5|||
146073638|NCT01305577|526789052|FG002|Overall Study|Withdrawal by Subject|6|||
146073639|NCT01305577|526789050|FG000|Overall Study|Lost to Follow-up|4|||
146073640|NCT01305577|526789051|FG001|Overall Study|Lost to Follow-up|3|||
146073641|NCT01305577|526789052|FG002|Overall Study|Lost to Follow-up|2|||
146073642|NCT01305577|526789050|FG000|Overall Study|Protocol Deviation|0|||
146073643|NCT01305577|526789051|FG001|Overall Study|Protocol Deviation|1|||
146073644|NCT01305577|526789052|FG002|Overall Study|Protocol Deviation|1|||
146073645|NCT00796978|526789053|FG000|Overall Study|Cardiac adverse event|5|||
146073646|NCT00796978|526789053|FG000|Overall Study|Adverse Event|4|||
146073647|NCT00796978|526789053|FG000|Overall Study|Withdrawal by Subject|3|||
146073648|NCT01092546|526789057|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
146073649|NCT00622440|526789070|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
146073650|NCT00622440|526789071|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
146073651|NCT00622440|526789070|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
146073652|NCT00622440|526789071|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
146073653|NCT00622440|526789070|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
146073654|NCT00622440|526789071|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
146073655|NCT00622440|526789070|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
146073656|NCT00622440|526789071|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
146073657|NCT00771953|526789072|FG000|Overall Study|Adverse Event|5|||
146073658|NCT00771953|526789073|FG001|Overall Study|Adverse Event|3|||
146073659|NCT00771953|526789072|FG000|Overall Study|Death|2|||
146073660|NCT00771953|526789073|FG001|Overall Study|Death|2|||
146073661|NCT00771953|526789072|FG000|Overall Study|Progression before active Tx|1|||
146073662|NCT00771953|526789073|FG001|Overall Study|Progression before active Tx|2|||
146073663|NCT00771953|526789072|FG000|Overall Study|Sponsor decision|1|||
146073664|NCT00771953|526789073|FG001|Overall Study|Sponsor decision|0|||
146073665|NCT00771953|526789072|FG000|Overall Study|Other complicating disease|1|||
146073666|NCT00771953|526789073|FG001|Overall Study|Other complicating disease|0|||
146073667|NCT00771953|526789072|FG000|Overall Study|Withdrawal by Subject|0|||
146073668|NCT00771953|526789073|FG001|Overall Study|Withdrawal by Subject|3|||
146073669|NCT00947193|526789076|FG000|Overall Study|Lost to Follow-up|1|||
146073670|NCT00947193|526789077|FG001|Overall Study|Lost to Follow-up|0|||
146073671|NCT00947193|526789076|FG000|Overall Study|Withdrawal by Subject|1|||
146073672|NCT00947193|526789077|FG001|Overall Study|Withdrawal by Subject|0|||
146073673|NCT00947193|526789076|FG000|Overall Study|Factor VIII >1%|1|||
146073674|NCT00947193|526789077|FG001|Overall Study|Factor VIII >1%|0|||
146073675|NCT04364984|526789078|FG000|Overall Study|Death|2|||
146073676|NCT04364984|526789079|FG001|Overall Study|Death|2|||
146073677|NCT04364984|526789080|FG002|Overall Study|Death|0|||
146073678|NCT01652534|526789081|FG000|Overall Study|Lack of Efficacy|1|||
146073679|NCT01652534|526789082|FG001|Overall Study|Lack of Efficacy|0|||
146073680|NCT00811018|526789083|FG000|Overall Study|Additional Chronic Treatment|31|||
146073681|NCT00811018|526789083|FG000|Overall Study|Adverse Event|79|||
146283903|NCT01146782|527551873|FG000|Primary Endpoint Cohort|Physician Decision|1|||
146410212|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
146410213|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
146410214|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
146410215|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
146410216|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
146410217|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
146410218|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
146410219|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
146410220|NCT01872689|528007791|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
146410221|NCT01872689|528007792|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
146410222|NCT01872689|528007793|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
146410223|NCT01872689|528007794|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
146410224|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
146410225|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
146410226|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
146410227|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
146410228|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
146410229|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
146410230|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
146073682|NCT00811018|526789083|FG000|Overall Study|Death|147|||
146073683|NCT00811018|526789083|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
146073684|NCT00811018|526789083|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
146073685|NCT00811018|526789083|FG000|Overall Study|Investigator Decision|57|||
146073686|NCT00811018|526789083|FG000|Overall Study|Lost to Follow-up|19|||
146073687|NCT00811018|526789083|FG000|Overall Study|Pregnancy|6|||
146073688|NCT00811018|526789083|FG000|Overall Study|Sponsor Decision|450|||
146073689|NCT00811018|526789083|FG000|Overall Study|Withdrawal by Subject|70|||
146073690|NCT00811018|526789083|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
146073691|NCT00811018|526789083|FG000|Overall Study|Other|26|||
146073692|NCT02722304|526789087|FG000|Overall Study|Study Terminated by Sponsor|1|||
146073693|NCT02722304|526789088|FG001|Overall Study|Study Terminated by Sponsor|0|||
146073694|NCT02722304|526789089|FG002|Overall Study|Study Terminated by Sponsor|2|||
146073695|NCT02722304|526789090|FG003|Overall Study|Study Terminated by Sponsor|1|||
146073696|NCT02722304|526789091|FG004|Overall Study|Study Terminated by Sponsor|1|||
146073697|NCT02722304|526789087|FG000|Overall Study|Other|0|||
146073698|NCT02722304|526789088|FG001|Overall Study|Other|0|||
146073699|NCT02722304|526789089|FG002|Overall Study|Other|0|||
146073700|NCT02722304|526789090|FG003|Overall Study|Other|1|||
146073701|NCT02722304|526789091|FG004|Overall Study|Other|1|||
146073702|NCT04380519|526789094|FG000|Overall Study|Withdrawal by Subject|4|||
146073703|NCT04380519|526789095|FG001|Overall Study|Withdrawal by Subject|0|||
146073704|NCT04380519|526789096|FG002|Overall Study|Withdrawal by Subject|1|||
146073705|NCT04380519|526789094|FG000|Overall Study|Death|14|||
146073706|NCT04380519|526789095|FG001|Overall Study|Death|9|||
146073707|NCT04380519|526789096|FG002|Overall Study|Death|6|||
146073708|NCT04380519|526789094|FG000|Overall Study|Adverse Event|0|||
146073709|NCT04380519|526789095|FG001|Overall Study|Adverse Event|1|||
146073710|NCT04380519|526789096|FG002|Overall Study|Adverse Event|0|||
146073711|NCT04380519|526789094|FG000|Overall Study|relatives' decision|0|||
146073712|NCT04380519|526789095|FG001|Overall Study|relatives' decision|1|||
146073713|NCT04380519|526789096|FG002|Overall Study|relatives' decision|0|||
146073714|NCT02147561|526789101|FG000|Overall Study|Lost to Follow-up|3|||
146073715|NCT02147561|526789101|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
146073716|NCT00393861|526789102|FG000|Overall Study|Adverse Event|2|||
146073717|NCT00393861|526789102|FG000|Overall Study|Disease Progression|24|||
146073718|NCT05300763|526789103|FG000|Overall Study|Adverse Event|0|||
146073719|NCT05300763|526789104|FG001|Overall Study|Adverse Event|1|||
146073720|NCT05300763|526789103|FG000|Overall Study|Major Protocol Deviation|1|||
146073721|NCT05300763|526789104|FG001|Overall Study|Major Protocol Deviation|0|||
146073722|NCT05300763|526789103|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
146073723|NCT05300763|526789104|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
146073724|NCT02283762|526789105|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
146073725|NCT02283762|526789106|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
146073726|NCT02283762|526789105|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
146073727|NCT02283762|526789106|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
146073728|NCT02283762|526789105|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
146073729|NCT02283762|526789106|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
146073730|NCT02283762|526789105|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
146073731|NCT02283762|526789106|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
146073732|NCT02283762|526789105|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
146073733|NCT02283762|526789106|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
146073734|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
146073735|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
146073736|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
146073737|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
146073738|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
146073739|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
146073740|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
146073741|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
146073742|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
146073743|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
146073744|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
146073745|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
146073746|NCT02283762|526789105|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
146073747|NCT02283762|526789106|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
146073748|NCT01598506|526789112|FG000|Overall Study|Withdrawal by Subject|2|||
146073749|NCT02367833|526789113|FG000|Overall Study|Withdrawal by Subject|1|||
146073750|NCT02367833|526789114|FG001|Overall Study|Withdrawal by Subject|1|||
146073751|NCT02367833|526789115|FG002|Overall Study|Withdrawal by Subject|0|||
146073752|NCT00889720|526789118|FG000|Overall Study|Withdrawal by Subject|4|||
146073753|NCT00889720|526789118|FG000|Overall Study|Other|4|||
146073754|NCT02504216|526789119|FG000|Overall Study|Lost to Follow-up|3|||
146073755|NCT02504216|526789120|FG001|Overall Study|Lost to Follow-up|3|||
146073756|NCT02504216|526789119|FG000|Overall Study|Withdrawal by Subject|8|||
146073757|NCT02504216|526789120|FG001|Overall Study|Withdrawal by Subject|12|||
146073758|NCT00223080|526789121|FG000|Overall Study|Withdrawal by Subject|253|||
146073759|NCT00223080|526789122|FG001|Overall Study|Withdrawal by Subject|232|||
146073760|NCT00223080|526789121|FG000|Overall Study|Required contraindicated med|0|||
146073761|NCT00223080|526789122|FG001|Overall Study|Required contraindicated med|1|||
146073762|NCT00223080|526789121|FG000|Overall Study|Non-compliant|7|||
146073763|NCT00223080|526789122|FG001|Overall Study|Non-compliant|7|||
146073764|NCT00223080|526789121|FG000|Overall Study|Moved from study area|37|||
146073765|NCT00223080|526789122|FG001|Overall Study|Moved from study area|47|||
146073766|NCT00223080|526789121|FG000|Overall Study|Lost to Follow-up|259|||
146073767|NCT00223080|526789122|FG001|Overall Study|Lost to Follow-up|284|||
146073768|NCT00223080|526789121|FG000|Overall Study|Death|85|||
146073769|NCT00223080|526789122|FG001|Overall Study|Death|74|||
146073770|NCT00223080|526789121|FG000|Overall Study|Other|14|||
146073771|NCT00223080|526789122|FG001|Overall Study|Other|11|||
146073772|NCT00223080|526789121|FG000|Overall Study|Reason not provided|141|||
146073773|NCT00223080|526789122|FG001|Overall Study|Reason not provided|140|||
146073774|NCT00223080|526789121|FG000|Overall Study|Adverse Event|0|||
146073775|NCT00223080|526789122|FG001|Overall Study|Adverse Event|1|||
146073776|NCT02598583|526789123|FG000|Extension Period|Withdrawal by Subject|1|||
146073777|NCT02598583|526789124|FG001|Extension Period|Withdrawal by Subject|0|||
146073778|NCT00947882|526789132|FG000|Overall Study|Adverse Event|0|||
146073779|NCT00947882|526789133|FG001|Overall Study|Adverse Event|1|||
146073780|NCT00947882|526789134|FG002|Overall Study|Adverse Event|4|||
146073781|NCT00947882|526789135|FG003|Overall Study|Adverse Event|4|||
146073782|NCT00947882|526789132|FG000|Overall Study|Withdrawal by Subject|2|||
146073783|NCT00947882|526789133|FG001|Overall Study|Withdrawal by Subject|0|||
146073784|NCT00947882|526789134|FG002|Overall Study|Withdrawal by Subject|8|||
146073785|NCT00947882|526789135|FG003|Overall Study|Withdrawal by Subject|2|||
146073786|NCT00947882|526789132|FG000|Overall Study|Protocol Violation|0|||
146073787|NCT00947882|526789133|FG001|Overall Study|Protocol Violation|0|||
146073788|NCT00947882|526789134|FG002|Overall Study|Protocol Violation|1|||
146073789|NCT00947882|526789135|FG003|Overall Study|Protocol Violation|0|||
146073790|NCT00947882|526789132|FG000|Overall Study|Lost to Follow-up|0|||
146073791|NCT00947882|526789133|FG001|Overall Study|Lost to Follow-up|2|||
146073792|NCT00947882|526789134|FG002|Overall Study|Lost to Follow-up|1|||
146073793|NCT00947882|526789135|FG003|Overall Study|Lost to Follow-up|0|||
146073794|NCT00947882|526789132|FG000|Overall Study|Other/Unknown|10|||
146173637|NCT01992549|527148979|FG000|Overall Study|Product Switch to Extend Half Life|1|||
146173638|NCT00767104|527148981|FG000|Overall Study|Lost to Follow-up|1|||
146173639|NCT00767104|527148982|FG001|Overall Study|Lost to Follow-up|2|||
146173640|NCT00840996|527148983|FG000|Overall Study|Withdrawal by Subject|1|||
146173641|NCT00840996|527148984|FG001|Overall Study|Withdrawal by Subject|0|||
146173642|NCT04022889|527148985|FG000|Stage 1: Period 1|Adverse Event|1|||
146173643|NCT04022889|527148986|FG001|Stage 1: Period 1|Adverse Event|0|||
146173644|NCT04022889|527148987|FG002|Stage 1: Period 1|Adverse Event|0|||
146173645|NCT04022889|527148985|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
146173646|NCT04022889|527148986|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
146173647|NCT04022889|527148987|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
146173648|NCT04022889|527148985|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
146173649|NCT04022889|527148986|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
146173650|NCT04022889|527148987|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
146173651|NCT04022889|527148985|FG000|Stage 2|Screen Failure|0|||
146173652|NCT04022889|527148986|FG001|Stage 2|Screen Failure|0|||
146173653|NCT04022889|527148987|FG002|Stage 2|Screen Failure|3|||
146173654|NCT04022889|527148985|FG000|Stage 2|Ineligible for apheresis donation|0|||
146173655|NCT04022889|527148986|FG001|Stage 2|Ineligible for apheresis donation|0|||
146173656|NCT04022889|527148987|FG002|Stage 2|Ineligible for apheresis donation|2|||
146173657|NCT04022889|527148985|FG000|Stage 2|Adverse Event|0|||
146173658|NCT04022889|527148986|FG001|Stage 2|Adverse Event|0|||
146173659|NCT04022889|527148987|FG002|Stage 2|Adverse Event|2|||
146173660|NCT04022889|527148985|FG000|Stage 2|Protocol Violation|0|||
146173661|NCT04022889|527148986|FG001|Stage 2|Protocol Violation|0|||
146173662|NCT04022889|527148987|FG002|Stage 2|Protocol Violation|1|||
146173663|NCT04022889|527148985|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
146173664|NCT04022889|527148986|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
146173665|NCT04022889|527148987|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
146173666|NCT03015116|527148990|FG000|Overall Study|Lost to Follow-up|3|||
146173667|NCT03015116|527148991|FG001|Overall Study|Lost to Follow-up|0|||
146173668|NCT03015116|527148992|FG002|Overall Study|Lost to Follow-up|2|||
146173669|NCT03015116|527148990|FG000|Overall Study|Withdrawal by Subject|3|||
146173670|NCT03015116|527148991|FG001|Overall Study|Withdrawal by Subject|1|||
146173671|NCT03015116|527148992|FG002|Overall Study|Withdrawal by Subject|0|||
146173672|NCT03015116|527148990|FG000|Overall Study|Subject has New Medical Status|1|||
146173673|NCT03015116|527148991|FG001|Overall Study|Subject has New Medical Status|0|||
146173674|NCT03015116|527148992|FG002|Overall Study|Subject has New Medical Status|0|||
146173675|NCT03015116|527148990|FG000|Overall Study|Physician Decision|0|||
146173676|NCT03015116|527148991|FG001|Overall Study|Physician Decision|1|||
146173677|NCT03015116|527148992|FG002|Overall Study|Physician Decision|0|||
146410231|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
146410232|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146410233|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
146410234|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146410235|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
146410236|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
146410237|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
146410238|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
146410239|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
146410240|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
146410241|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
146410242|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
146410243|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
146410244|NCT01872689|528007791|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
146410245|NCT01872689|528007792|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
146410246|NCT01872689|528007793|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
146410247|NCT01872689|528007794|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
146410248|NCT00660790|528007797|FG000|Baseline to 3 Months|Death|1|||
146410249|NCT00660790|528007797|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
146410250|NCT00660790|528007797|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
146410251|NCT00686374|528007800|FG000|Overall Study|Lack of Efficacy|10|||
146410252|NCT00686374|528007800|FG000|Overall Study|Adverse Event|8|||
146410253|NCT00686374|528007800|FG000|Overall Study|Withdrew consent|5|||
146410254|NCT00686374|528007800|FG000|Overall Study|Lost to Follow-up|1|||
146410255|NCT00686374|528007800|FG000|Overall Study|Missing reason|33|||
146173678|NCT01077362|527148996|FG000|Overall Study|Lack of Efficacy|13|||
146173679|NCT01077362|527148997|FG001|Overall Study|Lack of Efficacy|8|||
146173680|NCT01077362|527148998|FG002|Overall Study|Lack of Efficacy|10|||
146073795|NCT00947882|526789133|FG001|Overall Study|Other/Unknown|13|||
146073796|NCT00947882|526789134|FG002|Overall Study|Other/Unknown|3|||
146073797|NCT00947882|526789135|FG003|Overall Study|Other/Unknown|6|||
146073798|NCT00947882|526789132|FG000|Overall Study|Trial Terminated by Sponsor|62|||
146073799|NCT00947882|526789133|FG001|Overall Study|Trial Terminated by Sponsor|61|||
146073800|NCT00947882|526789134|FG002|Overall Study|Trial Terminated by Sponsor|62|||
146073801|NCT00947882|526789135|FG003|Overall Study|Trial Terminated by Sponsor|70|||
146073802|NCT01262820|526789136|FG000|Overall Study|Adverse Event|5|||
146073803|NCT01262820|526789136|FG000|Overall Study|Lack of Efficacy|9|||
146073804|NCT01262820|526789136|FG000|Overall Study|Drug held for 21+ days|1|||
146073805|NCT00452361|526789137|FG000|Overall Study|Adverse Event|8|||
146073806|NCT00452361|526789138|FG001|Overall Study|Adverse Event|0|||
146073807|NCT00452361|526789137|FG000|Overall Study|Withdrawal by Subject|0|||
146073808|NCT00452361|526789138|FG001|Overall Study|Withdrawal by Subject|1|||
146073809|NCT00452361|526789137|FG000|Overall Study|Premature termination|13|||
146073810|NCT00452361|526789138|FG001|Overall Study|Premature termination|9|||
146073811|NCT05188053|526789139|FG000|Overall Study|Lost to Follow-up|23|||
146073812|NCT05188053|526789140|FG001|Overall Study|Lost to Follow-up|30|||
146073813|NCT05188053|526789139|FG000|Overall Study|Protocol Violation|16|||
146073814|NCT05188053|526789140|FG001|Overall Study|Protocol Violation|16|||
146073815|NCT05188053|526789139|FG000|Overall Study|Physician Decision|3|||
146073816|NCT05188053|526789140|FG001|Overall Study|Physician Decision|0|||
146073817|NCT05188053|526789139|FG000|Overall Study|Withdrawal by Subject|0|||
146073818|NCT05188053|526789140|FG001|Overall Study|Withdrawal by Subject|1|||
146073819|NCT01010867|526789144|FG000|Overall Study|< 50% adherence to probiotic|1|||
146073820|NCT01120964|526789148|FG000|Overall Study|Did not receive full treatment|1|||
146073821|NCT01120964|526789149|FG001|Overall Study|Did not receive full treatment|0|||
146073822|NCT02621151|526789150|FG000|Overall Study|Not eligible for trial|6|||
146073823|NCT04198714|526789151|FG000|Overall Study|Physician Decision|0|||
146073824|NCT04198714|526789152|FG001|Overall Study|Physician Decision|1|||
146073825|NCT04238819|526789153|FG000|Overall Study|Ongoing Treatment|0|||
146073826|NCT04238819|526789154|FG001|Overall Study|Ongoing Treatment|0|||
146073827|NCT04238819|526789155|FG002|Overall Study|Ongoing Treatment|0|||
146073828|NCT04238819|526789156|FG003|Overall Study|Ongoing Treatment|0|||
146073829|NCT04238819|526789157|FG004|Overall Study|Ongoing Treatment|1|||
146073830|NCT04238819|526789158|FG005|Overall Study|Ongoing Treatment|4|||
146073831|NCT04238819|526789159|FG006|Overall Study|Ongoing Treatment|0|||
146073832|NCT04238819|526789153|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
146073833|NCT04238819|526789154|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
146073834|NCT04238819|526789155|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
146073835|NCT04238819|526789156|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
146073836|NCT04238819|526789157|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
146073837|NCT04238819|526789158|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
146073838|NCT04238819|526789159|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
146073839|NCT02529553|526789160|FG000|Overall Study|Progressive Disease|1|||
146073840|NCT02529553|526789161|FG001|Overall Study|Progressive Disease|0|||
146073841|NCT02529553|526789162|FG002|Overall Study|Progressive Disease|1|||
146073842|NCT02529553|526789163|FG003|Overall Study|Progressive Disease|3|||
146073843|NCT02529553|526789164|FG004|Overall Study|Progressive Disease|2|||
146073844|NCT02529553|526789165|FG005|Overall Study|Progressive Disease|3|||
146073845|NCT02529553|526789166|FG006|Overall Study|Progressive Disease|3|||
146073846|NCT02529553|526789167|FG007|Overall Study|Progressive Disease|5|||
146073847|NCT02529553|526789168|FG008|Overall Study|Progressive Disease|3|||
146073848|NCT02529553|526789160|FG000|Overall Study|Physician Decision|0|||
146073849|NCT02529553|526789161|FG001|Overall Study|Physician Decision|1|||
146073850|NCT02529553|526789162|FG002|Overall Study|Physician Decision|0|||
146073851|NCT02529553|526789163|FG003|Overall Study|Physician Decision|0|||
146073852|NCT02529553|526789164|FG004|Overall Study|Physician Decision|1|||
146073853|NCT02529553|526789165|FG005|Overall Study|Physician Decision|0|||
146073854|NCT02529553|526789166|FG006|Overall Study|Physician Decision|0|||
146073855|NCT02529553|526789167|FG007|Overall Study|Physician Decision|0|||
146073856|NCT02529553|526789168|FG008|Overall Study|Physician Decision|0|||
146073857|NCT02529553|526789160|FG000|Overall Study|Withdrawal by Subject|0|||
146073858|NCT02529553|526789161|FG001|Overall Study|Withdrawal by Subject|0|||
146073859|NCT02529553|526789162|FG002|Overall Study|Withdrawal by Subject|0|||
146073860|NCT02529553|526789163|FG003|Overall Study|Withdrawal by Subject|0|||
146073861|NCT02529553|526789164|FG004|Overall Study|Withdrawal by Subject|0|||
146073862|NCT02529553|526789165|FG005|Overall Study|Withdrawal by Subject|1|||
146073863|NCT02529553|526789166|FG006|Overall Study|Withdrawal by Subject|0|||
146073864|NCT02529553|526789167|FG007|Overall Study|Withdrawal by Subject|1|||
146073865|NCT02529553|526789168|FG008|Overall Study|Withdrawal by Subject|0|||
146073866|NCT02355184|526789170|FG000|Overall Study|Lost to Follow-up|2|||
146073867|NCT02355184|526789170|FG000|Overall Study|Study Terminated|10|||
146073868|NCT01124864|526790694|FG000|Overall Study|Follow up phase competed as per protocol|18|||
146073869|NCT01124864|526790695|FG001|Overall Study|Follow up phase competed as per protocol|22|||
146073870|NCT01124864|526790696|FG002|Overall Study|Follow up phase competed as per protocol|24|||
146073871|NCT01124864|526790697|FG003|Overall Study|Follow up phase competed as per protocol|18|||
146173681|NCT01077362|527148996|FG000|Overall Study|Lost to Follow-up|1|||
146173682|NCT01077362|527148997|FG001|Overall Study|Lost to Follow-up|0|||
146173683|NCT01077362|527148998|FG002|Overall Study|Lost to Follow-up|3|||
146173684|NCT01077362|527148996|FG000|Overall Study|Adverse Event|12|||
146173685|NCT01077362|527148997|FG001|Overall Study|Adverse Event|7|||
146410256|NCT00686374|528007800|FG000|Overall Study|Other, not specified|4|||
145945305|NCT02407054|526308207|FG002|Overall Study|Adverse Event|1|||
146410257|NCT02143947|528007801|FG000|Overall Study|Lost to Follow-up|4|||
146410258|NCT02143947|528007802|FG001|Overall Study|Lost to Follow-up|2|||
146410259|NCT01244815|528007805|FG000|Overall Study|Not Treated|0|||
146410260|NCT01244815|528007806|FG001|Overall Study|Not Treated|1|||
146410261|NCT01244815|528007807|FG002|Overall Study|Not Treated|0|||
146410262|NCT01244815|528007808|FG003|Overall Study|Not Treated|0|||
146410263|NCT01244815|528007805|FG000|Overall Study|Adverse Event|4|||
146410264|NCT01244815|528007806|FG001|Overall Study|Adverse Event|7|||
146410265|NCT01244815|528007807|FG002|Overall Study|Adverse Event|5|||
146410266|NCT01244815|528007808|FG003|Overall Study|Adverse Event|5|||
146410267|NCT01244815|528007805|FG000|Overall Study|Treatment Failure|0|||
146410268|NCT01244815|528007806|FG001|Overall Study|Treatment Failure|0|||
146410269|NCT01244815|528007807|FG002|Overall Study|Treatment Failure|0|||
146410270|NCT01244815|528007808|FG003|Overall Study|Treatment Failure|1|||
146410271|NCT01244815|528007805|FG000|Overall Study|Lost to Follow-up|3|||
146410272|NCT01244815|528007806|FG001|Overall Study|Lost to Follow-up|2|||
146410273|NCT01244815|528007807|FG002|Overall Study|Lost to Follow-up|3|||
146410274|NCT01244815|528007808|FG003|Overall Study|Lost to Follow-up|2|||
146410275|NCT01244815|528007805|FG000|Overall Study|Withdrawal by Subject|0|||
146410276|NCT01244815|528007806|FG001|Overall Study|Withdrawal by Subject|2|||
146410277|NCT01244815|528007807|FG002|Overall Study|Withdrawal by Subject|0|||
146410278|NCT01244815|528007808|FG003|Overall Study|Withdrawal by Subject|3|||
146410279|NCT01244815|528007805|FG000|Overall Study|Protocol Violation|7|||
146410280|NCT01244815|528007806|FG001|Overall Study|Protocol Violation|4|||
146410281|NCT01244815|528007807|FG002|Overall Study|Protocol Violation|3|||
146410282|NCT01244815|528007808|FG003|Overall Study|Protocol Violation|1|||
146410283|NCT01244815|528007805|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146410284|NCT01244815|528007806|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146410285|NCT01244815|528007807|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
146410286|NCT01244815|528007808|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
146410287|NCT01808209|528007810|FG000|Overall Study|Lost to Follow-up|0|||
146410288|NCT01808209|528007811|FG001|Overall Study|Lost to Follow-up|1|||
146410289|NCT00697112|528007812|FG000|Overall Study|Adverse Event|8|||
146410290|NCT00697112|528007812|FG000|Overall Study|Lost to Follow-up|1|||
146410291|NCT00697112|528007812|FG000|Overall Study|Did not meet inclusion criteria|1|||
146410292|NCT01427920|528007817|FG000|Overall Study|Adverse Event|1|||
146410293|NCT01427920|528007818|FG001|Overall Study|Adverse Event|2|||
146410294|NCT01427920|528007817|FG000|Overall Study|Lack of Efficacy|1|||
146410295|NCT01427920|528007818|FG001|Overall Study|Lack of Efficacy|0|||
146410296|NCT01427920|528007817|FG000|Overall Study|Protocol Violation|1|||
146173686|NCT01077362|527148998|FG002|Overall Study|Adverse Event|4|||
146283904|NCT00470366|527551874|FG000|Overall Study|Adverse Event|3|||
146410297|NCT01427920|528007818|FG001|Overall Study|Protocol Violation|3|||
146410298|NCT01427920|528007817|FG000|Overall Study|Withdrawal Criteria|4|||
146410299|NCT01427920|528007818|FG001|Overall Study|Withdrawal Criteria|4|||
146410300|NCT01427920|528007817|FG000|Overall Study|Unclassified|2|||
146410301|NCT01427920|528007818|FG001|Overall Study|Unclassified|8|||
146410302|NCT04228302|528007819|FG000|Overall Study|Adverse Event|0|||
146410303|NCT04228302|528007820|FG001|Overall Study|Adverse Event|0|||
146410304|NCT04228302|528007821|FG002|Overall Study|Adverse Event|0|||
146410305|NCT04228302|528007822|FG003|Overall Study|Adverse Event|0|||
146073872|NCT01124864|526790698|FG004|Overall Study|Follow up phase competed as per protocol|26|||
146073873|NCT01124864|526790699|FG005|Overall Study|Follow up phase competed as per protocol|2|||
146073874|NCT01124864|526790694|FG000|Overall Study|Death|6|||
146073875|NCT01124864|526790695|FG001|Overall Study|Death|9|||
146073876|NCT01124864|526790696|FG002|Overall Study|Death|6|||
146073877|NCT01124864|526790697|FG003|Overall Study|Death|2|||
146073878|NCT01124864|526790698|FG004|Overall Study|Death|1|||
146073879|NCT01124864|526790699|FG005|Overall Study|Death|0|||
146073880|NCT01124864|526790694|FG000|Overall Study|Withdrawal by Subject|2|||
146073881|NCT01124864|526790695|FG001|Overall Study|Withdrawal by Subject|3|||
146073882|NCT01124864|526790696|FG002|Overall Study|Withdrawal by Subject|4|||
146073883|NCT01124864|526790697|FG003|Overall Study|Withdrawal by Subject|0|||
146073884|NCT01124864|526790698|FG004|Overall Study|Withdrawal by Subject|2|||
146073885|NCT01124864|526790699|FG005|Overall Study|Withdrawal by Subject|1|||
146073886|NCT01124864|526790694|FG000|Overall Study|Lost to Follow-up|1|||
146073887|NCT01124864|526790695|FG001|Overall Study|Lost to Follow-up|1|||
146073888|NCT01124864|526790696|FG002|Overall Study|Lost to Follow-up|0|||
146073889|NCT01124864|526790697|FG003|Overall Study|Lost to Follow-up|1|||
146073890|NCT01124864|526790698|FG004|Overall Study|Lost to Follow-up|0|||
146073891|NCT01124864|526790699|FG005|Overall Study|Lost to Follow-up|0|||
146073892|NCT01124864|526790694|FG000|Overall Study|Protocol Violation|1|||
146073893|NCT01124864|526790695|FG001|Overall Study|Protocol Violation|0|||
146073894|NCT01124864|526790696|FG002|Overall Study|Protocol Violation|0|||
146073895|NCT01124864|526790697|FG003|Overall Study|Protocol Violation|0|||
146073896|NCT01124864|526790698|FG004|Overall Study|Protocol Violation|1|||
146073897|NCT01124864|526790699|FG005|Overall Study|Protocol Violation|0|||
146073898|NCT01243242|526790700|FG000|Overall Study|Adverse Event|1|||
146073899|NCT01243242|526790701|FG001|Overall Study|Adverse Event|1|||
146073900|NCT01243242|526790700|FG000|Overall Study|Withdrawal by Subject|1|||
146073901|NCT01243242|526790701|FG001|Overall Study|Withdrawal by Subject|1|||
146073902|NCT01243242|526790700|FG000|Overall Study|Physician Decision|0|||
146073903|NCT01243242|526790701|FG001|Overall Study|Physician Decision|1|||
146073904|NCT01243242|526790700|FG000|Overall Study|sponsor decision|0|||
146073905|NCT01243242|526790701|FG001|Overall Study|sponsor decision|1|||
146073906|NCT01243242|526790700|FG000|Overall Study|non compliance|1|||
146073907|NCT01243242|526790701|FG001|Overall Study|non compliance|0|||
146073908|NCT02160899|526790710|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
146073909|NCT02160899|526790711|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146073910|NCT02160899|526790712|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
146073911|NCT02160899|526790713|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
146073912|NCT02160899|526790714|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
146073913|NCT02160899|526790715|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
146073914|NCT01256294|526790716|FG000|Overall Study|Adverse Event|1|||
146073915|NCT01256294|526790717|FG001|Overall Study|Adverse Event|0|||
146073916|NCT01256294|526790716|FG000|Overall Study|Withdrawal by Subject|1|||
146073917|NCT01256294|526790717|FG001|Overall Study|Withdrawal by Subject|1|||
146073918|NCT01256294|526790716|FG000|Overall Study|Protocol deviation|2|||
146073919|NCT01256294|526790717|FG001|Overall Study|Protocol deviation|1|||
146073920|NCT04129151|526790718|FG000|Overall Study|Adverse Event|1|||
146073921|NCT04129151|526790718|FG000|Overall Study|Disease Progression|7|||
146073922|NCT04129151|526790718|FG000|Overall Study|Study closure|1|||
146073923|NCT00724711|526790720|FG000|Overall Study|Adverse Event|7|||
146073924|NCT00724711|526790721|FG001|Overall Study|Adverse Event|3|||
146073925|NCT00724711|526790720|FG000|Overall Study|Pregnancy|0|||
146073926|NCT00724711|526790721|FG001|Overall Study|Pregnancy|1|||
146073927|NCT00724711|526790720|FG000|Overall Study|Lack of Efficacy|0|||
146073928|NCT00724711|526790721|FG001|Overall Study|Lack of Efficacy|1|||
146073929|NCT00724711|526790720|FG000|Overall Study|Physician Decision|0|||
146073930|NCT00724711|526790721|FG001|Overall Study|Physician Decision|3|||
146073931|NCT00724711|526790720|FG000|Overall Study|Withdrawal by Subject|5|||
146073932|NCT00724711|526790721|FG001|Overall Study|Withdrawal by Subject|4|||
146073933|NCT00724711|526790720|FG000|Overall Study|Lost to Follow-up|4|||
146073934|NCT00724711|526790721|FG001|Overall Study|Lost to Follow-up|5|||
146073935|NCT00724711|526790720|FG000|Overall Study|Protocol Violation|1|||
146073936|NCT00724711|526790721|FG001|Overall Study|Protocol Violation|0|||
146073937|NCT01088048|526790723|FG000|Overall Study|Adverse Event|7|||
146073938|NCT01088048|526790724|FG001|Overall Study|Adverse Event|9|||
146073939|NCT01088048|526790725|FG002|Overall Study|Adverse Event|7|||
146073940|NCT01088048|526790726|FG003|Overall Study|Adverse Event|5|||
146073941|NCT01088048|526790727|FG004|Overall Study|Adverse Event|6|||
146073942|NCT01088048|526790728|FG005|Overall Study|Adverse Event|3|||
146073943|NCT01088048|526790729|FG006|Overall Study|Adverse Event|3|||
146073944|NCT01088048|526790730|FG007|Overall Study|Adverse Event|0|||
146073945|NCT01088048|526790731|FG008|Overall Study|Adverse Event|2|||
146073946|NCT01088048|526790732|FG009|Overall Study|Adverse Event|2|||
146073947|NCT01088048|526790723|FG000|Overall Study|Withdrew Consent|1|||
146073948|NCT01088048|526790724|FG001|Overall Study|Withdrew Consent|1|||
146073949|NCT01088048|526790725|FG002|Overall Study|Withdrew Consent|1|||
146073950|NCT01088048|526790726|FG003|Overall Study|Withdrew Consent|1|||
146073951|NCT01088048|526790727|FG004|Overall Study|Withdrew Consent|2|||
146073952|NCT01088048|526790728|FG005|Overall Study|Withdrew Consent|1|||
146073953|NCT01088048|526790729|FG006|Overall Study|Withdrew Consent|0|||
146073954|NCT01088048|526790730|FG007|Overall Study|Withdrew Consent|2|||
146073955|NCT01088048|526790731|FG008|Overall Study|Withdrew Consent|2|||
146073956|NCT01088048|526790732|FG009|Overall Study|Withdrew Consent|1|||
146073957|NCT01088048|526790723|FG000|Overall Study|Concomitant Medication Prohibited|1|||
146073958|NCT01088048|526790724|FG001|Overall Study|Concomitant Medication Prohibited|0|||
146073959|NCT01088048|526790725|FG002|Overall Study|Concomitant Medication Prohibited|0|||
146073960|NCT01088048|526790726|FG003|Overall Study|Concomitant Medication Prohibited|0|||
146073961|NCT01088048|526790727|FG004|Overall Study|Concomitant Medication Prohibited|0|||
146073962|NCT01088048|526790728|FG005|Overall Study|Concomitant Medication Prohibited|0|||
146073963|NCT01088048|526790729|FG006|Overall Study|Concomitant Medication Prohibited|0|||
146073964|NCT01088048|526790730|FG007|Overall Study|Concomitant Medication Prohibited|0|||
146410306|NCT04228302|528007823|FG004|Overall Study|Adverse Event|1|||
146073965|NCT01088048|526790731|FG008|Overall Study|Concomitant Medication Prohibited|0|||
146073966|NCT01088048|526790732|FG009|Overall Study|Concomitant Medication Prohibited|0|||
146073967|NCT01088048|526790723|FG000|Overall Study|Investigator Request|2|||
146073968|NCT01088048|526790724|FG001|Overall Study|Investigator Request|2|||
146073969|NCT01088048|526790725|FG002|Overall Study|Investigator Request|0|||
146073970|NCT01088048|526790726|FG003|Overall Study|Investigator Request|0|||
146410307|NCT04228302|528007824|FG005|Overall Study|Adverse Event|0|||
146410308|NCT03066440|528007827|FG000|Overall Study|Physician Decision|1|||
146410309|NCT03066440|528007828|FG001|Overall Study|Physician Decision|1|||
146410310|NCT03066440|528007827|FG000|Overall Study|Protocol Violation|0|||
146410311|NCT03066440|528007828|FG001|Overall Study|Protocol Violation|2|||
146410312|NCT04991311|528007829|FG000|Overall Study|Adverse Event|1|||
146410313|NCT01223196|528007830|FG000|Overall Study|Lost to Follow-up|2|||
146410314|NCT01223196|528007831|FG001|Overall Study|Lost to Follow-up|0|||
146410315|NCT01223196|528007830|FG000|Overall Study|Physician Decision|1|||
146073971|NCT01088048|526790727|FG004|Overall Study|Investigator Request|3|||
146073972|NCT01088048|526790728|FG005|Overall Study|Investigator Request|1|||
146073973|NCT01088048|526790729|FG006|Overall Study|Investigator Request|1|||
146073974|NCT01088048|526790730|FG007|Overall Study|Investigator Request|0|||
146073975|NCT01088048|526790731|FG008|Overall Study|Investigator Request|0|||
146073976|NCT01088048|526790732|FG009|Overall Study|Investigator Request|0|||
146073977|NCT01088048|526790723|FG000|Overall Study|Patient Non-compliance|0|||
146073978|NCT01088048|526790724|FG001|Overall Study|Patient Non-compliance|1|||
146073979|NCT01088048|526790725|FG002|Overall Study|Patient Non-compliance|0|||
146073980|NCT01088048|526790726|FG003|Overall Study|Patient Non-compliance|0|||
146073981|NCT01088048|526790727|FG004|Overall Study|Patient Non-compliance|0|||
146073982|NCT01088048|526790728|FG005|Overall Study|Patient Non-compliance|0|||
146073983|NCT01088048|526790729|FG006|Overall Study|Patient Non-compliance|0|||
146073984|NCT01088048|526790730|FG007|Overall Study|Patient Non-compliance|0|||
146073985|NCT01088048|526790731|FG008|Overall Study|Patient Non-compliance|0|||
146073986|NCT01088048|526790732|FG009|Overall Study|Patient Non-compliance|0|||
146073987|NCT01088048|526790723|FG000|Overall Study|Disease Progression|7|||
146073988|NCT01088048|526790724|FG001|Overall Study|Disease Progression|4|||
146073989|NCT01088048|526790725|FG002|Overall Study|Disease Progression|3|||
146073990|NCT01088048|526790726|FG003|Overall Study|Disease Progression|5|||
146073991|NCT01088048|526790727|FG004|Overall Study|Disease Progression|3|||
146073992|NCT01088048|526790728|FG005|Overall Study|Disease Progression|3|||
146073993|NCT01088048|526790729|FG006|Overall Study|Disease Progression|2|||
146073994|NCT01088048|526790730|FG007|Overall Study|Disease Progression|1|||
146073995|NCT01088048|526790731|FG008|Overall Study|Disease Progression|0|||
146073996|NCT01088048|526790732|FG009|Overall Study|Disease Progression|0|||
146073997|NCT01088048|526790723|FG000|Overall Study|Death|1|||
146073998|NCT01088048|526790724|FG001|Overall Study|Death|5|||
146073999|NCT01088048|526790725|FG002|Overall Study|Death|3|||
146074000|NCT01088048|526790726|FG003|Overall Study|Death|3|||
146074001|NCT01088048|526790727|FG004|Overall Study|Death|1|||
146074002|NCT01088048|526790728|FG005|Overall Study|Death|3|||
146074003|NCT01088048|526790729|FG006|Overall Study|Death|0|||
146074004|NCT01088048|526790730|FG007|Overall Study|Death|0|||
146074005|NCT01088048|526790731|FG008|Overall Study|Death|3|||
146074006|NCT01088048|526790732|FG009|Overall Study|Death|1|||
146074007|NCT01088048|526790723|FG000|Overall Study|Other|3|||
146074008|NCT01088048|526790724|FG001|Overall Study|Other|5|||
146074009|NCT01088048|526790725|FG002|Overall Study|Other|0|||
146074010|NCT01088048|526790726|FG003|Overall Study|Other|0|||
146074011|NCT01088048|526790727|FG004|Overall Study|Other|2|||
146074012|NCT01088048|526790728|FG005|Overall Study|Other|0|||
146074013|NCT01088048|526790729|FG006|Overall Study|Other|0|||
146074014|NCT01088048|526790730|FG007|Overall Study|Other|2|||
146074015|NCT01088048|526790731|FG008|Overall Study|Other|0|||
146074016|NCT01088048|526790732|FG009|Overall Study|Other|0|||
146074017|NCT01621802|526790733|FG000|Overall Study|Protocol Violation|0|||
146074018|NCT01621802|526790734|FG001|Overall Study|Protocol Violation|0|||
146074019|NCT01621802|526790735|FG002|Overall Study|Protocol Violation|0|||
146074020|NCT01621802|526790736|FG003|Overall Study|Protocol Violation|0|||
146074021|NCT01621802|526790737|FG004|Overall Study|Protocol Violation|0|||
146074022|NCT01621802|526790738|FG005|Overall Study|Protocol Violation|1|||
146074023|NCT01621802|526790733|FG000|Overall Study|Withdrawal by Subject|8|||
146074024|NCT01621802|526790734|FG001|Overall Study|Withdrawal by Subject|4|||
146074025|NCT01621802|526790735|FG002|Overall Study|Withdrawal by Subject|4|||
146074026|NCT01621802|526790736|FG003|Overall Study|Withdrawal by Subject|2|||
146074027|NCT01621802|526790737|FG004|Overall Study|Withdrawal by Subject|2|||
146074028|NCT01621802|526790738|FG005|Overall Study|Withdrawal by Subject|0|||
146074029|NCT01621802|526790733|FG000|Overall Study|Migrated/moved from study area|0|||
146074030|NCT01621802|526790734|FG001|Overall Study|Migrated/moved from study area|0|||
146074031|NCT01621802|526790735|FG002|Overall Study|Migrated/moved from study area|2|||
146074032|NCT01621802|526790736|FG003|Overall Study|Migrated/moved from study area|0|||
146074033|NCT01621802|526790737|FG004|Overall Study|Migrated/moved from study area|1|||
146074034|NCT01621802|526790738|FG005|Overall Study|Migrated/moved from study area|0|||
146074035|NCT01621802|526790733|FG000|Overall Study|Others|3|||
146410316|NCT01223196|528007831|FG001|Overall Study|Physician Decision|0|||
146074036|NCT01621802|526790734|FG001|Overall Study|Others|3|||
146074037|NCT01621802|526790735|FG002|Overall Study|Others|3|||
146074038|NCT01621802|526790736|FG003|Overall Study|Others|2|||
146074039|NCT01621802|526790737|FG004|Overall Study|Others|1|||
146074040|NCT01621802|526790738|FG005|Overall Study|Others|0|||
146074041|NCT01621802|526790733|FG000|Overall Study|Lost to Follow-up|36|||
146074042|NCT01621802|526790734|FG001|Overall Study|Lost to Follow-up|16|||
146074043|NCT01621802|526790735|FG002|Overall Study|Lost to Follow-up|24|||
146173687|NCT01077362|527148996|FG000|Overall Study|Withdrawal by Subject|5|||
146173688|NCT01077362|527148997|FG001|Overall Study|Withdrawal by Subject|3|||
146173689|NCT01077362|527148998|FG002|Overall Study|Withdrawal by Subject|5|||
146173690|NCT01077362|527148996|FG000|Overall Study|Other|0|||
146173691|NCT01077362|527148997|FG001|Overall Study|Other|1|||
146173692|NCT01077362|527148998|FG002|Overall Study|Other|2|||
146173693|NCT02387216|527149002|FG000|Overall Study|Progressive disease|2|||
146173694|NCT02387216|527149003|FG001|Overall Study|Progressive disease|0|||
146173695|NCT02387216|527149002|FG000|Overall Study|Withdrawal by Subject|3|||
146173696|NCT02387216|527149003|FG001|Overall Study|Withdrawal by Subject|5|||
146173697|NCT02387216|527149002|FG000|Overall Study|Physician Decision|2|||
146173698|NCT02387216|527149003|FG001|Overall Study|Physician Decision|0|||
146173699|NCT02387216|527149002|FG000|Overall Study|Sponsor Decision|28|||
146173700|NCT02387216|527149003|FG001|Overall Study|Sponsor Decision|12|||
146173701|NCT02387216|527149002|FG000|Overall Study|Death|60|||
146173702|NCT02387216|527149003|FG001|Overall Study|Death|23|||
146173703|NCT02387216|527149002|FG000|Overall Study|Other|5|||
146173704|NCT02387216|527149003|FG001|Overall Study|Other|4|||
146173705|NCT02387216|527149002|FG000|Overall Study|Lost to Follow-up|0|||
146173706|NCT02387216|527149003|FG001|Overall Study|Lost to Follow-up|3|||
146173707|NCT02306265|527149004|FG000|Overall Study|Withdrawal by Subject|1|||
146173708|NCT03812536|527149008|FG000|Overall Study|Protocol Violation|2|||
146173709|NCT03812536|527149009|FG001|Overall Study|Protocol Violation|0|||
146173710|NCT03812536|527149008|FG000|Overall Study|Withdrawal by Subject|1|||
146173711|NCT03812536|527149009|FG001|Overall Study|Withdrawal by Subject|1|||
146173712|NCT00152009|527149010|FG000|Overall Study|Adverse Event|9|||
146173713|NCT00152009|527149011|FG001|Overall Study|Adverse Event|13|||
146173714|NCT00152009|527149012|FG002|Overall Study|Adverse Event|20|||
146173715|NCT00152009|527149013|FG003|Overall Study|Adverse Event|1|||
146173716|NCT00152009|527149010|FG000|Overall Study|Protocol Violation|3|||
146173717|NCT00152009|527149011|FG001|Overall Study|Protocol Violation|0|||
146173718|NCT00152009|527149012|FG002|Overall Study|Protocol Violation|0|||
146173719|NCT00152009|527149013|FG003|Overall Study|Protocol Violation|1|||
146173720|NCT00152009|527149010|FG000|Overall Study|Withdrawal by Subject|2|||
146173721|NCT00152009|527149011|FG001|Overall Study|Withdrawal by Subject|3|||
146173722|NCT00152009|527149012|FG002|Overall Study|Withdrawal by Subject|4|||
146173723|NCT00152009|527149013|FG003|Overall Study|Withdrawal by Subject|9|||
146173724|NCT00152009|527149010|FG000|Overall Study|Lost to Follow-up|2|||
146173725|NCT00152009|527149011|FG001|Overall Study|Lost to Follow-up|4|||
146173726|NCT00152009|527149012|FG002|Overall Study|Lost to Follow-up|3|||
146173727|NCT00152009|527149013|FG003|Overall Study|Lost to Follow-up|3|||
146173728|NCT00152009|527149010|FG000|Overall Study|Lack of Efficacy|8|||
146173729|NCT00152009|527149011|FG001|Overall Study|Lack of Efficacy|6|||
146173730|NCT00152009|527149012|FG002|Overall Study|Lack of Efficacy|7|||
146173731|NCT00152009|527149013|FG003|Overall Study|Lack of Efficacy|15|||
146173732|NCT00152009|527149010|FG000|Overall Study|ECG abnormalities|2|||
146173733|NCT00152009|527149011|FG001|Overall Study|ECG abnormalities|2|||
146173734|NCT00152009|527149012|FG002|Overall Study|ECG abnormalities|2|||
146173735|NCT00152009|527149013|FG003|Overall Study|ECG abnormalities|1|||
146173736|NCT00152009|527149010|FG000|Overall Study|Sponsor's decision|3|||
146173737|NCT00152009|527149011|FG001|Overall Study|Sponsor's decision|3|||
146074044|NCT01621802|526790736|FG003|Overall Study|Lost to Follow-up|7|||
146074045|NCT01621802|526790737|FG004|Overall Study|Lost to Follow-up|31|||
146074046|NCT01621802|526790738|FG005|Overall Study|Lost to Follow-up|11|||
146074047|NCT01149148|526790739|FG000|Overall Study|Lost to Follow-up|1|||
146074048|NCT01149148|526790740|FG001|Overall Study|Lost to Follow-up|2|||
146074049|NCT01149148|526790739|FG000|Overall Study|Death|1|||
146074050|NCT01149148|526790740|FG001|Overall Study|Death|0|||
146074051|NCT03436082|526790741|FG000|Overall Study|Did not undergo procedure|1|||
146074052|NCT03436082|526790742|FG001|Overall Study|Did not undergo procedure|0|||
146074053|NCT00950859|526790743|FG000|Overall Study|Adverse Event|3|||
146074054|NCT00950859|526790744|FG001|Overall Study|Adverse Event|3|||
146074055|NCT00950859|526790743|FG000|Overall Study|Insufficient Viral Load Response|12|||
146074056|NCT00950859|526790744|FG001|Overall Study|Insufficient Viral Load Response|3|||
146074057|NCT00950859|526790743|FG000|Overall Study|Protocol Violation|1|||
146074058|NCT00950859|526790744|FG001|Overall Study|Protocol Violation|1|||
146173738|NCT00152009|527149012|FG002|Overall Study|Sponsor's decision|1|||
146173739|NCT00152009|527149013|FG003|Overall Study|Sponsor's decision|3|||
146173740|NCT04091360|527149016|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173741|NCT04091360|527149017|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173742|NCT04091360|527149018|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173743|NCT04091360|527149019|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173744|NCT04091360|527149020|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173745|NCT04091360|527149021|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173746|NCT04091360|527149022|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173747|NCT04091360|527149023|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
146173748|NCT04091360|527149024|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
146173749|NCT04091360|527149025|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
146173750|NCT04091360|527149016|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173751|NCT04091360|527149017|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173752|NCT04091360|527149018|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173753|NCT04091360|527149019|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173754|NCT04091360|527149020|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146410317|NCT01223196|528007830|FG000|Overall Study|Withdrawal by Subject|1|||
146410318|NCT01223196|528007831|FG001|Overall Study|Withdrawal by Subject|0|||
146410319|NCT02598193|528007832|FG000|Overall Study|Adverse Event|13|||
146173755|NCT04091360|527149021|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173756|NCT04091360|527149022|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
146173757|NCT04091360|527149023|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
146173758|NCT04091360|527149024|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173759|NCT04091360|527149025|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
146173760|NCT04091360|527149016|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173761|NCT04091360|527149017|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173762|NCT04091360|527149018|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173763|NCT04091360|527149019|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173764|NCT04091360|527149020|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173765|NCT04091360|527149021|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146410320|NCT02598193|528007832|FG000|Overall Study|Withdrawal by Subject|1|||
146410321|NCT02598193|528007832|FG000|Overall Study|Listed in active lung transplant list|1|||
146410322|NCT02598193|528007832|FG000|Overall Study|Does not want to take Nintedanib|1|||
146410323|NCT02487979|528007833|FG000|Overall Study|Physician Decision|2|||
146410324|NCT02487979|528007833|FG000|Overall Study|Withdrawal by Subject|2|||
146410325|NCT02487979|528007833|FG000|Overall Study|Progressive Disease|17|||
146410326|NCT01169987|528007834|FG000|Overall Study|Withdrawal by Subject|3|||
146410327|NCT01169987|528007834|FG000|Overall Study|Lost to Follow-up|24|||
146410328|NCT01169987|528007834|FG000|Overall Study|Other|4|||
146410329|NCT00829439|528007835|FG000|Overall Study|Adverse Event|0|||
146410330|NCT00829439|528007836|FG001|Overall Study|Adverse Event|0|||
146410331|NCT00829439|528007837|FG002|Overall Study|Adverse Event|1|||
146173766|NCT04091360|527149022|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
146173767|NCT04091360|527149023|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173768|NCT04091360|527149024|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
146173769|NCT04091360|527149025|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
146173770|NCT01735396|527149026|FG000|Overall Study|not evaluable|1|||
146173771|NCT00572624|527149027|FG000|Overall Study|Lost to Follow-up|10|||
146173772|NCT00572624|527149028|FG001|Overall Study|Lost to Follow-up|4|||
146173773|NCT00572624|527149027|FG000|Overall Study|Wanted to do a different diet program|1|||
146173774|NCT00572624|527149028|FG001|Overall Study|Wanted to do a different diet program|0|||
146173775|NCT00572624|527149027|FG000|Overall Study|Medication change|1|||
146173776|NCT00572624|527149028|FG001|Overall Study|Medication change|0|||
146173777|NCT00572624|527149027|FG000|Overall Study|Started a new job-- no time for study|1|||
146173778|NCT00572624|527149028|FG001|Overall Study|Started a new job-- no time for study|0|||
146173779|NCT00572624|527149027|FG000|Overall Study|Admitted to being a smoker|1|||
146173780|NCT00572624|527149028|FG001|Overall Study|Admitted to being a smoker|0|||
146173781|NCT00572624|527149027|FG000|Overall Study|Refused to do the stress test|1|||
146173782|NCT00572624|527149028|FG001|Overall Study|Refused to do the stress test|0|||
146173783|NCT00572624|527149027|FG000|Overall Study|Problem with vascular access|1|||
146173784|NCT00572624|527149028|FG001|Overall Study|Problem with vascular access|0|||
146173785|NCT00572624|527149027|FG000|Overall Study|Health issues unrelated to the study|1|||
146173786|NCT00572624|527149028|FG001|Overall Study|Health issues unrelated to the study|0|||
146410332|NCT00829439|528007838|FG003|Overall Study|Adverse Event|0|||
146410333|NCT00386100|528007839|FG000|Overall Study|Did not receive study medication|6|||
146410334|NCT00386100|528007840|FG001|Overall Study|Did not receive study medication|4|||
146410335|NCT00386100|528007839|FG000|Overall Study|Adverse Event|15|||
146410336|NCT00386100|528007840|FG001|Overall Study|Adverse Event|25|||
146410337|NCT00386100|528007839|FG000|Overall Study|Death|0|||
146410338|NCT00386100|528007840|FG001|Overall Study|Death|1|||
146410339|NCT00386100|528007839|FG000|Overall Study|Insufficient therapeutic effect|30|||
146410340|NCT00386100|528007840|FG001|Overall Study|Insufficient therapeutic effect|6|||
146410341|NCT00386100|528007839|FG000|Overall Study|Lost to Follow-up|29|||
146410342|NCT00386100|528007840|FG001|Overall Study|Lost to Follow-up|29|||
146410343|NCT00386100|528007839|FG000|Overall Study|Non-compliance|18|||
146410344|NCT00386100|528007840|FG001|Overall Study|Non-compliance|19|||
146410345|NCT00386100|528007839|FG000|Overall Study|Protocol Violation|5|||
146410346|NCT00386100|528007840|FG001|Overall Study|Protocol Violation|3|||
146410347|NCT00386100|528007839|FG000|Overall Study|Withdrawal by Subject|32|||
146410348|NCT00386100|528007840|FG001|Overall Study|Withdrawal by Subject|31|||
146410349|NCT00386100|528007839|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
146410350|NCT00386100|528007840|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
146410351|NCT00386100|528007839|FG000|Overall Study|BMD <2.5|1|||
146410352|NCT00386100|528007840|FG001|Overall Study|BMD <2.5|0|||
146410353|NCT00386100|528007839|FG000|Overall Study|Consecutive elevated Hba1C|1|||
146410354|NCT00386100|528007840|FG001|Overall Study|Consecutive elevated Hba1C|0|||
146410355|NCT00386100|528007839|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
146410356|NCT00386100|528007840|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
146410357|NCT00386100|528007839|FG000|Overall Study|Laboratory findings|1|||
146410358|NCT00386100|528007840|FG001|Overall Study|Laboratory findings|0|||
146410359|NCT00386100|528007839|FG000|Overall Study|Participant's concern due to CPK levels|1|||
146410360|NCT00386100|528007840|FG001|Overall Study|Participant's concern due to CPK levels|0|||
146410361|NCT00386100|528007839|FG000|Overall Study|Participant moving out of state|2|||
146410362|NCT00386100|528007840|FG001|Overall Study|Participant moving out of state|0|||
146410363|NCT00386100|528007839|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
146410364|NCT00386100|528007840|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
146410365|NCT00386100|528007839|FG000|Overall Study|Didn't meet entry criteria|1|||
146410366|NCT00386100|528007840|FG001|Overall Study|Didn't meet entry criteria|1|||
146410367|NCT00386100|528007839|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
146410368|NCT00386100|528007840|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
146410369|NCT00386100|528007839|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
146410370|NCT00386100|528007840|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
146410371|NCT00386100|528007839|FG000|Overall Study|Bad metabolic control & patient security|1|||
146410372|NCT00386100|528007840|FG001|Overall Study|Bad metabolic control & patient security|0|||
146410373|NCT00386100|528007839|FG000|Overall Study|Bone loss by DXA bone scan|1|||
146410374|NCT00386100|528007840|FG001|Overall Study|Bone loss by DXA bone scan|0|||
146410375|NCT00386100|528007839|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
146410376|NCT00386100|528007840|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
146410377|NCT00386100|528007839|FG000|Overall Study|7.6% bone loss|1|||
146410378|NCT00386100|528007840|FG001|Overall Study|7.6% bone loss|0|||
146410379|NCT00386100|528007839|FG000|Overall Study|Osteoporosis|0|||
146410380|NCT00386100|528007840|FG001|Overall Study|Osteoporosis|1|||
146410381|NCT00386100|528007839|FG000|Overall Study|Positive pregnancy test|1|||
146410382|NCT00386100|528007840|FG001|Overall Study|Positive pregnancy test|3|||
146410383|NCT00386100|528007839|FG000|Overall Study|Out of country for 5 months|1|||
146410384|NCT00386100|528007840|FG001|Overall Study|Out of country for 5 months|0|||
146410385|NCT00386100|528007839|FG000|Overall Study|Hb1Ac >8%|0|||
146410386|NCT00386100|528007840|FG001|Overall Study|Hb1Ac >8%|1|||
146410387|NCT00386100|528007839|FG000|Overall Study|Participant randomized in error|1|||
146410388|NCT00386100|528007840|FG001|Overall Study|Participant randomized in error|0|||
146410389|NCT01493531|528007850|FG000|Overall Study|Adverse Event|4|||
146410390|NCT01493531|528007851|FG001|Overall Study|Adverse Event|12|||
146410391|NCT01493531|528007852|FG002|Overall Study|Adverse Event|9|||
146410392|NCT01493531|528007850|FG000|Overall Study|Gout flare|3|||
146410393|NCT01493531|528007851|FG001|Overall Study|Gout flare|0|||
146410394|NCT01493531|528007852|FG002|Overall Study|Gout flare|2|||
146410395|NCT01493531|528007850|FG000|Overall Study|Protocol Violation|8|||
146410396|NCT01493531|528007851|FG001|Overall Study|Protocol Violation|15|||
146410397|NCT01493531|528007852|FG002|Overall Study|Protocol Violation|12|||
146410398|NCT01493531|528007850|FG000|Overall Study|Sponsor terminated study|5|||
146410399|NCT01493531|528007851|FG001|Overall Study|Sponsor terminated study|2|||
146410400|NCT01493531|528007852|FG002|Overall Study|Sponsor terminated study|3|||
146410401|NCT01493531|528007850|FG000|Overall Study|Lost to Follow-up|5|||
146410402|NCT01493531|528007851|FG001|Overall Study|Lost to Follow-up|7|||
146410403|NCT01493531|528007852|FG002|Overall Study|Lost to Follow-up|11|||
146410404|NCT01493531|528007850|FG000|Overall Study|Withdrawal by Subject|16|||
146410405|NCT01493531|528007851|FG001|Overall Study|Withdrawal by Subject|13|||
146410406|NCT01493531|528007852|FG002|Overall Study|Withdrawal by Subject|11|||
146410407|NCT01493531|528007850|FG000|Overall Study|Death|0|||
146410408|NCT01493531|528007851|FG001|Overall Study|Death|1|||
146410409|NCT01493531|528007852|FG002|Overall Study|Death|0|||
146410410|NCT01946282|528007853|FG000|Year 1|Did not return FIT kit|4186|||
146410411|NCT01946282|528007854|FG001|Year 1|Did not return FIT kit|608|||
146410412|NCT01946282|528007855|FG002|Year 1|Did not return FIT kit|654|||
146410413|NCT01946282|528007853|FG000|Year 2|Did not return FIT kit|803|||
146410414|NCT01946282|528007854|FG001|Year 2|Did not return FIT kit|131|||
146410415|NCT01946282|528007855|FG002|Year 2|Did not return FIT kit|115|||
146410416|NCT01946282|528007853|FG000|Year 3|Did not return FIT kit|288|||
146410417|NCT01946282|528007854|FG001|Year 3|Did not return FIT kit|43|||
146410418|NCT01946282|528007855|FG002|Year 3|Did not return FIT kit|30|||
146410419|NCT03031431|528007856|FG000|Overall Study|Infant removed by maternal request|1|||
146410420|NCT03670537|528007861|FG000|Overall Study|Protocol Violation|1|||
146410421|NCT04133519|528007862|FG000|Overall Study|Withdrawal by Subject|5|||
146410422|NCT04133519|528007863|FG001|Overall Study|Withdrawal by Subject|4|||
146410423|NCT04133519|528007862|FG000|Overall Study|Protocol Violation|0|||
146410424|NCT04133519|528007863|FG001|Overall Study|Protocol Violation|1|||
146410425|NCT04133519|528007862|FG000|Overall Study|Never started treatment|1|||
146410426|NCT04133519|528007863|FG001|Overall Study|Never started treatment|1|||
146410427|NCT02217345|528007864|FG000|Overall Study|Lost to Follow-up|2|||
146410428|NCT02217345|528007865|FG001|Overall Study|Lost to Follow-up|1|||
146410429|NCT02217345|528007864|FG000|Overall Study|Withdrawal by Subject|3|||
146410430|NCT02217345|528007865|FG001|Overall Study|Withdrawal by Subject|2|||
146410431|NCT02217345|528007864|FG000|Overall Study|Adverse Event|2|||
146410432|NCT02217345|528007865|FG001|Overall Study|Adverse Event|1|||
146410433|NCT02217345|528007864|FG000|Overall Study|Physician Decision|0|||
146410434|NCT02217345|528007865|FG001|Overall Study|Physician Decision|1|||
146410435|NCT00789828|528007870|FG000|Core Period (48 Weeks)|Administrative problems|0|||
146410436|NCT00789828|528007871|FG001|Core Period (48 Weeks)|Administrative problems|1|||
146410437|NCT00789828|528007870|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
146410438|NCT00789828|528007871|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
146410439|NCT00789828|528007870|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
146410440|NCT00789828|528007871|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
146410441|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
146410442|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
146410443|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
146410444|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
146074059|NCT00950859|526790743|FG000|Overall Study|Lost to Follow-up|0|||
146173787|NCT04145037|527149029|FG000|Overall Study|Study terminated|2|||
146074060|NCT00950859|526790744|FG001|Overall Study|Lost to Follow-up|3|||
146074061|NCT04896086|526790745|FG000|Overall Study|Lost to Follow-up|0|||
146074062|NCT04896086|526790746|FG001|Overall Study|Lost to Follow-up|2|||
146074063|NCT04896086|526790747|FG002|Overall Study|Lost to Follow-up|1|||
146074064|NCT04896086|526790748|FG003|Overall Study|Lost to Follow-up|0|||
146074065|NCT04896086|526790749|FG004|Overall Study|Lost to Follow-up|0|||
146074066|NCT04896086|526790745|FG000|Overall Study|Physician Decision|0|||
146074067|NCT04896086|526790746|FG001|Overall Study|Physician Decision|1|||
146074068|NCT04896086|526790747|FG002|Overall Study|Physician Decision|0|||
146074069|NCT04896086|526790748|FG003|Overall Study|Physician Decision|0|||
146074070|NCT04896086|526790749|FG004|Overall Study|Physician Decision|0|||
146173788|NCT04145037|527149030|FG001|Overall Study|Study terminated|0|||
146173789|NCT04145037|527149029|FG000|Overall Study|Withdrawal by Subject|1|||
146173790|NCT04145037|527149030|FG001|Overall Study|Withdrawal by Subject|0|||
146173791|NCT04145037|527149029|FG000|Overall Study|Lost to Follow-up|1|||
146173792|NCT04145037|527149030|FG001|Overall Study|Lost to Follow-up|0|||
146173793|NCT00098254|527149035|FG000|Overall Study|Adverse Event|2|||
146173794|NCT00098254|527149035|FG000|Overall Study|Death|1|||
146173795|NCT00744263|527149038|FG000|Overall Study|Death|3006|||
146173796|NCT00744263|527149039|FG001|Overall Study|Death|3005|||
146173797|NCT00744263|527149038|FG000|Overall Study|Lost to Follow-up|2038|||
146173798|NCT00744263|527149039|FG001|Overall Study|Lost to Follow-up|2135|||
146173799|NCT00744263|527149038|FG000|Overall Study|Withdrawal by Subject|166|||
146173800|NCT00744263|527149039|FG001|Overall Study|Withdrawal by Subject|150|||
146173801|NCT00744263|527149038|FG000|Overall Study|Physician Decision|20|||
146173802|NCT00744263|527149039|FG001|Overall Study|Physician Decision|23|||
146173803|NCT00744263|527149038|FG000|Overall Study|Protocol Violation|3|||
146173804|NCT00744263|527149039|FG001|Overall Study|Protocol Violation|5|||
146173805|NCT00744263|527149038|FG000|Overall Study|Adverse Event|1|||
146173806|NCT00744263|527149039|FG001|Overall Study|Adverse Event|0|||
146173807|NCT00744263|527149038|FG000|Overall Study|Other|2|||
146173808|NCT00744263|527149039|FG001|Overall Study|Other|2|||
146173809|NCT03107377|527149040|FG000|Overall Study|Adverse Event|3|||
146173810|NCT03107377|527149041|FG001|Overall Study|Adverse Event|3|||
146173811|NCT03107377|527149040|FG000|Overall Study|Protocol Violation|9|||
146173812|NCT03107377|527149041|FG001|Overall Study|Protocol Violation|12|||
146173813|NCT03107377|527149040|FG000|Overall Study|Physician Decision|3|||
146173814|NCT03107377|527149041|FG001|Overall Study|Physician Decision|6|||
146173815|NCT03107377|527149040|FG000|Overall Study|Pregnancy|7|||
146173816|NCT03107377|527149041|FG001|Overall Study|Pregnancy|7|||
146173817|NCT03107377|527149040|FG000|Overall Study|Withdrawal by Subject|16|||
146173818|NCT03107377|527149041|FG001|Overall Study|Withdrawal by Subject|22|||
146173819|NCT03107377|527149040|FG000|Overall Study|Lost to Follow-up|37|||
146173820|NCT03107377|527149041|FG001|Overall Study|Lost to Follow-up|34|||
146173821|NCT03107377|527149040|FG000|Overall Study|Other reason not specified|16|||
146173822|NCT03107377|527149041|FG001|Overall Study|Other reason not specified|15|||
146173823|NCT00211237|527149042|FG000|Baseline|Withdrew|1|||
146173824|NCT00211237|527149043|FG001|Baseline|Withdrew|3|||
146173825|NCT00211237|527149044|FG002|Baseline|Withdrew|0|||
146173826|NCT00211237|527149042|FG000|Baseline|Refused random assignment|1|||
146173827|NCT00211237|527149043|FG001|Baseline|Refused random assignment|0|||
146173828|NCT00211237|527149044|FG002|Baseline|Refused random assignment|0|||
146173829|NCT00211237|527149042|FG000|1 Month|Death|2|||
146173830|NCT00211237|527149043|FG001|1 Month|Death|1|||
146173831|NCT00211237|527149044|FG002|1 Month|Death|0|||
146173832|NCT00211237|527149042|FG000|1 Month|Lost to Follow-up|0|||
146173833|NCT00211237|527149043|FG001|1 Month|Lost to Follow-up|2|||
146173834|NCT00211237|527149044|FG002|1 Month|Lost to Follow-up|0|||
146173835|NCT00211237|527149042|FG000|1 Month|Withdrew|0|||
146173836|NCT00211237|527149043|FG001|1 Month|Withdrew|4|||
146173837|NCT00211237|527149044|FG002|1 Month|Withdrew|0|||
146173838|NCT00211237|527149042|FG000|1 Month|Additional surgery needed|1|||
146173839|NCT00211237|527149043|FG001|1 Month|Additional surgery needed|0|||
146173840|NCT00211237|527149044|FG002|1 Month|Additional surgery needed|0|||
146173841|NCT00211237|527149042|FG000|1 Month|Non-medical problem|0|||
146173842|NCT00211237|527149043|FG001|1 Month|Non-medical problem|2|||
146173843|NCT00211237|527149044|FG002|1 Month|Non-medical problem|0|||
146173844|NCT00211237|527149042|FG000|3 Months|Death|7|||
146173845|NCT00211237|527149043|FG001|3 Months|Death|3|||
146173846|NCT00211237|527149044|FG002|3 Months|Death|0|||
146173847|NCT00211237|527149042|FG000|3 Months|Could not comply with protocol|1|||
146173848|NCT00211237|527149043|FG001|3 Months|Could not comply with protocol|0|||
146173849|NCT00211237|527149044|FG002|3 Months|Could not comply with protocol|0|||
146173850|NCT00211237|527149042|FG000|3 Months|Withdrew|0|||
146173851|NCT00211237|527149043|FG001|3 Months|Withdrew|1|||
146173852|NCT00211237|527149044|FG002|3 Months|Withdrew|0|||
146173853|NCT00211237|527149042|FG000|3 Months|Non-medical problem|0|||
146173854|NCT00211237|527149043|FG001|3 Months|Non-medical problem|0|||
146173855|NCT00211237|527149044|FG002|3 Months|Non-medical problem|1|||
146173856|NCT00211237|527149042|FG000|6 Months|Death|6|||
146173857|NCT00211237|527149043|FG001|6 Months|Death|0|||
146173858|NCT00211237|527149044|FG002|6 Months|Death|3|||
146173859|NCT00211237|527149042|FG000|6 Months|Lost to Follow-up|2|||
146173860|NCT00211237|527149043|FG001|6 Months|Lost to Follow-up|0|||
146173861|NCT00211237|527149044|FG002|6 Months|Lost to Follow-up|0|||
146173862|NCT00211237|527149042|FG000|6 Months|Could not comply with protocol|0|||
146173863|NCT00211237|527149043|FG001|6 Months|Could not comply with protocol|2|||
146173864|NCT00211237|527149044|FG002|6 Months|Could not comply with protocol|0|||
146173865|NCT00211237|527149042|FG000|12 Months|Death|8|||
146173866|NCT00211237|527149043|FG001|12 Months|Death|2|||
146173867|NCT00211237|527149044|FG002|12 Months|Death|3|||
146173868|NCT00211237|527149042|FG000|12 Months|Lost to Follow-up|1|||
146173869|NCT00211237|527149043|FG001|12 Months|Lost to Follow-up|0|||
146173870|NCT00211237|527149044|FG002|12 Months|Lost to Follow-up|1|||
146173871|NCT00211237|527149042|FG000|12 Months|Withdrew|0|||
146173872|NCT00211237|527149043|FG001|12 Months|Withdrew|0|||
146173873|NCT00211237|527149044|FG002|12 Months|Withdrew|1|||
146173874|NCT00211237|527149042|FG000|12 Months|unrelated medical problem|0|||
146173875|NCT00211237|527149043|FG001|12 Months|unrelated medical problem|0|||
146173876|NCT00211237|527149044|FG002|12 Months|unrelated medical problem|1|||
146173877|NCT00453102|527149048|FG000|Overall Study|Withdrawal by Subject|2|||
146173878|NCT04078035|527149049|FG000|Session 2|Lost to Follow-up|3|||
146173879|NCT04078035|527149050|FG001|Session 2|Lost to Follow-up|1|||
146173880|NCT04078035|527149049|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
146173881|NCT04078035|527149050|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
146173882|NCT01650519|527149060|FG000|Overall Study|Withdrawal by Subject|1|||
146173883|NCT01650519|527149061|FG001|Overall Study|Withdrawal by Subject|0|||
146173884|NCT05458024|527149064|FG000|Overall Study|Withdrawal by Subject|1|||
146173885|NCT05458024|527149065|FG001|Overall Study|Withdrawal by Subject|1|||
146173886|NCT02954458|527149067|FG000|Overall Study|Adverse Event|0|||
146173887|NCT02954458|527149068|FG001|Overall Study|Adverse Event|0|||
146173888|NCT02954458|527149069|FG002|Overall Study|Adverse Event|0|||
146173889|NCT02954458|527149070|FG003|Overall Study|Adverse Event|1|||
146173890|NCT02954458|527149067|FG000|Overall Study|Withdrawal by Subject|0|||
146173891|NCT02954458|527149068|FG001|Overall Study|Withdrawal by Subject|0|||
146173892|NCT02954458|527149069|FG002|Overall Study|Withdrawal by Subject|0|||
146173893|NCT02954458|527149070|FG003|Overall Study|Withdrawal by Subject|1|||
146173894|NCT02954458|527149067|FG000|Overall Study|Physician Decision|0|||
146173895|NCT02954458|527149068|FG001|Overall Study|Physician Decision|0|||
146173896|NCT02954458|527149069|FG002|Overall Study|Physician Decision|1|||
146173897|NCT02954458|527149070|FG003|Overall Study|Physician Decision|1|||
146173898|NCT02954458|527149067|FG000|Overall Study|Lost to Follow-up|1|||
146173899|NCT02954458|527149068|FG001|Overall Study|Lost to Follow-up|0|||
146410445|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
146173900|NCT02954458|527149069|FG002|Overall Study|Lost to Follow-up|0|||
146173901|NCT02954458|527149070|FG003|Overall Study|Lost to Follow-up|1|||
146173902|NCT02954458|527149067|FG000|Overall Study|Death|0|||
146410446|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
146410447|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
146410448|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
146410449|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Death|1|||
146173903|NCT02954458|527149068|FG001|Overall Study|Death|0|||
146173904|NCT02954458|527149069|FG002|Overall Study|Death|0|||
146173905|NCT02954458|527149070|FG003|Overall Study|Death|1|||
146173906|NCT02954458|527149067|FG000|Overall Study|Other|0|||
146410450|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Death|0|||
146410451|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
146410452|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
146410453|NCT00789828|528007870|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
146410454|NCT00789828|528007871|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
146410455|NCT01133392|528007872|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
146410456|NCT01133392|528007873|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
146410457|NCT01133392|528007872|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
146410458|NCT01133392|528007873|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
146410459|NCT03185949|528007874|FG000|ITT Analysis|Withdrawal by Subject|4|||
146410460|NCT03185949|528007875|FG001|ITT Analysis|Withdrawal by Subject|3|||
146410461|NCT03185949|528007874|FG000|PP Analysis|Protocol Violation|2|||
146410462|NCT03185949|528007875|FG001|PP Analysis|Protocol Violation|2|||
146410463|NCT03185949|528007874|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
146410464|NCT03185949|528007875|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
146410465|NCT05788237|528007881|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146410466|NCT05788237|528007882|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
146410467|NCT05788237|528007883|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146410468|NCT05788237|528007884|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
146410469|NCT05788237|528007881|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146410470|NCT05788237|528007882|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
146410471|NCT05788237|528007883|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146410472|NCT05788237|528007884|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
146410473|NCT05788237|528007881|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
146410474|NCT05788237|528007882|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
146410475|NCT05788237|528007883|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
146410476|NCT05788237|528007884|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
146410477|NCT05788237|528007881|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
146410478|NCT05788237|528007882|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
146410479|NCT05788237|528007883|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
146410480|NCT05788237|528007884|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
146410481|NCT05788237|528007881|FG000|SSA (Approximately 2 Months)|Death|0|||
146410482|NCT05788237|528007882|FG001|SSA (Approximately 2 Months)|Death|1|||
146410483|NCT05788237|528007883|FG002|SSA (Approximately 2 Months)|Death|0|||
146410484|NCT05788237|528007884|FG003|SSA (Approximately 2 Months)|Death|0|||
146410485|NCT05788237|528007881|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146410486|NCT05788237|528007882|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146410487|NCT05788237|528007883|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
146410488|NCT05788237|528007884|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
146410489|NCT05788237|528007881|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146410490|NCT05788237|528007882|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146410491|NCT05788237|528007883|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
146410492|NCT05788237|528007884|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
146410493|NCT05788237|528007881|FG000|SSB (Approximately 1 Month)|Other|0|||
146410494|NCT05788237|528007882|FG001|SSB (Approximately 1 Month)|Other|0|||
146410495|NCT05788237|528007883|FG002|SSB (Approximately 1 Month)|Other|0|||
146410496|NCT05788237|528007884|FG003|SSB (Approximately 1 Month)|Other|1|||
146410497|NCT01835470|528009364|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
146410498|NCT01835470|528009364|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
146410499|NCT00304954|528009365|FG000|Overall Study|Withdrawal by Subject|0|||
146410500|NCT00304954|528009366|FG001|Overall Study|Withdrawal by Subject|0|||
146410501|NCT00304954|528009367|FG002|Overall Study|Withdrawal by Subject|1|||
146410502|NCT00304954|528009368|FG003|Overall Study|Withdrawal by Subject|0|||
146410503|NCT00304954|528009365|FG000|Overall Study|Adverse Event|1|||
146410504|NCT00304954|528009366|FG001|Overall Study|Adverse Event|0|||
146410505|NCT00304954|528009367|FG002|Overall Study|Adverse Event|0|||
146410506|NCT00304954|528009368|FG003|Overall Study|Adverse Event|0|||
146410507|NCT01406873|528009373|FG000|Overall Study|Withdrawal by Subject|1|||
146410508|NCT01406873|528009374|FG001|Overall Study|Withdrawal by Subject|1|||
146410509|NCT00207714|528009375|FG000|Overall Study|Adverse Event|6|||
146410510|NCT00207714|528009376|FG001|Overall Study|Adverse Event|2|||
146410511|NCT00207714|528009377|FG002|Overall Study|Adverse Event|4|||
146410512|NCT00207714|528009378|FG003|Overall Study|Adverse Event|3|||
146410513|NCT00207714|528009379|FG004|Overall Study|Adverse Event|1|||
146410514|NCT00207714|528009375|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146173907|NCT02954458|527149068|FG001|Overall Study|Other|0|||
146410515|NCT00207714|528009376|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146410516|NCT00207714|528009377|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146410517|NCT00207714|528009378|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
146410518|NCT00207714|528009379|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
146410519|NCT00207714|528009375|FG000|Overall Study|Other|3|||
146173908|NCT02954458|527149069|FG002|Overall Study|Other|0|||
146173909|NCT02954458|527149070|FG003|Overall Study|Other|7|||
146173910|NCT00747123|527149071|FG000|Overall Study|Investigator's request|0|||
146173911|NCT00747123|527149072|FG001|Overall Study|Investigator's request|0|||
146173912|NCT00747123|527149073|FG002|Overall Study|Investigator's request|1|||
146283905|NCT00470366|527551874|FG000|Overall Study|Poor compliance|1|||
146173913|NCT00747123|527149074|FG003|Overall Study|Investigator's request|0|||
146173914|NCT00747123|527149071|FG000|Overall Study|Withdrew consent|0|||
146173915|NCT00747123|527149072|FG001|Overall Study|Withdrew consent|1|||
146173916|NCT00747123|527149073|FG002|Overall Study|Withdrew consent|0|||
146173917|NCT00747123|527149074|FG003|Overall Study|Withdrew consent|0|||
146173918|NCT00747123|527149071|FG000|Overall Study|Adverse Event|0|||
146173919|NCT00747123|527149072|FG001|Overall Study|Adverse Event|1|||
146173920|NCT00747123|527149073|FG002|Overall Study|Adverse Event|0|||
146173921|NCT00747123|527149074|FG003|Overall Study|Adverse Event|1|||
146173922|NCT03929562|527149077|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
146173923|NCT03929562|527149078|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
146173924|NCT03929562|527149077|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
146173925|NCT03929562|527149078|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
146173926|NCT03929562|527149077|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
146173927|NCT03929562|527149078|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
146173928|NCT01778556|527149086|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
146173929|NCT01778556|527149087|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
146173930|NCT01778556|527149086|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146173931|NCT01778556|527149087|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
146173932|NCT01778556|527149086|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
146173933|NCT01778556|527149087|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
146173934|NCT01778556|527149086|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
146173935|NCT01778556|527149087|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
146173936|NCT01036022|527149088|FG000|Overall Study|Adverse Event|1|||
146173937|NCT01036022|527149089|FG001|Overall Study|Adverse Event|3|||
146173938|NCT01036022|527149090|FG002|Overall Study|Adverse Event|2|||
146173939|NCT01036022|527149091|FG003|Overall Study|Adverse Event|1|||
146173940|NCT01036022|527149092|FG004|Overall Study|Adverse Event|0|||
146173941|NCT01036022|527149093|FG005|Overall Study|Adverse Event|2|||
146173942|NCT01036022|527149088|FG000|Overall Study|Lack of Efficacy|1|||
146173943|NCT01036022|527149089|FG001|Overall Study|Lack of Efficacy|1|||
146173944|NCT01036022|527149090|FG002|Overall Study|Lack of Efficacy|1|||
146173945|NCT01036022|527149091|FG003|Overall Study|Lack of Efficacy|0|||
146173946|NCT01036022|527149092|FG004|Overall Study|Lack of Efficacy|1|||
146173947|NCT01036022|527149093|FG005|Overall Study|Lack of Efficacy|1|||
146173948|NCT01036022|527149088|FG000|Overall Study|Physician Decision|0|||
146173949|NCT01036022|527149089|FG001|Overall Study|Physician Decision|0|||
146173950|NCT01036022|527149090|FG002|Overall Study|Physician Decision|1|||
146173951|NCT01036022|527149091|FG003|Overall Study|Physician Decision|0|||
146173952|NCT01036022|527149092|FG004|Overall Study|Physician Decision|0|||
146173953|NCT01036022|527149093|FG005|Overall Study|Physician Decision|0|||
146173954|NCT01036022|527149088|FG000|Overall Study|Withdrawal by Subject|0|||
146173955|NCT01036022|527149089|FG001|Overall Study|Withdrawal by Subject|0|||
146173956|NCT01036022|527149090|FG002|Overall Study|Withdrawal by Subject|0|||
146173957|NCT01036022|527149091|FG003|Overall Study|Withdrawal by Subject|1|||
146074071|NCT04896086|526790745|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146074072|NCT04896086|526790746|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146074073|NCT04896086|526790747|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146074074|NCT04896086|526790748|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
146074075|NCT04896086|526790749|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
146074076|NCT04896086|526790745|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
146074077|NCT04896086|526790746|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
146074078|NCT04896086|526790747|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
146074079|NCT04896086|526790748|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
146074080|NCT04896086|526790749|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
146074081|NCT02249832|526790752|FG000|Overall Study|Withdrawal by Subject|3|||
146074082|NCT02249832|526790752|FG000|Overall Study|Lost to Follow-up|10|||
146074083|NCT00724867|526790757|FG000|Overall Study|Adverse Event|25|||
146074084|NCT00724867|526790757|FG000|Overall Study|Lack of Efficacy|14|||
146074085|NCT00724867|526790757|FG000|Overall Study|Lost to Follow-up|12|||
146074086|NCT00724867|526790757|FG000|Overall Study|Non-compliance with study drug|6|||
146074087|NCT00724867|526790757|FG000|Overall Study|Physician Decision|17|||
146074088|NCT00724867|526790757|FG000|Overall Study|Protocol Violation|1|||
146074089|NCT00724867|526790757|FG000|Overall Study|Withdrawal by Subject|31|||
146074090|NCT00724867|526790757|FG000|Overall Study|Sponsor decision to end study|14|||
146074091|NCT00724867|526790757|FG000|Overall Study|Subject incarcerated|1|||
146074092|NCT00724867|526790757|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
146074093|NCT00724867|526790757|FG000|Overall Study|Subject moved out of state|1|||
146074094|NCT00724867|526790757|FG000|Overall Study|Elected to exit due to site closure|2|||
146074095|NCT00436345|526790758|FG000|Overall Study|ICU resident beyond follow-up period|3|||
146074096|NCT00436345|526790759|FG001|Overall Study|ICU resident beyond follow-up period|0|||
146074097|NCT01175083|526790760|FG000|Primary Epoch|Withdrawal by Subject|0|||
146074098|NCT01175083|526790761|FG001|Primary Epoch|Withdrawal by Subject|0|||
146074099|NCT01175083|526790762|FG002|Primary Epoch|Withdrawal by Subject|0|||
146074100|NCT01175083|526790763|FG003|Primary Epoch|Withdrawal by Subject|0|||
146074101|NCT01175083|526790764|FG004|Primary Epoch|Withdrawal by Subject|0|||
146074102|NCT01175083|526790765|FG005|Primary Epoch|Withdrawal by Subject|2|||
146074103|NCT01175083|526790760|FG000|Primary Epoch|Lost to Follow-up|0|||
146074104|NCT01175083|526790761|FG001|Primary Epoch|Lost to Follow-up|0|||
146074105|NCT01175083|526790762|FG002|Primary Epoch|Lost to Follow-up|0|||
146074106|NCT01175083|526790763|FG003|Primary Epoch|Lost to Follow-up|0|||
146074107|NCT01175083|526790764|FG004|Primary Epoch|Lost to Follow-up|0|||
146074108|NCT01175083|526790765|FG005|Primary Epoch|Lost to Follow-up|1|||
146074109|NCT01175083|526790760|FG000|Booster Epoch|Death|0|||
146074110|NCT01175083|526790761|FG001|Booster Epoch|Death|0|||
146074111|NCT01175083|526790762|FG002|Booster Epoch|Death|1|||
146074112|NCT01175083|526790763|FG003|Booster Epoch|Death|0|||
146074113|NCT01175083|526790764|FG004|Booster Epoch|Death|0|||
146074114|NCT01175083|526790765|FG005|Booster Epoch|Death|0|||
146074115|NCT01175083|526790760|FG000|Booster Epoch|Withdrawal by Subject|0|||
146074116|NCT01175083|526790761|FG001|Booster Epoch|Withdrawal by Subject|0|||
146074117|NCT01175083|526790762|FG002|Booster Epoch|Withdrawal by Subject|0|||
146074118|NCT01175083|526790763|FG003|Booster Epoch|Withdrawal by Subject|1|||
146074119|NCT01175083|526790764|FG004|Booster Epoch|Withdrawal by Subject|0|||
146074120|NCT01175083|526790765|FG005|Booster Epoch|Withdrawal by Subject|0|||
146074121|NCT04027608|526790766|FG000|Overall Study|Withdrawal by Subject|13|||
146074122|NCT04027608|526790767|FG001|Overall Study|Withdrawal by Subject|2|||
146074123|NCT04027608|526790766|FG000|Overall Study|Protocol Violation|2|||
146074124|NCT04027608|526790767|FG001|Overall Study|Protocol Violation|1|||
146074125|NCT04027608|526790766|FG000|Overall Study|Physician Decision|1|||
146074126|NCT04027608|526790767|FG001|Overall Study|Physician Decision|0|||
146173958|NCT01036022|527149092|FG004|Overall Study|Withdrawal by Subject|2|||
146173959|NCT01036022|527149093|FG005|Overall Study|Withdrawal by Subject|0|||
146173960|NCT02087501|527149094|FG000|Overall Study|Death|7|||
146173961|NCT02087501|527149094|FG000|Overall Study|Open repair of aneurysm|1|||
146173962|NCT02087501|527149094|FG000|Overall Study|Lost to Follow-up|2|||
146173963|NCT00265330|527149095|FG000|Overall Study|Adverse Event|41|||
146173964|NCT00265330|527149095|FG000|Overall Study|Lost to Follow-up|8|||
146173965|NCT00265330|527149095|FG000|Overall Study|Withdrawal by Subject|34|||
146173966|NCT00265330|527149095|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
146173967|NCT00265330|527149095|FG000|Overall Study|Lack of Efficacy|4|||
146173968|NCT00265330|527149095|FG000|Overall Study|Family Scheduling Conflicts|1|||
146173969|NCT00265330|527149095|FG000|Overall Study|Began Taking Formulary Geodon|1|||
146173970|NCT00265330|527149095|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
146173971|NCT00265330|527149095|FG000|Overall Study|Site Closed by Sponsor|1|||
146173972|NCT00265330|527149095|FG000|Overall Study|Principal Investigators Request|1|||
146173973|NCT00265330|527149095|FG000|Overall Study|Withdrew Consent|1|||
146173974|NCT00265330|527149095|FG000|Overall Study|Protocol Violation|1|||
146173975|NCT03403426|527149108|FG000|Overall Study|Death|1|||
146173976|NCT03403426|527149108|FG000|Overall Study|Lost to Follow-up|2|||
146173977|NCT03520400|527149111|FG000|Overall Study|Physician Decision|15|||
146173978|NCT03520400|527149112|FG001|Overall Study|Physician Decision|7|||
146173979|NCT01933880|527149113|FG000|Overall Study|Withdrawal by Subject|5|||
146173980|NCT01933880|527149114|FG001|Overall Study|Withdrawal by Subject|0|||
146173981|NCT01933880|527149113|FG000|Overall Study|Lack of Efficacy|1|||
146173982|NCT01933880|527149114|FG001|Overall Study|Lack of Efficacy|0|||
146173983|NCT01933880|527149113|FG000|Overall Study|Concomitant medication Interference|0|||
146173984|NCT01933880|527149114|FG001|Overall Study|Concomitant medication Interference|1|||
146173985|NCT01933880|527149113|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
146173986|NCT01933880|527149114|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
146173987|NCT01933880|527149113|FG000|Overall Study|Other|4|||
146173988|NCT01933880|527149114|FG001|Overall Study|Other|0|||
146173989|NCT01933880|527149113|FG000|Overall Study|Protocol Violation|1|||
146173990|NCT01933880|527149114|FG001|Overall Study|Protocol Violation|0|||
146173991|NCT00510458|527149115|FG000|Overall Study|5 year not evaluable/missed|21|||
146173992|NCT00510458|527149115|FG000|Overall Study|Death|1|||
146173993|NCT00510458|527149115|FG000|Overall Study|Terminated|14|||
146173994|NCT00510458|527149115|FG000|Overall Study|Lost to Follow-up|6|||
146173995|NCT00510458|527149115|FG000|Overall Study|Withdrawal by Subject|3|||
146173996|NCT00510458|527149115|FG000|Overall Study|Revision|2|||
146173997|NCT03474549|527149116|FG000|Overall Study|Death|31|||
146173998|NCT03474549|527149116|FG000|Overall Study|Lost to Follow-up|4|||
146173999|NCT03474549|527149116|FG000|Overall Study|Withdrawal by Subject|2|||
146174000|NCT00738101|527149119|FG000|Overall Study|Physician Decision|5|||
146174001|NCT00738101|527149119|FG000|Overall Study|Death|1|||
146174002|NCT00738101|527149119|FG000|Overall Study|Repeat enrollment|1|||
146174003|NCT00709059|527149124|FG000|Overall Study|Lost to Follow-up|34|||
146174004|NCT00709059|527149124|FG000|Overall Study|Withdrawal by Subject|19|||
146174005|NCT00709059|527149124|FG000|Overall Study|Physician Decision|7|||
146174006|NCT00709059|527149124|FG000|Overall Study|Disease complication|3|||
146174007|NCT00709059|527149124|FG000|Overall Study|Side effects|20|||
146174008|NCT00709059|527149124|FG000|Overall Study|Serious side effects|11|||
146174009|NCT01396317|527149125|FG000|Overall Study|Adverse Event|1|||
146174010|NCT01396317|527149126|FG001|Overall Study|Adverse Event|0|||
146174011|NCT03315130|527149127|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146174012|NCT03315130|527149128|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
146174013|NCT03315130|527149129|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146174014|NCT03315130|527149130|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
146174015|NCT03315130|527149127|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146174016|NCT03315130|527149128|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
146174017|NCT03315130|527149129|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146174018|NCT03315130|527149130|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
146174019|NCT03315130|527149127|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
146174020|NCT03315130|527149128|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146283906|NCT01021215|527551877|FG000|Overall Study|Lost to Follow-up|3|||
146074127|NCT04027608|526790766|FG000|Overall Study|Lost to Follow-up|20|||
146074128|NCT04027608|526790767|FG001|Overall Study|Lost to Follow-up|4|||
146074129|NCT01349959|526790774|FG000|Overall Study|Adverse Event|7|||
146074130|NCT02675634|526790775|FG000|Test Period 1|Adverse Event|0|||
146074131|NCT02675634|526790776|FG001|Test Period 1|Adverse Event|1|||
146074132|NCT02675634|526790777|FG002|Test Period 1|Adverse Event|0|||
146074133|NCT02675634|526790778|FG003|Test Period 1|Adverse Event|1|||
146074134|NCT02675634|526790779|FG004|Test Period 1|Adverse Event|0|||
146074135|NCT02675634|526790780|FG005|Test Period 1|Adverse Event|0|||
146074136|NCT02675634|526790775|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
146074137|NCT02675634|526790776|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
146074138|NCT02675634|526790777|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
146074139|NCT02675634|526790778|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
146074140|NCT02675634|526790779|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
146074141|NCT02675634|526790780|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
146174021|NCT03315130|527149129|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146174022|NCT03315130|527149130|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
146174023|NCT03315130|527149127|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146174024|NCT03315130|527149128|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
146174025|NCT03315130|527149129|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146174026|NCT03315130|527149130|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
146174027|NCT03315130|527149127|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146174028|NCT03315130|527149128|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
146174029|NCT03315130|527149129|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146174030|NCT03315130|527149130|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
146174031|NCT03315130|527149127|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
146174032|NCT03315130|527149128|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
146174033|NCT03315130|527149129|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
146174034|NCT03315130|527149130|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
146174035|NCT02089230|527149131|FG000|Overall Study|Death|0|||
146174036|NCT02089230|527149132|FG001|Overall Study|Death|0|||
146174037|NCT02089230|527149133|FG002|Overall Study|Death|2|||
146174038|NCT02089230|527149131|FG000|Overall Study|Seeking Alternative Therapy|0|||
146174039|NCT02089230|527149132|FG001|Overall Study|Seeking Alternative Therapy|0|||
146174040|NCT02089230|527149133|FG002|Overall Study|Seeking Alternative Therapy|4|||
146174041|NCT04867785|527151242|FG000|Overall Study|Adverse Event|1|||
146174042|NCT04867785|527151243|FG001|Overall Study|Adverse Event|0|||
146174043|NCT04867785|527151244|FG002|Overall Study|Adverse Event|1|||
146174044|NCT04867785|527151245|FG003|Overall Study|Adverse Event|0|||
146174045|NCT04867785|527151246|FG004|Overall Study|Adverse Event|0|||
146174046|NCT04867785|527151247|FG005|Overall Study|Adverse Event|0|||
146174047|NCT04867785|527151248|FG006|Overall Study|Adverse Event|0|||
146174048|NCT04867785|527151249|FG007|Overall Study|Adverse Event|2|||
146174049|NCT04867785|527151242|FG000|Overall Study|Lost to Follow-up|4|||
146174050|NCT04867785|527151243|FG001|Overall Study|Lost to Follow-up|4|||
146174051|NCT04867785|527151244|FG002|Overall Study|Lost to Follow-up|3|||
146174052|NCT04867785|527151245|FG003|Overall Study|Lost to Follow-up|2|||
146174053|NCT04867785|527151246|FG004|Overall Study|Lost to Follow-up|0|||
146174054|NCT04867785|527151247|FG005|Overall Study|Lost to Follow-up|1|||
146174055|NCT04867785|527151248|FG006|Overall Study|Lost to Follow-up|0|||
146174056|NCT04867785|527151249|FG007|Overall Study|Lost to Follow-up|1|||
146174057|NCT04867785|527151242|FG000|Overall Study|Withdrawal by Subject|6|||
146174058|NCT04867785|527151243|FG001|Overall Study|Withdrawal by Subject|2|||
146174059|NCT04867785|527151244|FG002|Overall Study|Withdrawal by Subject|2|||
146174060|NCT04867785|527151245|FG003|Overall Study|Withdrawal by Subject|1|||
146174061|NCT04867785|527151246|FG004|Overall Study|Withdrawal by Subject|2|||
146174062|NCT04867785|527151247|FG005|Overall Study|Withdrawal by Subject|0|||
146174063|NCT04867785|527151248|FG006|Overall Study|Withdrawal by Subject|2|||
146174064|NCT04867785|527151249|FG007|Overall Study|Withdrawal by Subject|5|||
146174065|NCT04867785|527151242|FG000|Overall Study|Physician Decision|0|||
146174066|NCT04867785|527151243|FG001|Overall Study|Physician Decision|0|||
146174067|NCT04867785|527151244|FG002|Overall Study|Physician Decision|0|||
146174068|NCT04867785|527151245|FG003|Overall Study|Physician Decision|0|||
146174069|NCT04867785|527151246|FG004|Overall Study|Physician Decision|0|||
146174070|NCT04867785|527151247|FG005|Overall Study|Physician Decision|0|||
146174071|NCT04867785|527151248|FG006|Overall Study|Physician Decision|0|||
146174072|NCT04867785|527151249|FG007|Overall Study|Physician Decision|1|||
146174073|NCT04867785|527151242|FG000|Overall Study|Inadvertent Enrollment|0|||
146174074|NCT04867785|527151243|FG001|Overall Study|Inadvertent Enrollment|0|||
146410520|NCT00207714|528009376|FG001|Overall Study|Other|2|||
146410521|NCT00207714|528009377|FG002|Overall Study|Other|5|||
146410522|NCT00207714|528009378|FG003|Overall Study|Other|1|||
146410523|NCT00207714|528009379|FG004|Overall Study|Other|0|||
146410524|NCT03627195|528009380|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
146410525|NCT03627195|528009381|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146410526|NCT03627195|528009382|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146410527|NCT03627195|528009383|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146410528|NCT03627195|528009384|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146410529|NCT03627195|528009385|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
146410530|NCT02290028|528009388|FG000|Overall Study|Death|217|||
146410531|NCT02290028|528009388|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
146410532|NCT02290028|528009388|FG000|Overall Study|No longer under care of study physician|76|||
146410533|NCT02290028|528009388|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
146410534|NCT02290028|528009388|FG000|Overall Study|Withdrawal by Subject|52|||
146410535|NCT02290028|528009388|FG000|Overall Study|Study site closure|44|||
146410536|NCT02290028|528009388|FG000|Overall Study|Lost to Follow-up|34|||
146410537|NCT02290028|528009388|FG000|Overall Study|Miscellaneous|10|||
146410538|NCT02290028|528009388|FG000|Overall Study|Transition to EP PASSION|1295|||
146410539|NCT02290028|528009388|FG000|Overall Study|Planned study completion at 12 months|257|||
146410540|NCT01681771|528009389|FG000|Overall Study|Lost to Follow-up|4|||
146410541|NCT01681771|528009390|FG001|Overall Study|Lost to Follow-up|2|||
146410542|NCT04242186|528009393|FG000|Overall Study|Death|5|||
146410543|NCT00331773|528009394|FG000|Overall Study|Withdrawal by Subject|6|||
146410544|NCT00331773|528009395|FG001|Overall Study|Withdrawal by Subject|4|||
146410545|NCT00331773|528009394|FG000|Overall Study|Protocol Violation|10|||
146410546|NCT00331773|528009395|FG001|Overall Study|Protocol Violation|3|||
146410547|NCT01792284|528009396|FG000|Lead-in Period|Adverse Event|15|||
146410548|NCT01792284|528009397|FG001|Lead-in Period|Adverse Event|0|||
146410549|NCT01792284|528009398|FG002|Lead-in Period|Adverse Event|0|||
146410550|NCT01792284|528009396|FG000|Lead-in Period|Lost to Follow-up|2|||
146410551|NCT01792284|528009397|FG001|Lead-in Period|Lost to Follow-up|0|||
146410552|NCT01792284|528009398|FG002|Lead-in Period|Lost to Follow-up|0|||
146410553|NCT01792284|528009396|FG000|Lead-in Period|Protocol Violation|1|||
146410554|NCT01792284|528009397|FG001|Lead-in Period|Protocol Violation|0|||
146410555|NCT01792284|528009398|FG002|Lead-in Period|Protocol Violation|0|||
146410556|NCT01792284|528009396|FG000|Lead-in Period|Withdrawal by Subject|10|||
146074142|NCT02675634|526790775|FG000|Test Period 2|Lack of Efficacy|1|||
146074143|NCT02675634|526790776|FG001|Test Period 2|Lack of Efficacy|0|||
146074144|NCT02675634|526790777|FG002|Test Period 2|Lack of Efficacy|0|||
146074145|NCT02675634|526790778|FG003|Test Period 2|Lack of Efficacy|0|||
146074146|NCT02675634|526790779|FG004|Test Period 2|Lack of Efficacy|0|||
146074147|NCT02675634|526790780|FG005|Test Period 2|Lack of Efficacy|0|||
146074148|NCT02675634|526790775|FG000|Test Period 2|Adverse Event|0|||
146074149|NCT02675634|526790776|FG001|Test Period 2|Adverse Event|0|||
146074150|NCT02675634|526790777|FG002|Test Period 2|Adverse Event|0|||
146074151|NCT02675634|526790778|FG003|Test Period 2|Adverse Event|0|||
146074152|NCT02675634|526790779|FG004|Test Period 2|Adverse Event|0|||
146074153|NCT02675634|526790780|FG005|Test Period 2|Adverse Event|1|||
146074154|NCT01941186|526790781|FG000|Follow-up|Lost to Follow-up|1|||
146074155|NCT01941186|526790782|FG001|Follow-up|Lost to Follow-up|0|||
146074156|NCT02105961|526790783|FG000|Overall Study|Adverse Event|18|||
146074157|NCT02105961|526790784|FG001|Overall Study|Adverse Event|7|||
146074158|NCT02105961|526790785|FG002|Overall Study|Adverse Event|13|||
146074159|NCT02105961|526790783|FG000|Overall Study|Lack of Efficacy|3|||
146074160|NCT02105961|526790784|FG001|Overall Study|Lack of Efficacy|0|||
146074161|NCT02105961|526790785|FG002|Overall Study|Lack of Efficacy|3|||
146074162|NCT02105961|526790783|FG000|Overall Study|Lost to Follow-up|2|||
146074163|NCT02105961|526790784|FG001|Overall Study|Lost to Follow-up|0|||
146074164|NCT02105961|526790785|FG002|Overall Study|Lost to Follow-up|1|||
146074165|NCT02105961|526790783|FG000|Overall Study|Physician Decision|3|||
146074166|NCT02105961|526790784|FG001|Overall Study|Physician Decision|3|||
146074167|NCT02105961|526790785|FG002|Overall Study|Physician Decision|2|||
146074168|NCT02105961|526790783|FG000|Overall Study|Withdrawal by Subject|15|||
146074169|NCT02105961|526790784|FG001|Overall Study|Withdrawal by Subject|7|||
146074170|NCT02105961|526790785|FG002|Overall Study|Withdrawal by Subject|11|||
146074171|NCT03860259|526790786|FG000|Overall Study|Lost to Follow-up|5|||
146074172|NCT03860259|526790787|FG001|Overall Study|Lost to Follow-up|5|||
146074173|NCT03860259|526790786|FG000|Overall Study|Protocol Violation|1|||
146074174|NCT03860259|526790787|FG001|Overall Study|Protocol Violation|0|||
146074175|NCT00934362|526790788|FG000|Overall Study|Adverse Event|1|||
146074176|NCT00934362|526790789|FG001|Overall Study|Adverse Event|0|||
146074177|NCT04154189|526790790|FG000|Overall Study|Withdrawal by Subject|4|||
146074178|NCT04154189|526790791|FG001|Overall Study|Withdrawal by Subject|6|||
146074179|NCT04154189|526790790|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
146074180|NCT04154189|526790791|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
146074181|NCT04154189|526790790|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
146074182|NCT04154189|526790791|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
146074183|NCT04154189|526790790|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
146074184|NCT04154189|526790791|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
146074185|NCT04154189|526790790|FG000|Overall Study|Death|25|||
146074186|NCT04154189|526790791|FG001|Overall Study|Death|25|||
146074187|NCT02280408|526790792|FG000|Overall Study|Lost to Follow-up|0|||
146074188|NCT02280408|526790793|FG001|Overall Study|Lost to Follow-up|2|||
146074189|NCT02280408|526790794|FG002|Overall Study|Lost to Follow-up|0|||
146074190|NCT02280408|526790795|FG003|Overall Study|Lost to Follow-up|0|||
146074191|NCT01092117|526790796|FG000|Index Procedure to 1 Month|Death|1|||
146074192|NCT01092117|526790796|FG000|1 Month|Death|1|||
146074193|NCT01092117|526790796|FG000|1 Month|Withdrawal by Subject|1|||
146074194|NCT01092117|526790796|FG000|1 Month|Lost to Follow-up|1|||
146074195|NCT01092117|526790796|FG000|6 Months|Death|2|||
146074196|NCT01092117|526790796|FG000|6 Months|Withdrawal by Subject|3|||
146074197|NCT01092117|526790796|FG000|12 Month|Death|11|||
146074198|NCT01092117|526790796|FG000|12 Month|Withdrawal by Subject|2|||
146074199|NCT01092117|526790796|FG000|12 Month|Lost to Follow-up|1|||
146074200|NCT01092117|526790796|FG000|Year 2|Death|5|||
146074201|NCT01092117|526790796|FG000|Year 2|Withdrawal by Subject|4|||
146074202|NCT01092117|526790796|FG000|Year 2|Lost to Follow-up|1|||
146074203|NCT01092117|526790796|FG000|Year 3|Death|7|||
146074204|NCT01092117|526790796|FG000|Year 3|Withdrawal by Subject|9|||
146074205|NCT01092117|526790796|FG000|Year 3|Lost to Follow-up|3|||
146074206|NCT01092117|526790796|FG000|Year 4|Death|8|||
146074207|NCT01092117|526790796|FG000|Year 4|Withdrawal by Subject|4|||
146074208|NCT01092117|526790796|FG000|Year 4|Lost to Follow-up|4|||
146074209|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
146074210|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
146074211|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
146074212|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
146074213|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
146074214|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
146074215|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
146074216|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
146074217|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
146074218|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
146074219|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
146074220|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
146074221|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
146074222|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
146074223|NCT04173494|526790797|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
146074224|NCT04173494|526790798|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
146074225|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
146174075|NCT04867785|527151244|FG002|Overall Study|Inadvertent Enrollment|0|||
146174076|NCT04867785|527151245|FG003|Overall Study|Inadvertent Enrollment|1|||
146174077|NCT04867785|527151246|FG004|Overall Study|Inadvertent Enrollment|1|||
146174078|NCT04867785|527151247|FG005|Overall Study|Inadvertent Enrollment|0|||
146174079|NCT04867785|527151248|FG006|Overall Study|Inadvertent Enrollment|0|||
146174080|NCT04867785|527151249|FG007|Overall Study|Inadvertent Enrollment|1|||
146174081|NCT04867785|527151242|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146174082|NCT04867785|527151243|FG001|Overall Study|Eligibility Criteria Not Met|0|||
146174083|NCT04867785|527151244|FG002|Overall Study|Eligibility Criteria Not Met|0|||
146174084|NCT04867785|527151245|FG003|Overall Study|Eligibility Criteria Not Met|0|||
146174085|NCT04867785|527151246|FG004|Overall Study|Eligibility Criteria Not Met|0|||
146174086|NCT04867785|527151247|FG005|Overall Study|Eligibility Criteria Not Met|0|||
146174087|NCT04867785|527151248|FG006|Overall Study|Eligibility Criteria Not Met|0|||
146174088|NCT04867785|527151249|FG007|Overall Study|Eligibility Criteria Not Met|1|||
146174089|NCT02494921|527151250|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
146174090|NCT02494921|527151251|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
146174091|NCT02494921|527151252|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
146174092|NCT02494921|527151253|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
146174093|NCT02494921|527151254|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
146174094|NCT02494921|527151250|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
146174095|NCT02494921|527151251|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
146174096|NCT02494921|527151252|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
146174097|NCT02494921|527151253|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
146174098|NCT02494921|527151254|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
146174099|NCT02494921|527151250|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
146174100|NCT02494921|527151251|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
146174101|NCT02494921|527151252|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
146174102|NCT02494921|527151253|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
146174103|NCT02494921|527151254|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
146410557|NCT01792284|528009397|FG001|Lead-in Period|Withdrawal by Subject|0|||
146410558|NCT01792284|528009398|FG002|Lead-in Period|Withdrawal by Subject|0|||
146410559|NCT01792284|528009396|FG000|Lead-in Period|Physician Decision|1|||
146410560|NCT01792284|528009397|FG001|Lead-in Period|Physician Decision|0|||
146410561|NCT01792284|528009398|FG002|Lead-in Period|Physician Decision|0|||
146410562|NCT01792284|528009396|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
146410563|NCT01792284|528009397|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
146410564|NCT01792284|528009398|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
146410565|NCT01792284|528009396|FG000|Randomization Period 1|Withdrawal by Subject|0|||
146410566|NCT01792284|528009397|FG001|Randomization Period 1|Withdrawal by Subject|1|||
146410567|NCT01792284|528009398|FG002|Randomization Period 1|Withdrawal by Subject|1|||
146410568|NCT01792284|528009396|FG000|Randomization Period 1|Physician Decision|0|||
146410569|NCT01792284|528009397|FG001|Randomization Period 1|Physician Decision|1|||
146410570|NCT01792284|528009398|FG002|Randomization Period 1|Physician Decision|1|||
146410571|NCT01792284|528009396|FG000|Randomization Period 1|Adverse Event|0|||
146410572|NCT01792284|528009397|FG001|Randomization Period 1|Adverse Event|0|||
146410573|NCT01792284|528009398|FG002|Randomization Period 1|Adverse Event|2|||
146410574|NCT01792284|528009396|FG000|Randomization Period 1|Lost to Follow-up|0|||
146410575|NCT01792284|528009397|FG001|Randomization Period 1|Lost to Follow-up|0|||
146410576|NCT01792284|528009398|FG002|Randomization Period 1|Lost to Follow-up|1|||
146410577|NCT01792284|528009396|FG000|Randomization Period 2|Protocol Violation|0|||
146410578|NCT01792284|528009397|FG001|Randomization Period 2|Protocol Violation|1|||
146410579|NCT01792284|528009398|FG002|Randomization Period 2|Protocol Violation|0|||
146410580|NCT01792284|528009396|FG000|Randomization Period 2|Withdrawal by Subject|0|||
146410581|NCT01792284|528009397|FG001|Randomization Period 2|Withdrawal by Subject|2|||
146410582|NCT01792284|528009398|FG002|Randomization Period 2|Withdrawal by Subject|0|||
146410583|NCT00379587|528009404|FG000|Overall Study|Lost to Follow-up|2|||
146410584|NCT00054275|528009407|FG000|Overall Study|Withdrawal by Subject|4|||
146410585|NCT00054275|528009407|FG000|Overall Study|Adverse Event|5|||
146410586|NCT00054275|528009407|FG000|Overall Study|Progressive disease in cycle 1|1|||
146410587|NCT00054275|528009407|FG000|Overall Study|Physician Decision|1|||
146410588|NCT00755937|528009408|FG000|Recruitment|Unknown if infliximab received|164|||
146410589|NCT00755937|528009408|FG000|Observational Follow-up|Lost to Follow-up|148|||
146410590|NCT01106352|528009409|FG000|Overall Study|Subjects untreated|0|||
146410591|NCT01106352|528009410|FG001|Overall Study|Subjects untreated|0|||
146410592|NCT01106352|528009411|FG002|Overall Study|Subjects untreated|0|||
146410593|NCT01106352|528009412|FG003|Overall Study|Subjects untreated|3|||
146410594|NCT01106352|528009413|FG004|Overall Study|Subjects untreated|4|||
146410595|NCT01106352|528009409|FG000|Overall Study|Sponsor Decision|1|||
146410596|NCT01106352|528009410|FG001|Overall Study|Sponsor Decision|0|||
146410597|NCT01106352|528009411|FG002|Overall Study|Sponsor Decision|0|||
146410598|NCT01106352|528009412|FG003|Overall Study|Sponsor Decision|0|||
146410599|NCT01106352|528009413|FG004|Overall Study|Sponsor Decision|0|||
146410600|NCT01106352|528009409|FG000|Overall Study|Too ill to come in for the visit|0|||
146410601|NCT01106352|528009410|FG001|Overall Study|Too ill to come in for the visit|0|||
146174104|NCT03239873|527151255|FG000|Overall Study|Lost to Follow-up|15|||
146174105|NCT03239873|527151256|FG001|Overall Study|Lost to Follow-up|16|||
146174106|NCT03239873|527151255|FG000|Overall Study|Physician Decision|1|||
146174107|NCT03239873|527151256|FG001|Overall Study|Physician Decision|0|||
146174108|NCT03239873|527151255|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
146174109|NCT03239873|527151256|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
146174110|NCT03239873|527151255|FG000|Overall Study|Withdrawal by Subject|2|||
146283907|NCT01021215|527551878|FG001|Overall Study|Lost to Follow-up|0|||
146174111|NCT03239873|527151256|FG001|Overall Study|Withdrawal by Subject|0|||
146174112|NCT03239873|527151255|FG000|Overall Study|Contraindication to study medication|1|||
146174113|NCT03239873|527151256|FG001|Overall Study|Contraindication to study medication|0|||
146174114|NCT03239873|527151255|FG000|Overall Study|Protocol Violation|1|||
146074226|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
146074227|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
146074228|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
146074229|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
146074230|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
146074231|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
146074232|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
146074233|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
146074234|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
146074235|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
146074236|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
146074237|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
146074238|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
146074239|NCT04173494|526790797|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
146074240|NCT04173494|526790798|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
146074241|NCT02474069|526790799|FG000|Selection Phase (SP)|Adverse Event|8|||
146074242|NCT02474069|526790800|FG001|Selection Phase (SP)|Adverse Event|0|||
146074243|NCT02474069|526790801|FG002|Selection Phase (SP)|Adverse Event|0|||
146074244|NCT02474069|526790799|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
146074245|NCT02474069|526790800|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
146074246|NCT02474069|526790801|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
146074247|NCT02474069|526790799|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
146074248|NCT02474069|526790800|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
146074249|NCT02474069|526790801|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
146074250|NCT02474069|526790799|FG000|Selection Phase (SP)|Physician Decision|1|||
146074251|NCT02474069|526790800|FG001|Selection Phase (SP)|Physician Decision|0|||
146074252|NCT02474069|526790801|FG002|Selection Phase (SP)|Physician Decision|0|||
146074253|NCT02474069|526790799|FG000|Selection Phase (SP)|Protocol Violation|1|||
146074254|NCT02474069|526790800|FG001|Selection Phase (SP)|Protocol Violation|0|||
146074255|NCT02474069|526790801|FG002|Selection Phase (SP)|Protocol Violation|0|||
146074256|NCT02474069|526790799|FG000|Selection Phase (SP)|No longer requires treatment|1|||
146074257|NCT02474069|526790800|FG001|Selection Phase (SP)|No longer requires treatment|0|||
146074258|NCT02474069|526790801|FG002|Selection Phase (SP)|No longer requires treatment|0|||
146074259|NCT02474069|526790799|FG000|Selection Phase (SP)|Technical Problem|1|||
146074260|NCT02474069|526790800|FG001|Selection Phase (SP)|Technical Problem|0|||
146074261|NCT02474069|526790801|FG002|Selection Phase (SP)|Technical Problem|0|||
146074262|NCT02474069|526790799|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
146074263|NCT02474069|526790800|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
146074264|NCT02474069|526790801|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
146074265|NCT02474069|526790799|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
146074266|NCT02474069|526790800|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
146074267|NCT02474069|526790801|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
146174115|NCT03239873|527151256|FG001|Overall Study|Protocol Violation|0|||
146174116|NCT01478113|527151266|FG000|Overall Study|Withdrawal by Subject|0|||
146410602|NCT01106352|528009411|FG002|Overall Study|Too ill to come in for the visit|1|||
146410603|NCT01106352|528009412|FG003|Overall Study|Too ill to come in for the visit|0|||
146410604|NCT01106352|528009413|FG004|Overall Study|Too ill to come in for the visit|0|||
146410605|NCT01106352|528009409|FG000|Overall Study|Lost to Follow-up|0|||
146410606|NCT01106352|528009410|FG001|Overall Study|Lost to Follow-up|0|||
146410607|NCT01106352|528009411|FG002|Overall Study|Lost to Follow-up|0|||
146410608|NCT01106352|528009412|FG003|Overall Study|Lost to Follow-up|0|||
146410609|NCT01106352|528009413|FG004|Overall Study|Lost to Follow-up|1|||
146410610|NCT01106352|528009409|FG000|Overall Study|Death|0|||
146410611|NCT01106352|528009410|FG001|Overall Study|Death|0|||
146410612|NCT01106352|528009411|FG002|Overall Study|Death|1|||
146410613|NCT01106352|528009412|FG003|Overall Study|Death|3|||
146410614|NCT01106352|528009413|FG004|Overall Study|Death|1|||
146410615|NCT01106352|528009409|FG000|Overall Study|Disease progression|0|||
146410616|NCT01106352|528009410|FG001|Overall Study|Disease progression|0|||
146410617|NCT01106352|528009411|FG002|Overall Study|Disease progression|0|||
146410618|NCT01106352|528009412|FG003|Overall Study|Disease progression|1|||
146410619|NCT01106352|528009413|FG004|Overall Study|Disease progression|0|||
146410620|NCT01106352|528009409|FG000|Overall Study|Withdrawal by Subject|0|||
146410621|NCT01106352|528009410|FG001|Overall Study|Withdrawal by Subject|0|||
146410622|NCT01106352|528009411|FG002|Overall Study|Withdrawal by Subject|0|||
146410623|NCT01106352|528009412|FG003|Overall Study|Withdrawal by Subject|3|||
146410624|NCT01106352|528009413|FG004|Overall Study|Withdrawal by Subject|2|||
146410625|NCT01106352|528009409|FG000|Overall Study|Went on hospice|0|||
146410626|NCT01106352|528009410|FG001|Overall Study|Went on hospice|0|||
146410627|NCT01106352|528009411|FG002|Overall Study|Went on hospice|0|||
146410628|NCT01106352|528009412|FG003|Overall Study|Went on hospice|1|||
146074268|NCT02474069|526790799|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
146074269|NCT02474069|526790800|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
146074270|NCT02474069|526790801|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
146074271|NCT02474069|526790799|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
146074272|NCT02474069|526790800|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
146074273|NCT02474069|526790801|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
146074274|NCT02474069|526790799|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
146074275|NCT02474069|526790800|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
146074276|NCT02474069|526790801|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
146074277|NCT02474069|526790799|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
146074278|NCT02474069|526790800|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
146074279|NCT02474069|526790801|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
146074280|NCT01623050|526790802|FG000|Overall Study|Lost to Follow-up|9|||
146074281|NCT01191762|526790803|FG000|Overall Study|Adverse Event|1|||
146074282|NCT01191762|526790804|FG001|Overall Study|Adverse Event|0|||
146074283|NCT01519869|526790807|FG000|Overall Study|Lost to Follow-up|1|||
146074284|NCT03023813|526790808|FG000|Overall Study|Lost to Follow-up|1|||
146074285|NCT03023813|526790809|FG001|Overall Study|Lost to Follow-up|2|||
146074286|NCT03023813|526790810|FG002|Overall Study|Lost to Follow-up|0|||
146074287|NCT00202878|526790811|FG000|Overall Study|Death|964|||
146074288|NCT00202878|526790812|FG001|Overall Study|Death|968|||
146074289|NCT00202878|526790811|FG000|Overall Study|Only Vital Status Known|357|||
146074290|NCT00202878|526790812|FG001|Overall Study|Only Vital Status Known|356|||
146074291|NCT00202878|526790811|FG000|Overall Study|Lost to Follow-up|44|||
146074292|NCT00202878|526790812|FG001|Overall Study|Lost to Follow-up|49|||
146074293|NCT00202878|526790811|FG000|Overall Study|Site Closure|39|||
146074294|NCT00202878|526790812|FG001|Overall Study|Site Closure|36|||
146074295|NCT00202878|526790811|FG000|Overall Study|Withdrawal by Subject|795|||
146074296|NCT00202878|526790812|FG001|Overall Study|Withdrawal by Subject|808|||
146074297|NCT02123472|526790814|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
146074298|NCT02123472|526790815|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
146074299|NCT02433080|526790817|FG000|Overall Study|Lost to Follow-up|1|||
146074300|NCT02433080|526790818|FG001|Overall Study|Lost to Follow-up|2|||
146074301|NCT02433080|526790817|FG000|Overall Study|Withdrawal by Subject|0|||
146074302|NCT02433080|526790818|FG001|Overall Study|Withdrawal by Subject|2|||
146074303|NCT03801031|526790819|FG000|Overall Study|Lost to Follow-up|1|||
146074304|NCT03801031|526790820|FG001|Overall Study|Lost to Follow-up|0|||
146074305|NCT03801031|526790819|FG000|Overall Study|Unable to comply|1|||
146074306|NCT03801031|526790820|FG001|Overall Study|Unable to comply|0|||
146074307|NCT03801031|526790819|FG000|Overall Study|Withdrawal by Subject|0|||
146074308|NCT03801031|526790820|FG001|Overall Study|Withdrawal by Subject|1|||
146074309|NCT00126490|526790825|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
146074310|NCT02087423|526790826|FG000|Overall Study|Withdrawal by Subject|20|||
146074311|NCT02087423|526790827|FG001|Overall Study|Withdrawal by Subject|20|||
146074312|NCT02087423|526790828|FG002|Overall Study|Withdrawal by Subject|3|||
146074313|NCT02087423|526790826|FG000|Overall Study|Death|68|||
146074314|NCT02087423|526790827|FG001|Overall Study|Death|207|||
146074315|NCT02087423|526790828|FG002|Overall Study|Death|40|||
146074316|NCT02087423|526790826|FG000|Overall Study|Lost to Follow-up|0|||
146074317|NCT02087423|526790827|FG001|Overall Study|Lost to Follow-up|2|||
146074318|NCT02087423|526790828|FG002|Overall Study|Lost to Follow-up|0|||
146074319|NCT02087423|526790826|FG000|Overall Study|Terminated from study at final DCO|23|||
146074320|NCT02087423|526790827|FG001|Overall Study|Terminated from study at final DCO|36|||
146074321|NCT02087423|526790828|FG002|Overall Study|Terminated from study at final DCO|25|||
146074322|NCT02762370|526790831|FG000|Overall Study|Protocol Violation|1|||
146074323|NCT02762370|526790832|FG001|Overall Study|Protocol Violation|0|||
146074324|NCT04393454|526790836|FG000|Overall Study|Death|1|||
146074325|NCT04393454|526790836|FG000|Overall Study|Lost to Follow-up|1|||
146074326|NCT03304249|526790838|FG000|Overall Study|Lost to Follow-up|8|||
146074327|NCT03304249|526790839|FG001|Overall Study|Lost to Follow-up|10|||
146074328|NCT03304249|526790838|FG000|Overall Study|Withdrawal by Subject|12|||
146074329|NCT03304249|526790839|FG001|Overall Study|Withdrawal by Subject|2|||
146074330|NCT03304249|526790838|FG000|Overall Study|Moved Out of District|4|||
146074331|NCT03304249|526790839|FG001|Overall Study|Moved Out of District|2|||
146074332|NCT00924027|526790840|FG000|Overall Study|Lost to Further Follow-Up|4|||
146174117|NCT01478113|527151267|FG001|Overall Study|Withdrawal by Subject|1|||
146174118|NCT01478113|527151266|FG000|Overall Study|Physician Decision|1|||
146174119|NCT01478113|527151267|FG001|Overall Study|Physician Decision|0|||
146174120|NCT03585296|527151270|FG000|Overall Study|Adverse Event|1|||
146174121|NCT03585296|527151270|FG000|Overall Study|Lost to Follow-up|2|||
146174122|NCT03585296|527151270|FG000|Overall Study|Withdrawal by Subject|2|||
146174123|NCT03980184|527151273|FG000|Overall Study|Dropped out before treatment|2|||
146174124|NCT03980184|527151274|FG001|Overall Study|Dropped out before treatment|2|||
146174125|NCT03980184|527151273|FG000|Overall Study|Lost to Follow-up|11|||
146174126|NCT03980184|527151274|FG001|Overall Study|Lost to Follow-up|13|||
146174127|NCT00462670|527151275|FG000|Overall Study|Adverse Event|3|||
146174128|NCT00462670|527151276|FG001|Overall Study|Adverse Event|5|||
146174129|NCT00462670|527151275|FG000|Overall Study|Lack of Efficacy|1|||
146174130|NCT00462670|527151276|FG001|Overall Study|Lack of Efficacy|0|||
146174131|NCT00462670|527151275|FG000|Overall Study|Protocol Violation|1|||
146174132|NCT00462670|527151276|FG001|Overall Study|Protocol Violation|0|||
146174133|NCT00462670|527151275|FG000|Overall Study|Resolution of signs and symptoms|0|||
146174134|NCT00462670|527151276|FG001|Overall Study|Resolution of signs and symptoms|2|||
146174135|NCT02002884|527151277|FG000|Main Period (MP)|Other|0|||
146174136|NCT02002884|527151278|FG001|Main Period (MP)|Other|3|||
146174137|NCT02002884|527151279|FG002|Main Period (MP)|Other|3|||
146174138|NCT02002884|527151280|FG003|Main Period (MP)|Other|0|||
146174139|NCT02002884|527151277|FG000|Main Period (MP)|Adverse Event|0|||
146174140|NCT02002884|527151278|FG001|Main Period (MP)|Adverse Event|1|||
146174141|NCT02002884|527151279|FG002|Main Period (MP)|Adverse Event|1|||
146174142|NCT02002884|527151280|FG003|Main Period (MP)|Adverse Event|0|||
146174143|NCT02002884|527151277|FG000|Main Period (MP)|Withdrawal by Subject|6|||
146174144|NCT02002884|527151278|FG001|Main Period (MP)|Withdrawal by Subject|2|||
146174145|NCT02002884|527151279|FG002|Main Period (MP)|Withdrawal by Subject|2|||
146174146|NCT02002884|527151280|FG003|Main Period (MP)|Withdrawal by Subject|0|||
146174147|NCT02002884|527151277|FG000|Main Period (MP)|Lost to Follow-up|0|||
146174148|NCT02002884|527151278|FG001|Main Period (MP)|Lost to Follow-up|0|||
146174149|NCT02002884|527151279|FG002|Main Period (MP)|Lost to Follow-up|2|||
146174150|NCT02002884|527151280|FG003|Main Period (MP)|Lost to Follow-up|0|||
146174151|NCT02002884|527151277|FG000|Open-Label Extension Period (OLEX)|Other|0|||
146174152|NCT02002884|527151278|FG001|Open-Label Extension Period (OLEX)|Other|0|||
146174153|NCT02002884|527151279|FG002|Open-Label Extension Period (OLEX)|Other|0|||
146174154|NCT02002884|527151280|FG003|Open-Label Extension Period (OLEX)|Other|24|||
146283908|NCT01942590|527551879|FG000|Overall Study|Withdrawal by Subject|0|||
146410629|NCT01106352|528009413|FG004|Overall Study|Went on hospice|0|||
146410630|NCT01106352|528009409|FG000|Overall Study|Subject entered hospice|0|||
146410631|NCT01106352|528009410|FG001|Overall Study|Subject entered hospice|0|||
146410632|NCT01106352|528009411|FG002|Overall Study|Subject entered hospice|0|||
146410633|NCT01106352|528009412|FG003|Overall Study|Subject entered hospice|1|||
146410634|NCT01106352|528009413|FG004|Overall Study|Subject entered hospice|0|||
146410635|NCT01106352|528009409|FG000|Overall Study|Home hospice since July 2013|0|||
146410636|NCT01106352|528009410|FG001|Overall Study|Home hospice since July 2013|0|||
146410637|NCT01106352|528009411|FG002|Overall Study|Home hospice since July 2013|0|||
146410638|NCT01106352|528009412|FG003|Overall Study|Home hospice since July 2013|1|||
146410639|NCT01106352|528009413|FG004|Overall Study|Home hospice since July 2013|0|||
146410640|NCT03547531|528009414|FG000|Overall Study|not coming in data collection : sick|2|||
146410641|NCT03547531|528009415|FG001|Overall Study|not coming in data collection : sick|2|||
146410642|NCT03547531|528009414|FG000|Overall Study|having family occasion|0|||
146410643|NCT03547531|528009415|FG001|Overall Study|having family occasion|2|||
146410644|NCT03944707|528009416|FG000|Overall Study|Adverse Event|0|||
146410645|NCT03944707|528009417|FG001|Overall Study|Adverse Event|2|||
146410646|NCT03944707|528009416|FG000|Overall Study|Study terminated by sponsor|12|||
146410647|NCT03944707|528009417|FG001|Overall Study|Study terminated by sponsor|7|||
146410648|NCT03944707|528009416|FG000|Overall Study|Subject decision|0|||
146410649|NCT03944707|528009417|FG001|Overall Study|Subject decision|1|||
146410650|NCT03402126|528009425|FG000|Overall Study|Lost to Follow-up|6|||
146410651|NCT03402126|528009425|FG000|Overall Study|Protocol Violation|10|||
146410652|NCT03402126|528009425|FG000|Overall Study|Sponsor request/Study termination|29|||
146410653|NCT03402126|528009425|FG000|Overall Study|Study product no longer in use|1|||
146410654|NCT03402126|528009425|FG000|Overall Study|Technical problems|1|||
146410655|NCT03402126|528009425|FG000|Overall Study|Withdrawal by Subject|6|||
146410656|NCT03402126|528009425|FG000|Overall Study|Physician Decision|2|||
146410657|NCT03402126|528009425|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
146410658|NCT03402126|528009425|FG000|Overall Study|Death|4|||
146410659|NCT02444182|528009426|FG000|Overall Study|non-compliance|2|||
146410660|NCT02444182|528009427|FG001|Overall Study|non-compliance|1|||
146410661|NCT02444182|528009426|FG000|Overall Study|Lost to Follow-up|0|||
146410662|NCT02444182|528009427|FG001|Overall Study|Lost to Follow-up|4|||
146410663|NCT01959230|528009430|FG000|Overall Study|Failure to follow study procedures|0|||
146174155|NCT02002884|527151277|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146174156|NCT02002884|527151278|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146074333|NCT00924027|526790841|FG001|Overall Study|Lost to Further Follow-Up|0|||
146074334|NCT00924027|526790842|FG002|Overall Study|Lost to Further Follow-Up|0|||
146074335|NCT00924027|526790843|FG003|Overall Study|Lost to Further Follow-Up|0|||
146074336|NCT00924027|526790840|FG000|Overall Study|Physician Decision|1|||
146074337|NCT00924027|526790841|FG001|Overall Study|Physician Decision|0|||
146074338|NCT00924027|526790842|FG002|Overall Study|Physician Decision|0|||
146074339|NCT00924027|526790843|FG003|Overall Study|Physician Decision|1|||
146074340|NCT00924027|526790840|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
146074341|NCT00924027|526790841|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
146074342|NCT00924027|526790842|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
146074343|NCT00924027|526790843|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
146074344|NCT00924027|526790840|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
146074345|NCT00924027|526790841|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
146074346|NCT00924027|526790842|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
146074347|NCT00924027|526790843|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
146074348|NCT00924027|526790840|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
146074349|NCT00924027|526790841|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
146074350|NCT00924027|526790842|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
146074351|NCT00924027|526790843|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
146074352|NCT04549545|526792737|FG000|Initial Period|Withdrawal by Subject|4|||
146074353|NCT04549545|526792738|FG001|Initial Period|Withdrawal by Subject|0|||
146074354|NCT04549545|526792737|FG000|Initial Period|Additional ENT Procedure|3|||
146074355|NCT04549545|526792738|FG001|Initial Period|Additional ENT Procedure|0|||
146074356|NCT04549545|526792737|FG000|Initial Period|Lost to Follow-up|3|||
146074357|NCT04549545|526792738|FG001|Initial Period|Lost to Follow-up|1|||
146074358|NCT04549545|526792737|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
146074359|NCT04549545|526792738|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
146074360|NCT04549545|526792737|FG000|Crossover Period|Additional ENT Procedure|0|||
146074361|NCT04549545|526792738|FG001|Crossover Period|Additional ENT Procedure|6|||
146074362|NCT04549545|526792737|FG000|Crossover Period|Lost to Follow-up|0|||
146074363|NCT04549545|526792738|FG001|Crossover Period|Lost to Follow-up|1|||
146074364|NCT04549545|526792737|FG000|Crossover Period|Withdrawal by Subject|0|||
146074365|NCT04549545|526792738|FG001|Crossover Period|Withdrawal by Subject|4|||
146074366|NCT01395524|526792743|FG000|Overall Study|Non-compliance with study schedule|1|||
146074367|NCT01395524|526792744|FG001|Overall Study|Non-compliance with study schedule|0|||
146074368|NCT01395524|526792745|FG002|Overall Study|Non-compliance with study schedule|1|||
146074369|NCT01395524|526792743|FG000|Overall Study|Lost to Follow-up|3|||
146074370|NCT01395524|526792744|FG001|Overall Study|Lost to Follow-up|1|||
146074371|NCT01395524|526792745|FG002|Overall Study|Lost to Follow-up|1|||
146074372|NCT01395524|526792743|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
146074373|NCT01395524|526792744|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
146074374|NCT01395524|526792745|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
146074375|NCT01395524|526792743|FG000|Overall Study|Severe noncompliance with protocol|1|||
146074376|NCT01395524|526792744|FG001|Overall Study|Severe noncompliance with protocol|0|||
146074377|NCT01395524|526792745|FG002|Overall Study|Severe noncompliance with protocol|0|||
146074378|NCT01395524|526792743|FG000|Overall Study|Adverse Event|4|||
146074379|NCT01395524|526792744|FG001|Overall Study|Adverse Event|4|||
146074380|NCT01395524|526792745|FG002|Overall Study|Adverse Event|3|||
146074381|NCT01395524|526792743|FG000|Overall Study|Death|1|||
146074382|NCT01395524|526792744|FG001|Overall Study|Death|0|||
146074383|NCT01395524|526792745|FG002|Overall Study|Death|0|||
146074384|NCT01395524|526792743|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146074385|NCT01395524|526792744|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146074386|NCT01395524|526792745|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146074387|NCT01395524|526792743|FG000|Overall Study|Withdrawal by Subject|4|||
146074388|NCT01395524|526792744|FG001|Overall Study|Withdrawal by Subject|8|||
146074389|NCT01395524|526792745|FG002|Overall Study|Withdrawal by Subject|8|||
146074390|NCT01395524|526792743|FG000|Overall Study|Did not receive treatment|1|||
146074391|NCT01395524|526792744|FG001|Overall Study|Did not receive treatment|1|||
146074392|NCT01395524|526792745|FG002|Overall Study|Did not receive treatment|3|||
146074393|NCT01395524|526792743|FG000|Overall Study|Subject had spinal surgery|0|||
146074394|NCT01395524|526792744|FG001|Overall Study|Subject had spinal surgery|0|||
146283909|NCT01942590|527551880|FG001|Overall Study|Withdrawal by Subject|1|||
146410664|NCT01959230|528009431|FG001|Overall Study|Failure to follow study procedures|1|||
146410665|NCT01959230|528009430|FG000|Overall Study|Administrative reasons|2|||
146410666|NCT01959230|528009431|FG001|Overall Study|Administrative reasons|0|||
146410667|NCT01959230|528009430|FG000|Overall Study|Withdrawal by Subject|2|||
146410668|NCT01959230|528009431|FG001|Overall Study|Withdrawal by Subject|0|||
146410669|NCT00751998|528009432|FG000|Overall Study|Lost to Follow-up|7|||
146410670|NCT00751998|528009432|FG000|Overall Study|Death|11|||
146410671|NCT00751998|528009432|FG000|Overall Study|Withdrawal by Subject|2|||
146410672|NCT04126733|528009433|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
146410673|NCT04126733|528009433|FG000|Treatment Period|Adverse Event|8|||
146174157|NCT02002884|527151279|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
146174158|NCT02002884|527151280|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
146174159|NCT02002884|527151277|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146174160|NCT02002884|527151278|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146174161|NCT02002884|527151279|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
146174162|NCT02002884|527151280|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
146174163|NCT02002884|527151277|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146174164|NCT02002884|527151278|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146174165|NCT02002884|527151279|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
146174166|NCT02002884|527151280|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
146174167|NCT02002884|527151277|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146174168|NCT02002884|527151278|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146174169|NCT02002884|527151279|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
146174170|NCT02002884|527151280|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
146174171|NCT02966002|527151281|FG000|Overall Study|Withdrawal by Subject|2|||
146174172|NCT02966002|527151281|FG000|Overall Study|Adverse Event|1|||
146174173|NCT02966002|527151281|FG000|Overall Study|Lost to Follow-up|1|||
146174174|NCT02291432|527151283|FG000|Overall Study|Withdrawal by Subject|2|||
146074395|NCT01395524|526792745|FG002|Overall Study|Subject had spinal surgery|1|||
146074396|NCT01657461|526792746|FG000|Overall Study|Death|9|||
146074397|NCT01657461|526792747|FG001|Overall Study|Death|12|||
146074398|NCT01657461|526792746|FG000|Overall Study|Lost to Follow-up|0|||
146074399|NCT01657461|526792747|FG001|Overall Study|Lost to Follow-up|3|||
146074400|NCT01657461|526792746|FG000|Overall Study|Physician Decision|0|||
146074401|NCT01657461|526792747|FG001|Overall Study|Physician Decision|2|||
146074402|NCT01657461|526792746|FG000|Overall Study|Withdrawal by Subject|1|||
146074403|NCT01657461|526792747|FG001|Overall Study|Withdrawal by Subject|3|||
146074404|NCT01868542|526792748|FG000|Overall Study|Protocol Violation|0|||
146074405|NCT01868542|526792749|FG001|Overall Study|Protocol Violation|1|||
146074406|NCT01868542|526792748|FG000|Overall Study|Unclassified|0|||
146074407|NCT01868542|526792749|FG001|Overall Study|Unclassified|1|||
146074408|NCT00130247|526792750|FG000|Overall Study|Pregnancy|1|||
146074409|NCT00130247|526792751|FG001|Overall Study|Pregnancy|0|||
146074410|NCT00130247|526792750|FG000|Overall Study|Post-randomization exclusion|1|||
146074411|NCT00130247|526792751|FG001|Overall Study|Post-randomization exclusion|2|||
146074412|NCT00130247|526792750|FG000|Overall Study|Not compliant with DOT|0|||
146074413|NCT00130247|526792751|FG001|Overall Study|Not compliant with DOT|2|||
146074414|NCT00843284|526792756|FG000|Overall Study|Adverse Event|39|||
146074415|NCT00843284|526792756|FG000|Overall Study|Lack of Efficacy|5|||
146074416|NCT00843284|526792756|FG000|Overall Study|Lost to Follow-up|11|||
146074417|NCT00843284|526792756|FG000|Overall Study|Other|10|||
146074418|NCT00843284|526792756|FG000|Overall Study|Withdrawal by Subject|4|||
146074419|NCT00843284|526792756|FG000|Overall Study|Death|3|||
146074420|NCT00122980|526792757|FG000|Overall Study|Death|0|||
146074421|NCT00122980|526792758|FG001|Overall Study|Death|1|||
146074422|NCT00122980|526792757|FG000|Overall Study|Physician Decision|2|||
146074423|NCT00122980|526792758|FG001|Overall Study|Physician Decision|0|||
146074424|NCT00122980|526792757|FG000|Overall Study|Protocol Violation|5|||
146074425|NCT00122980|526792758|FG001|Overall Study|Protocol Violation|1|||
146074426|NCT00122980|526792757|FG000|Overall Study|Withdrawal by Subject|2|||
146074427|NCT00122980|526792758|FG001|Overall Study|Withdrawal by Subject|3|||
146074428|NCT00122980|526792757|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
146074429|NCT00122980|526792758|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
146074430|NCT00122980|526792757|FG000|Overall Study|Study termination|27|||
146074431|NCT00122980|526792758|FG001|Overall Study|Study termination|35|||
146074432|NCT03844945|526792759|FG000|Overall Study|Adverse Event|1|||
146074433|NCT03844945|526792760|FG001|Overall Study|Adverse Event|1|||
146074434|NCT03844945|526792761|FG002|Overall Study|Adverse Event|4|||
146074435|NCT03844945|526792762|FG003|Overall Study|Adverse Event|0|||
146074436|NCT03844945|526792759|FG000|Overall Study|Withdrawal by Subject|0|||
146074437|NCT03844945|526792760|FG001|Overall Study|Withdrawal by Subject|0|||
146074438|NCT03844945|526792761|FG002|Overall Study|Withdrawal by Subject|1|||
146074439|NCT03844945|526792762|FG003|Overall Study|Withdrawal by Subject|0|||
146074440|NCT03844945|526792759|FG000|Overall Study|Lack of Efficacy|0|||
146074441|NCT03844945|526792760|FG001|Overall Study|Lack of Efficacy|0|||
146074442|NCT03844945|526792761|FG002|Overall Study|Lack of Efficacy|0|||
146074443|NCT03844945|526792762|FG003|Overall Study|Lack of Efficacy|1|||
146074444|NCT01139008|526792772|FG000|Overall Study|Withdrawal by Subject|5|||
146074445|NCT01139008|526792772|FG000|Overall Study|Non-compliant, lost product|1|||
146074446|NCT00545272|526792778|FG000|Overall Study|Protocol deviation|0|||
146283910|NCT01942590|527551879|FG000|Overall Study|Adverse Event|1|||
146074447|NCT00545272|526792779|FG001|Overall Study|Protocol deviation|1|||
146074448|NCT00545272|526792780|FG002|Overall Study|Protocol deviation|0|||
146074449|NCT00545272|526792781|FG003|Overall Study|Protocol deviation|1|||
146074450|NCT00545272|526792782|FG004|Overall Study|Protocol deviation|0|||
146074451|NCT00545272|526792783|FG005|Overall Study|Protocol deviation|1|||
146074452|NCT00545272|526792778|FG000|Overall Study|Adverse Event|0|||
146074453|NCT00545272|526792779|FG001|Overall Study|Adverse Event|0|||
146074454|NCT00545272|526792780|FG002|Overall Study|Adverse Event|1|||
146074455|NCT00545272|526792781|FG003|Overall Study|Adverse Event|0|||
146074456|NCT00545272|526792782|FG004|Overall Study|Adverse Event|0|||
146074457|NCT00545272|526792783|FG005|Overall Study|Adverse Event|1|||
146074458|NCT00545272|526792778|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146074459|NCT00545272|526792779|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146074460|NCT00545272|526792780|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146074461|NCT00545272|526792781|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146074462|NCT00545272|526792782|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146074463|NCT00545272|526792783|FG005|Overall Study|Abnormal laboratory value(s)|1|||
146074464|NCT00545272|526792778|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146174175|NCT02145078|527151286|FG000|Overall Study|Death|1|||
146174176|NCT02145078|527151286|FG000|Overall Study|Reason not given|3|||
146174177|NCT03327402|527151287|FG000|Overall Study|Withdrawal by Subject|1|||
146174178|NCT03327402|527151287|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
146174179|NCT01454830|527151290|FG000|Overall Study|Withdrawal by Subject|4|||
146174180|NCT01454830|527151291|FG001|Overall Study|Withdrawal by Subject|4|||
146174181|NCT01454830|527151290|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
146174182|NCT01454830|527151291|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
146174183|NCT01454830|527151290|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
146174184|NCT01454830|527151291|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
146174185|NCT01454830|527151290|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
146174186|NCT01454830|527151291|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
146174187|NCT01454830|527151290|FG000|Overall Study|Withdrawal - no polysomnography|3|||
146174188|NCT01454830|527151291|FG001|Overall Study|Withdrawal - no polysomnography|2|||
146174189|NCT00584805|527151292|FG000|Overall Study|No longer at risk of exposure|39|||
146174190|NCT00584805|527151292|FG000|Overall Study|Relocation|36|||
146174191|NCT00584805|527151292|FG000|Overall Study|Withdrawal by Subject|18|||
146174192|NCT00584805|527151292|FG000|Overall Study|Non-compliance|1|||
146174193|NCT00584805|527151292|FG000|Overall Study|Lost to follow up|3|||
146174194|NCT00584805|527151292|FG000|Overall Study|Screen failures|2|||
146074465|NCT00545272|526792779|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146074466|NCT00545272|526792780|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146074467|NCT00545272|526792781|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146074468|NCT00545272|526792782|FG004|Overall Study|Abnormal test procedure result(s)|1|||
146074469|NCT00545272|526792783|FG005|Overall Study|Abnormal test procedure result(s)|0|||
146074470|NCT00545272|526792778|FG000|Overall Study|Lost to Follow-up|0|||
146074471|NCT00545272|526792779|FG001|Overall Study|Lost to Follow-up|0|||
146074472|NCT00545272|526792780|FG002|Overall Study|Lost to Follow-up|0|||
146074473|NCT00545272|526792781|FG003|Overall Study|Lost to Follow-up|0|||
146074474|NCT00545272|526792782|FG004|Overall Study|Lost to Follow-up|1|||
146074475|NCT00545272|526792783|FG005|Overall Study|Lost to Follow-up|0|||
146074476|NCT02934503|526792784|FG000|Overall Study|progression of disease|3|||
146074477|NCT02934503|526792784|FG000|Overall Study|Withdrawal by Subject|1|||
146074478|NCT04248491|526792785|FG000|Overall Study|Lost to Follow-up|1|||
146074479|NCT04248491|526792786|FG001|Overall Study|Lost to Follow-up|0|||
146074480|NCT01311024|526792789|FG000|Overall Study|Protocol Violation|35|||
146074481|NCT01311024|526792790|FG001|Overall Study|Protocol Violation|22|||
146174195|NCT03097861|527151298|FG000|Overall Study|Adverse Event|3|||
146174196|NCT03097861|527151299|FG001|Overall Study|Adverse Event|8|||
146074482|NCT01652469|526792791|FG000|Overall Study|Withdrawal by Subject|1|||
146074483|NCT01652469|526792792|FG001|Overall Study|Withdrawal by Subject|4|||
146074484|NCT01652469|526792791|FG000|Overall Study|Lost to Follow-up|0|||
146174197|NCT03097861|527151300|FG002|Overall Study|Adverse Event|4|||
146174198|NCT03097861|527151298|FG000|Overall Study|Investigator Decision|0|||
146174199|NCT03097861|527151299|FG001|Overall Study|Investigator Decision|1|||
146174200|NCT03097861|527151300|FG002|Overall Study|Investigator Decision|0|||
146174201|NCT03097861|527151298|FG000|Overall Study|Lost to Follow-up|0|||
146174202|NCT03097861|527151299|FG001|Overall Study|Lost to Follow-up|7|||
146174203|NCT03097861|527151300|FG002|Overall Study|Lost to Follow-up|1|||
146174204|NCT03097861|527151298|FG000|Overall Study|Withdrawal by Subject|1|||
146174205|NCT03097861|527151299|FG001|Overall Study|Withdrawal by Subject|5|||
146174206|NCT03097861|527151300|FG002|Overall Study|Withdrawal by Subject|3|||
146174207|NCT03097861|527151298|FG000|Overall Study|Reason not provided|3|||
146174208|NCT03097861|527151299|FG001|Overall Study|Reason not provided|1|||
146174209|NCT03097861|527151300|FG002|Overall Study|Reason not provided|1|||
146174210|NCT01785563|527151301|FG000|Overall Study|Physician Decision|10|||
146174211|NCT01785563|527151301|FG000|Overall Study|Withdrawal by Subject|1|||
146174212|NCT01785563|527151301|FG000|Overall Study|Protocol Violation|2|||
146174213|NCT01616771|527151304|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
146174214|NCT00744328|527151305|FG000|Overall Study|Lost to Follow-up|2|||
146174215|NCT00744328|527151306|FG001|Overall Study|Lost to Follow-up|5|||
146174216|NCT00744328|527151307|FG002|Overall Study|Lost to Follow-up|3|||
146174217|NCT00744328|527151305|FG000|Overall Study|Withdrawal by Subject|5|||
146174218|NCT00744328|527151306|FG001|Overall Study|Withdrawal by Subject|3|||
146174219|NCT00744328|527151307|FG002|Overall Study|Withdrawal by Subject|4|||
146174220|NCT00744328|527151305|FG000|Overall Study|Found ineligible after randomization|0|||
146174221|NCT00744328|527151306|FG001|Overall Study|Found ineligible after randomization|0|||
146174222|NCT00744328|527151307|FG002|Overall Study|Found ineligible after randomization|1|||
146174223|NCT04399356|527151309|FG000|Overall Study|Lost to Follow-up|1|||
146074485|NCT01652469|526792792|FG001|Overall Study|Lost to Follow-up|2|||
146074486|NCT02834793|526792793|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
146074487|NCT02834793|526792794|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
146074488|NCT02834793|526792795|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
146074489|NCT02834793|526792796|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
146074490|NCT02834793|526792793|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
146074491|NCT02834793|526792794|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146074492|NCT02834793|526792795|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146074493|NCT02834793|526792796|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
146074494|NCT02834793|526792793|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
146074495|NCT02834793|526792794|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146074496|NCT02834793|526792795|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146074497|NCT02834793|526792796|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
146074498|NCT02834793|526792793|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146074499|NCT02834793|526792794|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
146074500|NCT02834793|526792795|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146074501|NCT02834793|526792796|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
146074502|NCT02834793|526792793|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146074503|NCT02834793|526792794|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
146074504|NCT02834793|526792795|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146074505|NCT02834793|526792796|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
146174224|NCT04399356|527151310|FG001|Overall Study|Lost to Follow-up|1|||
146174225|NCT04399356|527151309|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
146174226|NCT04399356|527151310|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
146174227|NCT04399356|527151309|FG000|Overall Study|Withdrawal by Subject|1|||
146174228|NCT04399356|527151310|FG001|Overall Study|Withdrawal by Subject|0|||
146174229|NCT00154310|527151311|FG000|Overall Study|Adverse Event|19|||
146174230|NCT00154310|527151312|FG001|Overall Study|Adverse Event|9|||
146174231|NCT00154310|527151311|FG000|Overall Study|Lack of Efficacy|5|||
146174232|NCT00154310|527151312|FG001|Overall Study|Lack of Efficacy|4|||
146174233|NCT00154310|527151311|FG000|Overall Study|Protocol Violation|4|||
146174234|NCT00154310|527151312|FG001|Overall Study|Protocol Violation|2|||
146174235|NCT00154310|527151311|FG000|Overall Study|Withdrawal by Subject|9|||
146174236|NCT00154310|527151312|FG001|Overall Study|Withdrawal by Subject|3|||
146174237|NCT00154310|527151311|FG000|Overall Study|Lost to Follow-up|0|||
146174238|NCT00154310|527151312|FG001|Overall Study|Lost to Follow-up|8|||
146174239|NCT00154310|527151311|FG000|Overall Study|Administrative problems|0|||
146174240|NCT00154310|527151312|FG001|Overall Study|Administrative problems|1|||
146174241|NCT00154310|527151311|FG000|Overall Study|Death|0|||
146174242|NCT00154310|527151312|FG001|Overall Study|Death|1|||
146174243|NCT04041440|527151313|FG000|Overall Study|Withdrawal by Subject|0|||
146174244|NCT04041440|527151314|FG001|Overall Study|Withdrawal by Subject|1|||
146174245|NCT04041440|527151313|FG000|Overall Study|Lost to Follow-up|0|||
146174246|NCT04041440|527151314|FG001|Overall Study|Lost to Follow-up|1|||
146174247|NCT02247804|527151319|FG000|Treatment Period 1|Adverse Event|9|||
146174248|NCT02247804|527151320|FG001|Treatment Period 1|Adverse Event|2|||
146174249|NCT02247804|527151321|FG002|Treatment Period 1|Adverse Event|0|||
146174250|NCT02247804|527151319|FG000|Treatment Period 1|Lack of Efficacy|0|||
146174251|NCT02247804|527151320|FG001|Treatment Period 1|Lack of Efficacy|0|||
146174252|NCT02247804|527151321|FG002|Treatment Period 1|Lack of Efficacy|2|||
146174253|NCT02247804|527151319|FG000|Treatment Period 1|Lost to Follow-up|1|||
146174254|NCT02247804|527151320|FG001|Treatment Period 1|Lost to Follow-up|0|||
146174255|NCT02247804|527151321|FG002|Treatment Period 1|Lost to Follow-up|2|||
146174256|NCT02247804|527151319|FG000|Treatment Period 1|Personal Reasons|7|||
146174257|NCT02247804|527151320|FG001|Treatment Period 1|Personal Reasons|1|||
146174258|NCT02247804|527151321|FG002|Treatment Period 1|Personal Reasons|2|||
146174259|NCT02247804|527151319|FG000|Treatment Period 1|Protocol Deviation|0|||
146174260|NCT02247804|527151320|FG001|Treatment Period 1|Protocol Deviation|0|||
146174261|NCT02247804|527151321|FG002|Treatment Period 1|Protocol Deviation|1|||
146174262|NCT02247804|527151319|FG000|Treatment Period 1|Randomized but not Treated|5|||
146174263|NCT02247804|527151320|FG001|Treatment Period 1|Randomized but not Treated|1|||
146174264|NCT02247804|527151321|FG002|Treatment Period 1|Randomized but not Treated|1|||
146174265|NCT02247804|527151319|FG000|Treatment Period 2|Adverse Event|6|||
146174266|NCT02247804|527151320|FG001|Treatment Period 2|Adverse Event|3|||
146174267|NCT02247804|527151321|FG002|Treatment Period 2|Adverse Event|3|||
146174268|NCT02247804|527151319|FG000|Treatment Period 2|Lack of Efficacy|0|||
146174269|NCT02247804|527151320|FG001|Treatment Period 2|Lack of Efficacy|0|||
146174270|NCT02247804|527151321|FG002|Treatment Period 2|Lack of Efficacy|1|||
146174271|NCT02247804|527151319|FG000|Treatment Period 2|Lost to Follow-up|0|||
146174272|NCT02247804|527151320|FG001|Treatment Period 2|Lost to Follow-up|1|||
146174273|NCT02247804|527151321|FG002|Treatment Period 2|Lost to Follow-up|1|||
146174274|NCT02247804|527151319|FG000|Treatment Period 2|Personal Reasons|2|||
146174275|NCT02247804|527151320|FG001|Treatment Period 2|Personal Reasons|1|||
146174276|NCT02247804|527151321|FG002|Treatment Period 2|Personal Reasons|1|||
146174277|NCT02247804|527151319|FG000|Treatment Period 2|Reason not Specified|0|||
146174278|NCT02247804|527151320|FG001|Treatment Period 2|Reason not Specified|0|||
146174279|NCT02247804|527151321|FG002|Treatment Period 2|Reason not Specified|2|||
146174280|NCT02247804|527151319|FG000|Treatment Period 3|Adverse Event|4|||
146174281|NCT02247804|527151320|FG001|Treatment Period 3|Adverse Event|3|||
146174282|NCT02247804|527151321|FG002|Treatment Period 3|Adverse Event|3|||
146174283|NCT02247804|527151319|FG000|Treatment Period 3|Lack of Efficacy|0|||
146074506|NCT02834793|526792793|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146074507|NCT02834793|526792794|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146074508|NCT02834793|526792795|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
146074509|NCT02834793|526792796|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
146074510|NCT02834793|526792793|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146074511|NCT02834793|526792794|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146074512|NCT02834793|526792795|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
146074513|NCT02834793|526792796|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
146074514|NCT02834793|526792793|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146074515|NCT02834793|526792794|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146074516|NCT02834793|526792795|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
146074517|NCT02834793|526792796|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
146074518|NCT02834793|526792793|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146074519|NCT02834793|526792794|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146074520|NCT02834793|526792795|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
146074521|NCT02834793|526792796|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
146074522|NCT02834793|526792793|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
146074523|NCT02834793|526792794|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
146074524|NCT02834793|526792795|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
146074525|NCT02834793|526792796|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
146174284|NCT02247804|527151320|FG001|Treatment Period 3|Lack of Efficacy|1|||
146074526|NCT02834793|526792793|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146074527|NCT02834793|526792794|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146074528|NCT02834793|526792795|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
146074529|NCT02834793|526792796|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
146074530|NCT02834793|526792793|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146074531|NCT02834793|526792794|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146074532|NCT02834793|526792795|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
146074533|NCT02834793|526792796|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
146074534|NCT02834793|526792793|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146074535|NCT02834793|526792794|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146074536|NCT02834793|526792795|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
146074537|NCT02834793|526792796|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
146074538|NCT02834793|526792793|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
146074539|NCT02834793|526792794|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
146074540|NCT02834793|526792795|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
146074541|NCT02834793|526792796|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
146074542|NCT02834793|526792793|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146074543|NCT02834793|526792794|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146074544|NCT02834793|526792795|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
146074545|NCT02834793|526792796|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
146074546|NCT02364336|526792797|FG000|Overall Study|Adverse Event|0|||
146074547|NCT02364336|526792798|FG001|Overall Study|Adverse Event|1|||
146074548|NCT01731938|526792799|FG000|Preliminary Part I|Withdrawal by Subject|2|||
146074549|NCT01731938|526792800|FG001|Preliminary Part I|Withdrawal by Subject|2|||
146074550|NCT01731938|526792799|FG000|Preliminary Part I|Physician Decision|1|||
146074551|NCT01731938|526792800|FG001|Preliminary Part I|Physician Decision|0|||
146074552|NCT01731938|526792799|FG000|Preliminary Part I|Lost to Follow-up|0|||
146074553|NCT01731938|526792800|FG001|Preliminary Part I|Lost to Follow-up|3|||
146074554|NCT01731938|526792799|FG000|Preliminary Part I|Missed Week 6 visit|0|||
146074555|NCT01731938|526792800|FG001|Preliminary Part I|Missed Week 6 visit|3|||
146074556|NCT01731938|526792799|FG000|Primary Part II|Withdrawal by Subject|5|||
146074557|NCT01731938|526792800|FG001|Primary Part II|Withdrawal by Subject|4|||
146074558|NCT01731938|526792799|FG000|Primary Part II|Lost to Follow-up|4|||
146074559|NCT01731938|526792800|FG001|Primary Part II|Lost to Follow-up|5|||
146074560|NCT01731938|526792799|FG000|Primary Part II|Death|2|||
146074561|NCT01731938|526792800|FG001|Primary Part II|Death|1|||
146074562|NCT01731938|526792799|FG000|Primary Part II|Missed Week 6 visit|2|||
146074563|NCT01731938|526792800|FG001|Primary Part II|Missed Week 6 visit|3|||
146074564|NCT04931888|526792801|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
146074565|NCT04931888|526792802|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
146074566|NCT04931888|526792803|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
146074567|NCT04931888|526792804|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
146074568|NCT01049009|526792805|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146074569|NCT01049009|526792806|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146074570|NCT01049009|526792805|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146074571|NCT01049009|526792806|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146074572|NCT01049009|526792805|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
146074573|NCT01049009|526792806|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
146074574|NCT01049009|526792805|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
146074575|NCT01049009|526792806|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
146074576|NCT03179202|526792807|FG000|Overall Study|Screen Failure|67|||
146074577|NCT03179202|526792807|FG000|Overall Study|Subject Lost to Follow Up|12|||
146074578|NCT03179202|526792807|FG000|Overall Study|Withdrawal by Subject|7|||
146074579|NCT03179202|526792807|FG000|Overall Study|Adverse Event|3|||
146074580|NCT03179202|526792807|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
146074581|NCT03179202|526792807|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
146074582|NCT00859638|526792808|FG000|Overall Study|Lost to Follow-up|6|||
146074583|NCT00859638|526792809|FG001|Overall Study|Lost to Follow-up|1|||
146074584|NCT00859638|526792808|FG000|Overall Study|Withdrawal by Subject|3|||
146074585|NCT00859638|526792809|FG001|Overall Study|Withdrawal by Subject|2|||
146074586|NCT00859638|526792808|FG000|Overall Study|Ill health|1|||
146074587|NCT00859638|526792809|FG001|Overall Study|Ill health|1|||
146074588|NCT02969408|526792811|FG000|Overall Study|Adverse Event|2|||
146074589|NCT02969408|526792811|FG000|Overall Study|Withdrawal by Subject|8|||
146074590|NCT02969408|526792811|FG000|Overall Study|Lost to Follow-up|4|||
146074591|NCT02969408|526792811|FG000|Overall Study|Protocol Violation|1|||
146074592|NCT02969408|526792811|FG000|Overall Study|Other than specified|1|||
146074593|NCT04643158|526792812|FG000|Overall Study|Study terminated by sponsor|0|||
146074594|NCT04643158|526792813|FG001|Overall Study|Study terminated by sponsor|0|||
146074595|NCT04643158|526792814|FG002|Overall Study|Study terminated by sponsor|1|||
146074596|NCT04643158|526792815|FG003|Overall Study|Study terminated by sponsor|0|||
146074597|NCT04643158|526792816|FG004|Overall Study|Study terminated by sponsor|0|||
146074598|NCT04643158|526792817|FG005|Overall Study|Study terminated by sponsor|1|||
146074599|NCT04643158|526792818|FG006|Overall Study|Study terminated by sponsor|0|||
146074600|NCT04643158|526792812|FG000|Overall Study|Global/country situation|0|||
146074601|NCT04643158|526792813|FG001|Overall Study|Global/country situation|0|||
146074602|NCT04643158|526792814|FG002|Overall Study|Global/country situation|1|||
146074603|NCT04643158|526792815|FG003|Overall Study|Global/country situation|0|||
146074604|NCT04643158|526792816|FG004|Overall Study|Global/country situation|0|||
146074605|NCT04643158|526792817|FG005|Overall Study|Global/country situation|0|||
146074606|NCT04643158|526792818|FG006|Overall Study|Global/country situation|0|||
146074607|NCT04643158|526792812|FG000|Overall Study|Withdrawal by Subject|0|||
146074608|NCT04643158|526792813|FG001|Overall Study|Withdrawal by Subject|0|||
146074609|NCT04643158|526792814|FG002|Overall Study|Withdrawal by Subject|0|||
146074610|NCT04643158|526792815|FG003|Overall Study|Withdrawal by Subject|0|||
146074611|NCT04643158|526792816|FG004|Overall Study|Withdrawal by Subject|0|||
146074612|NCT04643158|526792817|FG005|Overall Study|Withdrawal by Subject|1|||
146074613|NCT04643158|526792818|FG006|Overall Study|Withdrawal by Subject|0|||
146074614|NCT01068600|526792819|FG000|Overall Study|Withdrawal by Subject|5|||
146074615|NCT01068600|526792820|FG001|Overall Study|Withdrawal by Subject|6|||
146074616|NCT01068600|526792819|FG000|Overall Study|Adverse Event|3|||
146074617|NCT01068600|526792820|FG001|Overall Study|Adverse Event|3|||
146074618|NCT01068600|526792819|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146074619|NCT01068600|526792820|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146074620|NCT01068600|526792819|FG000|Overall Study|Lost to Follow-up|1|||
146174285|NCT02247804|527151321|FG002|Treatment Period 3|Lack of Efficacy|0|||
146174286|NCT02247804|527151319|FG000|Treatment Period 3|Lost to Follow-up|1|||
146174287|NCT02247804|527151320|FG001|Treatment Period 3|Lost to Follow-up|2|||
146174288|NCT02247804|527151321|FG002|Treatment Period 3|Lost to Follow-up|2|||
146174289|NCT02247804|527151319|FG000|Treatment Period 3|Personal Reasons|4|||
146174290|NCT02247804|527151320|FG001|Treatment Period 3|Personal Reasons|3|||
146174291|NCT02247804|527151321|FG002|Treatment Period 3|Personal Reasons|2|||
146174292|NCT02247804|527151319|FG000|Treatment Period 3|Reason not Specified|2|||
146174293|NCT02247804|527151320|FG001|Treatment Period 3|Reason not Specified|1|||
146174294|NCT02247804|527151321|FG002|Treatment Period 3|Reason not Specified|3|||
146174295|NCT03447730|527151322|FG000|Overall Study|Adverse Event|0|||
146174296|NCT03447730|527151323|FG001|Overall Study|Adverse Event|2|||
146174297|NCT03447730|527151324|FG002|Overall Study|Adverse Event|0|||
146174298|NCT01350505|527151326|FG000|Overall Study|Lost to Follow-up|4|||
146174299|NCT04251065|527151327|FG000|Overall Study|Death|2|||
146410674|NCT04126733|528009433|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
146410675|NCT04126733|528009433|FG000|Treatment Period|Physician Decision|5|||
146410676|NCT04126733|528009433|FG000|Treatment Period|Death|1|||
146410677|NCT04126733|528009433|FG000|Treatment Period|Other Reasons|2|||
146410678|NCT04126733|528009433|FG000|Active Follow-up Period|Death|13|||
146410679|NCT04126733|528009433|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
146410680|NCT04126733|528009433|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
146410681|NCT04126733|528009433|FG000|Active Follow-up Period|Other Reasons|1|||
146410682|NCT04126733|528009433|FG000|Long-term Follow-up Period|Death|22|||
146410683|NCT04126733|528009433|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
146410684|NCT04126733|528009433|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
146410685|NCT01965535|528009434|FG000|Overall Study|Lack of Efficacy|2|||
146410686|NCT01965535|528009435|FG001|Overall Study|Lack of Efficacy|1|||
146410687|NCT01825876|528009436|FG000|Period 2|Withdrawal by Subject|0|||
146410688|NCT01825876|528009437|FG001|Period 2|Withdrawal by Subject|1|||
146410689|NCT03751020|528009440|FG000|Overall Study|Withdrawal by Subject|2|||
146410690|NCT03751020|528009441|FG001|Overall Study|Withdrawal by Subject|0|||
146410691|NCT03751020|528009442|FG002|Overall Study|Withdrawal by Subject|0|||
146410692|NCT03751020|528009440|FG000|Overall Study|Lost to Follow-up|7|||
146410693|NCT03751020|528009441|FG001|Overall Study|Lost to Follow-up|4|||
146410694|NCT03751020|528009442|FG002|Overall Study|Lost to Follow-up|10|||
146410695|NCT01889862|528009443|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
146410696|NCT01889862|528009444|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146410697|NCT01889862|528009445|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146410698|NCT01889862|528009446|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146410699|NCT01889862|528009447|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
146410700|NCT01889862|528009443|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
146410701|NCT01889862|528009444|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146410702|NCT01889862|528009445|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146410703|NCT01889862|528009446|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146410704|NCT01889862|528009447|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
146410705|NCT01889862|528009443|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
146410706|NCT01889862|528009444|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146410707|NCT01889862|528009445|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146410708|NCT01889862|528009446|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146410709|NCT01889862|528009447|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
146410710|NCT01889862|528009443|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
146410711|NCT01889862|528009444|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146410712|NCT01889862|528009445|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146410713|NCT01889862|528009446|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146410714|NCT01889862|528009447|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
146410715|NCT01889862|528009443|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146410716|NCT01889862|528009444|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146410717|NCT01889862|528009445|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
146410718|NCT01889862|528009446|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146410719|NCT01889862|528009447|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
146410720|NCT01889862|528009443|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146410721|NCT01889862|528009444|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146410722|NCT01889862|528009445|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146410723|NCT01889862|528009446|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
146410724|NCT01889862|528009447|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
146410725|NCT01889862|528009443|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146410726|NCT01889862|528009444|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146410727|NCT01889862|528009445|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146410728|NCT01889862|528009446|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
146174300|NCT04251065|527151327|FG000|Overall Study|Lack of Efficacy|3|||
146174301|NCT04251065|527151327|FG000|Overall Study|Death|1|||
146174302|NCT01054573|527151328|FG000|Overall Study|Adverse Event|1|||
146174303|NCT01054573|527151329|FG001|Overall Study|Adverse Event|0|||
146174304|NCT01054573|527151330|FG002|Overall Study|Adverse Event|1|||
146174305|NCT01054573|527151331|FG003|Overall Study|Adverse Event|1|||
146174306|NCT01054573|527151328|FG000|Overall Study|Lost to Follow-up|0|||
146174307|NCT01054573|527151329|FG001|Overall Study|Lost to Follow-up|2|||
146174308|NCT01054573|527151330|FG002|Overall Study|Lost to Follow-up|0|||
146174309|NCT01054573|527151331|FG003|Overall Study|Lost to Follow-up|0|||
146174310|NCT01054573|527151328|FG000|Overall Study|Withdrawal by Subject|0|||
146174311|NCT01054573|527151329|FG001|Overall Study|Withdrawal by Subject|2|||
146174312|NCT01054573|527151330|FG002|Overall Study|Withdrawal by Subject|2|||
146174313|NCT01054573|527151331|FG003|Overall Study|Withdrawal by Subject|1|||
146174314|NCT05266963|527151332|FG000|Drug Period A|Withdrawal by Subject|0|||
146174315|NCT05266963|527151333|FG001|Drug Period A|Withdrawal by Subject|1|||
146174316|NCT00393523|527151334|FG000|Overall Study|Lost to Follow-up|0|||
146174317|NCT00393523|527151335|FG001|Overall Study|Lost to Follow-up|0|||
146174318|NCT00393523|527151336|FG002|Overall Study|Lost to Follow-up|0|||
146174319|NCT00393523|527151337|FG003|Overall Study|Lost to Follow-up|2|||
146174320|NCT00393523|527151338|FG004|Overall Study|Lost to Follow-up|1|||
146174321|NCT00393523|527151334|FG000|Overall Study|Protocol Violation|6|||
146174322|NCT00393523|527151335|FG001|Overall Study|Protocol Violation|2|||
146174323|NCT00393523|527151336|FG002|Overall Study|Protocol Violation|0|||
146174324|NCT00393523|527151337|FG003|Overall Study|Protocol Violation|1|||
146174325|NCT00393523|527151338|FG004|Overall Study|Protocol Violation|0|||
146174326|NCT00393523|527151334|FG000|Overall Study|Withdrawal by Subject|6|||
146174327|NCT00393523|527151335|FG001|Overall Study|Withdrawal by Subject|7|||
146174328|NCT00393523|527151336|FG002|Overall Study|Withdrawal by Subject|2|||
146174329|NCT00393523|527151337|FG003|Overall Study|Withdrawal by Subject|3|||
146174330|NCT00393523|527151338|FG004|Overall Study|Withdrawal by Subject|0|||
146174331|NCT00393523|527151334|FG000|Overall Study|Difficulties in specimen collection|0|||
146174332|NCT00393523|527151335|FG001|Overall Study|Difficulties in specimen collection|0|||
146174333|NCT00393523|527151336|FG002|Overall Study|Difficulties in specimen collection|1|||
146174334|NCT00393523|527151337|FG003|Overall Study|Difficulties in specimen collection|0|||
146174335|NCT00393523|527151338|FG004|Overall Study|Difficulties in specimen collection|0|||
146174336|NCT00393523|527151334|FG000|Overall Study|Vaccine supply issue|0|||
146174337|NCT00393523|527151335|FG001|Overall Study|Vaccine supply issue|0|||
146174338|NCT00393523|527151336|FG002|Overall Study|Vaccine supply issue|1|||
146174339|NCT00393523|527151337|FG003|Overall Study|Vaccine supply issue|0|||
146174340|NCT00393523|527151338|FG004|Overall Study|Vaccine supply issue|0|||
146174341|NCT00423852|527151341|FG000|Overall Study|Removed pior to the high-dose portion|3|||
146174342|NCT00980005|527151342|FG000|Overall Study|Withdrawal by Subject|6|||
146174343|NCT00980005|527151343|FG001|Overall Study|Withdrawal by Subject|17|||
146174344|NCT00980005|527151342|FG000|Overall Study|Lost to Follow-up|37|||
146174345|NCT00980005|527151343|FG001|Overall Study|Lost to Follow-up|43|||
146174346|NCT00980005|527151342|FG000|Overall Study|Other|4|||
146174347|NCT00980005|527151343|FG001|Overall Study|Other|3|||
146074621|NCT01068600|526792820|FG001|Overall Study|Lost to Follow-up|2|||
146074622|NCT01068600|526792819|FG000|Overall Study|Protocol deviation|1|||
146074623|NCT01068600|526792820|FG001|Overall Study|Protocol deviation|1|||
146074624|NCT01068600|526792819|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146074625|NCT01068600|526792820|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146074626|NCT01068600|526792819|FG000|Overall Study|Administrative problems|0|||
146074627|NCT01068600|526792820|FG001|Overall Study|Administrative problems|1|||
146074628|NCT01474018|526792821|FG000|Overall Study|Lost to Follow-up|0|||
146074629|NCT01474018|526792822|FG001|Overall Study|Lost to Follow-up|1|||
146074630|NCT01474018|526792821|FG000|Overall Study|Withdrawal by Subject|0|||
146074631|NCT01474018|526792822|FG001|Overall Study|Withdrawal by Subject|2|||
146074632|NCT00486291|526792827|FG000|Overall Study|Adverse Event|3|||
146074633|NCT00486291|526792828|FG001|Overall Study|Adverse Event|4|||
146074634|NCT00486291|526792827|FG000|Overall Study|Lost to Follow-up|3|||
146074635|NCT00486291|526792828|FG001|Overall Study|Lost to Follow-up|7|||
146074636|NCT00486291|526792827|FG000|Overall Study|protocol non-compliance|10|||
146074637|NCT00486291|526792828|FG001|Overall Study|protocol non-compliance|15|||
146074638|NCT00486291|526792827|FG000|Overall Study|requirement for restricted medication|0|||
146074639|NCT00486291|526792828|FG001|Overall Study|requirement for restricted medication|3|||
146074640|NCT03462511|526792832|FG000|Overall Study|Withdrawal by Subject|2|||
146074641|NCT03462511|526792833|FG001|Overall Study|Withdrawal by Subject|3|||
146074642|NCT02925416|526792834|FG000|Overall Study|Adverse Event|2|||
146074643|NCT02925416|526792835|FG001|Overall Study|Adverse Event|0|||
146074644|NCT02625909|526792836|FG000|Overall Study|Death|2|||
146074645|NCT02625909|526792837|FG001|Overall Study|Death|0|||
146410729|NCT01889862|528009447|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
146410730|NCT01889862|528009443|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146410731|NCT01889862|528009444|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146410732|NCT01889862|528009445|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146410733|NCT01889862|528009446|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
146410734|NCT01889862|528009447|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
146410735|NCT01889862|528009443|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146410736|NCT01889862|528009444|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146410737|NCT01889862|528009445|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146410738|NCT01889862|528009446|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
146410739|NCT01889862|528009447|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
146410740|NCT01889862|528009443|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146410741|NCT01889862|528009444|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146410742|NCT01889862|528009445|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146410743|NCT01889862|528009446|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
146410744|NCT01889862|528009447|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
146410745|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
146410746|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146410747|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
146410748|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146410749|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146410750|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146410751|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
146410752|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
146410753|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
146410754|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
146410755|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
146410756|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
146410757|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
146410758|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146410759|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146410760|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
146410761|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146410762|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146410763|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
146410764|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
146410765|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
146410766|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
146410767|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
146410768|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
146410769|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146410770|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146410771|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
146410772|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
146410773|NCT00528879|528009448|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
146410774|NCT00528879|528009449|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
146410775|NCT00528879|528009450|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
146410776|NCT00528879|528009451|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
146074646|NCT02625909|526792836|FG000|Overall Study|Lost to Follow-up|3|||
146074647|NCT02625909|526792837|FG001|Overall Study|Lost to Follow-up|5|||
146074648|NCT02625909|526792836|FG000|Overall Study|Lack of Efficacy|9|||
146074649|NCT02625909|526792837|FG001|Overall Study|Lack of Efficacy|2|||
146074650|NCT02625909|526792836|FG000|Overall Study|Reinfection|3|||
146074651|NCT02625909|526792837|FG001|Overall Study|Reinfection|2|||
146074652|NCT00200356|526792838|FG000|Overall Study|Lack of Efficacy|3|||
146074653|NCT00200356|526792839|FG001|Overall Study|Lack of Efficacy|3|||
146074654|NCT00200356|526792838|FG000|Overall Study|Protocol Violation|4|||
146074655|NCT00200356|526792839|FG001|Overall Study|Protocol Violation|4|||
146074656|NCT00200356|526792838|FG000|Overall Study|Nontreatment|1|||
146074657|NCT00200356|526792839|FG001|Overall Study|Nontreatment|0|||
146074658|NCT00035932|526792846|FG000|Overall Study|Adverse Event|10|||
146074659|NCT00035932|526792847|FG001|Overall Study|Adverse Event|9|||
146074660|NCT00035932|526792848|FG002|Overall Study|Adverse Event|9|||
146074661|NCT00035932|526792846|FG000|Overall Study|Death|0|||
146074662|NCT00035932|526792847|FG001|Overall Study|Death|0|||
146074663|NCT00035932|526792848|FG002|Overall Study|Death|1|||
146074664|NCT00035932|526792846|FG000|Overall Study|Disease Progression / Relapse|1|||
146074665|NCT00035932|526792847|FG001|Overall Study|Disease Progression / Relapse|1|||
146074666|NCT00035932|526792848|FG002|Overall Study|Disease Progression / Relapse|0|||
146074667|NCT00035932|526792846|FG000|Overall Study|Lost to Follow-up|4|||
146074668|NCT00035932|526792847|FG001|Overall Study|Lost to Follow-up|4|||
146074669|NCT00035932|526792848|FG002|Overall Study|Lost to Follow-up|3|||
146074670|NCT00035932|526792846|FG000|Overall Study|Noncompliance|6|||
146074671|NCT00035932|526792847|FG001|Overall Study|Noncompliance|7|||
146074672|NCT00035932|526792848|FG002|Overall Study|Noncompliance|6|||
146074673|NCT00035932|526792846|FG000|Overall Study|Protocol Violation While on Study|0|||
146074674|NCT00035932|526792847|FG001|Overall Study|Protocol Violation While on Study|1|||
146074675|NCT00035932|526792848|FG002|Overall Study|Protocol Violation While on Study|2|||
146074676|NCT00035932|526792846|FG000|Overall Study|Withdrawal by Subject|1|||
146074677|NCT00035932|526792847|FG001|Overall Study|Withdrawal by Subject|5|||
146074678|NCT00035932|526792848|FG002|Overall Study|Withdrawal by Subject|0|||
146074679|NCT00035932|526792846|FG000|Overall Study|Study Termination by Sponsor|1|||
146074680|NCT00035932|526792847|FG001|Overall Study|Study Termination by Sponsor|0|||
146074681|NCT00035932|526792848|FG002|Overall Study|Study Termination by Sponsor|0|||
146074682|NCT00035932|526792846|FG000|Overall Study|Lack of Efficacy|33|||
146074683|NCT00035932|526792847|FG001|Overall Study|Lack of Efficacy|33|||
146074684|NCT00035932|526792848|FG002|Overall Study|Lack of Efficacy|28|||
146074685|NCT01297491|526792849|FG000|Overall Study|Adverse Event|11|||
146074686|NCT01297491|526792850|FG001|Overall Study|Adverse Event|6|||
146074687|NCT01297491|526792849|FG000|Overall Study|Physician Decision|3|||
146174348|NCT02597933|527151344|FG000|Overall Study|Withdrawal by Subject|7|||
146174349|NCT02597933|527151345|FG001|Overall Study|Withdrawal by Subject|5|||
146174350|NCT02597933|527151344|FG000|Overall Study|Protocol Violation|2|||
146174351|NCT02597933|527151345|FG001|Overall Study|Protocol Violation|2|||
146174352|NCT02597933|527151344|FG000|Overall Study|Adverse Event|20|||
146174353|NCT02597933|527151345|FG001|Overall Study|Adverse Event|28|||
146174354|NCT02597933|527151344|FG000|Overall Study|Not treated|2|||
146174355|NCT02597933|527151345|FG001|Overall Study|Not treated|2|||
146174356|NCT02597933|527151344|FG000|Overall Study|Other than stated above|7|||
146174357|NCT02597933|527151345|FG001|Overall Study|Other than stated above|14|||
146174358|NCT00130793|527151349|FG000|Overall Study|Lost to Follow-up|1|||
146174359|NCT00130793|527151350|FG001|Overall Study|Lost to Follow-up|4|||
146174360|NCT00130793|527151349|FG000|Overall Study|Withdrew consent|2|||
146174361|NCT00130793|527151350|FG001|Overall Study|Withdrew consent|0|||
146174362|NCT02100722|527151351|FG000|Overall Study|Withdrawal pre-procedure|4|||
146174363|NCT02100722|527151352|FG001|Overall Study|Withdrawal pre-procedure|9|||
146174364|NCT02100722|527151351|FG000|Overall Study|Withdrawal post-procedure|0|||
146174365|NCT02100722|527151352|FG001|Overall Study|Withdrawal post-procedure|3|||
146174366|NCT02100722|527151351|FG000|Overall Study|Lost to Follow-up|2|||
146174367|NCT02100722|527151352|FG001|Overall Study|Lost to Follow-up|2|||
146074688|NCT01297491|526792850|FG001|Overall Study|Physician Decision|2|||
146174368|NCT02100722|527151351|FG000|Overall Study|Continuing on study|751|||
146174369|NCT02100722|527151352|FG001|Overall Study|Continuing on study|729|||
146174370|NCT02569710|527151365|FG000|Overall Study|Adverse Event|1|||
146174371|NCT02569710|527151366|FG001|Overall Study|Adverse Event|0|||
146174372|NCT02569710|527151367|FG002|Overall Study|Adverse Event|0|||
146174373|NCT02569710|527151368|FG003|Overall Study|Adverse Event|0|||
146174374|NCT02569710|527151369|FG004|Overall Study|Adverse Event|0|||
146174375|NCT02569710|527151370|FG005|Overall Study|Adverse Event|0|||
146174376|NCT02569710|527151371|FG006|Overall Study|Adverse Event|0|||
146174377|NCT02569710|527151372|FG007|Overall Study|Adverse Event|0|||
146174378|NCT02569710|527151373|FG008|Overall Study|Adverse Event|0|||
146174379|NCT02569710|527151374|FG009|Overall Study|Adverse Event|0|||
146174380|NCT02569710|527151365|FG000|Overall Study|Lost to Follow-up|0|||
146174381|NCT02569710|527151366|FG001|Overall Study|Lost to Follow-up|0|||
146174382|NCT02569710|527151367|FG002|Overall Study|Lost to Follow-up|0|||
146174383|NCT02569710|527151368|FG003|Overall Study|Lost to Follow-up|0|||
146174384|NCT02569710|527151369|FG004|Overall Study|Lost to Follow-up|0|||
146174385|NCT02569710|527151370|FG005|Overall Study|Lost to Follow-up|0|||
146174386|NCT02569710|527151371|FG006|Overall Study|Lost to Follow-up|1|||
146174387|NCT02569710|527151372|FG007|Overall Study|Lost to Follow-up|0|||
146174388|NCT02569710|527151373|FG008|Overall Study|Lost to Follow-up|1|||
146074689|NCT01297491|526792849|FG000|Overall Study|Progressive disease|11|||
146074690|NCT01297491|526792850|FG001|Overall Study|Progressive disease|20|||
146074691|NCT01297491|526792849|FG000|Overall Study|Patient/Guardian decision|3|||
146074692|NCT01297491|526792850|FG001|Overall Study|Patient/Guardian decision|4|||
146074693|NCT01297491|526792849|FG000|Overall Study|Death|2|||
146074694|NCT01297491|526792850|FG001|Overall Study|Death|1|||
146074695|NCT04413617|526792854|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146074696|NCT04413617|526792855|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146074697|NCT04413617|526792856|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146074698|NCT04413617|526792857|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
146074699|NCT04413617|526792858|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
146074700|NCT04413617|526792854|FG000|Overall Study|Protocol Violation|0|||
146074701|NCT04413617|526792855|FG001|Overall Study|Protocol Violation|1|||
146074702|NCT04413617|526792856|FG002|Overall Study|Protocol Violation|0|||
146074703|NCT04413617|526792857|FG003|Overall Study|Protocol Violation|0|||
146074704|NCT04413617|526792858|FG004|Overall Study|Protocol Violation|1|||
146074705|NCT04413617|526792854|FG000|Overall Study|Lack of Efficacy|2|||
146074706|NCT04413617|526792855|FG001|Overall Study|Lack of Efficacy|0|||
146074707|NCT04413617|526792856|FG002|Overall Study|Lack of Efficacy|2|||
146074708|NCT04413617|526792857|FG003|Overall Study|Lack of Efficacy|1|||
146074709|NCT04413617|526792858|FG004|Overall Study|Lack of Efficacy|0|||
146074710|NCT04413617|526792854|FG000|Overall Study|Withdrawal by Subject|3|||
146074711|NCT04413617|526792855|FG001|Overall Study|Withdrawal by Subject|4|||
146074712|NCT04413617|526792856|FG002|Overall Study|Withdrawal by Subject|2|||
146074713|NCT04413617|526792857|FG003|Overall Study|Withdrawal by Subject|5|||
146074714|NCT04413617|526792858|FG004|Overall Study|Withdrawal by Subject|3|||
146074715|NCT04413617|526792854|FG000|Overall Study|Death|1|||
146074716|NCT04413617|526792855|FG001|Overall Study|Death|0|||
146074717|NCT04413617|526792856|FG002|Overall Study|Death|0|||
146074718|NCT04413617|526792857|FG003|Overall Study|Death|0|||
146074719|NCT04413617|526792858|FG004|Overall Study|Death|0|||
146074720|NCT04413617|526792854|FG000|Overall Study|Adverse Event|1|||
146074721|NCT04413617|526792855|FG001|Overall Study|Adverse Event|0|||
146074722|NCT04413617|526792856|FG002|Overall Study|Adverse Event|0|||
146074723|NCT04413617|526792857|FG003|Overall Study|Adverse Event|1|||
146074724|NCT04413617|526792858|FG004|Overall Study|Adverse Event|1|||
146074725|NCT04413617|526792854|FG000|Overall Study|COVID-19|0|||
146074726|NCT04413617|526792855|FG001|Overall Study|COVID-19|1|||
146074727|NCT04413617|526792856|FG002|Overall Study|COVID-19|0|||
146074728|NCT04413617|526792857|FG003|Overall Study|COVID-19|0|||
146074729|NCT04413617|526792858|FG004|Overall Study|COVID-19|0|||
146074730|NCT00312195|526792859|FG000|Overall Study|Adverse Event|4|||
146074731|NCT00312195|526792860|FG001|Overall Study|Adverse Event|6|||
146074732|NCT00312195|526792859|FG000|Overall Study|Lost to Follow-up|1|||
146074733|NCT00312195|526792860|FG001|Overall Study|Lost to Follow-up|0|||
146074734|NCT00312195|526792859|FG000|Overall Study|Protocol Violation|1|||
146074735|NCT00312195|526792860|FG001|Overall Study|Protocol Violation|0|||
146074736|NCT02511106|526792863|FG000|Overall Study|Lost to Follow-up|6|||
146074737|NCT02511106|526792864|FG001|Overall Study|Lost to Follow-up|4|||
146074738|NCT02511106|526792863|FG000|Overall Study|Withdrawal by Subject|24|||
146074739|NCT02511106|526792864|FG001|Overall Study|Withdrawal by Subject|21|||
146074740|NCT02511106|526792863|FG000|Overall Study|Death|42|||
146074741|NCT02511106|526792864|FG001|Overall Study|Death|82|||
146074742|NCT02511106|526792863|FG000|Overall Study|Ongoing study at data cut-off|3|||
146074743|NCT02511106|526792864|FG001|Overall Study|Ongoing study at data cut-off|2|||
146074744|NCT02511106|526792863|FG000|Overall Study|Without specified reason|3|||
146074745|NCT02511106|526792864|FG001|Overall Study|Without specified reason|0|||
146074746|NCT01015638|526792865|FG000|Overall Study|Withdrawal by Subject|1|||
146074747|NCT01015638|526792866|FG001|Overall Study|Withdrawal by Subject|0|||
146074748|NCT01703754|526792869|FG000|Overall Study|Clinically significant disease progression|2|||
146074749|NCT01703754|526792870|FG001|Overall Study|Clinically significant disease progression|2|||
146074750|NCT01703754|526792871|FG002|Overall Study|Clinically significant disease progression|1|||
146074751|NCT01703754|526792869|FG000|Overall Study|Adverse Event|1|||
146074752|NCT01703754|526792870|FG001|Overall Study|Adverse Event|1|||
146074753|NCT01703754|526792871|FG002|Overall Study|Adverse Event|0|||
146074754|NCT01703754|526792869|FG000|Overall Study|Withdrawal by Subject|2|||
146074755|NCT01703754|526792870|FG001|Overall Study|Withdrawal by Subject|0|||
146074756|NCT01703754|526792871|FG002|Overall Study|Withdrawal by Subject|0|||
146074757|NCT01459497|526792875|FG000|Overall Study|Inability to meet trial constraints.|1|||
146074758|NCT01459497|526792876|FG001|Overall Study|Inability to meet trial constraints.|0|||
146074759|NCT01459497|526792875|FG000|Overall Study|Physician Decision|1|||
146074760|NCT01459497|526792876|FG001|Overall Study|Physician Decision|1|||
146074761|NCT01459497|526792875|FG000|Overall Study|Hospitalization.|0|||
146074762|NCT01459497|526792876|FG001|Overall Study|Hospitalization.|3|||
146074763|NCT01459497|526792875|FG000|Overall Study|Disease progression.|0|||
146074764|NCT01459497|526792876|FG001|Overall Study|Disease progression.|1|||
146074765|NCT03530124|526792877|FG000|Overall Study|Withdrawal by Subject|0|||
146074766|NCT03530124|526792878|FG001|Overall Study|Withdrawal by Subject|1|||
146074767|NCT03530124|526792877|FG000|Overall Study|Protocol Violation|1|||
146074768|NCT03530124|526792878|FG001|Overall Study|Protocol Violation|0|||
146074769|NCT03530124|526792877|FG000|Overall Study|Discharged prior to study completion|1|||
146074770|NCT03530124|526792878|FG001|Overall Study|Discharged prior to study completion|0|||
146074771|NCT03179319|526792879|FG000|Overall Study|Lost to Follow-up|6|||
146074772|NCT03179319|526792880|FG001|Overall Study|Lost to Follow-up|0|||
146074773|NCT01120717|526792881|FG000|Overall Study|Withdrawal by Subject|11|||
146074774|NCT01120717|526792882|FG001|Overall Study|Withdrawal by Subject|6|||
146074775|NCT01120717|526792881|FG000|Overall Study|Adverse Event|10|||
146074776|NCT01120717|526792882|FG001|Overall Study|Adverse Event|6|||
146074777|NCT01120717|526792881|FG000|Overall Study|Protocol Deviation|2|||
146074778|NCT01120717|526792882|FG001|Overall Study|Protocol Deviation|5|||
146074779|NCT01120717|526792881|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146074780|NCT01120717|526792882|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146074781|NCT01120717|526792881|FG000|Overall Study|Lost to Follow-up|2|||
146074782|NCT01120717|526792882|FG001|Overall Study|Lost to Follow-up|3|||
146074783|NCT01120717|526792881|FG000|Overall Study|Death|3|||
146074784|NCT01120717|526792882|FG001|Overall Study|Death|1|||
146074785|NCT01120717|526792881|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146074786|NCT01120717|526792882|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146074787|NCT02379637|526792887|FG000|Overall Study|Protocol Violation|0|||
146074788|NCT02379637|526792888|FG001|Overall Study|Protocol Violation|1|||
145945306|NCT02407054|526308205|FG000|Overall Study|Non-compliance with Study|0|||
145945307|NCT02407054|526308206|FG001|Overall Study|Non-compliance with Study|2|||
145945308|NCT02407054|526308207|FG002|Overall Study|Non-compliance with Study|1|||
145945309|NCT02407054|526308205|FG000|Overall Study|Physician Decision|1|||
145945310|NCT02407054|526308206|FG001|Overall Study|Physician Decision|3|||
145945311|NCT02407054|526308207|FG002|Overall Study|Physician Decision|3|||
145945312|NCT02407054|526308205|FG000|Overall Study|Withdrawal by Subject|5|||
145945313|NCT02407054|526308206|FG001|Overall Study|Withdrawal by Subject|9|||
145945314|NCT02407054|526308207|FG002|Overall Study|Withdrawal by Subject|2|||
145945315|NCT00415597|526308208|FG000|Enrollment|Withdrawal by Subject|1|||
145945316|NCT00415597|526308208|FG000|Enrollment|Protocol Violation|1|||
145945317|NCT00415597|526308208|FG000|Treatment|Adverse Event|110|||
145945318|NCT00415597|526308208|FG000|Treatment|Lack of Efficacy|39|||
145945319|NCT00415597|526308208|FG000|Treatment|Protocol Violation|67|||
145945320|NCT00415597|526308208|FG000|Treatment|Physician Decision|3|||
145945321|NCT00415597|526308208|FG000|Treatment|Withdrawal by Subject|51|||
145945322|NCT00415597|526308208|FG000|Treatment|Lost to Follow-up|28|||
145945323|NCT00415597|526308208|FG000|Treatment|Drug Screen|2|||
145945324|NCT00415597|526308208|FG000|Treatment|Administrative|3|||
145945325|NCT00415597|526308208|FG000|Treatment|Sponsor Decision|1|||
145945326|NCT00415597|526308208|FG000|Treatment|Multiple Reasons|1|||
145945327|NCT04102865|526308210|FG000|Overall Study|Adverse Event|4|||
145945328|NCT04102865|526308211|FG001|Overall Study|Adverse Event|0|||
145945329|NCT04102865|526308210|FG000|Overall Study|Lost to Follow-up|1|||
146074789|NCT02379637|526792887|FG000|Overall Study|Adverse Event|1|||
146074790|NCT02379637|526792888|FG001|Overall Study|Adverse Event|0|||
146074791|NCT02379637|526792887|FG000|Overall Study|Withdrawal by Subject|1|||
146074792|NCT02379637|526792888|FG001|Overall Study|Withdrawal by Subject|0|||
146074793|NCT01309282|526792890|FG000|Overall Study|Lost to Follow-up|1|||
146074794|NCT02445794|526792891|FG000|Overall Study|Adverse Event|0|||
146074795|NCT02445794|526792892|FG001|Overall Study|Adverse Event|0|||
146074796|NCT02445794|526792893|FG002|Overall Study|Adverse Event|2|||
146074797|NCT02445794|526792894|FG003|Overall Study|Adverse Event|0|||
146074798|NCT01136785|526792895|FG000|Overall Study|Protocol Violation|2|||
146074799|NCT01136785|526792896|FG001|Overall Study|Protocol Violation|1|||
146074800|NCT00233064|526792897|FG000|Overall Study|Lost to Follow-up|7|||
146074801|NCT00233064|526792898|FG001|Overall Study|Lost to Follow-up|7|||
146074802|NCT00233064|526792897|FG000|Overall Study|Withdrawal by Subject|5|||
146074803|NCT00233064|526792898|FG001|Overall Study|Withdrawal by Subject|3|||
146074804|NCT00233064|526792897|FG000|Overall Study|Death|0|||
146074805|NCT00233064|526792898|FG001|Overall Study|Death|1|||
146074806|NCT00233064|526792897|FG000|Overall Study|Relocation|0|||
146074807|NCT00233064|526792898|FG001|Overall Study|Relocation|1|||
146074808|NCT00233064|526792897|FG000|Overall Study|Protocol Violation|1|||
146074809|NCT00233064|526792898|FG001|Overall Study|Protocol Violation|0|||
146074810|NCT00233064|526792897|FG000|Overall Study|Moved to Dom. Republic|1|||
146074811|NCT00233064|526792898|FG001|Overall Study|Moved to Dom. Republic|0|||
146074812|NCT04976192|526792901|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074813|NCT04976192|526792902|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
146074814|NCT04976192|526792903|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074815|NCT04976192|526792904|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074816|NCT04976192|526792905|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074817|NCT04976192|526792906|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074818|NCT04976192|526792907|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074819|NCT04976192|526792908|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074820|NCT04976192|526792909|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074821|NCT04976192|526792910|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
146074822|NCT04976192|526792901|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
146074823|NCT04976192|526792902|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146074824|NCT04976192|526792903|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
146074825|NCT04976192|526792904|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146074826|NCT04976192|526792905|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074827|NCT04976192|526792906|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074828|NCT04976192|526792907|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074829|NCT04976192|526792908|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074830|NCT04976192|526792909|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074831|NCT04976192|526792910|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074832|NCT04976192|526792901|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
146074833|NCT04976192|526792902|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074834|NCT04976192|526792903|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
146074835|NCT04976192|526792904|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074836|NCT04976192|526792905|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074837|NCT04976192|526792906|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074838|NCT04976192|526792907|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074839|NCT04976192|526792908|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074840|NCT04976192|526792909|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074841|NCT04976192|526792910|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
146074842|NCT04976192|526792901|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074843|NCT04976192|526792902|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074844|NCT04976192|526792903|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074845|NCT04976192|526792904|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146074846|NCT04976192|526792905|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
146074847|NCT04976192|526792906|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146074848|NCT04976192|526792907|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146074849|NCT04976192|526792908|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146074850|NCT04976192|526792909|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146074851|NCT04976192|526792910|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146074852|NCT04976192|526792901|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074853|NCT04976192|526792902|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074854|NCT04976192|526792903|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074855|NCT04976192|526792904|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146174389|NCT02569710|527151374|FG009|Overall Study|Lost to Follow-up|0|||
146174390|NCT02569710|527151365|FG000|Overall Study|Virologic failure|0|||
145945330|NCT04102865|526308211|FG001|Overall Study|Lost to Follow-up|0|||
145945331|NCT04102865|526308210|FG000|Overall Study|Withdrawal by Subject|2|||
146074856|NCT04976192|526792905|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
146074857|NCT04976192|526792906|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074858|NCT04976192|526792907|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074859|NCT04976192|526792908|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074860|NCT04976192|526792909|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074861|NCT04976192|526792910|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
146074862|NCT04976192|526792901|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074863|NCT04976192|526792902|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074864|NCT04976192|526792903|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074865|NCT04976192|526792904|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074866|NCT04976192|526792905|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074867|NCT04976192|526792906|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146074868|NCT04976192|526792907|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074869|NCT04976192|526792908|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074870|NCT04976192|526792909|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074871|NCT04976192|526792910|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146074872|NCT01925131|526794889|FG000|Overall Study|Death|0|||
146074873|NCT01925131|526794890|FG001|Overall Study|Death|0|||
146074874|NCT01925131|526794891|FG002|Overall Study|Death|1|||
146074875|NCT01925131|526794892|FG003|Overall Study|Death|0|||
146074876|NCT01925131|526794893|FG004|Overall Study|Death|0|||
146074877|NCT01925131|526794894|FG005|Overall Study|Death|0|||
146074878|NCT01925131|526794889|FG000|Overall Study|Progression/Relapse|1|||
146074879|NCT01925131|526794890|FG001|Overall Study|Progression/Relapse|1|||
146074880|NCT01925131|526794891|FG002|Overall Study|Progression/Relapse|4|||
146074881|NCT01925131|526794892|FG003|Overall Study|Progression/Relapse|0|||
146074882|NCT01925131|526794893|FG004|Overall Study|Progression/Relapse|0|||
146074883|NCT01925131|526794894|FG005|Overall Study|Progression/Relapse|1|||
146074884|NCT01925131|526794889|FG000|Overall Study|Patient Refusal|1|||
146074885|NCT01925131|526794890|FG001|Overall Study|Patient Refusal|0|||
146074886|NCT01925131|526794891|FG002|Overall Study|Patient Refusal|0|||
146074887|NCT01925131|526794892|FG003|Overall Study|Patient Refusal|0|||
146074888|NCT01925131|526794893|FG004|Overall Study|Patient Refusal|0|||
146074889|NCT01925131|526794894|FG005|Overall Study|Patient Refusal|0|||
146074890|NCT01925131|526794889|FG000|Overall Study|Adverse Event|0|||
146074891|NCT01925131|526794890|FG001|Overall Study|Adverse Event|0|||
146074892|NCT01925131|526794891|FG002|Overall Study|Adverse Event|2|||
146074893|NCT01925131|526794892|FG003|Overall Study|Adverse Event|0|||
146074894|NCT01925131|526794893|FG004|Overall Study|Adverse Event|1|||
146074895|NCT01925131|526794894|FG005|Overall Study|Adverse Event|3|||
146074896|NCT01925131|526794889|FG000|Overall Study|Other - Not Protocol Specified|3|||
146074897|NCT01925131|526794890|FG001|Overall Study|Other - Not Protocol Specified|1|||
146074898|NCT01925131|526794891|FG002|Overall Study|Other - Not Protocol Specified|2|||
146074899|NCT01925131|526794892|FG003|Overall Study|Other - Not Protocol Specified|5|||
146074900|NCT01925131|526794893|FG004|Overall Study|Other - Not Protocol Specified|10|||
146074901|NCT01925131|526794894|FG005|Overall Study|Other - Not Protocol Specified|6|||
146074902|NCT04838977|526794895|FG000|Overall Study|Lost to Follow-up|2|||
146074903|NCT04838977|526794896|FG001|Overall Study|Lost to Follow-up|3|||
146074904|NCT04838977|526794895|FG000|Overall Study|Withdrawal by Subject|1|||
146074905|NCT04838977|526794896|FG001|Overall Study|Withdrawal by Subject|1|||
146074906|NCT00265148|526794897|FG000|Overall Study|Adverse Event|2|||
146074907|NCT00265148|526794898|FG001|Overall Study|Adverse Event|2|||
146074908|NCT00265148|526794897|FG000|Overall Study|Lack of Efficacy|0|||
146074909|NCT00265148|526794898|FG001|Overall Study|Lack of Efficacy|2|||
146074910|NCT00265148|526794897|FG000|Overall Study|Protocol Violation|3|||
146074911|NCT00265148|526794898|FG001|Overall Study|Protocol Violation|2|||
146074912|NCT00265148|526794897|FG000|Overall Study|Lost to Follow-up|0|||
146074913|NCT00265148|526794898|FG001|Overall Study|Lost to Follow-up|1|||
146074914|NCT00265148|526794897|FG000|Overall Study|Withdrawal by Subject|2|||
146074915|NCT00265148|526794898|FG001|Overall Study|Withdrawal by Subject|1|||
146074916|NCT00265148|526794897|FG000|Overall Study|Physician Decision|1|||
146074917|NCT00265148|526794898|FG001|Overall Study|Physician Decision|0|||
146074918|NCT00265148|526794897|FG000|Overall Study|Increasing frailty|0|||
146074919|NCT00265148|526794898|FG001|Overall Study|Increasing frailty|1|||
146074920|NCT00265148|526794897|FG000|Overall Study|Subject chose to change of the dose|1|||
146074921|NCT00265148|526794898|FG001|Overall Study|Subject chose to change of the dose|0|||
146074922|NCT01463007|526794899|FG000|Overall Study|Physician Decision|1|||
146074923|NCT00942994|526794900|FG000|Overall Study|Adverse Event|7|||
146074924|NCT00942994|526794901|FG001|Overall Study|Adverse Event|4|||
146074925|NCT00942994|526794900|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146074926|NCT00942994|526794901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146074927|NCT00942994|526794900|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146074928|NCT00942994|526794901|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146074929|NCT00942994|526794900|FG000|Overall Study|Patient withdrew consent|5|||
146074930|NCT00942994|526794901|FG001|Overall Study|Patient withdrew consent|8|||
146074931|NCT00942994|526794900|FG000|Overall Study|Lost to Follow-up|1|||
146074932|NCT00942994|526794901|FG001|Overall Study|Lost to Follow-up|4|||
146074933|NCT00942994|526794900|FG000|Overall Study|Protocol deviation|1|||
146074934|NCT00942994|526794901|FG001|Overall Study|Protocol deviation|2|||
146074935|NCT03583385|526794902|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146074936|NCT03583385|526794903|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146074937|NCT03583385|526794902|FG000|Treatment Period 2|Adverse Event|1|||
146074938|NCT03583385|526794903|FG001|Treatment Period 2|Adverse Event|0|||
146074939|NCT00095940|526794904|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
146074940|NCT00095940|526794905|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
146074941|NCT00095940|526794906|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
146074942|NCT00095940|526794907|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
146074943|NCT00095940|526794908|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
146074944|NCT00095940|526794909|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
146074945|NCT00095940|526794910|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
146074946|NCT00095940|526794911|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
146074947|NCT00095940|526794912|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
146074948|NCT00095940|526794904|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146074949|NCT00095940|526794905|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146410777|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
146410778|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
146410779|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
146410780|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
146410781|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
146410782|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
146410783|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
146410784|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
146410785|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
146410786|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
146410787|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
146410788|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
146410789|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
146410790|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
146410791|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
146410792|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
146410793|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
146410794|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
146410795|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
146410796|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
146410797|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
146410798|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
146410799|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
146410800|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
146410801|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
146410802|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146410803|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146410804|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
146410805|NCT00528879|528009448|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146410806|NCT00528879|528009449|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146410807|NCT00528879|528009450|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
146410808|NCT00528879|528009451|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
146410809|NCT00971204|528009452|FG000|Overall Study|Did not meet all criteria-not treated|14|||
146410810|NCT00971204|528009452|FG000|Overall Study|Lost to Follow-up|10|||
146410811|NCT01280981|528009455|FG000|Overall Study|Withdrawal by Subject|11|||
146410812|NCT01280981|528009455|FG000|Overall Study|Protocol Violation|2|||
146410813|NCT01280981|528009455|FG000|Overall Study|Lack of Efficacy|13|||
146410814|NCT01280981|528009455|FG000|Overall Study|Lost to Follow-up|3|||
146410815|NCT01280981|528009455|FG000|Overall Study|Adverse Event|6|||
146410816|NCT01280981|528009455|FG000|Overall Study|Irregular or discontinued menses|3|||
146410817|NCT01280981|528009455|FG000|Overall Study|Failed to return|45|||
146410818|NCT01280981|528009455|FG000|Overall Study|Non-compliance with protocol|3|||
146410819|NCT01280981|528009455|FG000|Overall Study|Withdrawal of consent|3|||
146410820|NCT01280981|528009455|FG000|Overall Study|Elective surgery|2|||
146410821|NCT01280981|528009455|FG000|Overall Study|Study site closure|1|||
146410822|NCT01256398|528009456|FG000|Overall Study|Withdrawal by Subject|1|||
146410823|NCT01364298|528009462|FG000|Overall Study|Adverse Event|3|||
146410824|NCT01364298|528009463|FG001|Overall Study|Adverse Event|4|||
146174391|NCT02569710|527151366|FG001|Overall Study|Virologic failure|0|||
146074950|NCT00095940|526794906|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146074951|NCT00095940|526794907|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146074952|NCT00095940|526794908|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146074953|NCT00095940|526794909|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146074954|NCT00095940|526794910|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146410825|NCT01364298|528009462|FG000|Overall Study|Lack of adherence to treatment|1|||
146410826|NCT01364298|528009463|FG001|Overall Study|Lack of adherence to treatment|3|||
146410827|NCT01364298|528009462|FG000|Overall Study|Lack of Efficacy|1|||
146410828|NCT01364298|528009463|FG001|Overall Study|Lack of Efficacy|0|||
146410829|NCT01364298|528009462|FG000|Overall Study|Lost to Follow-up|5|||
146410830|NCT01364298|528009463|FG001|Overall Study|Lost to Follow-up|10|||
146410831|NCT01364298|528009462|FG000|Overall Study|Withdrawal by Subject|3|||
146410832|NCT01364298|528009463|FG001|Overall Study|Withdrawal by Subject|3|||
146410833|NCT01364298|528009462|FG000|Overall Study|Other|1|||
146410834|NCT01364298|528009463|FG001|Overall Study|Other|3|||
146410835|NCT03550794|528009464|FG000|Overall Study|No longer met inclusion criteria|1|||
146410836|NCT03550794|528009465|FG001|Overall Study|No longer met inclusion criteria|2|||
146410837|NCT03550794|528009464|FG000|Overall Study|Goals of care changed|1|||
146410838|NCT03550794|528009465|FG001|Overall Study|Goals of care changed|0|||
146410839|NCT03550794|528009464|FG000|Overall Study|Withdrawal by Subject|2|||
146410840|NCT03550794|528009465|FG001|Overall Study|Withdrawal by Subject|0|||
146410841|NCT03550794|528009464|FG000|Overall Study|Death|0|||
146410842|NCT03550794|528009465|FG001|Overall Study|Death|1|||
146410843|NCT01864525|528009466|FG000|Overall Study|Adverse Event|1|||
146410844|NCT01864525|528009467|FG001|Overall Study|Adverse Event|0|||
146410845|NCT01890785|528009468|FG000|Third Intervention|Withdrawal by Subject|0|||
146410846|NCT01890785|528009469|FG001|Third Intervention|Withdrawal by Subject|1|||
146410847|NCT01890785|528009470|FG002|Third Intervention|Withdrawal by Subject|0|||
146410848|NCT01890785|528009471|FG003|Third Intervention|Withdrawal by Subject|0|||
146410849|NCT01890785|528009472|FG004|Third Intervention|Withdrawal by Subject|0|||
146410850|NCT01890785|528009473|FG005|Third Intervention|Withdrawal by Subject|0|||
146410851|NCT03296553|528009474|FG000|Overall Study|Withdrawal by Subject|1|||
146410852|NCT03296553|528009475|FG001|Overall Study|Withdrawal by Subject|1|||
146410853|NCT03296553|528009474|FG000|Overall Study|Death|1|||
146410854|NCT03296553|528009475|FG001|Overall Study|Death|0|||
146410855|NCT00065065|528009476|FG000|Overall Study|Adverse Event|3|||
146410856|NCT00065065|528009477|FG001|Overall Study|Adverse Event|2|||
146410857|NCT00065065|528009476|FG000|Overall Study|Withdrawal by Subject|1|||
146410858|NCT00065065|528009477|FG001|Overall Study|Withdrawal by Subject|5|||
146410859|NCT00065065|528009476|FG000|Overall Study|Lack of Efficacy|4|||
146410860|NCT00065065|528009477|FG001|Overall Study|Lack of Efficacy|11|||
146410861|NCT00065065|528009476|FG000|Overall Study|Other|2|||
146410862|NCT00065065|528009477|FG001|Overall Study|Other|2|||
146410863|NCT01050673|528009478|FG000|Overall Study|Physician Decision|4|||
146410864|NCT01050673|528009479|FG001|Overall Study|Physician Decision|5|||
146410865|NCT04363736|528009480|FG000|Overall Study|Withdrawal by Subject|1|||
146410866|NCT04363736|528009481|FG001|Overall Study|Withdrawal by Subject|0|||
146410867|NCT04363736|528009480|FG000|Overall Study|Lost to Follow-up|10|||
146410868|NCT04363736|528009481|FG001|Overall Study|Lost to Follow-up|7|||
146410869|NCT04363736|528009480|FG000|Overall Study|Death|8|||
146410870|NCT04363736|528009481|FG001|Overall Study|Death|6|||
146410871|NCT01254045|528009482|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
146410872|NCT01254045|528009483|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146410873|NCT01254045|528009484|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146410874|NCT01254045|528009485|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146410875|NCT01254045|528009486|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146174392|NCT02569710|527151367|FG002|Overall Study|Virologic failure|0|||
146174393|NCT02569710|527151368|FG003|Overall Study|Virologic failure|0|||
146174394|NCT02569710|527151369|FG004|Overall Study|Virologic failure|1|||
146174395|NCT02569710|527151370|FG005|Overall Study|Virologic failure|0|||
146174396|NCT02569710|527151371|FG006|Overall Study|Virologic failure|1|||
146174397|NCT02569710|527151372|FG007|Overall Study|Virologic failure|0|||
146174398|NCT02569710|527151373|FG008|Overall Study|Virologic failure|0|||
146174399|NCT02569710|527151374|FG009|Overall Study|Virologic failure|0|||
146174400|NCT02569710|527151365|FG000|Overall Study|Withdrawal by Subject|0|||
146174401|NCT02569710|527151366|FG001|Overall Study|Withdrawal by Subject|0|||
146174402|NCT02569710|527151367|FG002|Overall Study|Withdrawal by Subject|0|||
146174403|NCT02569710|527151368|FG003|Overall Study|Withdrawal by Subject|0|||
146174404|NCT02569710|527151369|FG004|Overall Study|Withdrawal by Subject|0|||
146174405|NCT02569710|527151370|FG005|Overall Study|Withdrawal by Subject|1|||
146174406|NCT02569710|527151371|FG006|Overall Study|Withdrawal by Subject|0|||
146174407|NCT02569710|527151372|FG007|Overall Study|Withdrawal by Subject|0|||
146174408|NCT02569710|527151373|FG008|Overall Study|Withdrawal by Subject|0|||
146174409|NCT02569710|527151374|FG009|Overall Study|Withdrawal by Subject|0|||
146174410|NCT01125722|527151375|FG000|Overall Study|Withdrawal by Subject|2|||
146174411|NCT01125722|527151376|FG001|Overall Study|Withdrawal by Subject|1|||
146174412|NCT01125722|527151375|FG000|Overall Study|Lost to Follow-up|1|||
146174413|NCT01125722|527151376|FG001|Overall Study|Lost to Follow-up|0|||
146174414|NCT03573908|527151377|FG000|Treatment Period|Adverse Event|4|||
146174415|NCT03573908|527151378|FG001|Treatment Period|Adverse Event|9|||
146174416|NCT03573908|527151379|FG002|Treatment Period|Adverse Event|0|||
146174417|NCT03573908|527151380|FG003|Treatment Period|Adverse Event|0|||
146174418|NCT03573908|527151381|FG004|Treatment Period|Adverse Event|0|||
146174419|NCT03573908|527151377|FG000|Treatment Period|Protocol Violation|1|||
146174420|NCT03573908|527151378|FG001|Treatment Period|Protocol Violation|0|||
146174421|NCT03573908|527151379|FG002|Treatment Period|Protocol Violation|0|||
146174422|NCT03573908|527151380|FG003|Treatment Period|Protocol Violation|0|||
146174423|NCT03573908|527151381|FG004|Treatment Period|Protocol Violation|0|||
146174424|NCT03573908|527151377|FG000|Treatment Period|Withdrawal by Subject|7|||
146174425|NCT03573908|527151378|FG001|Treatment Period|Withdrawal by Subject|5|||
146174426|NCT03573908|527151379|FG002|Treatment Period|Withdrawal by Subject|0|||
146174427|NCT03573908|527151380|FG003|Treatment Period|Withdrawal by Subject|0|||
146174428|NCT03573908|527151381|FG004|Treatment Period|Withdrawal by Subject|0|||
146174429|NCT03573908|527151377|FG000|Treatment Period|Lost to Follow-up|7|||
146174430|NCT03573908|527151378|FG001|Treatment Period|Lost to Follow-up|6|||
146174431|NCT03573908|527151379|FG002|Treatment Period|Lost to Follow-up|0|||
146174432|NCT03573908|527151380|FG003|Treatment Period|Lost to Follow-up|0|||
146174433|NCT03573908|527151381|FG004|Treatment Period|Lost to Follow-up|0|||
146174434|NCT03573908|527151377|FG000|Treatment Period|Pregnancy|1|||
146174435|NCT03573908|527151378|FG001|Treatment Period|Pregnancy|0|||
146174436|NCT03573908|527151379|FG002|Treatment Period|Pregnancy|0|||
146174437|NCT03573908|527151380|FG003|Treatment Period|Pregnancy|0|||
146174438|NCT03573908|527151381|FG004|Treatment Period|Pregnancy|0|||
146174439|NCT03573908|527151377|FG000|Treatment Period|Other, Not Specified|4|||
146174440|NCT03573908|527151378|FG001|Treatment Period|Other, Not Specified|6|||
146174441|NCT03573908|527151379|FG002|Treatment Period|Other, Not Specified|0|||
146174442|NCT03573908|527151380|FG003|Treatment Period|Other, Not Specified|0|||
146174443|NCT03573908|527151381|FG004|Treatment Period|Other, Not Specified|0|||
146174444|NCT03573908|527151377|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146174445|NCT03573908|527151378|FG001|Randomized Withdrawal Period|Adverse Event|0|||
146174446|NCT03573908|527151379|FG002|Randomized Withdrawal Period|Adverse Event|3|||
146174447|NCT03573908|527151380|FG003|Randomized Withdrawal Period|Adverse Event|0|||
146174448|NCT03573908|527151381|FG004|Randomized Withdrawal Period|Adverse Event|0|||
146174449|NCT03573908|527151377|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146174450|NCT03573908|527151378|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146174451|NCT03573908|527151379|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146174452|NCT03573908|527151380|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146174453|NCT03573908|527151381|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
146174454|NCT03573908|527151377|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
146174455|NCT03573908|527151378|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
146174456|NCT03573908|527151379|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
146174457|NCT03573908|527151380|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
146174458|NCT03573908|527151381|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
146174459|NCT03573908|527151377|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
146174460|NCT03573908|527151378|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
146174461|NCT03573908|527151379|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
146174462|NCT03573908|527151380|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
146174463|NCT03573908|527151381|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
146174464|NCT04006925|527151382|FG000|Overall Study|Side effects|2|||
146174465|NCT04006925|527151383|FG001|Overall Study|Side effects|0|||
146174466|NCT01555164|527151390|FG000|Overall Study|Adverse Event|5|||
146174467|NCT01555164|527151391|FG001|Overall Study|Adverse Event|7|||
146174468|NCT01555164|527151390|FG000|Overall Study|Hyperglycemia|0|||
146410876|NCT01254045|528009487|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
146410877|NCT00520351|528009488|FG000|First Intervention|Withdrawal by Subject|1|||
146410878|NCT00520351|528009489|FG001|First Intervention|Withdrawal by Subject|1|||
146410879|NCT03797222|528009491|FG000|Overall Study|Withdrawal by Subject|1|||
146410880|NCT03439293|528009493|FG000|Overall Study|Death|22|||
146410881|NCT03439293|528009493|FG000|Overall Study|Withdrawal by Subject|8|||
146410882|NCT03439293|528009493|FG000|Overall Study|Lost to Follow-up|2|||
146410883|NCT03439293|528009493|FG000|Overall Study|Reason Not Specified|28|||
146410884|NCT03439293|528009493|FG000|Overall Study|Missing|1|||
146410885|NCT04288115|528009500|FG000|Overall Study|Withdrawal by Subject|0|||
146410886|NCT04288115|528009501|FG001|Overall Study|Withdrawal by Subject|1|||
146410887|NCT04288115|528009500|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
146410888|NCT04288115|528009501|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
146410889|NCT00729365|528009502|FG000|Overall Study|Physician Decision|33|||
146410890|NCT00729365|528009503|FG001|Overall Study|Physician Decision|6|||
146410891|NCT00729365|528009504|FG002|Overall Study|Physician Decision|7|||
146410892|NCT00869089|528009508|FG000|Overall Study|Lost to Follow-up|1|||
146410893|NCT00869089|528009508|FG000|Overall Study|Withdrawal by Subject|1|||
146410894|NCT00869089|528009508|FG000|Overall Study|Screen Fail|1|||
146410895|NCT02766400|528009509|FG000|Overall Study|Death|1|||
146410896|NCT02766400|528009510|FG001|Overall Study|Death|2|||
146410897|NCT02766400|528009509|FG000|Overall Study|Withdrawal by Subject|1|||
146410898|NCT02766400|528009510|FG001|Overall Study|Withdrawal by Subject|0|||
146410899|NCT01374906|528009511|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146410900|NCT01374906|528009512|FG001|Overall Study|Abnormal laboratory value(s)|3|||
146410901|NCT01374906|528009511|FG000|Overall Study|Administrative problems|2|||
146174469|NCT01555164|527151391|FG001|Overall Study|Hyperglycemia|1|||
146283911|NCT01942590|527551880|FG001|Overall Study|Adverse Event|0|||
146174470|NCT01555164|527151390|FG000|Overall Study|Investigator's Discretion|2|||
146174471|NCT01555164|527151391|FG001|Overall Study|Investigator's Discretion|2|||
146174472|NCT01555164|527151390|FG000|Overall Study|Lost to Follow-up|4|||
146174473|NCT01555164|527151391|FG001|Overall Study|Lost to Follow-up|3|||
146174474|NCT01555164|527151390|FG000|Overall Study|Protocol Violation|9|||
146174475|NCT01555164|527151391|FG001|Overall Study|Protocol Violation|5|||
146174476|NCT01555164|527151390|FG000|Overall Study|Subject Non-compliance|14|||
146174477|NCT01555164|527151391|FG001|Overall Study|Subject Non-compliance|6|||
146410902|NCT01374906|528009512|FG001|Overall Study|Administrative problems|2|||
146410903|NCT01374906|528009511|FG000|Overall Study|Adverse Event|10|||
146410904|NCT01374906|528009512|FG001|Overall Study|Adverse Event|11|||
146410905|NCT01374906|528009511|FG000|Overall Study|Death|0|||
146410906|NCT01374906|528009512|FG001|Overall Study|Death|2|||
146410907|NCT01374906|528009511|FG000|Overall Study|Protocol Violation|2|||
146410908|NCT01374906|528009512|FG001|Overall Study|Protocol Violation|2|||
146410909|NCT01374906|528009511|FG000|Overall Study|Withdrawal by Subject|15|||
146410910|NCT01374906|528009512|FG001|Overall Study|Withdrawal by Subject|9|||
146410911|NCT01374906|528009511|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
146410912|NCT01374906|528009512|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
146410913|NCT00430638|528009517|FG000|Overall Study|Adverse Event|15|||
146410914|NCT00430638|528009518|FG001|Overall Study|Adverse Event|15|||
146410915|NCT00430638|528009517|FG000|Overall Study|Uncontrolled blood pressure|48|||
146410916|NCT00430638|528009518|FG001|Overall Study|Uncontrolled blood pressure|13|||
146410917|NCT00430638|528009517|FG000|Overall Study|Lost to Follow-up|1|||
146410918|NCT00430638|528009518|FG001|Overall Study|Lost to Follow-up|7|||
146410919|NCT00430638|528009517|FG000|Overall Study|Protocol Violation|6|||
146410920|NCT00430638|528009518|FG001|Overall Study|Protocol Violation|4|||
146410921|NCT00430638|528009517|FG000|Overall Study|Withdrawal by Subject|4|||
146410922|NCT00430638|528009518|FG001|Overall Study|Withdrawal by Subject|6|||
146410923|NCT00430638|528009517|FG000|Overall Study|Non-compliant|2|||
146410924|NCT00430638|528009518|FG001|Overall Study|Non-compliant|1|||
146410925|NCT00430638|528009517|FG000|Overall Study|Other|2|||
146410926|NCT00430638|528009518|FG001|Overall Study|Other|2|||
146410927|NCT02367781|528009519|FG000|Overall Study|Withdrawal by Subject|20|||
146410928|NCT02367781|528009520|FG001|Overall Study|Withdrawal by Subject|13|||
146410929|NCT02367781|528009519|FG000|Overall Study|Protocol Violation|0|||
146410930|NCT02367781|528009520|FG001|Overall Study|Protocol Violation|1|||
146410931|NCT02367781|528009519|FG000|Overall Study|Physician Decision|7|||
146410932|NCT02367781|528009520|FG001|Overall Study|Physician Decision|0|||
146410933|NCT02367781|528009519|FG000|Overall Study|Randomized in Error|5|||
146410934|NCT02367781|528009520|FG001|Overall Study|Randomized in Error|4|||
146410935|NCT02367781|528009519|FG000|Overall Study|Non-Compliance|1|||
146410936|NCT02367781|528009520|FG001|Overall Study|Non-Compliance|0|||
146410937|NCT02367781|528009519|FG000|Overall Study|Lost to Follow-up|1|||
146410938|NCT02367781|528009520|FG001|Overall Study|Lost to Follow-up|2|||
146410939|NCT02367781|528009519|FG000|Overall Study|Death|330|||
146410940|NCT02367781|528009520|FG001|Overall Study|Death|176|||
146410941|NCT02367781|528009519|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
146410942|NCT02367781|528009520|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
146410943|NCT02367781|528009519|FG000|Overall Study|Prolonged Hospitalization|1|||
146410944|NCT02367781|528009520|FG001|Overall Study|Prolonged Hospitalization|0|||
146410945|NCT02367781|528009519|FG000|Overall Study|Death Prior First Dose|1|||
146410946|NCT02367781|528009520|FG001|Overall Study|Death Prior First Dose|0|||
146410947|NCT02367781|528009519|FG000|Overall Study|Administrative-Change Facility|1|||
146410948|NCT02367781|528009520|FG001|Overall Study|Administrative-Change Facility|0|||
146410949|NCT02367781|528009519|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
146410950|NCT02367781|528009520|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
146410951|NCT02367781|528009519|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
146410952|NCT02367781|528009520|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
146410953|NCT02367781|528009519|FG000|Overall Study|Study Terminated by Sponsor|3|||
146410954|NCT02367781|528009520|FG001|Overall Study|Study Terminated by Sponsor|1|||
146410955|NCT02367781|528009519|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
146410956|NCT02367781|528009520|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
146410957|NCT02367781|528009519|FG000|Overall Study|Sponsor Decision|2|||
146410958|NCT02367781|528009520|FG001|Overall Study|Sponsor Decision|0|||
146410959|NCT02367781|528009519|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
146410960|NCT02367781|528009520|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
146410961|NCT01529749|528009521|FG000|Overall Study|Lost to Follow-up|0|||
146410962|NCT01529749|528009522|FG001|Overall Study|Lost to Follow-up|1|||
146410963|NCT01529749|528009523|FG002|Overall Study|Lost to Follow-up|1|||
146410964|NCT01529749|528009524|FG003|Overall Study|Lost to Follow-up|0|||
146410965|NCT01529749|528009521|FG000|Overall Study|Physician Decision|0|||
146410966|NCT01529749|528009522|FG001|Overall Study|Physician Decision|0|||
146410967|NCT01529749|528009523|FG002|Overall Study|Physician Decision|0|||
146410968|NCT01529749|528009524|FG003|Overall Study|Physician Decision|1|||
146410969|NCT01529749|528009521|FG000|Overall Study|Withdrawal by Subject|0|||
146410970|NCT01529749|528009522|FG001|Overall Study|Withdrawal by Subject|1|||
146410971|NCT01529749|528009523|FG002|Overall Study|Withdrawal by Subject|1|||
146410972|NCT01529749|528009524|FG003|Overall Study|Withdrawal by Subject|0|||
146410973|NCT01529749|528009521|FG000|Overall Study|Protocol Violation|0|||
146410974|NCT01529749|528009522|FG001|Overall Study|Protocol Violation|0|||
146410975|NCT01529749|528009523|FG002|Overall Study|Protocol Violation|0|||
146410976|NCT01529749|528009524|FG003|Overall Study|Protocol Violation|1|||
146410977|NCT00378482|528009525|FG000|Overall Study|Lost to Follow-up|1|||
145945332|NCT04102865|526308211|FG001|Overall Study|Withdrawal by Subject|0|||
145945333|NCT01764997|526308212|FG000|Run-in Period|Adverse Event|15|||
146174478|NCT01555164|527151390|FG000|Overall Study|Subject Withdrew Consent|6|||
146174479|NCT01555164|527151391|FG001|Overall Study|Subject Withdrew Consent|11|||
146174480|NCT03443713|527151392|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
146174481|NCT03443713|527151393|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
146174482|NCT03443713|527151394|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
146174483|NCT01672853|527151399|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
146174484|NCT01672853|527151400|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
146283912|NCT03562975|527551892|FG000|Overall Study|Death|1|||
146410978|NCT00378482|528009525|FG000|Overall Study|Lack of Efficacy|8|||
146410979|NCT00378482|528009525|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
146410980|NCT00378482|528009525|FG000|Overall Study|Withdrawal by Subject|4|||
146410981|NCT00378482|528009525|FG000|Overall Study|Adverse Event|9|||
146410982|NCT05166421|528009526|FG000|Overall Study|Other|3|||
146410983|NCT05166421|528009527|FG001|Overall Study|Other|1|||
146410984|NCT05166421|528009528|FG002|Overall Study|Other|1|||
146410985|NCT05166421|528009526|FG000|Overall Study|Withdrawal by Subject|5|||
146410986|NCT05166421|528009527|FG001|Overall Study|Withdrawal by Subject|3|||
146410987|NCT05166421|528009528|FG002|Overall Study|Withdrawal by Subject|6|||
146410988|NCT05166421|528009526|FG000|Overall Study|Lost to Follow-up|4|||
146410989|NCT05166421|528009527|FG001|Overall Study|Lost to Follow-up|1|||
146410990|NCT05166421|528009528|FG002|Overall Study|Lost to Follow-up|7|||
146410991|NCT01335399|528010687|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
146410992|NCT01335399|528010688|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
146410993|NCT01335399|528010687|FG000|Pre-treatment Period|Participant request to discontinue|0|||
146410994|NCT01335399|528010688|FG001|Pre-treatment Period|Participant request to discontinue|1|||
146410995|NCT01335399|528010687|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
146410996|NCT01335399|528010688|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
146410997|NCT01335399|528010687|FG000|Pre-treatment Period|Consent withdrawal|3|||
146410998|NCT01335399|528010688|FG001|Pre-treatment Period|Consent withdrawal|0|||
146410999|NCT01335399|528010687|FG000|Treatment Period|Disease progression|117|||
146411000|NCT01335399|528010688|FG001|Treatment Period|Disease progression|145|||
146411001|NCT01335399|528010687|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
146411002|NCT01335399|528010688|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
146411003|NCT01335399|528010687|FG000|Treatment Period|Study drug toxicity|52|||
146411004|NCT01335399|528010688|FG001|Treatment Period|Study drug toxicity|64|||
146411005|NCT01335399|528010687|FG000|Treatment Period|Participant request to discontinue|30|||
146411006|NCT01335399|528010688|FG001|Treatment Period|Participant request to discontinue|22|||
146411007|NCT01335399|528010687|FG000|Treatment Period|Other reasons|30|||
146411008|NCT01335399|528010688|FG001|Treatment Period|Other reasons|30|||
146411009|NCT01335399|528010687|FG000|Treatment Period|Consent withdrawal|10|||
146411010|NCT01335399|528010688|FG001|Treatment Period|Consent withdrawal|7|||
146411011|NCT01335399|528010687|FG000|Treatment Period|Death|7|||
146411012|NCT01335399|528010688|FG001|Treatment Period|Death|6|||
146411013|NCT01335399|528010687|FG000|Treatment Period|Poor/Non-compliance|3|||
146411014|NCT01335399|528010688|FG001|Treatment Period|Poor/Non-compliance|4|||
146411015|NCT01335399|528010687|FG000|Treatment Period|Lost to Follow-up|2|||
146411016|NCT01335399|528010688|FG001|Treatment Period|Lost to Follow-up|2|||
146411017|NCT01335399|528010687|FG000|Treatment Period|Maximum clinical benefit|1|||
146411018|NCT01335399|528010688|FG001|Treatment Period|Maximum clinical benefit|1|||
146411019|NCT01335399|528010687|FG000|Treatment Period|No longer meet study criteria|1|||
146411020|NCT01335399|528010688|FG001|Treatment Period|No longer meet study criteria|1|||
146411021|NCT01335399|528010687|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
146411022|NCT01335399|528010688|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
146411023|NCT03202511|528010692|FG000|Overall Study|Withdrawal by Subject|1|||
146411024|NCT03202511|528010693|FG001|Overall Study|Withdrawal by Subject|0|||
146411025|NCT00096382|528010694|FG000|Overall Study|Not treated|1|||
146411026|NCT00096382|528010695|FG001|Overall Study|Not treated|0|||
146411027|NCT00096382|528010694|FG000|Overall Study|Death during treatment|1|||
146411028|NCT00096382|528010695|FG001|Overall Study|Death during treatment|0|||
146411029|NCT01270841|528010696|FG000|Overall Study|Adverse Event|0|||
146411030|NCT01270841|528010697|FG001|Overall Study|Adverse Event|1|||
146411031|NCT01270841|528010698|FG002|Overall Study|Adverse Event|0|||
146411032|NCT01270841|528010699|FG003|Overall Study|Adverse Event|3|||
146411033|NCT01270841|528010696|FG000|Overall Study|Withdrawal by Subject|3|||
146411034|NCT01270841|528010697|FG001|Overall Study|Withdrawal by Subject|2|||
146411035|NCT01270841|528010698|FG002|Overall Study|Withdrawal by Subject|3|||
146411036|NCT01270841|528010699|FG003|Overall Study|Withdrawal by Subject|3|||
146411037|NCT01270841|528010696|FG000|Overall Study|Lost to Follow-up|3|||
146411038|NCT01270841|528010697|FG001|Overall Study|Lost to Follow-up|1|||
146411039|NCT01270841|528010698|FG002|Overall Study|Lost to Follow-up|4|||
146411040|NCT01270841|528010699|FG003|Overall Study|Lost to Follow-up|2|||
146411041|NCT01270841|528010696|FG000|Overall Study|Physician Decision|0|||
146411042|NCT01270841|528010697|FG001|Overall Study|Physician Decision|1|||
146411043|NCT01270841|528010698|FG002|Overall Study|Physician Decision|0|||
146411044|NCT01270841|528010699|FG003|Overall Study|Physician Decision|0|||
146411045|NCT01270841|528010696|FG000|Overall Study|Did not qualify|6|||
146411046|NCT01270841|528010697|FG001|Overall Study|Did not qualify|3|||
146411047|NCT01270841|528010698|FG002|Overall Study|Did not qualify|4|||
146411048|NCT01270841|528010699|FG003|Overall Study|Did not qualify|5|||
146411049|NCT01270841|528010696|FG000|Overall Study|Protocol Violation|1|||
146411050|NCT01270841|528010697|FG001|Overall Study|Protocol Violation|5|||
146411051|NCT01270841|528010698|FG002|Overall Study|Protocol Violation|0|||
146411052|NCT01270841|528010699|FG003|Overall Study|Protocol Violation|0|||
146411053|NCT01270841|528010696|FG000|Overall Study|Enrolled in error|0|||
146411054|NCT01270841|528010697|FG001|Overall Study|Enrolled in error|1|||
146411055|NCT01270841|528010698|FG002|Overall Study|Enrolled in error|0|||
146411056|NCT01270841|528010699|FG003|Overall Study|Enrolled in error|0|||
146411057|NCT01375010|528010700|FG000|Overall Study|Lost to Follow-up|8|||
146411058|NCT01375010|528010701|FG001|Overall Study|Lost to Follow-up|2|||
146411059|NCT01375010|528010700|FG000|Overall Study|Withdrawal by Subject|4|||
146411060|NCT01375010|528010701|FG001|Overall Study|Withdrawal by Subject|2|||
146411061|NCT02614703|528010702|FG000|Overall Study|Withdrawal by Subject|7|||
146411062|NCT02614703|528010703|FG001|Overall Study|Withdrawal by Subject|1|||
146411063|NCT02402933|528010704|FG000|Overall Study|Withdrawal by Subject|4|||
146411064|NCT02402933|528010704|FG000|Overall Study|Discontinued; Site Termination|10|||
146411065|NCT01977352|528010713|FG000|Overall Study|Lost to Follow-up|1|||
146411066|NCT01977352|528010714|FG001|Overall Study|Lost to Follow-up|2|||
146411067|NCT00409188|528010715|FG000|Overall Study|Ongoing at data cut-off|383|||
146411068|NCT00409188|528010716|FG001|Overall Study|Ongoing at data cut-off|175|||
146411069|NCT00854620|528010717|FG000|Overall Study|Adverse Event|1|||
146411070|NCT02323295|528010725|FG000|Overall Study|Adverse Event|0|||
146411071|NCT02323295|528010726|FG001|Overall Study|Adverse Event|1|||
146411072|NCT02323295|528010725|FG000|Overall Study|Withdrawal by Subject|0|||
146411073|NCT02323295|528010726|FG001|Overall Study|Withdrawal by Subject|1|||
146411074|NCT02323295|528010725|FG000|Overall Study|Patient did not have surgery as planned.|0|||
146411075|NCT02323295|528010726|FG001|Overall Study|Patient did not have surgery as planned.|1|||
146411076|NCT00775983|528010727|FG000|Overall Study|Protocol Violation|1|||
146411077|NCT00775983|528010728|FG001|Overall Study|Protocol Violation|2|||
146411078|NCT01059071|528010729|FG000|Overall Study|Lack of Efficacy|1|||
146411079|NCT01059071|528010730|FG001|Overall Study|Lack of Efficacy|4|||
146411080|NCT01059071|528010731|FG002|Overall Study|Lack of Efficacy|2|||
146411081|NCT01059071|528010732|FG003|Overall Study|Lack of Efficacy|3|||
146411082|NCT01059071|528010729|FG000|Overall Study|Withdrawal by Subject|1|||
146411083|NCT01059071|528010730|FG001|Overall Study|Withdrawal by Subject|0|||
146411084|NCT01059071|528010731|FG002|Overall Study|Withdrawal by Subject|0|||
146411085|NCT01059071|528010732|FG003|Overall Study|Withdrawal by Subject|2|||
146411086|NCT01059071|528010729|FG000|Overall Study|Physician Decision|0|||
146411087|NCT01059071|528010730|FG001|Overall Study|Physician Decision|0|||
146411088|NCT01059071|528010731|FG002|Overall Study|Physician Decision|0|||
146411089|NCT01059071|528010732|FG003|Overall Study|Physician Decision|1|||
146411090|NCT02962882|528010733|FG000|Overall Study|Adverse Event|2|||
146411091|NCT02962882|528010733|FG000|Overall Study|Withdrawal by Subject|2|||
146411092|NCT02962882|528010733|FG000|Overall Study|Transfer from ICU|32|||
146411093|NCT03763331|528010738|FG000|Overall Study|Lost to Follow-up|1|||
146411094|NCT03763331|528010739|FG001|Overall Study|Lost to Follow-up|0|||
146411095|NCT03763331|528010738|FG000|Overall Study|Withdrawal by Subject|1|||
146411096|NCT03763331|528010739|FG001|Overall Study|Withdrawal by Subject|0|||
146411097|NCT03763331|528010738|FG000|Overall Study|Non-compliance|0|||
146411098|NCT03763331|528010739|FG001|Overall Study|Non-compliance|3|||
146411099|NCT01155063|528010740|FG000|Overall Study|Adverse Event|1|||
146411100|NCT01155063|528010740|FG000|Overall Study|Withdrawal by Subject|1|||
146411101|NCT01155063|528010740|FG000|Overall Study|Study terminated by sponsor|87|||
146411102|NCT00936884|528010741|FG000|Double-blind|Withdrawal by Subject|6|||
146411103|NCT00936884|528010742|FG001|Double-blind|Withdrawal by Subject|4|||
146411104|NCT00936884|528010743|FG002|Double-blind|Withdrawal by Subject|0|||
146411105|NCT00936884|528010741|FG000|Double-blind|Death|2|||
146411106|NCT00936884|528010742|FG001|Double-blind|Death|1|||
146411107|NCT00936884|528010743|FG002|Double-blind|Death|0|||
146411108|NCT00936884|528010741|FG000|Double-blind|Lack of Efficacy|1|||
146411109|NCT00936884|528010742|FG001|Double-blind|Lack of Efficacy|1|||
146411110|NCT00936884|528010743|FG002|Double-blind|Lack of Efficacy|0|||
146411111|NCT00936884|528010741|FG000|Double-blind|Adverse Event|1|||
146411112|NCT00936884|528010742|FG001|Double-blind|Adverse Event|0|||
146411113|NCT00936884|528010743|FG002|Double-blind|Adverse Event|0|||
146411114|NCT00936884|528010741|FG000|Double-blind|Physician Decision|1|||
146411115|NCT00936884|528010742|FG001|Double-blind|Physician Decision|0|||
146411116|NCT00936884|528010743|FG002|Double-blind|Physician Decision|0|||
146411117|NCT00936884|528010741|FG000|Double-blind|No post baseline diary entry|1|||
146411118|NCT00936884|528010742|FG001|Double-blind|No post baseline diary entry|0|||
146411119|NCT00936884|528010743|FG002|Double-blind|No post baseline diary entry|0|||
146411120|NCT00936884|528010741|FG000|Double-blind|Did not receive study drug|0|||
146283913|NCT03562975|527551892|FG000|Overall Study|Lost to Follow-up|1|||
145945334|NCT01764997|526308213|FG001|Run-in Period|Adverse Event|0|||
146411121|NCT00936884|528010742|FG001|Double-blind|Did not receive study drug|1|||
146411122|NCT00936884|528010743|FG002|Double-blind|Did not receive study drug|0|||
146411123|NCT01314703|528010744|FG000|Overall Study|screen failure and closed enrollment|8|||
146411124|NCT00597584|528010745|FG000|Overall Study|Adverse Event|4|||
146411125|NCT00597584|528010746|FG001|Overall Study|Adverse Event|2|||
146411126|NCT00597584|528010745|FG000|Overall Study|Death|53|||
146411127|NCT00597584|528010746|FG001|Overall Study|Death|30|||
146411128|NCT00597584|528010745|FG000|Overall Study|Lack of Efficacy|1|||
146411129|NCT00597584|528010746|FG001|Overall Study|Lack of Efficacy|0|||
146411130|NCT00597584|528010745|FG000|Overall Study|Lost to Follow-up|2|||
146411131|NCT00597584|528010746|FG001|Overall Study|Lost to Follow-up|4|||
146411132|NCT00597584|528010745|FG000|Overall Study|Physician Decision|3|||
146411133|NCT00597584|528010746|FG001|Overall Study|Physician Decision|0|||
146411134|NCT00597584|528010745|FG000|Overall Study|Pregnancy|2|||
146411135|NCT00597584|528010746|FG001|Overall Study|Pregnancy|0|||
146411136|NCT00597584|528010745|FG000|Overall Study|Withdrawal by Subject|44|||
146411137|NCT00597584|528010746|FG001|Overall Study|Withdrawal by Subject|12|||
146411138|NCT00597584|528010745|FG000|Overall Study|Discontinued Dialysis|0|||
146411139|NCT00597584|528010746|FG001|Overall Study|Discontinued Dialysis|1|||
146411140|NCT00597584|528010745|FG000|Overall Study|Lost ability to consent|1|||
146411141|NCT00597584|528010746|FG001|Overall Study|Lost ability to consent|1|||
146411142|NCT00597584|528010745|FG000|Overall Study|Never dosed|1|||
146411143|NCT00597584|528010746|FG001|Overall Study|Never dosed|0|||
146411144|NCT00597584|528010745|FG000|Overall Study|Relocation|8|||
146411145|NCT00597584|528010746|FG001|Overall Study|Relocation|6|||
146411146|NCT00597584|528010745|FG000|Overall Study|Renal transplant|9|||
146411147|NCT00597584|528010746|FG001|Overall Study|Renal transplant|7|||
146411148|NCT00515073|528010753|FG000|Overall Study|Withdrawal by Subject|1|||
146411149|NCT00515073|528010753|FG000|Overall Study|Physician Decision|1|||
146411150|NCT00881959|528010754|FG000|Overall Study|Lost to Follow-up|2|||
146411151|NCT00881959|528010755|FG001|Overall Study|Lost to Follow-up|4|||
146411152|NCT02791659|528010756|FG000|Overall Study|Protocol Violation|0|||
146411153|NCT02791659|528010757|FG001|Overall Study|Protocol Violation|1|||
146411154|NCT01456052|528010758|FG000|Overall Study|Adverse Event|1|||
146411155|NCT01456052|528010759|FG001|Overall Study|Adverse Event|1|||
146411156|NCT01456052|528010760|FG002|Overall Study|Adverse Event|2|||
146411157|NCT01456052|528010758|FG000|Overall Study|Consent withdrawn|0|||
146411158|NCT01456052|528010759|FG001|Overall Study|Consent withdrawn|2|||
146411159|NCT01456052|528010760|FG002|Overall Study|Consent withdrawn|1|||
146411160|NCT01456052|528010758|FG000|Overall Study|Protocol Violation|0|||
146411161|NCT01456052|528010759|FG001|Overall Study|Protocol Violation|1|||
146411162|NCT01456052|528010760|FG002|Overall Study|Protocol Violation|0|||
146411163|NCT01456052|528010758|FG000|Overall Study|Physician Decision|1|||
146411164|NCT01456052|528010759|FG001|Overall Study|Physician Decision|0|||
146411165|NCT01456052|528010760|FG002|Overall Study|Physician Decision|1|||
146411166|NCT01456052|528010758|FG000|Overall Study|Treatment Failure|0|||
146411167|NCT01456052|528010759|FG001|Overall Study|Treatment Failure|1|||
146411168|NCT01456052|528010760|FG002|Overall Study|Treatment Failure|1|||
146411169|NCT00623623|528010761|FG000|Overall Study|Previous enrolment into this study|1|||
146411170|NCT00623623|528010762|FG001|Overall Study|Previous enrolment into this study|1|||
146411171|NCT02265952|528010764|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
146411172|NCT02265952|528010765|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
146411173|NCT02265952|528010764|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
146411174|NCT02265952|528010765|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
146411175|NCT01042977|528010766|FG000|Overall Study|Adverse Event|4|||
146411176|NCT01042977|528010767|FG001|Overall Study|Adverse Event|12|||
146411177|NCT01042977|528010766|FG000|Overall Study|Death|2|||
146411178|NCT01042977|528010767|FG001|Overall Study|Death|1|||
146411179|NCT01042977|528010766|FG000|Overall Study|Withdrawal by Subject|8|||
146411180|NCT01042977|528010767|FG001|Overall Study|Withdrawal by Subject|16|||
146411181|NCT01042977|528010766|FG000|Overall Study|Lost to Follow-up|0|||
146411182|NCT01042977|528010767|FG001|Overall Study|Lost to Follow-up|2|||
146411183|NCT01042977|528010766|FG000|Overall Study|Poor/non-compliance|3|||
146411184|NCT01042977|528010767|FG001|Overall Study|Poor/non-compliance|4|||
146411185|NCT01042977|528010766|FG000|Overall Study|Subject no longer meets study criteria|15|||
146411186|NCT01042977|528010767|FG001|Overall Study|Subject no longer meets study criteria|13|||
146411187|NCT01042977|528010766|FG000|Overall Study|Incorrect enrollment|6|||
146411188|NCT01042977|528010767|FG001|Overall Study|Incorrect enrollment|4|||
146411189|NCT01042977|528010766|FG000|Overall Study|Safety|0|||
146411190|NCT01042977|528010767|FG001|Overall Study|Safety|2|||
146411191|NCT01042977|528010766|FG000|Overall Study|Administrative reason by sponsor|0|||
146411192|NCT01042977|528010767|FG001|Overall Study|Administrative reason by sponsor|1|||
146411193|NCT01042977|528010766|FG000|Overall Study|Various|3|||
146411194|NCT01042977|528010767|FG001|Overall Study|Various|0|||
146411195|NCT02499354|528010768|FG000|Overall Study|Withdrawal by Subject|1|||
146411196|NCT02499354|528010769|FG001|Overall Study|Withdrawal by Subject|0|||
146411197|NCT04356573|528010771|FG000|Overall Study|Didn't Qualify|1|||
146411198|NCT04356573|528010772|FG001|Overall Study|Didn't Qualify|0|||
146411199|NCT02424565|528010773|FG000|Period 1 (D0)|Protocol Violation|0|||
146074955|NCT00095940|526794911|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
146074956|NCT00095940|526794912|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
146074957|NCT00095940|526794904|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074958|NCT00095940|526794905|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
146283914|NCT03562975|527551892|FG000|Overall Study|Withdrawal by Subject|1|||
146411200|NCT02424565|528010774|FG001|Period 1 (D0)|Protocol Violation|1|||
146411201|NCT01677910|528010775|FG000|Double-Blind Treatment Period|Adverse Event|6|||
146411202|NCT01677910|528010776|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146411203|NCT01677910|528010777|FG002|Double-Blind Treatment Period|Adverse Event|3|||
146411204|NCT01677910|528010778|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146411205|NCT01677910|528010775|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146411206|NCT01677910|528010776|FG001|Double-Blind Treatment Period|Physician Decision|0|||
146411207|NCT01677910|528010777|FG002|Double-Blind Treatment Period|Physician Decision|1|||
146411208|NCT01677910|528010778|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146411209|NCT01677910|528010775|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
146411210|NCT01677910|528010776|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
146411211|NCT01677910|528010777|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
146411212|NCT01677910|528010778|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
146411213|NCT01677910|528010775|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
146411214|NCT01677910|528010776|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
146411215|NCT01677910|528010777|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
146411216|NCT01677910|528010778|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
146411217|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
146411218|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
146411219|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
146411220|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
146411221|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146411222|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146411223|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146411224|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
146411225|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146411226|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146411227|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146411228|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
146411229|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146411230|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146411231|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146411232|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
146411233|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
146411234|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
146411235|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
146411236|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
146411237|NCT01677910|528010775|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146411238|NCT01677910|528010776|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146411239|NCT01677910|528010777|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
146411240|NCT01677910|528010778|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
146411241|NCT03650400|528010779|FG000|Overall Study|Study terminated by sponsor|0|||
146411242|NCT03650400|528010780|FG001|Overall Study|Study terminated by sponsor|5|||
146411243|NCT02410837|528010787|FG000|Overall Study|Death|387|||
146411244|NCT02410837|528010787|FG000|Overall Study|Lost to Follow-up|50|||
146411245|NCT02410837|528010787|FG000|Overall Study|Withdrawal by Subject|44|||
146411246|NCT02410837|528010787|FG000|Overall Study|Physician Decision|6|||
146411247|NCT02410837|528010787|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
146411248|NCT00078819|528010792|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146411249|NCT00078819|528010793|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
146411250|NCT00078819|528010794|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146411251|NCT00078819|528010795|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
146411252|NCT00078819|528010792|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
146411253|NCT00078819|528010793|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146411254|NCT00078819|528010794|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146411255|NCT00078819|528010795|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
146411256|NCT00078819|528010792|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
146411257|NCT00078819|528010793|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
146411258|NCT00078819|528010794|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
146411259|NCT00078819|528010795|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
146411260|NCT00078819|528010792|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
146411261|NCT00078819|528010793|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
146411262|NCT00078819|528010794|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
145945335|NCT01764997|526308214|FG002|Run-in Period|Adverse Event|0|||
146174485|NCT01672853|527151401|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
146411263|NCT00078819|528010795|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
146411264|NCT00078819|528010792|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
146411265|NCT00078819|528010793|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
146411266|NCT00078819|528010794|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
146411267|NCT00078819|528010795|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
146411268|NCT00078819|528010792|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
146411269|NCT00078819|528010793|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
146411270|NCT00078819|528010794|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
146411271|NCT00078819|528010795|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
146411272|NCT00078819|528010792|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
146411273|NCT00078819|528010793|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
146411274|NCT00078819|528010794|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
146411275|NCT00078819|528010795|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
146411276|NCT00078819|528010792|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146411277|NCT00078819|528010793|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146411278|NCT00078819|528010794|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
146411279|NCT00078819|528010795|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
146411280|NCT02555618|528010796|FG000|Overall Study|Sponsor's Circumstances|1|||
146411281|NCT02555618|528010797|FG001|Overall Study|Sponsor's Circumstances|0|||
146411282|NCT01325532|528010800|FG000|Overall Study|Withdrawal by Subject|2|||
146411283|NCT01325532|528010801|FG001|Overall Study|Withdrawal by Subject|0|||
146411284|NCT03196791|528010804|FG000|Overall Study|Protocol Violation|7|||
146411285|NCT03196791|528010805|FG001|Overall Study|Protocol Violation|3|||
146411286|NCT03196791|528010804|FG000|Overall Study|Withdrawal by Subject|3|||
146411287|NCT03196791|528010805|FG001|Overall Study|Withdrawal by Subject|2|||
146411288|NCT01749033|528010810|FG000|Overall Study|Did not receive allocated intervention|3|||
146411289|NCT01749033|528010811|FG001|Overall Study|Did not receive allocated intervention|3|||
146411290|NCT01749033|528010812|FG002|Overall Study|Did not receive allocated intervention|0|||
146411291|NCT01749033|528010810|FG000|Overall Study|Lost to Follow-up|0|||
146411292|NCT01749033|528010811|FG001|Overall Study|Lost to Follow-up|2|||
146411293|NCT01749033|528010812|FG002|Overall Study|Lost to Follow-up|1|||
146411294|NCT03056001|528010815|FG000|Overall Study|Death|24|||
146411295|NCT02295280|528010817|FG000|Overall Study|Adverse Event|0|||
146411296|NCT02295280|528010818|FG001|Overall Study|Adverse Event|1|||
146411297|NCT02875067|528010819|FG000|Overall Study|Withdrawal by Subject|1|||
146411298|NCT02875067|528010819|FG000|Overall Study|Withdrawal by Termination of Study|5|||
146411299|NCT02713243|528010821|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
146411300|NCT02713243|528010822|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
146411301|NCT02713243|528010821|FG000|Overall Study|Administrative problems|0|||
146411302|NCT02713243|528010822|FG001|Overall Study|Administrative problems|1|||
146411303|NCT02713243|528010821|FG000|Overall Study|Protocol deviation|0|||
146411304|NCT02713243|528010822|FG001|Overall Study|Protocol deviation|1|||
146411305|NCT03056352|528010823|FG000|Overall Study|Lost to Follow-up|1|||
146411306|NCT02971605|528010824|FG000|Overall Study|Withdrawal by Subject|1|||
146411307|NCT00597207|528010825|FG000|Overall Study|Lost to Follow-up|5|||
146411308|NCT00597207|528010826|FG001|Overall Study|Lost to Follow-up|7|||
146411309|NCT03077828|528010829|FG000|Treatment Cycles|Death|1|||
146411310|NCT03077828|528010829|FG000|Treatment Cycles|Withdrawal by Subject|1|||
146411311|NCT03077828|528010829|FG000|Treatment Cycles|Screen Fail|2|||
146411312|NCT03077828|528010829|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
146411313|NCT03077828|528010829|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
146411314|NCT03077828|528010829|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
146411315|NCT03077828|528010829|FG000|Follow-up|Patients still in follow-up|15|||
146411316|NCT05037409|528010831|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
146411317|NCT05037409|528010832|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
146411318|NCT05037409|528010833|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
146411319|NCT03499249|528010834|FG000|Overall Study|Physician Decision|1|||
146411320|NCT00435825|528010839|FG000|Overall Study|Abnormality of Laboratory Test|0|||
146411321|NCT00435825|528010840|FG001|Overall Study|Abnormality of Laboratory Test|1|||
146411322|NCT00435825|528010841|FG002|Overall Study|Abnormality of Laboratory Test|0|||
146411323|NCT00435825|528010842|FG003|Overall Study|Abnormality of Laboratory Test|0|||
146411324|NCT00435825|528010839|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146411325|NCT00435825|528010840|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146411326|NCT00435825|528010841|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146411327|NCT00435825|528010842|FG003|Overall Study|Insufficient Therapeutic Response|3|||
146411328|NCT00435825|528010839|FG000|Overall Study|Other Protocol Violation|1|||
146411329|NCT00435825|528010840|FG001|Overall Study|Other Protocol Violation|0|||
146411330|NCT00435825|528010841|FG002|Overall Study|Other Protocol Violation|0|||
146411331|NCT00435825|528010842|FG003|Overall Study|Other Protocol Violation|0|||
146411332|NCT00435825|528010839|FG000|Overall Study|Refused treatment|2|||
146411333|NCT00435825|528010840|FG001|Overall Study|Refused treatment|0|||
146411334|NCT00435825|528010841|FG002|Overall Study|Refused treatment|0|||
146074959|NCT00095940|526794906|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
146174486|NCT01672853|527151399|FG000|Overall Study|Pregnancy|0|||
146174487|NCT01672853|527151400|FG001|Overall Study|Pregnancy|1|||
146174488|NCT01672853|527151401|FG002|Overall Study|Pregnancy|0|||
146174489|NCT01672853|527151399|FG000|Overall Study|Investigator's Discretion|1|||
146411335|NCT00435825|528010842|FG003|Overall Study|Refused treatment|5|||
146411336|NCT00435825|528010839|FG000|Overall Study|Failure to return|5|||
146411337|NCT00435825|528010840|FG001|Overall Study|Failure to return|0|||
146411338|NCT00435825|528010841|FG002|Overall Study|Failure to return|4|||
146411339|NCT00435825|528010842|FG003|Overall Study|Failure to return|0|||
146411340|NCT00435825|528010839|FG000|Overall Study|Did not receive study drug|1|||
146411341|NCT00435825|528010840|FG001|Overall Study|Did not receive study drug|0|||
146411342|NCT00435825|528010841|FG002|Overall Study|Did not receive study drug|2|||
146411343|NCT00435825|528010842|FG003|Overall Study|Did not receive study drug|0|||
146411344|NCT00435825|528010839|FG000|Overall Study|Did not enter follow-up|0|||
146411345|NCT00435825|528010840|FG001|Overall Study|Did not enter follow-up|4|||
146411346|NCT00435825|528010841|FG002|Overall Study|Did not enter follow-up|1|||
146411347|NCT00435825|528010842|FG003|Overall Study|Did not enter follow-up|3|||
146411348|NCT00435825|528010839|FG000|Overall Study|Did not complete full follow-up period|6|||
146174490|NCT01672853|527151400|FG001|Overall Study|Investigator's Discretion|0|||
146411349|NCT00435825|528010840|FG001|Overall Study|Did not complete full follow-up period|6|||
146411350|NCT00435825|528010841|FG002|Overall Study|Did not complete full follow-up period|4|||
146411351|NCT00435825|528010842|FG003|Overall Study|Did not complete full follow-up period|5|||
146411352|NCT01963676|528012532|FG000|Overall Study|Withdrawal by Subject|1|||
146411353|NCT01963676|528012533|FG001|Overall Study|Withdrawal by Subject|0|||
146411354|NCT01120600|528012534|FG000|Overall Study|Adverse Event|7|||
146411355|NCT01120600|528012535|FG001|Overall Study|Adverse Event|7|||
146411356|NCT01120600|528012534|FG000|Overall Study|Excessive Bone Loss|0|||
146411357|NCT01120600|528012535|FG001|Overall Study|Excessive Bone Loss|4|||
146411358|NCT01120600|528012534|FG000|Overall Study|Lost to Follow-up|1|||
146411359|NCT01120600|528012535|FG001|Overall Study|Lost to Follow-up|3|||
146411360|NCT01120600|528012534|FG000|Overall Study|Physician Decision|1|||
146411361|NCT01120600|528012535|FG001|Overall Study|Physician Decision|3|||
146411362|NCT01120600|528012534|FG000|Overall Study|Protocol Violation|0|||
146411363|NCT01120600|528012535|FG001|Overall Study|Protocol Violation|4|||
146411364|NCT01120600|528012534|FG000|Overall Study|Withdrawal by Subject|10|||
146411365|NCT01120600|528012535|FG001|Overall Study|Withdrawal by Subject|11|||
146411366|NCT00686790|528012536|FG000|Overall Study|Adverse Event|2|||
145945336|NCT01764997|526308215|FG003|Run-in Period|Adverse Event|0|||
146074960|NCT00095940|526794907|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074961|NCT00095940|526794908|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074962|NCT00095940|526794909|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074963|NCT00095940|526794910|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074964|NCT00095940|526794911|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
146074965|NCT00095940|526794912|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
146074966|NCT02314637|526794915|FG000|Overall Study|Adverse Event|4|||
146074967|NCT02314637|526794916|FG001|Overall Study|Adverse Event|8|||
146074968|NCT02314637|526794915|FG000|Overall Study|Lack of Efficacy|1|||
146411367|NCT00686790|528012536|FG000|Overall Study|Withdrawal by Subject|1|||
146411368|NCT00686790|528012536|FG000|Overall Study|Death|1|||
146411369|NCT00686790|528012536|FG000|Overall Study|Lost to Follow-up|12|||
146411370|NCT00382291|528012537|FG000|Overall Study|Adverse Event|1|||
146411371|NCT00382291|528012538|FG001|Overall Study|Adverse Event|2|||
146411372|NCT00382291|528012539|FG002|Overall Study|Adverse Event|2|||
146411373|NCT00382291|528012537|FG000|Overall Study|Protocol Violation|1|||
146411374|NCT00382291|528012538|FG001|Overall Study|Protocol Violation|0|||
146411375|NCT00382291|528012539|FG002|Overall Study|Protocol Violation|0|||
146411376|NCT00382291|528012537|FG000|Overall Study|Temporary study suspension|2|||
146411377|NCT00382291|528012538|FG001|Overall Study|Temporary study suspension|2|||
146411378|NCT00382291|528012539|FG002|Overall Study|Temporary study suspension|5|||
146411379|NCT00382291|528012537|FG000|Overall Study|Withdrawal by Subject|0|||
146411380|NCT00382291|528012538|FG001|Overall Study|Withdrawal by Subject|2|||
146411381|NCT00382291|528012539|FG002|Overall Study|Withdrawal by Subject|0|||
146411382|NCT00382291|528012537|FG000|Overall Study|Physician Decision|0|||
146411383|NCT00382291|528012538|FG001|Overall Study|Physician Decision|1|||
146411384|NCT00382291|528012539|FG002|Overall Study|Physician Decision|0|||
146411385|NCT00382291|528012537|FG000|Overall Study|Lack of Efficacy|0|||
146411386|NCT00382291|528012538|FG001|Overall Study|Lack of Efficacy|0|||
146411387|NCT00382291|528012539|FG002|Overall Study|Lack of Efficacy|1|||
146411388|NCT02266706|528012540|FG000|Overall Study|Withdrawal by Subject|0|||
146411389|NCT02266706|528012541|FG001|Overall Study|Withdrawal by Subject|1|||
146411390|NCT02266706|528012542|FG002|Overall Study|Withdrawal by Subject|1|||
146411391|NCT02266706|528012543|FG003|Overall Study|Withdrawal by Subject|0|||
146411392|NCT02266706|528012544|FG004|Overall Study|Withdrawal by Subject|0|||
146411393|NCT02266706|528012545|FG005|Overall Study|Withdrawal by Subject|1|||
146411394|NCT02266706|528012546|FG006|Overall Study|Withdrawal by Subject|0|||
146411395|NCT02266706|528012547|FG007|Overall Study|Withdrawal by Subject|0|||
146411396|NCT02266706|528012548|FG008|Overall Study|Withdrawal by Subject|0|||
146411397|NCT02266706|528012540|FG000|Overall Study|Screen failure|0|||
146411398|NCT02266706|528012541|FG001|Overall Study|Screen failure|0|||
146411399|NCT02266706|528012542|FG002|Overall Study|Screen failure|0|||
146411400|NCT02266706|528012543|FG003|Overall Study|Screen failure|0|||
146074969|NCT02314637|526794916|FG001|Overall Study|Lack of Efficacy|0|||
146074970|NCT02314637|526794915|FG000|Overall Study|Physician Decision|5|||
146074971|NCT02314637|526794916|FG001|Overall Study|Physician Decision|2|||
146074972|NCT02314637|526794915|FG000|Overall Study|Withdrawal by Subject|5|||
146074973|NCT02314637|526794916|FG001|Overall Study|Withdrawal by Subject|4|||
146074974|NCT02314637|526794915|FG000|Overall Study|Other Reason|1|||
146074975|NCT02314637|526794916|FG001|Overall Study|Other Reason|0|||
146074976|NCT02597478|526794933|FG000|Overall Study|Withdrawal by Subject|2|||
146074977|NCT02597478|526794934|FG001|Overall Study|Withdrawal by Subject|0|||
146074978|NCT02597478|526794933|FG000|Overall Study|Change of opioid dose|1|||
146074979|NCT02597478|526794934|FG001|Overall Study|Change of opioid dose|0|||
146074980|NCT02597478|526794933|FG000|Overall Study|Insufficient exertional dyspnea|0|||
146074981|NCT02597478|526794934|FG001|Overall Study|Insufficient exertional dyspnea|1|||
146074982|NCT01256190|526794936|FG000|Overall Study|Lost to Follow-up|2|||
146074983|NCT01256190|526794937|FG001|Overall Study|Lost to Follow-up|0|||
146074984|NCT02350478|526794938|FG000|Overall Study|Lost to Follow-up|5|||
146074985|NCT02350478|526794939|FG001|Overall Study|Lost to Follow-up|1|||
146074986|NCT02779556|526794940|FG000|Baseline|Partial baseline interview completed|1|||
146411401|NCT02266706|528012544|FG004|Overall Study|Screen failure|0|||
146074987|NCT02779556|526794941|FG001|Baseline|Partial baseline interview completed|0|||
146074988|NCT02779556|526794940|FG000|3 Months|Lost to Follow-up|40|||
146074989|NCT02779556|526794941|FG001|3 Months|Lost to Follow-up|29|||
146074990|NCT02779556|526794940|FG000|3 Months|Missed 3 month clinic visit|27|||
146074991|NCT02779556|526794941|FG001|3 Months|Missed 3 month clinic visit|19|||
146074992|NCT02779556|526794940|FG000|6 Month|Lost to Follow-up|33|||
146074993|NCT02779556|526794941|FG001|6 Month|Lost to Follow-up|39|||
146074994|NCT02779556|526794940|FG000|6 Month HbA1c|No value collected during window|69|||
146074995|NCT02779556|526794941|FG001|6 Month HbA1c|No value collected during window|50|||
146074996|NCT02779556|526794940|FG000|12 Month HbA1c|No value collected during window|138|||
146074997|NCT02779556|526794941|FG001|12 Month HbA1c|No value collected during window|102|||
146074998|NCT03110770|526794943|FG000|Overall Study|Death|1|||
146074999|NCT03110770|526794944|FG001|Overall Study|Death|0|||
146075000|NCT03110770|526794945|FG002|Overall Study|Death|0|||
146075001|NCT03110770|526794946|FG003|Overall Study|Death|1|||
146075002|NCT03110770|526794947|FG004|Overall Study|Death|0|||
146075003|NCT03110770|526794943|FG000|Overall Study|Enrolled but did not receive product|0|||
146075004|NCT03110770|526794944|FG001|Overall Study|Enrolled but did not receive product|0|||
146075005|NCT03110770|526794945|FG002|Overall Study|Enrolled but did not receive product|0|||
146075006|NCT03110770|526794946|FG003|Overall Study|Enrolled but did not receive product|8|||
146075007|NCT03110770|526794947|FG004|Overall Study|Enrolled but did not receive product|7|||
146075008|NCT03110770|526794943|FG000|Overall Study|Lost to Follow-up|0|||
146411402|NCT02266706|528012545|FG005|Overall Study|Screen failure|1|||
146411403|NCT02266706|528012546|FG006|Overall Study|Screen failure|1|||
146411404|NCT02266706|528012547|FG007|Overall Study|Screen failure|0|||
146411405|NCT02266706|528012548|FG008|Overall Study|Screen failure|0|||
146411406|NCT02266706|528012540|FG000|Overall Study|Enrollment in another study|0|||
146411407|NCT02266706|528012541|FG001|Overall Study|Enrollment in another study|0|||
146411408|NCT02266706|528012542|FG002|Overall Study|Enrollment in another study|0|||
146411409|NCT02266706|528012543|FG003|Overall Study|Enrollment in another study|1|||
146411410|NCT02266706|528012544|FG004|Overall Study|Enrollment in another study|0|||
146411411|NCT02266706|528012545|FG005|Overall Study|Enrollment in another study|0|||
146411412|NCT02266706|528012546|FG006|Overall Study|Enrollment in another study|0|||
146411413|NCT02266706|528012547|FG007|Overall Study|Enrollment in another study|0|||
146411414|NCT02266706|528012548|FG008|Overall Study|Enrollment in another study|0|||
146411415|NCT00534092|528012558|FG000|Overall Study|Lost to Follow-up|1|||
146411416|NCT00534092|528012559|FG001|Overall Study|Lost to Follow-up|0|||
146411417|NCT00534092|528012558|FG000|Overall Study|personal reasons/family concerns|1|||
146411418|NCT00534092|528012559|FG001|Overall Study|personal reasons/family concerns|0|||
146411419|NCT01169649|528012560|FG000|Overall Study|Patient Not Treated|3|||
146411420|NCT02919475|528012561|FG000|Overall Study|Adverse Event|3|||
146411421|NCT02919475|528012562|FG001|Overall Study|Adverse Event|3|||
146411422|NCT02919475|528012563|FG002|Overall Study|Adverse Event|3|||
146411423|NCT02919475|528012564|FG003|Overall Study|Adverse Event|9|||
146411424|NCT02919475|528012565|FG004|Overall Study|Adverse Event|2|||
146411425|NCT02919475|528012561|FG000|Overall Study|Death|0|||
146411426|NCT02919475|528012562|FG001|Overall Study|Death|1|||
146411427|NCT02919475|528012563|FG002|Overall Study|Death|0|||
146411428|NCT02919475|528012564|FG003|Overall Study|Death|0|||
146411429|NCT02919475|528012565|FG004|Overall Study|Death|0|||
146411430|NCT02919475|528012561|FG000|Overall Study|Lost to Follow-up|0|||
146411431|NCT02919475|528012562|FG001|Overall Study|Lost to Follow-up|0|||
146411432|NCT02919475|528012563|FG002|Overall Study|Lost to Follow-up|0|||
146411433|NCT02919475|528012564|FG003|Overall Study|Lost to Follow-up|1|||
146411434|NCT02919475|528012565|FG004|Overall Study|Lost to Follow-up|0|||
146411435|NCT02919475|528012561|FG000|Overall Study|Withdrawal by Subject|2|||
146411436|NCT02919475|528012562|FG001|Overall Study|Withdrawal by Subject|3|||
146411437|NCT02919475|528012563|FG002|Overall Study|Withdrawal by Subject|1|||
146411438|NCT02919475|528012564|FG003|Overall Study|Withdrawal by Subject|2|||
146174491|NCT01672853|527151401|FG002|Overall Study|Investigator's Discretion|0|||
146174492|NCT01672853|527151399|FG000|Overall Study|Withdrew Consent|5|||
146174493|NCT01672853|527151400|FG001|Overall Study|Withdrew Consent|5|||
146174494|NCT01672853|527151401|FG002|Overall Study|Withdrew Consent|5|||
146174495|NCT01672853|527151399|FG000|Overall Study|Adverse Event|4|||
146174496|NCT01672853|527151400|FG001|Overall Study|Adverse Event|6|||
146174497|NCT01672853|527151401|FG002|Overall Study|Adverse Event|8|||
146174498|NCT01672853|527151399|FG000|Overall Study|Lost to Follow-up|0|||
146174499|NCT01672853|527151400|FG001|Overall Study|Lost to Follow-up|1|||
146174500|NCT01672853|527151401|FG002|Overall Study|Lost to Follow-up|0|||
146174501|NCT01672853|527151399|FG000|Overall Study|Randomized but Never Treated|0|||
146174502|NCT01672853|527151400|FG001|Overall Study|Randomized but Never Treated|0|||
146174503|NCT01672853|527151401|FG002|Overall Study|Randomized but Never Treated|1|||
146174504|NCT02969525|527151404|FG000|Double-Blind Period|Adverse Event|0|||
146174505|NCT02969525|527151405|FG001|Double-Blind Period|Adverse Event|0|||
146174506|NCT02969525|527151406|FG002|Double-Blind Period|Adverse Event|1|||
146174507|NCT02969525|527151407|FG003|Double-Blind Period|Adverse Event|1|||
146174508|NCT02969525|527151408|FG004|Double-Blind Period|Adverse Event|0|||
146174509|NCT02969525|527151409|FG005|Double-Blind Period|Adverse Event|0|||
146174510|NCT02969525|527151410|FG006|Double-Blind Period|Adverse Event|0|||
146174511|NCT02969525|527151411|FG007|Double-Blind Period|Adverse Event|0|||
146174512|NCT02969525|527151412|FG008|Double-Blind Period|Adverse Event|0|||
146174513|NCT02969525|527151413|FG009|Double-Blind Period|Adverse Event|0|||
146174514|NCT02969525|527151414|FG010|Double-Blind Period|Adverse Event|0|||
146174515|NCT02969525|527151415|FG011|Double-Blind Period|Adverse Event|0|||
146174516|NCT02969525|527151404|FG000|Double-Blind Period|LOW EGFR|0|||
146174517|NCT02969525|527151405|FG001|Double-Blind Period|LOW EGFR|0|||
146174518|NCT02969525|527151406|FG002|Double-Blind Period|LOW EGFR|0|||
146174519|NCT02969525|527151407|FG003|Double-Blind Period|LOW EGFR|1|||
146174520|NCT02969525|527151408|FG004|Double-Blind Period|LOW EGFR|0|||
146174521|NCT02969525|527151409|FG005|Double-Blind Period|LOW EGFR|0|||
146174522|NCT02969525|527151410|FG006|Double-Blind Period|LOW EGFR|0|||
146174523|NCT02969525|527151411|FG007|Double-Blind Period|LOW EGFR|0|||
146174524|NCT02969525|527151412|FG008|Double-Blind Period|LOW EGFR|0|||
146174525|NCT02969525|527151413|FG009|Double-Blind Period|LOW EGFR|0|||
146174526|NCT02969525|527151414|FG010|Double-Blind Period|LOW EGFR|0|||
146174527|NCT02969525|527151415|FG011|Double-Blind Period|LOW EGFR|0|||
146174528|NCT02969525|527151404|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
146174529|NCT02969525|527151405|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174530|NCT02969525|527151406|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174531|NCT02969525|527151407|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
146174532|NCT02969525|527151408|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174533|NCT02969525|527151409|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174534|NCT02969525|527151410|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174535|NCT02969525|527151411|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146411439|NCT02919475|528012565|FG004|Overall Study|Withdrawal by Subject|2|||
146174536|NCT02969525|527151412|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174537|NCT02969525|527151413|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174538|NCT02969525|527151414|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174539|NCT02969525|527151415|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
146174540|NCT02969525|527151404|FG000|Dose-Blind Period|Adverse Event|0|||
146174541|NCT02969525|527151405|FG001|Dose-Blind Period|Adverse Event|0|||
146174542|NCT02969525|527151406|FG002|Dose-Blind Period|Adverse Event|0|||
146174543|NCT02969525|527151407|FG003|Dose-Blind Period|Adverse Event|0|||
146174544|NCT02969525|527151408|FG004|Dose-Blind Period|Adverse Event|0|||
146174545|NCT02969525|527151409|FG005|Dose-Blind Period|Adverse Event|0|||
146174546|NCT02969525|527151410|FG006|Dose-Blind Period|Adverse Event|0|||
146174547|NCT02969525|527151411|FG007|Dose-Blind Period|Adverse Event|0|||
146174548|NCT02969525|527151412|FG008|Dose-Blind Period|Adverse Event|0|||
146174549|NCT02969525|527151413|FG009|Dose-Blind Period|Adverse Event|1|||
146174550|NCT02969525|527151414|FG010|Dose-Blind Period|Adverse Event|1|||
146174551|NCT02969525|527151415|FG011|Dose-Blind Period|Adverse Event|1|||
146174552|NCT02969525|527151404|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
146174553|NCT02969525|527151405|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
146174554|NCT02969525|527151406|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
146174555|NCT02969525|527151407|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
146174556|NCT02969525|527151408|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
146174557|NCT02969525|527151409|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
146174558|NCT02969525|527151410|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
146174559|NCT02969525|527151411|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
146174560|NCT02969525|527151412|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
146174561|NCT02969525|527151413|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
146174562|NCT02969525|527151414|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
146174563|NCT02969525|527151415|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
146174564|NCT02969525|527151404|FG000|Dose-Blind Period|Non-cooperating patient|0|||
146174565|NCT02969525|527151405|FG001|Dose-Blind Period|Non-cooperating patient|0|||
146411440|NCT02919475|528012561|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146411441|NCT02919475|528012562|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146411442|NCT02919475|528012563|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146411443|NCT02919475|528012564|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146411444|NCT02919475|528012565|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146411445|NCT02370784|528012568|FG000|Overall Study|Patient started prohibited medication|0|||
146411446|NCT02370784|528012569|FG001|Overall Study|Patient started prohibited medication|1|||
146411447|NCT04741503|528012571|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
146411448|NCT04741503|528012572|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
146411449|NCT04741503|528012573|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
146411450|NCT04741503|528012571|FG000|Initial Enrollment|Overquotas removed|0|||
146411451|NCT04741503|528012572|FG001|Initial Enrollment|Overquotas removed|0|||
146411452|NCT04741503|528012573|FG002|Initial Enrollment|Overquotas removed|186|||
146411453|NCT04741503|528012571|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
146411454|NCT04741503|528012572|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
146411455|NCT04741503|528012573|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
146411456|NCT01663714|528012576|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
146411457|NCT01663714|528012576|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
146411458|NCT01663714|528012576|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
146411459|NCT01663714|528012576|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
146411460|NCT01663714|528012576|FG000|Long-Term Follow-Up|Death|4|||
146411461|NCT01663714|528012576|FG000|Long-Term Follow-Up|Non-compliance|1|||
146411462|NCT02280421|528012577|FG000|Washout (2 Weeks)|Adverse Event|0|||
146411463|NCT02280421|528012578|FG001|Washout (2 Weeks)|Adverse Event|1|||
146411464|NCT02280421|528012577|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146411465|NCT02280421|528012578|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146411466|NCT02764489|528012579|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
146411467|NCT02764489|528012580|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
146411468|NCT02764489|528012579|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
146075009|NCT03110770|526794944|FG001|Overall Study|Lost to Follow-up|0|||
146075010|NCT03110770|526794945|FG002|Overall Study|Lost to Follow-up|0|||
146075011|NCT03110770|526794946|FG003|Overall Study|Lost to Follow-up|53|||
146075012|NCT03110770|526794947|FG004|Overall Study|Lost to Follow-up|45|||
146075013|NCT03110770|526794943|FG000|Overall Study|Investigator Decision|0|||
146075014|NCT03110770|526794944|FG001|Overall Study|Investigator Decision|0|||
146075015|NCT03110770|526794945|FG002|Overall Study|Investigator Decision|0|||
146075016|NCT03110770|526794946|FG003|Overall Study|Investigator Decision|5|||
146075017|NCT03110770|526794947|FG004|Overall Study|Investigator Decision|3|||
146075018|NCT03110770|526794943|FG000|Overall Study|Withdrawal by Subject|0|||
146075019|NCT03110770|526794944|FG001|Overall Study|Withdrawal by Subject|0|||
146075020|NCT03110770|526794945|FG002|Overall Study|Withdrawal by Subject|0|||
146075021|NCT03110770|526794946|FG003|Overall Study|Withdrawal by Subject|24|||
146075022|NCT03110770|526794947|FG004|Overall Study|Withdrawal by Subject|24|||
146075023|NCT03110770|526794943|FG000|Overall Study|Moved from area|5|||
146075024|NCT03110770|526794944|FG001|Overall Study|Moved from area|0|||
146075025|NCT03110770|526794945|FG002|Overall Study|Moved from area|2|||
146075026|NCT03110770|526794946|FG003|Overall Study|Moved from area|42|||
146075027|NCT03110770|526794947|FG004|Overall Study|Moved from area|43|||
146075028|NCT03110770|526794943|FG000|Overall Study|Illness/Injury unrelated to product|0|||
146075029|NCT03110770|526794944|FG001|Overall Study|Illness/Injury unrelated to product|0|||
146075030|NCT03110770|526794945|FG002|Overall Study|Illness/Injury unrelated to product|0|||
146075031|NCT03110770|526794946|FG003|Overall Study|Illness/Injury unrelated to product|0|||
146075032|NCT03110770|526794947|FG004|Overall Study|Illness/Injury unrelated to product|1|||
146075033|NCT01667419|526794948|FG000|Overall Study|Reason Not Specified|1|||
146075034|NCT01667419|526794949|FG001|Overall Study|Reason Not Specified|0|||
146075035|NCT01667419|526794950|FG002|Overall Study|Reason Not Specified|0|||
146075036|NCT01667419|526794951|FG003|Overall Study|Reason Not Specified|0|||
146075037|NCT01667419|526794948|FG000|Overall Study|Withdrawal by Subject|16|||
146075038|NCT01667419|526794949|FG001|Overall Study|Withdrawal by Subject|8|||
146075039|NCT01667419|526794950|FG002|Overall Study|Withdrawal by Subject|9|||
146075040|NCT01667419|526794951|FG003|Overall Study|Withdrawal by Subject|8|||
146075041|NCT01667419|526794948|FG000|Overall Study|Non-compliance|0|||
146075042|NCT01667419|526794949|FG001|Overall Study|Non-compliance|0|||
146075043|NCT01667419|526794950|FG002|Overall Study|Non-compliance|0|||
146075044|NCT01667419|526794951|FG003|Overall Study|Non-compliance|1|||
146075045|NCT01667419|526794948|FG000|Overall Study|Protocol Violation|1|||
146075046|NCT01667419|526794949|FG001|Overall Study|Protocol Violation|0|||
146075047|NCT01667419|526794950|FG002|Overall Study|Protocol Violation|0|||
146075048|NCT01667419|526794951|FG003|Overall Study|Protocol Violation|0|||
146075049|NCT01667419|526794948|FG000|Overall Study|Lost to Follow-up|7|||
146075050|NCT01667419|526794949|FG001|Overall Study|Lost to Follow-up|6|||
146075051|NCT01667419|526794950|FG002|Overall Study|Lost to Follow-up|2|||
146075052|NCT01667419|526794951|FG003|Overall Study|Lost to Follow-up|4|||
146075053|NCT01667419|526794948|FG000|Overall Study|Death|18|||
146075054|NCT01667419|526794949|FG001|Overall Study|Death|33|||
146075055|NCT01667419|526794950|FG002|Overall Study|Death|25|||
146075056|NCT01667419|526794951|FG003|Overall Study|Death|26|||
146075057|NCT00856518|526794952|FG000|Overall Study|Lost to Follow-up|4|||
146075058|NCT00856518|526794953|FG001|Overall Study|Lost to Follow-up|2|||
146075059|NCT02082340|526794955|FG000|Overall Study|Lost to Follow-up|1|||
146075060|NCT02082340|526794956|FG001|Overall Study|Lost to Follow-up|1|||
146075061|NCT02644109|526794963|FG000|Overall Study|Adverse Event|0|||
146075062|NCT02644109|526794964|FG001|Overall Study|Adverse Event|4|||
146075063|NCT04195893|526794967|FG000|Second Intervention|Withdrawal by Subject|1|||
146075064|NCT04195893|526794968|FG001|Second Intervention|Withdrawal by Subject|0|||
146075065|NCT00918736|526794971|FG000|Overall Study|Withdrawal by Subject|4|||
146075066|NCT01942733|526794972|FG000|Overall Study|Lost to Follow-up|1|||
146075067|NCT01942733|526794972|FG000|Overall Study|Non-compliance with IMP|1|||
146075068|NCT01942733|526794972|FG000|Overall Study|Administrative|1|||
146411469|NCT02764489|528012580|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
146411470|NCT02764489|528012579|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
146411471|NCT02764489|528012580|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
146411472|NCT02764489|528012579|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
146411473|NCT02764489|528012580|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
146411474|NCT03840811|528012581|FG000|Overall Study|Lost to Follow-up|0|||
146411475|NCT03840811|528012582|FG001|Overall Study|Lost to Follow-up|0|||
146411476|NCT03840811|528012583|FG002|Overall Study|Lost to Follow-up|1|||
146411477|NCT01904383|528012584|FG000|Overall Study|CRF not collected|117|||
146411478|NCT01904383|528012584|FG000|Overall Study|Reason not listed|147|||
146411479|NCT01904383|528012584|FG000|Overall Study|Lost to Follow-up|674|||
146411480|NCT01904383|528012584|FG000|Overall Study|Lack of Efficacy|370|||
146411481|NCT01904383|528012584|FG000|Overall Study|Improvement|141|||
146411482|NCT01904383|528012584|FG000|Overall Study|Adverse Event|271|||
146411483|NCT01904383|528012584|FG000|Overall Study|No patient visit after entry|54|||
146411484|NCT01625845|528012585|FG000|Overall Study|Adverse Event|1|||
146411485|NCT01625845|528012586|FG001|Overall Study|Adverse Event|2|||
146411486|NCT01625845|528012585|FG000|Overall Study|Lost to Follow-up|2|||
146411487|NCT01625845|528012586|FG001|Overall Study|Lost to Follow-up|1|||
146411488|NCT01625845|528012585|FG000|Overall Study|Withdrawal by Subject|2|||
146411489|NCT01625845|528012586|FG001|Overall Study|Withdrawal by Subject|0|||
146411490|NCT02853929|528012587|FG000|Overall Study|Lost to Follow-up|3|||
146411491|NCT02853929|528012588|FG001|Overall Study|Lost to Follow-up|0|||
146411492|NCT02853929|528012587|FG000|Overall Study|Withdrawal by Subject|1|||
146411493|NCT02853929|528012588|FG001|Overall Study|Withdrawal by Subject|0|||
146411494|NCT02853929|528012587|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
146411495|NCT02853929|528012588|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
146411496|NCT01294592|528012589|FG000|Overall Study|Adverse Event|28|||
146411497|NCT01294592|528012590|FG001|Overall Study|Adverse Event|13|||
146411498|NCT01294592|528012589|FG000|Overall Study|Lack of Efficacy|7|||
146411499|NCT01294592|528012590|FG001|Overall Study|Lack of Efficacy|5|||
146411500|NCT01294592|528012589|FG000|Overall Study|Protocol Violation|1|||
146411501|NCT01294592|528012590|FG001|Overall Study|Protocol Violation|7|||
146411502|NCT01294592|528012589|FG000|Overall Study|Lost to Follow-up|7|||
146411503|NCT01294592|528012590|FG001|Overall Study|Lost to Follow-up|9|||
146411504|NCT01294592|528012589|FG000|Overall Study|Physician Decision|6|||
146411505|NCT01294592|528012590|FG001|Overall Study|Physician Decision|11|||
146411506|NCT01294592|528012589|FG000|Overall Study|Withdrawal by Subject|28|||
146411507|NCT01294592|528012590|FG001|Overall Study|Withdrawal by Subject|28|||
146411508|NCT00693784|528012591|FG000|Overall Study|Lost to Follow-up|2|||
146411509|NCT00693784|528012591|FG000|Overall Study|Withdrawal by Subject|2|||
146411510|NCT00326885|528012595|FG000|Overall Study|Adverse Event|1|||
146411511|NCT00326885|528012595|FG000|Overall Study|Withdrawal by Subject|3|||
146411512|NCT00326885|528012595|FG000|Overall Study|Physician Decision|1|||
146411513|NCT00326885|528012595|FG000|Overall Study|Hospice withdrew consent|2|||
146411514|NCT03568500|528012596|FG000|Overall Study|Lost to Follow-up|1|||
146411515|NCT03568500|528012597|FG001|Overall Study|Lost to Follow-up|1|||
146411516|NCT03568500|528012598|FG002|Overall Study|Lost to Follow-up|2|||
146411517|NCT03568500|528012596|FG000|Overall Study|Adverse Event|1|||
146411518|NCT03568500|528012597|FG001|Overall Study|Adverse Event|1|||
146411519|NCT03568500|528012598|FG002|Overall Study|Adverse Event|2|||
146411520|NCT03568500|528012596|FG000|Overall Study|Physician Decision|1|||
146411521|NCT03568500|528012597|FG001|Overall Study|Physician Decision|0|||
146411522|NCT03568500|528012598|FG002|Overall Study|Physician Decision|0|||
146411523|NCT03568500|528012596|FG000|Overall Study|Withdrawal by Subject|4|||
146411524|NCT03568500|528012597|FG001|Overall Study|Withdrawal by Subject|2|||
146411525|NCT03568500|528012598|FG002|Overall Study|Withdrawal by Subject|0|||
146411526|NCT03568500|528012596|FG000|Overall Study|Technical Problems|2|||
146411527|NCT03568500|528012597|FG001|Overall Study|Technical Problems|1|||
145945337|NCT01764997|526308216|FG004|Run-in Period|Adverse Event|0|||
146174566|NCT02969525|527151406|FG002|Dose-Blind Period|Non-cooperating patient|0|||
146174567|NCT02969525|527151407|FG003|Dose-Blind Period|Non-cooperating patient|0|||
146174568|NCT02969525|527151408|FG004|Dose-Blind Period|Non-cooperating patient|0|||
145945338|NCT01764997|526308212|FG000|Run-in Period|Lack of Efficacy|5|||
146174569|NCT02969525|527151409|FG005|Dose-Blind Period|Non-cooperating patient|0|||
146174570|NCT02969525|527151410|FG006|Dose-Blind Period|Non-cooperating patient|0|||
146174571|NCT02969525|527151411|FG007|Dose-Blind Period|Non-cooperating patient|0|||
146174572|NCT02969525|527151412|FG008|Dose-Blind Period|Non-cooperating patient|0|||
146174573|NCT02969525|527151413|FG009|Dose-Blind Period|Non-cooperating patient|0|||
146174574|NCT02969525|527151414|FG010|Dose-Blind Period|Non-cooperating patient|0|||
146174575|NCT02969525|527151415|FG011|Dose-Blind Period|Non-cooperating patient|1|||
146174576|NCT02969525|527151404|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174577|NCT02969525|527151405|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145945339|NCT01764997|526308213|FG001|Run-in Period|Lack of Efficacy|0|||
146075069|NCT04080167|526794976|FG000|Overall Study|Lost to Follow-up-Patients|7|||
146075070|NCT04080167|526794977|FG001|Overall Study|Lost to Follow-up-Patients|14|||
146075071|NCT04080167|526794978|FG002|Overall Study|Lost to Follow-up-Patients|0|||
146075072|NCT04080167|526794976|FG000|Overall Study|Lost to Follow-up-Providers|2|||
146075073|NCT04080167|526794977|FG001|Overall Study|Lost to Follow-up-Providers|2|||
146075074|NCT04080167|526794978|FG002|Overall Study|Lost to Follow-up-Providers|0|||
146075075|NCT04080167|526794976|FG000|Overall Study|Withdrawal by Subject|1|||
146075076|NCT04080167|526794977|FG001|Overall Study|Withdrawal by Subject|2|||
146075077|NCT04080167|526794978|FG002|Overall Study|Withdrawal by Subject|0|||
146075078|NCT04080167|526794976|FG000|Overall Study|Withdrawal by Provider|0|||
146075079|NCT04080167|526794977|FG001|Overall Study|Withdrawal by Provider|0|||
146075080|NCT04080167|526794978|FG002|Overall Study|Withdrawal by Provider|4|||
146075081|NCT04080167|526794976|FG000|Overall Study|Death-Patient|2|||
146075082|NCT04080167|526794977|FG001|Overall Study|Death-Patient|1|||
146075083|NCT04080167|526794978|FG002|Overall Study|Death-Patient|0|||
146075084|NCT04080167|526794976|FG000|Overall Study|Hydroxyurea New Starts|0|||
146075085|NCT04080167|526794977|FG001|Overall Study|Hydroxyurea New Starts|0|||
146075086|NCT04080167|526794978|FG002|Overall Study|Hydroxyurea New Starts|1|||
146075087|NCT04080167|526794976|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
146075088|NCT04080167|526794977|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
146075089|NCT04080167|526794978|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
146075090|NCT02167139|526794979|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
146075091|NCT02167139|526794980|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
146075092|NCT02167139|526794981|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
146075093|NCT02167139|526794982|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
146075094|NCT02167139|526794979|FG000|Randomised, Double-blind|Adverse Event|2|||
146075095|NCT02167139|526794980|FG001|Randomised, Double-blind|Adverse Event|9|||
146174578|NCT02969525|527151406|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174579|NCT02969525|527151407|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174580|NCT02969525|527151408|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174581|NCT02969525|527151409|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174582|NCT02969525|527151410|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174583|NCT02969525|527151411|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146411528|NCT03568500|528012598|FG002|Overall Study|Technical Problems|0|||
146411529|NCT03568500|528012596|FG000|Overall Study|Participant Noncompliance|1|||
146411530|NCT03568500|528012597|FG001|Overall Study|Participant Noncompliance|1|||
146411531|NCT03568500|528012598|FG002|Overall Study|Participant Noncompliance|0|||
146411532|NCT01703741|528012606|FG000|Overall Study|Withdrawal by Subject|6|||
146411533|NCT01703741|528012606|FG000|Overall Study|Adverse Event|2|||
146411534|NCT01703741|528012606|FG000|Overall Study|Physician Decision|2|||
146411535|NCT01703741|528012606|FG000|Overall Study|Protocol Violation|1|||
146411536|NCT01703741|528012606|FG000|Overall Study|Lost to Follow-up|3|||
146411537|NCT01703741|528012606|FG000|Overall Study|Subject did not want to continue|2|||
146411538|NCT01703741|528012606|FG000|Overall Study|Subject cannot comply with study visits|1|||
146411539|NCT01703741|528012606|FG000|Overall Study|Subject started testosterone injections|1|||
146411540|NCT01368276|528012607|FG000|Overall Study|Death|1|||
146411541|NCT01368276|528012608|FG001|Overall Study|Death|10|||
146411542|NCT02041494|528012609|FG000|Overall Study|Death|1|||
146411543|NCT02041494|528012610|FG001|Overall Study|Death|3|||
146411544|NCT02041494|528012609|FG000|Overall Study|Lost to Follow-up|2|||
146411545|NCT02041494|528012610|FG001|Overall Study|Lost to Follow-up|6|||
146411546|NCT02041494|528012609|FG000|Overall Study|study terminated|16|||
146411547|NCT02041494|528012610|FG001|Overall Study|study terminated|11|||
146411548|NCT03341273|528012611|FG000|Overall Study|Lost to Follow-up|7|||
146411549|NCT03341273|528012612|FG001|Overall Study|Lost to Follow-up|7|||
146411550|NCT03341273|528012611|FG000|Overall Study|Withdrawal by Subject|4|||
146411551|NCT03341273|528012612|FG001|Overall Study|Withdrawal by Subject|2|||
146411552|NCT03341273|528012611|FG000|Overall Study|Physician Decision|1|||
146411553|NCT03341273|528012612|FG001|Overall Study|Physician Decision|0|||
146411554|NCT03341273|528012611|FG000|Overall Study|Protocol Violation|0|||
146411555|NCT03341273|528012612|FG001|Overall Study|Protocol Violation|1|||
146411556|NCT03341273|528012611|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
146411557|NCT03341273|528012612|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
146411558|NCT03341273|528012611|FG000|Overall Study|Became ineligible after enrollment|1|||
146411559|NCT03341273|528012612|FG001|Overall Study|Became ineligible after enrollment|0|||
146411560|NCT03341273|528012611|FG000|Overall Study|Not Eligible at Enrollment|0|||
146411561|NCT03341273|528012612|FG001|Overall Study|Not Eligible at Enrollment|1|||
146411562|NCT03341273|528012611|FG000|Overall Study|Participant incarcerated|1|||
146411563|NCT03341273|528012612|FG001|Overall Study|Participant incarcerated|0|||
146411564|NCT00685919|528012613|FG000|Overall Study|Withdrawal by Subject|0|||
146411565|NCT00685919|528012614|FG001|Overall Study|Withdrawal by Subject|0|||
146411566|NCT00685919|528012615|FG002|Overall Study|Withdrawal by Subject|1|||
146411567|NCT00685919|528012616|FG003|Overall Study|Withdrawal by Subject|0|||
146411568|NCT00685919|528012613|FG000|Overall Study|Physician Decision|1|||
146411569|NCT00685919|528012614|FG001|Overall Study|Physician Decision|0|||
146411570|NCT00685919|528012615|FG002|Overall Study|Physician Decision|0|||
146411571|NCT00685919|528012616|FG003|Overall Study|Physician Decision|0|||
146411572|NCT01717456|528012617|FG000|End of Treatment|Physician Decision|0|||
146411573|NCT01717456|528012618|FG001|End of Treatment|Physician Decision|1|||
146411574|NCT01717456|528012617|FG000|End of Treatment|Lost to Follow-up|0|||
146411575|NCT01717456|528012618|FG001|End of Treatment|Lost to Follow-up|1|||
146411576|NCT01717456|528012617|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
146411577|NCT01717456|528012618|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
146411578|NCT00837577|528012619|FG000|Double-blind Period|Clinical Adverse Event|1|||
146411579|NCT00837577|528012620|FG001|Double-blind Period|Clinical Adverse Event|0|||
146411580|NCT00837577|528012619|FG000|Double-blind Period|Withdrawal by Subject|1|||
146411581|NCT00837577|528012620|FG001|Double-blind Period|Withdrawal by Subject|0|||
146411582|NCT00837577|528012619|FG000|Open-label Period|Clinical Adverse Event|2|||
146411583|NCT00837577|528012620|FG001|Open-label Period|Clinical Adverse Event|2|||
146411584|NCT00837577|528012619|FG000|Open-label Period|Laboratory Adverse Event|0|||
146411585|NCT00837577|528012620|FG001|Open-label Period|Laboratory Adverse Event|1|||
146411586|NCT00837577|528012619|FG000|Open-label Period|Lack of Efficacy|4|||
146411587|NCT00837577|528012620|FG001|Open-label Period|Lack of Efficacy|3|||
146411588|NCT00837577|528012619|FG000|Open-label Period|Withdrawal by Subject|1|||
146411589|NCT00837577|528012620|FG001|Open-label Period|Withdrawal by Subject|2|||
146411590|NCT00837577|528012619|FG000|Open-label Period|Other Reason|1|||
146411591|NCT00837577|528012620|FG001|Open-label Period|Other Reason|1|||
146411592|NCT00986154|528012621|FG000|Overall Study|Death|136|||
146411593|NCT00986154|528012622|FG001|Overall Study|Death|127|||
146411594|NCT00986154|528012621|FG000|Overall Study|Lost to Follow-up|7|||
146411595|NCT00986154|528012622|FG001|Overall Study|Lost to Follow-up|4|||
146411596|NCT00986154|528012621|FG000|Overall Study|Withdrawal by Subject|32|||
146174584|NCT02969525|527151412|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174585|NCT02969525|527151413|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174586|NCT02969525|527151414|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
146174587|NCT02969525|527151415|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
146174588|NCT03445065|527151416|FG000|Overall Study|Withdrawal by Subject|3|||
146174589|NCT03445065|527151417|FG001|Overall Study|Withdrawal by Subject|6|||
146174590|NCT03445065|527151418|FG002|Overall Study|Withdrawal by Subject|2|||
146174591|NCT03445065|527151419|FG003|Overall Study|Withdrawal by Subject|2|||
146174592|NCT03445065|527151416|FG000|Overall Study|Other|4|||
146174593|NCT03445065|527151417|FG001|Overall Study|Other|3|||
146174594|NCT03445065|527151418|FG002|Overall Study|Other|3|||
146174595|NCT03445065|527151419|FG003|Overall Study|Other|1|||
146174596|NCT00524030|527151420|FG000|Overall Study|Lack of Efficacy|10|||
146174597|NCT00524030|527151421|FG001|Overall Study|Lack of Efficacy|24|||
146174598|NCT00524030|527151420|FG000|Overall Study|Lost to Follow-up|0|||
146174599|NCT00524030|527151421|FG001|Overall Study|Lost to Follow-up|2|||
146174600|NCT00524030|527151420|FG000|Overall Study|Withdrawal by Subject|3|||
146174601|NCT00524030|527151421|FG001|Overall Study|Withdrawal by Subject|8|||
146174602|NCT00524030|527151420|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
146174603|NCT00524030|527151421|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
146174604|NCT00524030|527151420|FG000|Overall Study|Protocol Violation|0|||
146174605|NCT00524030|527151421|FG001|Overall Study|Protocol Violation|1|||
146174606|NCT00524030|527151420|FG000|Overall Study|Pregnancy|1|||
146174607|NCT00524030|527151421|FG001|Overall Study|Pregnancy|0|||
146174608|NCT00524030|527151420|FG000|Overall Study|Adverse Event|3|||
146174609|NCT00524030|527151421|FG001|Overall Study|Adverse Event|21|||
146411597|NCT00986154|528012622|FG001|Overall Study|Withdrawal by Subject|33|||
146411598|NCT00986154|528012621|FG000|Overall Study|investigator/subject decide not continue|6|||
146411599|NCT00986154|528012622|FG001|Overall Study|investigator/subject decide not continue|3|||
146411600|NCT00986154|528012621|FG000|Overall Study|never received study drug|25|||
146411601|NCT00986154|528012622|FG001|Overall Study|never received study drug|27|||
146411602|NCT00033631|528012627|FG000|Overall Study|Protocol Violation|14|||
146411603|NCT00033631|528012628|FG001|Overall Study|Protocol Violation|11|||
146411604|NCT00033631|528012627|FG000|Overall Study|Withdrawal by Subject|4|||
146411605|NCT00033631|528012628|FG001|Overall Study|Withdrawal by Subject|4|||
146411606|NCT01252238|528012631|FG000|Overall Study|Sponsor terminated study|4|||
146411607|NCT01252238|528012632|FG001|Overall Study|Sponsor terminated study|4|||
146411608|NCT01252238|528012633|FG002|Overall Study|Sponsor terminated study|4|||
146411609|NCT00272961|528012634|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
146411610|NCT00272961|528012635|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146411611|NCT00272961|528012636|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146411612|NCT00272961|528012637|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146411613|NCT00272961|528012638|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
146411614|NCT00272961|528012634|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
146411615|NCT00272961|528012635|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146411616|NCT00272961|528012636|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146411617|NCT00272961|528012637|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146411618|NCT00272961|528012638|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
146411619|NCT00272961|528012634|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
146411620|NCT00272961|528012635|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146411621|NCT00272961|528012636|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146411622|NCT00272961|528012637|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146411623|NCT00272961|528012638|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
146411624|NCT00272961|528012634|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
146411625|NCT00272961|528012635|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146411626|NCT00272961|528012636|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146411627|NCT00272961|528012637|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146411628|NCT00272961|528012638|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
146411629|NCT00272961|528012634|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
146411630|NCT00272961|528012635|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
146411631|NCT00272961|528012636|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
146411632|NCT00272961|528012637|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
146411633|NCT00272961|528012638|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
146411634|NCT00272961|528012634|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
146411635|NCT00272961|528012635|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
146411636|NCT00272961|528012636|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
146411637|NCT00272961|528012637|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
146411638|NCT00272961|528012638|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
146411639|NCT00272961|528012634|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
146411640|NCT00272961|528012635|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146174610|NCT00524030|527151420|FG000|Overall Study|Death|0|||
146174611|NCT00524030|527151421|FG001|Overall Study|Death|1|||
146174612|NCT02944656|527151429|FG000|Overall Study|No longer eligible|3|||
146174613|NCT02944656|527151430|FG001|Overall Study|No longer eligible|0|||
146174614|NCT02944656|527151429|FG000|Overall Study|Lost to Follow-up|7|||
146174615|NCT02944656|527151430|FG001|Overall Study|Lost to Follow-up|10|||
146174616|NCT04398537|527151431|FG000|Overall Study|Physician Decision|10|||
146174617|NCT04398537|527151432|FG001|Overall Study|Physician Decision|15|||
146174618|NCT02243631|527153020|FG000|Overall Study|no synovial fluid on second aspirate|0|||
146174619|NCT02243631|527153021|FG001|Overall Study|no synovial fluid on second aspirate|1|||
146174620|NCT01590771|527153022|FG000|Overall Study|Other Protocol Specified Criteria|5|||
146174621|NCT01590771|527153023|FG001|Overall Study|Other Protocol Specified Criteria|14|||
146174622|NCT01590771|527153022|FG000|Overall Study|Withdrawal by Subject|8|||
146174623|NCT01590771|527153023|FG001|Overall Study|Withdrawal by Subject|15|||
146174624|NCT01590771|527153022|FG000|Overall Study|Protocol Violation|1|||
146174625|NCT01590771|527153023|FG001|Overall Study|Protocol Violation|2|||
146174626|NCT01590771|527153022|FG000|Overall Study|Lost to Follow-up|1|||
146174627|NCT01590771|527153023|FG001|Overall Study|Lost to Follow-up|1|||
146174628|NCT01590771|527153022|FG000|Overall Study|Lack of Efficacy|1|||
146174629|NCT01590771|527153023|FG001|Overall Study|Lack of Efficacy|0|||
146174630|NCT01590771|527153022|FG000|Overall Study|Adverse Event|3|||
146174631|NCT01590771|527153023|FG001|Overall Study|Adverse Event|7|||
146174632|NCT01785628|527153024|FG000|Overall Study|Lost to Follow-up|2|||
146174633|NCT01785628|527153025|FG001|Overall Study|Lost to Follow-up|3|||
146174634|NCT02200939|527153026|FG000|Overall Study|Participant withdrew consent|0|||
146174635|NCT02200939|527153027|FG001|Overall Study|Participant withdrew consent|1|||
146174636|NCT02200939|527153026|FG000|Overall Study|Lost to Follow-up|2|||
146174637|NCT02200939|527153027|FG001|Overall Study|Lost to Follow-up|9|||
146174638|NCT02200939|527153026|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
146174639|NCT02200939|527153027|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
146174640|NCT02746575|527153028|FG000|Overall Study|Surgery cancelled or time chaned|13|||
146174641|NCT02746575|527153028|FG000|Overall Study|Received epidural|10|||
146174642|NCT02746575|527153028|FG000|Overall Study|Withdrawal by Subject|3|||
146174643|NCT02746575|527153028|FG000|Overall Study|Bradycardia/hypotension|9|||
146174644|NCT02746575|527153028|FG000|Overall Study|Study paused|8|||
146174645|NCT02746575|527153028|FG000|Overall Study|put on beta-blocker|3|||
146174646|NCT02746575|527153028|FG000|Overall Study|type of surgery|1|||
146174647|NCT02746575|527153028|FG000|Overall Study|typ of surgery|1|||
146174648|NCT02746575|527153028|FG000|Overall Study|PI unavailable|1|||
146075096|NCT02167139|526794981|FG002|Randomised, Double-blind|Adverse Event|0|||
146075097|NCT02167139|526794982|FG003|Randomised, Double-blind|Adverse Event|0|||
146075098|NCT02167139|526794979|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
146075099|NCT02167139|526794980|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
146075100|NCT02167139|526794981|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
146075101|NCT02167139|526794982|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
146075102|NCT02167139|526794979|FG000|Randomised, Double-blind|Other|3|||
146075103|NCT02167139|526794980|FG001|Randomised, Double-blind|Other|0|||
146075104|NCT02167139|526794981|FG002|Randomised, Double-blind|Other|0|||
146075105|NCT02167139|526794982|FG003|Randomised, Double-blind|Other|0|||
146075106|NCT02167139|526794979|FG000|Transition-extension|Adverse Event|2|||
146075107|NCT02167139|526794980|FG001|Transition-extension|Adverse Event|0|||
146075108|NCT02167139|526794981|FG002|Transition-extension|Adverse Event|2|||
146075109|NCT02167139|526794982|FG003|Transition-extension|Adverse Event|3|||
146075110|NCT02167139|526794979|FG000|Transition-extension|Withdrawal by Subject|2|||
146075111|NCT02167139|526794980|FG001|Transition-extension|Withdrawal by Subject|0|||
146075112|NCT02167139|526794981|FG002|Transition-extension|Withdrawal by Subject|4|||
146075113|NCT02167139|526794982|FG003|Transition-extension|Withdrawal by Subject|1|||
146075114|NCT02167139|526794979|FG000|Transition-extension|Lack of Efficacy|0|||
146075115|NCT02167139|526794980|FG001|Transition-extension|Lack of Efficacy|0|||
146075116|NCT02167139|526794981|FG002|Transition-extension|Lack of Efficacy|1|||
146075117|NCT02167139|526794982|FG003|Transition-extension|Lack of Efficacy|1|||
146075118|NCT02167139|526794979|FG000|Transition-extension|Other|1|||
146075119|NCT02167139|526794980|FG001|Transition-extension|Other|0|||
146075120|NCT02167139|526794981|FG002|Transition-extension|Other|1|||
146075121|NCT02167139|526794982|FG003|Transition-extension|Other|0|||
146075122|NCT02167139|526794979|FG000|Transition-extension|Lost to Follow-up|1|||
146075123|NCT02167139|526794980|FG001|Transition-extension|Lost to Follow-up|0|||
146075124|NCT02167139|526794981|FG002|Transition-extension|Lost to Follow-up|0|||
146075125|NCT02167139|526794982|FG003|Transition-extension|Lost to Follow-up|0|||
146075126|NCT00984620|526794985|FG000|Overall Study|Adverse Event|5|||
146075127|NCT00984620|526794986|FG001|Overall Study|Adverse Event|5|||
146075128|NCT00984620|526794985|FG000|Overall Study|Lost to Follow-up|1|||
146075129|NCT00984620|526794986|FG001|Overall Study|Lost to Follow-up|1|||
146075130|NCT00984620|526794985|FG000|Overall Study|Withdrawal by Subject|0|||
146075131|NCT00984620|526794986|FG001|Overall Study|Withdrawal by Subject|2|||
146075132|NCT00984620|526794985|FG000|Overall Study|reason other than listed above|0|||
146075133|NCT00984620|526794986|FG001|Overall Study|reason other than listed above|4|||
146075134|NCT00344487|526794989|FG000|Overall Study|immunologic failure|1|||
146075135|NCT02791763|526794993|FG000|Overall Study|Protocol Violation|0|||
146075136|NCT02791763|526794994|FG001|Overall Study|Protocol Violation|0|||
146075137|NCT02791763|526794995|FG002|Overall Study|Protocol Violation|1|||
146075138|NCT02791763|526794993|FG000|Overall Study|Withdrawal by Subject|5|||
146075139|NCT02791763|526794994|FG001|Overall Study|Withdrawal by Subject|1|||
146075140|NCT02791763|526794995|FG002|Overall Study|Withdrawal by Subject|0|||
146075141|NCT02791763|526794993|FG000|Overall Study|Physician Decision|0|||
146075142|NCT02791763|526794994|FG001|Overall Study|Physician Decision|1|||
146075143|NCT02791763|526794995|FG002|Overall Study|Physician Decision|0|||
146075144|NCT02791763|526794993|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
146075145|NCT02791763|526794994|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
146075146|NCT02791763|526794995|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
146075147|NCT02791763|526794993|FG000|Overall Study|Cancer event|1|||
146075148|NCT02791763|526794994|FG001|Overall Study|Cancer event|3|||
146075149|NCT02791763|526794995|FG002|Overall Study|Cancer event|0|||
146075150|NCT02791763|526794993|FG000|Overall Study|Participant had renal transplant|3|||
146075151|NCT02791763|526794994|FG001|Overall Study|Participant had renal transplant|0|||
146075152|NCT02791763|526794995|FG002|Overall Study|Participant had renal transplant|0|||
146075153|NCT02791763|526794993|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
146075154|NCT02791763|526794994|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
146075155|NCT02791763|526794995|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
146075156|NCT02791763|526794993|FG000|Overall Study|Adverse Event|12|||
146075157|NCT02791763|526794994|FG001|Overall Study|Adverse Event|13|||
146075158|NCT02791763|526794995|FG002|Overall Study|Adverse Event|7|||
146075159|NCT01561313|526795001|FG000|Overall Study|Withdrawal by Subject|1|||
146411641|NCT00272961|528012636|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
146411642|NCT00272961|528012637|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146411643|NCT00272961|528012638|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
146411644|NCT00272961|528012634|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
146411645|NCT00272961|528012635|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
146411646|NCT00272961|528012636|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
146411647|NCT00272961|528012637|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
146411648|NCT00272961|528012638|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
146411649|NCT01507831|528012640|FG000|Overall Study|Randomized but not treated|0|||
146411650|NCT01507831|528012641|FG001|Overall Study|Randomized but not treated|3|||
146411651|NCT01507831|528012640|FG000|Overall Study|Adverse Event|48|||
146411652|NCT01507831|528012641|FG001|Overall Study|Adverse Event|113|||
146411653|NCT01507831|528012640|FG000|Overall Study|Death|6|||
146411654|NCT01507831|528012641|FG001|Overall Study|Death|2|||
146411655|NCT01507831|528012640|FG000|Overall Study|Poor compliance to protocol|38|||
146174649|NCT02746575|527153028|FG000|Overall Study|Unknown history of CVA|1|||
146174650|NCT04567693|527153029|FG000|Overall Study|Death|0|||
146174651|NCT04567693|527153030|FG001|Overall Study|Death|0|||
146174652|NCT04567693|527153031|FG002|Overall Study|Death|2|||
146174653|NCT04567693|527153029|FG000|Overall Study|Lost to Follow-up|1|||
146174654|NCT04567693|527153030|FG001|Overall Study|Lost to Follow-up|0|||
146174655|NCT04567693|527153031|FG002|Overall Study|Lost to Follow-up|2|||
146174656|NCT04567693|527153029|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
146174657|NCT04567693|527153030|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
146174658|NCT04567693|527153031|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
146174659|NCT00976482|527153034|FG000|Overall Study|Death|208|||
146174660|NCT00976482|527153034|FG000|Overall Study|Withdrawal by Subject|45|||
146174661|NCT00976482|527153034|FG000|Overall Study|Center terminated|1|||
146174662|NCT00976482|527153034|FG000|Overall Study|Protocol Violation|5|||
146174663|NCT03722264|527153037|FG000|Overall Study|Physician Decision|3|||
146174664|NCT00720902|527153038|FG000|Overall Study|Withdrawal by Subject|1|||
146174665|NCT00720902|527153039|FG001|Overall Study|Withdrawal by Subject|0|||
146174666|NCT00720902|527153038|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
146174667|NCT00720902|527153039|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
146174668|NCT01486758|527153040|FG000|Overall Study|Lost to Follow-up|0|||
146174669|NCT01486758|527153041|FG001|Overall Study|Lost to Follow-up|1|||
146174670|NCT02959671|527153042|FG000|Overall Study|Adverse Event|2|||
146174671|NCT02959671|527153042|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
146174672|NCT03462706|527153045|FG000|Overall Study|Polyp was pedunculated|1|||
146174673|NCT03462706|527153046|FG001|Overall Study|Polyp was pedunculated|0|||
146174674|NCT03462706|527153047|FG002|Overall Study|Polyp was pedunculated|1|||
146174675|NCT03462706|527153048|FG003|Overall Study|Polyp was pedunculated|0|||
146174676|NCT03462706|527153045|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
146075160|NCT01561313|526795002|FG001|Overall Study|Withdrawal by Subject|0|||
146075161|NCT01561313|526795001|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
146075162|NCT01561313|526795002|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
146075163|NCT04535453|526795003|FG000|Overall Study|Death|0|||
146075164|NCT04535453|526795004|FG001|Overall Study|Death|1|||
146075165|NCT04535453|526795005|FG002|Overall Study|Death|0|||
146075166|NCT04535453|526795006|FG003|Overall Study|Death|0|||
146174677|NCT03462706|527153046|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
146174678|NCT03462706|527153047|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
146174679|NCT03462706|527153048|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
146174680|NCT04105972|527153059|FG000|Overall Study|Adverse Event|2|||
146174681|NCT04105972|527153060|FG001|Overall Study|Adverse Event|1|||
145945340|NCT01764997|526308214|FG002|Run-in Period|Lack of Efficacy|0|||
146075167|NCT04535453|526795007|FG004|Overall Study|Death|0|||
146075168|NCT04535453|526795008|FG005|Overall Study|Death|0|||
146075169|NCT04535453|526795009|FG006|Overall Study|Death|0|||
146075170|NCT04535453|526795010|FG007|Overall Study|Death|0|||
146075171|NCT04535453|526795011|FG008|Overall Study|Death|0|||
146075172|NCT04535453|526795012|FG009|Overall Study|Death|0|||
146075173|NCT04535453|526795013|FG010|Overall Study|Death|0|||
146075174|NCT04535453|526795014|FG011|Overall Study|Death|0|||
146075175|NCT04535453|526795003|FG000|Overall Study|Lost to Follow-up|1|||
146075176|NCT04535453|526795004|FG001|Overall Study|Lost to Follow-up|1|||
146075177|NCT04535453|526795005|FG002|Overall Study|Lost to Follow-up|1|||
146075178|NCT04535453|526795006|FG003|Overall Study|Lost to Follow-up|0|||
146075179|NCT04535453|526795007|FG004|Overall Study|Lost to Follow-up|3|||
146075180|NCT04535453|526795008|FG005|Overall Study|Lost to Follow-up|1|||
146075181|NCT04535453|526795009|FG006|Overall Study|Lost to Follow-up|0|||
146075182|NCT04535453|526795010|FG007|Overall Study|Lost to Follow-up|0|||
146075183|NCT04535453|526795011|FG008|Overall Study|Lost to Follow-up|1|||
146075184|NCT04535453|526795012|FG009|Overall Study|Lost to Follow-up|1|||
146075185|NCT04535453|526795013|FG010|Overall Study|Lost to Follow-up|0|||
146075186|NCT04535453|526795014|FG011|Overall Study|Lost to Follow-up|0|||
146075187|NCT04535453|526795003|FG000|Overall Study|Physician Decision|0|||
146075188|NCT04535453|526795004|FG001|Overall Study|Physician Decision|0|||
146075189|NCT04535453|526795005|FG002|Overall Study|Physician Decision|0|||
146075190|NCT04535453|526795006|FG003|Overall Study|Physician Decision|1|||
146075191|NCT04535453|526795007|FG004|Overall Study|Physician Decision|0|||
146075192|NCT04535453|526795008|FG005|Overall Study|Physician Decision|0|||
146075193|NCT04535453|526795009|FG006|Overall Study|Physician Decision|0|||
146075194|NCT04535453|526795010|FG007|Overall Study|Physician Decision|0|||
146075195|NCT04535453|526795011|FG008|Overall Study|Physician Decision|0|||
146075196|NCT04535453|526795012|FG009|Overall Study|Physician Decision|0|||
146075197|NCT04535453|526795013|FG010|Overall Study|Physician Decision|0|||
146075198|NCT04535453|526795014|FG011|Overall Study|Physician Decision|0|||
146075199|NCT04535453|526795003|FG000|Overall Study|Withdrawal by Subject|3|||
146075200|NCT04535453|526795004|FG001|Overall Study|Withdrawal by Subject|6|||
146075201|NCT04535453|526795005|FG002|Overall Study|Withdrawal by Subject|3|||
146075202|NCT04535453|526795006|FG003|Overall Study|Withdrawal by Subject|3|||
146075203|NCT04535453|526795007|FG004|Overall Study|Withdrawal by Subject|2|||
146075204|NCT04535453|526795008|FG005|Overall Study|Withdrawal by Subject|1|||
146075205|NCT04535453|526795009|FG006|Overall Study|Withdrawal by Subject|1|||
146075206|NCT04535453|526795010|FG007|Overall Study|Withdrawal by Subject|1|||
146075207|NCT04535453|526795011|FG008|Overall Study|Withdrawal by Subject|1|||
146075208|NCT04535453|526795012|FG009|Overall Study|Withdrawal by Subject|1|||
146075209|NCT04535453|526795013|FG010|Overall Study|Withdrawal by Subject|0|||
146075210|NCT04535453|526795014|FG011|Overall Study|Withdrawal by Subject|1|||
146075211|NCT04535453|526795003|FG000|Overall Study|Other|0|||
146075212|NCT04535453|526795004|FG001|Overall Study|Other|0|||
146075213|NCT04535453|526795005|FG002|Overall Study|Other|1|||
146075214|NCT04535453|526795006|FG003|Overall Study|Other|0|||
146075215|NCT04535453|526795007|FG004|Overall Study|Other|1|||
146075216|NCT04535453|526795008|FG005|Overall Study|Other|0|||
146075217|NCT04535453|526795009|FG006|Overall Study|Other|1|||
146075218|NCT04535453|526795010|FG007|Overall Study|Other|1|||
146075219|NCT04535453|526795011|FG008|Overall Study|Other|1|||
146075220|NCT04535453|526795012|FG009|Overall Study|Other|0|||
146075221|NCT04535453|526795013|FG010|Overall Study|Other|0|||
146075222|NCT04535453|526795014|FG011|Overall Study|Other|0|||
146075223|NCT01742286|526795015|FG000|Escalation Phase|Administrative problems|1|||
146075224|NCT01742286|526795016|FG001|Escalation Phase|Administrative problems|1|||
146075225|NCT01742286|526795017|FG002|Escalation Phase|Administrative problems|0|||
146075226|NCT01742286|526795018|FG003|Escalation Phase|Administrative problems|0|||
146075227|NCT01742286|526795019|FG004|Escalation Phase|Administrative problems|0|||
146075228|NCT01742286|526795020|FG005|Escalation Phase|Administrative problems|0|||
146075229|NCT01742286|526795021|FG006|Escalation Phase|Administrative problems|2|||
146075230|NCT01742286|526795015|FG000|Escalation Phase|Adverse Event|0|||
146075231|NCT01742286|526795016|FG001|Escalation Phase|Adverse Event|1|||
146075232|NCT01742286|526795017|FG002|Escalation Phase|Adverse Event|2|||
146075233|NCT01742286|526795018|FG003|Escalation Phase|Adverse Event|0|||
146075234|NCT01742286|526795019|FG004|Escalation Phase|Adverse Event|0|||
146075235|NCT01742286|526795020|FG005|Escalation Phase|Adverse Event|1|||
146075236|NCT01742286|526795021|FG006|Escalation Phase|Adverse Event|0|||
146075237|NCT01742286|526795015|FG000|Escalation Phase|Disease progression|3|||
146075238|NCT01742286|526795016|FG001|Escalation Phase|Disease progression|7|||
146075239|NCT01742286|526795017|FG002|Escalation Phase|Disease progression|4|||
146075240|NCT01742286|526795018|FG003|Escalation Phase|Disease progression|1|||
146075241|NCT01742286|526795019|FG004|Escalation Phase|Disease progression|4|||
146075242|NCT01742286|526795020|FG005|Escalation Phase|Disease progression|3|||
146075243|NCT01742286|526795021|FG006|Escalation Phase|Disease progression|2|||
146075244|NCT01742286|526795015|FG000|Escalation Phase|Death|0|||
146075245|NCT01742286|526795016|FG001|Escalation Phase|Death|0|||
146075246|NCT01742286|526795017|FG002|Escalation Phase|Death|0|||
146075247|NCT01742286|526795018|FG003|Escalation Phase|Death|0|||
146075248|NCT01742286|526795019|FG004|Escalation Phase|Death|0|||
146075249|NCT01742286|526795020|FG005|Escalation Phase|Death|1|||
146075250|NCT01742286|526795021|FG006|Escalation Phase|Death|0|||
146075251|NCT01742286|526795015|FG000|Escalation Phase|Physician Decision|0|||
146075252|NCT01742286|526795016|FG001|Escalation Phase|Physician Decision|3|||
146075253|NCT01742286|526795017|FG002|Escalation Phase|Physician Decision|0|||
146075254|NCT01742286|526795018|FG003|Escalation Phase|Physician Decision|1|||
146075255|NCT01742286|526795019|FG004|Escalation Phase|Physician Decision|0|||
146075256|NCT01742286|526795020|FG005|Escalation Phase|Physician Decision|0|||
146075257|NCT01742286|526795021|FG006|Escalation Phase|Physician Decision|2|||
146075258|NCT01742286|526795015|FG000|Escalation Phase|Subject/guardian decision|1|||
146075259|NCT01742286|526795016|FG001|Escalation Phase|Subject/guardian decision|0|||
146075260|NCT01742286|526795017|FG002|Escalation Phase|Subject/guardian decision|0|||
146174682|NCT00553202|527153063|FG000|Overall Study|Death|16|||
146411656|NCT01507831|528012641|FG001|Overall Study|Poor compliance to protocol|60|||
146411657|NCT01507831|528012640|FG000|Overall Study|Physician Decision|0|||
146411658|NCT01507831|528012641|FG001|Overall Study|Physician Decision|4|||
146411659|NCT01507831|528012640|FG000|Overall Study|Participant moved|5|||
146411660|NCT01507831|528012641|FG001|Overall Study|Participant moved|19|||
146411661|NCT01507831|528012640|FG000|Overall Study|Consent withdrawn by participant|34|||
146411662|NCT01507831|528012641|FG001|Overall Study|Consent withdrawn by participant|72|||
146411663|NCT01507831|528012640|FG000|Overall Study|Related to study drug administration|5|||
146411664|NCT01507831|528012641|FG001|Overall Study|Related to study drug administration|14|||
146411665|NCT01507831|528012640|FG000|Overall Study|Last visit outside protocol visit window|51|||
146411666|NCT01507831|528012641|FG001|Overall Study|Last visit outside protocol visit window|143|||
146411667|NCT01507831|528012640|FG000|Overall Study|Selection criteria finally not met|0|||
146411668|NCT01507831|528012641|FG001|Overall Study|Selection criteria finally not met|1|||
146411669|NCT01507831|528012640|FG000|Overall Study|Site closure|0|||
146411670|NCT01507831|528012641|FG001|Overall Study|Site closure|3|||
146411671|NCT01507831|528012640|FG000|Overall Study|Potential lost to follow-up|3|||
146411672|NCT01507831|528012641|FG001|Overall Study|Potential lost to follow-up|0|||
146411673|NCT01507831|528012640|FG000|Overall Study|Other|3|||
146411674|NCT01507831|528012641|FG001|Overall Study|Other|6|||
146411675|NCT00068237|528012642|FG000|Overall Study|Ineligible|3|||
146411676|NCT00068237|528012642|FG000|Overall Study|No protocol treatment received|2|||
146411677|NCT03276962|528012648|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
146411678|NCT03276962|528012649|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
146411679|NCT03276962|528012650|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
146411680|NCT03276962|528012651|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
146411681|NCT03276962|528012652|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
146411682|NCT03276962|528012648|FG000|Overall Study|Protocol Deviation|2|||
146411683|NCT03276962|528012649|FG001|Overall Study|Protocol Deviation|0|||
146411684|NCT03276962|528012650|FG002|Overall Study|Protocol Deviation|1|||
146411685|NCT03276962|528012651|FG003|Overall Study|Protocol Deviation|2|||
146411686|NCT03276962|528012652|FG004|Overall Study|Protocol Deviation|1|||
146411687|NCT03276962|528012648|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
146411688|NCT03276962|528012649|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146411689|NCT03276962|528012650|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
146411690|NCT03276962|528012651|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146411691|NCT03276962|528012652|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
146411692|NCT03276962|528012648|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
146411693|NCT03276962|528012649|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
146411694|NCT03276962|528012650|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
146411695|NCT03276962|528012651|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
146411696|NCT03276962|528012652|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
146411697|NCT03276962|528012648|FG000|Overall Study|Lost to Follow-up|10|||
146411698|NCT03276962|528012649|FG001|Overall Study|Lost to Follow-up|10|||
146411699|NCT03276962|528012650|FG002|Overall Study|Lost to Follow-up|4|||
146411700|NCT03276962|528012651|FG003|Overall Study|Lost to Follow-up|6|||
146411701|NCT03276962|528012652|FG004|Overall Study|Lost to Follow-up|10|||
146411702|NCT03276962|528012648|FG000|Overall Study|Other|0|||
146411703|NCT03276962|528012649|FG001|Overall Study|Other|2|||
146411704|NCT03276962|528012650|FG002|Overall Study|Other|0|||
146411705|NCT03276962|528012651|FG003|Overall Study|Other|2|||
146411706|NCT03276962|528012652|FG004|Overall Study|Other|1|||
146411707|NCT01238211|528012653|FG000|Overall Study|Continues active treatment|31|||
146411708|NCT01238211|528012653|FG000|Overall Study|Adverse Event|7|||
146411709|NCT01238211|528012653|FG000|Overall Study|Death|4|||
146411710|NCT01238211|528012653|FG000|Overall Study|Relapse/Progression|2|||
146411711|NCT01238211|528012653|FG000|Overall Study|Withdrawal by Subject|7|||
146411712|NCT01238211|528012653|FG000|Overall Study|Non-protocol treatment|4|||
146411713|NCT01238211|528012653|FG000|Overall Study|Investigator/Patient Decision|3|||
146411714|NCT01358708|528012654|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146411715|NCT01358708|528012655|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146411716|NCT01358708|528012654|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
146411717|NCT01358708|528012655|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
146411718|NCT02475980|528012658|FG000|Overall Study|Lost to Follow-up|4|||
146411719|NCT02475980|528012658|FG000|Overall Study|Withdrawal by Subject|1|||
146411720|NCT00990093|528012659|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
146411721|NCT00990093|528012660|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
146411722|NCT00990093|528012659|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
146411723|NCT00990093|528012660|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
146411724|NCT00990093|528012659|FG000|Test Period 1 (1-14 Days)|Other|1|||
146411725|NCT00990093|528012660|FG001|Test Period 1 (1-14 Days)|Other|0|||
146411726|NCT00990093|528012659|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
146411727|NCT00990093|528012660|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
146411728|NCT00990093|528012659|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
145890933|NCT01207440|526107570|FG000|Overall Study|Non-compliance with Study Drug|3|||
146174683|NCT00553202|527153063|FG000|Overall Study|Lost to Follow-up|1|||
146174684|NCT00553202|527153063|FG000|Overall Study|Physician Decision|28|||
146174685|NCT00553202|527153063|FG000|Overall Study|Withdrawal by Subject|1|||
146174686|NCT00553202|527153063|FG000|Overall Study|No donor identified|16|||
146174687|NCT00553202|527153063|FG000|Overall Study|Fails to meet organ function|6|||
146174688|NCT01161472|527153065|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
146174689|NCT01161472|527153066|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146174690|NCT01161472|527153067|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146174691|NCT01161472|527153068|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
146283915|NCT01758900|527551897|FG000|Overall Study|difficulty for further intubation|7|||
146411729|NCT00990093|528012660|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
146411730|NCT00990093|528012659|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
146411731|NCT00990093|528012660|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
146411732|NCT00990093|528012659|FG000|Test Period 2 (15-28 Days)|Other|0|||
146411733|NCT00990093|528012660|FG001|Test Period 2 (15-28 Days)|Other|1|||
146411734|NCT00343642|528013912|FG000|Overall Study|Lost to Follow-up|0|||
146411735|NCT00343642|528013913|FG001|Overall Study|Lost to Follow-up|1|||
146411736|NCT00343642|528013914|FG002|Overall Study|Lost to Follow-up|0|||
146411737|NCT00343642|528013912|FG000|Overall Study|Pregnancy|1|||
146411738|NCT00343642|528013913|FG001|Overall Study|Pregnancy|0|||
146411739|NCT00343642|528013914|FG002|Overall Study|Pregnancy|2|||
146411740|NCT00343642|528013912|FG000|Overall Study|Withdrawal by Subject|2|||
146411741|NCT00343642|528013913|FG001|Overall Study|Withdrawal by Subject|3|||
146411742|NCT00343642|528013914|FG002|Overall Study|Withdrawal by Subject|4|||
146411743|NCT00343642|528013912|FG000|Overall Study|Adverse Event|0|||
146411744|NCT00343642|528013913|FG001|Overall Study|Adverse Event|0|||
146411745|NCT00343642|528013914|FG002|Overall Study|Adverse Event|1|||
146411746|NCT00343642|528013912|FG000|Overall Study|Flare up|6|||
146411747|NCT00343642|528013913|FG001|Overall Study|Flare up|4|||
146411748|NCT00343642|528013914|FG002|Overall Study|Flare up|0|||
146411749|NCT00766506|528013915|FG000|Overall Study|Use rescue medication after 3 hours|3|||
146411750|NCT00766506|528013916|FG001|Overall Study|Use rescue medication after 3 hours|0|||
146411751|NCT00766506|528013915|FG000|Overall Study|Other|2|||
146411752|NCT00766506|528013916|FG001|Overall Study|Other|2|||
146411753|NCT00860574|528013917|FG000|Overall Study|Death|2|||
146411754|NCT00860574|528013917|FG000|Overall Study|Relapse|1|||
146411755|NCT01246986|528013918|FG000|Overall Study|Lost to Follow-up|0|||
146411756|NCT01246986|528013919|FG001|Overall Study|Lost to Follow-up|1|||
146411757|NCT01246986|528013920|FG002|Overall Study|Lost to Follow-up|3|||
146411758|NCT01246986|528013921|FG003|Overall Study|Lost to Follow-up|0|||
146411759|NCT01246986|528013922|FG004|Overall Study|Lost to Follow-up|0|||
146411760|NCT01246986|528013923|FG005|Overall Study|Lost to Follow-up|1|||
146411761|NCT01246986|528013924|FG006|Overall Study|Lost to Follow-up|0|||
146411762|NCT01246986|528013918|FG000|Overall Study|Withdrawal by Subject|3|||
146411763|NCT01246986|528013919|FG001|Overall Study|Withdrawal by Subject|4|||
146411764|NCT01246986|528013920|FG002|Overall Study|Withdrawal by Subject|3|||
146411765|NCT01246986|528013921|FG003|Overall Study|Withdrawal by Subject|0|||
146411766|NCT01246986|528013922|FG004|Overall Study|Withdrawal by Subject|4|||
146411767|NCT01246986|528013923|FG005|Overall Study|Withdrawal by Subject|0|||
146411768|NCT01246986|528013924|FG006|Overall Study|Withdrawal by Subject|0|||
146411769|NCT02496221|528013926|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
146411770|NCT02496221|528013927|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
146411771|NCT02496221|528013926|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
146411772|NCT02496221|528013927|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
146411773|NCT02496221|528013926|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
146411774|NCT02496221|528013927|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
146411775|NCT03262233|528013928|FG000|Overall Study|Withdrawal by Subject|12|||
146411776|NCT03262233|528013929|FG001|Overall Study|Withdrawal by Subject|8|||
146411777|NCT03262233|528013930|FG002|Overall Study|Withdrawal by Subject|21|||
146411778|NCT03262233|528013931|FG003|Overall Study|Withdrawal by Subject|13|||
146411779|NCT03262233|528013928|FG000|Overall Study|Declined due to shock|1|||
146411780|NCT03262233|528013929|FG001|Overall Study|Declined due to shock|2|||
146411781|NCT03262233|528013930|FG002|Overall Study|Declined due to shock|2|||
146411782|NCT03262233|528013931|FG003|Overall Study|Declined due to shock|3|||
146411783|NCT03262233|528013928|FG000|Overall Study|Protocol Violation|5|||
146411784|NCT03262233|528013929|FG001|Overall Study|Protocol Violation|10|||
146411785|NCT03262233|528013930|FG002|Overall Study|Protocol Violation|2|||
146411786|NCT03262233|528013931|FG003|Overall Study|Protocol Violation|13|||
146411787|NCT03262233|528013928|FG000|Overall Study|data collection artifact|0|||
146411788|NCT03262233|528013929|FG001|Overall Study|data collection artifact|1|||
146411789|NCT03262233|528013930|FG002|Overall Study|data collection artifact|0|||
146411790|NCT03262233|528013931|FG003|Overall Study|data collection artifact|0|||
146411791|NCT03990389|528013934|FG000|Overall Study|Lost to Follow-up|3|||
146411792|NCT03990389|528013935|FG001|Overall Study|Lost to Follow-up|0|||
146411793|NCT03770000|528013936|FG000|Overall Study|Premature discontinuation due to PD|0|||
146411794|NCT03770000|528013937|FG001|Overall Study|Premature discontinuation due to PD|0|||
146411795|NCT03770000|528013938|FG002|Overall Study|Premature discontinuation due to PD|1|||
146174692|NCT00798174|527153070|FG000|Overall Study|inability to implant azygos coil|3|||
146174693|NCT00798174|527153071|FG001|Overall Study|inability to implant azygos coil|3|||
146174694|NCT00798174|527153070|FG000|Overall Study|Inability to sedate for DFT testing|1|||
146174695|NCT00798174|527153071|FG001|Overall Study|Inability to sedate for DFT testing|0|||
146174696|NCT03093428|527153072|FG000|Overall Study|Not eligible for treatment|2|||
146174697|NCT03093428|527153073|FG001|Overall Study|Not eligible for treatment|1|||
146174698|NCT03093428|527153072|FG000|Overall Study|Progression|14|||
146174699|NCT03093428|527153073|FG001|Overall Study|Progression|4|||
146174700|NCT03093428|527153072|FG000|Overall Study|Death|1|||
146174701|NCT03093428|527153073|FG001|Overall Study|Death|0|||
146174702|NCT03093428|527153072|FG000|Overall Study|Adverse Event|1|||
146174703|NCT03093428|527153073|FG001|Overall Study|Adverse Event|0|||
146174704|NCT03093428|527153072|FG000|Overall Study|Withdrawal by Subject|1|||
146174705|NCT03093428|527153073|FG001|Overall Study|Withdrawal by Subject|1|||
146174706|NCT02176421|527153074|FG000|Overall Study|Lost to Follow-up|4|||
146174707|NCT02176421|527153074|FG000|Overall Study|Adverse Event|1|||
146174708|NCT01872910|527153086|FG000|Overall Study|Lost to Follow-up|2|||
146174709|NCT01872910|527153087|FG001|Overall Study|Lost to Follow-up|0|||
146174710|NCT01872910|527153088|FG002|Overall Study|Lost to Follow-up|2|||
146174711|NCT01872910|527153089|FG003|Overall Study|Lost to Follow-up|0|||
146174712|NCT01872910|527153090|FG004|Overall Study|Lost to Follow-up|0|||
146174713|NCT01872910|527153091|FG005|Overall Study|Lost to Follow-up|0|||
146174714|NCT02091739|527153092|FG000|MP: 16 Weeks|Adverse Event|1|||
146174715|NCT02091739|527153093|FG001|MP: 16 Weeks|Adverse Event|1|||
146174716|NCT02091739|527153094|FG002|MP: 16 Weeks|Adverse Event|1|||
146174717|NCT02091739|527153095|FG003|MP: 16 Weeks|Adverse Event|0|||
146174718|NCT02091739|527153096|FG004|MP: 16 Weeks|Adverse Event|0|||
146174719|NCT02091739|527153092|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
146174720|NCT02091739|527153093|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
146174721|NCT02091739|527153094|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
146174722|NCT02091739|527153095|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
146174723|NCT02091739|527153096|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
146174724|NCT02091739|527153092|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
146174725|NCT02091739|527153093|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
146174726|NCT02091739|527153094|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
146174727|NCT02091739|527153095|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
146174728|NCT02091739|527153096|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
146174729|NCT02091739|527153092|FG000|EP: 48 Weeks|Other|0|||
146174730|NCT02091739|527153093|FG001|EP: 48 Weeks|Other|0|||
146174731|NCT02091739|527153094|FG002|EP: 48 Weeks|Other|0|||
146174732|NCT02091739|527153095|FG003|EP: 48 Weeks|Other|1|||
146174733|NCT02091739|527153096|FG004|EP: 48 Weeks|Other|0|||
146174734|NCT02091739|527153092|FG000|EP: 48 Weeks|Death|0|||
146174735|NCT02091739|527153093|FG001|EP: 48 Weeks|Death|0|||
146174736|NCT02091739|527153094|FG002|EP: 48 Weeks|Death|0|||
146174737|NCT02091739|527153095|FG003|EP: 48 Weeks|Death|3|||
146174738|NCT02091739|527153096|FG004|EP: 48 Weeks|Death|2|||
146174739|NCT02091739|527153092|FG000|EP: 48 Weeks|Adverse Event|0|||
146174740|NCT02091739|527153093|FG001|EP: 48 Weeks|Adverse Event|0|||
146174741|NCT02091739|527153094|FG002|EP: 48 Weeks|Adverse Event|0|||
146174742|NCT02091739|527153095|FG003|EP: 48 Weeks|Adverse Event|2|||
146174743|NCT02091739|527153096|FG004|EP: 48 Weeks|Adverse Event|6|||
146174744|NCT02091739|527153092|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
146174745|NCT02091739|527153093|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
146174746|NCT02091739|527153094|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
146174747|NCT02091739|527153095|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
146174748|NCT02091739|527153096|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
146174749|NCT03469349|527153097|FG000|Overall Study|Withdrawal by Subject|1|||
146174750|NCT03469349|527153098|FG001|Overall Study|Withdrawal by Subject|3|||
146174751|NCT03469349|527153097|FG000|Overall Study|Progressive Disease|0|||
146174752|NCT03469349|527153098|FG001|Overall Study|Progressive Disease|1|||
146174753|NCT03469349|527153097|FG000|Overall Study|Lost to Follow-up|2|||
146174754|NCT03469349|527153098|FG001|Overall Study|Lost to Follow-up|2|||
146174755|NCT03469349|527153097|FG000|Overall Study|Adverse Event|2|||
146174756|NCT03469349|527153098|FG001|Overall Study|Adverse Event|4|||
146174757|NCT01306201|527153102|FG000|Overall Study|Arrhythmia|4|||
146174758|NCT01306201|527153102|FG000|Overall Study|Files could not be processed|3|||
146174759|NCT01306201|527153102|FG000|Overall Study|Files unreadable|3|||
146174760|NCT04702568|527153103|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
146174761|NCT04702568|527153104|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
146174762|NCT04702568|527153103|FG000|Overall Study|Pregnancy|1|||
146174763|NCT04702568|527153104|FG001|Overall Study|Pregnancy|0|||
146174764|NCT04702568|527153103|FG000|Overall Study|Bone marrow transplant|1|||
146174765|NCT04702568|527153104|FG001|Overall Study|Bone marrow transplant|0|||
146174766|NCT04702568|527153103|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
146174767|NCT04702568|527153104|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
146174768|NCT04702568|527153103|FG000|Overall Study|Withdrawal by Subject|0|||
146174769|NCT04702568|527153104|FG001|Overall Study|Withdrawal by Subject|2|||
146174770|NCT02912468|527153105|FG000|Overall Study|Adverse Event|3|||
146174771|NCT02912468|527153106|FG001|Overall Study|Adverse Event|2|||
146174772|NCT02912468|527153105|FG000|Overall Study|Withdrawal by Subject|6|||
146174773|NCT02912468|527153106|FG001|Overall Study|Withdrawal by Subject|2|||
146174774|NCT02912468|527153105|FG000|Overall Study|Randomized and not treated|0|||
146174775|NCT02912468|527153106|FG001|Overall Study|Randomized and not treated|1|||
146174776|NCT00692406|527153109|FG000|Overall Study|PI dropped, bad data|57|||
146174777|NCT04599101|527153110|FG000|Overall Study|Lost to Follow-up|5|||
146174778|NCT04599101|527153111|FG001|Overall Study|Lost to Follow-up|5|||
146174779|NCT00525265|527153116|FG000|Overall Study|Protocol Violation|1|||
146174780|NCT00525265|527153117|FG001|Overall Study|Protocol Violation|0|||
146174781|NCT01913639|527153118|FG000|Overall Study|Not Eligible|3|||
146174782|NCT01515189|527153130|FG000|Induction|Disease Progression|109|||
146174783|NCT01515189|527153131|FG001|Induction|Disease Progression|155|||
146174784|NCT01515189|527153130|FG000|Induction|Study drug toxicity|86|||
146174785|NCT01515189|527153131|FG001|Induction|Study drug toxicity|36|||
146174786|NCT01515189|527153130|FG000|Induction|Death|24|||
146174787|NCT01515189|527153131|FG001|Induction|Death|17|||
146174788|NCT01515189|527153130|FG000|Induction|Adverse Event|14|||
146174789|NCT01515189|527153131|FG001|Induction|Adverse Event|9|||
146174790|NCT01515189|527153130|FG000|Induction|Withdrawal by Subject|3|||
146174791|NCT01515189|527153131|FG001|Induction|Withdrawal by Subject|9|||
146174792|NCT01515189|527153130|FG000|Induction|No longer meets study criteria|0|||
146174793|NCT01515189|527153131|FG001|Induction|No longer meets study criteria|2|||
146174794|NCT01515189|527153130|FG000|Induction|Lost to Follow-up|1|||
146174795|NCT01515189|527153131|FG001|Induction|Lost to Follow-up|0|||
146174796|NCT01515189|527153130|FG000|Induction|Other|0|||
146174797|NCT01515189|527153131|FG001|Induction|Other|4|||
146174798|NCT01515189|527153130|FG000|First Re-Induction Phase|Disease progression|6|||
146174799|NCT01515189|527153131|FG001|First Re-Induction Phase|Disease progression|14|||
146174800|NCT01515189|527153130|FG000|First Re-Induction Phase|Study drug toxicity|5|||
146174801|NCT01515189|527153131|FG001|First Re-Induction Phase|Study drug toxicity|0|||
146174802|NCT01515189|527153130|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
146174803|NCT01515189|527153131|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
146174804|NCT01515189|527153130|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
146174805|NCT01515189|527153131|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
146174806|NCT01515189|527153130|FG000|First Re-Induction Phase|Other|1|||
146174807|NCT01515189|527153131|FG001|First Re-Induction Phase|Other|0|||
146174808|NCT01013792|527153132|FG000|Overall Study|Study suspended|2|||
146174809|NCT01013792|527153133|FG001|Overall Study|Study suspended|1|||
146174810|NCT01013792|527153132|FG000|Overall Study|Adverse Event|0|||
146174811|NCT01013792|527153133|FG001|Overall Study|Adverse Event|3|||
146174812|NCT01013792|527153132|FG000|Overall Study|Lost to Follow-up|0|||
146174813|NCT01013792|527153133|FG001|Overall Study|Lost to Follow-up|1|||
146174814|NCT05644353|527153134|FG000|Overall Study|Physician Decision|1|||
146174815|NCT05644353|527153135|FG001|Overall Study|Physician Decision|0|||
146174816|NCT05644353|527153136|FG002|Overall Study|Physician Decision|0|||
146174817|NCT05644353|527153137|FG003|Overall Study|Physician Decision|0|||
146174818|NCT05644353|527153138|FG004|Overall Study|Physician Decision|0|||
146174819|NCT05644353|527153139|FG005|Overall Study|Physician Decision|0|||
146174820|NCT05644353|527153134|FG000|Overall Study|Protocol Violation|1|||
146174821|NCT05644353|527153135|FG001|Overall Study|Protocol Violation|0|||
146174822|NCT05644353|527153136|FG002|Overall Study|Protocol Violation|0|||
146174823|NCT05644353|527153137|FG003|Overall Study|Protocol Violation|0|||
146174824|NCT05644353|527153138|FG004|Overall Study|Protocol Violation|0|||
146174825|NCT05644353|527153139|FG005|Overall Study|Protocol Violation|0|||
146174826|NCT05644353|527153134|FG000|Overall Study|Withdrawal by Subject|0|||
146174827|NCT05644353|527153135|FG001|Overall Study|Withdrawal by Subject|2|||
146174828|NCT05644353|527153136|FG002|Overall Study|Withdrawal by Subject|0|||
146174829|NCT05644353|527153137|FG003|Overall Study|Withdrawal by Subject|0|||
146174830|NCT05644353|527153138|FG004|Overall Study|Withdrawal by Subject|1|||
146174831|NCT05644353|527153139|FG005|Overall Study|Withdrawal by Subject|0|||
146174832|NCT05644353|527153134|FG000|Overall Study|Lost to Follow-up|0|||
146174833|NCT05644353|527153135|FG001|Overall Study|Lost to Follow-up|0|||
146174834|NCT05644353|527153136|FG002|Overall Study|Lost to Follow-up|1|||
146174835|NCT05644353|527153137|FG003|Overall Study|Lost to Follow-up|0|||
146174836|NCT05644353|527153138|FG004|Overall Study|Lost to Follow-up|0|||
146174837|NCT05644353|527153139|FG005|Overall Study|Lost to Follow-up|0|||
146174838|NCT03500640|527153140|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
146174839|NCT03500640|527153141|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
146174840|NCT03500640|527153142|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
146174841|NCT03500640|527153140|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
146174842|NCT03500640|527153141|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
146174843|NCT03500640|527153142|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
146174844|NCT03500640|527153140|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
146174845|NCT03500640|527153141|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
146174846|NCT03500640|527153142|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
146174847|NCT03500640|527153140|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
146075261|NCT01742286|526795018|FG003|Escalation Phase|Subject/guardian decision|0|||
146075262|NCT01742286|526795019|FG004|Escalation Phase|Subject/guardian decision|0|||
146075263|NCT01742286|526795020|FG005|Escalation Phase|Subject/guardian decision|0|||
146075264|NCT01742286|526795021|FG006|Escalation Phase|Subject/guardian decision|0|||
146075265|NCT01742286|526795015|FG000|Expansion Phase|Administrative problems|0|||
146075266|NCT01742286|526795016|FG001|Expansion Phase|Administrative problems|0|||
146075267|NCT01742286|526795017|FG002|Expansion Phase|Administrative problems|0|||
146075268|NCT01742286|526795018|FG003|Expansion Phase|Administrative problems|0|||
146075269|NCT01742286|526795019|FG004|Expansion Phase|Administrative problems|0|||
146075270|NCT01742286|526795020|FG005|Expansion Phase|Administrative problems|0|||
146075271|NCT01742286|526795021|FG006|Expansion Phase|Administrative problems|5|||
146075272|NCT01742286|526795015|FG000|Expansion Phase|Physician Decision|0|||
146075273|NCT01742286|526795016|FG001|Expansion Phase|Physician Decision|0|||
146075274|NCT01742286|526795017|FG002|Expansion Phase|Physician Decision|4|||
146075275|NCT01742286|526795018|FG003|Expansion Phase|Physician Decision|0|||
146075276|NCT01742286|526795019|FG004|Expansion Phase|Physician Decision|0|||
146075277|NCT01742286|526795020|FG005|Expansion Phase|Physician Decision|0|||
146075278|NCT01742286|526795021|FG006|Expansion Phase|Physician Decision|9|||
146075279|NCT01742286|526795015|FG000|Expansion Phase|Adverse Event|0|||
146075280|NCT01742286|526795016|FG001|Expansion Phase|Adverse Event|0|||
146075281|NCT01742286|526795017|FG002|Expansion Phase|Adverse Event|0|||
146075282|NCT01742286|526795018|FG003|Expansion Phase|Adverse Event|0|||
146075283|NCT01742286|526795019|FG004|Expansion Phase|Adverse Event|0|||
146075284|NCT01742286|526795020|FG005|Expansion Phase|Adverse Event|0|||
146075285|NCT01742286|526795021|FG006|Expansion Phase|Adverse Event|6|||
146075286|NCT01742286|526795015|FG000|Expansion Phase|Disease progression|0|||
146075287|NCT01742286|526795016|FG001|Expansion Phase|Disease progression|0|||
146075288|NCT01742286|526795017|FG002|Expansion Phase|Disease progression|3|||
146075289|NCT01742286|526795018|FG003|Expansion Phase|Disease progression|0|||
146075290|NCT01742286|526795019|FG004|Expansion Phase|Disease progression|0|||
146075291|NCT01742286|526795020|FG005|Expansion Phase|Disease progression|0|||
146075292|NCT01742286|526795021|FG006|Expansion Phase|Disease progression|15|||
146075293|NCT01742286|526795015|FG000|Expansion Phase|Withdrawal by Subject|0|||
146075294|NCT01742286|526795016|FG001|Expansion Phase|Withdrawal by Subject|0|||
146075295|NCT01742286|526795017|FG002|Expansion Phase|Withdrawal by Subject|0|||
146075296|NCT01742286|526795018|FG003|Expansion Phase|Withdrawal by Subject|0|||
146075297|NCT01742286|526795019|FG004|Expansion Phase|Withdrawal by Subject|0|||
146075298|NCT01742286|526795020|FG005|Expansion Phase|Withdrawal by Subject|0|||
146075299|NCT01742286|526795021|FG006|Expansion Phase|Withdrawal by Subject|1|||
146075300|NCT04530136|526795022|FG000|Overall Study|Lost to Follow-up|2|||
146075301|NCT04530136|526795023|FG001|Overall Study|Lost to Follow-up|3|||
146075302|NCT04530136|526795022|FG000|Overall Study|Withdrawal by Subject|1|||
146075303|NCT04530136|526795023|FG001|Overall Study|Withdrawal by Subject|0|||
146075304|NCT04530136|526795022|FG000|Overall Study|Death|0|||
146075305|NCT04530136|526795023|FG001|Overall Study|Death|1|||
146075306|NCT01387542|526795024|FG000|Overall Study|Adverse Event|3|||
146075307|NCT01387542|526795024|FG000|Overall Study|Withdrawal by Subject|1|||
146075308|NCT01387542|526795024|FG000|Overall Study|Changed diagnosis|1|||
146075309|NCT01387542|526795024|FG000|Overall Study|Insufficient response|1|||
146075310|NCT01387542|526795024|FG000|Overall Study|Non-compliant|1|||
146075311|NCT01387542|526795024|FG000|Overall Study|Lost to Follow-up|1|||
146075312|NCT01233232|526795025|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
146075313|NCT01233232|526795026|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
146075314|NCT01233232|526795027|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
146075315|NCT02633020|526795033|FG000|Overall Study|Adverse Event|1|||
146075316|NCT02633020|526795034|FG001|Overall Study|Adverse Event|0|||
146075317|NCT00934440|526795035|FG000|Overall Study|Lost to Follow-up|1|||
146075318|NCT02152956|526795036|FG000|Overall Study|Adverse Event|0|||
146411796|NCT03770000|528013939|FG003|Overall Study|Premature discontinuation due to PD|3|||
146075319|NCT02152956|526795037|FG001|Overall Study|Adverse Event|0|||
146075320|NCT02152956|526795038|FG002|Overall Study|Adverse Event|0|||
146075321|NCT02152956|526795039|FG003|Overall Study|Adverse Event|0|||
146075322|NCT02152956|526795040|FG004|Overall Study|Adverse Event|0|||
146075323|NCT02152956|526795041|FG005|Overall Study|Adverse Event|0|||
146075324|NCT02152956|526795042|FG006|Overall Study|Adverse Event|0|||
146075325|NCT02152956|526795043|FG007|Overall Study|Adverse Event|0|||
146075326|NCT02152956|526795044|FG008|Overall Study|Adverse Event|0|||
146075327|NCT02152956|526795045|FG009|Overall Study|Adverse Event|0|||
146075328|NCT02152956|526795046|FG010|Overall Study|Adverse Event|0|||
146075329|NCT02152956|526795047|FG011|Overall Study|Adverse Event|4|||
146075330|NCT02152956|526795048|FG012|Overall Study|Adverse Event|0|||
146075331|NCT02152956|526795036|FG000|Overall Study|Death|0|||
146075332|NCT02152956|526795037|FG001|Overall Study|Death|3|||
146075333|NCT02152956|526795038|FG002|Overall Study|Death|3|||
146075334|NCT02152956|526795039|FG003|Overall Study|Death|4|||
146075335|NCT02152956|526795040|FG004|Overall Study|Death|1|||
146075336|NCT02152956|526795041|FG005|Overall Study|Death|2|||
146075337|NCT02152956|526795042|FG006|Overall Study|Death|6|||
146174848|NCT03500640|527153141|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
146174849|NCT03500640|527153142|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
146174850|NCT03500640|527153140|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
146174851|NCT03500640|527153141|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
146174852|NCT03500640|527153142|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
146174853|NCT03500640|527153140|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
146174854|NCT03500640|527153141|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
146174855|NCT03500640|527153142|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
146174856|NCT03500640|527153140|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
146174857|NCT03500640|527153141|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
146174858|NCT03500640|527153142|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
146174859|NCT03500640|527153140|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
146174860|NCT03500640|527153141|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
146174861|NCT03500640|527153142|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
146174862|NCT03500640|527153140|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
146174863|NCT03500640|527153141|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
146174864|NCT03500640|527153142|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
146174865|NCT03500640|527153140|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
146174866|NCT03500640|527153141|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
146174867|NCT03500640|527153142|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
146174868|NCT01657266|527153145|FG000|Overall Study|Lost to Follow-up|2|||
146174869|NCT01657266|527153146|FG001|Overall Study|Lost to Follow-up|2|||
146174870|NCT01657266|527153145|FG000|Overall Study|Adverse Event|2|||
146174871|NCT01657266|527153146|FG001|Overall Study|Adverse Event|3|||
146174872|NCT01122381|527153153|FG000|Overall Study|study terminated early|0|||
146174873|NCT01122381|527153154|FG001|Overall Study|study terminated early|1|||
146174874|NCT00736489|527153155|FG000|Period 1|Lost to Follow-up|1|||
146174875|NCT00736489|527153156|FG001|Period 1|Lost to Follow-up|0|||
146174876|NCT00736489|527153157|FG002|Period 1|Lost to Follow-up|0|||
146174877|NCT00736489|527153158|FG003|Period 1|Lost to Follow-up|0|||
146174878|NCT00736489|527153159|FG004|Period 1|Lost to Follow-up|0|||
146174879|NCT00736489|527153160|FG005|Period 1|Lost to Follow-up|0|||
146174880|NCT00736489|527153155|FG000|Period 1|Withdrawal by Subject|0|||
146174881|NCT00736489|527153156|FG001|Period 1|Withdrawal by Subject|0|||
146174882|NCT00736489|527153157|FG002|Period 1|Withdrawal by Subject|0|||
146174883|NCT00736489|527153158|FG003|Period 1|Withdrawal by Subject|0|||
146174884|NCT00736489|527153159|FG004|Period 1|Withdrawal by Subject|0|||
146174885|NCT00736489|527153160|FG005|Period 1|Withdrawal by Subject|1|||
146174886|NCT02395133|527153165|FG000|Overall Study|Adverse Event|4|||
146174887|NCT02395133|527153166|FG001|Overall Study|Adverse Event|1|||
146174888|NCT02395133|527153167|FG002|Overall Study|Adverse Event|3|||
146174889|NCT02395133|527153168|FG003|Overall Study|Adverse Event|0|||
146174890|NCT02395133|527153165|FG000|Overall Study|Lack of Efficacy|1|||
146174891|NCT02395133|527153166|FG001|Overall Study|Lack of Efficacy|0|||
146174892|NCT02395133|527153167|FG002|Overall Study|Lack of Efficacy|1|||
146174893|NCT02395133|527153168|FG003|Overall Study|Lack of Efficacy|1|||
146174894|NCT02395133|527153165|FG000|Overall Study|Protocol Violation|1|||
146174895|NCT02395133|527153166|FG001|Overall Study|Protocol Violation|1|||
146174896|NCT02395133|527153167|FG002|Overall Study|Protocol Violation|0|||
146174897|NCT02395133|527153168|FG003|Overall Study|Protocol Violation|3|||
146174898|NCT02395133|527153165|FG000|Overall Study|Lost to Follow-up|0|||
146174899|NCT02395133|527153166|FG001|Overall Study|Lost to Follow-up|1|||
146174900|NCT02395133|527153167|FG002|Overall Study|Lost to Follow-up|1|||
146174901|NCT02395133|527153168|FG003|Overall Study|Lost to Follow-up|0|||
146174902|NCT02395133|527153165|FG000|Overall Study|Pregnancy|0|||
146174903|NCT02395133|527153166|FG001|Overall Study|Pregnancy|0|||
146174904|NCT02395133|527153167|FG002|Overall Study|Pregnancy|3|||
146174905|NCT02395133|527153168|FG003|Overall Study|Pregnancy|0|||
146174906|NCT02395133|527153165|FG000|Overall Study|Consent withdrawn with no reason given|1|||
146174907|NCT02395133|527153166|FG001|Overall Study|Consent withdrawn with no reason given|3|||
146174908|NCT02395133|527153167|FG002|Overall Study|Consent withdrawn with no reason given|0|||
146174909|NCT02395133|527153168|FG003|Overall Study|Consent withdrawn with no reason given|2|||
146174910|NCT02395133|527153165|FG000|Overall Study|Consent withdrawn with personal reason|0|||
146174911|NCT02395133|527153166|FG001|Overall Study|Consent withdrawn with personal reason|1|||
146174912|NCT02395133|527153167|FG002|Overall Study|Consent withdrawn with personal reason|0|||
146174913|NCT02395133|527153168|FG003|Overall Study|Consent withdrawn with personal reason|3|||
146174914|NCT02395133|527153165|FG000|Overall Study|Sponsor decision|2|||
146174915|NCT02395133|527153166|FG001|Overall Study|Sponsor decision|0|||
146174916|NCT02395133|527153167|FG002|Overall Study|Sponsor decision|0|||
146411797|NCT03770000|528013940|FG004|Overall Study|Premature discontinuation due to PD|2|||
146174917|NCT02395133|527153168|FG003|Overall Study|Sponsor decision|1|||
146174918|NCT02395133|527153165|FG000|Overall Study|Other than specified above|5|||
146411798|NCT02595528|528013942|FG000|Overall Study|Withdrawal by Subject|1|||
146174919|NCT02395133|527153166|FG001|Overall Study|Other than specified above|2|||
146174920|NCT02395133|527153167|FG002|Overall Study|Other than specified above|2|||
146174921|NCT02395133|527153168|FG003|Overall Study|Other than specified above|4|||
146174922|NCT01598298|527153171|FG000|Overall Study|Not eligible|5|||
146174923|NCT01598298|527153172|FG001|Overall Study|Not eligible|5|||
146174924|NCT01598298|527153171|FG000|Overall Study|Adverse Event|21|||
146174925|NCT01598298|527153172|FG001|Overall Study|Adverse Event|19|||
146174926|NCT01598298|527153171|FG000|Overall Study|Progression/relapse|0|||
146174927|NCT01598298|527153172|FG001|Overall Study|Progression/relapse|2|||
146174928|NCT01598298|527153171|FG000|Overall Study|Withdrawal by Subject|10|||
146174929|NCT01598298|527153172|FG001|Overall Study|Withdrawal by Subject|15|||
146174930|NCT01598298|527153171|FG000|Overall Study|Other reason (not protocol specified)|4|||
146174931|NCT01598298|527153172|FG001|Overall Study|Other reason (not protocol specified)|0|||
146174932|NCT02254408|527154460|FG000|Overall Study|Randomized But Not Treated|1|||
146174933|NCT02254408|527154461|FG001|Overall Study|Randomized But Not Treated|3|||
146174934|NCT02254408|527154460|FG000|Overall Study|Adverse Event|1|||
146174935|NCT02254408|527154461|FG001|Overall Study|Adverse Event|0|||
146174936|NCT02254408|527154460|FG000|Overall Study|Death|2|||
146174937|NCT02254408|527154461|FG001|Overall Study|Death|3|||
146174938|NCT02254408|527154460|FG000|Overall Study|Investigator's Discretion|0|||
146174939|NCT02254408|527154461|FG001|Overall Study|Investigator's Discretion|1|||
146174940|NCT02254408|527154460|FG000|Overall Study|Withdrawal by Subject|3|||
146174941|NCT02254408|527154461|FG001|Overall Study|Withdrawal by Subject|3|||
146174942|NCT02254408|527154460|FG000|Overall Study|Lost to Follow-up|1|||
146174943|NCT02254408|527154461|FG001|Overall Study|Lost to Follow-up|0|||
146174944|NCT02914184|527154465|FG000|Overall Study|Lost to Follow-up|7|||
146174945|NCT02914184|527154466|FG001|Overall Study|Lost to Follow-up|10|||
146174946|NCT02914184|527154467|FG002|Overall Study|Lost to Follow-up|8|||
146174947|NCT02914184|527154468|FG003|Overall Study|Lost to Follow-up|7|||
146174948|NCT02914184|527154465|FG000|Overall Study|Withdrawal by Subject|4|||
146174949|NCT02914184|527154466|FG001|Overall Study|Withdrawal by Subject|2|||
146174950|NCT02914184|527154467|FG002|Overall Study|Withdrawal by Subject|7|||
146174951|NCT02914184|527154468|FG003|Overall Study|Withdrawal by Subject|3|||
146174952|NCT02914184|527154465|FG000|Overall Study|Other|1|||
146174953|NCT02914184|527154466|FG001|Overall Study|Other|0|||
146174954|NCT02914184|527154467|FG002|Overall Study|Other|0|||
146174955|NCT02914184|527154468|FG003|Overall Study|Other|0|||
146174956|NCT02914184|527154465|FG000|Overall Study|Migrated/moved from the study area|2|||
146174957|NCT02914184|527154466|FG001|Overall Study|Migrated/moved from the study area|1|||
146174958|NCT02914184|527154467|FG002|Overall Study|Migrated/moved from the study area|2|||
146174959|NCT02914184|527154468|FG003|Overall Study|Migrated/moved from the study area|1|||
146174960|NCT00768430|527154469|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
146174961|NCT00768430|527154470|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
146174962|NCT00802659|527154471|FG000|Overall Study|Physician Decision|0|||
146174963|NCT00802659|527154472|FG001|Overall Study|Physician Decision|1|||
146174964|NCT00802659|527154473|FG002|Overall Study|Physician Decision|0|||
146174965|NCT00802659|527154474|FG003|Overall Study|Physician Decision|0|||
146174966|NCT00041756|527154475|FG000|Overall Study|Adverse Event|4|||
146174967|NCT00041756|527154476|FG001|Overall Study|Adverse Event|10|||
146174968|NCT00041756|527154477|FG002|Overall Study|Adverse Event|6|||
146174969|NCT00041756|527154478|FG003|Overall Study|Adverse Event|11|||
146174970|NCT00041756|527154479|FG004|Overall Study|Adverse Event|34|||
146174971|NCT00041756|527154475|FG000|Overall Study|Protocol Violation|1|||
146174972|NCT00041756|527154476|FG001|Overall Study|Protocol Violation|1|||
146174973|NCT00041756|527154477|FG002|Overall Study|Protocol Violation|2|||
146174974|NCT00041756|527154478|FG003|Overall Study|Protocol Violation|2|||
146174975|NCT00041756|527154479|FG004|Overall Study|Protocol Violation|1|||
146174976|NCT00041756|527154475|FG000|Overall Study|Withdrawal by Subject|3|||
146174977|NCT00041756|527154476|FG001|Overall Study|Withdrawal by Subject|3|||
146174978|NCT00041756|527154477|FG002|Overall Study|Withdrawal by Subject|4|||
146174979|NCT00041756|527154478|FG003|Overall Study|Withdrawal by Subject|2|||
146174980|NCT00041756|527154479|FG004|Overall Study|Withdrawal by Subject|3|||
146411799|NCT02595528|528013943|FG001|Overall Study|Withdrawal by Subject|2|||
146174981|NCT00041756|527154475|FG000|Overall Study|Lost to Follow-up|0|||
146174982|NCT00041756|527154476|FG001|Overall Study|Lost to Follow-up|1|||
146174983|NCT00041756|527154477|FG002|Overall Study|Lost to Follow-up|0|||
146174984|NCT00041756|527154478|FG003|Overall Study|Lost to Follow-up|1|||
146174985|NCT00041756|527154479|FG004|Overall Study|Lost to Follow-up|0|||
146174986|NCT00041756|527154475|FG000|Overall Study|Unable to meet protocol criteria|0|||
146174987|NCT00041756|527154476|FG001|Overall Study|Unable to meet protocol criteria|0|||
146174988|NCT00041756|527154477|FG002|Overall Study|Unable to meet protocol criteria|1|||
146174989|NCT00041756|527154478|FG003|Overall Study|Unable to meet protocol criteria|0|||
146174990|NCT00041756|527154479|FG004|Overall Study|Unable to meet protocol criteria|1|||
146174991|NCT00041756|527154475|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
146174992|NCT00041756|527154476|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
146174993|NCT00041756|527154477|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
146174994|NCT00041756|527154478|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
146174995|NCT00041756|527154479|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
146174996|NCT00067990|527154480|FG000|Overall Study|Death|5|||
146174997|NCT00067990|527154481|FG001|Overall Study|Death|7|||
146174998|NCT00067990|527154480|FG000|Overall Study|ESRD, Non IF/TA|1|||
146174999|NCT00067990|527154481|FG001|Overall Study|ESRD, Non IF/TA|3|||
146175000|NCT00067990|527154480|FG000|Overall Study|Withdrawal by Subject|4|||
146175001|NCT00067990|527154481|FG001|Overall Study|Withdrawal by Subject|12|||
146175002|NCT03810313|527154484|FG000|Overall Study|Study terminated by sponsor|164|||
146175003|NCT03810313|527154485|FG001|Overall Study|Study terminated by sponsor|159|||
146175004|NCT03810313|527154484|FG000|Overall Study|Subject decision|10|||
146175005|NCT03810313|527154485|FG001|Overall Study|Subject decision|11|||
146175006|NCT03810313|527154484|FG000|Overall Study|Lost to Follow-up|3|||
146175007|NCT03810313|527154485|FG001|Overall Study|Lost to Follow-up|3|||
146175008|NCT03810313|527154484|FG000|Overall Study|Adverse Event|2|||
146175009|NCT03810313|527154485|FG001|Overall Study|Adverse Event|1|||
146175010|NCT03810313|527154484|FG000|Overall Study|Death|2|||
146175011|NCT03810313|527154485|FG001|Overall Study|Death|1|||
146175012|NCT03810313|527154484|FG000|Overall Study|Physician Decision|0|||
146175013|NCT03810313|527154485|FG001|Overall Study|Physician Decision|1|||
146175014|NCT01111838|527154486|FG000|Overall Study|Patient Ineligible|2|||
146175015|NCT01111838|527154486|FG000|Overall Study|Not Treated|3|||
146175016|NCT01111838|527154486|FG000|Overall Study|Clinical deterioration|1|||
146175017|NCT01111838|527154486|FG000|Overall Study|Other Complicating Disease|1|||
146175018|NCT01540565|527154487|FG000|Overall Study|Ineligible|2|||
146175019|NCT02086162|527154489|FG000|Overall Study|Withdrawal by Subject|4|||
146175020|NCT02086162|527154490|FG001|Overall Study|Withdrawal by Subject|4|||
146175021|NCT02086162|527154489|FG000|Overall Study|moved|1|||
146175022|NCT02086162|527154490|FG001|Overall Study|moved|1|||
146175023|NCT02086162|527154489|FG000|Overall Study|Lost to Follow-up|4|||
146175024|NCT02086162|527154490|FG001|Overall Study|Lost to Follow-up|2|||
146175025|NCT02086162|527154489|FG000|Overall Study|Death|1|||
146175026|NCT02086162|527154490|FG001|Overall Study|Death|0|||
146175027|NCT01827254|527154494|FG000|Overall Study|Death|10|||
146175028|NCT01827254|527154494|FG000|Overall Study|Case report form not completed|4|||
146175029|NCT01827254|527154494|FG000|Overall Study|Invalidated centre|3|||
146175030|NCT01827254|527154494|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
146175031|NCT01827254|527154494|FG000|Overall Study|Did not complete re-challenge|1|||
146175032|NCT01827254|527154494|FG000|Overall Study|Disease progression|36|||
146175033|NCT01827254|527154494|FG000|Overall Study|Intolerance to treatment|4|||
146175034|NCT01834222|527154495|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
146175035|NCT01617005|527154505|FG000|Overall Study|Pregnancy|1|||
146175036|NCT01617005|527154505|FG000|Overall Study|Lack of motivation for treatment|1|||
146175037|NCT01320735|527154506|FG000|Overall Study|Adverse Event|3|||
146175038|NCT01320735|527154506|FG000|Overall Study|Withdrawal by Subject|3|||
146175039|NCT01320735|527154506|FG000|Overall Study|Lost to Follow-up|13|||
146175040|NCT01320735|527154506|FG000|Overall Study|Administrative Reason|6|||
146175041|NCT01320735|527154506|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
146175042|NCT01320735|527154506|FG000|Overall Study|Protocol Violation|1|||
146175043|NCT01320735|527154506|FG000|Overall Study|Other|1|||
146175044|NCT01320735|527154506|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
146175045|NCT01320735|527154506|FG000|Overall Study|Investigator Unable to be Contacted|17|||
146175046|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
146175047|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
146175048|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
146175049|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
146175050|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
146175051|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
146175052|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
146175053|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
146175054|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
146175055|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
146175056|NCT02307513|527154507|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
146175057|NCT02307513|527154508|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
146175058|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
146175059|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
146175060|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
146175061|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
146175062|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
146175063|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
146175064|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
146175065|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
146175066|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
146175067|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
146175068|NCT02307513|527154507|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
146175069|NCT02307513|527154508|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
146175070|NCT02307513|527154507|FG000|Long-term Extension|Physician Decision|1|||
146175071|NCT02307513|527154508|FG001|Long-term Extension|Physician Decision|0|||
146175072|NCT05952297|527154510|FG000|Overall Study|Withdrawal by Subject|1|||
146175073|NCT05952297|527154511|FG001|Overall Study|Withdrawal by Subject|0|||
146175074|NCT01107743|527154512|FG000|Overall Study|Protocol Violation|46|||
146175075|NCT00308737|527154513|FG000|Overall Study|Adverse Event|104|||
146175076|NCT00308737|527154514|FG001|Overall Study|Adverse Event|9|||
146175077|NCT00308737|527154515|FG002|Overall Study|Adverse Event|0|||
146175078|NCT00308737|527154513|FG000|Overall Study|Death|4|||
146175079|NCT00308737|527154514|FG001|Overall Study|Death|3|||
146175080|NCT00308737|527154515|FG002|Overall Study|Death|0|||
146175081|NCT00308737|527154513|FG000|Overall Study|Lost to Follow-up|56|||
146175082|NCT00308737|527154514|FG001|Overall Study|Lost to Follow-up|80|||
146175083|NCT00308737|527154515|FG002|Overall Study|Lost to Follow-up|5|||
146175084|NCT00308737|527154513|FG000|Overall Study|Physician Decision|15|||
146175085|NCT00308737|527154514|FG001|Overall Study|Physician Decision|2|||
146175086|NCT00308737|527154515|FG002|Overall Study|Physician Decision|1|||
146175087|NCT00308737|527154513|FG000|Overall Study|Protocol Violation|34|||
146175088|NCT00308737|527154514|FG001|Overall Study|Protocol Violation|9|||
146175089|NCT00308737|527154515|FG002|Overall Study|Protocol Violation|5|||
146175090|NCT00308737|527154513|FG000|Overall Study|Withdrawal by Subject|218|||
146175091|NCT00308737|527154514|FG001|Overall Study|Withdrawal by Subject|166|||
146175092|NCT00308737|527154515|FG002|Overall Study|Withdrawal by Subject|18|||
146175093|NCT00308737|527154513|FG000|Overall Study|Various|32|||
146175094|NCT00308737|527154514|FG001|Overall Study|Various|20|||
146175095|NCT00308737|527154515|FG002|Overall Study|Various|8|||
146175096|NCT01225822|527154516|FG000|Overall Study|Adverse Event|13|||
146175097|NCT01225822|527154517|FG001|Overall Study|Adverse Event|31|||
146175098|NCT01225822|527154518|FG002|Overall Study|Adverse Event|18|||
146175099|NCT01225822|527154519|FG003|Overall Study|Adverse Event|23|||
146175100|NCT01225822|527154520|FG004|Overall Study|Adverse Event|14|||
146175101|NCT01225822|527154516|FG000|Overall Study|Protocol Violation|6|||
146175102|NCT01225822|527154517|FG001|Overall Study|Protocol Violation|8|||
146175103|NCT01225822|527154518|FG002|Overall Study|Protocol Violation|6|||
146175104|NCT01225822|527154519|FG003|Overall Study|Protocol Violation|7|||
146075338|NCT02152956|526795043|FG007|Overall Study|Death|6|||
146075339|NCT02152956|526795044|FG008|Overall Study|Death|4|||
146075340|NCT02152956|526795045|FG009|Overall Study|Death|5|||
146075341|NCT02152956|526795046|FG010|Overall Study|Death|3|||
146075342|NCT02152956|526795047|FG011|Overall Study|Death|143|||
146075343|NCT02152956|526795048|FG012|Overall Study|Death|12|||
146075344|NCT02152956|526795036|FG000|Overall Study|Lost to Follow-up|0|||
146075345|NCT02152956|526795037|FG001|Overall Study|Lost to Follow-up|1|||
146075346|NCT02152956|526795038|FG002|Overall Study|Lost to Follow-up|0|||
146075347|NCT02152956|526795039|FG003|Overall Study|Lost to Follow-up|0|||
146075348|NCT02152956|526795040|FG004|Overall Study|Lost to Follow-up|0|||
146075349|NCT02152956|526795041|FG005|Overall Study|Lost to Follow-up|0|||
146075350|NCT02152956|526795042|FG006|Overall Study|Lost to Follow-up|0|||
146075351|NCT02152956|526795043|FG007|Overall Study|Lost to Follow-up|0|||
146075352|NCT02152956|526795044|FG008|Overall Study|Lost to Follow-up|0|||
146075353|NCT02152956|526795045|FG009|Overall Study|Lost to Follow-up|0|||
146075354|NCT02152956|526795046|FG010|Overall Study|Lost to Follow-up|0|||
146075355|NCT02152956|526795047|FG011|Overall Study|Lost to Follow-up|3|||
146075356|NCT02152956|526795048|FG012|Overall Study|Lost to Follow-up|0|||
146075357|NCT02152956|526795036|FG000|Overall Study|Withdrawal by Subject|1|||
146075358|NCT02152956|526795037|FG001|Overall Study|Withdrawal by Subject|0|||
146075359|NCT02152956|526795038|FG002|Overall Study|Withdrawal by Subject|1|||
146075360|NCT02152956|526795039|FG003|Overall Study|Withdrawal by Subject|0|||
146075361|NCT02152956|526795040|FG004|Overall Study|Withdrawal by Subject|2|||
146075362|NCT02152956|526795041|FG005|Overall Study|Withdrawal by Subject|2|||
146075363|NCT02152956|526795042|FG006|Overall Study|Withdrawal by Subject|0|||
146075364|NCT02152956|526795043|FG007|Overall Study|Withdrawal by Subject|0|||
146175105|NCT01225822|527154520|FG004|Overall Study|Protocol Violation|4|||
146283916|NCT01758900|527551898|FG001|Overall Study|difficulty for further intubation|8|||
146075365|NCT02152956|526795044|FG008|Overall Study|Withdrawal by Subject|1|||
146075366|NCT02152956|526795045|FG009|Overall Study|Withdrawal by Subject|0|||
146175106|NCT01225822|527154516|FG000|Overall Study|Lost to Follow-up|0|||
146175107|NCT01225822|527154517|FG001|Overall Study|Lost to Follow-up|0|||
146175108|NCT01225822|527154518|FG002|Overall Study|Lost to Follow-up|0|||
146175109|NCT01225822|527154519|FG003|Overall Study|Lost to Follow-up|1|||
146175110|NCT01225822|527154520|FG004|Overall Study|Lost to Follow-up|0|||
146175111|NCT01225822|527154516|FG000|Overall Study|Withdrawal by Subject|6|||
146175112|NCT01225822|527154517|FG001|Overall Study|Withdrawal by Subject|7|||
146175113|NCT01225822|527154518|FG002|Overall Study|Withdrawal by Subject|7|||
146075367|NCT02152956|526795046|FG010|Overall Study|Withdrawal by Subject|0|||
146075368|NCT02152956|526795047|FG011|Overall Study|Withdrawal by Subject|4|||
146075369|NCT02152956|526795048|FG012|Overall Study|Withdrawal by Subject|0|||
146075370|NCT02152956|526795036|FG000|Overall Study|Physician Decision|0|||
146075371|NCT02152956|526795037|FG001|Overall Study|Physician Decision|0|||
146075372|NCT02152956|526795038|FG002|Overall Study|Physician Decision|0|||
146075373|NCT02152956|526795039|FG003|Overall Study|Physician Decision|0|||
146075374|NCT02152956|526795040|FG004|Overall Study|Physician Decision|0|||
146075375|NCT02152956|526795041|FG005|Overall Study|Physician Decision|0|||
146075376|NCT02152956|526795042|FG006|Overall Study|Physician Decision|0|||
146075377|NCT02152956|526795043|FG007|Overall Study|Physician Decision|0|||
146075378|NCT02152956|526795044|FG008|Overall Study|Physician Decision|0|||
146075379|NCT02152956|526795045|FG009|Overall Study|Physician Decision|0|||
146075380|NCT02152956|526795046|FG010|Overall Study|Physician Decision|0|||
146075381|NCT02152956|526795047|FG011|Overall Study|Physician Decision|1|||
146075382|NCT02152956|526795048|FG012|Overall Study|Physician Decision|0|||
146075383|NCT02152956|526795036|FG000|Overall Study|Study terminated by sponsor|0|||
146075384|NCT02152956|526795037|FG001|Overall Study|Study terminated by sponsor|0|||
146075385|NCT02152956|526795038|FG002|Overall Study|Study terminated by sponsor|0|||
146075386|NCT02152956|526795039|FG003|Overall Study|Study terminated by sponsor|0|||
146075387|NCT02152956|526795040|FG004|Overall Study|Study terminated by sponsor|0|||
146075388|NCT02152956|526795041|FG005|Overall Study|Study terminated by sponsor|0|||
146075389|NCT02152956|526795042|FG006|Overall Study|Study terminated by sponsor|0|||
146075390|NCT02152956|526795043|FG007|Overall Study|Study terminated by sponsor|0|||
146075391|NCT02152956|526795044|FG008|Overall Study|Study terminated by sponsor|0|||
146075392|NCT02152956|526795045|FG009|Overall Study|Study terminated by sponsor|0|||
146075393|NCT02152956|526795046|FG010|Overall Study|Study terminated by sponsor|0|||
146075394|NCT02152956|526795047|FG011|Overall Study|Study terminated by sponsor|29|||
146075395|NCT02152956|526795048|FG012|Overall Study|Study terminated by sponsor|0|||
146075396|NCT02152956|526795036|FG000|Overall Study|progressive disease|0|||
146075397|NCT02152956|526795037|FG001|Overall Study|progressive disease|0|||
146075398|NCT02152956|526795038|FG002|Overall Study|progressive disease|0|||
146075399|NCT02152956|526795039|FG003|Overall Study|progressive disease|0|||
146075400|NCT02152956|526795040|FG004|Overall Study|progressive disease|0|||
146075401|NCT02152956|526795041|FG005|Overall Study|progressive disease|0|||
146075402|NCT02152956|526795042|FG006|Overall Study|progressive disease|0|||
146075403|NCT02152956|526795043|FG007|Overall Study|progressive disease|0|||
146075404|NCT02152956|526795044|FG008|Overall Study|progressive disease|1|||
146075405|NCT02152956|526795045|FG009|Overall Study|progressive disease|0|||
146075406|NCT02152956|526795046|FG010|Overall Study|progressive disease|0|||
146075407|NCT02152956|526795047|FG011|Overall Study|progressive disease|1|||
146075408|NCT02152956|526795048|FG012|Overall Study|progressive disease|0|||
146075409|NCT05661851|526795049|FG000|Overall Study|Protocol Violation|1|||
146075410|NCT05661851|526795050|FG001|Overall Study|Protocol Violation|1|||
146075411|NCT05661851|526795049|FG000|Overall Study|Covid-19 Related|3|||
146075412|NCT05661851|526795050|FG001|Overall Study|Covid-19 Related|4|||
146075413|NCT05661851|526795049|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
146075414|NCT05661851|526795050|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
146075415|NCT05661851|526795049|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
146075416|NCT05661851|526795050|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
146075417|NCT00530816|526795051|FG000|Overall Study|Progressive Disease|16|||
146075418|NCT00530816|526795052|FG001|Overall Study|Progressive Disease|24|||
146075419|NCT00530816|526795053|FG002|Overall Study|Progressive Disease|24|||
146075420|NCT00530816|526795051|FG000|Overall Study|Adverse Event|6|||
146075421|NCT00530816|526795052|FG001|Overall Study|Adverse Event|13|||
146075422|NCT00530816|526795053|FG002|Overall Study|Adverse Event|7|||
146075423|NCT00530816|526795051|FG000|Overall Study|Other|3|||
146075424|NCT00530816|526795052|FG001|Overall Study|Other|3|||
146075425|NCT00530816|526795053|FG002|Overall Study|Other|4|||
146075426|NCT00530816|526795051|FG000|Overall Study|Withdrawal by Subject|1|||
146075427|NCT00530816|526795052|FG001|Overall Study|Withdrawal by Subject|2|||
146075428|NCT00530816|526795053|FG002|Overall Study|Withdrawal by Subject|6|||
146075429|NCT01014910|526795054|FG000|Overall Study|Withdrawal by Subject|0|||
146075430|NCT01014910|526795055|FG001|Overall Study|Withdrawal by Subject|2|||
146075431|NCT01388985|526795056|FG000|Overall Study|Death|0|||
146075432|NCT01388985|526795057|FG001|Overall Study|Death|1|||
146075433|NCT01388985|526795056|FG000|Overall Study|Lost to Follow-up|30|||
146075434|NCT01388985|526795057|FG001|Overall Study|Lost to Follow-up|30|||
146075435|NCT01388985|526795056|FG000|Overall Study|Withdrawal by Subject|13|||
146075436|NCT01388985|526795057|FG001|Overall Study|Withdrawal by Subject|4|||
146075437|NCT01388985|526795056|FG000|Overall Study|Subject unavailable|1|||
146075438|NCT01388985|526795057|FG001|Overall Study|Subject unavailable|1|||
146075439|NCT01388985|526795056|FG000|Overall Study|Other (no reason)|0|||
146075440|NCT01388985|526795057|FG001|Overall Study|Other (no reason)|1|||
146075441|NCT01388985|526795056|FG000|Overall Study|Error of nurse|5|||
146075442|NCT01388985|526795057|FG001|Overall Study|Error of nurse|1|||
146075443|NCT01057589|526795058|FG000|Overall Study|Disease Progression|35|||
146075444|NCT01057589|526795058|FG000|Overall Study|Adverse Event|10|||
146075445|NCT01057589|526795058|FG000|Overall Study|Physician Decision|8|||
146075446|NCT01057589|526795058|FG000|Overall Study|Withdrawal by Subject|3|||
146075447|NCT01057589|526795058|FG000|Overall Study|Sponsor Decision|1|||
146075448|NCT01057589|526795058|FG000|Overall Study|Death|8|||
146075449|NCT01057589|526795058|FG000|Overall Study|Lost to Follow-up|1|||
146075450|NCT02954172|526795061|FG000|Overall Study|Protocol Violation|3|||
146075451|NCT02954172|526795062|FG001|Overall Study|Protocol Violation|0|||
146075452|NCT02954172|526795061|FG000|Overall Study|allergic reaction|2|||
146075453|NCT02954172|526795062|FG001|Overall Study|allergic reaction|1|||
146075454|NCT02954172|526795061|FG000|Overall Study|non-measurable lesions at baseline|1|||
146075455|NCT02954172|526795062|FG001|Overall Study|non-measurable lesions at baseline|2|||
146075456|NCT01519167|526795063|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
146075457|NCT01519167|526795064|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
146075458|NCT01519167|526795063|FG000|Overall Study|Adverse Event|0|||
146075459|NCT01519167|526795064|FG001|Overall Study|Adverse Event|1|||
146075460|NCT01519167|526795063|FG000|Overall Study|Lack of Efficacy|0|||
146075461|NCT01519167|526795064|FG001|Overall Study|Lack of Efficacy|1|||
146075462|NCT01519167|526795063|FG000|Overall Study|Medical condition changes&deep sedation|0|||
146075463|NCT01519167|526795064|FG001|Overall Study|Medical condition changes&deep sedation|2|||
146075464|NCT01519167|526795063|FG000|Overall Study|Physician Decision|0|||
146075465|NCT01519167|526795064|FG001|Overall Study|Physician Decision|1|||
146075466|NCT00870584|526795065|FG000|Overall Study|Adverse Event|3|||
146075467|NCT00870584|526795066|FG001|Overall Study|Adverse Event|3|||
146075468|NCT00870584|526795065|FG000|Overall Study|Withdrawal by Subject|6|||
146075469|NCT00870584|526795066|FG001|Overall Study|Withdrawal by Subject|7|||
146075470|NCT00870584|526795065|FG000|Overall Study|Lost to Follow-up|5|||
146075471|NCT00870584|526795066|FG001|Overall Study|Lost to Follow-up|1|||
146075472|NCT00870584|526795065|FG000|Overall Study|Protocol Deviation|2|||
146075473|NCT00870584|526795066|FG001|Overall Study|Protocol Deviation|2|||
146075474|NCT01497366|526795067|FG000|Overall Study|Virologic failure|2|||
146075475|NCT01497366|526795068|FG001|Overall Study|Virologic failure|50|||
146075476|NCT01497366|526795067|FG000|Overall Study|Lost to Follow-up|11|||
146075477|NCT01497366|526795068|FG001|Overall Study|Lost to Follow-up|10|||
146075478|NCT01497366|526795067|FG000|Overall Study|Withdrawal by Subject|6|||
146075479|NCT01497366|526795068|FG001|Overall Study|Withdrawal by Subject|6|||
146075480|NCT01497366|526795067|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
146075481|NCT01497366|526795068|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
146075482|NCT01497366|526795067|FG000|Overall Study|Other|5|||
146075483|NCT01497366|526795068|FG001|Overall Study|Other|0|||
146075484|NCT01497366|526795067|FG000|Overall Study|Death|1|||
146075485|NCT01497366|526795068|FG001|Overall Study|Death|1|||
146075486|NCT01497366|526795067|FG000|Overall Study|Randomized but not treated|7|||
146075487|NCT01497366|526795068|FG001|Overall Study|Randomized but not treated|21|||
146075488|NCT00472030|526795080|FG000|Overall Study|Physician Decision|1|||
146075489|NCT00472030|526795081|FG001|Overall Study|Physician Decision|0|||
146075490|NCT00829504|526795082|FG000|First Intervention|Adverse Event|1|||
146075491|NCT00829504|526795083|FG001|First Intervention|Adverse Event|0|||
146075492|NCT00829504|526795082|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146075493|NCT00829504|526795083|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146075494|NCT00829504|526795082|FG000|Second Intervention|Physician Decision|1|||
146075495|NCT00829504|526795083|FG001|Second Intervention|Physician Decision|0|||
146075496|NCT04189224|526795084|FG000|Period 2|Adverse Event|0|||
146075497|NCT04189224|526795085|FG001|Period 2|Adverse Event|1|||
146075498|NCT04236141|526797627|FG000|Overall Study|Death|18|||
146075499|NCT04236141|526797628|FG001|Overall Study|Death|10|||
146075500|NCT04236141|526797627|FG000|Overall Study|Withdrawal by Participant|1|||
146075501|NCT04236141|526797628|FG001|Overall Study|Withdrawal by Participant|0|||
146075502|NCT04236141|526797627|FG000|Overall Study|Reason not Specified|1|||
146075503|NCT04236141|526797628|FG001|Overall Study|Reason not Specified|0|||
146075504|NCT04236141|526797627|FG000|Overall Study|Study terminated by Sponsor|8|||
146075505|NCT04236141|526797628|FG001|Overall Study|Study terminated by Sponsor|4|||
146075506|NCT01217307|526797632|FG000|Overall Study|Withdrawal by Subject|0|||
146075507|NCT01217307|526797633|FG001|Overall Study|Withdrawal by Subject|1|||
146075508|NCT01888432|526797638|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
146075509|NCT01888432|526797639|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
146075510|NCT01888432|526797638|FG000|12-month Analysis (FAS)|Physician Decision|1|||
146075511|NCT01888432|526797639|FG001|12-month Analysis (FAS)|Physician Decision|1|||
146075512|NCT01888432|526797638|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
146075513|NCT01888432|526797639|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
146075514|NCT01888432|526797638|FG000|12-month Analysis (FAS)|Death|4|||
146075515|NCT01888432|526797639|FG001|12-month Analysis (FAS)|Death|3|||
146075516|NCT01888432|526797638|FG000|24-month Analysis (FAS)|Graft loss|0|||
146075517|NCT01888432|526797639|FG001|24-month Analysis (FAS)|Graft loss|1|||
146075518|NCT01888432|526797638|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
146075519|NCT01888432|526797639|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
146075520|NCT01888432|526797638|FG000|24-month Analysis (FAS)|Physician Decision|2|||
146075521|NCT01888432|526797639|FG001|24-month Analysis (FAS)|Physician Decision|4|||
146175114|NCT01225822|527154519|FG003|Overall Study|Withdrawal by Subject|11|||
146175115|NCT01225822|527154520|FG004|Overall Study|Withdrawal by Subject|6|||
146075522|NCT01888432|526797638|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
146075523|NCT01888432|526797639|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
146075524|NCT01888432|526797638|FG000|24-month Analysis (FAS)|Death|8|||
146075525|NCT01888432|526797639|FG001|24-month Analysis (FAS)|Death|4|||
146075526|NCT01888432|526797638|FG000|36-month Analysis (Extension)|Death|1|||
146075527|NCT01888432|526797639|FG001|36-month Analysis (Extension)|Death|0|||
146075528|NCT01696929|526797642|FG000|Overall Study|Physician Decision|1|||
146075529|NCT04473235|526797645|FG000|Overall Study|Lost to Follow-up|6|||
146075530|NCT04473235|526797646|FG001|Overall Study|Lost to Follow-up|5|||
146075531|NCT04473235|526797645|FG000|Overall Study|Declined continuation|2|||
146075532|NCT04473235|526797646|FG001|Overall Study|Declined continuation|0|||
146075533|NCT04473235|526797645|FG000|Overall Study|Physician Decision|1|||
146075534|NCT04473235|526797646|FG001|Overall Study|Physician Decision|1|||
146075535|NCT04473235|526797645|FG000|Overall Study|Protocol Violation|10|||
146075536|NCT04473235|526797646|FG001|Overall Study|Protocol Violation|6|||
146075537|NCT00798759|526797649|FG000|Overall Study|Adverse Event|3|||
146075538|NCT00798759|526797650|FG001|Overall Study|Adverse Event|3|||
146075539|NCT00798759|526797649|FG000|Overall Study|Lost to Follow-up|1|||
146075540|NCT00798759|526797650|FG001|Overall Study|Lost to Follow-up|1|||
146075541|NCT00798759|526797649|FG000|Overall Study|Protocol Violation|4|||
146075542|NCT00798759|526797650|FG001|Overall Study|Protocol Violation|8|||
146075543|NCT00798759|526797649|FG000|Overall Study|Other|0|||
146075544|NCT00798759|526797650|FG001|Overall Study|Other|1|||
146075545|NCT02156271|526797651|FG000|Overall Study|Physician Decision|4|||
146075546|NCT02156271|526797652|FG001|Overall Study|Physician Decision|3|||
146075547|NCT00955305|526797653|FG000|Overall Study|Disease progression|39|||
146075548|NCT00955305|526797654|FG001|Overall Study|Disease progression|41|||
146075549|NCT00955305|526797653|FG000|Overall Study|Adverse Event|22|||
146075550|NCT00955305|526797654|FG001|Overall Study|Adverse Event|22|||
146075551|NCT00955305|526797653|FG000|Overall Study|Death|2|||
146075552|NCT00955305|526797654|FG001|Overall Study|Death|1|||
146075553|NCT00955305|526797653|FG000|Overall Study|Withdrawal by Subject|5|||
146075554|NCT00955305|526797654|FG001|Overall Study|Withdrawal by Subject|4|||
146075555|NCT00955305|526797653|FG000|Overall Study|Alternative therapy|4|||
146075556|NCT00955305|526797654|FG001|Overall Study|Alternative therapy|0|||
146075557|NCT00955305|526797653|FG000|Overall Study|Other complicating disease|2|||
146075558|NCT00955305|526797654|FG001|Overall Study|Other complicating disease|4|||
146075559|NCT00955305|526797653|FG000|Overall Study|Physician Decision|1|||
146075560|NCT00955305|526797654|FG001|Overall Study|Physician Decision|0|||
146075561|NCT00955305|526797653|FG000|Overall Study|Continued presence of residual disease|0|||
146075562|NCT00955305|526797654|FG001|Overall Study|Continued presence of residual disease|1|||
146075563|NCT00955305|526797653|FG000|Overall Study|Functional decline|2|||
146075564|NCT00955305|526797654|FG001|Overall Study|Functional decline|0|||
146075565|NCT00955305|526797653|FG000|Overall Study|Maximum response achieved|0|||
146075566|NCT00955305|526797654|FG001|Overall Study|Maximum response achieved|1|||
146075567|NCT00955305|526797653|FG000|Overall Study|Lost to Follow-up|0|||
146075568|NCT00955305|526797654|FG001|Overall Study|Lost to Follow-up|1|||
146075569|NCT00955305|526797653|FG000|Overall Study|No off-treatment reason submitted|1|||
146075570|NCT00955305|526797654|FG001|Overall Study|No off-treatment reason submitted|0|||
146075571|NCT00955305|526797653|FG000|Overall Study|Never started protocol treatment|5|||
146075572|NCT00955305|526797654|FG001|Overall Study|Never started protocol treatment|5|||
146075573|NCT00955305|526797653|FG000|Overall Study|Ineligible|5|||
146075574|NCT00955305|526797654|FG001|Overall Study|Ineligible|7|||
146075575|NCT03387111|526797655|FG000|Overall Study|Progressive Disease|3|||
146075576|NCT03387111|526797655|FG000|Overall Study|Other|1|||
146075577|NCT01945710|526797659|FG000|Overall Study|Progressive Disease|5|||
146075578|NCT01945710|526797660|FG001|Overall Study|Progressive Disease|4|||
146075579|NCT01945710|526797661|FG002|Overall Study|Progressive Disease|3|||
146075580|NCT01945710|526797662|FG003|Overall Study|Progressive Disease|2|||
146075581|NCT01945710|526797663|FG004|Overall Study|Progressive Disease|7|||
146075582|NCT01945710|526797664|FG005|Overall Study|Progressive Disease|3|||
146075583|NCT01945710|526797665|FG006|Overall Study|Progressive Disease|19|||
146075584|NCT01945710|526797659|FG000|Overall Study|Adverse Event|0|||
146075585|NCT01945710|526797660|FG001|Overall Study|Adverse Event|1|||
146075586|NCT01945710|526797661|FG002|Overall Study|Adverse Event|0|||
146075587|NCT01945710|526797662|FG003|Overall Study|Adverse Event|0|||
146075588|NCT01945710|526797663|FG004|Overall Study|Adverse Event|0|||
146075589|NCT01945710|526797664|FG005|Overall Study|Adverse Event|0|||
146075590|NCT01945710|526797665|FG006|Overall Study|Adverse Event|0|||
146075591|NCT01945710|526797659|FG000|Overall Study|Other|2|||
146075592|NCT01945710|526797660|FG001|Overall Study|Other|0|||
146075593|NCT01945710|526797661|FG002|Overall Study|Other|3|||
146075594|NCT01945710|526797662|FG003|Overall Study|Other|1|||
146075595|NCT01945710|526797663|FG004|Overall Study|Other|1|||
146075596|NCT01945710|526797664|FG005|Overall Study|Other|0|||
146175116|NCT01225822|527154516|FG000|Overall Study|Other|13|||
146075597|NCT01945710|526797665|FG006|Overall Study|Other|4|||
146075598|NCT01945710|526797659|FG000|Overall Study|Withdrawal by Subject|0|||
146075599|NCT01945710|526797660|FG001|Overall Study|Withdrawal by Subject|1|||
146075600|NCT01945710|526797661|FG002|Overall Study|Withdrawal by Subject|1|||
146075601|NCT01945710|526797662|FG003|Overall Study|Withdrawal by Subject|0|||
146075602|NCT01945710|526797663|FG004|Overall Study|Withdrawal by Subject|1|||
146075603|NCT01945710|526797664|FG005|Overall Study|Withdrawal by Subject|0|||
146075604|NCT01945710|526797665|FG006|Overall Study|Withdrawal by Subject|0|||
146075605|NCT02730195|526797666|FG000|Overall Study|Withdrawal by Subject|1|||
146075606|NCT00375609|526797667|FG000|Overall Study|Did not receive treatment|1|||
146075607|NCT00375609|526797668|FG001|Overall Study|Did not receive treatment|0|||
146075608|NCT00375609|526797669|FG002|Overall Study|Did not receive treatment|0|||
146075609|NCT00375609|526797667|FG000|Overall Study|Adverse Event|0|||
146075610|NCT00375609|526797668|FG001|Overall Study|Adverse Event|3|||
146075611|NCT00375609|526797669|FG002|Overall Study|Adverse Event|0|||
146075612|NCT00375609|526797667|FG000|Overall Study|Lost to Follow-up|1|||
146075613|NCT00375609|526797668|FG001|Overall Study|Lost to Follow-up|0|||
146075614|NCT00375609|526797669|FG002|Overall Study|Lost to Follow-up|0|||
146075615|NCT00375609|526797667|FG000|Overall Study|Physician Decision|0|||
146075616|NCT00375609|526797668|FG001|Overall Study|Physician Decision|0|||
146075617|NCT00375609|526797669|FG002|Overall Study|Physician Decision|1|||
146075618|NCT00375609|526797667|FG000|Overall Study|Withdrawal by Subject|1|||
146075619|NCT00375609|526797668|FG001|Overall Study|Withdrawal by Subject|4|||
146075620|NCT00375609|526797669|FG002|Overall Study|Withdrawal by Subject|0|||
146075621|NCT00375609|526797667|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
146075622|NCT00375609|526797668|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
146075623|NCT00375609|526797669|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
146075624|NCT01368562|526797670|FG000|Overall Study|Adverse Event|1|||
146075625|NCT01368562|526797670|FG000|Overall Study|Disease progression|1|||
146075626|NCT01368562|526797670|FG000|Overall Study|Lost to Follow-up|1|||
146075627|NCT01368562|526797670|FG000|Overall Study|Death|6|||
146075628|NCT01368562|526797670|FG000|Overall Study|Unresponsive to treatment|5|||
146075629|NCT01368562|526797670|FG000|Overall Study|Other|3|||
146075630|NCT01368562|526797670|FG000|Overall Study|Other than specified|2|||
146075631|NCT02810444|526797672|FG000|Overall Study|Screen Failures|14|||
146075632|NCT02810444|526797672|FG000|Overall Study|Withdrawal by Subject|4|||
146075633|NCT02810444|526797672|FG000|Overall Study|Adverse Event|3|||
146075634|NCT01754727|526797675|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
146075635|NCT02785770|526797676|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
146075636|NCT02785770|526797677|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
146075637|NCT02785770|526797678|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
146075638|NCT02785770|526797679|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
146075639|NCT02785770|526797676|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
146075640|NCT02785770|526797677|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
146075641|NCT02785770|526797678|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
146075642|NCT02785770|526797679|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
146075643|NCT02785770|526797676|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
146075644|NCT02785770|526797677|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
146075645|NCT02785770|526797678|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
146075646|NCT02785770|526797679|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
146075647|NCT02338882|526797685|FG000|Overall Study|Death|1|||
146075648|NCT02338882|526797686|FG001|Overall Study|Death|0|||
146075649|NCT02338882|526797685|FG000|Overall Study|Lost to Follow-up|6|||
146075650|NCT02338882|526797686|FG001|Overall Study|Lost to Follow-up|3|||
146075651|NCT01904773|526797689|FG000|Screen|Screen failure|3|||
146075652|NCT01904773|526797690|FG001|Screen|Screen failure|0|||
146075653|NCT01904773|526797691|FG002|Screen|Screen failure|0|||
146075654|NCT01904773|526797692|FG003|Screen|Screen failure|0|||
146075655|NCT01904773|526797693|FG004|Screen|Screen failure|0|||
146075656|NCT01904773|526797694|FG005|Screen|Screen failure|0|||
146075657|NCT01904773|526797695|FG006|Screen|Screen failure|0|||
146175117|NCT01225822|527154517|FG001|Overall Study|Other|10|||
146075658|NCT01904773|526797696|FG007|Screen|Screen failure|0|||
146075659|NCT01904773|526797697|FG008|Screen|Screen failure|0|||
146075660|NCT01904773|526797689|FG000|Screen|Withdrawal by Subject|1|||
146075661|NCT01904773|526797690|FG001|Screen|Withdrawal by Subject|0|||
146075662|NCT01904773|526797691|FG002|Screen|Withdrawal by Subject|0|||
146075663|NCT01904773|526797692|FG003|Screen|Withdrawal by Subject|0|||
146075664|NCT01904773|526797693|FG004|Screen|Withdrawal by Subject|0|||
146075665|NCT01904773|526797694|FG005|Screen|Withdrawal by Subject|0|||
146075666|NCT01904773|526797695|FG006|Screen|Withdrawal by Subject|0|||
146075667|NCT01904773|526797696|FG007|Screen|Withdrawal by Subject|0|||
146075668|NCT01904773|526797697|FG008|Screen|Withdrawal by Subject|0|||
146075669|NCT01904773|526797689|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
146075670|NCT01904773|526797690|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075671|NCT01904773|526797691|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146175118|NCT01225822|527154518|FG002|Overall Study|Other|7|||
146175119|NCT01225822|527154519|FG003|Overall Study|Other|10|||
146175120|NCT01225822|527154520|FG004|Overall Study|Other|7|||
146175121|NCT01290822|527154521|FG000|Overall Study|Withdrawal by Subject|1|||
146175122|NCT01290822|527154521|FG000|Overall Study|Physician Decision|10|||
146175123|NCT00089895|527154522|FG000|Overall Study|Consent Withdrawn|11|||
146175124|NCT00089895|527154523|FG001|Overall Study|Consent Withdrawn|14|||
146175125|NCT00089895|527154522|FG000|Overall Study|Technical reason|7|||
146175126|NCT00089895|527154523|FG001|Overall Study|Technical reason|2|||
146175127|NCT00089895|527154522|FG000|Overall Study|Surgery|0|||
146175128|NCT00089895|527154523|FG001|Overall Study|Surgery|1|||
146175129|NCT00089895|527154522|FG000|Overall Study|Bleeding|0|||
146175130|NCT00089895|527154523|FG001|Overall Study|Bleeding|2|||
146175131|NCT00089895|527154522|FG000|Overall Study|Physician Decision|3|||
146175132|NCT00089895|527154523|FG001|Overall Study|Physician Decision|7|||
146175133|NCT00089895|527154522|FG000|Overall Study|Exclusion criteria met|6|||
146175134|NCT00089895|527154523|FG001|Overall Study|Exclusion criteria met|6|||
146175135|NCT00089895|527154522|FG000|Overall Study|Not otherwise specified|4|||
146175136|NCT00089895|527154523|FG001|Overall Study|Not otherwise specified|8|||
146175137|NCT00089895|527154522|FG000|Overall Study|Missing|4|||
146175138|NCT00089895|527154523|FG001|Overall Study|Missing|2|||
146175139|NCT02541383|527154524|FG000|Overall Study|Death|50|||
146175140|NCT02541383|527154525|FG001|Overall Study|Death|37|||
146175141|NCT02541383|527154526|FG002|Overall Study|Death|48|||
146175142|NCT02541383|527154527|FG003|Overall Study|Death|41|||
146175143|NCT02541383|527154528|FG004|Overall Study|Death|21|||
146175144|NCT02541383|527154529|FG005|Overall Study|Death|25|||
146175145|NCT02541383|527154524|FG000|Overall Study|Lost to Follow-up|5|||
146175146|NCT02541383|527154525|FG001|Overall Study|Lost to Follow-up|3|||
146175147|NCT02541383|527154526|FG002|Overall Study|Lost to Follow-up|1|||
146175148|NCT02541383|527154527|FG003|Overall Study|Lost to Follow-up|1|||
146175149|NCT02541383|527154528|FG004|Overall Study|Lost to Follow-up|3|||
146175150|NCT02541383|527154529|FG005|Overall Study|Lost to Follow-up|0|||
146175151|NCT02541383|527154524|FG000|Overall Study|Consent withdrawn|5|||
146175152|NCT02541383|527154525|FG001|Overall Study|Consent withdrawn|6|||
146175153|NCT02541383|527154526|FG002|Overall Study|Consent withdrawn|1|||
146175154|NCT02541383|527154527|FG003|Overall Study|Consent withdrawn|1|||
146175155|NCT02541383|527154528|FG004|Overall Study|Consent withdrawn|0|||
146175156|NCT02541383|527154529|FG005|Overall Study|Consent withdrawn|0|||
146175157|NCT02541383|527154524|FG000|Overall Study|Sponsor's decision|1|||
146175158|NCT02541383|527154525|FG001|Overall Study|Sponsor's decision|1|||
146175159|NCT02541383|527154526|FG002|Overall Study|Sponsor's decision|0|||
146175160|NCT02541383|527154527|FG003|Overall Study|Sponsor's decision|0|||
146175161|NCT02541383|527154528|FG004|Overall Study|Sponsor's decision|0|||
146175162|NCT02541383|527154529|FG005|Overall Study|Sponsor's decision|0|||
146175163|NCT02487095|527154535|FG000|Dose Expansion|Unable to scan/restage participant|0|||
146175164|NCT02487095|527154536|FG001|Dose Expansion|Unable to scan/restage participant|0|||
146175165|NCT02487095|527154537|FG002|Dose Expansion|Unable to scan/restage participant|0|||
146175166|NCT02487095|527154538|FG003|Dose Expansion|Unable to scan/restage participant|0|||
146175167|NCT02487095|527154539|FG004|Dose Expansion|Unable to scan/restage participant|1|||
146175168|NCT03108157|527154542|FG000|Overall Study|Protocol Violation|15|||
146175169|NCT03108157|527154543|FG001|Overall Study|Protocol Violation|4|||
146175170|NCT01279343|527154546|FG000|Overall Study|Did not receive treatment|2|||
146175171|NCT01279343|527154547|FG001|Overall Study|Did not receive treatment|6|||
146175172|NCT04534114|527154548|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146175173|NCT04534114|527154549|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
145945341|NCT01764997|526308215|FG003|Run-in Period|Lack of Efficacy|0|||
146175174|NCT04534114|527154550|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146175175|NCT04534114|527154551|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
146175176|NCT04534114|527154548|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
146175177|NCT04534114|527154549|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
146175178|NCT04534114|527154550|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
146175179|NCT04534114|527154551|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
146175180|NCT04534114|527154548|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
146175181|NCT04534114|527154549|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
146175182|NCT04534114|527154550|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
146075672|NCT01904773|526797692|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075673|NCT01904773|526797693|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075674|NCT01904773|526797694|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075675|NCT01904773|526797695|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075676|NCT01904773|526797696|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075677|NCT01904773|526797697|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
146075678|NCT01904773|526797689|FG000|First Intervention|Adverse Event|0|||
146075679|NCT01904773|526797690|FG001|First Intervention|Adverse Event|0|||
146075680|NCT01904773|526797691|FG002|First Intervention|Adverse Event|0|||
146075681|NCT01904773|526797692|FG003|First Intervention|Adverse Event|0|||
146075682|NCT01904773|526797693|FG004|First Intervention|Adverse Event|0|||
146075683|NCT01904773|526797694|FG005|First Intervention|Adverse Event|0|||
146075684|NCT01904773|526797695|FG006|First Intervention|Adverse Event|1|||
146075685|NCT01904773|526797696|FG007|First Intervention|Adverse Event|0|||
146075686|NCT01904773|526797697|FG008|First Intervention|Adverse Event|0|||
146075687|NCT01904773|526797689|FG000|Placebo Washout First Intervention|Condition worsened|0|||
146075688|NCT01904773|526797690|FG001|Placebo Washout First Intervention|Condition worsened|1|||
146075689|NCT01904773|526797691|FG002|Placebo Washout First Intervention|Condition worsened|0|||
146075690|NCT01904773|526797692|FG003|Placebo Washout First Intervention|Condition worsened|0|||
146075691|NCT01904773|526797693|FG004|Placebo Washout First Intervention|Condition worsened|0|||
146075692|NCT01904773|526797694|FG005|Placebo Washout First Intervention|Condition worsened|0|||
146075693|NCT01904773|526797695|FG006|Placebo Washout First Intervention|Condition worsened|0|||
146075694|NCT01904773|526797696|FG007|Placebo Washout First Intervention|Condition worsened|0|||
146075695|NCT01904773|526797697|FG008|Placebo Washout First Intervention|Condition worsened|0|||
146075696|NCT01904773|526797689|FG000|Fifth Intervention|Adverse Event|0|||
146075697|NCT01904773|526797690|FG001|Fifth Intervention|Adverse Event|0|||
146075698|NCT01904773|526797691|FG002|Fifth Intervention|Adverse Event|0|||
146075699|NCT01904773|526797692|FG003|Fifth Intervention|Adverse Event|0|||
146075700|NCT01904773|526797693|FG004|Fifth Intervention|Adverse Event|0|||
146075701|NCT01904773|526797694|FG005|Fifth Intervention|Adverse Event|0|||
146075702|NCT01904773|526797695|FG006|Fifth Intervention|Adverse Event|0|||
146075703|NCT01904773|526797696|FG007|Fifth Intervention|Adverse Event|1|||
146075704|NCT01904773|526797697|FG008|Fifth Intervention|Adverse Event|0|||
146075705|NCT01904773|526797689|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075706|NCT01904773|526797690|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
146075707|NCT01904773|526797691|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075708|NCT01904773|526797692|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075709|NCT01904773|526797693|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075710|NCT01904773|526797694|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075711|NCT01904773|526797695|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075712|NCT01904773|526797696|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075713|NCT01904773|526797697|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
146075714|NCT04518995|526797698|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
146075715|NCT04518995|526797699|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
146075716|NCT04518995|526797700|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
146075717|NCT04518995|526797698|FG000|Overall Study|Lack of Efficacy|2|||
146075718|NCT04518995|526797699|FG001|Overall Study|Lack of Efficacy|1|||
146075719|NCT04518995|526797700|FG002|Overall Study|Lack of Efficacy|0|||
146075720|NCT04518995|526797698|FG000|Overall Study|Non-compliance With Study Drug|0|||
146075721|NCT04518995|526797699|FG001|Overall Study|Non-compliance With Study Drug|3|||
146075722|NCT04518995|526797700|FG002|Overall Study|Non-compliance With Study Drug|2|||
146075723|NCT04518995|526797698|FG000|Overall Study|Pregnancy|0|||
146075724|NCT04518995|526797699|FG001|Overall Study|Pregnancy|0|||
146075725|NCT04518995|526797700|FG002|Overall Study|Pregnancy|1|||
146075726|NCT04518995|526797698|FG000|Overall Study|Protocol Violation|2|||
146075727|NCT04518995|526797699|FG001|Overall Study|Protocol Violation|0|||
146075728|NCT04518995|526797700|FG002|Overall Study|Protocol Violation|1|||
146075729|NCT04518995|526797698|FG000|Overall Study|Reason not Specified|4|||
146075730|NCT04518995|526797699|FG001|Overall Study|Reason not Specified|11|||
146075731|NCT04518995|526797700|FG002|Overall Study|Reason not Specified|2|||
146075732|NCT04518995|526797698|FG000|Overall Study|Lost to Follow-up|1|||
146075733|NCT04518995|526797699|FG001|Overall Study|Lost to Follow-up|10|||
146075734|NCT04518995|526797700|FG002|Overall Study|Lost to Follow-up|6|||
146075735|NCT00669409|526797703|FG000|Part 2|Withdrawal by Subject|0|||
146075736|NCT00669409|526797704|FG001|Part 2|Withdrawal by Subject|0|||
146075737|NCT00669409|526797705|FG002|Part 2|Withdrawal by Subject|0|||
146075738|NCT00669409|526797706|FG003|Part 2|Withdrawal by Subject|0|||
146075739|NCT00669409|526797707|FG004|Part 2|Withdrawal by Subject|0|||
146075740|NCT00669409|526797708|FG005|Part 2|Withdrawal by Subject|0|||
146075741|NCT00669409|526797709|FG006|Part 2|Withdrawal by Subject|0|||
146075742|NCT00669409|526797710|FG007|Part 2|Withdrawal by Subject|0|||
146075743|NCT00669409|526797711|FG008|Part 2|Withdrawal by Subject|0|||
146075744|NCT00669409|526797712|FG009|Part 2|Withdrawal by Subject|1|||
146075745|NCT00669409|526797713|FG010|Part 2|Withdrawal by Subject|0|||
146075746|NCT00813943|526797714|FG000|Overall Study|Ongoing at cut-off date|5|||
146075747|NCT00813943|526797715|FG001|Overall Study|Ongoing at cut-off date|5|||
146075748|NCT00813943|526797716|FG002|Overall Study|Ongoing at cut-off date|3|||
146075749|NCT05367492|526797717|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
146075750|NCT05367492|526797718|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
146075751|NCT05367492|526797719|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
146075752|NCT05367492|526797717|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
146075753|NCT05367492|526797718|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
146075754|NCT05367492|526797719|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
146075755|NCT05367492|526797717|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
146075756|NCT05367492|526797718|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
146075757|NCT05367492|526797719|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
146075758|NCT05367492|526797717|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
146075759|NCT05367492|526797718|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
146075760|NCT05367492|526797719|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
146075761|NCT02891070|526797725|FG000|Overall Study|Adverse Event|1|||
146075762|NCT02891070|526797726|FG001|Overall Study|Adverse Event|0|||
146075763|NCT02891070|526797725|FG000|Overall Study|Physician Decision|0|||
146075764|NCT02891070|526797726|FG001|Overall Study|Physician Decision|1|||
146075765|NCT02891070|526797725|FG000|Overall Study|Lost to Follow-up|4|||
146075766|NCT02891070|526797726|FG001|Overall Study|Lost to Follow-up|4|||
146075767|NCT02891070|526797725|FG000|Overall Study|Other|1|||
146075768|NCT02891070|526797726|FG001|Overall Study|Other|0|||
146075769|NCT02891070|526797725|FG000|Overall Study|Protocol Violation|0|||
146075770|NCT02891070|526797726|FG001|Overall Study|Protocol Violation|1|||
146075771|NCT02891070|526797725|FG000|Overall Study|Withdrawal by Subject|1|||
146075772|NCT02891070|526797726|FG001|Overall Study|Withdrawal by Subject|2|||
146075773|NCT02891070|526797725|FG000|Overall Study|Death|3|||
146075774|NCT02891070|526797726|FG001|Overall Study|Death|0|||
146075775|NCT04491604|526797733|FG000|Overall Study|Withdrawal by Subject|3|||
146075776|NCT01523275|526797738|FG000|Overall Study|Lost to Follow-up|1|||
146075777|NCT01523275|526797739|FG001|Overall Study|Lost to Follow-up|2|||
146075778|NCT01523275|526797738|FG000|Overall Study|Withdrawal by Subject|1|||
146075779|NCT01523275|526797739|FG001|Overall Study|Withdrawal by Subject|0|||
146075780|NCT02888119|526797744|FG000|Overall Study|Lost to Follow-up|5|||
146075781|NCT02888119|526797745|FG001|Overall Study|Lost to Follow-up|4|||
146075782|NCT02888119|526797746|FG002|Overall Study|Lost to Follow-up|0|||
146075783|NCT01767142|526797747|FG000|Overall Study|Lost to Follow-up|3|||
146075784|NCT00926029|526797753|FG000|Overall Study|Lost to Follow-up|2|||
146075785|NCT00926029|526797754|FG001|Overall Study|Lost to Follow-up|1|||
146075786|NCT00926029|526797755|FG002|Overall Study|Lost to Follow-up|1|||
146075787|NCT03206788|526797756|FG000|Overall Study|Withdrawal by Subject|0|||
146075788|NCT03206788|526797757|FG001|Overall Study|Withdrawal by Subject|1|||
146075789|NCT03206788|526797756|FG000|Overall Study|Adverse Event|0|||
146075790|NCT03206788|526797757|FG001|Overall Study|Adverse Event|1|||
146075791|NCT03206788|526797756|FG000|Overall Study|Physician Decision|0|||
146075792|NCT03206788|526797757|FG001|Overall Study|Physician Decision|1|||
146075793|NCT02471612|526797758|FG000|Overall Study|Lost to Follow-up|2|||
146075794|NCT05573386|526797759|FG000|Overall Study|Withdrawal by Subject|3|||
146075795|NCT05573386|526797760|FG001|Overall Study|Withdrawal by Subject|2|||
146075796|NCT05246514|526797761|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
146075797|NCT05246514|526797761|FG000|Overall Study|Withdrawal by Subject|1|||
146175183|NCT04534114|527154551|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
146075798|NCT05246514|526797761|FG000|Overall Study|Death|13|||
146075799|NCT03646123|526797762|FG000|Overall Study|Withdrawal by Subject|2|||
146075800|NCT03646123|526797763|FG001|Overall Study|Withdrawal by Subject|2|||
146075801|NCT03646123|526797764|FG002|Overall Study|Withdrawal by Subject|3|||
146075802|NCT03646123|526797762|FG000|Overall Study|Study termination by sponsor|0|||
146175184|NCT04534114|527154548|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146175185|NCT04534114|527154549|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
146175186|NCT04534114|527154550|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
146175187|NCT04534114|527154551|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146175188|NCT04534114|527154548|FG000|Main Treatment Period|Physician Decision|0|||
146175189|NCT04534114|527154549|FG001|Main Treatment Period|Physician Decision|0|||
146175190|NCT04534114|527154550|FG002|Main Treatment Period|Physician Decision|0|||
146175191|NCT04534114|527154551|FG003|Main Treatment Period|Physician Decision|1|||
146175192|NCT04534114|527154548|FG000|Main Treatment Period|Death|1|||
146175193|NCT04534114|527154549|FG001|Main Treatment Period|Death|0|||
146175194|NCT04534114|527154550|FG002|Main Treatment Period|Death|0|||
146175195|NCT04534114|527154551|FG003|Main Treatment Period|Death|1|||
146175196|NCT04534114|527154548|FG000|Main Treatment Period|Other reason|1|||
146175197|NCT04534114|527154549|FG001|Main Treatment Period|Other reason|1|||
146175198|NCT04534114|527154550|FG002|Main Treatment Period|Other reason|0|||
146175199|NCT04534114|527154551|FG003|Main Treatment Period|Other reason|0|||
146175200|NCT04534114|527154548|FG000|Main Treatment Period|Participant decision|1|||
146175201|NCT04534114|527154549|FG001|Main Treatment Period|Participant decision|3|||
146175202|NCT04534114|527154550|FG002|Main Treatment Period|Participant decision|3|||
146175203|NCT04534114|527154551|FG003|Main Treatment Period|Participant decision|1|||
146175204|NCT04534114|527154548|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
146175205|NCT04534114|527154549|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
146175206|NCT04534114|527154550|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
146175207|NCT04534114|527154551|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
146175208|NCT04534114|527154548|FG000|Main Treatment Period|Adverse Event|4|||
146175209|NCT04534114|527154549|FG001|Main Treatment Period|Adverse Event|2|||
146175210|NCT04534114|527154550|FG002|Main Treatment Period|Adverse Event|1|||
146175211|NCT04534114|527154551|FG003|Main Treatment Period|Adverse Event|2|||
146175212|NCT04534114|527154548|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146175213|NCT04534114|527154549|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146175214|NCT04534114|527154550|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
146175215|NCT04534114|527154551|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
146175216|NCT04534114|527154548|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
146175217|NCT04534114|527154549|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146175218|NCT04534114|527154550|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146175219|NCT04534114|527154551|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
146175220|NCT04534114|527154548|FG000|Extension Treatment Period|Other reason|0|||
146175221|NCT04534114|527154549|FG001|Extension Treatment Period|Other reason|1|||
146175222|NCT04534114|527154550|FG002|Extension Treatment Period|Other reason|0|||
146175223|NCT04534114|527154551|FG003|Extension Treatment Period|Other reason|0|||
146175224|NCT04534114|527154548|FG000|Extension Treatment Period|Death|0|||
146175225|NCT04534114|527154549|FG001|Extension Treatment Period|Death|0|||
146175226|NCT04534114|527154550|FG002|Extension Treatment Period|Death|1|||
146175227|NCT04534114|527154551|FG003|Extension Treatment Period|Death|2|||
146175228|NCT04534114|527154548|FG000|Extension Treatment Period|Adverse Event|0|||
146175229|NCT04534114|527154549|FG001|Extension Treatment Period|Adverse Event|1|||
146175230|NCT04534114|527154550|FG002|Extension Treatment Period|Adverse Event|0|||
146175231|NCT04534114|527154551|FG003|Extension Treatment Period|Adverse Event|1|||
146175232|NCT04534114|527154548|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
146175233|NCT04534114|527154549|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
146175234|NCT04534114|527154550|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
146175235|NCT04534114|527154551|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
146175236|NCT03287414|527154552|FG000|Treatment Epoch|Adverse Event|0|||
146175237|NCT03287414|527154553|FG001|Treatment Epoch|Adverse Event|1|||
146175238|NCT03287414|527154552|FG000|Treatment Epoch|Study terminated by sponsor|2|||
146175239|NCT03287414|527154553|FG001|Treatment Epoch|Study terminated by sponsor|2|||
146175240|NCT03287414|527154552|FG000|Treatment Epoch|Subject/Guardian decision|4|||
146175241|NCT03287414|527154553|FG001|Treatment Epoch|Subject/Guardian decision|0|||
146175242|NCT03287414|527154552|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
146175243|NCT03287414|527154553|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
146175244|NCT03287414|527154552|FG000|Treatment Epoch|Withdrawal by Subject|1|||
146175245|NCT03287414|527154553|FG001|Treatment Epoch|Withdrawal by Subject|0|||
146175246|NCT03287414|527154552|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
146175247|NCT03287414|527154553|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
146175248|NCT03287414|527154552|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
146175249|NCT03287414|527154553|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
146175250|NCT02759185|527154554|FG000|Stage 1|Adverse Event|0|||
146175251|NCT02759185|527154555|FG001|Stage 1|Adverse Event|1|||
146175252|NCT02759185|527154556|FG002|Stage 1|Adverse Event|3|||
146175253|NCT02759185|527154557|FG003|Stage 1|Adverse Event|0|||
146175254|NCT02759185|527154558|FG004|Stage 1|Adverse Event|0|||
146175255|NCT02759185|527154559|FG005|Stage 1|Adverse Event|0|||
146175256|NCT02759185|527154560|FG006|Stage 1|Adverse Event|0|||
146175257|NCT02759185|527154554|FG000|Stage 1|Withdrawal by Subject|1|||
146175258|NCT02759185|527154555|FG001|Stage 1|Withdrawal by Subject|0|||
146175259|NCT02759185|527154556|FG002|Stage 1|Withdrawal by Subject|0|||
146175260|NCT02759185|527154557|FG003|Stage 1|Withdrawal by Subject|0|||
146175261|NCT02759185|527154558|FG004|Stage 1|Withdrawal by Subject|0|||
146175262|NCT02759185|527154559|FG005|Stage 1|Withdrawal by Subject|0|||
146175263|NCT02759185|527154560|FG006|Stage 1|Withdrawal by Subject|0|||
146175264|NCT02759185|527154554|FG000|Stage 2|Adverse Event|0|||
146175265|NCT02759185|527154555|FG001|Stage 2|Adverse Event|0|||
146175266|NCT02759185|527154556|FG002|Stage 2|Adverse Event|0|||
146175267|NCT02759185|527154557|FG003|Stage 2|Adverse Event|0|||
146175268|NCT02759185|527154558|FG004|Stage 2|Adverse Event|1|||
146175269|NCT02759185|527154559|FG005|Stage 2|Adverse Event|2|||
146175270|NCT02759185|527154560|FG006|Stage 2|Adverse Event|0|||
146175271|NCT02759185|527154554|FG000|Stage 2|Withdrawal by Subject|0|||
146175272|NCT02759185|527154555|FG001|Stage 2|Withdrawal by Subject|0|||
146175273|NCT02759185|527154556|FG002|Stage 2|Withdrawal by Subject|0|||
146175274|NCT02759185|527154557|FG003|Stage 2|Withdrawal by Subject|0|||
146175275|NCT02759185|527154558|FG004|Stage 2|Withdrawal by Subject|1|||
146175276|NCT02759185|527154559|FG005|Stage 2|Withdrawal by Subject|1|||
146175277|NCT02759185|527154560|FG006|Stage 2|Withdrawal by Subject|1|||
146175278|NCT04395183|527154567|FG000|Overall Study|Withdrawal by Subject|1|||
146175279|NCT04395183|527154568|FG001|Overall Study|Withdrawal by Subject|0|||
146175280|NCT04395183|527154569|FG002|Overall Study|Withdrawal by Subject|2|||
146175281|NCT04395183|527154570|FG003|Overall Study|Withdrawal by Subject|2|||
146175282|NCT01008475|527154571|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
146175283|NCT01008475|527154572|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
146175284|NCT01008475|527154573|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
146175285|NCT01008475|527154574|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
146175286|NCT01008475|527154575|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
146175287|NCT01008475|527154576|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
146175288|NCT01008475|527154577|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
146175289|NCT02668016|527154578|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
146175290|NCT02668016|527154578|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
146175291|NCT02668016|527154578|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
146175292|NCT02668016|527154578|FG000|Month 4|Withdrawal due to severe symptoms|1|||
146175293|NCT02668016|527154578|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
146175294|NCT02668016|527154578|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
146175295|NCT02668016|527154578|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
146175296|NCT02668016|527154578|FG000|Month 6|Withdrawal due to severe symptoms|2|||
146175297|NCT02668016|527154578|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
146175298|NCT02668016|527154578|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
146175299|NCT02668016|527154578|FG000|Month 8|Withdrawal due to severe symptoms|1|||
146175300|NCT02668016|527154578|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
146175301|NCT02668016|527154578|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
146175302|NCT02668016|527154578|FG000|Month 10|Withdrawal due to severe symptoms|1|||
146175303|NCT02668016|527154578|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
146175304|NCT00962247|527154582|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
146175305|NCT00962247|527154582|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
146175306|NCT02234063|527154585|FG000|Overall Study|Lost to Follow-up|235|||
146175307|NCT02234063|527154586|FG001|Overall Study|Lost to Follow-up|42|||
146175308|NCT02234063|527154585|FG000|Overall Study|Withdrawal by Subject|20|||
146175309|NCT02234063|527154586|FG001|Overall Study|Withdrawal by Subject|1|||
146175310|NCT01861522|527154589|FG000|Overall Study|Adverse Event|1|||
146175311|NCT01861522|527154590|FG001|Overall Study|Adverse Event|0|||
146175312|NCT01861522|527154589|FG000|Overall Study|Withdrawal by Subject|2|||
146175313|NCT01861522|527154590|FG001|Overall Study|Withdrawal by Subject|0|||
146175314|NCT00926003|527154592|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
146175315|NCT00926003|527154593|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
146175316|NCT00926003|527154594|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
146175317|NCT00926003|527154592|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
146175318|NCT00926003|527154593|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
146175319|NCT00926003|527154594|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
146175320|NCT01103960|527154595|FG000|Overall Study|Adverse Event|2|||
146175321|NCT01103960|527154596|FG001|Overall Study|Adverse Event|1|||
146175322|NCT01103960|527154595|FG000|Overall Study|Withdrawal by Subject|2|||
146175323|NCT01103960|527154596|FG001|Overall Study|Withdrawal by Subject|1|||
146175324|NCT01103960|527154595|FG000|Overall Study|Other|1|||
146075803|NCT03646123|526797763|FG001|Overall Study|Study termination by sponsor|45|||
146075804|NCT03646123|526797764|FG002|Overall Study|Study termination by sponsor|139|||
146075805|NCT03646123|526797762|FG000|Overall Study|Lost to Follow-up|4|||
146075806|NCT03646123|526797763|FG001|Overall Study|Lost to Follow-up|10|||
146075807|NCT03646123|526797764|FG002|Overall Study|Lost to Follow-up|10|||
146075808|NCT03646123|526797762|FG000|Overall Study|Death|2|||
146075809|NCT03646123|526797763|FG001|Overall Study|Death|1|||
146075810|NCT03646123|526797764|FG002|Overall Study|Death|1|||
146075811|NCT03646123|526797762|FG000|Overall Study|Other|2|||
146075812|NCT03646123|526797763|FG001|Overall Study|Other|0|||
146075813|NCT03646123|526797764|FG002|Overall Study|Other|2|||
146075814|NCT01802073|526797767|FG000|Overall Study|Lost to Follow-up|0|||
146075815|NCT01802073|526797768|FG001|Overall Study|Lost to Follow-up|1|||
146075816|NCT01802073|526797767|FG000|Overall Study|Non-compliant|4|||
146075817|NCT01802073|526797768|FG001|Overall Study|Non-compliant|2|||
146075818|NCT01802073|526797767|FG000|Overall Study|Withdrawal by Subject|1|||
146075819|NCT01802073|526797768|FG001|Overall Study|Withdrawal by Subject|1|||
146075820|NCT01802073|526797767|FG000|Overall Study|Physician Decision|0|||
146075821|NCT01802073|526797768|FG001|Overall Study|Physician Decision|7|||
146075822|NCT02657408|526797771|FG000|Overall Study|Adverse Event|3|||
146075823|NCT02657408|526797772|FG001|Overall Study|Adverse Event|7|||
146075824|NCT00324961|526797774|FG000|Overall Study|Adverse Event|5|||
146075825|NCT00324961|526797774|FG000|Overall Study|Consent Withdrawn|11|||
146075826|NCT00324961|526797774|FG000|Overall Study|Lost to Follow-up|22|||
146075827|NCT00324961|526797774|FG000|Overall Study|Protocol Violation|3|||
146075828|NCT00324961|526797774|FG000|Overall Study|Other|2|||
146075829|NCT05343624|526797775|FG000|Overall Study|Chart review not completed|1|||
146075830|NCT02447302|526797776|FG000|Overall Study|Physician Decision|1|||
146075831|NCT02447302|526797777|FG001|Overall Study|Physician Decision|0|||
146075832|NCT02447302|526797778|FG002|Overall Study|Physician Decision|0|||
146075833|NCT02447302|526797776|FG000|Overall Study|Adverse Event|4|||
146075834|NCT02447302|526797777|FG001|Overall Study|Adverse Event|3|||
146075835|NCT02447302|526797778|FG002|Overall Study|Adverse Event|0|||
146075836|NCT02447302|526797776|FG000|Overall Study|Withdrawal by Subject|0|||
146075837|NCT02447302|526797777|FG001|Overall Study|Withdrawal by Subject|1|||
146075838|NCT02447302|526797778|FG002|Overall Study|Withdrawal by Subject|5|||
146075839|NCT02447302|526797776|FG000|Overall Study|Sponsor Decision|0|||
146075840|NCT02447302|526797777|FG001|Overall Study|Sponsor Decision|0|||
146075841|NCT02447302|526797778|FG002|Overall Study|Sponsor Decision|1|||
146075842|NCT05334212|526797783|FG000|Overall Study|Study terminated prematurely|7|||
146075843|NCT00910299|526797784|FG000|Overall Study|Withdrawal by Subject|16|||
146075844|NCT00910299|526797785|FG001|Overall Study|Withdrawal by Subject|13|||
146075845|NCT00910299|526797784|FG000|Overall Study|Sponsor Decision|58|||
146075846|NCT00910299|526797785|FG001|Overall Study|Sponsor Decision|60|||
146075847|NCT00910299|526797784|FG000|Overall Study|Didn't receive any study drug|2|||
146075848|NCT00910299|526797785|FG001|Overall Study|Didn't receive any study drug|1|||
146075849|NCT01456897|526797786|FG000|Overall Study|Adverse Event|19|||
146075850|NCT01456897|526797787|FG001|Overall Study|Adverse Event|22|||
146075851|NCT01456897|526797786|FG000|Overall Study|Protocol Violation|3|||
146075852|NCT01456897|526797787|FG001|Overall Study|Protocol Violation|4|||
146075853|NCT01456897|526797786|FG000|Overall Study|Physician Decision|5|||
146075854|NCT01456897|526797787|FG001|Overall Study|Physician Decision|3|||
146075855|NCT01456897|526797786|FG000|Overall Study|Withdrawal by Subject|44|||
146075856|NCT01456897|526797787|FG001|Overall Study|Withdrawal by Subject|17|||
146075857|NCT01456897|526797786|FG000|Overall Study|Lack of Efficacy|4|||
146075858|NCT01456897|526797787|FG001|Overall Study|Lack of Efficacy|11|||
146075859|NCT01396070|526797788|FG000|Overall Study|Withdrawal by Subject|2|||
146075860|NCT01396070|526797788|FG000|Overall Study|Death|2|||
146075861|NCT01396070|526797788|FG000|Overall Study|Adverse Event|8|||
146075862|NCT01396070|526797788|FG000|Overall Study|Physician Decision|3|||
146075863|NCT01396070|526797788|FG000|Overall Study|Lack of Efficacy|4|||
146075864|NCT04254913|526797790|FG000|Overall Study|Adverse Event|1|||
146175325|NCT01103960|527154596|FG001|Overall Study|Other|0|||
146075865|NCT01396057|526797791|FG000|Overall Study|Adverse Event|2|||
146075866|NCT01396057|526797792|FG001|Overall Study|Adverse Event|6|||
146075867|NCT01396057|526797791|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146075868|NCT01396057|526797792|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146075869|NCT01396057|526797791|FG000|Overall Study|Protocol deviation|4|||
146075870|NCT01396057|526797792|FG001|Overall Study|Protocol deviation|4|||
146075871|NCT01396057|526797791|FG000|Overall Study|Consent withdrawn|3|||
146075872|NCT01396057|526797792|FG001|Overall Study|Consent withdrawn|2|||
146075873|NCT02695420|526797793|FG000|Overall Study|Death|0|||
146075874|NCT02695420|526797794|FG001|Overall Study|Death|1|||
146075875|NCT02695420|526797795|FG002|Overall Study|Death|0|||
146075876|NCT02695420|526797796|FG003|Overall Study|Death|0|||
146075877|NCT02929407|526797799|FG000|Overall Study|Adverse Event|1|||
146075878|NCT00916929|526797800|FG000|Overall Study|Lost to Follow-up|1|||
146075879|NCT00916929|526797801|FG001|Overall Study|Lost to Follow-up|3|||
146075880|NCT00916929|526797800|FG000|Overall Study|Death|5|||
146075881|NCT00916929|526797801|FG001|Overall Study|Death|10|||
146075882|NCT00916929|526797800|FG000|Overall Study|Withdrawal by Subject|1|||
146075883|NCT00916929|526797801|FG001|Overall Study|Withdrawal by Subject|5|||
146075884|NCT00916929|526797800|FG000|Overall Study|Left ventricular epicardial lead|1|||
146075885|NCT00916929|526797801|FG001|Overall Study|Left ventricular epicardial lead|2|||
146075886|NCT00916929|526797800|FG000|Overall Study|Transferred to hospice care|1|||
146075887|NCT00916929|526797801|FG001|Overall Study|Transferred to hospice care|1|||
146075888|NCT00916929|526797800|FG000|Overall Study|System explant|1|||
146075889|NCT00916929|526797801|FG001|Overall Study|System explant|0|||
146075890|NCT00916929|526797800|FG000|Overall Study|Moved to another state|0|||
146075891|NCT00916929|526797801|FG001|Overall Study|Moved to another state|1|||
146075892|NCT00916929|526797800|FG000|Overall Study|Device unable to process impedance data|0|||
146075893|NCT00916929|526797801|FG001|Overall Study|Device unable to process impedance data|7|||
146075894|NCT02878798|526797804|FG000|Overall Study|Withdrawal by Subject|5|||
146075895|NCT02878798|526797805|FG001|Overall Study|Withdrawal by Subject|4|||
146075896|NCT02878798|526797804|FG000|Overall Study|Lost to Follow-up|2|||
146075897|NCT02878798|526797805|FG001|Overall Study|Lost to Follow-up|2|||
146075898|NCT02878798|526797804|FG000|Overall Study|Protocol Violation|0|||
146075899|NCT02878798|526797805|FG001|Overall Study|Protocol Violation|1|||
146075900|NCT03500224|526797806|FG000|Overall Study|Withdrawal by Subject|2|||
146075901|NCT01324401|526797807|FG000|Overall Study|Withdrawn before any treatment|0|||
146075902|NCT01324401|526797808|FG001|Overall Study|Withdrawn before any treatment|3|||
146075903|NCT01324401|526797807|FG000|Overall Study|Adverse Event|1|||
146075904|NCT01324401|526797808|FG001|Overall Study|Adverse Event|3|||
146075905|NCT01708902|526797810|FG000|Overall Study|Adverse Event|3|||
146075906|NCT01708902|526797811|FG001|Overall Study|Adverse Event|4|||
146075907|NCT01708902|526797812|FG002|Overall Study|Adverse Event|9|||
146075908|NCT01708902|526797813|FG003|Overall Study|Adverse Event|2|||
146075909|NCT01708902|526797814|FG004|Overall Study|Adverse Event|7|||
146075910|NCT01708902|526797815|FG005|Overall Study|Adverse Event|3|||
146075911|NCT01708902|526797816|FG006|Overall Study|Adverse Event|5|||
146075912|NCT01708902|526797810|FG000|Overall Study|Lack of Efficacy|3|||
146075913|NCT01708902|526797811|FG001|Overall Study|Lack of Efficacy|1|||
146075914|NCT01708902|526797812|FG002|Overall Study|Lack of Efficacy|0|||
146075915|NCT01708902|526797813|FG003|Overall Study|Lack of Efficacy|0|||
146075916|NCT01708902|526797814|FG004|Overall Study|Lack of Efficacy|0|||
146075917|NCT01708902|526797815|FG005|Overall Study|Lack of Efficacy|1|||
146075918|NCT01708902|526797816|FG006|Overall Study|Lack of Efficacy|0|||
146075919|NCT01708902|526797810|FG000|Overall Study|Non compliance with protocol|0|||
146075920|NCT01708902|526797811|FG001|Overall Study|Non compliance with protocol|2|||
146075921|NCT01708902|526797812|FG002|Overall Study|Non compliance with protocol|1|||
146075922|NCT01708902|526797813|FG003|Overall Study|Non compliance with protocol|3|||
146411800|NCT02595528|528013944|FG002|Overall Study|Withdrawal by Subject|1|||
146411801|NCT02595528|528013945|FG003|Overall Study|Withdrawal by Subject|3|||
146411802|NCT02595528|528013942|FG000|Overall Study|Lost to Follow-up|1|||
146411803|NCT02595528|528013943|FG001|Overall Study|Lost to Follow-up|1|||
146411804|NCT02595528|528013944|FG002|Overall Study|Lost to Follow-up|0|||
146411805|NCT02595528|528013945|FG003|Overall Study|Lost to Follow-up|1|||
146411806|NCT00833547|528013946|FG000|Overall Study|Withdrawal by Subject|2|||
146411807|NCT00833547|528013947|FG001|Overall Study|Withdrawal by Subject|2|||
145945342|NCT01764997|526308216|FG004|Run-in Period|Lack of Efficacy|0|||
146075923|NCT01708902|526797814|FG004|Overall Study|Non compliance with protocol|0|||
146075924|NCT01708902|526797815|FG005|Overall Study|Non compliance with protocol|0|||
146411808|NCT00566098|528013949|FG000|Collection of MILs|Withdrawal by Subject|1|||
146411809|NCT00566098|528013949|FG000|Collection of MILs|Relapsed|1|||
146075925|NCT01708902|526797816|FG006|Overall Study|Non compliance with protocol|0|||
146075926|NCT01708902|526797810|FG000|Overall Study|Lost to Follow-up|2|||
145945343|NCT01764997|526308212|FG000|Run-in Period|Poor compliance to protocol|1|||
146075927|NCT01708902|526797811|FG001|Overall Study|Lost to Follow-up|1|||
146175326|NCT00118898|527154600|FG000|Overall Study|Death|6|||
146175327|NCT00118898|527154601|FG001|Overall Study|Death|11|||
146175328|NCT00118898|527154602|FG002|Overall Study|Death|6|||
146175329|NCT00118898|527154603|FG003|Overall Study|Death|8|||
146175330|NCT00118898|527154600|FG000|Overall Study|Lost to Follow-up|26|||
146175331|NCT00118898|527154601|FG001|Overall Study|Lost to Follow-up|34|||
146175332|NCT00118898|527154602|FG002|Overall Study|Lost to Follow-up|33|||
146175333|NCT00118898|527154603|FG003|Overall Study|Lost to Follow-up|33|||
146175334|NCT00118898|527154600|FG000|Overall Study|Withdrawal by Subject|10|||
146175335|NCT00118898|527154601|FG001|Overall Study|Withdrawal by Subject|5|||
146175336|NCT00118898|527154602|FG002|Overall Study|Withdrawal by Subject|8|||
146175337|NCT00118898|527154603|FG003|Overall Study|Withdrawal by Subject|8|||
146175338|NCT00118898|527154600|FG000|Overall Study|Site Closure|33|||
146175339|NCT00118898|527154601|FG001|Overall Study|Site Closure|31|||
146175340|NCT00118898|527154602|FG002|Overall Study|Site Closure|28|||
146175341|NCT00118898|527154603|FG003|Overall Study|Site Closure|37|||
146175342|NCT00118898|527154600|FG000|Overall Study|Severe debilitation|1|||
146175343|NCT00118898|527154601|FG001|Overall Study|Severe debilitation|4|||
146075928|NCT01708902|526797812|FG002|Overall Study|Lost to Follow-up|2|||
146075929|NCT01708902|526797813|FG003|Overall Study|Lost to Follow-up|2|||
146075930|NCT01708902|526797814|FG004|Overall Study|Lost to Follow-up|0|||
146075931|NCT01708902|526797815|FG005|Overall Study|Lost to Follow-up|0|||
146075932|NCT01708902|526797816|FG006|Overall Study|Lost to Follow-up|1|||
146075933|NCT01708902|526797810|FG000|Overall Study|Refused to continue trial medication|8|||
146075934|NCT01708902|526797811|FG001|Overall Study|Refused to continue trial medication|0|||
146075935|NCT01708902|526797812|FG002|Overall Study|Refused to continue trial medication|4|||
146075936|NCT01708902|526797813|FG003|Overall Study|Refused to continue trial medication|2|||
146075937|NCT01708902|526797814|FG004|Overall Study|Refused to continue trial medication|8|||
146075938|NCT01708902|526797815|FG005|Overall Study|Refused to continue trial medication|1|||
146075939|NCT01708902|526797816|FG006|Overall Study|Refused to continue trial medication|1|||
146075940|NCT01708902|526797810|FG000|Overall Study|Other Reason|1|||
146075941|NCT01708902|526797811|FG001|Overall Study|Other Reason|0|||
146075942|NCT01708902|526797812|FG002|Overall Study|Other Reason|1|||
146075943|NCT01708902|526797813|FG003|Overall Study|Other Reason|1|||
146075944|NCT01708902|526797814|FG004|Overall Study|Other Reason|1|||
146075945|NCT01708902|526797815|FG005|Overall Study|Other Reason|2|||
146075946|NCT01708902|526797816|FG006|Overall Study|Other Reason|0|||
146075947|NCT00499590|526797819|FG000|Overall Study|Study Terminated|112|||
146075948|NCT00499590|526797820|FG001|Overall Study|Study Terminated|112|||
146075949|NCT00499590|526797821|FG002|Overall Study|Study Terminated|112|||
146075950|NCT00499590|526797819|FG000|Overall Study|Not treated|1|||
146075951|NCT00499590|526797820|FG001|Overall Study|Not treated|0|||
146075952|NCT00499590|526797821|FG002|Overall Study|Not treated|1|||
146075953|NCT00745849|526799400|FG000|First Intervention|Withdrawal by Subject|0|||
146075954|NCT00745849|526799401|FG001|First Intervention|Withdrawal by Subject|1|||
146075955|NCT00745849|526799400|FG000|First Intervention|Lost to Follow-up|1|||
146075956|NCT00745849|526799401|FG001|First Intervention|Lost to Follow-up|1|||
146075957|NCT00745849|526799400|FG000|Second Intervention|Lost to Follow-up|2|||
146075958|NCT00745849|526799401|FG001|Second Intervention|Lost to Follow-up|1|||
146075959|NCT01129583|526799402|FG000|Overall Study|Death|1|||
146075960|NCT01129583|526799403|FG001|Overall Study|Death|0|||
146075961|NCT01129583|526799402|FG000|Overall Study|Lost to Follow-up|1|||
146075962|NCT01129583|526799403|FG001|Overall Study|Lost to Follow-up|1|||
146075963|NCT01129583|526799402|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
146075964|NCT01129583|526799403|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
146075965|NCT02052414|526799409|FG000|Overall Study|Adverse Event|12|||
146075966|NCT02052414|526799409|FG000|Overall Study|Lack of Efficacy|2|||
146075967|NCT02052414|526799409|FG000|Overall Study|Withdrawal by Subject|3|||
146075968|NCT01343693|526799413|FG000|Overall Study|Lost to Follow-up|9|||
146075969|NCT02704143|526799414|FG000|Overall Study|disease progression|10|||
146075970|NCT01235598|526799415|FG000|Overall Study|Adverse Event|0|||
146075971|NCT01235598|526799416|FG001|Overall Study|Adverse Event|3|||
146075972|NCT01235598|526799415|FG000|Overall Study|Lack of Efficacy|0|||
146175344|NCT00118898|527154602|FG002|Overall Study|Severe debilitation|6|||
146175345|NCT00118898|527154603|FG003|Overall Study|Severe debilitation|4|||
146175346|NCT00118898|527154600|FG000|Overall Study|Not compliant with requirements|11|||
146175347|NCT00118898|527154601|FG001|Overall Study|Not compliant with requirements|13|||
146175348|NCT00118898|527154602|FG002|Overall Study|Not compliant with requirements|11|||
146075973|NCT01235598|526799416|FG001|Overall Study|Lack of Efficacy|1|||
146075974|NCT01235598|526799415|FG000|Overall Study|Withdrawal by Subject|1|||
146075975|NCT01235598|526799416|FG001|Overall Study|Withdrawal by Subject|0|||
146075976|NCT02551991|526799417|FG000|Overall Study|Death|5|||
146075977|NCT02551991|526799418|FG001|Overall Study|Death|7|||
146075978|NCT02551991|526799419|FG002|Overall Study|Death|8|||
146075979|NCT02551991|526799420|FG003|Overall Study|Death|7|||
146075980|NCT02551991|526799421|FG004|Overall Study|Death|17|||
146075981|NCT02551991|526799417|FG000|Overall Study|Withdrawal by Subject|1|||
146075982|NCT02551991|526799418|FG001|Overall Study|Withdrawal by Subject|0|||
146075983|NCT02551991|526799419|FG002|Overall Study|Withdrawal by Subject|0|||
146075984|NCT02551991|526799420|FG003|Overall Study|Withdrawal by Subject|0|||
146075985|NCT02551991|526799421|FG004|Overall Study|Withdrawal by Subject|2|||
146075986|NCT02551991|526799417|FG000|Overall Study|Lost to Follow-up|0|||
146075987|NCT02551991|526799418|FG001|Overall Study|Lost to Follow-up|0|||
146075988|NCT02551991|526799419|FG002|Overall Study|Lost to Follow-up|1|||
146075989|NCT02551991|526799420|FG003|Overall Study|Lost to Follow-up|0|||
146075990|NCT02551991|526799421|FG004|Overall Study|Lost to Follow-up|0|||
146075991|NCT02551991|526799417|FG000|Overall Study|Sponsor Decision|1|||
146075992|NCT02551991|526799418|FG001|Overall Study|Sponsor Decision|0|||
146075993|NCT02551991|526799419|FG002|Overall Study|Sponsor Decision|1|||
146075994|NCT02551991|526799420|FG003|Overall Study|Sponsor Decision|0|||
146075995|NCT02551991|526799421|FG004|Overall Study|Sponsor Decision|5|||
146075996|NCT02551991|526799417|FG000|Overall Study|Other|0|||
146075997|NCT02551991|526799418|FG001|Overall Study|Other|0|||
146075998|NCT02551991|526799419|FG002|Overall Study|Other|0|||
146075999|NCT02551991|526799420|FG003|Overall Study|Other|0|||
146076000|NCT02551991|526799421|FG004|Overall Study|Other|1|||
146076001|NCT00395343|526799422|FG000|Overall Study|Adverse Event|13|||
146076002|NCT00395343|526799423|FG001|Overall Study|Adverse Event|5|||
146076003|NCT00395343|526799422|FG000|Overall Study|Lack of Efficacy|0|||
146076004|NCT00395343|526799423|FG001|Overall Study|Lack of Efficacy|1|||
146076005|NCT00395343|526799422|FG000|Overall Study|Lost to Follow-up|4|||
146076006|NCT00395343|526799423|FG001|Overall Study|Lost to Follow-up|4|||
146076007|NCT00395343|526799422|FG000|Overall Study|Physician Decision|2|||
146076008|NCT00395343|526799423|FG001|Overall Study|Physician Decision|4|||
146076009|NCT00395343|526799422|FG000|Overall Study|Protocol Violation|6|||
146076010|NCT00395343|526799423|FG001|Overall Study|Protocol Violation|8|||
146076011|NCT00395343|526799422|FG000|Overall Study|Withdrawal by Subject|11|||
146076012|NCT00395343|526799423|FG001|Overall Study|Withdrawal by Subject|12|||
146076013|NCT00395343|526799422|FG000|Overall Study|Other|5|||
146076014|NCT00395343|526799423|FG001|Overall Study|Other|2|||
146076015|NCT00387790|526799426|FG000|Overall Study|Adverse Event|5|||
146076016|NCT00387790|526799426|FG000|Overall Study|Lack of Efficacy|2|||
146076017|NCT00387790|526799426|FG000|Overall Study|Physician Decision|2|||
146076018|NCT00387790|526799426|FG000|Overall Study|Withdrawal by Subject|3|||
146076019|NCT00387790|526799426|FG000|Overall Study|Ineligible for study|2|||
146076020|NCT01874340|526799427|FG000|Overall Study|Study terminated by Sponsor|6|||
146076021|NCT01874340|526799428|FG001|Overall Study|Study terminated by Sponsor|8|||
146076022|NCT01874340|526799429|FG002|Overall Study|Study terminated by Sponsor|8|||
146076023|NCT01874340|526799430|FG003|Overall Study|Study terminated by Sponsor|4|||
146076024|NCT01874340|526799427|FG000|Overall Study|Withdrawal by Subject|0|||
146076025|NCT01874340|526799428|FG001|Overall Study|Withdrawal by Subject|0|||
146076026|NCT01874340|526799429|FG002|Overall Study|Withdrawal by Subject|0|||
146076027|NCT01874340|526799430|FG003|Overall Study|Withdrawal by Subject|1|||
146076028|NCT03539549|526799431|FG000|Overall Study|Adverse Event|12|||
146076029|NCT03539549|526799431|FG000|Overall Study|Lost to Follow-up|1|||
146076030|NCT03539549|526799431|FG000|Overall Study|Death|2|||
146076031|NCT03539549|526799431|FG000|Overall Study|Progressive Disease|1|||
146076032|NCT03539549|526799431|FG000|Overall Study|Reason not Specified|1|||
146076033|NCT02864862|526799433|FG000|Overall Study|Lost to Follow-up|1|||
146076034|NCT02864862|526799434|FG001|Overall Study|Lost to Follow-up|0|||
146076035|NCT02864862|526799435|FG002|Overall Study|Lost to Follow-up|1|||
146076036|NCT02864862|526799433|FG000|Overall Study|Protocol Violation|0|||
146076037|NCT02864862|526799434|FG001|Overall Study|Protocol Violation|0|||
146076038|NCT02864862|526799435|FG002|Overall Study|Protocol Violation|1|||
146076039|NCT03263702|526799436|FG000|Overall Study|Lost to Follow-up|2|||
146076040|NCT03263702|526799437|FG001|Overall Study|Lost to Follow-up|2|||
146076041|NCT03263702|526799436|FG000|Overall Study|Withdrawal by Subject|1|||
146076042|NCT03263702|526799437|FG001|Overall Study|Withdrawal by Subject|2|||
146411810|NCT00566098|528013949|FG000|Generation of MILs Product|Relapsed|1|||
146411811|NCT00566098|528013949|FG000|Administration of ASCT+MILs|Death|10|||
146411812|NCT00566098|528013949|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
146411813|NCT01690520|528013952|FG000|Overall Study|Death|25|||
146411814|NCT01690520|528013953|FG001|Overall Study|Death|21|||
146411815|NCT01690520|528013952|FG000|Overall Study|Lost to Follow-up|2|||
146411816|NCT01690520|528013953|FG001|Overall Study|Lost to Follow-up|3|||
146411817|NCT01690520|528013952|FG000|Overall Study|Withdrawal by Subject|2|||
146411818|NCT01690520|528013953|FG001|Overall Study|Withdrawal by Subject|0|||
146411819|NCT01690520|528013952|FG000|Overall Study|Relapse|0|||
146411820|NCT01690520|528013953|FG001|Overall Study|Relapse|1|||
146411821|NCT01690520|528013952|FG000|Overall Study|Other|0|||
146411822|NCT01690520|528013953|FG001|Overall Study|Other|1|||
146411823|NCT01690520|528013952|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
146411824|NCT01690520|528013953|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
146411825|NCT00275028|528013954|FG000|Overall Study|Withdrew consent before treatment began|1|||
146411826|NCT00275028|528013954|FG000|Overall Study|Withdrawal by Subject|5|||
146411827|NCT00275028|528013954|FG000|Overall Study|Adverse Event|9|||
146175349|NCT00118898|527154603|FG003|Overall Study|Not compliant with requirements|11|||
146175350|NCT00118898|527154600|FG000|Overall Study|Not able to get to clinic|34|||
146175351|NCT00118898|527154601|FG001|Overall Study|Not able to get to clinic|43|||
146175352|NCT00118898|527154602|FG002|Overall Study|Not able to get to clinic|31|||
146175353|NCT00118898|527154603|FG003|Overall Study|Not able to get to clinic|40|||
146175354|NCT02073097|527154604|FG000|Overall Study|Adverse Event|0|||
146175355|NCT02073097|527154605|FG001|Overall Study|Adverse Event|0|||
146175356|NCT02073097|527154606|FG002|Overall Study|Adverse Event|0|||
146175357|NCT02073097|527154607|FG003|Overall Study|Adverse Event|0|||
146175358|NCT02073097|527154608|FG004|Overall Study|Adverse Event|0|||
146175359|NCT02073097|527154609|FG005|Overall Study|Adverse Event|0|||
146175360|NCT02073097|527154610|FG006|Overall Study|Adverse Event|0|||
146175361|NCT02073097|527154611|FG007|Overall Study|Adverse Event|2|||
146175362|NCT02073097|527154604|FG000|Overall Study|Withdrawal by Subject|0|||
146175363|NCT02073097|527154605|FG001|Overall Study|Withdrawal by Subject|0|||
146175364|NCT02073097|527154606|FG002|Overall Study|Withdrawal by Subject|0|||
146175365|NCT02073097|527154607|FG003|Overall Study|Withdrawal by Subject|0|||
146175366|NCT02073097|527154608|FG004|Overall Study|Withdrawal by Subject|0|||
146175367|NCT02073097|527154609|FG005|Overall Study|Withdrawal by Subject|0|||
146175368|NCT02073097|527154610|FG006|Overall Study|Withdrawal by Subject|0|||
146175369|NCT02073097|527154611|FG007|Overall Study|Withdrawal by Subject|2|||
146175370|NCT02073097|527154604|FG000|Overall Study|Death|0|||
146175371|NCT02073097|527154605|FG001|Overall Study|Death|0|||
146175372|NCT02073097|527154606|FG002|Overall Study|Death|0|||
146175373|NCT02073097|527154607|FG003|Overall Study|Death|0|||
146175374|NCT02073097|527154608|FG004|Overall Study|Death|0|||
146175375|NCT02073097|527154609|FG005|Overall Study|Death|0|||
146175376|NCT02073097|527154610|FG006|Overall Study|Death|0|||
146175377|NCT02073097|527154611|FG007|Overall Study|Death|1|||
146175378|NCT02073097|527154604|FG000|Overall Study|Physician Decision|0|||
146175379|NCT02073097|527154605|FG001|Overall Study|Physician Decision|0|||
146175380|NCT02073097|527154606|FG002|Overall Study|Physician Decision|0|||
146175381|NCT02073097|527154607|FG003|Overall Study|Physician Decision|0|||
146175382|NCT02073097|527154608|FG004|Overall Study|Physician Decision|0|||
146175383|NCT02073097|527154609|FG005|Overall Study|Physician Decision|0|||
146175384|NCT02073097|527154610|FG006|Overall Study|Physician Decision|0|||
146175385|NCT02073097|527154611|FG007|Overall Study|Physician Decision|1|||
146175386|NCT02318719|527156124|FG000|Double-blind Phase|Adverse Event|7|||
146175387|NCT02318719|527156125|FG001|Double-blind Phase|Adverse Event|6|||
146175388|NCT02318719|527156126|FG002|Double-blind Phase|Adverse Event|12|||
146175389|NCT02318719|527156127|FG003|Double-blind Phase|Adverse Event|4|||
146175390|NCT02318719|527156128|FG004|Double-blind Phase|Adverse Event|0|||
146175391|NCT02318719|527156124|FG000|Double-blind Phase|Lack of Efficacy|5|||
146175392|NCT02318719|527156125|FG001|Double-blind Phase|Lack of Efficacy|0|||
146175393|NCT02318719|527156126|FG002|Double-blind Phase|Lack of Efficacy|1|||
146175394|NCT02318719|527156127|FG003|Double-blind Phase|Lack of Efficacy|1|||
146175395|NCT02318719|527156128|FG004|Double-blind Phase|Lack of Efficacy|0|||
146175396|NCT02318719|527156124|FG000|Double-blind Phase|Protocol Violation|0|||
146175397|NCT02318719|527156125|FG001|Double-blind Phase|Protocol Violation|1|||
146175398|NCT02318719|527156126|FG002|Double-blind Phase|Protocol Violation|3|||
146175399|NCT02318719|527156127|FG003|Double-blind Phase|Protocol Violation|0|||
146175400|NCT02318719|527156128|FG004|Double-blind Phase|Protocol Violation|0|||
146175401|NCT02318719|527156124|FG000|Double-blind Phase|Withdrawal by Subject|25|||
146175402|NCT02318719|527156125|FG001|Double-blind Phase|Withdrawal by Subject|7|||
146175403|NCT02318719|527156126|FG002|Double-blind Phase|Withdrawal by Subject|9|||
146175404|NCT02318719|527156127|FG003|Double-blind Phase|Withdrawal by Subject|10|||
146175405|NCT02318719|527156128|FG004|Double-blind Phase|Withdrawal by Subject|0|||
146175406|NCT02318719|527156124|FG000|Double-blind Phase|Other|1|||
146175407|NCT02318719|527156125|FG001|Double-blind Phase|Other|2|||
146175408|NCT02318719|527156126|FG002|Double-blind Phase|Other|0|||
146175409|NCT02318719|527156127|FG003|Double-blind Phase|Other|0|||
146175410|NCT02318719|527156128|FG004|Double-blind Phase|Other|0|||
146175411|NCT02318719|527156124|FG000|Open-label Extension Phase|Adverse Event|0|||
146175412|NCT02318719|527156125|FG001|Open-label Extension Phase|Adverse Event|0|||
146175413|NCT02318719|527156126|FG002|Open-label Extension Phase|Adverse Event|0|||
146076043|NCT03598114|526799438|FG000|Overall Study|Staff turnover/left the program|3|||
146076044|NCT03598114|526799439|FG001|Overall Study|Staff turnover/left the program|39|||
146076045|NCT00689117|526799440|FG000|Overall Study|Adverse Event|6|||
146076046|NCT00689117|526799441|FG001|Overall Study|Adverse Event|0|||
146076047|NCT00689117|526799442|FG002|Overall Study|Adverse Event|5|||
146076048|NCT00689117|526799443|FG003|Overall Study|Adverse Event|0|||
146076049|NCT00689117|526799440|FG000|Overall Study|Lost to Follow-up|26|||
146076050|NCT00689117|526799441|FG001|Overall Study|Lost to Follow-up|19|||
146076051|NCT00689117|526799442|FG002|Overall Study|Lost to Follow-up|17|||
146076052|NCT00689117|526799443|FG003|Overall Study|Lost to Follow-up|11|||
146076053|NCT00689117|526799440|FG000|Overall Study|Lack of Efficacy|1|||
146076054|NCT00689117|526799441|FG001|Overall Study|Lack of Efficacy|2|||
146076055|NCT00689117|526799442|FG002|Overall Study|Lack of Efficacy|2|||
146076056|NCT00689117|526799443|FG003|Overall Study|Lack of Efficacy|2|||
146076057|NCT00689117|526799440|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
146076058|NCT00689117|526799441|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
146076059|NCT00689117|526799442|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
146076060|NCT00689117|526799443|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
146076061|NCT00689117|526799440|FG000|Overall Study|Withdrawal by Subject|19|||
146076062|NCT00689117|526799441|FG001|Overall Study|Withdrawal by Subject|18|||
146076063|NCT00689117|526799442|FG002|Overall Study|Withdrawal by Subject|26|||
146076064|NCT00689117|526799443|FG003|Overall Study|Withdrawal by Subject|13|||
146076065|NCT00689117|526799440|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
146076066|NCT00689117|526799441|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
146076067|NCT00689117|526799442|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
146076068|NCT00689117|526799443|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
146076069|NCT00689117|526799440|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146076070|NCT00689117|526799441|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146076071|NCT00689117|526799442|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146076072|NCT00689117|526799443|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146076073|NCT00689117|526799440|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
146076074|NCT00689117|526799441|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
146076075|NCT00689117|526799442|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
146076076|NCT00689117|526799443|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
146076077|NCT00689117|526799440|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
146076078|NCT00689117|526799441|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
146076079|NCT00689117|526799442|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
146076080|NCT00689117|526799443|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
146076081|NCT00689117|526799440|FG000|Overall Study|Use of Prohibitive Medication|2|||
146076082|NCT00689117|526799441|FG001|Overall Study|Use of Prohibitive Medication|1|||
146076083|NCT00689117|526799442|FG002|Overall Study|Use of Prohibitive Medication|3|||
146076084|NCT00689117|526799443|FG003|Overall Study|Use of Prohibitive Medication|0|||
146076085|NCT00689117|526799440|FG000|Overall Study|Pregnancy|0|||
146076086|NCT00689117|526799441|FG001|Overall Study|Pregnancy|2|||
146076087|NCT00689117|526799442|FG002|Overall Study|Pregnancy|0|||
146076088|NCT00689117|526799443|FG003|Overall Study|Pregnancy|2|||
146076089|NCT00689117|526799440|FG000|Overall Study|Incarceration|2|||
146076090|NCT00689117|526799441|FG001|Overall Study|Incarceration|0|||
146076091|NCT00689117|526799442|FG002|Overall Study|Incarceration|0|||
146076092|NCT00689117|526799443|FG003|Overall Study|Incarceration|0|||
146076093|NCT00689117|526799440|FG000|Overall Study|Fear of Birth Defects|0|||
146076094|NCT00689117|526799441|FG001|Overall Study|Fear of Birth Defects|0|||
146076095|NCT00689117|526799442|FG002|Overall Study|Fear of Birth Defects|1|||
146076096|NCT00689117|526799443|FG003|Overall Study|Fear of Birth Defects|0|||
146076097|NCT00689117|526799440|FG000|Overall Study|Transportation|1|||
146076098|NCT00689117|526799441|FG001|Overall Study|Transportation|0|||
146076099|NCT00689117|526799442|FG002|Overall Study|Transportation|0|||
146076100|NCT00689117|526799443|FG003|Overall Study|Transportation|0|||
146076101|NCT00689117|526799440|FG000|Overall Study|Patient Withdrew from Study|0|||
146076102|NCT00689117|526799441|FG001|Overall Study|Patient Withdrew from Study|0|||
146076103|NCT00689117|526799442|FG002|Overall Study|Patient Withdrew from Study|0|||
146076104|NCT00689117|526799443|FG003|Overall Study|Patient Withdrew from Study|1|||
146076105|NCT00689117|526799440|FG000|Overall Study|Personal Reason|0|||
146076106|NCT00689117|526799441|FG001|Overall Study|Personal Reason|1|||
146076107|NCT00689117|526799442|FG002|Overall Study|Personal Reason|0|||
146076108|NCT00689117|526799443|FG003|Overall Study|Personal Reason|0|||
146175414|NCT02318719|527156127|FG003|Open-label Extension Phase|Adverse Event|0|||
146175415|NCT02318719|527156128|FG004|Open-label Extension Phase|Adverse Event|15|||
146175416|NCT02318719|527156124|FG000|Open-label Extension Phase|Death|0|||
146175417|NCT02318719|527156125|FG001|Open-label Extension Phase|Death|0|||
146175418|NCT02318719|527156126|FG002|Open-label Extension Phase|Death|0|||
146175419|NCT02318719|527156127|FG003|Open-label Extension Phase|Death|0|||
146175420|NCT02318719|527156128|FG004|Open-label Extension Phase|Death|1|||
146175421|NCT02318719|527156124|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
146175422|NCT02318719|527156125|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
146175423|NCT02318719|527156126|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
146175424|NCT02318719|527156127|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
146175425|NCT02318719|527156128|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
146175426|NCT02318719|527156124|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
146175427|NCT02318719|527156125|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
146175428|NCT02318719|527156126|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
146175429|NCT02318719|527156127|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
146175430|NCT02318719|527156128|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
146175431|NCT02318719|527156124|FG000|Open-label Extension Phase|Other|0|||
146175432|NCT02318719|527156125|FG001|Open-label Extension Phase|Other|0|||
146175433|NCT02318719|527156126|FG002|Open-label Extension Phase|Other|0|||
146175434|NCT02318719|527156127|FG003|Open-label Extension Phase|Other|0|||
146175435|NCT02318719|527156128|FG004|Open-label Extension Phase|Other|7|||
146175436|NCT00432835|527156132|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
146175437|NCT00432835|527156133|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
146175438|NCT00289770|527156134|FG000|Year 15|Withdrawal by Subject|1|||
146175439|NCT00423293|527156135|FG000|Overall Study|Ineligible / No protocol treatment|11|||
146175440|NCT05340751|527156144|FG000|Overall Study|Physician Decision|3|||
146175441|NCT03820323|527156145|FG000|Overall Study|Lost to Follow-up|2|||
146175442|NCT03820323|527156146|FG001|Overall Study|Lost to Follow-up|1|||
146175443|NCT03820323|527156145|FG000|Overall Study|Missed 12-month visit|22|||
146175444|NCT03820323|527156146|FG001|Overall Study|Missed 12-month visit|14|||
146175445|NCT03820323|527156145|FG000|Overall Study|Death|2|||
146175446|NCT03820323|527156146|FG001|Overall Study|Death|1|||
146175447|NCT03820323|527156145|FG000|Overall Study|Transferred out|13|||
146175448|NCT03820323|527156146|FG001|Overall Study|Transferred out|11|||
146175449|NCT03820323|527156145|FG000|Overall Study|Terminated|0|||
146175450|NCT03820323|527156146|FG001|Overall Study|Terminated|3|||
146175451|NCT03820323|527156145|FG000|Overall Study|Withdrawal by Subject|1|||
146175452|NCT03820323|527156146|FG001|Overall Study|Withdrawal by Subject|6|||
146175453|NCT03151395|527156147|FG000|Overall Study|Adverse Event|2|||
146175454|NCT03151395|527156147|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
146175455|NCT03151395|527156147|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
146175456|NCT03151395|527156147|FG000|Overall Study|Unspecified reason|4|||
146175457|NCT01003639|527156150|FG000|Overall Study|Lost to Follow-up|6|||
146175458|NCT01003639|527156151|FG001|Overall Study|Lost to Follow-up|9|||
146175459|NCT01003639|527156150|FG000|Overall Study|Withdrawal by Subject|9|||
146175460|NCT01003639|527156151|FG001|Overall Study|Withdrawal by Subject|5|||
146175461|NCT01003639|527156150|FG000|Overall Study|Lack of Efficacy|1|||
146175462|NCT01003639|527156151|FG001|Overall Study|Lack of Efficacy|6|||
146175463|NCT01003639|527156150|FG000|Overall Study|Adverse Event|0|||
146175464|NCT01003639|527156151|FG001|Overall Study|Adverse Event|1|||
146175465|NCT01003639|527156150|FG000|Overall Study|Protocol Violation|0|||
146175466|NCT01003639|527156151|FG001|Overall Study|Protocol Violation|1|||
146175467|NCT01003639|527156150|FG000|Overall Study|Physician Decision|1|||
146175468|NCT01003639|527156151|FG001|Overall Study|Physician Decision|0|||
146175469|NCT00284089|527156154|FG000|Multiple Dose Phase|Adverse Event|1|||
146175470|NCT00284089|527156155|FG001|Multiple Dose Phase|Adverse Event|0|||
146175471|NCT00284089|527156156|FG002|Multiple Dose Phase|Adverse Event|1|||
146175472|NCT00284089|527156157|FG003|Multiple Dose Phase|Adverse Event|1|||
146175473|NCT00284089|527156154|FG000|Multiple Dose Phase|Protocol Violation|0|||
146175474|NCT00284089|527156155|FG001|Multiple Dose Phase|Protocol Violation|0|||
146175475|NCT00284089|527156156|FG002|Multiple Dose Phase|Protocol Violation|1|||
146175476|NCT00284089|527156157|FG003|Multiple Dose Phase|Protocol Violation|0|||
146175477|NCT00284089|527156154|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
146175478|NCT00284089|527156155|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
146175479|NCT00284089|527156156|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
146175480|NCT00284089|527156157|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
146175481|NCT00284089|527156154|FG000|Multiple Dose Phase|Death|0|||
146411828|NCT00275028|528013954|FG000|Overall Study|Progressive Disease|30|||
146411829|NCT00275028|528013954|FG000|Overall Study|Physician Decision|2|||
146411830|NCT01847313|528013957|FG000|Overall Study|Death|0|||
146411831|NCT01847313|528013958|FG001|Overall Study|Death|1|||
146411832|NCT01847313|528013957|FG000|Overall Study|Withdrawal by Subject|0|||
146411833|NCT01847313|528013958|FG001|Overall Study|Withdrawal by Subject|1|||
146411834|NCT00598559|528013960|FG000|Overall Study|Adverse Event|11|||
146411835|NCT00598559|528013961|FG001|Overall Study|Adverse Event|7|||
146411836|NCT00598559|528013962|FG002|Overall Study|Adverse Event|0|||
146175482|NCT00284089|527156155|FG001|Multiple Dose Phase|Death|0|||
146175483|NCT00284089|527156156|FG002|Multiple Dose Phase|Death|1|||
146175484|NCT00284089|527156157|FG003|Multiple Dose Phase|Death|1|||
146175485|NCT00284089|527156154|FG000|Extension Phase|Adverse Event|0|||
146175486|NCT00284089|527156155|FG001|Extension Phase|Adverse Event|0|||
146175487|NCT00284089|527156156|FG002|Extension Phase|Adverse Event|2|||
146175488|NCT00284089|527156157|FG003|Extension Phase|Adverse Event|2|||
146175489|NCT00284089|527156154|FG000|Extension Phase|condition no longer requires study drug|2|||
146175490|NCT00284089|527156155|FG001|Extension Phase|condition no longer requires study drug|0|||
146175491|NCT00284089|527156156|FG002|Extension Phase|condition no longer requires study drug|2|||
146175492|NCT00284089|527156157|FG003|Extension Phase|condition no longer requires study drug|7|||
146175493|NCT00284089|527156154|FG000|Extension Phase|Protocol Violation|0|||
146175494|NCT00284089|527156155|FG001|Extension Phase|Protocol Violation|0|||
146175495|NCT00284089|527156156|FG002|Extension Phase|Protocol Violation|1|||
146175496|NCT00284089|527156157|FG003|Extension Phase|Protocol Violation|0|||
146175497|NCT00284089|527156154|FG000|Extension Phase|Withdrawal by Subject|0|||
146175498|NCT00284089|527156155|FG001|Extension Phase|Withdrawal by Subject|0|||
146175499|NCT00284089|527156156|FG002|Extension Phase|Withdrawal by Subject|1|||
146175500|NCT00284089|527156157|FG003|Extension Phase|Withdrawal by Subject|3|||
146175501|NCT02494206|527156171|FG000|Overall Study|Adverse Event|1|||
146175502|NCT02494206|527156171|FG000|Overall Study|Disease Progression|1|||
146175503|NCT04986982|527156174|FG000|Overall Study|Withdrawal by Subject|3|||
146175504|NCT04986982|527156175|FG001|Overall Study|Withdrawal by Subject|1|||
146175505|NCT04986982|527156174|FG000|Overall Study|Lack of Efficacy|0|||
146175506|NCT04986982|527156175|FG001|Overall Study|Lack of Efficacy|2|||
146175507|NCT04986982|527156174|FG000|Overall Study|Ineligibility|3|||
146175508|NCT04986982|527156175|FG001|Overall Study|Ineligibility|0|||
146175509|NCT04986982|527156174|FG000|Overall Study|Adverse Event|4|||
146175510|NCT04986982|527156175|FG001|Overall Study|Adverse Event|4|||
146175511|NCT04986982|527156174|FG000|Overall Study|Lost to Follow-up|0|||
146175512|NCT04986982|527156175|FG001|Overall Study|Lost to Follow-up|1|||
146175513|NCT04986982|527156174|FG000|Overall Study|Sponsor's discretion|1|||
146175514|NCT04986982|527156175|FG001|Overall Study|Sponsor's discretion|0|||
146175515|NCT05796518|527156176|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
146175516|NCT01535274|527156177|FG000|Overall Study|Determined to be ineligible|0|||
146175517|NCT01535274|527156178|FG001|Overall Study|Determined to be ineligible|1|||
146175518|NCT01535274|527156177|FG000|Overall Study|Misallocated to propofol intervention|0|||
146175519|NCT01535274|527156178|FG001|Overall Study|Misallocated to propofol intervention|1|||
146175520|NCT03679767|527156179|FG000|Overall Study|Death|16|||
146175521|NCT03679767|527156180|FG001|Overall Study|Death|11|||
146175522|NCT03679767|527156181|FG002|Overall Study|Death|17|||
146175523|NCT03679767|527156182|FG003|Overall Study|Death|10|||
146411837|NCT00598559|528013960|FG000|Overall Study|Withdrawal by Subject|2|||
146411838|NCT00598559|528013961|FG001|Overall Study|Withdrawal by Subject|2|||
146411839|NCT00598559|528013962|FG002|Overall Study|Withdrawal by Subject|0|||
146411840|NCT00598559|528013960|FG000|Overall Study|Protocol Non-compliance|1|||
146411841|NCT00598559|528013961|FG001|Overall Study|Protocol Non-compliance|0|||
146411842|NCT00598559|528013962|FG002|Overall Study|Protocol Non-compliance|0|||
146411843|NCT00598559|528013960|FG000|Overall Study|Early discharge from hospital|9|||
146411844|NCT00598559|528013961|FG001|Overall Study|Early discharge from hospital|12|||
146411845|NCT00598559|528013962|FG002|Overall Study|Early discharge from hospital|3|||
146411846|NCT00598559|528013960|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
146411847|NCT00598559|528013961|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
146411848|NCT00598559|528013962|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
146411849|NCT02762565|528013963|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
146411850|NCT03549130|528013964|FG000|Overall Study|Adverse Event|0|||
146411851|NCT03549130|528013965|FG001|Overall Study|Adverse Event|1|||
146411852|NCT03549130|528013964|FG000|Overall Study|Lost to Follow-up|0|||
146411853|NCT03549130|528013965|FG001|Overall Study|Lost to Follow-up|1|||
146411854|NCT01113710|528013966|FG000|Overall Study|Adverse Event|64|||
146411855|NCT01113710|528013966|FG000|Overall Study|Lack of Efficacy|41|||
146411856|NCT01113710|528013966|FG000|Overall Study|No Information Available|40|||
146411857|NCT01113710|528013966|FG000|Overall Study|Withdrawal by Subject|28|||
146411858|NCT01113710|528013966|FG000|Overall Study|Lost to Follow-up|20|||
146411859|NCT01113710|528013966|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
146411860|NCT01113710|528013966|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
146411861|NCT01113710|528013966|FG000|Overall Study|Lack of Patient's Compliance|8|||
146411862|NCT01113710|528013966|FG000|Overall Study|Other|7|||
146411863|NCT01113710|528013966|FG000|Overall Study|Adverse Event/Other|5|||
146411864|NCT01113710|528013966|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
146411865|NCT01113710|528013966|FG000|Overall Study|Lack of Efficacy/Other|4|||
146411866|NCT01113710|528013966|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
146411867|NCT01113710|528013966|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
146411868|NCT01113710|528013966|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
146411869|NCT01113710|528013966|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
146076109|NCT00689117|526799440|FG000|Overall Study|Dispensing Error|0|||
146076110|NCT00689117|526799441|FG001|Overall Study|Dispensing Error|1|||
146076111|NCT00689117|526799442|FG002|Overall Study|Dispensing Error|0|||
146076112|NCT00689117|526799443|FG003|Overall Study|Dispensing Error|0|||
146076113|NCT01206322|526799444|FG000|Overall Study|Adverse Event|0|||
146076114|NCT01206322|526799445|FG001|Overall Study|Adverse Event|0|||
146076115|NCT01206322|526799446|FG002|Overall Study|Adverse Event|0|||
146076116|NCT01206322|526799447|FG003|Overall Study|Adverse Event|1|||
146076117|NCT00444678|526799448|FG000|Overall Study|Toxicity|11|||
146076118|NCT00444678|526799448|FG000|Overall Study|Disease Progression|12|||
146076119|NCT00444678|526799448|FG000|Overall Study|Death|3|||
146411870|NCT01113710|528013966|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
146411871|NCT01113710|528013966|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
146411872|NCT01113710|528013966|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
146411873|NCT01113710|528013966|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
146411874|NCT01113710|528013966|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
146411875|NCT01113710|528013966|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
146411876|NCT01113710|528013966|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
146411877|NCT01113710|528013966|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
146411878|NCT01113710|528013966|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
146411879|NCT01078623|528013968|FG000|Treatment Period 1|Adverse Event|1|||
146411880|NCT01078623|528013969|FG001|Treatment Period 1|Adverse Event|1|||
146411881|NCT01078623|528013970|FG002|Treatment Period 1|Adverse Event|1|||
146411882|NCT01078623|528013971|FG003|Treatment Period 1|Adverse Event|0|||
146411883|NCT01078623|528013972|FG004|Treatment Period 1|Adverse Event|0|||
146411884|NCT01078623|528013973|FG005|Treatment Period 1|Adverse Event|0|||
146411885|NCT01078623|528013974|FG006|Treatment Period 1|Adverse Event|1|||
146411886|NCT01078623|528013975|FG007|Treatment Period 1|Adverse Event|0|||
146411887|NCT01078623|528013976|FG008|Treatment Period 1|Adverse Event|1|||
146411888|NCT01078623|528013977|FG009|Treatment Period 1|Adverse Event|1|||
146411889|NCT01078623|528013978|FG010|Treatment Period 1|Adverse Event|0|||
146411890|NCT01078623|528013979|FG011|Treatment Period 1|Adverse Event|0|||
146411891|NCT01078623|528013980|FG012|Treatment Period 1|Adverse Event|0|||
146411892|NCT01078623|528013981|FG013|Treatment Period 1|Adverse Event|0|||
146411893|NCT01078623|528013982|FG014|Treatment Period 1|Adverse Event|0|||
146411894|NCT01078623|528013983|FG015|Treatment Period 1|Adverse Event|0|||
146411895|NCT01078623|528013984|FG016|Treatment Period 1|Adverse Event|0|||
146411896|NCT01078623|528013985|FG017|Treatment Period 1|Adverse Event|0|||
146411897|NCT01078623|528013986|FG018|Treatment Period 1|Adverse Event|0|||
146411898|NCT01078623|528013987|FG019|Treatment Period 1|Adverse Event|0|||
146411899|NCT01078623|528013968|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146411900|NCT01078623|528013969|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146411901|NCT01078623|528013970|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146411902|NCT01078623|528013971|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146411903|NCT01078623|528013972|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146411904|NCT01078623|528013973|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146411905|NCT01078623|528013974|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146411906|NCT01078623|528013975|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146411907|NCT01078623|528013976|FG008|Treatment Period 1|Withdrawal by Subject|0|||
146411908|NCT01078623|528013977|FG009|Treatment Period 1|Withdrawal by Subject|0|||
146411909|NCT01078623|528013978|FG010|Treatment Period 1|Withdrawal by Subject|1|||
146411910|NCT01078623|528013979|FG011|Treatment Period 1|Withdrawal by Subject|0|||
146411911|NCT01078623|528013980|FG012|Treatment Period 1|Withdrawal by Subject|0|||
146411912|NCT01078623|528013981|FG013|Treatment Period 1|Withdrawal by Subject|0|||
146411913|NCT01078623|528013982|FG014|Treatment Period 1|Withdrawal by Subject|0|||
146411914|NCT01078623|528013983|FG015|Treatment Period 1|Withdrawal by Subject|0|||
146411915|NCT01078623|528013984|FG016|Treatment Period 1|Withdrawal by Subject|0|||
146411916|NCT01078623|528013985|FG017|Treatment Period 1|Withdrawal by Subject|0|||
146411917|NCT01078623|528013986|FG018|Treatment Period 1|Withdrawal by Subject|0|||
146411918|NCT01078623|528013987|FG019|Treatment Period 1|Withdrawal by Subject|0|||
146411919|NCT01078623|528013968|FG000|Treatment Period 1|Protocol Violation|0|||
146411920|NCT01078623|528013969|FG001|Treatment Period 1|Protocol Violation|0|||
146411921|NCT01078623|528013970|FG002|Treatment Period 1|Protocol Violation|0|||
146411922|NCT01078623|528013971|FG003|Treatment Period 1|Protocol Violation|0|||
146411923|NCT01078623|528013972|FG004|Treatment Period 1|Protocol Violation|0|||
146411924|NCT01078623|528013973|FG005|Treatment Period 1|Protocol Violation|1|||
146411925|NCT01078623|528013974|FG006|Treatment Period 1|Protocol Violation|0|||
146411926|NCT01078623|528013975|FG007|Treatment Period 1|Protocol Violation|0|||
146411927|NCT01078623|528013976|FG008|Treatment Period 1|Protocol Violation|0|||
146411928|NCT01078623|528013977|FG009|Treatment Period 1|Protocol Violation|0|||
146411929|NCT01078623|528013978|FG010|Treatment Period 1|Protocol Violation|0|||
146411930|NCT01078623|528013979|FG011|Treatment Period 1|Protocol Violation|0|||
146411931|NCT01078623|528013980|FG012|Treatment Period 1|Protocol Violation|0|||
146411932|NCT01078623|528013981|FG013|Treatment Period 1|Protocol Violation|0|||
146411933|NCT01078623|528013982|FG014|Treatment Period 1|Protocol Violation|0|||
146411934|NCT01078623|528013983|FG015|Treatment Period 1|Protocol Violation|0|||
146411935|NCT01078623|528013984|FG016|Treatment Period 1|Protocol Violation|0|||
146175524|NCT03679767|527156179|FG000|Overall Study|Lost to Follow-up|1|||
146175525|NCT03679767|527156180|FG001|Overall Study|Lost to Follow-up|1|||
146175526|NCT03679767|527156181|FG002|Overall Study|Lost to Follow-up|1|||
146175527|NCT03679767|527156182|FG003|Overall Study|Lost to Follow-up|1|||
146175528|NCT03679767|527156179|FG000|Overall Study|Withdrawal by Subject|0|||
146175529|NCT03679767|527156180|FG001|Overall Study|Withdrawal by Subject|0|||
146175530|NCT03679767|527156181|FG002|Overall Study|Withdrawal by Subject|0|||
146175531|NCT03679767|527156182|FG003|Overall Study|Withdrawal by Subject|1|||
146175532|NCT03679767|527156179|FG000|Overall Study|Follow-up Completed|18|||
146175533|NCT03679767|527156180|FG001|Overall Study|Follow-up Completed|11|||
146175534|NCT03679767|527156181|FG002|Overall Study|Follow-up Completed|11|||
146175535|NCT03679767|527156182|FG003|Overall Study|Follow-up Completed|20|||
146175536|NCT03679767|527156179|FG000|Overall Study|Entered Hospice Care|0|||
146175537|NCT03679767|527156180|FG001|Overall Study|Entered Hospice Care|0|||
146175538|NCT03679767|527156181|FG002|Overall Study|Entered Hospice Care|0|||
146175539|NCT03679767|527156182|FG003|Overall Study|Entered Hospice Care|1|||
146175540|NCT03679767|527156179|FG000|Overall Study|Progressive Disease|0|||
146175541|NCT03679767|527156180|FG001|Overall Study|Progressive Disease|0|||
146175542|NCT03679767|527156181|FG002|Overall Study|Progressive Disease|0|||
146175543|NCT03679767|527156182|FG003|Overall Study|Progressive Disease|1|||
146175544|NCT02690077|527156183|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
146175545|NCT02690077|527156184|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
146175546|NCT02690077|527156183|FG000|Overall Study|Withdrawal by Subject|0|||
146175547|NCT02690077|527156184|FG001|Overall Study|Withdrawal by Subject|5|||
146175548|NCT02690077|527156183|FG000|Overall Study|Excluded by IRB|0|||
146175549|NCT02690077|527156184|FG001|Overall Study|Excluded by IRB|2|||
146175550|NCT05229653|527156185|FG000|Overall Study|Lost to Follow-up|1|||
146175551|NCT05229653|527156186|FG001|Overall Study|Lost to Follow-up|0|||
146175552|NCT01845974|527156187|FG000|Overall Study|screen failure|1|||
146175553|NCT01845974|527156188|FG001|Overall Study|screen failure|0|||
146175554|NCT02667886|527156189|FG000|Dose Escalation (Part A)|Adverse Event|1|||
146175555|NCT02667886|527156190|FG001|Dose Escalation (Part A)|Adverse Event|3|||
146175556|NCT02667886|527156191|FG002|Dose Escalation (Part A)|Adverse Event|1|||
146175557|NCT02667886|527156192|FG003|Dose Escalation (Part A)|Adverse Event|0|||
146175558|NCT02667886|527156193|FG004|Dose Escalation (Part A)|Adverse Event|0|||
146175559|NCT02667886|527156189|FG000|Dose Escalation (Part A)|Disease Progression|1|||
146411936|NCT01078623|528013985|FG017|Treatment Period 1|Protocol Violation|0|||
146411937|NCT01078623|528013986|FG018|Treatment Period 1|Protocol Violation|0|||
146411938|NCT01078623|528013987|FG019|Treatment Period 1|Protocol Violation|0|||
146411939|NCT01078623|528013968|FG000|Treatment Period 2|Adverse Event|0|||
146411940|NCT01078623|528013969|FG001|Treatment Period 2|Adverse Event|0|||
146411941|NCT01078623|528013970|FG002|Treatment Period 2|Adverse Event|0|||
146411942|NCT01078623|528013971|FG003|Treatment Period 2|Adverse Event|0|||
146411943|NCT01078623|528013972|FG004|Treatment Period 2|Adverse Event|0|||
146411944|NCT01078623|528013973|FG005|Treatment Period 2|Adverse Event|0|||
146411945|NCT01078623|528013974|FG006|Treatment Period 2|Adverse Event|1|||
146411946|NCT01078623|528013975|FG007|Treatment Period 2|Adverse Event|0|||
146411947|NCT01078623|528013976|FG008|Treatment Period 2|Adverse Event|0|||
146411948|NCT01078623|528013977|FG009|Treatment Period 2|Adverse Event|0|||
146411949|NCT01078623|528013978|FG010|Treatment Period 2|Adverse Event|0|||
146411950|NCT01078623|528013979|FG011|Treatment Period 2|Adverse Event|0|||
146411951|NCT01078623|528013980|FG012|Treatment Period 2|Adverse Event|0|||
146411952|NCT01078623|528013981|FG013|Treatment Period 2|Adverse Event|0|||
146411953|NCT01078623|528013982|FG014|Treatment Period 2|Adverse Event|0|||
146411954|NCT01078623|528013983|FG015|Treatment Period 2|Adverse Event|0|||
146411955|NCT01078623|528013984|FG016|Treatment Period 2|Adverse Event|0|||
146411956|NCT01078623|528013985|FG017|Treatment Period 2|Adverse Event|0|||
146411957|NCT01078623|528013986|FG018|Treatment Period 2|Adverse Event|1|||
146411958|NCT01078623|528013987|FG019|Treatment Period 2|Adverse Event|0|||
146411959|NCT01078623|528013968|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146411960|NCT01078623|528013969|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146411961|NCT01078623|528013970|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146411962|NCT01078623|528013971|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146175560|NCT02667886|527156190|FG001|Dose Escalation (Part A)|Disease Progression|4|||
146175561|NCT02667886|527156191|FG002|Dose Escalation (Part A)|Disease Progression|3|||
146175562|NCT02667886|527156192|FG003|Dose Escalation (Part A)|Disease Progression|0|||
146175563|NCT02667886|527156193|FG004|Dose Escalation (Part A)|Disease Progression|0|||
146175564|NCT02667886|527156189|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146175565|NCT02667886|527156190|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146175566|NCT02667886|527156191|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
146283917|NCT00935818|527551900|FG000|Overall Study|Withdrawal by Subject|45|||
146411963|NCT01078623|528013972|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146411964|NCT01078623|528013973|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146411965|NCT01078623|528013974|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146411966|NCT01078623|528013975|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146411967|NCT01078623|528013976|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146076120|NCT00444678|526799448|FG000|Overall Study|Physician Decision|3|||
146076121|NCT00444678|526799448|FG000|Overall Study|Withdrawal by Subject|2|||
146076122|NCT00329797|526799452|FG000|Overall Study|Protocol Violation|1|||
146076123|NCT00329797|526799453|FG001|Overall Study|Protocol Violation|0|||
146076124|NCT00329797|526799452|FG000|Overall Study|Withdrawal by Subject|6|||
146076125|NCT00329797|526799453|FG001|Overall Study|Withdrawal by Subject|6|||
146076126|NCT01761240|526799462|FG000|Overall Study|Progressive disease:radiology assessment|3|||
146076127|NCT01761240|526799463|FG001|Overall Study|Progressive disease:radiology assessment|3|||
146076128|NCT01761240|526799464|FG002|Overall Study|Progressive disease:radiology assessment|0|||
146076129|NCT01761240|526799465|FG003|Overall Study|Progressive disease:radiology assessment|0|||
146076130|NCT01761240|526799466|FG004|Overall Study|Progressive disease:radiology assessment|0|||
146076131|NCT01761240|526799462|FG000|Overall Study|Progressive disease:clinical assessment|0|||
146076132|NCT01761240|526799463|FG001|Overall Study|Progressive disease:clinical assessment|0|||
146076133|NCT01761240|526799464|FG002|Overall Study|Progressive disease:clinical assessment|3|||
146076134|NCT01761240|526799465|FG003|Overall Study|Progressive disease:clinical assessment|1|||
146076135|NCT01761240|526799466|FG004|Overall Study|Progressive disease:clinical assessment|0|||
146076136|NCT01761240|526799462|FG000|Overall Study|Withdrawal by Subject|0|||
146076137|NCT01761240|526799463|FG001|Overall Study|Withdrawal by Subject|0|||
146076138|NCT01761240|526799464|FG002|Overall Study|Withdrawal by Subject|0|||
146076139|NCT01761240|526799465|FG003|Overall Study|Withdrawal by Subject|3|||
146076140|NCT01761240|526799466|FG004|Overall Study|Withdrawal by Subject|1|||
146076141|NCT01761240|526799462|FG000|Overall Study|Adverse Event|0|||
146076142|NCT01761240|526799463|FG001|Overall Study|Adverse Event|0|||
146076143|NCT01761240|526799464|FG002|Overall Study|Adverse Event|0|||
146076144|NCT01761240|526799465|FG003|Overall Study|Adverse Event|1|||
146076145|NCT01761240|526799466|FG004|Overall Study|Adverse Event|6|||
146076146|NCT01761240|526799462|FG000|Overall Study|Death|0|||
146076147|NCT01761240|526799463|FG001|Overall Study|Death|1|||
146076148|NCT01761240|526799464|FG002|Overall Study|Death|1|||
146076149|NCT01761240|526799465|FG003|Overall Study|Death|2|||
146076150|NCT01761240|526799466|FG004|Overall Study|Death|1|||
146076151|NCT01761240|526799462|FG000|Overall Study|Non-compliance|0|||
146076152|NCT01761240|526799463|FG001|Overall Study|Non-compliance|0|||
146076153|NCT01761240|526799464|FG002|Overall Study|Non-compliance|1|||
146076154|NCT01761240|526799465|FG003|Overall Study|Non-compliance|0|||
146076155|NCT01761240|526799466|FG004|Overall Study|Non-compliance|0|||
146076156|NCT02055118|526799472|FG000|Overall Study|Withdrawal by Subject|0|||
146076157|NCT02055118|526799473|FG001|Overall Study|Withdrawal by Subject|2|||
146076158|NCT02055118|526799474|FG002|Overall Study|Withdrawal by Subject|0|||
146076159|NCT02281383|526799476|FG000|Overall Study|Progressive Disease|1|||
146076160|NCT02281383|526799476|FG000|Overall Study|Withdrawal by Subject|6|||
146076161|NCT02281383|526799476|FG000|Overall Study|Protocol Violation|2|||
146076162|NCT02281383|526799476|FG000|Overall Study|Death|1|||
146076163|NCT02281383|526799476|FG000|Overall Study|Adverse Event|2|||
146076164|NCT01215097|526799478|FG000|Overall Study|Adverse Event|1|||
146076165|NCT01215097|526799479|FG001|Overall Study|Adverse Event|3|||
146076166|NCT01215097|526799478|FG000|Overall Study|Protocol Violation|0|||
146076167|NCT01215097|526799479|FG001|Overall Study|Protocol Violation|2|||
146076168|NCT01215097|526799478|FG000|Overall Study|Lost to Follow-up|2|||
146076169|NCT01215097|526799479|FG001|Overall Study|Lost to Follow-up|0|||
146076170|NCT01215097|526799478|FG000|Overall Study|Withdrawal by Subject|6|||
146076171|NCT01215097|526799479|FG001|Overall Study|Withdrawal by Subject|3|||
146076172|NCT01215097|526799478|FG000|Overall Study|Lack of Efficacy|0|||
146076173|NCT01215097|526799479|FG001|Overall Study|Lack of Efficacy|3|||
146076174|NCT01215097|526799478|FG000|Overall Study|patient's refusal to come|2|||
146076175|NCT01215097|526799479|FG001|Overall Study|patient's refusal to come|2|||
146076176|NCT01215097|526799478|FG000|Overall Study|patient's private reason|1|||
146076177|NCT01215097|526799479|FG001|Overall Study|patient's private reason|1|||
146076178|NCT02252939|526799481|FG000|Overall Study|Lost to Follow-up|3|||
146076179|NCT01516034|526799482|FG000|Overall Study|Physician Decision|1|||
146076180|NCT01516034|526799482|FG000|Overall Study|Lack of Efficacy|7|||
146076181|NCT01033448|526799483|FG000|Overall Study|Withdrawal by Subject|4|||
146076182|NCT01033448|526799483|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
146076183|NCT01033448|526799483|FG000|Overall Study|Lost to Follow-up|3|||
146076184|NCT01033448|526799483|FG000|Overall Study|Withdrew due to other reasons|3|||
146076185|NCT01033448|526799483|FG000|Overall Study|Unknown disposition|1|||
146076186|NCT02560025|526799489|FG000|Overall Study|Ineligible after consent/ registration|3|||
146076187|NCT02703337|526799490|FG000|Period One (Part A)|Withdrawal by Subject|0|||
146076188|NCT02703337|526799491|FG001|Period One (Part A)|Withdrawal by Subject|0|||
146076189|NCT02703337|526799492|FG002|Period One (Part A)|Withdrawal by Subject|0|||
146076190|NCT02703337|526799493|FG003|Period One (Part A)|Withdrawal by Subject|0|||
146076191|NCT02703337|526799494|FG004|Period One (Part A)|Withdrawal by Subject|1|||
146076192|NCT02703337|526799495|FG005|Period One (Part A)|Withdrawal by Subject|0|||
146076193|NCT02703337|526799496|FG006|Period One (Part A)|Withdrawal by Subject|0|||
146076194|NCT02703337|526799497|FG007|Period One (Part A)|Withdrawal by Subject|0|||
146076195|NCT00282308|526799504|FG000|Treatment Period|Lost to Follow-up|1|||
146076196|NCT00282308|526799505|FG001|Treatment Period|Lost to Follow-up|0|||
146076197|NCT00282308|526799506|FG002|Treatment Period|Lost to Follow-up|0|||
146076198|NCT00282308|526799504|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
146076199|NCT00282308|526799505|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
146076200|NCT00282308|526799506|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
146076201|NCT00282308|526799504|FG000|Treatment Period|Adverse Event|0|||
146076202|NCT00282308|526799505|FG001|Treatment Period|Adverse Event|2|||
146076203|NCT00282308|526799506|FG002|Treatment Period|Adverse Event|0|||
146076204|NCT00282308|526799504|FG000|Treatment Period|Not Treated with Study Drug|1|||
146076205|NCT00282308|526799505|FG001|Treatment Period|Not Treated with Study Drug|0|||
146076206|NCT00282308|526799506|FG002|Treatment Period|Not Treated with Study Drug|0|||
146076207|NCT00282308|526799504|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
146076208|NCT00282308|526799505|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
146076209|NCT00282308|526799506|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
146076210|NCT00282308|526799504|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
146076211|NCT00282308|526799505|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
146076212|NCT00282308|526799506|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
146076213|NCT00282308|526799504|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
146076214|NCT00282308|526799505|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
146076215|NCT00282308|526799506|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
146076216|NCT00282308|526799504|FG000|Safety Follow-up Period|Adverse Event|0|||
146076217|NCT00282308|526799505|FG001|Safety Follow-up Period|Adverse Event|0|||
146076218|NCT00282308|526799506|FG002|Safety Follow-up Period|Adverse Event|1|||
146076219|NCT00282308|526799504|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
146076220|NCT00282308|526799505|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146076221|NCT00282308|526799506|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
146076222|NCT00282308|526799504|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
146076223|NCT00282308|526799505|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
146076224|NCT00282308|526799506|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
146076225|NCT00282308|526799504|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
146076226|NCT00282308|526799505|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
146076227|NCT00282308|526799506|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
146076228|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
146076229|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146076230|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146076231|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146076232|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
146076233|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
146076234|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
146076235|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
146076236|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
146076237|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
146076238|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
146076239|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146076240|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146076241|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146076242|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
146076243|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
146076244|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
146076245|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
146076246|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
146076247|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
146076248|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
146076249|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146076250|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146076251|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146076252|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
146076253|NCT01584440|526799508|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146076254|NCT01584440|526799509|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
146076255|NCT01584440|526799510|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146076256|NCT01584440|526799511|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146076257|NCT01584440|526799512|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
146076258|NCT01584440|526799508|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146175567|NCT02667886|527156192|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146175568|NCT02667886|527156193|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
146175569|NCT02667886|527156189|FG000|Dose Expansion (Part B)|Adverse Event|0|||
146175570|NCT02667886|527156190|FG001|Dose Expansion (Part B)|Adverse Event|0|||
146175571|NCT02667886|527156191|FG002|Dose Expansion (Part B)|Adverse Event|0|||
146175572|NCT02667886|527156192|FG003|Dose Expansion (Part B)|Adverse Event|9|||
146175573|NCT02667886|527156193|FG004|Dose Expansion (Part B)|Adverse Event|0|||
146175574|NCT02667886|527156189|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
146175575|NCT02667886|527156190|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
146175576|NCT02667886|527156191|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
146175577|NCT02667886|527156192|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
146175578|NCT02667886|527156193|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
146175579|NCT02667886|527156189|FG000|Dose Expansion (Part B)|Disease Progression|0|||
146175580|NCT02667886|527156190|FG001|Dose Expansion (Part B)|Disease Progression|0|||
146175581|NCT02667886|527156191|FG002|Dose Expansion (Part B)|Disease Progression|0|||
146175582|NCT02667886|527156192|FG003|Dose Expansion (Part B)|Disease Progression|38|||
146175583|NCT02667886|527156193|FG004|Dose Expansion (Part B)|Disease Progression|0|||
146175584|NCT02667886|527156189|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146175585|NCT02667886|527156190|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146175586|NCT02667886|527156191|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146175587|NCT02667886|527156192|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
146175588|NCT02667886|527156193|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
146175589|NCT02667886|527156189|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146283918|NCT00935818|527551901|FG001|Overall Study|Withdrawal by Subject|50|||
146076259|NCT01584440|526799509|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146076260|NCT01584440|526799510|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
146076261|NCT01584440|526799511|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
146076262|NCT01584440|526799512|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
146076263|NCT01584440|526799508|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
146076264|NCT01584440|526799509|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
146076265|NCT01584440|526799510|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
146076266|NCT01584440|526799511|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
146076267|NCT01584440|526799512|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
146076268|NCT01584440|526799508|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146076269|NCT01584440|526799509|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146076270|NCT01584440|526799510|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
146076271|NCT01584440|526799511|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146076272|NCT01584440|526799512|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
146076273|NCT04237116|526799513|FG000|Overall Study|Adverse Event|0|||
146076274|NCT04237116|526799514|FG001|Overall Study|Adverse Event|1|||
146076275|NCT04237116|526799513|FG000|Overall Study|Study terminated by Sponsor|4|||
146076276|NCT04237116|526799514|FG001|Overall Study|Study terminated by Sponsor|1|||
146076277|NCT00899431|526799515|FG000|Overall Study|Physician Decision|1|||
146076278|NCT00899431|526799516|FG001|Overall Study|Physician Decision|0|||
146076279|NCT00899431|526799517|FG002|Overall Study|Physician Decision|0|||
146076280|NCT03212144|526799518|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
146076281|NCT03212144|526799519|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
146076282|NCT03212144|526799518|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
146076283|NCT03212144|526799519|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
146076284|NCT00661427|526799520|FG000|Overall Study|Adverse Event|5|||
146076285|NCT00661427|526799521|FG001|Overall Study|Adverse Event|5|||
146076286|NCT00661427|526799520|FG000|Overall Study|Patient not treated|0|||
146076287|NCT00661427|526799521|FG001|Overall Study|Patient not treated|2|||
146076288|NCT00599339|526799522|FG000|Overall Study|Adverse Event|79|||
146076289|NCT00599339|526799522|FG000|Overall Study|Withdrawal by Subject|137|||
146076290|NCT00599339|526799522|FG000|Overall Study|Other Reason|179|||
146076291|NCT00599339|526799522|FG000|Overall Study|Lost to Follow-up|221|||
146076292|NCT00599339|526799522|FG000|Overall Study|No valid data consent|36|||
146076293|NCT00599339|526799522|FG000|Overall Study|Study Termination Status Unknown|12|||
146076294|NCT05564052|526799523|FG000|Overall Study|Withdrawal by Subject|0|||
146076295|NCT05564052|526799524|FG001|Overall Study|Withdrawal by Subject|0|||
146076296|NCT05564052|526799525|FG002|Overall Study|Withdrawal by Subject|0|||
146076297|NCT05564052|526799526|FG003|Overall Study|Withdrawal by Subject|1|||
146076298|NCT01821560|526799527|FG000|Overall Study|Lost to Follow-up|5|||
146076299|NCT01821560|526799528|FG001|Overall Study|Lost to Follow-up|5|||
146076300|NCT01821560|526799527|FG000|Overall Study|Withdrawal by Subject|1|||
146076301|NCT01821560|526799528|FG001|Overall Study|Withdrawal by Subject|1|||
146076302|NCT01821560|526799527|FG000|Overall Study|Protocol Violation|0|||
146076303|NCT01821560|526799528|FG001|Overall Study|Protocol Violation|1|||
146076304|NCT00531427|526799529|FG000|Overall Study|Withdrawal by Subject|7|||
146076305|NCT00531427|526799530|FG001|Overall Study|Withdrawal by Subject|13|||
146076306|NCT00531427|526799529|FG000|Overall Study|Adverse Event|44|||
146076307|NCT00531427|526799530|FG001|Overall Study|Adverse Event|30|||
146076308|NCT00531427|526799529|FG000|Overall Study|Lost to Follow-up|4|||
146076309|NCT00531427|526799530|FG001|Overall Study|Lost to Follow-up|3|||
146076310|NCT00531427|526799529|FG000|Overall Study|Lack of Efficacy|14|||
146076311|NCT00531427|526799530|FG001|Overall Study|Lack of Efficacy|39|||
146076312|NCT00531427|526799529|FG000|Overall Study|Administrative|4|||
146076313|NCT00531427|526799530|FG001|Overall Study|Administrative|9|||
146076314|NCT01338298|526799531|FG000|Overall Study|Withdrawal by Subject|1|||
146076315|NCT01338298|526799532|FG001|Overall Study|Withdrawal by Subject|1|||
146076316|NCT01338298|526799531|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
146076317|NCT01338298|526799532|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
146076318|NCT01338298|526799531|FG000|Overall Study|Administrative error|0|||
146076319|NCT01338298|526799532|FG001|Overall Study|Administrative error|1|||
146076320|NCT01338298|526799531|FG000|Overall Study|Positive symptom worsening|1|||
146175590|NCT02667886|527156190|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146283919|NCT00935818|527551900|FG000|Overall Study|Lost to Follow-up|40|||
146076321|NCT01338298|526799532|FG001|Overall Study|Positive symptom worsening|0|||
146076322|NCT01338298|526799531|FG000|Overall Study|Depressive symptoms and nausea|1|||
146076323|NCT01338298|526799532|FG001|Overall Study|Depressive symptoms and nausea|0|||
146076324|NCT01338298|526799531|FG000|Overall Study|Non-adherence|1|||
146076325|NCT01338298|526799532|FG001|Overall Study|Non-adherence|0|||
146076326|NCT02872285|526799533|FG000|Overall Study|Withdrawal by Subject|2|||
146076327|NCT02872285|526799534|FG001|Overall Study|Withdrawal by Subject|0|||
146076328|NCT02872285|526799533|FG000|Overall Study|Lost to Follow-up|2|||
146076329|NCT02872285|526799534|FG001|Overall Study|Lost to Follow-up|2|||
146076330|NCT02872285|526799533|FG000|Overall Study|Discontinued due to back surgery|1|||
146175591|NCT02667886|527156191|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146175592|NCT02667886|527156192|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
146175593|NCT02667886|527156193|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
146175594|NCT02667886|527156189|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
146175595|NCT02667886|527156190|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
146175596|NCT02667886|527156191|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
146175597|NCT02667886|527156192|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
146175598|NCT02667886|527156193|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
146175599|NCT00594217|527156194|FG000|Overall Study|Withdrawal by Subject|1|||
146175600|NCT00594217|527156195|FG001|Overall Study|Withdrawal by Subject|3|||
146175601|NCT05408468|527156196|FG000|Overall Study|Lost to Follow-up|3|||
146175602|NCT05408468|527156197|FG001|Overall Study|Lost to Follow-up|1|||
146175603|NCT05408468|527156196|FG000|Overall Study|Physician Decision|1|||
146175604|NCT05408468|527156197|FG001|Overall Study|Physician Decision|0|||
146175605|NCT05408468|527156196|FG000|Overall Study|Overwhelmed by clinical situation|3|||
146175606|NCT05408468|527156197|FG001|Overall Study|Overwhelmed by clinical situation|0|||
146175607|NCT05408468|527156196|FG000|Overall Study|Personal illness precluding participation|1|||
146175608|NCT05408468|527156197|FG001|Overall Study|Personal illness precluding participation|0|||
146175609|NCT05408468|527156196|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
146175610|NCT05408468|527156197|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
146175611|NCT04186403|527156198|FG000|Overall Study|Adverse Event|1|||
146175612|NCT04186403|527156199|FG001|Overall Study|Adverse Event|8|||
146175613|NCT04186403|527156198|FG000|Overall Study|Lost to Follow-up|7|||
146175614|NCT04186403|527156199|FG001|Overall Study|Lost to Follow-up|3|||
146175615|NCT04186403|527156198|FG000|Overall Study|Physician Decision|1|||
146175616|NCT04186403|527156199|FG001|Overall Study|Physician Decision|0|||
146175617|NCT04186403|527156198|FG000|Overall Study|Withdrawal by Subject|7|||
146175618|NCT04186403|527156199|FG001|Overall Study|Withdrawal by Subject|8|||
146175619|NCT04186403|527156198|FG000|Overall Study|Other: Not Related to Covid-19|3|||
146175620|NCT04186403|527156199|FG001|Overall Study|Other: Not Related to Covid-19|0|||
146175621|NCT01407354|527156203|FG000|First Intervention|Withdrawal by Subject|0|||
146175622|NCT01407354|527156204|FG001|First Intervention|Withdrawal by Subject|2|||
146175623|NCT01407354|527156203|FG000|First Intervention|Adverse Event|1|||
146175624|NCT01407354|527156204|FG001|First Intervention|Adverse Event|0|||
146175625|NCT01407354|527156203|FG000|First Intervention|Physician Decision|1|||
146175626|NCT01407354|527156204|FG001|First Intervention|Physician Decision|0|||
146175627|NCT02778399|527156205|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
146175628|NCT02778399|527156206|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
146175629|NCT02778399|527156207|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
146175630|NCT02778399|527156208|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
146175631|NCT02778399|527156209|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
146175632|NCT02778399|527156210|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
146175633|NCT02778399|527156205|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
146175634|NCT02778399|527156206|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
146175635|NCT02778399|527156207|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
146175636|NCT02778399|527156208|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
146175637|NCT02778399|527156209|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
146175638|NCT02778399|527156210|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
146175639|NCT02778399|527156205|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
146175640|NCT02778399|527156206|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
146175641|NCT02778399|527156207|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
146175642|NCT02778399|527156208|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
146175643|NCT02778399|527156209|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
146175644|NCT02778399|527156210|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
146175645|NCT02778399|527156205|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
146175646|NCT02778399|527156206|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146175647|NCT02778399|527156207|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146175648|NCT02778399|527156208|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146175649|NCT02778399|527156209|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
146175650|NCT02778399|527156210|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
146175651|NCT02778399|527156205|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
146175652|NCT02778399|527156206|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
146175653|NCT02778399|527156207|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
146175654|NCT02778399|527156208|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
146175655|NCT02778399|527156209|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
146175656|NCT02778399|527156210|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
146175657|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146175658|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
146411968|NCT01078623|528013977|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146411969|NCT01078623|528013978|FG010|Treatment Period 2|Withdrawal by Subject|0|||
146175659|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146175660|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
146175661|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
146175662|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
146175663|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
146175664|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146175665|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
146175666|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
146175667|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146175668|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
146175669|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146175670|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
146175671|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146175672|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146175673|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146175674|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
146175675|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
146076331|NCT02872285|526799534|FG001|Overall Study|Discontinued due to back surgery|0|||
146076332|NCT02660983|526799536|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
146076333|NCT02660983|526799537|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
146076334|NCT02660983|526799536|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
146076335|NCT02660983|526799537|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
146076336|NCT02660983|526799536|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
146076337|NCT02660983|526799537|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
146076338|NCT02660983|526799536|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
146076339|NCT02660983|526799537|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
146076340|NCT02660983|526799536|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
146076341|NCT02660983|526799537|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
146076342|NCT02660983|526799536|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
146076343|NCT02660983|526799537|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
146076344|NCT02660983|526799536|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
146076345|NCT02660983|526799537|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
146076346|NCT01253577|526799541|FG000|Overall Study|Lost to Follow-up|3|||
146076347|NCT00721968|526799542|FG000|Overall Study|Lost to Follow-up|2|||
146076348|NCT00721968|526799543|FG001|Overall Study|Lost to Follow-up|0|||
146076349|NCT05601544|526799544|FG000|Phase 2 Period 1|Adverse Event|0|||
146076350|NCT05601544|526799545|FG001|Phase 2 Period 1|Adverse Event|1|||
146076351|NCT05601544|526799546|FG002|Phase 2 Period 1|Adverse Event|0|||
146076352|NCT05601544|526799547|FG003|Phase 2 Period 1|Adverse Event|0|||
146076353|NCT05601544|526799548|FG004|Phase 2 Period 1|Adverse Event|0|||
146076354|NCT05601544|526799549|FG005|Phase 2 Period 1|Adverse Event|0|||
146076355|NCT01064947|526799550|FG000|Overall Study|negative culture|41|||
146175676|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
146175677|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
146411970|NCT01078623|528013979|FG011|Treatment Period 2|Withdrawal by Subject|0|||
146411971|NCT01078623|528013980|FG012|Treatment Period 2|Withdrawal by Subject|0|||
146411972|NCT01078623|528013981|FG013|Treatment Period 2|Withdrawal by Subject|0|||
146411973|NCT01078623|528013982|FG014|Treatment Period 2|Withdrawal by Subject|0|||
146411974|NCT01078623|528013983|FG015|Treatment Period 2|Withdrawal by Subject|0|||
146411975|NCT01078623|528013984|FG016|Treatment Period 2|Withdrawal by Subject|0|||
146411976|NCT01078623|528013985|FG017|Treatment Period 2|Withdrawal by Subject|0|||
146411977|NCT01078623|528013986|FG018|Treatment Period 2|Withdrawal by Subject|0|||
146411978|NCT01078623|528013987|FG019|Treatment Period 2|Withdrawal by Subject|0|||
146411979|NCT01078623|528013968|FG000|Treatment Period 3|Adverse Event|0|||
146411980|NCT01078623|528013969|FG001|Treatment Period 3|Adverse Event|0|||
146411981|NCT01078623|528013970|FG002|Treatment Period 3|Adverse Event|0|||
146411982|NCT01078623|528013971|FG003|Treatment Period 3|Adverse Event|0|||
146411983|NCT01078623|528013972|FG004|Treatment Period 3|Adverse Event|1|||
146411984|NCT01078623|528013973|FG005|Treatment Period 3|Adverse Event|0|||
146411985|NCT01078623|528013974|FG006|Treatment Period 3|Adverse Event|0|||
146411986|NCT01078623|528013975|FG007|Treatment Period 3|Adverse Event|0|||
146411987|NCT01078623|528013976|FG008|Treatment Period 3|Adverse Event|0|||
146411988|NCT01078623|528013977|FG009|Treatment Period 3|Adverse Event|0|||
146411989|NCT01078623|528013978|FG010|Treatment Period 3|Adverse Event|0|||
146411990|NCT01078623|528013979|FG011|Treatment Period 3|Adverse Event|0|||
146411991|NCT01078623|528013980|FG012|Treatment Period 3|Adverse Event|0|||
146411992|NCT01078623|528013981|FG013|Treatment Period 3|Adverse Event|1|||
146411993|NCT01078623|528013982|FG014|Treatment Period 3|Adverse Event|0|||
146411994|NCT01078623|528013983|FG015|Treatment Period 3|Adverse Event|0|||
146411995|NCT01078623|528013984|FG016|Treatment Period 3|Adverse Event|0|||
146411996|NCT01078623|528013985|FG017|Treatment Period 3|Adverse Event|0|||
146175678|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
146175679|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
146175680|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
146175681|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
146175682|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146175683|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
146175684|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146175685|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146175686|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
146175687|NCT02778399|527156205|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146175688|NCT02778399|527156206|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146175689|NCT02778399|527156207|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146175690|NCT02778399|527156208|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
146175691|NCT02778399|527156209|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146175692|NCT02778399|527156210|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
146175693|NCT00405639|527156212|FG000|Overall Study|Withdrawal by Subject|1|||
146175694|NCT00405639|527156213|FG001|Overall Study|Withdrawal by Subject|0|||
146175695|NCT00405639|527156212|FG000|Overall Study|Adverse Event|1|||
146175696|NCT00405639|527156213|FG001|Overall Study|Adverse Event|0|||
146175697|NCT00405639|527156212|FG000|Overall Study|Seizure prior to receiving BNP|1|||
146175698|NCT00405639|527156213|FG001|Overall Study|Seizure prior to receiving BNP|0|||
146175699|NCT00612534|527156216|FG000|Overall Study|Adverse Event|0|||
146175700|NCT00612534|527156217|FG001|Overall Study|Adverse Event|4|||
146175701|NCT00612534|527156218|FG002|Overall Study|Adverse Event|2|||
146175702|NCT00612534|527156219|FG003|Overall Study|Adverse Event|1|||
146175703|NCT00612534|527156216|FG000|Overall Study|Lack of Efficacy|13|||
146175704|NCT00612534|527156217|FG001|Overall Study|Lack of Efficacy|12|||
146175705|NCT00612534|527156218|FG002|Overall Study|Lack of Efficacy|5|||
146175706|NCT00612534|527156219|FG003|Overall Study|Lack of Efficacy|16|||
146175707|NCT00612534|527156216|FG000|Overall Study|Other Reason|0|||
146175708|NCT00612534|527156217|FG001|Overall Study|Other Reason|1|||
146175709|NCT00612534|527156218|FG002|Overall Study|Other Reason|0|||
146175710|NCT00612534|527156219|FG003|Overall Study|Other Reason|0|||
146175711|NCT02223754|527156221|FG000|Period 1|Adverse Event|1|||
146175712|NCT02223754|527156222|FG001|Period 1|Adverse Event|0|||
146175713|NCT02223754|527156221|FG000|Period 1|Lost to Follow-up|0|||
146175714|NCT02223754|527156222|FG001|Period 1|Lost to Follow-up|1|||
146175715|NCT02223754|527156221|FG000|Period 1|Protocol Violation|2|||
146175716|NCT02223754|527156222|FG001|Period 1|Protocol Violation|4|||
146175717|NCT02223754|527156221|FG000|Period 1|Withdrawal by Subject|0|||
146175718|NCT02223754|527156222|FG001|Period 1|Withdrawal by Subject|4|||
146175719|NCT02223754|527156221|FG000|Period 1|Test Article No Longer Available|1|||
146175720|NCT02223754|527156222|FG001|Period 1|Test Article No Longer Available|5|||
146175721|NCT02223754|527156221|FG000|Period 1|Unsatisfactory Visual Response|0|||
146175722|NCT02223754|527156222|FG001|Period 1|Unsatisfactory Visual Response|1|||
146175723|NCT02223754|527156221|FG000|Period 2|Adverse Event|0|||
146175724|NCT02223754|527156222|FG001|Period 2|Adverse Event|1|||
146175725|NCT02223754|527156221|FG000|Period 2|Protocol Violation|1|||
146175726|NCT02223754|527156222|FG001|Period 2|Protocol Violation|0|||
146175727|NCT02223754|527156221|FG000|Period 2|Lens Discomfort|1|||
146175728|NCT02223754|527156222|FG001|Period 2|Lens Discomfort|1|||
146175729|NCT02223754|527156221|FG000|Period 2|Lost to Follow-up|1|||
146175730|NCT02223754|527156222|FG001|Period 2|Lost to Follow-up|0|||
146175731|NCT02223754|527156221|FG000|Period 2|Test Article No Longer Available|0|||
146175732|NCT02223754|527156222|FG001|Period 2|Test Article No Longer Available|1|||
146175733|NCT01807650|527156230|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
146175734|NCT01807650|527156230|FG000|Overall Study|Adverse Event|5|||
146175735|NCT01807650|527156230|FG000|Overall Study|Other|2|||
146175736|NCT02946918|527156237|FG000|Overall Study|Patient unblinded himself|1|||
146175737|NCT02946918|527156238|FG001|Overall Study|Patient unblinded himself|0|||
146411997|NCT01078623|528013986|FG018|Treatment Period 3|Adverse Event|0|||
146411998|NCT01078623|528013987|FG019|Treatment Period 3|Adverse Event|0|||
146175738|NCT02946918|527156237|FG000|Overall Study|Physician Decision|0|||
146175739|NCT02946918|527156238|FG001|Overall Study|Physician Decision|2|||
146175740|NCT02946918|527156237|FG000|Overall Study|Ran out of study medication|0|||
146175741|NCT02946918|527156238|FG001|Overall Study|Ran out of study medication|1|||
146175742|NCT02716038|527156239|FG000|Overall Study|Not evaluable|1|||
146175743|NCT02716038|527156239|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
146411999|NCT01078623|528013968|FG000|Treatment Period 4|Adverse Event|0|||
146412000|NCT01078623|528013969|FG001|Treatment Period 4|Adverse Event|0|||
146175744|NCT02716038|527156239|FG000|Overall Study|Unresectable|3|||
146175745|NCT00069784|527156240|FG000|Overall Study|Adverse Event|105|||
146175746|NCT00069784|527156241|FG001|Overall Study|Adverse Event|0|||
146412001|NCT01078623|528013970|FG002|Treatment Period 4|Adverse Event|1|||
146412002|NCT01078623|528013971|FG003|Treatment Period 4|Adverse Event|0|||
146412003|NCT01078623|528013972|FG004|Treatment Period 4|Adverse Event|0|||
146175747|NCT00069784|527156240|FG000|Overall Study|Withdrawal by Subject|1090|||
146175748|NCT00069784|527156241|FG001|Overall Study|Withdrawal by Subject|0|||
146175749|NCT00069784|527156240|FG000|Overall Study|Other|17|||
146175750|NCT00069784|527156241|FG001|Overall Study|Other|0|||
146175751|NCT02669095|527156247|FG000|Overall Study|Adverse Event|1|||
146175752|NCT02669095|527156248|FG001|Overall Study|Adverse Event|0|||
146175753|NCT02669095|527156247|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146175754|NCT02669095|527156248|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146175755|NCT02669095|527156247|FG000|Overall Study|Torn Lens|0|||
146175756|NCT02669095|527156248|FG001|Overall Study|Torn Lens|1|||
146175757|NCT02669095|527156247|FG000|Overall Study|Visit 5 assessments not completed|0|||
146175758|NCT02669095|527156248|FG001|Overall Study|Visit 5 assessments not completed|1|||
146175759|NCT00886639|527156251|FG000|Overall Study|acute exacerbation|14|||
146175760|NCT00886639|527156251|FG000|Overall Study|non-compliance|2|||
146175761|NCT01871558|527156254|FG000|Overall Study|Other reason|0|||
146175762|NCT01871558|527156255|FG001|Overall Study|Other reason|1|||
146175763|NCT01871558|527156254|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
146175764|NCT01871558|527156255|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
146175765|NCT01871558|527156254|FG000|Overall Study|Withdrawal by Subject|2|||
146175766|NCT01871558|527156255|FG001|Overall Study|Withdrawal by Subject|0|||
146175767|NCT03203694|527156256|FG000|Overall Study|Withdrawal by Subject|2|||
146175768|NCT03203694|527156257|FG001|Overall Study|Withdrawal by Subject|0|||
146175769|NCT03203694|527156258|FG002|Overall Study|Withdrawal by Subject|0|||
146175770|NCT03203694|527156259|FG003|Overall Study|Withdrawal by Subject|0|||
146175771|NCT03203694|527156260|FG004|Overall Study|Withdrawal by Subject|0|||
146175772|NCT03203694|527156261|FG005|Overall Study|Withdrawal by Subject|0|||
146175773|NCT01709305|527156264|FG000|Phase 1|Clinical Adverse Event|80|||
146175774|NCT01709305|527156265|FG001|Phase 1|Clinical Adverse Event|0|||
146175775|NCT01709305|527156266|FG002|Phase 1|Clinical Adverse Event|0|||
146175776|NCT01709305|527156267|FG003|Phase 1|Clinical Adverse Event|0|||
146175777|NCT01709305|527156268|FG004|Phase 1|Clinical Adverse Event|0|||
146175778|NCT01709305|527156264|FG000|Phase 1|Death|2|||
146175779|NCT01709305|527156265|FG001|Phase 1|Death|0|||
146175780|NCT01709305|527156266|FG002|Phase 1|Death|0|||
146175781|NCT01709305|527156267|FG003|Phase 1|Death|0|||
146175782|NCT01709305|527156268|FG004|Phase 1|Death|0|||
146175783|NCT01709305|527156264|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
146175784|NCT01709305|527156265|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146175785|NCT01709305|527156266|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146175786|NCT01709305|527156267|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146175787|NCT01709305|527156268|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
146175788|NCT01709305|527156264|FG000|Phase 1|Laboratory Adverse Event|16|||
146175789|NCT01709305|527156265|FG001|Phase 1|Laboratory Adverse Event|0|||
146175790|NCT01709305|527156266|FG002|Phase 1|Laboratory Adverse Event|0|||
146175791|NCT01709305|527156267|FG003|Phase 1|Laboratory Adverse Event|0|||
146175792|NCT01709305|527156268|FG004|Phase 1|Laboratory Adverse Event|0|||
146175793|NCT01709305|527156264|FG000|Phase 1|Lost to Follow-up|147|||
146175794|NCT01709305|527156265|FG001|Phase 1|Lost to Follow-up|0|||
146175795|NCT01709305|527156266|FG002|Phase 1|Lost to Follow-up|0|||
146175796|NCT01709305|527156267|FG003|Phase 1|Lost to Follow-up|0|||
146175797|NCT01709305|527156268|FG004|Phase 1|Lost to Follow-up|0|||
146175798|NCT01709305|527156264|FG000|Phase 1|Travel, moving, etc.|30|||
146175799|NCT01709305|527156265|FG001|Phase 1|Travel, moving, etc.|0|||
146175800|NCT01709305|527156266|FG002|Phase 1|Travel, moving, etc.|0|||
146175801|NCT01709305|527156267|FG003|Phase 1|Travel, moving, etc.|0|||
146175802|NCT01709305|527156268|FG004|Phase 1|Travel, moving, etc.|0|||
146175803|NCT01709305|527156264|FG000|Phase 1|Physician Decision|13|||
146175804|NCT01709305|527156265|FG001|Phase 1|Physician Decision|0|||
146175805|NCT01709305|527156266|FG002|Phase 1|Physician Decision|0|||
146175806|NCT01709305|527156267|FG003|Phase 1|Physician Decision|0|||
146175807|NCT01709305|527156268|FG004|Phase 1|Physician Decision|0|||
146175808|NCT01709305|527156264|FG000|Phase 1|Protocol Violation|118|||
146175809|NCT01709305|527156265|FG001|Phase 1|Protocol Violation|0|||
146175810|NCT01709305|527156266|FG002|Phase 1|Protocol Violation|0|||
146175811|NCT01709305|527156267|FG003|Phase 1|Protocol Violation|0|||
146175812|NCT01709305|527156268|FG004|Phase 1|Protocol Violation|0|||
146175813|NCT01709305|527156264|FG000|Phase 1|Withdrawal by Subject|218|||
146175814|NCT01709305|527156265|FG001|Phase 1|Withdrawal by Subject|0|||
146175815|NCT01709305|527156266|FG002|Phase 1|Withdrawal by Subject|0|||
146175816|NCT01709305|527156267|FG003|Phase 1|Withdrawal by Subject|0|||
146175817|NCT01709305|527156268|FG004|Phase 1|Withdrawal by Subject|0|||
146175818|NCT01709305|527156264|FG000|Phase 2|Clinical Adverse Event|0|||
146175819|NCT01709305|527156265|FG001|Phase 2|Clinical Adverse Event|10|||
146175820|NCT01709305|527156266|FG002|Phase 2|Clinical Adverse Event|10|||
146175821|NCT01709305|527156267|FG003|Phase 2|Clinical Adverse Event|6|||
146175822|NCT01709305|527156268|FG004|Phase 2|Clinical Adverse Event|11|||
146175823|NCT01709305|527156264|FG000|Phase 2|Death|0|||
146175824|NCT01709305|527156265|FG001|Phase 2|Death|0|||
146175825|NCT01709305|527156266|FG002|Phase 2|Death|1|||
146175826|NCT01709305|527156267|FG003|Phase 2|Death|0|||
146175827|NCT01709305|527156268|FG004|Phase 2|Death|0|||
146175828|NCT01709305|527156264|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146175829|NCT01709305|527156265|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146175830|NCT01709305|527156266|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146175831|NCT01709305|527156267|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
146175832|NCT01709305|527156268|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
146175833|NCT01709305|527156264|FG000|Phase 2|Laboratory Adverse Event|0|||
146175834|NCT01709305|527156265|FG001|Phase 2|Laboratory Adverse Event|1|||
146175835|NCT01709305|527156266|FG002|Phase 2|Laboratory Adverse Event|0|||
146175836|NCT01709305|527156267|FG003|Phase 2|Laboratory Adverse Event|1|||
146175837|NCT01709305|527156268|FG004|Phase 2|Laboratory Adverse Event|1|||
146175838|NCT01709305|527156264|FG000|Phase 2|Lost to Follow-up|0|||
146175839|NCT01709305|527156265|FG001|Phase 2|Lost to Follow-up|10|||
146175840|NCT01709305|527156266|FG002|Phase 2|Lost to Follow-up|6|||
146175841|NCT01709305|527156267|FG003|Phase 2|Lost to Follow-up|9|||
146175842|NCT01709305|527156268|FG004|Phase 2|Lost to Follow-up|5|||
146175843|NCT01709305|527156264|FG000|Phase 2|Travel, moving, etc.|0|||
146175844|NCT01709305|527156265|FG001|Phase 2|Travel, moving, etc.|2|||
146175845|NCT01709305|527156266|FG002|Phase 2|Travel, moving, etc.|3|||
146175846|NCT01709305|527156267|FG003|Phase 2|Travel, moving, etc.|3|||
146175847|NCT01709305|527156268|FG004|Phase 2|Travel, moving, etc.|5|||
146175848|NCT01709305|527156264|FG000|Phase 2|Physician Decision|0|||
146175849|NCT01709305|527156265|FG001|Phase 2|Physician Decision|2|||
146175850|NCT01709305|527156266|FG002|Phase 2|Physician Decision|0|||
146175851|NCT01709305|527156267|FG003|Phase 2|Physician Decision|1|||
146175852|NCT01709305|527156268|FG004|Phase 2|Physician Decision|2|||
146175853|NCT01709305|527156264|FG000|Phase 2|Protocol Violation|0|||
146175854|NCT01709305|527156265|FG001|Phase 2|Protocol Violation|19|||
146175855|NCT01709305|527156266|FG002|Phase 2|Protocol Violation|19|||
146175856|NCT01709305|527156267|FG003|Phase 2|Protocol Violation|13|||
146175857|NCT01709305|527156268|FG004|Phase 2|Protocol Violation|9|||
146175858|NCT01709305|527156264|FG000|Phase 2|Withdrawal by Subject|0|||
146175859|NCT01709305|527156265|FG001|Phase 2|Withdrawal by Subject|8|||
146175860|NCT01709305|527156266|FG002|Phase 2|Withdrawal by Subject|6|||
146175861|NCT01709305|527156267|FG003|Phase 2|Withdrawal by Subject|15|||
146175862|NCT01709305|527156268|FG004|Phase 2|Withdrawal by Subject|12|||
146175863|NCT02294474|527156269|FG000|Overall Study|Adverse Event|7|||
146175864|NCT02294474|527156270|FG001|Overall Study|Adverse Event|7|||
146175865|NCT02294474|527156269|FG000|Overall Study|Lack of Efficacy|2|||
146175866|NCT02294474|527156270|FG001|Overall Study|Lack of Efficacy|1|||
146175867|NCT02294474|527156269|FG000|Overall Study|Protocol Violation|4|||
146175868|NCT02294474|527156270|FG001|Overall Study|Protocol Violation|2|||
146175869|NCT02294474|527156269|FG000|Overall Study|Other than specified above|12|||
146175870|NCT02294474|527156270|FG001|Overall Study|Other than specified above|12|||
146175871|NCT01338012|527156275|FG000|Overall Study|Death|4|||
146175872|NCT01338012|527156275|FG000|Overall Study|Study terminated|4|||
146175873|NCT02714205|527156276|FG000|Overall Study|Cannot tolerate medication|1|||
146175874|NCT02714205|527156277|FG001|Overall Study|Cannot tolerate medication|0|||
146175875|NCT02714205|527156276|FG000|Overall Study|Adverse Event|2|||
146175876|NCT02714205|527156277|FG001|Overall Study|Adverse Event|0|||
146175877|NCT02714205|527156276|FG000|Overall Study|Too busy|1|||
146175878|NCT02714205|527156277|FG001|Overall Study|Too busy|0|||
146175879|NCT02714205|527156276|FG000|Overall Study|Incomplete outcome data|0|||
146175880|NCT02714205|527156277|FG001|Overall Study|Incomplete outcome data|1|||
146175881|NCT05879198|527156278|FG000|Overall Study|Lost to Follow-up|1|||
146175882|NCT03813147|527156279|FG000|Overall Study|Lack of Efficacy|4|||
146175883|NCT03813147|527156280|FG001|Overall Study|Lack of Efficacy|4|||
146175884|NCT03813147|527156279|FG000|Overall Study|Physician Decision|2|||
146175885|NCT03813147|527156280|FG001|Overall Study|Physician Decision|1|||
146175886|NCT01693692|527156281|FG000|Overall Study|Withdrawal by Subject|12|||
146175887|NCT01693692|527156282|FG001|Overall Study|Withdrawal by Subject|10|||
146175888|NCT01693692|527156283|FG002|Overall Study|Withdrawal by Subject|11|||
146175889|NCT01693692|527156281|FG000|Overall Study|Adverse Event|7|||
146175890|NCT01693692|527156282|FG001|Overall Study|Adverse Event|14|||
146175891|NCT01693692|527156283|FG002|Overall Study|Adverse Event|9|||
146283920|NCT00935818|527551901|FG001|Overall Study|Lost to Follow-up|42|||
146175892|NCT01693692|527156281|FG000|Overall Study|Physician Decision|0|||
146175893|NCT01693692|527156282|FG001|Overall Study|Physician Decision|0|||
146175894|NCT01693692|527156283|FG002|Overall Study|Physician Decision|1|||
146175895|NCT01693692|527156281|FG000|Overall Study|Protocol Violation|5|||
146175896|NCT01693692|527156282|FG001|Overall Study|Protocol Violation|4|||
146175897|NCT01693692|527156283|FG002|Overall Study|Protocol Violation|6|||
146175898|NCT01693692|527156281|FG000|Overall Study|Lost to Follow-up|2|||
146175899|NCT01693692|527156282|FG001|Overall Study|Lost to Follow-up|2|||
146175900|NCT01693692|527156283|FG002|Overall Study|Lost to Follow-up|3|||
146175901|NCT01693692|527156281|FG000|Overall Study|Other|4|||
146175902|NCT01693692|527156282|FG001|Overall Study|Other|4|||
146175903|NCT01693692|527156283|FG002|Overall Study|Other|6|||
146175904|NCT00386308|527158459|FG000|Overall Study|Adverse Event|3|||
146175905|NCT00386308|527158460|FG001|Overall Study|Adverse Event|3|||
146175906|NCT00386308|527158459|FG000|Overall Study|Protocol Violation|2|||
146175907|NCT00386308|527158460|FG001|Overall Study|Protocol Violation|5|||
146175908|NCT00386308|527158459|FG000|Overall Study|Lack of Efficacy|0|||
146175909|NCT00386308|527158460|FG001|Overall Study|Lack of Efficacy|2|||
146175910|NCT00386308|527158459|FG000|Overall Study|Lost to Follow-up|10|||
146175911|NCT00386308|527158460|FG001|Overall Study|Lost to Follow-up|6|||
146175912|NCT00386308|527158459|FG000|Overall Study|Withdrawal by Subject|6|||
146175913|NCT00386308|527158460|FG001|Overall Study|Withdrawal by Subject|2|||
146175914|NCT00386308|527158459|FG000|Overall Study|Other Event|8|||
146175915|NCT00386308|527158460|FG001|Overall Study|Other Event|1|||
146175916|NCT01167179|527158463|FG000|Overall Study|disease recurrence|4|||
146175917|NCT01167179|527158464|FG001|Overall Study|disease recurrence|4|||
146175918|NCT01167179|527158463|FG000|Overall Study|Death|4|||
146175919|NCT01167179|527158464|FG001|Overall Study|Death|10|||
146175920|NCT01167179|527158463|FG000|Overall Study|Withdrawal by Subject|1|||
146175921|NCT01167179|527158464|FG001|Overall Study|Withdrawal by Subject|2|||
146175922|NCT01167179|527158463|FG000|Overall Study|diverse|6|||
146175923|NCT01167179|527158464|FG001|Overall Study|diverse|5|||
146175924|NCT00663117|527158465|FG000|Overall Study|Lack of Efficacy|1|||
146175925|NCT00663117|527158466|FG001|Overall Study|Lack of Efficacy|0|||
146175926|NCT01158378|527158467|FG000|Overall Study|Death|4|||
146175927|NCT01158378|527158468|FG001|Overall Study|Death|5|||
146175928|NCT01158378|527158467|FG000|Overall Study|Lost to Follow-up|2|||
146175929|NCT01158378|527158468|FG001|Overall Study|Lost to Follow-up|4|||
146175930|NCT01158378|527158467|FG000|Overall Study|Withdrawal by Subject|4|||
146175931|NCT01158378|527158468|FG001|Overall Study|Withdrawal by Subject|0|||
146175932|NCT02769065|527158469|FG000|Overall Study|Voluntary Withdrawal|1|||
146175933|NCT02769065|527158470|FG001|Overall Study|Voluntary Withdrawal|0|||
146175934|NCT02769065|527158471|FG002|Overall Study|Voluntary Withdrawal|0|||
146175935|NCT02769065|527158472|FG003|Overall Study|Voluntary Withdrawal|0|||
146175936|NCT02769065|527158473|FG004|Overall Study|Voluntary Withdrawal|0|||
146175937|NCT02769065|527158474|FG005|Overall Study|Voluntary Withdrawal|0|||
146175938|NCT02769065|527158475|FG006|Overall Study|Voluntary Withdrawal|0|||
146175939|NCT02769065|527158476|FG007|Overall Study|Voluntary Withdrawal|0|||
146175940|NCT02769065|527158477|FG008|Overall Study|Voluntary Withdrawal|0|||
146175941|NCT02769065|527158478|FG009|Overall Study|Voluntary Withdrawal|0|||
146175942|NCT02769065|527158479|FG010|Overall Study|Voluntary Withdrawal|0|||
146175943|NCT02769065|527158480|FG011|Overall Study|Voluntary Withdrawal|0|||
146175944|NCT02769065|527158481|FG012|Overall Study|Voluntary Withdrawal|0|||
146175945|NCT02769065|527158482|FG013|Overall Study|Voluntary Withdrawal|0|||
146175946|NCT02769065|527158483|FG014|Overall Study|Voluntary Withdrawal|0|||
146175947|NCT02769065|527158484|FG015|Overall Study|Voluntary Withdrawal|0|||
146175948|NCT02769065|527158485|FG016|Overall Study|Voluntary Withdrawal|0|||
146175949|NCT02769065|527158486|FG017|Overall Study|Voluntary Withdrawal|0|||
146412004|NCT01078623|528013973|FG005|Treatment Period 4|Adverse Event|0|||
146412005|NCT01078623|528013974|FG006|Treatment Period 4|Adverse Event|0|||
146412006|NCT01078623|528013975|FG007|Treatment Period 4|Adverse Event|0|||
146412007|NCT01078623|528013976|FG008|Treatment Period 4|Adverse Event|0|||
146412008|NCT01078623|528013977|FG009|Treatment Period 4|Adverse Event|0|||
146412009|NCT01078623|528013978|FG010|Treatment Period 4|Adverse Event|0|||
146175950|NCT02769065|527158487|FG018|Overall Study|Voluntary Withdrawal|0|||
146175951|NCT02769065|527158488|FG019|Overall Study|Voluntary Withdrawal|0|||
146175952|NCT02769065|527158489|FG020|Overall Study|Voluntary Withdrawal|0|||
146175953|NCT02769065|527158490|FG021|Overall Study|Voluntary Withdrawal|0|||
146175954|NCT02769065|527158491|FG022|Overall Study|Voluntary Withdrawal|0|||
146175955|NCT02769065|527158492|FG023|Overall Study|Voluntary Withdrawal|0|||
146175956|NCT02769065|527158493|FG024|Overall Study|Voluntary Withdrawal|0|||
146175957|NCT02769065|527158494|FG025|Overall Study|Voluntary Withdrawal|0|||
146175958|NCT02769065|527158495|FG026|Overall Study|Voluntary Withdrawal|0|||
146175959|NCT02769065|527158496|FG027|Overall Study|Voluntary Withdrawal|0|||
146175960|NCT02769065|527158497|FG028|Overall Study|Voluntary Withdrawal|0|||
146175961|NCT02769065|527158498|FG029|Overall Study|Voluntary Withdrawal|0|||
146175962|NCT02769065|527158469|FG000|Overall Study|Reason Not Specified|0|||
146175963|NCT02769065|527158470|FG001|Overall Study|Reason Not Specified|0|||
146175964|NCT02769065|527158471|FG002|Overall Study|Reason Not Specified|0|||
146412010|NCT01078623|528013979|FG011|Treatment Period 4|Adverse Event|0|||
146412011|NCT01078623|528013980|FG012|Treatment Period 4|Adverse Event|0|||
146175965|NCT02769065|527158472|FG003|Overall Study|Reason Not Specified|0|||
146175966|NCT02769065|527158473|FG004|Overall Study|Reason Not Specified|0|||
146175967|NCT02769065|527158474|FG005|Overall Study|Reason Not Specified|0|||
146175968|NCT02769065|527158475|FG006|Overall Study|Reason Not Specified|1|||
146175969|NCT02769065|527158476|FG007|Overall Study|Reason Not Specified|0|||
146175970|NCT02769065|527158477|FG008|Overall Study|Reason Not Specified|0|||
146175971|NCT02769065|527158478|FG009|Overall Study|Reason Not Specified|0|||
146175972|NCT02769065|527158479|FG010|Overall Study|Reason Not Specified|0|||
146175973|NCT02769065|527158480|FG011|Overall Study|Reason Not Specified|0|||
146175974|NCT02769065|527158481|FG012|Overall Study|Reason Not Specified|0|||
146175975|NCT02769065|527158482|FG013|Overall Study|Reason Not Specified|0|||
146175976|NCT02769065|527158483|FG014|Overall Study|Reason Not Specified|0|||
146175977|NCT02769065|527158484|FG015|Overall Study|Reason Not Specified|0|||
146175978|NCT02769065|527158485|FG016|Overall Study|Reason Not Specified|0|||
146175979|NCT02769065|527158486|FG017|Overall Study|Reason Not Specified|0|||
146175980|NCT02769065|527158487|FG018|Overall Study|Reason Not Specified|0|||
146175981|NCT02769065|527158488|FG019|Overall Study|Reason Not Specified|0|||
146175982|NCT02769065|527158489|FG020|Overall Study|Reason Not Specified|0|||
146175983|NCT02769065|527158490|FG021|Overall Study|Reason Not Specified|0|||
146175984|NCT02769065|527158491|FG022|Overall Study|Reason Not Specified|0|||
146175985|NCT02769065|527158492|FG023|Overall Study|Reason Not Specified|0|||
146175986|NCT02769065|527158493|FG024|Overall Study|Reason Not Specified|0|||
146175987|NCT02769065|527158494|FG025|Overall Study|Reason Not Specified|0|||
146175988|NCT02769065|527158495|FG026|Overall Study|Reason Not Specified|0|||
146175989|NCT02769065|527158496|FG027|Overall Study|Reason Not Specified|0|||
146175990|NCT02769065|527158497|FG028|Overall Study|Reason Not Specified|0|||
146175991|NCT02769065|527158498|FG029|Overall Study|Reason Not Specified|0|||
146175992|NCT02769065|527158469|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175993|NCT02769065|527158470|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175994|NCT02769065|527158471|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175995|NCT02769065|527158472|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175996|NCT02769065|527158473|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175997|NCT02769065|527158474|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175998|NCT02769065|527158475|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
146175999|NCT02769065|527158476|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176000|NCT02769065|527158477|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176001|NCT02769065|527158478|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176002|NCT02769065|527158479|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
146176003|NCT02769065|527158480|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176004|NCT02769065|527158481|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176005|NCT02769065|527158482|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176006|NCT02769065|527158483|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176007|NCT02769065|527158484|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176008|NCT02769065|527158485|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176009|NCT02769065|527158486|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176010|NCT02769065|527158487|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176011|NCT02769065|527158488|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176012|NCT02769065|527158489|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176013|NCT02769065|527158490|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176014|NCT02769065|527158491|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
146076356|NCT06457204|526799551|FG000|Washout|Adverse Event|0|||
146076357|NCT06457204|526799552|FG001|Washout|Adverse Event|2|||
146076358|NCT01601652|526799554|FG000|Overall Study|Death|1|||
146076359|NCT00488683|526799561|FG000|Overall Study|Withdrawal by Subject|1|||
146076360|NCT00488683|526799562|FG001|Overall Study|Withdrawal by Subject|2|||
146076361|NCT00488683|526799563|FG002|Overall Study|Withdrawal by Subject|2|||
146076362|NCT00488683|526799561|FG000|Overall Study|Lost to Follow-up|5|||
146076363|NCT00488683|526799562|FG001|Overall Study|Lost to Follow-up|3|||
146076364|NCT00488683|526799563|FG002|Overall Study|Lost to Follow-up|0|||
146076365|NCT00488683|526799561|FG000|Overall Study|Protocol Violation|5|||
146076366|NCT00488683|526799562|FG001|Overall Study|Protocol Violation|1|||
146076367|NCT00488683|526799563|FG002|Overall Study|Protocol Violation|0|||
146076368|NCT00488683|526799561|FG000|Overall Study|Unable to Classify|1|||
146176015|NCT02769065|527158492|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176016|NCT02769065|527158493|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176017|NCT02769065|527158494|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176018|NCT02769065|527158495|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176019|NCT02769065|527158496|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
146076369|NCT00488683|526799562|FG001|Overall Study|Unable to Classify|0|||
146176020|NCT02769065|527158497|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
146176021|NCT02769065|527158498|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
146076370|NCT00488683|526799563|FG002|Overall Study|Unable to Classify|0|||
146076371|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
146076372|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
146176022|NCT01806740|527158502|FG000|Overall Study|Withdrawal by Subject|4|||
146176023|NCT01806740|527158502|FG000|Overall Study|Physician Decision|1|||
146176024|NCT01806740|527158502|FG000|Overall Study|Patient's refusal of treatment|1|||
146176025|NCT02802319|527158510|FG000|Overall Study|Physician Decision|2|||
146176026|NCT02802319|527158511|FG001|Overall Study|Physician Decision|1|||
146176027|NCT02802319|527158510|FG000|Overall Study|Lost to Follow-up|0|||
146176028|NCT02802319|527158511|FG001|Overall Study|Lost to Follow-up|4|||
146176029|NCT04651114|527158512|FG000|Overall Study|Withdrawal by Subject|8|||
146176030|NCT01923896|527158517|FG000|Overall Study|Adverse Event|1|||
146176031|NCT01923896|527158518|FG001|Overall Study|Adverse Event|0|||
146176032|NCT03545113|527158521|FG000|Overall Study|Surgery Cancelled|1|||
146176033|NCT03545113|527158522|FG001|Overall Study|Surgery Cancelled|0|||
146176034|NCT03545113|527158521|FG000|Overall Study|Death|1|||
146176035|NCT03545113|527158522|FG001|Overall Study|Death|0|||
146176036|NCT03545113|527158521|FG000|Overall Study|Adverse Event|2|||
146176037|NCT03545113|527158522|FG001|Overall Study|Adverse Event|0|||
146176038|NCT03545113|527158521|FG000|Overall Study|Received different surgery|1|||
146176039|NCT03545113|527158522|FG001|Overall Study|Received different surgery|0|||
146176040|NCT00235443|527158523|FG000|Overall Study|Adverse Event|4|||
146176041|NCT00235443|527158524|FG001|Overall Study|Adverse Event|12|||
146176042|NCT00235443|527158525|FG002|Overall Study|Adverse Event|17|||
146176043|NCT00235443|527158526|FG003|Overall Study|Adverse Event|44|||
146176044|NCT00235443|527158527|FG004|Overall Study|Adverse Event|10|||
146176045|NCT00235443|527158528|FG005|Overall Study|Adverse Event|15|||
146176046|NCT00235443|527158523|FG000|Overall Study|Lack of Efficacy|0|||
146176047|NCT00235443|527158524|FG001|Overall Study|Lack of Efficacy|1|||
146176048|NCT00235443|527158525|FG002|Overall Study|Lack of Efficacy|5|||
146176049|NCT00235443|527158526|FG003|Overall Study|Lack of Efficacy|12|||
146176050|NCT00235443|527158527|FG004|Overall Study|Lack of Efficacy|2|||
146176051|NCT00235443|527158528|FG005|Overall Study|Lack of Efficacy|9|||
146176052|NCT00235443|527158523|FG000|Overall Study|Withdrawal by Subject|3|||
146176053|NCT00235443|527158524|FG001|Overall Study|Withdrawal by Subject|9|||
146176054|NCT00235443|527158525|FG002|Overall Study|Withdrawal by Subject|25|||
146176055|NCT00235443|527158526|FG003|Overall Study|Withdrawal by Subject|24|||
146176056|NCT00235443|527158527|FG004|Overall Study|Withdrawal by Subject|10|||
146176057|NCT00235443|527158528|FG005|Overall Study|Withdrawal by Subject|12|||
146176058|NCT00235443|527158523|FG000|Overall Study|Lost to Follow-up|0|||
146176059|NCT00235443|527158524|FG001|Overall Study|Lost to Follow-up|8|||
146176060|NCT00235443|527158525|FG002|Overall Study|Lost to Follow-up|6|||
146176061|NCT00235443|527158526|FG003|Overall Study|Lost to Follow-up|6|||
146176062|NCT00235443|527158527|FG004|Overall Study|Lost to Follow-up|4|||
146176063|NCT00235443|527158528|FG005|Overall Study|Lost to Follow-up|3|||
146176064|NCT00235443|527158523|FG000|Overall Study|Unsatisfactory compliance|0|||
146176065|NCT00235443|527158524|FG001|Overall Study|Unsatisfactory compliance|2|||
146176066|NCT00235443|527158525|FG002|Overall Study|Unsatisfactory compliance|3|||
146176067|NCT00235443|527158526|FG003|Overall Study|Unsatisfactory compliance|4|||
146176068|NCT00235443|527158527|FG004|Overall Study|Unsatisfactory compliance|1|||
146176069|NCT00235443|527158528|FG005|Overall Study|Unsatisfactory compliance|0|||
146176070|NCT00235443|527158523|FG000|Overall Study|Other reasons for premature termination|1|||
146176071|NCT00235443|527158524|FG001|Overall Study|Other reasons for premature termination|6|||
146176072|NCT00235443|527158525|FG002|Overall Study|Other reasons for premature termination|6|||
146176073|NCT00235443|527158526|FG003|Overall Study|Other reasons for premature termination|7|||
146176074|NCT00235443|527158527|FG004|Overall Study|Other reasons for premature termination|3|||
146176075|NCT00235443|527158528|FG005|Overall Study|Other reasons for premature termination|6|||
146176076|NCT02032173|527158529|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
146176077|NCT03661996|527158537|FG000|Overall Study|Adverse Event|0|||
146176078|NCT03661996|527158538|FG001|Overall Study|Adverse Event|0|||
146176079|NCT03661996|527158539|FG002|Overall Study|Adverse Event|1|||
146176080|NCT03661996|527158540|FG003|Overall Study|Adverse Event|1|||
146176081|NCT03661996|527158541|FG004|Overall Study|Adverse Event|0|||
146176082|NCT03661996|527158537|FG000|Overall Study|Lost to Follow-up|5|||
146176083|NCT03661996|527158538|FG001|Overall Study|Lost to Follow-up|1|||
146176084|NCT03661996|527158539|FG002|Overall Study|Lost to Follow-up|2|||
146176085|NCT03661996|527158540|FG003|Overall Study|Lost to Follow-up|2|||
146176086|NCT03661996|527158541|FG004|Overall Study|Lost to Follow-up|6|||
146176087|NCT03661996|527158537|FG000|Overall Study|Physician Decision|1|||
146176088|NCT03661996|527158538|FG001|Overall Study|Physician Decision|1|||
146176089|NCT03661996|527158539|FG002|Overall Study|Physician Decision|1|||
146176090|NCT03661996|527158540|FG003|Overall Study|Physician Decision|2|||
146176091|NCT03661996|527158541|FG004|Overall Study|Physician Decision|0|||
146176092|NCT03661996|527158537|FG000|Overall Study|Protocol Violation|0|||
146176093|NCT03661996|527158538|FG001|Overall Study|Protocol Violation|0|||
146176094|NCT03661996|527158539|FG002|Overall Study|Protocol Violation|0|||
146176095|NCT03661996|527158540|FG003|Overall Study|Protocol Violation|0|||
146176096|NCT03661996|527158541|FG004|Overall Study|Protocol Violation|1|||
146176097|NCT03661996|527158537|FG000|Overall Study|Withdrawal by Subject|3|||
146176098|NCT03661996|527158538|FG001|Overall Study|Withdrawal by Subject|5|||
146176099|NCT03661996|527158539|FG002|Overall Study|Withdrawal by Subject|1|||
146076373|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
146076374|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
146076375|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
146076376|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146076377|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146076378|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
146076379|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
146076380|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146076381|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146076382|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
146076383|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
146076384|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146076385|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146076386|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
146076387|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
146076388|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146076389|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146076390|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
146076391|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
146076392|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146076393|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146076394|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
146076395|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
146076396|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146076397|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146076398|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
146076399|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
146076400|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146076401|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146076402|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
146076403|NCT03818035|526799565|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
146076404|NCT03818035|526799566|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
146076405|NCT03818035|526799567|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
146076406|NCT03818035|526799568|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
146076407|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146076408|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146076409|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
146076410|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
146076411|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
146076412|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
146076413|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
146076414|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
146076415|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146076416|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146076417|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
146076418|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
146076419|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
146076420|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
146076421|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
146076422|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
146076423|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
146076424|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
146076425|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
146076426|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
146076427|NCT03818035|526799565|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
146076428|NCT03818035|526799566|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
146076429|NCT03818035|526799567|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
146076430|NCT03818035|526799568|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
146076431|NCT03374202|526799571|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
146076432|NCT03374202|526799572|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
146076433|NCT03374202|526799573|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
146076434|NCT03374202|526799571|FG000|Five Year Long Term Follow Up|Death|0|||
146076435|NCT03374202|526799572|FG001|Five Year Long Term Follow Up|Death|1|||
146076436|NCT03374202|526799573|FG002|Five Year Long Term Follow Up|Death|0|||
146076437|NCT01794338|526801913|FG000|Overall Study|Death|2|||
146076438|NCT01794338|526801914|FG001|Overall Study|Death|0|||
146076439|NCT01794338|526801913|FG000|Overall Study|Lost to Follow-up|6|||
146076440|NCT01794338|526801914|FG001|Overall Study|Lost to Follow-up|9|||
146176100|NCT03661996|527158540|FG003|Overall Study|Withdrawal by Subject|7|||
146176101|NCT03661996|527158541|FG004|Overall Study|Withdrawal by Subject|7|||
146176102|NCT03661996|527158537|FG000|Overall Study|Sponsors Decision|2|||
146176103|NCT03661996|527158538|FG001|Overall Study|Sponsors Decision|0|||
146176104|NCT03661996|527158539|FG002|Overall Study|Sponsors Decision|0|||
146176105|NCT03661996|527158540|FG003|Overall Study|Sponsors Decision|0|||
146176106|NCT03661996|527158541|FG004|Overall Study|Sponsors Decision|0|||
146176107|NCT03661996|527158537|FG000|Overall Study|Other|1|||
146176108|NCT03661996|527158538|FG001|Overall Study|Other|1|||
146176109|NCT03661996|527158539|FG002|Overall Study|Other|1|||
146176110|NCT03661996|527158540|FG003|Overall Study|Other|1|||
146176111|NCT03661996|527158541|FG004|Overall Study|Other|0|||
146176112|NCT03321513|527158542|FG000|Overall Study|Death|11|||
146176113|NCT03321513|527158543|FG001|Overall Study|Death|5|||
146176114|NCT03321513|527158542|FG000|Overall Study|Withdrawal by Subject|5|||
146176115|NCT03321513|527158543|FG001|Overall Study|Withdrawal by Subject|10|||
146176116|NCT03321513|527158542|FG000|Overall Study|Lost to Follow-up|10|||
146176117|NCT03321513|527158543|FG001|Overall Study|Lost to Follow-up|11|||
146176118|NCT03029247|527158544|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
146176119|NCT03029247|527158545|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
146176120|NCT03029247|527158544|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
146176121|NCT03029247|527158545|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
146176122|NCT03029247|527158544|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
146176123|NCT03029247|527158545|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
146176124|NCT03029247|527158544|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
146176125|NCT03029247|527158545|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
146176126|NCT01683994|527158566|FG000|Overall Study|Withdrawal by Subject|1|||
146176127|NCT01683994|527158567|FG001|Overall Study|Withdrawal by Subject|0|||
146176128|NCT01683994|527158568|FG002|Overall Study|Withdrawal by Subject|0|||
146176129|NCT01683994|527158569|FG003|Overall Study|Withdrawal by Subject|1|||
146176130|NCT01683994|527158570|FG004|Overall Study|Withdrawal by Subject|0|||
146176131|NCT01683994|527158566|FG000|Overall Study|Intercurrent illness|0|||
146176132|NCT01683994|527158567|FG001|Overall Study|Intercurrent illness|0|||
146176133|NCT01683994|527158568|FG002|Overall Study|Intercurrent illness|0|||
146176134|NCT01683994|527158569|FG003|Overall Study|Intercurrent illness|2|||
146176135|NCT01683994|527158570|FG004|Overall Study|Intercurrent illness|1|||
146176136|NCT00999661|527158571|FG000|Overall Study|Lost to Follow-up|59|||
146176137|NCT00999661|527158571|FG000|Overall Study|Adverse Event|1|||
146176138|NCT00999661|527158571|FG000|Overall Study|Withdrawal by Subject|1|||
146176139|NCT00999661|527158571|FG000|Overall Study|Not meeting eligibility criteria|9|||
146283921|NCT00935818|527551900|FG000|Overall Study|Adverse Event|6|||
146076441|NCT01754402|526801915|FG000|Overall Study|Death|0|||
146076442|NCT01754402|526801916|FG001|Overall Study|Death|0|||
146076443|NCT01754402|526801917|FG002|Overall Study|Death|1|||
146076444|NCT01754402|526801915|FG000|Overall Study|Adverse Event|2|||
146076445|NCT01754402|526801916|FG001|Overall Study|Adverse Event|2|||
146076446|NCT01754402|526801917|FG002|Overall Study|Adverse Event|1|||
146076447|NCT01754402|526801915|FG000|Overall Study|Withdrawal by Subject|0|||
146076448|NCT01754402|526801916|FG001|Overall Study|Withdrawal by Subject|0|||
146076449|NCT01754402|526801917|FG002|Overall Study|Withdrawal by Subject|1|||
146076450|NCT01754402|526801915|FG000|Overall Study|Lack of Efficacy|0|||
146076451|NCT01754402|526801916|FG001|Overall Study|Lack of Efficacy|0|||
146076452|NCT01754402|526801917|FG002|Overall Study|Lack of Efficacy|1|||
146076453|NCT01282463|526801918|FG000|Overall Study|Lost to Follow-up|1|||
146076454|NCT01282463|526801919|FG001|Overall Study|Lost to Follow-up|0|||
146076455|NCT01282463|526801920|FG002|Overall Study|Lost to Follow-up|0|||
146076456|NCT01282463|526801918|FG000|Overall Study|Withdrawal by Subject|6|||
146076457|NCT01282463|526801919|FG001|Overall Study|Withdrawal by Subject|2|||
146076458|NCT01282463|526801920|FG002|Overall Study|Withdrawal by Subject|3|||
146076459|NCT01282463|526801918|FG000|Overall Study|"Never Treated Death"|0|||
146076460|NCT01282463|526801919|FG001|Overall Study|"Never Treated Death"|1|||
146076461|NCT01282463|526801920|FG002|Overall Study|"Never Treated Death"|0|||
146076462|NCT01282463|526801918|FG000|Overall Study|"Never Treated PD"|0|||
146076463|NCT01282463|526801919|FG001|Overall Study|"Never Treated PD"|1|||
146076464|NCT01282463|526801920|FG002|Overall Study|"Never Treated PD"|0|||
146076465|NCT01282463|526801918|FG000|Overall Study|Protocol Violation|0|||
146076466|NCT01282463|526801919|FG001|Overall Study|Protocol Violation|0|||
146076467|NCT01282463|526801920|FG002|Overall Study|Protocol Violation|1|||
146076468|NCT01282463|526801918|FG000|Overall Study|Physician Decision|1|||
146076469|NCT01282463|526801919|FG001|Overall Study|Physician Decision|0|||
146076470|NCT01282463|526801920|FG002|Overall Study|Physician Decision|0|||
146176140|NCT00917267|527158572|FG000|Overall Study|Adverse Event|15|||
146176141|NCT00917267|527158573|FG001|Overall Study|Adverse Event|36|||
146176142|NCT00917267|527158572|FG000|Overall Study|Physician Decision|2|||
146176143|NCT00917267|527158573|FG001|Overall Study|Physician Decision|4|||
146176144|NCT00917267|527158572|FG000|Overall Study|Protocol Violation|9|||
146076471|NCT01954927|526801921|FG000|Overall Study|Withdrawal by Subject|3|||
146076472|NCT01954927|526801922|FG001|Overall Study|Withdrawal by Subject|1|||
146076473|NCT03320824|526801923|FG000|Overall Study|Withdrawal by Subject|8|||
146076474|NCT03320824|526801924|FG001|Overall Study|Withdrawal by Subject|1|||
146076475|NCT03320824|526801923|FG000|Overall Study|Lost to Follow-up|10|||
146076476|NCT03320824|526801924|FG001|Overall Study|Lost to Follow-up|1|||
146076477|NCT03320824|526801923|FG000|Overall Study|moved out of state|0|||
146076478|NCT03320824|526801924|FG001|Overall Study|moved out of state|1|||
146076479|NCT03320824|526801923|FG000|Overall Study|could not complete final visit|0|||
146076480|NCT03320824|526801924|FG001|Overall Study|could not complete final visit|1|||
146076481|NCT00109590|526801925|FG000|Overall Study|Lost to Follow-up|1|||
146076482|NCT00109590|526801926|FG001|Overall Study|Lost to Follow-up|0|||
146076483|NCT00109590|526801927|FG002|Overall Study|Lost to Follow-up|1|||
146076484|NCT00109590|526801925|FG000|Overall Study|Never Started Treatment|1|||
146076485|NCT00109590|526801926|FG001|Overall Study|Never Started Treatment|2|||
146076486|NCT00109590|526801927|FG002|Overall Study|Never Started Treatment|3|||
146076487|NCT01221285|526801928|FG000|Overall Study|Withdrawal by Subject|1|||
146076488|NCT02123251|526801929|FG000|Overall Study|Death|1|||
146076489|NCT02123251|526801930|FG001|Overall Study|Death|1|||
146076490|NCT02123251|526801929|FG000|Overall Study|Withdrawal by Subject|0|||
146076491|NCT02123251|526801930|FG001|Overall Study|Withdrawal by Subject|3|||
146076492|NCT02123251|526801929|FG000|Overall Study|Lost Medicaid eligibility|29|||
146076493|NCT02123251|526801930|FG001|Overall Study|Lost Medicaid eligibility|22|||
146076494|NCT02123251|526801929|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
146076495|NCT02123251|526801930|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
146076496|NCT00727441|526801933|FG000|Overall Study|Disease Progression|11|||
146076497|NCT00727441|526801934|FG001|Overall Study|Disease Progression|14|||
146076498|NCT00727441|526801935|FG002|Overall Study|Disease Progression|17|||
146076499|NCT00727441|526801933|FG000|Overall Study|Eligibility|7|||
146076500|NCT00727441|526801934|FG001|Overall Study|Eligibility|5|||
146076501|NCT00727441|526801935|FG002|Overall Study|Eligibility|7|||
146076502|NCT00727441|526801933|FG000|Overall Study|Death|0|||
146076503|NCT00727441|526801934|FG001|Overall Study|Death|1|||
146076504|NCT00727441|526801935|FG002|Overall Study|Death|1|||
146076505|NCT00727441|526801933|FG000|Overall Study|Physician Decision|0|||
146076506|NCT00727441|526801934|FG001|Overall Study|Physician Decision|1|||
146076507|NCT00727441|526801935|FG002|Overall Study|Physician Decision|0|||
146076508|NCT00727441|526801933|FG000|Overall Study|Withdrawal by Subject|0|||
146076509|NCT00727441|526801934|FG001|Overall Study|Withdrawal by Subject|1|||
146076510|NCT00727441|526801935|FG002|Overall Study|Withdrawal by Subject|0|||
146076511|NCT01239992|526801936|FG000|Overall Study|Withdrawal by Subject|2|||
146076512|NCT00535288|526801937|FG000|Overall Study|Adverse Event|20|||
146076513|NCT00535288|526801938|FG001|Overall Study|Adverse Event|19|||
146076514|NCT00535288|526801939|FG002|Overall Study|Adverse Event|25|||
146076515|NCT00535288|526801940|FG003|Overall Study|Adverse Event|20|||
146076516|NCT00535288|526801941|FG004|Overall Study|Adverse Event|30|||
146076517|NCT00535288|526801937|FG000|Overall Study|Lost to Follow-up|0|||
146076518|NCT00535288|526801938|FG001|Overall Study|Lost to Follow-up|3|||
146076519|NCT00535288|526801939|FG002|Overall Study|Lost to Follow-up|0|||
146076520|NCT00535288|526801940|FG003|Overall Study|Lost to Follow-up|0|||
146076521|NCT00535288|526801941|FG004|Overall Study|Lost to Follow-up|0|||
146076522|NCT00535288|526801937|FG000|Overall Study|Lack of Efficacy|26|||
146076523|NCT00535288|526801938|FG001|Overall Study|Lack of Efficacy|3|||
146076524|NCT00535288|526801939|FG002|Overall Study|Lack of Efficacy|4|||
146076525|NCT00535288|526801940|FG003|Overall Study|Lack of Efficacy|4|||
146076526|NCT00535288|526801941|FG004|Overall Study|Lack of Efficacy|7|||
146076527|NCT00535288|526801937|FG000|Overall Study|Unwilling to cooperate|6|||
146076528|NCT00535288|526801938|FG001|Overall Study|Unwilling to cooperate|6|||
146076529|NCT00535288|526801939|FG002|Overall Study|Unwilling to cooperate|3|||
146076530|NCT00535288|526801940|FG003|Overall Study|Unwilling to cooperate|3|||
146076531|NCT00535288|526801941|FG004|Overall Study|Unwilling to cooperate|4|||
146076532|NCT00535288|526801937|FG000|Overall Study|Other|2|||
146076533|NCT00535288|526801938|FG001|Overall Study|Other|1|||
146076534|NCT00535288|526801939|FG002|Overall Study|Other|1|||
146076535|NCT00535288|526801940|FG003|Overall Study|Other|2|||
146076536|NCT00535288|526801941|FG004|Overall Study|Other|1|||
146076537|NCT02848729|526801944|FG000|Overall Study|Withdrawal by Subject|1|||
146076538|NCT02848729|526801945|FG001|Overall Study|Withdrawal by Subject|0|||
146076539|NCT02848729|526801944|FG000|Overall Study|Emesis|15|||
146076540|NCT02848729|526801945|FG001|Overall Study|Emesis|11|||
146076541|NCT02617485|526801946|FG000|Treatment and Observation Period|Adverse Event|9|||
146076542|NCT02617485|526801947|FG001|Treatment and Observation Period|Adverse Event|1|||
146076543|NCT02617485|526801946|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
146076544|NCT02617485|526801947|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
146076545|NCT02617485|526801946|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
146076546|NCT02617485|526801947|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
146076547|NCT02617485|526801946|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
146076548|NCT02617485|526801947|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
146076549|NCT02617485|526801946|FG000|Treatment and Observation Period|Physician Decision|0|||
146076550|NCT02617485|526801947|FG001|Treatment and Observation Period|Physician Decision|1|||
146176145|NCT00917267|527158573|FG001|Overall Study|Protocol Violation|18|||
146176146|NCT00917267|527158572|FG000|Overall Study|Withdrawal by Subject|5|||
146176147|NCT00917267|527158573|FG001|Overall Study|Withdrawal by Subject|12|||
146176148|NCT00917267|527158572|FG000|Overall Study|Lost to follow up|0|||
146176149|NCT00917267|527158573|FG001|Overall Study|Lost to follow up|2|||
146176150|NCT00917267|527158572|FG000|Overall Study|Entry Criteria Not Met|1|||
146176151|NCT00917267|527158573|FG001|Overall Study|Entry Criteria Not Met|0|||
146176152|NCT00917267|527158572|FG000|Overall Study|Sponsor Decision|5|||
146176153|NCT00917267|527158573|FG001|Overall Study|Sponsor Decision|5|||
146176154|NCT00917267|527158572|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
146176155|NCT00917267|527158573|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
146176156|NCT02960763|527158575|FG000|Step 1|Withdrawal by Subject|10|||
146176157|NCT02960763|527158576|FG001|Step 1|Withdrawal by Subject|8|||
146176158|NCT02960763|527158577|FG002|Step 1|Withdrawal by Subject|13|||
146176159|NCT02960763|527158578|FG003|Step 1|Withdrawal by Subject|0|||
146176160|NCT02960763|527158579|FG004|Step 1|Withdrawal by Subject|0|||
146176161|NCT02960763|527158575|FG000|Step 1|Lost to Follow-up|7|||
146176162|NCT02960763|527158576|FG001|Step 1|Lost to Follow-up|9|||
146176163|NCT02960763|527158577|FG002|Step 1|Lost to Follow-up|12|||
146176164|NCT02960763|527158578|FG003|Step 1|Lost to Follow-up|0|||
146176165|NCT02960763|527158579|FG004|Step 1|Lost to Follow-up|0|||
146176166|NCT02960763|527158575|FG000|Step 1|Death|1|||
146176167|NCT02960763|527158576|FG001|Step 1|Death|1|||
146176168|NCT02960763|527158577|FG002|Step 1|Death|1|||
146176169|NCT02960763|527158578|FG003|Step 1|Death|0|||
146176170|NCT02960763|527158579|FG004|Step 1|Death|0|||
146176171|NCT02960763|527158575|FG000|Step 1|Investigator discretion|1|||
146176172|NCT02960763|527158576|FG001|Step 1|Investigator discretion|0|||
146176173|NCT02960763|527158577|FG002|Step 1|Investigator discretion|1|||
146176174|NCT02960763|527158578|FG003|Step 1|Investigator discretion|0|||
146176175|NCT02960763|527158579|FG004|Step 1|Investigator discretion|0|||
146176176|NCT02960763|527158575|FG000|Step 1|Other|0|||
146176177|NCT02960763|527158576|FG001|Step 1|Other|0|||
146176178|NCT02960763|527158577|FG002|Step 1|Other|1|||
146176179|NCT02960763|527158578|FG003|Step 1|Other|0|||
146176180|NCT02960763|527158579|FG004|Step 1|Other|0|||
146176181|NCT02960763|527158575|FG000|Step 2|Withdrawal by Subject|0|||
146176182|NCT02960763|527158576|FG001|Step 2|Withdrawal by Subject|0|||
146176183|NCT02960763|527158577|FG002|Step 2|Withdrawal by Subject|0|||
146176184|NCT02960763|527158578|FG003|Step 2|Withdrawal by Subject|7|||
146176185|NCT02960763|527158579|FG004|Step 2|Withdrawal by Subject|3|||
146176186|NCT02960763|527158575|FG000|Step 2|Lost to Follow-up|0|||
146176187|NCT02960763|527158576|FG001|Step 2|Lost to Follow-up|0|||
146176188|NCT02960763|527158577|FG002|Step 2|Lost to Follow-up|0|||
146176189|NCT02960763|527158578|FG003|Step 2|Lost to Follow-up|4|||
146176190|NCT02960763|527158579|FG004|Step 2|Lost to Follow-up|1|||
146176191|NCT02960763|527158575|FG000|Step 2|Investigator discretion|0|||
146176192|NCT02960763|527158576|FG001|Step 2|Investigator discretion|0|||
146176193|NCT02960763|527158577|FG002|Step 2|Investigator discretion|0|||
146176194|NCT02960763|527158578|FG003|Step 2|Investigator discretion|0|||
146176195|NCT02960763|527158579|FG004|Step 2|Investigator discretion|1|||
146176196|NCT00312858|527158581|FG000|Overall Study|Adverse Event|0|||
146176197|NCT00312858|527158582|FG001|Overall Study|Adverse Event|1|||
146176198|NCT00312858|527158581|FG000|Overall Study|Lost to Follow-up|25|||
146176199|NCT00312858|527158582|FG001|Overall Study|Lost to Follow-up|42|||
146176200|NCT00312858|527158581|FG000|Overall Study|Protocol Violation|3|||
146176201|NCT00312858|527158582|FG001|Overall Study|Protocol Violation|8|||
146176202|NCT00312858|527158581|FG000|Overall Study|Withdraw by Participant|20|||
146176203|NCT00312858|527158582|FG001|Overall Study|Withdraw by Participant|20|||
146176204|NCT00312858|527158581|FG000|Overall Study|Participant Moved|11|||
146176205|NCT00312858|527158582|FG001|Overall Study|Participant Moved|10|||
146176206|NCT00312858|527158581|FG000|Overall Study|Other|9|||
146176207|NCT00312858|527158582|FG001|Overall Study|Other|12|||
146176208|NCT03638635|527158583|FG000|Initial Hospitalization|Study terminated prematurely|0|||
146176209|NCT03638635|527158584|FG001|Initial Hospitalization|Study terminated prematurely|1|||
146176210|NCT03638635|527158583|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
146283922|NCT00935818|527551901|FG001|Overall Study|Adverse Event|7|||
146176211|NCT03638635|527158584|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
146176212|NCT03638635|527158583|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
146176213|NCT03638635|527158584|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
146176214|NCT04399551|527158587|FG000|Overall Study|Adverse Event|15|||
146176215|NCT04399551|527158587|FG000|Overall Study|Withdrawal by Subject|6|||
146176216|NCT04399551|527158587|FG000|Overall Study|Physician Decision|3|||
146176217|NCT04399551|527158587|FG000|Overall Study|Lost to Follow-up|2|||
146176218|NCT04399551|527158587|FG000|Overall Study|Protocol Deviation|2|||
146176219|NCT01014975|527158589|FG000|Overall Study|Withdrawal by Subject|1|||
146176220|NCT01014975|527158590|FG001|Overall Study|Withdrawal by Subject|0|||
146176221|NCT01014975|527158591|FG002|Overall Study|Withdrawal by Subject|1|||
146176222|NCT01014975|527158589|FG000|Overall Study|Death|3|||
146176223|NCT01014975|527158590|FG001|Overall Study|Death|3|||
146176224|NCT01014975|527158591|FG002|Overall Study|Death|4|||
146176225|NCT01014975|527158589|FG000|Overall Study|Lost to Follow-up|0|||
146176226|NCT01014975|527158590|FG001|Overall Study|Lost to Follow-up|0|||
146176227|NCT01014975|527158591|FG002|Overall Study|Lost to Follow-up|1|||
146176228|NCT01112514|527158594|FG000|Overall Study|Lost to Follow-up|1|||
146176229|NCT01336634|527158595|FG000|Overall Study|Study closed/terminated|5|||
146176230|NCT01336634|527158596|FG001|Overall Study|Study closed/terminated|6|||
146176231|NCT01336634|527158597|FG002|Overall Study|Study closed/terminated|6|||
146176232|NCT01336634|527158595|FG000|Overall Study|Lost to Follow-up|2|||
146176233|NCT01336634|527158596|FG001|Overall Study|Lost to Follow-up|1|||
146176234|NCT01336634|527158597|FG002|Overall Study|Lost to Follow-up|1|||
146176235|NCT01336634|527158595|FG000|Overall Study|Physician Decision|1|||
146176236|NCT01336634|527158596|FG001|Overall Study|Physician Decision|1|||
146176237|NCT01336634|527158597|FG002|Overall Study|Physician Decision|0|||
146176238|NCT01336634|527158595|FG000|Overall Study|Withdrawal by Subject|6|||
146176239|NCT01336634|527158596|FG001|Overall Study|Withdrawal by Subject|0|||
146176240|NCT01336634|527158597|FG002|Overall Study|Withdrawal by Subject|2|||
146176241|NCT03321006|527158608|FG000|Overall Study|Death|1|||
146176242|NCT03321006|527158609|FG001|Overall Study|Death|0|||
146176243|NCT03321006|527158608|FG000|Overall Study|Lack of Efficacy|1|||
146176244|NCT03321006|527158609|FG001|Overall Study|Lack of Efficacy|0|||
146176245|NCT02567825|527158612|FG000|Overall Study|No follow-up post-randomization|5|||
146176246|NCT02567825|527158613|FG001|Overall Study|No follow-up post-randomization|1|||
146176247|NCT02567825|527158612|FG000|Overall Study|Follow-up less than 23 months|16|||
146176248|NCT02567825|527158613|FG001|Overall Study|Follow-up less than 23 months|20|||
146176249|NCT04741802|527158614|FG000|Overall Study|Death|1|||
146176250|NCT04741802|527158614|FG000|Overall Study|Lost to Follow-up|11|||
146176251|NCT03101241|527158616|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
146176252|NCT03101241|527158617|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
146176253|NCT03101241|527158616|FG000|Overall Study|Participant withdrew consent|3|||
146176254|NCT03101241|527158617|FG001|Overall Study|Participant withdrew consent|1|||
146176255|NCT03101241|527158616|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
146176256|NCT03101241|527158617|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
146176257|NCT03101241|527158616|FG000|Overall Study|Lost to Follow-up|2|||
146176258|NCT03101241|527158617|FG001|Overall Study|Lost to Follow-up|0|||
146176259|NCT03101241|527158616|FG000|Overall Study|Lack of Efficacy|0|||
146176260|NCT03101241|527158617|FG001|Overall Study|Lack of Efficacy|1|||
146176261|NCT03101241|527158616|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
146176262|NCT03101241|527158617|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
146176263|NCT04498247|527158618|FG000|Overall Study|Lost to Follow-up|0|||
146176264|NCT04498247|527158619|FG001|Overall Study|Lost to Follow-up|0|||
146176265|NCT04498247|527158620|FG002|Overall Study|Lost to Follow-up|0|||
146176266|NCT04498247|527158621|FG003|Overall Study|Lost to Follow-up|1|||
146176267|NCT04498247|527158622|FG004|Overall Study|Lost to Follow-up|0|||
146176268|NCT04498247|527158623|FG005|Overall Study|Lost to Follow-up|0|||
146176269|NCT04498247|527158624|FG006|Overall Study|Lost to Follow-up|0|||
146176270|NCT04498247|527158625|FG007|Overall Study|Lost to Follow-up|0|||
146176271|NCT04498247|527158618|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
146176272|NCT04498247|527158619|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176273|NCT04498247|527158620|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176274|NCT04498247|527158621|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176275|NCT04498247|527158622|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176276|NCT04498247|527158623|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176277|NCT04498247|527158624|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176278|NCT04498247|527158625|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
146176279|NCT04498247|527158618|FG000|Overall Study|Withdrawal by Subject|0|||
146176280|NCT04498247|527158619|FG001|Overall Study|Withdrawal by Subject|8|||
146176281|NCT04498247|527158620|FG002|Overall Study|Withdrawal by Subject|0|||
146176282|NCT04498247|527158621|FG003|Overall Study|Withdrawal by Subject|7|||
146176283|NCT04498247|527158622|FG004|Overall Study|Withdrawal by Subject|0|||
146176284|NCT04498247|527158623|FG005|Overall Study|Withdrawal by Subject|0|||
146176285|NCT04498247|527158624|FG006|Overall Study|Withdrawal by Subject|1|||
146176286|NCT04498247|527158625|FG007|Overall Study|Withdrawal by Subject|0|||
146176287|NCT04498247|527158618|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146176288|NCT04498247|527158619|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
146176289|NCT04498247|527158620|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146176290|NCT04498247|527158621|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
146176291|NCT04498247|527158622|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146176292|NCT04498247|527158623|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146176293|NCT04498247|527158624|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
146176294|NCT04498247|527158625|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
146176295|NCT01381874|527158626|FG000|Overall Study|Lost to Follow-up|1|||
146176296|NCT01381874|527158627|FG001|Overall Study|Lost to Follow-up|1|||
146176297|NCT01381874|527158628|FG002|Overall Study|Lost to Follow-up|0|||
146176298|NCT01381874|527158626|FG000|Overall Study|Withdrawal by Subject|9|||
146176299|NCT01381874|527158627|FG001|Overall Study|Withdrawal by Subject|10|||
146176300|NCT01381874|527158628|FG002|Overall Study|Withdrawal by Subject|9|||
146176301|NCT01381874|527158626|FG000|Overall Study|Other|67|||
146176302|NCT01381874|527158627|FG001|Overall Study|Other|52|||
146176303|NCT01381874|527158628|FG002|Overall Study|Other|67|||
146176304|NCT04488003|527158629|FG000|Assessed for Eligibility|Screen Failure|24|||
146176305|NCT04488003|527158630|FG001|Assessed for Eligibility|Screen Failure|0|||
146176306|NCT04488003|527158631|FG002|Assessed for Eligibility|Screen Failure|0|||
146176307|NCT04488003|527158629|FG000|Assessed for Eligibility|Adverse Event|1|||
146176308|NCT04488003|527158630|FG001|Assessed for Eligibility|Adverse Event|0|||
146176309|NCT04488003|527158631|FG002|Assessed for Eligibility|Adverse Event|0|||
146176310|NCT04488003|527158629|FG000|Assessed for Eligibility|Death|1|||
146176311|NCT04488003|527158630|FG001|Assessed for Eligibility|Death|0|||
146176312|NCT04488003|527158631|FG002|Assessed for Eligibility|Death|0|||
146176313|NCT04488003|527158629|FG000|Assessed for Eligibility|Physician Decision|1|||
146176314|NCT04488003|527158630|FG001|Assessed for Eligibility|Physician Decision|0|||
146176315|NCT04488003|527158631|FG002|Assessed for Eligibility|Physician Decision|0|||
146176316|NCT04488003|527158629|FG000|Allocated to Treatment|Progressive Disease|51|||
146176317|NCT04488003|527158630|FG001|Allocated to Treatment|Progressive Disease|0|||
146176318|NCT04488003|527158631|FG002|Allocated to Treatment|Progressive Disease|0|||
146176319|NCT04488003|527158629|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
146176320|NCT04488003|527158630|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
146176321|NCT04488003|527158631|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
146176322|NCT04488003|527158629|FG000|Allocated to Treatment|Adverse Event|6|||
146176323|NCT04488003|527158630|FG001|Allocated to Treatment|Adverse Event|0|||
146176324|NCT04488003|527158631|FG002|Allocated to Treatment|Adverse Event|0|||
146176325|NCT04488003|527158629|FG000|Allocated to Treatment|Other|5|||
146176326|NCT04488003|527158630|FG001|Allocated to Treatment|Other|0|||
146176327|NCT04488003|527158631|FG002|Allocated to Treatment|Other|0|||
146176328|NCT04488003|527158629|FG000|Allocated to Treatment|Physician Decision|4|||
146176329|NCT04488003|527158630|FG001|Allocated to Treatment|Physician Decision|0|||
146176330|NCT04488003|527158631|FG002|Allocated to Treatment|Physician Decision|0|||
146176331|NCT04488003|527158629|FG000|Allocated to Treatment|Death|4|||
146176332|NCT04488003|527158630|FG001|Allocated to Treatment|Death|0|||
146176333|NCT04488003|527158631|FG002|Allocated to Treatment|Death|0|||
146176334|NCT01248962|527158632|FG000|Overall Study|Withdrawal by Subject|1|||
146176335|NCT01248962|527158633|FG001|Overall Study|Withdrawal by Subject|1|||
146176336|NCT01248962|527158632|FG000|Overall Study|Adverse Event|2|||
146176337|NCT01248962|527158633|FG001|Overall Study|Adverse Event|1|||
146176338|NCT01248962|527158632|FG000|Overall Study|Complete Response after 4 Cycles|1|||
146176339|NCT01248962|527158633|FG001|Overall Study|Complete Response after 4 Cycles|0|||
146176340|NCT01248962|527158632|FG000|Overall Study|Complete Response after 3 Cycles|0|||
146176341|NCT01248962|527158633|FG001|Overall Study|Complete Response after 3 Cycles|1|||
146176342|NCT01248962|527158632|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
146176343|NCT01248962|527158633|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
146176344|NCT00245856|527158634|FG000|Period Two|Withdrawal by Subject|0|||
146176345|NCT00245856|527158635|FG001|Period Two|Withdrawal by Subject|1|||
146176346|NCT01003184|527158636|FG000|Overall Study|Adverse Event|12|||
146176347|NCT01003184|527158637|FG001|Overall Study|Adverse Event|5|||
146176348|NCT01003184|527158636|FG000|Overall Study|Lost to Follow-up|1|||
146176349|NCT01003184|527158637|FG001|Overall Study|Lost to Follow-up|0|||
146176350|NCT01003184|527158636|FG000|Overall Study|Loss of glucose control|1|||
146176351|NCT01003184|527158637|FG001|Overall Study|Loss of glucose control|1|||
146176352|NCT01003184|527158636|FG000|Overall Study|Protocol Violation|3|||
146176353|NCT01003184|527158637|FG001|Overall Study|Protocol Violation|0|||
146176354|NCT01003184|527158636|FG000|Overall Study|Withdrawal by Subject|1|||
146176355|NCT01003184|527158637|FG001|Overall Study|Withdrawal by Subject|6|||
146176356|NCT01003184|527158636|FG000|Overall Study|Physician Decision|1|||
146176357|NCT01003184|527158637|FG001|Overall Study|Physician Decision|0|||
146176358|NCT00557622|527158638|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
146176359|NCT00557622|527158639|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
146176360|NCT00557622|527158638|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
146176361|NCT00557622|527158639|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
146176362|NCT00557622|527158638|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
146176363|NCT00557622|527158639|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
146176364|NCT01539863|527158640|FG000|Overall Study|Lost to Follow-up|5|||
146176365|NCT01539863|527158641|FG001|Overall Study|Lost to Follow-up|4|||
146176366|NCT04848662|527158642|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
146176367|NCT04848662|527158643|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
146176368|NCT03662997|527158650|FG000|Overall Study|Adverse Event|0|||
146176369|NCT03662997|527158651|FG001|Overall Study|Adverse Event|2|||
146176370|NCT03662997|527158652|FG002|Overall Study|Adverse Event|0|||
146176371|NCT03662997|527158653|FG003|Overall Study|Adverse Event|0|||
146176372|NCT00007475|527158654|FG000|Overall Study|Withdrawal by Subject|1|||
146176373|NCT00007475|527158655|FG001|Overall Study|Withdrawal by Subject|0|||
146176374|NCT00007475|527158656|FG002|Overall Study|Withdrawal by Subject|0|||
146176375|NCT00007475|527158657|FG003|Overall Study|Withdrawal by Subject|0|||
146176376|NCT00007475|527158654|FG000|Overall Study|Adverse Event|3|||
146176377|NCT00007475|527158655|FG001|Overall Study|Adverse Event|0|||
146176378|NCT00007475|527158656|FG002|Overall Study|Adverse Event|0|||
146176379|NCT00007475|527158657|FG003|Overall Study|Adverse Event|0|||
146176380|NCT01719224|527158658|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
146176381|NCT01719224|527158659|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
146176382|NCT03000673|527158660|FG000|Overall Study|Withdrawal by Subject|1|||
146176383|NCT03000673|527158661|FG001|Overall Study|Withdrawal by Subject|0|||
146176384|NCT03000673|527158662|FG002|Overall Study|Withdrawal by Subject|0|||
146176385|NCT03000673|527158663|FG003|Overall Study|Withdrawal by Subject|0|||
146176386|NCT01121484|527158665|FG000|Overall Study|Adverse Event|12|||
146176387|NCT01121484|527158666|FG001|Overall Study|Adverse Event|5|||
146176388|NCT01121484|527158665|FG000|Overall Study|Lack of Efficacy|3|||
146176389|NCT01121484|527158666|FG001|Overall Study|Lack of Efficacy|11|||
146176390|NCT01121484|527158665|FG000|Overall Study|Lost to Follow-up|5|||
146176391|NCT01121484|527158666|FG001|Overall Study|Lost to Follow-up|9|||
146176392|NCT01121484|527158665|FG000|Overall Study|Physician Decision|0|||
146176393|NCT01121484|527158666|FG001|Overall Study|Physician Decision|3|||
146176394|NCT01121484|527158665|FG000|Overall Study|Protocol Violation|1|||
146176395|NCT01121484|527158666|FG001|Overall Study|Protocol Violation|0|||
146176396|NCT01121484|527158665|FG000|Overall Study|Withdrawal by Subject|8|||
146176397|NCT01121484|527158666|FG001|Overall Study|Withdrawal by Subject|7|||
146176398|NCT01121484|527158665|FG000|Overall Study|Discontinuation of study by sponsor|0|||
146176399|NCT01121484|527158666|FG001|Overall Study|Discontinuation of study by sponsor|1|||
146176400|NCT01121484|527158665|FG000|Overall Study|Other|3|||
146176401|NCT01121484|527158666|FG001|Overall Study|Other|3|||
146176402|NCT01121484|527158665|FG000|Overall Study|Randomized, not treated|1|||
146176403|NCT01121484|527158666|FG001|Overall Study|Randomized, not treated|4|||
146176404|NCT01512745|527158667|FG000|Overall Study|Adverse Event|22|||
146176405|NCT01512745|527158668|FG001|Overall Study|Adverse Event|3|||
146176406|NCT01512745|527158667|FG000|Overall Study|Death|9|||
146176407|NCT01512745|527158668|FG001|Overall Study|Death|13|||
146176408|NCT01512745|527158667|FG000|Overall Study|Withdrawal by Subject|2|||
146176409|NCT01512745|527158668|FG001|Overall Study|Withdrawal by Subject|2|||
146176410|NCT01512745|527158667|FG000|Overall Study|Lost to Follow-up|4|||
146176411|NCT01512745|527158668|FG001|Overall Study|Lost to Follow-up|0|||
146176412|NCT01512745|527158667|FG000|Overall Study|Lack of Efficacy|2|||
146176413|NCT01512745|527158668|FG001|Overall Study|Lack of Efficacy|2|||
146176414|NCT01512745|527158667|FG000|Overall Study|Protocol Violation|1|||
146176415|NCT01512745|527158668|FG001|Overall Study|Protocol Violation|0|||
146176416|NCT02357810|527158669|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
146176417|NCT02357810|527158669|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
146176418|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Adverse Event|5|||
146176419|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
146176420|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
146176421|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
146176422|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Death|1|||
146283923|NCT00935818|527551900|FG000|Overall Study|Physician Decision|0|||
146176423|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Physician Decision|1|||
146176424|NCT02357810|527158669|FG000|Reached 12 Weeks Response|Other|1|||
146176425|NCT02357810|527158669|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
146176426|NCT02357810|527158669|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
146176427|NCT02357810|527158669|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
146176428|NCT02357810|527158669|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
146176429|NCT02357810|527158669|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
146176430|NCT02357810|527158669|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
146176431|NCT00562978|527158670|FG000|Overall Study|Patient had imaging dose only|1|||
146176432|NCT00562978|527158671|FG001|Overall Study|Patient had imaging dose only|11|||
146176433|NCT00152971|527158673|FG000|Overall Study|Adverse Event|12|||
146176434|NCT00152971|527158674|FG001|Overall Study|Adverse Event|10|||
146176435|NCT00152971|527158675|FG002|Overall Study|Adverse Event|9|||
146176436|NCT00152971|527158673|FG000|Overall Study|Protocol Violation|10|||
146176437|NCT00152971|527158674|FG001|Overall Study|Protocol Violation|11|||
146176438|NCT00152971|527158675|FG002|Overall Study|Protocol Violation|8|||
146176439|NCT00152971|527158673|FG000|Overall Study|Lost to Follow-up|17|||
146176440|NCT00152971|527158674|FG001|Overall Study|Lost to Follow-up|14|||
146176441|NCT00152971|527158675|FG002|Overall Study|Lost to Follow-up|13|||
146176442|NCT00152971|527158673|FG000|Overall Study|Withdrawal by Subject|9|||
146176443|NCT00152971|527158674|FG001|Overall Study|Withdrawal by Subject|8|||
146176444|NCT00152971|527158675|FG002|Overall Study|Withdrawal by Subject|14|||
146176445|NCT00152971|527158673|FG000|Overall Study|Other|3|||
146176446|NCT00152971|527158674|FG001|Overall Study|Other|5|||
146176447|NCT00152971|527158675|FG002|Overall Study|Other|5|||
146176448|NCT00152971|527158673|FG000|Treatment|Adverse Event|49|||
146176449|NCT00152971|527158674|FG001|Treatment|Adverse Event|40|||
146176450|NCT00152971|527158675|FG002|Treatment|Adverse Event|54|||
146176451|NCT00152971|527158673|FG000|Treatment|Protocol Violation|8|||
146176452|NCT00152971|527158674|FG001|Treatment|Protocol Violation|6|||
146176453|NCT00152971|527158675|FG002|Treatment|Protocol Violation|10|||
146176454|NCT00152971|527158673|FG000|Treatment|Lost to Follow-up|1|||
146176455|NCT00152971|527158674|FG001|Treatment|Lost to Follow-up|2|||
146176456|NCT00152971|527158675|FG002|Treatment|Lost to Follow-up|1|||
146176457|NCT00152971|527158673|FG000|Treatment|Withdrawal by Subject|4|||
146176458|NCT00152971|527158674|FG001|Treatment|Withdrawal by Subject|4|||
146176459|NCT00152971|527158675|FG002|Treatment|Withdrawal by Subject|5|||
146176460|NCT00152971|527158673|FG000|Treatment|Other|9|||
146176461|NCT00152971|527158674|FG001|Treatment|Other|11|||
146176462|NCT00152971|527158675|FG002|Treatment|Other|10|||
146176463|NCT00675506|527158676|FG000|Overall Study|Lost to Follow-up|1|||
146176464|NCT00675506|527158677|FG001|Overall Study|Lost to Follow-up|5|||
146176465|NCT00675506|527158676|FG000|Overall Study|Lost interest|3|||
146176466|NCT00675506|527158677|FG001|Overall Study|Lost interest|5|||
146176467|NCT00675506|527158676|FG000|Overall Study|Elevated fasting glucose|2|||
146176468|NCT00675506|527158677|FG001|Overall Study|Elevated fasting glucose|1|||
146176469|NCT00675506|527158676|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
146176470|NCT00675506|527158677|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
146176471|NCT00675506|527158676|FG000|Overall Study|Elevated IGF-1|2|||
146176472|NCT00675506|527158677|FG001|Overall Study|Elevated IGF-1|0|||
146176473|NCT00675506|527158676|FG000|Overall Study|Hypersensitivity Reaction|1|||
146176474|NCT00675506|527158677|FG001|Overall Study|Hypersensitivity Reaction|0|||
146176475|NCT00675506|527158676|FG000|Overall Study|Disclosed history of cancer|1|||
146176476|NCT00675506|527158677|FG001|Overall Study|Disclosed history of cancer|0|||
146176477|NCT00675506|527158676|FG000|Overall Study|Declined participation|1|||
146176478|NCT00675506|527158677|FG001|Overall Study|Declined participation|0|||
146176479|NCT00675506|527158676|FG000|Overall Study|Schedule conflict|0|||
146176480|NCT00675506|527158677|FG001|Overall Study|Schedule conflict|1|||
146176481|NCT03017235|527160607|FG000|Overall Study|Withdrawal by Subject|4|||
146176482|NCT03017235|527160608|FG001|Overall Study|Withdrawal by Subject|3|||
146176483|NCT03017235|527160607|FG000|Overall Study|Lost to Follow-up|2|||
146176484|NCT03017235|527160608|FG001|Overall Study|Lost to Follow-up|7|||
146412012|NCT01078623|528013981|FG013|Treatment Period 4|Adverse Event|0|||
146176485|NCT03017235|527160607|FG000|Overall Study|Adverse Event|0|||
146176486|NCT03017235|527160608|FG001|Overall Study|Adverse Event|1|||
146176487|NCT03017235|527160607|FG000|Overall Study|Protocol Violation|2|||
146176488|NCT03017235|527160608|FG001|Overall Study|Protocol Violation|1|||
146176489|NCT03017235|527160607|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
146176490|NCT03017235|527160608|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
146176491|NCT00437125|527160609|FG000|Overall Study|Adverse Event|12|||
146176492|NCT00437125|527160609|FG000|Overall Study|Death|1|||
146176493|NCT00437125|527160609|FG000|Overall Study|Clinical Relapse|1|||
146176494|NCT00437125|527160609|FG000|Overall Study|Lack of Efficacy|1|||
146412013|NCT01078623|528013982|FG014|Treatment Period 4|Adverse Event|0|||
146176495|NCT00437125|527160609|FG000|Overall Study|Lost to Follow-up|1|||
146176496|NCT00437125|527160609|FG000|Overall Study|Withdrawal by Subject|13|||
146176497|NCT00437125|527160609|FG000|Overall Study|Withdrawal by Caregiver|2|||
146176498|NCT00437125|527160609|FG000|Overall Study|Physician Decision|1|||
146076551|NCT02617485|526801946|FG000|Follow-up Period|Adverse Event|1|||
146076552|NCT02617485|526801947|FG001|Follow-up Period|Adverse Event|0|||
146076553|NCT02617485|526801946|FG000|Follow-up Period|Withdrawal by Subject|1|||
146076554|NCT02617485|526801947|FG001|Follow-up Period|Withdrawal by Subject|0|||
146076555|NCT02617485|526801946|FG000|Follow-up Period|Disease progression|2|||
146076556|NCT02617485|526801947|FG001|Follow-up Period|Disease progression|1|||
146076557|NCT02617485|526801946|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
146076558|NCT02617485|526801947|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
146076559|NCT02617485|526801946|FG000|Follow-up Period|Patient needed radiotherapy|9|||
146076560|NCT02617485|526801947|FG001|Follow-up Period|Patient needed radiotherapy|5|||
146076561|NCT02617485|526801946|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
146076562|NCT02617485|526801947|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
146076563|NCT00220779|526801951|FG000|Overall Study|Adverse Event|1|||
146076564|NCT00220779|526801952|FG001|Overall Study|Adverse Event|0|||
146076565|NCT00220779|526801953|FG002|Overall Study|Adverse Event|0|||
146076566|NCT00220779|526801951|FG000|Overall Study|Withdrawal by Subject|1|||
146076567|NCT00220779|526801952|FG001|Overall Study|Withdrawal by Subject|4|||
146076568|NCT00220779|526801953|FG002|Overall Study|Withdrawal by Subject|1|||
146076569|NCT00220779|526801951|FG000|Overall Study|Non-compliance|1|||
146076570|NCT00220779|526801952|FG001|Overall Study|Non-compliance|0|||
146076571|NCT00220779|526801953|FG002|Overall Study|Non-compliance|0|||
146076572|NCT00220779|526801951|FG000|Overall Study|Too time consuming|1|||
146076573|NCT00220779|526801952|FG001|Overall Study|Too time consuming|0|||
146076574|NCT00220779|526801953|FG002|Overall Study|Too time consuming|0|||
146076575|NCT00220779|526801951|FG000|Overall Study|Pregnancy|0|||
146076576|NCT00220779|526801952|FG001|Overall Study|Pregnancy|0|||
146076577|NCT00220779|526801953|FG002|Overall Study|Pregnancy|2|||
146076578|NCT00220779|526801951|FG000|Overall Study|Lack of Efficacy|3|||
146076579|NCT00220779|526801952|FG001|Overall Study|Lack of Efficacy|0|||
146076580|NCT00220779|526801953|FG002|Overall Study|Lack of Efficacy|1|||
146076581|NCT00791076|526801954|FG000|Overall Study|Study was terminated,PI left institution|8|||
146076582|NCT02248675|526801961|FG000|Overall Study|Lost to Follow-up|3|||
146076583|NCT02248675|526801962|FG001|Overall Study|Lost to Follow-up|1|||
146076584|NCT03390101|526801965|FG000|Weeks 0-12|Withdrawal by Subject|0|||
146076585|NCT03390101|526801966|FG001|Weeks 0-12|Withdrawal by Subject|1|||
146076586|NCT03390101|526801967|FG002|Weeks 0-12|Withdrawal by Subject|1|||
146076587|NCT03390101|526801965|FG000|Weeks 0-12|Lost to Follow-up|0|||
146076588|NCT03390101|526801966|FG001|Weeks 0-12|Lost to Follow-up|1|||
146076589|NCT03390101|526801967|FG002|Weeks 0-12|Lost to Follow-up|0|||
146076590|NCT03390101|526801965|FG000|Weeks 12-54|Withdrawal by Subject|0|||
146076591|NCT03390101|526801966|FG001|Weeks 12-54|Withdrawal by Subject|3|||
146076592|NCT03390101|526801967|FG002|Weeks 12-54|Withdrawal by Subject|1|||
146076593|NCT03390101|526801965|FG000|Weeks 12-54|Pregnancy|1|||
146076594|NCT03390101|526801966|FG001|Weeks 12-54|Pregnancy|0|||
146076595|NCT03390101|526801967|FG002|Weeks 12-54|Pregnancy|0|||
146076596|NCT03390101|526801965|FG000|Weeks 12-54|Adverse Event|2|||
146076597|NCT03390101|526801966|FG001|Weeks 12-54|Adverse Event|1|||
146076598|NCT03390101|526801967|FG002|Weeks 12-54|Adverse Event|1|||
146076599|NCT01511055|526801968|FG000|Overall Study|Withdrawal by Subject|6|||
146076600|NCT00830869|526801969|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
146076601|NCT00830869|526801970|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
146076602|NCT00830869|526801971|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
146076603|NCT00830869|526801972|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
146076604|NCT00830869|526801973|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
146076605|NCT00830869|526801974|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
146076606|NCT00830869|526801975|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
146076607|NCT00830869|526801976|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
146076608|NCT00830869|526801977|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
146076609|NCT00830869|526801978|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
146076610|NCT00830869|526801979|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
146076611|NCT00830869|526801980|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
146076612|NCT00830869|526801969|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
146076613|NCT00830869|526801970|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
146076614|NCT00830869|526801971|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
146076615|NCT00830869|526801972|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
146076616|NCT00830869|526801973|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
146076617|NCT00830869|526801974|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
146076618|NCT00830869|526801975|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
146076619|NCT00830869|526801976|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
146076620|NCT00830869|526801977|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
146076621|NCT00830869|526801978|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
146076622|NCT00830869|526801979|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
146076623|NCT00830869|526801980|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
146076624|NCT00830869|526801969|FG000|Period 1: Part 1|Adverse Event|0|||
146176499|NCT02248961|527160610|FG000|Overall Study|Adverse Event|1|||
146176500|NCT02248961|527160611|FG001|Overall Study|Adverse Event|0|||
146176501|NCT02248961|527160610|FG000|Overall Study|Withdrawal by Subject|1|||
146176502|NCT02248961|527160611|FG001|Overall Study|Withdrawal by Subject|2|||
146176503|NCT02248961|527160610|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
146176504|NCT02248961|527160611|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
146176505|NCT03518658|527160612|FG000|Overall Study|Other|51|||
146176506|NCT03518658|527160613|FG001|Overall Study|Other|0|||
146176507|NCT02531295|527160614|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
146176508|NCT02531295|527160615|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
146176509|NCT02531295|527160616|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
146176510|NCT02531295|527160617|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
146176511|NCT02531295|527160618|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
146176512|NCT02531295|527160619|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
146176513|NCT00649389|527160620|FG000|Overall Study|Adverse Event|22|||
146176514|NCT00649389|527160621|FG001|Overall Study|Adverse Event|46|||
146176515|NCT00649389|527160622|FG002|Overall Study|Adverse Event|38|||
146176516|NCT00649389|527160623|FG003|Overall Study|Adverse Event|48|||
146176517|NCT00649389|527160620|FG000|Overall Study|Lost to Follow-up|15|||
146176518|NCT00649389|527160621|FG001|Overall Study|Lost to Follow-up|17|||
146176519|NCT00649389|527160622|FG002|Overall Study|Lost to Follow-up|21|||
146176520|NCT00649389|527160623|FG003|Overall Study|Lost to Follow-up|26|||
146176521|NCT00649389|527160620|FG000|Overall Study|Protocol Violation|11|||
146176522|NCT00649389|527160621|FG001|Overall Study|Protocol Violation|13|||
146176523|NCT00649389|527160622|FG002|Overall Study|Protocol Violation|9|||
146176524|NCT00649389|527160623|FG003|Overall Study|Protocol Violation|8|||
146176525|NCT00649389|527160620|FG000|Overall Study|Withdrawal by Subject|20|||
146176526|NCT00649389|527160621|FG001|Overall Study|Withdrawal by Subject|21|||
146176527|NCT00649389|527160622|FG002|Overall Study|Withdrawal by Subject|19|||
146176528|NCT00649389|527160623|FG003|Overall Study|Withdrawal by Subject|23|||
146176529|NCT00649389|527160620|FG000|Overall Study|Other|3|||
146176530|NCT00649389|527160621|FG001|Overall Study|Other|9|||
146176531|NCT00649389|527160622|FG002|Overall Study|Other|1|||
146176532|NCT00649389|527160623|FG003|Overall Study|Other|6|||
146176533|NCT00453310|527160626|FG000|Overall Study|Progression of Disease|10|||
146176534|NCT04666922|527160627|FG000|Overall Study|Withdrawal by Subject|1|||
146176535|NCT04666922|527160628|FG001|Overall Study|Withdrawal by Subject|0|||
146176536|NCT04666922|527160629|FG002|Overall Study|Withdrawal by Subject|0|||
146176537|NCT04666922|527160630|FG003|Overall Study|Withdrawal by Subject|0|||
146176538|NCT04666922|527160631|FG004|Overall Study|Withdrawal by Subject|0|||
146176539|NCT04666922|527160632|FG005|Overall Study|Withdrawal by Subject|0|||
146176540|NCT04666922|527160633|FG006|Overall Study|Withdrawal by Subject|0|||
146176541|NCT01382940|527160634|FG000|Overall Study|Adverse Event|19|||
146176542|NCT01382940|527160634|FG000|Overall Study|Lost to Follow-up|4|||
146176543|NCT01382940|527160634|FG000|Overall Study|Physician Decision|7|||
146176544|NCT01382940|527160634|FG000|Overall Study|Withdrawal by Subject|23|||
146176545|NCT01382940|527160634|FG000|Overall Study|Protocol Violation|20|||
146176546|NCT00244374|527160637|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
146176547|NCT00244374|527160638|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146176548|NCT00244374|527160639|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146176549|NCT00244374|527160640|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146176550|NCT00244374|527160641|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
146176551|NCT00244374|527160637|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
146176552|NCT00244374|527160638|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146176553|NCT00244374|527160639|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146176554|NCT00244374|527160640|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146176555|NCT00244374|527160641|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
146176556|NCT00244374|527160637|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
146176557|NCT00244374|527160638|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146176558|NCT00244374|527160639|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146176559|NCT00244374|527160640|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146176560|NCT00244374|527160641|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
146176561|NCT00244374|527160637|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
146176562|NCT00244374|527160638|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146176563|NCT00244374|527160639|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146176564|NCT00244374|527160640|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146176565|NCT00244374|527160641|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
146283924|NCT00935818|527551901|FG001|Overall Study|Physician Decision|1|||
146283925|NCT00604825|527551904|FG000|Overall Study|Adverse Event|2|||
146176566|NCT00244374|527160637|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
146176567|NCT00244374|527160638|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146176568|NCT00244374|527160639|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146176569|NCT00244374|527160640|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146176570|NCT00244374|527160641|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
146176571|NCT00244374|527160637|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
146176572|NCT00244374|527160638|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146176573|NCT00244374|527160639|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146176574|NCT00244374|527160640|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146176575|NCT00244374|527160641|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
146176576|NCT00244374|527160637|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
146176577|NCT00244374|527160638|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146176578|NCT00244374|527160639|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146176579|NCT00244374|527160640|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146176580|NCT00244374|527160641|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
146176581|NCT00244374|527160637|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
146176582|NCT00244374|527160638|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146176583|NCT00244374|527160639|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146176584|NCT00244374|527160640|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146176585|NCT00244374|527160641|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
146176586|NCT00244374|527160637|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
146176587|NCT00244374|527160638|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146176588|NCT00244374|527160639|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146176589|NCT00244374|527160640|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146176590|NCT00244374|527160641|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
146176591|NCT02105636|527160642|FG000|Pre-Treatment|Disease Progression|1|||
146176592|NCT02105636|527160643|FG001|Pre-Treatment|Disease Progression|0|||
146176593|NCT02105636|527160642|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
146176594|NCT02105636|527160643|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
146176595|NCT02105636|527160642|FG000|Pre-Treatment|Participant withdrew consent|0|||
146176596|NCT02105636|527160643|FG001|Pre-Treatment|Participant withdrew consent|6|||
146176597|NCT02105636|527160642|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146176598|NCT02105636|527160643|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
146176599|NCT02105636|527160642|FG000|Treatment|Study Drug Toxicity|14|||
146176600|NCT02105636|527160643|FG001|Treatment|Study Drug Toxicity|10|||
146176601|NCT02105636|527160642|FG000|Treatment|Adverse event unrelated to study drug|19|||
146176602|NCT02105636|527160643|FG001|Treatment|Adverse event unrelated to study drug|3|||
146176603|NCT02105636|527160642|FG000|Treatment|Participant request to discontinue study treatment|8|||
146176604|NCT02105636|527160643|FG001|Treatment|Participant request to discontinue study treatment|6|||
146176605|NCT02105636|527160642|FG000|Treatment|Participant withdrew consent|5|||
146176606|NCT02105636|527160643|FG001|Treatment|Participant withdrew consent|1|||
146176607|NCT02105636|527160642|FG000|Treatment|Lost to Follow-up|1|||
146176608|NCT02105636|527160643|FG001|Treatment|Lost to Follow-up|0|||
146176609|NCT02105636|527160642|FG000|Treatment|Maximum Clinical Benefit|1|||
146176610|NCT02105636|527160643|FG001|Treatment|Maximum Clinical Benefit|3|||
146176611|NCT02105636|527160642|FG000|Treatment|Poor/Non-compliance|0|||
146176612|NCT02105636|527160643|FG001|Treatment|Poor/Non-compliance|1|||
146176613|NCT02105636|527160642|FG000|Treatment|Participant no longer meets study criteria|1|||
146176614|NCT02105636|527160643|FG001|Treatment|Participant no longer meets study criteria|0|||
146176615|NCT02105636|527160642|FG000|Treatment|Other reasons|1|||
146176616|NCT02105636|527160643|FG001|Treatment|Other reasons|0|||
146176617|NCT02105636|527160642|FG000|Treatment|Disease Progression|185|||
146176618|NCT02105636|527160643|FG001|Treatment|Disease Progression|87|||
146176619|NCT00474929|527160644|FG000|Overall Study|Withdrawal by Subject|0|||
146176620|NCT00474929|527160645|FG001|Overall Study|Withdrawal by Subject|1|||
146176621|NCT00474929|527160646|FG002|Overall Study|Withdrawal by Subject|0|||
146176622|NCT00474929|527160647|FG003|Overall Study|Withdrawal by Subject|0|||
146176623|NCT00474929|527160648|FG004|Overall Study|Withdrawal by Subject|0|||
146176624|NCT00474929|527160644|FG000|Overall Study|Unrelated medical condition|0|||
146176625|NCT00474929|527160645|FG001|Overall Study|Unrelated medical condition|0|||
146176626|NCT00474929|527160646|FG002|Overall Study|Unrelated medical condition|1|||
146176627|NCT00474929|527160647|FG003|Overall Study|Unrelated medical condition|0|||
146176628|NCT00474929|527160648|FG004|Overall Study|Unrelated medical condition|0|||
146176629|NCT00474929|527160644|FG000|Overall Study|Physician Decision|0|||
146176630|NCT00474929|527160645|FG001|Overall Study|Physician Decision|0|||
146176631|NCT00474929|527160646|FG002|Overall Study|Physician Decision|1|||
146176632|NCT00474929|527160647|FG003|Overall Study|Physician Decision|2|||
146176633|NCT00474929|527160648|FG004|Overall Study|Physician Decision|0|||
146176634|NCT02593305|527160649|FG000|Post 1|Comparison only group. No intervention.|0|||
146176635|NCT02593305|527160650|FG001|Post 1|Comparison only group. No intervention.|0|||
146176636|NCT02593305|527160651|FG002|Post 1|Comparison only group. No intervention.|10|||
146176637|NCT01993017|527160652|FG000|Overall Study|Death|23|||
146176638|NCT01993017|527160653|FG001|Overall Study|Death|26|||
146176639|NCT01993017|527160654|FG002|Overall Study|Death|18|||
146176640|NCT01993017|527160652|FG000|Overall Study|Could not be contacted|43|||
146176641|NCT01993017|527160653|FG001|Overall Study|Could not be contacted|42|||
146176642|NCT01993017|527160654|FG002|Overall Study|Could not be contacted|38|||
146176643|NCT01993017|527160652|FG000|Overall Study|Dropped out|19|||
146176644|NCT01993017|527160653|FG001|Overall Study|Dropped out|6|||
146176645|NCT01993017|527160654|FG002|Overall Study|Dropped out|11|||
146176646|NCT01993017|527160652|FG000|Overall Study|Other reasons|17|||
146176647|NCT01993017|527160653|FG001|Overall Study|Other reasons|11|||
146176648|NCT01993017|527160654|FG002|Overall Study|Other reasons|7|||
146176649|NCT01993017|527160652|FG000|Overall Study|Ineligible after randomization|4|||
146176650|NCT01993017|527160653|FG001|Overall Study|Ineligible after randomization|5|||
146176651|NCT01993017|527160654|FG002|Overall Study|Ineligible after randomization|5|||
146176652|NCT00068380|527160655|FG000|Overall Study|Withdrawal by Subject|3|||
146176653|NCT00068380|527160655|FG000|Overall Study|Adverse Event|2|||
146176654|NCT01976364|527160656|FG000|Main Study (36 Months)|Adverse Event|63|||
146176655|NCT01976364|527160657|FG001|Main Study (36 Months)|Adverse Event|0|||
146176656|NCT01976364|527160658|FG002|Main Study (36 Months)|Adverse Event|0|||
146176657|NCT01976364|527160656|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
146176658|NCT01976364|527160657|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
146176659|NCT01976364|527160658|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
146176660|NCT01976364|527160656|FG000|Main Study (36 Months)|Other|13|||
146176661|NCT01976364|527160657|FG001|Main Study (36 Months)|Other|0|||
146176662|NCT01976364|527160658|FG002|Main Study (36 Months)|Other|0|||
146176663|NCT01976364|527160656|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
146176664|NCT01976364|527160657|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
146176665|NCT01976364|527160658|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
146176666|NCT01976364|527160656|FG000|Main Study (36 Months)|Medication error|1|||
146176667|NCT01976364|527160657|FG001|Main Study (36 Months)|Medication error|0|||
146176668|NCT01976364|527160658|FG002|Main Study (36 Months)|Medication error|0|||
146176669|NCT01976364|527160656|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
146176670|NCT01976364|527160657|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
146176671|NCT01976364|527160658|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
146176672|NCT01976364|527160656|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
146176673|NCT01976364|527160657|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
146176674|NCT01976364|527160658|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
146176675|NCT01976364|527160656|FG000|Main Study (36 Months)|Protocol Violation|13|||
146176676|NCT01976364|527160657|FG001|Main Study (36 Months)|Protocol Violation|0|||
146176677|NCT01976364|527160658|FG002|Main Study (36 Months)|Protocol Violation|0|||
146176678|NCT01976364|527160656|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
146176679|NCT01976364|527160657|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
146176680|NCT01976364|527160658|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
146176681|NCT01976364|527160656|FG000|Main Study (36 Months)|Death|5|||
146176682|NCT01976364|527160657|FG001|Main Study (36 Months)|Death|0|||
146412014|NCT01078623|528013983|FG015|Treatment Period 4|Adverse Event|0|||
146412015|NCT01078623|528013984|FG016|Treatment Period 4|Adverse Event|0|||
146412016|NCT01078623|528013985|FG017|Treatment Period 4|Adverse Event|0|||
146412017|NCT01078623|528013986|FG018|Treatment Period 4|Adverse Event|0|||
146412018|NCT01078623|528013987|FG019|Treatment Period 4|Adverse Event|0|||
146412019|NCT01078623|528013968|FG000|Treatment Period 4|Withdrawal by Subject|0|||
146412020|NCT01078623|528013969|FG001|Treatment Period 4|Withdrawal by Subject|0|||
146412021|NCT01078623|528013970|FG002|Treatment Period 4|Withdrawal by Subject|0|||
146412022|NCT01078623|528013971|FG003|Treatment Period 4|Withdrawal by Subject|0|||
146412023|NCT01078623|528013972|FG004|Treatment Period 4|Withdrawal by Subject|0|||
146412024|NCT01078623|528013973|FG005|Treatment Period 4|Withdrawal by Subject|0|||
146412025|NCT01078623|528013974|FG006|Treatment Period 4|Withdrawal by Subject|0|||
146412026|NCT01078623|528013975|FG007|Treatment Period 4|Withdrawal by Subject|0|||
146412027|NCT01078623|528013976|FG008|Treatment Period 4|Withdrawal by Subject|0|||
146412028|NCT01078623|528013977|FG009|Treatment Period 4|Withdrawal by Subject|0|||
146412029|NCT01078623|528013978|FG010|Treatment Period 4|Withdrawal by Subject|0|||
146412030|NCT01078623|528013979|FG011|Treatment Period 4|Withdrawal by Subject|0|||
146176683|NCT01976364|527160658|FG002|Main Study (36 Months)|Death|0|||
146176684|NCT01976364|527160656|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
146176685|NCT01976364|527160657|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
146176686|NCT01976364|527160658|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
146176687|NCT01976364|527160656|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
146176688|NCT01976364|527160657|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
146176689|NCT01976364|527160658|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
146176690|NCT01976364|527160656|FG000|Sub-study (12 Months)|Protocol Violation|0|||
146176691|NCT01976364|527160657|FG001|Sub-study (12 Months)|Protocol Violation|1|||
146176692|NCT01976364|527160658|FG002|Sub-study (12 Months)|Protocol Violation|1|||
146176693|NCT01976364|527160656|FG000|Sub-study (12 Months)|Adverse Event|0|||
146176694|NCT01976364|527160657|FG001|Sub-study (12 Months)|Adverse Event|4|||
146176695|NCT01976364|527160658|FG002|Sub-study (12 Months)|Adverse Event|3|||
146176696|NCT02757521|527160659|FG000|Overall Study|Adverse Event|1|||
146176697|NCT02757521|527160660|FG001|Overall Study|Adverse Event|0|||
146176698|NCT01190215|527160661|FG000|Up to Month 6|Lost to Follow-up|2|||
146176699|NCT01190215|527160662|FG001|Up to Month 6|Lost to Follow-up|0|||
146176700|NCT00003511|527160663|FG000|Overall Study|Not evaluable|4|||
146176701|NCT00603265|527160667|FG000|Overall Study|Adverse Event|2|||
146176702|NCT00603265|527160668|FG001|Overall Study|Adverse Event|11|||
146176703|NCT00603265|527160669|FG002|Overall Study|Adverse Event|1|||
146176704|NCT00603265|527160667|FG000|Overall Study|Withdrawal by Subject|1|||
146176705|NCT00603265|527160668|FG001|Overall Study|Withdrawal by Subject|2|||
146176706|NCT00603265|527160669|FG002|Overall Study|Withdrawal by Subject|1|||
146176707|NCT00603265|527160667|FG000|Overall Study|Lack of Efficacy|3|||
146176708|NCT00603265|527160668|FG001|Overall Study|Lack of Efficacy|0|||
146176709|NCT00603265|527160669|FG002|Overall Study|Lack of Efficacy|3|||
146176710|NCT00603265|527160667|FG000|Overall Study|Lost to Follow-up|0|||
146176711|NCT00603265|527160668|FG001|Overall Study|Lost to Follow-up|1|||
146176712|NCT00603265|527160669|FG002|Overall Study|Lost to Follow-up|0|||
146176713|NCT00603265|527160667|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
146176714|NCT00603265|527160668|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
146176715|NCT00603265|527160669|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
146176716|NCT00603265|527160667|FG000|Overall Study|Participant Left Country, No Responses|0|||
146176717|NCT00603265|527160668|FG001|Overall Study|Participant Left Country, No Responses|1|||
146176718|NCT00603265|527160669|FG002|Overall Study|Participant Left Country, No Responses|0|||
146176719|NCT00603265|527160667|FG000|Overall Study|Protocol Violation|1|||
146176720|NCT00603265|527160668|FG001|Overall Study|Protocol Violation|0|||
146176721|NCT00603265|527160669|FG002|Overall Study|Protocol Violation|0|||
146176722|NCT01642602|527160685|FG000|Overall Study|Adverse Event|2|||
146176723|NCT02961881|527160686|FG000|Overall Study|Adverse Event|1|||
146176724|NCT02961881|527160687|FG001|Overall Study|Adverse Event|2|||
146176725|NCT02961881|527160688|FG002|Overall Study|Adverse Event|2|||
146176726|NCT02961881|527160689|FG003|Overall Study|Adverse Event|0|||
146176727|NCT02961881|527160690|FG004|Overall Study|Adverse Event|1|||
146176728|NCT02961881|527160686|FG000|Overall Study|Participant request|0|||
146176729|NCT02961881|527160687|FG001|Overall Study|Participant request|2|||
146176730|NCT02961881|527160688|FG002|Overall Study|Participant request|0|||
146176731|NCT02961881|527160689|FG003|Overall Study|Participant request|0|||
146176732|NCT02961881|527160690|FG004|Overall Study|Participant request|0|||
146176733|NCT02961881|527160686|FG000|Overall Study|Disease progression|1|||
146176734|NCT02961881|527160687|FG001|Overall Study|Disease progression|0|||
146176735|NCT02961881|527160688|FG002|Overall Study|Disease progression|1|||
146076625|NCT00830869|526801970|FG001|Period 1: Part 1|Adverse Event|0|||
146076626|NCT00830869|526801971|FG002|Period 1: Part 1|Adverse Event|0|||
146076627|NCT00830869|526801972|FG003|Period 1: Part 1|Adverse Event|0|||
146076628|NCT00830869|526801973|FG004|Period 1: Part 1|Adverse Event|0|||
146076629|NCT00830869|526801974|FG005|Period 1: Part 1|Adverse Event|1|||
146076630|NCT00830869|526801975|FG006|Period 1: Part 1|Adverse Event|1|||
146076631|NCT00830869|526801976|FG007|Period 1: Part 1|Adverse Event|0|||
146076632|NCT00830869|526801977|FG008|Period 1: Part 1|Adverse Event|0|||
146176736|NCT02961881|527160689|FG003|Overall Study|Disease progression|0|||
146176737|NCT02961881|527160690|FG004|Overall Study|Disease progression|0|||
146176738|NCT01118455|527160691|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
146176739|NCT01118455|527160692|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
146076633|NCT00830869|526801978|FG009|Period 1: Part 1|Adverse Event|0|||
146076634|NCT00830869|526801979|FG010|Period 1: Part 1|Adverse Event|0|||
146176740|NCT01973491|527160693|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
146176741|NCT01973491|527160693|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
146076635|NCT00830869|526801980|FG011|Period 1: Part 1|Adverse Event|0|||
146076636|NCT00830869|526801969|FG000|Period 1: Part 1|Progressive disease|1|||
146176742|NCT01973491|527160693|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
146176743|NCT01863043|527160695|FG000|Overall Study|Death|6|||
146176744|NCT01863043|527160696|FG001|Overall Study|Death|1|||
146176745|NCT01863043|527160695|FG000|Overall Study|Withdrawal by Subject|0|||
146176746|NCT01863043|527160696|FG001|Overall Study|Withdrawal by Subject|2|||
146176747|NCT01863043|527160695|FG000|Overall Study|Adverse Event|7|||
146176748|NCT01863043|527160696|FG001|Overall Study|Adverse Event|8|||
146176749|NCT01863043|527160695|FG000|Overall Study|exclusion criteria found after enrollment|0|||
146176750|NCT01863043|527160696|FG001|Overall Study|exclusion criteria found after enrollment|1|||
146176751|NCT03377790|527160697|FG000|Overall Study|Withdrawal by Subject|1|||
146176752|NCT03377790|527160698|FG001|Overall Study|Withdrawal by Subject|0|||
146176753|NCT03377790|527160697|FG000|Overall Study|Adverse Event|1|||
146176754|NCT03377790|527160698|FG001|Overall Study|Adverse Event|0|||
146176755|NCT03377790|527160697|FG000|Overall Study|Lost to Follow-up|0|||
146176756|NCT03377790|527160698|FG001|Overall Study|Lost to Follow-up|2|||
146176757|NCT03377790|527160697|FG000|Overall Study|Randomized but not treated|1|||
146176758|NCT03377790|527160698|FG001|Overall Study|Randomized but not treated|0|||
146176759|NCT03377790|527160697|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
146176760|NCT03377790|527160698|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
146176761|NCT01987596|527160699|FG000|Overall Study|Physician Decision|1|||
146176762|NCT01987596|527160700|FG001|Overall Study|Physician Decision|0|||
146176763|NCT01987596|527160699|FG000|Overall Study|Progressive Disease; missing all period|0|||
146176764|NCT01987596|527160700|FG001|Overall Study|Progressive Disease; missing all period|1|||
146176765|NCT02632786|527160701|FG000|Overall Study|Adverse Event|2|||
146176766|NCT02632786|527160702|FG001|Overall Study|Adverse Event|1|||
146176767|NCT02632786|527160701|FG000|Overall Study|Death|3|||
146176768|NCT02632786|527160702|FG001|Overall Study|Death|2|||
146176769|NCT02632786|527160701|FG000|Overall Study|Physician Decision|5|||
146176770|NCT02632786|527160702|FG001|Overall Study|Physician Decision|4|||
146176771|NCT02632786|527160701|FG000|Overall Study|Withdrawal by Subject|1|||
146176772|NCT02632786|527160702|FG001|Overall Study|Withdrawal by Subject|0|||
146176773|NCT01928225|527160703|FG000|Overall Study|Pregnancy|1|||
146176774|NCT01928225|527160704|FG001|Overall Study|Pregnancy|0|||
146176775|NCT01928225|527160703|FG000|Overall Study|basaloid cervical cancer|1|||
146176776|NCT01928225|527160704|FG001|Overall Study|basaloid cervical cancer|0|||
146176777|NCT01928225|527160703|FG000|Overall Study|Lost to Follow-up|1|||
146076637|NCT00830869|526801970|FG001|Period 1: Part 1|Progressive disease|0|||
146076638|NCT00830869|526801971|FG002|Period 1: Part 1|Progressive disease|1|||
146076639|NCT00830869|526801972|FG003|Period 1: Part 1|Progressive disease|6|||
146076640|NCT00830869|526801973|FG004|Period 1: Part 1|Progressive disease|4|||
146076641|NCT00830869|526801974|FG005|Period 1: Part 1|Progressive disease|4|||
146076642|NCT00830869|526801975|FG006|Period 1: Part 1|Progressive disease|1|||
146076643|NCT00830869|526801976|FG007|Period 1: Part 1|Progressive disease|0|||
146076644|NCT00830869|526801977|FG008|Period 1: Part 1|Progressive disease|0|||
146076645|NCT00830869|526801978|FG009|Period 1: Part 1|Progressive disease|0|||
146076646|NCT00830869|526801979|FG010|Period 1: Part 1|Progressive disease|0|||
146076647|NCT00830869|526801980|FG011|Period 1: Part 1|Progressive disease|0|||
146076648|NCT00830869|526801969|FG000|Period 2: Part 2|Protocol Violation|0|||
146076649|NCT00830869|526801970|FG001|Period 2: Part 2|Protocol Violation|0|||
146076650|NCT00830869|526801971|FG002|Period 2: Part 2|Protocol Violation|0|||
146076651|NCT00830869|526801972|FG003|Period 2: Part 2|Protocol Violation|0|||
146076652|NCT00830869|526801973|FG004|Period 2: Part 2|Protocol Violation|0|||
146076653|NCT00830869|526801974|FG005|Period 2: Part 2|Protocol Violation|0|||
146076654|NCT00830869|526801975|FG006|Period 2: Part 2|Protocol Violation|0|||
146076655|NCT00830869|526801976|FG007|Period 2: Part 2|Protocol Violation|1|||
146076656|NCT00830869|526801977|FG008|Period 2: Part 2|Protocol Violation|0|||
146076657|NCT00830869|526801978|FG009|Period 2: Part 2|Protocol Violation|1|||
146176778|NCT01928225|527160704|FG001|Overall Study|Lost to Follow-up|3|||
146176779|NCT00854295|527160705|FG000|Overall Study|Death|7|||
146176780|NCT00854295|527160706|FG001|Overall Study|Death|0|||
146176781|NCT00854295|527160707|FG002|Overall Study|Death|1|||
146176782|NCT00854295|527160708|FG003|Overall Study|Death|1|||
146176783|NCT00854295|527160705|FG000|Overall Study|Adverse Event|6|||
146076658|NCT00830869|526801979|FG010|Period 2: Part 2|Protocol Violation|0|||
146176784|NCT00854295|527160706|FG001|Overall Study|Adverse Event|1|||
146176785|NCT00854295|527160707|FG002|Overall Study|Adverse Event|1|||
146176786|NCT00854295|527160708|FG003|Overall Study|Adverse Event|3|||
146176787|NCT00854295|527160705|FG000|Overall Study|Lost to Follow-up|18|||
146176788|NCT00854295|527160706|FG001|Overall Study|Lost to Follow-up|5|||
146176789|NCT00854295|527160707|FG002|Overall Study|Lost to Follow-up|21|||
146176790|NCT00854295|527160708|FG003|Overall Study|Lost to Follow-up|21|||
146176791|NCT00854295|527160705|FG000|Overall Study|Physician Decision|10|||
146176792|NCT00854295|527160706|FG001|Overall Study|Physician Decision|0|||
146176793|NCT00854295|527160707|FG002|Overall Study|Physician Decision|0|||
146176794|NCT00854295|527160708|FG003|Overall Study|Physician Decision|0|||
146176795|NCT00709592|527160709|FG000|Overall Study|Unable to proceed to transplant|0|||
146176796|NCT00709592|527160710|FG001|Overall Study|Unable to proceed to transplant|1|||
146176797|NCT03154359|527160714|FG000|Overall Study|Adverse Event|1|||
146176798|NCT03154359|527160714|FG000|Overall Study|Lack of Efficacy|2|||
146176799|NCT03154359|527160714|FG000|Overall Study|Lost to Follow-up|3|||
146176800|NCT03154359|527160714|FG000|Overall Study|Physician Decision|3|||
146176801|NCT03154359|527160714|FG000|Overall Study|Protocol Violation|4|||
146176802|NCT03154359|527160714|FG000|Overall Study|Withdrawal by Subject|5|||
146176803|NCT03154359|527160714|FG000|Overall Study|Disruption of study due to COVID-19|4|||
146176804|NCT02440594|527160715|FG000|Overall Study|Lost to Follow-up|34|||
146176805|NCT02440594|527160716|FG001|Overall Study|Lost to Follow-up|33|||
146176806|NCT02440594|527160717|FG002|Overall Study|Lost to Follow-up|54|||
146176807|NCT02440594|527160718|FG003|Overall Study|Lost to Follow-up|47|||
146176808|NCT02440594|527160719|FG004|Overall Study|Lost to Follow-up|5|||
146176809|NCT02440594|527160720|FG005|Overall Study|Lost to Follow-up|4|||
146176810|NCT02440594|527160721|FG006|Overall Study|Lost to Follow-up|28|||
146176811|NCT02440594|527160722|FG007|Overall Study|Lost to Follow-up|48|||
146176812|NCT02440594|527160715|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
146176813|NCT02440594|527160716|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
146176814|NCT02440594|527160717|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
146176815|NCT02440594|527160718|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
146176816|NCT02440594|527160719|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
146176817|NCT02440594|527160720|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
146176818|NCT02440594|527160721|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
146176819|NCT02440594|527160722|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
146176820|NCT02440594|527160715|FG000|Overall Study|Withdrawal by Subject|81|||
146176821|NCT02440594|527160716|FG001|Overall Study|Withdrawal by Subject|67|||
146176822|NCT02440594|527160717|FG002|Overall Study|Withdrawal by Subject|59|||
146176823|NCT02440594|527160718|FG003|Overall Study|Withdrawal by Subject|38|||
146176824|NCT02440594|527160719|FG004|Overall Study|Withdrawal by Subject|2|||
146176825|NCT02440594|527160720|FG005|Overall Study|Withdrawal by Subject|2|||
146176826|NCT02440594|527160721|FG006|Overall Study|Withdrawal by Subject|7|||
146176827|NCT02440594|527160722|FG007|Overall Study|Withdrawal by Subject|7|||
146176828|NCT02440594|527160715|FG000|Overall Study|Administratively w/drawn|3|||
146176829|NCT02440594|527160716|FG001|Overall Study|Administratively w/drawn|2|||
146176830|NCT02440594|527160717|FG002|Overall Study|Administratively w/drawn|0|||
146176831|NCT02440594|527160718|FG003|Overall Study|Administratively w/drawn|0|||
146176832|NCT02440594|527160719|FG004|Overall Study|Administratively w/drawn|0|||
146176833|NCT02440594|527160720|FG005|Overall Study|Administratively w/drawn|0|||
146176834|NCT02440594|527160721|FG006|Overall Study|Administratively w/drawn|2|||
146176835|NCT02440594|527160722|FG007|Overall Study|Administratively w/drawn|1|||
146176836|NCT04250337|527160723|FG000|Overall Study|Adverse Event|0|||
146176837|NCT04250337|527160724|FG001|Overall Study|Adverse Event|3|||
146176838|NCT04250337|527160723|FG000|Overall Study|Lack of Efficacy|1|||
146176839|NCT04250337|527160724|FG001|Overall Study|Lack of Efficacy|3|||
146176840|NCT04250337|527160723|FG000|Overall Study|Physician Decision|1|||
146176841|NCT04250337|527160724|FG001|Overall Study|Physician Decision|0|||
146176842|NCT04250337|527160723|FG000|Overall Study|Protocol Deviation|2|||
146176843|NCT04250337|527160724|FG001|Overall Study|Protocol Deviation|2|||
146176844|NCT04250337|527160723|FG000|Overall Study|Withdrawal by Subject|4|||
146176845|NCT04250337|527160724|FG001|Overall Study|Withdrawal by Subject|3|||
146176846|NCT00152763|527160725|FG000|Overall Study|Death|4|||
146176847|NCT00152763|527160726|FG001|Overall Study|Death|1|||
146176848|NCT00152763|527160727|FG002|Overall Study|Death|2|||
146176849|NCT00152763|527160728|FG003|Overall Study|Death|1|||
146176850|NCT00152763|527160725|FG000|Overall Study|Lost to Follow-up|6|||
146176851|NCT00152763|527160726|FG001|Overall Study|Lost to Follow-up|4|||
146176852|NCT00152763|527160727|FG002|Overall Study|Lost to Follow-up|2|||
146176853|NCT00152763|527160728|FG003|Overall Study|Lost to Follow-up|13|||
146176854|NCT00669903|527160729|FG000|Overall Study|Adverse Event|0|||
146176855|NCT00669903|527160730|FG001|Overall Study|Adverse Event|1|||
146176856|NCT00669903|527160731|FG002|Overall Study|Adverse Event|3|||
146176857|NCT00669903|527160732|FG003|Overall Study|Adverse Event|1|||
146176858|NCT00669903|527160729|FG000|Overall Study|Withdrawal by Subject|0|||
146176859|NCT00669903|527160730|FG001|Overall Study|Withdrawal by Subject|2|||
146176860|NCT00669903|527160731|FG002|Overall Study|Withdrawal by Subject|2|||
146176861|NCT00669903|527160732|FG003|Overall Study|Withdrawal by Subject|2|||
146176862|NCT00669903|527160729|FG000|Overall Study|Lost to Follow-up|1|||
146176863|NCT00669903|527160730|FG001|Overall Study|Lost to Follow-up|1|||
146176864|NCT00669903|527160731|FG002|Overall Study|Lost to Follow-up|0|||
146176865|NCT00669903|527160732|FG003|Overall Study|Lost to Follow-up|1|||
146176866|NCT00669903|527160729|FG000|Overall Study|Protocol Violation|0|||
146176867|NCT00669903|527160730|FG001|Overall Study|Protocol Violation|1|||
146176868|NCT00669903|527160731|FG002|Overall Study|Protocol Violation|0|||
146176869|NCT00669903|527160732|FG003|Overall Study|Protocol Violation|0|||
146176870|NCT01678820|527160733|FG000|Overall Study|Study Terminated by Sponsor|45|||
146176871|NCT01678820|527160734|FG001|Overall Study|Study Terminated by Sponsor|43|||
146176872|NCT01678820|527160735|FG002|Overall Study|Study Terminated by Sponsor|43|||
146176873|NCT01678820|527160733|FG000|Overall Study|Withdrawal by Subject|2|||
146176874|NCT01678820|527160734|FG001|Overall Study|Withdrawal by Subject|5|||
146176875|NCT01678820|527160735|FG002|Overall Study|Withdrawal by Subject|2|||
146176876|NCT01678820|527160733|FG000|Overall Study|Protocol Specified Criteria|2|||
146176877|NCT01678820|527160734|FG001|Overall Study|Protocol Specified Criteria|3|||
146176878|NCT01678820|527160735|FG002|Overall Study|Protocol Specified Criteria|1|||
146176879|NCT01678820|527160733|FG000|Overall Study|Adverse Event|2|||
146176880|NCT01678820|527160734|FG001|Overall Study|Adverse Event|2|||
146176881|NCT01678820|527160735|FG002|Overall Study|Adverse Event|2|||
146176882|NCT01678820|527160733|FG000|Overall Study|Lost to Follow-up|7|||
146176883|NCT01678820|527160734|FG001|Overall Study|Lost to Follow-up|2|||
146176884|NCT01678820|527160735|FG002|Overall Study|Lost to Follow-up|2|||
146176885|NCT01678820|527160733|FG000|Overall Study|Non-compliance with study drug|0|||
146176886|NCT01678820|527160734|FG001|Overall Study|Non-compliance with study drug|1|||
146176887|NCT01678820|527160735|FG002|Overall Study|Non-compliance with study drug|0|||
146176888|NCT01678820|527160733|FG000|Overall Study|Physician Decision|0|||
146176889|NCT01678820|527160734|FG001|Overall Study|Physician Decision|0|||
146176890|NCT01678820|527160735|FG002|Overall Study|Physician Decision|1|||
146176891|NCT01678820|527160733|FG000|Overall Study|Protocol Violation|4|||
146176892|NCT01678820|527160734|FG001|Overall Study|Protocol Violation|5|||
146176893|NCT01678820|527160735|FG002|Overall Study|Protocol Violation|4|||
146176894|NCT01678820|527160733|FG000|Overall Study|Not treated with double-blind study drug|0|||
146176895|NCT01678820|527160734|FG001|Overall Study|Not treated with double-blind study drug|2|||
146176896|NCT01678820|527160735|FG002|Overall Study|Not treated with double-blind study drug|2|||
146176897|NCT00936221|527160740|FG000|Overall Study|Withdrawal by Subject|1|||
146176898|NCT00936221|527160741|FG001|Overall Study|Withdrawal by Subject|1|||
146176899|NCT01348776|527160742|FG000|Overall Study|Lost to Follow-up|3|||
146176900|NCT04362137|527160746|FG000|Overall Study|Death|9|||
146176901|NCT04362137|527160747|FG001|Overall Study|Death|3|||
146176902|NCT04362137|527160746|FG000|Overall Study|Patient decision|6|||
146176903|NCT04362137|527160747|FG001|Overall Study|Patient decision|3|||
146176904|NCT04362137|527160746|FG000|Overall Study|Adverse Event|1|||
146176905|NCT04362137|527160747|FG001|Overall Study|Adverse Event|0|||
146176906|NCT04362137|527160746|FG000|Overall Study|Lost to Follow-up|1|||
146176907|NCT04362137|527160747|FG001|Overall Study|Lost to Follow-up|0|||
146176908|NCT04362137|527160746|FG000|Overall Study|Protocol deviation|1|||
146176909|NCT04362137|527160747|FG001|Overall Study|Protocol deviation|0|||
146176910|NCT02204579|527160750|FG000|Overall Study|Screen failures|2|||
146176911|NCT03176238|527160754|FG000|Overall Study|Unacceptable AEs|15|||
146176912|NCT03176238|527160755|FG001|Overall Study|Unacceptable AEs|8|||
146176913|NCT03176238|527160754|FG000|Overall Study|Abnormal lab value(s)|2|||
146176914|NCT03176238|527160755|FG001|Overall Study|Abnormal lab value(s)|0|||
146176915|NCT03176238|527160754|FG000|Overall Study|Inter-current illness|0|||
146176916|NCT03176238|527160755|FG001|Overall Study|Inter-current illness|1|||
146176917|NCT03176238|527160754|FG000|Overall Study|Consent withdrawal|14|||
146176918|NCT03176238|527160755|FG001|Overall Study|Consent withdrawal|2|||
146176919|NCT03176238|527160754|FG000|Overall Study|Lost to Follow-up|3|||
146176920|NCT03176238|527160755|FG001|Overall Study|Lost to Follow-up|0|||
146176921|NCT03176238|527160754|FG000|Overall Study|Administrative problems|1|||
146176922|NCT03176238|527160755|FG001|Overall Study|Administrative problems|0|||
146176923|NCT03176238|527160754|FG000|Overall Study|Death|3|||
146176924|NCT03176238|527160755|FG001|Overall Study|Death|0|||
146176925|NCT03176238|527160754|FG000|Overall Study|Disease Progression|133|||
146176926|NCT03176238|527160755|FG001|Overall Study|Disease Progression|22|||
146176927|NCT03176238|527160754|FG000|Overall Study|Tx duration completed per EAP|0|||
146176928|NCT03176238|527160755|FG001|Overall Study|Tx duration completed per EAP|1|||
146176929|NCT03176238|527160754|FG000|Overall Study|Patient is switched to commercial drug|16|||
146176930|NCT03176238|527160755|FG001|Overall Study|Patient is switched to commercial drug|1|||
146176931|NCT03176238|527160754|FG000|Overall Study|Protocol Violation|1|||
146176932|NCT03176238|527160755|FG001|Overall Study|Protocol Violation|0|||
146176933|NCT03176238|527160754|FG000|Overall Study|Changes in the patient's condition|2|||
146176934|NCT03176238|527160755|FG001|Overall Study|Changes in the patient's condition|1|||
146176935|NCT03176238|527160754|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
146176936|NCT03176238|527160755|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
146176937|NCT03556358|527160756|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
146176938|NCT03556358|527160757|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
146176939|NCT03556358|527160756|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
146176940|NCT03556358|527160757|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
146176941|NCT03556358|527160756|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
146176942|NCT03556358|527160757|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
146176943|NCT03556358|527160756|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
146176944|NCT03556358|527160757|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
146176945|NCT03556358|527160756|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
146176946|NCT03556358|527160757|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
146176947|NCT03556358|527160756|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
146176948|NCT03556358|527160757|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
146176949|NCT03556358|527160756|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
146176950|NCT03556358|527160757|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
146176951|NCT01351025|527160759|FG000|Week 0 - 20|Lost to Follow-up|2|||
146176952|NCT01351025|527160760|FG001|Week 0 - 20|Lost to Follow-up|1|||
146176953|NCT01351025|527160759|FG000|Week 0 - 20|Withdrawal by Subject|1|||
146176954|NCT01351025|527160760|FG001|Week 0 - 20|Withdrawal by Subject|0|||
146176955|NCT01351025|527160759|FG000|Week 24 - 44|Lost to Follow-up|0|||
146176956|NCT01351025|527160760|FG001|Week 24 - 44|Lost to Follow-up|2|||
146176957|NCT01351025|527160759|FG000|Week 24 - 44|Site closed|0|||
146176958|NCT01351025|527160760|FG001|Week 24 - 44|Site closed|1|||
146176959|NCT01351025|527160759|FG000|Week 24 - 44|unable to get to clinic|1|||
146176960|NCT01351025|527160760|FG001|Week 24 - 44|unable to get to clinic|1|||
146176961|NCT05067933|527160764|FG000|Overall Study|Withdrawal by Subject|2|||
146176962|NCT05067933|527160765|FG001|Overall Study|Withdrawal by Subject|0|||
146176963|NCT05067933|527160766|FG002|Overall Study|Withdrawal by Subject|0|||
146176964|NCT05067933|527160767|FG003|Overall Study|Withdrawal by Subject|0|||
146176965|NCT05067933|527160768|FG004|Overall Study|Withdrawal by Subject|0|||
146176966|NCT05067933|527160769|FG005|Overall Study|Withdrawal by Subject|0|||
146176967|NCT05067933|527160764|FG000|Overall Study|Lost to Follow-up|1|||
146176968|NCT05067933|527160765|FG001|Overall Study|Lost to Follow-up|1|||
146176969|NCT05067933|527160766|FG002|Overall Study|Lost to Follow-up|1|||
146176970|NCT05067933|527160767|FG003|Overall Study|Lost to Follow-up|2|||
146176971|NCT05067933|527160768|FG004|Overall Study|Lost to Follow-up|1|||
146176972|NCT05067933|527160769|FG005|Overall Study|Lost to Follow-up|0|||
146176973|NCT05067933|527160764|FG000|Overall Study|Miscellaneous|1|||
146176974|NCT05067933|527160765|FG001|Overall Study|Miscellaneous|0|||
146176975|NCT05067933|527160766|FG002|Overall Study|Miscellaneous|0|||
146176976|NCT05067933|527160767|FG003|Overall Study|Miscellaneous|0|||
146176977|NCT05067933|527160768|FG004|Overall Study|Miscellaneous|0|||
146176978|NCT05067933|527160769|FG005|Overall Study|Miscellaneous|0|||
146176979|NCT05067933|527160764|FG000|Overall Study|Death|0|||
146176980|NCT05067933|527160765|FG001|Overall Study|Death|0|||
146176981|NCT05067933|527160766|FG002|Overall Study|Death|0|||
146176982|NCT05067933|527160767|FG003|Overall Study|Death|1|||
146176983|NCT05067933|527160768|FG004|Overall Study|Death|0|||
146176984|NCT05067933|527160769|FG005|Overall Study|Death|0|||
146176985|NCT01065350|527160770|FG000|Overall Study|Received incorrect drug allocation|0|||
146176986|NCT01065350|527160771|FG001|Overall Study|Received incorrect drug allocation|1|||
146176987|NCT02875834|527160774|FG000|Open-label Phase|Withdrawal by Subject|3|||
146176988|NCT02875834|527160775|FG001|Open-label Phase|Withdrawal by Subject|0|||
146176989|NCT02875834|527160776|FG002|Open-label Phase|Withdrawal by Subject|0|||
146176990|NCT02875834|527160777|FG003|Open-label Phase|Withdrawal by Subject|0|||
146176991|NCT02875834|527160774|FG000|Open-label Phase|(Not collected)|4|||
146176992|NCT02875834|527160775|FG001|Open-label Phase|(Not collected)|0|||
146176993|NCT02875834|527160776|FG002|Open-label Phase|(Not collected)|0|||
146176994|NCT02875834|527160777|FG003|Open-label Phase|(Not collected)|0|||
146283926|NCT00604825|527551905|FG001|Overall Study|Adverse Event|6|||
146176995|NCT02875834|527160774|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
146176996|NCT02875834|527160775|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
146176997|NCT02875834|527160776|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
146176998|NCT02875834|527160777|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
146176999|NCT02875834|527160774|FG000|Randomized Treatment Phase|Protocol Violation|0|||
146177000|NCT02875834|527160775|FG001|Randomized Treatment Phase|Protocol Violation|2|||
146177001|NCT02875834|527160776|FG002|Randomized Treatment Phase|Protocol Violation|0|||
146177002|NCT02875834|527160777|FG003|Randomized Treatment Phase|Protocol Violation|0|||
146177003|NCT02875834|527160774|FG000|Randomized Treatment Phase|(Not collected)|0|||
146177004|NCT02875834|527160775|FG001|Randomized Treatment Phase|(Not collected)|9|||
146177005|NCT02875834|527160776|FG002|Randomized Treatment Phase|(Not collected)|10|||
146177006|NCT02875834|527160777|FG003|Randomized Treatment Phase|(Not collected)|9|||
146177007|NCT05200936|527160779|FG000|Overall Study|Withdrawal by Subject|2|||
146177008|NCT05200936|527160780|FG001|Overall Study|Withdrawal by Subject|2|||
146177009|NCT05200936|527160779|FG000|Overall Study|Lost to Follow-up|2|||
146177010|NCT05200936|527160780|FG001|Overall Study|Lost to Follow-up|0|||
146177011|NCT05200936|527160779|FG000|Overall Study|Pregnancy|0|||
146177012|NCT05200936|527160780|FG001|Overall Study|Pregnancy|1|||
146177013|NCT00539279|527160781|FG000|Treatment|Withdrawal by Subject|10|||
146177014|NCT00539279|527160782|FG001|Treatment|Withdrawal by Subject|8|||
146177015|NCT00539279|527160781|FG000|Treatment|Death|1|||
146177016|NCT00539279|527160782|FG001|Treatment|Death|0|||
146177017|NCT00539279|527160781|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
146177018|NCT00539279|527160782|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
146177019|NCT00539279|527160781|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
146177020|NCT00539279|527160782|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
146177021|NCT02906683|527162131|FG000|Overall Study|Adverse Event|0|||
146177022|NCT02906683|527162132|FG001|Overall Study|Adverse Event|1|||
146177023|NCT02906683|527162133|FG002|Overall Study|Adverse Event|0|||
146177024|NCT02906683|527162131|FG000|Overall Study|Physician Decision|0|||
146177025|NCT02906683|527162132|FG001|Overall Study|Physician Decision|1|||
146177026|NCT02906683|527162133|FG002|Overall Study|Physician Decision|1|||
146177027|NCT02906683|527162131|FG000|Overall Study|Withdrawal by Subject|0|||
146177028|NCT02906683|527162132|FG001|Overall Study|Withdrawal by Subject|2|||
146177029|NCT02906683|527162133|FG002|Overall Study|Withdrawal by Subject|1|||
146177030|NCT02906683|527162131|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
146177031|NCT02906683|527162132|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
146177032|NCT02906683|527162133|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
146177033|NCT02906683|527162131|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
146177034|NCT02906683|527162132|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146177035|NCT02906683|527162133|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146177036|NCT02781506|527162134|FG000|Overall Study|Adverse Event|5|||
146177037|NCT01340482|527162136|FG000|Overall Study|Adverse Event|2|||
146177038|NCT01340482|527162137|FG001|Overall Study|Adverse Event|0|||
146177039|NCT01340482|527162138|FG002|Overall Study|Adverse Event|0|||
146177040|NCT02593539|527162139|FG000|Overall Study|Adverse Event|1|||
146177041|NCT00451217|527162143|FG000|Overall Study|Lost to Follow-up|0|||
146177042|NCT00451217|527162144|FG001|Overall Study|Lost to Follow-up|1|||
146177043|NCT00451217|527162145|FG002|Overall Study|Lost to Follow-up|1|||
146177044|NCT00451217|527162146|FG003|Overall Study|Lost to Follow-up|1|||
146177045|NCT00451217|527162143|FG000|Overall Study|Withdrawal by Subject|1|||
146177046|NCT00451217|527162144|FG001|Overall Study|Withdrawal by Subject|0|||
146177047|NCT00451217|527162145|FG002|Overall Study|Withdrawal by Subject|0|||
146177048|NCT00451217|527162146|FG003|Overall Study|Withdrawal by Subject|0|||
146177049|NCT00451217|527162143|FG000|Overall Study|Not Treated|1|||
146177050|NCT00451217|527162144|FG001|Overall Study|Not Treated|1|||
146177051|NCT00451217|527162145|FG002|Overall Study|Not Treated|3|||
146177052|NCT00451217|527162146|FG003|Overall Study|Not Treated|4|||
146177053|NCT04668989|527162153|FG000|First Intervention|Covid-19 related self-isolation|0|||
146177054|NCT04668989|527162154|FG001|First Intervention|Covid-19 related self-isolation|1|||
146177055|NCT04668989|527162153|FG000|Second Intervention|Adverse Event|0|||
146177056|NCT04668989|527162154|FG001|Second Intervention|Adverse Event|1|||
146177057|NCT00569803|527162155|FG000|Overall Study|Lost to Follow-up|1|||
146177058|NCT00569803|527162156|FG001|Overall Study|Lost to Follow-up|0|||
146177059|NCT00569803|527162157|FG002|Overall Study|Lost to Follow-up|0|||
146177060|NCT00569803|527162158|FG003|Overall Study|Lost to Follow-up|0|||
146177061|NCT00569803|527162159|FG004|Overall Study|Lost to Follow-up|0|||
146177062|NCT00569803|527162160|FG005|Overall Study|Lost to Follow-up|0|||
146177063|NCT00569803|527162161|FG006|Overall Study|Lost to Follow-up|0|||
146177064|NCT00569803|527162162|FG007|Overall Study|Lost to Follow-up|0|||
146177065|NCT00569803|527162155|FG000|Overall Study|injection syringe leaked during dosing|0|||
146283927|NCT00604825|527551906|FG002|Overall Study|Adverse Event|7|||
146283928|NCT00604825|527551907|FG003|Overall Study|Adverse Event|4|||
146177066|NCT00569803|527162156|FG001|Overall Study|injection syringe leaked during dosing|0|||
146177067|NCT00569803|527162157|FG002|Overall Study|injection syringe leaked during dosing|0|||
146177068|NCT00569803|527162158|FG003|Overall Study|injection syringe leaked during dosing|1|||
146177069|NCT00569803|527162159|FG004|Overall Study|injection syringe leaked during dosing|0|||
146177070|NCT00569803|527162160|FG005|Overall Study|injection syringe leaked during dosing|0|||
146177071|NCT00569803|527162161|FG006|Overall Study|injection syringe leaked during dosing|0|||
146177072|NCT00569803|527162162|FG007|Overall Study|injection syringe leaked during dosing|0|||
146177073|NCT00569803|527162155|FG000|Overall Study|Withdrawal by Subject|0|||
146177074|NCT00569803|527162156|FG001|Overall Study|Withdrawal by Subject|0|||
146177075|NCT00569803|527162157|FG002|Overall Study|Withdrawal by Subject|0|||
146177076|NCT00569803|527162158|FG003|Overall Study|Withdrawal by Subject|0|||
146177077|NCT00569803|527162159|FG004|Overall Study|Withdrawal by Subject|0|||
146177078|NCT00569803|527162160|FG005|Overall Study|Withdrawal by Subject|0|||
146177079|NCT00569803|527162161|FG006|Overall Study|Withdrawal by Subject|0|||
146177080|NCT00569803|527162162|FG007|Overall Study|Withdrawal by Subject|1|||
146177081|NCT01993823|527162163|FG000|Overall Study|Requested by the patient|6|||
146177082|NCT01993823|527162164|FG001|Overall Study|Requested by the patient|11|||
146177083|NCT01993823|527162163|FG000|Overall Study|Protocol Violation|0|||
146177084|NCT01993823|527162164|FG001|Overall Study|Protocol Violation|1|||
146177085|NCT01993823|527162163|FG000|Overall Study|Lost to Follow-up|1|||
146177086|NCT01993823|527162164|FG001|Overall Study|Lost to Follow-up|4|||
146177087|NCT01235975|527162166|FG000|Overall Study|Serious Adverse Event|0|||
146177088|NCT01235975|527162167|FG001|Overall Study|Serious Adverse Event|1|||
146177089|NCT01235975|527162166|FG000|Overall Study|Withdrawal by Subject|8|||
146177090|NCT01235975|527162167|FG001|Overall Study|Withdrawal by Subject|2|||
146177091|NCT01235975|527162166|FG000|Overall Study|Migrated/moved from study area|2|||
146177092|NCT01235975|527162167|FG001|Overall Study|Migrated/moved from study area|1|||
146177093|NCT01235975|527162166|FG000|Overall Study|Lost to Follow-up|7|||
146177094|NCT01235975|527162167|FG001|Overall Study|Lost to Follow-up|3|||
146177095|NCT05033743|527162172|FG000|Overall Study|Lost to Follow-up|1|||
146177096|NCT05033743|527162172|FG000|Overall Study|Protocol Violation|2|||
146177097|NCT05033743|527162172|FG000|Overall Study|Withdrawal by Subject|1|||
146177098|NCT01622348|527162173|FG000|Overall Study|Withdrawal by Subject|1|||
146177099|NCT01622348|527162174|FG001|Overall Study|Withdrawal by Subject|0|||
146177100|NCT01622348|527162175|FG002|Overall Study|Withdrawal by Subject|1|||
146177101|NCT00791921|527162178|FG000|Overall Study|Protocol planed|24|||
146177102|NCT00791921|527162179|FG001|Overall Study|Protocol planed|88|||
146177103|NCT00791921|527162178|FG000|Overall Study|Withdrawal by Subject|1|||
146177104|NCT00791921|527162179|FG001|Overall Study|Withdrawal by Subject|2|||
146177105|NCT00791921|527162178|FG000|Overall Study|Adverse Event|8|||
146177106|NCT00791921|527162179|FG001|Overall Study|Adverse Event|2|||
146177107|NCT00791921|527162178|FG000|Overall Study|Lack of Efficacy|0|||
146177108|NCT00791921|527162179|FG001|Overall Study|Lack of Efficacy|2|||
146177109|NCT00791921|527162178|FG000|Overall Study|Lack of study drug administration|1|||
146177110|NCT00791921|527162179|FG001|Overall Study|Lack of study drug administration|1|||
146177111|NCT00791921|527162178|FG000|Overall Study|Reason other than those above|0|||
146177112|NCT00791921|527162179|FG001|Overall Study|Reason other than those above|1|||
146177113|NCT01592695|527162183|FG000|Overall Study|Lost to Follow-up|8|||
146177114|NCT01592695|527162184|FG001|Overall Study|Lost to Follow-up|4|||
146177115|NCT00422799|527162185|FG000|Overall Study|Withdrawal by Subject|6|||
146177116|NCT00422799|527162185|FG000|Overall Study|Adverse Event|7|||
146177117|NCT01965158|527162186|FG000|Overall Study|Adverse Event|14|||
146177118|NCT01965158|527162187|FG001|Overall Study|Adverse Event|5|||
146177119|NCT01965158|527162186|FG000|Overall Study|Withdrawal by Subject|16|||
146177120|NCT01965158|527162187|FG001|Overall Study|Withdrawal by Subject|24|||
146177121|NCT01965158|527162186|FG000|Overall Study|Lost to Follow-up|7|||
146177122|NCT01965158|527162187|FG001|Overall Study|Lost to Follow-up|5|||
146177123|NCT01965158|527162186|FG000|Overall Study|Protocol Violation|1|||
146177124|NCT01965158|527162187|FG001|Overall Study|Protocol Violation|1|||
146177125|NCT01965158|527162186|FG000|Overall Study|Other - Miscellaneous|3|||
146177126|NCT01965158|527162187|FG001|Overall Study|Other - Miscellaneous|0|||
146177127|NCT00474175|527162188|FG000|Overall Study|Lack of Efficacy|0|||
146177128|NCT00474175|527162189|FG001|Overall Study|Lack of Efficacy|0|||
146177129|NCT00474175|527162190|FG002|Overall Study|Lack of Efficacy|1|||
146177130|NCT00474175|527162188|FG000|Overall Study|Withdrawal by Subject|0|||
146177131|NCT00474175|527162189|FG001|Overall Study|Withdrawal by Subject|1|||
146177132|NCT00474175|527162190|FG002|Overall Study|Withdrawal by Subject|1|||
146177133|NCT00474175|527162188|FG000|Overall Study|Ineligible|1|||
146177134|NCT00474175|527162189|FG001|Overall Study|Ineligible|3|||
146177135|NCT00474175|527162190|FG002|Overall Study|Ineligible|1|||
146177136|NCT00474175|527162188|FG000|Overall Study|Protocol Violation|0|||
146177137|NCT00474175|527162189|FG001|Overall Study|Protocol Violation|2|||
146177138|NCT00474175|527162190|FG002|Overall Study|Protocol Violation|1|||
146177139|NCT00474175|527162188|FG000|Overall Study|Administrative|0|||
146177140|NCT00474175|527162189|FG001|Overall Study|Administrative|1|||
146177141|NCT00474175|527162190|FG002|Overall Study|Administrative|0|||
146177142|NCT00467142|527162194|FG000|Overall Study|Withdrawal by Subject|1|||
146177143|NCT00467142|527162194|FG000|Overall Study|Adverse Event|1|||
146177144|NCT00467142|527162194|FG000|Overall Study|Protocol Violation|1|||
146177145|NCT01619787|527162195|FG000|Overall Study|Lost to Follow-up|5|||
146177146|NCT03029780|527162205|FG000|Overall Study|Disease Progression|20|||
146177147|NCT03029780|527162206|FG001|Overall Study|Disease Progression|22|||
146177148|NCT03029780|527162205|FG000|Overall Study|Study Drug Toxicity|15|||
146177149|NCT03029780|527162206|FG001|Overall Study|Study Drug Toxicity|11|||
146177150|NCT03029780|527162205|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146177151|NCT03029780|527162206|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146177152|NCT03029780|527162205|FG000|Overall Study|Participant request to discontinue study treatment|4|||
146177153|NCT03029780|527162206|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146076659|NCT00830869|526801980|FG011|Period 2: Part 2|Protocol Violation|0|||
146076660|NCT00830869|526801969|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
146076661|NCT00830869|526801970|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
146076662|NCT00830869|526801971|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
146076663|NCT00830869|526801972|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
146076664|NCT00830869|526801973|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
146076665|NCT00830869|526801974|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
146076666|NCT00830869|526801975|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
146076667|NCT00830869|526801976|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
146076668|NCT00830869|526801977|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
146076669|NCT00830869|526801978|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
146076670|NCT00830869|526801979|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
146076671|NCT00830869|526801980|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
146076672|NCT00830869|526801969|FG000|Period 2: Part 2|Adverse Event|0|||
146076673|NCT00830869|526801970|FG001|Period 2: Part 2|Adverse Event|0|||
146076674|NCT00830869|526801971|FG002|Period 2: Part 2|Adverse Event|0|||
146076675|NCT00830869|526801972|FG003|Period 2: Part 2|Adverse Event|0|||
146076676|NCT00830869|526801973|FG004|Period 2: Part 2|Adverse Event|0|||
146076677|NCT00830869|526801974|FG005|Period 2: Part 2|Adverse Event|0|||
146076678|NCT00830869|526801975|FG006|Period 2: Part 2|Adverse Event|0|||
146076679|NCT00830869|526801976|FG007|Period 2: Part 2|Adverse Event|4|||
146076680|NCT00830869|526801977|FG008|Period 2: Part 2|Adverse Event|3|||
146076681|NCT00830869|526801978|FG009|Period 2: Part 2|Adverse Event|2|||
146076682|NCT00830869|526801979|FG010|Period 2: Part 2|Adverse Event|2|||
146076683|NCT00830869|526801980|FG011|Period 2: Part 2|Adverse Event|0|||
146076684|NCT00830869|526801969|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
146076685|NCT00830869|526801970|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
146076686|NCT00830869|526801971|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
146076687|NCT00830869|526801972|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
146076688|NCT00830869|526801973|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
146076689|NCT00830869|526801974|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
146076690|NCT00830869|526801975|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
146076691|NCT00830869|526801976|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
146076692|NCT00830869|526801977|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
146076693|NCT00830869|526801978|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
146076694|NCT00830869|526801979|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
146076695|NCT00830869|526801980|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
146076696|NCT00830869|526801969|FG000|Period 2: Part 2|Progressive disease|0|||
146076697|NCT00830869|526801970|FG001|Period 2: Part 2|Progressive disease|0|||
146076698|NCT00830869|526801971|FG002|Period 2: Part 2|Progressive disease|0|||
146076699|NCT00830869|526801972|FG003|Period 2: Part 2|Progressive disease|0|||
146076700|NCT00830869|526801973|FG004|Period 2: Part 2|Progressive disease|0|||
146076701|NCT00830869|526801974|FG005|Period 2: Part 2|Progressive disease|0|||
146076702|NCT00830869|526801975|FG006|Period 2: Part 2|Progressive disease|0|||
146076703|NCT00830869|526801976|FG007|Period 2: Part 2|Progressive disease|14|||
146076704|NCT00830869|526801977|FG008|Period 2: Part 2|Progressive disease|11|||
146076705|NCT00830869|526801978|FG009|Period 2: Part 2|Progressive disease|12|||
146076706|NCT00830869|526801979|FG010|Period 2: Part 2|Progressive disease|8|||
146076707|NCT00830869|526801980|FG011|Period 2: Part 2|Progressive disease|15|||
146076708|NCT00830869|526801969|FG000|Period 2: Part 2|Other|0|||
146076709|NCT00830869|526801970|FG001|Period 2: Part 2|Other|0|||
146076710|NCT00830869|526801971|FG002|Period 2: Part 2|Other|0|||
146076711|NCT00830869|526801972|FG003|Period 2: Part 2|Other|0|||
146076712|NCT00830869|526801973|FG004|Period 2: Part 2|Other|0|||
146076713|NCT00830869|526801974|FG005|Period 2: Part 2|Other|0|||
146076714|NCT00830869|526801975|FG006|Period 2: Part 2|Other|0|||
146076715|NCT00830869|526801976|FG007|Period 2: Part 2|Other|0|||
146076716|NCT00830869|526801977|FG008|Period 2: Part 2|Other|0|||
146076717|NCT00830869|526801978|FG009|Period 2: Part 2|Other|1|||
146076718|NCT00830869|526801979|FG010|Period 2: Part 2|Other|0|||
146076719|NCT00830869|526801980|FG011|Period 2: Part 2|Other|0|||
146076720|NCT00281658|526801986|FG000|Randomized Phase|Adverse Event|0|||
146076721|NCT00281658|526801987|FG001|Randomized Phase|Adverse Event|2|||
146076722|NCT00281658|526801988|FG002|Randomized Phase|Adverse Event|0|||
146076723|NCT00281658|526801989|FG003|Randomized Phase|Adverse Event|0|||
146076724|NCT00281658|526801986|FG000|Randomized Phase|Lost to Follow-up|34|||
146076725|NCT00281658|526801987|FG001|Randomized Phase|Lost to Follow-up|27|||
146076726|NCT00281658|526801988|FG002|Randomized Phase|Lost to Follow-up|0|||
146076727|NCT00281658|526801989|FG003|Randomized Phase|Lost to Follow-up|0|||
146076728|NCT00281658|526801986|FG000|Randomized Phase|Withdrawal by Subject|8|||
146076729|NCT00281658|526801987|FG001|Randomized Phase|Withdrawal by Subject|7|||
146076730|NCT00281658|526801988|FG002|Randomized Phase|Withdrawal by Subject|0|||
146076731|NCT00281658|526801989|FG003|Randomized Phase|Withdrawal by Subject|0|||
146076732|NCT00281658|526801986|FG000|Randomized Phase|Study closed/terminated|1|||
146076733|NCT00281658|526801987|FG001|Randomized Phase|Study closed/terminated|1|||
146076734|NCT00281658|526801988|FG002|Randomized Phase|Study closed/terminated|0|||
146076735|NCT00281658|526801989|FG003|Randomized Phase|Study closed/terminated|0|||
146076736|NCT00281658|526801986|FG000|Randomized Phase|Disease progression|36|||
146076737|NCT00281658|526801987|FG001|Randomized Phase|Disease progression|27|||
146076738|NCT00281658|526801988|FG002|Randomized Phase|Disease progression|0|||
146076739|NCT00281658|526801989|FG003|Randomized Phase|Disease progression|0|||
146076740|NCT00281658|526801986|FG000|Randomized Phase|Physician Decision|1|||
146076741|NCT00281658|526801987|FG001|Randomized Phase|Physician Decision|1|||
146076742|NCT00281658|526801988|FG002|Randomized Phase|Physician Decision|0|||
146076743|NCT00281658|526801989|FG003|Randomized Phase|Physician Decision|0|||
146076744|NCT00281658|526801986|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
146076745|NCT00281658|526801987|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
146076746|NCT00281658|526801988|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
146076747|NCT00281658|526801989|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
146076748|NCT00281658|526801986|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
146076749|NCT00281658|526801987|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
146076750|NCT00281658|526801988|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
146076751|NCT00281658|526801989|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
146076752|NCT00281658|526801986|FG000|Randomized Phase|Treatment ongoing|1|||
146076753|NCT00281658|526801987|FG001|Randomized Phase|Treatment ongoing|0|||
146076754|NCT00281658|526801988|FG002|Randomized Phase|Treatment ongoing|0|||
146076755|NCT00281658|526801989|FG003|Randomized Phase|Treatment ongoing|0|||
146076756|NCT00281658|526801986|FG000|Open Label Phase|Adverse Event|0|||
146076757|NCT00281658|526801987|FG001|Open Label Phase|Adverse Event|0|||
146076758|NCT00281658|526801988|FG002|Open Label Phase|Adverse Event|1|||
146076759|NCT00281658|526801989|FG003|Open Label Phase|Adverse Event|0|||
146076760|NCT00281658|526801986|FG000|Open Label Phase|Lost to Follow-up|0|||
146076761|NCT00281658|526801987|FG001|Open Label Phase|Lost to Follow-up|0|||
146076762|NCT00281658|526801988|FG002|Open Label Phase|Lost to Follow-up|16|||
146076763|NCT00281658|526801989|FG003|Open Label Phase|Lost to Follow-up|2|||
146076764|NCT00281658|526801986|FG000|Open Label Phase|Withdrawal by Subject|0|||
146076765|NCT00281658|526801987|FG001|Open Label Phase|Withdrawal by Subject|0|||
146076766|NCT00281658|526801988|FG002|Open Label Phase|Withdrawal by Subject|3|||
146076767|NCT00281658|526801989|FG003|Open Label Phase|Withdrawal by Subject|2|||
146076768|NCT00281658|526801986|FG000|Open Label Phase|Disease progression|0|||
146076769|NCT00281658|526801987|FG001|Open Label Phase|Disease progression|0|||
146076770|NCT00281658|526801988|FG002|Open Label Phase|Disease progression|18|||
146076771|NCT00281658|526801989|FG003|Open Label Phase|Disease progression|0|||
146076772|NCT00281658|526801986|FG000|Open Label Phase|Physician Decision|0|||
146076773|NCT00281658|526801987|FG001|Open Label Phase|Physician Decision|0|||
146076774|NCT00281658|526801988|FG002|Open Label Phase|Physician Decision|1|||
146076775|NCT00281658|526801989|FG003|Open Label Phase|Physician Decision|0|||
146076776|NCT00281658|526801986|FG000|Open Label Phase|Relocation of patient|0|||
146076777|NCT00281658|526801987|FG001|Open Label Phase|Relocation of patient|0|||
146076778|NCT00281658|526801988|FG002|Open Label Phase|Relocation of patient|1|||
146076779|NCT00281658|526801989|FG003|Open Label Phase|Relocation of patient|0|||
146076780|NCT00281658|526801986|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
146076781|NCT00281658|526801987|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
146076782|NCT00281658|526801988|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
146076783|NCT00281658|526801989|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
146076784|NCT04590248|526801990|FG000|Overall Study|Lost to Follow-up|1|||
146076785|NCT04590248|526801990|FG000|Overall Study|Withdrawal by Subject|16|||
146076786|NCT04590248|526801990|FG000|Overall Study|Other|2|||
146076787|NCT02151773|526801998|FG000|Overall Study|Protocol Deviation|64|||
146076788|NCT04605991|526802000|FG000|Overall Study|Adverse Event|5|||
146076789|NCT04605991|526802000|FG000|Overall Study|Lack of Efficacy|1|||
146076790|NCT04605991|526802000|FG000|Overall Study|Lost to Follow-up|8|||
146076791|NCT04605991|526802000|FG000|Overall Study|Physician Decision|4|||
146076792|NCT04605991|526802000|FG000|Overall Study|Withdrawal by Subject|14|||
146076793|NCT04605991|526802000|FG000|Overall Study|Non-compliance with study|1|||
146076794|NCT02527200|526802001|FG000|Overall Study|Withdrawal by Subject|3|||
146177154|NCT03029780|527162205|FG000|Overall Study|Maximum clinical benefit|1|||
146177155|NCT03029780|527162206|FG001|Overall Study|Maximum clinical benefit|0|||
146177156|NCT03029780|527162205|FG000|Overall Study|Participant no longer meets study criteria|0|||
146177157|NCT03029780|527162206|FG001|Overall Study|Participant no longer meets study criteria|1|||
146177158|NCT03029780|527162205|FG000|Overall Study|Other reasons|6|||
146177159|NCT03029780|527162206|FG001|Overall Study|Other reasons|6|||
146177160|NCT03029780|527162205|FG000|Overall Study|Not reported|1|||
146177161|NCT03029780|527162206|FG001|Overall Study|Not reported|1|||
146177162|NCT03029780|527162205|FG000|Overall Study|Death|2|||
146177163|NCT03029780|527162206|FG001|Overall Study|Death|6|||
146177164|NCT00197028|527162207|FG000|Overall Study|Adverse Event|2|||
146177165|NCT00197028|527162208|FG001|Overall Study|Adverse Event|2|||
146177166|NCT00197028|527162207|FG000|Overall Study|Protocol Violation|2|||
146177167|NCT00197028|527162208|FG001|Overall Study|Protocol Violation|1|||
146177168|NCT00197028|527162207|FG000|Overall Study|Withdrawal by Subject|8|||
146177169|NCT00197028|527162208|FG001|Overall Study|Withdrawal by Subject|12|||
146177170|NCT00197028|527162207|FG000|Overall Study|Lost to Follow-up|1|||
146177171|NCT00197028|527162208|FG001|Overall Study|Lost to Follow-up|0|||
146177172|NCT00197028|527162207|FG000|Overall Study|Other|3|||
146177173|NCT00197028|527162208|FG001|Overall Study|Other|6|||
146177174|NCT00178256|527162209|FG000|Overall Study|Adverse Event|2|||
146177175|NCT00178256|527162210|FG001|Overall Study|Adverse Event|0|||
146177176|NCT00178256|527162211|FG002|Overall Study|Adverse Event|0|||
146177177|NCT00178256|527162212|FG003|Overall Study|Adverse Event|0|||
146177178|NCT00178256|527162209|FG000|Overall Study|Death|0|||
146177179|NCT00178256|527162210|FG001|Overall Study|Death|1|||
146177180|NCT00178256|527162211|FG002|Overall Study|Death|0|||
146177181|NCT00178256|527162212|FG003|Overall Study|Death|1|||
146177182|NCT00178256|527162209|FG000|Overall Study|Cancer progression|2|||
146177183|NCT00178256|527162210|FG001|Overall Study|Cancer progression|0|||
146177184|NCT00178256|527162211|FG002|Overall Study|Cancer progression|0|||
146177185|NCT00178256|527162212|FG003|Overall Study|Cancer progression|1|||
146177186|NCT03066622|527162213|FG000|Overall Study|Lost to Follow-up|24|||
146177187|NCT03066622|527162214|FG001|Overall Study|Lost to Follow-up|25|||
146177188|NCT03066622|527162213|FG000|Overall Study|Withdrawal by Subject|2|||
146177189|NCT03066622|527162214|FG001|Overall Study|Withdrawal by Subject|1|||
146177190|NCT01763788|527162215|FG000|Overall Study|Lost to Follow-up|0|||
146177191|NCT01763788|527162216|FG001|Overall Study|Lost to Follow-up|0|||
146177192|NCT01763788|527162217|FG002|Overall Study|Lost to Follow-up|1|||
146177193|NCT01763788|527162218|FG003|Overall Study|Lost to Follow-up|0|||
146177194|NCT00641719|527162219|FG000|Overall Study|Lack of Efficacy|1|||
146177195|NCT00641719|527162220|FG001|Overall Study|Lack of Efficacy|2|||
146177196|NCT00641719|527162219|FG000|Overall Study|Adverse Event|24|||
146177197|NCT00641719|527162220|FG001|Overall Study|Adverse Event|29|||
146177198|NCT00641719|527162219|FG000|Overall Study|Withdrawal by Subject|4|||
146177199|NCT00641719|527162220|FG001|Overall Study|Withdrawal by Subject|4|||
146177200|NCT00641719|527162219|FG000|Overall Study|Reason Not Specified|1|||
146177201|NCT00641719|527162220|FG001|Overall Study|Reason Not Specified|2|||
146177202|NCT03303469|527162221|FG000|Overall Study|Lost to Follow-up|2|||
146177203|NCT00885352|527162226|FG000|Overall Study|Adverse Event|2|||
146177204|NCT00885352|527162227|FG001|Overall Study|Adverse Event|3|||
146177205|NCT00885352|527162226|FG000|Overall Study|Lost to Follow-up|2|||
146177206|NCT00885352|527162227|FG001|Overall Study|Lost to Follow-up|2|||
146177207|NCT00885352|527162226|FG000|Overall Study|Physician Decision|0|||
146177208|NCT00885352|527162227|FG001|Overall Study|Physician Decision|3|||
146177209|NCT00885352|527162226|FG000|Overall Study|Protocol Violation|0|||
146177210|NCT00885352|527162227|FG001|Overall Study|Protocol Violation|2|||
146177211|NCT00885352|527162226|FG000|Overall Study|Withdrawal by Subject|1|||
146177212|NCT00885352|527162227|FG001|Overall Study|Withdrawal by Subject|5|||
146177213|NCT00885352|527162226|FG000|Overall Study|Contradiction to study medication|0|||
146177214|NCT00885352|527162227|FG001|Overall Study|Contradiction to study medication|2|||
146177215|NCT00885352|527162226|FG000|Overall Study|Excluded medication|2|||
146177216|NCT00885352|527162227|FG001|Overall Study|Excluded medication|2|||
146177217|NCT00885352|527162226|FG000|Overall Study|Lab abnormalities|1|||
146177218|NCT00885352|527162227|FG001|Overall Study|Lab abnormalities|1|||
146177219|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
146177220|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
146177221|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146177222|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
146177223|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
146177224|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
146177225|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
146177226|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
146177227|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
146177228|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
146177229|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
146177230|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
146177231|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
146177232|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
146177233|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
146177234|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
146177235|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
146177236|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
146177237|NCT00365378|527162228|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
146177238|NCT00365378|527162229|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
146177239|NCT00365378|527162230|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
146177240|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
146177241|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
146177242|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
146177243|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
146177244|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
146177245|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
146177246|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
146177247|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
146177248|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
146177249|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
146177250|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
146177251|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
146177252|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
146177253|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
146177254|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
146177255|NCT00365378|527162228|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
146177256|NCT00365378|527162229|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
146177257|NCT00365378|527162230|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
146177258|NCT00365378|527162228|FG000|Extension|Adverse Event|0|||
146177259|NCT00365378|527162229|FG001|Extension|Adverse Event|0|||
146177260|NCT00365378|527162230|FG002|Extension|Adverse Event|1|||
146177261|NCT00365378|527162228|FG000|Extension|Moved|0|||
146177262|NCT00365378|527162229|FG001|Extension|Moved|0|||
146177263|NCT00365378|527162230|FG002|Extension|Moved|8|||
146177264|NCT00365378|527162228|FG000|Extension|Lost to Follow-up|0|||
146177265|NCT00365378|527162229|FG001|Extension|Lost to Follow-up|0|||
146177266|NCT00365378|527162230|FG002|Extension|Lost to Follow-up|57|||
146177267|NCT00365378|527162228|FG000|Extension|Protocol Violation|0|||
146177268|NCT00365378|527162229|FG001|Extension|Protocol Violation|0|||
146177269|NCT00365378|527162230|FG002|Extension|Protocol Violation|2|||
146177270|NCT00365378|527162228|FG000|Extension|Withdrawal by Subject|0|||
146177271|NCT00365378|527162229|FG001|Extension|Withdrawal by Subject|0|||
146177272|NCT00365378|527162230|FG002|Extension|Withdrawal by Subject|98|||
146177273|NCT00365378|527162228|FG000|Extension|Other|0|||
146177274|NCT00365378|527162229|FG001|Extension|Other|0|||
146177275|NCT00365378|527162230|FG002|Extension|Other|31|||
146177276|NCT03560258|527162233|FG000|Overall Study|Lost to Follow-up|3|||
146177277|NCT03560258|527162234|FG001|Overall Study|Lost to Follow-up|0|||
146177278|NCT03560258|527162235|FG002|Overall Study|Lost to Follow-up|0|||
146177279|NCT03560258|527162233|FG000|Overall Study|Protocol Violation|0|||
146177280|NCT03560258|527162234|FG001|Overall Study|Protocol Violation|1|||
146177281|NCT03560258|527162235|FG002|Overall Study|Protocol Violation|0|||
146177282|NCT03560258|527162233|FG000|Overall Study|Withdrawal by Subject|0|||
146177283|NCT03560258|527162234|FG001|Overall Study|Withdrawal by Subject|0|||
146177284|NCT03560258|527162235|FG002|Overall Study|Withdrawal by Subject|1|||
146177285|NCT01460160|527162236|FG000|Treatment Phase|Lack of Efficacy|3|||
146177286|NCT01460160|527162236|FG000|Treatment Phase|Study Drug Toxicity|2|||
146177287|NCT01460160|527162236|FG000|Treatment Phase|Adverse Event|8|||
146177288|NCT01460160|527162236|FG000|Treatment Phase|Withdrawal by Subject|4|||
146177289|NCT01460160|527162236|FG000|Treatment Phase|Death|2|||
146177290|NCT01460160|527162236|FG000|Treatment Phase|Other reasons|9|||
146177291|NCT01460160|527162236|FG000|Follow-up Phase|Withdrawal by Subject|4|||
146177292|NCT01460160|527162236|FG000|Follow-up Phase|Death|14|||
146177293|NCT01460160|527162236|FG000|Follow-up Phase|Lost to Follow-up|7|||
146177294|NCT01460160|527162236|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
146177295|NCT01460160|527162236|FG000|Follow-up Phase|Other and not reported reasons|5|||
146177296|NCT03893825|527162237|FG000|Overall Study|Death|2|||
146177297|NCT03893825|527162238|FG001|Overall Study|Death|1|||
146177298|NCT03893825|527162237|FG000|Overall Study|Adverse Event|0|||
146177299|NCT03893825|527162238|FG001|Overall Study|Adverse Event|2|||
146177300|NCT03893825|527162237|FG000|Overall Study|Withdrawal by Subject|19|||
146177301|NCT03893825|527162238|FG001|Overall Study|Withdrawal by Subject|21|||
146177302|NCT03893825|527162237|FG000|Overall Study|Protocol deviation|1|||
146177303|NCT03893825|527162238|FG001|Overall Study|Protocol deviation|0|||
146177304|NCT03893825|527162237|FG000|Overall Study|Lost to Follow-up|10|||
146177305|NCT03893825|527162238|FG001|Overall Study|Lost to Follow-up|10|||
146177306|NCT03893825|527162237|FG000|Overall Study|Other than specified|7|||
146177307|NCT03893825|527162238|FG001|Overall Study|Other than specified|6|||
146177308|NCT04161807|527162239|FG000|Overall Study|Withdrawal by Subject|2|||
146177309|NCT04161807|527162239|FG000|Overall Study|Performed only 1 treatment|2|||
146177310|NCT02006121|527162240|FG000|Double Blind Phase|Adverse Event|6|||
146177311|NCT02006121|527162241|FG001|Double Blind Phase|Adverse Event|0|||
146177312|NCT02006121|527162240|FG000|Double Blind Phase|Lack of Efficacy|1|||
146177313|NCT02006121|527162241|FG001|Double Blind Phase|Lack of Efficacy|16|||
146177314|NCT02006121|527162240|FG000|Double Blind Phase|Withdrawal by Subject|3|||
146177315|NCT02006121|527162241|FG001|Double Blind Phase|Withdrawal by Subject|4|||
146177316|NCT02006121|527162240|FG000|Double Blind Phase|Non-compliance with study drug|1|||
146177317|NCT02006121|527162241|FG001|Double Blind Phase|Non-compliance with study drug|3|||
146177318|NCT02006121|527162240|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
146177319|NCT02006121|527162241|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
146177320|NCT02006121|527162240|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
146177321|NCT02006121|527162241|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
146177322|NCT02006121|527162240|FG000|Open Label Phase|Adverse Event|15|||
146177323|NCT02006121|527162241|FG001|Open Label Phase|Adverse Event|0|||
146177324|NCT02006121|527162240|FG000|Open Label Phase|Lack of Efficacy|2|||
146177325|NCT02006121|527162241|FG001|Open Label Phase|Lack of Efficacy|0|||
146177326|NCT02006121|527162240|FG000|Open Label Phase|Protocol Violation|2|||
146177327|NCT02006121|527162241|FG001|Open Label Phase|Protocol Violation|0|||
146177328|NCT02006121|527162240|FG000|Open Label Phase|Withdrawal by Subject|3|||
146177329|NCT02006121|527162241|FG001|Open Label Phase|Withdrawal by Subject|0|||
146177330|NCT02006121|527162240|FG000|Open Label Phase|Non-compliance with study drug|3|||
146177331|NCT02006121|527162241|FG001|Open Label Phase|Non-compliance with study drug|0|||
146177332|NCT00192023|527162252|FG000|Period III - Double-Blind|Adverse Event|3|||
146177333|NCT00192023|527162253|FG001|Period III - Double-Blind|Adverse Event|0|||
146177334|NCT00192023|527162252|FG000|Period III - Double-Blind|Physician Decision|2|||
146177335|NCT00192023|527162253|FG001|Period III - Double-Blind|Physician Decision|0|||
146177336|NCT00192023|527162252|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
146177337|NCT00192023|527162253|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
146177338|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
146177339|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
146177340|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
146177341|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
146177342|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
146177343|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
146177344|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
146177345|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
146177346|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
146177347|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
146177348|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
146177349|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
146177350|NCT00192023|527162252|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
146177351|NCT00192023|527162253|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
146177352|NCT01737996|527162259|FG000|Overall Study|Adverse Event|0|||
146177353|NCT01737996|527162260|FG001|Overall Study|Adverse Event|1|||
146177354|NCT01737996|527162261|FG002|Overall Study|Adverse Event|1|||
146177355|NCT01737996|527162259|FG000|Overall Study|Withdrawal by Subject|0|||
146177356|NCT01737996|527162260|FG001|Overall Study|Withdrawal by Subject|0|||
146177357|NCT01737996|527162261|FG002|Overall Study|Withdrawal by Subject|1|||
146177358|NCT02693834|527162270|FG000|Baseline Measurement|Withdrawal by Subject|1|||
146177359|NCT02693834|527162271|FG001|Baseline Measurement|Withdrawal by Subject|0|||
146177360|NCT02693834|527162270|FG000|Baseline Measurement|Adverse Event|1|||
146177361|NCT02693834|527162271|FG001|Baseline Measurement|Adverse Event|0|||
146177362|NCT02693834|527162270|FG000|Week 2 Practice|Adverse Event|0|||
146177363|NCT02693834|527162271|FG001|Week 2 Practice|Adverse Event|1|||
146177364|NCT02765490|527162274|FG000|Overall Study|Lost to Follow-up|1|||
146177365|NCT02765490|527162275|FG001|Overall Study|Lost to Follow-up|1|||
146177366|NCT02765490|527162274|FG000|Overall Study|Other|0|||
146177367|NCT02765490|527162275|FG001|Overall Study|Other|1|||
146177368|NCT02765490|527162274|FG000|Overall Study|Death|0|||
146177369|NCT02765490|527162275|FG001|Overall Study|Death|1|||
146177370|NCT01468922|527162276|FG000|Overall Study|Screening failure|0|||
146177371|NCT01468922|527162277|FG001|Overall Study|Screening failure|0|||
146177372|NCT01468922|527162278|FG002|Overall Study|Screening failure|0|||
146177373|NCT01468922|527162279|FG003|Overall Study|Screening failure|0|||
146177374|NCT01468922|527162280|FG004|Overall Study|Screening failure|0|||
146177375|NCT01468922|527162281|FG005|Overall Study|Screening failure|0|||
146177376|NCT01468922|527162282|FG006|Overall Study|Screening failure|0|||
146177377|NCT01468922|527162283|FG007|Overall Study|Screening failure|0|||
146177378|NCT01468922|527162284|FG008|Overall Study|Screening failure|1|||
146177379|NCT01468922|527162276|FG000|Overall Study|Per patient choice|1|||
146177380|NCT01468922|527162277|FG001|Overall Study|Per patient choice|0|||
146076795|NCT02527200|526802002|FG001|Overall Study|Withdrawal by Subject|2|||
146076796|NCT02527200|526802003|FG002|Overall Study|Withdrawal by Subject|1|||
146076797|NCT02527200|526802004|FG003|Overall Study|Withdrawal by Subject|0|||
146076798|NCT02527200|526802001|FG000|Overall Study|Unclassified|0|||
146076799|NCT02527200|526802002|FG001|Overall Study|Unclassified|1|||
146076800|NCT02527200|526802003|FG002|Overall Study|Unclassified|0|||
146076801|NCT02527200|526802004|FG003|Overall Study|Unclassified|0|||
146076802|NCT02527200|526802001|FG000|Overall Study|Lost to Follow-up|0|||
146076803|NCT02527200|526802002|FG001|Overall Study|Lost to Follow-up|0|||
146076804|NCT02527200|526802003|FG002|Overall Study|Lost to Follow-up|1|||
146076805|NCT02527200|526802004|FG003|Overall Study|Lost to Follow-up|0|||
146076806|NCT00966875|526802006|FG000|Part A|Adverse Event|2|||
146076807|NCT00966875|526802007|FG001|Part A|Adverse Event|1|||
146076808|NCT00966875|526802008|FG002|Part A|Adverse Event|0|||
146076809|NCT00966875|526802009|FG003|Part A|Adverse Event|1|||
146076810|NCT00966875|526802010|FG004|Part A|Adverse Event|0|||
146076811|NCT00966875|526802011|FG005|Part A|Adverse Event|1|||
146076812|NCT00966875|526802012|FG006|Part A|Adverse Event|0|||
146076813|NCT00966875|526802013|FG007|Part A|Adverse Event|3|||
146076814|NCT00966875|526802014|FG008|Part A|Adverse Event|3|||
146076815|NCT00966875|526802006|FG000|Part A|Entry Criteria|0|||
146076816|NCT00966875|526802007|FG001|Part A|Entry Criteria|0|||
146076817|NCT00966875|526802008|FG002|Part A|Entry Criteria|0|||
146076818|NCT00966875|526802009|FG003|Part A|Entry Criteria|0|||
146076819|NCT00966875|526802010|FG004|Part A|Entry Criteria|0|||
146076820|NCT00966875|526802011|FG005|Part A|Entry Criteria|2|||
146076821|NCT00966875|526802012|FG006|Part A|Entry Criteria|0|||
146076822|NCT00966875|526802013|FG007|Part A|Entry Criteria|0|||
146076823|NCT00966875|526802014|FG008|Part A|Entry Criteria|0|||
146076824|NCT00966875|526802006|FG000|Part A|Lack of Efficacy|0|||
146076825|NCT00966875|526802007|FG001|Part A|Lack of Efficacy|1|||
146076826|NCT00966875|526802008|FG002|Part A|Lack of Efficacy|0|||
146076827|NCT00966875|526802009|FG003|Part A|Lack of Efficacy|0|||
146076828|NCT00966875|526802010|FG004|Part A|Lack of Efficacy|0|||
146076829|NCT00966875|526802011|FG005|Part A|Lack of Efficacy|0|||
146076830|NCT00966875|526802012|FG006|Part A|Lack of Efficacy|4|||
146076831|NCT00966875|526802013|FG007|Part A|Lack of Efficacy|0|||
146076832|NCT00966875|526802014|FG008|Part A|Lack of Efficacy|0|||
146076833|NCT00966875|526802006|FG000|Part A|Lost to Follow-up|2|||
146076834|NCT00966875|526802007|FG001|Part A|Lost to Follow-up|0|||
146076835|NCT00966875|526802008|FG002|Part A|Lost to Follow-up|0|||
146076836|NCT00966875|526802009|FG003|Part A|Lost to Follow-up|0|||
146076837|NCT00966875|526802010|FG004|Part A|Lost to Follow-up|0|||
146076838|NCT00966875|526802011|FG005|Part A|Lost to Follow-up|1|||
146076839|NCT00966875|526802012|FG006|Part A|Lost to Follow-up|0|||
146076840|NCT00966875|526802013|FG007|Part A|Lost to Follow-up|0|||
146076841|NCT00966875|526802014|FG008|Part A|Lost to Follow-up|0|||
146076842|NCT00966875|526802006|FG000|Part A|Parent/Caregiver Decision|0|||
146076843|NCT00966875|526802007|FG001|Part A|Parent/Caregiver Decision|0|||
146076844|NCT00966875|526802008|FG002|Part A|Parent/Caregiver Decision|0|||
146076845|NCT00966875|526802009|FG003|Part A|Parent/Caregiver Decision|1|||
146076846|NCT00966875|526802010|FG004|Part A|Parent/Caregiver Decision|0|||
146076847|NCT00966875|526802011|FG005|Part A|Parent/Caregiver Decision|0|||
146076848|NCT00966875|526802012|FG006|Part A|Parent/Caregiver Decision|0|||
146076849|NCT00966875|526802013|FG007|Part A|Parent/Caregiver Decision|0|||
146076850|NCT00966875|526802014|FG008|Part A|Parent/Caregiver Decision|0|||
146076851|NCT00966875|526802006|FG000|Part A|Physician Decision|0|||
146076852|NCT00966875|526802007|FG001|Part A|Physician Decision|0|||
146076853|NCT00966875|526802008|FG002|Part A|Physician Decision|0|||
146076854|NCT00966875|526802009|FG003|Part A|Physician Decision|0|||
146076855|NCT00966875|526802010|FG004|Part A|Physician Decision|1|||
146076856|NCT00966875|526802011|FG005|Part A|Physician Decision|0|||
146076857|NCT00966875|526802012|FG006|Part A|Physician Decision|1|||
146076858|NCT00966875|526802013|FG007|Part A|Physician Decision|0|||
146076859|NCT00966875|526802014|FG008|Part A|Physician Decision|2|||
146076860|NCT00966875|526802006|FG000|Part A|Sponsor Decision|0|||
146076861|NCT00966875|526802007|FG001|Part A|Sponsor Decision|0|||
146076862|NCT00966875|526802008|FG002|Part A|Sponsor Decision|1|||
146076863|NCT00966875|526802009|FG003|Part A|Sponsor Decision|0|||
146076864|NCT00966875|526802010|FG004|Part A|Sponsor Decision|1|||
146076865|NCT00966875|526802011|FG005|Part A|Sponsor Decision|0|||
146076866|NCT00966875|526802012|FG006|Part A|Sponsor Decision|0|||
146076867|NCT00966875|526802013|FG007|Part A|Sponsor Decision|2|||
146076868|NCT00966875|526802014|FG008|Part A|Sponsor Decision|1|||
146076869|NCT00966875|526802006|FG000|Part A|Withdrawal by Subject|2|||
146076870|NCT00966875|526802007|FG001|Part A|Withdrawal by Subject|2|||
146076871|NCT00966875|526802008|FG002|Part A|Withdrawal by Subject|1|||
146076872|NCT00966875|526802009|FG003|Part A|Withdrawal by Subject|1|||
146076873|NCT00966875|526802010|FG004|Part A|Withdrawal by Subject|3|||
146076874|NCT00966875|526802011|FG005|Part A|Withdrawal by Subject|0|||
146076875|NCT00966875|526802012|FG006|Part A|Withdrawal by Subject|5|||
146076876|NCT00966875|526802013|FG007|Part A|Withdrawal by Subject|1|||
146076877|NCT00966875|526802014|FG008|Part A|Withdrawal by Subject|1|||
146076878|NCT00966875|526802006|FG000|Part A|Protocol Violation|0|||
146076879|NCT00966875|526802007|FG001|Part A|Protocol Violation|0|||
146076880|NCT00966875|526802008|FG002|Part A|Protocol Violation|0|||
146076881|NCT00966875|526802009|FG003|Part A|Protocol Violation|0|||
146076882|NCT00966875|526802010|FG004|Part A|Protocol Violation|0|||
146076883|NCT00966875|526802011|FG005|Part A|Protocol Violation|0|||
146076884|NCT00966875|526802012|FG006|Part A|Protocol Violation|2|||
146076885|NCT00966875|526802013|FG007|Part A|Protocol Violation|1|||
146076886|NCT00966875|526802014|FG008|Part A|Protocol Violation|1|||
146076887|NCT00966875|526802006|FG000|Part B|Adverse Event|0|||
146076888|NCT00966875|526802007|FG001|Part B|Adverse Event|1|||
146076889|NCT00966875|526802008|FG002|Part B|Adverse Event|1|||
146076890|NCT00966875|526802009|FG003|Part B|Adverse Event|0|||
146076891|NCT00966875|526802010|FG004|Part B|Adverse Event|1|||
146076892|NCT00966875|526802011|FG005|Part B|Adverse Event|0|||
146076893|NCT00966875|526802012|FG006|Part B|Adverse Event|5|||
146076894|NCT00966875|526802013|FG007|Part B|Adverse Event|2|||
146076895|NCT00966875|526802014|FG008|Part B|Adverse Event|2|||
146076896|NCT00966875|526802006|FG000|Part B|Death|0|||
146076897|NCT00966875|526802007|FG001|Part B|Death|0|||
146076898|NCT00966875|526802008|FG002|Part B|Death|1|||
146076899|NCT00966875|526802009|FG003|Part B|Death|0|||
146076900|NCT00966875|526802010|FG004|Part B|Death|0|||
146076901|NCT00966875|526802011|FG005|Part B|Death|0|||
146076902|NCT00966875|526802012|FG006|Part B|Death|0|||
146076903|NCT00966875|526802013|FG007|Part B|Death|1|||
146076904|NCT00966875|526802014|FG008|Part B|Death|0|||
146076905|NCT00966875|526802006|FG000|Part B|Lack of Efficacy|2|||
146076906|NCT00966875|526802007|FG001|Part B|Lack of Efficacy|1|||
146076907|NCT00966875|526802008|FG002|Part B|Lack of Efficacy|1|||
146076908|NCT00966875|526802009|FG003|Part B|Lack of Efficacy|1|||
146076909|NCT00966875|526802010|FG004|Part B|Lack of Efficacy|2|||
146076910|NCT00966875|526802011|FG005|Part B|Lack of Efficacy|3|||
146076911|NCT00966875|526802012|FG006|Part B|Lack of Efficacy|12|||
146076912|NCT00966875|526802013|FG007|Part B|Lack of Efficacy|9|||
146076913|NCT00966875|526802014|FG008|Part B|Lack of Efficacy|6|||
146076914|NCT00966875|526802006|FG000|Part B|Lost to Follow-up|0|||
146177381|NCT01468922|527162278|FG002|Overall Study|Per patient choice|0|||
146177382|NCT01468922|527162279|FG003|Overall Study|Per patient choice|0|||
146177383|NCT01468922|527162280|FG004|Overall Study|Per patient choice|0|||
146076915|NCT00966875|526802007|FG001|Part B|Lost to Follow-up|0|||
146076916|NCT00966875|526802008|FG002|Part B|Lost to Follow-up|0|||
146076917|NCT00966875|526802009|FG003|Part B|Lost to Follow-up|1|||
146076918|NCT00966875|526802010|FG004|Part B|Lost to Follow-up|0|||
146076919|NCT00966875|526802011|FG005|Part B|Lost to Follow-up|0|||
146076920|NCT00966875|526802012|FG006|Part B|Lost to Follow-up|0|||
146076921|NCT00966875|526802013|FG007|Part B|Lost to Follow-up|0|||
146076922|NCT00966875|526802014|FG008|Part B|Lost to Follow-up|1|||
146076923|NCT00966875|526802006|FG000|Part B|Physician Decision|0|||
146076924|NCT00966875|526802007|FG001|Part B|Physician Decision|0|||
146076925|NCT00966875|526802008|FG002|Part B|Physician Decision|1|||
146076926|NCT00966875|526802009|FG003|Part B|Physician Decision|0|||
146177384|NCT01468922|527162281|FG005|Overall Study|Per patient choice|0|||
146076927|NCT00966875|526802010|FG004|Part B|Physician Decision|2|||
146076928|NCT00966875|526802011|FG005|Part B|Physician Decision|1|||
146076929|NCT00966875|526802012|FG006|Part B|Physician Decision|0|||
146076930|NCT00966875|526802013|FG007|Part B|Physician Decision|0|||
146076931|NCT00966875|526802014|FG008|Part B|Physician Decision|2|||
146076932|NCT00966875|526802006|FG000|Part B|Sponsor Decision|1|||
146076933|NCT00966875|526802007|FG001|Part B|Sponsor Decision|0|||
146076934|NCT00966875|526802008|FG002|Part B|Sponsor Decision|0|||
146076935|NCT00966875|526802009|FG003|Part B|Sponsor Decision|0|||
146076936|NCT00966875|526802010|FG004|Part B|Sponsor Decision|0|||
146076937|NCT00966875|526802011|FG005|Part B|Sponsor Decision|1|||
146076938|NCT00966875|526802012|FG006|Part B|Sponsor Decision|0|||
146076939|NCT00966875|526802013|FG007|Part B|Sponsor Decision|2|||
146076940|NCT00966875|526802014|FG008|Part B|Sponsor Decision|1|||
146076941|NCT00966875|526802006|FG000|Part B|Withdrawal by Subject|2|||
146076942|NCT00966875|526802007|FG001|Part B|Withdrawal by Subject|1|||
146076943|NCT00966875|526802008|FG002|Part B|Withdrawal by Subject|2|||
146076944|NCT00966875|526802009|FG003|Part B|Withdrawal by Subject|1|||
146076945|NCT00966875|526802010|FG004|Part B|Withdrawal by Subject|2|||
146076946|NCT00966875|526802011|FG005|Part B|Withdrawal by Subject|1|||
146076947|NCT00966875|526802012|FG006|Part B|Withdrawal by Subject|4|||
146076948|NCT00966875|526802013|FG007|Part B|Withdrawal by Subject|5|||
146076949|NCT00966875|526802014|FG008|Part B|Withdrawal by Subject|5|||
146076950|NCT00966875|526802006|FG000|Part B|Entry Criteria|0|||
146076951|NCT00966875|526802007|FG001|Part B|Entry Criteria|0|||
146076952|NCT00966875|526802008|FG002|Part B|Entry Criteria|0|||
146076953|NCT00966875|526802009|FG003|Part B|Entry Criteria|0|||
146076954|NCT00966875|526802010|FG004|Part B|Entry Criteria|0|||
146076955|NCT00966875|526802011|FG005|Part B|Entry Criteria|0|||
146076956|NCT00966875|526802012|FG006|Part B|Entry Criteria|1|||
146076957|NCT00966875|526802013|FG007|Part B|Entry Criteria|0|||
146076958|NCT00966875|526802014|FG008|Part B|Entry Criteria|1|||
146076959|NCT01589653|526802017|FG000|Overall Study|Protocol Violation|3|||
146076960|NCT01589653|526802018|FG001|Overall Study|Protocol Violation|1|||
146076961|NCT01589653|526802017|FG000|Overall Study|Withdrawal criteria|4|||
146076962|NCT01589653|526802018|FG001|Overall Study|Withdrawal criteria|7|||
146076963|NCT01589653|526802017|FG000|Overall Study|Unclassified|0|||
146076964|NCT01589653|526802018|FG001|Overall Study|Unclassified|3|||
146076965|NCT01536067|526802019|FG000|Overall Study|Disease Progression|1|||
146076966|NCT02386189|526802022|FG000|Overall Study|Lost to Follow-up|2|||
146076967|NCT02386189|526802023|FG001|Overall Study|Lost to Follow-up|3|||
146076968|NCT02386189|526802022|FG000|Overall Study|Withdrawal by Subject|1|||
146076969|NCT02386189|526802023|FG001|Overall Study|Withdrawal by Subject|0|||
146076970|NCT02386189|526802022|FG000|Overall Study|Death|1|||
146076971|NCT02386189|526802023|FG001|Overall Study|Death|0|||
146076972|NCT00606905|526802024|FG000|Overall Study|No Pregnancy|9|||
146076973|NCT00606905|526802025|FG001|Overall Study|No Pregnancy|6|||
146076974|NCT00606905|526802024|FG000|Overall Study|Non-Index Pregnancy|1|||
146076975|NCT00606905|526802025|FG001|Overall Study|Non-Index Pregnancy|4|||
146076976|NCT00606905|526802024|FG000|Overall Study|Withdrew|5|||
146076977|NCT00606905|526802025|FG001|Overall Study|Withdrew|5|||
146076978|NCT04657666|526802026|FG000|Period 1|Withdrawal of participant consent|2|||
146076979|NCT04657666|526802027|FG001|Period 1|Withdrawal of participant consent|1|||
146076980|NCT04657666|526802026|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
146076981|NCT04657666|526802027|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
146076982|NCT04657666|526802026|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
146076983|NCT04657666|526802027|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
146076984|NCT04657666|526802026|FG000|Period 2|Other|2|||
146076985|NCT04657666|526802027|FG001|Period 2|Other|0|||
146076986|NCT04657666|526802026|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
146076987|NCT04657666|526802027|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
146076988|NCT03120351|526802028|FG000|Overall Study|Physician Decision|1|||
146076989|NCT03120351|526802029|FG001|Overall Study|Physician Decision|1|||
146076990|NCT04250077|526802038|FG000|Overall Study|Withdrawal by Subject|0|||
146076991|NCT04250077|526802039|FG001|Overall Study|Withdrawal by Subject|1|||
146076992|NCT04250077|526802040|FG002|Overall Study|Withdrawal by Subject|0|||
146076993|NCT04250077|526802038|FG000|Overall Study|Lost to Follow-up|2|||
146076994|NCT04250077|526802039|FG001|Overall Study|Lost to Follow-up|3|||
146076995|NCT04250077|526802040|FG002|Overall Study|Lost to Follow-up|0|||
146076996|NCT01022398|526802041|FG000|Overall Study|Study terminated|2|||
146076997|NCT01022398|526802042|FG001|Overall Study|Study terminated|2|||
146076998|NCT03319745|526802044|FG000|Overall Study|Death|1|||
146076999|NCT03319745|526802044|FG000|Overall Study|Toxicity Precluding Surgery|1|||
146077000|NCT00870103|526802045|FG000|Overall Study|Physician Decision|2|||
145890934|NCT01207440|526107571|FG001|Overall Study|Non-compliance with Study Drug|0|||
146077001|NCT00870103|526802045|FG000|Overall Study|Lost to Follow-up|2|||
146077002|NCT01317550|526802046|FG000|Overall Study|Withdrawal by Subject|1|||
146077003|NCT01317550|526802047|FG001|Overall Study|Withdrawal by Subject|0|||
146077004|NCT01317550|526802048|FG002|Overall Study|Withdrawal by Subject|0|||
146077005|NCT01317550|526802049|FG003|Overall Study|Withdrawal by Subject|0|||
146077006|NCT01317550|526802046|FG000|Overall Study|Lack of compliance study med|1|||
146177385|NCT01468922|527162282|FG006|Overall Study|Per patient choice|0|||
146177386|NCT01468922|527162283|FG007|Overall Study|Per patient choice|0|||
146177387|NCT01468922|527162284|FG008|Overall Study|Per patient choice|0|||
146177388|NCT01468922|527162276|FG000|Overall Study|Switched to alternative treatment|1|||
146177389|NCT01468922|527162277|FG001|Overall Study|Switched to alternative treatment|0|||
146177390|NCT01468922|527162278|FG002|Overall Study|Switched to alternative treatment|0|||
146177391|NCT01468922|527162279|FG003|Overall Study|Switched to alternative treatment|0|||
146177392|NCT01468922|527162280|FG004|Overall Study|Switched to alternative treatment|1|||
146177393|NCT01468922|527162281|FG005|Overall Study|Switched to alternative treatment|0|||
146177394|NCT01468922|527162282|FG006|Overall Study|Switched to alternative treatment|0|||
146177395|NCT01468922|527162283|FG007|Overall Study|Switched to alternative treatment|0|||
146177396|NCT01468922|527162284|FG008|Overall Study|Switched to alternative treatment|0|||
146177397|NCT01468922|527162276|FG000|Overall Study|Enrolled on new protocol|0|||
146177398|NCT01468922|527162277|FG001|Overall Study|Enrolled on new protocol|0|||
146177399|NCT01468922|527162278|FG002|Overall Study|Enrolled on new protocol|0|||
146177400|NCT01468922|527162279|FG003|Overall Study|Enrolled on new protocol|0|||
146177401|NCT01468922|527162280|FG004|Overall Study|Enrolled on new protocol|1|||
146177402|NCT01468922|527162281|FG005|Overall Study|Enrolled on new protocol|0|||
146177403|NCT01468922|527162282|FG006|Overall Study|Enrolled on new protocol|0|||
146177404|NCT01468922|527162283|FG007|Overall Study|Enrolled on new protocol|0|||
146177405|NCT01468922|527162284|FG008|Overall Study|Enrolled on new protocol|0|||
146177406|NCT01468922|527162276|FG000|Overall Study|Adverse Event|0|||
146177407|NCT01468922|527162277|FG001|Overall Study|Adverse Event|0|||
146177408|NCT01468922|527162278|FG002|Overall Study|Adverse Event|0|||
146177409|NCT01468922|527162279|FG003|Overall Study|Adverse Event|0|||
146177410|NCT01468922|527162280|FG004|Overall Study|Adverse Event|0|||
146177411|NCT01468922|527162281|FG005|Overall Study|Adverse Event|0|||
146177412|NCT01468922|527162282|FG006|Overall Study|Adverse Event|0|||
146177413|NCT01468922|527162283|FG007|Overall Study|Adverse Event|1|||
146177414|NCT01468922|527162284|FG008|Overall Study|Adverse Event|0|||
146077007|NCT01317550|526802047|FG001|Overall Study|Lack of compliance study med|0|||
146077008|NCT01317550|526802048|FG002|Overall Study|Lack of compliance study med|0|||
146077009|NCT01317550|526802049|FG003|Overall Study|Lack of compliance study med|0|||
146077010|NCT03255629|526802050|FG000|Overall Study|Adverse Event|1|||
146077011|NCT03255629|526802051|FG001|Overall Study|Adverse Event|0|||
146077012|NCT03255629|526802050|FG000|Overall Study|did not experience hypoglycemia|2|||
146077013|NCT03255629|526802051|FG001|Overall Study|did not experience hypoglycemia|1|||
146077014|NCT04540198|526802052|FG000|Overall Study|Lost to Follow-up|25|||
146077015|NCT04540198|526802053|FG001|Overall Study|Lost to Follow-up|23|||
146077016|NCT04540198|526802052|FG000|Overall Study|Withdrawal by Subject|15|||
146077017|NCT04540198|526802053|FG001|Overall Study|Withdrawal by Subject|9|||
146077018|NCT04540198|526802052|FG000|Overall Study|Discontinued|1|||
146077019|NCT04540198|526802053|FG001|Overall Study|Discontinued|0|||
146077020|NCT01086358|526802054|FG000|First Intervention|Lost to Follow-up|9|||
146077021|NCT01086358|526802055|FG001|First Intervention|Lost to Follow-up|4|||
146077022|NCT01086358|526802054|FG000|First Intervention|Withdrawal by Subject|0|||
146077023|NCT01086358|526802055|FG001|First Intervention|Withdrawal by Subject|1|||
146077024|NCT01086358|526802054|FG000|Second Intervention|Lost to Follow-up|4|||
146077025|NCT01086358|526802055|FG001|Second Intervention|Lost to Follow-up|4|||
146077026|NCT00833417|526802056|FG000|Overall Study|Adverse Event|5|||
146077027|NCT00833417|526802057|FG001|Overall Study|Adverse Event|16|||
146077028|NCT00833417|526802056|FG000|Overall Study|Death|1|||
146077029|NCT00833417|526802057|FG001|Overall Study|Death|3|||
146077030|NCT00833417|526802056|FG000|Overall Study|Lost to Follow-up|1|||
146077031|NCT00833417|526802057|FG001|Overall Study|Lost to Follow-up|2|||
146077032|NCT00833417|526802056|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
146077033|NCT00833417|526802057|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
146077034|NCT00833417|526802056|FG000|Overall Study|Patient Decision to Withdraw|4|||
146077035|NCT00833417|526802057|FG001|Overall Study|Patient Decision to Withdraw|23|||
146077036|NCT00833417|526802056|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
146077037|NCT00833417|526802057|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
146077038|NCT00833417|526802056|FG000|Overall Study|Disease Progression|18|||
146077039|NCT00833417|526802057|FG001|Overall Study|Disease Progression|17|||
146077040|NCT00833417|526802056|FG000|Overall Study|Reason Not Specified|0|||
146077041|NCT00833417|526802057|FG001|Overall Study|Reason Not Specified|1|||
146077042|NCT03330002|526802058|FG000|Overall Study|Lost to Follow-up|15|||
146077043|NCT03330002|526802058|FG000|Overall Study|Death|7|||
146077044|NCT03679754|526802059|FG000|Overall Study|Investigator request|1|||
146077045|NCT00964171|526802060|FG000|Overall Study|Death|5|||
146077046|NCT02872935|526802061|FG000|Overall Study|Other|0|||
146077047|NCT02872935|526802062|FG001|Overall Study|Other|1|||
146077048|NCT03037580|526802066|FG000|Overall Study|Withdrawal by Subject|3|||
146077049|NCT03037580|526802067|FG001|Overall Study|Withdrawal by Subject|0|||
146077050|NCT03037580|526802066|FG000|Overall Study|Adverse Event|1|||
146077051|NCT03037580|526802067|FG001|Overall Study|Adverse Event|0|||
146077052|NCT03037580|526802066|FG000|Overall Study|Study Terminated by Sponsor|12|||
146077053|NCT03037580|526802067|FG001|Overall Study|Study Terminated by Sponsor|15|||
146077054|NCT03037580|526802066|FG000|Overall Study|Death|0|||
146077055|NCT03037580|526802067|FG001|Overall Study|Death|1|||
146077056|NCT02873429|526802068|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
146077057|NCT02873429|526802069|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
146077058|NCT02873429|526802068|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
146077059|NCT02873429|526802069|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
146077060|NCT02873429|526802068|FG000|16 Weeks|Lost to Follow-up|3|||
146077061|NCT02873429|526802069|FG001|16 Weeks|Lost to Follow-up|0|||
146077062|NCT00853567|526802071|FG000|Overall Study|Study prematurely terminated|71|||
146077063|NCT00782834|526802072|FG000|Treatment Phase|fibrous tumor not GIST|1|||
146077064|NCT02259088|526802073|FG000|Overall Study|Adverse Event|6|||
146077065|NCT02259088|526802074|FG001|Overall Study|Adverse Event|4|||
146077066|NCT02259088|526802073|FG000|Overall Study|Lost to Follow-up|2|||
146077067|NCT02259088|526802074|FG001|Overall Study|Lost to Follow-up|0|||
146077068|NCT02259088|526802073|FG000|Overall Study|Death|2|||
146077069|NCT02259088|526802074|FG001|Overall Study|Death|0|||
146077070|NCT02259088|526802073|FG000|Overall Study|Physician Decision|5|||
146077071|NCT02259088|526802074|FG001|Overall Study|Physician Decision|2|||
146077072|NCT02259088|526802073|FG000|Overall Study|Protocol deviation|5|||
146077073|NCT02259088|526802074|FG001|Overall Study|Protocol deviation|0|||
146077074|NCT02259088|526802073|FG000|Overall Study|Subject/guardian decision|8|||
146077075|NCT02259088|526802074|FG001|Overall Study|Subject/guardian decision|8|||
146077076|NCT01818752|526802075|FG000|Overall Study|Adverse Event|64|||
146077077|NCT01818752|526802076|FG001|Overall Study|Adverse Event|74|||
146077078|NCT01818752|526802075|FG000|Overall Study|Death|14|||
146077079|NCT01818752|526802076|FG001|Overall Study|Death|18|||
146077080|NCT01818752|526802075|FG000|Overall Study|Non-compliance|16|||
146177415|NCT01468922|527162276|FG000|Overall Study|Infection of blood|0|||
146177416|NCT01468922|527162277|FG001|Overall Study|Infection of blood|0|||
146177417|NCT01468922|527162278|FG002|Overall Study|Infection of blood|0|||
146177418|NCT01468922|527162279|FG003|Overall Study|Infection of blood|0|||
146177419|NCT01468922|527162280|FG004|Overall Study|Infection of blood|0|||
146177420|NCT01468922|527162281|FG005|Overall Study|Infection of blood|0|||
146177421|NCT01468922|527162282|FG006|Overall Study|Infection of blood|0|||
146177422|NCT01468922|527162283|FG007|Overall Study|Infection of blood|1|||
146177423|NCT01468922|527162284|FG008|Overall Study|Infection of blood|0|||
146177424|NCT01468922|527162276|FG000|Overall Study|Patient choice - surgery|0|||
146177425|NCT01468922|527162277|FG001|Overall Study|Patient choice - surgery|0|||
146177426|NCT01468922|527162278|FG002|Overall Study|Patient choice - surgery|0|||
146177427|NCT01468922|527162279|FG003|Overall Study|Patient choice - surgery|0|||
146177428|NCT01468922|527162280|FG004|Overall Study|Patient choice - surgery|0|||
146177429|NCT01468922|527162281|FG005|Overall Study|Patient choice - surgery|0|||
146177430|NCT01468922|527162282|FG006|Overall Study|Patient choice - surgery|0|||
146177431|NCT01468922|527162283|FG007|Overall Study|Patient choice - surgery|1|||
146177432|NCT01468922|527162284|FG008|Overall Study|Patient choice - surgery|0|||
146177433|NCT01468922|527162276|FG000|Overall Study|Refused further treatment|0|||
146177434|NCT01468922|527162277|FG001|Overall Study|Refused further treatment|0|||
146177435|NCT01468922|527162278|FG002|Overall Study|Refused further treatment|0|||
146177436|NCT01468922|527162279|FG003|Overall Study|Refused further treatment|0|||
146177437|NCT01468922|527162280|FG004|Overall Study|Refused further treatment|0|||
146177438|NCT01468922|527162281|FG005|Overall Study|Refused further treatment|0|||
146177439|NCT01468922|527162282|FG006|Overall Study|Refused further treatment|0|||
146177440|NCT01468922|527162283|FG007|Overall Study|Refused further treatment|1|||
146177441|NCT01468922|527162284|FG008|Overall Study|Refused further treatment|0|||
146177442|NCT01923389|527162285|FG000|Overall Study|Protocol Violation|1|||
146177443|NCT01923389|527162286|FG001|Overall Study|Protocol Violation|0|||
146177444|NCT02761629|527162291|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
146177445|NCT02761629|527162292|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
146177446|NCT02761629|527162291|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146177447|NCT02761629|527162292|FG001|Overall Study|Insufficient Therapeutic Response|7|||
146177448|NCT02761629|527162291|FG000|Overall Study|Failure to Return|2|||
146177449|NCT02761629|527162292|FG001|Overall Study|Failure to Return|4|||
146177450|NCT02761629|527162291|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
146177451|NCT02761629|527162292|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
146177452|NCT02761629|527162291|FG000|Overall Study|Protocol Violation|2|||
146177453|NCT02761629|527162292|FG001|Overall Study|Protocol Violation|2|||
146177454|NCT02761629|527162291|FG000|Overall Study|Withdrawal by Subject|0|||
146177455|NCT02761629|527162292|FG001|Overall Study|Withdrawal by Subject|3|||
146177456|NCT02761629|527162291|FG000|Overall Study|Other|0|||
146177457|NCT02761629|527162292|FG001|Overall Study|Other|2|||
146177458|NCT02761629|527162291|FG000|Overall Study|Lost to Follow-up|4|||
146177459|NCT02761629|527162292|FG001|Overall Study|Lost to Follow-up|1|||
146177460|NCT02761629|527162291|FG000|Overall Study|Randomized But Not Treated|8|||
146177461|NCT02761629|527162292|FG001|Overall Study|Randomized But Not Treated|4|||
146177462|NCT02340520|527162295|FG000|Overall Study|Lost to Follow-up|1|||
146177463|NCT02340520|527162295|FG000|Overall Study|Patient did not take drug as specified|1|||
146177464|NCT02340520|527162295|FG000|Overall Study|Withdrawal by Subject|1|||
146177465|NCT00447954|527162296|FG000|Overall Study|Adverse Event|0|||
146177466|NCT00447954|527162297|FG001|Overall Study|Adverse Event|2|||
146177467|NCT00447954|527162298|FG002|Overall Study|Adverse Event|0|||
146177468|NCT00447954|527162296|FG000|Overall Study|Withdrawal by Subject|0|||
146177469|NCT00447954|527162297|FG001|Overall Study|Withdrawal by Subject|1|||
146177470|NCT00447954|527162298|FG002|Overall Study|Withdrawal by Subject|1|||
146177471|NCT00447954|527162296|FG000|Overall Study|Lost to Follow-up|0|||
146177472|NCT00447954|527162297|FG001|Overall Study|Lost to Follow-up|1|||
146177473|NCT00447954|527162298|FG002|Overall Study|Lost to Follow-up|0|||
146177474|NCT00447954|527162296|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
146177475|NCT00447954|527162297|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
146177476|NCT00447954|527162298|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
146177477|NCT01282476|527163521|FG000|Overall Study|Death|11|||
146177478|NCT01811563|527163528|FG000|Overall Study|Lost to Follow-up|5|||
146283929|NCT00604825|527551904|FG000|Overall Study|Lost to Follow-up|0|||
146177479|NCT01811563|527163529|FG001|Overall Study|Lost to Follow-up|2|||
146177480|NCT01811563|527163528|FG000|Overall Study|Incorrect Randomization procedure|0|||
146177481|NCT01811563|527163529|FG001|Overall Study|Incorrect Randomization procedure|1|||
146177482|NCT04424290|527163530|FG000|Overall Study|Not treated|0|||
146177483|NCT04424290|527163531|FG001|Overall Study|Not treated|0|||
146177484|NCT04424290|527163532|FG002|Overall Study|Not treated|1|||
146177485|NCT04424290|527163533|FG003|Overall Study|Not treated|0|||
146177486|NCT04424290|527163534|FG004|Overall Study|Not treated|1|||
146177487|NCT04424290|527163530|FG000|Overall Study|Adverse Event|0|||
146177488|NCT04424290|527163531|FG001|Overall Study|Adverse Event|0|||
146177489|NCT04424290|527163532|FG002|Overall Study|Adverse Event|0|||
146177490|NCT04424290|527163533|FG003|Overall Study|Adverse Event|2|||
146177491|NCT04424290|527163534|FG004|Overall Study|Adverse Event|0|||
146177492|NCT04424290|527163530|FG000|Overall Study|Withdrawal by Subject|0|||
146177493|NCT04424290|527163531|FG001|Overall Study|Withdrawal by Subject|0|||
146177494|NCT04424290|527163532|FG002|Overall Study|Withdrawal by Subject|0|||
146177495|NCT04424290|527163533|FG003|Overall Study|Withdrawal by Subject|0|||
146177496|NCT04424290|527163534|FG004|Overall Study|Withdrawal by Subject|1|||
146177497|NCT04424290|527163530|FG000|Overall Study|Other than listed|0|||
146177498|NCT04424290|527163531|FG001|Overall Study|Other than listed|0|||
146177499|NCT04424290|527163532|FG002|Overall Study|Other than listed|0|||
146177500|NCT04424290|527163533|FG003|Overall Study|Other than listed|1|||
146177501|NCT04424290|527163534|FG004|Overall Study|Other than listed|0|||
146177502|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
146177503|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
146177504|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
146177505|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
146177506|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
146177507|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
146177508|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Death|0|||
146177509|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Death|1|||
146177510|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Adverse Event|11|||
146177511|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Adverse Event|11|||
146177512|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
146177513|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
146177514|NCT02936037|527163535|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146177515|NCT02936037|527163536|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146177516|NCT02936037|527163535|FG000|Open Label Extension|Adverse Event|0|||
146177517|NCT02936037|527163536|FG001|Open Label Extension|Adverse Event|3|||
146177518|NCT02936037|527163535|FG000|Open Label Extension|Other|0|||
146177519|NCT02936037|527163536|FG001|Open Label Extension|Other|3|||
146177520|NCT02936037|527163535|FG000|Open Label Extension|Withdrawal by Subject|0|||
146177521|NCT02936037|527163536|FG001|Open Label Extension|Withdrawal by Subject|4|||
146177522|NCT01267825|527163537|FG000|Overall Study|study terminated. no data collected.|1|||
146177523|NCT01267825|527163538|FG001|Overall Study|study terminated. no data collected.|0|||
146177524|NCT02791490|527163542|FG000|Overall Study|Lost to Follow-up|1|||
146177525|NCT02791490|527163543|FG001|Overall Study|Lost to Follow-up|2|||
146177526|NCT02791490|527163542|FG000|Overall Study|Withdrawal by Subject|2|||
146177527|NCT02791490|527163543|FG001|Overall Study|Withdrawal by Subject|6|||
146177528|NCT01189890|527163544|FG000|Overall Study|Adverse Event|3|||
146177529|NCT01189890|527163545|FG001|Overall Study|Adverse Event|4|||
146177530|NCT01189890|527163544|FG000|Overall Study|Lack of Efficacy|7|||
146177531|NCT01189890|527163545|FG001|Overall Study|Lack of Efficacy|2|||
146177532|NCT01189890|527163544|FG000|Overall Study|Lost to Follow-up|1|||
146177533|NCT01189890|527163545|FG001|Overall Study|Lost to Follow-up|7|||
146177534|NCT01189890|527163544|FG000|Overall Study|Protocol Violation|1|||
146177535|NCT01189890|527163545|FG001|Overall Study|Protocol Violation|5|||
146177536|NCT01189890|527163544|FG000|Overall Study|Withdrawal by Subject|15|||
146177537|NCT01189890|527163545|FG001|Overall Study|Withdrawal by Subject|11|||
146177538|NCT01189890|527163544|FG000|Overall Study|Non Compliance|0|||
146177539|NCT01189890|527163545|FG001|Overall Study|Non Compliance|1|||
146177540|NCT01189890|527163544|FG000|Overall Study|Physician Decision|5|||
146177541|NCT01189890|527163545|FG001|Overall Study|Physician Decision|4|||
146177542|NCT01189890|527163544|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
146077081|NCT01818752|526802076|FG001|Overall Study|Non-compliance|20|||
146077082|NCT01818752|526802075|FG000|Overall Study|Withdrawal by Subject|15|||
146077083|NCT01818752|526802076|FG001|Overall Study|Withdrawal by Subject|14|||
146077084|NCT01818752|526802075|FG000|Overall Study|Physician Decision|9|||
146077085|NCT01818752|526802076|FG001|Overall Study|Physician Decision|8|||
146077086|NCT01818752|526802075|FG000|Overall Study|Disease Progression|54|||
146077087|NCT01818752|526802076|FG001|Overall Study|Disease Progression|48|||
146077088|NCT01818752|526802075|FG000|Overall Study|Other|7|||
146077089|NCT01818752|526802076|FG001|Overall Study|Other|8|||
146077090|NCT01818752|526802075|FG000|Overall Study|Continuing Treatment|1|||
146077091|NCT01818752|526802076|FG001|Overall Study|Continuing Treatment|4|||
146077092|NCT01818752|526802075|FG000|Overall Study|Randomized but not Dosed|7|||
146077093|NCT01818752|526802076|FG001|Overall Study|Randomized but not Dosed|4|||
146077094|NCT04270370|526802077|FG000|Overall Study|Lost to Follow-up|1|||
146077095|NCT04270370|526802078|FG001|Overall Study|Lost to Follow-up|0|||
146077096|NCT04270370|526802079|FG002|Overall Study|Lost to Follow-up|0|||
146077097|NCT04270370|526802080|FG003|Overall Study|Lost to Follow-up|0|||
146077098|NCT04270370|526802081|FG004|Overall Study|Lost to Follow-up|0|||
146077099|NCT04270370|526802082|FG005|Overall Study|Lost to Follow-up|0|||
146077100|NCT04270370|526802083|FG006|Overall Study|Lost to Follow-up|0|||
146077101|NCT04270370|526802084|FG007|Overall Study|Lost to Follow-up|0|||
146077102|NCT04270370|526802085|FG008|Overall Study|Lost to Follow-up|1|||
146177543|NCT01189890|527163545|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
146177544|NCT00077636|527163546|FG000|Overall Study|Refused Treatment|9|||
146177545|NCT00077636|527163547|FG001|Overall Study|Refused Treatment|31|||
146177546|NCT00077636|527163546|FG000|Overall Study|Admin|3|||
146177547|NCT00077636|527163547|FG001|Overall Study|Admin|3|||
146177548|NCT00077636|527163546|FG000|Overall Study|Withdrawal by Subject|2|||
146177549|NCT00077636|527163547|FG001|Overall Study|Withdrawal by Subject|2|||
146177550|NCT00077636|527163546|FG000|Overall Study|Adverse Event|17|||
146177551|NCT00077636|527163547|FG001|Overall Study|Adverse Event|34|||
146177552|NCT00077636|527163546|FG000|Overall Study|Protocol Violation|0|||
146177553|NCT00077636|527163547|FG001|Overall Study|Protocol Violation|2|||
146177554|NCT00077636|527163546|FG000|Overall Study|Lost to Follow-up|10|||
146177555|NCT00077636|527163547|FG001|Overall Study|Lost to Follow-up|18|||
146177556|NCT00077636|527163546|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
146177557|NCT00077636|527163547|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
146177558|NCT00592319|527163548|FG000|Overall Study|Lost to Follow-up|0|||
146177559|NCT00592319|527163549|FG001|Overall Study|Lost to Follow-up|3|||
146177560|NCT01017120|527163553|FG000|Overall Study|Adverse Event|9|||
146177561|NCT01017120|527163554|FG001|Overall Study|Adverse Event|0|||
146177562|NCT01017120|527163553|FG000|Overall Study|Lost to Follow-up|13|||
146177563|NCT01017120|527163554|FG001|Overall Study|Lost to Follow-up|11|||
146177564|NCT01017120|527163553|FG000|Overall Study|Lack of Efficacy|1|||
146177565|NCT01017120|527163554|FG001|Overall Study|Lack of Efficacy|0|||
146177566|NCT01017120|527163553|FG000|Overall Study|Withdrawal by Subject|39|||
146177567|NCT01017120|527163554|FG001|Overall Study|Withdrawal by Subject|21|||
146177568|NCT01017120|527163553|FG000|Overall Study|Pregnancy|1|||
146177569|NCT01017120|527163554|FG001|Overall Study|Pregnancy|1|||
146177570|NCT01017120|527163553|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146177571|NCT01017120|527163554|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146177572|NCT01017120|527163553|FG000|Overall Study|Relocated Out of Town|0|||
146177573|NCT01017120|527163554|FG001|Overall Study|Relocated Out of Town|2|||
146177574|NCT01017120|527163553|FG000|Overall Study|Protocol Violation|1|||
146177575|NCT01017120|527163554|FG001|Overall Study|Protocol Violation|0|||
146177576|NCT01017120|527163553|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
146177577|NCT01017120|527163554|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
146177578|NCT01087723|527163558|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
146177579|NCT01087723|527163559|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
146177580|NCT01087723|527163558|FG000|Overall Study|Withdrawal by Subject|10|||
146177581|NCT01087723|527163559|FG001|Overall Study|Withdrawal by Subject|13|||
146177582|NCT01087723|527163558|FG000|Overall Study|Physician Decision|2|||
146177583|NCT01087723|527163559|FG001|Overall Study|Physician Decision|0|||
146177584|NCT01087723|527163558|FG000|Overall Study|Lost to Follow-up|1|||
146177585|NCT01087723|527163559|FG001|Overall Study|Lost to Follow-up|4|||
146177586|NCT01087723|527163558|FG000|Overall Study|Reason Not Specified|1|||
146177587|NCT01087723|527163559|FG001|Overall Study|Reason Not Specified|2|||
146177588|NCT01868035|527163560|FG000|Overall Study|Lost to Follow-up|3|||
146177589|NCT01868035|527163560|FG000|Overall Study|Withdrawal by Subject|1|||
146177590|NCT01868035|527163560|FG000|Overall Study|Progressive Disease|2|||
146177591|NCT01868035|527163560|FG000|Overall Study|Non-compliance|1|||
146177592|NCT00806624|527163561|FG000|Overall Study|Adverse Event|2|||
146177593|NCT00806624|527163562|FG001|Overall Study|Adverse Event|8|||
146177594|NCT00806624|527163563|FG002|Overall Study|Adverse Event|0|||
146177595|NCT00806624|527163561|FG000|Overall Study|Death|0|||
146177596|NCT00806624|527163562|FG001|Overall Study|Death|1|||
146177597|NCT00806624|527163563|FG002|Overall Study|Death|1|||
146177598|NCT00806624|527163561|FG000|Overall Study|Lost to Follow-up|1|||
146412031|NCT01078623|528013980|FG012|Treatment Period 4|Withdrawal by Subject|0|||
146412032|NCT01078623|528013981|FG013|Treatment Period 4|Withdrawal by Subject|0|||
146177599|NCT00806624|527163562|FG001|Overall Study|Lost to Follow-up|0|||
146177600|NCT00806624|527163563|FG002|Overall Study|Lost to Follow-up|1|||
146177601|NCT00806624|527163561|FG000|Overall Study|Withdrawal by Subject|6|||
146177602|NCT00806624|527163562|FG001|Overall Study|Withdrawal by Subject|3|||
146177603|NCT00806624|527163563|FG002|Overall Study|Withdrawal by Subject|3|||
146177604|NCT00806624|527163561|FG000|Overall Study|discontinued before start of treatment|0|||
146177605|NCT00806624|527163562|FG001|Overall Study|discontinued before start of treatment|0|||
146177606|NCT00806624|527163563|FG002|Overall Study|discontinued before start of treatment|1|||
146177607|NCT01912222|527163568|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
146177608|NCT01912222|527163569|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
146177609|NCT01912222|527163570|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
146177610|NCT01912222|527163568|FG000|Part B: Treatment Period|Progressive disease|10|||
146412033|NCT01078623|528013982|FG014|Treatment Period 4|Withdrawal by Subject|0|||
146412034|NCT01078623|528013983|FG015|Treatment Period 4|Withdrawal by Subject|1|||
146412035|NCT01078623|528013984|FG016|Treatment Period 4|Withdrawal by Subject|0|||
146412036|NCT01078623|528013985|FG017|Treatment Period 4|Withdrawal by Subject|0|||
146412037|NCT01078623|528013986|FG018|Treatment Period 4|Withdrawal by Subject|0|||
146412038|NCT01078623|528013987|FG019|Treatment Period 4|Withdrawal by Subject|0|||
146077103|NCT04270370|526802086|FG009|Overall Study|Lost to Follow-up|0|||
146077104|NCT04270370|526802087|FG010|Overall Study|Lost to Follow-up|0|||
146077105|NCT04270370|526802088|FG011|Overall Study|Lost to Follow-up|0|||
146077106|NCT01324141|526802089|FG000|Overall Study|Declined to participate before treatment started|1|||
146077107|NCT01324141|526802089|FG000|Overall Study|Disease progression on study|1|||
146077108|NCT02745080|526802090|FG000|Overall Study|Adverse Event|13|||
146077109|NCT02745080|526802091|FG001|Overall Study|Adverse Event|21|||
146077110|NCT02745080|526802090|FG000|Overall Study|Lack of Efficacy|11|||
146077111|NCT02745080|526802091|FG001|Overall Study|Lack of Efficacy|23|||
146077112|NCT02745080|526802090|FG000|Overall Study|Lost to Follow-up|3|||
146077113|NCT02745080|526802091|FG001|Overall Study|Lost to Follow-up|3|||
146077114|NCT02745080|526802090|FG000|Overall Study|Physician Decision|3|||
146077115|NCT02745080|526802091|FG001|Overall Study|Physician Decision|0|||
146077116|NCT02745080|526802090|FG000|Overall Study|Protocol Violation|3|||
146077117|NCT02745080|526802091|FG001|Overall Study|Protocol Violation|1|||
146077118|NCT02745080|526802090|FG000|Overall Study|Withdrawal by Subject|22|||
146077119|NCT02745080|526802091|FG001|Overall Study|Withdrawal by Subject|41|||
146077120|NCT01001325|526802093|FG000|Overall Study|Lost to Follow-up|16|||
146077121|NCT01001325|526802094|FG001|Overall Study|Lost to Follow-up|10|||
146077122|NCT01001325|526802093|FG000|Overall Study|Protocol Violation|2|||
146077123|NCT01001325|526802094|FG001|Overall Study|Protocol Violation|0|||
146077124|NCT02051933|526804096|FG000|Overall Study|Physician Decision|0|||
146077125|NCT02051933|526804097|FG001|Overall Study|Physician Decision|1|||
146077126|NCT03745820|526804102|FG000|Overall Study|Adverse Event|0|||
146077127|NCT03745820|526804103|FG001|Overall Study|Adverse Event|3|||
146077128|NCT03745820|526804104|FG002|Overall Study|Adverse Event|2|||
146077129|NCT03745820|526804102|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146077130|NCT03745820|526804103|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146077131|NCT03745820|526804104|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146077132|NCT03745820|526804102|FG000|Overall Study|Withdrawal by Subject|4|||
146077133|NCT03745820|526804103|FG001|Overall Study|Withdrawal by Subject|4|||
146077134|NCT03745820|526804104|FG002|Overall Study|Withdrawal by Subject|4|||
146077135|NCT03745820|526804102|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
146077136|NCT03745820|526804103|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
146077137|NCT03745820|526804104|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
146077138|NCT03745820|526804102|FG000|Overall Study|Lost to Follow-up|2|||
146077139|NCT03745820|526804103|FG001|Overall Study|Lost to Follow-up|0|||
146077140|NCT03745820|526804104|FG002|Overall Study|Lost to Follow-up|3|||
146077141|NCT03745820|526804102|FG000|Overall Study|Reason not Specified|2|||
146077142|NCT03745820|526804103|FG001|Overall Study|Reason not Specified|4|||
146077143|NCT03745820|526804104|FG002|Overall Study|Reason not Specified|1|||
146077144|NCT00507728|526804105|FG000|Randomization to Month 3|Lost to Follow-up|15|||
146077145|NCT00507728|526804106|FG001|Randomization to Month 3|Lost to Follow-up|14|||
146077146|NCT00507728|526804107|FG002|Randomization to Month 3|Lost to Follow-up|20|||
146077147|NCT00507728|526804105|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
146077148|NCT00507728|526804106|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
146077149|NCT00507728|526804107|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
146077150|NCT01625260|526804112|FG000|Overall Study|Adverse Event|3|||
146077151|NCT01625260|526804113|FG001|Overall Study|Adverse Event|0|||
146077152|NCT01625260|526804112|FG000|Overall Study|Study Terminated by Investigator|2|||
146077153|NCT01625260|526804113|FG001|Overall Study|Study Terminated by Investigator|0|||
146077154|NCT01625260|526804112|FG000|Overall Study|Disease Progression|2|||
146077155|NCT01625260|526804113|FG001|Overall Study|Disease Progression|0|||
146077156|NCT01625260|526804112|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
146077157|NCT01625260|526804113|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
146077158|NCT03899805|526804114|FG000|Overall Study|Physician Decision|3|||
146177611|NCT01912222|527163569|FG001|Part B: Treatment Period|Progressive disease|12|||
146177612|NCT01912222|527163570|FG002|Part B: Treatment Period|Progressive disease|15|||
146177613|NCT01912222|527163568|FG000|Part B: Treatment Period|Adverse Event|1|||
146177614|NCT01912222|527163569|FG001|Part B: Treatment Period|Adverse Event|2|||
146177615|NCT01912222|527163570|FG002|Part B: Treatment Period|Adverse Event|3|||
146177616|NCT01912222|527163568|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
146177617|NCT01912222|527163569|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
146177618|NCT01912222|527163570|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
146177619|NCT01804673|527163571|FG000|Overall Study|Adverse Event|4|||
146177620|NCT01804673|527163571|FG000|Overall Study|Withdrawal by Subject|1|||
146177621|NCT01804673|527163571|FG000|Overall Study|Lack of Efficacy|9|||
146177622|NCT01804673|527163571|FG000|Overall Study|Change to Oral Therapy|37|||
146177623|NCT01804673|527163571|FG000|Overall Study|No Further Therapy Required|84|||
146177624|NCT01804673|527163571|FG000|Overall Study|Use of Prohibited Medication|1|||
146177625|NCT01804673|527163571|FG000|Overall Study|Other|4|||
146177626|NCT01024959|527163572|FG000|Overall Study|ineligible|12|||
146177627|NCT01024959|527163572|FG000|Overall Study|results not evaluable|12|||
146177628|NCT01024959|527163572|FG000|Overall Study|missing results required for analysis|17|||
146177629|NCT00313911|527163580|FG000|Overall Study|Serious adverse event|6|||
146177630|NCT00313911|527163581|FG001|Overall Study|Serious adverse event|1|||
146177631|NCT00313911|527163580|FG000|Overall Study|Adverse Event|2|||
146177632|NCT00313911|527163581|FG001|Overall Study|Adverse Event|3|||
146177633|NCT00313911|527163580|FG000|Overall Study|Protocol Violation|19|||
146177634|NCT00313911|527163581|FG001|Overall Study|Protocol Violation|10|||
146177635|NCT00313911|527163580|FG000|Overall Study|Lost to Follow-up|27|||
146177636|NCT00313911|527163581|FG001|Overall Study|Lost to Follow-up|14|||
146177637|NCT00313911|527163580|FG000|Overall Study|Withdrawal by Subject|39|||
146177638|NCT00313911|527163581|FG001|Overall Study|Withdrawal by Subject|12|||
146177639|NCT00313911|527163580|FG000|Overall Study|Did not meet age criteria|1|||
146177640|NCT00313911|527163581|FG001|Overall Study|Did not meet age criteria|1|||
146177641|NCT00636792|527163584|FG000|Overall Study|Adverse Event|16|||
146177642|NCT00636792|527163584|FG000|Overall Study|Physician Decision|7|||
146177643|NCT00636792|527163584|FG000|Overall Study|Progressive Disease|4|||
146177644|NCT00636792|527163584|FG000|Overall Study|Withdrawal by Subject|3|||
146177645|NCT00636792|527163584|FG000|Overall Study|Other|3|||
146177646|NCT01912781|527163585|FG000|Overall Study|Withdrawal by Subject|2|||
146177647|NCT01912781|527163586|FG001|Overall Study|Withdrawal by Subject|0|||
146177648|NCT01129336|527163589|FG000|Overall Study|Protocol Violation|1|||
146177649|NCT01129336|527163590|FG001|Overall Study|Protocol Violation|0|||
146177650|NCT01129336|527163589|FG000|Overall Study|Disease Progression|1|||
146177651|NCT01129336|527163590|FG001|Overall Study|Disease Progression|4|||
146177652|NCT01129336|527163589|FG000|Overall Study|Lost to Follow-up|1|||
146177653|NCT01129336|527163590|FG001|Overall Study|Lost to Follow-up|0|||
146177654|NCT01129336|527163589|FG000|Overall Study|Withdrawal by Subject|7|||
146177655|NCT01129336|527163590|FG001|Overall Study|Withdrawal by Subject|4|||
146177656|NCT01129336|527163589|FG000|Overall Study|Adverse Event|0|||
146177657|NCT01129336|527163590|FG001|Overall Study|Adverse Event|1|||
146177658|NCT01129336|527163589|FG000|Overall Study|Missing Study Completion Status|2|||
146177659|NCT01129336|527163590|FG001|Overall Study|Missing Study Completion Status|3|||
146177660|NCT01129336|527163589|FG000|Overall Study|Death|0|||
146177661|NCT01129336|527163590|FG001|Overall Study|Death|4|||
146177662|NCT04537897|527163591|FG000|Overall Study|Other than listed|0|||
146177663|NCT04537897|527163592|FG001|Overall Study|Other than listed|0|||
146177664|NCT04537897|527163593|FG002|Overall Study|Other than listed|0|||
146177665|NCT04537897|527163594|FG003|Overall Study|Other than listed|0|||
146177666|NCT04537897|527163595|FG004|Overall Study|Other than listed|0|||
146177667|NCT04537897|527163596|FG005|Overall Study|Other than listed|0|||
146177668|NCT04537897|527163597|FG006|Overall Study|Other than listed|1|||
146177669|NCT04537897|527163598|FG007|Overall Study|Other than listed|0|||
146177670|NCT04537897|527163599|FG008|Overall Study|Other than listed|0|||
146177671|NCT04537897|527163591|FG000|Overall Study|Adverse Event|0|||
146177672|NCT04537897|527163592|FG001|Overall Study|Adverse Event|0|||
146177673|NCT04537897|527163593|FG002|Overall Study|Adverse Event|0|||
146177674|NCT04537897|527163594|FG003|Overall Study|Adverse Event|1|||
146177675|NCT04537897|527163595|FG004|Overall Study|Adverse Event|0|||
146177676|NCT04537897|527163596|FG005|Overall Study|Adverse Event|0|||
146177677|NCT04537897|527163597|FG006|Overall Study|Adverse Event|0|||
146177678|NCT04537897|527163598|FG007|Overall Study|Adverse Event|0|||
146177679|NCT04537897|527163599|FG008|Overall Study|Adverse Event|0|||
146177680|NCT04537897|527163591|FG000|Overall Study|Withdrawal by Subject|0|||
146177681|NCT04537897|527163592|FG001|Overall Study|Withdrawal by Subject|1|||
146177682|NCT04537897|527163593|FG002|Overall Study|Withdrawal by Subject|0|||
146177683|NCT04537897|527163594|FG003|Overall Study|Withdrawal by Subject|0|||
146177684|NCT04537897|527163595|FG004|Overall Study|Withdrawal by Subject|0|||
146177685|NCT04537897|527163596|FG005|Overall Study|Withdrawal by Subject|0|||
146177686|NCT04537897|527163597|FG006|Overall Study|Withdrawal by Subject|0|||
146177687|NCT04537897|527163598|FG007|Overall Study|Withdrawal by Subject|0|||
146177688|NCT04537897|527163599|FG008|Overall Study|Withdrawal by Subject|0|||
146177689|NCT00919893|527163600|FG000|Overall Study|Protocol Violation|19|||
146177690|NCT00919893|527163601|FG001|Overall Study|Protocol Violation|9|||
146177691|NCT00708305|527163611|FG000|Period 1|Protocol Violation|1|||
146177692|NCT00708305|527163612|FG001|Period 1|Protocol Violation|0|||
146177693|NCT00708305|527163613|FG002|Period 1|Protocol Violation|1|||
146177694|NCT00708305|527163614|FG003|Period 1|Protocol Violation|0|||
146177695|NCT00708305|527163611|FG000|Period 1|Other Reason|0|||
146177696|NCT00708305|527163612|FG001|Period 1|Other Reason|0|||
146177697|NCT00708305|527163613|FG002|Period 1|Other Reason|0|||
146177698|NCT00708305|527163614|FG003|Period 1|Other Reason|2|||
146177699|NCT00708305|527163611|FG000|Period 2|Lost to Follow-up|0|||
146177700|NCT00708305|527163612|FG001|Period 2|Lost to Follow-up|1|||
146177701|NCT00708305|527163613|FG002|Period 2|Lost to Follow-up|0|||
146177702|NCT00708305|527163614|FG003|Period 2|Lost to Follow-up|0|||
146412039|NCT00463866|528013988|FG000|Overall Study|Adverse Event|70|||
146412040|NCT00463866|528013989|FG001|Overall Study|Adverse Event|93|||
146177703|NCT00708305|527163611|FG000|Period 2|Protocol Violation|0|||
146177704|NCT00708305|527163612|FG001|Period 2|Protocol Violation|1|||
146177705|NCT00708305|527163613|FG002|Period 2|Protocol Violation|0|||
146177706|NCT00708305|527163614|FG003|Period 2|Protocol Violation|0|||
146177707|NCT00708305|527163611|FG000|Period 2|Other Reason|1|||
146177708|NCT00708305|527163612|FG001|Period 2|Other Reason|0|||
146177709|NCT00708305|527163613|FG002|Period 2|Other Reason|0|||
146177710|NCT00708305|527163614|FG003|Period 2|Other Reason|1|||
146177711|NCT00708305|527163611|FG000|Period 3|Protocol Violation|0|||
146177712|NCT00708305|527163612|FG001|Period 3|Protocol Violation|2|||
146412041|NCT00463866|528013988|FG000|Overall Study|Withdrawal by Subject|81|||
146412042|NCT00463866|528013989|FG001|Overall Study|Withdrawal by Subject|79|||
146412043|NCT00463866|528013988|FG000|Overall Study|Lost to Follow-up|46|||
146412044|NCT00463866|528013989|FG001|Overall Study|Lost to Follow-up|55|||
146412045|NCT00463866|528013988|FG000|Overall Study|Incorrect Enrolment|64|||
146412046|NCT00463866|528013989|FG001|Overall Study|Incorrect Enrolment|66|||
146412047|NCT00463866|528013988|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
146412048|NCT00463866|528013989|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
146412049|NCT00463866|528013988|FG000|Overall Study|Safety Reason|1|||
146412050|NCT00463866|528013989|FG001|Overall Study|Safety Reason|3|||
146412051|NCT00463866|528013988|FG000|Overall Study|Mis-Randomization of subject|0|||
146412052|NCT00463866|528013989|FG001|Overall Study|Mis-Randomization of subject|1|||
146412053|NCT00463866|528013988|FG000|Overall Study|Other|22|||
146412054|NCT00463866|528013989|FG001|Overall Study|Other|22|||
146412055|NCT01170364|528014002|FG000|Overall Study|Protocol Violation|4|||
146412056|NCT01170364|528014003|FG001|Overall Study|Protocol Violation|1|||
146412057|NCT02622074|528014008|FG000|Overall Study|Death|4|||
146177713|NCT00708305|527163613|FG002|Period 3|Protocol Violation|0|||
146177714|NCT00708305|527163614|FG003|Period 3|Protocol Violation|0|||
146177715|NCT00708305|527163611|FG000|Period 3|Other Reason|1|||
146177716|NCT00708305|527163612|FG001|Period 3|Other Reason|0|||
146177717|NCT00708305|527163613|FG002|Period 3|Other Reason|0|||
146177718|NCT00708305|527163614|FG003|Period 3|Other Reason|0|||
146177719|NCT00734214|527163616|FG000|Overall Study|Withdrawal by Subject|3|||
146177720|NCT00734214|527163617|FG001|Overall Study|Withdrawal by Subject|4|||
146177721|NCT00734214|527163616|FG000|Overall Study|MD withdrawal|1|||
146177722|NCT00734214|527163617|FG001|Overall Study|MD withdrawal|0|||
146177723|NCT00550550|527163618|FG000|Overall Study|Adverse Event|13|||
146177724|NCT00550550|527163619|FG001|Overall Study|Adverse Event|5|||
146177725|NCT00550550|527163618|FG000|Overall Study|Treatment Failure|0|||
146177726|NCT00550550|527163619|FG001|Overall Study|Treatment Failure|1|||
146177727|NCT00550550|527163618|FG000|Overall Study|Lost to Follow-up|4|||
146177728|NCT00550550|527163619|FG001|Overall Study|Lost to Follow-up|0|||
146177729|NCT00550550|527163618|FG000|Overall Study|Withdrawal by Subject|10|||
146177730|NCT00550550|527163619|FG001|Overall Study|Withdrawal by Subject|8|||
146177731|NCT00550550|527163618|FG000|Overall Study|Protocol Violation|5|||
146177732|NCT00550550|527163619|FG001|Overall Study|Protocol Violation|14|||
146177733|NCT00550550|527163618|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
146177734|NCT00550550|527163619|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146177735|NCT00550550|527163618|FG000|Overall Study|Randomized But Not Treated|1|||
146177736|NCT00550550|527163619|FG001|Overall Study|Randomized But Not Treated|0|||
146177737|NCT03311230|527163623|FG000|Overall Study|Withdrawal by Subject|1|||
146177738|NCT03311230|527163624|FG001|Overall Study|Withdrawal by Subject|4|||
146177739|NCT03311230|527163625|FG002|Overall Study|Withdrawal by Subject|2|||
146177740|NCT03311230|527163626|FG003|Overall Study|Withdrawal by Subject|7|||
146177741|NCT03311230|527163623|FG000|Overall Study|Unrelated injury|0|||
146177742|NCT03311230|527163624|FG001|Overall Study|Unrelated injury|1|||
146177743|NCT03311230|527163625|FG002|Overall Study|Unrelated injury|0|||
146177744|NCT03311230|527163626|FG003|Overall Study|Unrelated injury|0|||
146177745|NCT01302938|527163627|FG000|Overall Study|Withdrawal by Subject|1|||
146177746|NCT01302938|527163628|FG001|Overall Study|Withdrawal by Subject|0|||
146177747|NCT01302938|527163627|FG000|Overall Study|Adverse Event|1|||
146177748|NCT01302938|527163628|FG001|Overall Study|Adverse Event|0|||
146177749|NCT00171873|527163629|FG000|Overall Study|Withdrawal by Subject|4|||
146177750|NCT00171873|527163630|FG001|Overall Study|Withdrawal by Subject|2|||
146177751|NCT00171873|527163629|FG000|Overall Study|Adverse Event|5|||
146177752|NCT00171873|527163630|FG001|Overall Study|Adverse Event|0|||
146177753|NCT00171873|527163629|FG000|Overall Study|Switched to Octreotide|0|||
146177754|NCT00171873|527163630|FG001|Overall Study|Switched to Octreotide|1|||
146177755|NCT01518946|527163647|FG000|Open-label Phase|Other|4|||
146177756|NCT01518946|527163648|FG001|Open-label Phase|Other|0|||
146177757|NCT01518946|527163649|FG002|Open-label Phase|Other|0|||
146177758|NCT01518946|527163647|FG000|Randomized Phase (First Intervention)|Other|0|||
146177759|NCT01518946|527163648|FG001|Randomized Phase (First Intervention)|Other|1|||
146177760|NCT01518946|527163649|FG002|Randomized Phase (First Intervention)|Other|0|||
146177761|NCT03857841|527163650|FG000|Overall Study|Death|1|||
146177762|NCT03857841|527163651|FG001|Overall Study|Death|0|||
146177763|NCT03857841|527163652|FG002|Overall Study|Death|0|||
146177764|NCT03857841|527163653|FG003|Overall Study|Death|0|||
146177765|NCT03857841|527163650|FG000|Overall Study|Study Terminated by Sponsor|1|||
146177766|NCT03857841|527163651|FG001|Overall Study|Study Terminated by Sponsor|0|||
146177767|NCT03857841|527163652|FG002|Overall Study|Study Terminated by Sponsor|0|||
146177768|NCT03857841|527163653|FG003|Overall Study|Study Terminated by Sponsor|0|||
146177769|NCT00384059|527163654|FG000|Infant Series|Not consented|2|||
146177770|NCT00384059|527163655|FG001|Infant Series|Not consented|6|||
146177771|NCT00384059|527163654|FG000|Infant Series|Withdrawal by Subject|2|||
146177772|NCT00384059|527163655|FG001|Infant Series|Withdrawal by Subject|2|||
146177773|NCT00384059|527163654|FG000|Infant Series|Adverse Event|1|||
146177774|NCT00384059|527163655|FG001|Infant Series|Adverse Event|2|||
146177775|NCT00384059|527163654|FG000|Infant Series|Protocol Violation|1|||
146177776|NCT00384059|527163655|FG001|Infant Series|Protocol Violation|2|||
146177777|NCT00384059|527163654|FG000|Infant Series|Lost to Follow-up|0|||
146177778|NCT00384059|527163655|FG001|Infant Series|Lost to Follow-up|1|||
146177779|NCT00384059|527163654|FG000|After Infant Series|Protocol Violation|2|||
146177780|NCT00384059|527163655|FG001|After Infant Series|Protocol Violation|3|||
146177781|NCT00384059|527163654|FG000|After Infant Series|Withdrawal by Subject|2|||
146177782|NCT00384059|527163655|FG001|After Infant Series|Withdrawal by Subject|2|||
146177783|NCT00384059|527163654|FG000|After Infant Series|Failed to Return|0|||
146177784|NCT00384059|527163655|FG001|After Infant Series|Failed to Return|2|||
146177785|NCT00384059|527163654|FG000|After Infant Series|Adverse Event|0|||
146177786|NCT00384059|527163655|FG001|After Infant Series|Adverse Event|1|||
146077159|NCT03899805|526804115|FG001|Overall Study|Physician Decision|0|||
146077160|NCT03899805|526804116|FG002|Overall Study|Physician Decision|2|||
146077161|NCT03899805|526804114|FG000|Overall Study|Withdrawal by Subject|1|||
146077162|NCT03899805|526804115|FG001|Overall Study|Withdrawal by Subject|0|||
146077163|NCT03899805|526804116|FG002|Overall Study|Withdrawal by Subject|2|||
146077164|NCT03899805|526804114|FG000|Overall Study|Progressive Disease|10|||
146077165|NCT03899805|526804115|FG001|Overall Study|Progressive Disease|18|||
146077166|NCT03899805|526804116|FG002|Overall Study|Progressive Disease|12|||
146077167|NCT03899805|526804114|FG000|Overall Study|Adverse Event|3|||
146077168|NCT03899805|526804115|FG001|Overall Study|Adverse Event|1|||
146077169|NCT03899805|526804116|FG002|Overall Study|Adverse Event|0|||
146077170|NCT03899805|526804114|FG000|Overall Study|Death|2|||
146077171|NCT03899805|526804115|FG001|Overall Study|Death|0|||
146077172|NCT03899805|526804116|FG002|Overall Study|Death|0|||
146077173|NCT03899805|526804114|FG000|Overall Study|Came off for surgery|0|||
146077174|NCT03899805|526804115|FG001|Overall Study|Came off for surgery|0|||
146077175|NCT03899805|526804116|FG002|Overall Study|Came off for surgery|1|||
146077176|NCT03317405|526804117|FG000|Overall Study|Withdrawal by Subject|1|||
146077177|NCT03317405|526804118|FG001|Overall Study|Withdrawal by Subject|0|||
146077178|NCT03317405|526804119|FG002|Overall Study|Withdrawal by Subject|0|||
146077179|NCT03317405|526804117|FG000|Overall Study|Physician Decision|0|||
146077180|NCT03317405|526804118|FG001|Overall Study|Physician Decision|0|||
146077181|NCT03317405|526804119|FG002|Overall Study|Physician Decision|1|||
146077182|NCT03317405|526804117|FG000|Overall Study|Surgery Rescheduled|0|||
146077183|NCT03317405|526804118|FG001|Overall Study|Surgery Rescheduled|1|||
146077184|NCT03317405|526804119|FG002|Overall Study|Surgery Rescheduled|0|||
146077185|NCT04075734|526804122|FG000|Overall Study|Lost to Follow-up|1|||
146077186|NCT04075734|526804123|FG001|Overall Study|Lost to Follow-up|1|||
146077187|NCT04075734|526804124|FG002|Overall Study|Lost to Follow-up|0|||
146077188|NCT04075734|526804122|FG000|Overall Study|Withdrawal by Subject|3|||
146077189|NCT04075734|526804123|FG001|Overall Study|Withdrawal by Subject|0|||
146177787|NCT00384059|527163654|FG000|After Infant Series|Physician Decision|0|||
146177788|NCT00384059|527163655|FG001|After Infant Series|Physician Decision|1|||
146177789|NCT00384059|527163654|FG000|After Infant Series|Lost to Follow-up|0|||
146077190|NCT04075734|526804124|FG002|Overall Study|Withdrawal by Subject|0|||
146077191|NCT01137604|526804127|FG000|Overall Study|Adverse Event|3|||
146077192|NCT01137604|526804128|FG001|Overall Study|Adverse Event|6|||
146077193|NCT01137604|526804129|FG002|Overall Study|Adverse Event|9|||
146177790|NCT00384059|527163655|FG001|After Infant Series|Lost to Follow-up|1|||
146177791|NCT00384059|527163654|FG000|Toddler Dose|Lost to Follow-up|1|||
146177792|NCT00384059|527163655|FG001|Toddler Dose|Lost to Follow-up|1|||
146177793|NCT00384059|527163654|FG000|Toddler Dose|Failed to return|0|||
146177794|NCT00384059|527163655|FG001|Toddler Dose|Failed to return|1|||
146177795|NCT00381641|527163656|FG000|Overall Study|Withdrawal by Subject|0|||
146177796|NCT00381641|527163657|FG001|Overall Study|Withdrawal by Subject|2|||
146177797|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146177798|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
146177799|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
146177800|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146177801|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146177802|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146177803|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
146177804|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
146177805|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177806|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177807|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177808|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177809|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177810|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146177811|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
146177812|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146177813|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146177814|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146177815|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146177816|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146177817|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146177818|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146177819|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
146177820|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
146177821|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146177822|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146177823|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146177824|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
146177825|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177826|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177827|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
146177828|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177829|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177830|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177831|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
146177832|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
146177833|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
146177834|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
146177835|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146177836|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146177837|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146177838|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146177839|NCT04921969|527163658|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
146177840|NCT04921969|527163659|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
146177841|NCT04921969|527163660|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146177842|NCT04921969|527163661|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146177843|NCT04921969|527163662|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146177844|NCT04921969|527163663|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146177845|NCT04921969|527163664|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
146177846|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177847|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177848|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177849|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177850|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177851|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
146177852|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
146177853|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146177854|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146177855|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146177856|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146177857|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146177858|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
146177859|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146177860|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146177861|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146177862|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146177863|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
146177864|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
146177865|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
146177866|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
146177867|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146177868|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146177869|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146177870|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146177871|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
146177872|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146177873|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
146177874|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146177875|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146177876|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146177877|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
146177878|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
146177879|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
146177880|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
146177881|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146177882|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146177883|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146177884|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
146177885|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
146177886|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
146177887|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
146177888|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146177889|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146177890|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146177891|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
146177892|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146177893|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
146177894|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
146177895|NCT04921969|527163658|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146177896|NCT04921969|527163659|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146177897|NCT04921969|527163660|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146177898|NCT04921969|527163661|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146177899|NCT04921969|527163662|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
146177900|NCT04921969|527163663|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
146177901|NCT04921969|527163664|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
146177902|NCT04287868|527163665|FG000|Overall Study|Screening fail|1|||
146177903|NCT04287868|527163666|FG001|Overall Study|Screening fail|0|||
146177904|NCT04249336|527165521|FG000|Overall Study|Lost to Follow-up|3|||
146177905|NCT04249336|527165522|FG001|Overall Study|Lost to Follow-up|3|||
146177906|NCT04249336|527165523|FG002|Overall Study|Lost to Follow-up|3|||
146177907|NCT04249336|527165524|FG003|Overall Study|Lost to Follow-up|3|||
146177908|NCT01242176|527165525|FG000|Washout Period of 7 Days|Adverse Event|0|||
146177909|NCT01242176|527165526|FG001|Washout Period of 7 Days|Adverse Event|2|||
146177910|NCT01242176|527165525|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
146177911|NCT01242176|527165526|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
146177912|NCT00871351|527165527|FG000|Overall Study|Withdrawal by Subject|1|||
146177913|NCT00871351|527165528|FG001|Overall Study|Withdrawal by Subject|0|||
146177914|NCT00871351|527165529|FG002|Overall Study|Withdrawal by Subject|0|||
146177915|NCT00871351|527165527|FG000|Overall Study|Adverse Event|3|||
146177916|NCT00871351|527165528|FG001|Overall Study|Adverse Event|1|||
146177917|NCT00871351|527165529|FG002|Overall Study|Adverse Event|0|||
146177918|NCT02291289|527165531|FG000|Induction Treatment|Withdrawal by Subject|0|||
146177919|NCT02291289|527165532|FG001|Induction Treatment|Withdrawal by Subject|0|||
146177920|NCT02291289|527165533|FG002|Induction Treatment|Withdrawal by Subject|0|||
146177921|NCT02291289|527165534|FG003|Induction Treatment|Withdrawal by Subject|24|||
146177922|NCT02291289|527165535|FG004|Induction Treatment|Withdrawal by Subject|0|||
146177923|NCT02291289|527165536|FG005|Induction Treatment|Withdrawal by Subject|0|||
146177924|NCT02291289|527165537|FG006|Induction Treatment|Withdrawal by Subject|0|||
146412058|NCT02622074|528014009|FG001|Overall Study|Death|0|||
146177925|NCT02291289|527165538|FG007|Induction Treatment|Withdrawal by Subject|0|||
146177926|NCT02291289|527165539|FG008|Induction Treatment|Withdrawal by Subject|0|||
146177927|NCT02291289|527165540|FG009|Induction Treatment|Withdrawal by Subject|18|||
146412059|NCT02622074|528014010|FG002|Overall Study|Death|0|||
146077194|NCT01137604|526804130|FG003|Overall Study|Adverse Event|9|||
146077195|NCT01137604|526804127|FG000|Overall Study|Participant Choice|0|||
146077196|NCT01137604|526804128|FG001|Overall Study|Participant Choice|2|||
146077197|NCT01137604|526804129|FG002|Overall Study|Participant Choice|2|||
146077198|NCT01137604|526804130|FG003|Overall Study|Participant Choice|0|||
146077199|NCT01137604|526804127|FG000|Overall Study|Withdrawal of consent|0|||
146077200|NCT01137604|526804128|FG001|Overall Study|Withdrawal of consent|0|||
146077201|NCT01137604|526804129|FG002|Overall Study|Withdrawal of consent|0|||
146077202|NCT01137604|526804130|FG003|Overall Study|Withdrawal of consent|2|||
146077203|NCT01137604|526804127|FG000|Overall Study|Clinical progression/deterioration|1|||
146077204|NCT01137604|526804128|FG001|Overall Study|Clinical progression/deterioration|2|||
146077205|NCT01137604|526804129|FG002|Overall Study|Clinical progression/deterioration|2|||
146077206|NCT01137604|526804130|FG003|Overall Study|Clinical progression/deterioration|0|||
146077207|NCT00591318|526804131|FG000|Overall Study|Lack of Efficacy|2|||
146077208|NCT00591318|526804132|FG001|Overall Study|Lack of Efficacy|0|||
146077209|NCT00591318|526804131|FG000|Overall Study|Adverse Event|2|||
146077210|NCT00591318|526804132|FG001|Overall Study|Adverse Event|0|||
146077211|NCT01776307|526804133|FG000|Overall Study|Not dosed|0|||
146077212|NCT01776307|526804134|FG001|Overall Study|Not dosed|0|||
146077213|NCT01776307|526804135|FG002|Overall Study|Not dosed|1|||
146077214|NCT01024309|526804141|FG000|Overall Study|Physician Decision|4|||
146077215|NCT01024309|526804142|FG001|Overall Study|Physician Decision|0|||
146077216|NCT01024309|526804141|FG000|Overall Study|Withdrawal by Subject|4|||
146077217|NCT01024309|526804142|FG001|Overall Study|Withdrawal by Subject|4|||
146077218|NCT02745145|526804145|FG000|Overall Study|Adverse Event|1|||
146077219|NCT02745145|526804146|FG001|Overall Study|Adverse Event|0|||
146077220|NCT02745145|526804147|FG002|Overall Study|Adverse Event|0|||
146077221|NCT02745145|526804145|FG000|Overall Study|Death|0|||
146077222|NCT02745145|526804146|FG001|Overall Study|Death|1|||
146077223|NCT02745145|526804147|FG002|Overall Study|Death|0|||
146077224|NCT02745145|526804145|FG000|Overall Study|Progressive disease|0|||
146077225|NCT02745145|526804146|FG001|Overall Study|Progressive disease|0|||
146077226|NCT02745145|526804147|FG002|Overall Study|Progressive disease|1|||
146077227|NCT02745145|526804145|FG000|Overall Study|Withdrew consent|1|||
146177928|NCT02291289|527165541|FG010|Induction Treatment|Withdrawal by Subject|0|||
146177929|NCT02291289|527165542|FG011|Induction Treatment|Withdrawal by Subject|0|||
146177930|NCT02291289|527165543|FG012|Induction Treatment|Withdrawal by Subject|0|||
146177931|NCT02291289|527165531|FG000|Induction Treatment|Adverse Event|0|||
146177932|NCT02291289|527165532|FG001|Induction Treatment|Adverse Event|0|||
146177933|NCT02291289|527165533|FG002|Induction Treatment|Adverse Event|0|||
146177934|NCT02291289|527165534|FG003|Induction Treatment|Adverse Event|3|||
146177935|NCT02291289|527165535|FG004|Induction Treatment|Adverse Event|0|||
146177936|NCT02291289|527165536|FG005|Induction Treatment|Adverse Event|0|||
146177937|NCT02291289|527165537|FG006|Induction Treatment|Adverse Event|0|||
146177938|NCT02291289|527165538|FG007|Induction Treatment|Adverse Event|0|||
146177939|NCT02291289|527165539|FG008|Induction Treatment|Adverse Event|0|||
146177940|NCT02291289|527165540|FG009|Induction Treatment|Adverse Event|1|||
146177941|NCT02291289|527165541|FG010|Induction Treatment|Adverse Event|0|||
146177942|NCT02291289|527165542|FG011|Induction Treatment|Adverse Event|0|||
146177943|NCT02291289|527165543|FG012|Induction Treatment|Adverse Event|0|||
146177944|NCT02291289|527165531|FG000|Induction Treatment|Death|25|||
146177945|NCT02291289|527165532|FG001|Induction Treatment|Death|0|||
146177946|NCT02291289|527165533|FG002|Induction Treatment|Death|0|||
146177947|NCT02291289|527165534|FG003|Induction Treatment|Death|111|||
146177948|NCT02291289|527165535|FG004|Induction Treatment|Death|0|||
146177949|NCT02291289|527165536|FG005|Induction Treatment|Death|0|||
146177950|NCT02291289|527165537|FG006|Induction Treatment|Death|1|||
146177951|NCT02291289|527165538|FG007|Induction Treatment|Death|0|||
146177952|NCT02291289|527165539|FG008|Induction Treatment|Death|0|||
146177953|NCT02291289|527165540|FG009|Induction Treatment|Death|82|||
146177954|NCT02291289|527165541|FG010|Induction Treatment|Death|0|||
146177955|NCT02291289|527165542|FG011|Induction Treatment|Death|0|||
146177956|NCT02291289|527165543|FG012|Induction Treatment|Death|0|||
146177957|NCT02291289|527165531|FG000|Induction Treatment|Lost to Follow-up|1|||
146177958|NCT02291289|527165532|FG001|Induction Treatment|Lost to Follow-up|0|||
146177959|NCT02291289|527165533|FG002|Induction Treatment|Lost to Follow-up|0|||
146177960|NCT02291289|527165534|FG003|Induction Treatment|Lost to Follow-up|12|||
146177961|NCT02291289|527165535|FG004|Induction Treatment|Lost to Follow-up|0|||
146177962|NCT02291289|527165536|FG005|Induction Treatment|Lost to Follow-up|0|||
146177963|NCT02291289|527165537|FG006|Induction Treatment|Lost to Follow-up|0|||
146177964|NCT02291289|527165538|FG007|Induction Treatment|Lost to Follow-up|0|||
146177965|NCT02291289|527165539|FG008|Induction Treatment|Lost to Follow-up|0|||
146177966|NCT02291289|527165540|FG009|Induction Treatment|Lost to Follow-up|9|||
146177967|NCT02291289|527165541|FG010|Induction Treatment|Lost to Follow-up|0|||
146177968|NCT02291289|527165542|FG011|Induction Treatment|Lost to Follow-up|0|||
146177969|NCT02291289|527165543|FG012|Induction Treatment|Lost to Follow-up|0|||
146177970|NCT02291289|527165531|FG000|Induction Treatment|Non-Compliance|0|||
146177971|NCT02291289|527165532|FG001|Induction Treatment|Non-Compliance|0|||
146177972|NCT02291289|527165533|FG002|Induction Treatment|Non-Compliance|0|||
146177973|NCT02291289|527165534|FG003|Induction Treatment|Non-Compliance|1|||
146177974|NCT02291289|527165535|FG004|Induction Treatment|Non-Compliance|0|||
146177975|NCT02291289|527165536|FG005|Induction Treatment|Non-Compliance|0|||
146177976|NCT02291289|527165537|FG006|Induction Treatment|Non-Compliance|0|||
146177977|NCT02291289|527165538|FG007|Induction Treatment|Non-Compliance|0|||
146177978|NCT02291289|527165539|FG008|Induction Treatment|Non-Compliance|0|||
146177979|NCT02291289|527165540|FG009|Induction Treatment|Non-Compliance|1|||
146177980|NCT02291289|527165541|FG010|Induction Treatment|Non-Compliance|0|||
146177981|NCT02291289|527165542|FG011|Induction Treatment|Non-Compliance|0|||
146177982|NCT02291289|527165543|FG012|Induction Treatment|Non-Compliance|0|||
146177983|NCT02291289|527165531|FG000|Induction Treatment|Reason Not Specified|0|||
146177984|NCT02291289|527165532|FG001|Induction Treatment|Reason Not Specified|0|||
146177985|NCT02291289|527165533|FG002|Induction Treatment|Reason Not Specified|0|||
146177986|NCT02291289|527165534|FG003|Induction Treatment|Reason Not Specified|4|||
146177987|NCT02291289|527165535|FG004|Induction Treatment|Reason Not Specified|0|||
146177988|NCT02291289|527165536|FG005|Induction Treatment|Reason Not Specified|0|||
146177989|NCT02291289|527165537|FG006|Induction Treatment|Reason Not Specified|0|||
146177990|NCT02291289|527165538|FG007|Induction Treatment|Reason Not Specified|0|||
146177991|NCT02291289|527165539|FG008|Induction Treatment|Reason Not Specified|0|||
146177992|NCT02291289|527165540|FG009|Induction Treatment|Reason Not Specified|7|||
146177993|NCT02291289|527165541|FG010|Induction Treatment|Reason Not Specified|0|||
146177994|NCT02291289|527165542|FG011|Induction Treatment|Reason Not Specified|0|||
146177995|NCT02291289|527165543|FG012|Induction Treatment|Reason Not Specified|0|||
146177996|NCT02291289|527165531|FG000|Induction Treatment|Physician Decision|0|||
146177997|NCT02291289|527165532|FG001|Induction Treatment|Physician Decision|0|||
146177998|NCT02291289|527165533|FG002|Induction Treatment|Physician Decision|0|||
146177999|NCT02291289|527165534|FG003|Induction Treatment|Physician Decision|3|||
146178000|NCT02291289|527165535|FG004|Induction Treatment|Physician Decision|0|||
146178001|NCT02291289|527165536|FG005|Induction Treatment|Physician Decision|0|||
146178002|NCT02291289|527165537|FG006|Induction Treatment|Physician Decision|0|||
146178003|NCT02291289|527165538|FG007|Induction Treatment|Physician Decision|0|||
146178004|NCT02291289|527165539|FG008|Induction Treatment|Physician Decision|0|||
146178005|NCT02291289|527165540|FG009|Induction Treatment|Physician Decision|1|||
146077228|NCT02745145|526804146|FG001|Overall Study|Withdrew consent|1|||
146077229|NCT02745145|526804147|FG002|Overall Study|Withdrew consent|1|||
146077230|NCT02745145|526804145|FG000|Overall Study|Study Termination|8|||
146077231|NCT02745145|526804146|FG001|Overall Study|Study Termination|3|||
146077232|NCT02745145|526804147|FG002|Overall Study|Study Termination|7|||
146077233|NCT03083990|526804148|FG000|Overall Study|Adverse Event|1|||
146077234|NCT03083990|526804149|FG001|Overall Study|Adverse Event|0|||
146077235|NCT01018810|526804150|FG000|Overall Study|Withdrawal by Subject|0|||
146077236|NCT01018810|526804151|FG001|Overall Study|Withdrawal by Subject|1|||
146077237|NCT01018810|526804152|FG002|Overall Study|Withdrawal by Subject|0|||
146077238|NCT01018810|526804153|FG003|Overall Study|Withdrawal by Subject|0|||
146077239|NCT01018810|526804154|FG004|Overall Study|Withdrawal by Subject|0|||
146077240|NCT01018810|526804150|FG000|Overall Study|Sponsor Decision|2|||
146077241|NCT01018810|526804151|FG001|Overall Study|Sponsor Decision|0|||
146077242|NCT01018810|526804152|FG002|Overall Study|Sponsor Decision|1|||
146077243|NCT01018810|526804153|FG003|Overall Study|Sponsor Decision|1|||
146077244|NCT01018810|526804154|FG004|Overall Study|Sponsor Decision|1|||
146077245|NCT02424578|526804155|FG000|Overall Study|Withdrawal by Subject|0|||
146077246|NCT02424578|526804156|FG001|Overall Study|Withdrawal by Subject|1|||
146077247|NCT02640508|526804162|FG000|Overall Study|Death|19|||
146077248|NCT02640508|526804162|FG000|Overall Study|Withdrawal by Subject|8|||
146077249|NCT02640508|526804162|FG000|Overall Study|Physician Decision|1|||
146077250|NCT02640508|526804162|FG000|Overall Study|Lost to Follow-up|1|||
146077251|NCT00862082|526804163|FG000|Overall Study|Sponsor decision to terminate the study|5|||
146077252|NCT00862082|526804164|FG001|Overall Study|Sponsor decision to terminate the study|0|||
146077253|NCT00862082|526804163|FG000|Overall Study|Withdrawal by Subject|0|||
146077254|NCT00862082|526804164|FG001|Overall Study|Withdrawal by Subject|1|||
146077255|NCT05405257|526804165|FG000|Overall Study|Withdrawal by Subject|1|||
146077256|NCT00776919|526804166|FG000|Overall Study|Withdrawal by Subject|16|||
146077257|NCT00776919|526804167|FG001|Overall Study|Withdrawal by Subject|14|||
146077258|NCT00776919|526804168|FG002|Overall Study|Withdrawal by Subject|15|||
146077259|NCT00776919|526804169|FG003|Overall Study|Withdrawal by Subject|26|||
146077260|NCT00776919|526804166|FG000|Overall Study|Lost to Follow-up|8|||
146077261|NCT00776919|526804167|FG001|Overall Study|Lost to Follow-up|12|||
146077262|NCT00776919|526804168|FG002|Overall Study|Lost to Follow-up|11|||
146077263|NCT00776919|526804169|FG003|Overall Study|Lost to Follow-up|8|||
146077264|NCT00776919|526804166|FG000|Overall Study|Adverse Event|1|||
146077265|NCT00776919|526804167|FG001|Overall Study|Adverse Event|0|||
146077266|NCT00776919|526804168|FG002|Overall Study|Adverse Event|2|||
146077267|NCT00776919|526804169|FG003|Overall Study|Adverse Event|2|||
146077268|NCT00776919|526804166|FG000|Overall Study|Protocol Violation|1|||
146077269|NCT00776919|526804167|FG001|Overall Study|Protocol Violation|2|||
146178006|NCT02291289|527165541|FG010|Induction Treatment|Physician Decision|0|||
146178007|NCT02291289|527165542|FG011|Induction Treatment|Physician Decision|0|||
146178008|NCT02291289|527165543|FG012|Induction Treatment|Physician Decision|0|||
146178009|NCT02291289|527165531|FG000|Induction Treatment|Protocol Violation|0|||
146178010|NCT02291289|527165532|FG001|Induction Treatment|Protocol Violation|0|||
146178011|NCT02291289|527165533|FG002|Induction Treatment|Protocol Violation|0|||
146178012|NCT02291289|527165534|FG003|Induction Treatment|Protocol Violation|3|||
146178013|NCT02291289|527165535|FG004|Induction Treatment|Protocol Violation|0|||
146178014|NCT02291289|527165536|FG005|Induction Treatment|Protocol Violation|0|||
146178015|NCT02291289|527165537|FG006|Induction Treatment|Protocol Violation|0|||
146178016|NCT02291289|527165538|FG007|Induction Treatment|Protocol Violation|0|||
146178017|NCT02291289|527165539|FG008|Induction Treatment|Protocol Violation|0|||
146178018|NCT02291289|527165540|FG009|Induction Treatment|Protocol Violation|2|||
146178019|NCT02291289|527165541|FG010|Induction Treatment|Protocol Violation|0|||
146178020|NCT02291289|527165542|FG011|Induction Treatment|Protocol Violation|0|||
146178021|NCT02291289|527165543|FG012|Induction Treatment|Protocol Violation|0|||
146178022|NCT02291289|527165531|FG000|Induction Treatment|Missing|4|||
146178023|NCT02291289|527165532|FG001|Induction Treatment|Missing|0|||
146178024|NCT02291289|527165533|FG002|Induction Treatment|Missing|0|||
146178025|NCT02291289|527165534|FG003|Induction Treatment|Missing|14|||
146178026|NCT02291289|527165535|FG004|Induction Treatment|Missing|0|||
146178027|NCT02291289|527165536|FG005|Induction Treatment|Missing|0|||
146178028|NCT02291289|527165537|FG006|Induction Treatment|Missing|0|||
146178029|NCT02291289|527165538|FG007|Induction Treatment|Missing|0|||
146178030|NCT02291289|527165539|FG008|Induction Treatment|Missing|0|||
146178031|NCT02291289|527165540|FG009|Induction Treatment|Missing|54|||
146178032|NCT02291289|527165541|FG010|Induction Treatment|Missing|0|||
146178033|NCT02291289|527165542|FG011|Induction Treatment|Missing|0|||
146178034|NCT02291289|527165543|FG012|Induction Treatment|Missing|0|||
146178035|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178036|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178037|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178038|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178039|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
146178040|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
146178041|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146077270|NCT00776919|526804168|FG002|Overall Study|Protocol Violation|0|||
146077271|NCT00776919|526804169|FG003|Overall Study|Protocol Violation|1|||
146077272|NCT00776919|526804166|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
146077273|NCT00776919|526804167|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
146077274|NCT00776919|526804168|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
146077275|NCT00776919|526804169|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
146077276|NCT03116152|526804170|FG000|Overall Study|Disease Progression|49|||
146077277|NCT03116152|526804171|FG001|Overall Study|Disease Progression|47|||
146077278|NCT03116152|526804170|FG000|Overall Study|Death|5|||
146077279|NCT03116152|526804171|FG001|Overall Study|Death|2|||
146077280|NCT03116152|526804170|FG000|Overall Study|Adverse Event|21|||
146077281|NCT03116152|526804171|FG001|Overall Study|Adverse Event|7|||
146077282|NCT03116152|526804170|FG000|Overall Study|Protocol Violation|2|||
146077283|NCT03116152|526804171|FG001|Overall Study|Protocol Violation|2|||
146077284|NCT03116152|526804170|FG000|Overall Study|Withdrawal by Subject|0|||
146077285|NCT03116152|526804171|FG001|Overall Study|Withdrawal by Subject|1|||
146077286|NCT03116152|526804170|FG000|Overall Study|Physician Decision|3|||
146077287|NCT03116152|526804171|FG001|Overall Study|Physician Decision|2|||
146077288|NCT03116152|526804170|FG000|Overall Study|other|11|||
146077289|NCT03116152|526804171|FG001|Overall Study|other|34|||
146077290|NCT00862641|526804173|FG000|Overall Study|Randomized, but drug not received|1|||
146077291|NCT00862641|526804174|FG001|Overall Study|Randomized, but drug not received|4|||
146077292|NCT00862641|526804175|FG002|Overall Study|Randomized, but drug not received|1|||
146077293|NCT00862641|526804176|FG003|Overall Study|Randomized, but drug not received|4|||
146077294|NCT03179605|526804177|FG000|Overall Study|Withdrawal by Subject|1|||
146077295|NCT00635999|526804178|FG000|Overall Study|Withdrawal by Subject|4|||
146077296|NCT00635999|526804179|FG001|Overall Study|Withdrawal by Subject|2|||
146077297|NCT00635999|526804180|FG002|Overall Study|Withdrawal by Subject|1|||
146077298|NCT00711477|526804181|FG000|Overall Study|Adverse Event|3|||
146077299|NCT00711477|526804182|FG001|Overall Study|Adverse Event|1|||
146077300|NCT00711477|526804181|FG000|Overall Study|Lost to Follow-up|0|||
146077301|NCT00711477|526804182|FG001|Overall Study|Lost to Follow-up|1|||
146077302|NCT00711477|526804181|FG000|Overall Study|Noncompliance|0|||
146077303|NCT00711477|526804182|FG001|Overall Study|Noncompliance|1|||
146077304|NCT01798849|526804183|FG000|Overall Study|Physician Decision|0|||
146077305|NCT01798849|526804184|FG001|Overall Study|Physician Decision|0|||
146077306|NCT01798849|526804185|FG002|Overall Study|Physician Decision|1|||
146077307|NCT02636361|526804186|FG000|Period 4|Physician Decision|0|||
146077308|NCT02636361|526804187|FG001|Period 4|Physician Decision|0|||
146077309|NCT02636361|526804188|FG002|Period 4|Physician Decision|0|||
146077310|NCT02636361|526804189|FG003|Period 4|Physician Decision|1|||
146077311|NCT02636361|526804190|FG004|Period 4|Physician Decision|0|||
146077312|NCT02410343|526804196|FG000|Core Period (24 Weeks)|Adverse Event|1|||
146077313|NCT02410343|526804197|FG001|Core Period (24 Weeks)|Adverse Event|0|||
146077314|NCT02410343|526804196|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
146077315|NCT02410343|526804197|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
146077316|NCT02410343|526804196|FG000|Extension Period (12 Months)|Adverse Event|1|||
146077317|NCT02410343|526804197|FG001|Extension Period (12 Months)|Adverse Event|0|||
146077318|NCT02410343|526804196|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
146077319|NCT02410343|526804197|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
146077320|NCT02036853|526804198|FG000|Overall Study|Adverse Event|0|||
146077321|NCT02036853|526804199|FG001|Overall Study|Adverse Event|2|||
146077322|NCT02036853|526804198|FG000|Overall Study|Lack of Efficacy|0|||
146077323|NCT02036853|526804199|FG001|Overall Study|Lack of Efficacy|2|||
146077324|NCT02036853|526804198|FG000|Overall Study|Physician Decision|0|||
146077325|NCT02036853|526804199|FG001|Overall Study|Physician Decision|1|||
146077326|NCT02036853|526804198|FG000|Overall Study|Withdrawal by Subject|0|||
146077327|NCT02036853|526804199|FG001|Overall Study|Withdrawal by Subject|1|||
146077328|NCT00228553|526804200|FG000|Overall Study|Adverse Event|112|||
146077329|NCT00228553|526804200|FG000|Overall Study|Lack of Efficacy|34|||
146077330|NCT00228553|526804200|FG000|Overall Study|Lost to Follow-up|67|||
146077331|NCT00228553|526804200|FG000|Overall Study|Physician Decision|48|||
146077332|NCT00228553|526804200|FG000|Overall Study|Protocol Violation|6|||
146077333|NCT00228553|526804200|FG000|Overall Study|Withdrawal by Subject|115|||
146077334|NCT00228553|526804200|FG000|Overall Study|Pregnancy|2|||
146077335|NCT00228553|526804200|FG000|Overall Study|Miscellaneous|46|||
146077336|NCT04556383|526804203|FG000|PCP|Lack of Efficacy|28|||
146077337|NCT04556383|526804204|FG001|PCP|Lack of Efficacy|23|||
146077338|NCT04556383|526804205|FG002|PCP|Lack of Efficacy|23|||
146077339|NCT04556383|526804206|FG003|PCP|Lack of Efficacy|0|||
146077340|NCT04556383|526804203|FG000|PCP|Study terminated by sponsor|15|||
146077341|NCT04556383|526804204|FG001|PCP|Study terminated by sponsor|13|||
146077342|NCT04556383|526804205|FG002|PCP|Study terminated by sponsor|16|||
146077343|NCT04556383|526804206|FG003|PCP|Study terminated by sponsor|0|||
146178042|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178043|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178044|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178045|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
146178046|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
146178047|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146178048|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Death|0|||
146178049|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Death|29|||
146178050|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Death|16|||
146178051|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Death|0|||
146178052|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Death|188|||
146178053|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Death|107|||
146178054|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Death|0|||
146178055|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Death|1|||
146178056|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Death|1|||
146178057|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Death|0|||
146178058|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Death|46|||
146178059|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Death|19|||
146178060|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Death|0|||
146178061|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146178062|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Adverse Event|0|||
146178063|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Adverse Event|0|||
146178064|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Adverse Event|0|||
146178065|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Adverse Event|1|||
146178066|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Adverse Event|1|||
146178067|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Adverse Event|0|||
146178068|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Adverse Event|0|||
146178069|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Adverse Event|0|||
146178070|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Adverse Event|0|||
146178071|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Adverse Event|0|||
146178072|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Adverse Event|0|||
146178073|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Adverse Event|0|||
146178074|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178075|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
146178076|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178077|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178078|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
146178079|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
146178080|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178081|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
146178082|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178083|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178084|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
146178085|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
146178086|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
146178087|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
146178088|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
146178089|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
146178090|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
146178091|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
146178092|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
146178093|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
146178094|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
146178095|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
146178096|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
146178097|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
146178098|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
146178099|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
146178100|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Physician Decision|0|||
146178101|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Physician Decision|2|||
146178102|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Physician Decision|0|||
146178103|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Physician Decision|0|||
146178104|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Physician Decision|3|||
146178105|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Physician Decision|0|||
146178106|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Physician Decision|0|||
146178107|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Physician Decision|0|||
146178108|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Physician Decision|0|||
146178109|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Physician Decision|0|||
146178110|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Physician Decision|1|||
146178111|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Physician Decision|3|||
146178112|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Physician Decision|0|||
146178113|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Not Treated|0|||
146178114|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Not Treated|0|||
146178115|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Not Treated|2|||
146178116|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Not Treated|0|||
146178117|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Not Treated|0|||
146178118|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Not Treated|0|||
146178119|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Not Treated|0|||
146178120|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Not Treated|0|||
146178121|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Not Treated|0|||
146178122|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Not Treated|0|||
146178123|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Not Treated|0|||
146178124|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Not Treated|0|||
146178125|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Not Treated|0|||
146178126|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178127|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
146178128|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178129|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178130|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178131|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178132|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178133|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178134|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178135|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178136|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178137|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178138|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
146178139|NCT02291289|527165531|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
146178140|NCT02291289|527165532|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
146178141|NCT02291289|527165533|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
146178142|NCT02291289|527165534|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
146178143|NCT02291289|527165535|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
146178144|NCT02291289|527165536|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
146178145|NCT02291289|527165537|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
146178146|NCT02291289|527165538|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
146178147|NCT02291289|527165539|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
146178148|NCT02291289|527165540|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
146178149|NCT02291289|527165541|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
146178150|NCT02291289|527165542|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
146178151|NCT02291289|527165543|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
146178152|NCT02291289|527165531|FG000|Early Disease Progression|Death|0|||
146178153|NCT02291289|527165532|FG001|Early Disease Progression|Death|0|||
146178154|NCT02291289|527165533|FG002|Early Disease Progression|Death|0|||
146178155|NCT02291289|527165534|FG003|Early Disease Progression|Death|0|||
146178156|NCT02291289|527165535|FG004|Early Disease Progression|Death|0|||
146178157|NCT02291289|527165536|FG005|Early Disease Progression|Death|0|||
146178158|NCT02291289|527165537|FG006|Early Disease Progression|Death|0|||
146178159|NCT02291289|527165538|FG007|Early Disease Progression|Death|0|||
146178160|NCT02291289|527165539|FG008|Early Disease Progression|Death|0|||
146178161|NCT02291289|527165540|FG009|Early Disease Progression|Death|0|||
146178162|NCT02291289|527165541|FG010|Early Disease Progression|Death|0|||
146178163|NCT02291289|527165542|FG011|Early Disease Progression|Death|0|||
146178164|NCT02291289|527165543|FG012|Early Disease Progression|Death|10|||
146178165|NCT02291289|527165531|FG000|Early Disease Progression|Lost to Follow-up|0|||
146178166|NCT02291289|527165532|FG001|Early Disease Progression|Lost to Follow-up|0|||
146178167|NCT02291289|527165533|FG002|Early Disease Progression|Lost to Follow-up|0|||
146178168|NCT02291289|527165534|FG003|Early Disease Progression|Lost to Follow-up|0|||
146178169|NCT02291289|527165535|FG004|Early Disease Progression|Lost to Follow-up|0|||
146178170|NCT02291289|527165536|FG005|Early Disease Progression|Lost to Follow-up|0|||
146178171|NCT02291289|527165537|FG006|Early Disease Progression|Lost to Follow-up|0|||
146178172|NCT02291289|527165538|FG007|Early Disease Progression|Lost to Follow-up|0|||
146178173|NCT02291289|527165539|FG008|Early Disease Progression|Lost to Follow-up|0|||
146178174|NCT02291289|527165540|FG009|Early Disease Progression|Lost to Follow-up|0|||
146178175|NCT02291289|527165541|FG010|Early Disease Progression|Lost to Follow-up|0|||
146178176|NCT02291289|527165542|FG011|Early Disease Progression|Lost to Follow-up|0|||
146178177|NCT02291289|527165543|FG012|Early Disease Progression|Lost to Follow-up|1|||
146178178|NCT00154063|527165544|FG000|Overall Study|Adverse Event|4|||
146178179|NCT00154063|527165545|FG001|Overall Study|Adverse Event|8|||
146178180|NCT00154063|527165544|FG000|Overall Study|Protocol Violation|1|||
146178181|NCT00154063|527165545|FG001|Overall Study|Protocol Violation|1|||
146178182|NCT00154063|527165544|FG000|Overall Study|Investigator or Sponsor Request|0|||
146178183|NCT00154063|527165545|FG001|Overall Study|Investigator or Sponsor Request|1|||
146178184|NCT00154063|527165544|FG000|Overall Study|Withdrawal by Subject|4|||
146178185|NCT00154063|527165545|FG001|Overall Study|Withdrawal by Subject|9|||
146178186|NCT00154063|527165544|FG000|Overall Study|Other|3|||
146178187|NCT00154063|527165545|FG001|Overall Study|Other|3|||
146178188|NCT01857934|527165553|FG000|Overall Study|Relapse or progression|2|||
146178189|NCT01857934|527165553|FG000|Overall Study|Unacceptable toxicity|3|||
146178190|NCT01857934|527165553|FG000|Overall Study|Unwillingness or inability to comply|2|||
146178191|NCT01857934|527165553|FG000|Overall Study|Physician Decision|3|||
146178192|NCT00251927|527165559|FG000|Overall Study|Adverse Event|3|||
146178193|NCT00251927|527165560|FG001|Overall Study|Adverse Event|15|||
146178194|NCT00251927|527165559|FG000|Overall Study|Lack of Efficacy|22|||
146178195|NCT00251927|527165560|FG001|Overall Study|Lack of Efficacy|16|||
146178196|NCT00251927|527165559|FG000|Overall Study|Lost to Follow-up|22|||
146178197|NCT00251927|527165560|FG001|Overall Study|Lost to Follow-up|8|||
146178198|NCT00251927|527165559|FG000|Overall Study|Protocol Violation|1|||
146178199|NCT00251927|527165560|FG001|Overall Study|Protocol Violation|2|||
146178200|NCT00251927|527165559|FG000|Overall Study|Pregnancy|2|||
146178201|NCT00251927|527165560|FG001|Overall Study|Pregnancy|0|||
146412060|NCT02622074|528014011|FG003|Overall Study|Death|1|||
146178202|NCT00251927|527165559|FG000|Overall Study|Withdrawal by Subject|40|||
146178203|NCT00251927|527165560|FG001|Overall Study|Withdrawal by Subject|25|||
146178204|NCT00251927|527165559|FG000|Overall Study|Study-specific discont. achieved|13|||
146178205|NCT00251927|527165560|FG001|Overall Study|Study-specific discont. achieved|2|||
146178206|NCT00251927|527165559|FG000|Overall Study|Study procedure non-compliance|5|||
146412061|NCT02622074|528014012|FG004|Overall Study|Death|1|||
146412062|NCT02622074|528014013|FG005|Overall Study|Death|0|||
146412063|NCT02622074|528014008|FG000|Overall Study|Withdrawal by Subject|0|||
146412064|NCT02622074|528014009|FG001|Overall Study|Withdrawal by Subject|1|||
146412065|NCT02622074|528014010|FG002|Overall Study|Withdrawal by Subject|0|||
146412066|NCT02622074|528014011|FG003|Overall Study|Withdrawal by Subject|0|||
146412067|NCT02622074|528014012|FG004|Overall Study|Withdrawal by Subject|0|||
146412068|NCT02622074|528014013|FG005|Overall Study|Withdrawal by Subject|0|||
146412069|NCT02114931|528014014|FG000|Overall Study|Withdrawal by Subject|15|||
146412070|NCT02114931|528014015|FG001|Overall Study|Withdrawal by Subject|18|||
146412071|NCT02114931|528014014|FG000|Overall Study|Adverse Event|4|||
146412072|NCT02114931|528014015|FG001|Overall Study|Adverse Event|6|||
146412073|NCT02114931|528014014|FG000|Overall Study|Lost to Follow-up|3|||
146412074|NCT02114931|528014015|FG001|Overall Study|Lost to Follow-up|3|||
146412075|NCT02114931|528014014|FG000|Overall Study|Physician Decision|1|||
146412076|NCT02114931|528014015|FG001|Overall Study|Physician Decision|2|||
146412077|NCT02114931|528014014|FG000|Overall Study|Other|2|||
146412078|NCT02114931|528014015|FG001|Overall Study|Other|1|||
146412079|NCT03870997|528014016|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
146412080|NCT03870997|528014017|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
146412081|NCT03870997|528014018|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
146412082|NCT03870997|528014019|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
146412083|NCT03870997|528014020|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
146412084|NCT03870997|528014021|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
146412085|NCT03726437|528014022|FG000|Overall Study|Lost to Follow-up|85|||
146412086|NCT03726437|528014023|FG001|Overall Study|Lost to Follow-up|76|||
146412087|NCT00267007|528014024|FG000|Overall Study|Withdrawal by Subject|6|||
146412088|NCT00267007|528014025|FG001|Overall Study|Withdrawal by Subject|0|||
146412089|NCT00267007|528014024|FG000|Overall Study|Lost to Follow-up|1|||
146412090|NCT00267007|528014025|FG001|Overall Study|Lost to Follow-up|0|||
146412091|NCT00267007|528014024|FG000|Overall Study|Non-compliance|0|||
146412092|NCT00267007|528014025|FG001|Overall Study|Non-compliance|1|||
146412093|NCT00267007|528014024|FG000|Overall Study|Adverse Event|1|||
146412094|NCT00267007|528014025|FG001|Overall Study|Adverse Event|0|||
146412095|NCT01205529|528014029|FG000|Overall Study|Procedure Cancelled|4|||
146412096|NCT01205529|528014029|FG000|Overall Study|Withdrawal by Subject|2|||
146412097|NCT01205529|528014029|FG000|Overall Study|Physician Decision|4|||
146283930|NCT00604825|527551905|FG001|Overall Study|Lost to Follow-up|3|||
146077344|NCT04556383|526804203|FG000|PCP|Withdrawal by Subject|8|||
146077345|NCT04556383|526804204|FG001|PCP|Withdrawal by Subject|6|||
146077346|NCT04556383|526804205|FG002|PCP|Withdrawal by Subject|6|||
146077347|NCT04556383|526804206|FG003|PCP|Withdrawal by Subject|0|||
146077348|NCT04556383|526804203|FG000|PCP|Adverse Event|1|||
146077349|NCT04556383|526804204|FG001|PCP|Adverse Event|7|||
146077350|NCT04556383|526804205|FG002|PCP|Adverse Event|7|||
146077351|NCT04556383|526804206|FG003|PCP|Adverse Event|0|||
146077352|NCT04556383|526804203|FG000|PCP|Other, Not Specified|1|||
146077353|NCT04556383|526804204|FG001|PCP|Other, Not Specified|2|||
146077354|NCT04556383|526804205|FG002|PCP|Other, Not Specified|1|||
146077355|NCT04556383|526804206|FG003|PCP|Other, Not Specified|0|||
146077356|NCT04556383|526804203|FG000|PCP|Protocol Violation|1|||
146077357|NCT04556383|526804204|FG001|PCP|Protocol Violation|0|||
146077358|NCT04556383|526804205|FG002|PCP|Protocol Violation|1|||
146077359|NCT04556383|526804206|FG003|PCP|Protocol Violation|0|||
146077360|NCT04556383|526804203|FG000|PCP|Lost to Follow-up|1|||
146077361|NCT04556383|526804204|FG001|PCP|Lost to Follow-up|0|||
146077362|NCT04556383|526804205|FG002|PCP|Lost to Follow-up|0|||
146077363|NCT04556383|526804206|FG003|PCP|Lost to Follow-up|0|||
146077364|NCT04556383|526804203|FG000|PCP|Physician Decision|0|||
146077365|NCT04556383|526804204|FG001|PCP|Physician Decision|1|||
146077366|NCT04556383|526804205|FG002|PCP|Physician Decision|0|||
146077367|NCT04556383|526804206|FG003|PCP|Physician Decision|0|||
146077368|NCT04556383|526804203|FG000|PCP|Site terminated by sponsor|0|||
146077369|NCT04556383|526804204|FG001|PCP|Site terminated by sponsor|1|||
146077370|NCT04556383|526804205|FG002|PCP|Site terminated by sponsor|0|||
146077371|NCT04556383|526804206|FG003|PCP|Site terminated by sponsor|0|||
146077372|NCT04556383|526804203|FG000|OLE|Study terminated by sponsor|0|||
146077373|NCT04556383|526804204|FG001|OLE|Study terminated by sponsor|0|||
146077374|NCT04556383|526804205|FG002|OLE|Study terminated by sponsor|0|||
146077375|NCT04556383|526804206|FG003|OLE|Study terminated by sponsor|68|||
146077376|NCT04556383|526804203|FG000|OLE|Withdrawal by Subject|0|||
146077377|NCT04556383|526804204|FG001|OLE|Withdrawal by Subject|0|||
146077378|NCT04556383|526804205|FG002|OLE|Withdrawal by Subject|0|||
146077379|NCT04556383|526804206|FG003|OLE|Withdrawal by Subject|10|||
146077380|NCT04556383|526804203|FG000|OLE|Lack of Efficacy|0|||
146077381|NCT04556383|526804204|FG001|OLE|Lack of Efficacy|0|||
146077382|NCT04556383|526804205|FG002|OLE|Lack of Efficacy|0|||
146077383|NCT04556383|526804206|FG003|OLE|Lack of Efficacy|7|||
146077384|NCT04556383|526804203|FG000|OLE|Adverse Event|0|||
146077385|NCT04556383|526804204|FG001|OLE|Adverse Event|0|||
146077386|NCT04556383|526804205|FG002|OLE|Adverse Event|0|||
146077387|NCT04556383|526804206|FG003|OLE|Adverse Event|2|||
146077388|NCT04556383|526804203|FG000|OLE|Other, Not Specified|0|||
146077389|NCT04556383|526804204|FG001|OLE|Other, Not Specified|0|||
146077390|NCT04556383|526804205|FG002|OLE|Other, Not Specified|0|||
146077391|NCT04556383|526804206|FG003|OLE|Other, Not Specified|2|||
146077392|NCT04556383|526804203|FG000|OLE|Death|0|||
146077393|NCT04556383|526804204|FG001|OLE|Death|0|||
146077394|NCT04556383|526804205|FG002|OLE|Death|0|||
146077395|NCT04556383|526804206|FG003|OLE|Death|1|||
146077396|NCT04556383|526804203|FG000|OLE|Lost to Follow-up|0|||
146077397|NCT04556383|526804204|FG001|OLE|Lost to Follow-up|0|||
146077398|NCT04556383|526804205|FG002|OLE|Lost to Follow-up|0|||
146077399|NCT04556383|526804206|FG003|OLE|Lost to Follow-up|1|||
146077400|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
146077401|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146077402|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146077403|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
146077404|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Death|3|||
146077405|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Death|0|||
146077406|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Death|0|||
146077407|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Death|0|||
146077408|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
146077409|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146077410|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146077411|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
146077412|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
146077413|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146077414|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146077415|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
146077416|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
146077417|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
146077418|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
146077419|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
146077420|NCT00884741|526804214|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
146077421|NCT00884741|526804215|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146077422|NCT00884741|526804216|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146077423|NCT00884741|526804217|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
146077424|NCT00884741|526804214|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146077425|NCT00884741|526804215|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
146077426|NCT00884741|526804216|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146077427|NCT00884741|526804217|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
146077428|NCT00884741|526804214|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
146077429|NCT00884741|526804215|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
146077430|NCT00884741|526804216|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
146077431|NCT00884741|526804217|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
146077432|NCT00884741|526804214|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146077433|NCT00884741|526804215|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
146077434|NCT00884741|526804216|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146077435|NCT00884741|526804217|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
146077436|NCT00884741|526804214|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146077437|NCT00884741|526804215|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
146077438|NCT00884741|526804216|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146077439|NCT00884741|526804217|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
146077440|NCT00884741|526804214|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146077441|NCT00884741|526804215|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
146077442|NCT00884741|526804216|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146077443|NCT00884741|526804217|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
146077444|NCT00884741|526804214|FG000|Randomization|Protocol Violation|0|||
146077445|NCT00884741|526804215|FG001|Randomization|Protocol Violation|0|||
146077446|NCT00884741|526804216|FG002|Randomization|Protocol Violation|8|||
146077447|NCT00884741|526804217|FG003|Randomization|Protocol Violation|8|||
146077448|NCT00335764|526804218|FG000|Overall Study|wrong histology|1|||
146077449|NCT00335764|526804219|FG001|Overall Study|wrong histology|0|||
146077450|NCT00335764|526804220|FG002|Overall Study|wrong histology|0|||
146077451|NCT00335764|526804221|FG003|Overall Study|wrong histology|0|||
146077452|NCT00335764|526804222|FG004|Overall Study|wrong histology|1|||
146077453|NCT00612807|526804223|FG000|Overall Study|Withdrawal by Subject|2|||
146077454|NCT00612807|526804224|FG001|Overall Study|Withdrawal by Subject|0|||
146077455|NCT00744042|526804229|FG000|Overall Study|Withdrawal by Subject|1|||
146077456|NCT04303195|526804230|FG000|Overall Study|Adverse Event|1|||
146077457|NCT04303195|526804231|FG001|Overall Study|Adverse Event|3|||
146077458|NCT04303195|526804232|FG002|Overall Study|Adverse Event|7|||
146077459|NCT04303195|526804233|FG003|Overall Study|Adverse Event|0|||
146077460|NCT04303195|526804230|FG000|Overall Study|Lost to Follow-up|1|||
146077461|NCT04303195|526804231|FG001|Overall Study|Lost to Follow-up|0|||
146077462|NCT04303195|526804232|FG002|Overall Study|Lost to Follow-up|1|||
146077463|NCT04303195|526804233|FG003|Overall Study|Lost to Follow-up|4|||
146077464|NCT04303195|526804230|FG000|Overall Study|Withdrawal by Subject|3|||
146077465|NCT04303195|526804231|FG001|Overall Study|Withdrawal by Subject|1|||
146178207|NCT00251927|527165560|FG001|Overall Study|Study procedure non-compliance|6|||
146178208|NCT00452413|527165564|FG000|Overall Study|Progressive Disease|4|||
146178209|NCT00452413|527165565|FG001|Overall Study|Progressive Disease|11|||
146178210|NCT00452413|527165566|FG002|Overall Study|Progressive Disease|30|||
146178211|NCT00452413|527165564|FG000|Overall Study|Withdrawal by Subject|0|||
146178212|NCT00452413|527165565|FG001|Overall Study|Withdrawal by Subject|1|||
146178213|NCT00452413|527165566|FG002|Overall Study|Withdrawal by Subject|4|||
146178214|NCT00452413|527165564|FG000|Overall Study|Adverse Event|0|||
146178215|NCT00452413|527165565|FG001|Overall Study|Adverse Event|0|||
146178216|NCT00452413|527165566|FG002|Overall Study|Adverse Event|5|||
146178217|NCT00452413|527165564|FG000|Overall Study|Physician Decision|0|||
146178218|NCT00452413|527165565|FG001|Overall Study|Physician Decision|0|||
146178219|NCT00452413|527165566|FG002|Overall Study|Physician Decision|4|||
146178220|NCT00452413|527165564|FG000|Overall Study|Death due to study disease|0|||
146178221|NCT00452413|527165565|FG001|Overall Study|Death due to study disease|0|||
146178222|NCT00452413|527165566|FG002|Overall Study|Death due to study disease|2|||
146178223|NCT00452413|527165564|FG000|Overall Study|Death due to adverse event (AE)|0|||
146178224|NCT00452413|527165565|FG001|Overall Study|Death due to adverse event (AE)|0|||
146178225|NCT00452413|527165566|FG002|Overall Study|Death due to adverse event (AE)|1|||
146178226|NCT00452413|527165564|FG000|Overall Study|On treatment|0|||
146178227|NCT00452413|527165565|FG001|Overall Study|On treatment|0|||
146178228|NCT00452413|527165566|FG002|Overall Study|On treatment|3|||
146178229|NCT04789577|527165567|FG000|Overall Study|Withdrawal by Subject|1|||
146178230|NCT04789577|527165568|FG001|Overall Study|Withdrawal by Subject|1|||
146178231|NCT04789577|527165569|FG002|Overall Study|Withdrawal by Subject|1|||
146178232|NCT04789577|527165570|FG003|Overall Study|Withdrawal by Subject|3|||
146178233|NCT04789577|527165571|FG004|Overall Study|Withdrawal by Subject|1|||
146178234|NCT04789577|527165572|FG005|Overall Study|Withdrawal by Subject|7|||
146178235|NCT04789577|527165573|FG006|Overall Study|Withdrawal by Subject|1|||
146178236|NCT04789577|527165567|FG000|Overall Study|Lost to Follow-up|7|||
146178237|NCT04789577|527165568|FG001|Overall Study|Lost to Follow-up|12|||
146178238|NCT04789577|527165569|FG002|Overall Study|Lost to Follow-up|7|||
146178239|NCT04789577|527165570|FG003|Overall Study|Lost to Follow-up|10|||
146178240|NCT04789577|527165571|FG004|Overall Study|Lost to Follow-up|8|||
146178241|NCT04789577|527165572|FG005|Overall Study|Lost to Follow-up|6|||
146178242|NCT04789577|527165573|FG006|Overall Study|Lost to Follow-up|10|||
146178243|NCT04789577|527165567|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
146178244|NCT04789577|527165568|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
146178245|NCT04789577|527165569|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
146178246|NCT04789577|527165570|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
146178247|NCT04789577|527165571|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
146178248|NCT04789577|527165572|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
146178249|NCT04789577|527165573|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
146178250|NCT04789577|527165567|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
146178251|NCT04789577|527165568|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
146178252|NCT04789577|527165569|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
146178253|NCT04789577|527165570|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
146178254|NCT04789577|527165571|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
146178255|NCT04789577|527165572|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
146178256|NCT04789577|527165573|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
146178257|NCT01275196|527165575|FG000|Overall Study|Adverse Event|3|||
146178258|NCT01275196|527165576|FG001|Overall Study|Adverse Event|5|||
146178259|NCT01275196|527165575|FG000|Overall Study|Withdrawal by Subject|4|||
146178260|NCT01275196|527165576|FG001|Overall Study|Withdrawal by Subject|5|||
146178261|NCT01275196|527165575|FG000|Overall Study|Lost to Follow-up|1|||
146178262|NCT01275196|527165576|FG001|Overall Study|Lost to Follow-up|0|||
146178263|NCT01275196|527165575|FG000|Overall Study|Disease Progression|6|||
146178264|NCT01275196|527165576|FG001|Overall Study|Disease Progression|5|||
146178265|NCT01275196|527165575|FG000|Overall Study|Protocol Violation|1|||
146178266|NCT01275196|527165576|FG001|Overall Study|Protocol Violation|0|||
146178267|NCT01275196|527165575|FG000|Overall Study|Suboptimal response/treatment failure|5|||
146178268|NCT01275196|527165576|FG001|Overall Study|Suboptimal response/treatment failure|6|||
146178269|NCT01027364|527165577|FG000|Overall Study|Adverse Event|1|||
146178270|NCT01027364|527165578|FG001|Overall Study|Adverse Event|0|||
146178271|NCT01027364|527165579|FG002|Overall Study|Adverse Event|1|||
146178272|NCT01027364|527165580|FG003|Overall Study|Adverse Event|0|||
146178273|NCT01027364|527165577|FG000|Overall Study|Lost to Follow-up|1|||
146178274|NCT01027364|527165578|FG001|Overall Study|Lost to Follow-up|0|||
146178275|NCT01027364|527165579|FG002|Overall Study|Lost to Follow-up|0|||
146178276|NCT01027364|527165580|FG003|Overall Study|Lost to Follow-up|0|||
146178277|NCT01027364|527165577|FG000|Overall Study|Protocol Violation|1|||
146178278|NCT01027364|527165578|FG001|Overall Study|Protocol Violation|0|||
146178279|NCT01027364|527165579|FG002|Overall Study|Protocol Violation|0|||
146077466|NCT04303195|526804232|FG002|Overall Study|Withdrawal by Subject|1|||
146077467|NCT04303195|526804233|FG003|Overall Study|Withdrawal by Subject|1|||
146077468|NCT04303195|526804230|FG000|Overall Study|No study drug administered or protocol deviation|0|||
146077469|NCT04303195|526804231|FG001|Overall Study|No study drug administered or protocol deviation|2|||
146077470|NCT04303195|526804232|FG002|Overall Study|No study drug administered or protocol deviation|0|||
146077471|NCT04303195|526804233|FG003|Overall Study|No study drug administered or protocol deviation|2|||
146077472|NCT02970942|526804234|FG000|Overall Study|Death|0|||
146077473|NCT02970942|526804235|FG001|Overall Study|Death|1|||
146077474|NCT02970942|526804236|FG002|Overall Study|Death|0|||
146077475|NCT02970942|526804237|FG003|Overall Study|Death|0|||
146077476|NCT02970942|526804234|FG000|Overall Study|Lost to Follow-up|1|||
146077477|NCT02970942|526804235|FG001|Overall Study|Lost to Follow-up|0|||
146077478|NCT02970942|526804236|FG002|Overall Study|Lost to Follow-up|2|||
146077479|NCT02970942|526804237|FG003|Overall Study|Lost to Follow-up|1|||
146077480|NCT02970942|526804234|FG000|Overall Study|Withdrawal by Subject|3|||
146077481|NCT02970942|526804235|FG001|Overall Study|Withdrawal by Subject|5|||
146077482|NCT02970942|526804236|FG002|Overall Study|Withdrawal by Subject|3|||
146077483|NCT02970942|526804237|FG003|Overall Study|Withdrawal by Subject|2|||
146077484|NCT01065454|526804240|FG000|Treatment|Adverse Event|7|||
146077485|NCT01065454|526804241|FG001|Treatment|Adverse Event|4|||
146077486|NCT01065454|526804242|FG002|Treatment|Adverse Event|3|||
146077487|NCT01065454|526804243|FG003|Treatment|Adverse Event|6|||
146077488|NCT01065454|526804240|FG000|Treatment|Death|1|||
146077489|NCT01065454|526804241|FG001|Treatment|Death|0|||
146077490|NCT01065454|526804242|FG002|Treatment|Death|0|||
146077491|NCT01065454|526804243|FG003|Treatment|Death|0|||
146077492|NCT01065454|526804240|FG000|Treatment|Non-compliance|1|||
146077493|NCT01065454|526804241|FG001|Treatment|Non-compliance|0|||
146077494|NCT01065454|526804242|FG002|Treatment|Non-compliance|0|||
146077495|NCT01065454|526804243|FG003|Treatment|Non-compliance|1|||
146077496|NCT01065454|526804240|FG000|Treatment|Protocol Decision|0|||
146077497|NCT01065454|526804241|FG001|Treatment|Protocol Decision|0|||
146077498|NCT01065454|526804242|FG002|Treatment|Protocol Decision|3|||
146077499|NCT01065454|526804243|FG003|Treatment|Protocol Decision|2|||
146077500|NCT01065454|526804240|FG000|Treatment|Protocol Violation|1|||
146077501|NCT01065454|526804241|FG001|Treatment|Protocol Violation|0|||
146077502|NCT01065454|526804242|FG002|Treatment|Protocol Violation|1|||
146077503|NCT01065454|526804243|FG003|Treatment|Protocol Violation|0|||
146077504|NCT01065454|526804240|FG000|Treatment|Withdrawal by Subject|3|||
146077505|NCT01065454|526804241|FG001|Treatment|Withdrawal by Subject|1|||
145945344|NCT01764997|526308213|FG001|Run-in Period|Poor compliance to protocol|0|||
145945345|NCT01764997|526308214|FG002|Run-in Period|Poor compliance to protocol|0|||
146077506|NCT01065454|526804242|FG002|Treatment|Withdrawal by Subject|2|||
146077507|NCT01065454|526804243|FG003|Treatment|Withdrawal by Subject|3|||
146077508|NCT01065454|526804240|FG000|Follow up|Adverse Event|1|||
146077509|NCT01065454|526804241|FG001|Follow up|Adverse Event|0|||
146077510|NCT01065454|526804242|FG002|Follow up|Adverse Event|0|||
146077511|NCT01065454|526804243|FG003|Follow up|Adverse Event|1|||
146077512|NCT01065454|526804240|FG000|Follow up|Death|0|||
146077513|NCT01065454|526804241|FG001|Follow up|Death|1|||
146077514|NCT01065454|526804242|FG002|Follow up|Death|1|||
146178280|NCT01027364|527165580|FG003|Overall Study|Protocol Violation|1|||
146077515|NCT01065454|526804243|FG003|Follow up|Death|0|||
146077516|NCT01065454|526804240|FG000|Follow up|Lost to Follow-up|0|||
146077517|NCT01065454|526804241|FG001|Follow up|Lost to Follow-up|0|||
146077518|NCT01065454|526804242|FG002|Follow up|Lost to Follow-up|0|||
146077519|NCT01065454|526804243|FG003|Follow up|Lost to Follow-up|1|||
146077520|NCT01065454|526804240|FG000|Follow up|Progressive disease|0|||
146077521|NCT01065454|526804241|FG001|Follow up|Progressive disease|0|||
146077522|NCT01065454|526804242|FG002|Follow up|Progressive disease|0|||
146077523|NCT01065454|526804243|FG003|Follow up|Progressive disease|1|||
146077524|NCT01065454|526804240|FG000|Follow up|Withdrawal by Subject|1|||
146077525|NCT01065454|526804241|FG001|Follow up|Withdrawal by Subject|1|||
146077526|NCT01065454|526804242|FG002|Follow up|Withdrawal by Subject|1|||
146077527|NCT01065454|526804243|FG003|Follow up|Withdrawal by Subject|0|||
146077528|NCT01065454|526804240|FG000|Follow up|study ongoing|37|||
146077529|NCT01065454|526804241|FG001|Follow up|study ongoing|22|||
146178281|NCT01027364|527165577|FG000|Overall Study|Withdrawal by Subject|1|||
146178282|NCT01027364|527165578|FG001|Overall Study|Withdrawal by Subject|2|||
146178283|NCT01027364|527165579|FG002|Overall Study|Withdrawal by Subject|0|||
146178284|NCT01027364|527165580|FG003|Overall Study|Withdrawal by Subject|0|||
146178285|NCT03119610|527165581|FG000|Overall Study|Adverse Event|1|||
146178286|NCT03119610|527165582|FG001|Overall Study|Adverse Event|0|||
146178287|NCT03119610|527165581|FG000|Overall Study|Lost to Follow-up|0|||
146178288|NCT03119610|527165582|FG001|Overall Study|Lost to Follow-up|1|||
146178289|NCT00114634|527165607|FG000|Overall Study|failure to return forms|3|||
146178290|NCT03283696|527165608|FG000|Overall Study|Physician Decision|5|||
146178291|NCT03283696|527165609|FG001|Overall Study|Physician Decision|6|||
146178292|NCT03283696|527165608|FG000|Overall Study|Withdrawal by Subject|2|||
146178293|NCT03283696|527165609|FG001|Overall Study|Withdrawal by Subject|0|||
146178294|NCT00684762|527165612|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
146178295|NCT00684762|527165613|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
146178296|NCT03237013|527165623|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
146178297|NCT03237013|527165624|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
146178298|NCT03237013|527165625|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
146178299|NCT00258440|527165630|FG000|Overall Study|Withdrawal by Subject|0|||
146178300|NCT00258440|527165631|FG001|Overall Study|Withdrawal by Subject|0|||
146178301|NCT00258440|527165632|FG002|Overall Study|Withdrawal by Subject|1|||
146178302|NCT00737061|527165633|FG000|Waiting Period|Lost to Follow-up|6|||
146178303|NCT00737061|527165633|FG000|Waiting Period|Withdrawal by Subject|1|||
146178304|NCT00737061|527165633|FG000|Waiting Period|Bilateral placement failure|34|||
146178305|NCT00737061|527165633|FG000|Waiting Period|Deemed patent following HSG|26|||
146178306|NCT00737061|527165633|FG000|Waiting Period|Alternative contraception failure|3|||
146178307|NCT00737061|527165633|FG000|Waiting Period|Elected surgical tubal ligation|5|||
146178308|NCT00737061|527165633|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
146178309|NCT00737061|527165633|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
146178310|NCT00737061|527165633|FG000|1 Year Wearing Period|Discontinued reilance|3|||
146178311|NCT00737061|527165633|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
146178312|NCT00439179|527165634|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146178313|NCT00439179|527165635|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
146178314|NCT00439179|527165636|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146178315|NCT00439179|527165637|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
146178316|NCT06173570|527165644|FG000|Overall Study|Adverse Event|1|||
146178317|NCT06173570|527165645|FG001|Overall Study|Adverse Event|0|||
146178318|NCT06173570|527165646|FG002|Overall Study|Adverse Event|0|||
146178319|NCT06173570|527165647|FG003|Overall Study|Adverse Event|2|||
146178320|NCT06173570|527165648|FG004|Overall Study|Adverse Event|0|||
146178321|NCT06173570|527165644|FG000|Overall Study|Lost to Follow-up|1|||
146178322|NCT06173570|527165645|FG001|Overall Study|Lost to Follow-up|0|||
146178323|NCT06173570|527165646|FG002|Overall Study|Lost to Follow-up|0|||
146178324|NCT06173570|527165647|FG003|Overall Study|Lost to Follow-up|0|||
146178325|NCT06173570|527165648|FG004|Overall Study|Lost to Follow-up|2|||
146178326|NCT06173570|527165644|FG000|Overall Study|Protocol Violation|0|||
146178327|NCT06173570|527165645|FG001|Overall Study|Protocol Violation|2|||
146178328|NCT06173570|527165646|FG002|Overall Study|Protocol Violation|0|||
146178329|NCT06173570|527165647|FG003|Overall Study|Protocol Violation|0|||
146178330|NCT06173570|527165648|FG004|Overall Study|Protocol Violation|1|||
146178331|NCT06173570|527165644|FG000|Overall Study|Withdrawal by Subject|0|||
146178332|NCT06173570|527165645|FG001|Overall Study|Withdrawal by Subject|1|||
146178333|NCT06173570|527165646|FG002|Overall Study|Withdrawal by Subject|1|||
146178334|NCT06173570|527165647|FG003|Overall Study|Withdrawal by Subject|1|||
146178335|NCT06173570|527165648|FG004|Overall Study|Withdrawal by Subject|1|||
146178336|NCT06173570|527165644|FG000|Overall Study|Non-compliance with Study Drug|1|||
146178337|NCT06173570|527165645|FG001|Overall Study|Non-compliance with Study Drug|0|||
146178338|NCT06173570|527165646|FG002|Overall Study|Non-compliance with Study Drug|0|||
146178339|NCT06173570|527165647|FG003|Overall Study|Non-compliance with Study Drug|0|||
146178340|NCT06173570|527165648|FG004|Overall Study|Non-compliance with Study Drug|0|||
146178341|NCT06173570|527165644|FG000|Overall Study|Screen Failure|0|||
146178342|NCT06173570|527165645|FG001|Overall Study|Screen Failure|0|||
146178343|NCT06173570|527165646|FG002|Overall Study|Screen Failure|0|||
146178344|NCT06173570|527165647|FG003|Overall Study|Screen Failure|0|||
146178345|NCT06173570|527165648|FG004|Overall Study|Screen Failure|1|||
146178346|NCT06173570|527165644|FG000|Overall Study|Other|2|||
146178347|NCT06173570|527165645|FG001|Overall Study|Other|1|||
146178348|NCT06173570|527165646|FG002|Overall Study|Other|0|||
146178349|NCT06173570|527165647|FG003|Overall Study|Other|2|||
146077530|NCT01065454|526804242|FG002|Follow up|study ongoing|15|||
146077531|NCT01065454|526804243|FG003|Follow up|study ongoing|41|||
146077532|NCT05688670|526804244|FG000|Overall Study|Change in surgery plan|1|||
146077533|NCT05688670|526804245|FG001|Overall Study|Change in surgery plan|4|||
146077534|NCT05688670|526804244|FG000|Overall Study|Inability to extubate|1|||
146077535|NCT05688670|526804245|FG001|Overall Study|Inability to extubate|2|||
146077536|NCT05688670|526804244|FG000|Overall Study|Day of surgery cancellation|0|||
146077537|NCT05688670|526804245|FG001|Overall Study|Day of surgery cancellation|1|||
146077538|NCT05688670|526804244|FG000|Overall Study|Reintubated on PCICU arrival|0|||
146077539|NCT05688670|526804245|FG001|Overall Study|Reintubated on PCICU arrival|1|||
146077540|NCT02537015|526804252|FG000|Overall Study|Adverse Event|3|||
146077541|NCT02537015|526804252|FG000|Overall Study|Withdrawal by Subject|2|||
146077542|NCT02537015|526804252|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146077543|NCT01097005|526804256|FG000|Overall Study|Case Report Form not collected|18|||
146077544|NCT01097005|526804256|FG000|Overall Study|Subjects cannot visit the hospital|1|||
146077545|NCT01097005|526804256|FG000|Overall Study|Poor medication compliance|1|||
146077546|NCT01097005|526804256|FG000|Overall Study|No examination data available|244|||
146077547|NCT01097005|526804256|FG000|Overall Study|Deviation from exclusion criteria|37|||
146077548|NCT01097005|526804256|FG000|Overall Study|Adverse Event|14|||
146077549|NCT01097005|526804256|FG000|Overall Study|Discontinuance by complication|50|||
146077550|NCT00588861|526805392|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
146077551|NCT00588861|526805393|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
146077552|NCT00588861|526805392|FG000|6 Months|Patients did not return for follow-up|98|||
146077553|NCT00588861|526805393|FG001|6 Months|Patients did not return for follow-up|73|||
146077554|NCT00588861|526805392|FG000|1 Year|Patients did not return for follow-up|89|||
146077555|NCT00588861|526805393|FG001|1 Year|Patients did not return for follow-up|82|||
146077556|NCT00588861|526805392|FG000|2 Years|Patients did not return for follow-up|92|||
146077557|NCT00588861|526805393|FG001|2 Years|Patients did not return for follow-up|87|||
146077558|NCT00588861|526805392|FG000|4 Years|Patients did not return for follow-up|91|||
146077559|NCT00588861|526805393|FG001|4 Years|Patients did not return for follow-up|103|||
146077560|NCT00588861|526805392|FG000|6 Years|Patients did not return for follow-up|104|||
146077561|NCT00588861|526805393|FG001|6 Years|Patients did not return for follow-up|109|||
146077562|NCT00588861|526805392|FG000|8 Years|Patients did not return for follow-up|105|||
146077563|NCT00588861|526805393|FG001|8 Years|Patients did not return for follow-up|114|||
146077564|NCT00588861|526805392|FG000|10 Years|Incomplete due to study termination|107|||
146077565|NCT00588861|526805393|FG001|10 Years|Incomplete due to study termination|114|||
146077566|NCT03254459|526805399|FG000|Overall Study|Adverse Event|7|||
146077567|NCT03254459|526805400|FG001|Overall Study|Adverse Event|20|||
146077568|NCT03254459|526805399|FG000|Overall Study|Withdrawal by Subject Consent|3|||
146077569|NCT03254459|526805400|FG001|Overall Study|Withdrawal by Subject Consent|1|||
146077570|NCT03254459|526805399|FG000|Overall Study|Lost to Follow-up|0|||
146077571|NCT03254459|526805400|FG001|Overall Study|Lost to Follow-up|1|||
146077572|NCT03254459|526805399|FG000|Overall Study|Miscellaneous|0|||
146077573|NCT03254459|526805400|FG001|Overall Study|Miscellaneous|1|||
146077574|NCT00617669|526805407|FG000|Overall Study|Withdrawal by Subject|71|||
146077575|NCT00617669|526805408|FG001|Overall Study|Withdrawal by Subject|77|||
146077576|NCT00617669|526805407|FG000|Overall Study|Lost to Follow-up|3|||
146077577|NCT00617669|526805408|FG001|Overall Study|Lost to Follow-up|2|||
146077578|NCT00617669|526805407|FG000|Overall Study|Adverse Event|87|||
146077579|NCT00617669|526805408|FG001|Overall Study|Adverse Event|76|||
146077580|NCT00617669|526805407|FG000|Overall Study|Protocol Violation|2|||
146077581|NCT00617669|526805408|FG001|Overall Study|Protocol Violation|3|||
146077582|NCT00617669|526805407|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
146077583|NCT00617669|526805408|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
146077584|NCT00617669|526805407|FG000|Overall Study|Patients randomized but not treated|2|||
146077585|NCT00617669|526805408|FG001|Overall Study|Patients randomized but not treated|3|||
146077586|NCT03680742|526805409|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
146077587|NCT02894502|526805410|FG000|Baseline|Withdrawal by Subject|24|||
146077588|NCT02894502|526805411|FG001|Baseline|Withdrawal by Subject|31|||
146077589|NCT02894502|526805412|FG002|Baseline|Withdrawal by Subject|36|||
146077590|NCT02894502|526805410|FG000|Baseline|Death|3|||
146077591|NCT02894502|526805411|FG001|Baseline|Death|1|||
146077592|NCT02894502|526805412|FG002|Baseline|Death|9|||
146077593|NCT02894502|526805410|FG000|First Follow up|Withdrawal by Subject|32|||
146077594|NCT02894502|526805411|FG001|First Follow up|Withdrawal by Subject|29|||
146077595|NCT02894502|526805412|FG002|First Follow up|Withdrawal by Subject|37|||
146178350|NCT06173570|527165648|FG004|Overall Study|Other|0|||
146178351|NCT01844115|527165651|FG000|Overall Study|Adverse Event|4|||
146178352|NCT01844115|527165652|FG001|Overall Study|Adverse Event|22|||
146178353|NCT01844115|527165651|FG000|Overall Study|Lack of Efficacy|1|||
146178354|NCT01844115|527165652|FG001|Overall Study|Lack of Efficacy|4|||
146178355|NCT01844115|527165651|FG000|Overall Study|Protocol Violation|12|||
146178356|NCT01844115|527165652|FG001|Overall Study|Protocol Violation|10|||
146178357|NCT01844115|527165651|FG000|Overall Study|Withdrawal by Subject|11|||
146178358|NCT01844115|527165652|FG001|Overall Study|Withdrawal by Subject|11|||
146178359|NCT01844115|527165651|FG000|Overall Study|Lost to Follow-up|11|||
146178360|NCT01844115|527165652|FG001|Overall Study|Lost to Follow-up|10|||
146178361|NCT01844115|527165651|FG000|Overall Study|Pregnancy|0|||
146178362|NCT01844115|527165652|FG001|Overall Study|Pregnancy|1|||
146178363|NCT00758160|527165653|FG000|Overall Study|No Longer Requires Study Medication|4|||
146178364|NCT00758160|527165653|FG000|Overall Study|Administration Problems|3|||
146178365|NCT00758160|527165653|FG000|Overall Study|Adverse Event|15|||
146178366|NCT00758160|527165653|FG000|Overall Study|Lack of Efficacy|10|||
146178367|NCT00758160|527165653|FG000|Overall Study|Lost to Follow-up|14|||
146178368|NCT00758160|527165653|FG000|Overall Study|Protocol Violation|12|||
146178369|NCT00758160|527165653|FG000|Overall Study|Withdrawal by Subject|8|||
146178370|NCT00545363|527165654|FG000|Overall Study|Adverse Event|6|||
146178371|NCT00545363|527165655|FG001|Overall Study|Adverse Event|7|||
146178372|NCT00545363|527165654|FG000|Overall Study|Withdrawal by Subject|6|||
146178373|NCT00545363|527165655|FG001|Overall Study|Withdrawal by Subject|5|||
146178374|NCT00545363|527165654|FG000|Overall Study|Non-compliance|3|||
146178375|NCT00545363|527165655|FG001|Overall Study|Non-compliance|1|||
146178376|NCT00545363|527165654|FG000|Overall Study|Did not meet entry criteria|1|||
146178377|NCT00545363|527165655|FG001|Overall Study|Did not meet entry criteria|1|||
146178378|NCT00545363|527165654|FG000|Overall Study|Lost to Follow-up|2|||
146178379|NCT00545363|527165655|FG001|Overall Study|Lost to Follow-up|0|||
146178380|NCT00545363|527165654|FG000|Overall Study|Other|1|||
146178381|NCT00545363|527165655|FG001|Overall Study|Other|1|||
146178382|NCT00366301|527165656|FG000|Overall Study|Lost to Follow-up|4|||
146178383|NCT00366301|527165657|FG001|Overall Study|Lost to Follow-up|4|||
146178384|NCT00366301|527165658|FG002|Overall Study|Lost to Follow-up|3|||
146178385|NCT00366301|527165659|FG003|Overall Study|Lost to Follow-up|7|||
146178386|NCT00366301|527165656|FG000|Overall Study|Withdrawal by Subject|4|||
146178387|NCT00366301|527165657|FG001|Overall Study|Withdrawal by Subject|2|||
146178388|NCT00366301|527165658|FG002|Overall Study|Withdrawal by Subject|1|||
146178389|NCT00366301|527165659|FG003|Overall Study|Withdrawal by Subject|1|||
146178390|NCT01372605|527165660|FG000|Overall Study|Death|1|||
146178391|NCT01372605|527165661|FG001|Overall Study|Death|2|||
146178392|NCT01372605|527165660|FG000|Overall Study|Lost to Follow-up|2|||
146178393|NCT01372605|527165661|FG001|Overall Study|Lost to Follow-up|1|||
146178394|NCT01372605|527165660|FG000|Overall Study|Withdrawal by Subject|4|||
146178395|NCT01372605|527165661|FG001|Overall Study|Withdrawal by Subject|7|||
146178396|NCT01372605|527165660|FG000|Overall Study|Moved|3|||
146178397|NCT01372605|527165661|FG001|Overall Study|Moved|0|||
146178398|NCT01372605|527165660|FG000|Overall Study|Changed medical home|2|||
146178399|NCT01372605|527165661|FG001|Overall Study|Changed medical home|0|||
146178400|NCT00951509|527165662|FG000|Overall Study|Withdrawal by Subject|2|||
146178401|NCT00582491|527165663|FG000|Overall Study|Withdrawal by Subject|1|||
146178402|NCT00582491|527165664|FG001|Overall Study|Withdrawal by Subject|0|||
146178403|NCT01193582|527165665|FG000|Vaccination Series|Withdrawal by Subject|11|||
146178404|NCT01193582|527165666|FG001|Vaccination Series|Withdrawal by Subject|13|||
146178405|NCT01193582|527165667|FG002|Vaccination Series|Withdrawal by Subject|8|||
146178406|NCT01193582|527165668|FG003|Vaccination Series|Withdrawal by Subject|3|||
146178407|NCT01193582|527165665|FG000|12 Month Follow-up|Death|0|||
146178408|NCT01193582|527165666|FG001|12 Month Follow-up|Death|0|||
146178409|NCT01193582|527165667|FG002|12 Month Follow-up|Death|1|||
146178410|NCT01193582|527165668|FG003|12 Month Follow-up|Death|0|||
146178411|NCT01193582|527165665|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
146178412|NCT01193582|527165666|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
146178413|NCT01193582|527165667|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
146178414|NCT01193582|527165668|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
146178415|NCT01425632|527165669|FG000|Overall Study|Adverse Event|0|||
146178416|NCT01425632|527165670|FG001|Overall Study|Adverse Event|1|||
146178417|NCT01425632|527165671|FG002|Overall Study|Adverse Event|1|||
146178418|NCT01425632|527165669|FG000|Overall Study|Physician Decision|1|||
146178419|NCT01425632|527165670|FG001|Overall Study|Physician Decision|0|||
146178420|NCT01425632|527165671|FG002|Overall Study|Physician Decision|0|||
146178421|NCT01425632|527165669|FG000|Overall Study|Protocol Violation|0|||
146178422|NCT01425632|527165670|FG001|Overall Study|Protocol Violation|0|||
146178423|NCT01425632|527165671|FG002|Overall Study|Protocol Violation|2|||
146178424|NCT01425632|527165669|FG000|Overall Study|Withdrawal by Subject|0|||
146178425|NCT01425632|527165670|FG001|Overall Study|Withdrawal by Subject|0|||
146178426|NCT01425632|527165671|FG002|Overall Study|Withdrawal by Subject|1|||
146178427|NCT00406419|527165678|FG000|Overall Study|Death|3|||
146178428|NCT00406419|527165679|FG001|Overall Study|Death|1|||
146178429|NCT00406419|527165680|FG002|Overall Study|Death|4|||
146178430|NCT00406419|527165678|FG000|Overall Study|Protocol Violation|6|||
146178431|NCT00406419|527165679|FG001|Overall Study|Protocol Violation|2|||
146178432|NCT00406419|527165680|FG002|Overall Study|Protocol Violation|5|||
146178433|NCT00406419|527165678|FG000|Overall Study|Study Terminated by Sponsor|260|||
146178434|NCT00406419|527165679|FG001|Overall Study|Study Terminated by Sponsor|288|||
146178435|NCT00406419|527165680|FG002|Overall Study|Study Terminated by Sponsor|282|||
146178436|NCT00406419|527165678|FG000|Overall Study|Withdrawal by Subject|17|||
146178437|NCT00406419|527165679|FG001|Overall Study|Withdrawal by Subject|24|||
146178438|NCT00406419|527165680|FG002|Overall Study|Withdrawal by Subject|26|||
146178439|NCT00406419|527165678|FG000|Overall Study|Lack of Efficacy|12|||
146178440|NCT00406419|527165679|FG001|Overall Study|Lack of Efficacy|1|||
146178441|NCT00406419|527165680|FG002|Overall Study|Lack of Efficacy|6|||
146178442|NCT00406419|527165678|FG000|Overall Study|Non-Compliance with Study Drug|5|||
146178443|NCT00406419|527165679|FG001|Overall Study|Non-Compliance with Study Drug|6|||
146178444|NCT00406419|527165680|FG002|Overall Study|Non-Compliance with Study Drug|3|||
146178445|NCT00406419|527165678|FG000|Overall Study|Adverse Event|10|||
146178446|NCT00406419|527165679|FG001|Overall Study|Adverse Event|12|||
146178447|NCT00406419|527165680|FG002|Overall Study|Adverse Event|16|||
146178448|NCT00406419|527165678|FG000|Overall Study|Lost to Follow-up|11|||
146178449|NCT00406419|527165679|FG001|Overall Study|Lost to Follow-up|10|||
146178450|NCT00406419|527165680|FG002|Overall Study|Lost to Follow-up|5|||
146178451|NCT01775930|527165681|FG000|Overall Study|Futility stopping boundary met|1|||
146178452|NCT02009696|527165684|FG000|Overall Study|Withdrawal by Subject|2|||
146178453|NCT02120664|527165685|FG000|Overall Study|Withdrawal by Subject|0|||
146178454|NCT02120664|527165686|FG001|Overall Study|Withdrawal by Subject|0|||
146178455|NCT02120664|527165687|FG002|Overall Study|Withdrawal by Subject|0|||
146178456|NCT02120664|527165688|FG003|Overall Study|Withdrawal by Subject|1|||
146178457|NCT02120664|527165689|FG004|Overall Study|Withdrawal by Subject|0|||
146178458|NCT03916744|527165690|FG000|Overall Study|Withdrawal by Subject|0|||
146178459|NCT03916744|527165691|FG001|Overall Study|Withdrawal by Subject|1|||
146178460|NCT03916744|527165692|FG002|Overall Study|Withdrawal by Subject|2|||
146178461|NCT02460263|527165693|FG000|Transition Period|Withdrawal by Subject|1|||
146178462|NCT02460263|527165693|FG000|Transition Period|Death|1|||
146178463|NCT04524598|527165694|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
146178464|NCT04524598|527165695|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
146178465|NCT04524598|527165696|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
146178466|NCT04524598|527165697|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
146178467|NCT04524598|527165698|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
146178468|NCT04524598|527165694|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
146178469|NCT04524598|527165695|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
146178470|NCT04524598|527165696|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178471|NCT04524598|527165697|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178472|NCT04524598|527165698|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178473|NCT04524598|527165694|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
146178474|NCT04524598|527165695|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
146178475|NCT04524598|527165696|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
146178476|NCT04524598|527165697|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
146178477|NCT04524598|527165698|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
146178478|NCT04524598|527165694|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
146178479|NCT04524598|527165695|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
146178480|NCT04524598|527165696|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
146178481|NCT04524598|527165697|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
146178482|NCT04524598|527165698|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
146178483|NCT04524598|527165694|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178484|NCT04524598|527165695|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178485|NCT04524598|527165696|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
146178486|NCT04524598|527165697|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
146178487|NCT04524598|527165698|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178488|NCT04524598|527165694|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
146178489|NCT04524598|527165695|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
146178490|NCT04524598|527165696|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
146178491|NCT04524598|527165697|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
146178492|NCT04524598|527165698|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
146178493|NCT04524598|527165694|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178494|NCT04524598|527165695|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178495|NCT04524598|527165696|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178496|NCT04524598|527165697|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
146178497|NCT04524598|527165698|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
146178498|NCT02301156|527165699|FG000|Overall Study|Adverse Event|13|||
146178499|NCT02301156|527165700|FG001|Overall Study|Adverse Event|14|||
146178500|NCT02301156|527165699|FG000|Overall Study|Death|1|||
146178501|NCT02301156|527165700|FG001|Overall Study|Death|5|||
146178502|NCT02301156|527165699|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
146178503|NCT02301156|527165700|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
146178504|NCT02301156|527165699|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
146178505|NCT02301156|527165700|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
146178506|NCT02301156|527165699|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
146178507|NCT02301156|527165700|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
146178508|NCT02301156|527165699|FG000|Overall Study|Reason not Specified|6|||
146178509|NCT02301156|527165700|FG001|Overall Study|Reason not Specified|3|||
146178510|NCT02638623|527165701|FG000|Overall Study|Surgery timing|5|||
146178511|NCT02638623|527165702|FG001|Overall Study|Surgery timing|6|||
146178512|NCT02638623|527165701|FG000|Overall Study|Not given intervention|2|||
146178513|NCT02638623|527165702|FG001|Overall Study|Not given intervention|0|||
146178514|NCT00591864|527165705|FG000|Overall Study|Incomplete Imaging|5|||
146178515|NCT00118092|527165706|FG000|Overall Study|Withdrawal by Subject|1|||
146178516|NCT00118092|527165706|FG000|Overall Study|Protocol Violation|1|||
146178517|NCT02459093|527165711|FG000|Overall Study|Protocol Violation|6|||
146178518|NCT02459093|527165712|FG001|Overall Study|Protocol Violation|11|||
146178519|NCT02459093|527165711|FG000|Overall Study|Lost to Follow-up|6|||
146178520|NCT02459093|527165712|FG001|Overall Study|Lost to Follow-up|7|||
146178521|NCT02090634|527165713|FG000|Overall Study|Lost to Follow-up|0|||
146178522|NCT02090634|527165714|FG001|Overall Study|Lost to Follow-up|1|||
146178523|NCT02090634|527165713|FG000|Overall Study|Death|0|||
146178524|NCT02090634|527165714|FG001|Overall Study|Death|1|||
146178525|NCT02090634|527165713|FG000|Overall Study|Protocol Violation|3|||
146178526|NCT02090634|527165714|FG001|Overall Study|Protocol Violation|1|||
146178527|NCT02090634|527165713|FG000|Overall Study|Adverse Event|2|||
146178528|NCT02090634|527165714|FG001|Overall Study|Adverse Event|0|||
146178529|NCT01164228|527165715|FG000|Overall Study|Progression|24|||
146178530|NCT01164228|527165716|FG001|Overall Study|Progression|25|||
146178531|NCT01164228|527165715|FG000|Overall Study|Adverse Event|13|||
146178532|NCT01164228|527165716|FG001|Overall Study|Adverse Event|7|||
146178533|NCT01164228|527165715|FG000|Overall Study|Death|1|||
146178534|NCT01164228|527165716|FG001|Overall Study|Death|1|||
146178535|NCT01164228|527165715|FG000|Overall Study|Withdrawal by Subject|2|||
146178536|NCT01164228|527165716|FG001|Overall Study|Withdrawal by Subject|0|||
146178537|NCT01164228|527165715|FG000|Overall Study|Physician Decision|1|||
146178538|NCT01164228|527165716|FG001|Overall Study|Physician Decision|2|||
146178539|NCT01164228|527165715|FG000|Overall Study|Symptomatic deterioration|1|||
146178540|NCT01164228|527165716|FG001|Overall Study|Symptomatic deterioration|0|||
146178541|NCT01164228|527165715|FG000|Overall Study|Never started treatment|1|||
146178542|NCT01164228|527165716|FG001|Overall Study|Never started treatment|3|||
146178543|NCT01164228|527165715|FG000|Overall Study|Ineligible|1|||
146178544|NCT01164228|527165716|FG001|Overall Study|Ineligible|0|||
146178545|NCT03342053|527165719|FG000|Overall Study|Adverse Event|2|||
146178546|NCT03342053|527165720|FG001|Overall Study|Adverse Event|0|||
146178547|NCT03342053|527165719|FG000|Overall Study|Withdrawal by Subject|0|||
146178548|NCT03342053|527165720|FG001|Overall Study|Withdrawal by Subject|1|||
146178549|NCT00735644|527165721|FG000|Overall Study|Did not receive study vaccine|0|||
146178550|NCT00735644|527165722|FG001|Overall Study|Did not receive study vaccine|1|||
146178551|NCT00735644|527165723|FG002|Overall Study|Did not receive study vaccine|0|||
146178552|NCT00735644|527165724|FG003|Overall Study|Did not receive study vaccine|0|||
146178553|NCT00735644|527165725|FG004|Overall Study|Did not receive study vaccine|0|||
146178554|NCT00735644|527165721|FG000|Overall Study|Withdrawal by Subject|0|||
146178555|NCT00735644|527165722|FG001|Overall Study|Withdrawal by Subject|1|||
146178556|NCT00735644|527165723|FG002|Overall Study|Withdrawal by Subject|1|||
146178557|NCT00735644|527165724|FG003|Overall Study|Withdrawal by Subject|1|||
146178558|NCT00735644|527165725|FG004|Overall Study|Withdrawal by Subject|0|||
146178559|NCT00621296|527165730|FG000|Overall Study|Adverse Event|2|||
146178560|NCT00621296|527165730|FG000|Overall Study|Lack of Efficacy|1|||
146178561|NCT00621296|527165730|FG000|Overall Study|Physician Decision|7|||
146178562|NCT00621296|527165730|FG000|Overall Study|Unmatch Criteria|1|||
146178563|NCT00621296|527165730|FG000|Overall Study|Stopping Criteria|3|||
146178564|NCT01108510|527167507|FG000|Overall Study|Randomized but Not Treated|5|||
146178565|NCT01108510|527167508|FG001|Overall Study|Randomized but Not Treated|1|||
146178566|NCT01108510|527167507|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
146077596|NCT02894502|526805410|FG000|First Follow up|Death|2|||
146077597|NCT02894502|526805411|FG001|First Follow up|Death|2|||
146077598|NCT02894502|526805412|FG002|First Follow up|Death|3|||
146077599|NCT02894502|526805410|FG000|Second Follow up|Withdrawal by Subject|13|||
146077600|NCT02894502|526805411|FG001|Second Follow up|Withdrawal by Subject|15|||
146077601|NCT02894502|526805412|FG002|Second Follow up|Withdrawal by Subject|13|||
146077602|NCT02894502|526805410|FG000|Second Follow up|Death|2|||
146077603|NCT02894502|526805411|FG001|Second Follow up|Death|3|||
146077604|NCT02894502|526805412|FG002|Second Follow up|Death|1|||
146077605|NCT02894502|526805410|FG000|Third Follow up|Withdrawal by Subject|5|||
146077606|NCT02894502|526805411|FG001|Third Follow up|Withdrawal by Subject|6|||
146077607|NCT02894502|526805412|FG002|Third Follow up|Withdrawal by Subject|3|||
146077608|NCT02894502|526805410|FG000|Third Follow up|Death|1|||
146077609|NCT02894502|526805411|FG001|Third Follow up|Death|1|||
146077610|NCT02894502|526805412|FG002|Third Follow up|Death|0|||
146077611|NCT00615901|526805413|FG000|Overall Study|Withdrawal by Subject|2|||
146077612|NCT00615901|526805413|FG000|Overall Study|Adverse Event|7|||
146077613|NCT00796445|526805418|FG000|Overall Study|Protocol Violation|5|||
146077614|NCT00796445|526805419|FG001|Overall Study|Protocol Violation|3|||
146077615|NCT00796445|526805418|FG000|Overall Study|Adverse event, serious fatal|10|||
146077616|NCT00796445|526805419|FG001|Overall Study|Adverse event, serious fatal|5|||
146077617|NCT00796445|526805418|FG000|Overall Study|Adverse event, non-fatal|4|||
146077618|NCT00796445|526805419|FG001|Overall Study|Adverse event, non-fatal|0|||
146077619|NCT00796445|526805418|FG000|Overall Study|Disease progression/recurrence|537|||
146077620|NCT00796445|526805419|FG001|Overall Study|Disease progression/recurrence|268|||
146077621|NCT00796445|526805418|FG000|Overall Study|Other|10|||
146077622|NCT00796445|526805419|FG001|Overall Study|Other|7|||
146077623|NCT00796445|526805418|FG000|Overall Study|Withdrawal by Subject|18|||
146077624|NCT00796445|526805419|FG001|Overall Study|Withdrawal by Subject|9|||
146077625|NCT00796445|526805418|FG000|Overall Study|Invalid Informed Consent Form|1|||
146077626|NCT00796445|526805419|FG001|Overall Study|Invalid Informed Consent Form|0|||
146077627|NCT00388583|526805422|FG000|Overall Study|Protocol Violation|1|||
146077628|NCT00388583|526805423|FG001|Overall Study|Protocol Violation|0|||
146077629|NCT00388583|526805422|FG000|Overall Study|Withdrawal by Subject|3|||
146077630|NCT00388583|526805423|FG001|Overall Study|Withdrawal by Subject|3|||
146077631|NCT00388583|526805422|FG000|Overall Study|Serious Adverse Event|2|||
146077632|NCT00388583|526805423|FG001|Overall Study|Serious Adverse Event|0|||
146077633|NCT00388583|526805422|FG000|Overall Study|Did not receive vaccine|0|||
146077634|NCT00388583|526805423|FG001|Overall Study|Did not receive vaccine|1|||
146077635|NCT05194579|526805424|FG000|Overall Study|Lost to Follow-up|2|||
146077636|NCT05194579|526805425|FG001|Overall Study|Lost to Follow-up|3|||
146077637|NCT05194579|526805424|FG000|Overall Study|Withdrawal by Subject|3|||
146077638|NCT05194579|526805425|FG001|Overall Study|Withdrawal by Subject|4|||
146077639|NCT05194579|526805424|FG000|Overall Study|Refused further study procedures|0|||
146077640|NCT05194579|526805425|FG001|Overall Study|Refused further study procedures|1|||
146077641|NCT05194579|526805424|FG000|Overall Study|Protocol deviation|1|||
146077642|NCT05194579|526805425|FG001|Overall Study|Protocol deviation|0|||
146077643|NCT03595228|526805430|FG000|Overall Study|Death|2|||
146077644|NCT03595228|526805430|FG000|Overall Study|Lack of Efficacy|13|||
146077645|NCT03595228|526805430|FG000|Overall Study|Withdrawal by Subject|3|||
146077646|NCT03595228|526805430|FG000|Overall Study|Withdrawal by Sponsor|1|||
146077647|NCT03232333|526805431|FG000|Overall Study|Infection or Osteomyelitis|9|||
146077648|NCT03232333|526805431|FG000|Overall Study|Lost to Follow-up|4|||
146077649|NCT03232333|526805431|FG000|Overall Study|Withdrawal by Subject|2|||
146077650|NCT01087736|526805432|FG000|Overall Study|Lost to Follow-up|1|||
146077651|NCT01087736|526805433|FG001|Overall Study|Lost to Follow-up|0|||
146077652|NCT01087736|526805432|FG000|Overall Study|Death|0|||
146077653|NCT01087736|526805433|FG001|Overall Study|Death|1|||
146077654|NCT01087736|526805432|FG000|Overall Study|Withdrawal by Subject|0|||
146077655|NCT01087736|526805433|FG001|Overall Study|Withdrawal by Subject|1|||
146077656|NCT01253811|526805434|FG000|Overall Study|Withdrawal criteria|1|||
146077657|NCT00435045|526805436|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
146077658|NCT00435045|526805437|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
146077659|NCT00435045|526805436|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
146077660|NCT00435045|526805437|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
146077661|NCT00435045|526805436|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
146077662|NCT00435045|526805437|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
146077663|NCT00435045|526805436|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
146077664|NCT00435045|526805437|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
146077665|NCT00435045|526805436|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
146077666|NCT00435045|526805437|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
146077667|NCT00435045|526805436|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
146178567|NCT01108510|527167508|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
146178568|NCT01108510|527167507|FG000|Overall Study|Adverse Event|26|||
146178569|NCT01108510|527167508|FG001|Overall Study|Adverse Event|19|||
146178570|NCT01108510|527167507|FG000|Overall Study|Lost to Follow-up|20|||
146178571|NCT01108510|527167508|FG001|Overall Study|Lost to Follow-up|17|||
146178572|NCT01108510|527167507|FG000|Overall Study|Withdrew Consent|21|||
146178573|NCT01108510|527167508|FG001|Overall Study|Withdrew Consent|15|||
146178574|NCT01108510|527167507|FG000|Overall Study|Investigator's Discretion|12|||
146178575|NCT01108510|527167508|FG001|Overall Study|Investigator's Discretion|10|||
146178576|NCT01108510|527167507|FG000|Overall Study|Participant Noncompliance|5|||
146178577|NCT01108510|527167508|FG001|Overall Study|Participant Noncompliance|7|||
146178578|NCT01108510|527167507|FG000|Overall Study|Lack of Efficacy|3|||
146178579|NCT01108510|527167508|FG001|Overall Study|Lack of Efficacy|0|||
146178580|NCT01108510|527167507|FG000|Overall Study|Pregnancy|0|||
146178581|NCT01108510|527167508|FG001|Overall Study|Pregnancy|3|||
146178582|NCT01108510|527167507|FG000|Overall Study|Death|1|||
146178583|NCT01108510|527167508|FG001|Overall Study|Death|1|||
146178584|NCT00210119|527167509|FG000|Overall Study|Protocol Violation|1|||
146178585|NCT00210119|527167509|FG000|Overall Study|Withdrawal by Subject|1|||
146178586|NCT01830881|527167511|FG000|Overall Study|Changed decision to have an abortion|0|||
146178587|NCT01830881|527167512|FG001|Overall Study|Changed decision to have an abortion|1|||
146178588|NCT03125941|527167513|FG000|Overall Study|did not receive intervention|1|||
146178589|NCT03125941|527167514|FG001|Overall Study|did not receive intervention|2|||
146178590|NCT01258660|527167515|FG000|Overall Study|Adverse Event|2|||
146178591|NCT01258660|527167516|FG001|Overall Study|Adverse Event|4|||
146178592|NCT01258660|527167515|FG000|Overall Study|Withdrawal by Subject|3|||
146178593|NCT01258660|527167516|FG001|Overall Study|Withdrawal by Subject|0|||
146178594|NCT01258660|527167515|FG000|Overall Study|due to relocation|2|||
146178595|NCT01258660|527167516|FG001|Overall Study|due to relocation|0|||
146178596|NCT01258660|527167515|FG000|Overall Study|Protocol Violation|0|||
146178597|NCT01258660|527167516|FG001|Overall Study|Protocol Violation|1|||
146178598|NCT01258660|527167515|FG000|Overall Study|Invalid for primary analysis data set|4|||
146178599|NCT01258660|527167516|FG001|Overall Study|Invalid for primary analysis data set|6|||
146178600|NCT04192630|527167519|FG000|Overall Study|Discontinued before surgery|2|||
146178601|NCT04192630|527167520|FG001|Overall Study|Discontinued before surgery|0|||
146178602|NCT04192630|527167519|FG000|Overall Study|Discontinued after surgery|5|||
146178603|NCT04192630|527167520|FG001|Overall Study|Discontinued after surgery|3|||
146178604|NCT01208415|527167521|FG000|Overall Study|Death|1|||
146178605|NCT01208415|527167521|FG000|Overall Study|Lost to Follow-up|2|||
146178606|NCT01208415|527167521|FG000|Overall Study|Withdrawal by Subject|3|||
146178607|NCT01208415|527167521|FG000|Overall Study|Device not placed|1|||
146178608|NCT01208415|527167521|FG000|Overall Study|Still be eligible for follow-up|33|||
146178609|NCT01115491|527167522|FG000|Overall Study|Death|22|||
146178610|NCT01115491|527167522|FG000|Overall Study|Adverse Event|3|||
146178611|NCT01115491|527167522|FG000|Overall Study|Lost to Follow-up|3|||
146178612|NCT01115491|527167522|FG000|Overall Study|Withdrawal by Subject|1|||
146178613|NCT01115491|527167522|FG000|Overall Study|Physician Decision|1|||
146178614|NCT03856996|527167523|FG000|Overall Study|Withdrawal by Subject|1|||
146178615|NCT03856996|527167524|FG001|Overall Study|Withdrawal by Subject|0|||
146178616|NCT03856996|527167523|FG000|Overall Study|Lost to Follow-up|0|||
146178617|NCT03856996|527167524|FG001|Overall Study|Lost to Follow-up|1|||
146178618|NCT03856996|527167523|FG000|Overall Study|Adverse Event|1|||
146178619|NCT03856996|527167524|FG001|Overall Study|Adverse Event|1|||
146178620|NCT03856996|527167523|FG000|Overall Study|Other|1|||
146178621|NCT03856996|527167524|FG001|Overall Study|Other|0|||
146178622|NCT01586338|527167526|FG000|Overall Study|Adverse Event|3|||
146178623|NCT01586338|527167526|FG000|Overall Study|Lost to Follow-up|1|||
146178624|NCT01586338|527167526|FG000|Overall Study|Withdrawal by participant|3|||
146178625|NCT01586338|527167526|FG000|Overall Study|Other|1|||
146178626|NCT03306043|527167529|FG000|Overall Study|Adverse Event|1|||
146178627|NCT03306043|527167529|FG000|Overall Study|Lost to Follow-up|1|||
146178628|NCT03306043|527167529|FG000|Overall Study|Withdrawal by Subject|2|||
146178629|NCT01544491|527167530|FG000|Overall Study|Withdrawal by Subject|3|||
146178630|NCT01544491|527167531|FG001|Overall Study|Withdrawal by Subject|2|||
146178631|NCT01544491|527167530|FG000|Overall Study|Lost to Follow-up|0|||
146178632|NCT01544491|527167531|FG001|Overall Study|Lost to Follow-up|1|||
146178633|NCT01544491|527167530|FG000|Overall Study|administrative problems|2|||
146178634|NCT01544491|527167531|FG001|Overall Study|administrative problems|0|||
146178635|NCT01799720|527167532|FG000|Overall Study|Withdrawal by Subject|3|||
146178636|NCT01799720|527167533|FG001|Overall Study|Withdrawal by Subject|0|||
146178637|NCT01799720|527167534|FG002|Overall Study|Withdrawal by Subject|0|||
146178638|NCT01799720|527167532|FG000|Overall Study|Protocol Violation|0|||
146178639|NCT01799720|527167533|FG001|Overall Study|Protocol Violation|1|||
146178640|NCT01799720|527167534|FG002|Overall Study|Protocol Violation|0|||
146178641|NCT01799720|527167532|FG000|Overall Study|Pregnancy|0|||
146178642|NCT01799720|527167533|FG001|Overall Study|Pregnancy|0|||
146178643|NCT01799720|527167534|FG002|Overall Study|Pregnancy|1|||
146178644|NCT00896454|527167536|FG000|Overall Study|Death|10|||
146178645|NCT00896454|527167536|FG000|Overall Study|Adverse Event|8|||
145945346|NCT01764997|526308215|FG003|Run-in Period|Poor compliance to protocol|0|||
146077668|NCT00435045|526805437|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
146077669|NCT00435045|526805436|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
146077670|NCT00435045|526805437|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
146077671|NCT00435045|526805436|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
146077672|NCT00435045|526805437|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
146077673|NCT00435045|526805436|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
146077674|NCT00435045|526805437|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
146077675|NCT00435045|526805436|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
146077676|NCT00435045|526805437|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
146077677|NCT00435045|526805436|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
146077678|NCT00435045|526805437|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
146077679|NCT00567255|526805438|FG000|Overall Study|Adverse Event|241|||
146077680|NCT00567255|526805439|FG001|Overall Study|Adverse Event|68|||
146077681|NCT00567255|526805438|FG000|Overall Study|Lost to Follow-up|77|||
146077682|NCT00567255|526805439|FG001|Overall Study|Lost to Follow-up|48|||
146077683|NCT00567255|526805438|FG000|Overall Study|Withdrawal by Subject|75|||
146077684|NCT00567255|526805439|FG001|Overall Study|Withdrawal by Subject|56|||
146077685|NCT00567255|526805438|FG000|Overall Study|Lack of Efficacy|19|||
146077686|NCT00567255|526805439|FG001|Overall Study|Lack of Efficacy|33|||
146077687|NCT00567255|526805438|FG000|Overall Study|Protocol Violation|20|||
146077688|NCT00567255|526805439|FG001|Overall Study|Protocol Violation|8|||
146077689|NCT00567255|526805438|FG000|Overall Study|Pregnancy|6|||
146077690|NCT00567255|526805439|FG001|Overall Study|Pregnancy|0|||
146077691|NCT00567255|526805438|FG000|Overall Study|Drug noncompliance,moved,other|25|||
146077692|NCT00567255|526805439|FG001|Overall Study|Drug noncompliance,moved,other|15|||
146077693|NCT01743001|526805442|FG000|Overall Study|Physician Decision|1|||
146077694|NCT01743001|526805443|FG001|Overall Study|Physician Decision|0|||
146077695|NCT01743001|526805442|FG000|Overall Study|Pregnancy|1|||
146077696|NCT01743001|526805443|FG001|Overall Study|Pregnancy|0|||
146077697|NCT01743001|526805442|FG000|Overall Study|Death|1|||
146077698|NCT01743001|526805443|FG001|Overall Study|Death|0|||
146178646|NCT00896454|527167536|FG000|Overall Study|Disease Progression|5|||
146178647|NCT00896454|527167536|FG000|Overall Study|Other|4|||
146178648|NCT00896454|527167536|FG000|Overall Study|Requirement for alternative therapy|3|||
146178649|NCT00896454|527167536|FG000|Overall Study|Ongoing in study|2|||
146178650|NCT00896454|527167536|FG000|Overall Study|Withdrawal by Subject|1|||
146178651|NCT01234649|527167537|FG000|Overall Study|Withdrawal by Subject|32|||
146178652|NCT01234649|527167538|FG001|Overall Study|Withdrawal by Subject|26|||
146178653|NCT01234649|527167537|FG000|Overall Study|Pregnancy|6|||
146178654|NCT01234649|527167538|FG001|Overall Study|Pregnancy|6|||
146178655|NCT01234649|527167537|FG000|Overall Study|intolerant to side effects|4|||
146178656|NCT01234649|527167538|FG001|Overall Study|intolerant to side effects|3|||
146178657|NCT01234649|527167537|FG000|Overall Study|Allergic reaction|1|||
146178658|NCT01234649|527167538|FG001|Overall Study|Allergic reaction|0|||
146178659|NCT01234649|527167537|FG000|Overall Study|Lack of Efficacy|0|||
146178660|NCT01234649|527167538|FG001|Overall Study|Lack of Efficacy|3|||
146178661|NCT01461993|527167543|FG000|Overall Study|Withdrawal by Subject|60|||
146178662|NCT01461993|527167544|FG001|Overall Study|Withdrawal by Subject|53|||
146178663|NCT01461993|527167545|FG002|Overall Study|Withdrawal by Subject|16|||
146178664|NCT01461993|527167543|FG000|Overall Study|Lost to Follow-up|44|||
146178665|NCT01461993|527167544|FG001|Overall Study|Lost to Follow-up|48|||
146178666|NCT01461993|527167545|FG002|Overall Study|Lost to Follow-up|22|||
146178667|NCT01461993|527167543|FG000|Overall Study|Protocol Violation|10|||
146178668|NCT01461993|527167544|FG001|Overall Study|Protocol Violation|9|||
146178669|NCT01461993|527167545|FG002|Overall Study|Protocol Violation|7|||
146178670|NCT01461993|527167543|FG000|Overall Study|Adverse Event|9|||
146178671|NCT01461993|527167544|FG001|Overall Study|Adverse Event|11|||
146178672|NCT01461993|527167545|FG002|Overall Study|Adverse Event|3|||
146178673|NCT01461993|527167543|FG000|Overall Study|No longer met eligibility criteria|13|||
146178674|NCT01461993|527167544|FG001|Overall Study|No longer met eligibility criteria|18|||
146178675|NCT01461993|527167545|FG002|Overall Study|No longer met eligibility criteria|10|||
146178676|NCT01461993|527167543|FG000|Overall Study|Did not meet entrance criteria|2|||
146178677|NCT01461993|527167544|FG001|Overall Study|Did not meet entrance criteria|3|||
146178678|NCT01461993|527167545|FG002|Overall Study|Did not meet entrance criteria|0|||
146178679|NCT01461993|527167543|FG000|Overall Study|Other|13|||
146178680|NCT01461993|527167544|FG001|Overall Study|Other|15|||
146178681|NCT01461993|527167545|FG002|Overall Study|Other|6|||
146178682|NCT00680056|527167547|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
146178683|NCT00680056|527167548|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
146178684|NCT00680056|527167547|FG000|Second Intervention|Protocol Violation|3|||
146178685|NCT00680056|527167548|FG001|Second Intervention|Protocol Violation|1|||
146178686|NCT02733042|527167554|FG000|Overall Study|Adverse Event|1|||
146178687|NCT02733042|527167555|FG001|Overall Study|Adverse Event|0|||
146178688|NCT02733042|527167556|FG002|Overall Study|Adverse Event|1|||
146178689|NCT02733042|527167557|FG003|Overall Study|Adverse Event|1|||
146178690|NCT02733042|527167558|FG004|Overall Study|Adverse Event|0|||
146178691|NCT02733042|527167559|FG005|Overall Study|Adverse Event|0|||
146178692|NCT02733042|527167560|FG006|Overall Study|Adverse Event|0|||
146178693|NCT02733042|527167561|FG007|Overall Study|Adverse Event|0|||
146178694|NCT02733042|527167562|FG008|Overall Study|Adverse Event|0|||
146178695|NCT02733042|527167563|FG009|Overall Study|Adverse Event|0|||
146178696|NCT02733042|527167564|FG010|Overall Study|Adverse Event|2|||
146178697|NCT02733042|527167565|FG011|Overall Study|Adverse Event|2|||
146178698|NCT02733042|527167566|FG012|Overall Study|Adverse Event|0|||
146178699|NCT02733042|527167567|FG013|Overall Study|Adverse Event|2|||
146178700|NCT02733042|527167568|FG014|Overall Study|Adverse Event|0|||
146178701|NCT02733042|527167569|FG015|Overall Study|Adverse Event|0|||
146178702|NCT02733042|527167570|FG016|Overall Study|Adverse Event|0|||
146178703|NCT02733042|527167571|FG017|Overall Study|Adverse Event|1|||
146178704|NCT02733042|527167572|FG018|Overall Study|Adverse Event|0|||
146178705|NCT02733042|527167554|FG000|Overall Study|Progressive Disease|2|||
146178706|NCT02733042|527167555|FG001|Overall Study|Progressive Disease|1|||
146178707|NCT02733042|527167556|FG002|Overall Study|Progressive Disease|3|||
146178708|NCT02733042|527167557|FG003|Overall Study|Progressive Disease|1|||
146178709|NCT02733042|527167558|FG004|Overall Study|Progressive Disease|2|||
146178710|NCT02733042|527167559|FG005|Overall Study|Progressive Disease|3|||
146178711|NCT02733042|527167560|FG006|Overall Study|Progressive Disease|0|||
146178712|NCT02733042|527167561|FG007|Overall Study|Progressive Disease|3|||
146178713|NCT02733042|527167562|FG008|Overall Study|Progressive Disease|3|||
146178714|NCT02733042|527167563|FG009|Overall Study|Progressive Disease|2|||
146178715|NCT02733042|527167564|FG010|Overall Study|Progressive Disease|2|||
146178716|NCT02733042|527167565|FG011|Overall Study|Progressive Disease|2|||
146178717|NCT02733042|527167566|FG012|Overall Study|Progressive Disease|8|||
146178718|NCT02733042|527167567|FG013|Overall Study|Progressive Disease|1|||
146178719|NCT02733042|527167568|FG014|Overall Study|Progressive Disease|4|||
146178720|NCT02733042|527167569|FG015|Overall Study|Progressive Disease|7|||
146178721|NCT02733042|527167570|FG016|Overall Study|Progressive Disease|2|||
146178722|NCT02733042|527167571|FG017|Overall Study|Progressive Disease|3|||
146178723|NCT02733042|527167572|FG018|Overall Study|Progressive Disease|4|||
146178724|NCT02733042|527167554|FG000|Overall Study|Withdrawal by Subject|0|||
146178725|NCT02733042|527167555|FG001|Overall Study|Withdrawal by Subject|1|||
146178726|NCT02733042|527167556|FG002|Overall Study|Withdrawal by Subject|2|||
146178727|NCT02733042|527167557|FG003|Overall Study|Withdrawal by Subject|1|||
146178728|NCT02733042|527167558|FG004|Overall Study|Withdrawal by Subject|1|||
146178729|NCT02733042|527167559|FG005|Overall Study|Withdrawal by Subject|0|||
146178730|NCT02733042|527167560|FG006|Overall Study|Withdrawal by Subject|0|||
146178731|NCT02733042|527167561|FG007|Overall Study|Withdrawal by Subject|0|||
146178732|NCT02733042|527167562|FG008|Overall Study|Withdrawal by Subject|1|||
146178733|NCT02733042|527167563|FG009|Overall Study|Withdrawal by Subject|1|||
146178734|NCT02733042|527167564|FG010|Overall Study|Withdrawal by Subject|0|||
146178735|NCT02733042|527167565|FG011|Overall Study|Withdrawal by Subject|2|||
146178736|NCT02733042|527167566|FG012|Overall Study|Withdrawal by Subject|1|||
146178737|NCT02733042|527167567|FG013|Overall Study|Withdrawal by Subject|1|||
146178738|NCT02733042|527167568|FG014|Overall Study|Withdrawal by Subject|0|||
146178739|NCT02733042|527167569|FG015|Overall Study|Withdrawal by Subject|0|||
146178740|NCT02733042|527167570|FG016|Overall Study|Withdrawal by Subject|0|||
146178741|NCT02733042|527167571|FG017|Overall Study|Withdrawal by Subject|0|||
146178742|NCT02733042|527167572|FG018|Overall Study|Withdrawal by Subject|0|||
146178743|NCT02733042|527167554|FG000|Overall Study|Other Reasons|0|||
146178744|NCT02733042|527167555|FG001|Overall Study|Other Reasons|0|||
146178745|NCT02733042|527167556|FG002|Overall Study|Other Reasons|1|||
146178746|NCT02733042|527167557|FG003|Overall Study|Other Reasons|0|||
146178747|NCT02733042|527167558|FG004|Overall Study|Other Reasons|0|||
146178748|NCT02733042|527167559|FG005|Overall Study|Other Reasons|0|||
146178749|NCT02733042|527167560|FG006|Overall Study|Other Reasons|0|||
146178750|NCT02733042|527167561|FG007|Overall Study|Other Reasons|0|||
146178751|NCT02733042|527167562|FG008|Overall Study|Other Reasons|0|||
146178752|NCT02733042|527167563|FG009|Overall Study|Other Reasons|1|||
146178753|NCT02733042|527167564|FG010|Overall Study|Other Reasons|1|||
146178754|NCT02733042|527167565|FG011|Overall Study|Other Reasons|0|||
146178755|NCT02733042|527167566|FG012|Overall Study|Other Reasons|0|||
146178756|NCT02733042|527167567|FG013|Overall Study|Other Reasons|0|||
146178757|NCT02733042|527167568|FG014|Overall Study|Other Reasons|0|||
146178758|NCT02733042|527167569|FG015|Overall Study|Other Reasons|1|||
146178759|NCT02733042|527167570|FG016|Overall Study|Other Reasons|0|||
146178760|NCT02733042|527167571|FG017|Overall Study|Other Reasons|1|||
146178761|NCT02733042|527167572|FG018|Overall Study|Other Reasons|0|||
146178762|NCT02733042|527167554|FG000|Overall Study|Death|0|||
146178763|NCT02733042|527167555|FG001|Overall Study|Death|0|||
146178764|NCT02733042|527167556|FG002|Overall Study|Death|0|||
146178765|NCT02733042|527167557|FG003|Overall Study|Death|0|||
146077699|NCT03052426|526805446|FG000|Overall Study|Withdrawal by Subject|0|||
146077700|NCT03052426|526805447|FG001|Overall Study|Withdrawal by Subject|1|||
146077701|NCT03052426|526805448|FG002|Overall Study|Withdrawal by Subject|0|||
146077702|NCT03052426|526805446|FG000|Overall Study|Lost to Follow-up|2|||
146077703|NCT03052426|526805447|FG001|Overall Study|Lost to Follow-up|0|||
146077704|NCT03052426|526805448|FG002|Overall Study|Lost to Follow-up|1|||
146077705|NCT01565343|526805451|FG000|Overall Study|Administrative decision/technical issues|1|||
146077706|NCT01565343|526805452|FG001|Overall Study|Administrative decision/technical issues|0|||
146077707|NCT01565343|526805453|FG002|Overall Study|Administrative decision/technical issues|0|||
146077708|NCT01853839|526805459|FG000|Overall Study|Violated inclusion criteria|2|||
146077709|NCT01853839|526805459|FG000|Overall Study|Not meet ITT population definition|58|||
146077710|NCT01853839|526805459|FG000|Overall Study|End of treatment visit too early|33|||
146077711|NCT01853839|526805459|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
146077712|NCT03672097|526805460|FG000|Period 1|Withdrawal by Subject|2|||
146077713|NCT03672097|526805460|FG000|Period 1|Adverse Event|1|||
146077714|NCT03672097|526805460|FG000|Period 1|Did not receive treatment|1|||
146077715|NCT03672097|526805460|FG000|Period 2|Withdrawal by Subject|3|||
146077716|NCT03672097|526805460|FG000|Period 2|Other|1|||
146077717|NCT03087617|526805462|FG000|Overall Study|Lost to Follow-up|32|||
146077718|NCT03087617|526805463|FG001|Overall Study|Lost to Follow-up|30|||
146077719|NCT03087617|526805464|FG002|Overall Study|Lost to Follow-up|30|||
146077720|NCT03087617|526805465|FG003|Overall Study|Lost to Follow-up|39|||
146077721|NCT02059291|526805469|FG000|Epoch 2|Lack of Efficacy|0|||
146077722|NCT02059291|526805470|FG001|Epoch 2|Lack of Efficacy|0|||
146077723|NCT02059291|526805471|FG002|Epoch 2|Lack of Efficacy|0|||
146077724|NCT02059291|526805472|FG003|Epoch 2|Lack of Efficacy|1|||
146077725|NCT02059291|526805473|FG004|Epoch 2|Lack of Efficacy|0|||
146077726|NCT02059291|526805474|FG005|Epoch 2|Lack of Efficacy|1|||
146077727|NCT02059291|526805475|FG006|Epoch 2|Lack of Efficacy|0|||
146077728|NCT02059291|526805476|FG007|Epoch 2|Lack of Efficacy|0|||
146077729|NCT02059291|526805477|FG008|Epoch 2|Lack of Efficacy|0|||
146077730|NCT02059291|526805478|FG009|Epoch 2|Lack of Efficacy|0|||
146077731|NCT02059291|526805479|FG010|Epoch 2|Lack of Efficacy|0|||
146077732|NCT02059291|526805480|FG011|Epoch 2|Lack of Efficacy|0|||
146077733|NCT02059291|526805481|FG012|Epoch 2|Lack of Efficacy|0|||
146077734|NCT02059291|526805482|FG013|Epoch 2|Lack of Efficacy|0|||
146077735|NCT02059291|526805483|FG014|Epoch 2|Lack of Efficacy|0|||
146077736|NCT02059291|526805484|FG015|Epoch 2|Lack of Efficacy|0|||
146077737|NCT02059291|526805485|FG016|Epoch 2|Lack of Efficacy|0|||
146077738|NCT02059291|526805486|FG017|Epoch 2|Lack of Efficacy|0|||
146077739|NCT02059291|526805487|FG018|Epoch 2|Lack of Efficacy|0|||
146077740|NCT02059291|526805488|FG019|Epoch 2|Lack of Efficacy|0|||
146077741|NCT02059291|526805489|FG020|Epoch 2|Lack of Efficacy|0|||
146077742|NCT02059291|526805490|FG021|Epoch 2|Lack of Efficacy|0|||
146077743|NCT02059291|526805491|FG022|Epoch 2|Lack of Efficacy|0|||
146077744|NCT02059291|526805492|FG023|Epoch 2|Lack of Efficacy|0|||
146077745|NCT02059291|526805493|FG024|Epoch 2|Lack of Efficacy|0|||
146077746|NCT02059291|526805469|FG000|Epoch 2|Adverse Event|0|||
146077747|NCT02059291|526805470|FG001|Epoch 2|Adverse Event|0|||
146077748|NCT02059291|526805471|FG002|Epoch 2|Adverse Event|1|||
146077749|NCT02059291|526805472|FG003|Epoch 2|Adverse Event|1|||
146077750|NCT02059291|526805473|FG004|Epoch 2|Adverse Event|0|||
146077751|NCT02059291|526805474|FG005|Epoch 2|Adverse Event|0|||
146077752|NCT02059291|526805475|FG006|Epoch 2|Adverse Event|0|||
146077753|NCT02059291|526805476|FG007|Epoch 2|Adverse Event|1|||
146077754|NCT02059291|526805477|FG008|Epoch 2|Adverse Event|1|||
146178766|NCT02733042|527167558|FG004|Overall Study|Death|0|||
146077755|NCT02059291|526805478|FG009|Epoch 2|Adverse Event|0|||
146077756|NCT02059291|526805479|FG010|Epoch 2|Adverse Event|0|||
146077757|NCT02059291|526805480|FG011|Epoch 2|Adverse Event|0|||
146077758|NCT02059291|526805481|FG012|Epoch 2|Adverse Event|0|||
146077759|NCT02059291|526805482|FG013|Epoch 2|Adverse Event|0|||
146077760|NCT02059291|526805483|FG014|Epoch 2|Adverse Event|0|||
146178767|NCT02733042|527167559|FG005|Overall Study|Death|0|||
146077761|NCT02059291|526805484|FG015|Epoch 2|Adverse Event|0|||
146077762|NCT02059291|526805485|FG016|Epoch 2|Adverse Event|0|||
146077763|NCT02059291|526805486|FG017|Epoch 2|Adverse Event|0|||
146077764|NCT02059291|526805487|FG018|Epoch 2|Adverse Event|0|||
146077765|NCT02059291|526805488|FG019|Epoch 2|Adverse Event|0|||
146077766|NCT02059291|526805489|FG020|Epoch 2|Adverse Event|0|||
146178768|NCT02733042|527167560|FG006|Overall Study|Death|1|||
146178769|NCT02733042|527167561|FG007|Overall Study|Death|0|||
146178770|NCT02733042|527167562|FG008|Overall Study|Death|1|||
146178771|NCT02733042|527167563|FG009|Overall Study|Death|0|||
146178772|NCT02733042|527167564|FG010|Overall Study|Death|1|||
146178773|NCT02733042|527167565|FG011|Overall Study|Death|0|||
146178774|NCT02733042|527167566|FG012|Overall Study|Death|0|||
146178775|NCT02733042|527167567|FG013|Overall Study|Death|0|||
146178776|NCT02733042|527167568|FG014|Overall Study|Death|1|||
146178777|NCT02733042|527167569|FG015|Overall Study|Death|2|||
146077767|NCT02059291|526805490|FG021|Epoch 2|Adverse Event|0|||
146077768|NCT02059291|526805491|FG022|Epoch 2|Adverse Event|0|||
146077769|NCT02059291|526805492|FG023|Epoch 2|Adverse Event|0|||
146077770|NCT02059291|526805493|FG024|Epoch 2|Adverse Event|0|||
146077771|NCT02059291|526805469|FG000|Epoch 2|Withdrawal by Subject|0|||
146077772|NCT02059291|526805470|FG001|Epoch 2|Withdrawal by Subject|1|||
146077773|NCT02059291|526805471|FG002|Epoch 2|Withdrawal by Subject|0|||
146077774|NCT02059291|526805472|FG003|Epoch 2|Withdrawal by Subject|0|||
146077775|NCT02059291|526805473|FG004|Epoch 2|Withdrawal by Subject|0|||
146077776|NCT02059291|526805474|FG005|Epoch 2|Withdrawal by Subject|1|||
146077777|NCT02059291|526805475|FG006|Epoch 2|Withdrawal by Subject|0|||
146077778|NCT02059291|526805476|FG007|Epoch 2|Withdrawal by Subject|0|||
146077779|NCT02059291|526805477|FG008|Epoch 2|Withdrawal by Subject|1|||
146077780|NCT02059291|526805478|FG009|Epoch 2|Withdrawal by Subject|0|||
146077781|NCT02059291|526805479|FG010|Epoch 2|Withdrawal by Subject|0|||
146077782|NCT02059291|526805480|FG011|Epoch 2|Withdrawal by Subject|0|||
146077783|NCT02059291|526805481|FG012|Epoch 2|Withdrawal by Subject|0|||
146077784|NCT02059291|526805482|FG013|Epoch 2|Withdrawal by Subject|0|||
146077785|NCT02059291|526805483|FG014|Epoch 2|Withdrawal by Subject|0|||
146077786|NCT02059291|526805484|FG015|Epoch 2|Withdrawal by Subject|0|||
146077787|NCT02059291|526805485|FG016|Epoch 2|Withdrawal by Subject|0|||
146077788|NCT02059291|526805486|FG017|Epoch 2|Withdrawal by Subject|0|||
146077789|NCT02059291|526805487|FG018|Epoch 2|Withdrawal by Subject|0|||
146077790|NCT02059291|526805488|FG019|Epoch 2|Withdrawal by Subject|0|||
146077791|NCT02059291|526805489|FG020|Epoch 2|Withdrawal by Subject|0|||
146077792|NCT02059291|526805490|FG021|Epoch 2|Withdrawal by Subject|0|||
146077793|NCT02059291|526805491|FG022|Epoch 2|Withdrawal by Subject|0|||
146077794|NCT02059291|526805492|FG023|Epoch 2|Withdrawal by Subject|0|||
146077795|NCT02059291|526805493|FG024|Epoch 2|Withdrawal by Subject|0|||
146178778|NCT02733042|527167570|FG016|Overall Study|Death|0|||
146178779|NCT02733042|527167571|FG017|Overall Study|Death|0|||
146178780|NCT02733042|527167572|FG018|Overall Study|Death|0|||
146178781|NCT02838628|527167574|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
146178782|NCT02838628|527167575|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
146178783|NCT02838628|527167574|FG000|Recurrence Follow-up Period|Adverse Event|1|||
146178784|NCT02838628|527167575|FG001|Recurrence Follow-up Period|Adverse Event|0|||
146178785|NCT02838628|527167574|FG000|Recurrence Follow-up Period|Non-compliance|0|||
146178786|NCT02838628|527167575|FG001|Recurrence Follow-up Period|Non-compliance|1|||
146178787|NCT02838628|527167574|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
146178788|NCT02838628|527167575|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
146178789|NCT02838628|527167574|FG000|Recurrence Follow-up Period|Other un-specified|1|||
146178790|NCT02838628|527167575|FG001|Recurrence Follow-up Period|Other un-specified|1|||
146178791|NCT01821898|527167576|FG000|Overall Study|Withdrawal by Subject|2|||
146178792|NCT01821898|527167577|FG001|Overall Study|Withdrawal by Subject|1|||
146178793|NCT01155661|527167578|FG000|Overall Study|Adverse Event|101|||
146178794|NCT01155661|527167578|FG000|Overall Study|Death|1|||
146178795|NCT01155661|527167578|FG000|Overall Study|Lack of Efficacy|32|||
146178796|NCT01155661|527167578|FG000|Overall Study|Lost to Follow-up|22|||
146178797|NCT01155661|527167578|FG000|Overall Study|Physician Decision|3|||
146178798|NCT01155661|527167578|FG000|Overall Study|Protocol Violation|35|||
146178799|NCT01155661|527167578|FG000|Overall Study|Withdrawal by Subject|73|||
146178800|NCT01155661|527167578|FG000|Overall Study|Sponsor Decision|13|||
146178801|NCT03915951|527167579|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
146178802|NCT03915951|527167580|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
146178803|NCT03915951|527167579|FG000|Overall Study|Adverse Event|12|||
146178804|NCT03915951|527167580|FG001|Overall Study|Adverse Event|6|||
146178805|NCT03915951|527167579|FG000|Overall Study|Disease progression (radiological)|17|||
146178806|NCT03915951|527167580|FG001|Overall Study|Disease progression (radiological)|15|||
146178807|NCT03915951|527167579|FG000|Overall Study|Disease progression (clinical)|4|||
146178808|NCT03915951|527167580|FG001|Overall Study|Disease progression (clinical)|1|||
146178809|NCT03915951|527167579|FG000|Overall Study|Patient decision|0|||
146178810|NCT03915951|527167580|FG001|Overall Study|Patient decision|4|||
146178811|NCT03915951|527167579|FG000|Overall Study|Investigator decision|0|||
146178812|NCT03915951|527167580|FG001|Overall Study|Investigator decision|1|||
146178813|NCT03915951|527167579|FG000|Overall Study|Consent withdrawn|1|||
146178814|NCT03915951|527167580|FG001|Overall Study|Consent withdrawn|1|||
146178815|NCT03915951|527167579|FG000|Overall Study|Death|0|||
146178816|NCT03915951|527167580|FG001|Overall Study|Death|3|||
146178817|NCT05832437|527167581|FG000|Overall Study|time off work|1|||
146178818|NCT05832437|527167582|FG001|Overall Study|time off work|0|||
146178819|NCT05832437|527167583|FG002|Overall Study|time off work|0|||
146178820|NCT05832437|527167584|FG003|Overall Study|time off work|0|||
146178821|NCT05064735|527167585|FG000|Overall Study|Withdrawal by Subject|7|||
146178822|NCT05064735|527167586|FG001|Overall Study|Withdrawal by Subject|8|||
146178823|NCT05064735|527167585|FG000|Overall Study|Lost to Follow-up|7|||
146178824|NCT05064735|527167586|FG001|Overall Study|Lost to Follow-up|2|||
146178825|NCT05064735|527167585|FG000|Overall Study|Physician Decision|2|||
146178826|NCT05064735|527167586|FG001|Overall Study|Physician Decision|1|||
146178827|NCT05064735|527167585|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
146178828|NCT05064735|527167586|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
146178829|NCT05064735|527167585|FG000|Overall Study|Site Closure|7|||
146178830|NCT05064735|527167586|FG001|Overall Study|Site Closure|2|||
146178831|NCT01396395|527167587|FG000|Overall Study|Withdrawal by Subject|10|||
146178832|NCT01396395|527167588|FG001|Overall Study|Withdrawal by Subject|12|||
146178833|NCT01396395|527167587|FG000|Overall Study|Protocol Violation|3|||
146178834|NCT01396395|527167588|FG001|Overall Study|Protocol Violation|1|||
146178835|NCT01396395|527167587|FG000|Overall Study|Adverse Event|10|||
146178836|NCT01396395|527167588|FG001|Overall Study|Adverse Event|2|||
146178837|NCT01396395|527167587|FG000|Overall Study|Lost to Follow-up|17|||
146178838|NCT01396395|527167588|FG001|Overall Study|Lost to Follow-up|11|||
146178839|NCT01396395|527167587|FG000|Overall Study|Other|0|||
146178840|NCT01396395|527167588|FG001|Overall Study|Other|1|||
146178841|NCT00337662|527167589|FG000|Study Period II|Lost to Follow-up|0|||
146178842|NCT00337662|527167590|FG001|Study Period II|Lost to Follow-up|0|||
146178843|NCT00337662|527167591|FG002|Study Period II|Lost to Follow-up|0|||
146178844|NCT00337662|527167592|FG003|Study Period II|Lost to Follow-up|35|||
146178845|NCT00337662|527167589|FG000|Study Period II|Withdrawal by Subject|0|||
146178846|NCT00337662|527167590|FG001|Study Period II|Withdrawal by Subject|0|||
146178847|NCT00337662|527167591|FG002|Study Period II|Withdrawal by Subject|0|||
146178848|NCT00337662|527167592|FG003|Study Period II|Withdrawal by Subject|20|||
146178849|NCT00337662|527167589|FG000|Study Period II|Adverse Event|0|||
146178850|NCT00337662|527167590|FG001|Study Period II|Adverse Event|0|||
146178851|NCT00337662|527167591|FG002|Study Period II|Adverse Event|0|||
146178852|NCT00337662|527167592|FG003|Study Period II|Adverse Event|16|||
146178853|NCT00337662|527167589|FG000|Study Period II|Physician Decision|0|||
146178854|NCT00337662|527167590|FG001|Study Period II|Physician Decision|0|||
146178855|NCT00337662|527167591|FG002|Study Period II|Physician Decision|0|||
146178856|NCT00337662|527167592|FG003|Study Period II|Physician Decision|13|||
146178857|NCT00337662|527167589|FG000|Study Period II|Entry Criteria Not Met|0|||
146178858|NCT00337662|527167590|FG001|Study Period II|Entry Criteria Not Met|0|||
146178859|NCT00337662|527167591|FG002|Study Period II|Entry Criteria Not Met|0|||
146178860|NCT00337662|527167592|FG003|Study Period II|Entry Criteria Not Met|6|||
146178861|NCT00337662|527167589|FG000|Study Period II|Protocol Violation|0|||
146178862|NCT00337662|527167590|FG001|Study Period II|Protocol Violation|0|||
146178863|NCT00337662|527167591|FG002|Study Period II|Protocol Violation|0|||
146178864|NCT00337662|527167592|FG003|Study Period II|Protocol Violation|6|||
146178865|NCT00337662|527167589|FG000|Study Period II|Lack of Efficacy|0|||
146178866|NCT00337662|527167590|FG001|Study Period II|Lack of Efficacy|0|||
146178867|NCT00337662|527167591|FG002|Study Period II|Lack of Efficacy|0|||
146178868|NCT00337662|527167592|FG003|Study Period II|Lack of Efficacy|7|||
146178869|NCT00337662|527167589|FG000|Study Period II|Sponsor Decision|0|||
146178870|NCT00337662|527167590|FG001|Study Period II|Sponsor Decision|0|||
146178871|NCT00337662|527167591|FG002|Study Period II|Sponsor Decision|0|||
146178872|NCT00337662|527167592|FG003|Study Period II|Sponsor Decision|2|||
146178873|NCT00337662|527167589|FG000|Study Period II|Parent/Caregiver Decision|0|||
146178874|NCT00337662|527167590|FG001|Study Period II|Parent/Caregiver Decision|0|||
146178875|NCT00337662|527167591|FG002|Study Period II|Parent/Caregiver Decision|0|||
146178876|NCT00337662|527167592|FG003|Study Period II|Parent/Caregiver Decision|1|||
146178877|NCT00337662|527167589|FG000|Study Period III|Lost to Follow-up|14|||
146178878|NCT00337662|527167590|FG001|Study Period III|Lost to Follow-up|16|||
146178879|NCT00337662|527167591|FG002|Study Period III|Lost to Follow-up|14|||
146178880|NCT00337662|527167592|FG003|Study Period III|Lost to Follow-up|0|||
146178881|NCT00337662|527167589|FG000|Study Period III|Withdrawal by Subject|18|||
146178882|NCT00337662|527167590|FG001|Study Period III|Withdrawal by Subject|14|||
146178883|NCT00337662|527167591|FG002|Study Period III|Withdrawal by Subject|12|||
146178884|NCT00337662|527167592|FG003|Study Period III|Withdrawal by Subject|0|||
146178885|NCT00337662|527167589|FG000|Study Period III|Adverse Event|9|||
146178886|NCT00337662|527167590|FG001|Study Period III|Adverse Event|10|||
146178887|NCT00337662|527167591|FG002|Study Period III|Adverse Event|8|||
146178888|NCT00337662|527167592|FG003|Study Period III|Adverse Event|0|||
146178889|NCT00337662|527167589|FG000|Study Period III|Protocol Violation|3|||
146178890|NCT00337662|527167590|FG001|Study Period III|Protocol Violation|8|||
146178891|NCT00337662|527167591|FG002|Study Period III|Protocol Violation|2|||
146178892|NCT00337662|527167592|FG003|Study Period III|Protocol Violation|0|||
146178893|NCT00337662|527167589|FG000|Study Period III|Physician Decision|6|||
146178894|NCT00337662|527167590|FG001|Study Period III|Physician Decision|5|||
146178895|NCT00337662|527167591|FG002|Study Period III|Physician Decision|0|||
146178896|NCT00337662|527167592|FG003|Study Period III|Physician Decision|0|||
146178897|NCT00337662|527167589|FG000|Study Period III|Entry Criteria Not Met|4|||
146178898|NCT00337662|527167590|FG001|Study Period III|Entry Criteria Not Met|1|||
146178899|NCT00337662|527167591|FG002|Study Period III|Entry Criteria Not Met|3|||
146178900|NCT00337662|527167592|FG003|Study Period III|Entry Criteria Not Met|0|||
146178901|NCT00337662|527167589|FG000|Study Period III|Lack of Efficacy|4|||
146178902|NCT00337662|527167590|FG001|Study Period III|Lack of Efficacy|4|||
146178903|NCT00337662|527167591|FG002|Study Period III|Lack of Efficacy|2|||
146178904|NCT00337662|527167592|FG003|Study Period III|Lack of Efficacy|0|||
146178905|NCT00337662|527167589|FG000|Study Period III|Parent/Caregiver Decision|0|||
146178906|NCT00337662|527167590|FG001|Study Period III|Parent/Caregiver Decision|0|||
146178907|NCT00337662|527167591|FG002|Study Period III|Parent/Caregiver Decision|2|||
146077796|NCT02059291|526805469|FG000|Epoch 3|Physician Decision|0|||
146077797|NCT02059291|526805470|FG001|Epoch 3|Physician Decision|0|||
146077798|NCT02059291|526805471|FG002|Epoch 3|Physician Decision|0|||
146077799|NCT02059291|526805472|FG003|Epoch 3|Physician Decision|0|||
146077800|NCT02059291|526805473|FG004|Epoch 3|Physician Decision|0|||
146077801|NCT02059291|526805474|FG005|Epoch 3|Physician Decision|0|||
146077802|NCT02059291|526805475|FG006|Epoch 3|Physician Decision|0|||
146077803|NCT02059291|526805476|FG007|Epoch 3|Physician Decision|0|||
146077804|NCT02059291|526805477|FG008|Epoch 3|Physician Decision|0|||
146077805|NCT02059291|526805478|FG009|Epoch 3|Physician Decision|0|||
146077806|NCT02059291|526805479|FG010|Epoch 3|Physician Decision|0|||
146077807|NCT02059291|526805480|FG011|Epoch 3|Physician Decision|0|||
146077808|NCT02059291|526805481|FG012|Epoch 3|Physician Decision|0|||
146077809|NCT02059291|526805482|FG013|Epoch 3|Physician Decision|1|||
146077810|NCT02059291|526805483|FG014|Epoch 3|Physician Decision|0|||
146077811|NCT02059291|526805484|FG015|Epoch 3|Physician Decision|1|||
146077812|NCT02059291|526805485|FG016|Epoch 3|Physician Decision|0|||
146077813|NCT02059291|526805486|FG017|Epoch 3|Physician Decision|0|||
146077814|NCT02059291|526805487|FG018|Epoch 3|Physician Decision|0|||
146077815|NCT02059291|526805488|FG019|Epoch 3|Physician Decision|0|||
146077816|NCT02059291|526805489|FG020|Epoch 3|Physician Decision|0|||
146077817|NCT02059291|526805490|FG021|Epoch 3|Physician Decision|0|||
146077818|NCT02059291|526805491|FG022|Epoch 3|Physician Decision|0|||
146077819|NCT02059291|526805492|FG023|Epoch 3|Physician Decision|0|||
146077820|NCT02059291|526805493|FG024|Epoch 3|Physician Decision|0|||
146077821|NCT02059291|526805469|FG000|Epoch 3|Adverse Event|0|||
146077822|NCT02059291|526805470|FG001|Epoch 3|Adverse Event|0|||
146077823|NCT02059291|526805471|FG002|Epoch 3|Adverse Event|0|||
146077824|NCT02059291|526805472|FG003|Epoch 3|Adverse Event|0|||
146077825|NCT02059291|526805473|FG004|Epoch 3|Adverse Event|0|||
146077826|NCT02059291|526805474|FG005|Epoch 3|Adverse Event|0|||
146077827|NCT02059291|526805475|FG006|Epoch 3|Adverse Event|0|||
146077828|NCT02059291|526805476|FG007|Epoch 3|Adverse Event|0|||
146077829|NCT02059291|526805477|FG008|Epoch 3|Adverse Event|0|||
146077830|NCT02059291|526805478|FG009|Epoch 3|Adverse Event|0|||
146077831|NCT02059291|526805479|FG010|Epoch 3|Adverse Event|0|||
146077832|NCT02059291|526805480|FG011|Epoch 3|Adverse Event|0|||
146077833|NCT02059291|526805481|FG012|Epoch 3|Adverse Event|0|||
146077834|NCT02059291|526805482|FG013|Epoch 3|Adverse Event|0|||
146077835|NCT02059291|526805483|FG014|Epoch 3|Adverse Event|0|||
146077836|NCT02059291|526805484|FG015|Epoch 3|Adverse Event|1|||
146077837|NCT02059291|526805485|FG016|Epoch 3|Adverse Event|0|||
146077838|NCT02059291|526805486|FG017|Epoch 3|Adverse Event|0|||
146077839|NCT02059291|526805487|FG018|Epoch 3|Adverse Event|0|||
146077840|NCT02059291|526805488|FG019|Epoch 3|Adverse Event|0|||
146077841|NCT02059291|526805489|FG020|Epoch 3|Adverse Event|0|||
146077842|NCT02059291|526805490|FG021|Epoch 3|Adverse Event|0|||
146077843|NCT02059291|526805491|FG022|Epoch 3|Adverse Event|0|||
146077844|NCT02059291|526805492|FG023|Epoch 3|Adverse Event|0|||
146077845|NCT02059291|526805493|FG024|Epoch 3|Adverse Event|0|||
146077846|NCT02059291|526805469|FG000|Epoch 3|Lack of Efficacy|0|||
146077847|NCT02059291|526805470|FG001|Epoch 3|Lack of Efficacy|0|||
146077848|NCT02059291|526805471|FG002|Epoch 3|Lack of Efficacy|0|||
146077849|NCT02059291|526805472|FG003|Epoch 3|Lack of Efficacy|0|||
146077850|NCT02059291|526805473|FG004|Epoch 3|Lack of Efficacy|0|||
146077851|NCT02059291|526805474|FG005|Epoch 3|Lack of Efficacy|0|||
146077852|NCT02059291|526805475|FG006|Epoch 3|Lack of Efficacy|0|||
146077853|NCT02059291|526805476|FG007|Epoch 3|Lack of Efficacy|0|||
146077854|NCT02059291|526805477|FG008|Epoch 3|Lack of Efficacy|0|||
146077855|NCT02059291|526805478|FG009|Epoch 3|Lack of Efficacy|0|||
146077856|NCT02059291|526805479|FG010|Epoch 3|Lack of Efficacy|0|||
146077857|NCT02059291|526805480|FG011|Epoch 3|Lack of Efficacy|0|||
146077858|NCT02059291|526805481|FG012|Epoch 3|Lack of Efficacy|0|||
146077859|NCT02059291|526805482|FG013|Epoch 3|Lack of Efficacy|0|||
146077860|NCT02059291|526805483|FG014|Epoch 3|Lack of Efficacy|0|||
146077861|NCT02059291|526805484|FG015|Epoch 3|Lack of Efficacy|3|||
146077862|NCT02059291|526805485|FG016|Epoch 3|Lack of Efficacy|0|||
146077863|NCT02059291|526805486|FG017|Epoch 3|Lack of Efficacy|0|||
146077864|NCT02059291|526805487|FG018|Epoch 3|Lack of Efficacy|0|||
146077865|NCT02059291|526805488|FG019|Epoch 3|Lack of Efficacy|0|||
146077866|NCT02059291|526805489|FG020|Epoch 3|Lack of Efficacy|0|||
146077867|NCT02059291|526805490|FG021|Epoch 3|Lack of Efficacy|0|||
146077868|NCT02059291|526805491|FG022|Epoch 3|Lack of Efficacy|0|||
146077869|NCT02059291|526805492|FG023|Epoch 3|Lack of Efficacy|0|||
146077870|NCT02059291|526805493|FG024|Epoch 3|Lack of Efficacy|0|||
146077871|NCT02059291|526805469|FG000|Epoch 3|Withdrawal by Subject|0|||
146077872|NCT02059291|526805470|FG001|Epoch 3|Withdrawal by Subject|0|||
146077873|NCT02059291|526805471|FG002|Epoch 3|Withdrawal by Subject|0|||
146077874|NCT02059291|526805472|FG003|Epoch 3|Withdrawal by Subject|0|||
146077875|NCT02059291|526805473|FG004|Epoch 3|Withdrawal by Subject|0|||
146077876|NCT02059291|526805474|FG005|Epoch 3|Withdrawal by Subject|0|||
146077877|NCT02059291|526805475|FG006|Epoch 3|Withdrawal by Subject|0|||
146077878|NCT02059291|526805476|FG007|Epoch 3|Withdrawal by Subject|0|||
146077879|NCT02059291|526805477|FG008|Epoch 3|Withdrawal by Subject|0|||
146077880|NCT02059291|526805478|FG009|Epoch 3|Withdrawal by Subject|0|||
146077881|NCT02059291|526805479|FG010|Epoch 3|Withdrawal by Subject|0|||
146077882|NCT02059291|526805480|FG011|Epoch 3|Withdrawal by Subject|0|||
146077883|NCT02059291|526805481|FG012|Epoch 3|Withdrawal by Subject|0|||
146077884|NCT02059291|526805482|FG013|Epoch 3|Withdrawal by Subject|0|||
146077885|NCT02059291|526805483|FG014|Epoch 3|Withdrawal by Subject|0|||
146077886|NCT02059291|526805484|FG015|Epoch 3|Withdrawal by Subject|1|||
146077887|NCT02059291|526805485|FG016|Epoch 3|Withdrawal by Subject|0|||
146077888|NCT02059291|526805486|FG017|Epoch 3|Withdrawal by Subject|0|||
146077889|NCT02059291|526805487|FG018|Epoch 3|Withdrawal by Subject|0|||
146077890|NCT02059291|526805488|FG019|Epoch 3|Withdrawal by Subject|0|||
146077891|NCT02059291|526805489|FG020|Epoch 3|Withdrawal by Subject|0|||
146077892|NCT02059291|526805490|FG021|Epoch 3|Withdrawal by Subject|0|||
146077893|NCT02059291|526805491|FG022|Epoch 3|Withdrawal by Subject|0|||
146077894|NCT02059291|526805492|FG023|Epoch 3|Withdrawal by Subject|0|||
146077895|NCT02059291|526805493|FG024|Epoch 3|Withdrawal by Subject|0|||
146077896|NCT02059291|526805469|FG000|Epoch 4|Adverse Event|0|||
146077897|NCT02059291|526805470|FG001|Epoch 4|Adverse Event|0|||
146077898|NCT02059291|526805471|FG002|Epoch 4|Adverse Event|0|||
146077899|NCT02059291|526805472|FG003|Epoch 4|Adverse Event|0|||
146077900|NCT02059291|526805473|FG004|Epoch 4|Adverse Event|0|||
146077901|NCT02059291|526805474|FG005|Epoch 4|Adverse Event|0|||
146077902|NCT02059291|526805475|FG006|Epoch 4|Adverse Event|0|||
146077903|NCT02059291|526805476|FG007|Epoch 4|Adverse Event|0|||
146077904|NCT02059291|526805477|FG008|Epoch 4|Adverse Event|0|||
146077905|NCT02059291|526805478|FG009|Epoch 4|Adverse Event|0|||
146077906|NCT02059291|526805479|FG010|Epoch 4|Adverse Event|0|||
146077907|NCT02059291|526805480|FG011|Epoch 4|Adverse Event|0|||
146077908|NCT02059291|526805481|FG012|Epoch 4|Adverse Event|0|||
146077909|NCT02059291|526805482|FG013|Epoch 4|Adverse Event|0|||
146077910|NCT02059291|526805483|FG014|Epoch 4|Adverse Event|0|||
146077911|NCT02059291|526805484|FG015|Epoch 4|Adverse Event|0|||
146077912|NCT02059291|526805485|FG016|Epoch 4|Adverse Event|1|||
146077913|NCT02059291|526805486|FG017|Epoch 4|Adverse Event|0|||
146077914|NCT02059291|526805487|FG018|Epoch 4|Adverse Event|0|||
146077915|NCT02059291|526805488|FG019|Epoch 4|Adverse Event|0|||
146077916|NCT02059291|526805489|FG020|Epoch 4|Adverse Event|0|||
146077917|NCT02059291|526805490|FG021|Epoch 4|Adverse Event|0|||
146077918|NCT02059291|526805491|FG022|Epoch 4|Adverse Event|1|||
146077919|NCT02059291|526805492|FG023|Epoch 4|Adverse Event|0|||
146077920|NCT02059291|526805493|FG024|Epoch 4|Adverse Event|0|||
146077921|NCT02059291|526805469|FG000|Epoch 4|Pregnancy|0|||
146077922|NCT02059291|526805470|FG001|Epoch 4|Pregnancy|0|||
146077923|NCT02059291|526805471|FG002|Epoch 4|Pregnancy|0|||
146077924|NCT02059291|526805472|FG003|Epoch 4|Pregnancy|0|||
146077925|NCT02059291|526805473|FG004|Epoch 4|Pregnancy|0|||
146077926|NCT02059291|526805474|FG005|Epoch 4|Pregnancy|0|||
146077927|NCT02059291|526805475|FG006|Epoch 4|Pregnancy|0|||
146077928|NCT02059291|526805476|FG007|Epoch 4|Pregnancy|0|||
146077929|NCT02059291|526805477|FG008|Epoch 4|Pregnancy|0|||
146077930|NCT02059291|526805478|FG009|Epoch 4|Pregnancy|0|||
146077931|NCT02059291|526805479|FG010|Epoch 4|Pregnancy|0|||
146077932|NCT02059291|526805480|FG011|Epoch 4|Pregnancy|0|||
146077933|NCT02059291|526805481|FG012|Epoch 4|Pregnancy|0|||
146077934|NCT02059291|526805482|FG013|Epoch 4|Pregnancy|0|||
146077935|NCT02059291|526805483|FG014|Epoch 4|Pregnancy|0|||
146077936|NCT02059291|526805484|FG015|Epoch 4|Pregnancy|0|||
146077937|NCT02059291|526805485|FG016|Epoch 4|Pregnancy|1|||
146077938|NCT02059291|526805486|FG017|Epoch 4|Pregnancy|0|||
146077939|NCT02059291|526805487|FG018|Epoch 4|Pregnancy|0|||
146077940|NCT02059291|526805488|FG019|Epoch 4|Pregnancy|0|||
146077941|NCT02059291|526805489|FG020|Epoch 4|Pregnancy|0|||
146077942|NCT02059291|526805490|FG021|Epoch 4|Pregnancy|0|||
146077943|NCT02059291|526805491|FG022|Epoch 4|Pregnancy|0|||
146077944|NCT02059291|526805492|FG023|Epoch 4|Pregnancy|0|||
146077945|NCT02059291|526805493|FG024|Epoch 4|Pregnancy|0|||
146077946|NCT02059291|526805469|FG000|Epoch 4|Withdrawal by Subject|0|||
146077947|NCT02059291|526805470|FG001|Epoch 4|Withdrawal by Subject|0|||
146077948|NCT02059291|526805471|FG002|Epoch 4|Withdrawal by Subject|0|||
146077949|NCT02059291|526805472|FG003|Epoch 4|Withdrawal by Subject|0|||
146077950|NCT02059291|526805473|FG004|Epoch 4|Withdrawal by Subject|0|||
146077951|NCT02059291|526805474|FG005|Epoch 4|Withdrawal by Subject|0|||
146077952|NCT02059291|526805475|FG006|Epoch 4|Withdrawal by Subject|0|||
146077953|NCT02059291|526805476|FG007|Epoch 4|Withdrawal by Subject|0|||
146077954|NCT02059291|526805477|FG008|Epoch 4|Withdrawal by Subject|0|||
146077955|NCT02059291|526805478|FG009|Epoch 4|Withdrawal by Subject|0|||
146077956|NCT02059291|526805479|FG010|Epoch 4|Withdrawal by Subject|0|||
146178908|NCT00337662|527167592|FG003|Study Period III|Parent/Caregiver Decision|0|||
146178909|NCT00337662|527167589|FG000|Study Period III|Sponsor Decision|1|||
146178910|NCT00337662|527167590|FG001|Study Period III|Sponsor Decision|0|||
146178911|NCT00337662|527167591|FG002|Study Period III|Sponsor Decision|1|||
146178912|NCT00337662|527167592|FG003|Study Period III|Sponsor Decision|0|||
146178913|NCT00337662|527167589|FG000|Study Period III|Clinical Relapse|1|||
146178914|NCT00337662|527167590|FG001|Study Period III|Clinical Relapse|0|||
146178915|NCT00337662|527167591|FG002|Study Period III|Clinical Relapse|0|||
146178916|NCT00337662|527167592|FG003|Study Period III|Clinical Relapse|0|||
146178917|NCT00882921|527167596|FG000|Overall Study|Death|2|||
146178918|NCT00882921|527167596|FG000|Overall Study|Other|3|||
146178919|NCT00882921|527167596|FG000|Overall Study|Lost to Follow-up|2|||
146178920|NCT00882921|527167596|FG000|Overall Study|Termination By Investigator|3|||
146178921|NCT00882921|527167596|FG000|Overall Study|Withdrawal Of Consent|1|||
146178922|NCT01370005|527167597|FG000|Overall Study|Not treated|1|||
146178923|NCT01370005|527167598|FG001|Overall Study|Not treated|0|||
146178924|NCT01370005|527167599|FG002|Overall Study|Not treated|0|||
146178925|NCT01370005|527167597|FG000|Overall Study|Adverse Event|5|||
146178926|NCT01370005|527167598|FG001|Overall Study|Adverse Event|5|||
146178927|NCT01370005|527167599|FG002|Overall Study|Adverse Event|6|||
146178928|NCT01370005|527167597|FG000|Overall Study|Lack of Efficacy|1|||
146178929|NCT01370005|527167598|FG001|Overall Study|Lack of Efficacy|0|||
146178930|NCT01370005|527167599|FG002|Overall Study|Lack of Efficacy|0|||
146178931|NCT01370005|527167597|FG000|Overall Study|Non compliant with protocol|0|||
146178932|NCT01370005|527167598|FG001|Overall Study|Non compliant with protocol|1|||
146178933|NCT01370005|527167599|FG002|Overall Study|Non compliant with protocol|2|||
146178934|NCT01370005|527167597|FG000|Overall Study|Lost to Follow-up|1|||
146178935|NCT01370005|527167598|FG001|Overall Study|Lost to Follow-up|1|||
146178936|NCT01370005|527167599|FG002|Overall Study|Lost to Follow-up|1|||
146178937|NCT01370005|527167597|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
146178938|NCT01370005|527167598|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
146178939|NCT01370005|527167599|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
146178940|NCT01370005|527167597|FG000|Overall Study|Other reason not defined above|3|||
146178941|NCT01370005|527167598|FG001|Overall Study|Other reason not defined above|0|||
146178942|NCT01370005|527167599|FG002|Overall Study|Other reason not defined above|2|||
146178943|NCT03691948|527167600|FG000|Overall Study|Lost to Follow-up|1|||
146178944|NCT03691948|527167601|FG001|Overall Study|Lost to Follow-up|3|||
146178945|NCT01018563|527167604|FG000|Overall Study|Termination of the study by Sponsor|2|||
146178946|NCT01018563|527167605|FG001|Overall Study|Termination of the study by Sponsor|1|||
146178947|NCT02344537|527167606|FG000|Overall Study|Protocol Violation|1|||
146178948|NCT02344537|527167607|FG001|Overall Study|Protocol Violation|1|||
146178949|NCT02344537|527167606|FG000|Overall Study|Subject started another treatment after wk 6|1|||
146178950|NCT02344537|527167607|FG001|Overall Study|Subject started another treatment after wk 6|0|||
146178951|NCT02344537|527167606|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
146178952|NCT02344537|527167607|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
146178953|NCT00960752|527167616|FG000|Overall Study|Adverse Event|0|||
146178954|NCT00960752|527167617|FG001|Overall Study|Adverse Event|0|||
146178955|NCT00960752|527167618|FG002|Overall Study|Adverse Event|1|||
146178956|NCT00960752|527167616|FG000|Overall Study|Progression|0|||
146178957|NCT00960752|527167617|FG001|Overall Study|Progression|0|||
146178958|NCT00960752|527167618|FG002|Overall Study|Progression|1|||
146178959|NCT04844970|527167619|FG000|Overall Study|Adverse Event|0|||
146178960|NCT04844970|527167620|FG001|Overall Study|Adverse Event|1|||
146178961|NCT04844970|527167619|FG000|Overall Study|Withdrawal by Subject|2|||
146178962|NCT04844970|527167620|FG001|Overall Study|Withdrawal by Subject|0|||
146178963|NCT05490329|527167621|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
146178964|NCT05490329|527167622|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
146178965|NCT05490329|527167621|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
146178966|NCT05490329|527167622|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
146178967|NCT05490329|527167621|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
146178968|NCT05490329|527167622|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
146178969|NCT03169881|527167623|FG000|Overall Study|Incomplete Follow-up|10|||
146178970|NCT03169881|527167624|FG001|Overall Study|Incomplete Follow-up|15|||
146178971|NCT03169881|527167623|FG000|Overall Study|Lost to Follow-up|18|||
146178972|NCT03169881|527167624|FG001|Overall Study|Lost to Follow-up|20|||
146178973|NCT03169881|527167623|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
146178974|NCT03169881|527167624|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
146178975|NCT02306122|527167625|FG000|Initial Physician Randomization|Physician Decision|0|||
146178976|NCT02306122|527167626|FG001|Initial Physician Randomization|Physician Decision|0|||
146178977|NCT02306122|527167627|FG002|Initial Physician Randomization|Physician Decision|0|||
146178978|NCT02306122|527167628|FG003|Initial Physician Randomization|Physician Decision|0|||
146178979|NCT02306122|527167629|FG004|Initial Physician Randomization|Physician Decision|0|||
146178980|NCT02306122|527167630|FG005|Initial Physician Randomization|Physician Decision|0|||
146178981|NCT02306122|527167631|FG006|Initial Physician Randomization|Physician Decision|0|||
146178982|NCT02306122|527167632|FG007|Initial Physician Randomization|Physician Decision|0|||
146178983|NCT02306122|527167633|FG008|Initial Physician Randomization|Physician Decision|1|||
146178984|NCT02306122|527167634|FG009|Initial Physician Randomization|Physician Decision|0|||
146178985|NCT02306122|527167635|FG010|Initial Physician Randomization|Physician Decision|0|||
146178986|NCT03734991|527167639|FG000|Overall Study|Adverse Event|4|||
146178987|NCT03734991|527167640|FG001|Overall Study|Adverse Event|0|||
146178988|NCT03734991|527167639|FG000|Overall Study|Lost to Follow-up|4|||
146178989|NCT03734991|527167640|FG001|Overall Study|Lost to Follow-up|0|||
146178990|NCT03734991|527167639|FG000|Overall Study|Physician Decision|0|||
146178991|NCT03734991|527167640|FG001|Overall Study|Physician Decision|1|||
146178992|NCT03734991|527167639|FG000|Overall Study|Pregnancy|1|||
146178993|NCT03734991|527167640|FG001|Overall Study|Pregnancy|0|||
146178994|NCT03734991|527167639|FG000|Overall Study|Withdrawal by Subject|6|||
146178995|NCT03734991|527167640|FG001|Overall Study|Withdrawal by Subject|3|||
146178996|NCT03734991|527167639|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
146178997|NCT03734991|527167640|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
146178998|NCT03734991|527167639|FG000|Overall Study|Other|2|||
146178999|NCT03734991|527167640|FG001|Overall Study|Other|2|||
146179000|NCT00180713|527167641|FG000|Overall Study|Withdrawal by Subject|2|||
146179001|NCT00180713|527167642|FG001|Overall Study|Withdrawal by Subject|0|||
146179002|NCT00180713|527167641|FG000|Overall Study|Adverse Event|3|||
146179003|NCT00180713|527167642|FG001|Overall Study|Adverse Event|3|||
146179004|NCT05295732|527167645|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
146179005|NCT05295732|527167646|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
146179006|NCT05295732|527167647|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
146179007|NCT05295732|527167648|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
146179008|NCT05295732|527167649|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
146179009|NCT05295732|527167645|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146179010|NCT05295732|527167646|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146179011|NCT05295732|527167647|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
146179012|NCT05295732|527167648|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
146179013|NCT05295732|527167649|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
146179014|NCT02322814|527167650|FG000|Overall Study|Death|7|||
146179015|NCT02322814|527167651|FG001|Overall Study|Death|29|||
146179016|NCT02322814|527167652|FG002|Overall Study|Death|32|||
146179017|NCT02322814|527167653|FG003|Overall Study|Death|23|||
146179018|NCT02322814|527167654|FG004|Overall Study|Death|14|||
146179019|NCT02322814|527167650|FG000|Overall Study|Lost to Follow-up|1|||
146179020|NCT02322814|527167651|FG001|Overall Study|Lost to Follow-up|3|||
146179021|NCT02322814|527167652|FG002|Overall Study|Lost to Follow-up|3|||
146179022|NCT02322814|527167653|FG003|Overall Study|Lost to Follow-up|1|||
146179023|NCT02322814|527167654|FG004|Overall Study|Lost to Follow-up|0|||
146179024|NCT02322814|527167650|FG000|Overall Study|Various Reasons|2|||
146179025|NCT02322814|527167651|FG001|Overall Study|Various Reasons|0|||
146179026|NCT02322814|527167652|FG002|Overall Study|Various Reasons|1|||
146179027|NCT02322814|527167653|FG003|Overall Study|Various Reasons|1|||
146179028|NCT02322814|527167654|FG004|Overall Study|Various Reasons|0|||
146179029|NCT02322814|527167650|FG000|Overall Study|Progressive Disease|0|||
146179030|NCT02322814|527167651|FG001|Overall Study|Progressive Disease|0|||
146179031|NCT02322814|527167652|FG002|Overall Study|Progressive Disease|0|||
146179032|NCT02322814|527167653|FG003|Overall Study|Progressive Disease|1|||
146179033|NCT02322814|527167654|FG004|Overall Study|Progressive Disease|1|||
146179034|NCT02322814|527167650|FG000|Overall Study|Protocol Violation|1|||
146179035|NCT02322814|527167651|FG001|Overall Study|Protocol Violation|0|||
146179036|NCT02322814|527167652|FG002|Overall Study|Protocol Violation|0|||
146179037|NCT02322814|527167653|FG003|Overall Study|Protocol Violation|0|||
146179038|NCT02322814|527167654|FG004|Overall Study|Protocol Violation|0|||
146179039|NCT02322814|527167650|FG000|Overall Study|Study Terminated by Sponsor|0|||
146179040|NCT02322814|527167651|FG001|Overall Study|Study Terminated by Sponsor|7|||
146179041|NCT02322814|527167652|FG002|Overall Study|Study Terminated by Sponsor|9|||
146179042|NCT02322814|527167653|FG003|Overall Study|Study Terminated by Sponsor|5|||
146179043|NCT02322814|527167654|FG004|Overall Study|Study Terminated by Sponsor|13|||
146179044|NCT02322814|527167650|FG000|Overall Study|Withdrawal by Subject|5|||
146179045|NCT02322814|527167651|FG001|Overall Study|Withdrawal by Subject|4|||
146179046|NCT02322814|527167652|FG002|Overall Study|Withdrawal by Subject|2|||
146179047|NCT02322814|527167653|FG003|Overall Study|Withdrawal by Subject|1|||
146179048|NCT02322814|527167654|FG004|Overall Study|Withdrawal by Subject|3|||
146179049|NCT03012061|527167655|FG000|Overall Study|Withdrawal by Subject|1|||
146179050|NCT03012061|527167656|FG001|Overall Study|Withdrawal by Subject|5|||
146179051|NCT03012061|527167657|FG002|Overall Study|Withdrawal by Subject|4|||
146179052|NCT03012061|527167655|FG000|Overall Study|Investigator Site Closed|1|||
146179053|NCT03012061|527167656|FG001|Overall Study|Investigator Site Closed|2|||
146179054|NCT03012061|527167657|FG002|Overall Study|Investigator Site Closed|0|||
146179055|NCT03012061|527167655|FG000|Overall Study|Lost to Follow-up|2|||
146179056|NCT03012061|527167656|FG001|Overall Study|Lost to Follow-up|1|||
146179057|NCT03012061|527167657|FG002|Overall Study|Lost to Follow-up|0|||
146077957|NCT02059291|526805480|FG011|Epoch 4|Withdrawal by Subject|0|||
146077958|NCT02059291|526805481|FG012|Epoch 4|Withdrawal by Subject|0|||
146077959|NCT02059291|526805482|FG013|Epoch 4|Withdrawal by Subject|0|||
146077960|NCT02059291|526805483|FG014|Epoch 4|Withdrawal by Subject|0|||
146077961|NCT02059291|526805484|FG015|Epoch 4|Withdrawal by Subject|0|||
146077962|NCT02059291|526805485|FG016|Epoch 4|Withdrawal by Subject|0|||
146077963|NCT02059291|526805486|FG017|Epoch 4|Withdrawal by Subject|0|||
146077964|NCT02059291|526805487|FG018|Epoch 4|Withdrawal by Subject|0|||
146077965|NCT02059291|526805488|FG019|Epoch 4|Withdrawal by Subject|0|||
146077966|NCT02059291|526805489|FG020|Epoch 4|Withdrawal by Subject|1|||
146077967|NCT02059291|526805490|FG021|Epoch 4|Withdrawal by Subject|0|||
146077968|NCT02059291|526805491|FG022|Epoch 4|Withdrawal by Subject|0|||
146077969|NCT02059291|526805492|FG023|Epoch 4|Withdrawal by Subject|0|||
146077970|NCT02059291|526805493|FG024|Epoch 4|Withdrawal by Subject|0|||
146077971|NCT02059291|526805469|FG000|Epoch 4|Lack of Efficacy|0|||
146077972|NCT02059291|526805470|FG001|Epoch 4|Lack of Efficacy|0|||
146077973|NCT02059291|526805471|FG002|Epoch 4|Lack of Efficacy|0|||
146077974|NCT02059291|526805472|FG003|Epoch 4|Lack of Efficacy|0|||
146077975|NCT02059291|526805473|FG004|Epoch 4|Lack of Efficacy|0|||
146077976|NCT02059291|526805474|FG005|Epoch 4|Lack of Efficacy|0|||
146077977|NCT02059291|526805475|FG006|Epoch 4|Lack of Efficacy|0|||
146077978|NCT02059291|526805476|FG007|Epoch 4|Lack of Efficacy|0|||
146077979|NCT02059291|526805477|FG008|Epoch 4|Lack of Efficacy|0|||
146077980|NCT02059291|526805478|FG009|Epoch 4|Lack of Efficacy|0|||
146077981|NCT02059291|526805479|FG010|Epoch 4|Lack of Efficacy|0|||
146077982|NCT02059291|526805480|FG011|Epoch 4|Lack of Efficacy|0|||
146077983|NCT02059291|526805481|FG012|Epoch 4|Lack of Efficacy|0|||
146077984|NCT02059291|526805482|FG013|Epoch 4|Lack of Efficacy|0|||
146077985|NCT02059291|526805483|FG014|Epoch 4|Lack of Efficacy|0|||
146077986|NCT02059291|526805484|FG015|Epoch 4|Lack of Efficacy|0|||
146077987|NCT02059291|526805485|FG016|Epoch 4|Lack of Efficacy|0|||
146077988|NCT02059291|526805486|FG017|Epoch 4|Lack of Efficacy|0|||
146077989|NCT02059291|526805487|FG018|Epoch 4|Lack of Efficacy|0|||
146077990|NCT02059291|526805488|FG019|Epoch 4|Lack of Efficacy|0|||
146077991|NCT02059291|526805489|FG020|Epoch 4|Lack of Efficacy|0|||
146077992|NCT02059291|526805490|FG021|Epoch 4|Lack of Efficacy|0|||
146077993|NCT02059291|526805491|FG022|Epoch 4|Lack of Efficacy|0|||
146077994|NCT02059291|526805492|FG023|Epoch 4|Lack of Efficacy|1|||
146077995|NCT02059291|526805493|FG024|Epoch 4|Lack of Efficacy|0|||
146077996|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
146077997|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
146077998|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Adverse Event|7|||
146077999|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Adverse Event|6|||
146078000|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
146078001|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
146078002|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Physician Decision|4|||
146078003|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Physician Decision|4|||
146078004|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
146078005|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
146078006|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
146078007|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
146078008|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
146078009|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
146078010|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Non-compliance|1|||
146078011|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Non-compliance|0|||
146078012|NCT00470834|526805494|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
146078013|NCT00470834|526805495|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
146078014|NCT00470834|526805494|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
146078015|NCT00470834|526805495|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
146078016|NCT00470834|526805494|FG000|Extension Period (24 Months)|Adverse Event|3|||
146078017|NCT00470834|526805495|FG001|Extension Period (24 Months)|Adverse Event|4|||
146078018|NCT00470834|526805494|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
146078019|NCT00470834|526805495|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
146078020|NCT00470834|526805494|FG000|Extension Period (24 Months)|Physician Decision|4|||
146078021|NCT00470834|526805495|FG001|Extension Period (24 Months)|Physician Decision|3|||
146078022|NCT00470834|526805494|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
146078023|NCT00470834|526805495|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
146078024|NCT00470834|526805494|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
146078025|NCT00470834|526805495|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
146078026|NCT00470834|526805494|FG000|Extension Period (24 Months)|Non-compliance|0|||
146078027|NCT00470834|526805495|FG001|Extension Period (24 Months)|Non-compliance|1|||
146078028|NCT00470834|526805494|FG000|Extension Period (24 Months)|Disease Progression|0|||
146078029|NCT00470834|526805495|FG001|Extension Period (24 Months)|Disease Progression|1|||
146078030|NCT01989208|526805498|FG000|200 mg (7 Days)|Protocol Violation|0|||
146078031|NCT01989208|526805499|FG001|200 mg (7 Days)|Protocol Violation|1|||
146078032|NCT00080899|526805503|FG000|Overall Study|Adverse Event|1|||
146179058|NCT03012061|527167655|FG000|Overall Study|Study closed/ Terminated|0|||
146179059|NCT03012061|527167656|FG001|Overall Study|Study closed/ Terminated|0|||
146179060|NCT03012061|527167657|FG002|Overall Study|Study closed/ Terminated|1|||
146179061|NCT03012061|527167655|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
146179062|NCT03012061|527167656|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
146179063|NCT03012061|527167657|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
146179064|NCT03012061|527167655|FG000|Overall Study|Protocol Violation|0|||
146179065|NCT03012061|527167656|FG001|Overall Study|Protocol Violation|0|||
146179066|NCT03012061|527167657|FG002|Overall Study|Protocol Violation|2|||
146179067|NCT03012061|527167655|FG000|Overall Study|Lack of Efficacy|0|||
146179068|NCT03012061|527167656|FG001|Overall Study|Lack of Efficacy|1|||
146179069|NCT03012061|527167657|FG002|Overall Study|Lack of Efficacy|0|||
146179070|NCT03012061|527167655|FG000|Overall Study|Adverse Event|2|||
146179071|NCT03012061|527167656|FG001|Overall Study|Adverse Event|0|||
146179072|NCT03012061|527167657|FG002|Overall Study|Adverse Event|0|||
146179073|NCT04152343|527167658|FG000|Overall Study|Transplanted|5|||
146179074|NCT04152343|527167658|FG000|Overall Study|Death|20|||
146179075|NCT04152343|527167658|FG000|Overall Study|Lost to Follow-up|3|||
146179076|NCT01965938|527167659|FG000|Overall Study|Withdrawal by Subject|1|||
146179077|NCT01965938|527167660|FG001|Overall Study|Withdrawal by Subject|0|||
146179078|NCT03757234|527167661|FG000|Overall Study|Adverse Event|0|||
146179079|NCT03757234|527167662|FG001|Overall Study|Adverse Event|0|||
146179080|NCT03757234|527167663|FG002|Overall Study|Adverse Event|0|||
146179081|NCT03757234|527167664|FG003|Overall Study|Adverse Event|0|||
146179082|NCT03757234|527167665|FG004|Overall Study|Adverse Event|1|||
146179083|NCT03757234|527167661|FG000|Overall Study|Lost to Follow-up|1|||
146179084|NCT03757234|527167662|FG001|Overall Study|Lost to Follow-up|0|||
146179085|NCT03757234|527167663|FG002|Overall Study|Lost to Follow-up|0|||
146179086|NCT03757234|527167664|FG003|Overall Study|Lost to Follow-up|0|||
146179087|NCT03757234|527167665|FG004|Overall Study|Lost to Follow-up|1|||
146179088|NCT03757234|527167661|FG000|Overall Study|Withdrawal by Subject|1|||
146179089|NCT03757234|527167662|FG001|Overall Study|Withdrawal by Subject|1|||
146078033|NCT01276054|526805506|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
146078034|NCT01276054|526805507|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
146078035|NCT00787267|526805508|FG000|Overall Study|Screen failure/Ineligible|10|||
146078036|NCT00787267|526805508|FG000|Overall Study|No Reason Provided|1|||
146078037|NCT00787267|526805508|FG000|Overall Study|Withdrawal by Subject|1|||
146078038|NCT04343235|526805509|FG000|Overall Study|Lost to Follow-up|3|||
146078039|NCT04343235|526805510|FG001|Overall Study|Lost to Follow-up|2|||
146078040|NCT01763996|526805511|FG000|Treatment Period 2|Adverse Event|0|||
146078041|NCT01763996|526805512|FG001|Treatment Period 2|Adverse Event|1|||
146078042|NCT00865280|526805513|FG000|Overall Study|Withdrawal by Subject|4|||
146078043|NCT00865280|526805514|FG001|Overall Study|Withdrawal by Subject|1|||
146078044|NCT00865280|526805513|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
146078045|NCT00865280|526805514|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
146078046|NCT00865280|526805513|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
146078047|NCT00865280|526805514|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
146078048|NCT00865280|526805513|FG000|Overall Study|Exclusion Condition|1|||
146078049|NCT00865280|526805514|FG001|Overall Study|Exclusion Condition|0|||
146078050|NCT00865280|526805513|FG000|Overall Study|Adverse Event|0|||
146078051|NCT00865280|526805514|FG001|Overall Study|Adverse Event|1|||
146078052|NCT00743106|526805515|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
146078053|NCT00743106|526805516|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
146078054|NCT00145977|526805517|FG000|Overall Study|Lack of Efficacy|0|||
146078055|NCT00145977|526805518|FG001|Overall Study|Lack of Efficacy|4|||
146078056|NCT00145977|526805517|FG000|Overall Study|Lost to Follow-up|1|||
146078057|NCT00145977|526805518|FG001|Overall Study|Lost to Follow-up|0|||
146078058|NCT00145977|526805517|FG000|Overall Study|Withdrawal by Subject|1|||
146078059|NCT00145977|526805518|FG001|Overall Study|Withdrawal by Subject|0|||
146078060|NCT03060551|526805519|FG000|Overall Study|Withdrawal by Subject|1|||
146179090|NCT03757234|527167663|FG002|Overall Study|Withdrawal by Subject|0|||
146179091|NCT03757234|527167664|FG003|Overall Study|Withdrawal by Subject|1|||
146179092|NCT03757234|527167665|FG004|Overall Study|Withdrawal by Subject|2|||
146179093|NCT03757234|527167661|FG000|Overall Study|Other|1|||
146179094|NCT03757234|527167662|FG001|Overall Study|Other|1|||
146179095|NCT03757234|527167663|FG002|Overall Study|Other|0|||
146179096|NCT03757234|527167664|FG003|Overall Study|Other|0|||
146179097|NCT03757234|527167665|FG004|Overall Study|Other|0|||
146179098|NCT02736968|527167669|FG000|Overall Study|Lost to Follow-up|0|||
146179099|NCT02736968|527167670|FG001|Overall Study|Lost to Follow-up|0|||
146179100|NCT02736968|527167671|FG002|Overall Study|Lost to Follow-up|0|||
146179101|NCT02736968|527167672|FG003|Overall Study|Lost to Follow-up|0|||
146179102|NCT02736968|527167673|FG004|Overall Study|Lost to Follow-up|0|||
146179103|NCT02736968|527167674|FG005|Overall Study|Lost to Follow-up|0|||
146179104|NCT02736968|527167675|FG006|Overall Study|Lost to Follow-up|5|||
146179105|NCT02736968|527167676|FG007|Overall Study|Lost to Follow-up|2|||
146179106|NCT02736968|527167669|FG000|Overall Study|COVID-19 Pandemic|0|||
146179107|NCT02736968|527167670|FG001|Overall Study|COVID-19 Pandemic|0|||
146179108|NCT02736968|527167671|FG002|Overall Study|COVID-19 Pandemic|0|||
146179109|NCT02736968|527167672|FG003|Overall Study|COVID-19 Pandemic|0|||
146179110|NCT02736968|527167673|FG004|Overall Study|COVID-19 Pandemic|0|||
146179111|NCT02736968|527167674|FG005|Overall Study|COVID-19 Pandemic|0|||
146179112|NCT02736968|527167675|FG006|Overall Study|COVID-19 Pandemic|2|||
146179113|NCT02736968|527167676|FG007|Overall Study|COVID-19 Pandemic|0|||
146179114|NCT02736968|527167669|FG000|Overall Study|Withdrawal by Subject|0|||
146179115|NCT02736968|527167670|FG001|Overall Study|Withdrawal by Subject|0|||
146179116|NCT02736968|527167671|FG002|Overall Study|Withdrawal by Subject|0|||
146179117|NCT02736968|527167672|FG003|Overall Study|Withdrawal by Subject|0|||
146179118|NCT02736968|527167673|FG004|Overall Study|Withdrawal by Subject|0|||
146179119|NCT02736968|527167674|FG005|Overall Study|Withdrawal by Subject|0|||
146179120|NCT02736968|527167675|FG006|Overall Study|Withdrawal by Subject|1|||
146179121|NCT02736968|527167676|FG007|Overall Study|Withdrawal by Subject|0|||
146179122|NCT02961374|527167679|FG000|Overall Study|Adverse Event|4|||
146179123|NCT02041923|527167682|FG000|Overall Study|Lost to Follow-up|26|||
146179124|NCT02041923|527167683|FG001|Overall Study|Lost to Follow-up|30|||
146179125|NCT04297241|527168841|FG000|Overall Study|Withdrawal by Subject|1|||
146179126|NCT04297241|527168841|FG000|Overall Study|Adverse Event|1|||
146179127|NCT04297241|527168841|FG000|Overall Study|Physician Decision|3|||
146179128|NCT03688711|527168852|FG000|Overall Study|Withdrawal by Subject|0|||
146179129|NCT03688711|527168853|FG001|Overall Study|Withdrawal by Subject|1|||
146179130|NCT04654468|527168856|FG000|Overall Study|Death|1|||
146179131|NCT04654468|527168856|FG000|Overall Study|Ongoing in the Study|50|||
146179132|NCT06390826|527168857|FG000|Overall Study|Never Start Protocol Therapy|1|||
146179133|NCT06390826|527168857|FG000|Overall Study|Adverse Event|1|||
146179134|NCT06390826|527168857|FG000|Overall Study|Disease Progression|8|||
146179135|NCT04159415|527168869|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179136|NCT04159415|527168870|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179137|NCT04159415|527168871|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179138|NCT04159415|527168872|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179139|NCT04159415|527168873|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179140|NCT04159415|527168874|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179141|NCT04159415|527168875|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
146179142|NCT04159415|527168876|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
146179143|NCT04159415|527168877|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179144|NCT04159415|527168878|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
146179145|NCT04159415|527168869|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179146|NCT04159415|527168870|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179147|NCT04159415|527168871|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179148|NCT04159415|527168872|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179149|NCT04159415|527168873|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179150|NCT04159415|527168874|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179151|NCT04159415|527168875|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179152|NCT04159415|527168876|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
146179153|NCT04159415|527168877|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179154|NCT04159415|527168878|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
146179155|NCT04159415|527168869|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179156|NCT04159415|527168870|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179157|NCT04159415|527168871|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179158|NCT04159415|527168872|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179159|NCT04159415|527168873|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179160|NCT04159415|527168874|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179161|NCT04159415|527168875|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146234942|NCT02347332|527378426|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
146179162|NCT04159415|527168876|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
146179163|NCT04159415|527168877|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179164|NCT04159415|527168878|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
146179165|NCT04159415|527168869|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179166|NCT04159415|527168870|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179167|NCT04159415|527168871|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179168|NCT04159415|527168872|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179169|NCT04159415|527168873|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179170|NCT04159415|527168874|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179171|NCT04159415|527168875|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179172|NCT04159415|527168876|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179173|NCT04159415|527168877|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
146179174|NCT04159415|527168878|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
146179175|NCT00856661|527168879|FG000|Overall Study|Death|15|||
146179176|NCT00856661|527168880|FG001|Overall Study|Death|18|||
146179177|NCT00856661|527168879|FG000|Overall Study|Protocol Violation|2|||
146179178|NCT00856661|527168880|FG001|Overall Study|Protocol Violation|1|||
146179179|NCT00856661|527168879|FG000|Overall Study|Withdrawal by Subject|1|||
146179180|NCT00856661|527168880|FG001|Overall Study|Withdrawal by Subject|2|||
146179181|NCT00856661|527168879|FG000|Overall Study|Lost to Follow-up|1|||
146179182|NCT00856661|527168880|FG001|Overall Study|Lost to Follow-up|3|||
146179183|NCT00856661|527168879|FG000|Overall Study|Physician Judgement|8|||
146179184|NCT00856661|527168880|FG001|Overall Study|Physician Judgement|5|||
146179185|NCT03936777|527168881|FG000|Overall Study|Adverse Event|3|||
146179186|NCT03936777|527168881|FG000|Overall Study|Death|3|||
146179187|NCT03936777|527168881|FG000|Overall Study|Lack of Efficacy|24|||
146179188|NCT03936777|527168881|FG000|Overall Study|Lost to Follow-up|3|||
146179189|NCT03936777|527168881|FG000|Overall Study|Physician Decision|1|||
146179190|NCT03936777|527168881|FG000|Overall Study|Withdrawal by Subject|11|||
146179191|NCT03936777|527168881|FG000|Overall Study|Subjected Weaned of ZX008|1|||
146179192|NCT03936777|527168881|FG000|Overall Study|Missing|6|||
146179193|NCT04150029|527168883|FG000|Overall Study|Disease Relapse|0|||
146179194|NCT04150029|527168884|FG001|Overall Study|Disease Relapse|18|||
146179195|NCT04150029|527168883|FG000|Overall Study|Progressive Disease|2|||
146179196|NCT04150029|527168884|FG001|Overall Study|Progressive Disease|16|||
146179197|NCT04150029|527168883|FG000|Overall Study|Adverse Event|1|||
146179198|NCT04150029|527168884|FG001|Overall Study|Adverse Event|11|||
146179199|NCT04150029|527168883|FG000|Overall Study|Physician Decision|0|||
146179200|NCT04150029|527168884|FG001|Overall Study|Physician Decision|10|||
146179201|NCT04150029|527168883|FG000|Overall Study|Study Terminated by Sponsor|1|||
146179202|NCT04150029|527168884|FG001|Overall Study|Study Terminated by Sponsor|10|||
146179203|NCT04150029|527168883|FG000|Overall Study|Death|0|||
146179204|NCT04150029|527168884|FG001|Overall Study|Death|8|||
146179205|NCT04150029|527168883|FG000|Overall Study|Participant Decision|0|||
146179206|NCT04150029|527168884|FG001|Overall Study|Participant Decision|7|||
146179207|NCT04150029|527168883|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
146179208|NCT04150029|527168884|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
146179209|NCT02364713|527168888|FG000|Overall Study|Ineligible|2|||
146179210|NCT02364713|527168889|FG001|Overall Study|Ineligible|2|||
146179211|NCT00147225|527168890|FG000|Overall Study|Withdrawal by Subject|1|||
146179212|NCT00147225|527168891|FG001|Overall Study|Withdrawal by Subject|0|||
146179213|NCT00147225|527168892|FG002|Overall Study|Withdrawal by Subject|1|||
146179214|NCT00147225|527168893|FG003|Overall Study|Withdrawal by Subject|0|||
146179215|NCT00147225|527168894|FG004|Overall Study|Withdrawal by Subject|0|||
146179216|NCT00147225|527168895|FG005|Overall Study|Withdrawal by Subject|1|||
146179217|NCT00147225|527168890|FG000|Overall Study|Adverse Event|0|||
146179218|NCT00147225|527168891|FG001|Overall Study|Adverse Event|0|||
146179219|NCT00147225|527168892|FG002|Overall Study|Adverse Event|1|||
146179220|NCT00147225|527168893|FG003|Overall Study|Adverse Event|1|||
146179221|NCT00147225|527168894|FG004|Overall Study|Adverse Event|0|||
146179222|NCT00147225|527168895|FG005|Overall Study|Adverse Event|0|||
146179223|NCT00147225|527168890|FG000|Overall Study|Screen Failure|0|||
146179224|NCT00147225|527168891|FG001|Overall Study|Screen Failure|0|||
146179225|NCT00147225|527168892|FG002|Overall Study|Screen Failure|0|||
146179226|NCT00147225|527168893|FG003|Overall Study|Screen Failure|0|||
146179227|NCT00147225|527168894|FG004|Overall Study|Screen Failure|1|||
146179228|NCT00147225|527168895|FG005|Overall Study|Screen Failure|0|||
146179229|NCT00147225|527168890|FG000|Overall Study|Chemotherapy Changed|0|||
146179230|NCT00147225|527168891|FG001|Overall Study|Chemotherapy Changed|0|||
146179231|NCT00147225|527168892|FG002|Overall Study|Chemotherapy Changed|0|||
146179232|NCT00147225|527168893|FG003|Overall Study|Chemotherapy Changed|0|||
146179233|NCT00147225|527168894|FG004|Overall Study|Chemotherapy Changed|0|||
146179234|NCT00147225|527168895|FG005|Overall Study|Chemotherapy Changed|1|||
146179235|NCT01032044|527168896|FG000|Overall Study|Protocol Violation|14|||
146179236|NCT01032044|527168897|FG001|Overall Study|Protocol Violation|8|||
146179237|NCT01032044|527168896|FG000|Overall Study|Adverse Event|0|||
146179238|NCT01032044|527168897|FG001|Overall Study|Adverse Event|1|||
146179239|NCT01032044|527168896|FG000|Overall Study|Lost to Follow-up|11|||
146179240|NCT01032044|527168897|FG001|Overall Study|Lost to Follow-up|11|||
146179241|NCT01233609|527168898|FG000|Overall Study|Death|1|||
146179242|NCT01233609|527168899|FG001|Overall Study|Death|0|||
146179243|NCT01233609|527168898|FG000|Overall Study|Lost to Follow-up|3|||
146179244|NCT01233609|527168899|FG001|Overall Study|Lost to Follow-up|1|||
146179245|NCT01233609|527168898|FG000|Overall Study|Adverse Event|2|||
146179246|NCT01233609|527168899|FG001|Overall Study|Adverse Event|1|||
146179247|NCT01233609|527168898|FG000|Overall Study|Withdrawal by Subject|3|||
146179248|NCT01233609|527168899|FG001|Overall Study|Withdrawal by Subject|0|||
146179249|NCT00309608|527168902|FG000|Overall Study|Adverse Event|1|||
146179250|NCT00309608|527168903|FG001|Overall Study|Adverse Event|5|||
146179251|NCT00309608|527168904|FG002|Overall Study|Adverse Event|3|||
146179252|NCT00309608|527168905|FG003|Overall Study|Adverse Event|2|||
146179253|NCT00309608|527168906|FG004|Overall Study|Adverse Event|3|||
146179254|NCT00309608|527168902|FG000|Overall Study|Protocol Violation|2|||
146179255|NCT00309608|527168903|FG001|Overall Study|Protocol Violation|0|||
146179256|NCT00309608|527168904|FG002|Overall Study|Protocol Violation|0|||
146179257|NCT00309608|527168905|FG003|Overall Study|Protocol Violation|0|||
146179258|NCT00309608|527168906|FG004|Overall Study|Protocol Violation|0|||
146179259|NCT00309608|527168902|FG000|Overall Study|Lost to Follow-up|0|||
146179260|NCT00309608|527168903|FG001|Overall Study|Lost to Follow-up|0|||
146179261|NCT00309608|527168904|FG002|Overall Study|Lost to Follow-up|2|||
146179262|NCT00309608|527168905|FG003|Overall Study|Lost to Follow-up|0|||
146179263|NCT00309608|527168906|FG004|Overall Study|Lost to Follow-up|1|||
146179264|NCT00309608|527168902|FG000|Overall Study|Withdrawal by Subject|1|||
146179265|NCT00309608|527168903|FG001|Overall Study|Withdrawal by Subject|4|||
146179266|NCT00309608|527168904|FG002|Overall Study|Withdrawal by Subject|2|||
146179267|NCT00309608|527168905|FG003|Overall Study|Withdrawal by Subject|0|||
146179268|NCT00309608|527168906|FG004|Overall Study|Withdrawal by Subject|0|||
146179269|NCT00309608|527168902|FG000|Overall Study|Other incl. Lack of efficacy|10|||
146179270|NCT00309608|527168903|FG001|Overall Study|Other incl. Lack of efficacy|4|||
146179271|NCT00309608|527168904|FG002|Overall Study|Other incl. Lack of efficacy|3|||
146179272|NCT00309608|527168905|FG003|Overall Study|Other incl. Lack of efficacy|4|||
146179273|NCT00309608|527168906|FG004|Overall Study|Other incl. Lack of efficacy|0|||
146179274|NCT00127413|527168907|FG000|Overall Study|Lost to Follow-up|6|||
146179275|NCT00127413|527168908|FG001|Overall Study|Lost to Follow-up|4|||
146179276|NCT00127413|527168909|FG002|Overall Study|Lost to Follow-up|8|||
146179277|NCT00127413|527168910|FG003|Overall Study|Lost to Follow-up|2|||
146179278|NCT01051063|527168911|FG000|Overall Study|Death|2|||
146179279|NCT01051063|527168912|FG001|Overall Study|Death|2|||
146179280|NCT01051063|527168911|FG000|Overall Study|Withdrawal by Subject|1|||
146179281|NCT01051063|527168912|FG001|Overall Study|Withdrawal by Subject|1|||
146179282|NCT01051063|527168911|FG000|Overall Study|Termination of the study|5|||
146179283|NCT01051063|527168912|FG001|Overall Study|Termination of the study|0|||
146179284|NCT01051063|527168911|FG000|Overall Study|Moved from the study site area|1|||
146179285|NCT01051063|527168912|FG001|Overall Study|Moved from the study site area|0|||
146179286|NCT01051063|527168911|FG000|Overall Study|Other|1|||
146179287|NCT01051063|527168912|FG001|Overall Study|Other|0|||
146179288|NCT01051063|527168911|FG000|Overall Study|Lost to Follow-up|0|||
146078061|NCT03060551|526805519|FG000|Overall Study|Adverse Event|1|||
146078062|NCT04359901|526805524|FG000|Overall Study|Withdrawal by Subject|0|||
146078063|NCT04359901|526805525|FG001|Overall Study|Withdrawal by Subject|1|||
146078064|NCT04359901|526805524|FG000|Overall Study|Death|6|||
146078065|NCT04359901|526805525|FG001|Overall Study|Death|2|||
146078066|NCT04627285|526805532|FG000|Overall Study|Adverse Event|0|||
146078067|NCT04627285|526805533|FG001|Overall Study|Adverse Event|2|||
146078068|NCT04627285|526805532|FG000|Overall Study|Lost to Follow-up|1|||
146078069|NCT04627285|526805533|FG001|Overall Study|Lost to Follow-up|0|||
146078070|NCT04627285|526805532|FG000|Overall Study|Withdrawal by Subject|1|||
146078071|NCT04627285|526805533|FG001|Overall Study|Withdrawal by Subject|1|||
146078072|NCT04627285|526805532|FG000|Overall Study|Sponsor decision|5|||
146078073|NCT04627285|526805533|FG001|Overall Study|Sponsor decision|0|||
146078074|NCT04627285|526805532|FG000|Overall Study|Participant left country; aunt informed the site|0|||
146078075|NCT04627285|526805533|FG001|Overall Study|Participant left country; aunt informed the site|1|||
146078076|NCT00635219|526807380|FG000|Overall Study|Adverse Event|12|||
146078077|NCT00635219|526807381|FG001|Overall Study|Adverse Event|10|||
146078078|NCT00635219|526807382|FG002|Overall Study|Adverse Event|18|||
146078079|NCT00635219|526807383|FG003|Overall Study|Adverse Event|15|||
146078080|NCT00635219|526807384|FG004|Overall Study|Adverse Event|19|||
146078081|NCT00635219|526807380|FG000|Overall Study|Lack of Efficacy|5|||
146078082|NCT00635219|526807381|FG001|Overall Study|Lack of Efficacy|6|||
146078083|NCT00635219|526807382|FG002|Overall Study|Lack of Efficacy|3|||
146078084|NCT00635219|526807383|FG003|Overall Study|Lack of Efficacy|4|||
146078085|NCT00635219|526807384|FG004|Overall Study|Lack of Efficacy|6|||
146078086|NCT00635219|526807380|FG000|Overall Study|Non-compliance With Study Product|0|||
146078087|NCT00635219|526807381|FG001|Overall Study|Non-compliance With Study Product|0|||
146078088|NCT00635219|526807382|FG002|Overall Study|Non-compliance With Study Product|0|||
146078089|NCT00635219|526807383|FG003|Overall Study|Non-compliance With Study Product|2|||
146078090|NCT00635219|526807384|FG004|Overall Study|Non-compliance With Study Product|1|||
146078091|NCT00635219|526807380|FG000|Overall Study|Protocol Violation|0|||
146078092|NCT00635219|526807381|FG001|Overall Study|Protocol Violation|2|||
146078093|NCT00635219|526807382|FG002|Overall Study|Protocol Violation|3|||
146078094|NCT00635219|526807383|FG003|Overall Study|Protocol Violation|2|||
146078095|NCT00635219|526807384|FG004|Overall Study|Protocol Violation|4|||
146078096|NCT00635219|526807380|FG000|Overall Study|Withdrawal of Consent|8|||
146078097|NCT00635219|526807381|FG001|Overall Study|Withdrawal of Consent|6|||
146078098|NCT00635219|526807382|FG002|Overall Study|Withdrawal of Consent|8|||
146078099|NCT00635219|526807383|FG003|Overall Study|Withdrawal of Consent|11|||
146078100|NCT00635219|526807384|FG004|Overall Study|Withdrawal of Consent|8|||
146078101|NCT00635219|526807380|FG000|Overall Study|Lost to Follow-up|0|||
146078102|NCT00635219|526807381|FG001|Overall Study|Lost to Follow-up|0|||
146078103|NCT00635219|526807382|FG002|Overall Study|Lost to Follow-up|2|||
146078104|NCT00635219|526807383|FG003|Overall Study|Lost to Follow-up|0|||
146078105|NCT00635219|526807384|FG004|Overall Study|Lost to Follow-up|3|||
146078106|NCT00635219|526807380|FG000|Overall Study|Administrative or Other Reasons|0|||
146078107|NCT00635219|526807381|FG001|Overall Study|Administrative or Other Reasons|1|||
146078108|NCT00635219|526807382|FG002|Overall Study|Administrative or Other Reasons|1|||
146078109|NCT00635219|526807383|FG003|Overall Study|Administrative or Other Reasons|0|||
146078110|NCT00635219|526807384|FG004|Overall Study|Administrative or Other Reasons|1|||
146078111|NCT01639729|526807385|FG000|Overall Study|Withdrawal by Subject|1|||
146078112|NCT01639729|526807386|FG001|Overall Study|Withdrawal by Subject|0|||
146078113|NCT01639729|526807387|FG002|Overall Study|Withdrawal by Subject|1|||
146078114|NCT01639729|526807388|FG003|Overall Study|Withdrawal by Subject|1|||
146078115|NCT01639729|526807389|FG004|Overall Study|Withdrawal by Subject|0|||
146078116|NCT01639729|526807390|FG005|Overall Study|Withdrawal by Subject|0|||
146078117|NCT00759564|526807391|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
146078118|NCT00759564|526807392|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
146078119|NCT00759564|526807393|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
146078120|NCT00759564|526807394|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
146078121|NCT00759564|526807395|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
146078122|NCT04145219|526807396|FG000|Overall Study|Adverse Event|18|||
146078123|NCT04145219|526807397|FG001|Overall Study|Adverse Event|6|||
146078124|NCT04145219|526807396|FG000|Overall Study|Lost to Follow-up|2|||
146078125|NCT04145219|526807397|FG001|Overall Study|Lost to Follow-up|3|||
146078126|NCT04145219|526807396|FG000|Overall Study|Physician Decision|0|||
146078127|NCT04145219|526807397|FG001|Overall Study|Physician Decision|2|||
146078128|NCT04145219|526807396|FG000|Overall Study|Withdrawal by Subject|12|||
146078129|NCT04145219|526807397|FG001|Overall Study|Withdrawal by Subject|8|||
146078130|NCT04145219|526807396|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
146078131|NCT04145219|526807397|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
146078132|NCT01640314|526807398|FG000|Overall Study|Protocol Violation|0|||
146078133|NCT01640314|526807399|FG001|Overall Study|Protocol Violation|1|||
146078134|NCT01290796|526807400|FG000|Overall Study|Lost to Follow-up|21|||
146078135|NCT01290796|526807400|FG000|Overall Study|Withdrawal by Subject|4|||
146078136|NCT01290796|526807400|FG000|Overall Study|Physician Decision|2|||
146078137|NCT01290796|526807400|FG000|Overall Study|Secondary Surgical Intervention|2|||
146078138|NCT01290796|526807400|FG000|Overall Study|Withdrawal by Sponsor|1|||
146078139|NCT02709538|526807402|FG000|Overall Study|Adverse Event|13|||
146078140|NCT02709538|526807403|FG001|Overall Study|Adverse Event|2|||
146078141|NCT02709538|526807404|FG002|Overall Study|Adverse Event|3|||
146078142|NCT02709538|526807402|FG000|Overall Study|Lack of Efficacy|1|||
146078143|NCT02709538|526807403|FG001|Overall Study|Lack of Efficacy|0|||
146078144|NCT02709538|526807404|FG002|Overall Study|Lack of Efficacy|0|||
146078145|NCT02709538|526807402|FG000|Overall Study|Lost to Follow-up|24|||
146078146|NCT02709538|526807403|FG001|Overall Study|Lost to Follow-up|8|||
146078147|NCT02709538|526807404|FG002|Overall Study|Lost to Follow-up|4|||
146078148|NCT02709538|526807402|FG000|Overall Study|Physician Decision|1|||
146078149|NCT02709538|526807403|FG001|Overall Study|Physician Decision|0|||
146078150|NCT02709538|526807404|FG002|Overall Study|Physician Decision|0|||
146078151|NCT02709538|526807402|FG000|Overall Study|Withdrawal by Subject|40|||
146078152|NCT02709538|526807403|FG001|Overall Study|Withdrawal by Subject|7|||
146078153|NCT02709538|526807404|FG002|Overall Study|Withdrawal by Subject|4|||
146078154|NCT02709538|526807402|FG000|Overall Study|Non-compliance with study procedures|5|||
146078155|NCT02709538|526807403|FG001|Overall Study|Non-compliance with study procedures|0|||
146078156|NCT02709538|526807404|FG002|Overall Study|Non-compliance with study procedures|0|||
146078157|NCT02709538|526807402|FG000|Overall Study|Non-compliance with study drug|2|||
146078158|NCT02709538|526807403|FG001|Overall Study|Non-compliance with study drug|0|||
146078159|NCT02709538|526807404|FG002|Overall Study|Non-compliance with study drug|0|||
146179289|NCT01051063|527168912|FG001|Overall Study|Lost to Follow-up|1|||
146078160|NCT02709538|526807402|FG000|Overall Study|Protocol deviation|10|||
146078161|NCT02709538|526807403|FG001|Overall Study|Protocol deviation|4|||
146078162|NCT02709538|526807404|FG002|Overall Study|Protocol deviation|4|||
146078163|NCT02709538|526807402|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
146078164|NCT02709538|526807403|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
146078165|NCT02709538|526807404|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
146078166|NCT02709538|526807402|FG000|Overall Study|Other|16|||
146078167|NCT02709538|526807403|FG001|Overall Study|Other|7|||
146078168|NCT02709538|526807404|FG002|Overall Study|Other|5|||
146078169|NCT00835211|526807405|FG000|First Intervention|Withdrawal by Subject|0|||
146078170|NCT00835211|526807406|FG001|First Intervention|Withdrawal by Subject|1|||
146078171|NCT00835211|526807405|FG000|Washout: 7 Days|Adverse Event|2|||
146078172|NCT00835211|526807406|FG001|Washout: 7 Days|Adverse Event|1|||
146078173|NCT00835211|526807405|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146078174|NCT00835211|526807406|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146078175|NCT02343549|526807408|FG000|Overall Study|Death|11|||
146078176|NCT02343549|526807408|FG000|Overall Study|Withdrawal by Subject|2|||
146078177|NCT02160041|526807409|FG000|Overall Study|Adverse Event|11|||
146078178|NCT02160041|526807409|FG000|Overall Study|Death|2|||
146078179|NCT02160041|526807409|FG000|Overall Study|disease progression|57|||
146078180|NCT02160041|526807409|FG000|Overall Study|Protocol Violation|1|||
146078181|NCT02160041|526807409|FG000|Overall Study|non-compliance with study|1|||
146078182|NCT02160041|526807409|FG000|Overall Study|Physician Decision|3|||
146078183|NCT02160041|526807409|FG000|Overall Study|Withdrawal by Subject|8|||
146078184|NCT02160041|526807409|FG000|Overall Study|study terminated by by sponsor|1|||
146078185|NCT01403948|526807410|FG000|Overall Study|Progressive disease|0|||
146078186|NCT01403948|526807411|FG001|Overall Study|Progressive disease|2|||
146078187|NCT01403948|526807412|FG002|Overall Study|Progressive disease|2|||
146078188|NCT01403948|526807413|FG003|Overall Study|Progressive disease|4|||
146078189|NCT01403948|526807414|FG004|Overall Study|Progressive disease|2|||
146078190|NCT01403948|526807415|FG005|Overall Study|Progressive disease|6|||
146078191|NCT01403948|526807416|FG006|Overall Study|Progressive disease|2|||
146078192|NCT01403948|526807417|FG007|Overall Study|Progressive disease|4|||
146078193|NCT01403948|526807418|FG008|Overall Study|Progressive disease|5|||
146078194|NCT01403948|526807419|FG009|Overall Study|Progressive disease|5|||
146078195|NCT01403948|526807410|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078196|NCT01403948|526807411|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078197|NCT01403948|526807412|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078198|NCT01403948|526807413|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078199|NCT01403948|526807414|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
146078200|NCT01403948|526807415|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078201|NCT01403948|526807416|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
146078202|NCT01403948|526807417|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078203|NCT01403948|526807418|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
146078204|NCT01403948|526807419|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
146078205|NCT01403948|526807410|FG000|Overall Study|Lost to Follow-up|0|||
146078206|NCT01403948|526807411|FG001|Overall Study|Lost to Follow-up|0|||
146078207|NCT01403948|526807412|FG002|Overall Study|Lost to Follow-up|0|||
146078208|NCT01403948|526807413|FG003|Overall Study|Lost to Follow-up|0|||
146078209|NCT01403948|526807414|FG004|Overall Study|Lost to Follow-up|0|||
146078210|NCT01403948|526807415|FG005|Overall Study|Lost to Follow-up|0|||
146078211|NCT01403948|526807416|FG006|Overall Study|Lost to Follow-up|0|||
146078212|NCT01403948|526807417|FG007|Overall Study|Lost to Follow-up|0|||
146078213|NCT01403948|526807418|FG008|Overall Study|Lost to Follow-up|0|||
146078214|NCT01403948|526807419|FG009|Overall Study|Lost to Follow-up|1|||
146078215|NCT01403948|526807410|FG000|Overall Study|Refused cont. medication|0|||
146078216|NCT01403948|526807411|FG001|Overall Study|Refused cont. medication|0|||
146078217|NCT01403948|526807412|FG002|Overall Study|Refused cont. medication|0|||
146078218|NCT01403948|526807413|FG003|Overall Study|Refused cont. medication|0|||
146078219|NCT01403948|526807414|FG004|Overall Study|Refused cont. medication|1|||
146179290|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
146179291|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
146179292|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
146179293|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
146179294|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
146179295|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
146179296|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
146179297|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
146179298|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
146179299|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
146179300|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
146179301|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
146179302|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
146179303|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
146179304|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
146179305|NCT02023879|527168915|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
146179306|NCT02023879|527168916|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
146179307|NCT02023879|527168917|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
146179308|NCT02023879|527168915|FG000|Extension Open Label Treatment|Adverse Event|1|||
146179309|NCT02023879|527168916|FG001|Extension Open Label Treatment|Adverse Event|7|||
146179310|NCT02023879|527168917|FG002|Extension Open Label Treatment|Adverse Event|3|||
146179311|NCT02023879|527168915|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
146179312|NCT02023879|527168916|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
146179313|NCT02023879|527168917|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
146179314|NCT02023879|527168915|FG000|Extension Open Label Treatment|Participant moved|1|||
146179315|NCT02023879|527168916|FG001|Extension Open Label Treatment|Participant moved|2|||
146179316|NCT02023879|527168917|FG002|Extension Open Label Treatment|Participant moved|0|||
146179317|NCT02023879|527168915|FG000|Extension Open Label Treatment|Other than specified above|2|||
146179318|NCT02023879|527168916|FG001|Extension Open Label Treatment|Other than specified above|7|||
146179319|NCT02023879|527168917|FG002|Extension Open Label Treatment|Other than specified above|2|||
146179320|NCT00874432|527168918|FG000|Overall Study|Withdrawal by Subject|1|||
146179321|NCT00874432|527168919|FG001|Overall Study|Withdrawal by Subject|0|||
146179322|NCT00874432|527168920|FG002|Overall Study|Withdrawal by Subject|0|||
146179323|NCT00874432|527168921|FG003|Overall Study|Withdrawal by Subject|0|||
146179324|NCT00874432|527168918|FG000|Overall Study|Physician Decision|1|||
146179325|NCT00874432|527168919|FG001|Overall Study|Physician Decision|0|||
146179326|NCT00874432|527168920|FG002|Overall Study|Physician Decision|0|||
146179327|NCT00874432|527168921|FG003|Overall Study|Physician Decision|0|||
146179328|NCT00874432|527168918|FG000|Overall Study|Other|1|||
146179329|NCT00874432|527168919|FG001|Overall Study|Other|2|||
146179330|NCT00874432|527168920|FG002|Overall Study|Other|8|||
146179331|NCT00874432|527168921|FG003|Overall Study|Other|3|||
146179332|NCT03713021|527168922|FG000|Overall Study|Did not have CT sim scan available|6|||
146179333|NCT03713021|527168922|FG000|Overall Study|Not eligible|4|||
146179334|NCT03713021|527168922|FG000|Overall Study|Issues with TraceIT markers|5|||
146179335|NCT05256381|527168923|FG000|Overall Study|Withdrawal by Subject|4|||
146179336|NCT05256381|527168924|FG001|Overall Study|Withdrawal by Subject|0|||
146179337|NCT05256381|527168925|FG002|Overall Study|Withdrawal by Subject|2|||
146179338|NCT05256381|527168926|FG003|Overall Study|Withdrawal by Subject|2|||
146179339|NCT05256381|527168927|FG004|Overall Study|Withdrawal by Subject|8|||
146179340|NCT05256381|527168928|FG005|Overall Study|Withdrawal by Subject|6|||
146179341|NCT05256381|527168923|FG000|Overall Study|Physician Decision|0|||
146179342|NCT05256381|527168924|FG001|Overall Study|Physician Decision|0|||
146179343|NCT05256381|527168925|FG002|Overall Study|Physician Decision|1|||
146179344|NCT05256381|527168926|FG003|Overall Study|Physician Decision|0|||
146179345|NCT05256381|527168927|FG004|Overall Study|Physician Decision|2|||
146179346|NCT05256381|527168928|FG005|Overall Study|Physician Decision|0|||
146179347|NCT05256381|527168923|FG000|Overall Study|Death|17|||
146179348|NCT05256381|527168924|FG001|Overall Study|Death|3|||
146179349|NCT05256381|527168925|FG002|Overall Study|Death|4|||
146179350|NCT05256381|527168926|FG003|Overall Study|Death|5|||
146179351|NCT05256381|527168927|FG004|Overall Study|Death|24|||
146179352|NCT05256381|527168928|FG005|Overall Study|Death|21|||
146179353|NCT05256381|527168923|FG000|Overall Study|Other, not specified|0|||
146179354|NCT05256381|527168924|FG001|Overall Study|Other, not specified|0|||
146179355|NCT05256381|527168925|FG002|Overall Study|Other, not specified|0|||
146179356|NCT05256381|527168926|FG003|Overall Study|Other, not specified|0|||
146179357|NCT05256381|527168927|FG004|Overall Study|Other, not specified|2|||
146179358|NCT05256381|527168928|FG005|Overall Study|Other, not specified|1|||
146179359|NCT05256381|527168923|FG000|Overall Study|Study terminated by sponsor|18|||
146179360|NCT05256381|527168924|FG001|Overall Study|Study terminated by sponsor|5|||
146179361|NCT05256381|527168925|FG002|Overall Study|Study terminated by sponsor|5|||
146179362|NCT05256381|527168926|FG003|Overall Study|Study terminated by sponsor|5|||
146179363|NCT05256381|527168927|FG004|Overall Study|Study terminated by sponsor|18|||
146179364|NCT05256381|527168928|FG005|Overall Study|Study terminated by sponsor|11|||
146179365|NCT05256381|527168923|FG000|Overall Study|Lost to Follow-up|1|||
146179366|NCT05256381|527168924|FG001|Overall Study|Lost to Follow-up|0|||
146179367|NCT05256381|527168925|FG002|Overall Study|Lost to Follow-up|0|||
146179368|NCT05256381|527168926|FG003|Overall Study|Lost to Follow-up|0|||
146179369|NCT05256381|527168927|FG004|Overall Study|Lost to Follow-up|1|||
146179370|NCT05256381|527168928|FG005|Overall Study|Lost to Follow-up|0|||
146179371|NCT04213989|527170796|FG000|Overall Study|Withdrawal by Subject|3|||
146179372|NCT04213989|527170797|FG001|Overall Study|Withdrawal by Subject|2|||
146179373|NCT04213989|527170796|FG000|Overall Study|Physician Decision|1|||
146179374|NCT04213989|527170797|FG001|Overall Study|Physician Decision|0|||
146179375|NCT04213989|527170796|FG000|Overall Study|Lost to Follow-up|0|||
146179376|NCT04213989|527170797|FG001|Overall Study|Lost to Follow-up|4|||
146179377|NCT03390036|527170803|FG000|Overall Study|Lost to Follow-up|1|||
146179378|NCT03390036|527170804|FG001|Overall Study|Lost to Follow-up|0|||
146179379|NCT03390036|527170805|FG002|Overall Study|Lost to Follow-up|0|||
146179380|NCT03390036|527170803|FG000|Overall Study|Lack of Efficacy|1|||
146179381|NCT03390036|527170804|FG001|Overall Study|Lack of Efficacy|0|||
146179382|NCT03390036|527170805|FG002|Overall Study|Lack of Efficacy|0|||
146179383|NCT00744237|527170808|FG000|Overall Study|Lack of Efficacy|1|||
146179384|NCT00744237|527170809|FG001|Overall Study|Lack of Efficacy|1|||
146179385|NCT00744237|527170810|FG002|Overall Study|Lack of Efficacy|0|||
146179386|NCT00744237|527170808|FG000|Overall Study|Withdrawal by Subject|9|||
146179387|NCT00744237|527170809|FG001|Overall Study|Withdrawal by Subject|5|||
146179388|NCT00744237|527170810|FG002|Overall Study|Withdrawal by Subject|3|||
146179389|NCT00744237|527170808|FG000|Overall Study|Lost to Follow-up|1|||
146179390|NCT00744237|527170809|FG001|Overall Study|Lost to Follow-up|1|||
146179391|NCT00744237|527170810|FG002|Overall Study|Lost to Follow-up|1|||
146179392|NCT00744237|527170808|FG000|Overall Study|Protocol Violation|3|||
146179393|NCT00744237|527170809|FG001|Overall Study|Protocol Violation|4|||
146179394|NCT00744237|527170810|FG002|Overall Study|Protocol Violation|3|||
146179395|NCT00744237|527170808|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
146179396|NCT00744237|527170809|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
146179397|NCT00744237|527170810|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
146179398|NCT00744237|527170808|FG000|Overall Study|Dosing Error|1|||
146179399|NCT00744237|527170809|FG001|Overall Study|Dosing Error|0|||
146179400|NCT00744237|527170810|FG002|Overall Study|Dosing Error|1|||
146179401|NCT00744237|527170808|FG000|Overall Study|Study Drug Error|1|||
146179402|NCT00744237|527170809|FG001|Overall Study|Study Drug Error|0|||
146179403|NCT00744237|527170810|FG002|Overall Study|Study Drug Error|0|||
146179404|NCT00744237|527170808|FG000|Overall Study|Prohibited Concomitant Medication|0|||
146179405|NCT00744237|527170809|FG001|Overall Study|Prohibited Concomitant Medication|0|||
146179406|NCT00744237|527170810|FG002|Overall Study|Prohibited Concomitant Medication|1|||
146179407|NCT00744237|527170808|FG000|Overall Study|Poor Compliance|0|||
146179408|NCT00744237|527170809|FG001|Overall Study|Poor Compliance|2|||
146179409|NCT00744237|527170810|FG002|Overall Study|Poor Compliance|0|||
146179410|NCT00744237|527170808|FG000|Overall Study|Administrative. Site Closed|1|||
146179411|NCT00744237|527170809|FG001|Overall Study|Administrative. Site Closed|1|||
146179412|NCT00744237|527170810|FG002|Overall Study|Administrative. Site Closed|1|||
146179413|NCT00744237|527170808|FG000|Overall Study|Adverse Event|9|||
146179414|NCT00744237|527170809|FG001|Overall Study|Adverse Event|13|||
146179415|NCT00744237|527170810|FG002|Overall Study|Adverse Event|5|||
146179416|NCT01984424|527170811|FG000|Overall Study|Withdrawal by Subject|3|||
146179417|NCT01984424|527170812|FG001|Overall Study|Withdrawal by Subject|5|||
146179418|NCT01984424|527170811|FG000|Overall Study|Sponsor Decision|0|||
146179419|NCT01984424|527170812|FG001|Overall Study|Sponsor Decision|1|||
146179420|NCT01984424|527170811|FG000|Overall Study|Lost to Follow-up|0|||
146412098|NCT01205529|528014029|FG000|Overall Study|Unstable post op|15|||
146179421|NCT01984424|527170812|FG001|Overall Study|Lost to Follow-up|1|||
146179422|NCT01807221|527170813|FG000|Overall Study|Progressive disease|1|||
146179423|NCT01807221|527170814|FG001|Overall Study|Progressive disease|0|||
146179424|NCT01807221|527170815|FG002|Overall Study|Progressive disease|1|||
146179425|NCT01807221|527170816|FG003|Overall Study|Progressive disease|0|||
146179426|NCT01807221|527170817|FG004|Overall Study|Progressive disease|0|||
146179427|NCT01807221|527170818|FG005|Overall Study|Progressive disease|0|||
146179428|NCT01807221|527170813|FG000|Overall Study|Death|7|||
146179429|NCT01807221|527170814|FG001|Overall Study|Death|9|||
146179430|NCT01807221|527170815|FG002|Overall Study|Death|4|||
146179431|NCT01807221|527170816|FG003|Overall Study|Death|2|||
146179432|NCT01807221|527170817|FG004|Overall Study|Death|1|||
146179433|NCT01807221|527170818|FG005|Overall Study|Death|6|||
146179434|NCT01807221|527170813|FG000|Overall Study|Physician Decision|2|||
146412099|NCT01205529|528014029|FG000|Overall Study|No longer met criteria|30|||
146078220|NCT01403948|526807415|FG005|Overall Study|Refused cont. medication|0|||
146078221|NCT01403948|526807416|FG006|Overall Study|Refused cont. medication|0|||
146078222|NCT01403948|526807417|FG007|Overall Study|Refused cont. medication|0|||
146078223|NCT01403948|526807418|FG008|Overall Study|Refused cont. medication|0|||
146078224|NCT01403948|526807419|FG009|Overall Study|Refused cont. medication|1|||
146078225|NCT01403948|526807410|FG000|Overall Study|other than above|1|||
146078226|NCT01403948|526807411|FG001|Overall Study|other than above|2|||
146078227|NCT01403948|526807412|FG002|Overall Study|other than above|1|||
146078228|NCT01403948|526807413|FG003|Overall Study|other than above|0|||
146078229|NCT01403948|526807414|FG004|Overall Study|other than above|1|||
146078230|NCT01403948|526807415|FG005|Overall Study|other than above|1|||
146078231|NCT01403948|526807416|FG006|Overall Study|other than above|2|||
146078232|NCT01403948|526807417|FG007|Overall Study|other than above|0|||
146078233|NCT01403948|526807418|FG008|Overall Study|other than above|0|||
146078234|NCT01403948|526807419|FG009|Overall Study|other than above|0|||
146078235|NCT04450381|526807420|FG000|Overall Study|Protocol Violation|4|||
146078236|NCT04450381|526807420|FG000|Overall Study|Wrong device setting|2|||
146078237|NCT01090323|526807421|FG000|Overall Study|Adverse Event|12|||
146078238|NCT01090323|526807422|FG001|Overall Study|Adverse Event|2|||
146078239|NCT01090323|526807421|FG000|Overall Study|Abnormal Lab Values|3|||
146078240|NCT01090323|526807422|FG001|Overall Study|Abnormal Lab Values|1|||
146078241|NCT01090323|526807421|FG000|Overall Study|Abnormal Test Procedure Results|2|||
146078242|NCT01090323|526807422|FG001|Overall Study|Abnormal Test Procedure Results|0|||
146078243|NCT01090323|526807421|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146078244|NCT01090323|526807422|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146078245|NCT01090323|526807421|FG000|Overall Study|Condition no longer requires drug|5|||
146078246|NCT01090323|526807422|FG001|Overall Study|Condition no longer requires drug|4|||
146078247|NCT01090323|526807421|FG000|Overall Study|Protocol Violation|2|||
146078248|NCT01090323|526807422|FG001|Overall Study|Protocol Violation|1|||
146078249|NCT01090323|526807421|FG000|Overall Study|Withdrew consent|33|||
146078250|NCT01090323|526807422|FG001|Overall Study|Withdrew consent|11|||
146078251|NCT01090323|526807421|FG000|Overall Study|Lost to Follow-up|11|||
146078252|NCT01090323|526807422|FG001|Overall Study|Lost to Follow-up|6|||
146078253|NCT01090323|526807421|FG000|Overall Study|Administrative problems|6|||
146078254|NCT01090323|526807422|FG001|Overall Study|Administrative problems|4|||
146078255|NCT01090323|526807421|FG000|Overall Study|Death|1|||
146078256|NCT01090323|526807422|FG001|Overall Study|Death|2|||
146078257|NCT01090323|526807421|FG000|Overall Study|Stopped end of core|7|||
146078258|NCT01090323|526807422|FG001|Overall Study|Stopped end of core|0|||
146078259|NCT01090323|526807421|FG000|Overall Study|Stopped end of extension 1#|3|||
146078260|NCT01090323|526807422|FG001|Overall Study|Stopped end of extension 1#|1|||
146078261|NCT05498701|526807423|FG000|Period 3|Adverse Event|1|||
146078262|NCT05498701|526807424|FG001|Period 3|Adverse Event|0|||
146078263|NCT01864005|526807425|FG000|Overall Study|Protocol Violation|0|||
146078264|NCT01864005|526807426|FG001|Overall Study|Protocol Violation|1|||
146179435|NCT01807221|527170814|FG001|Overall Study|Physician Decision|1|||
146179436|NCT01807221|527170815|FG002|Overall Study|Physician Decision|0|||
146078265|NCT01864005|526807425|FG000|Overall Study|Withdrawal by Subject|0|||
146078266|NCT01864005|526807426|FG001|Overall Study|Withdrawal by Subject|1|||
146078267|NCT01864005|526807425|FG000|Overall Study|Incorrect enrolment|1|||
146078268|NCT01864005|526807426|FG001|Overall Study|Incorrect enrolment|0|||
146078269|NCT01864005|526807425|FG000|Overall Study|Disease need|1|||
146078270|NCT01864005|526807426|FG001|Overall Study|Disease need|1|||
146078271|NCT01864005|526807425|FG000|Overall Study|Need GP IIb/IIIa|1|||
146078272|NCT01864005|526807426|FG001|Overall Study|Need GP IIb/IIIa|3|||
146078273|NCT00763698|526807432|FG000|Overall Study|Unsuccessful Implant|5|||
146078274|NCT00763698|526807432|FG000|Overall Study|Death|4|||
146078275|NCT00763698|526807432|FG000|Overall Study|Withdrawal by Subject|1|||
146078276|NCT02184572|526807433|FG000|Overall Study|Lost to Follow-up|29|||
146078277|NCT02184572|526807434|FG001|Overall Study|Lost to Follow-up|21|||
146078278|NCT02184572|526807433|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
146078279|NCT02184572|526807434|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
146078280|NCT02184572|526807433|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
146078281|NCT02184572|526807434|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
146078282|NCT02184572|526807433|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
146078283|NCT02184572|526807434|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
146078284|NCT02184572|526807433|FG000|Overall Study|Traveling Outside The Country|1|||
146078285|NCT02184572|526807434|FG001|Overall Study|Traveling Outside The Country|0|||
146078286|NCT02184572|526807433|FG000|Overall Study|Withdrawal by Subject|14|||
146078287|NCT02184572|526807434|FG001|Overall Study|Withdrawal by Subject|9|||
146078288|NCT00638183|526807438|FG000|Overall Study|Adverse Event|23|||
146078289|NCT00638183|526807438|FG000|Overall Study|Lack of Efficacy|14|||
146078290|NCT00638183|526807438|FG000|Overall Study|Physician Decision|9|||
146078291|NCT00638183|526807438|FG000|Overall Study|Lost to Follow-up|46|||
146078292|NCT00638183|526807438|FG000|Overall Study|Other reason not defined above|27|||
146078293|NCT00006409|526807439|FG000|Baseline|Protocol Violation|48|||
146078294|NCT00006409|526807440|FG001|Baseline|Protocol Violation|70|||
146078295|NCT00006409|526807441|FG002|Baseline|Protocol Violation|0|||
146078296|NCT00006409|526807442|FG003|Baseline|Protocol Violation|0|||
146078297|NCT00006409|526807443|FG004|Baseline|Protocol Violation|0|||
146078298|NCT00006409|526807444|FG005|Baseline|Protocol Violation|0|||
146078299|NCT00006409|526807439|FG000|Post-2 Year Intervention|Protocol Violation|0|||
146078300|NCT00006409|526807440|FG001|Post-2 Year Intervention|Protocol Violation|0|||
146078301|NCT00006409|526807441|FG002|Post-2 Year Intervention|Protocol Violation|251|||
146078302|NCT00006409|526807442|FG003|Post-2 Year Intervention|Protocol Violation|168|||
146078303|NCT00006409|526807443|FG004|Post-2 Year Intervention|Protocol Violation|0|||
146078304|NCT00006409|526807444|FG005|Post-2 Year Intervention|Protocol Violation|0|||
146078305|NCT00006409|526807439|FG000|Post-3 Year Intervention|Protocol Violation|0|||
146078306|NCT00006409|526807440|FG001|Post-3 Year Intervention|Protocol Violation|0|||
146078307|NCT00006409|526807441|FG002|Post-3 Year Intervention|Protocol Violation|0|||
146078308|NCT00006409|526807442|FG003|Post-3 Year Intervention|Protocol Violation|0|||
146078309|NCT00006409|526807443|FG004|Post-3 Year Intervention|Protocol Violation|62|||
146078310|NCT00006409|526807444|FG005|Post-3 Year Intervention|Protocol Violation|62|||
146078311|NCT01433289|526807445|FG000|Overall Study|Pregnancy|0|||
146078312|NCT01433289|526807446|FG001|Overall Study|Pregnancy|1|||
146078313|NCT01433289|526807447|FG002|Overall Study|Pregnancy|0|||
146078314|NCT01433289|526807448|FG003|Overall Study|Pregnancy|0|||
146078315|NCT04973436|526807452|FG000|Overall Study|Lost to Follow-up|3|||
146078316|NCT04973436|526807452|FG000|Overall Study|Withdrawal by Subject|1|||
146078317|NCT04973436|526807452|FG000|Overall Study|Death|2|||
146078318|NCT01788215|526807456|FG000|Overall Study|Withdrawal by Subject|0|||
146078319|NCT01788215|526807457|FG001|Overall Study|Withdrawal by Subject|1|||
146078320|NCT01788215|526807456|FG000|Overall Study|Lost to Follow-up|2|||
146078321|NCT01788215|526807457|FG001|Overall Study|Lost to Follow-up|0|||
146078322|NCT02365480|526807462|FG000|Overall Study|Withdrawal by Subject|2|||
146078323|NCT02365480|526807463|FG001|Overall Study|Withdrawal by Subject|0|||
146078324|NCT03091348|526807464|FG000|Overall Study|Lost to Follow-up|2|||
146078325|NCT03091348|526807465|FG001|Overall Study|Lost to Follow-up|1|||
146078326|NCT00706342|526807466|FG000|Overall Study|Adverse Event|3|||
146078327|NCT00706342|526807466|FG000|Overall Study|Not responding to treatment|2|||
146078328|NCT00706342|526807466|FG000|Overall Study|Withdrawn due to failure to respond|1|||
146078329|NCT00706342|526807466|FG000|Overall Study|Death|1|||
146078330|NCT00706342|526807466|FG000|Overall Study|Withdrew from the study on his own.|1|||
146078331|NCT00706342|526807466|FG000|Overall Study|Investigator discretion|2|||
146078332|NCT00706342|526807466|FG000|Overall Study|Non-responder Week 12|1|||
146078333|NCT00706342|526807466|FG000|Overall Study|Ongoing|6|||
146078334|NCT00706342|526807466|FG000|Overall Study|WIthdrawal of consent|1|||
146078335|NCT04534686|526807467|FG000|Baseline Measurement|Lost to Follow-up|4|||
146078336|NCT04534686|526807468|FG001|Baseline Measurement|Lost to Follow-up|6|||
146078337|NCT04534686|526807467|FG000|Baseline Measurement|Withdrawal by Subject|3|||
146078338|NCT04534686|526807468|FG001|Baseline Measurement|Withdrawal by Subject|1|||
146412100|NCT03840135|528014030|FG000|Overall Study|Protocol Violation|6|||
146078339|NCT04534686|526807467|FG000|Intervention|Withdrawal by Subject|2|||
146078340|NCT04534686|526807468|FG001|Intervention|Withdrawal by Subject|2|||
146078341|NCT01419197|526807473|FG000|Overall Study|Death|247|||
146412101|NCT03840135|528014031|FG001|Overall Study|Protocol Violation|1|||
146412102|NCT03840135|528014030|FG000|Overall Study|Withdrawal by Subject|1|||
146412103|NCT03840135|528014031|FG001|Overall Study|Withdrawal by Subject|0|||
146179437|NCT01807221|527170816|FG003|Overall Study|Physician Decision|0|||
146179438|NCT01807221|527170817|FG004|Overall Study|Physician Decision|0|||
146179439|NCT01807221|527170818|FG005|Overall Study|Physician Decision|0|||
146179440|NCT01807221|527170813|FG000|Overall Study|Adverse Event|33|||
146179441|NCT01807221|527170814|FG001|Overall Study|Adverse Event|22|||
146179442|NCT01807221|527170815|FG002|Overall Study|Adverse Event|26|||
146179443|NCT01807221|527170816|FG003|Overall Study|Adverse Event|25|||
146179444|NCT01807221|527170817|FG004|Overall Study|Adverse Event|18|||
146179445|NCT01807221|527170818|FG005|Overall Study|Adverse Event|21|||
146179446|NCT01807221|527170813|FG000|Overall Study|Protocol Violation|0|||
146179447|NCT01807221|527170814|FG001|Overall Study|Protocol Violation|2|||
146179448|NCT01807221|527170815|FG002|Overall Study|Protocol Violation|1|||
146179449|NCT01807221|527170816|FG003|Overall Study|Protocol Violation|2|||
146179450|NCT01807221|527170817|FG004|Overall Study|Protocol Violation|0|||
146179451|NCT01807221|527170818|FG005|Overall Study|Protocol Violation|1|||
146179452|NCT01807221|527170813|FG000|Overall Study|Non-compliance|1|||
146179453|NCT01807221|527170814|FG001|Overall Study|Non-compliance|2|||
146179454|NCT01807221|527170815|FG002|Overall Study|Non-compliance|0|||
146179455|NCT01807221|527170816|FG003|Overall Study|Non-compliance|1|||
146179456|NCT01807221|527170817|FG004|Overall Study|Non-compliance|0|||
146179457|NCT01807221|527170818|FG005|Overall Study|Non-compliance|0|||
146179458|NCT01807221|527170813|FG000|Overall Study|Logistical difficulties|0|||
146179459|NCT01807221|527170814|FG001|Overall Study|Logistical difficulties|1|||
146179460|NCT01807221|527170815|FG002|Overall Study|Logistical difficulties|0|||
146179461|NCT01807221|527170816|FG003|Overall Study|Logistical difficulties|0|||
146179462|NCT01807221|527170817|FG004|Overall Study|Logistical difficulties|1|||
146179463|NCT01807221|527170818|FG005|Overall Study|Logistical difficulties|0|||
146179464|NCT01807221|527170813|FG000|Overall Study|Withdrawal by Subject|33|||
146179465|NCT01807221|527170814|FG001|Overall Study|Withdrawal by Subject|15|||
146179466|NCT01807221|527170815|FG002|Overall Study|Withdrawal by Subject|8|||
146179467|NCT01807221|527170816|FG003|Overall Study|Withdrawal by Subject|14|||
146179468|NCT01807221|527170817|FG004|Overall Study|Withdrawal by Subject|16|||
146179469|NCT01807221|527170818|FG005|Overall Study|Withdrawal by Subject|13|||
146179470|NCT01807221|527170813|FG000|Overall Study|Sponsor decision|2|||
146179471|NCT01807221|527170814|FG001|Overall Study|Sponsor decision|0|||
146179472|NCT01807221|527170815|FG002|Overall Study|Sponsor decision|1|||
146179473|NCT01807221|527170816|FG003|Overall Study|Sponsor decision|1|||
146179474|NCT01807221|527170817|FG004|Overall Study|Sponsor decision|0|||
146179475|NCT01807221|527170818|FG005|Overall Study|Sponsor decision|0|||
146179476|NCT01807221|527170813|FG000|Overall Study|Lost to Follow-up|1|||
146179477|NCT01807221|527170814|FG001|Overall Study|Lost to Follow-up|0|||
146179478|NCT01807221|527170815|FG002|Overall Study|Lost to Follow-up|2|||
146179479|NCT01807221|527170816|FG003|Overall Study|Lost to Follow-up|1|||
146179480|NCT01807221|527170817|FG004|Overall Study|Lost to Follow-up|0|||
146179481|NCT01807221|527170818|FG005|Overall Study|Lost to Follow-up|0|||
146179482|NCT06017999|527170819|FG000|Overall Study|Withdrawal by Subject|0|||
146179483|NCT06017999|527170820|FG001|Overall Study|Withdrawal by Subject|4|||
146179484|NCT06017999|527170821|FG002|Overall Study|Withdrawal by Subject|3|||
146179485|NCT06017999|527170819|FG000|Overall Study|Adverse Event|2|||
146179486|NCT06017999|527170820|FG001|Overall Study|Adverse Event|1|||
146179487|NCT06017999|527170821|FG002|Overall Study|Adverse Event|1|||
146179488|NCT06017999|527170819|FG000|Overall Study|Lost to Follow-up|0|||
146179489|NCT06017999|527170820|FG001|Overall Study|Lost to Follow-up|0|||
146179490|NCT06017999|527170821|FG002|Overall Study|Lost to Follow-up|1|||
146179491|NCT06017999|527170819|FG000|Overall Study|Physician Decision|1|||
146179492|NCT06017999|527170820|FG001|Overall Study|Physician Decision|1|||
146179493|NCT06017999|527170821|FG002|Overall Study|Physician Decision|0|||
146179494|NCT06017999|527170819|FG000|Overall Study|Non-Compliance|0|||
146179495|NCT06017999|527170820|FG001|Overall Study|Non-Compliance|0|||
146179496|NCT06017999|527170821|FG002|Overall Study|Non-Compliance|1|||
146179497|NCT06017999|527170819|FG000|Overall Study|Lack of Efficacy|1|||
146179498|NCT06017999|527170820|FG001|Overall Study|Lack of Efficacy|0|||
146179499|NCT06017999|527170821|FG002|Overall Study|Lack of Efficacy|7|||
146179500|NCT06017999|527170819|FG000|Overall Study|COVID Positive|0|||
146179501|NCT06017999|527170820|FG001|Overall Study|COVID Positive|1|||
146179502|NCT06017999|527170821|FG002|Overall Study|COVID Positive|0|||
146179503|NCT06017999|527170819|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
146179504|NCT06017999|527170820|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
146179505|NCT06017999|527170821|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
146179506|NCT04338581|527170822|FG000|Overall Study|Lack of Efficacy|1|||
146179507|NCT04338581|527170823|FG001|Overall Study|Lack of Efficacy|0|||
146179508|NCT04338581|527170822|FG000|Overall Study|Withdrawal by Subject|4|||
146179509|NCT04338581|527170823|FG001|Overall Study|Withdrawal by Subject|4|||
146179510|NCT04338581|527170822|FG000|Overall Study|Prohibited Medication|1|||
146179511|NCT04338581|527170823|FG001|Overall Study|Prohibited Medication|0|||
146179512|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
146179513|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
146179514|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
146179515|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
146078342|NCT01419197|526807474|FG001|Overall Study|Death|122|||
146078343|NCT01419197|526807473|FG000|Overall Study|Physician Decision|4|||
146078344|NCT01419197|526807474|FG001|Overall Study|Physician Decision|4|||
146078345|NCT01419197|526807473|FG000|Overall Study|Non-compliance|3|||
146078346|NCT01419197|526807474|FG001|Overall Study|Non-compliance|1|||
146078347|NCT01419197|526807473|FG000|Overall Study|Withdrawal by Subject|33|||
146078348|NCT01419197|526807474|FG001|Overall Study|Withdrawal by Subject|32|||
146078349|NCT01419197|526807473|FG000|Overall Study|Study Completed by Sponsor|103|||
146078350|NCT01419197|526807474|FG001|Overall Study|Study Completed by Sponsor|34|||
146078351|NCT01419197|526807473|FG000|Overall Study|Reason Not Specified|0|||
146078352|NCT01419197|526807474|FG001|Overall Study|Reason Not Specified|1|||
146078353|NCT01419197|526807473|FG000|Overall Study|Lost to Follow-up|14|||
146078354|NCT01419197|526807474|FG001|Overall Study|Lost to Follow-up|4|||
146078355|NCT01781299|526807475|FG000|Overall Study|Withdrawal by Subject|0|||
146078356|NCT01781299|526807476|FG001|Overall Study|Withdrawal by Subject|1|||
146179516|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
146179517|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
146078357|NCT00146848|526807480|FG000|Pre-randomization|Death|19|||
146078358|NCT00146848|526807481|FG001|Pre-randomization|Death|0|||
146078359|NCT00146848|526807482|FG002|Pre-randomization|Death|0|||
146078360|NCT00146848|526807480|FG000|Pre-randomization|Lost to Follow-up|70|||
146078361|NCT00146848|526807481|FG001|Pre-randomization|Lost to Follow-up|0|||
146179518|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
146179519|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
146179520|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146179521|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146179522|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146179523|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
146179524|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
146179525|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
146179526|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146179527|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146179528|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146179529|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
146179530|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146179531|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
146179532|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146179533|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146179534|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146179535|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
146179536|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
146179537|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
146179538|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
146179539|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
146179540|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
146179541|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
146179542|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
146179543|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
146179544|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146179545|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146179546|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146179547|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
146179548|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
146179549|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
146179550|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146179551|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146179552|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146179553|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
146179554|NCT01089556|527170826|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
146179555|NCT01089556|527170827|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
146179556|NCT01089556|527170828|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146179557|NCT01089556|527170829|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146179558|NCT01089556|527170830|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146179559|NCT01089556|527170831|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
146179560|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
146179561|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
146179562|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
146179563|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
146179564|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
146179565|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
146179566|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
146179567|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
146179568|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146179569|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146179570|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146179571|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
146179572|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146179573|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146179574|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146179575|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
146179576|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
146179577|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
146179578|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146179579|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146179580|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
146179581|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146179582|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146179583|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
146179584|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146179585|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146179586|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146179587|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146179588|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
146179589|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
146179590|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
146179591|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
146179592|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
146179593|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
146179594|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
146179595|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
146179596|NCT01089556|527170826|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146179597|NCT01089556|527170827|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146179598|NCT01089556|527170828|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
146179599|NCT01089556|527170829|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
146179600|NCT01089556|527170830|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
146179601|NCT01089556|527170831|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
146179602|NCT01757665|527170834|FG000|Overall Study|Still on Study - Visit Completed|240|||
146179603|NCT01757665|527170835|FG001|Overall Study|Still on Study - Visit Completed|30|||
146179604|NCT01757665|527170834|FG000|Overall Study|Still on Study - Visit Pending|398|||
146179605|NCT01757665|527170835|FG001|Overall Study|Still on Study - Visit Pending|40|||
146179606|NCT01757665|527170834|FG000|Overall Study|Still on Study - Missed Visit|14|||
146179607|NCT01757665|527170835|FG001|Overall Study|Still on Study - Missed Visit|1|||
146179608|NCT01757665|527170834|FG000|Overall Study|Death|25|||
146179609|NCT01757665|527170835|FG001|Overall Study|Death|8|||
146179610|NCT01757665|527170834|FG000|Overall Study|Explant|1|||
146179611|NCT01757665|527170835|FG001|Overall Study|Explant|2|||
146179612|NCT01757665|527170834|FG000|Overall Study|Withdrawal by Subject|10|||
146179613|NCT01757665|527170835|FG001|Overall Study|Withdrawal by Subject|0|||
146179614|NCT01757665|527170834|FG000|Overall Study|Lost to Follow-up|1|||
146179615|NCT01757665|527170835|FG001|Overall Study|Lost to Follow-up|1|||
146179616|NCT01757665|527170834|FG000|Overall Study|Not Implanted with Device|5|||
146179617|NCT01757665|527170835|FG001|Overall Study|Not Implanted with Device|1|||
146179618|NCT01702428|527170836|FG000|Overall Study|Adverse Event|2|||
146179619|NCT01702428|527170837|FG001|Overall Study|Adverse Event|0|||
146179620|NCT01702428|527170838|FG002|Overall Study|Adverse Event|0|||
146179621|NCT01702428|527170839|FG003|Overall Study|Adverse Event|0|||
146179622|NCT01702428|527170836|FG000|Overall Study|Lost to Follow-up|33|||
146179623|NCT01702428|527170837|FG001|Overall Study|Lost to Follow-up|41|||
146179624|NCT01702428|527170838|FG002|Overall Study|Lost to Follow-up|37|||
146078362|NCT00146848|526807482|FG002|Pre-randomization|Lost to Follow-up|0|||
146078363|NCT00146848|526807480|FG000|Pre-randomization|Physician Decision|8|||
146078364|NCT00146848|526807481|FG001|Pre-randomization|Physician Decision|0|||
146078365|NCT00146848|526807482|FG002|Pre-randomization|Physician Decision|0|||
146078366|NCT00146848|526807480|FG000|Pre-randomization|Protocol Violation|172|||
146078367|NCT00146848|526807481|FG001|Pre-randomization|Protocol Violation|0|||
146078368|NCT00146848|526807482|FG002|Pre-randomization|Protocol Violation|0|||
146078369|NCT00146848|526807480|FG000|Pre-randomization|Withdrawal by Subject|40|||
146078370|NCT00146848|526807481|FG001|Pre-randomization|Withdrawal by Subject|0|||
146078371|NCT00146848|526807482|FG002|Pre-randomization|Withdrawal by Subject|0|||
146078372|NCT00146848|526807480|FG000|Post-randomization|Lost to Follow-up|12|||
146078373|NCT00146848|526807481|FG001|Post-randomization|Lost to Follow-up|15|||
146078374|NCT00146848|526807482|FG002|Post-randomization|Lost to Follow-up|12|||
146078375|NCT00146848|526807480|FG000|Post-randomization|Withdrawn|26|||
146078376|NCT00146848|526807481|FG001|Post-randomization|Withdrawn|32|||
146078377|NCT00146848|526807482|FG002|Post-randomization|Withdrawn|27|||
146078378|NCT00119678|526807485|FG000|Double-blind Treatment Period|Death|1|||
146078379|NCT00119678|526807486|FG001|Double-blind Treatment Period|Death|0|||
146078380|NCT00119678|526807485|FG000|Double-blind Treatment Period|Adverse Event|7|||
146078381|NCT00119678|526807486|FG001|Double-blind Treatment Period|Adverse Event|1|||
146078382|NCT00119678|526807485|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
146078383|NCT00119678|526807486|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
146078384|NCT00119678|526807485|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146078385|NCT00119678|526807486|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
146078386|NCT00119678|526807485|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
146078387|NCT00119678|526807486|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
146078388|NCT00119678|526807485|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
146078389|NCT00119678|526807486|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
146078390|NCT00119678|526807485|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
146078391|NCT00119678|526807486|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
146078392|NCT00119678|526807485|FG000|Double-blind Treatment Period|Pregnancy|0|||
146078393|NCT00119678|526807486|FG001|Double-blind Treatment Period|Pregnancy|2|||
146078394|NCT00119678|526807485|FG000|Double-blind Treatment Period|Not treated|1|||
146078395|NCT00119678|526807486|FG001|Double-blind Treatment Period|Not treated|2|||
146078396|NCT00119678|526807485|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
146078397|NCT00119678|526807486|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
146078398|NCT00119678|526807485|FG000|Open-label Treatment Period|Death|1|||
146078399|NCT00119678|526807486|FG001|Open-label Treatment Period|Death|0|||
146078400|NCT00119678|526807485|FG000|Open-label Treatment Period|Adverse Event|3|||
146078401|NCT00119678|526807486|FG001|Open-label Treatment Period|Adverse Event|0|||
146078402|NCT00119678|526807485|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
146078403|NCT00119678|526807486|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
146078404|NCT00119678|526807485|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
146078405|NCT00119678|526807486|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146078406|NCT00119678|526807485|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
146078407|NCT00119678|526807486|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
146078408|NCT00119678|526807485|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
146078409|NCT00119678|526807486|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
146078410|NCT00119678|526807485|FG000|Open-label Treatment Period|Pregnancy|1|||
146078411|NCT00119678|526807486|FG001|Open-label Treatment Period|Pregnancy|0|||
146078412|NCT00119678|526807485|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
146078413|NCT00119678|526807486|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
146078414|NCT02720042|526807487|FG000|Overall Study|Death|3|||
146078415|NCT02720042|526807487|FG000|Overall Study|Lost to Follow-up|4|||
146078416|NCT02720042|526807487|FG000|Overall Study|Withdrawal by Subject|1|||
146078417|NCT02720042|526807487|FG000|Overall Study|Physician Decision|3|||
146078418|NCT02720042|526807487|FG000|Overall Study|Phasix Mesh explanted|1|||
146078419|NCT02720042|526807487|FG000|Overall Study|unable due to non-study-related illness|3|||
146078420|NCT03704636|526807488|FG000|Overall Study|Inadequate Venous Flow|3|||
145945347|NCT01764997|526308216|FG004|Run-in Period|Poor compliance to protocol|0|||
146078421|NCT01134705|526807493|FG000|Overall Study|Adverse Event|1|||
146078422|NCT01134705|526807494|FG001|Overall Study|Adverse Event|7|||
146078423|NCT01134705|526807493|FG000|Overall Study|Withdrawal by Subject|6|||
146078424|NCT01134705|526807494|FG001|Overall Study|Withdrawal by Subject|6|||
146412104|NCT00667719|528014032|FG000|Overall Study|Adverse Event|39|||
146078425|NCT01134705|526807493|FG000|Overall Study|Pregnancy|1|||
146078426|NCT01134705|526807494|FG001|Overall Study|Pregnancy|0|||
146078427|NCT01134705|526807493|FG000|Overall Study|Lost to Follow-up|5|||
146078428|NCT01134705|526807494|FG001|Overall Study|Lost to Follow-up|2|||
146078429|NCT01134705|526807493|FG000|Overall Study|Protocol Violation|1|||
146078430|NCT01134705|526807494|FG001|Overall Study|Protocol Violation|1|||
146078431|NCT01134705|526807493|FG000|Overall Study|Other|1|||
146078432|NCT01134705|526807494|FG001|Overall Study|Other|6|||
146078433|NCT00509145|526807495|FG000|Overall Study|Death|0|||
146078434|NCT00509145|526807496|FG001|Overall Study|Death|2|||
146078435|NCT00509145|526807495|FG000|Overall Study|Adverse Event|42|||
146078436|NCT00509145|526807496|FG001|Overall Study|Adverse Event|28|||
146078437|NCT00509145|526807495|FG000|Overall Study|Withdrawal by Subject|32|||
146078438|NCT00509145|526807496|FG001|Overall Study|Withdrawal by Subject|38|||
146078439|NCT00509145|526807495|FG000|Overall Study|Physician Decision|11|||
146078440|NCT00509145|526807496|FG001|Overall Study|Physician Decision|14|||
146078441|NCT00509145|526807495|FG000|Overall Study|Protocol Violation|1|||
146078442|NCT00509145|526807496|FG001|Overall Study|Protocol Violation|6|||
146078443|NCT00509145|526807495|FG000|Overall Study|Pregnancy|3|||
146078444|NCT00509145|526807496|FG001|Overall Study|Pregnancy|8|||
146078445|NCT00509145|526807495|FG000|Overall Study|Lost to Follow-up|6|||
146078446|NCT00509145|526807496|FG001|Overall Study|Lost to Follow-up|5|||
146078447|NCT00509145|526807495|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
146078448|NCT00509145|526807496|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
146078449|NCT00509145|526807495|FG000|Overall Study|Other|6|||
146078450|NCT00509145|526807496|FG001|Overall Study|Other|6|||
146078451|NCT00246740|526807497|FG000|Initial Enrollment|Death|1|||
146078452|NCT00246740|526807498|FG001|Initial Enrollment|Death|0|||
146078453|NCT00246740|526807497|FG000|Initial Enrollment|Additional surgery scheduled|0|||
146078454|NCT00246740|526807498|FG001|Initial Enrollment|Additional surgery scheduled|2|||
146078455|NCT00246740|526807497|FG000|Initial Enrollment|Surgery schedule change|4|||
146179625|NCT01702428|527170839|FG003|Overall Study|Lost to Follow-up|44|||
146412105|NCT00667719|528014032|FG000|Overall Study|Abnormal Test Procedure|1|||
146412106|NCT00667719|528014032|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146412107|NCT00667719|528014032|FG000|Overall Study|Protocol Violation|3|||
146412108|NCT00667719|528014032|FG000|Overall Study|Withdrawal by Subject|17|||
146412109|NCT00667719|528014032|FG000|Overall Study|Lost to Follow-up|8|||
146412110|NCT01159769|528014033|FG000|Overall Study|Adverse Event|1|||
146412111|NCT01827371|528014034|FG000|Overall Study|Adverse Event|0|||
146412112|NCT01827371|528014035|FG001|Overall Study|Adverse Event|0|||
146412113|NCT01827371|528014036|FG002|Overall Study|Adverse Event|4|||
146412114|NCT01827371|528014037|FG003|Overall Study|Adverse Event|2|||
146412115|NCT01827371|528014034|FG000|Overall Study|Lost to Follow-up|0|||
146412116|NCT01827371|528014035|FG001|Overall Study|Lost to Follow-up|2|||
146412117|NCT01827371|528014036|FG002|Overall Study|Lost to Follow-up|0|||
146412118|NCT01827371|528014037|FG003|Overall Study|Lost to Follow-up|4|||
146412119|NCT01827371|528014034|FG000|Overall Study|Protocol Violation|1|||
146412120|NCT01827371|528014035|FG001|Overall Study|Protocol Violation|0|||
146412121|NCT01827371|528014036|FG002|Overall Study|Protocol Violation|0|||
146412122|NCT01827371|528014037|FG003|Overall Study|Protocol Violation|0|||
146412123|NCT01827371|528014034|FG000|Overall Study|Withdrawal by Subject|1|||
146412124|NCT01827371|528014035|FG001|Overall Study|Withdrawal by Subject|2|||
146412125|NCT01827371|528014036|FG002|Overall Study|Withdrawal by Subject|2|||
146412126|NCT01827371|528014037|FG003|Overall Study|Withdrawal by Subject|3|||
146412127|NCT01827371|528014034|FG000|Overall Study|Physician Decision|0|||
146412128|NCT01827371|528014035|FG001|Overall Study|Physician Decision|1|||
146412129|NCT01827371|528014036|FG002|Overall Study|Physician Decision|0|||
146412130|NCT01827371|528014037|FG003|Overall Study|Physician Decision|1|||
146412131|NCT01827371|528014034|FG000|Overall Study|Temporary study halt to vaccinations|11|||
146412132|NCT01827371|528014035|FG001|Overall Study|Temporary study halt to vaccinations|2|||
146412133|NCT01827371|528014036|FG002|Overall Study|Temporary study halt to vaccinations|5|||
146412134|NCT01827371|528014037|FG003|Overall Study|Temporary study halt to vaccinations|13|||
146412135|NCT01361607|528014038|FG000|Overall Study|Adverse Event|38|||
146412136|NCT01361607|528014039|FG001|Overall Study|Adverse Event|29|||
146412137|NCT01361607|528014038|FG000|Overall Study|Withdrawal by Subject|19|||
146412138|NCT01361607|528014039|FG001|Overall Study|Withdrawal by Subject|8|||
146412139|NCT01361607|528014038|FG000|Overall Study|Withdrawal by Investigator|5|||
146412140|NCT01361607|528014039|FG001|Overall Study|Withdrawal by Investigator|3|||
146412141|NCT01361607|528014038|FG000|Overall Study|Lost to Follow-up|1|||
146412142|NCT01361607|528014039|FG001|Overall Study|Lost to Follow-up|0|||
146412143|NCT01361607|528014038|FG000|Overall Study|Met Withdrawal Criteria|1|||
146412144|NCT01361607|528014039|FG001|Overall Study|Met Withdrawal Criteria|1|||
146412145|NCT00373685|528014040|FG000|Overall Study|Death|2|||
146412146|NCT00373685|528014041|FG001|Overall Study|Death|1|||
146412147|NCT00373685|528014040|FG000|Overall Study|Adverse Event|278|||
146412148|NCT00373685|528014041|FG001|Overall Study|Adverse Event|253|||
146179626|NCT01702428|527170836|FG000|Overall Study|Parents cannot assist to site|1|||
146179627|NCT01702428|527170837|FG001|Overall Study|Parents cannot assist to site|0|||
146179628|NCT01702428|527170838|FG002|Overall Study|Parents cannot assist to site|1|||
146179629|NCT01702428|527170839|FG003|Overall Study|Parents cannot assist to site|0|||
146179630|NCT01702428|527170836|FG000|Overall Study|Lost Coverage|0|||
146179631|NCT01702428|527170837|FG001|Overall Study|Lost Coverage|0|||
146179632|NCT01702428|527170838|FG002|Overall Study|Lost Coverage|0|||
146179633|NCT01702428|527170839|FG003|Overall Study|Lost Coverage|1|||
146179634|NCT01702428|527170836|FG000|Overall Study|Lost Health Plan|3|||
146179635|NCT01702428|527170837|FG001|Overall Study|Lost Health Plan|5|||
146179636|NCT01702428|527170838|FG002|Overall Study|Lost Health Plan|0|||
146179637|NCT01702428|527170839|FG003|Overall Study|Lost Health Plan|2|||
146179638|NCT01702428|527170836|FG000|Overall Study|Mother transferred care|0|||
146179639|NCT01702428|527170837|FG001|Overall Study|Mother transferred care|1|||
146179640|NCT01702428|527170838|FG002|Overall Study|Mother transferred care|0|||
146179641|NCT01702428|527170839|FG003|Overall Study|Mother transferred care|0|||
146179642|NCT01702428|527170836|FG000|Overall Study|Parents too busy|1|||
146179643|NCT01702428|527170837|FG001|Overall Study|Parents too busy|0|||
146179644|NCT01702428|527170838|FG002|Overall Study|Parents too busy|0|||
146179645|NCT01702428|527170839|FG003|Overall Study|Parents too busy|0|||
146179646|NCT01702428|527170836|FG000|Overall Study|Protocol Violation|3|||
146179647|NCT01702428|527170837|FG001|Overall Study|Protocol Violation|0|||
146179648|NCT01702428|527170838|FG002|Overall Study|Protocol Violation|1|||
146179649|NCT01702428|527170839|FG003|Overall Study|Protocol Violation|0|||
146179650|NCT01702428|527170836|FG000|Overall Study|Withdrawal by Subject|21|||
146179651|NCT01702428|527170837|FG001|Overall Study|Withdrawal by Subject|23|||
146179652|NCT01702428|527170838|FG002|Overall Study|Withdrawal by Subject|14|||
146179653|NCT01702428|527170839|FG003|Overall Study|Withdrawal by Subject|10|||
146179654|NCT02091869|527170842|FG000|Overall Study|Withdrawal by Subject|0|||
146179655|NCT02091869|527170843|FG001|Overall Study|Withdrawal by Subject|3|||
146179656|NCT00594906|527170847|FG000|Overall Study|Physician Decision|1|||
146179657|NCT00594906|527170848|FG001|Overall Study|Physician Decision|0|||
146179658|NCT00594906|527170847|FG000|Overall Study|Physician Decision|0|||
146179659|NCT00594906|527170848|FG001|Overall Study|Physician Decision|1|||
146179660|NCT00594906|527170847|FG000|Overall Study|Death|0|||
146179661|NCT00594906|527170848|FG001|Overall Study|Death|1|||
146179662|NCT01533714|527170850|FG000|Overall Study|Adverse Event|0|||
146179663|NCT01533714|527170851|FG001|Overall Study|Adverse Event|1|||
146179664|NCT01533714|527170852|FG002|Overall Study|Adverse Event|2|||
146179665|NCT01533714|527170853|FG003|Overall Study|Adverse Event|2|||
146179666|NCT01533714|527170854|FG004|Overall Study|Adverse Event|2|||
146179667|NCT01533714|527170855|FG005|Overall Study|Adverse Event|1|||
146179668|NCT01533714|527170850|FG000|Overall Study|Lack of Efficacy|0|||
146179669|NCT01533714|527170851|FG001|Overall Study|Lack of Efficacy|0|||
146179670|NCT01533714|527170852|FG002|Overall Study|Lack of Efficacy|0|||
146179671|NCT01533714|527170853|FG003|Overall Study|Lack of Efficacy|0|||
146179672|NCT01533714|527170854|FG004|Overall Study|Lack of Efficacy|0|||
146179673|NCT01533714|527170855|FG005|Overall Study|Lack of Efficacy|1|||
146179674|NCT01533714|527170850|FG000|Overall Study|Withdrawal by Subject|0|||
146179675|NCT01533714|527170851|FG001|Overall Study|Withdrawal by Subject|1|||
146179676|NCT01533714|527170852|FG002|Overall Study|Withdrawal by Subject|0|||
146179677|NCT01533714|527170853|FG003|Overall Study|Withdrawal by Subject|1|||
146179678|NCT01533714|527170854|FG004|Overall Study|Withdrawal by Subject|1|||
146179679|NCT01533714|527170855|FG005|Overall Study|Withdrawal by Subject|0|||
146179680|NCT01533714|527170850|FG000|Overall Study|Exclusion criteria|0|||
146179681|NCT01533714|527170851|FG001|Overall Study|Exclusion criteria|1|||
146179682|NCT01533714|527170852|FG002|Overall Study|Exclusion criteria|0|||
146179683|NCT01533714|527170853|FG003|Overall Study|Exclusion criteria|0|||
146179684|NCT01533714|527170854|FG004|Overall Study|Exclusion criteria|0|||
146179685|NCT01533714|527170855|FG005|Overall Study|Exclusion criteria|0|||
146179686|NCT01533714|527170850|FG000|Overall Study|Positive for purified protein derivative|0|||
146179687|NCT01533714|527170851|FG001|Overall Study|Positive for purified protein derivative|0|||
146179688|NCT01533714|527170852|FG002|Overall Study|Positive for purified protein derivative|1|||
146179689|NCT01533714|527170853|FG003|Overall Study|Positive for purified protein derivative|0|||
146179690|NCT01533714|527170854|FG004|Overall Study|Positive for purified protein derivative|1|||
146179691|NCT01533714|527170855|FG005|Overall Study|Positive for purified protein derivative|0|||
146179692|NCT01533714|527170850|FG000|Overall Study|Withdrawal criteria|0|||
146179693|NCT01533714|527170851|FG001|Overall Study|Withdrawal criteria|0|||
146179694|NCT01533714|527170852|FG002|Overall Study|Withdrawal criteria|1|||
146179695|NCT01533714|527170853|FG003|Overall Study|Withdrawal criteria|0|||
146078456|NCT00246740|526807498|FG001|Initial Enrollment|Surgery schedule change|4|||
146078457|NCT00246740|526807497|FG000|Initial Enrollment|Other|1|||
146078458|NCT00246740|526807498|FG001|Initial Enrollment|Other|2|||
146078459|NCT00101452|526807501|FG000|Overall Study|Adverse Event|2|||
146078460|NCT00101452|526807502|FG001|Overall Study|Adverse Event|0|||
146078461|NCT00101452|526807503|FG002|Overall Study|Adverse Event|1|||
146078462|NCT00101452|526807501|FG000|Overall Study|Lost to Follow-up|13|||
146078463|NCT00101452|526807502|FG001|Overall Study|Lost to Follow-up|8|||
146078464|NCT00101452|526807503|FG002|Overall Study|Lost to Follow-up|14|||
146078465|NCT00101452|526807501|FG000|Overall Study|Withdrawal by Subject|10|||
146179696|NCT01533714|527170854|FG004|Overall Study|Withdrawal criteria|3|||
146179697|NCT01533714|527170855|FG005|Overall Study|Withdrawal criteria|1|||
146179698|NCT01533714|527170850|FG000|Overall Study|Ineligibility reason|0|||
146179699|NCT01533714|527170851|FG001|Overall Study|Ineligibility reason|0|||
146179700|NCT01533714|527170852|FG002|Overall Study|Ineligibility reason|0|||
146179701|NCT01533714|527170853|FG003|Overall Study|Ineligibility reason|1|||
146179702|NCT01533714|527170854|FG004|Overall Study|Ineligibility reason|0|||
146179703|NCT01533714|527170855|FG005|Overall Study|Ineligibility reason|0|||
146179704|NCT02564055|527170860|FG000|Overall Study|Adverse Event|1|||
146179705|NCT02564055|527170861|FG001|Overall Study|Adverse Event|0|||
146179706|NCT02564055|527170862|FG002|Overall Study|Adverse Event|4|||
146179707|NCT02564055|527170863|FG003|Overall Study|Adverse Event|1|||
146179708|NCT02564055|527170864|FG004|Overall Study|Adverse Event|4|||
146179709|NCT02564055|527170865|FG005|Overall Study|Adverse Event|1|||
146179710|NCT02564055|527170860|FG000|Overall Study|Protocol Violation|1|||
146179711|NCT02564055|527170861|FG001|Overall Study|Protocol Violation|0|||
146179712|NCT02564055|527170862|FG002|Overall Study|Protocol Violation|0|||
146179713|NCT02564055|527170863|FG003|Overall Study|Protocol Violation|0|||
146179714|NCT02564055|527170864|FG004|Overall Study|Protocol Violation|0|||
146179715|NCT02564055|527170865|FG005|Overall Study|Protocol Violation|0|||
146179716|NCT02564055|527170860|FG000|Overall Study|Reached stopping criteria|0|||
146179717|NCT02564055|527170861|FG001|Overall Study|Reached stopping criteria|0|||
146179718|NCT02564055|527170862|FG002|Overall Study|Reached stopping criteria|0|||
146179719|NCT02564055|527170863|FG003|Overall Study|Reached stopping criteria|0|||
146179720|NCT02564055|527170864|FG004|Overall Study|Reached stopping criteria|0|||
146179721|NCT02564055|527170865|FG005|Overall Study|Reached stopping criteria|1|||
146179722|NCT02564055|527170860|FG000|Overall Study|Lost to Follow-up|0|||
146179723|NCT02564055|527170861|FG001|Overall Study|Lost to Follow-up|1|||
146179724|NCT02564055|527170862|FG002|Overall Study|Lost to Follow-up|4|||
146179725|NCT02564055|527170863|FG003|Overall Study|Lost to Follow-up|2|||
146179726|NCT02564055|527170864|FG004|Overall Study|Lost to Follow-up|1|||
146179727|NCT02564055|527170865|FG005|Overall Study|Lost to Follow-up|0|||
146179728|NCT02564055|527170860|FG000|Overall Study|Physician Decision|0|||
146179729|NCT02564055|527170861|FG001|Overall Study|Physician Decision|0|||
146179730|NCT02564055|527170862|FG002|Overall Study|Physician Decision|1|||
146179731|NCT02564055|527170863|FG003|Overall Study|Physician Decision|0|||
146179732|NCT02564055|527170864|FG004|Overall Study|Physician Decision|0|||
146179733|NCT02564055|527170865|FG005|Overall Study|Physician Decision|0|||
146179734|NCT02564055|527170860|FG000|Overall Study|Withdrawal by Subject|4|||
146179735|NCT02564055|527170861|FG001|Overall Study|Withdrawal by Subject|4|||
146179736|NCT02564055|527170862|FG002|Overall Study|Withdrawal by Subject|3|||
146179737|NCT02564055|527170863|FG003|Overall Study|Withdrawal by Subject|3|||
146179738|NCT02564055|527170864|FG004|Overall Study|Withdrawal by Subject|10|||
146179739|NCT02564055|527170865|FG005|Overall Study|Withdrawal by Subject|10|||
146179740|NCT01375959|527170866|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
146179741|NCT01375959|527170867|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
146179742|NCT01375959|527170866|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
146179743|NCT01375959|527170867|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
146179744|NCT01375959|527170866|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146179745|NCT01375959|527170867|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
146179746|NCT02572817|527170869|FG000|Overall Study|Death|6|||
146179747|NCT02572817|527170870|FG001|Overall Study|Death|3|||
146179748|NCT02572817|527170869|FG000|Overall Study|Lost to Follow-up|3|||
146179749|NCT02572817|527170870|FG001|Overall Study|Lost to Follow-up|3|||
146179750|NCT01394250|527170871|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
146179751|NCT01394250|527170872|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
146179752|NCT01394250|527170871|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
146179753|NCT01394250|527170872|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
146179754|NCT02310126|527170873|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
146179755|NCT02310126|527170874|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
146179756|NCT02310126|527170873|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
146179757|NCT02310126|527170874|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
146179758|NCT02222896|527170878|FG000|Abdomen|Did not qualify|34|||
146179759|NCT02222896|527170879|FG001|Abdomen|Did not qualify|10|||
146179760|NCT02222896|527170880|FG002|Abdomen|Did not qualify|32|||
146179761|NCT02222896|527170878|FG000|Groin|Did not qualify|43|||
146179762|NCT02222896|527170879|FG001|Groin|Did not qualify|9|||
146179763|NCT02222896|527170880|FG002|Groin|Did not qualify|40|||
146179764|NCT02441946|527170881|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
146179765|NCT02441946|527170882|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
146179766|NCT02441946|527170883|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
146179767|NCT02441946|527170881|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
146179768|NCT02441946|527170882|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
146179769|NCT02441946|527170883|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
146179770|NCT02441946|527170881|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146179771|NCT02441946|527170882|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
146179772|NCT02441946|527170883|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146179773|NCT02441946|527170881|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
146179774|NCT02441946|527170882|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
146179775|NCT02441946|527170883|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
146179776|NCT02441946|527170881|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
146179777|NCT02441946|527170882|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
146179778|NCT02441946|527170883|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
146179779|NCT02441946|527170881|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
146179780|NCT02441946|527170882|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
146179781|NCT02441946|527170883|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
146179782|NCT02441946|527170881|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
146179783|NCT02441946|527170882|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
146179784|NCT02441946|527170883|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
146179785|NCT02441946|527170881|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
146179786|NCT02441946|527170882|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
146179787|NCT02441946|527170883|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
146179788|NCT02441946|527170881|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
146179789|NCT02441946|527170882|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
146179790|NCT02441946|527170883|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
146179791|NCT02441946|527170881|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
146179792|NCT02441946|527170882|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
146179793|NCT02441946|527170883|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
146179794|NCT02441946|527170881|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
146179795|NCT02441946|527170882|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146179796|NCT02441946|527170883|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146179797|NCT04422639|527170888|FG000|Overall Study|Death|1|||
146179798|NCT04422639|527170889|FG001|Overall Study|Death|0|||
146179799|NCT04422639|527170888|FG000|Overall Study|study closed prior to completion of FU visits|0|||
146179800|NCT04422639|527170889|FG001|Overall Study|study closed prior to completion of FU visits|2|||
146179801|NCT01964521|527170890|FG000|Overall Study|Lost to Follow-up|4|||
146179802|NCT04267614|527170891|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
146179803|NCT04267614|527170891|FG000|Overall Study|Lost to Follow-up|115|||
146179804|NCT01463293|527170892|FG000|Overall Study|Lost to Follow-up|1|||
146179805|NCT01463293|527170893|FG001|Overall Study|Lost to Follow-up|4|||
146179806|NCT01463293|527170894|FG002|Overall Study|Lost to Follow-up|5|||
146179807|NCT01463293|527170892|FG000|Overall Study|Adverse Event|1|||
146179808|NCT01463293|527170893|FG001|Overall Study|Adverse Event|2|||
146179809|NCT01463293|527170894|FG002|Overall Study|Adverse Event|0|||
146179810|NCT01463293|527170892|FG000|Overall Study|Withdrawal by Subject|4|||
146179811|NCT01463293|527170893|FG001|Overall Study|Withdrawal by Subject|10|||
146179812|NCT01463293|527170894|FG002|Overall Study|Withdrawal by Subject|5|||
146179813|NCT01463293|527170892|FG000|Overall Study|Other|0|||
146179814|NCT01463293|527170893|FG001|Overall Study|Other|0|||
146179815|NCT01463293|527170894|FG002|Overall Study|Other|2|||
146179816|NCT00119262|527170898|FG000|Overall Study|Lack of Efficacy|0|||
146179817|NCT00119262|527170899|FG001|Overall Study|Lack of Efficacy|3|||
146179818|NCT00119262|527170898|FG000|Overall Study|Withdrawal by Subject|12|||
146179819|NCT00119262|527170899|FG001|Overall Study|Withdrawal by Subject|11|||
146179820|NCT00119262|527170898|FG000|Overall Study|Adverse Event|33|||
146179821|NCT00119262|527170899|FG001|Overall Study|Adverse Event|35|||
146179822|NCT00119262|527170898|FG000|Overall Study|other disease|0|||
146179823|NCT00119262|527170899|FG001|Overall Study|other disease|2|||
146179824|NCT00119262|527170898|FG000|Overall Study|ineligble|1|||
146179825|NCT00119262|527170899|FG001|Overall Study|ineligble|2|||
146179826|NCT00119262|527170898|FG000|Overall Study|others|0|||
146179827|NCT00119262|527170899|FG001|Overall Study|others|5|||
146179828|NCT03853317|527170900|FG000|Overall Study|Progressive Disease|5|||
146179829|NCT03853317|527170900|FG000|Overall Study|Adverse Event|1|||
146179830|NCT03853317|527170900|FG000|Overall Study|Death|1|||
146179831|NCT03853317|527170900|FG000|Overall Study|other event|2|||
146179832|NCT00779584|527170905|FG000|Overall Study|Protocol Violation|0|||
146179833|NCT00779584|527170906|FG001|Overall Study|Protocol Violation|0|||
146179834|NCT00779584|527170907|FG002|Overall Study|Protocol Violation|0|||
146179835|NCT00779584|527170908|FG003|Overall Study|Protocol Violation|0|||
146179836|NCT00779584|527170909|FG004|Overall Study|Protocol Violation|0|||
146179837|NCT00779584|527170910|FG005|Overall Study|Protocol Violation|1|||
146179838|NCT00779584|527170911|FG006|Overall Study|Protocol Violation|0|||
146179839|NCT00779584|527170912|FG007|Overall Study|Protocol Violation|0|||
146179840|NCT00779584|527170913|FG008|Overall Study|Protocol Violation|0|||
146179841|NCT00779584|527170905|FG000|Overall Study|Withdrawal by Subject|1|||
146179842|NCT00779584|527170906|FG001|Overall Study|Withdrawal by Subject|1|||
146179843|NCT00779584|527170907|FG002|Overall Study|Withdrawal by Subject|2|||
146179844|NCT00779584|527170908|FG003|Overall Study|Withdrawal by Subject|0|||
146179845|NCT00779584|527170909|FG004|Overall Study|Withdrawal by Subject|0|||
146179846|NCT00779584|527170910|FG005|Overall Study|Withdrawal by Subject|2|||
146179847|NCT00779584|527170911|FG006|Overall Study|Withdrawal by Subject|1|||
146179848|NCT00779584|527170912|FG007|Overall Study|Withdrawal by Subject|0|||
146179849|NCT00779584|527170913|FG008|Overall Study|Withdrawal by Subject|0|||
146179850|NCT00779584|527170905|FG000|Overall Study|Lost to Follow-up|0|||
146179851|NCT00779584|527170906|FG001|Overall Study|Lost to Follow-up|0|||
146179852|NCT00779584|527170907|FG002|Overall Study|Lost to Follow-up|0|||
146179853|NCT00779584|527170908|FG003|Overall Study|Lost to Follow-up|0|||
146179854|NCT00779584|527170909|FG004|Overall Study|Lost to Follow-up|1|||
146179855|NCT00779584|527170910|FG005|Overall Study|Lost to Follow-up|0|||
146179856|NCT00779584|527170911|FG006|Overall Study|Lost to Follow-up|0|||
146179857|NCT00779584|527170912|FG007|Overall Study|Lost to Follow-up|0|||
146179858|NCT00779584|527170913|FG008|Overall Study|Lost to Follow-up|0|||
146179859|NCT00779584|527170905|FG000|Overall Study|Progression of Disease|0|||
146179860|NCT00779584|527170906|FG001|Overall Study|Progression of Disease|1|||
146179861|NCT00779584|527170907|FG002|Overall Study|Progression of Disease|2|||
146179862|NCT00779584|527170908|FG003|Overall Study|Progression of Disease|6|||
146179863|NCT00779584|527170909|FG004|Overall Study|Progression of Disease|5|||
146179864|NCT00779584|527170910|FG005|Overall Study|Progression of Disease|1|||
146179865|NCT00779584|527170911|FG006|Overall Study|Progression of Disease|4|||
146179866|NCT00779584|527170912|FG007|Overall Study|Progression of Disease|2|||
146179867|NCT00779584|527170913|FG008|Overall Study|Progression of Disease|1|||
146179868|NCT00779584|527170905|FG000|Overall Study|Adverse Event|1|||
146179869|NCT00779584|527170906|FG001|Overall Study|Adverse Event|0|||
146179870|NCT00779584|527170907|FG002|Overall Study|Adverse Event|2|||
146179871|NCT00779584|527170908|FG003|Overall Study|Adverse Event|0|||
146179872|NCT00779584|527170909|FG004|Overall Study|Adverse Event|0|||
146179873|NCT00779584|527170910|FG005|Overall Study|Adverse Event|0|||
146179874|NCT00779584|527170911|FG006|Overall Study|Adverse Event|2|||
146179875|NCT00779584|527170912|FG007|Overall Study|Adverse Event|1|||
146179876|NCT00779584|527170913|FG008|Overall Study|Adverse Event|1|||
146179877|NCT00779584|527170905|FG000|Overall Study|Symptomatic Deterioration|1|||
146179878|NCT00779584|527170906|FG001|Overall Study|Symptomatic Deterioration|1|||
146179879|NCT00779584|527170907|FG002|Overall Study|Symptomatic Deterioration|1|||
146179880|NCT00779584|527170908|FG003|Overall Study|Symptomatic Deterioration|0|||
146179881|NCT00779584|527170909|FG004|Overall Study|Symptomatic Deterioration|0|||
146179882|NCT00779584|527170910|FG005|Overall Study|Symptomatic Deterioration|1|||
146179883|NCT00779584|527170911|FG006|Overall Study|Symptomatic Deterioration|1|||
146179884|NCT00779584|527170912|FG007|Overall Study|Symptomatic Deterioration|0|||
146179885|NCT00779584|527170913|FG008|Overall Study|Symptomatic Deterioration|0|||
146179886|NCT00779584|527170905|FG000|Overall Study|Ongoing in Study|0|||
146179887|NCT00779584|527170906|FG001|Overall Study|Ongoing in Study|0|||
146179888|NCT00779584|527170907|FG002|Overall Study|Ongoing in Study|0|||
146179889|NCT00779584|527170908|FG003|Overall Study|Ongoing in Study|0|||
146179890|NCT00779584|527170909|FG004|Overall Study|Ongoing in Study|1|||
146179891|NCT00779584|527170910|FG005|Overall Study|Ongoing in Study|1|||
146179892|NCT00779584|527170911|FG006|Overall Study|Ongoing in Study|0|||
146179893|NCT00779584|527170912|FG007|Overall Study|Ongoing in Study|0|||
146179894|NCT00779584|527170913|FG008|Overall Study|Ongoing in Study|0|||
146179895|NCT03632434|527170916|FG000|Overall Study|Withdrawal by Subject|2|||
146179896|NCT00786474|527170920|FG000|Overall Study|Death|5|||
146179897|NCT00786474|527170921|FG001|Overall Study|Death|4|||
146179898|NCT00786474|527170920|FG000|Overall Study|Withdrawal by Subject|23|||
146179899|NCT00786474|527170921|FG001|Overall Study|Withdrawal by Subject|31|||
146179900|NCT00786474|527170920|FG000|Overall Study|Lost to Follow-up|3|||
146179901|NCT00786474|527170921|FG001|Overall Study|Lost to Follow-up|3|||
146179902|NCT00786474|527170920|FG000|Overall Study|Physician Decision|2|||
146179903|NCT00786474|527170921|FG001|Overall Study|Physician Decision|1|||
146179904|NCT00786474|527170920|FG000|Overall Study|Other|4|||
146179905|NCT00786474|527170921|FG001|Overall Study|Other|4|||
146179906|NCT01868074|527170922|FG000|Overall Study|Lost to Follow-up|3|||
146179907|NCT01868074|527170923|FG001|Overall Study|Lost to Follow-up|2|||
146179908|NCT01868074|527170922|FG000|Overall Study|Withdrawal by Subject|4|||
146179909|NCT01868074|527170923|FG001|Overall Study|Withdrawal by Subject|2|||
146179910|NCT03904693|527170927|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146179911|NCT03904693|527170928|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146179912|NCT03904693|527170929|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
146179913|NCT03904693|527170930|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146179914|NCT03904693|527170931|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146179915|NCT03904693|527170932|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
146179916|NCT03904693|527170927|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146179917|NCT03904693|527170928|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146179918|NCT03904693|527170929|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
146179919|NCT03904693|527170930|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146179920|NCT03904693|527170931|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146179921|NCT03904693|527170932|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146179922|NCT03904693|527170927|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146179923|NCT03904693|527170928|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
146179924|NCT03904693|527170929|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
146179925|NCT03904693|527170930|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146179926|NCT03904693|527170931|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146179927|NCT03904693|527170932|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146179928|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146179929|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146179930|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
146179931|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
146179932|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
146179933|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
146179934|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
146179935|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
146179936|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
146179937|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
146179938|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
146179939|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
146179940|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146179941|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146179942|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146179943|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
146179944|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146179945|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
146179946|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146179947|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146179948|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146179949|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
146179950|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146179951|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
146179952|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146179953|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146179954|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146179955|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146179956|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
146179957|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
146179958|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146179959|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146179960|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146179961|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146179962|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
146179963|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
146179964|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146179965|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146179966|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146179967|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146179968|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
146179969|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
146179970|NCT03904693|527170927|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146179971|NCT03904693|527170928|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146179972|NCT03904693|527170929|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146179973|NCT03904693|527170930|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146179974|NCT03904693|527170931|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
146179975|NCT03904693|527170932|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
146179976|NCT04175912|527170933|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
146179977|NCT04175912|527170934|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
146179978|NCT04175912|527170933|FG000|Overall Study|Adverse Event|0|||
146179979|NCT04175912|527170934|FG001|Overall Study|Adverse Event|3|||
146179980|NCT04175912|527170933|FG000|Overall Study|Never started treatment|3|||
146179981|NCT04175912|527170934|FG001|Overall Study|Never started treatment|3|||
146179982|NCT04175912|527170933|FG000|Overall Study|Death|0|||
146179983|NCT04175912|527170934|FG001|Overall Study|Death|1|||
146179984|NCT02303626|527170935|FG000|Overall Study|Lack of Efficacy|1|||
146179985|NCT02303626|527170936|FG001|Overall Study|Lack of Efficacy|0|||
146179986|NCT02303626|527170937|FG002|Overall Study|Lack of Efficacy|1|||
146179987|NCT02303626|527170935|FG000|Overall Study|Adverse Event|0|||
146179988|NCT02303626|527170936|FG001|Overall Study|Adverse Event|2|||
146179989|NCT02303626|527170937|FG002|Overall Study|Adverse Event|0|||
146179990|NCT02303626|527170935|FG000|Overall Study|Protocol Violation|0|||
146179991|NCT02303626|527170936|FG001|Overall Study|Protocol Violation|1|||
146179992|NCT02303626|527170937|FG002|Overall Study|Protocol Violation|0|||
146179993|NCT02303626|527170935|FG000|Overall Study|Pregnancy|0|||
146179994|NCT02303626|527170936|FG001|Overall Study|Pregnancy|0|||
146179995|NCT02303626|527170937|FG002|Overall Study|Pregnancy|1|||
146179996|NCT02303626|527170935|FG000|Overall Study|Subject Non-Compliance|0|||
146179997|NCT02303626|527170936|FG001|Overall Study|Subject Non-Compliance|0|||
146179998|NCT02303626|527170937|FG002|Overall Study|Subject Non-Compliance|1|||
146179999|NCT03698019|527170938|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
146180000|NCT03698019|527170939|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
146180001|NCT03698019|527170938|FG000|Step 1: Registration|Withdrawal by Subject|7|||
146180002|NCT03698019|527170939|FG001|Step 1: Registration|Withdrawal by Subject|2|||
146180003|NCT03698019|527170938|FG000|Step 1: Registration|Toxicity|0|||
146180004|NCT03698019|527170939|FG001|Step 1: Registration|Toxicity|1|||
146180005|NCT03698019|527170938|FG000|Step 1: Registration|Disease Progression|0|||
146180006|NCT03698019|527170939|FG001|Step 1: Registration|Disease Progression|12|||
146180007|NCT03698019|527170938|FG000|Step 1: Registration|Co-morbidities|0|||
146180008|NCT03698019|527170939|FG001|Step 1: Registration|Co-morbidities|1|||
146180009|NCT03698019|527170938|FG000|Step 1: Registration|Scheduling Issues|1|||
146180010|NCT03698019|527170939|FG001|Step 1: Registration|Scheduling Issues|0|||
146180011|NCT03698019|527170938|FG000|Step 1: Registration|Participant Refusal|0|||
146180012|NCT03698019|527170939|FG001|Step 1: Registration|Participant Refusal|1|||
146180013|NCT03698019|527170938|FG000|Step 2: Surgery|Participant Refusal|2|||
146180014|NCT03698019|527170939|FG001|Step 2: Surgery|Participant Refusal|1|||
146180015|NCT03698019|527170938|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
146180016|NCT03698019|527170939|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
146180017|NCT03698019|527170938|FG000|Step 2: Surgery|Metastatic Disease|16|||
146180018|NCT03698019|527170939|FG001|Step 2: Surgery|Metastatic Disease|9|||
146180019|NCT03698019|527170938|FG000|Step 2: Surgery|Residual Disease|2|||
146180020|NCT03698019|527170939|FG001|Step 2: Surgery|Residual Disease|1|||
146180021|NCT03698019|527170938|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
146180022|NCT03698019|527170939|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
146180023|NCT03698019|527170938|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
146180024|NCT03698019|527170939|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
146180025|NCT03698019|527170938|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
146180026|NCT03698019|527170939|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
146180027|NCT03698019|527170938|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
146180028|NCT03698019|527170939|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
146180029|NCT03698019|527170938|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
146180030|NCT03698019|527170939|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
146180031|NCT03698019|527170938|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
146180032|NCT03698019|527170939|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
146180033|NCT03698019|527170938|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
146180034|NCT03698019|527170939|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
146180035|NCT03698019|527170938|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
146180036|NCT03698019|527170939|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
146180037|NCT05376371|527170940|FG000|Overall Study|change in release date|10|||
146180038|NCT05407311|527170941|FG000|Overall Study|Withdrawal by Subject|5|||
146180039|NCT05407311|527170941|FG000|Overall Study|Protocol Violation|3|||
146180040|NCT05407311|527170941|FG000|Overall Study|Physician Decision|1|||
146180041|NCT05407311|527170941|FG000|Overall Study|Non-compliance|1|||
146180042|NCT05027074|527170946|FG000|Overall Study|Death|47|||
146180043|NCT05027074|527170947|FG001|Overall Study|Death|42|||
146180044|NCT05027074|527170948|FG002|Overall Study|Death|39|||
146180045|NCT05027074|527170946|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146180046|NCT05027074|527170947|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146180047|NCT05027074|527170948|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146180048|NCT05027074|527170946|FG000|Overall Study|Site Terminated By Sponsor|3|||
146180049|NCT05027074|527170947|FG001|Overall Study|Site Terminated By Sponsor|0|||
146180050|NCT05027074|527170948|FG002|Overall Study|Site Terminated By Sponsor|2|||
146180051|NCT05027074|527170946|FG000|Overall Study|Withdrawal by Subject|13|||
146180052|NCT05027074|527170947|FG001|Overall Study|Withdrawal by Subject|8|||
146180053|NCT05027074|527170948|FG002|Overall Study|Withdrawal by Subject|10|||
146180054|NCT05027074|527170946|FG000|Overall Study|Lost to Follow-up|2|||
146180055|NCT05027074|527170947|FG001|Overall Study|Lost to Follow-up|4|||
146180056|NCT05027074|527170948|FG002|Overall Study|Lost to Follow-up|3|||
146180057|NCT05027074|527170946|FG000|Overall Study|Status Not Recorded|0|||
146180058|NCT05027074|527170947|FG001|Overall Study|Status Not Recorded|0|||
146180059|NCT05027074|527170948|FG002|Overall Study|Status Not Recorded|1|||
146180060|NCT03797326|527170949|FG000|Overall Study|Lost to Follow-up|1|||
146180061|NCT03797326|527170950|FG001|Overall Study|Lost to Follow-up|0|||
146180062|NCT03797326|527170951|FG002|Overall Study|Lost to Follow-up|0|||
146180063|NCT03797326|527170952|FG003|Overall Study|Lost to Follow-up|1|||
146180064|NCT03797326|527170953|FG004|Overall Study|Lost to Follow-up|0|||
146180065|NCT03797326|527170954|FG005|Overall Study|Lost to Follow-up|0|||
146180066|NCT03797326|527170955|FG006|Overall Study|Lost to Follow-up|0|||
146180067|NCT03797326|527170956|FG007|Overall Study|Lost to Follow-up|0|||
146180068|NCT03797326|527170949|FG000|Overall Study|Withdrawal by Subject|0|||
146180069|NCT03797326|527170950|FG001|Overall Study|Withdrawal by Subject|0|||
146180070|NCT03797326|527170951|FG002|Overall Study|Withdrawal by Subject|1|||
146180071|NCT03797326|527170952|FG003|Overall Study|Withdrawal by Subject|3|||
146180072|NCT03797326|527170953|FG004|Overall Study|Withdrawal by Subject|0|||
146180073|NCT03797326|527170954|FG005|Overall Study|Withdrawal by Subject|2|||
146180074|NCT03797326|527170955|FG006|Overall Study|Withdrawal by Subject|2|||
146180075|NCT03797326|527170956|FG007|Overall Study|Withdrawal by Subject|3|||
146180076|NCT03797326|527170949|FG000|Overall Study|Sponsor Decision|3|||
146180077|NCT03797326|527170950|FG001|Overall Study|Sponsor Decision|3|||
146180078|NCT03797326|527170951|FG002|Overall Study|Sponsor Decision|3|||
146180079|NCT03797326|527170952|FG003|Overall Study|Sponsor Decision|6|||
146180080|NCT03797326|527170953|FG004|Overall Study|Sponsor Decision|0|||
146180081|NCT03797326|527170954|FG005|Overall Study|Sponsor Decision|3|||
146180082|NCT03797326|527170955|FG006|Overall Study|Sponsor Decision|3|||
146180083|NCT03797326|527170956|FG007|Overall Study|Sponsor Decision|2|||
146180084|NCT03797326|527170949|FG000|Overall Study|Death|27|||
146180085|NCT03797326|527170950|FG001|Overall Study|Death|28|||
146180086|NCT03797326|527170951|FG002|Overall Study|Death|95|||
146180087|NCT03797326|527170952|FG003|Overall Study|Death|95|||
146180088|NCT03797326|527170953|FG004|Overall Study|Death|30|||
146180089|NCT03797326|527170954|FG005|Overall Study|Death|96|||
146180090|NCT03797326|527170955|FG006|Overall Study|Death|97|||
146180091|NCT03797326|527170956|FG007|Overall Study|Death|98|||
146180092|NCT03797326|527170949|FG000|Overall Study|Enrolled in error|0|||
146180093|NCT03797326|527170950|FG001|Overall Study|Enrolled in error|0|||
146180094|NCT03797326|527170951|FG002|Overall Study|Enrolled in error|3|||
146180095|NCT03797326|527170952|FG003|Overall Study|Enrolled in error|2|||
146180096|NCT03797326|527170953|FG004|Overall Study|Enrolled in error|2|||
146180097|NCT03797326|527170954|FG005|Overall Study|Enrolled in error|1|||
146180098|NCT03797326|527170955|FG006|Overall Study|Enrolled in error|1|||
146180099|NCT03797326|527170956|FG007|Overall Study|Enrolled in error|0|||
146180100|NCT04908449|527170957|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
146180101|NCT04908449|527170958|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
146180102|NCT04908449|527170957|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
146180103|NCT04908449|527170958|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
146180104|NCT01567865|527170959|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
146180105|NCT01567865|527170960|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
146180106|NCT01567865|527170961|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
146180107|NCT01567865|527170962|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
146180108|NCT01567865|527170959|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
146180109|NCT01567865|527170960|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
146180110|NCT01567865|527170961|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
146180111|NCT01567865|527170962|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
146180112|NCT06385483|527170963|FG000|Overall Study|Withdrawal by Subject|2|||
146180113|NCT06385483|527170963|FG000|Overall Study|Never start protocol therapy|2|||
146180114|NCT06385483|527170963|FG000|Overall Study|Disease progression|15|||
146180115|NCT05569954|527170964|FG000|Overall Study|Lost to Follow-up|3|||
146180116|NCT05569954|527170965|FG001|Overall Study|Lost to Follow-up|4|||
146180117|NCT05569954|527170964|FG000|Overall Study|Protocol Violation|1|||
146180118|NCT05569954|527170965|FG001|Overall Study|Protocol Violation|2|||
146180119|NCT05569954|527170964|FG000|Overall Study|Withdrawal by Subject|4|||
146180120|NCT05569954|527170965|FG001|Overall Study|Withdrawal by Subject|2|||
146180121|NCT00802737|527172071|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
146180122|NCT00802737|527172072|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
146180123|NCT00802737|527172073|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
146180124|NCT00802737|527172071|FG000|Overall Study|Death|6|||
146180125|NCT00802737|527172072|FG001|Overall Study|Death|5|||
146180126|NCT00802737|527172073|FG002|Overall Study|Death|1|||
146180127|NCT00802737|527172071|FG000|Overall Study|Adverse Event|1|||
146180128|NCT00802737|527172072|FG001|Overall Study|Adverse Event|0|||
146180129|NCT00802737|527172073|FG002|Overall Study|Adverse Event|0|||
146078466|NCT00101452|526807502|FG001|Overall Study|Withdrawal by Subject|14|||
146078467|NCT00101452|526807503|FG002|Overall Study|Withdrawal by Subject|9|||
146078468|NCT00101452|526807501|FG000|Overall Study|Baseline Fail|2|||
146078469|NCT00101452|526807502|FG001|Overall Study|Baseline Fail|1|||
146078470|NCT00101452|526807503|FG002|Overall Study|Baseline Fail|2|||
146078471|NCT00101452|526807501|FG000|Overall Study|Physician Decision|0|||
146078472|NCT00101452|526807502|FG001|Overall Study|Physician Decision|3|||
146078473|NCT00101452|526807503|FG002|Overall Study|Physician Decision|2|||
146078474|NCT00101452|526807501|FG000|Overall Study|Protocol Violation|2|||
146078475|NCT00101452|526807502|FG001|Overall Study|Protocol Violation|1|||
146078476|NCT00101452|526807503|FG002|Overall Study|Protocol Violation|3|||
146078477|NCT00101452|526807501|FG000|Overall Study|Other|15|||
146078478|NCT00101452|526807502|FG001|Overall Study|Other|16|||
146078479|NCT00101452|526807503|FG002|Overall Study|Other|12|||
146078480|NCT01994889|526807504|FG000|Overall Study|Adverse Event|5|||
146078481|NCT01994889|526807505|FG001|Overall Study|Adverse Event|12|||
146078482|NCT01994889|526807506|FG002|Overall Study|Adverse Event|11|||
146078483|NCT01994889|526807504|FG000|Overall Study|Cardiac Device Implantation|0|||
146078484|NCT01994889|526807505|FG001|Overall Study|Cardiac Device Implantation|2|||
146078485|NCT01994889|526807506|FG002|Overall Study|Cardiac Device Implantation|0|||
146078486|NCT01994889|526807504|FG000|Overall Study|Organ Transplantation|1|||
146078487|NCT01994889|526807505|FG001|Overall Study|Organ Transplantation|5|||
146078488|NCT01994889|526807506|FG002|Overall Study|Organ Transplantation|5|||
146078489|NCT01994889|526807504|FG000|Overall Study|No longer willing to participate|8|||
146078490|NCT01994889|526807505|FG001|Overall Study|No longer willing to participate|17|||
146078491|NCT01994889|526807506|FG002|Overall Study|No longer willing to participate|37|||
146078492|NCT01994889|526807504|FG000|Overall Study|Lost to Follow-up|0|||
146078493|NCT01994889|526807505|FG001|Overall Study|Lost to Follow-up|1|||
146078494|NCT01994889|526807506|FG002|Overall Study|Lost to Follow-up|0|||
146078495|NCT01994889|526807504|FG000|Overall Study|Protocol Violation|0|||
146078496|NCT01994889|526807505|FG001|Overall Study|Protocol Violation|1|||
146078497|NCT01994889|526807506|FG002|Overall Study|Protocol Violation|1|||
146078498|NCT01994889|526807504|FG000|Overall Study|Death|14|||
146078499|NCT01994889|526807505|FG001|Overall Study|Death|25|||
146078500|NCT01994889|526807506|FG002|Overall Study|Death|38|||
146078501|NCT02969655|526807507|FG000|Overall Study|Withdrawal by Subject|3|||
146078502|NCT02969655|526807508|FG001|Overall Study|Withdrawal by Subject|2|||
146078503|NCT02969655|526807507|FG000|Overall Study|Physician Decision|4|||
146078504|NCT02969655|526807508|FG001|Overall Study|Physician Decision|3|||
146078505|NCT02969655|526807507|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
146078506|NCT02969655|526807508|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
146078507|NCT02969655|526807507|FG000|Overall Study|Adverse Event|10|||
146078508|NCT02969655|526807508|FG001|Overall Study|Adverse Event|8|||
146078509|NCT02674204|526807509|FG000|Overall Study|Adverse Event|1|||
146078510|NCT02674204|526807510|FG001|Overall Study|Adverse Event|0|||
146078511|NCT02466659|526807511|FG000|Overall Study|Lost to Follow-up|5|||
146078512|NCT02466659|526807512|FG001|Overall Study|Lost to Follow-up|2|||
146078513|NCT01536392|526807515|FG000|Overall Study|Adverse Event|2|||
146078514|NCT01536392|526807516|FG001|Overall Study|Adverse Event|2|||
146078515|NCT01536392|526807515|FG000|Overall Study|Physician Decision|2|||
146078516|NCT01536392|526807516|FG001|Overall Study|Physician Decision|3|||
146078517|NCT01536392|526807515|FG000|Overall Study|Withdrawal by Subject|3|||
146078518|NCT01536392|526807516|FG001|Overall Study|Withdrawal by Subject|6|||
146078519|NCT01536392|526807515|FG000|Overall Study|Non Compliance|3|||
146078520|NCT01536392|526807516|FG001|Overall Study|Non Compliance|4|||
146078521|NCT01536392|526807515|FG000|Overall Study|Completed therapy early|3|||
146078522|NCT01536392|526807516|FG001|Overall Study|Completed therapy early|0|||
146078523|NCT03753789|526807517|FG000|Overall Study|Withdrawal by Subject|2|||
146078524|NCT04629066|526807523|FG000|Overall Study|Lost to Follow-up|3|||
146078525|NCT04629066|526807524|FG001|Overall Study|Lost to Follow-up|2|||
146078526|NCT01030666|526807525|FG000|Overall Study|Lost to Follow-up|3|||
146078527|NCT01030666|526807526|FG001|Overall Study|Lost to Follow-up|2|||
146078528|NCT04002908|526807529|FG000|Overall Study|Death|41|||
146078529|NCT04002908|526807530|FG001|Overall Study|Death|0|||
146078530|NCT04002908|526807531|FG002|Overall Study|Death|0|||
146078531|NCT04002908|526807532|FG003|Overall Study|Death|0|||
146078532|NCT04002908|526807529|FG000|Overall Study|Withdrawal by Subject|112|||
146078533|NCT04002908|526807530|FG001|Overall Study|Withdrawal by Subject|0|||
146078534|NCT04002908|526807531|FG002|Overall Study|Withdrawal by Subject|0|||
146078535|NCT04002908|526807532|FG003|Overall Study|Withdrawal by Subject|0|||
146078536|NCT04002908|526807529|FG000|Overall Study|Lost to Follow-up|72|||
146078537|NCT04002908|526807530|FG001|Overall Study|Lost to Follow-up|0|||
146078538|NCT04002908|526807531|FG002|Overall Study|Lost to Follow-up|0|||
146078539|NCT04002908|526807532|FG003|Overall Study|Lost to Follow-up|0|||
146078540|NCT04002908|526807529|FG000|Overall Study|Infant died, so mother withdrawn|34|||
146078541|NCT04002908|526807530|FG001|Overall Study|Infant died, so mother withdrawn|0|||
146078542|NCT04002908|526807531|FG002|Overall Study|Infant died, so mother withdrawn|0|||
146078543|NCT04002908|526807532|FG003|Overall Study|Infant died, so mother withdrawn|0|||
146078544|NCT05477108|526807536|FG000|Overall Study|Participants randomized, not treated|1|||
146078545|NCT05477108|526807537|FG001|Overall Study|Participants randomized, not treated|1|||
146078546|NCT05477108|526807538|FG002|Overall Study|Participants randomized, not treated|1|||
146078547|NCT05477108|526807536|FG000|Overall Study|Physician Decision|0|||
146078548|NCT05477108|526807537|FG001|Overall Study|Physician Decision|0|||
146078549|NCT05477108|526807538|FG002|Overall Study|Physician Decision|1|||
146078550|NCT05477108|526807536|FG000|Overall Study|withdrawn from study|0|||
146078551|NCT05477108|526807537|FG001|Overall Study|withdrawn from study|0|||
146078552|NCT05477108|526807538|FG002|Overall Study|withdrawn from study|1|||
146078553|NCT00334113|526807540|FG000|Overall Study|Lost to Follow-up|2|||
146078554|NCT00334113|526807541|FG001|Overall Study|Lost to Follow-up|2|||
146078555|NCT00334113|526807540|FG000|Overall Study|Withdrawal by Subject|0|||
146078556|NCT00334113|526807541|FG001|Overall Study|Withdrawal by Subject|1|||
146078557|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
146078558|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
146078559|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
146078560|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
146078561|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Other|2|||
146078562|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
146078563|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
146078564|NCT02509026|526807546|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
146078565|NCT02509026|526807546|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
146078566|NCT02509026|526807546|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
146078567|NCT02509026|526807546|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
146078568|NCT02509026|526807546|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
146078569|NCT02509026|526807546|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
146078570|NCT00243841|526807547|FG000|Overall Study|Physician Decision|0|||
146078571|NCT00243841|526807548|FG001|Overall Study|Physician Decision|0|||
146078572|NCT00243841|526807549|FG002|Overall Study|Physician Decision|1|||
146078573|NCT00243841|526807550|FG003|Overall Study|Physician Decision|0|||
146078574|NCT00243841|526807551|FG004|Overall Study|Physician Decision|0|||
146078575|NCT00243841|526807552|FG005|Overall Study|Physician Decision|2|||
146078576|NCT01808092|526807553|FG000|Overall Study|Death|39|||
146078577|NCT01808092|526807554|FG001|Overall Study|Death|29|||
146078578|NCT01808092|526807553|FG000|Overall Study|Lost to Follow-up|3|||
146078579|NCT01808092|526807554|FG001|Overall Study|Lost to Follow-up|7|||
146078580|NCT01808092|526807553|FG000|Overall Study|Withdrawal by Subject|9|||
146078581|NCT01808092|526807554|FG001|Overall Study|Withdrawal by Subject|4|||
146078582|NCT01808092|526807553|FG000|Overall Study|Other Eligibility criteria|3|||
146078583|NCT01808092|526807554|FG001|Overall Study|Other Eligibility criteria|5|||
146078584|NCT03425253|526807559|FG000|Overall Study|Adverse Event|2|||
146078585|NCT03425253|526807559|FG000|Overall Study|Lost to Follow-up|3|||
146078586|NCT03425253|526807559|FG000|Overall Study|Withdrew Consent|6|||
146078587|NCT03425253|526807559|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
146078588|NCT04614324|526807560|FG000|Overall Study|Lost to Follow-up|3|||
146078589|NCT04614324|526807560|FG000|Overall Study|Physician Decision|1|||
146078590|NCT04614324|526807560|FG000|Overall Study|Withdrawal by Subject|2|||
146078591|NCT04614324|526807560|FG000|Overall Study|Remaining in Follow up|123|||
146078592|NCT01031836|526809083|FG000|Stage I|Adverse Event|1|||
146078593|NCT01031836|526809084|FG001|Stage I|Adverse Event|1|||
146078594|NCT01031836|526809085|FG002|Stage I|Adverse Event|0|||
146078595|NCT01031836|526809086|FG003|Stage I|Adverse Event|0|||
146078596|NCT01031836|526809087|FG004|Stage I|Adverse Event|0|||
146078597|NCT01031836|526809088|FG005|Stage I|Adverse Event|0|||
146078598|NCT01031836|526809083|FG000|Stage I|Other|0|||
146078599|NCT01031836|526809084|FG001|Stage I|Other|1|||
146078600|NCT01031836|526809085|FG002|Stage I|Other|0|||
146078601|NCT01031836|526809086|FG003|Stage I|Other|0|||
146078602|NCT01031836|526809087|FG004|Stage I|Other|0|||
146078603|NCT01031836|526809088|FG005|Stage I|Other|1|||
146078604|NCT01031836|526809083|FG000|Stage II|Adverse Event|0|||
146078605|NCT01031836|526809084|FG001|Stage II|Adverse Event|0|||
146078606|NCT01031836|526809085|FG002|Stage II|Adverse Event|2|||
146078607|NCT01031836|526809086|FG003|Stage II|Adverse Event|2|||
146078608|NCT01031836|526809087|FG004|Stage II|Adverse Event|1|||
146078609|NCT01031836|526809088|FG005|Stage II|Adverse Event|1|||
146078610|NCT01031836|526809083|FG000|Stage II|Other|2|||
146078611|NCT01031836|526809084|FG001|Stage II|Other|0|||
146078612|NCT01031836|526809085|FG002|Stage II|Other|0|||
146078613|NCT01031836|526809086|FG003|Stage II|Other|1|||
146078614|NCT01031836|526809087|FG004|Stage II|Other|1|||
146078615|NCT01031836|526809088|FG005|Stage II|Other|0|||
146078616|NCT00490529|526809089|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
146078617|NCT00490529|526809089|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
146078618|NCT00490529|526809089|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
146087738|NCT04393298|526841818|FG008|Overall Study|Patient Discharged to Hospice|1|||
146180130|NCT00802737|527172071|FG000|Overall Study|Received Prohibited Therapy|1|||
146180131|NCT00802737|527172072|FG001|Overall Study|Received Prohibited Therapy|0|||
146180132|NCT00802737|527172073|FG002|Overall Study|Received Prohibited Therapy|0|||
146180133|NCT00802737|527172071|FG000|Overall Study|Ongoing CLL-Treatment|0|||
146180134|NCT00802737|527172072|FG001|Overall Study|Ongoing CLL-Treatment|1|||
146180135|NCT00802737|527172073|FG002|Overall Study|Ongoing CLL-Treatment|0|||
146180136|NCT00802737|527172071|FG000|Overall Study|Participant too Unwell|0|||
146180137|NCT00802737|527172072|FG001|Overall Study|Participant too Unwell|2|||
146180138|NCT00802737|527172073|FG002|Overall Study|Participant too Unwell|0|||
146180139|NCT03864926|527172074|FG000|Overall Study|Death|0|||
146180140|NCT03864926|527172075|FG001|Overall Study|Death|2|||
146180141|NCT00445601|527172076|FG000|Overall Study|Withdrawal by Subject|11|||
146180142|NCT00445601|527172077|FG001|Overall Study|Withdrawal by Subject|11|||
146180143|NCT00445601|527172076|FG000|Overall Study|TURBT Complication|12|||
146180144|NCT00445601|527172077|FG001|Overall Study|TURBT Complication|8|||
146180145|NCT00445601|527172076|FG000|Overall Study|Incorrect Disease Status|6|||
146180146|NCT00445601|527172077|FG001|Overall Study|Incorrect Disease Status|6|||
146180147|NCT00445601|527172076|FG000|Overall Study|Drug Delivery Issue|2|||
146180148|NCT00445601|527172077|FG001|Overall Study|Drug Delivery Issue|2|||
146180149|NCT00445601|527172076|FG000|Overall Study|Adverse Event|2|||
146180150|NCT00445601|527172077|FG001|Overall Study|Adverse Event|0|||
146180151|NCT00445601|527172076|FG000|Overall Study|Death prior to TURBT|0|||
146180152|NCT00445601|527172077|FG001|Overall Study|Death prior to TURBT|1|||
146180153|NCT01091428|527172078|FG000|Phase 1|Progressive Disease|24|||
146180154|NCT01091428|527172079|FG001|Phase 1|Progressive Disease|8|||
146180155|NCT01091428|527172080|FG002|Phase 1|Progressive Disease|0|||
146180156|NCT01091428|527172081|FG003|Phase 1|Progressive Disease|0|||
146180157|NCT01091428|527172078|FG000|Phase 1|Symptomatic Deterioration|3|||
146180158|NCT01091428|527172079|FG001|Phase 1|Symptomatic Deterioration|2|||
146180159|NCT01091428|527172080|FG002|Phase 1|Symptomatic Deterioration|0|||
146180160|NCT01091428|527172081|FG003|Phase 1|Symptomatic Deterioration|0|||
146180161|NCT01091428|527172078|FG000|Phase 1|Adverse Event|2|||
146180162|NCT01091428|527172079|FG001|Phase 1|Adverse Event|0|||
146180163|NCT01091428|527172080|FG002|Phase 1|Adverse Event|0|||
146180164|NCT01091428|527172081|FG003|Phase 1|Adverse Event|0|||
146180165|NCT01091428|527172078|FG000|Phase 1|Withdrawal by Subject|7|||
146180166|NCT01091428|527172079|FG001|Phase 1|Withdrawal by Subject|0|||
146180167|NCT01091428|527172080|FG002|Phase 1|Withdrawal by Subject|0|||
146180168|NCT01091428|527172081|FG003|Phase 1|Withdrawal by Subject|0|||
146180169|NCT01091428|527172078|FG000|Phase 1|Reason not specified|0|||
146180170|NCT01091428|527172079|FG001|Phase 1|Reason not specified|1|||
146180171|NCT01091428|527172080|FG002|Phase 1|Reason not specified|0|||
146180172|NCT01091428|527172081|FG003|Phase 1|Reason not specified|0|||
146180173|NCT01091428|527172078|FG000|Phase 1|Single-Patient IND|2|||
146180174|NCT01091428|527172079|FG001|Phase 1|Single-Patient IND|0|||
146180175|NCT01091428|527172080|FG002|Phase 1|Single-Patient IND|0|||
146180176|NCT01091428|527172081|FG003|Phase 1|Single-Patient IND|0|||
146180177|NCT01091428|527172078|FG000|Phase 2|Progressive Disease|0|||
146180178|NCT01091428|527172079|FG001|Phase 2|Progressive Disease|0|||
146180179|NCT01091428|527172080|FG002|Phase 2|Progressive Disease|44|||
146180180|NCT01091428|527172081|FG003|Phase 2|Progressive Disease|46|||
146180181|NCT01091428|527172078|FG000|Phase 2|Symptomatic Deterioration|0|||
146180182|NCT01091428|527172079|FG001|Phase 2|Symptomatic Deterioration|0|||
146180183|NCT01091428|527172080|FG002|Phase 2|Symptomatic Deterioration|1|||
146180184|NCT01091428|527172081|FG003|Phase 2|Symptomatic Deterioration|6|||
146180185|NCT01091428|527172078|FG000|Phase 2|Adverse Event|0|||
146180186|NCT01091428|527172079|FG001|Phase 2|Adverse Event|0|||
146180187|NCT01091428|527172080|FG002|Phase 2|Adverse Event|12|||
146180188|NCT01091428|527172081|FG003|Phase 2|Adverse Event|5|||
146180189|NCT01091428|527172078|FG000|Phase 2|Withdrawal by Subject|0|||
146180190|NCT01091428|527172079|FG001|Phase 2|Withdrawal by Subject|0|||
146180191|NCT01091428|527172080|FG002|Phase 2|Withdrawal by Subject|9|||
146180192|NCT01091428|527172081|FG003|Phase 2|Withdrawal by Subject|8|||
146180193|NCT01091428|527172078|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
146180194|NCT01091428|527172079|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
146180195|NCT01091428|527172080|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
146180196|NCT01091428|527172081|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
146180197|NCT01091428|527172078|FG000|Phase 2|Reason not specified|0|||
146180198|NCT01091428|527172079|FG001|Phase 2|Reason not specified|0|||
146180199|NCT01091428|527172080|FG002|Phase 2|Reason not specified|4|||
146180200|NCT01091428|527172081|FG003|Phase 2|Reason not specified|3|||
146180201|NCT01091428|527172078|FG000|Phase 2|Physician Decision|0|||
146180202|NCT01091428|527172079|FG001|Phase 2|Physician Decision|0|||
146180203|NCT01091428|527172080|FG002|Phase 2|Physician Decision|2|||
146180204|NCT01091428|527172081|FG003|Phase 2|Physician Decision|0|||
146180205|NCT02391038|527172082|FG000|Overall Study|Progressive disease|3|||
146180206|NCT02391038|527172083|FG001|Overall Study|Progressive disease|3|||
146180207|NCT02391038|527172084|FG002|Overall Study|Progressive disease|6|||
146180208|NCT02959138|527172085|FG000|Overall Study|Enrolled but Never Treated|0|||
146180209|NCT02959138|527172086|FG001|Overall Study|Enrolled but Never Treated|1|||
146180210|NCT02959138|527172087|FG002|Overall Study|Enrolled but Never Treated|0|||
146180211|NCT01327547|527172088|FG000|Overall Study|Adverse Event|4|||
146180212|NCT01327547|527172089|FG001|Overall Study|Adverse Event|1|||
146180213|NCT01327547|527172088|FG000|Overall Study|Death|1|||
146180214|NCT01327547|527172089|FG001|Overall Study|Death|2|||
146180215|NCT01327547|527172088|FG000|Overall Study|Lost to Follow-up|6|||
146180216|NCT01327547|527172089|FG001|Overall Study|Lost to Follow-up|6|||
146180217|NCT01327547|527172088|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146180218|NCT01327547|527172089|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
146180219|NCT01327547|527172088|FG000|Overall Study|Withdrawal by Subject|3|||
146180220|NCT01327547|527172089|FG001|Overall Study|Withdrawal by Subject|7|||
146180221|NCT01327547|527172088|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
146180222|NCT01327547|527172089|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
146180223|NCT01327547|527172088|FG000|Overall Study|Protocol Violation|1|||
146180224|NCT01327547|527172089|FG001|Overall Study|Protocol Violation|0|||
146180225|NCT01327547|527172088|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
146180226|NCT01327547|527172089|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
146180227|NCT01327547|527172088|FG000|Overall Study|Required prohibited medication|2|||
146180228|NCT01327547|527172089|FG001|Overall Study|Required prohibited medication|0|||
146180229|NCT01327547|527172088|FG000|Overall Study|Non-compliance with study procedures|1|||
146180230|NCT01327547|527172089|FG001|Overall Study|Non-compliance with study procedures|0|||
146180231|NCT01327547|527172088|FG000|Overall Study|By investigator in subject's interest|0|||
146180232|NCT01327547|527172089|FG001|Overall Study|By investigator in subject's interest|1|||
146180233|NCT00329719|527172090|FG000|Overall Study|Lost to Follow-up|0|||
146180234|NCT00329719|527172091|FG001|Overall Study|Lost to Follow-up|0|||
146180235|NCT00329719|527172092|FG002|Overall Study|Lost to Follow-up|0|||
146180236|NCT00329719|527172093|FG003|Overall Study|Lost to Follow-up|1|||
146180237|NCT03918239|527172094|FG000|Overall Study|Lost to Follow-up|3|||
146180238|NCT03918239|527172095|FG001|Overall Study|Lost to Follow-up|1|||
146180239|NCT03918239|527172094|FG000|Overall Study|Pregnancy|0|||
146180240|NCT03918239|527172095|FG001|Overall Study|Pregnancy|2|||
146180241|NCT03918239|527172094|FG000|Overall Study|Withdrawal by Subject|3|||
146180242|NCT03918239|527172095|FG001|Overall Study|Withdrawal by Subject|3|||
146180243|NCT03918239|527172094|FG000|Overall Study|positive urine drug screening results|4|||
146180244|NCT03918239|527172095|FG001|Overall Study|positive urine drug screening results|1|||
146180245|NCT02930122|527172096|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
146180246|NCT02930122|527172097|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
146180247|NCT00358215|527172098|FG000|Overall Study|Ineligibility determined|4|||
146180248|NCT00358215|527172099|FG001|Overall Study|Ineligibility determined|3|||
146180249|NCT00358215|527172098|FG000|Overall Study|Adverse Event|83|||
146180250|NCT00358215|527172099|FG001|Overall Study|Adverse Event|65|||
146180251|NCT00358215|527172098|FG000|Overall Study|Withdrawal by Subject|111|||
146180252|NCT00358215|527172099|FG001|Overall Study|Withdrawal by Subject|102|||
146180253|NCT00358215|527172098|FG000|Overall Study|Participant request|65|||
146180254|NCT00358215|527172099|FG001|Overall Study|Participant request|64|||
146180255|NCT00358215|527172098|FG000|Overall Study|Physician Decision|47|||
146180256|NCT00358215|527172099|FG001|Overall Study|Physician Decision|39|||
146180257|NCT00358215|527172098|FG000|Overall Study|Lost to Follow-up|16|||
146180258|NCT00358215|527172099|FG001|Overall Study|Lost to Follow-up|22|||
146180259|NCT00358215|527172098|FG000|Overall Study|Death|265|||
146180260|NCT00358215|527172099|FG001|Overall Study|Death|281|||
146180261|NCT00358215|527172098|FG000|Overall Study|Protocol Violation|64|||
146180262|NCT00358215|527172099|FG001|Overall Study|Protocol Violation|59|||
146180263|NCT00358215|527172098|FG000|Overall Study|Pregnancy|1|||
146180264|NCT00358215|527172099|FG001|Overall Study|Pregnancy|0|||
146180265|NCT00358215|527172098|FG000|Overall Study|Other|21|||
146180266|NCT00358215|527172099|FG001|Overall Study|Other|14|||
146180267|NCT00358215|527172098|FG000|Overall Study|Did not receive investigational product|2|||
146180268|NCT00358215|527172099|FG001|Overall Study|Did not receive investigational product|3|||
146180269|NCT01681368|527172102|FG000|Overall Study|Refused further treatment|1|||
146180270|NCT01681368|527172102|FG000|Overall Study|Refused further follow up|1|||
146180271|NCT00373295|527172103|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146180272|NCT00373295|527172104|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
146180273|NCT00373295|527172105|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146180274|NCT00373295|527172106|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146180275|NCT00373295|527172107|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146180276|NCT00373295|527172108|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146180277|NCT01238575|527172114|FG000|Overall Study|Lack of Efficacy|2|||
146180278|NCT01238575|527172115|FG001|Overall Study|Lack of Efficacy|4|||
146180279|NCT01238575|527172114|FG000|Overall Study|Adverse Event|2|||
146180280|NCT01238575|527172115|FG001|Overall Study|Adverse Event|0|||
146180281|NCT02771210|527172116|FG000|Period 1|Adverse Event|5|||
146180282|NCT02771210|527172117|FG001|Period 1|Adverse Event|3|||
146180283|NCT02771210|527172116|FG000|Period 1|Lack of Efficacy|3|||
146180284|NCT02771210|527172117|FG001|Period 1|Lack of Efficacy|6|||
146180285|NCT02771210|527172116|FG000|Period 1|Lost to Follow-up|2|||
146180286|NCT02771210|527172117|FG001|Period 1|Lost to Follow-up|0|||
146180287|NCT02771210|527172116|FG000|Period 1|Physician Decision|0|||
146180288|NCT02771210|527172117|FG001|Period 1|Physician Decision|1|||
146180289|NCT02771210|527172116|FG000|Period 1|Withdrawal by Subject|0|||
146180290|NCT02771210|527172117|FG001|Period 1|Withdrawal by Subject|3|||
146180291|NCT02771210|527172116|FG000|Period 1|Withdrawal of informed consent|1|||
146180292|NCT02771210|527172117|FG001|Period 1|Withdrawal of informed consent|5|||
146180293|NCT02771210|527172116|FG000|Period 2|Adverse Event|1|||
146180294|NCT02771210|527172117|FG001|Period 2|Adverse Event|0|||
146180295|NCT02771210|527172116|FG000|Period 2|Lack of Efficacy|0|||
146180296|NCT02771210|527172117|FG001|Period 2|Lack of Efficacy|1|||
146180297|NCT02771210|527172116|FG000|Period 2|Withdrawal by Subject|1|||
146180298|NCT02771210|527172117|FG001|Period 2|Withdrawal by Subject|0|||
146180299|NCT02771210|527172116|FG000|Period 2|Withdrawal of informed consent|0|||
146180300|NCT02771210|527172117|FG001|Period 2|Withdrawal of informed consent|2|||
146180301|NCT04012814|527172122|FG000|Overall Study|Lost to Follow-up|4|||
146180302|NCT04012814|527172122|FG000|Overall Study|Withdrawal by Subject|2|||
146180303|NCT04012814|527172122|FG000|Overall Study|Protocol Violation|1|||
146180304|NCT04012814|527172122|FG000|Overall Study|Adverse Event|1|||
146180305|NCT04397523|527172123|FG000|Overall Study|Lost to Follow-up|3|||
146180306|NCT04397523|527172123|FG000|Overall Study|Transfer from/to other hospital|8|||
146180307|NCT02111213|527172129|FG000|Overall Study|Withdrawal by Subject|3|||
146180308|NCT02111213|527172130|FG001|Overall Study|Withdrawal by Subject|2|||
146180309|NCT02111213|527172129|FG000|Overall Study|Lost to Follow-up|3|||
146180310|NCT02111213|527172130|FG001|Overall Study|Lost to Follow-up|4|||
146180311|NCT02226172|527172133|FG000|Overall Study|Participant refused further follow-up|4|||
146180312|NCT02226172|527172133|FG000|Overall Study|Other|5|||
146180313|NCT02226172|527172133|FG000|Overall Study|Death|1|||
146180314|NCT02226172|527172133|FG000|Overall Study|Study terminated by sponsor|1|||
146180315|NCT02226172|527172133|FG000|Overall Study|Adverse Event|6|||
146180316|NCT01865617|527172134|FG000|Overall Study|Death|27|||
146180317|NCT01865617|527172135|FG001|Overall Study|Death|3|||
146180318|NCT01865617|527172136|FG002|Overall Study|Death|1|||
146180319|NCT01865617|527172137|FG003|Overall Study|Death|1|||
146180320|NCT01865617|527172138|FG004|Overall Study|Death|5|||
146180321|NCT01865617|527172139|FG005|Overall Study|Death|1|||
146180322|NCT01865617|527172140|FG006|Overall Study|Death|11|||
146180323|NCT01865617|527172141|FG007|Overall Study|Death|1|||
146180324|NCT01865617|527172142|FG008|Overall Study|Death|11|||
146180325|NCT01865617|527172143|FG009|Overall Study|Death|3|||
146180326|NCT01865617|527172144|FG010|Overall Study|Death|32|||
146180327|NCT01865617|527172145|FG011|Overall Study|Death|6|||
146180328|NCT01865617|527172146|FG012|Overall Study|Death|13|||
146180329|NCT01865617|527172134|FG000|Overall Study|Lost to Follow-up|2|||
146180330|NCT01865617|527172135|FG001|Overall Study|Lost to Follow-up|0|||
146180331|NCT01865617|527172136|FG002|Overall Study|Lost to Follow-up|0|||
146180332|NCT01865617|527172137|FG003|Overall Study|Lost to Follow-up|0|||
146180333|NCT01865617|527172138|FG004|Overall Study|Lost to Follow-up|0|||
146180334|NCT01865617|527172139|FG005|Overall Study|Lost to Follow-up|0|||
146180335|NCT01865617|527172140|FG006|Overall Study|Lost to Follow-up|0|||
146180336|NCT01865617|527172141|FG007|Overall Study|Lost to Follow-up|0|||
146180337|NCT01865617|527172142|FG008|Overall Study|Lost to Follow-up|0|||
146180338|NCT01865617|527172143|FG009|Overall Study|Lost to Follow-up|0|||
146180339|NCT01865617|527172144|FG010|Overall Study|Lost to Follow-up|0|||
146180340|NCT01865617|527172145|FG011|Overall Study|Lost to Follow-up|0|||
146180341|NCT01865617|527172146|FG012|Overall Study|Lost to Follow-up|0|||
146180342|NCT01865617|527172134|FG000|Overall Study|Withdrawal by Subject|1|||
146180343|NCT01865617|527172135|FG001|Overall Study|Withdrawal by Subject|0|||
146180344|NCT01865617|527172136|FG002|Overall Study|Withdrawal by Subject|0|||
146180345|NCT01865617|527172137|FG003|Overall Study|Withdrawal by Subject|0|||
146180346|NCT01865617|527172138|FG004|Overall Study|Withdrawal by Subject|0|||
146180347|NCT01865617|527172139|FG005|Overall Study|Withdrawal by Subject|0|||
146180348|NCT01865617|527172140|FG006|Overall Study|Withdrawal by Subject|0|||
146180349|NCT01865617|527172141|FG007|Overall Study|Withdrawal by Subject|0|||
146180350|NCT01865617|527172142|FG008|Overall Study|Withdrawal by Subject|0|||
146180351|NCT01865617|527172143|FG009|Overall Study|Withdrawal by Subject|0|||
146180352|NCT01865617|527172144|FG010|Overall Study|Withdrawal by Subject|0|||
146180353|NCT01865617|527172145|FG011|Overall Study|Withdrawal by Subject|0|||
146180354|NCT01865617|527172146|FG012|Overall Study|Withdrawal by Subject|0|||
146180355|NCT01865617|527172134|FG000|Overall Study|Patient proceeded to new therapy|0|||
146180356|NCT01865617|527172135|FG001|Overall Study|Patient proceeded to new therapy|0|||
146180357|NCT01865617|527172136|FG002|Overall Study|Patient proceeded to new therapy|0|||
146180358|NCT01865617|527172137|FG003|Overall Study|Patient proceeded to new therapy|0|||
146180359|NCT01865617|527172138|FG004|Overall Study|Patient proceeded to new therapy|2|||
146180360|NCT01865617|527172139|FG005|Overall Study|Patient proceeded to new therapy|0|||
146180361|NCT01865617|527172140|FG006|Overall Study|Patient proceeded to new therapy|0|||
146180362|NCT01865617|527172141|FG007|Overall Study|Patient proceeded to new therapy|0|||
146180363|NCT01865617|527172142|FG008|Overall Study|Patient proceeded to new therapy|0|||
146180364|NCT01865617|527172143|FG009|Overall Study|Patient proceeded to new therapy|0|||
146180365|NCT01865617|527172144|FG010|Overall Study|Patient proceeded to new therapy|0|||
146180366|NCT01865617|527172145|FG011|Overall Study|Patient proceeded to new therapy|0|||
146180367|NCT01865617|527172146|FG012|Overall Study|Patient proceeded to new therapy|0|||
146180368|NCT01865617|527172134|FG000|Overall Study|Other|0|||
146180369|NCT01865617|527172135|FG001|Overall Study|Other|0|||
146180370|NCT01865617|527172136|FG002|Overall Study|Other|0|||
146180371|NCT01865617|527172137|FG003|Overall Study|Other|0|||
146180372|NCT01865617|527172138|FG004|Overall Study|Other|0|||
146180373|NCT01865617|527172139|FG005|Overall Study|Other|0|||
146180374|NCT01865617|527172140|FG006|Overall Study|Other|1|||
146078619|NCT00490529|526809089|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
146078620|NCT00490529|526809089|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
146078621|NCT00490529|526809089|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
146078622|NCT01410357|526809092|FG000|Overall Study|Death|2|||
146078623|NCT01410357|526809093|FG001|Overall Study|Death|1|||
146078624|NCT01410357|526809092|FG000|Overall Study|Withdrawal by Subject|1|||
146078625|NCT01410357|526809093|FG001|Overall Study|Withdrawal by Subject|2|||
146078626|NCT01410357|526809092|FG000|Overall Study|Lost to Follow-up|23|||
146078627|NCT01410357|526809093|FG001|Overall Study|Lost to Follow-up|21|||
146078628|NCT03467152|526809098|FG000|Overall Study|Adverse Event|4|||
146078629|NCT03467152|526809099|FG001|Overall Study|Adverse Event|5|||
146078630|NCT03467152|526809100|FG002|Overall Study|Adverse Event|0|||
146078631|NCT03467152|526809098|FG000|Overall Study|Subject Choice|1|||
146078632|NCT03467152|526809099|FG001|Overall Study|Subject Choice|3|||
146078633|NCT03467152|526809100|FG002|Overall Study|Subject Choice|0|||
146180375|NCT01865617|527172141|FG007|Overall Study|Other|0|||
146180376|NCT01865617|527172142|FG008|Overall Study|Other|0|||
146180377|NCT01865617|527172143|FG009|Overall Study|Other|0|||
146180378|NCT01865617|527172144|FG010|Overall Study|Other|0|||
146180379|NCT01865617|527172145|FG011|Overall Study|Other|0|||
146180380|NCT01865617|527172146|FG012|Overall Study|Other|0|||
146180381|NCT00502996|527172147|FG000|Overall Study|Lost to Follow-up|9|||
146180382|NCT00502996|527172147|FG000|Overall Study|Protocol Violation|2|||
146180383|NCT00502996|527172147|FG000|Overall Study|Treatment failure|25|||
146180384|NCT00502996|527172147|FG000|Overall Study|Withdrawal Informed Consent|6|||
146180385|NCT00502996|527172147|FG000|Overall Study|Adverse Event|2|||
146180386|NCT02500979|527172148|FG000|Period 1|Hyperglycemia|1|||
146180387|NCT02500979|527172149|FG001|Period 1|Hyperglycemia|0|||
146180388|NCT02500979|527172148|FG000|Period 1|Severe non-compliance to protocol|0|||
146180389|NCT02500979|527172149|FG001|Period 1|Severe non-compliance to protocol|1|||
146180390|NCT02500979|527172148|FG000|Period 1|Adverse Event|1|||
146180391|NCT02500979|527172149|FG001|Period 1|Adverse Event|0|||
146180392|NCT02500979|527172148|FG000|Period 1|Subject decision|2|||
146180393|NCT02500979|527172149|FG001|Period 1|Subject decision|0|||
146180394|NCT02500979|527172148|FG000|Period 2|Change in risk|1|||
146180395|NCT02500979|527172149|FG001|Period 2|Change in risk|0|||
146180396|NCT01613027|527172152|FG000|Overall Study|Lost to Follow-up|5|||
146180397|NCT01613027|527172152|FG000|Overall Study|Switched Physician|1|||
146180398|NCT01613027|527172152|FG000|Overall Study|Lack of Efficacy|1|||
146180399|NCT01613027|527172152|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
146180400|NCT02153359|527172153|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
146078634|NCT03467152|526809098|FG000|Overall Study|Lost to Follow-up|1|||
146078635|NCT03467152|526809099|FG001|Overall Study|Lost to Follow-up|0|||
146078636|NCT03467152|526809100|FG002|Overall Study|Lost to Follow-up|0|||
146078637|NCT03467152|526809098|FG000|Overall Study|Withdrawal by Subject|4|||
146078638|NCT03467152|526809099|FG001|Overall Study|Withdrawal by Subject|2|||
146078639|NCT03467152|526809100|FG002|Overall Study|Withdrawal by Subject|0|||
146078640|NCT03467152|526809098|FG000|Overall Study|Others|3|||
146078641|NCT03467152|526809099|FG001|Overall Study|Others|0|||
146078642|NCT03467152|526809100|FG002|Overall Study|Others|0|||
146078643|NCT03467152|526809098|FG000|Overall Study|Not treated|3|||
146078644|NCT03467152|526809099|FG001|Overall Study|Not treated|1|||
146078645|NCT03467152|526809100|FG002|Overall Study|Not treated|6|||
146078646|NCT00945906|526809102|FG000|Overall Study|Withdrawal by Subject|1|||
146078647|NCT00945906|526809102|FG000|Overall Study|Did not want to return for last visit|2|||
146078648|NCT00945906|526809102|FG000|Overall Study|Unable to return for last visit|2|||
146078649|NCT00945906|526809102|FG000|Overall Study|Moved to another country|2|||
146078650|NCT03700684|526809103|FG000|Overall Study|COVID-19|0|||
146078651|NCT03700684|526809104|FG001|Overall Study|COVID-19|0|||
146078652|NCT03700684|526809105|FG002|Overall Study|COVID-19|2|||
146078653|NCT01120782|526809106|FG000|Overall Study|Test article shipping error|11|||
146078654|NCT04140227|526809107|FG000|Overall Study|Withdrawal by Subject|26|||
146078655|NCT04140227|526809107|FG000|Overall Study|Lost to Follow-up|8|||
146078656|NCT04140227|526809107|FG000|Overall Study|Adverse Event|8|||
146180401|NCT02153359|527172154|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
146180402|NCT01040780|527173389|FG000|Overall Study|Protocol Violation|1|||
146180403|NCT01040780|527173390|FG001|Overall Study|Protocol Violation|3|||
146180404|NCT03681639|527173391|FG000|Overall Study|Death|4|||
146180405|NCT03681639|527173391|FG000|Overall Study|Lost to Follow-up|2|||
146180406|NCT03681639|527173391|FG000|Overall Study|Withdrawal by Subject|1|||
146180407|NCT03681639|527173391|FG000|Overall Study|Adverse Event|2|||
146180408|NCT01625910|527173405|FG000|Overall Study|Lost to Follow-up|3|||
146180409|NCT01625910|527173406|FG001|Overall Study|Lost to Follow-up|4|||
146180410|NCT02796963|527173420|FG000|Overall Study|Lost to Follow-up|89|||
146180411|NCT02796963|527173421|FG001|Overall Study|Lost to Follow-up|76|||
146180412|NCT02796963|527173422|FG002|Overall Study|Lost to Follow-up|69|||
146180413|NCT02796963|527173423|FG003|Overall Study|Lost to Follow-up|72|||
146180414|NCT00988351|527173425|FG000|Overall Study|Withdrawal by Subject|8|||
146180415|NCT00988351|527173426|FG001|Overall Study|Withdrawal by Subject|0|||
146180416|NCT00988351|527173425|FG000|Overall Study|Lost to Follow-up|6|||
146180417|NCT00988351|527173426|FG001|Overall Study|Lost to Follow-up|9|||
146180418|NCT00988351|527173425|FG000|Overall Study|not using CPAP|5|||
146180419|NCT00988351|527173426|FG001|Overall Study|not using CPAP|3|||
146180420|NCT01551303|527173438|FG000|Overall Study|failed awareness check on vision test|4|||
146180421|NCT01551303|527173439|FG001|Overall Study|failed awareness check on vision test|7|||
146180422|NCT02878213|527173440|FG000|Overall Study|Withdrawal by Subject|2|||
146180423|NCT02878213|527173440|FG000|Overall Study|Adverse Event|1|||
146180424|NCT02471404|527173446|FG000|Overall Study|Adverse Event|7|||
146180425|NCT02471404|527173447|FG001|Overall Study|Adverse Event|1|||
146078657|NCT04140227|526809107|FG000|Overall Study|Death|1|||
146078658|NCT04140227|526809107|FG000|Overall Study|Other|3|||
146078659|NCT04140227|526809107|FG000|Overall Study|Protocol Violation|2|||
146078660|NCT03180619|526809116|FG000|Overall Study|Withdrew Consent|5|||
146078661|NCT03180619|526809117|FG001|Overall Study|Withdrew Consent|0|||
146078662|NCT03180619|526809118|FG002|Overall Study|Withdrew Consent|2|||
146078663|NCT03180619|526809116|FG000|Overall Study|Death|2|||
146078664|NCT03180619|526809117|FG001|Overall Study|Death|1|||
146078665|NCT03180619|526809118|FG002|Overall Study|Death|2|||
146078666|NCT03180619|526809116|FG000|Overall Study|Adverse Event|2|||
146078667|NCT03180619|526809117|FG001|Overall Study|Adverse Event|0|||
146078668|NCT03180619|526809118|FG002|Overall Study|Adverse Event|1|||
146078669|NCT03180619|526809116|FG000|Overall Study|Investigator's discretion|2|||
146078670|NCT03180619|526809117|FG001|Overall Study|Investigator's discretion|0|||
146078671|NCT03180619|526809118|FG002|Overall Study|Investigator's discretion|1|||
146078672|NCT00729469|526809119|FG000|Overall Study|Adverse Event|14|||
146078673|NCT00729469|526809120|FG001|Overall Study|Adverse Event|25|||
146078674|NCT00729469|526809119|FG000|Overall Study|Lost to Follow-up|9|||
146078675|NCT00729469|526809120|FG001|Overall Study|Lost to Follow-up|9|||
146078676|NCT00729469|526809119|FG000|Overall Study|Protocol Violation|2|||
146078677|NCT00729469|526809120|FG001|Overall Study|Protocol Violation|1|||
146078678|NCT00729469|526809119|FG000|Overall Study|Withdrawal by Subject|19|||
146078679|NCT00729469|526809120|FG001|Overall Study|Withdrawal by Subject|8|||
146078680|NCT00729469|526809119|FG000|Overall Study|Other-Not mentioned|9|||
146078681|NCT00729469|526809120|FG001|Overall Study|Other-Not mentioned|4|||
146078682|NCT00561977|526809123|FG000|Overall Study|Withdrawal by Subject|0|||
146078683|NCT00561977|526809124|FG001|Overall Study|Withdrawal by Subject|2|||
146078684|NCT00561977|526809125|FG002|Overall Study|Withdrawal by Subject|1|||
146078685|NCT00561977|526809123|FG000|Overall Study|Pregnancy|0|||
146078686|NCT00561977|526809124|FG001|Overall Study|Pregnancy|1|||
146078687|NCT00561977|526809125|FG002|Overall Study|Pregnancy|1|||
146078688|NCT04975438|526809126|FG000|Overall Study|Lost to Follow-up|1|||
146078689|NCT04975438|526809127|FG001|Overall Study|Lost to Follow-up|0|||
146078690|NCT04975438|526809128|FG002|Overall Study|Lost to Follow-up|1|||
146078691|NCT04975438|526809129|FG003|Overall Study|Lost to Follow-up|0|||
146078692|NCT04975438|526809126|FG000|Overall Study|Withdrawal by Subject|1|||
146078693|NCT04975438|526809127|FG001|Overall Study|Withdrawal by Subject|0|||
146078694|NCT04975438|526809128|FG002|Overall Study|Withdrawal by Subject|0|||
146078695|NCT04975438|526809129|FG003|Overall Study|Withdrawal by Subject|0|||
146078696|NCT00977080|526809130|FG000|Overall Study|Adverse Event|2|||
146078697|NCT00977080|526809131|FG001|Overall Study|Adverse Event|7|||
146078698|NCT00977080|526809132|FG002|Overall Study|Adverse Event|7|||
146078699|NCT00977080|526809133|FG003|Overall Study|Adverse Event|7|||
146078700|NCT00977080|526809130|FG000|Overall Study|Withdrawal by Subject|1|||
146078701|NCT00977080|526809131|FG001|Overall Study|Withdrawal by Subject|5|||
146078702|NCT00977080|526809132|FG002|Overall Study|Withdrawal by Subject|1|||
146078703|NCT00977080|526809133|FG003|Overall Study|Withdrawal by Subject|5|||
146078704|NCT00977080|526809130|FG000|Overall Study|Protocol Violation|7|||
146078705|NCT00977080|526809131|FG001|Overall Study|Protocol Violation|3|||
146078706|NCT00977080|526809132|FG002|Overall Study|Protocol Violation|4|||
146078707|NCT00977080|526809133|FG003|Overall Study|Protocol Violation|3|||
146078708|NCT00977080|526809130|FG000|Overall Study|Noncompliance|0|||
146078709|NCT00977080|526809131|FG001|Overall Study|Noncompliance|2|||
146078710|NCT00977080|526809132|FG002|Overall Study|Noncompliance|1|||
146078711|NCT00977080|526809133|FG003|Overall Study|Noncompliance|0|||
146078712|NCT00977080|526809130|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146078713|NCT00977080|526809131|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146078714|NCT00977080|526809132|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
146180426|NCT02471404|527173448|FG002|Overall Study|Adverse Event|2|||
146078715|NCT00977080|526809133|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
146078716|NCT00977080|526809130|FG000|Overall Study|Required kidney transplantation|1|||
146078717|NCT00977080|526809131|FG001|Overall Study|Required kidney transplantation|3|||
146078718|NCT00977080|526809132|FG002|Overall Study|Required kidney transplantation|3|||
146078719|NCT00977080|526809133|FG003|Overall Study|Required kidney transplantation|1|||
146078720|NCT00977080|526809130|FG000|Overall Study|Travel for family reasons|1|||
146078721|NCT00977080|526809131|FG001|Overall Study|Travel for family reasons|0|||
146078722|NCT00977080|526809132|FG002|Overall Study|Travel for family reasons|0|||
146180427|NCT02471404|527173446|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
146180428|NCT02471404|527173447|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
146180429|NCT02471404|527173448|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
146180430|NCT02471404|527173446|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
146180431|NCT02471404|527173447|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146180432|NCT02471404|527173448|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
146180433|NCT02471404|527173446|FG000|Overall Study|Lost to Follow-up|1|||
146180434|NCT02471404|527173447|FG001|Overall Study|Lost to Follow-up|1|||
146180435|NCT02471404|527173448|FG002|Overall Study|Lost to Follow-up|3|||
146180436|NCT02471404|527173446|FG000|Overall Study|Protocol Violation|1|||
146180437|NCT02471404|527173447|FG001|Overall Study|Protocol Violation|0|||
146180438|NCT02471404|527173448|FG002|Overall Study|Protocol Violation|0|||
146180439|NCT02471404|527173446|FG000|Overall Study|Withdrawal by Subject|8|||
146180440|NCT02471404|527173447|FG001|Overall Study|Withdrawal by Subject|4|||
146180441|NCT02471404|527173448|FG002|Overall Study|Withdrawal by Subject|5|||
146180442|NCT02471404|527173446|FG000|Overall Study|Other reasons not specified|10|||
146180443|NCT02471404|527173447|FG001|Overall Study|Other reasons not specified|7|||
146180444|NCT02471404|527173448|FG002|Overall Study|Other reasons not specified|12|||
146180445|NCT01927731|527173449|FG000|Overall Study|Graft Failure|1|||
146180446|NCT01927731|527173450|FG001|Overall Study|Graft Failure|2|||
146180447|NCT01927731|527173449|FG000|Overall Study|Physician Decision|2|||
146180448|NCT01927731|527173450|FG001|Overall Study|Physician Decision|3|||
146180449|NCT01927731|527173449|FG000|Overall Study|Withdrawal by Subject|0|||
146180450|NCT01927731|527173450|FG001|Overall Study|Withdrawal by Subject|2|||
146180451|NCT01927731|527173449|FG000|Overall Study|Death|0|||
146180452|NCT01927731|527173450|FG001|Overall Study|Death|3|||
146180453|NCT00305864|527173451|FG000|Overall Study|Ineligible / No protocol treatment|0|||
146180454|NCT00305864|527173452|FG001|Overall Study|Ineligible / No protocol treatment|1|||
146180455|NCT00305864|527173453|FG002|Overall Study|Ineligible / No protocol treatment|1|||
146180456|NCT00305864|527173454|FG003|Overall Study|Ineligible / No protocol treatment|13|||
146180457|NCT01464255|527173455|FG000|Overall Study|unresolve corneal staining|0|||
146180458|NCT01464255|527173456|FG001|Overall Study|unresolve corneal staining|1|||
146180459|NCT00785538|527173458|FG000|Treatment Period|Adverse Event|1|||
146180460|NCT00785538|527173459|FG001|Treatment Period|Adverse Event|2|||
146180461|NCT00785538|527173460|FG002|Treatment Period|Adverse Event|2|||
146180462|NCT00785538|527173461|FG003|Treatment Period|Adverse Event|0|||
146180463|NCT00785538|527173458|FG000|Treatment Period|Withdrawal by Subject|0|||
146180464|NCT00785538|527173459|FG001|Treatment Period|Withdrawal by Subject|0|||
146180465|NCT00785538|527173460|FG002|Treatment Period|Withdrawal by Subject|0|||
146180466|NCT00785538|527173461|FG003|Treatment Period|Withdrawal by Subject|1|||
146180467|NCT04276090|527173462|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
146180468|NCT04276090|527173463|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
146180469|NCT04642469|527173464|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
146180470|NCT04642469|527173465|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
146412149|NCT00373685|528014040|FG000|Overall Study|Insufficient clinical response|169|||
146412150|NCT00373685|528014041|FG001|Overall Study|Insufficient clinical response|119|||
146412151|NCT00373685|528014040|FG000|Overall Study|Did not meet entrance criteria|167|||
146412152|NCT00373685|528014041|FG001|Overall Study|Did not meet entrance criteria|184|||
146412153|NCT00373685|528014040|FG000|Overall Study|Lost to follow up|83|||
146412154|NCT00373685|528014041|FG001|Overall Study|Lost to follow up|103|||
146412155|NCT00373685|528014040|FG000|Overall Study|No longer willing to participate|337|||
146412156|NCT00373685|528014041|FG001|Overall Study|No longer willing to participate|352|||
146412157|NCT00373685|528014040|FG000|Overall Study|Other|149|||
146412158|NCT00373685|528014041|FG001|Overall Study|Other|146|||
146412159|NCT00373685|528014040|FG000|Overall Study|Protocol Violation|191|||
146412160|NCT00373685|528014041|FG001|Overall Study|Protocol Violation|182|||
146412161|NCT00373685|528014040|FG000|Overall Study|Final Status Unknown|12|||
146412162|NCT00373685|528014041|FG001|Overall Study|Final Status Unknown|4|||
146412163|NCT00373685|528014040|FG000|Overall Study|Randomized, not treated|51|||
146412164|NCT00373685|528014041|FG001|Overall Study|Randomized, not treated|77|||
146412165|NCT02570165|528014042|FG000|Overall Study|Adverse Event|1|||
146412166|NCT02570165|528014043|FG001|Overall Study|Adverse Event|0|||
146412167|NCT02570165|528014044|FG002|Overall Study|Adverse Event|2|||
146412168|NCT02570165|528014045|FG003|Overall Study|Adverse Event|0|||
146412169|NCT02570165|528014046|FG004|Overall Study|Adverse Event|0|||
146412170|NCT02570165|528014047|FG005|Overall Study|Adverse Event|0|||
146412171|NCT02570165|528014048|FG006|Overall Study|Adverse Event|0|||
146412172|NCT02570165|528014042|FG000|Overall Study|Lack of Efficacy|0|||
146412173|NCT02570165|528014043|FG001|Overall Study|Lack of Efficacy|1|||
146412174|NCT02570165|528014044|FG002|Overall Study|Lack of Efficacy|0|||
146412175|NCT02570165|528014045|FG003|Overall Study|Lack of Efficacy|0|||
146412176|NCT02570165|528014046|FG004|Overall Study|Lack of Efficacy|4|||
146412177|NCT02570165|528014047|FG005|Overall Study|Lack of Efficacy|0|||
146412178|NCT02570165|528014048|FG006|Overall Study|Lack of Efficacy|0|||
146412179|NCT02570165|528014042|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
146412180|NCT02570165|528014043|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
146412181|NCT02570165|528014044|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
146412182|NCT02570165|528014045|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
146412183|NCT02570165|528014046|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
146412184|NCT02570165|528014047|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
146412185|NCT02570165|528014048|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
146412186|NCT02570165|528014042|FG000|Overall Study|Lost to Follow-up|0|||
146412187|NCT02570165|528014043|FG001|Overall Study|Lost to Follow-up|0|||
146412188|NCT02570165|528014044|FG002|Overall Study|Lost to Follow-up|1|||
146412189|NCT02570165|528014045|FG003|Overall Study|Lost to Follow-up|1|||
146412190|NCT02570165|528014046|FG004|Overall Study|Lost to Follow-up|0|||
146412191|NCT02570165|528014047|FG005|Overall Study|Lost to Follow-up|0|||
146412192|NCT02570165|528014048|FG006|Overall Study|Lost to Follow-up|0|||
146412193|NCT02570165|528014042|FG000|Overall Study|Physician Decision|0|||
146412194|NCT02570165|528014043|FG001|Overall Study|Physician Decision|1|||
146412195|NCT02570165|528014044|FG002|Overall Study|Physician Decision|0|||
146412196|NCT02570165|528014045|FG003|Overall Study|Physician Decision|0|||
146412197|NCT02570165|528014046|FG004|Overall Study|Physician Decision|0|||
146078723|NCT00977080|526809133|FG003|Overall Study|Travel for family reasons|0|||
146078724|NCT00566696|526809134|FG000|Overall Study|Met Exclusion Criteria|2|||
146078725|NCT00566696|526809134|FG000|Overall Study|Muromonab not available|1|||
146078726|NCT00566696|526809134|FG000|Overall Study|Health Status Change|1|||
146078727|NCT00566696|526809134|FG000|Overall Study|Physician Decision|1|||
146078728|NCT00566696|526809134|FG000|Overall Study|Non-Patient Donors|37|||
146078729|NCT00275340|526809142|FG000|Overall Study|Lost to Follow-up|2|||
146078730|NCT00275340|526809143|FG001|Overall Study|Lost to Follow-up|4|||
146078731|NCT02032238|526809145|FG000|Overall Study|Lost to Follow-up|2|||
146078732|NCT02032238|526809146|FG001|Overall Study|Lost to Follow-up|0|||
146078733|NCT00653939|526809147|FG000|Overall Study|Adverse Event|1|||
146078734|NCT00653939|526809148|FG001|Overall Study|Adverse Event|3|||
146078735|NCT00653939|526809147|FG000|Overall Study|Withdrawal by Subject|3|||
146078736|NCT00653939|526809148|FG001|Overall Study|Withdrawal by Subject|3|||
146078737|NCT00653939|526809147|FG000|Overall Study|Physician Decision|4|||
146078738|NCT00653939|526809148|FG001|Overall Study|Physician Decision|0|||
146078739|NCT00653939|526809147|FG000|Overall Study|Disease Progression|2|||
146078740|NCT00653939|526809148|FG001|Overall Study|Disease Progression|3|||
146078741|NCT00653939|526809147|FG000|Overall Study|Other|2|||
146078742|NCT00653939|526809148|FG001|Overall Study|Other|6|||
146078743|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
146078744|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
146078745|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
146078746|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
146078747|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
146078748|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
146078749|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
146078750|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
146078751|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
146078752|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
146078753|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
146078754|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
146078755|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
146078756|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
146180471|NCT04642469|527173464|FG000|Overall Study|Death|1|||
146078757|NCT00612105|526809149|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
146180472|NCT04642469|527173465|FG001|Overall Study|Death|2|||
146180473|NCT04642469|527173464|FG000|Overall Study|Study/site closed following amendment 1|11|||
146180474|NCT04642469|527173465|FG001|Overall Study|Study/site closed following amendment 1|11|||
146180475|NCT04642469|527173464|FG000|Overall Study|Other|1|||
146180476|NCT04642469|527173465|FG001|Overall Study|Other|1|||
146180477|NCT04642469|527173464|FG000|Overall Study|Withdrawal by Subject|1|||
146180478|NCT04642469|527173465|FG001|Overall Study|Withdrawal by Subject|0|||
146180479|NCT01088529|527173467|FG000|Overall Study|Did not receive study treatment|0|||
146180480|NCT01088529|527173468|FG001|Overall Study|Did not receive study treatment|1|||
146180481|NCT02066532|527173471|FG000|Phase II|Withdrawal by Subject|1|||
146180482|NCT02066532|527173472|FG001|Phase II|Withdrawal by Subject|0|||
146180483|NCT02066532|527173473|FG002|Phase II|Withdrawal by Subject|0|||
146180484|NCT02066532|527173474|FG003|Phase II|Withdrawal by Subject|0|||
146180485|NCT05033080|527173475|FG000|Overall Study|Adverse Event|4|||
146180486|NCT05033080|527173476|FG001|Overall Study|Adverse Event|4|||
146180487|NCT05033080|527173475|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
146180488|NCT05033080|527173476|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
146180489|NCT05033080|527173475|FG000|Overall Study|Lost to Follow-up|1|||
146180490|NCT05033080|527173476|FG001|Overall Study|Lost to Follow-up|0|||
146412198|NCT02570165|528014047|FG005|Overall Study|Physician Decision|0|||
146412199|NCT02570165|528014048|FG006|Overall Study|Physician Decision|0|||
146283931|NCT00604825|527551906|FG002|Overall Study|Lost to Follow-up|1|||
146412200|NCT02570165|528014042|FG000|Overall Study|Withdrawal by Subject|0|||
146412201|NCT02570165|528014043|FG001|Overall Study|Withdrawal by Subject|0|||
146412202|NCT02570165|528014044|FG002|Overall Study|Withdrawal by Subject|0|||
146412203|NCT02570165|528014045|FG003|Overall Study|Withdrawal by Subject|2|||
146412204|NCT02570165|528014046|FG004|Overall Study|Withdrawal by Subject|1|||
146412205|NCT02570165|528014047|FG005|Overall Study|Withdrawal by Subject|0|||
146412206|NCT02570165|528014048|FG006|Overall Study|Withdrawal by Subject|0|||
146412207|NCT02570165|528014042|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412208|NCT02570165|528014043|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412209|NCT02570165|528014044|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412210|NCT02570165|528014045|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412211|NCT02570165|528014046|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412212|NCT02570165|528014047|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
146412213|NCT02570165|528014048|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
146412214|NCT02570165|528014042|FG000|Overall Study|Withdrawal Request by GSK|0|||
146412215|NCT02570165|528014043|FG001|Overall Study|Withdrawal Request by GSK|0|||
146412216|NCT02570165|528014044|FG002|Overall Study|Withdrawal Request by GSK|2|||
146412217|NCT02570165|528014045|FG003|Overall Study|Withdrawal Request by GSK|0|||
146412218|NCT02570165|528014046|FG004|Overall Study|Withdrawal Request by GSK|0|||
146412219|NCT02570165|528014047|FG005|Overall Study|Withdrawal Request by GSK|0|||
146412220|NCT02570165|528014048|FG006|Overall Study|Withdrawal Request by GSK|0|||
146412221|NCT00411762|528014051|FG000|Overall Study|Withdrawal by Subject|5|||
146412222|NCT04428502|528014052|FG000|Overall Study|Did not meet entrance criteria|14|||
146412223|NCT03712228|528014056|FG000|Treatment Period 1|Lack of Efficacy|0|||
146412224|NCT03712228|528014057|FG001|Treatment Period 1|Lack of Efficacy|0|||
146412225|NCT03712228|528014058|FG002|Treatment Period 1|Lack of Efficacy|0|||
146412226|NCT03712228|528014059|FG003|Treatment Period 1|Lack of Efficacy|0|||
146412227|NCT03712228|528014060|FG004|Treatment Period 1|Lack of Efficacy|0|||
146412228|NCT03712228|528014061|FG005|Treatment Period 1|Lack of Efficacy|1|||
146412229|NCT03712228|528014056|FG000|Treatment Period 2|Pregnancy|0|||
146412230|NCT03712228|528014057|FG001|Treatment Period 2|Pregnancy|0|||
146412231|NCT03712228|528014058|FG002|Treatment Period 2|Pregnancy|0|||
146412232|NCT03712228|528014059|FG003|Treatment Period 2|Pregnancy|1|||
146412233|NCT03712228|528014060|FG004|Treatment Period 2|Pregnancy|0|||
146412234|NCT03712228|528014061|FG005|Treatment Period 2|Pregnancy|0|||
146412235|NCT03712228|528014056|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146412236|NCT03712228|528014057|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146412237|NCT03712228|528014058|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146412238|NCT03712228|528014059|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146412239|NCT03712228|528014060|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146412240|NCT03712228|528014061|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146412241|NCT01430104|528014062|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
146412242|NCT05288673|528014063|FG000|Overall Study|Consent withdrawn by subject|0|||
146412243|NCT05288673|528014064|FG001|Overall Study|Consent withdrawn by subject|0|||
146412244|NCT05288673|528014065|FG002|Overall Study|Consent withdrawn by subject|1|||
146412245|NCT04147611|528014073|FG000|Overall Study|Physician Decision|0|||
146412246|NCT04147611|528014074|FG001|Overall Study|Physician Decision|1|||
146412247|NCT05003167|528014075|FG000|Overall Study|Withdrawal by Subject|1|||
146412248|NCT01010230|528014076|FG000|Overall Study|Withdrawal by Subject|6|||
146412249|NCT01010230|528014077|FG001|Overall Study|Withdrawal by Subject|5|||
146412250|NCT01010230|528014076|FG000|Overall Study|Lost to Follow-up|4|||
146412251|NCT01010230|528014077|FG001|Overall Study|Lost to Follow-up|2|||
146412252|NCT01585831|528014078|FG000|Overall Study|Physician Decision|0|||
146412253|NCT01585831|528014079|FG001|Overall Study|Physician Decision|1|||
146412254|NCT01585831|528014078|FG000|Overall Study|Withdrawal by Subject|2|||
146412255|NCT01585831|528014079|FG001|Overall Study|Withdrawal by Subject|1|||
146412256|NCT01123980|528014080|FG000|Overall Study|Adverse Event|1|||
146412257|NCT01123980|528014081|FG001|Overall Study|Adverse Event|1|||
146412258|NCT01123980|528014080|FG000|Overall Study|Lack of Efficacy|1|||
146412259|NCT01123980|528014081|FG001|Overall Study|Lack of Efficacy|0|||
146412260|NCT01123980|528014080|FG000|Overall Study|Physician Decision|0|||
146412261|NCT01123980|528014081|FG001|Overall Study|Physician Decision|1|||
146412262|NCT01123980|528014080|FG000|Overall Study|Lost to Follow-up|0|||
146412263|NCT01123980|528014081|FG001|Overall Study|Lost to Follow-up|6|||
146412264|NCT01123980|528014080|FG000|Overall Study|Protocol Violation|6|||
146412265|NCT01123980|528014081|FG001|Overall Study|Protocol Violation|6|||
146412266|NCT01123980|528014080|FG000|Overall Study|Withdrawal by Subject|5|||
146412267|NCT01123980|528014081|FG001|Overall Study|Withdrawal by Subject|3|||
146412268|NCT01123980|528014080|FG000|Overall Study|Unclassified|6|||
146412269|NCT01123980|528014081|FG001|Overall Study|Unclassified|7|||
146180491|NCT05033080|527173475|FG000|Overall Study|Other non-compliance|0|||
146180492|NCT05033080|527173476|FG001|Overall Study|Other non-compliance|1|||
146180493|NCT05033080|527173475|FG000|Overall Study|Physician Decision|0|||
146180494|NCT05033080|527173476|FG001|Overall Study|Physician Decision|1|||
146180495|NCT05033080|527173475|FG000|Overall Study|Other|1|||
146180496|NCT05033080|527173476|FG001|Overall Study|Other|1|||
146180497|NCT03560245|527173477|FG000|Overall Study|Withdrawal by Subject|3|||
146180498|NCT03560245|527173478|FG001|Overall Study|Withdrawal by Subject|2|||
146180499|NCT03560245|527173477|FG000|Overall Study|Adverse Event|1|||
146180500|NCT03560245|527173478|FG001|Overall Study|Adverse Event|1|||
146180501|NCT03560245|527173477|FG000|Overall Study|Protocol Violation|1|||
146180502|NCT03560245|527173478|FG001|Overall Study|Protocol Violation|0|||
146180503|NCT03560245|527173477|FG000|Overall Study|Death|0|||
146180504|NCT03560245|527173478|FG001|Overall Study|Death|1|||
146180505|NCT03560245|527173477|FG000|Overall Study|Lost to Follow-up|0|||
146180506|NCT03560245|527173478|FG001|Overall Study|Lost to Follow-up|1|||
146180507|NCT03560245|527173477|FG000|Overall Study|Physician Decision|0|||
146180508|NCT03560245|527173478|FG001|Overall Study|Physician Decision|1|||
146180509|NCT03560245|527173477|FG000|Overall Study|Other|0|||
146180510|NCT03560245|527173478|FG001|Overall Study|Other|1|||
146180511|NCT01265823|527173479|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
146180512|NCT01265823|527173479|FG000|Overall Study|Failure to Return|4|||
146180513|NCT01265823|527173479|FG000|Overall Study|Protocol Violation|1|||
146180514|NCT01265823|527173479|FG000|Overall Study|Participant Request|1|||
146180515|NCT01263106|527173480|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146180516|NCT01263106|527173481|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146180517|NCT02302066|527173485|FG000|Overall Study|Adverse Event|1|||
146180518|NCT02302066|527173486|FG001|Overall Study|Adverse Event|1|||
146180519|NCT02302066|527173487|FG002|Overall Study|Adverse Event|3|||
146180520|NCT02302066|527173488|FG003|Overall Study|Adverse Event|0|||
146180521|NCT02302066|527173485|FG000|Overall Study|Lost to Follow-up|4|||
146180522|NCT02302066|527173486|FG001|Overall Study|Lost to Follow-up|5|||
146180523|NCT02302066|527173487|FG002|Overall Study|Lost to Follow-up|24|||
146180524|NCT02302066|527173488|FG003|Overall Study|Lost to Follow-up|7|||
146180525|NCT02302066|527173485|FG000|Overall Study|Withdrawal by Subject|25|||
146180526|NCT02302066|527173486|FG001|Overall Study|Withdrawal by Subject|58|||
146180527|NCT02302066|527173487|FG002|Overall Study|Withdrawal by Subject|124|||
146180528|NCT02302066|527173488|FG003|Overall Study|Withdrawal by Subject|33|||
146180529|NCT02302066|527173485|FG000|Overall Study|Pregnancy|2|||
146180530|NCT02302066|527173486|FG001|Overall Study|Pregnancy|10|||
146180531|NCT02302066|527173487|FG002|Overall Study|Pregnancy|12|||
146180532|NCT02302066|527173488|FG003|Overall Study|Pregnancy|0|||
146078758|NCT00612105|526809150|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
146078759|NCT00612105|526809149|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
146078760|NCT00612105|526809150|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
146078761|NCT00612105|526809149|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
146078762|NCT00612105|526809150|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
146078763|NCT00612105|526809149|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
146078764|NCT00612105|526809150|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
146078765|NCT00612105|526809149|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
146078766|NCT00612105|526809150|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
146078767|NCT00717236|526809151|FG000|Double-Blind Period|Adverse Event|33|||
146078768|NCT00717236|526809152|FG001|Double-Blind Period|Adverse Event|6|||
146078769|NCT00717236|526809151|FG000|Double-Blind Period|Lack of Efficacy|6|||
146078770|NCT00717236|526809152|FG001|Double-Blind Period|Lack of Efficacy|6|||
146078771|NCT00717236|526809151|FG000|Double-Blind Period|Lost to Follow-up|3|||
146078772|NCT00717236|526809152|FG001|Double-Blind Period|Lost to Follow-up|5|||
146078773|NCT00717236|526809151|FG000|Double-Blind Period|Withdrawal by Subject|10|||
146078774|NCT00717236|526809152|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146078775|NCT00717236|526809151|FG000|Double-Blind Period|Loss of efficacy|3|||
146078776|NCT00717236|526809152|FG001|Double-Blind Period|Loss of efficacy|0|||
146078777|NCT00717236|526809151|FG000|Double-Blind Period|Other: Death|1|||
146078778|NCT00717236|526809152|FG001|Double-Blind Period|Other: Death|0|||
146078779|NCT00717236|526809151|FG000|Double-Blind Period|Other: Pregnancy|1|||
146078780|NCT00717236|526809152|FG001|Double-Blind Period|Other: Pregnancy|0|||
146078781|NCT00717236|526809151|FG000|Double-Blind Period|Other: Protocol Violation|2|||
146078782|NCT00717236|526809152|FG001|Double-Blind Period|Other: Protocol Violation|0|||
146078783|NCT00717236|526809151|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
146078784|NCT00717236|526809152|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
146078785|NCT00717236|526809151|FG000|Double-Blind Period|Other: Site withdrew|2|||
146078786|NCT00717236|526809152|FG001|Double-Blind Period|Other: Site withdrew|0|||
146078787|NCT00717236|526809151|FG000|Double-Blind Period|Other: Screening failure|1|||
146078788|NCT00717236|526809152|FG001|Double-Blind Period|Other: Screening failure|0|||
146078789|NCT00717236|526809151|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
146078790|NCT00717236|526809152|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
146078791|NCT00717236|526809151|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
146078792|NCT00717236|526809152|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
146078793|NCT00717236|526809151|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
146078794|NCT00717236|526809152|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
146078795|NCT00717236|526809151|FG000|Double-Blind Period|Other: History of cancer|1|||
146078796|NCT00717236|526809152|FG001|Double-Blind Period|Other: History of cancer|0|||
146078797|NCT00717236|526809151|FG000|Double-Blind Period|Other: Sponsor request|1|||
146078798|NCT00717236|526809152|FG001|Double-Blind Period|Other: Sponsor request|0|||
146078799|NCT00717236|526809151|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
146078800|NCT00717236|526809152|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
146078801|NCT00717236|526809151|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
146078802|NCT00717236|526809152|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
146078803|NCT00717236|526809151|FG000|Double-Blind Period|Other: Subject moved|1|||
146078804|NCT00717236|526809152|FG001|Double-Blind Period|Other: Subject moved|1|||
146078805|NCT00717236|526809151|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
146078806|NCT00717236|526809152|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
146078807|NCT00717236|526809151|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
146078808|NCT00717236|526809152|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
146078809|NCT00717236|526809151|FG000|Double-Blind Period|Other: Transportation problems|0|||
146078810|NCT00717236|526809152|FG001|Double-Blind Period|Other: Transportation problems|1|||
146078811|NCT00717236|526809151|FG000|Double-Blind Period|Other: Investigator Decision|0|||
146078812|NCT00717236|526809152|FG001|Double-Blind Period|Other: Investigator Decision|1|||
146078813|NCT00717236|526809151|FG000|Open-Label Period|Adverse Event|29|||
146078814|NCT00717236|526809152|FG001|Open-Label Period|Adverse Event|4|||
146078815|NCT00717236|526809151|FG000|Open-Label Period|Lack of Efficacy|30|||
146078816|NCT00717236|526809152|FG001|Open-Label Period|Lack of Efficacy|8|||
146078817|NCT00717236|526809151|FG000|Open-Label Period|Lost to Follow-up|28|||
146078818|NCT00717236|526809152|FG001|Open-Label Period|Lost to Follow-up|4|||
146078819|NCT00717236|526809151|FG000|Open-Label Period|Withdrawal by Subject|20|||
146078820|NCT00717236|526809152|FG001|Open-Label Period|Withdrawal by Subject|2|||
146283932|NCT00604825|527551907|FG003|Overall Study|Lost to Follow-up|0|||
146078821|NCT00717236|526809151|FG000|Open-Label Period|Loss of Efficacy|6|||
146078822|NCT00717236|526809152|FG001|Open-Label Period|Loss of Efficacy|1|||
146078823|NCT00717236|526809151|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
146078824|NCT00717236|526809152|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
146078825|NCT00717236|526809151|FG000|Open-Label Period|Other: Lack of Compliance|1|||
146412270|NCT01225991|528014082|FG000|Overall Study|Withdrawal by Subject|6|||
146412271|NCT04444752|528014083|FG000|Overall Study|Adverse Event|1|||
146412272|NCT04444752|528014084|FG001|Overall Study|Adverse Event|0|||
146412273|NCT04444752|528014085|FG002|Overall Study|Adverse Event|0|||
146412274|NCT04444752|528014086|FG003|Overall Study|Adverse Event|2|||
146412275|NCT04444752|528014083|FG000|Overall Study|Lost to Follow-up|2|||
146412276|NCT04444752|528014084|FG001|Overall Study|Lost to Follow-up|6|||
146412277|NCT04444752|528014085|FG002|Overall Study|Lost to Follow-up|2|||
146412278|NCT04444752|528014086|FG003|Overall Study|Lost to Follow-up|5|||
146412279|NCT04444752|528014083|FG000|Overall Study|Physician Decision|0|||
146412280|NCT04444752|528014084|FG001|Overall Study|Physician Decision|0|||
146412281|NCT04444752|528014085|FG002|Overall Study|Physician Decision|0|||
146412282|NCT04444752|528014086|FG003|Overall Study|Physician Decision|2|||
146412283|NCT04444752|528014083|FG000|Overall Study|Pregnancy|0|||
146412284|NCT04444752|528014084|FG001|Overall Study|Pregnancy|0|||
146412285|NCT04444752|528014085|FG002|Overall Study|Pregnancy|0|||
146412286|NCT04444752|528014086|FG003|Overall Study|Pregnancy|1|||
146412287|NCT04444752|528014083|FG000|Overall Study|Withdrawal by Subject|6|||
146412288|NCT04444752|528014084|FG001|Overall Study|Withdrawal by Subject|5|||
146412289|NCT04444752|528014085|FG002|Overall Study|Withdrawal by Subject|3|||
146412290|NCT04444752|528014086|FG003|Overall Study|Withdrawal by Subject|4|||
146078826|NCT00717236|526809152|FG001|Open-Label Period|Other: Lack of Compliance|1|||
146078827|NCT00717236|526809151|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
146078828|NCT00717236|526809152|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
146078829|NCT00717236|526809151|FG000|Open-Label Period|Other: Moved|1|||
146078830|NCT00717236|526809152|FG001|Open-Label Period|Other: Moved|0|||
146078831|NCT00717236|526809151|FG000|Open-Label Period|Other: Investigator Decision|1|||
146078832|NCT00717236|526809152|FG001|Open-Label Period|Other: Investigator Decision|0|||
146078833|NCT00717236|526809151|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
146078834|NCT00717236|526809152|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
146078835|NCT00717236|526809151|FG000|Open-Label Period|Other: Sponsor Request|3|||
146078836|NCT00717236|526809152|FG001|Open-Label Period|Other: Sponsor Request|0|||
146078837|NCT00717236|526809151|FG000|Open-Label Period|Other: Cataract Surgery|1|||
146078838|NCT00717236|526809152|FG001|Open-Label Period|Other: Cataract Surgery|0|||
146078839|NCT00717236|526809151|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
146078840|NCT00717236|526809152|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
146078841|NCT00717236|526809151|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
146078842|NCT00717236|526809152|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
146078843|NCT00717236|526809151|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
146078844|NCT00717236|526809152|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
146078845|NCT00475982|526809153|FG000|Overall Study|surgery rescheduled|7|||
146078846|NCT00475982|526809154|FG001|Overall Study|surgery rescheduled|3|||
146078847|NCT01105767|526809155|FG000|Overall Study|Lost to Follow-up|1160|||
146078848|NCT01105767|526809156|FG001|Overall Study|Lost to Follow-up|1614|||
146078849|NCT01105767|526809157|FG002|Overall Study|Lost to Follow-up|1184|||
146412291|NCT04444752|528014083|FG000|Overall Study|Protocol Violation|1|||
146412292|NCT04444752|528014084|FG001|Overall Study|Protocol Violation|1|||
146412293|NCT04444752|528014085|FG002|Overall Study|Protocol Violation|0|||
146412294|NCT04444752|528014086|FG003|Overall Study|Protocol Violation|0|||
146180533|NCT02302066|527173485|FG000|Overall Study|Reason Not Specified|1|||
146180534|NCT02302066|527173486|FG001|Overall Study|Reason Not Specified|1|||
146180535|NCT02302066|527173487|FG002|Overall Study|Reason Not Specified|9|||
146180536|NCT02302066|527173488|FG003|Overall Study|Reason Not Specified|1|||
146180537|NCT02180438|527173504|FG000|Overall Study|Lost to Follow-up|1|||
146180538|NCT02058290|527173505|FG000|Overall Study|Protocol Violation|2|||
146180539|NCT02058290|527173506|FG001|Overall Study|Protocol Violation|1|||
146180540|NCT02058290|527173505|FG000|Overall Study|Physician Decision|1|||
146180541|NCT02058290|527173506|FG001|Overall Study|Physician Decision|0|||
146180542|NCT02058290|527173505|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
146180543|NCT02058290|527173506|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
146180544|NCT02058290|527173505|FG000|Overall Study|Withdrawal by Subject|0|||
146180545|NCT02058290|527173506|FG001|Overall Study|Withdrawal by Subject|1|||
146180546|NCT00785707|527173508|FG000|Overall Study|Lost to Follow-up|7|||
146180547|NCT00105586|527173511|FG000|Overall Study|Adverse Event|4|||
146180548|NCT00105586|527173512|FG001|Overall Study|Adverse Event|3|||
146180549|NCT00105586|527173511|FG000|Overall Study|Physician Decision|13|||
146180550|NCT00105586|527173512|FG001|Overall Study|Physician Decision|13|||
146180551|NCT02262260|527173515|FG000|Overall Study|Adverse Event|4|||
146180552|NCT02262260|527173516|FG001|Overall Study|Adverse Event|1|||
146180553|NCT02262260|527173515|FG000|Overall Study|Withdrawal of consent|4|||
146180554|NCT02262260|527173516|FG001|Overall Study|Withdrawal of consent|2|||
146180555|NCT02262260|527173515|FG000|Overall Study|Lost to Follow-up|1|||
146180556|NCT02262260|527173516|FG001|Overall Study|Lost to Follow-up|2|||
146180557|NCT02262260|527173515|FG000|Overall Study|Protocol deviation|2|||
146180558|NCT02262260|527173516|FG001|Overall Study|Protocol deviation|5|||
146078850|NCT00783198|526809163|FG000|Overall Study|Adverse Event|15|||
146078851|NCT00783198|526809164|FG001|Overall Study|Adverse Event|19|||
146078852|NCT00783198|526809165|FG002|Overall Study|Adverse Event|3|||
146078853|NCT00783198|526809163|FG000|Overall Study|Lost to Follow-up|11|||
146078854|NCT00783198|526809164|FG001|Overall Study|Lost to Follow-up|1|||
146078855|NCT00783198|526809165|FG002|Overall Study|Lost to Follow-up|7|||
146078856|NCT00783198|526809163|FG000|Overall Study|Withdrawal by Subject|22|||
146078857|NCT00783198|526809164|FG001|Overall Study|Withdrawal by Subject|14|||
146078858|NCT00783198|526809165|FG002|Overall Study|Withdrawal by Subject|20|||
146078859|NCT00783198|526809163|FG000|Overall Study|Noncompliance with protocol|7|||
146078860|NCT00783198|526809164|FG001|Overall Study|Noncompliance with protocol|7|||
146078861|NCT00783198|526809165|FG002|Overall Study|Noncompliance with protocol|10|||
146078862|NCT00783198|526809163|FG000|Overall Study|Did not meet protocol eligibility|0|||
146078863|NCT00783198|526809164|FG001|Overall Study|Did not meet protocol eligibility|1|||
146078864|NCT00783198|526809165|FG002|Overall Study|Did not meet protocol eligibility|0|||
146078865|NCT00783198|526809163|FG000|Overall Study|Administrative|2|||
146078866|NCT00783198|526809164|FG001|Overall Study|Administrative|1|||
146078867|NCT00783198|526809165|FG002|Overall Study|Administrative|2|||
146078868|NCT01510769|526809166|FG000|Overall Study|Adverse Event|7|||
146078869|NCT01510769|526809167|FG001|Overall Study|Adverse Event|6|||
146078870|NCT01510769|526809168|FG002|Overall Study|Adverse Event|4|||
146078871|NCT01510769|526809166|FG000|Overall Study|Gout Flare|0|||
146078872|NCT01510769|526809167|FG001|Overall Study|Gout Flare|3|||
146078873|NCT01510769|526809168|FG002|Overall Study|Gout Flare|1|||
146078874|NCT01510769|526809166|FG000|Overall Study|Protocol Violation|11|||
146078875|NCT01510769|526809167|FG001|Overall Study|Protocol Violation|10|||
146078876|NCT01510769|526809168|FG002|Overall Study|Protocol Violation|9|||
146078877|NCT01510769|526809166|FG000|Overall Study|Lost to Follow-up|5|||
146078878|NCT01510769|526809167|FG001|Overall Study|Lost to Follow-up|1|||
146078879|NCT01510769|526809168|FG002|Overall Study|Lost to Follow-up|5|||
146078880|NCT01510769|526809166|FG000|Overall Study|Withdrawal by Subject|3|||
146078881|NCT01510769|526809167|FG001|Overall Study|Withdrawal by Subject|4|||
146078882|NCT01510769|526809168|FG002|Overall Study|Withdrawal by Subject|3|||
146078883|NCT01510769|526809166|FG000|Overall Study|Death|1|||
146078884|NCT01510769|526809167|FG001|Overall Study|Death|1|||
146078885|NCT01510769|526809168|FG002|Overall Study|Death|0|||
146078886|NCT00929643|526809169|FG000|Overall Study|Protocol Violation|2|||
146078887|NCT02874144|526809170|FG000|Overall Study|Lost to Follow-up|3|||
146078888|NCT02874144|526809171|FG001|Overall Study|Lost to Follow-up|5|||
146078889|NCT01578850|526809175|FG000|Period 1|Insufficient Clinical Response|1|||
146078890|NCT01578850|526809176|FG001|Period 1|Insufficient Clinical Response|0|||
146078891|NCT01578850|526809177|FG002|Period 1|Insufficient Clinical Response|0|||
146078892|NCT01578850|526809175|FG000|Period 1|Adverse Event|11|||
146078893|NCT01578850|526809176|FG001|Period 1|Adverse Event|0|||
146078894|NCT01578850|526809177|FG002|Period 1|Adverse Event|0|||
146180559|NCT01794117|527173517|FG000|Overall Study|Adverse Event|1|||
146078895|NCT01578850|526809175|FG000|Period 1|Death|1|||
146078896|NCT01578850|526809176|FG001|Period 1|Death|0|||
146078897|NCT01578850|526809177|FG002|Period 1|Death|0|||
146078898|NCT01578850|526809175|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
146078899|NCT01578850|526809176|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
146078900|NCT01578850|526809177|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
146078901|NCT01578850|526809175|FG000|Period 1|Withdrawal by Subject|9|||
146078902|NCT01578850|526809176|FG001|Period 1|Withdrawal by Subject|0|||
146078903|NCT01578850|526809177|FG002|Period 1|Withdrawal by Subject|0|||
146078904|NCT01578850|526809175|FG000|Period 1|Study Terminated by Sponsor|3|||
146078905|NCT01578850|526809176|FG001|Period 1|Study Terminated by Sponsor|0|||
146078906|NCT01578850|526809177|FG002|Period 1|Study Terminated by Sponsor|0|||
146078907|NCT01578850|526809175|FG000|Period 2|Insufficient Clinical Response|0|||
146180560|NCT01794117|527173518|FG001|Overall Study|Adverse Event|0|||
146180561|NCT01794117|527173519|FG002|Overall Study|Adverse Event|0|||
146180562|NCT01794117|527173520|FG003|Overall Study|Adverse Event|0|||
146180563|NCT01794117|527173517|FG000|Overall Study|Participant noncompliance|0|||
146180564|NCT01794117|527173518|FG001|Overall Study|Participant noncompliance|1|||
146180565|NCT01794117|527173519|FG002|Overall Study|Participant noncompliance|0|||
146180566|NCT01794117|527173520|FG003|Overall Study|Participant noncompliance|0|||
146180567|NCT01794117|527173517|FG000|Overall Study|Refused further treatment|0|||
146180568|NCT01794117|527173518|FG001|Overall Study|Refused further treatment|2|||
146180569|NCT01794117|527173519|FG002|Overall Study|Refused further treatment|0|||
146180570|NCT01794117|527173520|FG003|Overall Study|Refused further treatment|0|||
146180571|NCT02696902|527173523|FG000|Overall Study|Lost to Follow-up|0|||
146180572|NCT02696902|527173524|FG001|Overall Study|Lost to Follow-up|1|||
146180573|NCT02696902|527173525|FG002|Overall Study|Lost to Follow-up|1|||
146180574|NCT02696902|527173523|FG000|Overall Study|Withdrawal by Subject|0|||
146180575|NCT02696902|527173524|FG001|Overall Study|Withdrawal by Subject|0|||
146180576|NCT02696902|527173525|FG002|Overall Study|Withdrawal by Subject|1|||
146180577|NCT02696902|527173523|FG000|Overall Study|Death|19|||
146180578|NCT02696902|527173524|FG001|Overall Study|Death|3|||
146180579|NCT02696902|527173525|FG002|Overall Study|Death|24|||
146180580|NCT02696902|527173523|FG000|Overall Study|Participant not fit post-randomization|0|||
146180581|NCT02696902|527173524|FG001|Overall Study|Participant not fit post-randomization|0|||
146180582|NCT02696902|527173525|FG002|Overall Study|Participant not fit post-randomization|1|||
146180583|NCT02696902|527173523|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
146180584|NCT02696902|527173524|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
146180585|NCT02696902|527173525|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
146180586|NCT02696902|527173523|FG000|Overall Study|Principal investigator's decision|1|||
146180587|NCT02696902|527173524|FG001|Overall Study|Principal investigator's decision|0|||
146180588|NCT02696902|527173525|FG002|Overall Study|Principal investigator's decision|0|||
146180589|NCT02696902|527173523|FG000|Overall Study|Sponsor's decision|1|||
146180590|NCT02696902|527173524|FG001|Overall Study|Sponsor's decision|0|||
146180591|NCT02696902|527173525|FG002|Overall Study|Sponsor's decision|0|||
146180592|NCT02696902|527173523|FG000|Overall Study|Transferred to other hospital|1|||
146180593|NCT02696902|527173524|FG001|Overall Study|Transferred to other hospital|0|||
146078908|NCT01578850|526809176|FG001|Period 2|Insufficient Clinical Response|1|||
146078909|NCT01578850|526809177|FG002|Period 2|Insufficient Clinical Response|0|||
146078910|NCT01578850|526809175|FG000|Period 2|Adverse Event|0|||
146078911|NCT01578850|526809176|FG001|Period 2|Adverse Event|3|||
146412295|NCT04444752|528014083|FG000|Overall Study|Patient moving out of town|1|||
146412296|NCT04444752|528014084|FG001|Overall Study|Patient moving out of town|0|||
146412297|NCT04444752|528014085|FG002|Overall Study|Patient moving out of town|0|||
146412298|NCT04444752|528014086|FG003|Overall Study|Patient moving out of town|1|||
146412299|NCT04444752|528014083|FG000|Overall Study|Lack of Efficacy|0|||
146412300|NCT04444752|528014084|FG001|Overall Study|Lack of Efficacy|0|||
146412301|NCT04444752|528014085|FG002|Overall Study|Lack of Efficacy|0|||
146412302|NCT04444752|528014086|FG003|Overall Study|Lack of Efficacy|1|||
146078912|NCT01578850|526809177|FG002|Period 2|Adverse Event|6|||
146078913|NCT01578850|526809175|FG000|Period 2|Lost to Follow-up|0|||
146078914|NCT01578850|526809176|FG001|Period 2|Lost to Follow-up|1|||
146078915|NCT01578850|526809177|FG002|Period 2|Lost to Follow-up|2|||
146078916|NCT01578850|526809175|FG000|Period 2|Withdrawal by Subject|0|||
146078917|NCT01578850|526809176|FG001|Period 2|Withdrawal by Subject|2|||
146078918|NCT01578850|526809177|FG002|Period 2|Withdrawal by Subject|2|||
146078919|NCT01578850|526809175|FG000|Period 2|Study Terminated by Sponsor|0|||
146078920|NCT01578850|526809176|FG001|Period 2|Study Terminated by Sponsor|5|||
146180594|NCT02696902|527173525|FG002|Overall Study|Transferred to other hospital|0|||
146180595|NCT02401308|527173527|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
146180596|NCT02401308|527173528|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
146412303|NCT04444752|528014083|FG000|Overall Study|Death|0|||
146412304|NCT04444752|528014084|FG001|Overall Study|Death|0|||
146412305|NCT04444752|528014085|FG002|Overall Study|Death|1|||
146412306|NCT04444752|528014086|FG003|Overall Study|Death|0|||
146412307|NCT00579254|528014087|FG000|Overall Study|Lost to Follow-up|39|||
146412308|NCT00579254|528014087|FG000|Overall Study|Discontinued when study terminated|73|||
146412309|NCT02557672|528014088|FG000|Overall Study|Withdrawal by Subject|4|||
146412310|NCT02557672|528014089|FG001|Overall Study|Withdrawal by Subject|2|||
146412311|NCT01165242|528015495|FG000|Overall Study|Unreachable Subjects|1|||
146412312|NCT01165242|528015496|FG001|Overall Study|Unreachable Subjects|0|||
146412313|NCT01165242|528015497|FG002|Overall Study|Unreachable Subjects|0|||
146412314|NCT01165242|528015495|FG000|Overall Study|Incarcerated Subjects|0|||
146412315|NCT01165242|528015496|FG001|Overall Study|Incarcerated Subjects|1|||
146412316|NCT01165242|528015497|FG002|Overall Study|Incarcerated Subjects|0|||
146412317|NCT01165242|528015495|FG000|Overall Study|Visit 2 Declined by Subject|0|||
146412318|NCT01165242|528015496|FG001|Overall Study|Visit 2 Declined by Subject|0|||
146412319|NCT01165242|528015497|FG002|Overall Study|Visit 2 Declined by Subject|1|||
146078921|NCT01578850|526809177|FG002|Period 2|Study Terminated by Sponsor|4|||
146078922|NCT01578850|526809175|FG000|Period 2|Unspecified Reasons|0|||
146078923|NCT01578850|526809176|FG001|Period 2|Unspecified Reasons|1|||
146078924|NCT01578850|526809177|FG002|Period 2|Unspecified Reasons|0|||
146078925|NCT01711216|526809178|FG000|Overall Study|Adverse Event|4|||
146078926|NCT01711216|526809178|FG000|Overall Study|Pregnancy|56|||
146078927|NCT01711216|526809178|FG000|Overall Study|Withdrawal by Subject|6|||
146078928|NCT01711216|526809178|FG000|Overall Study|Lost to Follow-up|46|||
146412320|NCT01165242|528015495|FG000|Overall Study|Withdrawal by Subject|0|||
146412321|NCT01165242|528015496|FG001|Overall Study|Withdrawal by Subject|2|||
146412322|NCT01165242|528015497|FG002|Overall Study|Withdrawal by Subject|2|||
146412323|NCT01165242|528015495|FG000|Overall Study|Extended Holiday|0|||
146078929|NCT01711216|526809178|FG000|Overall Study|variety of other minor reasons|83|||
146078930|NCT01711216|526809178|FG000|Overall Study|no reason specified|22|||
146078931|NCT02228980|526809179|FG000|Overall Study|Adverse Event|14|||
146078932|NCT02228980|526809180|FG001|Overall Study|Adverse Event|0|||
146078933|NCT02228980|526809181|FG002|Overall Study|Adverse Event|0|||
146078934|NCT02228980|526809182|FG003|Overall Study|Adverse Event|0|||
146078935|NCT02228980|526809179|FG000|Overall Study|Protocol Violation|7|||
146078936|NCT02228980|526809180|FG001|Overall Study|Protocol Violation|0|||
146078937|NCT02228980|526809181|FG002|Overall Study|Protocol Violation|0|||
146078938|NCT02228980|526809182|FG003|Overall Study|Protocol Violation|0|||
146180597|NCT02998021|527173529|FG000|Overall Study|Withdrawal by Subject|3|||
146180598|NCT02998021|527173530|FG001|Overall Study|Withdrawal by Subject|1|||
146180599|NCT02998021|527173529|FG000|Overall Study|unsafe home|0|||
146180600|NCT02998021|527173530|FG001|Overall Study|unsafe home|1|||
146180601|NCT01734434|527173531|FG000|Overall Study|Death Infant|3|||
146180602|NCT01734434|527173532|FG001|Overall Study|Death Infant|1|||
146180603|NCT01734434|527173533|FG002|Overall Study|Death Infant|17|||
146180604|NCT01734434|527173534|FG003|Overall Study|Death Infant|5|||
146180605|NCT01734434|527173531|FG000|Overall Study|Lost to Follow-up|2|||
146180606|NCT01734434|527173532|FG001|Overall Study|Lost to Follow-up|9|||
146180607|NCT01734434|527173533|FG002|Overall Study|Lost to Follow-up|67|||
146180608|NCT01734434|527173534|FG003|Overall Study|Lost to Follow-up|11|||
146180609|NCT01734434|527173531|FG000|Overall Study|No Live Birth|1|||
146180610|NCT01734434|527173532|FG001|Overall Study|No Live Birth|2|||
146180611|NCT01734434|527173533|FG002|Overall Study|No Live Birth|32|||
146180612|NCT01734434|527173534|FG003|Overall Study|No Live Birth|6|||
146180613|NCT01734434|527173531|FG000|Overall Study|Withdrawal by Subject|4|||
146180614|NCT01734434|527173532|FG001|Overall Study|Withdrawal by Subject|0|||
146180615|NCT01734434|527173533|FG002|Overall Study|Withdrawal by Subject|8|||
146180616|NCT01734434|527173534|FG003|Overall Study|Withdrawal by Subject|1|||
146180617|NCT01734434|527173531|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
146180618|NCT01734434|527173532|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
146180619|NCT01734434|527173533|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
146180620|NCT01734434|527173534|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
146180621|NCT01734434|527173531|FG000|Overall Study|Subject Not Reachable|0|||
146180622|NCT01734434|527173532|FG001|Overall Study|Subject Not Reachable|0|||
146180623|NCT01734434|527173533|FG002|Overall Study|Subject Not Reachable|1|||
146180624|NCT01734434|527173534|FG003|Overall Study|Subject Not Reachable|0|||
146180625|NCT01734434|527173531|FG000|Overall Study|Treatment Defaulter|0|||
146180626|NCT01734434|527173532|FG001|Overall Study|Treatment Defaulter|0|||
146180627|NCT01734434|527173533|FG002|Overall Study|Treatment Defaulter|1|||
146180628|NCT01734434|527173534|FG003|Overall Study|Treatment Defaulter|0|||
146283933|NCT00604825|527551904|FG000|Overall Study|Protocol Violation|0|||
146180629|NCT01734434|527173531|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
146180630|NCT01734434|527173532|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
146180631|NCT01734434|527173533|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
146180632|NCT01734434|527173534|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
146180633|NCT01734434|527173531|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146180634|NCT01734434|527173532|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146180635|NCT01734434|527173533|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
146180636|NCT01734434|527173534|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
146180637|NCT00654940|527174987|FG000|Period 1|Adverse Event|0|||
146180638|NCT00654940|527174988|FG001|Period 1|Adverse Event|1|||
146180639|NCT00654940|527174987|FG000|Period 1|Intolerable Pain Level|1|||
146180640|NCT00654940|527174988|FG001|Period 1|Intolerable Pain Level|0|||
146180641|NCT00962585|527174992|FG000|Overall Study|Adverse Event|0|||
146180642|NCT00962585|527174993|FG001|Overall Study|Adverse Event|2|||
146180643|NCT00962585|527174994|FG002|Overall Study|Adverse Event|1|||
146180644|NCT00962585|527174995|FG003|Overall Study|Adverse Event|0|||
146180645|NCT00962585|527174992|FG000|Overall Study|Lost to Follow-up|3|||
146180646|NCT00962585|527174993|FG001|Overall Study|Lost to Follow-up|0|||
146180647|NCT00962585|527174994|FG002|Overall Study|Lost to Follow-up|1|||
146180648|NCT00962585|527174995|FG003|Overall Study|Lost to Follow-up|0|||
146180649|NCT00962585|527174992|FG000|Overall Study|Protocol Violation|0|||
146180650|NCT00962585|527174993|FG001|Overall Study|Protocol Violation|0|||
146180651|NCT00962585|527174994|FG002|Overall Study|Protocol Violation|1|||
146180652|NCT00962585|527174995|FG003|Overall Study|Protocol Violation|0|||
146180653|NCT00962585|527174992|FG000|Overall Study|Withdrawal by Subject|1|||
146180654|NCT00962585|527174993|FG001|Overall Study|Withdrawal by Subject|0|||
146180655|NCT00962585|527174994|FG002|Overall Study|Withdrawal by Subject|0|||
146180656|NCT00962585|527174995|FG003|Overall Study|Withdrawal by Subject|0|||
146180657|NCT00962585|527174992|FG000|Overall Study|Withdrew Consent|2|||
146180658|NCT00962585|527174993|FG001|Overall Study|Withdrew Consent|0|||
146180659|NCT00962585|527174994|FG002|Overall Study|Withdrew Consent|0|||
146180660|NCT00962585|527174995|FG003|Overall Study|Withdrew Consent|0|||
146078939|NCT02228980|526809179|FG000|Overall Study|Withdrawal by Subject|3|||
146078940|NCT02228980|526809180|FG001|Overall Study|Withdrawal by Subject|3|||
146078941|NCT02228980|526809181|FG002|Overall Study|Withdrawal by Subject|2|||
146078942|NCT02228980|526809182|FG003|Overall Study|Withdrawal by Subject|3|||
146078943|NCT02929498|526809183|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
146078944|NCT02929498|526809184|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
146078945|NCT02929498|526809185|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
146078946|NCT02929498|526809183|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
146078947|NCT02929498|526809184|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
146078948|NCT02929498|526809185|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
146078949|NCT00750152|526809188|FG000|Overall Study|Adverse Event|2|||
146078950|NCT00750152|526809189|FG001|Overall Study|Adverse Event|1|||
146078951|NCT00750152|526809188|FG000|Overall Study|Lost to Follow-up|8|||
146078952|NCT00750152|526809189|FG001|Overall Study|Lost to Follow-up|13|||
146078953|NCT00750152|526809188|FG000|Overall Study|Withdrawal by Subject|3|||
146078954|NCT00750152|526809189|FG001|Overall Study|Withdrawal by Subject|3|||
146078955|NCT00750152|526809188|FG000|Overall Study|Physician Decision|1|||
146078956|NCT00750152|526809189|FG001|Overall Study|Physician Decision|1|||
146078957|NCT00750152|526809188|FG000|Overall Study|Non-compliance|0|||
146078958|NCT00750152|526809189|FG001|Overall Study|Non-compliance|1|||
146078959|NCT00750152|526809188|FG000|Overall Study|Termination by sponsor|1|||
146078960|NCT00750152|526809189|FG001|Overall Study|Termination by sponsor|0|||
146078961|NCT00750152|526809188|FG000|Overall Study|Other|7|||
146078962|NCT00750152|526809189|FG001|Overall Study|Other|8|||
146078963|NCT00715910|526809190|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
146078964|NCT00715910|526809191|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
146078965|NCT00715910|526809192|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
146078966|NCT00715910|526809193|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
146078967|NCT00715910|526809194|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
146078968|NCT00715910|526809195|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
146078969|NCT00715910|526809190|FG000|Booster and ESFU Phase|Other|0|||
146078970|NCT00715910|526809191|FG001|Booster and ESFU Phase|Other|0|||
146078971|NCT00715910|526809192|FG002|Booster and ESFU Phase|Other|0|||
146078972|NCT00715910|526809193|FG003|Booster and ESFU Phase|Other|5|||
146078973|NCT00715910|526809194|FG004|Booster and ESFU Phase|Other|1|||
146078974|NCT00715910|526809195|FG005|Booster and ESFU Phase|Other|0|||
146078975|NCT03698591|526809196|FG000|Overall Study|Withdrawal by Subject|2|||
146078976|NCT03698591|526809197|FG001|Overall Study|Withdrawal by Subject|2|||
146078977|NCT03698591|526809196|FG000|Overall Study|Failed drug screen|1|||
146078978|NCT03698591|526809197|FG001|Overall Study|Failed drug screen|1|||
146078979|NCT03698591|526809196|FG000|Overall Study|Failed health screen|0|||
146078980|NCT03698591|526809197|FG001|Overall Study|Failed health screen|1|||
146078981|NCT03698591|526809196|FG000|Overall Study|Ineligible for financial compensation|1|||
146078982|NCT03698591|526809197|FG001|Overall Study|Ineligible for financial compensation|0|||
146078983|NCT03698591|526809196|FG000|Overall Study|Equipment Error|1|||
146078984|NCT03698591|526809197|FG001|Overall Study|Equipment Error|0|||
146078985|NCT03698591|526809196|FG000|Overall Study|Could not establish TMS dosage|0|||
146078986|NCT03698591|526809197|FG001|Overall Study|Could not establish TMS dosage|1|||
146078987|NCT01165216|526809198|FG000|Overall Study|Adverse Event|6|||
146078988|NCT01165216|526809199|FG001|Overall Study|Adverse Event|3|||
146078989|NCT01165216|526809198|FG000|Overall Study|Withdrawal by Subject|1|||
146078990|NCT01165216|526809199|FG001|Overall Study|Withdrawal by Subject|1|||
146078991|NCT01165216|526809198|FG000|Overall Study|Disease progression|1|||
146078992|NCT01165216|526809199|FG001|Overall Study|Disease progression|3|||
146078993|NCT01379508|526809202|FG000|Treatment to Week 104|Adverse Event|2|||
146078994|NCT01379508|526809203|FG001|Treatment to Week 104|Adverse Event|0|||
146078995|NCT01379508|526809204|FG002|Treatment to Week 104|Adverse Event|5|||
146078996|NCT01379508|526809205|FG003|Treatment to Week 104|Adverse Event|0|||
146078997|NCT01379508|526809202|FG000|Treatment to Week 104|Abnormal lab value|1|||
146078998|NCT01379508|526809203|FG001|Treatment to Week 104|Abnormal lab value|0|||
146078999|NCT01379508|526809204|FG002|Treatment to Week 104|Abnormal lab value|0|||
146079000|NCT01379508|526809205|FG003|Treatment to Week 104|Abnormal lab value|0|||
146079001|NCT01379508|526809202|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
146079002|NCT01379508|526809203|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146079003|NCT01379508|526809204|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146079004|NCT01379508|526809205|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
146079005|NCT01379508|526809202|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
146079006|NCT01379508|526809203|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
146079007|NCT01379508|526809204|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
146079008|NCT01379508|526809205|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
146079009|NCT01379508|526809202|FG000|Treatment to Week 104|Lost to Follow-up|5|||
146079010|NCT01379508|526809203|FG001|Treatment to Week 104|Lost to Follow-up|0|||
146079011|NCT01379508|526809204|FG002|Treatment to Week 104|Lost to Follow-up|3|||
146079012|NCT01379508|526809205|FG003|Treatment to Week 104|Lost to Follow-up|0|||
146079013|NCT01379508|526809202|FG000|Treatment to Week 104|Administrative problems|3|||
146180661|NCT02254421|527174996|FG000|Overall Study|Randomized but Not Treated|1|||
146180662|NCT02254421|527174997|FG001|Overall Study|Randomized but Not Treated|0|||
146180663|NCT02254421|527174996|FG000|Overall Study|Death|0|||
146180664|NCT02254421|527174997|FG001|Overall Study|Death|2|||
146180665|NCT02254421|527174996|FG000|Overall Study|Withdrew Consent|1|||
146079014|NCT01379508|526809203|FG001|Treatment to Week 104|Administrative problems|1|||
146079015|NCT01379508|526809204|FG002|Treatment to Week 104|Administrative problems|0|||
146079016|NCT01379508|526809205|FG003|Treatment to Week 104|Administrative problems|0|||
146079017|NCT01379508|526809202|FG000|Treatment to Week 104|Protocol Violation|1|||
146079018|NCT01379508|526809203|FG001|Treatment to Week 104|Protocol Violation|1|||
146079019|NCT01379508|526809204|FG002|Treatment to Week 104|Protocol Violation|1|||
146079020|NCT01379508|526809205|FG003|Treatment to Week 104|Protocol Violation|0|||
146079021|NCT01379508|526809202|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
146079022|NCT01379508|526809203|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
146079023|NCT01379508|526809204|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
146079024|NCT01379508|526809205|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
146079025|NCT01379508|526809202|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
146079026|NCT01379508|526809203|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
146079027|NCT01379508|526809204|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
146079028|NCT01379508|526809205|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
146079029|NCT01379508|526809202|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
146079030|NCT01379508|526809203|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
146079031|NCT01379508|526809204|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
146079032|NCT01379508|526809205|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
146079033|NCT01379508|526809202|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
146079034|NCT01379508|526809203|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
146079035|NCT01379508|526809204|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
146079036|NCT01379508|526809205|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
146079037|NCT02626624|526809208|FG000|Overall Study|Adverse Event|1|||
146079038|NCT02626624|526809208|FG000|Overall Study|Lost to Follow-up|3|||
146079039|NCT02626624|526809208|FG000|Overall Study|Protocol Violation|4|||
146079040|NCT02626624|526809208|FG000|Overall Study|Death|2|||
146079041|NCT01948193|526811270|FG000|Overall Study|Serious event|2|||
146079042|NCT01948193|526811270|FG000|Overall Study|Lost to Follow-up|7|||
146079043|NCT01964755|526811272|FG000|Overall Study|Death|2|||
146079044|NCT00361634|526811275|FG000|Overall Study|Lost to Follow-up|1|||
146079045|NCT00361634|526811275|FG000|Overall Study|Withdrawal by Subject|1|||
146079046|NCT05315908|526811276|FG000|Overall Study|Lost to Follow-up|4477|||
146079047|NCT05315908|526811277|FG001|Overall Study|Lost to Follow-up|4606|||
146079048|NCT00294762|526811278|FG000|Overall Study|Did not receive study treatment|3|||
146079049|NCT00294762|526811279|FG001|Overall Study|Did not receive study treatment|3|||
146079050|NCT02937584|526811280|FG000|Period 1|Adverse Event|1|||
146079051|NCT02937584|526811281|FG001|Period 1|Adverse Event|2|||
146079052|NCT02937584|526811280|FG000|Washout|Adverse Event|0|||
146079053|NCT02937584|526811281|FG001|Washout|Adverse Event|1|||
146079054|NCT02238080|526811290|FG000|Overall Study|Death|13|||
146079055|NCT02238080|526811290|FG000|Overall Study|Treatment interrupted|6|||
146079056|NCT02238080|526811290|FG000|Overall Study|Withdrawal by Subject|2|||
146079057|NCT02238080|526811290|FG000|Overall Study|Other|4|||
146079058|NCT01738646|526811291|FG000|Overall Study|Still Receiving Treatment|2|||
146079059|NCT01598129|526811292|FG000|Overall Study|Disease progression|6|||
146079060|NCT01598129|526811292|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
146079061|NCT01598129|526811292|FG000|Overall Study|Withdrawal by Subject|1|||
146079062|NCT00505076|526811293|FG000|Overall Study|Adverse Event|1|||
146079063|NCT00505076|526811294|FG001|Overall Study|Adverse Event|0|||
146079064|NCT00505076|526811295|FG002|Overall Study|Adverse Event|1|||
146079065|NCT00505076|526811293|FG000|Overall Study|Protocol Violation|2|||
146079066|NCT00505076|526811294|FG001|Overall Study|Protocol Violation|1|||
146079067|NCT00505076|526811295|FG002|Overall Study|Protocol Violation|2|||
146079068|NCT00505076|526811293|FG000|Overall Study|Withdrawal by Subject|0|||
146079069|NCT00505076|526811294|FG001|Overall Study|Withdrawal by Subject|1|||
146079070|NCT00505076|526811295|FG002|Overall Study|Withdrawal by Subject|2|||
146079071|NCT04093024|526811298|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
146079072|NCT04093024|526811299|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
146079073|NCT04093024|526811298|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
146079074|NCT04093024|526811299|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
146079075|NCT04093024|526811298|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
146079076|NCT04093024|526811299|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
146079077|NCT04093024|526811298|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
146079078|NCT04093024|526811299|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
146079079|NCT00647270|526811304|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
146180666|NCT02254421|527174997|FG001|Overall Study|Withdrew Consent|1|||
146180667|NCT00867490|527175000|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
146180668|NCT00867490|527175000|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
146180669|NCT00867490|527175000|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
146180670|NCT00867490|527175000|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
146180671|NCT00867490|527175000|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
146180672|NCT00179010|527175001|FG000|Overall Study|Muscle probe defective|1|||
146180673|NCT00179010|527175002|FG001|Overall Study|Muscle probe defective|1|||
146180674|NCT00179010|527175001|FG000|Overall Study|Failure to place arterial line|0|||
146180675|NCT00179010|527175002|FG001|Overall Study|Failure to place arterial line|1|||
146180676|NCT02823964|527175033|FG000|Overall Study|Adverse Event|2|||
146180677|NCT02823964|527175033|FG000|Overall Study|Physician Decision|1|||
146180678|NCT02823964|527175033|FG000|Overall Study|Lack of Efficacy|1|||
146180679|NCT02823964|527175033|FG000|Overall Study|Withdrawal by Subject|1|||
146180680|NCT01744496|527175053|FG000|Titration Period|Adverse Event|2|||
146180681|NCT01744496|527175054|FG001|Titration Period|Adverse Event|1|||
146180682|NCT01744496|527175053|FG000|Titration Period|Personal reasons|0|||
146180683|NCT01744496|527175054|FG001|Titration Period|Personal reasons|1|||
146180684|NCT01744496|527175053|FG000|Maintenance Period|Adverse Event|1|||
146180685|NCT01744496|527175054|FG001|Maintenance Period|Adverse Event|3|||
146180686|NCT01744496|527175053|FG000|Maintenance Period|Protocol Violation|1|||
146180687|NCT01744496|527175054|FG001|Maintenance Period|Protocol Violation|0|||
146180688|NCT01744496|527175053|FG000|Maintenance Period|Withdrawal by Subject|1|||
146180689|NCT01744496|527175054|FG001|Maintenance Period|Withdrawal by Subject|1|||
146180690|NCT01744496|527175053|FG000|Maintenance Period|Subject left town|1|||
146180691|NCT01744496|527175054|FG001|Maintenance Period|Subject left town|0|||
146180692|NCT03537261|527175055|FG000|Overall Study|Lost to Follow-up|4|||
146180693|NCT03537261|527175056|FG001|Overall Study|Lost to Follow-up|5|||
146180694|NCT03537261|527175055|FG000|Overall Study|Withdrawal by Subject|4|||
146180695|NCT03537261|527175056|FG001|Overall Study|Withdrawal by Subject|6|||
146180696|NCT03537261|527175055|FG000|Overall Study|Did not return study questionnaires|0|||
146180697|NCT03537261|527175056|FG001|Overall Study|Did not return study questionnaires|1|||
146180698|NCT01177813|527175059|FG000|Overall Study|Adverse Event|8|||
146180699|NCT01177813|527175060|FG001|Overall Study|Adverse Event|2|||
146180700|NCT01177813|527175061|FG002|Overall Study|Adverse Event|4|||
146180701|NCT01177813|527175062|FG003|Overall Study|Adverse Event|6|||
146180702|NCT01177813|527175063|FG004|Overall Study|Adverse Event|3|||
146180703|NCT01177813|527175059|FG000|Overall Study|Lack of Efficacy|1|||
146180704|NCT01177813|527175060|FG001|Overall Study|Lack of Efficacy|0|||
146180705|NCT01177813|527175061|FG002|Overall Study|Lack of Efficacy|0|||
146180706|NCT01177813|527175062|FG003|Overall Study|Lack of Efficacy|0|||
146180707|NCT01177813|527175063|FG004|Overall Study|Lack of Efficacy|0|||
146180708|NCT01177813|527175059|FG000|Overall Study|Protocol Violation|3|||
146180709|NCT01177813|527175060|FG001|Overall Study|Protocol Violation|2|||
146180710|NCT01177813|527175061|FG002|Overall Study|Protocol Violation|2|||
146180711|NCT01177813|527175062|FG003|Overall Study|Protocol Violation|0|||
146180712|NCT01177813|527175063|FG004|Overall Study|Protocol Violation|1|||
146180713|NCT01177813|527175059|FG000|Overall Study|Lost to Follow-up|12|||
146180714|NCT01177813|527175060|FG001|Overall Study|Lost to Follow-up|5|||
146180715|NCT01177813|527175061|FG002|Overall Study|Lost to Follow-up|6|||
146180716|NCT01177813|527175062|FG003|Overall Study|Lost to Follow-up|3|||
146180717|NCT01177813|527175063|FG004|Overall Study|Lost to Follow-up|0|||
146180718|NCT01177813|527175059|FG000|Overall Study|Withdrawal by Subject|12|||
146180719|NCT01177813|527175060|FG001|Overall Study|Withdrawal by Subject|7|||
146180720|NCT01177813|527175061|FG002|Overall Study|Withdrawal by Subject|6|||
146180721|NCT01177813|527175062|FG003|Overall Study|Withdrawal by Subject|5|||
146180722|NCT01177813|527175063|FG004|Overall Study|Withdrawal by Subject|3|||
146180723|NCT01177813|527175059|FG000|Overall Study|Other reason not defined above|5|||
146180724|NCT01177813|527175060|FG001|Overall Study|Other reason not defined above|2|||
146180725|NCT01177813|527175061|FG002|Overall Study|Other reason not defined above|2|||
146180726|NCT01177813|527175062|FG003|Overall Study|Other reason not defined above|3|||
146180727|NCT01177813|527175063|FG004|Overall Study|Other reason not defined above|2|||
146180728|NCT01729728|527175064|FG000|Overall Study|Adverse Event|0|||
146180729|NCT01729728|527175065|FG001|Overall Study|Adverse Event|6|||
146180730|NCT01729728|527175066|FG002|Overall Study|Adverse Event|0|||
146079080|NCT00647270|526811305|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
146079081|NCT00647270|526811306|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
146079082|NCT00647270|526811304|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
146079083|NCT00647270|526811305|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
146079084|NCT00647270|526811306|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
146079085|NCT00647270|526811304|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
146180731|NCT01729728|527175064|FG000|Overall Study|Protocol Violation|1|||
146079086|NCT00647270|526811305|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
146079087|NCT00647270|526811306|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
146180732|NCT01729728|527175065|FG001|Overall Study|Protocol Violation|0|||
145945348|NCT01764997|526308212|FG000|Run-in Period|Other than specified above|17|||
146079088|NCT00647270|526811304|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
146079089|NCT00647270|526811305|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
146079090|NCT00647270|526811306|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
146079091|NCT00647270|526811304|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
146079092|NCT00647270|526811305|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
146079093|NCT00647270|526811306|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
146079094|NCT00647270|526811304|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
146079095|NCT00647270|526811305|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
146079096|NCT00647270|526811306|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
146079097|NCT00647270|526811304|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
146079098|NCT00647270|526811305|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
146079099|NCT00647270|526811306|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
146079100|NCT03615040|526811307|FG000|Overall Study|Withdrawal by Subject|2|||
146079101|NCT03615040|526811308|FG001|Overall Study|Withdrawal by Subject|1|||
146079102|NCT03615040|526811307|FG000|Overall Study|Physician Decision|2|||
146079103|NCT03615040|526811308|FG001|Overall Study|Physician Decision|2|||
146079104|NCT03615040|526811307|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
146079105|NCT03615040|526811308|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
146079106|NCT03615040|526811307|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
146079107|NCT03615040|526811308|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
146079108|NCT03615040|526811307|FG000|Overall Study|Death|0|||
146079109|NCT03615040|526811308|FG001|Overall Study|Death|2|||
146079110|NCT01541397|526811313|FG000|Overall Study|Study ended prior to data collection|4|||
146079111|NCT01541397|526811314|FG001|Overall Study|Study ended prior to data collection|2|||
146079112|NCT02267317|526811315|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
146079113|NCT02267317|526811316|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146079114|NCT02267317|526811317|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146079115|NCT02267317|526811318|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146079116|NCT02267317|526811319|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146079117|NCT02267317|526811320|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
146079118|NCT02267317|526811315|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
146079119|NCT02267317|526811316|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146079120|NCT02267317|526811317|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146079121|NCT02267317|526811318|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146079122|NCT02267317|526811319|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146079123|NCT02267317|526811320|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
146079124|NCT01128621|526811323|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
146079125|NCT01128621|526811324|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
146079126|NCT00233454|526811325|FG000|Overall Study|Death|6|||
146079127|NCT04224688|526811329|FG000|Overall Study|Withdrawal by Subject|1|||
146079128|NCT04224688|526811330|FG001|Overall Study|Withdrawal by Subject|3|||
146079129|NCT04224688|526811329|FG000|Overall Study|Lack of Efficacy|1|||
146079130|NCT04224688|526811330|FG001|Overall Study|Lack of Efficacy|1|||
146079131|NCT04224688|526811329|FG000|Overall Study|Adverse event, not fatal|0|||
146079132|NCT04224688|526811330|FG001|Overall Study|Adverse event, not fatal|2|||
146079133|NCT04224688|526811329|FG000|Overall Study|COVID-19|0|||
146079134|NCT04224688|526811330|FG001|Overall Study|COVID-19|1|||
146079135|NCT04074161|526811331|FG000|Overall Study|Withdrawal by Subject|2|||
146079136|NCT04074161|526811332|FG001|Overall Study|Withdrawal by Subject|4|||
146079137|NCT04074161|526811333|FG002|Overall Study|Withdrawal by Subject|1|||
146079138|NCT04074161|526811331|FG000|Overall Study|Lost to Follow-up|4|||
146079139|NCT04074161|526811332|FG001|Overall Study|Lost to Follow-up|5|||
146079140|NCT04074161|526811333|FG002|Overall Study|Lost to Follow-up|3|||
146079141|NCT00329849|526811336|FG000|Overall Study|Withdrawal by Subject|6|||
146079142|NCT00329849|526811337|FG001|Overall Study|Withdrawal by Subject|4|||
146079143|NCT00322621|526811338|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
146079144|NCT00322621|526811339|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
146079145|NCT00322621|526811340|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
146079146|NCT00322621|526811338|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
146079147|NCT00322621|526811339|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
146079148|NCT00322621|526811340|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
146079149|NCT00322621|526811338|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
146079150|NCT00322621|526811339|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
146180733|NCT01729728|527175066|FG002|Overall Study|Protocol Violation|1|||
146180734|NCT03772314|527175069|FG000|Overall Study|Adverse Event|7|||
146079151|NCT00322621|526811340|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
146079152|NCT00322621|526811338|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
146079153|NCT00322621|526811339|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
146079154|NCT00322621|526811340|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
146079155|NCT00322621|526811338|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
146079156|NCT00322621|526811339|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
146180735|NCT03772314|527175070|FG001|Overall Study|Adverse Event|2|||
146180736|NCT02001974|527175071|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
146180737|NCT02001974|527175072|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
146180738|NCT02001974|527175073|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
146180739|NCT02001974|527175071|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
146180740|NCT02001974|527175072|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
146180741|NCT02001974|527175073|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
146180742|NCT02001974|527175071|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
146180743|NCT02001974|527175072|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
146180744|NCT02001974|527175073|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
146180745|NCT02001974|527175071|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
146180746|NCT02001974|527175072|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
146180747|NCT02001974|527175073|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
146180748|NCT01380990|527175074|FG000|Overall Study|Treatment Failure|1|||
146180749|NCT01380990|527175075|FG001|Overall Study|Treatment Failure|0|||
146180750|NCT01380990|527175074|FG000|Overall Study|Death|0|||
146180751|NCT01380990|527175075|FG001|Overall Study|Death|1|||
146180752|NCT01009047|527175078|FG000|Overall Study|Adverse Event|5|||
146180753|NCT01009047|527175079|FG001|Overall Study|Adverse Event|0|||
146180754|NCT01009047|527175078|FG000|Overall Study|Lost to Follow-up|0|||
146180755|NCT01009047|527175079|FG001|Overall Study|Lost to Follow-up|2|||
146180756|NCT01009047|527175078|FG000|Overall Study|Lack of Efficacy|4|||
146180757|NCT01009047|527175079|FG001|Overall Study|Lack of Efficacy|11|||
146180758|NCT01009047|527175078|FG000|Overall Study|Withdrawal by consent|16|||
146180759|NCT01009047|527175079|FG001|Overall Study|Withdrawal by consent|11|||
146180760|NCT01009047|527175078|FG000|Overall Study|Other|3|||
146180761|NCT01009047|527175079|FG001|Overall Study|Other|2|||
146180762|NCT01630590|527175081|FG000|Overall Study|Adverse Event|9|||
146180763|NCT01630590|527175081|FG000|Overall Study|Lack of Efficacy|37|||
146180764|NCT01630590|527175081|FG000|Overall Study|Withdrawal by Subject|4|||
146180765|NCT01630590|527175081|FG000|Overall Study|2nd primary tumor|2|||
146180766|NCT01630590|527175081|FG000|Overall Study|Automobile accident|1|||
146180767|NCT01630590|527175081|FG000|Overall Study|Maximum benefit|4|||
146180768|NCT02366936|527175082|FG000|Overall Study|Withdrawal by Subject|2|||
146180769|NCT02366936|527175082|FG000|Overall Study|Lost to Follow-up|4|||
146180770|NCT02366936|527175082|FG000|Overall Study|Physician Decision|2|||
146180771|NCT01751113|527175085|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146180772|NCT01751113|527175086|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146180773|NCT01751113|527175087|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146180774|NCT01751113|527175088|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
146180775|NCT01751113|527175089|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
146180776|NCT01751113|527175090|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
146180777|NCT01751113|527175085|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146180778|NCT01751113|527175086|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146180779|NCT01751113|527175087|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146180780|NCT01751113|527175088|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146180781|NCT01751113|527175089|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
146180782|NCT01751113|527175090|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
146180783|NCT02743793|527175093|FG000|Overall Study|Death|1|||
146180784|NCT02743793|527175094|FG001|Overall Study|Death|1|||
146180785|NCT02743793|527175093|FG000|Overall Study|Withdrawal by Subject|0|||
146180786|NCT02743793|527175094|FG001|Overall Study|Withdrawal by Subject|1|||
146180787|NCT02743793|527175093|FG000|Overall Study|Screen Failure|4|||
146180788|NCT02743793|527175094|FG001|Overall Study|Screen Failure|0|||
146180789|NCT02743793|527175093|FG000|Overall Study|No Primary Care Physician|0|||
146180790|NCT02743793|527175094|FG001|Overall Study|No Primary Care Physician|1|||
146180791|NCT02743793|527175093|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
146180792|NCT02743793|527175094|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
146180793|NCT02743793|527175093|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
146180794|NCT02743793|527175094|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
146180795|NCT00849680|527175101|FG000|Overall Study|Adverse Event|0|||
146180796|NCT00849680|527175102|FG001|Overall Study|Adverse Event|0|||
146180797|NCT00849680|527175103|FG002|Overall Study|Adverse Event|0|||
146180798|NCT00849680|527175104|FG003|Overall Study|Adverse Event|0|||
146180799|NCT00849680|527175105|FG004|Overall Study|Adverse Event|0|||
146180800|NCT00849680|527175106|FG005|Overall Study|Adverse Event|0|||
146180801|NCT00849680|527175107|FG006|Overall Study|Adverse Event|2|||
146412324|NCT01165242|528015496|FG001|Overall Study|Extended Holiday|0|||
146180802|NCT00849680|527175108|FG007|Overall Study|Adverse Event|0|||
146180803|NCT00849680|527175101|FG000|Overall Study|Lost to Follow-up|7|||
146180804|NCT00849680|527175102|FG001|Overall Study|Lost to Follow-up|3|||
146180805|NCT00849680|527175103|FG002|Overall Study|Lost to Follow-up|12|||
146180806|NCT00849680|527175104|FG003|Overall Study|Lost to Follow-up|11|||
146180807|NCT00849680|527175105|FG004|Overall Study|Lost to Follow-up|8|||
146180808|NCT00849680|527175106|FG005|Overall Study|Lost to Follow-up|11|||
146180809|NCT00849680|527175107|FG006|Overall Study|Lost to Follow-up|12|||
146180810|NCT00849680|527175108|FG007|Overall Study|Lost to Follow-up|5|||
146180811|NCT00849680|527175101|FG000|Overall Study|Subject moved|1|||
146180812|NCT00849680|527175102|FG001|Overall Study|Subject moved|0|||
146180813|NCT00849680|527175103|FG002|Overall Study|Subject moved|3|||
146412325|NCT01165242|528015497|FG002|Overall Study|Extended Holiday|1|||
146412326|NCT01165242|528015495|FG000|Overall Study|Lost to Follow-up|9|||
146412327|NCT01165242|528015496|FG001|Overall Study|Lost to Follow-up|7|||
146412328|NCT01165242|528015497|FG002|Overall Study|Lost to Follow-up|10|||
146412329|NCT03877237|528015498|FG000|Overall Study|Adverse Event|1|||
146412330|NCT03877237|528015499|FG001|Overall Study|Adverse Event|2|||
146412331|NCT03877237|528015498|FG000|Overall Study|Death|3|||
146412332|NCT03877237|528015499|FG001|Overall Study|Death|2|||
146412333|NCT03877237|528015498|FG000|Overall Study|Physician Decision|1|||
146412334|NCT03877237|528015499|FG001|Overall Study|Physician Decision|0|||
146412335|NCT03877237|528015498|FG000|Overall Study|Withdrawal by Subject|0|||
146412336|NCT03877237|528015499|FG001|Overall Study|Withdrawal by Subject|2|||
146412337|NCT03372083|528015500|FG000|Overall Study|Adverse Event|3|||
146412338|NCT03372083|528015500|FG000|Overall Study|Physician Decision|1|||
146412339|NCT03372083|528015500|FG000|Overall Study|Withdrawal by Subject|1|||
146412340|NCT02236754|528015501|FG000|Overall Study|Withdrawal by Subject|1|||
146180814|NCT00849680|527175104|FG003|Overall Study|Subject moved|1|||
146180815|NCT00849680|527175105|FG004|Overall Study|Subject moved|0|||
146180816|NCT00849680|527175106|FG005|Overall Study|Subject moved|2|||
146180817|NCT00849680|527175107|FG006|Overall Study|Subject moved|2|||
146180818|NCT00849680|527175108|FG007|Overall Study|Subject moved|2|||
146180819|NCT00849680|527175101|FG000|Overall Study|Withdrawal by Subject|2|||
146180820|NCT00849680|527175102|FG001|Overall Study|Withdrawal by Subject|0|||
146180821|NCT00849680|527175103|FG002|Overall Study|Withdrawal by Subject|0|||
146180822|NCT00849680|527175104|FG003|Overall Study|Withdrawal by Subject|2|||
146180823|NCT00849680|527175105|FG004|Overall Study|Withdrawal by Subject|2|||
146180824|NCT00849680|527175106|FG005|Overall Study|Withdrawal by Subject|2|||
146180825|NCT00849680|527175107|FG006|Overall Study|Withdrawal by Subject|1|||
146180826|NCT00849680|527175108|FG007|Overall Study|Withdrawal by Subject|1|||
146180827|NCT00849680|527175101|FG000|Overall Study|Subject unable to comply with protocol|1|||
146180828|NCT00849680|527175102|FG001|Overall Study|Subject unable to comply with protocol|0|||
146180829|NCT00849680|527175103|FG002|Overall Study|Subject unable to comply with protocol|0|||
146180830|NCT00849680|527175104|FG003|Overall Study|Subject unable to comply with protocol|0|||
146180831|NCT00849680|527175105|FG004|Overall Study|Subject unable to comply with protocol|0|||
146180832|NCT00849680|527175106|FG005|Overall Study|Subject unable to comply with protocol|0|||
146180833|NCT00849680|527175107|FG006|Overall Study|Subject unable to comply with protocol|0|||
146180834|NCT00849680|527175108|FG007|Overall Study|Subject unable to comply with protocol|0|||
146180835|NCT03053492|527175109|FG000|Overall Study|Adverse Event|1|||
146180836|NCT03053492|527175110|FG001|Overall Study|Adverse Event|1|||
146180837|NCT03053492|527175109|FG000|Overall Study|Withdrawal by Subject|7|||
146180838|NCT03053492|527175110|FG001|Overall Study|Withdrawal by Subject|5|||
146180839|NCT03382600|527175111|FG000|Overall Study|Adverse Event|3|||
146180840|NCT03382600|527175112|FG001|Overall Study|Adverse Event|3|||
146180841|NCT03382600|527175111|FG000|Overall Study|Clinical Disease Progression|2|||
146180842|NCT03382600|527175112|FG001|Overall Study|Clinical Disease Progression|4|||
146180843|NCT03382600|527175111|FG000|Overall Study|Radiological Progression|40|||
146180844|NCT03382600|527175112|FG001|Overall Study|Radiological Progression|31|||
146180845|NCT03382600|527175111|FG000|Overall Study|Withdrawal by Subject|0|||
146180846|NCT03382600|527175112|FG001|Overall Study|Withdrawal by Subject|1|||
146180847|NCT03382600|527175111|FG000|Overall Study|Other|9|||
146180848|NCT03382600|527175112|FG001|Overall Study|Other|7|||
146180849|NCT00967018|527175113|FG000|Overall Study|Adverse Event|2|||
146180850|NCT00967018|527175113|FG000|Overall Study|Physician Decision|7|||
146180851|NCT00967018|527175113|FG000|Overall Study|Lost to Follow-up|2|||
146180852|NCT00967018|527175113|FG000|Overall Study|Withdrawal by Subject|1|||
146180853|NCT00967018|527175113|FG000|Overall Study|Miscellaneous Reasons|9|||
146180854|NCT01680458|527175121|FG000|Overall Study|Protocol Violation|3|||
146180855|NCT03406702|527175126|FG000|Overall Study|Missed Day 27 Dosing|1|||
146180856|NCT00514046|527175134|FG000|Overall Study|transferred to another protocol|2|||
146412341|NCT02236754|528015502|FG001|Overall Study|Withdrawal by Subject|0|||
146180857|NCT00514046|527175135|FG001|Overall Study|transferred to another protocol|1|||
146180858|NCT00514046|527175136|FG002|Overall Study|transferred to another protocol|3|||
146180859|NCT00514046|527175137|FG003|Overall Study|transferred to another protocol|0|||
146412342|NCT02544633|528015503|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
146412343|NCT02544633|528015504|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
146412344|NCT02544633|528015505|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
146180860|NCT00514046|527175138|FG004|Overall Study|transferred to another protocol|1|||
146180861|NCT00514046|527175139|FG005|Overall Study|transferred to another protocol|0|||
146180862|NCT00514046|527175140|FG006|Overall Study|transferred to another protocol|0|||
146180863|NCT00514046|527175141|FG007|Overall Study|transferred to another protocol|0|||
146180864|NCT00514046|527175142|FG008|Overall Study|transferred to another protocol|0|||
146180865|NCT00514046|527175134|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
146180866|NCT00514046|527175135|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
146180867|NCT00514046|527175136|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
146180868|NCT00514046|527175137|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
146180869|NCT00514046|527175138|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
146180870|NCT00514046|527175139|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
146180871|NCT00514046|527175140|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
146180872|NCT00514046|527175141|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
146180873|NCT00514046|527175142|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
146180874|NCT00514046|527175134|FG000|Overall Study|Disease progression on study|0|||
146180875|NCT00514046|527175135|FG001|Overall Study|Disease progression on study|0|||
146180876|NCT00514046|527175136|FG002|Overall Study|Disease progression on study|2|||
146180877|NCT00514046|527175137|FG003|Overall Study|Disease progression on study|0|||
146180878|NCT00514046|527175138|FG004|Overall Study|Disease progression on study|0|||
146180879|NCT00514046|527175139|FG005|Overall Study|Disease progression on study|1|||
146180880|NCT00514046|527175140|FG006|Overall Study|Disease progression on study|0|||
146180881|NCT00514046|527175141|FG007|Overall Study|Disease progression on study|0|||
146180882|NCT00514046|527175142|FG008|Overall Study|Disease progression on study|0|||
146180883|NCT00655551|527175143|FG000|All Periods Combined|Adverse Event|0|||
146180884|NCT00655551|527175144|FG001|All Periods Combined|Adverse Event|3|||
146180885|NCT00655551|527175145|FG002|All Periods Combined|Adverse Event|4|||
146180886|NCT00655551|527175143|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
146180887|NCT00655551|527175144|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
146180888|NCT00655551|527175145|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
146180889|NCT00655551|527175143|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
146180890|NCT00655551|527175144|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
146180891|NCT00655551|527175145|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
146180892|NCT00655551|527175143|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
146180893|NCT00655551|527175144|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
146180894|NCT00655551|527175145|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
146180895|NCT00383240|527175150|FG000|Overall Study|Adverse Event|4|||
146180896|NCT00383240|527175151|FG001|Overall Study|Adverse Event|6|||
146180897|NCT00383240|527175152|FG002|Overall Study|Adverse Event|9|||
146180898|NCT00383240|527175153|FG003|Overall Study|Adverse Event|7|||
146180899|NCT00383240|527175150|FG000|Overall Study|Treatment Failure|8|||
146180900|NCT00383240|527175151|FG001|Overall Study|Treatment Failure|13|||
146180901|NCT00383240|527175152|FG002|Overall Study|Treatment Failure|47|||
146180902|NCT00383240|527175153|FG003|Overall Study|Treatment Failure|46|||
146180903|NCT00383240|527175150|FG000|Overall Study|Lost to Follow-up|3|||
146180904|NCT00383240|527175151|FG001|Overall Study|Lost to Follow-up|0|||
146180905|NCT00383240|527175152|FG002|Overall Study|Lost to Follow-up|0|||
146180906|NCT00383240|527175153|FG003|Overall Study|Lost to Follow-up|2|||
146180907|NCT00383240|527175150|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
146180908|NCT00383240|527175151|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
146180909|NCT00383240|527175152|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
146180910|NCT00383240|527175153|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
146180911|NCT00383240|527175150|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
146180912|NCT00383240|527175151|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
146180913|NCT00383240|527175152|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
146180914|NCT00383240|527175153|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
146180915|NCT00383240|527175150|FG000|Overall Study|Protocol Violation|4|||
146180916|NCT00383240|527175151|FG001|Overall Study|Protocol Violation|5|||
146180917|NCT00383240|527175152|FG002|Overall Study|Protocol Violation|9|||
146180918|NCT00383240|527175153|FG003|Overall Study|Protocol Violation|6|||
146180919|NCT00383240|527175150|FG000|Overall Study|Did not meet protocol eligibility|9|||
146180920|NCT00383240|527175151|FG001|Overall Study|Did not meet protocol eligibility|4|||
146180921|NCT00383240|527175152|FG002|Overall Study|Did not meet protocol eligibility|9|||
146180922|NCT00383240|527175153|FG003|Overall Study|Did not meet protocol eligibility|3|||
146180923|NCT00383240|527175150|FG000|Overall Study|Administrative|1|||
146180924|NCT00383240|527175151|FG001|Overall Study|Administrative|1|||
146180925|NCT00383240|527175152|FG002|Overall Study|Administrative|0|||
146412345|NCT02544633|528015506|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
146412346|NCT02544633|528015503|FG000|Treatment Period|Adverse Event|7|||
146079157|NCT00322621|526811340|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
146079158|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
146079159|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
146079160|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
146079161|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
146079162|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
146079163|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
146079164|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
146079165|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
146079166|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
146079167|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
146079168|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
146079169|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
146079170|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
146079171|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
146079172|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
146079173|NCT00322621|526811338|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
146079174|NCT00322621|526811339|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
146079175|NCT00322621|526811340|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
146079176|NCT01038869|526811343|FG000|Overall Study|Withdrawal by Subject|1|||
146079177|NCT01038869|526811343|FG000|Overall Study|Lost to Follow-up|6|||
146079178|NCT02238067|526811344|FG000|Overall Study|Not completed survey at Month 6|45|||
146079179|NCT03726996|526811348|FG000|Overall Study|Parent's decision|2|||
146079180|NCT03726996|526811348|FG000|Overall Study|Study early termination|2|||
146079181|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146079182|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146079183|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146079184|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146079185|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
146079186|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
146079187|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146079188|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146079189|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146079190|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146079191|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146079192|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
146079193|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146180926|NCT00383240|527175153|FG003|Overall Study|Administrative|0|||
146180927|NCT02049710|527175154|FG000|Overall Study|Lost to Follow-up|319|||
146180928|NCT02049710|527175155|FG001|Overall Study|Lost to Follow-up|324|||
146180929|NCT02044458|527175156|FG000|Overall Study|Protocol Violation|3|||
146180930|NCT02044458|527175157|FG001|Overall Study|Protocol Violation|8|||
146180931|NCT03391960|527175158|FG000|Overall Study|Protocol Violation|0|||
146180932|NCT03391960|527175159|FG001|Overall Study|Protocol Violation|0|||
146180933|NCT02924389|527175161|FG000|Overall Study|Lost to Follow-up|1|||
146180934|NCT02924389|527175162|FG001|Overall Study|Lost to Follow-up|0|||
146180935|NCT02924389|527175161|FG000|Overall Study|Physician Decision|2|||
146180936|NCT02924389|527175162|FG001|Overall Study|Physician Decision|0|||
146180937|NCT02924389|527175161|FG000|Overall Study|Withdrawal by Subject|3|||
146180938|NCT02924389|527175162|FG001|Overall Study|Withdrawal by Subject|0|||
146180939|NCT02924389|527175161|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
146180940|NCT02924389|527175162|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
146180941|NCT00581113|527177769|FG000|Overall Study|Withdrawal by Subject|0|||
146180942|NCT00581113|527177770|FG001|Overall Study|Withdrawal by Subject|1|||
146180943|NCT01818141|527177771|FG000|Overall Study|Withdrawal by Subject|2|||
146180944|NCT01818141|527177772|FG001|Overall Study|Withdrawal by Subject|0|||
146180945|NCT01818141|527177771|FG000|Overall Study|No baseline C.diff colonies|1|||
146180946|NCT01818141|527177772|FG001|Overall Study|No baseline C.diff colonies|1|||
146180947|NCT01818141|527177771|FG000|Overall Study|Lost to Follow-up|0|||
146180948|NCT01818141|527177772|FG001|Overall Study|Lost to Follow-up|2|||
146180949|NCT00619476|527177773|FG000|Overall Study|Adverse Event|12|||
146180950|NCT00619476|527177774|FG001|Overall Study|Adverse Event|6|||
146180951|NCT00619476|527177775|FG002|Overall Study|Adverse Event|12|||
146180952|NCT00619476|527177776|FG003|Overall Study|Adverse Event|16|||
146180953|NCT00619476|527177773|FG000|Overall Study|Lack of Efficacy|6|||
146180954|NCT00619476|527177774|FG001|Overall Study|Lack of Efficacy|1|||
146180955|NCT00619476|527177775|FG002|Overall Study|Lack of Efficacy|1|||
146180956|NCT00619476|527177776|FG003|Overall Study|Lack of Efficacy|4|||
146180957|NCT00619476|527177773|FG000|Overall Study|Protocol Violation|5|||
146180958|NCT00619476|527177774|FG001|Overall Study|Protocol Violation|4|||
146180959|NCT00619476|527177775|FG002|Overall Study|Protocol Violation|4|||
146180960|NCT00619476|527177776|FG003|Overall Study|Protocol Violation|9|||
146180961|NCT00619476|527177773|FG000|Overall Study|Lost to Follow-up|1|||
146180962|NCT00619476|527177774|FG001|Overall Study|Lost to Follow-up|2|||
146180963|NCT00619476|527177775|FG002|Overall Study|Lost to Follow-up|0|||
146180964|NCT00619476|527177776|FG003|Overall Study|Lost to Follow-up|1|||
146180965|NCT00619476|527177773|FG000|Overall Study|Investigator Discretion|2|||
146180966|NCT00619476|527177774|FG001|Overall Study|Investigator Discretion|2|||
146180967|NCT00619476|527177775|FG002|Overall Study|Investigator Discretion|2|||
146180968|NCT00619476|527177776|FG003|Overall Study|Investigator Discretion|0|||
146180969|NCT00619476|527177773|FG000|Overall Study|Withdrawal by Subject|5|||
146180970|NCT00619476|527177774|FG001|Overall Study|Withdrawal by Subject|7|||
146180971|NCT00619476|527177775|FG002|Overall Study|Withdrawal by Subject|5|||
146180972|NCT00619476|527177776|FG003|Overall Study|Withdrawal by Subject|4|||
146180973|NCT02169830|527177779|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
146180974|NCT02169830|527177780|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
146180975|NCT02169830|527177781|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
146180976|NCT02169830|527177779|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
146180977|NCT02169830|527177780|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146180978|NCT02169830|527177781|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146180979|NCT02169830|527177779|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146180980|NCT02169830|527177780|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
146180981|NCT02169830|527177781|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146180982|NCT02169830|527177779|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
146180983|NCT02169830|527177780|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
146180984|NCT02169830|527177781|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
146180985|NCT02169830|527177779|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
146180986|NCT02169830|527177780|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
146180987|NCT02169830|527177781|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
146180988|NCT03204695|527177782|FG000|Overall Study|Death|1|||
146180989|NCT03204695|527177782|FG000|Overall Study|Participant was treated with another device|1|||
146180990|NCT03204695|527177782|FG000|Overall Study|Physician Decision|2|||
146180991|NCT04834362|527177783|FG000|Overall Study|Death|1|||
146180992|NCT04834362|527177784|FG001|Overall Study|Death|2|||
146180993|NCT02555371|527177785|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
146180994|NCT02555371|527177786|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146180995|NCT02555371|527177787|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146180996|NCT02555371|527177788|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146180997|NCT02555371|527177789|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
146180998|NCT02555371|527177785|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
146180999|NCT02555371|527177786|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146181000|NCT02555371|527177787|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146181001|NCT02555371|527177788|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146181002|NCT02555371|527177789|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
146181003|NCT02555371|527177785|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
146181004|NCT02555371|527177786|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146181005|NCT02555371|527177787|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146181006|NCT02555371|527177788|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146181007|NCT02555371|527177789|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
146181008|NCT02555371|527177785|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
146181009|NCT02555371|527177786|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146181010|NCT02555371|527177787|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146181011|NCT02555371|527177788|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146181012|NCT02555371|527177789|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
146181013|NCT02555371|527177785|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
146181014|NCT02555371|527177786|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146181015|NCT02555371|527177787|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146181016|NCT02555371|527177788|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146181017|NCT02555371|527177789|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
146181018|NCT02555371|527177785|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146181019|NCT02555371|527177786|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
146181020|NCT02555371|527177787|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
146181021|NCT02555371|527177788|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146181022|NCT02555371|527177789|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
146181023|NCT02555371|527177785|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146181024|NCT02555371|527177786|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
146181025|NCT02555371|527177787|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
146181026|NCT02555371|527177788|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146181027|NCT02555371|527177789|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
146181028|NCT02555371|527177785|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146181029|NCT02555371|527177786|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
146181030|NCT02555371|527177787|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146181031|NCT02555371|527177788|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146181032|NCT02555371|527177789|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
146181033|NCT02555371|527177785|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146181034|NCT02555371|527177786|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
146181035|NCT02555371|527177787|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
146181036|NCT02555371|527177788|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146181037|NCT02555371|527177789|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
146181038|NCT02555371|527177785|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146181039|NCT02555371|527177786|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146181040|NCT02555371|527177787|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146181041|NCT02555371|527177788|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
146181042|NCT02555371|527177789|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
146181043|NCT02555371|527177785|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146181044|NCT02555371|527177786|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146181045|NCT02555371|527177787|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146181046|NCT02555371|527177788|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
146181047|NCT02555371|527177789|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
146181048|NCT02555371|527177785|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146181049|NCT02555371|527177786|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146283934|NCT00604825|527551905|FG001|Overall Study|Protocol Violation|1|||
146079194|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146079195|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146079196|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146079197|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146079198|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146079199|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146079200|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
146079201|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146079202|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146079203|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
146079204|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
146079205|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
146079206|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146079207|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146079208|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146079209|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146079210|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146412347|NCT02544633|528015504|FG001|Treatment Period|Adverse Event|4|||
146079211|NCT01328444|526811349|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146079212|NCT01328444|526811350|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
146079213|NCT01328444|526811351|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146079214|NCT01328444|526811352|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
146079215|NCT01328444|526811353|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146079216|NCT01328444|526811354|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146079217|NCT01328444|526811349|FG000|Washout Period (14 Days)|Adverse Event|1|||
146079218|NCT01328444|526811350|FG001|Washout Period (14 Days)|Adverse Event|1|||
146181050|NCT02555371|527177787|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146181051|NCT02555371|527177788|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
146181052|NCT02555371|527177789|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
146181053|NCT02555371|527177785|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146181054|NCT02555371|527177786|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146181055|NCT02555371|527177787|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146181056|NCT02555371|527177788|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
146181057|NCT02555371|527177789|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
146181058|NCT02555371|527177785|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146181059|NCT02555371|527177786|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146181060|NCT02555371|527177787|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146181061|NCT02555371|527177788|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
146079219|NCT01328444|526811351|FG002|Washout Period (14 Days)|Adverse Event|0|||
146079220|NCT01328444|526811352|FG003|Washout Period (14 Days)|Adverse Event|1|||
146079221|NCT01328444|526811353|FG004|Washout Period (14 Days)|Adverse Event|1|||
146079222|NCT01328444|526811354|FG005|Washout Period (14 Days)|Adverse Event|2|||
146079223|NCT01328444|526811349|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
146079224|NCT01328444|526811350|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
146079225|NCT01328444|526811351|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
146079226|NCT01328444|526811352|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
146079227|NCT01328444|526811353|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
146079228|NCT01328444|526811354|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
146079229|NCT01328444|526811349|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
146079230|NCT01328444|526811350|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
146079231|NCT01328444|526811351|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
146181062|NCT02555371|527177789|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
146181063|NCT03095599|527177790|FG000|Overall Study|Withdrawal by Subject|1|||
146181064|NCT03095599|527177791|FG001|Overall Study|Withdrawal by Subject|0|||
146181065|NCT03095599|527177790|FG000|Overall Study|Lost to Follow-up|1|||
146181066|NCT03095599|527177791|FG001|Overall Study|Lost to Follow-up|0|||
146181067|NCT03095599|527177790|FG000|Overall Study|Withdrawal prior to vaccination|1|||
146181068|NCT03095599|527177791|FG001|Overall Study|Withdrawal prior to vaccination|0|||
146181069|NCT00742885|527177795|FG000|Overall Study|Lost to Follow-up|1|||
146181070|NCT00742885|527177796|FG001|Overall Study|Lost to Follow-up|0|||
146181071|NCT04781647|527177797|FG000|Overall Study|Study terminated by Sponsor|11|||
146181072|NCT04781647|527177798|FG001|Overall Study|Study terminated by Sponsor|9|||
146181073|NCT04781647|527177799|FG002|Overall Study|Study terminated by Sponsor|9|||
146181074|NCT04781647|527177797|FG000|Overall Study|Withdrawal by Subject|1|||
146181075|NCT04781647|527177798|FG001|Overall Study|Withdrawal by Subject|2|||
146181076|NCT04781647|527177799|FG002|Overall Study|Withdrawal by Subject|0|||
146181077|NCT04781647|527177797|FG000|Overall Study|Adverse Event|0|||
146181078|NCT04781647|527177798|FG001|Overall Study|Adverse Event|1|||
146181079|NCT04781647|527177799|FG002|Overall Study|Adverse Event|1|||
146181080|NCT04781647|527177797|FG000|Overall Study|Protocol Violation|1|||
146181081|NCT04781647|527177798|FG001|Overall Study|Protocol Violation|0|||
146181082|NCT04781647|527177799|FG002|Overall Study|Protocol Violation|0|||
146181083|NCT04781647|527177797|FG000|Overall Study|Pregnancy|0|||
146181084|NCT04781647|527177798|FG001|Overall Study|Pregnancy|0|||
146181085|NCT04781647|527177799|FG002|Overall Study|Pregnancy|1|||
146181086|NCT04781647|527177797|FG000|Overall Study|Virology rebounded|1|||
146181087|NCT04781647|527177798|FG001|Overall Study|Virology rebounded|0|||
146181088|NCT04781647|527177799|FG002|Overall Study|Virology rebounded|0|||
146181089|NCT01755689|527177800|FG000|Overall Study|Withdrawal by Subject|1|||
146283935|NCT00604825|527551906|FG002|Overall Study|Protocol Violation|0|||
146079232|NCT01328444|526811352|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
146079233|NCT01328444|526811353|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
146079234|NCT01328444|526811354|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
146079235|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
146079236|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146079237|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146079238|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146079239|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146079240|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146079241|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
146079242|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146079243|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146079244|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146079245|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
146079246|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
146079247|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
146079248|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146079249|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146079250|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146079251|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
146079252|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
146079253|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146079254|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146079255|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146079256|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146079257|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146079258|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
146079259|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146079260|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146079261|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146079262|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146079263|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146079264|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
146079265|NCT01328444|526811349|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146079266|NCT01328444|526811350|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146079267|NCT01328444|526811351|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146079268|NCT01328444|526811352|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146079269|NCT01328444|526811353|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146079270|NCT01328444|526811354|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146079271|NCT03531632|526811355|FG000|Overall Study|Adverse Event|0|||
146079272|NCT03531632|526811356|FG001|Overall Study|Adverse Event|0|||
146079273|NCT03531632|526811357|FG002|Overall Study|Adverse Event|1|||
146079274|NCT03531632|526811355|FG000|Overall Study|Death|4|||
146079275|NCT03531632|526811356|FG001|Overall Study|Death|0|||
146079276|NCT03531632|526811357|FG002|Overall Study|Death|14|||
146079277|NCT03531632|526811355|FG000|Overall Study|Study Terminated|1|||
146079278|NCT03531632|526811356|FG001|Overall Study|Study Terminated|3|||
146079279|NCT03531632|526811357|FG002|Overall Study|Study Terminated|11|||
146079280|NCT02743611|526811358|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
146079281|NCT02743611|526811359|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
146079282|NCT02743611|526811360|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
146079283|NCT02743611|526811361|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
146079284|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
146079285|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
146079286|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
146079287|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
146079288|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
146079289|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
146079290|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146079291|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
146079292|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
146079293|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146079294|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146079295|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146079296|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146079297|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146079298|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
146079299|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146079300|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
146079301|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
146079302|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
146079303|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146079304|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146079305|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146079306|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146079307|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
146079308|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
146079309|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
146079310|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
146079311|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
146079312|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
146079313|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
146079314|NCT00600119|526811362|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
146079315|NCT00600119|526811363|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
146079316|NCT00600119|526811364|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146079317|NCT00600119|526811365|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146181090|NCT01755689|527177801|FG001|Overall Study|Withdrawal by Subject|3|||
146181091|NCT01755689|527177802|FG002|Overall Study|Withdrawal by Subject|2|||
146181092|NCT01755689|527177803|FG003|Overall Study|Withdrawal by Subject|1|||
146181093|NCT01755689|527177804|FG004|Overall Study|Withdrawal by Subject|1|||
146181094|NCT01755689|527177800|FG000|Overall Study|Migrated/moved from study area|0|||
146181095|NCT01755689|527177801|FG001|Overall Study|Migrated/moved from study area|1|||
146181096|NCT01755689|527177802|FG002|Overall Study|Migrated/moved from study area|1|||
146181097|NCT01755689|527177803|FG003|Overall Study|Migrated/moved from study area|1|||
146181098|NCT01755689|527177804|FG004|Overall Study|Migrated/moved from study area|1|||
146181099|NCT01755689|527177800|FG000|Overall Study|Lost to Follow-up|1|||
146181100|NCT01755689|527177801|FG001|Overall Study|Lost to Follow-up|0|||
146181101|NCT01755689|527177802|FG002|Overall Study|Lost to Follow-up|1|||
146079318|NCT00600119|526811366|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146079319|NCT00600119|526811367|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
146079320|NCT00600119|526811362|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
146079321|NCT00600119|526811363|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146079322|NCT00600119|526811364|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146079323|NCT00600119|526811365|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
146079324|NCT00600119|526811366|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146079325|NCT00600119|526811367|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
146181102|NCT01755689|527177803|FG003|Overall Study|Lost to Follow-up|0|||
146181103|NCT01755689|527177804|FG004|Overall Study|Lost to Follow-up|2|||
146181104|NCT01755689|527177800|FG000|Overall Study|Pregnancy|1|||
146181105|NCT01755689|527177801|FG001|Overall Study|Pregnancy|1|||
146181106|NCT01755689|527177802|FG002|Overall Study|Pregnancy|2|||
146181107|NCT01755689|527177803|FG003|Overall Study|Pregnancy|4|||
146181108|NCT01755689|527177804|FG004|Overall Study|Pregnancy|2|||
146181109|NCT02609659|527177809|FG000|Overall Study|Adverse Event|1|||
146079326|NCT00600119|526811362|FG000|Double-blind Treatment Period|Other|0|||
146079327|NCT00600119|526811363|FG001|Double-blind Treatment Period|Other|0|||
146079328|NCT00600119|526811364|FG002|Double-blind Treatment Period|Other|0|||
146079329|NCT00600119|526811365|FG003|Double-blind Treatment Period|Other|0|||
146079330|NCT00600119|526811366|FG004|Double-blind Treatment Period|Other|2|||
146181110|NCT02609659|527177809|FG000|Overall Study|Lost to Follow-up|6|||
146181111|NCT02609659|527177809|FG000|Overall Study|Other|1|||
146181112|NCT01155388|527177812|FG000|Overall Study|Adverse Event|1|||
146181113|NCT01155388|527177813|FG001|Overall Study|Adverse Event|0|||
146181114|NCT01004250|527177814|FG000|Induction Therapy Period|Adverse Event|10|||
146181115|NCT01004250|527177814|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
146181116|NCT01004250|527177814|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
146181117|NCT01004250|527177814|FG000|Induction Therapy Period|Physician Decision|2|||
146181118|NCT01004250|527177814|FG000|Maintenance Therapy Period|Adverse Event|15|||
146181119|NCT01004250|527177814|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
146181120|NCT01004250|527177814|FG000|Maintenance Therapy Period|Protocol Violation|1|||
146181121|NCT01004250|527177814|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
146181122|NCT01004250|527177814|FG000|Maintenance Therapy Period|Physician Decision|4|||
146181123|NCT01004250|527177814|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
146181124|NCT03943589|527177815|FG000|Overall Study|Death|1|||
146181125|NCT03943589|527177815|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
146181126|NCT04329104|527177816|FG000|Efficacy Study|Withdrawal by Subject|0|||
146181127|NCT04329104|527177817|FG001|Efficacy Study|Withdrawal by Subject|0|||
146181128|NCT04329104|527177818|FG002|Efficacy Study|Withdrawal by Subject|0|||
146181129|NCT04329104|527177819|FG003|Efficacy Study|Withdrawal by Subject|5|||
146181130|NCT04329104|527177820|FG004|Efficacy Study|Withdrawal by Subject|6|||
146181131|NCT04329104|527177821|FG005|Efficacy Study|Withdrawal by Subject|8|||
146181132|NCT03884231|527177822|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
146181133|NCT03884231|527177822|FG000|Overall Study|Subject Withdrew Consent|1|||
146181134|NCT03884231|527177822|FG000|Overall Study|MRI Scan Not Performed|1|||
146079331|NCT00600119|526811367|FG005|Double-blind Treatment Period|Other|1|||
146079332|NCT00600119|526811362|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
145945349|NCT01764997|526308213|FG001|Run-in Period|Other than specified above|0|||
146181135|NCT00900627|527177823|FG000|Overall Study|Condition under investigation worsened|4|||
146181136|NCT00900627|527177824|FG001|Overall Study|Condition under investigation worsened|0|||
146181137|NCT00900627|527177825|FG002|Overall Study|Condition under investigation worsened|5|||
146181138|NCT00900627|527177826|FG003|Overall Study|Condition under investigation worsened|3|||
146181139|NCT00900627|527177827|FG004|Overall Study|Condition under investigation worsened|0|||
146181140|NCT00900627|527177828|FG005|Overall Study|Condition under investigation worsened|0|||
146181141|NCT00900627|527177823|FG000|Overall Study|Withdrawal by Subject|1|||
146181142|NCT00900627|527177824|FG001|Overall Study|Withdrawal by Subject|0|||
146181143|NCT00900627|527177825|FG002|Overall Study|Withdrawal by Subject|1|||
146181144|NCT00900627|527177826|FG003|Overall Study|Withdrawal by Subject|0|||
146181145|NCT00900627|527177827|FG004|Overall Study|Withdrawal by Subject|1|||
146181146|NCT00900627|527177828|FG005|Overall Study|Withdrawal by Subject|2|||
146181147|NCT00900627|527177823|FG000|Overall Study|Adverse Event|1|||
146181148|NCT00900627|527177824|FG001|Overall Study|Adverse Event|2|||
146181149|NCT00900627|527177825|FG002|Overall Study|Adverse Event|0|||
146181150|NCT00900627|527177826|FG003|Overall Study|Adverse Event|3|||
146181151|NCT00900627|527177827|FG004|Overall Study|Adverse Event|0|||
146181152|NCT00900627|527177828|FG005|Overall Study|Adverse Event|0|||
146181153|NCT00900627|527177823|FG000|Overall Study|Death|0|||
146181154|NCT00900627|527177824|FG001|Overall Study|Death|0|||
146181155|NCT00900627|527177825|FG002|Overall Study|Death|0|||
146181156|NCT00900627|527177826|FG003|Overall Study|Death|0|||
146181157|NCT00900627|527177827|FG004|Overall Study|Death|28|||
146181158|NCT00900627|527177828|FG005|Overall Study|Death|24|||
146181159|NCT00830947|527177829|FG000|Overall Study|Lost to Follow-up|4|||
146181160|NCT00830947|527177830|FG001|Overall Study|Lost to Follow-up|4|||
146181161|NCT00358150|527177832|FG000|Overall Study|Adverse Event|3|||
146181162|NCT00358150|527177832|FG000|Overall Study|Withdrawal by Subject|1|||
146181163|NCT00358150|527177832|FG000|Overall Study|Undefined|3|||
146181164|NCT03685708|527177833|FG000|Overall Study|Withdrawal by Subject|0|||
146181165|NCT03685708|527177834|FG001|Overall Study|Withdrawal by Subject|0|||
146181166|NCT03685708|527177835|FG002|Overall Study|Withdrawal by Subject|1|||
146079333|NCT00600119|526811363|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
146079334|NCT00600119|526811364|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146079335|NCT00600119|526811365|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146079336|NCT00600119|526811366|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
146079337|NCT00600119|526811367|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
146079338|NCT00600119|526811362|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146079339|NCT00600119|526811363|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
146079340|NCT00600119|526811364|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146079341|NCT00600119|526811365|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146079342|NCT00600119|526811366|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146079343|NCT00600119|526811367|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
146079344|NCT00600119|526811362|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
146079345|NCT00600119|526811363|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
146079346|NCT00600119|526811364|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
146079347|NCT00600119|526811365|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
146079348|NCT00600119|526811366|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
146079349|NCT00600119|526811367|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
146079350|NCT00600119|526811362|FG000|Double-blind Treatment Period|Physician Decision|2|||
146412348|NCT02544633|528015505|FG002|Treatment Period|Adverse Event|0|||
146412349|NCT02544633|528015506|FG003|Treatment Period|Adverse Event|5|||
146079351|NCT00600119|526811363|FG001|Double-blind Treatment Period|Physician Decision|0|||
146079352|NCT00600119|526811364|FG002|Double-blind Treatment Period|Physician Decision|0|||
146079353|NCT00600119|526811365|FG003|Double-blind Treatment Period|Physician Decision|0|||
146079354|NCT00600119|526811366|FG004|Double-blind Treatment Period|Physician Decision|0|||
146079355|NCT00600119|526811367|FG005|Double-blind Treatment Period|Physician Decision|0|||
146079356|NCT00600119|526811362|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146079357|NCT00600119|526811363|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146079358|NCT00600119|526811364|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146079359|NCT00600119|526811365|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146079360|NCT00600119|526811366|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
146079361|NCT00600119|526811367|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
146079362|NCT00600119|526811362|FG000|Double-blind Treatment Period|Adverse Event|1|||
146079363|NCT00600119|526811363|FG001|Double-blind Treatment Period|Adverse Event|1|||
146079364|NCT00600119|526811364|FG002|Double-blind Treatment Period|Adverse Event|0|||
146079365|NCT00600119|526811365|FG003|Double-blind Treatment Period|Adverse Event|1|||
146079366|NCT00600119|526811366|FG004|Double-blind Treatment Period|Adverse Event|2|||
146079367|NCT00600119|526811367|FG005|Double-blind Treatment Period|Adverse Event|10|||
146079368|NCT00600119|526811362|FG000|Follow-up Period|Adverse Event|0|||
146079369|NCT00600119|526811363|FG001|Follow-up Period|Adverse Event|0|||
146079370|NCT00600119|526811364|FG002|Follow-up Period|Adverse Event|0|||
146079371|NCT00600119|526811365|FG003|Follow-up Period|Adverse Event|0|||
146079372|NCT00600119|526811366|FG004|Follow-up Period|Adverse Event|0|||
146079373|NCT00600119|526811367|FG005|Follow-up Period|Adverse Event|1|||
146079374|NCT00600119|526811362|FG000|Follow-up Period|Other|1|||
146079375|NCT00600119|526811363|FG001|Follow-up Period|Other|0|||
146079376|NCT00600119|526811364|FG002|Follow-up Period|Other|0|||
146079377|NCT00600119|526811365|FG003|Follow-up Period|Other|0|||
146079378|NCT00600119|526811366|FG004|Follow-up Period|Other|0|||
146079379|NCT00600119|526811367|FG005|Follow-up Period|Other|0|||
146079380|NCT01616693|526811368|FG000|Evaluated for Safety|Physician Decision|1|||
146079381|NCT01616693|526811369|FG001|Evaluated for Safety|Physician Decision|0|||
146079382|NCT01616693|526811370|FG002|Evaluated for Safety|Physician Decision|1|||
146079383|NCT01616693|526811371|FG003|Evaluated for Safety|Physician Decision|0|||
146079384|NCT01616693|526811368|FG000|Received Both Vaccines|Adverse Event|2|||
146079385|NCT01616693|526811369|FG001|Received Both Vaccines|Adverse Event|0|||
146079386|NCT01616693|526811370|FG002|Received Both Vaccines|Adverse Event|0|||
146079387|NCT01616693|526811371|FG003|Received Both Vaccines|Adverse Event|0|||
146079388|NCT01616693|526811368|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
146181167|NCT03685708|527177833|FG000|Overall Study|Screen Fail|0|||
146079389|NCT01616693|526811369|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
146181168|NCT03685708|527177834|FG001|Overall Study|Screen Fail|1|||
146079390|NCT01616693|526811370|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
146079391|NCT01616693|526811371|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
146079392|NCT01616693|526811368|FG000|Received Both Vaccines|Lost to Follow-up|4|||
146079393|NCT01616693|526811369|FG001|Received Both Vaccines|Lost to Follow-up|3|||
146079394|NCT01616693|526811370|FG002|Received Both Vaccines|Lost to Follow-up|4|||
146079395|NCT01616693|526811371|FG003|Received Both Vaccines|Lost to Follow-up|4|||
146079396|NCT01616693|526811368|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
146079397|NCT01616693|526811369|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
146079398|NCT01616693|526811370|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
146079399|NCT01616693|526811371|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
146079400|NCT01950013|526811372|FG000|Overall Study|Withdrawal by Subject|0|||
146079401|NCT01950013|526811373|FG001|Overall Study|Withdrawal by Subject|2|||
146079402|NCT01950013|526811374|FG002|Overall Study|Withdrawal by Subject|0|||
146079403|NCT00271505|526811378|FG000|Overall Study|Screen Failure|3|||
146079404|NCT00271505|526811378|FG000|Overall Study|Adverse Event|1|||
146079405|NCT00271505|526811378|FG000|Overall Study|Death|1|||
146079406|NCT00539188|526811379|FG000|Overall Study|Withdrawal by Subject|1|||
146079407|NCT00539188|526811380|FG001|Overall Study|Withdrawal by Subject|0|||
146181169|NCT03685708|527177835|FG002|Overall Study|Screen Fail|1|||
146079408|NCT00539188|526811379|FG000|Overall Study|Lost to Follow-up|2|||
146181170|NCT03685708|527177833|FG000|Overall Study|COVID 19 Pandemic|1|||
146181171|NCT03685708|527177834|FG001|Overall Study|COVID 19 Pandemic|1|||
146181172|NCT03685708|527177835|FG002|Overall Study|COVID 19 Pandemic|6|||
146181173|NCT03685708|527177833|FG000|Overall Study|Disease Progression|0|||
146181174|NCT03685708|527177834|FG001|Overall Study|Disease Progression|0|||
146181175|NCT03685708|527177835|FG002|Overall Study|Disease Progression|1|||
145945350|NCT01764997|526308214|FG002|Run-in Period|Other than specified above|0|||
146181176|NCT00610675|527177847|FG000|Overall Study|Untreated|4|||
146181177|NCT00610675|527177847|FG000|Overall Study|Adverse Event|67|||
146181178|NCT00610675|527177847|FG000|Overall Study|Insufficient Effect|31|||
146181179|NCT00610675|527177847|FG000|Overall Study|Withdrawal by Subject|28|||
146181180|NCT00610675|527177847|FG000|Overall Study|Reasons unrelated to trial|27|||
146181181|NCT00610675|527177847|FG000|Overall Study|Lack of Compliance|7|||
146181182|NCT00610675|527177847|FG000|Overall Study|Lost to Follow-up|31|||
146181183|NCT00610675|527177847|FG000|Overall Study|Other reason (not specified)|25|||
146181184|NCT04011384|527177856|FG000|Overall Study|Withdrawal by Subject|2|||
146181185|NCT04011384|527177857|FG001|Overall Study|Withdrawal by Subject|0|||
146181186|NCT00993317|527177858|FG000|Overall Study|Adverse Event|2|||
146181187|NCT00993317|527177859|FG001|Overall Study|Adverse Event|4|||
146181188|NCT00993317|527177858|FG000|Overall Study|Lack of Efficacy|18|||
146181189|NCT00993317|527177859|FG001|Overall Study|Lack of Efficacy|18|||
146181190|NCT00993317|527177858|FG000|Overall Study|Withdrawal by Subject|0|||
146181191|NCT00993317|527177859|FG001|Overall Study|Withdrawal by Subject|2|||
146181192|NCT00993317|527177858|FG000|Overall Study|Investigator's opinion|0|||
146181193|NCT00993317|527177859|FG001|Overall Study|Investigator's opinion|1|||
146181194|NCT00993317|527177858|FG000|Overall Study|Early study termination at the site|1|||
146181195|NCT00993317|527177859|FG001|Overall Study|Early study termination at the site|0|||
146181196|NCT00672958|527177860|FG000|Overall Study|Adverse Event|11|||
146181197|NCT00672958|527177861|FG001|Overall Study|Adverse Event|9|||
146181198|NCT00672958|527177860|FG000|Overall Study|Lack of Efficacy|6|||
146181199|NCT00672958|527177861|FG001|Overall Study|Lack of Efficacy|11|||
146181200|NCT00672958|527177860|FG000|Overall Study|Non-compliance with study drug|2|||
146181201|NCT00672958|527177861|FG001|Overall Study|Non-compliance with study drug|3|||
146181202|NCT00672958|527177860|FG000|Overall Study|Protocol deviations|11|||
146181203|NCT00672958|527177861|FG001|Overall Study|Protocol deviations|5|||
146412350|NCT02544633|528015503|FG000|Treatment Period|Lack of Efficacy|17|||
146412351|NCT02544633|528015504|FG001|Treatment Period|Lack of Efficacy|11|||
146412352|NCT02544633|528015505|FG002|Treatment Period|Lack of Efficacy|5|||
146079409|NCT00539188|526811380|FG001|Overall Study|Lost to Follow-up|1|||
146079410|NCT04784442|526811381|FG000|Overall Study|Adverse Event|1|||
146079411|NCT04784442|526811382|FG001|Overall Study|Adverse Event|0|||
146079412|NCT04784442|526811383|FG002|Overall Study|Adverse Event|2|||
146079413|NCT04784442|526811384|FG003|Overall Study|Adverse Event|1|||
146181204|NCT00672958|527177860|FG000|Overall Study|Voluntary withdrawal|12|||
146181205|NCT00672958|527177861|FG001|Overall Study|Voluntary withdrawal|8|||
146079414|NCT04784442|526811381|FG000|Overall Study|Protocol Violation|1|||
146079415|NCT04784442|526811382|FG001|Overall Study|Protocol Violation|0|||
146079416|NCT04784442|526811383|FG002|Overall Study|Protocol Violation|0|||
146079417|NCT04784442|526811384|FG003|Overall Study|Protocol Violation|0|||
146181206|NCT00672958|527177860|FG000|Overall Study|Lost to Follow-up|22|||
146181207|NCT00672958|527177861|FG001|Overall Study|Lost to Follow-up|17|||
146181208|NCT00672958|527177860|FG000|Overall Study|Reason not specified|0|||
146181209|NCT00672958|527177861|FG001|Overall Study|Reason not specified|3|||
146181210|NCT02374593|527177862|FG000|Overall Study|non-compliant|2|||
146181211|NCT02374593|527177863|FG001|Overall Study|non-compliant|0|||
146079418|NCT04784442|526811381|FG000|Overall Study|Non-compliance with study drug|1|||
146079419|NCT04784442|526811382|FG001|Overall Study|Non-compliance with study drug|0|||
146181212|NCT00579982|527177864|FG000|Overall Study|Adverse Event|4|||
146181213|NCT00579982|527177864|FG000|Overall Study|Protocol Violation|4|||
146181214|NCT03192215|527177865|FG000|Overall Study|Death|28|||
146181215|NCT03192215|527177866|FG001|Overall Study|Death|23|||
146079420|NCT04784442|526811383|FG002|Overall Study|Non-compliance with study drug|0|||
146079421|NCT04784442|526811384|FG003|Overall Study|Non-compliance with study drug|0|||
146079422|NCT00486811|526811387|FG000|Overall Study|Adverse Event|28|||
146079423|NCT00486811|526811388|FG001|Overall Study|Adverse Event|60|||
146079424|NCT00486811|526811389|FG002|Overall Study|Adverse Event|135|||
146079425|NCT00486811|526811387|FG000|Overall Study|Lack of Efficacy|34|||
146079426|NCT00486811|526811388|FG001|Overall Study|Lack of Efficacy|14|||
146079427|NCT00486811|526811389|FG002|Overall Study|Lack of Efficacy|7|||
146079428|NCT00486811|526811387|FG000|Overall Study|Lost to Follow-up|4|||
146079429|NCT00486811|526811388|FG001|Overall Study|Lost to Follow-up|6|||
146079430|NCT00486811|526811389|FG002|Overall Study|Lost to Follow-up|4|||
146079431|NCT00486811|526811387|FG000|Overall Study|Withdrawal by Subject|33|||
146079432|NCT00486811|526811388|FG001|Overall Study|Withdrawal by Subject|44|||
146079433|NCT00486811|526811389|FG002|Overall Study|Withdrawal by Subject|58|||
146079434|NCT00486811|526811387|FG000|Overall Study|Study drug non-compliant|5|||
146079435|NCT00486811|526811388|FG001|Overall Study|Study drug non-compliant|6|||
146079436|NCT00486811|526811389|FG002|Overall Study|Study drug non-compliant|3|||
146079437|NCT00486811|526811387|FG000|Overall Study|All other|18|||
146079438|NCT00486811|526811388|FG001|Overall Study|All other|11|||
146079439|NCT00486811|526811389|FG002|Overall Study|All other|7|||
146079440|NCT00852371|526811393|FG000|Overall Study|Lost to Follow-up|2|||
146079441|NCT00852371|526811394|FG001|Overall Study|Lost to Follow-up|3|||
146079442|NCT00852371|526811395|FG002|Overall Study|Lost to Follow-up|4|||
146079443|NCT00852371|526811396|FG003|Overall Study|Lost to Follow-up|2|||
146079444|NCT02756806|526811397|FG000|Overall Study|Study terminated early|5|||
146079445|NCT03158285|526811398|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
146079446|NCT03158285|526811399|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
146079447|NCT03158285|526811400|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
146079448|NCT03158285|526811398|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146079449|NCT03158285|526811399|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
146079450|NCT03158285|526811400|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
146079451|NCT03158285|526811398|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146079452|NCT03158285|526811399|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146079453|NCT03158285|526811400|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
146079454|NCT03158285|526811398|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146079455|NCT03158285|526811399|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
146079456|NCT03158285|526811400|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146079457|NCT03158285|526811398|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
146079458|NCT03158285|526811399|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
146079459|NCT03158285|526811400|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
146079460|NCT03158285|526811398|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
146079461|NCT03158285|526811399|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
146181216|NCT03192215|527177865|FG000|Overall Study|Lost to Follow-up|10|||
146079462|NCT03158285|526811400|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
146079463|NCT03158285|526811398|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
146079464|NCT03158285|526811399|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
146079465|NCT03158285|526811400|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
146079466|NCT03158285|526811398|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
146079467|NCT03158285|526811399|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
146079468|NCT03158285|526811400|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
146079469|NCT03158285|526811398|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
146079470|NCT03158285|526811399|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
146079471|NCT03158285|526811400|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
146079472|NCT03158285|526811398|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
146079473|NCT03158285|526811399|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
146079474|NCT03158285|526811400|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
146079475|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
146079476|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
146079477|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
146079478|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
146079479|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
146079480|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
146079481|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
146079482|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
146079483|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
146079484|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
146079485|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
146079486|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
146079487|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Death|1|||
146079488|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Death|0|||
146079489|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Death|0|||
146079490|NCT03158285|526811398|FG000|Active Treatment Period: Week 52-100|Other|4|||
146079491|NCT03158285|526811399|FG001|Active Treatment Period: Week 52-100|Other|1|||
146181217|NCT03192215|527177866|FG001|Overall Study|Lost to Follow-up|15|||
146079492|NCT03158285|526811400|FG002|Active Treatment Period: Week 52-100|Other|0|||
146079493|NCT01008423|526811403|FG000|Overall Study|Adverse Event|13|||
146079494|NCT01008423|526811404|FG001|Overall Study|Adverse Event|6|||
146079495|NCT01008423|526811403|FG000|Overall Study|Withdrawal by Subject|4|||
146079496|NCT01008423|526811404|FG001|Overall Study|Withdrawal by Subject|7|||
146079497|NCT01008423|526811403|FG000|Overall Study|Lost to Follow-up|0|||
146079498|NCT01008423|526811404|FG001|Overall Study|Lost to Follow-up|2|||
146079499|NCT01008423|526811403|FG000|Overall Study|Low Cortisol|0|||
146079500|NCT01008423|526811404|FG001|Overall Study|Low Cortisol|1|||
146079501|NCT01008423|526811403|FG000|Overall Study|Lack of Efficacy|0|||
146079502|NCT01008423|526811404|FG001|Overall Study|Lack of Efficacy|5|||
146079503|NCT01008423|526811403|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
146283936|NCT00604825|527551907|FG003|Overall Study|Protocol Violation|0|||
146079504|NCT01008423|526811404|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
146079505|NCT01008423|526811403|FG000|Overall Study|Personal Conflict|1|||
146079506|NCT01008423|526811404|FG001|Overall Study|Personal Conflict|0|||
146079507|NCT01008423|526811403|FG000|Overall Study|Other|0|||
146079508|NCT01008423|526811404|FG001|Overall Study|Other|1|||
146079509|NCT01028300|526811407|FG000|Overall Study|Study Terminated|4|||
146079510|NCT00946153|526811411|FG000|Phase 2|Adverse Event|0|||
146079511|NCT00946153|526811412|FG001|Phase 2|Adverse Event|0|||
146079512|NCT00946153|526811413|FG002|Phase 2|Adverse Event|0|||
146079513|NCT00946153|526811414|FG003|Phase 2|Adverse Event|0|||
146079514|NCT00946153|526811415|FG004|Phase 2|Adverse Event|6|||
146079515|NCT00946153|526811411|FG000|Phase 2|Need more reduction of dose|0|||
146079516|NCT00946153|526811412|FG001|Phase 2|Need more reduction of dose|0|||
146181218|NCT03192215|527177865|FG000|Overall Study|Withdrawal by Subject|49|||
145890935|NCT01207440|526107572|FG002|Overall Study|Non-compliance with Study Drug|1|||
146412353|NCT02544633|528015506|FG003|Treatment Period|Lack of Efficacy|5|||
146181219|NCT03192215|527177866|FG001|Overall Study|Withdrawal by Subject|48|||
146181220|NCT03192215|527177865|FG000|Overall Study|Other as reported in analysis|4|||
146181221|NCT03192215|527177866|FG001|Overall Study|Other as reported in analysis|1|||
146181222|NCT02038764|527177867|FG000|Overall Study|Adverse Event|0|||
146181223|NCT02038764|527177868|FG001|Overall Study|Adverse Event|0|||
146181224|NCT02038764|527177869|FG002|Overall Study|Adverse Event|1|||
146181225|NCT02038764|527177870|FG003|Overall Study|Adverse Event|0|||
146181226|NCT02038764|527177871|FG004|Overall Study|Adverse Event|0|||
146181227|NCT02038764|527177867|FG000|Overall Study|Lost to Follow-up|0|||
146181228|NCT02038764|527177868|FG001|Overall Study|Lost to Follow-up|1|||
146181229|NCT02038764|527177869|FG002|Overall Study|Lost to Follow-up|0|||
146181230|NCT02038764|527177870|FG003|Overall Study|Lost to Follow-up|0|||
146181231|NCT02038764|527177871|FG004|Overall Study|Lost to Follow-up|0|||
146079517|NCT00946153|526811413|FG002|Phase 2|Need more reduction of dose|0|||
146079518|NCT00946153|526811414|FG003|Phase 2|Need more reduction of dose|0|||
146079519|NCT00946153|526811415|FG004|Phase 2|Need more reduction of dose|2|||
146079520|NCT00946153|526811411|FG000|Phase 2|Physician Decision|0|||
146079521|NCT00946153|526811412|FG001|Phase 2|Physician Decision|0|||
146079522|NCT00946153|526811413|FG002|Phase 2|Physician Decision|0|||
146079523|NCT00946153|526811414|FG003|Phase 2|Physician Decision|0|||
146079524|NCT00946153|526811415|FG004|Phase 2|Physician Decision|1|||
146079525|NCT00946153|526811411|FG000|Phase 2|14 days washout for recovery due to AE|0|||
146079526|NCT00946153|526811412|FG001|Phase 2|14 days washout for recovery due to AE|0|||
146079527|NCT00946153|526811413|FG002|Phase 2|14 days washout for recovery due to AE|0|||
146079528|NCT00946153|526811414|FG003|Phase 2|14 days washout for recovery due to AE|0|||
146079529|NCT00946153|526811415|FG004|Phase 2|14 days washout for recovery due to AE|4|||
146079530|NCT00530504|526811418|FG000|Overall Study|Death|54|||
146079531|NCT00530504|526811418|FG000|Overall Study|Lost to Follow-up|26|||
146079532|NCT00530504|526811418|FG000|Overall Study|Withdrawal by Subject|39|||
146079533|NCT00530504|526811418|FG000|Overall Study|Exited study due to other reasons|33|||
146079534|NCT00006289|526811419|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
146079535|NCT00006289|526811420|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
146079536|NCT00006289|526811419|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
146079537|NCT00006289|526811420|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
146079538|NCT05141448|526811427|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146079539|NCT05141448|526811428|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
146079540|NCT05141448|526811429|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146079541|NCT05141448|526811430|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146079542|NCT05141448|526811431|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146079543|NCT05141448|526811432|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146079544|NCT05141448|526811427|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146079545|NCT05141448|526811428|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146079546|NCT05141448|526811429|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146079547|NCT05141448|526811430|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146079548|NCT05141448|526811431|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146079549|NCT05141448|526811432|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146079550|NCT05141448|526811427|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146079551|NCT05141448|526811428|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146079552|NCT05141448|526811429|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146079553|NCT05141448|526811430|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146079554|NCT05141448|526811431|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146079555|NCT05141448|526811432|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146079556|NCT05141448|526811427|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146079557|NCT05141448|526811428|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146079558|NCT05141448|526811429|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146079559|NCT05141448|526811430|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146412354|NCT02544633|528015503|FG000|Treatment Period|Global Deterioration of Health|3|||
146087739|NCT04393298|526841819|FG009|Overall Study|Patient Discharged to Hospice|0|||
146079560|NCT05141448|526811431|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146079561|NCT05141448|526811432|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146079562|NCT05141448|526811427|FG000|Period 2|COVID-19 Related|0|||
146079563|NCT05141448|526811428|FG001|Period 2|COVID-19 Related|0|||
146079564|NCT05141448|526811429|FG002|Period 2|COVID-19 Related|0|||
146079565|NCT05141448|526811430|FG003|Period 2|COVID-19 Related|1|||
146079566|NCT05141448|526811431|FG004|Period 2|COVID-19 Related|0|||
146079567|NCT05141448|526811432|FG005|Period 2|COVID-19 Related|1|||
146079568|NCT05141448|526811427|FG000|3|Covid-19 related|2|||
146079569|NCT05141448|526811428|FG001|3|Covid-19 related|0|||
146079570|NCT05141448|526811429|FG002|3|Covid-19 related|0|||
146079571|NCT05141448|526811430|FG003|3|Covid-19 related|0|||
146181232|NCT02038764|527177867|FG000|Overall Study|Withdrawal by Subject|0|||
146181233|NCT02038764|527177868|FG001|Overall Study|Withdrawal by Subject|0|||
146181234|NCT02038764|527177869|FG002|Overall Study|Withdrawal by Subject|0|||
146181235|NCT02038764|527177870|FG003|Overall Study|Withdrawal by Subject|0|||
146181236|NCT02038764|527177871|FG004|Overall Study|Withdrawal by Subject|1|||
146181237|NCT02038764|527177867|FG000|Overall Study|Other|1|||
146181238|NCT02038764|527177868|FG001|Overall Study|Other|0|||
146181239|NCT02038764|527177869|FG002|Overall Study|Other|1|||
146181240|NCT02038764|527177870|FG003|Overall Study|Other|0|||
146181241|NCT02038764|527177871|FG004|Overall Study|Other|0|||
146181242|NCT04844918|527177873|FG000|Overall Study|Adverse Event|7|||
146181243|NCT04844918|527177874|FG001|Overall Study|Adverse Event|8|||
146181244|NCT04844918|527177875|FG002|Overall Study|Adverse Event|5|||
146181245|NCT04844918|527177873|FG000|Overall Study|Physician Decision|0|||
146181246|NCT04844918|527177874|FG001|Overall Study|Physician Decision|1|||
146181247|NCT04844918|527177875|FG002|Overall Study|Physician Decision|0|||
146181248|NCT04844918|527177873|FG000|Overall Study|Withdrawal by Subject|6|||
146181249|NCT04844918|527177874|FG001|Overall Study|Withdrawal by Subject|3|||
146181250|NCT04844918|527177875|FG002|Overall Study|Withdrawal by Subject|3|||
146181251|NCT04844918|527177873|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
146181252|NCT04844918|527177874|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
146181253|NCT04844918|527177875|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
146181254|NCT04716881|527177877|FG000|Overall Study|Adverse Event|1|||
146181255|NCT04716881|527177877|FG000|Overall Study|Lost to Follow-up|1|||
146181256|NCT00363896|527177878|FG000|Overall Study|Withdrawal by Subject|29|||
146181257|NCT00363896|527177879|FG001|Overall Study|Withdrawal by Subject|16|||
146181258|NCT00363896|527177878|FG000|Overall Study|Adverse Event|24|||
146079572|NCT05141448|526811431|FG004|3|Covid-19 related|0|||
146079573|NCT05141448|526811432|FG005|3|Covid-19 related|1|||
146079574|NCT05141448|526811427|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
146079575|NCT05141448|526811428|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
146079576|NCT05141448|526811429|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
146079577|NCT05141448|526811430|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
146079578|NCT05141448|526811431|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
146079579|NCT05141448|526811432|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
146079580|NCT03865316|526812828|FG000|Overall Study|Procedure Cancelled|4|||
146079581|NCT03865316|526812828|FG000|Overall Study|Equipment failure|4|||
146079582|NCT03137069|526812834|FG000|Overall Study|Withdrawal by Subject|1|||
146079583|NCT03137069|526812835|FG001|Overall Study|Withdrawal by Subject|2|||
146079584|NCT03137069|526812836|FG002|Overall Study|Withdrawal by Subject|2|||
146079585|NCT03137069|526812837|FG003|Overall Study|Withdrawal by Subject|2|||
146079586|NCT03137069|526812838|FG004|Overall Study|Withdrawal by Subject|0|||
146079587|NCT03137069|526812839|FG005|Overall Study|Withdrawal by Subject|0|||
146079588|NCT03137069|526812834|FG000|Overall Study|Adverse Event|0|||
146079589|NCT03137069|526812835|FG001|Overall Study|Adverse Event|3|||
146079590|NCT03137069|526812836|FG002|Overall Study|Adverse Event|1|||
146079591|NCT03137069|526812837|FG003|Overall Study|Adverse Event|1|||
146079592|NCT03137069|526812838|FG004|Overall Study|Adverse Event|0|||
146079593|NCT03137069|526812839|FG005|Overall Study|Adverse Event|1|||
146079594|NCT03137069|526812834|FG000|Overall Study|Protocol Violation|0|||
146079595|NCT03137069|526812835|FG001|Overall Study|Protocol Violation|1|||
146079596|NCT03137069|526812836|FG002|Overall Study|Protocol Violation|0|||
146079597|NCT03137069|526812837|FG003|Overall Study|Protocol Violation|1|||
146079598|NCT03137069|526812838|FG004|Overall Study|Protocol Violation|1|||
146079599|NCT03137069|526812839|FG005|Overall Study|Protocol Violation|1|||
146079600|NCT03137069|526812834|FG000|Overall Study|Physician Decision|0|||
146079601|NCT03137069|526812835|FG001|Overall Study|Physician Decision|0|||
146079602|NCT03137069|526812836|FG002|Overall Study|Physician Decision|0|||
146079603|NCT03137069|526812837|FG003|Overall Study|Physician Decision|1|||
146079604|NCT03137069|526812838|FG004|Overall Study|Physician Decision|0|||
146079605|NCT03137069|526812839|FG005|Overall Study|Physician Decision|0|||
146079606|NCT03137069|526812834|FG000|Overall Study|Study Terminated by Sponsor|0|||
146079607|NCT03137069|526812835|FG001|Overall Study|Study Terminated by Sponsor|0|||
146079608|NCT03137069|526812836|FG002|Overall Study|Study Terminated by Sponsor|0|||
146079609|NCT03137069|526812837|FG003|Overall Study|Study Terminated by Sponsor|0|||
146079610|NCT03137069|526812838|FG004|Overall Study|Study Terminated by Sponsor|1|||
146079611|NCT03137069|526812839|FG005|Overall Study|Study Terminated by Sponsor|0|||
146079612|NCT03137069|526812834|FG000|Overall Study|Data Entry Error|0|||
146412355|NCT02544633|528015504|FG001|Treatment Period|Global Deterioration of Health|3|||
146412356|NCT02544633|528015505|FG002|Treatment Period|Global Deterioration of Health|0|||
146412357|NCT02544633|528015506|FG003|Treatment Period|Global Deterioration of Health|1|||
146079613|NCT03137069|526812835|FG001|Overall Study|Data Entry Error|0|||
146079614|NCT03137069|526812836|FG002|Overall Study|Data Entry Error|0|||
146079615|NCT03137069|526812837|FG003|Overall Study|Data Entry Error|1|||
146079616|NCT03137069|526812838|FG004|Overall Study|Data Entry Error|0|||
146079617|NCT03137069|526812839|FG005|Overall Study|Data Entry Error|0|||
146079618|NCT00336856|526812840|FG000|Overall Study|Withdrawal by Subject|3|||
146079619|NCT00336856|526812840|FG000|Overall Study|Found ineligible at time of analysis|1|||
146079620|NCT02522624|526812842|FG000|Overall Study|Technical failure|1|||
146079621|NCT02522624|526812843|FG001|Overall Study|Technical failure|0|||
146079622|NCT01325337|526812844|FG000|Overall Study|Adverse Event|0|||
146079623|NCT01325337|526812845|FG001|Overall Study|Adverse Event|2|||
146079624|NCT01325337|526812846|FG002|Overall Study|Adverse Event|2|||
146079625|NCT01325337|526812847|FG003|Overall Study|Adverse Event|1|||
146079626|NCT01325337|526812848|FG004|Overall Study|Adverse Event|2|||
146079627|NCT01325337|526812844|FG000|Overall Study|Lost to Follow-up|2|||
146079628|NCT01325337|526812845|FG001|Overall Study|Lost to Follow-up|2|||
146079629|NCT01325337|526812846|FG002|Overall Study|Lost to Follow-up|2|||
146079630|NCT01325337|526812847|FG003|Overall Study|Lost to Follow-up|1|||
146079631|NCT01325337|526812848|FG004|Overall Study|Lost to Follow-up|2|||
146079632|NCT01325337|526812844|FG000|Overall Study|Personal Reasons|2|||
146079633|NCT01325337|526812845|FG001|Overall Study|Personal Reasons|5|||
146079634|NCT01325337|526812846|FG002|Overall Study|Personal Reasons|4|||
146079635|NCT01325337|526812847|FG003|Overall Study|Personal Reasons|8|||
146079636|NCT01325337|526812848|FG004|Overall Study|Personal Reasons|3|||
146079637|NCT01325337|526812844|FG000|Overall Study|Withdrawal by Subject|1|||
146079638|NCT01325337|526812845|FG001|Overall Study|Withdrawal by Subject|0|||
146079639|NCT01325337|526812846|FG002|Overall Study|Withdrawal by Subject|1|||
146079640|NCT01325337|526812847|FG003|Overall Study|Withdrawal by Subject|0|||
146079641|NCT01325337|526812848|FG004|Overall Study|Withdrawal by Subject|1|||
146079642|NCT00843778|526812861|FG000|Overall Study|Adverse Event|15|||
146079643|NCT00843778|526812861|FG000|Overall Study|Lack of Efficacy|14|||
146079644|NCT00843778|526812861|FG000|Overall Study|Loss of efficacy|2|||
146079645|NCT00843778|526812861|FG000|Overall Study|Withdrawal by Subject|4|||
146079646|NCT00369629|526812862|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
146079647|NCT00369629|526812863|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
146079648|NCT00369629|526812864|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
146079649|NCT00369629|526812865|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
146079650|NCT00369629|526812862|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146079651|NCT00369629|526812863|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146079652|NCT00369629|526812864|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
146079653|NCT00369629|526812865|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
146079654|NCT00369629|526812862|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
146079655|NCT00369629|526812863|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146079656|NCT00369629|526812864|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146079657|NCT00369629|526812865|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
146079658|NCT00369629|526812862|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
146079659|NCT00369629|526812863|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
146079660|NCT00369629|526812864|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
146079661|NCT00369629|526812865|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
146079662|NCT00369629|526812862|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
146079663|NCT00369629|526812863|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
146079664|NCT00369629|526812864|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
146079665|NCT00369629|526812865|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
146079666|NCT00369629|526812862|FG000|Completed 4 More Cycles|Progressive disease|2|||
146079667|NCT00369629|526812863|FG001|Completed 4 More Cycles|Progressive disease|1|||
146079668|NCT00369629|526812864|FG002|Completed 4 More Cycles|Progressive disease|2|||
146079669|NCT00369629|526812865|FG003|Completed 4 More Cycles|Progressive disease|0|||
146079670|NCT00369629|526812862|FG000|Follow up for 1 Year|Death|2|||
146079671|NCT00369629|526812863|FG001|Follow up for 1 Year|Death|1|||
146079672|NCT00369629|526812864|FG002|Follow up for 1 Year|Death|1|||
146079673|NCT00369629|526812865|FG003|Follow up for 1 Year|Death|0|||
146079674|NCT00369629|526812862|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
146079675|NCT00369629|526812863|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
146079676|NCT00369629|526812864|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
146079677|NCT00369629|526812865|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
146181259|NCT00363896|527177879|FG001|Overall Study|Adverse Event|13|||
146181260|NCT00363896|527177878|FG000|Overall Study|COPD exacerbation|13|||
146181261|NCT00363896|527177879|FG001|Overall Study|COPD exacerbation|7|||
146181262|NCT00363896|527177878|FG000|Overall Study|Lack of Efficacy|12|||
146181263|NCT00363896|527177879|FG001|Overall Study|Lack of Efficacy|8|||
146181264|NCT00363896|527177878|FG000|Overall Study|Protocol Violation|6|||
146181265|NCT00363896|527177879|FG001|Overall Study|Protocol Violation|1|||
146181266|NCT00363896|527177878|FG000|Overall Study|Lost to Follow-up|3|||
146181267|NCT00363896|527177879|FG001|Overall Study|Lost to Follow-up|0|||
146181268|NCT00363896|527177878|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
146181269|NCT00363896|527177879|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
146181270|NCT00363896|527177878|FG000|Overall Study|Other|1|||
146181271|NCT00363896|527177879|FG001|Overall Study|Other|2|||
146181272|NCT01558674|527177880|FG000|Part 1|Study Terminated by Sponsor|10|||
146181273|NCT01558674|527177881|FG001|Part 1|Study Terminated by Sponsor|0|||
146181274|NCT01558674|527177880|FG000|Part 1|Withdrawal by Subject|1|||
146181275|NCT01558674|527177881|FG001|Part 1|Withdrawal by Subject|0|||
146181276|NCT00924469|527177882|FG000|Overall Study|Adverse Event|2|||
146181277|NCT00924469|527177883|FG001|Overall Study|Adverse Event|0|||
146181278|NCT00924469|527177882|FG000|Overall Study|Withdrawal by Subject|0|||
146181279|NCT00924469|527177883|FG001|Overall Study|Withdrawal by Subject|1|||
146181280|NCT00924469|527177882|FG000|Overall Study|Lost to Follow-up|0|||
146181281|NCT00924469|527177883|FG001|Overall Study|Lost to Follow-up|1|||
146181282|NCT00630058|527177884|FG000|Overall Study|Adverse Event|1|||
146181283|NCT00630058|527177885|FG001|Overall Study|Adverse Event|1|||
146181284|NCT00630058|527177884|FG000|Overall Study|Withdrawal by Subject|0|||
146181285|NCT00630058|527177885|FG001|Overall Study|Withdrawal by Subject|1|||
146181286|NCT00630058|527177884|FG000|Overall Study|stopping criteria|3|||
146181287|NCT00630058|527177885|FG001|Overall Study|stopping criteria|2|||
146181288|NCT01651936|527177886|FG000|Base Study|Adverse Event|3|||
146412358|NCT02544633|528015503|FG000|Treatment Period|Withdrawal by Subject|1|||
146181289|NCT01651936|527177887|FG001|Base Study|Adverse Event|0|||
146181290|NCT01651936|527177888|FG002|Base Study|Adverse Event|0|||
146181291|NCT01651936|527177886|FG000|Base Study|Withdrawal by Subject|1|||
146181292|NCT01651936|527177887|FG001|Base Study|Withdrawal by Subject|1|||
146181293|NCT01651936|527177888|FG002|Base Study|Withdrawal by Subject|0|||
146181294|NCT01651936|527177886|FG000|Base Study|Early Escape|2|||
146181295|NCT01651936|527177887|FG001|Base Study|Early Escape|8|||
146181296|NCT01651936|527177888|FG002|Base Study|Early Escape|0|||
146181297|NCT01651936|527177886|FG000|Base Study|Study terminated by sponsor|21|||
146181298|NCT01651936|527177887|FG001|Base Study|Study terminated by sponsor|16|||
146181299|NCT01651936|527177888|FG002|Base Study|Study terminated by sponsor|0|||
146181300|NCT01651936|527177886|FG000|Extension Study|Lack of Efficacy|0|||
146181301|NCT01651936|527177887|FG001|Extension Study|Lack of Efficacy|0|||
146181302|NCT01651936|527177888|FG002|Extension Study|Lack of Efficacy|1|||
146181303|NCT01651936|527177886|FG000|Extension Study|Study terminated by sponsor|0|||
146181304|NCT01651936|527177887|FG001|Extension Study|Study terminated by sponsor|0|||
146181305|NCT01651936|527177888|FG002|Extension Study|Study terminated by sponsor|13|||
146181306|NCT03044353|527177889|FG000|Overall Study|Adverse Event|0|||
146181307|NCT03044353|527177890|FG001|Overall Study|Adverse Event|1|||
146181308|NCT03044353|527177891|FG002|Overall Study|Adverse Event|0|||
146181309|NCT02141659|527177901|FG000|Overall Study|Major Protocol Deviation|0|||
146181310|NCT02141659|527177902|FG001|Overall Study|Major Protocol Deviation|1|||
146181311|NCT02141659|527177903|FG002|Overall Study|Major Protocol Deviation|0|||
146181312|NCT02141659|527177904|FG003|Overall Study|Major Protocol Deviation|0|||
146181313|NCT02141659|527177905|FG004|Overall Study|Major Protocol Deviation|0|||
146181314|NCT02141659|527177906|FG005|Overall Study|Major Protocol Deviation|0|||
146181315|NCT02141659|527177901|FG000|Overall Study|Lack of Efficacy|0|||
146181316|NCT02141659|527177902|FG001|Overall Study|Lack of Efficacy|0|||
146181317|NCT02141659|527177903|FG002|Overall Study|Lack of Efficacy|0|||
146181318|NCT02141659|527177904|FG003|Overall Study|Lack of Efficacy|0|||
146181319|NCT02141659|527177905|FG004|Overall Study|Lack of Efficacy|0|||
146181320|NCT02141659|527177906|FG005|Overall Study|Lack of Efficacy|1|||
146181321|NCT02141659|527177901|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
146181322|NCT02141659|527177902|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
146181323|NCT02141659|527177903|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
146181324|NCT02141659|527177904|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
146181325|NCT02141659|527177905|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
146181326|NCT02141659|527177906|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
146181327|NCT02836613|527177915|FG000|Overall Study|Accidental drowning|1|||
146181328|NCT02836613|527177916|FG001|Overall Study|Accidental drowning|0|||
146181329|NCT02836613|527177915|FG000|Overall Study|Lost to Follow-up|0|||
146181330|NCT02836613|527177916|FG001|Overall Study|Lost to Follow-up|1|||
146181331|NCT02836613|527177915|FG000|Overall Study|Withdrawal by Subject|0|||
146181332|NCT02836613|527177916|FG001|Overall Study|Withdrawal by Subject|2|||
146181333|NCT03881059|527177917|FG000|Treatment Period - Part A|Adverse Event|1|||
146181334|NCT03881059|527177918|FG001|Treatment Period - Part A|Adverse Event|3|||
146181335|NCT03881059|527177919|FG002|Treatment Period - Part A|Adverse Event|4|||
146181336|NCT03881059|527177917|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
146181337|NCT03881059|527177918|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
146181338|NCT03881059|527177919|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
146181339|NCT03881059|527177917|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
146181340|NCT03881059|527177918|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
146181341|NCT03881059|527177919|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
146181342|NCT03881059|527177917|FG000|Treatment Period - Part A|Other reasons|2|||
146181343|NCT03881059|527177918|FG001|Treatment Period - Part A|Other reasons|1|||
146181344|NCT03881059|527177919|FG002|Treatment Period - Part A|Other reasons|0|||
146181345|NCT03881059|527177917|FG000|Treatment Period - Part B|Adverse Event|0|||
146181346|NCT03881059|527177918|FG001|Treatment Period - Part B|Adverse Event|0|||
146181347|NCT03881059|527177919|FG002|Treatment Period - Part B|Adverse Event|3|||
146181348|NCT03881059|527177917|FG000|Treatment Period - Part B|Death|0|||
146181349|NCT03881059|527177918|FG001|Treatment Period - Part B|Death|1|||
146181350|NCT03881059|527177919|FG002|Treatment Period - Part B|Death|1|||
146181351|NCT03881059|527177917|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
146181352|NCT03881059|527177918|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
146181353|NCT03881059|527177919|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
146181354|NCT03881059|527177917|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
146181355|NCT03881059|527177918|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
146181356|NCT03881059|527177919|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
146181357|NCT03881059|527177917|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
146181358|NCT03881059|527177918|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
146181359|NCT03881059|527177919|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
146181360|NCT03881059|527177917|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
146181361|NCT03881059|527177918|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
146181362|NCT03881059|527177919|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
146181363|NCT03881059|527177917|FG000|Treatment Period - Part B|Other reasons|4|||
146181364|NCT03881059|527177918|FG001|Treatment Period - Part B|Other reasons|3|||
146181365|NCT03881059|527177919|FG002|Treatment Period - Part B|Other reasons|3|||
146181366|NCT05284019|527177920|FG000|Overall Study|Study terminated|2|||
146181367|NCT05284019|527177921|FG001|Overall Study|Study terminated|2|||
146181368|NCT05284019|527177922|FG002|Overall Study|Study terminated|2|||
146181369|NCT05284019|527177923|FG003|Overall Study|Study terminated|5|||
146181370|NCT05284019|527177924|FG004|Overall Study|Study terminated|15|||
146181371|NCT05284019|527177920|FG000|Overall Study|Withdrawal by Subject|0|||
146181372|NCT05284019|527177921|FG001|Overall Study|Withdrawal by Subject|0|||
146181373|NCT05284019|527177922|FG002|Overall Study|Withdrawal by Subject|0|||
146181374|NCT05284019|527177923|FG003|Overall Study|Withdrawal by Subject|1|||
146181375|NCT05284019|527177924|FG004|Overall Study|Withdrawal by Subject|1|||
146181376|NCT05284019|527177920|FG000|Overall Study|Lost to Follow-up|1|||
146181377|NCT05284019|527177921|FG001|Overall Study|Lost to Follow-up|0|||
146181378|NCT05284019|527177922|FG002|Overall Study|Lost to Follow-up|0|||
146181379|NCT05284019|527177923|FG003|Overall Study|Lost to Follow-up|2|||
146181380|NCT05284019|527177924|FG004|Overall Study|Lost to Follow-up|1|||
146181381|NCT02065570|527177925|FG000|Induction Study|Adverse Event|5|||
146181382|NCT02065570|527177926|FG001|Induction Study|Adverse Event|12|||
146181383|NCT02065570|527177927|FG002|Induction Study|Adverse Event|0|||
146181384|NCT02065570|527177928|FG003|Induction Study|Adverse Event|0|||
146181385|NCT02065570|527177925|FG000|Induction Study|Withdrawal by Subject|2|||
146181386|NCT02065570|527177926|FG001|Induction Study|Withdrawal by Subject|3|||
146181387|NCT02065570|527177927|FG002|Induction Study|Withdrawal by Subject|0|||
146181388|NCT02065570|527177928|FG003|Induction Study|Withdrawal by Subject|0|||
146181389|NCT02065570|527177925|FG000|Induction Study|Lost to Follow-up|1|||
146181390|NCT02065570|527177926|FG001|Induction Study|Lost to Follow-up|1|||
146181391|NCT02065570|527177927|FG002|Induction Study|Lost to Follow-up|0|||
146181392|NCT02065570|527177928|FG003|Induction Study|Lost to Follow-up|0|||
146181393|NCT02065570|527177925|FG000|Induction Study|Other, Not Specified|6|||
146181394|NCT02065570|527177926|FG001|Induction Study|Other, Not Specified|5|||
146181395|NCT02065570|527177927|FG002|Induction Study|Other, Not Specified|0|||
146181396|NCT02065570|527177928|FG003|Induction Study|Other, Not Specified|0|||
146181397|NCT02065570|527177925|FG000|Maintenance Study|Adverse Event|0|||
146181398|NCT02065570|527177926|FG001|Maintenance Study|Adverse Event|0|||
146181399|NCT02065570|527177927|FG002|Maintenance Study|Adverse Event|8|||
146181400|NCT02065570|527177928|FG003|Maintenance Study|Adverse Event|8|||
146181401|NCT02065570|527177925|FG000|Maintenance Study|Withdrawal by Subject|0|||
146181402|NCT02065570|527177926|FG001|Maintenance Study|Withdrawal by Subject|0|||
146181403|NCT02065570|527177927|FG002|Maintenance Study|Withdrawal by Subject|1|||
146181404|NCT02065570|527177928|FG003|Maintenance Study|Withdrawal by Subject|4|||
146181405|NCT02065570|527177925|FG000|Maintenance Study|Lost to Follow-up|0|||
146181406|NCT02065570|527177926|FG001|Maintenance Study|Lost to Follow-up|0|||
146181407|NCT02065570|527177927|FG002|Maintenance Study|Lost to Follow-up|2|||
146181408|NCT02065570|527177928|FG003|Maintenance Study|Lost to Follow-up|2|||
146181409|NCT02065570|527177925|FG000|Maintenance Study|Other, Not Specified|0|||
146181410|NCT02065570|527177926|FG001|Maintenance Study|Other, Not Specified|0|||
146181411|NCT02065570|527177927|FG002|Maintenance Study|Other, Not Specified|11|||
146181412|NCT02065570|527177928|FG003|Maintenance Study|Other, Not Specified|5|||
146181413|NCT01231503|527177929|FG000|Overall Study|Adverse Event|0|||
146181414|NCT01231503|527177930|FG001|Overall Study|Adverse Event|0|||
146181415|NCT01231503|527177931|FG002|Overall Study|Adverse Event|0|||
146181416|NCT01231503|527177932|FG003|Overall Study|Adverse Event|0|||
146181417|NCT01231503|527177933|FG004|Overall Study|Adverse Event|0|||
146181418|NCT01231503|527177934|FG005|Overall Study|Adverse Event|1|||
146181419|NCT01231503|527177935|FG006|Overall Study|Adverse Event|0|||
146181420|NCT01231503|527177936|FG007|Overall Study|Adverse Event|0|||
146181421|NCT01231503|527177929|FG000|Overall Study|Adverse event, serious fatal|0|||
146181422|NCT01231503|527177930|FG001|Overall Study|Adverse event, serious fatal|0|||
146181423|NCT01231503|527177931|FG002|Overall Study|Adverse event, serious fatal|1|||
146181424|NCT01231503|527177932|FG003|Overall Study|Adverse event, serious fatal|1|||
146181425|NCT01231503|527177933|FG004|Overall Study|Adverse event, serious fatal|0|||
146181426|NCT01231503|527177934|FG005|Overall Study|Adverse event, serious fatal|1|||
146181427|NCT01231503|527177935|FG006|Overall Study|Adverse event, serious fatal|0|||
146181428|NCT01231503|527177936|FG007|Overall Study|Adverse event, serious fatal|0|||
146181429|NCT01231503|527177929|FG000|Overall Study|Withdrawal by Subject|6|||
146181430|NCT01231503|527177930|FG001|Overall Study|Withdrawal by Subject|3|||
146181431|NCT01231503|527177931|FG002|Overall Study|Withdrawal by Subject|3|||
146181432|NCT01231503|527177932|FG003|Overall Study|Withdrawal by Subject|1|||
146181433|NCT01231503|527177933|FG004|Overall Study|Withdrawal by Subject|3|||
146181434|NCT01231503|527177934|FG005|Overall Study|Withdrawal by Subject|5|||
146181435|NCT01231503|527177935|FG006|Overall Study|Withdrawal by Subject|1|||
146181436|NCT01231503|527177936|FG007|Overall Study|Withdrawal by Subject|2|||
146181437|NCT01231503|527177929|FG000|Overall Study|Lost to Follow-up|8|||
146079678|NCT00369629|526812862|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
146079679|NCT00369629|526812863|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
146079680|NCT00369629|526812864|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
146079681|NCT00369629|526812865|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
146079682|NCT02600871|526812866|FG000|Overall Study|Lost to Follow-up|13|||
146079683|NCT02600871|526812867|FG001|Overall Study|Lost to Follow-up|10|||
146079684|NCT03338959|526812868|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
146079685|NCT03338959|526812868|FG000|Overall Study|Physician Decision|1|||
146079686|NCT01604278|526812873|FG000|Overall Study|Lack of Efficacy|0|||
146079687|NCT01604278|526812874|FG001|Overall Study|Lack of Efficacy|1|||
146079688|NCT01604278|526812873|FG000|Overall Study|Lost to Follow-up|1|||
146079689|NCT01604278|526812874|FG001|Overall Study|Lost to Follow-up|0|||
146079690|NCT01604278|526812873|FG000|Overall Study|Administrative problems|2|||
146079691|NCT01604278|526812874|FG001|Overall Study|Administrative problems|1|||
146079692|NCT01604278|526812873|FG000|Overall Study|Withdrawal by Subject|3|||
146079693|NCT01604278|526812874|FG001|Overall Study|Withdrawal by Subject|3|||
146079694|NCT01604278|526812873|FG000|Overall Study|Adverse Event|3|||
146079695|NCT01604278|526812874|FG001|Overall Study|Adverse Event|5|||
146079696|NCT01604278|526812873|FG000|Overall Study|Protocol Deviation|5|||
146079697|NCT01604278|526812874|FG001|Overall Study|Protocol Deviation|3|||
146079698|NCT00409331|526812875|FG000|Overall Study|Physician Decision|1|||
146079699|NCT02184455|526812876|FG000|Overall Study|Lost to Follow-up|1|||
146079700|NCT01347580|526812881|FG000|Overall Study|Withdrawal by Subject|13|||
146079701|NCT01347580|526812882|FG001|Overall Study|Withdrawal by Subject|23|||
146079702|NCT01347580|526812881|FG000|Overall Study|Death|30|||
146079703|NCT01347580|526812882|FG001|Overall Study|Death|19|||
146079704|NCT01347580|526812881|FG000|Overall Study|Protocol Violation|10|||
146079705|NCT01347580|526812882|FG001|Overall Study|Protocol Violation|7|||
146079706|NCT01347580|526812881|FG000|Overall Study|Lost to Follow-up|3|||
146079707|NCT01347580|526812882|FG001|Overall Study|Lost to Follow-up|1|||
146079708|NCT01347580|526812881|FG000|Overall Study|Had other reason|9|||
146079709|NCT01347580|526812882|FG001|Overall Study|Had other reason|6|||
146079710|NCT00730028|526812883|FG000|Overall Study|Adverse Event|23|||
146079711|NCT00730028|526812884|FG001|Overall Study|Adverse Event|26|||
146079712|NCT00730028|526812885|FG002|Overall Study|Adverse Event|16|||
146079713|NCT00730028|526812886|FG003|Overall Study|Adverse Event|20|||
146079714|NCT00730028|526812887|FG004|Overall Study|Adverse Event|43|||
146079715|NCT00730028|526812883|FG000|Overall Study|Lost to Follow-up|13|||
146079716|NCT00730028|526812884|FG001|Overall Study|Lost to Follow-up|26|||
146079717|NCT00730028|526812885|FG002|Overall Study|Lost to Follow-up|22|||
146079718|NCT00730028|526812886|FG003|Overall Study|Lost to Follow-up|26|||
146079719|NCT00730028|526812887|FG004|Overall Study|Lost to Follow-up|25|||
146079720|NCT00730028|526812883|FG000|Overall Study|Protocol Violation|6|||
146079721|NCT00730028|526812884|FG001|Overall Study|Protocol Violation|1|||
146079722|NCT00730028|526812885|FG002|Overall Study|Protocol Violation|1|||
146079723|NCT00730028|526812886|FG003|Overall Study|Protocol Violation|2|||
146079724|NCT00730028|526812887|FG004|Overall Study|Protocol Violation|0|||
146079725|NCT00730028|526812883|FG000|Overall Study|Withdrawal by Subject|9|||
146079726|NCT00730028|526812884|FG001|Overall Study|Withdrawal by Subject|5|||
146079727|NCT00730028|526812885|FG002|Overall Study|Withdrawal by Subject|4|||
146079728|NCT00730028|526812886|FG003|Overall Study|Withdrawal by Subject|5|||
146079729|NCT00730028|526812887|FG004|Overall Study|Withdrawal by Subject|9|||
146079730|NCT00730028|526812883|FG000|Overall Study|Physician Decision|3|||
146079731|NCT00730028|526812884|FG001|Overall Study|Physician Decision|3|||
146079732|NCT00730028|526812885|FG002|Overall Study|Physician Decision|2|||
146079733|NCT00730028|526812886|FG003|Overall Study|Physician Decision|3|||
146079734|NCT00730028|526812887|FG004|Overall Study|Physician Decision|2|||
146079735|NCT00730028|526812883|FG000|Overall Study|Treatment Failure|5|||
146079736|NCT00730028|526812884|FG001|Overall Study|Treatment Failure|5|||
146079737|NCT00730028|526812885|FG002|Overall Study|Treatment Failure|0|||
146079738|NCT00730028|526812886|FG003|Overall Study|Treatment Failure|0|||
146079739|NCT00730028|526812887|FG004|Overall Study|Treatment Failure|1|||
146079740|NCT00730028|526812883|FG000|Overall Study|Randomization Error|1|||
146079741|NCT00730028|526812884|FG001|Overall Study|Randomization Error|0|||
146079742|NCT00730028|526812885|FG002|Overall Study|Randomization Error|0|||
146079743|NCT00730028|526812886|FG003|Overall Study|Randomization Error|0|||
146079744|NCT00730028|526812887|FG004|Overall Study|Randomization Error|2|||
146079745|NCT00874939|526812888|FG000|Overall Study|Study terminated|4|||
146079746|NCT02870933|526812889|FG000|Overall Study|Death|2|||
146079747|NCT02870933|526812890|FG001|Overall Study|Death|1|||
146079748|NCT02870933|526812889|FG000|Overall Study|Withdrawal by Subject|0|||
146079749|NCT02870933|526812890|FG001|Overall Study|Withdrawal by Subject|1|||
146079750|NCT01250496|526812893|FG000|Overall Study|Study terminated|124|||
146079751|NCT01250496|526812894|FG001|Overall Study|Study terminated|124|||
146079752|NCT00003590|526812895|FG000|Overall Study|Ineligible Patient|1|||
146079753|NCT00003590|526812895|FG000|Overall Study|Adverse Event|7|||
146079754|NCT00003590|526812895|FG000|Overall Study|Withdrawal by Subject|1|||
146079755|NCT00003590|526812895|FG000|Overall Study|Lack of Efficacy|11|||
146079756|NCT00003590|526812895|FG000|Overall Study|Death|1|||
146079757|NCT00003590|526812895|FG000|Overall Study|Physician Decision|1|||
146079758|NCT01425463|526812901|FG000|Overall Study|Adverse Event|5|||
146079759|NCT01425463|526812902|FG001|Overall Study|Adverse Event|7|||
146079760|NCT01425463|526812901|FG000|Overall Study|Lack of Efficacy|1|||
146079761|NCT01425463|526812902|FG001|Overall Study|Lack of Efficacy|1|||
146079762|NCT01425463|526812901|FG000|Overall Study|Protocol Violation|2|||
146079763|NCT01425463|526812902|FG001|Overall Study|Protocol Violation|2|||
146079764|NCT01425463|526812901|FG000|Overall Study|Lost to Follow-up|5|||
146079765|NCT01425463|526812902|FG001|Overall Study|Lost to Follow-up|2|||
146079766|NCT01425463|526812901|FG000|Overall Study|Withdrawal by Subject|7|||
146181438|NCT01231503|527177930|FG001|Overall Study|Lost to Follow-up|10|||
146181439|NCT01231503|527177931|FG002|Overall Study|Lost to Follow-up|8|||
146181440|NCT01231503|527177932|FG003|Overall Study|Lost to Follow-up|5|||
146181441|NCT01231503|527177933|FG004|Overall Study|Lost to Follow-up|7|||
146181442|NCT01231503|527177934|FG005|Overall Study|Lost to Follow-up|9|||
146181443|NCT01231503|527177935|FG006|Overall Study|Lost to Follow-up|6|||
146181444|NCT01231503|527177936|FG007|Overall Study|Lost to Follow-up|6|||
146181445|NCT01231503|527177929|FG000|Overall Study|Protocol Violation|0|||
146181446|NCT01231503|527177930|FG001|Overall Study|Protocol Violation|0|||
146181447|NCT01231503|527177931|FG002|Overall Study|Protocol Violation|0|||
146181448|NCT01231503|527177932|FG003|Overall Study|Protocol Violation|1|||
146181449|NCT01231503|527177933|FG004|Overall Study|Protocol Violation|0|||
146181450|NCT01231503|527177934|FG005|Overall Study|Protocol Violation|0|||
146181451|NCT01231503|527177935|FG006|Overall Study|Protocol Violation|0|||
146181452|NCT01231503|527177936|FG007|Overall Study|Protocol Violation|0|||
146181453|NCT01146574|527177937|FG000|Overall Study|Death|0|||
146181454|NCT01146574|527177938|FG001|Overall Study|Death|1|||
146181455|NCT01146574|527177939|FG002|Overall Study|Death|1|||
146181456|NCT01146574|527177940|FG003|Overall Study|Death|0|||
146181457|NCT01146574|527177941|FG004|Overall Study|Death|0|||
146181458|NCT01146574|527177942|FG005|Overall Study|Death|0|||
146181459|NCT01146574|527177943|FG006|Overall Study|Death|0|||
146181460|NCT01146574|527177937|FG000|Overall Study|Other reasons|0|||
146181461|NCT01146574|527177938|FG001|Overall Study|Other reasons|0|||
146181462|NCT01146574|527177939|FG002|Overall Study|Other reasons|3|||
146181463|NCT01146574|527177940|FG003|Overall Study|Other reasons|0|||
146181464|NCT01146574|527177941|FG004|Overall Study|Other reasons|0|||
146181465|NCT01146574|527177942|FG005|Overall Study|Other reasons|0|||
146181466|NCT01146574|527177943|FG006|Overall Study|Other reasons|0|||
146181467|NCT01146574|527177937|FG000|Overall Study|Kidney transplant|0|||
146181468|NCT01146574|527177938|FG001|Overall Study|Kidney transplant|0|||
146181469|NCT01146574|527177939|FG002|Overall Study|Kidney transplant|1|||
146181470|NCT01146574|527177940|FG003|Overall Study|Kidney transplant|1|||
146181471|NCT01146574|527177941|FG004|Overall Study|Kidney transplant|0|||
146181472|NCT01146574|527177942|FG005|Overall Study|Kidney transplant|0|||
146181473|NCT01146574|527177943|FG006|Overall Study|Kidney transplant|0|||
146181474|NCT01146574|527177937|FG000|Overall Study|Withdrew consent|0|||
146181475|NCT01146574|527177938|FG001|Overall Study|Withdrew consent|0|||
146181476|NCT01146574|527177939|FG002|Overall Study|Withdrew consent|1|||
146181477|NCT01146574|527177940|FG003|Overall Study|Withdrew consent|1|||
146181478|NCT01146574|527177941|FG004|Overall Study|Withdrew consent|2|||
146181479|NCT01146574|527177942|FG005|Overall Study|Withdrew consent|1|||
146181480|NCT01146574|527177943|FG006|Overall Study|Withdrew consent|1|||
146181481|NCT03285113|527177946|FG000|Overall Study|Unable to implant leads|2|||
146181482|NCT01076088|527177947|FG000|Overall Study|Adverse Event|1|||
146181483|NCT01076088|527177948|FG001|Overall Study|Adverse Event|6|||
146181484|NCT01076088|527177949|FG002|Overall Study|Adverse Event|3|||
146181485|NCT01076088|527177950|FG003|Overall Study|Adverse Event|2|||
146181486|NCT01076088|527177951|FG004|Overall Study|Adverse Event|3|||
146181487|NCT01076088|527177952|FG005|Overall Study|Adverse Event|3|||
146181488|NCT01076088|527177947|FG000|Overall Study|Lost to Follow-up|1|||
146181489|NCT01076088|527177948|FG001|Overall Study|Lost to Follow-up|1|||
146181490|NCT01076088|527177949|FG002|Overall Study|Lost to Follow-up|0|||
146181491|NCT01076088|527177950|FG003|Overall Study|Lost to Follow-up|1|||
146181492|NCT01076088|527177951|FG004|Overall Study|Lost to Follow-up|1|||
146181493|NCT01076088|527177952|FG005|Overall Study|Lost to Follow-up|2|||
146181494|NCT01076088|527177947|FG000|Overall Study|Non-compliance with study drug|0|||
146181495|NCT01076088|527177948|FG001|Overall Study|Non-compliance with study drug|0|||
146181496|NCT01076088|527177949|FG002|Overall Study|Non-compliance with study drug|0|||
146181497|NCT01076088|527177950|FG003|Overall Study|Non-compliance with study drug|1|||
146181498|NCT01076088|527177951|FG004|Overall Study|Non-compliance with study drug|0|||
146181499|NCT01076088|527177952|FG005|Overall Study|Non-compliance with study drug|0|||
146181500|NCT01076088|527177947|FG000|Overall Study|Physician Decision|1|||
146181501|NCT01076088|527177948|FG001|Overall Study|Physician Decision|3|||
146181502|NCT01076088|527177949|FG002|Overall Study|Physician Decision|0|||
146181503|NCT01076088|527177950|FG003|Overall Study|Physician Decision|1|||
146181504|NCT01076088|527177951|FG004|Overall Study|Physician Decision|1|||
146181505|NCT01076088|527177952|FG005|Overall Study|Physician Decision|0|||
146181506|NCT01076088|527177947|FG000|Overall Study|Withdrawal by Subject|8|||
146181507|NCT01076088|527177948|FG001|Overall Study|Withdrawal by Subject|8|||
146181508|NCT01076088|527177949|FG002|Overall Study|Withdrawal by Subject|14|||
146181509|NCT01076088|527177950|FG003|Overall Study|Withdrawal by Subject|10|||
146181510|NCT01076088|527177951|FG004|Overall Study|Withdrawal by Subject|11|||
146181511|NCT01076088|527177952|FG005|Overall Study|Withdrawal by Subject|17|||
146181512|NCT01076088|527177947|FG000|Overall Study|Other protocol specified criteria|0|||
146181513|NCT01076088|527177948|FG001|Overall Study|Other protocol specified criteria|0|||
146181514|NCT01076088|527177949|FG002|Overall Study|Other protocol specified criteria|0|||
146181515|NCT01076088|527177950|FG003|Overall Study|Other protocol specified criteria|0|||
146181516|NCT01076088|527177951|FG004|Overall Study|Other protocol specified criteria|0|||
146412359|NCT02544633|528015504|FG001|Treatment Period|Withdrawal by Subject|0|||
146181517|NCT01076088|527177952|FG005|Overall Study|Other protocol specified criteria|1|||
146181518|NCT02207374|527177956|FG000|Overall Study|Withdrawal by Subject|5|||
146181519|NCT02207374|527177957|FG001|Overall Study|Withdrawal by Subject|9|||
146181520|NCT02207374|527177958|FG002|Overall Study|Withdrawal by Subject|4|||
146181521|NCT02207374|527177956|FG000|Overall Study|Death|1|||
146181522|NCT02207374|527177957|FG001|Overall Study|Death|0|||
146181523|NCT02207374|527177958|FG002|Overall Study|Death|1|||
146181524|NCT02207374|527177956|FG000|Overall Study|Missing follow-up information|0|||
146079767|NCT01425463|526812902|FG001|Overall Study|Withdrawal by Subject|5|||
146079768|NCT01425463|526812901|FG000|Overall Study|Unknown Reason|4|||
146079769|NCT01425463|526812902|FG001|Overall Study|Unknown Reason|7|||
146079770|NCT01332799|526812903|FG000|Overall Study|Insufficient funding|10|||
146079771|NCT01332799|526812904|FG001|Overall Study|Insufficient funding|10|||
146079772|NCT00668733|526812905|FG000|Overall Study|Lost to Follow-up|2|||
146079773|NCT00668733|526812906|FG001|Overall Study|Lost to Follow-up|3|||
146079774|NCT00668733|526812905|FG000|Overall Study|Withdrawal by Subject|0|||
146079775|NCT00668733|526812906|FG001|Overall Study|Withdrawal by Subject|4|||
146079776|NCT01909791|526812907|FG000|Overall Study|Death|9|||
146079777|NCT01909791|526812908|FG001|Overall Study|Death|8|||
146079778|NCT01909791|526812909|FG002|Overall Study|Death|4|||
146079779|NCT01909791|526812907|FG000|Overall Study|Withdrawal by Subject|5|||
146079780|NCT01909791|526812908|FG001|Overall Study|Withdrawal by Subject|9|||
146079781|NCT01909791|526812909|FG002|Overall Study|Withdrawal by Subject|13|||
146079782|NCT01909791|526812907|FG000|Overall Study|Lost to Follow-up|5|||
146079783|NCT01909791|526812908|FG001|Overall Study|Lost to Follow-up|11|||
146079784|NCT01909791|526812909|FG002|Overall Study|Lost to Follow-up|10|||
146079785|NCT01909791|526812907|FG000|Overall Study|Missed Visit|2|||
146079786|NCT01909791|526812908|FG001|Overall Study|Missed Visit|0|||
146079787|NCT01909791|526812909|FG002|Overall Study|Missed Visit|1|||
146079788|NCT00538785|526812913|FG000|Overall Study|Death|9|||
146079789|NCT00538785|526812914|FG001|Overall Study|Death|10|||
146079790|NCT00538785|526812913|FG000|Overall Study|Withdrawal of consent|9|||
146079791|NCT00538785|526812914|FG001|Overall Study|Withdrawal of consent|7|||
146079792|NCT00538785|526812913|FG000|Overall Study|Lost to Follow-up|1|||
146079793|NCT00538785|526812914|FG001|Overall Study|Lost to Follow-up|0|||
146079794|NCT04022733|526812915|FG000|Overall Study|conversion to open surgery|3|||
146079795|NCT04022733|526812916|FG001|Overall Study|conversion to open surgery|2|||
146079796|NCT04022733|526812915|FG000|Overall Study|bradycardia|0|||
146079797|NCT04022733|526812916|FG001|Overall Study|bradycardia|1|||
146079798|NCT02208063|526812922|FG000|Overall Study|Death|3|||
146079799|NCT02208063|526812923|FG001|Overall Study|Death|5|||
146079800|NCT02208063|526812922|FG000|Overall Study|Not Specified in report|3|||
146079801|NCT02208063|526812923|FG001|Overall Study|Not Specified in report|4|||
146079802|NCT02208063|526812922|FG000|Overall Study|Withdrawal by Subject|5|||
146079803|NCT02208063|526812923|FG001|Overall Study|Withdrawal by Subject|2|||
146079804|NCT02208063|526812922|FG000|Overall Study|Lost to Follow-up|1|||
146079805|NCT02208063|526812923|FG001|Overall Study|Lost to Follow-up|0|||
146079806|NCT02122783|526812929|FG000|Overall Study|Adverse Event|0|||
146079807|NCT02122783|526812930|FG001|Overall Study|Adverse Event|1|||
146079808|NCT02213133|526812937|FG000|Overall Study|Participant discontinued study therapy|2|||
146079809|NCT02213133|526812938|FG001|Overall Study|Participant discontinued study therapy|0|||
146079810|NCT02213133|526812939|FG002|Overall Study|Participant discontinued study therapy|0|||
146079811|NCT02213133|526812937|FG000|Overall Study|Participant withdrew informed consent|2|||
146079812|NCT02213133|526812938|FG001|Overall Study|Participant withdrew informed consent|1|||
146079813|NCT02213133|526812939|FG002|Overall Study|Participant withdrew informed consent|2|||
146079814|NCT02213133|526812937|FG000|Overall Study|Disease progression|11|||
146079815|NCT02213133|526812938|FG001|Overall Study|Disease progression|2|||
146079816|NCT02213133|526812939|FG002|Overall Study|Disease progression|0|||
146079817|NCT02213133|526812937|FG000|Overall Study|Adverse Event (AE)|1|||
146079818|NCT02213133|526812938|FG001|Overall Study|Adverse Event (AE)|0|||
146079819|NCT02213133|526812939|FG002|Overall Study|Adverse Event (AE)|0|||
146079820|NCT02213133|526812937|FG000|Overall Study|Death|16|||
146079821|NCT02213133|526812938|FG001|Overall Study|Death|2|||
146079822|NCT02213133|526812939|FG002|Overall Study|Death|1|||
146079823|NCT02213133|526812937|FG000|Overall Study|Other|5|||
146079824|NCT02213133|526812938|FG001|Overall Study|Other|0|||
146079825|NCT02213133|526812939|FG002|Overall Study|Other|0|||
146079826|NCT02744040|526812942|FG000|Overall Study|Withdrawal by Subject|3|||
146079827|NCT02744040|526812943|FG001|Overall Study|Withdrawal by Subject|2|||
146079828|NCT02744040|526812944|FG002|Overall Study|Withdrawal by Subject|2|||
146079829|NCT02744040|526812942|FG000|Overall Study|Physician Decision|0|||
146079830|NCT02744040|526812943|FG001|Overall Study|Physician Decision|8|||
146079831|NCT02744040|526812944|FG002|Overall Study|Physician Decision|13|||
146079832|NCT02744040|526812942|FG000|Overall Study|Lost to Follow-up|3|||
146079833|NCT02744040|526812943|FG001|Overall Study|Lost to Follow-up|1|||
146079834|NCT02744040|526812944|FG002|Overall Study|Lost to Follow-up|7|||
146079835|NCT01642615|526812945|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
146079836|NCT01642615|526812946|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146079837|NCT01642615|526812947|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146079838|NCT01642615|526812945|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
146079839|NCT01642615|526812946|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
146079840|NCT01642615|526812947|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
146079841|NCT01642615|526812945|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
146079842|NCT01642615|526812946|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
146079843|NCT01642615|526812947|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
146181525|NCT02207374|527177957|FG001|Overall Study|Missing follow-up information|1|||
146181526|NCT02207374|527177958|FG002|Overall Study|Missing follow-up information|1|||
146181527|NCT01000376|527177960|FG000|Cycle 1 Day 1|Adverse Event|1|||
146181528|NCT01000376|527177961|FG001|Cycle 1 Day 1|Adverse Event|0|||
146181529|NCT01000376|527177960|FG000|Cycle 1 Day 1|Progressive Disease|1|||
146181530|NCT01000376|527177961|FG001|Cycle 1 Day 1|Progressive Disease|0|||
145945351|NCT01764997|526308215|FG003|Run-in Period|Other than specified above|0|||
146079844|NCT01642615|526812945|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
146079845|NCT01642615|526812946|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
146079846|NCT01642615|526812947|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
146079847|NCT01642615|526812945|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
146079848|NCT01642615|526812946|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
146079849|NCT01642615|526812947|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
146079850|NCT01642615|526812945|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
146079851|NCT01642615|526812946|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
146079852|NCT01642615|526812947|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
146079853|NCT01642615|526812945|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
146079854|NCT01642615|526812946|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
146079855|NCT01642615|526812947|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
146181531|NCT00318149|527177962|FG000|Overall Study|Adverse Event|0|||
146181532|NCT00318149|527177963|FG001|Overall Study|Adverse Event|0|||
146181533|NCT00318149|527177964|FG002|Overall Study|Adverse Event|0|||
146181534|NCT00318149|527177965|FG003|Overall Study|Adverse Event|0|||
146181535|NCT00318149|527177966|FG004|Overall Study|Adverse Event|0|||
146181536|NCT00318149|527177967|FG005|Overall Study|Adverse Event|2|||
146181537|NCT00219141|527177968|FG000|Overall Study|Adverse Event|4|||
146181538|NCT00219141|527177969|FG001|Overall Study|Adverse Event|10|||
146181539|NCT00219141|527177970|FG002|Overall Study|Adverse Event|5|||
146181540|NCT00219141|527177968|FG000|Overall Study|Lack of Efficacy|3|||
146181541|NCT00219141|527177969|FG001|Overall Study|Lack of Efficacy|2|||
146181542|NCT00219141|527177970|FG002|Overall Study|Lack of Efficacy|0|||
146181543|NCT00219141|527177968|FG000|Overall Study|Administrative problems|0|||
146181544|NCT00219141|527177969|FG001|Overall Study|Administrative problems|1|||
146181545|NCT00219141|527177970|FG002|Overall Study|Administrative problems|0|||
146181546|NCT00219141|527177968|FG000|Overall Study|Lost to Follow-up|2|||
146181547|NCT00219141|527177969|FG001|Overall Study|Lost to Follow-up|4|||
146181548|NCT00219141|527177970|FG002|Overall Study|Lost to Follow-up|1|||
146181549|NCT00219141|527177968|FG000|Overall Study|Protocol Violation|3|||
146181550|NCT00219141|527177969|FG001|Overall Study|Protocol Violation|1|||
146181551|NCT00219141|527177970|FG002|Overall Study|Protocol Violation|1|||
146181552|NCT00219141|527177968|FG000|Overall Study|Withdrawal by Subject|1|||
146181553|NCT00219141|527177969|FG001|Overall Study|Withdrawal by Subject|3|||
146181554|NCT00219141|527177970|FG002|Overall Study|Withdrawal by Subject|5|||
146181555|NCT00219141|527177968|FG000|Overall Study|Condition no longer requires study drug|1|||
146079856|NCT01642615|526812945|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146079857|NCT01642615|526812946|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
146079858|NCT01642615|526812947|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146079859|NCT01642615|526812945|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
146079860|NCT01642615|526812946|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
146079861|NCT01642615|526812947|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
146079862|NCT00096356|526812948|FG000|Overall Study|Adverse Event|11|||
146079863|NCT00096356|526812949|FG001|Overall Study|Adverse Event|9|||
146079864|NCT00096356|526812948|FG000|Overall Study|Physician Decision|5|||
146079865|NCT00096356|526812949|FG001|Overall Study|Physician Decision|3|||
146079866|NCT00096356|526812948|FG000|Overall Study|Withdrawal by Subject|17|||
146079867|NCT00096356|526812949|FG001|Overall Study|Withdrawal by Subject|23|||
146079868|NCT00096356|526812948|FG000|Overall Study|Lack of Efficacy|1|||
146079869|NCT00096356|526812949|FG001|Overall Study|Lack of Efficacy|0|||
146079870|NCT00096356|526812948|FG000|Overall Study|multiple reasons|10|||
146079871|NCT00096356|526812949|FG001|Overall Study|multiple reasons|18|||
146079872|NCT00402740|526812953|FG000|Overall Study|Withdrawal by Subject|18|||
146079873|NCT00402740|526812953|FG000|Overall Study|Death|50|||
146079874|NCT00402740|526812953|FG000|Overall Study|Lost to Follow-up|6|||
146079875|NCT00402740|526812953|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
146079876|NCT00402740|526812953|FG000|Overall Study|Subject disposition unknown.|1|||
146079877|NCT01699867|526812956|FG000|Overall Study|Screening Failure|3|||
146079878|NCT01675167|526812972|FG000|Open-label Titration Phase|Adverse Event|81|||
146079879|NCT01675167|526812973|FG001|Open-label Titration Phase|Adverse Event|0|||
146079880|NCT01675167|526812974|FG002|Open-label Titration Phase|Adverse Event|0|||
146079881|NCT01675167|526812972|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
146079882|NCT01675167|526812973|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
146079883|NCT01675167|526812974|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
146079884|NCT01675167|526812972|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
146079885|NCT01675167|526812973|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
146079886|NCT01675167|526812974|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
146079887|NCT01675167|526812972|FG000|Open-label Titration Phase|Protocol Violation|43|||
146079888|NCT01675167|526812973|FG001|Open-label Titration Phase|Protocol Violation|0|||
146181556|NCT00219141|527177969|FG001|Overall Study|Condition no longer requires study drug|0|||
146181557|NCT00219141|527177970|FG002|Overall Study|Condition no longer requires study drug|0|||
146181558|NCT01994720|527177971|FG000|Overall Study|Withdrawal by Subject|46|||
146181559|NCT01994720|527177972|FG001|Overall Study|Withdrawal by Subject|56|||
146181560|NCT04318093|527177977|FG000|Overall Study|Adverse Event|2|||
146181561|NCT04318093|527177978|FG001|Overall Study|Adverse Event|2|||
146181562|NCT04318093|527177977|FG000|Overall Study|Participant withdrew consent|1|||
146181563|NCT04318093|527177978|FG001|Overall Study|Participant withdrew consent|0|||
146181564|NCT04318093|527177977|FG000|Overall Study|Other reasons|0|||
146181565|NCT04318093|527177978|FG001|Overall Study|Other reasons|1|||
146181566|NCT02855164|527177986|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146181567|NCT02855164|527177987|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146181568|NCT02855164|527177988|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
146181569|NCT02855164|527177989|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
146181570|NCT02855164|527177990|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
146181571|NCT02855164|527177991|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146079889|NCT01675167|526812974|FG002|Open-label Titration Phase|Protocol Violation|0|||
146079890|NCT01675167|526812972|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
146079891|NCT01675167|526812973|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
146079892|NCT01675167|526812974|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
146079893|NCT01675167|526812972|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
146079894|NCT01675167|526812973|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
146079895|NCT01675167|526812974|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
146079896|NCT01675167|526812972|FG000|Open-label Titration Phase|Other|55|||
146079897|NCT01675167|526812973|FG001|Open-label Titration Phase|Other|0|||
146079898|NCT01675167|526812974|FG002|Open-label Titration Phase|Other|0|||
146079899|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146079900|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
146079901|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
146079902|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146079903|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146079904|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146079905|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146079906|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Adverse Event|5|||
146079907|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Adverse Event|13|||
146079908|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146079909|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
146079910|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
146079911|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146079912|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
146079913|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
146079914|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
146079915|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
146079916|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
146079917|NCT01675167|526812972|FG000|Double-blind Treatment Phase|Other|0|||
146079918|NCT01675167|526812973|FG001|Double-blind Treatment Phase|Other|7|||
146079919|NCT01675167|526812974|FG002|Double-blind Treatment Phase|Other|5|||
146079920|NCT03255083|526812975|FG000|Overall Study|Clinical progression|1|||
146079921|NCT03255083|526812976|FG001|Overall Study|Clinical progression|0|||
146079922|NCT03255083|526812977|FG002|Overall Study|Clinical progression|0|||
146079923|NCT03255083|526812978|FG003|Overall Study|Clinical progression|0|||
146079924|NCT03255083|526812975|FG000|Overall Study|Adverse Event|0|||
146079925|NCT03255083|526812976|FG001|Overall Study|Adverse Event|1|||
146079926|NCT03255083|526812977|FG002|Overall Study|Adverse Event|0|||
146079927|NCT03255083|526812978|FG003|Overall Study|Adverse Event|0|||
146079928|NCT03255083|526812975|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
146079929|NCT03255083|526812976|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
146079930|NCT03255083|526812977|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
146079931|NCT03255083|526812978|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
146079932|NCT03255083|526812975|FG000|Overall Study|Withdrawal by Subject|1|||
146079933|NCT03255083|526812976|FG001|Overall Study|Withdrawal by Subject|1|||
146079934|NCT03255083|526812977|FG002|Overall Study|Withdrawal by Subject|1|||
146079935|NCT03255083|526812978|FG003|Overall Study|Withdrawal by Subject|0|||
146079936|NCT00363545|526812979|FG000|Overall Study|Serious Adverse Event|0|||
146079937|NCT00363545|526812980|FG001|Overall Study|Serious Adverse Event|1|||
146079938|NCT00363545|526812979|FG000|Overall Study|Withdrawal by Subject|12|||
146079939|NCT00363545|526812980|FG001|Overall Study|Withdrawal by Subject|15|||
146079940|NCT00363545|526812979|FG000|Overall Study|Migrated/moved from study area|3|||
146079941|NCT00363545|526812980|FG001|Overall Study|Migrated/moved from study area|6|||
146079942|NCT00363545|526812979|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
146079943|NCT00363545|526812980|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
146079944|NCT00363545|526812979|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
146079945|NCT00363545|526812980|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
146079946|NCT00363545|526812979|FG000|Overall Study|Others|1|||
146079947|NCT00363545|526812980|FG001|Overall Study|Others|0|||
146079948|NCT01457352|526812981|FG000|Period 1|Adverse Event|2|||
146079949|NCT01457352|526812982|FG001|Period 1|Adverse Event|0|||
146412360|NCT02544633|528015505|FG002|Treatment Period|Withdrawal by Subject|0|||
146181572|NCT02855164|527177992|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146181573|NCT02855164|527177993|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
146181574|NCT02855164|527177986|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
146181575|NCT02855164|527177987|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
146181576|NCT02855164|527177988|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
146181577|NCT02855164|527177989|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
146181578|NCT02855164|527177990|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
146181579|NCT02855164|527177991|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
146181580|NCT02855164|527177992|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
146181581|NCT02855164|527177993|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
146181582|NCT02855164|527177986|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
146181583|NCT02855164|527177987|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
146181584|NCT02855164|527177988|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
146181585|NCT02855164|527177989|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
146181586|NCT02855164|527177990|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
146181587|NCT02855164|527177991|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
146181588|NCT02855164|527177992|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
146181589|NCT02855164|527177993|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
146181590|NCT02855164|527177986|FG000|Part C (Randomized Set)|Adverse Event|0|||
146181591|NCT02855164|527177987|FG001|Part C (Randomized Set)|Adverse Event|0|||
146181592|NCT02855164|527177988|FG002|Part C (Randomized Set)|Adverse Event|0|||
146181593|NCT02855164|527177989|FG003|Part C (Randomized Set)|Adverse Event|0|||
146181594|NCT02855164|527177990|FG004|Part C (Randomized Set)|Adverse Event|0|||
146181595|NCT02855164|527177991|FG005|Part C (Randomized Set)|Adverse Event|5|||
146181596|NCT02855164|527177992|FG006|Part C (Randomized Set)|Adverse Event|9|||
146181597|NCT02855164|527177993|FG007|Part C (Randomized Set)|Adverse Event|2|||
146181598|NCT02855164|527177986|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
146181599|NCT02855164|527177987|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
146181600|NCT02855164|527177988|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
146181601|NCT02855164|527177989|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
146181602|NCT02855164|527177990|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
146181603|NCT02855164|527177991|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
146181604|NCT02855164|527177992|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
146181605|NCT02855164|527177993|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
146181606|NCT02855164|527177986|FG000|Part C (Randomized Set)|Physician Decision|0|||
146181607|NCT02855164|527177987|FG001|Part C (Randomized Set)|Physician Decision|0|||
146181608|NCT02855164|527177988|FG002|Part C (Randomized Set)|Physician Decision|0|||
146181609|NCT02855164|527177989|FG003|Part C (Randomized Set)|Physician Decision|0|||
146181610|NCT02855164|527177990|FG004|Part C (Randomized Set)|Physician Decision|0|||
146181611|NCT02855164|527177991|FG005|Part C (Randomized Set)|Physician Decision|1|||
146181612|NCT02855164|527177992|FG006|Part C (Randomized Set)|Physician Decision|0|||
146181613|NCT02855164|527177993|FG007|Part C (Randomized Set)|Physician Decision|1|||
146181614|NCT02855164|527177986|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
146181615|NCT02855164|527177987|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
146181616|NCT02855164|527177988|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
146181617|NCT02855164|527177989|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
146181618|NCT02855164|527177990|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
146181619|NCT02855164|527177991|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
146181620|NCT02855164|527177992|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
146181621|NCT02855164|527177993|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
146181622|NCT00876460|527177994|FG000|Combination Therapy Phase|Progressive disease|2|||
146181623|NCT00876460|527177995|FG001|Combination Therapy Phase|Progressive disease|3|||
146181624|NCT00876460|527177996|FG002|Combination Therapy Phase|Progressive disease|3|||
146181625|NCT00876460|527177997|FG003|Combination Therapy Phase|Progressive disease|3|||
146181626|NCT00876460|527177998|FG004|Combination Therapy Phase|Progressive disease|3|||
146181627|NCT00876460|527177999|FG005|Combination Therapy Phase|Progressive disease|1|||
146181628|NCT00876460|527178000|FG006|Combination Therapy Phase|Progressive disease|1|||
146181629|NCT00876460|527178001|FG007|Combination Therapy Phase|Progressive disease|1|||
146181630|NCT00876460|527177994|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
146181631|NCT00876460|527177995|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
146181632|NCT00876460|527177996|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
146181633|NCT00876460|527177997|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
146181634|NCT00876460|527177998|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
146181635|NCT00876460|527177999|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
146181636|NCT00876460|527178000|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
146181637|NCT00876460|527178001|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
146181638|NCT00876460|527177994|FG000|Combination Therapy Phase|Adverse Event|0|||
146181639|NCT00876460|527177995|FG001|Combination Therapy Phase|Adverse Event|2|||
146181640|NCT00876460|527177996|FG002|Combination Therapy Phase|Adverse Event|0|||
146181641|NCT00876460|527177997|FG003|Combination Therapy Phase|Adverse Event|2|||
146181642|NCT00876460|527177998|FG004|Combination Therapy Phase|Adverse Event|2|||
146181643|NCT00876460|527177999|FG005|Combination Therapy Phase|Adverse Event|0|||
146181644|NCT00876460|527178000|FG006|Combination Therapy Phase|Adverse Event|3|||
146181645|NCT00876460|527178001|FG007|Combination Therapy Phase|Adverse Event|2|||
146181646|NCT00876460|527177994|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
146181647|NCT00876460|527177995|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
146181648|NCT00876460|527177996|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
146181649|NCT00876460|527177997|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
146181650|NCT00876460|527177998|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
146181651|NCT00876460|527177999|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
146181652|NCT00876460|527178000|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
146181653|NCT00876460|527178001|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
146181654|NCT00876460|527177994|FG000|Combination Therapy Phase|Other reason not defined above|0|||
146181655|NCT00876460|527177995|FG001|Combination Therapy Phase|Other reason not defined above|0|||
146181656|NCT00876460|527177996|FG002|Combination Therapy Phase|Other reason not defined above|0|||
146181657|NCT00876460|527177997|FG003|Combination Therapy Phase|Other reason not defined above|0|||
146181658|NCT00876460|527177998|FG004|Combination Therapy Phase|Other reason not defined above|0|||
146181659|NCT00876460|527177999|FG005|Combination Therapy Phase|Other reason not defined above|0|||
146181660|NCT00876460|527178000|FG006|Combination Therapy Phase|Other reason not defined above|1|||
146181661|NCT00876460|527178001|FG007|Combination Therapy Phase|Other reason not defined above|2|||
146181662|NCT00876460|527177994|FG000|Combination Therapy Phase|Not treated|0|||
146181663|NCT00876460|527177995|FG001|Combination Therapy Phase|Not treated|0|||
146181664|NCT00876460|527177996|FG002|Combination Therapy Phase|Not treated|0|||
146181665|NCT00876460|527177997|FG003|Combination Therapy Phase|Not treated|0|||
146181666|NCT00876460|527177998|FG004|Combination Therapy Phase|Not treated|0|||
146181667|NCT00876460|527177999|FG005|Combination Therapy Phase|Not treated|0|||
146181668|NCT00876460|527178000|FG006|Combination Therapy Phase|Not treated|1|||
146181669|NCT00876460|527178001|FG007|Combination Therapy Phase|Not treated|0|||
146181670|NCT00876460|527177994|FG000|Mono Therapy Phase|Progressive disease|0|||
146181671|NCT00876460|527177995|FG001|Mono Therapy Phase|Progressive disease|0|||
146181672|NCT00876460|527177996|FG002|Mono Therapy Phase|Progressive disease|0|||
146181673|NCT00876460|527177997|FG003|Mono Therapy Phase|Progressive disease|0|||
146181674|NCT00876460|527177998|FG004|Mono Therapy Phase|Progressive disease|2|||
146181675|NCT00876460|527177999|FG005|Mono Therapy Phase|Progressive disease|0|||
146181676|NCT00876460|527178000|FG006|Mono Therapy Phase|Progressive disease|1|||
146181677|NCT00876460|527178001|FG007|Mono Therapy Phase|Progressive disease|3|||
146181678|NCT00876460|527177994|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
146181679|NCT00876460|527177995|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
146181680|NCT00876460|527177996|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
146181681|NCT00876460|527177997|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
146181682|NCT00876460|527177998|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
146181683|NCT00876460|527177999|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
146181684|NCT00876460|527178000|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
146181685|NCT00876460|527178001|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
146181686|NCT00876460|527177994|FG000|Mono Therapy Phase|Adverse Event|0|||
146181687|NCT00876460|527177995|FG001|Mono Therapy Phase|Adverse Event|0|||
146181688|NCT00876460|527177996|FG002|Mono Therapy Phase|Adverse Event|0|||
146181689|NCT00876460|527177997|FG003|Mono Therapy Phase|Adverse Event|1|||
146181690|NCT00876460|527177998|FG004|Mono Therapy Phase|Adverse Event|0|||
146181691|NCT00876460|527177999|FG005|Mono Therapy Phase|Adverse Event|0|||
146181692|NCT00876460|527178000|FG006|Mono Therapy Phase|Adverse Event|0|||
146181693|NCT00876460|527178001|FG007|Mono Therapy Phase|Adverse Event|0|||
146181694|NCT00513019|527179443|FG000|Overall Study|Adverse Event|1|||
146181695|NCT00513019|527179444|FG001|Overall Study|Adverse Event|0|||
146181696|NCT00513019|527179443|FG000|Overall Study|Withdrawal by Subject|4|||
146181697|NCT00513019|527179444|FG001|Overall Study|Withdrawal by Subject|5|||
146181698|NCT01853254|527179445|FG000|Overall Study|Abnormal Laboratory Test|1|||
146181699|NCT01853254|527179445|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
146181700|NCT01853254|527179445|FG000|Overall Study|Death|1|||
146181701|NCT01853254|527179445|FG000|Overall Study|Failure to Return|43|||
146181702|NCT01853254|527179445|FG000|Overall Study|Insufficient Therapeutic Response|22|||
146181703|NCT01853254|527179445|FG000|Overall Study|Refusal of Treatment|1|||
146412361|NCT02544633|528015506|FG003|Treatment Period|Withdrawal by Subject|0|||
146412362|NCT02544633|528015503|FG000|Treatment Period|Lost to Follow-up|0|||
146412363|NCT02544633|528015504|FG001|Treatment Period|Lost to Follow-up|1|||
146412364|NCT02544633|528015505|FG002|Treatment Period|Lost to Follow-up|0|||
146181704|NCT01853254|527179445|FG000|Overall Study|Other Protocol Violation|1|||
146181705|NCT01853254|527179445|FG000|Overall Study|Withdrawal of Consent|16|||
146181706|NCT01853254|527179445|FG000|Overall Study|Administrative/Other|16|||
146181707|NCT02462083|527179446|FG000|Overall Study|Sponsor request|39|||
146181708|NCT02462083|527179446|FG000|Overall Study|Withdrawal by Subject|87|||
146181709|NCT02462083|527179446|FG000|Overall Study|Lost to Follow-up|41|||
146181710|NCT02462083|527179446|FG000|Overall Study|Lack of Efficacy|151|||
146181711|NCT02462083|527179446|FG000|Overall Study|Pregnancy|1|||
146181712|NCT02462083|527179446|FG000|Overall Study|Protocol Violation|6|||
146181713|NCT02462083|527179446|FG000|Overall Study|Adverse Event|33|||
146181714|NCT02462083|527179446|FG000|Overall Study|Worsening condition|16|||
146181715|NCT02462083|527179446|FG000|Overall Study|Other than specified|45|||
146181716|NCT01642186|527179447|FG000|Overall Study|Death|0|||
146181717|NCT01642186|527179448|FG001|Overall Study|Death|2|||
146181718|NCT01642186|527179449|FG002|Overall Study|Death|2|||
146181719|NCT01642186|527179447|FG000|Overall Study|Lost to Follow-up|0|||
146181720|NCT01642186|527179448|FG001|Overall Study|Lost to Follow-up|0|||
146181721|NCT01642186|527179449|FG002|Overall Study|Lost to Follow-up|1|||
146181722|NCT01668147|527179450|FG000|Overall Study|Withdrawal by Subject|6|||
146181723|NCT01474512|527179452|FG000|Induction Period|Adverse Event|6|||
146181724|NCT01474512|527179453|FG001|Induction Period|Adverse Event|10|||
146181725|NCT01474512|527179454|FG002|Induction Period|Adverse Event|10|||
146181726|NCT01474512|527179455|FG003|Induction Period|Adverse Event|0|||
146181727|NCT01474512|527179456|FG004|Induction Period|Adverse Event|0|||
146181728|NCT01474512|527179457|FG005|Induction Period|Adverse Event|0|||
146181729|NCT01474512|527179458|FG006|Induction Period|Adverse Event|0|||
146181730|NCT01474512|527179459|FG007|Induction Period|Adverse Event|0|||
146181731|NCT01474512|527179460|FG008|Induction Period|Adverse Event|0|||
146181732|NCT01474512|527179461|FG009|Induction Period|Adverse Event|0|||
146181733|NCT01474512|527179462|FG010|Induction Period|Adverse Event|0|||
146181734|NCT01474512|527179463|FG011|Induction Period|Adverse Event|0|||
146181735|NCT01474512|527179464|FG012|Induction Period|Adverse Event|0|||
146181736|NCT01474512|527179465|FG013|Induction Period|Adverse Event|0|||
146181737|NCT01474512|527179466|FG014|Induction Period|Adverse Event|0|||
146181738|NCT01474512|527179467|FG015|Induction Period|Adverse Event|0|||
146181739|NCT01474512|527179468|FG016|Induction Period|Adverse Event|0|||
146181740|NCT01474512|527179469|FG017|Induction Period|Adverse Event|0|||
146181741|NCT01474512|527179452|FG000|Induction Period|Lack of Efficacy|7|||
146079950|NCT01457352|526812981|FG000|Period 1|Withdrawal by Subject|2|||
146079951|NCT01457352|526812982|FG001|Period 1|Withdrawal by Subject|0|||
146079952|NCT01457352|526812981|FG000|Period 1|Physician Decision|2|||
146079953|NCT01457352|526812982|FG001|Period 1|Physician Decision|0|||
146079954|NCT01457352|526812981|FG000|Period 1|MS related disease progression|1|||
146079955|NCT01457352|526812982|FG001|Period 1|MS related disease progression|0|||
146079956|NCT01457352|526812981|FG000|Period 1|Withdrawn|1|||
146079957|NCT01457352|526812982|FG001|Period 1|Withdrawn|0|||
146079958|NCT01457352|526812981|FG000|Period 1|withdrew per sponsor|1|||
146079959|NCT01457352|526812982|FG001|Period 1|withdrew per sponsor|0|||
146079960|NCT01457352|526812981|FG000|Period 1|Protocol Violation|4|||
146079961|NCT01457352|526812982|FG001|Period 1|Protocol Violation|0|||
146079962|NCT01457352|526812981|FG000|Period 1|Did not meet eligibility criteria|3|||
146079963|NCT01457352|526812982|FG001|Period 1|Did not meet eligibility criteria|0|||
146079964|NCT01457352|526812981|FG000|Period 2|Withdrawal by Subject|23|||
146079965|NCT01457352|526812982|FG001|Period 2|Withdrawal by Subject|0|||
146079966|NCT01457352|526812981|FG000|Period 2|Adverse Event|22|||
146079967|NCT01457352|526812982|FG001|Period 2|Adverse Event|0|||
146079968|NCT01457352|526812981|FG000|Period 2|no analysis|10|||
146079969|NCT01457352|526812982|FG001|Period 2|no analysis|0|||
146079970|NCT01457352|526812981|FG000|Period 2|Lack of Efficacy|8|||
146079971|NCT01457352|526812982|FG001|Period 2|Lack of Efficacy|0|||
146079972|NCT01457352|526812981|FG000|Period 2|Protocol Violation|4|||
146181742|NCT01474512|527179453|FG001|Induction Period|Lack of Efficacy|1|||
146181743|NCT01474512|527179454|FG002|Induction Period|Lack of Efficacy|0|||
146181744|NCT01474512|527179455|FG003|Induction Period|Lack of Efficacy|0|||
146181745|NCT01474512|527179456|FG004|Induction Period|Lack of Efficacy|0|||
146181746|NCT01474512|527179457|FG005|Induction Period|Lack of Efficacy|0|||
146181747|NCT01474512|527179458|FG006|Induction Period|Lack of Efficacy|0|||
146181748|NCT01474512|527179459|FG007|Induction Period|Lack of Efficacy|0|||
146181749|NCT01474512|527179460|FG008|Induction Period|Lack of Efficacy|0|||
146079973|NCT01457352|526812982|FG001|Period 2|Protocol Violation|0|||
146079974|NCT01457352|526812981|FG000|Period 2|Sponsor's withdrawal|7|||
146079975|NCT01457352|526812982|FG001|Period 2|Sponsor's withdrawal|0|||
146079976|NCT01457352|526812981|FG000|Period 2|Lost to Follow-up|1|||
146079977|NCT01457352|526812982|FG001|Period 2|Lost to Follow-up|0|||
146079978|NCT01457352|526812981|FG000|Period 2|dose change|1|||
146181750|NCT01474512|527179461|FG009|Induction Period|Lack of Efficacy|0|||
146079979|NCT01457352|526812982|FG001|Period 2|dose change|0|||
146079980|NCT01457352|526812981|FG000|Period 2|Physician Decision|1|||
146079981|NCT01457352|526812982|FG001|Period 2|Physician Decision|0|||
146079982|NCT01457352|526812981|FG000|Period 2|Did not meet eligibility criteria|3|||
146079983|NCT01457352|526812982|FG001|Period 2|Did not meet eligibility criteria|0|||
146079984|NCT01457352|526812981|FG000|Period 3|Adverse Event|1|||
146079985|NCT01457352|526812982|FG001|Period 3|Adverse Event|1|||
146079986|NCT01457352|526812981|FG000|Period 3|Withdrawal by Subject|0|||
146079987|NCT01457352|526812982|FG001|Period 3|Withdrawal by Subject|2|||
146079988|NCT01457352|526812981|FG000|Period 3|incorrect treatment|0|||
146079989|NCT01457352|526812982|FG001|Period 3|incorrect treatment|1|||
146079990|NCT01457352|526812981|FG000|Period 3|Sponsor's withdrawal|0|||
146079991|NCT01457352|526812982|FG001|Period 3|Sponsor's withdrawal|1|||
146079992|NCT03952039|526812983|FG000|Overall Study|Adverse Event|22|||
146079993|NCT03952039|526812984|FG001|Overall Study|Adverse Event|8|||
146079994|NCT03952039|526812983|FG000|Overall Study|Withdrawal by Participant|17|||
146079995|NCT03952039|526812984|FG001|Overall Study|Withdrawal by Participant|12|||
146079996|NCT03952039|526812983|FG000|Overall Study|Death|13|||
146079997|NCT03952039|526812984|FG001|Overall Study|Death|6|||
146079998|NCT03952039|526812983|FG000|Overall Study|Lack of Efficacy|12|||
146079999|NCT03952039|526812984|FG001|Overall Study|Lack of Efficacy|2|||
146080000|NCT03952039|526812983|FG000|Overall Study|Physician Decision|9|||
146080001|NCT03952039|526812984|FG001|Overall Study|Physician Decision|3|||
146080002|NCT03952039|526812983|FG000|Overall Study|Progressive Disease|6|||
146080003|NCT03952039|526812984|FG001|Overall Study|Progressive Disease|4|||
146080004|NCT03952039|526812983|FG000|Overall Study|Other Reasons|12|||
146080005|NCT03952039|526812984|FG001|Overall Study|Other Reasons|4|||
146080006|NCT05009979|526812985|FG000|Overall Study|Withdrawal by Subject|1|||
146080007|NCT04174365|526812986|FG000|Overall Study|Lost to Follow-up|1|||
146080008|NCT04174365|526812987|FG001|Overall Study|Lost to Follow-up|2|||
146080009|NCT04174365|526812986|FG000|Overall Study|Adverse Event|2|||
146080010|NCT04174365|526812987|FG001|Overall Study|Adverse Event|1|||
146080011|NCT04174365|526812986|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
146080012|NCT04174365|526812987|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
146080013|NCT04174365|526812986|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
146080014|NCT04174365|526812987|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
146080015|NCT04174365|526812986|FG000|Overall Study|Protocol Deviation|1|||
146080016|NCT04174365|526812987|FG001|Overall Study|Protocol Deviation|0|||
146080017|NCT04174365|526812986|FG000|Overall Study|Lack of Efficacy|0|||
146080018|NCT04174365|526812987|FG001|Overall Study|Lack of Efficacy|2|||
146080019|NCT04174365|526812986|FG000|Overall Study|Disease Relapse|1|||
146080020|NCT04174365|526812987|FG001|Overall Study|Disease Relapse|0|||
146080021|NCT04174365|526812986|FG000|Overall Study|Reason Not Specified|0|||
146080022|NCT04174365|526812987|FG001|Overall Study|Reason Not Specified|1|||
146080023|NCT03472547|526812988|FG000|Overall Study|Withdrawal by Subject|30|||
146080024|NCT02168387|526814547|FG000|Overall Study|Planned exubation|6|||
146080025|NCT02168387|526814548|FG001|Overall Study|Planned exubation|3|||
146080026|NCT02168387|526814547|FG000|Overall Study|Death|1|||
146080027|NCT02168387|526814548|FG001|Overall Study|Death|0|||
146080028|NCT01659554|526814549|FG000|Overall Study|Study Termination|4|||
146080029|NCT01236547|526814552|FG000|Overall Study|Protocol Violation|0|||
146080030|NCT01236547|526814553|FG001|Overall Study|Protocol Violation|1|||
146080031|NCT01236547|526814554|FG002|Overall Study|Protocol Violation|1|||
146080032|NCT01236547|526814555|FG003|Overall Study|Protocol Violation|6|||
146080033|NCT01236547|526814556|FG004|Overall Study|Protocol Violation|12|||
146080034|NCT00640224|526814561|FG000|Overall Study|Lost to Follow-up|5|||
146080035|NCT00640224|526814562|FG001|Overall Study|Lost to Follow-up|2|||
146181751|NCT01474512|527179462|FG010|Induction Period|Lack of Efficacy|0|||
146181752|NCT01474512|527179463|FG011|Induction Period|Lack of Efficacy|0|||
146181753|NCT01474512|527179464|FG012|Induction Period|Lack of Efficacy|0|||
146181754|NCT01474512|527179465|FG013|Induction Period|Lack of Efficacy|0|||
146181755|NCT01474512|527179466|FG014|Induction Period|Lack of Efficacy|0|||
146181756|NCT01474512|527179467|FG015|Induction Period|Lack of Efficacy|0|||
146181757|NCT01474512|527179468|FG016|Induction Period|Lack of Efficacy|0|||
146181758|NCT01474512|527179469|FG017|Induction Period|Lack of Efficacy|0|||
146181759|NCT01474512|527179452|FG000|Induction Period|Withdrawal by Subject|6|||
146181760|NCT01474512|527179453|FG001|Induction Period|Withdrawal by Subject|6|||
146181761|NCT01474512|527179454|FG002|Induction Period|Withdrawal by Subject|5|||
146181762|NCT01474512|527179455|FG003|Induction Period|Withdrawal by Subject|0|||
146181763|NCT01474512|527179456|FG004|Induction Period|Withdrawal by Subject|0|||
146181764|NCT01474512|527179457|FG005|Induction Period|Withdrawal by Subject|0|||
146181765|NCT01474512|527179458|FG006|Induction Period|Withdrawal by Subject|0|||
146181766|NCT01474512|527179459|FG007|Induction Period|Withdrawal by Subject|0|||
146181767|NCT01474512|527179460|FG008|Induction Period|Withdrawal by Subject|0|||
146181768|NCT01474512|527179461|FG009|Induction Period|Withdrawal by Subject|0|||
146181769|NCT01474512|527179462|FG010|Induction Period|Withdrawal by Subject|0|||
146181770|NCT01474512|527179463|FG011|Induction Period|Withdrawal by Subject|0|||
146181771|NCT01474512|527179464|FG012|Induction Period|Withdrawal by Subject|0|||
146181772|NCT01474512|527179465|FG013|Induction Period|Withdrawal by Subject|0|||
146181773|NCT01474512|527179466|FG014|Induction Period|Withdrawal by Subject|0|||
146181774|NCT01474512|527179467|FG015|Induction Period|Withdrawal by Subject|0|||
146181775|NCT01474512|527179468|FG016|Induction Period|Withdrawal by Subject|0|||
146181776|NCT01474512|527179469|FG017|Induction Period|Withdrawal by Subject|0|||
146181777|NCT01474512|527179452|FG000|Induction Period|Protocol Violation|3|||
146181778|NCT01474512|527179453|FG001|Induction Period|Protocol Violation|6|||
146181779|NCT01474512|527179454|FG002|Induction Period|Protocol Violation|0|||
146181780|NCT01474512|527179455|FG003|Induction Period|Protocol Violation|0|||
146181781|NCT01474512|527179456|FG004|Induction Period|Protocol Violation|0|||
146181782|NCT01474512|527179457|FG005|Induction Period|Protocol Violation|0|||
146181783|NCT01474512|527179458|FG006|Induction Period|Protocol Violation|0|||
146181784|NCT01474512|527179459|FG007|Induction Period|Protocol Violation|0|||
146181785|NCT01474512|527179460|FG008|Induction Period|Protocol Violation|0|||
146181786|NCT01474512|527179461|FG009|Induction Period|Protocol Violation|0|||
146080036|NCT00640224|526814563|FG002|Overall Study|Lost to Follow-up|0|||
146080037|NCT00640224|526814564|FG003|Overall Study|Lost to Follow-up|0|||
146080038|NCT00640224|526814561|FG000|Overall Study|Withdrawal by Subject|1|||
146080039|NCT00640224|526814562|FG001|Overall Study|Withdrawal by Subject|0|||
146080040|NCT00640224|526814563|FG002|Overall Study|Withdrawal by Subject|0|||
146080041|NCT00640224|526814564|FG003|Overall Study|Withdrawal by Subject|0|||
146080042|NCT00640224|526814561|FG000|Overall Study|Headaches|0|||
146080043|NCT00640224|526814562|FG001|Overall Study|Headaches|1|||
146080044|NCT00640224|526814563|FG002|Overall Study|Headaches|0|||
146080045|NCT00640224|526814564|FG003|Overall Study|Headaches|0|||
146080046|NCT00422513|526814565|FG000|Overall Study|Lack of Efficacy|4|||
146080047|NCT00422513|526814566|FG001|Overall Study|Lack of Efficacy|5|||
146080048|NCT00422513|526814565|FG000|Overall Study|Protocol Violation|23|||
146080049|NCT00422513|526814566|FG001|Overall Study|Protocol Violation|7|||
146080050|NCT00422513|526814565|FG000|Overall Study|Refused Treatment|4|||
146080051|NCT00422513|526814566|FG001|Overall Study|Refused Treatment|2|||
146080052|NCT00422513|526814565|FG000|Overall Study|Withdrawal by Subject|2|||
146080053|NCT00422513|526814566|FG001|Overall Study|Withdrawal by Subject|1|||
146080054|NCT00422513|526814565|FG000|Overall Study|early termination of the study|67|||
146080055|NCT00422513|526814566|FG001|Overall Study|early termination of the study|80|||
146080056|NCT00422513|526814565|FG000|Overall Study|Adverse Event|4|||
146080057|NCT00422513|526814566|FG001|Overall Study|Adverse Event|4|||
146080058|NCT00422513|526814565|FG000|Overall Study|Death|3|||
146080059|NCT00422513|526814566|FG001|Overall Study|Death|7|||
146080060|NCT03135119|526814567|FG000|Overall Study|Lost to Follow-up|2|||
146080061|NCT03135119|526814568|FG001|Overall Study|Lost to Follow-up|0|||
146080062|NCT03135119|526814567|FG000|Overall Study|Physician Decision|1|||
146181787|NCT01474512|527179462|FG010|Induction Period|Protocol Violation|0|||
146181788|NCT01474512|527179463|FG011|Induction Period|Protocol Violation|0|||
146181789|NCT01474512|527179464|FG012|Induction Period|Protocol Violation|0|||
146181790|NCT01474512|527179465|FG013|Induction Period|Protocol Violation|0|||
146080063|NCT03135119|526814568|FG001|Overall Study|Physician Decision|1|||
146080064|NCT03135119|526814567|FG000|Overall Study|COVID-19 Shutdown|2|||
146080065|NCT03135119|526814568|FG001|Overall Study|COVID-19 Shutdown|2|||
146080066|NCT01478048|526814569|FG000|Overall Study|Disease Progression|52|||
146080067|NCT01478048|526814570|FG001|Overall Study|Disease Progression|35|||
146080068|NCT01478048|526814569|FG000|Overall Study|study drug toxicity|11|||
146080069|NCT01478048|526814570|FG001|Overall Study|study drug toxicity|14|||
146181791|NCT01474512|527179466|FG014|Induction Period|Protocol Violation|0|||
146181792|NCT01474512|527179467|FG015|Induction Period|Protocol Violation|0|||
146181793|NCT01474512|527179468|FG016|Induction Period|Protocol Violation|0|||
146181794|NCT01474512|527179469|FG017|Induction Period|Protocol Violation|0|||
146181795|NCT01474512|527179452|FG000|Induction Period|Sponsor Decision|1|||
146181796|NCT01474512|527179453|FG001|Induction Period|Sponsor Decision|1|||
146181797|NCT01474512|527179454|FG002|Induction Period|Sponsor Decision|1|||
146181798|NCT01474512|527179455|FG003|Induction Period|Sponsor Decision|0|||
146181799|NCT01474512|527179456|FG004|Induction Period|Sponsor Decision|0|||
146181800|NCT01474512|527179457|FG005|Induction Period|Sponsor Decision|0|||
146181801|NCT01474512|527179458|FG006|Induction Period|Sponsor Decision|0|||
146181802|NCT01474512|527179459|FG007|Induction Period|Sponsor Decision|0|||
146181803|NCT01474512|527179460|FG008|Induction Period|Sponsor Decision|0|||
146181804|NCT01474512|527179461|FG009|Induction Period|Sponsor Decision|0|||
146181805|NCT01474512|527179462|FG010|Induction Period|Sponsor Decision|0|||
146181806|NCT01474512|527179463|FG011|Induction Period|Sponsor Decision|0|||
146181807|NCT01474512|527179464|FG012|Induction Period|Sponsor Decision|0|||
146181808|NCT01474512|527179465|FG013|Induction Period|Sponsor Decision|0|||
146181809|NCT01474512|527179466|FG014|Induction Period|Sponsor Decision|0|||
146181810|NCT01474512|527179467|FG015|Induction Period|Sponsor Decision|0|||
146181811|NCT01474512|527179468|FG016|Induction Period|Sponsor Decision|0|||
146181812|NCT01474512|527179469|FG017|Induction Period|Sponsor Decision|0|||
146181813|NCT01474512|527179452|FG000|Induction Period|Lost to Follow-up|1|||
146181814|NCT01474512|527179453|FG001|Induction Period|Lost to Follow-up|0|||
146181815|NCT01474512|527179454|FG002|Induction Period|Lost to Follow-up|2|||
146181816|NCT01474512|527179455|FG003|Induction Period|Lost to Follow-up|0|||
146181817|NCT01474512|527179456|FG004|Induction Period|Lost to Follow-up|0|||
146181818|NCT01474512|527179457|FG005|Induction Period|Lost to Follow-up|0|||
146181819|NCT01474512|527179458|FG006|Induction Period|Lost to Follow-up|0|||
146181820|NCT01474512|527179459|FG007|Induction Period|Lost to Follow-up|0|||
146181821|NCT01474512|527179460|FG008|Induction Period|Lost to Follow-up|0|||
146181822|NCT01474512|527179461|FG009|Induction Period|Lost to Follow-up|0|||
146181823|NCT01474512|527179462|FG010|Induction Period|Lost to Follow-up|0|||
146181824|NCT01474512|527179463|FG011|Induction Period|Lost to Follow-up|0|||
146181825|NCT01474512|527179464|FG012|Induction Period|Lost to Follow-up|0|||
146181826|NCT01474512|527179465|FG013|Induction Period|Lost to Follow-up|0|||
146181827|NCT01474512|527179466|FG014|Induction Period|Lost to Follow-up|0|||
146181828|NCT01474512|527179467|FG015|Induction Period|Lost to Follow-up|0|||
146181829|NCT01474512|527179468|FG016|Induction Period|Lost to Follow-up|0|||
146181830|NCT01474512|527179469|FG017|Induction Period|Lost to Follow-up|0|||
146181831|NCT01474512|527179452|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181832|NCT01474512|527179453|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181833|NCT01474512|527179454|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181834|NCT01474512|527179455|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
146181835|NCT01474512|527179456|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
146181836|NCT01474512|527179457|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
146181837|NCT01474512|527179458|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
146181838|NCT01474512|527179459|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181839|NCT01474512|527179460|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181840|NCT01474512|527179461|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181841|NCT01474512|527179462|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181842|NCT01474512|527179463|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181843|NCT01474512|527179464|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181844|NCT01474512|527179465|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181845|NCT01474512|527179466|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181846|NCT01474512|527179467|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181847|NCT01474512|527179468|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181848|NCT01474512|527179469|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
146181849|NCT01474512|527179452|FG000|Maintenance Period|Adverse Event|0|||
146181850|NCT01474512|527179453|FG001|Maintenance Period|Adverse Event|0|||
146181851|NCT01474512|527179454|FG002|Maintenance Period|Adverse Event|0|||
146181852|NCT01474512|527179455|FG003|Maintenance Period|Adverse Event|4|||
146181853|NCT01474512|527179456|FG004|Maintenance Period|Adverse Event|2|||
146181854|NCT01474512|527179457|FG005|Maintenance Period|Adverse Event|7|||
146181855|NCT01474512|527179458|FG006|Maintenance Period|Adverse Event|0|||
146181856|NCT01474512|527179459|FG007|Maintenance Period|Adverse Event|19|||
146181857|NCT01474512|527179460|FG008|Maintenance Period|Adverse Event|1|||
146181858|NCT01474512|527179461|FG009|Maintenance Period|Adverse Event|3|||
146181859|NCT01474512|527179462|FG010|Maintenance Period|Adverse Event|0|||
146181860|NCT01474512|527179463|FG011|Maintenance Period|Adverse Event|0|||
146181861|NCT01474512|527179464|FG012|Maintenance Period|Adverse Event|0|||
146181862|NCT01474512|527179465|FG013|Maintenance Period|Adverse Event|0|||
146181863|NCT01474512|527179466|FG014|Maintenance Period|Adverse Event|0|||
146181864|NCT01474512|527179467|FG015|Maintenance Period|Adverse Event|0|||
146181865|NCT01474512|527179468|FG016|Maintenance Period|Adverse Event|0|||
146181866|NCT01474512|527179469|FG017|Maintenance Period|Adverse Event|0|||
146181867|NCT01474512|527179452|FG000|Maintenance Period|Withdrawal by Subject|0|||
146181868|NCT01474512|527179453|FG001|Maintenance Period|Withdrawal by Subject|0|||
146181869|NCT01474512|527179454|FG002|Maintenance Period|Withdrawal by Subject|0|||
146181870|NCT01474512|527179455|FG003|Maintenance Period|Withdrawal by Subject|6|||
146181871|NCT01474512|527179456|FG004|Maintenance Period|Withdrawal by Subject|2|||
146181872|NCT01474512|527179457|FG005|Maintenance Period|Withdrawal by Subject|3|||
146181873|NCT01474512|527179458|FG006|Maintenance Period|Withdrawal by Subject|1|||
146181874|NCT01474512|527179459|FG007|Maintenance Period|Withdrawal by Subject|6|||
146181875|NCT01474512|527179460|FG008|Maintenance Period|Withdrawal by Subject|3|||
146181876|NCT01474512|527179461|FG009|Maintenance Period|Withdrawal by Subject|1|||
146181877|NCT01474512|527179462|FG010|Maintenance Period|Withdrawal by Subject|0|||
146181878|NCT01474512|527179463|FG011|Maintenance Period|Withdrawal by Subject|0|||
146181879|NCT01474512|527179464|FG012|Maintenance Period|Withdrawal by Subject|0|||
146181880|NCT01474512|527179465|FG013|Maintenance Period|Withdrawal by Subject|0|||
146181881|NCT01474512|527179466|FG014|Maintenance Period|Withdrawal by Subject|0|||
146181882|NCT01474512|527179467|FG015|Maintenance Period|Withdrawal by Subject|0|||
146181883|NCT01474512|527179468|FG016|Maintenance Period|Withdrawal by Subject|0|||
146181884|NCT01474512|527179469|FG017|Maintenance Period|Withdrawal by Subject|0|||
146181885|NCT01474512|527179452|FG000|Maintenance Period|Lost to Follow-up|0|||
146181886|NCT01474512|527179453|FG001|Maintenance Period|Lost to Follow-up|0|||
146181887|NCT01474512|527179454|FG002|Maintenance Period|Lost to Follow-up|0|||
146181888|NCT01474512|527179455|FG003|Maintenance Period|Lost to Follow-up|3|||
146181889|NCT01474512|527179456|FG004|Maintenance Period|Lost to Follow-up|3|||
146181890|NCT01474512|527179457|FG005|Maintenance Period|Lost to Follow-up|0|||
146181891|NCT01474512|527179458|FG006|Maintenance Period|Lost to Follow-up|0|||
146181892|NCT01474512|527179459|FG007|Maintenance Period|Lost to Follow-up|2|||
146181893|NCT01474512|527179460|FG008|Maintenance Period|Lost to Follow-up|1|||
146181894|NCT01474512|527179461|FG009|Maintenance Period|Lost to Follow-up|1|||
146181895|NCT01474512|527179462|FG010|Maintenance Period|Lost to Follow-up|0|||
146181896|NCT01474512|527179463|FG011|Maintenance Period|Lost to Follow-up|0|||
146181897|NCT01474512|527179464|FG012|Maintenance Period|Lost to Follow-up|0|||
146181898|NCT01474512|527179465|FG013|Maintenance Period|Lost to Follow-up|0|||
146181899|NCT01474512|527179466|FG014|Maintenance Period|Lost to Follow-up|0|||
146181900|NCT01474512|527179467|FG015|Maintenance Period|Lost to Follow-up|0|||
146181901|NCT01474512|527179468|FG016|Maintenance Period|Lost to Follow-up|0|||
146181902|NCT01474512|527179469|FG017|Maintenance Period|Lost to Follow-up|0|||
146181903|NCT01474512|527179452|FG000|Maintenance Period|Death|0|||
146181904|NCT01474512|527179453|FG001|Maintenance Period|Death|0|||
146181905|NCT01474512|527179454|FG002|Maintenance Period|Death|0|||
146181906|NCT01474512|527179455|FG003|Maintenance Period|Death|0|||
146181907|NCT01474512|527179456|FG004|Maintenance Period|Death|0|||
146412365|NCT02544633|528015506|FG003|Treatment Period|Lost to Follow-up|0|||
146412366|NCT02544633|528015503|FG000|Treatment Period|Death|0|||
146181908|NCT01474512|527179457|FG005|Maintenance Period|Death|2|||
146181909|NCT01474512|527179458|FG006|Maintenance Period|Death|0|||
146181910|NCT01474512|527179459|FG007|Maintenance Period|Death|0|||
146181911|NCT01474512|527179460|FG008|Maintenance Period|Death|0|||
146181912|NCT01474512|527179461|FG009|Maintenance Period|Death|0|||
146181913|NCT01474512|527179462|FG010|Maintenance Period|Death|0|||
146181914|NCT01474512|527179463|FG011|Maintenance Period|Death|0|||
146181915|NCT01474512|527179464|FG012|Maintenance Period|Death|0|||
146181916|NCT01474512|527179465|FG013|Maintenance Period|Death|0|||
146181917|NCT01474512|527179466|FG014|Maintenance Period|Death|0|||
146181918|NCT01474512|527179467|FG015|Maintenance Period|Death|0|||
146181919|NCT01474512|527179468|FG016|Maintenance Period|Death|0|||
146181920|NCT01474512|527179469|FG017|Maintenance Period|Death|0|||
146181921|NCT01474512|527179452|FG000|Maintenance Period|Physician Decision|0|||
146181922|NCT01474512|527179453|FG001|Maintenance Period|Physician Decision|0|||
146181923|NCT01474512|527179454|FG002|Maintenance Period|Physician Decision|0|||
146181924|NCT01474512|527179455|FG003|Maintenance Period|Physician Decision|0|||
146181925|NCT01474512|527179456|FG004|Maintenance Period|Physician Decision|0|||
146181926|NCT01474512|527179457|FG005|Maintenance Period|Physician Decision|1|||
146181927|NCT01474512|527179458|FG006|Maintenance Period|Physician Decision|0|||
146181928|NCT01474512|527179459|FG007|Maintenance Period|Physician Decision|2|||
146181929|NCT01474512|527179460|FG008|Maintenance Period|Physician Decision|0|||
146181930|NCT01474512|527179461|FG009|Maintenance Period|Physician Decision|0|||
146181931|NCT01474512|527179462|FG010|Maintenance Period|Physician Decision|0|||
146181932|NCT01474512|527179463|FG011|Maintenance Period|Physician Decision|0|||
146181933|NCT01474512|527179464|FG012|Maintenance Period|Physician Decision|0|||
146181934|NCT01474512|527179465|FG013|Maintenance Period|Physician Decision|0|||
146181935|NCT01474512|527179466|FG014|Maintenance Period|Physician Decision|0|||
146181936|NCT01474512|527179467|FG015|Maintenance Period|Physician Decision|0|||
146181937|NCT01474512|527179468|FG016|Maintenance Period|Physician Decision|0|||
146181938|NCT01474512|527179469|FG017|Maintenance Period|Physician Decision|0|||
146181939|NCT01474512|527179452|FG000|Maintenance Period|Clinical Relapse|0|||
146181940|NCT01474512|527179453|FG001|Maintenance Period|Clinical Relapse|0|||
146181941|NCT01474512|527179454|FG002|Maintenance Period|Clinical Relapse|0|||
146181942|NCT01474512|527179455|FG003|Maintenance Period|Clinical Relapse|1|||
146181943|NCT01474512|527179456|FG004|Maintenance Period|Clinical Relapse|0|||
146181944|NCT01474512|527179457|FG005|Maintenance Period|Clinical Relapse|0|||
146181945|NCT01474512|527179458|FG006|Maintenance Period|Clinical Relapse|0|||
146181946|NCT01474512|527179459|FG007|Maintenance Period|Clinical Relapse|0|||
146181947|NCT01474512|527179460|FG008|Maintenance Period|Clinical Relapse|0|||
146181948|NCT01474512|527179461|FG009|Maintenance Period|Clinical Relapse|0|||
146181949|NCT01474512|527179462|FG010|Maintenance Period|Clinical Relapse|0|||
146181950|NCT01474512|527179463|FG011|Maintenance Period|Clinical Relapse|0|||
146181951|NCT01474512|527179464|FG012|Maintenance Period|Clinical Relapse|0|||
146181952|NCT01474512|527179465|FG013|Maintenance Period|Clinical Relapse|0|||
146181953|NCT01474512|527179466|FG014|Maintenance Period|Clinical Relapse|0|||
146181954|NCT01474512|527179467|FG015|Maintenance Period|Clinical Relapse|0|||
146181955|NCT01474512|527179468|FG016|Maintenance Period|Clinical Relapse|0|||
146181956|NCT01474512|527179469|FG017|Maintenance Period|Clinical Relapse|0|||
146181957|NCT01474512|527179452|FG000|Maintenance Period|Lack of Efficacy|0|||
146181958|NCT01474512|527179453|FG001|Maintenance Period|Lack of Efficacy|0|||
146181959|NCT01474512|527179454|FG002|Maintenance Period|Lack of Efficacy|0|||
146181960|NCT01474512|527179455|FG003|Maintenance Period|Lack of Efficacy|1|||
146181961|NCT01474512|527179456|FG004|Maintenance Period|Lack of Efficacy|0|||
146181962|NCT01474512|527179457|FG005|Maintenance Period|Lack of Efficacy|0|||
146181963|NCT01474512|527179458|FG006|Maintenance Period|Lack of Efficacy|0|||
146181964|NCT01474512|527179459|FG007|Maintenance Period|Lack of Efficacy|11|||
146181965|NCT01474512|527179460|FG008|Maintenance Period|Lack of Efficacy|11|||
146181966|NCT01474512|527179461|FG009|Maintenance Period|Lack of Efficacy|12|||
146181967|NCT01474512|527179462|FG010|Maintenance Period|Lack of Efficacy|0|||
146181968|NCT01474512|527179463|FG011|Maintenance Period|Lack of Efficacy|0|||
146181969|NCT01474512|527179464|FG012|Maintenance Period|Lack of Efficacy|0|||
146181970|NCT01474512|527179465|FG013|Maintenance Period|Lack of Efficacy|0|||
146181971|NCT01474512|527179466|FG014|Maintenance Period|Lack of Efficacy|0|||
146181972|NCT01474512|527179467|FG015|Maintenance Period|Lack of Efficacy|0|||
146181973|NCT01474512|527179468|FG016|Maintenance Period|Lack of Efficacy|0|||
146181974|NCT01474512|527179469|FG017|Maintenance Period|Lack of Efficacy|0|||
146412367|NCT02544633|528015504|FG001|Treatment Period|Death|0|||
146412368|NCT02544633|528015505|FG002|Treatment Period|Death|1|||
146181975|NCT01474512|527179452|FG000|Maintenance Period|Protocol Violation|0|||
146181976|NCT01474512|527179453|FG001|Maintenance Period|Protocol Violation|0|||
146181977|NCT01474512|527179454|FG002|Maintenance Period|Protocol Violation|0|||
146181978|NCT01474512|527179455|FG003|Maintenance Period|Protocol Violation|1|||
146181979|NCT01474512|527179456|FG004|Maintenance Period|Protocol Violation|0|||
146181980|NCT01474512|527179457|FG005|Maintenance Period|Protocol Violation|0|||
146181981|NCT01474512|527179458|FG006|Maintenance Period|Protocol Violation|0|||
146181982|NCT01474512|527179459|FG007|Maintenance Period|Protocol Violation|1|||
146181983|NCT01474512|527179460|FG008|Maintenance Period|Protocol Violation|0|||
146181984|NCT01474512|527179461|FG009|Maintenance Period|Protocol Violation|1|||
146181985|NCT01474512|527179462|FG010|Maintenance Period|Protocol Violation|0|||
146181986|NCT01474512|527179463|FG011|Maintenance Period|Protocol Violation|0|||
146181987|NCT01474512|527179464|FG012|Maintenance Period|Protocol Violation|0|||
146181988|NCT01474512|527179465|FG013|Maintenance Period|Protocol Violation|0|||
146181989|NCT01474512|527179466|FG014|Maintenance Period|Protocol Violation|0|||
146181990|NCT01474512|527179467|FG015|Maintenance Period|Protocol Violation|0|||
146181991|NCT01474512|527179468|FG016|Maintenance Period|Protocol Violation|0|||
146181992|NCT01474512|527179469|FG017|Maintenance Period|Protocol Violation|0|||
146181993|NCT01474512|527179452|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
146181994|NCT01474512|527179453|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
146181995|NCT01474512|527179454|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
146181996|NCT01474512|527179455|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
146181997|NCT01474512|527179456|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
146181998|NCT01474512|527179457|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
146181999|NCT01474512|527179458|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
146182000|NCT01474512|527179459|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
146182001|NCT01474512|527179460|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
146182002|NCT01474512|527179461|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
146182003|NCT01474512|527179462|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
146182004|NCT01474512|527179463|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
146182005|NCT01474512|527179464|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
146182006|NCT01474512|527179465|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
146182007|NCT01474512|527179466|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
146182008|NCT01474512|527179467|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
146182009|NCT01474512|527179468|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
146182010|NCT01474512|527179469|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
146182011|NCT01474512|527179452|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
146182012|NCT01474512|527179453|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
146182013|NCT01474512|527179454|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
146182014|NCT01474512|527179455|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
146182015|NCT01474512|527179456|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
146182016|NCT01474512|527179457|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
146182017|NCT01474512|527179458|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
146182018|NCT01474512|527179459|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
146182019|NCT01474512|527179460|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
146182020|NCT01474512|527179461|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
146182021|NCT01474512|527179462|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
146182022|NCT01474512|527179463|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
146182023|NCT01474512|527179464|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
146182024|NCT01474512|527179465|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
146182025|NCT01474512|527179466|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
146182026|NCT01474512|527179467|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
146182027|NCT01474512|527179468|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
146182028|NCT01474512|527179469|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
146182029|NCT01474512|527179452|FG000|Long-Term Extension Period|Adverse Event|0|||
146182030|NCT01474512|527179453|FG001|Long-Term Extension Period|Adverse Event|0|||
146182031|NCT01474512|527179454|FG002|Long-Term Extension Period|Adverse Event|0|||
146182032|NCT01474512|527179455|FG003|Long-Term Extension Period|Adverse Event|0|||
146182033|NCT01474512|527179456|FG004|Long-Term Extension Period|Adverse Event|0|||
146182034|NCT01474512|527179457|FG005|Long-Term Extension Period|Adverse Event|0|||
146182035|NCT01474512|527179458|FG006|Long-Term Extension Period|Adverse Event|0|||
146182036|NCT01474512|527179459|FG007|Long-Term Extension Period|Adverse Event|0|||
146182037|NCT01474512|527179460|FG008|Long-Term Extension Period|Adverse Event|0|||
146182038|NCT01474512|527179461|FG009|Long-Term Extension Period|Adverse Event|0|||
146182039|NCT01474512|527179462|FG010|Long-Term Extension Period|Adverse Event|0|||
146182040|NCT01474512|527179463|FG011|Long-Term Extension Period|Adverse Event|1|||
146182041|NCT01474512|527179464|FG012|Long-Term Extension Period|Adverse Event|57|||
146182042|NCT01474512|527179465|FG013|Long-Term Extension Period|Adverse Event|58|||
146182043|NCT01474512|527179466|FG014|Long-Term Extension Period|Adverse Event|0|||
146182044|NCT01474512|527179467|FG015|Long-Term Extension Period|Adverse Event|0|||
146182045|NCT01474512|527179468|FG016|Long-Term Extension Period|Adverse Event|0|||
146182046|NCT01474512|527179469|FG017|Long-Term Extension Period|Adverse Event|0|||
146182047|NCT01474512|527179452|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
146182048|NCT01474512|527179453|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
146182049|NCT01474512|527179454|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
146182050|NCT01474512|527179455|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
146182051|NCT01474512|527179456|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
146182052|NCT01474512|527179457|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
146182053|NCT01474512|527179458|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
146182054|NCT01474512|527179459|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
146182055|NCT01474512|527179460|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
146182056|NCT01474512|527179461|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
146182057|NCT01474512|527179462|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
146182058|NCT01474512|527179463|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
146182059|NCT01474512|527179464|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
146182060|NCT01474512|527179465|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
146182061|NCT01474512|527179466|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
146182062|NCT01474512|527179467|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
146182063|NCT01474512|527179468|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
146182064|NCT01474512|527179469|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
146182065|NCT01474512|527179452|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
146182066|NCT01474512|527179453|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
146182067|NCT01474512|527179454|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
146182068|NCT01474512|527179455|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
146182069|NCT01474512|527179456|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
146182070|NCT01474512|527179457|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
146182071|NCT01474512|527179458|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
146182072|NCT01474512|527179459|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
146182073|NCT01474512|527179460|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
146182074|NCT01474512|527179461|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
146182075|NCT01474512|527179462|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
146182076|NCT01474512|527179463|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
146182077|NCT01474512|527179464|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
146182078|NCT01474512|527179465|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
146182079|NCT01474512|527179466|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
146182080|NCT01474512|527179467|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
146182081|NCT01474512|527179468|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
146182082|NCT01474512|527179469|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
146182083|NCT01474512|527179452|FG000|Long-Term Extension Period|Physician Decision|0|||
146182084|NCT01474512|527179453|FG001|Long-Term Extension Period|Physician Decision|0|||
146182085|NCT01474512|527179454|FG002|Long-Term Extension Period|Physician Decision|0|||
146182086|NCT01474512|527179455|FG003|Long-Term Extension Period|Physician Decision|0|||
146182087|NCT01474512|527179456|FG004|Long-Term Extension Period|Physician Decision|0|||
146182088|NCT01474512|527179457|FG005|Long-Term Extension Period|Physician Decision|0|||
146182089|NCT01474512|527179458|FG006|Long-Term Extension Period|Physician Decision|0|||
146182090|NCT01474512|527179459|FG007|Long-Term Extension Period|Physician Decision|0|||
146182091|NCT01474512|527179460|FG008|Long-Term Extension Period|Physician Decision|0|||
146182092|NCT01474512|527179461|FG009|Long-Term Extension Period|Physician Decision|0|||
146182093|NCT01474512|527179462|FG010|Long-Term Extension Period|Physician Decision|0|||
146182094|NCT01474512|527179463|FG011|Long-Term Extension Period|Physician Decision|0|||
146412369|NCT02544633|528015506|FG003|Treatment Period|Death|0|||
146182095|NCT01474512|527179464|FG012|Long-Term Extension Period|Physician Decision|21|||
146182096|NCT01474512|527179465|FG013|Long-Term Extension Period|Physician Decision|21|||
146182097|NCT01474512|527179466|FG014|Long-Term Extension Period|Physician Decision|0|||
146412370|NCT02544633|528015503|FG000|Treatment Period|Non-compliance|0|||
146412371|NCT02544633|528015504|FG001|Treatment Period|Non-compliance|0|||
146182098|NCT01474512|527179467|FG015|Long-Term Extension Period|Physician Decision|0|||
146182099|NCT01474512|527179468|FG016|Long-Term Extension Period|Physician Decision|0|||
146182100|NCT01474512|527179469|FG017|Long-Term Extension Period|Physician Decision|0|||
146182101|NCT01474512|527179452|FG000|Long-Term Extension Period|Clinical Relapse|0|||
146182102|NCT01474512|527179453|FG001|Long-Term Extension Period|Clinical Relapse|0|||
146182103|NCT01474512|527179454|FG002|Long-Term Extension Period|Clinical Relapse|0|||
146182104|NCT01474512|527179455|FG003|Long-Term Extension Period|Clinical Relapse|0|||
146182105|NCT01474512|527179456|FG004|Long-Term Extension Period|Clinical Relapse|0|||
146182106|NCT01474512|527179457|FG005|Long-Term Extension Period|Clinical Relapse|0|||
146182107|NCT01474512|527179458|FG006|Long-Term Extension Period|Clinical Relapse|0|||
146182108|NCT01474512|527179459|FG007|Long-Term Extension Period|Clinical Relapse|0|||
146182109|NCT01474512|527179460|FG008|Long-Term Extension Period|Clinical Relapse|0|||
146182110|NCT01474512|527179461|FG009|Long-Term Extension Period|Clinical Relapse|0|||
146080070|NCT01478048|526814569|FG000|Overall Study|Adverse Event|2|||
146080071|NCT01478048|526814570|FG001|Overall Study|Adverse Event|11|||
146080072|NCT01478048|526814569|FG000|Overall Study|subject request to discontinue treatment|3|||
146080073|NCT01478048|526814570|FG001|Overall Study|subject request to discontinue treatment|5|||
146080074|NCT01478048|526814569|FG000|Overall Study|Withdrawal by Subject|2|||
146080075|NCT01478048|526814570|FG001|Overall Study|Withdrawal by Subject|5|||
146080076|NCT01478048|526814569|FG000|Overall Study|non-specified|6|||
146080077|NCT01478048|526814570|FG001|Overall Study|non-specified|4|||
146080078|NCT01478048|526814569|FG000|Overall Study|poor/non-compliance|0|||
146080079|NCT01478048|526814570|FG001|Overall Study|poor/non-compliance|1|||
146080080|NCT01478048|526814569|FG000|Overall Study|no longer meets study criteria|1|||
146080081|NCT01478048|526814570|FG001|Overall Study|no longer meets study criteria|0|||
146080082|NCT01252667|526814575|FG000|Overall Study|Transplant aborted post-conditioning|0|||
146080083|NCT01252667|526814576|FG001|Overall Study|Transplant aborted post-conditioning|0|||
146080084|NCT01252667|526814577|FG002|Overall Study|Transplant aborted post-conditioning|0|||
146080085|NCT01252667|526814578|FG003|Overall Study|Transplant aborted post-conditioning|0|||
146080086|NCT01252667|526814579|FG004|Overall Study|Transplant aborted post-conditioning|0|||
146080087|NCT01252667|526814580|FG005|Overall Study|Transplant aborted post-conditioning|1|||
146080088|NCT03032380|526814581|FG000|Overall Study|Adverse Event|0|||
146080089|NCT03032380|526814582|FG001|Overall Study|Adverse Event|1|||
146080090|NCT03032380|526814581|FG000|Overall Study|Lack of Efficacy|1|||
146080091|NCT03032380|526814582|FG001|Overall Study|Lack of Efficacy|0|||
146080092|NCT03032380|526814581|FG000|Overall Study|Withdrawal by Subject|2|||
146080093|NCT03032380|526814582|FG001|Overall Study|Withdrawal by Subject|3|||
146080094|NCT03032380|526814581|FG000|Overall Study|Recovery|0|||
146080095|NCT03032380|526814582|FG001|Overall Study|Recovery|1|||
146080096|NCT03032380|526814581|FG000|Overall Study|Death|39|||
146080097|NCT03032380|526814582|FG001|Overall Study|Death|34|||
146080098|NCT03032380|526814581|FG000|Overall Study|Other - Miscellaneous|0|||
146080099|NCT03032380|526814582|FG001|Overall Study|Other - Miscellaneous|1|||
146080100|NCT04644315|526814583|FG000|Overall Study|Subject withdrawal of consent|1|||
146080101|NCT01836276|526814584|FG000|Overall Study|Lost to Follow-up|28|||
146080102|NCT01836276|526814585|FG001|Overall Study|Lost to Follow-up|51|||
146080103|NCT01561898|526814586|FG000|Overall Study|Withdrawal by Subject|0|||
146080104|NCT01561898|526814587|FG001|Overall Study|Withdrawal by Subject|8|||
146080105|NCT01561898|526814588|FG002|Overall Study|Withdrawal by Subject|12|||
146080106|NCT01561898|526814589|FG003|Overall Study|Withdrawal by Subject|5|||
146080107|NCT01561898|526814586|FG000|Overall Study|Lack of Efficacy|0|||
146080108|NCT01561898|526814587|FG001|Overall Study|Lack of Efficacy|8|||
146080109|NCT01561898|526814588|FG002|Overall Study|Lack of Efficacy|10|||
146080110|NCT01561898|526814589|FG003|Overall Study|Lack of Efficacy|5|||
146080111|NCT01561898|526814586|FG000|Overall Study|Worsening of complications|0|||
146080112|NCT01561898|526814587|FG001|Overall Study|Worsening of complications|1|||
146080113|NCT01561898|526814588|FG002|Overall Study|Worsening of complications|0|||
146080114|NCT01561898|526814589|FG003|Overall Study|Worsening of complications|0|||
146080115|NCT01561898|526814586|FG000|Overall Study|Lost to Follow-up|0|||
146080116|NCT01561898|526814587|FG001|Overall Study|Lost to Follow-up|0|||
146080117|NCT01561898|526814588|FG002|Overall Study|Lost to Follow-up|1|||
146080118|NCT01561898|526814589|FG003|Overall Study|Lost to Follow-up|0|||
146080119|NCT01561898|526814586|FG000|Overall Study|Adverse Event|1|||
146080120|NCT01561898|526814587|FG001|Overall Study|Adverse Event|19|||
146080121|NCT01561898|526814588|FG002|Overall Study|Adverse Event|14|||
146080122|NCT01561898|526814589|FG003|Overall Study|Adverse Event|9|||
146080123|NCT01561898|526814586|FG000|Overall Study|Physician Decision|1|||
146080124|NCT01561898|526814587|FG001|Overall Study|Physician Decision|5|||
146080125|NCT01561898|526814588|FG002|Overall Study|Physician Decision|7|||
146080126|NCT01561898|526814589|FG003|Overall Study|Physician Decision|1|||
146080127|NCT00331552|526814592|FG000|Period 3: Phase II|Neurological Symptoms|1|||
146080128|NCT00331552|526814593|FG001|Period 3: Phase II|Neurological Symptoms|0|||
146080129|NCT00331552|526814592|FG000|Period 3: Phase II|Severe Nausea|1|||
146080130|NCT00331552|526814593|FG001|Period 3: Phase II|Severe Nausea|0|||
146080131|NCT01445548|526814594|FG000|Overall Study|Adverse Event|1|||
146080132|NCT01883453|526814596|FG000|Overall Study|No episode of common cold|25|||
146080133|NCT01883453|526814597|FG001|Overall Study|No episode of common cold|23|||
146080134|NCT03642132|526814599|FG000|Chemotherapy Period|Adverse Event|1|||
146080135|NCT03642132|526814600|FG001|Chemotherapy Period|Adverse Event|1|||
146080136|NCT03642132|526814601|FG002|Chemotherapy Period|Adverse Event|0|||
146080137|NCT03642132|526814599|FG000|Chemotherapy Period|Physician's decision|4|||
146080138|NCT03642132|526814600|FG001|Chemotherapy Period|Physician's decision|1|||
146080139|NCT03642132|526814601|FG002|Chemotherapy Period|Physician's decision|0|||
146080140|NCT03642132|526814599|FG000|Chemotherapy Period|Progressive disease|0|||
146080141|NCT03642132|526814600|FG001|Chemotherapy Period|Progressive disease|0|||
146080142|NCT03642132|526814601|FG002|Chemotherapy Period|Progressive disease|1|||
146080143|NCT03642132|526814599|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
146080144|NCT03642132|526814600|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
146080145|NCT03642132|526814601|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
146080146|NCT03642132|526814599|FG000|Chemotherapy Period|Other|1|||
146080147|NCT03642132|526814600|FG001|Chemotherapy Period|Other|0|||
146080148|NCT03642132|526814601|FG002|Chemotherapy Period|Other|2|||
146080149|NCT03642132|526814599|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
146080150|NCT03642132|526814600|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
146080151|NCT03642132|526814601|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
146080152|NCT03642132|526814599|FG000|Maintenance Period|Adverse Event|1|||
146080153|NCT03642132|526814600|FG001|Maintenance Period|Adverse Event|2|||
146080154|NCT03642132|526814601|FG002|Maintenance Period|Adverse Event|0|||
146080155|NCT03642132|526814599|FG000|Maintenance Period|Non-compliance with study drug|0|||
146080156|NCT03642132|526814600|FG001|Maintenance Period|Non-compliance with study drug|0|||
146080157|NCT03642132|526814601|FG002|Maintenance Period|Non-compliance with study drug|1|||
146080158|NCT03642132|526814599|FG000|Maintenance Period|Physician's decision|2|||
146080159|NCT03642132|526814600|FG001|Maintenance Period|Physician's decision|2|||
146080160|NCT03642132|526814601|FG002|Maintenance Period|Physician's decision|2|||
146080161|NCT03642132|526814599|FG000|Maintenance Period|Progressive disease|9|||
146080162|NCT03642132|526814600|FG001|Maintenance Period|Progressive disease|3|||
146080163|NCT03642132|526814601|FG002|Maintenance Period|Progressive disease|6|||
146080164|NCT03642132|526814599|FG000|Maintenance Period|Other|0|||
146080165|NCT03642132|526814600|FG001|Maintenance Period|Other|0|||
146080166|NCT03642132|526814601|FG002|Maintenance Period|Other|3|||
146080167|NCT03642132|526814599|FG000|Maintenance Period|Withdrawal by Subject|1|||
146080168|NCT03642132|526814600|FG001|Maintenance Period|Withdrawal by Subject|1|||
146080169|NCT03642132|526814601|FG002|Maintenance Period|Withdrawal by Subject|2|||
146080170|NCT03642132|526814599|FG000|Follow-up Period|Other|0|||
146080171|NCT03642132|526814600|FG001|Follow-up Period|Other|0|||
146080172|NCT03642132|526814601|FG002|Follow-up Period|Other|1|||
146080173|NCT03642132|526814599|FG000|Follow-up Period|Withdrawal by Subject|1|||
146080174|NCT03642132|526814600|FG001|Follow-up Period|Withdrawal by Subject|2|||
146080175|NCT03642132|526814601|FG002|Follow-up Period|Withdrawal by Subject|0|||
146080176|NCT03642132|526814599|FG000|Follow-up Period|Study terminated by sponsor|1|||
146080177|NCT03642132|526814600|FG001|Follow-up Period|Study terminated by sponsor|0|||
146412372|NCT02544633|528015505|FG002|Treatment Period|Non-compliance|1|||
146182111|NCT01474512|527179462|FG010|Long-Term Extension Period|Clinical Relapse|0|||
146182112|NCT01474512|527179463|FG011|Long-Term Extension Period|Clinical Relapse|0|||
146182113|NCT01474512|527179464|FG012|Long-Term Extension Period|Clinical Relapse|9|||
146182114|NCT01474512|527179465|FG013|Long-Term Extension Period|Clinical Relapse|9|||
146182115|NCT01474512|527179466|FG014|Long-Term Extension Period|Clinical Relapse|0|||
146182116|NCT01474512|527179467|FG015|Long-Term Extension Period|Clinical Relapse|0|||
146182117|NCT01474512|527179468|FG016|Long-Term Extension Period|Clinical Relapse|0|||
146182118|NCT01474512|527179469|FG017|Long-Term Extension Period|Clinical Relapse|0|||
146182119|NCT01474512|527179452|FG000|Long-Term Extension Period|Death|0|||
146182120|NCT01474512|527179453|FG001|Long-Term Extension Period|Death|0|||
146182121|NCT01474512|527179454|FG002|Long-Term Extension Period|Death|0|||
146182122|NCT01474512|527179455|FG003|Long-Term Extension Period|Death|0|||
146182123|NCT01474512|527179456|FG004|Long-Term Extension Period|Death|0|||
146182124|NCT01474512|527179457|FG005|Long-Term Extension Period|Death|0|||
146182125|NCT01474512|527179458|FG006|Long-Term Extension Period|Death|0|||
146182126|NCT01474512|527179459|FG007|Long-Term Extension Period|Death|0|||
146182127|NCT01474512|527179460|FG008|Long-Term Extension Period|Death|0|||
146182128|NCT01474512|527179461|FG009|Long-Term Extension Period|Death|0|||
146182129|NCT01474512|527179462|FG010|Long-Term Extension Period|Death|0|||
146182130|NCT01474512|527179463|FG011|Long-Term Extension Period|Death|0|||
146182131|NCT01474512|527179464|FG012|Long-Term Extension Period|Death|9|||
146182132|NCT01474512|527179465|FG013|Long-Term Extension Period|Death|9|||
146182133|NCT01474512|527179466|FG014|Long-Term Extension Period|Death|0|||
146182134|NCT01474512|527179467|FG015|Long-Term Extension Period|Death|0|||
146182135|NCT01474512|527179468|FG016|Long-Term Extension Period|Death|0|||
146182136|NCT01474512|527179469|FG017|Long-Term Extension Period|Death|0|||
146182137|NCT01474512|527179452|FG000|Long-Term Extension Period|Sponsor Decision|0|||
146182138|NCT01474512|527179453|FG001|Long-Term Extension Period|Sponsor Decision|0|||
146182139|NCT01474512|527179454|FG002|Long-Term Extension Period|Sponsor Decision|0|||
146182140|NCT01474512|527179455|FG003|Long-Term Extension Period|Sponsor Decision|0|||
146182141|NCT01474512|527179456|FG004|Long-Term Extension Period|Sponsor Decision|0|||
146182142|NCT01474512|527179457|FG005|Long-Term Extension Period|Sponsor Decision|0|||
146182143|NCT01474512|527179458|FG006|Long-Term Extension Period|Sponsor Decision|0|||
146182144|NCT01474512|527179459|FG007|Long-Term Extension Period|Sponsor Decision|0|||
146182145|NCT01474512|527179460|FG008|Long-Term Extension Period|Sponsor Decision|0|||
146182146|NCT01474512|527179461|FG009|Long-Term Extension Period|Sponsor Decision|0|||
146182147|NCT01474512|527179462|FG010|Long-Term Extension Period|Sponsor Decision|0|||
146182148|NCT01474512|527179463|FG011|Long-Term Extension Period|Sponsor Decision|0|||
146182149|NCT01474512|527179464|FG012|Long-Term Extension Period|Sponsor Decision|6|||
146182150|NCT01474512|527179465|FG013|Long-Term Extension Period|Sponsor Decision|6|||
146182151|NCT01474512|527179466|FG014|Long-Term Extension Period|Sponsor Decision|0|||
146182152|NCT01474512|527179467|FG015|Long-Term Extension Period|Sponsor Decision|0|||
146182153|NCT01474512|527179468|FG016|Long-Term Extension Period|Sponsor Decision|0|||
146182154|NCT01474512|527179469|FG017|Long-Term Extension Period|Sponsor Decision|0|||
146182155|NCT01474512|527179452|FG000|Long-Term Extension Period|Protocol Violation|0|||
146182156|NCT01474512|527179453|FG001|Long-Term Extension Period|Protocol Violation|0|||
146182157|NCT01474512|527179454|FG002|Long-Term Extension Period|Protocol Violation|0|||
146182158|NCT01474512|527179455|FG003|Long-Term Extension Period|Protocol Violation|0|||
146182159|NCT01474512|527179456|FG004|Long-Term Extension Period|Protocol Violation|0|||
146182160|NCT01474512|527179457|FG005|Long-Term Extension Period|Protocol Violation|0|||
146182161|NCT01474512|527179458|FG006|Long-Term Extension Period|Protocol Violation|0|||
146182162|NCT01474512|527179459|FG007|Long-Term Extension Period|Protocol Violation|0|||
146182163|NCT01474512|527179460|FG008|Long-Term Extension Period|Protocol Violation|0|||
146182164|NCT01474512|527179461|FG009|Long-Term Extension Period|Protocol Violation|0|||
146182165|NCT01474512|527179462|FG010|Long-Term Extension Period|Protocol Violation|0|||
146182166|NCT01474512|527179463|FG011|Long-Term Extension Period|Protocol Violation|0|||
146182167|NCT01474512|527179464|FG012|Long-Term Extension Period|Protocol Violation|5|||
146182168|NCT01474512|527179465|FG013|Long-Term Extension Period|Protocol Violation|5|||
146182169|NCT01474512|527179466|FG014|Long-Term Extension Period|Protocol Violation|0|||
146182170|NCT01474512|527179467|FG015|Long-Term Extension Period|Protocol Violation|0|||
146182171|NCT01474512|527179468|FG016|Long-Term Extension Period|Protocol Violation|0|||
146182172|NCT01474512|527179469|FG017|Long-Term Extension Period|Protocol Violation|0|||
146182173|NCT01474512|527179452|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182174|NCT01474512|527179453|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182175|NCT01474512|527179454|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182176|NCT01474512|527179455|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182177|NCT01474512|527179456|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182178|NCT01474512|527179457|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182179|NCT01474512|527179458|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182180|NCT01474512|527179459|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182181|NCT01474512|527179460|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182182|NCT01474512|527179461|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182183|NCT01474512|527179462|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182184|NCT01474512|527179463|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182185|NCT01474512|527179464|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
146182186|NCT01474512|527179465|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
146182187|NCT01474512|527179466|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182188|NCT01474512|527179467|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182189|NCT01474512|527179468|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182190|NCT01474512|527179469|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
146182191|NCT01474512|527179452|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182192|NCT01474512|527179453|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182193|NCT01474512|527179454|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182194|NCT01474512|527179455|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182195|NCT01474512|527179456|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182196|NCT01474512|527179457|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182197|NCT01474512|527179458|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182198|NCT01474512|527179459|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182199|NCT01474512|527179460|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182200|NCT01474512|527179461|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182201|NCT01474512|527179462|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182202|NCT01474512|527179463|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
146182203|NCT01474512|527179464|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182204|NCT01474512|527179465|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182205|NCT01474512|527179466|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182206|NCT01474512|527179467|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182207|NCT01474512|527179468|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182208|NCT01474512|527179469|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
146182209|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
146182210|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
146182211|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
146182212|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
146182213|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
146182214|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
146182215|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
146182216|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
146182217|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
146182218|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
146182219|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
146182220|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
146182221|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
146182222|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
146182223|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
146182224|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
146182225|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
146182226|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
146182227|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182228|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182229|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182230|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182231|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182232|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182233|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182234|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182235|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182236|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182237|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182238|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182239|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182240|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
146182241|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
146080178|NCT03642132|526814601|FG002|Follow-up Period|Study terminated by sponsor|1|||
146080179|NCT03642132|526814599|FG000|Follow-up Period|Lack of Efficacy|1|||
146080180|NCT03642132|526814600|FG001|Follow-up Period|Lack of Efficacy|0|||
146080181|NCT03642132|526814601|FG002|Follow-up Period|Lack of Efficacy|0|||
146080182|NCT03642132|526814599|FG000|Follow-up Period|Death|1|||
146080183|NCT03642132|526814600|FG001|Follow-up Period|Death|0|||
146080184|NCT03642132|526814601|FG002|Follow-up Period|Death|2|||
146080185|NCT03642132|526814599|FG000|Follow-up Period|Adverse Event|1|||
146080186|NCT03642132|526814600|FG001|Follow-up Period|Adverse Event|0|||
146080187|NCT03642132|526814601|FG002|Follow-up Period|Adverse Event|0|||
146080188|NCT02577887|526814603|FG000|Overall Study|Death|93|||
146080189|NCT02577887|526814603|FG000|Overall Study|Protocol Violation|125|||
146080190|NCT02577887|526814603|FG000|Overall Study|Withdrawal by Subject|80|||
146080191|NCT00913458|526814604|FG000|Phase 1|Non-Responder|54|||
146080192|NCT00913458|526814605|FG001|Phase 1|Non-Responder|0|||
146080193|NCT00913458|526814606|FG002|Phase 1|Non-Responder|0|||
146080194|NCT00913458|526814607|FG003|Phase 1|Non-Responder|0|||
146080195|NCT00913458|526814608|FG004|Phase 1|Non-Responder|0|||
146080196|NCT00913458|526814609|FG005|Phase 1|Non-Responder|0|||
146080197|NCT00913458|526814610|FG006|Phase 1|Non-Responder|0|||
146080198|NCT00913458|526814604|FG000|Phase 1|Subject Request|17|||
146080199|NCT00913458|526814605|FG001|Phase 1|Subject Request|0|||
146080200|NCT00913458|526814606|FG002|Phase 1|Subject Request|0|||
146080201|NCT00913458|526814607|FG003|Phase 1|Subject Request|0|||
146080202|NCT00913458|526814608|FG004|Phase 1|Subject Request|0|||
146080203|NCT00913458|526814609|FG005|Phase 1|Subject Request|0|||
146080204|NCT00913458|526814610|FG006|Phase 1|Subject Request|0|||
146080205|NCT00913458|526814604|FG000|Phase 1|Adverse Event|20|||
146080206|NCT00913458|526814605|FG001|Phase 1|Adverse Event|0|||
146080207|NCT00913458|526814606|FG002|Phase 1|Adverse Event|0|||
146080208|NCT00913458|526814607|FG003|Phase 1|Adverse Event|0|||
146080209|NCT00913458|526814608|FG004|Phase 1|Adverse Event|0|||
146080210|NCT00913458|526814609|FG005|Phase 1|Adverse Event|0|||
146080211|NCT00913458|526814610|FG006|Phase 1|Adverse Event|0|||
146080212|NCT00913458|526814604|FG000|Phase 1|Lost to Follow-up|2|||
146080213|NCT00913458|526814605|FG001|Phase 1|Lost to Follow-up|0|||
146080214|NCT00913458|526814606|FG002|Phase 1|Lost to Follow-up|0|||
146080215|NCT00913458|526814607|FG003|Phase 1|Lost to Follow-up|0|||
146080216|NCT00913458|526814608|FG004|Phase 1|Lost to Follow-up|0|||
146080217|NCT00913458|526814609|FG005|Phase 1|Lost to Follow-up|0|||
146080218|NCT00913458|526814610|FG006|Phase 1|Lost to Follow-up|0|||
146080219|NCT00913458|526814604|FG000|Phase 1|Protocol Violation|10|||
146080220|NCT00913458|526814605|FG001|Phase 1|Protocol Violation|0|||
146080221|NCT00913458|526814606|FG002|Phase 1|Protocol Violation|0|||
146080222|NCT00913458|526814607|FG003|Phase 1|Protocol Violation|0|||
146080223|NCT00913458|526814608|FG004|Phase 1|Protocol Violation|0|||
146080224|NCT00913458|526814609|FG005|Phase 1|Protocol Violation|0|||
146080225|NCT00913458|526814610|FG006|Phase 1|Protocol Violation|0|||
146080226|NCT00913458|526814604|FG000|Phase 1|Sponsor|2|||
146080227|NCT00913458|526814605|FG001|Phase 1|Sponsor|0|||
146080228|NCT00913458|526814606|FG002|Phase 1|Sponsor|0|||
146080229|NCT00913458|526814607|FG003|Phase 1|Sponsor|0|||
146080230|NCT00913458|526814608|FG004|Phase 1|Sponsor|0|||
146080231|NCT00913458|526814609|FG005|Phase 1|Sponsor|0|||
146080232|NCT00913458|526814610|FG006|Phase 1|Sponsor|0|||
146080233|NCT00913458|526814604|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
146080234|NCT00913458|526814605|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
146080235|NCT00913458|526814606|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
146080236|NCT00913458|526814607|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
146080237|NCT00913458|526814608|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
146080238|NCT00913458|526814609|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
146080239|NCT00913458|526814610|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
146182242|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
146080240|NCT00913458|526814604|FG000|Phase 2|Non-Responder|0|||
146080241|NCT00913458|526814605|FG001|Phase 2|Non-Responder|5|||
146080242|NCT00913458|526814606|FG002|Phase 2|Non-Responder|7|||
146080243|NCT00913458|526814607|FG003|Phase 2|Non-Responder|12|||
146080244|NCT00913458|526814608|FG004|Phase 2|Non-Responder|0|||
146080245|NCT00913458|526814609|FG005|Phase 2|Non-Responder|0|||
146080246|NCT00913458|526814610|FG006|Phase 2|Non-Responder|0|||
146080247|NCT00913458|526814604|FG000|Phase 2|Subject Request|0|||
146080248|NCT00913458|526814605|FG001|Phase 2|Subject Request|0|||
146182243|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
146080249|NCT00913458|526814606|FG002|Phase 2|Subject Request|1|||
146080250|NCT00913458|526814607|FG003|Phase 2|Subject Request|2|||
146080251|NCT00913458|526814608|FG004|Phase 2|Subject Request|0|||
146080252|NCT00913458|526814609|FG005|Phase 2|Subject Request|0|||
146080253|NCT00913458|526814610|FG006|Phase 2|Subject Request|0|||
146080254|NCT00913458|526814604|FG000|Phase 2|Adverse Event|0|||
146080255|NCT00913458|526814605|FG001|Phase 2|Adverse Event|3|||
146080256|NCT00913458|526814606|FG002|Phase 2|Adverse Event|0|||
146080257|NCT00913458|526814607|FG003|Phase 2|Adverse Event|1|||
146080258|NCT00913458|526814608|FG004|Phase 2|Adverse Event|0|||
146080259|NCT00913458|526814609|FG005|Phase 2|Adverse Event|0|||
146080260|NCT00913458|526814610|FG006|Phase 2|Adverse Event|0|||
146080261|NCT00913458|526814604|FG000|Phase 2|Lost to Follow-up|0|||
146080262|NCT00913458|526814605|FG001|Phase 2|Lost to Follow-up|0|||
146080263|NCT00913458|526814606|FG002|Phase 2|Lost to Follow-up|0|||
146080264|NCT00913458|526814607|FG003|Phase 2|Lost to Follow-up|1|||
146080265|NCT00913458|526814608|FG004|Phase 2|Lost to Follow-up|0|||
146080266|NCT00913458|526814609|FG005|Phase 2|Lost to Follow-up|0|||
146080267|NCT00913458|526814610|FG006|Phase 2|Lost to Follow-up|0|||
146080268|NCT00913458|526814604|FG000|Phase 2|Protocol Violation|0|||
146080269|NCT00913458|526814605|FG001|Phase 2|Protocol Violation|2|||
146080270|NCT00913458|526814606|FG002|Phase 2|Protocol Violation|0|||
146080271|NCT00913458|526814607|FG003|Phase 2|Protocol Violation|0|||
146080272|NCT00913458|526814608|FG004|Phase 2|Protocol Violation|0|||
146080273|NCT00913458|526814609|FG005|Phase 2|Protocol Violation|0|||
146080274|NCT00913458|526814610|FG006|Phase 2|Protocol Violation|0|||
146080275|NCT00913458|526814604|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
146080276|NCT00913458|526814605|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
146080277|NCT00913458|526814606|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
146080278|NCT00913458|526814607|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
146080279|NCT00913458|526814608|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
146080280|NCT00913458|526814609|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
146080281|NCT00913458|526814610|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
146080282|NCT00913458|526814604|FG000|Phase 3|Adverse Event|0|||
146080283|NCT00913458|526814605|FG001|Phase 3|Adverse Event|0|||
146080284|NCT00913458|526814606|FG002|Phase 3|Adverse Event|0|||
146080285|NCT00913458|526814607|FG003|Phase 3|Adverse Event|0|||
146080286|NCT00913458|526814608|FG004|Phase 3|Adverse Event|5|||
146080287|NCT00913458|526814609|FG005|Phase 3|Adverse Event|4|||
146080288|NCT00913458|526814610|FG006|Phase 3|Adverse Event|1|||
146080289|NCT00913458|526814604|FG000|Phase 3|Lost to Follow-up|0|||
146080290|NCT00913458|526814605|FG001|Phase 3|Lost to Follow-up|0|||
146080291|NCT00913458|526814606|FG002|Phase 3|Lost to Follow-up|0|||
146080292|NCT00913458|526814607|FG003|Phase 3|Lost to Follow-up|0|||
146080293|NCT00913458|526814608|FG004|Phase 3|Lost to Follow-up|2|||
146080294|NCT00913458|526814609|FG005|Phase 3|Lost to Follow-up|0|||
146080295|NCT00913458|526814610|FG006|Phase 3|Lost to Follow-up|0|||
146080296|NCT00913458|526814604|FG000|Phase 3|Non-Responder|0|||
146080297|NCT00913458|526814605|FG001|Phase 3|Non-Responder|0|||
146080298|NCT00913458|526814606|FG002|Phase 3|Non-Responder|0|||
146080299|NCT00913458|526814607|FG003|Phase 3|Non-Responder|0|||
146080300|NCT00913458|526814608|FG004|Phase 3|Non-Responder|0|||
146080301|NCT00913458|526814609|FG005|Phase 3|Non-Responder|1|||
146080302|NCT00913458|526814610|FG006|Phase 3|Non-Responder|3|||
146080303|NCT00913458|526814604|FG000|Phase 3|Withdrawal by Subject|0|||
146080304|NCT00913458|526814605|FG001|Phase 3|Withdrawal by Subject|0|||
146080305|NCT00913458|526814606|FG002|Phase 3|Withdrawal by Subject|0|||
146080306|NCT00913458|526814607|FG003|Phase 3|Withdrawal by Subject|0|||
146080307|NCT00913458|526814608|FG004|Phase 3|Withdrawal by Subject|1|||
146080308|NCT00913458|526814609|FG005|Phase 3|Withdrawal by Subject|2|||
146080309|NCT00913458|526814610|FG006|Phase 3|Withdrawal by Subject|0|||
146080310|NCT00913458|526814604|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
146080311|NCT00913458|526814605|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
146182244|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
146182245|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182246|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182247|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182248|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182249|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182250|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182251|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182252|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182253|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182254|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182255|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182256|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182257|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146182258|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
146412373|NCT02544633|528015506|FG003|Treatment Period|Non-compliance|0|||
146080312|NCT00913458|526814606|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
146080313|NCT00913458|526814607|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
146080314|NCT00913458|526814608|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
146080315|NCT00913458|526814609|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
146080316|NCT00913458|526814610|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
146080317|NCT02366091|526814611|FG000|Overall Study|Withdrawal by Subject|3|||
146080318|NCT02366091|526814612|FG001|Overall Study|Withdrawal by Subject|7|||
146080319|NCT02366091|526814613|FG002|Overall Study|Withdrawal by Subject|3|||
146080320|NCT02366091|526814614|FG003|Overall Study|Withdrawal by Subject|1|||
146080321|NCT03595618|526814615|FG000|Overall Study|Adverse Event|16|||
146080322|NCT03595618|526814616|FG001|Overall Study|Adverse Event|17|||
146080323|NCT03595618|526814617|FG002|Overall Study|Adverse Event|20|||
146080324|NCT03595618|526814618|FG003|Overall Study|Adverse Event|8|||
146080325|NCT03595618|526814615|FG000|Overall Study|Withdrawal by Subject|12|||
146080326|NCT03595618|526814616|FG001|Overall Study|Withdrawal by Subject|14|||
146080327|NCT03595618|526814617|FG002|Overall Study|Withdrawal by Subject|14|||
146080328|NCT03595618|526814618|FG003|Overall Study|Withdrawal by Subject|10|||
146080329|NCT03595618|526814615|FG000|Overall Study|Lost to Follow-up|6|||
146080330|NCT03595618|526814616|FG001|Overall Study|Lost to Follow-up|4|||
146080331|NCT03595618|526814617|FG002|Overall Study|Lost to Follow-up|5|||
146080332|NCT03595618|526814618|FG003|Overall Study|Lost to Follow-up|6|||
146080333|NCT03595618|526814615|FG000|Overall Study|Protocol Violation|2|||
146080334|NCT03595618|526814616|FG001|Overall Study|Protocol Violation|0|||
146080335|NCT03595618|526814617|FG002|Overall Study|Protocol Violation|6|||
146080336|NCT03595618|526814618|FG003|Overall Study|Protocol Violation|2|||
146080337|NCT03595618|526814615|FG000|Overall Study|Physician Decision|0|||
146080338|NCT03595618|526814616|FG001|Overall Study|Physician Decision|0|||
146080339|NCT03595618|526814617|FG002|Overall Study|Physician Decision|1|||
146080340|NCT03595618|526814618|FG003|Overall Study|Physician Decision|2|||
146080341|NCT03595618|526814615|FG000|Overall Study|Miscellaneous|7|||
146080342|NCT03595618|526814616|FG001|Overall Study|Miscellaneous|5|||
146080343|NCT03595618|526814617|FG002|Overall Study|Miscellaneous|10|||
146080344|NCT03595618|526814618|FG003|Overall Study|Miscellaneous|6|||
146080345|NCT02338232|526814619|FG000|Overall Study|Screen Failure|3|||
146080346|NCT02338232|526814619|FG000|Overall Study|Withdrawal by Subject|6|||
146080347|NCT02338232|526814619|FG000|Overall Study|Adverse Event|2|||
146080348|NCT02279407|526814620|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
146080349|NCT02279407|526814621|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
146080350|NCT02279407|526814622|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
146080351|NCT02279407|526814623|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
146080352|NCT02279407|526814620|FG000|Overall Study|Withdrawal by Subject|1|||
146080353|NCT02279407|526814621|FG001|Overall Study|Withdrawal by Subject|0|||
146080354|NCT02279407|526814622|FG002|Overall Study|Withdrawal by Subject|1|||
146080355|NCT02279407|526814623|FG003|Overall Study|Withdrawal by Subject|1|||
146080356|NCT02279407|526814620|FG000|Overall Study|Adverse Event|1|||
146080357|NCT02279407|526814621|FG001|Overall Study|Adverse Event|1|||
146080358|NCT02279407|526814622|FG002|Overall Study|Adverse Event|2|||
146080359|NCT02279407|526814623|FG003|Overall Study|Adverse Event|0|||
146080360|NCT02500056|526814624|FG000|Overall Study|Lost to Follow-up|3|||
146080361|NCT02500056|526814625|FG001|Overall Study|Lost to Follow-up|7|||
146080362|NCT02500056|526814624|FG000|Overall Study|Recurrence|1|||
146080363|NCT02500056|526814625|FG001|Overall Study|Recurrence|0|||
146080364|NCT02500056|526814624|FG000|Overall Study|Death|3|||
146080365|NCT02500056|526814625|FG001|Overall Study|Death|1|||
146080366|NCT03890666|526814627|FG000|Overall Study|Withdrawal by Subject|0|||
146080367|NCT03890666|526814628|FG001|Overall Study|Withdrawal by Subject|1|||
146080368|NCT03890666|526814627|FG000|Overall Study|Protocol deviation|1|||
146080369|NCT03890666|526814628|FG001|Overall Study|Protocol deviation|4|||
146080370|NCT03890666|526814627|FG000|Overall Study|Lost to Follow-up|2|||
146080371|NCT03890666|526814628|FG001|Overall Study|Lost to Follow-up|5|||
146182259|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
146182260|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
146182261|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
146182262|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
146182263|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182264|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182265|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182266|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182267|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182268|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182269|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182270|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182271|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182272|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182273|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182274|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182275|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182276|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182277|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182278|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
146182279|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
146182280|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
146182281|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
146182282|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
146182283|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
146182284|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
146182285|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
146182286|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
146182287|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
146182288|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
146182289|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
146182290|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
146182291|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
146182292|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
146182293|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
146182294|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
146182295|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
146182296|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
146182297|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
146182298|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
146182299|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182300|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182301|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182302|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182303|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182304|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182305|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182306|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182307|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182308|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182309|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182310|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182311|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182312|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182313|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182314|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
146182315|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
146182316|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
146182317|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
146182318|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
146182319|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
146182320|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
146182321|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
146182322|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
146182323|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
146182324|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
146182325|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
146182326|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
146182327|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
146182328|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
146182329|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
146182330|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
146080372|NCT03890666|526814627|FG000|Overall Study|Other than specified|1|||
146080373|NCT03890666|526814628|FG001|Overall Study|Other than specified|8|||
146080374|NCT01105065|526814629|FG000|Overall Study|Adverse Event|5|||
146080375|NCT01105065|526814629|FG000|Overall Study|Technical Problems|1|||
146080376|NCT01155011|526814634|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
146080377|NCT01155011|526814635|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
146080378|NCT01155011|526814634|FG000|Baseline to 6 Months|investigator decision, moved|4|||
146080379|NCT01155011|526814635|FG001|Baseline to 6 Months|investigator decision, moved|5|||
146080380|NCT01155011|526814634|FG000|Baseline to 6 Months|Death|0|||
146080381|NCT01155011|526814635|FG001|Baseline to 6 Months|Death|1|||
146080382|NCT01155011|526814634|FG000|6 to 12 Months|Withdrawal by Subject|8|||
146080383|NCT01155011|526814635|FG001|6 to 12 Months|Withdrawal by Subject|5|||
146080384|NCT01155011|526814634|FG000|6 to 12 Months|Death|1|||
146080385|NCT01155011|526814635|FG001|6 to 12 Months|Death|5|||
146080386|NCT04620798|526814638|FG000|Overall Study|Lost to Follow-up|126|||
146080387|NCT04620798|526814639|FG001|Overall Study|Lost to Follow-up|138|||
146080388|NCT01960907|526814640|FG000|Overall Study|Death|4|||
146080389|NCT01960907|526814641|FG001|Overall Study|Death|3|||
146080390|NCT01960907|526814640|FG000|Overall Study|Withdrawal by Subject|32|||
146080391|NCT01960907|526814641|FG001|Overall Study|Withdrawal by Subject|42|||
146080392|NCT03288142|526814649|FG000|Overall Study|Lost to Follow-up|22|||
146080393|NCT03288142|526814650|FG001|Overall Study|Lost to Follow-up|15|||
146080394|NCT01214395|526814653|FG000|Overall Study|All patients had infection|5|||
146080395|NCT02034409|526814654|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
146080396|NCT02034409|526814655|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
146080397|NCT02034409|526814654|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
146080398|NCT02034409|526814655|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
146080399|NCT02034409|526814654|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
146080400|NCT02034409|526814655|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
146080401|NCT02034409|526814654|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
146080402|NCT02034409|526814655|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
146080403|NCT02034409|526814654|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
146080404|NCT02034409|526814655|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
146080405|NCT02034409|526814654|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
146080406|NCT02034409|526814655|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
146080407|NCT00934843|526814656|FG000|Overall Study|Protocol Violation|0|||
146080408|NCT00934843|526814657|FG001|Overall Study|Protocol Violation|1|||
146080409|NCT00831493|526814660|FG000|Overall Study|Intractable nausea and vomiting|1|||
146080410|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146080411|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
146080412|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146080413|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
146080414|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146080415|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
146080416|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
146080417|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
146080418|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
146080419|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
146080420|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080421|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
146080422|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080423|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080424|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080425|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080426|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080427|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
146080428|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
146080429|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
146080430|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
146080431|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
146080432|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
146182331|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
146182332|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
146182333|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
146182334|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
146182335|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182336|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182337|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182338|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182339|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182340|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182341|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182342|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182343|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182344|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182345|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182346|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182347|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182348|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182349|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
146182350|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182351|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
146182352|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
146182353|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182354|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182355|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182356|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182357|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182358|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182359|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182360|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182361|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182362|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182363|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182364|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182365|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182366|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182367|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
146182368|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182369|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
146182370|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
146182371|NCT01474512|527179452|FG000|Post-Treatment Follow-Up|Death|0|||
146182372|NCT01474512|527179453|FG001|Post-Treatment Follow-Up|Death|0|||
146182373|NCT01474512|527179454|FG002|Post-Treatment Follow-Up|Death|0|||
146182374|NCT01474512|527179455|FG003|Post-Treatment Follow-Up|Death|0|||
146182375|NCT01474512|527179456|FG004|Post-Treatment Follow-Up|Death|0|||
146182376|NCT01474512|527179457|FG005|Post-Treatment Follow-Up|Death|0|||
146182377|NCT01474512|527179458|FG006|Post-Treatment Follow-Up|Death|0|||
146182378|NCT01474512|527179459|FG007|Post-Treatment Follow-Up|Death|0|||
146182379|NCT01474512|527179460|FG008|Post-Treatment Follow-Up|Death|0|||
146182380|NCT01474512|527179461|FG009|Post-Treatment Follow-Up|Death|0|||
146182381|NCT01474512|527179462|FG010|Post-Treatment Follow-Up|Death|0|||
146182382|NCT01474512|527179463|FG011|Post-Treatment Follow-Up|Death|0|||
146182383|NCT01474512|527179464|FG012|Post-Treatment Follow-Up|Death|0|||
146182384|NCT01474512|527179465|FG013|Post-Treatment Follow-Up|Death|0|||
146182385|NCT01474512|527179466|FG014|Post-Treatment Follow-Up|Death|0|||
146182386|NCT01474512|527179467|FG015|Post-Treatment Follow-Up|Death|0|||
146182387|NCT01474512|527179468|FG016|Post-Treatment Follow-Up|Death|1|||
146182388|NCT01474512|527179469|FG017|Post-Treatment Follow-Up|Death|0|||
146182389|NCT01118962|527179474|FG000|Overall Study|Adverse Event|2|||
146182390|NCT01118962|527179474|FG000|Overall Study|Lack of Efficacy|1|||
146182391|NCT01118962|527179474|FG000|Overall Study|Protocol Violation|1|||
146182392|NCT01118962|527179474|FG000|Overall Study|Withdrawal by Subject|4|||
146182393|NCT01118962|527179474|FG000|Overall Study|Pregnancy|1|||
146182394|NCT01118962|527179474|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
146182395|NCT00506285|527179477|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
146182396|NCT00506285|527179478|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
146182397|NCT00506285|527179477|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
146182398|NCT00506285|527179478|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
146182399|NCT00506285|527179477|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
146182400|NCT00506285|527179478|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
146182401|NCT00506285|527179477|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
146182402|NCT00506285|527179478|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
146182403|NCT00506285|527179477|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
146182404|NCT00506285|527179478|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
146182405|NCT00551213|527179479|FG000|Overall Study|Adverse Event|6|||
146182406|NCT00551213|527179480|FG001|Overall Study|Adverse Event|3|||
146182407|NCT00551213|527179479|FG000|Overall Study|Progressive Disease|41|||
146182408|NCT00551213|527179480|FG001|Overall Study|Progressive Disease|12|||
146182409|NCT00551213|527179479|FG000|Overall Study|Withdrawal by Subject|2|||
146182410|NCT00551213|527179480|FG001|Overall Study|Withdrawal by Subject|0|||
146182411|NCT00551213|527179479|FG000|Overall Study|Not Treated|1|||
146182412|NCT00551213|527179480|FG001|Overall Study|Not Treated|2|||
146182413|NCT01254565|527179488|FG000|Overall Study|Non-compliance to Study Procedures|0|||
146182414|NCT01254565|527179489|FG001|Overall Study|Non-compliance to Study Procedures|0|||
146182415|NCT01254565|527179490|FG002|Overall Study|Non-compliance to Study Procedures|0|||
146182416|NCT01254565|527179491|FG003|Overall Study|Non-compliance to Study Procedures|0|||
146182417|NCT01254565|527179492|FG004|Overall Study|Non-compliance to Study Procedures|1|||
146182418|NCT01254565|527179493|FG005|Overall Study|Non-compliance to Study Procedures|0|||
146182419|NCT01254565|527179488|FG000|Overall Study|Did not Receive Treatment|1|||
146182420|NCT01254565|527179489|FG001|Overall Study|Did not Receive Treatment|1|||
146182421|NCT01254565|527179490|FG002|Overall Study|Did not Receive Treatment|0|||
146182422|NCT01254565|527179491|FG003|Overall Study|Did not Receive Treatment|0|||
146182423|NCT01254565|527179492|FG004|Overall Study|Did not Receive Treatment|3|||
146182424|NCT01254565|527179493|FG005|Overall Study|Did not Receive Treatment|4|||
146182425|NCT01254565|527179488|FG000|Overall Study|Other|0|||
146080433|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
146080434|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
146080435|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
146080436|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
146080437|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|Other|0|||
146080438|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|Other|0|||
146080439|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|Other|1|||
146080440|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|Other|1|||
146080441|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|Other|0|||
146080442|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|Other|0|||
146080443|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|Other|0|||
146080444|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|Other|1|||
146080445|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|Other|0|||
146080446|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|Death|0|||
146080447|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|Death|0|||
146080448|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|Death|0|||
146080449|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|Death|0|||
146080450|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|Death|0|||
146080451|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|Death|1|||
146080452|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|Death|0|||
146080453|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|Death|0|||
146080454|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|Death|0|||
146080455|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080456|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080457|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080458|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080459|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080460|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
146080461|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
146080462|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080463|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
146080464|NCT00557856|526814663|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
146080465|NCT00557856|526814664|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080466|NCT00557856|526814665|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080467|NCT00557856|526814666|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080468|NCT00557856|526814667|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080469|NCT00557856|526814668|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080470|NCT00557856|526814669|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080471|NCT00557856|526814670|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080472|NCT00557856|526814671|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
146080473|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080474|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080475|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080476|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080477|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080478|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
146182426|NCT01254565|527179489|FG001|Overall Study|Other|0|||
146182427|NCT01254565|527179490|FG002|Overall Study|Other|0|||
146182428|NCT01254565|527179491|FG003|Overall Study|Other|1|||
146182429|NCT01254565|527179492|FG004|Overall Study|Other|0|||
146182430|NCT01254565|527179493|FG005|Overall Study|Other|0|||
146182431|NCT02726399|527179494|FG000|Overall Study|Participant Non-Compliance|1|||
146182432|NCT02726399|527179494|FG000|Overall Study|Adverse Event|2|||
146182433|NCT02726399|527179494|FG000|Overall Study|Progression of disease|4|||
146182434|NCT04747275|527179495|FG000|Overall Study|Study terminated|0|||
146182435|NCT04747275|527179496|FG001|Overall Study|Study terminated|1|||
146182436|NCT03268590|527179499|FG000|Overall Study|Previously unknown exclusion criteria|1|||
146080479|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080480|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
146080481|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
146080482|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080483|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080484|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080485|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080486|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080487|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080488|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080489|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
146080490|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
146080491|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
146080492|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
146080493|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
146080494|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
146080495|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
146080496|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
146080497|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
146080498|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
146080499|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
146080500|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|Other|0|||
146080501|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|Other|0|||
146080502|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|Other|0|||
146080503|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|Other|0|||
146080504|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|Other|0|||
146080505|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|Other|0|||
146080506|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|Other|0|||
146080507|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|Other|0|||
146080508|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|Other|1|||
146080509|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|Death|0|||
146080510|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|Death|0|||
146080511|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|Death|0|||
146080512|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|Death|0|||
146080513|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|Death|0|||
146080514|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|Death|0|||
146080515|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|Death|0|||
146080516|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|Death|0|||
146080517|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|Death|2|||
146080518|NCT00557856|526814663|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080519|NCT00557856|526814664|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080520|NCT00557856|526814665|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080521|NCT00557856|526814666|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080522|NCT00557856|526814667|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080523|NCT00557856|526814668|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080524|NCT00557856|526814669|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080525|NCT00557856|526814670|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
146080526|NCT00557856|526814671|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
146080527|NCT05092360|526814672|FG000|Overall Study|Withdrawal by Subject|21|||
146080528|NCT05092360|526814673|FG001|Overall Study|Withdrawal by Subject|4|||
146080529|NCT05092360|526814674|FG002|Overall Study|Withdrawal by Subject|9|||
146080530|NCT05092360|526814675|FG003|Overall Study|Withdrawal by Subject|26|||
146080531|NCT05092360|526814672|FG000|Overall Study|Death|97|||
146080532|NCT05092360|526814673|FG001|Overall Study|Death|14|||
146080533|NCT05092360|526814674|FG002|Overall Study|Death|31|||
146080534|NCT05092360|526814675|FG003|Overall Study|Death|101|||
146080535|NCT05092360|526814672|FG000|Overall Study|Lost to Follow-up|1|||
146080536|NCT05092360|526814673|FG001|Overall Study|Lost to Follow-up|2|||
146080537|NCT05092360|526814674|FG002|Overall Study|Lost to Follow-up|2|||
146182437|NCT00531011|527179500|FG000|Overall Study|Withdrawal by Subject|2|||
146182438|NCT00531011|527179501|FG001|Overall Study|Withdrawal by Subject|4|||
146182439|NCT00531011|527179500|FG000|Overall Study|Death|1|||
146182440|NCT00531011|527179501|FG001|Overall Study|Death|0|||
146182441|NCT00531011|527179500|FG000|Overall Study|Lost to Follow-up|1|||
146182442|NCT00531011|527179501|FG001|Overall Study|Lost to Follow-up|0|||
146182443|NCT00531011|527179500|FG000|Overall Study|Physician Decision|0|||
146182444|NCT00531011|527179501|FG001|Overall Study|Physician Decision|3|||
146182445|NCT02206152|527179504|FG000|Pre-Randomization|Withdrawal by Subject|2|||
146182446|NCT02080520|527179505|FG000|Overall Study|Self-reported symptoms|5|||
146182447|NCT02080520|527179506|FG001|Overall Study|Self-reported symptoms|6|||
146182448|NCT02080520|527179505|FG000|Overall Study|Unable to contact|2|||
146182449|NCT02080520|527179506|FG001|Overall Study|Unable to contact|1|||
146182450|NCT02080520|527179505|FG000|Overall Study|Initiated aspirin|2|||
146182451|NCT02080520|527179506|FG001|Overall Study|Initiated aspirin|0|||
146182452|NCT02080520|527179505|FG000|Overall Study|Atrial fibrillation|1|||
146182453|NCT02080520|527179506|FG001|Overall Study|Atrial fibrillation|1|||
146182454|NCT02080520|527179505|FG000|Overall Study|Cancer|1|||
146182455|NCT02080520|527179506|FG001|Overall Study|Cancer|2|||
146182456|NCT02080520|527179505|FG000|Overall Study|Not interested in study|1|||
146182457|NCT02080520|527179506|FG001|Overall Study|Not interested in study|3|||
146182458|NCT02080520|527179505|FG000|Overall Study|Too busy|1|||
146182459|NCT02080520|527179506|FG001|Overall Study|Too busy|1|||
146182460|NCT02080520|527179505|FG000|Overall Study|Work-related injury|1|||
146182461|NCT02080520|527179506|FG001|Overall Study|Work-related injury|0|||
146182462|NCT02080520|527179505|FG000|Overall Study|Personal reasons|0|||
146182463|NCT02080520|527179506|FG001|Overall Study|Personal reasons|3|||
146182464|NCT00390455|527179508|FG000|Overall Study|Adverse Event|17|||
146182465|NCT00390455|527179509|FG001|Overall Study|Adverse Event|3|||
146182466|NCT00390455|527179508|FG000|Overall Study|Withdrawal by Subject|8|||
146182467|NCT00390455|527179509|FG001|Overall Study|Withdrawal by Subject|8|||
146182468|NCT00390455|527179508|FG000|Overall Study|Alternate Treatment|0|||
146182469|NCT00390455|527179509|FG001|Overall Study|Alternate Treatment|1|||
146182470|NCT00390455|527179508|FG000|Overall Study|Other Medical Reasons|7|||
146182471|NCT00390455|527179509|FG001|Overall Study|Other Medical Reasons|11|||
146182472|NCT00794820|527179512|FG000|Overall Study|Adverse Event|11|||
146182473|NCT00794820|527179512|FG000|Overall Study|Secondary Malignancies|2|||
146182474|NCT00794820|527179512|FG000|Overall Study|Resistant Disease|2|||
146182475|NCT00794820|527179512|FG000|Overall Study|Ineligible/Screen Failure|1|||
146182476|NCT04076020|527179514|FG000|Overall Study|Death|4|||
146182477|NCT04076020|527179515|FG001|Overall Study|Death|6|||
146182478|NCT04076020|527179514|FG000|Overall Study|Withdrawal by Subject|12|||
146182479|NCT04076020|527179515|FG001|Overall Study|Withdrawal by Subject|8|||
146182480|NCT02406261|527179517|FG000|Period 1|Lost to Follow-up|2|||
146182481|NCT02406261|527179518|FG001|Period 1|Lost to Follow-up|0|||
146182482|NCT02406261|527179517|FG000|Period 1|Adverse Event|1|||
146182483|NCT02406261|527179518|FG001|Period 1|Adverse Event|0|||
146182484|NCT02406261|527179517|FG000|Period 2|Physician Decision|0|||
146182485|NCT02406261|527179518|FG001|Period 2|Physician Decision|1|||
146182486|NCT02406261|527179517|FG000|Period 2|Protocol Violation|0|||
146182487|NCT02406261|527179518|FG001|Period 2|Protocol Violation|1|||
146182488|NCT02406261|527179517|FG000|Period 2|Withdrawal by Subject|0|||
146182489|NCT02406261|527179518|FG001|Period 2|Withdrawal by Subject|1|||
146182490|NCT01591460|527179521|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
146182491|NCT01591460|527179521|FG000|Overall Study|Futility Rule (Week 12)|7|||
146182492|NCT01591460|527179521|FG000|Overall Study|Futility Rule (Week 24)|3|||
146182493|NCT01591460|527179521|FG000|Overall Study|Rebound or Breakthrough|3|||
146182494|NCT01591460|527179521|FG000|Overall Study|Treatment Discontinued by Error|1|||
146182495|NCT01591460|527179521|FG000|Overall Study|Lost to Follow-up|1|||
146182496|NCT01591460|527179521|FG000|Overall Study|Noncompliance|1|||
146182497|NCT01591460|527179521|FG000|Overall Study|Participant Refusal|3|||
146182498|NCT01591460|527179521|FG000|Overall Study|Withdrawal by Subject|1|||
146182499|NCT01591460|527179521|FG000|Overall Study|Protocol Violation|1|||
146182500|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
146182501|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
146182502|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
146182503|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
146182504|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146182505|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
146182506|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146182507|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
146182508|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
146182509|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
146182510|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146182511|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
146182512|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
146182513|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
146182514|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146182515|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
146182516|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
146182517|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
146182518|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
146182519|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
146182520|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
146182521|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
146182522|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
146182523|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
146182524|NCT03230864|527179522|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
146182525|NCT03230864|527179523|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146182526|NCT03230864|527179524|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146182527|NCT03230864|527179525|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
146182528|NCT03230864|527179522|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
146182529|NCT03230864|527179523|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
146182530|NCT03230864|527179524|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
146182531|NCT03230864|527179525|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
146182532|NCT03230864|527179522|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146182533|NCT03230864|527179523|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146182534|NCT03230864|527179524|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
146182535|NCT03230864|527179525|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
146182536|NCT03230864|527179522|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146182537|NCT03230864|527179523|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146182538|NCT03230864|527179524|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
146182539|NCT03230864|527179525|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
146182540|NCT00432679|527179530|FG000|Overall Study|Adverse Event|2|||
146182541|NCT00432679|527179531|FG001|Overall Study|Adverse Event|1|||
146182542|NCT00432679|527179530|FG000|Overall Study|Withdrawal by Subject|3|||
146182543|NCT00432679|527179531|FG001|Overall Study|Withdrawal by Subject|2|||
146182544|NCT01686932|527179542|FG000|Period 1|Adverse Event|1|||
146182545|NCT01686932|527179543|FG001|Period 1|Adverse Event|1|||
146182546|NCT01284140|527179544|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
146182547|NCT01284140|527179545|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
146182548|NCT01284140|527179544|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
146182549|NCT01284140|527179545|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
146182550|NCT04147260|527179547|FG000|Overall Study|Adverse Event|1|||
146182551|NCT04147260|527179548|FG001|Overall Study|Adverse Event|0|||
146182552|NCT04147260|527179549|FG002|Overall Study|Adverse Event|1|||
146182553|NCT04147260|527179550|FG003|Overall Study|Adverse Event|2|||
146182554|NCT04147260|527179551|FG004|Overall Study|Adverse Event|0|||
146182555|NCT04147260|527179547|FG000|Overall Study|Withdrawal by Subject|0|||
146182556|NCT04147260|527179548|FG001|Overall Study|Withdrawal by Subject|0|||
146182557|NCT04147260|527179549|FG002|Overall Study|Withdrawal by Subject|1|||
146182558|NCT04147260|527179550|FG003|Overall Study|Withdrawal by Subject|1|||
146182559|NCT04147260|527179551|FG004|Overall Study|Withdrawal by Subject|0|||
146182560|NCT01555021|527179552|FG000|Overall Study|Lost to Follow-up|1|||
146182561|NCT01555021|527179553|FG001|Overall Study|Lost to Follow-up|2|||
146182562|NCT01313923|527179554|FG000|Overall Study|Physician Decision|3|||
146182563|NCT00322374|527179555|FG000|Starting Dose|Physician Decision|2|||
146182564|NCT00322374|527179556|FG001|Starting Dose|Physician Decision|0|||
146182565|NCT00322374|527179557|FG002|Starting Dose|Physician Decision|0|||
146182566|NCT00322374|527179558|FG003|Starting Dose|Physician Decision|0|||
146182567|NCT00322374|527179555|FG000|Starting Dose|Study Drug Toxicity|4|||
146182568|NCT00322374|527179556|FG001|Starting Dose|Study Drug Toxicity|0|||
146182569|NCT00322374|527179557|FG002|Starting Dose|Study Drug Toxicity|0|||
146182570|NCT00322374|527179558|FG003|Starting Dose|Study Drug Toxicity|0|||
146182571|NCT00322374|527179555|FG000|First Escalation|Documented Disease Progression|0|||
146182572|NCT00322374|527179556|FG001|First Escalation|Documented Disease Progression|6|||
146182573|NCT00322374|527179557|FG002|First Escalation|Documented Disease Progression|0|||
146182574|NCT00322374|527179558|FG003|First Escalation|Documented Disease Progression|0|||
146182575|NCT00322374|527179555|FG000|First Escalation|Physician Decision|0|||
146182576|NCT00322374|527179556|FG001|First Escalation|Physician Decision|12|||
146182577|NCT00322374|527179557|FG002|First Escalation|Physician Decision|0|||
146182578|NCT00322374|527179558|FG003|First Escalation|Physician Decision|0|||
146182579|NCT00322374|527179555|FG000|First Escalation|Study Drug Toxicity|0|||
146182580|NCT00322374|527179556|FG001|First Escalation|Study Drug Toxicity|11|||
146182581|NCT00322374|527179557|FG002|First Escalation|Study Drug Toxicity|0|||
146182582|NCT00322374|527179558|FG003|First Escalation|Study Drug Toxicity|0|||
146182583|NCT00322374|527179555|FG000|First Escalation|Participant Request|0|||
146182584|NCT00322374|527179556|FG001|First Escalation|Participant Request|1|||
146182585|NCT00322374|527179557|FG002|First Escalation|Participant Request|0|||
146182586|NCT00322374|527179558|FG003|First Escalation|Participant Request|0|||
146182587|NCT00322374|527179555|FG000|Second Escalation|Physician Decision|0|||
146182588|NCT00322374|527179556|FG001|Second Escalation|Physician Decision|0|||
146182589|NCT00322374|527179557|FG002|Second Escalation|Physician Decision|5|||
146182590|NCT00322374|527179558|FG003|Second Escalation|Physician Decision|0|||
146182591|NCT00322374|527179555|FG000|Second Escalation|Study Drug Toxicity|0|||
146182592|NCT00322374|527179556|FG001|Second Escalation|Study Drug Toxicity|0|||
146182593|NCT00322374|527179557|FG002|Second Escalation|Study Drug Toxicity|1|||
146182594|NCT00322374|527179558|FG003|Second Escalation|Study Drug Toxicity|0|||
146182595|NCT02372058|527179563|FG000|Overall Study|Withdrawal by Subject|3|||
146182596|NCT00903786|527179571|FG000|Overall Study|Physician Decision|6|||
146182597|NCT00903786|527179571|FG000|Overall Study|Lack of Efficacy|5|||
146182598|NCT00903786|527179571|FG000|Overall Study|Reason other than lack of efficacy|4|||
146182599|NCT00845871|527179578|FG000|Assessment Period|Adverse Event|2|||
146182600|NCT00845871|527179578|FG000|Assessment Period|Abnormal laboratory values|1|||
146182601|NCT00845871|527179578|FG000|Assessment Period|Abnormal test procedure results|1|||
146182602|NCT00845871|527179578|FG000|Assessment Period|Patient withdrew consent|3|||
146182603|NCT01857622|527179579|FG000|Overall Study|Adverse Event|5|||
146182604|NCT01857622|527179580|FG001|Overall Study|Adverse Event|0|||
146182605|NCT01857622|527179581|FG002|Overall Study|Adverse Event|2|||
146182606|NCT01857622|527179579|FG000|Overall Study|Physician Decision|1|||
146182607|NCT01857622|527179580|FG001|Overall Study|Physician Decision|0|||
146182608|NCT01857622|527179581|FG002|Overall Study|Physician Decision|0|||
146182609|NCT01857622|527179579|FG000|Overall Study|Protocol Violation|4|||
146182610|NCT01857622|527179580|FG001|Overall Study|Protocol Violation|1|||
146182611|NCT01857622|527179581|FG002|Overall Study|Protocol Violation|0|||
146182612|NCT01857622|527179579|FG000|Overall Study|Withdrawal by Subject|1|||
146182613|NCT01857622|527179580|FG001|Overall Study|Withdrawal by Subject|0|||
146182614|NCT01857622|527179581|FG002|Overall Study|Withdrawal by Subject|0|||
146182615|NCT01291225|527179585|FG000|Overall Study|Lost to Follow-up|85|||
146182616|NCT01291225|527179586|FG001|Overall Study|Lost to Follow-up|39|||
146182617|NCT01267253|527179587|FG000|Overall Study|Ineligible - required test not done|1|||
146182618|NCT01267253|527179587|FG000|Overall Study|Inevaluable-never received study treatme|2|||
146182619|NCT00064025|527179588|FG000|Overall Study|Ineligible|4|||
146182620|NCT00064025|527179588|FG000|Overall Study|Inevaluable|3|||
146182621|NCT02468934|527179589|FG000|Overall Study|Withdrawal by Subject|4|||
146182622|NCT02468934|527179589|FG000|Overall Study|Screen Failure|3|||
146182623|NCT00547911|527179593|FG000|Overall Study|Adverse Event|0|||
146182624|NCT00547911|527179594|FG001|Overall Study|Adverse Event|0|||
146182625|NCT00547911|527179595|FG002|Overall Study|Adverse Event|0|||
146182626|NCT00547911|527179596|FG003|Overall Study|Adverse Event|1|||
146182627|NCT00547911|527179597|FG004|Overall Study|Adverse Event|0|||
146182628|NCT00547911|527179598|FG005|Overall Study|Adverse Event|0|||
146182629|NCT01644474|527179599|FG000|Overall Study|Poor compliance to protocol|1|||
146182630|NCT01644474|527179600|FG001|Overall Study|Poor compliance to protocol|0|||
146182631|NCT01644474|527179599|FG000|Overall Study|Consent withdrawn by participant|0|||
146182632|NCT01644474|527179600|FG001|Overall Study|Consent withdrawn by participant|1|||
146182633|NCT01644474|527179599|FG000|Overall Study|Participant moved|0|||
146182634|NCT01644474|527179600|FG001|Overall Study|Participant moved|1|||
146182635|NCT01644474|527179599|FG000|Overall Study|Adverse Event|4|||
146182636|NCT01644474|527179600|FG001|Overall Study|Adverse Event|5|||
146182637|NCT01644474|527179599|FG000|Overall Study|Site scheduling error|1|||
146182638|NCT01644474|527179600|FG001|Overall Study|Site scheduling error|1|||
146182639|NCT01644474|527179599|FG000|Overall Study|Protocol Violation|1|||
146182640|NCT01644474|527179600|FG001|Overall Study|Protocol Violation|0|||
146182641|NCT01500226|527181539|FG000|Overall Study|Adverse Event|31|||
146182642|NCT01500226|527181540|FG001|Overall Study|Adverse Event|38|||
146182643|NCT01500226|527181539|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
146182644|NCT01500226|527181540|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
146182645|NCT01500226|527181539|FG000|Overall Study|Withdrawal by Subject|93|||
146182646|NCT01500226|527181540|FG001|Overall Study|Withdrawal by Subject|96|||
146182647|NCT01500226|527181539|FG000|Overall Study|Death|12|||
146182648|NCT01500226|527181540|FG001|Overall Study|Death|4|||
146182649|NCT01500226|527181539|FG000|Overall Study|Disease Progression|16|||
146182650|NCT01500226|527181540|FG001|Overall Study|Disease Progression|14|||
146182651|NCT01500226|527181539|FG000|Overall Study|Protocol Violation|53|||
146182652|NCT01500226|527181540|FG001|Overall Study|Protocol Violation|39|||
146182653|NCT01500226|527181539|FG000|Overall Study|Physician Decision|17|||
146182654|NCT01500226|527181540|FG001|Overall Study|Physician Decision|15|||
146182655|NCT01500226|527181539|FG000|Overall Study|Lack of Efficacy|14|||
146182656|NCT01500226|527181540|FG001|Overall Study|Lack of Efficacy|30|||
146182657|NCT01500226|527181539|FG000|Overall Study|Lost to Follow-up|9|||
146182658|NCT01500226|527181540|FG001|Overall Study|Lost to Follow-up|5|||
146182659|NCT01500226|527181539|FG000|Overall Study|Other Reasons|19|||
146182660|NCT01500226|527181540|FG001|Overall Study|Other Reasons|16|||
146182661|NCT04212169|527181541|FG000|Overall Study|Adverse Event|0|||
146182662|NCT04212169|527181542|FG001|Overall Study|Adverse Event|0|||
146182663|NCT04212169|527181543|FG002|Overall Study|Adverse Event|0|||
146182664|NCT04212169|527181544|FG003|Overall Study|Adverse Event|2|||
146182665|NCT04212169|527181541|FG000|Overall Study|Lost to Follow-up|1|||
146182666|NCT04212169|527181542|FG001|Overall Study|Lost to Follow-up|0|||
146182667|NCT04212169|527181543|FG002|Overall Study|Lost to Follow-up|0|||
146182668|NCT04212169|527181544|FG003|Overall Study|Lost to Follow-up|2|||
146182669|NCT04212169|527181541|FG000|Overall Study|Withdrawal by Subject|10|||
146182670|NCT04212169|527181542|FG001|Overall Study|Withdrawal by Subject|2|||
146182671|NCT04212169|527181543|FG002|Overall Study|Withdrawal by Subject|5|||
146182672|NCT04212169|527181544|FG003|Overall Study|Withdrawal by Subject|7|||
146182673|NCT04212169|527181541|FG000|Overall Study|Other reason, unspecified|3|||
146182674|NCT04212169|527181542|FG001|Overall Study|Other reason, unspecified|1|||
146182675|NCT04212169|527181543|FG002|Overall Study|Other reason, unspecified|0|||
146182676|NCT04212169|527181544|FG003|Overall Study|Other reason, unspecified|2|||
146182677|NCT02176928|527181545|FG000|Overall Study|Lost to Follow-up|2|||
146182678|NCT02176928|527181546|FG001|Overall Study|Lost to Follow-up|4|||
146182679|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146182680|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
146182681|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
146182682|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
146182683|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
146182684|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
146182685|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146182686|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146182687|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146412374|NCT02544633|528015503|FG000|Treatment Period|Clinical Disease Progression|0|||
146412375|NCT02544633|528015504|FG001|Treatment Period|Clinical Disease Progression|0|||
146182688|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
146182689|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182690|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182691|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182692|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
146182693|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
146182694|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182695|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182696|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182697|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182698|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
146182699|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146182700|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146182701|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146182702|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
146182703|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
146182704|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
146182705|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146182706|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146182707|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146182708|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
146182709|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
146182710|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182711|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182712|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
146182713|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
146182714|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182715|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182716|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182717|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182718|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
146182719|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182720|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182721|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
146182722|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
146182723|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182724|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182725|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182726|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182727|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182728|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
146182729|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182730|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182731|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182732|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182733|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
146182734|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182735|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182736|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182737|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182738|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
146182739|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182740|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182741|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182742|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
146182743|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
146182744|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
146182745|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182746|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182747|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182748|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
146182749|NCT02018861|527181554|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182750|NCT02018861|527181555|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182751|NCT02018861|527181556|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182752|NCT02018861|527181557|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
146182753|NCT02018861|527181558|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
146182754|NCT02018861|527181559|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182755|NCT02018861|527181560|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146080538|NCT05092360|526814675|FG003|Overall Study|Lost to Follow-up|2|||
146080539|NCT05092360|526814672|FG000|Overall Study|Study terminated by sponsor|65|||
146080540|NCT05092360|526814673|FG001|Overall Study|Study terminated by sponsor|7|||
146080541|NCT05092360|526814674|FG002|Overall Study|Study terminated by sponsor|13|||
146080542|NCT05092360|526814675|FG003|Overall Study|Study terminated by sponsor|61|||
146080543|NCT01525225|526814676|FG000|Enrollment|No longer met study criteria|1|||
146080544|NCT01525225|526814676|FG000|Enrollment|Other|1|||
146080545|NCT00910624|526816630|FG000|Treatment Phase|Adverse Event|2|||
146080546|NCT00910624|526816631|FG001|Treatment Phase|Adverse Event|6|||
146080547|NCT00910624|526816632|FG002|Treatment Phase|Adverse Event|6|||
146080548|NCT00910624|526816633|FG003|Treatment Phase|Adverse Event|0|||
146080549|NCT00910624|526816630|FG000|Treatment Phase|Treatment Failure|23|||
146080550|NCT00910624|526816631|FG001|Treatment Phase|Treatment Failure|10|||
146080551|NCT00910624|526816632|FG002|Treatment Phase|Treatment Failure|0|||
146080552|NCT00910624|526816633|FG003|Treatment Phase|Treatment Failure|0|||
146080553|NCT00910624|526816630|FG000|Treatment Phase|Lost to Follow-up|0|||
146080554|NCT00910624|526816631|FG001|Treatment Phase|Lost to Follow-up|0|||
146080555|NCT00910624|526816632|FG002|Treatment Phase|Lost to Follow-up|1|||
146080556|NCT00910624|526816633|FG003|Treatment Phase|Lost to Follow-up|0|||
146080557|NCT00910624|526816630|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
146080558|NCT00910624|526816631|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
146080559|NCT00910624|526816632|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
146080560|NCT00910624|526816633|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
146080561|NCT00910624|526816630|FG000|Treatment Phase|Withdrawal by Subject|2|||
146080562|NCT00910624|526816631|FG001|Treatment Phase|Withdrawal by Subject|1|||
146080563|NCT00910624|526816632|FG002|Treatment Phase|Withdrawal by Subject|0|||
146080564|NCT00910624|526816633|FG003|Treatment Phase|Withdrawal by Subject|0|||
146080565|NCT00910624|526816630|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
146080566|NCT00910624|526816631|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
146080567|NCT00910624|526816632|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
146080568|NCT00910624|526816633|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
146080569|NCT00910624|526816630|FG000|Follow-Up Phase|Adverse Event|0|||
146080570|NCT00910624|526816631|FG001|Follow-Up Phase|Adverse Event|0|||
146080571|NCT00910624|526816632|FG002|Follow-Up Phase|Adverse Event|1|||
146080572|NCT00910624|526816633|FG003|Follow-Up Phase|Adverse Event|0|||
146080573|NCT00910624|526816630|FG000|Follow-Up Phase|Lost to Follow-up|3|||
146080574|NCT00910624|526816631|FG001|Follow-Up Phase|Lost to Follow-up|1|||
146080575|NCT00910624|526816632|FG002|Follow-Up Phase|Lost to Follow-up|2|||
146080576|NCT00910624|526816633|FG003|Follow-Up Phase|Lost to Follow-up|0|||
146080577|NCT00910624|526816630|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
146080578|NCT00910624|526816631|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
146080579|NCT00910624|526816632|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
146080580|NCT00910624|526816633|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
146080581|NCT00910624|526816630|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
146080582|NCT00910624|526816631|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146080583|NCT00910624|526816632|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
146080584|NCT00910624|526816633|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
146080585|NCT00910624|526816630|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
146080586|NCT00910624|526816631|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146080587|NCT00910624|526816632|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146080588|NCT00910624|526816633|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
146080589|NCT00910624|526816630|FG000|Follow-Up Phase|Administrative|0|||
146080590|NCT00910624|526816631|FG001|Follow-Up Phase|Administrative|1|||
146080591|NCT00910624|526816632|FG002|Follow-Up Phase|Administrative|1|||
146080592|NCT00910624|526816633|FG003|Follow-Up Phase|Administrative|0|||
146080593|NCT01122264|526816634|FG000|Overall Study|Adverse Event|6|||
146080594|NCT01122264|526816635|FG001|Overall Study|Adverse Event|5|||
146080595|NCT01122264|526816636|FG002|Overall Study|Adverse Event|7|||
146080596|NCT01122264|526816634|FG000|Overall Study|Death|1|||
146080597|NCT01122264|526816635|FG001|Overall Study|Death|0|||
146080598|NCT01122264|526816636|FG002|Overall Study|Death|0|||
146080599|NCT01122264|526816634|FG000|Overall Study|Lost to Follow-up|5|||
146080600|NCT01122264|526816635|FG001|Overall Study|Lost to Follow-up|9|||
146080601|NCT01122264|526816636|FG002|Overall Study|Lost to Follow-up|13|||
146080602|NCT01122264|526816634|FG000|Overall Study|Entry Criteria Not Met|1|||
146080603|NCT01122264|526816635|FG001|Overall Study|Entry Criteria Not Met|0|||
146080604|NCT01122264|526816636|FG002|Overall Study|Entry Criteria Not Met|0|||
146080605|NCT01122264|526816634|FG000|Overall Study|Protocol Violation|7|||
146080606|NCT01122264|526816635|FG001|Overall Study|Protocol Violation|7|||
146080607|NCT01122264|526816636|FG002|Overall Study|Protocol Violation|9|||
146080608|NCT01122264|526816634|FG000|Overall Study|Withdrawal by Subject|6|||
146080609|NCT01122264|526816635|FG001|Overall Study|Withdrawal by Subject|6|||
146080610|NCT01122264|526816636|FG002|Overall Study|Withdrawal by Subject|16|||
146080611|NCT01122264|526816634|FG000|Overall Study|Physician Decision|3|||
146080612|NCT01122264|526816635|FG001|Overall Study|Physician Decision|1|||
146080613|NCT01122264|526816636|FG002|Overall Study|Physician Decision|1|||
146080614|NCT01122264|526816634|FG000|Overall Study|Lack of Efficacy|3|||
146080615|NCT01122264|526816635|FG001|Overall Study|Lack of Efficacy|1|||
146080616|NCT01122264|526816636|FG002|Overall Study|Lack of Efficacy|1|||
146080617|NCT00097981|526816645|FG000|Overall Study|Adverse Event|31|||
146080618|NCT00097981|526816646|FG001|Overall Study|Adverse Event|44|||
146080619|NCT00097981|526816645|FG000|Overall Study|Withdrawal by Subject|10|||
146080620|NCT00097981|526816646|FG001|Overall Study|Withdrawal by Subject|8|||
146080621|NCT00097981|526816645|FG000|Overall Study|Protocol Violation|1|||
146080622|NCT00097981|526816646|FG001|Overall Study|Protocol Violation|1|||
146080623|NCT00097981|526816645|FG000|Overall Study|Death|2|||
146080624|NCT00097981|526816646|FG001|Overall Study|Death|4|||
146080625|NCT00097981|526816645|FG000|Overall Study|Physician Decision|7|||
146080626|NCT00097981|526816646|FG001|Overall Study|Physician Decision|1|||
146080627|NCT00097981|526816645|FG000|Overall Study|Disease Progression|8|||
146080628|NCT00097981|526816646|FG001|Overall Study|Disease Progression|2|||
146080629|NCT00097981|526816645|FG000|Overall Study|Transplant planned|28|||
146080630|NCT00097981|526816646|FG001|Overall Study|Transplant planned|27|||
146080631|NCT00097981|526816645|FG000|Overall Study|Other|19|||
146080632|NCT00097981|526816646|FG001|Overall Study|Other|13|||
146080633|NCT00412373|526816647|FG000|Overall Study|Adverse Event|8|||
146080634|NCT00412373|526816648|FG001|Overall Study|Adverse Event|13|||
146080635|NCT00412373|526816647|FG000|Overall Study|Lack of Efficacy|16|||
146080636|NCT00412373|526816648|FG001|Overall Study|Lack of Efficacy|22|||
146080637|NCT00412373|526816647|FG000|Overall Study|Lost to Follow-up|7|||
146080638|NCT00412373|526816648|FG001|Overall Study|Lost to Follow-up|13|||
146080639|NCT00412373|526816647|FG000|Overall Study|Withdrawal by Subject|8|||
146080640|NCT00412373|526816648|FG001|Overall Study|Withdrawal by Subject|27|||
146080641|NCT00412373|526816647|FG000|Overall Study|Other|2|||
146080642|NCT00412373|526816648|FG001|Overall Study|Other|2|||
146080643|NCT01009840|526816649|FG000|Overall Study|Lost to Follow-up|1|||
146080644|NCT01009840|526816649|FG000|Overall Study|Adverse Event|4|||
146080645|NCT01009840|526816649|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
146080646|NCT01009840|526816649|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
146080647|NCT01009840|526816649|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
146080648|NCT01002820|526816657|FG000|Overall Study|Adverse Event|1|||
146080649|NCT01002820|526816657|FG000|Overall Study|Withdrawal by Subject|2|||
146080650|NCT01002820|526816657|FG000|Overall Study|Lack of Efficacy|1|||
146080651|NCT01673347|526816658|FG000|Overall Study|failure of allograft|7|||
146080652|NCT00895011|526816664|FG000|Overall Study|Withdrawal by Subject|14|||
146080653|NCT00895011|526816665|FG001|Overall Study|Withdrawal by Subject|7|||
146080654|NCT00895011|526816666|FG002|Overall Study|Withdrawal by Subject|2|||
146080655|NCT00895011|526816664|FG000|Overall Study|Lost to Follow-up|5|||
146080656|NCT00895011|526816665|FG001|Overall Study|Lost to Follow-up|4|||
146080657|NCT00895011|526816666|FG002|Overall Study|Lost to Follow-up|1|||
146080658|NCT00895011|526816664|FG000|Overall Study|Protocol Violation|3|||
146080659|NCT00895011|526816665|FG001|Overall Study|Protocol Violation|1|||
146080660|NCT00895011|526816666|FG002|Overall Study|Protocol Violation|3|||
146080661|NCT00895011|526816664|FG000|Overall Study|Adverse Event|1|||
146080662|NCT00895011|526816665|FG001|Overall Study|Adverse Event|2|||
146080663|NCT00895011|526816666|FG002|Overall Study|Adverse Event|2|||
146080664|NCT00895011|526816664|FG000|Overall Study|schedule conflict|1|||
146080665|NCT00895011|526816665|FG001|Overall Study|schedule conflict|0|||
146080666|NCT00895011|526816666|FG002|Overall Study|schedule conflict|0|||
146080667|NCT02661178|526816674|FG000|Part 1|Protocol Violation|1|||
146080668|NCT02661178|526816675|FG001|Part 1|Protocol Violation|0|||
146080669|NCT02661178|526816676|FG002|Part 1|Protocol Violation|0|||
146080670|NCT02661178|526816677|FG003|Part 1|Protocol Violation|0|||
146080671|NCT02661178|526816678|FG004|Part 1|Protocol Violation|0|||
146080672|NCT02661178|526816679|FG005|Part 1|Protocol Violation|0|||
146080673|NCT02661178|526816680|FG006|Part 1|Protocol Violation|0|||
146080674|NCT02661178|526816681|FG007|Part 1|Protocol Violation|0|||
146080675|NCT02661178|526816682|FG008|Part 1|Protocol Violation|0|||
146080676|NCT02661178|526816683|FG009|Part 1|Protocol Violation|0|||
146080677|NCT02661178|526816684|FG010|Part 1|Protocol Violation|0|||
146080678|NCT02661178|526816685|FG011|Part 1|Protocol Violation|0|||
146080679|NCT02661178|526816686|FG012|Part 1|Protocol Violation|0|||
146080680|NCT02661178|526816687|FG013|Part 1|Protocol Violation|0|||
146080681|NCT02661178|526816688|FG014|Part 1|Protocol Violation|0|||
146080682|NCT03859973|526816689|FG000|Overall Study|Other reason than listed|3|||
146080683|NCT03859973|526816690|FG001|Overall Study|Other reason than listed|2|||
146182756|NCT02018861|527181561|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182757|NCT02018861|527181562|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182758|NCT02018861|527181563|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
146182759|NCT02018861|527181554|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182760|NCT02018861|527181555|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182761|NCT02018861|527181556|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182762|NCT02018861|527181557|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182763|NCT02018861|527181558|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182764|NCT02018861|527181559|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182765|NCT02018861|527181560|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
146182766|NCT02018861|527181561|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
146182767|NCT02018861|527181562|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182768|NCT02018861|527181563|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
146182769|NCT02018861|527181554|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182770|NCT02018861|527181555|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182771|NCT02018861|527181556|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182772|NCT02018861|527181557|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182773|NCT02018861|527181558|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182774|NCT02018861|527181559|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182775|NCT02018861|527181560|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
146182776|NCT02018861|527181561|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
146182777|NCT02018861|527181562|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182778|NCT02018861|527181563|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
146182779|NCT02018861|527181554|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182780|NCT02018861|527181555|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182781|NCT02018861|527181556|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182782|NCT02018861|527181557|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182783|NCT02018861|527181558|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182784|NCT02018861|527181559|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182785|NCT02018861|527181560|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182786|NCT02018861|527181561|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182787|NCT02018861|527181562|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
146182788|NCT02018861|527181563|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
146182789|NCT02018861|527181554|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182790|NCT02018861|527181555|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182791|NCT02018861|527181556|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182792|NCT02018861|527181557|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182793|NCT02018861|527181558|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182794|NCT02018861|527181559|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182795|NCT02018861|527181560|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182796|NCT02018861|527181561|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182797|NCT02018861|527181562|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
146182798|NCT02018861|527181563|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
146182799|NCT02018861|527181554|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182800|NCT02018861|527181555|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182801|NCT02018861|527181556|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182802|NCT02018861|527181557|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182803|NCT02018861|527181558|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182804|NCT02018861|527181559|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182805|NCT02018861|527181560|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182806|NCT02018861|527181561|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182807|NCT02018861|527181562|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
146182808|NCT02018861|527181563|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
146182809|NCT00504348|527181567|FG000|Overall Study|Adverse Event|3|||
146182810|NCT00504348|527181567|FG000|Overall Study|Lack of Efficacy|4|||
146182811|NCT00504348|527181567|FG000|Overall Study|Physician Decision|1|||
146182812|NCT00224133|527181568|FG000|Overall Study|Adverse Event|93|||
146182813|NCT00224133|527181568|FG000|Overall Study|Protocol Violation|6|||
146182814|NCT00224133|527181568|FG000|Overall Study|Withdrawal by Subject|33|||
146182815|NCT00224133|527181568|FG000|Overall Study|Lack of Efficacy|58|||
146182816|NCT00224133|527181568|FG000|Overall Study|Lost to Follow-up|21|||
146182817|NCT00224133|527181568|FG000|Overall Study|Physician Decision|1|||
146182818|NCT00224133|527181568|FG000|Overall Study|Other|14|||
146182819|NCT03699124|527181570|FG000|Overall Study|Adverse Event|6|||
146182820|NCT03699124|527181571|FG001|Overall Study|Adverse Event|5|||
146182821|NCT03699124|527181572|FG002|Overall Study|Adverse Event|2|||
146182822|NCT03699124|527181570|FG000|Overall Study|Death|0|||
146182823|NCT03699124|527181571|FG001|Overall Study|Death|2|||
146182824|NCT03699124|527181572|FG002|Overall Study|Death|0|||
146182825|NCT03699124|527181570|FG000|Overall Study|Lost to Follow-up|20|||
146182826|NCT03699124|527181571|FG001|Overall Study|Lost to Follow-up|16|||
146182827|NCT03699124|527181572|FG002|Overall Study|Lost to Follow-up|15|||
146182828|NCT03699124|527181570|FG000|Overall Study|Protocol Violation|1|||
146182829|NCT03699124|527181571|FG001|Overall Study|Protocol Violation|0|||
146182830|NCT03699124|527181572|FG002|Overall Study|Protocol Violation|0|||
146182831|NCT03699124|527181570|FG000|Overall Study|Withdrawal by Subject|13|||
146182832|NCT03699124|527181571|FG001|Overall Study|Withdrawal by Subject|14|||
146182833|NCT03699124|527181572|FG002|Overall Study|Withdrawal by Subject|13|||
146182834|NCT03699124|527181570|FG000|Overall Study|Other reasons|5|||
146182835|NCT03699124|527181571|FG001|Overall Study|Other reasons|3|||
146182836|NCT03699124|527181572|FG002|Overall Study|Other reasons|10|||
146182837|NCT01890967|527181576|FG000|Overall Study|Adverse Event|3|||
146182838|NCT01890967|527181577|FG001|Overall Study|Adverse Event|3|||
146182839|NCT01890967|527181578|FG002|Overall Study|Adverse Event|3|||
146182840|NCT01890967|527181579|FG003|Overall Study|Adverse Event|2|||
146182841|NCT01890967|527181580|FG004|Overall Study|Adverse Event|1|||
146182842|NCT01890967|527181581|FG005|Overall Study|Adverse Event|7|||
146182843|NCT01890967|527181576|FG000|Overall Study|Death|1|||
146182844|NCT01890967|527181577|FG001|Overall Study|Death|0|||
146182845|NCT01890967|527181578|FG002|Overall Study|Death|0|||
146182846|NCT01890967|527181579|FG003|Overall Study|Death|0|||
146182847|NCT01890967|527181580|FG004|Overall Study|Death|0|||
146182848|NCT01890967|527181581|FG005|Overall Study|Death|0|||
146182849|NCT01890967|527181576|FG000|Overall Study|Lost to Follow-up|1|||
146182850|NCT01890967|527181577|FG001|Overall Study|Lost to Follow-up|1|||
146182851|NCT01890967|527181578|FG002|Overall Study|Lost to Follow-up|1|||
146182852|NCT01890967|527181579|FG003|Overall Study|Lost to Follow-up|1|||
146182853|NCT01890967|527181580|FG004|Overall Study|Lost to Follow-up|0|||
146182854|NCT01890967|527181581|FG005|Overall Study|Lost to Follow-up|1|||
146182855|NCT01890967|527181576|FG000|Overall Study|Protocol Violation|0|||
146182856|NCT01890967|527181577|FG001|Overall Study|Protocol Violation|3|||
146182857|NCT01890967|527181578|FG002|Overall Study|Protocol Violation|3|||
146182858|NCT01890967|527181579|FG003|Overall Study|Protocol Violation|2|||
146182859|NCT01890967|527181580|FG004|Overall Study|Protocol Violation|4|||
146182860|NCT01890967|527181581|FG005|Overall Study|Protocol Violation|1|||
146182861|NCT01890967|527181576|FG000|Overall Study|Sponsor Decision|2|||
146182862|NCT01890967|527181577|FG001|Overall Study|Sponsor Decision|0|||
146182863|NCT01890967|527181578|FG002|Overall Study|Sponsor Decision|1|||
146182864|NCT01890967|527181579|FG003|Overall Study|Sponsor Decision|3|||
146182865|NCT01890967|527181580|FG004|Overall Study|Sponsor Decision|2|||
146182866|NCT01890967|527181581|FG005|Overall Study|Sponsor Decision|3|||
146182867|NCT01890967|527181576|FG000|Overall Study|Withdrawal by Subject|3|||
146182868|NCT01890967|527181577|FG001|Overall Study|Withdrawal by Subject|4|||
146182869|NCT01890967|527181578|FG002|Overall Study|Withdrawal by Subject|2|||
146182870|NCT01890967|527181579|FG003|Overall Study|Withdrawal by Subject|3|||
146182871|NCT01890967|527181580|FG004|Overall Study|Withdrawal by Subject|3|||
146182872|NCT01890967|527181581|FG005|Overall Study|Withdrawal by Subject|1|||
146182873|NCT01383993|527181584|FG000|Overall Study|Adverse Event|1|||
146182874|NCT01383993|527181585|FG001|Overall Study|Adverse Event|1|||
146182875|NCT01383993|527181586|FG002|Overall Study|Adverse Event|0|||
146182876|NCT01383993|527181584|FG000|Overall Study|Withdrawal by Subject|0|||
146182877|NCT01383993|527181585|FG001|Overall Study|Withdrawal by Subject|0|||
146182878|NCT01383993|527181586|FG002|Overall Study|Withdrawal by Subject|1|||
146182879|NCT01383993|527181584|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
146182880|NCT01383993|527181585|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
146182881|NCT01383993|527181586|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
146182882|NCT00593554|527181587|FG000|Overall Study|Death|1|||
146182883|NCT00593554|527181588|FG001|Overall Study|Death|2|||
146182884|NCT00593554|527181587|FG000|Overall Study|Physician Decision|0|||
146182885|NCT00593554|527181588|FG001|Overall Study|Physician Decision|1|||
146182886|NCT00593554|527181587|FG000|Overall Study|Withdrawal by Subject|1|||
146182887|NCT00593554|527181588|FG001|Overall Study|Withdrawal by Subject|0|||
146182888|NCT00593554|527181587|FG000|Overall Study|Disease Progression|1|||
146182889|NCT00593554|527181588|FG001|Overall Study|Disease Progression|2|||
146182890|NCT00795132|527181592|FG000|Overall Study|Death|1|||
146182891|NCT00795132|527181592|FG000|Overall Study|Relapse|2|||
146182892|NCT02561455|527181593|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
146182893|NCT02561455|527181594|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
146182894|NCT02561455|527181595|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
146182895|NCT02561455|527181596|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
146182896|NCT02561455|527181593|FG000|Overall Study|Withdrawal by Subject|1|||
146182897|NCT02561455|527181594|FG001|Overall Study|Withdrawal by Subject|0|||
146182898|NCT02561455|527181595|FG002|Overall Study|Withdrawal by Subject|1|||
146182899|NCT02561455|527181596|FG003|Overall Study|Withdrawal by Subject|0|||
146182900|NCT02561455|527181593|FG000|Overall Study|Disease Progression|0|||
146182901|NCT02561455|527181594|FG001|Overall Study|Disease Progression|1|||
146182902|NCT02561455|527181595|FG002|Overall Study|Disease Progression|0|||
146182903|NCT02561455|527181596|FG003|Overall Study|Disease Progression|0|||
146182904|NCT04254679|527181597|FG000|Overall Study|Protocol Violation|1|||
146182905|NCT04254679|527181598|FG001|Overall Study|Protocol Violation|1|||
146182906|NCT04254679|527181597|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
146182907|NCT04254679|527181598|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
146182908|NCT02086552|527181599|FG000|Overall Study|Withdrawal by Subject|1|||
146182909|NCT00478608|527181604|FG000|Overall Study|Adverse Event|1|||
146182910|NCT00478608|527181604|FG000|Overall Study|Serious Adverse Event|14|||
146182911|NCT00478608|527181604|FG000|Overall Study|Withdrawal by Subject|2|||
146182912|NCT00478608|527181604|FG000|Overall Study|Protocol Violation|3|||
146182913|NCT01316692|527181605|FG000|Overall Study|Adverse Event|5|||
146182914|NCT01316692|527181605|FG000|Overall Study|Disease Progression|7|||
146182915|NCT01388530|527181609|FG000|Overall Study|Lost to Follow-up|5|||
146182916|NCT01990300|527181610|FG000|Overall Study|Case Report Forms Uncollected|89|||
146182917|NCT01990300|527181610|FG000|Overall Study|Protocol Deviation|53|||
146182918|NCT02204293|527181611|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
146182919|NCT02204293|527181612|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
146182920|NCT02204293|527181613|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
146182921|NCT02204293|527181614|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
146182922|NCT02204293|527181615|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
146182923|NCT02204293|527181616|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
146182924|NCT02204293|527181611|FG000|Core Study Part I|Adverse Event|1|||
146182925|NCT02204293|527181612|FG001|Core Study Part I|Adverse Event|0|||
146182926|NCT02204293|527181613|FG002|Core Study Part I|Adverse Event|0|||
146182927|NCT02204293|527181614|FG003|Core Study Part I|Adverse Event|0|||
146182928|NCT02204293|527181615|FG004|Core Study Part I|Adverse Event|0|||
146182929|NCT02204293|527181616|FG005|Core Study Part I|Adverse Event|0|||
146182930|NCT02204293|527181611|FG000|Core Study Part I|Physician Decision|0|||
146182931|NCT02204293|527181612|FG001|Core Study Part I|Physician Decision|3|||
146182932|NCT02204293|527181613|FG002|Core Study Part I|Physician Decision|0|||
146182933|NCT02204293|527181614|FG003|Core Study Part I|Physician Decision|0|||
146182934|NCT02204293|527181615|FG004|Core Study Part I|Physician Decision|0|||
146182935|NCT02204293|527181616|FG005|Core Study Part I|Physician Decision|0|||
146182936|NCT02204293|527181611|FG000|LTE Phase|Study Suspended|0|||
146182937|NCT02204293|527181612|FG001|LTE Phase|Study Suspended|0|||
146182938|NCT02204293|527181613|FG002|LTE Phase|Study Suspended|0|||
146182939|NCT02204293|527181614|FG003|LTE Phase|Study Suspended|0|||
146182940|NCT02204293|527181615|FG004|LTE Phase|Study Suspended|0|||
146182941|NCT02204293|527181616|FG005|LTE Phase|Study Suspended|7|||
146182942|NCT02420327|527181617|FG000|Overall Study|Adverse Event|7|||
146182943|NCT02420327|527181617|FG000|Overall Study|Pregnancy|1|||
146182944|NCT02420327|527181617|FG000|Overall Study|Withdrawal by Subject|6|||
146182945|NCT02420327|527181617|FG000|Overall Study|Lost to Follow-up|1|||
146182946|NCT02420327|527181617|FG000|Overall Study|Protocol Violation|1|||
146182947|NCT01225835|527181620|FG000|Overall Study|Completed protocol|2|||
146182948|NCT01225835|527181621|FG001|Overall Study|Completed protocol|1|||
146182949|NCT01225835|527181620|FG000|Overall Study|Did not meet hCG criterion|2|||
146182950|NCT01225835|527181621|FG001|Overall Study|Did not meet hCG criterion|0|||
146182951|NCT01225835|527181620|FG000|Overall Study|Adverse Event|2|||
146182952|NCT01225835|527181621|FG001|Overall Study|Adverse Event|1|||
146182953|NCT01225835|527181620|FG000|Overall Study|Other|1|||
146182954|NCT01225835|527181621|FG001|Overall Study|Other|1|||
146182955|NCT02589392|527181622|FG000|Overall Study|Adverse Event|1|||
146182956|NCT02589392|527181623|FG001|Overall Study|Adverse Event|1|||
146182957|NCT02589392|527181622|FG000|Overall Study|Withdrawal by Subject|1|||
146182958|NCT02589392|527181623|FG001|Overall Study|Withdrawal by Subject|2|||
146182959|NCT02589392|527181622|FG000|Overall Study|Protocol Violation|1|||
146182960|NCT02589392|527181623|FG001|Overall Study|Protocol Violation|1|||
146182961|NCT02589392|527181622|FG000|Overall Study|Lost to Follow-up|2|||
146182962|NCT02589392|527181623|FG001|Overall Study|Lost to Follow-up|2|||
146182963|NCT02589392|527181622|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
146182964|NCT02589392|527181623|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
146182965|NCT03051659|527181624|FG000|Treatment Period|Withdrawal by Subject|0|||
146182966|NCT03051659|527181625|FG001|Treatment Period|Withdrawal by Subject|2|||
146182967|NCT03051659|527181624|FG000|Survival Follow-up|Lost to Follow-up|23|||
146182968|NCT03051659|527181625|FG001|Survival Follow-up|Lost to Follow-up|22|||
146182969|NCT01266993|527181626|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
146182970|NCT01266993|527181627|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
146182971|NCT01266993|527181626|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
146182972|NCT01266993|527181627|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
146182973|NCT02293837|527181628|FG000|Overall Study|Lost to Follow-up|0|||
146182974|NCT02293837|527181629|FG001|Overall Study|Lost to Follow-up|2|||
146182975|NCT02293837|527181630|FG002|Overall Study|Lost to Follow-up|1|||
146182976|NCT02293837|527181631|FG003|Overall Study|Lost to Follow-up|0|||
146182977|NCT02293837|527181628|FG000|Overall Study|Withdrawal by Subject|2|||
146182978|NCT02293837|527181629|FG001|Overall Study|Withdrawal by Subject|1|||
146182979|NCT02293837|527181630|FG002|Overall Study|Withdrawal by Subject|2|||
146182980|NCT02293837|527181631|FG003|Overall Study|Withdrawal by Subject|1|||
146182981|NCT02293837|527181628|FG000|Overall Study|COVID-19 Related|1|||
146182982|NCT02293837|527181629|FG001|Overall Study|COVID-19 Related|1|||
146182983|NCT02293837|527181630|FG002|Overall Study|COVID-19 Related|0|||
146182984|NCT02293837|527181631|FG003|Overall Study|COVID-19 Related|0|||
146182985|NCT02293837|527181628|FG000|Overall Study|Participant ill and could not be infused|0|||
146182986|NCT02293837|527181629|FG001|Overall Study|Participant ill and could not be infused|0|||
146182987|NCT02293837|527181630|FG002|Overall Study|Participant ill and could not be infused|1|||
146182988|NCT02293837|527181631|FG003|Overall Study|Participant ill and could not be infused|0|||
146182989|NCT04779242|527181632|FG000|Overall Study|Adverse Event|1|||
146182990|NCT04779242|527181633|FG001|Overall Study|Adverse Event|1|||
146182991|NCT04779242|527181632|FG000|Overall Study|Lost to Follow-up|2|||
146182992|NCT04779242|527181633|FG001|Overall Study|Lost to Follow-up|4|||
146182993|NCT04779242|527181632|FG000|Overall Study|Withdrawal by Subject|7|||
146182994|NCT04779242|527181633|FG001|Overall Study|Withdrawal by Subject|9|||
146182995|NCT04779242|527181632|FG000|Overall Study|Death|6|||
146182996|NCT04779242|527181633|FG001|Overall Study|Death|6|||
146182997|NCT04779242|527181632|FG000|Overall Study|COVID-19 related reasons|2|||
146182998|NCT04779242|527181633|FG001|Overall Study|COVID-19 related reasons|1|||
146182999|NCT04779242|527181632|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
146183000|NCT04779242|527181633|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
146183001|NCT04779242|527181632|FG000|Overall Study|Martial Law in Ukraine|2|||
146183002|NCT04779242|527181633|FG001|Overall Study|Martial Law in Ukraine|3|||
146183003|NCT02087150|527181634|FG000|Overall Study|Death|0|||
146183004|NCT02087150|527181635|FG001|Overall Study|Death|1|||
146183005|NCT02087150|527181636|FG002|Overall Study|Death|0|||
146183006|NCT02087150|527181634|FG000|Overall Study|Lost to Follow-up|6|||
146183007|NCT02087150|527181635|FG001|Overall Study|Lost to Follow-up|13|||
146183008|NCT02087150|527181636|FG002|Overall Study|Lost to Follow-up|7|||
146183009|NCT02087150|527181634|FG000|Overall Study|Withdrawal by Subject|2|||
146183010|NCT02087150|527181635|FG001|Overall Study|Withdrawal by Subject|5|||
146183011|NCT02087150|527181636|FG002|Overall Study|Withdrawal by Subject|3|||
146183012|NCT02087150|527181634|FG000|Overall Study|Physician Decision|0|||
146183013|NCT02087150|527181635|FG001|Overall Study|Physician Decision|1|||
146183014|NCT02087150|527181636|FG002|Overall Study|Physician Decision|0|||
146183015|NCT02087150|527181634|FG000|Overall Study|Procedure not done|1|||
146183016|NCT02087150|527181635|FG001|Overall Study|Procedure not done|13|||
146183017|NCT02087150|527181636|FG002|Overall Study|Procedure not done|0|||
146183018|NCT02087150|527181634|FG000|Overall Study|F/U not completed w/in study window|0|||
146183019|NCT02087150|527181635|FG001|Overall Study|F/U not completed w/in study window|0|||
146183020|NCT02087150|527181636|FG002|Overall Study|F/U not completed w/in study window|1|||
146183021|NCT02087150|527181634|FG000|Overall Study|Other|1|||
146183022|NCT02087150|527181635|FG001|Overall Study|Other|0|||
146183023|NCT02087150|527181636|FG002|Overall Study|Other|0|||
146183024|NCT02087150|527181634|FG000|Overall Study|Pt moved out of town|0|||
146183025|NCT02087150|527181635|FG001|Overall Study|Pt moved out of town|1|||
146183026|NCT02087150|527181636|FG002|Overall Study|Pt moved out of town|0|||
146183027|NCT01448044|527181638|FG000|Treatment Period|Adverse Event|4|||
146183028|NCT01448044|527181639|FG001|Treatment Period|Adverse Event|3|||
146183029|NCT01448044|527181638|FG000|Treatment Period|Lack of Efficacy|5|||
146183030|NCT01448044|527181639|FG001|Treatment Period|Lack of Efficacy|12|||
146183031|NCT01448044|527181638|FG000|Treatment Period|Subject requested discontinue study drug|1|||
146183032|NCT01448044|527181639|FG001|Treatment Period|Subject requested discontinue study drug|0|||
146183033|NCT01448044|527181638|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
146183034|NCT01448044|527181639|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
146183035|NCT01448044|527181638|FG000|Treatment Period|Participant does not meet study criteria|1|||
146183036|NCT01448044|527181639|FG001|Treatment Period|Participant does not meet study criteria|0|||
146183037|NCT01448044|527181638|FG000|Treatment Period|Lost to Follow-up|2|||
146183038|NCT01448044|527181639|FG001|Treatment Period|Lost to Follow-up|1|||
146183039|NCT01448044|527181638|FG000|Treatment Period|Other reason|2|||
146183040|NCT01448044|527181639|FG001|Treatment Period|Other reason|0|||
146183041|NCT01448044|527181638|FG000|Follow Up Period|Withdrawal by Subject|1|||
146183042|NCT01448044|527181639|FG001|Follow Up Period|Withdrawal by Subject|1|||
146183043|NCT01448044|527181638|FG000|Follow Up Period|Lost to Follow-up|6|||
146183044|NCT01448044|527181639|FG001|Follow Up Period|Lost to Follow-up|2|||
146183045|NCT01448044|527181638|FG000|Follow Up Period|Other|5|||
146183046|NCT01448044|527181639|FG001|Follow Up Period|Other|11|||
146183047|NCT04230980|527181640|FG000|Overall Study|Lost to Follow-up|1|||
146183048|NCT04230980|527181641|FG001|Overall Study|Lost to Follow-up|2|||
146183049|NCT04230980|527181640|FG000|Overall Study|Adverse Event|0|||
146183050|NCT04230980|527181641|FG001|Overall Study|Adverse Event|1|||
146183051|NCT02269943|527181642|FG000|Treatment Period|Death|0|||
146183052|NCT02269943|527181643|FG001|Treatment Period|Death|1|||
146183053|NCT02269943|527181642|FG000|Treatment Period|Adverse Event|1|||
146183054|NCT02269943|527181643|FG001|Treatment Period|Adverse Event|10|||
146183055|NCT02269943|527181642|FG000|Treatment Period|Progressive Disease|5|||
146183056|NCT02269943|527181643|FG001|Treatment Period|Progressive Disease|17|||
146183057|NCT02269943|527181642|FG000|Treatment Period|Symptomatic Deterioration|0|||
146183058|NCT02269943|527181643|FG001|Treatment Period|Symptomatic Deterioration|2|||
146183059|NCT02269943|527181642|FG000|Follow-Up Survival Period|Death|3|||
146183060|NCT02269943|527181643|FG001|Follow-Up Survival Period|Death|16|||
146183061|NCT02269943|527181642|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
146183062|NCT02269943|527181643|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
146183063|NCT02269943|527181642|FG000|Follow-Up Survival Period|Alive|2|||
146183064|NCT02269943|527181643|FG001|Follow-Up Survival Period|Alive|8|||
146183065|NCT03523871|527181644|FG000|Overall Study|Death|1|||
146183066|NCT00972179|527181646|FG000|Overall Study|Noncompliance|1|||
146183067|NCT00972179|527181647|FG001|Overall Study|Noncompliance|0|||
146183068|NCT00972179|527181648|FG002|Overall Study|Noncompliance|0|||
146183069|NCT00972179|527181649|FG003|Overall Study|Noncompliance|0|||
146183070|NCT00972179|527181650|FG004|Overall Study|Noncompliance|1|||
146183071|NCT00972179|527181651|FG005|Overall Study|Noncompliance|0|||
146183072|NCT00972179|527181652|FG006|Overall Study|Noncompliance|1|||
146183073|NCT00972179|527181646|FG000|Overall Study|Withdrawal by Subject|0|||
146183074|NCT00972179|527181647|FG001|Overall Study|Withdrawal by Subject|3|||
146183075|NCT00972179|527181648|FG002|Overall Study|Withdrawal by Subject|0|||
146183076|NCT00972179|527181649|FG003|Overall Study|Withdrawal by Subject|1|||
146183077|NCT00972179|527181650|FG004|Overall Study|Withdrawal by Subject|0|||
146183078|NCT00972179|527181651|FG005|Overall Study|Withdrawal by Subject|0|||
146183079|NCT00972179|527181652|FG006|Overall Study|Withdrawal by Subject|2|||
146183080|NCT00972179|527181646|FG000|Overall Study|Administrative Decision|0|||
146183081|NCT00972179|527181647|FG001|Overall Study|Administrative Decision|0|||
146183082|NCT00972179|527181648|FG002|Overall Study|Administrative Decision|0|||
146183083|NCT00972179|527181649|FG003|Overall Study|Administrative Decision|0|||
146183084|NCT00972179|527181650|FG004|Overall Study|Administrative Decision|1|||
146183085|NCT00972179|527181651|FG005|Overall Study|Administrative Decision|0|||
146183086|NCT00972179|527181652|FG006|Overall Study|Administrative Decision|0|||
146183087|NCT00972179|527181646|FG000|Overall Study|Lost to Follow-up|0|||
146183088|NCT00972179|527181647|FG001|Overall Study|Lost to Follow-up|0|||
146183089|NCT00972179|527181648|FG002|Overall Study|Lost to Follow-up|1|||
146183090|NCT00972179|527181649|FG003|Overall Study|Lost to Follow-up|0|||
146183091|NCT00972179|527181650|FG004|Overall Study|Lost to Follow-up|0|||
146183092|NCT00972179|527181651|FG005|Overall Study|Lost to Follow-up|3|||
146183093|NCT00972179|527181652|FG006|Overall Study|Lost to Follow-up|1|||
146183094|NCT04285229|527181655|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146183095|NCT04285229|527181656|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146183096|NCT04285229|527181657|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146183097|NCT04285229|527181658|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146183098|NCT04285229|527181659|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146183099|NCT04285229|527181660|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146183100|NCT04285229|527181655|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
146183101|NCT04285229|527181656|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
146183102|NCT04285229|527181657|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
146183103|NCT04285229|527181658|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
146183104|NCT04285229|527181659|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
146183105|NCT04285229|527181660|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
146183106|NCT04285229|527181655|FG000|Extended Treatment Period|Adverse Event|0|||
146183107|NCT04285229|527181656|FG001|Extended Treatment Period|Adverse Event|0|||
146183108|NCT04285229|527181657|FG002|Extended Treatment Period|Adverse Event|0|||
146183109|NCT04285229|527181658|FG003|Extended Treatment Period|Adverse Event|1|||
146183110|NCT04285229|527181659|FG004|Extended Treatment Period|Adverse Event|0|||
146183111|NCT04285229|527181660|FG005|Extended Treatment Period|Adverse Event|0|||
146183112|NCT04285229|527181655|FG000|Extended Treatment Period|Physician Decision|0|||
146183113|NCT04285229|527181656|FG001|Extended Treatment Period|Physician Decision|0|||
146183114|NCT04285229|527181657|FG002|Extended Treatment Period|Physician Decision|1|||
146183115|NCT04285229|527181658|FG003|Extended Treatment Period|Physician Decision|0|||
146183116|NCT04285229|527181659|FG004|Extended Treatment Period|Physician Decision|0|||
146183117|NCT04285229|527181660|FG005|Extended Treatment Period|Physician Decision|0|||
146183118|NCT04285229|527181655|FG000|Follow-up Period|Adverse Event|0|||
146183119|NCT04285229|527181656|FG001|Follow-up Period|Adverse Event|0|||
146183120|NCT04285229|527181657|FG002|Follow-up Period|Adverse Event|0|||
146183121|NCT04285229|527181658|FG003|Follow-up Period|Adverse Event|0|||
146183122|NCT04285229|527181659|FG004|Follow-up Period|Adverse Event|1|||
146183123|NCT04285229|527181660|FG005|Follow-up Period|Adverse Event|4|||
146183124|NCT04285229|527181655|FG000|Follow-up Period|Withdrawal by Subject|0|||
146183125|NCT04285229|527181656|FG001|Follow-up Period|Withdrawal by Subject|0|||
146183126|NCT04285229|527181657|FG002|Follow-up Period|Withdrawal by Subject|0|||
146183127|NCT04285229|527181658|FG003|Follow-up Period|Withdrawal by Subject|0|||
146183128|NCT04285229|527181659|FG004|Follow-up Period|Withdrawal by Subject|0|||
146183129|NCT04285229|527181660|FG005|Follow-up Period|Withdrawal by Subject|5|||
146183130|NCT04285229|527181655|FG000|Follow-up Period|Covid-19|0|||
146183131|NCT04285229|527181656|FG001|Follow-up Period|Covid-19|0|||
146183132|NCT04285229|527181657|FG002|Follow-up Period|Covid-19|0|||
146183133|NCT04285229|527181658|FG003|Follow-up Period|Covid-19|0|||
146183134|NCT04285229|527181659|FG004|Follow-up Period|Covid-19|0|||
146183135|NCT04285229|527181660|FG005|Follow-up Period|Covid-19|2|||
146183136|NCT04285229|527181655|FG000|Follow-up Period|Physician Decision|0|||
146183137|NCT04285229|527181656|FG001|Follow-up Period|Physician Decision|0|||
146183138|NCT04285229|527181657|FG002|Follow-up Period|Physician Decision|0|||
146183139|NCT04285229|527181658|FG003|Follow-up Period|Physician Decision|0|||
146183140|NCT04285229|527181659|FG004|Follow-up Period|Physician Decision|0|||
146183141|NCT04285229|527181660|FG005|Follow-up Period|Physician Decision|1|||
146183142|NCT01012973|527181661|FG000|Overall Study|Adverse Event|5|||
146183143|NCT01012973|527181662|FG001|Overall Study|Adverse Event|5|||
146183144|NCT01012973|527181661|FG000|Overall Study|Lack of Efficacy|0|||
146183145|NCT01012973|527181662|FG001|Overall Study|Lack of Efficacy|5|||
146183146|NCT01012973|527181661|FG000|Overall Study|Lost to Follow-up|1|||
146183147|NCT01012973|527181662|FG001|Overall Study|Lost to Follow-up|0|||
146183148|NCT01012973|527181661|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
146183149|NCT01012973|527181662|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
146183150|NCT01012973|527181661|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
146183151|NCT01012973|527181662|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
146183152|NCT01012973|527181661|FG000|Overall Study|Protocol Violation|5|||
146183153|NCT01012973|527181662|FG001|Overall Study|Protocol Violation|2|||
146183154|NCT01012973|527181661|FG000|Overall Study|Withdrawal by Subject|4|||
146183155|NCT01012973|527181662|FG001|Overall Study|Withdrawal by Subject|6|||
146183156|NCT02061761|527181663|FG000|Overall Study|Disease progression|2|||
146183157|NCT02061761|527181664|FG001|Overall Study|Disease progression|8|||
146183158|NCT02061761|527181665|FG002|Overall Study|Disease progression|4|||
146183159|NCT02061761|527181666|FG003|Overall Study|Disease progression|5|||
146183160|NCT02061761|527181667|FG004|Overall Study|Disease progression|9|||
146183161|NCT02061761|527181668|FG005|Overall Study|Disease progression|3|||
146183162|NCT02061761|527181669|FG006|Overall Study|Disease progression|1|||
146183163|NCT02061761|527181670|FG007|Overall Study|Disease progression|2|||
146183164|NCT02061761|527181671|FG008|Overall Study|Disease progression|28|||
146183165|NCT02061761|527181663|FG000|Overall Study|Study Drug toxicity|0|||
146183166|NCT02061761|527181664|FG001|Overall Study|Study Drug toxicity|0|||
146183167|NCT02061761|527181665|FG002|Overall Study|Study Drug toxicity|0|||
146183168|NCT02061761|527181666|FG003|Overall Study|Study Drug toxicity|0|||
146183169|NCT02061761|527181667|FG004|Overall Study|Study Drug toxicity|0|||
146183170|NCT02061761|527181668|FG005|Overall Study|Study Drug toxicity|1|||
146183171|NCT02061761|527181669|FG006|Overall Study|Study Drug toxicity|0|||
146183172|NCT02061761|527181670|FG007|Overall Study|Study Drug toxicity|2|||
146183173|NCT02061761|527181671|FG008|Overall Study|Study Drug toxicity|6|||
146183174|NCT02061761|527181663|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
146183175|NCT02061761|527181664|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
146183176|NCT02061761|527181665|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
146183177|NCT02061761|527181666|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
146183178|NCT02061761|527181667|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
146183179|NCT02061761|527181668|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
146183180|NCT02061761|527181669|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
146183181|NCT02061761|527181670|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
146183182|NCT02061761|527181671|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
146183183|NCT02061761|527181663|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146183184|NCT02061761|527181664|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146183185|NCT02061761|527181665|FG002|Overall Study|Participant request to discontinue study treatment|2|||
146183186|NCT02061761|527181666|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146183187|NCT02061761|527181667|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146183188|NCT02061761|527181668|FG005|Overall Study|Participant request to discontinue study treatment|1|||
146183189|NCT02061761|527181669|FG006|Overall Study|Participant request to discontinue study treatment|0|||
146183190|NCT02061761|527181670|FG007|Overall Study|Participant request to discontinue study treatment|0|||
146183191|NCT02061761|527181671|FG008|Overall Study|Participant request to discontinue study treatment|2|||
146183192|NCT02061761|527181663|FG000|Overall Study|Withdrawal by Subject|0|||
146183193|NCT02061761|527181664|FG001|Overall Study|Withdrawal by Subject|0|||
146183194|NCT02061761|527181665|FG002|Overall Study|Withdrawal by Subject|0|||
146183195|NCT02061761|527181666|FG003|Overall Study|Withdrawal by Subject|0|||
146183196|NCT02061761|527181667|FG004|Overall Study|Withdrawal by Subject|0|||
146183197|NCT02061761|527181668|FG005|Overall Study|Withdrawal by Subject|0|||
146183198|NCT02061761|527181669|FG006|Overall Study|Withdrawal by Subject|0|||
146183199|NCT02061761|527181670|FG007|Overall Study|Withdrawal by Subject|0|||
146183200|NCT02061761|527181671|FG008|Overall Study|Withdrawal by Subject|2|||
146183201|NCT02061761|527181663|FG000|Overall Study|Maximum clinical benefit|0|||
146183202|NCT02061761|527181664|FG001|Overall Study|Maximum clinical benefit|0|||
146183203|NCT02061761|527181665|FG002|Overall Study|Maximum clinical benefit|0|||
146183204|NCT02061761|527181666|FG003|Overall Study|Maximum clinical benefit|1|||
146183205|NCT02061761|527181667|FG004|Overall Study|Maximum clinical benefit|0|||
146183206|NCT02061761|527181668|FG005|Overall Study|Maximum clinical benefit|0|||
146183207|NCT02061761|527181669|FG006|Overall Study|Maximum clinical benefit|0|||
146183208|NCT02061761|527181670|FG007|Overall Study|Maximum clinical benefit|0|||
146183209|NCT02061761|527181671|FG008|Overall Study|Maximum clinical benefit|6|||
146183210|NCT02061761|527181663|FG000|Overall Study|Participant no longer meets study criteria|0|||
146183211|NCT02061761|527181664|FG001|Overall Study|Participant no longer meets study criteria|0|||
146183212|NCT02061761|527181665|FG002|Overall Study|Participant no longer meets study criteria|0|||
146183213|NCT02061761|527181666|FG003|Overall Study|Participant no longer meets study criteria|0|||
146183214|NCT02061761|527181667|FG004|Overall Study|Participant no longer meets study criteria|0|||
146183215|NCT02061761|527181668|FG005|Overall Study|Participant no longer meets study criteria|0|||
146183216|NCT02061761|527181669|FG006|Overall Study|Participant no longer meets study criteria|0|||
146183217|NCT02061761|527181670|FG007|Overall Study|Participant no longer meets study criteria|0|||
146183218|NCT02061761|527181671|FG008|Overall Study|Participant no longer meets study criteria|1|||
146183219|NCT02061761|527181663|FG000|Overall Study|Other reasons|0|||
146183220|NCT02061761|527181664|FG001|Overall Study|Other reasons|0|||
146183221|NCT02061761|527181665|FG002|Overall Study|Other reasons|0|||
146183222|NCT02061761|527181666|FG003|Overall Study|Other reasons|0|||
146183223|NCT02061761|527181667|FG004|Overall Study|Other reasons|2|||
146183224|NCT02061761|527181668|FG005|Overall Study|Other reasons|0|||
146183225|NCT02061761|527181669|FG006|Overall Study|Other reasons|0|||
146183226|NCT02061761|527181670|FG007|Overall Study|Other reasons|0|||
146183227|NCT02061761|527181671|FG008|Overall Study|Other reasons|6|||
146183228|NCT04170296|527181675|FG000|Overall Study|Adverse Event|1|||
146183229|NCT04170296|527181676|FG001|Overall Study|Adverse Event|0|||
146183230|NCT04170296|527181675|FG000|Overall Study|Withdrawal by Subject|3|||
146183231|NCT04170296|527181676|FG001|Overall Study|Withdrawal by Subject|2|||
146183232|NCT04170296|527181675|FG000|Overall Study|Lost to Follow-up|4|||
146183233|NCT04170296|527181676|FG001|Overall Study|Lost to Follow-up|2|||
146183234|NCT02138747|527181677|FG000|Treatment Period 1|Adverse Event|10|||
146183235|NCT02138747|527181678|FG001|Treatment Period 1|Adverse Event|14|||
146183236|NCT02138747|527181679|FG002|Treatment Period 1|Adverse Event|2|||
146183237|NCT02138747|527181680|FG003|Treatment Period 1|Adverse Event|1|||
146183238|NCT02138747|527181677|FG000|Treatment Period 1|Lost to Follow-up|0|||
146183239|NCT02138747|527181678|FG001|Treatment Period 1|Lost to Follow-up|1|||
146183240|NCT02138747|527181679|FG002|Treatment Period 1|Lost to Follow-up|1|||
146183241|NCT02138747|527181680|FG003|Treatment Period 1|Lost to Follow-up|0|||
146183242|NCT02138747|527181677|FG000|Treatment Period 1|Protocol Violation|0|||
146183243|NCT02138747|527181678|FG001|Treatment Period 1|Protocol Violation|2|||
146183244|NCT02138747|527181679|FG002|Treatment Period 1|Protocol Violation|0|||
146183245|NCT02138747|527181680|FG003|Treatment Period 1|Protocol Violation|0|||
146183246|NCT02138747|527181677|FG000|Treatment Period 1|Withdrawal by Subject|8|||
146183247|NCT02138747|527181678|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146183248|NCT02138747|527181679|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146183249|NCT02138747|527181680|FG003|Treatment Period 1|Withdrawal by Subject|3|||
146183250|NCT02138747|527181677|FG000|Treatment Period 1|Other - Miscellaneous|2|||
146183251|NCT02138747|527181678|FG001|Treatment Period 1|Other - Miscellaneous|4|||
146183252|NCT02138747|527181679|FG002|Treatment Period 1|Other - Miscellaneous|0|||
146183253|NCT02138747|527181680|FG003|Treatment Period 1|Other - Miscellaneous|0|||
146183254|NCT02138747|527181677|FG000|Treatment Period 2|Adverse Event|6|||
146183255|NCT02138747|527181678|FG001|Treatment Period 2|Adverse Event|3|||
146183256|NCT02138747|527181679|FG002|Treatment Period 2|Adverse Event|1|||
146183257|NCT02138747|527181680|FG003|Treatment Period 2|Adverse Event|1|||
146183258|NCT02138747|527181677|FG000|Treatment Period 2|Lost to Follow-up|2|||
146183259|NCT02138747|527181678|FG001|Treatment Period 2|Lost to Follow-up|0|||
146183260|NCT02138747|527181679|FG002|Treatment Period 2|Lost to Follow-up|0|||
146183261|NCT02138747|527181680|FG003|Treatment Period 2|Lost to Follow-up|0|||
146183262|NCT02138747|527181677|FG000|Treatment Period 2|Protocol Violation|1|||
146183263|NCT02138747|527181678|FG001|Treatment Period 2|Protocol Violation|0|||
146183264|NCT02138747|527181679|FG002|Treatment Period 2|Protocol Violation|0|||
146183265|NCT02138747|527181680|FG003|Treatment Period 2|Protocol Violation|0|||
146183266|NCT02138747|527181677|FG000|Treatment Period 2|Withdrawal by Subject|5|||
146183267|NCT02138747|527181678|FG001|Treatment Period 2|Withdrawal by Subject|4|||
146183268|NCT02138747|527181679|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146183269|NCT02138747|527181680|FG003|Treatment Period 2|Withdrawal by Subject|2|||
146183270|NCT02138747|527181677|FG000|Treatment Period 2|Other - Miscellaneous|3|||
146183271|NCT02138747|527181678|FG001|Treatment Period 2|Other - Miscellaneous|0|||
146183272|NCT02138747|527181679|FG002|Treatment Period 2|Other - Miscellaneous|0|||
146183273|NCT02138747|527181680|FG003|Treatment Period 2|Other - Miscellaneous|0|||
146183274|NCT00653263|527181681|FG000|Overall Study|Withdrawal by Subject|1|||
146183275|NCT00653263|527181681|FG000|Overall Study|Physician Decision|1|||
146183276|NCT00776100|527181682|FG000|Overall Study|Disease Progression|1|||
146183277|NCT00776100|527181683|FG001|Overall Study|Disease Progression|0|||
146183278|NCT04793464|527181684|FG000|Overall Study|Lost to Follow-up|458|||
146183279|NCT04793464|527181685|FG001|Overall Study|Lost to Follow-up|168|||
146183280|NCT04793464|527181686|FG002|Overall Study|Lost to Follow-up|5|||
146183281|NCT04793464|527181684|FG000|Overall Study|Withdrawal by Subject|43|||
146183282|NCT04793464|527181685|FG001|Overall Study|Withdrawal by Subject|15|||
146183283|NCT04793464|527181686|FG002|Overall Study|Withdrawal by Subject|0|||
146183284|NCT02285595|527181688|FG000|Overall Study|Lost to Follow-up|14|||
146183285|NCT02285595|527181688|FG000|Overall Study|Withdrawal by Subject|1|||
146183286|NCT01960790|527181689|FG000|Overall Study|Survey forms could not be recovered|3|||
146183287|NCT01960790|527181689|FG000|Overall Study|Treat with Humira outside survey period|3|||
146183288|NCT01960790|527181689|FG000|Overall Study|Transferred to another hospital|4|||
146183289|NCT01960790|527181689|FG000|Overall Study|Unevaluable for safety|1|||
146183290|NCT00195715|527181690|FG000|Overall Study|Adverse Event|122|||
146183291|NCT00195715|527181690|FG000|Overall Study|Withdrawal by Subject|58|||
146183292|NCT00195715|527181690|FG000|Overall Study|Lost to Follow-up|27|||
146183293|NCT00195715|527181690|FG000|Overall Study|Protocol Violation|13|||
146183294|NCT00195715|527181690|FG000|Overall Study|Lack of Efficacy|93|||
146183295|NCT00195715|527181690|FG000|Overall Study|Pregnancy|14|||
146183296|NCT00195715|527181690|FG000|Overall Study|Investigative site closure|8|||
146183297|NCT00195715|527181690|FG000|Overall Study|Subject moved/relocated|7|||
146183298|NCT00195715|527181690|FG000|Overall Study|Subject non-compliance|6|||
146183299|NCT00195715|527181690|FG000|Overall Study|Subject started commercial Humira|5|||
146183300|NCT00195715|527181690|FG000|Overall Study|Subject choice|3|||
146183301|NCT00195715|527181690|FG000|Overall Study|Loss of response/no improvement|3|||
146183302|NCT00195715|527181690|FG000|Overall Study|Sponsor stopped study|1|||
146183303|NCT00195715|527181690|FG000|Overall Study|Administrative reasons|2|||
146183304|NCT00195715|527181690|FG000|Overall Study|Investigator's decision|2|||
146183305|NCT00195715|527181690|FG000|Overall Study|Subject wants to get pregnant|4|||
146183306|NCT00195715|527181690|FG000|Overall Study|Use of prohibited medication|2|||
146183307|NCT00195715|527181690|FG000|Overall Study|Planned surgery|2|||
146183308|NCT00195715|527181690|FG000|Overall Study|Increased infection rate|1|||
146183309|NCT00195715|527181690|FG000|Overall Study|Ineligible|1|||
146183310|NCT00195715|527181690|FG000|Overall Study|Colonic stricture|1|||
146183311|NCT00195715|527181690|FG000|Overall Study|Sponsor discontinued trial|1|||
146183312|NCT00195715|527181690|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
146183313|NCT05822921|527181695|FG000|Overall Study|Lost to Follow-up|1|||
146183314|NCT05822921|527181696|FG001|Overall Study|Lost to Follow-up|1|||
146183315|NCT00544544|527181698|FG000|Overall Study|Withdrawal by Subject|1|||
146183316|NCT00544544|527181698|FG000|Overall Study|Adverse Event|1|||
146183317|NCT00544544|527181698|FG000|Overall Study|Lost to Follow-up|1|||
146183318|NCT01370603|527181704|FG000|Period 1|Adverse Event|5|||
146183319|NCT01370603|527181705|FG001|Period 1|Adverse Event|3|||
146183320|NCT01370603|527181704|FG000|Period 1|Lost to Follow-up|2|||
146183321|NCT01370603|527181705|FG001|Period 1|Lost to Follow-up|0|||
146183322|NCT01370603|527181704|FG000|Period 1|Protocol Violation|2|||
146183323|NCT01370603|527181705|FG001|Period 1|Protocol Violation|2|||
146183324|NCT01370603|527181704|FG000|Period 1|Withdrawal by Subject|5|||
146183325|NCT01370603|527181705|FG001|Period 1|Withdrawal by Subject|5|||
146183326|NCT01370603|527181704|FG000|Crossover Washout|Adverse Event|2|||
146183327|NCT01370603|527181705|FG001|Crossover Washout|Adverse Event|1|||
146183328|NCT01370603|527181704|FG000|Crossover Washout|Lost to Follow-up|2|||
146183329|NCT01370603|527181705|FG001|Crossover Washout|Lost to Follow-up|0|||
146183330|NCT01370603|527181704|FG000|Crossover Washout|Protocol Violation|1|||
146183331|NCT01370603|527181705|FG001|Crossover Washout|Protocol Violation|0|||
146183332|NCT01370603|527181704|FG000|Crossover Washout|Withdrawal by Subject|4|||
146183333|NCT01370603|527181705|FG001|Crossover Washout|Withdrawal by Subject|1|||
146183334|NCT01370603|527181704|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
146183335|NCT01370603|527181705|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
146183336|NCT01370603|527181704|FG000|Period 2|Adverse Event|1|||
146183337|NCT01370603|527181705|FG001|Period 2|Adverse Event|4|||
146183338|NCT01370603|527181704|FG000|Period 2|Lost to Follow-up|1|||
146183339|NCT01370603|527181705|FG001|Period 2|Lost to Follow-up|0|||
146183340|NCT01370603|527181704|FG000|Period 2|Withdrawal by Subject|1|||
146183341|NCT01370603|527181705|FG001|Period 2|Withdrawal by Subject|0|||
146183342|NCT02133924|527181710|FG000|Overall Study|Death|38|||
146183343|NCT02133924|527181710|FG000|Overall Study|Physician Decision|1|||
146183344|NCT02133924|527181710|FG000|Overall Study|Withdrawal by Subject|3|||
146183345|NCT00003458|527181711|FG000|Overall Study|Not evaluable|4|||
146183346|NCT01163747|527181717|FG000|Overall Study|Adverse Event|0|||
146183347|NCT01163747|527181718|FG001|Overall Study|Adverse Event|5|||
146183348|NCT01163747|527181717|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146183349|NCT01163747|527181718|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146183350|NCT01163747|527181717|FG000|Overall Study|Protocol Violation|0|||
146183351|NCT01163747|527181718|FG001|Overall Study|Protocol Violation|1|||
146183352|NCT01163747|527181717|FG000|Overall Study|Refused Treatment|6|||
146183353|NCT01163747|527181718|FG001|Overall Study|Refused Treatment|4|||
146183354|NCT01216293|527181719|FG000|Main Study|Adverse Event|1|||
146183355|NCT01216293|527181720|FG001|Main Study|Adverse Event|4|||
146183356|NCT01216293|527181721|FG002|Main Study|Adverse Event|2|||
146183357|NCT01216293|527181719|FG000|Main Study|Major Protocol Deviation|1|||
146183358|NCT01216293|527181720|FG001|Main Study|Major Protocol Deviation|0|||
146183359|NCT01216293|527181721|FG002|Main Study|Major Protocol Deviation|1|||
146183360|NCT01216293|527181719|FG000|Main Study|Lost to Follow-up|3|||
146183361|NCT01216293|527181720|FG001|Main Study|Lost to Follow-up|1|||
146183362|NCT01216293|527181721|FG002|Main Study|Lost to Follow-up|0|||
146183363|NCT01216293|527181719|FG000|Main Study|Voluntary Withdrawal|2|||
146183364|NCT01216293|527181720|FG001|Main Study|Voluntary Withdrawal|2|||
146183365|NCT01216293|527181721|FG002|Main Study|Voluntary Withdrawal|2|||
146183366|NCT01216293|527181719|FG000|Main Study|Other Reason Not Specified|0|||
146183367|NCT01216293|527181720|FG001|Main Study|Other Reason Not Specified|1|||
146183368|NCT01216293|527181721|FG002|Main Study|Other Reason Not Specified|1|||
146183369|NCT01216293|527181719|FG000|Main Study|Randomized, Not Treated|1|||
146183370|NCT01216293|527181720|FG001|Main Study|Randomized, Not Treated|0|||
146183371|NCT01216293|527181721|FG002|Main Study|Randomized, Not Treated|0|||
146183372|NCT01216293|527181719|FG000|Calcium Absorption Substudy|Adverse Event|0|||
146183373|NCT01216293|527181720|FG001|Calcium Absorption Substudy|Adverse Event|2|||
146183374|NCT01216293|527181721|FG002|Calcium Absorption Substudy|Adverse Event|0|||
146183375|NCT01216293|527181719|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
146183376|NCT01216293|527181720|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
146183377|NCT01216293|527181721|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
146183378|NCT01216293|527181719|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
146183379|NCT01216293|527181720|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
146183380|NCT01216293|527181721|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
146183381|NCT02451930|527183944|FG000|Overall Study|Death|0|||
146183382|NCT02451930|527183945|FG001|Overall Study|Death|15|||
146183383|NCT02451930|527183944|FG000|Overall Study|Lost to Follow-up|0|||
146183384|NCT02451930|527183945|FG001|Overall Study|Lost to Follow-up|3|||
146183385|NCT02451930|527183944|FG000|Overall Study|Sponsor Decision|2|||
146183386|NCT02451930|527183945|FG001|Overall Study|Sponsor Decision|10|||
146183387|NCT02451930|527183944|FG000|Overall Study|Withdrawal by Subject|0|||
146183388|NCT02451930|527183945|FG001|Overall Study|Withdrawal by Subject|1|||
146183389|NCT02451930|527183944|FG000|Overall Study|Other|0|||
146183390|NCT02451930|527183945|FG001|Overall Study|Other|1|||
146183391|NCT00262743|527183946|FG000|Overall Study|Adverse Event|0|||
146183392|NCT00262743|527183947|FG001|Overall Study|Adverse Event|9|||
146183393|NCT00262743|527183946|FG000|Overall Study|Disease progression|0|||
146183394|NCT00262743|527183947|FG001|Overall Study|Disease progression|3|||
146183395|NCT01950273|527183957|FG000|Overall Study|Protocol Violation|1|||
146183396|NCT01950273|527183958|FG001|Overall Study|Protocol Violation|0|||
146183397|NCT01950273|527183957|FG000|Overall Study|Withdrawal by Subject|2|||
146183398|NCT01950273|527183958|FG001|Overall Study|Withdrawal by Subject|0|||
146183399|NCT01950273|527183957|FG000|Overall Study|Other not defined above|1|||
146183400|NCT01950273|527183958|FG001|Overall Study|Other not defined above|0|||
146183401|NCT00472186|527183959|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
146183402|NCT00472186|527183960|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
146183403|NCT01154036|527183965|FG000|Phase I|Physician Decision|0|||
146183404|NCT01154036|527183966|FG001|Phase I|Physician Decision|1|||
146183405|NCT01154036|527183967|FG002|Phase I|Physician Decision|0|||
146183406|NCT01154036|527183968|FG003|Phase I|Physician Decision|0|||
146183407|NCT01154036|527183969|FG004|Phase I|Physician Decision|0|||
146183408|NCT01154036|527183970|FG005|Phase I|Physician Decision|0|||
146183409|NCT01154036|527183971|FG006|Phase I|Physician Decision|0|||
146183410|NCT01154036|527183972|FG007|Phase I|Physician Decision|0|||
146183411|NCT01154036|527183965|FG000|Phase I|Lost to Follow-up|0|||
146183412|NCT01154036|527183966|FG001|Phase I|Lost to Follow-up|3|||
146183413|NCT01154036|527183967|FG002|Phase I|Lost to Follow-up|6|||
146183414|NCT01154036|527183968|FG003|Phase I|Lost to Follow-up|0|||
146183415|NCT01154036|527183969|FG004|Phase I|Lost to Follow-up|0|||
146183416|NCT01154036|527183970|FG005|Phase I|Lost to Follow-up|0|||
146183417|NCT01154036|527183971|FG006|Phase I|Lost to Follow-up|0|||
146183418|NCT01154036|527183972|FG007|Phase I|Lost to Follow-up|0|||
146183419|NCT01154036|527183965|FG000|Phase I|Protocol Violation|0|||
146183420|NCT01154036|527183966|FG001|Phase I|Protocol Violation|3|||
146183421|NCT01154036|527183967|FG002|Phase I|Protocol Violation|9|||
146183422|NCT01154036|527183968|FG003|Phase I|Protocol Violation|0|||
146183423|NCT01154036|527183969|FG004|Phase I|Protocol Violation|0|||
146183424|NCT01154036|527183970|FG005|Phase I|Protocol Violation|0|||
146183425|NCT01154036|527183971|FG006|Phase I|Protocol Violation|0|||
146183426|NCT01154036|527183972|FG007|Phase I|Protocol Violation|0|||
146183427|NCT01154036|527183965|FG000|Phase I|Withdrawal by Subject|2|||
146183428|NCT01154036|527183966|FG001|Phase I|Withdrawal by Subject|10|||
146183429|NCT01154036|527183967|FG002|Phase I|Withdrawal by Subject|29|||
146183430|NCT01154036|527183968|FG003|Phase I|Withdrawal by Subject|0|||
146183431|NCT01154036|527183969|FG004|Phase I|Withdrawal by Subject|0|||
146183432|NCT01154036|527183970|FG005|Phase I|Withdrawal by Subject|0|||
146183433|NCT01154036|527183971|FG006|Phase I|Withdrawal by Subject|0|||
146183434|NCT01154036|527183972|FG007|Phase I|Withdrawal by Subject|0|||
146183435|NCT01154036|527183965|FG000|Phase I|Adverse Event|1|||
146183436|NCT01154036|527183966|FG001|Phase I|Adverse Event|11|||
146183437|NCT01154036|527183967|FG002|Phase I|Adverse Event|12|||
146183438|NCT01154036|527183968|FG003|Phase I|Adverse Event|0|||
146183439|NCT01154036|527183969|FG004|Phase I|Adverse Event|0|||
146183440|NCT01154036|527183970|FG005|Phase I|Adverse Event|0|||
146183441|NCT01154036|527183971|FG006|Phase I|Adverse Event|0|||
146183442|NCT01154036|527183972|FG007|Phase I|Adverse Event|0|||
146183443|NCT01154036|527183965|FG000|Phase II|Adverse Event|0|||
146183444|NCT01154036|527183966|FG001|Phase II|Adverse Event|0|||
146183445|NCT01154036|527183967|FG002|Phase II|Adverse Event|0|||
146183446|NCT01154036|527183968|FG003|Phase II|Adverse Event|0|||
146183447|NCT01154036|527183969|FG004|Phase II|Adverse Event|1|||
146183448|NCT01154036|527183970|FG005|Phase II|Adverse Event|1|||
146183449|NCT01154036|527183971|FG006|Phase II|Adverse Event|1|||
146183450|NCT01154036|527183972|FG007|Phase II|Adverse Event|1|||
146183451|NCT01154036|527183965|FG000|Phase II|Physician Decision|0|||
146183452|NCT01154036|527183966|FG001|Phase II|Physician Decision|0|||
146183453|NCT01154036|527183967|FG002|Phase II|Physician Decision|0|||
146183454|NCT01154036|527183968|FG003|Phase II|Physician Decision|0|||
146183455|NCT01154036|527183969|FG004|Phase II|Physician Decision|0|||
146183456|NCT01154036|527183970|FG005|Phase II|Physician Decision|0|||
146183457|NCT01154036|527183971|FG006|Phase II|Physician Decision|1|||
146183458|NCT01154036|527183972|FG007|Phase II|Physician Decision|0|||
146183459|NCT01154036|527183965|FG000|Phase II|Lost to Follow-up|0|||
146183460|NCT01154036|527183966|FG001|Phase II|Lost to Follow-up|0|||
146183461|NCT01154036|527183967|FG002|Phase II|Lost to Follow-up|0|||
146183462|NCT01154036|527183968|FG003|Phase II|Lost to Follow-up|1|||
146183463|NCT01154036|527183969|FG004|Phase II|Lost to Follow-up|2|||
146183464|NCT01154036|527183970|FG005|Phase II|Lost to Follow-up|0|||
146183465|NCT01154036|527183971|FG006|Phase II|Lost to Follow-up|2|||
146183466|NCT01154036|527183972|FG007|Phase II|Lost to Follow-up|1|||
146183467|NCT01154036|527183965|FG000|Phase II|Protocol Violation|0|||
146183468|NCT01154036|527183966|FG001|Phase II|Protocol Violation|0|||
146183469|NCT01154036|527183967|FG002|Phase II|Protocol Violation|0|||
146183470|NCT01154036|527183968|FG003|Phase II|Protocol Violation|0|||
146183471|NCT01154036|527183969|FG004|Phase II|Protocol Violation|1|||
146183472|NCT01154036|527183970|FG005|Phase II|Protocol Violation|2|||
146183473|NCT01154036|527183971|FG006|Phase II|Protocol Violation|0|||
146183474|NCT01154036|527183972|FG007|Phase II|Protocol Violation|0|||
146183475|NCT01154036|527183965|FG000|Phase II|Withdrawal by Subject|0|||
146183476|NCT01154036|527183966|FG001|Phase II|Withdrawal by Subject|0|||
146183477|NCT01154036|527183967|FG002|Phase II|Withdrawal by Subject|0|||
146183478|NCT01154036|527183968|FG003|Phase II|Withdrawal by Subject|0|||
146183479|NCT01154036|527183969|FG004|Phase II|Withdrawal by Subject|4|||
146183480|NCT01154036|527183970|FG005|Phase II|Withdrawal by Subject|2|||
146183481|NCT01154036|527183971|FG006|Phase II|Withdrawal by Subject|5|||
146183482|NCT01154036|527183972|FG007|Phase II|Withdrawal by Subject|4|||
146183483|NCT02264574|527183973|FG000|Overall Study|Death|21|||
146183484|NCT02264574|527183974|FG001|Overall Study|Death|21|||
146183485|NCT02264574|527183973|FG000|Overall Study|Withdrawal by Subject|8|||
146183486|NCT02264574|527183974|FG001|Overall Study|Withdrawal by Subject|6|||
146183487|NCT02264574|527183973|FG000|Overall Study|Other, Not Specified|0|||
146183488|NCT02264574|527183974|FG001|Overall Study|Other, Not Specified|3|||
146183489|NCT01567163|527183981|FG000|Overall Study|Progressive Disease|2|||
146183490|NCT01567163|527183981|FG000|Overall Study|Lost to Follow-up|2|||
146183491|NCT03405662|527183983|FG000|Overall Study|COVID-19 restriction|1|||
146183492|NCT03405662|527183984|FG001|Overall Study|COVID-19 restriction|0|||
146183493|NCT03405662|527183983|FG000|Overall Study|unblinding|0|||
146183494|NCT03405662|527183984|FG001|Overall Study|unblinding|1|||
146183495|NCT03405662|527183983|FG000|Overall Study|placement in memory care facility|0|||
146183496|NCT03405662|527183984|FG001|Overall Study|placement in memory care facility|2|||
146183497|NCT00280293|527183985|FG000|Overall Study|Protocol Violation|3|||
146183498|NCT00280293|527183986|FG001|Overall Study|Protocol Violation|0|||
146183499|NCT00280293|527183985|FG000|Overall Study|Physician Decision|5|||
146183500|NCT00280293|527183986|FG001|Overall Study|Physician Decision|4|||
146183501|NCT00280293|527183985|FG000|Overall Study|Lost to Follow-up|14|||
146183502|NCT00280293|527183986|FG001|Overall Study|Lost to Follow-up|12|||
146183503|NCT00280293|527183985|FG000|Overall Study|Withdrawal by Subject|3|||
146183504|NCT00280293|527183986|FG001|Overall Study|Withdrawal by Subject|5|||
146183505|NCT00280293|527183985|FG000|Overall Study|Incarceration/Legal Reasons|1|||
146183506|NCT00280293|527183986|FG001|Overall Study|Incarceration/Legal Reasons|1|||
146183507|NCT00280293|527183985|FG000|Overall Study|Adverse Event|0|||
146183508|NCT00280293|527183986|FG001|Overall Study|Adverse Event|1|||
146183509|NCT01458249|527183987|FG000|Overall Study|Not treated|1|||
146183510|NCT01458249|527183987|FG000|Overall Study|Adverse Event|4|||
146183511|NCT01458249|527183987|FG000|Overall Study|Other|2|||
146183512|NCT01458249|527183987|FG000|Overall Study|Ongoing|1|||
146183513|NCT02056119|527183988|FG000|Overall Study|Death|1|||
146183514|NCT02056119|527183989|FG001|Overall Study|Death|2|||
146183515|NCT02056119|527183988|FG000|Overall Study|Intubated for less than 24 hrs|2|||
146183516|NCT02056119|527183989|FG001|Overall Study|Intubated for less than 24 hrs|7|||
146183517|NCT02056119|527183988|FG000|Overall Study|No aerosol treatments were given.|3|||
146183518|NCT02056119|527183989|FG001|Overall Study|No aerosol treatments were given.|2|||
146183519|NCT02056119|527183988|FG000|Overall Study|Received Metaneb treatment|0|||
146183520|NCT02056119|527183989|FG001|Overall Study|Received Metaneb treatment|2|||
146183521|NCT02056119|527183988|FG000|Overall Study|Protocol Violation|4|||
146183522|NCT02056119|527183989|FG001|Overall Study|Protocol Violation|7|||
146183523|NCT03220737|527183990|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146183524|NCT03220737|527183991|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
146183525|NCT03220737|527183992|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146183526|NCT03220737|527183993|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
146183527|NCT03220737|527183994|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
146183528|NCT03220737|527183995|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
146183529|NCT03220737|527183996|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
146183530|NCT03220737|527183990|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
146183531|NCT03220737|527183991|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146183532|NCT03220737|527183992|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
146183533|NCT03220737|527183993|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146183534|NCT03220737|527183994|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
146183535|NCT03220737|527183995|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
146183536|NCT03220737|527183996|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
146183537|NCT03220737|527183990|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
146183538|NCT03220737|527183991|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
146183539|NCT03220737|527183992|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
146183540|NCT03220737|527183993|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
146183541|NCT03220737|527183994|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
146183542|NCT03220737|527183995|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
146183543|NCT03220737|527183996|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
146183544|NCT03220737|527183990|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183545|NCT03220737|527183991|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183546|NCT03220737|527183992|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
146183547|NCT03220737|527183993|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183548|NCT03220737|527183994|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183549|NCT03220737|527183995|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183550|NCT03220737|527183996|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
146183551|NCT03220737|527183990|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183552|NCT03220737|527183991|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183553|NCT03220737|527183992|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183554|NCT03220737|527183993|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183555|NCT03220737|527183994|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
146183556|NCT03220737|527183995|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183557|NCT03220737|527183996|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
146183558|NCT03220737|527183990|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
146183559|NCT03220737|527183991|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183560|NCT03220737|527183992|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183561|NCT03220737|527183993|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183562|NCT03220737|527183994|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183563|NCT03220737|527183995|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183564|NCT03220737|527183996|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
146183565|NCT03220737|527183990|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
146183566|NCT03220737|527183991|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183567|NCT03220737|527183992|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183568|NCT03220737|527183993|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183569|NCT03220737|527183994|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183570|NCT03220737|527183995|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183571|NCT03220737|527183996|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
146183572|NCT03220737|527183990|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
146183573|NCT03220737|527183991|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183574|NCT03220737|527183992|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183575|NCT03220737|527183993|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183576|NCT03220737|527183994|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183577|NCT03220737|527183995|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183578|NCT03220737|527183996|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
146183579|NCT01720797|527183997|FG000|Overall Study|Withdrawal by Subject|3|||
146183580|NCT01720797|527183998|FG001|Overall Study|Withdrawal by Subject|0|||
146183581|NCT00983619|527184008|FG000|Overall Study|Lost to Follow-up|0|||
146183582|NCT00983619|527184009|FG001|Overall Study|Lost to Follow-up|1|||
146183583|NCT00983619|527184010|FG002|Overall Study|Lost to Follow-up|0|||
146183584|NCT00983619|527184011|FG003|Overall Study|Lost to Follow-up|0|||
146183585|NCT00983619|527184012|FG004|Overall Study|Lost to Follow-up|0|||
146183586|NCT00983619|527184013|FG005|Overall Study|Lost to Follow-up|2|||
146183587|NCT00983619|527184014|FG006|Overall Study|Lost to Follow-up|0|||
146183588|NCT00983619|527184015|FG007|Overall Study|Lost to Follow-up|0|||
146183589|NCT00983619|527184016|FG008|Overall Study|Lost to Follow-up|0|||
146183590|NCT00983619|527184017|FG009|Overall Study|Lost to Follow-up|0|||
146183591|NCT00983619|527184018|FG010|Overall Study|Lost to Follow-up|0|||
146183592|NCT00983619|527184019|FG011|Overall Study|Lost to Follow-up|2|||
146183593|NCT00983619|527184008|FG000|Overall Study|Withdrawal by Subject|2|||
146183594|NCT00983619|527184009|FG001|Overall Study|Withdrawal by Subject|1|||
146183595|NCT00983619|527184010|FG002|Overall Study|Withdrawal by Subject|1|||
146183596|NCT00983619|527184011|FG003|Overall Study|Withdrawal by Subject|3|||
146183597|NCT00983619|527184012|FG004|Overall Study|Withdrawal by Subject|1|||
146183598|NCT00983619|527184013|FG005|Overall Study|Withdrawal by Subject|23|||
146183599|NCT00983619|527184014|FG006|Overall Study|Withdrawal by Subject|0|||
146183600|NCT00983619|527184015|FG007|Overall Study|Withdrawal by Subject|0|||
146183601|NCT00983619|527184016|FG008|Overall Study|Withdrawal by Subject|0|||
146183602|NCT00983619|527184017|FG009|Overall Study|Withdrawal by Subject|0|||
146183603|NCT00983619|527184018|FG010|Overall Study|Withdrawal by Subject|1|||
146183604|NCT00983619|527184019|FG011|Overall Study|Withdrawal by Subject|1|||
146183605|NCT00983619|527184008|FG000|Overall Study|Death|0|||
146183606|NCT00983619|527184009|FG001|Overall Study|Death|2|||
146183607|NCT00983619|527184010|FG002|Overall Study|Death|2|||
146183608|NCT00983619|527184011|FG003|Overall Study|Death|1|||
146183609|NCT00983619|527184012|FG004|Overall Study|Death|2|||
146183610|NCT00983619|527184013|FG005|Overall Study|Death|30|||
146183611|NCT00983619|527184014|FG006|Overall Study|Death|1|||
146183612|NCT00983619|527184015|FG007|Overall Study|Death|0|||
146183613|NCT00983619|527184016|FG008|Overall Study|Death|1|||
146183614|NCT00983619|527184017|FG009|Overall Study|Death|2|||
146183615|NCT00983619|527184018|FG010|Overall Study|Death|9|||
146183616|NCT00983619|527184019|FG011|Overall Study|Death|8|||
146183617|NCT00983619|527184008|FG000|Overall Study|Other|1|||
146183618|NCT00983619|527184009|FG001|Overall Study|Other|0|||
146183619|NCT00983619|527184010|FG002|Overall Study|Other|0|||
146183620|NCT00983619|527184011|FG003|Overall Study|Other|1|||
146183621|NCT00983619|527184012|FG004|Overall Study|Other|0|||
146183622|NCT00983619|527184013|FG005|Overall Study|Other|12|||
146183623|NCT00983619|527184014|FG006|Overall Study|Other|2|||
146183624|NCT00983619|527184015|FG007|Overall Study|Other|2|||
146183625|NCT00983619|527184016|FG008|Overall Study|Other|0|||
146183626|NCT00983619|527184017|FG009|Overall Study|Other|1|||
146183627|NCT00983619|527184018|FG010|Overall Study|Other|1|||
146183628|NCT00983619|527184019|FG011|Overall Study|Other|0|||
146183629|NCT04827134|527184023|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146183630|NCT04827134|527184024|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146183631|NCT04827134|527184025|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
146183632|NCT04827134|527184026|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
146183633|NCT02443103|527184031|FG000|Overall Study|Adverse Event|2|||
146183634|NCT02443103|527184031|FG000|Overall Study|Noncompliance|1|||
146183635|NCT03358329|527184036|FG000|Overall Study|Lost to Follow-up|2|||
146183636|NCT03358329|527184036|FG000|Overall Study|Withdrawal by Subject|2|||
146183637|NCT02982720|527184037|FG000|Overall Study|Adverse Event|3|||
146183638|NCT02982720|527184037|FG000|Overall Study|Death|1|||
146183639|NCT03875911|527184040|FG000|Overall Study|Lost to Follow-up|3|||
146183640|NCT03875911|527184041|FG001|Overall Study|Lost to Follow-up|6|||
146183641|NCT03875911|527184042|FG002|Overall Study|Lost to Follow-up|2|||
146183642|NCT03875911|527184040|FG000|Overall Study|Surgery cancelled|1|||
146183643|NCT03875911|527184041|FG001|Overall Study|Surgery cancelled|0|||
146183644|NCT03875911|527184042|FG002|Overall Study|Surgery cancelled|1|||
146183645|NCT03875911|527184040|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
146183646|NCT03875911|527184041|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
146183647|NCT03875911|527184042|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
146183648|NCT00287469|527184048|FG000|Overall Study|serious adverse event|1|||
146183649|NCT00287469|527184049|FG001|Overall Study|serious adverse event|6|||
146183650|NCT00287469|527184048|FG000|Overall Study|Adverse Event|1|||
146183651|NCT00287469|527184049|FG001|Overall Study|Adverse Event|1|||
146183652|NCT00287469|527184048|FG000|Overall Study|moved from area|144|||
146183653|NCT00287469|527184049|FG001|Overall Study|moved from area|138|||
146183654|NCT00287469|527184048|FG000|Overall Study|Lost to Follow-up|74|||
146183655|NCT00287469|527184049|FG001|Overall Study|Lost to Follow-up|69|||
146183656|NCT00065468|527184050|FG000|Overall Study|Death|172|||
146183657|NCT00065468|527184051|FG001|Overall Study|Death|169|||
146183658|NCT00065468|527184052|FG002|Overall Study|Death|171|||
146183659|NCT00065468|527184050|FG000|Overall Study|Withdrawal by Subject|3|||
146183660|NCT00065468|527184051|FG001|Overall Study|Withdrawal by Subject|4|||
146183661|NCT00065468|527184052|FG002|Overall Study|Withdrawal by Subject|5|||
146183662|NCT00065468|527184050|FG000|Overall Study|Lost to Follow-up|5|||
146183663|NCT00065468|527184051|FG001|Overall Study|Lost to Follow-up|3|||
146183664|NCT00065468|527184052|FG002|Overall Study|Lost to Follow-up|2|||
146183665|NCT00065468|527184050|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
146183666|NCT00065468|527184051|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
146183667|NCT00065468|527184052|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
146183668|NCT00065468|527184050|FG000|Overall Study|Disease progression|0|||
146183669|NCT00065468|527184051|FG001|Overall Study|Disease progression|0|||
146183670|NCT00065468|527184052|FG002|Overall Study|Disease progression|1|||
146183671|NCT00065468|527184050|FG000|Overall Study|Other|14|||
146183672|NCT00065468|527184051|FG001|Overall Study|Other|24|||
146183673|NCT00065468|527184052|FG002|Overall Study|Other|18|||
146183674|NCT02019602|527184058|FG000|Screening Period|Ineligibility|4|||
146183675|NCT02019602|527184059|FG001|Screening Period|Ineligibility|0|||
146183676|NCT02019602|527184058|FG000|Screening Period|Adverse Event|1|||
146183677|NCT02019602|527184059|FG001|Screening Period|Adverse Event|0|||
146183678|NCT00683449|527184060|FG000|Overall Study|Lost to Follow-up|0|||
146183679|NCT00683449|527184061|FG001|Overall Study|Lost to Follow-up|1|||
146183680|NCT00683449|527184062|FG002|Overall Study|Lost to Follow-up|0|||
146183681|NCT00683449|527184063|FG003|Overall Study|Lost to Follow-up|0|||
146183682|NCT00683449|527184064|FG004|Overall Study|Lost to Follow-up|0|||
146183683|NCT01058863|527184065|FG000|Overall Study|Lost to Follow-up|1|||
146183684|NCT01058863|527184065|FG000|Overall Study|Withdrawal by Subject|1|||
146183685|NCT01058863|527184065|FG000|Overall Study|Sponsor requested withdrawal|1|||
146183686|NCT01058863|527184065|FG000|Overall Study|Randomized in error|1|||
146183687|NCT00507026|527184066|FG000|Overall Study|Lack of Efficacy|6|||
146183688|NCT00507026|527184067|FG001|Overall Study|Lack of Efficacy|4|||
146183689|NCT00507026|527184068|FG002|Overall Study|Lack of Efficacy|21|||
146183690|NCT00507026|527184066|FG000|Overall Study|Withdrawal by Subject|2|||
146183691|NCT00507026|527184067|FG001|Overall Study|Withdrawal by Subject|0|||
146183692|NCT00507026|527184068|FG002|Overall Study|Withdrawal by Subject|0|||
146183693|NCT00507026|527184066|FG000|Overall Study|Investigator Decision|1|||
146183694|NCT00507026|527184067|FG001|Overall Study|Investigator Decision|0|||
146183695|NCT00507026|527184068|FG002|Overall Study|Investigator Decision|0|||
146183696|NCT00507026|527184066|FG000|Overall Study|Adverse Event|2|||
146183697|NCT00507026|527184067|FG001|Overall Study|Adverse Event|0|||
146183698|NCT00507026|527184068|FG002|Overall Study|Adverse Event|0|||
146183699|NCT00507026|527184066|FG000|Overall Study|Protocol Violation|1|||
146183700|NCT00507026|527184067|FG001|Overall Study|Protocol Violation|0|||
146183701|NCT00507026|527184068|FG002|Overall Study|Protocol Violation|0|||
146183702|NCT00507026|527184066|FG000|Overall Study|Other|1|||
146183703|NCT00507026|527184067|FG001|Overall Study|Other|0|||
146183704|NCT00507026|527184068|FG002|Overall Study|Other|0|||
146183705|NCT03653416|527184069|FG000|Overall Study|Protocol Violation|6|||
146183706|NCT03653416|527184070|FG001|Overall Study|Protocol Violation|1|||
146183707|NCT00681187|527184071|FG000|Overall Study|Withdrawal by Subject|1|||
146183708|NCT00681187|527184072|FG001|Overall Study|Withdrawal by Subject|0|||
146183709|NCT00681187|527184071|FG000|Overall Study|Death|0|||
146183710|NCT00681187|527184072|FG001|Overall Study|Death|1|||
146183711|NCT00681187|527184071|FG000|Overall Study|Adverse Event|0|||
146183712|NCT00681187|527184072|FG001|Overall Study|Adverse Event|1|||
146183713|NCT02788006|527184078|FG000|Overall Study|Patient not treated|1|||
146183714|NCT03541642|527184081|FG000|Overall Study|Withdrawal by Subject|1|||
146183715|NCT03541642|527184082|FG001|Overall Study|Withdrawal by Subject|2|||
146183716|NCT03541642|527184081|FG000|Overall Study|Lost to Follow-up|16|||
146183717|NCT03541642|527184082|FG001|Overall Study|Lost to Follow-up|12|||
146183718|NCT03541642|527184081|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
146183719|NCT03541642|527184082|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
146183720|NCT03050398|527184085|FG000|Overall Study|Study terminated by sponsor|8|||
146183721|NCT03055832|527184086|FG000|Week 2|Withdrawal by Subject|1|||
146183722|NCT03055832|527184087|FG001|Week 2|Withdrawal by Subject|0|||
146183723|NCT03619174|527184088|FG000|Overall Study|Lost to Follow-up|3|||
146183724|NCT03619174|527184089|FG001|Overall Study|Lost to Follow-up|0|||
146183725|NCT03619174|527184088|FG000|Overall Study|Withdrawal by Subject|4|||
146183726|NCT03619174|527184089|FG001|Overall Study|Withdrawal by Subject|3|||
146183727|NCT03619174|527184088|FG000|Overall Study|Pregnancy|1|||
146183728|NCT03619174|527184089|FG001|Overall Study|Pregnancy|1|||
146183729|NCT03619174|527184088|FG000|Overall Study|Discomfort during treatment|1|||
146183730|NCT03619174|527184089|FG001|Overall Study|Discomfort during treatment|0|||
146183731|NCT01991197|527184090|FG000|Overall Study|Lost to Follow-up|1|||
146183732|NCT01991197|527184091|FG001|Overall Study|Lost to Follow-up|1|||
146183733|NCT01991197|527184090|FG000|Overall Study|Physician Decision|0|||
146183734|NCT01991197|527184091|FG001|Overall Study|Physician Decision|2|||
146183735|NCT01991197|527184090|FG000|Overall Study|Withdrawal by Subject|2|||
146183736|NCT01991197|527184091|FG001|Overall Study|Withdrawal by Subject|0|||
146183737|NCT01010217|527184092|FG000|Overall Study|Lost to Follow-up|4|||
146183738|NCT01010217|527184093|FG001|Overall Study|Lost to Follow-up|5|||
146183739|NCT01010217|527184094|FG002|Overall Study|Lost to Follow-up|1|||
146183740|NCT01010217|527184095|FG003|Overall Study|Lost to Follow-up|0|||
146183741|NCT01010217|527184096|FG004|Overall Study|Lost to Follow-up|0|||
146183742|NCT01010217|527184092|FG000|Overall Study|Withdrawal by Subject|1|||
146183743|NCT01010217|527184093|FG001|Overall Study|Withdrawal by Subject|0|||
146183744|NCT01010217|527184094|FG002|Overall Study|Withdrawal by Subject|0|||
146183745|NCT01010217|527184095|FG003|Overall Study|Withdrawal by Subject|0|||
146183746|NCT01010217|527184096|FG004|Overall Study|Withdrawal by Subject|0|||
146183747|NCT01010217|527184092|FG000|Overall Study|Physician Decision|0|||
146183748|NCT01010217|527184093|FG001|Overall Study|Physician Decision|0|||
146183749|NCT01010217|527184094|FG002|Overall Study|Physician Decision|0|||
146183750|NCT01010217|527184095|FG003|Overall Study|Physician Decision|6|||
146183751|NCT01010217|527184096|FG004|Overall Study|Physician Decision|3|||
146183752|NCT04242875|527184099|FG000|Overall Study|Adverse Event|2|||
146183753|NCT01556763|527184110|FG000|Overall Study|Withdrawal by Subject|0|||
146183754|NCT01556763|527184111|FG001|Overall Study|Withdrawal by Subject|1|||
146183755|NCT01556763|527184112|FG002|Overall Study|Withdrawal by Subject|0|||
146183756|NCT02258464|527184113|FG000|Overall Study|Progressive disease (PD)|9|||
146183757|NCT02258464|527184114|FG001|Overall Study|Progressive disease (PD)|17|||
146183758|NCT02258464|527184113|FG000|Overall Study|Study drug never administered|1|||
146183759|NCT02258464|527184114|FG001|Overall Study|Study drug never administered|1|||
146183760|NCT02258464|527184113|FG000|Overall Study|AE not related to clinical PD|1|||
146183761|NCT02258464|527184114|FG001|Overall Study|AE not related to clinical PD|3|||
146183762|NCT02258464|527184113|FG000|Overall Study|Withdrawal by Subject|5|||
146183763|NCT02258464|527184114|FG001|Overall Study|Withdrawal by Subject|4|||
146183764|NCT02258464|527184113|FG000|Overall Study|AE related to clinical PD|1|||
146183765|NCT02258464|527184114|FG001|Overall Study|AE related to clinical PD|0|||
146183766|NCT00932646|527184115|FG000|Overall Study|Adverse Event|2|||
146183767|NCT00932646|527184116|FG001|Overall Study|Adverse Event|1|||
146183768|NCT00932646|527184117|FG002|Overall Study|Adverse Event|1|||
146183769|NCT00932646|527184118|FG003|Overall Study|Adverse Event|1|||
146183770|NCT00932646|527184115|FG000|Overall Study|Lost to Follow-up|2|||
146183771|NCT00932646|527184116|FG001|Overall Study|Lost to Follow-up|1|||
146183772|NCT00932646|527184117|FG002|Overall Study|Lost to Follow-up|0|||
146183773|NCT00932646|527184118|FG003|Overall Study|Lost to Follow-up|0|||
146183774|NCT00932646|527184115|FG000|Overall Study|Withdrawal by Subject|1|||
146183775|NCT00932646|527184116|FG001|Overall Study|Withdrawal by Subject|1|||
146183776|NCT00932646|527184117|FG002|Overall Study|Withdrawal by Subject|3|||
146183777|NCT00932646|527184118|FG003|Overall Study|Withdrawal by Subject|0|||
146183778|NCT02611830|527184119|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
146183779|NCT02611830|527184120|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146183780|NCT02611830|527184121|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146183781|NCT02611830|527184122|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
146183782|NCT02611830|527184119|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
146183783|NCT02611830|527184120|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
146183784|NCT02611830|527184121|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
146183785|NCT02611830|527184122|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
146183786|NCT02611830|527184119|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
146183787|NCT02611830|527184120|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
146183788|NCT02611830|527184121|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
146183789|NCT02611830|527184122|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
146183790|NCT02611830|527184119|FG000|OL Induction Phase|Lack of Efficacy|9|||
146183791|NCT02611830|527184120|FG001|OL Induction Phase|Lack of Efficacy|0|||
146183792|NCT02611830|527184121|FG002|OL Induction Phase|Lack of Efficacy|0|||
146183793|NCT02611830|527184122|FG003|OL Induction Phase|Lack of Efficacy|0|||
146183794|NCT02611830|527184119|FG000|OL Induction Phase|Reason not specified|3|||
146183795|NCT02611830|527184120|FG001|OL Induction Phase|Reason not specified|0|||
146183796|NCT02611830|527184121|FG002|OL Induction Phase|Reason not specified|0|||
146183797|NCT02611830|527184122|FG003|OL Induction Phase|Reason not specified|0|||
146183798|NCT02611830|527184119|FG000|Maintenance Phase|Lack of Efficacy|0|||
146183799|NCT02611830|527184120|FG001|Maintenance Phase|Lack of Efficacy|29|||
146183800|NCT02611830|527184121|FG002|Maintenance Phase|Lack of Efficacy|18|||
146183801|NCT02611830|527184122|FG003|Maintenance Phase|Lack of Efficacy|6|||
146183802|NCT02611830|527184119|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
146183803|NCT02611830|527184120|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
146183804|NCT02611830|527184121|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
146183805|NCT02611830|527184122|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
146183806|NCT02611830|527184119|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
146183807|NCT02611830|527184120|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
146183808|NCT02611830|527184121|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
146183809|NCT02611830|527184122|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
146183810|NCT02611830|527184119|FG000|Maintenance Phase|Lost to Follow-up|0|||
146183811|NCT02611830|527184120|FG001|Maintenance Phase|Lost to Follow-up|0|||
146183812|NCT02611830|527184121|FG002|Maintenance Phase|Lost to Follow-up|0|||
146183813|NCT02611830|527184122|FG003|Maintenance Phase|Lost to Follow-up|1|||
146183814|NCT02611830|527184119|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
146183815|NCT02611830|527184120|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
146183816|NCT02611830|527184121|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
146080684|NCT03859973|526816689|FG000|Overall Study|COVID-19 related, not due to AE|3|||
146080685|NCT03859973|526816690|FG001|Overall Study|COVID-19 related, not due to AE|4|||
146080686|NCT03859973|526816689|FG000|Overall Study|Withdrawal by Subject|8|||
146080687|NCT03859973|526816690|FG001|Overall Study|Withdrawal by Subject|9|||
146080688|NCT03859973|526816689|FG000|Overall Study|Lost to Follow-up|2|||
146080689|NCT03859973|526816690|FG001|Overall Study|Lost to Follow-up|3|||
146080690|NCT03859973|526816689|FG000|Overall Study|Protocol Violation|1|||
146080691|NCT03859973|526816690|FG001|Overall Study|Protocol Violation|3|||
146080692|NCT03859973|526816689|FG000|Overall Study|Adverse Event|3|||
146080693|NCT03859973|526816690|FG001|Overall Study|Adverse Event|5|||
146080694|NCT02855541|526816691|FG000|Overall Study|Change in health status|2|||
146080695|NCT02855541|526816691|FG000|Overall Study|Withdrawal by Subject|2|||
146080696|NCT04493892|526816697|FG000|Overall Study|Withdrawal by Subject|15|||
146080697|NCT01689532|526816698|FG000|Overall Study|Adverse Event|9|||
146080698|NCT01689532|526816699|FG001|Overall Study|Adverse Event|5|||
146080699|NCT01689532|526816698|FG000|Overall Study|Lack of Efficacy|2|||
146080700|NCT01689532|526816699|FG001|Overall Study|Lack of Efficacy|2|||
146080701|NCT01689532|526816698|FG000|Overall Study|Withdrawal by Subject|1|||
146080702|NCT01689532|526816699|FG001|Overall Study|Withdrawal by Subject|2|||
146080703|NCT01689532|526816698|FG000|Overall Study|Physician Decision|2|||
146080704|NCT01689532|526816699|FG001|Overall Study|Physician Decision|0|||
146080705|NCT01363349|526816700|FG000|Overall Study|Adverse Event|6|||
146080706|NCT01363349|526816701|FG001|Overall Study|Adverse Event|7|||
146080707|NCT01363349|526816700|FG000|Overall Study|Lack of Efficacy|3|||
146080708|NCT01363349|526816701|FG001|Overall Study|Lack of Efficacy|10|||
146080709|NCT01363349|526816700|FG000|Overall Study|Non compliance/Protocol deviations|2|||
146080710|NCT01363349|526816701|FG001|Overall Study|Non compliance/Protocol deviations|2|||
146080711|NCT01363349|526816700|FG000|Overall Study|Withdrawal by Subject|14|||
146080712|NCT01363349|526816701|FG001|Overall Study|Withdrawal by Subject|6|||
146080713|NCT01363349|526816700|FG000|Overall Study|Lost to Follow-up|5|||
146080714|NCT01363349|526816701|FG001|Overall Study|Lost to Follow-up|6|||
146080715|NCT01363349|526816700|FG000|Overall Study|Not reported|36|||
146080716|NCT01363349|526816701|FG001|Overall Study|Not reported|37|||
146080717|NCT01363349|526816700|FG000|Overall Study|missing|1|||
146080718|NCT01363349|526816701|FG001|Overall Study|missing|2|||
146080719|NCT01958489|526816702|FG000|Period 2|Adverse Event|0|||
146080720|NCT01958489|526816703|FG001|Period 2|Adverse Event|1|||
146080721|NCT00864916|526816706|FG000|Overall Study|Lost to Follow-up|4|||
146080722|NCT00864916|526816707|FG001|Overall Study|Lost to Follow-up|4|||
146080723|NCT00864916|526816706|FG000|Overall Study|Protocol Violation|1|||
146080724|NCT00864916|526816707|FG001|Overall Study|Protocol Violation|0|||
146080725|NCT00864916|526816706|FG000|Overall Study|Withdrawal by Subject|1|||
146080726|NCT00864916|526816707|FG001|Overall Study|Withdrawal by Subject|0|||
146080727|NCT00422084|526816708|FG000|Overall Study|Adverse Event|21|||
146080728|NCT00422084|526816709|FG001|Overall Study|Adverse Event|7|||
146080729|NCT00422084|526816708|FG000|Overall Study|Withdrawal by Subject|12|||
146080730|NCT00422084|526816709|FG001|Overall Study|Withdrawal by Subject|9|||
146080731|NCT00422084|526816708|FG000|Overall Study|Lost to Follow-up|14|||
146080732|NCT00422084|526816709|FG001|Overall Study|Lost to Follow-up|9|||
146080733|NCT00422084|526816708|FG000|Overall Study|Protocol Violation|4|||
146080734|NCT00422084|526816709|FG001|Overall Study|Protocol Violation|1|||
146080735|NCT00422084|526816708|FG000|Overall Study|Lack of Efficacy|40|||
146080736|NCT00422084|526816709|FG001|Overall Study|Lack of Efficacy|42|||
146080737|NCT00422084|526816708|FG000|Overall Study|P. vivax infection|3|||
146080738|NCT00422084|526816709|FG001|Overall Study|P. vivax infection|6|||
146080739|NCT00422084|526816708|FG000|Overall Study|Cyesis|1|||
146080740|NCT00422084|526816709|FG001|Overall Study|Cyesis|0|||
146080741|NCT00422084|526816708|FG000|Overall Study|Withdrawn from study accidentally|1|||
146080742|NCT00422084|526816709|FG001|Overall Study|Withdrawn from study accidentally|0|||
146080743|NCT00422084|526816708|FG000|Overall Study|Non-compliance|1|||
146080744|NCT00422084|526816709|FG001|Overall Study|Non-compliance|0|||
146080745|NCT00422084|526816708|FG000|Overall Study|Re-location|0|||
146080746|NCT00422084|526816709|FG001|Overall Study|Re-location|1|||
146080747|NCT00422084|526816708|FG000|Overall Study|Not defined|1|||
146080748|NCT00422084|526816709|FG001|Overall Study|Not defined|1|||
146080749|NCT03774823|526816710|FG000|Overall Study|Withdrawal by Subject|1|||
146080750|NCT03774823|526816711|FG001|Overall Study|Withdrawal by Subject|1|||
146080751|NCT03996369|526816716|FG000|Overall Study|Protocol deviation|1|||
146080752|NCT03996369|526816717|FG001|Overall Study|Protocol deviation|1|||
146080753|NCT03996369|526816716|FG000|Overall Study|Physician Decision|4|||
146080754|NCT03996369|526816717|FG001|Overall Study|Physician Decision|2|||
146080755|NCT03996369|526816716|FG000|Overall Study|Participant decision|0|||
146080756|NCT03996369|526816717|FG001|Overall Study|Participant decision|1|||
146080757|NCT03996369|526816716|FG000|Overall Study|Lack of Efficacy|4|||
146080758|NCT03996369|526816717|FG001|Overall Study|Lack of Efficacy|0|||
146080759|NCT03996369|526816716|FG000|Overall Study|Adverse Event|9|||
146080760|NCT03996369|526816717|FG001|Overall Study|Adverse Event|0|||
146080761|NCT03996369|526816716|FG000|Overall Study|Withdrawal by Subject|6|||
146080762|NCT03996369|526816717|FG001|Overall Study|Withdrawal by Subject|8|||
146183817|NCT02611830|527184122|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
146183818|NCT02611830|527184119|FG000|Maintenance Phase|Pregnancy|0|||
146183819|NCT02611830|527184120|FG001|Maintenance Phase|Pregnancy|0|||
146183820|NCT02611830|527184121|FG002|Maintenance Phase|Pregnancy|1|||
146183821|NCT02611830|527184122|FG003|Maintenance Phase|Pregnancy|0|||
146183822|NCT02611830|527184119|FG000|Maintenance Phase|Reason not specified|0|||
146183823|NCT02611830|527184120|FG001|Maintenance Phase|Reason not specified|1|||
146183824|NCT02611830|527184121|FG002|Maintenance Phase|Reason not specified|4|||
146183825|NCT02611830|527184122|FG003|Maintenance Phase|Reason not specified|0|||
146183826|NCT03567993|527184125|FG000|Overall Study|Lost to Follow-up|4|||
146183827|NCT03567993|527184126|FG001|Overall Study|Lost to Follow-up|2|||
146183828|NCT03567993|527184125|FG000|Overall Study|Death|1|||
146183829|NCT03567993|527184126|FG001|Overall Study|Death|1|||
146183830|NCT03567993|527184125|FG000|Overall Study|Withdrawal by Subject|1|||
146183831|NCT03567993|527184126|FG001|Overall Study|Withdrawal by Subject|0|||
146183832|NCT01671748|527184127|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
146183833|NCT01671748|527184128|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
146183834|NCT01671748|527184127|FG000|4 Week run-in Phase|Adverse Event|1|||
146183835|NCT01671748|527184128|FG001|4 Week run-in Phase|Adverse Event|0|||
146183836|NCT01671748|527184127|FG000|4 Week run-in Phase|Not eligible|9|||
146183837|NCT01671748|527184128|FG001|4 Week run-in Phase|Not eligible|0|||
146183838|NCT04714216|527185633|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
146183839|NCT04714216|527185633|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
146183840|NCT01349829|527185637|FG000|Overall Study|Lost to Follow-up|4|||
146183841|NCT01349829|527185638|FG001|Overall Study|Lost to Follow-up|8|||
146183842|NCT01349829|527185637|FG000|Overall Study|Consent withdrawal|3|||
146183843|NCT01349829|527185638|FG001|Overall Study|Consent withdrawal|8|||
146183844|NCT01349829|527185637|FG000|Overall Study|Migrated/moved|2|||
146183845|NCT01349829|527185638|FG001|Overall Study|Migrated/moved|7|||
146183846|NCT00777803|527185639|FG000|Overall Study|Lost to Follow-up|12|||
146183847|NCT00777803|527185640|FG001|Overall Study|Lost to Follow-up|5|||
146183848|NCT00777803|527185639|FG000|Overall Study|Adverse Event|1|||
146183849|NCT00777803|527185640|FG001|Overall Study|Adverse Event|0|||
146183850|NCT00777803|527185639|FG000|Overall Study|Non-compliance|2|||
146183851|NCT00777803|527185640|FG001|Overall Study|Non-compliance|2|||
146183852|NCT01995357|527185643|FG000|Period 5|Lack of Efficacy|1|||
146183853|NCT01995357|527185644|FG001|Period 5|Lack of Efficacy|0|||
146183854|NCT01995357|527185645|FG002|Period 5|Lack of Efficacy|0|||
146183855|NCT01995357|527185646|FG003|Period 5|Lack of Efficacy|0|||
146183856|NCT01995357|527185647|FG004|Period 5|Lack of Efficacy|0|||
146183857|NCT01995357|527185648|FG005|Period 5|Lack of Efficacy|0|||
146183858|NCT01995357|527185643|FG000|Period 5|Adverse Event|1|||
146183859|NCT01995357|527185644|FG001|Period 5|Adverse Event|0|||
146183860|NCT01995357|527185645|FG002|Period 5|Adverse Event|1|||
146183861|NCT01995357|527185646|FG003|Period 5|Adverse Event|0|||
146183862|NCT01995357|527185647|FG004|Period 5|Adverse Event|0|||
146183863|NCT01995357|527185648|FG005|Period 5|Adverse Event|0|||
146183864|NCT04129580|527185649|FG000|Overall Study|Lost to Follow-up|14|||
146183865|NCT04129580|527185650|FG001|Overall Study|Lost to Follow-up|25|||
146183866|NCT02711995|527185653|FG000|Washout (90 Days)|Conflicting medication|1|||
146183867|NCT03615482|527185654|FG000|Overall Study|Death|1|||
146183868|NCT03615482|527185655|FG001|Overall Study|Death|0|||
146183869|NCT03615482|527185654|FG000|Overall Study|Lost to Follow-up|7|||
146183870|NCT03615482|527185655|FG001|Overall Study|Lost to Follow-up|7|||
146183871|NCT03615482|527185654|FG000|Overall Study|Physician Decision|2|||
146183872|NCT03615482|527185655|FG001|Overall Study|Physician Decision|3|||
146183873|NCT03615482|527185654|FG000|Overall Study|Withdrawal by Subject|7|||
146183874|NCT03615482|527185655|FG001|Overall Study|Withdrawal by Subject|7|||
146183875|NCT00322868|527185656|FG000|Overall Study|disease progression|1|||
146183876|NCT01852162|527185658|FG000|Overall Study|Adverse Event|1|||
146412376|NCT02544633|528015505|FG002|Treatment Period|Clinical Disease Progression|0|||
146412377|NCT02544633|528015506|FG003|Treatment Period|Clinical Disease Progression|1|||
146183877|NCT01852162|527185659|FG001|Overall Study|Adverse Event|0|||
146183878|NCT01852162|527185658|FG000|Overall Study|Withdrawal by Subject|3|||
146183879|NCT01852162|527185659|FG001|Overall Study|Withdrawal by Subject|1|||
146183880|NCT02955277|527185662|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
146183881|NCT02955277|527185663|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
146183882|NCT02955277|527185662|FG000|Post to Follow-up|Lost to Follow-up|8|||
146183883|NCT02955277|527185663|FG001|Post to Follow-up|Lost to Follow-up|11|||
146183884|NCT00163215|527185673|FG000|Overall Study|Lack of Efficacy|3|||
146183885|NCT00163215|527185673|FG000|Overall Study|Withdrawal by Subject|5|||
146183886|NCT00163215|527185673|FG000|Overall Study|Other|7|||
146183887|NCT01809210|527185676|FG000|Overall Study|Withdrawal by Subject|0|||
146183888|NCT01809210|527185677|FG001|Overall Study|Withdrawal by Subject|0|||
146183889|NCT01809210|527185678|FG002|Overall Study|Withdrawal by Subject|1|||
146183890|NCT01809210|527185679|FG003|Overall Study|Withdrawal by Subject|1|||
146183891|NCT01809210|527185680|FG004|Overall Study|Withdrawal by Subject|1|||
146183892|NCT01809210|527185681|FG005|Overall Study|Withdrawal by Subject|0|||
146183893|NCT01809210|527185682|FG006|Overall Study|Withdrawal by Subject|4|||
146183894|NCT01809210|527185676|FG000|Overall Study|Death|1|||
146183895|NCT01809210|527185677|FG001|Overall Study|Death|1|||
146183896|NCT01809210|527185678|FG002|Overall Study|Death|2|||
146183897|NCT01809210|527185679|FG003|Overall Study|Death|0|||
146183898|NCT01809210|527185680|FG004|Overall Study|Death|1|||
146183899|NCT01809210|527185681|FG005|Overall Study|Death|3|||
146183900|NCT01809210|527185682|FG006|Overall Study|Death|1|||
146183901|NCT01115998|527185684|FG000|Overall Study|Lost to Follow-up|6|||
146183902|NCT01115998|527185685|FG001|Overall Study|Lost to Follow-up|6|||
146183903|NCT00590980|527185686|FG000|Overall Study|Did not meet all inclusion criteria|10|||
146183904|NCT02819479|527185687|FG000|Overall Study|Adverse Event|2|||
146183905|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
146183906|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
146183907|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
146183908|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
146183909|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
146183910|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
146183911|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
146183912|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
146183913|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
146183914|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
146183915|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
146183916|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
146183917|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
146183918|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
146183919|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
146183920|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
146183921|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
146183922|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
146183923|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
146183924|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
146183925|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
146183926|NCT02718417|527185690|FG000|Chemotherapy Phase (CP)|Other|2|||
146183927|NCT02718417|527185691|FG001|Chemotherapy Phase (CP)|Other|0|||
146183928|NCT02718417|527185692|FG002|Chemotherapy Phase (CP)|Other|1|||
146183929|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Adverse Event|21|||
146183930|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Adverse Event|26|||
146183931|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Adverse Event|0|||
146183932|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
146183933|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
146183934|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
146183935|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
146183936|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
146183937|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
146183938|NCT02718417|527185690|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
146183939|NCT02718417|527185691|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
146183940|NCT02718417|527185692|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
146183941|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Physician's decision|6|||
146183942|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Physician's decision|7|||
146183943|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Physician's decision|0|||
146183944|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Progressive disease|100|||
146183945|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Progressive disease|88|||
146183946|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Progressive disease|0|||
146183947|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Other|2|||
146183948|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Other|1|||
146183949|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Other|0|||
146183950|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
146183951|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
146183952|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
146183953|NCT02718417|527185690|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
146183954|NCT02718417|527185691|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
146183955|NCT02718417|527185692|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
146183956|NCT02718417|527185690|FG000|Observation Phase (OP)|Adverse Event|0|||
146183957|NCT02718417|527185691|FG001|Observation Phase (OP)|Adverse Event|0|||
146183958|NCT02718417|527185692|FG002|Observation Phase (OP)|Adverse Event|1|||
146183959|NCT02718417|527185690|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
146183960|NCT02718417|527185691|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
146183961|NCT02718417|527185692|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
146183962|NCT02718417|527185690|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
146183963|NCT02718417|527185691|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
146183964|NCT02718417|527185692|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
146183965|NCT02718417|527185690|FG000|Observation Phase (OP)|Physician Decision|0|||
146183966|NCT02718417|527185691|FG001|Observation Phase (OP)|Physician Decision|0|||
146183967|NCT02718417|527185692|FG002|Observation Phase (OP)|Physician Decision|9|||
146183968|NCT02718417|527185690|FG000|Observation Phase (OP)|Progressive disease|0|||
146183969|NCT02718417|527185691|FG001|Observation Phase (OP)|Progressive disease|0|||
146183970|NCT02718417|527185692|FG002|Observation Phase (OP)|Progressive disease|92|||
146183971|NCT02718417|527185690|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
146183972|NCT02718417|527185691|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
146183973|NCT02718417|527185692|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
146183974|NCT02718417|527185690|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
146183975|NCT02718417|527185691|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
146183976|NCT02718417|527185692|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
146183977|NCT02718417|527185690|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
146183978|NCT02718417|527185691|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
146183979|NCT02718417|527185692|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
146183980|NCT02718417|527185690|FG000|Observation Phase (OP)|Other|0|||
146183981|NCT02718417|527185691|FG001|Observation Phase (OP)|Other|0|||
146183982|NCT02718417|527185692|FG002|Observation Phase (OP)|Other|7|||
146183983|NCT02718417|527185690|FG000|Follow-up Phase|Adverse Event|3|||
146183984|NCT02718417|527185691|FG001|Follow-up Phase|Adverse Event|1|||
146183985|NCT02718417|527185692|FG002|Follow-up Phase|Adverse Event|1|||
146183986|NCT02718417|527185690|FG000|Follow-up Phase|Other|4|||
146183987|NCT02718417|527185691|FG001|Follow-up Phase|Other|6|||
146183988|NCT02718417|527185692|FG002|Follow-up Phase|Other|4|||
146183989|NCT02718417|527185690|FG000|Follow-up Phase|Withdrawal by Subject|19|||
146183990|NCT02718417|527185691|FG001|Follow-up Phase|Withdrawal by Subject|17|||
146080763|NCT03996369|526816716|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
146080764|NCT03996369|526816717|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
146080765|NCT03996369|526816716|FG000|Overall Study|Lost to Follow-up|0|||
146080766|NCT03996369|526816717|FG001|Overall Study|Lost to Follow-up|1|||
146080767|NCT00653432|526816719|FG000|Overall Study|Adverse Event|4|||
146080768|NCT00653432|526816720|FG001|Overall Study|Adverse Event|1|||
146080769|NCT00653432|526816719|FG000|Overall Study|Withdrawal by Subject|4|||
146080770|NCT00653432|526816720|FG001|Overall Study|Withdrawal by Subject|5|||
146080771|NCT00653432|526816719|FG000|Overall Study|Lost to Follow-up|7|||
146080772|NCT00653432|526816720|FG001|Overall Study|Lost to Follow-up|6|||
146080773|NCT00653432|526816719|FG000|Overall Study|Use/Need of Con Therapy|2|||
146080774|NCT00653432|526816720|FG001|Overall Study|Use/Need of Con Therapy|1|||
146080775|NCT00653432|526816719|FG000|Overall Study|Other - Reason Not Provided|5|||
146080776|NCT00653432|526816720|FG001|Overall Study|Other - Reason Not Provided|3|||
146080777|NCT05277337|526816721|FG000|Overall Study|Lost to Follow-up|2|||
146080778|NCT05277337|526816722|FG001|Overall Study|Lost to Follow-up|0|||
146080779|NCT05277337|526816721|FG000|Overall Study|Withdrawal by Subject|1|||
146080780|NCT05277337|526816722|FG001|Overall Study|Withdrawal by Subject|0|||
146080781|NCT01782469|526816723|FG000|Overall Study|Lost to Follow-up|1|||
146080782|NCT00357760|526816726|FG000|Overall Study|Disease progression|44|||
146080783|NCT00357760|526816727|FG001|Overall Study|Disease progression|17|||
146080784|NCT00357760|526816726|FG000|Overall Study|Adverse Event|10|||
146080785|NCT00357760|526816727|FG001|Overall Study|Adverse Event|7|||
146080786|NCT00357760|526816726|FG000|Overall Study|Death|0|||
146080787|NCT00357760|526816727|FG001|Overall Study|Death|3|||
146080788|NCT00357760|526816726|FG000|Overall Study|Alternative therapy|1|||
146080789|NCT00357760|526816727|FG001|Overall Study|Alternative therapy|0|||
146080790|NCT00357760|526816726|FG000|Overall Study|Withdrawal by Subject|0|||
146080791|NCT00357760|526816727|FG001|Overall Study|Withdrawal by Subject|2|||
146080792|NCT00357760|526816726|FG000|Overall Study|Never started treatment|2|||
146080793|NCT00357760|526816727|FG001|Overall Study|Never started treatment|1|||
146080794|NCT00357760|526816726|FG000|Overall Study|Ineligible|0|||
146080795|NCT00357760|526816727|FG001|Overall Study|Ineligible|2|||
146080796|NCT00357760|526816726|FG000|Overall Study|Physician Decision|2|||
146080797|NCT00357760|526816727|FG001|Overall Study|Physician Decision|1|||
146080798|NCT00357760|526816726|FG000|Overall Study|Protocol Violation|0|||
146080799|NCT00357760|526816727|FG001|Overall Study|Protocol Violation|1|||
146080800|NCT00357760|526816726|FG000|Overall Study|To receive hospice care|0|||
146080801|NCT00357760|526816727|FG001|Overall Study|To receive hospice care|1|||
146080802|NCT02350764|526816728|FG000|Overall Study|Adverse Event|4|||
146080803|NCT02350764|526816728|FG000|Overall Study|Death|3|||
146183991|NCT02718417|527185692|FG002|Follow-up Phase|Withdrawal by Subject|5|||
146183992|NCT02718417|527185690|FG000|Follow-up Phase|Study terminated by sponsor|100|||
146183993|NCT02718417|527185691|FG001|Follow-up Phase|Study terminated by sponsor|138|||
146183994|NCT02718417|527185692|FG002|Follow-up Phase|Study terminated by sponsor|6|||
146080804|NCT02350764|526816728|FG000|Overall Study|Physician Decision|2|||
146080805|NCT02350764|526816728|FG000|Overall Study|Withdrawal by Subject|2|||
146080806|NCT01224782|526816732|FG000|Overall Study|Lost to Follow-up|177|||
146080807|NCT01224782|526816732|FG000|Overall Study|Withdrawal by Subject|16|||
146080808|NCT01224782|526816732|FG000|Overall Study|Death|14|||
146183995|NCT02718417|527185690|FG000|Follow-up Phase|Lost to Follow-up|2|||
146183996|NCT02718417|527185691|FG001|Follow-up Phase|Lost to Follow-up|3|||
146183997|NCT02718417|527185692|FG002|Follow-up Phase|Lost to Follow-up|0|||
146183998|NCT02718417|527185690|FG000|Follow-up Phase|Death leading to discontinuation|7|||
146183999|NCT02718417|527185691|FG001|Follow-up Phase|Death leading to discontinuation|7|||
146184000|NCT02718417|527185692|FG002|Follow-up Phase|Death leading to discontinuation|3|||
146184001|NCT02718417|527185690|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
146184002|NCT02718417|527185691|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
146184003|NCT02718417|527185692|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
146184004|NCT02718417|527185690|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
146184005|NCT02718417|527185691|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
146184006|NCT02718417|527185692|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
146184007|NCT02718417|527185690|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
146184008|NCT02718417|527185691|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
146184009|NCT02718417|527185692|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
146184010|NCT02718417|527185690|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
146080809|NCT01224782|526816732|FG000|Overall Study|Improvement|13|||
146080810|NCT01224782|526816732|FG000|Overall Study|Adverse Event|12|||
146080811|NCT01224782|526816732|FG000|Overall Study|Adverse Reaction|11|||
146080812|NCT01224782|526816732|FG000|Overall Study|Noncompliance|10|||
146080813|NCT01224782|526816732|FG000|Overall Study|Other|4|||
146080814|NCT01224782|526816732|FG000|Overall Study|Start of Dialysis|3|||
146080815|NCT01224782|526816732|FG000|Overall Study|Change of Treatment|1|||
146080816|NCT01224782|526816732|FG000|Overall Study|Financial Reasons|1|||
146080817|NCT01224782|526816732|FG000|Overall Study|Deterioration|1|||
146080818|NCT01224782|526816732|FG000|Overall Study|Transplantation|1|||
146080819|NCT00441116|526816733|FG000|Overall Study|Adverse Event|1|||
146080820|NCT00441116|526816734|FG001|Overall Study|Adverse Event|1|||
146080821|NCT00441116|526816733|FG000|Overall Study|Withdrawal by Subject|1|||
146080822|NCT00441116|526816734|FG001|Overall Study|Withdrawal by Subject|0|||
146080823|NCT00441116|526816733|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
146080824|NCT00441116|526816734|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
146080825|NCT02925338|526816735|FG000|Overall Study|Death|0|||
146080826|NCT02925338|526816736|FG001|Overall Study|Death|2|||
146080827|NCT02925338|526816737|FG002|Overall Study|Death|1|||
146080828|NCT02925338|526816738|FG003|Overall Study|Death|0|||
146080829|NCT02925338|526816739|FG004|Overall Study|Death|0|||
146184011|NCT02718417|527185691|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
146184012|NCT02718417|527185692|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
146184013|NCT02718417|527185690|FG000|Long-term Follow-up Phase|Other|0|||
146184014|NCT02718417|527185691|FG001|Long-term Follow-up Phase|Other|2|||
146184015|NCT02718417|527185692|FG002|Long-term Follow-up Phase|Other|0|||
146184016|NCT01023308|527185693|FG000|Overall Study|Abnormal test proceedure results|3|||
146184017|NCT01023308|527185694|FG001|Overall Study|Abnormal test proceedure results|8|||
146184018|NCT01023308|527185693|FG000|Overall Study|Administrative problems|2|||
146184019|NCT01023308|527185694|FG001|Overall Study|Administrative problems|1|||
146184020|NCT01023308|527185693|FG000|Overall Study|Adverse Event|130|||
146184021|NCT01023308|527185694|FG001|Overall Study|Adverse Event|66|||
146184022|NCT01023308|527185693|FG000|Overall Study|Death|21|||
146184023|NCT01023308|527185694|FG001|Overall Study|Death|17|||
146184024|NCT01023308|527185693|FG000|Overall Study|Disease progression|82|||
146184025|NCT01023308|527185694|FG001|Overall Study|Disease progression|153|||
146184026|NCT01023308|527185693|FG000|Overall Study|New Cancer therapy|4|||
146184027|NCT01023308|527185694|FG001|Overall Study|New Cancer therapy|7|||
146184028|NCT01023308|527185693|FG000|Overall Study|Protocol Violation|3|||
146184029|NCT01023308|527185694|FG001|Overall Study|Protocol Violation|4|||
146184030|NCT01023308|527185693|FG000|Overall Study|Untreated|5|||
146184031|NCT01023308|527185694|FG001|Overall Study|Untreated|5|||
146184032|NCT01023308|527185693|FG000|Overall Study|Lost to Follow-up|1|||
146184033|NCT01023308|527185694|FG001|Overall Study|Lost to Follow-up|0|||
146184034|NCT01023308|527185693|FG000|Overall Study|Withdrawal by Subject|34|||
146184035|NCT01023308|527185694|FG001|Overall Study|Withdrawal by Subject|18|||
146184036|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
146184037|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
146080830|NCT02925338|526816735|FG000|Overall Study|Lost to Follow-up|30|||
146080831|NCT02925338|526816736|FG001|Overall Study|Lost to Follow-up|10|||
146184038|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
146184039|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
146080832|NCT02925338|526816737|FG002|Overall Study|Lost to Follow-up|1|||
146184040|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
146080833|NCT02925338|526816738|FG003|Overall Study|Lost to Follow-up|16|||
146184041|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
146184042|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
146184043|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
146412378|NCT02544633|528015503|FG000|Survival Follow-up Period|Death|12|||
146080834|NCT02925338|526816739|FG004|Overall Study|Lost to Follow-up|3|||
146080835|NCT02925338|526816735|FG000|Overall Study|Withdrawal by Subject|3|||
146080836|NCT02925338|526816736|FG001|Overall Study|Withdrawal by Subject|0|||
146184044|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146184045|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
146184046|NCT01646320|527185701|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
146184047|NCT01646320|527185702|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
146184048|NCT01646320|527185701|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
146184049|NCT01646320|527185702|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
146184050|NCT01646320|527185701|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
146184051|NCT01646320|527185702|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
146184052|NCT01646320|527185701|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
146184053|NCT01646320|527185702|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
146184054|NCT01646320|527185701|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
146184055|NCT01646320|527185702|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
146184056|NCT01646320|527185701|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
146184057|NCT01646320|527185702|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
146184058|NCT02485353|527185705|FG000|Overall Study|Death|1|||
146184059|NCT02485353|527185705|FG000|Overall Study|Disease Progression|1|||
146184060|NCT00839917|527185706|FG000|Overall Study|Lost to Follow-up|1|||
146184061|NCT00839917|527185707|FG001|Overall Study|Lost to Follow-up|0|||
146184062|NCT00839917|527185706|FG000|Overall Study|Did not receive vaccine|0|||
146184063|NCT00839917|527185707|FG001|Overall Study|Did not receive vaccine|1|||
146184064|NCT03354637|527185708|FG000|Double-blind Period|Protocol Violation|2|||
146184065|NCT03354637|527185709|FG001|Double-blind Period|Protocol Violation|0|||
146184066|NCT03354637|527185710|FG002|Double-blind Period|Protocol Violation|0|||
146184067|NCT03354637|527185708|FG000|Double-blind Period|Adverse Event|1|||
146184068|NCT03354637|527185709|FG001|Double-blind Period|Adverse Event|2|||
146184069|NCT03354637|527185710|FG002|Double-blind Period|Adverse Event|0|||
146184070|NCT03354637|527185708|FG000|Double-blind Period|Lost to Follow-up|3|||
146184071|NCT03354637|527185709|FG001|Double-blind Period|Lost to Follow-up|4|||
146184072|NCT03354637|527185710|FG002|Double-blind Period|Lost to Follow-up|3|||
146080837|NCT02925338|526816737|FG002|Overall Study|Withdrawal by Subject|3|||
146080838|NCT02925338|526816738|FG003|Overall Study|Withdrawal by Subject|2|||
146080839|NCT02925338|526816739|FG004|Overall Study|Withdrawal by Subject|2|||
146080840|NCT02925338|526816735|FG000|Overall Study|Missing|38|||
146080841|NCT02925338|526816736|FG001|Overall Study|Missing|27|||
146080842|NCT02925338|526816737|FG002|Overall Study|Missing|0|||
146080843|NCT02925338|526816738|FG003|Overall Study|Missing|3|||
146080844|NCT02925338|526816739|FG004|Overall Study|Missing|2|||
146080845|NCT02925338|526816735|FG000|Overall Study|Participant's Decision|11|||
146080846|NCT02925338|526816736|FG001|Overall Study|Participant's Decision|7|||
146080847|NCT02925338|526816737|FG002|Overall Study|Participant's Decision|3|||
146080848|NCT02925338|526816738|FG003|Overall Study|Participant's Decision|8|||
146080849|NCT02925338|526816739|FG004|Overall Study|Participant's Decision|1|||
146080850|NCT02925338|526816735|FG000|Overall Study|Treatment Discontinuation|144|||
146080851|NCT02925338|526816736|FG001|Overall Study|Treatment Discontinuation|65|||
146080852|NCT02925338|526816737|FG002|Overall Study|Treatment Discontinuation|56|||
146080853|NCT02925338|526816738|FG003|Overall Study|Treatment Discontinuation|131|||
146080854|NCT02925338|526816739|FG004|Overall Study|Treatment Discontinuation|22|||
146080855|NCT00548184|526816740|FG000|Overall Study|Adverse Event|3|||
146080856|NCT00548184|526816740|FG000|Overall Study|took other drug|1|||
146080857|NCT00548184|526816740|FG000|Overall Study|Found Her2 negative|1|||
146080858|NCT02395172|526816741|FG000|Overall Study|Participants randomized but not treated|3|||
146080859|NCT02395172|526816742|FG001|Overall Study|Participants randomized but not treated|31|||
146080860|NCT00029146|526816745|FG000|Overall Study|Lost to Follow-up|2|||
146080861|NCT00029146|526816746|FG001|Overall Study|Lost to Follow-up|1|||
146080862|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
146080863|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
146080864|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
146080865|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
146080866|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
146080867|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
146080868|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
146080869|NCT00946985|526816747|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
146080870|NCT00946985|526816747|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
146080871|NCT01546623|526816748|FG000|Overall Study|Adverse Event|2|||
146080872|NCT01546623|526816749|FG001|Overall Study|Adverse Event|3|||
146080873|NCT01546623|526816748|FG000|Overall Study|Major Protocol Deviation|1|||
146080874|NCT01546623|526816749|FG001|Overall Study|Major Protocol Deviation|1|||
146080875|NCT01546623|526816748|FG000|Overall Study|High Prostate specific antigen|2|||
146080876|NCT01546623|526816749|FG001|Overall Study|High Prostate specific antigen|1|||
146184073|NCT03354637|527185708|FG000|Double-blind Period|Withdrawal by Subject|10|||
146184074|NCT03354637|527185709|FG001|Double-blind Period|Withdrawal by Subject|6|||
146184075|NCT03354637|527185710|FG002|Double-blind Period|Withdrawal by Subject|4|||
146184076|NCT03354637|527185708|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
146184077|NCT03354637|527185709|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
146184078|NCT03354637|527185710|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
146184079|NCT03354637|527185708|FG000|Open Label Extension|Adverse Event|0|||
146184080|NCT03354637|527185709|FG001|Open Label Extension|Adverse Event|0|||
146184081|NCT03354637|527185710|FG002|Open Label Extension|Adverse Event|1|||
146184082|NCT03354637|527185708|FG000|Open Label Extension|Lost to Follow-up|0|||
146184083|NCT03354637|527185709|FG001|Open Label Extension|Lost to Follow-up|0|||
146184084|NCT03354637|527185710|FG002|Open Label Extension|Lost to Follow-up|2|||
146184085|NCT03354637|527185708|FG000|Open Label Extension|Withdrawal by Subject|0|||
146184086|NCT03354637|527185709|FG001|Open Label Extension|Withdrawal by Subject|0|||
146184087|NCT03354637|527185710|FG002|Open Label Extension|Withdrawal by Subject|5|||
146184088|NCT03354637|527185708|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
146184089|NCT03354637|527185709|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
146184090|NCT03354637|527185710|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
146184091|NCT03354637|527185708|FG000|Open Label Extension|Subject Noncompliance|0|||
146184092|NCT03354637|527185709|FG001|Open Label Extension|Subject Noncompliance|0|||
146184093|NCT03354637|527185710|FG002|Open Label Extension|Subject Noncompliance|1|||
146184094|NCT03354637|527185708|FG000|Open Label Extension|Lack of Efficacy|0|||
146184095|NCT03354637|527185709|FG001|Open Label Extension|Lack of Efficacy|0|||
146184096|NCT03354637|527185710|FG002|Open Label Extension|Lack of Efficacy|1|||
146184097|NCT03354637|527185708|FG000|Open Label Extension|Physician Decision|0|||
146184098|NCT03354637|527185709|FG001|Open Label Extension|Physician Decision|0|||
146184099|NCT03354637|527185710|FG002|Open Label Extension|Physician Decision|1|||
146184100|NCT04006366|527185715|FG000|Overall Study|Withdrawal by Subject|1|||
146184101|NCT04430335|527185716|FG000|Overall Study|Withdrawal by Subject|1|||
146184102|NCT03249376|527185726|FG000|Overall Study|Adverse Event|11|||
146184103|NCT03249376|527185727|FG001|Overall Study|Adverse Event|5|||
146184104|NCT03249376|527185726|FG000|Overall Study|Lack of Efficacy|2|||
146184105|NCT03249376|527185727|FG001|Overall Study|Lack of Efficacy|4|||
146184106|NCT03249376|527185726|FG000|Overall Study|Protocol Violation|3|||
146184107|NCT03249376|527185727|FG001|Overall Study|Protocol Violation|2|||
146184108|NCT03249376|527185726|FG000|Overall Study|Physician Decision|0|||
146184109|NCT03249376|527185727|FG001|Overall Study|Physician Decision|2|||
146184110|NCT03249376|527185726|FG000|Overall Study|Withdrawal by Subject|3|||
146184111|NCT03249376|527185727|FG001|Overall Study|Withdrawal by Subject|9|||
146184112|NCT03249376|527185726|FG000|Overall Study|LTFU|2|||
146184113|NCT03249376|527185727|FG001|Overall Study|LTFU|1|||
146184114|NCT00627042|527185728|FG000|Overall Study|Withdrawal by Subject|2|||
146184115|NCT03583541|527185729|FG000|Overall Study|Lost to Follow-up|31|||
146184116|NCT03583541|527185730|FG001|Overall Study|Lost to Follow-up|65|||
146184117|NCT04102540|527185731|FG000|Overall Study|Withdrawn by PI|2|||
146184118|NCT04102540|527185731|FG000|Overall Study|Lost to Follow-up|6|||
146184119|NCT01348854|527185734|FG000|Overall Study|Lost to Follow-up|2|||
146184120|NCT01348854|527185735|FG001|Overall Study|Lost to Follow-up|1|||
146184121|NCT01348854|527185734|FG000|Overall Study|Withdrawal by Subject|1|||
146184122|NCT01348854|527185735|FG001|Overall Study|Withdrawal by Subject|0|||
146184123|NCT00724061|527185736|FG000|Dose Escalation Phase|Adverse Event|2|||
146184124|NCT00724061|527185736|FG000|Dose Escalation Phase|Disease Progression|3|||
146184125|NCT00594932|527185741|FG000|First 3 Months|Withdrawal by Subject|1|||
146184126|NCT00594932|527185742|FG001|First 3 Months|Withdrawal by Subject|3|||
146184127|NCT00594932|527185741|FG000|Final 3 Months|Withdrawal by Subject|4|||
146184128|NCT00594932|527185742|FG001|Final 3 Months|Withdrawal by Subject|3|||
146184129|NCT01094171|527185743|FG000|Overall Study|Lost to Follow-up|2|||
146184130|NCT01094171|527185743|FG000|Overall Study|Informed consent withdrawal|4|||
146184131|NCT01094171|527185743|FG000|Overall Study|Migration from the study area|3|||
146184132|NCT01094171|527185743|FG000|Overall Study|Other|1|||
146184133|NCT01536145|527185744|FG000|Overall Study|Progressive disease|3|||
146184134|NCT01536145|527185745|FG001|Overall Study|Progressive disease|4|||
146184135|NCT01536145|527185746|FG002|Overall Study|Progressive disease|1|||
146184136|NCT01536145|527185747|FG003|Overall Study|Progressive disease|2|||
146184137|NCT01536145|527185748|FG004|Overall Study|Progressive disease|1|||
146184138|NCT01536145|527185749|FG005|Overall Study|Progressive disease|2|||
146184139|NCT01536145|527185750|FG006|Overall Study|Progressive disease|1|||
146184140|NCT01536145|527185751|FG007|Overall Study|Progressive disease|2|||
146184141|NCT01536145|527185752|FG008|Overall Study|Progressive disease|1|||
146184142|NCT01536145|527185753|FG009|Overall Study|Progressive disease|3|||
146184143|NCT01536145|527185754|FG010|Overall Study|Progressive disease|3|||
146184144|NCT01536145|527185744|FG000|Overall Study|Withdrawal by Subject|0|||
146184145|NCT01536145|527185745|FG001|Overall Study|Withdrawal by Subject|0|||
146184146|NCT01536145|527185746|FG002|Overall Study|Withdrawal by Subject|1|||
146184147|NCT01536145|527185747|FG003|Overall Study|Withdrawal by Subject|0|||
146184148|NCT01536145|527185748|FG004|Overall Study|Withdrawal by Subject|0|||
146184149|NCT01536145|527185749|FG005|Overall Study|Withdrawal by Subject|1|||
146184150|NCT01536145|527185750|FG006|Overall Study|Withdrawal by Subject|0|||
146184151|NCT01536145|527185751|FG007|Overall Study|Withdrawal by Subject|0|||
146184152|NCT01536145|527185752|FG008|Overall Study|Withdrawal by Subject|2|||
146184153|NCT01536145|527185753|FG009|Overall Study|Withdrawal by Subject|0|||
146184154|NCT01536145|527185754|FG010|Overall Study|Withdrawal by Subject|2|||
146184155|NCT01536145|527185744|FG000|Overall Study|Other|0|||
146184156|NCT01536145|527185745|FG001|Overall Study|Other|0|||
146184157|NCT01536145|527185746|FG002|Overall Study|Other|0|||
146184158|NCT01536145|527185747|FG003|Overall Study|Other|0|||
146184159|NCT01536145|527185748|FG004|Overall Study|Other|1|||
146184160|NCT01536145|527185749|FG005|Overall Study|Other|0|||
146184161|NCT01536145|527185750|FG006|Overall Study|Other|0|||
146184162|NCT01536145|527185751|FG007|Overall Study|Other|0|||
146184163|NCT01536145|527185752|FG008|Overall Study|Other|0|||
146184164|NCT01536145|527185753|FG009|Overall Study|Other|3|||
146184165|NCT01536145|527185754|FG010|Overall Study|Other|2|||
146184166|NCT01536145|527185744|FG000|Overall Study|Death|0|||
146184167|NCT01536145|527185745|FG001|Overall Study|Death|0|||
146184168|NCT01536145|527185746|FG002|Overall Study|Death|0|||
146184169|NCT01536145|527185747|FG003|Overall Study|Death|0|||
146184170|NCT01536145|527185748|FG004|Overall Study|Death|0|||
146184171|NCT01536145|527185749|FG005|Overall Study|Death|0|||
146184172|NCT01536145|527185750|FG006|Overall Study|Death|1|||
146184173|NCT01536145|527185751|FG007|Overall Study|Death|0|||
146184174|NCT01536145|527185752|FG008|Overall Study|Death|0|||
146184175|NCT01536145|527185753|FG009|Overall Study|Death|0|||
146184176|NCT01536145|527185754|FG010|Overall Study|Death|0|||
146184177|NCT01536145|527185744|FG000|Overall Study|Adverse Event|0|||
146184178|NCT01536145|527185745|FG001|Overall Study|Adverse Event|0|||
146184179|NCT01536145|527185746|FG002|Overall Study|Adverse Event|0|||
146184180|NCT01536145|527185747|FG003|Overall Study|Adverse Event|0|||
146184181|NCT01536145|527185748|FG004|Overall Study|Adverse Event|0|||
146184182|NCT01536145|527185749|FG005|Overall Study|Adverse Event|0|||
146184183|NCT01536145|527185750|FG006|Overall Study|Adverse Event|0|||
146184184|NCT01536145|527185751|FG007|Overall Study|Adverse Event|2|||
146184185|NCT01536145|527185752|FG008|Overall Study|Adverse Event|0|||
146184186|NCT01536145|527185753|FG009|Overall Study|Adverse Event|0|||
146184187|NCT01536145|527185754|FG010|Overall Study|Adverse Event|3|||
146184188|NCT00088205|527185757|FG000|Overall Study|Adverse Event|4|||
146184189|NCT00088205|527185757|FG000|Overall Study|Progressive Disease|51|||
146184190|NCT00088205|527185757|FG000|Overall Study|Physician Decision|1|||
146184191|NCT00088205|527185757|FG000|Overall Study|Death Due to Study Disease|4|||
146184192|NCT05199233|527185758|FG000|Overall Study|Lack of Efficacy|1|||
146184193|NCT01364727|527185763|FG000|Overall Study|Not Eligible|2|||
146184194|NCT00688259|527185764|FG000|Overall Study|Lost to Follow-up|2|||
146184195|NCT00688259|527185765|FG001|Overall Study|Lost to Follow-up|4|||
146184196|NCT00688259|527185764|FG000|Overall Study|Physician Decision|1|||
146184197|NCT00688259|527185765|FG001|Overall Study|Physician Decision|0|||
146184198|NCT00688259|527185764|FG000|Overall Study|Withdrawal by Subject|2|||
146184199|NCT00688259|527185765|FG001|Overall Study|Withdrawal by Subject|0|||
146184200|NCT00688259|527185764|FG000|Overall Study|Declined Interview|2|||
146184201|NCT00688259|527185765|FG001|Overall Study|Declined Interview|3|||
146184202|NCT00688259|527185764|FG000|Overall Study|Hospitalized at Follow-up|0|||
146184203|NCT00688259|527185765|FG001|Overall Study|Hospitalized at Follow-up|1|||
146184204|NCT01676220|527185767|FG000|Overall Study|Randomized But Not Treated|4|||
146184205|NCT01676220|527185768|FG001|Overall Study|Randomized But Not Treated|1|||
146184206|NCT01676220|527185767|FG000|Overall Study|Adverse Event|10|||
146184207|NCT01676220|527185768|FG001|Overall Study|Adverse Event|8|||
146184208|NCT01676220|527185767|FG000|Overall Study|Lack of Efficacy|2|||
146184209|NCT01676220|527185768|FG001|Overall Study|Lack of Efficacy|5|||
146184210|NCT01676220|527185767|FG000|Overall Study|Protocol Violation|11|||
146184211|NCT01676220|527185768|FG001|Overall Study|Protocol Violation|12|||
146184212|NCT01676220|527185767|FG000|Overall Study|Received Rescue Therapy|14|||
146184213|NCT01676220|527185768|FG001|Overall Study|Received Rescue Therapy|22|||
146184214|NCT01676220|527185767|FG000|Overall Study|Personal Reason|34|||
146184215|NCT01676220|527185768|FG001|Overall Study|Personal Reason|45|||
146184216|NCT01676220|527185767|FG000|Overall Study|Lost to Follow-up|11|||
146184217|NCT01676220|527185768|FG001|Overall Study|Lost to Follow-up|18|||
146184218|NCT01676220|527185767|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
146184219|NCT01676220|527185768|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
146184220|NCT01676220|527185767|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
146184221|NCT01676220|527185768|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
146184222|NCT01676220|527185767|FG000|Overall Study|Perceived Lack of Efficacy|3|||
146184223|NCT01676220|527185768|FG001|Overall Study|Perceived Lack of Efficacy|1|||
146184224|NCT01676220|527185767|FG000|Overall Study|Non Serious Hypoglycemia|2|||
146184225|NCT01676220|527185768|FG001|Overall Study|Non Serious Hypoglycemia|0|||
146184226|NCT01676220|527185767|FG000|Overall Study|No More Need of Insulin|1|||
146184227|NCT01676220|527185768|FG001|Overall Study|No More Need of Insulin|0|||
146184228|NCT03824938|527185771|FG000|Overall Study|Withdrawal by Subject|2|||
146184229|NCT03824938|527185772|FG001|Overall Study|Withdrawal by Subject|1|||
146184230|NCT03824938|527185773|FG002|Overall Study|Withdrawal by Subject|0|||
146184231|NCT03824938|527185774|FG003|Overall Study|Withdrawal by Subject|2|||
146184232|NCT03824938|527185775|FG004|Overall Study|Withdrawal by Subject|0|||
146184233|NCT03824938|527185776|FG005|Overall Study|Withdrawal by Subject|1|||
146184234|NCT03824938|527185771|FG000|Overall Study|Lost to Follow-up|0|||
146184235|NCT03824938|527185772|FG001|Overall Study|Lost to Follow-up|1|||
146184236|NCT03824938|527185773|FG002|Overall Study|Lost to Follow-up|0|||
146184237|NCT03824938|527185774|FG003|Overall Study|Lost to Follow-up|0|||
146184238|NCT03824938|527185775|FG004|Overall Study|Lost to Follow-up|1|||
146184239|NCT03824938|527185776|FG005|Overall Study|Lost to Follow-up|0|||
146184240|NCT02397460|527185777|FG000|Treatment Period 2|Adverse Event|0|||
146184241|NCT02397460|527185778|FG001|Treatment Period 2|Adverse Event|0|||
146184242|NCT02397460|527185779|FG002|Treatment Period 2|Adverse Event|0|||
146184243|NCT02397460|527185780|FG003|Treatment Period 2|Adverse Event|0|||
146184244|NCT02397460|527185781|FG004|Treatment Period 2|Adverse Event|0|||
146184245|NCT02397460|527185782|FG005|Treatment Period 2|Adverse Event|0|||
146184246|NCT02397460|527185783|FG006|Treatment Period 2|Adverse Event|0|||
146184247|NCT02397460|527185784|FG007|Treatment Period 2|Adverse Event|1|||
146184248|NCT02397460|527185777|FG000|Treatment Period 4|Adverse Event|0|||
146184249|NCT02397460|527185778|FG001|Treatment Period 4|Adverse Event|1|||
146184250|NCT02397460|527185779|FG002|Treatment Period 4|Adverse Event|0|||
146184251|NCT02397460|527185780|FG003|Treatment Period 4|Adverse Event|0|||
146184252|NCT02397460|527185781|FG004|Treatment Period 4|Adverse Event|0|||
146184253|NCT02397460|527185782|FG005|Treatment Period 4|Adverse Event|0|||
146184254|NCT02397460|527185783|FG006|Treatment Period 4|Adverse Event|0|||
146184255|NCT02397460|527185784|FG007|Treatment Period 4|Adverse Event|0|||
146184256|NCT02397460|527185777|FG000|Treatment Period 4|Physician Decision|0|||
146184257|NCT02397460|527185778|FG001|Treatment Period 4|Physician Decision|0|||
146184258|NCT02397460|527185779|FG002|Treatment Period 4|Physician Decision|0|||
146184259|NCT02397460|527185780|FG003|Treatment Period 4|Physician Decision|0|||
146184260|NCT02397460|527185781|FG004|Treatment Period 4|Physician Decision|1|||
146184261|NCT02397460|527185782|FG005|Treatment Period 4|Physician Decision|0|||
146184262|NCT02397460|527185783|FG006|Treatment Period 4|Physician Decision|0|||
146184263|NCT02397460|527185784|FG007|Treatment Period 4|Physician Decision|0|||
146184264|NCT01489020|527187323|FG000|Overall Study|Withdrawal by Subject|1|||
146184265|NCT01489020|527187324|FG001|Overall Study|Withdrawal by Subject|0|||
146184266|NCT01489020|527187325|FG002|Overall Study|Withdrawal by Subject|0|||
146184267|NCT01489020|527187326|FG003|Overall Study|Withdrawal by Subject|0|||
146184268|NCT01489020|527187327|FG004|Overall Study|Withdrawal by Subject|0|||
146184269|NCT01489020|527187328|FG005|Overall Study|Withdrawal by Subject|0|||
146184270|NCT01489020|527187323|FG000|Overall Study|Adverse Event|0|||
146184271|NCT01489020|527187324|FG001|Overall Study|Adverse Event|0|||
146184272|NCT01489020|527187325|FG002|Overall Study|Adverse Event|3|||
146184273|NCT01489020|527187326|FG003|Overall Study|Adverse Event|0|||
146184274|NCT01489020|527187327|FG004|Overall Study|Adverse Event|3|||
146184275|NCT01489020|527187328|FG005|Overall Study|Adverse Event|0|||
146184276|NCT01489020|527187323|FG000|Overall Study|Concomitant disease|0|||
146184277|NCT01489020|527187324|FG001|Overall Study|Concomitant disease|0|||
146184278|NCT01489020|527187325|FG002|Overall Study|Concomitant disease|0|||
146184279|NCT01489020|527187326|FG003|Overall Study|Concomitant disease|0|||
146184280|NCT01489020|527187327|FG004|Overall Study|Concomitant disease|3|||
146184281|NCT01489020|527187328|FG005|Overall Study|Concomitant disease|0|||
146184282|NCT01174550|527187329|FG000|Overall Study|Death|75|||
146184283|NCT01174550|527187330|FG001|Overall Study|Death|74|||
146184284|NCT01174550|527187329|FG000|Overall Study|Lost to Follow-up|652|||
146184285|NCT01174550|527187330|FG001|Overall Study|Lost to Follow-up|510|||
146184286|NCT01174550|527187329|FG000|Overall Study|Withdrawal by Subject|543|||
146184287|NCT01174550|527187330|FG001|Overall Study|Withdrawal by Subject|289|||
146184288|NCT01440049|527187337|FG000|Overall Study|Adverse Event|5|||
146184289|NCT02268552|527187338|FG000|Part 1|Death|1|||
146184290|NCT02268552|527187339|FG001|Part 1|Death|1|||
146184291|NCT02268552|527187340|FG002|Part 1|Death|1|||
146184292|NCT02268552|527187341|FG003|Part 1|Death|2|||
146184293|NCT02268552|527187342|FG004|Part 1|Death|0|||
146184294|NCT02268552|527187343|FG005|Part 1|Death|0|||
146184295|NCT02268552|527187344|FG006|Part 1|Death|0|||
146184296|NCT02268552|527187338|FG000|Part 1|Subject/guardian decision|0|||
146184297|NCT02268552|527187339|FG001|Part 1|Subject/guardian decision|0|||
146184298|NCT02268552|527187340|FG002|Part 1|Subject/guardian decision|0|||
146184299|NCT02268552|527187341|FG003|Part 1|Subject/guardian decision|1|||
146184300|NCT02268552|527187342|FG004|Part 1|Subject/guardian decision|0|||
146184301|NCT02268552|527187343|FG005|Part 1|Subject/guardian decision|0|||
146184302|NCT02268552|527187344|FG006|Part 1|Subject/guardian decision|0|||
146184303|NCT02268552|527187338|FG000|Part 2|Death|0|||
146184304|NCT02268552|527187339|FG001|Part 2|Death|0|||
146184305|NCT02268552|527187340|FG002|Part 2|Death|0|||
146184306|NCT02268552|527187341|FG003|Part 2|Death|0|||
146184307|NCT02268552|527187342|FG004|Part 2|Death|0|||
146184308|NCT02268552|527187343|FG005|Part 2|Death|0|||
146184309|NCT02268552|527187344|FG006|Part 2|Death|2|||
146184310|NCT02268552|527187338|FG000|Part 2|Subject/guardian decision|0|||
146184311|NCT02268552|527187339|FG001|Part 2|Subject/guardian decision|0|||
146184312|NCT02268552|527187340|FG002|Part 2|Subject/guardian decision|0|||
146184313|NCT02268552|527187341|FG003|Part 2|Subject/guardian decision|0|||
146184314|NCT02268552|527187342|FG004|Part 2|Subject/guardian decision|0|||
146184315|NCT02268552|527187343|FG005|Part 2|Subject/guardian decision|0|||
146184316|NCT02268552|527187344|FG006|Part 2|Subject/guardian decision|1|||
146184317|NCT02268552|527187338|FG000|Part 3 Extension|Death|0|||
146184318|NCT02268552|527187339|FG001|Part 3 Extension|Death|1|||
146184319|NCT02268552|527187340|FG002|Part 3 Extension|Death|1|||
146184320|NCT02268552|527187341|FG003|Part 3 Extension|Death|1|||
146184321|NCT02268552|527187342|FG004|Part 3 Extension|Death|1|||
146184322|NCT02268552|527187343|FG005|Part 3 Extension|Death|1|||
146184323|NCT02268552|527187344|FG006|Part 3 Extension|Death|0|||
146184324|NCT02268552|527187338|FG000|Part 3 Extension|Early termination of trial|1|||
146184325|NCT02268552|527187339|FG001|Part 3 Extension|Early termination of trial|0|||
146184326|NCT02268552|527187340|FG002|Part 3 Extension|Early termination of trial|0|||
146184327|NCT02268552|527187341|FG003|Part 3 Extension|Early termination of trial|0|||
146184328|NCT02268552|527187342|FG004|Part 3 Extension|Early termination of trial|2|||
146184329|NCT02268552|527187343|FG005|Part 3 Extension|Early termination of trial|9|||
146184330|NCT02268552|527187344|FG006|Part 3 Extension|Early termination of trial|11|||
146184331|NCT02268552|527187338|FG000|Part 3 Extension|Subject/guardian decision|0|||
146184332|NCT02268552|527187339|FG001|Part 3 Extension|Subject/guardian decision|0|||
146184333|NCT02268552|527187340|FG002|Part 3 Extension|Subject/guardian decision|0|||
146184334|NCT02268552|527187341|FG003|Part 3 Extension|Subject/guardian decision|0|||
146184335|NCT02268552|527187342|FG004|Part 3 Extension|Subject/guardian decision|0|||
146184336|NCT02268552|527187343|FG005|Part 3 Extension|Subject/guardian decision|0|||
146184337|NCT02268552|527187344|FG006|Part 3 Extension|Subject/guardian decision|1|||
146184338|NCT02139982|527187346|FG000|Overall Study|Lack of Efficacy|0|||
146184339|NCT02139982|527187347|FG001|Overall Study|Lack of Efficacy|1|||
146184340|NCT02139982|527187348|FG002|Overall Study|Lack of Efficacy|0|||
146184341|NCT02139982|527187349|FG003|Overall Study|Lack of Efficacy|1|||
146184342|NCT02139982|527187350|FG004|Overall Study|Lack of Efficacy|0|||
146184343|NCT02139982|527187351|FG005|Overall Study|Lack of Efficacy|0|||
146184344|NCT02139982|527187352|FG006|Overall Study|Lack of Efficacy|0|||
146184345|NCT02139982|527187353|FG007|Overall Study|Lack of Efficacy|0|||
146184346|NCT02139982|527187354|FG008|Overall Study|Lack of Efficacy|0|||
146184347|NCT02139982|527187355|FG009|Overall Study|Lack of Efficacy|0|||
146184348|NCT02748512|527187358|FG000|Overall Study|Lost to Follow-up|1|||
146184349|NCT02748512|527187359|FG001|Overall Study|Lost to Follow-up|1|||
146184350|NCT00997243|527187360|FG000|Overall Study|Early termination of study by sponsor|7|||
146184351|NCT03415022|527187369|FG000|Overall Study|Withdrawal by Subject|1|||
146184352|NCT03415022|527187370|FG001|Overall Study|Withdrawal by Subject|2|||
146184353|NCT03415022|527187369|FG000|Overall Study|COVID-19 Suspension|2|||
146184354|NCT03415022|527187370|FG001|Overall Study|COVID-19 Suspension|3|||
146184355|NCT03415022|527187369|FG000|Overall Study|Lost to Follow-up|2|||
146184356|NCT03415022|527187370|FG001|Overall Study|Lost to Follow-up|0|||
146184357|NCT04466618|527187371|FG000|Overall Study|Withdrawal by Subject|0|||
146184358|NCT04466618|527187372|FG001|Overall Study|Withdrawal by Subject|1|||
146184359|NCT00884286|527187378|FG000|Overall Study|Progressive disease|21|||
146184360|NCT00884286|527187379|FG001|Overall Study|Progressive disease|28|||
146184361|NCT00884286|527187378|FG000|Overall Study|Toxicity|4|||
146184362|NCT00884286|527187379|FG001|Overall Study|Toxicity|1|||
146184363|NCT00884286|527187378|FG000|Overall Study|Death|2|||
146184364|NCT00884286|527187379|FG001|Overall Study|Death|2|||
146184365|NCT00884286|527187378|FG000|Overall Study|Physician Decision|1|||
146184366|NCT00884286|527187379|FG001|Overall Study|Physician Decision|0|||
146184367|NCT00884286|527187378|FG000|Overall Study|Septic shock|1|||
146184368|NCT00884286|527187379|FG001|Overall Study|Septic shock|0|||
146184369|NCT00884286|527187378|FG000|Overall Study|Thrombus in right auricle|1|||
146184370|NCT00884286|527187379|FG001|Overall Study|Thrombus in right auricle|0|||
146184371|NCT00884286|527187378|FG000|Overall Study|Not treated|2|||
146184372|NCT00884286|527187379|FG001|Overall Study|Not treated|1|||
146184373|NCT00884286|527187378|FG000|Overall Study|Comprised lung carcinoma|0|||
146184374|NCT00884286|527187379|FG001|Overall Study|Comprised lung carcinoma|1|||
146184375|NCT00109928|527187380|FG000|Overall Study|Adverse Event|2|||
146184376|NCT00109928|527187380|FG000|Overall Study|Progression|6|||
146184377|NCT00109928|527187380|FG000|Overall Study|Death|2|||
146184378|NCT00109928|527187380|FG000|Overall Study|not protocol specified|2|||
146184379|NCT00109928|527187380|FG000|Overall Study|not eligible|1|||
146184380|NCT01196104|527187381|FG000|Overall Study|Lost to Follow-up|1|||
146184381|NCT01196104|527187382|FG001|Overall Study|Lost to Follow-up|0|||
146184382|NCT01196104|527187381|FG000|Overall Study|Physician Decision|0|||
146184383|NCT01196104|527187382|FG001|Overall Study|Physician Decision|1|||
146184384|NCT01196104|527187381|FG000|Overall Study|Withdrawal by Subject|3|||
146184385|NCT01196104|527187382|FG001|Overall Study|Withdrawal by Subject|3|||
146184386|NCT01196104|527187381|FG000|Overall Study|Various|0|||
146184387|NCT01196104|527187382|FG001|Overall Study|Various|1|||
146184388|NCT02411591|527187387|FG000|Overall Study|Adverse Event|0|||
146184389|NCT02411591|527187388|FG001|Overall Study|Adverse Event|4|||
146184390|NCT02411591|527187389|FG002|Overall Study|Adverse Event|2|||
146184391|NCT02411591|527187387|FG000|Overall Study|Withdrawal by Subject|0|||
146184392|NCT02411591|527187388|FG001|Overall Study|Withdrawal by Subject|3|||
146184393|NCT02411591|527187389|FG002|Overall Study|Withdrawal by Subject|0|||
146184394|NCT02411591|527187387|FG000|Overall Study|Physician Decision|0|||
146184395|NCT02411591|527187388|FG001|Overall Study|Physician Decision|3|||
146184396|NCT02411591|527187389|FG002|Overall Study|Physician Decision|1|||
146184397|NCT02491892|527187390|FG000|Overall Study|Adverse Event|1|||
146184398|NCT02491892|527187391|FG001|Overall Study|Adverse Event|1|||
146184399|NCT02491892|527187390|FG000|Overall Study|Death|1|||
146184400|NCT02491892|527187391|FG001|Overall Study|Death|1|||
146184401|NCT02491892|527187390|FG000|Overall Study|Lack of Efficacy|37|||
146184402|NCT02491892|527187391|FG001|Overall Study|Lack of Efficacy|36|||
146184403|NCT02491892|527187390|FG000|Overall Study|Refused Treatment|1|||
146184404|NCT02491892|527187391|FG001|Overall Study|Refused Treatment|0|||
146184405|NCT02491892|527187390|FG000|Overall Study|Lost to Follow-up|1|||
146184406|NCT02491892|527187391|FG001|Overall Study|Lost to Follow-up|0|||
146184407|NCT04227340|527187392|FG000|Overall Study|Withdrawal by Subject|3|||
146184408|NCT00393094|527187395|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
146184409|NCT00393094|527187395|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
146184410|NCT03018106|527187396|FG000|Overall Study|Lost to Follow-up|0|||
146184411|NCT03018106|527187397|FG001|Overall Study|Lost to Follow-up|1|||
146184412|NCT00136916|527187398|FG000|Overall Study|Never received study treatment|3|||
146184413|NCT00136916|527187399|FG001|Overall Study|Never received study treatment|5|||
146184414|NCT00136916|527187398|FG000|Overall Study|Death|1|||
146184415|NCT00136916|527187399|FG001|Overall Study|Death|3|||
146184416|NCT00136916|527187398|FG000|Overall Study|Adverse Event|27|||
146184417|NCT00136916|527187399|FG001|Overall Study|Adverse Event|8|||
146184418|NCT00136916|527187398|FG000|Overall Study|Laboratory abnormality|0|||
146184419|NCT00136916|527187399|FG001|Overall Study|Laboratory abnormality|1|||
146184420|NCT00136916|527187398|FG000|Overall Study|Lack of Efficacy|13|||
146184421|NCT00136916|527187399|FG001|Overall Study|Lack of Efficacy|3|||
146184422|NCT00136916|527187398|FG000|Overall Study|Lost to Follow-up|12|||
146184423|NCT00136916|527187399|FG001|Overall Study|Lost to Follow-up|14|||
146184424|NCT00136916|527187398|FG000|Overall Study|Withdrawal by Subject|44|||
146184425|NCT00136916|527187399|FG001|Overall Study|Withdrawal by Subject|46|||
146184426|NCT00136916|527187398|FG000|Overall Study|Other|22|||
146184427|NCT00136916|527187399|FG001|Overall Study|Other|24|||
146184428|NCT00136916|527187398|FG000|Overall Study|Discontinued in follow up period|3|||
146184429|NCT00136916|527187399|FG001|Overall Study|Discontinued in follow up period|0|||
146184430|NCT02213055|527187401|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
146184431|NCT02213055|527187402|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
146184432|NCT02213055|527187401|FG000|Overall Study|Protocol was not Followed during Study|1|||
146184433|NCT02213055|527187402|FG001|Overall Study|Protocol was not Followed during Study|0|||
146184434|NCT02213055|527187401|FG000|Overall Study|Documentation Issue at Enrollment|1|||
146184435|NCT02213055|527187402|FG001|Overall Study|Documentation Issue at Enrollment|0|||
146184436|NCT02213055|527187401|FG000|Overall Study|Documentation Issue during Study|10|||
146184437|NCT02213055|527187402|FG001|Overall Study|Documentation Issue during Study|0|||
146184438|NCT02213055|527187401|FG000|Overall Study|Did not have Live Lice|8|||
146184439|NCT02213055|527187402|FG001|Overall Study|Did not have Live Lice|0|||
146184440|NCT02213055|527187401|FG000|Overall Study|Had another Treatment during the Study|3|||
146184441|NCT02213055|527187402|FG001|Overall Study|Had another Treatment during the Study|0|||
146184442|NCT02213055|527187401|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
146184443|NCT02213055|527187402|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
146184444|NCT02213055|527187401|FG000|Overall Study|Did not Return to School|5|||
146184445|NCT02213055|527187402|FG001|Overall Study|Did not Return to School|0|||
146184446|NCT00231894|527187403|FG000|Overall Study|Withdrawal by Subject|1|||
146184447|NCT00231894|527187404|FG001|Overall Study|Withdrawal by Subject|1|||
146184448|NCT02025205|527187406|FG000|Overall Study|Withdrawal by Subject|1|||
146184449|NCT02025205|527187407|FG001|Overall Study|Withdrawal by Subject|1|||
146184450|NCT02025205|527187406|FG000|Overall Study|Protocol Violation|2|||
146184451|NCT02025205|527187407|FG001|Overall Study|Protocol Violation|1|||
146184452|NCT02025205|527187406|FG000|Overall Study|Death|0|||
146184453|NCT02025205|527187407|FG001|Overall Study|Death|1|||
146184454|NCT01767129|527187408|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146184455|NCT01767129|527187409|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
146184456|NCT01024751|527187410|FG000|Enrolled Participants|Ineligible at baseline|3|||
146184457|NCT01024751|527187411|FG001|Enrolled Participants|Ineligible at baseline|4|||
146184458|NCT01024751|527187410|FG000|Eligible Participants|Withdrawal by Subject|0|||
146184459|NCT01024751|527187411|FG001|Eligible Participants|Withdrawal by Subject|1|||
146184460|NCT01024751|527187410|FG000|Eligible Participants|Lost to Follow-up|0|||
146184461|NCT01024751|527187411|FG001|Eligible Participants|Lost to Follow-up|1|||
146080877|NCT01546623|526816748|FG000|Overall Study|Did Not Receive Study Drug|1|||
146080878|NCT01546623|526816749|FG001|Overall Study|Did Not Receive Study Drug|1|||
146080879|NCT01590758|526816750|FG000|Overall Study|Withdrawal by Subject|0|||
146080880|NCT01590758|526816751|FG001|Overall Study|Withdrawal by Subject|3|||
146080881|NCT01590758|526816750|FG000|Overall Study|Physician Decision|1|||
146080882|NCT01590758|526816751|FG001|Overall Study|Physician Decision|2|||
146080883|NCT01590758|526816750|FG000|Overall Study|Lost to Follow-up|4|||
146080884|NCT01590758|526816751|FG001|Overall Study|Lost to Follow-up|2|||
146080885|NCT04525885|526816752|FG000|Overall Study|Screen Failure|1|||
146080886|NCT04525885|526816753|FG001|Overall Study|Screen Failure|0|||
146080887|NCT04525885|526816754|FG002|Overall Study|Screen Failure|0|||
146080888|NCT04525885|526816752|FG000|Overall Study|Withdrawal by Subject|14|||
146080889|NCT04525885|526816753|FG001|Overall Study|Withdrawal by Subject|6|||
146080890|NCT04525885|526816754|FG002|Overall Study|Withdrawal by Subject|20|||
146080891|NCT04525885|526816752|FG000|Overall Study|Physician Decision|1|||
146080892|NCT04525885|526816753|FG001|Overall Study|Physician Decision|0|||
146080893|NCT04525885|526816754|FG002|Overall Study|Physician Decision|1|||
146080894|NCT02717832|526816755|FG000|Overall Study|Inability to place IV|3|||
146080895|NCT00978757|526816758|FG000|Overall Study|Physician Decision|1|||
146080896|NCT00978757|526816759|FG001|Overall Study|Physician Decision|3|||
146080897|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146080898|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146080899|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146080900|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
146080901|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
146080902|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146080903|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146080904|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146080905|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146080906|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
146080907|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080908|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080909|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080910|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080911|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
146080912|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080913|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080914|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080915|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080916|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
146080917|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
146080918|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080919|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080920|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080921|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
146080922|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080923|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080924|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080925|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080926|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
146080927|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080928|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080929|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
146080930|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080931|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
146080932|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080933|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080934|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080935|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080936|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
146080937|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080938|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080939|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080940|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080941|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
146080942|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080943|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080944|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080945|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080946|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
146080947|NCT01185353|526816760|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
146080948|NCT01185353|526816761|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146184462|NCT01024751|527187410|FG000|Eligible Participants|Ineligible|0|||
146184463|NCT01024751|527187411|FG001|Eligible Participants|Ineligible|1|||
146184464|NCT03246672|527187416|FG000|Overall Study|Lost to Follow-up|2|||
146184465|NCT02500316|527187417|FG000|Overall Study|Adverse Event|3|||
146184466|NCT02500316|527187417|FG000|Overall Study|Lost to Follow-up|2|||
146184467|NCT02500316|527187417|FG000|Overall Study|Protocol Violation|1|||
146184468|NCT02500316|527187417|FG000|Overall Study|Withdrawal by Subject|15|||
146184469|NCT02500316|527187417|FG000|Overall Study|Final height achieved|5|||
146184470|NCT02500316|527187417|FG000|Overall Study|Due to war activity|1|||
146184471|NCT01406717|527187418|FG000|Overall Study|Subject non-compliance|4|||
146184472|NCT01406717|527187419|FG001|Overall Study|Subject non-compliance|3|||
146184473|NCT01406717|527187418|FG000|Overall Study|Protocol Violation|5|||
146184474|NCT01406717|527187419|FG001|Overall Study|Protocol Violation|1|||
146184475|NCT01406717|527187418|FG000|Overall Study|Lost to Follow-up|14|||
146184476|NCT01406717|527187419|FG001|Overall Study|Lost to Follow-up|8|||
146184477|NCT01406717|527187418|FG000|Overall Study|Withdrawal by Subject|19|||
146184478|NCT01406717|527187419|FG001|Overall Study|Withdrawal by Subject|15|||
146184479|NCT01406717|527187418|FG000|Overall Study|Adverse Event|1|||
146184480|NCT01406717|527187419|FG001|Overall Study|Adverse Event|2|||
146184481|NCT01406717|527187418|FG000|Overall Study|Lack of Efficacy|0|||
146184482|NCT01406717|527187419|FG001|Overall Study|Lack of Efficacy|1|||
146184483|NCT01406717|527187418|FG000|Overall Study|Non-completion of visit activity|0|||
146184484|NCT01406717|527187419|FG001|Overall Study|Non-completion of visit activity|1|||
146184485|NCT03257995|527187420|FG000|Overall Study|Adverse Event|0|||
146184486|NCT03257995|527187421|FG001|Overall Study|Adverse Event|1|||
146184487|NCT03257995|527187422|FG002|Overall Study|Adverse Event|0|||
146184488|NCT03257995|527187423|FG003|Overall Study|Adverse Event|0|||
146184489|NCT03257995|527187424|FG004|Overall Study|Adverse Event|0|||
146184490|NCT03257995|527187425|FG005|Overall Study|Adverse Event|0|||
146184491|NCT03257995|527187420|FG000|Overall Study|Protocol deviation|0|||
146184492|NCT03257995|527187421|FG001|Overall Study|Protocol deviation|0|||
146184493|NCT03257995|527187422|FG002|Overall Study|Protocol deviation|0|||
146184494|NCT03257995|527187423|FG003|Overall Study|Protocol deviation|0|||
146184495|NCT03257995|527187424|FG004|Overall Study|Protocol deviation|0|||
146184496|NCT03257995|527187425|FG005|Overall Study|Protocol deviation|2|||
146184497|NCT01987830|527187437|FG000|Overall Study|Never received baseline scan|1|||
146184498|NCT00057811|527187446|FG000|Overall Study|Lack of Efficacy|1|||
146184499|NCT00057811|527187447|FG001|Overall Study|Lack of Efficacy|4|||
146184500|NCT00057811|527187446|FG000|Overall Study|Physician Decision|1|||
146184501|NCT00057811|527187447|FG001|Overall Study|Physician Decision|0|||
146184502|NCT00057811|527187446|FG000|Overall Study|Withdrawal by Subject|3|||
146184503|NCT00057811|527187447|FG001|Overall Study|Withdrawal by Subject|4|||
146184504|NCT00057811|527187446|FG000|Overall Study|Ineligible|4|||
146184505|NCT00057811|527187447|FG001|Overall Study|Ineligible|2|||
146184506|NCT00057811|527187446|FG000|Overall Study|Inevaluable|1|||
146184507|NCT00057811|527187447|FG001|Overall Study|Inevaluable|2|||
146184508|NCT00556374|527187448|FG000|Overall Study|Withdrawal by Subject|235|||
146184509|NCT00556374|527187449|FG001|Overall Study|Withdrawal by Subject|205|||
146184510|NCT00556374|527187448|FG000|Overall Study|Death|158|||
146184511|NCT00556374|527187449|FG001|Overall Study|Death|127|||
146184512|NCT00556374|527187448|FG000|Overall Study|Lost to Follow-up|24|||
146184513|NCT00556374|527187449|FG001|Overall Study|Lost to Follow-up|17|||
146184514|NCT00556374|527187448|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
146184515|NCT00556374|527187449|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
146184516|NCT04131907|527187450|FG000|Overall Study|Adverse Event|2|||
146184517|NCT04131907|527187451|FG001|Overall Study|Adverse Event|0|||
146184518|NCT04131907|527187452|FG002|Overall Study|Adverse Event|0|||
146184519|NCT04131907|527187450|FG000|Overall Study|Physician Decision|4|||
146184520|NCT04131907|527187451|FG001|Overall Study|Physician Decision|22|||
146184521|NCT04131907|527187452|FG002|Overall Study|Physician Decision|0|||
146184522|NCT04131907|527187450|FG000|Overall Study|Withdrawal by Subject|2|||
146184523|NCT04131907|527187451|FG001|Overall Study|Withdrawal by Subject|0|||
146184524|NCT04131907|527187452|FG002|Overall Study|Withdrawal by Subject|1|||
146184525|NCT04131907|527187450|FG000|Overall Study|Treatment failure|2|||
146184526|NCT04131907|527187451|FG001|Overall Study|Treatment failure|0|||
146184527|NCT04131907|527187452|FG002|Overall Study|Treatment failure|1|||
146184528|NCT02036515|527187453|FG000|Overall Study|Adverse Event|1|||
146184529|NCT02036515|527187454|FG001|Overall Study|Adverse Event|1|||
146184530|NCT02036515|527187455|FG002|Overall Study|Adverse Event|2|||
146184531|NCT02036515|527187453|FG000|Overall Study|Lost to Follow-up|0|||
146184532|NCT02036515|527187454|FG001|Overall Study|Lost to Follow-up|2|||
146184533|NCT02036515|527187455|FG002|Overall Study|Lost to Follow-up|0|||
146184534|NCT02036515|527187453|FG000|Overall Study|Non-compliance with study drug|0|||
146184535|NCT02036515|527187454|FG001|Overall Study|Non-compliance with study drug|0|||
146184536|NCT02036515|527187455|FG002|Overall Study|Non-compliance with study drug|2|||
146184537|NCT02036515|527187453|FG000|Overall Study|Screen failure|0|||
146184538|NCT02036515|527187454|FG001|Overall Study|Screen failure|2|||
146184539|NCT02036515|527187455|FG002|Overall Study|Screen failure|0|||
146184540|NCT02036515|527187453|FG000|Overall Study|Withdrawal by Subject|4|||
146184541|NCT02036515|527187454|FG001|Overall Study|Withdrawal by Subject|7|||
146184542|NCT02036515|527187455|FG002|Overall Study|Withdrawal by Subject|9|||
146184543|NCT02036515|527187453|FG000|Overall Study|Hyperglycemia|0|||
146184544|NCT02036515|527187454|FG001|Overall Study|Hyperglycemia|0|||
146184545|NCT02036515|527187455|FG002|Overall Study|Hyperglycemia|1|||
146184546|NCT02218489|527187458|FG000|Overall Study|Withdrawal by Subject|4|||
146184547|NCT02218489|527187459|FG001|Overall Study|Withdrawal by Subject|3|||
146184548|NCT02218489|527187458|FG000|Overall Study|Lost to Follow-up|1|||
146184549|NCT02218489|527187459|FG001|Overall Study|Lost to Follow-up|0|||
146184550|NCT01700348|527187460|FG000|Overall Study|Withdrawal by Subject|22|||
146184551|NCT01700348|527187460|FG000|Overall Study|Lost to Follow-up|1|||
146184552|NCT02404493|527187461|FG000|Overall Study|Adverse Event|1|||
146184553|NCT02404493|527187462|FG001|Overall Study|Adverse Event|1|||
146184554|NCT03958630|527187463|FG000|Overall Study|Withdrawal by Subject|0|||
146184555|NCT03958630|527187464|FG001|Overall Study|Withdrawal by Subject|0|||
146184556|NCT03958630|527187465|FG002|Overall Study|Withdrawal by Subject|1|||
146184557|NCT03958630|527187463|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
146184558|NCT03958630|527187464|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
146184559|NCT03958630|527187465|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
146184560|NCT04157686|527187470|FG000|Overall Study|Adverse Event|1|||
146184561|NCT04157686|527187471|FG001|Overall Study|Adverse Event|0|||
146184562|NCT04157686|527187472|FG002|Overall Study|Adverse Event|1|||
146184563|NCT04157686|527187473|FG003|Overall Study|Adverse Event|0|||
146184564|NCT04157686|527187474|FG004|Overall Study|Adverse Event|1|||
146184565|NCT04157686|527187475|FG005|Overall Study|Adverse Event|0|||
146184566|NCT04157686|527187476|FG006|Overall Study|Adverse Event|0|||
146184567|NCT04157686|527187477|FG007|Overall Study|Adverse Event|0|||
146184568|NCT04157686|527187470|FG000|Overall Study|Pregnancy|0|||
146184569|NCT04157686|527187471|FG001|Overall Study|Pregnancy|1|||
146184570|NCT04157686|527187472|FG002|Overall Study|Pregnancy|3|||
146184571|NCT04157686|527187473|FG003|Overall Study|Pregnancy|0|||
146184572|NCT04157686|527187474|FG004|Overall Study|Pregnancy|0|||
146184573|NCT04157686|527187475|FG005|Overall Study|Pregnancy|0|||
146184574|NCT04157686|527187476|FG006|Overall Study|Pregnancy|3|||
146184575|NCT04157686|527187477|FG007|Overall Study|Pregnancy|0|||
146184576|NCT04157686|527187470|FG000|Overall Study|Lost to Follow-up|1|||
146184577|NCT04157686|527187471|FG001|Overall Study|Lost to Follow-up|2|||
146184578|NCT04157686|527187472|FG002|Overall Study|Lost to Follow-up|8|||
146184579|NCT04157686|527187473|FG003|Overall Study|Lost to Follow-up|6|||
146184580|NCT04157686|527187474|FG004|Overall Study|Lost to Follow-up|6|||
146184581|NCT04157686|527187475|FG005|Overall Study|Lost to Follow-up|3|||
146184582|NCT04157686|527187476|FG006|Overall Study|Lost to Follow-up|7|||
146184583|NCT04157686|527187477|FG007|Overall Study|Lost to Follow-up|9|||
146184584|NCT04157686|527187470|FG000|Overall Study|Lack of Efficacy|0|||
146184585|NCT04157686|527187471|FG001|Overall Study|Lack of Efficacy|0|||
146184586|NCT04157686|527187472|FG002|Overall Study|Lack of Efficacy|0|||
146184587|NCT04157686|527187473|FG003|Overall Study|Lack of Efficacy|0|||
146184588|NCT04157686|527187474|FG004|Overall Study|Lack of Efficacy|0|||
146184589|NCT04157686|527187475|FG005|Overall Study|Lack of Efficacy|2|||
146184590|NCT04157686|527187476|FG006|Overall Study|Lack of Efficacy|0|||
146184591|NCT04157686|527187477|FG007|Overall Study|Lack of Efficacy|1|||
146184592|NCT04157686|527187470|FG000|Overall Study|Withdrawal by Subject|10|||
146184593|NCT04157686|527187471|FG001|Overall Study|Withdrawal by Subject|10|||
146184594|NCT04157686|527187472|FG002|Overall Study|Withdrawal by Subject|12|||
146184595|NCT04157686|527187473|FG003|Overall Study|Withdrawal by Subject|20|||
146184596|NCT04157686|527187474|FG004|Overall Study|Withdrawal by Subject|12|||
146184597|NCT04157686|527187475|FG005|Overall Study|Withdrawal by Subject|11|||
146184598|NCT04157686|527187476|FG006|Overall Study|Withdrawal by Subject|18|||
146184599|NCT04157686|527187477|FG007|Overall Study|Withdrawal by Subject|24|||
146184600|NCT04157686|527187470|FG000|Overall Study|Physician Decision|0|||
146184601|NCT04157686|527187471|FG001|Overall Study|Physician Decision|0|||
146184602|NCT04157686|527187472|FG002|Overall Study|Physician Decision|1|||
146184603|NCT04157686|527187473|FG003|Overall Study|Physician Decision|0|||
146184604|NCT04157686|527187474|FG004|Overall Study|Physician Decision|1|||
146184605|NCT04157686|527187475|FG005|Overall Study|Physician Decision|0|||
146184606|NCT04157686|527187476|FG006|Overall Study|Physician Decision|3|||
146184607|NCT04157686|527187477|FG007|Overall Study|Physician Decision|0|||
146184608|NCT04157686|527187470|FG000|Overall Study|Death|0|||
146184609|NCT04157686|527187471|FG001|Overall Study|Death|0|||
146184610|NCT04157686|527187472|FG002|Overall Study|Death|0|||
146184611|NCT04157686|527187473|FG003|Overall Study|Death|2|||
146184612|NCT04157686|527187474|FG004|Overall Study|Death|0|||
146184613|NCT04157686|527187475|FG005|Overall Study|Death|0|||
146184614|NCT04157686|527187476|FG006|Overall Study|Death|0|||
146184615|NCT04157686|527187477|FG007|Overall Study|Death|0|||
146184616|NCT04157686|527187470|FG000|Overall Study|Protocol Violation|0|||
146184617|NCT04157686|527187471|FG001|Overall Study|Protocol Violation|0|||
146184618|NCT04157686|527187472|FG002|Overall Study|Protocol Violation|0|||
146184619|NCT04157686|527187473|FG003|Overall Study|Protocol Violation|0|||
146184620|NCT04157686|527187474|FG004|Overall Study|Protocol Violation|1|||
146184621|NCT04157686|527187475|FG005|Overall Study|Protocol Violation|0|||
146184622|NCT04157686|527187476|FG006|Overall Study|Protocol Violation|0|||
146184623|NCT04157686|527187477|FG007|Overall Study|Protocol Violation|0|||
146184624|NCT04157686|527187470|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
146184625|NCT04157686|527187471|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
146184626|NCT04157686|527187472|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
146184627|NCT04157686|527187473|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
146184628|NCT04157686|527187474|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
146184629|NCT04157686|527187475|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
146184630|NCT04157686|527187476|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
146184631|NCT04157686|527187477|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
146184632|NCT02601937|527187484|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184633|NCT02601937|527187485|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184634|NCT02601937|527187486|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184635|NCT02601937|527187487|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184636|NCT02601937|527187488|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184637|NCT02601937|527187489|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
146184638|NCT02601937|527187490|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184639|NCT02601937|527187491|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184640|NCT02601937|527187492|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184641|NCT02601937|527187493|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184642|NCT02601937|527187494|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
146184643|NCT02601937|527187484|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
146184644|NCT02601937|527187485|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184645|NCT02601937|527187486|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184646|NCT02601937|527187487|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184647|NCT02601937|527187488|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184648|NCT02601937|527187489|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184649|NCT02601937|527187490|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
146184650|NCT02601937|527187491|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184651|NCT02601937|527187492|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184652|NCT02601937|527187493|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184653|NCT02601937|527187494|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
146184654|NCT02601937|527187484|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184655|NCT02601937|527187485|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184656|NCT02601937|527187486|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
146184657|NCT02601937|527187487|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184658|NCT02601937|527187488|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184659|NCT02601937|527187489|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184660|NCT02601937|527187490|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184661|NCT02601937|527187491|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184662|NCT02601937|527187492|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184663|NCT02601937|527187493|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184664|NCT02601937|527187494|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
146184665|NCT02601937|527187484|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
146184666|NCT02601937|527187485|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
146184667|NCT02601937|527187486|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
146184668|NCT02601937|527187487|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
146184669|NCT02601937|527187488|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
146184670|NCT02601937|527187489|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
146184671|NCT02601937|527187490|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
146184672|NCT02601937|527187491|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
146184673|NCT02601937|527187492|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
146184674|NCT02601937|527187493|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
146184675|NCT02601937|527187494|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
146184676|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184677|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184678|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184679|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184680|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184681|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184682|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184683|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184684|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146184685|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
146184686|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
146234943|NCT02347332|527378427|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
146184687|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184688|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184689|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184690|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184691|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184692|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184693|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184694|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
146184695|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184696|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184697|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
146184698|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184699|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184700|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184701|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184702|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184703|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184704|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184705|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184706|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
146184707|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
146184708|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
146184709|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184710|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184711|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184712|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184713|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184714|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184715|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
146184716|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
146184717|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
146184718|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
146184719|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
146184720|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Other|0|||
146184721|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Other|0|||
146184722|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Other|0|||
146184723|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Other|0|||
146184724|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Other|0|||
146184725|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Other|0|||
146184726|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Other|0|||
146184727|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Other|0|||
146184728|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Other|2|||
146184729|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Other|2|||
146184730|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Other|0|||
146184731|NCT02601937|527187484|FG000|Period 2: Dose Expansion Cohort|Death|0|||
146184732|NCT02601937|527187485|FG001|Period 2: Dose Expansion Cohort|Death|0|||
146184733|NCT02601937|527187486|FG002|Period 2: Dose Expansion Cohort|Death|0|||
146184734|NCT02601937|527187487|FG003|Period 2: Dose Expansion Cohort|Death|0|||
146184735|NCT02601937|527187488|FG004|Period 2: Dose Expansion Cohort|Death|0|||
146184736|NCT02601937|527187489|FG005|Period 2: Dose Expansion Cohort|Death|0|||
146184737|NCT02601937|527187490|FG006|Period 2: Dose Expansion Cohort|Death|0|||
146184738|NCT02601937|527187491|FG007|Period 2: Dose Expansion Cohort|Death|0|||
146184739|NCT02601937|527187492|FG008|Period 2: Dose Expansion Cohort|Death|1|||
146184740|NCT02601937|527187493|FG009|Period 2: Dose Expansion Cohort|Death|0|||
146184741|NCT02601937|527187494|FG010|Period 2: Dose Expansion Cohort|Death|0|||
146184742|NCT03038672|527189388|FG000|Initial Treatment|Unacceptable chemistry|0|||
146184743|NCT03038672|527189389|FG001|Initial Treatment|Unacceptable chemistry|1|||
146184744|NCT03038672|527189388|FG000|Initial Treatment|Progression prior to treatment|1|||
146184745|NCT03038672|527189389|FG001|Initial Treatment|Progression prior to treatment|0|||
146184746|NCT03038672|527189388|FG000|Initial Treatment|No treatment per protocol|1|||
146184747|NCT03038672|527189389|FG001|Initial Treatment|No treatment per protocol|0|||
146184748|NCT04423393|527189390|FG000|Overall Study|Withdrawal by Subject|0|||
146184749|NCT04423393|527189391|FG001|Overall Study|Withdrawal by Subject|0|||
146184750|NCT04423393|527189392|FG002|Overall Study|Withdrawal by Subject|0|||
146184751|NCT04423393|527189393|FG003|Overall Study|Withdrawal by Subject|0|||
146184752|NCT04423393|527189394|FG004|Overall Study|Withdrawal by Subject|0|||
146184753|NCT04423393|527189395|FG005|Overall Study|Withdrawal by Subject|1|||
146184754|NCT04423393|527189396|FG006|Overall Study|Withdrawal by Subject|0|||
146184755|NCT04423393|527189397|FG007|Overall Study|Withdrawal by Subject|0|||
146184756|NCT04423393|527189398|FG008|Overall Study|Withdrawal by Subject|0|||
146184757|NCT04423393|527189399|FG009|Overall Study|Withdrawal by Subject|0|||
146184758|NCT04423393|527189400|FG010|Overall Study|Withdrawal by Subject|0|||
146184759|NCT04423393|527189401|FG011|Overall Study|Withdrawal by Subject|0|||
146184760|NCT04423393|527189402|FG012|Overall Study|Withdrawal by Subject|0|||
146184761|NCT04423393|527189403|FG013|Overall Study|Withdrawal by Subject|1|||
146184762|NCT04423393|527189404|FG014|Overall Study|Withdrawal by Subject|0|||
146184763|NCT04423393|527189405|FG015|Overall Study|Withdrawal by Subject|0|||
146184764|NCT04423393|527189406|FG016|Overall Study|Withdrawal by Subject|0|||
146184765|NCT04423393|527189407|FG017|Overall Study|Withdrawal by Subject|0|||
146184766|NCT04423393|527189390|FG000|Overall Study|Sponsor Decision|0|||
146184767|NCT04423393|527189391|FG001|Overall Study|Sponsor Decision|0|||
146184768|NCT04423393|527189392|FG002|Overall Study|Sponsor Decision|0|||
146184769|NCT04423393|527189393|FG003|Overall Study|Sponsor Decision|0|||
146184770|NCT04423393|527189394|FG004|Overall Study|Sponsor Decision|0|||
146184771|NCT04423393|527189395|FG005|Overall Study|Sponsor Decision|0|||
146184772|NCT04423393|527189396|FG006|Overall Study|Sponsor Decision|0|||
146184773|NCT04423393|527189397|FG007|Overall Study|Sponsor Decision|0|||
146184774|NCT04423393|527189398|FG008|Overall Study|Sponsor Decision|0|||
146184775|NCT04423393|527189399|FG009|Overall Study|Sponsor Decision|0|||
146184776|NCT04423393|527189400|FG010|Overall Study|Sponsor Decision|0|||
146184777|NCT04423393|527189401|FG011|Overall Study|Sponsor Decision|0|||
146184778|NCT04423393|527189402|FG012|Overall Study|Sponsor Decision|0|||
146184779|NCT04423393|527189403|FG013|Overall Study|Sponsor Decision|1|||
146184780|NCT04423393|527189404|FG014|Overall Study|Sponsor Decision|0|||
146184781|NCT04423393|527189405|FG015|Overall Study|Sponsor Decision|0|||
146184782|NCT04423393|527189406|FG016|Overall Study|Sponsor Decision|0|||
146184783|NCT04423393|527189407|FG017|Overall Study|Sponsor Decision|0|||
146184784|NCT05220501|527189408|FG000|Overall Study|Withdrawal by Subject|11|||
146184785|NCT05220501|527189409|FG001|Overall Study|Withdrawal by Subject|21|||
146184786|NCT05220501|527189410|FG002|Overall Study|Withdrawal by Subject|32|||
146184787|NCT05220501|527189408|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
146184788|NCT05220501|527189409|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
146184789|NCT05220501|527189410|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
146184790|NCT02692235|527189411|FG000|Overall Study|Withdrawal by Subject|2|||
146184791|NCT02692235|527189412|FG001|Overall Study|Withdrawal by Subject|1|||
146184792|NCT02692235|527189411|FG000|Overall Study|Adverse Event|1|||
146184793|NCT02692235|527189412|FG001|Overall Study|Adverse Event|2|||
146184794|NCT01929993|527189416|FG000|Overall Study|Protocol Violation|4|||
146184795|NCT01929993|527189417|FG001|Overall Study|Protocol Violation|6|||
146184796|NCT01929993|527189416|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
146184797|NCT01929993|527189417|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
146184798|NCT00107380|527189418|FG000|Overall Study|Adverse Event|7|||
146184799|NCT00107380|527189418|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
146184800|NCT00107380|527189418|FG000|Overall Study|Progression/relapse|4|||
146184801|NCT00107380|527189418|FG000|Overall Study|Death|3|||
146184802|NCT00107380|527189418|FG000|Overall Study|Other - not protocol specified|7|||
146184803|NCT00107380|527189418|FG000|Overall Study|Ineligible|2|||
146184804|NCT03673098|527189419|FG000|Overall Study|Lost to Follow-up|2|||
146184805|NCT03673098|527189420|FG001|Overall Study|Lost to Follow-up|3|||
146184806|NCT03673098|527189419|FG000|Overall Study|Withdrawal by Subject|6|||
146184807|NCT03673098|527189420|FG001|Overall Study|Withdrawal by Subject|1|||
146184808|NCT03673098|527189419|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
146184809|NCT03673098|527189420|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
146184810|NCT01268059|527189428|FG000|Overall Study|Lost to Follow-up|0|||
146184811|NCT01268059|527189429|FG001|Overall Study|Lost to Follow-up|1|||
146184812|NCT01268059|527189430|FG002|Overall Study|Lost to Follow-up|0|||
146184813|NCT01268059|527189431|FG003|Overall Study|Lost to Follow-up|0|||
146184814|NCT01268059|527189428|FG000|Overall Study|Withdrawal by Subject|7|||
146184815|NCT01268059|527189429|FG001|Overall Study|Withdrawal by Subject|4|||
146184816|NCT01268059|527189430|FG002|Overall Study|Withdrawal by Subject|0|||
146184817|NCT01268059|527189431|FG003|Overall Study|Withdrawal by Subject|0|||
146184818|NCT01268059|527189428|FG000|Overall Study|Death|20|||
146184819|NCT01268059|527189429|FG001|Overall Study|Death|30|||
146184820|NCT01268059|527189430|FG002|Overall Study|Death|3|||
146184821|NCT01268059|527189431|FG003|Overall Study|Death|5|||
146184822|NCT01268059|527189428|FG000|Overall Study|Progression of disease|1|||
146184823|NCT01268059|527189429|FG001|Overall Study|Progression of disease|0|||
146184824|NCT01268059|527189430|FG002|Overall Study|Progression of disease|0|||
146184825|NCT01268059|527189431|FG003|Overall Study|Progression of disease|0|||
146184826|NCT03660943|527189432|FG000|Overall Study|Adverse Event|5|||
146184827|NCT03660943|527189433|FG001|Overall Study|Adverse Event|3|||
146184828|NCT03660943|527189432|FG000|Overall Study|Death|0|||
146184829|NCT03660943|527189433|FG001|Overall Study|Death|2|||
146184830|NCT03660943|527189432|FG000|Overall Study|Lost to Follow-up|7|||
146184831|NCT03660943|527189433|FG001|Overall Study|Lost to Follow-up|3|||
146184832|NCT03660943|527189432|FG000|Overall Study|Protocol Violation|3|||
146184833|NCT03660943|527189433|FG001|Overall Study|Protocol Violation|5|||
146184834|NCT03660943|527189432|FG000|Overall Study|Withdrawal by Subject|8|||
146184835|NCT03660943|527189433|FG001|Overall Study|Withdrawal by Subject|15|||
146184836|NCT03660943|527189432|FG000|Overall Study|Lack of Efficacy|9|||
146184837|NCT03660943|527189433|FG001|Overall Study|Lack of Efficacy|12|||
146184838|NCT03660943|527189432|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
146184839|NCT03660943|527189433|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
146184840|NCT03850444|527189434|FG000|Overall Study|Adverse Event|16|||
146184841|NCT03850444|527189435|FG001|Overall Study|Adverse Event|10|||
146184842|NCT03850444|527189434|FG000|Overall Study|Death|87|||
146184843|NCT03850444|527189435|FG001|Overall Study|Death|107|||
146184844|NCT03850444|527189434|FG000|Overall Study|Lost to Follow-up|1|||
146184845|NCT03850444|527189435|FG001|Overall Study|Lost to Follow-up|1|||
146184846|NCT03850444|527189434|FG000|Overall Study|Withdrawal by Subject|1|||
146184847|NCT03850444|527189435|FG001|Overall Study|Withdrawal by Subject|5|||
146184848|NCT03850444|527189434|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
146184849|NCT03850444|527189435|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
146184850|NCT03531905|527189436|FG000|Overall Study|Withdrawal by Subject|3|||
146184851|NCT03531905|527189437|FG001|Overall Study|Withdrawal by Subject|3|||
146184852|NCT03531905|527189438|FG002|Overall Study|Withdrawal by Subject|2|||
146184853|NCT03531905|527189436|FG000|Overall Study|Lost to Follow-up|2|||
146184854|NCT03531905|527189437|FG001|Overall Study|Lost to Follow-up|2|||
146184855|NCT03531905|527189438|FG002|Overall Study|Lost to Follow-up|1|||
146184856|NCT03531905|527189436|FG000|Overall Study|Participant was out of town|1|||
146184857|NCT03531905|527189437|FG001|Overall Study|Participant was out of town|0|||
146184858|NCT03531905|527189438|FG002|Overall Study|Participant was out of town|0|||
146184859|NCT03531905|527189436|FG000|Overall Study|Could not speak with the participant|1|||
146184860|NCT03531905|527189437|FG001|Overall Study|Could not speak with the participant|0|||
146184861|NCT03531905|527189438|FG002|Overall Study|Could not speak with the participant|0|||
146184862|NCT01036087|527189439|FG000|Overall Study|Adverse Event|2|||
146184863|NCT01036087|527189439|FG000|Overall Study|Lack of Efficacy|1|||
146184864|NCT01021878|527189440|FG000|Overall Study|Lost to Follow-up|4|||
146184865|NCT01021878|527189441|FG001|Overall Study|Lost to Follow-up|3|||
146184866|NCT01021878|527189440|FG000|Overall Study|Death|0|||
146184867|NCT01021878|527189441|FG001|Overall Study|Death|1|||
146184868|NCT01021878|527189440|FG000|Overall Study|Adverse Event|6|||
146184869|NCT01021878|527189441|FG001|Overall Study|Adverse Event|5|||
146184870|NCT01021878|527189440|FG000|Overall Study|Transplantation|6|||
146184871|NCT01021878|527189441|FG001|Overall Study|Transplantation|1|||
146184872|NCT01155726|527189444|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
146184873|NCT01155726|527189445|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
146184874|NCT01155726|527189446|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
146184875|NCT01155726|527189447|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
146184876|NCT02892409|527189448|FG000|Overall Study|Adverse Event|1|||
146184877|NCT02892409|527189449|FG001|Overall Study|Adverse Event|0|||
146184878|NCT02892409|527189448|FG000|Overall Study|Withdrawal by Subject|2|||
146184879|NCT02892409|527189449|FG001|Overall Study|Withdrawal by Subject|1|||
146184880|NCT05305040|527189450|FG000|Overall Study|Not Dosed|37|||
146184881|NCT05305040|527189451|FG001|Overall Study|Not Dosed|37|||
146184882|NCT05305040|527189450|FG000|Overall Study|Study Closure|34|||
146184883|NCT05305040|527189451|FG001|Overall Study|Study Closure|46|||
146184884|NCT05305040|527189450|FG000|Overall Study|Death|14|||
146184885|NCT05305040|527189451|FG001|Overall Study|Death|13|||
146184886|NCT05305040|527189450|FG000|Overall Study|Withdrawal by Subject|15|||
146184887|NCT05305040|527189451|FG001|Overall Study|Withdrawal by Subject|10|||
146184888|NCT05305040|527189450|FG000|Overall Study|Other|13|||
146184889|NCT05305040|527189451|FG001|Overall Study|Other|10|||
146184890|NCT05305040|527189450|FG000|Overall Study|Primary Malignancy Relapse|3|||
146184891|NCT05305040|527189451|FG001|Overall Study|Primary Malignancy Relapse|4|||
146184892|NCT05305040|527189450|FG000|Overall Study|Adverse Event|3|||
146184893|NCT05305040|527189451|FG001|Overall Study|Adverse Event|3|||
146184894|NCT05305040|527189450|FG000|Overall Study|Lost to Follow-up|2|||
146184895|NCT05305040|527189451|FG001|Overall Study|Lost to Follow-up|1|||
146184896|NCT05305040|527189450|FG000|Overall Study|Graft versus host disease|2|||
146184897|NCT05305040|527189451|FG001|Overall Study|Graft versus host disease|0|||
146184898|NCT05305040|527189450|FG000|Overall Study|Investigator's Decision|1|||
146184899|NCT05305040|527189451|FG001|Overall Study|Investigator's Decision|1|||
146184900|NCT05305040|527189450|FG000|Overall Study|COVID-19 Reasons|1|||
146184901|NCT05305040|527189451|FG001|Overall Study|COVID-19 Reasons|0|||
146184902|NCT01195675|527189455|FG000|Overall Study|Adverse Event|1|||
146184903|NCT01195675|527189455|FG000|Overall Study|Withdrawal by Subject|2|||
146184904|NCT02424344|527189456|FG000|Overall Study|Lack of Efficacy|0|||
146184905|NCT02424344|527189457|FG001|Overall Study|Lack of Efficacy|1|||
146184906|NCT02424344|527189456|FG000|Overall Study|Withdrawal by Subject|2|||
146184907|NCT02424344|527189457|FG001|Overall Study|Withdrawal by Subject|1|||
146184908|NCT02424344|527189456|FG000|Overall Study|Lost to Follow-up|1|||
146184909|NCT02424344|527189457|FG001|Overall Study|Lost to Follow-up|0|||
146184910|NCT02424344|527189456|FG000|Overall Study|Adverse Event|4|||
146184911|NCT02424344|527189457|FG001|Overall Study|Adverse Event|8|||
146184912|NCT01536262|527189458|FG000|Overall Study|Adverse Event|6|||
146184913|NCT01536262|527189459|FG001|Overall Study|Adverse Event|1|||
146184914|NCT01536262|527189460|FG002|Overall Study|Adverse Event|2|||
146184915|NCT01536262|527189458|FG000|Overall Study|Withdrawal by Subject|1|||
146184916|NCT01536262|527189459|FG001|Overall Study|Withdrawal by Subject|1|||
146184917|NCT01536262|527189460|FG002|Overall Study|Withdrawal by Subject|0|||
146184918|NCT01536262|527189458|FG000|Overall Study|Other than stated above|1|||
146184919|NCT01536262|527189459|FG001|Overall Study|Other than stated above|0|||
146184920|NCT01536262|527189460|FG002|Overall Study|Other than stated above|0|||
146184921|NCT05257837|527189464|FG000|Overall Study|Excluded (did not find the guns)|4|||
146184922|NCT05257837|527189465|FG001|Overall Study|Excluded (did not find the guns)|2|||
146184923|NCT05257837|527189466|FG002|Overall Study|Excluded (did not find the guns)|4|||
146184924|NCT05257837|527189467|FG003|Overall Study|Excluded (did not find the guns)|0|||
146184925|NCT01625338|527189468|FG000|Overall Study|Enrolled but not Treated|0|||
146184926|NCT01625338|527189469|FG001|Overall Study|Enrolled but not Treated|0|||
146184927|NCT01625338|527189470|FG002|Overall Study|Enrolled but not Treated|1|||
146184928|NCT01625338|527189468|FG000|Overall Study|Efficacy Failure|27|||
146184929|NCT01625338|527189469|FG001|Overall Study|Efficacy Failure|39|||
146184930|NCT01625338|527189470|FG002|Overall Study|Efficacy Failure|31|||
146184931|NCT01625338|527189468|FG000|Overall Study|Lost to Follow-up|3|||
146184932|NCT01625338|527189469|FG001|Overall Study|Lost to Follow-up|3|||
146184933|NCT01625338|527189470|FG002|Overall Study|Lost to Follow-up|2|||
146184934|NCT01625338|527189468|FG000|Overall Study|Investigator Decision|0|||
146184935|NCT01625338|527189469|FG001|Overall Study|Investigator Decision|2|||
146184936|NCT01625338|527189470|FG002|Overall Study|Investigator Decision|1|||
146184937|NCT01625338|527189468|FG000|Overall Study|Subject Withdrew Consent|1|||
146184938|NCT01625338|527189469|FG001|Overall Study|Subject Withdrew Consent|0|||
146184939|NCT01625338|527189470|FG002|Overall Study|Subject Withdrew Consent|2|||
146184940|NCT01625338|527189468|FG000|Overall Study|Adverse Event|1|||
146184941|NCT01625338|527189469|FG001|Overall Study|Adverse Event|0|||
146184942|NCT01625338|527189470|FG002|Overall Study|Adverse Event|1|||
146184943|NCT01625338|527189468|FG000|Overall Study|Study Discontinued by Sponsor|0|||
146184944|NCT01625338|527189469|FG001|Overall Study|Study Discontinued by Sponsor|0|||
146184945|NCT01625338|527189470|FG002|Overall Study|Study Discontinued by Sponsor|1|||
146184946|NCT01781611|527189471|FG000|Overall Study|Adverse Event|4|||
146184947|NCT01781611|527189472|FG001|Overall Study|Adverse Event|0|||
146184948|NCT03639675|527189473|FG000|Overall Study|Withdrawal by Subject|1|||
146184949|NCT02459587|527189474|FG000|3-Month Follow-up Assessment|Death|0|||
146184950|NCT02459587|527189475|FG001|3-Month Follow-up Assessment|Death|2|||
146184951|NCT02459587|527189474|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
146184952|NCT02459587|527189475|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
146184953|NCT02459587|527189474|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
146184954|NCT02459587|527189475|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
146184955|NCT02459587|527189474|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
146184956|NCT02459587|527189475|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
146184957|NCT02459587|527189474|FG000|6-month Follow-up Assessment|Death|2|||
146184958|NCT02459587|527189475|FG001|6-month Follow-up Assessment|Death|1|||
146184959|NCT02459587|527189474|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
146184960|NCT02459587|527189475|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
146184961|NCT02459587|527189474|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
146184962|NCT02459587|527189475|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
146184963|NCT02459587|527189474|FG000|12-month Follow-up Assessment|Death|2|||
146184964|NCT02459587|527189475|FG001|12-month Follow-up Assessment|Death|0|||
146184965|NCT02459587|527189474|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
146184966|NCT02459587|527189475|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
146184967|NCT02459587|527189474|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
146184968|NCT02459587|527189475|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
146184969|NCT02459587|527189474|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
146184970|NCT02459587|527189475|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
146184971|NCT01734850|527189476|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
146184972|NCT01734850|527189477|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
146184973|NCT01734850|527189478|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
146184974|NCT01734850|527189476|FG000|Overall Study|Not infused due to manufacturing failure|0|||
146184975|NCT01734850|527189477|FG001|Overall Study|Not infused due to manufacturing failure|0|||
146184976|NCT01734850|527189478|FG002|Overall Study|Not infused due to manufacturing failure|1|||
146184977|NCT00750893|527189479|FG000|Overall Study|Adverse Event|5|||
146184978|NCT00750893|527189479|FG000|Overall Study|Withdrawal by Subject|10|||
146184979|NCT00750893|527189479|FG000|Overall Study|Lost to Follow-up|510|||
146184980|NCT00750893|527189479|FG000|Overall Study|Other|17|||
146184981|NCT00661258|527189481|FG000|Overall Study|Death|1|||
146184982|NCT00661258|527189482|FG001|Overall Study|Death|0|||
146184983|NCT00661258|527189481|FG000|Overall Study|caught by police and in detox center|2|||
146184984|NCT00661258|527189482|FG001|Overall Study|caught by police and in detox center|1|||
146184985|NCT04496167|527189483|FG000|Overall Study|Adverse Event|6|||
146184986|NCT04496167|527189484|FG001|Overall Study|Adverse Event|2|||
146184987|NCT04496167|527189483|FG000|Overall Study|Withdrawal by Subject|7|||
146184988|NCT04496167|527189484|FG001|Overall Study|Withdrawal by Subject|6|||
146184989|NCT04496167|527189483|FG000|Overall Study|Lost to Follow-up|3|||
146184990|NCT04496167|527189484|FG001|Overall Study|Lost to Follow-up|5|||
146184991|NCT04496167|527189483|FG000|Overall Study|Not Treated|1|||
146184992|NCT04496167|527189484|FG001|Overall Study|Not Treated|2|||
146184993|NCT04496167|527189483|FG000|Overall Study|Other Than Specified|1|||
146184994|NCT04496167|527189484|FG001|Overall Study|Other Than Specified|1|||
146184995|NCT00598481|527189487|FG000|Treatment|Physician Decision|1|||
146184996|NCT01083160|527189488|FG000|Overall Study|Adverse Event|1|||
146184997|NCT01951092|527189491|FG000|Overall Study|Lost to Follow-up|10|||
146080949|NCT01185353|526816762|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080950|NCT01185353|526816763|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080951|NCT01185353|526816764|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
146080952|NCT01185353|526816765|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080953|NCT01185353|526816766|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080954|NCT01185353|526816767|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080955|NCT01185353|526816768|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080956|NCT01185353|526816769|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
146080957|NCT01185353|526816760|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080958|NCT01185353|526816761|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080959|NCT01185353|526816762|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
146080960|NCT01185353|526816763|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080961|NCT01185353|526816764|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080962|NCT01185353|526816765|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
146080963|NCT01185353|526816766|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080964|NCT01185353|526816767|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080965|NCT01185353|526816768|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080966|NCT01185353|526816769|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
146080967|NCT01185353|526816760|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080968|NCT01185353|526816761|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
146080969|NCT01185353|526816762|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080970|NCT01185353|526816763|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
146080971|NCT01185353|526816764|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080972|NCT01185353|526816765|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080973|NCT01185353|526816766|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080974|NCT01185353|526816767|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080975|NCT01185353|526816768|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080976|NCT01185353|526816769|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
146080977|NCT01185353|526816760|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080978|NCT01185353|526816761|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080979|NCT01185353|526816762|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080980|NCT01185353|526816763|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
146080981|NCT01185353|526816764|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080982|NCT01185353|526816765|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080983|NCT01185353|526816766|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
146080984|NCT01185353|526816767|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080985|NCT01185353|526816768|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080986|NCT01185353|526816769|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
146080987|NCT01185353|526816760|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080988|NCT01185353|526816761|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080989|NCT01185353|526816762|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
146080990|NCT01185353|526816763|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
146080991|NCT01185353|526816764|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080992|NCT01185353|526816765|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
146080993|NCT01185353|526816766|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
146080994|NCT01185353|526816767|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080995|NCT01185353|526816768|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080996|NCT01185353|526816769|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
146080997|NCT01185353|526816760|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146080998|NCT01185353|526816761|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146080999|NCT01185353|526816762|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081000|NCT01185353|526816763|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081001|NCT01185353|526816764|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081002|NCT01185353|526816765|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081003|NCT01185353|526816766|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
146184998|NCT01951092|527189491|FG000|Overall Study|Incarceration|1|||
146184999|NCT01951092|527189491|FG000|Overall Study|Transfer of Care|1|||
146185000|NCT00918749|527189492|FG000|Overall Study|Adverse Event|1|||
146185001|NCT00918749|527189493|FG001|Overall Study|Adverse Event|0|||
146185002|NCT00918749|527189494|FG002|Overall Study|Adverse Event|1|||
146185003|NCT00918749|527189492|FG000|Overall Study|Lost to Follow-up|0|||
146185004|NCT00918749|527189493|FG001|Overall Study|Lost to Follow-up|0|||
146185005|NCT00918749|527189494|FG002|Overall Study|Lost to Follow-up|1|||
146185006|NCT00918749|527189492|FG000|Overall Study|Withdrawal by Subject|5|||
146185007|NCT00918749|527189493|FG001|Overall Study|Withdrawal by Subject|3|||
146185008|NCT00918749|527189494|FG002|Overall Study|Withdrawal by Subject|5|||
146185009|NCT00918749|527189492|FG000|Overall Study|No Study Medication Taken|1|||
146185010|NCT00918749|527189493|FG001|Overall Study|No Study Medication Taken|0|||
146185011|NCT00918749|527189494|FG002|Overall Study|No Study Medication Taken|0|||
146185012|NCT01712789|527189495|FG000|Overall Study|Lack of Efficacy|2|||
146185013|NCT01712789|527189495|FG000|Overall Study|Lost to Follow-up|1|||
146185014|NCT01712789|527189495|FG000|Overall Study|Progressive Disease|504|||
146185015|NCT01712789|527189495|FG000|Overall Study|Death|57|||
146185016|NCT01712789|527189495|FG000|Overall Study|Adverse Event|52|||
146185017|NCT01712789|527189495|FG000|Overall Study|Miscellaneous|31|||
146185018|NCT01712789|527189495|FG000|Overall Study|Withdrawal by Subject|21|||
146185019|NCT01712789|527189495|FG000|Overall Study|Transition to Commercial Treatment|8|||
146185020|NCT01712789|527189495|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
146185021|NCT01708187|527189496|FG000|Overall Study|Lost to Follow-up|0|||
146185022|NCT01708187|527189497|FG001|Overall Study|Lost to Follow-up|1|||
146185023|NCT01439711|527189499|FG000|Overall Study|Ineligible|13|||
146185024|NCT01439711|527189499|FG000|Overall Study|Cancel|3|||
146185025|NCT01439711|527189499|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
146185026|NCT01439711|527189499|FG000|Overall Study|Adverse Event|5|||
146185027|NCT01439711|527189499|FG000|Overall Study|Withdrawal by Subject|3|||
146185028|NCT01439711|527189499|FG000|Overall Study|Progression During Active Tx|3|||
146185029|NCT01439711|527189499|FG000|Overall Study|Noncompliance|3|||
146185030|NCT01439711|527189499|FG000|Overall Study|No MRI|9|||
146185031|NCT01603121|527189506|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
146185032|NCT01603121|527189507|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
146185033|NCT00577720|527189508|FG000|Overall Study|Adverse Event|2|||
146185034|NCT00577720|527189509|FG001|Overall Study|Adverse Event|1|||
146185035|NCT00577720|527189510|FG002|Overall Study|Adverse Event|0|||
146185036|NCT00577720|527189511|FG003|Overall Study|Adverse Event|4|||
146185037|NCT00577720|527189508|FG000|Overall Study|Lost to Follow-up|0|||
146185038|NCT00577720|527189509|FG001|Overall Study|Lost to Follow-up|0|||
146185039|NCT00577720|527189510|FG002|Overall Study|Lost to Follow-up|1|||
146185040|NCT00577720|527189511|FG003|Overall Study|Lost to Follow-up|0|||
146185041|NCT00577720|527189508|FG000|Overall Study|Protocol Violation|0|||
146185042|NCT00577720|527189509|FG001|Overall Study|Protocol Violation|0|||
146185043|NCT00577720|527189510|FG002|Overall Study|Protocol Violation|0|||
146185044|NCT00577720|527189511|FG003|Overall Study|Protocol Violation|1|||
146185045|NCT00577720|527189508|FG000|Overall Study|Withdrawal by Subject|2|||
146185046|NCT00577720|527189509|FG001|Overall Study|Withdrawal by Subject|0|||
146185047|NCT00577720|527189510|FG002|Overall Study|Withdrawal by Subject|0|||
146185048|NCT00577720|527189511|FG003|Overall Study|Withdrawal by Subject|2|||
146185049|NCT01628510|527189515|FG000|Overall Study|Withdrawal by Subject|0|||
146185050|NCT01628510|527189516|FG001|Overall Study|Withdrawal by Subject|4|||
146185051|NCT01628510|527189515|FG000|Overall Study|Death|3|||
146185052|NCT01628510|527189516|FG001|Overall Study|Death|1|||
146185053|NCT01656759|527189517|FG000|Overall Study|Protocol Violation|2|||
146185054|NCT01656759|527189518|FG001|Overall Study|Protocol Violation|3|||
146185055|NCT04707391|527189519|FG000|Overall Study|Adverse Event|5|||
146185056|NCT04707391|527189520|FG001|Overall Study|Adverse Event|8|||
146185057|NCT04707391|527189519|FG000|Overall Study|Lost to Follow-up|44|||
146185058|NCT04707391|527189520|FG001|Overall Study|Lost to Follow-up|31|||
146185059|NCT04707391|527189519|FG000|Overall Study|Protocol Violation|1|||
146185060|NCT04707391|527189520|FG001|Overall Study|Protocol Violation|5|||
146185061|NCT04707391|527189519|FG000|Overall Study|Withdrawal by Subject|27|||
146185062|NCT04707391|527189520|FG001|Overall Study|Withdrawal by Subject|25|||
146081004|NCT01185353|526816767|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081005|NCT01185353|526816768|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081006|NCT01185353|526816769|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
146081007|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081008|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081009|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081010|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081011|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081012|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081013|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
146081014|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
146081015|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
146081016|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
146081017|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081018|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081019|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081020|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081021|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081022|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081023|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
146081024|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
146081025|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
146081026|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
146081027|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081028|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081029|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081030|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081031|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081032|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081033|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
146081034|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
146081035|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
146081036|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
146081037|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081038|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081039|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081040|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081041|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081042|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081043|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081044|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081045|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
146185063|NCT04707391|527189519|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
146185064|NCT04707391|527189520|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
146185065|NCT04707391|527189519|FG000|Overall Study|Other|0|||
146185066|NCT04707391|527189520|FG001|Overall Study|Other|2|||
146185067|NCT01932996|527189521|FG000|Overall Study|Protocol Violation|2|||
146185068|NCT01932996|527189522|FG001|Overall Study|Protocol Violation|0|||
146185069|NCT02040090|527189526|FG000|Overall Study|Adverse Event|2|||
146185070|NCT02040090|527189527|FG001|Overall Study|Adverse Event|0|||
146185071|NCT02040090|527189526|FG000|Overall Study|Physician Decision|1|||
146185072|NCT02040090|527189527|FG001|Overall Study|Physician Decision|0|||
146081046|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
146081047|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Death|0|||
146081048|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Death|0|||
146081049|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Death|0|||
146081050|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Death|0|||
146081051|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Death|0|||
146081052|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Death|0|||
146081053|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Death|0|||
146081054|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Death|0|||
146081055|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Death|0|||
146081056|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Death|1|||
146081057|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081058|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081059|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081060|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081061|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081062|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081063|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081064|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081065|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
146081066|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
146081067|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081068|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081069|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081070|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081071|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081072|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081073|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081074|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081075|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
146081076|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
146081077|NCT01185353|526816760|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081078|NCT01185353|526816761|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081079|NCT01185353|526816762|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081080|NCT01185353|526816763|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081081|NCT01185353|526816764|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081082|NCT01185353|526816765|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081083|NCT01185353|526816766|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081084|NCT01185353|526816767|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081085|NCT01185353|526816768|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
146081086|NCT01185353|526816769|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
146081087|NCT01185353|526816760|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081088|NCT01185353|526816761|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081089|NCT01185353|526816762|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081090|NCT01185353|526816763|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081091|NCT01185353|526816764|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081092|NCT01185353|526816765|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081093|NCT01185353|526816766|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081094|NCT01185353|526816767|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
146081095|NCT01185353|526816768|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
146081096|NCT01185353|526816769|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
146081097|NCT01185353|526816760|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081098|NCT01185353|526816761|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081099|NCT01185353|526816762|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081100|NCT01185353|526816763|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081101|NCT01185353|526816764|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081102|NCT01185353|526816765|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081103|NCT01185353|526816766|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
146081104|NCT01185353|526816767|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
146081105|NCT01185353|526816768|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
146081106|NCT01185353|526816769|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
146081107|NCT01185353|526816760|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081108|NCT01185353|526816761|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081109|NCT01185353|526816762|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146185073|NCT02040090|527189526|FG000|Overall Study|Withdrawal by Subject|0|||
146185074|NCT02040090|527189527|FG001|Overall Study|Withdrawal by Subject|1|||
146185075|NCT02040090|527189526|FG000|Overall Study|Lost to Follow-up|0|||
146185076|NCT02040090|527189527|FG001|Overall Study|Lost to Follow-up|1|||
146185077|NCT02584855|527189533|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
146185078|NCT02584855|527189534|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146185079|NCT02584855|527189535|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146185080|NCT02584855|527189536|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146185081|NCT02584855|527189537|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
146185082|NCT02584855|527189538|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
146185083|NCT02584855|527189533|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
146185084|NCT02584855|527189534|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146185085|NCT02584855|527189535|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146185086|NCT02584855|527189536|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146185087|NCT02584855|527189537|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
146185088|NCT02584855|527189538|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
146185089|NCT02584855|527189533|FG000|Open-Label Treatment Period|Adverse Event|14|||
146185090|NCT02584855|527189534|FG001|Open-Label Treatment Period|Adverse Event|0|||
146185091|NCT02584855|527189535|FG002|Open-Label Treatment Period|Adverse Event|0|||
146185092|NCT02584855|527189536|FG003|Open-Label Treatment Period|Adverse Event|0|||
146185093|NCT02584855|527189537|FG004|Open-Label Treatment Period|Adverse Event|0|||
146185094|NCT02584855|527189538|FG005|Open-Label Treatment Period|Adverse Event|0|||
146185095|NCT02584855|527189533|FG000|Open-Label Treatment Period|Death|2|||
146185096|NCT02584855|527189534|FG001|Open-Label Treatment Period|Death|0|||
146185097|NCT02584855|527189535|FG002|Open-Label Treatment Period|Death|0|||
146185098|NCT02584855|527189536|FG003|Open-Label Treatment Period|Death|0|||
146185099|NCT02584855|527189537|FG004|Open-Label Treatment Period|Death|0|||
146185100|NCT02584855|527189538|FG005|Open-Label Treatment Period|Death|0|||
146185101|NCT02584855|527189533|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
146185102|NCT02584855|527189534|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146185103|NCT02584855|527189535|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146185104|NCT02584855|527189536|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146185105|NCT02584855|527189537|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
146185106|NCT02584855|527189538|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
146185107|NCT02584855|527189533|FG000|Open-Label Treatment Period|Protocol Violation|1|||
146185108|NCT02584855|527189534|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146185109|NCT02584855|527189535|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146185110|NCT02584855|527189536|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146185111|NCT02584855|527189537|FG004|Open-Label Treatment Period|Protocol Violation|0|||
146185112|NCT02584855|527189538|FG005|Open-Label Treatment Period|Protocol Violation|0|||
146185113|NCT02584855|527189533|FG000|Open-Label Treatment Period|No PI Available|2|||
146185114|NCT02584855|527189534|FG001|Open-Label Treatment Period|No PI Available|0|||
146185115|NCT02584855|527189535|FG002|Open-Label Treatment Period|No PI Available|0|||
146185116|NCT02584855|527189536|FG003|Open-Label Treatment Period|No PI Available|0|||
146185117|NCT02584855|527189537|FG004|Open-Label Treatment Period|No PI Available|0|||
146185118|NCT02584855|527189538|FG005|Open-Label Treatment Period|No PI Available|0|||
146185119|NCT02584855|527189533|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
146185120|NCT02584855|527189534|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
146185121|NCT02584855|527189535|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
146185122|NCT02584855|527189536|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
146185123|NCT02584855|527189537|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
146185124|NCT02584855|527189538|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
146185125|NCT02584855|527189533|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146185126|NCT02584855|527189534|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146185127|NCT02584855|527189535|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
146185128|NCT02584855|527189536|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146185129|NCT02584855|527189537|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146185130|NCT02584855|527189538|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
146185131|NCT02584855|527189533|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
146185132|NCT02584855|527189534|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
146185133|NCT02584855|527189535|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
146185134|NCT02584855|527189536|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
146185135|NCT02584855|527189537|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
146185136|NCT02584855|527189538|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
146185137|NCT02584855|527189533|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146185138|NCT02584855|527189534|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
146081110|NCT01185353|526816763|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081111|NCT01185353|526816764|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081112|NCT01185353|526816765|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081113|NCT01185353|526816766|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081114|NCT01185353|526816767|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
146081115|NCT01185353|526816768|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
146081116|NCT01185353|526816769|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
146081117|NCT02270944|526816773|FG000|Overall Study|Lost to Follow-up|9|||
146081118|NCT02270944|526816774|FG001|Overall Study|Lost to Follow-up|4|||
146081119|NCT02270944|526816773|FG000|Overall Study|Withdrawal by Subject|2|||
146081120|NCT02270944|526816774|FG001|Overall Study|Withdrawal by Subject|1|||
146081121|NCT01144299|526816775|FG000|Overall Study|Lost to Follow-up|1|||
146081122|NCT01144299|526816776|FG001|Overall Study|Lost to Follow-up|0|||
146081123|NCT01144299|526816775|FG000|Overall Study|Withdrawal by Subject|1|||
146081124|NCT01144299|526816776|FG001|Overall Study|Withdrawal by Subject|0|||
146081125|NCT02342418|526816779|FG000|Overall Study|Adverse Event|0|||
146081126|NCT02342418|526816780|FG001|Overall Study|Adverse Event|1|||
146081127|NCT04255394|526816781|FG000|Overall Study|Death|35|||
146081128|NCT04255394|526816782|FG001|Overall Study|Death|25|||
146081129|NCT04255394|526816781|FG000|Overall Study|Device removed|2|||
146081130|NCT04255394|526816782|FG001|Overall Study|Device removed|10|||
146081131|NCT04255394|526816781|FG000|Overall Study|Withdrawal by Subject|9|||
146081132|NCT04255394|526816782|FG001|Overall Study|Withdrawal by Subject|8|||
146081133|NCT04255394|526816781|FG000|Overall Study|Screen Failure/Not treated|12|||
146081134|NCT04255394|526816782|FG001|Overall Study|Screen Failure/Not treated|8|||
146081135|NCT04255394|526816781|FG000|Overall Study|Lost to Follow-up|123|||
146081136|NCT04255394|526816782|FG001|Overall Study|Lost to Follow-up|265|||
146081137|NCT04255394|526816781|FG000|Overall Study|Adverse Event|1|||
146081138|NCT04255394|526816782|FG001|Overall Study|Adverse Event|3|||
146081139|NCT03612856|526816792|FG000|Pre-dose Period|Physician Decision|0|||
146081140|NCT03612856|526816793|FG001|Pre-dose Period|Physician Decision|1|||
146081141|NCT03612856|526816794|FG002|Pre-dose Period|Physician Decision|1|||
146185139|NCT02584855|527189535|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146185140|NCT02584855|527189536|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146185141|NCT02584855|527189537|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146185142|NCT02584855|527189538|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
146185143|NCT02584855|527189533|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146185144|NCT02584855|527189534|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
146185145|NCT02584855|527189535|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146185146|NCT02584855|527189536|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146185147|NCT02584855|527189537|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146185148|NCT02584855|527189538|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
146185149|NCT02584855|527189533|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146185150|NCT02584855|527189534|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146185151|NCT02584855|527189535|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146185152|NCT02584855|527189536|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146185153|NCT02584855|527189537|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
146185154|NCT02584855|527189538|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
146185155|NCT02584855|527189533|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
146185156|NCT02584855|527189534|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
146185157|NCT02584855|527189535|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
146185158|NCT02584855|527189536|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
146185159|NCT02584855|527189537|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
146185160|NCT02584855|527189538|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
146185161|NCT02337478|527189539|FG000|Overall Study|Lack of Efficacy|5|||
146185162|NCT00895843|527189540|FG000|Overall Study|Protocol Violation|12|||
146185163|NCT00895843|527189541|FG001|Overall Study|Protocol Violation|12|||
146185164|NCT04963062|527189545|FG000|Overall Study|withdrew by the study team|4|||
146185165|NCT04963062|527189546|FG001|Overall Study|withdrew by the study team|2|||
146185166|NCT04504916|527189554|FG000|Overall Study|Study terminated|7|||
146185167|NCT04504916|527189555|FG001|Overall Study|Study terminated|8|||
146185168|NCT04504916|527189554|FG000|Overall Study|Death|54|||
146185169|NCT04504916|527189555|FG001|Overall Study|Death|18|||
146185170|NCT04504916|527189554|FG000|Overall Study|Lost to Follow-up|1|||
146185171|NCT04504916|527189555|FG001|Overall Study|Lost to Follow-up|1|||
146185172|NCT04504916|527189554|FG000|Overall Study|Withdrawal by Subject|8|||
146185173|NCT04504916|527189555|FG001|Overall Study|Withdrawal by Subject|4|||
146185174|NCT04504916|527189554|FG000|Overall Study|Did not agree to follow-up|0|||
146185175|NCT04504916|527189555|FG001|Overall Study|Did not agree to follow-up|1|||
146185176|NCT01368211|527189556|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
146185177|NCT01368211|527189557|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
146185178|NCT01513967|527189561|FG000|Overall Study|Pregnancy|0|||
146185179|NCT01513967|527189562|FG001|Overall Study|Pregnancy|0|||
146185180|NCT01513967|527189563|FG002|Overall Study|Pregnancy|0|||
146185181|NCT01513967|527189564|FG003|Overall Study|Pregnancy|0|||
146185182|NCT01513967|527189565|FG004|Overall Study|Pregnancy|0|||
146185183|NCT01513967|527189566|FG005|Overall Study|Pregnancy|0|||
146185184|NCT01513967|527189567|FG006|Overall Study|Pregnancy|1|||
146185185|NCT01513967|527189568|FG007|Overall Study|Pregnancy|0|||
146185186|NCT01513967|527189561|FG000|Overall Study|missed a study visit|0|||
146185187|NCT01513967|527189562|FG001|Overall Study|missed a study visit|0|||
146185188|NCT01513967|527189563|FG002|Overall Study|missed a study visit|0|||
146185189|NCT01513967|527189564|FG003|Overall Study|missed a study visit|0|||
146185190|NCT01513967|527189565|FG004|Overall Study|missed a study visit|0|||
146185191|NCT01513967|527189566|FG005|Overall Study|missed a study visit|0|||
146185192|NCT01513967|527189567|FG006|Overall Study|missed a study visit|1|||
146185193|NCT01513967|527189568|FG007|Overall Study|missed a study visit|0|||
146185194|NCT01513967|527189561|FG000|Overall Study|excluded due to positive drug screen|0|||
146185195|NCT01513967|527189562|FG001|Overall Study|excluded due to positive drug screen|0|||
146185196|NCT01513967|527189563|FG002|Overall Study|excluded due to positive drug screen|0|||
146185197|NCT01513967|527189564|FG003|Overall Study|excluded due to positive drug screen|0|||
146185198|NCT01513967|527189565|FG004|Overall Study|excluded due to positive drug screen|0|||
146185199|NCT01513967|527189566|FG005|Overall Study|excluded due to positive drug screen|0|||
146185200|NCT01513967|527189567|FG006|Overall Study|excluded due to positive drug screen|0|||
146185201|NCT01513967|527189568|FG007|Overall Study|excluded due to positive drug screen|2|||
146185202|NCT01513967|527189561|FG000|Overall Study|Physician Decision|0|||
146185203|NCT01513967|527189562|FG001|Overall Study|Physician Decision|0|||
146185204|NCT01513967|527189563|FG002|Overall Study|Physician Decision|0|||
146185205|NCT01513967|527189564|FG003|Overall Study|Physician Decision|0|||
146185206|NCT01513967|527189565|FG004|Overall Study|Physician Decision|0|||
146185207|NCT01513967|527189566|FG005|Overall Study|Physician Decision|1|||
146185208|NCT01513967|527189567|FG006|Overall Study|Physician Decision|0|||
146185209|NCT01513967|527189568|FG007|Overall Study|Physician Decision|0|||
146185210|NCT02906202|527189569|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
146185211|NCT01349660|527189570|FG000|Overall Study|Still Receiving Study Treatment|0|||
146185212|NCT01349660|527189571|FG001|Overall Study|Still Receiving Study Treatment|0|||
146185213|NCT01349660|527189572|FG002|Overall Study|Still Receiving Study Treatment|1|||
146185214|NCT01349660|527189570|FG000|Overall Study|Disease Progression|2|||
146185215|NCT01349660|527189571|FG001|Overall Study|Disease Progression|4|||
146185216|NCT01349660|527189572|FG002|Overall Study|Disease Progression|50|||
146185217|NCT01349660|527189570|FG000|Overall Study|Adverse Event|1|||
146185218|NCT01349660|527189571|FG001|Overall Study|Adverse Event|1|||
146185219|NCT01349660|527189572|FG002|Overall Study|Adverse Event|12|||
146185220|NCT01349660|527189570|FG000|Overall Study|Withdrawal by Subject|2|||
146185221|NCT01349660|527189571|FG001|Overall Study|Withdrawal by Subject|0|||
146185222|NCT01349660|527189572|FG002|Overall Study|Withdrawal by Subject|9|||
146185223|NCT01349660|527189570|FG000|Overall Study|Death|1|||
146185224|NCT01349660|527189571|FG001|Overall Study|Death|1|||
146185225|NCT01349660|527189572|FG002|Overall Study|Death|0|||
146185226|NCT01349660|527189570|FG000|Overall Study|Non-Permitted Interventions|0|||
146185227|NCT01349660|527189571|FG001|Overall Study|Non-Permitted Interventions|0|||
146185228|NCT01349660|527189572|FG002|Overall Study|Non-Permitted Interventions|2|||
146185229|NCT01349660|527189570|FG000|Overall Study|Study Compliance|0|||
146185230|NCT01349660|527189571|FG001|Overall Study|Study Compliance|0|||
146185231|NCT01349660|527189572|FG002|Overall Study|Study Compliance|1|||
146185232|NCT01349660|527189570|FG000|Overall Study|Declining Performance Status|0|||
146185233|NCT01349660|527189571|FG001|Overall Study|Declining Performance Status|0|||
146185234|NCT01349660|527189572|FG002|Overall Study|Declining Performance Status|1|||
146185235|NCT00847301|527189575|FG000|Overall Study|Adverse Event|35|||
146185236|NCT00847301|527189575|FG000|Overall Study|Switch to other anticoagulants|16|||
146185237|NCT00847301|527189575|FG000|Overall Study|Lost to Follow-up|1|||
146185238|NCT00847301|527189575|FG000|Overall Study|No prescription after hospital discharge|1|||
146185239|NCT00847301|527189575|FG000|Overall Study|Other reason not defined above|1|||
146185240|NCT04248465|527189579|FG000|Randomized-Controlled Period|Death|12|||
146185241|NCT04248465|527189580|FG001|Randomized-Controlled Period|Death|5|||
146185242|NCT04248465|527189579|FG000|Randomized-Controlled Period|Adverse Event|2|||
146185243|NCT04248465|527189580|FG001|Randomized-Controlled Period|Adverse Event|0|||
146185244|NCT04248465|527189579|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
146185245|NCT04248465|527189580|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
146185246|NCT04248465|527189579|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
146185247|NCT04248465|527189580|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
146185248|NCT04248465|527189579|FG000|Randomized-Controlled Period|Physician Decision|1|||
146185249|NCT04248465|527189580|FG001|Randomized-Controlled Period|Physician Decision|1|||
146185250|NCT04248465|527189579|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
146185251|NCT04248465|527189580|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
146185252|NCT04248465|527189579|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
146185253|NCT04248465|527189580|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
146185254|NCT04248465|527189579|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146185255|NCT04248465|527189580|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
146185256|NCT05708846|527189581|FG000|Overall Study|Death|5|||
146185257|NCT05708846|527189581|FG000|Overall Study|Withdrawal by Subject|20|||
146185258|NCT03428815|527189582|FG000|Overall Study|Lost to Follow-up|2|||
146185259|NCT03428815|527189583|FG001|Overall Study|Lost to Follow-up|2|||
146185260|NCT03428815|527189582|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
146185261|NCT03428815|527189583|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
146185262|NCT03428815|527189582|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
146234944|NCT02347332|527378426|FG000|Overall Study|Protocol Violation|1|||
146081142|NCT03612856|526816792|FG000|Pre-dose Period|Withdrawal by Subject|0|||
146081143|NCT03612856|526816793|FG001|Pre-dose Period|Withdrawal by Subject|1|||
146081144|NCT03612856|526816794|FG002|Pre-dose Period|Withdrawal by Subject|0|||
146081145|NCT01576159|526816795|FG000|Overall Study|Withdrawal by Subject|0|||
146081146|NCT01576159|526816796|FG001|Overall Study|Withdrawal by Subject|1|||
146081147|NCT01576159|526816797|FG002|Overall Study|Withdrawal by Subject|0|||
146081148|NCT01576159|526816798|FG003|Overall Study|Withdrawal by Subject|0|||
146081149|NCT01576159|526816795|FG000|Overall Study|Physician Decision|0|||
146081150|NCT01576159|526816796|FG001|Overall Study|Physician Decision|0|||
146081151|NCT01576159|526816797|FG002|Overall Study|Physician Decision|1|||
146081152|NCT01576159|526816798|FG003|Overall Study|Physician Decision|0|||
146081153|NCT01576159|526816795|FG000|Overall Study|Lost to Follow-up|0|||
146081154|NCT01576159|526816796|FG001|Overall Study|Lost to Follow-up|0|||
146081155|NCT01576159|526816797|FG002|Overall Study|Lost to Follow-up|0|||
146081156|NCT01576159|526816798|FG003|Overall Study|Lost to Follow-up|1|||
146081157|NCT01576159|526816795|FG000|Overall Study|Protocol Violation|1|||
146081158|NCT01576159|526816796|FG001|Overall Study|Protocol Violation|0|||
146081159|NCT01576159|526816797|FG002|Overall Study|Protocol Violation|0|||
146081160|NCT01576159|526816798|FG003|Overall Study|Protocol Violation|0|||
146081161|NCT01181986|526816799|FG000|Phase 1|Lost to Follow-up|0|||
146081162|NCT01181986|526816800|FG001|Phase 1|Lost to Follow-up|1|||
146081163|NCT01181986|526816801|FG002|Phase 1|Lost to Follow-up|1|||
146081164|NCT01181986|526816799|FG000|Phase 1|Adverse Event|0|||
146081165|NCT01181986|526816800|FG001|Phase 1|Adverse Event|0|||
146081166|NCT01181986|526816801|FG002|Phase 1|Adverse Event|1|||
146081167|NCT01181986|526816799|FG000|Phase 1|Protocol Violation|1|||
146081168|NCT01181986|526816800|FG001|Phase 1|Protocol Violation|0|||
146081169|NCT01181986|526816801|FG002|Phase 1|Protocol Violation|0|||
146081170|NCT01181986|526816799|FG000|Phase 2|Adverse Event|0|||
146081171|NCT01181986|526816800|FG001|Phase 2|Adverse Event|3|||
146081172|NCT01181986|526816801|FG002|Phase 2|Adverse Event|0|||
146081173|NCT01181986|526816799|FG000|Phase 2|Medical condition|0|||
146081174|NCT01181986|526816800|FG001|Phase 2|Medical condition|1|||
146081175|NCT01181986|526816801|FG002|Phase 2|Medical condition|0|||
146081176|NCT01011309|526816802|FG000|Overall Study|Adverse Event|2|||
146081177|NCT01011309|526816803|FG001|Overall Study|Adverse Event|1|||
146081178|NCT01011309|526816804|FG002|Overall Study|Adverse Event|2|||
146081179|NCT01011309|526816802|FG000|Overall Study|Lack of Efficacy|0|||
146081180|NCT01011309|526816803|FG001|Overall Study|Lack of Efficacy|1|||
146081181|NCT01011309|526816804|FG002|Overall Study|Lack of Efficacy|0|||
146081182|NCT01011309|526816802|FG000|Overall Study|Protocol Violation|0|||
146081183|NCT01011309|526816803|FG001|Overall Study|Protocol Violation|1|||
146081184|NCT01011309|526816804|FG002|Overall Study|Protocol Violation|3|||
146081185|NCT01182844|526816814|FG000|Overall Study|Withdrawal by Subject|0|||
146081186|NCT01182844|526816815|FG001|Overall Study|Withdrawal by Subject|2|||
146081187|NCT01330017|526818164|FG000|Overall Study|Adverse Event|0|||
146081188|NCT01330017|526818165|FG001|Overall Study|Adverse Event|1|||
146081189|NCT01330017|526818166|FG002|Overall Study|Adverse Event|1|||
146081190|NCT01330017|526818167|FG003|Overall Study|Adverse Event|4|||
146081191|NCT01330017|526818168|FG004|Overall Study|Adverse Event|0|||
146081192|NCT01330017|526818164|FG000|Overall Study|Withdrawal by Subject|0|||
146081193|NCT01330017|526818165|FG001|Overall Study|Withdrawal by Subject|0|||
146081194|NCT01330017|526818166|FG002|Overall Study|Withdrawal by Subject|1|||
146081195|NCT01330017|526818167|FG003|Overall Study|Withdrawal by Subject|0|||
146081196|NCT01330017|526818168|FG004|Overall Study|Withdrawal by Subject|1|||
146081197|NCT01330017|526818164|FG000|Overall Study|Lost to Follow-up|0|||
146081198|NCT01330017|526818165|FG001|Overall Study|Lost to Follow-up|0|||
146081199|NCT01330017|526818166|FG002|Overall Study|Lost to Follow-up|1|||
146081200|NCT01330017|526818167|FG003|Overall Study|Lost to Follow-up|0|||
146081201|NCT01330017|526818168|FG004|Overall Study|Lost to Follow-up|0|||
146081202|NCT01330017|526818164|FG000|Overall Study|Protocol Violation|0|||
146081203|NCT01330017|526818165|FG001|Overall Study|Protocol Violation|0|||
146081204|NCT01330017|526818166|FG002|Overall Study|Protocol Violation|0|||
146081205|NCT01330017|526818167|FG003|Overall Study|Protocol Violation|1|||
146081206|NCT01330017|526818168|FG004|Overall Study|Protocol Violation|0|||
146081207|NCT01330017|526818164|FG000|Overall Study|Unknown Reason|5|||
146081208|NCT01330017|526818165|FG001|Overall Study|Unknown Reason|3|||
146081209|NCT01330017|526818166|FG002|Overall Study|Unknown Reason|5|||
146185263|NCT03428815|527189583|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
146185264|NCT05221749|527189584|FG000|Overall Study|Lost to Follow-up|2|||
146185265|NCT05221749|527189585|FG001|Overall Study|Lost to Follow-up|3|||
146185266|NCT00519636|527189586|FG000|Treatment Period 1|Adverse Event|1|||
146185267|NCT00519636|527189587|FG001|Treatment Period 1|Adverse Event|0|||
146185268|NCT00519636|527189588|FG002|Treatment Period 1|Adverse Event|1|||
146185269|NCT00519636|527189589|FG003|Treatment Period 1|Adverse Event|0|||
146185270|NCT00519636|527189586|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
146185271|NCT00519636|527189587|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
146185272|NCT00519636|527189588|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
146185273|NCT00519636|527189589|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
146185274|NCT00519636|527189586|FG000|Washout Period|Adverse Event|2|||
146185275|NCT00519636|527189587|FG001|Washout Period|Adverse Event|1|||
146185276|NCT00519636|527189588|FG002|Washout Period|Adverse Event|1|||
146185277|NCT00519636|527189589|FG003|Washout Period|Adverse Event|0|||
146185278|NCT00519636|527189586|FG000|Washout Period|Lost to Follow-up|1|||
146185279|NCT00519636|527189587|FG001|Washout Period|Lost to Follow-up|0|||
146185280|NCT00519636|527189588|FG002|Washout Period|Lost to Follow-up|0|||
146185281|NCT00519636|527189589|FG003|Washout Period|Lost to Follow-up|0|||
146185282|NCT00519636|527189586|FG000|Washout Period|Protocol Violation|0|||
146185283|NCT00519636|527189587|FG001|Washout Period|Protocol Violation|0|||
146185284|NCT00519636|527189588|FG002|Washout Period|Protocol Violation|1|||
146185285|NCT00519636|527189589|FG003|Washout Period|Protocol Violation|2|||
146185286|NCT00519636|527189586|FG000|Washout Period|Withdrawal by Subject|1|||
146185287|NCT00519636|527189587|FG001|Washout Period|Withdrawal by Subject|0|||
146185288|NCT00519636|527189588|FG002|Washout Period|Withdrawal by Subject|1|||
146185289|NCT00519636|527189589|FG003|Washout Period|Withdrawal by Subject|0|||
146185290|NCT00519636|527189586|FG000|Washout Period|Failed to meet continuation criteria|14|||
146185291|NCT00519636|527189587|FG001|Washout Period|Failed to meet continuation criteria|11|||
146185292|NCT00519636|527189588|FG002|Washout Period|Failed to meet continuation criteria|9|||
146185293|NCT00519636|527189589|FG003|Washout Period|Failed to meet continuation criteria|3|||
146185294|NCT00519636|527189586|FG000|Washout Period|Out of pollen area > 48 hours|1|||
146185295|NCT00519636|527189587|FG001|Washout Period|Out of pollen area > 48 hours|0|||
146185296|NCT00519636|527189588|FG002|Washout Period|Out of pollen area > 48 hours|0|||
146185297|NCT00519636|527189589|FG003|Washout Period|Out of pollen area > 48 hours|0|||
146185298|NCT00519636|527189586|FG000|Washout Period|Participating in study at another site|1|||
146185299|NCT00519636|527189587|FG001|Washout Period|Participating in study at another site|0|||
146185300|NCT00519636|527189588|FG002|Washout Period|Participating in study at another site|0|||
146185301|NCT00519636|527189589|FG003|Washout Period|Participating in study at another site|0|||
146185302|NCT00519636|527189586|FG000|Washout Period|Non-compliant|0|||
146185303|NCT00519636|527189587|FG001|Washout Period|Non-compliant|1|||
146185304|NCT00519636|527189588|FG002|Washout Period|Non-compliant|0|||
146185305|NCT00519636|527189589|FG003|Washout Period|Non-compliant|0|||
146185306|NCT00519636|527189586|FG000|Washout Period|Per doctors request|0|||
146185307|NCT00519636|527189587|FG001|Washout Period|Per doctors request|1|||
146185308|NCT00519636|527189588|FG002|Washout Period|Per doctors request|0|||
146185309|NCT00519636|527189589|FG003|Washout Period|Per doctors request|0|||
146185310|NCT00519636|527189586|FG000|Washout Period|Subject randomized in error|0|||
146185311|NCT00519636|527189587|FG001|Washout Period|Subject randomized in error|0|||
146185312|NCT00519636|527189588|FG002|Washout Period|Subject randomized in error|1|||
146185313|NCT00519636|527189589|FG003|Washout Period|Subject randomized in error|0|||
146185314|NCT00519636|527189586|FG000|Washout Period|Prohibited medications|0|||
146185315|NCT00519636|527189587|FG001|Washout Period|Prohibited medications|0|||
146185316|NCT00519636|527189588|FG002|Washout Period|Prohibited medications|1|||
146185317|NCT00519636|527189589|FG003|Washout Period|Prohibited medications|0|||
146185318|NCT00519636|527189586|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146185319|NCT00519636|527189587|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146185320|NCT00519636|527189588|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
146185321|NCT00519636|527189589|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
146185322|NCT00519636|527189586|FG000|Treatment Period 2|Subject randomized in error|0|||
146185323|NCT00519636|527189587|FG001|Treatment Period 2|Subject randomized in error|1|||
146185324|NCT00519636|527189588|FG002|Treatment Period 2|Subject randomized in error|0|||
146185325|NCT00519636|527189589|FG003|Treatment Period 2|Subject randomized in error|0|||
146185326|NCT00519636|527189586|FG000|Treatment Period 2|Per doctors request|0|||
146185327|NCT00519636|527189587|FG001|Treatment Period 2|Per doctors request|0|||
146185328|NCT00519636|527189588|FG002|Treatment Period 2|Per doctors request|1|||
146185329|NCT00519636|527189589|FG003|Treatment Period 2|Per doctors request|0|||
146185330|NCT00519636|527189586|FG000|Treatment Period 2|Subject misrandomized|0|||
146185331|NCT00519636|527189587|FG001|Treatment Period 2|Subject misrandomized|0|||
146185332|NCT00519636|527189588|FG002|Treatment Period 2|Subject misrandomized|0|||
146185333|NCT00519636|527189589|FG003|Treatment Period 2|Subject misrandomized|1|||
146185334|NCT00519636|527189586|FG000|Post Study Period|Subject randomized in error|0|||
146185335|NCT00519636|527189587|FG001|Post Study Period|Subject randomized in error|0|||
146185336|NCT00519636|527189588|FG002|Post Study Period|Subject randomized in error|0|||
146185337|NCT00519636|527189589|FG003|Post Study Period|Subject randomized in error|1|||
146185338|NCT02388074|527189590|FG000|Overall Study|Lost in Transit|2|||
146185339|NCT02388074|527189590|FG000|Overall Study|Sample Not Returned|1|||
146185340|NCT01254890|527189595|FG000|Overall Study|Ineligible|0|||
146185341|NCT01254890|527189596|FG001|Overall Study|Ineligible|3|||
146185342|NCT01254890|527189595|FG000|Overall Study|Withdrawal by Subject|1|||
146185343|NCT01254890|527189596|FG001|Overall Study|Withdrawal by Subject|2|||
146185344|NCT01254890|527189595|FG000|Overall Study|Disease Progression|0|||
146185345|NCT01254890|527189596|FG001|Overall Study|Disease Progression|5|||
146185346|NCT03363659|527189598|FG000|Overall Study|Adverse Event|1|||
146185347|NCT03363659|527189598|FG000|Overall Study|Screen fail|1|||
146185348|NCT03363659|527189598|FG000|Overall Study|Withdrawal by Subject|1|||
146185349|NCT00904150|527189599|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
146185350|NCT00904150|527189600|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
146185351|NCT00904150|527189599|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
146185352|NCT00904150|527189600|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
146185353|NCT03872388|527189601|FG000|Overall Study|Disease Progression|0|||
146185354|NCT03872388|527189602|FG001|Overall Study|Disease Progression|0|||
146185355|NCT03872388|527189603|FG002|Overall Study|Disease Progression|0|||
146185356|NCT03872388|527189604|FG003|Overall Study|Disease Progression|0|||
146185357|NCT03872388|527189605|FG004|Overall Study|Disease Progression|0|||
146185358|NCT03872388|527189606|FG005|Overall Study|Disease Progression|0|||
146185359|NCT03872388|527189607|FG006|Overall Study|Disease Progression|1|||
146185360|NCT03872388|527189608|FG007|Overall Study|Disease Progression|1|||
146185361|NCT05343455|527191580|FG000|Overall Study|Withdrawal by Subject|4|||
146185362|NCT05343455|527191581|FG001|Overall Study|Withdrawal by Subject|9|||
146185363|NCT05343455|527191582|FG002|Overall Study|Withdrawal by Subject|7|||
146185364|NCT05343455|527191580|FG000|Overall Study|Adverse Event|2|||
146185365|NCT05343455|527191581|FG001|Overall Study|Adverse Event|1|||
146185366|NCT05343455|527191582|FG002|Overall Study|Adverse Event|2|||
146185367|NCT05343455|527191580|FG000|Overall Study|Lost to Follow-up|1|||
146185368|NCT05343455|527191581|FG001|Overall Study|Lost to Follow-up|1|||
146185369|NCT05343455|527191582|FG002|Overall Study|Lost to Follow-up|3|||
146185370|NCT05343455|527191580|FG000|Overall Study|Pregnancy|1|||
146185371|NCT05343455|527191581|FG001|Overall Study|Pregnancy|0|||
146185372|NCT05343455|527191582|FG002|Overall Study|Pregnancy|0|||
146185373|NCT05343455|527191580|FG000|Overall Study|Physician Decision|0|||
146185374|NCT05343455|527191581|FG001|Overall Study|Physician Decision|0|||
146185375|NCT05343455|527191582|FG002|Overall Study|Physician Decision|1|||
146185376|NCT05343455|527191580|FG000|Overall Study|Protocol Violation|0|||
146185377|NCT05343455|527191581|FG001|Overall Study|Protocol Violation|1|||
146185378|NCT05343455|527191582|FG002|Overall Study|Protocol Violation|1|||
146185379|NCT03468426|527191583|FG000|Overall Study|Progressive disease|3|||
146185380|NCT03468426|527191584|FG001|Overall Study|Progressive disease|0|||
146185381|NCT03468426|527191585|FG002|Overall Study|Progressive disease|4|||
146185382|NCT03468426|527191586|FG003|Overall Study|Progressive disease|20|||
146185383|NCT03468426|527191587|FG004|Overall Study|Progressive disease|23|||
146185384|NCT03468426|527191588|FG005|Overall Study|Progressive disease|15|||
146185385|NCT03468426|527191589|FG006|Overall Study|Progressive disease|24|||
146185386|NCT03468426|527191590|FG007|Overall Study|Progressive disease|27|||
146185387|NCT03468426|527191591|FG008|Overall Study|Progressive disease|13|||
146185388|NCT03468426|527191592|FG009|Overall Study|Progressive disease|13|||
146185389|NCT03468426|527191593|FG010|Overall Study|Progressive disease|0|||
146185390|NCT03468426|527191583|FG000|Overall Study|Other adverse event or clinical progression|0|||
146185391|NCT03468426|527191584|FG001|Overall Study|Other adverse event or clinical progression|1|||
146185392|NCT03468426|527191585|FG002|Overall Study|Other adverse event or clinical progression|3|||
146185393|NCT03468426|527191586|FG003|Overall Study|Other adverse event or clinical progression|14|||
146185394|NCT03468426|527191587|FG004|Overall Study|Other adverse event or clinical progression|10|||
146185395|NCT03468426|527191588|FG005|Overall Study|Other adverse event or clinical progression|8|||
146185396|NCT03468426|527191589|FG006|Overall Study|Other adverse event or clinical progression|5|||
146185397|NCT03468426|527191590|FG007|Overall Study|Other adverse event or clinical progression|4|||
146185398|NCT03468426|527191591|FG008|Overall Study|Other adverse event or clinical progression|6|||
146185399|NCT03468426|527191592|FG009|Overall Study|Other adverse event or clinical progression|11|||
146185400|NCT03468426|527191593|FG010|Overall Study|Other adverse event or clinical progression|0|||
146185401|NCT03468426|527191583|FG000|Overall Study|Refused to continue taking trial medication|0|||
146185402|NCT03468426|527191584|FG001|Overall Study|Refused to continue taking trial medication|0|||
146185403|NCT03468426|527191585|FG002|Overall Study|Refused to continue taking trial medication|0|||
146185404|NCT03468426|527191586|FG003|Overall Study|Refused to continue taking trial medication|2|||
146185405|NCT03468426|527191587|FG004|Overall Study|Refused to continue taking trial medication|0|||
146185406|NCT03468426|527191588|FG005|Overall Study|Refused to continue taking trial medication|3|||
146185407|NCT03468426|527191589|FG006|Overall Study|Refused to continue taking trial medication|0|||
146185408|NCT03468426|527191590|FG007|Overall Study|Refused to continue taking trial medication|0|||
146185409|NCT03468426|527191591|FG008|Overall Study|Refused to continue taking trial medication|1|||
146185410|NCT03468426|527191592|FG009|Overall Study|Refused to continue taking trial medication|0|||
146185411|NCT03468426|527191593|FG010|Overall Study|Refused to continue taking trial medication|0|||
146185412|NCT03468426|527191583|FG000|Overall Study|Other than listed|0|||
146185413|NCT03468426|527191584|FG001|Overall Study|Other than listed|1|||
146185414|NCT03468426|527191585|FG002|Overall Study|Other than listed|0|||
146185415|NCT03468426|527191586|FG003|Overall Study|Other than listed|0|||
146185416|NCT03468426|527191587|FG004|Overall Study|Other than listed|2|||
146185417|NCT03468426|527191588|FG005|Overall Study|Other than listed|2|||
146185418|NCT03468426|527191589|FG006|Overall Study|Other than listed|0|||
146185419|NCT03468426|527191590|FG007|Overall Study|Other than listed|0|||
146185420|NCT03468426|527191591|FG008|Overall Study|Other than listed|4|||
146185421|NCT03468426|527191592|FG009|Overall Study|Other than listed|4|||
146185422|NCT03468426|527191593|FG010|Overall Study|Other than listed|1|||
146185423|NCT03468426|527191583|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185424|NCT03468426|527191584|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185425|NCT03468426|527191585|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146185426|NCT03468426|527191586|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185427|NCT03468426|527191587|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185428|NCT03468426|527191588|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185429|NCT03468426|527191589|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185430|NCT03468426|527191590|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185431|NCT03468426|527191591|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185432|NCT03468426|527191592|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185433|NCT03468426|527191593|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146185434|NCT03468426|527191583|FG000|Overall Study|missing reason|0|||
146185435|NCT03468426|527191584|FG001|Overall Study|missing reason|0|||
146185436|NCT03468426|527191585|FG002|Overall Study|missing reason|0|||
146185437|NCT03468426|527191586|FG003|Overall Study|missing reason|0|||
146185438|NCT03468426|527191587|FG004|Overall Study|missing reason|0|||
146185439|NCT03468426|527191588|FG005|Overall Study|missing reason|0|||
146185440|NCT03468426|527191589|FG006|Overall Study|missing reason|0|||
146185441|NCT03468426|527191590|FG007|Overall Study|missing reason|0|||
146185442|NCT03468426|527191591|FG008|Overall Study|missing reason|0|||
146185443|NCT03468426|527191592|FG009|Overall Study|missing reason|1|||
146185444|NCT03468426|527191593|FG010|Overall Study|missing reason|0|||
146185445|NCT01349907|527191602|FG000|Overall Study|Adverse Event|37|||
146185446|NCT01349907|527191603|FG001|Overall Study|Adverse Event|11|||
146185447|NCT01349907|527191602|FG000|Overall Study|Treatment failure|13|||
146185448|NCT01349907|527191603|FG001|Overall Study|Treatment failure|4|||
146185449|NCT01349907|527191602|FG000|Overall Study|Lost to Follow-up|25|||
146185450|NCT01349907|527191603|FG001|Overall Study|Lost to Follow-up|6|||
146185451|NCT01349907|527191602|FG000|Overall Study|Withdrawal by Subject|30|||
146185452|NCT01349907|527191603|FG001|Overall Study|Withdrawal by Subject|8|||
146185453|NCT01349907|527191602|FG000|Overall Study|Protocol Violation|33|||
146185454|NCT01349907|527191603|FG001|Overall Study|Protocol Violation|13|||
146185455|NCT01349907|527191602|FG000|Overall Study|Administrative|1|||
146185456|NCT01349907|527191603|FG001|Overall Study|Administrative|1|||
146185457|NCT01477749|527191606|FG000|Overall Study|Physician Decision|4|||
146185458|NCT04004208|527191610|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146185459|NCT04004208|527191611|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146185460|NCT04004208|527191610|FG000|Overall Study|Death|3|||
146185461|NCT04004208|527191611|FG001|Overall Study|Death|0|||
146185462|NCT04004208|527191610|FG000|Overall Study|COVID-19 pandemic|1|||
146185463|NCT04004208|527191611|FG001|Overall Study|COVID-19 pandemic|0|||
146185464|NCT04004208|527191610|FG000|Overall Study|Physician Decision|1|||
146185465|NCT04004208|527191611|FG001|Overall Study|Physician Decision|0|||
146185466|NCT04004208|527191610|FG000|Overall Study|Adverse Event|1|||
146185467|NCT04004208|527191611|FG001|Overall Study|Adverse Event|1|||
146185468|NCT01310868|527191617|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
146185469|NCT01628874|527191624|FG000|Overall Study|Physician Decision|1|||
146185470|NCT01628874|527191625|FG001|Overall Study|Physician Decision|1|||
146185471|NCT01628874|527191624|FG000|Overall Study|Age >4 months|4|||
146185472|NCT01628874|527191625|FG001|Overall Study|Age >4 months|2|||
146185473|NCT00873093|527191626|FG000|Overall Study|Adverse Event|0|||
146185474|NCT00873093|527191627|FG001|Overall Study|Adverse Event|2|||
146185475|NCT00873093|527191628|FG002|Overall Study|Adverse Event|0|||
146185476|NCT00873093|527191629|FG003|Overall Study|Adverse Event|0|||
146185477|NCT00873093|527191630|FG004|Overall Study|Adverse Event|0|||
146185478|NCT00873093|527191626|FG000|Overall Study|Death|0|||
146185479|NCT00873093|527191627|FG001|Overall Study|Death|3|||
146185480|NCT00873093|527191628|FG002|Overall Study|Death|2|||
146185481|NCT00873093|527191629|FG003|Overall Study|Death|0|||
146185482|NCT00873093|527191630|FG004|Overall Study|Death|0|||
146185483|NCT00873093|527191626|FG000|Overall Study|Physician Decision|0|||
146185484|NCT00873093|527191627|FG001|Overall Study|Physician Decision|17|||
146185485|NCT00873093|527191628|FG002|Overall Study|Physician Decision|10|||
146185486|NCT00873093|527191629|FG003|Overall Study|Physician Decision|10|||
146185487|NCT00873093|527191630|FG004|Overall Study|Physician Decision|2|||
146081210|NCT01330017|526818167|FG003|Overall Study|Unknown Reason|7|||
146185488|NCT00873093|527191626|FG000|Overall Study|Withdrawal by Subject|1|||
146185489|NCT00873093|527191627|FG001|Overall Study|Withdrawal by Subject|4|||
146185490|NCT00873093|527191628|FG002|Overall Study|Withdrawal by Subject|4|||
146185491|NCT00873093|527191629|FG003|Overall Study|Withdrawal by Subject|0|||
146185492|NCT00873093|527191630|FG004|Overall Study|Withdrawal by Subject|0|||
146185493|NCT00873093|527191626|FG000|Overall Study|Ineligible|0|||
146185494|NCT00873093|527191627|FG001|Overall Study|Ineligible|1|||
146185495|NCT00873093|527191628|FG002|Overall Study|Ineligible|0|||
146185496|NCT00873093|527191629|FG003|Overall Study|Ineligible|1|||
146185497|NCT00873093|527191630|FG004|Overall Study|Ineligible|0|||
146185498|NCT01152554|527191631|FG000|Overall Study|Withdrawal by Subject|73|||
146185499|NCT01152554|527191632|FG001|Overall Study|Withdrawal by Subject|28|||
146185500|NCT01152554|527191631|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
146185501|NCT01152554|527191632|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
146185502|NCT01152554|527191631|FG000|Overall Study|Adverse Event|67|||
146185503|NCT01152554|527191632|FG001|Overall Study|Adverse Event|14|||
146185504|NCT01152554|527191631|FG000|Overall Study|Severe non-compliance to protocol|36|||
146185505|NCT01152554|527191632|FG001|Overall Study|Severe non-compliance to protocol|14|||
146185506|NCT01152554|527191631|FG000|Overall Study|Condition under investigation worsened|5|||
146185507|NCT01152554|527191632|FG001|Overall Study|Condition under investigation worsened|2|||
146185508|NCT01152554|527191631|FG000|Overall Study|Lack of Efficacy|20|||
146185509|NCT01152554|527191632|FG001|Overall Study|Lack of Efficacy|3|||
146081211|NCT01330017|526818168|FG004|Overall Study|Unknown Reason|2|||
146081212|NCT01221272|526818170|FG000|Period 1|Adverse Event|2|||
146081213|NCT01221272|526818171|FG001|Period 1|Adverse Event|0|||
146081214|NCT01221272|526818170|FG000|Period 1|Consent Withdrawal|0|||
146081215|NCT01221272|526818171|FG001|Period 1|Consent Withdrawal|1|||
146081216|NCT01221272|526818170|FG000|Period 1|Significant Dosing Noncompliance|0|||
146081217|NCT01221272|526818171|FG001|Period 1|Significant Dosing Noncompliance|1|||
146081218|NCT01221272|526818170|FG000|Period 2|Adverse Event|0|||
146081219|NCT01221272|526818171|FG001|Period 2|Adverse Event|2|||
146081220|NCT02043899|526818175|FG000|Overall Study|Adverse Event|3|||
146081221|NCT02043899|526818175|FG000|Overall Study|Physician Decision|1|||
146081222|NCT02043899|526818175|FG000|Overall Study|Withdrawal by Subject|2|||
146081223|NCT02043899|526818175|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
146185510|NCT01152554|527191631|FG000|Overall Study|Study-specific withdrawal criteria|17|||
146185511|NCT01152554|527191632|FG001|Overall Study|Study-specific withdrawal criteria|8|||
146185512|NCT01152554|527191631|FG000|Overall Study|Lost to Follow-up|87|||
146185513|NCT01152554|527191632|FG001|Overall Study|Lost to Follow-up|32|||
146185514|NCT01152554|527191631|FG000|Overall Study|Other|28|||
146185515|NCT01152554|527191632|FG001|Overall Study|Other|8|||
146185516|NCT01152554|527191631|FG000|Overall Study|Death|1|||
146185517|NCT01152554|527191632|FG001|Overall Study|Death|1|||
146185518|NCT02117544|527191633|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
146185519|NCT02117544|527191634|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
146185520|NCT03486899|527191635|FG000|Overall Study|Lost to Follow-up|4|||
146185521|NCT03486899|527191636|FG001|Overall Study|Lost to Follow-up|1|||
146185522|NCT03486899|527191637|FG002|Overall Study|Lost to Follow-up|4|||
146185523|NCT03486899|527191638|FG003|Overall Study|Lost to Follow-up|3|||
146185524|NCT03486899|527191635|FG000|Overall Study|Death|1|||
146185525|NCT03486899|527191636|FG001|Overall Study|Death|0|||
146185526|NCT03486899|527191637|FG002|Overall Study|Death|0|||
146185527|NCT03486899|527191638|FG003|Overall Study|Death|1|||
146185528|NCT03486899|527191635|FG000|Overall Study|Adverse Event|0|||
146185529|NCT03486899|527191636|FG001|Overall Study|Adverse Event|2|||
146185530|NCT03486899|527191637|FG002|Overall Study|Adverse Event|0|||
146185531|NCT03486899|527191638|FG003|Overall Study|Adverse Event|2|||
146185532|NCT03486899|527191635|FG000|Overall Study|Withdrawal by Subject|3|||
146185533|NCT03486899|527191636|FG001|Overall Study|Withdrawal by Subject|7|||
146185534|NCT03486899|527191637|FG002|Overall Study|Withdrawal by Subject|4|||
146185535|NCT03486899|527191638|FG003|Overall Study|Withdrawal by Subject|3|||
146185536|NCT03486899|527191635|FG000|Overall Study|Other Reasons|0|||
146412379|NCT02544633|528015504|FG001|Survival Follow-up Period|Death|14|||
146185537|NCT03486899|527191636|FG001|Overall Study|Other Reasons|1|||
146185538|NCT03486899|527191637|FG002|Overall Study|Other Reasons|0|||
146185539|NCT03486899|527191638|FG003|Overall Study|Other Reasons|1|||
146185540|NCT02408549|527191639|FG000|Overall Study|Adverse Event|15|||
146185541|NCT02408549|527191639|FG000|Overall Study|Death|4|||
146185542|NCT02408549|527191639|FG000|Overall Study|Lack of Efficacy|17|||
146185543|NCT02408549|527191639|FG000|Overall Study|Protocol Violation|4|||
146185544|NCT02408549|527191639|FG000|Overall Study|Lost to Follow-up|6|||
146185545|NCT02408549|527191639|FG000|Overall Study|Consent withdrawn|30|||
146185546|NCT02408549|527191639|FG000|Overall Study|Neurology research program closing at site|1|||
146185547|NCT02408549|527191639|FG000|Overall Study|Site closure|1|||
146185548|NCT02408549|527191639|FG000|Overall Study|Pregnancy|1|||
146185549|NCT02408549|527191639|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
146185550|NCT02408549|527191639|FG000|Overall Study|Subject moved to another place, far from site|1|||
146185551|NCT02408549|527191639|FG000|Overall Study|Study terminated at site|1|||
146185552|NCT02448719|527191642|FG000|Overall Study|Withdrawal by Subject|0|||
146185553|NCT02448719|527191643|FG001|Overall Study|Withdrawal by Subject|0|||
146185554|NCT02448719|527191644|FG002|Overall Study|Withdrawal by Subject|0|||
146185555|NCT02448719|527191645|FG003|Overall Study|Withdrawal by Subject|0|||
146185556|NCT02448719|527191646|FG004|Overall Study|Withdrawal by Subject|1|||
146185557|NCT02448719|527191647|FG005|Overall Study|Withdrawal by Subject|0|||
146185558|NCT02448719|527191648|FG006|Overall Study|Withdrawal by Subject|0|||
146185559|NCT02448719|527191649|FG007|Overall Study|Withdrawal by Subject|0|||
146185560|NCT02448719|527191650|FG008|Overall Study|Withdrawal by Subject|0|||
146185561|NCT02448719|527191651|FG009|Overall Study|Withdrawal by Subject|0|||
146185562|NCT02448719|527191652|FG010|Overall Study|Withdrawal by Subject|0|||
146185563|NCT01232556|527191653|FG000|Overall Study|Withdrawal by Subject|21|||
146185564|NCT01232556|527191654|FG001|Overall Study|Withdrawal by Subject|17|||
146185565|NCT01232556|527191653|FG000|Overall Study|Death|97|||
146185566|NCT01232556|527191654|FG001|Overall Study|Death|97|||
146185567|NCT01232556|527191653|FG000|Overall Study|Lost to Follow-up|0|||
146185568|NCT01232556|527191654|FG001|Overall Study|Lost to Follow-up|2|||
146185569|NCT01232556|527191653|FG000|Overall Study|Terminated by Sponsor|35|||
146185570|NCT01232556|527191654|FG001|Overall Study|Terminated by Sponsor|51|||
146185571|NCT01232556|527191653|FG000|Overall Study|Other|6|||
146185572|NCT01232556|527191654|FG001|Overall Study|Other|4|||
146185573|NCT01473420|527191656|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
146185574|NCT01473420|527191657|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
146185575|NCT01473420|527191656|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
146185576|NCT01473420|527191657|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
146185577|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
146185578|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
146185579|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
146185580|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
146185581|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
146185582|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
146185583|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
146185584|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
146185585|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
146185586|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
146185587|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
146185588|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
146185589|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
146185590|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
146185591|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
146185592|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
146185593|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
146185594|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
146185595|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
146185596|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
146185597|NCT01473420|527191656|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
146185598|NCT01473420|527191657|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
146185599|NCT04172987|527191658|FG000|Lead In Period|Adverse Event|1|||
146185600|NCT04172987|527191658|FG000|Lead In Period|Protocol Violation|1|||
146185601|NCT04172987|527191658|FG000|Period 1|Physician Decision|1|||
146185602|NCT04172987|527191658|FG000|Period 2|Adverse Event|5|||
146185603|NCT04172987|527191658|FG000|Period 2|Dosing Termination by Sponsor|4|||
146185604|NCT00738530|527191663|FG000|Overall Study|Death|220|||
146185605|NCT00738530|527191664|FG001|Overall Study|Death|224|||
146185606|NCT00738530|527191663|FG000|Overall Study|Lost to Follow-up|8|||
146185607|NCT00738530|527191664|FG001|Overall Study|Lost to Follow-up|6|||
146185608|NCT00738530|527191663|FG000|Overall Study|Withdrawal by Subject|6|||
146185609|NCT00738530|527191664|FG001|Overall Study|Withdrawal by Subject|8|||
146185610|NCT04179461|527191665|FG000|Overall Study|Lost to Follow-up|4|||
146185611|NCT03100838|527191666|FG000|Overall Study|Adverse Event|1|||
146185612|NCT03100838|527191667|FG001|Overall Study|Adverse Event|0|||
146185613|NCT03100838|527191668|FG002|Overall Study|Adverse Event|0|||
146185614|NCT03100838|527191669|FG003|Overall Study|Adverse Event|0|||
146185615|NCT03100838|527191666|FG000|Overall Study|Physician Decision|1|||
146185616|NCT03100838|527191667|FG001|Overall Study|Physician Decision|1|||
146185617|NCT03100838|527191668|FG002|Overall Study|Physician Decision|1|||
146185618|NCT03100838|527191669|FG003|Overall Study|Physician Decision|1|||
146185619|NCT03100838|527191666|FG000|Overall Study|Pregnancy|0|||
146185620|NCT03100838|527191667|FG001|Overall Study|Pregnancy|1|||
146185621|NCT03100838|527191668|FG002|Overall Study|Pregnancy|0|||
146185622|NCT03100838|527191669|FG003|Overall Study|Pregnancy|0|||
146185623|NCT03100838|527191666|FG000|Overall Study|Lost to Follow-up|0|||
146185624|NCT03100838|527191667|FG001|Overall Study|Lost to Follow-up|0|||
146185625|NCT03100838|527191668|FG002|Overall Study|Lost to Follow-up|1|||
146185626|NCT03100838|527191669|FG003|Overall Study|Lost to Follow-up|0|||
146185627|NCT00184028|527191670|FG000|Overall Study|Death|1|||
146185628|NCT00184028|527191670|FG000|Overall Study|Lack of Efficacy|4|||
146185629|NCT00184028|527191670|FG000|Overall Study|Adverse Event|2|||
146185630|NCT00184028|527191670|FG000|Overall Study|Withdrawal by Subject|1|||
146185631|NCT00184028|527191670|FG000|Overall Study|Non-compliance|2|||
146185632|NCT01347645|527191671|FG000|Overall Study|Death|1|||
146185633|NCT01347645|527191672|FG001|Overall Study|Death|5|||
146185634|NCT01347645|527191673|FG002|Overall Study|Death|2|||
146185635|NCT01347645|527191674|FG003|Overall Study|Death|7|||
146185636|NCT01347645|527191675|FG004|Overall Study|Death|7|||
146185637|NCT01347645|527191671|FG000|Overall Study|Lost to Follow-up|1|||
146185638|NCT01347645|527191672|FG001|Overall Study|Lost to Follow-up|1|||
146185639|NCT01347645|527191673|FG002|Overall Study|Lost to Follow-up|0|||
146185640|NCT01347645|527191674|FG003|Overall Study|Lost to Follow-up|1|||
146185641|NCT01347645|527191675|FG004|Overall Study|Lost to Follow-up|1|||
146185642|NCT01347645|527191671|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
146185643|NCT01347645|527191672|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
146185644|NCT01347645|527191673|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
146185645|NCT01347645|527191674|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
146412380|NCT02544633|528015505|FG002|Survival Follow-up Period|Death|3|||
146185646|NCT01347645|527191675|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
146185647|NCT01347645|527191671|FG000|Overall Study|Other|1|||
146185648|NCT01347645|527191672|FG001|Overall Study|Other|0|||
146185649|NCT01347645|527191673|FG002|Overall Study|Other|0|||
146185650|NCT01347645|527191674|FG003|Overall Study|Other|0|||
146185651|NCT01347645|527191675|FG004|Overall Study|Other|1|||
146185652|NCT01347645|527191671|FG000|Overall Study|Withdrawal by Subject|0|||
146185653|NCT01347645|527191672|FG001|Overall Study|Withdrawal by Subject|0|||
146185654|NCT01347645|527191673|FG002|Overall Study|Withdrawal by Subject|0|||
146185655|NCT01347645|527191674|FG003|Overall Study|Withdrawal by Subject|3|||
146185656|NCT01347645|527191675|FG004|Overall Study|Withdrawal by Subject|3|||
146185657|NCT01347645|527191671|FG000|Overall Study|Physician Decision|0|||
146185658|NCT01347645|527191672|FG001|Overall Study|Physician Decision|0|||
146185659|NCT01347645|527191673|FG002|Overall Study|Physician Decision|0|||
146185660|NCT01347645|527191674|FG003|Overall Study|Physician Decision|0|||
146185661|NCT01347645|527191675|FG004|Overall Study|Physician Decision|1|||
146185662|NCT01347645|527191671|FG000|Overall Study|Adverse Event|0|||
146185663|NCT01347645|527191672|FG001|Overall Study|Adverse Event|0|||
146185664|NCT01347645|527191673|FG002|Overall Study|Adverse Event|0|||
146185665|NCT01347645|527191674|FG003|Overall Study|Adverse Event|1|||
146185666|NCT01347645|527191675|FG004|Overall Study|Adverse Event|1|||
146185667|NCT01141660|527191676|FG000|Overall Study|Physician Decision|0|||
146185668|NCT01141660|527191677|FG001|Overall Study|Physician Decision|12|||
146185669|NCT00209027|527191679|FG000|Overall Study|study terminated|10|||
146185670|NCT00209027|527191680|FG001|Overall Study|study terminated|0|||
146185671|NCT03785340|527191681|FG000|Overall Study|Lost to Follow-up|2|||
146185672|NCT03785340|527191682|FG001|Overall Study|Lost to Follow-up|0|||
146185673|NCT03785340|527191681|FG000|Overall Study|Adverse Event|1|||
146185674|NCT03785340|527191682|FG001|Overall Study|Adverse Event|0|||
146185675|NCT01848834|527191683|FG000|Overall Study|Adverse Event|3|||
146185676|NCT01848834|527191684|FG001|Overall Study|Adverse Event|11|||
146185677|NCT01848834|527191685|FG002|Overall Study|Adverse Event|3|||
146185678|NCT01848834|527191686|FG003|Overall Study|Adverse Event|5|||
146185679|NCT01848834|527191687|FG004|Overall Study|Adverse Event|9|||
146185680|NCT01848834|527191683|FG000|Overall Study|Death|2|||
146185681|NCT01848834|527191684|FG001|Overall Study|Death|11|||
146185682|NCT01848834|527191685|FG002|Overall Study|Death|1|||
146185683|NCT01848834|527191686|FG003|Overall Study|Death|8|||
146185684|NCT01848834|527191687|FG004|Overall Study|Death|27|||
146185685|NCT01848834|527191683|FG000|Overall Study|Excluded Medication|5|||
146185686|NCT01848834|527191684|FG001|Overall Study|Excluded Medication|4|||
146185687|NCT01848834|527191685|FG002|Overall Study|Excluded Medication|3|||
146185688|NCT01848834|527191686|FG003|Overall Study|Excluded Medication|6|||
146185689|NCT01848834|527191687|FG004|Overall Study|Excluded Medication|6|||
146185690|NCT01848834|527191683|FG000|Overall Study|Lost to Follow-up|5|||
146185691|NCT01848834|527191684|FG001|Overall Study|Lost to Follow-up|5|||
146185692|NCT01848834|527191685|FG002|Overall Study|Lost to Follow-up|3|||
146185693|NCT01848834|527191686|FG003|Overall Study|Lost to Follow-up|0|||
146185694|NCT01848834|527191687|FG004|Overall Study|Lost to Follow-up|3|||
146185695|NCT01848834|527191683|FG000|Overall Study|Physician Decision|1|||
146185696|NCT01848834|527191684|FG001|Overall Study|Physician Decision|3|||
146185697|NCT01848834|527191685|FG002|Overall Study|Physician Decision|4|||
146185698|NCT01848834|527191686|FG003|Overall Study|Physician Decision|0|||
146185699|NCT01848834|527191687|FG004|Overall Study|Physician Decision|11|||
146185700|NCT01848834|527191683|FG000|Overall Study|Protocol Violation|0|||
146185701|NCT01848834|527191684|FG001|Overall Study|Protocol Violation|0|||
146185702|NCT01848834|527191685|FG002|Overall Study|Protocol Violation|0|||
146185703|NCT01848834|527191686|FG003|Overall Study|Protocol Violation|0|||
146185704|NCT01848834|527191687|FG004|Overall Study|Protocol Violation|1|||
146185705|NCT01848834|527191683|FG000|Overall Study|Sponsor Decision|1|||
146185706|NCT01848834|527191684|FG001|Overall Study|Sponsor Decision|1|||
146185707|NCT01848834|527191685|FG002|Overall Study|Sponsor Decision|0|||
146185708|NCT01848834|527191686|FG003|Overall Study|Sponsor Decision|1|||
146185709|NCT01848834|527191687|FG004|Overall Study|Sponsor Decision|1|||
146185710|NCT01848834|527191683|FG000|Overall Study|Withdrawal by Subject|2|||
146185711|NCT01848834|527191684|FG001|Overall Study|Withdrawal by Subject|13|||
146185712|NCT01848834|527191685|FG002|Overall Study|Withdrawal by Subject|10|||
146185713|NCT01848834|527191686|FG003|Overall Study|Withdrawal by Subject|6|||
146185714|NCT01848834|527191687|FG004|Overall Study|Withdrawal by Subject|36|||
146185715|NCT03259373|527191692|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
146234945|NCT02347332|527378427|FG001|Overall Study|Protocol Violation|1|||
146185716|NCT03259373|527191693|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
146185717|NCT03259373|527191692|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
146185718|NCT03259373|527191693|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
146185719|NCT03259373|527191692|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
146185720|NCT03259373|527191693|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
146185721|NCT03259373|527191692|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
146185722|NCT03259373|527191693|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
146185723|NCT03259373|527191692|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
146185724|NCT03259373|527191693|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
146185725|NCT03259373|527191692|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
146185726|NCT03259373|527191693|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
146185727|NCT00885495|527191694|FG000|Overall Study|Adverse Event|1|||
146185728|NCT00885495|527191695|FG001|Overall Study|Adverse Event|2|||
146185729|NCT00885495|527191694|FG000|Overall Study|Protocol Violation|0|||
146185730|NCT00885495|527191695|FG001|Overall Study|Protocol Violation|1|||
146185731|NCT00885495|527191694|FG000|Overall Study|Withdrawal by Subject|1|||
146185732|NCT00885495|527191695|FG001|Overall Study|Withdrawal by Subject|0|||
146185733|NCT01563978|527191696|FG000|Overall Study|Physician Decision|1|||
146185734|NCT01563978|527191697|FG001|Overall Study|Physician Decision|0|||
146185735|NCT01563978|527191696|FG000|Overall Study|Lost to Follow-up|1|||
146185736|NCT01563978|527191697|FG001|Overall Study|Lost to Follow-up|0|||
146185737|NCT01563978|527191696|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
146185738|NCT01563978|527191697|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146185739|NCT01563978|527191696|FG000|Overall Study|Adverse Event|1|||
146185740|NCT01563978|527191697|FG001|Overall Study|Adverse Event|2|||
146185741|NCT05764239|527191698|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
146185742|NCT05764239|527191698|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
146185743|NCT05764239|527191698|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
146185744|NCT05764239|527191698|FG000|DEP (Part 1)|Adverse Event|1|||
146185745|NCT05764239|527191698|FG000|DEP (Part 1)|Lost to Follow-up|1|||
146185746|NCT05764239|527191698|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
146185747|NCT05764239|527191698|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
146185748|NCT05764239|527191698|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
146185749|NCT05764239|527191698|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
146185750|NCT05593211|527191699|FG000|Overall Study|Withdrawal by Subject|1|||
146185751|NCT03225846|527191700|FG000|Overall Study|Adverse Event|0|||
146185752|NCT03225846|527191701|FG001|Overall Study|Adverse Event|0|||
146185753|NCT03225846|527191702|FG002|Overall Study|Adverse Event|0|||
146185754|NCT03225846|527191703|FG003|Overall Study|Adverse Event|0|||
146185755|NCT03225846|527191704|FG004|Overall Study|Adverse Event|0|||
146185756|NCT03225846|527191705|FG005|Overall Study|Adverse Event|0|||
146185757|NCT03225846|527191706|FG006|Overall Study|Adverse Event|6|||
146185758|NCT03225846|527191700|FG000|Overall Study|Withdrawal by Subject|0|||
146185759|NCT03225846|527191701|FG001|Overall Study|Withdrawal by Subject|1|||
146185760|NCT03225846|527191702|FG002|Overall Study|Withdrawal by Subject|0|||
146185761|NCT03225846|527191703|FG003|Overall Study|Withdrawal by Subject|0|||
146185762|NCT03225846|527191704|FG004|Overall Study|Withdrawal by Subject|0|||
146185763|NCT03225846|527191705|FG005|Overall Study|Withdrawal by Subject|0|||
146185764|NCT03225846|527191706|FG006|Overall Study|Withdrawal by Subject|0|||
146185765|NCT03225846|527191700|FG000|Overall Study|Death|0|||
146185766|NCT03225846|527191701|FG001|Overall Study|Death|1|||
146185767|NCT03225846|527191702|FG002|Overall Study|Death|0|||
146185768|NCT03225846|527191703|FG003|Overall Study|Death|0|||
146283937|NCT00604825|527551904|FG000|Overall Study|Withdrawal by Subject|4|||
146283938|NCT00604825|527551905|FG001|Overall Study|Withdrawal by Subject|3|||
146283939|NCT00604825|527551906|FG002|Overall Study|Withdrawal by Subject|5|||
146283940|NCT00604825|527551907|FG003|Overall Study|Withdrawal by Subject|5|||
146283941|NCT00604825|527551904|FG000|Overall Study|Lack of Efficacy|3|||
146283942|NCT00604825|527551905|FG001|Overall Study|Lack of Efficacy|2|||
146283943|NCT00604825|527551906|FG002|Overall Study|Lack of Efficacy|1|||
146283944|NCT00604825|527551907|FG003|Overall Study|Lack of Efficacy|0|||
146283945|NCT00604825|527551904|FG000|Overall Study|Did not meet eligibility criteria|0|||
146283946|NCT00604825|527551905|FG001|Overall Study|Did not meet eligibility criteria|0|||
146283947|NCT00604825|527551906|FG002|Overall Study|Did not meet eligibility criteria|2|||
146283948|NCT00604825|527551907|FG003|Overall Study|Did not meet eligibility criteria|0|||
146283949|NCT00604825|527551904|FG000|Overall Study|Physician Decision|0|||
146283950|NCT00604825|527551905|FG001|Overall Study|Physician Decision|0|||
146283951|NCT00604825|527551906|FG002|Overall Study|Physician Decision|0|||
146283952|NCT00604825|527551907|FG003|Overall Study|Physician Decision|1|||
146283953|NCT00604825|527551904|FG000|Overall Study|Exclusion criterion met|0|||
146283954|NCT00604825|527551905|FG001|Overall Study|Exclusion criterion met|0|||
146283955|NCT00604825|527551906|FG002|Overall Study|Exclusion criterion met|0|||
146283956|NCT00604825|527551907|FG003|Overall Study|Exclusion criterion met|1|||
146283957|NCT05593445|527551908|FG000|12-Week DBVC Period|Adverse Event|1|||
146283958|NCT05593445|527551909|FG001|12-Week DBVC Period|Adverse Event|0|||
146283959|NCT05593445|527551910|FG002|12-Week DBVC Period|Adverse Event|0|||
146283960|NCT05593445|527551911|FG003|12-Week DBVC Period|Adverse Event|0|||
146283961|NCT05593445|527551908|FG000|12-Week DBVC Period|Physician Decision|0|||
146283962|NCT05593445|527551909|FG001|12-Week DBVC Period|Physician Decision|1|||
146283963|NCT05593445|527551910|FG002|12-Week DBVC Period|Physician Decision|0|||
146283964|NCT05593445|527551911|FG003|12-Week DBVC Period|Physician Decision|0|||
146283965|NCT05593445|527551908|FG000|12-Week DBVC Period|Protocol Violation|0|||
146283966|NCT05593445|527551909|FG001|12-Week DBVC Period|Protocol Violation|1|||
146283967|NCT05593445|527551910|FG002|12-Week DBVC Period|Protocol Violation|0|||
146283968|NCT05593445|527551911|FG003|12-Week DBVC Period|Protocol Violation|0|||
146283969|NCT05593445|527551908|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
146283970|NCT05593445|527551909|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
146283971|NCT05593445|527551910|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
146283972|NCT05593445|527551911|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
146283973|NCT05593445|527551908|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
146283974|NCT05593445|527551909|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146283975|NCT05593445|527551910|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146283976|NCT05593445|527551911|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
146283977|NCT05593445|527551908|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
146283978|NCT05593445|527551909|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
146283979|NCT05593445|527551910|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
146283980|NCT05593445|527551911|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
146283981|NCT05593445|527551908|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
146283982|NCT05593445|527551909|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
146283983|NCT05593445|527551910|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
146283984|NCT05593445|527551911|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
146283985|NCT05593445|527551908|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146283986|NCT05593445|527551909|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146283987|NCT05593445|527551910|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
146283988|NCT05593445|527551911|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146283989|NCT03647488|527553562|FG000|Overall Study|Progressive disease|10|||
146283990|NCT03647488|527553563|FG001|Overall Study|Progressive disease|0|||
146283991|NCT03647488|527553564|FG002|Overall Study|Progressive disease|0|||
146283992|NCT03647488|527553562|FG000|Overall Study|Adverse Event|5|||
146283993|NCT03647488|527553563|FG001|Overall Study|Adverse Event|0|||
146283994|NCT03647488|527553564|FG002|Overall Study|Adverse Event|0|||
146283995|NCT03647488|527553562|FG000|Overall Study|Clinical progression|2|||
146283996|NCT03647488|527553563|FG001|Overall Study|Clinical progression|0|||
146283997|NCT03647488|527553564|FG002|Overall Study|Clinical progression|0|||
146283998|NCT03647488|527553562|FG000|Overall Study|Participant refused to take investigational product|1|||
146283999|NCT03647488|527553563|FG001|Overall Study|Participant refused to take investigational product|0|||
146284000|NCT03647488|527553564|FG002|Overall Study|Participant refused to take investigational product|0|||
146284001|NCT00812331|527553565|FG000|Overall Study|Adverse Event|1|||
146284002|NCT00812331|527553566|FG001|Overall Study|Adverse Event|0|||
146284003|NCT00812331|527553567|FG002|Overall Study|Adverse Event|0|||
146284004|NCT00812331|527553568|FG003|Overall Study|Adverse Event|0|||
146284005|NCT00812331|527553569|FG004|Overall Study|Adverse Event|0|||
146284006|NCT01506453|527553570|FG000|Overall Study|Withdrawal prior to treatment|0|||
146284007|NCT01506453|527553571|FG001|Overall Study|Withdrawal prior to treatment|2|||
146284008|NCT03694275|527553572|FG000|Overall Study|Adverse Event|0|||
146081224|NCT02043899|526818175|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
146081225|NCT02043899|526818175|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
146081226|NCT02043899|526818175|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
146081227|NCT02043899|526818175|FG000|Overall Study|Treatment delayed|1|||
146081228|NCT03254108|526818176|FG000|Overall Study|Adverse Event|0|||
146081229|NCT03254108|526818177|FG001|Overall Study|Adverse Event|2|||
146081230|NCT03254108|526818178|FG002|Overall Study|Adverse Event|0|||
146081231|NCT03254108|526818179|FG003|Overall Study|Adverse Event|1|||
146284009|NCT03694275|527553573|FG001|Overall Study|Adverse Event|1|||
146284010|NCT03694275|527553572|FG000|Overall Study|Reason not Specified|0|||
146284011|NCT03694275|527553573|FG001|Overall Study|Reason not Specified|1|||
146284012|NCT02502799|527553574|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146185769|NCT03225846|527191704|FG004|Overall Study|Death|0|||
146185770|NCT03225846|527191705|FG005|Overall Study|Death|0|||
146185771|NCT03225846|527191706|FG006|Overall Study|Death|0|||
146185772|NCT03225846|527191700|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
146185773|NCT03225846|527191701|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
146185774|NCT03225846|527191702|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
146185775|NCT03225846|527191703|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
146185776|NCT03225846|527191704|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
146185777|NCT03225846|527191705|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
146185778|NCT03225846|527191706|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
146284013|NCT02502799|527553575|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146284014|NCT02502799|527553576|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
146284015|NCT02502799|527553577|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
146284016|NCT02502799|527553574|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146284017|NCT02502799|527553575|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146284018|NCT02502799|527553576|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
146284019|NCT02502799|527553577|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
146284020|NCT02502799|527553574|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
146284021|NCT02502799|527553575|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
146284022|NCT02502799|527553576|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
146284023|NCT02502799|527553577|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
146284024|NCT02502799|527553574|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
146284025|NCT02502799|527553575|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
146284026|NCT02502799|527553576|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
146284027|NCT02502799|527553577|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
146284028|NCT02502799|527553574|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
146284029|NCT02502799|527553575|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
146284030|NCT02502799|527553576|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
146284031|NCT02502799|527553577|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
146284032|NCT00153062|527553583|FG000|Overall Study|Death|360|||
146284033|NCT00153062|527553584|FG001|Overall Study|Death|352|||
146284034|NCT00153062|527553585|FG002|Overall Study|Death|369|||
146284035|NCT00153062|527553586|FG003|Overall Study|Death|365|||
146284036|NCT00153062|527553583|FG000|Overall Study|Withdrawal by Subject|14|||
146284037|NCT00153062|527553584|FG001|Overall Study|Withdrawal by Subject|30|||
146284038|NCT00153062|527553585|FG002|Overall Study|Withdrawal by Subject|27|||
146284039|NCT00153062|527553586|FG003|Overall Study|Withdrawal by Subject|28|||
146284040|NCT00153062|527553583|FG000|Overall Study|Lost to Follow-up|12|||
146284041|NCT00153062|527553584|FG001|Overall Study|Lost to Follow-up|20|||
146284042|NCT00153062|527553585|FG002|Overall Study|Lost to Follow-up|15|||
146284043|NCT00153062|527553586|FG003|Overall Study|Lost to Follow-up|16|||
146284044|NCT00153062|527553583|FG000|Overall Study|Adverse Event|0|||
146284045|NCT00153062|527553584|FG001|Overall Study|Adverse Event|1|||
146284046|NCT00153062|527553585|FG002|Overall Study|Adverse Event|1|||
146284047|NCT00153062|527553586|FG003|Overall Study|Adverse Event|0|||
146284048|NCT00153062|527553583|FG000|Overall Study|Protocol Violation|0|||
146284049|NCT00153062|527553584|FG001|Overall Study|Protocol Violation|2|||
146284050|NCT00153062|527553585|FG002|Overall Study|Protocol Violation|1|||
146284051|NCT00153062|527553586|FG003|Overall Study|Protocol Violation|1|||
146284052|NCT00153062|527553583|FG000|Overall Study|No disposition data available|1|||
146284053|NCT00153062|527553584|FG001|Overall Study|No disposition data available|1|||
146284054|NCT00153062|527553585|FG002|Overall Study|No disposition data available|1|||
146284055|NCT00153062|527553586|FG003|Overall Study|No disposition data available|1|||
146284056|NCT00153062|527553583|FG000|Overall Study|Other|0|||
146185779|NCT03225846|527191700|FG000|Overall Study|Patient decision|0|||
146185780|NCT03225846|527191701|FG001|Overall Study|Patient decision|0|||
146185781|NCT03225846|527191702|FG002|Overall Study|Patient decision|0|||
146284057|NCT00153062|527553584|FG001|Overall Study|Other|0|||
146284058|NCT00153062|527553585|FG002|Overall Study|Other|1|||
146284059|NCT00153062|527553586|FG003|Overall Study|Other|0|||
146284060|NCT01589237|527553608|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
146284061|NCT01589237|527553609|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
146185782|NCT03225846|527191703|FG003|Overall Study|Patient decision|0|||
146185783|NCT03225846|527191704|FG004|Overall Study|Patient decision|0|||
146284062|NCT01589237|527553610|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
146284063|NCT01589237|527553611|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
146284064|NCT01589237|527553608|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146284065|NCT01589237|527553609|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
146185784|NCT03225846|527191705|FG005|Overall Study|Patient decision|0|||
146081232|NCT03254108|526818180|FG004|Overall Study|Adverse Event|1|||
146081233|NCT03254108|526818176|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146081234|NCT03254108|526818177|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146081235|NCT03254108|526818178|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146185785|NCT03225846|527191706|FG006|Overall Study|Patient decision|1|||
146185786|NCT00996580|527191707|FG000|Overall Study|Adverse Event|466|||
146185787|NCT00996580|527191707|FG000|Overall Study|Lost to Follow-up|480|||
146185788|NCT00996580|527191707|FG000|Overall Study|Noncompliance with the protocol|137|||
146185789|NCT00996580|527191707|FG000|Overall Study|Physician Decision|5|||
146185790|NCT00996580|527191707|FG000|Overall Study|Pregnancy|68|||
146185791|NCT00996580|527191707|FG000|Overall Study|Protocol Violation|16|||
146185792|NCT00996580|527191707|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
146185793|NCT00996580|527191707|FG000|Overall Study|Withdrawal by Subject|217|||
146185794|NCT00996580|527191707|FG000|Overall Study|Other|29|||
146185795|NCT00238420|527191708|FG000|Overall Study|Protocol Violation|1|||
146185796|NCT00238420|527191709|FG001|Overall Study|Protocol Violation|1|||
146185797|NCT00442286|527191710|FG000|Overall Study|Death|2|||
146185798|NCT00442286|527191711|FG001|Overall Study|Death|2|||
146185799|NCT00442286|527191710|FG000|Overall Study|Lost to Follow-up|1|||
146185800|NCT00442286|527191711|FG001|Overall Study|Lost to Follow-up|0|||
146185801|NCT00442286|527191710|FG000|Overall Study|Withdrawal by Subject|2|||
146185802|NCT00442286|527191711|FG001|Overall Study|Withdrawal by Subject|0|||
146185803|NCT00442286|527191710|FG000|Overall Study|System explanted|1|||
146185804|NCT00442286|527191711|FG001|Overall Study|System explanted|0|||
146185805|NCT00442286|527191710|FG000|Overall Study|Patient Injury|1|||
146185806|NCT00442286|527191711|FG001|Overall Study|Patient Injury|0|||
146185807|NCT00641186|527191712|FG000|Overall Study|Adverse Event|3|||
146185808|NCT04140890|527191715|FG000|Overall Study|Withdrawal by Subject|0|||
146185809|NCT04140890|527191716|FG001|Overall Study|Withdrawal by Subject|1|||
146185810|NCT02102464|527191717|FG000|Randomized Study|Withdrawal by Subject|0|||
146185811|NCT02102464|527191718|FG001|Randomized Study|Withdrawal by Subject|1|||
146185812|NCT02102464|527191719|FG002|Randomized Study|Withdrawal by Subject|0|||
146185813|NCT01778062|527191722|FG000|Overall Study|Adverse Event|1|||
146185814|NCT01778062|527191723|FG001|Overall Study|Adverse Event|3|||
146185815|NCT01778062|527191722|FG000|Overall Study|Consent Withdrawal|1|||
146185816|NCT01778062|527191723|FG001|Overall Study|Consent Withdrawal|5|||
146185817|NCT01778062|527191722|FG000|Overall Study|major protocol deviation|4|||
146185818|NCT01778062|527191723|FG001|Overall Study|major protocol deviation|3|||
146185819|NCT01824472|527191724|FG000|Overall Study|Lost to Follow-up|0|||
146185820|NCT01824472|527191725|FG001|Overall Study|Lost to Follow-up|0|||
146185821|NCT01824472|527191726|FG002|Overall Study|Lost to Follow-up|1|||
146185822|NCT01824472|527191724|FG000|Overall Study|Withdrawal by Subject|1|||
146185823|NCT01824472|527191725|FG001|Overall Study|Withdrawal by Subject|5|||
146185824|NCT01824472|527191726|FG002|Overall Study|Withdrawal by Subject|3|||
146185825|NCT01824472|527191724|FG000|Overall Study|Ineligible post randomization&screening|0|||
146185826|NCT01824472|527191725|FG001|Overall Study|Ineligible post randomization&screening|2|||
146185827|NCT01824472|527191726|FG002|Overall Study|Ineligible post randomization&screening|0|||
146185828|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
146185829|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
146185830|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
146185831|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
146185832|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
146185833|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
146185834|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
146185835|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
146185836|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
146185837|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
146185838|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
146185839|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
146185840|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
146185841|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
146185842|NCT01815736|527191727|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
146185843|NCT01815736|527191728|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
146185844|NCT01815736|527191727|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
146185845|NCT01815736|527191728|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
146185846|NCT01815736|527191727|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
146185847|NCT01815736|527191728|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
146185848|NCT01815736|527191727|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
146185849|NCT01815736|527191728|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
146185850|NCT01815736|527191727|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
146185851|NCT01815736|527191728|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
146185852|NCT01815736|527191727|FG000|Extension Treatment Phase- After Week 96|Death|1|||
146185853|NCT01815736|527191728|FG001|Extension Treatment Phase- After Week 96|Death|0|||
146185854|NCT04039503|527191729|FG000|Overall Study|Adverse Event|3|||
146185855|NCT04039503|527191730|FG001|Overall Study|Adverse Event|0|||
146185856|NCT04039503|527191731|FG002|Overall Study|Adverse Event|2|||
146185857|NCT04039503|527191732|FG003|Overall Study|Adverse Event|0|||
146185858|NCT04039503|527191729|FG000|Overall Study|Lost to Follow-up|0|||
146185859|NCT04039503|527191730|FG001|Overall Study|Lost to Follow-up|0|||
146185860|NCT04039503|527191731|FG002|Overall Study|Lost to Follow-up|1|||
146185861|NCT04039503|527191732|FG003|Overall Study|Lost to Follow-up|0|||
146185862|NCT04039503|527191729|FG000|Overall Study|Protocol Violation|0|||
146185863|NCT04039503|527191730|FG001|Overall Study|Protocol Violation|1|||
146185864|NCT04039503|527191731|FG002|Overall Study|Protocol Violation|2|||
146185865|NCT04039503|527191732|FG003|Overall Study|Protocol Violation|1|||
146185866|NCT04039503|527191729|FG000|Overall Study|Withdrawal by Subject|4|||
146185867|NCT04039503|527191730|FG001|Overall Study|Withdrawal by Subject|3|||
146185868|NCT04039503|527191731|FG002|Overall Study|Withdrawal by Subject|5|||
146185869|NCT04039503|527191732|FG003|Overall Study|Withdrawal by Subject|2|||
146185870|NCT03387514|527191734|FG000|Overall Study|Withdrawal by Subject|2|||
146185871|NCT03387514|527191734|FG000|Overall Study|Physician Decision|1|||
146185872|NCT03387514|527191734|FG000|Overall Study|Lost to Follow-up|2|||
146185873|NCT02846558|527191745|FG000|Overall Study|Adverse Event|1|||
146185874|NCT02846558|527191746|FG001|Overall Study|Adverse Event|0|||
146185875|NCT02846558|527191747|FG002|Overall Study|Adverse Event|0|||
146185876|NCT02846558|527191748|FG003|Overall Study|Adverse Event|0|||
146185877|NCT02846558|527191745|FG000|Overall Study|Withdrawal by Subject|5|||
146185878|NCT02846558|527191746|FG001|Overall Study|Withdrawal by Subject|4|||
146185879|NCT02846558|527191747|FG002|Overall Study|Withdrawal by Subject|2|||
146185880|NCT02846558|527191748|FG003|Overall Study|Withdrawal by Subject|2|||
146185881|NCT02846558|527191745|FG000|Overall Study|Lost to Follow-up|2|||
146185882|NCT02846558|527191746|FG001|Overall Study|Lost to Follow-up|0|||
146185883|NCT02846558|527191747|FG002|Overall Study|Lost to Follow-up|0|||
146185884|NCT02846558|527191748|FG003|Overall Study|Lost to Follow-up|0|||
146185885|NCT04445155|527191749|FG000|Overall Study|Lost to Follow-up|11|||
146185886|NCT04445155|527191750|FG001|Overall Study|Lost to Follow-up|2|||
146185887|NCT04445155|527191751|FG002|Overall Study|Lost to Follow-up|3|||
146185888|NCT04445155|527191752|FG003|Overall Study|Lost to Follow-up|0|||
146185889|NCT04445155|527191749|FG000|Overall Study|Withdrawal by Subject|8|||
146185890|NCT04445155|527191750|FG001|Overall Study|Withdrawal by Subject|0|||
146185891|NCT04445155|527191751|FG002|Overall Study|Withdrawal by Subject|0|||
146185892|NCT04445155|527191752|FG003|Overall Study|Withdrawal by Subject|0|||
146185893|NCT04445155|527191749|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
146185894|NCT04445155|527191750|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146185895|NCT04445155|527191751|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146185896|NCT04445155|527191752|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
146185897|NCT04445155|527191749|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
146185898|NCT04445155|527191750|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146185899|NCT04445155|527191751|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146185900|NCT04445155|527191752|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
146185901|NCT04894903|527193045|FG000|Overall Study|Death|1|||
146185902|NCT04894903|527193046|FG001|Overall Study|Death|0|||
146185903|NCT04894903|527193045|FG000|Overall Study|Pregnancy|1|||
146185904|NCT04894903|527193046|FG001|Overall Study|Pregnancy|0|||
146185905|NCT04894903|527193045|FG000|Overall Study|Withdrawal by Subject|1|||
146185906|NCT04894903|527193046|FG001|Overall Study|Withdrawal by Subject|1|||
146185907|NCT04894903|527193045|FG000|Overall Study|moved or exited health system|1|||
146185908|NCT04894903|527193046|FG001|Overall Study|moved or exited health system|3|||
146185909|NCT01670500|527193047|FG000|Overall Study|Withdrawal by Subject|1|||
146185910|NCT01670500|527193048|FG001|Overall Study|Withdrawal by Subject|0|||
146185911|NCT01923428|527193050|FG000|Overall Study|Adverse Event|8|||
146185912|NCT01923428|527193051|FG001|Overall Study|Adverse Event|6|||
146185913|NCT01923428|527193052|FG002|Overall Study|Adverse Event|3|||
146412381|NCT02544633|528015506|FG003|Survival Follow-up Period|Death|9|||
146185914|NCT01923428|527193053|FG003|Overall Study|Adverse Event|3|||
146185915|NCT01923428|527193050|FG000|Overall Study|Withdrawal by Subject|5|||
146185916|NCT01923428|527193051|FG001|Overall Study|Withdrawal by Subject|3|||
146185917|NCT01923428|527193052|FG002|Overall Study|Withdrawal by Subject|0|||
146185918|NCT01923428|527193053|FG003|Overall Study|Withdrawal by Subject|4|||
146185919|NCT01923428|527193050|FG000|Overall Study|Lost to Follow-up|2|||
146185920|NCT01923428|527193051|FG001|Overall Study|Lost to Follow-up|1|||
146284066|NCT01589237|527553610|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146284067|NCT01589237|527553611|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
146284068|NCT01589237|527553608|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
146284069|NCT01589237|527553609|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
146284070|NCT01589237|527553610|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
146284071|NCT01589237|527553611|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
146284072|NCT01589237|527553608|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146284073|NCT01589237|527553609|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146284074|NCT01589237|527553610|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
146284075|NCT01589237|527553611|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
146284076|NCT00117845|527553612|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
146284077|NCT00734097|527553613|FG000|Screening|Protocol Violation|12|||
146284078|NCT00734097|527553613|FG000|Screening|Withdrawal by Subject|5|||
146284079|NCT00734097|527553613|FG000|Screening|Lost to Follow-up|2|||
146284080|NCT00734097|527553613|FG000|Screening|Unconfirmed pregnancy|1|||
146284081|NCT00734097|527553613|FG000|Open Label|Lost to Follow-up|7|||
146284082|NCT00734097|527553613|FG000|Open Label|Withdrawal by Subject|5|||
146185921|NCT01923428|527193052|FG002|Overall Study|Lost to Follow-up|5|||
146185922|NCT01923428|527193053|FG003|Overall Study|Lost to Follow-up|0|||
146185923|NCT01923428|527193050|FG000|Overall Study|Protocol Violation|3|||
146185924|NCT01923428|527193051|FG001|Overall Study|Protocol Violation|0|||
146185925|NCT01923428|527193052|FG002|Overall Study|Protocol Violation|2|||
146185926|NCT01923428|527193053|FG003|Overall Study|Protocol Violation|1|||
146185927|NCT01923428|527193050|FG000|Overall Study|Non Compliance to treatment|1|||
146185928|NCT01923428|527193051|FG001|Overall Study|Non Compliance to treatment|2|||
146185929|NCT01923428|527193052|FG002|Overall Study|Non Compliance to treatment|0|||
146185930|NCT01923428|527193053|FG003|Overall Study|Non Compliance to treatment|1|||
146284083|NCT00734097|527553613|FG000|Open Label|Protocol Violation|4|||
146284084|NCT00910689|527553614|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
146185931|NCT01923428|527193050|FG000|Overall Study|Lack of Efficacy|0|||
146185932|NCT01923428|527193051|FG001|Overall Study|Lack of Efficacy|0|||
146185933|NCT01923428|527193052|FG002|Overall Study|Lack of Efficacy|1|||
146185934|NCT01923428|527193053|FG003|Overall Study|Lack of Efficacy|1|||
146284085|NCT00910689|527553615|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
146284086|NCT00910689|527553616|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
146284087|NCT00910689|527553617|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
146284088|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
146284089|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
146284090|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
146284091|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
146284092|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
146284093|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
146284094|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
146284095|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
146284096|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
146284097|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
146284098|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
146284099|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
146284100|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
146284101|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
146284102|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
146185935|NCT02550873|527193054|FG000|Randomized Double Blind|Adverse Event|3|||
146185936|NCT02550873|527193055|FG001|Randomized Double Blind|Adverse Event|1|||
146284103|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
146284104|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146284105|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146284106|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
146284107|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
146284108|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
146185937|NCT02550873|527193056|FG002|Randomized Double Blind|Adverse Event|0|||
146185938|NCT02550873|527193054|FG000|Randomized Double Blind|Disease progression|1|||
146185939|NCT02550873|527193055|FG001|Randomized Double Blind|Disease progression|1|||
146185940|NCT02550873|527193056|FG002|Randomized Double Blind|Disease progression|0|||
146185941|NCT02550873|527193054|FG000|Open Label Extension|Study ongoing|0|||
146185942|NCT02550873|527193055|FG001|Open Label Extension|Study ongoing|0|||
146185943|NCT02550873|527193056|FG002|Open Label Extension|Study ongoing|111|||
146185944|NCT01822353|527193057|FG000|Overall Study|Adverse Event|1|||
146185945|NCT01822353|527193058|FG001|Overall Study|Adverse Event|3|||
146284109|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
146284110|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
146185946|NCT01822353|527193059|FG002|Overall Study|Adverse Event|1|||
146284111|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
146284112|NCT00910689|527553614|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
146284113|NCT00910689|527553615|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
146284114|NCT00910689|527553616|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
146284115|NCT00910689|527553617|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
146284116|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
146284117|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
146284118|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
146284119|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
146284120|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
146284121|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
146284122|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
146284123|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
146284124|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
146284125|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146284126|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146284127|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
146284128|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
146284129|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
146284130|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
146284131|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
146284132|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146284133|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146284134|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
146284135|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
146284136|NCT00910689|527553614|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
146284137|NCT00910689|527553615|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
146284138|NCT00910689|527553616|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
146284139|NCT00910689|527553617|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
146284140|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
146284141|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
146284142|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
146284143|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
146284144|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146284145|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
146185947|NCT01822353|527193057|FG000|Overall Study|Pregnancy|0|||
146185948|NCT01822353|527193058|FG001|Overall Study|Pregnancy|1|||
146185949|NCT01822353|527193059|FG002|Overall Study|Pregnancy|0|||
146185950|NCT01822353|527193057|FG000|Overall Study|Withdrawal by Subject|3|||
146185951|NCT01822353|527193058|FG001|Overall Study|Withdrawal by Subject|1|||
146185952|NCT01822353|527193059|FG002|Overall Study|Withdrawal by Subject|0|||
146185953|NCT03873246|527193060|FG000|Overall Study|Adverse Event|1|||
146185954|NCT03873246|527193061|FG001|Overall Study|Adverse Event|3|||
146185955|NCT03873246|527193062|FG002|Overall Study|Adverse Event|3|||
146185956|NCT03873246|527193060|FG000|Overall Study|Lost to Follow-up|4|||
146185957|NCT03873246|527193061|FG001|Overall Study|Lost to Follow-up|4|||
146185958|NCT03873246|527193062|FG002|Overall Study|Lost to Follow-up|5|||
146185959|NCT03873246|527193060|FG000|Overall Study|Protocol Violation|0|||
146185960|NCT03873246|527193061|FG001|Overall Study|Protocol Violation|1|||
146185961|NCT03873246|527193062|FG002|Overall Study|Protocol Violation|0|||
146185962|NCT03873246|527193060|FG000|Overall Study|Withdrawal by Subject|0|||
146185963|NCT03873246|527193061|FG001|Overall Study|Withdrawal by Subject|4|||
146185964|NCT03873246|527193062|FG002|Overall Study|Withdrawal by Subject|1|||
146185965|NCT01857323|527193063|FG000|Overall Study|Adverse Event|1|||
146185966|NCT01857323|527193063|FG000|Overall Study|Withdrawal by Subject|3|||
146185967|NCT01857323|527193063|FG000|Overall Study|Non-compliance|1|||
146185968|NCT01857323|527193063|FG000|Overall Study|Protocol Violation|6|||
146185969|NCT01857323|527193063|FG000|Overall Study|Lost to Follow-up|1|||
146185970|NCT01857323|527193063|FG000|Overall Study|Other|4|||
146185971|NCT01857323|527193063|FG000|Overall Study|Did not complete 180 doses|48|||
146185972|NCT02107443|527193064|FG000|Overall Study|Death|42|||
146185973|NCT02107443|527193065|FG001|Overall Study|Death|30|||
146185974|NCT02107443|527193064|FG000|Overall Study|Study Protocol Violation|3|||
146185975|NCT02107443|527193065|FG001|Overall Study|Study Protocol Violation|1|||
146185976|NCT02107443|527193064|FG000|Overall Study|Registered but Not Eligible|0|||
146185977|NCT02107443|527193065|FG001|Overall Study|Registered but Not Eligible|1|||
146185978|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
146185979|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
146185980|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
146185981|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
146185982|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Changed Mind|2|||
146185983|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Changed Mind|0|||
146185984|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
146185985|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
146185986|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
146185987|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
146185988|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
146185989|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
146185990|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
146185991|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
146185992|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Other Medical|9|||
146185993|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Other Medical|5|||
146185994|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Disease Progression|4|||
146185995|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Disease Progression|2|||
146185996|NCT02107443|527193064|FG000|Overall Study|Withdrawal: Personal Issues|0|||
146185997|NCT02107443|527193065|FG001|Overall Study|Withdrawal: Personal Issues|3|||
146185998|NCT01400893|527193066|FG000|Overall Study|Death|27|||
146185999|NCT01400893|527193067|FG001|Overall Study|Death|21|||
146186000|NCT01400893|527193066|FG000|Overall Study|Lost to Follow-up|0|||
146186001|NCT01400893|527193067|FG001|Overall Study|Lost to Follow-up|6|||
146186002|NCT00946647|527193068|FG000|Phase 1 Part|Adverse Event|2|||
146186003|NCT00946647|527193069|FG001|Phase 1 Part|Adverse Event|5|||
146186004|NCT00946647|527193070|FG002|Phase 1 Part|Adverse Event|3|||
146186005|NCT00946647|527193071|FG003|Phase 1 Part|Adverse Event|0|||
146186006|NCT00946647|527193072|FG004|Phase 1 Part|Adverse Event|0|||
146186007|NCT00946647|527193068|FG000|Phase 1 Part|Disease progression|3|||
146186008|NCT00946647|527193069|FG001|Phase 1 Part|Disease progression|6|||
146186009|NCT00946647|527193070|FG002|Phase 1 Part|Disease progression|1|||
146186010|NCT00946647|527193071|FG003|Phase 1 Part|Disease progression|0|||
146186011|NCT00946647|527193072|FG004|Phase 1 Part|Disease progression|0|||
146186012|NCT00946647|527193068|FG000|Phase 1 Part|Withdrawal by Subject|1|||
146186013|NCT00946647|527193069|FG001|Phase 1 Part|Withdrawal by Subject|4|||
146186014|NCT00946647|527193070|FG002|Phase 1 Part|Withdrawal by Subject|3|||
146186015|NCT00946647|527193071|FG003|Phase 1 Part|Withdrawal by Subject|0|||
146186016|NCT00946647|527193072|FG004|Phase 1 Part|Withdrawal by Subject|0|||
146186017|NCT00946647|527193068|FG000|Phase 1 Part|Abnormal values|0|||
146186018|NCT00946647|527193069|FG001|Phase 1 Part|Abnormal values|2|||
146186019|NCT00946647|527193070|FG002|Phase 1 Part|Abnormal values|0|||
146186020|NCT00946647|527193071|FG003|Phase 1 Part|Abnormal values|0|||
146186021|NCT00946647|527193072|FG004|Phase 1 Part|Abnormal values|0|||
146186022|NCT00946647|527193068|FG000|Phase 1 Part|Reason missing|0|||
146186023|NCT00946647|527193069|FG001|Phase 1 Part|Reason missing|1|||
146186024|NCT00946647|527193070|FG002|Phase 1 Part|Reason missing|0|||
146186025|NCT00946647|527193071|FG003|Phase 1 Part|Reason missing|0|||
146186026|NCT00946647|527193072|FG004|Phase 1 Part|Reason missing|0|||
146186027|NCT00946647|527193068|FG000|Phase ll Part|Untreated|0|||
146186028|NCT00946647|527193069|FG001|Phase ll Part|Untreated|0|||
146186029|NCT00946647|527193070|FG002|Phase ll Part|Untreated|0|||
146186030|NCT00946647|527193071|FG003|Phase ll Part|Untreated|0|||
146186031|NCT00946647|527193072|FG004|Phase ll Part|Untreated|2|||
146186032|NCT00946647|527193068|FG000|Phase ll Part|Adverse Event|0|||
146186033|NCT00946647|527193069|FG001|Phase ll Part|Adverse Event|0|||
146186034|NCT00946647|527193070|FG002|Phase ll Part|Adverse Event|0|||
146186035|NCT00946647|527193071|FG003|Phase ll Part|Adverse Event|10|||
146186036|NCT00946647|527193072|FG004|Phase ll Part|Adverse Event|6|||
146186037|NCT00946647|527193068|FG000|Phase ll Part|Withdrawal by Subject|0|||
146186038|NCT00946647|527193069|FG001|Phase ll Part|Withdrawal by Subject|0|||
146186039|NCT00946647|527193070|FG002|Phase ll Part|Withdrawal by Subject|0|||
146186040|NCT00946647|527193071|FG003|Phase ll Part|Withdrawal by Subject|8|||
146186041|NCT00946647|527193072|FG004|Phase ll Part|Withdrawal by Subject|6|||
146186042|NCT00946647|527193068|FG000|Phase ll Part|Administrative problems|0|||
146186043|NCT00946647|527193069|FG001|Phase ll Part|Administrative problems|0|||
146186044|NCT00946647|527193070|FG002|Phase ll Part|Administrative problems|0|||
146186045|NCT00946647|527193071|FG003|Phase ll Part|Administrative problems|3|||
146186046|NCT00946647|527193072|FG004|Phase ll Part|Administrative problems|8|||
146186047|NCT00946647|527193068|FG000|Phase ll Part|Death|0|||
146186048|NCT00946647|527193069|FG001|Phase ll Part|Death|0|||
146186049|NCT00946647|527193070|FG002|Phase ll Part|Death|0|||
146186050|NCT00946647|527193071|FG003|Phase ll Part|Death|7|||
146186051|NCT00946647|527193072|FG004|Phase ll Part|Death|4|||
146186052|NCT00946647|527193068|FG000|Phase ll Part|Disease progression|0|||
146186053|NCT00946647|527193069|FG001|Phase ll Part|Disease progression|0|||
146186054|NCT00946647|527193070|FG002|Phase ll Part|Disease progression|0|||
146186055|NCT00946647|527193071|FG003|Phase ll Part|Disease progression|6|||
146186056|NCT00946647|527193072|FG004|Phase ll Part|Disease progression|14|||
146186057|NCT00946647|527193068|FG000|Phase ll Part|Protocol Violation|0|||
146186058|NCT00946647|527193069|FG001|Phase ll Part|Protocol Violation|0|||
146186059|NCT00946647|527193070|FG002|Phase ll Part|Protocol Violation|0|||
146186060|NCT00946647|527193071|FG003|Phase ll Part|Protocol Violation|4|||
146186061|NCT00946647|527193072|FG004|Phase ll Part|Protocol Violation|2|||
146186062|NCT00946647|527193068|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
146186063|NCT00946647|527193069|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
146186064|NCT00946647|527193070|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
146186065|NCT00946647|527193071|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
146186066|NCT00946647|527193072|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
146186067|NCT04209790|527193073|FG000|Overall Study|Physician Decision|1|||
146186068|NCT03057834|527193074|FG000|Overall Study|Withdrawal by Subject|25|||
146186069|NCT03057834|527193075|FG001|Overall Study|Withdrawal by Subject|29|||
146186070|NCT05617040|527193078|FG000|Overall Study|Adverse Event|0|||
146186071|NCT05617040|527193079|FG001|Overall Study|Adverse Event|1|||
146186072|NCT05617040|527193080|FG002|Overall Study|Adverse Event|0|||
146186073|NCT05617040|527193078|FG000|Overall Study|Death|0|||
146186074|NCT05617040|527193079|FG001|Overall Study|Death|0|||
146186075|NCT05617040|527193080|FG002|Overall Study|Death|1|||
146186076|NCT03173248|527193082|FG000|Overall Study|Death|28|||
146186077|NCT03173248|527193083|FG001|Overall Study|Death|46|||
146186078|NCT03173248|527193082|FG000|Overall Study|Lost to Follow-up|0|||
146186079|NCT03173248|527193083|FG001|Overall Study|Lost to Follow-up|1|||
146186080|NCT03173248|527193082|FG000|Overall Study|Withdrawal by Subject|6|||
146186081|NCT03173248|527193083|FG001|Overall Study|Withdrawal by Subject|4|||
146186082|NCT03173248|527193082|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
146186083|NCT03173248|527193083|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
146186084|NCT04630756|527193084|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
146186085|NCT04630756|527193085|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
146186086|NCT04630756|527193086|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
146186087|NCT03077620|527193088|FG000|Overall Study|Unable to place lumbar catheter|1|||
146186088|NCT03077620|527193089|FG001|Overall Study|Unable to place lumbar catheter|0|||
146186089|NCT03077620|527193090|FG002|Overall Study|Unable to place lumbar catheter|1|||
146186090|NCT03077620|527193091|FG003|Overall Study|Unable to place lumbar catheter|0|||
146186091|NCT03077620|527193088|FG000|Overall Study|Withdrawal by Subject|0|||
146186092|NCT03077620|527193089|FG001|Overall Study|Withdrawal by Subject|1|||
146186093|NCT03077620|527193090|FG002|Overall Study|Withdrawal by Subject|0|||
146186094|NCT03077620|527193091|FG003|Overall Study|Withdrawal by Subject|0|||
146186095|NCT03077620|527193088|FG000|Overall Study|Physician Decision|0|||
146186096|NCT03077620|527193089|FG001|Overall Study|Physician Decision|0|||
146186097|NCT03077620|527193090|FG002|Overall Study|Physician Decision|1|||
146186098|NCT03077620|527193091|FG003|Overall Study|Physician Decision|0|||
146186099|NCT03621982|527193092|FG000|Overall Study|Withdrawal by Subject|1|||
146186100|NCT03621982|527193093|FG001|Overall Study|Withdrawal by Subject|0|||
146186101|NCT03621982|527193094|FG002|Overall Study|Withdrawal by Subject|0|||
146186102|NCT03621982|527193095|FG003|Overall Study|Withdrawal by Subject|1|||
146186103|NCT03621982|527193096|FG004|Overall Study|Withdrawal by Subject|0|||
146186104|NCT03621982|527193097|FG005|Overall Study|Withdrawal by Subject|1|||
146186105|NCT03621982|527193098|FG006|Overall Study|Withdrawal by Subject|1|||
146186106|NCT03621982|527193099|FG007|Overall Study|Withdrawal by Subject|0|||
146186107|NCT03621982|527193100|FG008|Overall Study|Withdrawal by Subject|1|||
146186108|NCT03621982|527193101|FG009|Overall Study|Withdrawal by Subject|0|||
146186109|NCT03621982|527193102|FG010|Overall Study|Withdrawal by Subject|2|||
146186110|NCT03621982|527193103|FG011|Overall Study|Withdrawal by Subject|1|||
146186111|NCT03621982|527193104|FG012|Overall Study|Withdrawal by Subject|2|||
146186112|NCT03621982|527193105|FG013|Overall Study|Withdrawal by Subject|2|||
146186113|NCT03621982|527193092|FG000|Overall Study|Investigator/Sponsor decision|0|||
146186114|NCT03621982|527193093|FG001|Overall Study|Investigator/Sponsor decision|0|||
146186115|NCT03621982|527193094|FG002|Overall Study|Investigator/Sponsor decision|0|||
146186116|NCT03621982|527193095|FG003|Overall Study|Investigator/Sponsor decision|0|||
146186117|NCT03621982|527193096|FG004|Overall Study|Investigator/Sponsor decision|0|||
146186118|NCT03621982|527193097|FG005|Overall Study|Investigator/Sponsor decision|0|||
146186119|NCT03621982|527193098|FG006|Overall Study|Investigator/Sponsor decision|0|||
146186120|NCT03621982|527193099|FG007|Overall Study|Investigator/Sponsor decision|0|||
146186121|NCT03621982|527193100|FG008|Overall Study|Investigator/Sponsor decision|0|||
146186122|NCT03621982|527193101|FG009|Overall Study|Investigator/Sponsor decision|0|||
146186123|NCT03621982|527193102|FG010|Overall Study|Investigator/Sponsor decision|0|||
146186124|NCT03621982|527193103|FG011|Overall Study|Investigator/Sponsor decision|4|||
146186125|NCT03621982|527193104|FG012|Overall Study|Investigator/Sponsor decision|0|||
146186126|NCT03621982|527193105|FG013|Overall Study|Investigator/Sponsor decision|2|||
146186127|NCT03621982|527193092|FG000|Overall Study|Death|2|||
146186128|NCT03621982|527193093|FG001|Overall Study|Death|4|||
146186129|NCT03621982|527193094|FG002|Overall Study|Death|4|||
146186130|NCT03621982|527193095|FG003|Overall Study|Death|3|||
146186131|NCT03621982|527193096|FG004|Overall Study|Death|8|||
146186132|NCT03621982|527193097|FG005|Overall Study|Death|4|||
146186133|NCT03621982|527193098|FG006|Overall Study|Death|6|||
146186134|NCT03621982|527193099|FG007|Overall Study|Death|3|||
146186135|NCT03621982|527193100|FG008|Overall Study|Death|0|||
146186136|NCT03621982|527193101|FG009|Overall Study|Death|3|||
146186137|NCT03621982|527193102|FG010|Overall Study|Death|8|||
146186138|NCT03621982|527193103|FG011|Overall Study|Death|4|||
146186139|NCT03621982|527193104|FG012|Overall Study|Death|2|||
146186140|NCT03621982|527193105|FG013|Overall Study|Death|2|||
146186141|NCT03621982|527193092|FG000|Overall Study|Lost to Follow-up|0|||
146186142|NCT03621982|527193093|FG001|Overall Study|Lost to Follow-up|0|||
146186143|NCT03621982|527193094|FG002|Overall Study|Lost to Follow-up|1|||
146186144|NCT03621982|527193095|FG003|Overall Study|Lost to Follow-up|0|||
146186145|NCT03621982|527193096|FG004|Overall Study|Lost to Follow-up|0|||
146186146|NCT03621982|527193097|FG005|Overall Study|Lost to Follow-up|0|||
146186147|NCT03621982|527193098|FG006|Overall Study|Lost to Follow-up|1|||
146186148|NCT03621982|527193099|FG007|Overall Study|Lost to Follow-up|0|||
146186149|NCT03621982|527193100|FG008|Overall Study|Lost to Follow-up|0|||
146186150|NCT03621982|527193101|FG009|Overall Study|Lost to Follow-up|1|||
146186151|NCT03621982|527193102|FG010|Overall Study|Lost to Follow-up|0|||
146186152|NCT03621982|527193103|FG011|Overall Study|Lost to Follow-up|0|||
146186153|NCT03621982|527193104|FG012|Overall Study|Lost to Follow-up|0|||
146186154|NCT03621982|527193105|FG013|Overall Study|Lost to Follow-up|0|||
146186155|NCT01544582|527193106|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
146186156|NCT01544582|527193107|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146186157|NCT01544582|527193108|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146186158|NCT01544582|527193109|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
146186159|NCT01544582|527193106|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
146186160|NCT01544582|527193107|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146186161|NCT01544582|527193108|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146186162|NCT01544582|527193109|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
146186163|NCT01544582|527193106|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
146186164|NCT01544582|527193107|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
146186165|NCT01544582|527193108|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
146186166|NCT01544582|527193109|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
146186167|NCT01544582|527193106|FG000|Analysis Population|Physician Decision|0|||
146186168|NCT01544582|527193107|FG001|Analysis Population|Physician Decision|13|||
146186169|NCT01544582|527193108|FG002|Analysis Population|Physician Decision|10|||
146186170|NCT01544582|527193109|FG003|Analysis Population|Physician Decision|9|||
146284146|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146284147|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
146284148|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
146284149|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146284150|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146284151|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
146284152|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
146284153|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
146284154|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
146284155|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
146284156|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
146284157|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
146284158|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
146284159|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
146284160|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146284161|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146284162|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
146284163|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
146284164|NCT00910689|527553614|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
146284165|NCT00910689|527553615|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
146284166|NCT00910689|527553616|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
146284167|NCT00910689|527553617|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
146284168|NCT00645801|527553618|FG000|Overall Study|unclear if patient took all the medication.|1|||
146284169|NCT00645801|527553619|FG001|Overall Study|unclear if patient took all the medication.|0|||
146284170|NCT00645801|527553618|FG000|Overall Study|Lost to Follow-up|19|||
146284171|NCT00645801|527553619|FG001|Overall Study|Lost to Follow-up|15|||
146284172|NCT00203476|527553620|FG000|Overall Study|Lost to Follow-up|1|||
146284173|NCT00203476|527553621|FG001|Overall Study|Lost to Follow-up|0|||
146284174|NCT00203476|527553622|FG002|Overall Study|Lost to Follow-up|0|||
146284175|NCT00203476|527553620|FG000|Overall Study|Withdrawal by Subject|0|||
146284176|NCT00203476|527553621|FG001|Overall Study|Withdrawal by Subject|1|||
146284177|NCT00203476|527553622|FG002|Overall Study|Withdrawal by Subject|0|||
146284178|NCT01813929|527553624|FG000|Overall Study|Withdrawal by Subject|0|||
146284179|NCT01813929|527553625|FG001|Overall Study|Withdrawal by Subject|1|||
146284180|NCT00007345|527553626|FG000|Overall Study|Refused further treatment|0|||
146284181|NCT00007345|527553627|FG001|Overall Study|Refused further treatment|7|||
146284182|NCT00007345|527553626|FG000|Overall Study|Switched to alternative treatment|0|||
146284183|NCT00007345|527553627|FG001|Overall Study|Switched to alternative treatment|3|||
146284184|NCT00007345|527553626|FG000|Overall Study|Intercurrent illness|1|||
146284185|NCT00007345|527553627|FG001|Overall Study|Intercurrent illness|0|||
146284186|NCT00007345|527553626|FG000|Overall Study|Death on study|1|||
146284187|NCT00007345|527553627|FG001|Overall Study|Death on study|1|||
146284188|NCT04433585|527553628|FG000|Overall Study|Withdrawal by Subject|15|||
146284189|NCT04433585|527553629|FG001|Overall Study|Withdrawal by Subject|3|||
146284190|NCT04433585|527553630|FG002|Overall Study|Withdrawal by Subject|15|||
146284191|NCT04433585|527553631|FG003|Overall Study|Withdrawal by Subject|6|||
146186171|NCT01544582|527193106|FG000|Analysis Population|Safety Reason|0|||
146186172|NCT01544582|527193107|FG001|Analysis Population|Safety Reason|33|||
146186173|NCT01544582|527193108|FG002|Analysis Population|Safety Reason|31|||
146186174|NCT01544582|527193109|FG003|Analysis Population|Safety Reason|8|||
146186175|NCT01544582|527193106|FG000|Analysis Population|Effectiveness Reason|0|||
146284192|NCT04433585|527553628|FG000|Overall Study|Adverse Event|10|||
146284193|NCT04433585|527553629|FG001|Overall Study|Adverse Event|4|||
146284194|NCT04433585|527553630|FG002|Overall Study|Adverse Event|1|||
146284195|NCT04433585|527553631|FG003|Overall Study|Adverse Event|0|||
146284196|NCT04433585|527553628|FG000|Overall Study|Due to the conflict in Ukraine|2|||
146284197|NCT04433585|527553629|FG001|Overall Study|Due to the conflict in Ukraine|1|||
146284198|NCT04433585|527553630|FG002|Overall Study|Due to the conflict in Ukraine|1|||
146284199|NCT04433585|527553631|FG003|Overall Study|Due to the conflict in Ukraine|2|||
146284200|NCT04433585|527553628|FG000|Overall Study|Physician Decision|1|||
146284201|NCT04433585|527553629|FG001|Overall Study|Physician Decision|2|||
146284202|NCT04433585|527553630|FG002|Overall Study|Physician Decision|0|||
146284203|NCT04433585|527553631|FG003|Overall Study|Physician Decision|0|||
146284204|NCT04433585|527553628|FG000|Overall Study|Lost to Follow-up|1|||
146284205|NCT04433585|527553629|FG001|Overall Study|Lost to Follow-up|1|||
146284206|NCT04433585|527553630|FG002|Overall Study|Lost to Follow-up|1|||
146284207|NCT04433585|527553631|FG003|Overall Study|Lost to Follow-up|0|||
146284208|NCT04433585|527553628|FG000|Overall Study|Lack of Efficacy|0|||
146284209|NCT04433585|527553629|FG001|Overall Study|Lack of Efficacy|1|||
146284210|NCT04433585|527553630|FG002|Overall Study|Lack of Efficacy|1|||
146284211|NCT04433585|527553631|FG003|Overall Study|Lack of Efficacy|1|||
146284212|NCT04433585|527553628|FG000|Overall Study|Death|0|||
146284213|NCT04433585|527553629|FG001|Overall Study|Death|1|||
146284214|NCT04433585|527553630|FG002|Overall Study|Death|0|||
146284215|NCT04433585|527553631|FG003|Overall Study|Death|0|||
146284216|NCT00194987|527553632|FG000|Overall Study|Withdrawal by Subject|0|||
146284217|NCT00194987|527553633|FG001|Overall Study|Withdrawal by Subject|3|||
146284218|NCT02342743|527553634|FG000|Baseline Period|Withdrawal by Subject|3|||
146284219|NCT02342743|527553634|FG000|Baseline Period|Lost to Follow-up|2|||
146284220|NCT02342743|527553634|FG000|Baseline Period|Change in prophylactic medication|3|||
146284221|NCT02342743|527553634|FG000|Baseline Period|Screening failure regarding baseline|7|||
146284222|NCT02342743|527553634|FG000|Treatment Period|Withdrawal by Subject|2|||
146284223|NCT02342743|527553634|FG000|Treatment Period|Lost to Follow-up|8|||
146284224|NCT02342743|527553634|FG000|Treatment Period|Change in prophylactic medication|1|||
146284225|NCT00938470|527553637|FG000|Overall Study|Disease Progression|3|||
146284226|NCT00938470|527553638|FG001|Overall Study|Disease Progression|0|||
146284227|NCT00938470|527553637|FG000|Overall Study|Alternate Treatment|1|||
146284228|NCT00938470|527553638|FG001|Overall Study|Alternate Treatment|0|||
146284229|NCT00938470|527553637|FG000|Overall Study|Death|3|||
146284230|NCT00938470|527553638|FG001|Overall Study|Death|2|||
146284231|NCT00938470|527553637|FG000|Overall Study|Other Reason|0|||
146284232|NCT00938470|527553638|FG001|Overall Study|Other Reason|1|||
146284233|NCT01970345|527553639|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146081236|NCT03254108|526818179|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
146081237|NCT03254108|526818180|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
146081238|NCT01771809|526818181|FG000|Overall Study|Adverse Event|4|||
146081239|NCT01771809|526818182|FG001|Overall Study|Adverse Event|12|||
146081240|NCT01771809|526818181|FG000|Overall Study|Protocol Violation|0|||
146081241|NCT01771809|526818182|FG001|Overall Study|Protocol Violation|1|||
146081242|NCT01771809|526818181|FG000|Overall Study|Withdrawal by Subject|34|||
146081243|NCT01771809|526818182|FG001|Overall Study|Withdrawal by Subject|42|||
146081244|NCT01771809|526818181|FG000|Overall Study|Lost to Follow-up|1|||
146081245|NCT01771809|526818182|FG001|Overall Study|Lost to Follow-up|3|||
146081246|NCT01771809|526818181|FG000|Overall Study|Other (Insufficient clinical response)|22|||
146081247|NCT01771809|526818182|FG001|Overall Study|Other (Insufficient clinical response)|20|||
146081248|NCT01771809|526818181|FG000|Overall Study|Death|1|||
146081249|NCT01771809|526818182|FG001|Overall Study|Death|0|||
146081250|NCT01771809|526818181|FG000|Overall Study|Other (other)|9|||
146081251|NCT01771809|526818182|FG001|Overall Study|Other (other)|5|||
146081252|NCT00362180|526818183|FG000|Treated Period|Withdrawal by Subject|1|||
146081253|NCT00362180|526818184|FG001|Treated Period|Withdrawal by Subject|0|||
146081254|NCT00362180|526818185|FG002|Treated Period|Withdrawal by Subject|0|||
146081255|NCT00362180|526818186|FG003|Treated Period|Withdrawal by Subject|0|||
146081256|NCT00362180|526818187|FG004|Treated Period|Withdrawal by Subject|0|||
146081257|NCT00362180|526818188|FG005|Treated Period|Withdrawal by Subject|0|||
146081258|NCT00362180|526818189|FG006|Treated Period|Withdrawal by Subject|0|||
146081259|NCT00362180|526818190|FG007|Treated Period|Withdrawal by Subject|0|||
146081260|NCT00362180|526818191|FG008|Treated Period|Withdrawal by Subject|0|||
146081261|NCT00362180|526818183|FG000|Treated Period|Adverse Event|0|||
146081262|NCT00362180|526818184|FG001|Treated Period|Adverse Event|0|||
146081263|NCT00362180|526818185|FG002|Treated Period|Adverse Event|0|||
146081264|NCT00362180|526818186|FG003|Treated Period|Adverse Event|0|||
146081265|NCT00362180|526818187|FG004|Treated Period|Adverse Event|0|||
146081266|NCT00362180|526818188|FG005|Treated Period|Adverse Event|1|||
146081267|NCT00362180|526818189|FG006|Treated Period|Adverse Event|0|||
146081268|NCT00362180|526818190|FG007|Treated Period|Adverse Event|1|||
146081269|NCT00362180|526818191|FG008|Treated Period|Adverse Event|0|||
146081270|NCT01106092|526818192|FG000|Overall Study|Withdrawal by Subject|0|||
146081271|NCT01106092|526818193|FG001|Overall Study|Withdrawal by Subject|0|||
146081272|NCT01106092|526818194|FG002|Overall Study|Withdrawal by Subject|0|||
146081273|NCT01106092|526818195|FG003|Overall Study|Withdrawal by Subject|1|||
146081274|NCT02434471|526818200|FG000|Overall Study|Physician Decision|9|||
146081275|NCT04839562|526818205|FG000|Overall Study|Withdrawal by Subject|0|||
146081276|NCT04839562|526818206|FG001|Overall Study|Withdrawal by Subject|1|||
146081277|NCT04839562|526818205|FG000|Overall Study|Physician Decision|0|||
146186176|NCT01544582|527193107|FG001|Analysis Population|Effectiveness Reason|48|||
146186177|NCT01544582|527193108|FG002|Analysis Population|Effectiveness Reason|29|||
146186178|NCT01544582|527193109|FG003|Analysis Population|Effectiveness Reason|12|||
146186179|NCT01544582|527193106|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146186180|NCT01544582|527193107|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146186181|NCT01544582|527193108|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
146186182|NCT01544582|527193109|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
146186183|NCT01544582|527193106|FG000|Analysis Population|Lost to Follow-up|0|||
146186184|NCT01544582|527193107|FG001|Analysis Population|Lost to Follow-up|6|||
146412382|NCT02544633|528015503|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
146186185|NCT01544582|527193108|FG002|Analysis Population|Lost to Follow-up|6|||
146186186|NCT01544582|527193109|FG003|Analysis Population|Lost to Follow-up|5|||
146186187|NCT01544582|527193106|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
146186188|NCT01544582|527193107|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
146186189|NCT01544582|527193108|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
146186190|NCT01544582|527193109|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
146186191|NCT01544582|527193106|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146186192|NCT01544582|527193107|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146186193|NCT01544582|527193108|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
146186194|NCT01544582|527193109|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
146186195|NCT01544582|527193106|FG000|Analysis Population|Intolerance|0|||
146186196|NCT01544582|527193107|FG001|Analysis Population|Intolerance|1|||
146186197|NCT01544582|527193108|FG002|Analysis Population|Intolerance|0|||
146186198|NCT01544582|527193109|FG003|Analysis Population|Intolerance|0|||
146186199|NCT01544582|527193106|FG000|Analysis Population|Liver Transplantation|0|||
146186200|NCT01544582|527193107|FG001|Analysis Population|Liver Transplantation|0|||
146186201|NCT01544582|527193108|FG002|Analysis Population|Liver Transplantation|1|||
146186202|NCT01544582|527193109|FG003|Analysis Population|Liver Transplantation|0|||
146186203|NCT01544582|527193106|FG000|Analysis Population|No Social Insurance|0|||
146186204|NCT01544582|527193107|FG001|Analysis Population|No Social Insurance|0|||
146186205|NCT01544582|527193108|FG002|Analysis Population|No Social Insurance|1|||
146186206|NCT01544582|527193109|FG003|Analysis Population|No Social Insurance|0|||
146186207|NCT01544582|527193106|FG000|Analysis Population|Poor Adherence|0|||
146186208|NCT01544582|527193107|FG001|Analysis Population|Poor Adherence|0|||
146186209|NCT01544582|527193108|FG002|Analysis Population|Poor Adherence|1|||
146186210|NCT01544582|527193109|FG003|Analysis Population|Poor Adherence|0|||
146186211|NCT01544582|527193106|FG000|Analysis Population|Poor Participant Compliance|0|||
146186212|NCT01544582|527193107|FG001|Analysis Population|Poor Participant Compliance|1|||
146186213|NCT01544582|527193108|FG002|Analysis Population|Poor Participant Compliance|0|||
146186214|NCT01544582|527193109|FG003|Analysis Population|Poor Participant Compliance|0|||
146186215|NCT01544582|527193106|FG000|Analysis Population|Programmed Surgery|0|||
146186216|NCT01544582|527193107|FG001|Analysis Population|Programmed Surgery|1|||
146186217|NCT01544582|527193108|FG002|Analysis Population|Programmed Surgery|0|||
146186218|NCT01544582|527193109|FG003|Analysis Population|Programmed Surgery|0|||
146186219|NCT01544582|527193106|FG000|Analysis Population|Participant in Jail|0|||
146186220|NCT01544582|527193107|FG001|Analysis Population|Participant in Jail|0|||
146186221|NCT01544582|527193108|FG002|Analysis Population|Participant in Jail|1|||
146186222|NCT01544582|527193109|FG003|Analysis Population|Participant in Jail|0|||
146186223|NCT00245011|527193110|FG000|Overall Study|Lack of Efficacy|1|||
146186224|NCT03040687|527193117|FG000|Overall Study|Withdrawal by Subject|1|||
146186225|NCT03040687|527193118|FG001|Overall Study|Withdrawal by Subject|0|||
146186226|NCT03040687|527193119|FG002|Overall Study|Withdrawal by Subject|0|||
146186227|NCT03317379|527193120|FG000|Overall Study|Lost to Follow-up|0|||
146186228|NCT03317379|527193121|FG001|Overall Study|Lost to Follow-up|3|||
146186229|NCT03317379|527193122|FG002|Overall Study|Lost to Follow-up|2|||
146186230|NCT00550173|527193123|FG000|Overall Study|Death|45|||
146186231|NCT00550173|527193124|FG001|Overall Study|Death|38|||
146186232|NCT00550173|527193125|FG002|Overall Study|Death|50|||
146186233|NCT00550173|527193123|FG000|Overall Study|Physician Decision|1|||
146186234|NCT00550173|527193124|FG001|Overall Study|Physician Decision|2|||
146186235|NCT00550173|527193125|FG002|Overall Study|Physician Decision|2|||
146186236|NCT00550173|527193123|FG000|Overall Study|Withdrawal by Subject|9|||
146186237|NCT00550173|527193124|FG001|Overall Study|Withdrawal by Subject|12|||
146186238|NCT00550173|527193125|FG002|Overall Study|Withdrawal by Subject|17|||
146186239|NCT00550173|527193123|FG000|Overall Study|Sponsor Decision|13|||
146186240|NCT00550173|527193124|FG001|Overall Study|Sponsor Decision|7|||
146186241|NCT00550173|527193125|FG002|Overall Study|Sponsor Decision|1|||
146186242|NCT00550173|527193123|FG000|Overall Study|Lost to Follow-up|4|||
146186243|NCT00550173|527193124|FG001|Overall Study|Lost to Follow-up|4|||
146186244|NCT00550173|527193125|FG002|Overall Study|Lost to Follow-up|3|||
146186245|NCT00810641|527193134|FG000|Overall Study|Withdrawal by Subject|0|||
146186246|NCT00810641|527193135|FG001|Overall Study|Withdrawal by Subject|1|||
146284234|NCT01970345|527553640|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146186247|NCT00810641|527193136|FG002|Overall Study|Withdrawal by Subject|2|||
146186248|NCT01556243|527193137|FG000|Overall Study|Ineligible|34|||
146186249|NCT01556243|527193137|FG000|Overall Study|Converted to mastectomy|14|||
146412383|NCT02544633|528015504|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
146284235|NCT01970345|527553639|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
146284236|NCT01970345|527553640|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
146284237|NCT01346475|527553645|FG000|First Intervention|Lost to Follow-up|4|||
146284238|NCT01346475|527553646|FG001|First Intervention|Lost to Follow-up|3|||
146284239|NCT01552603|527553647|FG000|Overall Study|Physician Decision|1|||
146284240|NCT00618618|527553648|FG000|Overall Study|Patient Request|0|||
146284241|NCT00618618|527553649|FG001|Overall Study|Patient Request|0|||
146284242|NCT00618618|527553650|FG002|Overall Study|Patient Request|2|||
146284243|NCT00618618|527553651|FG003|Overall Study|Patient Request|0|||
146284244|NCT00618618|527553648|FG000|Overall Study|Inability to Complete Study Procedures|0|||
146284245|NCT00618618|527553649|FG001|Overall Study|Inability to Complete Study Procedures|1|||
146284246|NCT00618618|527553650|FG002|Overall Study|Inability to Complete Study Procedures|0|||
146284247|NCT00618618|527553651|FG003|Overall Study|Inability to Complete Study Procedures|0|||
146284248|NCT00618618|527553648|FG000|Overall Study|Lost to Follow-up|3|||
146284249|NCT00618618|527553649|FG001|Overall Study|Lost to Follow-up|0|||
146284250|NCT00618618|527553650|FG002|Overall Study|Lost to Follow-up|0|||
146284251|NCT00618618|527553651|FG003|Overall Study|Lost to Follow-up|1|||
146284252|NCT00618618|527553648|FG000|Overall Study|Non-compliance|1|||
146284253|NCT00618618|527553649|FG001|Overall Study|Non-compliance|1|||
146284254|NCT00618618|527553650|FG002|Overall Study|Non-compliance|0|||
146284255|NCT00618618|527553651|FG003|Overall Study|Non-compliance|0|||
146284256|NCT00618618|527553648|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
146284257|NCT00618618|527553649|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
146284258|NCT00618618|527553650|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
146284259|NCT00618618|527553651|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
146284260|NCT00618618|527553648|FG000|Overall Study|Death|0|||
146284261|NCT00618618|527553649|FG001|Overall Study|Death|1|||
146284262|NCT00618618|527553650|FG002|Overall Study|Death|0|||
146186250|NCT01556243|527193137|FG000|Overall Study|Unable to achieve negative margins|2|||
146186251|NCT01556243|527193137|FG000|Overall Study|Withdrawal by Subject|16|||
146186252|NCT01388543|527193138|FG000|Day 14|Adverse Event|1|||
146186253|NCT01388543|527193139|FG001|Day 14|Adverse Event|4|||
146186254|NCT02325713|527193142|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146284263|NCT00618618|527553651|FG003|Overall Study|Death|0|||
146186255|NCT02325713|527193143|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186256|NCT02325713|527193144|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186257|NCT02325713|527193145|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146284264|NCT04797650|527553657|FG000|Overall Study|Reason Not Specified|5|||
146284265|NCT04797650|527553658|FG001|Overall Study|Reason Not Specified|12|||
146186258|NCT02325713|527193146|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146284266|NCT04797650|527553659|FG002|Overall Study|Reason Not Specified|5|||
146284267|NCT04797650|527553657|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
146284268|NCT04797650|527553658|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
146284269|NCT04797650|527553659|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
146284270|NCT04797650|527553657|FG000|Overall Study|Lack of Efficacy|1|||
146284271|NCT04797650|527553658|FG001|Overall Study|Lack of Efficacy|0|||
146284272|NCT04797650|527553659|FG002|Overall Study|Lack of Efficacy|1|||
146284273|NCT04797650|527553657|FG000|Overall Study|Non-compliance with Study Drug|0|||
146284274|NCT04797650|527553658|FG001|Overall Study|Non-compliance with Study Drug|0|||
146284275|NCT04797650|527553659|FG002|Overall Study|Non-compliance with Study Drug|2|||
146284276|NCT04797650|527553657|FG000|Overall Study|Lost to Follow-up|4|||
146284277|NCT04797650|527553658|FG001|Overall Study|Lost to Follow-up|6|||
146284278|NCT04797650|527553659|FG002|Overall Study|Lost to Follow-up|1|||
146284279|NCT01183234|527553662|FG000|First Intervention|Adverse Event|1|||
146284280|NCT01183234|527553663|FG001|First Intervention|Adverse Event|0|||
146284281|NCT00473265|527553668|FG000|Overall Study|Unrelated adverse event|5|||
146284282|NCT00473265|527553668|FG000|Overall Study|Off treatment early|15|||
146284283|NCT01156792|527553671|FG000|Overall Study|Adverse Event|1|||
146284284|NCT01156792|527553671|FG000|Overall Study|Lack of Efficacy|36|||
146284285|NCT01156792|527553671|FG000|Overall Study|Protocol Violation|6|||
146284286|NCT01156792|527553671|FG000|Overall Study|Lost to Follow-up|3|||
146284287|NCT01156792|527553671|FG000|Overall Study|Physician Decision|3|||
146284288|NCT01156792|527553671|FG000|Overall Study|Withdrawal by Subject|9|||
146284289|NCT01156792|527553671|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
146284290|NCT01097707|527553672|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146284291|NCT01097707|527553673|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146284292|NCT01097707|527553674|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146186259|NCT02325713|527193147|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186260|NCT02325713|527193148|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186261|NCT02325713|527193149|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186262|NCT02325713|527193150|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186263|NCT02325713|527193151|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186264|NCT02325713|527193152|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
146186265|NCT02325713|527193153|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146284293|NCT01097707|527553675|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146284294|NCT01097707|527553676|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146284295|NCT01097707|527553672|FG000|Overall Study|Adverse Event|4|||
146284296|NCT01097707|527553673|FG001|Overall Study|Adverse Event|2|||
146284297|NCT01097707|527553674|FG002|Overall Study|Adverse Event|3|||
146284298|NCT01097707|527553675|FG003|Overall Study|Adverse Event|1|||
146284299|NCT01097707|527553676|FG004|Overall Study|Adverse Event|3|||
146284300|NCT01097707|527553672|FG000|Overall Study|Entry Criteria Not Met|2|||
146284301|NCT01097707|527553673|FG001|Overall Study|Entry Criteria Not Met|1|||
146284302|NCT01097707|527553674|FG002|Overall Study|Entry Criteria Not Met|1|||
146284303|NCT01097707|527553675|FG003|Overall Study|Entry Criteria Not Met|0|||
146284304|NCT01097707|527553676|FG004|Overall Study|Entry Criteria Not Met|1|||
146284305|NCT01097707|527553672|FG000|Overall Study|Lack of Efficacy|1|||
146284306|NCT01097707|527553673|FG001|Overall Study|Lack of Efficacy|0|||
146284307|NCT01097707|527553674|FG002|Overall Study|Lack of Efficacy|0|||
146284308|NCT01097707|527553675|FG003|Overall Study|Lack of Efficacy|1|||
146284309|NCT01097707|527553676|FG004|Overall Study|Lack of Efficacy|0|||
146284310|NCT01097707|527553672|FG000|Overall Study|Lost to Follow-up|1|||
146284311|NCT01097707|527553673|FG001|Overall Study|Lost to Follow-up|1|||
146284312|NCT01097707|527553674|FG002|Overall Study|Lost to Follow-up|2|||
146284313|NCT01097707|527553675|FG003|Overall Study|Lost to Follow-up|0|||
146284314|NCT01097707|527553676|FG004|Overall Study|Lost to Follow-up|3|||
146284315|NCT01097707|527553672|FG000|Overall Study|Protocol Violation|2|||
146284316|NCT01097707|527553673|FG001|Overall Study|Protocol Violation|2|||
146284317|NCT01097707|527553674|FG002|Overall Study|Protocol Violation|3|||
146284318|NCT01097707|527553675|FG003|Overall Study|Protocol Violation|2|||
146284319|NCT01097707|527553676|FG004|Overall Study|Protocol Violation|2|||
146284320|NCT01097707|527553672|FG000|Overall Study|Sponsor Decision|31|||
146284321|NCT01097707|527553673|FG001|Overall Study|Sponsor Decision|31|||
146284322|NCT01097707|527553674|FG002|Overall Study|Sponsor Decision|34|||
146284323|NCT01097707|527553675|FG003|Overall Study|Sponsor Decision|35|||
146284324|NCT01097707|527553676|FG004|Overall Study|Sponsor Decision|36|||
146284325|NCT01097707|527553672|FG000|Overall Study|Withdrawal by Subject|3|||
146284326|NCT01097707|527553673|FG001|Overall Study|Withdrawal by Subject|6|||
146186266|NCT02325713|527193154|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146284327|NCT01097707|527553674|FG002|Overall Study|Withdrawal by Subject|1|||
146284328|NCT01097707|527553675|FG003|Overall Study|Withdrawal by Subject|4|||
146186267|NCT02325713|527193155|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186268|NCT02325713|527193156|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186269|NCT02325713|527193157|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
146186270|NCT02325713|527193142|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
146186271|NCT02325713|527193143|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186272|NCT02325713|527193144|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186273|NCT02325713|527193145|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186274|NCT02325713|527193146|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186275|NCT02325713|527193147|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186276|NCT02325713|527193148|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186277|NCT02325713|527193149|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186278|NCT02325713|527193150|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186279|NCT02325713|527193151|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186280|NCT02325713|527193152|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186281|NCT02325713|527193153|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186282|NCT02325713|527193154|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186283|NCT02325713|527193155|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186284|NCT02325713|527193156|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186285|NCT02325713|527193157|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
146186286|NCT02325713|527193142|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186287|NCT02325713|527193143|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146234946|NCT02347332|527378426|FG000|Overall Study|Lost to Follow-up|2|||
146234947|NCT02347332|527378427|FG001|Overall Study|Lost to Follow-up|1|||
146234948|NCT02347332|527378426|FG000|Overall Study|Physician Decision|4|||
146234949|NCT02347332|527378427|FG001|Overall Study|Physician Decision|3|||
146234950|NCT02347332|527378426|FG000|Overall Study|Withdrawal by Subject|20|||
146234951|NCT02347332|527378427|FG001|Overall Study|Withdrawal by Subject|14|||
146234952|NCT02347332|527378426|FG000|Overall Study|Protocol requirement|1|||
146234953|NCT02347332|527378427|FG001|Overall Study|Protocol requirement|1|||
146234954|NCT02347332|527378426|FG000|Overall Study|Switch Post-Trial program|0|||
146234955|NCT02347332|527378427|FG001|Overall Study|Switch Post-Trial program|1|||
146234956|NCT01478594|527378429|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
146234957|NCT01478594|527378430|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
146234958|NCT01478594|527378429|FG000|Overall Study|Death|45|||
146234959|NCT01478594|527378430|FG001|Overall Study|Death|18|||
146234960|NCT01478594|527378429|FG000|Overall Study|Lost to Follow-up|3|||
146234961|NCT01478594|527378430|FG001|Overall Study|Lost to Follow-up|1|||
146234962|NCT01478594|527378429|FG000|Overall Study|Withdrawal by Subject|9|||
146234963|NCT01478594|527378430|FG001|Overall Study|Withdrawal by Subject|3|||
146234964|NCT01478594|527378429|FG000|Overall Study|Study Closed by Sponsor|8|||
146234965|NCT01478594|527378430|FG001|Overall Study|Study Closed by Sponsor|5|||
146234966|NCT01313884|527378432|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
146234967|NCT01970007|527378433|FG000|Overall Study|Death|5|||
146234968|NCT01970007|527378433|FG000|Overall Study|Withdrawal by Subject|23|||
146234969|NCT01970007|527378433|FG000|Overall Study|Lost to Follow-up|24|||
146234970|NCT01970007|527378433|FG000|Overall Study|"Other endpoint"|3|||
146234971|NCT02854436|527378434|FG000|Overall Study|Adverse Event|1|||
146234972|NCT02854436|527378434|FG000|Overall Study|Death|208|||
146234973|NCT02854436|527378434|FG000|Overall Study|Lost to Follow-up|5|||
146234974|NCT02854436|527378434|FG000|Overall Study|Withdrawal by Subject|24|||
146234975|NCT02854436|527378434|FG000|Overall Study|Other|45|||
146234976|NCT02854436|527378434|FG000|Overall Study|Physician Decision|6|||
146234977|NCT04250194|527378435|FG000|Overall Study|Declined to schedule biopsy|6|||
146234978|NCT04250194|527378436|FG001|Overall Study|Declined to schedule biopsy|10|||
146234979|NCT04250194|527378435|FG000|Overall Study|Medically Unfit for Biopsy|2|||
146234980|NCT04250194|527378436|FG001|Overall Study|Medically Unfit for Biopsy|1|||
146234981|NCT04250194|527378435|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
146234982|NCT04250194|527378436|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
146234983|NCT04250194|527378435|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
146234984|NCT04250194|527378436|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
146234985|NCT04250194|527378435|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
146234986|NCT04250194|527378436|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
146234987|NCT01499849|527378439|FG000|Overall Study|Adverse Event|28|||
146234988|NCT01499849|527378440|FG001|Overall Study|Adverse Event|32|||
146234989|NCT01499849|527378439|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
146234990|NCT01499849|527378440|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
146234991|NCT01499849|527378439|FG000|Overall Study|Withdrawal by Subject|43|||
146234992|NCT01499849|527378440|FG001|Overall Study|Withdrawal by Subject|43|||
146186288|NCT02325713|527193144|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186289|NCT02325713|527193145|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186290|NCT02325713|527193146|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146081278|NCT04839562|526818206|FG001|Overall Study|Physician Decision|1|||
146081279|NCT00003472|526818212|FG000|Overall Study|Not evaluable|3|||
146081280|NCT01012219|526818213|FG000|Period 1|Withdrawal by Subject|1|||
146081281|NCT01012219|526818213|FG000|Period 2|Withdrawal by Subject|1|||
146081282|NCT01444092|526818218|FG000|Overall Study|Adverse Event|8|||
146081283|NCT01444092|526818218|FG000|Overall Study|Protocol Violation|1|||
146081284|NCT01444092|526818218|FG000|Overall Study|Withdrawal by Subject|1|||
146081285|NCT01444092|526818218|FG000|Overall Study|Other Eligibility criteria|7|||
146081286|NCT01328366|526818221|FG000|Overall Study|Death|1|||
146081287|NCT01328366|526818221|FG000|Overall Study|Withdrawal by Subject|2|||
146081288|NCT01328366|526818221|FG000|Overall Study|Lost to Follow-up|7|||
146081289|NCT03005873|526818222|FG000|Overall Study|Prohibited medication use post radnomization|1|||
146081290|NCT03005873|526818223|FG001|Overall Study|Prohibited medication use post radnomization|1|||
146081291|NCT03005873|526818224|FG002|Overall Study|Prohibited medication use post radnomization|1|||
146081292|NCT03005873|526818222|FG000|Overall Study|Withdrew consent|0|||
146081293|NCT03005873|526818223|FG001|Overall Study|Withdrew consent|1|||
146081294|NCT03005873|526818224|FG002|Overall Study|Withdrew consent|2|||
146081295|NCT03005873|526818222|FG000|Overall Study|Lost to Follow-up|0|||
146081296|NCT03005873|526818223|FG001|Overall Study|Lost to Follow-up|1|||
146081297|NCT03005873|526818224|FG002|Overall Study|Lost to Follow-up|0|||
146081298|NCT03005873|526818222|FG000|Overall Study|Ineligible post randomization|0|||
146081299|NCT03005873|526818223|FG001|Overall Study|Ineligible post randomization|0|||
146081300|NCT03005873|526818224|FG002|Overall Study|Ineligible post randomization|1|||
146081301|NCT04585009|526818225|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
146081302|NCT04585009|526818226|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081303|NCT04585009|526818227|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081304|NCT04585009|526818228|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081305|NCT04585009|526818229|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081306|NCT04585009|526818230|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081307|NCT04585009|526818231|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146186291|NCT02325713|527193147|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186292|NCT02325713|527193148|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186293|NCT02325713|527193149|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186294|NCT02325713|527193150|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186295|NCT02325713|527193151|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
146186296|NCT02325713|527193152|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186297|NCT02325713|527193153|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186298|NCT02325713|527193154|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186299|NCT02325713|527193155|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186300|NCT02325713|527193156|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186301|NCT02325713|527193157|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
146186302|NCT01213173|527193158|FG000|Overall Study|Protocol Violation|2|||
146186303|NCT01213173|527193159|FG001|Overall Study|Protocol Violation|0|||
146186304|NCT01213173|527193158|FG000|Overall Study|Adverse Event|4|||
146186305|NCT01213173|527193159|FG001|Overall Study|Adverse Event|8|||
146186306|NCT01213173|527193158|FG000|Overall Study|Withdrawal by Subject|5|||
146186307|NCT01213173|527193159|FG001|Overall Study|Withdrawal by Subject|5|||
146186308|NCT01213173|527193158|FG000|Overall Study|Incorrect Enrollment|1|||
146186309|NCT01213173|527193159|FG001|Overall Study|Incorrect Enrollment|3|||
146186310|NCT02253316|527193160|FG000|Consolidation|Progression|4|||
146186311|NCT02253316|527193161|FG001|Consolidation|Progression|0|||
146186312|NCT02253316|527193162|FG002|Consolidation|Progression|0|||
146186313|NCT02253316|527193160|FG000|Consolidation|Non-Compliance|1|||
146186314|NCT02253316|527193161|FG001|Consolidation|Non-Compliance|0|||
146186315|NCT02253316|527193162|FG002|Consolidation|Non-Compliance|0|||
146186316|NCT02253316|527193160|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
146186317|NCT02253316|527193161|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
146186318|NCT02253316|527193162|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
146186319|NCT02253316|527193160|FG000|Consolidation|Secondary Malignancy|2|||
146186320|NCT02253316|527193161|FG001|Consolidation|Secondary Malignancy|0|||
146186321|NCT02253316|527193162|FG002|Consolidation|Secondary Malignancy|0|||
146186322|NCT02253316|527193160|FG000|Consolidation|Adverse Event|7|||
146186323|NCT02253316|527193161|FG001|Consolidation|Adverse Event|0|||
146186324|NCT02253316|527193162|FG002|Consolidation|Adverse Event|0|||
146186325|NCT02253316|527193160|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
146186326|NCT02253316|527193161|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
146081308|NCT04585009|526818232|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081309|NCT04585009|526818233|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146186327|NCT02253316|527193162|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
146186328|NCT02253316|527193160|FG000|Maintenance|Physician Decision|0|||
146186329|NCT02253316|527193161|FG001|Maintenance|Physician Decision|7|||
146186330|NCT02253316|527193162|FG002|Maintenance|Physician Decision|16|||
146186331|NCT02253316|527193160|FG000|Maintenance|Non-Compliance|0|||
146186332|NCT02253316|527193161|FG001|Maintenance|Non-Compliance|1|||
146186333|NCT02253316|527193162|FG002|Maintenance|Non-Compliance|1|||
146186334|NCT02253316|527193160|FG000|Maintenance|Secondary Malignancy|0|||
146186335|NCT02253316|527193161|FG001|Maintenance|Secondary Malignancy|2|||
146186336|NCT02253316|527193162|FG002|Maintenance|Secondary Malignancy|6|||
146186337|NCT02253316|527193160|FG000|Maintenance|Adverse Event|0|||
146186338|NCT02253316|527193161|FG001|Maintenance|Adverse Event|8|||
146186339|NCT02253316|527193162|FG002|Maintenance|Adverse Event|12|||
146186340|NCT02253316|527193160|FG000|Maintenance|Still receiving active treatment|0|||
146186341|NCT02253316|527193161|FG001|Maintenance|Still receiving active treatment|4|||
146186342|NCT02253316|527193162|FG002|Maintenance|Still receiving active treatment|0|||
146186343|NCT02353832|527193163|FG000|Overall Study|Ineligible after enrollment|1|||
146186344|NCT02353832|527193163|FG000|Overall Study|Lost to Follow-up|1|||
146186345|NCT02684903|527193164|FG000|Overall Study|COVID-19 shutdown of lab|4|||
146186346|NCT02684903|527193165|FG001|Overall Study|COVID-19 shutdown of lab|6|||
146186347|NCT02684903|527193164|FG000|Overall Study|Lost to Follow-up|31|||
146186348|NCT02684903|527193165|FG001|Overall Study|Lost to Follow-up|41|||
146186349|NCT01950390|527193170|FG000|Overall Study|Never started treatment|3|||
146186350|NCT01950390|527193171|FG001|Overall Study|Never started treatment|2|||
146186351|NCT01950390|527193170|FG000|Overall Study|Disease progression|45|||
146186352|NCT01950390|527193171|FG001|Overall Study|Disease progression|52|||
146186353|NCT01950390|527193170|FG000|Overall Study|Adverse Event|22|||
146186354|NCT01950390|527193171|FG001|Overall Study|Adverse Event|16|||
146186355|NCT01950390|527193170|FG000|Overall Study|Death|5|||
146186356|NCT01950390|527193171|FG001|Overall Study|Death|3|||
146186357|NCT01950390|527193170|FG000|Overall Study|Withdrawal by Subject|5|||
146186358|NCT01950390|527193171|FG001|Overall Study|Withdrawal by Subject|1|||
146186359|NCT01950390|527193170|FG000|Overall Study|Alternative therapy|0|||
146186360|NCT01950390|527193171|FG001|Overall Study|Alternative therapy|3|||
146186361|NCT01950390|527193170|FG000|Overall Study|Complicating disease|1|||
146186362|NCT01950390|527193171|FG001|Overall Study|Complicating disease|0|||
146186363|NCT01950390|527193170|FG000|Overall Study|On treatment|1|||
146186364|NCT01950390|527193171|FG001|Overall Study|On treatment|0|||
146186365|NCT01950390|527193170|FG000|Overall Study|Symptomatic deterioration|2|||
146186366|NCT01950390|527193171|FG001|Overall Study|Symptomatic deterioration|1|||
146186367|NCT01950390|527193170|FG000|Overall Study|Physician Decision|0|||
146186368|NCT01950390|527193171|FG001|Overall Study|Physician Decision|4|||
146186369|NCT01950390|527193170|FG000|Overall Study|Lack of clinical benefit|0|||
146186370|NCT01950390|527193171|FG001|Overall Study|Lack of clinical benefit|1|||
146186371|NCT01950390|527193170|FG000|Overall Study|Maintained PR and moved to observation only|0|||
146186372|NCT01950390|527193171|FG001|Overall Study|Maintained PR and moved to observation only|1|||
146186373|NCT03280563|527194953|FG000|Stage 1|Death|2|||
146186374|NCT03280563|527194954|FG001|Stage 1|Death|1|||
146186375|NCT03280563|527194955|FG002|Stage 1|Death|0|||
146186376|NCT03280563|527194956|FG003|Stage 1|Death|0|||
146186377|NCT03280563|527194957|FG004|Stage 1|Death|0|||
146186378|NCT03280563|527194958|FG005|Stage 1|Death|3|||
146186379|NCT03280563|527194959|FG006|Stage 1|Death|0|||
146186380|NCT03280563|527194960|FG007|Stage 1|Death|0|||
146186381|NCT03280563|527194961|FG008|Stage 1|Death|0|||
146186382|NCT03280563|527194953|FG000|Stage 1|Study Ended by Sponsor|0|||
146186383|NCT03280563|527194954|FG001|Stage 1|Study Ended by Sponsor|0|||
146186384|NCT03280563|527194955|FG002|Stage 1|Study Ended by Sponsor|1|||
146186385|NCT03280563|527194956|FG003|Stage 1|Study Ended by Sponsor|0|||
146186386|NCT03280563|527194957|FG004|Stage 1|Study Ended by Sponsor|0|||
146186387|NCT03280563|527194958|FG005|Stage 1|Study Ended by Sponsor|1|||
146186388|NCT03280563|527194959|FG006|Stage 1|Study Ended by Sponsor|0|||
146186389|NCT03280563|527194960|FG007|Stage 1|Study Ended by Sponsor|0|||
146186390|NCT03280563|527194961|FG008|Stage 1|Study Ended by Sponsor|0|||
146186391|NCT03280563|527194953|FG000|Stage 1|Withdrawal by Subject|5|||
146186392|NCT03280563|527194954|FG001|Stage 1|Withdrawal by Subject|1|||
146186393|NCT03280563|527194955|FG002|Stage 1|Withdrawal by Subject|2|||
146186394|NCT03280563|527194956|FG003|Stage 1|Withdrawal by Subject|0|||
146186395|NCT03280563|527194957|FG004|Stage 1|Withdrawal by Subject|0|||
146186396|NCT03280563|527194958|FG005|Stage 1|Withdrawal by Subject|2|||
146284329|NCT01097707|527553676|FG004|Overall Study|Withdrawal by Subject|3|||
146186397|NCT03280563|527194959|FG006|Stage 1|Withdrawal by Subject|0|||
146186398|NCT03280563|527194960|FG007|Stage 1|Withdrawal by Subject|0|||
146186399|NCT03280563|527194961|FG008|Stage 1|Withdrawal by Subject|0|||
146186400|NCT03280563|527194953|FG000|Stage 1|Reason Not Specified|0|||
146186401|NCT03280563|527194954|FG001|Stage 1|Reason Not Specified|0|||
146186402|NCT03280563|527194955|FG002|Stage 1|Reason Not Specified|0|||
146186403|NCT03280563|527194956|FG003|Stage 1|Reason Not Specified|0|||
146186404|NCT03280563|527194957|FG004|Stage 1|Reason Not Specified|0|||
146186405|NCT03280563|527194958|FG005|Stage 1|Reason Not Specified|1|||
146186406|NCT03280563|527194959|FG006|Stage 1|Reason Not Specified|0|||
146284330|NCT01097707|527553672|FG000|Overall Study|Reason unknown|0|||
146284331|NCT01097707|527553673|FG001|Overall Study|Reason unknown|0|||
146284332|NCT01097707|527553674|FG002|Overall Study|Reason unknown|0|||
146284333|NCT01097707|527553675|FG003|Overall Study|Reason unknown|0|||
146284334|NCT01097707|527553676|FG004|Overall Study|Reason unknown|1|||
146284335|NCT01236534|527553679|FG000|Overall Study|Adverse Event|3|||
146284336|NCT01236534|527553680|FG001|Overall Study|Adverse Event|0|||
146284337|NCT01844687|527553681|FG000|Visit 1|Protocol Violation|3|||
146284338|NCT01844687|527553681|FG000|Visit 1|Lost to Follow-up|5|||
146284339|NCT01844687|527553681|FG000|Visit 2|Withdrawal by Subject|1|||
146284340|NCT01844687|527553681|FG000|Visit 2|Protocol Violation|1|||
146284341|NCT01844687|527553681|FG000|Visit 3|Lost to Follow-up|1|||
146284342|NCT01844687|527553681|FG000|Visit 3|Withdrawal by Subject|3|||
146284343|NCT01844687|527553681|FG000|Visit 3|child care problems|1|||
146284344|NCT01844687|527553681|FG000|Visit 4|Pregnancy|1|||
146284345|NCT01844687|527553681|FG000|Visit 4|Lost to Follow-up|1|||
146284346|NCT01844687|527553681|FG000|Visit 4|Withdrawal by Subject|2|||
146284347|NCT00938860|527553692|FG000|Overall Study|Adverse Event|2|||
146284348|NCT00938860|527553693|FG001|Overall Study|Adverse Event|1|||
146284349|NCT00938860|527553692|FG000|Overall Study|Abnormal laboratory values|2|||
146284350|NCT00938860|527553693|FG001|Overall Study|Abnormal laboratory values|2|||
146284351|NCT00938860|527553692|FG000|Overall Study|Withdrawal by Subject|11|||
146284352|NCT00938860|527553693|FG001|Overall Study|Withdrawal by Subject|8|||
146284353|NCT00938860|527553692|FG000|Overall Study|Lost to Follow-up|4|||
146284354|NCT00938860|527553693|FG001|Overall Study|Lost to Follow-up|4|||
146284355|NCT00938860|527553692|FG000|Overall Study|Administration problems|2|||
146284356|NCT00938860|527553693|FG001|Overall Study|Administration problems|0|||
146284357|NCT00938860|527553692|FG000|Overall Study|Death|1|||
146284358|NCT00938860|527553693|FG001|Overall Study|Death|1|||
146284359|NCT00938860|527553692|FG000|Overall Study|Protocol Violation|3|||
146284360|NCT00938860|527553693|FG001|Overall Study|Protocol Violation|1|||
146284361|NCT01605019|527553694|FG000|Overall Study|pt did not meet transplant endpoint|3|||
146284362|NCT01605019|527553695|FG001|Overall Study|pt did not meet transplant endpoint|0|||
146284363|NCT00324116|527553699|FG000|Overall Study|Adverse Event|5|||
146284364|NCT00324116|527553699|FG000|Overall Study|Lack of Efficacy|17|||
146284365|NCT00324116|527553699|FG000|Overall Study|Withdrawal by Subject|5|||
146284366|NCT00324116|527553699|FG000|Overall Study|Other|5|||
146284367|NCT02971761|527553700|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
146284368|NCT02624791|527553701|FG000|Overall Study|Withdrawal by Subject|2|||
146284369|NCT02624791|527553702|FG001|Overall Study|Withdrawal by Subject|0|||
146284370|NCT02624791|527553703|FG002|Overall Study|Withdrawal by Subject|0|||
146284371|NCT02624791|527553704|FG003|Overall Study|Withdrawal by Subject|0|||
146284372|NCT02624791|527553705|FG004|Overall Study|Withdrawal by Subject|0|||
146284373|NCT02624791|527553706|FG005|Overall Study|Withdrawal by Subject|0|||
146284374|NCT01642251|527553707|FG000|Overall Study|Progressive disease|0|||
146284375|NCT01642251|527553708|FG001|Overall Study|Progressive disease|0|||
146284376|NCT01642251|527553709|FG002|Overall Study|Progressive disease|3|||
146284377|NCT01642251|527553710|FG003|Overall Study|Progressive disease|3|||
146284378|NCT01642251|527553707|FG000|Overall Study|Adverse Event|0|||
146284379|NCT01642251|527553708|FG001|Overall Study|Adverse Event|0|||
146284380|NCT01642251|527553709|FG002|Overall Study|Adverse Event|5|||
146284381|NCT01642251|527553710|FG003|Overall Study|Adverse Event|4|||
146284382|NCT01642251|527553707|FG000|Overall Study|Death|0|||
146284383|NCT01642251|527553708|FG001|Overall Study|Death|0|||
146284384|NCT01642251|527553709|FG002|Overall Study|Death|1|||
146284385|NCT01642251|527553710|FG003|Overall Study|Death|3|||
146284386|NCT01642251|527553707|FG000|Overall Study|Withdrawal by Subject|0|||
146284387|NCT01642251|527553708|FG001|Overall Study|Withdrawal by Subject|0|||
146284388|NCT01642251|527553709|FG002|Overall Study|Withdrawal by Subject|1|||
146284389|NCT01642251|527553710|FG003|Overall Study|Withdrawal by Subject|3|||
146284390|NCT01642251|527553707|FG000|Overall Study|Alternative therapy|0|||
146284391|NCT01642251|527553708|FG001|Overall Study|Alternative therapy|0|||
146284392|NCT01642251|527553709|FG002|Overall Study|Alternative therapy|0|||
146284393|NCT01642251|527553710|FG003|Overall Study|Alternative therapy|2|||
146284394|NCT01642251|527553707|FG000|Overall Study|Other complicating disease|0|||
146284395|NCT01642251|527553708|FG001|Overall Study|Other complicating disease|0|||
146284396|NCT01642251|527553709|FG002|Overall Study|Other complicating disease|1|||
146284397|NCT01642251|527553710|FG003|Overall Study|Other complicating disease|0|||
146284398|NCT01642251|527553707|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
146284399|NCT01642251|527553708|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
146284400|NCT01642251|527553709|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
146284401|NCT01642251|527553710|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
146284402|NCT02414932|527553712|FG000|Overall Study|Withdrawal by Subject|2|||
146284403|NCT02414932|527553713|FG001|Overall Study|Withdrawal by Subject|3|||
146284404|NCT02414932|527553712|FG000|Overall Study|Adverse Event|1|||
146284405|NCT02414932|527553713|FG001|Overall Study|Adverse Event|0|||
146284406|NCT00540046|527553714|FG000|Overall Study|Lost to Follow-up|33|||
146284407|NCT00540046|527553715|FG001|Overall Study|Lost to Follow-up|23|||
146284408|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
146284409|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
146186407|NCT03280563|527194960|FG007|Stage 1|Reason Not Specified|0|||
146186408|NCT03280563|527194961|FG008|Stage 1|Reason Not Specified|0|||
146284410|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
146284411|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
146284412|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
146284413|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
146284414|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
146284415|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
146284416|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
146284417|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
146284418|NCT01237587|527553716|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
146284419|NCT01237587|527553717|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
146284420|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
146284421|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
146284422|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
146284423|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
146284424|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
146284425|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
146284426|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
146284427|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
146186409|NCT03280563|527194953|FG000|Stage 1|Physician Decision|0|||
146186410|NCT03280563|527194954|FG001|Stage 1|Physician Decision|1|||
146186411|NCT03280563|527194955|FG002|Stage 1|Physician Decision|0|||
146186412|NCT03280563|527194956|FG003|Stage 1|Physician Decision|0|||
146186413|NCT03280563|527194957|FG004|Stage 1|Physician Decision|0|||
146186414|NCT03280563|527194958|FG005|Stage 1|Physician Decision|0|||
146186415|NCT03280563|527194959|FG006|Stage 1|Physician Decision|0|||
146186416|NCT03280563|527194960|FG007|Stage 1|Physician Decision|0|||
146186417|NCT03280563|527194961|FG008|Stage 1|Physician Decision|0|||
146186418|NCT03280563|527194953|FG000|Stage 2|Death|0|||
146186419|NCT03280563|527194954|FG001|Stage 2|Death|0|||
146186420|NCT03280563|527194955|FG002|Stage 2|Death|0|||
146186421|NCT03280563|527194956|FG003|Stage 2|Death|0|||
146186422|NCT03280563|527194957|FG004|Stage 2|Death|0|||
146284428|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
146186423|NCT03280563|527194958|FG005|Stage 2|Death|0|||
146186424|NCT03280563|527194959|FG006|Stage 2|Death|0|||
146186425|NCT03280563|527194960|FG007|Stage 2|Death|1|||
146186426|NCT03280563|527194961|FG008|Stage 2|Death|0|||
146284429|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
146284430|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
146284431|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
146284432|NCT01237587|527553716|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
146284433|NCT01237587|527553717|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
146284434|NCT01237587|527553716|FG000|Taper Phase|Adverse Event|0|||
146284435|NCT01237587|527553717|FG001|Taper Phase|Adverse Event|2|||
146284436|NCT01237587|527553716|FG000|Taper Phase|Protocol Violation|2|||
146284437|NCT01237587|527553717|FG001|Taper Phase|Protocol Violation|0|||
146284438|NCT01237587|527553716|FG000|Taper Phase|Lack of Efficacy|2|||
146284439|NCT01237587|527553717|FG001|Taper Phase|Lack of Efficacy|5|||
146284440|NCT01237587|527553716|FG000|Taper Phase|Parent/Guardian Decision|0|||
146186427|NCT03280563|527194953|FG000|Stage 2|Progressive Disease|0|||
146186428|NCT03280563|527194954|FG001|Stage 2|Progressive Disease|0|||
146186429|NCT03280563|527194955|FG002|Stage 2|Progressive Disease|0|||
146186430|NCT03280563|527194956|FG003|Stage 2|Progressive Disease|0|||
146284441|NCT01237587|527553717|FG001|Taper Phase|Parent/Guardian Decision|2|||
146284442|NCT01237587|527553716|FG000|Taper Phase|Sponsor Decision|1|||
146284443|NCT01237587|527553717|FG001|Taper Phase|Sponsor Decision|0|||
146284444|NCT01237587|527553716|FG000|Taper Phase|Withdrawal by Subject|0|||
146186431|NCT03280563|527194957|FG004|Stage 2|Progressive Disease|0|||
146186432|NCT03280563|527194958|FG005|Stage 2|Progressive Disease|0|||
146284445|NCT01237587|527553717|FG001|Taper Phase|Withdrawal by Subject|1|||
146284446|NCT01226095|527553718|FG000|Overall Study|Poor compliance|1|||
146284447|NCT01688830|527553719|FG000|Overall Study|Lost to Follow-up|0|||
146284448|NCT01688830|527553720|FG001|Overall Study|Lost to Follow-up|0|||
146284449|NCT01688830|527553721|FG002|Overall Study|Lost to Follow-up|0|||
146284450|NCT01688830|527553722|FG003|Overall Study|Lost to Follow-up|0|||
146412384|NCT02544633|528015505|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
146186433|NCT03280563|527194959|FG006|Stage 2|Progressive Disease|2|||
146186434|NCT03280563|527194960|FG007|Stage 2|Progressive Disease|0|||
146186435|NCT03280563|527194961|FG008|Stage 2|Progressive Disease|0|||
146186436|NCT03280563|527194953|FG000|Long-term Survival Follow-up|Death|10|||
146186437|NCT03280563|527194954|FG001|Long-term Survival Follow-up|Death|14|||
146186438|NCT03280563|527194955|FG002|Long-term Survival Follow-up|Death|15|||
146186439|NCT03280563|527194956|FG003|Long-term Survival Follow-up|Death|3|||
146186440|NCT03280563|527194957|FG004|Long-term Survival Follow-up|Death|6|||
146186441|NCT03280563|527194958|FG005|Long-term Survival Follow-up|Death|18|||
146186442|NCT03280563|527194959|FG006|Long-term Survival Follow-up|Death|11|||
146186443|NCT03280563|527194960|FG007|Long-term Survival Follow-up|Death|1|||
146186444|NCT03280563|527194961|FG008|Long-term Survival Follow-up|Death|3|||
146186445|NCT03280563|527194953|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
146186446|NCT03280563|527194954|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
146186447|NCT03280563|527194955|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
146186448|NCT03280563|527194956|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146186449|NCT03280563|527194957|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146186450|NCT03280563|527194958|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
146186451|NCT03280563|527194959|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146186452|NCT03280563|527194960|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
146186453|NCT03280563|527194961|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
146186454|NCT03280563|527194953|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146186455|NCT03280563|527194954|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146186456|NCT03280563|527194955|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146186457|NCT03280563|527194956|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146186458|NCT03280563|527194957|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
146186459|NCT03280563|527194958|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146186460|NCT03280563|527194959|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146186461|NCT03280563|527194960|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146186462|NCT03280563|527194961|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
146186463|NCT03280563|527194953|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
146186464|NCT03280563|527194954|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
146186465|NCT03280563|527194955|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
146186466|NCT03280563|527194956|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
146186467|NCT03280563|527194957|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
146186468|NCT03280563|527194958|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
146186469|NCT03280563|527194959|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
146186470|NCT03280563|527194960|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
146186471|NCT03280563|527194961|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
146186472|NCT00731042|527194962|FG000|Second Intervention|Did not meet inclusion criteria|0|||
146186473|NCT00731042|527194963|FG001|Second Intervention|Did not meet inclusion criteria|2|||
146186474|NCT04213846|527194964|FG000|Overall Study|Withdrawal by Subject|7|||
146186475|NCT04213846|527194965|FG001|Overall Study|Withdrawal by Subject|6|||
146186476|NCT04213846|527194964|FG000|Overall Study|Lost to Follow-up|15|||
146186477|NCT04213846|527194965|FG001|Overall Study|Lost to Follow-up|21|||
146186478|NCT00802841|527194974|FG000|Overall Study|Administrative problems|1|||
146186479|NCT00802841|527194975|FG001|Overall Study|Administrative problems|0|||
146186480|NCT00802841|527194974|FG000|Overall Study|Lost to Follow-up|2|||
146186481|NCT00802841|527194975|FG001|Overall Study|Lost to Follow-up|1|||
146186482|NCT00802841|527194974|FG000|Overall Study|Death|1|||
146186483|NCT00802841|527194975|FG001|Overall Study|Death|2|||
146186484|NCT00802841|527194974|FG000|Overall Study|Adverse Event|8|||
146186485|NCT00802841|527194975|FG001|Overall Study|Adverse Event|2|||
146186486|NCT00802841|527194974|FG000|Overall Study|Disease progression|7|||
146186487|NCT00802841|527194975|FG001|Overall Study|Disease progression|3|||
146186488|NCT00802841|527194974|FG000|Overall Study|Withdrawal by Subject|9|||
146186489|NCT00802841|527194975|FG001|Overall Study|Withdrawal by Subject|5|||
146186490|NCT00802841|527194974|FG000|Overall Study|Protocol deviation|2|||
146186491|NCT00802841|527194975|FG001|Overall Study|Protocol deviation|6|||
146186492|NCT00802841|527194974|FG000|Overall Study|Treatment duration completed|66|||
146186493|NCT00802841|527194975|FG001|Overall Study|Treatment duration completed|76|||
146186494|NCT00432159|527194978|FG000|Overall Study|Death|0|||
146186495|NCT00432159|527194979|FG001|Overall Study|Death|1|||
146186496|NCT00432159|527194980|FG002|Overall Study|Death|0|||
146186497|NCT00432159|527194981|FG003|Overall Study|Death|0|||
146186498|NCT00432159|527194982|FG004|Overall Study|Death|0|||
146186499|NCT00432159|527194978|FG000|Overall Study|Failure|9|||
146186500|NCT00432159|527194979|FG001|Overall Study|Failure|5|||
146284451|NCT01688830|527553723|FG004|Overall Study|Lost to Follow-up|0|||
146081310|NCT04585009|526818234|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081311|NCT04585009|526818235|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081312|NCT04585009|526818236|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
146081313|NCT04585009|526818225|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
146081314|NCT04585009|526818226|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081315|NCT04585009|526818227|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081316|NCT04585009|526818228|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081317|NCT04585009|526818229|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146284452|NCT01688830|527553724|FG005|Overall Study|Lost to Follow-up|0|||
146186501|NCT00432159|527194980|FG002|Overall Study|Failure|3|||
146186502|NCT00432159|527194981|FG003|Overall Study|Failure|2|||
146186503|NCT00432159|527194982|FG004|Overall Study|Failure|3|||
146186504|NCT00432159|527194978|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
146186505|NCT00432159|527194979|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
146186506|NCT00432159|527194980|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
146186507|NCT00432159|527194981|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
146186508|NCT00432159|527194982|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
146186509|NCT04096365|527194984|FG000|Overall Study|Adverse Event|1|||
146186510|NCT01939158|527194987|FG000|Overall Study|Adverse Event|1|||
146186511|NCT01939158|527194988|FG001|Overall Study|Adverse Event|0|||
146186512|NCT01939158|527194989|FG002|Overall Study|Adverse Event|0|||
146186513|NCT01939158|527194990|FG003|Overall Study|Adverse Event|0|||
146186514|NCT01939158|527194987|FG000|Overall Study|Withdrawal by Subject|22|||
146186515|NCT01939158|527194988|FG001|Overall Study|Withdrawal by Subject|25|||
146186516|NCT01939158|527194989|FG002|Overall Study|Withdrawal by Subject|15|||
146186517|NCT01939158|527194990|FG003|Overall Study|Withdrawal by Subject|17|||
146186518|NCT01939158|527194987|FG000|Overall Study|Migrated/moved from study area|5|||
146186519|NCT01939158|527194988|FG001|Overall Study|Migrated/moved from study area|7|||
146186520|NCT01939158|527194989|FG002|Overall Study|Migrated/moved from study area|3|||
146186521|NCT01939158|527194990|FG003|Overall Study|Migrated/moved from study area|6|||
146186522|NCT01939158|527194987|FG000|Overall Study|Lost to Follow-up|18|||
146186523|NCT01939158|527194988|FG001|Overall Study|Lost to Follow-up|17|||
146186524|NCT01939158|527194989|FG002|Overall Study|Lost to Follow-up|17|||
146186525|NCT01939158|527194990|FG003|Overall Study|Lost to Follow-up|17|||
146186526|NCT01939158|527194987|FG000|Overall Study|Death|0|||
146186527|NCT01939158|527194988|FG001|Overall Study|Death|0|||
146186528|NCT01939158|527194989|FG002|Overall Study|Death|1|||
146186529|NCT01939158|527194990|FG003|Overall Study|Death|1|||
146186530|NCT01939158|527194987|FG000|Overall Study|No longer meets eligibility criteria|0|||
146186531|NCT01939158|527194988|FG001|Overall Study|No longer meets eligibility criteria|0|||
146186532|NCT01939158|527194989|FG002|Overall Study|No longer meets eligibility criteria|1|||
146186533|NCT01939158|527194990|FG003|Overall Study|No longer meets eligibility criteria|0|||
146186534|NCT01939158|527194987|FG000|Overall Study|Other|1|||
146186535|NCT01939158|527194988|FG001|Overall Study|Other|3|||
146186536|NCT01939158|527194989|FG002|Overall Study|Other|4|||
146186537|NCT01939158|527194990|FG003|Overall Study|Other|3|||
146186538|NCT05310084|527194991|FG000|Overall Study|Withdrawal by Subject|2|||
146186539|NCT05310084|527194992|FG001|Overall Study|Withdrawal by Subject|3|||
146186540|NCT05310084|527194991|FG000|Overall Study|Participant availability|0|||
146186541|NCT05310084|527194992|FG001|Overall Study|Participant availability|4|||
146186542|NCT05310084|527194991|FG000|Overall Study|Lost to Follow-up|1|||
146186543|NCT05310084|527194992|FG001|Overall Study|Lost to Follow-up|1|||
146186544|NCT05310084|527194991|FG000|Overall Study|Adverse Event|1|||
146186545|NCT05310084|527194992|FG001|Overall Study|Adverse Event|1|||
146186546|NCT05310084|527194991|FG000|Overall Study|Randomized but not vaccinated|4|||
146186547|NCT05310084|527194992|FG001|Overall Study|Randomized but not vaccinated|2|||
146186548|NCT02065245|527194994|FG000|Infusion 1|Lost to Follow-up|0|||
146186549|NCT02065245|527194995|FG001|Infusion 1|Lost to Follow-up|0|||
146186550|NCT02065245|527194996|FG002|Infusion 1|Lost to Follow-up|0|||
146186551|NCT02065245|527194997|FG003|Infusion 1|Lost to Follow-up|0|||
146186552|NCT02065245|527194998|FG004|Infusion 1|Lost to Follow-up|0|||
146186553|NCT02065245|527194999|FG005|Infusion 1|Lost to Follow-up|0|||
146186554|NCT02065245|527195000|FG006|Infusion 1|Lost to Follow-up|1|||
146186555|NCT02065245|527194994|FG000|Infusion 1|Death|0|||
146186556|NCT02065245|527194995|FG001|Infusion 1|Death|0|||
146186557|NCT02065245|527194996|FG002|Infusion 1|Death|1|||
146186558|NCT02065245|527194997|FG003|Infusion 1|Death|0|||
146186559|NCT02065245|527194998|FG004|Infusion 1|Death|1|||
146186560|NCT02065245|527194999|FG005|Infusion 1|Death|0|||
146186561|NCT02065245|527195000|FG006|Infusion 1|Death|0|||
146186562|NCT02065245|527194994|FG000|Infusion 2|Death|0|||
146186563|NCT02065245|527194995|FG001|Infusion 2|Death|0|||
146186564|NCT02065245|527194996|FG002|Infusion 2|Death|0|||
146186565|NCT02065245|527194997|FG003|Infusion 2|Death|0|||
146186566|NCT02065245|527194998|FG004|Infusion 2|Death|0|||
146186567|NCT02065245|527194999|FG005|Infusion 2|Death|0|||
146186568|NCT02065245|527195000|FG006|Infusion 2|Death|1|||
146186569|NCT02065245|527194994|FG000|Infusion 3|Lost to Follow-up|1|||
146186570|NCT02065245|527194995|FG001|Infusion 3|Lost to Follow-up|1|||
146186571|NCT02065245|527194996|FG002|Infusion 3|Lost to Follow-up|0|||
146186572|NCT02065245|527194997|FG003|Infusion 3|Lost to Follow-up|0|||
146186573|NCT02065245|527194998|FG004|Infusion 3|Lost to Follow-up|0|||
146186574|NCT02065245|527194999|FG005|Infusion 3|Lost to Follow-up|0|||
146186575|NCT02065245|527195000|FG006|Infusion 3|Lost to Follow-up|0|||
146186576|NCT01518257|527195001|FG000|Overall Study|Lost to Follow-up|1|||
146186577|NCT01518257|527195002|FG001|Overall Study|Lost to Follow-up|0|||
146186578|NCT01518257|527195001|FG000|Overall Study|Other Miscellaneous Reason|1|||
146186579|NCT01518257|527195002|FG001|Overall Study|Other Miscellaneous Reason|0|||
146186580|NCT02107274|527195003|FG000|Treatment vs. Placebo|Adverse Event|3|||
146186581|NCT02107274|527195004|FG001|Treatment vs. Placebo|Adverse Event|0|||
146186582|NCT02107274|527195003|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
146186583|NCT02107274|527195004|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
146186584|NCT02107274|527195003|FG000|Control Phase|Lost to Follow-up|1|||
146186585|NCT02107274|527195004|FG001|Control Phase|Lost to Follow-up|1|||
146186586|NCT02107274|527195003|FG000|Control Phase|Death|2|||
146186587|NCT02107274|527195004|FG001|Control Phase|Death|0|||
146186588|NCT02107274|527195003|FG000|Control Phase|Adverse Event|0|||
146186589|NCT02107274|527195004|FG001|Control Phase|Adverse Event|1|||
146186590|NCT03158948|527195008|FG000|Overall Study|Death|1|||
146186591|NCT03158948|527195009|FG001|Overall Study|Death|1|||
146186592|NCT03158948|527195010|FG002|Overall Study|Death|3|||
146186593|NCT03158948|527195011|FG003|Overall Study|Death|2|||
146186594|NCT03158948|527195008|FG000|Overall Study|Physician Decision|0|||
146186595|NCT03158948|527195009|FG001|Overall Study|Physician Decision|0|||
146186596|NCT03158948|527195010|FG002|Overall Study|Physician Decision|0|||
146186597|NCT03158948|527195011|FG003|Overall Study|Physician Decision|1|||
146186598|NCT04730947|527195012|FG000|Overall Study|Withdrawal by Subject|0|||
146186599|NCT04730947|527195013|FG001|Overall Study|Withdrawal by Subject|1|||
146186600|NCT03527277|527195014|FG000|Overall Study|Withdrawal by Subject|5|||
146186601|NCT03527277|527195015|FG001|Overall Study|Withdrawal by Subject|0|||
146186602|NCT03527277|527195014|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
146186603|NCT03527277|527195015|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
146081318|NCT04585009|526818230|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081319|NCT04585009|526818231|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081320|NCT04585009|526818232|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081321|NCT04585009|526818233|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081322|NCT04585009|526818234|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081323|NCT04585009|526818235|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081324|NCT04585009|526818236|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
146081325|NCT04585009|526818225|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081326|NCT04585009|526818226|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081327|NCT04585009|526818227|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081328|NCT04585009|526818228|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081329|NCT04585009|526818229|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081330|NCT04585009|526818230|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081331|NCT04585009|526818231|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081332|NCT04585009|526818232|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
146081333|NCT04585009|526818233|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146186604|NCT03527277|527195014|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
146186605|NCT03527277|527195015|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
146186606|NCT00354029|527195018|FG000|Overall Study|Protocol Violation|4|||
146186607|NCT00354029|527195019|FG001|Overall Study|Protocol Violation|2|||
146186608|NCT01021332|527195020|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
146186609|NCT01021332|527195020|FG000|Overall Study|Adverse Event|43|||
146186610|NCT01021332|527195020|FG000|Overall Study|Lack of Efficacy|19|||
146186611|NCT01021332|527195020|FG000|Overall Study|Withdrawal of Consent|23|||
146186612|NCT01021332|527195020|FG000|Overall Study|Lost to Follow-up|4|||
146186613|NCT01021332|527195020|FG000|Overall Study|Protocol Violation|9|||
146186614|NCT01021332|527195020|FG000|Overall Study|Miscellaneous|3|||
146186615|NCT03930186|527195021|FG000|Weeks 0 to 16|Adverse Event|6|||
146186616|NCT03930186|527195021|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
146186617|NCT03930186|527195021|FG000|Weeks 16 to 32|Adverse Event|1|||
146186618|NCT03930186|527195021|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
146186619|NCT01782326|527195031|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
146186620|NCT01782326|527195032|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
146186621|NCT01782326|527195031|FG000|Planned Treatment Epoch|Death|29|||
146186622|NCT01782326|527195032|FG001|Planned Treatment Epoch|Death|30|||
146186623|NCT01782326|527195031|FG000|Planned Treatment Epoch|Physician Decision|18|||
146186624|NCT01782326|527195032|FG001|Planned Treatment Epoch|Physician Decision|16|||
146186625|NCT01782326|527195031|FG000|Planned Treatment Epoch|Protocol deviation|2|||
146186626|NCT01782326|527195032|FG001|Planned Treatment Epoch|Protocol deviation|3|||
146186627|NCT01782326|527195031|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
146186628|NCT01782326|527195032|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
146186629|NCT01782326|527195031|FG000|Planned Treatment Epoch|Technical problems|0|||
146186630|NCT01782326|527195032|FG001|Planned Treatment Epoch|Technical problems|4|||
146186631|NCT01782326|527195031|FG000|Double-blind Treatment|Adverse Event|129|||
146186632|NCT01782326|527195032|FG001|Double-blind Treatment|Adverse Event|145|||
146186633|NCT01782326|527195031|FG000|Double-blind Treatment|Subject/guardian decision|111|||
146186634|NCT01782326|527195032|FG001|Double-blind Treatment|Subject/guardian decision|125|||
146186635|NCT01782326|527195031|FG000|Double-blind Treatment|Lack of Efficacy|17|||
146186636|NCT01782326|527195032|FG001|Double-blind Treatment|Lack of Efficacy|22|||
146186637|NCT01782326|527195031|FG000|Double-blind Treatment|Physician Decision|13|||
146186638|NCT01782326|527195032|FG001|Double-blind Treatment|Physician Decision|16|||
146186639|NCT01782326|527195031|FG000|Double-blind Treatment|Protocol deviation|8|||
146186640|NCT01782326|527195032|FG001|Double-blind Treatment|Protocol deviation|7|||
146186641|NCT01782326|527195031|FG000|Double-blind Treatment|Technical problems|0|||
146186642|NCT01782326|527195032|FG001|Double-blind Treatment|Technical problems|5|||
146186643|NCT02559817|527195033|FG000|Treatment Period|Adverse Event|1|||
146186644|NCT02559817|527195034|FG001|Treatment Period|Adverse Event|0|||
146186645|NCT02559817|527195035|FG002|Treatment Period|Adverse Event|1|||
146186646|NCT02559817|527195036|FG003|Treatment Period|Adverse Event|0|||
146186647|NCT02559817|527195037|FG004|Treatment Period|Adverse Event|0|||
146186648|NCT02559817|527195033|FG000|Treatment Period|Lack of Efficacy|0|||
146186649|NCT02559817|527195034|FG001|Treatment Period|Lack of Efficacy|1|||
146186650|NCT02559817|527195035|FG002|Treatment Period|Lack of Efficacy|0|||
146186651|NCT02559817|527195036|FG003|Treatment Period|Lack of Efficacy|0|||
146186652|NCT02559817|527195037|FG004|Treatment Period|Lack of Efficacy|0|||
146186653|NCT02559817|527195033|FG000|Treatment Period|Lost to Follow-up|0|||
146186654|NCT02559817|527195034|FG001|Treatment Period|Lost to Follow-up|1|||
146186655|NCT02559817|527195035|FG002|Treatment Period|Lost to Follow-up|0|||
146186656|NCT02559817|527195036|FG003|Treatment Period|Lost to Follow-up|1|||
146186657|NCT02559817|527195037|FG004|Treatment Period|Lost to Follow-up|0|||
146186658|NCT02559817|527195033|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
146186659|NCT02559817|527195034|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
146186660|NCT02559817|527195035|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
146186661|NCT02559817|527195036|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
146186662|NCT02559817|527195037|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
146186663|NCT02559817|527195033|FG000|Treatment Period|Protocol Violation|0|||
146186664|NCT02559817|527195034|FG001|Treatment Period|Protocol Violation|0|||
146186665|NCT02559817|527195035|FG002|Treatment Period|Protocol Violation|0|||
146186666|NCT02559817|527195036|FG003|Treatment Period|Protocol Violation|1|||
146186667|NCT02559817|527195037|FG004|Treatment Period|Protocol Violation|0|||
146186668|NCT03389893|527195038|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
146186669|NCT03389893|527195039|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
146186670|NCT03389893|527195040|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
146186671|NCT03389893|527195041|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
146186672|NCT03389893|527195038|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
146186673|NCT03389893|527195039|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
146186674|NCT03389893|527195040|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
146186675|NCT03389893|527195041|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
146081334|NCT04585009|526818234|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081335|NCT04585009|526818235|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081336|NCT04585009|526818236|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
146081337|NCT04585009|526818225|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081338|NCT04585009|526818226|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081339|NCT04585009|526818227|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081340|NCT04585009|526818228|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146186676|NCT03389893|527195038|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
146186677|NCT03389893|527195039|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
146186678|NCT03389893|527195040|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
146186679|NCT03389893|527195041|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
146186680|NCT03389893|527195038|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
146186681|NCT03389893|527195039|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
146186682|NCT03389893|527195040|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
146186683|NCT03389893|527195041|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
146186684|NCT03160079|527195044|FG000|Overall Study|Adverse Event|2|||
146186685|NCT03160079|527195045|FG001|Overall Study|Adverse Event|0|||
146186686|NCT03160079|527195044|FG000|Overall Study|Disease Progression|1|||
146186687|NCT03160079|527195045|FG001|Overall Study|Disease Progression|0|||
146186688|NCT03160079|527195044|FG000|Overall Study|Physician Decision|1|||
146186689|NCT03160079|527195045|FG001|Overall Study|Physician Decision|0|||
146186690|NCT04955626|527195055|FG000|Blinded Period|Lost to Follow-up|28|||
146186691|NCT04955626|527195056|FG001|Blinded Period|Lost to Follow-up|28|||
146186692|NCT04955626|527195057|FG002|Blinded Period|Lost to Follow-up|7|||
146186693|NCT04955626|527195058|FG003|Blinded Period|Lost to Follow-up|14|||
146186694|NCT04955626|527195059|FG004|Blinded Period|Lost to Follow-up|3|||
146186695|NCT04955626|527195060|FG005|Blinded Period|Lost to Follow-up|2|||
146186696|NCT04955626|527195061|FG006|Blinded Period|Lost to Follow-up|6|||
146186697|NCT04955626|527195062|FG007|Blinded Period|Lost to Follow-up|4|||
146186698|NCT04955626|527195063|FG008|Blinded Period|Lost to Follow-up|5|||
146186699|NCT04955626|527195064|FG009|Blinded Period|Lost to Follow-up|8|||
146186700|NCT04955626|527195065|FG010|Blinded Period|Lost to Follow-up|10|||
146186701|NCT04955626|527195066|FG011|Blinded Period|Lost to Follow-up|32|||
146186702|NCT04955626|527195067|FG012|Blinded Period|Lost to Follow-up|0|||
146186703|NCT04955626|527195068|FG013|Blinded Period|Lost to Follow-up|0|||
146186704|NCT04955626|527195069|FG014|Blinded Period|Lost to Follow-up|0|||
146186705|NCT04955626|527195070|FG015|Blinded Period|Lost to Follow-up|12|||
146186706|NCT04955626|527195071|FG016|Blinded Period|Lost to Follow-up|2|||
146186707|NCT04955626|527195072|FG017|Blinded Period|Lost to Follow-up|5|||
146186708|NCT04955626|527195073|FG018|Blinded Period|Lost to Follow-up|0|||
146186709|NCT04955626|527195074|FG019|Blinded Period|Lost to Follow-up|0|||
146186710|NCT04955626|527195075|FG020|Blinded Period|Lost to Follow-up|0|||
146186711|NCT04955626|527195076|FG021|Blinded Period|Lost to Follow-up|0|||
146186712|NCT04955626|527195077|FG022|Blinded Period|Lost to Follow-up|0|||
146186713|NCT04955626|527195078|FG023|Blinded Period|Lost to Follow-up|0|||
146186714|NCT04955626|527195079|FG024|Blinded Period|Lost to Follow-up|3|||
146186715|NCT04955626|527195080|FG025|Blinded Period|Lost to Follow-up|1|||
146186716|NCT04955626|527195081|FG026|Blinded Period|Lost to Follow-up|2|||
146186717|NCT04955626|527195082|FG027|Blinded Period|Lost to Follow-up|2|||
146186718|NCT04955626|527195083|FG028|Blinded Period|Lost to Follow-up|2|||
146186719|NCT04955626|527195084|FG029|Blinded Period|Lost to Follow-up|0|||
146186720|NCT04955626|527195085|FG030|Blinded Period|Lost to Follow-up|0|||
146186721|NCT04955626|527195086|FG031|Blinded Period|Lost to Follow-up|0|||
146186722|NCT04955626|527195087|FG032|Blinded Period|Lost to Follow-up|0|||
146186723|NCT04955626|527195088|FG033|Blinded Period|Lost to Follow-up|0|||
146186724|NCT04955626|527195089|FG034|Blinded Period|Lost to Follow-up|0|||
146186725|NCT04955626|527195090|FG035|Blinded Period|Lost to Follow-up|0|||
146186726|NCT04955626|527195055|FG000|Blinded Period|Protocol Violation|5|||
146186727|NCT04955626|527195056|FG001|Blinded Period|Protocol Violation|14|||
146186728|NCT04955626|527195057|FG002|Blinded Period|Protocol Violation|0|||
146186729|NCT04955626|527195058|FG003|Blinded Period|Protocol Violation|1|||
146186730|NCT04955626|527195059|FG004|Blinded Period|Protocol Violation|2|||
146186731|NCT04955626|527195060|FG005|Blinded Period|Protocol Violation|2|||
146186732|NCT04955626|527195061|FG006|Blinded Period|Protocol Violation|0|||
146186733|NCT04955626|527195062|FG007|Blinded Period|Protocol Violation|0|||
146186734|NCT04955626|527195063|FG008|Blinded Period|Protocol Violation|0|||
146186735|NCT04955626|527195064|FG009|Blinded Period|Protocol Violation|4|||
146186736|NCT04955626|527195065|FG010|Blinded Period|Protocol Violation|6|||
146186737|NCT04955626|527195066|FG011|Blinded Period|Protocol Violation|1|||
146186738|NCT04955626|527195067|FG012|Blinded Period|Protocol Violation|0|||
146186739|NCT04955626|527195068|FG013|Blinded Period|Protocol Violation|0|||
146186740|NCT04955626|527195069|FG014|Blinded Period|Protocol Violation|2|||
146186741|NCT04955626|527195070|FG015|Blinded Period|Protocol Violation|6|||
146186742|NCT04955626|527195071|FG016|Blinded Period|Protocol Violation|4|||
146186743|NCT04955626|527195072|FG017|Blinded Period|Protocol Violation|6|||
146186744|NCT04955626|527195073|FG018|Blinded Period|Protocol Violation|0|||
146186745|NCT04955626|527195074|FG019|Blinded Period|Protocol Violation|1|||
146186746|NCT04955626|527195075|FG020|Blinded Period|Protocol Violation|0|||
146186747|NCT04955626|527195076|FG021|Blinded Period|Protocol Violation|1|||
146186748|NCT04955626|527195077|FG022|Blinded Period|Protocol Violation|0|||
146186749|NCT04955626|527195078|FG023|Blinded Period|Protocol Violation|0|||
146186750|NCT04955626|527195079|FG024|Blinded Period|Protocol Violation|4|||
146186751|NCT04955626|527195080|FG025|Blinded Period|Protocol Violation|6|||
146186752|NCT04955626|527195081|FG026|Blinded Period|Protocol Violation|5|||
146186753|NCT04955626|527195082|FG027|Blinded Period|Protocol Violation|3|||
146186754|NCT04955626|527195083|FG028|Blinded Period|Protocol Violation|4|||
146186755|NCT04955626|527195084|FG029|Blinded Period|Protocol Violation|3|||
146186756|NCT04955626|527195085|FG030|Blinded Period|Protocol Violation|0|||
146081341|NCT04585009|526818229|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
146081342|NCT04585009|526818230|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081343|NCT04585009|526818231|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081344|NCT04585009|526818232|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081345|NCT04585009|526818233|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081346|NCT04585009|526818234|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081347|NCT04585009|526818235|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081348|NCT04585009|526818236|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
146081349|NCT04585009|526818225|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081350|NCT04585009|526818226|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081351|NCT04585009|526818227|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081352|NCT04585009|526818228|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081353|NCT04585009|526818229|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081354|NCT04585009|526818230|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081355|NCT04585009|526818231|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081356|NCT04585009|526818232|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081357|NCT04585009|526818233|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081358|NCT04585009|526818234|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
146081359|NCT04585009|526818235|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081360|NCT04585009|526818236|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
146081361|NCT04585009|526818225|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081362|NCT04585009|526818226|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081363|NCT04585009|526818227|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081364|NCT04585009|526818228|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081365|NCT04585009|526818229|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081366|NCT04585009|526818230|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081367|NCT04585009|526818231|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081368|NCT04585009|526818232|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081369|NCT04585009|526818233|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081370|NCT04585009|526818234|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081371|NCT04585009|526818235|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
146081372|NCT04585009|526818236|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
146081373|NCT01713933|526818237|FG000|Overall Study|Lost to Follow-up|2|||
146081374|NCT01713933|526818237|FG000|Overall Study|Withdrawal by Subject|3|||
146081375|NCT01713933|526818237|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
146081376|NCT01104376|526818244|FG000|Overall Study|Withdrawal by Subject|15|||
146081377|NCT01104376|526818244|FG000|Overall Study|Consented but excluded after labs|13|||
146081378|NCT00797966|526818245|FG000|Phase A|Lost to Follow-up|0|||
146081379|NCT00797966|526818246|FG001|Phase A|Lost to Follow-up|0|||
146081380|NCT00797966|526818247|FG002|Phase A|Lost to Follow-up|0|||
146081381|NCT00797966|526818248|FG003|Phase A|Lost to Follow-up|0|||
146081382|NCT00797966|526818249|FG004|Phase A|Lost to Follow-up|33|||
146081383|NCT00797966|526818250|FG005|Phase A|Lost to Follow-up|0|||
146081384|NCT00797966|526818245|FG000|Phase A|Adverse Event|0|||
146081385|NCT00797966|526818246|FG001|Phase A|Adverse Event|0|||
146081386|NCT00797966|526818247|FG002|Phase A|Adverse Event|0|||
146081387|NCT00797966|526818248|FG003|Phase A|Adverse Event|0|||
146081388|NCT00797966|526818249|FG004|Phase A|Adverse Event|46|||
146081389|NCT00797966|526818250|FG005|Phase A|Adverse Event|0|||
146081390|NCT00797966|526818245|FG000|Phase A|Met withdrawal criteria|0|||
146081391|NCT00797966|526818246|FG001|Phase A|Met withdrawal criteria|0|||
146081392|NCT00797966|526818247|FG002|Phase A|Met withdrawal criteria|0|||
146081393|NCT00797966|526818248|FG003|Phase A|Met withdrawal criteria|0|||
146081394|NCT00797966|526818249|FG004|Phase A|Met withdrawal criteria|4|||
146081395|NCT00797966|526818250|FG005|Phase A|Met withdrawal criteria|0|||
146081396|NCT00797966|526818245|FG000|Phase A|Physician Decision|0|||
146081397|NCT00797966|526818246|FG001|Phase A|Physician Decision|0|||
146081398|NCT00797966|526818247|FG002|Phase A|Physician Decision|0|||
146081399|NCT00797966|526818248|FG003|Phase A|Physician Decision|0|||
146081400|NCT00797966|526818249|FG004|Phase A|Physician Decision|13|||
146081401|NCT00797966|526818250|FG005|Phase A|Physician Decision|0|||
146081402|NCT00797966|526818245|FG000|Phase A|Withdrawal by Subject|0|||
146081403|NCT00797966|526818246|FG001|Phase A|Withdrawal by Subject|0|||
146186757|NCT04955626|527195086|FG031|Blinded Period|Protocol Violation|0|||
146186758|NCT04955626|527195087|FG032|Blinded Period|Protocol Violation|0|||
146186759|NCT04955626|527195088|FG033|Blinded Period|Protocol Violation|0|||
146186760|NCT04955626|527195089|FG034|Blinded Period|Protocol Violation|0|||
146186761|NCT04955626|527195090|FG035|Blinded Period|Protocol Violation|0|||
146186762|NCT04955626|527195055|FG000|Blinded Period|Death|0|||
146186763|NCT04955626|527195056|FG001|Blinded Period|Death|2|||
146186764|NCT04955626|527195057|FG002|Blinded Period|Death|0|||
146186765|NCT04955626|527195058|FG003|Blinded Period|Death|0|||
146186766|NCT04955626|527195059|FG004|Blinded Period|Death|0|||
146186767|NCT04955626|527195060|FG005|Blinded Period|Death|0|||
146186768|NCT04955626|527195061|FG006|Blinded Period|Death|0|||
146186769|NCT04955626|527195062|FG007|Blinded Period|Death|2|||
146186770|NCT04955626|527195063|FG008|Blinded Period|Death|1|||
146186771|NCT04955626|527195064|FG009|Blinded Period|Death|1|||
146186772|NCT04955626|527195065|FG010|Blinded Period|Death|0|||
146186773|NCT04955626|527195066|FG011|Blinded Period|Death|2|||
146186774|NCT04955626|527195067|FG012|Blinded Period|Death|0|||
146186775|NCT04955626|527195068|FG013|Blinded Period|Death|0|||
146186776|NCT04955626|527195069|FG014|Blinded Period|Death|0|||
146186777|NCT04955626|527195070|FG015|Blinded Period|Death|0|||
146186778|NCT04955626|527195071|FG016|Blinded Period|Death|0|||
146186779|NCT04955626|527195072|FG017|Blinded Period|Death|0|||
146186780|NCT04955626|527195073|FG018|Blinded Period|Death|0|||
146186781|NCT04955626|527195074|FG019|Blinded Period|Death|0|||
146186782|NCT04955626|527195075|FG020|Blinded Period|Death|0|||
146186783|NCT04955626|527195076|FG021|Blinded Period|Death|0|||
146186784|NCT04955626|527195077|FG022|Blinded Period|Death|0|||
146186785|NCT04955626|527195078|FG023|Blinded Period|Death|1|||
146186786|NCT04955626|527195079|FG024|Blinded Period|Death|0|||
146186787|NCT04955626|527195080|FG025|Blinded Period|Death|0|||
146186788|NCT04955626|527195081|FG026|Blinded Period|Death|1|||
146186789|NCT04955626|527195082|FG027|Blinded Period|Death|1|||
146186790|NCT04955626|527195083|FG028|Blinded Period|Death|0|||
146186791|NCT04955626|527195084|FG029|Blinded Period|Death|1|||
146186792|NCT04955626|527195085|FG030|Blinded Period|Death|0|||
146186793|NCT04955626|527195086|FG031|Blinded Period|Death|0|||
146186794|NCT04955626|527195087|FG032|Blinded Period|Death|0|||
146186795|NCT04955626|527195088|FG033|Blinded Period|Death|0|||
146186796|NCT04955626|527195089|FG034|Blinded Period|Death|0|||
146186797|NCT04955626|527195090|FG035|Blinded Period|Death|0|||
146186798|NCT04955626|527195055|FG000|Blinded Period|Adverse Event|0|||
146186799|NCT04955626|527195056|FG001|Blinded Period|Adverse Event|1|||
146186800|NCT04955626|527195057|FG002|Blinded Period|Adverse Event|1|||
146186801|NCT04955626|527195058|FG003|Blinded Period|Adverse Event|1|||
146186802|NCT04955626|527195059|FG004|Blinded Period|Adverse Event|0|||
146186803|NCT04955626|527195060|FG005|Blinded Period|Adverse Event|0|||
146186804|NCT04955626|527195061|FG006|Blinded Period|Adverse Event|0|||
146186805|NCT04955626|527195062|FG007|Blinded Period|Adverse Event|0|||
146186806|NCT04955626|527195063|FG008|Blinded Period|Adverse Event|0|||
146186807|NCT04955626|527195064|FG009|Blinded Period|Adverse Event|1|||
146186808|NCT04955626|527195065|FG010|Blinded Period|Adverse Event|1|||
146186809|NCT04955626|527195066|FG011|Blinded Period|Adverse Event|0|||
146186810|NCT04955626|527195067|FG012|Blinded Period|Adverse Event|0|||
146081404|NCT00797966|526818247|FG002|Phase A|Withdrawal by Subject|0|||
146186811|NCT04955626|527195068|FG013|Blinded Period|Adverse Event|0|||
146186812|NCT04955626|527195069|FG014|Blinded Period|Adverse Event|0|||
146081405|NCT00797966|526818248|FG003|Phase A|Withdrawal by Subject|0|||
146081406|NCT00797966|526818249|FG004|Phase A|Withdrawal by Subject|33|||
146081407|NCT00797966|526818250|FG005|Phase A|Withdrawal by Subject|0|||
146081408|NCT00797966|526818245|FG000|Phase A|Protocol deviation|0|||
146081409|NCT00797966|526818246|FG001|Phase A|Protocol deviation|0|||
146081410|NCT00797966|526818247|FG002|Phase A|Protocol deviation|0|||
146081411|NCT00797966|526818248|FG003|Phase A|Protocol deviation|0|||
146081412|NCT00797966|526818249|FG004|Phase A|Protocol deviation|56|||
146081413|NCT00797966|526818250|FG005|Phase A|Protocol deviation|0|||
146081414|NCT00797966|526818245|FG000|Phase B|Lost to Follow-up|0|||
146081415|NCT00797966|526818246|FG001|Phase B|Lost to Follow-up|1|||
146081416|NCT00797966|526818247|FG002|Phase B|Lost to Follow-up|3|||
146081417|NCT00797966|526818248|FG003|Phase B|Lost to Follow-up|0|||
146081418|NCT00797966|526818249|FG004|Phase B|Lost to Follow-up|0|||
146081419|NCT00797966|526818250|FG005|Phase B|Lost to Follow-up|0|||
146186813|NCT04955626|527195070|FG015|Blinded Period|Adverse Event|0|||
146186814|NCT04955626|527195071|FG016|Blinded Period|Adverse Event|0|||
146186815|NCT04955626|527195072|FG017|Blinded Period|Adverse Event|0|||
146186816|NCT04955626|527195073|FG018|Blinded Period|Adverse Event|1|||
146186817|NCT04955626|527195074|FG019|Blinded Period|Adverse Event|0|||
146186818|NCT04955626|527195075|FG020|Blinded Period|Adverse Event|0|||
146186819|NCT04955626|527195076|FG021|Blinded Period|Adverse Event|0|||
146186820|NCT04955626|527195077|FG022|Blinded Period|Adverse Event|0|||
146186821|NCT04955626|527195078|FG023|Blinded Period|Adverse Event|0|||
146186822|NCT04955626|527195079|FG024|Blinded Period|Adverse Event|0|||
146186823|NCT04955626|527195080|FG025|Blinded Period|Adverse Event|0|||
146186824|NCT04955626|527195081|FG026|Blinded Period|Adverse Event|1|||
146186825|NCT04955626|527195082|FG027|Blinded Period|Adverse Event|0|||
146186826|NCT04955626|527195083|FG028|Blinded Period|Adverse Event|0|||
146186827|NCT04955626|527195084|FG029|Blinded Period|Adverse Event|0|||
146186828|NCT04955626|527195085|FG030|Blinded Period|Adverse Event|0|||
146186829|NCT04955626|527195086|FG031|Blinded Period|Adverse Event|0|||
146186830|NCT04955626|527195087|FG032|Blinded Period|Adverse Event|0|||
146186831|NCT04955626|527195088|FG033|Blinded Period|Adverse Event|0|||
146186832|NCT04955626|527195089|FG034|Blinded Period|Adverse Event|0|||
146186833|NCT04955626|527195090|FG035|Blinded Period|Adverse Event|0|||
146186834|NCT04955626|527195055|FG000|Blinded Period|No longer meets eligibility criteria|1|||
146186835|NCT04955626|527195056|FG001|Blinded Period|No longer meets eligibility criteria|2|||
146186836|NCT04955626|527195057|FG002|Blinded Period|No longer meets eligibility criteria|0|||
146186837|NCT04955626|527195058|FG003|Blinded Period|No longer meets eligibility criteria|1|||
146186838|NCT04955626|527195059|FG004|Blinded Period|No longer meets eligibility criteria|0|||
146186839|NCT04955626|527195060|FG005|Blinded Period|No longer meets eligibility criteria|0|||
146186840|NCT04955626|527195061|FG006|Blinded Period|No longer meets eligibility criteria|0|||
146186841|NCT04955626|527195062|FG007|Blinded Period|No longer meets eligibility criteria|0|||
146186842|NCT04955626|527195063|FG008|Blinded Period|No longer meets eligibility criteria|1|||
146186843|NCT04955626|527195064|FG009|Blinded Period|No longer meets eligibility criteria|0|||
146186844|NCT04955626|527195065|FG010|Blinded Period|No longer meets eligibility criteria|1|||
146186845|NCT04955626|527195066|FG011|Blinded Period|No longer meets eligibility criteria|1|||
146186846|NCT04955626|527195067|FG012|Blinded Period|No longer meets eligibility criteria|0|||
146186847|NCT04955626|527195068|FG013|Blinded Period|No longer meets eligibility criteria|0|||
146186848|NCT04955626|527195069|FG014|Blinded Period|No longer meets eligibility criteria|0|||
146186849|NCT04955626|527195070|FG015|Blinded Period|No longer meets eligibility criteria|3|||
146186850|NCT04955626|527195071|FG016|Blinded Period|No longer meets eligibility criteria|0|||
146186851|NCT04955626|527195072|FG017|Blinded Period|No longer meets eligibility criteria|2|||
146186852|NCT04955626|527195073|FG018|Blinded Period|No longer meets eligibility criteria|0|||
146186853|NCT04955626|527195074|FG019|Blinded Period|No longer meets eligibility criteria|0|||
146186854|NCT04955626|527195075|FG020|Blinded Period|No longer meets eligibility criteria|0|||
146186855|NCT04955626|527195076|FG021|Blinded Period|No longer meets eligibility criteria|0|||
146186856|NCT04955626|527195077|FG022|Blinded Period|No longer meets eligibility criteria|0|||
146186857|NCT04955626|527195078|FG023|Blinded Period|No longer meets eligibility criteria|0|||
146186858|NCT04955626|527195079|FG024|Blinded Period|No longer meets eligibility criteria|1|||
146186859|NCT04955626|527195080|FG025|Blinded Period|No longer meets eligibility criteria|0|||
146186860|NCT04955626|527195081|FG026|Blinded Period|No longer meets eligibility criteria|0|||
146186861|NCT04955626|527195082|FG027|Blinded Period|No longer meets eligibility criteria|1|||
146186862|NCT04955626|527195083|FG028|Blinded Period|No longer meets eligibility criteria|0|||
146186863|NCT04955626|527195084|FG029|Blinded Period|No longer meets eligibility criteria|0|||
146186864|NCT04955626|527195085|FG030|Blinded Period|No longer meets eligibility criteria|0|||
146186865|NCT04955626|527195086|FG031|Blinded Period|No longer meets eligibility criteria|0|||
146186866|NCT04955626|527195087|FG032|Blinded Period|No longer meets eligibility criteria|0|||
146186867|NCT04955626|527195088|FG033|Blinded Period|No longer meets eligibility criteria|0|||
146186868|NCT04955626|527195089|FG034|Blinded Period|No longer meets eligibility criteria|0|||
146186869|NCT04955626|527195090|FG035|Blinded Period|No longer meets eligibility criteria|0|||
146186870|NCT04955626|527195055|FG000|Blinded Period|Other|54|||
146186871|NCT04955626|527195056|FG001|Blinded Period|Other|3|||
146186872|NCT04955626|527195057|FG002|Blinded Period|Other|4|||
146186873|NCT04955626|527195058|FG003|Blinded Period|Other|2|||
146186874|NCT04955626|527195059|FG004|Blinded Period|Other|0|||
146186875|NCT04955626|527195060|FG005|Blinded Period|Other|0|||
146186876|NCT04955626|527195061|FG006|Blinded Period|Other|2|||
146186877|NCT04955626|527195062|FG007|Blinded Period|Other|2|||
146186878|NCT04955626|527195063|FG008|Blinded Period|Other|1|||
146186879|NCT04955626|527195064|FG009|Blinded Period|Other|0|||
146186880|NCT04955626|527195065|FG010|Blinded Period|Other|1|||
146186881|NCT04955626|527195066|FG011|Blinded Period|Other|1|||
146186882|NCT04955626|527195067|FG012|Blinded Period|Other|0|||
146186883|NCT04955626|527195068|FG013|Blinded Period|Other|0|||
146186884|NCT04955626|527195069|FG014|Blinded Period|Other|0|||
146186885|NCT04955626|527195070|FG015|Blinded Period|Other|0|||
146186886|NCT04955626|527195071|FG016|Blinded Period|Other|0|||
146186887|NCT04955626|527195072|FG017|Blinded Period|Other|1|||
146186888|NCT04955626|527195073|FG018|Blinded Period|Other|0|||
146186889|NCT04955626|527195074|FG019|Blinded Period|Other|0|||
146186890|NCT04955626|527195075|FG020|Blinded Period|Other|0|||
146186891|NCT04955626|527195076|FG021|Blinded Period|Other|0|||
146186892|NCT04955626|527195077|FG022|Blinded Period|Other|0|||
146186893|NCT04955626|527195078|FG023|Blinded Period|Other|0|||
146186894|NCT04955626|527195079|FG024|Blinded Period|Other|0|||
146186895|NCT04955626|527195080|FG025|Blinded Period|Other|0|||
146186896|NCT04955626|527195081|FG026|Blinded Period|Other|2|||
146186897|NCT04955626|527195082|FG027|Blinded Period|Other|0|||
146186898|NCT04955626|527195083|FG028|Blinded Period|Other|0|||
146186899|NCT04955626|527195084|FG029|Blinded Period|Other|0|||
146186900|NCT04955626|527195085|FG030|Blinded Period|Other|0|||
146186901|NCT04955626|527195086|FG031|Blinded Period|Other|0|||
146186902|NCT04955626|527195087|FG032|Blinded Period|Other|0|||
146186903|NCT04955626|527195088|FG033|Blinded Period|Other|0|||
146186904|NCT04955626|527195089|FG034|Blinded Period|Other|0|||
146186905|NCT04955626|527195090|FG035|Blinded Period|Other|0|||
146186906|NCT04955626|527195055|FG000|Blinded Period|Physician Decision|1|||
146186907|NCT04955626|527195056|FG001|Blinded Period|Physician Decision|1|||
146186908|NCT04955626|527195057|FG002|Blinded Period|Physician Decision|0|||
146186909|NCT04955626|527195058|FG003|Blinded Period|Physician Decision|3|||
146186910|NCT04955626|527195059|FG004|Blinded Period|Physician Decision|0|||
146186911|NCT04955626|527195060|FG005|Blinded Period|Physician Decision|0|||
146186912|NCT04955626|527195061|FG006|Blinded Period|Physician Decision|1|||
146186913|NCT04955626|527195062|FG007|Blinded Period|Physician Decision|1|||
146186914|NCT04955626|527195063|FG008|Blinded Period|Physician Decision|0|||
146186915|NCT04955626|527195064|FG009|Blinded Period|Physician Decision|0|||
146186916|NCT04955626|527195065|FG010|Blinded Period|Physician Decision|0|||
146186917|NCT04955626|527195066|FG011|Blinded Period|Physician Decision|5|||
146186918|NCT04955626|527195067|FG012|Blinded Period|Physician Decision|0|||
146186919|NCT04955626|527195068|FG013|Blinded Period|Physician Decision|0|||
146186920|NCT04955626|527195069|FG014|Blinded Period|Physician Decision|0|||
146186921|NCT04955626|527195070|FG015|Blinded Period|Physician Decision|0|||
146186922|NCT04955626|527195071|FG016|Blinded Period|Physician Decision|0|||
146186923|NCT04955626|527195072|FG017|Blinded Period|Physician Decision|0|||
146186924|NCT04955626|527195073|FG018|Blinded Period|Physician Decision|0|||
146186925|NCT04955626|527195074|FG019|Blinded Period|Physician Decision|0|||
146186926|NCT04955626|527195075|FG020|Blinded Period|Physician Decision|0|||
146186927|NCT04955626|527195076|FG021|Blinded Period|Physician Decision|0|||
146186928|NCT04955626|527195077|FG022|Blinded Period|Physician Decision|0|||
146186929|NCT04955626|527195078|FG023|Blinded Period|Physician Decision|0|||
146186930|NCT04955626|527195079|FG024|Blinded Period|Physician Decision|0|||
146186931|NCT04955626|527195080|FG025|Blinded Period|Physician Decision|0|||
146186932|NCT04955626|527195081|FG026|Blinded Period|Physician Decision|0|||
146186933|NCT04955626|527195082|FG027|Blinded Period|Physician Decision|0|||
146186934|NCT04955626|527195083|FG028|Blinded Period|Physician Decision|0|||
146186935|NCT04955626|527195084|FG029|Blinded Period|Physician Decision|0|||
146186936|NCT04955626|527195085|FG030|Blinded Period|Physician Decision|0|||
146186937|NCT04955626|527195086|FG031|Blinded Period|Physician Decision|0|||
146186938|NCT04955626|527195087|FG032|Blinded Period|Physician Decision|0|||
146186939|NCT04955626|527195088|FG033|Blinded Period|Physician Decision|0|||
146186940|NCT04955626|527195089|FG034|Blinded Period|Physician Decision|0|||
146186941|NCT04955626|527195090|FG035|Blinded Period|Physician Decision|0|||
146186942|NCT04955626|527195055|FG000|Blinded Period|Withdrawal by Subject|26|||
146186943|NCT04955626|527195056|FG001|Blinded Period|Withdrawal by Subject|62|||
146186944|NCT04955626|527195057|FG002|Blinded Period|Withdrawal by Subject|14|||
146186945|NCT04955626|527195058|FG003|Blinded Period|Withdrawal by Subject|16|||
146186946|NCT04955626|527195059|FG004|Blinded Period|Withdrawal by Subject|1|||
146186947|NCT04955626|527195060|FG005|Blinded Period|Withdrawal by Subject|2|||
146186948|NCT04955626|527195061|FG006|Blinded Period|Withdrawal by Subject|9|||
146186949|NCT04955626|527195062|FG007|Blinded Period|Withdrawal by Subject|5|||
146186950|NCT04955626|527195063|FG008|Blinded Period|Withdrawal by Subject|3|||
146186951|NCT04955626|527195064|FG009|Blinded Period|Withdrawal by Subject|15|||
146186952|NCT04955626|527195065|FG010|Blinded Period|Withdrawal by Subject|11|||
146186953|NCT04955626|527195066|FG011|Blinded Period|Withdrawal by Subject|7|||
146186954|NCT04955626|527195067|FG012|Blinded Period|Withdrawal by Subject|2|||
146186955|NCT04955626|527195068|FG013|Blinded Period|Withdrawal by Subject|0|||
146186956|NCT04955626|527195069|FG014|Blinded Period|Withdrawal by Subject|1|||
146186957|NCT04955626|527195070|FG015|Blinded Period|Withdrawal by Subject|11|||
146186958|NCT04955626|527195071|FG016|Blinded Period|Withdrawal by Subject|2|||
146186959|NCT04955626|527195072|FG017|Blinded Period|Withdrawal by Subject|5|||
146186960|NCT04955626|527195073|FG018|Blinded Period|Withdrawal by Subject|0|||
146186961|NCT04955626|527195074|FG019|Blinded Period|Withdrawal by Subject|0|||
146186962|NCT04955626|527195075|FG020|Blinded Period|Withdrawal by Subject|1|||
146186963|NCT04955626|527195076|FG021|Blinded Period|Withdrawal by Subject|0|||
146186964|NCT04955626|527195077|FG022|Blinded Period|Withdrawal by Subject|0|||
146186965|NCT04955626|527195078|FG023|Blinded Period|Withdrawal by Subject|0|||
146186966|NCT04955626|527195079|FG024|Blinded Period|Withdrawal by Subject|5|||
146186967|NCT04955626|527195080|FG025|Blinded Period|Withdrawal by Subject|1|||
146186968|NCT04955626|527195081|FG026|Blinded Period|Withdrawal by Subject|5|||
146186969|NCT04955626|527195082|FG027|Blinded Period|Withdrawal by Subject|1|||
146186970|NCT04955626|527195083|FG028|Blinded Period|Withdrawal by Subject|4|||
146186971|NCT04955626|527195084|FG029|Blinded Period|Withdrawal by Subject|2|||
146186972|NCT04955626|527195085|FG030|Blinded Period|Withdrawal by Subject|0|||
146186973|NCT04955626|527195086|FG031|Blinded Period|Withdrawal by Subject|0|||
146186974|NCT04955626|527195087|FG032|Blinded Period|Withdrawal by Subject|0|||
146186975|NCT04955626|527195088|FG033|Blinded Period|Withdrawal by Subject|0|||
146186976|NCT04955626|527195089|FG034|Blinded Period|Withdrawal by Subject|0|||
146186977|NCT04955626|527195090|FG035|Blinded Period|Withdrawal by Subject|0|||
146186978|NCT04955626|527195055|FG000|Blinded Period|Refused further study procedures|0|||
146186979|NCT04955626|527195056|FG001|Blinded Period|Refused further study procedures|0|||
146186980|NCT04955626|527195057|FG002|Blinded Period|Refused further study procedures|0|||
146186981|NCT04955626|527195058|FG003|Blinded Period|Refused further study procedures|0|||
146186982|NCT04955626|527195059|FG004|Blinded Period|Refused further study procedures|0|||
146081420|NCT00797966|526818245|FG000|Phase B|Adverse Event|2|||
146081421|NCT00797966|526818246|FG001|Phase B|Adverse Event|1|||
146081422|NCT00797966|526818247|FG002|Phase B|Adverse Event|3|||
146081423|NCT00797966|526818248|FG003|Phase B|Adverse Event|1|||
146081424|NCT00797966|526818249|FG004|Phase B|Adverse Event|0|||
146081425|NCT00797966|526818250|FG005|Phase B|Adverse Event|0|||
146081426|NCT00797966|526818245|FG000|Phase B|Met Withdrawal Criteria|3|||
146081427|NCT00797966|526818246|FG001|Phase B|Met Withdrawal Criteria|3|||
146081428|NCT00797966|526818247|FG002|Phase B|Met Withdrawal Criteria|6|||
146081429|NCT00797966|526818248|FG003|Phase B|Met Withdrawal Criteria|1|||
146081430|NCT00797966|526818249|FG004|Phase B|Met Withdrawal Criteria|0|||
146081431|NCT00797966|526818250|FG005|Phase B|Met Withdrawal Criteria|0|||
146081432|NCT00797966|526818245|FG000|Phase B|Physician Decision|1|||
146081433|NCT00797966|526818246|FG001|Phase B|Physician Decision|0|||
146081434|NCT00797966|526818247|FG002|Phase B|Physician Decision|3|||
146081435|NCT00797966|526818248|FG003|Phase B|Physician Decision|1|||
146081436|NCT00797966|526818249|FG004|Phase B|Physician Decision|0|||
146081437|NCT00797966|526818250|FG005|Phase B|Physician Decision|0|||
146081438|NCT00797966|526818245|FG000|Phase B|Withdrawal by Subject|1|||
146081439|NCT00797966|526818246|FG001|Phase B|Withdrawal by Subject|4|||
146081440|NCT00797966|526818247|FG002|Phase B|Withdrawal by Subject|3|||
146081441|NCT00797966|526818248|FG003|Phase B|Withdrawal by Subject|3|||
146081442|NCT00797966|526818249|FG004|Phase B|Withdrawal by Subject|0|||
146081443|NCT00797966|526818250|FG005|Phase B|Withdrawal by Subject|0|||
146081444|NCT00797966|526818245|FG000|Phase B|Protocol Deviation|4|||
146081445|NCT00797966|526818246|FG001|Phase B|Protocol Deviation|8|||
146081446|NCT00797966|526818247|FG002|Phase B|Protocol Deviation|2|||
146081447|NCT00797966|526818248|FG003|Phase B|Protocol Deviation|6|||
146081448|NCT00797966|526818249|FG004|Phase B|Protocol Deviation|0|||
146081449|NCT00797966|526818250|FG005|Phase B|Protocol Deviation|0|||
146081450|NCT00797966|526818245|FG000|Phase B|Lack of Efficacy|0|||
146081451|NCT00797966|526818246|FG001|Phase B|Lack of Efficacy|1|||
146081452|NCT00797966|526818247|FG002|Phase B|Lack of Efficacy|1|||
146081453|NCT00797966|526818248|FG003|Phase B|Lack of Efficacy|4|||
146081454|NCT00797966|526818249|FG004|Phase B|Lack of Efficacy|0|||
146081455|NCT00797966|526818250|FG005|Phase B|Lack of Efficacy|0|||
146081456|NCT00797966|526818245|FG000|Phase A+|Lost to Follow-up|0|||
146081457|NCT00797966|526818246|FG001|Phase A+|Lost to Follow-up|0|||
146081458|NCT00797966|526818247|FG002|Phase A+|Lost to Follow-up|0|||
146081459|NCT00797966|526818248|FG003|Phase A+|Lost to Follow-up|0|||
146081460|NCT00797966|526818249|FG004|Phase A+|Lost to Follow-up|0|||
146081461|NCT00797966|526818250|FG005|Phase A+|Lost to Follow-up|9|||
146081462|NCT00797966|526818245|FG000|Phase A+|Met withdrawal criteria|0|||
146081463|NCT00797966|526818246|FG001|Phase A+|Met withdrawal criteria|0|||
146081464|NCT00797966|526818247|FG002|Phase A+|Met withdrawal criteria|0|||
146081465|NCT00797966|526818248|FG003|Phase A+|Met withdrawal criteria|0|||
146081466|NCT00797966|526818249|FG004|Phase A+|Met withdrawal criteria|0|||
146081467|NCT00797966|526818250|FG005|Phase A+|Met withdrawal criteria|5|||
146081468|NCT00797966|526818245|FG000|Phase A+|Withdrawal by Subject|0|||
146081469|NCT00797966|526818246|FG001|Phase A+|Withdrawal by Subject|0|||
146081470|NCT00797966|526818247|FG002|Phase A+|Withdrawal by Subject|0|||
146081471|NCT00797966|526818248|FG003|Phase A+|Withdrawal by Subject|0|||
146081472|NCT00797966|526818249|FG004|Phase A+|Withdrawal by Subject|0|||
146081473|NCT00797966|526818250|FG005|Phase A+|Withdrawal by Subject|6|||
146081474|NCT00797966|526818245|FG000|Phase A+|Adverse Event|0|||
146081475|NCT00797966|526818246|FG001|Phase A+|Adverse Event|0|||
146081476|NCT00797966|526818247|FG002|Phase A+|Adverse Event|0|||
146081477|NCT00797966|526818248|FG003|Phase A+|Adverse Event|0|||
146081478|NCT00797966|526818249|FG004|Phase A+|Adverse Event|0|||
146081479|NCT00797966|526818250|FG005|Phase A+|Adverse Event|4|||
146412385|NCT02544633|528015506|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
146412386|NCT02544633|528015503|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
146412387|NCT02544633|528015504|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
146412388|NCT02544633|528015505|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
146412389|NCT02544633|528015506|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
146412390|NCT02544633|528015503|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
146412391|NCT02544633|528015504|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
146412392|NCT02544633|528015505|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
146412393|NCT02544633|528015506|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
146412394|NCT02092961|528015507|FG000|Overall Study|Not reported|1|||
146412395|NCT02092961|528015508|FG001|Overall Study|Not reported|0|||
146412396|NCT02092961|528015509|FG002|Overall Study|Not reported|1|||
146412397|NCT02092961|528015507|FG000|Overall Study|Study stopped|13|||
146412398|NCT02092961|528015508|FG001|Overall Study|Study stopped|9|||
146412399|NCT02092961|528015509|FG002|Overall Study|Study stopped|12|||
146412400|NCT02092961|528015507|FG000|Overall Study|Lack of therapeutic response|2|||
146412401|NCT02092961|528015508|FG001|Overall Study|Lack of therapeutic response|1|||
146412402|NCT02092961|528015509|FG002|Overall Study|Lack of therapeutic response|3|||
146412403|NCT02092961|528015507|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
146412404|NCT02092961|528015508|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146412405|NCT02092961|528015509|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
146412406|NCT02092961|528015507|FG000|Overall Study|Adverse Event|2|||
146412407|NCT02092961|528015508|FG001|Overall Study|Adverse Event|4|||
146412408|NCT02092961|528015509|FG002|Overall Study|Adverse Event|0|||
146412409|NCT02270983|528015510|FG000|Overall Study|Adverse Event|3|||
146412410|NCT02270983|528015511|FG001|Overall Study|Adverse Event|2|||
146412411|NCT02270983|528015512|FG002|Overall Study|Adverse Event|6|||
146412412|NCT02270983|528015510|FG000|Overall Study|Lack of Efficacy|2|||
146412413|NCT02270983|528015511|FG001|Overall Study|Lack of Efficacy|1|||
146412414|NCT02270983|528015512|FG002|Overall Study|Lack of Efficacy|1|||
146412415|NCT02270983|528015510|FG000|Overall Study|Withdrawal by Subject|1|||
146412416|NCT02270983|528015511|FG001|Overall Study|Withdrawal by Subject|0|||
146412417|NCT02270983|528015512|FG002|Overall Study|Withdrawal by Subject|2|||
146412418|NCT02270983|528015510|FG000|Overall Study|Lost to Follow-up|1|||
146412419|NCT02270983|528015511|FG001|Overall Study|Lost to Follow-up|1|||
146412420|NCT02270983|528015512|FG002|Overall Study|Lost to Follow-up|2|||
146412421|NCT02270983|528015510|FG000|Overall Study|Protocol Violation|1|||
146412422|NCT02270983|528015511|FG001|Overall Study|Protocol Violation|1|||
146412423|NCT02270983|528015512|FG002|Overall Study|Protocol Violation|1|||
146412424|NCT02270983|528015510|FG000|Overall Study|family emergency|0|||
146412425|NCT02270983|528015511|FG001|Overall Study|family emergency|1|||
146412426|NCT02270983|528015512|FG002|Overall Study|family emergency|0|||
146412427|NCT02270983|528015510|FG000|Overall Study|study procedure non-compliance|1|||
146412428|NCT02270983|528015511|FG001|Overall Study|study procedure non-compliance|0|||
146412429|NCT02270983|528015512|FG002|Overall Study|study procedure non-compliance|0|||
146412430|NCT02270983|528015510|FG000|Overall Study|moved away from study site|0|||
146412431|NCT02270983|528015511|FG001|Overall Study|moved away from study site|1|||
146412432|NCT02270983|528015512|FG002|Overall Study|moved away from study site|0|||
146412433|NCT01623830|528015515|FG000|Overall Study|Withdrawal by Subject|6|||
146412434|NCT01623830|528015516|FG001|Overall Study|Withdrawal by Subject|7|||
146412435|NCT01623830|528015515|FG000|Overall Study|Exclusion from Study|1|||
146186983|NCT04955626|527195060|FG005|Blinded Period|Refused further study procedures|0|||
146234993|NCT01499849|527378439|FG000|Overall Study|Death|5|||
146284453|NCT01688830|527553725|FG006|Overall Study|Lost to Follow-up|0|||
146081480|NCT00797966|526818245|FG000|Phase A+|Protocol deviation|0|||
146081481|NCT00797966|526818246|FG001|Phase A+|Protocol deviation|0|||
146081482|NCT00797966|526818247|FG002|Phase A+|Protocol deviation|0|||
146081483|NCT00797966|526818248|FG003|Phase A+|Protocol deviation|0|||
146081484|NCT00797966|526818249|FG004|Phase A+|Protocol deviation|0|||
146081485|NCT00797966|526818250|FG005|Phase A+|Protocol deviation|4|||
146081486|NCT01242813|526818251|FG000|Overall Study|Lost to Follow-up|2|||
146081487|NCT03337490|526818253|FG000|Overall Study|Withdrawal by Subject|1|||
146081488|NCT03337490|526818254|FG001|Overall Study|Withdrawal by Subject|0|||
146081489|NCT03337490|526818255|FG002|Overall Study|Withdrawal by Subject|0|||
146081490|NCT03337490|526818253|FG000|Overall Study|Lack of Efficacy|10|||
146081491|NCT03337490|526818254|FG001|Overall Study|Lack of Efficacy|12|||
146081492|NCT03337490|526818255|FG002|Overall Study|Lack of Efficacy|35|||
146081493|NCT03337490|526818253|FG000|Overall Study|Physician Decision|0|||
146081494|NCT03337490|526818254|FG001|Overall Study|Physician Decision|1|||
146081495|NCT03337490|526818255|FG002|Overall Study|Physician Decision|0|||
146081496|NCT03337490|526818253|FG000|Overall Study|Lost to Follow-up|0|||
146081497|NCT03337490|526818254|FG001|Overall Study|Lost to Follow-up|1|||
146081498|NCT03337490|526818255|FG002|Overall Study|Lost to Follow-up|0|||
146186984|NCT04955626|527195061|FG006|Blinded Period|Refused further study procedures|1|||
146186985|NCT04955626|527195062|FG007|Blinded Period|Refused further study procedures|0|||
146186986|NCT04955626|527195063|FG008|Blinded Period|Refused further study procedures|0|||
146186987|NCT04955626|527195064|FG009|Blinded Period|Refused further study procedures|0|||
146186988|NCT04955626|527195065|FG010|Blinded Period|Refused further study procedures|0|||
146186989|NCT04955626|527195066|FG011|Blinded Period|Refused further study procedures|2|||
146186990|NCT04955626|527195067|FG012|Blinded Period|Refused further study procedures|0|||
146186991|NCT04955626|527195068|FG013|Blinded Period|Refused further study procedures|0|||
146186992|NCT04955626|527195069|FG014|Blinded Period|Refused further study procedures|0|||
146186993|NCT04955626|527195070|FG015|Blinded Period|Refused further study procedures|0|||
146186994|NCT04955626|527195071|FG016|Blinded Period|Refused further study procedures|0|||
146186995|NCT04955626|527195072|FG017|Blinded Period|Refused further study procedures|0|||
146186996|NCT04955626|527195073|FG018|Blinded Period|Refused further study procedures|0|||
146186997|NCT04955626|527195074|FG019|Blinded Period|Refused further study procedures|0|||
146186998|NCT04955626|527195075|FG020|Blinded Period|Refused further study procedures|0|||
146186999|NCT04955626|527195076|FG021|Blinded Period|Refused further study procedures|0|||
146187000|NCT04955626|527195077|FG022|Blinded Period|Refused further study procedures|0|||
146187001|NCT04955626|527195078|FG023|Blinded Period|Refused further study procedures|0|||
146187002|NCT04955626|527195079|FG024|Blinded Period|Refused further study procedures|0|||
146187003|NCT04955626|527195080|FG025|Blinded Period|Refused further study procedures|0|||
146187004|NCT04955626|527195081|FG026|Blinded Period|Refused further study procedures|0|||
146187005|NCT04955626|527195082|FG027|Blinded Period|Refused further study procedures|0|||
146187006|NCT04955626|527195083|FG028|Blinded Period|Refused further study procedures|0|||
146187007|NCT04955626|527195084|FG029|Blinded Period|Refused further study procedures|0|||
146187008|NCT04955626|527195085|FG030|Blinded Period|Refused further study procedures|0|||
146187009|NCT04955626|527195086|FG031|Blinded Period|Refused further study procedures|0|||
146187010|NCT04955626|527195087|FG032|Blinded Period|Refused further study procedures|0|||
146187011|NCT04955626|527195088|FG033|Blinded Period|Refused further study procedures|0|||
146187012|NCT04955626|527195089|FG034|Blinded Period|Refused further study procedures|0|||
146187013|NCT04955626|527195090|FG035|Blinded Period|Refused further study procedures|0|||
146187014|NCT04955626|527195055|FG000|Blinded Period|Participants entered open label period|4544|||
146187015|NCT04955626|527195056|FG001|Blinded Period|Participants entered open label period|4906|||
146187016|NCT04955626|527195057|FG002|Blinded Period|Participants entered open label period|0|||
146187017|NCT04955626|527195058|FG003|Blinded Period|Participants entered open label period|0|||
146187018|NCT04955626|527195059|FG004|Blinded Period|Participants entered open label period|0|||
146187019|NCT04955626|527195060|FG005|Blinded Period|Participants entered open label period|0|||
146187020|NCT04955626|527195061|FG006|Blinded Period|Participants entered open label period|0|||
146187021|NCT04955626|527195062|FG007|Blinded Period|Participants entered open label period|0|||
146187022|NCT04955626|527195063|FG008|Blinded Period|Participants entered open label period|0|||
146187023|NCT04955626|527195064|FG009|Blinded Period|Participants entered open label period|0|||
146187024|NCT04955626|527195065|FG010|Blinded Period|Participants entered open label period|0|||
146187025|NCT04955626|527195066|FG011|Blinded Period|Participants entered open label period|0|||
146187026|NCT04955626|527195067|FG012|Blinded Period|Participants entered open label period|0|||
146187027|NCT04955626|527195068|FG013|Blinded Period|Participants entered open label period|0|||
146187028|NCT04955626|527195069|FG014|Blinded Period|Participants entered open label period|0|||
146187029|NCT04955626|527195070|FG015|Blinded Period|Participants entered open label period|0|||
146187030|NCT04955626|527195071|FG016|Blinded Period|Participants entered open label period|0|||
146187031|NCT04955626|527195072|FG017|Blinded Period|Participants entered open label period|0|||
146187032|NCT04955626|527195073|FG018|Blinded Period|Participants entered open label period|0|||
146187033|NCT04955626|527195074|FG019|Blinded Period|Participants entered open label period|0|||
146234994|NCT01499849|527378440|FG001|Overall Study|Death|7|||
146412436|NCT01623830|528015516|FG001|Overall Study|Exclusion from Study|2|||
146187034|NCT04955626|527195075|FG020|Blinded Period|Participants entered open label period|0|||
146187035|NCT04955626|527195076|FG021|Blinded Period|Participants entered open label period|0|||
146187036|NCT04955626|527195077|FG022|Blinded Period|Participants entered open label period|0|||
146187037|NCT04955626|527195078|FG023|Blinded Period|Participants entered open label period|0|||
146187038|NCT04955626|527195079|FG024|Blinded Period|Participants entered open label period|0|||
146187039|NCT04955626|527195080|FG025|Blinded Period|Participants entered open label period|0|||
146187040|NCT04955626|527195081|FG026|Blinded Period|Participants entered open label period|0|||
146187041|NCT04955626|527195082|FG027|Blinded Period|Participants entered open label period|0|||
146187042|NCT04955626|527195083|FG028|Blinded Period|Participants entered open label period|0|||
146187043|NCT04955626|527195084|FG029|Blinded Period|Participants entered open label period|0|||
146187044|NCT04955626|527195085|FG030|Blinded Period|Participants entered open label period|0|||
146081499|NCT03560518|526818256|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
146081500|NCT03560518|526818257|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
146081501|NCT03560518|526818258|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
146081502|NCT03560518|526818256|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
146081503|NCT03560518|526818257|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
146081504|NCT03560518|526818258|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
146081505|NCT03560518|526818256|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146081506|NCT03560518|526818257|FG001|Double Blind Treatment Period|Protocol Violation|2|||
146081507|NCT03560518|526818258|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146081508|NCT03560518|526818256|FG000|Double Blind Treatment Period|Pregnancy|0|||
146081509|NCT03560518|526818257|FG001|Double Blind Treatment Period|Pregnancy|2|||
146081510|NCT03560518|526818258|FG002|Double Blind Treatment Period|Pregnancy|0|||
146081511|NCT03560518|526818256|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
146081512|NCT03560518|526818257|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
146081513|NCT03560518|526818258|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
146081514|NCT03560518|526818256|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
146234995|NCT01499849|527378439|FG000|Overall Study|Disease Progression|11|||
146081515|NCT03560518|526818257|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
146081516|NCT03560518|526818258|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
146081517|NCT03560518|526818256|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
146081518|NCT03560518|526818257|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
146081519|NCT03560518|526818258|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
146081520|NCT03560518|526818256|FG000|Double Blind Treatment Period|Adverse Event|0|||
146081521|NCT03560518|526818257|FG001|Double Blind Treatment Period|Adverse Event|3|||
146081522|NCT03560518|526818258|FG002|Double Blind Treatment Period|Adverse Event|1|||
146081523|NCT00917644|526818259|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
146081524|NCT00917644|526818260|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
146081525|NCT00917644|526818259|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
146081526|NCT00917644|526818260|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
146081527|NCT00917644|526818259|FG000|Period 2: Second Intervention|family emergency|1|||
146081528|NCT00917644|526818260|FG001|Period 2: Second Intervention|family emergency|0|||
146081529|NCT00958438|526818263|FG000|Overall Study|Protocol Violation|3|||
146081530|NCT00958438|526818264|FG001|Overall Study|Protocol Violation|2|||
146081531|NCT00958438|526818265|FG002|Overall Study|Protocol Violation|2|||
146081532|NCT00958438|526818263|FG000|Overall Study|Withdrawal by Subject|4|||
146081533|NCT00958438|526818264|FG001|Overall Study|Withdrawal by Subject|2|||
146081534|NCT00958438|526818265|FG002|Overall Study|Withdrawal by Subject|1|||
146081535|NCT00958438|526818263|FG000|Overall Study|Adverse Event|0|||
146081536|NCT00958438|526818264|FG001|Overall Study|Adverse Event|3|||
146081537|NCT00958438|526818265|FG002|Overall Study|Adverse Event|0|||
146081538|NCT00958438|526818263|FG000|Overall Study|Physician Decision|1|||
146081539|NCT00958438|526818264|FG001|Overall Study|Physician Decision|0|||
146081540|NCT00958438|526818265|FG002|Overall Study|Physician Decision|1|||
146081541|NCT00958438|526818263|FG000|Overall Study|Other than specified above|2|||
146081542|NCT00958438|526818264|FG001|Overall Study|Other than specified above|3|||
146081543|NCT00958438|526818265|FG002|Overall Study|Other than specified above|2|||
146081544|NCT02788279|526818266|FG000|Overall Study|Death|62|||
146081545|NCT02788279|526818267|FG001|Overall Study|Death|136|||
146081546|NCT02788279|526818268|FG002|Overall Study|Death|72|||
146081547|NCT02788279|526818266|FG000|Overall Study|Withdrawal by Subject|10|||
146081548|NCT02788279|526818267|FG001|Overall Study|Withdrawal by Subject|15|||
146081549|NCT02788279|526818268|FG002|Overall Study|Withdrawal by Subject|5|||
146081550|NCT02788279|526818266|FG000|Overall Study|Lost to Follow-up|0|||
146081551|NCT02788279|526818267|FG001|Overall Study|Lost to Follow-up|3|||
146081552|NCT02788279|526818268|FG002|Overall Study|Lost to Follow-up|2|||
146081553|NCT02788279|526818266|FG000|Overall Study|Sponsor decision|18|||
146081554|NCT02788279|526818267|FG001|Overall Study|Sponsor decision|29|||
146081555|NCT02788279|526818268|FG002|Overall Study|Sponsor decision|11|||
146081556|NCT01579812|526818269|FG000|Overall Study|Ineligible after treatment start|40|||
146081557|NCT01579812|526818269|FG000|Overall Study|Patient choice|3|||
146081558|NCT01579812|526818269|FG000|Overall Study|Noncompliance|3|||
146081559|NCT01579812|526818269|FG000|Overall Study|Withdrawal by Subject|6|||
146081560|NCT04987944|526818271|FG000|Overall Study|Adverse Event|0|||
146081561|NCT04987944|526818272|FG001|Overall Study|Adverse Event|1|||
146081562|NCT04987944|526818271|FG000|Overall Study|Withdrawal by Subject|0|||
146081563|NCT04987944|526818272|FG001|Overall Study|Withdrawal by Subject|1|||
146081564|NCT04136444|526818278|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
146081565|NCT04136444|526818279|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
146081566|NCT02946931|526818289|FG000|Overall Study|Did not require collection of CRFs|588|||
146081567|NCT02946931|526818289|FG000|Overall Study|Other than listed|37|||
146081568|NCT02946931|526818289|FG000|Overall Study|Discharge from hospital|118|||
146081569|NCT02946931|526818289|FG000|Overall Study|Adverse Event|81|||
146081570|NCT02946931|526818289|FG000|Overall Study|CRFs not valid|1|||
146081571|NCT02946931|526818289|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
146081572|NCT03339297|526818290|FG000|Overall Study|Relapse of Hematologic Disease|1|||
146081573|NCT03339297|526818291|FG001|Overall Study|Relapse of Hematologic Disease|0|||
146081574|NCT03339297|526818290|FG000|Overall Study|Death|10|||
146081575|NCT03339297|526818291|FG001|Overall Study|Death|7|||
146081576|NCT03339297|526818290|FG000|Overall Study|Hepatic Candidosis|1|||
146081577|NCT03339297|526818291|FG001|Overall Study|Hepatic Candidosis|0|||
146081578|NCT03339297|526818290|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
146081579|NCT03339297|526818291|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
146081580|NCT03339297|526818290|FG000|Overall Study|Consent Withdrawn by Participant|3|||
146081581|NCT03339297|526818291|FG001|Overall Study|Consent Withdrawn by Participant|3|||
146081582|NCT03339297|526818290|FG000|Overall Study|Disease Relapse|2|||
146081583|NCT03339297|526818291|FG001|Overall Study|Disease Relapse|0|||
146284454|NCT01688830|527553726|FG007|Overall Study|Lost to Follow-up|0|||
146081584|NCT03339297|526818290|FG000|Overall Study|Physician Decision|1|||
146081585|NCT03339297|526818291|FG001|Overall Study|Physician Decision|1|||
146081586|NCT03339297|526818290|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
146187045|NCT04955626|527195086|FG031|Blinded Period|Participants entered open label period|0|||
146187046|NCT04955626|527195087|FG032|Blinded Period|Participants entered open label period|0|||
146187047|NCT04955626|527195088|FG033|Blinded Period|Participants entered open label period|0|||
146187048|NCT04955626|527195089|FG034|Blinded Period|Participants entered open label period|0|||
146187049|NCT04955626|527195090|FG035|Blinded Period|Participants entered open label period|0|||
146187050|NCT04955626|527195055|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
146187051|NCT04955626|527195056|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
146187052|NCT04955626|527195057|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
146187053|NCT04955626|527195058|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
146187054|NCT04955626|527195059|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
146187055|NCT04955626|527195060|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
146187056|NCT04955626|527195061|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
146187057|NCT04955626|527195062|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
146187058|NCT04955626|527195063|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
146187059|NCT04955626|527195064|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
146187060|NCT04955626|527195065|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
146187061|NCT04955626|527195066|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
146187062|NCT04955626|527195067|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
146187063|NCT04955626|527195068|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
146187064|NCT04955626|527195069|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
146187065|NCT04955626|527195070|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
146187066|NCT04955626|527195071|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
146187067|NCT04955626|527195072|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
146187068|NCT04955626|527195073|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
146187069|NCT04955626|527195074|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
146187070|NCT04955626|527195075|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
146187071|NCT04955626|527195076|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
146187072|NCT04955626|527195077|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
146187073|NCT04955626|527195078|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
146187074|NCT04955626|527195079|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
146187075|NCT04955626|527195080|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
146187076|NCT04955626|527195081|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
146187077|NCT04955626|527195082|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
146187078|NCT04955626|527195083|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
146187079|NCT04955626|527195084|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
146187080|NCT04955626|527195085|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
146187081|NCT04955626|527195086|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
146187082|NCT04955626|527195087|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
146187083|NCT04955626|527195088|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
146187084|NCT04955626|527195089|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
146187085|NCT04955626|527195090|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
146187086|NCT04955626|527195055|FG000|Blinded Period|Medication error|0|||
146187087|NCT04955626|527195056|FG001|Blinded Period|Medication error|0|||
146187088|NCT04955626|527195057|FG002|Blinded Period|Medication error|0|||
146187089|NCT04955626|527195058|FG003|Blinded Period|Medication error|0|||
146187090|NCT04955626|527195059|FG004|Blinded Period|Medication error|0|||
146187091|NCT04955626|527195060|FG005|Blinded Period|Medication error|0|||
146187092|NCT04955626|527195061|FG006|Blinded Period|Medication error|0|||
146187093|NCT04955626|527195062|FG007|Blinded Period|Medication error|0|||
146187094|NCT04955626|527195063|FG008|Blinded Period|Medication error|0|||
146187095|NCT04955626|527195064|FG009|Blinded Period|Medication error|0|||
146187096|NCT04955626|527195065|FG010|Blinded Period|Medication error|2|||
146187097|NCT04955626|527195066|FG011|Blinded Period|Medication error|0|||
146187098|NCT04955626|527195067|FG012|Blinded Period|Medication error|0|||
146187099|NCT04955626|527195068|FG013|Blinded Period|Medication error|0|||
146187100|NCT04955626|527195069|FG014|Blinded Period|Medication error|0|||
146187101|NCT04955626|527195070|FG015|Blinded Period|Medication error|0|||
146187102|NCT04955626|527195071|FG016|Blinded Period|Medication error|0|||
146187103|NCT04955626|527195072|FG017|Blinded Period|Medication error|0|||
146187104|NCT04955626|527195073|FG018|Blinded Period|Medication error|0|||
146187105|NCT04955626|527195074|FG019|Blinded Period|Medication error|0|||
146187106|NCT04955626|527195075|FG020|Blinded Period|Medication error|0|||
146187107|NCT04955626|527195076|FG021|Blinded Period|Medication error|0|||
146187108|NCT04955626|527195077|FG022|Blinded Period|Medication error|0|||
146187109|NCT04955626|527195078|FG023|Blinded Period|Medication error|0|||
146187110|NCT04955626|527195079|FG024|Blinded Period|Medication error|0|||
146187111|NCT04955626|527195080|FG025|Blinded Period|Medication error|0|||
146187112|NCT04955626|527195081|FG026|Blinded Period|Medication error|0|||
146187113|NCT04955626|527195082|FG027|Blinded Period|Medication error|0|||
146187114|NCT04955626|527195083|FG028|Blinded Period|Medication error|4|||
146187115|NCT04955626|527195084|FG029|Blinded Period|Medication error|0|||
146187116|NCT04955626|527195085|FG030|Blinded Period|Medication error|0|||
146187117|NCT04955626|527195086|FG031|Blinded Period|Medication error|0|||
146187118|NCT04955626|527195087|FG032|Blinded Period|Medication error|0|||
146187119|NCT04955626|527195088|FG033|Blinded Period|Medication error|0|||
146187120|NCT04955626|527195089|FG034|Blinded Period|Medication error|0|||
146187121|NCT04955626|527195090|FG035|Blinded Period|Medication error|0|||
146187122|NCT04955626|527195055|FG000|Open-Label Period|Lost to Follow-up|109|||
146187123|NCT04955626|527195056|FG001|Open-Label Period|Lost to Follow-up|41|||
146187124|NCT04955626|527195057|FG002|Open-Label Period|Lost to Follow-up|0|||
146187125|NCT04955626|527195058|FG003|Open-Label Period|Lost to Follow-up|0|||
146187126|NCT04955626|527195059|FG004|Open-Label Period|Lost to Follow-up|0|||
146187127|NCT04955626|527195060|FG005|Open-Label Period|Lost to Follow-up|0|||
146187128|NCT04955626|527195061|FG006|Open-Label Period|Lost to Follow-up|0|||
146187129|NCT04955626|527195062|FG007|Open-Label Period|Lost to Follow-up|0|||
146187130|NCT04955626|527195063|FG008|Open-Label Period|Lost to Follow-up|0|||
146187131|NCT04955626|527195064|FG009|Open-Label Period|Lost to Follow-up|0|||
146187132|NCT04955626|527195065|FG010|Open-Label Period|Lost to Follow-up|0|||
146187133|NCT04955626|527195066|FG011|Open-Label Period|Lost to Follow-up|0|||
146187134|NCT04955626|527195067|FG012|Open-Label Period|Lost to Follow-up|0|||
146187135|NCT04955626|527195068|FG013|Open-Label Period|Lost to Follow-up|0|||
146187136|NCT04955626|527195069|FG014|Open-Label Period|Lost to Follow-up|0|||
146187137|NCT04955626|527195070|FG015|Open-Label Period|Lost to Follow-up|0|||
146187138|NCT04955626|527195071|FG016|Open-Label Period|Lost to Follow-up|0|||
146187139|NCT04955626|527195072|FG017|Open-Label Period|Lost to Follow-up|0|||
146187140|NCT04955626|527195073|FG018|Open-Label Period|Lost to Follow-up|0|||
146187141|NCT04955626|527195074|FG019|Open-Label Period|Lost to Follow-up|0|||
146187142|NCT04955626|527195075|FG020|Open-Label Period|Lost to Follow-up|0|||
146187143|NCT04955626|527195076|FG021|Open-Label Period|Lost to Follow-up|0|||
146187144|NCT04955626|527195077|FG022|Open-Label Period|Lost to Follow-up|0|||
146187145|NCT04955626|527195078|FG023|Open-Label Period|Lost to Follow-up|0|||
146187146|NCT04955626|527195079|FG024|Open-Label Period|Lost to Follow-up|0|||
146187147|NCT04955626|527195080|FG025|Open-Label Period|Lost to Follow-up|0|||
146187148|NCT04955626|527195081|FG026|Open-Label Period|Lost to Follow-up|0|||
146187149|NCT04955626|527195082|FG027|Open-Label Period|Lost to Follow-up|0|||
146187150|NCT04955626|527195083|FG028|Open-Label Period|Lost to Follow-up|0|||
146187151|NCT04955626|527195084|FG029|Open-Label Period|Lost to Follow-up|0|||
146187152|NCT04955626|527195085|FG030|Open-Label Period|Lost to Follow-up|0|||
146187153|NCT04955626|527195086|FG031|Open-Label Period|Lost to Follow-up|0|||
146187154|NCT04955626|527195087|FG032|Open-Label Period|Lost to Follow-up|0|||
146187155|NCT04955626|527195088|FG033|Open-Label Period|Lost to Follow-up|0|||
146187156|NCT04955626|527195089|FG034|Open-Label Period|Lost to Follow-up|0|||
146187157|NCT04955626|527195090|FG035|Open-Label Period|Lost to Follow-up|0|||
146187158|NCT04955626|527195055|FG000|Open-Label Period|Protocol Violation|377|||
146187159|NCT04955626|527195056|FG001|Open-Label Period|Protocol Violation|48|||
146187160|NCT04955626|527195057|FG002|Open-Label Period|Protocol Violation|0|||
146187161|NCT04955626|527195058|FG003|Open-Label Period|Protocol Violation|0|||
146187162|NCT04955626|527195059|FG004|Open-Label Period|Protocol Violation|0|||
146187163|NCT04955626|527195060|FG005|Open-Label Period|Protocol Violation|0|||
146187164|NCT04955626|527195061|FG006|Open-Label Period|Protocol Violation|0|||
146187165|NCT04955626|527195062|FG007|Open-Label Period|Protocol Violation|0|||
146187166|NCT04955626|527195063|FG008|Open-Label Period|Protocol Violation|0|||
146187167|NCT04955626|527195064|FG009|Open-Label Period|Protocol Violation|0|||
146187168|NCT04955626|527195065|FG010|Open-Label Period|Protocol Violation|0|||
146187169|NCT04955626|527195066|FG011|Open-Label Period|Protocol Violation|0|||
146187170|NCT04955626|527195067|FG012|Open-Label Period|Protocol Violation|0|||
146187171|NCT04955626|527195068|FG013|Open-Label Period|Protocol Violation|0|||
146187172|NCT04955626|527195069|FG014|Open-Label Period|Protocol Violation|0|||
146187173|NCT04955626|527195070|FG015|Open-Label Period|Protocol Violation|0|||
146187174|NCT04955626|527195071|FG016|Open-Label Period|Protocol Violation|0|||
146187175|NCT04955626|527195072|FG017|Open-Label Period|Protocol Violation|0|||
146187176|NCT04955626|527195073|FG018|Open-Label Period|Protocol Violation|0|||
146187177|NCT04955626|527195074|FG019|Open-Label Period|Protocol Violation|0|||
146187178|NCT04955626|527195075|FG020|Open-Label Period|Protocol Violation|0|||
146187179|NCT04955626|527195076|FG021|Open-Label Period|Protocol Violation|0|||
146187180|NCT04955626|527195077|FG022|Open-Label Period|Protocol Violation|0|||
146187181|NCT04955626|527195078|FG023|Open-Label Period|Protocol Violation|0|||
146187182|NCT04955626|527195079|FG024|Open-Label Period|Protocol Violation|0|||
146187183|NCT04955626|527195080|FG025|Open-Label Period|Protocol Violation|0|||
146187184|NCT04955626|527195081|FG026|Open-Label Period|Protocol Violation|0|||
146187185|NCT04955626|527195082|FG027|Open-Label Period|Protocol Violation|0|||
146187186|NCT04955626|527195083|FG028|Open-Label Period|Protocol Violation|0|||
146187187|NCT04955626|527195084|FG029|Open-Label Period|Protocol Violation|0|||
146187188|NCT04955626|527195085|FG030|Open-Label Period|Protocol Violation|0|||
146187189|NCT04955626|527195086|FG031|Open-Label Period|Protocol Violation|0|||
146187190|NCT04955626|527195087|FG032|Open-Label Period|Protocol Violation|0|||
146187191|NCT04955626|527195088|FG033|Open-Label Period|Protocol Violation|0|||
146187192|NCT04955626|527195089|FG034|Open-Label Period|Protocol Violation|0|||
146187193|NCT04955626|527195090|FG035|Open-Label Period|Protocol Violation|0|||
146187194|NCT04955626|527195055|FG000|Open-Label Period|Death|5|||
146187195|NCT04955626|527195056|FG001|Open-Label Period|Death|5|||
146187196|NCT04955626|527195057|FG002|Open-Label Period|Death|0|||
146187197|NCT04955626|527195058|FG003|Open-Label Period|Death|0|||
146187198|NCT04955626|527195059|FG004|Open-Label Period|Death|0|||
146187199|NCT04955626|527195060|FG005|Open-Label Period|Death|0|||
146187200|NCT04955626|527195061|FG006|Open-Label Period|Death|0|||
146187201|NCT04955626|527195062|FG007|Open-Label Period|Death|0|||
146187202|NCT04955626|527195063|FG008|Open-Label Period|Death|0|||
146187203|NCT04955626|527195064|FG009|Open-Label Period|Death|0|||
146187204|NCT04955626|527195065|FG010|Open-Label Period|Death|0|||
146187205|NCT04955626|527195066|FG011|Open-Label Period|Death|0|||
146187206|NCT04955626|527195067|FG012|Open-Label Period|Death|0|||
146187207|NCT04955626|527195068|FG013|Open-Label Period|Death|0|||
146187208|NCT04955626|527195069|FG014|Open-Label Period|Death|0|||
146187209|NCT04955626|527195070|FG015|Open-Label Period|Death|0|||
146187210|NCT04955626|527195071|FG016|Open-Label Period|Death|0|||
146187211|NCT04955626|527195072|FG017|Open-Label Period|Death|0|||
146187212|NCT04955626|527195073|FG018|Open-Label Period|Death|0|||
146187213|NCT04955626|527195074|FG019|Open-Label Period|Death|0|||
146187214|NCT04955626|527195075|FG020|Open-Label Period|Death|0|||
146187215|NCT04955626|527195076|FG021|Open-Label Period|Death|0|||
146187216|NCT04955626|527195077|FG022|Open-Label Period|Death|0|||
146187217|NCT04955626|527195078|FG023|Open-Label Period|Death|0|||
146187218|NCT04955626|527195079|FG024|Open-Label Period|Death|0|||
146187219|NCT04955626|527195080|FG025|Open-Label Period|Death|0|||
146187220|NCT04955626|527195081|FG026|Open-Label Period|Death|0|||
146187221|NCT04955626|527195082|FG027|Open-Label Period|Death|0|||
146187222|NCT04955626|527195083|FG028|Open-Label Period|Death|0|||
146187223|NCT04955626|527195084|FG029|Open-Label Period|Death|0|||
146187224|NCT04955626|527195085|FG030|Open-Label Period|Death|0|||
146187225|NCT04955626|527195086|FG031|Open-Label Period|Death|0|||
146187226|NCT04955626|527195087|FG032|Open-Label Period|Death|0|||
146187227|NCT04955626|527195088|FG033|Open-Label Period|Death|0|||
146187228|NCT04955626|527195089|FG034|Open-Label Period|Death|0|||
146187229|NCT04955626|527195090|FG035|Open-Label Period|Death|0|||
146187230|NCT04955626|527195055|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
146187231|NCT04955626|527195056|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
146187232|NCT04955626|527195057|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
146187233|NCT04955626|527195058|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
146187234|NCT04955626|527195059|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
146187235|NCT04955626|527195060|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
146187236|NCT04955626|527195061|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
146187237|NCT04955626|527195062|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
146187238|NCT04955626|527195063|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
146187239|NCT04955626|527195064|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
146187240|NCT04955626|527195065|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
146187241|NCT04955626|527195066|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
146187242|NCT04955626|527195067|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
146187243|NCT04955626|527195068|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
146187244|NCT04955626|527195069|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
146187245|NCT04955626|527195070|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
146187246|NCT04955626|527195071|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
146187247|NCT04955626|527195072|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
146187248|NCT04955626|527195073|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
146187249|NCT04955626|527195074|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
146187250|NCT04955626|527195075|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
146187251|NCT04955626|527195076|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
146187252|NCT04955626|527195077|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
146187253|NCT04955626|527195078|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
146187254|NCT04955626|527195079|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
146187255|NCT04955626|527195080|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
146412437|NCT00928252|528015517|FG000|Overall Study|Physician Decision|3|||
146081587|NCT03339297|526818291|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
146081588|NCT03339297|526818290|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
146081589|NCT03339297|526818291|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
146081590|NCT03339297|526818290|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
146081591|NCT03339297|526818291|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
146081592|NCT03339297|526818290|FG000|Overall Study|Adverse Event, Non-fatal|1|||
146081593|NCT03339297|526818291|FG001|Overall Study|Adverse Event, Non-fatal|0|||
146081594|NCT03339297|526818290|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
146187256|NCT04955626|527195081|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
146187257|NCT04955626|527195082|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
146187258|NCT04955626|527195083|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
146187259|NCT04955626|527195084|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
146187260|NCT04955626|527195085|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
146187261|NCT04955626|527195086|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
146187262|NCT04955626|527195087|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
146187263|NCT04955626|527195088|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
146187264|NCT04955626|527195089|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
146187265|NCT04955626|527195090|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
146187266|NCT04955626|527195055|FG000|Open-Label Period|Other|621|||
146187267|NCT04955626|527195056|FG001|Open-Label Period|Other|429|||
146187268|NCT04955626|527195057|FG002|Open-Label Period|Other|0|||
146187269|NCT04955626|527195058|FG003|Open-Label Period|Other|0|||
146187270|NCT04955626|527195059|FG004|Open-Label Period|Other|0|||
146187271|NCT04955626|527195060|FG005|Open-Label Period|Other|0|||
146187272|NCT04955626|527195061|FG006|Open-Label Period|Other|0|||
146187273|NCT04955626|527195062|FG007|Open-Label Period|Other|0|||
146187274|NCT04955626|527195063|FG008|Open-Label Period|Other|0|||
146187275|NCT04955626|527195064|FG009|Open-Label Period|Other|0|||
146187276|NCT04955626|527195065|FG010|Open-Label Period|Other|0|||
146187277|NCT04955626|527195066|FG011|Open-Label Period|Other|0|||
146187278|NCT04955626|527195067|FG012|Open-Label Period|Other|0|||
146187279|NCT04955626|527195068|FG013|Open-Label Period|Other|0|||
146187280|NCT04955626|527195069|FG014|Open-Label Period|Other|0|||
146187281|NCT04955626|527195070|FG015|Open-Label Period|Other|0|||
146187282|NCT04955626|527195071|FG016|Open-Label Period|Other|0|||
146187283|NCT04955626|527195072|FG017|Open-Label Period|Other|0|||
146187284|NCT04955626|527195073|FG018|Open-Label Period|Other|0|||
146187285|NCT04955626|527195074|FG019|Open-Label Period|Other|0|||
146187286|NCT04955626|527195075|FG020|Open-Label Period|Other|0|||
146187287|NCT04955626|527195076|FG021|Open-Label Period|Other|0|||
146187288|NCT04955626|527195077|FG022|Open-Label Period|Other|0|||
146187289|NCT04955626|527195078|FG023|Open-Label Period|Other|0|||
146187290|NCT04955626|527195079|FG024|Open-Label Period|Other|0|||
146187291|NCT04955626|527195080|FG025|Open-Label Period|Other|0|||
146187292|NCT04955626|527195081|FG026|Open-Label Period|Other|0|||
146187293|NCT04955626|527195082|FG027|Open-Label Period|Other|0|||
146187294|NCT04955626|527195083|FG028|Open-Label Period|Other|0|||
146187295|NCT04955626|527195084|FG029|Open-Label Period|Other|0|||
146187296|NCT04955626|527195085|FG030|Open-Label Period|Other|0|||
146187297|NCT04955626|527195086|FG031|Open-Label Period|Other|0|||
146187298|NCT04955626|527195087|FG032|Open-Label Period|Other|0|||
146187299|NCT04955626|527195088|FG033|Open-Label Period|Other|0|||
146187300|NCT04955626|527195089|FG034|Open-Label Period|Other|0|||
146187301|NCT04955626|527195090|FG035|Open-Label Period|Other|0|||
146187302|NCT04955626|527195055|FG000|Open-Label Period|Physician Decision|2|||
146187303|NCT04955626|527195056|FG001|Open-Label Period|Physician Decision|0|||
146187304|NCT04955626|527195057|FG002|Open-Label Period|Physician Decision|0|||
146187305|NCT04955626|527195058|FG003|Open-Label Period|Physician Decision|0|||
146187306|NCT04955626|527195059|FG004|Open-Label Period|Physician Decision|0|||
146187307|NCT04955626|527195060|FG005|Open-Label Period|Physician Decision|0|||
146187308|NCT04955626|527195061|FG006|Open-Label Period|Physician Decision|0|||
146187309|NCT04955626|527195062|FG007|Open-Label Period|Physician Decision|0|||
146187310|NCT04955626|527195063|FG008|Open-Label Period|Physician Decision|0|||
146187311|NCT04955626|527195064|FG009|Open-Label Period|Physician Decision|0|||
146187312|NCT04955626|527195065|FG010|Open-Label Period|Physician Decision|0|||
146187313|NCT04955626|527195066|FG011|Open-Label Period|Physician Decision|0|||
146187314|NCT04955626|527195067|FG012|Open-Label Period|Physician Decision|0|||
146187315|NCT04955626|527195068|FG013|Open-Label Period|Physician Decision|0|||
146187316|NCT04955626|527195069|FG014|Open-Label Period|Physician Decision|0|||
146187317|NCT04955626|527195070|FG015|Open-Label Period|Physician Decision|0|||
146187318|NCT04955626|527195071|FG016|Open-Label Period|Physician Decision|0|||
146187319|NCT04955626|527195072|FG017|Open-Label Period|Physician Decision|0|||
146187320|NCT04955626|527195073|FG018|Open-Label Period|Physician Decision|0|||
146187321|NCT04955626|527195074|FG019|Open-Label Period|Physician Decision|0|||
146187322|NCT04955626|527195075|FG020|Open-Label Period|Physician Decision|0|||
146187323|NCT04955626|527195076|FG021|Open-Label Period|Physician Decision|0|||
146187324|NCT04955626|527195077|FG022|Open-Label Period|Physician Decision|0|||
146187325|NCT04955626|527195078|FG023|Open-Label Period|Physician Decision|0|||
146187326|NCT04955626|527195079|FG024|Open-Label Period|Physician Decision|0|||
146187327|NCT04955626|527195080|FG025|Open-Label Period|Physician Decision|0|||
146187328|NCT04955626|527195081|FG026|Open-Label Period|Physician Decision|0|||
146187329|NCT04955626|527195082|FG027|Open-Label Period|Physician Decision|0|||
146187330|NCT04955626|527195083|FG028|Open-Label Period|Physician Decision|0|||
146187331|NCT04955626|527195084|FG029|Open-Label Period|Physician Decision|0|||
146187332|NCT04955626|527195085|FG030|Open-Label Period|Physician Decision|0|||
146187333|NCT04955626|527195086|FG031|Open-Label Period|Physician Decision|0|||
146187334|NCT04955626|527195087|FG032|Open-Label Period|Physician Decision|0|||
146187335|NCT04955626|527195088|FG033|Open-Label Period|Physician Decision|0|||
146187336|NCT04955626|527195089|FG034|Open-Label Period|Physician Decision|0|||
146187337|NCT04955626|527195090|FG035|Open-Label Period|Physician Decision|0|||
146187338|NCT04955626|527195055|FG000|Open-Label Period|Withdrawal by Subject|135|||
146187339|NCT04955626|527195056|FG001|Open-Label Period|Withdrawal by Subject|25|||
146187340|NCT04955626|527195057|FG002|Open-Label Period|Withdrawal by Subject|0|||
146187341|NCT04955626|527195058|FG003|Open-Label Period|Withdrawal by Subject|0|||
146187342|NCT04955626|527195059|FG004|Open-Label Period|Withdrawal by Subject|0|||
146187343|NCT04955626|527195060|FG005|Open-Label Period|Withdrawal by Subject|0|||
146187344|NCT04955626|527195061|FG006|Open-Label Period|Withdrawal by Subject|0|||
146187345|NCT04955626|527195062|FG007|Open-Label Period|Withdrawal by Subject|0|||
146187346|NCT04955626|527195063|FG008|Open-Label Period|Withdrawal by Subject|0|||
146187347|NCT04955626|527195064|FG009|Open-Label Period|Withdrawal by Subject|0|||
146187348|NCT04955626|527195065|FG010|Open-Label Period|Withdrawal by Subject|0|||
146187349|NCT04955626|527195066|FG011|Open-Label Period|Withdrawal by Subject|0|||
146187350|NCT04955626|527195067|FG012|Open-Label Period|Withdrawal by Subject|0|||
146187351|NCT04955626|527195068|FG013|Open-Label Period|Withdrawal by Subject|0|||
146187352|NCT04955626|527195069|FG014|Open-Label Period|Withdrawal by Subject|0|||
146187353|NCT04955626|527195070|FG015|Open-Label Period|Withdrawal by Subject|0|||
146187354|NCT04955626|527195071|FG016|Open-Label Period|Withdrawal by Subject|0|||
146187355|NCT04955626|527195072|FG017|Open-Label Period|Withdrawal by Subject|0|||
146187356|NCT04955626|527195073|FG018|Open-Label Period|Withdrawal by Subject|0|||
146187357|NCT04955626|527195074|FG019|Open-Label Period|Withdrawal by Subject|0|||
146187358|NCT04955626|527195075|FG020|Open-Label Period|Withdrawal by Subject|0|||
146187359|NCT04955626|527195076|FG021|Open-Label Period|Withdrawal by Subject|0|||
146187360|NCT04955626|527195077|FG022|Open-Label Period|Withdrawal by Subject|0|||
146187361|NCT04955626|527195078|FG023|Open-Label Period|Withdrawal by Subject|0|||
146187362|NCT04955626|527195079|FG024|Open-Label Period|Withdrawal by Subject|0|||
146187363|NCT04955626|527195080|FG025|Open-Label Period|Withdrawal by Subject|0|||
146187364|NCT04955626|527195081|FG026|Open-Label Period|Withdrawal by Subject|0|||
146187365|NCT04955626|527195082|FG027|Open-Label Period|Withdrawal by Subject|0|||
146187366|NCT04955626|527195083|FG028|Open-Label Period|Withdrawal by Subject|0|||
146187367|NCT04955626|527195084|FG029|Open-Label Period|Withdrawal by Subject|0|||
146187368|NCT04955626|527195085|FG030|Open-Label Period|Withdrawal by Subject|0|||
146187369|NCT04955626|527195086|FG031|Open-Label Period|Withdrawal by Subject|0|||
146187370|NCT04955626|527195087|FG032|Open-Label Period|Withdrawal by Subject|0|||
146187371|NCT04955626|527195088|FG033|Open-Label Period|Withdrawal by Subject|0|||
146187372|NCT04955626|527195089|FG034|Open-Label Period|Withdrawal by Subject|0|||
146187373|NCT04955626|527195090|FG035|Open-Label Period|Withdrawal by Subject|0|||
146187374|NCT04955626|527195055|FG000|Open-Label Period|Refused further study procedures|1|||
146187375|NCT04955626|527195056|FG001|Open-Label Period|Refused further study procedures|0|||
146187376|NCT04955626|527195057|FG002|Open-Label Period|Refused further study procedures|0|||
146187377|NCT04955626|527195058|FG003|Open-Label Period|Refused further study procedures|0|||
146187378|NCT04955626|527195059|FG004|Open-Label Period|Refused further study procedures|0|||
146187379|NCT04955626|527195060|FG005|Open-Label Period|Refused further study procedures|0|||
146187380|NCT04955626|527195061|FG006|Open-Label Period|Refused further study procedures|0|||
146187381|NCT04955626|527195062|FG007|Open-Label Period|Refused further study procedures|0|||
146187382|NCT04955626|527195063|FG008|Open-Label Period|Refused further study procedures|0|||
146187383|NCT04955626|527195064|FG009|Open-Label Period|Refused further study procedures|0|||
146187384|NCT04955626|527195065|FG010|Open-Label Period|Refused further study procedures|0|||
146187385|NCT04955626|527195066|FG011|Open-Label Period|Refused further study procedures|0|||
146187386|NCT04955626|527195067|FG012|Open-Label Period|Refused further study procedures|0|||
146187387|NCT04955626|527195068|FG013|Open-Label Period|Refused further study procedures|0|||
146187388|NCT04955626|527195069|FG014|Open-Label Period|Refused further study procedures|0|||
146187389|NCT04955626|527195070|FG015|Open-Label Period|Refused further study procedures|0|||
146187390|NCT04955626|527195071|FG016|Open-Label Period|Refused further study procedures|0|||
146187391|NCT04955626|527195072|FG017|Open-Label Period|Refused further study procedures|0|||
146187392|NCT04955626|527195073|FG018|Open-Label Period|Refused further study procedures|0|||
146187393|NCT04955626|527195074|FG019|Open-Label Period|Refused further study procedures|0|||
146187394|NCT04955626|527195075|FG020|Open-Label Period|Refused further study procedures|0|||
146187395|NCT04955626|527195076|FG021|Open-Label Period|Refused further study procedures|0|||
146187396|NCT04955626|527195077|FG022|Open-Label Period|Refused further study procedures|0|||
146187397|NCT04955626|527195078|FG023|Open-Label Period|Refused further study procedures|0|||
146187398|NCT04955626|527195079|FG024|Open-Label Period|Refused further study procedures|0|||
146187399|NCT04955626|527195080|FG025|Open-Label Period|Refused further study procedures|0|||
146187400|NCT04955626|527195081|FG026|Open-Label Period|Refused further study procedures|0|||
146187401|NCT04955626|527195082|FG027|Open-Label Period|Refused further study procedures|0|||
146187402|NCT04955626|527195083|FG028|Open-Label Period|Refused further study procedures|0|||
146187403|NCT04955626|527195084|FG029|Open-Label Period|Refused further study procedures|0|||
146187404|NCT04955626|527195085|FG030|Open-Label Period|Refused further study procedures|0|||
146187405|NCT04955626|527195086|FG031|Open-Label Period|Refused further study procedures|0|||
146187406|NCT04955626|527195087|FG032|Open-Label Period|Refused further study procedures|0|||
146187407|NCT04955626|527195088|FG033|Open-Label Period|Refused further study procedures|0|||
146187408|NCT04955626|527195089|FG034|Open-Label Period|Refused further study procedures|0|||
146187409|NCT04955626|527195090|FG035|Open-Label Period|Refused further study procedures|0|||
146187410|NCT04955626|527195055|FG000|Open-Label Period|Adverse Event|1|||
146187411|NCT04955626|527195056|FG001|Open-Label Period|Adverse Event|0|||
146187412|NCT04955626|527195057|FG002|Open-Label Period|Adverse Event|0|||
146187413|NCT04955626|527195058|FG003|Open-Label Period|Adverse Event|0|||
146187414|NCT04955626|527195059|FG004|Open-Label Period|Adverse Event|0|||
146187415|NCT04955626|527195060|FG005|Open-Label Period|Adverse Event|0|||
146187416|NCT04955626|527195061|FG006|Open-Label Period|Adverse Event|0|||
146187417|NCT04955626|527195062|FG007|Open-Label Period|Adverse Event|0|||
146187418|NCT04955626|527195063|FG008|Open-Label Period|Adverse Event|0|||
146187419|NCT04955626|527195064|FG009|Open-Label Period|Adverse Event|0|||
146187420|NCT04955626|527195065|FG010|Open-Label Period|Adverse Event|0|||
146187421|NCT04955626|527195066|FG011|Open-Label Period|Adverse Event|0|||
146187422|NCT04955626|527195067|FG012|Open-Label Period|Adverse Event|0|||
146187423|NCT04955626|527195068|FG013|Open-Label Period|Adverse Event|0|||
146187424|NCT04955626|527195069|FG014|Open-Label Period|Adverse Event|0|||
146187425|NCT04955626|527195070|FG015|Open-Label Period|Adverse Event|0|||
146187426|NCT04955626|527195071|FG016|Open-Label Period|Adverse Event|0|||
146187427|NCT04955626|527195072|FG017|Open-Label Period|Adverse Event|0|||
146187428|NCT04955626|527195073|FG018|Open-Label Period|Adverse Event|0|||
146187429|NCT04955626|527195074|FG019|Open-Label Period|Adverse Event|0|||
146187430|NCT04955626|527195075|FG020|Open-Label Period|Adverse Event|0|||
146187431|NCT04955626|527195076|FG021|Open-Label Period|Adverse Event|0|||
146187432|NCT04955626|527195077|FG022|Open-Label Period|Adverse Event|0|||
146187433|NCT04955626|527195078|FG023|Open-Label Period|Adverse Event|0|||
146187434|NCT04955626|527195079|FG024|Open-Label Period|Adverse Event|0|||
146187435|NCT04955626|527195080|FG025|Open-Label Period|Adverse Event|0|||
146187436|NCT04955626|527195081|FG026|Open-Label Period|Adverse Event|0|||
146187437|NCT04955626|527195082|FG027|Open-Label Period|Adverse Event|0|||
146187438|NCT04955626|527195083|FG028|Open-Label Period|Adverse Event|0|||
146187439|NCT04955626|527195084|FG029|Open-Label Period|Adverse Event|0|||
146187440|NCT04955626|527195085|FG030|Open-Label Period|Adverse Event|0|||
146187441|NCT04955626|527195086|FG031|Open-Label Period|Adverse Event|0|||
146187442|NCT04955626|527195087|FG032|Open-Label Period|Adverse Event|0|||
146187443|NCT04955626|527195088|FG033|Open-Label Period|Adverse Event|0|||
146187444|NCT04955626|527195089|FG034|Open-Label Period|Adverse Event|0|||
146187445|NCT04955626|527195090|FG035|Open-Label Period|Adverse Event|0|||
146187446|NCT04955626|527195055|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
146187447|NCT04955626|527195056|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
146187448|NCT04955626|527195057|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
146187449|NCT04955626|527195058|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
146187450|NCT04955626|527195059|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
146187451|NCT04955626|527195060|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
146187452|NCT04955626|527195061|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
146187453|NCT04955626|527195062|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
146187454|NCT04955626|527195063|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
146187455|NCT04955626|527195064|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
146187456|NCT04955626|527195065|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
146187457|NCT04955626|527195066|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
146187458|NCT04955626|527195067|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
146187459|NCT04955626|527195068|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
146187460|NCT04955626|527195069|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
146187461|NCT04955626|527195070|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
146187462|NCT04955626|527195071|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
146187463|NCT04955626|527195072|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
146187464|NCT04955626|527195073|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
146187465|NCT04955626|527195074|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
146187466|NCT04955626|527195075|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
146187467|NCT04955626|527195076|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
146187468|NCT04955626|527195077|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
146187469|NCT04955626|527195078|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
146187470|NCT04955626|527195079|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
146187471|NCT04955626|527195080|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
146187472|NCT04955626|527195081|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
146187473|NCT04955626|527195082|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
146187474|NCT04955626|527195083|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
146187475|NCT04955626|527195084|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
146187476|NCT04955626|527195085|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
146187477|NCT04955626|527195086|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
146187478|NCT04955626|527195087|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
146187479|NCT04955626|527195088|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
146187480|NCT04955626|527195089|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
146081595|NCT03339297|526818291|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
146081596|NCT03339297|526818290|FG000|Overall Study|Patient Was Not Eligible|1|||
146081597|NCT03339297|526818291|FG001|Overall Study|Patient Was Not Eligible|0|||
146081598|NCT03241368|526818298|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
146081599|NCT03241368|526818298|FG000|Overall Study|Lost to Follow-up|1|||
146081600|NCT03241368|526818298|FG000|Overall Study|Physician Decision|6|||
146081601|NCT03241368|526818298|FG000|Overall Study|Withdrawal by Subject|6|||
146081602|NCT03241368|526818298|FG000|Overall Study|Protocol Violation|1|||
146234996|NCT01499849|527378440|FG001|Overall Study|Disease Progression|10|||
146187481|NCT04955626|527195090|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
146187482|NCT04955626|527195055|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187483|NCT04955626|527195056|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
146187484|NCT04955626|527195057|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187485|NCT04955626|527195058|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187486|NCT04955626|527195059|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187487|NCT04955626|527195060|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187488|NCT04955626|527195061|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187489|NCT04955626|527195062|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187490|NCT04955626|527195063|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187491|NCT04955626|527195064|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146234997|NCT01499849|527378439|FG000|Overall Study|Protocol Violation|11|||
146187492|NCT04955626|527195065|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187493|NCT04955626|527195066|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187494|NCT04955626|527195067|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187495|NCT04955626|527195068|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187496|NCT04955626|527195069|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187497|NCT04955626|527195070|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187498|NCT04955626|527195071|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187499|NCT04955626|527195072|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187500|NCT04955626|527195073|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187501|NCT04955626|527195074|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187502|NCT04955626|527195075|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187503|NCT04955626|527195076|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187504|NCT04955626|527195077|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187505|NCT04955626|527195078|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187506|NCT04955626|527195079|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187507|NCT04955626|527195080|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187508|NCT04955626|527195081|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187509|NCT04955626|527195082|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187510|NCT04955626|527195083|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187511|NCT04955626|527195084|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187512|NCT04955626|527195085|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187513|NCT04955626|527195086|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187514|NCT04955626|527195087|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187515|NCT04955626|527195088|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187516|NCT04955626|527195089|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187517|NCT04955626|527195090|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
146187518|NCT04320615|527195091|FG000|Overall Study|Withdrawal by Subject|4|||
146187519|NCT04320615|527195092|FG001|Overall Study|Withdrawal by Subject|10|||
146187520|NCT04320615|527195091|FG000|Overall Study|Physician Decision|2|||
146187521|NCT04320615|527195092|FG001|Overall Study|Physician Decision|0|||
146187522|NCT04320615|527195091|FG000|Overall Study|Other|2|||
146187523|NCT04320615|527195092|FG001|Overall Study|Other|0|||
146187524|NCT04320615|527195091|FG000|Overall Study|Lost to Follow-up|5|||
146187525|NCT04320615|527195092|FG001|Overall Study|Lost to Follow-up|23|||
146187526|NCT04320615|527195091|FG000|Overall Study|Death|35|||
146187527|NCT04320615|527195092|FG001|Overall Study|Death|71|||
146187528|NCT04060680|527195094|FG000|Overall Study|Unsuccessful implant|17|||
146187529|NCT04060680|527195095|FG001|Overall Study|Unsuccessful implant|2|||
146187530|NCT04060680|527195094|FG000|Overall Study|Adverse Event|3|||
146187531|NCT04060680|527195095|FG001|Overall Study|Adverse Event|0|||
146187532|NCT04060680|527195094|FG000|Overall Study|Death|2|||
146187533|NCT04060680|527195095|FG001|Overall Study|Death|0|||
146187534|NCT04060680|527195094|FG000|Overall Study|Study product no longer in use|1|||
146187535|NCT04060680|527195095|FG001|Overall Study|Study product no longer in use|0|||
146187536|NCT04060680|527195094|FG000|Overall Study|Withdrawal by Subject|1|||
146187537|NCT04060680|527195095|FG001|Overall Study|Withdrawal by Subject|0|||
146187538|NCT03990363|527195096|FG000|Overall Study|Withdrawal by Subject|10|||
146187539|NCT03990363|527195097|FG001|Overall Study|Withdrawal by Subject|9|||
146187540|NCT03990363|527195098|FG002|Overall Study|Withdrawal by Subject|18|||
146187541|NCT03990363|527195099|FG003|Overall Study|Withdrawal by Subject|11|||
146187542|NCT03990363|527195100|FG004|Overall Study|Withdrawal by Subject|9|||
146187543|NCT03990363|527195096|FG000|Overall Study|Physician Decision|1|||
146187544|NCT03990363|527195097|FG001|Overall Study|Physician Decision|0|||
146187545|NCT03990363|527195098|FG002|Overall Study|Physician Decision|0|||
146187546|NCT03990363|527195099|FG003|Overall Study|Physician Decision|0|||
146187547|NCT03990363|527195100|FG004|Overall Study|Physician Decision|0|||
146187548|NCT03990363|527195096|FG000|Overall Study|Adverse Event|1|||
146187549|NCT03990363|527195097|FG001|Overall Study|Adverse Event|3|||
146187550|NCT03990363|527195098|FG002|Overall Study|Adverse Event|2|||
146187551|NCT03990363|527195099|FG003|Overall Study|Adverse Event|2|||
146187552|NCT03990363|527195100|FG004|Overall Study|Adverse Event|0|||
146187553|NCT03990363|527195096|FG000|Overall Study|Death|14|||
146187554|NCT03990363|527195097|FG001|Overall Study|Death|8|||
146187555|NCT03990363|527195098|FG002|Overall Study|Death|14|||
146187556|NCT03990363|527195099|FG003|Overall Study|Death|10|||
146187557|NCT03990363|527195100|FG004|Overall Study|Death|11|||
146187558|NCT03990363|527195096|FG000|Overall Study|Failure to meet randomization criteria|0|||
146187559|NCT03990363|527195097|FG001|Overall Study|Failure to meet randomization criteria|1|||
146187560|NCT03990363|527195098|FG002|Overall Study|Failure to meet randomization criteria|1|||
146187561|NCT03990363|527195099|FG003|Overall Study|Failure to meet randomization criteria|0|||
146187562|NCT03990363|527195100|FG004|Overall Study|Failure to meet randomization criteria|0|||
146187563|NCT03990363|527195096|FG000|Overall Study|Lost to Follow-up|0|||
146187564|NCT03990363|527195097|FG001|Overall Study|Lost to Follow-up|0|||
146187565|NCT03990363|527195098|FG002|Overall Study|Lost to Follow-up|0|||
146187566|NCT03990363|527195099|FG003|Overall Study|Lost to Follow-up|1|||
146187567|NCT03990363|527195100|FG004|Overall Study|Lost to Follow-up|2|||
146187568|NCT03990363|527195096|FG000|Overall Study|Non-compliance with study drug|2|||
146187569|NCT03990363|527195097|FG001|Overall Study|Non-compliance with study drug|1|||
146187570|NCT03990363|527195098|FG002|Overall Study|Non-compliance with study drug|2|||
146187571|NCT03990363|527195099|FG003|Overall Study|Non-compliance with study drug|0|||
146187572|NCT03990363|527195100|FG004|Overall Study|Non-compliance with study drug|0|||
146187573|NCT03990363|527195096|FG000|Overall Study|Study terminated by sponsor|0|||
146187574|NCT03990363|527195097|FG001|Overall Study|Study terminated by sponsor|1|||
146187575|NCT03990363|527195098|FG002|Overall Study|Study terminated by sponsor|0|||
146187576|NCT03990363|527195099|FG003|Overall Study|Study terminated by sponsor|0|||
146187577|NCT03990363|527195100|FG004|Overall Study|Study terminated by sponsor|0|||
146187578|NCT03990363|527195096|FG000|Overall Study|Site terminated by sponsor|2|||
146187579|NCT03990363|527195097|FG001|Overall Study|Site terminated by sponsor|1|||
146187580|NCT03990363|527195098|FG002|Overall Study|Site terminated by sponsor|2|||
146187581|NCT03990363|527195099|FG003|Overall Study|Site terminated by sponsor|0|||
146187582|NCT03990363|527195100|FG004|Overall Study|Site terminated by sponsor|2|||
146187583|NCT03990363|527195096|FG000|Overall Study|Not categorized|5|||
146187584|NCT03990363|527195097|FG001|Overall Study|Not categorized|5|||
146187585|NCT03990363|527195098|FG002|Overall Study|Not categorized|3|||
146187586|NCT03990363|527195099|FG003|Overall Study|Not categorized|2|||
146187587|NCT03990363|527195100|FG004|Overall Study|Not categorized|2|||
146187588|NCT02169219|527195102|FG000|Overall Study|Lack of Efficacy|6|||
146187589|NCT02886936|527195103|FG000|Overall Study|Lost to Follow-up|4|||
146187590|NCT02886936|527195104|FG001|Overall Study|Lost to Follow-up|3|||
146187591|NCT02886936|527195105|FG002|Overall Study|Lost to Follow-up|0|||
146187592|NCT04562779|527195106|FG000|Overall Study|Lost to Follow-up|7|||
146187593|NCT04562779|527195107|FG001|Overall Study|Lost to Follow-up|5|||
146187594|NCT04562779|527195108|FG002|Overall Study|Lost to Follow-up|10|||
146187595|NCT04562779|527195106|FG000|Overall Study|Protocol Violation|2|||
146187596|NCT04562779|527195107|FG001|Overall Study|Protocol Violation|2|||
146187597|NCT04562779|527195108|FG002|Overall Study|Protocol Violation|0|||
146187598|NCT02320721|527195109|FG000|Overall Study|Adverse Event|6|||
146187599|NCT02320721|527195110|FG001|Overall Study|Adverse Event|6|||
146187600|NCT02320721|527195109|FG000|Overall Study|Lack of Efficacy|2|||
146187601|NCT02320721|527195110|FG001|Overall Study|Lack of Efficacy|0|||
146187602|NCT02320721|527195109|FG000|Overall Study|Poor compliance to protocol|3|||
146187603|NCT02320721|527195110|FG001|Overall Study|Poor compliance to protocol|7|||
146187604|NCT02320721|527195109|FG000|Overall Study|Randomized but not treated|0|||
146187605|NCT02320721|527195110|FG001|Overall Study|Randomized but not treated|1|||
146187606|NCT02320721|527195109|FG000|Overall Study|Hypoglycemia|1|||
146187607|NCT02320721|527195110|FG001|Overall Study|Hypoglycemia|0|||
146187608|NCT02320721|527195109|FG000|Overall Study|Other than specified above|15|||
146187609|NCT02320721|527195110|FG001|Overall Study|Other than specified above|20|||
146187610|NCT05397470|527195111|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
146187611|NCT05397470|527195112|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
146187612|NCT05397470|527195113|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
146187613|NCT05397470|527195111|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
146187614|NCT05397470|527195112|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
146187615|NCT05397470|527195113|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
146187616|NCT05397470|527195111|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
146187617|NCT05397470|527195112|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
146187618|NCT05397470|527195113|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
146187619|NCT05397470|527195111|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
146187620|NCT05397470|527195112|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
146187621|NCT05397470|527195113|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
146187622|NCT05397470|527195111|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
146187623|NCT05397470|527195112|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
146187624|NCT05397470|527195113|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
146187625|NCT05397470|527195111|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
146187626|NCT05397470|527195112|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
146187627|NCT05397470|527195113|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
146187628|NCT05397470|527195111|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
146187629|NCT05397470|527195112|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
146187630|NCT05397470|527195113|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
146187631|NCT05567952|527196204|FG000|Overall Study|Lost to Follow-up|3|||
146187632|NCT05567952|527196205|FG001|Overall Study|Lost to Follow-up|2|||
146187633|NCT05567952|527196204|FG000|Overall Study|Withdrawal by Subject|6|||
146187634|NCT05567952|527196205|FG001|Overall Study|Withdrawal by Subject|3|||
146187635|NCT05567952|527196204|FG000|Overall Study|Other|3|||
146187636|NCT05567952|527196205|FG001|Overall Study|Other|1|||
146187637|NCT05194735|527196206|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
146187638|NCT05194735|527196207|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
146187639|NCT05194735|527196208|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
146187640|NCT05194735|527196206|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
146187641|NCT05194735|527196207|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
146234998|NCT01499849|527378440|FG001|Overall Study|Protocol Violation|11|||
146187642|NCT05194735|527196208|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
146187643|NCT05194735|527196206|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
146187644|NCT05194735|527196207|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
146187645|NCT05194735|527196208|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
146187646|NCT05194735|527196206|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
146187647|NCT05194735|527196207|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
146187648|NCT05194735|527196208|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
146187649|NCT01616563|527196210|FG000|Overall Study|Lost to Follow-up|40|||
146187650|NCT01106287|527196211|FG000|Overall Study|Adverse Event|1|||
146187651|NCT01106287|527196212|FG001|Overall Study|Adverse Event|0|||
146187652|NCT01106287|527196213|FG002|Overall Study|Adverse Event|0|||
146187653|NCT01106287|527196214|FG003|Overall Study|Adverse Event|0|||
146187654|NCT00072475|527196215|FG000|Overall Study|Adverse Event|44|||
146187655|NCT00072475|527196215|FG000|Overall Study|Death|3|||
146187656|NCT00072475|527196215|FG000|Overall Study|Withdrawal by Subject|46|||
146187657|NCT00072475|527196215|FG000|Overall Study|Patient/Investigator Decision|4|||
146187658|NCT02123966|527196218|FG000|Overall Study|Intercurrent Illness|1|||
146187659|NCT01460381|527196219|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
146187660|NCT01460381|527196220|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
146187661|NCT01097655|527196221|FG000|Overall Study|Withdrawal by Subject|1|||
146187662|NCT01097655|527196221|FG000|Overall Study|Subject Documented Twice|1|||
146187663|NCT01097655|527196221|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
146187664|NCT01033643|527196223|FG000|Overall Study|Withdrew Consent|0|||
146187665|NCT01033643|527196224|FG001|Overall Study|Withdrew Consent|3|||
146187666|NCT01033643|527196225|FG002|Overall Study|Withdrew Consent|0|||
146187667|NCT01033643|527196226|FG003|Overall Study|Withdrew Consent|0|||
146187668|NCT01033643|527196227|FG004|Overall Study|Withdrew Consent|0|||
146187669|NCT01033643|527196228|FG005|Overall Study|Withdrew Consent|1|||
146187670|NCT02652130|527196235|FG000|Overall Study|Death|1|||
146187671|NCT02028884|527196236|FG000|Double-blind Period|Adverse Event|5|||
146187672|NCT02028884|527196237|FG001|Double-blind Period|Adverse Event|3|||
146187673|NCT02028884|527196238|FG002|Double-blind Period|Adverse Event|0|||
146187674|NCT02028884|527196236|FG000|Double-blind Period|Eligibility Violation|1|||
146187675|NCT02028884|527196237|FG001|Double-blind Period|Eligibility Violation|0|||
146187676|NCT02028884|527196238|FG002|Double-blind Period|Eligibility Violation|0|||
146187677|NCT02028884|527196236|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
146187678|NCT02028884|527196237|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
146187679|NCT02028884|527196238|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
146187680|NCT02028884|527196236|FG000|Double-blind Period|Withdrawal by Subject|2|||
146187681|NCT02028884|527196237|FG001|Double-blind Period|Withdrawal by Subject|0|||
146187682|NCT02028884|527196238|FG002|Double-blind Period|Withdrawal by Subject|0|||
146187683|NCT02028884|527196236|FG000|Open-label Extension Period|Adverse Event|3|||
146187684|NCT02028884|527196237|FG001|Open-label Extension Period|Adverse Event|1|||
146187685|NCT02028884|527196238|FG002|Open-label Extension Period|Adverse Event|0|||
146187686|NCT02028884|527196236|FG000|Open-label Extension Period|Lack of Efficacy|3|||
146187687|NCT02028884|527196237|FG001|Open-label Extension Period|Lack of Efficacy|0|||
146187688|NCT02028884|527196238|FG002|Open-label Extension Period|Lack of Efficacy|0|||
146187689|NCT02028884|527196236|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146187690|NCT02028884|527196237|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
146187691|NCT02028884|527196238|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146187692|NCT02028884|527196236|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146187693|NCT02028884|527196237|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
146187694|NCT02028884|527196238|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
146187695|NCT02028884|527196236|FG000|Open-label Extension Period|Switched to another treatment option|3|||
146187696|NCT02028884|527196237|FG001|Open-label Extension Period|Switched to another treatment option|0|||
146187697|NCT02028884|527196238|FG002|Open-label Extension Period|Switched to another treatment option|0|||
146187698|NCT02403674|527196239|FG000|Base Study|Death|1|||
146187699|NCT02403674|527196240|FG001|Base Study|Death|4|||
146187700|NCT02403674|527196239|FG000|Base Study|Adverse Event|11|||
146187701|NCT02403674|527196240|FG001|Base Study|Adverse Event|26|||
146187702|NCT02403674|527196239|FG000|Base Study|Lack of Efficacy|31|||
146187703|NCT02403674|527196240|FG001|Base Study|Lack of Efficacy|23|||
146187704|NCT02403674|527196239|FG000|Base Study|Lost to Follow-up|6|||
146187705|NCT02403674|527196240|FG001|Base Study|Lost to Follow-up|8|||
146187706|NCT02403674|527196239|FG000|Base Study|Withdrawal by Subject|10|||
146187707|NCT02403674|527196240|FG001|Base Study|Withdrawal by Subject|17|||
146187708|NCT02403674|527196239|FG000|Base Study|Physician Decision|2|||
146187709|NCT02403674|527196240|FG001|Base Study|Physician Decision|2|||
146187710|NCT02403674|527196239|FG000|Base Study|Pregnancy|2|||
146187711|NCT02403674|527196240|FG001|Base Study|Pregnancy|2|||
146187712|NCT02403674|527196239|FG000|Base Study|Protocol Violation|8|||
146187713|NCT02403674|527196240|FG001|Base Study|Protocol Violation|4|||
146187714|NCT02403674|527196239|FG000|Base Study|Non-Compliance with study drug|1|||
146187715|NCT02403674|527196240|FG001|Base Study|Non-Compliance with study drug|4|||
146187716|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
146187717|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
146187718|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
146187719|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
146187720|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
146187721|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
146187722|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
146187723|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
146187724|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
146187725|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
146187726|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
146187727|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
146187728|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Death|1|||
146187729|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Death|0|||
146187730|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
146187731|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
146187732|NCT02403674|527196239|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
146187733|NCT02403674|527196240|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
146187734|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
146187735|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
146187736|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
146187737|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
146187738|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
146187739|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
146187740|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
146187741|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
146187742|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
146187743|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
146187744|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Death|2|||
146187745|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Death|2|||
146187746|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
146187747|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
146187748|NCT02403674|527196239|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
146187749|NCT02403674|527196240|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
146187750|NCT02403674|527196239|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
146187751|NCT02403674|527196240|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
146187752|NCT02403674|527196239|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
146187753|NCT02403674|527196240|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
146187754|NCT02403674|527196239|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
146187755|NCT02403674|527196240|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
146187756|NCT02403674|527196239|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
146187757|NCT02403674|527196240|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
146187758|NCT02403674|527196239|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
146187759|NCT02403674|527196240|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
146187760|NCT00826280|527196241|FG000|Overall Study|Randomized but drug not received|1|||
146187761|NCT00826280|527196242|FG001|Overall Study|Randomized but drug not received|0|||
146187762|NCT00826280|527196243|FG002|Overall Study|Randomized but drug not received|1|||
146187763|NCT00826280|527196241|FG000|Overall Study|Adverse Event|1|||
146187764|NCT00826280|527196242|FG001|Overall Study|Adverse Event|3|||
146187765|NCT00826280|527196243|FG002|Overall Study|Adverse Event|0|||
146187766|NCT00826280|527196241|FG000|Overall Study|Lost to Follow-up|0|||
146187767|NCT00826280|527196242|FG001|Overall Study|Lost to Follow-up|1|||
146187768|NCT00826280|527196243|FG002|Overall Study|Lost to Follow-up|0|||
146187769|NCT00826280|527196241|FG000|Overall Study|Sponsor discontinued subject or study|1|||
146187770|NCT00826280|527196242|FG001|Overall Study|Sponsor discontinued subject or study|0|||
146234999|NCT01499849|527378439|FG000|Overall Study|Physician Decision|20|||
146187771|NCT00826280|527196243|FG002|Overall Study|Sponsor discontinued subject or study|0|||
146187772|NCT00826280|527196241|FG000|Overall Study|Reversible ischemic defect not present|43|||
146187773|NCT00826280|527196242|FG001|Overall Study|Reversible ischemic defect not present|40|||
146187774|NCT00826280|527196243|FG002|Overall Study|Reversible ischemic defect not present|44|||
146187775|NCT00826280|527196241|FG000|Overall Study|Interpretation Failure|1|||
146187776|NCT00826280|527196242|FG001|Overall Study|Interpretation Failure|0|||
146187777|NCT00826280|527196243|FG002|Overall Study|Interpretation Failure|0|||
146187778|NCT00826280|527196241|FG000|Overall Study|Machine Failure|1|||
146187779|NCT00826280|527196242|FG001|Overall Study|Machine Failure|1|||
146187780|NCT00826280|527196243|FG002|Overall Study|Machine Failure|0|||
146187781|NCT00826280|527196241|FG000|Overall Study|One or more non-interpretable scan|0|||
146187782|NCT00826280|527196242|FG001|Overall Study|One or more non-interpretable scan|1|||
146187783|NCT00826280|527196243|FG002|Overall Study|One or more non-interpretable scan|1|||
146187784|NCT03487666|527196244|FG000|Overall Study|Disease progression|4|||
146187785|NCT03487666|527196245|FG001|Overall Study|Disease progression|2|||
146187786|NCT03487666|527196246|FG002|Overall Study|Disease progression|0|||
146187787|NCT03487666|527196244|FG000|Overall Study|Adverse Event|0|||
146187788|NCT03487666|527196245|FG001|Overall Study|Adverse Event|0|||
146187789|NCT03487666|527196246|FG002|Overall Study|Adverse Event|1|||
146187790|NCT03201757|527196247|FG000|Overall Study|Withdrawal by Subject|133|||
146187791|NCT03201757|527196247|FG000|Overall Study|Adverse Event|44|||
146187792|NCT03201757|527196247|FG000|Overall Study|Lost to Follow-up|37|||
146187793|NCT03201757|527196247|FG000|Overall Study|Pregnancy|2|||
146187794|NCT03201757|527196247|FG000|Overall Study|Lack of Efficacy|1|||
146187795|NCT03201757|527196247|FG000|Overall Study|Protocol Violation|20|||
146187796|NCT03201757|527196247|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
146187797|NCT03201757|527196247|FG000|Overall Study|Not Yet Determined|5|||
146187798|NCT03201757|527196247|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
146187799|NCT03201757|527196247|FG000|Overall Study|Other|20|||
146187800|NCT00765362|527196249|FG000|Overall Study|Death|9|||
146187801|NCT00765362|527196249|FG000|Overall Study|Adverse Event|2|||
146187802|NCT00765362|527196249|FG000|Overall Study|Protocol Violation|18|||
146187803|NCT00765362|527196249|FG000|Overall Study|Withdrawal by Subject|13|||
146187804|NCT00765362|527196249|FG000|Overall Study|Lost to Follow-up|95|||
146187805|NCT00664521|527196253|FG000|Overall Study|Adverse Event|4|||
146187806|NCT00664521|527196254|FG001|Overall Study|Adverse Event|1|||
146187807|NCT00664521|527196253|FG000|Overall Study|Lost to Follow-up|1|||
146187808|NCT00664521|527196254|FG001|Overall Study|Lost to Follow-up|0|||
146187809|NCT00664521|527196253|FG000|Overall Study|Other|1|||
146187810|NCT00664521|527196254|FG001|Overall Study|Other|0|||
146187811|NCT02800928|527196257|FG000|Overall Study|Withdrawal by Subject|1|||
146187812|NCT02800928|527196258|FG001|Overall Study|Withdrawal by Subject|1|||
146187813|NCT02800928|527196257|FG000|Overall Study|Protocol Violation|1|||
146187814|NCT02800928|527196258|FG001|Overall Study|Protocol Violation|1|||
146187815|NCT02118714|527196267|FG000|Overall Study|Lost to Follow-up|2|||
146187816|NCT02118714|527196267|FG000|Overall Study|Protocol Violation|1|||
146187817|NCT02013687|527196268|FG000|Overall Study|Lost to Follow-up|0|||
146187818|NCT02013687|527196269|FG001|Overall Study|Lost to Follow-up|0|||
146187819|NCT02013687|527196270|FG002|Overall Study|Lost to Follow-up|1|||
146187820|NCT02013687|527196271|FG003|Overall Study|Lost to Follow-up|0|||
146187821|NCT02013687|527196268|FG000|Overall Study|Protocol Violation|0|||
146187822|NCT02013687|527196269|FG001|Overall Study|Protocol Violation|0|||
146187823|NCT02013687|527196270|FG002|Overall Study|Protocol Violation|0|||
146187824|NCT02013687|527196271|FG003|Overall Study|Protocol Violation|1|||
146187825|NCT02013687|527196268|FG000|Overall Study|Withdrawal by Subject|0|||
146187826|NCT02013687|527196269|FG001|Overall Study|Withdrawal by Subject|0|||
146187827|NCT02013687|527196270|FG002|Overall Study|Withdrawal by Subject|0|||
146187828|NCT02013687|527196271|FG003|Overall Study|Withdrawal by Subject|1|||
146187829|NCT02013687|527196268|FG000|Overall Study|Missed visits due to patient travel|0|||
146187830|NCT02013687|527196269|FG001|Overall Study|Missed visits due to patient travel|0|||
146187831|NCT02013687|527196270|FG002|Overall Study|Missed visits due to patient travel|1|||
146187832|NCT02013687|527196271|FG003|Overall Study|Missed visits due to patient travel|0|||
146187833|NCT01653847|527196272|FG000|Overall Study|Withdrawal by Subject|1|||
146187834|NCT01653847|527196273|FG001|Overall Study|Withdrawal by Subject|0|||
146187835|NCT00388362|527196274|FG000|Enrolled|Ineligible|1|||
146187836|NCT00388362|527196274|FG000|Enrolled|Adverse Event|9|||
146187837|NCT00388362|527196274|FG000|Enrolled|Death|1|||
146187838|NCT00388362|527196274|FG000|Enrolled|Loss insurance|1|||
146187839|NCT00388362|527196274|FG000|Enrolled|Withdrawal by Subject|1|||
146187840|NCT00388362|527196274|FG000|Remained on Study Median of 514 Days|Death|2|||
146187841|NCT02335268|527196275|FG000|Overall Study|Physician Decision|5|||
146187842|NCT02335268|527196276|FG001|Overall Study|Physician Decision|1|||
146187843|NCT02335268|527196275|FG000|Overall Study|Lack of Efficacy|2|||
146187844|NCT02335268|527196276|FG001|Overall Study|Lack of Efficacy|1|||
146187845|NCT02335268|527196275|FG000|Overall Study|Adverse Event|5|||
146187846|NCT02335268|527196276|FG001|Overall Study|Adverse Event|2|||
146187847|NCT02335268|527196275|FG000|Overall Study|increase blasts|2|||
146187848|NCT02335268|527196276|FG001|Overall Study|increase blasts|0|||
146187849|NCT02335268|527196275|FG000|Overall Study|Withdrawal by Subject|3|||
146187850|NCT02335268|527196276|FG001|Overall Study|Withdrawal by Subject|2|||
146187851|NCT05893797|527196281|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
146187852|NCT05893797|527196281|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
146187853|NCT05893797|527196281|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
146187854|NCT05893797|527196281|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
146187855|NCT04770220|527196282|FG000|Overall Study|Adverse Event|2|||
146187856|NCT04770220|527196283|FG001|Overall Study|Adverse Event|11|||
146187857|NCT04770220|527196282|FG000|Overall Study|Withdrawal by Subject|5|||
146187858|NCT04770220|527196283|FG001|Overall Study|Withdrawal by Subject|11|||
146187859|NCT04770220|527196282|FG000|Overall Study|Lost to Follow-up|4|||
146187860|NCT04770220|527196283|FG001|Overall Study|Lost to Follow-up|3|||
146187861|NCT04770220|527196282|FG000|Overall Study|not otherwise specified|2|||
146187862|NCT04770220|527196283|FG001|Overall Study|not otherwise specified|3|||
146187863|NCT04770220|527196282|FG000|Overall Study|Physician Decision|1|||
146187864|NCT04770220|527196283|FG001|Overall Study|Physician Decision|3|||
146187865|NCT00003509|527196285|FG000|Overall Study|Not evaluable|5|||
146187866|NCT03658811|527196286|FG000|Overall Study|Lost to Follow-up|3|||
146187867|NCT04951479|527196288|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
146187868|NCT03706690|527196289|FG000|Overall Study|Withdrawal by Subject|8|||
146187869|NCT03706690|527196290|FG001|Overall Study|Withdrawal by Subject|8|||
146187870|NCT03706690|527196289|FG000|Overall Study|Death|143|||
146187871|NCT03706690|527196290|FG001|Overall Study|Death|75|||
146187872|NCT03706690|527196289|FG000|Overall Study|Ongoing at DCO|121|||
146187873|NCT03706690|527196290|FG001|Overall Study|Ongoing at DCO|52|||
146187874|NCT03803774|527196291|FG000|Dose Escalation|Withdrawal by Subject|0|||
146187875|NCT03803774|527196292|FG001|Dose Escalation|Withdrawal by Subject|0|||
146187876|NCT03803774|527196293|FG002|Dose Escalation|Withdrawal by Subject|0|||
146187877|NCT03803774|527196294|FG003|Dose Escalation|Withdrawal by Subject|1|||
146187878|NCT03803774|527196295|FG004|Dose Escalation|Withdrawal by Subject|0|||
146187879|NCT02711826|527196296|FG000|Overall Study|Physician Decision|0|||
146187880|NCT02711826|527196297|FG001|Overall Study|Physician Decision|0|||
146187881|NCT02711826|527196298|FG002|Overall Study|Physician Decision|0|||
146187882|NCT02711826|527196299|FG003|Overall Study|Physician Decision|1|||
146187883|NCT02711826|527196300|FG004|Overall Study|Physician Decision|0|||
146187884|NCT02711826|527196296|FG000|Overall Study|Withdrawal by Subject|0|||
146187885|NCT02711826|527196297|FG001|Overall Study|Withdrawal by Subject|1|||
146187886|NCT02711826|527196298|FG002|Overall Study|Withdrawal by Subject|0|||
146187887|NCT02711826|527196299|FG003|Overall Study|Withdrawal by Subject|4|||
146187888|NCT02711826|527196300|FG004|Overall Study|Withdrawal by Subject|0|||
146187889|NCT02711826|527196296|FG000|Overall Study|Failure to manufacture cellular product|0|||
146187890|NCT02711826|527196297|FG001|Overall Study|Failure to manufacture cellular product|0|||
146187891|NCT02711826|527196298|FG002|Overall Study|Failure to manufacture cellular product|5|||
146187892|NCT02711826|527196299|FG003|Overall Study|Failure to manufacture cellular product|0|||
146187893|NCT02711826|527196300|FG004|Overall Study|Failure to manufacture cellular product|0|||
146187894|NCT02711826|527196296|FG000|Overall Study|Infusion canceled for active infection|0|||
146187895|NCT02711826|527196297|FG001|Overall Study|Infusion canceled for active infection|1|||
146187896|NCT02711826|527196298|FG002|Overall Study|Infusion canceled for active infection|0|||
146187897|NCT02711826|527196299|FG003|Overall Study|Infusion canceled for active infection|0|||
146187898|NCT02711826|527196300|FG004|Overall Study|Infusion canceled for active infection|0|||
146187899|NCT02711826|527196296|FG000|Overall Study|Screen failures|0|||
146187900|NCT02711826|527196297|FG001|Overall Study|Screen failures|0|||
146187901|NCT02711826|527196298|FG002|Overall Study|Screen failures|0|||
146187902|NCT02711826|527196299|FG003|Overall Study|Screen failures|4|||
146187903|NCT02711826|527196300|FG004|Overall Study|Screen failures|0|||
146187904|NCT00729690|527196301|FG000|Overall Study|IT Catheter Malfunction|0|||
146187905|NCT00729690|527196302|FG001|Overall Study|IT Catheter Malfunction|2|||
146187906|NCT00729690|527196303|FG002|Overall Study|IT Catheter Malfunction|2|||
146187907|NCT02507219|527196304|FG000|Overall Study|Physician Decision|1|||
146187908|NCT02507219|527196305|FG001|Overall Study|Physician Decision|0|||
146187909|NCT02507219|527196306|FG002|Overall Study|Physician Decision|0|||
146187910|NCT02507219|527196307|FG003|Overall Study|Physician Decision|0|||
146187911|NCT02507219|527196308|FG004|Overall Study|Physician Decision|0|||
146187912|NCT02507219|527196309|FG005|Overall Study|Physician Decision|0|||
146187913|NCT02507219|527196304|FG000|Overall Study|Withdrawal by Subject|0|||
146187914|NCT02507219|527196305|FG001|Overall Study|Withdrawal by Subject|0|||
146187915|NCT02507219|527196306|FG002|Overall Study|Withdrawal by Subject|0|||
146187916|NCT02507219|527196307|FG003|Overall Study|Withdrawal by Subject|0|||
146187917|NCT02507219|527196308|FG004|Overall Study|Withdrawal by Subject|1|||
146187918|NCT02507219|527196309|FG005|Overall Study|Withdrawal by Subject|0|||
146187919|NCT02419755|527196310|FG000|Overall Study|Death|1|||
146187920|NCT02419755|527196311|FG001|Overall Study|Death|3|||
146187921|NCT02419755|527196310|FG000|Overall Study|Relapse|0|||
146187922|NCT02419755|527196311|FG001|Overall Study|Relapse|1|||
146187923|NCT02419755|527196310|FG000|Overall Study|Ineligible|1|||
146187924|NCT02419755|527196311|FG001|Overall Study|Ineligible|0|||
146187925|NCT02419755|527196310|FG000|Overall Study|Withdrawal by Subject|1|||
146187926|NCT02419755|527196311|FG001|Overall Study|Withdrawal by Subject|0|||
146187927|NCT06403605|527196314|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
146187928|NCT06403605|527196315|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
146187929|NCT06403605|527196314|FG000|Follow-up|Adverse Event|4|||
146187930|NCT06403605|527196315|FG001|Follow-up|Adverse Event|2|||
146187931|NCT06403605|527196314|FG000|Follow-up|Withdrawal by Subject|2|||
146187932|NCT06403605|527196315|FG001|Follow-up|Withdrawal by Subject|3|||
146187933|NCT06403605|527196314|FG000|Follow-up|Lost to Follow-up|1|||
146187934|NCT06403605|527196315|FG001|Follow-up|Lost to Follow-up|0|||
146187935|NCT06403605|527196314|FG000|Follow-up|Death|1|||
146187936|NCT06403605|527196315|FG001|Follow-up|Death|0|||
146187937|NCT06403605|527196314|FG000|Follow-up|Other reasons|0|||
146187938|NCT06403605|527196315|FG001|Follow-up|Other reasons|4|||
146187939|NCT00394095|527198088|FG000|Screening|Withdrawal by Subject|1|||
146187940|NCT00394095|527198089|FG001|Screening|Withdrawal by Subject|0|||
146187941|NCT00394095|527198088|FG000|Randomized|Withdrawal by Subject|5|||
146187942|NCT00394095|527198089|FG001|Randomized|Withdrawal by Subject|1|||
146187943|NCT00394095|527198088|FG000|Randomized|Adverse Event|1|||
146187944|NCT00394095|527198089|FG001|Randomized|Adverse Event|1|||
146187945|NCT00394095|527198088|FG000|Randomized|Overdose|1|||
146187946|NCT00394095|527198089|FG001|Randomized|Overdose|0|||
146187947|NCT00394095|527198088|FG000|Randomized|Lost to Follow-up|1|||
146187948|NCT00394095|527198089|FG001|Randomized|Lost to Follow-up|2|||
146187949|NCT01256476|527198091|FG000|Overall Study|Adverse Event|2|||
146187950|NCT01256476|527198092|FG001|Overall Study|Adverse Event|1|||
146187951|NCT01256476|527198091|FG000|Overall Study|Withdrawal by Subject|2|||
146187952|NCT01256476|527198092|FG001|Overall Study|Withdrawal by Subject|1|||
146187953|NCT01256476|527198091|FG000|Overall Study|Lost to Follow-up|1|||
146187954|NCT01256476|527198092|FG001|Overall Study|Lost to Follow-up|2|||
146187955|NCT01256476|527198091|FG000|Overall Study|Persistent ALT or AST elevation|1|||
146187956|NCT01256476|527198092|FG001|Overall Study|Persistent ALT or AST elevation|0|||
146187957|NCT01256476|527198091|FG000|Overall Study|Physician Decision|0|||
146187958|NCT01256476|527198092|FG001|Overall Study|Physician Decision|1|||
146187959|NCT01256476|527198091|FG000|Overall Study|Subject non-compliance|0|||
146187960|NCT01256476|527198092|FG001|Overall Study|Subject non-compliance|1|||
146187961|NCT01256476|527198091|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
146187962|NCT01256476|527198092|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
146187963|NCT02401529|527198095|FG000|Overall Study|Lost to Follow-up|2|||
146187964|NCT02401529|527198096|FG001|Overall Study|Lost to Follow-up|1|||
146187965|NCT02401529|527198095|FG000|Overall Study|Physician Decision|2|||
146187966|NCT02401529|527198096|FG001|Overall Study|Physician Decision|6|||
146187967|NCT02401529|527198095|FG000|Overall Study|Protocol Violation|5|||
146187968|NCT02401529|527198096|FG001|Overall Study|Protocol Violation|0|||
146187969|NCT00924664|527198099|FG000|Overall Study|Adverse Event|23|||
146187970|NCT00924664|527198100|FG001|Overall Study|Adverse Event|39|||
146187971|NCT00924664|527198099|FG000|Overall Study|Lack of Efficacy|10|||
146187972|NCT00924664|527198100|FG001|Overall Study|Lack of Efficacy|15|||
146187973|NCT00924664|527198099|FG000|Overall Study|Lost to Follow-up|10|||
146187974|NCT00924664|527198100|FG001|Overall Study|Lost to Follow-up|12|||
146187975|NCT00924664|527198099|FG000|Overall Study|Withdrawal by Subject|47|||
146187976|NCT00924664|527198100|FG001|Overall Study|Withdrawal by Subject|71|||
146187977|NCT00924664|527198099|FG000|Overall Study|Protocol Violation|2|||
146187978|NCT00924664|527198100|FG001|Overall Study|Protocol Violation|5|||
146187979|NCT00924664|527198099|FG000|Overall Study|Pregnancy|1|||
146187980|NCT00924664|527198100|FG001|Overall Study|Pregnancy|1|||
146187981|NCT00924664|527198099|FG000|Overall Study|Death|0|||
146187982|NCT00924664|527198100|FG001|Overall Study|Death|2|||
146187983|NCT00924664|527198099|FG000|Overall Study|Study terminated by sponsor|199|||
146187984|NCT00924664|527198100|FG001|Overall Study|Study terminated by sponsor|330|||
146187985|NCT00924664|527198099|FG000|Overall Study|Other|29|||
146187986|NCT00924664|527198100|FG001|Overall Study|Other|52|||
146187987|NCT00924664|527198099|FG000|Overall Study|Randomized but not Treated|1|||
146187988|NCT00924664|527198100|FG001|Overall Study|Randomized but not Treated|0|||
146187989|NCT01598987|527198101|FG000|Baseline to Month 12|Administrative problems|2|||
146187990|NCT01598987|527198101|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
146187991|NCT01598987|527198101|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
146187992|NCT01598987|527198101|FG000|Baseline to 24 Month|Administrative problems|2|||
146187993|NCT01598987|527198101|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
146187994|NCT01450943|527198105|FG000|Overall Study|Screen failure, loss to follow-up|2|||
146187995|NCT01450943|527198106|FG001|Overall Study|Screen failure, loss to follow-up|7|||
146187996|NCT01450943|527198107|FG002|Overall Study|Screen failure, loss to follow-up|6|||
146187997|NCT03303105|527198108|FG000|Overall Study|Adverse Event|0|||
146187998|NCT03303105|527198109|FG001|Overall Study|Adverse Event|2|||
146187999|NCT03303105|527198108|FG000|Overall Study|Lack of Efficacy|1|||
146188000|NCT03303105|527198109|FG001|Overall Study|Lack of Efficacy|0|||
146188001|NCT03303105|527198108|FG000|Overall Study|Protocol Violation|1|||
146188002|NCT03303105|527198109|FG001|Overall Study|Protocol Violation|0|||
146188003|NCT03303105|527198108|FG000|Overall Study|Withdrawal by Subject|0|||
146188004|NCT03303105|527198109|FG001|Overall Study|Withdrawal by Subject|2|||
146188005|NCT04822298|527198112|FG000|Overall Study|Death|3|||
146188006|NCT01333943|527198116|FG000|Overall Study|Known neuropathy|1|||
146188007|NCT01333943|527198117|FG001|Overall Study|Known neuropathy|0|||
146188008|NCT01789203|527198118|FG000|Overall Study|Adverse Event|2|||
146188009|NCT01789203|527198119|FG001|Overall Study|Adverse Event|2|||
146188010|NCT01789203|527198118|FG000|Overall Study|Withdrawal by Subject|1|||
146188011|NCT01789203|527198119|FG001|Overall Study|Withdrawal by Subject|0|||
146188012|NCT01789203|527198118|FG000|Overall Study|Death|1|||
146188013|NCT01789203|527198119|FG001|Overall Study|Death|0|||
146188014|NCT01789203|527198118|FG000|Overall Study|Protocol Violation|2|||
146188015|NCT01789203|527198119|FG001|Overall Study|Protocol Violation|1|||
146188016|NCT01789203|527198118|FG000|Overall Study|Other|1|||
146188017|NCT01789203|527198119|FG001|Overall Study|Other|1|||
146188018|NCT01789203|527198118|FG000|Overall Study|patient non-adherent|2|||
146188019|NCT01789203|527198119|FG001|Overall Study|patient non-adherent|0|||
146188020|NCT01254305|527198126|FG000|Overall Study|Adverse Event|6|||
146188021|NCT01254305|527198127|FG001|Overall Study|Adverse Event|3|||
146188022|NCT01254305|527198128|FG002|Overall Study|Adverse Event|2|||
146188023|NCT01254305|527198126|FG000|Overall Study|Lack of Efficacy|1|||
146188024|NCT01254305|527198127|FG001|Overall Study|Lack of Efficacy|0|||
146188025|NCT01254305|527198128|FG002|Overall Study|Lack of Efficacy|1|||
146188026|NCT01254305|527198126|FG000|Overall Study|Protocol Violation|1|||
146188027|NCT01254305|527198127|FG001|Overall Study|Protocol Violation|7|||
146188028|NCT01254305|527198128|FG002|Overall Study|Protocol Violation|3|||
146188029|NCT01254305|527198126|FG000|Overall Study|Withdrawal by Subject|4|||
146188030|NCT01254305|527198127|FG001|Overall Study|Withdrawal by Subject|2|||
146188031|NCT01254305|527198128|FG002|Overall Study|Withdrawal by Subject|4|||
146188032|NCT01254305|527198126|FG000|Overall Study|Lost to Follow-up|10|||
146188033|NCT01254305|527198127|FG001|Overall Study|Lost to Follow-up|6|||
146188034|NCT01254305|527198128|FG002|Overall Study|Lost to Follow-up|5|||
146188035|NCT01254305|527198126|FG000|Overall Study|Other Reasons|0|||
146188036|NCT01254305|527198127|FG001|Overall Study|Other Reasons|0|||
146188037|NCT01254305|527198128|FG002|Overall Study|Other Reasons|2|||
146188038|NCT00557505|527198132|FG000|Overall Study|Death|0|||
146188039|NCT00557505|527198133|FG001|Overall Study|Death|0|||
146188040|NCT00557505|527198134|FG002|Overall Study|Death|0|||
146188041|NCT00557505|527198135|FG003|Overall Study|Death|0|||
146188042|NCT00557505|527198136|FG004|Overall Study|Death|0|||
146188043|NCT00557505|527198137|FG005|Overall Study|Death|0|||
146188044|NCT00557505|527198138|FG006|Overall Study|Death|0|||
146188045|NCT00557505|527198139|FG007|Overall Study|Death|0|||
146188046|NCT00557505|527198140|FG008|Overall Study|Death|1|||
146188047|NCT00557505|527198132|FG000|Overall Study|Adverse Event|0|||
146188048|NCT00557505|527198133|FG001|Overall Study|Adverse Event|0|||
146188049|NCT00557505|527198134|FG002|Overall Study|Adverse Event|1|||
146188050|NCT00557505|527198135|FG003|Overall Study|Adverse Event|0|||
146188051|NCT00557505|527198136|FG004|Overall Study|Adverse Event|0|||
146188052|NCT00557505|527198137|FG005|Overall Study|Adverse Event|0|||
146188053|NCT00557505|527198138|FG006|Overall Study|Adverse Event|1|||
146188054|NCT00557505|527198139|FG007|Overall Study|Adverse Event|0|||
146188055|NCT00557505|527198140|FG008|Overall Study|Adverse Event|0|||
146188056|NCT00557505|527198132|FG000|Overall Study|Global deterioration of health|1|||
146188057|NCT00557505|527198133|FG001|Overall Study|Global deterioration of health|0|||
146188058|NCT00557505|527198134|FG002|Overall Study|Global deterioration of health|0|||
146188059|NCT00557505|527198135|FG003|Overall Study|Global deterioration of health|0|||
146188060|NCT00557505|527198136|FG004|Overall Study|Global deterioration of health|0|||
146188061|NCT00557505|527198137|FG005|Overall Study|Global deterioration of health|0|||
146188062|NCT00557505|527198138|FG006|Overall Study|Global deterioration of health|0|||
146188063|NCT00557505|527198139|FG007|Overall Study|Global deterioration of health|0|||
146188064|NCT00557505|527198140|FG008|Overall Study|Global deterioration of health|0|||
146188065|NCT00557505|527198132|FG000|Overall Study|Objective progression or relapse|2|||
146188066|NCT00557505|527198133|FG001|Overall Study|Objective progression or relapse|3|||
146188067|NCT00557505|527198134|FG002|Overall Study|Objective progression or relapse|3|||
146188068|NCT00557505|527198135|FG003|Overall Study|Objective progression or relapse|2|||
146188069|NCT00557505|527198136|FG004|Overall Study|Objective progression or relapse|2|||
146188070|NCT00557505|527198137|FG005|Overall Study|Objective progression or relapse|3|||
146188071|NCT00557505|527198138|FG006|Overall Study|Objective progression or relapse|2|||
146188072|NCT00557505|527198139|FG007|Overall Study|Objective progression or relapse|5|||
146188073|NCT00557505|527198140|FG008|Overall Study|Objective progression or relapse|15|||
146188074|NCT00557505|527198132|FG000|Overall Study|Withdrawal by Subject|0|||
146188075|NCT00557505|527198133|FG001|Overall Study|Withdrawal by Subject|0|||
146188076|NCT00557505|527198134|FG002|Overall Study|Withdrawal by Subject|0|||
146188077|NCT00557505|527198135|FG003|Overall Study|Withdrawal by Subject|1|||
146188078|NCT00557505|527198136|FG004|Overall Study|Withdrawal by Subject|0|||
146188079|NCT00557505|527198137|FG005|Overall Study|Withdrawal by Subject|0|||
146188080|NCT00557505|527198138|FG006|Overall Study|Withdrawal by Subject|0|||
146188081|NCT00557505|527198139|FG007|Overall Study|Withdrawal by Subject|0|||
146188082|NCT00557505|527198140|FG008|Overall Study|Withdrawal by Subject|1|||
146188083|NCT03019458|527198141|FG000|Overall Study|Death|0|||
146188084|NCT03019458|527198142|FG001|Overall Study|Death|1|||
146188085|NCT00031447|527198143|FG000|Overall Study|Lost to Follow-up|0|||
146188086|NCT00031447|527198144|FG001|Overall Study|Lost to Follow-up|1|||
146188087|NCT00031447|527198143|FG000|Overall Study|Non-compliant|1|||
146188088|NCT00031447|527198144|FG001|Overall Study|Non-compliant|1|||
146188089|NCT00031447|527198143|FG000|Overall Study|Re-activation of Disease|2|||
146188090|NCT00031447|527198144|FG001|Overall Study|Re-activation of Disease|1|||
146188091|NCT00031447|527198143|FG000|Overall Study|Disruption of blinded study drug supply|7|||
146188092|NCT00031447|527198144|FG001|Overall Study|Disruption of blinded study drug supply|4|||
146188093|NCT01636362|527198145|FG000|Overall Study|Physician Decision|6|||
146188094|NCT01636362|527198145|FG000|Overall Study|Subject healed, not returning|1|||
146188095|NCT01636362|527198145|FG000|Overall Study|Withdrawal by Subject|1|||
146188096|NCT00519779|527198148|FG000|Overall Study|Withdrawal by Subject|0|||
146188097|NCT00519779|527198149|FG001|Overall Study|Withdrawal by Subject|1|||
146188098|NCT03330119|527198150|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
146188099|NCT03330119|527198151|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
146188100|NCT01561079|527198152|FG000|Overall Study|Physician Decision|17|||
146188101|NCT01561079|527198152|FG000|Overall Study|Withdrawal by Subject|59|||
146188102|NCT01561079|527198152|FG000|Overall Study|Protocol Violation|2|||
146188103|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
146188104|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146188105|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
146188106|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146188107|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
146188108|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
146188109|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
146188110|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
146188111|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
146188112|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
146188113|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
146188114|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
146188115|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146188116|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
146188117|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146188118|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146188119|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
146188120|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
146188121|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146188122|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146188123|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146188124|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146188125|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
146188126|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146188127|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146188128|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146188129|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146188130|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146188131|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146188132|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146188133|NCT01323660|527198153|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
146188134|NCT01323660|527198154|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146188135|NCT01323660|527198155|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146188136|NCT01323660|527198156|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146188137|NCT01323660|527198157|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146188138|NCT01323660|527198158|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146188139|NCT01323660|527198153|FG000|Washout Period (14 Days)|Adverse Event|0|||
146188140|NCT01323660|527198154|FG001|Washout Period (14 Days)|Adverse Event|0|||
146188141|NCT01323660|527198155|FG002|Washout Period (14 Days)|Adverse Event|0|||
146188142|NCT01323660|527198156|FG003|Washout Period (14 Days)|Adverse Event|0|||
146188143|NCT01323660|527198157|FG004|Washout Period (14 Days)|Adverse Event|1|||
146188144|NCT01323660|527198158|FG005|Washout Period (14 Days)|Adverse Event|0|||
146188145|NCT01323660|527198153|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
146188146|NCT01323660|527198154|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
146188147|NCT01323660|527198155|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
146188148|NCT01323660|527198156|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
146188149|NCT01323660|527198157|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
146188150|NCT01323660|527198158|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
146188151|NCT01323660|527198153|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146188152|NCT01323660|527198154|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146188153|NCT01323660|527198155|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146188154|NCT01323660|527198156|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146188155|NCT01323660|527198157|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
146188156|NCT01323660|527198158|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
146188157|NCT01323660|527198153|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
146188158|NCT01323660|527198154|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146188159|NCT01323660|527198155|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146188160|NCT01323660|527198156|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
146188161|NCT01323660|527198157|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146188162|NCT01323660|527198158|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
146188163|NCT01323660|527198153|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146188164|NCT01323660|527198154|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146188165|NCT01323660|527198155|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146188166|NCT01323660|527198156|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146188167|NCT01323660|527198157|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
146188168|NCT01323660|527198158|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
146188169|NCT01323660|527198153|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146188170|NCT01323660|527198154|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146188171|NCT01323660|527198155|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146188172|NCT01323660|527198156|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146188173|NCT01323660|527198157|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
146188174|NCT01323660|527198158|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
146188175|NCT01323660|527198153|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146188176|NCT01323660|527198154|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146188177|NCT01323660|527198155|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146188178|NCT01323660|527198156|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146188179|NCT01323660|527198157|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
146188180|NCT01323660|527198158|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146188181|NCT02886728|527198165|FG000|Overall Study|Withdrew Consent|31|||
146188182|NCT02886728|527198166|FG001|Overall Study|Withdrew Consent|13|||
146188183|NCT02886728|527198167|FG002|Overall Study|Withdrew Consent|11|||
146188184|NCT02886728|527198168|FG003|Overall Study|Withdrew Consent|47|||
146188185|NCT02886728|527198165|FG000|Overall Study|Lost to Follow-up|12|||
146188186|NCT02886728|527198166|FG001|Overall Study|Lost to Follow-up|6|||
146188187|NCT02886728|527198167|FG002|Overall Study|Lost to Follow-up|13|||
146188188|NCT02886728|527198168|FG003|Overall Study|Lost to Follow-up|12|||
146188189|NCT02886728|527198165|FG000|Overall Study|Adverse Event|13|||
146188190|NCT02886728|527198166|FG001|Overall Study|Adverse Event|5|||
146188191|NCT02886728|527198167|FG002|Overall Study|Adverse Event|5|||
146188192|NCT02886728|527198168|FG003|Overall Study|Adverse Event|11|||
146188193|NCT02886728|527198165|FG000|Overall Study|Investigator's Discretion|11|||
146188194|NCT02886728|527198166|FG001|Overall Study|Investigator's Discretion|7|||
146188195|NCT02886728|527198167|FG002|Overall Study|Investigator's Discretion|5|||
146188196|NCT02886728|527198168|FG003|Overall Study|Investigator's Discretion|11|||
146188197|NCT02886728|527198165|FG000|Overall Study|Death|3|||
146188198|NCT02886728|527198166|FG001|Overall Study|Death|1|||
146188199|NCT02886728|527198167|FG002|Overall Study|Death|0|||
146188200|NCT02886728|527198168|FG003|Overall Study|Death|0|||
146188201|NCT02886728|527198165|FG000|Overall Study|Protocol Violation|0|||
146188202|NCT02886728|527198166|FG001|Overall Study|Protocol Violation|0|||
146188203|NCT02886728|527198167|FG002|Overall Study|Protocol Violation|0|||
146188204|NCT02886728|527198168|FG003|Overall Study|Protocol Violation|4|||
146188205|NCT02886728|527198165|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146188206|NCT02886728|527198166|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146188207|NCT02886728|527198167|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146188208|NCT02886728|527198168|FG003|Overall Study|Non-Compliance with Study Drug|0|||
146188209|NCT02886728|527198165|FG000|Overall Study|Pregnancy|0|||
146188210|NCT02886728|527198166|FG001|Overall Study|Pregnancy|0|||
146188211|NCT02886728|527198167|FG002|Overall Study|Pregnancy|1|||
146081603|NCT00065429|526818301|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081604|NCT00065429|526818302|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081605|NCT00065429|526818303|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081606|NCT00065429|526818304|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081607|NCT00065429|526818305|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081608|NCT00065429|526818306|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
146081609|NCT00065429|526818307|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
146081610|NCT00065429|526818301|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081611|NCT00065429|526818302|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081612|NCT00065429|526818303|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
146081613|NCT00065429|526818304|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081614|NCT00065429|526818305|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081615|NCT00065429|526818306|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081616|NCT00065429|526818307|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
146081617|NCT00065429|526818301|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
146081618|NCT00065429|526818302|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081619|NCT00065429|526818303|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081620|NCT00065429|526818304|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081621|NCT00065429|526818305|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081622|NCT00065429|526818306|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081623|NCT00065429|526818307|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
146081624|NCT00065429|526818301|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
146081625|NCT00065429|526818302|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
146081626|NCT00065429|526818303|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
146081627|NCT00065429|526818304|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
146188212|NCT02886728|527198168|FG003|Overall Study|Pregnancy|0|||
146081628|NCT00065429|526818305|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
146081629|NCT00065429|526818306|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
146081630|NCT00065429|526818307|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
146081631|NCT00065429|526818301|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146081632|NCT00065429|526818302|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146081633|NCT00065429|526818303|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146081634|NCT00065429|526818304|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
146081635|NCT00065429|526818305|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
146081636|NCT00065429|526818306|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
146081637|NCT00065429|526818307|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
146081638|NCT00065429|526818301|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081639|NCT00065429|526818302|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081640|NCT00065429|526818303|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081641|NCT00065429|526818304|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081642|NCT00065429|526818305|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
146081643|NCT00065429|526818306|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081644|NCT00065429|526818307|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
146081645|NCT00065429|526818301|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081646|NCT00065429|526818302|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081647|NCT00065429|526818303|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081648|NCT00065429|526818304|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081649|NCT00065429|526818305|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
146081650|NCT00065429|526818306|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081651|NCT00065429|526818307|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
146081652|NCT00832624|526818311|FG000|Overall Study|Study Terminated|10|||
146081653|NCT00636363|526818314|FG000|Overall Study|Conjunctivitis|0|||
146081654|NCT00636363|526818315|FG001|Overall Study|Conjunctivitis|0|||
146081655|NCT00636363|526818316|FG002|Overall Study|Conjunctivitis|1|||
146081656|NCT00636363|526818314|FG000|Overall Study|Adverse Event|0|||
146081657|NCT00636363|526818315|FG001|Overall Study|Adverse Event|0|||
146081658|NCT00636363|526818316|FG002|Overall Study|Adverse Event|1|||
146081659|NCT00636363|526818314|FG000|Overall Study|Positive slit lamp finding|0|||
146081660|NCT00636363|526818315|FG001|Overall Study|Positive slit lamp finding|2|||
146081661|NCT00636363|526818316|FG002|Overall Study|Positive slit lamp finding|1|||
146081662|NCT00636363|526818314|FG000|Overall Study|Study related symptoms/complaints|8|||
146081663|NCT00636363|526818315|FG001|Overall Study|Study related symptoms/complaints|7|||
146081664|NCT00636363|526818316|FG002|Overall Study|Study related symptoms/complaints|4|||
146081665|NCT00636363|526818314|FG000|Overall Study|Met ineligibility criteria|0|||
146081666|NCT00636363|526818315|FG001|Overall Study|Met ineligibility criteria|0|||
146081667|NCT00636363|526818316|FG002|Overall Study|Met ineligibility criteria|3|||
146081668|NCT00636363|526818314|FG000|Overall Study|Missed > 1 visit|0|||
146081669|NCT00636363|526818315|FG001|Overall Study|Missed > 1 visit|1|||
146081670|NCT00636363|526818316|FG002|Overall Study|Missed > 1 visit|3|||
146081671|NCT00636363|526818314|FG000|Overall Study|Lack of motivation|1|||
146081672|NCT00636363|526818315|FG001|Overall Study|Lack of motivation|0|||
146081673|NCT00636363|526818316|FG002|Overall Study|Lack of motivation|1|||
146081674|NCT00636363|526818314|FG000|Overall Study|Protocol Violation|0|||
146081675|NCT00636363|526818315|FG001|Overall Study|Protocol Violation|3|||
146081676|NCT00636363|526818316|FG002|Overall Study|Protocol Violation|0|||
146081677|NCT00636363|526818314|FG000|Overall Study|Lost to Follow-up|3|||
146081678|NCT00636363|526818315|FG001|Overall Study|Lost to Follow-up|4|||
146081679|NCT00636363|526818316|FG002|Overall Study|Lost to Follow-up|2|||
146081680|NCT00636363|526818314|FG000|Overall Study|Withdrawal by Subject|1|||
146081681|NCT00636363|526818315|FG001|Overall Study|Withdrawal by Subject|3|||
146081682|NCT00636363|526818316|FG002|Overall Study|Withdrawal by Subject|2|||
146081683|NCT00280748|526818320|FG000|Overall Study|Decline in performance|3|||
146081684|NCT00280748|526818320|FG000|Overall Study|Extra-cranial disease progression|1|||
146081685|NCT01765218|526818321|FG000|Overall Study|Protocol Violation|1|||
146081686|NCT01765218|526818322|FG001|Overall Study|Protocol Violation|2|||
146081687|NCT00313781|526818323|FG000|Before Crossover|Death|22|||
146081688|NCT00313781|526818324|FG001|Before Crossover|Death|8|||
146081689|NCT00313781|526818325|FG002|Before Crossover|Death|0|||
146081690|NCT00313781|526818323|FG000|Before Crossover|Lost to Follow-up|0|||
146081691|NCT00313781|526818324|FG001|Before Crossover|Lost to Follow-up|3|||
146081692|NCT00313781|526818325|FG002|Before Crossover|Lost to Follow-up|0|||
146081693|NCT00313781|526818323|FG000|Before Crossover|Withdrawal by Subject|3|||
146081694|NCT00313781|526818324|FG001|Before Crossover|Withdrawal by Subject|1|||
146081695|NCT00313781|526818325|FG002|Before Crossover|Withdrawal by Subject|0|||
146081696|NCT00313781|526818323|FG000|Before Crossover|Other|45|||
146081697|NCT00313781|526818324|FG001|Before Crossover|Other|30|||
146081698|NCT00313781|526818325|FG002|Before Crossover|Other|0|||
146081699|NCT00313781|526818323|FG000|Before Crossover|Crossover|0|||
146081700|NCT00313781|526818324|FG001|Before Crossover|Crossover|37|||
146081701|NCT00313781|526818325|FG002|Before Crossover|Crossover|0|||
146081702|NCT00313781|526818323|FG000|Before Crossover|Randomized, not treated|5|||
146188213|NCT02886728|527198165|FG000|Overall Study|Randomized but Not Dosed|1|||
146188214|NCT02886728|527198166|FG001|Overall Study|Randomized but Not Dosed|0|||
146188215|NCT02886728|527198167|FG002|Overall Study|Randomized but Not Dosed|0|||
146188216|NCT02886728|527198168|FG003|Overall Study|Randomized but Not Dosed|2|||
146188217|NCT04990440|527198173|FG000|Overall Study|Sponsor's Decision|0|||
146188218|NCT04990440|527198174|FG001|Overall Study|Sponsor's Decision|0|||
146188219|NCT04990440|527198175|FG002|Overall Study|Sponsor's Decision|1|||
146188220|NCT03712098|527198176|FG000|Overall Study|Lost to Follow-up|3|||
146188221|NCT03712098|527198177|FG001|Overall Study|Lost to Follow-up|7|||
146188222|NCT03712098|527198176|FG000|Overall Study|Withdrawal by Subject|9|||
146188223|NCT03712098|527198177|FG001|Overall Study|Withdrawal by Subject|4|||
146188224|NCT03712098|527198176|FG000|Overall Study|Protocol Violation|2|||
146188225|NCT03712098|527198177|FG001|Overall Study|Protocol Violation|1|||
146188226|NCT02954575|527198182|FG000|Overall Study|Withdrawal by Subject|2|||
146188227|NCT02954575|527198182|FG000|Overall Study|Adverse Event|1|||
146188228|NCT01066156|527198184|FG000|Overall Study|ineligible|2|||
146188229|NCT01066156|527198184|FG000|Overall Study|Lost to Follow-up|7|||
146188230|NCT01066156|527198184|FG000|Overall Study|Withdrawal by Subject|1|||
146188231|NCT00570661|527198185|FG000|Overall Study|Disease worsening|5|||
146188232|NCT00570661|527198185|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
146188233|NCT00570661|527198185|FG000|Overall Study|Adverse Event|1|||
146188234|NCT01734382|527198189|FG000|Part 1|Adverse Event|2|||
146188235|NCT01734382|527198190|FG001|Part 1|Adverse Event|0|||
146188236|NCT01734382|527198191|FG002|Part 1|Adverse Event|0|||
146188237|NCT01734382|527198189|FG000|Part 2|Adverse Event|0|||
146188238|NCT01734382|527198190|FG001|Part 2|Adverse Event|0|||
146188239|NCT01734382|527198191|FG002|Part 2|Adverse Event|1|||
146188240|NCT01734382|527198189|FG000|Part 2|Lack of Efficacy|0|||
146188241|NCT01734382|527198190|FG001|Part 2|Lack of Efficacy|1|||
146188242|NCT01734382|527198191|FG002|Part 2|Lack of Efficacy|1|||
146188243|NCT01734382|527198189|FG000|Part 2|Other|0|||
146188244|NCT01734382|527198190|FG001|Part 2|Other|0|||
146188245|NCT01734382|527198191|FG002|Part 2|Other|1|||
146188246|NCT01734382|527198189|FG000|Part 2|Physician Decision|0|||
146188247|NCT01734382|527198190|FG001|Part 2|Physician Decision|0|||
146188248|NCT01734382|527198191|FG002|Part 2|Physician Decision|3|||
146188249|NCT01734382|527198189|FG000|Part 2|Protocol Violation|0|||
146188250|NCT01734382|527198190|FG001|Part 2|Protocol Violation|1|||
146188251|NCT01734382|527198191|FG002|Part 2|Protocol Violation|0|||
146188252|NCT01734382|527198189|FG000|Part 2|Withdrawal by Subject|0|||
146188253|NCT01734382|527198190|FG001|Part 2|Withdrawal by Subject|0|||
146188254|NCT01734382|527198191|FG002|Part 2|Withdrawal by Subject|1|||
146188255|NCT02015663|527198193|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
146188256|NCT02015663|527198194|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
146188257|NCT02015663|527198193|FG000|Overall Study|Withdrawal by Subject|1|||
146188258|NCT02015663|527198194|FG001|Overall Study|Withdrawal by Subject|0|||
146188259|NCT02015663|527198193|FG000|Overall Study|Protocol Violation|0|||
146188260|NCT02015663|527198194|FG001|Overall Study|Protocol Violation|1|||
146188261|NCT02015663|527198193|FG000|Overall Study|Adverse Event|3|||
146188262|NCT02015663|527198194|FG001|Overall Study|Adverse Event|0|||
146188263|NCT02015663|527198193|FG000|Overall Study|Administrative problems|10|||
146188264|NCT02015663|527198194|FG001|Overall Study|Administrative problems|11|||
146188265|NCT00146640|527198199|FG000|Overall Study|Adverse Event|12|||
146188266|NCT00146640|527198200|FG001|Overall Study|Adverse Event|10|||
146188267|NCT00146640|527198199|FG000|Overall Study|Medical Reasons|3|||
146188268|NCT00146640|527198200|FG001|Overall Study|Medical Reasons|0|||
146188269|NCT00146640|527198199|FG000|Overall Study|Non-Medical Reasons|8|||
146188270|NCT00146640|527198200|FG001|Overall Study|Non-Medical Reasons|4|||
146188271|NCT02059161|527198203|FG000|Overall Study|Pregnancy|0|||
146188272|NCT02059161|527198204|FG001|Overall Study|Pregnancy|2|||
146188273|NCT02059161|527198203|FG000|Overall Study|Adverse Event|2|||
146188274|NCT02059161|527198204|FG001|Overall Study|Adverse Event|6|||
146188275|NCT02059161|527198203|FG000|Overall Study|Lost to Follow-up|20|||
146188276|NCT02059161|527198204|FG001|Overall Study|Lost to Follow-up|12|||
146188277|NCT02059161|527198203|FG000|Overall Study|Physician Decision|4|||
146188278|NCT02059161|527198204|FG001|Overall Study|Physician Decision|4|||
146188279|NCT02059161|527198203|FG000|Overall Study|Protocol Violation|1|||
146188280|NCT02059161|527198204|FG001|Overall Study|Protocol Violation|1|||
146188281|NCT02059161|527198203|FG000|Overall Study|Withdrawal by Subject|16|||
146188282|NCT02059161|527198204|FG001|Overall Study|Withdrawal by Subject|13|||
146188283|NCT02059161|527198203|FG000|Overall Study|Randomized in error, no study drug|0|||
146188284|NCT02059161|527198204|FG001|Overall Study|Randomized in error, no study drug|1|||
146188285|NCT02059161|527198203|FG000|Overall Study|Non-compliance with study drug|6|||
146188286|NCT02059161|527198204|FG001|Overall Study|Non-compliance with study drug|2|||
146188287|NCT03293485|527198205|FG000|Overall Study|Death|1|||
146188288|NCT03293485|527198205|FG000|Overall Study|Screen Failure|2|||
146188289|NCT03293485|527198205|FG000|Overall Study|Withdrawal by Subject|2|||
146188290|NCT01723826|527198209|FG000|Overall Study|Adverse Event|4|||
146188291|NCT01723826|527198210|FG001|Overall Study|Adverse Event|1|||
146188292|NCT01723826|527198211|FG002|Overall Study|Adverse Event|4|||
146188293|NCT01723826|527198212|FG003|Overall Study|Adverse Event|5|||
146188294|NCT01723826|527198209|FG000|Overall Study|Death according to AE eCRF|2|||
146188295|NCT01723826|527198210|FG001|Overall Study|Death according to AE eCRF|3|||
146188296|NCT01723826|527198211|FG002|Overall Study|Death according to AE eCRF|3|||
146188297|NCT01723826|527198212|FG003|Overall Study|Death according to AE eCRF|7|||
146188298|NCT01723826|527198209|FG000|Overall Study|Lost to Follow-up|1|||
146188299|NCT01723826|527198210|FG001|Overall Study|Lost to Follow-up|3|||
146188300|NCT01723826|527198211|FG002|Overall Study|Lost to Follow-up|1|||
146188301|NCT01723826|527198212|FG003|Overall Study|Lost to Follow-up|1|||
146188302|NCT01723826|527198209|FG000|Overall Study|Non-compliance|0|||
146188303|NCT01723826|527198210|FG001|Overall Study|Non-compliance|1|||
146188304|NCT01723826|527198211|FG002|Overall Study|Non-compliance|3|||
146188305|NCT01723826|527198212|FG003|Overall Study|Non-compliance|3|||
146188306|NCT01723826|527198209|FG000|Overall Study|Non-compliance With Study Drug|0|||
146188307|NCT01723826|527198210|FG001|Overall Study|Non-compliance With Study Drug|1|||
146188308|NCT01723826|527198211|FG002|Overall Study|Non-compliance With Study Drug|0|||
146188309|NCT01723826|527198212|FG003|Overall Study|Non-compliance With Study Drug|0|||
146188310|NCT01723826|527198209|FG000|Overall Study|Other Reason|8|||
146188311|NCT01723826|527198210|FG001|Overall Study|Other Reason|6|||
146188312|NCT01723826|527198211|FG002|Overall Study|Other Reason|12|||
146188313|NCT01723826|527198212|FG003|Overall Study|Other Reason|14|||
146188314|NCT01723826|527198209|FG000|Overall Study|Physician Decision|1|||
146188315|NCT01723826|527198210|FG001|Overall Study|Physician Decision|3|||
146188316|NCT01723826|527198211|FG002|Overall Study|Physician Decision|4|||
146188317|NCT01723826|527198212|FG003|Overall Study|Physician Decision|11|||
146188318|NCT01723826|527198209|FG000|Overall Study|Protocol Violation|1|||
146188319|NCT01723826|527198210|FG001|Overall Study|Protocol Violation|1|||
146188320|NCT01723826|527198211|FG002|Overall Study|Protocol Violation|3|||
146188321|NCT01723826|527198212|FG003|Overall Study|Protocol Violation|1|||
146188322|NCT01723826|527198209|FG000|Overall Study|Withdrawal by Subject|10|||
146188323|NCT01723826|527198210|FG001|Overall Study|Withdrawal by Subject|17|||
146188324|NCT01723826|527198211|FG002|Overall Study|Withdrawal by Subject|27|||
146188325|NCT01723826|527198212|FG003|Overall Study|Withdrawal by Subject|48|||
146188326|NCT01627340|527198213|FG000|Overall Study|Adverse Event|1|||
146188327|NCT01627340|527198214|FG001|Overall Study|Adverse Event|0|||
146188328|NCT01627340|527198213|FG000|Overall Study|Lost to Follow-up|8|||
146188329|NCT01627340|527198214|FG001|Overall Study|Lost to Follow-up|4|||
146188330|NCT01627340|527198213|FG000|Overall Study|Pregnancy|1|||
146188331|NCT01627340|527198214|FG001|Overall Study|Pregnancy|0|||
146188332|NCT01627340|527198213|FG000|Overall Study|Withdrawal by Subject|2|||
146188333|NCT01627340|527198214|FG001|Overall Study|Withdrawal by Subject|0|||
146188334|NCT03633903|527198217|FG000|Overall Study|Withdrawal by Subject|1|||
146188335|NCT03633903|527198218|FG001|Overall Study|Withdrawal by Subject|2|||
146188336|NCT03633903|527198217|FG000|Overall Study|Lost to Follow-up|5|||
146188337|NCT03633903|527198218|FG001|Overall Study|Lost to Follow-up|5|||
146188338|NCT02687919|527198229|FG000|Overall Study|Withdrawal by Subject|6|||
146188339|NCT02687919|527198230|FG001|Overall Study|Withdrawal by Subject|6|||
146188340|NCT02687919|527198229|FG000|Overall Study|Protocol Violation|2|||
146188341|NCT02687919|527198230|FG001|Overall Study|Protocol Violation|0|||
146188342|NCT00419003|527198231|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
146188343|NCT00419003|527198232|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
146188344|NCT00419003|527198231|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
146188345|NCT00419003|527198232|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
146188346|NCT00131911|527198233|FG000|Overall Study|Withdrawal by Subject|1|||
146188347|NCT00131911|527198234|FG001|Overall Study|Withdrawal by Subject|0|||
146188348|NCT02554513|527198235|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
146188349|NCT02554513|527198236|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
146188350|NCT01606189|527198239|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
146188351|NCT01606189|527198240|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
146188352|NCT01606189|527198241|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
146188353|NCT01606189|527198242|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
146188354|NCT01606189|527198243|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
146188355|NCT01606189|527198244|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
146188356|NCT01606189|527198239|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146188357|NCT01606189|527198240|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146188358|NCT01606189|527198241|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146188359|NCT01606189|527198242|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146188360|NCT01606189|527198243|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
146188361|NCT01606189|527198244|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
146188362|NCT01354938|527198245|FG000|Overall Study|Lost to Follow-up|1|||
146188363|NCT01167023|527198246|FG000|Overall Study|Lost to Follow-up|0|||
146188364|NCT01167023|527198247|FG001|Overall Study|Lost to Follow-up|1|||
146188365|NCT01167023|527198248|FG002|Overall Study|Lost to Follow-up|1|||
146188366|NCT01167023|527198246|FG000|Overall Study|Screen Failure|0|||
146188367|NCT01167023|527198247|FG001|Overall Study|Screen Failure|1|||
146188368|NCT01167023|527198248|FG002|Overall Study|Screen Failure|0|||
146188369|NCT01167023|527198246|FG000|Overall Study|Sponsor Decision|0|||
146188370|NCT01167023|527198247|FG001|Overall Study|Sponsor Decision|1|||
146188371|NCT01167023|527198248|FG002|Overall Study|Sponsor Decision|0|||
146188372|NCT01167023|527198246|FG000|Overall Study|Withdrawal by Subject|0|||
146188373|NCT01167023|527198247|FG001|Overall Study|Withdrawal by Subject|0|||
146188374|NCT01167023|527198248|FG002|Overall Study|Withdrawal by Subject|1|||
146188375|NCT00114959|527198261|FG000|Overall Study|Lack of Efficacy|6|||
146188376|NCT00114959|527198261|FG000|Overall Study|Physician Decision|1|||
146188377|NCT00114959|527198261|FG000|Overall Study|Death|1|||
146188378|NCT02491411|527199939|FG000|Overall Study|Physician Decision|4|||
146188379|NCT04034238|527199940|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
146188380|NCT04034238|527199941|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146188381|NCT04034238|527199942|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146188382|NCT04034238|527199943|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146188383|NCT04034238|527199940|FG000|Dose Escalation Phase|Screen failures|0|||
146188384|NCT04034238|527199941|FG001|Dose Escalation Phase|Screen failures|0|||
146188385|NCT04034238|527199942|FG002|Dose Escalation Phase|Screen failures|0|||
146188386|NCT04034238|527199943|FG003|Dose Escalation Phase|Screen failures|2|||
146188387|NCT04034238|527199940|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
146188388|NCT04034238|527199941|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
146188389|NCT04034238|527199942|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
146188390|NCT04034238|527199943|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
146188391|NCT04034238|527199940|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146188392|NCT04034238|527199941|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146188393|NCT04034238|527199942|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
146188394|NCT04034238|527199943|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
146188395|NCT00465361|527199944|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
146188396|NCT01511536|527199945|FG000|Phase 1|Other|0|||
146188397|NCT01511536|527199946|FG001|Phase 1|Other|1|||
146188398|NCT01511536|527199947|FG002|Phase 1|Other|0|||
146188399|NCT01511536|527199945|FG000|Phase 2|Other|0|||
146188400|NCT01511536|527199946|FG001|Phase 2|Other|0|||
146188401|NCT01511536|527199947|FG002|Phase 2|Other|9|||
146188402|NCT02297503|527199951|FG000|Overall Study|Withdrawal by Subject|1|||
146188403|NCT02297503|527199952|FG001|Overall Study|Withdrawal by Subject|1|||
146188404|NCT02297503|527199951|FG000|Overall Study|Protocol Violation|1|||
146188405|NCT02297503|527199952|FG001|Overall Study|Protocol Violation|0|||
146188406|NCT02297503|527199951|FG000|Overall Study|Pregnancy|0|||
146188407|NCT02297503|527199952|FG001|Overall Study|Pregnancy|1|||
146188408|NCT02297503|527199951|FG000|Overall Study|Lost to Follow-up|0|||
146188409|NCT02297503|527199952|FG001|Overall Study|Lost to Follow-up|1|||
146188410|NCT02297503|527199951|FG000|Overall Study|Medical reason|0|||
146188411|NCT02297503|527199952|FG001|Overall Study|Medical reason|1|||
146188412|NCT02703532|527199954|FG000|Overall Study|Withdrawal by Subject|0|||
146188413|NCT02703532|527199955|FG001|Overall Study|Withdrawal by Subject|1|||
146188414|NCT02703532|527199956|FG002|Overall Study|Withdrawal by Subject|0|||
146188415|NCT02703532|527199957|FG003|Overall Study|Withdrawal by Subject|1|||
146188416|NCT02703532|527199954|FG000|Overall Study|Lost to Follow-up|2|||
146188417|NCT02703532|527199955|FG001|Overall Study|Lost to Follow-up|0|||
146188418|NCT02703532|527199956|FG002|Overall Study|Lost to Follow-up|2|||
146188419|NCT02703532|527199957|FG003|Overall Study|Lost to Follow-up|0|||
146188420|NCT03738241|527199961|FG000|Overall Study|Withdrawal by Subject|0|||
146188421|NCT03738241|527199962|FG001|Overall Study|Withdrawal by Subject|0|||
146188422|NCT03738241|527199963|FG002|Overall Study|Withdrawal by Subject|0|||
146188423|NCT03738241|527199964|FG003|Overall Study|Withdrawal by Subject|0|||
146188424|NCT03738241|527199965|FG004|Overall Study|Withdrawal by Subject|0|||
146188425|NCT03738241|527199966|FG005|Overall Study|Withdrawal by Subject|0|||
146188426|NCT03738241|527199967|FG006|Overall Study|Withdrawal by Subject|0|||
146188427|NCT03738241|527199968|FG007|Overall Study|Withdrawal by Subject|0|||
146188428|NCT03738241|527199969|FG008|Overall Study|Withdrawal by Subject|0|||
146188429|NCT03738241|527199970|FG009|Overall Study|Withdrawal by Subject|1|||
146188430|NCT03738241|527199961|FG000|Overall Study|Physician Decision|0|||
146188431|NCT03738241|527199962|FG001|Overall Study|Physician Decision|0|||
146188432|NCT03738241|527199963|FG002|Overall Study|Physician Decision|0|||
146188433|NCT03738241|527199964|FG003|Overall Study|Physician Decision|0|||
146188434|NCT03738241|527199965|FG004|Overall Study|Physician Decision|0|||
146188435|NCT03738241|527199966|FG005|Overall Study|Physician Decision|0|||
146188436|NCT03738241|527199967|FG006|Overall Study|Physician Decision|0|||
146188437|NCT03738241|527199968|FG007|Overall Study|Physician Decision|0|||
146188438|NCT03738241|527199969|FG008|Overall Study|Physician Decision|1|||
146188439|NCT03738241|527199970|FG009|Overall Study|Physician Decision|0|||
146188440|NCT03738241|527199961|FG000|Overall Study|Adverse Event|1|||
146188441|NCT03738241|527199962|FG001|Overall Study|Adverse Event|0|||
146188442|NCT03738241|527199963|FG002|Overall Study|Adverse Event|0|||
146188443|NCT03738241|527199964|FG003|Overall Study|Adverse Event|0|||
146188444|NCT03738241|527199965|FG004|Overall Study|Adverse Event|0|||
146188445|NCT03738241|527199966|FG005|Overall Study|Adverse Event|0|||
146188446|NCT03738241|527199967|FG006|Overall Study|Adverse Event|0|||
146188447|NCT03738241|527199968|FG007|Overall Study|Adverse Event|0|||
146188448|NCT03738241|527199969|FG008|Overall Study|Adverse Event|0|||
146188449|NCT03738241|527199970|FG009|Overall Study|Adverse Event|0|||
146188450|NCT01244763|527199971|FG000|Overall Study|Adverse Event|1|||
146188451|NCT01244763|527199972|FG001|Overall Study|Adverse Event|0|||
146188452|NCT01244763|527199973|FG002|Overall Study|Adverse Event|0|||
146188453|NCT01244763|527199974|FG003|Overall Study|Adverse Event|0|||
146188454|NCT01244763|527199975|FG004|Overall Study|Adverse Event|0|||
146188455|NCT01244763|527199976|FG005|Overall Study|Adverse Event|1|||
146188456|NCT01244763|527199971|FG000|Overall Study|Death|1|||
146188457|NCT01244763|527199972|FG001|Overall Study|Death|0|||
146188458|NCT01244763|527199973|FG002|Overall Study|Death|1|||
146412438|NCT01605461|528015518|FG000|Overall Study|Lost to Follow-up|3|||
146412439|NCT01605461|528015518|FG000|Overall Study|Withdrawal by Subject|1|||
146412440|NCT02024698|528015519|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
146412441|NCT02024698|528015520|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
146412454|NCT04313283|528015523|FG000|Overall Study|did not complete intervention|4|||
146412455|NCT04132232|528015525|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
146412456|NCT04132232|528015526|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
146412457|NCT04132232|528015525|FG000|Overall Study|Lost to Follow-up|6|||
146412458|NCT04132232|528015526|FG001|Overall Study|Lost to Follow-up|7|||
146412459|NCT00368537|528015528|FG000|Randomization|No study drug dosed|13|||
146412460|NCT00368537|528015529|FG001|Randomization|No study drug dosed|6|||
146412461|NCT00368537|528015528|FG000|Baseline Participants|Lost to Follow-up|16|||
146412462|NCT00368537|528015529|FG001|Baseline Participants|Lost to Follow-up|17|||
146412463|NCT00368537|528015528|FG000|Baseline Participants|Withdrawal by Subject|6|||
146412464|NCT00368537|528015529|FG001|Baseline Participants|Withdrawal by Subject|4|||
146412465|NCT00368537|528015528|FG000|Baseline Participants|Death|1|||
146412466|NCT00368537|528015529|FG001|Baseline Participants|Death|2|||
146412467|NCT00368537|528015528|FG000|Baseline Participants|No susceptibility|1|||
146412468|NCT00368537|528015529|FG001|Baseline Participants|No susceptibility|0|||
146188459|NCT01244763|527199974|FG003|Overall Study|Death|0|||
146188460|NCT01244763|527199975|FG004|Overall Study|Death|2|||
146188461|NCT01244763|527199976|FG005|Overall Study|Death|0|||
146188462|NCT01244763|527199971|FG000|Overall Study|Physician Decision|0|||
146188463|NCT01244763|527199972|FG001|Overall Study|Physician Decision|0|||
146188464|NCT01244763|527199973|FG002|Overall Study|Physician Decision|1|||
146188465|NCT01244763|527199974|FG003|Overall Study|Physician Decision|0|||
146188466|NCT01244763|527199975|FG004|Overall Study|Physician Decision|0|||
146188467|NCT01244763|527199976|FG005|Overall Study|Physician Decision|0|||
146188468|NCT01244763|527199971|FG000|Overall Study|Withdrawal by Subject|1|||
146188469|NCT01244763|527199972|FG001|Overall Study|Withdrawal by Subject|2|||
146188470|NCT01244763|527199973|FG002|Overall Study|Withdrawal by Subject|0|||
146188471|NCT01244763|527199974|FG003|Overall Study|Withdrawal by Subject|1|||
146188472|NCT01244763|527199975|FG004|Overall Study|Withdrawal by Subject|1|||
146188473|NCT01244763|527199976|FG005|Overall Study|Withdrawal by Subject|2|||
146412469|NCT00368537|528015528|FG000|Baseline Participants|Patient uncompliant|0|||
146188474|NCT01244763|527199971|FG000|Overall Study|Lost to Follow-up|0|||
146188475|NCT01244763|527199972|FG001|Overall Study|Lost to Follow-up|1|||
146188476|NCT01244763|527199973|FG002|Overall Study|Lost to Follow-up|0|||
146188477|NCT01244763|527199974|FG003|Overall Study|Lost to Follow-up|0|||
146188478|NCT01244763|527199975|FG004|Overall Study|Lost to Follow-up|0|||
146188479|NCT01244763|527199976|FG005|Overall Study|Lost to Follow-up|0|||
146188480|NCT01244763|527199971|FG000|Overall Study|Enrolled into the Extension Study|0|||
146188481|NCT01244763|527199972|FG001|Overall Study|Enrolled into the Extension Study|0|||
146188482|NCT01244763|527199973|FG002|Overall Study|Enrolled into the Extension Study|0|||
146188483|NCT01244763|527199974|FG003|Overall Study|Enrolled into the Extension Study|0|||
146188484|NCT01244763|527199975|FG004|Overall Study|Enrolled into the Extension Study|0|||
146188485|NCT01244763|527199976|FG005|Overall Study|Enrolled into the Extension Study|1|||
146188486|NCT02788656|527199977|FG000|Overall Study|Withdrawal by Subject|1|||
146188487|NCT02788656|527199978|FG001|Overall Study|Withdrawal by Subject|0|||
146188488|NCT03169361|527199979|FG000|Overall Study|Protocol Violation|32|||
146188489|NCT02263885|527199980|FG000|Overall Study|Withdrawal by Subject|7|||
146188490|NCT02263885|527199980|FG000|Overall Study|Alternative Treatment|3|||
146188491|NCT00953160|527199993|FG000|Overall Study|Lost to Follow-up|23|||
146188492|NCT00953160|527199993|FG000|Overall Study|Withdrawal by Subject|4|||
146188493|NCT00425503|527199994|FG000|Overall Study|Adverse Event|2|||
146188494|NCT00425503|527199994|FG000|Overall Study|Protocol Violation|1|||
146188495|NCT02179918|527199995|FG000|Overall Study|Death|0|||
146188496|NCT02179918|527199996|FG001|Overall Study|Death|0|||
146188497|NCT02179918|527199997|FG002|Overall Study|Death|0|||
146188498|NCT02179918|527199998|FG003|Overall Study|Death|1|||
146188499|NCT02179918|527199999|FG004|Overall Study|Death|0|||
146188500|NCT02179918|527199995|FG000|Overall Study|Lost to Follow-up|0|||
146188501|NCT02179918|527199996|FG001|Overall Study|Lost to Follow-up|0|||
146188502|NCT02179918|527199997|FG002|Overall Study|Lost to Follow-up|1|||
146188503|NCT02179918|527199998|FG003|Overall Study|Lost to Follow-up|0|||
146188504|NCT02179918|527199999|FG004|Overall Study|Lost to Follow-up|0|||
146188505|NCT02179918|527199995|FG000|Overall Study|Progressive Disease|4|||
146188506|NCT02179918|527199996|FG001|Overall Study|Progressive Disease|1|||
146188507|NCT02179918|527199997|FG002|Overall Study|Progressive Disease|1|||
146188508|NCT02179918|527199998|FG003|Overall Study|Progressive Disease|2|||
146188509|NCT02179918|527199999|FG004|Overall Study|Progressive Disease|6|||
146188510|NCT02179918|527199995|FG000|Overall Study|Other|0|||
146188511|NCT02179918|527199996|FG001|Overall Study|Other|1|||
146188512|NCT02179918|527199997|FG002|Overall Study|Other|0|||
146188513|NCT02179918|527199998|FG003|Overall Study|Other|0|||
146188514|NCT02179918|527199999|FG004|Overall Study|Other|1|||
146188515|NCT02179918|527199995|FG000|Overall Study|Subject refused further follow-up|0|||
146188516|NCT02179918|527199996|FG001|Overall Study|Subject refused further follow-up|1|||
146188517|NCT02179918|527199997|FG002|Overall Study|Subject refused further follow-up|0|||
146188518|NCT02179918|527199998|FG003|Overall Study|Subject refused further follow-up|0|||
146188519|NCT02179918|527199999|FG004|Overall Study|Subject refused further follow-up|1|||
146188520|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
146188521|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
146188522|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
146188523|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
146188524|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
146188525|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
146188526|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
146188527|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
146188528|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
146188529|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
146188530|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
146188531|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
146412470|NCT00368537|528015529|FG001|Baseline Participants|Patient uncompliant|1|||
146412471|NCT02732561|528015545|FG000|Overall Study|Lost to Follow-up|1|||
146188532|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
146188533|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
146188534|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
146188535|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
146188536|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
146188537|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
146188538|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
146188539|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
146188540|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
146188541|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
146188542|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
146188543|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
146235000|NCT01499849|527378440|FG001|Overall Study|Physician Decision|19|||
146188544|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
146188545|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146188546|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146188547|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
146188548|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146188549|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
146188550|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146188551|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
146188552|NCT03890120|527200003|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146188553|NCT03890120|527200004|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
146188554|NCT03890120|527200005|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146188555|NCT03890120|527200006|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
146188556|NCT03890120|527200003|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
146188557|NCT03890120|527200004|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
146188558|NCT03890120|527200005|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
146188559|NCT03890120|527200006|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
146188560|NCT03890120|527200003|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
146188561|NCT03890120|527200004|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
146188562|NCT03890120|527200005|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
146188563|NCT03890120|527200006|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
146188564|NCT03890120|527200003|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146188565|NCT03890120|527200004|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146188566|NCT03890120|527200005|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
146188567|NCT03890120|527200006|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
146188568|NCT03890120|527200003|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146188569|NCT03890120|527200004|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146188570|NCT03890120|527200005|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
146188571|NCT03890120|527200006|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
146188572|NCT04003974|527200007|FG000|Overall Study|Missing|1|||
146188573|NCT04003974|527200008|FG001|Overall Study|Missing|0|||
146188574|NCT04003974|527200007|FG000|Overall Study|Withdrawal by Subject|0|||
146188575|NCT04003974|527200008|FG001|Overall Study|Withdrawal by Subject|2|||
146188576|NCT02400307|527200009|FG000|Overall Study|Enrolled and Never Dosed|1|||
146188577|NCT02400307|527200010|FG001|Overall Study|Enrolled and Never Dosed|0|||
146188578|NCT01052662|527200013|FG000|Overall Study|Lost to Follow-up|15|||
146188579|NCT01052662|527200014|FG001|Overall Study|Lost to Follow-up|13|||
146188580|NCT01052662|527200015|FG002|Overall Study|Lost to Follow-up|18|||
146188581|NCT01052662|527200013|FG000|Overall Study|Withdrawal by Subject|3|||
146188582|NCT01052662|527200014|FG001|Overall Study|Withdrawal by Subject|2|||
146188583|NCT01052662|527200015|FG002|Overall Study|Withdrawal by Subject|1|||
146188584|NCT01052662|527200013|FG000|Overall Study|Pharmacy issue|1|||
146188585|NCT01052662|527200014|FG001|Overall Study|Pharmacy issue|3|||
146188586|NCT01052662|527200015|FG002|Overall Study|Pharmacy issue|3|||
146188587|NCT01052662|527200013|FG000|Overall Study|Adverse Event|1|||
146188588|NCT01052662|527200014|FG001|Overall Study|Adverse Event|1|||
146188589|NCT01052662|527200015|FG002|Overall Study|Adverse Event|0|||
146188590|NCT01052662|527200013|FG000|Overall Study|Legal Problem|2|||
146188591|NCT01052662|527200014|FG001|Overall Study|Legal Problem|0|||
146188592|NCT01052662|527200015|FG002|Overall Study|Legal Problem|0|||
146188593|NCT01052662|527200013|FG000|Overall Study|Administrative|0|||
146188594|NCT01052662|527200014|FG001|Overall Study|Administrative|3|||
146188595|NCT01052662|527200015|FG002|Overall Study|Administrative|0|||
146188596|NCT00479674|527200016|FG000|Overall Study|Adverse Event|18|||
146188597|NCT00479674|527200016|FG000|Overall Study|Withdrawal by Subject|6|||
146188598|NCT00479674|527200016|FG000|Overall Study|Physician Decision|14|||
146188599|NCT00479674|527200016|FG000|Overall Study|none provided|3|||
146188600|NCT03023332|527200017|FG000|Overall Study|Withdrawal by Subject|10|||
146188601|NCT03023332|527200018|FG001|Overall Study|Withdrawal by Subject|5|||
146188602|NCT03023332|527200019|FG002|Overall Study|Withdrawal by Subject|4|||
146188603|NCT03023332|527200020|FG003|Overall Study|Withdrawal by Subject|7|||
146188604|NCT03023332|527200017|FG000|Overall Study|Lost to Follow-up|13|||
146188605|NCT03023332|527200018|FG001|Overall Study|Lost to Follow-up|16|||
146188606|NCT03023332|527200019|FG002|Overall Study|Lost to Follow-up|8|||
146188607|NCT03023332|527200020|FG003|Overall Study|Lost to Follow-up|13|||
146188608|NCT03023332|527200017|FG000|Overall Study|Death|1|||
146188609|NCT03023332|527200018|FG001|Overall Study|Death|0|||
146188610|NCT03023332|527200019|FG002|Overall Study|Death|0|||
146188611|NCT03023332|527200020|FG003|Overall Study|Death|0|||
146188612|NCT01272011|527200023|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
146188613|NCT01272011|527200024|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
146188614|NCT01272011|527200025|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
146188615|NCT02240680|527200026|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
146188616|NCT02240680|527200027|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
146188617|NCT02240680|527200028|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
146188618|NCT02240680|527200029|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
146188619|NCT02240680|527200026|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
146188620|NCT02240680|527200027|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
146188621|NCT02240680|527200028|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
146188622|NCT02240680|527200029|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
146188623|NCT02240680|527200026|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
146188624|NCT02240680|527200027|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146188625|NCT02240680|527200028|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146188626|NCT02240680|527200029|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
146188627|NCT02240680|527200026|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
146188628|NCT02240680|527200027|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
146188629|NCT02240680|527200028|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
146188630|NCT02240680|527200029|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
146188631|NCT02240680|527200026|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
146188632|NCT02240680|527200027|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146188633|NCT02240680|527200028|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146188634|NCT02240680|527200029|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
146188635|NCT02240680|527200026|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
146188636|NCT02240680|527200027|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
146188637|NCT02240680|527200028|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
146188638|NCT02240680|527200029|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
146188639|NCT02240680|527200026|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146188640|NCT02240680|527200027|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146188641|NCT02240680|527200028|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
146188642|NCT02240680|527200029|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
146188643|NCT02240680|527200026|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146188644|NCT02240680|527200027|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146188645|NCT02240680|527200028|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
146188646|NCT02240680|527200029|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
146188647|NCT01657032|527200030|FG000|Overall Study|Lost to Follow-up|0|||
146188648|NCT01657032|527200031|FG001|Overall Study|Lost to Follow-up|7|||
146188649|NCT05968482|527200032|FG000|First Crossover Period|Withdrawal by Subject|0|||
146188650|NCT05968482|527200033|FG001|First Crossover Period|Withdrawal by Subject|0|||
146188651|NCT05968482|527200034|FG002|First Crossover Period|Withdrawal by Subject|1|||
146188652|NCT05968482|527200035|FG003|First Crossover Period|Withdrawal by Subject|0|||
146188653|NCT05968482|527200036|FG004|First Crossover Period|Withdrawal by Subject|0|||
146188654|NCT05968482|527200037|FG005|First Crossover Period|Withdrawal by Subject|0|||
146188655|NCT05968482|527200032|FG000|First Crossover Period|Adverse Event|0|||
146188656|NCT05968482|527200033|FG001|First Crossover Period|Adverse Event|0|||
146188657|NCT05968482|527200034|FG002|First Crossover Period|Adverse Event|0|||
146188658|NCT05968482|527200035|FG003|First Crossover Period|Adverse Event|0|||
146188659|NCT05968482|527200036|FG004|First Crossover Period|Adverse Event|0|||
146188660|NCT05968482|527200037|FG005|First Crossover Period|Adverse Event|1|||
146188661|NCT05968482|527200032|FG000|Second Crossover Period|Withdrawal by Subject|0|||
146188662|NCT05968482|527200033|FG001|Second Crossover Period|Withdrawal by Subject|0|||
146188663|NCT05968482|527200034|FG002|Second Crossover Period|Withdrawal by Subject|0|||
146188664|NCT05968482|527200035|FG003|Second Crossover Period|Withdrawal by Subject|0|||
146188665|NCT05968482|527200036|FG004|Second Crossover Period|Withdrawal by Subject|1|||
146188666|NCT05968482|527200037|FG005|Second Crossover Period|Withdrawal by Subject|0|||
146188667|NCT05968482|527200032|FG000|Third Crossover Period|Adverse Event|0|||
146188668|NCT05968482|527200033|FG001|Third Crossover Period|Adverse Event|0|||
146188669|NCT05968482|527200034|FG002|Third Crossover Period|Adverse Event|0|||
146188670|NCT05968482|527200035|FG003|Third Crossover Period|Adverse Event|0|||
146188671|NCT05968482|527200036|FG004|Third Crossover Period|Adverse Event|1|||
146188672|NCT05968482|527200037|FG005|Third Crossover Period|Adverse Event|0|||
146188673|NCT05968482|527200032|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
146188674|NCT05968482|527200033|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
146188675|NCT05968482|527200034|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
146188676|NCT05968482|527200035|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
146188677|NCT05968482|527200036|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
146188678|NCT05968482|527200037|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
146188679|NCT01925170|527200040|FG000|Overall Study|Unverified cancer status|53|||
146188680|NCT01077024|527200041|FG000|Overall Study|Lost to Follow-up|20|||
146188681|NCT01077024|527200042|FG001|Overall Study|Lost to Follow-up|14|||
146188682|NCT01077024|527200041|FG000|Overall Study|Withdrawal by Subject|0|||
146188683|NCT01077024|527200042|FG001|Overall Study|Withdrawal by Subject|2|||
146188684|NCT01077024|527200041|FG000|Overall Study|Incarcerated|7|||
146188685|NCT01077024|527200042|FG001|Overall Study|Incarcerated|8|||
146188686|NCT01077024|527200041|FG000|Overall Study|Other|4|||
146188687|NCT01077024|527200042|FG001|Overall Study|Other|4|||
146188688|NCT02034435|527200043|FG000|Overall Study|Withdrawal by Subject|1|||
146188689|NCT02034435|527200044|FG001|Overall Study|Withdrawal by Subject|0|||
146188690|NCT02034435|527200045|FG002|Overall Study|Withdrawal by Subject|0|||
146188691|NCT02034435|527200046|FG003|Overall Study|Withdrawal by Subject|0|||
146188692|NCT02034435|527200043|FG000|Overall Study|Illness|0|||
146188693|NCT02034435|527200044|FG001|Overall Study|Illness|2|||
146188694|NCT02034435|527200045|FG002|Overall Study|Illness|0|||
146188695|NCT02034435|527200046|FG003|Overall Study|Illness|0|||
146188696|NCT02034435|527200043|FG000|Overall Study|Inadequate IV access|1|||
146188697|NCT02034435|527200044|FG001|Overall Study|Inadequate IV access|0|||
146188698|NCT02034435|527200045|FG002|Overall Study|Inadequate IV access|0|||
146188699|NCT02034435|527200046|FG003|Overall Study|Inadequate IV access|1|||
146188700|NCT02300311|527200049|FG000|Overall Study|Other than the reason specified|1|||
146188701|NCT02300311|527200050|FG001|Overall Study|Other than the reason specified|0|||
146188702|NCT02300311|527200049|FG000|Overall Study|Refused to continue taking medication|18|||
146188703|NCT02300311|527200050|FG001|Overall Study|Refused to continue taking medication|0|||
146188704|NCT02839681|527200051|FG000|Overall Study|Death|2|||
146188705|NCT00772928|527200052|FG000|Overall Study|Lost to Follow-up|9|||
146188706|NCT00772928|527200053|FG001|Overall Study|Lost to Follow-up|6|||
146188707|NCT00772928|527200052|FG000|Overall Study|Protocol Violation|10|||
146188708|NCT00772928|527200053|FG001|Overall Study|Protocol Violation|12|||
146188709|NCT00772928|527200052|FG000|Overall Study|Withdrawal by Subject|25|||
146188710|NCT00772928|527200053|FG001|Overall Study|Withdrawal by Subject|22|||
146188711|NCT00772928|527200052|FG000|Overall Study|Did not receive vaccine|0|||
146188712|NCT00772928|527200053|FG001|Overall Study|Did not receive vaccine|1|||
146188713|NCT00801242|527200058|FG000|Overall Study|Adverse Event|10|||
146188714|NCT00801242|527200058|FG000|Overall Study|Withdrawal by Subject|13|||
146188715|NCT00801242|527200058|FG000|Overall Study|Protocol Violation|5|||
146188716|NCT00801242|527200058|FG000|Overall Study|Physician Decision|3|||
146188717|NCT00801242|527200058|FG000|Overall Study|Lost to Follow-up|1|||
146188718|NCT00801242|527200058|FG000|Overall Study|Miscellaneous reasons|20|||
146188719|NCT02015195|527200060|FG000|Overall Study|Adverse Event|0|||
146188720|NCT02015195|527200061|FG001|Overall Study|Adverse Event|0|||
146188721|NCT02015195|527200062|FG002|Overall Study|Adverse Event|0|||
146188722|NCT02015195|527200063|FG003|Overall Study|Adverse Event|1|||
146188723|NCT02015195|527200064|FG004|Overall Study|Adverse Event|0|||
146188724|NCT02015195|527200065|FG005|Overall Study|Adverse Event|0|||
146188725|NCT02015195|527200066|FG006|Overall Study|Adverse Event|0|||
146188726|NCT01318811|527200067|FG000|Overall Study|Physician Decision|1|||
146188727|NCT01318811|527200068|FG001|Overall Study|Physician Decision|1|||
146188728|NCT01318811|527200067|FG000|Overall Study|CRRT stopped for head CT|0|||
146188729|NCT01318811|527200068|FG001|Overall Study|CRRT stopped for head CT|1|||
146188730|NCT01318811|527200067|FG000|Overall Study|Death|0|||
146188731|NCT01318811|527200068|FG001|Overall Study|Death|1|||
146412472|NCT02732561|528015546|FG001|Overall Study|Lost to Follow-up|1|||
146188732|NCT01318811|527200067|FG000|Overall Study|CRRT stopped for head MRI|0|||
146188733|NCT01318811|527200068|FG001|Overall Study|CRRT stopped for head MRI|1|||
146188734|NCT00577629|527200069|FG000|Treatment Period|Death|1|||
146188735|NCT00577629|527200069|FG000|Long Term Follow-Up|Death|15|||
146188736|NCT00577629|527200069|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
146188737|NCT00577629|527200069|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
146188738|NCT00577629|527200069|FG000|Long Term Follow-Up|Physician Decision|1|||
146188739|NCT01449721|527200071|FG000|Overall Study|Physician Decision|0|||
146188740|NCT01449721|527200072|FG001|Overall Study|Physician Decision|1|||
146188741|NCT01449721|527200071|FG000|Overall Study|Physician Decision|0|||
146188742|NCT01449721|527200072|FG001|Overall Study|Physician Decision|1|||
146188743|NCT03212365|527200084|FG000|Overall Study|Discharged prior to Xa level|12|||
146188744|NCT03212365|527200085|FG001|Overall Study|Discharged prior to Xa level|8|||
146188745|NCT03212365|527200084|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
146188746|NCT03212365|527200085|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
146188747|NCT03212365|527200084|FG000|Overall Study|Refused study medication|3|||
146188748|NCT03212365|527200085|FG001|Overall Study|Refused study medication|0|||
146188749|NCT03212365|527200084|FG000|Overall Study|Initiated heparin infusion on floor|1|||
146188750|NCT03212365|527200085|FG001|Overall Study|Initiated heparin infusion on floor|1|||
146188751|NCT03212365|527200084|FG000|Overall Study|Unexpected return to OR|1|||
146188752|NCT03212365|527200085|FG001|Overall Study|Unexpected return to OR|1|||
146188753|NCT03212365|527200084|FG000|Overall Study|Medication distribution error|1|||
146188754|NCT03212365|527200085|FG001|Overall Study|Medication distribution error|0|||
146188755|NCT03212365|527200084|FG000|Overall Study|Required epidural placement|1|||
146188756|NCT03212365|527200085|FG001|Overall Study|Required epidural placement|0|||
146188757|NCT03212365|527200084|FG000|Overall Study|Withdrawal by Subject|0|||
146188758|NCT03212365|527200085|FG001|Overall Study|Withdrawal by Subject|1|||
146188759|NCT03212365|527200084|FG000|Overall Study|developed acute renal failure|0|||
146188760|NCT03212365|527200085|FG001|Overall Study|developed acute renal failure|1|||
146188761|NCT00333138|527200086|FG000|Core Study (6 Months)|Adverse Event|4|||
146188762|NCT00333138|527200087|FG001|Core Study (6 Months)|Adverse Event|5|||
146188763|NCT00333138|527200088|FG002|Core Study (6 Months)|Adverse Event|8|||
146188764|NCT00333138|527200086|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
146188765|NCT00333138|527200087|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
146188766|NCT00333138|527200088|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
146188767|NCT00333138|527200086|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
146188768|NCT00333138|527200087|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
146188769|NCT00333138|527200088|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
146188770|NCT00333138|527200086|FG000|Core Study (6 Months)|Protocol Violation|1|||
146188771|NCT00333138|527200087|FG001|Core Study (6 Months)|Protocol Violation|0|||
146188772|NCT00333138|527200088|FG002|Core Study (6 Months)|Protocol Violation|1|||
146188773|NCT00333138|527200086|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
146188774|NCT00333138|527200087|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
146188775|NCT00333138|527200088|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
146188776|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
146188777|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
146188778|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
146188779|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
146188780|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
146188781|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
146188782|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
146188783|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
146188784|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
146188785|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
146188786|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
146188787|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
146188788|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
146188789|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
146188790|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
146188791|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
146188792|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
146188793|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
146188794|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
146188795|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
146188796|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
146188797|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
146188798|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
146188799|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
146188800|NCT00333138|527200086|FG000|Extension Study (Month6 to End of Study)|Death|0|||
146188801|NCT00333138|527200087|FG001|Extension Study (Month6 to End of Study)|Death|1|||
146188802|NCT00333138|527200088|FG002|Extension Study (Month6 to End of Study)|Death|0|||
146188803|NCT01342887|527200090|FG000|Overall Study|Death|2|||
146188804|NCT04880161|527200092|FG000|Overall Study|Withdrawal by Subject|1|||
146188805|NCT04880161|527200093|FG001|Overall Study|Withdrawal by Subject|0|||
146188806|NCT04880161|527200092|FG000|Overall Study|Lack of Compliance|1|||
146188807|NCT04880161|527200093|FG001|Overall Study|Lack of Compliance|1|||
146188808|NCT04880161|527200092|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
146188809|NCT04880161|527200093|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
146188810|NCT04880161|527200092|FG000|Overall Study|Screen Failure|0|||
146188811|NCT04880161|527200093|FG001|Overall Study|Screen Failure|1|||
146188812|NCT01354106|527200094|FG000|Overall Study|Withdrawal by Subject|2|||
146188813|NCT02459964|527202007|FG000|Overall Study|Withdrawal by Subject|0|||
146188814|NCT02459964|527202008|FG001|Overall Study|Withdrawal by Subject|0|||
146188815|NCT02459964|527202009|FG002|Overall Study|Withdrawal by Subject|1|||
146188816|NCT02459964|527202007|FG000|Overall Study|Abnormal EKG changes|0|||
146188817|NCT02459964|527202008|FG001|Overall Study|Abnormal EKG changes|0|||
146188818|NCT02459964|527202009|FG002|Overall Study|Abnormal EKG changes|1|||
146188819|NCT00550732|527202010|FG000|Overall Study|Death|4|||
146188820|NCT00550732|527202010|FG000|Overall Study|Withdrawal by Subject|2|||
146188821|NCT00550732|527202010|FG000|Overall Study|Physician Decision|2|||
146188822|NCT00550732|527202010|FG000|Overall Study|Lost to Follow-up|1|||
146188823|NCT00550732|527202010|FG000|Overall Study|Palliative care|1|||
146188824|NCT00550732|527202010|FG000|Overall Study|Adverse Event|1|||
146188825|NCT00751790|527202016|FG000|Overall Study|Lost to Follow-up|1|||
146188826|NCT00751790|527202016|FG000|Overall Study|Death|3|||
146188827|NCT00751790|527202016|FG000|Overall Study|Withdrawal by Subject|1|||
146188828|NCT03302910|527202017|FG000|Overall Study|Protocol Violation|1|||
146188829|NCT03302910|527202018|FG001|Overall Study|Protocol Violation|0|||
146188830|NCT01106976|527202021|FG000|Overall Study|Lost to Follow-up|8|||
146188831|NCT04170023|527202026|FG000|LTE Period|Withdrawal by Subject|1|||
146188832|NCT04170023|527202027|FG001|LTE Period|Withdrawal by Subject|0|||
146188833|NCT04170023|527202028|FG002|LTE Period|Withdrawal by Subject|0|||
146188834|NCT04170023|527202026|FG000|LTE Period|Study Termination|11|||
146188835|NCT04170023|527202027|FG001|LTE Period|Study Termination|11|||
146188836|NCT04170023|527202028|FG002|LTE Period|Study Termination|5|||
146188837|NCT03836664|527202031|FG000|Overall Study|Didn't complete forms and lost drug|3|||
146188838|NCT03836664|527202032|FG001|Overall Study|Didn't complete forms and lost drug|3|||
146188839|NCT03566680|527202033|FG000|Overall Study|Pregnancy|1|||
146188840|NCT03566680|527202033|FG000|Overall Study|Lost to Follow-up|13|||
146188841|NCT03566680|527202033|FG000|Overall Study|Withdrawal by Subject|3|||
146188842|NCT02724020|527202034|FG000|Overall Study|Death|16|||
146188843|NCT02724020|527202035|FG001|Overall Study|Death|18|||
146188844|NCT02724020|527202036|FG002|Overall Study|Death|19|||
146188845|NCT02724020|527202034|FG000|Overall Study|Lost to Follow-up|0|||
146188846|NCT02724020|527202035|FG001|Overall Study|Lost to Follow-up|3|||
146188847|NCT02724020|527202036|FG002|Overall Study|Lost to Follow-up|0|||
146188848|NCT02724020|527202034|FG000|Overall Study|Site Terminated by Sponsor|15|||
146188849|NCT02724020|527202035|FG001|Overall Study|Site Terminated by Sponsor|8|||
146188850|NCT02724020|527202036|FG002|Overall Study|Site Terminated by Sponsor|8|||
146412473|NCT02732561|528015545|FG000|Overall Study|Withdrawal by Subject|1|||
146412474|NCT02732561|528015546|FG001|Overall Study|Withdrawal by Subject|0|||
146412475|NCT01886300|528015547|FG000|Overall Study|Trial terminated by sponsor|16|||
146412476|NCT01797120|528015550|FG000|Overall Study|Disesae progression|37|||
146188851|NCT02724020|527202034|FG000|Overall Study|Withdrawal by Subject|1|||
146188852|NCT02724020|527202035|FG001|Overall Study|Withdrawal by Subject|3|||
146188853|NCT02724020|527202036|FG002|Overall Study|Withdrawal by Subject|5|||
146188854|NCT04337489|527202038|FG000|Overall Study|Withdrawal by Subject|1|||
146188855|NCT04537949|527202040|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
146412477|NCT01797120|528015551|FG001|Overall Study|Disesae progression|49|||
146412478|NCT01797120|528015550|FG000|Overall Study|Adverse Event|13|||
146412479|NCT01797120|528015551|FG001|Overall Study|Adverse Event|5|||
146412480|NCT01797120|528015550|FG000|Overall Study|Withdrawal by Subject|6|||
146188856|NCT04537949|527202041|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
146188857|NCT04537949|527202042|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
146188858|NCT04537949|527202043|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
146188859|NCT04537949|527202044|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
146188860|NCT04537949|527202045|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
146188861|NCT04537949|527202046|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
146188862|NCT04537949|527202047|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
146188863|NCT04537949|527202040|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
146188864|NCT04537949|527202041|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146188865|NCT04537949|527202042|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
146188866|NCT04537949|527202043|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
146188867|NCT04537949|527202044|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146188868|NCT04537949|527202045|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
146188869|NCT04537949|527202046|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
146188870|NCT04537949|527202047|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
146188871|NCT04537949|527202040|FG000|Follow-up Phase|Lost to Follow-up|0|||
146188872|NCT04537949|527202041|FG001|Follow-up Phase|Lost to Follow-up|3|||
146188873|NCT04537949|527202042|FG002|Follow-up Phase|Lost to Follow-up|0|||
146188874|NCT04537949|527202043|FG003|Follow-up Phase|Lost to Follow-up|0|||
146188875|NCT04537949|527202044|FG004|Follow-up Phase|Lost to Follow-up|0|||
146188876|NCT04537949|527202045|FG005|Follow-up Phase|Lost to Follow-up|0|||
146188877|NCT04537949|527202046|FG006|Follow-up Phase|Lost to Follow-up|0|||
146188878|NCT04537949|527202047|FG007|Follow-up Phase|Lost to Follow-up|0|||
146188879|NCT04537949|527202040|FG000|Follow-up Phase|personal reasons|0|||
146188880|NCT04537949|527202041|FG001|Follow-up Phase|personal reasons|0|||
146188881|NCT04537949|527202042|FG002|Follow-up Phase|personal reasons|0|||
146188882|NCT04537949|527202043|FG003|Follow-up Phase|personal reasons|1|||
146188883|NCT04537949|527202044|FG004|Follow-up Phase|personal reasons|1|||
146188884|NCT04537949|527202045|FG005|Follow-up Phase|personal reasons|0|||
146188885|NCT04537949|527202046|FG006|Follow-up Phase|personal reasons|0|||
146188886|NCT04537949|527202047|FG007|Follow-up Phase|personal reasons|0|||
146188887|NCT04537949|527202040|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146188888|NCT04537949|527202041|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146188889|NCT04537949|527202042|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146188890|NCT04537949|527202043|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146188891|NCT04537949|527202044|FG004|Follow-up Phase|Withdrawal by Subject|1|||
146188892|NCT04537949|527202045|FG005|Follow-up Phase|Withdrawal by Subject|0|||
146188893|NCT04537949|527202046|FG006|Follow-up Phase|Withdrawal by Subject|0|||
146188894|NCT04537949|527202047|FG007|Follow-up Phase|Withdrawal by Subject|0|||
146188895|NCT01113463|527202052|FG000|Overall Study|Physician Decision|5|||
146188896|NCT01657682|527202054|FG000|Overall Study|Lost to Follow-up|1|||
146188897|NCT01657682|527202055|FG001|Overall Study|Lost to Follow-up|0|||
146188898|NCT01657682|527202056|FG002|Overall Study|Lost to Follow-up|0|||
146188899|NCT01657682|527202054|FG000|Overall Study|Withdrawal by Subject|0|||
146188900|NCT01657682|527202055|FG001|Overall Study|Withdrawal by Subject|1|||
146188901|NCT01657682|527202056|FG002|Overall Study|Withdrawal by Subject|1|||
146188902|NCT01657682|527202054|FG000|Overall Study|Adverse Event|0|||
146188903|NCT01657682|527202055|FG001|Overall Study|Adverse Event|1|||
146188904|NCT01657682|527202056|FG002|Overall Study|Adverse Event|0|||
146188905|NCT01719861|527202059|FG000|Cycle 1|Death|4|||
146188906|NCT01719861|527202059|FG000|Cycle 2|Death|1|||
146188907|NCT00958009|527202060|FG000|Overall Study|Adverse Event|1|||
146188908|NCT00958009|527202060|FG000|Overall Study|Subject found device difficult to use|1|||
146188909|NCT00087490|527202063|FG000|Overall Study|Death|6|||
146188910|NCT00087490|527202064|FG001|Overall Study|Death|4|||
146188911|NCT00087490|527202063|FG000|Overall Study|Adverse Event|3|||
146188912|NCT00087490|527202064|FG001|Overall Study|Adverse Event|8|||
146188913|NCT00087490|527202063|FG000|Overall Study|Lack of Efficacy|0|||
146188914|NCT00087490|527202064|FG001|Overall Study|Lack of Efficacy|2|||
146188915|NCT00087490|527202063|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
146188916|NCT00087490|527202064|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
146188917|NCT00087490|527202063|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
146188918|NCT00087490|527202064|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
146188919|NCT00087490|527202063|FG000|Overall Study|Randomized but not treated|7|||
146188920|NCT00087490|527202064|FG001|Overall Study|Randomized but not treated|18|||
146188921|NCT00761774|527202065|FG000|Overall Study|Adverse Event|17|||
146188922|NCT00761774|527202065|FG000|Overall Study|Lack of Efficacy|37|||
146188923|NCT00761774|527202065|FG000|Overall Study|Lost to Follow-up|2|||
146188924|NCT00761774|527202065|FG000|Overall Study|Withdrawal by Subject|9|||
146188925|NCT00761774|527202065|FG000|Overall Study|Non-compliance|4|||
146188926|NCT00761774|527202065|FG000|Overall Study|End of study|2|||
146188927|NCT00761774|527202065|FG000|Overall Study|Reclassification of seizures|1|||
146188928|NCT00761774|527202065|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
146188929|NCT00761774|527202065|FG000|Overall Study|Sponsor decision|1|||
146188930|NCT00761774|527202065|FG000|Overall Study|Investigator clinical judgement|1|||
146188931|NCT00761774|527202065|FG000|Overall Study|Patient moved out of study area|1|||
146188932|NCT00761774|527202065|FG000|Overall Study|Coordinator leaving site|1|||
146188933|NCT00761774|527202065|FG000|Overall Study|Subject IP non-compliance|1|||
146188934|NCT00761774|527202065|FG000|Overall Study|IP stopped by hospital physician|1|||
146188935|NCT03379233|527202069|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
146188936|NCT03379233|527202070|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
146188937|NCT00965484|527202071|FG000|Overall Study|Protocol Violation|1|||
146188938|NCT00965484|527202071|FG000|Overall Study|Withdrawal by Subject|1|||
146188939|NCT00848211|527202072|FG000|Overall Study|Protocol Violation|0|||
146188940|NCT00848211|527202073|FG001|Overall Study|Protocol Violation|1|||
146188941|NCT00848211|527202074|FG002|Overall Study|Protocol Violation|1|||
146188942|NCT00848211|527202075|FG003|Overall Study|Protocol Violation|0|||
146188943|NCT00848211|527202072|FG000|Overall Study|Adverse Event|0|||
146188944|NCT00848211|527202073|FG001|Overall Study|Adverse Event|0|||
146188945|NCT00848211|527202074|FG002|Overall Study|Adverse Event|0|||
146188946|NCT00848211|527202075|FG003|Overall Study|Adverse Event|0|||
146188947|NCT00811187|527202077|FG000|Overall Study|Unable to place device / procedure abort|3|||
146188948|NCT00811187|527202078|FG001|Overall Study|Unable to place device / procedure abort|3|||
146188949|NCT02825043|527202079|FG000|Overall Study|Lost to Follow-up|4|||
146188950|NCT00329303|527202080|FG000|Overall Study|Lack of Efficacy|1|||
146188951|NCT00329303|527202081|FG001|Overall Study|Lack of Efficacy|0|||
146188952|NCT00329303|527202080|FG000|Overall Study|Decision of the sponsor|0|||
146188953|NCT00329303|527202081|FG001|Overall Study|Decision of the sponsor|1|||
146188954|NCT00329303|527202080|FG000|Overall Study|Patient no longer available|1|||
146188955|NCT00329303|527202081|FG001|Overall Study|Patient no longer available|0|||
146188956|NCT00329303|527202080|FG000|Overall Study|Patient relocated|0|||
146188957|NCT00329303|527202081|FG001|Overall Study|Patient relocated|1|||
146188958|NCT03582137|527202084|FG000|Overall Study|Adverse Event|1|||
146188959|NCT03582137|527202085|FG001|Overall Study|Adverse Event|0|||
146188960|NCT02303574|527202091|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188961|NCT02303574|527202092|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188962|NCT02303574|527202093|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
146188963|NCT02303574|527202094|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188964|NCT02303574|527202095|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188965|NCT02303574|527202096|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188966|NCT02303574|527202097|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188967|NCT02303574|527202098|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188968|NCT02303574|527202099|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188969|NCT02303574|527202100|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
146188970|NCT02303574|527202091|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188971|NCT02303574|527202092|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188972|NCT02303574|527202093|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188973|NCT02303574|527202094|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188974|NCT02303574|527202095|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188975|NCT02303574|527202096|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188976|NCT02303574|527202097|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188977|NCT02303574|527202098|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
146188978|NCT02303574|527202099|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188979|NCT02303574|527202100|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
146188980|NCT00994279|527202105|FG000|Overall Study|Withdrawal by Subject|2|||
146188981|NCT00994279|527202106|FG001|Overall Study|Withdrawal by Subject|2|||
146188982|NCT00994279|527202105|FG000|Overall Study|Toxicity|1|||
146188983|NCT00994279|527202106|FG001|Overall Study|Toxicity|0|||
146188984|NCT00994279|527202105|FG000|Overall Study|Multiple reasons|1|||
146188985|NCT00994279|527202106|FG001|Overall Study|Multiple reasons|3|||
146188986|NCT00859014|527202107|FG000|Overall Study|Death|4|||
146188987|NCT00859014|527202107|FG000|Overall Study|Lost to Follow-up|1|||
146188988|NCT00162942|527202108|FG000|Overall Study|Adverse Event|10|||
146188989|NCT00162942|527202109|FG001|Overall Study|Adverse Event|6|||
146188990|NCT00162942|527202108|FG000|Overall Study|Death|1|||
146188991|NCT00162942|527202109|FG001|Overall Study|Death|0|||
146188992|NCT00162942|527202108|FG000|Overall Study|Withdrawal by Subject|3|||
146188993|NCT00162942|527202109|FG001|Overall Study|Withdrawal by Subject|6|||
146188994|NCT00162942|527202108|FG000|Overall Study|Physician Decision|1|||
146188995|NCT00162942|527202109|FG001|Overall Study|Physician Decision|0|||
146188996|NCT00162942|527202108|FG000|Overall Study|Enter Open-Label Study|76|||
146188997|NCT00162942|527202109|FG001|Overall Study|Enter Open-Label Study|35|||
146188998|NCT00162942|527202108|FG000|Overall Study|Alternate Therapy|6|||
146188999|NCT00162942|527202109|FG001|Overall Study|Alternate Therapy|2|||
146189000|NCT00162942|527202108|FG000|Overall Study|Lack of Efficacy|1|||
146189001|NCT00162942|527202109|FG001|Overall Study|Lack of Efficacy|0|||
146189002|NCT00162942|527202108|FG000|Overall Study|Flare During Active Treatment|7|||
146189003|NCT00162942|527202109|FG001|Overall Study|Flare During Active Treatment|3|||
146189004|NCT00162942|527202108|FG000|Overall Study|2 or more consecutive treatments missed|1|||
146189005|NCT00162942|527202109|FG001|Overall Study|2 or more consecutive treatments missed|0|||
146189006|NCT01163149|527202113|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
146189007|NCT01163149|527202114|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146189008|NCT01163149|527202115|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
146189009|NCT01163149|527202113|FG000|Extension Treatment Period|Adverse Event|0|||
146189010|NCT01163149|527202114|FG001|Extension Treatment Period|Adverse Event|1|||
146189011|NCT01163149|527202115|FG002|Extension Treatment Period|Adverse Event|0|||
146189012|NCT01163149|527202113|FG000|Extension Treatment Period|Noncompliance|0|||
146189013|NCT01163149|527202114|FG001|Extension Treatment Period|Noncompliance|0|||
146189014|NCT01163149|527202115|FG002|Extension Treatment Period|Noncompliance|1|||
146189015|NCT01192295|527202116|FG000|Overall Study|Adverse Event|3|||
146189016|NCT01192295|527202117|FG001|Overall Study|Adverse Event|7|||
146189017|NCT01192295|527202116|FG000|Overall Study|Withdrawal by Subject|3|||
146189018|NCT01192295|527202117|FG001|Overall Study|Withdrawal by Subject|4|||
146189019|NCT01192295|527202116|FG000|Overall Study|Lost to Follow-up|0|||
146189020|NCT01192295|527202117|FG001|Overall Study|Lost to Follow-up|1|||
146189021|NCT01192295|527202116|FG000|Overall Study|Lack of Efficacy|0|||
146189022|NCT01192295|527202117|FG001|Overall Study|Lack of Efficacy|5|||
146189023|NCT01192295|527202116|FG000|Overall Study|Administrative|4|||
146189024|NCT01192295|527202117|FG001|Overall Study|Administrative|6|||
146189025|NCT00630539|527202118|FG000|Overall Study|Adverse Event|1|||
146189026|NCT00630539|527202119|FG001|Overall Study|Adverse Event|3|||
146189027|NCT00630539|527202120|FG002|Overall Study|Adverse Event|1|||
146189028|NCT00630539|527202121|FG003|Overall Study|Adverse Event|2|||
146189029|NCT00630539|527202118|FG000|Overall Study|Withdrawal by Subject|0|||
146189030|NCT00630539|527202119|FG001|Overall Study|Withdrawal by Subject|1|||
146189031|NCT00630539|527202120|FG002|Overall Study|Withdrawal by Subject|0|||
146189032|NCT00630539|527202121|FG003|Overall Study|Withdrawal by Subject|1|||
146189033|NCT01700530|527202124|FG000|Overall Study|Withdrawal by Subject|0|||
146189034|NCT01700530|527202125|FG001|Overall Study|Withdrawal by Subject|3|||
146189035|NCT01700530|527202126|FG002|Overall Study|Withdrawal by Subject|1|||
146189036|NCT02806336|527202137|FG000|Overall Study|Physician Decision|1|||
146189037|NCT02806336|527202138|FG001|Overall Study|Physician Decision|0|||
146189038|NCT02806336|527202137|FG000|Overall Study|Withdrawal by Subject|2|||
146189039|NCT02806336|527202138|FG001|Overall Study|Withdrawal by Subject|4|||
146189040|NCT02806336|527202137|FG000|Overall Study|COVID-19 research shut down|3|||
146189041|NCT02806336|527202138|FG001|Overall Study|COVID-19 research shut down|4|||
146189042|NCT02806336|527202137|FG000|Overall Study|Lack of Efficacy|0|||
146189043|NCT02806336|527202138|FG001|Overall Study|Lack of Efficacy|1|||
146189044|NCT04159896|527202139|FG000|Overall Study|Lack of Efficacy|7|||
146189045|NCT04159896|527202139|FG000|Overall Study|Withdrawal by Subject|1|||
146189046|NCT04159896|527202139|FG000|Overall Study|Adverse Event|1|||
146189047|NCT04159896|527202139|FG000|Overall Study|A transient ischaemic attack|1|||
146189048|NCT05705167|527202140|FG000|Overall Study|Randomised but not Treated|0|||
146189049|NCT05705167|527202141|FG001|Overall Study|Randomised but not Treated|2|||
146189050|NCT05705167|527202142|FG002|Overall Study|Randomised but not Treated|0|||
146189051|NCT05705167|527202143|FG003|Overall Study|Randomised but not Treated|7|||
146189052|NCT05705167|527202144|FG004|Overall Study|Randomised but not Treated|0|||
146189053|NCT05705167|527202145|FG005|Overall Study|Randomised but not Treated|0|||
146189054|NCT05705167|527202146|FG006|Overall Study|Randomised but not Treated|0|||
146189055|NCT05705167|527202140|FG000|Overall Study|Death|0|||
146189056|NCT05705167|527202141|FG001|Overall Study|Death|0|||
146189057|NCT05705167|527202142|FG002|Overall Study|Death|3|||
146189058|NCT05705167|527202143|FG003|Overall Study|Death|0|||
146189059|NCT05705167|527202144|FG004|Overall Study|Death|1|||
146189060|NCT05705167|527202145|FG005|Overall Study|Death|1|||
146189061|NCT05705167|527202146|FG006|Overall Study|Death|1|||
146189062|NCT05705167|527202140|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146189063|NCT05705167|527202141|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146189064|NCT05705167|527202142|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146189065|NCT05705167|527202143|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146189066|NCT05705167|527202144|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146189067|NCT05705167|527202145|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
146189068|NCT05705167|527202146|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
146189069|NCT04529538|527202147|FG000|Overall Study|Lost to Follow-up|3|||
146189070|NCT04529538|527202148|FG001|Overall Study|Lost to Follow-up|2|||
146189071|NCT04529538|527202149|FG002|Overall Study|Lost to Follow-up|1|||
146189072|NCT04529538|527202150|FG003|Overall Study|Lost to Follow-up|0|||
146189073|NCT04529538|527202151|FG004|Overall Study|Lost to Follow-up|1|||
146189074|NCT04529538|527202152|FG005|Overall Study|Lost to Follow-up|1|||
146189075|NCT04529538|527202153|FG006|Overall Study|Lost to Follow-up|2|||
146189076|NCT04529538|527202154|FG007|Overall Study|Lost to Follow-up|0|||
146189077|NCT04529538|527202147|FG000|Overall Study|Not eligible at enrollment|0|||
146189078|NCT04529538|527202148|FG001|Overall Study|Not eligible at enrollment|1|||
146189079|NCT04529538|527202149|FG002|Overall Study|Not eligible at enrollment|2|||
146189080|NCT04529538|527202150|FG003|Overall Study|Not eligible at enrollment|1|||
146189081|NCT04529538|527202151|FG004|Overall Study|Not eligible at enrollment|0|||
146189082|NCT04529538|527202152|FG005|Overall Study|Not eligible at enrollment|0|||
146189083|NCT04529538|527202153|FG006|Overall Study|Not eligible at enrollment|0|||
146189084|NCT04529538|527202154|FG007|Overall Study|Not eligible at enrollment|1|||
146189085|NCT04529538|527202147|FG000|Overall Study|Withdrawal by Subject|0|||
146189086|NCT04529538|527202148|FG001|Overall Study|Withdrawal by Subject|1|||
146189087|NCT04529538|527202149|FG002|Overall Study|Withdrawal by Subject|1|||
146189088|NCT04529538|527202150|FG003|Overall Study|Withdrawal by Subject|2|||
146189089|NCT04529538|527202151|FG004|Overall Study|Withdrawal by Subject|0|||
146189090|NCT04529538|527202152|FG005|Overall Study|Withdrawal by Subject|2|||
146189091|NCT04529538|527202153|FG006|Overall Study|Withdrawal by Subject|3|||
146189092|NCT04529538|527202154|FG007|Overall Study|Withdrawal by Subject|0|||
146189093|NCT04529538|527202147|FG000|Overall Study|Other|0|||
146189094|NCT04529538|527202148|FG001|Overall Study|Other|1|||
146189095|NCT04529538|527202149|FG002|Overall Study|Other|0|||
146189096|NCT04529538|527202150|FG003|Overall Study|Other|0|||
146189097|NCT04529538|527202151|FG004|Overall Study|Other|0|||
146189098|NCT04529538|527202152|FG005|Overall Study|Other|0|||
146189099|NCT04529538|527202153|FG006|Overall Study|Other|0|||
146189100|NCT04529538|527202154|FG007|Overall Study|Other|0|||
146189101|NCT04529538|527202147|FG000|Overall Study|Adverse Event|0|||
146189102|NCT04529538|527202148|FG001|Overall Study|Adverse Event|0|||
146189103|NCT04529538|527202149|FG002|Overall Study|Adverse Event|0|||
146189104|NCT04529538|527202150|FG003|Overall Study|Adverse Event|1|||
146189105|NCT04529538|527202151|FG004|Overall Study|Adverse Event|0|||
146189106|NCT04529538|527202152|FG005|Overall Study|Adverse Event|0|||
146189107|NCT04529538|527202153|FG006|Overall Study|Adverse Event|0|||
146189108|NCT04529538|527202154|FG007|Overall Study|Adverse Event|0|||
146189109|NCT04529538|527202147|FG000|Overall Study|Protocol Deviation|0|||
146189110|NCT04529538|527202148|FG001|Overall Study|Protocol Deviation|0|||
146189111|NCT04529538|527202149|FG002|Overall Study|Protocol Deviation|0|||
146189112|NCT04529538|527202150|FG003|Overall Study|Protocol Deviation|1|||
146189113|NCT04529538|527202151|FG004|Overall Study|Protocol Deviation|0|||
146189114|NCT04529538|527202152|FG005|Overall Study|Protocol Deviation|0|||
146189115|NCT04529538|527202153|FG006|Overall Study|Protocol Deviation|0|||
146189116|NCT04529538|527202154|FG007|Overall Study|Protocol Deviation|0|||
146189117|NCT04529538|527202147|FG000|Overall Study|Physician Decision|0|||
146189118|NCT04529538|527202148|FG001|Overall Study|Physician Decision|0|||
146189119|NCT04529538|527202149|FG002|Overall Study|Physician Decision|0|||
146189120|NCT04529538|527202150|FG003|Overall Study|Physician Decision|0|||
146189121|NCT04529538|527202151|FG004|Overall Study|Physician Decision|0|||
146189122|NCT04529538|527202152|FG005|Overall Study|Physician Decision|1|||
146189123|NCT04529538|527202153|FG006|Overall Study|Physician Decision|0|||
146189124|NCT04529538|527202154|FG007|Overall Study|Physician Decision|1|||
146189125|NCT02223182|527202155|FG000|Double-Blind Period|Adverse Event|0|||
146189126|NCT02223182|527202156|FG001|Double-Blind Period|Adverse Event|2|||
146189127|NCT02223182|527202157|FG002|Double-Blind Period|Adverse Event|1|||
146189128|NCT02223182|527202158|FG003|Double-Blind Period|Adverse Event|0|||
146189129|NCT02223182|527202155|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146189130|NCT02223182|527202156|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146189131|NCT02223182|527202157|FG002|Double-Blind Period|Withdrawal by Subject|1|||
146189132|NCT02223182|527202158|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146189133|NCT02223182|527202155|FG000|Double-Blind Period|Lost to Follow-up|0|||
146189134|NCT02223182|527202156|FG001|Double-Blind Period|Lost to Follow-up|1|||
146189135|NCT02223182|527202157|FG002|Double-Blind Period|Lost to Follow-up|0|||
146189136|NCT02223182|527202158|FG003|Double-Blind Period|Lost to Follow-up|0|||
146189137|NCT02223182|527202155|FG000|Double-Blind Period|Non Compliance|0|||
146189138|NCT02223182|527202156|FG001|Double-Blind Period|Non Compliance|0|||
146189139|NCT02223182|527202157|FG002|Double-Blind Period|Non Compliance|0|||
146189140|NCT02223182|527202158|FG003|Double-Blind Period|Non Compliance|1|||
146189141|NCT02223182|527202155|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
146189142|NCT02223182|527202156|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146189143|NCT02223182|527202157|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146189144|NCT02223182|527202158|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
146189145|NCT02223182|527202155|FG000|Open-Label 500 Period|Adverse Event|1|||
146189146|NCT02223182|527202156|FG001|Open-Label 500 Period|Adverse Event|0|||
146189147|NCT02223182|527202157|FG002|Open-Label 500 Period|Adverse Event|2|||
146189148|NCT02223182|527202158|FG003|Open-Label 500 Period|Adverse Event|1|||
146189149|NCT02223182|527202155|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
146189150|NCT02223182|527202156|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
146189151|NCT02223182|527202157|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
146189152|NCT02223182|527202158|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
146189153|NCT02223182|527202155|FG000|Open-Label 500 Period|Physician Decision|0|||
146189154|NCT02223182|527202156|FG001|Open-Label 500 Period|Physician Decision|0|||
146189155|NCT02223182|527202157|FG002|Open-Label 500 Period|Physician Decision|0|||
146189156|NCT02223182|527202158|FG003|Open-Label 500 Period|Physician Decision|1|||
146189157|NCT02223182|527202155|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146189158|NCT02223182|527202156|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146189159|NCT02223182|527202157|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
146189160|NCT02223182|527202158|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
146189161|NCT02223182|527202155|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
146189162|NCT02223182|527202156|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
146189163|NCT02223182|527202157|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
146412481|NCT01797120|528015551|FG001|Overall Study|Withdrawal by Subject|6|||
146412482|NCT01797120|528015550|FG000|Overall Study|Symptomatic progression|2|||
146412483|NCT01797120|528015551|FG001|Overall Study|Symptomatic progression|1|||
146412484|NCT01797120|528015550|FG000|Overall Study|Non-compliance|1|||
146412485|NCT01797120|528015551|FG001|Overall Study|Non-compliance|0|||
146412486|NCT01797120|528015550|FG000|Overall Study|Physician Decision|3|||
146412487|NCT01797120|528015551|FG001|Overall Study|Physician Decision|0|||
146412488|NCT01797120|528015550|FG000|Overall Study|still on treatment|2|||
146412489|NCT01797120|528015551|FG001|Overall Study|still on treatment|4|||
146412490|NCT01797120|528015550|FG000|Overall Study|never start protocol therapy|2|||
146189164|NCT02223182|527202158|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
146189165|NCT02223182|527202155|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
146189166|NCT02223182|527202156|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
146189167|NCT02223182|527202157|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
146189168|NCT02223182|527202158|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
146189169|NCT02223182|527202155|FG000|Open-Label 300 Period|Non Compliance|0|||
146189170|NCT02223182|527202156|FG001|Open-Label 300 Period|Non Compliance|2|||
146189171|NCT02223182|527202157|FG002|Open-Label 300 Period|Non Compliance|1|||
146412491|NCT01797120|528015551|FG001|Overall Study|never start protocol therapy|0|||
146412492|NCT00295854|528015552|FG000|Overall Study|Adverse Event|7|||
146412493|NCT00295854|528015553|FG001|Overall Study|Adverse Event|7|||
146412494|NCT00295854|528015554|FG002|Overall Study|Adverse Event|6|||
146189172|NCT02223182|527202158|FG003|Open-Label 300 Period|Non Compliance|0|||
146189173|NCT02099539|527202163|FG000|Overall Study|Progressive Disease|3|||
146189174|NCT02099539|527202164|FG001|Overall Study|Progressive Disease|2|||
146189175|NCT02099539|527202165|FG002|Overall Study|Progressive Disease|2|||
146189176|NCT02099539|527202166|FG003|Overall Study|Progressive Disease|1|||
146189177|NCT02099539|527202167|FG004|Overall Study|Progressive Disease|4|||
146189178|NCT02099539|527202168|FG005|Overall Study|Progressive Disease|2|||
146189179|NCT02099539|527202169|FG006|Overall Study|Progressive Disease|0|||
146189180|NCT02099539|527202163|FG000|Overall Study|Adverse Event|0|||
146189181|NCT02099539|527202164|FG001|Overall Study|Adverse Event|0|||
146189182|NCT02099539|527202165|FG002|Overall Study|Adverse Event|1|||
146189183|NCT02099539|527202166|FG003|Overall Study|Adverse Event|1|||
146189184|NCT02099539|527202167|FG004|Overall Study|Adverse Event|0|||
146189185|NCT02099539|527202168|FG005|Overall Study|Adverse Event|0|||
146189186|NCT02099539|527202169|FG006|Overall Study|Adverse Event|0|||
146189187|NCT02099539|527202163|FG000|Overall Study|Physician Decision|0|||
146189188|NCT02099539|527202164|FG001|Overall Study|Physician Decision|0|||
146189189|NCT02099539|527202165|FG002|Overall Study|Physician Decision|0|||
146189190|NCT02099539|527202166|FG003|Overall Study|Physician Decision|0|||
146189191|NCT02099539|527202167|FG004|Overall Study|Physician Decision|0|||
146412495|NCT00295854|528015552|FG000|Overall Study|Protocol Violation|1|||
146189192|NCT02099539|527202168|FG005|Overall Study|Physician Decision|1|||
146412496|NCT00295854|528015553|FG001|Overall Study|Protocol Violation|1|||
146189193|NCT02099539|527202169|FG006|Overall Study|Physician Decision|0|||
146189194|NCT03473756|527202171|FG000|Overall Study|Withdrawal by Subject|1|||
146189195|NCT03473756|527202172|FG001|Overall Study|Withdrawal by Subject|4|||
146189196|NCT03473756|527202171|FG000|Overall Study|Adverse Event|6|||
146189197|NCT03473756|527202172|FG001|Overall Study|Adverse Event|7|||
146189198|NCT03473756|527202171|FG000|Overall Study|Lack of Efficacy|3|||
146189199|NCT03473756|527202172|FG001|Overall Study|Lack of Efficacy|10|||
146189200|NCT03473756|527202171|FG000|Overall Study|Physician Decision|0|||
146189201|NCT03473756|527202172|FG001|Overall Study|Physician Decision|2|||
146189202|NCT03473756|527202171|FG000|Overall Study|End of study treatment|0|||
146189203|NCT03473756|527202172|FG001|Overall Study|End of study treatment|2|||
146189204|NCT03473756|527202171|FG000|Overall Study|Lost to Follow-up|0|||
146189205|NCT03473756|527202172|FG001|Overall Study|Lost to Follow-up|1|||
146189206|NCT03714022|527202173|FG000|Overall Study|Adverse Event|1|||
146189207|NCT03714022|527202174|FG001|Overall Study|Adverse Event|0|||
146189208|NCT03714022|527202173|FG000|Overall Study|Consent withdrawal|0|||
146189209|NCT03714022|527202174|FG001|Overall Study|Consent withdrawal|1|||
146189210|NCT03714022|527202173|FG000|Overall Study|Lost to Follow-up|3|||
146189211|NCT03714022|527202174|FG001|Overall Study|Lost to Follow-up|2|||
146189212|NCT01007552|527202175|FG000|Overall Study|Withdrawal by Subject|1|||
146189213|NCT00231179|527203830|FG000|Overall Study|Lost to Follow-up|21|||
146189214|NCT00231179|527203831|FG001|Overall Study|Lost to Follow-up|21|||
146189215|NCT00231179|527203830|FG000|Overall Study|Withdrawal by Subject|3|||
146189216|NCT00231179|527203831|FG001|Overall Study|Withdrawal by Subject|3|||
146189217|NCT02206685|527203832|FG000|Overall Study|Surgery cancelled/changed|2|||
146189218|NCT02206685|527203833|FG001|Overall Study|Surgery cancelled/changed|3|||
146189219|NCT02206685|527203832|FG000|Overall Study|Withdrawal by Subject|1|||
146189220|NCT02206685|527203833|FG001|Overall Study|Withdrawal by Subject|2|||
146189221|NCT02206685|527203832|FG000|Overall Study|Protocol Violation|2|||
146189222|NCT02206685|527203833|FG001|Overall Study|Protocol Violation|2|||
146189223|NCT01345292|527203834|FG000|Overall Study|Withdrawal by Subject|2|||
146189224|NCT01345292|527203835|FG001|Overall Study|Withdrawal by Subject|0|||
146189225|NCT01345292|527203836|FG002|Overall Study|Withdrawal by Subject|1|||
146189226|NCT05406791|527203840|FG000|Overall Study|Lost to Follow-up|13|||
146189227|NCT05406791|527203841|FG001|Overall Study|Lost to Follow-up|10|||
146189228|NCT00515086|527203842|FG000|Overall Study|Adverse Event|1|||
146189229|NCT00515086|527203843|FG001|Overall Study|Adverse Event|1|||
146189230|NCT00515086|527203844|FG002|Overall Study|Adverse Event|2|||
146189231|NCT00515086|527203845|FG003|Overall Study|Adverse Event|3|||
146189232|NCT00515086|527203842|FG000|Overall Study|Administrative|1|||
146189233|NCT00515086|527203843|FG001|Overall Study|Administrative|1|||
146189234|NCT00515086|527203844|FG002|Overall Study|Administrative|0|||
146189235|NCT00515086|527203845|FG003|Overall Study|Administrative|0|||
146189236|NCT00515086|527203842|FG000|Overall Study|Withdrawal by Subject|1|||
146189237|NCT00515086|527203843|FG001|Overall Study|Withdrawal by Subject|0|||
146189238|NCT00515086|527203844|FG002|Overall Study|Withdrawal by Subject|0|||
146189239|NCT00515086|527203845|FG003|Overall Study|Withdrawal by Subject|1|||
146189240|NCT00515086|527203842|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
146189241|NCT00515086|527203843|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146189242|NCT00515086|527203844|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146189243|NCT00515086|527203845|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146189244|NCT00515086|527203842|FG000|Overall Study|Lost to Follow-up|1|||
146189245|NCT00515086|527203843|FG001|Overall Study|Lost to Follow-up|0|||
146189246|NCT00515086|527203844|FG002|Overall Study|Lost to Follow-up|0|||
146189247|NCT00515086|527203845|FG003|Overall Study|Lost to Follow-up|0|||
146189248|NCT00515086|527203842|FG000|Overall Study|Study drug no longer required|0|||
146189249|NCT00515086|527203843|FG001|Overall Study|Study drug no longer required|1|||
146189250|NCT00515086|527203844|FG002|Overall Study|Study drug no longer required|0|||
146189251|NCT00515086|527203845|FG003|Overall Study|Study drug no longer required|0|||
146189252|NCT00515086|527203842|FG000|Overall Study|Death|2|||
146189253|NCT00515086|527203843|FG001|Overall Study|Death|0|||
146189254|NCT00515086|527203844|FG002|Overall Study|Death|0|||
146189255|NCT00515086|527203845|FG003|Overall Study|Death|0|||
146189256|NCT02373813|527203846|FG000|Run-In Period|Other, Not Specified|5|||
146189257|NCT02373813|527203847|FG001|Run-In Period|Other, Not Specified|0|||
146189258|NCT02373813|527203848|FG002|Run-In Period|Other, Not Specified|0|||
146189259|NCT02373813|527203849|FG003|Run-In Period|Other, Not Specified|0|||
146189260|NCT02373813|527203846|FG000|Run-In Period|Withdrawal by Subject|16|||
146189261|NCT02373813|527203847|FG001|Run-In Period|Withdrawal by Subject|0|||
146189262|NCT02373813|527203848|FG002|Run-In Period|Withdrawal by Subject|0|||
146189263|NCT02373813|527203849|FG003|Run-In Period|Withdrawal by Subject|0|||
146189264|NCT02373813|527203846|FG000|Run-In Period|Decision by Sponsor|11|||
146189265|NCT02373813|527203847|FG001|Run-In Period|Decision by Sponsor|0|||
146189266|NCT02373813|527203848|FG002|Run-In Period|Decision by Sponsor|0|||
146189267|NCT02373813|527203849|FG003|Run-In Period|Decision by Sponsor|0|||
146189268|NCT02373813|527203846|FG000|Run-In Period|Protocol Violation|75|||
146189269|NCT02373813|527203847|FG001|Run-In Period|Protocol Violation|0|||
146189270|NCT02373813|527203848|FG002|Run-In Period|Protocol Violation|0|||
146189271|NCT02373813|527203849|FG003|Run-In Period|Protocol Violation|0|||
146189272|NCT02373813|527203846|FG000|Run-In Period|Lost to Follow-up|2|||
146189273|NCT02373813|527203847|FG001|Run-In Period|Lost to Follow-up|0|||
146189274|NCT02373813|527203848|FG002|Run-In Period|Lost to Follow-up|0|||
146189275|NCT02373813|527203849|FG003|Run-In Period|Lost to Follow-up|0|||
146189276|NCT02373813|527203846|FG000|Run-In Period|Adverse Event|3|||
146189277|NCT02373813|527203847|FG001|Run-In Period|Adverse Event|0|||
146189278|NCT02373813|527203848|FG002|Run-In Period|Adverse Event|0|||
146189279|NCT02373813|527203849|FG003|Run-In Period|Adverse Event|0|||
146189280|NCT02373813|527203846|FG000|Run-In Period|Noncompliance|1|||
146189281|NCT02373813|527203847|FG001|Run-In Period|Noncompliance|0|||
146189282|NCT02373813|527203848|FG002|Run-In Period|Noncompliance|0|||
146189283|NCT02373813|527203849|FG003|Run-In Period|Noncompliance|0|||
146189284|NCT02373813|527203846|FG000|Run-In Period|Ineligibility Determined|3|||
146189285|NCT02373813|527203847|FG001|Run-In Period|Ineligibility Determined|0|||
146189286|NCT02373813|527203848|FG002|Run-In Period|Ineligibility Determined|0|||
146189287|NCT02373813|527203849|FG003|Run-In Period|Ineligibility Determined|0|||
146189288|NCT02373813|527203846|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
146189289|NCT02373813|527203847|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
146189290|NCT02373813|527203848|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
146189291|NCT02373813|527203849|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
146189292|NCT02373813|527203846|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146189293|NCT02373813|527203847|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
146189294|NCT02373813|527203848|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
146189295|NCT02373813|527203849|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
146189296|NCT02373813|527203846|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146189297|NCT02373813|527203847|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146189298|NCT02373813|527203848|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
146189299|NCT02373813|527203849|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146189300|NCT02373813|527203846|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146189301|NCT02373813|527203847|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
146189302|NCT02373813|527203848|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146189303|NCT02373813|527203849|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
146189304|NCT01764386|527203857|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
146189305|NCT01764386|527203858|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
146189306|NCT01764386|527203857|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
146189307|NCT01764386|527203858|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
146189308|NCT01764386|527203857|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
146189309|NCT01764386|527203858|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
146189310|NCT01764386|527203857|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
146189311|NCT01764386|527203858|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
146189312|NCT01764386|527203857|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
146189313|NCT01764386|527203858|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
146189314|NCT01764386|527203857|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
146189315|NCT01764386|527203858|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
146189316|NCT01764386|527203857|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
146189317|NCT01764386|527203858|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
146189318|NCT01764386|527203857|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
146189319|NCT01764386|527203858|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
146189320|NCT02271594|527203859|FG000|Overall Study|Study closed; recruiting failure|19|||
146189321|NCT02271594|527203860|FG001|Overall Study|Study closed; recruiting failure|12|||
146189322|NCT00495469|527203861|FG000|Overall Study|Adverse Event|0|||
146189323|NCT00495469|527203862|FG001|Overall Study|Adverse Event|1|||
146189324|NCT00495469|527203863|FG002|Overall Study|Adverse Event|3|||
146189325|NCT00495469|527203864|FG003|Overall Study|Adverse Event|0|||
146189326|NCT00495469|527203865|FG004|Overall Study|Adverse Event|1|||
146189327|NCT00495469|527203866|FG005|Overall Study|Adverse Event|1|||
146189328|NCT00495469|527203867|FG006|Overall Study|Adverse Event|1|||
146189329|NCT00495469|527203861|FG000|Overall Study|Lost to Follow-up|1|||
146189330|NCT00495469|527203862|FG001|Overall Study|Lost to Follow-up|1|||
146189331|NCT00495469|527203863|FG002|Overall Study|Lost to Follow-up|3|||
146189332|NCT00495469|527203864|FG003|Overall Study|Lost to Follow-up|1|||
146189333|NCT00495469|527203865|FG004|Overall Study|Lost to Follow-up|0|||
146189334|NCT00495469|527203866|FG005|Overall Study|Lost to Follow-up|0|||
146189335|NCT00495469|527203867|FG006|Overall Study|Lost to Follow-up|0|||
146189336|NCT00495469|527203861|FG000|Overall Study|Protocol Violation|0|||
146189337|NCT00495469|527203862|FG001|Overall Study|Protocol Violation|0|||
146189338|NCT00495469|527203863|FG002|Overall Study|Protocol Violation|0|||
146189339|NCT00495469|527203864|FG003|Overall Study|Protocol Violation|0|||
146189340|NCT00495469|527203865|FG004|Overall Study|Protocol Violation|1|||
146081703|NCT00313781|526818324|FG001|Before Crossover|Randomized, not treated|0|||
146081704|NCT00313781|526818325|FG002|Before Crossover|Randomized, not treated|0|||
146189341|NCT00495469|527203866|FG005|Overall Study|Protocol Violation|2|||
146189342|NCT00495469|527203867|FG006|Overall Study|Protocol Violation|0|||
146189343|NCT00495469|527203861|FG000|Overall Study|Withdrawal by Subject|5|||
146189344|NCT00495469|527203862|FG001|Overall Study|Withdrawal by Subject|3|||
146189345|NCT00495469|527203863|FG002|Overall Study|Withdrawal by Subject|1|||
146189346|NCT00495469|527203864|FG003|Overall Study|Withdrawal by Subject|3|||
146189347|NCT00495469|527203865|FG004|Overall Study|Withdrawal by Subject|3|||
146189348|NCT00495469|527203866|FG005|Overall Study|Withdrawal by Subject|2|||
146189349|NCT00495469|527203867|FG006|Overall Study|Withdrawal by Subject|3|||
146189350|NCT00495469|527203861|FG000|Overall Study|Lack of Efficacy|0|||
146189351|NCT00495469|527203862|FG001|Overall Study|Lack of Efficacy|0|||
146189352|NCT00495469|527203863|FG002|Overall Study|Lack of Efficacy|0|||
146189353|NCT00495469|527203864|FG003|Overall Study|Lack of Efficacy|0|||
146189354|NCT00495469|527203865|FG004|Overall Study|Lack of Efficacy|0|||
146189355|NCT00495469|527203866|FG005|Overall Study|Lack of Efficacy|0|||
146189356|NCT00495469|527203867|FG006|Overall Study|Lack of Efficacy|1|||
146189357|NCT00495469|527203861|FG000|Overall Study|Liver function test abnormality|0|||
146189358|NCT00495469|527203862|FG001|Overall Study|Liver function test abnormality|1|||
146189359|NCT00495469|527203863|FG002|Overall Study|Liver function test abnormality|0|||
146189360|NCT00495469|527203864|FG003|Overall Study|Liver function test abnormality|0|||
146189361|NCT00495469|527203865|FG004|Overall Study|Liver function test abnormality|0|||
146189362|NCT00495469|527203866|FG005|Overall Study|Liver function test abnormality|0|||
146189363|NCT00495469|527203867|FG006|Overall Study|Liver function test abnormality|0|||
146081705|NCT00313781|526818323|FG000|After Crossover|Death|0|||
146081706|NCT00313781|526818324|FG001|After Crossover|Death|0|||
146081707|NCT00313781|526818325|FG002|After Crossover|Death|6|||
146081708|NCT00313781|526818323|FG000|After Crossover|Withdrawal by Subject|0|||
146081709|NCT00313781|526818324|FG001|After Crossover|Withdrawal by Subject|0|||
146081710|NCT00313781|526818325|FG002|After Crossover|Withdrawal by Subject|3|||
146081711|NCT00313781|526818323|FG000|After Crossover|Other|0|||
146081712|NCT00313781|526818324|FG001|After Crossover|Other|0|||
146081713|NCT00313781|526818325|FG002|After Crossover|Other|18|||
146081714|NCT03567343|526818327|FG000|Overall Study|Lost to Follow-up|2|||
146081715|NCT03567343|526818328|FG001|Overall Study|Lost to Follow-up|1|||
146081716|NCT03567343|526818327|FG000|Overall Study|No longer eligible|2|||
146081717|NCT03567343|526818328|FG001|Overall Study|No longer eligible|1|||
146081718|NCT03567343|526818327|FG000|Overall Study|Adverse Event|1|||
146081719|NCT03567343|526818328|FG001|Overall Study|Adverse Event|0|||
146081720|NCT03567343|526818327|FG000|Overall Study|Protocol Violation|1|||
146081721|NCT03567343|526818328|FG001|Overall Study|Protocol Violation|1|||
146081722|NCT01433250|526818329|FG000|Overall Study|Protocol Violation|0|||
146081723|NCT01433250|526818330|FG001|Overall Study|Protocol Violation|1|||
146081724|NCT01433250|526818329|FG000|Overall Study|Withdrawal by Subject|3|||
146081725|NCT01433250|526818330|FG001|Overall Study|Withdrawal by Subject|2|||
146081726|NCT03148691|526818331|FG000|Overall Study|Protocol Violation|1|||
146081727|NCT03148691|526818332|FG001|Overall Study|Protocol Violation|2|||
146081728|NCT03148691|526818333|FG002|Overall Study|Protocol Violation|7|||
146189364|NCT00495469|527203861|FG000|Overall Study|ST depression at randomisation in ECG|0|||
146189365|NCT00495469|527203862|FG001|Overall Study|ST depression at randomisation in ECG|1|||
146189366|NCT00495469|527203863|FG002|Overall Study|ST depression at randomisation in ECG|0|||
146189367|NCT00495469|527203864|FG003|Overall Study|ST depression at randomisation in ECG|0|||
146189368|NCT00495469|527203865|FG004|Overall Study|ST depression at randomisation in ECG|0|||
146189369|NCT00495469|527203866|FG005|Overall Study|ST depression at randomisation in ECG|0|||
146189370|NCT00495469|527203867|FG006|Overall Study|ST depression at randomisation in ECG|0|||
146189371|NCT04454567|527203868|FG000|Overall Study|Study Terminated by Sponsor|1|||
146189372|NCT04454567|527203869|FG001|Overall Study|Study Terminated by Sponsor|1|||
146189373|NCT01123161|527203874|FG000|Overall Study|Lost to Follow-up|1|||
146189374|NCT01123161|527203875|FG001|Overall Study|Lost to Follow-up|0|||
146189375|NCT01123161|527203874|FG000|Overall Study|Withdrawal by Subject|1|||
146189376|NCT01123161|527203875|FG001|Overall Study|Withdrawal by Subject|0|||
146189377|NCT02412761|527203882|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146189378|NCT02412761|527203883|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146189379|NCT02412761|527203884|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146189380|NCT02412761|527203885|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146189381|NCT02412761|527203886|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146189382|NCT02412761|527203887|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146189383|NCT00562965|527203888|FG000|Overall Study|Withdrawal by Subject|0|||
146189384|NCT00562965|527203889|FG001|Overall Study|Withdrawal by Subject|1|||
146189385|NCT00562965|527203888|FG000|Overall Study|Death|2|||
146189386|NCT00562965|527203889|FG001|Overall Study|Death|4|||
146189387|NCT00562965|527203888|FG000|Overall Study|Lost to Follow-up|1|||
146189388|NCT00562965|527203889|FG001|Overall Study|Lost to Follow-up|0|||
146189389|NCT00562965|527203888|FG000|Overall Study|Other|0|||
146189390|NCT00562965|527203889|FG001|Overall Study|Other|1|||
146189391|NCT02531438|527203890|FG000|Overall Study|Adverse Event|7|||
146189392|NCT02531438|527203891|FG001|Overall Study|Adverse Event|9|||
146189393|NCT02531438|527203890|FG000|Overall Study|Lost to Follow-up|0|||
146189394|NCT02531438|527203891|FG001|Overall Study|Lost to Follow-up|3|||
146189395|NCT02531438|527203890|FG000|Overall Study|Withdrawal by Subject|7|||
146189396|NCT02531438|527203891|FG001|Overall Study|Withdrawal by Subject|8|||
146189397|NCT02531438|527203890|FG000|Overall Study|Physician Decision|0|||
146189398|NCT02531438|527203891|FG001|Overall Study|Physician Decision|1|||
146189399|NCT02531438|527203890|FG000|Overall Study|Death|6|||
146189400|NCT02531438|527203891|FG001|Overall Study|Death|3|||
146189401|NCT02531438|527203890|FG000|Overall Study|Randomized, but Not Treated|4|||
146189402|NCT02531438|527203891|FG001|Overall Study|Randomized, but Not Treated|0|||
146189403|NCT02531438|527203890|FG000|Overall Study|Missed EOT/PTE Visit|5|||
146189404|NCT02531438|527203891|FG001|Overall Study|Missed EOT/PTE Visit|2|||
146189405|NCT02531438|527203890|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
146189406|NCT02531438|527203891|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
146189407|NCT01124617|527203892|FG000|Overall Study|Adverse Event|5|||
146189408|NCT01124617|527203893|FG001|Overall Study|Adverse Event|2|||
146189409|NCT01124617|527203892|FG000|Overall Study|Lack of Efficacy|2|||
146189410|NCT01124617|527203893|FG001|Overall Study|Lack of Efficacy|1|||
146189411|NCT01124617|527203892|FG000|Overall Study|Protocol Violation|1|||
146412497|NCT00295854|528015554|FG002|Overall Study|Protocol Violation|1|||
146189412|NCT01124617|527203893|FG001|Overall Study|Protocol Violation|1|||
146189413|NCT01124617|527203892|FG000|Overall Study|Withdrawal by Subject|9|||
146189414|NCT01124617|527203893|FG001|Overall Study|Withdrawal by Subject|1|||
146189415|NCT01124617|527203892|FG000|Overall Study|Other|2|||
146189416|NCT01124617|527203893|FG001|Overall Study|Other|1|||
146189417|NCT00945477|527203894|FG000|Overall Study|Adverse Event|3|||
146189418|NCT00945477|527203894|FG000|Overall Study|Lack of Efficacy|2|||
146189419|NCT00945477|527203894|FG000|Overall Study|Withdrawal by Subject|1|||
146189420|NCT01813422|527203895|FG000|Overall Study|Withdrawal by Subject|14|||
146189421|NCT01813422|527203896|FG001|Overall Study|Withdrawal by Subject|8|||
146189422|NCT01813422|527203895|FG000|Overall Study|Death|2|||
146189423|NCT01813422|527203896|FG001|Overall Study|Death|3|||
146189424|NCT01813422|527203895|FG000|Overall Study|Sponsor Decision|2|||
146189425|NCT01813422|527203896|FG001|Overall Study|Sponsor Decision|1|||
146189426|NCT01813422|527203895|FG000|Overall Study|Lost to Follow-up|2|||
146189427|NCT01813422|527203896|FG001|Overall Study|Lost to Follow-up|4|||
146189428|NCT01653743|527203897|FG000|Overall Study|Withdrawal by Subject|1|||
146189429|NCT01653743|527203898|FG001|Overall Study|Withdrawal by Subject|0|||
146189430|NCT01653743|527203897|FG000|Overall Study|Investigator discretion|3|||
146189431|NCT01653743|527203898|FG001|Overall Study|Investigator discretion|0|||
146189432|NCT03704298|527203902|FG000|Overall Study|Death|3|||
146189433|NCT03704298|527203903|FG001|Overall Study|Death|1|||
146189434|NCT03704298|527203904|FG002|Overall Study|Death|1|||
146189435|NCT03704298|527203905|FG003|Overall Study|Death|0|||
146189436|NCT03704298|527203902|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
146189437|NCT03704298|527203903|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
146189438|NCT03704298|527203904|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
146189439|NCT03704298|527203905|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
146189440|NCT03704298|527203902|FG000|Overall Study|Withdrawal by Subject|1|||
146189441|NCT03704298|527203903|FG001|Overall Study|Withdrawal by Subject|0|||
146189442|NCT03704298|527203904|FG002|Overall Study|Withdrawal by Subject|0|||
146189443|NCT03704298|527203905|FG003|Overall Study|Withdrawal by Subject|0|||
146189444|NCT03704298|527203902|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146189445|NCT03704298|527203903|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
146189446|NCT03704298|527203904|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146189447|NCT03704298|527203905|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
146189448|NCT04796935|527203906|FG000|Overall Study|Withdrawal by Subject|0|||
146189449|NCT04796935|527203907|FG001|Overall Study|Withdrawal by Subject|1|||
146189450|NCT04796935|527203906|FG000|Overall Study|Physician Decision|0|||
146189451|NCT04796935|527203907|FG001|Overall Study|Physician Decision|1|||
146189452|NCT04796935|527203906|FG000|Overall Study|Device not available|1|||
146189453|NCT04796935|527203907|FG001|Overall Study|Device not available|0|||
146189454|NCT04796935|527203906|FG000|Overall Study|Trained provider not available|1|||
146189455|NCT04796935|527203907|FG001|Overall Study|Trained provider not available|0|||
146189456|NCT00410384|527203908|FG000|Overall Study|Withdrawal by Subject|28|||
146189457|NCT00410384|527203909|FG001|Overall Study|Withdrawal by Subject|17|||
146189458|NCT00410384|527203910|FG002|Overall Study|Withdrawal by Subject|20|||
146189459|NCT00410384|527203908|FG000|Overall Study|Adverse Event|23|||
146189460|NCT00410384|527203909|FG001|Overall Study|Adverse Event|18|||
146189461|NCT00410384|527203910|FG002|Overall Study|Adverse Event|23|||
146189462|NCT00410384|527203908|FG000|Overall Study|Lack of Efficacy|20|||
146189463|NCT00410384|527203909|FG001|Overall Study|Lack of Efficacy|12|||
146189464|NCT00410384|527203910|FG002|Overall Study|Lack of Efficacy|17|||
146189465|NCT00410384|527203908|FG000|Overall Study|Lack of Compliance|2|||
146189466|NCT00410384|527203909|FG001|Overall Study|Lack of Compliance|2|||
146189467|NCT00410384|527203910|FG002|Overall Study|Lack of Compliance|2|||
146189468|NCT00410384|527203908|FG000|Overall Study|Lost to Follow-up|4|||
146189469|NCT00410384|527203909|FG001|Overall Study|Lost to Follow-up|6|||
146189470|NCT00410384|527203910|FG002|Overall Study|Lost to Follow-up|6|||
146189471|NCT00410384|527203908|FG000|Overall Study|Protocol Violation|6|||
146189472|NCT00410384|527203909|FG001|Overall Study|Protocol Violation|6|||
146189473|NCT00410384|527203910|FG002|Overall Study|Protocol Violation|6|||
146189474|NCT00410384|527203908|FG000|Overall Study|Physician Decision|3|||
146189475|NCT00410384|527203909|FG001|Overall Study|Physician Decision|3|||
146189476|NCT00410384|527203910|FG002|Overall Study|Physician Decision|4|||
146189477|NCT00410384|527203908|FG000|Overall Study|Other|3|||
146189478|NCT00410384|527203909|FG001|Overall Study|Other|8|||
146189479|NCT00410384|527203910|FG002|Overall Study|Other|4|||
146189480|NCT01253200|527203911|FG000|Overall Study|Death|1|||
146189481|NCT01253200|527203912|FG001|Overall Study|Death|0|||
146189482|NCT01253200|527203913|FG002|Overall Study|Death|0|||
146189483|NCT01253200|527203914|FG003|Overall Study|Death|0|||
146189484|NCT01253200|527203915|FG004|Overall Study|Death|0|||
146189485|NCT01253200|527203911|FG000|Overall Study|Lost to Follow-up|1|||
146189486|NCT01253200|527203912|FG001|Overall Study|Lost to Follow-up|1|||
146189487|NCT01253200|527203913|FG002|Overall Study|Lost to Follow-up|0|||
146189488|NCT01253200|527203914|FG003|Overall Study|Lost to Follow-up|0|||
146189489|NCT01253200|527203915|FG004|Overall Study|Lost to Follow-up|0|||
146189490|NCT01253200|527203911|FG000|Overall Study|Withdrawal by Subject|2|||
146189491|NCT01253200|527203912|FG001|Overall Study|Withdrawal by Subject|0|||
146189492|NCT01253200|527203913|FG002|Overall Study|Withdrawal by Subject|0|||
146189493|NCT01253200|527203914|FG003|Overall Study|Withdrawal by Subject|0|||
146189494|NCT01253200|527203915|FG004|Overall Study|Withdrawal by Subject|0|||
146189495|NCT01253200|527203911|FG000|Overall Study|Protocol Violation|1|||
146189496|NCT01253200|527203912|FG001|Overall Study|Protocol Violation|4|||
146189497|NCT01253200|527203913|FG002|Overall Study|Protocol Violation|0|||
146189498|NCT01253200|527203914|FG003|Overall Study|Protocol Violation|0|||
146189499|NCT01253200|527203915|FG004|Overall Study|Protocol Violation|5|||
146189500|NCT01253200|527203911|FG000|Overall Study|intents|10|||
146189501|NCT01253200|527203912|FG001|Overall Study|intents|10|||
146189502|NCT01253200|527203913|FG002|Overall Study|intents|1|||
146189503|NCT01253200|527203914|FG003|Overall Study|intents|3|||
146189504|NCT01253200|527203915|FG004|Overall Study|intents|0|||
146189505|NCT01253200|527203911|FG000|Overall Study|Attempts|6|||
146189506|NCT01253200|527203912|FG001|Overall Study|Attempts|4|||
146189507|NCT01253200|527203913|FG002|Overall Study|Attempts|1|||
146189508|NCT01253200|527203914|FG003|Overall Study|Attempts|2|||
146189509|NCT01253200|527203915|FG004|Overall Study|Attempts|0|||
146189510|NCT02049437|527203916|FG000|Period 1|Adverse Event|1|||
146189511|NCT02049437|527203917|FG001|Period 1|Adverse Event|1|||
146189512|NCT02049437|527203916|FG000|Period 1|Adverse Event|1|||
146189513|NCT02049437|527203917|FG001|Period 1|Adverse Event|0|||
146189514|NCT00783718|527203918|FG000|Induction Phase|Adverse Event|4|||
146189515|NCT00783718|527203919|FG001|Induction Phase|Adverse Event|0|||
146189516|NCT00783718|527203920|FG002|Induction Phase|Adverse Event|7|||
146189517|NCT00783718|527203921|FG003|Induction Phase|Adverse Event|0|||
146189518|NCT00783718|527203922|FG004|Induction Phase|Adverse Event|0|||
146189519|NCT00783718|527203923|FG005|Induction Phase|Adverse Event|0|||
146189520|NCT00783718|527203924|FG006|Induction Phase|Adverse Event|0|||
146189521|NCT00783718|527203918|FG000|Induction Phase|Protocol Violation|1|||
146189522|NCT00783718|527203919|FG001|Induction Phase|Protocol Violation|1|||
146189523|NCT00783718|527203920|FG002|Induction Phase|Protocol Violation|6|||
146189524|NCT00783718|527203921|FG003|Induction Phase|Protocol Violation|0|||
146189525|NCT00783718|527203922|FG004|Induction Phase|Protocol Violation|0|||
146189526|NCT00783718|527203923|FG005|Induction Phase|Protocol Violation|0|||
146189527|NCT00783718|527203924|FG006|Induction Phase|Protocol Violation|0|||
146189528|NCT00783718|527203918|FG000|Induction Phase|Lack of Efficacy|5|||
146189529|NCT00783718|527203919|FG001|Induction Phase|Lack of Efficacy|2|||
146189530|NCT00783718|527203920|FG002|Induction Phase|Lack of Efficacy|14|||
146189531|NCT00783718|527203921|FG003|Induction Phase|Lack of Efficacy|0|||
146189532|NCT00783718|527203922|FG004|Induction Phase|Lack of Efficacy|0|||
146189533|NCT00783718|527203923|FG005|Induction Phase|Lack of Efficacy|0|||
146189534|NCT00783718|527203924|FG006|Induction Phase|Lack of Efficacy|0|||
146189535|NCT00783718|527203918|FG000|Induction Phase|Withdrawal by Subject|3|||
146189536|NCT00783718|527203919|FG001|Induction Phase|Withdrawal by Subject|4|||
146189537|NCT00783718|527203920|FG002|Induction Phase|Withdrawal by Subject|8|||
146189538|NCT00783718|527203921|FG003|Induction Phase|Withdrawal by Subject|0|||
146189539|NCT00783718|527203922|FG004|Induction Phase|Withdrawal by Subject|0|||
146189540|NCT00783718|527203923|FG005|Induction Phase|Withdrawal by Subject|0|||
146189541|NCT00783718|527203924|FG006|Induction Phase|Withdrawal by Subject|0|||
146189542|NCT00783718|527203918|FG000|Induction Phase|Lost to Follow-up|1|||
146189543|NCT00783718|527203919|FG001|Induction Phase|Lost to Follow-up|0|||
146189544|NCT00783718|527203920|FG002|Induction Phase|Lost to Follow-up|1|||
146189545|NCT00783718|527203921|FG003|Induction Phase|Lost to Follow-up|0|||
146189546|NCT00783718|527203922|FG004|Induction Phase|Lost to Follow-up|0|||
146189547|NCT00783718|527203923|FG005|Induction Phase|Lost to Follow-up|0|||
146189548|NCT00783718|527203924|FG006|Induction Phase|Lost to Follow-up|0|||
146189549|NCT00783718|527203918|FG000|Maintenance Phase|Adverse Event|12|||
146189550|NCT00783718|527203919|FG001|Maintenance Phase|Adverse Event|0|||
146189551|NCT00783718|527203920|FG002|Maintenance Phase|Adverse Event|0|||
146189552|NCT00783718|527203921|FG003|Maintenance Phase|Adverse Event|15|||
146189553|NCT00783718|527203922|FG004|Maintenance Phase|Adverse Event|7|||
146189554|NCT00783718|527203923|FG005|Maintenance Phase|Adverse Event|6|||
146189555|NCT00783718|527203924|FG006|Maintenance Phase|Adverse Event|16|||
146189556|NCT00783718|527203918|FG000|Maintenance Phase|Protocol Violation|1|||
146189557|NCT00783718|527203919|FG001|Maintenance Phase|Protocol Violation|0|||
146189558|NCT00783718|527203920|FG002|Maintenance Phase|Protocol Violation|0|||
146189559|NCT00783718|527203921|FG003|Maintenance Phase|Protocol Violation|0|||
146189560|NCT00783718|527203922|FG004|Maintenance Phase|Protocol Violation|0|||
146189561|NCT00783718|527203923|FG005|Maintenance Phase|Protocol Violation|0|||
146189562|NCT00783718|527203924|FG006|Maintenance Phase|Protocol Violation|2|||
146189563|NCT00783718|527203918|FG000|Maintenance Phase|Lack of Efficacy|83|||
146189564|NCT00783718|527203919|FG001|Maintenance Phase|Lack of Efficacy|0|||
146189565|NCT00783718|527203920|FG002|Maintenance Phase|Lack of Efficacy|0|||
146189566|NCT00783718|527203921|FG003|Maintenance Phase|Lack of Efficacy|61|||
146189567|NCT00783718|527203922|FG004|Maintenance Phase|Lack of Efficacy|31|||
146189568|NCT00783718|527203923|FG005|Maintenance Phase|Lack of Efficacy|33|||
146189569|NCT00783718|527203924|FG006|Maintenance Phase|Lack of Efficacy|155|||
146189570|NCT00783718|527203918|FG000|Maintenance Phase|Withdrawal by Subject|6|||
146189571|NCT00783718|527203919|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146189572|NCT00783718|527203920|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146189573|NCT00783718|527203921|FG003|Maintenance Phase|Withdrawal by Subject|2|||
146189574|NCT00783718|527203922|FG004|Maintenance Phase|Withdrawal by Subject|5|||
146189575|NCT00783718|527203923|FG005|Maintenance Phase|Withdrawal by Subject|2|||
146189576|NCT00783718|527203924|FG006|Maintenance Phase|Withdrawal by Subject|20|||
146189577|NCT00783718|527203918|FG000|Maintenance Phase|Lost to Follow-up|3|||
146189578|NCT00783718|527203919|FG001|Maintenance Phase|Lost to Follow-up|0|||
146189579|NCT00783718|527203920|FG002|Maintenance Phase|Lost to Follow-up|0|||
146189580|NCT00783718|527203921|FG003|Maintenance Phase|Lost to Follow-up|0|||
146189581|NCT00783718|527203922|FG004|Maintenance Phase|Lost to Follow-up|2|||
146189582|NCT00783718|527203923|FG005|Maintenance Phase|Lost to Follow-up|0|||
146189583|NCT00783718|527203924|FG006|Maintenance Phase|Lost to Follow-up|2|||
146189584|NCT01605136|527203927|FG000|Study Period|Withdrawal by Subject|2|||
146189585|NCT01605136|527203928|FG001|Study Period|Withdrawal by Subject|0|||
146189586|NCT01605136|527203927|FG000|Study Period|Physician Decision|1|||
146189587|NCT01605136|527203928|FG001|Study Period|Physician Decision|1|||
146189588|NCT01605136|527203927|FG000|Study Period|Lost to Follow-up|0|||
146189589|NCT01605136|527203928|FG001|Study Period|Lost to Follow-up|2|||
146189590|NCT01605136|527203927|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
146189591|NCT01605136|527203928|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
146189592|NCT01072929|527203929|FG000|Overall Study|Adverse Event|8|||
146189593|NCT01072929|527203930|FG001|Overall Study|Adverse Event|11|||
146189594|NCT01072929|527203931|FG002|Overall Study|Adverse Event|2|||
146189595|NCT01072929|527203929|FG000|Overall Study|Lack of Efficacy|7|||
146189596|NCT01072929|527203930|FG001|Overall Study|Lack of Efficacy|4|||
146189597|NCT01072929|527203931|FG002|Overall Study|Lack of Efficacy|0|||
146189598|NCT01072929|527203929|FG000|Overall Study|Withdrawal by Subject|7|||
146189599|NCT01072929|527203930|FG001|Overall Study|Withdrawal by Subject|15|||
146189600|NCT01072929|527203931|FG002|Overall Study|Withdrawal by Subject|3|||
146189601|NCT01072929|527203929|FG000|Overall Study|Protocol Violation|13|||
146189602|NCT01072929|527203930|FG001|Overall Study|Protocol Violation|11|||
146189603|NCT01072929|527203931|FG002|Overall Study|Protocol Violation|2|||
146189604|NCT01072929|527203929|FG000|Overall Study|Lost to Follow-up|8|||
146189605|NCT01072929|527203930|FG001|Overall Study|Lost to Follow-up|4|||
146189606|NCT01072929|527203931|FG002|Overall Study|Lost to Follow-up|1|||
146189607|NCT01072929|527203929|FG000|Overall Study|Noncompliance with study medication|0|||
146189608|NCT01072929|527203930|FG001|Overall Study|Noncompliance with study medication|3|||
146189609|NCT01072929|527203931|FG002|Overall Study|Noncompliance with study medication|0|||
146189610|NCT01072929|527203929|FG000|Overall Study|Noncompliance with study procedures|1|||
146189611|NCT01072929|527203930|FG001|Overall Study|Noncompliance with study procedures|0|||
146189612|NCT01072929|527203931|FG002|Overall Study|Noncompliance with study procedures|1|||
146189613|NCT01072929|527203929|FG000|Overall Study|Other|0|||
146189614|NCT01072929|527203930|FG001|Overall Study|Other|3|||
146189615|NCT01072929|527203931|FG002|Overall Study|Other|0|||
146189616|NCT01027871|527203932|FG000|Overall Study|Physician Decision|1|||
146189617|NCT01027871|527203933|FG001|Overall Study|Physician Decision|5|||
146189618|NCT01027871|527203934|FG002|Overall Study|Physician Decision|0|||
146189619|NCT01027871|527203932|FG000|Overall Study|Protocol Violation|0|||
146189620|NCT01027871|527203933|FG001|Overall Study|Protocol Violation|2|||
146189621|NCT01027871|527203934|FG002|Overall Study|Protocol Violation|2|||
146189622|NCT01027871|527203932|FG000|Overall Study|Withdrawal by Subject|1|||
146189623|NCT01027871|527203933|FG001|Overall Study|Withdrawal by Subject|2|||
146189624|NCT01027871|527203934|FG002|Overall Study|Withdrawal by Subject|2|||
146189625|NCT01027871|527203932|FG000|Overall Study|Adverse Event|0|||
146189626|NCT01027871|527203933|FG001|Overall Study|Adverse Event|2|||
146189627|NCT01027871|527203934|FG002|Overall Study|Adverse Event|2|||
146189628|NCT01027871|527203932|FG000|Overall Study|Sponsor Decision|0|||
146189629|NCT01027871|527203933|FG001|Overall Study|Sponsor Decision|2|||
146189630|NCT01027871|527203934|FG002|Overall Study|Sponsor Decision|0|||
146189631|NCT01027871|527203932|FG000|Overall Study|Discontinued Prior to Treatment|0|||
146189632|NCT01027871|527203933|FG001|Overall Study|Discontinued Prior to Treatment|0|||
146189633|NCT01027871|527203934|FG002|Overall Study|Discontinued Prior to Treatment|1|||
146189634|NCT04833855|527203935|FG000|Overall Study|Decision by sponsor|0|||
146189635|NCT04833855|527203936|FG001|Overall Study|Decision by sponsor|1|||
146189636|NCT04833855|527203937|FG002|Overall Study|Decision by sponsor|0|||
146189637|NCT04833855|527203938|FG003|Overall Study|Decision by sponsor|0|||
146189638|NCT04833855|527203935|FG000|Overall Study|Withdrawal by Subject|4|||
146189639|NCT04833855|527203936|FG001|Overall Study|Withdrawal by Subject|1|||
146189640|NCT04833855|527203937|FG002|Overall Study|Withdrawal by Subject|3|||
146189641|NCT04833855|527203938|FG003|Overall Study|Withdrawal by Subject|1|||
146189642|NCT04833855|527203935|FG000|Overall Study|Lost to Follow-up|1|||
146412498|NCT00295854|528015552|FG000|Overall Study|Lost to Follow-up|2|||
146412499|NCT00295854|528015553|FG001|Overall Study|Lost to Follow-up|0|||
146412500|NCT00295854|528015554|FG002|Overall Study|Lost to Follow-up|1|||
146412501|NCT00295854|528015552|FG000|Overall Study|Withdrawal by Subject|3|||
146412502|NCT00295854|528015553|FG001|Overall Study|Withdrawal by Subject|7|||
146412503|NCT00295854|528015554|FG002|Overall Study|Withdrawal by Subject|4|||
146412504|NCT00295854|528015552|FG000|Overall Study|did not continue to meet criteria|1|||
146412505|NCT00295854|528015553|FG001|Overall Study|did not continue to meet criteria|1|||
146412506|NCT00295854|528015554|FG002|Overall Study|did not continue to meet criteria|2|||
146412507|NCT00295854|528015552|FG000|Overall Study|required a prohibited medication|1|||
146412508|NCT00295854|528015553|FG001|Overall Study|required a prohibited medication|0|||
146412509|NCT00295854|528015554|FG002|Overall Study|required a prohibited medication|0|||
146412510|NCT00295854|528015552|FG000|Overall Study|Other|3|||
146412511|NCT00295854|528015553|FG001|Overall Study|Other|5|||
146412512|NCT00295854|528015554|FG002|Overall Study|Other|1|||
146412513|NCT00672620|528015555|FG000|Overall Study|Adverse Event|7|||
146412514|NCT00672620|528015556|FG001|Overall Study|Adverse Event|7|||
146412515|NCT00672620|528015557|FG002|Overall Study|Adverse Event|12|||
146412516|NCT00672620|528015558|FG003|Overall Study|Adverse Event|17|||
146412517|NCT00672620|528015555|FG000|Overall Study|Lack of Efficacy|1|||
146412518|NCT00672620|528015556|FG001|Overall Study|Lack of Efficacy|2|||
146412519|NCT00672620|528015557|FG002|Overall Study|Lack of Efficacy|2|||
146412520|NCT00672620|528015558|FG003|Overall Study|Lack of Efficacy|0|||
146412521|NCT00672620|528015555|FG000|Overall Study|Noncompliance with Study Drug|3|||
146412522|NCT00672620|528015556|FG001|Overall Study|Noncompliance with Study Drug|4|||
146412523|NCT00672620|528015557|FG002|Overall Study|Noncompliance with Study Drug|0|||
146412524|NCT00672620|528015558|FG003|Overall Study|Noncompliance with Study Drug|2|||
146412525|NCT00672620|528015555|FG000|Overall Study|Protocol Deviations|5|||
146412526|NCT00672620|528015556|FG001|Overall Study|Protocol Deviations|7|||
146189643|NCT04833855|527203936|FG001|Overall Study|Lost to Follow-up|0|||
146189644|NCT04833855|527203937|FG002|Overall Study|Lost to Follow-up|2|||
146189645|NCT04833855|527203938|FG003|Overall Study|Lost to Follow-up|2|||
146189646|NCT04833855|527203935|FG000|Overall Study|Protocol specified criteria|0|||
146412527|NCT00672620|528015557|FG002|Overall Study|Protocol Deviations|2|||
146412528|NCT00672620|528015558|FG003|Overall Study|Protocol Deviations|5|||
146412529|NCT00672620|528015555|FG000|Overall Study|Withdrawal of Consent|6|||
146412530|NCT00672620|528015556|FG001|Overall Study|Withdrawal of Consent|12|||
146412531|NCT00672620|528015557|FG002|Overall Study|Withdrawal of Consent|5|||
146412532|NCT00672620|528015558|FG003|Overall Study|Withdrawal of Consent|6|||
146412533|NCT00672620|528015555|FG000|Overall Study|Lost to Follow-up|8|||
146412534|NCT00672620|528015556|FG001|Overall Study|Lost to Follow-up|19|||
146412535|NCT00672620|528015557|FG002|Overall Study|Lost to Follow-up|8|||
146412536|NCT00672620|528015558|FG003|Overall Study|Lost to Follow-up|11|||
146189647|NCT04833855|527203936|FG001|Overall Study|Protocol specified criteria|0|||
146412537|NCT00672620|528015555|FG000|Overall Study|Reason not Specified|3|||
146412538|NCT00672620|528015556|FG001|Overall Study|Reason not Specified|3|||
146412539|NCT00672620|528015557|FG002|Overall Study|Reason not Specified|2|||
146412540|NCT00672620|528015558|FG003|Overall Study|Reason not Specified|1|||
146412541|NCT02736227|528015562|FG000|Overall Study|Withdrawal by Subject|0|||
146189648|NCT04833855|527203937|FG002|Overall Study|Protocol specified criteria|2|||
146189649|NCT04833855|527203938|FG003|Overall Study|Protocol specified criteria|1|||
146189650|NCT03782727|527203939|FG000|Overall Study|Lost to Follow-up|32|||
146412542|NCT02736227|528015563|FG001|Overall Study|Withdrawal by Subject|0|||
146412543|NCT02736227|528015564|FG002|Overall Study|Withdrawal by Subject|1|||
146412544|NCT02736227|528015562|FG000|Overall Study|Physician Decision|0|||
146412545|NCT02736227|528015563|FG001|Overall Study|Physician Decision|0|||
146412546|NCT02736227|528015564|FG002|Overall Study|Physician Decision|5|||
146412547|NCT02736227|528015562|FG000|Overall Study|Non Compliant|0|||
146412548|NCT02736227|528015563|FG001|Overall Study|Non Compliant|0|||
146412549|NCT02736227|528015564|FG002|Overall Study|Non Compliant|2|||
146412550|NCT04120194|528015565|FG000|Overall Study|Lost to Follow-up|11|||
146412551|NCT04120194|528015566|FG001|Overall Study|Lost to Follow-up|8|||
146412552|NCT04120194|528015565|FG000|Overall Study|Adverse Event|4|||
146412553|NCT04120194|528015566|FG001|Overall Study|Adverse Event|5|||
146412554|NCT04120194|528015565|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
146412555|NCT04120194|528015566|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
146412556|NCT04120194|528015565|FG000|Overall Study|Miscellaneous|4|||
146412557|NCT04120194|528015566|FG001|Overall Study|Miscellaneous|5|||
146412558|NCT00219557|528015573|FG000|Phase 1|Lack of Efficacy|3|||
146412559|NCT00219557|528015574|FG001|Phase 1|Lack of Efficacy|0|||
146412560|NCT00219557|528015575|FG002|Phase 1|Lack of Efficacy|0|||
146412561|NCT00219557|528015573|FG000|Phase 1|Adverse Event|2|||
146412562|NCT00219557|528015574|FG001|Phase 1|Adverse Event|0|||
146412563|NCT00219557|528015575|FG002|Phase 1|Adverse Event|0|||
146412564|NCT00219557|528015573|FG000|Phase 1|Withdrawal by Subject|1|||
146412565|NCT00219557|528015574|FG001|Phase 1|Withdrawal by Subject|0|||
146412566|NCT00219557|528015575|FG002|Phase 1|Withdrawal by Subject|0|||
146412567|NCT00219557|528015573|FG000|Phase 1|Started chemotherapy at other institute|1|||
146412568|NCT00219557|528015574|FG001|Phase 1|Started chemotherapy at other institute|0|||
146412569|NCT00219557|528015575|FG002|Phase 1|Started chemotherapy at other institute|0|||
146412570|NCT00219557|528015573|FG000|Phase 2|Lack of Efficacy|0|||
146412571|NCT00219557|528015574|FG001|Phase 2|Lack of Efficacy|21|||
146412572|NCT00219557|528015575|FG002|Phase 2|Lack of Efficacy|15|||
146412573|NCT00219557|528015573|FG000|Phase 2|Adverse Event|0|||
146412574|NCT00219557|528015574|FG001|Phase 2|Adverse Event|22|||
146412575|NCT00219557|528015575|FG002|Phase 2|Adverse Event|2|||
146412576|NCT00219557|528015573|FG000|Phase 2|Death|0|||
146412577|NCT00219557|528015574|FG001|Phase 2|Death|8|||
146412578|NCT00219557|528015575|FG002|Phase 2|Death|2|||
146412579|NCT00219557|528015573|FG000|Phase 2|Other|0|||
146412580|NCT00219557|528015574|FG001|Phase 2|Other|8|||
146412581|NCT00219557|528015575|FG002|Phase 2|Other|6|||
146412582|NCT00219557|528015573|FG000|Phase 2|Withdrawal by Subject|0|||
146412583|NCT00219557|528015574|FG001|Phase 2|Withdrawal by Subject|9|||
146412584|NCT00219557|528015575|FG002|Phase 2|Withdrawal by Subject|5|||
146412585|NCT00219557|528015573|FG000|Phase 2|Treatment not received|0|||
146412586|NCT00219557|528015574|FG001|Phase 2|Treatment not received|1|||
146412587|NCT00219557|528015575|FG002|Phase 2|Treatment not received|3|||
146412588|NCT03063632|528015576|FG000|Overall Study|Death|4|||
146412589|NCT03063632|528015577|FG001|Overall Study|Death|6|||
146412590|NCT03063632|528015576|FG000|Overall Study|Lost to Follow-up|0|||
146412591|NCT03063632|528015577|FG001|Overall Study|Lost to Follow-up|1|||
146412592|NCT03063632|528015576|FG000|Overall Study|Withdrawal by Subject|0|||
146412593|NCT03063632|528015577|FG001|Overall Study|Withdrawal by Subject|2|||
146412594|NCT03063632|528015576|FG000|Overall Study|Physician Decision|2|||
146412595|NCT03063632|528015577|FG001|Overall Study|Physician Decision|0|||
146412596|NCT03063632|528015576|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
146412597|NCT03063632|528015577|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
146412598|NCT00106028|528015578|FG000|Overall Study|Adverse Event|3|||
146412599|NCT00106028|528015579|FG001|Overall Study|Adverse Event|2|||
146412600|NCT00106028|528015578|FG000|Overall Study|Protocol Violation|1|||
146412601|NCT00106028|528015579|FG001|Overall Study|Protocol Violation|1|||
146412602|NCT00106028|528015578|FG000|Overall Study|Withdrawal by Subject|2|||
146412603|NCT00106028|528015579|FG001|Overall Study|Withdrawal by Subject|8|||
146412604|NCT00106028|528015578|FG000|Overall Study|Lost to Follow-up|0|||
146412605|NCT00106028|528015579|FG001|Overall Study|Lost to Follow-up|1|||
146412606|NCT00947011|528015581|FG000|Overall Study|Study was terminated,PI left institution|12|||
146189651|NCT04824131|527203942|FG000|CAB LA Oral Phase|Adverse Event|1|||
146189652|NCT04824131|527203942|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
146412607|NCT00814658|528015582|FG000|Overall Study|Lost to Follow-up|0|||
146189653|NCT04824131|527203942|FG000|Step 3|Withdrawal by Subject|2|||
146412608|NCT00814658|528015583|FG001|Overall Study|Lost to Follow-up|1|||
146412609|NCT00814658|528015582|FG000|Overall Study|Physician Decision|1|||
146412610|NCT00814658|528015583|FG001|Overall Study|Physician Decision|0|||
146412611|NCT00814658|528015582|FG000|Overall Study|Adverse Event|3|||
146412612|NCT00814658|528015583|FG001|Overall Study|Adverse Event|3|||
146412613|NCT05266456|528015584|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
146412614|NCT05266456|528015585|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
146412615|NCT05266456|528015586|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
146412616|NCT05266456|528015587|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
146412617|NCT05266456|528015584|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146412618|NCT05266456|528015585|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146189654|NCT03686384|527203944|FG000|Overall Study|Lack of Efficacy|4|||
146189655|NCT03686384|527203945|FG001|Overall Study|Lack of Efficacy|13|||
146189656|NCT03686384|527203944|FG000|Overall Study|Lost to Follow-up|3|||
146189657|NCT03686384|527203945|FG001|Overall Study|Lost to Follow-up|0|||
146189658|NCT03686384|527203944|FG000|Overall Study|Physician Decision|0|||
146189659|NCT03686384|527203945|FG001|Overall Study|Physician Decision|1|||
146189660|NCT03686384|527203944|FG000|Overall Study|Took prohibited medication|0|||
146189661|NCT03686384|527203945|FG001|Overall Study|Took prohibited medication|1|||
146189662|NCT04640571|527203946|FG000|Overall Study|Withdrawal by Subject|0|||
146189663|NCT04640571|527203947|FG001|Overall Study|Withdrawal by Subject|0|||
146189664|NCT04640571|527203948|FG002|Overall Study|Withdrawal by Subject|0|||
146189665|NCT04640571|527203949|FG003|Overall Study|Withdrawal by Subject|0|||
146189666|NCT04640571|527203950|FG004|Overall Study|Withdrawal by Subject|0|||
146189667|NCT04640571|527203951|FG005|Overall Study|Withdrawal by Subject|2|||
146189668|NCT03008122|527203953|FG000|Overall Study|Physician Decision|3|||
146189669|NCT03008122|527203954|FG001|Overall Study|Physician Decision|2|||
146189670|NCT03008122|527203955|FG002|Overall Study|Physician Decision|0|||
146189671|NCT03008122|527203953|FG000|Overall Study|Withdrawal by Subject|1|||
146189672|NCT03008122|527203954|FG001|Overall Study|Withdrawal by Subject|3|||
146189673|NCT03008122|527203955|FG002|Overall Study|Withdrawal by Subject|0|||
146189674|NCT03008122|527203953|FG000|Overall Study|Lost to Follow-up|4|||
146189675|NCT03008122|527203954|FG001|Overall Study|Lost to Follow-up|8|||
146189676|NCT03008122|527203955|FG002|Overall Study|Lost to Follow-up|3|||
146189677|NCT03008122|527203953|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
146189678|NCT03008122|527203954|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146189679|NCT03008122|527203955|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146189680|NCT03008122|527203953|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
146189681|NCT03008122|527203954|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
146189682|NCT03008122|527203955|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
146189683|NCT03008122|527203953|FG000|Overall Study|Death|0|||
146189684|NCT03008122|527203954|FG001|Overall Study|Death|0|||
146189685|NCT03008122|527203955|FG002|Overall Study|Death|1|||
146189686|NCT02338609|527203958|FG000|Overall Study|Physician Decision|1|||
146189687|NCT02338609|527203958|FG000|Overall Study|Death|1|||
146189688|NCT04736056|527203960|FG000|Overall Study|Death|0|||
146189689|NCT04736056|527203961|FG001|Overall Study|Death|0|||
146189690|NCT04736056|527203962|FG002|Overall Study|Death|0|||
146189691|NCT04736056|527203963|FG003|Overall Study|Death|1|||
146189692|NCT04736056|527203960|FG000|Overall Study|Lost to Follow-up|1|||
146189693|NCT04736056|527203961|FG001|Overall Study|Lost to Follow-up|0|||
146189694|NCT04736056|527203962|FG002|Overall Study|Lost to Follow-up|1|||
146189695|NCT04736056|527203963|FG003|Overall Study|Lost to Follow-up|1|||
146189696|NCT04736056|527203960|FG000|Overall Study|Withdrawal by Subject|2|||
146189697|NCT04736056|527203961|FG001|Overall Study|Withdrawal by Subject|0|||
146189698|NCT04736056|527203962|FG002|Overall Study|Withdrawal by Subject|0|||
146189699|NCT04736056|527203963|FG003|Overall Study|Withdrawal by Subject|0|||
146189700|NCT04736056|527203960|FG000|Overall Study|Physician Decision|1|||
146189701|NCT04736056|527203961|FG001|Overall Study|Physician Decision|0|||
146189702|NCT04736056|527203962|FG002|Overall Study|Physician Decision|1|||
146189703|NCT04736056|527203963|FG003|Overall Study|Physician Decision|0|||
146189704|NCT02148718|527203964|FG000|Overall Study|Protocol Violation|26|||
146189705|NCT02148718|527203964|FG000|Overall Study|Discontinued Study Prematurely|5|||
146189706|NCT02956967|527203965|FG000|Overall Study|Adverse Event|3|||
146189707|NCT02956967|527203965|FG000|Overall Study|Reason non-related to neutropenia|10|||
146189708|NCT02956967|527203965|FG000|Overall Study|Lost to Follow-up|5|||
146189709|NCT02956967|527203965|FG000|Overall Study|Missing|1|||
146189710|NCT02956967|527203965|FG000|Overall Study|Termination of Nivestim administration|29|||
146189711|NCT02322775|527203966|FG000|Overall Study|Adverse Event|1|||
146189712|NCT02322775|527203967|FG001|Overall Study|Adverse Event|0|||
146189713|NCT02322775|527203966|FG000|Overall Study|Lost to Follow-up|0|||
146189714|NCT02322775|527203967|FG001|Overall Study|Lost to Follow-up|1|||
146189715|NCT02322775|527203966|FG000|Overall Study|Protocol Violation|1|||
146189716|NCT02322775|527203967|FG001|Overall Study|Protocol Violation|0|||
146189717|NCT02322775|527203966|FG000|Overall Study|Withdrawal by Subject|3|||
146189718|NCT02322775|527203967|FG001|Overall Study|Withdrawal by Subject|4|||
146189719|NCT02322775|527203966|FG000|Overall Study|Not willing to perform all FU visits|0|||
146189720|NCT02322775|527203967|FG001|Overall Study|Not willing to perform all FU visits|1|||
146189721|NCT00663962|527203968|FG000|Overall Study|somnolence|1|||
146189722|NCT00663962|527203969|FG001|Overall Study|somnolence|0|||
146189723|NCT02624778|527205828|FG000|Overall Study|Lost to Follow-up|0|||
146189724|NCT02624778|527205829|FG001|Overall Study|Lost to Follow-up|0|||
146412619|NCT05266456|528015586|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
146412620|NCT05266456|528015587|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
146412621|NCT05266456|528015584|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
146412622|NCT05266456|528015585|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
146412623|NCT05266456|528015586|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
146412624|NCT05266456|528015587|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
146189725|NCT02624778|527205830|FG002|Overall Study|Lost to Follow-up|1|||
146189726|NCT02624778|527205831|FG003|Overall Study|Lost to Follow-up|0|||
146189727|NCT02624778|527205832|FG004|Overall Study|Lost to Follow-up|0|||
146189728|NCT02624778|527205833|FG005|Overall Study|Lost to Follow-up|0|||
146189729|NCT02624778|527205834|FG006|Overall Study|Lost to Follow-up|0|||
146189730|NCT02624778|527205835|FG007|Overall Study|Lost to Follow-up|0|||
146189731|NCT02624778|527205836|FG008|Overall Study|Lost to Follow-up|0|||
146189732|NCT02624778|527205828|FG000|Overall Study|Withdrawal by Subject|0|||
146189733|NCT02624778|527205829|FG001|Overall Study|Withdrawal by Subject|1|||
146189734|NCT02624778|527205830|FG002|Overall Study|Withdrawal by Subject|0|||
146189735|NCT02624778|527205831|FG003|Overall Study|Withdrawal by Subject|0|||
146189736|NCT02624778|527205832|FG004|Overall Study|Withdrawal by Subject|0|||
146189737|NCT02624778|527205833|FG005|Overall Study|Withdrawal by Subject|1|||
146189738|NCT02624778|527205834|FG006|Overall Study|Withdrawal by Subject|1|||
146189739|NCT02624778|527205835|FG007|Overall Study|Withdrawal by Subject|1|||
146189740|NCT02624778|527205836|FG008|Overall Study|Withdrawal by Subject|1|||
146189741|NCT02624778|527205828|FG000|Overall Study|Adverse Event|0|||
146189742|NCT02624778|527205829|FG001|Overall Study|Adverse Event|0|||
146189743|NCT02624778|527205830|FG002|Overall Study|Adverse Event|0|||
146189744|NCT02624778|527205831|FG003|Overall Study|Adverse Event|0|||
146189745|NCT02624778|527205832|FG004|Overall Study|Adverse Event|0|||
146189746|NCT02624778|527205833|FG005|Overall Study|Adverse Event|0|||
146189747|NCT02624778|527205834|FG006|Overall Study|Adverse Event|0|||
146189748|NCT02624778|527205835|FG007|Overall Study|Adverse Event|0|||
146189749|NCT02624778|527205836|FG008|Overall Study|Adverse Event|2|||
146189750|NCT02624778|527205828|FG000|Overall Study|Death|0|||
146189751|NCT02624778|527205829|FG001|Overall Study|Death|0|||
146189752|NCT02624778|527205830|FG002|Overall Study|Death|0|||
146189753|NCT02624778|527205831|FG003|Overall Study|Death|0|||
146189754|NCT02624778|527205832|FG004|Overall Study|Death|0|||
146189755|NCT02624778|527205833|FG005|Overall Study|Death|0|||
146189756|NCT02624778|527205834|FG006|Overall Study|Death|1|||
146189757|NCT02624778|527205835|FG007|Overall Study|Death|0|||
146189758|NCT02624778|527205836|FG008|Overall Study|Death|0|||
146189759|NCT02624778|527205828|FG000|Overall Study|Physician Decision|0|||
146189760|NCT02624778|527205829|FG001|Overall Study|Physician Decision|0|||
146189761|NCT02624778|527205830|FG002|Overall Study|Physician Decision|0|||
146189762|NCT02624778|527205831|FG003|Overall Study|Physician Decision|0|||
146189763|NCT02624778|527205832|FG004|Overall Study|Physician Decision|0|||
146189764|NCT02624778|527205833|FG005|Overall Study|Physician Decision|0|||
146189765|NCT02624778|527205834|FG006|Overall Study|Physician Decision|0|||
146189766|NCT02624778|527205835|FG007|Overall Study|Physician Decision|3|||
146189767|NCT02624778|527205836|FG008|Overall Study|Physician Decision|3|||
146189768|NCT04610684|527205837|FG000|Study Treatment|Withdrawal by Subject|1|||
146189769|NCT04610684|527205837|FG000|Study Treatment|Disease Progression|2|||
146189770|NCT04610684|527205837|FG000|Follow up|Death|2|||
146189771|NCT04610684|527205837|FG000|Follow up|Withdrawal by Subject|1|||
146189772|NCT02153788|527205838|FG000|Overall Study|Physician Decision|2|||
146189773|NCT02153788|527205839|FG001|Overall Study|Physician Decision|1|||
146189774|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
146189775|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
146189776|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
146189777|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
146189778|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
146189779|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
146189780|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
146189781|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
146189782|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
146189783|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
146189784|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
146189785|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
146189786|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
146189787|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
146189788|NCT04672460|527205840|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
146189789|NCT04672460|527205841|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
146189790|NCT04672460|527205840|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
146189791|NCT04672460|527205841|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
146189792|NCT04672460|527205840|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
146235001|NCT01499849|527378439|FG000|Overall Study|Lack of Efficacy|3|||
146189793|NCT04672460|527205841|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
146189794|NCT04672460|527205840|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
146189795|NCT04672460|527205841|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
146189796|NCT04672460|527205840|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
146189797|NCT04672460|527205841|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
146189798|NCT04672460|527205840|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
146189799|NCT04672460|527205841|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
146189800|NCT04672460|527205840|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
146189801|NCT04672460|527205841|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
146189802|NCT04672460|527205840|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
146189803|NCT04672460|527205841|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
146189804|NCT04672460|527205840|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
146189805|NCT04672460|527205841|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
146189806|NCT04672460|527205840|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
146189807|NCT04672460|527205841|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
146189808|NCT01876043|527205844|FG000|Overall Study|Death|1|||
146189809|NCT01876043|527205844|FG000|Overall Study|Withdrawal by Subject|1|||
146189810|NCT00079937|527205845|FG000|Overall Study|Adverse Event|2|||
146189811|NCT00079937|527205846|FG001|Overall Study|Adverse Event|1|||
146189812|NCT00079937|527205845|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146189813|NCT00079937|527205846|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146189814|NCT00079937|527205845|FG000|Overall Study|Subject no longer requires study drug|3|||
146189815|NCT00079937|527205846|FG001|Overall Study|Subject no longer requires study drug|0|||
146189816|NCT00079937|527205845|FG000|Overall Study|Protocol Violation|8|||
146189817|NCT00079937|527205846|FG001|Overall Study|Protocol Violation|6|||
146189818|NCT00079937|527205845|FG000|Overall Study|Withdrawal by Subject|21|||
146189819|NCT00079937|527205846|FG001|Overall Study|Withdrawal by Subject|7|||
146189820|NCT00079937|527205845|FG000|Overall Study|Lost to Follow-up|12|||
146189821|NCT00079937|527205846|FG001|Overall Study|Lost to Follow-up|5|||
146189822|NCT00079937|527205845|FG000|Overall Study|Administrative problems|22|||
146189823|NCT00079937|527205846|FG001|Overall Study|Administrative problems|11|||
146189824|NCT02949271|527205847|FG000|Overall Study|Lack of Efficacy|5|||
146189825|NCT02949271|527205848|FG001|Overall Study|Lack of Efficacy|4|||
146189826|NCT02949271|527205847|FG000|Overall Study|Lost to Follow-up|3|||
146189827|NCT02949271|527205848|FG001|Overall Study|Lost to Follow-up|6|||
146189828|NCT02949271|527205847|FG000|Overall Study|Physician Decision|5|||
146189829|NCT02949271|527205848|FG001|Overall Study|Physician Decision|5|||
146189830|NCT02949271|527205847|FG000|Overall Study|Protocol Violation|6|||
146189831|NCT02949271|527205848|FG001|Overall Study|Protocol Violation|3|||
146189832|NCT02949271|527205847|FG000|Overall Study|Withdrawal by Subject|1|||
146189833|NCT02949271|527205848|FG001|Overall Study|Withdrawal by Subject|0|||
146189834|NCT02949271|527205847|FG000|Overall Study|Delivered prior to intervention|7|||
146189835|NCT02949271|527205848|FG001|Overall Study|Delivered prior to intervention|9|||
146189836|NCT02949271|527205847|FG000|Overall Study|Outside the window for cervical dilation|2|||
146189837|NCT02949271|527205848|FG001|Overall Study|Outside the window for cervical dilation|3|||
146189838|NCT05458102|527205849|FG000|Overall Study|Withdrew consent|2|||
146189839|NCT05458102|527205850|FG001|Overall Study|Withdrew consent|0|||
146189840|NCT05458102|527205849|FG000|Overall Study|Adverse Event|1|||
146189841|NCT05458102|527205850|FG001|Overall Study|Adverse Event|0|||
146189842|NCT05458102|527205849|FG000|Overall Study|Enrolled but never treated|1|||
146189843|NCT05458102|527205850|FG001|Overall Study|Enrolled but never treated|0|||
146189844|NCT05458102|527205849|FG000|Overall Study|Protocol Violation|1|||
146189845|NCT05458102|527205850|FG001|Overall Study|Protocol Violation|0|||
146189846|NCT00852475|527205851|FG000|Overall Study|Lost to Follow-up|3|||
146081729|NCT03148691|526818331|FG000|Overall Study|Lost to Follow-up|0|||
146081730|NCT03148691|526818332|FG001|Overall Study|Lost to Follow-up|0|||
146081731|NCT03148691|526818333|FG002|Overall Study|Lost to Follow-up|1|||
146081732|NCT03148691|526818331|FG000|Overall Study|Other|1|||
146081733|NCT03148691|526818332|FG001|Overall Study|Other|0|||
146081734|NCT03148691|526818333|FG002|Overall Study|Other|0|||
146081735|NCT03148691|526818331|FG000|Overall Study|Withdrawal by Subject|1|||
146081736|NCT03148691|526818332|FG001|Overall Study|Withdrawal by Subject|0|||
146081737|NCT03148691|526818333|FG002|Overall Study|Withdrawal by Subject|0|||
146081738|NCT00576420|526820471|FG000|Overall Study|Death|0|||
146081739|NCT00576420|526820472|FG001|Overall Study|Death|0|||
146081740|NCT00576420|526820473|FG002|Overall Study|Death|1|||
146081741|NCT01340872|526820475|FG000|Double-blind Phase|Adverse Event|6|||
146081742|NCT01340872|526820476|FG001|Double-blind Phase|Adverse Event|4|||
146081743|NCT01340872|526820477|FG002|Double-blind Phase|Adverse Event|0|||
146081744|NCT01340872|526820478|FG003|Double-blind Phase|Adverse Event|0|||
146081745|NCT01340872|526820475|FG000|Double-blind Phase|Withdrawal by Subject|3|||
146081746|NCT01340872|526820476|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146189847|NCT00852475|527205852|FG001|Overall Study|Lost to Follow-up|4|||
146189848|NCT00367237|527205854|FG000|Overall Study|Adverse Event|7|||
146189849|NCT00367237|527205855|FG001|Overall Study|Adverse Event|2|||
146189850|NCT00367237|527205854|FG000|Overall Study|Lost to Follow-up|1|||
146189851|NCT00367237|527205855|FG001|Overall Study|Lost to Follow-up|0|||
146189852|NCT00367237|527205854|FG000|Overall Study|Withdrawal by Subject|0|||
146189853|NCT00367237|527205855|FG001|Overall Study|Withdrawal by Subject|4|||
146189854|NCT00367237|527205854|FG000|Overall Study|Protocol Violation|2|||
146189855|NCT00367237|527205855|FG001|Overall Study|Protocol Violation|5|||
146189856|NCT01175707|527205856|FG000|Overall Study|Adverse Event|4|||
146189857|NCT01175707|527205857|FG001|Overall Study|Adverse Event|6|||
146189858|NCT04531540|527205866|FG000|Overall Study|Adverse Event|1|||
146189859|NCT04531540|527205866|FG000|Overall Study|Protocol Violation|3|||
146189860|NCT04531540|527205866|FG000|Overall Study|Withdrawal by Subject|4|||
146189861|NCT04531540|527205866|FG000|Overall Study|Found to be Ineligible|1|||
146189862|NCT03239210|527205867|FG000|Overall Study|Lost to Follow-up|2|||
146189863|NCT03239210|527205868|FG001|Overall Study|Lost to Follow-up|2|||
146189864|NCT03239210|527205867|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
146189865|NCT03239210|527205868|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
146189866|NCT03239210|527205867|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
146189867|NCT03239210|527205868|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
146189868|NCT00926393|527205871|FG000|Overall Study|Withdrawal by Subject|1|||
146189869|NCT00926393|527205872|FG001|Overall Study|Withdrawal by Subject|2|||
146189870|NCT00926393|527205871|FG000|Overall Study|Adverse Event|1|||
146189871|NCT00926393|527205872|FG001|Overall Study|Adverse Event|1|||
146189872|NCT01403987|527205874|FG000|Overall Study|Residents forgot their secret PIN|18|||
146189873|NCT01403987|527205875|FG001|Overall Study|Residents forgot their secret PIN|17|||
146189874|NCT01403987|527205876|FG002|Overall Study|Residents forgot their secret PIN|18|||
146189875|NCT01094743|527205881|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
146189876|NCT02851511|527205882|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
146189877|NCT02851511|527205883|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
146189878|NCT02851511|527205884|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
146189879|NCT02851511|527205885|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
146189880|NCT02851511|527205882|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
146189881|NCT02851511|527205883|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
146189882|NCT02851511|527205884|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
146189883|NCT02851511|527205885|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
146189884|NCT02851511|527205882|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
146189885|NCT02851511|527205883|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
146189886|NCT02851511|527205884|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
146189887|NCT02851511|527205885|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
146189888|NCT02851511|527205882|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146189889|NCT02851511|527205883|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
146189890|NCT02851511|527205884|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146189891|NCT02851511|527205885|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
146189892|NCT02851511|527205882|FG000|Phase I|Physician Decision|0|||
146189893|NCT02851511|527205883|FG001|Phase I|Physician Decision|0|||
146189894|NCT02851511|527205884|FG002|Phase I|Physician Decision|0|||
146189895|NCT02851511|527205885|FG003|Phase I|Physician Decision|1|||
146189896|NCT02851511|527205882|FG000|Phase I|Withdrawal by Subject|2|||
146189897|NCT02851511|527205883|FG001|Phase I|Withdrawal by Subject|1|||
146189898|NCT02851511|527205884|FG002|Phase I|Withdrawal by Subject|0|||
146189899|NCT02851511|527205885|FG003|Phase I|Withdrawal by Subject|3|||
146189900|NCT02851511|527205882|FG000|Phase II|Physician Decision|18|||
146189901|NCT02851511|527205883|FG001|Phase II|Physician Decision|16|||
146189902|NCT02851511|527205884|FG002|Phase II|Physician Decision|0|||
146189903|NCT02851511|527205885|FG003|Phase II|Physician Decision|0|||
146189904|NCT02851511|527205882|FG000|Phase II|Withdrawal by Subject|18|||
146189905|NCT02851511|527205883|FG001|Phase II|Withdrawal by Subject|16|||
146189906|NCT02851511|527205884|FG002|Phase II|Withdrawal by Subject|0|||
146189907|NCT02851511|527205885|FG003|Phase II|Withdrawal by Subject|0|||
146189908|NCT02851511|527205882|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
146189909|NCT02851511|527205883|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
146189910|NCT02851511|527205884|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
146189911|NCT02851511|527205885|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
146189912|NCT02851511|527205882|FG000|Phase II|Lost to Follow-up|0|||
146412625|NCT05266456|528015584|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146412626|NCT05266456|528015585|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146189913|NCT02851511|527205883|FG001|Phase II|Lost to Follow-up|1|||
146189914|NCT02851511|527205884|FG002|Phase II|Lost to Follow-up|0|||
146412627|NCT05266456|528015586|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
146189915|NCT02851511|527205885|FG003|Phase II|Lost to Follow-up|0|||
146189916|NCT00051311|527205886|FG000|Overall Study|Starting new study|0|||
146189917|NCT00051311|527205887|FG001|Overall Study|Starting new study|1|||
146189918|NCT00051311|527205886|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
146189919|NCT00051311|527205887|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
146412628|NCT05266456|528015587|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
146412629|NCT05266456|528015584|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
146412630|NCT05266456|528015585|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
146412631|NCT05266456|528015586|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
146412632|NCT05266456|528015587|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
146412633|NCT01610167|528015589|FG000|Overall Study|Scheduling conflict.|0|||
146412634|NCT01610167|528015590|FG001|Overall Study|Scheduling conflict.|0|||
146412635|NCT01610167|528015591|FG002|Overall Study|Scheduling conflict.|2|||
146412636|NCT06371079|528015593|FG000|Overall Study|Missing data|88|||
146412637|NCT06371079|528015594|FG001|Overall Study|Missing data|247|||
146412638|NCT01964105|528015595|FG000|Overall Study|Lost to Follow-up|2|||
146412639|NCT01964105|528015596|FG001|Overall Study|Lost to Follow-up|13|||
146412640|NCT01964105|528015597|FG002|Overall Study|Lost to Follow-up|0|||
146412641|NCT02746705|528015598|FG000|Overall Study|Physician Decision|1|||
146412642|NCT02746705|528015599|FG001|Overall Study|Physician Decision|1|||
146412643|NCT02746705|528015598|FG000|Overall Study|Lost to Follow-up|1|||
146412644|NCT02746705|528015599|FG001|Overall Study|Lost to Follow-up|0|||
146412645|NCT02746705|528015598|FG000|Overall Study|outlier scores deemed not valid|0|||
146412646|NCT02746705|528015599|FG001|Overall Study|outlier scores deemed not valid|1|||
146412647|NCT00575328|528015600|FG000|Overall Study|Adverse Event|1|||
146412648|NCT00575328|528015601|FG001|Overall Study|Adverse Event|1|||
146412649|NCT00575328|528015600|FG000|Overall Study|Lost to Follow-up|2|||
146412650|NCT00575328|528015601|FG001|Overall Study|Lost to Follow-up|1|||
146412651|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
146412652|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
146412653|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
146412654|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
146412655|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
146412656|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
146412657|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
146412658|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412659|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
146412660|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
146412661|NCT00124449|528015606|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
146412662|NCT00124449|528015607|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
146412663|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
146412664|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
146412665|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
146412666|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
146412667|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
146412668|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
146412669|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
146412670|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
146412671|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
146412672|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
146412673|NCT00124449|528015606|FG000|18-Month Untreated Observation Period|Relocated|1|||
146412674|NCT00124449|528015607|FG001|18-Month Untreated Observation Period|Relocated|0|||
146412675|NCT03940586|528015608|FG000|Overall Study|Death|3|||
146412676|NCT03940586|528015609|FG001|Overall Study|Death|2|||
146412677|NCT03940586|528015610|FG002|Overall Study|Death|0|||
146412678|NCT03940586|528015608|FG000|Overall Study|Physician Decision|1|||
146081747|NCT01340872|526820477|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146081748|NCT01340872|526820478|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146081749|NCT01340872|526820475|FG000|Double-blind Phase|Lost to Follow-up|0|||
146081750|NCT01340872|526820476|FG001|Double-blind Phase|Lost to Follow-up|1|||
146081751|NCT01340872|526820477|FG002|Double-blind Phase|Lost to Follow-up|0|||
146081752|NCT01340872|526820478|FG003|Double-blind Phase|Lost to Follow-up|0|||
146081753|NCT01340872|526820475|FG000|Double-blind Phase|Protocol Violation|0|||
146081754|NCT01340872|526820476|FG001|Double-blind Phase|Protocol Violation|1|||
146081755|NCT01340872|526820477|FG002|Double-blind Phase|Protocol Violation|0|||
146081756|NCT01340872|526820478|FG003|Double-blind Phase|Protocol Violation|0|||
146081757|NCT01340872|526820475|FG000|Open-label Phase|Physician Decision|0|||
146081758|NCT01340872|526820476|FG001|Open-label Phase|Physician Decision|0|||
146412679|NCT03940586|528015609|FG001|Overall Study|Physician Decision|0|||
146412680|NCT03940586|528015610|FG002|Overall Study|Physician Decision|1|||
146412681|NCT03940586|528015608|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
146412682|NCT03940586|528015609|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
146412683|NCT03940586|528015610|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146189920|NCT00051311|527205886|FG000|Overall Study|Death of recipient|8|||
146189921|NCT00051311|527205887|FG001|Overall Study|Death of recipient|8|||
146189922|NCT00051311|527205886|FG000|Overall Study|Recipient taken off study|4|||
146189923|NCT00051311|527205887|FG001|Overall Study|Recipient taken off study|4|||
146189924|NCT02256969|527205888|FG000|Overall Study|Screenfailed or withdrew|2|||
146189925|NCT02256969|527205889|FG001|Overall Study|Screenfailed or withdrew|1|||
146189926|NCT02256969|527205890|FG002|Overall Study|Screenfailed or withdrew|1|||
146189927|NCT01427907|527205891|FG000|Overall Study|Withdrawal by Subject|3|||
146189928|NCT01427907|527205892|FG001|Overall Study|Withdrawal by Subject|4|||
146189929|NCT00335153|527205893|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
146189930|NCT00335153|527205893|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
146189931|NCT00335153|527205893|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
146189932|NCT00335153|527205893|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
146189933|NCT00335153|527205893|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
146189934|NCT00335153|527205893|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
146189935|NCT00335153|527205893|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
146189936|NCT00335153|527205893|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
146189937|NCT00335153|527205893|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
146189938|NCT00335153|527205893|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
146189939|NCT02478359|527205894|FG000|Overall Study|Disenrolled from health plan|106|||
146189940|NCT02478359|527205895|FG001|Overall Study|Disenrolled from health plan|65|||
146189941|NCT00372528|527205896|FG000|Overall Study|Lack of Efficacy|1|||
146189942|NCT00372528|527205896|FG000|Overall Study|Adverse Event|1|||
146189943|NCT00372528|527205896|FG000|Overall Study|Study Terminated by Sponsor|18|||
146189944|NCT00372528|527205896|FG000|Overall Study|Other|1|||
146189945|NCT01818700|527205897|FG000|Overall Study|Adverse Event|67|||
146189946|NCT01818700|527205897|FG000|Overall Study|Lack of Efficacy|2|||
146189947|NCT01818700|527205897|FG000|Overall Study|Lost to Follow-up|5|||
146189948|NCT01818700|527205897|FG000|Overall Study|Withdrawal by Subject|27|||
146189949|NCT01818700|527205897|FG000|Overall Study|Protocol Violation|2|||
146189950|NCT01818700|527205897|FG000|Overall Study|Other|1|||
146189951|NCT01417000|527205898|FG000|Overall Study|Death|59|||
146189952|NCT01417000|527205899|FG001|Overall Study|Death|28|||
146189953|NCT01417000|527205898|FG000|Overall Study|Lost to Follow-up|1|||
146189954|NCT01417000|527205899|FG001|Overall Study|Lost to Follow-up|0|||
146189955|NCT01417000|527205898|FG000|Overall Study|Study Terminated by Sponsor|1|||
146189956|NCT01417000|527205899|FG001|Overall Study|Study Terminated by Sponsor|1|||
146189957|NCT00558753|527205911|FG000|Overall Study|Lost to Follow-up|5|||
146189958|NCT00558753|527205912|FG001|Overall Study|Lost to Follow-up|7|||
146189959|NCT01414166|527205916|FG000|Overall Study|Adverse Event|10|||
146189960|NCT01414166|527205917|FG001|Overall Study|Adverse Event|2|||
146189961|NCT01414166|527205916|FG000|Overall Study|Lost to Follow-up|4|||
146189962|NCT01414166|527205917|FG001|Overall Study|Lost to Follow-up|1|||
146189963|NCT01414166|527205916|FG000|Overall Study|Non-compliance with study drug|2|||
146189964|NCT01414166|527205917|FG001|Overall Study|Non-compliance with study drug|0|||
146189965|NCT01414166|527205916|FG000|Overall Study|Physician Decision|2|||
146189966|NCT01414166|527205917|FG001|Overall Study|Physician Decision|0|||
146189967|NCT01414166|527205916|FG000|Overall Study|Protocol Violation|2|||
146189968|NCT01414166|527205917|FG001|Overall Study|Protocol Violation|0|||
146189969|NCT01414166|527205916|FG000|Overall Study|Study terminated by Sponsor|68|||
146189970|NCT01414166|527205917|FG001|Overall Study|Study terminated by Sponsor|75|||
146189971|NCT01414166|527205916|FG000|Overall Study|Withdrawal by Subject|3|||
146189972|NCT01414166|527205917|FG001|Overall Study|Withdrawal by Subject|5|||
146189973|NCT03682536|527205918|FG000|Randomization|Withdrawal by Subject|0|||
146189974|NCT03682536|527205919|FG001|Randomization|Withdrawal by Subject|2|||
146189975|NCT03682536|527205918|FG000|Treatment|Other Reasons|8|||
146189976|NCT03682536|527205919|FG001|Treatment|Other Reasons|7|||
146189977|NCT03682536|527205918|FG000|Treatment|Physician Decision|5|||
146189978|NCT03682536|527205919|FG001|Treatment|Physician Decision|5|||
146189979|NCT03682536|527205918|FG000|Treatment|Protocol Violation|1|||
146189980|NCT03682536|527205919|FG001|Treatment|Protocol Violation|0|||
146189981|NCT03682536|527205918|FG000|Treatment|Study Terminated by Sponsor|1|||
146189982|NCT03682536|527205919|FG001|Treatment|Study Terminated by Sponsor|2|||
146189983|NCT03682536|527205918|FG000|Treatment|Lost to Follow-up|0|||
146189984|NCT03682536|527205919|FG001|Treatment|Lost to Follow-up|1|||
146189985|NCT03682536|527205918|FG000|Treatment|Withdrawal by Subject|16|||
146189986|NCT03682536|527205919|FG001|Treatment|Withdrawal by Subject|18|||
146189987|NCT03682536|527205918|FG000|Treatment|Lack of Efficacy|41|||
146189988|NCT03682536|527205919|FG001|Treatment|Lack of Efficacy|68|||
146189989|NCT03682536|527205918|FG000|Treatment|Disease Progression|9|||
146189990|NCT03682536|527205919|FG001|Treatment|Disease Progression|7|||
146189991|NCT03682536|527205918|FG000|Treatment|Adverse Event|9|||
146189992|NCT03682536|527205919|FG001|Treatment|Adverse Event|5|||
146189993|NCT03682536|527205918|FG000|Treatment|Death|14|||
146189994|NCT03682536|527205919|FG001|Treatment|Death|13|||
146189995|NCT05489224|527205920|FG000|Treatment Period I|Withdrawal by Subject|6|||
146189996|NCT05489224|527205921|FG001|Treatment Period I|Withdrawal by Subject|5|||
146189997|NCT05489224|527205922|FG002|Treatment Period I|Withdrawal by Subject|0|||
146189998|NCT05489224|527205920|FG000|Treatment Period I|Adverse Event|3|||
146189999|NCT05489224|527205921|FG001|Treatment Period I|Adverse Event|11|||
146190000|NCT05489224|527205922|FG002|Treatment Period I|Adverse Event|0|||
146190001|NCT05489224|527205920|FG000|Treatment Period I|Lost to Follow-up|0|||
146190002|NCT05489224|527205921|FG001|Treatment Period I|Lost to Follow-up|1|||
146190003|NCT05489224|527205922|FG002|Treatment Period I|Lost to Follow-up|0|||
146190004|NCT05489224|527205920|FG000|Treatment Period I|Physician Decision|0|||
146190005|NCT05489224|527205921|FG001|Treatment Period I|Physician Decision|1|||
146190006|NCT05489224|527205922|FG002|Treatment Period I|Physician Decision|0|||
146190007|NCT05489224|527205920|FG000|Treatment Period II up to Week 32|Ongoing|222|||
146190008|NCT05489224|527205921|FG001|Treatment Period II up to Week 32|Ongoing|107|||
146190009|NCT05489224|527205922|FG002|Treatment Period II up to Week 32|Ongoing|107|||
146190010|NCT05489224|527205920|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
146190011|NCT05489224|527205921|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
146190012|NCT05489224|527205922|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
146190013|NCT05489224|527205920|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
146190014|NCT05489224|527205921|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
146412684|NCT03940586|528015608|FG000|Overall Study|Not Treated|0|||
146412685|NCT03940586|528015609|FG001|Overall Study|Not Treated|2|||
146412686|NCT03940586|528015610|FG002|Overall Study|Not Treated|0|||
146190015|NCT05489224|527205922|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
146190016|NCT04887285|527205923|FG000|Overall Study|Lost to Follow-up|0|||
146190017|NCT04887285|527205924|FG001|Overall Study|Lost to Follow-up|2|||
146190018|NCT04887285|527205925|FG002|Overall Study|Lost to Follow-up|3|||
146190019|NCT02820051|527205926|FG000|Overall Study|Lost to Follow-up|7|||
146190020|NCT02820051|527205927|FG001|Overall Study|Lost to Follow-up|4|||
146190021|NCT01222247|527205932|FG000|Overall Study|Lost to Follow-up|2|||
146190022|NCT01222247|527205933|FG001|Overall Study|Lost to Follow-up|2|||
146190023|NCT03289455|527205934|FG000|Overall Study|Death|1|||
146190024|NCT03289455|527205935|FG001|Overall Study|Death|0|||
146190025|NCT03289455|527205936|FG002|Overall Study|Death|0|||
146190026|NCT03289455|527205934|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
146190027|NCT03289455|527205935|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
146190028|NCT03289455|527205936|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
146190029|NCT03289455|527205934|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
146190030|NCT03289455|527205935|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
146190031|NCT03289455|527205936|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
146190032|NCT03289455|527205934|FG000|Overall Study|Progressive disease|3|||
146190033|NCT03289455|527205935|FG001|Overall Study|Progressive disease|4|||
146190034|NCT03289455|527205936|FG002|Overall Study|Progressive disease|5|||
146190035|NCT00333788|527205937|FG000|Overall Study|Adverse Event|44|||
146190036|NCT00333788|527205937|FG000|Overall Study|Lack of Efficacy|80|||
146190037|NCT00333788|527205937|FG000|Overall Study|Lost to Follow-up|2|||
146190038|NCT00333788|527205937|FG000|Overall Study|Withdrawal by Subject|24|||
146190039|NCT00333788|527205937|FG000|Overall Study|Other: Non-compliance|2|||
146190040|NCT00333788|527205937|FG000|Overall Study|Other: Moved|2|||
146190041|NCT00333788|527205937|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
146190042|NCT00333788|527205937|FG000|Overall Study|Other: Investigator decision|1|||
146190043|NCT00333788|527205937|FG000|Overall Study|Other: Quality of life concern|1|||
146190044|NCT00333788|527205937|FG000|Overall Study|Other: Sponsor decision|1|||
146190045|NCT00333788|527205937|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
146190046|NCT00333788|527205937|FG000|Overall Study|Other: Medical monitor decision|1|||
146190047|NCT00333788|527205937|FG000|Overall Study|Other: Physician decision|1|||
146190048|NCT00333788|527205937|FG000|Overall Study|Other: Signed consent for another study|1|||
146412687|NCT02006147|528015611|FG000|Overall Study|Protocol Violation|1|||
146190049|NCT04482855|527205941|FG000|Overall Study|Lost to Follow-up|1|||
146190050|NCT04482855|527205942|FG001|Overall Study|Lost to Follow-up|0|||
146190051|NCT04482855|527205941|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
146412688|NCT02006147|528015612|FG001|Overall Study|Protocol Violation|1|||
146412689|NCT02006147|528015613|FG002|Overall Study|Protocol Violation|0|||
146412690|NCT02006147|528015614|FG003|Overall Study|Protocol Violation|0|||
146412691|NCT02006147|528015611|FG000|Overall Study|Withdrawal by Subject|0|||
146412692|NCT02006147|528015612|FG001|Overall Study|Withdrawal by Subject|1|||
146412693|NCT02006147|528015613|FG002|Overall Study|Withdrawal by Subject|0|||
146412694|NCT02006147|528015614|FG003|Overall Study|Withdrawal by Subject|0|||
146412695|NCT02006147|528015611|FG000|Overall Study|Withdrawal by Sponsor|1|||
146412696|NCT02006147|528015612|FG001|Overall Study|Withdrawal by Sponsor|0|||
146412697|NCT02006147|528015613|FG002|Overall Study|Withdrawal by Sponsor|0|||
146412698|NCT02006147|528015614|FG003|Overall Study|Withdrawal by Sponsor|0|||
146412699|NCT00811070|528015618|FG000|Overall Study|Death|0|||
146412700|NCT00811070|528015619|FG001|Overall Study|Death|0|||
146412701|NCT00811070|528015620|FG002|Overall Study|Death|0|||
146412702|NCT00811070|528015621|FG003|Overall Study|Death|2|||
146412703|NCT00811070|528015622|FG004|Overall Study|Death|5|||
146412704|NCT00811070|528015623|FG005|Overall Study|Death|0|||
146412705|NCT00811070|528015618|FG000|Overall Study|Other|1|||
146412706|NCT00811070|528015619|FG001|Overall Study|Other|0|||
146412707|NCT00811070|528015620|FG002|Overall Study|Other|0|||
146190052|NCT04482855|527205942|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
146412708|NCT00811070|528015621|FG003|Overall Study|Other|0|||
146412709|NCT00811070|528015622|FG004|Overall Study|Other|0|||
146190053|NCT04482855|527205941|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
146190054|NCT04482855|527205942|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
146190055|NCT00764868|527205943|FG000|Overall Study|Adverse Event|18|||
146190056|NCT00764868|527205943|FG000|Overall Study|Withdrawal by Subject|31|||
146190057|NCT00764868|527205943|FG000|Overall Study|Non-compliance|16|||
146190058|NCT00764868|527205943|FG000|Overall Study|Lost to Follow-up|25|||
146190059|NCT00764868|527205943|FG000|Overall Study|Lack of Efficacy|5|||
146190060|NCT00764868|527205943|FG000|Overall Study|Subject moved|7|||
146190061|NCT00764868|527205943|FG000|Overall Study|Pregnancy|3|||
146190062|NCT00764868|527205943|FG000|Overall Study|Prohibited medication|1|||
146190063|NCT00764868|527205943|FG000|Overall Study|Out of town|1|||
146190064|NCT00764868|527205943|FG000|Overall Study|Misuse and compliance of study drug|1|||
146190065|NCT00764868|527205943|FG000|Overall Study|Subject sent to boarding school|1|||
146190066|NCT00764868|527205943|FG000|Overall Study|Met an exclusion criteria|1|||
146190067|NCT00764868|527205943|FG000|Overall Study|Positive drug screen|2|||
146190068|NCT00764868|527205943|FG000|Overall Study|Sponsor requested withdrawal|1|||
146190069|NCT00819234|527205952|FG000|Overall Study|Withdrawal by Subject|8|||
146190070|NCT00819234|527205953|FG001|Overall Study|Withdrawal by Subject|13|||
146190071|NCT00819234|527205954|FG002|Overall Study|Withdrawal by Subject|6|||
146190072|NCT00819234|527205955|FG003|Overall Study|Withdrawal by Subject|3|||
146190073|NCT00819234|527205956|FG004|Overall Study|Withdrawal by Subject|0|||
146190074|NCT00819234|527205957|FG005|Overall Study|Withdrawal by Subject|4|||
146190075|NCT00819234|527205958|FG006|Overall Study|Withdrawal by Subject|4|||
146190076|NCT00819234|527205959|FG007|Overall Study|Withdrawal by Subject|8|||
146190077|NCT00819234|527205960|FG008|Overall Study|Withdrawal by Subject|5|||
146190078|NCT00819234|527205961|FG009|Overall Study|Withdrawal by Subject|3|||
146190079|NCT00819234|527205952|FG000|Overall Study|Adverse Event|0|||
146190080|NCT00819234|527205953|FG001|Overall Study|Adverse Event|0|||
146190081|NCT00819234|527205954|FG002|Overall Study|Adverse Event|1|||
146190082|NCT00819234|527205955|FG003|Overall Study|Adverse Event|0|||
146190083|NCT00819234|527205956|FG004|Overall Study|Adverse Event|0|||
146190084|NCT00819234|527205957|FG005|Overall Study|Adverse Event|2|||
146190085|NCT00819234|527205958|FG006|Overall Study|Adverse Event|0|||
146190086|NCT00819234|527205959|FG007|Overall Study|Adverse Event|0|||
146190087|NCT00819234|527205960|FG008|Overall Study|Adverse Event|0|||
146190088|NCT00819234|527205961|FG009|Overall Study|Adverse Event|0|||
146190089|NCT00819234|527205952|FG000|Overall Study|Physician Decision|0|||
146190090|NCT00819234|527205953|FG001|Overall Study|Physician Decision|0|||
146190091|NCT00819234|527205954|FG002|Overall Study|Physician Decision|0|||
146190092|NCT00819234|527205955|FG003|Overall Study|Physician Decision|1|||
146190093|NCT00819234|527205956|FG004|Overall Study|Physician Decision|0|||
146190094|NCT00819234|527205957|FG005|Overall Study|Physician Decision|0|||
146190095|NCT00819234|527205958|FG006|Overall Study|Physician Decision|0|||
146190096|NCT00819234|527205959|FG007|Overall Study|Physician Decision|0|||
146190097|NCT00819234|527205960|FG008|Overall Study|Physician Decision|0|||
146412710|NCT00811070|528015623|FG005|Overall Study|Other|0|||
146412711|NCT00811070|528015618|FG000|Overall Study|Withdrawal by Subject|0|||
146412712|NCT00811070|528015619|FG001|Overall Study|Withdrawal by Subject|1|||
146412713|NCT00811070|528015620|FG002|Overall Study|Withdrawal by Subject|0|||
146412714|NCT00811070|528015621|FG003|Overall Study|Withdrawal by Subject|0|||
146412715|NCT00811070|528015622|FG004|Overall Study|Withdrawal by Subject|0|||
146412716|NCT00811070|528015623|FG005|Overall Study|Withdrawal by Subject|0|||
146412717|NCT00811070|528015618|FG000|Overall Study|Physician Decision|0|||
146412718|NCT00811070|528015619|FG001|Overall Study|Physician Decision|0|||
146412719|NCT00811070|528015620|FG002|Overall Study|Physician Decision|0|||
146412720|NCT00811070|528015621|FG003|Overall Study|Physician Decision|0|||
146412721|NCT00811070|528015622|FG004|Overall Study|Physician Decision|0|||
146412722|NCT00811070|528015623|FG005|Overall Study|Physician Decision|1|||
146190098|NCT00819234|527205961|FG009|Overall Study|Physician Decision|2|||
146190099|NCT00819234|527205952|FG000|Overall Study|Protocol Violation|0|||
146190100|NCT00819234|527205953|FG001|Overall Study|Protocol Violation|0|||
146190101|NCT00819234|527205954|FG002|Overall Study|Protocol Violation|1|||
146190102|NCT00819234|527205955|FG003|Overall Study|Protocol Violation|0|||
146190103|NCT00819234|527205956|FG004|Overall Study|Protocol Violation|0|||
146190104|NCT00819234|527205957|FG005|Overall Study|Protocol Violation|0|||
146190105|NCT00819234|527205958|FG006|Overall Study|Protocol Violation|0|||
146412723|NCT00585039|528015625|FG000|Overall Study|medication spilled|2|||
146412724|NCT00585039|528015626|FG001|Overall Study|medication spilled|0|||
146412725|NCT02133352|528015633|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
146412726|NCT00185211|528015634|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
146412727|NCT00185211|528015635|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
146412728|NCT00185211|528015634|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
146412729|NCT00185211|528015635|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
146412730|NCT00185211|528015634|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
146412731|NCT00185211|528015635|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
146412732|NCT00185211|528015634|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
146412733|NCT00185211|528015635|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
146190106|NCT00819234|527205959|FG007|Overall Study|Protocol Violation|0|||
146190107|NCT00819234|527205960|FG008|Overall Study|Protocol Violation|0|||
146190108|NCT00819234|527205961|FG009|Overall Study|Protocol Violation|0|||
146190109|NCT00819234|527205952|FG000|Overall Study|Lost to Follow-up|2|||
146190110|NCT00819234|527205953|FG001|Overall Study|Lost to Follow-up|2|||
146190111|NCT00819234|527205954|FG002|Overall Study|Lost to Follow-up|0|||
146190112|NCT00819234|527205955|FG003|Overall Study|Lost to Follow-up|2|||
146190113|NCT00819234|527205956|FG004|Overall Study|Lost to Follow-up|1|||
146190114|NCT00819234|527205957|FG005|Overall Study|Lost to Follow-up|1|||
146190115|NCT00819234|527205958|FG006|Overall Study|Lost to Follow-up|1|||
146190116|NCT00819234|527205959|FG007|Overall Study|Lost to Follow-up|1|||
146190117|NCT00819234|527205960|FG008|Overall Study|Lost to Follow-up|1|||
146190118|NCT00819234|527205961|FG009|Overall Study|Lost to Follow-up|2|||
146412734|NCT00185211|528015634|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
146412735|NCT00185211|528015635|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
146412736|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
146412737|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
146412738|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
146412739|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
146412740|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
146412741|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
146412742|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
146412743|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
146412744|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
146412745|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
146412746|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
146412747|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
146412748|NCT00185211|528015634|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
146412749|NCT00185211|528015635|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
146412750|NCT01759537|528015636|FG000|Overall Study|Death|1|||
146412751|NCT01759537|528015637|FG001|Overall Study|Death|1|||
146412752|NCT01759537|528015636|FG000|Overall Study|Pregnancy|1|||
146412753|NCT01759537|528015637|FG001|Overall Study|Pregnancy|1|||
146412754|NCT01759537|528015636|FG000|Overall Study|Lost to Follow-up|9|||
146412755|NCT01759537|528015637|FG001|Overall Study|Lost to Follow-up|9|||
146412756|NCT01759537|528015636|FG000|Overall Study|Accident involving jaw fracture|1|||
146412757|NCT01759537|528015637|FG001|Overall Study|Accident involving jaw fracture|1|||
146190119|NCT04438785|527205962|FG000|Overall Study|change of weight, give up intervention|2|||
146190120|NCT04438785|527205963|FG001|Overall Study|change of weight, give up intervention|10|||
146190121|NCT04011033|527205964|FG000|Overall Study|Physician Decision|2|||
146190122|NCT04011033|527205965|FG001|Overall Study|Physician Decision|3|||
146412758|NCT01759537|528015636|FG000|Overall Study|Subcrestal implant too coronal|1|||
146412759|NCT01759537|528015637|FG001|Overall Study|Subcrestal implant too coronal|1|||
146190123|NCT04011033|527205964|FG000|Overall Study|Withdrawal by Subject|1|||
146190124|NCT04011033|527205965|FG001|Overall Study|Withdrawal by Subject|0|||
146190125|NCT01823341|527205966|FG000|Overall Study|Failed run-in|7|||
146190126|NCT01823341|527205966|FG000|Overall Study|Withdrawal by Subject|7|||
146190127|NCT01823341|527205966|FG000|Overall Study|Adverse Event|1|||
146412760|NCT00420290|528015638|FG000|Overall Study|Adverse Event|3|||
146412761|NCT00420290|528015639|FG001|Overall Study|Adverse Event|1|||
146412762|NCT00420290|528015638|FG000|Overall Study|Withdrawal by Subject|0|||
146412763|NCT00420290|528015639|FG001|Overall Study|Withdrawal by Subject|2|||
146412764|NCT00420290|528015638|FG000|Overall Study|did not meet inclusion/exclusion|1|||
146412765|NCT00420290|528015639|FG001|Overall Study|did not meet inclusion/exclusion|1|||
146412766|NCT01859390|528017951|FG000|Overall Study|Insufficient Sputum Collected|1|||
146412767|NCT01859390|528017952|FG001|Overall Study|Insufficient Sputum Collected|3|||
146412768|NCT01859390|528017951|FG000|Overall Study|Sample Missing Collection Date|0|||
146412769|NCT01859390|528017952|FG001|Overall Study|Sample Missing Collection Date|1|||
146412770|NCT01859390|528017951|FG000|Overall Study|Tube Cracked|0|||
146412771|NCT01859390|528017952|FG001|Overall Study|Tube Cracked|2|||
146412772|NCT01859390|528017951|FG000|Overall Study|Shipment Error|0|||
146412773|NCT01859390|528017952|FG001|Overall Study|Shipment Error|1|||
146412774|NCT01706198|528017954|FG000|Overall Study|Adverse Event|12|||
146412775|NCT01706198|528017955|FG001|Overall Study|Adverse Event|15|||
146412776|NCT01706198|528017954|FG000|Overall Study|Protocol Violation|7|||
146412777|NCT01706198|528017955|FG001|Overall Study|Protocol Violation|5|||
146412778|NCT01706198|528017954|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
146412779|NCT01706198|528017955|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
146412780|NCT01706198|528017954|FG000|Overall Study|Lost to Follow-up|97|||
146412781|NCT01706198|528017955|FG001|Overall Study|Lost to Follow-up|93|||
146412782|NCT01706198|528017954|FG000|Overall Study|Physician Decision|23|||
146412783|NCT01706198|528017955|FG001|Overall Study|Physician Decision|37|||
146412784|NCT01706198|528017954|FG000|Overall Study|Withdrawal by Subject|23|||
146412785|NCT01706198|528017955|FG001|Overall Study|Withdrawal by Subject|31|||
146412786|NCT01084005|528017956|FG000|Overall Study|Adverse Event|1|||
146412787|NCT01084005|528017957|FG001|Overall Study|Adverse Event|8|||
146412788|NCT01084005|528017956|FG000|Overall Study|Protocol Violation|3|||
146412789|NCT01084005|528017957|FG001|Overall Study|Protocol Violation|7|||
146190128|NCT02027935|527205967|FG000|Overall Study|Death|1|||
146190129|NCT02027935|527205967|FG000|Overall Study|Lack of Efficacy|5|||
146190130|NCT02027935|527205967|FG000|Overall Study|Study Closure|1|||
146190131|NCT00689104|527205968|FG000|Overall Study|Eligibility criterion not met|5|||
146190132|NCT00689104|527205969|FG001|Overall Study|Eligibility criterion not met|8|||
146190133|NCT00689104|527205970|FG002|Overall Study|Eligibility criterion not met|0|||
146190134|NCT00689104|527205971|FG003|Overall Study|Eligibility criterion not met|4|||
146190135|NCT00689104|527205968|FG000|Overall Study|Adverse Event|13|||
146190136|NCT00689104|527205969|FG001|Overall Study|Adverse Event|25|||
146190137|NCT00689104|527205970|FG002|Overall Study|Adverse Event|16|||
146190138|NCT00689104|527205971|FG003|Overall Study|Adverse Event|24|||
146190139|NCT00689104|527205968|FG000|Overall Study|Lack of Efficacy|5|||
146190140|NCT00689104|527205969|FG001|Overall Study|Lack of Efficacy|6|||
146190141|NCT00689104|527205970|FG002|Overall Study|Lack of Efficacy|2|||
146190142|NCT00689104|527205971|FG003|Overall Study|Lack of Efficacy|3|||
146190143|NCT00689104|527205968|FG000|Overall Study|Withdrawal by Subject|12|||
146190144|NCT00689104|527205969|FG001|Overall Study|Withdrawal by Subject|11|||
146190145|NCT00689104|527205970|FG002|Overall Study|Withdrawal by Subject|18|||
146190146|NCT00689104|527205971|FG003|Overall Study|Withdrawal by Subject|11|||
146190147|NCT00689104|527205968|FG000|Overall Study|Lost to Follow-up|4|||
146190148|NCT00689104|527205969|FG001|Overall Study|Lost to Follow-up|3|||
146190149|NCT00689104|527205970|FG002|Overall Study|Lost to Follow-up|2|||
146190150|NCT00689104|527205971|FG003|Overall Study|Lost to Follow-up|5|||
146190151|NCT00689104|527205968|FG000|Overall Study|Protocol Violation|2|||
146190152|NCT00689104|527205969|FG001|Overall Study|Protocol Violation|3|||
146190153|NCT00689104|527205970|FG002|Overall Study|Protocol Violation|5|||
146190154|NCT00689104|527205971|FG003|Overall Study|Protocol Violation|3|||
146190155|NCT00689104|527205968|FG000|Overall Study|Randomized but never received study drug|2|||
146190156|NCT00689104|527205969|FG001|Overall Study|Randomized but never received study drug|1|||
146190157|NCT00689104|527205970|FG002|Overall Study|Randomized but never received study drug|1|||
146190158|NCT00689104|527205971|FG003|Overall Study|Randomized but never received study drug|0|||
146190159|NCT00689104|527205968|FG000|Overall Study|Physician Decision|1|||
146190160|NCT00689104|527205969|FG001|Overall Study|Physician Decision|0|||
146190161|NCT00689104|527205970|FG002|Overall Study|Physician Decision|0|||
146190162|NCT00689104|527205971|FG003|Overall Study|Physician Decision|0|||
146190163|NCT00689104|527205968|FG000|Overall Study|Non-compliance with study procedures|0|||
146190164|NCT00689104|527205969|FG001|Overall Study|Non-compliance with study procedures|0|||
146190165|NCT00689104|527205970|FG002|Overall Study|Non-compliance with study procedures|1|||
146190166|NCT00689104|527205971|FG003|Overall Study|Non-compliance with study procedures|0|||
146190167|NCT04873817|527205972|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
146190168|NCT04873817|527205972|FG000|Overall Study|Lost to Follow-up|4|||
146190169|NCT04873817|527205972|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
146190170|NCT04873817|527205972|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
146190171|NCT04873817|527205972|FG000|Overall Study|Other Reasons|3|||
146190172|NCT00924560|527205976|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
146412790|NCT01084005|528017956|FG000|Overall Study|Withdrawal by Subject|1|||
146412791|NCT01084005|528017957|FG001|Overall Study|Withdrawal by Subject|1|||
146190173|NCT00924560|527205977|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
146190174|NCT00924560|527205978|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
146190175|NCT00924560|527205976|FG000|Overall Study|Non Compliance with the Protocol|20|||
146190176|NCT00924560|527205977|FG001|Overall Study|Non Compliance with the Protocol|15|||
146190177|NCT00924560|527205978|FG002|Overall Study|Non Compliance with the Protocol|4|||
146190178|NCT00924560|527205976|FG000|Overall Study|Physician Decision|2|||
146190179|NCT00924560|527205977|FG001|Overall Study|Physician Decision|3|||
146190180|NCT00924560|527205978|FG002|Overall Study|Physician Decision|4|||
146190181|NCT00924560|527205976|FG000|Overall Study|Withdrawal by Subject|50|||
146190182|NCT00924560|527205977|FG001|Overall Study|Withdrawal by Subject|44|||
146190183|NCT00924560|527205978|FG002|Overall Study|Withdrawal by Subject|18|||
146190184|NCT00924560|527205976|FG000|Overall Study|Adverse Event|39|||
146190185|NCT00924560|527205977|FG001|Overall Study|Adverse Event|33|||
146190186|NCT00924560|527205978|FG002|Overall Study|Adverse Event|0|||
146190187|NCT00924560|527205976|FG000|Overall Study|Pregnancy|5|||
146190188|NCT00924560|527205977|FG001|Overall Study|Pregnancy|7|||
146190189|NCT00924560|527205978|FG002|Overall Study|Pregnancy|1|||
146190190|NCT00924560|527205976|FG000|Overall Study|Lost to Follow-up|78|||
146190191|NCT00924560|527205977|FG001|Overall Study|Lost to Follow-up|94|||
146190192|NCT00924560|527205978|FG002|Overall Study|Lost to Follow-up|45|||
146190193|NCT00924560|527205976|FG000|Overall Study|Miscellaneous Reasons|13|||
146190194|NCT00924560|527205977|FG001|Overall Study|Miscellaneous Reasons|10|||
146190195|NCT00924560|527205978|FG002|Overall Study|Miscellaneous Reasons|10|||
146190196|NCT00604786|527205981|FG000|Overall Study|Lost to Follow-up|2|||
146190197|NCT00604786|527205982|FG001|Overall Study|Lost to Follow-up|0|||
146190198|NCT00665561|527205987|FG000|Overall Study|Death recorded on subject summary pages|75|||
146190199|NCT00665561|527205988|FG001|Overall Study|Death recorded on subject summary pages|75|||
146190200|NCT00665561|527205987|FG000|Overall Study|Does not meet entrance criteria|19|||
146190201|NCT00665561|527205988|FG001|Overall Study|Does not meet entrance criteria|21|||
146190202|NCT00665561|527205987|FG000|Overall Study|Lost to Follow-up|203|||
146190203|NCT00665561|527205988|FG001|Overall Study|Lost to Follow-up|264|||
146190204|NCT00665561|527205987|FG000|Overall Study|Withdrawal by Subject|74|||
146190205|NCT00665561|527205988|FG001|Overall Study|Withdrawal by Subject|65|||
146190206|NCT00665561|527205987|FG000|Overall Study|Other|123|||
146190207|NCT00665561|527205988|FG001|Overall Study|Other|108|||
146190208|NCT00665561|527205987|FG000|Overall Study|Site closed|8|||
146190209|NCT00665561|527205988|FG001|Overall Study|Site closed|0|||
146190210|NCT00665561|527205987|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146190211|NCT00665561|527205988|FG001|Overall Study|Withdrawn due to pregnancy|1|||
146190212|NCT02337361|527205989|FG000|3-month Follow-up|Lost to Follow-up|19|||
146190213|NCT02337361|527205990|FG001|3-month Follow-up|Lost to Follow-up|14|||
146190214|NCT02337361|527205989|FG000|6-month Follow-up|Lost to Follow-up|2|||
146190215|NCT02337361|527205990|FG001|6-month Follow-up|Lost to Follow-up|4|||
146190216|NCT01101542|527205991|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
146190217|NCT01101542|527205991|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
146190218|NCT01101542|527205991|FG000|Year 4 Surveillance Period|Other|287|||
146190219|NCT01101542|527205991|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
146190220|NCT01101542|527205991|FG000|Year 5 Surveillance Period|Pregnancy|1|||
146190221|NCT01101542|527205991|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
146190222|NCT01101542|527205991|FG000|Year 6 Surveillance Period|Pregnancy|1|||
146190223|NCT01101542|527205991|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
146190224|NCT00701311|527205992|FG000|Overall Study|Lack of Efficacy|3|||
146190225|NCT00701311|527205992|FG000|Overall Study|Adverse Event|3|||
146190226|NCT00701311|527205992|FG000|Overall Study|Withdrawal by Subject|2|||
146190227|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Adverse Event|5|||
146190228|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Adverse Event|13|||
146190229|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Adverse Event|0|||
146190230|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
146190231|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
146190232|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
146190233|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
146190234|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
146190235|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
146190236|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
146190237|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
146190238|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
146190239|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
146190240|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
146190241|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
146190242|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146190243|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
146190244|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
146190245|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Physician Decision|2|||
146190246|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Physician Decision|3|||
146235002|NCT01499849|527378440|FG001|Overall Study|Lack of Efficacy|4|||
146412792|NCT03377556|528017962|FG000|Overall Study|Adverse Event|5|||
146412793|NCT03377556|528017962|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146412794|NCT03377556|528017962|FG000|Overall Study|Progression/relapse|38|||
146412795|NCT03377556|528017962|FG000|Overall Study|Death|3|||
146412796|NCT00472446|528017963|FG000|Overall Study|Protocol Violation|0|||
146412797|NCT00472446|528017964|FG001|Overall Study|Protocol Violation|0|||
146412798|NCT00472446|528017965|FG002|Overall Study|Protocol Violation|0|||
146412799|NCT00472446|528017966|FG003|Overall Study|Protocol Violation|1|||
146412800|NCT00472446|528017963|FG000|Overall Study|Reintervention|0|||
146412801|NCT00472446|528017964|FG001|Overall Study|Reintervention|0|||
146412802|NCT00472446|528017965|FG002|Overall Study|Reintervention|1|||
146412803|NCT00472446|528017966|FG003|Overall Study|Reintervention|1|||
146412804|NCT00472446|528017963|FG000|Overall Study|Questionnaires not returned|5|||
146412805|NCT00472446|528017964|FG001|Overall Study|Questionnaires not returned|6|||
146412806|NCT00472446|528017965|FG002|Overall Study|Questionnaires not returned|6|||
146412807|NCT00472446|528017966|FG003|Overall Study|Questionnaires not returned|4|||
146412808|NCT02008721|528017971|FG000|Overall Study|Withdrawal by Subject|5|||
146412809|NCT02008721|528017972|FG001|Overall Study|Withdrawal by Subject|1|||
146412810|NCT02008721|528017971|FG000|Overall Study|Death|4|||
146412811|NCT02008721|528017972|FG001|Overall Study|Death|2|||
146412812|NCT02008721|528017971|FG000|Overall Study|Adverse Event|3|||
146412813|NCT02008721|528017972|FG001|Overall Study|Adverse Event|5|||
146412814|NCT02008721|528017971|FG000|Overall Study|Protocol Violation|3|||
146412815|NCT02008721|528017972|FG001|Overall Study|Protocol Violation|2|||
146412816|NCT00772577|528017976|FG000|Overall Study|Adverse Event|6|||
146412817|NCT00772577|528017977|FG001|Overall Study|Adverse Event|3|||
146081759|NCT01340872|526820477|FG002|Open-label Phase|Physician Decision|2|||
146412818|NCT00772577|528017976|FG000|Overall Study|Abnormal laboratory values|0|||
146412819|NCT00772577|528017977|FG001|Overall Study|Abnormal laboratory values|1|||
146412820|NCT00772577|528017976|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146412821|NCT00772577|528017977|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146081760|NCT01340872|526820478|FG003|Open-label Phase|Physician Decision|1|||
146081761|NCT01340872|526820475|FG000|Open-label Phase|Pregnancy|0|||
146081762|NCT01340872|526820476|FG001|Open-label Phase|Pregnancy|0|||
146081763|NCT01340872|526820477|FG002|Open-label Phase|Pregnancy|1|||
146081764|NCT01340872|526820478|FG003|Open-label Phase|Pregnancy|0|||
146081765|NCT01340872|526820475|FG000|Open-label Phase|Adverse Event|0|||
146081766|NCT01340872|526820476|FG001|Open-label Phase|Adverse Event|0|||
146081767|NCT01340872|526820477|FG002|Open-label Phase|Adverse Event|8|||
146081768|NCT01340872|526820478|FG003|Open-label Phase|Adverse Event|4|||
146081769|NCT01340872|526820475|FG000|Open-label Phase|Withdrawal by Subject|0|||
146081770|NCT01340872|526820476|FG001|Open-label Phase|Withdrawal by Subject|0|||
146081771|NCT01340872|526820477|FG002|Open-label Phase|Withdrawal by Subject|1|||
146081772|NCT01340872|526820478|FG003|Open-label Phase|Withdrawal by Subject|6|||
146081773|NCT01340872|526820475|FG000|Open-label Phase|Worsening of IBD|0|||
146081774|NCT01340872|526820476|FG001|Open-label Phase|Worsening of IBD|0|||
146081775|NCT01340872|526820477|FG002|Open-label Phase|Worsening of IBD|1|||
146081776|NCT01340872|526820478|FG003|Open-label Phase|Worsening of IBD|0|||
146081777|NCT02656680|526820481|FG000|Overall Study|Lost to Follow-up|0|||
146081778|NCT02656680|526820482|FG001|Overall Study|Lost to Follow-up|1|||
146081779|NCT02656680|526820483|FG002|Overall Study|Lost to Follow-up|7|||
146081780|NCT01246466|526820486|FG000|Overall Study|Death|1|||
146081781|NCT01246466|526820486|FG000|Overall Study|Withdrawal by Subject|1|||
146081782|NCT00877773|526820487|FG000|Overall Study|Disease Progression|44|||
146081783|NCT01350544|526820490|FG000|Overall Study|Administrative Withdrawal|0|||
146081784|NCT01350544|526820491|FG001|Overall Study|Administrative Withdrawal|1|||
146081785|NCT01350544|526820490|FG000|Overall Study|Death|1|||
146081786|NCT01350544|526820491|FG001|Overall Study|Death|2|||
146081787|NCT01350544|526820490|FG000|Overall Study|Moved out of LA County|2|||
146081788|NCT01350544|526820491|FG001|Overall Study|Moved out of LA County|2|||
146081789|NCT01350544|526820490|FG000|Overall Study|Medical Issues|1|||
146081790|NCT01350544|526820491|FG001|Overall Study|Medical Issues|1|||
146081791|NCT01350544|526820490|FG000|Overall Study|Withdrawal by Subject|0|||
146081792|NCT01350544|526820491|FG001|Overall Study|Withdrawal by Subject|1|||
146081793|NCT01350544|526820490|FG000|Overall Study|Incarceration|1|||
146081794|NCT01350544|526820491|FG001|Overall Study|Incarceration|0|||
146081795|NCT01350544|526820490|FG000|Overall Study|Lost to Follow-up|18|||
146081796|NCT01350544|526820491|FG001|Overall Study|Lost to Follow-up|15|||
146081797|NCT02882152|526820492|FG000|Overall Study|Lost to Follow-up|1|||
146081798|NCT02882152|526820493|FG001|Overall Study|Lost to Follow-up|0|||
146081799|NCT01430754|526820496|FG000|Run-In Phase|Circadian Period Ineligible|24|||
146081800|NCT01430754|526820497|FG001|Run-In Phase|Circadian Period Ineligible|0|||
146412822|NCT00772577|528017976|FG000|Overall Study|Patient withdrew consent|8|||
146412823|NCT00772577|528017977|FG001|Overall Study|Patient withdrew consent|5|||
146412824|NCT00772577|528017976|FG000|Overall Study|Lost to Follow-up|4|||
146412825|NCT00772577|528017977|FG001|Overall Study|Lost to Follow-up|3|||
146412826|NCT00772577|528017976|FG000|Overall Study|Administrative problems|2|||
146412827|NCT00772577|528017977|FG001|Overall Study|Administrative problems|1|||
146412828|NCT00772577|528017976|FG000|Overall Study|Protocol Deviation|3|||
146412829|NCT00772577|528017977|FG001|Overall Study|Protocol Deviation|2|||
146412830|NCT03211156|528017978|FG000|Overall Study|Withdrawal by Subject|0|||
146412831|NCT03211156|528017979|FG001|Overall Study|Withdrawal by Subject|2|||
146412832|NCT03211156|528017978|FG000|Overall Study|Lost to Follow-up|1|||
146412833|NCT03211156|528017979|FG001|Overall Study|Lost to Follow-up|1|||
146412834|NCT03211156|528017978|FG000|Overall Study|Adverse Event|1|||
146412835|NCT03211156|528017979|FG001|Overall Study|Adverse Event|0|||
146412836|NCT00553540|528017990|FG000|Overall Study|discharged after first visit|2|||
146412837|NCT00553540|528017991|FG001|Overall Study|discharged after first visit|5|||
146412838|NCT03565211|528017998|FG000|Overall Study|Withdrawal by Subject|2|||
146412839|NCT03565211|528017998|FG000|Overall Study|Lost to Follow-up|1|||
146412840|NCT03565211|528017998|FG000|Overall Study|Adverse Event|44|||
146412841|NCT03565211|528017998|FG000|Overall Study|Personal issues|1|||
146412842|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412843|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412844|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412845|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
146412846|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412847|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412848|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412849|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412850|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412851|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
146412852|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146412853|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146412854|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Adverse Event|1|||
146412855|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Adverse Event|1|||
146412856|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Adverse Event|1|||
146412857|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Adverse Event|1|||
146412858|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Adverse Event|0|||
146412859|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Adverse Event|0|||
146412860|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Adverse Event|0|||
146412861|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Adverse Event|0|||
146412862|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
146412863|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
146412864|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
146412865|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
146412866|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
146412867|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
146412868|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
146412869|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
146412870|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
146412871|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
146412872|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412873|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412874|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412875|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146412876|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
146412877|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
146081801|NCT01430754|526820496|FG000|Run-In Phase|Protocol Violation|6|||
146412878|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412879|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
146412880|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412881|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
146412882|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146412883|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146412884|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146081802|NCT01430754|526820497|FG001|Run-In Phase|Protocol Violation|0|||
146081803|NCT01430754|526820496|FG000|Run-In Phase|Adverse Event|2|||
146081804|NCT01430754|526820497|FG001|Run-In Phase|Adverse Event|0|||
146081805|NCT01430754|526820496|FG000|Run-In Phase|Other|2|||
146081806|NCT01430754|526820497|FG001|Run-In Phase|Other|0|||
146081807|NCT01430754|526820496|FG000|Run-In Phase|Withdrawal by Subject|2|||
146190247|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Physician Decision|0|||
146190248|NCT01449929|527205993|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
146190249|NCT01449929|527205994|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
146190250|NCT01449929|527205995|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
146190251|NCT01449929|527205993|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
146190252|NCT01449929|527205994|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
146190253|NCT01449929|527205995|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
146190254|NCT01449929|527205993|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
146190255|NCT01449929|527205994|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
146190256|NCT01449929|527205995|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
146190257|NCT01449929|527205993|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
146190258|NCT01449929|527205994|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
146190259|NCT01449929|527205995|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
146190260|NCT03015740|527205996|FG000|Overall Study|Adverse Event|1|||
146190261|NCT03015740|527205997|FG001|Overall Study|Adverse Event|0|||
146190262|NCT03015740|527205998|FG002|Overall Study|Adverse Event|0|||
146190263|NCT03015740|527205996|FG000|Overall Study|Death|3|||
146190264|NCT03015740|527205997|FG001|Overall Study|Death|5|||
146190265|NCT03015740|527205998|FG002|Overall Study|Death|0|||
146190266|NCT03015740|527205996|FG000|Overall Study|Withdrawal by Subject|2|||
146190267|NCT03015740|527205997|FG001|Overall Study|Withdrawal by Subject|0|||
146190268|NCT03015740|527205998|FG002|Overall Study|Withdrawal by Subject|0|||
146190269|NCT03253653|527206003|FG000|Overall Study|Withdrawal by Subject|4|||
146190270|NCT03253653|527206004|FG001|Overall Study|Withdrawal by Subject|1|||
146190271|NCT03253653|527206003|FG000|Overall Study|Protocol Violation|0|||
146190272|NCT03253653|527206004|FG001|Overall Study|Protocol Violation|5|||
146190273|NCT01575860|527207988|FG000|Overall Study|Withdrawal by Subject|1|||
146190274|NCT01575860|527207988|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
146190275|NCT00180674|527207989|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
146190276|NCT00180674|527207989|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
146190277|NCT00278564|527207990|FG000|Overall Study|Lack of Efficacy|4|||
146190278|NCT03606460|527207991|FG000|Overall Study|Lost to Follow-up|1|||
146190279|NCT03606460|527207992|FG001|Overall Study|Lost to Follow-up|8|||
146190280|NCT00003377|527207993|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
146190281|NCT00003377|527207994|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
146190282|NCT00003377|527207995|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
146190283|NCT00003377|527207996|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
146190284|NCT00003377|527207997|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
146190285|NCT00003377|527207993|FG000|Period II|Ureteral stent complications|0|||
146190286|NCT00003377|527207994|FG001|Period II|Ureteral stent complications|0|||
146190287|NCT00003377|527207995|FG002|Period II|Ureteral stent complications|0|||
146190288|NCT00003377|527207996|FG003|Period II|Ureteral stent complications|0|||
146190289|NCT00003377|527207997|FG004|Period II|Ureteral stent complications|1|||
146190290|NCT04541186|527208002|FG000|Main Study|Adverse Event|0|||
146190291|NCT04541186|527208003|FG001|Main Study|Adverse Event|0|||
146190292|NCT04541186|527208004|FG002|Main Study|Adverse Event|4|||
146190293|NCT04541186|527208005|FG003|Main Study|Adverse Event|0|||
146190294|NCT04541186|527208006|FG004|Main Study|Adverse Event|0|||
146412885|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412886|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412887|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146190295|NCT04541186|527208002|FG000|Main Study|Investigator Decision|0|||
146190296|NCT04541186|527208003|FG001|Main Study|Investigator Decision|0|||
146190297|NCT04541186|527208004|FG002|Main Study|Investigator Decision|1|||
146190298|NCT04541186|527208005|FG003|Main Study|Investigator Decision|1|||
146190299|NCT04541186|527208006|FG004|Main Study|Investigator Decision|0|||
146190300|NCT04541186|527208002|FG000|Main Study|Withdrawal by Subject|1|||
146190301|NCT04541186|527208003|FG001|Main Study|Withdrawal by Subject|1|||
146190302|NCT04541186|527208004|FG002|Main Study|Withdrawal by Subject|0|||
146190303|NCT04541186|527208005|FG003|Main Study|Withdrawal by Subject|0|||
146190304|NCT04541186|527208006|FG004|Main Study|Withdrawal by Subject|0|||
146190305|NCT04541186|527208002|FG000|Main Study|COVID-19-related Dose Interruption|0|||
146190306|NCT04541186|527208003|FG001|Main Study|COVID-19-related Dose Interruption|0|||
146190307|NCT04541186|527208004|FG002|Main Study|COVID-19-related Dose Interruption|0|||
146190308|NCT04541186|527208005|FG003|Main Study|COVID-19-related Dose Interruption|0|||
146190309|NCT04541186|527208006|FG004|Main Study|COVID-19-related Dose Interruption|1|||
146412888|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412889|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
146190310|NCT04541186|527208002|FG000|Main Study|Randomized in Error Not Treated|0|||
146190311|NCT04541186|527208003|FG001|Main Study|Randomized in Error Not Treated|0|||
146190312|NCT04541186|527208004|FG002|Main Study|Randomized in Error Not Treated|1|||
146081808|NCT01430754|526820497|FG001|Run-In Phase|Withdrawal by Subject|0|||
146081809|NCT01430754|526820496|FG000|Run-In Phase|Lost to Follow-up|1|||
146081810|NCT01430754|526820497|FG001|Run-In Phase|Lost to Follow-up|0|||
146081811|NCT01369329|526820501|FG000|Overall Study|Withdrawal by Subject|8|||
146081812|NCT01369329|526820502|FG001|Overall Study|Withdrawal by Subject|6|||
146081813|NCT01369329|526820503|FG002|Overall Study|Withdrawal by Subject|10|||
146081814|NCT01369329|526820501|FG000|Overall Study|Lost to Follow-up|2|||
146081815|NCT01369329|526820502|FG001|Overall Study|Lost to Follow-up|2|||
146081816|NCT01369329|526820503|FG002|Overall Study|Lost to Follow-up|2|||
146081817|NCT01369329|526820501|FG000|Overall Study|Other|2|||
146081818|NCT01369329|526820502|FG001|Overall Study|Other|3|||
146081819|NCT01369329|526820503|FG002|Overall Study|Other|2|||
146081820|NCT00701662|526820504|FG000|Overall Study|Lack of Efficacy|1|||
146081821|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
146081822|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Adverse Event|9|||
146081823|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Death|4|||
146081824|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
146081825|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
146081826|NCT00159822|526820505|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
146081827|NCT00159822|526820505|FG000|Post-treatment Follow-up Period|Death|1|||
146081828|NCT00159822|526820505|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
146081829|NCT00159822|526820505|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
146081830|NCT00275821|526820507|FG000|Overall Study|Adverse Event|4|||
146081831|NCT00275821|526820508|FG001|Overall Study|Adverse Event|12|||
146081832|NCT00275821|526820509|FG002|Overall Study|Adverse Event|5|||
146081833|NCT00275821|526820507|FG000|Overall Study|Administrative problems|3|||
146081834|NCT00275821|526820508|FG001|Overall Study|Administrative problems|4|||
146081835|NCT00275821|526820509|FG002|Overall Study|Administrative problems|4|||
146081836|NCT00275821|526820507|FG000|Overall Study|Withdrawal by Subject|0|||
146081837|NCT00275821|526820508|FG001|Overall Study|Withdrawal by Subject|2|||
146081838|NCT00275821|526820509|FG002|Overall Study|Withdrawal by Subject|1|||
146081839|NCT00275821|526820507|FG000|Overall Study|Lost to Follow-up|0|||
146081840|NCT00275821|526820508|FG001|Overall Study|Lost to Follow-up|1|||
146081841|NCT00275821|526820509|FG002|Overall Study|Lost to Follow-up|1|||
146081842|NCT00275821|526820507|FG000|Overall Study|Death|0|||
146081843|NCT00275821|526820508|FG001|Overall Study|Death|2|||
146081844|NCT00275821|526820509|FG002|Overall Study|Death|1|||
146081845|NCT00275821|526820507|FG000|Overall Study|Lack of Efficacy|2|||
146081846|NCT00275821|526820508|FG001|Overall Study|Lack of Efficacy|1|||
146081847|NCT00275821|526820509|FG002|Overall Study|Lack of Efficacy|0|||
146081848|NCT00275821|526820507|FG000|Overall Study|Protocol Violation|5|||
146081849|NCT00275821|526820508|FG001|Overall Study|Protocol Violation|1|||
146081850|NCT00275821|526820509|FG002|Overall Study|Protocol Violation|0|||
146081851|NCT01133990|526820512|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
146081852|NCT01133990|526820513|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146081853|NCT01133990|526820514|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146081854|NCT01133990|526820515|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146081855|NCT01133990|526820516|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146081856|NCT01133990|526820517|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146081857|NCT01133990|526820512|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
146081858|NCT01133990|526820513|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146081859|NCT01133990|526820514|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146081860|NCT01133990|526820515|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146081861|NCT01133990|526820516|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146081862|NCT01133990|526820517|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
146081863|NCT01133990|526820512|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146081864|NCT01133990|526820513|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146081865|NCT01133990|526820514|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146081866|NCT01133990|526820515|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146412890|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412891|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
146412892|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412893|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412894|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412895|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412896|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
146190313|NCT04541186|527208005|FG003|Main Study|Randomized in Error Not Treated|0|||
146190314|NCT04541186|527208006|FG004|Main Study|Randomized in Error Not Treated|0|||
146190315|NCT04541186|527208002|FG000|Fibrate Expansion Study|Other than Specified|0|||
146190316|NCT04541186|527208003|FG001|Fibrate Expansion Study|Other than Specified|0|||
146190317|NCT04541186|527208004|FG002|Fibrate Expansion Study|Other than Specified|0|||
146190318|NCT04541186|527208005|FG003|Fibrate Expansion Study|Other than Specified|0|||
146190319|NCT04541186|527208006|FG004|Fibrate Expansion Study|Other than Specified|1|||
146190320|NCT00303303|527208016|FG000|Overall Study|Withdrawal by Subject|0|||
146190321|NCT00303303|527208017|FG001|Overall Study|Withdrawal by Subject|0|||
146190322|NCT00303303|527208018|FG002|Overall Study|Withdrawal by Subject|1|||
146190323|NCT00058058|527208020|FG000|Overall Study|Withdrawal by Subject|4|||
146190324|NCT00058058|527208020|FG000|Overall Study|Ineligible|20|||
146190325|NCT00058058|527208020|FG000|Overall Study|Claustrophobic|5|||
146190326|NCT00058058|527208020|FG000|Overall Study|technical issues|6|||
146190327|NCT00058058|527208020|FG000|Overall Study|Poor positioning, illness,pain|3|||
146412897|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
146412898|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412899|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412900|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412901|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
146412902|NCT00950599|528018003|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
146412903|NCT00950599|528018004|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146412904|NCT00950599|528018005|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146412905|NCT00950599|528018006|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
146412906|NCT00950599|528018007|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
146412907|NCT00950599|528018008|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
146412908|NCT00950599|528018009|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146412909|NCT00950599|528018010|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
146412910|NCT00950599|528018011|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146412911|NCT00950599|528018012|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
146412912|NCT00950599|528018003|FG000|Follow-Up Period|Adverse Event|0|||
146412913|NCT00950599|528018004|FG001|Follow-Up Period|Adverse Event|0|||
146412914|NCT00950599|528018005|FG002|Follow-Up Period|Adverse Event|0|||
146412915|NCT00950599|528018006|FG003|Follow-Up Period|Adverse Event|0|||
146412916|NCT00950599|528018007|FG004|Follow-Up Period|Adverse Event|0|||
146412917|NCT00950599|528018008|FG005|Follow-Up Period|Adverse Event|0|||
146412918|NCT00950599|528018009|FG006|Follow-Up Period|Adverse Event|0|||
146412919|NCT00950599|528018010|FG007|Follow-Up Period|Adverse Event|0|||
146081867|NCT01133990|526820516|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146081868|NCT01133990|526820517|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146081869|NCT01133990|526820512|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
146412920|NCT00950599|528018011|FG008|Follow-Up Period|Adverse Event|1|||
146412921|NCT00950599|528018012|FG009|Follow-Up Period|Adverse Event|0|||
146081870|NCT01133990|526820513|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146081871|NCT01133990|526820514|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146081872|NCT01133990|526820515|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146081873|NCT01133990|526820516|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146081874|NCT01133990|526820517|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
146081875|NCT02282345|526820519|FG000|Overall Study|Progression|0|||
146081876|NCT02282345|526820520|FG001|Overall Study|Progression|1|||
146081877|NCT01185301|526820521|FG000|Overall Study|Adverse Event|3|||
146081878|NCT01185301|526820522|FG001|Overall Study|Adverse Event|0|||
146081879|NCT01185301|526820523|FG002|Overall Study|Adverse Event|2|||
146081880|NCT01185301|526820524|FG003|Overall Study|Adverse Event|3|||
146081881|NCT01185301|526820521|FG000|Overall Study|Withdrawal by Subject|7|||
146081882|NCT01185301|526820522|FG001|Overall Study|Withdrawal by Subject|5|||
146081883|NCT01185301|526820523|FG002|Overall Study|Withdrawal by Subject|2|||
146081884|NCT01185301|526820524|FG003|Overall Study|Withdrawal by Subject|3|||
146081885|NCT01185301|526820521|FG000|Overall Study|Lost to Follow-up|2|||
146081886|NCT01185301|526820522|FG001|Overall Study|Lost to Follow-up|0|||
146081887|NCT01185301|526820523|FG002|Overall Study|Lost to Follow-up|0|||
146081888|NCT01185301|526820524|FG003|Overall Study|Lost to Follow-up|1|||
146081889|NCT01185301|526820521|FG000|Overall Study|Other Reason|3|||
146190328|NCT03085017|527208021|FG000|Overall Study|Death|0|||
146190329|NCT03085017|527208022|FG001|Overall Study|Death|3|||
146190330|NCT00582790|527208025|FG000|Overall Study|Rapid progression of disease|1|||
146190331|NCT02374957|527208029|FG000|Overall Study|Patient did not complete forms correctly|1|||
146190332|NCT02374957|527208030|FG001|Overall Study|Patient did not complete forms correctly|0|||
146190333|NCT03681691|527208031|FG000|Overall Study|COVID|1|||
146190334|NCT03681691|527208032|FG001|Overall Study|COVID|0|||
146190335|NCT03681691|527208031|FG000|Overall Study|prolonged bleeding|1|||
146190336|NCT03681691|527208032|FG001|Overall Study|prolonged bleeding|0|||
146190337|NCT03681691|527208031|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
146190338|NCT03681691|527208032|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
146190339|NCT00748969|527208033|FG000|Overall Study|Withdrawal by Subject|1|||
146190340|NCT00748969|527208034|FG001|Overall Study|Withdrawal by Subject|0|||
146190341|NCT00748969|527208033|FG000|Overall Study|Withdrawal by Subject|0|||
146190342|NCT00748969|527208034|FG001|Overall Study|Withdrawal by Subject|1|||
146190343|NCT02334306|527208035|FG000|Double-blind Period|Adverse Event|0|||
146190344|NCT02334306|527208036|FG001|Double-blind Period|Adverse Event|1|||
146190345|NCT02334306|527208035|FG000|Double-blind Period|Withdrawal by Subject|1|||
146190346|NCT02334306|527208036|FG001|Double-blind Period|Withdrawal by Subject|1|||
146190347|NCT03302156|527208037|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
146190348|NCT03302156|527208038|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
146190349|NCT03302156|527208039|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
146190350|NCT02390557|527208040|FG000|Wave 2|Survey non-respondent|72|||
146190351|NCT02390557|527208041|FG001|Wave 2|Survey non-respondent|41|||
146190352|NCT02390557|527208042|FG002|Wave 2|Survey non-respondent|23|||
146190353|NCT03278028|527208045|FG000|Overall Study|Lost to Follow-up|1|||
146190354|NCT03278028|527208046|FG001|Overall Study|Lost to Follow-up|0|||
146190355|NCT03278028|527208045|FG000|Overall Study|Withdrawal by Subject|3|||
146190356|NCT03278028|527208046|FG001|Overall Study|Withdrawal by Subject|1|||
146190357|NCT03278028|527208045|FG000|Overall Study|Pregnancy|0|||
146190358|NCT03278028|527208046|FG001|Overall Study|Pregnancy|1|||
146190359|NCT00463151|527208047|FG000|Overall Study|Adverse Event|0|||
146190360|NCT00463151|527208048|FG001|Overall Study|Adverse Event|0|||
146190361|NCT00463151|527208049|FG002|Overall Study|Adverse Event|1|||
146190362|NCT00463151|527208050|FG003|Overall Study|Adverse Event|0|||
146190363|NCT00463151|527208047|FG000|Overall Study|Lack of Efficacy|2|||
146190364|NCT00463151|527208048|FG001|Overall Study|Lack of Efficacy|5|||
146190365|NCT00463151|527208049|FG002|Overall Study|Lack of Efficacy|2|||
146190366|NCT00463151|527208050|FG003|Overall Study|Lack of Efficacy|5|||
146190367|NCT00463151|527208047|FG000|Overall Study|Protocol Violation|0|||
146190368|NCT00463151|527208048|FG001|Overall Study|Protocol Violation|0|||
146190369|NCT00463151|527208049|FG002|Overall Study|Protocol Violation|0|||
146190370|NCT00463151|527208050|FG003|Overall Study|Protocol Violation|1|||
146190371|NCT00463151|527208047|FG000|Overall Study|Withdrawal by Subject|0|||
146190372|NCT00463151|527208048|FG001|Overall Study|Withdrawal by Subject|0|||
146190373|NCT00463151|527208049|FG002|Overall Study|Withdrawal by Subject|0|||
146190374|NCT00463151|527208050|FG003|Overall Study|Withdrawal by Subject|1|||
146412922|NCT00950599|528018003|FG000|Follow-Up Period|Lack of Efficacy|0|||
146412923|NCT00950599|528018004|FG001|Follow-Up Period|Lack of Efficacy|0|||
146412924|NCT00950599|528018005|FG002|Follow-Up Period|Lack of Efficacy|0|||
146412925|NCT00950599|528018006|FG003|Follow-Up Period|Lack of Efficacy|0|||
146412926|NCT00950599|528018007|FG004|Follow-Up Period|Lack of Efficacy|0|||
146412927|NCT00950599|528018008|FG005|Follow-Up Period|Lack of Efficacy|0|||
146412928|NCT00950599|528018009|FG006|Follow-Up Period|Lack of Efficacy|0|||
146412929|NCT00950599|528018010|FG007|Follow-Up Period|Lack of Efficacy|0|||
146412930|NCT00950599|528018011|FG008|Follow-Up Period|Lack of Efficacy|3|||
146412931|NCT00950599|528018012|FG009|Follow-Up Period|Lack of Efficacy|0|||
146412932|NCT00950599|528018003|FG000|Follow-Up Period|Lost to Follow-up|0|||
146412933|NCT00950599|528018004|FG001|Follow-Up Period|Lost to Follow-up|0|||
146412934|NCT00950599|528018005|FG002|Follow-Up Period|Lost to Follow-up|0|||
146190375|NCT05349084|527208051|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
146190376|NCT00972543|527208052|FG000|Overall Study|Adverse Event|1|||
146190377|NCT00972543|527208053|FG001|Overall Study|Adverse Event|0|||
146190378|NCT00972543|527208052|FG000|Overall Study|Early study termination by sponsor|4|||
146190379|NCT00972543|527208053|FG001|Overall Study|Early study termination by sponsor|1|||
146190380|NCT03255941|527208054|FG000|Overall Study|Not eligible or refused injection|37|||
146190381|NCT03255941|527208055|FG001|Overall Study|Not eligible or refused injection|44|||
146412935|NCT00950599|528018006|FG003|Follow-Up Period|Lost to Follow-up|0|||
146412936|NCT00950599|528018007|FG004|Follow-Up Period|Lost to Follow-up|0|||
146190382|NCT03255941|527208056|FG002|Overall Study|Not eligible or refused injection|5|||
146190383|NCT03255941|527208057|FG003|Overall Study|Not eligible or refused injection|6|||
146190384|NCT03255941|527208054|FG000|Overall Study|Did not complete exit interview|1|||
146190385|NCT03255941|527208055|FG001|Overall Study|Did not complete exit interview|2|||
146412937|NCT00950599|528018008|FG005|Follow-Up Period|Lost to Follow-up|0|||
146412938|NCT00950599|528018009|FG006|Follow-Up Period|Lost to Follow-up|0|||
146412939|NCT00950599|528018010|FG007|Follow-Up Period|Lost to Follow-up|0|||
146412940|NCT00950599|528018011|FG008|Follow-Up Period|Lost to Follow-up|5|||
146412941|NCT00950599|528018012|FG009|Follow-Up Period|Lost to Follow-up|1|||
146412942|NCT00950599|528018003|FG000|Follow-Up Period|Physician Decision|0|||
146412943|NCT00950599|528018004|FG001|Follow-Up Period|Physician Decision|0|||
146412944|NCT00950599|528018005|FG002|Follow-Up Period|Physician Decision|0|||
146412945|NCT00950599|528018006|FG003|Follow-Up Period|Physician Decision|0|||
146412946|NCT00950599|528018007|FG004|Follow-Up Period|Physician Decision|0|||
146412947|NCT00950599|528018008|FG005|Follow-Up Period|Physician Decision|0|||
146412948|NCT00950599|528018009|FG006|Follow-Up Period|Physician Decision|0|||
146412949|NCT00950599|528018010|FG007|Follow-Up Period|Physician Decision|0|||
146412950|NCT00950599|528018011|FG008|Follow-Up Period|Physician Decision|1|||
146412951|NCT00950599|528018012|FG009|Follow-Up Period|Physician Decision|0|||
146412952|NCT00950599|528018003|FG000|Follow-Up Period|Poor/Noncompliance|0|||
146412953|NCT00950599|528018004|FG001|Follow-Up Period|Poor/Noncompliance|0|||
146412954|NCT00950599|528018005|FG002|Follow-Up Period|Poor/Noncompliance|0|||
146412955|NCT00950599|528018006|FG003|Follow-Up Period|Poor/Noncompliance|0|||
146412956|NCT00950599|528018007|FG004|Follow-Up Period|Poor/Noncompliance|0|||
146412957|NCT00950599|528018008|FG005|Follow-Up Period|Poor/Noncompliance|0|||
146412958|NCT00950599|528018009|FG006|Follow-Up Period|Poor/Noncompliance|0|||
146190386|NCT03255941|527208056|FG002|Overall Study|Did not complete exit interview|0|||
146190387|NCT03255941|527208057|FG003|Overall Study|Did not complete exit interview|0|||
146190388|NCT01004263|527208058|FG000|Overall Study|Adverse Event|15|||
146190389|NCT01004263|527208058|FG000|Overall Study|Withdrawal by Subject|58|||
146190390|NCT01004263|527208058|FG000|Overall Study|Protocol Violation|10|||
146190391|NCT01004263|527208058|FG000|Overall Study|Lost to Follow-up|64|||
146190392|NCT01004263|527208058|FG000|Overall Study|Lack of Efficacy|13|||
146190393|NCT01004263|527208058|FG000|Overall Study|Pregnancy|2|||
146190394|NCT01004263|527208058|FG000|Overall Study|Physician Decision|15|||
146190395|NCT01004263|527208058|FG000|Overall Study|Lack of Qualifying Event|2|||
146190396|NCT01528709|527208059|FG000|Overall Study|Death|2|||
146190397|NCT01528709|527208060|FG001|Overall Study|Death|0|||
146190398|NCT01528709|527208059|FG000|Overall Study|Withdrawal by Subject|10|||
146190399|NCT01528709|527208060|FG001|Overall Study|Withdrawal by Subject|15|||
146412959|NCT00950599|528018010|FG007|Follow-Up Period|Poor/Noncompliance|0|||
146412960|NCT00950599|528018011|FG008|Follow-Up Period|Poor/Noncompliance|1|||
146412961|NCT00950599|528018012|FG009|Follow-Up Period|Poor/Noncompliance|0|||
146412962|NCT00950599|528018003|FG000|Follow-Up Period|Subject withdrew Consent|0|||
146412963|NCT00950599|528018004|FG001|Follow-Up Period|Subject withdrew Consent|0|||
146412964|NCT00950599|528018005|FG002|Follow-Up Period|Subject withdrew Consent|0|||
146412965|NCT00950599|528018006|FG003|Follow-Up Period|Subject withdrew Consent|0|||
146412966|NCT00950599|528018007|FG004|Follow-Up Period|Subject withdrew Consent|0|||
146412967|NCT00950599|528018008|FG005|Follow-Up Period|Subject withdrew Consent|0|||
146412968|NCT00950599|528018009|FG006|Follow-Up Period|Subject withdrew Consent|0|||
146412969|NCT00950599|528018010|FG007|Follow-Up Period|Subject withdrew Consent|0|||
146412970|NCT00950599|528018011|FG008|Follow-Up Period|Subject withdrew Consent|2|||
146412971|NCT00950599|528018012|FG009|Follow-Up Period|Subject withdrew Consent|1|||
146412972|NCT01684722|528018013|FG000|Overall Study|Lost to Follow-up|78|||
146412973|NCT01684722|528018014|FG001|Overall Study|Lost to Follow-up|56|||
146412974|NCT01684722|528018015|FG002|Overall Study|Lost to Follow-up|75|||
146412975|NCT01684722|528018016|FG003|Overall Study|Lost to Follow-up|89|||
146412976|NCT01684722|528018013|FG000|Overall Study|Death|19|||
146412977|NCT01684722|528018014|FG001|Overall Study|Death|21|||
146190400|NCT01528709|527208059|FG000|Overall Study|allergy|1|||
146190401|NCT01528709|527208060|FG001|Overall Study|allergy|0|||
146190402|NCT01237678|527208062|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
146190403|NCT01237678|527208063|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
146190404|NCT01237678|527208064|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
146190405|NCT01237678|527208062|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
146412978|NCT01684722|528018015|FG002|Overall Study|Death|19|||
146412979|NCT01684722|528018016|FG003|Overall Study|Death|21|||
146412980|NCT02741271|528018027|FG000|Overall Study|Lost to Follow-up|2|||
146412981|NCT02741271|528018028|FG001|Overall Study|Lost to Follow-up|0|||
146412982|NCT02741271|528018027|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146412983|NCT02741271|528018028|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146412984|NCT03652961|528018029|FG000|Overall Study|Lost to Follow-up|3|||
146412985|NCT03652961|528018029|FG000|Overall Study|Screen Failure|1|||
146412986|NCT00410410|528018030|FG000|Induction Period (IP)|Death|1|||
146190406|NCT01237678|527208063|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
146190407|NCT01237678|527208064|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
146190408|NCT01237678|527208062|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
146412987|NCT00410410|528018031|FG001|Induction Period (IP)|Death|0|||
146412988|NCT00410410|528018032|FG002|Induction Period (IP)|Death|0|||
146412989|NCT00410410|528018033|FG003|Induction Period (IP)|Death|0|||
146412990|NCT00410410|528018034|FG004|Induction Period (IP)|Death|0|||
146412991|NCT00410410|528018035|FG005|Induction Period (IP)|Death|0|||
146412992|NCT00410410|528018036|FG006|Induction Period (IP)|Death|0|||
146190409|NCT01237678|527208063|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
146412993|NCT00410410|528018037|FG007|Induction Period (IP)|Death|0|||
146412994|NCT00410410|528018038|FG008|Induction Period (IP)|Death|0|||
146412995|NCT00410410|528018030|FG000|Induction Period (IP)|Adverse Event|3|||
146412996|NCT00410410|528018031|FG001|Induction Period (IP)|Adverse Event|4|||
146412997|NCT00410410|528018032|FG002|Induction Period (IP)|Adverse Event|2|||
146412998|NCT00410410|528018033|FG003|Induction Period (IP)|Adverse Event|4|||
146412999|NCT00410410|528018034|FG004|Induction Period (IP)|Adverse Event|1|||
146413000|NCT00410410|528018035|FG005|Induction Period (IP)|Adverse Event|0|||
146413001|NCT00410410|528018036|FG006|Induction Period (IP)|Adverse Event|0|||
146413002|NCT00410410|528018037|FG007|Induction Period (IP)|Adverse Event|0|||
146413003|NCT00410410|528018038|FG008|Induction Period (IP)|Adverse Event|0|||
146413004|NCT00410410|528018030|FG000|Induction Period (IP)|Lack of Efficacy|26|||
146413005|NCT00410410|528018031|FG001|Induction Period (IP)|Lack of Efficacy|24|||
146413006|NCT00410410|528018032|FG002|Induction Period (IP)|Lack of Efficacy|8|||
146413007|NCT00410410|528018033|FG003|Induction Period (IP)|Lack of Efficacy|8|||
146413008|NCT00410410|528018034|FG004|Induction Period (IP)|Lack of Efficacy|7|||
146413009|NCT00410410|528018035|FG005|Induction Period (IP)|Lack of Efficacy|7|||
146413010|NCT00410410|528018036|FG006|Induction Period (IP)|Lack of Efficacy|0|||
146413011|NCT00410410|528018037|FG007|Induction Period (IP)|Lack of Efficacy|0|||
146413012|NCT00410410|528018038|FG008|Induction Period (IP)|Lack of Efficacy|0|||
146413013|NCT00410410|528018030|FG000|Induction Period (IP)|Lost to Follow-up|2|||
146413014|NCT00410410|528018031|FG001|Induction Period (IP)|Lost to Follow-up|2|||
146413015|NCT00410410|528018032|FG002|Induction Period (IP)|Lost to Follow-up|2|||
146413016|NCT00410410|528018033|FG003|Induction Period (IP)|Lost to Follow-up|3|||
146413017|NCT00410410|528018034|FG004|Induction Period (IP)|Lost to Follow-up|0|||
146413018|NCT00410410|528018035|FG005|Induction Period (IP)|Lost to Follow-up|1|||
146413019|NCT00410410|528018036|FG006|Induction Period (IP)|Lost to Follow-up|0|||
146413020|NCT00410410|528018037|FG007|Induction Period (IP)|Lost to Follow-up|0|||
146413021|NCT00410410|528018038|FG008|Induction Period (IP)|Lost to Follow-up|0|||
146413022|NCT00410410|528018030|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
146413023|NCT00410410|528018031|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
146413024|NCT00410410|528018032|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
146413025|NCT00410410|528018033|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
146413026|NCT00410410|528018034|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
146413027|NCT00410410|528018035|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
146413028|NCT00410410|528018036|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
146413029|NCT00410410|528018037|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
146413030|NCT00410410|528018038|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
146413031|NCT00410410|528018030|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413032|NCT00410410|528018031|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413033|NCT00410410|528018032|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
146413034|NCT00410410|528018033|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146190410|NCT01237678|527208064|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
146190411|NCT01237678|527208062|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
146190412|NCT01237678|527208063|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
146190413|NCT01237678|527208064|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
146190414|NCT01237678|527208062|FG000|Phase II|Adverse Event|0|||
146190415|NCT01237678|527208063|FG001|Phase II|Adverse Event|39|||
146190416|NCT01237678|527208064|FG002|Phase II|Adverse Event|9|||
146190417|NCT01237678|527208062|FG000|Phase II|Death|0|||
146190418|NCT01237678|527208063|FG001|Phase II|Death|0|||
146190419|NCT01237678|527208064|FG002|Phase II|Death|2|||
146190420|NCT01237678|527208062|FG000|Phase II|Lack of Efficacy|0|||
146413035|NCT00410410|528018034|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413036|NCT00410410|528018035|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413037|NCT00410410|528018036|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413038|NCT00410410|528018037|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413039|NCT00410410|528018038|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
146413040|NCT00410410|528018030|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413041|NCT00410410|528018031|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413042|NCT00410410|528018032|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146190421|NCT01237678|527208063|FG001|Phase II|Lack of Efficacy|25|||
146190422|NCT01237678|527208064|FG002|Phase II|Lack of Efficacy|3|||
146190423|NCT01237678|527208062|FG000|Phase II|Withdrawal by Subject|0|||
146190424|NCT01237678|527208063|FG001|Phase II|Withdrawal by Subject|1|||
146190425|NCT01237678|527208064|FG002|Phase II|Withdrawal by Subject|5|||
146190426|NCT01237678|527208062|FG000|Phase II|Completed Cycles 4-6|0|||
146190427|NCT01237678|527208063|FG001|Phase II|Completed Cycles 4-6|11|||
146190428|NCT01237678|527208064|FG002|Phase II|Completed Cycles 4-6|21|||
146190429|NCT01237678|527208062|FG000|Phase II|Sponsor Decision/Study Closed|0|||
146190430|NCT01237678|527208063|FG001|Phase II|Sponsor Decision/Study Closed|18|||
146190431|NCT01237678|527208064|FG002|Phase II|Sponsor Decision/Study Closed|7|||
146190432|NCT01237678|527208062|FG000|Phase II|Randomized but were not treated|0|||
146190433|NCT01237678|527208063|FG001|Phase II|Randomized but were not treated|4|||
146190434|NCT01237678|527208064|FG002|Phase II|Randomized but were not treated|3|||
146190435|NCT05124899|527208065|FG000|Overall Study|Lost to Follow-up|3|||
146190436|NCT03432533|527208066|FG000|Overall Study|Lost to Follow-up|1|||
146190437|NCT03432533|527208067|FG001|Overall Study|Lost to Follow-up|2|||
146190438|NCT03432533|527208066|FG000|Overall Study|Withdrawal by Subject|14|||
146190439|NCT03432533|527208067|FG001|Overall Study|Withdrawal by Subject|9|||
146190440|NCT00797225|527208071|FG000|Weeks 1 to 12|Adverse Event|0|||
146190441|NCT00797225|527208072|FG001|Weeks 1 to 12|Adverse Event|0|||
146190442|NCT00797225|527208073|FG002|Weeks 1 to 12|Adverse Event|1|||
146190443|NCT00797225|527208074|FG003|Weeks 1 to 12|Adverse Event|0|||
146190444|NCT00797225|527208075|FG004|Weeks 1 to 12|Adverse Event|0|||
146190445|NCT00797225|527208076|FG005|Weeks 1 to 12|Adverse Event|0|||
146190446|NCT00797225|527208077|FG006|Weeks 1 to 12|Adverse Event|0|||
146190447|NCT00797225|527208078|FG007|Weeks 1 to 12|Adverse Event|0|||
146190448|NCT00797225|527208071|FG000|Weeks 1 to 12|Non-compliance|0|||
146190449|NCT00797225|527208072|FG001|Weeks 1 to 12|Non-compliance|1|||
146190450|NCT00797225|527208073|FG002|Weeks 1 to 12|Non-compliance|0|||
146190451|NCT00797225|527208074|FG003|Weeks 1 to 12|Non-compliance|0|||
146190452|NCT00797225|527208075|FG004|Weeks 1 to 12|Non-compliance|0|||
146190453|NCT00797225|527208076|FG005|Weeks 1 to 12|Non-compliance|0|||
146190454|NCT00797225|527208077|FG006|Weeks 1 to 12|Non-compliance|0|||
146190455|NCT00797225|527208078|FG007|Weeks 1 to 12|Non-compliance|0|||
146190456|NCT00797225|527208071|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
146190457|NCT00797225|527208072|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
146190458|NCT00797225|527208073|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
146190459|NCT00797225|527208074|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
146190460|NCT00797225|527208075|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
146190461|NCT00797225|527208076|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
146190462|NCT00797225|527208077|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
146190463|NCT00797225|527208078|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
146190464|NCT00797225|527208071|FG000|Weeks 1 to 12|Sponsor Decision|1|||
146190465|NCT00797225|527208072|FG001|Weeks 1 to 12|Sponsor Decision|0|||
146190466|NCT00797225|527208073|FG002|Weeks 1 to 12|Sponsor Decision|0|||
146190467|NCT00797225|527208074|FG003|Weeks 1 to 12|Sponsor Decision|0|||
146190468|NCT00797225|527208075|FG004|Weeks 1 to 12|Sponsor Decision|0|||
146190469|NCT00797225|527208076|FG005|Weeks 1 to 12|Sponsor Decision|0|||
146190470|NCT00797225|527208077|FG006|Weeks 1 to 12|Sponsor Decision|0|||
146190471|NCT00797225|527208078|FG007|Weeks 1 to 12|Sponsor Decision|0|||
146190472|NCT00797225|527208071|FG000|Weeks 13 to 24|Non-compliance|0|||
146190473|NCT00797225|527208072|FG001|Weeks 13 to 24|Non-compliance|2|||
146190474|NCT00797225|527208073|FG002|Weeks 13 to 24|Non-compliance|0|||
146190475|NCT00797225|527208074|FG003|Weeks 13 to 24|Non-compliance|0|||
146190476|NCT00797225|527208075|FG004|Weeks 13 to 24|Non-compliance|0|||
146190477|NCT00797225|527208076|FG005|Weeks 13 to 24|Non-compliance|0|||
146190478|NCT00797225|527208077|FG006|Weeks 13 to 24|Non-compliance|0|||
146190479|NCT00797225|527208078|FG007|Weeks 13 to 24|Non-compliance|0|||
146190480|NCT00797225|527208071|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
146190481|NCT00797225|527208072|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
146190482|NCT00797225|527208073|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
146190483|NCT00797225|527208074|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
146190484|NCT00797225|527208075|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
146190485|NCT00797225|527208076|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
146190486|NCT00797225|527208077|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
146190487|NCT00797225|527208078|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
146190488|NCT00797225|527208071|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
146190489|NCT00797225|527208072|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
146190490|NCT00797225|527208073|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
146190491|NCT00797225|527208074|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
146190492|NCT00797225|527208075|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
146190493|NCT00797225|527208076|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
146190494|NCT00797225|527208077|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
146190495|NCT00797225|527208078|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
146190496|NCT00797225|527208071|FG000|Weeks 13 to 24|Adverse Event|0|||
146190497|NCT00797225|527208072|FG001|Weeks 13 to 24|Adverse Event|1|||
146190498|NCT00797225|527208073|FG002|Weeks 13 to 24|Adverse Event|0|||
146190499|NCT00797225|527208074|FG003|Weeks 13 to 24|Adverse Event|0|||
146190500|NCT00797225|527208075|FG004|Weeks 13 to 24|Adverse Event|0|||
146190501|NCT00797225|527208076|FG005|Weeks 13 to 24|Adverse Event|0|||
146413043|NCT00410410|528018033|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413044|NCT00410410|528018034|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
146413045|NCT00410410|528018035|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
146413046|NCT00410410|528018036|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413047|NCT00410410|528018037|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413048|NCT00410410|528018038|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
146413049|NCT00410410|528018030|FG000|Induction Period (IP)|Other|0|||
146413050|NCT00410410|528018031|FG001|Induction Period (IP)|Other|0|||
146413051|NCT00410410|528018032|FG002|Induction Period (IP)|Other|1|||
146413052|NCT00410410|528018033|FG003|Induction Period (IP)|Other|0|||
146413053|NCT00410410|528018034|FG004|Induction Period (IP)|Other|0|||
146413054|NCT00410410|528018035|FG005|Induction Period (IP)|Other|0|||
146413055|NCT00410410|528018036|FG006|Induction Period (IP)|Other|0|||
146413056|NCT00410410|528018037|FG007|Induction Period (IP)|Other|0|||
146413057|NCT00410410|528018038|FG008|Induction Period (IP)|Other|0|||
146413058|NCT00410410|528018030|FG000|Maintenance Period (MP)|Death|0|||
146413059|NCT00410410|528018031|FG001|Maintenance Period (MP)|Death|0|||
146413060|NCT00410410|528018032|FG002|Maintenance Period (MP)|Death|0|||
146413061|NCT00410410|528018033|FG003|Maintenance Period (MP)|Death|0|||
146413062|NCT00410410|528018034|FG004|Maintenance Period (MP)|Death|0|||
146190502|NCT00797225|527208077|FG006|Weeks 13 to 24|Adverse Event|1|||
146190503|NCT00797225|527208078|FG007|Weeks 13 to 24|Adverse Event|0|||
146190504|NCT00797225|527208071|FG000|Weeks 13 to 24|Sponsor Decision|0|||
146190505|NCT00797225|527208072|FG001|Weeks 13 to 24|Sponsor Decision|0|||
146190506|NCT00797225|527208073|FG002|Weeks 13 to 24|Sponsor Decision|0|||
146190507|NCT00797225|527208074|FG003|Weeks 13 to 24|Sponsor Decision|0|||
146190508|NCT00797225|527208075|FG004|Weeks 13 to 24|Sponsor Decision|0|||
146190509|NCT00797225|527208076|FG005|Weeks 13 to 24|Sponsor Decision|0|||
146190510|NCT00797225|527208077|FG006|Weeks 13 to 24|Sponsor Decision|1|||
146190511|NCT00797225|527208078|FG007|Weeks 13 to 24|Sponsor Decision|0|||
146190512|NCT00578227|527208079|FG000|Overall Study|Lost to Follow-up|0|||
146190513|NCT00578227|527208080|FG001|Overall Study|Lost to Follow-up|1|||
146190514|NCT00578227|527208081|FG002|Overall Study|Lost to Follow-up|1|||
146190515|NCT00578227|527208079|FG000|Overall Study|Withdrawal by Subject|5|||
146190516|NCT00578227|527208080|FG001|Overall Study|Withdrawal by Subject|1|||
146190517|NCT00578227|527208081|FG002|Overall Study|Withdrawal by Subject|3|||
146190518|NCT01511250|527208082|FG000|Overall Study|Withdrawal of Consent|1|||
146190519|NCT01511250|527208083|FG001|Overall Study|Withdrawal of Consent|0|||
146190520|NCT01511250|527208084|FG002|Overall Study|Withdrawal of Consent|0|||
146190521|NCT01511250|527208085|FG003|Overall Study|Withdrawal of Consent|0|||
146190522|NCT01511250|527208086|FG004|Overall Study|Withdrawal of Consent|0|||
146190523|NCT01511250|527208087|FG005|Overall Study|Withdrawal of Consent|0|||
146190524|NCT01511250|527208088|FG006|Overall Study|Withdrawal of Consent|0|||
146190525|NCT01511250|527208089|FG007|Overall Study|Withdrawal of Consent|1|||
146190526|NCT01511250|527208090|FG008|Overall Study|Withdrawal of Consent|1|||
146413063|NCT00410410|528018035|FG005|Maintenance Period (MP)|Death|0|||
146413064|NCT00410410|528018036|FG006|Maintenance Period (MP)|Death|1|||
146190527|NCT01511250|527208091|FG009|Overall Study|Withdrawal of Consent|0|||
146413065|NCT00410410|528018037|FG007|Maintenance Period (MP)|Death|0|||
146190528|NCT01511250|527208082|FG000|Overall Study|Sponsor/Investigator Decision|1|||
146190529|NCT01511250|527208083|FG001|Overall Study|Sponsor/Investigator Decision|0|||
146190530|NCT01511250|527208084|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146190531|NCT01511250|527208085|FG003|Overall Study|Sponsor/Investigator Decision|0|||
146190532|NCT01511250|527208086|FG004|Overall Study|Sponsor/Investigator Decision|0|||
146190533|NCT01511250|527208087|FG005|Overall Study|Sponsor/Investigator Decision|0|||
146190534|NCT01511250|527208088|FG006|Overall Study|Sponsor/Investigator Decision|0|||
146190535|NCT01511250|527208089|FG007|Overall Study|Sponsor/Investigator Decision|0|||
146190536|NCT01511250|527208090|FG008|Overall Study|Sponsor/Investigator Decision|0|||
146190537|NCT01511250|527208091|FG009|Overall Study|Sponsor/Investigator Decision|0|||
146190538|NCT01511250|527208082|FG000|Overall Study|Lost to Follow-up|7|||
146190539|NCT01511250|527208083|FG001|Overall Study|Lost to Follow-up|3|||
146190540|NCT01511250|527208084|FG002|Overall Study|Lost to Follow-up|3|||
146190541|NCT01511250|527208085|FG003|Overall Study|Lost to Follow-up|3|||
146190542|NCT01511250|527208086|FG004|Overall Study|Lost to Follow-up|0|||
146190543|NCT01511250|527208087|FG005|Overall Study|Lost to Follow-up|0|||
146190544|NCT01511250|527208088|FG006|Overall Study|Lost to Follow-up|2|||
146190545|NCT01511250|527208089|FG007|Overall Study|Lost to Follow-up|3|||
146190546|NCT01511250|527208090|FG008|Overall Study|Lost to Follow-up|13|||
146190547|NCT01511250|527208091|FG009|Overall Study|Lost to Follow-up|5|||
146190548|NCT01511250|527208082|FG000|Overall Study|Protocol Violation|0|||
146190549|NCT01511250|527208083|FG001|Overall Study|Protocol Violation|2|||
146190550|NCT01511250|527208084|FG002|Overall Study|Protocol Violation|1|||
146190551|NCT01511250|527208085|FG003|Overall Study|Protocol Violation|0|||
146190552|NCT01511250|527208086|FG004|Overall Study|Protocol Violation|0|||
146190553|NCT01511250|527208087|FG005|Overall Study|Protocol Violation|0|||
146190554|NCT01511250|527208088|FG006|Overall Study|Protocol Violation|0|||
146190555|NCT01511250|527208089|FG007|Overall Study|Protocol Violation|0|||
146190556|NCT01511250|527208090|FG008|Overall Study|Protocol Violation|0|||
146190557|NCT01511250|527208091|FG009|Overall Study|Protocol Violation|0|||
146190558|NCT00916006|527208099|FG000|Overall Study|Adverse Event|1|||
146190559|NCT00916006|527208100|FG001|Overall Study|Adverse Event|1|||
146190560|NCT00916006|527208099|FG000|Overall Study|Withdrawal by Subject|2|||
146190561|NCT00916006|527208100|FG001|Overall Study|Withdrawal by Subject|5|||
146190562|NCT00916006|527208099|FG000|Overall Study|Protocol Violation|0|||
146190563|NCT00916006|527208100|FG001|Overall Study|Protocol Violation|1|||
146190564|NCT02929108|527208105|FG000|Overall Study|Hospice patient death|100|||
146190565|NCT02929108|527208106|FG001|Overall Study|Hospice patient death|64|||
146190566|NCT02929108|527208107|FG002|Overall Study|Hospice patient death|28|||
146190567|NCT02929108|527208108|FG003|Overall Study|Hospice patient death|46|||
146190568|NCT02929108|527208109|FG004|Overall Study|Hospice patient death|55|||
146190569|NCT02929108|527208110|FG005|Overall Study|Hospice patient death|28|||
146190570|NCT02929108|527208111|FG006|Overall Study|Hospice patient death|78|||
146190571|NCT00052962|527208112|FG000|Overall Study|Not evaluable|0|||
146190572|NCT00052962|527208113|FG001|Overall Study|Not evaluable|2|||
146190573|NCT00052962|527208112|FG000|Overall Study|Not randomized/not evaluable|1|||
146190574|NCT00052962|527208113|FG001|Overall Study|Not randomized/not evaluable|0|||
146190575|NCT02084082|527208117|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
146190576|NCT02084082|527208118|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
146190577|NCT02084082|527208119|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
146190578|NCT02084082|527208120|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
146190579|NCT02084082|527208117|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146190580|NCT02084082|527208118|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146190581|NCT02084082|527208119|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146190582|NCT02084082|527208120|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
146413066|NCT00410410|528018038|FG008|Maintenance Period (MP)|Death|0|||
146413067|NCT00410410|528018030|FG000|Maintenance Period (MP)|Adverse Event|0|||
146413068|NCT00410410|528018031|FG001|Maintenance Period (MP)|Adverse Event|0|||
146413069|NCT00410410|528018032|FG002|Maintenance Period (MP)|Adverse Event|0|||
146413070|NCT00410410|528018033|FG003|Maintenance Period (MP)|Adverse Event|0|||
146413071|NCT00410410|528018034|FG004|Maintenance Period (MP)|Adverse Event|0|||
146413072|NCT00410410|528018035|FG005|Maintenance Period (MP)|Adverse Event|0|||
146413073|NCT00410410|528018036|FG006|Maintenance Period (MP)|Adverse Event|1|||
146190583|NCT04739423|527208141|FG000|Overall Study|Protocol Violation|0|||
146190584|NCT04739423|527208142|FG001|Overall Study|Protocol Violation|1|||
146190585|NCT04739423|527208143|FG002|Overall Study|Protocol Violation|0|||
146190586|NCT04739423|527208144|FG003|Overall Study|Protocol Violation|0|||
146190587|NCT04739423|527208145|FG004|Overall Study|Protocol Violation|0|||
146190588|NCT04739423|527208146|FG005|Overall Study|Protocol Violation|0|||
146190589|NCT04739423|527208141|FG000|Overall Study|Adverse Event|0|||
146190590|NCT04739423|527208142|FG001|Overall Study|Adverse Event|0|||
146190591|NCT04739423|527208143|FG002|Overall Study|Adverse Event|1|||
146190592|NCT04739423|527208144|FG003|Overall Study|Adverse Event|0|||
146190593|NCT04739423|527208145|FG004|Overall Study|Adverse Event|1|||
146190594|NCT04739423|527208146|FG005|Overall Study|Adverse Event|0|||
146190595|NCT04739423|527208141|FG000|Overall Study|Withdrawal by Subject|0|||
146190596|NCT04739423|527208142|FG001|Overall Study|Withdrawal by Subject|0|||
146190597|NCT04739423|527208143|FG002|Overall Study|Withdrawal by Subject|0|||
146190598|NCT04739423|527208144|FG003|Overall Study|Withdrawal by Subject|0|||
146190599|NCT04739423|527208145|FG004|Overall Study|Withdrawal by Subject|0|||
146190600|NCT04739423|527208146|FG005|Overall Study|Withdrawal by Subject|1|||
146413074|NCT00410410|528018037|FG007|Maintenance Period (MP)|Adverse Event|3|||
146413075|NCT00410410|528018038|FG008|Maintenance Period (MP)|Adverse Event|0|||
146413076|NCT00410410|528018030|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
146413077|NCT00410410|528018031|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
146413078|NCT00410410|528018032|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
146413079|NCT00410410|528018033|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
146413080|NCT00410410|528018034|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
146413081|NCT00410410|528018035|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
146413082|NCT00410410|528018036|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
146413083|NCT00410410|528018037|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
146413084|NCT00410410|528018038|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
146413085|NCT00410410|528018030|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
146413086|NCT00410410|528018031|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
146413087|NCT00410410|528018032|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
146413088|NCT00410410|528018033|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
146413089|NCT00410410|528018034|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
146413090|NCT00410410|528018035|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
146413091|NCT00410410|528018036|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
146413092|NCT00410410|528018037|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
146413093|NCT00410410|528018038|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
146413094|NCT00410410|528018030|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413095|NCT00410410|528018031|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413096|NCT00410410|528018032|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413097|NCT00410410|528018033|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413098|NCT00410410|528018034|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413099|NCT00410410|528018035|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413100|NCT00410410|528018036|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
146413101|NCT00410410|528018037|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
146413102|NCT00410410|528018038|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
146413103|NCT00410410|528018030|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413104|NCT00410410|528018031|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413105|NCT00410410|528018032|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413106|NCT00410410|528018033|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413107|NCT00410410|528018034|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413108|NCT00410410|528018035|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146413109|NCT00410410|528018036|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
146413110|NCT00410410|528018037|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
146413111|NCT00410410|528018038|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
146190601|NCT05174065|527208153|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146190602|NCT05174065|527208154|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
146190603|NCT05174065|527208155|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
146190604|NCT05174065|527208153|FG000|Placebo-controlled Period|Other|0|||
146190605|NCT05174065|527208154|FG001|Placebo-controlled Period|Other|1|||
146190606|NCT05174065|527208155|FG002|Placebo-controlled Period|Other|0|||
146190607|NCT05174065|527208153|FG000|Placebo-controlled Period|Adverse Event|1|||
146190608|NCT05174065|527208154|FG001|Placebo-controlled Period|Adverse Event|1|||
146190609|NCT05174065|527208155|FG002|Placebo-controlled Period|Adverse Event|0|||
146284455|NCT01688830|527553727|FG008|Overall Study|Lost to Follow-up|0|||
146284456|NCT01688830|527553728|FG009|Overall Study|Lost to Follow-up|0|||
146413112|NCT00410410|528018030|FG000|Open-Label Period (OL)|Death|0|||
146413113|NCT00410410|528018031|FG001|Open-Label Period (OL)|Death|0|||
146413114|NCT00410410|528018032|FG002|Open-Label Period (OL)|Death|0|||
146081890|NCT01185301|526820522|FG001|Overall Study|Other Reason|2|||
146081891|NCT01185301|526820523|FG002|Overall Study|Other Reason|2|||
146081892|NCT01185301|526820524|FG003|Overall Study|Other Reason|2|||
146081893|NCT02683746|526820525|FG000|Overall Study|Adverse Event|3|||
146081894|NCT02683746|526820526|FG001|Overall Study|Adverse Event|2|||
146081895|NCT02683746|526820525|FG000|Overall Study|Lost to Follow-up|5|||
146081896|NCT02683746|526820526|FG001|Overall Study|Lost to Follow-up|6|||
146081897|NCT02683746|526820525|FG000|Overall Study|Withdrawal by Subject|6|||
146081898|NCT02683746|526820526|FG001|Overall Study|Withdrawal by Subject|5|||
146081899|NCT02683746|526820525|FG000|Overall Study|Physician Decision|2|||
146081900|NCT02683746|526820526|FG001|Overall Study|Physician Decision|1|||
146081901|NCT02095132|526820532|FG000|Overall Study|Adverse Event|0|||
146081902|NCT02095132|526820533|FG001|Overall Study|Adverse Event|0|||
146081903|NCT02095132|526820534|FG002|Overall Study|Adverse Event|0|||
146081904|NCT02095132|526820535|FG003|Overall Study|Adverse Event|0|||
146081905|NCT02095132|526820536|FG004|Overall Study|Adverse Event|1|||
146190610|NCT05174065|527208153|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
146190611|NCT05174065|527208154|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
146190612|NCT05174065|527208155|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
146190613|NCT05174065|527208153|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
146190614|NCT05174065|527208154|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
146190615|NCT05174065|527208155|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
146190616|NCT05174065|527208153|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
146190617|NCT05174065|527208154|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
146190618|NCT05174065|527208155|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
146190619|NCT01641861|527208156|FG000|Overall Study|Lost to Follow-up|21|||
146190620|NCT01641861|527208157|FG001|Overall Study|Lost to Follow-up|16|||
146190621|NCT01641861|527208156|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
146190622|NCT01641861|527208157|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
146190623|NCT01641861|527208156|FG000|Overall Study|Died due to drowning|0|||
146190624|NCT01641861|527208157|FG001|Overall Study|Died due to drowning|1|||
146190625|NCT00814489|527208183|FG000|Overall Study|Other|2|||
146190626|NCT00814489|527208184|FG001|Overall Study|Other|0|||
146190627|NCT00814489|527208185|FG002|Overall Study|Other|1|||
146190628|NCT01515319|527208186|FG000|Overall Study|Withdrawal by Subject|0|||
146190629|NCT01515319|527208187|FG001|Overall Study|Withdrawal by Subject|0|||
146190630|NCT01515319|527208188|FG002|Overall Study|Withdrawal by Subject|0|||
146190631|NCT01515319|527208189|FG003|Overall Study|Withdrawal by Subject|0|||
146190632|NCT01515319|527208190|FG004|Overall Study|Withdrawal by Subject|0|||
146190633|NCT01515319|527208191|FG005|Overall Study|Withdrawal by Subject|0|||
146190634|NCT01515319|527208192|FG006|Overall Study|Withdrawal by Subject|1|||
146190635|NCT01515319|527208193|FG007|Overall Study|Withdrawal by Subject|0|||
146190636|NCT01515319|527208194|FG008|Overall Study|Withdrawal by Subject|0|||
146190637|NCT01515319|527208195|FG009|Overall Study|Withdrawal by Subject|0|||
146190638|NCT01515319|527208186|FG000|Overall Study|Adverse Event|0|||
146190639|NCT01515319|527208187|FG001|Overall Study|Adverse Event|0|||
146190640|NCT01515319|527208188|FG002|Overall Study|Adverse Event|0|||
146190641|NCT01515319|527208189|FG003|Overall Study|Adverse Event|0|||
146190642|NCT01515319|527208190|FG004|Overall Study|Adverse Event|0|||
146190643|NCT01515319|527208191|FG005|Overall Study|Adverse Event|0|||
146190644|NCT01515319|527208192|FG006|Overall Study|Adverse Event|0|||
146190645|NCT01515319|527208193|FG007|Overall Study|Adverse Event|0|||
146190646|NCT01515319|527208194|FG008|Overall Study|Adverse Event|3|||
146190647|NCT01515319|527208195|FG009|Overall Study|Adverse Event|0|||
146190648|NCT01515319|527208186|FG000|Overall Study|Protocol Violation|0|||
146190649|NCT01515319|527208187|FG001|Overall Study|Protocol Violation|0|||
146190650|NCT01515319|527208188|FG002|Overall Study|Protocol Violation|0|||
146190651|NCT01515319|527208189|FG003|Overall Study|Protocol Violation|0|||
146190652|NCT01515319|527208190|FG004|Overall Study|Protocol Violation|0|||
146190653|NCT01515319|527208191|FG005|Overall Study|Protocol Violation|0|||
146190654|NCT01515319|527208192|FG006|Overall Study|Protocol Violation|0|||
146190655|NCT01515319|527208193|FG007|Overall Study|Protocol Violation|0|||
146190656|NCT01515319|527208194|FG008|Overall Study|Protocol Violation|2|||
146190657|NCT01515319|527208195|FG009|Overall Study|Protocol Violation|0|||
146190658|NCT04091672|527210312|FG000|Overall Study|Death|6|||
146190659|NCT04091672|527210313|FG001|Overall Study|Death|6|||
146190660|NCT04091672|527210312|FG000|Overall Study|Lost to Follow-up|7|||
146190661|NCT04091672|527210313|FG001|Overall Study|Lost to Follow-up|7|||
146190662|NCT04091672|527210312|FG000|Overall Study|Withdrawal by Subject|3|||
146190663|NCT04091672|527210313|FG001|Overall Study|Withdrawal by Subject|3|||
146190664|NCT04091672|527210312|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
146190665|NCT04091672|527210313|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
146190666|NCT05296629|527210314|FG000|Overall Study|Withdrawal by Subject|3|||
146190667|NCT05296629|527210315|FG001|Overall Study|Withdrawal by Subject|10|||
146190668|NCT05296629|527210316|FG002|Overall Study|Withdrawal by Subject|4|||
146190669|NCT05296629|527210314|FG000|Overall Study|Lost to Follow-up|2|||
146190670|NCT05296629|527210315|FG001|Overall Study|Lost to Follow-up|7|||
146190671|NCT05296629|527210316|FG002|Overall Study|Lost to Follow-up|1|||
146190672|NCT05296629|527210314|FG000|Overall Study|Adverse Event|0|||
146190673|NCT05296629|527210315|FG001|Overall Study|Adverse Event|4|||
146190674|NCT05296629|527210316|FG002|Overall Study|Adverse Event|2|||
146190675|NCT05296629|527210314|FG000|Overall Study|Protocol Violation|0|||
146190676|NCT05296629|527210315|FG001|Overall Study|Protocol Violation|2|||
146190677|NCT05296629|527210316|FG002|Overall Study|Protocol Violation|0|||
146190678|NCT02268396|527210317|FG000|Overall Study|Adverse Event|3|||
146190679|NCT02268396|527210317|FG000|Overall Study|Administrative|2|||
146190680|NCT02268396|527210317|FG000|Overall Study|Withdrawal by Subject|1|||
146190681|NCT02268396|527210317|FG000|Overall Study|Lost to Follow-up|2|||
146190682|NCT02268396|527210317|FG000|Overall Study|Protocol-Specified Criteria|2|||
146190683|NCT02268396|527210317|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
146190684|NCT01304706|527210318|FG000|Overall Study|Adverse Event|2|||
146190685|NCT01304706|527210318|FG000|Overall Study|Lack of Efficacy|1|||
146190686|NCT01304706|527210318|FG000|Overall Study|Death|3|||
146413115|NCT00410410|528018033|FG003|Open-Label Period (OL)|Death|0|||
146413116|NCT00410410|528018034|FG004|Open-Label Period (OL)|Death|0|||
146413117|NCT00410410|528018035|FG005|Open-Label Period (OL)|Death|0|||
146413118|NCT00410410|528018036|FG006|Open-Label Period (OL)|Death|0|||
146413119|NCT00410410|528018037|FG007|Open-Label Period (OL)|Death|0|||
146413120|NCT00410410|528018038|FG008|Open-Label Period (OL)|Death|1|||
146413121|NCT00410410|528018030|FG000|Open-Label Period (OL)|Adverse Event|0|||
146413122|NCT00410410|528018031|FG001|Open-Label Period (OL)|Adverse Event|0|||
146413123|NCT00410410|528018032|FG002|Open-Label Period (OL)|Adverse Event|0|||
146413124|NCT00410410|528018033|FG003|Open-Label Period (OL)|Adverse Event|0|||
146413125|NCT00410410|528018034|FG004|Open-Label Period (OL)|Adverse Event|0|||
146413126|NCT00410410|528018035|FG005|Open-Label Period (OL)|Adverse Event|0|||
146413127|NCT00410410|528018036|FG006|Open-Label Period (OL)|Adverse Event|0|||
146413128|NCT00410410|528018037|FG007|Open-Label Period (OL)|Adverse Event|0|||
146413129|NCT00410410|528018038|FG008|Open-Label Period (OL)|Adverse Event|10|||
146413130|NCT00410410|528018030|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
146413131|NCT00410410|528018031|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
146413132|NCT00410410|528018032|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
146413133|NCT00410410|528018033|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
146413134|NCT00410410|528018034|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
146413135|NCT00410410|528018035|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
146413136|NCT00410410|528018036|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
146413137|NCT00410410|528018037|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
146413138|NCT00410410|528018038|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
146413139|NCT00410410|528018030|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
146413140|NCT00410410|528018031|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
146413141|NCT00410410|528018032|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
146413142|NCT00410410|528018033|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
146413143|NCT00410410|528018034|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
146413144|NCT00410410|528018035|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
146413145|NCT00410410|528018036|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
146413146|NCT00410410|528018037|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
146413147|NCT00410410|528018038|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
146413148|NCT00410410|528018030|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413149|NCT00410410|528018031|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413150|NCT00410410|528018032|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413151|NCT00410410|528018033|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413152|NCT00410410|528018034|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413153|NCT00410410|528018035|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413154|NCT00410410|528018036|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413155|NCT00410410|528018037|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
146413156|NCT00410410|528018038|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
146081906|NCT02095132|526820537|FG005|Overall Study|Adverse Event|0|||
146081907|NCT02095132|526820538|FG006|Overall Study|Adverse Event|1|||
146413157|NCT00410410|528018030|FG000|Open-Label Period (OL)|Pregnancy|0|||
146081908|NCT02095132|526820539|FG007|Overall Study|Adverse Event|0|||
146081909|NCT02095132|526820540|FG008|Overall Study|Adverse Event|0|||
146081910|NCT02095132|526820532|FG000|Overall Study|Death|0|||
146081911|NCT02095132|526820533|FG001|Overall Study|Death|0|||
146081912|NCT02095132|526820534|FG002|Overall Study|Death|0|||
146081913|NCT02095132|526820535|FG003|Overall Study|Death|0|||
146081914|NCT02095132|526820536|FG004|Overall Study|Death|0|||
146081915|NCT02095132|526820537|FG005|Overall Study|Death|0|||
146081916|NCT02095132|526820538|FG006|Overall Study|Death|1|||
146081917|NCT02095132|526820539|FG007|Overall Study|Death|0|||
146081918|NCT02095132|526820540|FG008|Overall Study|Death|0|||
146081919|NCT02095132|526820532|FG000|Overall Study|Lack of Efficacy|3|||
146081920|NCT02095132|526820533|FG001|Overall Study|Lack of Efficacy|5|||
146081921|NCT02095132|526820534|FG002|Overall Study|Lack of Efficacy|2|||
146190687|NCT01304706|527210318|FG000|Overall Study|Withdrawal by Subject|3|||
146190688|NCT01304706|527210318|FG000|Overall Study|Lost to Follow-up|7|||
146190689|NCT01304706|527210318|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
146190690|NCT04978363|527210324|FG000|Overall Study|Other medical issues unrelated to the study|0|||
146190691|NCT04978363|527210325|FG001|Overall Study|Other medical issues unrelated to the study|0|||
146190692|NCT04978363|527210326|FG002|Overall Study|Other medical issues unrelated to the study|0|||
146190693|NCT04978363|527210327|FG003|Overall Study|Other medical issues unrelated to the study|0|||
146190694|NCT04978363|527210328|FG004|Overall Study|Other medical issues unrelated to the study|1|||
146190695|NCT04978363|527210329|FG005|Overall Study|Other medical issues unrelated to the study|0|||
146190696|NCT04978363|527210330|FG006|Overall Study|Other medical issues unrelated to the study|0|||
146190697|NCT04978363|527210331|FG007|Overall Study|Other medical issues unrelated to the study|0|||
146190698|NCT04978363|527210332|FG008|Overall Study|Other medical issues unrelated to the study|0|||
146190699|NCT04978363|527210333|FG009|Overall Study|Other medical issues unrelated to the study|0|||
146190700|NCT04978363|527210334|FG010|Overall Study|Other medical issues unrelated to the study|0|||
146190701|NCT04978363|527210324|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
146190702|NCT04978363|527210325|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
146190703|NCT04978363|527210326|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
146190704|NCT04978363|527210327|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
146190705|NCT04978363|527210328|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
146190706|NCT04978363|527210329|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
146190707|NCT04978363|527210330|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
146190708|NCT04978363|527210331|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
146190709|NCT04978363|527210332|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
146190710|NCT04978363|527210333|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
146190711|NCT04978363|527210334|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
146190712|NCT04978363|527210324|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190713|NCT04978363|527210325|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
146190714|NCT04978363|527210326|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190715|NCT04978363|527210327|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190716|NCT04978363|527210328|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190717|NCT04978363|527210329|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190718|NCT04978363|527210330|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190719|NCT04978363|527210331|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190720|NCT04978363|527210332|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190721|NCT04978363|527210333|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190722|NCT04978363|527210334|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
146190723|NCT01251614|527210335|FG000|Overall Study|Adverse Event|1|||
146190724|NCT01251614|527210336|FG001|Overall Study|Adverse Event|0|||
146190725|NCT01251614|527210337|FG002|Overall Study|Adverse Event|1|||
146190726|NCT01251614|527210335|FG000|Overall Study|Lack of Efficacy|1|||
146190727|NCT01251614|527210336|FG001|Overall Study|Lack of Efficacy|9|||
146190728|NCT01251614|527210337|FG002|Overall Study|Lack of Efficacy|4|||
146190729|NCT01251614|527210335|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
146190730|NCT01251614|527210336|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
146190731|NCT01251614|527210337|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
146190732|NCT01251614|527210335|FG000|Overall Study|Pregnancy|0|||
146190733|NCT01251614|527210336|FG001|Overall Study|Pregnancy|0|||
146190734|NCT01251614|527210337|FG002|Overall Study|Pregnancy|2|||
146413158|NCT00410410|528018031|FG001|Open-Label Period (OL)|Pregnancy|0|||
146413159|NCT00410410|528018032|FG002|Open-Label Period (OL)|Pregnancy|0|||
146413160|NCT00410410|528018033|FG003|Open-Label Period (OL)|Pregnancy|0|||
146413161|NCT00410410|528018034|FG004|Open-Label Period (OL)|Pregnancy|0|||
146413162|NCT00410410|528018035|FG005|Open-Label Period (OL)|Pregnancy|0|||
146413163|NCT00410410|528018036|FG006|Open-Label Period (OL)|Pregnancy|0|||
146413164|NCT00410410|528018037|FG007|Open-Label Period (OL)|Pregnancy|0|||
146413165|NCT00410410|528018038|FG008|Open-Label Period (OL)|Pregnancy|1|||
146413166|NCT00410410|528018030|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413167|NCT00410410|528018031|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413168|NCT00410410|528018032|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413169|NCT00410410|528018033|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413170|NCT00410410|528018034|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146190735|NCT01251614|527210335|FG000|Overall Study|Loss of Disease Control|0|||
146190736|NCT01251614|527210336|FG001|Overall Study|Loss of Disease Control|1|||
146190737|NCT01251614|527210337|FG002|Overall Study|Loss of Disease Control|0|||
146413171|NCT00410410|528018035|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413172|NCT00410410|528018036|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413173|NCT00410410|528018037|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
146413174|NCT00410410|528018038|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
146413175|NCT00410410|528018030|FG000|Open-Label Period (OL)|Other|0|||
146413176|NCT00410410|528018031|FG001|Open-Label Period (OL)|Other|0|||
146413177|NCT00410410|528018032|FG002|Open-Label Period (OL)|Other|0|||
146413178|NCT00410410|528018033|FG003|Open-Label Period (OL)|Other|0|||
146413179|NCT00410410|528018034|FG004|Open-Label Period (OL)|Other|0|||
146413180|NCT00410410|528018035|FG005|Open-Label Period (OL)|Other|0|||
146413181|NCT00410410|528018036|FG006|Open-Label Period (OL)|Other|0|||
146413182|NCT00410410|528018037|FG007|Open-Label Period (OL)|Other|0|||
146413183|NCT00410410|528018038|FG008|Open-Label Period (OL)|Other|7|||
146413184|NCT01783496|528018039|FG000|Overall Study|Lost to Follow-up|0|||
146413185|NCT01783496|528018040|FG001|Overall Study|Lost to Follow-up|0|||
146413186|NCT01783496|528018041|FG002|Overall Study|Lost to Follow-up|0|||
146413187|NCT01783496|528018042|FG003|Overall Study|Lost to Follow-up|2|||
146413188|NCT01783496|528018043|FG004|Overall Study|Lost to Follow-up|0|||
146413189|NCT01783496|528018044|FG005|Overall Study|Lost to Follow-up|1|||
146413190|NCT01783496|528018039|FG000|Overall Study|Withdrawal by Subject|1|||
146413191|NCT01783496|528018040|FG001|Overall Study|Withdrawal by Subject|0|||
146413192|NCT01783496|528018041|FG002|Overall Study|Withdrawal by Subject|0|||
146413193|NCT01783496|528018042|FG003|Overall Study|Withdrawal by Subject|0|||
146413194|NCT01783496|528018043|FG004|Overall Study|Withdrawal by Subject|0|||
146413195|NCT01783496|528018044|FG005|Overall Study|Withdrawal by Subject|0|||
146413196|NCT01023269|528018045|FG000|Overall Study|early termination of the study|2|||
146413197|NCT01023269|528018046|FG001|Overall Study|early termination of the study|0|||
146413198|NCT01953783|528018047|FG000|Overall Study|Progressive disease|2|||
146413199|NCT01789281|528018048|FG000|Overall Study|Disease progression|15|||
146413200|NCT01789281|528018049|FG001|Overall Study|Disease progression|4|||
146413201|NCT01789281|528018048|FG000|Overall Study|Adverse Event|5|||
146413202|NCT01789281|528018049|FG001|Overall Study|Adverse Event|5|||
146413203|NCT01789281|528018048|FG000|Overall Study|Withdrawal by Subject|1|||
146413204|NCT01789281|528018049|FG001|Overall Study|Withdrawal by Subject|0|||
146190738|NCT01251614|527210335|FG000|Overall Study|Withdrawal by Subject|0|||
146190739|NCT01251614|527210336|FG001|Overall Study|Withdrawal by Subject|2|||
146190740|NCT01251614|527210337|FG002|Overall Study|Withdrawal by Subject|1|||
146190741|NCT01251614|527210335|FG000|Overall Study|Lost to Follow-up|0|||
146190742|NCT01251614|527210336|FG001|Overall Study|Lost to Follow-up|1|||
146190743|NCT01251614|527210337|FG002|Overall Study|Lost to Follow-up|0|||
146190744|NCT00049517|527210338|FG000|Induction|Disease progression|0|||
146190745|NCT00049517|527210339|FG001|Induction|Disease progression|0|||
146190746|NCT00049517|527210340|FG002|Induction|Disease progression|0|||
146190747|NCT00049517|527210341|FG003|Induction|Disease progression|0|||
146190748|NCT00049517|527210342|FG004|Induction|Disease progression|18|||
146190749|NCT00049517|527210343|FG005|Induction|Disease progression|11|||
146190750|NCT00049517|527210338|FG000|Induction|Adverse Event|0|||
146190751|NCT00049517|527210339|FG001|Induction|Adverse Event|0|||
146190752|NCT00049517|527210340|FG002|Induction|Adverse Event|0|||
146190753|NCT00049517|527210341|FG003|Induction|Adverse Event|0|||
146190754|NCT00049517|527210342|FG004|Induction|Adverse Event|5|||
146190755|NCT00049517|527210343|FG005|Induction|Adverse Event|7|||
146190756|NCT00049517|527210338|FG000|Induction|Death|0|||
146190757|NCT00049517|527210339|FG001|Induction|Death|0|||
146190758|NCT00049517|527210340|FG002|Induction|Death|0|||
146190759|NCT00049517|527210341|FG003|Induction|Death|0|||
146190760|NCT00049517|527210342|FG004|Induction|Death|9|||
146190761|NCT00049517|527210343|FG005|Induction|Death|6|||
146190762|NCT00049517|527210338|FG000|Induction|Withdrawal by Subject|0|||
146190763|NCT00049517|527210339|FG001|Induction|Withdrawal by Subject|0|||
146190764|NCT00049517|527210340|FG002|Induction|Withdrawal by Subject|0|||
146190765|NCT00049517|527210341|FG003|Induction|Withdrawal by Subject|0|||
146190766|NCT00049517|527210342|FG004|Induction|Withdrawal by Subject|1|||
146190767|NCT00049517|527210343|FG005|Induction|Withdrawal by Subject|3|||
146190768|NCT00049517|527210338|FG000|Induction|Alternative therapy|0|||
146190769|NCT00049517|527210339|FG001|Induction|Alternative therapy|0|||
146190770|NCT00049517|527210340|FG002|Induction|Alternative therapy|0|||
146190771|NCT00049517|527210341|FG003|Induction|Alternative therapy|0|||
146190772|NCT00049517|527210342|FG004|Induction|Alternative therapy|2|||
146190773|NCT00049517|527210343|FG005|Induction|Alternative therapy|2|||
146190774|NCT00049517|527210338|FG000|Induction|Other complicating disease|0|||
146190775|NCT00049517|527210339|FG001|Induction|Other complicating disease|0|||
146190776|NCT00049517|527210340|FG002|Induction|Other complicating disease|0|||
146190777|NCT00049517|527210341|FG003|Induction|Other complicating disease|0|||
146190778|NCT00049517|527210342|FG004|Induction|Other complicating disease|3|||
146190779|NCT00049517|527210343|FG005|Induction|Other complicating disease|0|||
146190780|NCT00049517|527210338|FG000|Induction|Reasons not reported|0|||
146190781|NCT00049517|527210339|FG001|Induction|Reasons not reported|0|||
146190782|NCT00049517|527210340|FG002|Induction|Reasons not reported|0|||
146190783|NCT00049517|527210341|FG003|Induction|Reasons not reported|0|||
146190784|NCT00049517|527210342|FG004|Induction|Reasons not reported|22|||
146190785|NCT00049517|527210343|FG005|Induction|Reasons not reported|25|||
146190786|NCT00049517|527210338|FG000|Conditioning/Transplant|Disease progression|14|||
146190787|NCT00049517|527210339|FG001|Conditioning/Transplant|Disease progression|6|||
146190788|NCT00049517|527210340|FG002|Conditioning/Transplant|Disease progression|10|||
146190789|NCT00049517|527210341|FG003|Conditioning/Transplant|Disease progression|6|||
146190790|NCT00049517|527210342|FG004|Conditioning/Transplant|Disease progression|0|||
146190791|NCT00049517|527210343|FG005|Conditioning/Transplant|Disease progression|0|||
146190792|NCT00049517|527210338|FG000|Conditioning/Transplant|Adverse Event|2|||
146190793|NCT00049517|527210339|FG001|Conditioning/Transplant|Adverse Event|1|||
146190794|NCT00049517|527210340|FG002|Conditioning/Transplant|Adverse Event|4|||
146190795|NCT00049517|527210341|FG003|Conditioning/Transplant|Adverse Event|8|||
146190796|NCT00049517|527210342|FG004|Conditioning/Transplant|Adverse Event|0|||
146190797|NCT00049517|527210343|FG005|Conditioning/Transplant|Adverse Event|0|||
146190798|NCT00049517|527210338|FG000|Conditioning/Transplant|Death|1|||
146190799|NCT00049517|527210339|FG001|Conditioning/Transplant|Death|0|||
146190800|NCT00049517|527210340|FG002|Conditioning/Transplant|Death|0|||
146190801|NCT00049517|527210341|FG003|Conditioning/Transplant|Death|2|||
146190802|NCT00049517|527210342|FG004|Conditioning/Transplant|Death|0|||
146190803|NCT00049517|527210343|FG005|Conditioning/Transplant|Death|0|||
146190804|NCT00049517|527210338|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
146190805|NCT00049517|527210339|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
146190806|NCT00049517|527210340|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
146190807|NCT00049517|527210341|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
146190808|NCT00049517|527210342|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
146190809|NCT00049517|527210343|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
146190810|NCT00049517|527210338|FG000|Conditioning/Transplant|Alternative therapy|4|||
146190811|NCT00049517|527210339|FG001|Conditioning/Transplant|Alternative therapy|4|||
146190812|NCT00049517|527210340|FG002|Conditioning/Transplant|Alternative therapy|2|||
146190813|NCT00049517|527210341|FG003|Conditioning/Transplant|Alternative therapy|1|||
146190814|NCT00049517|527210342|FG004|Conditioning/Transplant|Alternative therapy|1|||
146190815|NCT00049517|527210343|FG005|Conditioning/Transplant|Alternative therapy|0|||
146235003|NCT01499849|527378439|FG000|Overall Study|Lost to Follow-up|6|||
146081922|NCT02095132|526820535|FG003|Overall Study|Lack of Efficacy|8|||
146081923|NCT02095132|526820536|FG004|Overall Study|Lack of Efficacy|3|||
146081924|NCT02095132|526820537|FG005|Overall Study|Lack of Efficacy|6|||
146081925|NCT02095132|526820538|FG006|Overall Study|Lack of Efficacy|10|||
146081926|NCT02095132|526820539|FG007|Overall Study|Lack of Efficacy|9|||
146081927|NCT02095132|526820540|FG008|Overall Study|Lack of Efficacy|8|||
146081928|NCT02095132|526820532|FG000|Overall Study|Physician Decision|1|||
146081929|NCT02095132|526820533|FG001|Overall Study|Physician Decision|0|||
146081930|NCT02095132|526820534|FG002|Overall Study|Physician Decision|0|||
146081931|NCT02095132|526820535|FG003|Overall Study|Physician Decision|0|||
146081932|NCT02095132|526820536|FG004|Overall Study|Physician Decision|0|||
146081933|NCT02095132|526820537|FG005|Overall Study|Physician Decision|0|||
146081934|NCT02095132|526820538|FG006|Overall Study|Physician Decision|1|||
146081935|NCT02095132|526820539|FG007|Overall Study|Physician Decision|0|||
146081936|NCT02095132|526820540|FG008|Overall Study|Physician Decision|2|||
146081937|NCT02095132|526820532|FG000|Overall Study|Withdrawal by Subject|0|||
146081938|NCT02095132|526820533|FG001|Overall Study|Withdrawal by Subject|0|||
146081939|NCT02095132|526820534|FG002|Overall Study|Withdrawal by Subject|2|||
146081940|NCT02095132|526820535|FG003|Overall Study|Withdrawal by Subject|2|||
146081941|NCT02095132|526820536|FG004|Overall Study|Withdrawal by Subject|3|||
146081942|NCT02095132|526820537|FG005|Overall Study|Withdrawal by Subject|0|||
146081943|NCT02095132|526820538|FG006|Overall Study|Withdrawal by Subject|5|||
146081944|NCT02095132|526820539|FG007|Overall Study|Withdrawal by Subject|0|||
146081945|NCT02095132|526820540|FG008|Overall Study|Withdrawal by Subject|0|||
146081946|NCT04905498|526820541|FG000|Overall Study|Lost to Follow-up|0|||
146081947|NCT04905498|526820542|FG001|Overall Study|Lost to Follow-up|2|||
146081948|NCT04905498|526820541|FG000|Overall Study|COVID lockdown|1|||
146081949|NCT04905498|526820542|FG001|Overall Study|COVID lockdown|0|||
146081950|NCT00409175|526820543|FG000|Overall Study|Adverse Event|4|||
146081951|NCT00409175|526820544|FG001|Overall Study|Adverse Event|3|||
146081952|NCT00409175|526820543|FG000|Overall Study|Withdrawal by Subject|1|||
146081953|NCT00409175|526820544|FG001|Overall Study|Withdrawal by Subject|2|||
146081954|NCT00409175|526820543|FG000|Overall Study|Negative genotype|0|||
146081955|NCT00409175|526820544|FG001|Overall Study|Negative genotype|1|||
146081956|NCT00409175|526820543|FG000|Overall Study|Liver transplantation|13|||
146081957|NCT00409175|526820544|FG001|Overall Study|Liver transplantation|13|||
146081958|NCT02108262|526820547|FG000|Overall Study|Non-compliance|0|||
146081959|NCT02108262|526820548|FG001|Overall Study|Non-compliance|2|||
146081960|NCT02108262|526820549|FG002|Overall Study|Non-compliance|1|||
146081961|NCT02108262|526820550|FG003|Overall Study|Non-compliance|1|||
146081962|NCT02108262|526820547|FG000|Overall Study|Randomized by error/screen failure|0|||
146081963|NCT02108262|526820548|FG001|Overall Study|Randomized by error/screen failure|0|||
146081964|NCT02108262|526820549|FG002|Overall Study|Randomized by error/screen failure|1|||
146081965|NCT02108262|526820550|FG003|Overall Study|Randomized by error/screen failure|0|||
146081966|NCT02108262|526820547|FG000|Overall Study|Distance to center|0|||
146081967|NCT02108262|526820548|FG001|Overall Study|Distance to center|1|||
146081968|NCT02108262|526820549|FG002|Overall Study|Distance to center|1|||
146081969|NCT02108262|526820550|FG003|Overall Study|Distance to center|0|||
146081970|NCT02108262|526820547|FG000|Overall Study|Adverse Event|0|||
146081971|NCT02108262|526820548|FG001|Overall Study|Adverse Event|11|||
146081972|NCT02108262|526820549|FG002|Overall Study|Adverse Event|6|||
146081973|NCT02108262|526820550|FG003|Overall Study|Adverse Event|12|||
146081974|NCT02108262|526820547|FG000|Overall Study|Death|0|||
146081975|NCT02108262|526820548|FG001|Overall Study|Death|2|||
146081976|NCT02108262|526820549|FG002|Overall Study|Death|2|||
146081977|NCT02108262|526820550|FG003|Overall Study|Death|1|||
146081978|NCT02108262|526820547|FG000|Overall Study|Lost to Follow-up|0|||
146081979|NCT02108262|526820548|FG001|Overall Study|Lost to Follow-up|0|||
146081980|NCT02108262|526820549|FG002|Overall Study|Lost to Follow-up|1|||
146190816|NCT00049517|527210338|FG000|Conditioning/Transplant|Other complicating disease|2|||
146190817|NCT00049517|527210339|FG001|Conditioning/Transplant|Other complicating disease|0|||
146190818|NCT00049517|527210340|FG002|Conditioning/Transplant|Other complicating disease|0|||
146190819|NCT00049517|527210341|FG003|Conditioning/Transplant|Other complicating disease|4|||
146190820|NCT00049517|527210342|FG004|Conditioning/Transplant|Other complicating disease|0|||
146190821|NCT00049517|527210343|FG005|Conditioning/Transplant|Other complicating disease|1|||
146190822|NCT00049517|527210338|FG000|Conditioning/Transplant|Reasons not reported|25|||
146190823|NCT00049517|527210339|FG001|Conditioning/Transplant|Reasons not reported|31|||
146190824|NCT00049517|527210340|FG002|Conditioning/Transplant|Reasons not reported|18|||
146190825|NCT00049517|527210341|FG003|Conditioning/Transplant|Reasons not reported|15|||
146190826|NCT00049517|527210342|FG004|Conditioning/Transplant|Reasons not reported|5|||
146190827|NCT00049517|527210343|FG005|Conditioning/Transplant|Reasons not reported|5|||
146190828|NCT00940017|527210344|FG000|Overall Study|did not meet entrance criteria|3|||
146190829|NCT00940017|527210344|FG000|Overall Study|Adverse Event|1|||
146190830|NCT01684046|527210345|FG000|Period 1, First 30 Days|Adverse Event|0|||
146190831|NCT01684046|527210346|FG001|Period 1, First 30 Days|Adverse Event|2|||
146190832|NCT00498186|527210351|FG000|Overall Study|Protocol Violation|10|||
146190833|NCT00498186|527210351|FG000|Overall Study|Lack of Efficacy|31|||
146190834|NCT00498186|527210351|FG000|Overall Study|Adverse Event|89|||
146190835|NCT00498186|527210351|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
146190836|NCT00498186|527210351|FG000|Overall Study|Withdrawal by Subject|18|||
146190837|NCT00498186|527210351|FG000|Overall Study|Lost to Follow-up|3|||
146190838|NCT00498186|527210351|FG000|Overall Study|Other|10|||
146190839|NCT03929302|527210352|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
146190840|NCT03929302|527210353|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
146190841|NCT03929302|527210354|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
146190842|NCT03929302|527210352|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
146190843|NCT03929302|527210353|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
146190844|NCT03929302|527210354|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
146190845|NCT03929302|527210352|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
146190846|NCT03929302|527210353|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
146190847|NCT03929302|527210354|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
146190848|NCT02321540|527210355|FG000|Overall Study|Death|0|||
146190849|NCT02321540|527210356|FG001|Overall Study|Death|1|||
146413205|NCT01789281|528018048|FG000|Overall Study|Lost to Follow-up|1|||
146190850|NCT02321540|527210355|FG000|Overall Study|Progression|3|||
146190851|NCT02321540|527210356|FG001|Overall Study|Progression|9|||
146190852|NCT00372567|527210357|FG000|Phase 3 Study|Adverse Event|5|||
146190853|NCT00372567|527210358|FG001|Phase 3 Study|Adverse Event|1|||
146190854|NCT00372567|527210359|FG002|Phase 3 Study|Adverse Event|1|||
146413206|NCT01789281|528018049|FG001|Overall Study|Lost to Follow-up|0|||
146413207|NCT01789281|528018048|FG000|Overall Study|Administrative problems|0|||
146413208|NCT01789281|528018049|FG001|Overall Study|Administrative problems|1|||
146413209|NCT00686920|528018050|FG000|Overall Study|Death|45|||
146413210|NCT00686920|528018051|FG001|Overall Study|Death|14|||
146413211|NCT00686920|528018050|FG000|Overall Study|Liver Transplant|23|||
146413212|NCT00686920|528018051|FG001|Overall Study|Liver Transplant|8|||
146413213|NCT00686920|528018050|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
146413214|NCT00686920|528018051|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
146413215|NCT00686920|528018050|FG000|Overall Study|Withdrawal by Subject|23|||
146413216|NCT00686920|528018051|FG001|Overall Study|Withdrawal by Subject|5|||
146413217|NCT00686920|528018050|FG000|Overall Study|Protocol Violation|2|||
146413218|NCT00686920|528018051|FG001|Overall Study|Protocol Violation|1|||
146413219|NCT00686920|528018050|FG000|Overall Study|Adverse Event|10|||
146413220|NCT00686920|528018051|FG001|Overall Study|Adverse Event|2|||
146413221|NCT00686920|528018050|FG000|Overall Study|Personal Reason|0|||
146413222|NCT00686920|528018051|FG001|Overall Study|Personal Reason|1|||
146413223|NCT00686920|528018050|FG000|Overall Study|Lost to Follow-up|15|||
146413224|NCT00686920|528018051|FG001|Overall Study|Lost to Follow-up|3|||
146413225|NCT00686920|528018050|FG000|Overall Study|Moved to Another State|1|||
146190855|NCT00372567|527210357|FG000|Phase 3 Study|Death|1|||
146413226|NCT00686920|528018051|FG001|Overall Study|Moved to Another State|0|||
146190856|NCT00372567|527210358|FG001|Phase 3 Study|Death|1|||
146190857|NCT00372567|527210359|FG002|Phase 3 Study|Death|0|||
146190858|NCT00372567|527210357|FG000|Phase 3 Study|Protocol Violation|0|||
146190859|NCT00372567|527210358|FG001|Phase 3 Study|Protocol Violation|0|||
146190860|NCT00372567|527210359|FG002|Phase 3 Study|Protocol Violation|1|||
146190861|NCT00372567|527210357|FG000|Phase 3 Study|Objective progression or relapse|10|||
146190862|NCT00372567|527210358|FG001|Phase 3 Study|Objective progression or relapse|13|||
146190863|NCT00372567|527210359|FG002|Phase 3 Study|Objective progression or relapse|4|||
146190864|NCT00372567|527210357|FG000|Phase 3 Study|Global deterioration of health status|0|||
146190865|NCT00372567|527210358|FG001|Phase 3 Study|Global deterioration of health status|1|||
146190866|NCT00372567|527210359|FG002|Phase 3 Study|Global deterioration of health status|0|||
146190867|NCT00372567|527210357|FG000|Phase 3 Study|Other|2|||
146190868|NCT00372567|527210358|FG001|Phase 3 Study|Other|2|||
146190869|NCT00372567|527210359|FG002|Phase 3 Study|Other|1|||
146190870|NCT00372567|527210357|FG000|Phase 3 Study|study terminated by sponsor|13|||
146190871|NCT00372567|527210358|FG001|Phase 3 Study|study terminated by sponsor|8|||
146190872|NCT00372567|527210359|FG002|Phase 3 Study|study terminated by sponsor|5|||
146190873|NCT02347943|527210360|FG000|Overall Study|Study was cancelled|140|||
146190874|NCT02347943|527210361|FG001|Overall Study|Study was cancelled|67|||
146190875|NCT02347943|527210362|FG002|Overall Study|Study was cancelled|45|||
146190876|NCT00691028|527210363|FG000|Open-label Period|Adverse Event|0|||
146190877|NCT00691028|527210364|FG001|Open-label Period|Adverse Event|0|||
146190878|NCT00691028|527210365|FG002|Open-label Period|Adverse Event|0|||
146190879|NCT00691028|527210366|FG003|Open-label Period|Adverse Event|16|||
146190880|NCT00691028|527210363|FG000|Open-label Period|Withdrawal by Subject|0|||
146190881|NCT00691028|527210364|FG001|Open-label Period|Withdrawal by Subject|0|||
146190882|NCT00691028|527210365|FG002|Open-label Period|Withdrawal by Subject|0|||
146190883|NCT00691028|527210366|FG003|Open-label Period|Withdrawal by Subject|3|||
146190884|NCT00691028|527210363|FG000|Open-label Period|not come to a hospital|0|||
146190885|NCT00691028|527210364|FG001|Open-label Period|not come to a hospital|0|||
146190886|NCT00691028|527210365|FG002|Open-label Period|not come to a hospital|0|||
146190887|NCT00691028|527210366|FG003|Open-label Period|not come to a hospital|1|||
146190888|NCT00691028|527210363|FG000|Double-blind Period|Adverse Event|8|||
146190889|NCT00691028|527210364|FG001|Double-blind Period|Adverse Event|9|||
146190890|NCT00691028|527210365|FG002|Double-blind Period|Adverse Event|6|||
146190891|NCT00691028|527210366|FG003|Double-blind Period|Adverse Event|0|||
146190892|NCT00691028|527210363|FG000|Double-blind Period|Lack of Efficacy|4|||
146413227|NCT00686920|528018050|FG000|Overall Study|Transferred to Nursing Home|1|||
146413228|NCT00686920|528018051|FG001|Overall Study|Transferred to Nursing Home|0|||
146413229|NCT00686920|528018050|FG000|Overall Study|Noncompliance|9|||
146413230|NCT00686920|528018051|FG001|Overall Study|Noncompliance|0|||
146413231|NCT00686920|528018050|FG000|Overall Study|Principal Investigator Decision|2|||
146413232|NCT00686920|528018051|FG001|Overall Study|Principal Investigator Decision|0|||
146413233|NCT00449930|528018052|FG000|Overall Study|Adverse Event|9|||
146413234|NCT00449930|528018053|FG001|Overall Study|Adverse Event|19|||
146413235|NCT00449930|528018052|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
146190893|NCT00691028|527210364|FG001|Double-blind Period|Lack of Efficacy|3|||
146190894|NCT00691028|527210365|FG002|Double-blind Period|Lack of Efficacy|2|||
146190895|NCT00691028|527210366|FG003|Double-blind Period|Lack of Efficacy|0|||
146190896|NCT00691028|527210363|FG000|Double-blind Period|Withdrawal by Subject|1|||
146190897|NCT00691028|527210364|FG001|Double-blind Period|Withdrawal by Subject|0|||
146190898|NCT00691028|527210365|FG002|Double-blind Period|Withdrawal by Subject|1|||
146190899|NCT00691028|527210366|FG003|Double-blind Period|Withdrawal by Subject|0|||
146190900|NCT00691028|527210363|FG000|Double-blind Period|not come to a hospital.|0|||
146190901|NCT00691028|527210364|FG001|Double-blind Period|not come to a hospital.|1|||
146413236|NCT00449930|528018053|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
146413237|NCT00449930|528018052|FG000|Overall Study|Lack of Efficacy|10|||
146413238|NCT00449930|528018053|FG001|Overall Study|Lack of Efficacy|1|||
146413239|NCT00449930|528018052|FG000|Overall Study|Lost to Follow-up|9|||
146413240|NCT00449930|528018053|FG001|Overall Study|Lost to Follow-up|14|||
146413241|NCT00449930|528018052|FG000|Overall Study|Physician Decision|1|||
146413242|NCT00449930|528018053|FG001|Overall Study|Physician Decision|2|||
146413243|NCT00449930|528018052|FG000|Overall Study|Protocol Violation|14|||
146413244|NCT00449930|528018053|FG001|Overall Study|Protocol Violation|15|||
146413245|NCT00449930|528018052|FG000|Overall Study|Withdrawal by Subject|16|||
146413246|NCT00449930|528018053|FG001|Overall Study|Withdrawal by Subject|23|||
146413247|NCT00449930|528018052|FG000|Overall Study|Glycemic discontinuation criteria|1|||
146413248|NCT00449930|528018053|FG001|Overall Study|Glycemic discontinuation criteria|1|||
146413249|NCT03124381|528018059|FG000|Overall Study|Lost to Follow-up|1|||
146413250|NCT03124381|528018060|FG001|Overall Study|Lost to Follow-up|1|||
146413251|NCT03124381|528018059|FG000|Overall Study|Withdrawal by Subject|6|||
146413252|NCT03124381|528018060|FG001|Overall Study|Withdrawal by Subject|3|||
146413253|NCT03124381|528018059|FG000|Overall Study|Protocol Violation|0|||
146413254|NCT03124381|528018060|FG001|Overall Study|Protocol Violation|1|||
146413255|NCT03124381|528018059|FG000|Overall Study|Adverse Event|1|||
146413256|NCT03124381|528018060|FG001|Overall Study|Adverse Event|1|||
146413257|NCT03124381|528018059|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
146413258|NCT03124381|528018060|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
146413259|NCT03210259|528018066|FG000|12-Week Run-in Period|Adverse Event|1|||
146413260|NCT03210259|528018067|FG001|12-Week Run-in Period|Adverse Event|0|||
146413261|NCT03210259|528018068|FG002|12-Week Run-in Period|Adverse Event|0|||
146413262|NCT03210259|528018066|FG000|12-Week Run-in Period|Death|1|||
146413263|NCT03210259|528018067|FG001|12-Week Run-in Period|Death|0|||
146413264|NCT03210259|528018068|FG002|12-Week Run-in Period|Death|0|||
146413265|NCT03210259|528018066|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
146413266|NCT03210259|528018067|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
146081981|NCT02108262|526820550|FG003|Overall Study|Lost to Follow-up|0|||
146081982|NCT02108262|526820547|FG000|Overall Study|Physician Decision|0|||
146081983|NCT02108262|526820548|FG001|Overall Study|Physician Decision|0|||
146081984|NCT02108262|526820549|FG002|Overall Study|Physician Decision|2|||
146081985|NCT02108262|526820550|FG003|Overall Study|Physician Decision|0|||
146081986|NCT02108262|526820547|FG000|Overall Study|Withdrawal by Subject|0|||
146081987|NCT02108262|526820548|FG001|Overall Study|Withdrawal by Subject|7|||
146081988|NCT02108262|526820549|FG002|Overall Study|Withdrawal by Subject|3|||
146081989|NCT02108262|526820550|FG003|Overall Study|Withdrawal by Subject|4|||
146081990|NCT02108262|526820547|FG000|Overall Study|Due to key hepatic values|0|||
146081991|NCT02108262|526820548|FG001|Overall Study|Due to key hepatic values|1|||
146081992|NCT02108262|526820549|FG002|Overall Study|Due to key hepatic values|0|||
146081993|NCT02108262|526820550|FG003|Overall Study|Due to key hepatic values|0|||
146081994|NCT02108262|526820547|FG000|Overall Study|Unable to contact patient|0|||
146081995|NCT02108262|526820548|FG001|Overall Study|Unable to contact patient|3|||
146081996|NCT02108262|526820549|FG002|Overall Study|Unable to contact patient|1|||
146081997|NCT02108262|526820550|FG003|Overall Study|Unable to contact patient|2|||
146081998|NCT02108262|526820547|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
146081999|NCT02108262|526820548|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
146082000|NCT02108262|526820549|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
146082001|NCT02108262|526820550|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
146082002|NCT02108262|526820547|FG000|Overall Study|Patient did not want another infusion|0|||
146082003|NCT02108262|526820548|FG001|Overall Study|Patient did not want another infusion|3|||
146082004|NCT02108262|526820549|FG002|Overall Study|Patient did not want another infusion|3|||
146082005|NCT02108262|526820550|FG003|Overall Study|Patient did not want another infusion|2|||
146082006|NCT02108262|526820547|FG000|Overall Study|Vacation|0|||
146082007|NCT02108262|526820548|FG001|Overall Study|Vacation|1|||
146082008|NCT02108262|526820549|FG002|Overall Study|Vacation|0|||
146082009|NCT02108262|526820550|FG003|Overall Study|Vacation|0|||
146082010|NCT02108262|526820547|FG000|Overall Study|Patient decision|0|||
146082011|NCT02108262|526820548|FG001|Overall Study|Patient decision|7|||
146082012|NCT02108262|526820549|FG002|Overall Study|Patient decision|9|||
146082013|NCT02108262|526820550|FG003|Overall Study|Patient decision|14|||
146082014|NCT02108262|526820547|FG000|Overall Study|Missed IV due to pharmacy error|0|||
146082015|NCT02108262|526820548|FG001|Overall Study|Missed IV due to pharmacy error|0|||
146082016|NCT02108262|526820549|FG002|Overall Study|Missed IV due to pharmacy error|1|||
146190902|NCT00691028|527210365|FG002|Double-blind Period|not come to a hospital.|0|||
146190903|NCT00691028|527210366|FG003|Double-blind Period|not come to a hospital.|0|||
146190904|NCT02680756|527210380|FG000|Overall Study|Adverse Event|10|||
146190905|NCT02680756|527210381|FG001|Overall Study|Adverse Event|2|||
146190906|NCT02680756|527210380|FG000|Overall Study|Lost to Follow-up|7|||
146190907|NCT02680756|527210381|FG001|Overall Study|Lost to Follow-up|6|||
146190908|NCT02680756|527210380|FG000|Overall Study|Withdrawal by Subject|5|||
146190909|NCT02680756|527210381|FG001|Overall Study|Withdrawal by Subject|5|||
146190910|NCT02680756|527210380|FG000|Overall Study|Physician Decision|4|||
146190911|NCT02680756|527210381|FG001|Overall Study|Physician Decision|1|||
146190912|NCT02680756|527210380|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
146190913|NCT02680756|527210381|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
146190914|NCT02680756|527210380|FG000|Overall Study|Blood transfusion for any reason|0|||
146190915|NCT02680756|527210381|FG001|Overall Study|Blood transfusion for any reason|1|||
146190916|NCT02680756|527210380|FG000|Overall Study|Death|1|||
146190917|NCT02680756|527210381|FG001|Overall Study|Death|0|||
146190918|NCT02680756|527210380|FG000|Overall Study|Protocol Violation|1|||
146190919|NCT02680756|527210381|FG001|Overall Study|Protocol Violation|0|||
146190920|NCT02680756|527210380|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
146190921|NCT02680756|527210381|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
146190922|NCT02680756|527210380|FG000|Overall Study|None of above or not recorded|3|||
146190923|NCT02680756|527210381|FG001|Overall Study|None of above or not recorded|2|||
146190924|NCT00480441|527210382|FG000|Screening|Not Eligible|37|||
146190925|NCT00480441|527210383|FG001|Screening|Not Eligible|0|||
146190926|NCT00480441|527210384|FG002|Screening|Not Eligible|0|||
146190927|NCT00480441|527210382|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
146190928|NCT00480441|527210383|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
146190929|NCT00480441|527210384|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
146190930|NCT00480441|527210382|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
146190931|NCT00480441|527210383|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
146190932|NCT00480441|527210384|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
146190933|NCT00480441|527210382|FG000|Baseline Functional MRI|physical contraindication|4|||
146190934|NCT00480441|527210383|FG001|Baseline Functional MRI|physical contraindication|0|||
146190935|NCT00480441|527210384|FG002|Baseline Functional MRI|physical contraindication|0|||
146190936|NCT00480441|527210382|FG000|Randomization|Lost to Follow-up|0|||
146190937|NCT00480441|527210383|FG001|Randomization|Lost to Follow-up|7|||
146190938|NCT00480441|527210384|FG002|Randomization|Lost to Follow-up|2|||
146190939|NCT00465985|527210385|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
146190940|NCT00465985|527210386|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
146190941|NCT00465985|527210385|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
146190942|NCT00465985|527210386|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
146190943|NCT00465985|527210385|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
146190944|NCT00465985|527210386|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
146190945|NCT00465985|527210385|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
146190946|NCT00465985|527210386|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
146190947|NCT01687270|527210387|FG000|Overall Study|Lack of Efficacy|11|||
146190948|NCT01687270|527210387|FG000|Overall Study|Lost to Follow-up|1|||
146190949|NCT00293462|527210388|FG000|Overall Study|Withdrawal by Subject|4|||
146190950|NCT00293462|527210389|FG001|Overall Study|Withdrawal by Subject|3|||
146190951|NCT00293462|527210390|FG002|Overall Study|Withdrawal by Subject|8|||
146190952|NCT00293462|527210388|FG000|Overall Study|Death|1|||
146190953|NCT00293462|527210389|FG001|Overall Study|Death|0|||
146190954|NCT00293462|527210390|FG002|Overall Study|Death|0|||
146190955|NCT00293462|527210388|FG000|Overall Study|Lost to Follow-up|0|||
146190956|NCT00293462|527210389|FG001|Overall Study|Lost to Follow-up|1|||
146190957|NCT00293462|527210390|FG002|Overall Study|Lost to Follow-up|0|||
146190958|NCT00293462|527210388|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
146190959|NCT00293462|527210389|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
146190960|NCT00293462|527210390|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
146190961|NCT00293462|527210388|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
146190962|NCT00293462|527210389|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
146190963|NCT00293462|527210390|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
146190964|NCT00293462|527210388|FG000|Overall Study|Refuse Radiation Treatment|1|||
146190965|NCT00293462|527210389|FG001|Overall Study|Refuse Radiation Treatment|0|||
146190966|NCT00293462|527210390|FG002|Overall Study|Refuse Radiation Treatment|0|||
146190967|NCT00293462|527210388|FG000|Overall Study|No Show|0|||
146190968|NCT00293462|527210389|FG001|Overall Study|No Show|0|||
146190969|NCT00293462|527210390|FG002|Overall Study|No Show|1|||
146190970|NCT00293462|527210388|FG000|Overall Study|Went back to his home country|0|||
146190971|NCT00293462|527210389|FG001|Overall Study|Went back to his home country|0|||
146190972|NCT00293462|527210390|FG002|Overall Study|Went back to his home country|1|||
146190973|NCT00293462|527210388|FG000|Overall Study|Blood clot after chemotherapy|0|||
146190974|NCT00293462|527210389|FG001|Overall Study|Blood clot after chemotherapy|0|||
146190975|NCT00293462|527210390|FG002|Overall Study|Blood clot after chemotherapy|1|||
146190976|NCT00293462|527210388|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
146190977|NCT00293462|527210389|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
146190978|NCT00293462|527210390|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
146190979|NCT00293462|527210388|FG000|Overall Study|Possible Tracheostomy leakage|0|||
146190980|NCT00293462|527210389|FG001|Overall Study|Possible Tracheostomy leakage|1|||
146190981|NCT00293462|527210390|FG002|Overall Study|Possible Tracheostomy leakage|0|||
146190982|NCT00293462|527210388|FG000|Overall Study|Low radiation dose in oral cavity|0|||
146190983|NCT00293462|527210389|FG001|Overall Study|Low radiation dose in oral cavity|1|||
146190984|NCT00293462|527210390|FG002|Overall Study|Low radiation dose in oral cavity|0|||
146190985|NCT00293462|527210388|FG000|Overall Study|Physician Decision|0|||
146190986|NCT00293462|527210389|FG001|Overall Study|Physician Decision|1|||
146190987|NCT00293462|527210390|FG002|Overall Study|Physician Decision|0|||
146190988|NCT00688688|527210391|FG000|Overall Study|Eligibility criterion not met|7|||
146190989|NCT00688688|527210392|FG001|Overall Study|Eligibility criterion not met|7|||
146190990|NCT00688688|527210393|FG002|Overall Study|Eligibility criterion not met|10|||
146190991|NCT00688688|527210391|FG000|Overall Study|Adverse Event|52|||
146190992|NCT00688688|527210392|FG001|Overall Study|Adverse Event|51|||
146190993|NCT00688688|527210393|FG002|Overall Study|Adverse Event|50|||
146190994|NCT00688688|527210391|FG000|Overall Study|Lack of Efficacy|34|||
146190995|NCT00688688|527210392|FG001|Overall Study|Lack of Efficacy|25|||
146190996|NCT00688688|527210393|FG002|Overall Study|Lack of Efficacy|45|||
146190997|NCT00688688|527210391|FG000|Overall Study|Withdrawal by Subject|66|||
146190998|NCT00688688|527210392|FG001|Overall Study|Withdrawal by Subject|75|||
146190999|NCT00688688|527210393|FG002|Overall Study|Withdrawal by Subject|65|||
146191000|NCT00688688|527210391|FG000|Overall Study|Lost to Follow-up|14|||
146191001|NCT00688688|527210392|FG001|Overall Study|Lost to Follow-up|7|||
146191002|NCT00688688|527210393|FG002|Overall Study|Lost to Follow-up|7|||
146191003|NCT00688688|527210391|FG000|Overall Study|Protocol Violation|6|||
146191004|NCT00688688|527210392|FG001|Overall Study|Protocol Violation|9|||
146191005|NCT00688688|527210393|FG002|Overall Study|Protocol Violation|11|||
146191006|NCT00688688|527210391|FG000|Overall Study|Randomized but never received study drug|1|||
146191007|NCT00688688|527210392|FG001|Overall Study|Randomized but never received study drug|0|||
146191008|NCT00688688|527210393|FG002|Overall Study|Randomized but never received study drug|0|||
146191009|NCT00688688|527210391|FG000|Overall Study|Non-compliance with study procedures|5|||
146191010|NCT00688688|527210392|FG001|Overall Study|Non-compliance with study procedures|3|||
146191011|NCT00688688|527210393|FG002|Overall Study|Non-compliance with study procedures|4|||
146191012|NCT00688688|527210391|FG000|Overall Study|Taking exclusionary medications|1|||
146191013|NCT00688688|527210392|FG001|Overall Study|Taking exclusionary medications|0|||
146191014|NCT00688688|527210393|FG002|Overall Study|Taking exclusionary medications|0|||
146191015|NCT00688688|527210391|FG000|Overall Study|Site closure|0|||
146191016|NCT00688688|527210392|FG001|Overall Study|Site closure|1|||
146191017|NCT00688688|527210393|FG002|Overall Study|Site closure|0|||
146191018|NCT00688688|527210391|FG000|Overall Study|Violation of exclusion criterion|0|||
146191019|NCT00688688|527210392|FG001|Overall Study|Violation of exclusion criterion|1|||
146191020|NCT00688688|527210393|FG002|Overall Study|Violation of exclusion criterion|0|||
146191021|NCT03283553|527210397|FG000|Patient Participant Flow|Death|5|||
146191022|NCT03283553|527210398|FG001|Patient Participant Flow|Death|10|||
146191023|NCT03283553|527210397|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
146191024|NCT03283553|527210398|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
146191025|NCT03283553|527210397|FG000|Patient Participant Flow|Lost to Follow-up|1|||
146191026|NCT03283553|527210398|FG001|Patient Participant Flow|Lost to Follow-up|1|||
146191027|NCT03283553|527210397|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
146191028|NCT03283553|527210398|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
146191029|NCT03283553|527210397|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
146191030|NCT03283553|527210398|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
146191031|NCT03283553|527210397|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
146191032|NCT03283553|527210398|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
146191033|NCT03686683|527210399|FG000|Overall Study|Withdrawal by Subject|52|||
146191034|NCT03686683|527210400|FG001|Overall Study|Withdrawal by Subject|32|||
146191035|NCT03686683|527210399|FG000|Overall Study|Lost to Follow-up|23|||
146191036|NCT03686683|527210400|FG001|Overall Study|Lost to Follow-up|19|||
146191037|NCT03686683|527210399|FG000|Overall Study|Adverse Event|1|||
146191038|NCT03686683|527210400|FG001|Overall Study|Adverse Event|0|||
146191039|NCT03686683|527210399|FG000|Overall Study|Death|10|||
146191040|NCT03686683|527210400|FG001|Overall Study|Death|5|||
146191041|NCT03686683|527210399|FG000|Overall Study|Progressive Disease|1|||
146191042|NCT03686683|527210400|FG001|Overall Study|Progressive Disease|1|||
146191043|NCT03686683|527210399|FG000|Overall Study|Noncompliance|1|||
146191044|NCT03686683|527210400|FG001|Overall Study|Noncompliance|0|||
146191045|NCT03686683|527210399|FG000|Overall Study|Physician Decision|1|||
146191046|NCT03686683|527210400|FG001|Overall Study|Physician Decision|1|||
146191047|NCT03686683|527210399|FG000|Overall Study|Screen fail post-randomization|1|||
146191048|NCT03686683|527210400|FG001|Overall Study|Screen fail post-randomization|0|||
146191049|NCT03686683|527210399|FG000|Overall Study|Protocol Violation|3|||
146191050|NCT03686683|527210400|FG001|Overall Study|Protocol Violation|0|||
146191051|NCT03686683|527210399|FG000|Overall Study|No data available|1|||
146191052|NCT03686683|527210400|FG001|Overall Study|No data available|0|||
146191053|NCT00372060|527210401|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
146191054|NCT00372060|527210402|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
146191055|NCT00372060|527210401|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
146191056|NCT00372060|527210402|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
146191057|NCT00372060|527210401|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
146191058|NCT00372060|527210402|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
146191059|NCT00372060|527210401|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
146191060|NCT00372060|527210402|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
146191061|NCT00372060|527210401|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
146191062|NCT00372060|527210402|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
146191063|NCT00372060|527210401|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
146191064|NCT00372060|527210402|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
146191065|NCT01579578|527210414|FG000|Overall Study|Death|4|||
146191066|NCT01579578|527210415|FG001|Overall Study|Death|1|||
146191067|NCT01579578|527210414|FG000|Overall Study|Lost to Follow-up|1|||
146191068|NCT01579578|527210415|FG001|Overall Study|Lost to Follow-up|1|||
146191069|NCT01579578|527210414|FG000|Overall Study|Withdrawal by Subject|2|||
146191070|NCT01579578|527210415|FG001|Overall Study|Withdrawal by Subject|1|||
146191071|NCT01579578|527210414|FG000|Overall Study|Eligibility criteria|3|||
146191072|NCT01579578|527210415|FG001|Overall Study|Eligibility criteria|9|||
146191073|NCT01579578|527210414|FG000|Overall Study|Ongoing|3|||
146191074|NCT01579578|527210415|FG001|Overall Study|Ongoing|0|||
146191075|NCT01770860|527210416|FG000|Overall Study|Withdrawal by Subject|4|||
146191076|NCT01770860|527210416|FG000|Overall Study|Lost to Follow-up|1|||
146191077|NCT01770860|527210416|FG000|Overall Study|Administrative decision made by the PI|1|||
146191078|NCT01648283|527210422|FG000|Overall Study|Withdrawal by Subject|14|||
146191079|NCT01763047|527210423|FG000|Period 1|Test Article Not Available|4|||
146191080|NCT01763047|527210424|FG001|Period 1|Test Article Not Available|1|||
146191081|NCT01763047|527210423|FG000|Period 1|Protocol Violation|4|||
146191082|NCT01763047|527210424|FG001|Period 1|Protocol Violation|4|||
146191083|NCT01763047|527210423|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
146191084|NCT01763047|527210424|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
146191085|NCT01763047|527210423|FG000|Period 1|Adverse Event|0|||
146191086|NCT01763047|527210424|FG001|Period 1|Adverse Event|1|||
146191087|NCT01763047|527210423|FG000|Period 1|Unsatisfactory Visual Response|0|||
146191088|NCT01763047|527210424|FG001|Period 1|Unsatisfactory Visual Response|3|||
146191089|NCT01763047|527210423|FG000|Period 1|Lens Power Not Available|0|||
146191090|NCT01763047|527210424|FG001|Period 1|Lens Power Not Available|1|||
146191091|NCT01763047|527210423|FG000|Period 1|Study Site office Closed|0|||
146191092|NCT01763047|527210424|FG001|Period 1|Study Site office Closed|1|||
146191093|NCT01763047|527210423|FG000|Period 2|Lens Discomfort|1|||
146191094|NCT01763047|527210424|FG001|Period 2|Lens Discomfort|0|||
146191095|NCT01763047|527210423|FG000|Period 2|No longer meets Eligibility Criteria|1|||
146191096|NCT01763047|527210424|FG001|Period 2|No longer meets Eligibility Criteria|0|||
146191097|NCT01763047|527210423|FG000|Period 2|Study Site office Closed|1|||
146191098|NCT01763047|527210424|FG001|Period 2|Study Site office Closed|1|||
146191099|NCT01763047|527210423|FG000|Period 2|Unsatisfactory Visual Response|1|||
146191100|NCT01763047|527210424|FG001|Period 2|Unsatisfactory Visual Response|1|||
146191101|NCT01763047|527210423|FG000|Period 2|Protocol Violation|0|||
146191102|NCT01763047|527210424|FG001|Period 2|Protocol Violation|2|||
146191103|NCT01763047|527210423|FG000|Period 2|Unsatisfactory lens Fitting|0|||
146191104|NCT01763047|527210424|FG001|Period 2|Unsatisfactory lens Fitting|1|||
146191105|NCT01008748|527210425|FG000|Overall Study|Lost to Follow-up|80|||
146191106|NCT01008748|527210425|FG000|Overall Study|Other|1|||
146191107|NCT00832780|527210428|FG000|Overall Study|Death|16|||
146191108|NCT00832780|527210428|FG000|Overall Study|Lost to Follow-up|4|||
146191109|NCT00832780|527210428|FG000|Overall Study|no reason given|2|||
146191110|NCT00832780|527210428|FG000|Overall Study|other complicating condition|2|||
146191111|NCT00832780|527210428|FG000|Overall Study|Physician Decision|1|||
146191112|NCT01767909|527210433|FG000|Overall Study|Withdrawal by Subject|4|||
146191113|NCT01767909|527210434|FG001|Overall Study|Withdrawal by Subject|7|||
146191114|NCT01767909|527210433|FG000|Overall Study|Adverse Event|3|||
146191115|NCT01767909|527210434|FG001|Overall Study|Adverse Event|1|||
146191116|NCT01767909|527210433|FG000|Overall Study|Withdrawal by Study Partner|3|||
146191117|NCT01767909|527210434|FG001|Overall Study|Withdrawal by Study Partner|1|||
146191118|NCT01767909|527210433|FG000|Overall Study|Non-Compliance|2|||
146191119|NCT01767909|527210434|FG001|Overall Study|Non-Compliance|0|||
146191120|NCT01767909|527210433|FG000|Overall Study|Perceived Lack of Efficacy|1|||
146191121|NCT01767909|527210434|FG001|Overall Study|Perceived Lack of Efficacy|0|||
146191122|NCT01767909|527210433|FG000|Overall Study|Investigator Recommendation|0|||
146191123|NCT01767909|527210434|FG001|Overall Study|Investigator Recommendation|1|||
146191124|NCT01767909|527210433|FG000|Overall Study|Lost to Follow-up|0|||
146191125|NCT01767909|527210434|FG001|Overall Study|Lost to Follow-up|1|||
146191126|NCT01767909|527210433|FG000|Overall Study|LP uncessessful|0|||
146191127|NCT01767909|527210434|FG001|Overall Study|LP uncessessful|1|||
146191128|NCT01723774|527210435|FG000|Neoadjuvant|Ki67 > 10%|4|||
146191129|NCT01723774|527210436|FG001|Neoadjuvant|Ki67 > 10%|0|||
146191130|NCT01723774|527210437|FG002|Neoadjuvant|Ki67 > 10%|10|||
146191131|NCT01723774|527210438|FG003|Neoadjuvant|Ki67 > 10%|0|||
146191132|NCT01723774|527210435|FG000|Neoadjuvant|Withdrawal by Subject|3|||
146191133|NCT01723774|527210436|FG001|Neoadjuvant|Withdrawal by Subject|1|||
146191134|NCT01723774|527210437|FG002|Neoadjuvant|Withdrawal by Subject|0|||
146191135|NCT01723774|527210438|FG003|Neoadjuvant|Withdrawal by Subject|0|||
146191136|NCT01723774|527210435|FG000|Neoadjuvant|Disease progression|0|||
146191137|NCT01723774|527210436|FG001|Neoadjuvant|Disease progression|1|||
146191138|NCT01723774|527210437|FG002|Neoadjuvant|Disease progression|1|||
146191139|NCT01723774|527210438|FG003|Neoadjuvant|Disease progression|0|||
146191140|NCT01723774|527210435|FG000|Neoadjuvant|Adverse Event|0|||
146191141|NCT01723774|527210436|FG001|Neoadjuvant|Adverse Event|1|||
146191142|NCT01723774|527210437|FG002|Neoadjuvant|Adverse Event|2|||
146191143|NCT01723774|527210438|FG003|Neoadjuvant|Adverse Event|0|||
146191144|NCT01723774|527210435|FG000|Neoadjuvant|High estradiol|0|||
146191145|NCT01723774|527210436|FG001|Neoadjuvant|High estradiol|1|||
146191146|NCT01723774|527210437|FG002|Neoadjuvant|High estradiol|0|||
146191147|NCT01723774|527210438|FG003|Neoadjuvant|High estradiol|0|||
146191148|NCT04956692|527210441|FG000|Overall Study|Death|115|||
146191149|NCT04956692|527210442|FG001|Overall Study|Death|47|||
146191150|NCT04956692|527210441|FG000|Overall Study|Lost to Follow-up|0|||
146191151|NCT04956692|527210442|FG001|Overall Study|Lost to Follow-up|1|||
146191152|NCT04956692|527210441|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146191153|NCT04956692|527210442|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146191154|NCT04956692|527210441|FG000|Overall Study|Withdrawal by Subject|5|||
146191155|NCT04956692|527210442|FG001|Overall Study|Withdrawal by Subject|2|||
146191156|NCT04956692|527210441|FG000|Overall Study|Ongoing in Study|236|||
146191157|NCT04956692|527210442|FG001|Overall Study|Ongoing in Study|123|||
146191158|NCT04639947|527210443|FG000|Overall Study|Screen fail|1|||
146191159|NCT02696785|527210448|FG000|Blinded Treatment Period|Adverse Event|0|||
146191160|NCT02696785|527210449|FG001|Blinded Treatment Period|Adverse Event|1|||
146191161|NCT02696785|527210450|FG002|Blinded Treatment Period|Adverse Event|3|||
146191162|NCT02696785|527210451|FG003|Blinded Treatment Period|Adverse Event|0|||
146191163|NCT02696785|527210448|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
146191164|NCT02696785|527210449|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
146191165|NCT02696785|527210450|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
146191166|NCT02696785|527210451|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
146191167|NCT02696785|527210448|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
146191168|NCT02696785|527210449|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
146191169|NCT02696785|527210450|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
146191170|NCT02696785|527210451|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
146191171|NCT02696785|527210448|FG000|Blinded Treatment Period|Screen Failure|1|||
146191172|NCT02696785|527210449|FG001|Blinded Treatment Period|Screen Failure|0|||
146191173|NCT02696785|527210450|FG002|Blinded Treatment Period|Screen Failure|0|||
146191174|NCT02696785|527210451|FG003|Blinded Treatment Period|Screen Failure|0|||
146191175|NCT02696785|527210448|FG000|Washout Period|Withdrawal by Subject|0|||
146191176|NCT02696785|527210449|FG001|Washout Period|Withdrawal by Subject|1|||
146191177|NCT02696785|527210450|FG002|Washout Period|Withdrawal by Subject|0|||
146191178|NCT02696785|527210451|FG003|Washout Period|Withdrawal by Subject|0|||
146191179|NCT02696785|527210448|FG000|Washout Period|Lack of Efficacy|0|||
146191180|NCT02696785|527210449|FG001|Washout Period|Lack of Efficacy|1|||
146191181|NCT02696785|527210450|FG002|Washout Period|Lack of Efficacy|0|||
146191182|NCT02696785|527210451|FG003|Washout Period|Lack of Efficacy|0|||
146191183|NCT02696785|527210448|FG000|Extended Treatment Period|Adverse Event|2|||
146191184|NCT02696785|527210449|FG001|Extended Treatment Period|Adverse Event|3|||
146191185|NCT02696785|527210450|FG002|Extended Treatment Period|Adverse Event|2|||
146191186|NCT02696785|527210451|FG003|Extended Treatment Period|Adverse Event|1|||
146191187|NCT02696785|527210448|FG000|Extended Treatment Period|Lack of Efficacy|0|||
146191188|NCT02696785|527210449|FG001|Extended Treatment Period|Lack of Efficacy|1|||
146191189|NCT02696785|527210450|FG002|Extended Treatment Period|Lack of Efficacy|0|||
146191190|NCT02696785|527210451|FG003|Extended Treatment Period|Lack of Efficacy|0|||
146191191|NCT02696785|527210448|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
146191192|NCT02696785|527210449|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
146191193|NCT02696785|527210450|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
146191194|NCT02696785|527210451|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
146191195|NCT02696785|527210448|FG000|Follow-up Period|Adverse Event|0|||
146191196|NCT02696785|527210449|FG001|Follow-up Period|Adverse Event|0|||
146191197|NCT02696785|527210450|FG002|Follow-up Period|Adverse Event|8|||
146191198|NCT02696785|527210451|FG003|Follow-up Period|Adverse Event|2|||
146191199|NCT02696785|527210448|FG000|Follow-up Period|Lost to Follow-up|0|||
146191200|NCT02696785|527210449|FG001|Follow-up Period|Lost to Follow-up|0|||
146191201|NCT02696785|527210450|FG002|Follow-up Period|Lost to Follow-up|0|||
146191202|NCT02696785|527210451|FG003|Follow-up Period|Lost to Follow-up|1|||
146191203|NCT02696785|527210448|FG000|Follow-up Period|Lack of Efficacy|0|||
146191204|NCT02696785|527210449|FG001|Follow-up Period|Lack of Efficacy|0|||
146082017|NCT02108262|526820550|FG003|Overall Study|Missed IV due to pharmacy error|0|||
146082018|NCT00869778|526820554|FG000|Overall Study|Adverse Event|2|||
146082019|NCT00869778|526820555|FG001|Overall Study|Adverse Event|0|||
146082020|NCT00869778|526820556|FG002|Overall Study|Adverse Event|0|||
146082021|NCT00869778|526820554|FG000|Overall Study|Withdrawal by Subject|3|||
146082022|NCT00869778|526820555|FG001|Overall Study|Withdrawal by Subject|4|||
146082023|NCT00869778|526820556|FG002|Overall Study|Withdrawal by Subject|5|||
146082024|NCT00869778|526820554|FG000|Overall Study|Pregnancy|1|||
146082025|NCT00869778|526820555|FG001|Overall Study|Pregnancy|0|||
146082026|NCT00869778|526820556|FG002|Overall Study|Pregnancy|0|||
146082027|NCT00869778|526820554|FG000|Overall Study|Protocol Violation|5|||
146082028|NCT00869778|526820555|FG001|Overall Study|Protocol Violation|3|||
146082029|NCT00869778|526820556|FG002|Overall Study|Protocol Violation|5|||
146082030|NCT00869778|526820554|FG000|Overall Study|Unblinding|1|||
146082031|NCT00869778|526820555|FG001|Overall Study|Unblinding|0|||
146191205|NCT02696785|527210450|FG002|Follow-up Period|Lack of Efficacy|0|||
146191206|NCT02696785|527210451|FG003|Follow-up Period|Lack of Efficacy|1|||
146191207|NCT02696785|527210448|FG000|Follow-up Period|Withdrawal by Subject|1|||
146191208|NCT02696785|527210449|FG001|Follow-up Period|Withdrawal by Subject|0|||
146191209|NCT02696785|527210450|FG002|Follow-up Period|Withdrawal by Subject|5|||
146191210|NCT02696785|527210451|FG003|Follow-up Period|Withdrawal by Subject|4|||
146191211|NCT04863898|527210455|FG000|Overall Study|Away from study clinic during intervention training period|2|||
146191212|NCT04863898|527210455|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
146191213|NCT04863898|527210455|FG000|Overall Study|Lost to Follow-up|3|||
146191214|NCT04863898|527210455|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
146191215|NCT04863898|527210455|FG000|Overall Study|No longer employed at clinic|3|||
146191216|NCT03285711|527210456|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
146191217|NCT03285711|527210457|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
146191218|NCT03285711|527210458|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
146191219|NCT03285711|527210459|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
146191220|NCT03285711|527210456|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
146191221|NCT03285711|527210457|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146191222|NCT03285711|527210458|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146191223|NCT03285711|527210459|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
146191224|NCT03285711|527210456|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146191225|NCT03285711|527210457|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146191226|NCT03285711|527210458|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
146191227|NCT03285711|527210459|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
146191228|NCT03285711|527210456|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146191229|NCT03285711|527210457|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
146191230|NCT03285711|527210458|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146191231|NCT03285711|527210459|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
146191232|NCT02431533|527210460|FG000|Overall Study|Withdrawal by Subject|1|||
146191233|NCT02431533|527210461|FG001|Overall Study|Withdrawal by Subject|3|||
146191234|NCT02431533|527210460|FG000|Overall Study|Developed Exclusionary criteria|1|||
146191235|NCT02431533|527210461|FG001|Overall Study|Developed Exclusionary criteria|0|||
146191236|NCT02234310|527210462|FG000|Overall Study|Physician Decision|1|||
146191237|NCT02234310|527210462|FG000|Overall Study|Adverse Event|1|||
146191238|NCT02234310|527210462|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
146191239|NCT02234310|527210462|FG000|Overall Study|Withdrawal by Subject|2|||
146191240|NCT00235495|527210463|FG000|Overall Study|Death|52|||
146191241|NCT00235495|527210464|FG001|Overall Study|Death|42|||
146191242|NCT00235495|527210463|FG000|Overall Study|Withdrawal by Subject|5|||
146191243|NCT00235495|527210464|FG001|Overall Study|Withdrawal by Subject|3|||
146191244|NCT00235495|527210463|FG000|Overall Study|Lost to Follow-up|11|||
146191245|NCT00235495|527210464|FG001|Overall Study|Lost to Follow-up|13|||
146191246|NCT00235495|527210463|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
146191247|NCT00235495|527210464|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
146191248|NCT03251378|527210465|FG000|Overall Study|Death|3|||
146191249|NCT03251378|527210466|FG001|Overall Study|Death|2|||
146191250|NCT03251378|527210467|FG002|Overall Study|Death|3|||
146191251|NCT03251378|527210468|FG003|Overall Study|Death|30|||
146191252|NCT03251378|527210469|FG004|Overall Study|Death|24|||
146191253|NCT03251378|527210470|FG005|Overall Study|Death|12|||
146191254|NCT03251378|527210471|FG006|Overall Study|Death|12|||
146191255|NCT03251378|527210465|FG000|Overall Study|Lost to Follow-up|0|||
146191256|NCT03251378|527210466|FG001|Overall Study|Lost to Follow-up|0|||
146191257|NCT03251378|527210467|FG002|Overall Study|Lost to Follow-up|1|||
146191258|NCT03251378|527210468|FG003|Overall Study|Lost to Follow-up|3|||
146191259|NCT03251378|527210469|FG004|Overall Study|Lost to Follow-up|0|||
146191260|NCT03251378|527210470|FG005|Overall Study|Lost to Follow-up|0|||
146191261|NCT03251378|527210471|FG006|Overall Study|Lost to Follow-up|0|||
146191262|NCT03251378|527210465|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146191263|NCT03251378|527210466|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146191264|NCT03251378|527210467|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
146191265|NCT03251378|527210468|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
146191266|NCT03251378|527210469|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
146191267|NCT03251378|527210470|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
146191268|NCT03251378|527210471|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
146191269|NCT03251378|527210465|FG000|Overall Study|Progressive disease|2|||
146191270|NCT03251378|527210466|FG001|Overall Study|Progressive disease|0|||
146191271|NCT03251378|527210467|FG002|Overall Study|Progressive disease|0|||
146191272|NCT03251378|527210468|FG003|Overall Study|Progressive disease|1|||
146191273|NCT03251378|527210469|FG004|Overall Study|Progressive disease|0|||
146191274|NCT03251378|527210470|FG005|Overall Study|Progressive disease|0|||
146191275|NCT03251378|527210471|FG006|Overall Study|Progressive disease|0|||
146191276|NCT03251378|527210465|FG000|Overall Study|Physician Decision|0|||
146191277|NCT03251378|527210466|FG001|Overall Study|Physician Decision|2|||
146191278|NCT03251378|527210467|FG002|Overall Study|Physician Decision|0|||
146191279|NCT03251378|527210468|FG003|Overall Study|Physician Decision|0|||
146191280|NCT03251378|527210469|FG004|Overall Study|Physician Decision|0|||
146191281|NCT03251378|527210470|FG005|Overall Study|Physician Decision|0|||
146191282|NCT03251378|527210471|FG006|Overall Study|Physician Decision|0|||
146191283|NCT03251378|527210465|FG000|Overall Study|Other|2|||
146191284|NCT03251378|527210466|FG001|Overall Study|Other|3|||
146191285|NCT03251378|527210467|FG002|Overall Study|Other|2|||
146191286|NCT03251378|527210468|FG003|Overall Study|Other|0|||
146191287|NCT03251378|527210469|FG004|Overall Study|Other|1|||
146191288|NCT03251378|527210470|FG005|Overall Study|Other|1|||
146191289|NCT03251378|527210471|FG006|Overall Study|Other|1|||
146191290|NCT03251378|527210465|FG000|Overall Study|Other|0|||
146191291|NCT03251378|527210466|FG001|Overall Study|Other|0|||
146191292|NCT03251378|527210467|FG002|Overall Study|Other|0|||
146191293|NCT03251378|527210468|FG003|Overall Study|Other|4|||
146191294|NCT03251378|527210469|FG004|Overall Study|Other|13|||
146191295|NCT03251378|527210470|FG005|Overall Study|Other|0|||
146191296|NCT03251378|527210471|FG006|Overall Study|Other|0|||
146191297|NCT03005288|527210476|FG000|Overall Study|Withdrawal by Subject|7|||
146191298|NCT03005288|527210477|FG001|Overall Study|Withdrawal by Subject|5|||
146191299|NCT03005288|527210476|FG000|Overall Study|Lost to Follow-up|0|||
146191300|NCT03005288|527210477|FG001|Overall Study|Lost to Follow-up|1|||
146191301|NCT03005288|527210476|FG000|Overall Study|Adverse Event|5|||
146191302|NCT03005288|527210477|FG001|Overall Study|Adverse Event|0|||
146191303|NCT03005288|527210476|FG000|Overall Study|Protocol deviation|0|||
146191304|NCT03005288|527210477|FG001|Overall Study|Protocol deviation|1|||
146191305|NCT03005288|527210476|FG000|Overall Study|Physician Decision|0|||
146191306|NCT03005288|527210477|FG001|Overall Study|Physician Decision|1|||
146191307|NCT03590743|527210479|FG000|Overall Study|Withdrawal by Subject|0|||
146191308|NCT03590743|527210480|FG001|Overall Study|Withdrawal by Subject|1|||
146191309|NCT01221181|527210488|FG000|Overall Study|Lost to Follow-up|1|||
146191310|NCT00429793|527210489|FG000|Overall Study|Improper pre-protocol treatment|3|||
146191311|NCT00429793|527210489|FG000|Overall Study|Required test not done|1|||
146191312|NCT00429793|527210489|FG000|Overall Study|Never treated|1|||
146191313|NCT00429793|527210489|FG000|Overall Study|Non-measurable|1|||
146191314|NCT01394991|527210490|FG000|Overall Study|Adverse Event|0|||
146191315|NCT01394991|527210491|FG001|Overall Study|Adverse Event|4|||
146191316|NCT01394991|527210490|FG000|Overall Study|Lack of Efficacy|5|||
146191317|NCT01394991|527210491|FG001|Overall Study|Lack of Efficacy|7|||
146191318|NCT01394991|527210490|FG000|Overall Study|Lost to Follow-up|6|||
146191319|NCT01394991|527210491|FG001|Overall Study|Lost to Follow-up|8|||
146191320|NCT01394991|527210490|FG000|Overall Study|Physician Decision|1|||
146191321|NCT01394991|527210491|FG001|Overall Study|Physician Decision|3|||
146191322|NCT01394991|527210490|FG000|Overall Study|Protocol Violation|1|||
146191323|NCT01394991|527210491|FG001|Overall Study|Protocol Violation|1|||
146191324|NCT01394991|527210490|FG000|Overall Study|Withdrawal by Subject|20|||
146191325|NCT01394991|527210491|FG001|Overall Study|Withdrawal by Subject|17|||
146191326|NCT01394991|527210490|FG000|Overall Study|Chemotherapy Termination|10|||
146191327|NCT01394991|527210491|FG001|Overall Study|Chemotherapy Termination|15|||
146191328|NCT01394991|527210490|FG000|Overall Study|Disease Progression|7|||
146191329|NCT01394991|527210491|FG001|Overall Study|Disease Progression|7|||
146191330|NCT01394991|527210490|FG000|Overall Study|Prematurely Termination of Trial|9|||
146191331|NCT01394991|527210491|FG001|Overall Study|Prematurely Termination of Trial|10|||
146191332|NCT03073005|527210492|FG000|Overall Study|Death|6|||
146191333|NCT03073005|527210493|FG001|Overall Study|Death|0|||
146191334|NCT03073005|527210494|FG002|Overall Study|Death|7|||
146191335|NCT03073005|527210495|FG003|Overall Study|Death|0|||
146191336|NCT03073005|527210492|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
146191337|NCT03073005|527210493|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
146191338|NCT03073005|527210494|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
146191339|NCT03073005|527210495|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
146191340|NCT03073005|527210492|FG000|Overall Study|Lost to Follow-up|2|||
146191341|NCT03073005|527210493|FG001|Overall Study|Lost to Follow-up|2|||
146191342|NCT03073005|527210494|FG002|Overall Study|Lost to Follow-up|1|||
146191343|NCT03073005|527210495|FG003|Overall Study|Lost to Follow-up|2|||
146191344|NCT03073005|527210492|FG000|Overall Study|Withdrawal by Subject|0|||
146191345|NCT03073005|527210493|FG001|Overall Study|Withdrawal by Subject|4|||
146191346|NCT03073005|527210494|FG002|Overall Study|Withdrawal by Subject|4|||
146191347|NCT03073005|527210495|FG003|Overall Study|Withdrawal by Subject|4|||
146191348|NCT02427646|527210496|FG000|Overall Study|Lack of Efficacy|2|||
146191349|NCT02427646|527210497|FG001|Overall Study|Lack of Efficacy|3|||
146191350|NCT02427646|527210496|FG000|Overall Study|Physician Decision|1|||
146191351|NCT02427646|527210497|FG001|Overall Study|Physician Decision|4|||
146191352|NCT02427646|527210496|FG000|Overall Study|Protocol Violation|3|||
146191353|NCT02427646|527210497|FG001|Overall Study|Protocol Violation|3|||
146191354|NCT02427646|527210496|FG000|Overall Study|Bothersome hand weakness|2|||
146191355|NCT02427646|527210497|FG001|Overall Study|Bothersome hand weakness|4|||
146191356|NCT01734811|527210498|FG000|Overall Study|Lost to Follow-up|2|||
146191357|NCT01734811|527210499|FG001|Overall Study|Lost to Follow-up|3|||
146191358|NCT01734811|527210498|FG000|Overall Study|Withdrawal by Subject|2|||
146191359|NCT01734811|527210499|FG001|Overall Study|Withdrawal by Subject|0|||
146191360|NCT03824236|527210500|FG000|Overall Study|Lost to Follow-up|0|||
146191361|NCT03824236|527210501|FG001|Overall Study|Lost to Follow-up|0|||
146191362|NCT03824236|527210502|FG002|Overall Study|Lost to Follow-up|1|||
146191363|NCT01290094|527210503|FG000|Overall Study|Withdrawal by Subject|1|||
146191364|NCT01290094|527210503|FG000|Overall Study|Lost to Follow-up|5|||
146191365|NCT01712685|527210508|FG000|Overall Study|pt declined to participate before trmt|1|||
146191366|NCT01871285|527210509|FG000|First Intervention (1 Day)|Adverse Event|1|||
146191367|NCT01871285|527210510|FG001|First Intervention (1 Day)|Adverse Event|0|||
146191368|NCT01871285|527210511|FG002|First Intervention (1 Day)|Adverse Event|0|||
146191369|NCT01871285|527210512|FG003|First Intervention (1 Day)|Adverse Event|0|||
146191370|NCT01871285|527210509|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
146191371|NCT01871285|527210510|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
146191372|NCT01871285|527210511|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
146191373|NCT01871285|527210512|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
146191374|NCT00359619|527212309|FG000|Overall Study|Adverse Event|0|||
146191375|NCT00359619|527212310|FG001|Overall Study|Adverse Event|0|||
146191376|NCT00359619|527212311|FG002|Overall Study|Adverse Event|1|||
146191377|NCT00359619|527212312|FG003|Overall Study|Adverse Event|0|||
146191378|NCT00359619|527212313|FG004|Overall Study|Adverse Event|0|||
146191379|NCT00359619|527212314|FG005|Overall Study|Adverse Event|0|||
146191380|NCT00359619|527212315|FG006|Overall Study|Adverse Event|1|||
146191381|NCT00359619|527212309|FG000|Overall Study|Withdrawal by Subject|3|||
146191382|NCT00359619|527212310|FG001|Overall Study|Withdrawal by Subject|1|||
146191383|NCT00359619|527212311|FG002|Overall Study|Withdrawal by Subject|4|||
146191384|NCT00359619|527212312|FG003|Overall Study|Withdrawal by Subject|2|||
146191385|NCT00359619|527212313|FG004|Overall Study|Withdrawal by Subject|2|||
146191386|NCT00359619|527212314|FG005|Overall Study|Withdrawal by Subject|0|||
146191387|NCT00359619|527212315|FG006|Overall Study|Withdrawal by Subject|3|||
146191388|NCT00359619|527212309|FG000|Overall Study|Other|1|||
146191389|NCT00359619|527212310|FG001|Overall Study|Other|0|||
146191390|NCT00359619|527212311|FG002|Overall Study|Other|0|||
146191391|NCT00359619|527212312|FG003|Overall Study|Other|0|||
146191392|NCT00359619|527212313|FG004|Overall Study|Other|0|||
146191393|NCT00359619|527212314|FG005|Overall Study|Other|0|||
146191394|NCT00359619|527212315|FG006|Overall Study|Other|0|||
146191395|NCT00359619|527212309|FG000|Overall Study|Lost to Follow-up|4|||
146191396|NCT00359619|527212310|FG001|Overall Study|Lost to Follow-up|4|||
146191397|NCT00359619|527212311|FG002|Overall Study|Lost to Follow-up|2|||
146191398|NCT00359619|527212312|FG003|Overall Study|Lost to Follow-up|1|||
146191399|NCT00359619|527212313|FG004|Overall Study|Lost to Follow-up|1|||
146191400|NCT00359619|527212314|FG005|Overall Study|Lost to Follow-up|5|||
146191401|NCT00359619|527212315|FG006|Overall Study|Lost to Follow-up|0|||
146191402|NCT01419717|527212316|FG000|Overall Study|Protocol-specified Criteria|62|||
146191403|NCT01419717|527212316|FG000|Overall Study|Adverse Event|19|||
146191404|NCT01419717|527212316|FG000|Overall Study|Death|17|||
146191405|NCT01419717|527212316|FG000|Overall Study|Withdrawal by Subject|10|||
146191406|NCT01419717|527212316|FG000|Overall Study|Disease Progression|9|||
146191407|NCT01419717|527212316|FG000|Overall Study|Other|4|||
146191408|NCT01419717|527212316|FG000|Overall Study|Lost to Follow-up|2|||
146191409|NCT01419717|527212316|FG000|Overall Study|Administrative Decision|1|||
146191410|NCT01419717|527212316|FG000|Overall Study|Noncompliance|1|||
146191411|NCT02857283|527212317|FG000|First Exposure|Withdrawal by Subject|1|||
146191412|NCT02857283|527212318|FG001|First Exposure|Withdrawal by Subject|0|||
146191413|NCT00093795|527212319|FG000|Overall Study|No follow up data|20|||
146191414|NCT00093795|527212320|FG001|Overall Study|No follow up data|16|||
146191415|NCT00093795|527212321|FG002|Overall Study|No follow up data|17|||
146191416|NCT00613301|527212322|FG000|Overall Study|Adverse Event|49|||
146191417|NCT00613301|527212322|FG000|Overall Study|Lost to Follow-up|88|||
146191418|NCT00613301|527212322|FG000|Overall Study|Withdrawal by Subject|5|||
146191419|NCT00613301|527212322|FG000|Overall Study|Death|6|||
146191420|NCT00613301|527212322|FG000|Overall Study|Lack of Efficacy|13|||
146191421|NCT00613301|527212322|FG000|Overall Study|Physician Decision|2|||
146191422|NCT00613301|527212322|FG000|Overall Study|No data was collected|53|||
146191423|NCT00613301|527212322|FG000|Overall Study|Irregularly enrolled patients|12|||
146191424|NCT00587288|527212325|FG000|Overall Study|Adverse Event|0|||
146191425|NCT00587288|527212326|FG001|Overall Study|Adverse Event|1|||
146191426|NCT00587288|527212325|FG000|Overall Study|Lack of Efficacy|2|||
146191427|NCT00587288|527212326|FG001|Overall Study|Lack of Efficacy|8|||
146191428|NCT00587288|527212325|FG000|Overall Study|Protocol Violation|1|||
146191429|NCT00587288|527212326|FG001|Overall Study|Protocol Violation|0|||
146191430|NCT02790606|527212334|FG000|Overall Study|Death|27|||
146191431|NCT02790606|527212334|FG000|Overall Study|Lost to Follow-up|4|||
146191432|NCT02790606|527212334|FG000|Overall Study|Physician Decision|3|||
146191433|NCT02790606|527212334|FG000|Overall Study|Withdrawal by Subject|1|||
146191434|NCT02735915|527212335|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
146191435|NCT02735915|527212335|FG000|Overall Study|Withdrawal following SAE|2|||
146191436|NCT02735915|527212335|FG000|Overall Study|Withdrawal by Subject|1|||
146191437|NCT05328973|527212336|FG000|Overall Study|Withdrawal by Subject|0|||
146191438|NCT05328973|527212337|FG001|Overall Study|Withdrawal by Subject|1|||
146191439|NCT00946114|527212338|FG000|Overall Study|Death|5|||
146191440|NCT00946114|527212339|FG001|Overall Study|Death|2|||
146191441|NCT00946114|527212338|FG000|Overall Study|Other|1|||
146191442|NCT00946114|527212339|FG001|Overall Study|Other|0|||
146191443|NCT00946114|527212338|FG000|Overall Study|Withdrawal by Subject|2|||
146191444|NCT00946114|527212339|FG001|Overall Study|Withdrawal by Subject|0|||
146191445|NCT00723294|527212340|FG000|Overall Study|Lobular histology|2|||
146191446|NCT00723294|527212340|FG000|Overall Study|>25% intraductal component|1|||
146191447|NCT00723294|527212340|FG000|Overall Study|No MRI tumor enhancement|1|||
146191448|NCT00723294|527212340|FG000|Overall Study|1.0-Tesla MRI|1|||
146191449|NCT00723294|527212340|FG000|Overall Study|No cryoabalation|2|||
146191450|NCT00723294|527212340|FG000|Overall Study|Did not undergo surgery|1|||
146191451|NCT00723294|527212340|FG000|Overall Study|Treated prior to registration|1|||
146191452|NCT00723294|527212340|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
146191453|NCT00723294|527212340|FG000|Overall Study|Benign lesion|1|||
146191454|NCT00723294|527212340|FG000|Overall Study|Withdrawal by Subject|1|||
146191455|NCT00723294|527212340|FG000|Overall Study|No treatment due to probe failure|1|||
146191456|NCT03532178|527212341|FG000|First Period|Withdrawal by Subject|1|||
146191457|NCT03532178|527212342|FG001|First Period|Withdrawal by Subject|3|||
146191458|NCT03532178|527212341|FG000|First Period|technical issues in data collection Technical issues|0|||
146191459|NCT03532178|527212342|FG001|First Period|technical issues in data collection Technical issues|1|||
146191460|NCT03532178|527212341|FG000|Second Period|Withdrawal by Subject|1|||
146191461|NCT03532178|527212342|FG001|Second Period|Withdrawal by Subject|1|||
146191462|NCT03532178|527212341|FG000|Second Period|Technical issues|0|||
146191463|NCT03532178|527212342|FG001|Second Period|Technical issues|1|||
146191464|NCT03635112|527212343|FG000|Overall Study|Adverse Event|5|||
146191465|NCT03635112|527212344|FG001|Overall Study|Adverse Event|9|||
146191466|NCT03635112|527212345|FG002|Overall Study|Adverse Event|14|||
146191467|NCT03635112|527212343|FG000|Overall Study|Lost to Follow-up|1|||
146191468|NCT03635112|527212344|FG001|Overall Study|Lost to Follow-up|0|||
146191469|NCT03635112|527212345|FG002|Overall Study|Lost to Follow-up|1|||
146191470|NCT03635112|527212343|FG000|Overall Study|Physician Decision|5|||
146191471|NCT03635112|527212344|FG001|Overall Study|Physician Decision|7|||
146191472|NCT03635112|527212345|FG002|Overall Study|Physician Decision|5|||
146191473|NCT03635112|527212343|FG000|Overall Study|Protocol Violation|0|||
146191474|NCT03635112|527212344|FG001|Overall Study|Protocol Violation|0|||
146191475|NCT03635112|527212345|FG002|Overall Study|Protocol Violation|1|||
146191476|NCT03635112|527212343|FG000|Overall Study|Study Terminated by Sponsor|11|||
146191477|NCT03635112|527212344|FG001|Overall Study|Study Terminated by Sponsor|17|||
146191478|NCT03635112|527212345|FG002|Overall Study|Study Terminated by Sponsor|21|||
146191479|NCT03635112|527212343|FG000|Overall Study|Withdrawal by Subject|4|||
146191480|NCT03635112|527212344|FG001|Overall Study|Withdrawal by Subject|9|||
146191481|NCT03635112|527212345|FG002|Overall Study|Withdrawal by Subject|7|||
146191482|NCT03635112|527212343|FG000|Overall Study|Miscellaneous|0|||
146191483|NCT03635112|527212344|FG001|Overall Study|Miscellaneous|0|||
146191484|NCT03635112|527212345|FG002|Overall Study|Miscellaneous|1|||
146191485|NCT01360840|527212346|FG000|Overall Study|Ongoing at data cut-off|10|||
146191486|NCT01360840|527212347|FG001|Overall Study|Ongoing at data cut-off|10|||
146191487|NCT01360840|527212348|FG002|Overall Study|Ongoing at data cut-off|9|||
146191488|NCT04296942|527212349|FG000|Overall Study|Study closure by sponsor|1|||
146191489|NCT04296942|527212350|FG001|Overall Study|Study closure by sponsor|0|||
146191490|NCT04296942|527212351|FG002|Overall Study|Study closure by sponsor|0|||
146191491|NCT00530777|527212357|FG000|Overall Study|Lost to Follow-up|0|||
146191492|NCT00530777|527212358|FG001|Overall Study|Lost to Follow-up|1|||
146191493|NCT00530777|527212357|FG000|Overall Study|Death|1|||
146191494|NCT00530777|527212358|FG001|Overall Study|Death|2|||
146191495|NCT00530777|527212357|FG000|Overall Study|Physician Decision|1|||
146191496|NCT00530777|527212358|FG001|Overall Study|Physician Decision|0|||
146191497|NCT00530777|527212357|FG000|Overall Study|Withdrawal by Subject|0|||
146191498|NCT00530777|527212358|FG001|Overall Study|Withdrawal by Subject|1|||
146191499|NCT00530777|527212357|FG000|Overall Study|Unable to adhere to visit schedule|5|||
146191500|NCT00530777|527212358|FG001|Overall Study|Unable to adhere to visit schedule|1|||
146191501|NCT01582243|527212363|FG000|Overall Study|Withdrawal by Subject|1|||
146191502|NCT01582243|527212363|FG000|Overall Study|Adverse Event|1|||
146191503|NCT01582243|527212363|FG000|Overall Study|Lost to Follow-up|1|||
146191504|NCT03382821|527212364|FG000|Overall Study|Did not receive allocated intervention.|0|||
146191505|NCT03382821|527212365|FG001|Overall Study|Did not receive allocated intervention.|3|||
146191506|NCT02096003|527212369|FG000|Overall Study|Protocol Violation|0|||
146191507|NCT02096003|527212370|FG001|Overall Study|Protocol Violation|2|||
146191508|NCT02096003|527212369|FG000|Overall Study|additional surgery|2|||
146191509|NCT02096003|527212370|FG001|Overall Study|additional surgery|1|||
146191510|NCT03178201|527212371|FG000|Overall Study|Off study|5|||
146191511|NCT04668144|527212372|FG000|Overall Study|Protocol Violation|0|||
146191512|NCT04668144|527212373|FG001|Overall Study|Protocol Violation|1|||
146191513|NCT04668144|527212374|FG002|Overall Study|Protocol Violation|2|||
146191514|NCT01872611|527212378|FG000|Overall Study|Adverse Event|3|||
146191515|NCT01872611|527212379|FG001|Overall Study|Adverse Event|1|||
146191516|NCT01872611|527212378|FG000|Overall Study|Adverse Event, prior to treatment|0|||
146191517|NCT01872611|527212379|FG001|Overall Study|Adverse Event, prior to treatment|1|||
146191518|NCT01872611|527212378|FG000|Overall Study|Death|0|||
146191519|NCT01872611|527212379|FG001|Overall Study|Death|1|||
146191520|NCT01872611|527212378|FG000|Overall Study|Death, prior to treatment|0|||
146191521|NCT01872611|527212379|FG001|Overall Study|Death, prior to treatment|1|||
146191522|NCT01872611|527212378|FG000|Overall Study|Lost to Follow-up|8|||
146191523|NCT01872611|527212379|FG001|Overall Study|Lost to Follow-up|1|||
146191524|NCT01872611|527212378|FG000|Overall Study|Physician Decision|1|||
146191525|NCT01872611|527212379|FG001|Overall Study|Physician Decision|0|||
146191526|NCT01872611|527212378|FG000|Overall Study|Withdrawal by Subject|6|||
146191527|NCT01872611|527212379|FG001|Overall Study|Withdrawal by Subject|1|||
146191528|NCT01872611|527212378|FG000|Overall Study|Reason not provided|6|||
146191529|NCT01872611|527212379|FG001|Overall Study|Reason not provided|6|||
146191530|NCT02487446|527212393|FG000|Period 1|Physician Decision|0|||
146191531|NCT02487446|527212394|FG001|Period 1|Physician Decision|1|||
146191532|NCT02487446|527212393|FG000|Period 1|Lack of Efficacy|1|||
146191533|NCT02487446|527212394|FG001|Period 1|Lack of Efficacy|0|||
146191534|NCT02487446|527212393|FG000|Period 1|Protocol deviation|3|||
146191535|NCT02487446|527212394|FG001|Period 1|Protocol deviation|2|||
146191536|NCT02487446|527212393|FG000|Period 1|Lost to Follow-up|2|||
146191537|NCT02487446|527212394|FG001|Period 1|Lost to Follow-up|0|||
146191538|NCT02487446|527212393|FG000|Period 1|Withdrawal by Subject|2|||
146191539|NCT02487446|527212394|FG001|Period 1|Withdrawal by Subject|0|||
146191540|NCT02487446|527212393|FG000|Period 1|Adverse Event|5|||
146191541|NCT02487446|527212394|FG001|Period 1|Adverse Event|5|||
146191542|NCT02487446|527212393|FG000|Washout|Lost to Follow-up|0|||
146191543|NCT02487446|527212394|FG001|Washout|Lost to Follow-up|2|||
146191544|NCT02487446|527212393|FG000|Washout|Withdrawal by Subject|1|||
146191545|NCT02487446|527212394|FG001|Washout|Withdrawal by Subject|4|||
146191546|NCT02487446|527212393|FG000|Washout|Adverse Event|2|||
146191547|NCT02487446|527212394|FG001|Washout|Adverse Event|2|||
146191548|NCT02487446|527212393|FG000|Period 2|Protocol deviation|0|||
146191549|NCT02487446|527212394|FG001|Period 2|Protocol deviation|1|||
146191550|NCT02487446|527212393|FG000|Period 2|Lost to Follow-up|1|||
146191551|NCT02487446|527212394|FG001|Period 2|Lost to Follow-up|1|||
146191552|NCT02487446|527212393|FG000|Period 2|Withdrawal by Subject|1|||
146191553|NCT02487446|527212394|FG001|Period 2|Withdrawal by Subject|1|||
146191554|NCT02487446|527212393|FG000|Period 2|Adverse Event|6|||
146191555|NCT02487446|527212394|FG001|Period 2|Adverse Event|2|||
146191556|NCT01822821|527212395|FG000|Overall Study|Eligible surgery cancelled|1|||
146191557|NCT01822821|527212396|FG001|Overall Study|Eligible surgery cancelled|1|||
146191558|NCT01822821|527212395|FG000|Overall Study|Other reasons|1|||
146191559|NCT01822821|527212396|FG001|Overall Study|Other reasons|0|||
146191560|NCT02320253|527212397|FG000|Overall Study|Withdrawal by Subject|3|||
146191561|NCT02320253|527212398|FG001|Overall Study|Withdrawal by Subject|0|||
146191562|NCT02320253|527212399|FG002|Overall Study|Withdrawal by Subject|0|||
146191563|NCT02320253|527212397|FG000|Overall Study|Lost to Follow-up|2|||
146191564|NCT02320253|527212398|FG001|Overall Study|Lost to Follow-up|2|||
146191565|NCT02320253|527212399|FG002|Overall Study|Lost to Follow-up|1|||
146191566|NCT02320253|527212397|FG000|Overall Study|Death|1|||
146191567|NCT02320253|527212398|FG001|Overall Study|Death|0|||
146191568|NCT02320253|527212399|FG002|Overall Study|Death|1|||
146191569|NCT05750745|527212400|FG000|Overall Study|Adverse Event|1|||
146191570|NCT05750745|527212401|FG001|Overall Study|Adverse Event|0|||
146191571|NCT05750745|527212402|FG002|Overall Study|Adverse Event|0|||
146191572|NCT05750745|527212400|FG000|Overall Study|Protocol Violation|1|||
146191573|NCT05750745|527212401|FG001|Overall Study|Protocol Violation|0|||
146191574|NCT05750745|527212402|FG002|Overall Study|Protocol Violation|0|||
146191575|NCT05750745|527212400|FG000|Overall Study|Withdrawal by Subject|0|||
146191576|NCT05750745|527212401|FG001|Overall Study|Withdrawal by Subject|1|||
146191577|NCT05750745|527212402|FG002|Overall Study|Withdrawal by Subject|0|||
146191578|NCT05780047|527212404|FG000|Overall Study|Did not submit baseline urine test kit|226|||
146191579|NCT05780047|527212404|FG000|Overall Study|Lost to Follow-up|34|||
146191580|NCT05780047|527212404|FG000|Overall Study|Did not submit second urine test kit|124|||
146191581|NCT00783692|527212414|FG000|Induction Phase|Adverse Event|7|||
146191582|NCT00783692|527212415|FG001|Induction Phase|Adverse Event|9|||
146191583|NCT00783692|527212416|FG002|Induction Phase|Adverse Event|24|||
146191584|NCT00783692|527212417|FG003|Induction Phase|Adverse Event|0|||
146191585|NCT00783692|527212418|FG004|Induction Phase|Adverse Event|0|||
146191586|NCT00783692|527212419|FG005|Induction Phase|Adverse Event|0|||
146191587|NCT00783692|527212420|FG006|Induction Phase|Adverse Event|0|||
146191588|NCT00783692|527212414|FG000|Induction Phase|Protocol Violation|0|||
146191589|NCT00783692|527212415|FG001|Induction Phase|Protocol Violation|0|||
146191590|NCT00783692|527212416|FG002|Induction Phase|Protocol Violation|1|||
146191591|NCT00783692|527212417|FG003|Induction Phase|Protocol Violation|0|||
146191592|NCT00783692|527212418|FG004|Induction Phase|Protocol Violation|0|||
146191593|NCT00783692|527212419|FG005|Induction Phase|Protocol Violation|0|||
146191594|NCT00783692|527212420|FG006|Induction Phase|Protocol Violation|0|||
146191595|NCT00783692|527212414|FG000|Induction Phase|Lack of Efficacy|1|||
146191596|NCT00783692|527212415|FG001|Induction Phase|Lack of Efficacy|3|||
146082032|NCT00869778|526820556|FG002|Overall Study|Unblinding|0|||
146082033|NCT03316911|526820566|FG000|Overall Study|Lost to Follow-up|33|||
146082034|NCT03316911|526820567|FG001|Overall Study|Lost to Follow-up|29|||
146082035|NCT01119937|526820568|FG000|Overall Study|Adverse Event|11|||
146082036|NCT01119937|526820569|FG001|Overall Study|Adverse Event|5|||
146082037|NCT01119937|526820568|FG000|Overall Study|Protocol deviation|3|||
146082038|NCT01119937|526820569|FG001|Overall Study|Protocol deviation|1|||
146082039|NCT01119937|526820568|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146082040|NCT01119937|526820569|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146082041|NCT01119937|526820568|FG000|Overall Study|Withdrawal by Subject|2|||
146082042|NCT01119937|526820569|FG001|Overall Study|Withdrawal by Subject|1|||
146082043|NCT01270802|526820570|FG000|Overall Study|Withdrawal by Subject|1|||
146082044|NCT01270802|526820571|FG001|Overall Study|Withdrawal by Subject|0|||
146082045|NCT01270802|526820570|FG000|Overall Study|Adverse Event|1|||
146082046|NCT01270802|526820571|FG001|Overall Study|Adverse Event|0|||
146191597|NCT00783692|527212416|FG002|Induction Phase|Lack of Efficacy|28|||
146191598|NCT00783692|527212417|FG003|Induction Phase|Lack of Efficacy|0|||
146191599|NCT00783692|527212418|FG004|Induction Phase|Lack of Efficacy|0|||
146191600|NCT00783692|527212419|FG005|Induction Phase|Lack of Efficacy|0|||
146191601|NCT00783692|527212420|FG006|Induction Phase|Lack of Efficacy|0|||
146191602|NCT00783692|527212414|FG000|Induction Phase|Withdrawal by Subject|3|||
146191603|NCT00783692|527212415|FG001|Induction Phase|Withdrawal by Subject|9|||
146191604|NCT00783692|527212416|FG002|Induction Phase|Withdrawal by Subject|16|||
146191605|NCT00783692|527212417|FG003|Induction Phase|Withdrawal by Subject|0|||
146191606|NCT00783692|527212418|FG004|Induction Phase|Withdrawal by Subject|0|||
146191607|NCT00783692|527212419|FG005|Induction Phase|Withdrawal by Subject|0|||
146191608|NCT00783692|527212420|FG006|Induction Phase|Withdrawal by Subject|0|||
146191609|NCT00783692|527212414|FG000|Induction Phase|Lost to Follow-up|0|||
146191610|NCT00783692|527212415|FG001|Induction Phase|Lost to Follow-up|0|||
146191611|NCT00783692|527212416|FG002|Induction Phase|Lost to Follow-up|3|||
146191612|NCT00783692|527212417|FG003|Induction Phase|Lost to Follow-up|0|||
146191613|NCT00783692|527212418|FG004|Induction Phase|Lost to Follow-up|0|||
146191614|NCT00783692|527212419|FG005|Induction Phase|Lost to Follow-up|0|||
146191615|NCT00783692|527212420|FG006|Induction Phase|Lost to Follow-up|0|||
146191616|NCT00783692|527212414|FG000|Induction Phase|Other|0|||
146191617|NCT00783692|527212415|FG001|Induction Phase|Other|0|||
146191618|NCT00783692|527212416|FG002|Induction Phase|Other|2|||
146191619|NCT00783692|527212417|FG003|Induction Phase|Other|0|||
146191620|NCT00783692|527212418|FG004|Induction Phase|Other|0|||
146191621|NCT00783692|527212419|FG005|Induction Phase|Other|0|||
146191622|NCT00783692|527212420|FG006|Induction Phase|Other|0|||
146191623|NCT00783692|527212414|FG000|Maintenance Phase|Adverse Event|7|||
146191624|NCT00783692|527212415|FG001|Maintenance Phase|Adverse Event|0|||
146191625|NCT00783692|527212416|FG002|Maintenance Phase|Adverse Event|0|||
146191626|NCT00783692|527212417|FG003|Maintenance Phase|Adverse Event|15|||
146191627|NCT00783692|527212418|FG004|Maintenance Phase|Adverse Event|12|||
146191628|NCT00783692|527212419|FG005|Maintenance Phase|Adverse Event|9|||
146191629|NCT00783692|527212420|FG006|Maintenance Phase|Adverse Event|38|||
146191630|NCT00783692|527212414|FG000|Maintenance Phase|Protocol Violation|0|||
146191631|NCT00783692|527212415|FG001|Maintenance Phase|Protocol Violation|0|||
146191632|NCT00783692|527212416|FG002|Maintenance Phase|Protocol Violation|0|||
146191633|NCT00783692|527212417|FG003|Maintenance Phase|Protocol Violation|1|||
146191634|NCT00783692|527212418|FG004|Maintenance Phase|Protocol Violation|2|||
146191635|NCT00783692|527212419|FG005|Maintenance Phase|Protocol Violation|3|||
146191636|NCT00783692|527212420|FG006|Maintenance Phase|Protocol Violation|4|||
146191637|NCT00783692|527212414|FG000|Maintenance Phase|Lack of Efficacy|79|||
146191638|NCT00783692|527212415|FG001|Maintenance Phase|Lack of Efficacy|0|||
146191639|NCT00783692|527212416|FG002|Maintenance Phase|Lack of Efficacy|0|||
146191640|NCT00783692|527212417|FG003|Maintenance Phase|Lack of Efficacy|64|||
146191641|NCT00783692|527212418|FG004|Maintenance Phase|Lack of Efficacy|58|||
146191642|NCT00783692|527212419|FG005|Maintenance Phase|Lack of Efficacy|48|||
146191643|NCT00783692|527212420|FG006|Maintenance Phase|Lack of Efficacy|177|||
146413267|NCT03210259|528018068|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
146191644|NCT00783692|527212414|FG000|Maintenance Phase|Withdrawal by Subject|7|||
146191645|NCT00783692|527212415|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146191646|NCT00783692|527212416|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146191647|NCT00783692|527212417|FG003|Maintenance Phase|Withdrawal by Subject|7|||
146191648|NCT00783692|527212418|FG004|Maintenance Phase|Withdrawal by Subject|6|||
146191649|NCT00783692|527212419|FG005|Maintenance Phase|Withdrawal by Subject|9|||
146191650|NCT00783692|527212420|FG006|Maintenance Phase|Withdrawal by Subject|24|||
146191651|NCT00783692|527212414|FG000|Maintenance Phase|Lost to Follow-up|2|||
146191652|NCT00783692|527212415|FG001|Maintenance Phase|Lost to Follow-up|0|||
146191653|NCT00783692|527212416|FG002|Maintenance Phase|Lost to Follow-up|0|||
146191654|NCT00783692|527212417|FG003|Maintenance Phase|Lost to Follow-up|1|||
146191655|NCT00783692|527212418|FG004|Maintenance Phase|Lost to Follow-up|3|||
146191656|NCT00783692|527212419|FG005|Maintenance Phase|Lost to Follow-up|2|||
146191657|NCT00783692|527212420|FG006|Maintenance Phase|Lost to Follow-up|5|||
146191658|NCT00783692|527212414|FG000|Maintenance Phase|Other|0|||
146191659|NCT00783692|527212415|FG001|Maintenance Phase|Other|0|||
146191660|NCT00783692|527212416|FG002|Maintenance Phase|Other|0|||
146191661|NCT00783692|527212417|FG003|Maintenance Phase|Other|1|||
146191662|NCT00783692|527212418|FG004|Maintenance Phase|Other|0|||
146191663|NCT00783692|527212419|FG005|Maintenance Phase|Other|1|||
146191664|NCT00783692|527212420|FG006|Maintenance Phase|Other|1|||
146191665|NCT00209274|527212425|FG000|Overall Study|Missed visit|3|||
146191666|NCT00209274|527212426|FG001|Overall Study|Missed visit|2|||
146191667|NCT00209274|527212425|FG000|Overall Study|Death|32|||
146191668|NCT00209274|527212426|FG001|Overall Study|Death|15|||
146191669|NCT00209274|527212425|FG000|Overall Study|Withdrawal by Subject|30|||
146191670|NCT00209274|527212426|FG001|Overall Study|Withdrawal by Subject|15|||
146191671|NCT00209274|527212425|FG000|Overall Study|Randomized not treated (RNT)|6|||
146191672|NCT00209274|527212426|FG001|Overall Study|Randomized not treated (RNT)|15|||
146191673|NCT02753530|527212427|FG000|Overall Study|Adverse Event|7|||
146191674|NCT02753530|527212428|FG001|Overall Study|Adverse Event|1|||
146191675|NCT02753530|527212427|FG000|Overall Study|Death|0|||
146191676|NCT02753530|527212428|FG001|Overall Study|Death|1|||
146191677|NCT02753530|527212427|FG000|Overall Study|Physician Decision|0|||
146191678|NCT02753530|527212428|FG001|Overall Study|Physician Decision|1|||
146191679|NCT02753530|527212427|FG000|Overall Study|Protocol Violation|1|||
146191680|NCT02753530|527212428|FG001|Overall Study|Protocol Violation|0|||
146191681|NCT02753530|527212427|FG000|Overall Study|Withdrawal by Subject|4|||
146191682|NCT02753530|527212428|FG001|Overall Study|Withdrawal by Subject|3|||
146191683|NCT02696226|527212429|FG000|Overall Study|Study terminated - lack of enrollment|1|||
146191684|NCT02696226|527212430|FG001|Overall Study|Study terminated - lack of enrollment|0|||
146191685|NCT02696226|527212431|FG002|Overall Study|Study terminated - lack of enrollment|2|||
146191686|NCT02696226|527212432|FG003|Overall Study|Study terminated - lack of enrollment|0|||
146191687|NCT00097370|527212437|FG000|Stage 1|Adverse Event|3|||
146191688|NCT00097370|527212437|FG000|Stage 1|Withdrawal by Subject|1|||
146191689|NCT00097370|527212437|FG000|Stage 1|Lack of Efficacy|2|||
146191690|NCT00097370|527212437|FG000|Stage 2|Adverse Event|5|||
146413268|NCT03210259|528018066|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
146191691|NCT00097370|527212437|FG000|Stage 2|Withdrawal by Subject|1|||
146191692|NCT00097370|527212437|FG000|Stage 2|Lack of Efficacy|3|||
146191693|NCT00097370|527212437|FG000|Stage 2|Pregnancy|1|||
146191694|NCT00097370|527212437|FG000|Stage 2|Sponsor Terminated Study|2|||
146191695|NCT00097370|527212437|FG000|Stage 2|Lost to Follow-up|1|||
146191696|NCT00097370|527212437|FG000|Stage 3|Adverse Event|2|||
146191697|NCT00097370|527212437|FG000|Stage 3|Withdrawal by Subject|3|||
146191698|NCT00097370|527212437|FG000|Stage 3|Lack of Efficacy|1|||
146191699|NCT00097370|527212437|FG000|Stage 3|Sponsor Terminated Study|52|||
146191700|NCT00097370|527212437|FG000|Stage 3|Lost to Follow-up|1|||
146191701|NCT00062868|527212447|FG000|Dose Level 1|Death|2|||
146191702|NCT00062868|527212448|FG001|Dose Level 1|Death|0|||
146191703|NCT00062868|527212449|FG002|Dose Level 1|Death|0|||
146191704|NCT00062868|527212450|FG003|Dose Level 1|Death|2|||
146191705|NCT00062868|527212451|FG004|Dose Level 1|Death|0|||
146191706|NCT00062868|527212452|FG005|Dose Level 1|Death|0|||
146191707|NCT00062868|527212453|FG006|Dose Level 1|Death|3|||
146191708|NCT00062868|527212454|FG007|Dose Level 1|Death|0|||
146191709|NCT00062868|527212455|FG008|Dose Level 1|Death|0|||
146191710|NCT00062868|527212456|FG009|Dose Level 1|Death|0|||
146191711|NCT00062868|527212457|FG010|Dose Level 1|Death|0|||
146191712|NCT00062868|527212458|FG011|Dose Level 1|Death|0|||
146191713|NCT00062868|527212459|FG012|Dose Level 1|Death|0|||
146191714|NCT00062868|527212460|FG013|Dose Level 1|Death|0|||
146191715|NCT00062868|527212461|FG014|Dose Level 1|Death|0|||
146191716|NCT00062868|527212462|FG015|Dose Level 1|Death|0|||
146191717|NCT00062868|527212463|FG016|Dose Level 1|Death|0|||
146191718|NCT00062868|527212464|FG017|Dose Level 1|Death|0|||
146191719|NCT00062868|527212465|FG018|Dose Level 1|Death|7|||
146191720|NCT00062868|527212466|FG019|Dose Level 1|Death|0|||
146191721|NCT00062868|527212467|FG020|Dose Level 1|Death|1|||
146191722|NCT00062868|527212447|FG000|Dose Level 1|Lost to Follow-up|0|||
146191723|NCT00062868|527212448|FG001|Dose Level 1|Lost to Follow-up|0|||
146191724|NCT00062868|527212449|FG002|Dose Level 1|Lost to Follow-up|0|||
146191725|NCT00062868|527212450|FG003|Dose Level 1|Lost to Follow-up|0|||
146191726|NCT00062868|527212451|FG004|Dose Level 1|Lost to Follow-up|0|||
146191727|NCT00062868|527212452|FG005|Dose Level 1|Lost to Follow-up|0|||
146191728|NCT00062868|527212453|FG006|Dose Level 1|Lost to Follow-up|0|||
146191729|NCT00062868|527212454|FG007|Dose Level 1|Lost to Follow-up|0|||
146191730|NCT00062868|527212455|FG008|Dose Level 1|Lost to Follow-up|0|||
146191731|NCT00062868|527212456|FG009|Dose Level 1|Lost to Follow-up|0|||
146191732|NCT00062868|527212457|FG010|Dose Level 1|Lost to Follow-up|0|||
146191733|NCT00062868|527212458|FG011|Dose Level 1|Lost to Follow-up|0|||
146191734|NCT00062868|527212459|FG012|Dose Level 1|Lost to Follow-up|1|||
146191735|NCT00062868|527212460|FG013|Dose Level 1|Lost to Follow-up|0|||
146191736|NCT00062868|527212461|FG014|Dose Level 1|Lost to Follow-up|0|||
146191737|NCT00062868|527212462|FG015|Dose Level 1|Lost to Follow-up|0|||
146191738|NCT00062868|527212463|FG016|Dose Level 1|Lost to Follow-up|0|||
146191739|NCT00062868|527212464|FG017|Dose Level 1|Lost to Follow-up|0|||
146191740|NCT00062868|527212465|FG018|Dose Level 1|Lost to Follow-up|2|||
146191741|NCT00062868|527212466|FG019|Dose Level 1|Lost to Follow-up|0|||
146191742|NCT00062868|527212467|FG020|Dose Level 1|Lost to Follow-up|1|||
146191743|NCT00062868|527212447|FG000|Dose Level 2|Death|0|||
146191744|NCT00062868|527212448|FG001|Dose Level 2|Death|3|||
146191745|NCT00062868|527212449|FG002|Dose Level 2|Death|0|||
146191746|NCT00062868|527212450|FG003|Dose Level 2|Death|0|||
146191747|NCT00062868|527212451|FG004|Dose Level 2|Death|2|||
146191748|NCT00062868|527212452|FG005|Dose Level 2|Death|0|||
146191749|NCT00062868|527212453|FG006|Dose Level 2|Death|0|||
146191750|NCT00062868|527212454|FG007|Dose Level 2|Death|0|||
146191751|NCT00062868|527212455|FG008|Dose Level 2|Death|0|||
146191752|NCT00062868|527212456|FG009|Dose Level 2|Death|0|||
146191753|NCT00062868|527212457|FG010|Dose Level 2|Death|1|||
146191754|NCT00062868|527212458|FG011|Dose Level 2|Death|0|||
146191755|NCT00062868|527212459|FG012|Dose Level 2|Death|0|||
146191756|NCT00062868|527212460|FG013|Dose Level 2|Death|0|||
146191757|NCT00062868|527212461|FG014|Dose Level 2|Death|0|||
146191758|NCT00062868|527212462|FG015|Dose Level 2|Death|0|||
146191759|NCT00062868|527212463|FG016|Dose Level 2|Death|2|||
146191760|NCT00062868|527212464|FG017|Dose Level 2|Death|0|||
146191761|NCT00062868|527212465|FG018|Dose Level 2|Death|0|||
146191762|NCT00062868|527212466|FG019|Dose Level 2|Death|0|||
146191763|NCT00062868|527212467|FG020|Dose Level 2|Death|0|||
146191764|NCT00062868|527212447|FG000|Dose Level 2|Lost to Follow-up|0|||
146191765|NCT00062868|527212448|FG001|Dose Level 2|Lost to Follow-up|0|||
146191766|NCT00062868|527212449|FG002|Dose Level 2|Lost to Follow-up|0|||
146191767|NCT00062868|527212450|FG003|Dose Level 2|Lost to Follow-up|0|||
146191768|NCT00062868|527212451|FG004|Dose Level 2|Lost to Follow-up|0|||
146191769|NCT00062868|527212452|FG005|Dose Level 2|Lost to Follow-up|0|||
146191770|NCT00062868|527212453|FG006|Dose Level 2|Lost to Follow-up|0|||
146191771|NCT00062868|527212454|FG007|Dose Level 2|Lost to Follow-up|0|||
146191772|NCT00062868|527212455|FG008|Dose Level 2|Lost to Follow-up|0|||
146191773|NCT00062868|527212456|FG009|Dose Level 2|Lost to Follow-up|0|||
146191774|NCT00062868|527212457|FG010|Dose Level 2|Lost to Follow-up|0|||
146191775|NCT00062868|527212458|FG011|Dose Level 2|Lost to Follow-up|0|||
146191776|NCT00062868|527212459|FG012|Dose Level 2|Lost to Follow-up|0|||
146191777|NCT00062868|527212460|FG013|Dose Level 2|Lost to Follow-up|1|||
146191778|NCT00062868|527212461|FG014|Dose Level 2|Lost to Follow-up|0|||
146191779|NCT00062868|527212462|FG015|Dose Level 2|Lost to Follow-up|0|||
146191780|NCT00062868|527212463|FG016|Dose Level 2|Lost to Follow-up|1|||
146191781|NCT00062868|527212464|FG017|Dose Level 2|Lost to Follow-up|0|||
146191782|NCT00062868|527212465|FG018|Dose Level 2|Lost to Follow-up|0|||
146191783|NCT00062868|527212466|FG019|Dose Level 2|Lost to Follow-up|0|||
146191784|NCT00062868|527212467|FG020|Dose Level 2|Lost to Follow-up|0|||
146191785|NCT00062868|527212447|FG000|Dose Level 3|Death|0|||
146191786|NCT00062868|527212448|FG001|Dose Level 3|Death|0|||
146191787|NCT00062868|527212449|FG002|Dose Level 3|Death|0|||
146191788|NCT00062868|527212450|FG003|Dose Level 3|Death|0|||
146191789|NCT00062868|527212451|FG004|Dose Level 3|Death|0|||
146191790|NCT00062868|527212452|FG005|Dose Level 3|Death|0|||
146191791|NCT00062868|527212453|FG006|Dose Level 3|Death|0|||
146191792|NCT00062868|527212454|FG007|Dose Level 3|Death|0|||
146191793|NCT00062868|527212455|FG008|Dose Level 3|Death|0|||
146191794|NCT00062868|527212456|FG009|Dose Level 3|Death|0|||
146191795|NCT00062868|527212457|FG010|Dose Level 3|Death|0|||
146191796|NCT00062868|527212458|FG011|Dose Level 3|Death|1|||
146191797|NCT00062868|527212459|FG012|Dose Level 3|Death|0|||
146191798|NCT00062868|527212460|FG013|Dose Level 3|Death|0|||
146191799|NCT00062868|527212461|FG014|Dose Level 3|Death|0|||
146191800|NCT00062868|527212462|FG015|Dose Level 3|Death|0|||
146191801|NCT00062868|527212463|FG016|Dose Level 3|Death|0|||
146191802|NCT00062868|527212464|FG017|Dose Level 3|Death|1|||
146191803|NCT00062868|527212465|FG018|Dose Level 3|Death|0|||
146191804|NCT00062868|527212466|FG019|Dose Level 3|Death|0|||
146191805|NCT00062868|527212467|FG020|Dose Level 3|Death|0|||
146191806|NCT00062868|527212447|FG000|Dose Level 3|Lost to Follow-up|0|||
146191807|NCT00062868|527212448|FG001|Dose Level 3|Lost to Follow-up|0|||
146191808|NCT00062868|527212449|FG002|Dose Level 3|Lost to Follow-up|0|||
146191809|NCT00062868|527212450|FG003|Dose Level 3|Lost to Follow-up|0|||
146191810|NCT00062868|527212451|FG004|Dose Level 3|Lost to Follow-up|0|||
146191811|NCT00062868|527212452|FG005|Dose Level 3|Lost to Follow-up|0|||
146191812|NCT00062868|527212453|FG006|Dose Level 3|Lost to Follow-up|0|||
146191813|NCT00062868|527212454|FG007|Dose Level 3|Lost to Follow-up|0|||
146191814|NCT00062868|527212455|FG008|Dose Level 3|Lost to Follow-up|0|||
146191815|NCT00062868|527212456|FG009|Dose Level 3|Lost to Follow-up|0|||
146191816|NCT00062868|527212457|FG010|Dose Level 3|Lost to Follow-up|0|||
146191817|NCT00062868|527212458|FG011|Dose Level 3|Lost to Follow-up|0|||
146191818|NCT00062868|527212459|FG012|Dose Level 3|Lost to Follow-up|0|||
146191819|NCT00062868|527212460|FG013|Dose Level 3|Lost to Follow-up|0|||
146191820|NCT00062868|527212461|FG014|Dose Level 3|Lost to Follow-up|1|||
146191821|NCT00062868|527212462|FG015|Dose Level 3|Lost to Follow-up|0|||
146191822|NCT00062868|527212463|FG016|Dose Level 3|Lost to Follow-up|0|||
146191823|NCT00062868|527212464|FG017|Dose Level 3|Lost to Follow-up|0|||
146191824|NCT00062868|527212465|FG018|Dose Level 3|Lost to Follow-up|0|||
146191825|NCT00062868|527212466|FG019|Dose Level 3|Lost to Follow-up|0|||
146191826|NCT00062868|527212467|FG020|Dose Level 3|Lost to Follow-up|0|||
146191827|NCT00062868|527212447|FG000|Dose Level 3|Withdrew|0|||
146191828|NCT00062868|527212448|FG001|Dose Level 3|Withdrew|0|||
146191829|NCT00062868|527212449|FG002|Dose Level 3|Withdrew|2|||
146191830|NCT00062868|527212450|FG003|Dose Level 3|Withdrew|0|||
146191831|NCT00062868|527212451|FG004|Dose Level 3|Withdrew|0|||
146191832|NCT00062868|527212452|FG005|Dose Level 3|Withdrew|0|||
146191833|NCT00062868|527212453|FG006|Dose Level 3|Withdrew|0|||
146191834|NCT00062868|527212454|FG007|Dose Level 3|Withdrew|0|||
146191835|NCT00062868|527212455|FG008|Dose Level 3|Withdrew|0|||
146191836|NCT00062868|527212456|FG009|Dose Level 3|Withdrew|0|||
146191837|NCT00062868|527212457|FG010|Dose Level 3|Withdrew|0|||
146191838|NCT00062868|527212458|FG011|Dose Level 3|Withdrew|0|||
146191839|NCT00062868|527212459|FG012|Dose Level 3|Withdrew|0|||
146191840|NCT00062868|527212460|FG013|Dose Level 3|Withdrew|0|||
146191841|NCT00062868|527212461|FG014|Dose Level 3|Withdrew|0|||
146191842|NCT00062868|527212462|FG015|Dose Level 3|Withdrew|0|||
146191843|NCT00062868|527212463|FG016|Dose Level 3|Withdrew|0|||
146191844|NCT00062868|527212464|FG017|Dose Level 3|Withdrew|0|||
146191845|NCT00062868|527212465|FG018|Dose Level 3|Withdrew|0|||
146191846|NCT00062868|527212466|FG019|Dose Level 3|Withdrew|0|||
146191847|NCT00062868|527212467|FG020|Dose Level 3|Withdrew|0|||
146191848|NCT00670540|527212470|FG000|Overall Study|ineligible|17|||
146082047|NCT01270802|526820570|FG000|Overall Study|Lost to Follow-up|0|||
146082048|NCT01270802|526820571|FG001|Overall Study|Lost to Follow-up|1|||
146082049|NCT04740905|526820572|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
146082050|NCT04740905|526820573|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
146082051|NCT04740905|526820572|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
146082052|NCT04740905|526820573|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
146082053|NCT04740905|526820572|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
146082054|NCT04740905|526820573|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
146082055|NCT04740905|526820572|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
146082056|NCT04740905|526820573|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
146082057|NCT04740905|526820572|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
146082058|NCT04740905|526820573|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
146082059|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
146082060|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
146082061|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
146082062|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
146082063|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
146082064|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
146082065|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
146082066|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
146082067|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
146082068|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
146082069|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
146082070|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
146082071|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
146082072|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
146082073|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
146082074|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
146082075|NCT04740905|526820572|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
146082076|NCT04740905|526820573|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
146082077|NCT01566214|526820574|FG000|Overall Study|Lost to Follow-up|3|||
146082078|NCT01566214|526820575|FG001|Overall Study|Lost to Follow-up|0|||
146082079|NCT03051620|526820576|FG000|Overall Study|Lost to Follow-up|6|||
146082080|NCT03051620|526820576|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
146082081|NCT01073462|526820580|FG000|Overall Study|Death|14|||
146082082|NCT01073462|526820580|FG000|Overall Study|Kidney transplant|10|||
146082083|NCT01073462|526820580|FG000|Overall Study|Low parathyroid hormone levels|8|||
146082084|NCT01073462|526820580|FG000|Overall Study|Serious adverse event|2|||
146082085|NCT01073462|526820580|FG000|Overall Study|Lost to Follow-up|7|||
146082086|NCT03554486|526820581|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
146082087|NCT03554486|526820582|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
146082088|NCT03554486|526820583|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
146082089|NCT03554486|526820581|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
146082090|NCT03554486|526820582|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
146082091|NCT03554486|526820583|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
146082092|NCT03554486|526820581|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146082093|NCT03554486|526820582|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146082094|NCT03554486|526820583|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146082095|NCT02509117|526820587|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082096|NCT02509117|526820588|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
146082097|NCT02509117|526820589|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082098|NCT02509117|526820590|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082099|NCT02509117|526820591|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082100|NCT02509117|526820592|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082101|NCT02509117|526820593|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082102|NCT02509117|526820594|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082103|NCT02509117|526820595|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082104|NCT02509117|526820596|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
146082105|NCT02509117|526820587|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146191849|NCT00670540|527212470|FG000|Overall Study|not living in France|348|||
146191850|NCT00670540|527212470|FG000|Overall Study|refused to participate|189|||
146191851|NCT00670540|527212470|FG000|Overall Study|controls randomised for no follow up|2770|||
146191852|NCT00670540|527212470|FG000|Overall Study|missing information inclusion criteria|1|||
146191853|NCT01866917|527212471|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
146191854|NCT01866917|527212472|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
146191855|NCT01140347|527212479|FG000|Overall Study|Lost to Follow-up|5|||
146191856|NCT01140347|527212480|FG001|Overall Study|Lost to Follow-up|6|||
146191857|NCT01140347|527212479|FG000|Overall Study|Withdrawal by Subject|13|||
146191858|NCT01140347|527212480|FG001|Overall Study|Withdrawal by Subject|8|||
146191859|NCT00901485|527212481|FG000|Overall Study|Lack of Efficacy|0|||
146191860|NCT00901485|527212482|FG001|Overall Study|Lack of Efficacy|2|||
146191861|NCT00901485|527212481|FG000|Overall Study|Withdrawal by Subject|1|||
146191862|NCT00901485|527212482|FG001|Overall Study|Withdrawal by Subject|2|||
146191863|NCT01959880|527212483|FG000|Overall Study|Withdrawal by Subject|11|||
146191864|NCT01959880|527212484|FG001|Overall Study|Withdrawal by Subject|13|||
146191865|NCT01959880|527212485|FG002|Overall Study|Withdrawal by Subject|8|||
146191866|NCT01959880|527212486|FG003|Overall Study|Withdrawal by Subject|7|||
146191867|NCT01959880|527212483|FG000|Overall Study|Death|1|||
146191868|NCT01959880|527212484|FG001|Overall Study|Death|10|||
146191869|NCT01959880|527212485|FG002|Overall Study|Death|1|||
146191870|NCT01959880|527212486|FG003|Overall Study|Death|2|||
146191871|NCT01959880|527212483|FG000|Overall Study|Lost to Follow-up|95|||
146191872|NCT01959880|527212484|FG001|Overall Study|Lost to Follow-up|18|||
146191873|NCT01959880|527212485|FG002|Overall Study|Lost to Follow-up|15|||
146191874|NCT01959880|527212486|FG003|Overall Study|Lost to Follow-up|8|||
146191875|NCT01959880|527212483|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
146191876|NCT01959880|527212484|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
146191877|NCT01959880|527212485|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
146191878|NCT01959880|527212486|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
146191879|NCT01959880|527212483|FG000|Overall Study|Study completed early-FDA approved|1003|||
146191880|NCT01959880|527212484|FG001|Overall Study|Study completed early-FDA approved|311|||
146191881|NCT01959880|527212485|FG002|Overall Study|Study completed early-FDA approved|179|||
146191882|NCT01959880|527212486|FG003|Overall Study|Study completed early-FDA approved|152|||
146191883|NCT01919619|527212487|FG000|Overall Study|Physician Decision|1|||
146191884|NCT01919619|527212488|FG001|Overall Study|Physician Decision|1|||
146191885|NCT00409708|527213862|FG000|Treatment|Abnormal test procedure result(s)|1|||
146191886|NCT00409708|527213863|FG001|Treatment|Abnormal test procedure result(s)|0|||
146191887|NCT00409708|527213862|FG000|Treatment|Lack of Efficacy|0|||
146191888|NCT00409708|527213863|FG001|Treatment|Lack of Efficacy|1|||
146191889|NCT00409708|527213862|FG000|Treatment|Protocol Violation|6|||
146191890|NCT00409708|527213863|FG001|Treatment|Protocol Violation|2|||
146191891|NCT00409708|527213862|FG000|Treatment|Withdrawal by Subject|3|||
146191892|NCT00409708|527213863|FG001|Treatment|Withdrawal by Subject|8|||
146191893|NCT00409708|527213862|FG000|Treatment|Lost to Follow-up|0|||
146191894|NCT00409708|527213863|FG001|Treatment|Lost to Follow-up|6|||
146191895|NCT00409708|527213862|FG000|Treatment|Administrative problems|5|||
146191896|NCT00409708|527213863|FG001|Treatment|Administrative problems|0|||
146191897|NCT00409708|527213862|FG000|Washout|Lack of Efficacy|9|||
146191898|NCT00409708|527213863|FG001|Washout|Lack of Efficacy|1|||
146191899|NCT00409708|527213862|FG000|Washout|Protocol Violation|0|||
146191900|NCT00409708|527213863|FG001|Washout|Protocol Violation|1|||
146191901|NCT00409708|527213862|FG000|Washout|Withdrawal by Subject|11|||
146191902|NCT00409708|527213863|FG001|Washout|Withdrawal by Subject|5|||
146191903|NCT00409708|527213862|FG000|Washout|Lost to Follow-up|1|||
146191904|NCT00409708|527213863|FG001|Washout|Lost to Follow-up|3|||
146191905|NCT01211665|527213864|FG000|Overall Study|Withdrawal by Subject|1|||
146191906|NCT01211665|527213865|FG001|Overall Study|Withdrawal by Subject|0|||
146191907|NCT01211665|527213864|FG000|Overall Study|Death|1|||
146191908|NCT01211665|527213865|FG001|Overall Study|Death|0|||
146191909|NCT00088465|527213870|FG000|Overall Study|Withdrawal by Subject|290|||
146191910|NCT00088465|527213870|FG000|Overall Study|Adverse Event|77|||
146191911|NCT00088465|527213870|FG000|Overall Study|Lost to Follow-up|57|||
146191912|NCT00088465|527213870|FG000|Overall Study|Physician Decision|45|||
146191913|NCT00088465|527213870|FG000|Overall Study|Sponsor Decision|37|||
146191914|NCT00088465|527213870|FG000|Overall Study|Lack of Efficacy|27|||
146191915|NCT00088465|527213870|FG000|Overall Study|Protocol Violation|17|||
146191916|NCT00088465|527213870|FG000|Overall Study|Death|11|||
146191917|NCT00448864|527213871|FG000|Overall Study|Death|1|||
146191918|NCT00448864|527213872|FG001|Overall Study|Death|0|||
146191919|NCT00448864|527213873|FG002|Overall Study|Death|0|||
146191920|NCT00448864|527213871|FG000|Overall Study|Lost to Follow-up|3|||
146191921|NCT00448864|527213872|FG001|Overall Study|Lost to Follow-up|1|||
146191922|NCT00448864|527213873|FG002|Overall Study|Lost to Follow-up|0|||
146191923|NCT00448864|527213871|FG000|Overall Study|Physician Decision|1|||
146191924|NCT00448864|527213872|FG001|Overall Study|Physician Decision|0|||
146191925|NCT00448864|527213873|FG002|Overall Study|Physician Decision|1|||
146191926|NCT00448864|527213871|FG000|Overall Study|Withdrawal by Subject|0|||
146191927|NCT00448864|527213872|FG001|Overall Study|Withdrawal by Subject|2|||
146191928|NCT00448864|527213873|FG002|Overall Study|Withdrawal by Subject|0|||
146191929|NCT00448864|527213871|FG000|Overall Study|Protocol Violation|0|||
146191930|NCT00448864|527213872|FG001|Overall Study|Protocol Violation|2|||
146191931|NCT00448864|527213873|FG002|Overall Study|Protocol Violation|0|||
146191932|NCT01390857|527213874|FG000|Overall Study|Protocol Violation|2|||
146191933|NCT01390857|527213874|FG000|Overall Study|Lost to Follow-up|1|||
146191934|NCT01390857|527213874|FG000|Overall Study|No Visit after the First Visit|7|||
146191935|NCT02757885|527213875|FG000|Overall Study|Screen Failures|4|||
146191936|NCT04565249|527213880|FG000|Overall Study|Death|0|||
146191937|NCT04565249|527213881|FG001|Overall Study|Death|0|||
146191938|NCT04565249|527213882|FG002|Overall Study|Death|0|||
146191939|NCT04565249|527213883|FG003|Overall Study|Death|1|||
146191940|NCT00886613|527213888|FG000|Overall Study|Protocol deviation (Part B)|1|||
146191941|NCT00886613|527213889|FG001|Overall Study|Protocol deviation (Part B)|0|||
146191942|NCT00886613|527213890|FG002|Overall Study|Protocol deviation (Part B)|0|||
146191943|NCT00886613|527213888|FG000|Overall Study|Lost to follow-up (Part B)|1|||
146191944|NCT00886613|527213889|FG001|Overall Study|Lost to follow-up (Part B)|0|||
146191945|NCT00886613|527213890|FG002|Overall Study|Lost to follow-up (Part B)|1|||
146191946|NCT00886613|527213888|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
146191947|NCT00886613|527213889|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
146191948|NCT00886613|527213890|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
146191949|NCT02333630|527213895|FG000|Overall Study|Lost to Follow-up|5|||
146191950|NCT02333630|527213896|FG001|Overall Study|Lost to Follow-up|2|||
146191951|NCT05349864|527213897|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
146191952|NCT05349864|527213898|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
146191953|NCT00984282|527213899|FG000|Double Blind Treatment|Adverse Event|40|||
146191954|NCT00984282|527213900|FG001|Double Blind Treatment|Adverse Event|6|||
146191955|NCT00984282|527213899|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
146191956|NCT00984282|527213900|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
146191957|NCT00984282|527213899|FG000|Double Blind Treatment|Physician Decision|1|||
146191958|NCT00984282|527213900|FG001|Double Blind Treatment|Physician Decision|2|||
146191959|NCT00984282|527213899|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
146191960|NCT00984282|527213900|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
146191961|NCT00984282|527213899|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
146191962|NCT00984282|527213900|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
146191963|NCT00984282|527213899|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
146191964|NCT00984282|527213900|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
146191965|NCT00984282|527213899|FG000|Double Blind Treatment|Lost to Follow-up|3|||
146191966|NCT00984282|527213900|FG001|Double Blind Treatment|Lost to Follow-up|0|||
146191967|NCT00984282|527213899|FG000|Double Blind Treatment|Death|8|||
146191968|NCT00984282|527213900|FG001|Double Blind Treatment|Death|4|||
146191969|NCT00984282|527213899|FG000|Double Blind Treatment|Not treated|0|||
146191970|NCT00984282|527213900|FG001|Double Blind Treatment|Not treated|1|||
146191971|NCT00984282|527213899|FG000|Double Blind Treatment|Switched to commercial drug|6|||
146191972|NCT00984282|527213900|FG001|Double Blind Treatment|Switched to commercial drug|1|||
146191973|NCT00984282|527213899|FG000|Double Blind Treatment|protocol driven decision point|1|||
146191974|NCT00984282|527213900|FG001|Double Blind Treatment|protocol driven decision point|1|||
146191975|NCT00984282|527213899|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
146191976|NCT00984282|527213900|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
146191977|NCT00984282|527213899|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
146191978|NCT00984282|527213900|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
146191979|NCT00984282|527213899|FG000|Open-label Treatment|Adverse Event|20|||
146191980|NCT00984282|527213900|FG001|Open-label Treatment|Adverse Event|30|||
146191981|NCT00984282|527213899|FG000|Open-label Treatment|Withdrawal by Subject|6|||
146191982|NCT00984282|527213900|FG001|Open-label Treatment|Withdrawal by Subject|21|||
146191983|NCT00984282|527213899|FG000|Open-label Treatment|Death|7|||
146191984|NCT00984282|527213900|FG001|Open-label Treatment|Death|15|||
146191985|NCT00984282|527213899|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
146191986|NCT00984282|527213900|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
146191987|NCT00984282|527213899|FG000|Open-label Treatment|Lost to Follow-up|1|||
146191988|NCT00984282|527213900|FG001|Open-label Treatment|Lost to Follow-up|1|||
146191989|NCT00984282|527213899|FG000|Open-label Treatment|Patient convenience|1|||
146191990|NCT00984282|527213900|FG001|Open-label Treatment|Patient convenience|0|||
146191991|NCT00984282|527213899|FG000|Open-label Treatment|Non-compliant with study medication|1|||
146191992|NCT00984282|527213900|FG001|Open-label Treatment|Non-compliant with study medication|0|||
146191993|NCT00984282|527213899|FG000|Open-label Treatment|Target lesion removed|0|||
146191994|NCT00984282|527213900|FG001|Open-label Treatment|Target lesion removed|1|||
146191995|NCT00984282|527213899|FG000|Open-label Treatment|Protocol driven decision point|1|||
146191996|NCT00984282|527213900|FG001|Open-label Treatment|Protocol driven decision point|1|||
146191997|NCT00984282|527213899|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
146191998|NCT00984282|527213900|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
146191999|NCT00984282|527213899|FG000|Open-label Treatment|Switched to commercial drug|6|||
146192000|NCT00984282|527213900|FG001|Open-label Treatment|Switched to commercial drug|7|||
146413269|NCT03210259|528018067|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
146413270|NCT03210259|528018068|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
146413271|NCT03210259|528018066|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
146192001|NCT00984282|527213899|FG000|Open-label Treatment|Physician Decision|1|||
146192002|NCT00984282|527213900|FG001|Open-label Treatment|Physician Decision|0|||
146192003|NCT00984282|527213899|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
146413272|NCT03210259|528018067|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
146192004|NCT00984282|527213900|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
146192005|NCT00984282|527213899|FG000|Long Term Follow-up|Death|27|||
146192006|NCT00984282|527213900|FG001|Long Term Follow-up|Death|68|||
146192007|NCT00984282|527213899|FG000|Long Term Follow-up|Lost to Follow-up|3|||
146192008|NCT00984282|527213900|FG001|Long Term Follow-up|Lost to Follow-up|6|||
146192009|NCT00984282|527213899|FG000|Long Term Follow-up|Protocol driven decision point|25|||
146192010|NCT00984282|527213900|FG001|Long Term Follow-up|Protocol driven decision point|26|||
146192011|NCT00984282|527213899|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
146192012|NCT00984282|527213900|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
146192013|NCT00984282|527213899|FG000|Long Term Follow-up|Switched to commercial drug|4|||
146192014|NCT00984282|527213900|FG001|Long Term Follow-up|Switched to commercial drug|2|||
146192015|NCT00984282|527213899|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
146192016|NCT00984282|527213900|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
146192017|NCT02223793|527213901|FG000|Overall Study|Lost to Follow-up|10|||
146192018|NCT02223793|527213902|FG001|Overall Study|Lost to Follow-up|1|||
146192019|NCT02223793|527213903|FG002|Overall Study|Lost to Follow-up|2|||
146192020|NCT02223793|527213901|FG000|Overall Study|Withdrawal by Subject|3|||
146192021|NCT02223793|527213902|FG001|Overall Study|Withdrawal by Subject|2|||
146192022|NCT02223793|527213903|FG002|Overall Study|Withdrawal by Subject|3|||
146192023|NCT02223793|527213901|FG000|Overall Study|Moved/studycenter unable to participate|4|||
146192024|NCT02223793|527213902|FG001|Overall Study|Moved/studycenter unable to participate|6|||
146192025|NCT02223793|527213903|FG002|Overall Study|Moved/studycenter unable to participate|8|||
146192026|NCT00315055|527213904|FG000|Overall Study|Protocol Violation|2|||
146192027|NCT00315055|527213905|FG001|Overall Study|Protocol Violation|4|||
146192028|NCT00315055|527213904|FG000|Overall Study|Lost to Follow-up|1|||
146192029|NCT00315055|527213905|FG001|Overall Study|Lost to Follow-up|1|||
146192030|NCT02359435|527213906|FG000|Overall Study|Lost to Follow-up|4|||
146192031|NCT02359435|527213907|FG001|Overall Study|Lost to Follow-up|4|||
146192032|NCT01289119|527213911|FG000|Overall Study|Adverse Event|2|||
146192033|NCT01289119|527213912|FG001|Overall Study|Adverse Event|1|||
146192034|NCT01289119|527213913|FG002|Overall Study|Adverse Event|0|||
146192035|NCT01289119|527213914|FG003|Overall Study|Adverse Event|2|||
146192036|NCT01289119|527213915|FG004|Overall Study|Adverse Event|1|||
146192037|NCT01289119|527213916|FG005|Overall Study|Adverse Event|0|||
146192038|NCT01289119|527213911|FG000|Overall Study|Major Protocol Deviation|2|||
146192039|NCT01289119|527213912|FG001|Overall Study|Major Protocol Deviation|1|||
146192040|NCT01289119|527213913|FG002|Overall Study|Major Protocol Deviation|3|||
146192041|NCT01289119|527213914|FG003|Overall Study|Major Protocol Deviation|0|||
146192042|NCT01289119|527213915|FG004|Overall Study|Major Protocol Deviation|2|||
146192043|NCT01289119|527213916|FG005|Overall Study|Major Protocol Deviation|1|||
146192044|NCT01289119|527213911|FG000|Overall Study|Lost to Follow-up|0|||
146192045|NCT01289119|527213912|FG001|Overall Study|Lost to Follow-up|3|||
146192046|NCT01289119|527213913|FG002|Overall Study|Lost to Follow-up|0|||
146192047|NCT01289119|527213914|FG003|Overall Study|Lost to Follow-up|0|||
146192048|NCT01289119|527213915|FG004|Overall Study|Lost to Follow-up|0|||
146192049|NCT01289119|527213916|FG005|Overall Study|Lost to Follow-up|1|||
146192050|NCT01289119|527213911|FG000|Overall Study|Withdrawal by Subject|4|||
146192051|NCT01289119|527213912|FG001|Overall Study|Withdrawal by Subject|2|||
146192052|NCT01289119|527213913|FG002|Overall Study|Withdrawal by Subject|4|||
146192053|NCT01289119|527213914|FG003|Overall Study|Withdrawal by Subject|3|||
146192054|NCT01289119|527213915|FG004|Overall Study|Withdrawal by Subject|1|||
146192055|NCT01289119|527213916|FG005|Overall Study|Withdrawal by Subject|1|||
146192056|NCT01289119|527213911|FG000|Overall Study|Pregnancy|0|||
146192057|NCT01289119|527213912|FG001|Overall Study|Pregnancy|1|||
146192058|NCT01289119|527213913|FG002|Overall Study|Pregnancy|0|||
146192059|NCT01289119|527213914|FG003|Overall Study|Pregnancy|0|||
146192060|NCT01289119|527213915|FG004|Overall Study|Pregnancy|0|||
146192061|NCT01289119|527213916|FG005|Overall Study|Pregnancy|0|||
146192062|NCT01289119|527213911|FG000|Overall Study|Lack of Efficacy|0|||
146192063|NCT01289119|527213912|FG001|Overall Study|Lack of Efficacy|1|||
146192064|NCT01289119|527213913|FG002|Overall Study|Lack of Efficacy|1|||
146192065|NCT01289119|527213914|FG003|Overall Study|Lack of Efficacy|1|||
146192066|NCT01289119|527213915|FG004|Overall Study|Lack of Efficacy|1|||
146192067|NCT01289119|527213916|FG005|Overall Study|Lack of Efficacy|1|||
146192068|NCT01289119|527213911|FG000|Overall Study|Other|1|||
146192069|NCT01289119|527213912|FG001|Overall Study|Other|0|||
146192070|NCT01289119|527213913|FG002|Overall Study|Other|1|||
146192071|NCT01289119|527213914|FG003|Overall Study|Other|0|||
146192072|NCT01289119|527213915|FG004|Overall Study|Other|0|||
146192073|NCT01289119|527213916|FG005|Overall Study|Other|0|||
146192074|NCT01704846|527213917|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146192075|NCT01704846|527213918|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146192076|NCT00530335|527213922|FG000|Overall Study|Adverse Event|3|||
146192077|NCT00530335|527213922|FG000|Overall Study|Protocol Violation|1|||
146192078|NCT00530335|527213922|FG000|Overall Study|Withdrawal by Subject|1|||
146192079|NCT00530335|527213922|FG000|Overall Study|Physician Decision|1|||
146192080|NCT01244984|527213923|FG000|Overall Study|Adverse Event|2|||
146192081|NCT01244984|527213924|FG001|Overall Study|Adverse Event|11|||
146192082|NCT01244984|527213925|FG002|Overall Study|Adverse Event|2|||
146413273|NCT03210259|528018068|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
146087740|NCT04393298|526841820|FG010|Overall Study|Patient Discharged to Hospice|0|||
146087741|NCT04393298|526841821|FG011|Overall Study|Patient Discharged to Hospice|0|||
146087742|NCT04393298|526841822|FG012|Overall Study|Patient Discharged to Hospice|0|||
146087743|NCT04393298|526841823|FG013|Overall Study|Patient Discharged to Hospice|0|||
146087744|NCT04393298|526841824|FG014|Overall Study|Patient Discharged to Hospice|0|||
146087745|NCT04393298|526841810|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087746|NCT04393298|526841811|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087747|NCT04393298|526841812|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087748|NCT04393298|526841813|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087749|NCT04393298|526841814|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087750|NCT04393298|526841815|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087751|NCT04393298|526841816|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087752|NCT04393298|526841817|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087753|NCT04393298|526841818|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087754|NCT04393298|526841819|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
146087755|NCT04393298|526841820|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087756|NCT04393298|526841821|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087757|NCT04393298|526841822|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087758|NCT04393298|526841823|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087759|NCT04393298|526841824|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
146087760|NCT04393298|526841810|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
146192083|NCT01244984|527213923|FG000|Overall Study|Protocol Violation|1|||
146192084|NCT01244984|527213924|FG001|Overall Study|Protocol Violation|0|||
146192085|NCT01244984|527213925|FG002|Overall Study|Protocol Violation|0|||
146192086|NCT01244984|527213923|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
146192087|NCT01244984|527213924|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
146192088|NCT01244984|527213925|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
146192089|NCT01244984|527213923|FG000|Overall Study|Withdrawal by Subject|1|||
146192090|NCT01244984|527213924|FG001|Overall Study|Withdrawal by Subject|2|||
146192091|NCT01244984|527213925|FG002|Overall Study|Withdrawal by Subject|2|||
146192092|NCT02072226|527213926|FG000|Overall Study|Lost to Follow-up|11|||
146192093|NCT02072226|527213927|FG001|Overall Study|Lost to Follow-up|7|||
146192094|NCT02072226|527213926|FG000|Overall Study|Patient Non-compliance|2|||
146192095|NCT02072226|527213927|FG001|Overall Study|Patient Non-compliance|3|||
146192096|NCT02072226|527213926|FG000|Overall Study|Death|1|||
146192097|NCT02072226|527213927|FG001|Overall Study|Death|0|||
146192098|NCT02072226|527213926|FG000|Overall Study|Patient Withdrawal of Consent|1|||
146192099|NCT02072226|527213927|FG001|Overall Study|Patient Withdrawal of Consent|0|||
146192100|NCT03255018|527213930|FG000|Overall Study|Death on study|0|||
146192101|NCT03255018|527213931|FG001|Overall Study|Death on study|5|||
146192102|NCT03255018|527213930|FG000|Overall Study|Withdrawal by Subject|0|||
146192103|NCT03255018|527213931|FG001|Overall Study|Withdrawal by Subject|2|||
146192104|NCT02950545|527213936|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146192105|NCT02950545|527213937|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146192106|NCT02950545|527213938|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146192107|NCT02950545|527213939|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146192108|NCT02950545|527213940|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
146192109|NCT02950545|527213941|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
146235004|NCT01499849|527378440|FG001|Overall Study|Lost to Follow-up|3|||
146192110|NCT02950545|527213936|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146192111|NCT02950545|527213937|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146192112|NCT02950545|527213938|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146192113|NCT02950545|527213939|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146192114|NCT02950545|527213940|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
146192115|NCT02950545|527213941|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
146192116|NCT02950545|527213936|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146192117|NCT02950545|527213937|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146192118|NCT02950545|527213938|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146192119|NCT02950545|527213939|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146192120|NCT02950545|527213940|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
146192121|NCT02950545|527213941|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
146192122|NCT02950545|527213936|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
146192123|NCT02950545|527213937|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146192124|NCT02950545|527213938|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146192125|NCT02950545|527213939|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146192126|NCT02950545|527213940|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146192127|NCT02950545|527213941|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
146192128|NCT02950545|527213936|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146192129|NCT02950545|527213937|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146192130|NCT02950545|527213938|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146192131|NCT02950545|527213939|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146192132|NCT02950545|527213940|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
146192133|NCT02950545|527213941|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
146192134|NCT03398356|527213942|FG000|Before Treatment|Lost to Follow-up|1|||
146192135|NCT03398356|527213943|FG001|Before Treatment|Lost to Follow-up|2|||
146192136|NCT03398356|527213944|FG002|Before Treatment|Lost to Follow-up|0|||
146192137|NCT03398356|527213942|FG000|Before Treatment|drug intolerance|2|||
146192138|NCT03398356|527213943|FG001|Before Treatment|drug intolerance|1|||
146192139|NCT03398356|527213944|FG002|Before Treatment|drug intolerance|0|||
146192140|NCT03398356|527213942|FG000|Before Treatment|Withdrawal by Subject|0|||
146192141|NCT03398356|527213943|FG001|Before Treatment|Withdrawal by Subject|5|||
146192142|NCT03398356|527213944|FG002|Before Treatment|Withdrawal by Subject|0|||
146192143|NCT03398356|527213942|FG000|Before Treatment|Physician Decision|0|||
146192144|NCT03398356|527213943|FG001|Before Treatment|Physician Decision|0|||
146192145|NCT03398356|527213944|FG002|Before Treatment|Physician Decision|11|||
146192146|NCT03398356|527213942|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
146192147|NCT03398356|527213943|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
146192148|NCT03398356|527213944|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
146192149|NCT00647348|527213946|FG000|Overall Study|Lost to Follow-up|3|||
146192150|NCT00647348|527213947|FG001|Overall Study|Lost to Follow-up|6|||
146192151|NCT00619151|527213948|FG000|Overall Study|Study terminated prior to followup|1|||
146192152|NCT00619151|527213949|FG001|Overall Study|Study terminated prior to followup|0|||
146192153|NCT04889118|527213950|FG000|Overall Study|Death|33|||
146192154|NCT04889118|527213951|FG001|Overall Study|Death|37|||
146192155|NCT04889118|527213950|FG000|Overall Study|Ongoing in Study|31|||
146192156|NCT04889118|527213951|FG001|Overall Study|Ongoing in Study|30|||
146192157|NCT01982760|527213952|FG000|Overall Study|Physician Decision|1|||
146192158|NCT01982760|527213953|FG001|Overall Study|Physician Decision|0|||
146192159|NCT00821236|527213954|FG000|Overall Study|Lost to Follow-up|3|||
146192160|NCT00282438|527213956|FG000|Overall Study|Lack of Efficacy|1|||
146192161|NCT00282438|527213957|FG001|Overall Study|Lack of Efficacy|0|||
146192162|NCT00282438|527213956|FG000|Overall Study|Death|0|||
146192163|NCT00282438|527213957|FG001|Overall Study|Death|1|||
146192164|NCT02397889|527213958|FG000|Overall Study|Physician Decision|1|||
146192165|NCT02397889|527213959|FG001|Overall Study|Physician Decision|0|||
146192166|NCT01928940|527213969|FG000|Overall Study|Adverse Event|0|||
146192167|NCT01928940|527213970|FG001|Overall Study|Adverse Event|1|||
146192168|NCT02954055|527213971|FG000|Overall Study|Did not initiate therapy|6|||
146192169|NCT02954055|527213972|FG001|Overall Study|Did not initiate therapy|1|||
146192170|NCT01352507|527213973|FG000|Treatment Period 1|Adverse Event|3|||
146192171|NCT01352507|527213974|FG001|Treatment Period 1|Adverse Event|0|||
146192172|NCT01352507|527213973|FG000|Treatment Period 1|Lost to Follow-up|3|||
146192173|NCT01352507|527213974|FG001|Treatment Period 1|Lost to Follow-up|4|||
146192174|NCT01352507|527213973|FG000|Treatment Period 1|Withdrawal by Subject|7|||
146192175|NCT01352507|527213974|FG001|Treatment Period 1|Withdrawal by Subject|5|||
146192176|NCT01352507|527213973|FG000|Treatment Period 1|Physician Decision|1|||
146192177|NCT01352507|527213974|FG001|Treatment Period 1|Physician Decision|0|||
146192178|NCT01352507|527213973|FG000|Washout Period|Withdrawal by Subject|0|||
146192179|NCT01352507|527213974|FG001|Washout Period|Withdrawal by Subject|1|||
146192180|NCT01352507|527213973|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
146192181|NCT01352507|527213974|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
146192182|NCT01352507|527213973|FG000|Treatment Period 2|Withdrawal by Subject|4|||
146192183|NCT01352507|527213974|FG001|Treatment Period 2|Withdrawal by Subject|3|||
146192184|NCT01352507|527213973|FG000|Treatment Period 2|Lack of Efficacy|1|||
146192185|NCT01352507|527213974|FG001|Treatment Period 2|Lack of Efficacy|0|||
146192186|NCT01119703|527213975|FG000|Overall Study|Adverse Event|0|||
146192187|NCT01119703|527213976|FG001|Overall Study|Adverse Event|1|||
146192188|NCT02282527|527213977|FG000|Overall Study|Lost to Follow-up|0|||
146192189|NCT02282527|527213978|FG001|Overall Study|Lost to Follow-up|1|||
146192190|NCT02282527|527213977|FG000|Overall Study|Lack of home health aid|1|||
146192191|NCT02282527|527213978|FG001|Overall Study|Lack of home health aid|0|||
146192192|NCT03537651|527213979|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
146192193|NCT03537651|527213979|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
146192194|NCT03537651|527213979|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
146192195|NCT03537651|527213979|FG000|Part A (Up to 96 Weeks)|Other|1|||
146192196|NCT03537651|527213979|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
146192197|NCT03537651|527213979|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
146192198|NCT03537651|527213979|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
146192199|NCT03537651|527213979|FG000|Part B (Up to 192 Weeks)|Other|1|||
146192200|NCT01076335|527213980|FG000|Overall Study|Withdrawal by Subject|3|||
146192201|NCT01076335|527213980|FG000|Overall Study|Withdrawal without treatment|1|||
146192202|NCT02939183|527213981|FG000|Overall Study|Death|0|||
146192203|NCT02939183|527213982|FG001|Overall Study|Death|0|||
146192204|NCT02939183|527213983|FG002|Overall Study|Death|1|||
146192205|NCT02939183|527213984|FG003|Overall Study|Death|0|||
146192206|NCT02939183|527213985|FG004|Overall Study|Death|0|||
146192207|NCT02939183|527213986|FG005|Overall Study|Death|2|||
146192208|NCT02939183|527213987|FG006|Overall Study|Death|1|||
146192209|NCT02939183|527213988|FG007|Overall Study|Death|0|||
146192210|NCT02939183|527213989|FG008|Overall Study|Death|0|||
146192211|NCT02939183|527213981|FG000|Overall Study|Sponsor decision|0|||
146192212|NCT02939183|527213982|FG001|Overall Study|Sponsor decision|1|||
146192213|NCT02939183|527213983|FG002|Overall Study|Sponsor decision|0|||
146192214|NCT02939183|527213984|FG003|Overall Study|Sponsor decision|1|||
146192215|NCT02939183|527213985|FG004|Overall Study|Sponsor decision|2|||
146192216|NCT02939183|527213986|FG005|Overall Study|Sponsor decision|0|||
146192217|NCT02939183|527213987|FG006|Overall Study|Sponsor decision|3|||
146192218|NCT02939183|527213988|FG007|Overall Study|Sponsor decision|1|||
146192219|NCT02939183|527213989|FG008|Overall Study|Sponsor decision|4|||
146192220|NCT02939183|527213981|FG000|Overall Study|Withdrawal by Subject|0|||
146192221|NCT02939183|527213982|FG001|Overall Study|Withdrawal by Subject|2|||
146192222|NCT02939183|527213983|FG002|Overall Study|Withdrawal by Subject|0|||
146192223|NCT02939183|527213984|FG003|Overall Study|Withdrawal by Subject|1|||
146192224|NCT02939183|527213985|FG004|Overall Study|Withdrawal by Subject|0|||
146192225|NCT02939183|527213986|FG005|Overall Study|Withdrawal by Subject|0|||
146192226|NCT02939183|527213987|FG006|Overall Study|Withdrawal by Subject|2|||
146192227|NCT02939183|527213988|FG007|Overall Study|Withdrawal by Subject|2|||
146192228|NCT02939183|527213989|FG008|Overall Study|Withdrawal by Subject|2|||
146192229|NCT02939183|527213981|FG000|Overall Study|Not treated due to adverse event|0|||
146192230|NCT02939183|527213982|FG001|Overall Study|Not treated due to adverse event|0|||
146192231|NCT02939183|527213983|FG002|Overall Study|Not treated due to adverse event|0|||
146192232|NCT02939183|527213984|FG003|Overall Study|Not treated due to adverse event|1|||
146192233|NCT02939183|527213985|FG004|Overall Study|Not treated due to adverse event|0|||
146192234|NCT02939183|527213986|FG005|Overall Study|Not treated due to adverse event|0|||
146192235|NCT02939183|527213987|FG006|Overall Study|Not treated due to adverse event|1|||
146192236|NCT02939183|527213988|FG007|Overall Study|Not treated due to adverse event|0|||
146192237|NCT02939183|527213989|FG008|Overall Study|Not treated due to adverse event|0|||
146192238|NCT02909101|527213991|FG000|Overall Study|Lost to Follow-up|1|||
146192239|NCT02909101|527213992|FG001|Overall Study|Lost to Follow-up|1|||
146192240|NCT02698436|527213993|FG000|Overall Study|Adverse Event|1|||
146192241|NCT02698436|527213994|FG001|Overall Study|Adverse Event|0|||
146413274|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
145945352|NCT01764997|526308216|FG004|Run-in Period|Other than specified above|0|||
145945353|NCT01764997|526308212|FG000|Study Drug Treatment Period|Adverse Event|0|||
145945354|NCT01764997|526308213|FG001|Study Drug Treatment Period|Adverse Event|1|||
145945355|NCT01764997|526308214|FG002|Study Drug Treatment Period|Adverse Event|0|||
145945356|NCT01764997|526308215|FG003|Study Drug Treatment Period|Adverse Event|0|||
145945357|NCT01764997|526308216|FG004|Study Drug Treatment Period|Adverse Event|24|||
145945358|NCT01764997|526308212|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
145945359|NCT01764997|526308213|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
145945360|NCT01764997|526308214|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
145945361|NCT01764997|526308215|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
145945362|NCT01764997|526308216|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
145945363|NCT01764997|526308212|FG000|Study Drug Treatment Period|Other than specified above|0|||
146413275|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
145945364|NCT01764997|526308213|FG001|Study Drug Treatment Period|Other than specified above|0|||
146413276|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
146413277|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
146413278|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
146413279|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
146235005|NCT01499849|527378439|FG000|Overall Study|Other Reasons|27|||
146082106|NCT02509117|526820588|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145945365|NCT01764997|526308214|FG002|Study Drug Treatment Period|Other than specified above|0|||
146413280|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
145945366|NCT01764997|526308215|FG003|Study Drug Treatment Period|Other than specified above|0|||
145945367|NCT01764997|526308216|FG004|Study Drug Treatment Period|Other than specified above|10|||
145945368|NCT00787917|526308217|FG000|Blinded Treatment|Adverse Event|1|||
145945369|NCT00787917|526308218|FG001|Blinded Treatment|Adverse Event|0|||
145945370|NCT00787917|526308217|FG000|Blinded Treatment|Lack of Efficacy|1|||
146192242|NCT02698436|527213993|FG000|Overall Study|Withdrawal by Subject|3|||
146413281|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
146413282|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
146413283|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
146413284|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
146413285|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
146413286|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
146413287|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
146413288|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
146413289|NCT03210259|528018066|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
146413290|NCT03210259|528018067|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
146413291|NCT03210259|528018068|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
146413292|NCT05017493|528018071|FG000|Overall Study|Withdrawal by Subject|26|||
146413293|NCT05017493|528018072|FG001|Overall Study|Withdrawal by Subject|0|||
146413294|NCT05017493|528018071|FG000|Overall Study|Physician Decision|15|||
146413295|NCT05017493|528018072|FG001|Overall Study|Physician Decision|0|||
146413296|NCT05017493|528018071|FG000|Overall Study|Protocol Violation|81|||
146413297|NCT05017493|528018072|FG001|Overall Study|Protocol Violation|0|||
146413298|NCT02473510|528018073|FG000|Overall Study|Lost to Follow-up|1|||
146413299|NCT02473510|528018074|FG001|Overall Study|Lost to Follow-up|2|||
146413300|NCT00964223|528018078|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
146413301|NCT00345683|528018083|FG000|Overall Study|Lost to Follow-up|19|||
146413302|NCT00345683|528018084|FG001|Overall Study|Lost to Follow-up|7|||
146413303|NCT00345683|528018083|FG000|Overall Study|Other|6|||
146413304|NCT00345683|528018084|FG001|Overall Study|Other|2|||
146413305|NCT03634488|528018087|FG000|Overall Study|Death|1|||
146413306|NCT03634488|528018088|FG001|Overall Study|Death|0|||
146413307|NCT03634488|528018089|FG002|Overall Study|Death|0|||
146413308|NCT03634488|528018087|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
146413309|NCT03634488|528018088|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
146413310|NCT03634488|528018089|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
146413311|NCT03182686|528018090|FG000|Overall Study|Lost to Follow-up|2|||
146413312|NCT03182686|528018091|FG001|Overall Study|Lost to Follow-up|0|||
146413313|NCT03182686|528018090|FG000|Overall Study|Adverse Event|2|||
146413314|NCT03182686|528018091|FG001|Overall Study|Adverse Event|0|||
146413315|NCT03182686|528018090|FG000|Overall Study|Withdrawal by Subject|3|||
146413316|NCT03182686|528018091|FG001|Overall Study|Withdrawal by Subject|0|||
146413317|NCT01154127|528018098|FG000|Period 1 (21 Days)|Adverse Event|3|||
146413318|NCT01154127|528018099|FG001|Period 1 (21 Days)|Adverse Event|4|||
146413319|NCT01154127|528018098|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
146413320|NCT01154127|528018099|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
146413321|NCT01154127|528018098|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
146413322|NCT01154127|528018099|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
146413323|NCT01154127|528018098|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
146413324|NCT01154127|528018099|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
146413325|NCT01154127|528018098|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
146413326|NCT01154127|528018099|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
146413327|NCT01697449|528018100|FG000|Overall Study|Disease progression|47|||
146413328|NCT01697449|528018100|FG000|Overall Study|Adverse Event|7|||
146413329|NCT01697449|528018100|FG000|Overall Study|Lost to Follow-up|5|||
146413330|NCT01697449|528018100|FG000|Overall Study|Withdrawal by Subject|2|||
146413331|NCT01697449|528018100|FG000|Overall Study|Physician Decision|1|||
145945371|NCT00787917|526308218|FG001|Blinded Treatment|Lack of Efficacy|0|||
145945372|NCT00787917|526308217|FG000|Blinded Treatment|Administrative problems|3|||
145945373|NCT00787917|526308218|FG001|Blinded Treatment|Administrative problems|2|||
145945374|NCT00787917|526308217|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
145945375|NCT00787917|526308218|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
145945376|NCT00787917|526308217|FG000|Open Label|Administrative problems|3|||
145945377|NCT00787917|526308218|FG001|Open Label|Administrative problems|0|||
145945378|NCT02172040|526308225|FG000|Overall Study|Adverse Event|0|||
145945379|NCT02172040|526308226|FG001|Overall Study|Adverse Event|2|||
145945380|NCT02172040|526308227|FG002|Overall Study|Adverse Event|0|||
145945381|NCT02172040|526308228|FG003|Overall Study|Adverse Event|0|||
145945382|NCT02172040|526308225|FG000|Overall Study|Protocol Violation|0|||
145945383|NCT02172040|526308226|FG001|Overall Study|Protocol Violation|1|||
145945384|NCT02172040|526308227|FG002|Overall Study|Protocol Violation|0|||
145945385|NCT02172040|526308228|FG003|Overall Study|Protocol Violation|0|||
145945386|NCT02172040|526308225|FG000|Overall Study|Withdrawal by Subject|0|||
145945387|NCT02172040|526308226|FG001|Overall Study|Withdrawal by Subject|0|||
145945388|NCT02172040|526308227|FG002|Overall Study|Withdrawal by Subject|1|||
145945389|NCT02172040|526308228|FG003|Overall Study|Withdrawal by Subject|0|||
145945390|NCT02172040|526308225|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
145945391|NCT02172040|526308226|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
145945392|NCT02172040|526308227|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
145945393|NCT02172040|526308228|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
145945394|NCT02172040|526308225|FG000|Overall Study|Family emergency abroad|0|||
145945395|NCT02172040|526308226|FG001|Overall Study|Family emergency abroad|0|||
145945396|NCT02172040|526308227|FG002|Overall Study|Family emergency abroad|0|||
145945397|NCT02172040|526308228|FG003|Overall Study|Family emergency abroad|1|||
145945398|NCT03774394|526310063|FG000|Overall Study|Withdrawal by Subject|2|||
145945399|NCT03774394|526310064|FG001|Overall Study|Withdrawal by Subject|0|||
145945400|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145945401|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
145945402|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145945403|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145945404|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145945405|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145945406|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145945407|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
145945408|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
145945409|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145945410|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145945411|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145945412|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
145945413|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
146235006|NCT01499849|527378440|FG001|Overall Study|Other Reasons|30|||
146235007|NCT00174252|527378441|FG000|Overall Study|Protocol Violation|2|||
145945414|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
145945415|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
145945416|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145945417|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145945418|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145945419|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
145945420|NCT00994214|526310065|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
145945421|NCT00994214|526310066|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
145945422|NCT00994214|526310067|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
145945423|NCT00994214|526310068|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
145945424|NCT05940077|526310073|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
145945425|NCT00388297|526310074|FG000|Overall Study|Lost to Follow-up|16|||
145945426|NCT00388297|526310075|FG001|Overall Study|Lost to Follow-up|12|||
145945427|NCT00388297|526310076|FG002|Overall Study|Lost to Follow-up|11|||
145945428|NCT00388297|526310077|FG003|Overall Study|Lost to Follow-up|8|||
145945429|NCT04105010|526310080|FG000|Overall Study|Death|3|||
145945430|NCT04105010|526310081|FG001|Overall Study|Death|1|||
145945431|NCT04105010|526310082|FG002|Overall Study|Death|1|||
145945432|NCT04105010|526310083|FG003|Overall Study|Death|54|||
145945433|NCT04105010|526310080|FG000|Overall Study|Lost to Follow-up|0|||
145945434|NCT04105010|526310081|FG001|Overall Study|Lost to Follow-up|0|||
145945435|NCT04105010|526310082|FG002|Overall Study|Lost to Follow-up|0|||
145945436|NCT04105010|526310083|FG003|Overall Study|Lost to Follow-up|4|||
145945437|NCT04105010|526310080|FG000|Overall Study|Withdrawal by Subject|8|||
145945438|NCT04105010|526310081|FG001|Overall Study|Withdrawal by Subject|1|||
145945439|NCT04105010|526310082|FG002|Overall Study|Withdrawal by Subject|1|||
145945440|NCT04105010|526310083|FG003|Overall Study|Withdrawal by Subject|4|||
145945441|NCT04105010|526310080|FG000|Overall Study|Other reason|4|||
145945442|NCT04105010|526310081|FG001|Overall Study|Other reason|7|||
145945443|NCT04105010|526310082|FG002|Overall Study|Other reason|0|||
145945444|NCT04105010|526310083|FG003|Overall Study|Other reason|19|||
145945445|NCT03570554|526310086|FG000|Overall Study|Non-compliance with study drug|0|||
145945446|NCT03570554|526310087|FG001|Overall Study|Non-compliance with study drug|0|||
145945447|NCT03570554|526310088|FG002|Overall Study|Non-compliance with study drug|1|||
145945448|NCT03570554|526310089|FG003|Overall Study|Non-compliance with study drug|0|||
145945449|NCT03570554|526310086|FG000|Overall Study|Adverse Event|0|||
145945450|NCT03570554|526310087|FG001|Overall Study|Adverse Event|0|||
145945451|NCT03570554|526310088|FG002|Overall Study|Adverse Event|0|||
145945452|NCT03570554|526310089|FG003|Overall Study|Adverse Event|1|||
145945453|NCT03114657|526310104|FG000|Overall Study|Adverse Event|9|||
145945454|NCT03114657|526310105|FG001|Overall Study|Adverse Event|6|||
145945455|NCT03114657|526310104|FG000|Overall Study|Death|4|||
146087761|NCT04393298|526841811|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
145945456|NCT03114657|526310105|FG001|Overall Study|Death|0|||
145945457|NCT03114657|526310104|FG000|Overall Study|Multiple Reasons|1|||
145945458|NCT03114657|526310105|FG001|Overall Study|Multiple Reasons|2|||
145945459|NCT03114657|526310104|FG000|Overall Study|Physician Decision|2|||
145945460|NCT03114657|526310105|FG001|Overall Study|Physician Decision|2|||
145945461|NCT03114657|526310104|FG000|Overall Study|Study Terminated By Sponsor|355|||
145945462|NCT03114657|526310105|FG001|Overall Study|Study Terminated By Sponsor|374|||
145945463|NCT03114657|526310104|FG000|Overall Study|Symptomatic Deterioration|0|||
145945464|NCT03114657|526310105|FG001|Overall Study|Symptomatic Deterioration|1|||
145945465|NCT03114657|526310104|FG000|Overall Study|Withdrawal by Subject|28|||
145945466|NCT03114657|526310105|FG001|Overall Study|Withdrawal by Subject|22|||
145945467|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
145945468|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
145945469|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
145945470|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
145945471|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
145945472|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
145945473|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
145945474|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
145945475|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
145945476|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
145945477|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
145945478|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
145945479|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2|Death|0|||
145945480|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2|Death|0|||
145945481|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2|Death|1|||
145945482|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2|Death|0|||
145945483|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145945484|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
145945485|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145945486|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145945487|NCT01179737|526310106|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
145945488|NCT01179737|526310107|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
145945489|NCT01179737|526310108|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
145945490|NCT01179737|526310109|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
145945491|NCT01179737|526310106|FG000|Extension|The study was terminated|3|||
145945492|NCT01179737|526310107|FG001|Extension|The study was terminated|0|||
145945493|NCT01179737|526310108|FG002|Extension|The study was terminated|0|||
145945494|NCT01179737|526310109|FG003|Extension|The study was terminated|0|||
145945495|NCT00115037|526310110|FG000|Phase1|Lost to Follow-up|16|||
145945496|NCT00115037|526310111|FG001|Phase1|Lost to Follow-up|23|||
145945497|NCT00115037|526310112|FG002|Phase1|Lost to Follow-up|0|||
145945498|NCT00115037|526310113|FG003|Phase1|Lost to Follow-up|0|||
145945499|NCT00115037|526310114|FG004|Phase1|Lost to Follow-up|0|||
145945500|NCT00115037|526310115|FG005|Phase1|Lost to Follow-up|0|||
145945501|NCT00115037|526310110|FG000|Phase1|Withdrawal by Subject|9|||
145945502|NCT00115037|526310111|FG001|Phase1|Withdrawal by Subject|4|||
145945503|NCT00115037|526310112|FG002|Phase1|Withdrawal by Subject|0|||
145945504|NCT00115037|526310113|FG003|Phase1|Withdrawal by Subject|0|||
145945505|NCT00115037|526310114|FG004|Phase1|Withdrawal by Subject|0|||
145945506|NCT00115037|526310115|FG005|Phase1|Withdrawal by Subject|0|||
145945507|NCT00115037|526310110|FG000|Phase2|Death|0|||
145945508|NCT00115037|526310111|FG001|Phase2|Death|0|||
145945509|NCT00115037|526310112|FG002|Phase2|Death|1|||
145945510|NCT00115037|526310113|FG003|Phase2|Death|0|||
145945511|NCT00115037|526310114|FG004|Phase2|Death|0|||
145945512|NCT00115037|526310115|FG005|Phase2|Death|1|||
145945513|NCT00115037|526310110|FG000|Phase2|Withdrawal by Subject|0|||
145945514|NCT00115037|526310111|FG001|Phase2|Withdrawal by Subject|0|||
145945515|NCT00115037|526310112|FG002|Phase2|Withdrawal by Subject|2|||
145945516|NCT00115037|526310113|FG003|Phase2|Withdrawal by Subject|1|||
145945517|NCT00115037|526310114|FG004|Phase2|Withdrawal by Subject|2|||
146413332|NCT01697449|528018100|FG000|Overall Study|Death|2|||
146413333|NCT01697449|528018100|FG000|Overall Study|Other|1|||
145945518|NCT00115037|526310115|FG005|Phase2|Withdrawal by Subject|1|||
145945519|NCT00115037|526310110|FG000|Phase2|Lost to Follow-up|0|||
145945520|NCT00115037|526310111|FG001|Phase2|Lost to Follow-up|0|||
145945521|NCT00115037|526310112|FG002|Phase2|Lost to Follow-up|12|||
145945522|NCT00115037|526310113|FG003|Phase2|Lost to Follow-up|14|||
145945523|NCT00115037|526310114|FG004|Phase2|Lost to Follow-up|4|||
145945524|NCT00115037|526310115|FG005|Phase2|Lost to Follow-up|10|||
145945525|NCT01398410|526310116|FG000|Overall Study|Adverse Event|12|||
145945526|NCT01398410|526310117|FG001|Overall Study|Adverse Event|16|||
145945527|NCT01398410|526310116|FG000|Overall Study|Participants Choice|8|||
146413334|NCT01697449|528018100|FG000|Overall Study|Missing|25|||
146413335|NCT01169844|528018101|FG000|Overall Study|Adverse Event|0|||
146413336|NCT01169844|528018102|FG001|Overall Study|Adverse Event|1|||
145945528|NCT01398410|526310117|FG001|Overall Study|Participants Choice|11|||
145945529|NCT01398410|526310116|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
145945530|NCT01398410|526310117|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
145945531|NCT01398410|526310116|FG000|Overall Study|Other|36|||
145945532|NCT01398410|526310117|FG001|Overall Study|Other|29|||
145945533|NCT00717275|526310118|FG000|Overall Study|Premature study termination.|3|||
145945534|NCT00424021|526310120|FG000|NCT00046319 Study Period|Adverse Event|1|||
145945535|NCT00424021|526310121|FG001|NCT00046319 Study Period|Adverse Event|0|||
145945536|NCT00424021|526310122|FG002|NCT00046319 Study Period|Adverse Event|1|||
145945537|NCT00424021|526310123|FG003|NCT00046319 Study Period|Adverse Event|1|||
145945538|NCT00424021|526310120|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
145945539|NCT00424021|526310121|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
145945540|NCT00424021|526310122|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
145945541|NCT00424021|526310123|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
145945542|NCT00424021|526310120|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
145945543|NCT00424021|526310121|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
145945544|NCT00424021|526310122|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
145945545|NCT00424021|526310123|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
145945546|NCT00424021|526310120|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
145945547|NCT00424021|526310121|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
145945548|NCT00424021|526310122|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
145945549|NCT00424021|526310123|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
145945550|NCT00424021|526310120|FG000|AMB-220-E Study Period|Adverse Event|1|||
145945551|NCT00424021|526310121|FG001|AMB-220-E Study Period|Adverse Event|1|||
145945552|NCT00424021|526310122|FG002|AMB-220-E Study Period|Adverse Event|3|||
145945553|NCT00424021|526310123|FG003|AMB-220-E Study Period|Adverse Event|7|||
145945554|NCT00424021|526310120|FG000|AMB-220-E Study Period|Death|0|||
145945555|NCT00424021|526310121|FG001|AMB-220-E Study Period|Death|0|||
145945556|NCT00424021|526310122|FG002|AMB-220-E Study Period|Death|1|||
145945557|NCT00424021|526310123|FG003|AMB-220-E Study Period|Death|1|||
145945558|NCT00424021|526310120|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
145945559|NCT00424021|526310121|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
145945560|NCT00424021|526310122|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
145945561|NCT00424021|526310123|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
145945562|NCT00424021|526310120|FG000|AMB-220-E Study Period|Physician Decision|0|||
145945563|NCT00424021|526310121|FG001|AMB-220-E Study Period|Physician Decision|0|||
145945564|NCT00424021|526310122|FG002|AMB-220-E Study Period|Physician Decision|0|||
145945565|NCT00424021|526310123|FG003|AMB-220-E Study Period|Physician Decision|1|||
145945566|NCT01254721|526310124|FG000|Overall Study|Lost to Follow-up|0|||
145945567|NCT01254721|526310125|FG001|Overall Study|Lost to Follow-up|4|||
145945568|NCT01254721|526310124|FG000|Overall Study|Lack of Efficacy|4|||
145945569|NCT01254721|526310125|FG001|Overall Study|Lack of Efficacy|2|||
145945570|NCT01254721|526310124|FG000|Overall Study|Death|0|||
145945571|NCT01254721|526310125|FG001|Overall Study|Death|1|||
145945572|NCT01254721|526310124|FG000|Overall Study|technical problum|1|||
145945573|NCT01254721|526310125|FG001|Overall Study|technical problum|0|||
145945574|NCT01254721|526310124|FG000|Overall Study|Adverse Event|2|||
145945575|NCT01254721|526310125|FG001|Overall Study|Adverse Event|3|||
145945576|NCT01254721|526310124|FG000|Overall Study|Withdrawal by Subject|8|||
145945577|NCT01254721|526310125|FG001|Overall Study|Withdrawal by Subject|11|||
145945578|NCT01254721|526310124|FG000|Overall Study|Wrongly randomization|0|||
145945579|NCT01254721|526310125|FG001|Overall Study|Wrongly randomization|1|||
145945580|NCT03769194|526310126|FG000|Overall Study|Withdrawal by Subject|0|||
145945581|NCT03769194|526310127|FG001|Overall Study|Withdrawal by Subject|7|||
145945582|NCT03769194|526310128|FG002|Overall Study|Withdrawal by Subject|4|||
145945583|NCT03769194|526310129|FG003|Overall Study|Withdrawal by Subject|1|||
145945584|NCT03769194|526310126|FG000|Overall Study|moved from study area|0|||
145945585|NCT03769194|526310127|FG001|Overall Study|moved from study area|2|||
145945586|NCT03769194|526310128|FG002|Overall Study|moved from study area|1|||
145945587|NCT03769194|526310129|FG003|Overall Study|moved from study area|1|||
145945588|NCT03769194|526310126|FG000|Overall Study|Lost to Follow-up|3|||
145945589|NCT03769194|526310127|FG001|Overall Study|Lost to Follow-up|6|||
145945590|NCT03769194|526310128|FG002|Overall Study|Lost to Follow-up|3|||
145945591|NCT03769194|526310129|FG003|Overall Study|Lost to Follow-up|6|||
145945592|NCT03769194|526310126|FG000|Overall Study|other|1|||
145945593|NCT03769194|526310127|FG001|Overall Study|other|3|||
145945594|NCT03769194|526310128|FG002|Overall Study|other|0|||
145945595|NCT03769194|526310129|FG003|Overall Study|other|1|||
145945596|NCT03597022|526310130|FG000|Overall Study|Premature termination of the study|7|||
145945597|NCT03597022|526310131|FG001|Overall Study|Premature termination of the study|7|||
145945598|NCT03597022|526310132|FG002|Overall Study|Premature termination of the study|8|||
145945599|NCT03597022|526310130|FG000|Overall Study|Serious adverse event|1|||
145945600|NCT03597022|526310131|FG001|Overall Study|Serious adverse event|1|||
145945601|NCT03597022|526310132|FG002|Overall Study|Serious adverse event|0|||
145945602|NCT00553358|526310133|FG000|Overall Study|Randomized but did not receive treatment|3|||
145945603|NCT00553358|526310134|FG001|Overall Study|Randomized but did not receive treatment|3|||
145945604|NCT00553358|526310135|FG002|Overall Study|Randomized but did not receive treatment|1|||
145945605|NCT00553358|526310133|FG000|Overall Study|Lost to Follow-up|22|||
145945606|NCT00553358|526310134|FG001|Overall Study|Lost to Follow-up|26|||
145945607|NCT00553358|526310135|FG002|Overall Study|Lost to Follow-up|18|||
145945608|NCT00553358|526310133|FG000|Overall Study|Withdrew completely|23|||
145945609|NCT00553358|526310134|FG001|Overall Study|Withdrew completely|33|||
145945610|NCT00553358|526310135|FG002|Overall Study|Withdrew completely|34|||
145945611|NCT00553358|526310133|FG000|Overall Study|Died during clinical follow-up|25|||
145945612|NCT00553358|526310134|FG001|Overall Study|Died during clinical follow-up|29|||
145945613|NCT00553358|526310135|FG002|Overall Study|Died during clinical follow-up|32|||
145945614|NCT00553358|526310133|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
145945615|NCT00553358|526310134|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
145945616|NCT00553358|526310135|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
145945617|NCT00553358|526310133|FG000|Overall Study|Died after clinical follow-up ended|1|||
145945618|NCT00553358|526310134|FG001|Overall Study|Died after clinical follow-up ended|2|||
145945619|NCT00553358|526310135|FG002|Overall Study|Died after clinical follow-up ended|0|||
145945620|NCT00553358|526310133|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145945621|NCT00553358|526310134|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145945622|NCT00553358|526310135|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145945623|NCT03209518|526310136|FG000|Overall Study|Case Report Forms Uncollected|1|||
145945624|NCT03209518|526310136|FG000|Overall Study|Protocol Deviation|1|||
145945625|NCT00236899|526310141|FG000|Overall Study|Adverse Event (Study Related)|1|||
145945626|NCT00236899|526310142|FG001|Overall Study|Adverse Event (Study Related)|1|||
145945627|NCT00236899|526310143|FG002|Overall Study|Adverse Event (Study Related)|2|||
145945628|NCT00236899|526310144|FG003|Overall Study|Adverse Event (Study Related)|1|||
145945629|NCT00236899|526310141|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
145945630|NCT00236899|526310142|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
145945631|NCT00236899|526310143|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
145945632|NCT00236899|526310144|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
145945633|NCT00236899|526310141|FG000|Overall Study|Death (Study Disease)|1|||
145945634|NCT00236899|526310142|FG001|Overall Study|Death (Study Disease)|4|||
145945635|NCT00236899|526310143|FG002|Overall Study|Death (Study Disease)|0|||
145945636|NCT00236899|526310144|FG003|Overall Study|Death (Study Disease)|0|||
145945637|NCT00236899|526310141|FG000|Overall Study|Death (Not Study Related)|2|||
145945638|NCT00236899|526310142|FG001|Overall Study|Death (Not Study Related)|0|||
145945639|NCT00236899|526310143|FG002|Overall Study|Death (Not Study Related)|0|||
145945640|NCT00236899|526310144|FG003|Overall Study|Death (Not Study Related)|0|||
145945641|NCT00236899|526310141|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
145945642|NCT00236899|526310142|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
145945643|NCT00236899|526310143|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
145945644|NCT00236899|526310144|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
145945645|NCT00236899|526310141|FG000|Overall Study|Lost to Follow-up|0|||
145945646|NCT00236899|526310142|FG001|Overall Study|Lost to Follow-up|1|||
145945647|NCT00236899|526310143|FG002|Overall Study|Lost to Follow-up|0|||
145945648|NCT00236899|526310144|FG003|Overall Study|Lost to Follow-up|0|||
145945649|NCT00236899|526310141|FG000|Overall Study|Entry Criteria Exclusion|0|||
145945650|NCT00236899|526310142|FG001|Overall Study|Entry Criteria Exclusion|1|||
145945651|NCT00236899|526310143|FG002|Overall Study|Entry Criteria Exclusion|1|||
145945652|NCT00236899|526310144|FG003|Overall Study|Entry Criteria Exclusion|0|||
145945653|NCT00236899|526310141|FG000|Overall Study|Protocol Violation|1|||
145945654|NCT00236899|526310142|FG001|Overall Study|Protocol Violation|0|||
145945655|NCT00236899|526310143|FG002|Overall Study|Protocol Violation|0|||
145945656|NCT00236899|526310144|FG003|Overall Study|Protocol Violation|0|||
145945657|NCT00236899|526310141|FG000|Overall Study|Withdrawal by Subject|6|||
145945658|NCT00236899|526310142|FG001|Overall Study|Withdrawal by Subject|4|||
145945659|NCT00236899|526310143|FG002|Overall Study|Withdrawal by Subject|5|||
145945660|NCT00236899|526310144|FG003|Overall Study|Withdrawal by Subject|2|||
145945661|NCT00236899|526310141|FG000|Overall Study|Physician Decision|7|||
145945662|NCT00236899|526310142|FG001|Overall Study|Physician Decision|8|||
145945663|NCT00236899|526310143|FG002|Overall Study|Physician Decision|7|||
145945664|NCT00236899|526310144|FG003|Overall Study|Physician Decision|6|||
145945665|NCT00236899|526310141|FG000|Overall Study|Satisfactory Response|2|||
145945666|NCT00236899|526310142|FG001|Overall Study|Satisfactory Response|0|||
145945667|NCT00236899|526310143|FG002|Overall Study|Satisfactory Response|0|||
145945668|NCT00236899|526310144|FG003|Overall Study|Satisfactory Response|1|||
145945669|NCT00236899|526310141|FG000|Overall Study|Lack of Efficacy|18|||
145945670|NCT00236899|526310142|FG001|Overall Study|Lack of Efficacy|18|||
145945671|NCT00236899|526310143|FG002|Overall Study|Lack of Efficacy|25|||
146082107|NCT02509117|526820589|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146284457|NCT01688830|527553729|FG010|Overall Study|Lost to Follow-up|1|||
145945672|NCT00236899|526310144|FG003|Overall Study|Lack of Efficacy|23|||
145945673|NCT01285492|526310145|FG000|Overall Study|Adverse Event|11|||
145945674|NCT01285492|526310146|FG001|Overall Study|Adverse Event|0|||
145945675|NCT01285492|526310145|FG000|Overall Study|Protocol Violation|3|||
145945676|NCT01285492|526310146|FG001|Overall Study|Protocol Violation|0|||
145945677|NCT01285492|526310145|FG000|Overall Study|Withdrawal by Subject|2|||
145945678|NCT01285492|526310146|FG001|Overall Study|Withdrawal by Subject|1|||
145945679|NCT01285492|526310145|FG000|Overall Study|Death|1|||
145945680|NCT01285492|526310146|FG001|Overall Study|Death|0|||
145945681|NCT00306787|526310147|FG000|Overall Study|Discontinued without taking study drug|208|||
145945682|NCT00306787|526310148|FG001|Overall Study|Discontinued without taking study drug|215|||
145945683|NCT00306787|526310147|FG000|Overall Study|Adverse Event|1|||
145945684|NCT00306787|526310148|FG001|Overall Study|Adverse Event|1|||
145945685|NCT00306787|526310147|FG000|Overall Study|Lack of Efficacy|1|||
145945686|NCT00306787|526310148|FG001|Overall Study|Lack of Efficacy|0|||
145945687|NCT00306787|526310147|FG000|Overall Study|Protocol Violation|8|||
145945688|NCT00306787|526310148|FG001|Overall Study|Protocol Violation|10|||
145945689|NCT00306787|526310147|FG000|Overall Study|Withdrawal by Subject|2|||
145945690|NCT00306787|526310148|FG001|Overall Study|Withdrawal by Subject|9|||
145945691|NCT00306787|526310147|FG000|Overall Study|Lost to Follow-up|9|||
145945692|NCT00306787|526310148|FG001|Overall Study|Lost to Follow-up|6|||
145945693|NCT00306787|526310147|FG000|Overall Study|Administrative problems|4|||
145945694|NCT00306787|526310148|FG001|Overall Study|Administrative problems|0|||
145945695|NCT00306787|526310147|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145945696|NCT00306787|526310148|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145945697|NCT01438814|526310149|FG000|Overall Study|Adverse Event|3|||
145945698|NCT01438814|526310150|FG001|Overall Study|Adverse Event|3|||
145945699|NCT01438814|526310149|FG000|Overall Study|Protocol Violation|1|||
145945700|NCT01438814|526310150|FG001|Overall Study|Protocol Violation|2|||
145945701|NCT01438814|526310149|FG000|Overall Study|Lost to Follow-up|4|||
145945702|NCT01438814|526310150|FG001|Overall Study|Lost to Follow-up|3|||
145945703|NCT01438814|526310149|FG000|Overall Study|Withdrawal by Subject|4|||
145945704|NCT01438814|526310150|FG001|Overall Study|Withdrawal by Subject|2|||
145945705|NCT01438814|526310149|FG000|Overall Study|Other|2|||
145945706|NCT01438814|526310150|FG001|Overall Study|Other|4|||
145945707|NCT02273908|526310151|FG000|Overall Study|Adverse Event|16|||
145945708|NCT02273908|526310152|FG001|Overall Study|Adverse Event|0|||
145945709|NCT02273908|526310151|FG000|Overall Study|Lost to Follow-up|10|||
145945710|NCT02273908|526310152|FG001|Overall Study|Lost to Follow-up|1|||
145945711|NCT02273908|526310151|FG000|Overall Study|Did not meet entrance criteria|3|||
145945712|NCT02273908|526310152|FG001|Overall Study|Did not meet entrance criteria|2|||
145945713|NCT02273908|526310151|FG000|Overall Study|Withdrawal by Subject|4|||
145945714|NCT02273908|526310152|FG001|Overall Study|Withdrawal by Subject|2|||
145945715|NCT00369161|526310153|FG000|Overall Study|Adverse Event|15|||
145945716|NCT00369161|526310154|FG001|Overall Study|Adverse Event|13|||
146192243|NCT02698436|527213994|FG001|Overall Study|Withdrawal by Subject|3|||
146192244|NCT02698436|527213993|FG000|Overall Study|Lost to Follow-up|2|||
146192245|NCT02698436|527213994|FG001|Overall Study|Lost to Follow-up|4|||
145945717|NCT00369161|526310153|FG000|Overall Study|Abnormal laboratory value|0|||
145945718|NCT00369161|526310154|FG001|Overall Study|Abnormal laboratory value|1|||
145945719|NCT00369161|526310153|FG000|Overall Study|Lack of Efficacy|3|||
145945720|NCT00369161|526310154|FG001|Overall Study|Lack of Efficacy|1|||
145945721|NCT00369161|526310153|FG000|Overall Study|Protocol Violation|0|||
146192246|NCT02698436|527213993|FG000|Overall Study|Non-compliance with study regimen|1|||
145945722|NCT00369161|526310154|FG001|Overall Study|Protocol Violation|2|||
145945723|NCT00369161|526310153|FG000|Overall Study|Withdrawal by Subject|2|||
145945724|NCT00369161|526310154|FG001|Overall Study|Withdrawal by Subject|3|||
145945725|NCT00369161|526310153|FG000|Overall Study|Death|1|||
145945726|NCT00369161|526310154|FG001|Overall Study|Death|2|||
145945727|NCT00369161|526310153|FG000|Overall Study|Graft loss|4|||
145945728|NCT00369161|526310154|FG001|Overall Study|Graft loss|0|||
145945729|NCT00369161|526310153|FG000|Overall Study|Administrative Problem|2|||
145945730|NCT00369161|526310154|FG001|Overall Study|Administrative Problem|2|||
145945731|NCT04908475|526310155|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
145945732|NCT04908475|526310156|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145945733|NCT04908475|526310157|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145945734|NCT04908475|526310158|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145945735|NCT04908475|526310159|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145945736|NCT04908475|526310160|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145945737|NCT04908475|526310155|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
145945738|NCT04908475|526310156|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145945739|NCT04908475|526310157|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145945740|NCT04908475|526310158|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145945741|NCT04908475|526310159|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145945742|NCT04908475|526310160|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145945743|NCT04908475|526310155|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
145945744|NCT04908475|526310156|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145945745|NCT04908475|526310157|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145945746|NCT04908475|526310158|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145945747|NCT04908475|526310159|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145945748|NCT04908475|526310160|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145945749|NCT04908475|526310155|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145945750|NCT04908475|526310156|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
145945751|NCT04908475|526310157|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
145945752|NCT04908475|526310158|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
145945753|NCT04908475|526310159|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145945754|NCT04908475|526310160|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145945755|NCT04908475|526310155|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
145945756|NCT04908475|526310156|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
145945757|NCT04908475|526310157|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
145945758|NCT04908475|526310158|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
145945759|NCT04908475|526310159|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
145945760|NCT04908475|526310160|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
145945761|NCT04908475|526310155|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
145945762|NCT04908475|526310156|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
145945763|NCT04908475|526310157|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
145945764|NCT04908475|526310158|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
145945765|NCT04908475|526310159|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
145945766|NCT04908475|526310160|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
145945767|NCT01870297|526310161|FG000|Overall Study|Adverse Event|0|||
145945768|NCT01870297|526310162|FG001|Overall Study|Adverse Event|0|||
145945769|NCT01870297|526310163|FG002|Overall Study|Adverse Event|0|||
145945770|NCT01870297|526310164|FG003|Overall Study|Adverse Event|0|||
145945771|NCT01870297|526310165|FG004|Overall Study|Adverse Event|2|||
145945772|NCT01870297|526310166|FG005|Overall Study|Adverse Event|0|||
145945773|NCT01870297|526310167|FG006|Overall Study|Adverse Event|0|||
145945774|NCT01870297|526310161|FG000|Overall Study|Lost to Follow-up|0|||
145945775|NCT01870297|526310162|FG001|Overall Study|Lost to Follow-up|1|||
145945776|NCT01870297|526310163|FG002|Overall Study|Lost to Follow-up|1|||
145945777|NCT01870297|526310164|FG003|Overall Study|Lost to Follow-up|0|||
145945778|NCT01870297|526310165|FG004|Overall Study|Lost to Follow-up|0|||
145945779|NCT01870297|526310166|FG005|Overall Study|Lost to Follow-up|0|||
145945780|NCT01870297|526310167|FG006|Overall Study|Lost to Follow-up|0|||
145945781|NCT01870297|526310161|FG000|Overall Study|Withdrawal by Subject|0|||
145945782|NCT01870297|526310162|FG001|Overall Study|Withdrawal by Subject|0|||
145945783|NCT01870297|526310163|FG002|Overall Study|Withdrawal by Subject|0|||
145945784|NCT01870297|526310164|FG003|Overall Study|Withdrawal by Subject|0|||
145945785|NCT01870297|526310165|FG004|Overall Study|Withdrawal by Subject|1|||
145945786|NCT01870297|526310166|FG005|Overall Study|Withdrawal by Subject|1|||
145945787|NCT01870297|526310167|FG006|Overall Study|Withdrawal by Subject|1|||
145945788|NCT01870297|526310161|FG000|Overall Study|Sponsor Decision|0|||
145945789|NCT01870297|526310162|FG001|Overall Study|Sponsor Decision|6|||
145945790|NCT01870297|526310163|FG002|Overall Study|Sponsor Decision|0|||
145945791|NCT01870297|526310164|FG003|Overall Study|Sponsor Decision|0|||
145945792|NCT01870297|526310165|FG004|Overall Study|Sponsor Decision|0|||
145945793|NCT01870297|526310166|FG005|Overall Study|Sponsor Decision|0|||
145945794|NCT01870297|526310167|FG006|Overall Study|Sponsor Decision|1|||
145945795|NCT01739764|526310168|FG000|Overall Study|Adverse Event|0|||
145945796|NCT01739764|526310169|FG001|Overall Study|Adverse Event|3|||
145945797|NCT01739764|526310170|FG002|Overall Study|Adverse Event|4|||
145945798|NCT01739764|526310168|FG000|Overall Study|Death|4|||
145945799|NCT01739764|526310169|FG001|Overall Study|Death|6|||
145945800|NCT01739764|526310170|FG002|Overall Study|Death|38|||
145945801|NCT01739764|526310168|FG000|Overall Study|Lost to Follow-up|0|||
145945802|NCT01739764|526310169|FG001|Overall Study|Lost to Follow-up|0|||
145945803|NCT01739764|526310170|FG002|Overall Study|Lost to Follow-up|5|||
145945804|NCT01739764|526310168|FG000|Overall Study|Non-Compliance|0|||
145945805|NCT01739764|526310169|FG001|Overall Study|Non-Compliance|0|||
145945806|NCT01739764|526310170|FG002|Overall Study|Non-Compliance|1|||
145945807|NCT01739764|526310168|FG000|Overall Study|Multiple Reasons|3|||
145945808|NCT01739764|526310169|FG001|Overall Study|Multiple Reasons|2|||
145945809|NCT01739764|526310170|FG002|Overall Study|Multiple Reasons|3|||
145945810|NCT01739764|526310168|FG000|Overall Study|Physician Decision|2|||
145945811|NCT01739764|526310169|FG001|Overall Study|Physician Decision|2|||
145945812|NCT01739764|526310170|FG002|Overall Study|Physician Decision|4|||
145945813|NCT01739764|526310168|FG000|Overall Study|Progressive Disease|3|||
145945814|NCT01739764|526310169|FG001|Overall Study|Progressive Disease|5|||
145945815|NCT01739764|526310170|FG002|Overall Study|Progressive Disease|16|||
145945816|NCT01739764|526310168|FG000|Overall Study|Protocol Violation|0|||
145945817|NCT01739764|526310169|FG001|Overall Study|Protocol Violation|0|||
145945818|NCT01739764|526310170|FG002|Overall Study|Protocol Violation|2|||
145945819|NCT01739764|526310168|FG000|Overall Study|Study Terminated by Sponsor|8|||
145945820|NCT01739764|526310169|FG001|Overall Study|Study Terminated by Sponsor|13|||
145945821|NCT01739764|526310170|FG002|Overall Study|Study Terminated by Sponsor|26|||
145945822|NCT01739764|526310168|FG000|Overall Study|Withdrawal by Subject|6|||
145945823|NCT01739764|526310169|FG001|Overall Study|Withdrawal by Subject|5|||
145945824|NCT01739764|526310170|FG002|Overall Study|Withdrawal by Subject|27|||
145945825|NCT00337779|526310171|FG000|Overall Study|Withdrawal by Subject|10|||
145945826|NCT00337779|526310172|FG001|Overall Study|Withdrawal by Subject|12|||
145945827|NCT00337779|526310171|FG000|Overall Study|Sponsor decision|1|||
145945828|NCT00337779|526310172|FG001|Overall Study|Sponsor decision|1|||
145945829|NCT00337779|526310171|FG000|Overall Study|Physician Decision|3|||
145945830|NCT00337779|526310172|FG001|Overall Study|Physician Decision|6|||
145945831|NCT00337779|526310171|FG000|Overall Study|Protocol Violation|1|||
145945832|NCT00337779|526310172|FG001|Overall Study|Protocol Violation|1|||
145945833|NCT00337779|526310171|FG000|Overall Study|Lost to Follow-up|6|||
145945834|NCT00337779|526310172|FG001|Overall Study|Lost to Follow-up|5|||
145945835|NCT00337779|526310171|FG000|Overall Study|Adverse Event|28|||
145945836|NCT00337779|526310172|FG001|Overall Study|Adverse Event|51|||
145945837|NCT00337779|526310171|FG000|Overall Study|Pregnancy|3|||
145945838|NCT00337779|526310172|FG001|Overall Study|Pregnancy|2|||
145945839|NCT00337779|526310171|FG000|Overall Study|Death|0|||
145945840|NCT00337779|526310172|FG001|Overall Study|Death|1|||
145945841|NCT00404924|526310173|FG000|Overall Study|Adverse Event|75|||
145945842|NCT00404924|526310174|FG001|Overall Study|Adverse Event|16|||
145945843|NCT00404924|526310173|FG000|Overall Study|Condition under investigation worsened|475|||
145945844|NCT00404924|526310174|FG001|Overall Study|Condition under investigation worsened|264|||
145945845|NCT00404924|526310173|FG000|Overall Study|Lost to Follow-up|1|||
145945846|NCT00404924|526310174|FG001|Overall Study|Lost to Follow-up|1|||
145945847|NCT00404924|526310173|FG000|Overall Study|Withdrawal by Subject|26|||
145945848|NCT00404924|526310174|FG001|Overall Study|Withdrawal by Subject|13|||
145945849|NCT00404924|526310173|FG000|Overall Study|Other|25|||
145945850|NCT00404924|526310174|FG001|Overall Study|Other|11|||
145945851|NCT00404924|526310173|FG000|Overall Study|Randomised but not received treatment|1|||
145945852|NCT00404924|526310174|FG001|Overall Study|Randomised but not received treatment|1|||
145945853|NCT01074255|526310181|FG000|Overall Study|Did not receive EMEND|2|||
145945854|NCT00422422|526310182|FG000|Overall Study|Lack of Efficacy|1|||
145945855|NCT00422422|526310182|FG000|Overall Study|Protocol Violation|1|||
145945856|NCT00422422|526310182|FG000|Overall Study|Withdrawal by Subject|2|||
145945857|NCT00422422|526310182|FG000|Overall Study|SAE, non-fatal|1|||
145945858|NCT00422422|526310182|FG000|Overall Study|AE, non-serious non-fatal|5|||
145945859|NCT02943785|526310183|FG000|Overall Study|Adverse Event|112|||
145945860|NCT02943785|526310184|FG001|Overall Study|Adverse Event|97|||
145945861|NCT02943785|526310183|FG000|Overall Study|Withdrawal by Subject|63|||
145945862|NCT02943785|526310184|FG001|Overall Study|Withdrawal by Subject|126|||
145945863|NCT02943785|526310183|FG000|Overall Study|Physician Decision|23|||
145945864|NCT02943785|526310184|FG001|Overall Study|Physician Decision|47|||
145945865|NCT02943785|526310183|FG000|Overall Study|Death|46|||
145945866|NCT02943785|526310184|FG001|Overall Study|Death|46|||
145945867|NCT02943785|526310183|FG000|Overall Study|Lost to Follow-up|1|||
145945868|NCT02943785|526310184|FG001|Overall Study|Lost to Follow-up|0|||
145945869|NCT02943785|526310183|FG000|Overall Study|Other|16|||
145945870|NCT02943785|526310184|FG001|Overall Study|Other|19|||
145945871|NCT02943785|526310183|FG000|Overall Study|Did not receive any study medication|21|||
145945872|NCT02943785|526310184|FG001|Overall Study|Did not receive any study medication|28|||
145945873|NCT03313310|526310186|FG000|Phase 2|Lost to Follow-up|4|||
145945874|NCT03313310|526310187|FG001|Phase 2|Lost to Follow-up|0|||
145945875|NCT03313310|526310186|FG000|Phase 3|Lost to Follow-up|0|||
145945876|NCT03313310|526310187|FG001|Phase 3|Lost to Follow-up|1|||
145945877|NCT03170609|526310188|FG000|Overall Study|Death|0|||
145945878|NCT03170609|526310189|FG001|Overall Study|Death|0|||
145945879|NCT03170609|526310190|FG002|Overall Study|Death|1|||
145945880|NCT03170609|526310191|FG003|Overall Study|Death|0|||
145945881|NCT03170609|526310192|FG004|Overall Study|Death|0|||
145945882|NCT03170609|526310193|FG005|Overall Study|Death|0|||
145945883|NCT03170609|526310194|FG006|Overall Study|Death|0|||
145945884|NCT03170609|526310188|FG000|Overall Study|Withdrawal by Subject|1|||
145945885|NCT03170609|526310189|FG001|Overall Study|Withdrawal by Subject|2|||
145945886|NCT03170609|526310190|FG002|Overall Study|Withdrawal by Subject|0|||
145945887|NCT03170609|526310191|FG003|Overall Study|Withdrawal by Subject|0|||
145945888|NCT03170609|526310192|FG004|Overall Study|Withdrawal by Subject|0|||
145945889|NCT03170609|526310193|FG005|Overall Study|Withdrawal by Subject|0|||
145945890|NCT03170609|526310194|FG006|Overall Study|Withdrawal by Subject|1|||
145945891|NCT03170609|526310188|FG000|Overall Study|Lost to Follow-up|1|||
145945892|NCT03170609|526310189|FG001|Overall Study|Lost to Follow-up|0|||
145945893|NCT03170609|526310190|FG002|Overall Study|Lost to Follow-up|5|||
145945894|NCT03170609|526310191|FG003|Overall Study|Lost to Follow-up|2|||
145945895|NCT03170609|526310192|FG004|Overall Study|Lost to Follow-up|1|||
145945896|NCT03170609|526310193|FG005|Overall Study|Lost to Follow-up|1|||
146413337|NCT01169844|528018101|FG000|Overall Study|Patient withdrew consent|4|||
146413338|NCT01169844|528018102|FG001|Overall Study|Patient withdrew consent|0|||
146413339|NCT01169844|528018101|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146413340|NCT01169844|528018102|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146413341|NCT01337050|528018106|FG000|Overall Study|Death|0|||
146413342|NCT01337050|528018107|FG001|Overall Study|Death|0|||
146413343|NCT01337050|528018108|FG002|Overall Study|Death|4|||
146413344|NCT01337050|528018106|FG000|Overall Study|Other|4|||
146413345|NCT01337050|528018107|FG001|Overall Study|Other|6|||
146413346|NCT01337050|528018108|FG002|Overall Study|Other|8|||
146413347|NCT01337050|528018106|FG000|Overall Study|Participants refused further follow-up|0|||
146413348|NCT01337050|528018107|FG001|Overall Study|Participants refused further follow-up|7|||
146413349|NCT01337050|528018108|FG002|Overall Study|Participants refused further follow-up|7|||
146413350|NCT00003102|528018109|FG000|Overall Study|Physician Decision|1|||
146413351|NCT00003102|528018110|FG001|Overall Study|Physician Decision|1|||
146192247|NCT02698436|527213994|FG001|Overall Study|Non-compliance with study regimen|0|||
146192248|NCT04949399|527213995|FG000|Overall Study|Lost to Follow-up|11|||
146192249|NCT04949399|527213996|FG001|Overall Study|Lost to Follow-up|6|||
146192250|NCT04949399|527213995|FG000|Overall Study|Withdrawal by Subject|2|||
146192251|NCT04949399|527213996|FG001|Overall Study|Withdrawal by Subject|3|||
146192252|NCT01306331|527215405|FG000|Overall Study|Adverse Event|28|||
146413352|NCT00003102|528018111|FG002|Overall Study|Physician Decision|0|||
146413353|NCT00003102|528018109|FG000|Overall Study|Progressive Disease|0|||
146413354|NCT00003102|528018110|FG001|Overall Study|Progressive Disease|1|||
146413355|NCT00003102|528018111|FG002|Overall Study|Progressive Disease|0|||
146413356|NCT00003102|528018109|FG000|Overall Study|Adverse Event|0|||
146192253|NCT01306331|527215406|FG001|Overall Study|Adverse Event|25|||
146413357|NCT00003102|528018110|FG001|Overall Study|Adverse Event|1|||
145945897|NCT03170609|526310194|FG006|Overall Study|Lost to Follow-up|0|||
145945898|NCT03170609|526310188|FG000|Overall Study|Other|1|||
145945899|NCT03170609|526310189|FG001|Overall Study|Other|0|||
145945900|NCT03170609|526310190|FG002|Overall Study|Other|0|||
145945901|NCT03170609|526310191|FG003|Overall Study|Other|0|||
145945902|NCT03170609|526310192|FG004|Overall Study|Other|0|||
146192254|NCT01306331|527215405|FG000|Overall Study|Lost to Follow-up|321|||
145945903|NCT03170609|526310193|FG005|Overall Study|Other|1|||
145945904|NCT03170609|526310194|FG006|Overall Study|Other|0|||
146192255|NCT01306331|527215406|FG001|Overall Study|Lost to Follow-up|323|||
146192256|NCT01306331|527215405|FG000|Overall Study|Physician Decision|26|||
146192257|NCT01306331|527215406|FG001|Overall Study|Physician Decision|22|||
146192258|NCT01306331|527215405|FG000|Overall Study|Pregnancy|136|||
146192259|NCT01306331|527215406|FG001|Overall Study|Pregnancy|151|||
146192260|NCT01306331|527215405|FG000|Overall Study|Protocol Violation|154|||
146192261|NCT01306331|527215406|FG001|Overall Study|Protocol Violation|124|||
146192262|NCT01306331|527215405|FG000|Overall Study|Withdrawal by Subject|163|||
146192263|NCT01306331|527215406|FG001|Overall Study|Withdrawal by Subject|152|||
146192264|NCT01306331|527215405|FG000|Overall Study|Not sexually active|29|||
146192265|NCT01306331|527215406|FG001|Overall Study|Not sexually active|28|||
146192266|NCT01306331|527215405|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
146192267|NCT01306331|527215406|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
146192268|NCT01306331|527215405|FG000|Overall Study|Other|34|||
146192269|NCT01306331|527215406|FG001|Overall Study|Other|32|||
146192270|NCT01474538|527215410|FG000|Treatment Period 1|Death|1|||
146192271|NCT01474538|527215411|FG001|Treatment Period 1|Death|0|||
146192272|NCT01474538|527215410|FG000|Treatment Period 1|Physician Decision|1|||
146192273|NCT01474538|527215411|FG001|Treatment Period 1|Physician Decision|0|||
146192274|NCT01474538|527215410|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146192275|NCT01474538|527215411|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146192276|NCT01474538|527215410|FG000|Treatment Period 1|Protocol Violation|0|||
146192277|NCT01474538|527215411|FG001|Treatment Period 1|Protocol Violation|1|||
146192278|NCT01474538|527215410|FG000|Treatment Period 2|Death|1|||
146192279|NCT01474538|527215411|FG001|Treatment Period 2|Death|0|||
146192280|NCT01474538|527215410|FG000|Treatment Period 2|Adverse Event|1|||
146192281|NCT01474538|527215411|FG001|Treatment Period 2|Adverse Event|1|||
146192282|NCT01474538|527215410|FG000|Treatment Period 2|Withdrawal by Subject|2|||
146192283|NCT01474538|527215411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146192284|NCT01474538|527215410|FG000|Treatment Period 2|Sponsor decision|1|||
146192285|NCT01474538|527215411|FG001|Treatment Period 2|Sponsor decision|0|||
146192286|NCT01474538|527215410|FG000|Treatment Period 2|Physician Decision|0|||
146192287|NCT01474538|527215411|FG001|Treatment Period 2|Physician Decision|1|||
146192288|NCT01474538|527215410|FG000|Treatment Period 2|Protocol Violation|1|||
146192289|NCT01474538|527215411|FG001|Treatment Period 2|Protocol Violation|0|||
146192290|NCT01456780|527215412|FG000|Overall Study|Lost to Follow-up|3|||
146192291|NCT01456780|527215413|FG001|Overall Study|Lost to Follow-up|3|||
146192292|NCT01456780|527215414|FG002|Overall Study|Lost to Follow-up|0|||
146192293|NCT02688621|527215415|FG000|Overall Study|Pregnancy|1|||
146192294|NCT02688621|527215416|FG001|Overall Study|Pregnancy|3|||
146192295|NCT02688621|527215415|FG000|Overall Study|Lost to Follow-up|38|||
146192296|NCT02688621|527215416|FG001|Overall Study|Lost to Follow-up|15|||
146192297|NCT02688621|527215415|FG000|Overall Study|Withdrawal by Subject|1|||
146192298|NCT02688621|527215416|FG001|Overall Study|Withdrawal by Subject|0|||
146192299|NCT04577183|527215418|FG000|Overall Study|Death|1|||
146192300|NCT04577183|527215418|FG000|Overall Study|Withdrawal by Subject|3|||
146192301|NCT04577183|527215418|FG000|Overall Study|Early termination|2|||
146192302|NCT01168401|527215419|FG000|Overall Study|Lost to Follow-up|1|||
146192303|NCT01168401|527215420|FG001|Overall Study|Lost to Follow-up|1|||
146192304|NCT01168401|527215421|FG002|Overall Study|Lost to Follow-up|2|||
146192305|NCT01168401|527215422|FG003|Overall Study|Lost to Follow-up|1|||
145945905|NCT01281956|526310195|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
146192306|NCT01168401|527215423|FG004|Overall Study|Lost to Follow-up|0|||
145945906|NCT01281956|526310196|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
145945907|NCT01593254|526310200|FG000|Overall Study|Disease progression|2|||
146192307|NCT01168401|527215424|FG005|Overall Study|Lost to Follow-up|0|||
146192308|NCT01168401|527215425|FG006|Overall Study|Lost to Follow-up|0|||
145945908|NCT01593254|526310201|FG001|Overall Study|Disease progression|7|||
145945909|NCT01593254|526310200|FG000|Overall Study|Study drug toxicity|6|||
145945910|NCT01593254|526310201|FG001|Overall Study|Study drug toxicity|20|||
145945911|NCT01593254|526310200|FG000|Overall Study|Death|3|||
146192309|NCT01168401|527215426|FG007|Overall Study|Lost to Follow-up|0|||
146192310|NCT01168401|527215427|FG008|Overall Study|Lost to Follow-up|0|||
146192311|NCT01168401|527215428|FG009|Overall Study|Lost to Follow-up|0|||
146192312|NCT01168401|527215429|FG010|Overall Study|Lost to Follow-up|0|||
146192313|NCT01168401|527215419|FG000|Overall Study|Withdrawal by Subject|0|||
146192314|NCT01168401|527215420|FG001|Overall Study|Withdrawal by Subject|0|||
146192315|NCT01168401|527215421|FG002|Overall Study|Withdrawal by Subject|0|||
146192316|NCT01168401|527215422|FG003|Overall Study|Withdrawal by Subject|1|||
146192317|NCT01168401|527215423|FG004|Overall Study|Withdrawal by Subject|0|||
146192318|NCT01168401|527215424|FG005|Overall Study|Withdrawal by Subject|0|||
146192319|NCT01168401|527215425|FG006|Overall Study|Withdrawal by Subject|0|||
146192320|NCT01168401|527215426|FG007|Overall Study|Withdrawal by Subject|0|||
146192321|NCT01168401|527215427|FG008|Overall Study|Withdrawal by Subject|0|||
146192322|NCT01168401|527215428|FG009|Overall Study|Withdrawal by Subject|0|||
146192323|NCT01168401|527215429|FG010|Overall Study|Withdrawal by Subject|0|||
146192324|NCT00672256|527215430|FG000|Overall Study|PI dropped, bad data|44|||
146192325|NCT01801930|527215432|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
146192326|NCT01801930|527215433|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
146192327|NCT01801930|527215434|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
146192328|NCT01801930|527215435|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
146192329|NCT01801930|527215432|FG000|Overall Study|DLT occurs|0|||
146192330|NCT01801930|527215433|FG001|Overall Study|DLT occurs|1|||
146192331|NCT01801930|527215434|FG002|Overall Study|DLT occurs|0|||
146192332|NCT01801930|527215435|FG003|Overall Study|DLT occurs|0|||
146192333|NCT03101592|527215446|FG000|Overall Study|participant files could not be located|111|||
146192334|NCT03101592|527215447|FG001|Overall Study|participant files could not be located|170|||
146192335|NCT03101592|527215448|FG002|Overall Study|participant files could not be located|118|||
146192336|NCT02095158|527215459|FG000|Overall Study|Adverse Event|14|||
146192337|NCT02095158|527215459|FG000|Overall Study|Lack of Efficacy|3|||
146192338|NCT02095158|527215459|FG000|Overall Study|Pregnancy|1|||
146192339|NCT02095158|527215459|FG000|Overall Study|Lost to Follow-up|20|||
146192340|NCT02095158|527215459|FG000|Overall Study|Personal Reasons|35|||
146192341|NCT02095158|527215459|FG000|Overall Study|Protocol Violation|1|||
146192342|NCT02095158|527215459|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146192343|NCT00941031|527215460|FG000|Induction Period|Lack of Efficacy|2|||
146192344|NCT00941031|527215461|FG001|Induction Period|Lack of Efficacy|1|||
146192345|NCT00941031|527215462|FG002|Induction Period|Lack of Efficacy|0|||
146192346|NCT00941031|527215463|FG003|Induction Period|Lack of Efficacy|5|||
146192347|NCT00941031|527215464|FG004|Induction Period|Lack of Efficacy|0|||
146192348|NCT00941031|527215465|FG005|Induction Period|Lack of Efficacy|0|||
146192349|NCT00941031|527215466|FG006|Induction Period|Lack of Efficacy|0|||
146192350|NCT00941031|527215460|FG000|Induction Period|Withdrawal by Subject|1|||
146192351|NCT00941031|527215461|FG001|Induction Period|Withdrawal by Subject|2|||
146192352|NCT00941031|527215462|FG002|Induction Period|Withdrawal by Subject|2|||
146192353|NCT00941031|527215463|FG003|Induction Period|Withdrawal by Subject|2|||
146192354|NCT00941031|527215464|FG004|Induction Period|Withdrawal by Subject|0|||
146192355|NCT00941031|527215465|FG005|Induction Period|Withdrawal by Subject|0|||
146192356|NCT00941031|527215466|FG006|Induction Period|Withdrawal by Subject|0|||
146192357|NCT00941031|527215460|FG000|Induction Period|Adminstative Problems|1|||
146192358|NCT00941031|527215461|FG001|Induction Period|Adminstative Problems|1|||
146192359|NCT00941031|527215462|FG002|Induction Period|Adminstative Problems|1|||
146192360|NCT00941031|527215463|FG003|Induction Period|Adminstative Problems|0|||
146192361|NCT00941031|527215464|FG004|Induction Period|Adminstative Problems|0|||
146192362|NCT00941031|527215465|FG005|Induction Period|Adminstative Problems|0|||
146192363|NCT00941031|527215466|FG006|Induction Period|Adminstative Problems|0|||
146192364|NCT00941031|527215460|FG000|Induction Period|Adverse Event|1|||
146192365|NCT00941031|527215461|FG001|Induction Period|Adverse Event|0|||
146192366|NCT00941031|527215462|FG002|Induction Period|Adverse Event|3|||
146192367|NCT00941031|527215463|FG003|Induction Period|Adverse Event|2|||
146192368|NCT00941031|527215464|FG004|Induction Period|Adverse Event|0|||
146192369|NCT00941031|527215465|FG005|Induction Period|Adverse Event|0|||
146192370|NCT00941031|527215466|FG006|Induction Period|Adverse Event|0|||
146192371|NCT00941031|527215460|FG000|Maintenance Period|Withdrawal by Subject|0|||
146192372|NCT00941031|527215461|FG001|Maintenance Period|Withdrawal by Subject|0|||
146192373|NCT00941031|527215462|FG002|Maintenance Period|Withdrawal by Subject|0|||
146192374|NCT00941031|527215463|FG003|Maintenance Period|Withdrawal by Subject|0|||
146192375|NCT00941031|527215464|FG004|Maintenance Period|Withdrawal by Subject|6|||
146192376|NCT00941031|527215465|FG005|Maintenance Period|Withdrawal by Subject|2|||
146192377|NCT00941031|527215466|FG006|Maintenance Period|Withdrawal by Subject|13|||
146192378|NCT00941031|527215460|FG000|Maintenance Period|Administrative Problems|0|||
146192379|NCT00941031|527215461|FG001|Maintenance Period|Administrative Problems|0|||
146192380|NCT00941031|527215462|FG002|Maintenance Period|Administrative Problems|0|||
146192381|NCT00941031|527215463|FG003|Maintenance Period|Administrative Problems|0|||
146192382|NCT00941031|527215464|FG004|Maintenance Period|Administrative Problems|1|||
146192383|NCT00941031|527215465|FG005|Maintenance Period|Administrative Problems|0|||
146192384|NCT00941031|527215466|FG006|Maintenance Period|Administrative Problems|1|||
146192385|NCT00941031|527215460|FG000|Maintenance Period|Protocol Violation|0|||
146192386|NCT00941031|527215461|FG001|Maintenance Period|Protocol Violation|0|||
146192387|NCT00941031|527215462|FG002|Maintenance Period|Protocol Violation|0|||
146192388|NCT00941031|527215463|FG003|Maintenance Period|Protocol Violation|0|||
146192389|NCT00941031|527215464|FG004|Maintenance Period|Protocol Violation|0|||
146192390|NCT00941031|527215465|FG005|Maintenance Period|Protocol Violation|0|||
146192391|NCT00941031|527215466|FG006|Maintenance Period|Protocol Violation|1|||
146192392|NCT00941031|527215460|FG000|Maintenance Period|Adverse Event|0|||
146192393|NCT00941031|527215461|FG001|Maintenance Period|Adverse Event|0|||
145945912|NCT01593254|526310201|FG001|Overall Study|Death|3|||
145945913|NCT01593254|526310200|FG000|Overall Study|AE unrelated to study drug|0|||
145945914|NCT01593254|526310201|FG001|Overall Study|AE unrelated to study drug|1|||
145945915|NCT01593254|526310200|FG000|Overall Study|participant request to discontinue study treatment|1|||
145945916|NCT01593254|526310201|FG001|Overall Study|participant request to discontinue study treatment|3|||
145945917|NCT01593254|526310200|FG000|Overall Study|participant withdrew consent|0|||
145945918|NCT01593254|526310201|FG001|Overall Study|participant withdrew consent|9|||
145945919|NCT01593254|526310200|FG000|Overall Study|lost to follow up|1|||
145945920|NCT01593254|526310201|FG001|Overall Study|lost to follow up|6|||
145945921|NCT01593254|526310200|FG000|Overall Study|maximum clinical benefit|1|||
145945922|NCT01593254|526310201|FG001|Overall Study|maximum clinical benefit|2|||
145945923|NCT01593254|526310200|FG000|Overall Study|Poor/non compliance|1|||
145945924|NCT01593254|526310201|FG001|Overall Study|Poor/non compliance|1|||
145945925|NCT01593254|526310200|FG000|Overall Study|Pregnancy|0|||
145945926|NCT01593254|526310201|FG001|Overall Study|Pregnancy|3|||
145945927|NCT01593254|526310200|FG000|Overall Study|participant no longer meets study criteria|1|||
145945928|NCT01593254|526310201|FG001|Overall Study|participant no longer meets study criteria|1|||
145945929|NCT01593254|526310200|FG000|Overall Study|Admin reason by sponsor|7|||
145945930|NCT01593254|526310201|FG001|Overall Study|Admin reason by sponsor|3|||
145945931|NCT01593254|526310200|FG000|Overall Study|Imatinib treatment failure|2|||
145945932|NCT01593254|526310201|FG001|Overall Study|Imatinib treatment failure|0|||
145945933|NCT01593254|526310200|FG000|Overall Study|Other Reasons|61|||
145945934|NCT01593254|526310201|FG001|Overall Study|Other Reasons|115|||
145945935|NCT00791492|526310204|FG000|Overall Study|Withdrawal by Subject|1|||
145945936|NCT00791492|526310205|FG001|Overall Study|Withdrawal by Subject|2|||
145945937|NCT00791492|526310204|FG000|Overall Study|Liver transplantation|5|||
145945938|NCT00791492|526310205|FG001|Overall Study|Liver transplantation|1|||
145945939|NCT00076999|526310208|FG000|Overall Study|Adverse Event|2|||
145945940|NCT00076999|526310209|FG001|Overall Study|Adverse Event|8|||
145945941|NCT00076999|526310210|FG002|Overall Study|Adverse Event|6|||
145945942|NCT00076999|526310211|FG003|Overall Study|Adverse Event|0|||
145945943|NCT00076999|526310212|FG004|Overall Study|Adverse Event|2|||
146192394|NCT00941031|527215462|FG002|Maintenance Period|Adverse Event|0|||
146192395|NCT00941031|527215463|FG003|Maintenance Period|Adverse Event|0|||
146192396|NCT00941031|527215464|FG004|Maintenance Period|Adverse Event|0|||
146192397|NCT00941031|527215465|FG005|Maintenance Period|Adverse Event|2|||
146192398|NCT00941031|527215466|FG006|Maintenance Period|Adverse Event|8|||
146192399|NCT00941031|527215460|FG000|Maintenance Period|Lost to Follow-up|0|||
146192400|NCT00941031|527215461|FG001|Maintenance Period|Lost to Follow-up|0|||
146192401|NCT00941031|527215462|FG002|Maintenance Period|Lost to Follow-up|0|||
146192402|NCT00941031|527215463|FG003|Maintenance Period|Lost to Follow-up|0|||
146192403|NCT00941031|527215464|FG004|Maintenance Period|Lost to Follow-up|2|||
146192404|NCT00941031|527215465|FG005|Maintenance Period|Lost to Follow-up|2|||
146192405|NCT00941031|527215466|FG006|Maintenance Period|Lost to Follow-up|7|||
145945944|NCT00076999|526310208|FG000|Overall Study|Protocol Violation|0|||
145945945|NCT00076999|526310209|FG001|Overall Study|Protocol Violation|3|||
145945946|NCT00076999|526310210|FG002|Overall Study|Protocol Violation|4|||
145945947|NCT00076999|526310211|FG003|Overall Study|Protocol Violation|0|||
145945948|NCT00076999|526310212|FG004|Overall Study|Protocol Violation|9|||
146082108|NCT02509117|526820590|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145945949|NCT00076999|526310208|FG000|Overall Study|Lost to Follow-up|2|||
145945950|NCT00076999|526310209|FG001|Overall Study|Lost to Follow-up|1|||
146192406|NCT00941031|527215460|FG000|Maintenance Period|Lack of Efficacy|0|||
146192407|NCT00941031|527215461|FG001|Maintenance Period|Lack of Efficacy|0|||
145945951|NCT00076999|526310210|FG002|Overall Study|Lost to Follow-up|0|||
145945952|NCT00076999|526310211|FG003|Overall Study|Lost to Follow-up|0|||
145945953|NCT00076999|526310212|FG004|Overall Study|Lost to Follow-up|0|||
145945954|NCT00076999|526310208|FG000|Overall Study|Withdrawal by Subject|0|||
145945955|NCT00076999|526310209|FG001|Overall Study|Withdrawal by Subject|4|||
145945956|NCT00076999|526310210|FG002|Overall Study|Withdrawal by Subject|3|||
145945957|NCT00076999|526310211|FG003|Overall Study|Withdrawal by Subject|0|||
145945958|NCT00076999|526310212|FG004|Overall Study|Withdrawal by Subject|1|||
145945959|NCT00076999|526310208|FG000|Overall Study|Other reason (not specified)|8|||
145945960|NCT00076999|526310209|FG001|Overall Study|Other reason (not specified)|8|||
145945961|NCT00076999|526310210|FG002|Overall Study|Other reason (not specified)|4|||
145945962|NCT00076999|526310211|FG003|Overall Study|Other reason (not specified)|1|||
145945963|NCT00076999|526310212|FG004|Overall Study|Other reason (not specified)|13|||
145945964|NCT00090987|526310215|FG000|Overall Study|Adverse Event|5|||
145945965|NCT00090987|526310215|FG000|Overall Study|Lack of Efficacy|7|||
145945966|NCT00090987|526310215|FG000|Overall Study|Withdrawal by Subject|3|||
145945967|NCT00090987|526310215|FG000|Overall Study|alternative therapy|1|||
145945968|NCT00090987|526310215|FG000|Overall Study|Non-compliance|4|||
145945969|NCT00090987|526310215|FG000|Overall Study|Incarcerated|1|||
145945970|NCT00990665|526310216|FG000|Overall Study|Unsuccessful Implant|8|||
145945971|NCT00990665|526310216|FG000|Overall Study|Death|29|||
146413358|NCT00003102|528018111|FG002|Overall Study|Adverse Event|1|||
145945972|NCT00990665|526310216|FG000|Overall Study|Heart Transplant|1|||
145945973|NCT00990665|526310216|FG000|Overall Study|Withdrawal by Subject|6|||
145945974|NCT00990665|526310216|FG000|Overall Study|Lost to Follow-up|1|||
146413359|NCT00003102|528018109|FG000|Overall Study|Death|0|||
146413360|NCT00003102|528018110|FG001|Overall Study|Death|0|||
146413361|NCT00003102|528018111|FG002|Overall Study|Death|1|||
146413362|NCT01559818|528018112|FG000|Overall Study|Physician Decision|1|||
146413363|NCT01559818|528018112|FG000|Overall Study|Pregnancy|1|||
146413364|NCT01559818|528018112|FG000|Overall Study|Study terminated by Sponsor|4|||
146413365|NCT01559818|528018112|FG000|Overall Study|Withdrawal by Subject|1|||
146413366|NCT04071626|528018113|FG000|Overall Study|Withdrawal by Subject|1|||
146413367|NCT04071626|528018114|FG001|Overall Study|Withdrawal by Subject|1|||
146413368|NCT04071626|528018113|FG000|Overall Study|Protocol Violation|0|||
146413369|NCT04071626|528018114|FG001|Overall Study|Protocol Violation|1|||
146413370|NCT00931385|528018115|FG000|Overall Study|Adverse Event|2|||
146413371|NCT00931385|528018116|FG001|Overall Study|Adverse Event|1|||
146413372|NCT00931385|528018117|FG002|Overall Study|Adverse Event|0|||
146413373|NCT00931385|528018118|FG003|Overall Study|Adverse Event|3|||
146413374|NCT00931385|528018115|FG000|Overall Study|Protocol Violation|0|||
146413375|NCT00931385|528018116|FG001|Overall Study|Protocol Violation|0|||
146413376|NCT00931385|528018117|FG002|Overall Study|Protocol Violation|1|||
146413377|NCT00931385|528018118|FG003|Overall Study|Protocol Violation|0|||
146413378|NCT00931385|528018115|FG000|Overall Study|Withdrawal by Subject|0|||
146413379|NCT00931385|528018116|FG001|Overall Study|Withdrawal by Subject|1|||
146413380|NCT00931385|528018117|FG002|Overall Study|Withdrawal by Subject|0|||
146413381|NCT00931385|528018118|FG003|Overall Study|Withdrawal by Subject|1|||
146413382|NCT00931385|528018115|FG000|Overall Study|Lost to Follow-up|0|||
146413383|NCT00931385|528018116|FG001|Overall Study|Lost to Follow-up|0|||
146413384|NCT00931385|528018117|FG002|Overall Study|Lost to Follow-up|0|||
146413385|NCT00931385|528018118|FG003|Overall Study|Lost to Follow-up|1|||
146413386|NCT00665626|528018123|FG000|Overall Study|Lack of Efficacy|8|||
146413387|NCT00665626|528018124|FG001|Overall Study|Lack of Efficacy|5|||
146413388|NCT00665626|528018123|FG000|Overall Study|Lost to Follow-up|0|||
146413389|NCT00665626|528018124|FG001|Overall Study|Lost to Follow-up|2|||
146413390|NCT00665626|528018123|FG000|Overall Study|Withdrawal by Subject|0|||
146413391|NCT00665626|528018124|FG001|Overall Study|Withdrawal by Subject|1|||
146413392|NCT00665626|528018123|FG000|Overall Study|Protocol Violation|0|||
146413393|NCT00665626|528018124|FG001|Overall Study|Protocol Violation|2|||
146413394|NCT00665626|528018123|FG000|Overall Study|Adverse Event|1|||
146413395|NCT00665626|528018124|FG001|Overall Study|Adverse Event|9|||
146413396|NCT00665626|528018123|FG000|Overall Study|Due to exclusion criteria|0|||
146413397|NCT00665626|528018124|FG001|Overall Study|Due to exclusion criteria|1|||
146413398|NCT00665626|528018123|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
146413399|NCT00665626|528018124|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
145945975|NCT00990665|526310216|FG000|Overall Study|System Explant|3|||
145945976|NCT02603562|526310219|FG000|Overall Study|Lost to Follow-up|1|||
145945977|NCT01534208|526310223|FG000|Overall Study|Lost to Follow-up|19|||
146413400|NCT00665626|528018123|FG000|Overall Study|Unably to comply with dosing regimen|0|||
146413401|NCT00665626|528018124|FG001|Overall Study|Unably to comply with dosing regimen|1|||
146413402|NCT00665626|528018123|FG000|Overall Study|Death|1|||
145945978|NCT01534208|526310224|FG001|Overall Study|Lost to Follow-up|14|||
145945979|NCT01534208|526310223|FG000|Overall Study|Withdrawal by Subject|6|||
146413403|NCT00665626|528018124|FG001|Overall Study|Death|0|||
146413404|NCT00530439|528018125|FG000|Overall Study|GDM|9|||
146413405|NCT00530439|528018126|FG001|Overall Study|GDM|3|||
146413406|NCT00530439|528018125|FG000|Overall Study|Withdraw|18|||
146413407|NCT00530439|528018126|FG001|Overall Study|Withdraw|14|||
145945980|NCT01534208|526310224|FG001|Overall Study|Withdrawal by Subject|20|||
145945981|NCT01534208|526310223|FG000|Overall Study|Adverse Event|15|||
145945982|NCT01534208|526310224|FG001|Overall Study|Adverse Event|8|||
145945983|NCT01534208|526310223|FG000|Overall Study|Physician Decision|2|||
145945984|NCT01534208|526310224|FG001|Overall Study|Physician Decision|0|||
145945985|NCT01534208|526310223|FG000|Overall Study|Lack of Efficacy|0|||
145945986|NCT01534208|526310224|FG001|Overall Study|Lack of Efficacy|3|||
145945987|NCT01534208|526310223|FG000|Overall Study|Protocol Violation|2|||
145945988|NCT01534208|526310224|FG001|Overall Study|Protocol Violation|2|||
145945989|NCT01534208|526310223|FG000|Overall Study|Sponsor decision|4|||
145945990|NCT01534208|526310224|FG001|Overall Study|Sponsor decision|1|||
145945991|NCT01534208|526310223|FG000|Overall Study|Subject relocation|2|||
145945992|NCT01534208|526310224|FG001|Overall Study|Subject relocation|0|||
145945993|NCT01534208|526310223|FG000|Overall Study|Lab assessment|2|||
145945994|NCT01534208|526310224|FG001|Overall Study|Lab assessment|1|||
145945995|NCT01534208|526310223|FG000|Overall Study|Eligibility error|3|||
145945996|NCT01534208|526310224|FG001|Overall Study|Eligibility error|0|||
145945997|NCT01534208|526310223|FG000|Overall Study|PCP decision|1|||
145945998|NCT01534208|526310224|FG001|Overall Study|PCP decision|0|||
145945999|NCT01534208|526310223|FG000|Overall Study|Needed prohibited meds|1|||
145946000|NCT01534208|526310224|FG001|Overall Study|Needed prohibited meds|0|||
145946001|NCT01904903|526310225|FG000|Overall Study|Withdrawal by Subject|1|||
145946002|NCT03578146|526310230|FG000|Overall Study|Did Not Receive Treatment|1|||
145946003|NCT03578146|526310231|FG001|Overall Study|Did Not Receive Treatment|0|||
145946004|NCT03578146|526310232|FG002|Overall Study|Did Not Receive Treatment|0|||
145946005|NCT03578146|526310233|FG003|Overall Study|Did Not Receive Treatment|0|||
145946006|NCT03578146|526310234|FG004|Overall Study|Did Not Receive Treatment|0|||
145946007|NCT03578146|526310235|FG005|Overall Study|Did Not Receive Treatment|2|||
145946008|NCT03578146|526310230|FG000|Overall Study|Lost to Follow-up|0|||
145946009|NCT03578146|526310231|FG001|Overall Study|Lost to Follow-up|1|||
145946010|NCT03578146|526310232|FG002|Overall Study|Lost to Follow-up|1|||
145946011|NCT03578146|526310233|FG003|Overall Study|Lost to Follow-up|0|||
145946012|NCT03578146|526310234|FG004|Overall Study|Lost to Follow-up|0|||
145946013|NCT03578146|526310235|FG005|Overall Study|Lost to Follow-up|1|||
145946014|NCT00634049|526310236|FG000|Overall Study|Never received study drug|1|||
145946015|NCT00634049|526310236|FG000|Overall Study|Died prior to receiving study drug|1|||
145946016|NCT00634049|526310236|FG000|Overall Study|Screening failure|1|||
145946017|NCT01717391|526310237|FG000|Overall Study|Withdrawal by Subject|5|||
145946018|NCT01717391|526310237|FG000|Overall Study|Physician Decision|1|||
145946019|NCT01717391|526310237|FG000|Overall Study|FLT technical failure|3|||
145946020|NCT00314132|526310238|FG000|Overall Study|Lost to Follow-up|3|||
145946021|NCT00314132|526310239|FG001|Overall Study|Lost to Follow-up|13|||
145946022|NCT00314132|526310238|FG000|Overall Study|Withdrawal by Subject|3|||
145946023|NCT00314132|526310239|FG001|Overall Study|Withdrawal by Subject|5|||
145946024|NCT00314132|526310238|FG000|Overall Study|Adverse Event|1|||
145946025|NCT00314132|526310239|FG001|Overall Study|Adverse Event|0|||
146413408|NCT00530439|528018125|FG000|Overall Study|Missed abortion|1|||
145946026|NCT00314132|526310238|FG000|Overall Study|Physician Decision|1|||
145946027|NCT00314132|526310239|FG001|Overall Study|Physician Decision|0|||
145946028|NCT04769739|526310240|FG000|Overall Study|Colorectal cancer obstruction|2|||
146413409|NCT00530439|528018126|FG001|Overall Study|Missed abortion|4|||
146413410|NCT00530439|528018125|FG000|Overall Study|Misclassification|2|||
146413411|NCT00530439|528018126|FG001|Overall Study|Misclassification|0|||
146413412|NCT00530439|528018125|FG000|Overall Study|Twin pregnancy|0|||
146413413|NCT00530439|528018126|FG001|Overall Study|Twin pregnancy|2|||
146413414|NCT00530439|528018125|FG000|Overall Study|Severe malformation/abortion|0|||
146413415|NCT00530439|528018126|FG001|Overall Study|Severe malformation/abortion|3|||
146413416|NCT01629693|528018129|FG000|Overall Study|Lost to Follow-up|2|||
146413417|NCT01629693|528018130|FG001|Overall Study|Lost to Follow-up|4|||
146413418|NCT01629693|528018129|FG000|Overall Study|Withdrawal by Subject|2|||
146413419|NCT01629693|528018130|FG001|Overall Study|Withdrawal by Subject|2|||
146413420|NCT01629693|528018129|FG000|Overall Study|Adverse Event|1|||
146413421|NCT01629693|528018130|FG001|Overall Study|Adverse Event|0|||
146413422|NCT01629693|528018129|FG000|Overall Study|Investigator decision|0|||
146413423|NCT01629693|528018130|FG001|Overall Study|Investigator decision|1|||
146413424|NCT01629693|528018129|FG000|Overall Study|Poor comfort of study lenses|0|||
146413425|NCT01629693|528018130|FG001|Overall Study|Poor comfort of study lenses|2|||
146413426|NCT01629693|528018129|FG000|Overall Study|Subject decision unrelated to AE|0|||
146413427|NCT01629693|528018130|FG001|Overall Study|Subject decision unrelated to AE|1|||
146413428|NCT04385199|528018131|FG000|Overall Study|Withdrawal by Subject|1|||
145946029|NCT04769739|526310241|FG001|Overall Study|Colorectal cancer obstruction|0|||
145946030|NCT04769739|526310242|FG002|Overall Study|Colorectal cancer obstruction|0|||
146413429|NCT04385199|528018132|FG001|Overall Study|Withdrawal by Subject|0|||
146413430|NCT04079842|528018134|FG000|Overall Study|Request of subject|2|||
145946031|NCT04769739|526310243|FG003|Overall Study|Colorectal cancer obstruction|0|||
145946032|NCT04769739|526310240|FG000|Overall Study|Failed cecal intubation|1|||
145946033|NCT04769739|526310241|FG001|Overall Study|Failed cecal intubation|0|||
145946034|NCT04769739|526310242|FG002|Overall Study|Failed cecal intubation|0|||
145946035|NCT04769739|526310243|FG003|Overall Study|Failed cecal intubation|1|||
145946036|NCT04769739|526310240|FG000|Overall Study|Poor bowel preparation|0|||
146413431|NCT04079842|528018134|FG000|Overall Study|Unable to draw Arterial samples|1|||
146413432|NCT01025193|528018135|FG000|Overall Study|Protocol Violation|1|||
145946037|NCT04769739|526310241|FG001|Overall Study|Poor bowel preparation|0|||
145946038|NCT04769739|526310242|FG002|Overall Study|Poor bowel preparation|0|||
145946039|NCT04769739|526310243|FG003|Overall Study|Poor bowel preparation|1|||
145946040|NCT01260584|526310244|FG000|Period 1|Protocol Violation|0|||
145946041|NCT01260584|526310245|FG001|Period 1|Protocol Violation|0|||
145946042|NCT01260584|526310246|FG002|Period 1|Protocol Violation|1|||
145946043|NCT01260584|526310247|FG003|Period 1|Protocol Violation|1|||
145946044|NCT01260584|526310244|FG000|Period 1|Adverse Event|0|||
145946045|NCT01260584|526310245|FG001|Period 1|Adverse Event|0|||
145946046|NCT01260584|526310246|FG002|Period 1|Adverse Event|1|||
145946047|NCT01260584|526310247|FG003|Period 1|Adverse Event|0|||
145946048|NCT01260584|526310244|FG000|Period 2|Protocol Violation|0|||
145946049|NCT01260584|526310245|FG001|Period 2|Protocol Violation|2|||
145946050|NCT01260584|526310246|FG002|Period 2|Protocol Violation|3|||
145946051|NCT01260584|526310247|FG003|Period 2|Protocol Violation|1|||
145946052|NCT01260584|526310244|FG000|Period 2|Adverse Event|1|||
145946053|NCT01260584|526310245|FG001|Period 2|Adverse Event|0|||
145946054|NCT01260584|526310246|FG002|Period 2|Adverse Event|2|||
145946055|NCT01260584|526310247|FG003|Period 2|Adverse Event|0|||
145946056|NCT01260584|526310244|FG000|Period 2|Withdrawal by Subject|0|||
145946057|NCT01260584|526310245|FG001|Period 2|Withdrawal by Subject|1|||
145946058|NCT01260584|526310246|FG002|Period 2|Withdrawal by Subject|0|||
145946059|NCT01260584|526310247|FG003|Period 2|Withdrawal by Subject|0|||
145946060|NCT00824382|526310252|FG000|Overall Study|Adverse Event|4|||
145946061|NCT00824382|526310253|FG001|Overall Study|Adverse Event|1|||
145946062|NCT00824382|526310254|FG002|Overall Study|Adverse Event|1|||
145946063|NCT00824382|526310255|FG003|Overall Study|Adverse Event|4|||
145946064|NCT00824382|526310252|FG000|Overall Study|Protocol Violation|1|||
145946065|NCT00824382|526310253|FG001|Overall Study|Protocol Violation|0|||
145946066|NCT00824382|526310254|FG002|Overall Study|Protocol Violation|0|||
145946067|NCT00824382|526310255|FG003|Overall Study|Protocol Violation|1|||
145946068|NCT00824382|526310252|FG000|Overall Study|Investigator's decision|0|||
145946069|NCT00824382|526310253|FG001|Overall Study|Investigator's decision|1|||
145946070|NCT00824382|526310254|FG002|Overall Study|Investigator's decision|2|||
145946071|NCT00824382|526310255|FG003|Overall Study|Investigator's decision|0|||
145946072|NCT02824562|526312042|FG000|Overall Study|Lost to Follow-up|3|||
145946073|NCT02824562|526312043|FG001|Overall Study|Lost to Follow-up|4|||
145946074|NCT02824562|526312042|FG000|Overall Study|Death|0|||
145946075|NCT02824562|526312043|FG001|Overall Study|Death|1|||
145946076|NCT02168777|526312044|FG000|Overall Study|Withdrawal by Subject|1|||
145946077|NCT02168777|526312045|FG001|Overall Study|Withdrawal by Subject|0|||
145946078|NCT02168777|526312046|FG002|Overall Study|Withdrawal by Subject|2|||
145946079|NCT02168777|526312044|FG000|Overall Study|Adverse Event|1|||
145946080|NCT02168777|526312045|FG001|Overall Study|Adverse Event|0|||
145946081|NCT02168777|526312046|FG002|Overall Study|Adverse Event|1|||
145946082|NCT02168777|526312044|FG000|Overall Study|Disease recurrence|0|||
145946083|NCT02168777|526312045|FG001|Overall Study|Disease recurrence|0|||
145946084|NCT02168777|526312046|FG002|Overall Study|Disease recurrence|1|||
145946085|NCT02168777|526312044|FG000|Overall Study|Radiological disease progression|0|||
145946086|NCT02168777|526312045|FG001|Overall Study|Radiological disease progression|5|||
145946087|NCT02168777|526312046|FG002|Overall Study|Radiological disease progression|5|||
145946088|NCT02168777|526312044|FG000|Overall Study|Clinical disease progression|0|||
145946089|NCT02168777|526312045|FG001|Overall Study|Clinical disease progression|1|||
145946090|NCT02168777|526312046|FG002|Overall Study|Clinical disease progression|2|||
145946091|NCT02168777|526312044|FG000|Overall Study|Other reason|0|||
145946092|NCT02168777|526312045|FG001|Overall Study|Other reason|1|||
145946093|NCT02168777|526312046|FG002|Overall Study|Other reason|0|||
145946094|NCT01663857|526312047|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
145946095|NCT01663857|526312048|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
145946096|NCT01663857|526312049|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
145946097|NCT01663857|526312050|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
145946098|NCT01663857|526312047|FG000|Overall Study|Lost to Follow-up|0|||
146082109|NCT02509117|526820591|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145946099|NCT01663857|526312048|FG001|Overall Study|Lost to Follow-up|0|||
145946100|NCT01663857|526312049|FG002|Overall Study|Lost to Follow-up|3|||
145946101|NCT01663857|526312050|FG003|Overall Study|Lost to Follow-up|1|||
145946102|NCT01172808|526312051|FG000|Overall Study|Adverse Event|8|||
145946103|NCT01172808|526312052|FG001|Overall Study|Adverse Event|4|||
145946104|NCT01172808|526312053|FG002|Overall Study|Adverse Event|8|||
145946105|NCT01172808|526312054|FG003|Overall Study|Adverse Event|3|||
145946106|NCT01172808|526312051|FG000|Overall Study|Lack of Efficacy|1|||
145946107|NCT01172808|526312052|FG001|Overall Study|Lack of Efficacy|0|||
145946108|NCT01172808|526312053|FG002|Overall Study|Lack of Efficacy|0|||
146087762|NCT04393298|526841812|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
145946109|NCT01172808|526312054|FG003|Overall Study|Lack of Efficacy|0|||
145946110|NCT01172808|526312051|FG000|Overall Study|Protocol Violation|2|||
146087763|NCT04393298|526841813|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
146087764|NCT04393298|526841814|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
146087765|NCT04393298|526841815|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
146087766|NCT04393298|526841816|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
145946111|NCT01172808|526312052|FG001|Overall Study|Protocol Violation|2|||
145946112|NCT01172808|526312053|FG002|Overall Study|Protocol Violation|2|||
145946113|NCT01172808|526312054|FG003|Overall Study|Protocol Violation|0|||
145946114|NCT01172808|526312051|FG000|Overall Study|Lost to Follow-up|0|||
145946115|NCT01172808|526312052|FG001|Overall Study|Lost to Follow-up|1|||
145946116|NCT01172808|526312053|FG002|Overall Study|Lost to Follow-up|1|||
145946117|NCT01172808|526312054|FG003|Overall Study|Lost to Follow-up|3|||
145946118|NCT01172808|526312051|FG000|Overall Study|Withdrawal by Subject|4|||
145946119|NCT01172808|526312052|FG001|Overall Study|Withdrawal by Subject|1|||
145946120|NCT01172808|526312053|FG002|Overall Study|Withdrawal by Subject|3|||
145946121|NCT01172808|526312054|FG003|Overall Study|Withdrawal by Subject|2|||
145946122|NCT01172808|526312051|FG000|Overall Study|Other|6|||
145946123|NCT01172808|526312052|FG001|Overall Study|Other|5|||
145946124|NCT01172808|526312053|FG002|Overall Study|Other|9|||
145946125|NCT01172808|526312054|FG003|Overall Study|Other|7|||
145946126|NCT00290693|526312055|FG000|Overall Study|Withdrawal by Subject|2|||
145946127|NCT05625477|526312056|FG000|Overall Study|Lost to Follow-up|2|||
146082110|NCT02509117|526820592|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145946128|NCT05625477|526312057|FG001|Overall Study|Lost to Follow-up|2|||
145946129|NCT05625477|526312058|FG002|Overall Study|Lost to Follow-up|1|||
145946130|NCT05625477|526312059|FG003|Overall Study|Lost to Follow-up|1|||
145946131|NCT05625477|526312060|FG004|Overall Study|Lost to Follow-up|0|||
145946132|NCT05625477|526312056|FG000|Overall Study|Covid quarantine|1|||
145946133|NCT05625477|526312057|FG001|Overall Study|Covid quarantine|0|||
145890936|NCT01207440|526107573|FG003|Overall Study|Non-compliance with Study Drug|0|||
145890937|NCT01207440|526107574|FG004|Overall Study|Non-compliance with Study Drug|0|||
145890938|NCT01207440|526107575|FG005|Overall Study|Non-compliance with Study Drug|0|||
145890939|NCT01207440|526107576|FG006|Overall Study|Non-compliance with Study Drug|0|||
145890940|NCT01207440|526107570|FG000|Overall Study|Physician Decision|6|||
145890941|NCT01207440|526107571|FG001|Overall Study|Physician Decision|5|||
145890942|NCT01207440|526107572|FG002|Overall Study|Physician Decision|5|||
145890943|NCT01207440|526107573|FG003|Overall Study|Physician Decision|0|||
145890944|NCT01207440|526107574|FG004|Overall Study|Physician Decision|1|||
145890945|NCT01207440|526107575|FG005|Overall Study|Physician Decision|0|||
145890946|NCT01207440|526107576|FG006|Overall Study|Physician Decision|0|||
145890947|NCT01207440|526107570|FG000|Overall Study|Progressive Disease|19|||
145890948|NCT01207440|526107571|FG001|Overall Study|Progressive Disease|10|||
145890949|NCT01207440|526107572|FG002|Overall Study|Progressive Disease|19|||
145890950|NCT01207440|526107573|FG003|Overall Study|Progressive Disease|7|||
145890951|NCT01207440|526107574|FG004|Overall Study|Progressive Disease|23|||
145890952|NCT01207440|526107575|FG005|Overall Study|Progressive Disease|27|||
145890953|NCT01207440|526107576|FG006|Overall Study|Progressive Disease|0|||
145890954|NCT01207440|526107570|FG000|Overall Study|Protocol Violation|2|||
146192408|NCT00941031|527215462|FG002|Maintenance Period|Lack of Efficacy|0|||
146192409|NCT00941031|527215463|FG003|Maintenance Period|Lack of Efficacy|0|||
146192410|NCT00941031|527215464|FG004|Maintenance Period|Lack of Efficacy|0|||
146192411|NCT00941031|527215465|FG005|Maintenance Period|Lack of Efficacy|0|||
146192412|NCT00941031|527215466|FG006|Maintenance Period|Lack of Efficacy|13|||
146192413|NCT00631917|527215467|FG000|Overall Study|Adverse Event|34|||
146192414|NCT00631917|527215468|FG001|Overall Study|Adverse Event|45|||
146192415|NCT00631917|527215467|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146192416|NCT00631917|527215468|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146192417|NCT00631917|527215467|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146192418|NCT00631917|527215468|FG001|Overall Study|Abnormal test procedure result(s)|2|||
146192419|NCT00631917|527215467|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
146192420|NCT00631917|527215468|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
146192421|NCT00631917|527215467|FG000|Overall Study|No longer required study drug|0|||
146192422|NCT00631917|527215468|FG001|Overall Study|No longer required study drug|1|||
146192423|NCT00631917|527215467|FG000|Overall Study|Protocol deviation|6|||
145946134|NCT05625477|526312058|FG002|Overall Study|Covid quarantine|0|||
145946135|NCT05625477|526312059|FG003|Overall Study|Covid quarantine|0|||
146192424|NCT00631917|527215468|FG001|Overall Study|Protocol deviation|5|||
146192425|NCT00631917|527215467|FG000|Overall Study|Subject withdrew consent|25|||
146192426|NCT00631917|527215468|FG001|Overall Study|Subject withdrew consent|33|||
146192427|NCT00631917|527215467|FG000|Overall Study|Lost to Follow-up|7|||
146192428|NCT00631917|527215468|FG001|Overall Study|Lost to Follow-up|7|||
146192429|NCT00631917|527215467|FG000|Overall Study|Administrative problems|2|||
146192430|NCT00631917|527215468|FG001|Overall Study|Administrative problems|0|||
146192431|NCT00631917|527215467|FG000|Overall Study|Death|1|||
146192432|NCT00631917|527215468|FG001|Overall Study|Death|0|||
146192433|NCT05487703|527215471|FG000|Overall Study|Other|19|||
146192434|NCT05487703|527215471|FG000|Overall Study|Participant not well|5|||
146192435|NCT05487703|527215471|FG000|Overall Study|Insurance Reasons|6|||
145946136|NCT05625477|526312060|FG004|Overall Study|Covid quarantine|0|||
145946137|NCT03013985|526312066|FG000|Overall Study|Protocol Violation|2|||
145946138|NCT03013985|526312067|FG001|Overall Study|Protocol Violation|2|||
145946139|NCT03013985|526312066|FG000|Overall Study|Withdrawal by Subject|14|||
145946140|NCT03013985|526312067|FG001|Overall Study|Withdrawal by Subject|17|||
145946141|NCT03411902|526312068|FG000|Overall Study|Lost to Follow-up|3|||
145946142|NCT03411902|526312069|FG001|Overall Study|Lost to Follow-up|0|||
145946143|NCT00574795|526312070|FG000|Infant Series|Withdrawal by Subject|2|||
145946144|NCT00574795|526312070|FG000|Infant Series|Protocol Violation|2|||
146192436|NCT05487703|527215471|FG000|Overall Study|Physician Decision|19|||
146192437|NCT05487703|527215471|FG000|Overall Study|Lack of Efficacy|60|||
146192438|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
146192439|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
146192440|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
146192441|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Death|3|||
146192442|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Death|0|||
146192443|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Death|0|||
146192444|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
146192445|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
145946145|NCT00574795|526312070|FG000|Infant Series|Adverse Event|1|||
145946146|NCT00574795|526312070|FG000|After Infant Series|Withdrawal by Subject|1|||
146192446|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
146192447|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
146192448|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
145946147|NCT00574795|526312070|FG000|After Infant Series|Adverse Event|2|||
145946148|NCT00574795|526312070|FG000|Toddler Dose|Withdrawal by Subject|1|||
145946149|NCT00672841|526312071|FG000|Overall Study|Comfort care|1|||
146192449|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
146192450|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
146192451|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
146192452|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
145890955|NCT01207440|526107571|FG001|Overall Study|Protocol Violation|0|||
145890956|NCT01207440|526107572|FG002|Overall Study|Protocol Violation|0|||
145890957|NCT01207440|526107573|FG003|Overall Study|Protocol Violation|0|||
145890958|NCT01207440|526107574|FG004|Overall Study|Protocol Violation|0|||
145890959|NCT01207440|526107575|FG005|Overall Study|Protocol Violation|0|||
145890960|NCT01207440|526107576|FG006|Overall Study|Protocol Violation|0|||
145890961|NCT01207440|526107570|FG000|Overall Study|Site Terminated by Sponsor|69|||
145890962|NCT01207440|526107571|FG001|Overall Study|Site Terminated by Sponsor|19|||
145890963|NCT01207440|526107572|FG002|Overall Study|Site Terminated by Sponsor|12|||
145890964|NCT01207440|526107573|FG003|Overall Study|Site Terminated by Sponsor|2|||
145946150|NCT00672841|526312072|FG001|Overall Study|Comfort care|4|||
145946151|NCT00672841|526312071|FG000|Overall Study|icteric specimens|0|||
145946152|NCT00672841|526312072|FG001|Overall Study|icteric specimens|3|||
145946153|NCT00672841|526312071|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
145946154|NCT00672841|526312072|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
145946155|NCT00672841|526312071|FG000|Overall Study|Adverse Event|0|||
145946156|NCT00672841|526312072|FG001|Overall Study|Adverse Event|3|||
145946157|NCT00672841|526312071|FG000|Overall Study|Pregnancy|0|||
145946158|NCT00672841|526312072|FG001|Overall Study|Pregnancy|1|||
145946159|NCT02638259|526312073|FG000|Treatment Period 1|Adverse Event|1|||
145946160|NCT02638259|526312074|FG001|Treatment Period 1|Adverse Event|5|||
145946161|NCT02638259|526312073|FG000|Treatment Period 1|Death|0|||
145946162|NCT02638259|526312074|FG001|Treatment Period 1|Death|1|||
145946163|NCT02638259|526312073|FG000|Treatment Period 1|Lack of Efficacy|0|||
145946164|NCT02638259|526312074|FG001|Treatment Period 1|Lack of Efficacy|1|||
145946165|NCT02638259|526312073|FG000|Treatment Period 1|Protocol Violation|0|||
145946166|NCT02638259|526312074|FG001|Treatment Period 1|Protocol Violation|3|||
146284458|NCT01688830|527553730|FG011|Overall Study|Lost to Follow-up|0|||
145946167|NCT02638259|526312073|FG000|Treatment Period 1|Withdrawal by Subject|4|||
145946168|NCT02638259|526312074|FG001|Treatment Period 1|Withdrawal by Subject|6|||
145946169|NCT02638259|526312073|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
145946170|NCT02638259|526312074|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
145946171|NCT02638259|526312073|FG000|Treatment Period 2|Adverse Event|5|||
145946172|NCT02638259|526312074|FG001|Treatment Period 2|Adverse Event|4|||
145946173|NCT02638259|526312073|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145946174|NCT02638259|526312074|FG001|Treatment Period 2|Withdrawal by Subject|7|||
145946175|NCT04299048|526312075|FG000|Overall Study|Death|1|||
145946176|NCT04299048|526312075|FG000|Overall Study|Global deterioration of health status|2|||
145946177|NCT04299048|526312075|FG000|Overall Study|Enrolled and not treated|1|||
145946178|NCT03677934|526312077|FG000|Overall Study|Adverse Event|1|||
145946179|NCT03677934|526312078|FG001|Overall Study|Adverse Event|1|||
145946180|NCT03677934|526312077|FG000|Overall Study|Death|8|||
145946181|NCT03677934|526312078|FG001|Overall Study|Death|4|||
145946182|NCT03677934|526312077|FG000|Overall Study|Lost to Follow-up|3|||
145946183|NCT03677934|526312078|FG001|Overall Study|Lost to Follow-up|0|||
145946184|NCT03677934|526312077|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145946185|NCT03677934|526312078|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145946186|NCT03677934|526312077|FG000|Overall Study|Physician Decision|0|||
145946187|NCT03677934|526312078|FG001|Overall Study|Physician Decision|1|||
145946188|NCT03677934|526312077|FG000|Overall Study|Withdrawal by Subject|1|||
145946189|NCT03677934|526312078|FG001|Overall Study|Withdrawal by Subject|7|||
145946190|NCT00045734|526312095|FG000|Overall Study|Protocol Violation|1|||
145946191|NCT02069093|526312096|FG000|Overall Study|Disease progression|14|||
145946192|NCT02069093|526312096|FG000|Overall Study|New cancer therapy|1|||
145946193|NCT02069093|526312096|FG000|Overall Study|Death|1|||
145946194|NCT02069093|526312096|FG000|Overall Study|Administrative problems|1|||
145946195|NCT02069093|526312096|FG000|Overall Study|Withdrawal by Subject|2|||
145946196|NCT02069093|526312096|FG000|Overall Study|Abnormal laboratory values|1|||
145946197|NCT02069093|526312096|FG000|Overall Study|Adverse Event|10|||
145946198|NCT00586508|526312101|FG000|Overall Study|Progressive disease|52|||
145946199|NCT00586508|526312102|FG001|Overall Study|Progressive disease|8|||
145946200|NCT00586508|526312101|FG000|Overall Study|Death|0|||
145946201|NCT00586508|526312102|FG001|Overall Study|Death|1|||
145946202|NCT00586508|526312101|FG000|Overall Study|Adverse Event|12|||
145946203|NCT00586508|526312102|FG001|Overall Study|Adverse Event|4|||
145946204|NCT00586508|526312101|FG000|Overall Study|Withdrawal by Subject|4|||
145946205|NCT00586508|526312102|FG001|Overall Study|Withdrawal by Subject|0|||
145946206|NCT02079636|526312104|FG000|Overall Study|Death|2|||
145946207|NCT02079636|526312105|FG001|Overall Study|Death|1|||
145946208|NCT02079636|526312106|FG002|Overall Study|Death|0|||
145946209|NCT02079636|526312107|FG003|Overall Study|Death|5|||
145946210|NCT02079636|526312108|FG004|Overall Study|Death|1|||
145946211|NCT02079636|526312109|FG005|Overall Study|Death|2|||
145946212|NCT02079636|526312110|FG006|Overall Study|Death|1|||
145946213|NCT02079636|526312111|FG007|Overall Study|Death|0|||
145946214|NCT02079636|526312112|FG008|Overall Study|Death|0|||
146192453|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
145946215|NCT02079636|526312113|FG009|Overall Study|Death|0|||
145946216|NCT02079636|526312114|FG010|Overall Study|Death|0|||
145946217|NCT02079636|526312115|FG011|Overall Study|Death|1|||
145946218|NCT02079636|526312116|FG012|Overall Study|Death|1|||
145946219|NCT02079636|526312117|FG013|Overall Study|Death|0|||
145946220|NCT02079636|526312118|FG014|Overall Study|Death|2|||
145946221|NCT02079636|526312104|FG000|Overall Study|Adverse Event|1|||
145946222|NCT02079636|526312105|FG001|Overall Study|Adverse Event|1|||
145946223|NCT02079636|526312106|FG002|Overall Study|Adverse Event|0|||
145946224|NCT02079636|526312107|FG003|Overall Study|Adverse Event|1|||
145946225|NCT02079636|526312108|FG004|Overall Study|Adverse Event|1|||
145946226|NCT02079636|526312109|FG005|Overall Study|Adverse Event|2|||
145946227|NCT02079636|526312110|FG006|Overall Study|Adverse Event|0|||
145946228|NCT02079636|526312111|FG007|Overall Study|Adverse Event|0|||
145946229|NCT02079636|526312112|FG008|Overall Study|Adverse Event|0|||
145946230|NCT02079636|526312113|FG009|Overall Study|Adverse Event|0|||
145946231|NCT02079636|526312114|FG010|Overall Study|Adverse Event|0|||
145946232|NCT02079636|526312115|FG011|Overall Study|Adverse Event|0|||
145946233|NCT02079636|526312116|FG012|Overall Study|Adverse Event|0|||
145946234|NCT02079636|526312117|FG013|Overall Study|Adverse Event|0|||
145946235|NCT02079636|526312118|FG014|Overall Study|Adverse Event|0|||
145946236|NCT02079636|526312104|FG000|Overall Study|Progressive disease|0|||
145946237|NCT02079636|526312105|FG001|Overall Study|Progressive disease|0|||
145946238|NCT02079636|526312106|FG002|Overall Study|Progressive disease|0|||
145946239|NCT02079636|526312107|FG003|Overall Study|Progressive disease|2|||
145946240|NCT02079636|526312108|FG004|Overall Study|Progressive disease|0|||
145946241|NCT02079636|526312109|FG005|Overall Study|Progressive disease|0|||
145946242|NCT02079636|526312110|FG006|Overall Study|Progressive disease|0|||
145946243|NCT02079636|526312111|FG007|Overall Study|Progressive disease|0|||
145946244|NCT02079636|526312112|FG008|Overall Study|Progressive disease|0|||
145946245|NCT02079636|526312113|FG009|Overall Study|Progressive disease|0|||
145946246|NCT02079636|526312114|FG010|Overall Study|Progressive disease|0|||
145946247|NCT02079636|526312115|FG011|Overall Study|Progressive disease|0|||
145946248|NCT02079636|526312116|FG012|Overall Study|Progressive disease|1|||
145946249|NCT02079636|526312117|FG013|Overall Study|Progressive disease|0|||
145946250|NCT02079636|526312118|FG014|Overall Study|Progressive disease|0|||
145946251|NCT02079636|526312104|FG000|Overall Study|Withdrawal by Subject|0|||
145946252|NCT02079636|526312105|FG001|Overall Study|Withdrawal by Subject|0|||
145946253|NCT02079636|526312106|FG002|Overall Study|Withdrawal by Subject|0|||
145946254|NCT02079636|526312107|FG003|Overall Study|Withdrawal by Subject|4|||
145946255|NCT02079636|526312108|FG004|Overall Study|Withdrawal by Subject|0|||
145946256|NCT02079636|526312109|FG005|Overall Study|Withdrawal by Subject|1|||
145946257|NCT02079636|526312110|FG006|Overall Study|Withdrawal by Subject|0|||
145946258|NCT02079636|526312111|FG007|Overall Study|Withdrawal by Subject|0|||
145946259|NCT02079636|526312112|FG008|Overall Study|Withdrawal by Subject|0|||
145946260|NCT02079636|526312113|FG009|Overall Study|Withdrawal by Subject|2|||
145946261|NCT02079636|526312114|FG010|Overall Study|Withdrawal by Subject|1|||
145946262|NCT02079636|526312115|FG011|Overall Study|Withdrawal by Subject|1|||
145946263|NCT02079636|526312116|FG012|Overall Study|Withdrawal by Subject|1|||
145946264|NCT02079636|526312117|FG013|Overall Study|Withdrawal by Subject|0|||
145946265|NCT02079636|526312118|FG014|Overall Study|Withdrawal by Subject|2|||
145946266|NCT02079636|526312104|FG000|Overall Study|Physician Decision|0|||
145946267|NCT02079636|526312105|FG001|Overall Study|Physician Decision|0|||
145946268|NCT02079636|526312106|FG002|Overall Study|Physician Decision|0|||
145946269|NCT02079636|526312107|FG003|Overall Study|Physician Decision|0|||
145946270|NCT02079636|526312108|FG004|Overall Study|Physician Decision|0|||
145946271|NCT02079636|526312109|FG005|Overall Study|Physician Decision|1|||
145946272|NCT02079636|526312110|FG006|Overall Study|Physician Decision|0|||
145946273|NCT02079636|526312111|FG007|Overall Study|Physician Decision|0|||
145946274|NCT02079636|526312112|FG008|Overall Study|Physician Decision|0|||
145946275|NCT02079636|526312113|FG009|Overall Study|Physician Decision|1|||
145946276|NCT02079636|526312114|FG010|Overall Study|Physician Decision|1|||
145946277|NCT02079636|526312115|FG011|Overall Study|Physician Decision|0|||
145946278|NCT02079636|526312116|FG012|Overall Study|Physician Decision|0|||
145946279|NCT02079636|526312117|FG013|Overall Study|Physician Decision|0|||
145946280|NCT02079636|526312118|FG014|Overall Study|Physician Decision|1|||
145946281|NCT02079636|526312104|FG000|Overall Study|Lost to Follow-up|0|||
145946282|NCT02079636|526312105|FG001|Overall Study|Lost to Follow-up|0|||
145946283|NCT02079636|526312106|FG002|Overall Study|Lost to Follow-up|0|||
145946284|NCT02079636|526312107|FG003|Overall Study|Lost to Follow-up|0|||
145946285|NCT02079636|526312108|FG004|Overall Study|Lost to Follow-up|0|||
145946286|NCT02079636|526312109|FG005|Overall Study|Lost to Follow-up|0|||
145946287|NCT02079636|526312110|FG006|Overall Study|Lost to Follow-up|0|||
145946288|NCT02079636|526312111|FG007|Overall Study|Lost to Follow-up|1|||
145946289|NCT02079636|526312112|FG008|Overall Study|Lost to Follow-up|0|||
145946290|NCT02079636|526312113|FG009|Overall Study|Lost to Follow-up|0|||
145946291|NCT02079636|526312114|FG010|Overall Study|Lost to Follow-up|0|||
145946292|NCT02079636|526312115|FG011|Overall Study|Lost to Follow-up|0|||
145946293|NCT02079636|526312116|FG012|Overall Study|Lost to Follow-up|0|||
145946294|NCT02079636|526312117|FG013|Overall Study|Lost to Follow-up|0|||
145946295|NCT02079636|526312118|FG014|Overall Study|Lost to Follow-up|0|||
145946296|NCT00561470|526312119|FG000|Overall Study|Adverse Event|74|||
145946297|NCT00561470|526312120|FG001|Overall Study|Adverse Event|163|||
145946298|NCT00561470|526312119|FG000|Overall Study|Disease progression|437|||
145946299|NCT00561470|526312120|FG001|Overall Study|Disease progression|305|||
145946300|NCT00561470|526312119|FG000|Overall Study|poor compliance to protocol|4|||
145946301|NCT00561470|526312120|FG001|Overall Study|poor compliance to protocol|4|||
145946302|NCT00561470|526312119|FG000|Overall Study|Lost to Follow-up|2|||
145946303|NCT00561470|526312120|FG001|Overall Study|Lost to Follow-up|0|||
145946304|NCT00561470|526312119|FG000|Overall Study|Physician Decision|21|||
145946305|NCT00561470|526312120|FG001|Overall Study|Physician Decision|20|||
145946306|NCT00561470|526312119|FG000|Overall Study|Consent Withdrawn|2|||
145946307|NCT00561470|526312120|FG001|Overall Study|Consent Withdrawn|6|||
145946308|NCT00561470|526312119|FG000|Overall Study|Subject request|43|||
145946309|NCT00561470|526312120|FG001|Overall Study|Subject request|77|||
145946310|NCT00561470|526312119|FG000|Overall Study|Metastatic surgery|10|||
145946311|NCT00561470|526312120|FG001|Overall Study|Metastatic surgery|12|||
145946312|NCT00561470|526312119|FG000|Overall Study|Unauthorized procedure|3|||
145946313|NCT00561470|526312120|FG001|Overall Study|Unauthorized procedure|1|||
145946314|NCT00561470|526312119|FG000|Overall Study|Randomized but not treated|5|||
145946315|NCT00561470|526312120|FG001|Overall Study|Randomized but not treated|5|||
146192454|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
146192455|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
146192456|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
146192457|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
145946316|NCT00561470|526312119|FG000|Overall Study|Missed visit window|1|||
145946317|NCT00561470|526312120|FG001|Overall Study|Missed visit window|4|||
145946318|NCT00561470|526312119|FG000|Overall Study|Planning surgery|1|||
145946319|NCT00561470|526312120|FG001|Overall Study|Planning surgery|1|||
145946320|NCT00561470|526312119|FG000|Overall Study|Ongoing Treatment|11|||
145946321|NCT00561470|526312120|FG001|Overall Study|Ongoing Treatment|14|||
145946322|NCT03434249|526312121|FG000|Overall Study|Adverse Event|1|||
145946323|NCT03434249|526312122|FG001|Overall Study|Adverse Event|0|||
145946324|NCT03434249|526312121|FG000|Overall Study|Lost to Follow-up|0|||
145946325|NCT03434249|526312122|FG001|Overall Study|Lost to Follow-up|1|||
145946326|NCT03434249|526312121|FG000|Overall Study|Non-compliance of family|2|||
145946327|NCT03434249|526312122|FG001|Overall Study|Non-compliance of family|1|||
145946328|NCT03434249|526312121|FG000|Overall Study|Difficulties in completing daily diary|2|||
145946329|NCT03434249|526312122|FG001|Overall Study|Difficulties in completing daily diary|1|||
145946330|NCT03325894|526312123|FG000|Overall Study|Adverse Event|2|||
145946331|NCT03325894|526312124|FG001|Overall Study|Adverse Event|3|||
145946332|NCT03325894|526312123|FG000|Overall Study|Protocol Violation|1|||
145946333|NCT03325894|526312124|FG001|Overall Study|Protocol Violation|2|||
145946334|NCT03325894|526312123|FG000|Overall Study|Withdrawal by Subject|10|||
145946335|NCT03325894|526312124|FG001|Overall Study|Withdrawal by Subject|6|||
145946336|NCT03325894|526312123|FG000|Overall Study|Lost to Follow-up|4|||
145946337|NCT03325894|526312124|FG001|Overall Study|Lost to Follow-up|9|||
145946338|NCT03325894|526312123|FG000|Overall Study|Lack of Efficacy|8|||
145946339|NCT03325894|526312124|FG001|Overall Study|Lack of Efficacy|14|||
145946340|NCT03325894|526312123|FG000|Overall Study|Study Terminated by Sponsor|38|||
145946341|NCT03325894|526312124|FG001|Overall Study|Study Terminated by Sponsor|43|||
145946342|NCT03325894|526312123|FG000|Overall Study|Other (Not received Treatment)|1|||
145946343|NCT03325894|526312124|FG001|Overall Study|Other (Not received Treatment)|0|||
145946344|NCT00335959|526312127|FG000|Overall Study|Adverse Event|2|||
145946345|NCT00335959|526312127|FG000|Overall Study|Ineligible|1|||
145946346|NCT01001598|526312131|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
145946347|NCT01001598|526312131|FG000|Overall Study|Adverse Event|1|||
145946348|NCT02450552|526312133|FG000|Overall Study|Withdrawal by Subject|4|||
145946349|NCT02450552|526312134|FG001|Overall Study|Withdrawal by Subject|0|||
145946350|NCT02450552|526312135|FG002|Overall Study|Withdrawal by Subject|4|||
145946351|NCT02450552|526312133|FG000|Overall Study|Physician Decision|1|||
145946352|NCT02450552|526312134|FG001|Overall Study|Physician Decision|0|||
145946353|NCT02450552|526312135|FG002|Overall Study|Physician Decision|1|||
145946354|NCT04148287|526312149|FG000|Overall Study|Death|2|||
145946355|NCT05079230|526312150|FG000|Overall Study|Study Terminated by Sponsor|101|||
145946356|NCT05079230|526312151|FG001|Overall Study|Study Terminated by Sponsor|102|||
145946357|NCT05079230|526312150|FG000|Overall Study|Death|72|||
145946358|NCT05079230|526312151|FG001|Overall Study|Death|66|||
145946359|NCT05079230|526312150|FG000|Overall Study|Withdrew Consent|16|||
145946360|NCT05079230|526312151|FG001|Overall Study|Withdrew Consent|18|||
145946361|NCT05079230|526312150|FG000|Overall Study|Lost to Follow-up|0|||
145946362|NCT05079230|526312151|FG001|Overall Study|Lost to Follow-up|3|||
145946363|NCT01524783|526312152|FG000|Blinded Period|Adverse Event|64|||
145946364|NCT01524783|526312153|FG001|Blinded Period|Adverse Event|7|||
145946365|NCT01524783|526312154|FG002|Blinded Period|Adverse Event|0|||
145946366|NCT01524783|526312152|FG000|Blinded Period|Disease Progression|89|||
145946367|NCT01524783|526312153|FG001|Blinded Period|Disease Progression|75|||
145946368|NCT01524783|526312154|FG002|Blinded Period|Disease Progression|0|||
145946369|NCT01524783|526312152|FG000|Blinded Period|Withdrawal by Subject|19|||
145946370|NCT01524783|526312153|FG001|Blinded Period|Withdrawal by Subject|6|||
145946371|NCT01524783|526312154|FG002|Blinded Period|Withdrawal by Subject|0|||
145946372|NCT01524783|526312152|FG000|Blinded Period|Protocol deviation|2|||
145946373|NCT01524783|526312153|FG001|Blinded Period|Protocol deviation|1|||
145946374|NCT01524783|526312154|FG002|Blinded Period|Protocol deviation|0|||
145946375|NCT01524783|526312152|FG000|Blinded Period|Death|5|||
145946376|NCT01524783|526312153|FG001|Blinded Period|Death|2|||
145946377|NCT01524783|526312154|FG002|Blinded Period|Death|0|||
145946378|NCT01524783|526312152|FG000|Open-label Period|Disease progression|13|||
145946379|NCT01524783|526312153|FG001|Open-label Period|Disease progression|0|||
145946380|NCT01524783|526312154|FG002|Open-label Period|Disease progression|2|||
145946381|NCT01524783|526312152|FG000|Open-label Period|Administrative problems|5|||
145946382|NCT01524783|526312153|FG001|Open-label Period|Administrative problems|0|||
145946383|NCT01524783|526312154|FG002|Open-label Period|Administrative problems|2|||
145946384|NCT01524783|526312152|FG000|Open-label Period|Adverse Event|5|||
145946385|NCT01524783|526312153|FG001|Open-label Period|Adverse Event|0|||
145946386|NCT01524783|526312154|FG002|Open-label Period|Adverse Event|1|||
145946387|NCT01524783|526312152|FG000|Open-label Period|Withdrawal by Subject|2|||
145946388|NCT01524783|526312153|FG001|Open-label Period|Withdrawal by Subject|0|||
145946389|NCT01524783|526312154|FG002|Open-label Period|Withdrawal by Subject|1|||
145946390|NCT01524783|526312152|FG000|Open-label Period|Protocol deviation|1|||
145946391|NCT01524783|526312153|FG001|Open-label Period|Protocol deviation|0|||
145946392|NCT01524783|526312154|FG002|Open-label Period|Protocol deviation|0|||
145946393|NCT03164265|526312156|FG000|Overall Study|Physician Decision|3|||
145946394|NCT03673345|526312157|FG000|Overall Study|Lost to Follow-up|1|||
145946395|NCT03673345|526312158|FG001|Overall Study|Lost to Follow-up|0|||
145946396|NCT03673345|526312159|FG002|Overall Study|Lost to Follow-up|3|||
145946397|NCT03673345|526312160|FG003|Overall Study|Lost to Follow-up|3|||
145946398|NCT03673345|526312161|FG004|Overall Study|Lost to Follow-up|2|||
145946399|NCT03673345|526312162|FG005|Overall Study|Lost to Follow-up|1|||
145946400|NCT03673345|526312163|FG006|Overall Study|Lost to Follow-up|0|||
145946401|NCT03673345|526312164|FG007|Overall Study|Lost to Follow-up|0|||
145946402|NCT03673345|526312157|FG000|Overall Study|Withdrawal by Subject|1|||
145946403|NCT03673345|526312158|FG001|Overall Study|Withdrawal by Subject|0|||
145946404|NCT03673345|526312159|FG002|Overall Study|Withdrawal by Subject|4|||
145946405|NCT03673345|526312160|FG003|Overall Study|Withdrawal by Subject|2|||
145946406|NCT03673345|526312161|FG004|Overall Study|Withdrawal by Subject|0|||
145946407|NCT03673345|526312162|FG005|Overall Study|Withdrawal by Subject|0|||
145946408|NCT03673345|526312163|FG006|Overall Study|Withdrawal by Subject|0|||
145946409|NCT03673345|526312164|FG007|Overall Study|Withdrawal by Subject|0|||
145946410|NCT03673345|526312157|FG000|Overall Study|Physician Decision|0|||
145946411|NCT03673345|526312158|FG001|Overall Study|Physician Decision|0|||
145946412|NCT03673345|526312159|FG002|Overall Study|Physician Decision|2|||
145946413|NCT03673345|526312160|FG003|Overall Study|Physician Decision|0|||
145946414|NCT03673345|526312161|FG004|Overall Study|Physician Decision|0|||
145946415|NCT03673345|526312162|FG005|Overall Study|Physician Decision|0|||
145946416|NCT03673345|526312163|FG006|Overall Study|Physician Decision|0|||
145946417|NCT03673345|526312164|FG007|Overall Study|Physician Decision|0|||
145946418|NCT03806231|526312165|FG000|Overall Study|Physician Decision|1|||
145946419|NCT03806231|526312166|FG001|Overall Study|Physician Decision|0|||
145946420|NCT03806231|526312165|FG000|Overall Study|Withdrawal by Subject|1|||
145946421|NCT03806231|526312166|FG001|Overall Study|Withdrawal by Subject|0|||
145946422|NCT00932698|526312167|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
145946423|NCT00932698|526312168|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
145946424|NCT00932698|526312169|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
145946425|NCT00932698|526312170|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
145946426|NCT00932698|526312171|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
145946427|NCT00932698|526312172|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
145946428|NCT00932698|526312173|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
145946429|NCT00932698|526312174|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
145946430|NCT00932698|526312175|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
145946431|NCT00932698|526312176|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
145946432|NCT00932698|526312177|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
145946433|NCT00932698|526312167|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946434|NCT00932698|526312168|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145946435|NCT00932698|526312169|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946436|NCT00932698|526312170|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145946437|NCT00932698|526312171|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946438|NCT00932698|526312172|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145946439|NCT00932698|526312173|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145946440|NCT00932698|526312174|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946441|NCT00932698|526312175|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946442|NCT00932698|526312176|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946443|NCT00932698|526312177|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145946444|NCT00932698|526312167|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
145946445|NCT00932698|526312168|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
145946446|NCT00932698|526312169|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
145946447|NCT00932698|526312170|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
145946448|NCT00932698|526312171|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
145946449|NCT00932698|526312172|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
145946450|NCT00932698|526312173|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
145946451|NCT00932698|526312174|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
145946452|NCT00932698|526312175|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
145946453|NCT00932698|526312176|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
145946454|NCT00932698|526312177|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
145946455|NCT00932698|526312167|FG000|Part 1 (Dose Escalation)|Other|0|||
145946456|NCT00932698|526312168|FG001|Part 1 (Dose Escalation)|Other|0|||
145946457|NCT00932698|526312169|FG002|Part 1 (Dose Escalation)|Other|1|||
145946458|NCT00932698|526312170|FG003|Part 1 (Dose Escalation)|Other|0|||
145946459|NCT00932698|526312171|FG004|Part 1 (Dose Escalation)|Other|0|||
145946460|NCT00932698|526312172|FG005|Part 1 (Dose Escalation)|Other|0|||
145946461|NCT00932698|526312173|FG006|Part 1 (Dose Escalation)|Other|1|||
145946462|NCT00932698|526312174|FG007|Part 1 (Dose Escalation)|Other|0|||
145946463|NCT00932698|526312175|FG008|Part 1 (Dose Escalation)|Other|0|||
145946464|NCT00932698|526312176|FG009|Part 1 (Dose Escalation)|Other|0|||
145946465|NCT00932698|526312177|FG010|Part 1 (Dose Escalation)|Other|0|||
145946466|NCT00932698|526312167|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946467|NCT00932698|526312168|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946468|NCT00932698|526312169|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946469|NCT00932698|526312170|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946470|NCT00932698|526312171|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946471|NCT00932698|526312172|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946472|NCT00932698|526312173|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
145946473|NCT00932698|526312174|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
145946474|NCT00932698|526312175|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
145946475|NCT00932698|526312176|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
145946476|NCT00932698|526312177|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
145946477|NCT00932698|526312167|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946478|NCT00932698|526312168|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946479|NCT00932698|526312169|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946480|NCT00932698|526312170|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946481|NCT00932698|526312171|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946482|NCT00932698|526312172|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946483|NCT00932698|526312173|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946484|NCT00932698|526312174|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
145946485|NCT00932698|526312175|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
145946486|NCT00932698|526312176|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
145946487|NCT00932698|526312177|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145946488|NCT00932698|526312167|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
145946489|NCT00932698|526312168|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
145946490|NCT00932698|526312169|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
145946491|NCT00932698|526312170|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
145946492|NCT00932698|526312171|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
145946493|NCT00932698|526312172|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
145946494|NCT00932698|526312173|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
145946495|NCT00932698|526312174|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
145946496|NCT00932698|526312175|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
145946497|NCT00932698|526312176|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
145946498|NCT00932698|526312177|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
145946499|NCT00131365|526312180|FG000|Overall Study|Withdrawal by Subject|1|||
145946500|NCT00131365|526312180|FG000|Overall Study|Alternative treatment|3|||
145946501|NCT04608344|526312181|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
145946502|NCT04608344|526312182|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
145946503|NCT04608344|526312181|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
145946504|NCT04608344|526312182|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
145946505|NCT05249127|526312183|FG000|Overall Study|Protocol Violation|13|||
145946506|NCT05249127|526312183|FG000|Overall Study|Physician Decision|4|||
145946507|NCT05249127|526312183|FG000|Overall Study|Withdrawal by Subject|2|||
145946508|NCT05249127|526312183|FG000|Overall Study|Participant Non-compliance|1|||
145946509|NCT02607306|526312184|FG000|Overall Study|Adverse Event|8|||
145946510|NCT02607306|526312185|FG001|Overall Study|Adverse Event|6|||
145946511|NCT02607306|526312186|FG002|Overall Study|Adverse Event|6|||
145946512|NCT02607306|526312184|FG000|Overall Study|Unclassified|1|||
145946513|NCT02607306|526312185|FG001|Overall Study|Unclassified|4|||
145946514|NCT02607306|526312186|FG002|Overall Study|Unclassified|0|||
145946515|NCT02607306|526312184|FG000|Overall Study|Withdrawal by Subject|8|||
145946516|NCT02607306|526312185|FG001|Overall Study|Withdrawal by Subject|10|||
145946517|NCT02607306|526312186|FG002|Overall Study|Withdrawal by Subject|2|||
145946518|NCT02607306|526312184|FG000|Overall Study|Lack of Efficacy|0|||
145946519|NCT02607306|526312185|FG001|Overall Study|Lack of Efficacy|1|||
145946520|NCT02607306|526312186|FG002|Overall Study|Lack of Efficacy|1|||
145946521|NCT02607306|526312184|FG000|Overall Study|Protocol Violation|4|||
145946522|NCT02607306|526312185|FG001|Overall Study|Protocol Violation|2|||
145946523|NCT02607306|526312186|FG002|Overall Study|Protocol Violation|1|||
145946524|NCT04849416|526313854|FG000|Overall Study|Ongoing Treatment|12|||
145946525|NCT04849416|526313855|FG001|Overall Study|Ongoing Treatment|5|||
145946526|NCT04849416|526313856|FG002|Overall Study|Ongoing Treatment|3|||
146082111|NCT02509117|526820593|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145946527|NCT04849416|526313854|FG000|Overall Study|On Post-Treatment Follow-up|8|||
145946528|NCT04849416|526313855|FG001|Overall Study|On Post-Treatment Follow-up|9|||
145946529|NCT04849416|526313856|FG002|Overall Study|On Post-Treatment Follow-up|10|||
145946530|NCT04849416|526313854|FG000|Overall Study|Withdrawal by Subject|0|||
145946531|NCT04849416|526313855|FG001|Overall Study|Withdrawal by Subject|0|||
145946532|NCT04849416|526313856|FG002|Overall Study|Withdrawal by Subject|1|||
145946533|NCT04849416|526313854|FG000|Overall Study|Lost to Follow-up|1|||
145946534|NCT04849416|526313855|FG001|Overall Study|Lost to Follow-up|0|||
145946535|NCT04849416|526313856|FG002|Overall Study|Lost to Follow-up|0|||
145946536|NCT04767529|526313857|FG000|Overall Study|Adverse Event|0|||
145946537|NCT04767529|526313858|FG001|Overall Study|Adverse Event|4|||
145946538|NCT04767529|526313859|FG002|Overall Study|Adverse Event|3|||
145946539|NCT04767529|526313857|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
145946540|NCT04767529|526313858|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
145946541|NCT04767529|526313859|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
146284459|NCT01688830|527553731|FG012|Overall Study|Lost to Follow-up|0|||
145946542|NCT04767529|526313857|FG000|Overall Study|Required use of a prohibited medication|0|||
145946543|NCT04767529|526313858|FG001|Overall Study|Required use of a prohibited medication|1|||
145946544|NCT04767529|526313859|FG002|Overall Study|Required use of a prohibited medication|0|||
145946545|NCT04767529|526313857|FG000|Overall Study|Withdrawal by Subject|7|||
145946546|NCT04767529|526313858|FG001|Overall Study|Withdrawal by Subject|5|||
145946547|NCT04767529|526313859|FG002|Overall Study|Withdrawal by Subject|4|||
145946548|NCT04767529|526313857|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
145946549|NCT04767529|526313858|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
145946550|NCT04767529|526313859|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
145946551|NCT04767529|526313857|FG000|Overall Study|Lost to Follow-up|0|||
145946552|NCT04767529|526313858|FG001|Overall Study|Lost to Follow-up|2|||
145946553|NCT04767529|526313859|FG002|Overall Study|Lost to Follow-up|3|||
145946554|NCT05916131|526313865|FG000|Overall Study|Lost to Follow-up|0|||
145946555|NCT05916131|526313866|FG001|Overall Study|Lost to Follow-up|0|||
145946556|NCT05916131|526313867|FG002|Overall Study|Lost to Follow-up|1|||
145946557|NCT05916131|526313868|FG003|Overall Study|Lost to Follow-up|0|||
145946558|NCT01636947|526313869|FG000|Overall Study|Not Treated|2|||
145946559|NCT01636947|526313870|FG001|Overall Study|Not Treated|2|||
145946560|NCT01636947|526313869|FG000|Overall Study|Lost to Follow-up|4|||
145946561|NCT01636947|526313870|FG001|Overall Study|Lost to Follow-up|0|||
145946562|NCT01636947|526313869|FG000|Overall Study|Protocol Violation|1|||
145946563|NCT01636947|526313870|FG001|Overall Study|Protocol Violation|1|||
145946564|NCT01636947|526313869|FG000|Overall Study|Withdrawal by Subject|3|||
145946565|NCT01636947|526313870|FG001|Overall Study|Withdrawal by Subject|3|||
145946566|NCT01636947|526313869|FG000|Overall Study|Adverse Event|1|||
145946567|NCT01636947|526313870|FG001|Overall Study|Adverse Event|1|||
145946568|NCT01636947|526313869|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
145946569|NCT01636947|526313870|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
145946570|NCT01211483|526313873|FG000|Phase 1b|Death|6|||
145946571|NCT01211483|526313874|FG001|Phase 1b|Death|0|||
145946572|NCT01211483|526313875|FG002|Phase 1b|Death|0|||
145946573|NCT01211483|526313876|FG003|Phase 1b|Death|0|||
145946574|NCT01211483|526313873|FG000|Phase 1b|Withdrawal by Subject|1|||
145946575|NCT01211483|526313874|FG001|Phase 1b|Withdrawal by Subject|0|||
145946576|NCT01211483|526313875|FG002|Phase 1b|Withdrawal by Subject|0|||
145946577|NCT01211483|526313876|FG003|Phase 1b|Withdrawal by Subject|0|||
145946578|NCT01211483|526313873|FG000|Phase 2|Lost to Follow-up|0|||
145946579|NCT01211483|526313874|FG001|Phase 2|Lost to Follow-up|1|||
145946580|NCT01211483|526313875|FG002|Phase 2|Lost to Follow-up|1|||
145946581|NCT01211483|526313876|FG003|Phase 2|Lost to Follow-up|2|||
145946582|NCT01211483|526313873|FG000|Phase 2|Death|0|||
145946583|NCT01211483|526313874|FG001|Phase 2|Death|64|||
145946584|NCT01211483|526313875|FG002|Phase 2|Death|53|||
145946585|NCT01211483|526313876|FG003|Phase 2|Death|53|||
145946586|NCT01211483|526313873|FG000|Phase 2|Withdrawal by Subject|0|||
145946587|NCT01211483|526313874|FG001|Phase 2|Withdrawal by Subject|1|||
145946588|NCT01211483|526313875|FG002|Phase 2|Withdrawal by Subject|10|||
145946589|NCT01211483|526313876|FG003|Phase 2|Withdrawal by Subject|5|||
145946590|NCT01211483|526313873|FG000|Phase 2|Study terminated by Sponsor|0|||
145946591|NCT01211483|526313874|FG001|Phase 2|Study terminated by Sponsor|6|||
145946592|NCT01211483|526313875|FG002|Phase 2|Study terminated by Sponsor|8|||
145946593|NCT01211483|526313876|FG003|Phase 2|Study terminated by Sponsor|11|||
145946594|NCT02284568|526313877|FG000|Overall Study|Adverse Event|2|||
145946595|NCT02284568|526313878|FG001|Overall Study|Adverse Event|9|||
146192458|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
146192459|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Other|1|||
145946596|NCT02284568|526313879|FG002|Overall Study|Adverse Event|4|||
145946597|NCT02284568|526313877|FG000|Overall Study|Withdrawal by Subject|22|||
145946598|NCT02284568|526313878|FG001|Overall Study|Withdrawal by Subject|21|||
145946599|NCT02284568|526313879|FG002|Overall Study|Withdrawal by Subject|1|||
145946600|NCT02284568|526313877|FG000|Overall Study|Noncompliance with study drug admin|1|||
145946601|NCT02284568|526313878|FG001|Overall Study|Noncompliance with study drug admin|2|||
145946602|NCT02284568|526313879|FG002|Overall Study|Noncompliance with study drug admin|0|||
145946603|NCT02284568|526313877|FG000|Overall Study|Noncompliance|1|||
145946604|NCT02284568|526313878|FG001|Overall Study|Noncompliance|0|||
145946605|NCT02284568|526313879|FG002|Overall Study|Noncompliance|0|||
145946606|NCT02284568|526313877|FG000|Overall Study|Protocol Violation|0|||
145946607|NCT02284568|526313878|FG001|Overall Study|Protocol Violation|1|||
145946608|NCT02284568|526313879|FG002|Overall Study|Protocol Violation|0|||
145946609|NCT02284568|526313877|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
145946610|NCT02284568|526313878|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
145946611|NCT02284568|526313879|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
145946612|NCT02284568|526313877|FG000|Overall Study|Lost to Follow-up|0|||
145946613|NCT02284568|526313878|FG001|Overall Study|Lost to Follow-up|3|||
145946614|NCT02284568|526313879|FG002|Overall Study|Lost to Follow-up|0|||
145946615|NCT02284568|526313877|FG000|Overall Study|Lack of Efficacy|4|||
145946616|NCT02284568|526313878|FG001|Overall Study|Lack of Efficacy|7|||
145946617|NCT02284568|526313879|FG002|Overall Study|Lack of Efficacy|0|||
145946618|NCT02284568|526313877|FG000|Overall Study|Other|1|||
145946619|NCT02284568|526313878|FG001|Overall Study|Other|2|||
145946620|NCT02284568|526313879|FG002|Overall Study|Other|0|||
145946621|NCT02284568|526313877|FG000|Overall Study|Withdrew before taking study drug|0|||
145946622|NCT02284568|526313878|FG001|Overall Study|Withdrew before taking study drug|1|||
145946623|NCT02284568|526313879|FG002|Overall Study|Withdrew before taking study drug|0|||
145946624|NCT00460265|526313880|FG000|Overall Study|Lost to Follow-up|14|||
145946625|NCT00460265|526313881|FG001|Overall Study|Lost to Follow-up|15|||
145946626|NCT00460265|526313880|FG000|Overall Study|Physician Decision|1|||
145946627|NCT00460265|526313881|FG001|Overall Study|Physician Decision|2|||
145946628|NCT00460265|526313880|FG000|Overall Study|Withdrawal by Subject|10|||
145946629|NCT00460265|526313881|FG001|Overall Study|Withdrawal by Subject|25|||
145946630|NCT00460265|526313880|FG000|Overall Study|Ongoing|60|||
145946631|NCT00460265|526313881|FG001|Overall Study|Ongoing|47|||
145946632|NCT02719353|526313883|FG000|First Intervention|Physician Decision|0|||
145946633|NCT02719353|526313884|FG001|First Intervention|Physician Decision|1|||
145946634|NCT03956615|526313886|FG000|Overall Study|No multiple myeloma confirmed|2|||
145946635|NCT03956615|526313886|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
146192460|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Other|0|||
146192461|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Other|0|||
146192462|NCT02403323|527215472|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
146192463|NCT02403323|527215473|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146192464|NCT02403323|527215474|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
146192465|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146192466|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
145946636|NCT03956615|526313886|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
145946637|NCT03956615|526313886|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
145946638|NCT00412217|526313887|FG000|Overall Study|Insufficient Data Available|8|||
145946639|NCT00412217|526313888|FG001|Overall Study|Insufficient Data Available|3|||
145946640|NCT00412217|526313887|FG000|Overall Study|Death|5|||
146192467|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
146192468|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
146192469|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
146192470|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
146192471|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
146192472|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
146192473|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
146192474|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146192475|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
146192476|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
146192477|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
146192478|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
146192479|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
145946641|NCT00412217|526313888|FG001|Overall Study|Death|4|||
145946642|NCT00412217|526313887|FG000|Overall Study|Disease Progression|2|||
145946643|NCT00412217|526313888|FG001|Overall Study|Disease Progression|3|||
145946644|NCT00412217|526313887|FG000|Overall Study|Investigator Decision|1|||
145946645|NCT00412217|526313888|FG001|Overall Study|Investigator Decision|0|||
145946646|NCT00412217|526313887|FG000|Overall Study|Withdrawal by Subject|2|||
145946647|NCT00412217|526313888|FG001|Overall Study|Withdrawal by Subject|0|||
145946648|NCT00412217|526313887|FG000|Overall Study|Lost to Follow-up|1|||
145946649|NCT00412217|526313888|FG001|Overall Study|Lost to Follow-up|4|||
145946650|NCT00412217|526313887|FG000|Overall Study|Study Terminated by Sponsor|26|||
145946651|NCT00412217|526313888|FG001|Overall Study|Study Terminated by Sponsor|33|||
145946652|NCT00412217|526313887|FG000|Overall Study|Other|1|||
145946653|NCT00412217|526313888|FG001|Overall Study|Other|1|||
145946654|NCT01069419|526313889|FG000|Overall Study|Adverse Event|233|||
145946655|NCT01069419|526313889|FG000|Overall Study|Lack of Efficacy|332|||
145946656|NCT01069419|526313889|FG000|Overall Study|Lost to Follow-up|49|||
145946657|NCT01069419|526313889|FG000|Overall Study|Remission of disease|11|||
145946658|NCT01069419|526313889|FG000|Overall Study|Withdrawal by Subject|34|||
145946659|NCT01069419|526313889|FG000|Overall Study|Other Reason|43|||
145946660|NCT01069419|526313889|FG000|Overall Study|Missing termination information|13|||
145946661|NCT02854605|526313891|FG000|Overall Study|Adverse Event|1|||
145946662|NCT02854605|526313892|FG001|Overall Study|Adverse Event|5|||
145946663|NCT02854605|526313893|FG002|Overall Study|Adverse Event|2|||
145946664|NCT02854605|526313891|FG000|Overall Study|Lost to Follow-up|0|||
145946665|NCT02854605|526313892|FG001|Overall Study|Lost to Follow-up|2|||
145946666|NCT02854605|526313893|FG002|Overall Study|Lost to Follow-up|0|||
145946667|NCT02854605|526313891|FG000|Overall Study|Withdrew Consent|1|||
145946668|NCT02854605|526313892|FG001|Overall Study|Withdrew Consent|0|||
145946669|NCT02854605|526313893|FG002|Overall Study|Withdrew Consent|1|||
145946670|NCT02854605|526313891|FG000|Overall Study|Investigator's Discretion|1|||
145946671|NCT02854605|526313892|FG001|Overall Study|Investigator's Discretion|0|||
145946672|NCT02854605|526313893|FG002|Overall Study|Investigator's Discretion|0|||
145946673|NCT02854605|526313891|FG000|Overall Study|Protocol Violation|0|||
145946674|NCT02854605|526313892|FG001|Overall Study|Protocol Violation|0|||
145946675|NCT02854605|526313893|FG002|Overall Study|Protocol Violation|1|||
145946676|NCT00568334|526313894|FG000|Overall Study|Withdrawal by Subject|0|||
145946677|NCT00568334|526313895|FG001|Overall Study|Withdrawal by Subject|1|||
145946678|NCT00568334|526313894|FG000|Overall Study|Lost to Follow-up|1|||
145946679|NCT00568334|526313895|FG001|Overall Study|Lost to Follow-up|0|||
145946680|NCT01897571|526313896|FG000|Overall Study|Lost to Follow-up|3|||
145946681|NCT01897571|526313897|FG001|Overall Study|Lost to Follow-up|0|||
145946682|NCT01897571|526313898|FG002|Overall Study|Lost to Follow-up|0|||
145946683|NCT01897571|526313899|FG003|Overall Study|Lost to Follow-up|0|||
145946684|NCT01897571|526313900|FG004|Overall Study|Lost to Follow-up|2|||
146192480|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
146192481|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
145946685|NCT01897571|526313901|FG005|Overall Study|Lost to Follow-up|0|||
145946686|NCT01897571|526313902|FG006|Overall Study|Lost to Follow-up|0|||
145946687|NCT01897571|526313903|FG007|Overall Study|Lost to Follow-up|0|||
145946688|NCT01897571|526313904|FG008|Overall Study|Lost to Follow-up|1|||
145946689|NCT01897571|526313905|FG009|Overall Study|Lost to Follow-up|2|||
145946690|NCT01897571|526313906|FG010|Overall Study|Lost to Follow-up|4|||
145946691|NCT01897571|526313896|FG000|Overall Study|Withdrawal by Subject|0|||
146192482|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
145946692|NCT01897571|526313897|FG001|Overall Study|Withdrawal by Subject|0|||
145946693|NCT01897571|526313898|FG002|Overall Study|Withdrawal by Subject|0|||
145946694|NCT01897571|526313899|FG003|Overall Study|Withdrawal by Subject|0|||
145946695|NCT01897571|526313900|FG004|Overall Study|Withdrawal by Subject|0|||
145946696|NCT01897571|526313901|FG005|Overall Study|Withdrawal by Subject|0|||
145946697|NCT01897571|526313902|FG006|Overall Study|Withdrawal by Subject|0|||
145946698|NCT01897571|526313903|FG007|Overall Study|Withdrawal by Subject|1|||
145946699|NCT01897571|526313904|FG008|Overall Study|Withdrawal by Subject|4|||
145946700|NCT01897571|526313905|FG009|Overall Study|Withdrawal by Subject|3|||
145946701|NCT01897571|526313906|FG010|Overall Study|Withdrawal by Subject|1|||
146082112|NCT02509117|526820594|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
146284460|NCT01688830|527553732|FG013|Overall Study|Lost to Follow-up|0|||
145946702|NCT01897571|526313896|FG000|Overall Study|Other|1|||
145946703|NCT01897571|526313897|FG001|Overall Study|Other|0|||
145946704|NCT01897571|526313898|FG002|Overall Study|Other|0|||
145946705|NCT01897571|526313899|FG003|Overall Study|Other|3|||
145946706|NCT01897571|526313900|FG004|Overall Study|Other|3|||
145946707|NCT01897571|526313901|FG005|Overall Study|Other|4|||
145946708|NCT01897571|526313902|FG006|Overall Study|Other|7|||
145946709|NCT01897571|526313903|FG007|Overall Study|Other|0|||
145946710|NCT01897571|526313904|FG008|Overall Study|Other|0|||
145946711|NCT01897571|526313905|FG009|Overall Study|Other|0|||
145946712|NCT01897571|526313906|FG010|Overall Study|Other|0|||
145946713|NCT01897571|526313896|FG000|Overall Study|Enrolled in rollover study|0|||
145946714|NCT01897571|526313897|FG001|Overall Study|Enrolled in rollover study|0|||
145946715|NCT01897571|526313898|FG002|Overall Study|Enrolled in rollover study|0|||
145946716|NCT01897571|526313899|FG003|Overall Study|Enrolled in rollover study|0|||
145946717|NCT01897571|526313900|FG004|Overall Study|Enrolled in rollover study|0|||
145946718|NCT01897571|526313901|FG005|Overall Study|Enrolled in rollover study|0|||
145946719|NCT01897571|526313902|FG006|Overall Study|Enrolled in rollover study|0|||
145946720|NCT01897571|526313903|FG007|Overall Study|Enrolled in rollover study|9|||
145946721|NCT01897571|526313904|FG008|Overall Study|Enrolled in rollover study|7|||
145946722|NCT01897571|526313905|FG009|Overall Study|Enrolled in rollover study|9|||
145946723|NCT01897571|526313906|FG010|Overall Study|Enrolled in rollover study|1|||
145946724|NCT01897571|526313896|FG000|Overall Study|Death|2|||
145946725|NCT01897571|526313897|FG001|Overall Study|Death|2|||
145946726|NCT01897571|526313898|FG002|Overall Study|Death|3|||
145946727|NCT01897571|526313899|FG003|Overall Study|Death|6|||
145946728|NCT01897571|526313900|FG004|Overall Study|Death|7|||
145946729|NCT01897571|526313901|FG005|Overall Study|Death|9|||
145946730|NCT01897571|526313902|FG006|Overall Study|Death|5|||
145946731|NCT01897571|526313903|FG007|Overall Study|Death|22|||
145946732|NCT01897571|526313904|FG008|Overall Study|Death|23|||
145946733|NCT01897571|526313905|FG009|Overall Study|Death|129|||
145946734|NCT01897571|526313906|FG010|Overall Study|Death|59|||
145946735|NCT01797094|526313907|FG000|Overall Study|Adverse Event|1|||
145946736|NCT01797094|526313908|FG001|Overall Study|Adverse Event|1|||
145946737|NCT01797094|526313907|FG000|Overall Study|Personal Reasons|4|||
145946738|NCT01797094|526313908|FG001|Overall Study|Personal Reasons|0|||
145946739|NCT01797094|526313907|FG000|Overall Study|Protocol Violation|0|||
145946740|NCT01797094|526313908|FG001|Overall Study|Protocol Violation|1|||
145946741|NCT01797094|526313907|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145946742|NCT01797094|526313908|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145946743|NCT03217968|526313909|FG000|Overall Study|Withdrawal by Subject|4|||
145946744|NCT03217968|526313909|FG000|Overall Study|Lost to Follow-up|1|||
145946745|NCT03217968|526313909|FG000|Overall Study|Protocol Violation|6|||
145946746|NCT05268016|526313912|FG000|Overall Study|Unacceptable toxicity or AE|2|||
145946747|NCT05268016|526313913|FG001|Overall Study|Unacceptable toxicity or AE|2|||
145946748|NCT05268016|526313914|FG002|Overall Study|Unacceptable toxicity or AE|4|||
145946749|NCT05268016|526313915|FG003|Overall Study|Unacceptable toxicity or AE|3|||
145946750|NCT05268016|526313916|FG004|Overall Study|Unacceptable toxicity or AE|1|||
145946751|NCT05268016|526313912|FG000|Overall Study|Withdrawal by Subject|1|||
145946752|NCT05268016|526313913|FG001|Overall Study|Withdrawal by Subject|3|||
145946753|NCT05268016|526313914|FG002|Overall Study|Withdrawal by Subject|2|||
145946754|NCT05268016|526313915|FG003|Overall Study|Withdrawal by Subject|2|||
145946755|NCT05268016|526313916|FG004|Overall Study|Withdrawal by Subject|1|||
145946756|NCT05268016|526313912|FG000|Overall Study|Lost to Follow-up|4|||
145946757|NCT05268016|526313913|FG001|Overall Study|Lost to Follow-up|7|||
145946758|NCT05268016|526313914|FG002|Overall Study|Lost to Follow-up|1|||
145946759|NCT05268016|526313915|FG003|Overall Study|Lost to Follow-up|3|||
145946760|NCT05268016|526313916|FG004|Overall Study|Lost to Follow-up|5|||
145946761|NCT05268016|526313912|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
145946762|NCT05268016|526313913|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
146192483|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
145946763|NCT05268016|526313914|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
145946764|NCT05268016|526313915|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
145946765|NCT05268016|526313916|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
145946766|NCT05268016|526313912|FG000|Overall Study|Lack of Efficacy|0|||
145946767|NCT05268016|526313913|FG001|Overall Study|Lack of Efficacy|0|||
145946768|NCT05268016|526313914|FG002|Overall Study|Lack of Efficacy|0|||
145946769|NCT05268016|526313915|FG003|Overall Study|Lack of Efficacy|0|||
145946770|NCT05268016|526313916|FG004|Overall Study|Lack of Efficacy|4|||
145946771|NCT05268016|526313912|FG000|Overall Study|Physician Decision|0|||
145946772|NCT05268016|526313913|FG001|Overall Study|Physician Decision|0|||
145946773|NCT05268016|526313914|FG002|Overall Study|Physician Decision|0|||
145946774|NCT05268016|526313915|FG003|Overall Study|Physician Decision|1|||
145946775|NCT05268016|526313916|FG004|Overall Study|Physician Decision|0|||
146192484|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
145946776|NCT05268016|526313912|FG000|Overall Study|Other|1|||
145946777|NCT05268016|526313913|FG001|Overall Study|Other|0|||
146284461|NCT01688830|527553733|FG014|Overall Study|Lost to Follow-up|0|||
145946778|NCT05268016|526313914|FG002|Overall Study|Other|1|||
145946779|NCT05268016|526313915|FG003|Overall Study|Other|2|||
145946780|NCT05268016|526313916|FG004|Overall Study|Other|0|||
145946781|NCT00089635|526313917|FG000|Overall Study|Adverse Event|2|||
145946782|NCT00089635|526313917|FG000|Overall Study|Death|17|||
145946783|NCT00089635|526313917|FG000|Overall Study|Disease Progression|12|||
145946784|NCT00089635|526313917|FG000|Overall Study|Lost to Follow-up|3|||
145946785|NCT00089635|526313917|FG000|Overall Study|Withdrawal by Subject|6|||
145946786|NCT00089635|526313917|FG000|Overall Study|Ineligibility determined|1|||
145946787|NCT00089635|526313917|FG000|Overall Study|Other|2|||
145946788|NCT00821015|526313920|FG000|Overall Study|Lost to Follow-up|12|||
145946789|NCT01887678|526313921|FG000|Overall Study|Adverse Event|4|||
145946790|NCT01887678|526313922|FG001|Overall Study|Adverse Event|6|||
145946791|NCT01887678|526313921|FG000|Overall Study|Exceeded rescue medication dosage|4|||
145946792|NCT01887678|526313922|FG001|Overall Study|Exceeded rescue medication dosage|5|||
145946793|NCT01887678|526313921|FG000|Overall Study|Withdrawal of consent|3|||
145946794|NCT01887678|526313922|FG001|Overall Study|Withdrawal of consent|4|||
145946795|NCT01887678|526313921|FG000|Overall Study|Lost to Follow-up|4|||
145946796|NCT01887678|526313922|FG001|Overall Study|Lost to Follow-up|2|||
145946797|NCT01887678|526313921|FG000|Overall Study|Deterioration of clinical condition|0|||
145946798|NCT01887678|526313922|FG001|Overall Study|Deterioration of clinical condition|4|||
145946799|NCT01887678|526313921|FG000|Overall Study|Lack of Efficacy|1|||
145946800|NCT01887678|526313922|FG001|Overall Study|Lack of Efficacy|2|||
145946801|NCT01887678|526313921|FG000|Overall Study|Non-compliance|0|||
145946802|NCT01887678|526313922|FG001|Overall Study|Non-compliance|3|||
145946803|NCT01887678|526313921|FG000|Overall Study|Specified|1|||
145946804|NCT01887678|526313922|FG001|Overall Study|Specified|2|||
145946805|NCT00270231|526313931|FG000|First Intervention|Lost to Follow-up|1|||
145946806|NCT00270231|526313932|FG001|First Intervention|Lost to Follow-up|1|||
145946807|NCT00270231|526313931|FG000|Washout Period|Lost to Follow-up|1|||
145946808|NCT00270231|526313932|FG001|Washout Period|Lost to Follow-up|0|||
145946809|NCT00270231|526313931|FG000|Second Intervention|Lost to Follow-up|0|||
145946810|NCT00270231|526313932|FG001|Second Intervention|Lost to Follow-up|1|||
145946811|NCT01080391|526313941|FG000|Overall Study|Randomized but not treated|7|||
145946812|NCT01080391|526313942|FG001|Overall Study|Randomized but not treated|4|||
145946813|NCT02240069|526313952|FG000|Overall Study|Withdrawal by Subject|5|||
145946814|NCT02240069|526313953|FG001|Overall Study|Withdrawal by Subject|5|||
145946815|NCT02240069|526313954|FG002|Overall Study|Withdrawal by Subject|2|||
145946816|NCT00106639|526313955|FG000|Overall Study|Adverse Event|3|||
145946817|NCT00106639|526313956|FG001|Overall Study|Adverse Event|4|||
145946818|NCT00106639|526313957|FG002|Overall Study|Adverse Event|1|||
145946819|NCT00106639|526313955|FG000|Overall Study|Protocol Violation|0|||
145946820|NCT00106639|526313956|FG001|Overall Study|Protocol Violation|1|||
145946821|NCT00106639|526313957|FG002|Overall Study|Protocol Violation|0|||
145946822|NCT00106639|526313955|FG000|Overall Study|Withdrawal by Subject|0|||
145946823|NCT00106639|526313956|FG001|Overall Study|Withdrawal by Subject|1|||
145946824|NCT00106639|526313957|FG002|Overall Study|Withdrawal by Subject|0|||
145946825|NCT00106639|526313955|FG000|Overall Study|Participant defaulted|0|||
145946826|NCT00106639|526313956|FG001|Overall Study|Participant defaulted|1|||
145946827|NCT00106639|526313957|FG002|Overall Study|Participant defaulted|1|||
145946828|NCT01876979|526313958|FG000|Overall Study|Physician Decision|2|||
145946829|NCT01876979|526313959|FG001|Overall Study|Physician Decision|3|||
145946830|NCT01096589|526313960|FG000|Overall Study|Adverse Event|2|||
145946831|NCT01096589|526313961|FG001|Overall Study|Adverse Event|1|||
145946832|NCT01096589|526313962|FG002|Overall Study|Adverse Event|2|||
145946833|NCT01096589|526313963|FG003|Overall Study|Adverse Event|1|||
145946834|NCT01096589|526313960|FG000|Overall Study|Withdrawal by Subject|2|||
145946835|NCT01096589|526313961|FG001|Overall Study|Withdrawal by Subject|1|||
145946836|NCT01096589|526313962|FG002|Overall Study|Withdrawal by Subject|1|||
145946837|NCT01096589|526313963|FG003|Overall Study|Withdrawal by Subject|1|||
145946838|NCT01096589|526313960|FG000|Overall Study|Compliance with protocol|0|||
145946839|NCT01096589|526313961|FG001|Overall Study|Compliance with protocol|0|||
145946840|NCT01096589|526313962|FG002|Overall Study|Compliance with protocol|1|||
145946841|NCT01096589|526313963|FG003|Overall Study|Compliance with protocol|0|||
145946842|NCT01096589|526313960|FG000|Overall Study|found treatment exhausting|0|||
145946843|NCT01096589|526313961|FG001|Overall Study|found treatment exhausting|0|||
145946844|NCT01096589|526313962|FG002|Overall Study|found treatment exhausting|0|||
145946845|NCT01096589|526313963|FG003|Overall Study|found treatment exhausting|1|||
145946846|NCT00721279|526313967|FG000|Overall Study|Lack of Efficacy|6|||
145946847|NCT00721279|526313968|FG001|Overall Study|Lack of Efficacy|3|||
145946848|NCT00721279|526313967|FG000|Overall Study|Tolerability insufficient|5|||
145946849|NCT00721279|526313968|FG001|Overall Study|Tolerability insufficient|2|||
145946850|NCT00721279|526313967|FG000|Overall Study|Withdrawal by Subject|13|||
145946851|NCT00721279|526313968|FG001|Overall Study|Withdrawal by Subject|3|||
145946852|NCT00721279|526313967|FG000|Overall Study|Other|12|||
145946853|NCT00721279|526313968|FG001|Overall Study|Other|16|||
145946854|NCT05153148|526313969|FG000|Overall Study|Adverse Event|1|||
145946855|NCT05153148|526313970|FG001|Overall Study|Adverse Event|0|||
145946856|NCT05153148|526313971|FG002|Overall Study|Adverse Event|3|||
145946857|NCT05153148|526313972|FG003|Overall Study|Adverse Event|5|||
145946858|NCT05153148|526313969|FG000|Overall Study|Lost to Follow-up|1|||
145946859|NCT05153148|526313970|FG001|Overall Study|Lost to Follow-up|1|||
145946860|NCT05153148|526313971|FG002|Overall Study|Lost to Follow-up|2|||
145946861|NCT05153148|526313972|FG003|Overall Study|Lost to Follow-up|0|||
145946862|NCT05153148|526313969|FG000|Overall Study|Withdrawal by Subject|6|||
145946863|NCT05153148|526313970|FG001|Overall Study|Withdrawal by Subject|8|||
145946864|NCT05153148|526313971|FG002|Overall Study|Withdrawal by Subject|6|||
145946865|NCT05153148|526313972|FG003|Overall Study|Withdrawal by Subject|8|||
145946866|NCT05153148|526313969|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145946867|NCT05153148|526313970|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145946868|NCT05153148|526313971|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
145946869|NCT05153148|526313972|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145946870|NCT05153148|526313969|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145946871|NCT05153148|526313970|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145946872|NCT05153148|526313971|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145946873|NCT05153148|526313972|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
145946874|NCT05153148|526313969|FG000|Overall Study|Reason not Specified|1|||
145946875|NCT05153148|526313970|FG001|Overall Study|Reason not Specified|1|||
145946876|NCT05153148|526313971|FG002|Overall Study|Reason not Specified|1|||
145946877|NCT05153148|526313972|FG003|Overall Study|Reason not Specified|1|||
145946878|NCT01712334|526313973|FG000|Treatment Period 1|Randomized in Error|0|||
145946879|NCT01712334|526313974|FG001|Treatment Period 1|Randomized in Error|2|||
145946880|NCT00232596|526313975|FG000|6-Week Titration Phase|Adverse Event|6|||
145946881|NCT00232596|526313976|FG001|6-Week Titration Phase|Adverse Event|19|||
145946882|NCT00232596|526313975|FG000|6-Week Titration Phase|Failed to Return|2|||
145946883|NCT00232596|526313976|FG001|6-Week Titration Phase|Failed to Return|1|||
145946884|NCT00232596|526313975|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
145946885|NCT00232596|526313976|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
145946886|NCT00232596|526313975|FG000|6-Week Titration Phase|Protocol Violation|1|||
145946887|NCT00232596|526313976|FG001|6-Week Titration Phase|Protocol Violation|3|||
145946888|NCT00232596|526313975|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
145946889|NCT00232596|526313976|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
145946890|NCT00232596|526313975|FG000|6-Week Titration Phase|Other|3|||
145946891|NCT00232596|526313976|FG001|6-Week Titration Phase|Other|3|||
145946892|NCT00232596|526313975|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145946893|NCT00232596|526313976|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
145946894|NCT00232596|526313975|FG000|12-Week Maintenance Phase|Adverse Event|7|||
145946895|NCT00232596|526313976|FG001|12-Week Maintenance Phase|Adverse Event|22|||
146192485|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
146192486|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
146192487|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
146192488|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
146192489|NCT02403323|527215472|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
146192490|NCT02403323|527215473|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
146192491|NCT02403323|527215474|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
146192492|NCT00197236|527215478|FG000|Overall Study|Adverse Event|1|||
146192493|NCT00197236|527215479|FG001|Overall Study|Adverse Event|0|||
146192494|NCT00197236|527215480|FG002|Overall Study|Adverse Event|1|||
146192495|NCT00197236|527215478|FG000|Overall Study|Lost to Follow-up|5|||
146192496|NCT00197236|527215479|FG001|Overall Study|Lost to Follow-up|14|||
146192497|NCT00197236|527215480|FG002|Overall Study|Lost to Follow-up|6|||
146192498|NCT00197236|527215478|FG000|Overall Study|Protocol Violation|0|||
146192499|NCT00197236|527215479|FG001|Overall Study|Protocol Violation|0|||
146192500|NCT00197236|527215480|FG002|Overall Study|Protocol Violation|1|||
146192501|NCT00197236|527215478|FG000|Overall Study|Withdrawal by Subject|7|||
146192502|NCT00197236|527215479|FG001|Overall Study|Withdrawal by Subject|3|||
146192503|NCT00197236|527215480|FG002|Overall Study|Withdrawal by Subject|11|||
146192504|NCT00197236|527215478|FG000|Overall Study|Study drug/medication expiration|1|||
146192505|NCT00197236|527215479|FG001|Overall Study|Study drug/medication expiration|0|||
145946896|NCT00232596|526313975|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
145946897|NCT00232596|526313976|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
145946898|NCT00232596|526313975|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
146192506|NCT00197236|527215480|FG002|Overall Study|Study drug/medication expiration|3|||
146192507|NCT00197236|527215478|FG000|Overall Study|Returned out of specified time window|0|||
146192508|NCT00197236|527215479|FG001|Overall Study|Returned out of specified time window|0|||
146284462|NCT01688830|527553734|FG015|Overall Study|Lost to Follow-up|0|||
145946899|NCT00232596|526313976|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
145946900|NCT00232596|526313975|FG000|12-Week Maintenance Phase|Other|1|||
145946901|NCT00232596|526313976|FG001|12-Week Maintenance Phase|Other|3|||
145946902|NCT01253174|526313977|FG000|Period 1|Randomized but not treated|0|||
145946903|NCT01253174|526313978|FG001|Period 1|Randomized but not treated|1|||
145946904|NCT01253174|526313979|FG002|Period 1|Randomized but not treated|1|||
145946905|NCT01253174|526313980|FG003|Period 1|Randomized but not treated|0|||
145946906|NCT01253174|526313981|FG004|Period 1|Randomized but not treated|1|||
145946907|NCT01253174|526313982|FG005|Period 1|Randomized but not treated|0|||
145946908|NCT01253174|526313977|FG000|Period 2|Adverse Event|0|||
145946909|NCT01253174|526313978|FG001|Period 2|Adverse Event|0|||
145946910|NCT01253174|526313979|FG002|Period 2|Adverse Event|1|||
145946911|NCT01253174|526313980|FG003|Period 2|Adverse Event|0|||
145946912|NCT01253174|526313981|FG004|Period 2|Adverse Event|0|||
145946913|NCT01253174|526313982|FG005|Period 2|Adverse Event|0|||
145946914|NCT01253174|526313977|FG000|Period 3|Withdrawal by Subject|0|||
145946915|NCT01253174|526313978|FG001|Period 3|Withdrawal by Subject|1|||
145946916|NCT01253174|526313979|FG002|Period 3|Withdrawal by Subject|0|||
145946917|NCT01253174|526313980|FG003|Period 3|Withdrawal by Subject|0|||
145946918|NCT01253174|526313981|FG004|Period 3|Withdrawal by Subject|1|||
145946919|NCT01253174|526313982|FG005|Period 3|Withdrawal by Subject|0|||
145946920|NCT01253174|526313977|FG000|Period 3|Pregnancy|0|||
145946921|NCT01253174|526313978|FG001|Period 3|Pregnancy|0|||
145946922|NCT01253174|526313979|FG002|Period 3|Pregnancy|1|||
145946923|NCT01253174|526313980|FG003|Period 3|Pregnancy|0|||
145946924|NCT01253174|526313981|FG004|Period 3|Pregnancy|0|||
145946925|NCT01253174|526313982|FG005|Period 3|Pregnancy|0|||
145946926|NCT02267135|526313983|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
145946927|NCT02267135|526313984|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
145946928|NCT02267135|526313983|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
145946929|NCT02267135|526313984|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
145946930|NCT02267135|526313983|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
145946931|NCT02267135|526313984|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
145946932|NCT02267135|526313983|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
145946933|NCT02267135|526313984|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
145946934|NCT02267135|526313983|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
145946935|NCT02267135|526313984|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
145946936|NCT00900731|526313985|FG000|Overall Study|Adverse Event|31|||
145946937|NCT00900731|526313986|FG001|Overall Study|Adverse Event|27|||
145946938|NCT00900731|526313985|FG000|Overall Study|Withdrawal by Subject|8|||
145946939|NCT00900731|526313986|FG001|Overall Study|Withdrawal by Subject|7|||
145946940|NCT00900731|526313985|FG000|Overall Study|Protocol Deviation|8|||
145946941|NCT00900731|526313986|FG001|Overall Study|Protocol Deviation|11|||
145946942|NCT00900731|526313985|FG000|Overall Study|Administrative Problems|5|||
145946943|NCT00900731|526313986|FG001|Overall Study|Administrative Problems|4|||
145946944|NCT00900731|526313985|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
145946945|NCT00900731|526313986|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145946946|NCT00900731|526313985|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
145946947|NCT00900731|526313986|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
145946948|NCT00900731|526313985|FG000|Overall Study|Lost to Follow-up|2|||
146192509|NCT00197236|527215480|FG002|Overall Study|Returned out of specified time window|1|||
145946949|NCT00900731|526313986|FG001|Overall Study|Lost to Follow-up|3|||
145946950|NCT00900731|526313985|FG000|Overall Study|Lack of Efficacy|1|||
145946951|NCT00900731|526313986|FG001|Overall Study|Lack of Efficacy|3|||
145946952|NCT00900731|526313985|FG000|Overall Study|Death|0|||
145946953|NCT00900731|526313986|FG001|Overall Study|Death|2|||
145946954|NCT02919267|526313987|FG000|Overall Study|Protocol Violation|0|||
145946955|NCT02919267|526313988|FG001|Overall Study|Protocol Violation|3|||
145946956|NCT02919267|526313989|FG002|Overall Study|Protocol Violation|3|||
145946957|NCT02919267|526313990|FG003|Overall Study|Protocol Violation|4|||
145946958|NCT03467763|526313991|FG000|Overall Study|Lost to Follow-up|1|||
145946959|NCT03467763|526313991|FG000|Overall Study|Protocol Violation|2|||
145946960|NCT02908074|526313992|FG000|Overall Study|sponsor/ICON decision|0|||
145946961|NCT02908074|526313993|FG001|Overall Study|sponsor/ICON decision|0|||
145946962|NCT02908074|526313994|FG002|Overall Study|sponsor/ICON decision|1|||
145946963|NCT02908074|526313995|FG003|Overall Study|sponsor/ICON decision|0|||
145946964|NCT02908074|526313996|FG004|Overall Study|sponsor/ICON decision|0|||
145946965|NCT02908074|526313997|FG005|Overall Study|sponsor/ICON decision|0|||
145946966|NCT02908074|526313992|FG000|Overall Study|Protocol Violation|0|||
145946967|NCT02908074|526313993|FG001|Overall Study|Protocol Violation|1|||
145946968|NCT02908074|526313994|FG002|Overall Study|Protocol Violation|0|||
145946969|NCT02908074|526313995|FG003|Overall Study|Protocol Violation|0|||
145946970|NCT02908074|526313996|FG004|Overall Study|Protocol Violation|0|||
145946971|NCT02908074|526313997|FG005|Overall Study|Protocol Violation|0|||
145946972|NCT02908074|526313992|FG000|Overall Study|Adverse Event|5|||
145946973|NCT02908074|526313993|FG001|Overall Study|Adverse Event|2|||
145946974|NCT02908074|526313994|FG002|Overall Study|Adverse Event|0|||
145946975|NCT02908074|526313995|FG003|Overall Study|Adverse Event|0|||
145946976|NCT02908074|526313996|FG004|Overall Study|Adverse Event|1|||
145946977|NCT02908074|526313997|FG005|Overall Study|Adverse Event|0|||
145946978|NCT02908074|526313992|FG000|Overall Study|AESI|1|||
145946979|NCT02908074|526313993|FG001|Overall Study|AESI|0|||
145946980|NCT02908074|526313994|FG002|Overall Study|AESI|1|||
145946981|NCT02908074|526313995|FG003|Overall Study|AESI|0|||
145946982|NCT02908074|526313996|FG004|Overall Study|AESI|1|||
145946983|NCT02908074|526313997|FG005|Overall Study|AESI|0|||
146284463|NCT01688830|527553735|FG016|Overall Study|Lost to Follow-up|0|||
146413433|NCT01025193|528018135|FG000|Overall Study|Adverse Event|3|||
146413434|NCT02904200|528018136|FG000|Overall Study|Withdrawal by Subject|1|||
146413435|NCT02904200|528018137|FG001|Overall Study|Withdrawal by Subject|0|||
146413436|NCT03705169|528018140|FG000|Overall Study|Lost to Follow-up|0|||
146413437|NCT03705169|528018141|FG001|Overall Study|Lost to Follow-up|0|||
145946984|NCT02908074|526313992|FG000|Overall Study|Discontinuation criteria per protocol|0|||
145946985|NCT02908074|526313993|FG001|Overall Study|Discontinuation criteria per protocol|0|||
145946986|NCT02908074|526313994|FG002|Overall Study|Discontinuation criteria per protocol|1|||
145946987|NCT02908074|526313995|FG003|Overall Study|Discontinuation criteria per protocol|0|||
145946988|NCT02908074|526313996|FG004|Overall Study|Discontinuation criteria per protocol|0|||
145946989|NCT02908074|526313997|FG005|Overall Study|Discontinuation criteria per protocol|1|||
145946990|NCT02908074|526313992|FG000|Overall Study|Withdrawal by Subject|3|||
145946991|NCT02908074|526313993|FG001|Overall Study|Withdrawal by Subject|2|||
145946992|NCT02908074|526313994|FG002|Overall Study|Withdrawal by Subject|2|||
145946993|NCT02908074|526313995|FG003|Overall Study|Withdrawal by Subject|2|||
145946994|NCT02908074|526313996|FG004|Overall Study|Withdrawal by Subject|2|||
145946995|NCT02908074|526313997|FG005|Overall Study|Withdrawal by Subject|2|||
145946996|NCT02908074|526313992|FG000|Overall Study|Lost to Follow-up|0|||
145946997|NCT02908074|526313993|FG001|Overall Study|Lost to Follow-up|1|||
145946998|NCT02908074|526313994|FG002|Overall Study|Lost to Follow-up|1|||
145946999|NCT02908074|526313995|FG003|Overall Study|Lost to Follow-up|1|||
145947000|NCT02908074|526313996|FG004|Overall Study|Lost to Follow-up|0|||
145947001|NCT02908074|526313997|FG005|Overall Study|Lost to Follow-up|1|||
145947002|NCT02073565|526313998|FG000|Cohort A|Withdrawal by Subject|1|||
145947003|NCT02073565|526313999|FG001|Cohort A|Withdrawal by Subject|0|||
145947004|NCT02073565|526313998|FG000|Cohort B|Withdrawal by Subject|1|||
145947005|NCT02073565|526313999|FG001|Cohort B|Withdrawal by Subject|2|||
145947006|NCT02073565|526313998|FG000|Cohort C|Withdrawal by Subject|0|||
145947007|NCT02073565|526313999|FG001|Cohort C|Withdrawal by Subject|2|||
145947008|NCT02073565|526313998|FG000|Cohort C|Lost to Follow-up|0|||
145947009|NCT02073565|526313999|FG001|Cohort C|Lost to Follow-up|2|||
145947010|NCT03646305|526314000|FG000|Overall Study|Lost to Follow-up|4|||
145947011|NCT03646305|526314001|FG001|Overall Study|Lost to Follow-up|2|||
145947012|NCT03646305|526314002|FG002|Overall Study|Lost to Follow-up|2|||
145947013|NCT03646305|526314003|FG003|Overall Study|Lost to Follow-up|1|||
145947014|NCT03646305|526314000|FG000|Overall Study|Withdrawal by Subject|1|||
145947015|NCT03646305|526314001|FG001|Overall Study|Withdrawal by Subject|0|||
145947016|NCT03646305|526314002|FG002|Overall Study|Withdrawal by Subject|0|||
145947017|NCT03646305|526314003|FG003|Overall Study|Withdrawal by Subject|1|||
145947018|NCT01554176|526314004|FG000|Treatment Phase|Protocol Violation|1|||
145947019|NCT01554176|526314005|FG001|Treatment Phase|Protocol Violation|2|||
145947020|NCT01554176|526314006|FG002|Treatment Phase|Protocol Violation|0|||
145947021|NCT01554176|526314007|FG003|Treatment Phase|Protocol Violation|0|||
145947022|NCT01554176|526314008|FG004|Treatment Phase|Protocol Violation|0|||
145947023|NCT01554176|526314004|FG000|Treatment Phase|Physician Decision|1|||
145947024|NCT01554176|526314005|FG001|Treatment Phase|Physician Decision|1|||
145947025|NCT01554176|526314006|FG002|Treatment Phase|Physician Decision|0|||
145947026|NCT01554176|526314007|FG003|Treatment Phase|Physician Decision|0|||
145947027|NCT01554176|526314008|FG004|Treatment Phase|Physician Decision|0|||
145947028|NCT01554176|526314004|FG000|Treatment Phase|Lack of Efficacy|0|||
145947029|NCT01554176|526314005|FG001|Treatment Phase|Lack of Efficacy|1|||
145947030|NCT01554176|526314006|FG002|Treatment Phase|Lack of Efficacy|0|||
145947031|NCT01554176|526314007|FG003|Treatment Phase|Lack of Efficacy|0|||
145947032|NCT01554176|526314008|FG004|Treatment Phase|Lack of Efficacy|0|||
145947033|NCT01554176|526314004|FG000|Treatment Phase|Adverse event, non-fatal|1|||
145947034|NCT01554176|526314005|FG001|Treatment Phase|Adverse event, non-fatal|1|||
145947035|NCT01554176|526314006|FG002|Treatment Phase|Adverse event, non-fatal|0|||
145947036|NCT01554176|526314007|FG003|Treatment Phase|Adverse event, non-fatal|0|||
145947037|NCT01554176|526314008|FG004|Treatment Phase|Adverse event, non-fatal|0|||
145947038|NCT01554176|526314004|FG000|Treatment Phase|Non-compliance with study drug|1|||
145947039|NCT01554176|526314005|FG001|Treatment Phase|Non-compliance with study drug|0|||
145947040|NCT01554176|526314006|FG002|Treatment Phase|Non-compliance with study drug|0|||
145947041|NCT01554176|526314007|FG003|Treatment Phase|Non-compliance with study drug|0|||
145947042|NCT01554176|526314008|FG004|Treatment Phase|Non-compliance with study drug|0|||
145947043|NCT01554176|526314004|FG000|Treatment Phase|Withdrawal by Subject|1|||
145947044|NCT01554176|526314005|FG001|Treatment Phase|Withdrawal by Subject|0|||
145947045|NCT01554176|526314006|FG002|Treatment Phase|Withdrawal by Subject|0|||
145947046|NCT01554176|526314007|FG003|Treatment Phase|Withdrawal by Subject|0|||
145947047|NCT01554176|526314008|FG004|Treatment Phase|Withdrawal by Subject|0|||
145947048|NCT01554176|526314004|FG000|Treatment Phase|Lost to Follow-up|3|||
145947049|NCT01554176|526314005|FG001|Treatment Phase|Lost to Follow-up|0|||
145947050|NCT01554176|526314006|FG002|Treatment Phase|Lost to Follow-up|0|||
145947051|NCT01554176|526314007|FG003|Treatment Phase|Lost to Follow-up|0|||
145947052|NCT01554176|526314008|FG004|Treatment Phase|Lost to Follow-up|0|||
145947053|NCT01554176|526314004|FG000|Run-out Phase|Protocol Violation|0|||
145947054|NCT01554176|526314005|FG001|Run-out Phase|Protocol Violation|0|||
145947055|NCT01554176|526314006|FG002|Run-out Phase|Protocol Violation|0|||
145947056|NCT01554176|526314007|FG003|Run-out Phase|Protocol Violation|1|||
145947057|NCT01554176|526314008|FG004|Run-out Phase|Protocol Violation|0|||
145947058|NCT02333383|526314011|FG000|Overall Study|Adalimumab discontinuation|21|||
145947059|NCT02333383|526314011|FG000|Overall Study|Lost to Follow-up|15|||
145947060|NCT02333383|526314011|FG000|Overall Study|Withdrawal by Subject|3|||
145947061|NCT02333383|526314011|FG000|Overall Study|Transfer to another hospital|2|||
145947062|NCT00463840|526314012|FG000|Overall Study|Disease progression|7|||
145947063|NCT00463840|526314012|FG000|Overall Study|Withdrawal by Subject|2|||
145947064|NCT00463840|526314012|FG000|Overall Study|Adverse Event|3|||
145947065|NCT01653327|526314013|FG000|Overall Study|Withdrawal by Subject|1|||
145947066|NCT02227368|526315598|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
145947067|NCT02227368|526315599|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
145947068|NCT02227368|526315598|FG000|Overall Study|Lost to Follow-up|1|||
145947069|NCT02227368|526315599|FG001|Overall Study|Lost to Follow-up|0|||
145947070|NCT02227368|526315598|FG000|Overall Study|Adverse Event|1|||
145947071|NCT02227368|526315599|FG001|Overall Study|Adverse Event|0|||
145947072|NCT02510820|526315603|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145947073|NCT02510820|526315604|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145947074|NCT02510820|526315603|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145947075|NCT02510820|526315604|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145947076|NCT03089853|526315605|FG000|Overall Study|Lost to Follow-up|2|||
145947077|NCT03089853|526315606|FG001|Overall Study|Lost to Follow-up|1|||
145947078|NCT00642954|526315607|FG000|Overall Study|Progressive Disease|3|||
145947079|NCT00642954|526315608|FG001|Overall Study|Progressive Disease|3|||
145947080|NCT00642954|526315609|FG002|Overall Study|Progressive Disease|3|||
145947081|NCT00642954|526315610|FG003|Overall Study|Progressive Disease|3|||
145947082|NCT00642954|526315611|FG004|Overall Study|Progressive Disease|9|||
145947083|NCT00642954|526315607|FG000|Overall Study|Withdrawal by Subject|0|||
145947084|NCT00642954|526315608|FG001|Overall Study|Withdrawal by Subject|0|||
145947085|NCT00642954|526315609|FG002|Overall Study|Withdrawal by Subject|0|||
145947086|NCT00642954|526315610|FG003|Overall Study|Withdrawal by Subject|0|||
145947087|NCT00642954|526315611|FG004|Overall Study|Withdrawal by Subject|1|||
145947088|NCT00642954|526315607|FG000|Overall Study|Adverse Event|1|||
145947089|NCT00642954|526315608|FG001|Overall Study|Adverse Event|1|||
145947090|NCT00642954|526315609|FG002|Overall Study|Adverse Event|0|||
145947091|NCT00642954|526315610|FG003|Overall Study|Adverse Event|0|||
145947092|NCT00642954|526315611|FG004|Overall Study|Adverse Event|6|||
145947093|NCT05243563|526315612|FG000|Overall Study|Withdrawal by Subject|1|||
145947094|NCT05243563|526315613|FG001|Overall Study|Withdrawal by Subject|0|||
145947095|NCT05243563|526315612|FG000|Overall Study|Physician Decision|1|||
145947096|NCT05243563|526315613|FG001|Overall Study|Physician Decision|0|||
145947097|NCT00441363|526315614|FG000|Overall Study|Adverse Event|4|||
145947098|NCT00441363|526315615|FG001|Overall Study|Adverse Event|2|||
145947099|NCT00441363|526315614|FG000|Overall Study|Withdrawal by Subject|3|||
145947100|NCT00441363|526315615|FG001|Overall Study|Withdrawal by Subject|4|||
145947101|NCT00441363|526315614|FG000|Overall Study|Physician Decision|6|||
145947102|NCT00441363|526315615|FG001|Overall Study|Physician Decision|7|||
145947103|NCT00441363|526315614|FG000|Overall Study|Lost to Follow-up|2|||
145947104|NCT00441363|526315615|FG001|Overall Study|Lost to Follow-up|2|||
145947105|NCT00441363|526315614|FG000|Overall Study|Other|2|||
145947106|NCT00441363|526315615|FG001|Overall Study|Other|0|||
145947107|NCT02437188|526315616|FG000|Overall Study|Randomized but did not receive surgery|4|||
145947108|NCT02437188|526315617|FG001|Overall Study|Randomized but did not receive surgery|8|||
145947109|NCT02437188|526315616|FG000|Overall Study|Adverse Event|0|||
145947110|NCT02437188|526315617|FG001|Overall Study|Adverse Event|1|||
145947111|NCT02661061|526315618|FG000|Overall Study|Lack of Efficacy|1|||
145947112|NCT02661061|526315619|FG001|Overall Study|Lack of Efficacy|1|||
145947113|NCT02661061|526315618|FG000|Overall Study|Withdrawal by Subject|1|||
145947114|NCT02661061|526315619|FG001|Overall Study|Withdrawal by Subject|1|||
145947115|NCT03052920|526315620|FG000|Overall Study|Withdrawal by Subject|1|||
145947116|NCT00298363|526315621|FG000|Overall Study|Lost to Follow-up|0|||
145947117|NCT00298363|526315622|FG001|Overall Study|Lost to Follow-up|0|||
145947118|NCT00298363|526315623|FG002|Overall Study|Lost to Follow-up|1|||
146192510|NCT03885596|527215481|FG000|Overall Study|Withdrawal by Subject|2|||
146192511|NCT03885596|527215482|FG001|Overall Study|Withdrawal by Subject|1|||
145947119|NCT00298363|526315621|FG000|Overall Study|Physician Decision|4|||
145947120|NCT00298363|526315622|FG001|Overall Study|Physician Decision|1|||
145947121|NCT00298363|526315623|FG002|Overall Study|Physician Decision|0|||
145947122|NCT00298363|526315621|FG000|Overall Study|Protocol Violation|1|||
145947123|NCT00298363|526315622|FG001|Overall Study|Protocol Violation|1|||
145947124|NCT00298363|526315623|FG002|Overall Study|Protocol Violation|0|||
145947125|NCT00298363|526315621|FG000|Overall Study|Withdrawal by Subject|5|||
145947126|NCT00298363|526315622|FG001|Overall Study|Withdrawal by Subject|1|||
145947127|NCT00298363|526315623|FG002|Overall Study|Withdrawal by Subject|3|||
145947128|NCT00298363|526315621|FG000|Overall Study|Adverse Event|5|||
145947129|NCT00298363|526315622|FG001|Overall Study|Adverse Event|2|||
145947130|NCT00298363|526315623|FG002|Overall Study|Adverse Event|2|||
145947131|NCT00298363|526315621|FG000|Overall Study|Lack of Efficacy|2|||
145947132|NCT00298363|526315622|FG001|Overall Study|Lack of Efficacy|3|||
145947133|NCT00298363|526315623|FG002|Overall Study|Lack of Efficacy|0|||
145947134|NCT00153816|526315624|FG000|Overall Study|Death|6|||
145947135|NCT00153816|526315625|FG001|Overall Study|Death|5|||
145947136|NCT00153816|526315626|FG002|Overall Study|Death|4|||
145947137|NCT00153816|526315627|FG003|Overall Study|Death|6|||
145947138|NCT00153816|526315628|FG004|Overall Study|Death|0|||
145947139|NCT00153816|526315629|FG005|Overall Study|Death|2|||
145947140|NCT00153816|526315624|FG000|Overall Study|Lost to Follow-up|7|||
145947141|NCT00153816|526315625|FG001|Overall Study|Lost to Follow-up|8|||
145947142|NCT00153816|526315626|FG002|Overall Study|Lost to Follow-up|5|||
145947143|NCT00153816|526315627|FG003|Overall Study|Lost to Follow-up|8|||
145947144|NCT00153816|526315628|FG004|Overall Study|Lost to Follow-up|7|||
145947145|NCT00153816|526315629|FG005|Overall Study|Lost to Follow-up|9|||
145947146|NCT00153816|526315624|FG000|Overall Study|Withdrawal by Subject|9|||
145947147|NCT00153816|526315625|FG001|Overall Study|Withdrawal by Subject|9|||
145947148|NCT00153816|526315626|FG002|Overall Study|Withdrawal by Subject|9|||
145947149|NCT00153816|526315627|FG003|Overall Study|Withdrawal by Subject|4|||
145947150|NCT00153816|526315628|FG004|Overall Study|Withdrawal by Subject|1|||
146082113|NCT02509117|526820595|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145947151|NCT00153816|526315629|FG005|Overall Study|Withdrawal by Subject|5|||
145947152|NCT00153816|526315624|FG000|Overall Study|Follow-up exam not done|8|||
145947153|NCT00153816|526315625|FG001|Overall Study|Follow-up exam not done|7|||
145947154|NCT00153816|526315626|FG002|Overall Study|Follow-up exam not done|11|||
145947155|NCT00153816|526315627|FG003|Overall Study|Follow-up exam not done|10|||
145947156|NCT00153816|526315628|FG004|Overall Study|Follow-up exam not done|8|||
146082114|NCT02509117|526820596|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
145947157|NCT00153816|526315629|FG005|Overall Study|Follow-up exam not done|9|||
145947158|NCT00153816|526315624|FG000|Overall Study|Follow-up exam done, histology missing|2|||
145947159|NCT00153816|526315625|FG001|Overall Study|Follow-up exam done, histology missing|3|||
145947160|NCT00153816|526315626|FG002|Overall Study|Follow-up exam done, histology missing|3|||
145947161|NCT00153816|526315627|FG003|Overall Study|Follow-up exam done, histology missing|3|||
145947162|NCT00153816|526315628|FG004|Overall Study|Follow-up exam done, histology missing|1|||
145947163|NCT00153816|526315629|FG005|Overall Study|Follow-up exam done, histology missing|2|||
145947164|NCT01533688|526315632|FG000|Overall Study|Withdrawal by Subject|5|||
145947165|NCT01533688|526315633|FG001|Overall Study|Withdrawal by Subject|4|||
145947166|NCT01533688|526315634|FG002|Overall Study|Withdrawal by Subject|3|||
145947167|NCT01533688|526315632|FG000|Overall Study|Medically unstable|1|||
145947168|NCT01533688|526315633|FG001|Overall Study|Medically unstable|3|||
145947169|NCT01533688|526315634|FG002|Overall Study|Medically unstable|3|||
145947170|NCT01533688|526315632|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
145947171|NCT01533688|526315633|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
145947172|NCT01533688|526315634|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
145947173|NCT02509078|526315635|FG000|Overall Study|Protocol Violation|1|||
145947174|NCT02509078|526315636|FG001|Overall Study|Protocol Violation|1|||
145947175|NCT03959488|526315639|FG000|Season 1|Other|6|||
145947176|NCT03959488|526315640|FG001|Season 1|Other|7|||
145947177|NCT03959488|526315641|FG002|Season 1|Other|0|||
145947178|NCT03959488|526315642|FG003|Season 1|Other|0|||
145947179|NCT03959488|526315643|FG004|Season 1|Other|0|||
145947180|NCT03959488|526315639|FG000|Season 1|Withdrawal by parent/guardian|43|||
145947181|NCT03959488|526315640|FG001|Season 1|Withdrawal by parent/guardian|28|||
145947182|NCT03959488|526315641|FG002|Season 1|Withdrawal by parent/guardian|0|||
145947183|NCT03959488|526315642|FG003|Season 1|Withdrawal by parent/guardian|0|||
145947184|NCT03959488|526315643|FG004|Season 1|Withdrawal by parent/guardian|0|||
145947185|NCT03959488|526315639|FG000|Season 1|Due to COVID-19 pandemic|2|||
145947186|NCT03959488|526315640|FG001|Season 1|Due to COVID-19 pandemic|3|||
145947187|NCT03959488|526315641|FG002|Season 1|Due to COVID-19 pandemic|0|||
145947188|NCT03959488|526315642|FG003|Season 1|Due to COVID-19 pandemic|0|||
146413438|NCT03705169|528018142|FG002|Overall Study|Lost to Follow-up|0|||
146413439|NCT03705169|528018143|FG003|Overall Study|Lost to Follow-up|2|||
145947189|NCT03959488|526315643|FG004|Season 1|Due to COVID-19 pandemic|0|||
145947190|NCT03959488|526315639|FG000|Season 1|Lost to Follow-up|17|||
145947191|NCT03959488|526315640|FG001|Season 1|Lost to Follow-up|7|||
145947192|NCT03959488|526315641|FG002|Season 1|Lost to Follow-up|0|||
145947193|NCT03959488|526315642|FG003|Season 1|Lost to Follow-up|0|||
145947194|NCT03959488|526315643|FG004|Season 1|Lost to Follow-up|0|||
145947195|NCT03959488|526315639|FG000|Season 1|Death|5|||
145947196|NCT03959488|526315640|FG001|Season 1|Death|1|||
145947197|NCT03959488|526315641|FG002|Season 1|Death|0|||
145947198|NCT03959488|526315642|FG003|Season 1|Death|0|||
146413440|NCT03705169|528018144|FG004|Overall Study|Lost to Follow-up|0|||
146413441|NCT03705169|528018145|FG005|Overall Study|Lost to Follow-up|2|||
146413442|NCT03705169|528018146|FG006|Overall Study|Lost to Follow-up|1|||
146413443|NCT03705169|528018147|FG007|Overall Study|Lost to Follow-up|0|||
146413444|NCT03705169|528018148|FG008|Overall Study|Lost to Follow-up|0|||
146413445|NCT03705169|528018149|FG009|Overall Study|Lost to Follow-up|1|||
146413446|NCT03705169|528018140|FG000|Overall Study|Adverse Event|0|||
146413447|NCT03705169|528018141|FG001|Overall Study|Adverse Event|0|||
146413448|NCT03705169|528018142|FG002|Overall Study|Adverse Event|0|||
146413449|NCT03705169|528018143|FG003|Overall Study|Adverse Event|1|||
146413450|NCT03705169|528018144|FG004|Overall Study|Adverse Event|0|||
146413451|NCT03705169|528018145|FG005|Overall Study|Adverse Event|0|||
146413452|NCT03705169|528018146|FG006|Overall Study|Adverse Event|0|||
146413453|NCT03705169|528018147|FG007|Overall Study|Adverse Event|0|||
146413454|NCT03705169|528018148|FG008|Overall Study|Adverse Event|0|||
146413455|NCT03705169|528018149|FG009|Overall Study|Adverse Event|0|||
146413456|NCT03705169|528018140|FG000|Overall Study|Site Closure|0|||
146413457|NCT03705169|528018141|FG001|Overall Study|Site Closure|0|||
146413458|NCT03705169|528018142|FG002|Overall Study|Site Closure|0|||
146413459|NCT03705169|528018143|FG003|Overall Study|Site Closure|1|||
146413460|NCT03705169|528018144|FG004|Overall Study|Site Closure|0|||
146413461|NCT03705169|528018145|FG005|Overall Study|Site Closure|0|||
146413462|NCT03705169|528018146|FG006|Overall Study|Site Closure|0|||
146413463|NCT03705169|528018147|FG007|Overall Study|Site Closure|0|||
146413464|NCT03705169|528018148|FG008|Overall Study|Site Closure|0|||
146413465|NCT03705169|528018149|FG009|Overall Study|Site Closure|0|||
146413466|NCT03705169|528018140|FG000|Overall Study|Did not receive study treatment|0|||
146413467|NCT03705169|528018141|FG001|Overall Study|Did not receive study treatment|0|||
146413468|NCT03705169|528018142|FG002|Overall Study|Did not receive study treatment|0|||
146413469|NCT03705169|528018143|FG003|Overall Study|Did not receive study treatment|1|||
146413470|NCT03705169|528018144|FG004|Overall Study|Did not receive study treatment|0|||
146413471|NCT03705169|528018145|FG005|Overall Study|Did not receive study treatment|0|||
146413472|NCT03705169|528018146|FG006|Overall Study|Did not receive study treatment|0|||
146413473|NCT03705169|528018147|FG007|Overall Study|Did not receive study treatment|0|||
146413474|NCT03705169|528018148|FG008|Overall Study|Did not receive study treatment|0|||
146413475|NCT03705169|528018149|FG009|Overall Study|Did not receive study treatment|0|||
146413476|NCT03705169|528018140|FG000|Overall Study|Concerns about study visit compliance|0|||
146413477|NCT03705169|528018141|FG001|Overall Study|Concerns about study visit compliance|0|||
146413478|NCT03705169|528018142|FG002|Overall Study|Concerns about study visit compliance|0|||
146413479|NCT03705169|528018143|FG003|Overall Study|Concerns about study visit compliance|1|||
146413480|NCT03705169|528018144|FG004|Overall Study|Concerns about study visit compliance|0|||
146413481|NCT03705169|528018145|FG005|Overall Study|Concerns about study visit compliance|0|||
146413482|NCT03705169|528018146|FG006|Overall Study|Concerns about study visit compliance|0|||
146413483|NCT03705169|528018147|FG007|Overall Study|Concerns about study visit compliance|0|||
146413484|NCT03705169|528018148|FG008|Overall Study|Concerns about study visit compliance|0|||
146413485|NCT03705169|528018149|FG009|Overall Study|Concerns about study visit compliance|0|||
146413486|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
146413487|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413488|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413489|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413490|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413491|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413492|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
146413493|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
146413494|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413495|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413496|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413497|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413498|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413499|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
146413500|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
146413501|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413502|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413503|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413504|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413505|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413506|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
146413507|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
146413508|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146413509|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145947199|NCT03959488|526315643|FG004|Season 1|Death|0|||
145947200|NCT03959488|526315639|FG000|Season 2|Other|0|||
145947201|NCT03959488|526315640|FG001|Season 2|Other|0|||
145947202|NCT03959488|526315641|FG002|Season 2|Other|2|||
145947203|NCT03959488|526315642|FG003|Season 2|Other|0|||
145947204|NCT03959488|526315643|FG004|Season 2|Other|0|||
145947205|NCT03959488|526315639|FG000|Season 2|Withdrawal by parent/guardian|0|||
145947206|NCT03959488|526315640|FG001|Season 2|Withdrawal by parent/guardian|0|||
145947207|NCT03959488|526315641|FG002|Season 2|Withdrawal by parent/guardian|3|||
145947208|NCT03959488|526315642|FG003|Season 2|Withdrawal by parent/guardian|1|||
145947209|NCT03959488|526315643|FG004|Season 2|Withdrawal by parent/guardian|1|||
145947210|NCT03959488|526315639|FG000|Season 2|Lost to Follow-up|0|||
145947211|NCT03959488|526315640|FG001|Season 2|Lost to Follow-up|0|||
145947212|NCT03959488|526315641|FG002|Season 2|Lost to Follow-up|1|||
145947213|NCT03959488|526315642|FG003|Season 2|Lost to Follow-up|0|||
145947214|NCT03959488|526315643|FG004|Season 2|Lost to Follow-up|1|||
145947215|NCT01760447|526315644|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
145947216|NCT01760447|526315645|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
145947217|NCT01760447|526315646|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
145947218|NCT01760447|526315647|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
145947219|NCT01760447|526315644|FG000|Weeks 0-20|Withdrawal by Subject|2|||
145947220|NCT01760447|526315645|FG001|Weeks 0-20|Withdrawal by Subject|0|||
145947221|NCT01760447|526315646|FG002|Weeks 0-20|Withdrawal by Subject|1|||
145947222|NCT01760447|526315647|FG003|Weeks 0-20|Withdrawal by Subject|0|||
145947223|NCT01760447|526315644|FG000|Weeks 0-20|Lost to Follow-up|1|||
145947224|NCT01760447|526315645|FG001|Weeks 0-20|Lost to Follow-up|0|||
145947225|NCT01760447|526315646|FG002|Weeks 0-20|Lost to Follow-up|1|||
145947226|NCT01760447|526315647|FG003|Weeks 0-20|Lost to Follow-up|1|||
145947227|NCT01760447|526315644|FG000|Weeks 0-20|Randomized but not treated|0|||
145947228|NCT01760447|526315645|FG001|Weeks 0-20|Randomized but not treated|0|||
145947229|NCT01760447|526315646|FG002|Weeks 0-20|Randomized but not treated|2|||
145947230|NCT01760447|526315647|FG003|Weeks 0-20|Randomized but not treated|0|||
145947231|NCT01760447|526315644|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145947232|NCT01760447|526315645|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145947233|NCT01760447|526315646|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145947234|NCT01760447|526315647|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
145947235|NCT01760447|526315644|FG000|Weeks 20-54|Withdrawal by Subject|2|||
145947236|NCT01760447|526315645|FG001|Weeks 20-54|Withdrawal by Subject|1|||
145947237|NCT01760447|526315646|FG002|Weeks 20-54|Withdrawal by Subject|1|||
145947238|NCT01760447|526315647|FG003|Weeks 20-54|Withdrawal by Subject|2|||
145947239|NCT01760447|526315644|FG000|Weeks 20-54|Lost to Follow-up|0|||
145947240|NCT01760447|526315645|FG001|Weeks 20-54|Lost to Follow-up|0|||
145947241|NCT01760447|526315646|FG002|Weeks 20-54|Lost to Follow-up|1|||
145947242|NCT01760447|526315647|FG003|Weeks 20-54|Lost to Follow-up|2|||
145947243|NCT02290925|526315652|FG000|First Period of Three Months|Lost to Follow-up|2|||
145947244|NCT02290925|526315653|FG001|First Period of Three Months|Lost to Follow-up|1|||
145947245|NCT02290925|526315652|FG000|First Period of Three Months|Death|1|||
145947246|NCT02290925|526315653|FG001|First Period of Three Months|Death|0|||
145947247|NCT02290925|526315652|FG000|First Period of Three Months|Insulin Started|1|||
145947248|NCT02290925|526315653|FG001|First Period of Three Months|Insulin Started|1|||
145947249|NCT02290925|526315652|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
145947250|NCT02290925|526315653|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
145947251|NCT02290925|526315652|FG000|Second Period of 3 Months|insulin started|0|||
145947252|NCT02290925|526315653|FG001|Second Period of 3 Months|insulin started|1|||
145947253|NCT00981058|526315662|FG000|Overall Study|Progressive Disease|38|||
145947254|NCT00981058|526315663|FG001|Overall Study|Progressive Disease|31|||
145947255|NCT00981058|526315662|FG000|Overall Study|Lost to Follow-up|3|||
145947256|NCT00981058|526315663|FG001|Overall Study|Lost to Follow-up|2|||
145947257|NCT00981058|526315662|FG000|Overall Study|Physician Decision|4|||
145947258|NCT00981058|526315663|FG001|Overall Study|Physician Decision|5|||
145947259|NCT00981058|526315662|FG000|Overall Study|Randomization Error|0|||
145947260|NCT00981058|526315663|FG001|Overall Study|Randomization Error|1|||
145947261|NCT00981058|526315662|FG000|Overall Study|Withdrawal by Subject|24|||
145947262|NCT00981058|526315663|FG001|Overall Study|Withdrawal by Subject|22|||
145947263|NCT02305446|526315670|FG000|Overall Study|Adverse Event|1|||
145947264|NCT00904839|526315683|FG000|Overall Study|Adverse Event|0|||
145947265|NCT00904839|526315684|FG001|Overall Study|Adverse Event|5|||
145947266|NCT00904839|526315685|FG002|Overall Study|Adverse Event|4|||
145947267|NCT00904839|526315683|FG000|Overall Study|Protocol Violation|0|||
145947268|NCT00904839|526315684|FG001|Overall Study|Protocol Violation|1|||
145947269|NCT00904839|526315685|FG002|Overall Study|Protocol Violation|1|||
145947270|NCT00904839|526315683|FG000|Overall Study|Lost to Follow-up|0|||
145947271|NCT00904839|526315684|FG001|Overall Study|Lost to Follow-up|1|||
145947272|NCT00904839|526315685|FG002|Overall Study|Lost to Follow-up|2|||
145947273|NCT00904839|526315683|FG000|Overall Study|Withdrawal by Subject|0|||
145947274|NCT00904839|526315684|FG001|Overall Study|Withdrawal by Subject|2|||
145947275|NCT00904839|526315685|FG002|Overall Study|Withdrawal by Subject|0|||
145947276|NCT00904839|526315683|FG000|Overall Study|Not treated|1|||
145947277|NCT00904839|526315684|FG001|Overall Study|Not treated|0|||
145947278|NCT00904839|526315685|FG002|Overall Study|Not treated|1|||
145947279|NCT00904839|526315683|FG000|Overall Study|Other than above|0|||
145947280|NCT00904839|526315684|FG001|Overall Study|Other than above|9|||
145947281|NCT00904839|526315685|FG002|Overall Study|Other than above|7|||
145947282|NCT04521114|526315688|FG000|Overall Study|Lost to Follow-up|1|||
145947283|NCT04521114|526315689|FG001|Overall Study|Lost to Follow-up|2|||
145947284|NCT04521114|526315690|FG002|Overall Study|Lost to Follow-up|0|||
145947285|NCT04521114|526315688|FG000|Overall Study|Withdrawal by Subject|1|||
145947286|NCT04521114|526315689|FG001|Overall Study|Withdrawal by Subject|2|||
145947287|NCT04521114|526315690|FG002|Overall Study|Withdrawal by Subject|2|||
145947288|NCT04521114|526315688|FG000|Overall Study|Adverse Event|1|||
145947289|NCT04521114|526315689|FG001|Overall Study|Adverse Event|0|||
145947290|NCT04521114|526315690|FG002|Overall Study|Adverse Event|0|||
145947291|NCT04521114|526315688|FG000|Overall Study|Sponsor Wish|1|||
145947292|NCT04521114|526315689|FG001|Overall Study|Sponsor Wish|0|||
145947293|NCT04521114|526315690|FG002|Overall Study|Sponsor Wish|0|||
145947294|NCT04521114|526315688|FG000|Overall Study|Withdrawal of Consent|2|||
145947295|NCT04521114|526315689|FG001|Overall Study|Withdrawal of Consent|2|||
145947296|NCT04521114|526315690|FG002|Overall Study|Withdrawal of Consent|0|||
145947297|NCT01167634|526315691|FG000|Overall Study|Lost to Follow-up|1|||
145947298|NCT01167634|526315692|FG001|Overall Study|Lost to Follow-up|3|||
145947299|NCT01167634|526315693|FG002|Overall Study|Lost to Follow-up|3|||
145947300|NCT01167634|526315694|FG003|Overall Study|Lost to Follow-up|4|||
145947301|NCT01167634|526315691|FG000|Overall Study|Withdrawal by Subject|1|||
145947302|NCT01167634|526315692|FG001|Overall Study|Withdrawal by Subject|1|||
145947303|NCT01167634|526315693|FG002|Overall Study|Withdrawal by Subject|0|||
145947304|NCT01167634|526315694|FG003|Overall Study|Withdrawal by Subject|0|||
145947305|NCT02614131|526315695|FG000|Overall Study|Withdrawal by Subject|1|||
145947306|NCT02614131|526315696|FG001|Overall Study|Withdrawal by Subject|0|||
145947307|NCT02614131|526315697|FG002|Overall Study|Withdrawal by Subject|0|||
145947308|NCT02614131|526315698|FG003|Overall Study|Withdrawal by Subject|0|||
145947309|NCT02614131|526315699|FG004|Overall Study|Withdrawal by Subject|0|||
145947310|NCT02614131|526315700|FG005|Overall Study|Withdrawal by Subject|0|||
145947311|NCT02614131|526315701|FG006|Overall Study|Withdrawal by Subject|0|||
145947312|NCT02614131|526315695|FG000|Overall Study|Adverse Event|0|||
145947313|NCT02614131|526315696|FG001|Overall Study|Adverse Event|0|||
145947314|NCT02614131|526315697|FG002|Overall Study|Adverse Event|0|||
145947315|NCT02614131|526315698|FG003|Overall Study|Adverse Event|0|||
145947316|NCT02614131|526315699|FG004|Overall Study|Adverse Event|0|||
145947317|NCT02614131|526315700|FG005|Overall Study|Adverse Event|0|||
145947318|NCT02614131|526315701|FG006|Overall Study|Adverse Event|1|||
145947319|NCT02603107|526315702|FG000|Randomized Phase|Withdrew consent|8|||
145947320|NCT02603107|526315703|FG001|Randomized Phase|Withdrew consent|15|||
145947321|NCT02603107|526315702|FG000|Randomized Phase|Lost to Follow-up|1|||
145947322|NCT02603107|526315703|FG001|Randomized Phase|Lost to Follow-up|3|||
145947323|NCT02603107|526315702|FG000|Randomized Phase|Adverse Event|2|||
145947324|NCT02603107|526315703|FG001|Randomized Phase|Adverse Event|0|||
145947325|NCT02603107|526315702|FG000|Randomized Phase|Death|1|||
145947326|NCT02603107|526315703|FG001|Randomized Phase|Death|1|||
145947327|NCT02603107|526315702|FG000|Randomized Phase|Non-compliance with study drug|1|||
145947328|NCT02603107|526315703|FG001|Randomized Phase|Non-compliance with study drug|1|||
145947329|NCT02603107|526315702|FG000|Randomized Phase|Investigator's discretion|0|||
145947330|NCT02603107|526315703|FG001|Randomized Phase|Investigator's discretion|1|||
145947331|NCT02603107|526315702|FG000|Randomized Phase|Lack of Efficacy|1|||
145947332|NCT02603107|526315703|FG001|Randomized Phase|Lack of Efficacy|0|||
145947333|NCT02603107|526315702|FG000|Randomized Phase|Protocol Violation|1|||
145947334|NCT02603107|526315703|FG001|Randomized Phase|Protocol Violation|0|||
145947335|NCT02603107|526315702|FG000|Optional Extension Phase|Lost to Follow-up|3|||
145947336|NCT02603107|526315703|FG001|Optional Extension Phase|Lost to Follow-up|3|||
145947337|NCT02603107|526315702|FG000|Optional Extension Phase|Withdrew consent|3|||
145947338|NCT02603107|526315703|FG001|Optional Extension Phase|Withdrew consent|2|||
146284464|NCT01688830|527553736|FG017|Overall Study|Lost to Follow-up|0|||
145947339|NCT02603107|526315702|FG000|Optional Extension Phase|Investigator's discretion|2|||
145947340|NCT02603107|526315703|FG001|Optional Extension Phase|Investigator's discretion|2|||
145947341|NCT02603107|526315702|FG000|Optional Extension Phase|Pregnancy|0|||
145947342|NCT02603107|526315703|FG001|Optional Extension Phase|Pregnancy|3|||
145947343|NCT02603107|526315702|FG000|Optional Extension Phase|Adverse Event|0|||
145947344|NCT02603107|526315703|FG001|Optional Extension Phase|Adverse Event|2|||
145947345|NCT02603107|526315702|FG000|Optional Extension Phase|Not treated in extension phase|0|||
145947346|NCT02603107|526315703|FG001|Optional Extension Phase|Not treated in extension phase|1|||
145947347|NCT02603107|526315702|FG000|Optional Extension Phase|Protocol Violation|1|||
145947348|NCT02603107|526315703|FG001|Optional Extension Phase|Protocol Violation|0|||
145947349|NCT00187278|526315710|FG000|Overall Study|Protocol Violation|10|||
145947350|NCT00187278|526315711|FG001|Overall Study|Protocol Violation|13|||
145947351|NCT01857102|526315712|FG000|Period 1|No longer meets Eligibility Criteria|0|||
145947352|NCT01857102|526315713|FG001|Period 1|No longer meets Eligibility Criteria|2|||
145947353|NCT01857102|526315712|FG000|Period 1|Lost to Follow-up|0|||
145947354|NCT01857102|526315713|FG001|Period 1|Lost to Follow-up|3|||
145947355|NCT01857102|526315712|FG000|Period 1|Unsatisfactory Lens Fit|1|||
145947356|NCT01857102|526315713|FG001|Period 1|Unsatisfactory Lens Fit|0|||
145947357|NCT01857102|526315712|FG000|Period 1|Unsatisfactory Visual Response|1|||
145947358|NCT01857102|526315713|FG001|Period 1|Unsatisfactory Visual Response|0|||
145947359|NCT01857102|526315712|FG000|Period 1|Physician Decision|1|||
145947360|NCT01857102|526315713|FG001|Period 1|Physician Decision|0|||
145947361|NCT01857102|526315712|FG000|Period 2|Lens Discomfort|1|||
145947362|NCT01857102|526315713|FG001|Period 2|Lens Discomfort|0|||
145947363|NCT01857102|526315712|FG000|Period 2|Unsatisfactory Lens Fit|1|||
145947364|NCT01857102|526315713|FG001|Period 2|Unsatisfactory Lens Fit|0|||
145947365|NCT00090584|526315719|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
145947366|NCT00090584|526315720|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
145947367|NCT00090584|526315719|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
145947368|NCT00090584|526315720|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
145947369|NCT02054910|526315724|FG000|Overall Study|Lost to Follow-up|4|||
145947370|NCT02054910|526315725|FG001|Overall Study|Lost to Follow-up|1|||
145947371|NCT02920177|526315726|FG000|Overall Study|Withdrawal by Subject|1|||
145947372|NCT02920177|526315727|FG001|Overall Study|Withdrawal by Subject|1|||
145947373|NCT02920177|526315726|FG000|Overall Study|Physician Decision|1|||
145947374|NCT02920177|526315727|FG001|Overall Study|Physician Decision|0|||
145947375|NCT02920177|526315726|FG000|Overall Study|Lost to Follow-up|0|||
145947376|NCT02920177|526315727|FG001|Overall Study|Lost to Follow-up|1|||
145947377|NCT04907227|526315728|FG000|Overall Study|Death|12|||
145947378|NCT04907227|526315729|FG001|Overall Study|Death|8|||
145947379|NCT04907227|526315728|FG000|Overall Study|Withdrawal by Subject|2|||
145947380|NCT04907227|526315729|FG001|Overall Study|Withdrawal by Subject|2|||
145947381|NCT04907227|526315728|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
145947382|NCT04907227|526315729|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145947383|NCT04907227|526315728|FG000|Overall Study|Sponsor Decision|25|||
145947384|NCT04907227|526315729|FG001|Overall Study|Sponsor Decision|30|||
145947385|NCT04907227|526315728|FG000|Overall Study|Physician Decision|1|||
145947386|NCT04907227|526315729|FG001|Overall Study|Physician Decision|0|||
145947387|NCT03723070|526315730|FG000|Overall Study|Lost to Follow-up|2|||
145947388|NCT03723070|526315730|FG000|Overall Study|Physician Decision|1|||
145947389|NCT03723070|526315730|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
145947390|NCT03053427|526315731|FG000|Overall Study|Adverse Event|4|||
145947391|NCT03053427|526315732|FG001|Overall Study|Adverse Event|4|||
145947392|NCT03053427|526315731|FG000|Overall Study|Lack of Efficacy|1|||
145947393|NCT03053427|526315732|FG001|Overall Study|Lack of Efficacy|3|||
145947394|NCT03053427|526315731|FG000|Overall Study|Lost to Follow-up|2|||
145947395|NCT03053427|526315732|FG001|Overall Study|Lost to Follow-up|2|||
145947396|NCT03053427|526315731|FG000|Overall Study|Worsening of the target disease|0|||
145947397|NCT03053427|526315732|FG001|Overall Study|Worsening of the target disease|1|||
145947398|NCT03053427|526315731|FG000|Overall Study|Protocol Deviation|3|||
145947399|NCT03053427|526315732|FG001|Overall Study|Protocol Deviation|3|||
145947400|NCT03053427|526315731|FG000|Overall Study|Withdrawal by Subject|3|||
145947401|NCT03053427|526315732|FG001|Overall Study|Withdrawal by Subject|2|||
145947402|NCT03053427|526315731|FG000|Overall Study|Miscellaneous|0|||
145947403|NCT03053427|526315732|FG001|Overall Study|Miscellaneous|1|||
145947404|NCT01324570|526315744|FG000|Overall Study|Adverse Event|4|||
145947405|NCT01324570|526315745|FG001|Overall Study|Adverse Event|7|||
145947406|NCT01324570|526315744|FG000|Overall Study|Withdrawal by Subject|0|||
145947407|NCT01324570|526315745|FG001|Overall Study|Withdrawal by Subject|3|||
145947408|NCT01324570|526315744|FG000|Overall Study|Lack of Efficacy|0|||
145947409|NCT01324570|526315745|FG001|Overall Study|Lack of Efficacy|1|||
145947410|NCT01324570|526315744|FG000|Overall Study|Confirmed or suspected diversion|0|||
145947411|NCT01324570|526315745|FG001|Overall Study|Confirmed or suspected diversion|1|||
145947412|NCT01324570|526315744|FG000|Overall Study|Administrative|0|||
145947413|NCT01324570|526315745|FG001|Overall Study|Administrative|2|||
145947414|NCT00207727|526315746|FG000|Overall Study|Withdrawal by Subject|0|||
145947415|NCT00207727|526315747|FG001|Overall Study|Withdrawal by Subject|0|||
145947416|NCT00207727|526315748|FG002|Overall Study|Withdrawal by Subject|0|||
145947417|NCT00207727|526315749|FG003|Overall Study|Withdrawal by Subject|0|||
145947418|NCT00207727|526315750|FG004|Overall Study|Withdrawal by Subject|1|||
145947419|NCT00207727|526315746|FG000|Overall Study|Lost to Follow-up|0|||
145947420|NCT00207727|526315747|FG001|Overall Study|Lost to Follow-up|1|||
145947421|NCT00207727|526315748|FG002|Overall Study|Lost to Follow-up|0|||
145947422|NCT00207727|526315749|FG003|Overall Study|Lost to Follow-up|0|||
145947423|NCT00207727|526315750|FG004|Overall Study|Lost to Follow-up|0|||
145947424|NCT00207727|526315746|FG000|Overall Study|Other|38|||
145947425|NCT00207727|526315747|FG001|Overall Study|Other|41|||
145947426|NCT00207727|526315748|FG002|Overall Study|Other|41|||
145947427|NCT00207727|526315749|FG003|Overall Study|Other|37|||
145947428|NCT00207727|526315750|FG004|Overall Study|Other|33|||
145947429|NCT00539032|526315754|FG000|Overall Study|Withdrawal by Subject|2|||
145947430|NCT00539032|526315755|FG001|Overall Study|Withdrawal by Subject|1|||
145947431|NCT04683939|526315762|FG000|Overall Study|Study termination by the sponsor|0|||
145947432|NCT04683939|526315763|FG001|Overall Study|Study termination by the sponsor|1|||
145947433|NCT04683939|526315764|FG002|Overall Study|Study termination by the sponsor|2|||
145947434|NCT04683939|526315765|FG003|Overall Study|Study termination by the sponsor|2|||
145947435|NCT04683939|526315762|FG000|Overall Study|Death|1|||
145947436|NCT04683939|526315763|FG001|Overall Study|Death|1|||
145947437|NCT04683939|526315764|FG002|Overall Study|Death|2|||
145947438|NCT04683939|526315765|FG003|Overall Study|Death|1|||
145947439|NCT04683939|526315762|FG000|Overall Study|Withdrawal by Subject|1|||
145947440|NCT04683939|526315763|FG001|Overall Study|Withdrawal by Subject|0|||
145947441|NCT04683939|526315764|FG002|Overall Study|Withdrawal by Subject|0|||
145947442|NCT04683939|526315765|FG003|Overall Study|Withdrawal by Subject|0|||
145947443|NCT04683939|526315762|FG000|Overall Study|Physician Decision|1|||
145947444|NCT04683939|526315763|FG001|Overall Study|Physician Decision|0|||
145947445|NCT04683939|526315764|FG002|Overall Study|Physician Decision|0|||
145947446|NCT04683939|526315765|FG003|Overall Study|Physician Decision|0|||
145947447|NCT04683939|526315762|FG000|Overall Study|Lost to Follow-up|0|||
145947448|NCT04683939|526315763|FG001|Overall Study|Lost to Follow-up|1|||
145947449|NCT04683939|526315764|FG002|Overall Study|Lost to Follow-up|0|||
145947450|NCT04683939|526315765|FG003|Overall Study|Lost to Follow-up|0|||
145947451|NCT03046056|526317216|FG000|Overall Study|Non-responder at Week 10|6|||
145947452|NCT03046056|526317217|FG001|Overall Study|Non-responder at Week 10|6|||
145947453|NCT03046056|526317218|FG002|Overall Study|Non-responder at Week 10|4|||
145947454|NCT03046056|526317216|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
145947455|NCT03046056|526317217|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
145947456|NCT03046056|526317218|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
145947457|NCT03046056|526317216|FG000|Overall Study|Adverse Event|1|||
145947458|NCT03046056|526317217|FG001|Overall Study|Adverse Event|5|||
145947459|NCT03046056|526317218|FG002|Overall Study|Adverse Event|0|||
145947460|NCT03046056|526317216|FG000|Overall Study|Non-compliance With Study Drug|0|||
145947461|NCT03046056|526317217|FG001|Overall Study|Non-compliance With Study Drug|0|||
145947462|NCT03046056|526317218|FG002|Overall Study|Non-compliance With Study Drug|2|||
145947463|NCT03046056|526317216|FG000|Overall Study|Protocol Violation|1|||
145947464|NCT03046056|526317217|FG001|Overall Study|Protocol Violation|1|||
145947465|NCT03046056|526317218|FG002|Overall Study|Protocol Violation|0|||
145947466|NCT03046056|526317216|FG000|Overall Study|Investigator's Discretion|0|||
145947467|NCT03046056|526317217|FG001|Overall Study|Investigator's Discretion|1|||
145947468|NCT03046056|526317218|FG002|Overall Study|Investigator's Discretion|0|||
145947469|NCT03046056|526317216|FG000|Overall Study|Withdrew Consent|1|||
145947470|NCT03046056|526317217|FG001|Overall Study|Withdrew Consent|0|||
145947471|NCT03046056|526317218|FG002|Overall Study|Withdrew Consent|0|||
145947472|NCT02913105|526317219|FG000|Overall Study|Adverse Event|11|||
145947473|NCT02913105|526317220|FG001|Overall Study|Adverse Event|0|||
145947474|NCT02913105|526317221|FG002|Overall Study|Adverse Event|4|||
145947475|NCT02913105|526317219|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145947476|NCT02913105|526317220|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145947477|NCT02913105|526317221|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145947478|NCT02913105|526317219|FG000|Overall Study|Reason Not Specified|3|||
145947479|NCT02913105|526317220|FG001|Overall Study|Reason Not Specified|1|||
145947480|NCT02913105|526317221|FG002|Overall Study|Reason Not Specified|1|||
145947481|NCT02913105|526317219|FG000|Overall Study|Physician Decision|1|||
145947482|NCT02913105|526317220|FG001|Overall Study|Physician Decision|1|||
145947483|NCT02913105|526317221|FG002|Overall Study|Physician Decision|0|||
145947484|NCT02913105|526317219|FG000|Overall Study|Withdrawal by Subject|0|||
145947485|NCT02913105|526317220|FG001|Overall Study|Withdrawal by Subject|3|||
145947486|NCT02913105|526317221|FG002|Overall Study|Withdrawal by Subject|1|||
145947487|NCT01317004|526317222|FG000|Overall Study|Withdrawal by Subject|1|||
145947488|NCT01317004|526317223|FG001|Overall Study|Withdrawal by Subject|4|||
145947489|NCT01317004|526317222|FG000|Overall Study|Protocol Violation|0|||
145947490|NCT01317004|526317223|FG001|Overall Study|Protocol Violation|2|||
145947491|NCT01317004|526317222|FG000|Overall Study|Adverse Event|3|||
145947492|NCT01317004|526317223|FG001|Overall Study|Adverse Event|3|||
145947493|NCT04114656|526317226|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
145947494|NCT04114656|526317227|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
145947495|NCT04114656|526317226|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
145947496|NCT04114656|526317227|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
145947497|NCT04114656|526317226|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
145947498|NCT04114656|526317227|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
145947499|NCT04114656|526317226|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
145947500|NCT04114656|526317227|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
145947501|NCT04114656|526317226|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
145947502|NCT04114656|526317227|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
145947503|NCT01980628|526317230|FG000|Overall Study|Adverse Event|12|||
145947504|NCT01980628|526317230|FG000|Overall Study|Physician Decision|5|||
145947505|NCT01980628|526317230|FG000|Overall Study|Withdrawal by Subject|4|||
145947506|NCT01980628|526317230|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
145947507|NCT02578940|526317231|FG000|Overall Study|Screening failure|5|||
145947508|NCT02578940|526317231|FG000|Overall Study|Lost to Follow-up|1|||
145947509|NCT01937715|526317240|FG000|Overall Study|Death|0|||
145947510|NCT01937715|526317241|FG001|Overall Study|Death|0|||
146284465|NCT01688830|527553737|FG018|Overall Study|Lost to Follow-up|0|||
145947511|NCT01937715|526317242|FG002|Overall Study|Death|0|||
145947512|NCT01937715|526317243|FG003|Overall Study|Death|1|||
145947513|NCT01937715|526317244|FG004|Overall Study|Death|0|||
145947514|NCT01937715|526317240|FG000|Overall Study|Withdrawal by Subject|0|||
145947515|NCT01937715|526317241|FG001|Overall Study|Withdrawal by Subject|1|||
145947516|NCT01937715|526317242|FG002|Overall Study|Withdrawal by Subject|0|||
145947517|NCT01937715|526317243|FG003|Overall Study|Withdrawal by Subject|0|||
145947518|NCT01937715|526317244|FG004|Overall Study|Withdrawal by Subject|2|||
145947519|NCT01937715|526317240|FG000|Overall Study|Other|0|||
145947520|NCT01937715|526317241|FG001|Overall Study|Other|0|||
145947521|NCT01937715|526317242|FG002|Overall Study|Other|0|||
145947522|NCT01937715|526317243|FG003|Overall Study|Other|3|||
145947523|NCT01937715|526317244|FG004|Overall Study|Other|0|||
145947524|NCT01698268|526317247|FG000|Overall Study|Physician Decision|2|||
145947525|NCT01698268|526317248|FG001|Overall Study|Physician Decision|1|||
145947526|NCT02469168|526317250|FG000|Overall Study|Trial closed|1|||
145947527|NCT02469168|526317251|FG001|Overall Study|Trial closed|0|||
145947528|NCT00135356|526317252|FG000|Overall Study|Adverse Event|6|||
145947529|NCT00135356|526317253|FG001|Overall Study|Adverse Event|2|||
145947530|NCT00135356|526317252|FG000|Overall Study|Lack of Efficacy|2|||
145947531|NCT00135356|526317253|FG001|Overall Study|Lack of Efficacy|0|||
145947532|NCT00135356|526317252|FG000|Overall Study|Lost to Follow-up|3|||
145947533|NCT00135356|526317253|FG001|Overall Study|Lost to Follow-up|1|||
145947534|NCT00135356|526317252|FG000|Overall Study|Surgery for abdominal fat|1|||
145947535|NCT00135356|526317253|FG001|Overall Study|Surgery for abdominal fat|0|||
145947536|NCT00135356|526317252|FG000|Overall Study|Change in antiviral regimen|0|||
146192512|NCT03885596|527215483|FG002|Overall Study|Withdrawal by Subject|0|||
146192513|NCT03885596|527215484|FG003|Overall Study|Withdrawal by Subject|0|||
146192514|NCT01835899|527215486|FG000|Overall Study|Adverse Event|0|||
146192515|NCT01835899|527215487|FG001|Overall Study|Adverse Event|0|||
145947537|NCT00135356|526317253|FG001|Overall Study|Change in antiviral regimen|1|||
145947538|NCT00135356|526317252|FG000|Overall Study|Poor/noncompliance|1|||
145947539|NCT00135356|526317253|FG001|Overall Study|Poor/noncompliance|1|||
145947540|NCT00135356|526317252|FG000|Overall Study|No longer meets study criteria|2|||
145947541|NCT00135356|526317253|FG001|Overall Study|No longer meets study criteria|0|||
145947542|NCT00135356|526317252|FG000|Overall Study|Withdrawal by Subject|2|||
145947543|NCT00135356|526317253|FG001|Overall Study|Withdrawal by Subject|4|||
145947544|NCT02263729|526317254|FG000|Overall Study|Lost to Follow-up|1|||
145947545|NCT02263729|526317255|FG001|Overall Study|Lost to Follow-up|1|||
145947546|NCT04591015|526317256|FG000|Overall Study|Death|6|||
145947547|NCT04591015|526317257|FG001|Overall Study|Death|4|||
145947548|NCT04591015|526317256|FG000|Overall Study|Withdrawal by Subject|6|||
145947549|NCT04591015|526317257|FG001|Overall Study|Withdrawal by Subject|3|||
145947550|NCT04591015|526317256|FG000|Overall Study|Lost to Follow-up|16|||
145947551|NCT04591015|526317257|FG001|Overall Study|Lost to Follow-up|11|||
145947552|NCT02686814|526317258|FG000|Overall Study|Physician Decision|14|||
145947553|NCT02686814|526317258|FG000|Overall Study|Withdrawal by Subject|4|||
145947554|NCT02686814|526317258|FG000|Overall Study|Death|1|||
145947555|NCT01716520|526317264|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
145947556|NCT01716520|526317265|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145947557|NCT01716520|526317266|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
145947558|NCT01716520|526317267|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
145947559|NCT01716520|526317268|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
145947560|NCT01716520|526317269|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
145947561|NCT01716520|526317264|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145947562|NCT01716520|526317265|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947563|NCT01716520|526317266|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
145947564|NCT01716520|526317267|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145947565|NCT01716520|526317268|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947566|NCT01716520|526317269|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145947567|NCT01716520|526317264|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145947568|NCT01716520|526317265|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145947569|NCT01716520|526317266|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145947570|NCT01716520|526317267|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145947571|NCT01716520|526317268|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145947572|NCT01716520|526317269|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145947573|NCT01716520|526317264|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145947574|NCT01716520|526317265|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
145947575|NCT01716520|526317266|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145947576|NCT01716520|526317267|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145947577|NCT01716520|526317268|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145947578|NCT01716520|526317269|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145947579|NCT01716520|526317264|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145947580|NCT01716520|526317265|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145947581|NCT01716520|526317266|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145947582|NCT01716520|526317267|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145947583|NCT01716520|526317268|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145947584|NCT01716520|526317269|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
145947585|NCT01716520|526317264|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145947586|NCT01716520|526317265|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145947587|NCT01716520|526317266|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
145947588|NCT01716520|526317267|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145947589|NCT01716520|526317268|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145947590|NCT01716520|526317269|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
145947591|NCT01716520|526317264|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
145947592|NCT01716520|526317265|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
146192516|NCT01835899|527215488|FG002|Overall Study|Adverse Event|1|||
146082115|NCT02509117|526820587|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146192517|NCT01835899|527215486|FG000|Overall Study|Other than stated above|0|||
146192518|NCT01835899|527215487|FG001|Overall Study|Other than stated above|1|||
146192519|NCT01835899|527215488|FG002|Overall Study|Other than stated above|0|||
146192520|NCT02616263|527215489|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
146192521|NCT02616263|527215490|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
146192522|NCT02616263|527215489|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
146192523|NCT02616263|527215490|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
146192524|NCT02616263|527215489|FG000|6 Month to 1.5 Year|Death|1|||
146192525|NCT02616263|527215490|FG001|6 Month to 1.5 Year|Death|0|||
146192526|NCT02616263|527215489|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
146192527|NCT02616263|527215490|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
146192528|NCT02616263|527215489|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
146192529|NCT02616263|527215490|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
146192530|NCT02616263|527215489|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
146192531|NCT02616263|527215490|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
146192532|NCT05015478|527215493|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
146192533|NCT05015478|527215494|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
146192534|NCT05015478|527215495|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
146192535|NCT05015478|527215496|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
146192536|NCT04319094|527215499|FG000|Baseline|Lost to Follow-up|4|||
146192537|NCT04319094|527215500|FG001|Baseline|Lost to Follow-up|5|||
146192538|NCT04319094|527215499|FG000|Baseline|Protocol Violation|0|||
146192539|NCT04319094|527215500|FG001|Baseline|Protocol Violation|3|||
146192540|NCT04319094|527215499|FG000|Baseline|Withdrawal by Subject|2|||
146192541|NCT04319094|527215500|FG001|Baseline|Withdrawal by Subject|1|||
146192542|NCT04319094|527215499|FG000|Post-Intervention|Death|0|||
146192543|NCT04319094|527215500|FG001|Post-Intervention|Death|1|||
146192544|NCT04319094|527215499|FG000|Post-Intervention|Lost to Follow-up|4|||
146192545|NCT04319094|527215500|FG001|Post-Intervention|Lost to Follow-up|4|||
146192546|NCT04319094|527215499|FG000|Post-Intervention|Withdrawal by Subject|8|||
146192547|NCT04319094|527215500|FG001|Post-Intervention|Withdrawal by Subject|5|||
146192548|NCT04319094|527215499|FG000|Post-Intervention|Incomplete Data Collection|1|||
146192549|NCT04319094|527215500|FG001|Post-Intervention|Incomplete Data Collection|3|||
146192550|NCT04319094|527215499|FG000|3-month|Death|1|||
146192551|NCT04319094|527215500|FG001|3-month|Death|0|||
146192552|NCT04319094|527215499|FG000|3-month|Lost to Follow-up|2|||
146192553|NCT04319094|527215500|FG001|3-month|Lost to Follow-up|2|||
146192554|NCT04319094|527215499|FG000|3-month|Withdrawal by Subject|0|||
146192555|NCT04319094|527215500|FG001|3-month|Withdrawal by Subject|3|||
146192556|NCT04319094|527215499|FG000|3-month|Incomplete data collection|9|||
146192557|NCT04319094|527215500|FG001|3-month|Incomplete data collection|7|||
146192558|NCT04319094|527215499|FG000|6-month|Lost to Follow-up|1|||
146192559|NCT04319094|527215500|FG001|6-month|Lost to Follow-up|1|||
146192560|NCT04319094|527215499|FG000|6-month|Withdrawal by Subject|0|||
146192561|NCT04319094|527215500|FG001|6-month|Withdrawal by Subject|3|||
146192562|NCT04319094|527215499|FG000|6-month|Incomplete data collection|14|||
146192563|NCT04319094|527215500|FG001|6-month|Incomplete data collection|9|||
146192564|NCT04319094|527215499|FG000|9-month|Lost to Follow-up|8|||
146192565|NCT04319094|527215500|FG001|9-month|Lost to Follow-up|4|||
146192566|NCT04319094|527215499|FG000|9-month|Withdrawal by Subject|0|||
146192567|NCT04319094|527215500|FG001|9-month|Withdrawal by Subject|1|||
146192568|NCT04319094|527215499|FG000|9-month|Incomplete data collection|8|||
146192569|NCT04319094|527215500|FG001|9-month|Incomplete data collection|5|||
146192570|NCT04319094|527215499|FG000|12-month|Lost to Follow-up|11|||
146192571|NCT04319094|527215500|FG001|12-month|Lost to Follow-up|8|||
146192572|NCT00614744|527215503|FG000|Overall Study|Lost to Follow-up|5|||
146192573|NCT00614744|527215504|FG001|Overall Study|Lost to Follow-up|4|||
146192574|NCT00614744|527215503|FG000|Overall Study|Incomplete for Behavior Issues|0|||
146192575|NCT00614744|527215504|FG001|Overall Study|Incomplete for Behavior Issues|2|||
146192576|NCT00877851|527215505|FG000|Overall Study|Lost to Follow-up|5|||
146192577|NCT00877851|527215506|FG001|Overall Study|Lost to Follow-up|5|||
146192578|NCT00877851|527215505|FG000|Overall Study|computer problem|3|||
146192579|NCT00877851|527215506|FG001|Overall Study|computer problem|0|||
146192580|NCT00877851|527215505|FG000|Overall Study|no longer interested in participating|1|||
146192581|NCT00877851|527215506|FG001|Overall Study|no longer interested in participating|0|||
146192582|NCT01446003|527215507|FG000|Period 1|Protocol Violation|2|||
146192583|NCT01446003|527215508|FG001|Period 1|Protocol Violation|0|||
146192584|NCT01446003|527215507|FG000|Period 2|Adverse Event|1|||
146192585|NCT01446003|527215508|FG001|Period 2|Adverse Event|0|||
146192586|NCT01740557|527215509|FG000|Overall Study|Ineligible|1|||
146192587|NCT01740557|527215509|FG000|Overall Study|Screen failure|1|||
146192588|NCT00490555|527215510|FG000|Overall Study|noncompliant with drug administration|0|||
146192589|NCT00490555|527215511|FG001|Overall Study|noncompliant with drug administration|0|||
146192590|NCT00490555|527215512|FG002|Overall Study|noncompliant with drug administration|2|||
146192591|NCT00490555|527215513|FG003|Overall Study|noncompliant with drug administration|0|||
146192592|NCT00603538|527215514|FG000|Overall Study|Adverse Event|0|||
146192593|NCT00603538|527215515|FG001|Overall Study|Adverse Event|4|||
146192594|NCT00603538|527215516|FG002|Overall Study|Adverse Event|2|||
146192595|NCT00603538|527215514|FG000|Overall Study|Objective progression or relapse|3|||
145947593|NCT01716520|526317266|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
145947594|NCT01716520|526317267|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
146192596|NCT00603538|527215515|FG001|Overall Study|Objective progression or relapse|0|||
146192597|NCT00603538|527215516|FG002|Overall Study|Objective progression or relapse|0|||
146192598|NCT04794179|527215517|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
146192599|NCT04794179|527215518|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
146192600|NCT01096056|527215519|FG000|Overall Study|Lost to Follow-up|0|||
146192601|NCT01096056|527215520|FG001|Overall Study|Lost to Follow-up|1|||
146192602|NCT01737268|527215523|FG000|Overall Study|Adverse Event|6|||
146192603|NCT01737268|527215523|FG000|Overall Study|Worsening of Target Disease|2|||
146192604|NCT01737268|527215523|FG000|Overall Study|In consideration of the patient's safety|1|||
146192605|NCT01190176|527215526|FG000|Overall Study|Withdrawal by Subject|1|||
146192606|NCT01190176|527215526|FG000|Overall Study|Lost to Follow-up|1|||
146192607|NCT02189863|527215527|FG000|First 2 Weeks|Motion Sickness|4|||
146192608|NCT02189863|527215528|FG001|First 2 Weeks|Motion Sickness|2|||
146192609|NCT03697460|527215529|FG000|Overall Study|Withdrawal by Subject|3|||
146192610|NCT03369951|527215530|FG000|Overall Study|Withdrawal by Subject|3|||
146192611|NCT03369951|527215530|FG000|Overall Study|Death|1|||
146192612|NCT03369951|527215530|FG000|Overall Study|Lost to Follow-up|1|||
146192613|NCT03369951|527215530|FG000|Overall Study|Protocol Violation|1|||
146192614|NCT00725010|527215540|FG000|Overall Study|Toxicity|9|||
146192615|NCT00725010|527215540|FG000|Overall Study|Tumor Progression|7|||
146192616|NCT00725010|527215540|FG000|Overall Study|Withdrawal by Subject|2|||
146192617|NCT00725010|527215540|FG000|Overall Study|Death|1|||
146192618|NCT00725010|527215540|FG000|Overall Study|Lost to Follow-up|1|||
146192619|NCT00725010|527215540|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
146192620|NCT00725010|527215540|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
146192621|NCT00725010|527215540|FG000|Overall Study|No further documentation|1|||
146192622|NCT00725010|527215540|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
146192623|NCT03499600|527215541|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
146192624|NCT03499600|527215542|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
146192625|NCT02414828|527215543|FG000|Overall Study|Lost to Follow-up|0|||
146192626|NCT02414828|527215544|FG001|Overall Study|Lost to Follow-up|1|||
146192627|NCT02414828|527215545|FG002|Overall Study|Lost to Follow-up|1|||
146192628|NCT02414828|527215546|FG003|Overall Study|Lost to Follow-up|2|||
146192629|NCT00389519|527215550|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
146192630|NCT00389519|527215551|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
146192631|NCT00389519|527215552|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
146192632|NCT00389519|527215553|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
146192633|NCT00389519|527215550|FG000|Placebo Run-In|Withdrawal by Subject|19|||
146192634|NCT00389519|527215551|FG001|Placebo Run-In|Withdrawal by Subject|0|||
146192635|NCT00389519|527215552|FG002|Placebo Run-In|Withdrawal by Subject|0|||
146192636|NCT00389519|527215553|FG003|Placebo Run-In|Withdrawal by Subject|0|||
146192637|NCT00389519|527215550|FG000|Placebo Run-In|Reason not specified|40|||
146192638|NCT00389519|527215551|FG001|Placebo Run-In|Reason not specified|0|||
146192639|NCT00389519|527215552|FG002|Placebo Run-In|Reason not specified|0|||
146192640|NCT00389519|527215553|FG003|Placebo Run-In|Reason not specified|0|||
146192641|NCT00389519|527215550|FG000|Randomized|Did not receive study drug|2|||
146192642|NCT00389519|527215551|FG001|Randomized|Did not receive study drug|0|||
146192643|NCT00389519|527215552|FG002|Randomized|Did not receive study drug|0|||
146192644|NCT00389519|527215553|FG003|Randomized|Did not receive study drug|0|||
146192645|NCT00389519|527215550|FG000|Treated|Adverse Event|1|||
146192646|NCT00389519|527215551|FG001|Treated|Adverse Event|0|||
146192647|NCT00389519|527215552|FG002|Treated|Adverse Event|0|||
146192648|NCT00389519|527215553|FG003|Treated|Adverse Event|2|||
146192649|NCT00389519|527215550|FG000|Treated|Reason not specified|1|||
146192650|NCT00389519|527215551|FG001|Treated|Reason not specified|1|||
146192651|NCT00389519|527215552|FG002|Treated|Reason not specified|0|||
146192652|NCT00389519|527215553|FG003|Treated|Reason not specified|2|||
146192653|NCT01537133|527217658|FG000|Overall Study|Withdrawal by Subject|2|||
146192654|NCT01537133|527217659|FG001|Overall Study|Withdrawal by Subject|0|||
146192655|NCT01537133|527217660|FG002|Overall Study|Withdrawal by Subject|0|||
146192656|NCT01537133|527217661|FG003|Overall Study|Withdrawal by Subject|0|||
146192657|NCT01537133|527217658|FG000|Overall Study|Lost to Follow-up|1|||
146192658|NCT01537133|527217659|FG001|Overall Study|Lost to Follow-up|0|||
146192659|NCT01537133|527217660|FG002|Overall Study|Lost to Follow-up|0|||
146192660|NCT01537133|527217661|FG003|Overall Study|Lost to Follow-up|0|||
146192661|NCT00569946|527217662|FG000|Overall Study|Adverse Event|16|||
146192662|NCT00569946|527217662|FG000|Overall Study|Objective Progression or Relapse|42|||
146192663|NCT00569946|527217662|FG000|Overall Study|Global Deterioration of Health Status|1|||
146192664|NCT00797862|527217663|FG000|Overall Study|Adverse Event|86|||
146192665|NCT00797862|527217664|FG001|Overall Study|Adverse Event|44|||
146192666|NCT00797862|527217665|FG002|Overall Study|Adverse Event|58|||
146192667|NCT00797862|527217663|FG000|Overall Study|Abnormal Test Procedure Result|0|||
146192668|NCT00797862|527217664|FG001|Overall Study|Abnormal Test Procedure Result|1|||
146192669|NCT00797862|527217665|FG002|Overall Study|Abnormal Test Procedure Result|1|||
146192670|NCT00797862|527217663|FG000|Overall Study|Lack of Efficacy|1|||
146192671|NCT00797862|527217664|FG001|Overall Study|Lack of Efficacy|7|||
146192672|NCT00797862|527217665|FG002|Overall Study|Lack of Efficacy|6|||
146192673|NCT00797862|527217663|FG000|Overall Study|No longer required study medication|1|||
146192674|NCT00797862|527217664|FG001|Overall Study|No longer required study medication|0|||
146192675|NCT00797862|527217665|FG002|Overall Study|No longer required study medication|0|||
146192676|NCT00797862|527217663|FG000|Overall Study|Withdrawal by Subject|14|||
146192677|NCT00797862|527217664|FG001|Overall Study|Withdrawal by Subject|7|||
146192678|NCT00797862|527217665|FG002|Overall Study|Withdrawal by Subject|7|||
146192679|NCT00797862|527217663|FG000|Overall Study|Lost to Follow-up|11|||
146192680|NCT00797862|527217664|FG001|Overall Study|Lost to Follow-up|0|||
146192681|NCT00797862|527217665|FG002|Overall Study|Lost to Follow-up|5|||
146192682|NCT00797862|527217663|FG000|Overall Study|Administrative Problem|4|||
146192683|NCT00797862|527217664|FG001|Overall Study|Administrative Problem|0|||
146192684|NCT00797862|527217665|FG002|Overall Study|Administrative Problem|0|||
146192685|NCT00797862|527217663|FG000|Overall Study|Protocol Violation|4|||
146192686|NCT00797862|527217664|FG001|Overall Study|Protocol Violation|6|||
146192687|NCT00797862|527217665|FG002|Overall Study|Protocol Violation|8|||
146192688|NCT00797862|527217663|FG000|Overall Study|Mis-randomized|3|||
146192689|NCT00797862|527217664|FG001|Overall Study|Mis-randomized|3|||
146192690|NCT00797862|527217665|FG002|Overall Study|Mis-randomized|1|||
146192691|NCT00531479|527217666|FG000|Overall Study|Death|68|||
146192692|NCT00531479|527217667|FG001|Overall Study|Death|71|||
146192693|NCT00531479|527217666|FG000|Overall Study|Lost to Follow-up|0|||
146192694|NCT00531479|527217667|FG001|Overall Study|Lost to Follow-up|2|||
146192695|NCT00531479|527217666|FG000|Overall Study|Other|0|||
146192696|NCT00531479|527217667|FG001|Overall Study|Other|1|||
146192697|NCT00531479|527217666|FG000|Overall Study|Withdrawal by Subject|6|||
146192698|NCT00531479|527217667|FG001|Overall Study|Withdrawal by Subject|6|||
146192699|NCT00531479|527217666|FG000|Overall Study|Did not receive treatment|2|||
146192700|NCT00531479|527217667|FG001|Overall Study|Did not receive treatment|3|||
146192701|NCT05074498|527217670|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146192702|NCT05074498|527217671|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146192703|NCT05074498|527217672|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146192704|NCT05074498|527217673|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
146192705|NCT05074498|527217674|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146192706|NCT05074498|527217675|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
146192707|NCT05074498|527217670|FG000|Part 1 (Upto Day 104)|Other|1|||
146192708|NCT05074498|527217671|FG001|Part 1 (Upto Day 104)|Other|0|||
146192709|NCT05074498|527217672|FG002|Part 1 (Upto Day 104)|Other|0|||
146192710|NCT05074498|527217673|FG003|Part 1 (Upto Day 104)|Other|0|||
146192711|NCT05074498|527217674|FG004|Part 1 (Upto Day 104)|Other|0|||
146192712|NCT05074498|527217675|FG005|Part 1 (Upto Day 104)|Other|0|||
146192713|NCT05074498|527217670|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146192714|NCT05074498|527217671|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146192715|NCT05074498|527217672|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146192716|NCT05074498|527217673|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146192717|NCT05074498|527217674|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
146192718|NCT05074498|527217675|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
146192719|NCT05074498|527217670|FG000|Part 2 (Upto Day 104)|Death|0|||
146192720|NCT05074498|527217671|FG001|Part 2 (Upto Day 104)|Death|0|||
146413510|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146413511|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146413512|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146413513|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
146413514|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
146413515|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413516|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413517|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413518|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413519|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413520|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
146413521|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
146413522|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
146413523|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
146413524|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
146413525|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
146413526|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
145947595|NCT01716520|526317268|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
145947596|NCT01716520|526317269|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
145947597|NCT01716520|526317264|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145947598|NCT01716520|526317265|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145947599|NCT01716520|526317266|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145947600|NCT01716520|526317267|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145947601|NCT01716520|526317268|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145947602|NCT01716520|526317269|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145947603|NCT01716520|526317264|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947604|NCT01716520|526317265|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947605|NCT01716520|526317266|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947606|NCT01716520|526317267|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
145947607|NCT01716520|526317268|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947608|NCT01716520|526317269|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145947609|NCT01716520|526317264|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145947610|NCT01716520|526317265|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145947611|NCT01716520|526317266|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145947612|NCT01716520|526317267|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145947613|NCT01716520|526317268|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145947614|NCT01716520|526317269|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145947615|NCT01716520|526317264|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
145947616|NCT01716520|526317265|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145947617|NCT01716520|526317266|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145947618|NCT01716520|526317267|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145947619|NCT01716520|526317268|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145947620|NCT01716520|526317269|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145947621|NCT01716520|526317264|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145947622|NCT01716520|526317265|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145947623|NCT01716520|526317266|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145947624|NCT01716520|526317267|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145947625|NCT01716520|526317268|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145947626|NCT01716520|526317269|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
145947627|NCT01716520|526317264|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145947628|NCT01716520|526317265|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
145947629|NCT01716520|526317266|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145947630|NCT01716520|526317267|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145947631|NCT01716520|526317268|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145947632|NCT01716520|526317269|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145947633|NCT01716520|526317264|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145947634|NCT01716520|526317265|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145947635|NCT01716520|526317266|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145947636|NCT01716520|526317267|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145947637|NCT01716520|526317268|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145947638|NCT01716520|526317269|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
145947639|NCT01716520|526317264|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145947640|NCT01716520|526317265|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146192721|NCT05074498|527217672|FG002|Part 2 (Upto Day 104)|Death|0|||
146192722|NCT05074498|527217673|FG003|Part 2 (Upto Day 104)|Death|0|||
146413527|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
146413528|NCT00606684|528019673|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
146413529|NCT00606684|528019674|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146413530|NCT00606684|528019675|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146413531|NCT00606684|528019676|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146284466|NCT01688830|527553738|FG019|Overall Study|Lost to Follow-up|0|||
146413532|NCT00606684|528019677|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146284467|NCT01688830|527553739|FG020|Overall Study|Lost to Follow-up|0|||
146284468|NCT01285609|527553740|FG000|Randomized|Progressive Disease|41|||
146284469|NCT01285609|527553741|FG001|Randomized|Progressive Disease|61|||
146284470|NCT01285609|527553740|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
146284471|NCT01285609|527553741|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
146413533|NCT00606684|528019678|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146284472|NCT01285609|527553740|FG000|Randomized|Study Drug Toxicity|13|||
146284473|NCT01285609|527553741|FG001|Randomized|Study Drug Toxicity|14|||
146284474|NCT01285609|527553740|FG000|Randomized|Death|5|||
146284475|NCT01285609|527553741|FG001|Randomized|Death|7|||
146284476|NCT01285609|527553740|FG000|Randomized|Withdrawal by Subject|8|||
146284477|NCT01285609|527553741|FG001|Randomized|Withdrawal by Subject|11|||
146284478|NCT01285609|527553740|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
146284479|NCT01285609|527553741|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
146284480|NCT01285609|527553740|FG000|Randomized|Undisclosed Reasons|1|||
146284481|NCT01285609|527553741|FG001|Randomized|Undisclosed Reasons|0|||
146284482|NCT01285609|527553740|FG000|Randomized|Randomized but not Treated|4|||
146284483|NCT01285609|527553741|FG001|Randomized|Randomized but not Treated|4|||
146284484|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
146082116|NCT02509117|526820588|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082117|NCT02509117|526820589|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082118|NCT02509117|526820590|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082119|NCT02509117|526820591|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082120|NCT02509117|526820592|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082121|NCT02509117|526820593|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082122|NCT02509117|526820594|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082123|NCT02509117|526820595|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
146082124|NCT02509117|526820596|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
146082125|NCT04345367|526820597|FG000|Overall Study|Other|3|||
146082126|NCT04345367|526820598|FG001|Overall Study|Other|4|||
146082127|NCT04345367|526820597|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
146082128|NCT04345367|526820598|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
146082129|NCT04345367|526820597|FG000|Overall Study|Withdrawal by Subject|11|||
146082130|NCT04345367|526820598|FG001|Overall Study|Withdrawal by Subject|11|||
146082131|NCT04345367|526820597|FG000|Overall Study|Protocol Violation|4|||
146082132|NCT04345367|526820598|FG001|Overall Study|Protocol Violation|3|||
146082133|NCT04345367|526820597|FG000|Overall Study|Lost to Follow-up|2|||
146082134|NCT04345367|526820598|FG001|Overall Study|Lost to Follow-up|4|||
146082135|NCT04345367|526820597|FG000|Overall Study|Lack of Efficacy|2|||
146082136|NCT04345367|526820598|FG001|Overall Study|Lack of Efficacy|0|||
146082137|NCT04345367|526820597|FG000|Overall Study|Death|2|||
146082138|NCT04345367|526820598|FG001|Overall Study|Death|0|||
146082139|NCT04345367|526820597|FG000|Overall Study|Adverse Event|10|||
146082140|NCT04345367|526820598|FG001|Overall Study|Adverse Event|9|||
146082141|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
146082142|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
146082143|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
146082144|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
146082145|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
146082146|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
146082147|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
146082148|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
146082149|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
146082150|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
146082151|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
146082152|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
146082153|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
146082154|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
146082155|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
146082156|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
146082157|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
146082158|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
145947641|NCT01716520|526317266|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
145947642|NCT01716520|526317267|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145947643|NCT01716520|526317268|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145947644|NCT01716520|526317269|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145947645|NCT00253370|526317270|FG000|Overall Study|Adverse Event|18|||
145947646|NCT00253370|526317270|FG000|Overall Study|Disease progression|13|||
145947647|NCT00253370|526317270|FG000|Overall Study|Death|2|||
145947648|NCT00253370|526317270|FG000|Overall Study|Withdrawal by Subject|6|||
145947649|NCT00253370|526317270|FG000|Overall Study|Non-protocol therapy|1|||
145947650|NCT00253370|526317270|FG000|Overall Study|Physician Decision|1|||
145947651|NCT00253370|526317270|FG000|Overall Study|Protocol Violation|1|||
145947652|NCT00253370|526317270|FG000|Overall Study|Abdominal pain due to disease|1|||
145947653|NCT00004088|526317275|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
145947654|NCT00004088|526317275|FG000|Overall Study|Withdrawal by Subject|1|||
145947655|NCT00004088|526317275|FG000|Overall Study|Protocol Violation|3|||
145947656|NCT00004088|526317275|FG000|Overall Study|Physician Decision|1|||
145947657|NCT01955109|526317276|FG000|Overall Study|Adverse Event|2|||
145947658|NCT01955109|526317277|FG001|Overall Study|Adverse Event|0|||
145947659|NCT01955109|526317276|FG000|Overall Study|Participant unwilling to continue|35|||
146192723|NCT05074498|527217674|FG004|Part 2 (Upto Day 104)|Death|1|||
146192724|NCT05074498|527217675|FG005|Part 2 (Upto Day 104)|Death|0|||
146192725|NCT05074498|527217670|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146192726|NCT05074498|527217671|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146192727|NCT05074498|527217672|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146192728|NCT05074498|527217673|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
146192729|NCT05074498|527217674|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
146192730|NCT05074498|527217675|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
146192731|NCT05074498|527217670|FG000|Part 2 (Upto Day 104)|Other|0|||
146192732|NCT05074498|527217671|FG001|Part 2 (Upto Day 104)|Other|0|||
146192733|NCT05074498|527217672|FG002|Part 2 (Upto Day 104)|Other|0|||
146192734|NCT05074498|527217673|FG003|Part 2 (Upto Day 104)|Other|0|||
146192735|NCT05074498|527217674|FG004|Part 2 (Upto Day 104)|Other|1|||
146192736|NCT05074498|527217675|FG005|Part 2 (Upto Day 104)|Other|0|||
146192737|NCT01240356|527217676|FG000|Overall Study|Withdrawal by Subject|2|||
146192738|NCT01240356|527217677|FG001|Overall Study|Withdrawal by Subject|0|||
146192739|NCT01240356|527217676|FG000|Overall Study|MRI contraindication|1|||
146192740|NCT01240356|527217677|FG001|Overall Study|MRI contraindication|0|||
146192741|NCT04048135|527217683|FG000|Overall Study|Withdrawal by Subject|1|||
146192742|NCT04048135|527217684|FG001|Overall Study|Withdrawal by Subject|1|||
145947660|NCT01955109|526317277|FG001|Overall Study|Participant unwilling to continue|7|||
145947661|NCT01955109|526317276|FG000|Overall Study|Physician Decision|2|||
145947662|NCT01955109|526317277|FG001|Overall Study|Physician Decision|0|||
145947663|NCT01955109|526317276|FG000|Overall Study|Lost to Follow-up|3|||
145947664|NCT01955109|526317277|FG001|Overall Study|Lost to Follow-up|1|||
145947665|NCT01955109|526317276|FG000|Overall Study|Non-compliance|3|||
145947666|NCT01955109|526317277|FG001|Overall Study|Non-compliance|1|||
145947667|NCT00419159|526317280|FG000|Overall Study|Adverse Event|7|||
145947668|NCT00419159|526317281|FG001|Overall Study|Adverse Event|15|||
145947669|NCT00419159|526317280|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145947670|NCT00419159|526317281|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145947671|NCT00419159|526317280|FG000|Overall Study|Subject's no longer requires study drug|0|||
145947672|NCT00419159|526317281|FG001|Overall Study|Subject's no longer requires study drug|1|||
145947673|NCT00419159|526317280|FG000|Overall Study|Protocol Violation|1|||
145947674|NCT00419159|526317281|FG001|Overall Study|Protocol Violation|0|||
145947675|NCT00419159|526317280|FG000|Overall Study|Withdrawal by Subject|10|||
145947676|NCT00419159|526317281|FG001|Overall Study|Withdrawal by Subject|3|||
145947677|NCT00419159|526317280|FG000|Overall Study|Lost to Follow-up|0|||
145947678|NCT00419159|526317281|FG001|Overall Study|Lost to Follow-up|1|||
145947679|NCT00419159|526317280|FG000|Overall Study|Death|2|||
145947680|NCT00419159|526317281|FG001|Overall Study|Death|2|||
146192743|NCT04048135|527217685|FG002|Overall Study|Withdrawal by Subject|1|||
145947681|NCT00419159|526317280|FG000|Overall Study|Disease progression|79|||
145947682|NCT00419159|526317281|FG001|Overall Study|Disease progression|76|||
145947683|NCT01017601|526317282|FG000|Overall Study|Disease Progression|12|||
145947684|NCT01017601|526317283|FG001|Overall Study|Disease Progression|12|||
145947685|NCT01017601|526317282|FG000|Overall Study|Withdrawal by Subject|0|||
146192744|NCT04048135|527217686|FG003|Overall Study|Withdrawal by Subject|2|||
146192745|NCT04048135|527217687|FG004|Overall Study|Withdrawal by Subject|0|||
146192746|NCT04048135|527217688|FG005|Overall Study|Withdrawal by Subject|0|||
146192747|NCT04048135|527217689|FG006|Overall Study|Withdrawal by Subject|1|||
145947686|NCT01017601|526317283|FG001|Overall Study|Withdrawal by Subject|1|||
145947687|NCT02735096|526317284|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
145947688|NCT02117713|526317285|FG000|Week 48|Adverse Event|4|||
145947689|NCT02117713|526317285|FG000|Week 48|Withdrawal by caregiver|2|||
145947690|NCT02117713|526317285|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
145947691|NCT02117713|526317285|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
146413534|NCT00606684|528019679|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
146413535|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146413536|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Adverse Event|3|||
146413537|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Adverse Event|2|||
146413538|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Adverse Event|4|||
146413539|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Adverse Event|2|||
146413540|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Adverse Event|0|||
146413541|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Adverse Event|1|||
146413542|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146413543|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
146413544|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
146413545|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
146413546|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
146413547|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
146413548|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
146413549|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146413550|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
146413551|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
146413552|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
146413553|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
146413554|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
146413555|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
146413556|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
146413557|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146413558|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
146413559|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146413560|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
146413561|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
146413562|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
146413563|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146413564|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Physician Decision|5|||
146413565|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Physician Decision|1|||
146413566|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146413567|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Physician Decision|3|||
146413568|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Physician Decision|1|||
146413569|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Physician Decision|2|||
146413570|NCT00606684|528019673|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146413571|NCT00606684|528019674|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146413572|NCT00606684|528019675|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146413573|NCT00606684|528019676|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146413574|NCT00606684|528019677|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146413575|NCT00606684|528019678|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146413576|NCT00606684|528019679|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146284485|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
146284486|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
146192748|NCT04048135|527217690|FG007|Overall Study|Withdrawal by Subject|1|||
146192749|NCT04048135|527217683|FG000|Overall Study|Adverse Event|0|||
146192750|NCT04048135|527217684|FG001|Overall Study|Adverse Event|0|||
146192751|NCT04048135|527217685|FG002|Overall Study|Adverse Event|0|||
146192752|NCT04048135|527217686|FG003|Overall Study|Adverse Event|1|||
146192753|NCT04048135|527217687|FG004|Overall Study|Adverse Event|1|||
146192754|NCT04048135|527217688|FG005|Overall Study|Adverse Event|0|||
146192755|NCT04048135|527217689|FG006|Overall Study|Adverse Event|0|||
146192756|NCT04048135|527217690|FG007|Overall Study|Adverse Event|0|||
146192757|NCT04048135|527217683|FG000|Overall Study|Protocol Violation|0|||
146192758|NCT04048135|527217684|FG001|Overall Study|Protocol Violation|0|||
146192759|NCT04048135|527217685|FG002|Overall Study|Protocol Violation|0|||
146192760|NCT04048135|527217686|FG003|Overall Study|Protocol Violation|0|||
146192761|NCT04048135|527217687|FG004|Overall Study|Protocol Violation|0|||
146192762|NCT04048135|527217688|FG005|Overall Study|Protocol Violation|1|||
146192763|NCT04048135|527217689|FG006|Overall Study|Protocol Violation|0|||
146413577|NCT01759381|528019682|FG000|Overall Study|Death|1|||
146192764|NCT04048135|527217690|FG007|Overall Study|Protocol Violation|0|||
146192765|NCT00172185|527217691|FG000|Overall Study|Adverse Event|0|||
146192766|NCT00172185|527217692|FG001|Overall Study|Adverse Event|1|||
146284487|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
146413578|NCT01759381|528019683|FG001|Overall Study|Death|0|||
146413579|NCT01907737|528019691|FG000|Overall Study|Withdrawal by Subject|1|||
146192767|NCT00172185|527217693|FG002|Overall Study|Adverse Event|3|||
146413580|NCT00909727|528019696|FG000|Overall Study|Adverse Event|1|||
146413581|NCT00909727|528019697|FG001|Overall Study|Adverse Event|0|||
146413582|NCT00909727|528019696|FG000|Overall Study|Wrong Genotype|1|||
146413583|NCT00909727|528019697|FG001|Overall Study|Wrong Genotype|0|||
146413584|NCT00909727|528019696|FG000|Overall Study|Withdrawal of Consent|1|||
146413585|NCT00909727|528019697|FG001|Overall Study|Withdrawal of Consent|0|||
146413586|NCT00909727|528019696|FG000|Overall Study|Prohibited Medication|1|||
146413587|NCT00909727|528019697|FG001|Overall Study|Prohibited Medication|0|||
146413588|NCT01339910|528019699|FG000|Overall Study|Withdrawal by Subject|1|||
146413589|NCT01339910|528019700|FG001|Overall Study|Withdrawal by Subject|0|||
146413590|NCT01339910|528019699|FG000|Overall Study|Physician Decision|1|||
146413591|NCT01339910|528019700|FG001|Overall Study|Physician Decision|0|||
146413592|NCT01339910|528019699|FG000|Overall Study|Disease relapse|1|||
146413593|NCT01339910|528019700|FG001|Overall Study|Disease relapse|4|||
146413594|NCT02965820|528019702|FG000|Period 2, Second 30 Days|Adverse Event|1|||
146413595|NCT02965820|528019703|FG001|Period 2, Second 30 Days|Adverse Event|1|||
146413596|NCT01567306|528019704|FG000|Overall Study|Protocol Violation|2|||
146413597|NCT01567306|528019705|FG001|Overall Study|Protocol Violation|2|||
146413598|NCT01567306|528019706|FG002|Overall Study|Protocol Violation|0|||
146413599|NCT01567306|528019707|FG003|Overall Study|Protocol Violation|3|||
146413600|NCT01567306|528019708|FG004|Overall Study|Protocol Violation|1|||
146413601|NCT01567306|528019709|FG005|Overall Study|Protocol Violation|1|||
146413602|NCT01567306|528019704|FG000|Overall Study|Change site living|1|||
146413603|NCT01567306|528019705|FG001|Overall Study|Change site living|0|||
146413604|NCT01567306|528019706|FG002|Overall Study|Change site living|0|||
146413605|NCT01567306|528019707|FG003|Overall Study|Change site living|0|||
146413606|NCT01567306|528019708|FG004|Overall Study|Change site living|0|||
146413607|NCT01567306|528019709|FG005|Overall Study|Change site living|0|||
146413608|NCT01567306|528019704|FG000|Overall Study|Adverse Event|0|||
146413609|NCT01567306|528019705|FG001|Overall Study|Adverse Event|0|||
146413610|NCT01567306|528019706|FG002|Overall Study|Adverse Event|0|||
146413611|NCT01567306|528019707|FG003|Overall Study|Adverse Event|2|||
146413612|NCT01567306|528019708|FG004|Overall Study|Adverse Event|4|||
146413613|NCT01567306|528019709|FG005|Overall Study|Adverse Event|1|||
146413614|NCT01567306|528019704|FG000|Overall Study|Lost to Follow-up|0|||
146413615|NCT01567306|528019705|FG001|Overall Study|Lost to Follow-up|0|||
146413616|NCT01567306|528019706|FG002|Overall Study|Lost to Follow-up|0|||
146413617|NCT01567306|528019707|FG003|Overall Study|Lost to Follow-up|0|||
146413618|NCT01567306|528019708|FG004|Overall Study|Lost to Follow-up|2|||
146413619|NCT01567306|528019709|FG005|Overall Study|Lost to Follow-up|0|||
146192768|NCT00172185|527217694|FG003|Overall Study|Adverse Event|4|||
146192769|NCT00172185|527217691|FG000|Overall Study|Physician Decision|0|||
146192770|NCT00172185|527217692|FG001|Overall Study|Physician Decision|0|||
146192771|NCT00172185|527217693|FG002|Overall Study|Physician Decision|1|||
146192772|NCT00172185|527217694|FG003|Overall Study|Physician Decision|0|||
146192773|NCT00172185|527217691|FG000|Overall Study|SPONSOR Decision|0|||
146192774|NCT00172185|527217692|FG001|Overall Study|SPONSOR Decision|1|||
146192775|NCT00172185|527217693|FG002|Overall Study|SPONSOR Decision|0|||
146192776|NCT00172185|527217694|FG003|Overall Study|SPONSOR Decision|0|||
146192777|NCT00172185|527217691|FG000|Overall Study|Withdrawal by Subject|0|||
146192778|NCT00172185|527217692|FG001|Overall Study|Withdrawal by Subject|0|||
146192779|NCT00172185|527217693|FG002|Overall Study|Withdrawal by Subject|1|||
146192780|NCT00172185|527217694|FG003|Overall Study|Withdrawal by Subject|0|||
146192781|NCT01677936|527217695|FG000|Overall Study|Lost to Follow-up|4|||
146192782|NCT01677936|527217696|FG001|Overall Study|Lost to Follow-up|1|||
146192783|NCT01677936|527217695|FG000|Overall Study|Protocol Violation|3|||
146192784|NCT01677936|527217696|FG001|Overall Study|Protocol Violation|0|||
146192785|NCT01677936|527217695|FG000|Overall Study|Adverse Event|1|||
146192786|NCT01677936|527217696|FG001|Overall Study|Adverse Event|0|||
146192787|NCT01677936|527217695|FG000|Overall Study|Lost to Follow-up|1|||
146192788|NCT01677936|527217696|FG001|Overall Study|Lost to Follow-up|0|||
146192789|NCT01677936|527217695|FG000|Overall Study|Protocol Violation|0|||
146192790|NCT01677936|527217696|FG001|Overall Study|Protocol Violation|4|||
146192791|NCT03837028|527217697|FG000|Overall Study|Lost to Follow-up|4|||
146192792|NCT03837028|527217698|FG001|Overall Study|Lost to Follow-up|0|||
146192793|NCT03837028|527217699|FG002|Overall Study|Lost to Follow-up|2|||
146192794|NCT03837028|527217700|FG003|Overall Study|Lost to Follow-up|0|||
146192795|NCT03837028|527217697|FG000|Overall Study|Withdrawal by Subject|12|||
146413620|NCT01567306|528019704|FG000|Overall Study|Withdrawal by Subject|0|||
146413621|NCT01567306|528019705|FG001|Overall Study|Withdrawal by Subject|0|||
146413622|NCT01567306|528019706|FG002|Overall Study|Withdrawal by Subject|0|||
146413623|NCT01567306|528019707|FG003|Overall Study|Withdrawal by Subject|0|||
146413624|NCT01567306|528019708|FG004|Overall Study|Withdrawal by Subject|0|||
146413625|NCT01567306|528019709|FG005|Overall Study|Withdrawal by Subject|1|||
146413626|NCT00829413|528019714|FG000|Overall Study|No study drug admimnistered|13|||
146192796|NCT03837028|527217698|FG001|Overall Study|Withdrawal by Subject|11|||
146192797|NCT03837028|527217699|FG002|Overall Study|Withdrawal by Subject|11|||
146192798|NCT03837028|527217700|FG003|Overall Study|Withdrawal by Subject|7|||
146413627|NCT00829413|528019714|FG000|Overall Study|Training Patients|67|||
146284488|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
146284489|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
146284490|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
146284491|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
146284492|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Death|11|||
146284493|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Death|3|||
146284494|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
146284495|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
146284496|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Not Reported|0|||
146284497|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Not Reported|2|||
146284498|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
146284499|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
146284500|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
146284501|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
146284502|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
146284503|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
146284504|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
146284505|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
146284506|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
146284507|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
146192799|NCT00157014|527217701|FG000|Overall Study|Death|4|||
146192800|NCT00157014|527217702|FG001|Overall Study|Death|2|||
146192801|NCT00157014|527217703|FG002|Overall Study|Death|1|||
146192802|NCT00157014|527217704|FG003|Overall Study|Death|1|||
146192803|NCT00157014|527217701|FG000|Overall Study|Physician Decision|0|||
146192804|NCT00157014|527217702|FG001|Overall Study|Physician Decision|1|||
146192805|NCT00157014|527217703|FG002|Overall Study|Physician Decision|0|||
146192806|NCT00157014|527217704|FG003|Overall Study|Physician Decision|0|||
146192807|NCT00157014|527217701|FG000|Overall Study|Medications withdrawn on family request|0|||
146192808|NCT00157014|527217702|FG001|Overall Study|Medications withdrawn on family request|1|||
146192809|NCT00157014|527217703|FG002|Overall Study|Medications withdrawn on family request|0|||
146192810|NCT00157014|527217704|FG003|Overall Study|Medications withdrawn on family request|0|||
146192811|NCT00157014|527217701|FG000|Overall Study|Patient withdrawn by investigator|1|||
146192812|NCT00157014|527217702|FG001|Overall Study|Patient withdrawn by investigator|0|||
146192813|NCT00157014|527217703|FG002|Overall Study|Patient withdrawn by investigator|0|||
146192814|NCT00157014|527217704|FG003|Overall Study|Patient withdrawn by investigator|0|||
146192815|NCT00157014|527217701|FG000|Overall Study|Patient unable to return in nursing home|1|||
146192816|NCT00157014|527217702|FG001|Overall Study|Patient unable to return in nursing home|0|||
146192817|NCT00157014|527217703|FG002|Overall Study|Patient unable to return in nursing home|0|||
146192818|NCT00157014|527217704|FG003|Overall Study|Patient unable to return in nursing home|0|||
146192819|NCT00157014|527217701|FG000|Overall Study|Patient would not receive transplant|0|||
146192820|NCT00157014|527217702|FG001|Overall Study|Patient would not receive transplant|1|||
146192821|NCT00157014|527217703|FG002|Overall Study|Patient would not receive transplant|0|||
146192822|NCT00157014|527217704|FG003|Overall Study|Patient would not receive transplant|0|||
146192823|NCT00157014|527217701|FG000|Overall Study|Withdrawal by Subject|1|||
146192824|NCT00157014|527217702|FG001|Overall Study|Withdrawal by Subject|0|||
146192825|NCT00157014|527217703|FG002|Overall Study|Withdrawal by Subject|0|||
146192826|NCT00157014|527217704|FG003|Overall Study|Withdrawal by Subject|0|||
146192827|NCT01362491|527217705|FG000|Overall Study|Ineligible|1|||
146192828|NCT01362491|527217706|FG001|Overall Study|Ineligible|0|||
146192829|NCT01362491|527217707|FG002|Overall Study|Ineligible|0|||
146192830|NCT01257503|527217708|FG000|Overall Study|Lost to Follow-up|7|||
146192831|NCT01257503|527217709|FG001|Overall Study|Lost to Follow-up|10|||
146192832|NCT01257503|527217708|FG000|Overall Study|Over 5 years old at enrollment|0|||
146192833|NCT01257503|527217709|FG001|Overall Study|Over 5 years old at enrollment|1|||
146192834|NCT01257503|527217708|FG000|Overall Study|strep culture positive at enrollment|1|||
146192835|NCT01257503|527217709|FG001|Overall Study|strep culture positive at enrollment|0|||
146192836|NCT01720043|527217713|FG000|Overall Study|Withdrawal by Subject|1|||
146192837|NCT04381494|527217715|FG000|Overall Study|Early termination of trial|19|||
146192838|NCT04381494|527217715|FG000|Overall Study|Investigator's discretion|1|||
146192839|NCT04381494|527217715|FG000|Overall Study|Withdrawal by Subject|9|||
146192840|NCT04381494|527217715|FG000|Overall Study|NSCLC disease progression|4|||
146192841|NCT04381494|527217715|FG000|Overall Study|Device-Related Adverse Event|2|||
146192842|NCT01941316|527217721|FG000|Overall Study|Adverse Event|0|||
146192843|NCT01941316|527217722|FG001|Overall Study|Adverse Event|1|||
146192844|NCT01941316|527217723|FG002|Overall Study|Adverse Event|0|||
146192845|NCT01941316|527217724|FG003|Overall Study|Adverse Event|7|||
146192846|NCT01941316|527217721|FG000|Overall Study|Progressive Disease|3|||
146192847|NCT01941316|527217722|FG001|Overall Study|Progressive Disease|6|||
146192848|NCT01941316|527217723|FG002|Overall Study|Progressive Disease|2|||
146192849|NCT01941316|527217724|FG003|Overall Study|Progressive Disease|29|||
146192850|NCT01941316|527217721|FG000|Overall Study|Withdrawal by Subject|0|||
146192851|NCT01941316|527217722|FG001|Overall Study|Withdrawal by Subject|2|||
146192852|NCT01941316|527217723|FG002|Overall Study|Withdrawal by Subject|1|||
146192853|NCT01941316|527217724|FG003|Overall Study|Withdrawal by Subject|8|||
146413628|NCT00829413|528019714|FG000|Overall Study|No truth standard procedure available|9|||
146413629|NCT00829413|528019714|FG000|Overall Study|Technically inadequate truth standard|2|||
146413630|NCT00829413|528019714|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
146413631|NCT04272775|528019716|FG000|Overall Study|Study Terminated by Sponsor|1|||
146413632|NCT04272775|528019717|FG001|Overall Study|Study Terminated by Sponsor|0|||
146413633|NCT04272775|528019716|FG000|Overall Study|Protocol Violation|0|||
146413634|NCT04272775|528019717|FG001|Overall Study|Protocol Violation|1|||
146413635|NCT04272775|528019716|FG000|Overall Study|Symptomatic Deterioration|1|||
146192854|NCT01941316|527217721|FG000|Overall Study|Death|0|||
146413636|NCT04272775|528019717|FG001|Overall Study|Symptomatic Deterioration|1|||
146413637|NCT04272775|528019716|FG000|Overall Study|Withdrawal by Subject|1|||
146413638|NCT04272775|528019717|FG001|Overall Study|Withdrawal by Subject|2|||
146413639|NCT04272775|528019716|FG000|Overall Study|Adverse Event|1|||
146413640|NCT04272775|528019717|FG001|Overall Study|Adverse Event|2|||
146413641|NCT04272775|528019716|FG000|Overall Study|Progressive Disease|3|||
146413642|NCT04272775|528019717|FG001|Overall Study|Progressive Disease|1|||
146413643|NCT00738673|528019718|FG000|Overall Study|Adverse Event|1|||
146413644|NCT00738673|528019719|FG001|Overall Study|Adverse Event|0|||
146413645|NCT00738673|528019718|FG000|Overall Study|Lack of Efficacy|19|||
146413646|NCT00738673|528019719|FG001|Overall Study|Lack of Efficacy|8|||
146413647|NCT00738673|528019718|FG000|Overall Study|Protocol Violation|1|||
146413648|NCT00738673|528019719|FG001|Overall Study|Protocol Violation|2|||
146413649|NCT00738673|528019718|FG000|Overall Study|Withdrawal by Subject|3|||
146413650|NCT00738673|528019719|FG001|Overall Study|Withdrawal by Subject|1|||
146413651|NCT01967888|528019720|FG000|Overall Study|Lost to Follow-up|6|||
146413652|NCT01967888|528019721|FG001|Overall Study|Lost to Follow-up|4|||
146413653|NCT01967888|528019720|FG000|Overall Study|Withdrawal by Subject|1|||
146413654|NCT01967888|528019721|FG001|Overall Study|Withdrawal by Subject|1|||
146413655|NCT01967888|528019720|FG000|Overall Study|Did Not Have Transplant|1|||
146413656|NCT01967888|528019721|FG001|Overall Study|Did Not Have Transplant|0|||
146413657|NCT01967888|528019720|FG000|Overall Study|Research visit not done, data recorded|1|||
146413658|NCT01967888|528019721|FG001|Overall Study|Research visit not done, data recorded|0|||
146413659|NCT01967888|528019720|FG000|Overall Study|Subject excluded after randomization|1|||
146413660|NCT01967888|528019721|FG001|Overall Study|Subject excluded after randomization|0|||
146413661|NCT01967888|528019720|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
146413662|NCT01967888|528019721|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
146413663|NCT01967888|528019720|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
146413664|NCT01967888|528019721|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
146413665|NCT00891774|528019722|FG000|Overall Study|Lost to Follow-up|5|||
146413666|NCT00891774|528019722|FG000|Overall Study|Illness (Self/Mother)|3|||
146413667|NCT00891774|528019722|FG000|Overall Study|Withdrawal by Subject|2|||
146413668|NCT00891774|528019722|FG000|Overall Study|Protocol Violation|4|||
146413669|NCT03175120|528019724|FG000|Overall Study|Adverse Event|2|||
146413670|NCT03175120|528019725|FG001|Overall Study|Adverse Event|2|||
146413671|NCT03175120|528019724|FG000|Overall Study|Protocol Violation|5|||
146413672|NCT03175120|528019725|FG001|Overall Study|Protocol Violation|2|||
146413673|NCT03175120|528019724|FG000|Overall Study|Lost to Follow-up|1|||
146413674|NCT03175120|528019725|FG001|Overall Study|Lost to Follow-up|0|||
146413675|NCT03175120|528019724|FG000|Overall Study|Withdrawal by Subject|2|||
146413676|NCT03175120|528019725|FG001|Overall Study|Withdrawal by Subject|5|||
146413677|NCT03175120|528019724|FG000|Overall Study|Other|2|||
146413678|NCT03175120|528019725|FG001|Overall Study|Other|3|||
146413679|NCT01894984|528019729|FG000|Overall Study|Other|314|||
146413680|NCT01894984|528019730|FG001|Overall Study|Other|175|||
146413681|NCT00827359|528019731|FG000|Overall Study|Progressive Diseas|19|||
146413682|NCT00827359|528019731|FG000|Overall Study|Unacceptable Toxicity|5|||
146413683|NCT00827359|528019731|FG000|Overall Study|Ineligible|1|||
146413684|NCT00323609|528019732|FG000|Overall Study|Death|16|||
146192855|NCT01941316|527217722|FG001|Overall Study|Death|0|||
146192856|NCT01941316|527217723|FG002|Overall Study|Death|0|||
146413685|NCT00323609|528019733|FG001|Overall Study|Death|21|||
146413686|NCT00323609|528019734|FG002|Overall Study|Death|0|||
146413687|NCT00323609|528019735|FG003|Overall Study|Death|0|||
146413688|NCT00323609|528019732|FG000|Overall Study|Lost to Follow-up|9|||
146413689|NCT00323609|528019733|FG001|Overall Study|Lost to Follow-up|10|||
146413690|NCT00323609|528019734|FG002|Overall Study|Lost to Follow-up|0|||
146192857|NCT01941316|527217724|FG003|Overall Study|Death|3|||
146192858|NCT01941316|527217721|FG000|Overall Study|Physician Decision|0|||
146413691|NCT00323609|528019735|FG003|Overall Study|Lost to Follow-up|0|||
146413692|NCT00323609|528019732|FG000|Overall Study|Physician Decision|2|||
146413693|NCT00323609|528019733|FG001|Overall Study|Physician Decision|0|||
146413694|NCT00323609|528019734|FG002|Overall Study|Physician Decision|0|||
146413695|NCT00323609|528019735|FG003|Overall Study|Physician Decision|1|||
146413696|NCT00323609|528019732|FG000|Overall Study|Withdrawal by Subject|11|||
146082159|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
146082160|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
146413697|NCT00323609|528019733|FG001|Overall Study|Withdrawal by Subject|23|||
146082161|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
146082162|NCT01227824|526820604|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
146082163|NCT01227824|526820605|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
146082164|NCT01227824|526820606|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
146082165|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
146082166|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
146082167|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
146082168|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
146082169|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
146082170|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
146082171|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
146082172|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
146082173|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
146082174|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
146082175|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
146082176|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
146082177|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
146082178|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
146082179|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
146082180|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
146082181|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
146082182|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
146082183|NCT01227824|526820604|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
146082184|NCT01227824|526820605|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
146082185|NCT01227824|526820606|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
146082186|NCT00781885|526820607|FG000|Overall Study|Physician Decision|1|||
146082187|NCT02576145|526820608|FG000|Overall Study|Adverse Event|1|||
146082188|NCT02576145|526820609|FG001|Overall Study|Adverse Event|0|||
146082189|NCT02576145|526820608|FG000|Overall Study|Withdrawal by Subject|1|||
146082190|NCT02576145|526820609|FG001|Overall Study|Withdrawal by Subject|0|||
146082191|NCT02576145|526820608|FG000|Overall Study|Acute rejection|1|||
146082192|NCT02576145|526820609|FG001|Overall Study|Acute rejection|0|||
146082193|NCT02576145|526820608|FG000|Overall Study|Tetanus Titers Decreased|0|||
146082194|NCT02576145|526820609|FG001|Overall Study|Tetanus Titers Decreased|1|||
146082195|NCT01755026|526820610|FG000|Overall Study|Adverse Event|1|||
146082196|NCT01755026|526820611|FG001|Overall Study|Adverse Event|0|||
146082197|NCT01755026|526820610|FG000|Overall Study|Withdrawal by Subject|1|||
146082198|NCT01755026|526820611|FG001|Overall Study|Withdrawal by Subject|1|||
146082199|NCT01700387|526820614|FG000|Overall Study|Withdrawal by Subject|1|||
146082200|NCT01700387|526820615|FG001|Overall Study|Withdrawal by Subject|2|||
146082201|NCT01700387|526820614|FG000|Overall Study|Adverse Event|1|||
146082202|NCT01700387|526820615|FG001|Overall Study|Adverse Event|1|||
146082203|NCT01700387|526820614|FG000|Overall Study|Lost to Follow-up|2|||
146082204|NCT01700387|526820615|FG001|Overall Study|Lost to Follow-up|1|||
146082205|NCT02730793|526820623|FG000|Overall Study|Physician Decision|0|||
146082206|NCT02730793|526820624|FG001|Overall Study|Physician Decision|1|||
146082207|NCT02730793|526820623|FG000|Overall Study|Withdrawal by Subject|0|||
146082208|NCT02730793|526820624|FG001|Overall Study|Withdrawal by Subject|1|||
146082209|NCT02365233|526820625|FG000|Overall Study|IRB withheld the data|1|||
146082210|NCT02365233|526820626|FG001|Overall Study|IRB withheld the data|2|||
146082211|NCT02365233|526820627|FG002|Overall Study|IRB withheld the data|2|||
146082212|NCT00995566|526820628|FG000|Overall Study|Adverse Event|2|||
146082213|NCT00995566|526820628|FG000|Overall Study|Early study termination|52|||
146082214|NCT03678870|526820629|FG000|Overall Study|prescribed non- protocol medications|10|||
146413698|NCT00323609|528019734|FG002|Overall Study|Withdrawal by Subject|4|||
146413699|NCT00323609|528019735|FG003|Overall Study|Withdrawal by Subject|4|||
146413700|NCT00323609|528019732|FG000|Overall Study|Other non-VCF-related medical condition|3|||
146413701|NCT00323609|528019733|FG001|Overall Study|Other non-VCF-related medical condition|2|||
146413702|NCT00323609|528019734|FG002|Overall Study|Other non-VCF-related medical condition|0|||
146413703|NCT00323609|528019735|FG003|Overall Study|Other non-VCF-related medical condition|0|||
146413704|NCT00323609|528019732|FG000|Overall Study|Sponsor discontinued trial|29|||
146413705|NCT00323609|528019733|FG001|Overall Study|Sponsor discontinued trial|29|||
146413706|NCT00323609|528019734|FG002|Overall Study|Sponsor discontinued trial|0|||
146413707|NCT00323609|528019735|FG003|Overall Study|Sponsor discontinued trial|0|||
146413708|NCT00323609|528019732|FG000|Overall Study|Unrelenting or severe back pain|1|||
146413709|NCT00323609|528019733|FG001|Overall Study|Unrelenting or severe back pain|1|||
146413710|NCT00323609|528019734|FG002|Overall Study|Unrelenting or severe back pain|0|||
146413711|NCT00323609|528019735|FG003|Overall Study|Unrelenting or severe back pain|0|||
146413712|NCT00323609|528019732|FG000|Overall Study|Logistical withdrawal|9|||
146192859|NCT01941316|527217722|FG001|Overall Study|Physician Decision|0|||
146192860|NCT01941316|527217723|FG002|Overall Study|Physician Decision|0|||
146192861|NCT01941316|527217724|FG003|Overall Study|Physician Decision|3|||
146192862|NCT01941316|527217721|FG000|Overall Study|Protocol Violation|0|||
146192863|NCT01941316|527217722|FG001|Overall Study|Protocol Violation|0|||
146192864|NCT01941316|527217723|FG002|Overall Study|Protocol Violation|0|||
146192865|NCT01941316|527217724|FG003|Overall Study|Protocol Violation|3|||
146192866|NCT01941316|527217721|FG000|Overall Study|Intercurrent illness|0|||
146192867|NCT01941316|527217722|FG001|Overall Study|Intercurrent illness|0|||
146192868|NCT01941316|527217723|FG002|Overall Study|Intercurrent illness|0|||
146192869|NCT01941316|527217724|FG003|Overall Study|Intercurrent illness|1|||
146192870|NCT01941316|527217721|FG000|Overall Study|Other, not specified|0|||
146192871|NCT01941316|527217722|FG001|Overall Study|Other, not specified|0|||
146192872|NCT01941316|527217723|FG002|Overall Study|Other, not specified|0|||
146192873|NCT01941316|527217724|FG003|Overall Study|Other, not specified|1|||
146192874|NCT02775435|527217725|FG000|Overall Study|Adverse Event|32|||
146192875|NCT02775435|527217726|FG001|Overall Study|Adverse Event|27|||
146192876|NCT02775435|527217725|FG000|Overall Study|Lost to Follow-up|2|||
146192877|NCT02775435|527217726|FG001|Overall Study|Lost to Follow-up|2|||
146192878|NCT02775435|527217725|FG000|Overall Study|Sponsor decision|44|||
146192879|NCT02775435|527217726|FG001|Overall Study|Sponsor decision|19|||
146192880|NCT02775435|527217725|FG000|Overall Study|Withdrawal by Subject|4|||
146413713|NCT00323609|528019733|FG001|Overall Study|Logistical withdrawal|5|||
146413714|NCT00323609|528019734|FG002|Overall Study|Logistical withdrawal|0|||
146413715|NCT00323609|528019735|FG003|Overall Study|Logistical withdrawal|1|||
146413716|NCT00323609|528019732|FG000|Overall Study|Other reason|11|||
146413717|NCT00323609|528019733|FG001|Overall Study|Other reason|8|||
146413718|NCT00323609|528019734|FG002|Overall Study|Other reason|4|||
146413719|NCT00323609|528019735|FG003|Overall Study|Other reason|9|||
146413720|NCT01612156|528019739|FG000|Overall Study|Protocol Violation|2|||
146413721|NCT01612156|528019740|FG001|Overall Study|Protocol Violation|0|||
146413722|NCT01141283|528019741|FG000|Overall Study|Adverse Event|56|||
146413723|NCT01141283|528019741|FG000|Overall Study|Lost to Follow-up|4|||
146413724|NCT01141283|528019741|FG000|Overall Study|Withdrawal by Subject|14|||
146413725|NCT01141283|528019741|FG000|Overall Study|Administrative|4|||
146413726|NCT01141283|528019741|FG000|Overall Study|Lack of Efficacy|10|||
146413727|NCT02124746|528019744|FG000|Overall Study|Adverse Event|2|||
146413728|NCT02124746|528019745|FG001|Overall Study|Adverse Event|1|||
146413729|NCT02124746|528019746|FG002|Overall Study|Adverse Event|2|||
146413730|NCT02124746|528019744|FG000|Overall Study|Death|2|||
146413731|NCT02124746|528019745|FG001|Overall Study|Death|1|||
146413732|NCT02124746|528019746|FG002|Overall Study|Death|3|||
146284508|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
146284509|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
146284510|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
146284511|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
146284512|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
146284513|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
146413733|NCT02124746|528019744|FG000|Overall Study|Lack of Efficacy|3|||
146192881|NCT02775435|527217726|FG001|Overall Study|Withdrawal by Subject|9|||
146192882|NCT02775435|527217725|FG000|Overall Study|Death|196|||
146284514|NCT01285609|527553740|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
146413734|NCT02124746|528019745|FG001|Overall Study|Lack of Efficacy|2|||
146413735|NCT02124746|528019746|FG002|Overall Study|Lack of Efficacy|2|||
146413736|NCT02124746|528019744|FG000|Overall Study|Physician Decision|6|||
146413737|NCT02124746|528019745|FG001|Overall Study|Physician Decision|4|||
146413738|NCT02124746|528019746|FG002|Overall Study|Physician Decision|5|||
146192883|NCT02775435|527217726|FG001|Overall Study|Death|224|||
146192884|NCT04555044|527217729|FG000|Overall Study|Adverse Event|0|||
146192885|NCT04555044|527217730|FG001|Overall Study|Adverse Event|1|||
146192886|NCT04939428|527217732|FG000|Overall Study|Death|0|||
146192887|NCT04939428|527217733|FG001|Overall Study|Death|1|||
146192888|NCT04939428|527217734|FG002|Overall Study|Death|0|||
146192889|NCT04939428|527217732|FG000|Overall Study|Lost to Follow-up|0|||
146192890|NCT04939428|527217733|FG001|Overall Study|Lost to Follow-up|5|||
146192891|NCT04939428|527217734|FG002|Overall Study|Lost to Follow-up|0|||
146192892|NCT04939428|527217732|FG000|Overall Study|Physician Decision|1|||
146192893|NCT04939428|527217733|FG001|Overall Study|Physician Decision|0|||
146192894|NCT04939428|527217734|FG002|Overall Study|Physician Decision|0|||
146192895|NCT04939428|527217732|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146192896|NCT04939428|527217733|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146192897|NCT04939428|527217734|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146192898|NCT04939428|527217732|FG000|Overall Study|Withdrawal by Subject|10|||
146192899|NCT04939428|527217733|FG001|Overall Study|Withdrawal by Subject|11|||
146192900|NCT04939428|527217734|FG002|Overall Study|Withdrawal by Subject|0|||
146192901|NCT04939428|527217732|FG000|Overall Study|Unkown|6|||
146192902|NCT04939428|527217733|FG001|Overall Study|Unkown|3|||
146192903|NCT04939428|527217734|FG002|Overall Study|Unkown|0|||
146192904|NCT04939428|527217732|FG000|Overall Study|Discotinued per protocol|0|||
146192905|NCT04939428|527217733|FG001|Overall Study|Discotinued per protocol|0|||
146192906|NCT04939428|527217734|FG002|Overall Study|Discotinued per protocol|902|||
146192907|NCT00654238|527217735|FG000|Overall Study|Screen Failures|4|||
146192908|NCT03424239|527217736|FG000|Overall Study|Withdrawal by Subject|2|||
146192909|NCT00770211|527217737|FG000|Overall Study|Lost to Follow-up|1|||
146192910|NCT00770211|527217738|FG001|Overall Study|Lost to Follow-up|0|||
146192911|NCT00770211|527217737|FG000|Overall Study|Withdrawal by Subject|0|||
146192912|NCT00770211|527217738|FG001|Overall Study|Withdrawal by Subject|2|||
146192913|NCT00318656|527217739|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
146192914|NCT00318656|527217740|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
146192915|NCT00318656|527217739|FG000|Overall Study|Did not receive any treatment|0|||
146192916|NCT00318656|527217740|FG001|Overall Study|Did not receive any treatment|1|||
146192917|NCT03905135|527217742|FG000|Dose Escalation|Adverse Event|1|||
146192918|NCT03905135|527217743|FG001|Dose Escalation|Adverse Event|1|||
146192919|NCT03905135|527217742|FG000|Dose Escalation|Progressive disease|3|||
146192920|NCT03905135|527217743|FG001|Dose Escalation|Progressive disease|1|||
146192921|NCT03905135|527217742|FG000|Dose Escalation|Intercurrent illness|1|||
146192922|NCT03905135|527217743|FG001|Dose Escalation|Intercurrent illness|0|||
146192923|NCT02042443|527217746|FG000|Overall Study|Adverse Event|2|||
146192924|NCT02042443|527217747|FG001|Overall Study|Adverse Event|1|||
146192925|NCT02042443|527217746|FG000|Overall Study|Withdrawal by Subject|0|||
146192926|NCT02042443|527217747|FG001|Overall Study|Withdrawal by Subject|1|||
146192927|NCT02042443|527217746|FG000|Overall Study|Progression|21|||
146192928|NCT02042443|527217747|FG001|Overall Study|Progression|17|||
146192929|NCT02042443|527217746|FG000|Overall Study|not protocol specified|1|||
146192930|NCT02042443|527217747|FG001|Overall Study|not protocol specified|1|||
146192931|NCT02042443|527217746|FG000|Overall Study|Not eligible/not analyzable|3|||
146192932|NCT02042443|527217747|FG001|Overall Study|Not eligible/not analyzable|6|||
146192933|NCT01007149|527217750|FG000|Overall Study|Administrative problems|0|||
146192934|NCT01007149|527217751|FG001|Overall Study|Administrative problems|1|||
146192935|NCT02784704|527217752|FG000|Overall Study|Adverse Event|4|||
146192936|NCT02784704|527217753|FG001|Overall Study|Adverse Event|2|||
146192937|NCT02784704|527217752|FG000|Overall Study|Lost to Follow-up|6|||
146192938|NCT02784704|527217753|FG001|Overall Study|Lost to Follow-up|4|||
146192939|NCT02784704|527217752|FG000|Overall Study|Withdrawal by Subject|1|||
146192940|NCT02784704|527217753|FG001|Overall Study|Withdrawal by Subject|3|||
146192941|NCT02784704|527217752|FG000|Overall Study|Subject Non Compliance|2|||
146192942|NCT02784704|527217753|FG001|Overall Study|Subject Non Compliance|0|||
146192943|NCT01913340|527217754|FG000|Overall Study|Death|2|||
146192944|NCT01913340|527217755|FG001|Overall Study|Death|5|||
145947692|NCT02117713|526317285|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
146192945|NCT01913340|527217754|FG000|Overall Study|Lost to Follow-up|1|||
146192946|NCT01913340|527217755|FG001|Overall Study|Lost to Follow-up|1|||
146192947|NCT05096884|527217757|FG000|Overall Study|Excluded based on negative tilt table test|4|||
145947693|NCT02117713|526317285|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
145947694|NCT01094782|526317286|FG000|Overall Study|Withdrawal by Subject|5|||
146192948|NCT03568162|527217758|FG000|Overall Study|Adverse Event|0|||
146192949|NCT03568162|527217759|FG001|Overall Study|Adverse Event|1|||
146192950|NCT03568162|527217760|FG002|Overall Study|Adverse Event|2|||
146413739|NCT02124746|528019744|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146413740|NCT02124746|528019745|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146192951|NCT03568162|527217761|FG003|Overall Study|Adverse Event|0|||
146192952|NCT03568162|527217762|FG004|Overall Study|Adverse Event|0|||
146192953|NCT03568162|527217763|FG005|Overall Study|Adverse Event|1|||
146192954|NCT03568162|527217758|FG000|Overall Study|Death|0|||
146192955|NCT03568162|527217759|FG001|Overall Study|Death|0|||
146192956|NCT03568162|527217760|FG002|Overall Study|Death|0|||
146192957|NCT03568162|527217761|FG003|Overall Study|Death|0|||
146192958|NCT03568162|527217762|FG004|Overall Study|Death|1|||
145947695|NCT01094782|526317287|FG001|Overall Study|Withdrawal by Subject|5|||
145947696|NCT01094782|526317288|FG002|Overall Study|Withdrawal by Subject|1|||
145947697|NCT01094782|526317289|FG003|Overall Study|Withdrawal by Subject|5|||
145947698|NCT01094782|526317290|FG004|Overall Study|Withdrawal by Subject|5|||
145947699|NCT01094782|526317291|FG005|Overall Study|Withdrawal by Subject|0|||
146413741|NCT02124746|528019746|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145947700|NCT01094782|526317286|FG000|Overall Study|Lost to Follow-up|1|||
145947701|NCT01094782|526317287|FG001|Overall Study|Lost to Follow-up|0|||
145947702|NCT01094782|526317288|FG002|Overall Study|Lost to Follow-up|0|||
145947703|NCT01094782|526317289|FG003|Overall Study|Lost to Follow-up|2|||
145947704|NCT01094782|526317290|FG004|Overall Study|Lost to Follow-up|1|||
145947705|NCT01094782|526317291|FG005|Overall Study|Lost to Follow-up|4|||
145947706|NCT01094782|526317286|FG000|Overall Study|Positive Drug Screen|2|||
145947707|NCT01094782|526317287|FG001|Overall Study|Positive Drug Screen|2|||
145947708|NCT01094782|526317288|FG002|Overall Study|Positive Drug Screen|1|||
145947709|NCT01094782|526317289|FG003|Overall Study|Positive Drug Screen|1|||
145947710|NCT01094782|526317290|FG004|Overall Study|Positive Drug Screen|3|||
146413742|NCT02124746|528019744|FG000|Overall Study|Withdrawal by Subject|3|||
146413743|NCT02124746|528019745|FG001|Overall Study|Withdrawal by Subject|3|||
145947711|NCT01094782|526317291|FG005|Overall Study|Positive Drug Screen|2|||
146082215|NCT03678870|526820630|FG001|Overall Study|prescribed non- protocol medications|6|||
145947712|NCT01094782|526317286|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
145947713|NCT01094782|526317287|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
146082216|NCT03678870|526820629|FG000|Overall Study|Lost to Follow-up|3|||
146082217|NCT03678870|526820630|FG001|Overall Study|Lost to Follow-up|2|||
146082218|NCT01454778|526820631|FG000|Overall Study|Lost to Follow-up|2|||
146082219|NCT01454778|526820631|FG000|Overall Study|Death|1|||
146082220|NCT00348881|526820632|FG000|Overall Study|Lost to Follow-up|12|||
146082221|NCT00348881|526820633|FG001|Overall Study|Lost to Follow-up|6|||
146082222|NCT00348881|526820632|FG000|Overall Study|Withdrawal by Subject|3|||
146082223|NCT00348881|526820633|FG001|Overall Study|Withdrawal by Subject|4|||
146082224|NCT00348881|526820632|FG000|Overall Study|Adverse Event|2|||
146082225|NCT00348881|526820633|FG001|Overall Study|Adverse Event|0|||
146082226|NCT00348881|526820632|FG000|Overall Study|Serious Adverse Event|0|||
146082227|NCT00348881|526820633|FG001|Overall Study|Serious Adverse Event|2|||
146082228|NCT01981551|526820640|FG000|Overall Study|Refused further treatment|8|||
146082229|NCT01981551|526820640|FG000|Overall Study|Adverse Event|1|||
146082230|NCT02880956|526820641|FG000|Overall Study|Adverse Event|3|||
146082231|NCT02880956|526820642|FG001|Overall Study|Adverse Event|6|||
146082232|NCT02880956|526820643|FG002|Overall Study|Adverse Event|5|||
146082233|NCT02880956|526820644|FG003|Overall Study|Adverse Event|4|||
146082234|NCT02880956|526820641|FG000|Overall Study|Withdrawal by Subject|9|||
146082235|NCT02880956|526820642|FG001|Overall Study|Withdrawal by Subject|4|||
146082236|NCT02880956|526820643|FG002|Overall Study|Withdrawal by Subject|6|||
146082237|NCT02880956|526820644|FG003|Overall Study|Withdrawal by Subject|11|||
146082238|NCT02880956|526820641|FG000|Overall Study|Lost to Follow-up|0|||
146082239|NCT02880956|526820642|FG001|Overall Study|Lost to Follow-up|1|||
146082240|NCT02880956|526820643|FG002|Overall Study|Lost to Follow-up|0|||
146082241|NCT02880956|526820644|FG003|Overall Study|Lost to Follow-up|0|||
146082242|NCT02880956|526820641|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146082243|NCT02880956|526820642|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
146082244|NCT02880956|526820643|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146082245|NCT02880956|526820644|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
146082246|NCT02880956|526820641|FG000|Overall Study|Other, Not Specified|4|||
146082247|NCT02880956|526820642|FG001|Overall Study|Other, Not Specified|2|||
146082248|NCT02880956|526820643|FG002|Overall Study|Other, Not Specified|0|||
146082249|NCT02880956|526820644|FG003|Overall Study|Other, Not Specified|3|||
146082250|NCT00393510|526822746|FG000|Overall Study|Physician Decision|3|||
146082251|NCT00393510|526822747|FG001|Overall Study|Physician Decision|9|||
146082252|NCT03077087|526822750|FG000|Overall Study|Physician Decision|2|||
146082253|NCT00770146|526822751|FG000|Treatment Period|Withdrawal by Subject|6|||
146082254|NCT00770146|526822752|FG001|Treatment Period|Withdrawal by Subject|13|||
146082255|NCT00770146|526822751|FG000|Treatment Period|Adverse Event|2|||
146082256|NCT00770146|526822752|FG001|Treatment Period|Adverse Event|26|||
146082257|NCT00770146|526822751|FG000|Treatment Period|Other|1|||
146082258|NCT00770146|526822752|FG001|Treatment Period|Other|5|||
146082259|NCT00770146|526822751|FG000|Treatment Period|Protocol non-compliance|0|||
146082260|NCT00770146|526822752|FG001|Treatment Period|Protocol non-compliance|1|||
146082261|NCT00770146|526822751|FG000|Follow-up Period|Withdrawal by Subject|7|||
146082262|NCT00770146|526822752|FG001|Follow-up Period|Withdrawal by Subject|13|||
146082263|NCT00770146|526822751|FG000|Follow-up Period|Adverse Event|0|||
146082264|NCT00770146|526822752|FG001|Follow-up Period|Adverse Event|2|||
146082265|NCT00770146|526822751|FG000|Follow-up Period|Other|4|||
146082266|NCT00770146|526822752|FG001|Follow-up Period|Other|5|||
146082267|NCT02412488|526822755|FG000|Overall Study|Lost to Follow-up|10|||
146082268|NCT02412488|526822755|FG000|Overall Study|Withdrawal by Subject|5|||
146413744|NCT02124746|528019746|FG002|Overall Study|Withdrawal by Subject|0|||
146413745|NCT02124746|528019744|FG000|Overall Study|Study Terminated by Sponsor|0|||
146413746|NCT02124746|528019745|FG001|Overall Study|Study Terminated by Sponsor|0|||
146413747|NCT02124746|528019746|FG002|Overall Study|Study Terminated by Sponsor|6|||
146413748|NCT02124746|528019744|FG000|Overall Study|Disease Progression|3|||
146413749|NCT02124746|528019745|FG001|Overall Study|Disease Progression|6|||
146413750|NCT02124746|528019746|FG002|Overall Study|Disease Progression|4|||
146413751|NCT02868281|528019749|FG000|Overall Study|Adverse Event|2|||
146413752|NCT02868281|528019750|FG001|Overall Study|Adverse Event|2|||
146413753|NCT02868281|528019749|FG000|Overall Study|Protocol Violation|13|||
146413754|NCT02868281|528019750|FG001|Overall Study|Protocol Violation|10|||
146413755|NCT02868281|528019749|FG000|Overall Study|Lost to Follow-up|3|||
146413756|NCT02868281|528019750|FG001|Overall Study|Lost to Follow-up|6|||
146413757|NCT02868281|528019749|FG000|Overall Study|Withdrawal by Subject|11|||
146413758|NCT02868281|528019750|FG001|Overall Study|Withdrawal by Subject|15|||
146413759|NCT02868281|528019749|FG000|Overall Study|Physician Decision|2|||
146413760|NCT02868281|528019750|FG001|Overall Study|Physician Decision|0|||
146413761|NCT02868281|528019749|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
146413762|NCT02868281|528019750|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
146413763|NCT02868281|528019749|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
146413764|NCT02868281|528019750|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
146413765|NCT02868281|528019749|FG000|Overall Study|Long journey/moving away|1|||
146413766|NCT02868281|528019750|FG001|Overall Study|Long journey/moving away|1|||
146413767|NCT01722266|528019751|FG000|Overall Study|Withdrawal by Subject|1|||
146413768|NCT01722266|528019752|FG001|Overall Study|Withdrawal by Subject|2|||
146413769|NCT01722266|528019753|FG002|Overall Study|Withdrawal by Subject|0|||
146413770|NCT01722266|528019754|FG003|Overall Study|Withdrawal by Subject|0|||
146413771|NCT01722266|528019751|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
146413772|NCT01722266|528019752|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
146413773|NCT01722266|528019753|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
146413774|NCT01722266|528019754|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
146413775|NCT01722266|528019751|FG000|Overall Study|Dropped out due to Nausea|0|||
146413776|NCT01722266|528019752|FG001|Overall Study|Dropped out due to Nausea|0|||
146413777|NCT01722266|528019753|FG002|Overall Study|Dropped out due to Nausea|2|||
146413778|NCT01722266|528019754|FG003|Overall Study|Dropped out due to Nausea|0|||
146413779|NCT03811249|528019755|FG000|Overall Study|Withdrawal by Subject|44|||
146413780|NCT03811249|528019755|FG000|Overall Study|Missed Visit|24|||
146413781|NCT01504867|528019759|FG000|Overall Study|Inclusion criteria not met|2|||
146413782|NCT01504867|528019760|FG001|Overall Study|Inclusion criteria not met|2|||
146413783|NCT01504867|528019759|FG000|Overall Study|Consent revoked|5|||
146413784|NCT01504867|528019760|FG001|Overall Study|Consent revoked|1|||
146413785|NCT00571922|528019761|FG000|Overall Study|Completion unknown|36|||
146413786|NCT00571922|528019762|FG001|Overall Study|Completion unknown|36|||
146413787|NCT01783730|528019769|FG000|Overall Study|Failed to meet inclusion criteria|6|||
146413788|NCT02533999|528019770|FG000|Overall Study|Lost to Follow-up|3|||
146413789|NCT02533999|528019771|FG001|Overall Study|Lost to Follow-up|5|||
146413790|NCT02533999|528019770|FG000|Overall Study|Protocol Violation|3|||
146413791|NCT02533999|528019771|FG001|Overall Study|Protocol Violation|0|||
146413792|NCT02533999|528019770|FG000|Overall Study|Adverse Event|0|||
146413793|NCT02533999|528019771|FG001|Overall Study|Adverse Event|1|||
146413794|NCT02533999|528019770|FG000|Overall Study|Randomized but intervention not received|0|||
146413795|NCT02533999|528019771|FG001|Overall Study|Randomized but intervention not received|1|||
146413796|NCT01154153|528019772|FG000|Overall Study|Poor compliance to protocol|2|||
146413797|NCT01154153|528019773|FG001|Overall Study|Poor compliance to protocol|0|||
146413798|NCT01154153|528019772|FG000|Overall Study|Unable to use labs|2|||
146413799|NCT01154153|528019773|FG001|Overall Study|Unable to use labs|3|||
146413800|NCT01154153|528019772|FG000|Overall Study|Withdrew consent|1|||
145947714|NCT01094782|526317288|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
145947715|NCT01094782|526317289|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
146413801|NCT01154153|528019773|FG001|Overall Study|Withdrew consent|0|||
145947716|NCT01094782|526317290|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
146192959|NCT03568162|527217763|FG005|Overall Study|Death|0|||
146192960|NCT03568162|527217758|FG000|Overall Study|Lost to Follow-up|3|||
146413802|NCT04304950|528019780|FG000|Overall Study|Lost to Follow-up|1|||
146413803|NCT04304950|528019781|FG001|Overall Study|Lost to Follow-up|1|||
146413804|NCT00408876|528019782|FG000|Overall Study|Adverse Event|9|||
146413805|NCT00408876|528019783|FG001|Overall Study|Adverse Event|17|||
146413806|NCT00408876|528019784|FG002|Overall Study|Adverse Event|27|||
146413807|NCT00408876|528019785|FG003|Overall Study|Adverse Event|10|||
146413808|NCT00408876|528019782|FG000|Overall Study|Withdrawal by Subject|3|||
146413809|NCT00408876|528019783|FG001|Overall Study|Withdrawal by Subject|6|||
146413810|NCT00408876|528019784|FG002|Overall Study|Withdrawal by Subject|6|||
146413811|NCT00408876|528019785|FG003|Overall Study|Withdrawal by Subject|14|||
146413812|NCT00408876|528019782|FG000|Overall Study|Lack of Efficacy|2|||
146413813|NCT00408876|528019783|FG001|Overall Study|Lack of Efficacy|4|||
146413814|NCT00408876|528019784|FG002|Overall Study|Lack of Efficacy|5|||
146413815|NCT00408876|528019785|FG003|Overall Study|Lack of Efficacy|6|||
146413816|NCT00408876|528019782|FG000|Overall Study|Lost to Follow-up|1|||
146413817|NCT00408876|528019783|FG001|Overall Study|Lost to Follow-up|6|||
146413818|NCT00408876|528019784|FG002|Overall Study|Lost to Follow-up|5|||
146413819|NCT00408876|528019785|FG003|Overall Study|Lost to Follow-up|2|||
146413820|NCT00408876|528019782|FG000|Overall Study|Protocol Violation|0|||
146413821|NCT00408876|528019783|FG001|Overall Study|Protocol Violation|3|||
146413822|NCT00408876|528019784|FG002|Overall Study|Protocol Violation|4|||
146413823|NCT00408876|528019785|FG003|Overall Study|Protocol Violation|3|||
146413824|NCT00408876|528019782|FG000|Overall Study|Physician Decision|1|||
146413825|NCT00408876|528019783|FG001|Overall Study|Physician Decision|0|||
146413826|NCT00408876|528019784|FG002|Overall Study|Physician Decision|3|||
146413827|NCT00408876|528019785|FG003|Overall Study|Physician Decision|0|||
146413828|NCT03404206|528019788|FG000|Overall Study|Withdrawal by Subject|1|||
146413829|NCT03404206|528019789|FG001|Overall Study|Withdrawal by Subject|1|||
146413830|NCT03404206|528019790|FG002|Overall Study|Withdrawal by Subject|0|||
146413831|NCT03404206|528019788|FG000|Overall Study|Lost to Follow-up|3|||
146413832|NCT03404206|528019789|FG001|Overall Study|Lost to Follow-up|1|||
146413833|NCT03404206|528019790|FG002|Overall Study|Lost to Follow-up|0|||
146413834|NCT05478603|528019791|FG000|Overall Study|Withdrawal by Subject|0|||
146413835|NCT05478603|528019792|FG001|Overall Study|Withdrawal by Subject|1|||
146413836|NCT05478603|528019793|FG002|Overall Study|Withdrawal by Subject|0|||
146413837|NCT05478603|528019794|FG003|Overall Study|Withdrawal by Subject|0|||
146413838|NCT00096486|528019795|FG000|Overall Study|Withdrawal by Subject|0|||
146413839|NCT00096486|528019796|FG001|Overall Study|Withdrawal by Subject|0|||
146413840|NCT00096486|528019797|FG002|Overall Study|Withdrawal by Subject|1|||
146413841|NCT00096486|528019798|FG003|Overall Study|Withdrawal by Subject|1|||
146413842|NCT00096486|528019795|FG000|Overall Study|Not Treated|0|||
146413843|NCT00096486|528019796|FG001|Overall Study|Not Treated|0|||
146413844|NCT00096486|528019797|FG002|Overall Study|Not Treated|1|||
146413845|NCT00096486|528019798|FG003|Overall Study|Not Treated|1|||
146413846|NCT01512979|528019799|FG000|Overall Study|Adverse Event|2|||
146413847|NCT01512979|528019800|FG001|Overall Study|Adverse Event|2|||
146413848|NCT01512979|528019799|FG000|Overall Study|Protocol Violation|1|||
146413849|NCT01512979|528019800|FG001|Overall Study|Protocol Violation|4|||
146413850|NCT01512979|528019799|FG000|Overall Study|Lost to Follow-up|2|||
146413851|NCT01512979|528019800|FG001|Overall Study|Lost to Follow-up|5|||
146413852|NCT01512979|528019799|FG000|Overall Study|Withdrawal by Subject|1|||
146413853|NCT01512979|528019800|FG001|Overall Study|Withdrawal by Subject|2|||
146413854|NCT01512979|528019799|FG000|Overall Study|Reason other than stated above|13|||
146413855|NCT01512979|528019800|FG001|Overall Study|Reason other than stated above|9|||
146413856|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
146413857|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
146413858|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
146413859|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
146413860|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
146413861|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
146413862|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
146413863|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
146413864|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
146413865|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
146413866|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
146413867|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
146413868|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
146413869|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
146413870|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
146082269|NCT02412488|526822755|FG000|Overall Study|Physician Decision|1|||
146413871|NCT00529568|528019801|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
146413872|NCT00529568|528019802|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
146413873|NCT00529568|528019803|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
146413874|NCT00529568|528019801|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
146413875|NCT00529568|528019802|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
146413876|NCT00529568|528019803|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
146413877|NCT00529568|528019801|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
146413878|NCT00529568|528019802|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
146413879|NCT00529568|528019803|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
146413880|NCT00529568|528019801|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
146413881|NCT00529568|528019802|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
146413882|NCT00529568|528019803|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
146413883|NCT00529568|528019801|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
146413884|NCT00529568|528019802|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
146413885|NCT00529568|528019803|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
146413886|NCT00529568|528019801|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
146413887|NCT00529568|528019802|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
146413888|NCT00529568|528019803|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
146413889|NCT04049552|528019804|FG000|Overall Study|Lost to Follow-up|1|||
146413890|NCT01201356|528019805|FG000|Overall Study|Adverse Event|170|||
146413891|NCT01201356|528019805|FG000|Overall Study|Abnormal laboratory value(s)|51|||
146413892|NCT01201356|528019805|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146413893|NCT01201356|528019805|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
146413894|NCT01201356|528019805|FG000|Overall Study|Condition no longer requires study drug|12|||
146413895|NCT01201356|528019805|FG000|Overall Study|Withdrawal by Subject|144|||
146413896|NCT01201356|528019805|FG000|Overall Study|Lost to Follow-up|50|||
146413897|NCT01201356|528019805|FG000|Overall Study|administrative problems|74|||
146413898|NCT01201356|528019805|FG000|Overall Study|Death|16|||
146413899|NCT01201356|528019805|FG000|Overall Study|Protocol Violation|12|||
146413900|NCT00738920|528019808|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
146413901|NCT00738920|528019809|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
146413902|NCT00738920|528019810|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
146413903|NCT00738920|528019808|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
146413904|NCT00738920|528019809|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
146413905|NCT00738920|528019810|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
146413906|NCT00738920|528019808|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
146413907|NCT00738920|528019809|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
146413908|NCT00738920|528019810|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
146413909|NCT00738920|528019808|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
146413910|NCT00738920|528019809|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
146413911|NCT00738920|528019810|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
146413912|NCT00738920|528019808|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
146413913|NCT00738920|528019809|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
146413914|NCT00738920|528019810|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
146413915|NCT00738920|528019808|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
146413916|NCT00738920|528019809|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
146413917|NCT00738920|528019810|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
146413918|NCT00738920|528019808|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
146413919|NCT00738920|528019809|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
146413920|NCT00738920|528019810|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
146413921|NCT00738920|528019808|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
146413922|NCT00738920|528019809|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
146413923|NCT00738920|528019810|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
146413924|NCT00738920|528019808|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
146413925|NCT00738920|528019809|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
146413926|NCT00738920|528019810|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
146413927|NCT00738920|528019808|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
146413928|NCT00738920|528019809|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
146413929|NCT00738920|528019810|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
146413930|NCT02046369|528019811|FG000|Overall Study|Adverse Event|3|||
146413931|NCT02046369|528019812|FG001|Overall Study|Adverse Event|3|||
146413932|NCT02046369|528019811|FG000|Overall Study|Lack of Efficacy|3|||
146413933|NCT02046369|528019812|FG001|Overall Study|Lack of Efficacy|3|||
146413934|NCT02046369|528019811|FG000|Overall Study|Lost to Follow-up|3|||
146413935|NCT02046369|528019812|FG001|Overall Study|Lost to Follow-up|3|||
146413936|NCT02046369|528019811|FG000|Overall Study|Protocol Violation|1|||
146192961|NCT03568162|527217759|FG001|Overall Study|Lost to Follow-up|2|||
146192962|NCT03568162|527217760|FG002|Overall Study|Lost to Follow-up|4|||
146192963|NCT03568162|527217761|FG003|Overall Study|Lost to Follow-up|2|||
146192964|NCT03568162|527217762|FG004|Overall Study|Lost to Follow-up|3|||
146192965|NCT03568162|527217763|FG005|Overall Study|Lost to Follow-up|2|||
146192966|NCT03568162|527217758|FG000|Overall Study|Physician Decision|0|||
146192967|NCT03568162|527217759|FG001|Overall Study|Physician Decision|1|||
146192968|NCT03568162|527217760|FG002|Overall Study|Physician Decision|1|||
146192969|NCT03568162|527217761|FG003|Overall Study|Physician Decision|0|||
146192970|NCT03568162|527217762|FG004|Overall Study|Physician Decision|1|||
146192971|NCT03568162|527217763|FG005|Overall Study|Physician Decision|0|||
146192972|NCT03568162|527217758|FG000|Overall Study|Pregnancy|0|||
146192973|NCT03568162|527217759|FG001|Overall Study|Pregnancy|0|||
146192974|NCT03568162|527217760|FG002|Overall Study|Pregnancy|0|||
146413937|NCT02046369|528019812|FG001|Overall Study|Protocol Violation|2|||
146413938|NCT02046369|528019811|FG000|Overall Study|Withdrawal by Subject|3|||
146413939|NCT02046369|528019812|FG001|Overall Study|Withdrawal by Subject|6|||
146413940|NCT02046369|528019811|FG000|Overall Study|never received study drug|0|||
146413941|NCT02046369|528019812|FG001|Overall Study|never received study drug|1|||
146413942|NCT02046369|528019811|FG000|Overall Study|non compliance|1|||
146413943|NCT02046369|528019812|FG001|Overall Study|non compliance|0|||
146413944|NCT02196506|528019813|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
146413945|NCT02196506|528019814|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
146413946|NCT02196506|528019815|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
146413947|NCT02196506|528019816|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
146413948|NCT02196506|528019813|FG000|Phase A|Withdrawal by Subject|34|||
146413949|NCT02196506|528019814|FG001|Phase A|Withdrawal by Subject|0|||
146413950|NCT02196506|528019815|FG002|Phase A|Withdrawal by Subject|0|||
146413951|NCT02196506|528019816|FG003|Phase A|Withdrawal by Subject|0|||
146413952|NCT02196506|528019813|FG000|Phase A|Adverse Event|22|||
146413953|NCT02196506|528019814|FG001|Phase A|Adverse Event|0|||
146413954|NCT02196506|528019815|FG002|Phase A|Adverse Event|0|||
146413955|NCT02196506|528019816|FG003|Phase A|Adverse Event|0|||
146413956|NCT02196506|528019813|FG000|Phase A|Lost to Follow-up|9|||
146413957|NCT02196506|528019814|FG001|Phase A|Lost to Follow-up|0|||
146413958|NCT02196506|528019815|FG002|Phase A|Lost to Follow-up|0|||
146413959|NCT02196506|528019816|FG003|Phase A|Lost to Follow-up|0|||
146413960|NCT02196506|528019813|FG000|Phase A|Protocol deviation|12|||
146413961|NCT02196506|528019814|FG001|Phase A|Protocol deviation|0|||
146413962|NCT02196506|528019815|FG002|Phase A|Protocol deviation|0|||
146413963|NCT02196506|528019816|FG003|Phase A|Protocol deviation|0|||
146413964|NCT02196506|528019813|FG000|Phase A|Participant withdrawn by investigator|10|||
146413965|NCT02196506|528019814|FG001|Phase A|Participant withdrawn by investigator|0|||
146413966|NCT02196506|528019815|FG002|Phase A|Participant withdrawn by investigator|0|||
146413967|NCT02196506|528019816|FG003|Phase A|Participant withdrawn by investigator|0|||
146413968|NCT02196506|528019813|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
146413969|NCT02196506|528019814|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
146413970|NCT02196506|528019815|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
146413971|NCT02196506|528019816|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
146413972|NCT02196506|528019813|FG000|Phase B|Lack of Efficacy|0|||
146413973|NCT02196506|528019814|FG001|Phase B|Lack of Efficacy|1|||
146413974|NCT02196506|528019815|FG002|Phase B|Lack of Efficacy|2|||
146413975|NCT02196506|528019816|FG003|Phase B|Lack of Efficacy|0|||
146413976|NCT02196506|528019813|FG000|Phase B|Withdrawal by Participant|0|||
146413977|NCT02196506|528019814|FG001|Phase B|Withdrawal by Participant|8|||
146413978|NCT02196506|528019815|FG002|Phase B|Withdrawal by Participant|1|||
146413979|NCT02196506|528019816|FG003|Phase B|Withdrawal by Participant|0|||
146413980|NCT02196506|528019813|FG000|Phase B|Adverse Event|0|||
146413981|NCT02196506|528019814|FG001|Phase B|Adverse Event|4|||
146413982|NCT02196506|528019815|FG002|Phase B|Adverse Event|1|||
146413983|NCT02196506|528019816|FG003|Phase B|Adverse Event|0|||
146413984|NCT02196506|528019813|FG000|Phase B|Lost to Follow-up|0|||
146413985|NCT02196506|528019814|FG001|Phase B|Lost to Follow-up|2|||
146413986|NCT02196506|528019815|FG002|Phase B|Lost to Follow-up|1|||
146413987|NCT02196506|528019816|FG003|Phase B|Lost to Follow-up|0|||
146413988|NCT02196506|528019813|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
146413989|NCT02196506|528019814|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
146413990|NCT02196506|528019815|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
146413991|NCT02196506|528019816|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
146413992|NCT02196506|528019813|FG000|Phase A+|Withdrawal by Participant|0|||
146413993|NCT02196506|528019814|FG001|Phase A+|Withdrawal by Participant|0|||
146413994|NCT02196506|528019815|FG002|Phase A+|Withdrawal by Participant|0|||
146413995|NCT02196506|528019816|FG003|Phase A+|Withdrawal by Participant|5|||
146413996|NCT02196506|528019813|FG000|Phase A+|Adverse Event|0|||
146413997|NCT02196506|528019814|FG001|Phase A+|Adverse Event|0|||
146413998|NCT02196506|528019815|FG002|Phase A+|Adverse Event|0|||
146413999|NCT02196506|528019816|FG003|Phase A+|Adverse Event|1|||
146414000|NCT02196506|528019813|FG000|Phase A+|Lost to Follow-up|0|||
146082270|NCT02412488|526822755|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
146082271|NCT02412488|526822755|FG000|Overall Study|Reveal LINQ explant|1|||
146082272|NCT01989468|526822756|FG000|Overall Study|Adverse Event|10|||
146082273|NCT01989468|526822757|FG001|Overall Study|Adverse Event|15|||
146414001|NCT02196506|528019814|FG001|Phase A+|Lost to Follow-up|0|||
146414002|NCT02196506|528019815|FG002|Phase A+|Lost to Follow-up|0|||
146082274|NCT01989468|526822758|FG002|Overall Study|Adverse Event|4|||
146082275|NCT01989468|526822759|FG003|Overall Study|Adverse Event|5|||
146082276|NCT01989468|526822760|FG004|Overall Study|Adverse Event|4|||
146082277|NCT01989468|526822756|FG000|Overall Study|Lack of Efficacy|11|||
146082278|NCT01989468|526822757|FG001|Overall Study|Lack of Efficacy|11|||
146082279|NCT01989468|526822758|FG002|Overall Study|Lack of Efficacy|7|||
146082280|NCT01989468|526822759|FG003|Overall Study|Lack of Efficacy|4|||
146082281|NCT01989468|526822760|FG004|Overall Study|Lack of Efficacy|2|||
146082282|NCT01989468|526822756|FG000|Overall Study|Lost to Follow-up|5|||
146414003|NCT02196506|528019816|FG003|Phase A+|Lost to Follow-up|6|||
146414004|NCT02196506|528019813|FG000|Phase A+|Participant withdrawn by investigator|0|||
146414005|NCT02196506|528019814|FG001|Phase A+|Participant withdrawn by investigator|0|||
146414006|NCT02196506|528019815|FG002|Phase A+|Participant withdrawn by investigator|0|||
146414007|NCT02196506|528019816|FG003|Phase A+|Participant withdrawn by investigator|1|||
146414008|NCT02257632|528022177|FG000|Overall Study|Withdrawal by Subject|0|||
146414009|NCT02257632|528022178|FG001|Overall Study|Withdrawal by Subject|1|||
146414010|NCT02257632|528022177|FG000|Overall Study|Adverse Event|1|||
146414011|NCT02257632|528022178|FG001|Overall Study|Adverse Event|2|||
146414012|NCT02468557|528022179|FG000|Overall Study|Adverse Event|1|||
146414013|NCT02468557|528022179|FG000|Overall Study|Death|1|||
146414014|NCT02468557|528022179|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
146414015|NCT02468557|528022179|FG000|Overall Study|All Enrolled but Never Dosed|4|||
146414016|NCT03322462|528022183|FG000|Overall Study|Technical difficulties|2|||
146414017|NCT03322462|528022183|FG000|Overall Study|Other|1|||
146414018|NCT01393990|528022184|FG000|Overall Study|Adverse Event|0|||
146414019|NCT01393990|528022185|FG001|Overall Study|Adverse Event|0|||
146414020|NCT01393990|528022186|FG002|Overall Study|Adverse Event|0|||
146414021|NCT01393990|528022187|FG003|Overall Study|Adverse Event|0|||
146414022|NCT01393990|528022188|FG004|Overall Study|Adverse Event|0|||
146414023|NCT01393990|528022189|FG005|Overall Study|Adverse Event|0|||
146414024|NCT01393990|528022190|FG006|Overall Study|Adverse Event|0|||
146414025|NCT01393990|528022191|FG007|Overall Study|Adverse Event|0|||
146414026|NCT01393990|528022192|FG008|Overall Study|Adverse Event|0|||
146414027|NCT01393990|528022193|FG009|Overall Study|Adverse Event|0|||
146414028|NCT01393990|528022194|FG010|Overall Study|Adverse Event|0|||
146414029|NCT01393990|528022195|FG011|Overall Study|Adverse Event|0|||
146414030|NCT01393990|528022196|FG012|Overall Study|Adverse Event|0|||
146414031|NCT01393990|528022197|FG013|Overall Study|Adverse Event|0|||
146414032|NCT01393990|528022198|FG014|Overall Study|Adverse Event|1|||
146414033|NCT01393990|528022199|FG015|Overall Study|Adverse Event|1|||
146414034|NCT01393990|528022200|FG016|Overall Study|Adverse Event|0|||
146414035|NCT01393990|528022201|FG017|Overall Study|Adverse Event|0|||
146414036|NCT01393990|528022184|FG000|Overall Study|Progressive Disease|1|||
146414037|NCT01393990|528022185|FG001|Overall Study|Progressive Disease|0|||
146414038|NCT01393990|528022186|FG002|Overall Study|Progressive Disease|0|||
146414039|NCT01393990|528022187|FG003|Overall Study|Progressive Disease|1|||
146414040|NCT01393990|528022188|FG004|Overall Study|Progressive Disease|1|||
146414041|NCT01393990|528022189|FG005|Overall Study|Progressive Disease|1|||
146414042|NCT01393990|528022190|FG006|Overall Study|Progressive Disease|1|||
146414043|NCT01393990|528022191|FG007|Overall Study|Progressive Disease|1|||
146414044|NCT01393990|528022192|FG008|Overall Study|Progressive Disease|3|||
146414045|NCT01393990|528022193|FG009|Overall Study|Progressive Disease|1|||
146414046|NCT01393990|528022194|FG010|Overall Study|Progressive Disease|0|||
146414047|NCT01393990|528022195|FG011|Overall Study|Progressive Disease|0|||
146414048|NCT01393990|528022196|FG012|Overall Study|Progressive Disease|0|||
146414049|NCT01393990|528022197|FG013|Overall Study|Progressive Disease|1|||
146414050|NCT01393990|528022198|FG014|Overall Study|Progressive Disease|6|||
146414051|NCT01393990|528022199|FG015|Overall Study|Progressive Disease|1|||
146414052|NCT01393990|528022200|FG016|Overall Study|Progressive Disease|0|||
146414053|NCT01393990|528022201|FG017|Overall Study|Progressive Disease|0|||
146414054|NCT01393990|528022184|FG000|Overall Study|Death|0|||
146414055|NCT01393990|528022185|FG001|Overall Study|Death|0|||
146414056|NCT01393990|528022186|FG002|Overall Study|Death|0|||
146414057|NCT01393990|528022187|FG003|Overall Study|Death|0|||
146414058|NCT01393990|528022188|FG004|Overall Study|Death|1|||
146414059|NCT01393990|528022189|FG005|Overall Study|Death|0|||
146414060|NCT01393990|528022190|FG006|Overall Study|Death|0|||
146414061|NCT01393990|528022191|FG007|Overall Study|Death|0|||
146414062|NCT01393990|528022192|FG008|Overall Study|Death|0|||
146414063|NCT01393990|528022193|FG009|Overall Study|Death|0|||
146414064|NCT01393990|528022194|FG010|Overall Study|Death|0|||
146414065|NCT01393990|528022195|FG011|Overall Study|Death|0|||
146414066|NCT01393990|528022196|FG012|Overall Study|Death|0|||
146414067|NCT01393990|528022197|FG013|Overall Study|Death|1|||
146414068|NCT01393990|528022198|FG014|Overall Study|Death|1|||
146414069|NCT01393990|528022199|FG015|Overall Study|Death|0|||
146082283|NCT01989468|526822757|FG001|Overall Study|Lost to Follow-up|2|||
146414070|NCT01393990|528022200|FG016|Overall Study|Death|0|||
146414071|NCT01393990|528022201|FG017|Overall Study|Death|0|||
146414072|NCT01393990|528022184|FG000|Overall Study|Withdrawal by Subject|0|||
146414073|NCT01393990|528022185|FG001|Overall Study|Withdrawal by Subject|0|||
146414074|NCT01393990|528022186|FG002|Overall Study|Withdrawal by Subject|0|||
146414075|NCT01393990|528022187|FG003|Overall Study|Withdrawal by Subject|0|||
146414076|NCT01393990|528022188|FG004|Overall Study|Withdrawal by Subject|0|||
146414077|NCT01393990|528022189|FG005|Overall Study|Withdrawal by Subject|0|||
146414078|NCT01393990|528022190|FG006|Overall Study|Withdrawal by Subject|0|||
146414079|NCT01393990|528022191|FG007|Overall Study|Withdrawal by Subject|0|||
146414080|NCT01393990|528022192|FG008|Overall Study|Withdrawal by Subject|0|||
146414081|NCT01393990|528022193|FG009|Overall Study|Withdrawal by Subject|0|||
146414082|NCT01393990|528022194|FG010|Overall Study|Withdrawal by Subject|0|||
146414083|NCT01393990|528022195|FG011|Overall Study|Withdrawal by Subject|0|||
146414084|NCT01393990|528022196|FG012|Overall Study|Withdrawal by Subject|0|||
146414085|NCT01393990|528022197|FG013|Overall Study|Withdrawal by Subject|0|||
146414086|NCT01393990|528022198|FG014|Overall Study|Withdrawal by Subject|1|||
146414087|NCT01393990|528022199|FG015|Overall Study|Withdrawal by Subject|1|||
146414088|NCT01393990|528022200|FG016|Overall Study|Withdrawal by Subject|0|||
146414089|NCT01393990|528022201|FG017|Overall Study|Withdrawal by Subject|0|||
146414090|NCT00331630|528022208|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
146414091|NCT00331630|528022208|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
146414092|NCT00331630|528022208|FG000|Follow up for 5 Years|Death|5|||
146414093|NCT00331630|528022208|FG000|Follow up for 5 Years|Data collection was stopped|24|||
146414094|NCT00720798|528022209|FG000|Overall Study|Adverse Event|304|||
146414095|NCT00720798|528022209|FG000|Overall Study|Death|39|||
146414096|NCT00720798|528022209|FG000|Overall Study|Insufficient Therapeutic Response|129|||
146414097|NCT00720798|528022209|FG000|Overall Study|Protocol Violation|4|||
146414098|NCT00720798|528022209|FG000|Overall Study|Refused Treatment|151|||
146414099|NCT00720798|528022209|FG000|Overall Study|Failure to Return|46|||
146414100|NCT00720798|528022209|FG000|Overall Study|Reason not Specified|83|||
146414101|NCT00433381|528022210|FG000|Overall Study|Ineligible / no protocol treatment|3|||
146414102|NCT00433381|528022211|FG001|Overall Study|Ineligible / no protocol treatment|3|||
146414103|NCT00434161|528022212|FG000|Overall Study|Adverse Event|5|||
146414104|NCT00434161|528022213|FG001|Overall Study|Adverse Event|1|||
146414105|NCT00434161|528022214|FG002|Overall Study|Adverse Event|4|||
146414106|NCT00434161|528022212|FG000|Overall Study|Lost to Follow-up|0|||
146414107|NCT00434161|528022213|FG001|Overall Study|Lost to Follow-up|1|||
146414108|NCT00434161|528022214|FG002|Overall Study|Lost to Follow-up|0|||
146414109|NCT00434161|528022212|FG000|Overall Study|Death|1|||
146414110|NCT00434161|528022213|FG001|Overall Study|Death|0|||
146414111|NCT00434161|528022214|FG002|Overall Study|Death|1|||
146414112|NCT00434161|528022212|FG000|Overall Study|Non-Compliance|1|||
146414113|NCT00434161|528022213|FG001|Overall Study|Non-Compliance|1|||
146414114|NCT00434161|528022214|FG002|Overall Study|Non-Compliance|0|||
146414115|NCT00434161|528022212|FG000|Overall Study|Withdrawal by Subject|2|||
146414116|NCT00434161|528022213|FG001|Overall Study|Withdrawal by Subject|0|||
146414117|NCT00434161|528022214|FG002|Overall Study|Withdrawal by Subject|3|||
146414118|NCT00434161|528022212|FG000|Overall Study|Logistical error study assessments|1|||
146414119|NCT00434161|528022213|FG001|Overall Study|Logistical error study assessments|0|||
146414120|NCT00434161|528022214|FG002|Overall Study|Logistical error study assessments|3|||
146414121|NCT01312779|528022215|FG000|Overall Study|Withdrawal by Subject|2|||
146414122|NCT01312779|528022215|FG000|Overall Study|Death|3|||
146414123|NCT01312779|528022215|FG000|Overall Study|Not Implanted with Device|27|||
146414124|NCT00549198|528022219|FG000|Overall Study|Adverse Event|28|||
146414125|NCT00549198|528022220|FG001|Overall Study|Adverse Event|26|||
146414126|NCT00549198|528022219|FG000|Overall Study|Insufficient Viral Load Response|4|||
146414127|NCT00549198|528022220|FG001|Overall Study|Insufficient Viral Load Response|2|||
146414128|NCT00549198|528022219|FG000|Overall Study|Protocol-defined Virological Failure|7|||
146414129|NCT00549198|528022220|FG001|Overall Study|Protocol-defined Virological Failure|0|||
146414130|NCT00549198|528022219|FG000|Overall Study|Non-compliance|2|||
146414131|NCT00549198|528022220|FG001|Overall Study|Non-compliance|4|||
146414132|NCT00549198|528022219|FG000|Overall Study|Lost to Follow-up|7|||
146414133|NCT00549198|528022220|FG001|Overall Study|Lost to Follow-up|8|||
146414134|NCT00549198|528022219|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
146414135|NCT00549198|528022220|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146414136|NCT00549198|528022219|FG000|Overall Study|Protocol Violation|7|||
146414137|NCT00549198|528022220|FG001|Overall Study|Protocol Violation|2|||
146414138|NCT00549198|528022219|FG000|Overall Study|Investigator Decision|4|||
146414139|NCT00549198|528022220|FG001|Overall Study|Investigator Decision|3|||
146414140|NCT00549198|528022219|FG000|Overall Study|Withdrawal by Subject|7|||
146414141|NCT00549198|528022220|FG001|Overall Study|Withdrawal by Subject|7|||
146414142|NCT00549198|528022219|FG000|Overall Study|Disease Progression|1|||
146414143|NCT00549198|528022220|FG001|Overall Study|Disease Progression|0|||
146414144|NCT00549198|528022219|FG000|Overall Study|Participant Moved|2|||
146414145|NCT00549198|528022220|FG001|Overall Study|Participant Moved|0|||
146284515|NCT01285609|527553741|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
146284516|NCT01285609|527553740|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
146284517|NCT01285609|527553741|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
146414146|NCT00549198|528022219|FG000|Overall Study|Participant not able to perform Week 96|1|||
146414147|NCT00549198|528022220|FG001|Overall Study|Participant not able to perform Week 96|0|||
146414148|NCT00549198|528022219|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
146414149|NCT00549198|528022220|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
146414150|NCT00549198|528022219|FG000|Overall Study|Prohibited Medication|1|||
146414151|NCT00549198|528022220|FG001|Overall Study|Prohibited Medication|2|||
146414152|NCT00549198|528022219|FG000|Overall Study|Participant planning pregnancy|1|||
146414153|NCT00549198|528022220|FG001|Overall Study|Participant planning pregnancy|0|||
146414154|NCT00549198|528022219|FG000|Overall Study|Participant overweight, no scan possible|1|||
146414155|NCT00549198|528022220|FG001|Overall Study|Participant overweight, no scan possible|0|||
146414156|NCT00549198|528022219|FG000|Overall Study|No scan facilities|0|||
146414157|NCT00549198|528022220|FG001|Overall Study|No scan facilities|2|||
146414158|NCT00549198|528022219|FG000|Overall Study|Pregnancy|0|||
146414159|NCT00549198|528022220|FG001|Overall Study|Pregnancy|3|||
146414160|NCT00549198|528022219|FG000|Overall Study|Not Exposed to Study Drug|3|||
146414161|NCT00549198|528022220|FG001|Overall Study|Not Exposed to Study Drug|4|||
146414162|NCT01473758|528022221|FG000|Cycle 1|Adverse Event|10|||
146414163|NCT01473758|528022222|FG001|Cycle 1|Adverse Event|2|||
146414164|NCT01473758|528022223|FG002|Cycle 1|Adverse Event|0|||
146414165|NCT01473758|528022224|FG003|Cycle 1|Adverse Event|0|||
146414166|NCT01473758|528022221|FG000|Cycle 1|Withdrawal by Subject|1|||
146414167|NCT01473758|528022222|FG001|Cycle 1|Withdrawal by Subject|1|||
146414168|NCT01473758|528022223|FG002|Cycle 1|Withdrawal by Subject|0|||
146414169|NCT01473758|528022224|FG003|Cycle 1|Withdrawal by Subject|0|||
146414170|NCT01473758|528022221|FG000|Cycle 2|Adverse Event|0|||
146414171|NCT01473758|528022222|FG001|Cycle 2|Adverse Event|0|||
146414172|NCT01473758|528022223|FG002|Cycle 2|Adverse Event|5|||
146414173|NCT01473758|528022224|FG003|Cycle 2|Adverse Event|0|||
146414174|NCT02480010|528022225|FG000|Overall Study|Adverse Event|3|||
146414175|NCT02480010|528022226|FG001|Overall Study|Adverse Event|1|||
146414176|NCT02480010|528022225|FG000|Overall Study|Death|1|||
146414177|NCT02480010|528022226|FG001|Overall Study|Death|0|||
146414178|NCT02480010|528022225|FG000|Overall Study|Insufficient therapeutic response|31|||
146414179|NCT02480010|528022226|FG001|Overall Study|Insufficient therapeutic response|29|||
146414180|NCT02480010|528022225|FG000|Overall Study|Refused Treatment|0|||
146414181|NCT02480010|528022226|FG001|Overall Study|Refused Treatment|3|||
146414182|NCT02763579|528022236|FG000|Global Period|Death|167|||
146414183|NCT02763579|528022237|FG001|Global Period|Death|151|||
146414184|NCT02763579|528022238|FG002|Global Period|Death|0|||
146414185|NCT02763579|528022239|FG003|Global Period|Death|0|||
146414186|NCT02763579|528022236|FG000|Global Period|Lost to Follow-up|2|||
146414187|NCT02763579|528022237|FG001|Global Period|Lost to Follow-up|4|||
146414188|NCT02763579|528022238|FG002|Global Period|Lost to Follow-up|0|||
146414189|NCT02763579|528022239|FG003|Global Period|Lost to Follow-up|0|||
146414190|NCT02763579|528022236|FG000|Global Period|Physician Decision|0|||
146414191|NCT02763579|528022237|FG001|Global Period|Physician Decision|2|||
146414192|NCT02763579|528022238|FG002|Global Period|Physician Decision|0|||
146414193|NCT02763579|528022239|FG003|Global Period|Physician Decision|0|||
146414194|NCT02763579|528022236|FG000|Global Period|Study Terminated By Sponsor|21|||
146414195|NCT02763579|528022237|FG001|Global Period|Study Terminated By Sponsor|26|||
146414196|NCT02763579|528022238|FG002|Global Period|Study Terminated By Sponsor|0|||
146414197|NCT02763579|528022239|FG003|Global Period|Study Terminated By Sponsor|0|||
146414198|NCT02763579|528022236|FG000|Global Period|Withdrawal by Subject|12|||
146414199|NCT02763579|528022237|FG001|Global Period|Withdrawal by Subject|18|||
146414200|NCT02763579|528022238|FG002|Global Period|Withdrawal by Subject|0|||
146414201|NCT02763579|528022239|FG003|Global Period|Withdrawal by Subject|0|||
146414202|NCT02763579|528022236|FG000|China Period|Death|0|||
146414203|NCT02763579|528022237|FG001|China Period|Death|0|||
146414204|NCT02763579|528022238|FG002|China Period|Death|46|||
146414205|NCT02763579|528022239|FG003|China Period|Death|48|||
146414206|NCT02763579|528022236|FG000|China Period|Lost to Follow-up|0|||
146414207|NCT02763579|528022237|FG001|China Period|Lost to Follow-up|0|||
146414208|NCT02763579|528022238|FG002|China Period|Lost to Follow-up|1|||
146082284|NCT01989468|526822758|FG002|Overall Study|Lost to Follow-up|0|||
146414209|NCT02763579|528022239|FG003|China Period|Lost to Follow-up|1|||
146414210|NCT02763579|528022236|FG000|China Period|Physician Decision|0|||
146414211|NCT02763579|528022237|FG001|China Period|Physician Decision|0|||
146414212|NCT02763579|528022238|FG002|China Period|Physician Decision|0|||
146414213|NCT02763579|528022239|FG003|China Period|Physician Decision|1|||
146414214|NCT02763579|528022236|FG000|China Period|Study Terminated By Sponsor|0|||
146414215|NCT02763579|528022237|FG001|China Period|Study Terminated By Sponsor|0|||
146414216|NCT02763579|528022238|FG002|China Period|Study Terminated By Sponsor|3|||
146414217|NCT02763579|528022239|FG003|China Period|Study Terminated By Sponsor|4|||
146414218|NCT02763579|528022236|FG000|China Period|Withdrawal by Subject|0|||
146414219|NCT02763579|528022237|FG001|China Period|Withdrawal by Subject|0|||
146082285|NCT01989468|526822759|FG003|Overall Study|Lost to Follow-up|1|||
146082286|NCT01989468|526822760|FG004|Overall Study|Lost to Follow-up|1|||
146082287|NCT01989468|526822756|FG000|Overall Study|Physician Decision|4|||
146082288|NCT01989468|526822757|FG001|Overall Study|Physician Decision|1|||
146082289|NCT01989468|526822758|FG002|Overall Study|Physician Decision|0|||
146082290|NCT01989468|526822759|FG003|Overall Study|Physician Decision|1|||
146082291|NCT01989468|526822760|FG004|Overall Study|Physician Decision|0|||
146082292|NCT01989468|526822756|FG000|Overall Study|Pregnancy|0|||
146082293|NCT01989468|526822757|FG001|Overall Study|Pregnancy|1|||
146082294|NCT01989468|526822758|FG002|Overall Study|Pregnancy|0|||
146082295|NCT01989468|526822759|FG003|Overall Study|Pregnancy|0|||
146414220|NCT02763579|528022238|FG002|China Period|Withdrawal by Subject|3|||
146414221|NCT02763579|528022239|FG003|China Period|Withdrawal by Subject|3|||
146414222|NCT01764854|528022242|FG000|Overall Study|Adverse Event|0|||
146414223|NCT01764854|528022243|FG001|Overall Study|Adverse Event|0|||
146414224|NCT01764854|528022244|FG002|Overall Study|Adverse Event|2|||
146414225|NCT01764854|528022245|FG003|Overall Study|Adverse Event|0|||
146414226|NCT01764854|528022242|FG000|Overall Study|Withdrawal by Subject|0|||
146414227|NCT01764854|528022243|FG001|Overall Study|Withdrawal by Subject|0|||
146414228|NCT01764854|528022244|FG002|Overall Study|Withdrawal by Subject|1|||
146414229|NCT01764854|528022245|FG003|Overall Study|Withdrawal by Subject|0|||
146414230|NCT01764854|528022242|FG000|Overall Study|relocation|0|||
146414231|NCT01764854|528022243|FG001|Overall Study|relocation|0|||
146414232|NCT01764854|528022244|FG002|Overall Study|relocation|2|||
146414233|NCT01764854|528022245|FG003|Overall Study|relocation|0|||
146414234|NCT01764854|528022242|FG000|Overall Study|Protocol Violation|0|||
146414235|NCT01764854|528022243|FG001|Overall Study|Protocol Violation|0|||
146414236|NCT01764854|528022244|FG002|Overall Study|Protocol Violation|1|||
146414237|NCT01764854|528022245|FG003|Overall Study|Protocol Violation|2|||
146414238|NCT00910858|528022254|FG000|Pharmacokinetic Phase|Adverse Event|1|||
146414239|NCT00910858|528022255|FG001|Pharmacokinetic Phase|Adverse Event|0|||
146414240|NCT00910858|528022256|FG002|Pharmacokinetic Phase|Adverse Event|0|||
146414241|NCT00910858|528022254|FG000|Monotherapy Phase|Adverse Event|3|||
146414242|NCT00910858|528022255|FG001|Monotherapy Phase|Adverse Event|2|||
146414243|NCT00910858|528022256|FG002|Monotherapy Phase|Adverse Event|0|||
146414244|NCT00910858|528022254|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
146414245|NCT00910858|528022255|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
146414246|NCT00910858|528022256|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
146414247|NCT00910858|528022254|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
146414248|NCT00910858|528022255|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
146414249|NCT00910858|528022256|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
146414250|NCT00910858|528022254|FG000|Monotherapy Phase|Protocol Violation|1|||
146414251|NCT00910858|528022255|FG001|Monotherapy Phase|Protocol Violation|0|||
146414252|NCT00910858|528022256|FG002|Monotherapy Phase|Protocol Violation|0|||
146414253|NCT00910858|528022254|FG000|Monotherapy Phase|Other|3|||
146414254|NCT00910858|528022255|FG001|Monotherapy Phase|Other|4|||
146414255|NCT00910858|528022256|FG002|Monotherapy Phase|Other|2|||
146414256|NCT00910858|528022254|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
146414257|NCT00910858|528022255|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
146414258|NCT00910858|528022256|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
146414259|NCT00910858|528022254|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
146414260|NCT00910858|528022255|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
146414261|NCT00910858|528022256|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
146414262|NCT00910858|528022254|FG000|Combined Treatment Phase|Protocol Violation|1|||
146414263|NCT00910858|528022255|FG001|Combined Treatment Phase|Protocol Violation|0|||
146414264|NCT00910858|528022256|FG002|Combined Treatment Phase|Protocol Violation|0|||
146414265|NCT00910858|528022254|FG000|Combined Treatment Phase|Other|0|||
146414266|NCT00910858|528022255|FG001|Combined Treatment Phase|Other|2|||
146414267|NCT00910858|528022256|FG002|Combined Treatment Phase|Other|1|||
146284518|NCT04822597|527553742|FG000|Overall Study|Withdrawal by Subject|0|||
146284519|NCT04822597|527553743|FG001|Overall Study|Withdrawal by Subject|1|||
146284520|NCT04822597|527553744|FG002|Overall Study|Withdrawal by Subject|1|||
146284521|NCT04822597|527553745|FG003|Overall Study|Withdrawal by Subject|0|||
146284522|NCT04822597|527553742|FG000|Overall Study|Physician Decision|0|||
146284523|NCT04822597|527553743|FG001|Overall Study|Physician Decision|0|||
146284524|NCT04822597|527553744|FG002|Overall Study|Physician Decision|1|||
146284525|NCT04822597|527553745|FG003|Overall Study|Physician Decision|1|||
146284526|NCT04822597|527553742|FG000|Overall Study|Subject withdrawn after enrollment|0|||
146284527|NCT04822597|527553743|FG001|Overall Study|Subject withdrawn after enrollment|1|||
146284528|NCT04822597|527553744|FG002|Overall Study|Subject withdrawn after enrollment|0|||
146284529|NCT04822597|527553745|FG003|Overall Study|Subject withdrawn after enrollment|1|||
146284530|NCT04822597|527553742|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
146284531|NCT04822597|527553743|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146284532|NCT04822597|527553744|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146284533|NCT04822597|527553745|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
146414268|NCT00827827|528022257|FG000|Overall Study|Lost to Follow-up|3|||
146284534|NCT00911768|527553750|FG000|Overall Study|Protocol Violation|5|||
146284535|NCT00911768|527553751|FG001|Overall Study|Protocol Violation|4|||
146284536|NCT00911768|527553750|FG000|Overall Study|Withdrawal by Subject|1|||
146414269|NCT00827827|528022258|FG001|Overall Study|Lost to Follow-up|0|||
146414270|NCT00827827|528022257|FG000|Overall Study|Fall at home- hospitalization|1|||
146414271|NCT00827827|528022258|FG001|Overall Study|Fall at home- hospitalization|0|||
146414272|NCT00827827|528022257|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
146414273|NCT00827827|528022258|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
146414274|NCT00827827|528022257|FG000|Overall Study|Gout|1|||
146414275|NCT00827827|528022258|FG001|Overall Study|Gout|0|||
146414276|NCT00827827|528022257|FG000|Overall Study|Transportation issues|1|||
146414277|NCT00827827|528022258|FG001|Overall Study|Transportation issues|0|||
146414278|NCT00827827|528022257|FG000|Overall Study|Burned with water at home|1|||
146414279|NCT00827827|528022258|FG001|Overall Study|Burned with water at home|0|||
146414280|NCT00447603|528022260|FG000|Screening|Withdrawal by Subject|1|||
146414281|NCT00447603|528022261|FG001|Screening|Withdrawal by Subject|0|||
146414282|NCT00447603|528022262|FG002|Screening|Withdrawal by Subject|0|||
146414283|NCT00447603|528022260|FG000|Screening|Protocol Violation|1|||
146414284|NCT00447603|528022261|FG001|Screening|Protocol Violation|0|||
146414285|NCT00447603|528022262|FG002|Screening|Protocol Violation|0|||
146414286|NCT00447603|528022260|FG000|Screening|Screen Failure|4|||
146414287|NCT00447603|528022261|FG001|Screening|Screen Failure|0|||
146414288|NCT00447603|528022262|FG002|Screening|Screen Failure|0|||
146414289|NCT00447603|528022260|FG000|Screening|Study Terminated by Sponsor|15|||
146414290|NCT00447603|528022261|FG001|Screening|Study Terminated by Sponsor|0|||
146414291|NCT00447603|528022262|FG002|Screening|Study Terminated by Sponsor|0|||
146414292|NCT00447603|528022260|FG000|Filter Period|Adverse Event|0|||
146414293|NCT00447603|528022261|FG001|Filter Period|Adverse Event|0|||
146414294|NCT00447603|528022262|FG002|Filter Period|Adverse Event|1|||
146414295|NCT00447603|528022260|FG000|Filter Period|Screen Failure|0|||
146414296|NCT00447603|528022261|FG001|Filter Period|Screen Failure|3|||
146414297|NCT00447603|528022262|FG002|Filter Period|Screen Failure|4|||
146414298|NCT00447603|528022260|FG000|Filter Period|Study terminated by Sponsor|0|||
146414299|NCT00447603|528022261|FG001|Filter Period|Study terminated by Sponsor|1|||
146414300|NCT00447603|528022262|FG002|Filter Period|Study terminated by Sponsor|10|||
146414301|NCT01165684|528022269|FG000|Overall Study|Adverse Event|1|||
146414302|NCT01165684|528022270|FG001|Overall Study|Adverse Event|1|||
146414303|NCT01165684|528022269|FG000|Overall Study|Lack of Efficacy|2|||
146414304|NCT01165684|528022270|FG001|Overall Study|Lack of Efficacy|1|||
146414305|NCT01165684|528022269|FG000|Overall Study|Protocol Violation|7|||
146414306|NCT01165684|528022270|FG001|Overall Study|Protocol Violation|15|||
146414307|NCT01165684|528022269|FG000|Overall Study|Withdrawal Criteria|2|||
146414308|NCT01165684|528022270|FG001|Overall Study|Withdrawal Criteria|13|||
146414309|NCT01165684|528022269|FG000|Overall Study|Unclassified|16|||
146414310|NCT01165684|528022270|FG001|Overall Study|Unclassified|22|||
146414311|NCT00901628|528022287|FG000|Overall Study|disconnection of catheter|4|||
146414312|NCT00901628|528022288|FG001|Overall Study|disconnection of catheter|8|||
146414313|NCT00901628|528022287|FG000|Overall Study|disconnection of drain|0|||
146414314|NCT00901628|528022288|FG001|Overall Study|disconnection of drain|1|||
146414315|NCT00901628|528022287|FG000|Overall Study|peroneal nerve palsy|0|||
146414316|NCT00901628|528022288|FG001|Overall Study|peroneal nerve palsy|1|||
146414317|NCT00608205|528022291|FG000|Overall Study|Adverse Event|3|||
146414318|NCT00608205|528022292|FG001|Overall Study|Adverse Event|2|||
146414319|NCT00608205|528022291|FG000|Overall Study|Patient non-compliant|0|||
146414320|NCT00608205|528022292|FG001|Overall Study|Patient non-compliant|1|||
146414321|NCT01003886|528022293|FG000|Overall Study|Lack of Efficacy|5|||
146414322|NCT01003886|528022293|FG000|Overall Study|Lost to Follow-up|169|||
146414323|NCT01003886|528022293|FG000|Overall Study|Withdrawal by Subject|39|||
146414324|NCT01003886|528022293|FG000|Overall Study|Other|14|||
146414325|NCT01003886|528022293|FG000|Overall Study|Adverse Event|3|||
146414326|NCT03882047|528022315|FG000|Overall Study|Adverse Event|0|||
146414327|NCT03882047|528022316|FG001|Overall Study|Adverse Event|2|||
146414328|NCT03882047|528022317|FG002|Overall Study|Adverse Event|2|||
146414329|NCT03882047|528022315|FG000|Overall Study|Treatment Failure|3|||
146414330|NCT03882047|528022316|FG001|Overall Study|Treatment Failure|3|||
146414331|NCT03882047|528022317|FG002|Overall Study|Treatment Failure|12|||
146414332|NCT03882047|528022315|FG000|Overall Study|Lost to Follow-up|0|||
146414333|NCT03882047|528022316|FG001|Overall Study|Lost to Follow-up|1|||
146414334|NCT03882047|528022317|FG002|Overall Study|Lost to Follow-up|0|||
146414335|NCT03882047|528022315|FG000|Overall Study|Did Not Wish to Continue|1|||
146414336|NCT03882047|528022316|FG001|Overall Study|Did Not Wish to Continue|4|||
146192975|NCT03568162|527217761|FG003|Overall Study|Pregnancy|1|||
146192976|NCT03568162|527217762|FG004|Overall Study|Pregnancy|0|||
146192977|NCT03568162|527217763|FG005|Overall Study|Pregnancy|0|||
146192978|NCT03568162|527217758|FG000|Overall Study|Protocol Violation|1|||
146414337|NCT03882047|528022317|FG002|Overall Study|Did Not Wish to Continue|1|||
146414338|NCT03882047|528022315|FG000|Overall Study|Noncompliance With Protocol|2|||
146414339|NCT03882047|528022316|FG001|Overall Study|Noncompliance With Protocol|0|||
146414340|NCT03882047|528022317|FG002|Overall Study|Noncompliance With Protocol|0|||
146414341|NCT03882047|528022315|FG000|Overall Study|Did Not Meet Eligibility|0|||
146414342|NCT03882047|528022316|FG001|Overall Study|Did Not Meet Eligibility|0|||
146192979|NCT03568162|527217759|FG001|Overall Study|Protocol Violation|0|||
146192980|NCT03568162|527217760|FG002|Overall Study|Protocol Violation|1|||
146414343|NCT03882047|528022317|FG002|Overall Study|Did Not Meet Eligibility|1|||
146414344|NCT00723554|528022318|FG000|Overall Study|Adverse Event|12|||
146414345|NCT00723554|528022318|FG000|Overall Study|Investigator's judgement|5|||
146414346|NCT00723554|528022318|FG000|Overall Study|Inhaled medication other than iloprost|4|||
146414347|NCT00723554|528022318|FG000|Overall Study|Withdrawal of consent|3|||
146414348|NCT00723554|528022318|FG000|Overall Study|Other|3|||
146414349|NCT00723554|528022318|FG000|Overall Study|Lost to Follow-up|1|||
146414350|NCT00723554|528022318|FG000|Overall Study|Non-compliance|1|||
146414351|NCT02436135|528022320|FG000|Overall Study|Progressive Disease|3|||
146414352|NCT02436135|528022321|FG001|Overall Study|Progressive Disease|1|||
146414353|NCT02436135|528022320|FG000|Overall Study|Investigator Discretion|1|||
146414354|NCT02436135|528022321|FG001|Overall Study|Investigator Discretion|2|||
146414355|NCT02436135|528022320|FG000|Overall Study|Adverse Event|1|||
146414356|NCT02436135|528022321|FG001|Overall Study|Adverse Event|0|||
146414357|NCT02436135|528022320|FG000|Overall Study|Withdrawal by Participant|1|||
146284537|NCT00911768|527553751|FG001|Overall Study|Withdrawal by Subject|0|||
146284538|NCT00515853|527553753|FG000|Overall Study|Lost to Follow-up|9|||
146284539|NCT00515853|527553754|FG001|Overall Study|Lost to Follow-up|13|||
146284540|NCT00515853|527553753|FG000|Overall Study|Withdrawal by Subject|6|||
146284541|NCT00515853|527553754|FG001|Overall Study|Withdrawal by Subject|4|||
146284542|NCT02631577|527553760|FG000|Overall Study|Death|1|||
146284543|NCT02631577|527553761|FG001|Overall Study|Death|7|||
146284544|NCT02631577|527553760|FG000|Overall Study|Withdrawal by Subject|0|||
146284545|NCT02631577|527553761|FG001|Overall Study|Withdrawal by Subject|3|||
146284546|NCT00979134|527553762|FG000|Overall Study|Disease progression|18|||
146284547|NCT00979134|527553763|FG001|Overall Study|Disease progression|2|||
146284548|NCT00979134|527553764|FG002|Overall Study|Disease progression|5|||
146284549|NCT00979134|527553762|FG000|Overall Study|Adverse Event|0|||
146284550|NCT00979134|527553763|FG001|Overall Study|Adverse Event|0|||
146284551|NCT00979134|527553764|FG002|Overall Study|Adverse Event|2|||
146284552|NCT00979134|527553762|FG000|Overall Study|Withdrawal by Subject|1|||
146284553|NCT00979134|527553763|FG001|Overall Study|Withdrawal by Subject|1|||
146284554|NCT00979134|527553764|FG002|Overall Study|Withdrawal by Subject|2|||
146284555|NCT00979134|527553762|FG000|Overall Study|Lost to Follow-up|2|||
146284556|NCT00979134|527553763|FG001|Overall Study|Lost to Follow-up|2|||
146284557|NCT00979134|527553764|FG002|Overall Study|Lost to Follow-up|0|||
146284558|NCT00979134|527553762|FG000|Overall Study|Death|4|||
146284559|NCT00979134|527553763|FG001|Overall Study|Death|0|||
146284560|NCT00979134|527553764|FG002|Overall Study|Death|26|||
146284561|NCT00979134|527553762|FG000|Overall Study|Other|8|||
146284562|NCT00979134|527553763|FG001|Overall Study|Other|1|||
146284563|NCT00979134|527553764|FG002|Overall Study|Other|5|||
146284564|NCT00867308|527553765|FG000|Overall Study|Death|1|||
146284565|NCT00867308|527553766|FG001|Overall Study|Death|0|||
146284566|NCT00867308|527553765|FG000|Overall Study|Adverse Event|1|||
146284567|NCT00867308|527553766|FG001|Overall Study|Adverse Event|4|||
146284568|NCT00867308|527553765|FG000|Overall Study|Lack of Efficacy|6|||
146284569|NCT00867308|527553766|FG001|Overall Study|Lack of Efficacy|12|||
146284570|NCT00867308|527553765|FG000|Overall Study|Withdrawal by Subject|1|||
146284571|NCT00867308|527553766|FG001|Overall Study|Withdrawal by Subject|2|||
146294394|NCT00300781|527594061|FG000|Overall Study|Withdrawal by Subject|1|||
146294395|NCT00300781|527594062|FG001|Overall Study|Withdrawal by Subject|2|||
146294396|NCT00300781|527594061|FG000|Overall Study|Physician Decision|1|||
146294397|NCT00300781|527594062|FG001|Overall Study|Physician Decision|0|||
146294398|NCT00300781|527594061|FG000|Overall Study|Not Recorded|0|||
146294399|NCT00300781|527594062|FG001|Overall Study|Not Recorded|1|||
146294400|NCT00300781|527594061|FG000|Overall Study|Symptomatic Deterioration|1|||
146294401|NCT00300781|527594062|FG001|Overall Study|Symptomatic Deterioration|0|||
146294402|NCT00300781|527594061|FG000|Overall Study|Lost to Follow-up|0|||
146294403|NCT00300781|527594062|FG001|Overall Study|Lost to Follow-up|1|||
146294404|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
146294405|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
146294406|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
146294407|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
146294408|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
146294409|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
146414358|NCT02436135|528022321|FG001|Overall Study|Withdrawal by Participant|0|||
146294410|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
146294411|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
146294412|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
146294413|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
146294414|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
146294415|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
146294416|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Death|3|||
146294417|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Death|1|||
146294418|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
146294419|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
146414359|NCT02436135|528022320|FG000|Overall Study|Study Terminated By Sponsor|0|||
146414360|NCT02436135|528022321|FG001|Overall Study|Study Terminated By Sponsor|1|||
146414361|NCT00475852|528022322|FG000|Overall Study|Death|444|||
146192981|NCT03568162|527217761|FG003|Overall Study|Protocol Violation|1|||
146192982|NCT03568162|527217762|FG004|Overall Study|Protocol Violation|1|||
146192983|NCT03568162|527217763|FG005|Overall Study|Protocol Violation|1|||
146192984|NCT03568162|527217758|FG000|Overall Study|Withdrawal by Subject|15|||
145947717|NCT01094782|526317291|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
145947718|NCT01094782|526317286|FG000|Overall Study|Unable to Complete Questionnaires|0|||
145947719|NCT01094782|526317287|FG001|Overall Study|Unable to Complete Questionnaires|1|||
145947720|NCT01094782|526317288|FG002|Overall Study|Unable to Complete Questionnaires|0|||
145947721|NCT01094782|526317289|FG003|Overall Study|Unable to Complete Questionnaires|0|||
145947722|NCT01094782|526317290|FG004|Overall Study|Unable to Complete Questionnaires|0|||
145947723|NCT01094782|526317291|FG005|Overall Study|Unable to Complete Questionnaires|0|||
145947724|NCT01094782|526317286|FG000|Overall Study|Healthy Subject Had Pain|0|||
145947725|NCT01094782|526317287|FG001|Overall Study|Healthy Subject Had Pain|1|||
145947726|NCT01094782|526317288|FG002|Overall Study|Healthy Subject Had Pain|0|||
145947727|NCT01094782|526317289|FG003|Overall Study|Healthy Subject Had Pain|0|||
145947728|NCT01094782|526317290|FG004|Overall Study|Healthy Subject Had Pain|0|||
145947729|NCT01094782|526317291|FG005|Overall Study|Healthy Subject Had Pain|0|||
145947730|NCT01094782|526317286|FG000|Overall Study|Hypertension|0|||
145947731|NCT01094782|526317287|FG001|Overall Study|Hypertension|0|||
145947732|NCT01094782|526317288|FG002|Overall Study|Hypertension|1|||
145947733|NCT01094782|526317289|FG003|Overall Study|Hypertension|0|||
145947734|NCT01094782|526317290|FG004|Overall Study|Hypertension|0|||
145947735|NCT01094782|526317291|FG005|Overall Study|Hypertension|0|||
145947736|NCT01094782|526317286|FG000|Overall Study|Wrong Pain Condition|0|||
145947737|NCT01094782|526317287|FG001|Overall Study|Wrong Pain Condition|0|||
145947738|NCT01094782|526317288|FG002|Overall Study|Wrong Pain Condition|0|||
145947739|NCT01094782|526317289|FG003|Overall Study|Wrong Pain Condition|2|||
145947740|NCT01094782|526317290|FG004|Overall Study|Wrong Pain Condition|1|||
145947741|NCT01094782|526317291|FG005|Overall Study|Wrong Pain Condition|1|||
145947742|NCT01094782|526317286|FG000|Overall Study|Recent Interventional Injection|0|||
145947743|NCT01094782|526317287|FG001|Overall Study|Recent Interventional Injection|0|||
145947744|NCT01094782|526317288|FG002|Overall Study|Recent Interventional Injection|0|||
145947745|NCT01094782|526317289|FG003|Overall Study|Recent Interventional Injection|0|||
145947746|NCT01094782|526317290|FG004|Overall Study|Recent Interventional Injection|0|||
145947747|NCT01094782|526317291|FG005|Overall Study|Recent Interventional Injection|1|||
145947748|NCT01094782|526317286|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145947749|NCT01094782|526317287|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145947750|NCT01094782|526317288|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145947751|NCT01094782|526317289|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145947752|NCT01094782|526317290|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
145947753|NCT01094782|526317291|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
146192985|NCT03568162|527217759|FG001|Overall Study|Withdrawal by Subject|15|||
146192986|NCT03568162|527217760|FG002|Overall Study|Withdrawal by Subject|26|||
146192987|NCT03568162|527217761|FG003|Overall Study|Withdrawal by Subject|22|||
145947754|NCT01094782|526317286|FG000|Overall Study|Noncompliance With Study Schedule|0|||
145947755|NCT01094782|526317287|FG001|Overall Study|Noncompliance With Study Schedule|0|||
145947756|NCT01094782|526317288|FG002|Overall Study|Noncompliance With Study Schedule|0|||
145947757|NCT01094782|526317289|FG003|Overall Study|Noncompliance With Study Schedule|1|||
145947758|NCT01094782|526317290|FG004|Overall Study|Noncompliance With Study Schedule|0|||
145947759|NCT01094782|526317291|FG005|Overall Study|Noncompliance With Study Schedule|0|||
146192988|NCT03568162|527217762|FG004|Overall Study|Withdrawal by Subject|6|||
146192989|NCT03568162|527217763|FG005|Overall Study|Withdrawal by Subject|9|||
145947760|NCT00957905|526317293|FG000|Part B|Not Treated|0|||
146192990|NCT03568162|527217758|FG000|Overall Study|Others|3|||
146192991|NCT03568162|527217759|FG001|Overall Study|Others|4|||
146192992|NCT03568162|527217760|FG002|Overall Study|Others|1|||
146192993|NCT03568162|527217761|FG003|Overall Study|Others|4|||
146192994|NCT03568162|527217762|FG004|Overall Study|Others|2|||
146192995|NCT03568162|527217763|FG005|Overall Study|Others|1|||
146192996|NCT03781804|527217764|FG000|Overall Study|Adverse Event|2|||
146192997|NCT03781804|527217765|FG001|Overall Study|Adverse Event|2|||
146192998|NCT03781804|527217766|FG002|Overall Study|Adverse Event|3|||
146192999|NCT03781804|527217764|FG000|Overall Study|Lost to Follow-up|1|||
146193000|NCT03781804|527217765|FG001|Overall Study|Lost to Follow-up|1|||
146193001|NCT03781804|527217766|FG002|Overall Study|Lost to Follow-up|2|||
146193002|NCT03781804|527217764|FG000|Overall Study|Lack of Efficacy|4|||
146193003|NCT03781804|527217765|FG001|Overall Study|Lack of Efficacy|2|||
146193004|NCT03781804|527217766|FG002|Overall Study|Lack of Efficacy|9|||
146193005|NCT03781804|527217764|FG000|Overall Study|Protocol Violation|0|||
146193006|NCT03781804|527217765|FG001|Overall Study|Protocol Violation|0|||
146193007|NCT03781804|527217766|FG002|Overall Study|Protocol Violation|1|||
146193008|NCT03781804|527217764|FG000|Overall Study|Withdrawal by Subject|0|||
146193009|NCT03781804|527217765|FG001|Overall Study|Withdrawal by Subject|1|||
146193010|NCT03781804|527217766|FG002|Overall Study|Withdrawal by Subject|1|||
146193011|NCT03781804|527217764|FG000|Overall Study|Reason not provided|2|||
146193012|NCT03781804|527217765|FG001|Overall Study|Reason not provided|2|||
146193013|NCT03781804|527217766|FG002|Overall Study|Reason not provided|0|||
146193014|NCT00768066|527217767|FG000|Overall Study|Did not receive study product injection.|3|||
146193015|NCT00768066|527217768|FG001|Overall Study|Did not receive study product injection.|3|||
146193016|NCT00768066|527217769|FG002|Overall Study|Did not receive study product injection.|0|||
146193017|NCT04831775|527217770|FG000|Overall Study|Lost to Follow-up|11|||
146193018|NCT04831775|527217771|FG001|Overall Study|Lost to Follow-up|13|||
146193019|NCT00337818|527217772|FG000|Overall Study|Lost to Follow-up|289|||
146193020|NCT00337818|527217773|FG001|Overall Study|Lost to Follow-up|91|||
146193021|NCT00337818|527217774|FG002|Overall Study|Lost to Follow-up|107|||
146193022|NCT04678830|527217775|FG000|Overall Study|Lack of Efficacy|2|||
146193023|NCT04678830|527217776|FG001|Overall Study|Lack of Efficacy|0|||
146284572|NCT01022268|527555505|FG000|Overall Study|Withdrawal by Subject|1|||
146193024|NCT04678830|527217775|FG000|Overall Study|Withdrawal by Subject|0|||
146193025|NCT04678830|527217776|FG001|Overall Study|Withdrawal by Subject|1|||
146193026|NCT05550337|527217777|FG000|Overall Study|Lack of Efficacy|0|||
146193027|NCT05550337|527217778|FG001|Overall Study|Lack of Efficacy|0|||
146193028|NCT05550337|527217779|FG002|Overall Study|Lack of Efficacy|1|||
146284573|NCT01022268|527555506|FG001|Overall Study|Withdrawal by Subject|0|||
146284574|NCT01022268|527555505|FG000|Overall Study|Withdrawal by Subject|1|||
146284575|NCT01022268|527555506|FG001|Overall Study|Withdrawal by Subject|0|||
146284576|NCT03207009|527555509|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
146284577|NCT00932113|527555512|FG000|Overall Study|Lost to Follow-up|1|||
146284578|NCT00932113|527555513|FG001|Overall Study|Lost to Follow-up|0|||
146284579|NCT01403610|527555514|FG000|Overall Study|Withdrawal by Subject|2|||
146284580|NCT01403610|527555515|FG001|Overall Study|Withdrawal by Subject|0|||
146284581|NCT01403610|527555516|FG002|Overall Study|Withdrawal by Subject|0|||
146284582|NCT01403610|527555517|FG003|Overall Study|Withdrawal by Subject|0|||
146284583|NCT01403610|527555514|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
146193029|NCT05550337|527217777|FG000|Overall Study|Adverse Event|1|||
146193030|NCT05550337|527217778|FG001|Overall Study|Adverse Event|5|||
146414362|NCT00475852|528022323|FG001|Overall Study|Death|456|||
146414363|NCT00475852|528022322|FG000|Overall Study|Withdrawal by Subject|19|||
146414364|NCT00475852|528022323|FG001|Overall Study|Withdrawal by Subject|24|||
146414365|NCT00475852|528022322|FG000|Overall Study|Lost to Follow-up|54|||
146414366|NCT00475852|528022323|FG001|Overall Study|Lost to Follow-up|68|||
146414367|NCT02063698|528022324|FG000|Overall Study|did not complete booklet for days 2-8|1|||
146414368|NCT02063698|528022325|FG001|Overall Study|did not complete booklet for days 2-8|2|||
146414369|NCT00297479|528022326|FG000|Overall Study|Lost to Follow-up|37|||
146414370|NCT00297479|528022327|FG001|Overall Study|Lost to Follow-up|54|||
146414371|NCT00297479|528022328|FG002|Overall Study|Lost to Follow-up|51|||
146414372|NCT01664494|528022329|FG000|Overall Study|Withdrawal by Subject|27|||
145947761|NCT00957905|526317294|FG001|Part B|Not Treated|1|||
146414373|NCT01664494|528022329|FG000|Overall Study|Death|18|||
146414374|NCT01664494|528022329|FG000|Overall Study|Other|49|||
146414375|NCT01664494|528022329|FG000|Overall Study|Lost to Follow-up|99|||
146414376|NCT03263819|528022330|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
146414377|NCT03263819|528022331|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
146414378|NCT01427803|528022333|FG000|Overall Study|Lost to Follow-up|32|||
146414379|NCT01427803|528022334|FG001|Overall Study|Lost to Follow-up|26|||
146414380|NCT01427803|528022333|FG000|Overall Study|Withdrawal by Subject|20|||
146414381|NCT01427803|528022334|FG001|Overall Study|Withdrawal by Subject|0|||
146414382|NCT01427803|528022333|FG000|Overall Study|Unable to complete full treatment period|6|||
146414383|NCT01427803|528022334|FG001|Overall Study|Unable to complete full treatment period|0|||
146414384|NCT01427803|528022333|FG000|Overall Study|Protocol Violation|1|||
146414385|NCT01427803|528022334|FG001|Overall Study|Protocol Violation|0|||
146414386|NCT01427803|528022333|FG000|Overall Study|Physician Decision|3|||
146414387|NCT01427803|528022334|FG001|Overall Study|Physician Decision|0|||
146414388|NCT01427803|528022333|FG000|Overall Study|did not take product|1|||
146414389|NCT01427803|528022334|FG001|Overall Study|did not take product|0|||
146414390|NCT00863057|528022337|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146414391|NCT00863057|528022338|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146414392|NCT00863057|528022339|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
146414393|NCT00863057|528022340|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
146414394|NCT00863057|528022337|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146414395|NCT00863057|528022338|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
146414396|NCT00863057|528022339|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146414397|NCT00863057|528022340|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
146414398|NCT00863057|528022337|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
146414399|NCT00863057|528022338|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
146414400|NCT00863057|528022339|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
146414401|NCT00863057|528022340|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
146414402|NCT00863057|528022337|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
146414403|NCT00863057|528022338|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
146414404|NCT00863057|528022339|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
146414405|NCT00863057|528022340|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
146414406|NCT03412019|528022341|FG000|Overall Study|Withdrawal by Subject|1|||
146414407|NCT03412019|528022342|FG001|Overall Study|Withdrawal by Subject|1|||
146414408|NCT02974114|528022353|FG000|Overall Study|Other (Not specified)|0|||
146414409|NCT02974114|528022354|FG001|Overall Study|Other (Not specified)|1|||
146414410|NCT02974114|528022355|FG002|Overall Study|Other (Not specified)|2|||
146414411|NCT01138150|528022358|FG000|Overall Study|blood unable to be processed|0|||
146414412|NCT01138150|528022359|FG001|Overall Study|blood unable to be processed|1|||
146414413|NCT01138150|528022358|FG000|Overall Study|Physician Decision|1|||
146414414|NCT01138150|528022359|FG001|Overall Study|Physician Decision|0|||
146414415|NCT00545233|528022360|FG000|Overall Study|Adverse Event|10|||
146414416|NCT00545233|528022361|FG001|Overall Study|Adverse Event|5|||
146414417|NCT00545233|528022360|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
146414418|NCT00545233|528022361|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146414419|NCT00545233|528022360|FG000|Overall Study|Protocol Violation|2|||
146414420|NCT00545233|528022361|FG001|Overall Study|Protocol Violation|0|||
146414421|NCT00545233|528022360|FG000|Overall Study|Refused Treatment|9|||
146414422|NCT00545233|528022361|FG001|Overall Study|Refused Treatment|7|||
146414423|NCT00545233|528022360|FG000|Overall Study|Failure to Return|4|||
146414424|NCT00545233|528022361|FG001|Overall Study|Failure to Return|6|||
146414425|NCT00545233|528022360|FG000|Overall Study|Insufficient response|14|||
146414426|NCT00545233|528022361|FG001|Overall Study|Insufficient response|15|||
146414427|NCT00545233|528022360|FG000|Overall Study|Physician Decision|2|||
146414428|NCT00545233|528022361|FG001|Overall Study|Physician Decision|1|||
146414429|NCT00479401|528022365|FG000|Overall Study|Adverse Event|24|||
146414430|NCT00479401|528022366|FG001|Overall Study|Adverse Event|20|||
146414431|NCT00479401|528022367|FG002|Overall Study|Adverse Event|4|||
145947762|NCT00957905|526317293|FG000|Part B|Physician Decision|0|||
145947763|NCT00957905|526317294|FG001|Part B|Physician Decision|1|||
145947764|NCT00957905|526317293|FG000|Part B|Death|0|||
145947765|NCT00957905|526317294|FG001|Part B|Death|1|||
146414432|NCT00479401|528022365|FG000|Overall Study|Lack of Efficacy|2|||
146414433|NCT00479401|528022366|FG001|Overall Study|Lack of Efficacy|2|||
146414434|NCT00479401|528022367|FG002|Overall Study|Lack of Efficacy|4|||
146414435|NCT00479401|528022365|FG000|Overall Study|Protocol Violation|2|||
146414436|NCT00479401|528022366|FG001|Overall Study|Protocol Violation|1|||
146414437|NCT00479401|528022367|FG002|Overall Study|Protocol Violation|1|||
146414438|NCT00479401|528022365|FG000|Overall Study|Lost to Follow-up|1|||
146414439|NCT00479401|528022366|FG001|Overall Study|Lost to Follow-up|1|||
146414440|NCT00479401|528022367|FG002|Overall Study|Lost to Follow-up|1|||
146414441|NCT00479401|528022365|FG000|Overall Study|Withdrawal by Subject|16|||
146414442|NCT00479401|528022366|FG001|Overall Study|Withdrawal by Subject|10|||
146414443|NCT00479401|528022367|FG002|Overall Study|Withdrawal by Subject|2|||
146414444|NCT00479401|528022365|FG000|Overall Study|Exclusion criteria, relocation|4|||
146414445|NCT00479401|528022366|FG001|Overall Study|Exclusion criteria, relocation|3|||
146414446|NCT00479401|528022367|FG002|Overall Study|Exclusion criteria, relocation|0|||
146414447|NCT01208402|528022370|FG000|Overall Study|Withdrawal by Subject|1|||
146414448|NCT01208402|528022371|FG001|Overall Study|Withdrawal by Subject|0|||
146414449|NCT01571635|528022372|FG000|Overall Study|Adverse Event|3|||
146414450|NCT01571635|528022373|FG001|Overall Study|Adverse Event|0|||
146414451|NCT01571635|528022374|FG002|Overall Study|Adverse Event|2|||
146414452|NCT01571635|528022375|FG003|Overall Study|Adverse Event|3|||
146414453|NCT01571635|528022376|FG004|Overall Study|Adverse Event|5|||
146414454|NCT01571635|528022372|FG000|Overall Study|Other reasons|2|||
146414455|NCT01571635|528022373|FG001|Overall Study|Other reasons|1|||
146414456|NCT01571635|528022374|FG002|Overall Study|Other reasons|2|||
146414457|NCT01571635|528022375|FG003|Overall Study|Other reasons|2|||
146414458|NCT01571635|528022376|FG004|Overall Study|Other reasons|1|||
146414459|NCT01571635|528022372|FG000|Overall Study|Study terminated by sponsor|0|||
146414460|NCT01571635|528022373|FG001|Overall Study|Study terminated by sponsor|4|||
146414461|NCT01571635|528022374|FG002|Overall Study|Study terminated by sponsor|1|||
145947766|NCT00957905|526317293|FG000|Part B|Protocol Violation|0|||
145947767|NCT00957905|526317294|FG001|Part B|Protocol Violation|1|||
145947768|NCT02083653|526317295|FG000|Overall Study|Randomized but not Treated|0|||
145947769|NCT02083653|526317296|FG001|Overall Study|Randomized but not Treated|2|||
145947770|NCT02083653|526317297|FG002|Overall Study|Randomized but not Treated|7|||
146414462|NCT01571635|528022375|FG003|Overall Study|Study terminated by sponsor|3|||
146414463|NCT01571635|528022376|FG004|Overall Study|Study terminated by sponsor|1|||
146414464|NCT01571635|528022372|FG000|Overall Study|Withdrew consent|1|||
146414465|NCT01571635|528022373|FG001|Overall Study|Withdrew consent|1|||
146414466|NCT01571635|528022374|FG002|Overall Study|Withdrew consent|2|||
146414467|NCT01571635|528022375|FG003|Overall Study|Withdrew consent|3|||
146414468|NCT01571635|528022376|FG004|Overall Study|Withdrew consent|0|||
146414469|NCT01571635|528022372|FG000|Overall Study|Lack of Efficacy|0|||
146414470|NCT01571635|528022373|FG001|Overall Study|Lack of Efficacy|2|||
146414471|NCT01571635|528022374|FG002|Overall Study|Lack of Efficacy|0|||
146414472|NCT01571635|528022375|FG003|Overall Study|Lack of Efficacy|1|||
146414473|NCT01571635|528022376|FG004|Overall Study|Lack of Efficacy|2|||
146414474|NCT02151461|528022379|FG000|Overall Study|Adverse Event|5|||
146414475|NCT02151461|528022380|FG001|Overall Study|Adverse Event|1|||
146414476|NCT02151461|528022381|FG002|Overall Study|Adverse Event|0|||
146414477|NCT02151461|528022382|FG003|Overall Study|Adverse Event|2|||
146414478|NCT02151461|528022379|FG000|Overall Study|Lost to Follow-up|0|||
146414479|NCT02151461|528022380|FG001|Overall Study|Lost to Follow-up|0|||
146414480|NCT02151461|528022381|FG002|Overall Study|Lost to Follow-up|1|||
146193031|NCT05550337|527217779|FG002|Overall Study|Adverse Event|0|||
146193032|NCT05550337|527217777|FG000|Overall Study|Withdrawal by Subject|8|||
146193033|NCT05550337|527217778|FG001|Overall Study|Withdrawal by Subject|14|||
146193034|NCT05550337|527217779|FG002|Overall Study|Withdrawal by Subject|10|||
146193035|NCT05550337|527217777|FG000|Overall Study|Pregnancy|0|||
146193036|NCT05550337|527217778|FG001|Overall Study|Pregnancy|0|||
146193037|NCT05550337|527217779|FG002|Overall Study|Pregnancy|1|||
146193038|NCT05550337|527217777|FG000|Overall Study|Protocol Violation|1|||
146193039|NCT05550337|527217778|FG001|Overall Study|Protocol Violation|3|||
146193040|NCT05550337|527217779|FG002|Overall Study|Protocol Violation|4|||
146193041|NCT05550337|527217777|FG000|Overall Study|Physician Decision|2|||
146193042|NCT05550337|527217778|FG001|Overall Study|Physician Decision|1|||
146193043|NCT05550337|527217779|FG002|Overall Study|Physician Decision|1|||
146193044|NCT05550337|527217777|FG000|Overall Study|Lost to Follow-up|16|||
146193045|NCT05550337|527217778|FG001|Overall Study|Lost to Follow-up|11|||
146193046|NCT05550337|527217779|FG002|Overall Study|Lost to Follow-up|11|||
146193047|NCT03115346|527217782|FG000|Overall Study|Did not have AAA surgery|28|||
146193048|NCT03115346|527217783|FG001|Overall Study|Did not have AAA surgery|15|||
146193049|NCT03115346|527217782|FG000|Overall Study|Death|3|||
146414481|NCT02151461|528022382|FG003|Overall Study|Lost to Follow-up|1|||
146414482|NCT02151461|528022379|FG000|Overall Study|Withdrawal by Subject|1|||
146414483|NCT02151461|528022380|FG001|Overall Study|Withdrawal by Subject|0|||
146414484|NCT02151461|528022381|FG002|Overall Study|Withdrawal by Subject|1|||
146414485|NCT02151461|528022382|FG003|Overall Study|Withdrawal by Subject|1|||
146414486|NCT02151461|528022379|FG000|Overall Study|Treatment discontinuation|0|||
146414487|NCT02151461|528022380|FG001|Overall Study|Treatment discontinuation|0|||
146414488|NCT02151461|528022381|FG002|Overall Study|Treatment discontinuation|1|||
146414489|NCT02151461|528022382|FG003|Overall Study|Treatment discontinuation|0|||
146414490|NCT00706706|528022383|FG000|Overall Study|Death|53|||
146414491|NCT00706706|528022383|FG000|Overall Study|Lost to Follow-up|7|||
146414492|NCT00706706|528022383|FG000|Overall Study|Study endpoint had reached|45|||
146414493|NCT02191579|528022384|FG000|Treatment 1|Multiple Reasons Specified|27|||
146414494|NCT02191579|528022385|FG001|Treatment 1|Multiple Reasons Specified|58|||
146414495|NCT02191579|528022384|FG000|Treatment 2|Multiple Reasons Specified|0|||
146414496|NCT02191579|528022385|FG001|Treatment 2|Multiple Reasons Specified|25|||
146414497|NCT01606137|528022390|FG000|Overall Study|Adverse Event|85|||
146414498|NCT01606137|528022390|FG000|Overall Study|Withdrawal by Subject|74|||
146414499|NCT01606137|528022390|FG000|Overall Study|Lack of Efficacy|56|||
146414500|NCT01606137|528022390|FG000|Overall Study|Lost to Follow-up|15|||
146414501|NCT01606137|528022390|FG000|Overall Study|Protocol Violation|1|||
146414502|NCT01606137|528022390|FG000|Overall Study|Patient non-compliance|9|||
146414503|NCT01606137|528022390|FG000|Overall Study|Death|1|||
146414504|NCT01606137|528022390|FG000|Overall Study|Decreased/no pain|4|||
146414505|NCT01606137|528022390|FG000|Overall Study|Issues with driving|4|||
146414506|NCT01606137|528022390|FG000|Overall Study|multiple sclerosis less stable|1|||
146414507|NCT01606137|528022390|FG000|Overall Study|Increased bilirubin|1|||
146414508|NCT01606137|528022390|FG000|Overall Study|Spray causes nausea|1|||
146193050|NCT03115346|527217783|FG001|Overall Study|Death|1|||
146414509|NCT01606137|528022390|FG000|Overall Study|Not enough improvement|4|||
146414510|NCT01606137|528022390|FG000|Overall Study|Wanted to try another treatment|1|||
146414511|NCT01606137|528022390|FG000|Overall Study|Patient leaving country|1|||
146414512|NCT01606137|528022390|FG000|Overall Study|Personal reasons|1|||
146414513|NCT01606137|528022390|FG000|Overall Study|Unable to tolerate study med. taste|1|||
146414514|NCT01606137|528022390|FG000|Overall Study|Patient moving|1|||
146193051|NCT03115346|527217782|FG000|Overall Study|Withdrawal by Subject|0|||
146193052|NCT03115346|527217783|FG001|Overall Study|Withdrawal by Subject|3|||
146414515|NCT01606137|528022390|FG000|Overall Study|Unable to collect consistent data|1|||
146193053|NCT03115346|527217782|FG000|Overall Study|Lost to Follow-up|0|||
146193054|NCT03115346|527217783|FG001|Overall Study|Lost to Follow-up|3|||
146193055|NCT03425539|527217787|FG000|Overall Study|Randomized but not treated|0|||
146193056|NCT03425539|527217788|FG001|Overall Study|Randomized but not treated|1|||
146414516|NCT00066807|528022391|FG000|Overall Study|Study was terminated early|14|||
146414517|NCT00066807|528022392|FG001|Overall Study|Study was terminated early|15|||
146414518|NCT05028751|528022393|FG000|Overall Study|Study Terminated by Sponsor|3|||
146193057|NCT03425539|527217787|FG000|Overall Study|Adverse Event|2|||
146414519|NCT05028751|528022394|FG001|Overall Study|Study Terminated by Sponsor|0|||
146414520|NCT05028751|528022395|FG002|Overall Study|Study Terminated by Sponsor|0|||
146414521|NCT05028751|528022396|FG003|Overall Study|Study Terminated by Sponsor|0|||
146414522|NCT05028751|528022393|FG000|Overall Study|Death|9|||
146414523|NCT05028751|528022394|FG001|Overall Study|Death|3|||
146414524|NCT05028751|528022395|FG002|Overall Study|Death|2|||
146414525|NCT05028751|528022396|FG003|Overall Study|Death|4|||
146414526|NCT05028751|528022393|FG000|Overall Study|Withdrawal by Subject|0|||
146414527|NCT05028751|528022394|FG001|Overall Study|Withdrawal by Subject|0|||
146414528|NCT05028751|528022395|FG002|Overall Study|Withdrawal by Subject|1|||
146414529|NCT05028751|528022396|FG003|Overall Study|Withdrawal by Subject|0|||
146414530|NCT05028751|528022393|FG000|Overall Study|Miscellaneous|2|||
146414531|NCT05028751|528022394|FG001|Overall Study|Miscellaneous|0|||
146414532|NCT05028751|528022395|FG002|Overall Study|Miscellaneous|0|||
146414533|NCT05028751|528022396|FG003|Overall Study|Miscellaneous|0|||
146414534|NCT04578548|528022397|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146414535|NCT04578548|528022398|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146414536|NCT04578548|528022397|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
146414537|NCT04578548|528022398|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
146414538|NCT04578548|528022397|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
146414539|NCT04578548|528022398|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146414540|NCT04578548|528022397|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
146414541|NCT04578548|528022398|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
146414542|NCT04578548|528022397|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
146414543|NCT04578548|528022398|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146414544|NCT04578548|528022397|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
146414545|NCT04578548|528022398|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
146414546|NCT00395083|528022401|FG000|Overall Study|Withdrawal by Subject|6|||
146414547|NCT00395083|528022402|FG001|Overall Study|Withdrawal by Subject|5|||
146414548|NCT00395083|528022401|FG000|Overall Study|Developed another disease|4|||
146414549|NCT00395083|528022402|FG001|Overall Study|Developed another disease|3|||
146414550|NCT00972153|528022403|FG000|Overall Study|Equipment malfunction during case|0|||
146414551|NCT00972153|528022404|FG001|Overall Study|Equipment malfunction during case|1|||
146414552|NCT00972153|528022405|FG002|Overall Study|Equipment malfunction during case|0|||
146414553|NCT01077713|528022406|FG000|Overall Study|Withdrawal by Subject|1|||
146414554|NCT01077713|528022407|FG001|Overall Study|Withdrawal by Subject|2|||
146414555|NCT01077713|528022406|FG000|Overall Study|Progressive Disease (PD)|0|||
146414556|NCT01077713|528022407|FG001|Overall Study|Progressive Disease (PD)|1|||
146414557|NCT01077713|528022406|FG000|Overall Study|Death|28|||
146414558|NCT01077713|528022407|FG001|Overall Study|Death|29|||
146414559|NCT01077713|528022406|FG000|Overall Study|Lost to Follow-up|1|||
146414560|NCT01077713|528022407|FG001|Overall Study|Lost to Follow-up|1|||
146414561|NCT01077713|528022406|FG000|Overall Study|Adverse Event|2|||
146414562|NCT01077713|528022407|FG001|Overall Study|Adverse Event|1|||
146414563|NCT01077713|528022406|FG000|Overall Study|Other|4|||
146414564|NCT01077713|528022407|FG001|Overall Study|Other|2|||
146414565|NCT04136626|528022408|FG000|Treatment Phase|Withdrawal by Subject|1|||
146414566|NCT04136626|528022409|FG001|Treatment Phase|Withdrawal by Subject|9|||
146414567|NCT04136626|528022408|FG000|Treatment Phase|Adverse Event|1|||
146414568|NCT04136626|528022409|FG001|Treatment Phase|Adverse Event|0|||
146414569|NCT04136626|528022408|FG000|Treatment Phase|Lost to Follow-up|1|||
146414570|NCT04136626|528022409|FG001|Treatment Phase|Lost to Follow-up|5|||
146414571|NCT04136626|528022408|FG000|12-month Follow-up|Lost to Follow-up|8|||
146414572|NCT04136626|528022409|FG001|12-month Follow-up|Lost to Follow-up|7|||
146414573|NCT00628745|528022410|FG000|Overall Study|Withdrawal by Subject|63|||
146414574|NCT00628745|528022411|FG001|Overall Study|Withdrawal by Subject|3|||
146414575|NCT00628745|528022412|FG002|Overall Study|Withdrawal by Subject|9|||
146414576|NCT00628745|528022413|FG003|Overall Study|Withdrawal by Subject|2|||
146414577|NCT00628745|528022414|FG004|Overall Study|Withdrawal by Subject|69|||
146414578|NCT00628745|528022410|FG000|Overall Study|Does not meet inclusion criteria|0|||
146414579|NCT00628745|528022411|FG001|Overall Study|Does not meet inclusion criteria|12|||
146414580|NCT00628745|528022412|FG002|Overall Study|Does not meet inclusion criteria|0|||
146414581|NCT00628745|528022413|FG003|Overall Study|Does not meet inclusion criteria|0|||
146414582|NCT00628745|528022414|FG004|Overall Study|Does not meet inclusion criteria|18|||
146414583|NCT00628745|528022410|FG000|Overall Study|Participation in an interventional clinical trial|81|||
146193058|NCT03425539|527217788|FG001|Overall Study|Adverse Event|2|||
146414584|NCT00628745|528022411|FG001|Overall Study|Participation in an interventional clinical trial|4|||
146414585|NCT00628745|528022412|FG002|Overall Study|Participation in an interventional clinical trial|7|||
146414586|NCT00628745|528022413|FG003|Overall Study|Participation in an interventional clinical trial|0|||
146414587|NCT00628745|528022414|FG004|Overall Study|Participation in an interventional clinical trial|63|||
146414588|NCT00628745|528022410|FG000|Overall Study|Physician Decision|8|||
146414589|NCT00628745|528022411|FG001|Overall Study|Physician Decision|4|||
146414590|NCT00628745|528022412|FG002|Overall Study|Physician Decision|3|||
146414591|NCT00628745|528022413|FG003|Overall Study|Physician Decision|0|||
146414592|NCT00628745|528022414|FG004|Overall Study|Physician Decision|30|||
146414593|NCT00628745|528022410|FG000|Overall Study|Lost to Follow-up|109|||
146414594|NCT00628745|528022411|FG001|Overall Study|Lost to Follow-up|7|||
146414595|NCT00628745|528022412|FG002|Overall Study|Lost to Follow-up|7|||
146414596|NCT00628745|528022413|FG003|Overall Study|Lost to Follow-up|0|||
146414597|NCT00628745|528022414|FG004|Overall Study|Lost to Follow-up|498|||
146414598|NCT00628745|528022410|FG000|Overall Study|Death|197|||
146414599|NCT00628745|528022411|FG001|Overall Study|Death|81|||
146414600|NCT00628745|528022412|FG002|Overall Study|Death|12|||
146414601|NCT00628745|528022413|FG003|Overall Study|Death|4|||
146414602|NCT00628745|528022414|FG004|Overall Study|Death|939|||
146414603|NCT00628745|528022410|FG000|Overall Study|Participant transferred to another THAOS site|6|||
146414604|NCT00628745|528022411|FG001|Overall Study|Participant transferred to another THAOS site|0|||
146414605|NCT00628745|528022412|FG002|Overall Study|Participant transferred to another THAOS site|0|||
146414606|NCT00628745|528022413|FG003|Overall Study|Participant transferred to another THAOS site|0|||
146414607|NCT00628745|528022414|FG004|Overall Study|Participant transferred to another THAOS site|7|||
146414608|NCT00628745|528022410|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
146414609|NCT00628745|528022411|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
146414610|NCT00628745|528022412|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
146414611|NCT00628745|528022413|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
146414612|NCT00628745|528022414|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
146414613|NCT00628745|528022410|FG000|Overall Study|Site closure|152|||
146414614|NCT00628745|528022411|FG001|Overall Study|Site closure|146|||
146414615|NCT00628745|528022412|FG002|Overall Study|Site closure|6|||
146414616|NCT00628745|528022413|FG003|Overall Study|Site closure|8|||
146414617|NCT00628745|528022414|FG004|Overall Study|Site closure|691|||
146414618|NCT00628745|528022410|FG000|Overall Study|Duplicate participant|0|||
146284584|NCT01403610|527555515|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
146284585|NCT01403610|527555516|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
146284586|NCT01403610|527555517|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
146284587|NCT01190514|527555518|FG000|First Intervention (Period 1)|Adverse Event|1|||
146284588|NCT01190514|527555519|FG001|First Intervention (Period 1)|Adverse Event|0|||
146284589|NCT01190514|527555520|FG002|First Intervention (Period 1)|Adverse Event|0|||
146284590|NCT01190514|527555521|FG003|First Intervention (Period 1)|Adverse Event|0|||
146284591|NCT01190514|527555518|FG000|Third Intervention (Period 3)|Adverse Event|1|||
146284592|NCT01190514|527555519|FG001|Third Intervention (Period 3)|Adverse Event|0|||
146284593|NCT01190514|527555520|FG002|Third Intervention (Period 3)|Adverse Event|0|||
146284594|NCT01190514|527555521|FG003|Third Intervention (Period 3)|Adverse Event|0|||
146284595|NCT00512317|527555522|FG000|Overall Study|Insufficient clinical response|36|||
146284596|NCT00512317|527555522|FG000|Overall Study|Withdrawal by Subject|23|||
146284597|NCT00512317|527555522|FG000|Overall Study|Sponsor closure of study|21|||
146284598|NCT00512317|527555522|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
146284599|NCT00512317|527555522|FG000|Overall Study|Adverse Event|13|||
146284600|NCT00512317|527555522|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
146284601|NCT00512317|527555522|FG000|Overall Study|Lost to Follow-up|2|||
146284602|NCT00512317|527555522|FG000|Overall Study|Other|2|||
146284603|NCT01775475|527555528|FG000|Overall Study|Death|3|||
146284604|NCT01775475|527555529|FG001|Overall Study|Death|3|||
146284605|NCT00896051|527555531|FG000|Overall Study|Adverse Event|2|||
146284606|NCT00896051|527555532|FG001|Overall Study|Adverse Event|1|||
146284607|NCT00896051|527555531|FG000|Overall Study|Lost to Follow-up|3|||
146284608|NCT00896051|527555532|FG001|Overall Study|Lost to Follow-up|2|||
146284609|NCT00896051|527555531|FG000|Overall Study|Withdrawal by Subject|3|||
146284610|NCT00896051|527555532|FG001|Overall Study|Withdrawal by Subject|2|||
146284611|NCT00896051|527555531|FG000|Overall Study|Subject noncompliant|1|||
146414619|NCT00628745|528022411|FG001|Overall Study|Duplicate participant|0|||
146414620|NCT00628745|528022412|FG002|Overall Study|Duplicate participant|0|||
146284612|NCT00896051|527555532|FG001|Overall Study|Subject noncompliant|3|||
146284613|NCT00896051|527555531|FG000|Overall Study|Other|1|||
146284614|NCT00896051|527555532|FG001|Overall Study|Other|1|||
146284615|NCT02935452|527555533|FG000|Overall Study|work and life commintment|3|||
146414621|NCT00628745|528022413|FG003|Overall Study|Duplicate participant|0|||
146414622|NCT00628745|528022414|FG004|Overall Study|Duplicate participant|1|||
145947771|NCT02083653|526317295|FG000|Overall Study|Adverse Event|12|||
145947772|NCT02083653|526317296|FG001|Overall Study|Adverse Event|5|||
145947773|NCT02083653|526317297|FG002|Overall Study|Adverse Event|4|||
146284616|NCT02935452|527555534|FG001|Overall Study|work and life commintment|1|||
146284617|NCT02074553|527555535|FG000|Intervention Period 1|Family Emergency|0|||
146284618|NCT02074553|527555536|FG001|Intervention Period 1|Family Emergency|0|||
146284619|NCT02074553|527555537|FG002|Intervention Period 1|Family Emergency|0|||
146284620|NCT02074553|527555538|FG003|Intervention Period 1|Family Emergency|1|||
146284621|NCT02074553|527555539|FG004|Intervention Period 1|Family Emergency|0|||
146414623|NCT00628745|528022410|FG000|Overall Study|Missing|4|||
146414624|NCT00628745|528022411|FG001|Overall Study|Missing|3|||
146414625|NCT00628745|528022412|FG002|Overall Study|Missing|0|||
146414626|NCT00628745|528022413|FG003|Overall Study|Missing|0|||
146414627|NCT00628745|528022414|FG004|Overall Study|Missing|10|||
146414628|NCT00628745|528022410|FG000|Overall Study|Othe reasons|987|||
146414629|NCT00628745|528022411|FG001|Overall Study|Othe reasons|373|||
146414630|NCT00628745|528022412|FG002|Overall Study|Othe reasons|105|||
146414631|NCT00628745|528022413|FG003|Overall Study|Othe reasons|1|||
146414632|NCT00628745|528022414|FG004|Overall Study|Othe reasons|1772|||
146414633|NCT02806232|528024528|FG000|Overall Study|Lost to Follow-up|1|||
146414634|NCT02806232|528024529|FG001|Overall Study|Lost to Follow-up|2|||
146414635|NCT02806232|528024530|FG002|Overall Study|Lost to Follow-up|1|||
146414636|NCT02806232|528024531|FG003|Overall Study|Lost to Follow-up|0|||
146414637|NCT02806232|528024532|FG004|Overall Study|Lost to Follow-up|0|||
146414638|NCT02806232|528024533|FG005|Overall Study|Lost to Follow-up|1|||
146414639|NCT02806232|528024534|FG006|Overall Study|Lost to Follow-up|0|||
146414640|NCT02806232|528024535|FG007|Overall Study|Lost to Follow-up|0|||
146414641|NCT02806232|528024536|FG008|Overall Study|Lost to Follow-up|0|||
146414642|NCT02806232|528024528|FG000|Overall Study|Withdrawal by Subject|0|||
146414643|NCT02806232|528024529|FG001|Overall Study|Withdrawal by Subject|2|||
146414644|NCT02806232|528024530|FG002|Overall Study|Withdrawal by Subject|0|||
146414645|NCT02806232|528024531|FG003|Overall Study|Withdrawal by Subject|0|||
146414646|NCT02806232|528024532|FG004|Overall Study|Withdrawal by Subject|2|||
146414647|NCT02806232|528024533|FG005|Overall Study|Withdrawal by Subject|1|||
146414648|NCT02806232|528024534|FG006|Overall Study|Withdrawal by Subject|0|||
146414649|NCT02806232|528024535|FG007|Overall Study|Withdrawal by Subject|0|||
146414650|NCT02806232|528024536|FG008|Overall Study|Withdrawal by Subject|0|||
146414651|NCT01133821|528024537|FG000|Overall Study|Lost to Follow-up|8|||
146414652|NCT01133821|528024538|FG001|Overall Study|Lost to Follow-up|11|||
146414653|NCT01133821|528024537|FG000|Overall Study|Withdrawal by Subject|8|||
146414654|NCT01133821|528024538|FG001|Overall Study|Withdrawal by Subject|3|||
146414655|NCT01133821|528024537|FG000|Overall Study|preferred other treatment|1|||
146414656|NCT01133821|528024538|FG001|Overall Study|preferred other treatment|1|||
146414657|NCT01133821|528024537|FG000|Overall Study|Protocol Violation|0|||
146414658|NCT01133821|528024538|FG001|Overall Study|Protocol Violation|1|||
146414659|NCT01133821|528024537|FG000|Overall Study|Refused participation|1|||
146414660|NCT01133821|528024538|FG001|Overall Study|Refused participation|3|||
146414661|NCT03342898|528024541|FG000|Overall Study|Adverse Event|3|||
146414662|NCT03342898|528024542|FG001|Overall Study|Adverse Event|1|||
146414663|NCT03342898|528024543|FG002|Overall Study|Adverse Event|0|||
146414664|NCT03342898|528024541|FG000|Overall Study|Lost to Follow-up|44|||
146414665|NCT03342898|528024542|FG001|Overall Study|Lost to Follow-up|40|||
146414666|NCT03342898|528024543|FG002|Overall Study|Lost to Follow-up|42|||
146414667|NCT03342898|528024541|FG000|Overall Study|Withdrawal of Consent|5|||
146414668|NCT03342898|528024542|FG001|Overall Study|Withdrawal of Consent|9|||
146414669|NCT03342898|528024543|FG002|Overall Study|Withdrawal of Consent|11|||
146414670|NCT03342898|528024541|FG000|Overall Study|Death|0|||
146414671|NCT03342898|528024542|FG001|Overall Study|Death|1|||
146414672|NCT03342898|528024543|FG002|Overall Study|Death|1|||
146414673|NCT03342898|528024541|FG000|Overall Study|Reason not Specified|2|||
146414674|NCT03342898|528024542|FG001|Overall Study|Reason not Specified|2|||
146414675|NCT03342898|528024543|FG002|Overall Study|Reason not Specified|0|||
146414676|NCT01387282|528024544|FG000|Overall Study|Death|47|||
146082296|NCT01989468|526822760|FG004|Overall Study|Pregnancy|0|||
146414677|NCT01387282|528024545|FG001|Overall Study|Death|16|||
146414678|NCT01387282|528024544|FG000|Overall Study|Other|5|||
146414679|NCT01387282|528024545|FG001|Overall Study|Other|1|||
146414680|NCT01387282|528024544|FG000|Overall Study|Unrelated AE|6|||
146414681|NCT01387282|528024545|FG001|Overall Study|Unrelated AE|4|||
146414682|NCT01387282|528024544|FG000|Overall Study|Withdrawal by patient|33|||
146414683|NCT01387282|528024545|FG001|Overall Study|Withdrawal by patient|23|||
146414684|NCT01387282|528024544|FG000|Overall Study|Study drug-related AE|2|||
146414685|NCT01387282|528024545|FG001|Overall Study|Study drug-related AE|2|||
146414686|NCT01387282|528024544|FG000|Overall Study|Lost to Follow-up|4|||
146082297|NCT01989468|526822756|FG000|Overall Study|Technical Problems|3|||
146082298|NCT01989468|526822757|FG001|Overall Study|Technical Problems|1|||
146082299|NCT01989468|526822758|FG002|Overall Study|Technical Problems|3|||
146082300|NCT01989468|526822759|FG003|Overall Study|Technical Problems|1|||
146082301|NCT01989468|526822760|FG004|Overall Study|Technical Problems|0|||
146082302|NCT01989468|526822756|FG000|Overall Study|Subject Guardian Decision|11|||
146082303|NCT01989468|526822757|FG001|Overall Study|Subject Guardian Decision|6|||
146082304|NCT01989468|526822758|FG002|Overall Study|Subject Guardian Decision|4|||
146082305|NCT01989468|526822759|FG003|Overall Study|Subject Guardian Decision|4|||
146082306|NCT01989468|526822760|FG004|Overall Study|Subject Guardian Decision|1|||
146082307|NCT01989468|526822756|FG000|Overall Study|Death|3|||
146082308|NCT01989468|526822757|FG001|Overall Study|Death|0|||
146082309|NCT01989468|526822758|FG002|Overall Study|Death|1|||
146082310|NCT01989468|526822759|FG003|Overall Study|Death|0|||
146082311|NCT01989468|526822760|FG004|Overall Study|Death|0|||
146414687|NCT01387282|528024545|FG001|Overall Study|Lost to Follow-up|1|||
146414688|NCT03997448|528024546|FG000|Study Treatment|Disease Progression|1|||
146414689|NCT03997448|528024546|FG000|Study Treatment|Symptomatic Deterioration|1|||
146414690|NCT03997448|528024546|FG000|Follow up|Death|2|||
146193059|NCT03425539|527217787|FG000|Overall Study|Withdrawal by Subject|3|||
146193060|NCT03425539|527217788|FG001|Overall Study|Withdrawal by Subject|0|||
146193061|NCT03425539|527217787|FG000|Overall Study|Lost to Follow-up|0|||
146193062|NCT03425539|527217788|FG001|Overall Study|Lost to Follow-up|1|||
146193063|NCT00946192|527217789|FG000|Overall Study|Lost to Follow-up|6|||
146193064|NCT00946192|527217790|FG001|Overall Study|Lost to Follow-up|11|||
146193065|NCT00946192|527217791|FG002|Overall Study|Lost to Follow-up|9|||
146193066|NCT00946192|527217789|FG000|Overall Study|Withdrawal by Subject|10|||
146193067|NCT00946192|527217790|FG001|Overall Study|Withdrawal by Subject|7|||
146193068|NCT00946192|527217791|FG002|Overall Study|Withdrawal by Subject|3|||
146193069|NCT00946192|527217789|FG000|Overall Study|Did not start medication|2|||
146193070|NCT00946192|527217790|FG001|Overall Study|Did not start medication|0|||
146193071|NCT00946192|527217791|FG002|Overall Study|Did not start medication|0|||
146193072|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
146193073|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
146193074|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
146193075|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
146193076|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
146193077|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
146193078|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
146193079|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
146193080|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Death|1|||
146193081|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Death|0|||
146193082|NCT01080131|527217792|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
146193083|NCT01080131|527217793|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
146193084|NCT01080131|527217792|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
146193085|NCT01080131|527217793|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
146193086|NCT01080131|527217792|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
146193087|NCT01080131|527217793|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
146284622|NCT02074553|527555540|FG005|Intervention Period 1|Family Emergency|0|||
146284623|NCT02074553|527555541|FG006|Intervention Period 1|Family Emergency|0|||
146284624|NCT02074553|527555542|FG007|Intervention Period 1|Family Emergency|0|||
146284625|NCT02074553|527555535|FG000|Washout Period 1|Adverse Event|1|||
146284626|NCT02074553|527555536|FG001|Washout Period 1|Adverse Event|0|||
146284627|NCT02074553|527555537|FG002|Washout Period 1|Adverse Event|0|||
146284628|NCT02074553|527555538|FG003|Washout Period 1|Adverse Event|0|||
146284629|NCT02074553|527555539|FG004|Washout Period 1|Adverse Event|0|||
146284630|NCT02074553|527555540|FG005|Washout Period 1|Adverse Event|0|||
146284631|NCT02074553|527555541|FG006|Washout Period 1|Adverse Event|0|||
146284632|NCT02074553|527555542|FG007|Washout Period 1|Adverse Event|0|||
146284633|NCT02074553|527555535|FG000|Washout Period 1|Physician Decision|0|||
146284634|NCT02074553|527555536|FG001|Washout Period 1|Physician Decision|0|||
146284635|NCT02074553|527555537|FG002|Washout Period 1|Physician Decision|0|||
146284636|NCT02074553|527555538|FG003|Washout Period 1|Physician Decision|1|||
146284637|NCT02074553|527555539|FG004|Washout Period 1|Physician Decision|0|||
146284638|NCT02074553|527555540|FG005|Washout Period 1|Physician Decision|0|||
146284639|NCT02074553|527555541|FG006|Washout Period 1|Physician Decision|0|||
146284640|NCT02074553|527555542|FG007|Washout Period 1|Physician Decision|0|||
146284641|NCT02074553|527555535|FG000|Washout Period 1|Other|0|||
146284642|NCT02074553|527555536|FG001|Washout Period 1|Other|0|||
146284643|NCT02074553|527555537|FG002|Washout Period 1|Other|0|||
146284644|NCT02074553|527555538|FG003|Washout Period 1|Other|0|||
146284645|NCT02074553|527555539|FG004|Washout Period 1|Other|0|||
146284646|NCT02074553|527555540|FG005|Washout Period 1|Other|1|||
146284647|NCT02074553|527555541|FG006|Washout Period 1|Other|0|||
146284648|NCT02074553|527555542|FG007|Washout Period 1|Other|0|||
146284649|NCT02074553|527555535|FG000|Washout Period 2|Adverse Event|0|||
146284650|NCT02074553|527555536|FG001|Washout Period 2|Adverse Event|0|||
146284651|NCT02074553|527555537|FG002|Washout Period 2|Adverse Event|0|||
146284652|NCT02074553|527555538|FG003|Washout Period 2|Adverse Event|0|||
146284653|NCT02074553|527555539|FG004|Washout Period 2|Adverse Event|0|||
146284654|NCT02074553|527555540|FG005|Washout Period 2|Adverse Event|0|||
146284655|NCT02074553|527555541|FG006|Washout Period 2|Adverse Event|1|||
146284656|NCT02074553|527555542|FG007|Washout Period 2|Adverse Event|0|||
146284657|NCT02074553|527555535|FG000|Washout Period 2|Physician Decision|0|||
146284658|NCT02074553|527555536|FG001|Washout Period 2|Physician Decision|0|||
146284659|NCT02074553|527555537|FG002|Washout Period 2|Physician Decision|0|||
146284660|NCT02074553|527555538|FG003|Washout Period 2|Physician Decision|0|||
146284661|NCT02074553|527555539|FG004|Washout Period 2|Physician Decision|0|||
146284662|NCT02074553|527555540|FG005|Washout Period 2|Physician Decision|1|||
146284663|NCT02074553|527555541|FG006|Washout Period 2|Physician Decision|0|||
145947774|NCT02083653|526317295|FG000|Overall Study|Lost to Follow-up|1|||
145947775|NCT02083653|526317296|FG001|Overall Study|Lost to Follow-up|0|||
145947776|NCT02083653|526317297|FG002|Overall Study|Lost to Follow-up|0|||
145947777|NCT02083653|526317295|FG000|Overall Study|Death|2|||
145947778|NCT02083653|526317296|FG001|Overall Study|Death|2|||
145947779|NCT02083653|526317297|FG002|Overall Study|Death|2|||
145947780|NCT02083653|526317295|FG000|Overall Study|Progressive Disease|65|||
145947781|NCT02083653|526317296|FG001|Overall Study|Progressive Disease|73|||
146193088|NCT01080131|527217792|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
146193089|NCT01080131|527217793|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
146193090|NCT01080131|527217792|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
146193091|NCT01080131|527217793|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
146193092|NCT01080131|527217792|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
146193093|NCT01080131|527217793|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
146193094|NCT01080131|527217792|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
146193095|NCT01080131|527217793|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
146414691|NCT03997448|528024546|FG000|Follow up|study terminated|1|||
146414692|NCT01621490|528024549|FG000|Overall Study|Subject no longer meets study criteria|0|||
146414693|NCT01621490|528024550|FG001|Overall Study|Subject no longer meets study criteria|0|||
146414694|NCT01621490|528024551|FG002|Overall Study|Subject no longer meets study criteria|0|||
146414695|NCT01621490|528024552|FG003|Overall Study|Subject no longer meets study criteria|0|||
146414696|NCT01621490|528024553|FG004|Overall Study|Subject no longer meets study criteria|1|||
146414697|NCT01621490|528024554|FG005|Overall Study|Subject no longer meets study criteria|0|||
146414698|NCT01621490|528024555|FG006|Overall Study|Subject no longer meets study criteria|0|||
146414699|NCT01621490|528024556|FG007|Overall Study|Subject no longer meets study criteria|0|||
146414700|NCT01621490|528024557|FG008|Overall Study|Subject no longer meets study criteria|0|||
146414701|NCT01621490|528024558|FG009|Overall Study|Subject no longer meets study criteria|0|||
146414702|NCT01621490|528024559|FG010|Overall Study|Subject no longer meets study criteria|0|||
146414703|NCT01621490|528024549|FG000|Overall Study|Maximum clinical benefit|3|||
146414704|NCT01621490|528024550|FG001|Overall Study|Maximum clinical benefit|2|||
146414705|NCT01621490|528024551|FG002|Overall Study|Maximum clinical benefit|0|||
146414706|NCT01621490|528024552|FG003|Overall Study|Maximum clinical benefit|0|||
146414707|NCT01621490|528024553|FG004|Overall Study|Maximum clinical benefit|0|||
146414708|NCT01621490|528024554|FG005|Overall Study|Maximum clinical benefit|0|||
146414709|NCT01621490|528024555|FG006|Overall Study|Maximum clinical benefit|1|||
146414710|NCT01621490|528024556|FG007|Overall Study|Maximum clinical benefit|2|||
146414711|NCT01621490|528024557|FG008|Overall Study|Maximum clinical benefit|2|||
146414712|NCT01621490|528024558|FG009|Overall Study|Maximum clinical benefit|0|||
146414713|NCT01621490|528024559|FG010|Overall Study|Maximum clinical benefit|0|||
146414714|NCT01621490|528024549|FG000|Overall Study|Withdrawal by Subject|1|||
146414715|NCT01621490|528024550|FG001|Overall Study|Withdrawal by Subject|0|||
146414716|NCT01621490|528024551|FG002|Overall Study|Withdrawal by Subject|0|||
146414717|NCT01621490|528024552|FG003|Overall Study|Withdrawal by Subject|0|||
146414718|NCT01621490|528024553|FG004|Overall Study|Withdrawal by Subject|0|||
146414719|NCT01621490|528024554|FG005|Overall Study|Withdrawal by Subject|1|||
146414720|NCT01621490|528024555|FG006|Overall Study|Withdrawal by Subject|0|||
146414721|NCT01621490|528024556|FG007|Overall Study|Withdrawal by Subject|0|||
146414722|NCT01621490|528024557|FG008|Overall Study|Withdrawal by Subject|0|||
146414723|NCT01621490|528024558|FG009|Overall Study|Withdrawal by Subject|0|||
146414724|NCT01621490|528024559|FG010|Overall Study|Withdrawal by Subject|0|||
146414725|NCT01621490|528024549|FG000|Overall Study|Subject request to discontinue study|1|||
146414726|NCT01621490|528024550|FG001|Overall Study|Subject request to discontinue study|3|||
146414727|NCT01621490|528024551|FG002|Overall Study|Subject request to discontinue study|1|||
146414728|NCT01621490|528024552|FG003|Overall Study|Subject request to discontinue study|1|||
146414729|NCT01621490|528024553|FG004|Overall Study|Subject request to discontinue study|0|||
146414730|NCT01621490|528024554|FG005|Overall Study|Subject request to discontinue study|2|||
146414731|NCT01621490|528024555|FG006|Overall Study|Subject request to discontinue study|1|||
146414732|NCT01621490|528024556|FG007|Overall Study|Subject request to discontinue study|0|||
146414733|NCT01621490|528024557|FG008|Overall Study|Subject request to discontinue study|1|||
146414734|NCT01621490|528024558|FG009|Overall Study|Subject request to discontinue study|0|||
146414735|NCT01621490|528024559|FG010|Overall Study|Subject request to discontinue study|0|||
146414736|NCT01621490|528024549|FG000|Overall Study|Adverse event unrelated to study drug|1|||
146414737|NCT01621490|528024550|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146414738|NCT01621490|528024551|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146414739|NCT01621490|528024552|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146414740|NCT01621490|528024553|FG004|Overall Study|Adverse event unrelated to study drug|0|||
146414741|NCT01621490|528024554|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145947782|NCT02083653|526317297|FG002|Overall Study|Progressive Disease|63|||
145947783|NCT02083653|526317295|FG000|Overall Study|Withdrawal by Subject|2|||
145947784|NCT02083653|526317296|FG001|Overall Study|Withdrawal by Subject|1|||
145947785|NCT02083653|526317297|FG002|Overall Study|Withdrawal by Subject|2|||
146414742|NCT01621490|528024555|FG006|Overall Study|Adverse event unrelated to study drug|0|||
146414743|NCT01621490|528024556|FG007|Overall Study|Adverse event unrelated to study drug|2|||
146414744|NCT01621490|528024557|FG008|Overall Study|Adverse event unrelated to study drug|0|||
146414745|NCT01621490|528024558|FG009|Overall Study|Adverse event unrelated to study drug|0|||
146414746|NCT01621490|528024559|FG010|Overall Study|Adverse event unrelated to study drug|0|||
146414747|NCT01621490|528024549|FG000|Overall Study|Disease progression|27|||
146414748|NCT01621490|528024550|FG001|Overall Study|Disease progression|28|||
146414749|NCT01621490|528024551|FG002|Overall Study|Disease progression|1|||
146414750|NCT01621490|528024552|FG003|Overall Study|Disease progression|5|||
146414751|NCT01621490|528024553|FG004|Overall Study|Disease progression|3|||
146414752|NCT01621490|528024554|FG005|Overall Study|Disease progression|8|||
146414753|NCT01621490|528024555|FG006|Overall Study|Disease progression|7|||
146414754|NCT01621490|528024556|FG007|Overall Study|Disease progression|1|||
146414755|NCT01621490|528024557|FG008|Overall Study|Disease progression|4|||
146414756|NCT01621490|528024558|FG009|Overall Study|Disease progression|1|||
146414757|NCT01621490|528024559|FG010|Overall Study|Disease progression|1|||
146414758|NCT01621490|528024549|FG000|Overall Study|Study drug toxicity|1|||
146414759|NCT01621490|528024550|FG001|Overall Study|Study drug toxicity|4|||
146414760|NCT01621490|528024551|FG002|Overall Study|Study drug toxicity|5|||
146414761|NCT01621490|528024552|FG003|Overall Study|Study drug toxicity|3|||
146414762|NCT01621490|528024553|FG004|Overall Study|Study drug toxicity|1|||
146414763|NCT01621490|528024554|FG005|Overall Study|Study drug toxicity|10|||
146414764|NCT01621490|528024555|FG006|Overall Study|Study drug toxicity|1|||
146414765|NCT01621490|528024556|FG007|Overall Study|Study drug toxicity|4|||
146414766|NCT01621490|528024557|FG008|Overall Study|Study drug toxicity|1|||
146414767|NCT01621490|528024558|FG009|Overall Study|Study drug toxicity|0|||
146414768|NCT01621490|528024559|FG010|Overall Study|Study drug toxicity|0|||
146414769|NCT01621490|528024549|FG000|Overall Study|Death|0|||
146414770|NCT01621490|528024550|FG001|Overall Study|Death|0|||
146414771|NCT01621490|528024551|FG002|Overall Study|Death|0|||
146414772|NCT01621490|528024552|FG003|Overall Study|Death|0|||
146414773|NCT01621490|528024553|FG004|Overall Study|Death|0|||
146414774|NCT01621490|528024554|FG005|Overall Study|Death|0|||
146414775|NCT01621490|528024555|FG006|Overall Study|Death|0|||
146414776|NCT01621490|528024556|FG007|Overall Study|Death|0|||
146414777|NCT01621490|528024557|FG008|Overall Study|Death|1|||
146414778|NCT01621490|528024558|FG009|Overall Study|Death|0|||
146414779|NCT01621490|528024559|FG010|Overall Study|Death|0|||
146414780|NCT01621490|528024549|FG000|Overall Study|Other reasons|7|||
146284664|NCT02074553|527555542|FG007|Washout Period 2|Physician Decision|0|||
146284665|NCT02074553|527555535|FG000|Washout Period 2|Lost to Follow-up|0|||
146284666|NCT02074553|527555536|FG001|Washout Period 2|Lost to Follow-up|0|||
146284667|NCT02074553|527555537|FG002|Washout Period 2|Lost to Follow-up|1|||
146284668|NCT02074553|527555538|FG003|Washout Period 2|Lost to Follow-up|0|||
146284669|NCT02074553|527555539|FG004|Washout Period 2|Lost to Follow-up|0|||
146284670|NCT02074553|527555540|FG005|Washout Period 2|Lost to Follow-up|0|||
146284671|NCT02074553|527555541|FG006|Washout Period 2|Lost to Follow-up|0|||
146284672|NCT02074553|527555542|FG007|Washout Period 2|Lost to Follow-up|0|||
146284673|NCT02074553|527555535|FG000|Washout Period 3|Physician Decision|0|||
146284674|NCT02074553|527555536|FG001|Washout Period 3|Physician Decision|0|||
146284675|NCT02074553|527555537|FG002|Washout Period 3|Physician Decision|0|||
146284676|NCT02074553|527555538|FG003|Washout Period 3|Physician Decision|0|||
146284677|NCT02074553|527555539|FG004|Washout Period 3|Physician Decision|0|||
146284678|NCT02074553|527555540|FG005|Washout Period 3|Physician Decision|0|||
146284679|NCT02074553|527555541|FG006|Washout Period 3|Physician Decision|0|||
146284680|NCT02074553|527555542|FG007|Washout Period 3|Physician Decision|1|||
146284681|NCT04875676|527555543|FG000|Overall Study|Lost to Follow-up|1|||
146284682|NCT04875676|527555544|FG001|Overall Study|Lost to Follow-up|0|||
146284683|NCT04875676|527555545|FG002|Overall Study|Lost to Follow-up|0|||
146284684|NCT03103763|527555546|FG000|Overall Study|Death|15|||
146284685|NCT03103763|527555547|FG001|Overall Study|Death|5|||
146284686|NCT03103763|527555548|FG002|Overall Study|Death|5|||
146284687|NCT03103763|527555546|FG000|Overall Study|Withdrawal by Subject|0|||
146284688|NCT03103763|527555547|FG001|Overall Study|Withdrawal by Subject|3|||
146284689|NCT03103763|527555548|FG002|Overall Study|Withdrawal by Subject|2|||
146284690|NCT00618982|527555549|FG000|Overall Study|Adverse Event|23|||
146284691|NCT00618982|527555549|FG000|Overall Study|Withdrawal by Subject|1|||
146284692|NCT00618982|527555549|FG000|Overall Study|Protocol Violation|1|||
146284693|NCT00618982|527555549|FG000|Overall Study|ongoing, still treated with study med.|25|||
146284694|NCT04289051|527555552|FG000|Overall Study|Lost to Follow-up|0|||
146284695|NCT04289051|527555553|FG001|Overall Study|Lost to Follow-up|0|||
146284696|NCT04289051|527555554|FG002|Overall Study|Lost to Follow-up|2|||
146284697|NCT00717067|527555555|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146414781|NCT01621490|528024550|FG001|Overall Study|Other reasons|6|||
146284698|NCT00717067|527555556|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146284699|NCT00717067|527555557|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
146284700|NCT00717067|527555558|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146414782|NCT01621490|528024551|FG002|Overall Study|Other reasons|4|||
146414783|NCT01621490|528024552|FG003|Overall Study|Other reasons|1|||
146414784|NCT01621490|528024553|FG004|Overall Study|Other reasons|1|||
146414785|NCT01621490|528024554|FG005|Overall Study|Other reasons|3|||
146414786|NCT01621490|528024555|FG006|Overall Study|Other reasons|1|||
146414787|NCT01621490|528024556|FG007|Overall Study|Other reasons|1|||
146414788|NCT01621490|528024557|FG008|Overall Study|Other reasons|1|||
146414789|NCT01621490|528024558|FG009|Overall Study|Other reasons|0|||
146414790|NCT01621490|528024559|FG010|Overall Study|Other reasons|0|||
146414791|NCT00506753|528024560|FG000|Overall Study|Lost to Follow-up|21|||
146414792|NCT00506753|528024561|FG001|Overall Study|Lost to Follow-up|15|||
146414793|NCT00125359|528024562|FG000|Overall Study|Death|4|||
146414794|NCT00125359|528024562|FG000|Overall Study|Adverse Event|5|||
146414795|NCT00125359|528024562|FG000|Overall Study|Physician Decision|14|||
146414796|NCT02451670|528024563|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
146414797|NCT02451670|528024564|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
146414798|NCT00461500|528024565|FG000|Overall Study|Adverse Event|1|||
146414799|NCT00461500|528024566|FG001|Overall Study|Adverse Event|0|||
146414800|NCT00461500|528024565|FG000|Overall Study|Lack of Efficacy|0|||
146414801|NCT00461500|528024566|FG001|Overall Study|Lack of Efficacy|1|||
146414802|NCT00461500|528024565|FG000|Overall Study|Expired Drug Treatment|1|||
146414803|NCT00461500|528024566|FG001|Overall Study|Expired Drug Treatment|1|||
146414804|NCT00461500|528024565|FG000|Overall Study|Study Stopped|1|||
146414805|NCT00461500|528024566|FG001|Overall Study|Study Stopped|2|||
146414806|NCT00461500|528024565|FG000|Overall Study|Drug Treatment Misuse|1|||
146414807|NCT00461500|528024566|FG001|Overall Study|Drug Treatment Misuse|0|||
146414808|NCT00461500|528024565|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
146414809|NCT00461500|528024566|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
146414810|NCT00461500|528024565|FG000|Overall Study|Lost to Follow-up|2|||
146414811|NCT00461500|528024566|FG001|Overall Study|Lost to Follow-up|2|||
146414812|NCT01513551|528024571|FG000|Overall Study|Death|0|||
146414813|NCT01513551|528024572|FG001|Overall Study|Death|1|||
146414814|NCT01513551|528024573|FG002|Overall Study|Death|0|||
146414815|NCT01513551|528024571|FG000|Overall Study|Lost to Follow-up|3|||
146414816|NCT01513551|528024572|FG001|Overall Study|Lost to Follow-up|5|||
146414817|NCT01513551|528024573|FG002|Overall Study|Lost to Follow-up|2|||
146414818|NCT01513551|528024571|FG000|Overall Study|Withdrawal by Subject|1|||
146414819|NCT01513551|528024572|FG001|Overall Study|Withdrawal by Subject|0|||
146414820|NCT01513551|528024573|FG002|Overall Study|Withdrawal by Subject|2|||
146414821|NCT01513551|528024571|FG000|Overall Study|Randomized but not vaccinated|0|||
146414822|NCT01513551|528024572|FG001|Overall Study|Randomized but not vaccinated|0|||
146414823|NCT01513551|528024573|FG002|Overall Study|Randomized but not vaccinated|1|||
146414824|NCT04467697|528024574|FG000|Overall Study|Adverse Event|2|||
146414825|NCT04467697|528024574|FG000|Overall Study|Lost to Follow-up|6|||
146414826|NCT04467697|528024574|FG000|Overall Study|Withdrawal by Subject|9|||
146414827|NCT04467697|528024574|FG000|Overall Study|Protocol Violation|3|||
146414828|NCT05751629|528024575|FG000|Overall Study|Withdrawal by Subject|6|||
146284701|NCT00717067|527555559|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
146284702|NCT00657020|527555560|FG000|PERIOD 1|Adverse Event|0|||
146284703|NCT00657020|527555561|FG001|PERIOD 1|Adverse Event|1|||
146284704|NCT00822172|527555564|FG000|Overall Study|Adverse Event|10|||
146284705|NCT00822172|527555565|FG001|Overall Study|Adverse Event|12|||
146284706|NCT00822172|527555564|FG000|Overall Study|Death|1|||
146284707|NCT00822172|527555565|FG001|Overall Study|Death|0|||
146284708|NCT00822172|527555564|FG000|Overall Study|Lost to Follow-up|3|||
146284709|NCT00822172|527555565|FG001|Overall Study|Lost to Follow-up|1|||
146284710|NCT00822172|527555564|FG000|Overall Study|Withdrawal by Subject|1|||
146284711|NCT00822172|527555565|FG001|Overall Study|Withdrawal by Subject|4|||
146284712|NCT00822172|527555564|FG000|Overall Study|site closed|0|||
146284713|NCT00822172|527555565|FG001|Overall Study|site closed|1|||
146284714|NCT00822172|527555564|FG000|Overall Study|Other|0|||
146284715|NCT00822172|527555565|FG001|Overall Study|Other|1|||
146284716|NCT00700258|527555566|FG000|Overall Study|Premature discontinuation of documentation|136|||
146414829|NCT05751629|528024575|FG000|Overall Study|Death|25|||
146082312|NCT03222492|526822762|FG000|Overall Study|Withdrawal by Subject|0|||
146082313|NCT03222492|526822763|FG001|Overall Study|Withdrawal by Subject|0|||
146284717|NCT00700258|527555566|FG000|Overall Study|Type of study end not documented|1|||
146284718|NCT00700258|527555566|FG000|Overall Study|Lost to Follow-up|81|||
146284719|NCT00700258|527555566|FG000|Overall Study|Premature discontinuation of therapy|1013|||
146284720|NCT00370331|527555567|FG000|Overall Study|Adverse Event|4|||
146284721|NCT00370331|527555568|FG001|Overall Study|Adverse Event|13|||
146284722|NCT00370331|527555567|FG000|Overall Study|Withdrawal by Subject|2|||
146414830|NCT05751629|528024575|FG000|Overall Study|Study Site Closed|9|||
146414831|NCT05751629|528024575|FG000|Overall Study|Physician Decision|1|||
146414832|NCT01909466|528024576|FG000|Overall Study|Lost to Follow-up|5|||
146414833|NCT01909466|528024577|FG001|Overall Study|Lost to Follow-up|7|||
146414834|NCT01909466|528024576|FG000|Overall Study|Adverse Event|3|||
145947786|NCT02083653|526317295|FG000|Overall Study|Other Events|0|||
146284723|NCT00370331|527555568|FG001|Overall Study|Withdrawal by Subject|4|||
146414835|NCT01909466|528024577|FG001|Overall Study|Adverse Event|4|||
146414836|NCT01909466|528024576|FG000|Overall Study|Met Withdrawal Criteria|0|||
146284724|NCT00370331|527555567|FG000|Overall Study|Lost to Follow-up|0|||
146284725|NCT00370331|527555568|FG001|Overall Study|Lost to Follow-up|3|||
146284726|NCT00370331|527555567|FG000|Overall Study|Lack of Efficacy|0|||
146284727|NCT00370331|527555568|FG001|Overall Study|Lack of Efficacy|1|||
146284728|NCT00370331|527555567|FG000|Overall Study|Non-compliance|0|||
146284729|NCT00370331|527555568|FG001|Overall Study|Non-compliance|1|||
146284730|NCT00370331|527555567|FG000|Overall Study|Protocol Violation|1|||
146284731|NCT00370331|527555568|FG001|Overall Study|Protocol Violation|1|||
146284732|NCT02937454|527555569|FG000|Overall Study|Adverse Event|0|||
146284733|NCT02937454|527555570|FG001|Overall Study|Adverse Event|1|||
146284734|NCT02937454|527555569|FG000|Overall Study|Death|98|||
146284735|NCT02937454|527555570|FG001|Overall Study|Death|95|||
146284736|NCT02937454|527555569|FG000|Overall Study|Lost to Follow-up|1|||
146284737|NCT02937454|527555570|FG001|Overall Study|Lost to Follow-up|1|||
146284738|NCT02937454|527555569|FG000|Overall Study|Physician Decision|0|||
146284739|NCT02937454|527555570|FG001|Overall Study|Physician Decision|1|||
146284740|NCT02937454|527555569|FG000|Overall Study|Protocol Violation|6|||
146284741|NCT02937454|527555570|FG001|Overall Study|Protocol Violation|10|||
146284742|NCT02937454|527555569|FG000|Overall Study|Withdrawal by Subject|27|||
146284743|NCT02937454|527555570|FG001|Overall Study|Withdrawal by Subject|15|||
146284744|NCT02937454|527555569|FG000|Overall Study|Other|8|||
146284745|NCT02937454|527555570|FG001|Overall Study|Other|5|||
146284746|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
146284747|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146284748|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146284749|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146284750|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146284751|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
146284752|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
146284753|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146284754|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146284755|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146284756|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146284757|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
146284758|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
146284759|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146284760|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146284761|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146284762|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146284763|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
146284764|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
146284765|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146284766|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146284767|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146284768|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146284769|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
146284770|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
146284771|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146284772|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146284773|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146284774|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146284775|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
146284776|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
146284777|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146284778|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146284779|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146284780|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146284781|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
146284782|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
146414837|NCT01909466|528024577|FG001|Overall Study|Met Withdrawal Criteria|3|||
146414838|NCT01909466|528024576|FG000|Overall Study|Physician Decision|2|||
146414839|NCT01909466|528024577|FG001|Overall Study|Physician Decision|0|||
146414840|NCT01909466|528024576|FG000|Overall Study|Withdrawal by Subject|11|||
146414841|NCT01909466|528024577|FG001|Overall Study|Withdrawal by Subject|9|||
146414842|NCT01909466|528024576|FG000|Overall Study|Lack of Efficacy|1|||
146414843|NCT01909466|528024577|FG001|Overall Study|Lack of Efficacy|0|||
146414844|NCT00673361|528024581|FG000|Overall Study|Screen Failure|2|||
146414845|NCT03038113|528024586|FG000|Overall Study|Withdrawal by Subject|0|||
146414846|NCT03038113|528024587|FG001|Overall Study|Withdrawal by Subject|0|||
146414847|NCT03038113|528024588|FG002|Overall Study|Withdrawal by Subject|1|||
146414848|NCT03038113|528024589|FG003|Overall Study|Withdrawal by Subject|0|||
146193096|NCT01080131|527217792|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
146193097|NCT01080131|527217793|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
146193098|NCT02014558|527217794|FG000|Overall Study|Never Received Study Drug|0|||
146193099|NCT02014558|527217795|FG001|Overall Study|Never Received Study Drug|0|||
146193100|NCT02014558|527217796|FG002|Overall Study|Never Received Study Drug|0|||
146193101|NCT02014558|527217797|FG003|Overall Study|Never Received Study Drug|0|||
146193102|NCT02014558|527217798|FG004|Overall Study|Never Received Study Drug|1|||
146193103|NCT02014558|527217799|FG005|Overall Study|Never Received Study Drug|0|||
146193104|NCT02014558|527217800|FG006|Overall Study|Never Received Study Drug|1|||
146193105|NCT02014558|527217801|FG007|Overall Study|Never Received Study Drug|0|||
146193106|NCT02014558|527217802|FG008|Overall Study|Never Received Study Drug|2|||
146193107|NCT02014558|527217803|FG009|Overall Study|Never Received Study Drug|0|||
146193108|NCT02014558|527217804|FG010|Overall Study|Never Received Study Drug|2|||
146193109|NCT02014558|527217805|FG011|Overall Study|Never Received Study Drug|2|||
146193110|NCT02014558|527217806|FG012|Overall Study|Never Received Study Drug|0|||
146193111|NCT02014558|527217794|FG000|Overall Study|Adverse Event|0|||
146193112|NCT02014558|527217795|FG001|Overall Study|Adverse Event|0|||
146193113|NCT02014558|527217796|FG002|Overall Study|Adverse Event|0|||
146193114|NCT02014558|527217797|FG003|Overall Study|Adverse Event|0|||
146193115|NCT02014558|527217798|FG004|Overall Study|Adverse Event|1|||
146193116|NCT02014558|527217799|FG005|Overall Study|Adverse Event|0|||
146193117|NCT02014558|527217800|FG006|Overall Study|Adverse Event|0|||
146193118|NCT02014558|527217801|FG007|Overall Study|Adverse Event|0|||
146193119|NCT02014558|527217802|FG008|Overall Study|Adverse Event|2|||
146193120|NCT02014558|527217803|FG009|Overall Study|Adverse Event|2|||
146193121|NCT02014558|527217804|FG010|Overall Study|Adverse Event|5|||
146193122|NCT02014558|527217805|FG011|Overall Study|Adverse Event|21|||
146193123|NCT02014558|527217806|FG012|Overall Study|Adverse Event|3|||
146193124|NCT02014558|527217794|FG000|Overall Study|Death|1|||
146193125|NCT02014558|527217795|FG001|Overall Study|Death|0|||
146193126|NCT02014558|527217796|FG002|Overall Study|Death|0|||
146193127|NCT02014558|527217797|FG003|Overall Study|Death|0|||
146193128|NCT02014558|527217798|FG004|Overall Study|Death|0|||
146193129|NCT02014558|527217799|FG005|Overall Study|Death|0|||
146193130|NCT02014558|527217800|FG006|Overall Study|Death|1|||
146193131|NCT02014558|527217801|FG007|Overall Study|Death|1|||
146193132|NCT02014558|527217802|FG008|Overall Study|Death|2|||
146193133|NCT02014558|527217803|FG009|Overall Study|Death|5|||
146193134|NCT02014558|527217804|FG010|Overall Study|Death|5|||
146193135|NCT02014558|527217805|FG011|Overall Study|Death|19|||
146193136|NCT02014558|527217806|FG012|Overall Study|Death|2|||
146193137|NCT02014558|527217794|FG000|Overall Study|Lack of Efficacy|1|||
146193138|NCT02014558|527217795|FG001|Overall Study|Lack of Efficacy|2|||
146193139|NCT02014558|527217796|FG002|Overall Study|Lack of Efficacy|1|||
146193140|NCT02014558|527217797|FG003|Overall Study|Lack of Efficacy|1|||
146193141|NCT02014558|527217798|FG004|Overall Study|Lack of Efficacy|0|||
146193142|NCT02014558|527217799|FG005|Overall Study|Lack of Efficacy|0|||
146193143|NCT02014558|527217800|FG006|Overall Study|Lack of Efficacy|1|||
146193144|NCT02014558|527217801|FG007|Overall Study|Lack of Efficacy|3|||
146193145|NCT02014558|527217802|FG008|Overall Study|Lack of Efficacy|3|||
146193146|NCT02014558|527217803|FG009|Overall Study|Lack of Efficacy|3|||
146193147|NCT02014558|527217804|FG010|Overall Study|Lack of Efficacy|16|||
146193148|NCT02014558|527217805|FG011|Overall Study|Lack of Efficacy|8|||
146193149|NCT02014558|527217806|FG012|Overall Study|Lack of Efficacy|5|||
146193150|NCT02014558|527217794|FG000|Overall Study|Lost to Follow-up|0|||
146193151|NCT02014558|527217795|FG001|Overall Study|Lost to Follow-up|0|||
146414849|NCT03038113|528024590|FG004|Overall Study|Withdrawal by Subject|0|||
146193152|NCT02014558|527217796|FG002|Overall Study|Lost to Follow-up|0|||
146193153|NCT02014558|527217797|FG003|Overall Study|Lost to Follow-up|0|||
146193154|NCT02014558|527217798|FG004|Overall Study|Lost to Follow-up|0|||
146193155|NCT02014558|527217799|FG005|Overall Study|Lost to Follow-up|0|||
146193156|NCT02014558|527217800|FG006|Overall Study|Lost to Follow-up|0|||
146193157|NCT02014558|527217801|FG007|Overall Study|Lost to Follow-up|0|||
146193158|NCT02014558|527217802|FG008|Overall Study|Lost to Follow-up|0|||
146193159|NCT02014558|527217803|FG009|Overall Study|Lost to Follow-up|0|||
146193160|NCT02014558|527217804|FG010|Overall Study|Lost to Follow-up|1|||
146414850|NCT03038113|528024591|FG005|Overall Study|Withdrawal by Subject|0|||
146414851|NCT03038113|528024592|FG006|Overall Study|Withdrawal by Subject|0|||
146414852|NCT03038113|528024593|FG007|Overall Study|Withdrawal by Subject|0|||
146414853|NCT03038113|528024594|FG008|Overall Study|Withdrawal by Subject|0|||
146414854|NCT03038113|528024595|FG009|Overall Study|Withdrawal by Subject|0|||
146414855|NCT03038113|528024596|FG010|Overall Study|Withdrawal by Subject|0|||
146414856|NCT03038113|528024597|FG011|Overall Study|Withdrawal by Subject|0|||
146414857|NCT03038113|528024598|FG012|Overall Study|Withdrawal by Subject|0|||
146414858|NCT03038113|528024599|FG013|Overall Study|Withdrawal by Subject|1|||
146414859|NCT03038113|528024586|FG000|Overall Study|Lost to Follow-up|0|||
146414860|NCT03038113|528024587|FG001|Overall Study|Lost to Follow-up|0|||
146414861|NCT03038113|528024588|FG002|Overall Study|Lost to Follow-up|0|||
146414862|NCT03038113|528024589|FG003|Overall Study|Lost to Follow-up|0|||
146414863|NCT03038113|528024590|FG004|Overall Study|Lost to Follow-up|0|||
146414864|NCT03038113|528024591|FG005|Overall Study|Lost to Follow-up|0|||
146414865|NCT03038113|528024592|FG006|Overall Study|Lost to Follow-up|1|||
146414866|NCT03038113|528024593|FG007|Overall Study|Lost to Follow-up|0|||
146414867|NCT03038113|528024594|FG008|Overall Study|Lost to Follow-up|0|||
146414868|NCT03038113|528024595|FG009|Overall Study|Lost to Follow-up|0|||
146414869|NCT03038113|528024596|FG010|Overall Study|Lost to Follow-up|0|||
146414870|NCT03038113|528024597|FG011|Overall Study|Lost to Follow-up|0|||
146414871|NCT03038113|528024598|FG012|Overall Study|Lost to Follow-up|0|||
146414872|NCT03038113|528024599|FG013|Overall Study|Lost to Follow-up|0|||
146414873|NCT01698320|528024608|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
146414874|NCT01698320|528024609|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
146414875|NCT01698320|528024610|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
146414876|NCT01698320|528024608|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
146414877|NCT01698320|528024609|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
146414878|NCT01698320|528024610|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
146414879|NCT01698320|528024608|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
146414880|NCT01698320|528024609|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
146414881|NCT01698320|528024610|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
146414882|NCT01698320|528024608|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
146414883|NCT01698320|528024609|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
146414884|NCT01698320|528024610|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
146414885|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Adverse Event|0|||
146414886|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Adverse Event|1|||
146414887|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Adverse Event|1|||
146414888|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
146414889|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
146414890|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
146414891|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
146414892|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
146414893|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
146414894|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Pregnancy|0|||
146414895|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Pregnancy|1|||
146414896|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Pregnancy|1|||
146414897|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
146414898|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
146414899|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
146414900|NCT01698320|528024608|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
146414901|NCT01698320|528024609|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
146414902|NCT01698320|528024610|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
146414903|NCT01698320|528024608|FG000|40-Week Open-Label Period|Adverse Event|0|||
146414904|NCT01698320|528024609|FG001|40-Week Open-Label Period|Adverse Event|3|||
146414905|NCT01698320|528024610|FG002|40-Week Open-Label Period|Adverse Event|2|||
146414906|NCT01698320|528024608|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
146414907|NCT01698320|528024609|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
146414908|NCT01698320|528024610|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
146414909|NCT01698320|528024608|FG000|40-Week Open-Label Period|Pregnancy|0|||
146082314|NCT03222492|526822764|FG002|Overall Study|Withdrawal by Subject|1|||
146082315|NCT03222492|526822765|FG003|Overall Study|Withdrawal by Subject|0|||
146284783|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146414910|NCT01698320|528024609|FG001|40-Week Open-Label Period|Pregnancy|2|||
146414911|NCT01698320|528024610|FG002|40-Week Open-Label Period|Pregnancy|1|||
146414912|NCT01698320|528024608|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
146414913|NCT01698320|528024609|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
146414914|NCT01698320|528024610|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
146414915|NCT01698320|528024608|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
146414916|NCT01698320|528024609|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
146414917|NCT01698320|528024610|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
146414918|NCT02040766|528024614|FG000|Overall Study|Adverse Event|1|||
146414919|NCT02040766|528024615|FG001|Overall Study|Adverse Event|1|||
146414920|NCT02040766|528024616|FG002|Overall Study|Adverse Event|1|||
146414921|NCT02040766|528024617|FG003|Overall Study|Adverse Event|0|||
146414922|NCT02040766|528024618|FG004|Overall Study|Adverse Event|2|||
146414923|NCT02040766|528024614|FG000|Overall Study|Withdrawal by Subject|4|||
146414924|NCT02040766|528024615|FG001|Overall Study|Withdrawal by Subject|3|||
146414925|NCT02040766|528024616|FG002|Overall Study|Withdrawal by Subject|2|||
146414926|NCT02040766|528024617|FG003|Overall Study|Withdrawal by Subject|3|||
146414927|NCT02040766|528024618|FG004|Overall Study|Withdrawal by Subject|2|||
146414928|NCT02040766|528024614|FG000|Overall Study|Non-compliance|0|||
146414929|NCT02040766|528024615|FG001|Overall Study|Non-compliance|1|||
146414930|NCT02040766|528024616|FG002|Overall Study|Non-compliance|0|||
146414931|NCT02040766|528024617|FG003|Overall Study|Non-compliance|0|||
146414932|NCT02040766|528024618|FG004|Overall Study|Non-compliance|0|||
146414933|NCT02040766|528024614|FG000|Overall Study|Protocol Violation|2|||
146414934|NCT02040766|528024615|FG001|Overall Study|Protocol Violation|1|||
146414935|NCT02040766|528024616|FG002|Overall Study|Protocol Violation|2|||
146414936|NCT02040766|528024617|FG003|Overall Study|Protocol Violation|3|||
146284784|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146284785|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146284786|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146284787|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
146284788|NCT01160289|527555571|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
146284789|NCT01160289|527555572|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146284790|NCT01160289|527555573|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146284791|NCT01160289|527555574|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146284792|NCT01160289|527555575|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146284793|NCT01160289|527555576|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
146284794|NCT01160289|527555571|FG000|Post-Randomization Period|Adverse Event|0|||
146284795|NCT01160289|527555572|FG001|Post-Randomization Period|Adverse Event|4|||
146284796|NCT01160289|527555573|FG002|Post-Randomization Period|Adverse Event|4|||
146284797|NCT01160289|527555574|FG003|Post-Randomization Period|Adverse Event|2|||
146284798|NCT01160289|527555575|FG004|Post-Randomization Period|Adverse Event|0|||
146284799|NCT01160289|527555576|FG005|Post-Randomization Period|Adverse Event|0|||
146284800|NCT01160289|527555571|FG000|Post-Randomization Period|Death|0|||
146284801|NCT01160289|527555572|FG001|Post-Randomization Period|Death|0|||
146284802|NCT01160289|527555573|FG002|Post-Randomization Period|Death|0|||
146284803|NCT01160289|527555574|FG003|Post-Randomization Period|Death|1|||
146284804|NCT01160289|527555575|FG004|Post-Randomization Period|Death|0|||
146284805|NCT01160289|527555576|FG005|Post-Randomization Period|Death|0|||
146284806|NCT01160289|527555571|FG000|Post-Randomization Period|Lack of Efficacy|0|||
146284807|NCT01160289|527555572|FG001|Post-Randomization Period|Lack of Efficacy|1|||
146284808|NCT01160289|527555573|FG002|Post-Randomization Period|Lack of Efficacy|0|||
146284809|NCT01160289|527555574|FG003|Post-Randomization Period|Lack of Efficacy|3|||
146284810|NCT01160289|527555575|FG004|Post-Randomization Period|Lack of Efficacy|0|||
146284811|NCT01160289|527555576|FG005|Post-Randomization Period|Lack of Efficacy|0|||
146284812|NCT01160289|527555571|FG000|Post-Randomization Period|Lost to Follow-up|0|||
146284813|NCT01160289|527555572|FG001|Post-Randomization Period|Lost to Follow-up|3|||
146284814|NCT01160289|527555573|FG002|Post-Randomization Period|Lost to Follow-up|2|||
146284815|NCT01160289|527555574|FG003|Post-Randomization Period|Lost to Follow-up|5|||
146284816|NCT01160289|527555575|FG004|Post-Randomization Period|Lost to Follow-up|3|||
146284817|NCT01160289|527555576|FG005|Post-Randomization Period|Lost to Follow-up|4|||
146284818|NCT01160289|527555571|FG000|Post-Randomization Period|Physician Decision|0|||
146284819|NCT01160289|527555572|FG001|Post-Randomization Period|Physician Decision|0|||
146284820|NCT01160289|527555573|FG002|Post-Randomization Period|Physician Decision|1|||
146284821|NCT01160289|527555574|FG003|Post-Randomization Period|Physician Decision|0|||
146284822|NCT01160289|527555575|FG004|Post-Randomization Period|Physician Decision|0|||
146284823|NCT01160289|527555576|FG005|Post-Randomization Period|Physician Decision|0|||
146284824|NCT01160289|527555571|FG000|Post-Randomization Period|Protocol Violation|0|||
146414937|NCT02040766|528024618|FG004|Overall Study|Protocol Violation|0|||
146414938|NCT02040766|528024614|FG000|Overall Study|Lost to Follow-up|4|||
146414939|NCT02040766|528024615|FG001|Overall Study|Lost to Follow-up|1|||
146414940|NCT02040766|528024616|FG002|Overall Study|Lost to Follow-up|3|||
146082316|NCT03222492|526822762|FG000|Overall Study|COVID-19 related|0|||
146082317|NCT03222492|526822763|FG001|Overall Study|COVID-19 related|0|||
146082318|NCT03222492|526822764|FG002|Overall Study|COVID-19 related|1|||
146414941|NCT02040766|528024617|FG003|Overall Study|Lost to Follow-up|1|||
146414942|NCT02040766|528024618|FG004|Overall Study|Lost to Follow-up|4|||
146414943|NCT02040766|528024614|FG000|Overall Study|Not reported|1|||
146414944|NCT02040766|528024615|FG001|Overall Study|Not reported|0|||
146414945|NCT02040766|528024616|FG002|Overall Study|Not reported|0|||
146414946|NCT02040766|528024617|FG003|Overall Study|Not reported|0|||
146414947|NCT02040766|528024618|FG004|Overall Study|Not reported|0|||
146414948|NCT02040766|528024614|FG000|Overall Study|Lack of Efficacy|6|||
146414949|NCT02040766|528024615|FG001|Overall Study|Lack of Efficacy|3|||
146414950|NCT02040766|528024616|FG002|Overall Study|Lack of Efficacy|4|||
146414951|NCT02040766|528024617|FG003|Overall Study|Lack of Efficacy|6|||
146082319|NCT03222492|526822765|FG003|Overall Study|COVID-19 related|0|||
146082320|NCT00674154|526822766|FG000|Overall Study|Withdrawal by Subject|3|||
146082321|NCT00674154|526822767|FG001|Overall Study|Withdrawal by Subject|1|||
146082322|NCT00674154|526822766|FG000|Overall Study|Did not want parathyroidectomy|0|||
146082323|NCT00674154|526822767|FG001|Overall Study|Did not want parathyroidectomy|2|||
146082324|NCT00816023|526822768|FG000|Overall Study|Lost to Follow-up|1|||
146414952|NCT02040766|528024618|FG004|Overall Study|Lack of Efficacy|5|||
146414953|NCT01271933|528024619|FG000|Single-Blind Phase|Lack of Efficacy|37|||
146414954|NCT01271933|528024620|FG001|Single-Blind Phase|Lack of Efficacy|0|||
146414955|NCT01271933|528024621|FG002|Single-Blind Phase|Lack of Efficacy|0|||
146414956|NCT01271933|528024619|FG000|Single-Blind Phase|Lost to Follow-up|10|||
146414957|NCT01271933|528024620|FG001|Single-Blind Phase|Lost to Follow-up|0|||
146414958|NCT01271933|528024621|FG002|Single-Blind Phase|Lost to Follow-up|0|||
146414959|NCT01271933|528024619|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
146414960|NCT01271933|528024620|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
146414961|NCT01271933|528024621|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
146414962|NCT01271933|528024619|FG000|Single-Blind Phase|Protocol Violation|3|||
146414963|NCT01271933|528024620|FG001|Single-Blind Phase|Protocol Violation|0|||
146414964|NCT01271933|528024621|FG002|Single-Blind Phase|Protocol Violation|0|||
146414965|NCT01271933|528024619|FG000|Single-Blind Phase|Adverse Event|52|||
146414966|NCT01271933|528024620|FG001|Single-Blind Phase|Adverse Event|0|||
146414967|NCT01271933|528024621|FG002|Single-Blind Phase|Adverse Event|0|||
146414968|NCT01271933|528024619|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
146414969|NCT01271933|528024620|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
146414970|NCT01271933|528024621|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
146414971|NCT01271933|528024619|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
146414972|NCT01271933|528024620|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
146414973|NCT01271933|528024621|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
146414974|NCT01271933|528024619|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
146414975|NCT01271933|528024620|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
146414976|NCT01271933|528024621|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
146414977|NCT01271933|528024619|FG000|Double-Blind Phase|Randomized but not treated|0|||
146414978|NCT01271933|528024620|FG001|Double-Blind Phase|Randomized but not treated|0|||
146414979|NCT01271933|528024621|FG002|Double-Blind Phase|Randomized but not treated|1|||
146414980|NCT01271933|528024619|FG000|Double-Blind Phase|Lack of Efficacy|0|||
146414981|NCT01271933|528024620|FG001|Double-Blind Phase|Lack of Efficacy|6|||
146414982|NCT01271933|528024621|FG002|Double-Blind Phase|Lack of Efficacy|9|||
146414983|NCT01271933|528024619|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146414984|NCT01271933|528024620|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146414985|NCT01271933|528024621|FG002|Double-Blind Phase|Lost to Follow-up|1|||
146414986|NCT01271933|528024619|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146414987|NCT01271933|528024620|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146414988|NCT01271933|528024621|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
146414989|NCT01271933|528024619|FG000|Double-Blind Phase|Adverse Event|0|||
146414990|NCT01271933|528024620|FG001|Double-Blind Phase|Adverse Event|3|||
146414991|NCT01271933|528024621|FG002|Double-Blind Phase|Adverse Event|0|||
146414992|NCT01271933|528024619|FG000|Double-Blind Phase|Participant request-personal reason|0|||
146414993|NCT01271933|528024620|FG001|Double-Blind Phase|Participant request-personal reason|1|||
146414994|NCT01271933|528024621|FG002|Double-Blind Phase|Participant request-personal reason|0|||
146414995|NCT01620983|528024622|FG000|Overall Study|Lost to Follow-up|8|||
146414996|NCT01620983|528024623|FG001|Overall Study|Lost to Follow-up|4|||
146414997|NCT01620983|528024624|FG002|Overall Study|Lost to Follow-up|9|||
146414998|NCT01620983|528024622|FG000|Overall Study|Withdrawal by Subject|6|||
146414999|NCT01620983|528024623|FG001|Overall Study|Withdrawal by Subject|8|||
146415000|NCT01620983|528024624|FG002|Overall Study|Withdrawal by Subject|1|||
146415001|NCT01620983|528024622|FG000|Overall Study|Death|2|||
146415002|NCT01620983|528024623|FG001|Overall Study|Death|0|||
146415003|NCT01620983|528024624|FG002|Overall Study|Death|0|||
146415004|NCT01620983|528024622|FG000|Overall Study|Physician Decision|3|||
146415005|NCT01620983|528024623|FG001|Overall Study|Physician Decision|10|||
146284825|NCT01160289|527555572|FG001|Post-Randomization Period|Protocol Violation|4|||
146284826|NCT01160289|527555573|FG002|Post-Randomization Period|Protocol Violation|2|||
146284827|NCT01160289|527555574|FG003|Post-Randomization Period|Protocol Violation|0|||
146415006|NCT01620983|528024624|FG002|Overall Study|Physician Decision|5|||
146415007|NCT01724359|528024625|FG000|Overall Study|Adverse Event|10|||
146415008|NCT01724359|528024625|FG000|Overall Study|Death|1|||
146415009|NCT01724359|528024625|FG000|Overall Study|Other|20|||
146415010|NCT01335464|528024626|FG000|Overall Study|Adverse Event|15|||
146415011|NCT01335464|528024627|FG001|Overall Study|Adverse Event|25|||
146415012|NCT01335464|528024626|FG000|Overall Study|Non compliant with protocol|2|||
146415013|NCT01335464|528024627|FG001|Overall Study|Non compliant with protocol|0|||
146415014|NCT01335464|528024626|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
146415015|NCT01335464|528024627|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
146415016|NCT01335464|528024626|FG000|Overall Study|Not treated|2|||
146415017|NCT01335464|528024627|FG001|Overall Study|Not treated|0|||
146415018|NCT01335464|528024626|FG000|Overall Study|Reason other than those stated above|1|||
146415019|NCT01335464|528024627|FG001|Overall Study|Reason other than those stated above|1|||
146415020|NCT00871169|528024628|FG000|Overall Study|Protocol Violation|1|||
146415021|NCT00871169|528024628|FG000|Overall Study|Patient did not receive study treatment|2|||
146415022|NCT00252187|528024629|FG000|Overall Study|Adverse Event|3|||
146415023|NCT00252187|528024630|FG001|Overall Study|Adverse Event|1|||
146415024|NCT00252187|528024629|FG000|Overall Study|Withdrawal by Subject|1|||
146415025|NCT00252187|528024630|FG001|Overall Study|Withdrawal by Subject|0|||
146415026|NCT02280356|528024642|FG000|Overall Study|Not Treated|2|||
146415027|NCT02280356|528024642|FG000|Overall Study|Withdrawal by Subject|1|||
146415028|NCT02280356|528024642|FG000|Overall Study|Not evaluable|2|||
146415029|NCT03493698|528024643|FG000|Treatment Period C|Adverse Event|1|||
146415030|NCT03493698|528024643|FG000|Treatment Period C|Withdrawal by Subject|1|||
146415031|NCT03361956|528024644|FG000|Overall Study|Adverse Event|1|||
146415032|NCT03361956|528024645|FG001|Overall Study|Adverse Event|0|||
146415033|NCT03361956|528024646|FG002|Overall Study|Adverse Event|1|||
146415034|NCT03361956|528024647|FG003|Overall Study|Adverse Event|1|||
146415035|NCT03361956|528024648|FG004|Overall Study|Adverse Event|0|||
146415036|NCT03361956|528024644|FG000|Overall Study|Other|0|||
146415037|NCT03361956|528024645|FG001|Overall Study|Other|0|||
146415038|NCT03361956|528024646|FG002|Overall Study|Other|0|||
146415039|NCT03361956|528024647|FG003|Overall Study|Other|1|||
146415040|NCT03361956|528024648|FG004|Overall Study|Other|0|||
146415041|NCT03361956|528024644|FG000|Overall Study|Withdrawal by Subject|2|||
146415042|NCT03361956|528024645|FG001|Overall Study|Withdrawal by Subject|2|||
146415043|NCT03361956|528024646|FG002|Overall Study|Withdrawal by Subject|2|||
146415044|NCT03361956|528024647|FG003|Overall Study|Withdrawal by Subject|0|||
146415045|NCT03361956|528024648|FG004|Overall Study|Withdrawal by Subject|3|||
146415046|NCT03361956|528024644|FG000|Overall Study|Disease Relapse|0|||
146415047|NCT03361956|528024645|FG001|Overall Study|Disease Relapse|0|||
146415048|NCT03361956|528024646|FG002|Overall Study|Disease Relapse|1|||
146415049|NCT03361956|528024647|FG003|Overall Study|Disease Relapse|0|||
146415050|NCT03361956|528024648|FG004|Overall Study|Disease Relapse|0|||
146415051|NCT03361956|528024644|FG000|Overall Study|Physician Decision|0|||
146415052|NCT03361956|528024645|FG001|Overall Study|Physician Decision|2|||
146415053|NCT03361956|528024646|FG002|Overall Study|Physician Decision|0|||
146415054|NCT03361956|528024647|FG003|Overall Study|Physician Decision|1|||
146415055|NCT03361956|528024648|FG004|Overall Study|Physician Decision|0|||
146415056|NCT03361956|528024644|FG000|Overall Study|Lost to Follow-up|0|||
146415057|NCT03361956|528024645|FG001|Overall Study|Lost to Follow-up|0|||
146415058|NCT03361956|528024646|FG002|Overall Study|Lost to Follow-up|1|||
146415059|NCT03361956|528024647|FG003|Overall Study|Lost to Follow-up|1|||
146415060|NCT03361956|528024648|FG004|Overall Study|Lost to Follow-up|2|||
146415061|NCT00291330|528024650|FG000|Overall Study|Adverse Event|47|||
146415062|NCT00291330|528024651|FG001|Overall Study|Adverse Event|40|||
146415063|NCT00291330|528024650|FG000|Overall Study|Protocol Violation|13|||
146415064|NCT00291330|528024651|FG001|Overall Study|Protocol Violation|20|||
146415065|NCT00291330|528024650|FG000|Overall Study|Lost to Follow-up|16|||
146415066|NCT00291330|528024651|FG001|Overall Study|Lost to Follow-up|11|||
146415067|NCT00291330|528024650|FG000|Overall Study|Withdrawal by Subject|22|||
146415068|NCT00291330|528024651|FG001|Overall Study|Withdrawal by Subject|25|||
146415069|NCT00291330|528024650|FG000|Overall Study|Other|3|||
146415070|NCT00291330|528024651|FG001|Overall Study|Other|1|||
146415071|NCT01829295|528024652|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
146415072|NCT01829295|528024653|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
146415073|NCT01829295|528024654|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
146415074|NCT01829295|528024655|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
146415075|NCT01829295|528024652|FG000|6-12 Months|Adverse Event|0|||
146415076|NCT01829295|528024653|FG001|6-12 Months|Adverse Event|0|||
146415077|NCT01829295|528024654|FG002|6-12 Months|Adverse Event|3|||
146415078|NCT01829295|528024655|FG003|6-12 Months|Adverse Event|2|||
146415079|NCT01829295|528024652|FG000|6-12 Months|Lost to Follow-up|2|||
146415080|NCT01829295|528024653|FG001|6-12 Months|Lost to Follow-up|0|||
146193161|NCT02014558|527217805|FG011|Overall Study|Lost to Follow-up|0|||
146415081|NCT01829295|528024654|FG002|6-12 Months|Lost to Follow-up|0|||
146415082|NCT01829295|528024655|FG003|6-12 Months|Lost to Follow-up|0|||
146415083|NCT01829295|528024652|FG000|6-12 Months|Withdrawal by Subject|2|||
146415084|NCT01829295|528024653|FG001|6-12 Months|Withdrawal by Subject|2|||
146415085|NCT01829295|528024654|FG002|6-12 Months|Withdrawal by Subject|0|||
146415086|NCT01829295|528024655|FG003|6-12 Months|Withdrawal by Subject|0|||
146193162|NCT02014558|527217806|FG012|Overall Study|Lost to Follow-up|0|||
146193163|NCT02014558|527217794|FG000|Overall Study|Progressive Disease|1|||
146193164|NCT02014558|527217795|FG001|Overall Study|Progressive Disease|0|||
146193165|NCT02014558|527217796|FG002|Overall Study|Progressive Disease|1|||
146415087|NCT02629965|528024658|FG000|Period 1|Adverse Event|1|||
146415088|NCT02629965|528024659|FG001|Period 1|Adverse Event|0|||
146415089|NCT02629965|528024658|FG000|Period 1|Unexpected worsening of disease|2|||
146193166|NCT02014558|527217797|FG003|Overall Study|Progressive Disease|1|||
146415090|NCT02629965|528024659|FG001|Period 1|Unexpected worsening of disease|0|||
146415091|NCT02629965|528024658|FG000|Period 1|Other than listed above|1|||
146415092|NCT02629965|528024659|FG001|Period 1|Other than listed above|2|||
146415093|NCT02629965|528024658|FG000|Period 2|Adverse Event|1|||
146415094|NCT02629965|528024659|FG001|Period 2|Adverse Event|0|||
146415095|NCT03443869|528024660|FG000|Overall Study|Death|3|||
146415096|NCT03443869|528024661|FG001|Overall Study|Death|3|||
146415097|NCT03443869|528024660|FG000|Overall Study|Withdrawal by Subject|34|||
146415098|NCT03443869|528024661|FG001|Overall Study|Withdrawal by Subject|22|||
146415099|NCT03443869|528024660|FG000|Overall Study|Lost to Follow-up|1|||
146415100|NCT03443869|528024661|FG001|Overall Study|Lost to Follow-up|2|||
146415101|NCT03443869|528024660|FG000|Overall Study|Physician Decision|3|||
146415102|NCT03443869|528024661|FG001|Overall Study|Physician Decision|3|||
146415103|NCT03443869|528024660|FG000|Overall Study|Other|4|||
146415104|NCT03443869|528024661|FG001|Overall Study|Other|4|||
146415105|NCT02390219|528024662|FG000|Overall Study|Death|1|||
146415106|NCT02390219|528024662|FG000|Overall Study|Physician Decision|1|||
146415107|NCT02390219|528024662|FG000|Overall Study|Adverse Event|6|||
146415108|NCT02390219|528024662|FG000|Overall Study|Withdrawal by Subject|1|||
146415109|NCT02390219|528024662|FG000|Overall Study|Lost to Follow-up|2|||
146415110|NCT02390219|528024662|FG000|Overall Study|Other|2|||
146415111|NCT00299728|528024663|FG000|Overall Study|Lost to Follow-up|0|||
146415112|NCT00299728|528024664|FG001|Overall Study|Lost to Follow-up|1|||
146415113|NCT00299728|528024663|FG000|Overall Study|Withdrawal by Subject|0|||
146415114|NCT00299728|528024664|FG001|Overall Study|Withdrawal by Subject|1|||
146415115|NCT00299728|528024663|FG000|Overall Study|Progressive disease|0|||
146415116|NCT00299728|528024664|FG001|Overall Study|Progressive disease|1|||
146415117|NCT02230085|528024665|FG000|Overall Study|Physician Decision|1|||
146415118|NCT02230085|528024665|FG000|Overall Study|Withdrawal by Subject|3|||
146415119|NCT00580983|528024666|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
146415120|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
146415121|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
146415122|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
146415123|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
146415124|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
146415125|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Adverse Event|60|||
146415126|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Adverse Event|0|||
146415127|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Adverse Event|0|||
146415128|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Adverse Event|0|||
146415129|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Adverse Event|0|||
146415130|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
146415131|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146415132|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146415133|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146415134|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
146415135|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Physician Decision|10|||
146415136|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Physician Decision|0|||
146415137|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Physician Decision|0|||
146415138|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Physician Decision|0|||
146415139|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Physician Decision|0|||
146415140|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
146415141|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146415142|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146415143|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146082325|NCT00816023|526822769|FG001|Overall Study|Lost to Follow-up|1|||
146415144|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
146415145|NCT01360632|528024667|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
146415146|NCT01360632|528024668|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
146415147|NCT01360632|528024669|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
146415148|NCT01360632|528024670|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
146415149|NCT01360632|528024671|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
146415150|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
146415151|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
146415152|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
146415153|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
146082326|NCT00816023|526822770|FG002|Overall Study|Lost to Follow-up|0|||
146082327|NCT00816023|526822771|FG003|Overall Study|Lost to Follow-up|0|||
146082328|NCT00816023|526822768|FG000|Overall Study|Withdrawal by Subject|1|||
146082329|NCT00816023|526822769|FG001|Overall Study|Withdrawal by Subject|0|||
146082330|NCT00816023|526822770|FG002|Overall Study|Withdrawal by Subject|0|||
146082331|NCT00816023|526822771|FG003|Overall Study|Withdrawal by Subject|0|||
146082332|NCT00816023|526822768|FG000|Overall Study|Physician Decision|0|||
146082333|NCT00816023|526822769|FG001|Overall Study|Physician Decision|0|||
146082334|NCT00816023|526822770|FG002|Overall Study|Physician Decision|1|||
146082335|NCT00816023|526822771|FG003|Overall Study|Physician Decision|0|||
146082336|NCT00816023|526822768|FG000|Overall Study|assessments complete prior to window|1|||
146082337|NCT00816023|526822769|FG001|Overall Study|assessments complete prior to window|1|||
146415154|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
146415155|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Adverse Event|0|||
146415156|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Adverse Event|3|||
146415157|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Adverse Event|9|||
146415158|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Adverse Event|3|||
146415159|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Adverse Event|0|||
146415160|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146415161|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146415162|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
146415163|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
146415164|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146415165|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Physician Decision|0|||
146415166|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Physician Decision|0|||
146415167|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Physician Decision|0|||
146415168|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Physician Decision|1|||
146415169|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Physician Decision|0|||
146415170|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146415171|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
146415172|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
146415173|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
146415174|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146415175|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
146415176|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
146415177|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
146415178|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
146415179|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
146415180|NCT01360632|528024667|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
146415181|NCT01360632|528024668|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
146415182|NCT01360632|528024669|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
146415183|NCT01360632|528024670|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
146415184|NCT01360632|528024671|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
146415185|NCT01360632|528024667|FG000|Phase A+|Lost to Follow-up|0|||
146415186|NCT01360632|528024668|FG001|Phase A+|Lost to Follow-up|0|||
146415187|NCT01360632|528024669|FG002|Phase A+|Lost to Follow-up|0|||
146415188|NCT01360632|528024670|FG003|Phase A+|Lost to Follow-up|0|||
146415189|NCT01360632|528024671|FG004|Phase A+|Lost to Follow-up|2|||
146415190|NCT01360632|528024667|FG000|Phase A+|Adverse Event|0|||
146415191|NCT01360632|528024668|FG001|Phase A+|Adverse Event|0|||
146415192|NCT01360632|528024669|FG002|Phase A+|Adverse Event|0|||
146415193|NCT01360632|528024670|FG003|Phase A+|Adverse Event|0|||
146415194|NCT01360632|528024671|FG004|Phase A+|Adverse Event|2|||
146415195|NCT01360632|528024667|FG000|Phase A+|Met Withdrawal Criteria|0|||
146415196|NCT01360632|528024668|FG001|Phase A+|Met Withdrawal Criteria|0|||
146415197|NCT01360632|528024669|FG002|Phase A+|Met Withdrawal Criteria|0|||
146415198|NCT01360632|528024670|FG003|Phase A+|Met Withdrawal Criteria|0|||
146415199|NCT01360632|528024671|FG004|Phase A+|Met Withdrawal Criteria|7|||
146415200|NCT01360632|528024667|FG000|Phase A+|Physician Decision|0|||
146415201|NCT01360632|528024668|FG001|Phase A+|Physician Decision|0|||
146415202|NCT01360632|528024669|FG002|Phase A+|Physician Decision|0|||
146415203|NCT01360632|528024670|FG003|Phase A+|Physician Decision|0|||
146415204|NCT01360632|528024671|FG004|Phase A+|Physician Decision|3|||
146415205|NCT01360632|528024667|FG000|Phase A+|Withdrawal by Subject|0|||
146415206|NCT01360632|528024668|FG001|Phase A+|Withdrawal by Subject|0|||
146415207|NCT01360632|528024669|FG002|Phase A+|Withdrawal by Subject|0|||
146415208|NCT01360632|528024670|FG003|Phase A+|Withdrawal by Subject|0|||
146415209|NCT01360632|528024671|FG004|Phase A+|Withdrawal by Subject|8|||
146415210|NCT01360632|528024667|FG000|Phase A+|Protocol Deviation|0|||
146415211|NCT01360632|528024668|FG001|Phase A+|Protocol Deviation|0|||
146415212|NCT01360632|528024669|FG002|Phase A+|Protocol Deviation|0|||
146415213|NCT01360632|528024670|FG003|Phase A+|Protocol Deviation|0|||
146415214|NCT01360632|528024671|FG004|Phase A+|Protocol Deviation|3|||
146415215|NCT01298596|528024672|FG000|Overall Study|Withdrawal by Subject|1|||
146415216|NCT01298596|528024673|FG001|Overall Study|Withdrawal by Subject|1|||
146415217|NCT01298596|528024672|FG000|Overall Study|Death|5|||
146415218|NCT01298596|528024673|FG001|Overall Study|Death|3|||
146415219|NCT01298596|528024672|FG000|Overall Study|Lost to Follow-up|6|||
146415220|NCT01298596|528024673|FG001|Overall Study|Lost to Follow-up|14|||
146415221|NCT01298596|528024672|FG000|Overall Study|Referred for further management|16|||
146415222|NCT01298596|528024673|FG001|Overall Study|Referred for further management|15|||
146415223|NCT04128696|528024674|FG000|Overall Study|Lost to Follow-up|3|||
146415224|NCT04128696|528024675|FG001|Overall Study|Lost to Follow-up|7|||
146415225|NCT04128696|528024674|FG000|Overall Study|Withdrawal by Subject|12|||
146415226|NCT04128696|528024675|FG001|Overall Study|Withdrawal by Subject|11|||
146415227|NCT04128696|528024674|FG000|Overall Study|Study Closed/Terminated|26|||
146415228|NCT04128696|528024675|FG001|Overall Study|Study Closed/Terminated|38|||
146415229|NCT04128696|528024674|FG000|Overall Study|Physician Decision|2|||
146415230|NCT04128696|528024675|FG001|Overall Study|Physician Decision|3|||
146415231|NCT02173301|528024676|FG000|Overall Study|Adverse Event|7|||
146415232|NCT02173301|528024677|FG001|Overall Study|Adverse Event|8|||
146193167|NCT02014558|527217798|FG004|Overall Study|Progressive Disease|1|||
146193168|NCT02014558|527217799|FG005|Overall Study|Progressive Disease|2|||
146193169|NCT02014558|527217800|FG006|Overall Study|Progressive Disease|1|||
146193170|NCT02014558|527217801|FG007|Overall Study|Progressive Disease|6|||
146193171|NCT02014558|527217802|FG008|Overall Study|Progressive Disease|5|||
146193172|NCT02014558|527217803|FG009|Overall Study|Progressive Disease|6|||
146193173|NCT02014558|527217804|FG010|Overall Study|Progressive Disease|22|||
146193174|NCT02014558|527217805|FG011|Overall Study|Progressive Disease|31|||
146193175|NCT02014558|527217806|FG012|Overall Study|Progressive Disease|6|||
146193176|NCT02014558|527217794|FG000|Overall Study|Withdrawal by Subject|0|||
146193177|NCT02014558|527217795|FG001|Overall Study|Withdrawal by Subject|0|||
146284828|NCT01160289|527555575|FG004|Post-Randomization Period|Protocol Violation|1|||
146284829|NCT01160289|527555576|FG005|Post-Randomization Period|Protocol Violation|3|||
146284830|NCT01160289|527555571|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
146284831|NCT01160289|527555572|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
146284832|NCT01160289|527555573|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
146284833|NCT01160289|527555574|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
146284834|NCT01160289|527555575|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
146284835|NCT01160289|527555576|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
146284836|NCT01160289|527555571|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
146284837|NCT01160289|527555572|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
146284838|NCT01160289|527555573|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
146284839|NCT01160289|527555574|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
146284840|NCT01160289|527555575|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
146284841|NCT01160289|527555576|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
146284842|NCT01160289|527555571|FG000|Post-Randomization Period|Sponsor Decision|0|||
146284843|NCT01160289|527555572|FG001|Post-Randomization Period|Sponsor Decision|1|||
146284844|NCT01160289|527555573|FG002|Post-Randomization Period|Sponsor Decision|0|||
146284845|NCT01160289|527555574|FG003|Post-Randomization Period|Sponsor Decision|0|||
146284846|NCT01160289|527555575|FG004|Post-Randomization Period|Sponsor Decision|0|||
146284847|NCT01160289|527555576|FG005|Post-Randomization Period|Sponsor Decision|0|||
146284848|NCT00993668|527555577|FG000|Single-Blind Period|Adverse Event|1|||
146284849|NCT00993668|527555578|FG001|Single-Blind Period|Adverse Event|1|||
146284850|NCT00993668|527555577|FG000|Single-Blind Period|Lack of Efficacy|0|||
146284851|NCT00993668|527555578|FG001|Single-Blind Period|Lack of Efficacy|1|||
146284852|NCT00993668|527555577|FG000|Single-Blind Period|Lost to Follow-up|3|||
146284853|NCT00993668|527555578|FG001|Single-Blind Period|Lost to Follow-up|1|||
146284854|NCT00993668|527555577|FG000|Open-Label Period|Adverse Event|9|||
146284855|NCT00993668|527555578|FG001|Open-Label Period|Adverse Event|8|||
146284856|NCT00993668|527555577|FG000|Open-Label Period|Lack of Efficacy|4|||
146284857|NCT00993668|527555578|FG001|Open-Label Period|Lack of Efficacy|3|||
146284858|NCT00993668|527555577|FG000|Open-Label Period|Withdrawal by Subject|4|||
146284859|NCT00993668|527555578|FG001|Open-Label Period|Withdrawal by Subject|3|||
146284860|NCT00993668|527555577|FG000|Open-Label Period|Lost to Follow-up|6|||
146284861|NCT00993668|527555578|FG001|Open-Label Period|Lost to Follow-up|1|||
146284862|NCT03606668|527555582|FG000|Overall Study|Screen Failure|1|||
146284863|NCT03606668|527555582|FG000|Overall Study|Lost to Follow-up|1|||
146284864|NCT01014143|527555583|FG000|Second Intervention|Lost to Follow-up|2|||
146193178|NCT02014558|527217796|FG002|Overall Study|Withdrawal by Subject|0|||
146193179|NCT02014558|527217797|FG003|Overall Study|Withdrawal by Subject|0|||
146284865|NCT01014143|527555584|FG001|Second Intervention|Lost to Follow-up|0|||
146284866|NCT01014143|527555585|FG002|Second Intervention|Lost to Follow-up|0|||
146284867|NCT01029652|527555588|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
146284868|NCT01029652|527555589|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
146284869|NCT01029652|527555588|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
146284870|NCT01029652|527555589|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
146284871|NCT01029652|527555588|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
146284872|NCT01029652|527555589|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
146284873|NCT01029652|527555588|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
146284874|NCT01029652|527555589|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
146284875|NCT01029652|527555588|FG000|Core Study (0-12 Weeks)|Death|0|||
146284876|NCT01029652|527555589|FG001|Core Study (0-12 Weeks)|Death|1|||
146284877|NCT01029652|527555588|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
146284878|NCT01029652|527555589|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
146284879|NCT01029652|527555588|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
146284880|NCT01029652|527555589|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
146284881|NCT01029652|527555588|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
146284882|NCT01029652|527555589|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
146284883|NCT01029652|527555588|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
146284884|NCT01029652|527555589|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
146284885|NCT01029652|527555588|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
146284886|NCT01029652|527555589|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
146284887|NCT01029652|527555588|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
146284888|NCT01029652|527555589|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
146284889|NCT01029652|527555588|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
146284890|NCT01029652|527555589|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
146284891|NCT02313233|527555590|FG000|Overall Study|Withdrawal by Subject|1|||
146284892|NCT02313233|527555591|FG001|Overall Study|Withdrawal by Subject|2|||
146284893|NCT02313233|527555590|FG000|Overall Study|Administrative reason|1|||
146284894|NCT02313233|527555591|FG001|Overall Study|Administrative reason|1|||
146284895|NCT02095951|527555592|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
146284896|NCT02095951|527555593|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
146284897|NCT04638920|527555594|FG000|Overall Study|Withdrawal by Subject|5|||
146284898|NCT05383508|527555595|FG000|Overall Study|Withdrawal by Subject|1|||
146284899|NCT05383508|527555596|FG001|Overall Study|Withdrawal by Subject|0|||
146284900|NCT05383508|527555597|FG002|Overall Study|Withdrawal by Subject|1|||
146284901|NCT05383508|527555598|FG003|Overall Study|Withdrawal by Subject|1|||
146284902|NCT05383508|527555599|FG004|Overall Study|Withdrawal by Subject|2|||
146284903|NCT05383508|527555600|FG005|Overall Study|Withdrawal by Subject|0|||
146284904|NCT03775434|527555602|FG000|Overall Study|Adverse Event|2|||
146284905|NCT03775434|527555602|FG000|Overall Study|Withdrawal by Subject|1|||
146284906|NCT01621568|527555603|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
146284907|NCT01621568|527555604|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
146284908|NCT01621568|527555603|FG000|Week 5-6 No Treatment|Death|1|||
146284909|NCT01621568|527555604|FG001|Week 5-6 No Treatment|Death|0|||
146284910|NCT01859988|527555605|FG000|Overall Study|Withdrawal by Subject|6|||
146284911|NCT01859988|527555606|FG001|Overall Study|Withdrawal by Subject|3|||
146284912|NCT01859988|527555607|FG002|Overall Study|Withdrawal by Subject|4|||
146284913|NCT01859988|527555608|FG003|Overall Study|Withdrawal by Subject|3|||
146284914|NCT01859988|527555609|FG004|Overall Study|Withdrawal by Subject|2|||
146284915|NCT01859988|527555610|FG005|Overall Study|Withdrawal by Subject|2|||
146284916|NCT01859988|527555605|FG000|Overall Study|Lack of Efficacy|1|||
146284917|NCT01859988|527555606|FG001|Overall Study|Lack of Efficacy|1|||
146284918|NCT01859988|527555607|FG002|Overall Study|Lack of Efficacy|5|||
146284919|NCT01859988|527555608|FG003|Overall Study|Lack of Efficacy|0|||
146284920|NCT01859988|527555609|FG004|Overall Study|Lack of Efficacy|7|||
146284921|NCT01859988|527555610|FG005|Overall Study|Lack of Efficacy|9|||
146284922|NCT01859988|527555605|FG000|Overall Study|Physician Decision|1|||
146284923|NCT01859988|527555606|FG001|Overall Study|Physician Decision|3|||
146284924|NCT01859988|527555607|FG002|Overall Study|Physician Decision|1|||
146284925|NCT01859988|527555608|FG003|Overall Study|Physician Decision|3|||
146284926|NCT01859988|527555609|FG004|Overall Study|Physician Decision|4|||
146284927|NCT01859988|527555610|FG005|Overall Study|Physician Decision|1|||
146284928|NCT01859988|527555605|FG000|Overall Study|Adverse Event|2|||
146284929|NCT01859988|527555606|FG001|Overall Study|Adverse Event|1|||
146284930|NCT01859988|527555607|FG002|Overall Study|Adverse Event|3|||
146284931|NCT01859988|527555608|FG003|Overall Study|Adverse Event|1|||
146284932|NCT01859988|527555609|FG004|Overall Study|Adverse Event|2|||
146284933|NCT01859988|527555610|FG005|Overall Study|Adverse Event|2|||
146082338|NCT00816023|526822770|FG002|Overall Study|assessments complete prior to window|2|||
146284934|NCT01859988|527555605|FG000|Overall Study|Lost to Follow-up|1|||
146284935|NCT01859988|527555606|FG001|Overall Study|Lost to Follow-up|2|||
146415233|NCT02173301|528024678|FG002|Overall Study|Adverse Event|13|||
146415234|NCT02173301|528024679|FG003|Overall Study|Adverse Event|5|||
146415235|NCT02173301|528024676|FG000|Overall Study|Withdrawal by Subject|8|||
146415236|NCT02173301|528024677|FG001|Overall Study|Withdrawal by Subject|10|||
146415237|NCT02173301|528024678|FG002|Overall Study|Withdrawal by Subject|4|||
146415238|NCT02173301|528024679|FG003|Overall Study|Withdrawal by Subject|8|||
146415239|NCT02173301|528024676|FG000|Overall Study|Lost to Follow-up|4|||
146415240|NCT02173301|528024677|FG001|Overall Study|Lost to Follow-up|4|||
146415241|NCT02173301|528024678|FG002|Overall Study|Lost to Follow-up|2|||
146415242|NCT02173301|528024679|FG003|Overall Study|Lost to Follow-up|2|||
146415243|NCT02173301|528024676|FG000|Overall Study|Protocol Violation|0|||
146415244|NCT02173301|528024677|FG001|Overall Study|Protocol Violation|1|||
146415245|NCT02173301|528024678|FG002|Overall Study|Protocol Violation|0|||
146415246|NCT02173301|528024679|FG003|Overall Study|Protocol Violation|0|||
146415247|NCT02173301|528024676|FG000|Overall Study|Physician Decision|0|||
146415248|NCT02173301|528024677|FG001|Overall Study|Physician Decision|0|||
146415249|NCT02173301|528024678|FG002|Overall Study|Physician Decision|1|||
146415250|NCT02173301|528024679|FG003|Overall Study|Physician Decision|0|||
146415251|NCT02173301|528024676|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
146415252|NCT02173301|528024677|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146415253|NCT02173301|528024678|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146415254|NCT02173301|528024679|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
146415255|NCT03740100|528024680|FG000|Overall Study|Adverse Event|1|||
146415256|NCT03740100|528024680|FG000|Overall Study|Death|1|||
146415257|NCT03120520|528024681|FG000|Overall Study|Lost to Follow-up|1|||
146415258|NCT03120520|528024682|FG001|Overall Study|Lost to Follow-up|1|||
146415259|NCT03120520|528024683|FG002|Overall Study|Lost to Follow-up|1|||
146415260|NCT03120520|528024684|FG003|Overall Study|Lost to Follow-up|1|||
146415261|NCT03120520|528024681|FG000|Overall Study|Withdrawal by Subject|3|||
146415262|NCT03120520|528024682|FG001|Overall Study|Withdrawal by Subject|2|||
146415263|NCT03120520|528024683|FG002|Overall Study|Withdrawal by Subject|3|||
146415264|NCT03120520|528024684|FG003|Overall Study|Withdrawal by Subject|2|||
146415265|NCT03120520|528024681|FG000|Overall Study|Other|0|||
146415266|NCT03120520|528024682|FG001|Overall Study|Other|1|||
146415267|NCT03120520|528024683|FG002|Overall Study|Other|0|||
146415268|NCT03120520|528024684|FG003|Overall Study|Other|0|||
146415269|NCT02123459|528024688|FG000|Washout Period (1 Day)|Adverse Event|1|||
146415270|NCT02123459|528024689|FG001|Washout Period (1 Day)|Adverse Event|0|||
146415271|NCT03387059|528024690|FG000|Overall Study|Study termination|5|||
146415272|NCT03387059|528024691|FG001|Overall Study|Study termination|4|||
146415273|NCT00254397|528024692|FG000|Overall Study|Disease Progression|4|||
146415274|NCT00254397|528024693|FG001|Overall Study|Disease Progression|1|||
146415275|NCT00254397|528024694|FG002|Overall Study|Disease Progression|16|||
146415276|NCT00254397|528024695|FG003|Overall Study|Disease Progression|23|||
146415277|NCT00254397|528024692|FG000|Overall Study|Non-Compliant|0|||
146415278|NCT00254397|528024693|FG001|Overall Study|Non-Compliant|0|||
146415279|NCT00254397|528024694|FG002|Overall Study|Non-Compliant|0|||
146415280|NCT00254397|528024695|FG003|Overall Study|Non-Compliant|1|||
146415281|NCT00254397|528024692|FG000|Overall Study|Adverse Event|2|||
146415282|NCT00254397|528024693|FG001|Overall Study|Adverse Event|0|||
146415283|NCT00254397|528024694|FG002|Overall Study|Adverse Event|3|||
146415284|NCT00254397|528024695|FG003|Overall Study|Adverse Event|1|||
146415285|NCT02482805|528026568|FG000|Overall Study|Lost to Follow-up|4|||
146415286|NCT02482805|528026569|FG001|Overall Study|Lost to Follow-up|4|||
146415287|NCT02482805|528026570|FG002|Overall Study|Lost to Follow-up|0|||
146415288|NCT01806597|528026573|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
146415289|NCT01806597|528026574|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
146082339|NCT00816023|526822771|FG003|Overall Study|assessments complete prior to window|1|||
146284936|NCT01859988|527555607|FG002|Overall Study|Lost to Follow-up|3|||
146284937|NCT01859988|527555608|FG003|Overall Study|Lost to Follow-up|0|||
146284938|NCT01859988|527555609|FG004|Overall Study|Lost to Follow-up|3|||
146284939|NCT01859988|527555610|FG005|Overall Study|Lost to Follow-up|2|||
146284940|NCT01859988|527555605|FG000|Overall Study|Protocol Violation|0|||
146415290|NCT01806597|528026575|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146415291|NCT01806597|528026576|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146415292|NCT01806597|528026577|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
146415293|NCT01806597|528026578|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
146415294|NCT01806597|528026573|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
146415295|NCT01806597|528026574|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146415296|NCT01806597|528026575|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146415297|NCT01806597|528026576|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146415298|NCT01806597|528026577|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
146415299|NCT01806597|528026578|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
146415300|NCT01806597|528026573|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146415301|NCT01806597|528026574|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
146415302|NCT01806597|528026575|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146415303|NCT01806597|528026576|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146415304|NCT01806597|528026577|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146415305|NCT01806597|528026578|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
146415306|NCT01806597|528026573|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
146415307|NCT01806597|528026574|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
146415308|NCT01806597|528026575|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146415309|NCT01806597|528026576|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146415310|NCT01806597|528026577|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
146415311|NCT01806597|528026578|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
146415312|NCT01806597|528026573|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146415313|NCT01806597|528026574|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
146415314|NCT01806597|528026575|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146415315|NCT01806597|528026576|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146415316|NCT01806597|528026577|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146415317|NCT01806597|528026578|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
146415318|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
146415319|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
146415320|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
146415321|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
146415322|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
146415323|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
146415324|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
146415325|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
146415326|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
146415327|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
146415328|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
146415329|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
146415330|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
146415331|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146415332|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146415333|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146415334|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146415335|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
146415336|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
146415337|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
146415338|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146415339|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146415340|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146415341|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
146415342|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
146415343|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146415344|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146415345|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146415346|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146415347|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
146415348|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146415349|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
146415350|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146415351|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
146415352|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146415353|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
146415354|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
146415355|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
146415356|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
146415357|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
146415358|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
146415359|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
146415360|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
146415361|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
146415362|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
146082340|NCT00816023|526822768|FG000|Overall Study|Randomized Not Treated|6|||
146082341|NCT00816023|526822769|FG001|Overall Study|Randomized Not Treated|4|||
146415363|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
146415364|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
146415365|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
146415366|NCT01806597|528026573|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
146415367|NCT01806597|528026574|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146415368|NCT01806597|528026575|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146415369|NCT01806597|528026576|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146415370|NCT01806597|528026577|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146415371|NCT01806597|528026578|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
146415372|NCT01806597|528026573|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146415373|NCT01806597|528026574|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146415374|NCT01806597|528026575|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146415375|NCT01806597|528026576|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146415376|NCT01806597|528026577|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
146415377|NCT01806597|528026578|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
146415378|NCT01806597|528026573|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146415379|NCT01806597|528026574|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146415380|NCT01806597|528026575|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146415381|NCT01806597|528026576|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146415382|NCT01806597|528026577|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
146415383|NCT01806597|528026578|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
146415384|NCT01806597|528026573|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146415385|NCT01806597|528026574|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146415386|NCT01806597|528026575|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146415387|NCT01806597|528026576|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146415388|NCT01806597|528026577|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
146415389|NCT01806597|528026578|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
146415390|NCT01806597|528026573|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146415391|NCT01806597|528026574|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146415392|NCT01806597|528026575|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146415393|NCT01806597|528026576|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146415394|NCT01806597|528026577|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
146415395|NCT01806597|528026578|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
146415396|NCT01806597|528026573|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146415397|NCT01806597|528026574|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146415398|NCT01806597|528026575|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146415399|NCT01806597|528026576|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146415400|NCT01806597|528026577|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
146415401|NCT01806597|528026578|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
146415402|NCT01144663|528026579|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
146415403|NCT01144663|528026580|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
146415404|NCT01144663|528026581|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
146415405|NCT01144663|528026582|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
146415406|NCT01144663|528026579|FG000|Primary Vaccination Phase|Adverse Event|1|||
146415407|NCT01144663|528026580|FG001|Primary Vaccination Phase|Adverse Event|0|||
146415408|NCT01144663|528026581|FG002|Primary Vaccination Phase|Adverse Event|0|||
146415409|NCT01144663|528026582|FG003|Primary Vaccination Phase|Adverse Event|1|||
146415410|NCT01144663|528026579|FG000|Primary Vaccination Phase|Protocol Violation|2|||
146415411|NCT01144663|528026580|FG001|Primary Vaccination Phase|Protocol Violation|0|||
146415412|NCT01144663|528026581|FG002|Primary Vaccination Phase|Protocol Violation|1|||
146415413|NCT01144663|528026582|FG003|Primary Vaccination Phase|Protocol Violation|0|||
146415414|NCT01144663|528026579|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
146415415|NCT01144663|528026580|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
146415416|NCT01144663|528026581|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
146415417|NCT01144663|528026582|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
146284941|NCT01859988|527555606|FG001|Overall Study|Protocol Violation|0|||
146284942|NCT01859988|527555607|FG002|Overall Study|Protocol Violation|1|||
146284943|NCT01859988|527555608|FG003|Overall Study|Protocol Violation|0|||
146284944|NCT01859988|527555609|FG004|Overall Study|Protocol Violation|0|||
146284945|NCT01859988|527555610|FG005|Overall Study|Protocol Violation|0|||
146284946|NCT01859988|527555605|FG000|Overall Study|Other than specified above|0|||
146415418|NCT01144663|528026579|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
146415419|NCT01144663|528026580|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
146415420|NCT01144663|528026581|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
146415421|NCT01144663|528026582|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
146415422|NCT01144663|528026579|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
146415423|NCT01144663|528026580|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
146415424|NCT01144663|528026581|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
146415425|NCT01144663|528026582|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
146415426|NCT01144663|528026579|FG000|Primary Vaccination Phase|Other|0|||
146415427|NCT01144663|528026580|FG001|Primary Vaccination Phase|Other|1|||
146415428|NCT01144663|528026581|FG002|Primary Vaccination Phase|Other|0|||
146415429|NCT01144663|528026582|FG003|Primary Vaccination Phase|Other|2|||
146415430|NCT01144663|528026579|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
146415431|NCT01144663|528026580|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146415432|NCT01144663|528026581|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
146415433|NCT01144663|528026582|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
146415434|NCT01144663|528026579|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
146415435|NCT01144663|528026580|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
146415436|NCT01144663|528026581|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
146415437|NCT01144663|528026582|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
146415438|NCT01144663|528026579|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
146415439|NCT01144663|528026580|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
146415440|NCT01144663|528026581|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
146415441|NCT01144663|528026582|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
146415442|NCT01144663|528026579|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
146415443|NCT01144663|528026580|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
146415444|NCT01144663|528026581|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
146415445|NCT01144663|528026582|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
146415446|NCT01144663|528026579|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
146415447|NCT01144663|528026580|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
146415448|NCT01144663|528026581|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
146415449|NCT01144663|528026582|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
146415450|NCT01144663|528026579|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
146415451|NCT01144663|528026580|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
146415452|NCT01144663|528026581|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
146415453|NCT01144663|528026582|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
146415454|NCT01267266|528026585|FG000|Enrollment Phase|Withdrawal by Subject|2|||
146415455|NCT01267266|528026586|FG001|Enrollment Phase|Withdrawal by Subject|0|||
146415456|NCT01267266|528026585|FG000|Lead-in Phase|Lack of Efficacy|20|||
146415457|NCT01267266|528026586|FG001|Lead-in Phase|Lack of Efficacy|0|||
146415458|NCT01267266|528026585|FG000|Lead-in Phase|Adverse Event|2|||
146415459|NCT01267266|528026586|FG001|Lead-in Phase|Adverse Event|0|||
146415460|NCT01267266|528026585|FG000|Lead-in Phase|Withdrawal by Subject|1|||
146415461|NCT01267266|528026586|FG001|Lead-in Phase|Withdrawal by Subject|0|||
146415462|NCT01335477|528026588|FG000|Overall Study|Adverse Event|30|||
146415463|NCT01335477|528026589|FG001|Overall Study|Adverse Event|42|||
146415464|NCT01335477|528026588|FG000|Overall Study|Non compliant with protocol|0|||
146415465|NCT01335477|528026589|FG001|Overall Study|Non compliant with protocol|2|||
146415466|NCT01335477|528026588|FG000|Overall Study|Lost to Follow-up|1|||
146415467|NCT01335477|528026589|FG001|Overall Study|Lost to Follow-up|2|||
146415468|NCT01335477|528026588|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
146415469|NCT01335477|528026589|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
146415470|NCT01335477|528026588|FG000|Overall Study|Not treated|1|||
146415471|NCT01335477|528026589|FG001|Overall Study|Not treated|2|||
146415472|NCT01335477|528026588|FG000|Overall Study|Reason other than those stated above|2|||
146415473|NCT01335477|528026589|FG001|Overall Study|Reason other than those stated above|2|||
146415474|NCT02038634|528026591|FG000|Overall Study|Lost to Follow-up|0|||
146415475|NCT02038634|528026592|FG001|Overall Study|Lost to Follow-up|1|||
146415476|NCT01034137|528026594|FG000|Overall Study|Adverse Event|9|||
146284947|NCT01859988|527555606|FG001|Overall Study|Other than specified above|2|||
146284948|NCT01859988|527555607|FG002|Overall Study|Other than specified above|11|||
146284949|NCT01859988|527555608|FG003|Overall Study|Other than specified above|3|||
146284950|NCT01859988|527555609|FG004|Overall Study|Other than specified above|5|||
146284951|NCT01859988|527555610|FG005|Overall Study|Other than specified above|3|||
146284952|NCT02081417|527555611|FG000|Overall Study|Lost to Follow-up|26|||
146284953|NCT02081417|527555612|FG001|Overall Study|Lost to Follow-up|23|||
146284954|NCT02081417|527555611|FG000|Overall Study|Moved Away|1|||
146415477|NCT01034137|528026595|FG001|Overall Study|Adverse Event|10|||
146415478|NCT01034137|528026596|FG002|Overall Study|Adverse Event|8|||
146415479|NCT01034137|528026594|FG000|Overall Study|Withdrawal by Subject|4|||
146415480|NCT01034137|528026595|FG001|Overall Study|Withdrawal by Subject|3|||
146415481|NCT01034137|528026596|FG002|Overall Study|Withdrawal by Subject|3|||
146415482|NCT01034137|528026594|FG000|Overall Study|Lack of Efficacy|9|||
146415483|NCT01034137|528026595|FG001|Overall Study|Lack of Efficacy|4|||
146415484|NCT01034137|528026596|FG002|Overall Study|Lack of Efficacy|13|||
146415485|NCT01034137|528026594|FG000|Overall Study|Protocol Violation|2|||
146415486|NCT01034137|528026595|FG001|Overall Study|Protocol Violation|2|||
146284955|NCT02081417|527555612|FG001|Overall Study|Moved Away|2|||
146415487|NCT01034137|528026596|FG002|Overall Study|Protocol Violation|1|||
146415488|NCT01034137|528026594|FG000|Overall Study|Refused treatment or did not cooperate|2|||
146415489|NCT01034137|528026595|FG001|Overall Study|Refused treatment or did not cooperate|0|||
146415490|NCT01034137|528026596|FG002|Overall Study|Refused treatment or did not cooperate|1|||
146415491|NCT01034137|528026594|FG000|Overall Study|Administrative or other|2|||
146415492|NCT01034137|528026595|FG001|Overall Study|Administrative or other|3|||
146415493|NCT01034137|528026596|FG002|Overall Study|Administrative or other|4|||
146415494|NCT03572933|528026597|FG000|Overall Study|Adverse Event|4|||
146415495|NCT03572933|528026598|FG001|Overall Study|Adverse Event|1|||
146415496|NCT03572933|528026597|FG000|Overall Study|Withdrawal by Subject|0|||
146415497|NCT03572933|528026598|FG001|Overall Study|Withdrawal by Subject|1|||
146415498|NCT02049359|528026603|FG000|Overall Study|Lost to Follow-up|26|||
146415499|NCT02049359|528026604|FG001|Overall Study|Lost to Follow-up|19|||
146415500|NCT01405950|528026605|FG000|Overall Study|Withdrawal by Subject|1|||
146415501|NCT01405950|528026606|FG001|Overall Study|Withdrawal by Subject|0|||
146415502|NCT01405950|528026607|FG002|Overall Study|Withdrawal by Subject|0|||
146415503|NCT01405950|528026608|FG003|Overall Study|Withdrawal by Subject|0|||
146415504|NCT01381900|528026609|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
146415505|NCT01381900|528026610|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
146415506|NCT01381900|528026611|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
146415507|NCT01381900|528026609|FG000|Overall Study|Adverse Event|4|||
146415508|NCT01381900|528026610|FG001|Overall Study|Adverse Event|6|||
146415509|NCT01381900|528026611|FG002|Overall Study|Adverse Event|7|||
146415510|NCT01381900|528026609|FG000|Overall Study|Noncompliance with study drug|0|||
146415511|NCT01381900|528026610|FG001|Overall Study|Noncompliance with study drug|0|||
146415512|NCT01381900|528026611|FG002|Overall Study|Noncompliance with study drug|1|||
146415513|NCT01381900|528026609|FG000|Overall Study|Physician Decision|0|||
146415514|NCT01381900|528026610|FG001|Overall Study|Physician Decision|1|||
146415515|NCT01381900|528026611|FG002|Overall Study|Physician Decision|1|||
146415516|NCT01381900|528026609|FG000|Overall Study|Protocol Violation|0|||
146415517|NCT01381900|528026610|FG001|Overall Study|Protocol Violation|1|||
146415518|NCT01381900|528026611|FG002|Overall Study|Protocol Violation|1|||
146415519|NCT01381900|528026609|FG000|Overall Study|Withdrawal by Subject|0|||
146415520|NCT01381900|528026610|FG001|Overall Study|Withdrawal by Subject|0|||
146415521|NCT01381900|528026611|FG002|Overall Study|Withdrawal by Subject|1|||
146415522|NCT01381900|528026609|FG000|Overall Study|Early withdraw|3|||
146415523|NCT01381900|528026610|FG001|Overall Study|Early withdraw|1|||
146415524|NCT01381900|528026611|FG002|Overall Study|Early withdraw|1|||
146415525|NCT01772368|528026612|FG000|Overall Study|Adverse Event|1|||
146415526|NCT01772368|528026612|FG000|Overall Study|Withdrawal by Subject|3|||
146415527|NCT01772368|528026612|FG000|Overall Study|Protocol Violation|2|||
146415528|NCT01772368|528026612|FG000|Overall Study|Other|1|||
146415529|NCT03347695|528026619|FG000|Overall Study|Death|0|||
146415530|NCT03347695|528026620|FG001|Overall Study|Death|4|||
146415531|NCT03347695|528026619|FG000|Overall Study|Lost to Follow-up|0|||
146415532|NCT03347695|528026620|FG001|Overall Study|Lost to Follow-up|1|||
146415533|NCT00671879|528026623|FG000|Overall Study|Withdrawal by Subject|0|||
146415534|NCT00671879|528026624|FG001|Overall Study|Withdrawal by Subject|4|||
146415535|NCT00671879|528026625|FG002|Overall Study|Withdrawal by Subject|6|||
146415536|NCT04633837|528026626|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
146415537|NCT04633837|528026627|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
146415538|NCT02668783|528026628|FG000|Overall Study|Pregnancy|0|||
146415539|NCT02668783|528026629|FG001|Overall Study|Pregnancy|1|||
146415540|NCT02668783|528026628|FG000|Overall Study|Protocol Violation|2|||
146415541|NCT02668783|528026629|FG001|Overall Study|Protocol Violation|1|||
146284956|NCT02081417|527555611|FG000|Overall Study|Incarcerated|2|||
146415542|NCT02668783|528026628|FG000|Overall Study|Study terminated by sponsor|9|||
146284957|NCT02081417|527555612|FG001|Overall Study|Incarcerated|2|||
146415543|NCT02668783|528026629|FG001|Overall Study|Study terminated by sponsor|10|||
146415544|NCT02668783|528026628|FG000|Overall Study|Subject moved|1|||
146415545|NCT02668783|528026629|FG001|Overall Study|Subject moved|0|||
146415546|NCT02668783|528026628|FG000|Overall Study|Withdrawal by Subject|1|||
146415547|NCT02668783|528026629|FG001|Overall Study|Withdrawal by Subject|0|||
146415548|NCT02884206|528026630|FG000|Valsartan Run-in Period|Death|1|||
146415549|NCT02884206|528026631|FG001|Valsartan Run-in Period|Death|0|||
146415550|NCT02884206|528026632|FG002|Valsartan Run-in Period|Death|0|||
146415551|NCT02884206|528026630|FG000|Valsartan Run-in Period|Adverse Event|31|||
146415552|NCT02884206|528026631|FG001|Valsartan Run-in Period|Adverse Event|0|||
146415553|NCT02884206|528026632|FG002|Valsartan Run-in Period|Adverse Event|0|||
146415554|NCT02884206|528026630|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
146415555|NCT02884206|528026631|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
146415556|NCT02884206|528026632|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
146415557|NCT02884206|528026630|FG000|Valsartan Run-in Period|Protocol deviation|4|||
146415558|NCT02884206|528026631|FG001|Valsartan Run-in Period|Protocol deviation|0|||
146415559|NCT02884206|528026632|FG002|Valsartan Run-in Period|Protocol deviation|0|||
146415560|NCT02884206|528026630|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
146415561|NCT02884206|528026631|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
146415562|NCT02884206|528026632|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
146415563|NCT02884206|528026630|FG000|Valsartan Run-in Period|Physician Decision|1|||
146415564|NCT02884206|528026631|FG001|Valsartan Run-in Period|Physician Decision|0|||
146415565|NCT02884206|528026632|FG002|Valsartan Run-in Period|Physician Decision|0|||
146415566|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Adverse Event|38|||
146415567|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Adverse Event|0|||
146415568|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Adverse Event|0|||
146415569|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Death|2|||
146415570|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Death|0|||
146415571|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Death|0|||
146415572|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
146415573|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
146415574|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
146415575|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
146415576|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
146415577|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
146415578|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
146415579|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
146415580|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
146415581|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Physician Decision|1|||
146415582|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Physician Decision|0|||
146415583|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Physician Decision|0|||
146415584|NCT02884206|528026630|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
146415585|NCT02884206|528026631|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
146415586|NCT02884206|528026632|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
146415587|NCT02884206|528026630|FG000|Double-Blind Period|Death|0|||
146415588|NCT02884206|528026631|FG001|Double-Blind Period|Death|28|||
146415589|NCT02884206|528026632|FG002|Double-Blind Period|Death|39|||
146415590|NCT02884206|528026630|FG000|Double-Blind Period|Patient/guardian decision|0|||
146415591|NCT02884206|528026631|FG001|Double-Blind Period|Patient/guardian decision|10|||
146415592|NCT02884206|528026632|FG002|Double-Blind Period|Patient/guardian decision|13|||
146415593|NCT02884206|528026630|FG000|Double-Blind Period|Lost to Follow-up|0|||
146415594|NCT02884206|528026631|FG001|Double-Blind Period|Lost to Follow-up|4|||
146415595|NCT02884206|528026632|FG002|Double-Blind Period|Lost to Follow-up|4|||
146415596|NCT02884206|528026630|FG000|Double-Blind Period|Physician Decision|0|||
146415597|NCT02884206|528026631|FG001|Double-Blind Period|Physician Decision|2|||
146415598|NCT02884206|528026632|FG002|Double-Blind Period|Physician Decision|0|||
146415599|NCT02884206|528026630|FG000|Double-Blind Period|Adverse Event|0|||
146415600|NCT02884206|528026631|FG001|Double-Blind Period|Adverse Event|0|||
146415601|NCT02884206|528026632|FG002|Double-Blind Period|Adverse Event|3|||
146415602|NCT02884206|528026630|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
146415603|NCT02884206|528026631|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
146415604|NCT02884206|528026632|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
146415605|NCT00112489|528026633|FG000|Overall Study|Refused further treatment|8|||
146415606|NCT00112489|528026633|FG000|Overall Study|Adverse Event|12|||
146415607|NCT00112489|528026633|FG000|Overall Study|Death|2|||
146415608|NCT00112489|528026633|FG000|Overall Study|Other, Not Specified|9|||
146415609|NCT00112489|528026633|FG000|Overall Study|Patient never treated|2|||
146193180|NCT02014558|527217798|FG004|Overall Study|Withdrawal by Subject|1|||
146193181|NCT02014558|527217799|FG005|Overall Study|Withdrawal by Subject|0|||
146193182|NCT02014558|527217800|FG006|Overall Study|Withdrawal by Subject|0|||
146415610|NCT00112489|528026633|FG000|Overall Study|Ineligible|7|||
146415611|NCT02231710|528026634|FG000|Overall Study|Physician Decision|1|||
146415612|NCT01399723|528026635|FG000|Overall Study|Lost to Follow-up|0|||
146415613|NCT01399723|528026636|FG001|Overall Study|Lost to Follow-up|1|||
146415614|NCT00124020|528026639|FG000|Overall Study|Death|67|||
146415615|NCT00124020|528026640|FG001|Overall Study|Death|71|||
146193183|NCT02014558|527217801|FG007|Overall Study|Withdrawal by Subject|0|||
146415616|NCT00124020|528026639|FG000|Overall Study|Withdrawal by Subject|13|||
146415617|NCT00124020|528026640|FG001|Overall Study|Withdrawal by Subject|11|||
146415618|NCT00124020|528026639|FG000|Overall Study|Lost to Follow-up|5|||
146415619|NCT00124020|528026640|FG001|Overall Study|Lost to Follow-up|8|||
146415620|NCT00124020|528026639|FG000|Overall Study|Other|1|||
146415621|NCT00124020|528026640|FG001|Overall Study|Other|1|||
146415622|NCT00124020|528026639|FG000|Overall Study|Transfer to another hospital|2|||
146415623|NCT00124020|528026640|FG001|Overall Study|Transfer to another hospital|0|||
146415624|NCT00268346|528026641|FG000|Overall Study|Adverse Event|0|||
146415625|NCT00268346|528026642|FG001|Overall Study|Adverse Event|1|||
146415626|NCT00268346|528026641|FG000|Overall Study|Death|0|||
146415627|NCT00268346|528026642|FG001|Overall Study|Death|1|||
146415628|NCT00268346|528026641|FG000|Overall Study|Withdrawal by Subject|0|||
146415629|NCT00268346|528026642|FG001|Overall Study|Withdrawal by Subject|1|||
146415630|NCT01799590|528026646|FG000|Overall Study|Adverse Event|13|||
146415631|NCT01799590|528026647|FG001|Overall Study|Adverse Event|7|||
146415632|NCT01799590|528026648|FG002|Overall Study|Adverse Event|5|||
146415633|NCT01799590|528026646|FG000|Overall Study|Pregnancy|2|||
146415634|NCT01799590|528026647|FG001|Overall Study|Pregnancy|0|||
146415635|NCT01799590|528026648|FG002|Overall Study|Pregnancy|0|||
146415636|NCT01799590|528026646|FG000|Overall Study|Lack of Efficacy|3|||
146415637|NCT01799590|528026647|FG001|Overall Study|Lack of Efficacy|1|||
146415638|NCT01799590|528026648|FG002|Overall Study|Lack of Efficacy|3|||
146415639|NCT01799590|528026646|FG000|Overall Study|Participants convenience|4|||
146415640|NCT01799590|528026647|FG001|Overall Study|Participants convenience|4|||
146415641|NCT01799590|528026648|FG002|Overall Study|Participants convenience|2|||
146415642|NCT01799590|528026646|FG000|Overall Study|Aggravation of complications|0|||
146415643|NCT01799590|528026647|FG001|Overall Study|Aggravation of complications|1|||
146415644|NCT01799590|528026648|FG002|Overall Study|Aggravation of complications|1|||
146415645|NCT01799590|528026646|FG000|Overall Study|Using drugs with restricted days of use|0|||
146415646|NCT01799590|528026647|FG001|Overall Study|Using drugs with restricted days of use|3|||
146415647|NCT01799590|528026648|FG002|Overall Study|Using drugs with restricted days of use|2|||
146415648|NCT01799590|528026646|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
146415649|NCT01799590|528026647|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
146415650|NCT01799590|528026648|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
146415651|NCT01799590|528026646|FG000|Overall Study|Other|3|||
146415652|NCT01799590|528026647|FG001|Overall Study|Other|0|||
146415653|NCT01799590|528026648|FG002|Overall Study|Other|1|||
146415654|NCT00294723|528026651|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
146415655|NCT00294723|528026652|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
146193184|NCT02014558|527217802|FG008|Overall Study|Withdrawal by Subject|0|||
146193185|NCT02014558|527217803|FG009|Overall Study|Withdrawal by Subject|2|||
146193186|NCT02014558|527217804|FG010|Overall Study|Withdrawal by Subject|6|||
146193187|NCT02014558|527217805|FG011|Overall Study|Withdrawal by Subject|10|||
146193188|NCT02014558|527217806|FG012|Overall Study|Withdrawal by Subject|0|||
146193189|NCT02014558|527217794|FG000|Overall Study|Miscellaneous|2|||
146193190|NCT02014558|527217795|FG001|Overall Study|Miscellaneous|1|||
146415656|NCT00294723|528026653|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
146415657|NCT00294723|528026651|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
146415658|NCT00294723|528026652|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
146193191|NCT02014558|527217796|FG002|Overall Study|Miscellaneous|1|||
146415659|NCT00294723|528026653|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
146415660|NCT00294723|528026651|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
146415661|NCT00294723|528026652|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
146415662|NCT00294723|528026653|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
146415663|NCT00294723|528026651|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
146415664|NCT00294723|528026652|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
146415665|NCT00294723|528026653|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
146415666|NCT00294723|528026651|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
146415667|NCT00294723|528026652|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
146415668|NCT00294723|528026653|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
146415669|NCT00294723|528026651|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
146415670|NCT00294723|528026652|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
146415671|NCT00294723|528026653|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
146415672|NCT00294723|528026651|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
146415673|NCT00294723|528026652|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
146415674|NCT00294723|528026653|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
146415675|NCT00294723|528026651|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
146415676|NCT00294723|528026652|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
146415677|NCT00294723|528026653|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
146415678|NCT00294723|528026651|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
146415679|NCT00294723|528026652|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
146415680|NCT00294723|528026653|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
146415681|NCT00294723|528026651|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
146415682|NCT00294723|528026652|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
146415683|NCT00294723|528026653|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
146415684|NCT00294723|528026651|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146415685|NCT00294723|528026652|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146415686|NCT00294723|528026653|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
146415687|NCT00294723|528026651|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
146415688|NCT00294723|528026652|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
146415689|NCT00294723|528026653|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
146415690|NCT00752791|528026654|FG000|Overall Study|Adverse Event|7|||
146415691|NCT00752791|528026654|FG000|Overall Study|Withdrawal by Subject|1|||
146415692|NCT00752791|528026654|FG000|Overall Study|Physician Decision|1|||
146415693|NCT00752791|528026654|FG000|Overall Study|Death|1|||
146415694|NCT00752791|528026654|FG000|Overall Study|Renal transplant|3|||
146415695|NCT00752791|528026654|FG000|Overall Study|Switched to hemodialysis|2|||
146415696|NCT00752791|528026654|FG000|Overall Study|Protocol deviation|1|||
146415697|NCT03341507|528026655|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
146415698|NCT02927847|528026656|FG000|Overall Study|Lost to Follow-up|1|||
146415699|NCT02927847|528026657|FG001|Overall Study|Lost to Follow-up|0|||
146415700|NCT02927847|528026656|FG000|Overall Study|Withdrawal by Subject|4|||
146415701|NCT02927847|528026657|FG001|Overall Study|Withdrawal by Subject|2|||
146415702|NCT02927847|528026656|FG000|Overall Study|PI withdrawn due to missed visits|1|||
146415703|NCT02927847|528026657|FG001|Overall Study|PI withdrawn due to missed visits|1|||
146415704|NCT01755858|528026660|FG000|Overall Study|Adverse Event|1|||
146415705|NCT01755858|528026661|FG001|Overall Study|Adverse Event|1|||
146415706|NCT03255031|528026662|FG000|Overall Study|Adverse Event|5|||
146415707|NCT03255031|528026663|FG001|Overall Study|Adverse Event|3|||
146415708|NCT03255031|528026662|FG000|Overall Study|Physician Decision|2|||
146415709|NCT03255031|528026663|FG001|Overall Study|Physician Decision|1|||
146415710|NCT03255031|528026662|FG000|Overall Study|Withdrawal by Subject|9|||
146415711|NCT03255031|528026663|FG001|Overall Study|Withdrawal by Subject|3|||
146415712|NCT01809314|528026664|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
146415713|NCT01809314|528026664|FG000|Overall Study|Adverse Event|6|||
146415714|NCT01809314|528026664|FG000|Overall Study|Insufficient Therapeutic Response|14|||
146415715|NCT01809314|528026664|FG000|Overall Study|Lost to Follow-up|724|||
146415716|NCT01092702|528026665|FG000|Overall Study|Withdrawal by Subject|7|||
146415717|NCT01092702|528026665|FG000|Overall Study|Lost to Follow-up|2|||
146415718|NCT03567057|528026666|FG000|Overall Study|Adverse Event|56|||
146082342|NCT00816023|526822770|FG002|Overall Study|Randomized Not Treated|6|||
146193192|NCT02014558|527217797|FG003|Overall Study|Miscellaneous|1|||
146415719|NCT03567057|528026667|FG001|Overall Study|Adverse Event|53|||
146415720|NCT03567057|528026668|FG002|Overall Study|Adverse Event|28|||
146415721|NCT03567057|528026666|FG000|Overall Study|Withdrawal by Subject|22|||
146415722|NCT03567057|528026667|FG001|Overall Study|Withdrawal by Subject|24|||
146415723|NCT03567057|528026668|FG002|Overall Study|Withdrawal by Subject|13|||
146415724|NCT03567057|528026666|FG000|Overall Study|Lost to Follow-up|3|||
146415725|NCT03567057|528026667|FG001|Overall Study|Lost to Follow-up|5|||
146415726|NCT03567057|528026668|FG002|Overall Study|Lost to Follow-up|2|||
146415727|NCT03567057|528026666|FG000|Overall Study|COVID-19 pandemic|4|||
146415728|NCT03567057|528026667|FG001|Overall Study|COVID-19 pandemic|3|||
146415729|NCT03567057|528026668|FG002|Overall Study|COVID-19 pandemic|0|||
146415730|NCT03567057|528026666|FG000|Overall Study|Non-compliance with study drug|4|||
146415731|NCT03567057|528026667|FG001|Overall Study|Non-compliance with study drug|2|||
146415732|NCT03567057|528026668|FG002|Overall Study|Non-compliance with study drug|0|||
146415733|NCT03567057|528026666|FG000|Overall Study|Lack of Efficacy|3|||
146415734|NCT03567057|528026667|FG001|Overall Study|Lack of Efficacy|0|||
146415735|NCT03567057|528026668|FG002|Overall Study|Lack of Efficacy|1|||
146415736|NCT03567057|528026666|FG000|Overall Study|Death|1|||
146415737|NCT03567057|528026667|FG001|Overall Study|Death|0|||
146415738|NCT03567057|528026668|FG002|Overall Study|Death|0|||
146415739|NCT03567057|528026666|FG000|Overall Study|Physician Decision|1|||
146415740|NCT03567057|528026667|FG001|Overall Study|Physician Decision|0|||
146415741|NCT03567057|528026668|FG002|Overall Study|Physician Decision|0|||
146082343|NCT00816023|526822771|FG003|Overall Study|Randomized Not Treated|11|||
146415742|NCT03567057|528026666|FG000|Overall Study|Unstable medical condition|1|||
146415743|NCT03567057|528026667|FG001|Overall Study|Unstable medical condition|0|||
146415744|NCT03567057|528026668|FG002|Overall Study|Unstable medical condition|0|||
146415745|NCT03567057|528026666|FG000|Overall Study|Medical history event|0|||
146415746|NCT03567057|528026667|FG001|Overall Study|Medical history event|0|||
146415747|NCT03567057|528026668|FG002|Overall Study|Medical history event|1|||
146415748|NCT03567057|528026666|FG000|Overall Study|Other|0|||
146415749|NCT03567057|528026667|FG001|Overall Study|Other|0|||
146415750|NCT03567057|528026668|FG002|Overall Study|Other|1|||
146082344|NCT04449029|526822773|FG000|Overall Study|Adverse Event|0|||
146082345|NCT04449029|526822774|FG001|Overall Study|Adverse Event|1|||
146082346|NCT04449029|526822775|FG002|Overall Study|Adverse Event|1|||
146082347|NCT04449029|526822776|FG003|Overall Study|Adverse Event|0|||
146415751|NCT00490061|528026669|FG000|Overall Study|Physician Decision|1|||
146415752|NCT01580020|528026670|FG000|Overall Study|Lack of Efficacy|0|||
146415753|NCT01580020|528026671|FG001|Overall Study|Lack of Efficacy|5|||
146415754|NCT01580020|528026672|FG002|Overall Study|Lack of Efficacy|0|||
146415755|NCT01580020|528026673|FG003|Overall Study|Lack of Efficacy|1|||
146415756|NCT01580020|528026670|FG000|Overall Study|Withdrawal by Subject|0|||
146415757|NCT01580020|528026671|FG001|Overall Study|Withdrawal by Subject|1|||
146415758|NCT01580020|528026672|FG002|Overall Study|Withdrawal by Subject|1|||
146415759|NCT01580020|528026673|FG003|Overall Study|Withdrawal by Subject|0|||
146415760|NCT01580020|528026670|FG000|Overall Study|Adverse Event|1|||
146415761|NCT01580020|528026671|FG001|Overall Study|Adverse Event|1|||
146415762|NCT01580020|528026672|FG002|Overall Study|Adverse Event|1|||
146415763|NCT01580020|528026673|FG003|Overall Study|Adverse Event|1|||
146415764|NCT01580020|528026670|FG000|Overall Study|Administrative Problems|0|||
146415765|NCT01580020|528026671|FG001|Overall Study|Administrative Problems|0|||
146415766|NCT01580020|528026672|FG002|Overall Study|Administrative Problems|1|||
146415767|NCT01580020|528026673|FG003|Overall Study|Administrative Problems|0|||
146415768|NCT01580020|528026670|FG000|Overall Study|Lost to Follow-up|0|||
146415769|NCT01580020|528026671|FG001|Overall Study|Lost to Follow-up|0|||
146415770|NCT01580020|528026672|FG002|Overall Study|Lost to Follow-up|1|||
146415771|NCT01580020|528026673|FG003|Overall Study|Lost to Follow-up|0|||
146415772|NCT00591253|528026675|FG000|Overall Study|Adverse Event|3|||
146415773|NCT00591253|528026676|FG001|Overall Study|Adverse Event|3|||
146415774|NCT00591253|528026677|FG002|Overall Study|Adverse Event|1|||
146415775|NCT00591253|528026675|FG000|Overall Study|Protocol Violation|2|||
146415776|NCT00591253|528026676|FG001|Overall Study|Protocol Violation|2|||
146415777|NCT00591253|528026677|FG002|Overall Study|Protocol Violation|2|||
146415778|NCT00591253|528026675|FG000|Overall Study|Lost to Follow-up|2|||
146415779|NCT00591253|528026676|FG001|Overall Study|Lost to Follow-up|4|||
146415780|NCT00591253|528026677|FG002|Overall Study|Lost to Follow-up|0|||
146415781|NCT00591253|528026675|FG000|Overall Study|Withdrawal by Subject|1|||
146415782|NCT00591253|528026676|FG001|Overall Study|Withdrawal by Subject|7|||
146415783|NCT00591253|528026677|FG002|Overall Study|Withdrawal by Subject|6|||
146415784|NCT00591253|528026675|FG000|Overall Study|Lack of Efficacy|1|||
146415785|NCT00591253|528026676|FG001|Overall Study|Lack of Efficacy|0|||
146415786|NCT00591253|528026677|FG002|Overall Study|Lack of Efficacy|3|||
146415787|NCT00591253|528026675|FG000|Overall Study|Other|5|||
146415788|NCT00591253|528026676|FG001|Overall Study|Other|5|||
146415789|NCT00591253|528026677|FG002|Overall Study|Other|3|||
146415790|NCT01841359|528026678|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
146415791|NCT01841359|528026678|FG000|Overall Study|Concommitant medical issues|2|||
146082348|NCT04449029|526822777|FG004|Overall Study|Adverse Event|1|||
146082349|NCT04449029|526822778|FG005|Overall Study|Adverse Event|0|||
146082350|NCT04449029|526822779|FG006|Overall Study|Adverse Event|1|||
146415792|NCT01841359|528026678|FG000|Overall Study|Adverse Event|3|||
146415793|NCT01841359|528026678|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
146415794|NCT01875445|528026681|FG000|Overall Study|Lost to Follow-up|5|||
146415795|NCT01875445|528026682|FG001|Overall Study|Lost to Follow-up|0|||
146415796|NCT01875445|528026681|FG000|Overall Study|Withdrawal by Subject|2|||
146415797|NCT01875445|528026682|FG001|Overall Study|Withdrawal by Subject|0|||
146415798|NCT01102777|528026683|FG000|Overall Study|Death|2|||
146415799|NCT01102777|528026684|FG001|Overall Study|Death|6|||
146415800|NCT01102777|528026683|FG000|Overall Study|Lost to Follow-up|7|||
146415801|NCT01102777|528026684|FG001|Overall Study|Lost to Follow-up|10|||
146415802|NCT01752920|528026689|FG000|Overall Study|Adverse Event|1|||
146415803|NCT01752920|528026690|FG001|Overall Study|Adverse Event|0|||
146415804|NCT01752920|528026691|FG002|Overall Study|Adverse Event|5|||
146415805|NCT01752920|528026692|FG003|Overall Study|Adverse Event|10|||
146415806|NCT01752920|528026689|FG000|Overall Study|Clinical Disease Progression|6|||
146415807|NCT01752920|528026690|FG001|Overall Study|Clinical Disease Progression|4|||
146415808|NCT01752920|528026691|FG002|Overall Study|Clinical Disease Progression|1|||
146415809|NCT01752920|528026692|FG003|Overall Study|Clinical Disease Progression|13|||
146415810|NCT01752920|528026689|FG000|Overall Study|Physician Decision|1|||
146415811|NCT01752920|528026690|FG001|Overall Study|Physician Decision|0|||
146415812|NCT01752920|528026691|FG002|Overall Study|Physician Decision|0|||
146415813|NCT01752920|528026692|FG003|Overall Study|Physician Decision|3|||
146415814|NCT01752920|528026689|FG000|Overall Study|Radiographic Disease Progression|20|||
146415815|NCT01752920|528026690|FG001|Overall Study|Radiographic Disease Progression|7|||
146415816|NCT01752920|528026691|FG002|Overall Study|Radiographic Disease Progression|12|||
146415817|NCT01752920|528026692|FG003|Overall Study|Radiographic Disease Progression|29|||
146415818|NCT01752920|528026689|FG000|Overall Study|Study Terminated by Sponsor|0|||
146415819|NCT01752920|528026690|FG001|Overall Study|Study Terminated by Sponsor|0|||
146415820|NCT01752920|528026691|FG002|Overall Study|Study Terminated by Sponsor|0|||
146415821|NCT01752920|528026692|FG003|Overall Study|Study Terminated by Sponsor|1|||
146415822|NCT01752920|528026689|FG000|Overall Study|Withdrawal by Subject|0|||
146415823|NCT01752920|528026690|FG001|Overall Study|Withdrawal by Subject|1|||
146415824|NCT01752920|528026691|FG002|Overall Study|Withdrawal by Subject|0|||
146415825|NCT01752920|528026692|FG003|Overall Study|Withdrawal by Subject|1|||
146415826|NCT01752920|528026689|FG000|Overall Study|Lack of clinical benefit|1|||
146415827|NCT01752920|528026690|FG001|Overall Study|Lack of clinical benefit|1|||
146415828|NCT01752920|528026691|FG002|Overall Study|Lack of clinical benefit|1|||
146415829|NCT01752920|528026692|FG003|Overall Study|Lack of clinical benefit|1|||
146415830|NCT01738581|528026693|FG000|Overall Study|Lost to Follow-up|1|||
146415831|NCT01738581|528026694|FG001|Overall Study|Lost to Follow-up|0|||
146415832|NCT00210626|528026695|FG000|Overall Study|Adverse Event|1|||
146415833|NCT00210626|528026696|FG001|Overall Study|Adverse Event|2|||
146415834|NCT00210626|528026695|FG000|Overall Study|Protocol Violation|1|||
146415835|NCT00210626|528026696|FG001|Overall Study|Protocol Violation|5|||
146415836|NCT00210626|528026695|FG000|Overall Study|Lost to Follow-up|11|||
146415837|NCT00210626|528026696|FG001|Overall Study|Lost to Follow-up|11|||
146415838|NCT00210626|528026695|FG000|Overall Study|Death|1|||
146415839|NCT00210626|528026696|FG001|Overall Study|Death|0|||
146415840|NCT00210626|528026695|FG000|Overall Study|Withdrawal by Subject|29|||
146193193|NCT02014558|527217798|FG004|Overall Study|Miscellaneous|0|||
146193194|NCT02014558|527217799|FG005|Overall Study|Miscellaneous|1|||
146193195|NCT02014558|527217800|FG006|Overall Study|Miscellaneous|0|||
146193196|NCT02014558|527217801|FG007|Overall Study|Miscellaneous|1|||
146193197|NCT02014558|527217802|FG008|Overall Study|Miscellaneous|1|||
146193198|NCT02014558|527217803|FG009|Overall Study|Miscellaneous|3|||
146193199|NCT02014558|527217804|FG010|Overall Study|Miscellaneous|12|||
146193200|NCT02014558|527217805|FG011|Overall Study|Miscellaneous|11|||
146193201|NCT02014558|527217806|FG012|Overall Study|Miscellaneous|1|||
146193202|NCT00299702|527217809|FG000|Overall Study|Death|1|||
146193203|NCT00299702|527217810|FG001|Overall Study|Death|0|||
146193204|NCT00299702|527217809|FG000|Overall Study|Adverse Event|0|||
146193205|NCT00299702|527217810|FG001|Overall Study|Adverse Event|4|||
146193206|NCT00299702|527217809|FG000|Overall Study|Lost to Follow-up|18|||
146415841|NCT00210626|528026696|FG001|Overall Study|Withdrawal by Subject|20|||
146415842|NCT00210626|528026695|FG000|Overall Study|Physician Decision|0|||
146415843|NCT00210626|528026696|FG001|Overall Study|Physician Decision|2|||
146415844|NCT00210626|528026695|FG000|Overall Study|Sponser Request|1|||
146415845|NCT00210626|528026696|FG001|Overall Study|Sponser Request|0|||
146415846|NCT00210626|528026695|FG000|Overall Study|Other|4|||
146415847|NCT00210626|528026696|FG001|Overall Study|Other|5|||
146415848|NCT00771901|528026697|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
146415849|NCT00771901|528026698|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
146193207|NCT00299702|527217810|FG001|Overall Study|Lost to Follow-up|10|||
146193208|NCT00299702|527217809|FG000|Overall Study|Withdrawal by Subject|25|||
146193209|NCT00299702|527217810|FG001|Overall Study|Withdrawal by Subject|23|||
146193210|NCT00299702|527217809|FG000|Overall Study|Pregnancy|0|||
146193211|NCT00299702|527217810|FG001|Overall Study|Pregnancy|1|||
146193212|NCT00299702|527217809|FG000|Overall Study|Insufficient Response|4|||
146193213|NCT00299702|527217810|FG001|Overall Study|Insufficient Response|3|||
146193214|NCT00299702|527217809|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
146193215|NCT00299702|527217810|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
146193216|NCT01560949|527217811|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
146193217|NCT01560949|527217811|FG000|Surgery Phase|Physician Decision|3|||
146193218|NCT00751036|527217812|FG000|Overall Study|Disease Progression|28|||
145947787|NCT02083653|526317296|FG001|Overall Study|Other Events|2|||
145947788|NCT02083653|526317297|FG002|Overall Study|Other Events|2|||
145947789|NCT02083653|526317295|FG000|Overall Study|Reason Missing|0|||
145947790|NCT02083653|526317296|FG001|Overall Study|Reason Missing|0|||
145947791|NCT02083653|526317297|FG002|Overall Study|Reason Missing|4|||
145947792|NCT02073656|526317300|FG000|Primary Study|Lost to Follow-up|6|||
145947793|NCT02073656|526317300|FG000|Primary Study|Death|1|||
145947794|NCT02073656|526317300|FG000|Primary Study|Withdrew Consent|1|||
145947795|NCT01987232|526317302|FG000|Overall Study|Ongoing in Study|0|||
145947796|NCT01987232|526317303|FG001|Overall Study|Ongoing in Study|0|||
145947797|NCT01987232|526317304|FG002|Overall Study|Ongoing in Study|0|||
145947798|NCT01987232|526317305|FG003|Overall Study|Ongoing in Study|1|||
145947799|NCT01987232|526317306|FG004|Overall Study|Ongoing in Study|0|||
145947800|NCT01969084|526317307|FG000|Overall Study|Adverse Event|0|||
145947801|NCT01969084|526317308|FG001|Overall Study|Adverse Event|1|||
145947802|NCT00862459|526317309|FG000|Overall Study|Lost to Follow-up|1|||
145947803|NCT00862459|526317310|FG001|Overall Study|Lost to Follow-up|2|||
145947804|NCT00862459|526317311|FG002|Overall Study|Lost to Follow-up|2|||
145947805|NCT00862459|526317309|FG000|Overall Study|Protocol Violation|1|||
145947806|NCT00862459|526317310|FG001|Overall Study|Protocol Violation|0|||
145947807|NCT00862459|526317311|FG002|Overall Study|Protocol Violation|0|||
145947808|NCT00862459|526317309|FG000|Overall Study|Withdrawal by Subject|1|||
145947809|NCT00862459|526317310|FG001|Overall Study|Withdrawal by Subject|1|||
145947810|NCT00862459|526317311|FG002|Overall Study|Withdrawal by Subject|3|||
145947811|NCT00862459|526317309|FG000|Overall Study|Adverse Event|0|||
145947812|NCT00862459|526317310|FG001|Overall Study|Adverse Event|1|||
145947813|NCT00862459|526317311|FG002|Overall Study|Adverse Event|0|||
145947814|NCT00862459|526317309|FG000|Overall Study|Personal reasons|1|||
145947815|NCT00862459|526317310|FG001|Overall Study|Personal reasons|0|||
145947816|NCT00862459|526317311|FG002|Overall Study|Personal reasons|0|||
145947817|NCT00862459|526317309|FG000|Overall Study|Operation|1|||
145947818|NCT00862459|526317310|FG001|Overall Study|Operation|1|||
145947819|NCT00862459|526317311|FG002|Overall Study|Operation|0|||
145947820|NCT00862459|526317309|FG000|Overall Study|Intravenous (IV) site problems|1|||
145947821|NCT00862459|526317310|FG001|Overall Study|Intravenous (IV) site problems|0|||
145947822|NCT00862459|526317311|FG002|Overall Study|Intravenous (IV) site problems|1|||
145947823|NCT00862459|526317309|FG000|Overall Study|Unable to hold still for imaging|0|||
145947824|NCT00862459|526317310|FG001|Overall Study|Unable to hold still for imaging|1|||
145947825|NCT00862459|526317311|FG002|Overall Study|Unable to hold still for imaging|0|||
145947826|NCT00862459|526317309|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
145947827|NCT00862459|526317310|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
145947828|NCT00862459|526317311|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
145947829|NCT00862459|526317309|FG000|Overall Study|Administrative problems|0|||
145947830|NCT00862459|526317310|FG001|Overall Study|Administrative problems|1|||
145947831|NCT00862459|526317311|FG002|Overall Study|Administrative problems|0|||
145947832|NCT03564795|526317312|FG000|Overall Study|Withdrawal by Subject|3|||
145947833|NCT03564795|526317312|FG000|Overall Study|Lost to Follow-up|6|||
145947834|NCT03564795|526317312|FG000|Overall Study|Physician Decision|2|||
145947835|NCT02208050|526317317|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
145947836|NCT02208050|526317318|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
145947837|NCT00477607|526317319|FG000|Overall Study|Lost to Follow-up|7|||
145947838|NCT00477607|526317320|FG001|Overall Study|Lost to Follow-up|7|||
145947839|NCT01732471|526317321|FG000|Overall Study|Withdrawal by Subject|1|||
145947840|NCT00474786|526317324|FG000|Overall Study|Not Meeting Study Criteria|0|||
145947841|NCT00474786|526317325|FG001|Overall Study|Not Meeting Study Criteria|1|||
145947842|NCT00474786|526317324|FG000|Overall Study|Investigator Request|2|||
145947843|NCT00474786|526317325|FG001|Overall Study|Investigator Request|1|||
145947844|NCT00474786|526317324|FG000|Overall Study|Death|189|||
145947845|NCT00474786|526317325|FG001|Overall Study|Death|170|||
145947846|NCT00474786|526317324|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
145947847|NCT00474786|526317325|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
145947848|NCT00474786|526317324|FG000|Overall Study|Lost to Follow-up|4|||
145947849|NCT00474786|526317325|FG001|Overall Study|Lost to Follow-up|7|||
145947850|NCT00474786|526317324|FG000|Overall Study|Protocol Violation|2|||
145947851|NCT00474786|526317325|FG001|Overall Study|Protocol Violation|0|||
145947852|NCT00474786|526317324|FG000|Overall Study|Withdrawal by Subject|15|||
145947853|NCT00474786|526317325|FG001|Overall Study|Withdrawal by Subject|15|||
145947854|NCT00474786|526317324|FG000|Overall Study|Other|5|||
145947855|NCT00474786|526317325|FG001|Overall Study|Other|0|||
145947856|NCT02892513|526317326|FG000|Overall Study|Withdrawal by Subject|0|||
145947857|NCT02892513|526317327|FG001|Overall Study|Withdrawal by Subject|1|||
145947858|NCT00432276|526317328|FG000|Overall Study|Hyperglycemic Rescue|44|||
145947859|NCT00432276|526317329|FG001|Overall Study|Hyperglycemic Rescue|87|||
145947860|NCT00432276|526317328|FG000|Overall Study|Adverse Event|13|||
145947861|NCT00432276|526317329|FG001|Overall Study|Adverse Event|16|||
145947862|NCT00432276|526317328|FG000|Overall Study|Protocol Violation|25|||
145947863|NCT00432276|526317329|FG001|Overall Study|Protocol Violation|20|||
145947864|NCT00432276|526317328|FG000|Overall Study|Lost to Follow-up|6|||
146284958|NCT02081417|527555611|FG000|Overall Study|Death|4|||
146284959|NCT02081417|527555612|FG001|Overall Study|Death|3|||
146284960|NCT02081417|527555611|FG000|Overall Study|Withdrawal by Subject|4|||
146284961|NCT02081417|527555612|FG001|Overall Study|Withdrawal by Subject|0|||
146284962|NCT02081417|527555611|FG000|Overall Study|Admitted to Residential Treatment|2|||
146284963|NCT02081417|527555612|FG001|Overall Study|Admitted to Residential Treatment|0|||
146284964|NCT02081417|527555611|FG000|Overall Study|Did not start treatment|17|||
146284965|NCT02081417|527555612|FG001|Overall Study|Did not start treatment|21|||
146284966|NCT01157676|527555616|FG000|Randomization|Death|1|||
146284967|NCT01157676|527555617|FG001|Randomization|Death|1|||
146284968|NCT01157676|527555616|FG000|Randomization|unresectable|2|||
146284969|NCT01157676|527555617|FG001|Randomization|unresectable|3|||
146284970|NCT01157676|527555616|FG000|Randomization|Withdrawal by Subject|17|||
146284971|NCT01157676|527555617|FG001|Randomization|Withdrawal by Subject|13|||
146284972|NCT01157676|527555616|FG000|Randomization|Physician Decision|1|||
146284973|NCT01157676|527555617|FG001|Randomization|Physician Decision|0|||
146284974|NCT01157676|527555616|FG000|Surgery|underwent open cystectomy|0|||
146284975|NCT01157676|527555617|FG001|Surgery|underwent open cystectomy|4|||
146284976|NCT01157676|527555616|FG000|Surgery|converted to open procedure|0|||
146284977|NCT01157676|527555617|FG001|Surgery|converted to open procedure|5|||
146284978|NCT01157676|527555616|FG000|Surgery|underwent robotic cystectomy|1|||
146284979|NCT01157676|527555617|FG001|Surgery|underwent robotic cystectomy|0|||
146284980|NCT00682890|527555618|FG000|Overall Study|Lost to Follow-up|1|||
146284981|NCT00682890|527555619|FG001|Overall Study|Lost to Follow-up|1|||
146284982|NCT00682890|527555618|FG000|Overall Study|subject moved away|0|||
145947865|NCT00432276|526317329|FG001|Overall Study|Lost to Follow-up|2|||
146284983|NCT00682890|527555619|FG001|Overall Study|subject moved away|1|||
145947866|NCT00432276|526317328|FG000|Overall Study|Withdrawal by Subject|25|||
145947867|NCT00432276|526317329|FG001|Overall Study|Withdrawal by Subject|20|||
145947868|NCT00432276|526317328|FG000|Overall Study|Physician Decision|6|||
145947869|NCT00432276|526317329|FG001|Overall Study|Physician Decision|8|||
145947870|NCT00432276|526317328|FG000|Overall Study|Other|2|||
145947871|NCT00432276|526317329|FG001|Overall Study|Other|3|||
145947872|NCT00655681|526317330|FG000|Overall Study|Lost to Follow-up|1|||
145947873|NCT00655681|526317331|FG001|Overall Study|Lost to Follow-up|1|||
145947874|NCT00467961|526317333|FG000|Overall Study|Technical Failures|5|||
145947875|NCT00467961|526317333|FG000|Overall Study|Disease Progression|2|||
145947876|NCT02429310|526317335|FG000|Overall Study|Lost to Follow-up|1|||
145947877|NCT02429310|526317336|FG001|Overall Study|Lost to Follow-up|2|||
145947878|NCT02429310|526317335|FG000|Overall Study|Protocol Violation|1|||
145947879|NCT02429310|526317336|FG001|Overall Study|Protocol Violation|1|||
145947880|NCT00394433|526317339|FG000|Overall Study|Adverse Event|2|||
145947881|NCT00394433|526317339|FG000|Overall Study|Alternative Therapy|1|||
145947882|NCT03417024|526317340|FG000|Overall Study|Study Termination prior to follow-up|11|||
145947883|NCT03417024|526317340|FG000|Overall Study|Physician Decision|2|||
145947884|NCT03168919|526317341|FG000|Overall Study|Withdrawal by Subject|2|||
145947885|NCT01085136|526317342|FG000|Part A|Other Adverse event|223|||
145947886|NCT01085136|526317343|FG001|Part A|Other Adverse event|0|||
145947887|NCT01085136|526317344|FG002|Part A|Other Adverse event|0|||
145947888|NCT01085136|526317342|FG000|Part A|Protocol Violation|3|||
145947889|NCT01085136|526317343|FG001|Part A|Protocol Violation|0|||
145947890|NCT01085136|526317344|FG002|Part A|Protocol Violation|0|||
145947891|NCT01085136|526317342|FG000|Part A|Lost to Follow-up|3|||
145947892|NCT01085136|526317343|FG001|Part A|Lost to Follow-up|0|||
145947893|NCT01085136|526317344|FG002|Part A|Lost to Follow-up|0|||
145947894|NCT01085136|526317342|FG000|Part A|Refusal to continue trial medication|64|||
145947895|NCT01085136|526317343|FG001|Part A|Refusal to continue trial medication|0|||
145947896|NCT01085136|526317344|FG002|Part A|Refusal to continue trial medication|0|||
145947897|NCT01085136|526317342|FG000|Part A|Other reason not defined above|30|||
145947898|NCT01085136|526317343|FG001|Part A|Other reason not defined above|0|||
145947899|NCT01085136|526317344|FG002|Part A|Other reason not defined above|0|||
145947900|NCT01085136|526317342|FG000|Part B|Other AE|0|||
145947901|NCT01085136|526317343|FG001|Part B|Other AE|29|||
145947902|NCT01085136|526317344|FG002|Part B|Other AE|8|||
145947903|NCT01085136|526317342|FG000|Part B|Refusal to continue trial medication|0|||
145947904|NCT01085136|526317343|FG001|Part B|Refusal to continue trial medication|12|||
145947905|NCT01085136|526317344|FG002|Part B|Refusal to continue trial medication|7|||
145947906|NCT01085136|526317342|FG000|Part B|Not treated|0|||
145947907|NCT01085136|526317343|FG001|Part B|Not treated|4|||
145947908|NCT01085136|526317344|FG002|Part B|Not treated|8|||
145947909|NCT01085136|526317342|FG000|Part B|Other reason not defined above|0|||
145947910|NCT01085136|526317343|FG001|Part B|Other reason not defined above|6|||
145947911|NCT01085136|526317344|FG002|Part B|Other reason not defined above|3|||
145947912|NCT00386425|526317345|FG000|Overall Study|Physician Decision|3|||
145947913|NCT00386425|526317346|FG001|Overall Study|Physician Decision|0|||
145947914|NCT00386425|526317347|FG002|Overall Study|Physician Decision|0|||
145947915|NCT00386425|526317345|FG000|Overall Study|Withdrawal by Subject|0|||
145947916|NCT00386425|526317346|FG001|Overall Study|Withdrawal by Subject|1|||
145947917|NCT00386425|526317347|FG002|Overall Study|Withdrawal by Subject|0|||
145947918|NCT04852276|526317348|FG000|Overall Study|Death|2|||
145947919|NCT04852276|526317349|FG001|Overall Study|Death|0|||
145947920|NCT04852276|526317348|FG000|Overall Study|Lost to Follow-up|15|||
145947921|NCT04852276|526317349|FG001|Overall Study|Lost to Follow-up|9|||
145947922|NCT04852276|526317348|FG000|Overall Study|Withdrawal by Subject|26|||
145947923|NCT04852276|526317349|FG001|Overall Study|Withdrawal by Subject|6|||
145947924|NCT01393106|526319501|FG000|Overall Study|Adverse Event|3|||
145947925|NCT01393106|526319501|FG000|Overall Study|Withdrawal by Subject|1|||
145947926|NCT01393106|526319501|FG000|Overall Study|Lack of Efficacy|1|||
145947927|NCT02732015|526319503|FG000|Overall Study|Lost to Follow-up|0|||
145947928|NCT02732015|526319504|FG001|Overall Study|Lost to Follow-up|1|||
145947929|NCT02474355|526319507|FG000|Overall Study|Other|43|||
145947930|NCT02474355|526319507|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
145947931|NCT02474355|526319507|FG000|Overall Study|Lost to Follow-up|98|||
145947932|NCT02474355|526319507|FG000|Overall Study|Withdrawal by Subject|124|||
145947933|NCT02474355|526319507|FG000|Overall Study|Death|1361|||
145947934|NCT00734656|526319508|FG000|Lab Session 1|Withdrawal by Subject|2|||
145947935|NCT00734656|526319509|FG001|Lab Session 1|Withdrawal by Subject|0|||
145947936|NCT00734656|526319510|FG002|Lab Session 1|Withdrawal by Subject|0|||
145947937|NCT00734656|526319511|FG003|Lab Session 1|Withdrawal by Subject|0|||
145947938|NCT00734656|526319508|FG000|Washout 1|Withdrawal by Subject|1|||
145947939|NCT00734656|526319509|FG001|Washout 1|Withdrawal by Subject|5|||
145947940|NCT00734656|526319510|FG002|Washout 1|Withdrawal by Subject|2|||
145947941|NCT00734656|526319511|FG003|Washout 1|Withdrawal by Subject|3|||
145947942|NCT00734656|526319508|FG000|Lab Session 2|Withdrawal by Subject|1|||
145947943|NCT00734656|526319509|FG001|Lab Session 2|Withdrawal by Subject|0|||
145947944|NCT00734656|526319510|FG002|Lab Session 2|Withdrawal by Subject|0|||
145947945|NCT00734656|526319511|FG003|Lab Session 2|Withdrawal by Subject|1|||
145947946|NCT00734656|526319508|FG000|Washout 2|Withdrawal by Subject|1|||
145947947|NCT00734656|526319509|FG001|Washout 2|Withdrawal by Subject|1|||
145947948|NCT00734656|526319510|FG002|Washout 2|Withdrawal by Subject|1|||
145947949|NCT00734656|526319511|FG003|Washout 2|Withdrawal by Subject|0|||
145947950|NCT00734656|526319508|FG000|Washout 3|Withdrawal by Subject|1|||
145947951|NCT00734656|526319509|FG001|Washout 3|Withdrawal by Subject|0|||
145947952|NCT00734656|526319510|FG002|Washout 3|Withdrawal by Subject|0|||
145947953|NCT00734656|526319511|FG003|Washout 3|Withdrawal by Subject|1|||
145947954|NCT00734656|526319508|FG000|Lab Session 4|Withdrawal by Subject|0|||
145947955|NCT00734656|526319509|FG001|Lab Session 4|Withdrawal by Subject|0|||
146284984|NCT00682890|527555618|FG000|Overall Study|heavy menstrual bleeding|1|||
146284985|NCT00682890|527555619|FG001|Overall Study|heavy menstrual bleeding|0|||
146284986|NCT01506609|527555623|FG000|Overall Study|Adverse Event Related to Progression|0|||
146284987|NCT01506609|527555624|FG001|Overall Study|Adverse Event Related to Progression|0|||
146284988|NCT01506609|527555625|FG002|Overall Study|Adverse Event Related to Progression|0|||
146284989|NCT01506609|527555626|FG003|Overall Study|Adverse Event Related to Progression|3|||
146284990|NCT01506609|527555627|FG004|Overall Study|Adverse Event Related to Progression|7|||
146284991|NCT01506609|527555628|FG005|Overall Study|Adverse Event Related to Progression|3|||
146284992|NCT01506609|527555623|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
146284993|NCT01506609|527555624|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
146284994|NCT01506609|527555625|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
146284995|NCT01506609|527555626|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
146284996|NCT01506609|527555627|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
146284997|NCT01506609|527555628|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
145947956|NCT00734656|526319510|FG002|Lab Session 4|Withdrawal by Subject|0|||
145947957|NCT00734656|526319511|FG003|Lab Session 4|Withdrawal by Subject|1|||
145947958|NCT03214679|526319512|FG000|Overall Study|Lost to Follow-up|12|||
145947959|NCT03214679|526319513|FG001|Overall Study|Lost to Follow-up|14|||
145947960|NCT03214679|526319512|FG000|Overall Study|not eligible|2|||
145947961|NCT03214679|526319513|FG001|Overall Study|not eligible|0|||
145947962|NCT03341936|526319520|FG000|Overall Study|Ineligible|1|||
145947963|NCT03341936|526319520|FG000|Overall Study|Disease Progression|2|||
145947964|NCT03341936|526319520|FG000|Overall Study|Withdrew Consent|4|||
145947965|NCT03341936|526319520|FG000|Overall Study|Non-Compliance|1|||
145947966|NCT03341936|526319520|FG000|Overall Study|Physician Decision|1|||
145947967|NCT03341936|526319520|FG000|Overall Study|Withdrawal by Subject|1|||
145947968|NCT03341936|526319520|FG000|Overall Study|Other|1|||
145947969|NCT02368886|526319521|FG000|Overall Study|Cancel|1|||
145947970|NCT02368886|526319522|FG001|Overall Study|Cancel|1|||
145947971|NCT02368886|526319523|FG002|Overall Study|Cancel|1|||
146284998|NCT01506609|527555623|FG000|Overall Study|Withdrawal by Subject|0|||
146284999|NCT01506609|527555624|FG001|Overall Study|Withdrawal by Subject|0|||
146285000|NCT01506609|527555625|FG002|Overall Study|Withdrawal by Subject|0|||
146285001|NCT01506609|527555626|FG003|Overall Study|Withdrawal by Subject|9|||
146285002|NCT01506609|527555627|FG004|Overall Study|Withdrawal by Subject|7|||
146285003|NCT01506609|527555628|FG005|Overall Study|Withdrawal by Subject|7|||
146285004|NCT01506609|527555623|FG000|Overall Study|Lost to Follow-up|0|||
146285005|NCT01506609|527555624|FG001|Overall Study|Lost to Follow-up|0|||
146285006|NCT01506609|527555625|FG002|Overall Study|Lost to Follow-up|0|||
146285007|NCT01506609|527555626|FG003|Overall Study|Lost to Follow-up|1|||
146285008|NCT01506609|527555627|FG004|Overall Study|Lost to Follow-up|2|||
146285009|NCT01506609|527555628|FG005|Overall Study|Lost to Follow-up|0|||
146285010|NCT01506609|527555623|FG000|Overall Study|Sponsor Discontinued Study|0|||
146285011|NCT01506609|527555624|FG001|Overall Study|Sponsor Discontinued Study|0|||
146285012|NCT01506609|527555625|FG002|Overall Study|Sponsor Discontinued Study|0|||
146285013|NCT01506609|527555626|FG003|Overall Study|Sponsor Discontinued Study|2|||
146285014|NCT01506609|527555627|FG004|Overall Study|Sponsor Discontinued Study|2|||
146285015|NCT01506609|527555628|FG005|Overall Study|Sponsor Discontinued Study|0|||
146285016|NCT01506609|527555623|FG000|Overall Study|Progressive Disease per Protocol|1|||
146285017|NCT01506609|527555624|FG001|Overall Study|Progressive Disease per Protocol|0|||
145947972|NCT02368886|526319524|FG003|Overall Study|Cancel|3|||
146285018|NCT01506609|527555625|FG002|Overall Study|Progressive Disease per Protocol|0|||
146285019|NCT01506609|527555626|FG003|Overall Study|Progressive Disease per Protocol|64|||
146285020|NCT01506609|527555627|FG004|Overall Study|Progressive Disease per Protocol|57|||
146285021|NCT01506609|527555628|FG005|Overall Study|Progressive Disease per Protocol|74|||
146285022|NCT01506609|527555623|FG000|Overall Study|Other, Not Specified|0|||
146285023|NCT01506609|527555624|FG001|Overall Study|Other, Not Specified|0|||
146285024|NCT01506609|527555625|FG002|Overall Study|Other, Not Specified|0|||
146285025|NCT01506609|527555626|FG003|Overall Study|Other, Not Specified|10|||
146285026|NCT01506609|527555627|FG004|Overall Study|Other, Not Specified|7|||
146285027|NCT01506609|527555628|FG005|Overall Study|Other, Not Specified|3|||
146285028|NCT01506609|527555623|FG000|Overall Study|Missing / Unknown Reason|1|||
146285029|NCT01506609|527555624|FG001|Overall Study|Missing / Unknown Reason|0|||
146285030|NCT01506609|527555625|FG002|Overall Study|Missing / Unknown Reason|1|||
146285031|NCT01506609|527555626|FG003|Overall Study|Missing / Unknown Reason|4|||
146285032|NCT01506609|527555627|FG004|Overall Study|Missing / Unknown Reason|4|||
146285033|NCT01506609|527555628|FG005|Overall Study|Missing / Unknown Reason|2|||
146285034|NCT00577473|527555633|FG000|Overall Study|Protocol Violation|1|||
146285035|NCT00577473|527555634|FG001|Overall Study|Protocol Violation|4|||
146285036|NCT00577473|527555633|FG000|Overall Study|Adverse Event|8|||
146285037|NCT00577473|527555634|FG001|Overall Study|Adverse Event|5|||
146285038|NCT00577473|527555633|FG000|Overall Study|Withdrawal by Subject|2|||
145947973|NCT02368886|526319521|FG000|Overall Study|Ineligible|0|||
145947974|NCT02368886|526319522|FG001|Overall Study|Ineligible|0|||
146285039|NCT00577473|527555634|FG001|Overall Study|Withdrawal by Subject|6|||
146285040|NCT00577473|527555633|FG000|Overall Study|Physician Decision|2|||
146285041|NCT00577473|527555634|FG001|Overall Study|Physician Decision|2|||
146285042|NCT00577473|527555633|FG000|Overall Study|Lack of Efficacy|8|||
146285043|NCT00577473|527555634|FG001|Overall Study|Lack of Efficacy|7|||
146285044|NCT02595073|527555637|FG000|Overall Study|Progressive Disease|0|||
146285045|NCT02595073|527555638|FG001|Overall Study|Progressive Disease|1|||
146285046|NCT02595073|527555637|FG000|Overall Study|Protocol Violation|2|||
145947975|NCT02368886|526319523|FG002|Overall Study|Ineligible|0|||
146285047|NCT02595073|527555638|FG001|Overall Study|Protocol Violation|0|||
146285048|NCT01990560|527555641|FG000|Overall Study|Withdrawal by Subject|1|||
145947976|NCT02368886|526319524|FG003|Overall Study|Ineligible|1|||
146285049|NCT01324440|527555647|FG000|Overall Study|Subject moved|0|||
146285050|NCT01324440|527555648|FG001|Overall Study|Subject moved|1|||
146285051|NCT02884908|527555649|FG000|Overall Study|Lost to Follow-up|13|||
146285052|NCT02884908|527555650|FG001|Overall Study|Lost to Follow-up|18|||
146285053|NCT01801735|527555651|FG000|Overall Study|Adverse Event|79|||
146285054|NCT01801735|527555651|FG000|Overall Study|Lack of Efficacy|28|||
146285055|NCT01801735|527555651|FG000|Overall Study|Withdrawal by Subject|27|||
146285056|NCT01801735|527555651|FG000|Overall Study|Protocol Violation|25|||
146285057|NCT01801735|527555651|FG000|Overall Study|Lost to Follow-up|15|||
146285058|NCT01801735|527555651|FG000|Overall Study|Non-compliance with Trial Drug|13|||
146285059|NCT01801735|527555651|FG000|Overall Study|Physician Decision|3|||
146285060|NCT01801735|527555651|FG000|Overall Study|Death|1|||
146285061|NCT01801735|527555651|FG000|Overall Study|Other, including site closure|19|||
146285062|NCT00468559|527555652|FG000|Open-label Treatment Phase|Adverse Event|5|||
146285063|NCT00468559|527555653|FG001|Open-label Treatment Phase|Adverse Event|0|||
146285064|NCT00468559|527555654|FG002|Open-label Treatment Phase|Adverse Event|0|||
146285065|NCT00468559|527555652|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
146285066|NCT00468559|527555653|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
146285067|NCT00468559|527555654|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
146285068|NCT00468559|527555652|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
146285069|NCT00468559|527555653|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
146285070|NCT00468559|527555654|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
146285071|NCT00468559|527555652|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
146285072|NCT00468559|527555653|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
146285073|NCT00468559|527555654|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
146285074|NCT00468559|527555652|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
146285075|NCT00468559|527555653|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
146285076|NCT00468559|527555654|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
146285077|NCT01153958|527555655|FG000|Overall Study|Study Terminated|36|||
146285078|NCT01153958|527555656|FG001|Overall Study|Study Terminated|32|||
146285079|NCT01034163|527555658|FG000|Overall Study|Treatment completed as per protocol|8|||
146285080|NCT01034163|527555659|FG001|Overall Study|Treatment completed as per protocol|7|||
146285081|NCT01034163|527555658|FG000|Overall Study|Withdrawal by Subject|8|||
146285082|NCT01034163|527555659|FG001|Overall Study|Withdrawal by Subject|2|||
146285083|NCT01034163|527555658|FG000|Overall Study|Protocol deviation|1|||
146285084|NCT01034163|527555659|FG001|Overall Study|Protocol deviation|0|||
146285085|NCT01034163|527555658|FG000|Overall Study|Disease progression|3|||
146285086|NCT01034163|527555659|FG001|Overall Study|Disease progression|4|||
146285087|NCT01034163|527555658|FG000|Overall Study|Adverse Event|6|||
146285088|NCT01034163|527555659|FG001|Overall Study|Adverse Event|0|||
146285089|NCT01034163|527555658|FG000|Overall Study|Administrative problems|0|||
146285090|NCT01034163|527555659|FG001|Overall Study|Administrative problems|1|||
146285091|NCT01034163|527555658|FG000|Overall Study|Abnormal laboratory value|1|||
146285092|NCT01034163|527555659|FG001|Overall Study|Abnormal laboratory value|0|||
146285093|NCT02996474|527555660|FG000|Overall Study|Physician Decision|5|||
146285094|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
146285095|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
146285096|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
146285097|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
146285098|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
146285099|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
146285100|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
146285101|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
146285102|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
146285103|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
146285104|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
146285105|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
146285106|NCT04493502|527555661|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
146285107|NCT04493502|527555662|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
146285108|NCT04493502|527555661|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
146285109|NCT04493502|527555662|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
146285110|NCT04493502|527555661|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
146285111|NCT04493502|527555662|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
146285112|NCT04493502|527555661|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
146285113|NCT04493502|527555662|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
146285114|NCT04493502|527555661|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
146285115|NCT04493502|527555662|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
146193219|NCT00751036|527217813|FG001|Overall Study|Disease Progression|29|||
146193220|NCT00751036|527217812|FG000|Overall Study|Adverse Event|6|||
146193221|NCT00751036|527217813|FG001|Overall Study|Adverse Event|4|||
146193222|NCT00751036|527217812|FG000|Overall Study|Administrative Problems|3|||
146193223|NCT00751036|527217813|FG001|Overall Study|Administrative Problems|4|||
146193224|NCT00751036|527217812|FG000|Overall Study|Withdrawal by Subject|5|||
146193225|NCT00751036|527217813|FG001|Overall Study|Withdrawal by Subject|2|||
146193226|NCT00751036|527217812|FG000|Overall Study|Death|3|||
146193227|NCT00751036|527217813|FG001|Overall Study|Death|3|||
146193228|NCT00751036|527217812|FG000|Overall Study|Lost to Follow-up|0|||
146193229|NCT00751036|527217813|FG001|Overall Study|Lost to Follow-up|1|||
146193230|NCT00751036|527217812|FG000|Overall Study|Protocol Violation|1|||
146193231|NCT00751036|527217813|FG001|Overall Study|Protocol Violation|0|||
146193232|NCT00751036|527217812|FG000|Overall Study|Missing end of Treatment Page|2|||
146193233|NCT00751036|527217813|FG001|Overall Study|Missing end of Treatment Page|3|||
146193234|NCT04580407|527217814|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
146193235|NCT01562743|527217822|FG000|Overall Study|Adverse Event|29|||
146193236|NCT01562743|527217822|FG000|Overall Study|Lack of Efficacy|3|||
146285116|NCT04493502|527555661|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
146285117|NCT04493502|527555662|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
146285118|NCT04493502|527555661|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
146285119|NCT04493502|527555662|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
146285120|NCT02533531|527555664|FG000|Overall Study|Device did not turn on|1|||
146285121|NCT02047903|527555665|FG000|Overall Study|Adverse Event|14|||
146285122|NCT02047903|527555665|FG000|Overall Study|Serious adverse event|10|||
146285123|NCT02047903|527555665|FG000|Overall Study|Withdrawal by Subject|16|||
146285124|NCT02047903|527555665|FG000|Overall Study|Lost to Follow-up|4|||
146285125|NCT02047903|527555665|FG000|Overall Study|Reason not listed|6|||
146285126|NCT02047903|527555665|FG000|Overall Study|Not Treated|9|||
146285127|NCT02924428|527557751|FG000|Overall Study|Adverse Event|1|||
146285128|NCT02924428|527557752|FG001|Overall Study|Adverse Event|0|||
146285129|NCT02924428|527557751|FG000|Overall Study|Physician Decision|1|||
146285130|NCT02924428|527557752|FG001|Overall Study|Physician Decision|0|||
146285131|NCT02924428|527557751|FG000|Overall Study|Lost to Follow-up|2|||
146285132|NCT02924428|527557752|FG001|Overall Study|Lost to Follow-up|4|||
146285133|NCT02924428|527557751|FG000|Overall Study|Pregnancy|0|||
146285134|NCT02924428|527557752|FG001|Overall Study|Pregnancy|1|||
146285135|NCT01877837|527557753|FG000|Overall Study|Lost to Follow-up|1|||
146285136|NCT01877837|527557753|FG000|Overall Study|Ineligible|4|||
146285137|NCT03064035|527557754|FG000|Overall Study|Did not receive allocated intervention|4|||
146285138|NCT03064035|527557755|FG001|Overall Study|Did not receive allocated intervention|2|||
146285139|NCT03064035|527557754|FG000|Overall Study|Lost to Follow-up|1|||
146285140|NCT03064035|527557755|FG001|Overall Study|Lost to Follow-up|1|||
146285141|NCT01143038|527557756|FG000|Overall Study|Withdrawal by Subject|4|||
146285142|NCT01143038|527557756|FG000|Overall Study|Requirement for alternative therapy|5|||
146285143|NCT01143038|527557756|FG000|Overall Study|Adverse Event|3|||
146285144|NCT01143038|527557756|FG000|Overall Study|Lost to Follow-up|2|||
146285145|NCT01143038|527557756|FG000|Overall Study|Protocol Deviation|1|||
146285146|NCT01143038|527557756|FG000|Overall Study|Death|1|||
146285147|NCT02336178|527557757|FG000|Overall Study|Lost to Follow-up|1|||
146285148|NCT02336178|527557757|FG000|Overall Study|Protocol Violation|1|||
146285149|NCT02336178|527557757|FG000|Overall Study|Withdrawal by Subject|1|||
146285150|NCT02336178|527557757|FG000|Overall Study|Other|1|||
146285151|NCT03310268|527557758|FG000|Overall Study|(Not specified)|1|||
146285152|NCT03310268|527557759|FG001|Overall Study|(Not specified)|5|||
146285153|NCT03310268|527557760|FG002|Overall Study|(Not specified)|0|||
146285154|NCT00706433|527557764|FG000|Overall Study|Lost to Follow-up|3|||
146285155|NCT00706433|527557765|FG001|Overall Study|Lost to Follow-up|1|||
146285156|NCT00706433|527557766|FG002|Overall Study|Lost to Follow-up|6|||
146285157|NCT00706433|527557767|FG003|Overall Study|Lost to Follow-up|0|||
146285158|NCT00706433|527557764|FG000|Overall Study|Withdrawal by Subject|1|||
146285159|NCT00706433|527557765|FG001|Overall Study|Withdrawal by Subject|2|||
146285160|NCT00706433|527557766|FG002|Overall Study|Withdrawal by Subject|3|||
146285161|NCT00706433|527557767|FG003|Overall Study|Withdrawal by Subject|1|||
146285162|NCT00706433|527557764|FG000|Overall Study|Adverse Event|0|||
146285163|NCT00706433|527557765|FG001|Overall Study|Adverse Event|0|||
146285164|NCT00706433|527557766|FG002|Overall Study|Adverse Event|1|||
146285165|NCT00706433|527557767|FG003|Overall Study|Adverse Event|0|||
146285166|NCT00706433|527557764|FG000|Overall Study|Protocol Violation|1|||
146285167|NCT00706433|527557765|FG001|Overall Study|Protocol Violation|0|||
146193237|NCT01562743|527217822|FG000|Overall Study|Withdrawal by Subject|13|||
146193238|NCT01562743|527217822|FG000|Overall Study|Protocol Violation|1|||
146193239|NCT01562743|527217822|FG000|Overall Study|Discontinuation criteria|2|||
146285168|NCT00706433|527557766|FG002|Overall Study|Protocol Violation|0|||
146285169|NCT00706433|527557767|FG003|Overall Study|Protocol Violation|0|||
146285170|NCT00706433|527557764|FG000|Overall Study|new job|0|||
146285171|NCT00706433|527557765|FG001|Overall Study|new job|0|||
146285172|NCT00706433|527557766|FG002|Overall Study|new job|0|||
145947977|NCT02131636|526319528|FG000|Overall Study|Personal Reasons|4|||
145947978|NCT02131636|526319529|FG001|Overall Study|Personal Reasons|4|||
145947979|NCT02131636|526319528|FG000|Overall Study|Lost to Follow-up|4|||
145947980|NCT02131636|526319529|FG001|Overall Study|Lost to Follow-up|0|||
145947981|NCT02131636|526319528|FG000|Overall Study|Adverse Event|4|||
145947982|NCT02131636|526319529|FG001|Overall Study|Adverse Event|1|||
145947983|NCT02173379|526319530|FG000|Overall Study|Lost to Follow-up|89|||
145947984|NCT02173379|526319531|FG001|Overall Study|Lost to Follow-up|81|||
145947985|NCT02173379|526319530|FG000|Overall Study|Withdrawal by Subject|24|||
145947986|NCT02173379|526319531|FG001|Overall Study|Withdrawal by Subject|29|||
145947987|NCT02173379|526319530|FG000|Overall Study|Physician Decision|8|||
145947988|NCT02173379|526319531|FG001|Overall Study|Physician Decision|8|||
145947989|NCT02173379|526319530|FG000|Overall Study|Death|75|||
145947990|NCT02173379|526319531|FG001|Overall Study|Death|72|||
145947991|NCT02173379|526319530|FG000|Overall Study|Other Reason|1|||
145947992|NCT02173379|526319531|FG001|Overall Study|Other Reason|0|||
145947993|NCT04278924|526319532|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
145947994|NCT04278924|526319533|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
145947995|NCT04278924|526319534|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145947996|NCT04278924|526319535|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
145947997|NCT04278924|526319536|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145947998|NCT04278924|526319537|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145947999|NCT04278924|526319538|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145948000|NCT04278924|526319532|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948001|NCT04278924|526319533|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
145948002|NCT04278924|526319534|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948003|NCT04278924|526319535|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948004|NCT04278924|526319536|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948005|NCT04278924|526319537|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948006|NCT04278924|526319538|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
145948007|NCT06226649|526319539|FG000|Overall Study|Withdrawal by Subject|4|||
145948008|NCT06226649|526319540|FG001|Overall Study|Withdrawal by Subject|1|||
145948009|NCT05600036|526319541|FG000|Overall Study|Adverse Event|0|||
145948010|NCT05600036|526319542|FG001|Overall Study|Adverse Event|2|||
145948011|NCT05600036|526319543|FG002|Overall Study|Adverse Event|1|||
145948012|NCT05600036|526319544|FG003|Overall Study|Adverse Event|0|||
145948013|NCT05600036|526319545|FG004|Overall Study|Adverse Event|1|||
145948014|NCT05600036|526319546|FG005|Overall Study|Adverse Event|0|||
145948015|NCT05600036|526319541|FG000|Overall Study|Lost to Follow-up|0|||
145948016|NCT05600036|526319542|FG001|Overall Study|Lost to Follow-up|2|||
145948017|NCT05600036|526319543|FG002|Overall Study|Lost to Follow-up|1|||
145948018|NCT05600036|526319544|FG003|Overall Study|Lost to Follow-up|1|||
145948019|NCT05600036|526319545|FG004|Overall Study|Lost to Follow-up|0|||
145948020|NCT05600036|526319546|FG005|Overall Study|Lost to Follow-up|0|||
145948021|NCT05600036|526319541|FG000|Overall Study|Protocol Violation|0|||
145948022|NCT05600036|526319542|FG001|Overall Study|Protocol Violation|0|||
145948023|NCT05600036|526319543|FG002|Overall Study|Protocol Violation|2|||
145948024|NCT05600036|526319544|FG003|Overall Study|Protocol Violation|0|||
145948025|NCT05600036|526319545|FG004|Overall Study|Protocol Violation|0|||
145948026|NCT05600036|526319546|FG005|Overall Study|Protocol Violation|0|||
145948027|NCT05600036|526319541|FG000|Overall Study|Withdrawal by Subject|0|||
145948028|NCT05600036|526319542|FG001|Overall Study|Withdrawal by Subject|1|||
145948029|NCT05600036|526319543|FG002|Overall Study|Withdrawal by Subject|2|||
145948030|NCT05600036|526319544|FG003|Overall Study|Withdrawal by Subject|0|||
145948031|NCT05600036|526319545|FG004|Overall Study|Withdrawal by Subject|3|||
145948032|NCT05600036|526319546|FG005|Overall Study|Withdrawal by Subject|5|||
145948033|NCT05600036|526319541|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145948034|NCT05600036|526319542|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145948035|NCT05600036|526319543|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145948036|NCT05600036|526319544|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
145948037|NCT05600036|526319545|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
146082351|NCT04449029|526822780|FG007|Overall Study|Adverse Event|0|||
145948038|NCT05600036|526319546|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145948039|NCT05600036|526319541|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145948040|NCT05600036|526319542|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
145948041|NCT05600036|526319543|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145948042|NCT05600036|526319544|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145948043|NCT05600036|526319545|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145948044|NCT05600036|526319546|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
146082352|NCT04449029|526822773|FG000|Overall Study|Lost to Follow-up|0|||
146082353|NCT04449029|526822774|FG001|Overall Study|Lost to Follow-up|1|||
146082354|NCT04449029|526822775|FG002|Overall Study|Lost to Follow-up|0|||
146082355|NCT04449029|526822776|FG003|Overall Study|Lost to Follow-up|0|||
146415850|NCT00771901|528026699|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
146415851|NCT02862535|528026700|FG000|Overall Study|Death|7|||
146193240|NCT01562743|527217822|FG000|Overall Study|Lost to Follow-up|2|||
146193241|NCT01562743|527217822|FG000|Overall Study|Physician Decision|2|||
146193242|NCT04155424|527217824|FG000|Overall Study|Other than specified|3|||
146193243|NCT04155424|527217824|FG000|Overall Study|Withdrawal by Subject|1|||
146193244|NCT04155424|527217824|FG000|Overall Study|Adverse Event|1|||
146193245|NCT04159506|527217825|FG000|Overall Study|Lost to Follow-up|2|||
146193246|NCT04159506|527217826|FG001|Overall Study|Lost to Follow-up|5|||
146193247|NCT02449044|527217827|FG000|Overall Study|Lost to Follow-up|2|||
146193248|NCT02449044|527217827|FG000|Overall Study|Withdrawal by Subject|13|||
146193249|NCT02449044|527217827|FG000|Overall Study|Adverse Event|30|||
146193250|NCT02449044|527217827|FG000|Overall Study|Met Withdrawal Criteria|7|||
146193251|NCT02449044|527217827|FG000|Overall Study|Physician Decision|9|||
146193252|NCT02449044|527217827|FG000|Overall Study|Sponsor Discontinued Trial|3|||
146193253|NCT00662909|527217828|FG000|Overall Study|Adverse Event|17|||
146193254|NCT00662909|527217829|FG001|Overall Study|Adverse Event|18|||
146193255|NCT00662909|527217830|FG002|Overall Study|Adverse Event|19|||
146193256|NCT00662909|527217828|FG000|Overall Study|Lack of Efficacy|9|||
146193257|NCT00662909|527217829|FG001|Overall Study|Lack of Efficacy|1|||
146193258|NCT00662909|527217830|FG002|Overall Study|Lack of Efficacy|5|||
146193259|NCT00662909|527217828|FG000|Overall Study|Withdrawal by Subject|29|||
146193260|NCT00662909|527217829|FG001|Overall Study|Withdrawal by Subject|22|||
146193261|NCT00662909|527217830|FG002|Overall Study|Withdrawal by Subject|16|||
146193262|NCT00662909|527217828|FG000|Overall Study|Lost to Follow-up|2|||
146193263|NCT00662909|527217829|FG001|Overall Study|Lost to Follow-up|9|||
146193264|NCT00662909|527217830|FG002|Overall Study|Lost to Follow-up|3|||
146193265|NCT00662909|527217828|FG000|Overall Study|Protocol Violation|7|||
146193266|NCT00662909|527217829|FG001|Overall Study|Protocol Violation|4|||
146193267|NCT00662909|527217830|FG002|Overall Study|Protocol Violation|5|||
146193268|NCT00662909|527217828|FG000|Overall Study|Randomized- never received study drug|1|||
146193269|NCT00662909|527217829|FG001|Overall Study|Randomized- never received study drug|0|||
146193270|NCT00662909|527217830|FG002|Overall Study|Randomized- never received study drug|0|||
146193271|NCT00662909|527217828|FG000|Overall Study|Non-compliance with study procedures|3|||
146193272|NCT00662909|527217829|FG001|Overall Study|Non-compliance with study procedures|3|||
146193273|NCT00662909|527217830|FG002|Overall Study|Non-compliance with study procedures|2|||
146193274|NCT00662909|527217828|FG000|Overall Study|Physician Decision|1|||
146193275|NCT00662909|527217829|FG001|Overall Study|Physician Decision|1|||
146193276|NCT00662909|527217830|FG002|Overall Study|Physician Decision|2|||
146193277|NCT00662909|527217828|FG000|Overall Study|Eligibility criterion not met|0|||
146193278|NCT00662909|527217829|FG001|Overall Study|Eligibility criterion not met|1|||
146193279|NCT00662909|527217830|FG002|Overall Study|Eligibility criterion not met|1|||
146193280|NCT02738840|527219821|FG000|Overall Study|MRI Scan not Performed|5|||
146193281|NCT02738840|527219821|FG000|Overall Study|Lost to Follow-up|1|||
146193282|NCT02738840|527219821|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
146193283|NCT02738840|527219821|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
146193284|NCT05526911|527219827|FG000|Overall Study|Adverse Event|2|||
146193285|NCT05025449|527219828|FG000|Overall Study|Withdrawal by Subject|1|||
146193286|NCT05025449|527219828|FG000|Overall Study|Patient emergently taken to operating room|1|||
146193287|NCT00256308|527219829|FG000|Overall Study|Death|2|||
146193288|NCT00762463|527219831|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
146193289|NCT00762463|527219832|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
146193290|NCT00762463|527219833|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
146193291|NCT00762463|527219834|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
146193292|NCT00762463|527219831|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
146193293|NCT00762463|527219832|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
146193294|NCT00762463|527219833|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
146193295|NCT00762463|527219834|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
146193296|NCT00762463|527219831|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
146193297|NCT00762463|527219832|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
146193298|NCT00762463|527219833|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
146193299|NCT00762463|527219834|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
146193300|NCT00762463|527219831|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
146193301|NCT00762463|527219832|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
146193302|NCT00762463|527219833|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
146193303|NCT00762463|527219834|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
146193304|NCT00762463|527219831|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
146193305|NCT00762463|527219832|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
146193306|NCT00762463|527219833|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
146193307|NCT00762463|527219834|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
145948045|NCT05600036|526319541|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145948046|NCT05600036|526319542|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145948047|NCT05600036|526319543|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145948048|NCT05600036|526319544|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
145948049|NCT05600036|526319545|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145948050|NCT05600036|526319546|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145948051|NCT00631163|526319547|FG000|Number of Participants in Year 1|Adverse Event|12|||
145948052|NCT00631163|526319547|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
145948053|NCT00631163|526319547|FG000|Number of Participants in Year 1|Death|6|||
145948054|NCT00631163|526319547|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
145948055|NCT00631163|526319547|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
146193308|NCT00762463|527219831|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146193309|NCT00762463|527219832|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146193310|NCT00762463|527219833|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
146193311|NCT00762463|527219834|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
146193312|NCT00762463|527219831|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
146193313|NCT00762463|527219832|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
145948056|NCT00631163|526319547|FG000|Number of Participants in Year 1|Administrative problems|6|||
145948057|NCT00631163|526319547|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
145948058|NCT00631163|526319547|FG000|Number of Participants in Year 2|Adverse Event|1|||
145948059|NCT00631163|526319547|FG000|Number of Participants in Year 2|Protocol Violation|1|||
145948060|NCT00631163|526319547|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
145948061|NCT00715520|526319548|FG000|Overall Study|Screen failure|8|||
145948062|NCT00715520|526319549|FG001|Overall Study|Screen failure|1|||
145948063|NCT00715520|526319550|FG002|Overall Study|Screen failure|1|||
145948064|NCT00715520|526319548|FG000|Overall Study|Withdrawal by Subject|2|||
145948065|NCT00715520|526319549|FG001|Overall Study|Withdrawal by Subject|0|||
145948066|NCT00715520|526319550|FG002|Overall Study|Withdrawal by Subject|1|||
145948067|NCT04122625|526319551|FG000|Part A (up to 2.92 Years)|Death|2|||
145948068|NCT04122625|526319552|FG001|Part A (up to 2.92 Years)|Death|4|||
145948069|NCT04122625|526319553|FG002|Part A (up to 2.92 Years)|Death|0|||
145948070|NCT04122625|526319554|FG003|Part A (up to 2.92 Years)|Death|0|||
145948071|NCT04122625|526319555|FG004|Part A (up to 2.92 Years)|Death|0|||
145948072|NCT04122625|526319556|FG005|Part A (up to 2.92 Years)|Death|0|||
145948073|NCT04122625|526319551|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145948074|NCT04122625|526319552|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145948075|NCT04122625|526319553|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
145948076|NCT04122625|526319554|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
145948077|NCT04122625|526319555|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
145948078|NCT04122625|526319556|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145948079|NCT04122625|526319551|FG000|Part B (up to 2.33 Years)|Death|0|||
145948080|NCT04122625|526319552|FG001|Part B (up to 2.33 Years)|Death|0|||
145948081|NCT04122625|526319553|FG002|Part B (up to 2.33 Years)|Death|5|||
145948082|NCT04122625|526319554|FG003|Part B (up to 2.33 Years)|Death|7|||
145948083|NCT04122625|526319555|FG004|Part B (up to 2.33 Years)|Death|6|||
145948084|NCT04122625|526319556|FG005|Part B (up to 2.33 Years)|Death|7|||
145948085|NCT02697591|526319557|FG000|Overall Study|Lost to Follow-up|0|||
145948086|NCT02697591|526319558|FG001|Overall Study|Lost to Follow-up|0|||
145948087|NCT02697591|526319559|FG002|Overall Study|Lost to Follow-up|0|||
145948088|NCT02697591|526319560|FG003|Overall Study|Lost to Follow-up|0|||
145948089|NCT02697591|526319561|FG004|Overall Study|Lost to Follow-up|0|||
145948090|NCT02697591|526319562|FG005|Overall Study|Lost to Follow-up|1|||
145948091|NCT02697591|526319563|FG006|Overall Study|Lost to Follow-up|1|||
145948092|NCT02697591|526319564|FG007|Overall Study|Lost to Follow-up|0|||
145948093|NCT02697591|526319565|FG008|Overall Study|Lost to Follow-up|0|||
145948094|NCT02697591|526319566|FG009|Overall Study|Lost to Follow-up|1|||
145948095|NCT02697591|526319557|FG000|Overall Study|Withdrawal by Subject|1|||
145948096|NCT02697591|526319558|FG001|Overall Study|Withdrawal by Subject|1|||
145948097|NCT02697591|526319559|FG002|Overall Study|Withdrawal by Subject|2|||
145948098|NCT02697591|526319560|FG003|Overall Study|Withdrawal by Subject|1|||
145948099|NCT02697591|526319561|FG004|Overall Study|Withdrawal by Subject|7|||
145948100|NCT02697591|526319562|FG005|Overall Study|Withdrawal by Subject|6|||
145948101|NCT02697591|526319563|FG006|Overall Study|Withdrawal by Subject|9|||
145948102|NCT02697591|526319564|FG007|Overall Study|Withdrawal by Subject|1|||
146193314|NCT00762463|527219833|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
146193315|NCT00762463|527219834|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
146193316|NCT00762463|527219831|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
145948103|NCT02697591|526319565|FG008|Overall Study|Withdrawal by Subject|6|||
145948104|NCT02697591|526319566|FG009|Overall Study|Withdrawal by Subject|10|||
145948105|NCT02697591|526319557|FG000|Overall Study|Physician Decision|1|||
145948106|NCT02697591|526319558|FG001|Overall Study|Physician Decision|0|||
145948107|NCT02697591|526319559|FG002|Overall Study|Physician Decision|0|||
145948108|NCT02697591|526319560|FG003|Overall Study|Physician Decision|0|||
145948109|NCT02697591|526319561|FG004|Overall Study|Physician Decision|1|||
145948110|NCT02697591|526319562|FG005|Overall Study|Physician Decision|2|||
145948111|NCT02697591|526319563|FG006|Overall Study|Physician Decision|0|||
145948112|NCT02697591|526319564|FG007|Overall Study|Physician Decision|0|||
145948113|NCT02697591|526319565|FG008|Overall Study|Physician Decision|1|||
145948114|NCT02697591|526319566|FG009|Overall Study|Physician Decision|1|||
145948115|NCT02697591|526319557|FG000|Overall Study|Death|2|||
145948116|NCT02697591|526319558|FG001|Overall Study|Death|3|||
145948117|NCT02697591|526319559|FG002|Overall Study|Death|1|||
145948118|NCT02697591|526319560|FG003|Overall Study|Death|1|||
145948119|NCT02697591|526319561|FG004|Overall Study|Death|4|||
145948120|NCT02697591|526319562|FG005|Overall Study|Death|5|||
145948121|NCT02697591|526319563|FG006|Overall Study|Death|3|||
145948122|NCT02697591|526319564|FG007|Overall Study|Death|1|||
145948123|NCT02697591|526319565|FG008|Overall Study|Death|1|||
145948124|NCT02697591|526319566|FG009|Overall Study|Death|5|||
145948125|NCT02697591|526319557|FG000|Overall Study|Reason not Specified|0|||
145948126|NCT02697591|526319558|FG001|Overall Study|Reason not Specified|0|||
145948127|NCT02697591|526319559|FG002|Overall Study|Reason not Specified|0|||
145948128|NCT02697591|526319560|FG003|Overall Study|Reason not Specified|1|||
145948129|NCT02697591|526319561|FG004|Overall Study|Reason not Specified|1|||
145948130|NCT02697591|526319562|FG005|Overall Study|Reason not Specified|2|||
145948131|NCT02697591|526319563|FG006|Overall Study|Reason not Specified|3|||
145948132|NCT02697591|526319564|FG007|Overall Study|Reason not Specified|1|||
145948133|NCT02697591|526319565|FG008|Overall Study|Reason not Specified|1|||
145948134|NCT02697591|526319566|FG009|Overall Study|Reason not Specified|3|||
145948135|NCT01937884|526319567|FG000|Overall Study|Withdrawal by Subject|1|||
145948136|NCT01937884|526319568|FG001|Overall Study|Withdrawal by Subject|0|||
145948137|NCT02147067|526319578|FG000|Overall Study|Withdrawal by Subject|2|||
145948138|NCT02147067|526319579|FG001|Overall Study|Withdrawal by Subject|2|||
145948139|NCT03742258|526319581|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
145948140|NCT03742258|526319582|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
145948141|NCT03742258|526319583|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
145948142|NCT03742258|526319581|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
145948143|NCT03742258|526319582|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
145948144|NCT03742258|526319583|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
145948145|NCT03742258|526319581|FG000|Survival Follow-Up|Still in Follow-up|0|||
145948146|NCT03742258|526319582|FG001|Survival Follow-Up|Still in Follow-up|0|||
145948147|NCT03742258|526319583|FG002|Survival Follow-Up|Still in Follow-up|2|||
145948148|NCT01380691|526319587|FG000|Washout (7 Days)|Protocol Violation|0|||
145948149|NCT01380691|526319588|FG001|Washout (7 Days)|Protocol Violation|0|||
145948150|NCT01380691|526319589|FG002|Washout (7 Days)|Protocol Violation|0|||
145948151|NCT01380691|526319590|FG003|Washout (7 Days)|Protocol Violation|1|||
145948152|NCT01380691|526319587|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
145948153|NCT01380691|526319588|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
145948154|NCT01380691|526319589|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
145948155|NCT01380691|526319590|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
145948156|NCT02536781|526319591|FG000|Overall Study|Lost to Follow-up|2|||
145948157|NCT02536781|526319592|FG001|Overall Study|Lost to Follow-up|0|||
145948158|NCT03423147|526319593|FG000|Overall Study|Lost to Follow-up|5|||
145948159|NCT03423147|526319594|FG001|Overall Study|Lost to Follow-up|8|||
145948160|NCT03423147|526319593|FG000|Overall Study|Withdrawal by Subject|1|||
145948161|NCT03423147|526319594|FG001|Overall Study|Withdrawal by Subject|0|||
145948162|NCT03423147|526319593|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
145948163|NCT03423147|526319594|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
145948164|NCT03423147|526319593|FG000|Overall Study|Age < 18|1|||
145948165|NCT03423147|526319594|FG001|Overall Study|Age < 18|0|||
145948166|NCT03423147|526319593|FG000|Overall Study|No Trial of Labor|0|||
145948167|NCT03423147|526319594|FG001|Overall Study|No Trial of Labor|1|||
145948168|NCT00508157|526319595|FG000|Overall Study|Adverse Event|0|||
145948169|NCT00508157|526319596|FG001|Overall Study|Adverse Event|1|||
145948170|NCT00508157|526319595|FG000|Overall Study|Subject Withdrew Consent|1|||
146193317|NCT00762463|527219832|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
145948171|NCT00508157|526319596|FG001|Overall Study|Subject Withdrew Consent|0|||
145948172|NCT00508157|526319595|FG000|Overall Study|Lost to Follow-up|1|||
145948173|NCT00508157|526319596|FG001|Overall Study|Lost to Follow-up|0|||
145948174|NCT00508157|526319595|FG000|Overall Study|Subject no longer met study criteria|0|||
146193318|NCT00762463|527219833|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
145948175|NCT00508157|526319596|FG001|Overall Study|Subject no longer met study criteria|1|||
145948176|NCT00508157|526319595|FG000|Overall Study|Other known cause|0|||
145948177|NCT00508157|526319596|FG001|Overall Study|Other known cause|1|||
145948178|NCT01952080|526319597|FG000|Overall Study|Withdrawal by Subject|0|||
145948179|NCT01952080|526319598|FG001|Overall Study|Withdrawal by Subject|0|||
146193319|NCT00762463|527219834|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
146285173|NCT00706433|527557767|FG003|Overall Study|new job|1|||
146285174|NCT01236365|527557769|FG000|Overall Study|Lost to Follow-up|0|||
146285175|NCT01236365|527557770|FG001|Overall Study|Lost to Follow-up|2|||
146285176|NCT01236365|527557769|FG000|Overall Study|Moved Out of State|1|||
146285177|NCT01236365|527557770|FG001|Overall Study|Moved Out of State|0|||
146285178|NCT01236365|527557769|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
146285179|NCT01236365|527557770|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
146285180|NCT00545051|527557771|FG000|Overall Study|Adverse Event|7|||
146285181|NCT00545051|527557772|FG001|Overall Study|Adverse Event|3|||
146285182|NCT00545051|527557771|FG000|Overall Study|Death|1|||
146285183|NCT00545051|527557772|FG001|Overall Study|Death|0|||
146285184|NCT00545051|527557771|FG000|Overall Study|Violation of inclusion/exclusion|0|||
146285185|NCT00545051|527557772|FG001|Overall Study|Violation of inclusion/exclusion|2|||
146285186|NCT00545051|527557771|FG000|Overall Study|Protocol Violation|1|||
146285187|NCT00545051|527557772|FG001|Overall Study|Protocol Violation|0|||
146285188|NCT00545051|527557771|FG000|Overall Study|Withdrawal by Subject|0|||
146285189|NCT00545051|527557772|FG001|Overall Study|Withdrawal by Subject|1|||
146285190|NCT00545051|527557771|FG000|Overall Study|Administrative reasons|0|||
146285191|NCT00545051|527557772|FG001|Overall Study|Administrative reasons|1|||
146285192|NCT03271021|527557774|FG000|Overall Study|Adverse Event|3|||
146285193|NCT03271021|527557775|FG001|Overall Study|Adverse Event|2|||
146285194|NCT03271021|527557774|FG000|Overall Study|Withdrawal by Subject|36|||
146285195|NCT03271021|527557775|FG001|Overall Study|Withdrawal by Subject|53|||
146285196|NCT03271021|527557774|FG000|Overall Study|Lost to Follow-up|34|||
146285197|NCT03271021|527557775|FG001|Overall Study|Lost to Follow-up|39|||
146285198|NCT03271021|527557774|FG000|Overall Study|Protocol Violation|6|||
146285199|NCT03271021|527557775|FG001|Overall Study|Protocol Violation|4|||
146285200|NCT03271021|527557774|FG000|Overall Study|Abnormal Lab Results|1|||
146285201|NCT03271021|527557775|FG001|Overall Study|Abnormal Lab Results|0|||
146285202|NCT03271021|527557774|FG000|Overall Study|Miscellaneous|9|||
146285203|NCT03271021|527557775|FG001|Overall Study|Miscellaneous|8|||
146285204|NCT01474434|527557776|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
146285205|NCT01474434|527557777|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
146285206|NCT01474434|527557778|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
146285207|NCT01474434|527557779|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
146285208|NCT01474434|527557776|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146285209|NCT01474434|527557777|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146285210|NCT01474434|527557778|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
146285211|NCT01474434|527557779|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
146285212|NCT01474434|527557776|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
146285213|NCT01474434|527557777|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146285214|NCT01474434|527557778|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146285215|NCT01474434|527557779|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
146285216|NCT02207569|527557783|FG000|1-Month|Death|6|||
146285217|NCT02207569|527557783|FG000|1-Month|Withdrawal by Subject|2|||
146285218|NCT02207569|527557783|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
146285219|NCT02207569|527557783|FG000|6-Month|Death|8|||
146285220|NCT02207569|527557783|FG000|6-Month|Withdrawal by Subject|2|||
146285221|NCT02207569|527557783|FG000|12-Month|Death|14|||
146285222|NCT02207569|527557783|FG000|12-Month|Withdrawal by Subject|2|||
146285223|NCT02207569|527557783|FG000|24-Month|Death|23|||
146285224|NCT02207569|527557783|FG000|24-Month|Withdrawal by Subject|3|||
146285225|NCT02207569|527557783|FG000|36-Month|Death|23|||
146285226|NCT02207569|527557783|FG000|36-Month|Withdrawal by Subject|4|||
146285227|NCT02207569|527557783|FG000|48-Month|Death|25|||
146285228|NCT02207569|527557783|FG000|48-Month|Withdrawal by Subject|2|||
146285229|NCT02207569|527557783|FG000|48-Month|Lost to Follow-up|4|||
146285230|NCT02207569|527557783|FG000|60-Month|Death|1|||
146285231|NCT02207569|527557783|FG000|60-Month|Lost to Follow-up|1|||
146285232|NCT02207569|527557783|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
146285233|NCT02207569|527557783|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
146285234|NCT00495586|527557786|FG000|Overall Study|Withdrawal by Subject|4|||
146285235|NCT00495586|527557787|FG001|Overall Study|Withdrawal by Subject|4|||
146285236|NCT03038438|527557788|FG000|Overall Study|Death|3|||
146285237|NCT03038438|527557788|FG000|Overall Study|Lost to Follow-up|8|||
146285238|NCT03038438|527557788|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
146285239|NCT03038438|527557788|FG000|Overall Study|Withdrawal by Subject|5|||
146285240|NCT03038438|527557788|FG000|Overall Study|No 36-Month Follow-Up|18|||
146193320|NCT04358549|527219835|FG000|Overall Study|Adverse Event|0|||
146415852|NCT02862535|528026701|FG001|Overall Study|Death|3|||
146193321|NCT04358549|527219836|FG001|Overall Study|Adverse Event|1|||
146193322|NCT04358549|527219835|FG000|Overall Study|Death|1|||
146193323|NCT04358549|527219836|FG001|Overall Study|Death|0|||
146193324|NCT04358549|527219835|FG000|Overall Study|Lost to Follow-up|2|||
146193325|NCT04358549|527219836|FG001|Overall Study|Lost to Follow-up|1|||
146193326|NCT04358549|527219835|FG000|Overall Study|Withdrawal by Subject|6|||
146193327|NCT04358549|527219836|FG001|Overall Study|Withdrawal by Subject|6|||
146193328|NCT04358549|527219835|FG000|Overall Study|Start remdesivir|1|||
146193329|NCT04358549|527219836|FG001|Overall Study|Start remdesivir|0|||
146193330|NCT04867902|527219840|FG000|Overall Study|Lost to Follow-up|1|||
146193331|NCT04867902|527219840|FG000|Overall Study|Withdrawal by Subject|2|||
146193332|NCT04867902|527219840|FG000|Overall Study|Protocol Violation|1|||
146193333|NCT05355116|527219841|FG000|Overall Study|Withdrawal by Subject|2|||
146193334|NCT02501629|527219842|FG000|Overall Study|Death|0|||
146193335|NCT02501629|527219843|FG001|Overall Study|Death|1|||
146193336|NCT02501629|527219842|FG000|Overall Study|Withdrawn from study by sponsor|1|||
146193337|NCT02501629|527219843|FG001|Overall Study|Withdrawn from study by sponsor|0|||
146193338|NCT02501629|527219842|FG000|Overall Study|Early termination by sponsor|1|||
146415853|NCT02862535|528026702|FG002|Overall Study|Death|2|||
146415854|NCT02862535|528026703|FG003|Overall Study|Death|5|||
146415855|NCT02862535|528026700|FG000|Overall Study|Study Terminated by Sponsor|1|||
146415856|NCT02862535|528026701|FG001|Overall Study|Study Terminated by Sponsor|3|||
146415857|NCT02862535|528026702|FG002|Overall Study|Study Terminated by Sponsor|8|||
146415858|NCT02862535|528026703|FG003|Overall Study|Study Terminated by Sponsor|5|||
146415859|NCT02862535|528026700|FG000|Overall Study|Enrolled, not Treated|1|||
146415860|NCT02862535|528026701|FG001|Overall Study|Enrolled, not Treated|0|||
146415861|NCT02862535|528026702|FG002|Overall Study|Enrolled, not Treated|0|||
146415862|NCT02862535|528026703|FG003|Overall Study|Enrolled, not Treated|1|||
146415863|NCT04147715|528026704|FG000|Overall Study|Adverse Event|0|||
146415864|NCT04147715|528026705|FG001|Overall Study|Adverse Event|0|||
146415865|NCT04147715|528026706|FG002|Overall Study|Adverse Event|0|||
146415866|NCT04147715|528026707|FG003|Overall Study|Adverse Event|0|||
146415867|NCT04147715|528026708|FG004|Overall Study|Adverse Event|0|||
146415868|NCT04147715|528026709|FG005|Overall Study|Adverse Event|0|||
146415869|NCT04147715|528026710|FG006|Overall Study|Adverse Event|0|||
146415870|NCT04147715|528026711|FG007|Overall Study|Adverse Event|2|||
146415871|NCT04147715|528026712|FG008|Overall Study|Adverse Event|1|||
146415872|NCT04147715|528026713|FG009|Overall Study|Adverse Event|0|||
146415873|NCT04147715|528026714|FG010|Overall Study|Adverse Event|0|||
146415874|NCT04147715|528026715|FG011|Overall Study|Adverse Event|0|||
146415875|NCT02418910|528026719|FG000|Overall Study|Lost to Follow-up|3|||
146415876|NCT02418910|528026719|FG000|Overall Study|Withdrawal by Subject|4|||
146415877|NCT02472977|528026720|FG000|Overall Study|Disease progression|4|||
146415878|NCT02472977|528026721|FG001|Overall Study|Disease progression|25|||
146415879|NCT02472977|528026722|FG002|Overall Study|Disease progression|6|||
146415880|NCT02472977|528026720|FG000|Overall Study|Withdrawal by Subject|0|||
146415881|NCT02472977|528026721|FG001|Overall Study|Withdrawal by Subject|1|||
146415882|NCT02472977|528026722|FG002|Overall Study|Withdrawal by Subject|0|||
146415883|NCT02472977|528026720|FG000|Overall Study|Study drug toxicity|2|||
146415884|NCT02472977|528026721|FG001|Overall Study|Study drug toxicity|0|||
146415885|NCT02472977|528026722|FG002|Overall Study|Study drug toxicity|2|||
146415886|NCT02472977|528026720|FG000|Overall Study|Subject request to discontinue treatment|0|||
146415887|NCT02472977|528026721|FG001|Overall Study|Subject request to discontinue treatment|1|||
146415888|NCT02472977|528026722|FG002|Overall Study|Subject request to discontinue treatment|0|||
146415889|NCT00566709|528026726|FG000|Overall Study|Protocol Violation|5|||
146415890|NCT00566709|528026727|FG001|Overall Study|Protocol Violation|0|||
146415891|NCT00658320|528028399|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
146285241|NCT03215810|527557789|FG000|Overall Study|Still responding to nivolumab|1|||
146285242|NCT03215810|527557789|FG000|Overall Study|Insufficient TIL growth|1|||
146193339|NCT02501629|527219843|FG001|Overall Study|Early termination by sponsor|0|||
146193340|NCT02501629|527219842|FG000|Overall Study|Withdrawal by Subject|3|||
146193341|NCT02501629|527219843|FG001|Overall Study|Withdrawal by Subject|5|||
146193342|NCT02501629|527219842|FG000|Overall Study|Subject did not return to site|0|||
146193343|NCT02501629|527219843|FG001|Overall Study|Subject did not return to site|1|||
146415892|NCT00658320|528028400|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
146415893|NCT00658320|528028399|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
146415894|NCT00658320|528028400|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
146415895|NCT00658320|528028399|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
146415896|NCT00658320|528028400|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
146415897|NCT00658320|528028399|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
146193344|NCT00868231|527219846|FG000|Treatment Period 1|Adverse Event|0|||
146415898|NCT00658320|528028400|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
146193345|NCT00868231|527219847|FG001|Treatment Period 1|Adverse Event|0|||
146193346|NCT00868231|527219848|FG002|Treatment Period 1|Adverse Event|0|||
146193347|NCT00868231|527219849|FG003|Treatment Period 1|Adverse Event|0|||
146415899|NCT00387712|528028416|FG000|Overall Study|Physician Decision|6|||
146415900|NCT00387712|528028417|FG001|Overall Study|Physician Decision|4|||
146415901|NCT00387712|528028416|FG000|Overall Study|Lost to Follow-up|17|||
146415902|NCT00387712|528028417|FG001|Overall Study|Lost to Follow-up|20|||
146415903|NCT00387712|528028416|FG000|Overall Study|Withdrawal by Subject|6|||
146415904|NCT00387712|528028417|FG001|Overall Study|Withdrawal by Subject|12|||
146415905|NCT02040428|528028418|FG000|Overall Study|Death|4|||
146415906|NCT02040428|528028419|FG001|Overall Study|Death|3|||
146193348|NCT00868231|527219850|FG004|Treatment Period 1|Adverse Event|1|||
146193349|NCT00868231|527219851|FG005|Treatment Period 1|Adverse Event|0|||
146193350|NCT00868231|527219846|FG000|Treatment Period 2|Adverse Event|1|||
146193351|NCT00868231|527219847|FG001|Treatment Period 2|Adverse Event|0|||
146193352|NCT00868231|527219848|FG002|Treatment Period 2|Adverse Event|0|||
146193353|NCT00868231|527219849|FG003|Treatment Period 2|Adverse Event|0|||
146193354|NCT00868231|527219850|FG004|Treatment Period 2|Adverse Event|0|||
146193355|NCT00868231|527219851|FG005|Treatment Period 2|Adverse Event|0|||
146193356|NCT00868231|527219846|FG000|Treatment Period 3|Adverse Event|0|||
146193357|NCT00868231|527219847|FG001|Treatment Period 3|Adverse Event|0|||
146193358|NCT00868231|527219848|FG002|Treatment Period 3|Adverse Event|1|||
146193359|NCT00868231|527219849|FG003|Treatment Period 3|Adverse Event|0|||
146193360|NCT00868231|527219850|FG004|Treatment Period 3|Adverse Event|0|||
146193361|NCT00868231|527219851|FG005|Treatment Period 3|Adverse Event|0|||
146193362|NCT03120676|527219852|FG000|Overall Study|Not treated|1|||
146193363|NCT01688973|527219856|FG000|Overall Study|Ineligible|2|||
146193364|NCT01688973|527219857|FG001|Overall Study|Ineligible|3|||
146193365|NCT01124162|527219858|FG000|First Intervention|Adverse Event|2|||
146193366|NCT01124162|527219859|FG001|First Intervention|Adverse Event|0|||
146193367|NCT01124162|527219858|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146193368|NCT01124162|527219859|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146193369|NCT01516892|527219863|FG000|Overall Study|Adverse Event|25|||
146193370|NCT01516892|527219863|FG000|Overall Study|Lack of Efficacy|35|||
146193371|NCT01516892|527219863|FG000|Overall Study|Pregnancy|5|||
146193372|NCT01516892|527219863|FG000|Overall Study|Lost to Follow-up|82|||
146193373|NCT01516892|527219863|FG000|Overall Study|Subject Withdrew Consent|92|||
146193374|NCT01516892|527219863|FG000|Overall Study|Protocol Violation|60|||
146193375|NCT01516892|527219863|FG000|Overall Study|Other Miscellaneous Reasons|43|||
146193376|NCT01516892|527219863|FG000|Overall Study|Missing|1|||
146193377|NCT00938340|527219864|FG000|Overall Study|Withdrawal by Subject|3|||
146193378|NCT00938340|527219864|FG000|Overall Study|Protocol Violation|1|||
146193379|NCT00938340|527219864|FG000|Overall Study|Adverse Event|1|||
146193380|NCT03613129|527219865|FG000|Pre-treatment Assessment|Protocol Violation|2|||
146193381|NCT03613129|527219866|FG001|Pre-treatment Assessment|Protocol Violation|0|||
146193382|NCT03613129|527219867|FG002|Pre-treatment Assessment|Protocol Violation|0|||
146193383|NCT03613129|527219868|FG003|Pre-treatment Assessment|Protocol Violation|0|||
146193384|NCT03613129|527219869|FG004|Pre-treatment Assessment|Protocol Violation|0|||
146193385|NCT03613129|527219865|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
146193386|NCT03613129|527219866|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
146193387|NCT03613129|527219867|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
146193388|NCT03613129|527219868|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
146193389|NCT03613129|527219869|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
146193390|NCT00711646|527219870|FG000|Overall Study|Adverse Event|6|||
146193391|NCT00711646|527219871|FG001|Overall Study|Adverse Event|1|||
146193392|NCT00711646|527219870|FG000|Overall Study|Withdrawal by Subject|4|||
146193393|NCT00711646|527219871|FG001|Overall Study|Withdrawal by Subject|0|||
146193394|NCT00711646|527219870|FG000|Overall Study|Protocol Violation|0|||
146193395|NCT00711646|527219871|FG001|Overall Study|Protocol Violation|1|||
146193396|NCT00711646|527219870|FG000|Overall Study|Lost to Follow-up|1|||
146193397|NCT00711646|527219871|FG001|Overall Study|Lost to Follow-up|0|||
146193398|NCT00711646|527219870|FG000|Overall Study|administrative decision|0|||
146193399|NCT00711646|527219871|FG001|Overall Study|administrative decision|1|||
146415907|NCT02040428|528028418|FG000|Overall Study|Withdrawal by Subject|1|||
146285243|NCT03215810|527557789|FG000|Overall Study|Decline in performance status|1|||
146285244|NCT03215810|527557789|FG000|Overall Study|Withdrawal by Subject|1|||
146285245|NCT02038543|527557790|FG000|Overall Study|Screen Failure|0|||
146285246|NCT02038543|527557791|FG001|Overall Study|Screen Failure|0|||
146285247|NCT02038543|527557792|FG002|Overall Study|Screen Failure|0|||
146285248|NCT02038543|527557793|FG003|Overall Study|Screen Failure|1|||
146285249|NCT02038543|527557790|FG000|Overall Study|Withdrawal by Subject|0|||
146285250|NCT02038543|527557791|FG001|Overall Study|Withdrawal by Subject|0|||
146285251|NCT02038543|527557792|FG002|Overall Study|Withdrawal by Subject|0|||
146285252|NCT02038543|527557793|FG003|Overall Study|Withdrawal by Subject|1|||
146285253|NCT02647866|527557794|FG000|Overall Study|Adverse Event|0|||
146285254|NCT02647866|527557795|FG001|Overall Study|Adverse Event|0|||
146285255|NCT02647866|527557796|FG002|Overall Study|Adverse Event|2|||
146285256|NCT02647866|527557797|FG003|Overall Study|Adverse Event|2|||
146285257|NCT02647866|527557798|FG004|Overall Study|Adverse Event|1|||
146285258|NCT02647866|527557794|FG000|Overall Study|Disease Worsening|3|||
146285259|NCT02647866|527557795|FG001|Overall Study|Disease Worsening|1|||
146285260|NCT02647866|527557796|FG002|Overall Study|Disease Worsening|0|||
146285261|NCT02647866|527557797|FG003|Overall Study|Disease Worsening|0|||
146285262|NCT02647866|527557798|FG004|Overall Study|Disease Worsening|1|||
146285263|NCT02647866|527557794|FG000|Overall Study|Withdrawal by Subject|1|||
146285264|NCT02647866|527557795|FG001|Overall Study|Withdrawal by Subject|1|||
146285265|NCT02647866|527557796|FG002|Overall Study|Withdrawal by Subject|2|||
146193400|NCT00711646|527219870|FG000|Overall Study|patient non-compliance|1|||
146193401|NCT00711646|527219871|FG001|Overall Study|patient non-compliance|0|||
146193402|NCT03441360|527219872|FG000|Overall Study|Radiological disease progression|5|||
146193403|NCT03441360|527219873|FG001|Overall Study|Radiological disease progression|6|||
146193404|NCT03441360|527219874|FG002|Overall Study|Radiological disease progression|4|||
146193405|NCT03441360|527219872|FG000|Overall Study|Clinical disease progression|2|||
146193406|NCT03441360|527219873|FG001|Overall Study|Clinical disease progression|2|||
146193407|NCT03441360|527219874|FG002|Overall Study|Clinical disease progression|0|||
146193408|NCT03441360|527219872|FG000|Overall Study|Adverse Event|1|||
146193409|NCT03441360|527219873|FG001|Overall Study|Adverse Event|0|||
146193410|NCT03441360|527219874|FG002|Overall Study|Adverse Event|1|||
146193411|NCT00269399|527219875|FG000|Overall Study|Lack of Efficacy|27|||
146193412|NCT00269399|527219876|FG001|Overall Study|Lack of Efficacy|10|||
146193413|NCT00269399|527219875|FG000|Overall Study|Adverse Event|10|||
146193414|NCT00269399|527219876|FG001|Overall Study|Adverse Event|4|||
146193415|NCT00269399|527219875|FG000|Overall Study|Withdrawal by Subject|2|||
146193416|NCT00269399|527219876|FG001|Overall Study|Withdrawal by Subject|5|||
146193417|NCT00269399|527219875|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
146193418|NCT00269399|527219876|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
146193419|NCT00269399|527219875|FG000|Overall Study|Other|0|||
146193420|NCT00269399|527219876|FG001|Overall Study|Other|4|||
146193421|NCT00269399|527219875|FG000|Overall Study|Development of exclusion criteria|0|||
146193422|NCT00269399|527219876|FG001|Overall Study|Development of exclusion criteria|1|||
146193423|NCT03396835|527219877|FG000|Overall Study|Withdrawn prior to completion|1|||
146193424|NCT03396835|527219877|FG000|Overall Study|Did not meet criteria for data analysis|1|||
146193425|NCT03439124|527219878|FG000|Overall Study|Adverse Event|2|||
146193426|NCT03439124|527219879|FG001|Overall Study|Adverse Event|0|||
146193427|NCT03439124|527219878|FG000|Overall Study|Lost to Follow-up|1|||
146285266|NCT02647866|527557797|FG003|Overall Study|Withdrawal by Subject|4|||
146285267|NCT02647866|527557798|FG004|Overall Study|Withdrawal by Subject|4|||
146285268|NCT02647866|527557794|FG000|Overall Study|Physician Decision|0|||
146285269|NCT02647866|527557795|FG001|Overall Study|Physician Decision|1|||
146285270|NCT02647866|527557796|FG002|Overall Study|Physician Decision|1|||
146285271|NCT02647866|527557797|FG003|Overall Study|Physician Decision|0|||
146285272|NCT02647866|527557798|FG004|Overall Study|Physician Decision|2|||
146285273|NCT02647866|527557794|FG000|Overall Study|Death|0|||
146285274|NCT02647866|527557795|FG001|Overall Study|Death|1|||
146285275|NCT02647866|527557796|FG002|Overall Study|Death|0|||
146285276|NCT02647866|527557797|FG003|Overall Study|Death|0|||
146193428|NCT03439124|527219879|FG001|Overall Study|Lost to Follow-up|0|||
146285277|NCT02647866|527557798|FG004|Overall Study|Death|0|||
146285278|NCT02647866|527557794|FG000|Overall Study|Subject moved to different country|1|||
146285279|NCT02647866|527557795|FG001|Overall Study|Subject moved to different country|0|||
146285280|NCT02647866|527557796|FG002|Overall Study|Subject moved to different country|0|||
146285281|NCT02647866|527557797|FG003|Overall Study|Subject moved to different country|0|||
146285282|NCT02647866|527557798|FG004|Overall Study|Subject moved to different country|0|||
146285283|NCT03406260|527557799|FG000|Period 1|Adverse Event|0|||
146285284|NCT03406260|527557800|FG001|Period 1|Adverse Event|0|||
146285285|NCT03406260|527557801|FG002|Period 1|Adverse Event|0|||
146285286|NCT03406260|527557802|FG003|Period 1|Adverse Event|0|||
146285287|NCT03406260|527557803|FG004|Period 1|Adverse Event|1|||
146285288|NCT03406260|527557804|FG005|Period 1|Adverse Event|0|||
146285289|NCT03618823|527557811|FG000|Overall Study|Lost to Follow-up|63|||
146285290|NCT03618823|527557812|FG001|Overall Study|Lost to Follow-up|61|||
146285291|NCT02292927|527557815|FG000|Overall Study|Protocol Violation|13|||
146285292|NCT02292927|527557816|FG001|Overall Study|Protocol Violation|7|||
146285293|NCT01656733|527557820|FG000|Overall Study|No permission to collect birth outcomes|0|||
146285294|NCT01656733|527557821|FG001|Overall Study|No permission to collect birth outcomes|1|||
146285295|NCT01656733|527557820|FG000|Overall Study|Delivery at another hospital|0|||
146285296|NCT01656733|527557821|FG001|Overall Study|Delivery at another hospital|2|||
146285297|NCT01656733|527557820|FG000|Overall Study|Spontaneous abortion|0|||
146285298|NCT01656733|527557821|FG001|Overall Study|Spontaneous abortion|1|||
146285299|NCT00141219|527557822|FG000|Overall Study|Protocol violations|5|||
146285300|NCT00141219|527557823|FG001|Overall Study|Protocol violations|4|||
146285301|NCT00141219|527557822|FG000|Overall Study|Adverse Event|8|||
146285302|NCT00141219|527557823|FG001|Overall Study|Adverse Event|6|||
146285303|NCT00141219|527557822|FG000|Overall Study|Lack of Efficacy|5|||
146285304|NCT00141219|527557823|FG001|Overall Study|Lack of Efficacy|4|||
146285305|NCT00141219|527557822|FG000|Overall Study|Withdrawal by Subject|6|||
146285306|NCT00141219|527557823|FG001|Overall Study|Withdrawal by Subject|2|||
146285307|NCT02054741|527557825|FG000|Overall Study|Protocol Violation|13|||
146285308|NCT02054741|527557826|FG001|Overall Study|Protocol Violation|2|||
146285309|NCT02054741|527557825|FG000|Overall Study|Withdrawal by Subject|10|||
146285310|NCT02054741|527557826|FG001|Overall Study|Withdrawal by Subject|5|||
146285311|NCT02054741|527557825|FG000|Overall Study|Death|94|||
146285312|NCT02054741|527557826|FG001|Overall Study|Death|90|||
146285313|NCT02054741|527557825|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
146285314|NCT02054741|527557826|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
146285315|NCT02325557|527557828|FG000|Overall Study|Progressive disease|1|||
146285316|NCT02325557|527557829|FG001|Overall Study|Progressive disease|0|||
146285317|NCT02325557|527557830|FG002|Overall Study|Progressive disease|0|||
146285318|NCT02325557|527557831|FG003|Overall Study|Progressive disease|0|||
146285319|NCT02325557|527557828|FG000|Overall Study|Withdrawal by Subject|4|||
146285320|NCT02325557|527557829|FG001|Overall Study|Withdrawal by Subject|0|||
146285321|NCT02325557|527557830|FG002|Overall Study|Withdrawal by Subject|0|||
146285322|NCT02325557|527557831|FG003|Overall Study|Withdrawal by Subject|15|||
146285323|NCT02325557|527557828|FG000|Overall Study|Death|5|||
146285324|NCT02325557|527557829|FG001|Overall Study|Death|1|||
146285325|NCT02325557|527557830|FG002|Overall Study|Death|1|||
146285326|NCT02325557|527557831|FG003|Overall Study|Death|16|||
146285327|NCT02325557|527557828|FG000|Overall Study|Lost to Follow-up|0|||
146285328|NCT02325557|527557829|FG001|Overall Study|Lost to Follow-up|0|||
146285329|NCT02325557|527557830|FG002|Overall Study|Lost to Follow-up|1|||
146285330|NCT02325557|527557831|FG003|Overall Study|Lost to Follow-up|1|||
146285331|NCT02325557|527557828|FG000|Overall Study|Other|0|||
146285332|NCT02325557|527557829|FG001|Overall Study|Other|0|||
146285333|NCT02325557|527557830|FG002|Overall Study|Other|0|||
146285334|NCT02325557|527557831|FG003|Overall Study|Other|5|||
145948180|NCT01952080|526319599|FG002|Overall Study|Withdrawal by Subject|0|||
146082356|NCT04449029|526822777|FG004|Overall Study|Lost to Follow-up|0|||
146082357|NCT04449029|526822778|FG005|Overall Study|Lost to Follow-up|0|||
146285335|NCT02084056|527557832|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146285336|NCT02084056|527557833|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146285337|NCT02084056|527557834|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146285338|NCT02084056|527557835|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146285339|NCT02084056|527557832|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
146285340|NCT02084056|527557833|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146285341|NCT02084056|527557834|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146285342|NCT02084056|527557835|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
146285343|NCT01488487|527557836|FG000|Overall Study|Adverse Event|6|||
146285344|NCT01488487|527557836|FG000|Overall Study|Death|1|||
146285345|NCT01488487|527557836|FG000|Overall Study|Withdrawal by Subject|2|||
146285346|NCT01293487|527557838|FG000|Overall Study|Lost to Follow-up|0|||
146285347|NCT01293487|527557839|FG001|Overall Study|Lost to Follow-up|0|||
146285348|NCT01293487|527557840|FG002|Overall Study|Lost to Follow-up|0|||
146285349|NCT01293487|527557841|FG003|Overall Study|Lost to Follow-up|1|||
146285350|NCT01293487|527557842|FG004|Overall Study|Lost to Follow-up|0|||
146193429|NCT03439124|527219878|FG000|Overall Study|Other reasons|1|||
146193430|NCT03439124|527219879|FG001|Overall Study|Other reasons|0|||
146193431|NCT01451814|527219880|FG000|Overall Study|Withdrawal by Subject|1|||
146193432|NCT01451814|527219881|FG001|Overall Study|Withdrawal by Subject|1|||
146193433|NCT01451814|527219880|FG000|Overall Study|Lost to Follow-up|5|||
146193434|NCT01451814|527219881|FG001|Overall Study|Lost to Follow-up|4|||
146193435|NCT04353037|527219883|FG000|Overall Study|Lost to Follow-up|0|||
146193436|NCT04353037|527219884|FG001|Overall Study|Lost to Follow-up|1|||
146193437|NCT04353037|527219885|FG002|Overall Study|Lost to Follow-up|2|||
146193438|NCT04353037|527219886|FG003|Overall Study|Lost to Follow-up|3|||
146193439|NCT04353037|527219883|FG000|Overall Study|Withdrawal by Subject|0|||
146193440|NCT04353037|527219884|FG001|Overall Study|Withdrawal by Subject|2|||
146193441|NCT04353037|527219885|FG002|Overall Study|Withdrawal by Subject|3|||
146193442|NCT04353037|527219886|FG003|Overall Study|Withdrawal by Subject|5|||
146193443|NCT04353037|527219883|FG000|Overall Study|Adverse Event|0|||
146193444|NCT04353037|527219884|FG001|Overall Study|Adverse Event|0|||
146193445|NCT04353037|527219885|FG002|Overall Study|Adverse Event|2|||
146193446|NCT04353037|527219886|FG003|Overall Study|Adverse Event|0|||
146193447|NCT04353037|527219883|FG000|Overall Study|Exposure Change|0|||
146193448|NCT04353037|527219884|FG001|Overall Study|Exposure Change|0|||
146193449|NCT04353037|527219885|FG002|Overall Study|Exposure Change|0|||
146193450|NCT04353037|527219886|FG003|Overall Study|Exposure Change|2|||
146193451|NCT03710564|527219887|FG000|Overall Study|Study Terminated by Sponsor|104|||
146193452|NCT03710564|527219888|FG001|Overall Study|Study Terminated by Sponsor|55|||
146193453|NCT03710564|527219887|FG000|Overall Study|Withdrawal by Subject|57|||
146193454|NCT03710564|527219888|FG001|Overall Study|Withdrawal by Subject|25|||
146193455|NCT03710564|527219887|FG000|Overall Study|Death|10|||
146193456|NCT03710564|527219888|FG001|Overall Study|Death|4|||
146193457|NCT03710564|527219887|FG000|Overall Study|Lost to Follow-up|5|||
146193458|NCT03710564|527219888|FG001|Overall Study|Lost to Follow-up|4|||
146193459|NCT03710564|527219887|FG000|Overall Study|Protocol Violation|3|||
146193460|NCT03710564|527219888|FG001|Overall Study|Protocol Violation|2|||
146193461|NCT03710564|527219887|FG000|Overall Study|Adverse Event|3|||
146193462|NCT03710564|527219888|FG001|Overall Study|Adverse Event|0|||
146193463|NCT03710564|527219887|FG000|Overall Study|Physician Decision|2|||
146193464|NCT03710564|527219888|FG001|Overall Study|Physician Decision|3|||
146193465|NCT02993471|527219889|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
146193466|NCT02993471|527219889|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
145948181|NCT01952080|526319600|FG003|Overall Study|Withdrawal by Subject|1|||
145948182|NCT01952080|526319597|FG000|Overall Study|Protocol Non-compliance|0|||
146415908|NCT02040428|528028419|FG001|Overall Study|Withdrawal by Subject|1|||
146415909|NCT03907280|528028431|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
146415910|NCT03907280|528028432|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
146415911|NCT03907280|528028433|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
146415912|NCT01927757|528028434|FG000|Overall Study|Withdrawal by Subject|14|||
146415913|NCT01927757|528028434|FG000|Overall Study|Lost to Follow-up|2|||
146415914|NCT01927757|528028434|FG000|Overall Study|Decision by Sponsor|2|||
146415915|NCT01927757|528028434|FG000|Overall Study|Other|1|||
146415916|NCT01927757|528028434|FG000|Overall Study|Ethical Reasons|4|||
146415917|NCT04081337|528028435|FG000|Overall Study|Adverse Event|0|||
146415918|NCT04081337|528028436|FG001|Overall Study|Adverse Event|1|||
146415919|NCT04081337|528028435|FG000|Overall Study|Withdrawal by Subject|2|||
146415920|NCT04081337|528028436|FG001|Overall Study|Withdrawal by Subject|0|||
146415921|NCT04081337|528028435|FG000|Overall Study|Physician Decision|1|||
146415922|NCT04081337|528028436|FG001|Overall Study|Physician Decision|2|||
146415923|NCT04081337|528028435|FG000|Overall Study|Lost to Follow-up|1|||
146415924|NCT04081337|528028436|FG001|Overall Study|Lost to Follow-up|0|||
146415925|NCT01464827|528028437|FG000|Overall Study|Adverse Event|0|||
146415926|NCT01464827|528028438|FG001|Overall Study|Adverse Event|0|||
146415927|NCT01464827|528028439|FG002|Overall Study|Adverse Event|0|||
146415928|NCT01464827|528028440|FG003|Overall Study|Adverse Event|0|||
146415929|NCT01464827|528028441|FG004|Overall Study|Adverse Event|0|||
146415930|NCT01464827|528028442|FG005|Overall Study|Adverse Event|0|||
146415931|NCT01464827|528028443|FG006|Overall Study|Adverse Event|0|||
146415932|NCT01464827|528028444|FG007|Overall Study|Adverse Event|0|||
146415933|NCT01464827|528028445|FG008|Overall Study|Adverse Event|0|||
146415934|NCT01464827|528028446|FG009|Overall Study|Adverse Event|0|||
146415935|NCT01464827|528028447|FG010|Overall Study|Adverse Event|0|||
146415936|NCT01464827|528028448|FG011|Overall Study|Adverse Event|0|||
146415937|NCT01464827|528028449|FG012|Overall Study|Adverse Event|1|||
146415938|NCT01464827|528028450|FG013|Overall Study|Adverse Event|0|||
146415939|NCT01464827|528028437|FG000|Overall Study|Withdrawal by Subject|1|||
146415940|NCT01464827|528028438|FG001|Overall Study|Withdrawal by Subject|0|||
146415941|NCT01464827|528028439|FG002|Overall Study|Withdrawal by Subject|0|||
146415942|NCT01464827|528028440|FG003|Overall Study|Withdrawal by Subject|0|||
146415943|NCT01464827|528028441|FG004|Overall Study|Withdrawal by Subject|1|||
146415944|NCT01464827|528028442|FG005|Overall Study|Withdrawal by Subject|0|||
146415945|NCT01464827|528028443|FG006|Overall Study|Withdrawal by Subject|0|||
146415946|NCT01464827|528028444|FG007|Overall Study|Withdrawal by Subject|1|||
146415947|NCT01464827|528028445|FG008|Overall Study|Withdrawal by Subject|0|||
146415948|NCT01464827|528028446|FG009|Overall Study|Withdrawal by Subject|0|||
146415949|NCT01464827|528028447|FG010|Overall Study|Withdrawal by Subject|0|||
146415950|NCT01464827|528028448|FG011|Overall Study|Withdrawal by Subject|0|||
146415951|NCT01464827|528028449|FG012|Overall Study|Withdrawal by Subject|0|||
146415952|NCT01464827|528028450|FG013|Overall Study|Withdrawal by Subject|0|||
146415953|NCT01464827|528028437|FG000|Overall Study|Lost to Follow-up|0|||
146415954|NCT01464827|528028438|FG001|Overall Study|Lost to Follow-up|2|||
146415955|NCT01464827|528028439|FG002|Overall Study|Lost to Follow-up|0|||
146415956|NCT01464827|528028440|FG003|Overall Study|Lost to Follow-up|2|||
146415957|NCT01464827|528028441|FG004|Overall Study|Lost to Follow-up|3|||
146415958|NCT01464827|528028442|FG005|Overall Study|Lost to Follow-up|1|||
146415959|NCT01464827|528028443|FG006|Overall Study|Lost to Follow-up|2|||
146415960|NCT01464827|528028444|FG007|Overall Study|Lost to Follow-up|2|||
146415961|NCT01464827|528028445|FG008|Overall Study|Lost to Follow-up|0|||
146415962|NCT01464827|528028446|FG009|Overall Study|Lost to Follow-up|0|||
146415963|NCT01464827|528028447|FG010|Overall Study|Lost to Follow-up|0|||
146415964|NCT01464827|528028448|FG011|Overall Study|Lost to Follow-up|1|||
146415965|NCT01464827|528028449|FG012|Overall Study|Lost to Follow-up|0|||
146415966|NCT01464827|528028450|FG013|Overall Study|Lost to Follow-up|1|||
146415967|NCT01464827|528028437|FG000|Overall Study|Other|2|||
146415968|NCT01464827|528028438|FG001|Overall Study|Other|3|||
146415969|NCT01464827|528028439|FG002|Overall Study|Other|0|||
146415970|NCT01464827|528028440|FG003|Overall Study|Other|2|||
146415971|NCT01464827|528028441|FG004|Overall Study|Other|3|||
146415972|NCT01464827|528028442|FG005|Overall Study|Other|0|||
146415973|NCT01464827|528028443|FG006|Overall Study|Other|1|||
146415974|NCT01464827|528028444|FG007|Overall Study|Other|0|||
146415975|NCT01464827|528028445|FG008|Overall Study|Other|3|||
146415976|NCT01464827|528028446|FG009|Overall Study|Other|1|||
146415977|NCT01464827|528028447|FG010|Overall Study|Other|2|||
146415978|NCT01464827|528028448|FG011|Overall Study|Other|0|||
146415979|NCT01464827|528028449|FG012|Overall Study|Other|1|||
146415980|NCT01464827|528028450|FG013|Overall Study|Other|0|||
146415981|NCT01464827|528028437|FG000|Overall Study|Not Treated|0|||
146415982|NCT01464827|528028438|FG001|Overall Study|Not Treated|2|||
146415983|NCT01464827|528028439|FG002|Overall Study|Not Treated|0|||
146415984|NCT01464827|528028440|FG003|Overall Study|Not Treated|0|||
146415985|NCT01464827|528028441|FG004|Overall Study|Not Treated|1|||
146415986|NCT01464827|528028442|FG005|Overall Study|Not Treated|0|||
146415987|NCT01464827|528028443|FG006|Overall Study|Not Treated|1|||
146415988|NCT01464827|528028444|FG007|Overall Study|Not Treated|0|||
146415989|NCT01464827|528028445|FG008|Overall Study|Not Treated|0|||
146415990|NCT01464827|528028446|FG009|Overall Study|Not Treated|2|||
146415991|NCT01464827|528028447|FG010|Overall Study|Not Treated|0|||
146415992|NCT01464827|528028448|FG011|Overall Study|Not Treated|1|||
146415993|NCT01464827|528028449|FG012|Overall Study|Not Treated|0|||
146415994|NCT01464827|528028450|FG013|Overall Study|Not Treated|2|||
146415995|NCT04604184|528028457|FG000|Overall Study|Adverse Event|5|||
146415996|NCT04604184|528028458|FG001|Overall Study|Adverse Event|5|||
146415997|NCT04604184|528028457|FG000|Overall Study|Death|2|||
146415998|NCT04604184|528028458|FG001|Overall Study|Death|1|||
146415999|NCT04604184|528028457|FG000|Overall Study|Withdrawal by Subject|1|||
146416000|NCT04604184|528028458|FG001|Overall Study|Withdrawal by Subject|3|||
146416001|NCT04604184|528028457|FG000|Overall Study|Not treated|2|||
146416002|NCT04604184|528028458|FG001|Overall Study|Not treated|2|||
146416003|NCT04604184|528028457|FG000|Overall Study|Due to sponsor decision|9|||
146416004|NCT04604184|528028458|FG001|Overall Study|Due to sponsor decision|7|||
146416005|NCT04604184|528028457|FG000|Overall Study|Physician Decision|0|||
146416006|NCT04604184|528028458|FG001|Overall Study|Physician Decision|1|||
146416007|NCT04604184|528028457|FG000|Overall Study|Transfer to healthcare|1|||
146416008|NCT04604184|528028458|FG001|Overall Study|Transfer to healthcare|0|||
146416009|NCT01769378|528028459|FG000|Overall Study|Adverse Event|10|||
146416010|NCT01769378|528028460|FG001|Overall Study|Adverse Event|0|||
146416011|NCT01769378|528028459|FG000|Overall Study|Entry criteria not met|1|||
146416012|NCT01769378|528028460|FG001|Overall Study|Entry criteria not met|0|||
146416013|NCT01769378|528028459|FG000|Overall Study|Protocol Violation|1|||
146416014|NCT01769378|528028460|FG001|Overall Study|Protocol Violation|1|||
146416015|NCT01769378|528028459|FG000|Overall Study|Withdrawal by Subject|10|||
146416016|NCT01769378|528028460|FG001|Overall Study|Withdrawal by Subject|3|||
146416017|NCT01769378|528028459|FG000|Overall Study|Sponsor Decision|1|||
146416018|NCT01769378|528028460|FG001|Overall Study|Sponsor Decision|0|||
146416019|NCT01769378|528028459|FG000|Overall Study|Lost to Follow-up|2|||
146416020|NCT01769378|528028460|FG001|Overall Study|Lost to Follow-up|0|||
146416021|NCT01090765|528028461|FG000|Overall Study|Patient withdrew consent|0|||
146416022|NCT01090765|528028462|FG001|Overall Study|Patient withdrew consent|0|||
146416023|NCT01090765|528028463|FG002|Overall Study|Patient withdrew consent|0|||
146416024|NCT01090765|528028464|FG003|Overall Study|Patient withdrew consent|0|||
146416025|NCT01090765|528028465|FG004|Overall Study|Patient withdrew consent|1|||
146416026|NCT01090765|528028466|FG005|Overall Study|Patient withdrew consent|1|||
146416027|NCT01090765|528028461|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
146416028|NCT01090765|528028462|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
146416029|NCT01090765|528028463|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
146416030|NCT01090765|528028464|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
146416031|NCT01090765|528028465|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
146416032|NCT01090765|528028466|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
146416033|NCT01090765|528028461|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
146416034|NCT01090765|528028462|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
146416035|NCT01090765|528028463|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
146416036|NCT01090765|528028464|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
146416037|NCT01090765|528028465|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
146416038|NCT01090765|528028466|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
146416039|NCT01977092|528028467|FG000|Overall Study|Death|3|||
146416040|NCT01977092|528028468|FG001|Overall Study|Death|4|||
146416041|NCT01977092|528028467|FG000|Overall Study|Lost to Follow-up|23|||
146416042|NCT01977092|528028468|FG001|Overall Study|Lost to Follow-up|14|||
146416043|NCT01977092|528028467|FG000|Overall Study|Withdrawal by Subject|2|||
146416044|NCT01977092|528028468|FG001|Overall Study|Withdrawal by Subject|1|||
146416045|NCT01977092|528028467|FG000|Overall Study|In prison|3|||
146416046|NCT01977092|528028468|FG001|Overall Study|In prison|11|||
146416047|NCT00678392|528028469|FG000|Overall Study|Adverse Event|0|||
146416048|NCT00678392|528028470|FG001|Overall Study|Adverse Event|6|||
146416049|NCT00678392|528028469|FG000|Overall Study|Death|280|||
146416050|NCT00678392|528028470|FG001|Overall Study|Death|269|||
146416051|NCT00678392|528028469|FG000|Overall Study|Lost to Follow-up|15|||
146416052|NCT00678392|528028470|FG001|Overall Study|Lost to Follow-up|13|||
146416053|NCT00678392|528028469|FG000|Overall Study|Objective Progression or Relapse|3|||
146416054|NCT00678392|528028470|FG001|Overall Study|Objective Progression or Relapse|8|||
146416055|NCT00678392|528028469|FG000|Overall Study|Sponsor's Decision|1|||
146416056|NCT00678392|528028470|FG001|Overall Study|Sponsor's Decision|2|||
146416057|NCT00678392|528028469|FG000|Overall Study|Withdrawal by Subject|4|||
146416058|NCT00678392|528028470|FG001|Overall Study|Withdrawal by Subject|4|||
146416059|NCT00678392|528028469|FG000|Overall Study|Randomized But Not Treated|2|||
146416060|NCT00678392|528028470|FG001|Overall Study|Randomized But Not Treated|7|||
146416061|NCT00678392|528028469|FG000|Overall Study|Other|56|||
146416062|NCT00678392|528028470|FG001|Overall Study|Other|53|||
146416063|NCT01958281|528028471|FG000|Overall Study|Lack of Efficacy|5|||
146416064|NCT01958281|528028472|FG001|Overall Study|Lack of Efficacy|2|||
146416065|NCT01958281|528028473|FG002|Overall Study|Lack of Efficacy|0|||
146416066|NCT01958281|528028471|FG000|Overall Study|Adverse Event|0|||
146416067|NCT01958281|528028472|FG001|Overall Study|Adverse Event|2|||
146416068|NCT01958281|528028473|FG002|Overall Study|Adverse Event|0|||
146416069|NCT01958281|528028471|FG000|Overall Study|Withdrew Consent|1|||
146416070|NCT01958281|528028472|FG001|Overall Study|Withdrew Consent|0|||
146416071|NCT01958281|528028473|FG002|Overall Study|Withdrew Consent|0|||
146416072|NCT02784106|528028476|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
146416073|NCT02784106|528028477|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
146416074|NCT02784106|528028478|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146416075|NCT02784106|528028479|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146416076|NCT02784106|528028476|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
146416077|NCT02784106|528028477|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146416078|NCT02784106|528028478|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146416079|NCT02784106|528028479|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146416080|NCT02784106|528028476|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
146416081|NCT02784106|528028477|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146416082|NCT02784106|528028478|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146416083|NCT02784106|528028479|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
146416084|NCT02784106|528028476|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
146416085|NCT02784106|528028477|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146193467|NCT03006341|527219893|FG000|Overall Study|Not linked in the EMR|25069|||
146193468|NCT03006341|527219894|FG001|Overall Study|Not linked in the EMR|67505|||
146193469|NCT03006341|527219895|FG002|Overall Study|Not linked in the EMR|30993|||
146193470|NCT03006341|527219896|FG003|Overall Study|Not linked in the EMR|10685|||
146416086|NCT02784106|528028478|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146193471|NCT00742274|527219899|FG000|Overall Study|Death|1|||
146416087|NCT02784106|528028479|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146416088|NCT02784106|528028476|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
146416089|NCT02784106|528028477|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
146416090|NCT02784106|528028478|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
146416091|NCT02784106|528028479|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
146416092|NCT02784106|528028476|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
146416093|NCT02784106|528028477|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
146416094|NCT02784106|528028478|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
146416095|NCT02784106|528028479|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
146416096|NCT01418352|528028492|FG000|Overall Study|Lost to Follow-up|2|||
146416097|NCT01418352|528028493|FG001|Overall Study|Lost to Follow-up|0|||
146416098|NCT01418352|528028494|FG002|Overall Study|Lost to Follow-up|0|||
146416099|NCT01418352|528028495|FG003|Overall Study|Lost to Follow-up|0|||
146416100|NCT01418352|528028492|FG000|Overall Study|Adverse Event|0|||
146416101|NCT01418352|528028493|FG001|Overall Study|Adverse Event|1|||
146416102|NCT01418352|528028494|FG002|Overall Study|Adverse Event|0|||
146416103|NCT01418352|528028495|FG003|Overall Study|Adverse Event|0|||
146416104|NCT01418352|528028492|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
146416105|NCT01418352|528028493|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
146416106|NCT01418352|528028494|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
146416107|NCT01418352|528028495|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
146416108|NCT01418352|528028492|FG000|Overall Study|Subject Withdrew Consent|0|||
146416109|NCT01418352|528028493|FG001|Overall Study|Subject Withdrew Consent|1|||
146416110|NCT01418352|528028494|FG002|Overall Study|Subject Withdrew Consent|2|||
146416111|NCT01418352|528028495|FG003|Overall Study|Subject Withdrew Consent|1|||
146416112|NCT01418352|528028492|FG000|Overall Study|Protocol Deviation|0|||
146416113|NCT01418352|528028493|FG001|Overall Study|Protocol Deviation|0|||
146416114|NCT01418352|528028494|FG002|Overall Study|Protocol Deviation|1|||
146416115|NCT01418352|528028495|FG003|Overall Study|Protocol Deviation|0|||
146416116|NCT01418352|528028492|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
146416117|NCT01418352|528028493|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146416118|NCT01418352|528028494|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146416119|NCT01418352|528028495|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
146416120|NCT01401478|528028497|FG000|Overall Study|Study drug not available|6|||
146416121|NCT01401478|528028497|FG000|Overall Study|Adverse Event|5|||
146416122|NCT01401478|528028497|FG000|Overall Study|Hyperphosphatemia|5|||
146416123|NCT01401478|528028497|FG000|Overall Study|Lost to Follow-up|5|||
146416124|NCT01401478|528028497|FG000|Overall Study|Kidney transplantation|3|||
146416125|NCT01401478|528028497|FG000|Overall Study|Withdrawal by Subject|3|||
146416126|NCT01401478|528028497|FG000|Overall Study|Blood samples not available|1|||
146416127|NCT01401478|528028497|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
146416128|NCT01401478|528028497|FG000|Overall Study|Low intact parathyroid hormone|1|||
146416129|NCT01401478|528028497|FG000|Overall Study|Serious adverse event|1|||
146416130|NCT01814137|528028498|FG000|Overall Study|Adverse Event|0|||
146416131|NCT01814137|528028499|FG001|Overall Study|Adverse Event|1|||
146416132|NCT01814137|528028498|FG000|Overall Study|Withdrawal by Subject|2|||
146416133|NCT01814137|528028499|FG001|Overall Study|Withdrawal by Subject|2|||
146416134|NCT01814137|528028498|FG000|Overall Study|Physician Decision|1|||
146416135|NCT01814137|528028499|FG001|Overall Study|Physician Decision|1|||
146416136|NCT01814137|528028498|FG000|Overall Study|Unclassified|2|||
146416137|NCT01814137|528028499|FG001|Overall Study|Unclassified|1|||
146416138|NCT01952574|528028500|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
146416139|NCT01952574|528028501|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
146416140|NCT01952574|528028502|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
146416141|NCT01952574|528028503|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
146416142|NCT01952574|528028504|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146416143|NCT01952574|528028505|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146416144|NCT01952574|528028506|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146416145|NCT01952574|528028500|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
146416146|NCT01952574|528028501|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
146416147|NCT01952574|528028502|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
146416148|NCT01952574|528028503|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
146416149|NCT01952574|528028504|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
146416150|NCT01952574|528028505|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
146416151|NCT01952574|528028506|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
146416152|NCT01952574|528028500|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
146416153|NCT01952574|528028501|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146416154|NCT01952574|528028502|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
146416155|NCT01952574|528028503|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
146416156|NCT01952574|528028504|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
146416157|NCT01952574|528028505|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
146193472|NCT00742274|527219900|FG001|Overall Study|Death|0|||
146416158|NCT01952574|528028506|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
146193473|NCT00742274|527219899|FG000|Overall Study|Withdrawal by Subject|1|||
146416159|NCT01952574|528028500|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416160|NCT01952574|528028501|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416161|NCT01952574|528028502|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416162|NCT01952574|528028503|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416163|NCT01952574|528028504|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
146416164|NCT01952574|528028505|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416165|NCT01952574|528028506|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
146416166|NCT01952574|528028500|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
146416167|NCT01952574|528028501|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
146416168|NCT01952574|528028502|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
146416169|NCT01952574|528028503|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
146416170|NCT01952574|528028504|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
146416171|NCT01952574|528028505|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
146416172|NCT01952574|528028506|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
146416173|NCT01952574|528028500|FG000|Open-label Treatment Phase|Missing|0|||
146416174|NCT01952574|528028501|FG001|Open-label Treatment Phase|Missing|0|||
146416175|NCT01952574|528028502|FG002|Open-label Treatment Phase|Missing|0|||
146416176|NCT01952574|528028503|FG003|Open-label Treatment Phase|Missing|0|||
146416177|NCT01952574|528028504|FG004|Open-label Treatment Phase|Missing|4|||
146416178|NCT01952574|528028505|FG005|Open-label Treatment Phase|Missing|0|||
146416179|NCT01952574|528028506|FG006|Open-label Treatment Phase|Missing|0|||
146416180|NCT01952574|528028500|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146416181|NCT01952574|528028501|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
146416182|NCT01952574|528028502|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
146416183|NCT01952574|528028503|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
146416184|NCT01952574|528028504|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
146416185|NCT01952574|528028505|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
146416186|NCT01952574|528028506|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
146416187|NCT01952574|528028500|FG000|Open-label Treatment Phase|Death|0|||
146416188|NCT01952574|528028501|FG001|Open-label Treatment Phase|Death|0|||
146416189|NCT01952574|528028502|FG002|Open-label Treatment Phase|Death|0|||
146416190|NCT01952574|528028503|FG003|Open-label Treatment Phase|Death|0|||
146416191|NCT01952574|528028504|FG004|Open-label Treatment Phase|Death|1|||
146416192|NCT01952574|528028505|FG005|Open-label Treatment Phase|Death|0|||
146416193|NCT01952574|528028506|FG006|Open-label Treatment Phase|Death|0|||
146416194|NCT01952574|528028500|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416195|NCT01952574|528028501|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416196|NCT01952574|528028502|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416197|NCT01952574|528028503|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416198|NCT01952574|528028504|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416199|NCT01952574|528028505|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
146416200|NCT01952574|528028506|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
146416201|NCT01952574|528028500|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
146416202|NCT01952574|528028501|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
146416203|NCT01952574|528028502|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
146416204|NCT01952574|528028503|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
146416205|NCT01952574|528028504|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
146416206|NCT01952574|528028505|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
146416207|NCT01952574|528028506|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
146416208|NCT00770991|528028510|FG000|Overall Study|Physician Decision|2|||
146416209|NCT00770991|528028511|FG001|Overall Study|Physician Decision|0|||
146416210|NCT00770991|528028510|FG000|Overall Study|Withdrawal by Subject|1|||
146416211|NCT00770991|528028511|FG001|Overall Study|Withdrawal by Subject|0|||
146416212|NCT00770991|528028510|FG000|Overall Study|Adverse Event|1|||
146416213|NCT00770991|528028511|FG001|Overall Study|Adverse Event|5|||
146416214|NCT00770991|528028510|FG000|Overall Study|Pregnancy|1|||
146416215|NCT00770991|528028511|FG001|Overall Study|Pregnancy|0|||
146416216|NCT02444533|528028513|FG000|Overall Study|Not able to complete forms|0|||
146416217|NCT02444533|528028514|FG001|Overall Study|Not able to complete forms|2|||
146416218|NCT02444533|528028513|FG000|Overall Study|Only gave post-procedure complications|2|||
146416219|NCT02444533|528028514|FG001|Overall Study|Only gave post-procedure complications|2|||
146416220|NCT00886483|528028519|FG000|Overall Study|Lost to Follow-up|0|||
146416221|NCT00886483|528028520|FG001|Overall Study|Lost to Follow-up|1|||
146416222|NCT00886483|528028519|FG000|Overall Study|Pursue medications|1|||
146416223|NCT00886483|528028520|FG001|Overall Study|Pursue medications|2|||
146416224|NCT00886483|528028519|FG000|Overall Study|Distance to center, poor grades|1|||
146416225|NCT00886483|528028520|FG001|Overall Study|Distance to center, poor grades|0|||
146416226|NCT02168270|528028522|FG000|Overall Study|Lack of Efficacy|4|||
146416227|NCT00593333|528028523|FG000|Overall Study|Lost to Follow-up|10|||
146416228|NCT00593333|528028524|FG001|Overall Study|Lost to Follow-up|11|||
146416229|NCT02175966|528028525|FG000|Follow-up Period|Lack of Efficacy|10|||
146416230|NCT02175966|528028526|FG001|Follow-up Period|Lack of Efficacy|6|||
146416231|NCT01086215|528028531|FG000|Overall Study|Death|14|||
146416232|NCT01086215|528028532|FG001|Overall Study|Death|8|||
146416233|NCT01086215|528028533|FG002|Overall Study|Death|8|||
146416234|NCT01086215|528028534|FG003|Overall Study|Death|1|||
146416235|NCT01086215|528028531|FG000|Overall Study|Lost to Follow-up|22|||
146416236|NCT01086215|528028532|FG001|Overall Study|Lost to Follow-up|39|||
146416237|NCT01086215|528028533|FG002|Overall Study|Lost to Follow-up|18|||
146416238|NCT01086215|528028534|FG003|Overall Study|Lost to Follow-up|2|||
146416239|NCT01965652|528028535|FG000|Overall Study|Adverse Event|40|||
146416240|NCT01965652|528028536|FG001|Overall Study|Adverse Event|37|||
146416241|NCT01965652|528028535|FG000|Overall Study|Withdrawal by Subject|62|||
146416242|NCT01965652|528028536|FG001|Overall Study|Withdrawal by Subject|69|||
146416243|NCT01965652|528028535|FG000|Overall Study|Lost to Follow-up|53|||
146416244|NCT01965652|528028536|FG001|Overall Study|Lost to Follow-up|40|||
146416245|NCT01965652|528028535|FG000|Overall Study|Protocol Violation|34|||
146416246|NCT01965652|528028536|FG001|Overall Study|Protocol Violation|38|||
146416247|NCT01965652|528028535|FG000|Overall Study|Death|3|||
146416248|NCT01965652|528028536|FG001|Overall Study|Death|4|||
146416249|NCT01965652|528028535|FG000|Overall Study|Other - Miscellaneous|18|||
146416250|NCT01965652|528028536|FG001|Overall Study|Other - Miscellaneous|21|||
146416251|NCT01965652|528028535|FG000|Overall Study|Pregnancy|0|||
146416252|NCT01965652|528028536|FG001|Overall Study|Pregnancy|1|||
146416253|NCT01121900|528028539|FG000|First Intervention Period|Adverse Event|1|||
146416254|NCT01121900|528028540|FG001|First Intervention Period|Adverse Event|1|||
146416255|NCT01121900|528028539|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146416256|NCT01121900|528028540|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146416257|NCT03469271|528028541|FG000|Overall Study|Withdrawal by Subject|2|||
146416258|NCT03469271|528028542|FG001|Overall Study|Withdrawal by Subject|0|||
146416259|NCT03469271|528028543|FG002|Overall Study|Withdrawal by Subject|0|||
146416260|NCT03469271|528028544|FG003|Overall Study|Withdrawal by Subject|1|||
146416261|NCT01328054|528028547|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
146416262|NCT01328054|528028548|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
146416263|NCT01328054|528028547|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
146416264|NCT01328054|528028548|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
146416265|NCT01328054|528028547|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
146416266|NCT01328054|528028548|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
146416267|NCT03760510|528028549|FG000|Overall Study|Not ventilated for 24 hours|105|||
146416268|NCT03760510|528028550|FG001|Overall Study|Not ventilated for 24 hours|97|||
146416269|NCT00871728|528028551|FG000|Overall Study|Adverse Event|1|||
146416270|NCT00871728|528028551|FG000|Overall Study|Protocol Violation|7|||
146416271|NCT00871728|528028551|FG000|Overall Study|Lost to Follow-up|2|||
146416272|NCT00871728|528028551|FG000|Overall Study|Failed to Visit Hospital|4|||
146416273|NCT00871728|528028551|FG000|Overall Study|Participant Non-compliance|1|||
146416274|NCT00871728|528028551|FG000|Overall Study|Withdrawal of Informed Consent|5|||
146416275|NCT03775681|528028559|FG000|Overall Study|Physician Decision|3|||
146416276|NCT00616928|528028560|FG000|Overall Study|Adverse Event|6|||
146416277|NCT00616928|528028561|FG001|Overall Study|Adverse Event|3|||
146416278|NCT00616928|528028562|FG002|Overall Study|Adverse Event|2|||
146416279|NCT00616928|528028563|FG003|Overall Study|Adverse Event|2|||
146416280|NCT00616928|528028560|FG000|Overall Study|Other|51|||
146416281|NCT00616928|528028561|FG001|Overall Study|Other|8|||
146416282|NCT00616928|528028562|FG002|Overall Study|Other|15|||
146416283|NCT00616928|528028563|FG003|Overall Study|Other|5|||
146416284|NCT00616928|528028560|FG000|Overall Study|Lost to Follow-up|5|||
146416285|NCT00616928|528028561|FG001|Overall Study|Lost to Follow-up|7|||
146416286|NCT00616928|528028562|FG002|Overall Study|Lost to Follow-up|0|||
146416287|NCT00616928|528028563|FG003|Overall Study|Lost to Follow-up|0|||
146416288|NCT00895583|528028564|FG000|Overall Study|Adverse Event|28|||
146416289|NCT00895583|528028565|FG001|Overall Study|Adverse Event|4|||
146416290|NCT00895583|528028564|FG000|Overall Study|Death|2|||
146416291|NCT00895583|528028565|FG001|Overall Study|Death|1|||
146416292|NCT00895583|528028564|FG000|Overall Study|Physician Decision|3|||
146416293|NCT00895583|528028565|FG001|Overall Study|Physician Decision|1|||
146416294|NCT00895583|528028564|FG000|Overall Study|Lost to Follow-up|1|||
146416295|NCT00895583|528028565|FG001|Overall Study|Lost to Follow-up|3|||
146416296|NCT00895583|528028564|FG000|Overall Study|Protocol Violation|1|||
146416297|NCT00895583|528028565|FG001|Overall Study|Protocol Violation|0|||
146416298|NCT00895583|528028564|FG000|Overall Study|Withdrawal by Subject|4|||
146416299|NCT00895583|528028565|FG001|Overall Study|Withdrawal by Subject|2|||
146416300|NCT00895583|528028564|FG000|Overall Study|Lack of Efficacy|5|||
146416301|NCT00895583|528028565|FG001|Overall Study|Lack of Efficacy|0|||
146416302|NCT00895583|528028564|FG000|Overall Study|Other|0|||
146416303|NCT00895583|528028565|FG001|Overall Study|Other|1|||
146416304|NCT03529955|528028566|FG000|Overall Study|Adverse Event|1|||
146416305|NCT03529955|528028566|FG000|Overall Study|Lack of Efficacy|1|||
146416306|NCT03016078|528028572|FG000|Overall Study|Protocol Violation|1|||
146416307|NCT03016078|528028572|FG000|Overall Study|Protocol Violation|1|||
146416308|NCT02378506|528028573|FG000|Overall Study|Lack of Efficacy|3|||
146416309|NCT02378506|528028573|FG000|Overall Study|Withdrawal by Subject|4|||
146416310|NCT02378506|528028573|FG000|Overall Study|Protocol Violation|2|||
146416311|NCT02378506|528028573|FG000|Overall Study|Death|1|||
146416312|NCT02378506|528028573|FG000|Overall Study|Adverse Event|14|||
146416313|NCT02378506|528028573|FG000|Overall Study|Randomized But Not Treated|1|||
146416314|NCT01070394|528028576|FG000|Overall Study|Adverse Event|6|||
146416315|NCT01070394|528028576|FG000|Overall Study|Withdrawal by Subject|1|||
146416316|NCT01715415|528028588|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
146416317|NCT01715415|528028589|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
146416318|NCT01715415|528028588|FG000|Double-blind Treatment|Adverse Event|3|||
146416319|NCT01715415|528028589|FG001|Double-blind Treatment|Adverse Event|0|||
146416320|NCT01715415|528028588|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
146416321|NCT01715415|528028589|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
146416322|NCT01715415|528028588|FG000|Double-blind Treatment|Other|1|||
146416323|NCT01715415|528028589|FG001|Double-blind Treatment|Other|0|||
146416324|NCT01715415|528028588|FG000|Open-label Treatment|Adverse Event|0|||
146416325|NCT01715415|528028589|FG001|Open-label Treatment|Adverse Event|1|||
146416326|NCT01715415|528028588|FG000|Open-label Treatment|Subject Noncompliant|0|||
146416327|NCT01715415|528028589|FG001|Open-label Treatment|Subject Noncompliant|1|||
146416328|NCT01015612|528028590|FG000|Overall Study|Death|113|||
146416329|NCT01015612|528028590|FG000|Overall Study|Withdrawal by Subject|40|||
146416330|NCT03586830|528028591|FG000|Overall Study|Site terminated by Sponsor|1|||
146416331|NCT03586830|528028592|FG001|Overall Study|Site terminated by Sponsor|4|||
146416332|NCT03586830|528028593|FG002|Overall Study|Site terminated by Sponsor|3|||
146416333|NCT03586830|528028594|FG003|Overall Study|Site terminated by Sponsor|3|||
146416334|NCT03586830|528028591|FG000|Overall Study|Lost to Follow-up|0|||
146416335|NCT03586830|528028592|FG001|Overall Study|Lost to Follow-up|2|||
146416336|NCT03586830|528028593|FG002|Overall Study|Lost to Follow-up|2|||
146416337|NCT03586830|528028594|FG003|Overall Study|Lost to Follow-up|1|||
146416338|NCT03586830|528028591|FG000|Overall Study|Withdrawal by Subject|1|||
146416339|NCT03586830|528028592|FG001|Overall Study|Withdrawal by Subject|0|||
146416340|NCT03586830|528028593|FG002|Overall Study|Withdrawal by Subject|3|||
146416341|NCT03586830|528028594|FG003|Overall Study|Withdrawal by Subject|1|||
146416342|NCT02497391|528030261|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
146416343|NCT02497391|528030262|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
146416344|NCT02497391|528030263|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
146416345|NCT02497391|528030264|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
146416346|NCT02497391|528030265|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
146416347|NCT02497391|528030266|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
146416348|NCT02497391|528030261|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
146416349|NCT02497391|528030262|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
146416350|NCT02497391|528030263|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
146416351|NCT02497391|528030264|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
146416352|NCT02497391|528030265|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
146416353|NCT02497391|528030266|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
146416354|NCT02497391|528030261|FG000|Period 3 (14 Days)|Adverse Event|0|||
146416355|NCT02497391|528030262|FG001|Period 3 (14 Days)|Adverse Event|1|||
146416356|NCT02497391|528030263|FG002|Period 3 (14 Days)|Adverse Event|0|||
146416357|NCT02497391|528030264|FG003|Period 3 (14 Days)|Adverse Event|0|||
146416358|NCT02497391|528030265|FG004|Period 3 (14 Days)|Adverse Event|0|||
146416359|NCT02497391|528030266|FG005|Period 3 (14 Days)|Adverse Event|0|||
146416360|NCT02497391|528030261|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
146416361|NCT02497391|528030262|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
146416362|NCT02497391|528030263|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
146416363|NCT02497391|528030264|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
146416364|NCT02497391|528030265|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
146416365|NCT02497391|528030266|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
146416366|NCT02497391|528030261|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
146416367|NCT02497391|528030262|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
146416368|NCT02497391|528030263|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
146416369|NCT02497391|528030264|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
146416370|NCT02497391|528030265|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
146416371|NCT02497391|528030266|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
146416372|NCT01664052|528030267|FG000|Phase 1|No device placement|6|||
146416373|NCT01664052|528030268|FG001|Phase 1|No device placement|0|||
146416374|NCT01664052|528030267|FG000|Phase 1|No HSG 1 hr post placement|1|||
146416375|NCT01664052|528030268|FG001|Phase 1|No HSG 1 hr post placement|0|||
146416376|NCT01664052|528030267|FG000|Phase 2|No device placement|0|||
146416377|NCT01664052|528030268|FG001|Phase 2|No device placement|4|||
146416378|NCT03740698|528030269|FG000|Overall Study|Physician Decision|0|||
146416379|NCT03740698|528030270|FG001|Overall Study|Physician Decision|1|||
146416380|NCT03740698|528030271|FG002|Overall Study|Physician Decision|1|||
146416381|NCT01466686|528030275|FG000|Overall Study|Withdrawal by Subject|1|||
146416382|NCT00633152|528030277|FG000|Overall Study|Adverse Event|1|||
146416383|NCT00633152|528030278|FG001|Overall Study|Adverse Event|0|||
146416384|NCT00633152|528030277|FG000|Overall Study|Randomized, did not receive study drug|5|||
146416385|NCT00633152|528030278|FG001|Overall Study|Randomized, did not receive study drug|2|||
146416386|NCT00633152|528030277|FG000|Overall Study|Withdrawal by Subject|1|||
146416387|NCT00633152|528030278|FG001|Overall Study|Withdrawal by Subject|1|||
146416388|NCT00633152|528030277|FG000|Overall Study|Lost to Follow-up|4|||
146416389|NCT00633152|528030278|FG001|Overall Study|Lost to Follow-up|1|||
146416390|NCT00633152|528030277|FG000|Overall Study|Miscellaneous Other|3|||
146416391|NCT00633152|528030278|FG001|Overall Study|Miscellaneous Other|2|||
146416392|NCT05216978|528030279|FG000|Overall Study|Withdrawal by Subject|3|||
146416393|NCT05216978|528030279|FG000|Overall Study|Lost to Follow-up|5|||
146416394|NCT02410252|528030284|FG000|Overall Study|Withdrawal by Subject|4|||
146416395|NCT02410252|528030284|FG000|Overall Study|Physician Decision|2|||
146416396|NCT01007916|528030289|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
146416397|NCT01007916|528030290|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
146416398|NCT01007916|528030289|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
146416399|NCT01007916|528030290|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
146416400|NCT02961920|528030294|FG000|Overall Study|did not achive stydy protocol schedule|1|||
146416401|NCT02961920|528030295|FG001|Overall Study|did not achive stydy protocol schedule|1|||
146416402|NCT04480463|528030300|FG000|Overall Study|Death|0|||
146416403|NCT04480463|528030301|FG001|Overall Study|Death|1|||
146416404|NCT04480463|528030300|FG000|Overall Study|Adverse Event|6|||
146416405|NCT04480463|528030301|FG001|Overall Study|Adverse Event|8|||
146416406|NCT04480463|528030300|FG000|Overall Study|Lost to Follow-up|3|||
146416407|NCT04480463|528030301|FG001|Overall Study|Lost to Follow-up|2|||
146416408|NCT04480463|528030300|FG000|Overall Study|Physician Decision|2|||
146416409|NCT04480463|528030301|FG001|Overall Study|Physician Decision|5|||
146416410|NCT04480463|528030300|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
146416411|NCT04480463|528030301|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
146416412|NCT04480463|528030300|FG000|Overall Study|Protocol Violation|2|||
146416413|NCT04480463|528030301|FG001|Overall Study|Protocol Violation|1|||
146416414|NCT04480463|528030300|FG000|Overall Study|Withdrawal by Subject|6|||
146416415|NCT04480463|528030301|FG001|Overall Study|Withdrawal by Subject|7|||
146416416|NCT04480463|528030300|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
146416417|NCT04480463|528030301|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
146416418|NCT04480463|528030300|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
146416419|NCT04480463|528030301|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
146416420|NCT04480463|528030300|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
146416421|NCT04480463|528030301|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
146416422|NCT04480463|528030300|FG000|Overall Study|Other|6|||
146416423|NCT04480463|528030301|FG001|Overall Study|Other|4|||
146416424|NCT00444795|528030302|FG000|Overall Study|Not Treated|1|||
146416425|NCT00444795|528030302|FG000|Overall Study|Treated Prior to the Contract Date|2|||
146416426|NCT02322879|528030303|FG000|First Intervention|Physician Decision|1|||
146416427|NCT02322879|528030304|FG001|First Intervention|Physician Decision|0|||
146416428|NCT00130520|528030305|FG000|Overall Study|Adverse Event|11|||
146416429|NCT00130520|528030305|FG000|Overall Study|Death|1|||
146416430|NCT00130520|528030305|FG000|Overall Study|Physician Decision|1|||
146416431|NCT00130520|528030305|FG000|Overall Study|Withdrawal by Subject|1|||
146416432|NCT00130520|528030305|FG000|Overall Study|Disease Progression|23|||
146416433|NCT00130520|528030305|FG000|Overall Study|Protocol non-compliance|1|||
146416434|NCT00130520|528030305|FG000|Overall Study|Did not meet re-treatment criteria|1|||
146416435|NCT03487796|528030306|FG000|Overall Study|Lost to Follow-up|18|||
146416436|NCT03487796|528030307|FG001|Overall Study|Lost to Follow-up|6|||
146416437|NCT00613574|528030310|FG000|Overall Study|Adverse Event|3|||
146416438|NCT00613574|528030310|FG000|Overall Study|Lost to Follow-up|2|||
146416439|NCT00613574|528030310|FG000|Overall Study|Other|1|||
146416440|NCT05487456|528030312|FG000|Overall Study|Withdrawal by Subject|0|||
146416441|NCT05487456|528030313|FG001|Overall Study|Withdrawal by Subject|0|||
146416442|NCT05487456|528030314|FG002|Overall Study|Withdrawal by Subject|1|||
146416443|NCT05487456|528030315|FG003|Overall Study|Withdrawal by Subject|0|||
146416444|NCT02711956|528030316|FG000|Overall Study|Adverse Event|0|||
146416445|NCT02711956|528030317|FG001|Overall Study|Adverse Event|0|||
146416446|NCT02711956|528030318|FG002|Overall Study|Adverse Event|0|||
146416447|NCT02711956|528030319|FG003|Overall Study|Adverse Event|1|||
146416448|NCT02711956|528030320|FG004|Overall Study|Adverse Event|2|||
146416449|NCT02711956|528030321|FG005|Overall Study|Adverse Event|0|||
146416450|NCT02711956|528030322|FG006|Overall Study|Adverse Event|0|||
146416451|NCT02711956|528030323|FG007|Overall Study|Adverse Event|1|||
146416452|NCT02711956|528030324|FG008|Overall Study|Adverse Event|1|||
146416453|NCT02711956|528030325|FG009|Overall Study|Adverse Event|1|||
146416454|NCT02711956|528030326|FG010|Overall Study|Adverse Event|1|||
146416455|NCT02711956|528030327|FG011|Overall Study|Adverse Event|0|||
146416456|NCT02711956|528030328|FG012|Overall Study|Adverse Event|0|||
146416457|NCT02711956|528030329|FG013|Overall Study|Adverse Event|0|||
146416458|NCT02711956|528030330|FG014|Overall Study|Adverse Event|2|||
146416459|NCT02711956|528030316|FG000|Overall Study|Physician Decision|0|||
146416460|NCT02711956|528030317|FG001|Overall Study|Physician Decision|0|||
146416461|NCT02711956|528030318|FG002|Overall Study|Physician Decision|0|||
146416462|NCT02711956|528030319|FG003|Overall Study|Physician Decision|2|||
146416463|NCT02711956|528030320|FG004|Overall Study|Physician Decision|0|||
146416464|NCT02711956|528030321|FG005|Overall Study|Physician Decision|0|||
146416465|NCT02711956|528030322|FG006|Overall Study|Physician Decision|0|||
146416466|NCT02711956|528030323|FG007|Overall Study|Physician Decision|0|||
146416467|NCT02711956|528030324|FG008|Overall Study|Physician Decision|0|||
146416468|NCT02711956|528030325|FG009|Overall Study|Physician Decision|0|||
146416469|NCT02711956|528030326|FG010|Overall Study|Physician Decision|0|||
146416470|NCT02711956|528030327|FG011|Overall Study|Physician Decision|0|||
146416471|NCT02711956|528030328|FG012|Overall Study|Physician Decision|0|||
146416472|NCT02711956|528030329|FG013|Overall Study|Physician Decision|0|||
146416473|NCT02711956|528030330|FG014|Overall Study|Physician Decision|0|||
146416474|NCT02711956|528030316|FG000|Overall Study|Withdrawal by Subject|0|||
146416475|NCT02711956|528030317|FG001|Overall Study|Withdrawal by Subject|0|||
146416476|NCT02711956|528030318|FG002|Overall Study|Withdrawal by Subject|0|||
146416477|NCT02711956|528030319|FG003|Overall Study|Withdrawal by Subject|0|||
146416478|NCT02711956|528030320|FG004|Overall Study|Withdrawal by Subject|0|||
146416479|NCT02711956|528030321|FG005|Overall Study|Withdrawal by Subject|0|||
146416480|NCT02711956|528030322|FG006|Overall Study|Withdrawal by Subject|1|||
146416481|NCT02711956|528030323|FG007|Overall Study|Withdrawal by Subject|0|||
146416482|NCT02711956|528030324|FG008|Overall Study|Withdrawal by Subject|0|||
146416483|NCT02711956|528030325|FG009|Overall Study|Withdrawal by Subject|0|||
146416484|NCT02711956|528030326|FG010|Overall Study|Withdrawal by Subject|0|||
146416485|NCT02711956|528030327|FG011|Overall Study|Withdrawal by Subject|1|||
146416486|NCT02711956|528030328|FG012|Overall Study|Withdrawal by Subject|6|||
146416487|NCT02711956|528030329|FG013|Overall Study|Withdrawal by Subject|0|||
146416488|NCT02711956|528030330|FG014|Overall Study|Withdrawal by Subject|1|||
146416489|NCT02711956|528030316|FG000|Overall Study|Clinical progression|1|||
146416490|NCT02711956|528030317|FG001|Overall Study|Clinical progression|0|||
146416491|NCT02711956|528030318|FG002|Overall Study|Clinical progression|0|||
146416492|NCT02711956|528030319|FG003|Overall Study|Clinical progression|0|||
146416493|NCT02711956|528030320|FG004|Overall Study|Clinical progression|0|||
146416494|NCT02711956|528030321|FG005|Overall Study|Clinical progression|0|||
146416495|NCT02711956|528030322|FG006|Overall Study|Clinical progression|1|||
146416496|NCT02711956|528030323|FG007|Overall Study|Clinical progression|0|||
146416497|NCT02711956|528030324|FG008|Overall Study|Clinical progression|1|||
146416498|NCT02711956|528030325|FG009|Overall Study|Clinical progression|0|||
146416499|NCT02711956|528030326|FG010|Overall Study|Clinical progression|0|||
146416500|NCT02711956|528030327|FG011|Overall Study|Clinical progression|2|||
146416501|NCT02711956|528030328|FG012|Overall Study|Clinical progression|4|||
146416502|NCT02711956|528030329|FG013|Overall Study|Clinical progression|1|||
146416503|NCT02711956|528030330|FG014|Overall Study|Clinical progression|1|||
146416504|NCT02711956|528030316|FG000|Overall Study|Radiographic progression|1|||
146416505|NCT02711956|528030317|FG001|Overall Study|Radiographic progression|1|||
146416506|NCT02711956|528030318|FG002|Overall Study|Radiographic progression|2|||
146416507|NCT02711956|528030319|FG003|Overall Study|Radiographic progression|0|||
146416508|NCT02711956|528030320|FG004|Overall Study|Radiographic progression|1|||
146416509|NCT02711956|528030321|FG005|Overall Study|Radiographic progression|0|||
146416510|NCT02711956|528030322|FG006|Overall Study|Radiographic progression|0|||
146416511|NCT02711956|528030323|FG007|Overall Study|Radiographic progression|0|||
146416512|NCT02711956|528030324|FG008|Overall Study|Radiographic progression|2|||
146416513|NCT02711956|528030325|FG009|Overall Study|Radiographic progression|1|||
146416514|NCT02711956|528030326|FG010|Overall Study|Radiographic progression|0|||
146416515|NCT02711956|528030327|FG011|Overall Study|Radiographic progression|5|||
146416516|NCT02711956|528030328|FG012|Overall Study|Radiographic progression|3|||
146416517|NCT02711956|528030329|FG013|Overall Study|Radiographic progression|0|||
146416518|NCT02711956|528030330|FG014|Overall Study|Radiographic progression|1|||
146416519|NCT02711956|528030316|FG000|Overall Study|PSA progression with clinical progression|0|||
146416520|NCT02711956|528030317|FG001|Overall Study|PSA progression with clinical progression|0|||
146416521|NCT02711956|528030318|FG002|Overall Study|PSA progression with clinical progression|0|||
146416522|NCT02711956|528030319|FG003|Overall Study|PSA progression with clinical progression|0|||
146416523|NCT02711956|528030320|FG004|Overall Study|PSA progression with clinical progression|1|||
146193474|NCT00742274|527219900|FG001|Overall Study|Withdrawal by Subject|2|||
146416524|NCT02711956|528030321|FG005|Overall Study|PSA progression with clinical progression|0|||
146416525|NCT02711956|528030322|FG006|Overall Study|PSA progression with clinical progression|0|||
146416526|NCT02711956|528030323|FG007|Overall Study|PSA progression with clinical progression|0|||
146416527|NCT02711956|528030324|FG008|Overall Study|PSA progression with clinical progression|0|||
146416528|NCT02711956|528030325|FG009|Overall Study|PSA progression with clinical progression|0|||
146416529|NCT02711956|528030326|FG010|Overall Study|PSA progression with clinical progression|0|||
146416530|NCT02711956|528030327|FG011|Overall Study|PSA progression with clinical progression|0|||
146416531|NCT02711956|528030328|FG012|Overall Study|PSA progression with clinical progression|1|||
146416532|NCT02711956|528030329|FG013|Overall Study|PSA progression with clinical progression|1|||
146416533|NCT02711956|528030330|FG014|Overall Study|PSA progression with clinical progression|0|||
146416534|NCT02711956|528030316|FG000|Overall Study|PSA progression with radiographic progression|0|||
145948183|NCT01952080|526319598|FG001|Overall Study|Protocol Non-compliance|1|||
146416535|NCT02711956|528030317|FG001|Overall Study|PSA progression with radiographic progression|1|||
146416536|NCT02711956|528030318|FG002|Overall Study|PSA progression with radiographic progression|0|||
146416537|NCT02711956|528030319|FG003|Overall Study|PSA progression with radiographic progression|0|||
146416538|NCT02711956|528030320|FG004|Overall Study|PSA progression with radiographic progression|0|||
146416539|NCT02711956|528030321|FG005|Overall Study|PSA progression with radiographic progression|2|||
146416540|NCT02711956|528030322|FG006|Overall Study|PSA progression with radiographic progression|2|||
146416541|NCT02711956|528030323|FG007|Overall Study|PSA progression with radiographic progression|1|||
146416542|NCT02711956|528030324|FG008|Overall Study|PSA progression with radiographic progression|0|||
146416543|NCT02711956|528030325|FG009|Overall Study|PSA progression with radiographic progression|1|||
146416544|NCT02711956|528030326|FG010|Overall Study|PSA progression with radiographic progression|0|||
146416545|NCT02711956|528030327|FG011|Overall Study|PSA progression with radiographic progression|1|||
146416546|NCT02711956|528030328|FG012|Overall Study|PSA progression with radiographic progression|2|||
146416547|NCT02711956|528030329|FG013|Overall Study|PSA progression with radiographic progression|3|||
146416548|NCT02711956|528030330|FG014|Overall Study|PSA progression with radiographic progression|3|||
146416549|NCT01625377|528030333|FG000|Overall Study|Death|1|||
146416550|NCT01625377|528030334|FG001|Overall Study|Death|1|||
146416551|NCT01625377|528030333|FG000|Overall Study|Administrative Problem|1|||
146416552|NCT01625377|528030334|FG001|Overall Study|Administrative Problem|1|||
146416553|NCT01625377|528030333|FG000|Overall Study|Protocol Violation|0|||
146416554|NCT01625377|528030334|FG001|Overall Study|Protocol Violation|3|||
146416555|NCT01625377|528030333|FG000|Overall Study|Adverse Event|3|||
146416556|NCT01625377|528030334|FG001|Overall Study|Adverse Event|16|||
146416557|NCT01625377|528030333|FG000|Overall Study|Graft loss|1|||
146416558|NCT01625377|528030334|FG001|Overall Study|Graft loss|0|||
146416559|NCT01625377|528030333|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146416560|NCT01625377|528030334|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146416561|NCT01625377|528030333|FG000|Overall Study|Abnormal laboratory values|1|||
146416562|NCT01625377|528030334|FG001|Overall Study|Abnormal laboratory values|0|||
146416563|NCT02043366|528030335|FG000|Overall Study|Lost to Follow-up|2|||
146416564|NCT02043366|528030336|FG001|Overall Study|Lost to Follow-up|2|||
146416565|NCT02043366|528030337|FG002|Overall Study|Lost to Follow-up|2|||
146416566|NCT02043366|528030338|FG003|Overall Study|Lost to Follow-up|2|||
146416567|NCT02043366|528030339|FG004|Overall Study|Lost to Follow-up|2|||
146416568|NCT02043366|528030340|FG005|Overall Study|Lost to Follow-up|2|||
146416569|NCT01489956|528030343|FG000|Overall Study|Lost to Follow-up|1|||
146416570|NCT01489956|528030344|FG001|Overall Study|Lost to Follow-up|0|||
146416571|NCT01489956|528030345|FG002|Overall Study|Lost to Follow-up|0|||
146416572|NCT01489956|528030343|FG000|Overall Study|Withdrawal by Subject|0|||
146416573|NCT01489956|528030344|FG001|Overall Study|Withdrawal by Subject|0|||
146416574|NCT01489956|528030345|FG002|Overall Study|Withdrawal by Subject|1|||
146416575|NCT00718159|528030348|FG000|Overall Study|Progressive Disease|3|||
146416576|NCT00718159|528030349|FG001|Overall Study|Progressive Disease|3|||
146416577|NCT00718159|528030350|FG002|Overall Study|Progressive Disease|2|||
146416578|NCT00718159|528030351|FG003|Overall Study|Progressive Disease|0|||
146416579|NCT00718159|528030352|FG004|Overall Study|Progressive Disease|6|||
146416580|NCT00718159|528030353|FG005|Overall Study|Progressive Disease|0|||
146416581|NCT00718159|528030354|FG006|Overall Study|Progressive Disease|0|||
146416582|NCT00718159|528030348|FG000|Overall Study|Death due to Adverse Event|0|||
146416583|NCT00718159|528030349|FG001|Overall Study|Death due to Adverse Event|0|||
146416584|NCT00718159|528030350|FG002|Overall Study|Death due to Adverse Event|0|||
146416585|NCT00718159|528030351|FG003|Overall Study|Death due to Adverse Event|2|||
146416586|NCT00718159|528030352|FG004|Overall Study|Death due to Adverse Event|2|||
146416587|NCT00718159|528030353|FG005|Overall Study|Death due to Adverse Event|0|||
146416588|NCT00718159|528030354|FG006|Overall Study|Death due to Adverse Event|0|||
146416589|NCT00718159|528030348|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
146416590|NCT00718159|528030349|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
146416591|NCT00718159|528030350|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
146416592|NCT00718159|528030351|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
146416593|NCT00718159|528030352|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
146416594|NCT00718159|528030353|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
146416595|NCT00718159|528030354|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
146416596|NCT00718159|528030348|FG000|Overall Study|Investigator Decision|0|||
146416597|NCT00718159|528030349|FG001|Overall Study|Investigator Decision|0|||
146416598|NCT00718159|528030350|FG002|Overall Study|Investigator Decision|0|||
146416599|NCT00718159|528030351|FG003|Overall Study|Investigator Decision|0|||
146416600|NCT00718159|528030352|FG004|Overall Study|Investigator Decision|0|||
146416601|NCT00718159|528030353|FG005|Overall Study|Investigator Decision|1|||
146416602|NCT00718159|528030354|FG006|Overall Study|Investigator Decision|1|||
146416603|NCT00782509|528030355|FG000|Overall Study|Adverse Event|20|||
146416604|NCT00782509|528030356|FG001|Overall Study|Adverse Event|10|||
146416605|NCT00782509|528030357|FG002|Overall Study|Adverse Event|20|||
146416606|NCT00782509|528030355|FG000|Overall Study|Lost to Follow-up|1|||
146416607|NCT00782509|528030356|FG001|Overall Study|Lost to Follow-up|2|||
146416608|NCT00782509|528030357|FG002|Overall Study|Lost to Follow-up|3|||
146416609|NCT00782509|528030355|FG000|Overall Study|Withdrawal by Subject|3|||
146416610|NCT00782509|528030356|FG001|Overall Study|Withdrawal by Subject|5|||
146416611|NCT00782509|528030357|FG002|Overall Study|Withdrawal by Subject|8|||
146416612|NCT00782509|528030355|FG000|Overall Study|Non compliance with protocol|2|||
146416613|NCT00782509|528030356|FG001|Overall Study|Non compliance with protocol|0|||
146416614|NCT00782509|528030357|FG002|Overall Study|Non compliance with protocol|0|||
146416615|NCT00782509|528030355|FG000|Overall Study|Other reasons not stated above|5|||
146416616|NCT00782509|528030356|FG001|Overall Study|Other reasons not stated above|2|||
146416617|NCT00782509|528030357|FG002|Overall Study|Other reasons not stated above|3|||
146416618|NCT00782509|528030355|FG000|Overall Study|Lack of Efficacy|10|||
146416619|NCT00782509|528030356|FG001|Overall Study|Lack of Efficacy|5|||
146416620|NCT00782509|528030357|FG002|Overall Study|Lack of Efficacy|2|||
146416621|NCT00175019|528030358|FG000|Overall Study|Adverse Event|54|||
146416622|NCT00175019|528030359|FG001|Overall Study|Adverse Event|22|||
146416623|NCT00175019|528030360|FG002|Overall Study|Adverse Event|2|||
146416624|NCT00175019|528030358|FG000|Overall Study|Protocol Violation|6|||
146416625|NCT00175019|528030359|FG001|Overall Study|Protocol Violation|3|||
146416626|NCT00175019|528030360|FG002|Overall Study|Protocol Violation|3|||
146416627|NCT00175019|528030358|FG000|Overall Study|Lost to Follow-up|42|||
146416628|NCT00175019|528030359|FG001|Overall Study|Lost to Follow-up|39|||
146416629|NCT00175019|528030360|FG002|Overall Study|Lost to Follow-up|9|||
146416630|NCT00175019|528030358|FG000|Overall Study|Did not continue under Amendment 4|1|||
146416631|NCT00175019|528030359|FG001|Overall Study|Did not continue under Amendment 4|1|||
146416632|NCT00175019|528030360|FG002|Overall Study|Did not continue under Amendment 4|2|||
146416633|NCT00175019|528030358|FG000|Overall Study|Personal Reason(s)|39|||
146416634|NCT00175019|528030359|FG001|Overall Study|Personal Reason(s)|31|||
146416635|NCT00175019|528030360|FG002|Overall Study|Personal Reason(s)|8|||
146416636|NCT00175019|528030358|FG000|Overall Study|Therapeutic Failure|10|||
146416637|NCT00175019|528030359|FG001|Overall Study|Therapeutic Failure|38|||
146416638|NCT00175019|528030360|FG002|Overall Study|Therapeutic Failure|22|||
146416639|NCT00175019|528030358|FG000|Overall Study|Gout Flare|2|||
146416640|NCT00175019|528030359|FG001|Overall Study|Gout Flare|3|||
146416641|NCT00175019|528030360|FG002|Overall Study|Gout Flare|0|||
146416642|NCT00175019|528030358|FG000|Overall Study|Reason Not Specified|40|||
146416643|NCT00175019|528030359|FG001|Overall Study|Reason Not Specified|34|||
146416644|NCT00175019|528030360|FG002|Overall Study|Reason Not Specified|11|||
146416645|NCT01405820|528030361|FG000|Randomized Treatment Period|Adverse Event|3|||
146416646|NCT01405820|528030362|FG001|Randomized Treatment Period|Adverse Event|3|||
146416647|NCT01405820|528030363|FG002|Randomized Treatment Period|Adverse Event|3|||
146416648|NCT01405820|528030364|FG003|Randomized Treatment Period|Adverse Event|0|||
146416649|NCT01405820|528030365|FG004|Randomized Treatment Period|Adverse Event|2|||
146416650|NCT01405820|528030366|FG005|Randomized Treatment Period|Adverse Event|1|||
146416651|NCT01405820|528030361|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
146416652|NCT01405820|528030362|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
146416653|NCT01405820|528030363|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
146416654|NCT01405820|528030364|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
146416655|NCT01405820|528030365|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
146416656|NCT01405820|528030366|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
146416657|NCT01405820|528030361|FG000|Randomized Treatment Period|Other|2|||
146416658|NCT01405820|528030362|FG001|Randomized Treatment Period|Other|2|||
146416659|NCT01405820|528030363|FG002|Randomized Treatment Period|Other|1|||
146416660|NCT01405820|528030364|FG003|Randomized Treatment Period|Other|1|||
146416661|NCT01405820|528030365|FG004|Randomized Treatment Period|Other|0|||
146416662|NCT01405820|528030366|FG005|Randomized Treatment Period|Other|0|||
146416663|NCT01405820|528030361|FG000|Randomized Treatment Period|Physician Decision|0|||
146416664|NCT01405820|528030362|FG001|Randomized Treatment Period|Physician Decision|2|||
146416665|NCT01405820|528030363|FG002|Randomized Treatment Period|Physician Decision|1|||
146416666|NCT01405820|528030364|FG003|Randomized Treatment Period|Physician Decision|0|||
146416667|NCT01405820|528030365|FG004|Randomized Treatment Period|Physician Decision|0|||
146416668|NCT01405820|528030366|FG005|Randomized Treatment Period|Physician Decision|0|||
146416669|NCT01405820|528030361|FG000|Randomized Treatment Period|Rescue|0|||
145948184|NCT01952080|526319599|FG002|Overall Study|Protocol Non-compliance|0|||
145948185|NCT01952080|526319600|FG003|Overall Study|Protocol Non-compliance|0|||
146416670|NCT01405820|528030362|FG001|Randomized Treatment Period|Rescue|1|||
146416671|NCT01405820|528030363|FG002|Randomized Treatment Period|Rescue|13|||
146416672|NCT01405820|528030364|FG003|Randomized Treatment Period|Rescue|10|||
146416673|NCT01405820|528030365|FG004|Randomized Treatment Period|Rescue|8|||
146416674|NCT01405820|528030366|FG005|Randomized Treatment Period|Rescue|8|||
146416675|NCT01405820|528030361|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
146416676|NCT01405820|528030362|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
146416677|NCT01405820|528030363|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
146416678|NCT01405820|528030364|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
146416679|NCT01405820|528030365|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
146416680|NCT01405820|528030366|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
146416681|NCT01405820|528030361|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
146193475|NCT00742274|527219899|FG000|Overall Study|Removed for medical reasons|1|||
146193476|NCT00742274|527219900|FG001|Overall Study|Removed for medical reasons|1|||
146416682|NCT01405820|528030362|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
146416683|NCT01405820|528030363|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
146416684|NCT01405820|528030364|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
146416685|NCT01405820|528030365|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
146416686|NCT01405820|528030366|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
146416687|NCT01405820|528030361|FG000|Randomized Treatment Period|Death|0|||
146416688|NCT01405820|528030362|FG001|Randomized Treatment Period|Death|0|||
146416689|NCT01405820|528030363|FG002|Randomized Treatment Period|Death|0|||
146416690|NCT01405820|528030364|FG003|Randomized Treatment Period|Death|1|||
146416691|NCT01405820|528030365|FG004|Randomized Treatment Period|Death|0|||
146416692|NCT01405820|528030366|FG005|Randomized Treatment Period|Death|0|||
146416693|NCT01405820|528030361|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146416694|NCT01405820|528030362|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146416695|NCT01405820|528030363|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146416696|NCT01405820|528030364|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
146416697|NCT01405820|528030365|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146416698|NCT01405820|528030366|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
146416699|NCT01405820|528030361|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
146416700|NCT01405820|528030362|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
146416701|NCT01405820|528030363|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
146416702|NCT01405820|528030364|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
146416703|NCT01405820|528030365|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
146416704|NCT01405820|528030366|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
146416705|NCT01405820|528030361|FG000|Open-Label Treatment Period|Other|1|||
146416706|NCT01405820|528030362|FG001|Open-Label Treatment Period|Other|1|||
146416707|NCT01405820|528030363|FG002|Open-Label Treatment Period|Other|1|||
146416708|NCT01405820|528030364|FG003|Open-Label Treatment Period|Other|1|||
146416709|NCT01405820|528030365|FG004|Open-Label Treatment Period|Other|1|||
146416710|NCT01405820|528030366|FG005|Open-Label Treatment Period|Other|1|||
146193477|NCT02365298|527219903|FG000|Period 2|incorrect Rx dispensed|1|||
146416711|NCT01405820|528030361|FG000|Open-Label Treatment Period|Physician Decision|0|||
146193478|NCT02365298|527219904|FG001|Period 2|incorrect Rx dispensed|0|||
146416712|NCT01405820|528030362|FG001|Open-Label Treatment Period|Physician Decision|0|||
146416713|NCT01405820|528030363|FG002|Open-Label Treatment Period|Physician Decision|1|||
146416714|NCT01405820|528030364|FG003|Open-Label Treatment Period|Physician Decision|2|||
146416715|NCT01405820|528030365|FG004|Open-Label Treatment Period|Physician Decision|1|||
146416716|NCT01405820|528030366|FG005|Open-Label Treatment Period|Physician Decision|0|||
146416717|NCT01405820|528030361|FG000|Open-Label Treatment Period|Adverse Event|0|||
146416718|NCT01405820|528030362|FG001|Open-Label Treatment Period|Adverse Event|0|||
146416719|NCT01405820|528030363|FG002|Open-Label Treatment Period|Adverse Event|0|||
146416720|NCT01405820|528030364|FG003|Open-Label Treatment Period|Adverse Event|1|||
146416721|NCT01405820|528030365|FG004|Open-Label Treatment Period|Adverse Event|0|||
146416722|NCT01405820|528030366|FG005|Open-Label Treatment Period|Adverse Event|0|||
146416723|NCT03222141|528030367|FG000|Overall Study|Death|15|||
146416724|NCT03222141|528030367|FG000|Overall Study|Lost to Follow-up|3|||
146416725|NCT00441584|528030368|FG000|Overall Study|Lack of Efficacy|79|||
146416726|NCT00441584|528030368|FG000|Overall Study|Withdrawal by Subject|8|||
146416727|NCT00441584|528030368|FG000|Overall Study|Adverse Event|6|||
146416728|NCT00441584|528030368|FG000|Overall Study|Protocol Violation|5|||
146416729|NCT00441584|528030368|FG000|Overall Study|Lost to Follow-up|4|||
146416730|NCT00441584|528030368|FG000|Overall Study|Failure to meet eligibility criteria|3|||
146416731|NCT00619619|528030371|FG000|Overall Study|Physician Decision|0|||
146416732|NCT00619619|528030372|FG001|Overall Study|Physician Decision|0|||
146416733|NCT00619619|528030373|FG002|Overall Study|Physician Decision|1|||
146416734|NCT00619619|528030374|FG003|Overall Study|Physician Decision|0|||
146416735|NCT00619619|528030375|FG004|Overall Study|Physician Decision|0|||
146416736|NCT00619619|528030376|FG005|Overall Study|Physician Decision|0|||
146416737|NCT00619619|528030377|FG006|Overall Study|Physician Decision|0|||
146416738|NCT00619619|528030378|FG007|Overall Study|Physician Decision|0|||
146416739|NCT00619619|528030371|FG000|Overall Study|Protocol Violation|0|||
146416740|NCT00619619|528030372|FG001|Overall Study|Protocol Violation|0|||
146416741|NCT00619619|528030373|FG002|Overall Study|Protocol Violation|0|||
146416742|NCT00619619|528030374|FG003|Overall Study|Protocol Violation|1|||
146416743|NCT00619619|528030375|FG004|Overall Study|Protocol Violation|0|||
146416744|NCT00619619|528030376|FG005|Overall Study|Protocol Violation|0|||
146416745|NCT00619619|528030377|FG006|Overall Study|Protocol Violation|1|||
146416746|NCT00619619|528030378|FG007|Overall Study|Protocol Violation|1|||
146416747|NCT00619619|528030371|FG000|Overall Study|Adverse Event|0|||
146416748|NCT00619619|528030372|FG001|Overall Study|Adverse Event|0|||
146416749|NCT00619619|528030373|FG002|Overall Study|Adverse Event|0|||
146416750|NCT00619619|528030374|FG003|Overall Study|Adverse Event|0|||
146416751|NCT00619619|528030375|FG004|Overall Study|Adverse Event|2|||
146193479|NCT02365298|527219903|FG000|Period 2|Discontinued at request of Sponsor|1|||
146193480|NCT02365298|527219904|FG001|Period 2|Discontinued at request of Sponsor|0|||
146193481|NCT02365298|527219903|FG000|Period 2|Test Article longer available|0|||
146193482|NCT02365298|527219904|FG001|Period 2|Test Article longer available|1|||
146193483|NCT02365298|527219903|FG000|Period 2|Protocol Violation|0|||
146193484|NCT02365298|527219904|FG001|Period 2|Protocol Violation|1|||
146416752|NCT00619619|528030376|FG005|Overall Study|Adverse Event|0|||
146416753|NCT00619619|528030377|FG006|Overall Study|Adverse Event|0|||
146416754|NCT00619619|528030378|FG007|Overall Study|Adverse Event|2|||
145948186|NCT02028169|526319601|FG000|Overall Study|Lost to Follow-up|21|||
146193485|NCT02974010|527219907|FG000|Overall Study|Lost to Follow-up|3|||
146193486|NCT02974010|527219908|FG001|Overall Study|Lost to Follow-up|1|||
146193487|NCT02974010|527219909|FG002|Overall Study|Lost to Follow-up|0|||
146416755|NCT00415532|528030380|FG000|Treatment Period|Adverse Event|2|||
146416756|NCT00415532|528030381|FG001|Treatment Period|Adverse Event|3|||
146416757|NCT00415532|528030380|FG000|Treatment Period|Death|2|||
146416758|NCT00415532|528030381|FG001|Treatment Period|Death|1|||
146416759|NCT00415532|528030380|FG000|Treatment Period|Lost to Follow-up|1|||
146416760|NCT00415532|528030381|FG001|Treatment Period|Lost to Follow-up|1|||
146416761|NCT00415532|528030380|FG000|Treatment Period|Protocol Violation|1|||
146416762|NCT00415532|528030381|FG001|Treatment Period|Protocol Violation|0|||
146416763|NCT00415532|528030380|FG000|Treatment Period|Withdrawal by Subject|6|||
146416764|NCT00415532|528030381|FG001|Treatment Period|Withdrawal by Subject|6|||
146416765|NCT00415532|528030380|FG000|Treatment Period|Other|2|||
146416766|NCT00415532|528030381|FG001|Treatment Period|Other|2|||
146416767|NCT00415532|528030380|FG000|Treatment Period|Ineligibility determined|1|||
146416768|NCT00415532|528030381|FG001|Treatment Period|Ineligibility determined|1|||
146416769|NCT00415532|528030380|FG000|Treatment Period|Noncompliance|1|||
146416770|NCT00415532|528030381|FG001|Treatment Period|Noncompliance|1|||
146416771|NCT00415532|528030380|FG000|Treatment Period|Requirement for alternative therapy|1|||
146416772|NCT00415532|528030381|FG001|Treatment Period|Requirement for alternative therapy|0|||
146416773|NCT00415532|528030380|FG000|Safety Follow Up Period|Adverse Event|1|||
146416774|NCT00415532|528030381|FG001|Safety Follow Up Period|Adverse Event|3|||
146416775|NCT00415532|528030380|FG000|Safety Follow Up Period|Death|3|||
146416776|NCT00415532|528030381|FG001|Safety Follow Up Period|Death|0|||
146416777|NCT00415532|528030380|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
146193488|NCT02974010|527219910|FG003|Overall Study|Lost to Follow-up|0|||
146193489|NCT02974010|527219907|FG000|Overall Study|Withdrawal by Subject|2|||
146193490|NCT02974010|527219908|FG001|Overall Study|Withdrawal by Subject|1|||
146193491|NCT02974010|527219909|FG002|Overall Study|Withdrawal by Subject|0|||
146193492|NCT02974010|527219910|FG003|Overall Study|Withdrawal by Subject|0|||
146416778|NCT00415532|528030381|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
146416779|NCT00415532|528030380|FG000|Safety Follow Up Period|Other|1|||
146416780|NCT00415532|528030381|FG001|Safety Follow Up Period|Other|4|||
146416781|NCT00415532|528030380|FG000|Safety Follow Up Period|Ineligibility determined|1|||
146416782|NCT00415532|528030381|FG001|Safety Follow Up Period|Ineligibility determined|1|||
146416783|NCT00415532|528030380|FG000|Safety Follow Up Period|Noncompliance|1|||
146416784|NCT00415532|528030381|FG001|Safety Follow Up Period|Noncompliance|0|||
146416785|NCT00415532|528030380|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
146416786|NCT00415532|528030381|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
146416787|NCT01798485|528030382|FG000|Overall Study|Adverse Event|32|||
146416788|NCT01798485|528030383|FG001|Overall Study|Adverse Event|40|||
146416789|NCT01798485|528030382|FG000|Overall Study|Withdrawal by Subject|27|||
146416790|NCT01798485|528030383|FG001|Overall Study|Withdrawal by Subject|31|||
146416791|NCT01798485|528030382|FG000|Overall Study|Lost to Follow-up|0|||
146416792|NCT01798485|528030383|FG001|Overall Study|Lost to Follow-up|3|||
146416793|NCT01798485|528030382|FG000|Overall Study|Physician Decision|14|||
146416794|NCT01798485|528030383|FG001|Overall Study|Physician Decision|10|||
146416795|NCT01798485|528030382|FG000|Overall Study|Objective Disease Progression|152|||
146416796|NCT01798485|528030383|FG001|Overall Study|Objective Disease Progression|106|||
146416797|NCT01798485|528030382|FG000|Overall Study|Death|25|||
146416798|NCT01798485|528030383|FG001|Overall Study|Death|22|||
146416799|NCT01798485|528030382|FG000|Overall Study|Sponsor Decision|61|||
146416800|NCT01798485|528030383|FG001|Overall Study|Sponsor Decision|54|||
146416801|NCT01798485|528030382|FG000|Overall Study|Clinical Progression|35|||
146416802|NCT01798485|528030383|FG001|Overall Study|Clinical Progression|24|||
146416803|NCT02087046|528030384|FG000|Overall Study|Adverse Event|4|||
146416804|NCT02087046|528030384|FG000|Overall Study|Death|1|||
146416805|NCT02087046|528030384|FG000|Overall Study|Lost to Follow-up|3|||
146416806|NCT02087046|528030384|FG000|Overall Study|Withdrawal by Subject|2|||
146416807|NCT02087046|528030384|FG000|Overall Study|Physician Decision|1|||
146416808|NCT01107535|528030385|FG000|Overall Study|Death|5|||
146416809|NCT01155583|528030386|FG000|Phase I|Screen failure - did not start treatment|0|||
146416810|NCT01155583|528030387|FG001|Phase I|Screen failure - did not start treatment|0|||
146416811|NCT01155583|528030388|FG002|Phase I|Screen failure - did not start treatment|0|||
146416812|NCT01155583|528030389|FG003|Phase I|Screen failure - did not start treatment|0|||
146416813|NCT01155583|528030390|FG004|Phase I|Screen failure - did not start treatment|1|||
146416814|NCT01155583|528030391|FG005|Phase I|Screen failure - did not start treatment|0|||
146416815|NCT01155583|528030392|FG006|Phase I|Screen failure - did not start treatment|0|||
146416816|NCT01155583|528030393|FG007|Phase I|Screen failure - did not start treatment|2|||
146416817|NCT01155583|528030394|FG008|Phase I|Screen failure - did not start treatment|0|||
146416818|NCT01155583|528030386|FG000|Phase I|Withdrawal by Subject|0|||
146416819|NCT01155583|528030387|FG001|Phase I|Withdrawal by Subject|0|||
146416820|NCT01155583|528030388|FG002|Phase I|Withdrawal by Subject|0|||
146416821|NCT01155583|528030389|FG003|Phase I|Withdrawal by Subject|0|||
146416822|NCT01155583|528030390|FG004|Phase I|Withdrawal by Subject|0|||
146416823|NCT01155583|528030391|FG005|Phase I|Withdrawal by Subject|0|||
146416824|NCT01155583|528030392|FG006|Phase I|Withdrawal by Subject|0|||
146416825|NCT01155583|528030393|FG007|Phase I|Withdrawal by Subject|1|||
146416826|NCT01155583|528030394|FG008|Phase I|Withdrawal by Subject|0|||
146416827|NCT00585351|528030395|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
146416828|NCT00585351|528030396|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
146416829|NCT00585351|528030397|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
146416830|NCT00585351|528030398|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
146416831|NCT00585351|528030399|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
146416832|NCT00585351|528030400|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
146416833|NCT00585351|528030401|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
146416834|NCT00585351|528030402|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
146416835|NCT00585351|528030395|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
146416836|NCT00585351|528030396|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
146416837|NCT00585351|528030397|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
146416838|NCT00585351|528030398|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
146416839|NCT00585351|528030399|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
146416840|NCT00585351|528030400|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
146416841|NCT00585351|528030401|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
146416842|NCT00585351|528030402|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
146416843|NCT00585351|528030395|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
146416844|NCT00585351|528030396|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
146416845|NCT00585351|528030397|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
146416846|NCT00585351|528030398|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
146416847|NCT00585351|528030399|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
146416848|NCT00585351|528030400|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
146416849|NCT00585351|528030401|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
146416850|NCT00585351|528030402|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
146416851|NCT00585351|528030395|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
146416852|NCT00585351|528030396|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
146416853|NCT00585351|528030397|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416854|NCT00585351|528030398|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416855|NCT00585351|528030399|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416856|NCT00585351|528030400|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416857|NCT00585351|528030401|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416858|NCT00585351|528030402|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
146416859|NCT00585351|528030395|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146082358|NCT04449029|526822779|FG006|Overall Study|Lost to Follow-up|0|||
146082359|NCT04449029|526822780|FG007|Overall Study|Lost to Follow-up|0|||
146416860|NCT00585351|528030396|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146416861|NCT00585351|528030397|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146416862|NCT00585351|528030398|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146416863|NCT00585351|528030399|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146416864|NCT00585351|528030400|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
146416865|NCT00585351|528030401|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
146416866|NCT00585351|528030402|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
146416867|NCT00585351|528030395|FG000|Enrollment Period (Intervention)|Death|0|||
146416868|NCT00585351|528030396|FG001|Enrollment Period (Intervention)|Death|0|||
146416869|NCT00585351|528030397|FG002|Enrollment Period (Intervention)|Death|0|||
146416870|NCT00585351|528030398|FG003|Enrollment Period (Intervention)|Death|0|||
146416871|NCT00585351|528030399|FG004|Enrollment Period (Intervention)|Death|1|||
146416872|NCT00585351|528030400|FG005|Enrollment Period (Intervention)|Death|0|||
146416873|NCT00585351|528030401|FG006|Enrollment Period (Intervention)|Death|1|||
146416874|NCT00585351|528030402|FG007|Enrollment Period (Intervention)|Death|0|||
146416875|NCT00585351|528030395|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416876|NCT00585351|528030396|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416877|NCT00585351|528030397|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416878|NCT00585351|528030398|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416879|NCT00585351|528030399|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
146416880|NCT00585351|528030400|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
146416881|NCT00585351|528030401|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416882|NCT00585351|528030402|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
146416883|NCT01001169|528030403|FG000|Overall Study|Withdrawal by Subject|2|||
146416884|NCT01001169|528030404|FG001|Overall Study|Withdrawal by Subject|1|||
146416885|NCT02536378|528030409|FG000|Overall Study|Physician Decision|0|||
146416886|NCT02536378|528030410|FG001|Overall Study|Physician Decision|2|||
146416887|NCT02536378|528030409|FG000|Overall Study|Withdrawal by Subject|0|||
146416888|NCT02536378|528030410|FG001|Overall Study|Withdrawal by Subject|1|||
146416889|NCT02536378|528030409|FG000|Overall Study|Death|1|||
146416890|NCT02536378|528030410|FG001|Overall Study|Death|2|||
146416891|NCT02536378|528030409|FG000|Overall Study|Patient refused further follow up|6|||
145948187|NCT02028169|526319601|FG000|Overall Study|Lack of Efficacy|2|||
146082360|NCT04449029|526822773|FG000|Overall Study|Protocol Violation|0|||
146082361|NCT04449029|526822774|FG001|Overall Study|Protocol Violation|1|||
146416892|NCT02536378|528030410|FG001|Overall Study|Patient refused further follow up|2|||
146416893|NCT00602030|528030411|FG000|Lead-in Phase|Disease Progression|2|||
146416894|NCT00602030|528030412|FG001|Lead-in Phase|Disease Progression|3|||
146416895|NCT00602030|528030413|FG002|Lead-in Phase|Disease Progression|0|||
146416896|NCT00602030|528030414|FG003|Lead-in Phase|Disease Progression|0|||
146416897|NCT00602030|528030415|FG004|Lead-in Phase|Disease Progression|0|||
146416898|NCT00602030|528030411|FG000|Lead-in Phase|Adverse Event|0|||
146416899|NCT00602030|528030412|FG001|Lead-in Phase|Adverse Event|2|||
146416900|NCT00602030|528030413|FG002|Lead-in Phase|Adverse Event|0|||
146416901|NCT00602030|528030414|FG003|Lead-in Phase|Adverse Event|0|||
146416902|NCT00602030|528030415|FG004|Lead-in Phase|Adverse Event|0|||
146416903|NCT00602030|528030411|FG000|Double-blind Phase|Disease progression|0|||
146416904|NCT00602030|528030412|FG001|Double-blind Phase|Disease progression|0|||
146416905|NCT00602030|528030413|FG002|Double-blind Phase|Disease progression|33|||
146416906|NCT00602030|528030414|FG003|Double-blind Phase|Disease progression|30|||
146416907|NCT00602030|528030415|FG004|Double-blind Phase|Disease progression|0|||
146416908|NCT00602030|528030411|FG000|Double-blind Phase|Adverse Event|0|||
146416909|NCT00602030|528030412|FG001|Double-blind Phase|Adverse Event|0|||
146416910|NCT00602030|528030413|FG002|Double-blind Phase|Adverse Event|9|||
146416911|NCT00602030|528030414|FG003|Double-blind Phase|Adverse Event|18|||
146416912|NCT00602030|528030415|FG004|Double-blind Phase|Adverse Event|0|||
146416913|NCT00602030|528030411|FG000|Double-blind Phase|Consent withdrawal|0|||
146416914|NCT00602030|528030412|FG001|Double-blind Phase|Consent withdrawal|0|||
146416915|NCT00602030|528030413|FG002|Double-blind Phase|Consent withdrawal|4|||
146416916|NCT00602030|528030414|FG003|Double-blind Phase|Consent withdrawal|3|||
146416917|NCT00602030|528030415|FG004|Double-blind Phase|Consent withdrawal|0|||
146416918|NCT00602030|528030411|FG000|Double-blind Phase|Death|0|||
146416919|NCT00602030|528030412|FG001|Double-blind Phase|Death|0|||
146416920|NCT00602030|528030413|FG002|Double-blind Phase|Death|3|||
146416921|NCT00602030|528030414|FG003|Double-blind Phase|Death|3|||
146416922|NCT00602030|528030415|FG004|Double-blind Phase|Death|0|||
146416923|NCT00602030|528030411|FG000|Double-blind Phase|Administrative decision|0|||
146416924|NCT00602030|528030412|FG001|Double-blind Phase|Administrative decision|0|||
146416925|NCT00602030|528030413|FG002|Double-blind Phase|Administrative decision|0|||
146416926|NCT00602030|528030414|FG003|Double-blind Phase|Administrative decision|2|||
146416927|NCT00602030|528030415|FG004|Double-blind Phase|Administrative decision|0|||
146416928|NCT00602030|528030411|FG000|Double-blind Phase|Ineligibility|0|||
146416929|NCT00602030|528030412|FG001|Double-blind Phase|Ineligibility|0|||
146416930|NCT00602030|528030413|FG002|Double-blind Phase|Ineligibility|0|||
146416931|NCT00602030|528030414|FG003|Double-blind Phase|Ineligibility|1|||
146416932|NCT00602030|528030415|FG004|Double-blind Phase|Ineligibility|0|||
146416933|NCT00602030|528030411|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
146416934|NCT00602030|528030412|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
146416935|NCT00602030|528030413|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
146416936|NCT00602030|528030414|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
146416937|NCT00602030|528030415|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
146416938|NCT00602030|528030411|FG000|Double-blind Phase|Reason not specified|0|||
146416939|NCT00602030|528030412|FG001|Double-blind Phase|Reason not specified|0|||
146416940|NCT00602030|528030413|FG002|Double-blind Phase|Reason not specified|4|||
146416941|NCT00602030|528030414|FG003|Double-blind Phase|Reason not specified|2|||
146416942|NCT00602030|528030415|FG004|Double-blind Phase|Reason not specified|0|||
146082362|NCT04449029|526822775|FG002|Overall Study|Protocol Violation|0|||
146082363|NCT04449029|526822776|FG003|Overall Study|Protocol Violation|0|||
146416943|NCT00602030|528030411|FG000|Crossover Phase|Disease Progression|0|||
146416944|NCT00602030|528030412|FG001|Crossover Phase|Disease Progression|0|||
146416945|NCT00602030|528030413|FG002|Crossover Phase|Disease Progression|0|||
146416946|NCT00602030|528030414|FG003|Crossover Phase|Disease Progression|0|||
146416947|NCT00602030|528030415|FG004|Crossover Phase|Disease Progression|11|||
146416948|NCT00602030|528030411|FG000|Crossover Phase|Adverse Event|0|||
146416949|NCT00602030|528030412|FG001|Crossover Phase|Adverse Event|0|||
146416950|NCT00602030|528030413|FG002|Crossover Phase|Adverse Event|0|||
146416951|NCT00602030|528030414|FG003|Crossover Phase|Adverse Event|0|||
146416952|NCT00602030|528030415|FG004|Crossover Phase|Adverse Event|3|||
146416953|NCT00602030|528030411|FG000|Crossover Phase|Consent withdrawal|0|||
146416954|NCT00602030|528030412|FG001|Crossover Phase|Consent withdrawal|0|||
146416955|NCT00602030|528030413|FG002|Crossover Phase|Consent withdrawal|0|||
146416956|NCT00602030|528030414|FG003|Crossover Phase|Consent withdrawal|0|||
146416957|NCT00602030|528030415|FG004|Crossover Phase|Consent withdrawal|2|||
146082364|NCT04449029|526822777|FG004|Overall Study|Protocol Violation|0|||
146416958|NCT00798889|528030416|FG000|Overall Study|Adverse Event|53|||
146416959|NCT00798889|528030416|FG000|Overall Study|Protocol Violation|2|||
146416960|NCT00798889|528030416|FG000|Overall Study|Withdrawal by Subject|31|||
146416961|NCT00798889|528030416|FG000|Overall Study|Lost to Follow-up|1|||
146416962|NCT00798889|528030416|FG000|Overall Study|Lack of Efficacy|213|||
146416963|NCT00798889|528030416|FG000|Overall Study|Decision of Sponsor|11|||
146416964|NCT00798889|528030416|FG000|Overall Study|Enrolled, Not treated|3|||
146416965|NCT05085964|528030417|FG000|Overall Study|Premature termination of study|21|||
146416966|NCT05085964|528030418|FG001|Overall Study|Premature termination of study|0|||
146416967|NCT03156270|528030423|FG000|Overall Study|Failed pre-treatment screening|1|||
146416968|NCT03156270|528030423|FG000|Overall Study|Lost to Follow-up|1|||
146416969|NCT00446654|528030424|FG000|Overall Study|Withdrawal by Subject|1|||
146416970|NCT00446654|528030425|FG001|Overall Study|Withdrawal by Subject|0|||
146416971|NCT00446654|528030424|FG000|Overall Study|Adverse Event|1|||
146416972|NCT00446654|528030425|FG001|Overall Study|Adverse Event|0|||
146416973|NCT02087059|528030427|FG000|Overall Study|Disease Progression|1|||
146416974|NCT02087059|528030427|FG000|Overall Study|Adverse Event|5|||
146416975|NCT02087059|528030427|FG000|Overall Study|Lost to Follow-up|1|||
146416976|NCT00947856|528030428|FG000|Treatment Period|Progressive Disease|33|||
146416977|NCT00947856|528030429|FG001|Treatment Period|Progressive Disease|12|||
146416978|NCT00947856|528030428|FG000|Treatment Period|Adverse Event|15|||
146416979|NCT00947856|528030429|FG001|Treatment Period|Adverse Event|9|||
146416980|NCT00947856|528030428|FG000|Treatment Period|Physician Decision|14|||
146416981|NCT00947856|528030429|FG001|Treatment Period|Physician Decision|6|||
146416982|NCT00947856|528030428|FG000|Treatment Period|Study Stopped by Sponsor|4|||
146416983|NCT00947856|528030429|FG001|Treatment Period|Study Stopped by Sponsor|4|||
146416984|NCT00947856|528030428|FG000|Treatment Period|Withdrawal by Subject|12|||
146416985|NCT00947856|528030429|FG001|Treatment Period|Withdrawal by Subject|1|||
146416986|NCT00947856|528030428|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
146416987|NCT00947856|528030429|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
146416988|NCT00947856|528030428|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
146416989|NCT00947856|528030429|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
146416990|NCT00947856|528030428|FG000|Follow-up Period|Lost to Follow-up|7|||
146416991|NCT00947856|528030429|FG001|Follow-up Period|Lost to Follow-up|0|||
146416992|NCT00947856|528030428|FG000|Follow-up Period|Patient unavailable for site visits|1|||
146416993|NCT00947856|528030429|FG001|Follow-up Period|Patient unavailable for site visits|0|||
146416994|NCT00947856|528030428|FG000|Follow-up Period|Withdrawal by Subject|1|||
146416995|NCT00947856|528030429|FG001|Follow-up Period|Withdrawal by Subject|0|||
146416996|NCT01261325|528030430|FG000|Overall Study|Lack of Efficacy|1|||
146416997|NCT01261325|528030431|FG001|Overall Study|Lack of Efficacy|1|||
146416998|NCT01261325|528030432|FG002|Overall Study|Lack of Efficacy|0|||
146416999|NCT01261325|528030430|FG000|Overall Study|Withdrawal by Subject|2|||
146417000|NCT01261325|528030431|FG001|Overall Study|Withdrawal by Subject|2|||
146417001|NCT01261325|528030432|FG002|Overall Study|Withdrawal by Subject|4|||
146417002|NCT01261325|528030430|FG000|Overall Study|SAE, non-fatal|1|||
146417003|NCT01261325|528030431|FG001|Overall Study|SAE, non-fatal|5|||
146417004|NCT01261325|528030432|FG002|Overall Study|SAE, non-fatal|1|||
146417005|NCT01261325|528030430|FG000|Overall Study|AE, non-serious non-fatal|9|||
146417006|NCT01261325|528030431|FG001|Overall Study|AE, non-serious non-fatal|15|||
146417007|NCT01261325|528030432|FG002|Overall Study|AE, non-serious non-fatal|13|||
146417008|NCT01261325|528030430|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146417009|NCT01261325|528030431|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146417010|NCT01261325|528030432|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146417011|NCT01261325|528030430|FG000|Overall Study|Non Compliance|2|||
146417012|NCT01261325|528030431|FG001|Overall Study|Non Compliance|0|||
146417013|NCT01261325|528030432|FG002|Overall Study|Non Compliance|0|||
146417014|NCT01261325|528030430|FG000|Overall Study|Patient Randomized by Mistake|0|||
146417015|NCT01261325|528030431|FG001|Overall Study|Patient Randomized by Mistake|1|||
146417016|NCT01261325|528030432|FG002|Overall Study|Patient Randomized by Mistake|0|||
146417017|NCT01261325|528030430|FG000|Overall Study|Erroneously Randomized|1|||
146417018|NCT01261325|528030431|FG001|Overall Study|Erroneously Randomized|0|||
146417019|NCT01261325|528030432|FG002|Overall Study|Erroneously Randomized|0|||
146417020|NCT01261325|528030430|FG000|Overall Study|Screen Failure|1|||
146417021|NCT01261325|528030431|FG001|Overall Study|Screen Failure|0|||
146417022|NCT01261325|528030432|FG002|Overall Study|Screen Failure|0|||
146417023|NCT01261325|528030430|FG000|Overall Study|Randomized in Error|0|||
146417024|NCT01261325|528030431|FG001|Overall Study|Randomized in Error|0|||
146082365|NCT04449029|526822778|FG005|Overall Study|Protocol Violation|0|||
146417025|NCT01261325|528030432|FG002|Overall Study|Randomized in Error|1|||
146417026|NCT01261325|528030430|FG000|Overall Study|Protocol Violation|0|||
146417027|NCT01261325|528030431|FG001|Overall Study|Protocol Violation|3|||
146417028|NCT01261325|528030432|FG002|Overall Study|Protocol Violation|1|||
146417029|NCT01261325|528030430|FG000|Overall Study|Lost to Follow-up|0|||
146417030|NCT01261325|528030431|FG001|Overall Study|Lost to Follow-up|1|||
146417031|NCT01261325|528030432|FG002|Overall Study|Lost to Follow-up|3|||
146417032|NCT01261325|528030430|FG000|Overall Study|AE, serious fatal|0|||
146417033|NCT01261325|528030431|FG001|Overall Study|AE, serious fatal|0|||
146417034|NCT01261325|528030432|FG002|Overall Study|AE, serious fatal|2|||
146417035|NCT02330081|528030443|FG000|Overall Study|Adverse Event|1|||
146417036|NCT02330081|528030443|FG000|Overall Study|Donation did not meet criteria|1|||
146417037|NCT02330081|528030443|FG000|Overall Study|Protocol Violation|6|||
146417038|NCT02668302|528030449|FG000|Overall Study|Withdrawal by Subject|1|||
146417039|NCT02668302|528030450|FG001|Overall Study|Withdrawal by Subject|0|||
146417040|NCT03558997|528030451|FG000|Overall Study|Adverse Event|0|||
146417041|NCT03558997|528030452|FG001|Overall Study|Adverse Event|2|||
146417042|NCT03558997|528030453|FG002|Overall Study|Adverse Event|5|||
146417043|NCT03558997|528030454|FG003|Overall Study|Adverse Event|1|||
146417044|NCT03558997|528030451|FG000|Overall Study|Physician Decision|0|||
146417045|NCT03558997|528030452|FG001|Overall Study|Physician Decision|0|||
146417046|NCT03558997|528030453|FG002|Overall Study|Physician Decision|1|||
146417047|NCT03558997|528030454|FG003|Overall Study|Physician Decision|0|||
146417048|NCT03558997|528030451|FG000|Overall Study|Withdrawal by Subject|1|||
146417049|NCT03558997|528030452|FG001|Overall Study|Withdrawal by Subject|0|||
146417050|NCT03558997|528030453|FG002|Overall Study|Withdrawal by Subject|1|||
146417051|NCT03558997|528030454|FG003|Overall Study|Withdrawal by Subject|1|||
146417052|NCT03558997|528030451|FG000|Overall Study|Lost to Follow-up|0|||
146417053|NCT03558997|528030452|FG001|Overall Study|Lost to Follow-up|0|||
146417054|NCT03558997|528030453|FG002|Overall Study|Lost to Follow-up|1|||
146417055|NCT03558997|528030454|FG003|Overall Study|Lost to Follow-up|0|||
146417056|NCT01688037|528030457|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
146417057|NCT01688037|528030458|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
146417058|NCT01688037|528030459|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
146417059|NCT01688037|528030457|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
146417060|NCT01688037|528030458|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
146417061|NCT01688037|528030459|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
146417062|NCT01688037|528030457|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
146417063|NCT01688037|528030458|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
146417064|NCT01688037|528030459|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
146417065|NCT01688037|528030457|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146417066|NCT01688037|528030458|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
146417067|NCT01688037|528030459|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146417068|NCT01688037|528030457|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
146417069|NCT01688037|528030458|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
146417070|NCT01688037|528030459|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
146417071|NCT01688037|528030457|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
146417072|NCT01688037|528030458|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
146417073|NCT01688037|528030459|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
146417074|NCT01688037|528030457|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
146417075|NCT01688037|528030458|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
146417076|NCT01688037|528030459|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
146417077|NCT01688037|528030457|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
146417078|NCT01688037|528030458|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
146417079|NCT01688037|528030459|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
146417080|NCT01688037|528030457|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
146417081|NCT01688037|528030458|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
146417082|NCT01688037|528030459|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
146417083|NCT01688037|528030457|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
146417084|NCT01688037|528030458|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
146417085|NCT01688037|528030459|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
146417086|NCT02100956|528030460|FG000|At Least One Week Between Injections|Adverse Event|0|||
146417087|NCT02100956|528030461|FG001|At Least One Week Between Injections|Adverse Event|1|||
146417088|NCT01859702|528030462|FG000|Overall Study|Protocol deviation|3|||
146417089|NCT01859702|528030462|FG000|Overall Study|Adverse Event|2|||
146417090|NCT02034799|528031871|FG000|Overall Study|Withdrawal by Subject|0|||
146417091|NCT02034799|528031872|FG001|Overall Study|Withdrawal by Subject|2|||
146417092|NCT02034799|528031871|FG000|Overall Study|Lost to Follow-up|0|||
146417093|NCT02034799|528031872|FG001|Overall Study|Lost to Follow-up|1|||
146417094|NCT02034799|528031871|FG000|Overall Study|Death|2|||
146417095|NCT02034799|528031872|FG001|Overall Study|Death|1|||
146417096|NCT03273387|528031881|FG000|Overall Study|Death|2|||
146417097|NCT03273387|528031882|FG001|Overall Study|Death|2|||
146417098|NCT03273387|528031881|FG000|Overall Study|Withdrawal by Subject|1|||
146417099|NCT03273387|528031882|FG001|Overall Study|Withdrawal by Subject|1|||
146417100|NCT03433001|528031883|FG000|Overall Study|Lack of Efficacy|109|||
146082366|NCT04449029|526822779|FG006|Overall Study|Protocol Violation|0|||
146082367|NCT04449029|526822780|FG007|Overall Study|Protocol Violation|0|||
146082368|NCT04449029|526822773|FG000|Overall Study|Physician Decision|0|||
146417101|NCT03433001|528031883|FG000|Overall Study|Adverse Event|69|||
146417102|NCT03433001|528031883|FG000|Overall Study|Withdrawal by Subject|10|||
146417103|NCT03433001|528031883|FG000|Overall Study|Death|12|||
146417104|NCT03433001|528031883|FG000|Overall Study|Lost to Follow-up|4|||
146417105|NCT03433001|528031883|FG000|Overall Study|Other|25|||
146417106|NCT02058628|528031884|FG000|Overall Study|Adverse Event|1|||
146417107|NCT02058628|528031885|FG001|Overall Study|Adverse Event|0|||
146417108|NCT02058628|528031884|FG000|Overall Study|Withdrawal by Subject|2|||
146417109|NCT02058628|528031885|FG001|Overall Study|Withdrawal by Subject|2|||
146417110|NCT02058628|528031884|FG000|Overall Study|Lost to Follow-up|2|||
146082369|NCT04449029|526822774|FG001|Overall Study|Physician Decision|0|||
146082370|NCT04449029|526822775|FG002|Overall Study|Physician Decision|0|||
146417111|NCT02058628|528031885|FG001|Overall Study|Lost to Follow-up|4|||
146417112|NCT02058628|528031884|FG000|Overall Study|Not in time schedule|0|||
146417113|NCT02058628|528031885|FG001|Overall Study|Not in time schedule|1|||
146417114|NCT02058628|528031884|FG000|Overall Study|The visit date was not in timeline|0|||
146417115|NCT02058628|528031885|FG001|Overall Study|The visit date was not in timeline|1|||
146417116|NCT02058628|528031884|FG000|Overall Study|A lot of time for study for participant|1|||
146417117|NCT02058628|528031885|FG001|Overall Study|A lot of time for study for participant|0|||
146417118|NCT02058628|528031884|FG000|Overall Study|Non compliance|1|||
146417119|NCT02058628|528031885|FG001|Overall Study|Non compliance|0|||
146417120|NCT01452529|528031886|FG000|Run-in Period|Adverse Event|96|||
146417121|NCT01452529|528031887|FG001|Run-in Period|Adverse Event|0|||
146417122|NCT01452529|528031888|FG002|Run-in Period|Adverse Event|0|||
146417123|NCT01452529|528031886|FG000|Run-in Period|Withdrawal by Subject|49|||
146417124|NCT01452529|528031887|FG001|Run-in Period|Withdrawal by Subject|0|||
146417125|NCT01452529|528031888|FG002|Run-in Period|Withdrawal by Subject|0|||
146417126|NCT01452529|528031886|FG000|Run-in Period|Lost to Follow-up|19|||
146417127|NCT01452529|528031887|FG001|Run-in Period|Lost to Follow-up|0|||
146417128|NCT01452529|528031888|FG002|Run-in Period|Lost to Follow-up|0|||
146417129|NCT01452529|528031886|FG000|Run-in Period|Lack of Efficacy|46|||
146417130|NCT01452529|528031887|FG001|Run-in Period|Lack of Efficacy|0|||
146417131|NCT01452529|528031888|FG002|Run-in Period|Lack of Efficacy|0|||
146417132|NCT01452529|528031886|FG000|Run-in Period|Confirmed or suspected diversion|23|||
146417133|NCT01452529|528031887|FG001|Run-in Period|Confirmed or suspected diversion|0|||
146417134|NCT01452529|528031888|FG002|Run-in Period|Confirmed or suspected diversion|0|||
146417135|NCT01452529|528031886|FG000|Run-in Period|Administrative|21|||
146417136|NCT01452529|528031887|FG001|Run-in Period|Administrative|0|||
146417137|NCT01452529|528031888|FG002|Run-in Period|Administrative|0|||
146417138|NCT01452529|528031886|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
146417139|NCT01452529|528031887|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
146417140|NCT01452529|528031888|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
146417141|NCT01452529|528031886|FG000|Double-blind (DB) Period|Adverse Event|0|||
146417142|NCT01452529|528031887|FG001|Double-blind (DB) Period|Adverse Event|18|||
146417143|NCT01452529|528031888|FG002|Double-blind (DB) Period|Adverse Event|11|||
146417144|NCT01452529|528031886|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
146417145|NCT01452529|528031887|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
146417146|NCT01452529|528031888|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
146417147|NCT01452529|528031886|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
146417148|NCT01452529|528031887|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
146417149|NCT01452529|528031888|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
146417150|NCT01452529|528031886|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
146417151|NCT01452529|528031887|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
146417152|NCT01452529|528031888|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
146417153|NCT01452529|528031886|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
146417154|NCT01452529|528031887|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
146417155|NCT01452529|528031888|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
146417156|NCT01452529|528031886|FG000|Double-blind (DB) Period|Administrative|0|||
146417157|NCT01452529|528031887|FG001|Double-blind (DB) Period|Administrative|11|||
146417158|NCT01452529|528031888|FG002|Double-blind (DB) Period|Administrative|7|||
146417159|NCT03551730|528031889|FG000|Overall Study|Adverse Event|1|||
146417160|NCT03551730|528031890|FG001|Overall Study|Adverse Event|0|||
146417161|NCT03551730|528031891|FG002|Overall Study|Adverse Event|0|||
146417162|NCT03551730|528031892|FG003|Overall Study|Adverse Event|0|||
146417163|NCT04527471|528031898|FG000|Overall Study|Adverse Event|1|||
146417164|NCT04527471|528031899|FG001|Overall Study|Adverse Event|0|||
146417165|NCT04527471|528031898|FG000|Overall Study|Lost to Follow-up|1|||
146417166|NCT04527471|528031899|FG001|Overall Study|Lost to Follow-up|0|||
146417167|NCT02891200|528031900|FG000|Overall Study|Lost to Follow-up|31|||
146417168|NCT02891200|528031901|FG001|Overall Study|Lost to Follow-up|36|||
146417169|NCT02891200|528031900|FG000|Overall Study|Death|10|||
146417170|NCT02891200|528031901|FG001|Overall Study|Death|9|||
146417171|NCT02891200|528031900|FG000|Overall Study|Withdrawal by Subject|1|||
146417172|NCT02891200|528031901|FG001|Overall Study|Withdrawal by Subject|4|||
146417173|NCT00988169|528031904|FG000|Overall Study|Withdrawal by Subject|1|||
146417174|NCT02637076|528031906|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
146417175|NCT02637076|528031907|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
146417176|NCT02637076|528031906|FG000|Overall Study|Withdrawal by Subject|0|||
146417177|NCT02637076|528031907|FG001|Overall Study|Withdrawal by Subject|4|||
146417178|NCT02295774|528031909|FG000|Overall Study|Physician Decision|1|||
146417179|NCT02295774|528031909|FG000|Overall Study|Withdrawal by Subject|2|||
146417180|NCT03083483|528031910|FG000|Overall Study|Adverse Event|1|||
146417181|NCT03083483|528031911|FG001|Overall Study|Adverse Event|1|||
146417182|NCT03083483|528031912|FG002|Overall Study|Adverse Event|1|||
146417183|NCT03083483|528031910|FG000|Overall Study|Lost to Follow-up|2|||
146417184|NCT03083483|528031911|FG001|Overall Study|Lost to Follow-up|1|||
146082371|NCT04449029|526822776|FG003|Overall Study|Physician Decision|0|||
146417185|NCT03083483|528031912|FG002|Overall Study|Lost to Follow-up|1|||
146417186|NCT03083483|528031910|FG000|Overall Study|technological issues|1|||
146417187|NCT03083483|528031911|FG001|Overall Study|technological issues|0|||
146417188|NCT03083483|528031912|FG002|Overall Study|technological issues|1|||
146417189|NCT01751412|528031913|FG000|Overall Study|Disease Progression Before Treatment|1|||
146417190|NCT00582036|528031914|FG000|Overall Study|Withdrawal by Subject|0|||
146417191|NCT00582036|528031915|FG001|Overall Study|Withdrawal by Subject|1|||
146417192|NCT03294538|528031918|FG000|Overall Study|Adverse Event|0|||
146417193|NCT03294538|528031919|FG001|Overall Study|Adverse Event|1|||
146417194|NCT03294538|528031920|FG002|Overall Study|Adverse Event|1|||
146417195|NCT03294538|528031918|FG000|Overall Study|Lost to Follow-up|1|||
146417196|NCT03294538|528031919|FG001|Overall Study|Lost to Follow-up|0|||
146417197|NCT03294538|528031920|FG002|Overall Study|Lost to Follow-up|0|||
146417198|NCT03294538|528031918|FG000|Overall Study|Outside of Visit Window|4|||
146417199|NCT03294538|528031919|FG001|Overall Study|Outside of Visit Window|4|||
146417200|NCT03294538|528031920|FG002|Overall Study|Outside of Visit Window|1|||
146417201|NCT02623959|528031923|FG000|Overall Study|Progression|0|||
146417202|NCT02623959|528031924|FG001|Overall Study|Progression|1|||
146417203|NCT03687125|528031926|FG000|Overall Study|Progressive Disease|2|||
146417204|NCT03687125|528031927|FG001|Overall Study|Progressive Disease|1|||
146417205|NCT03687125|528031926|FG000|Overall Study|Protocol Violation|1|||
146417206|NCT03687125|528031927|FG001|Overall Study|Protocol Violation|0|||
146417207|NCT01992107|528031928|FG000|Overall Study|Administrative reasons|2|||
146417208|NCT01992107|528031929|FG001|Overall Study|Administrative reasons|0|||
146417209|NCT01992107|528031930|FG002|Overall Study|Administrative reasons|0|||
146417210|NCT01992107|528031928|FG000|Overall Study|Adverse Event|0|||
146417211|NCT01992107|528031929|FG001|Overall Study|Adverse Event|1|||
146417212|NCT01992107|528031930|FG002|Overall Study|Adverse Event|0|||
146417213|NCT01992107|528031928|FG000|Overall Study|Lost to Follow-up|46|||
146417214|NCT01992107|528031929|FG001|Overall Study|Lost to Follow-up|22|||
146417215|NCT01992107|528031930|FG002|Overall Study|Lost to Follow-up|26|||
146417216|NCT01992107|528031928|FG000|Overall Study|noncompliance and were unavailable|7|||
146417217|NCT01992107|528031929|FG001|Overall Study|noncompliance and were unavailable|3|||
146417218|NCT01992107|528031930|FG002|Overall Study|noncompliance and were unavailable|2|||
146417219|NCT01992107|528031928|FG000|Overall Study|Withdrawal by Subject|13|||
146417220|NCT01992107|528031929|FG001|Overall Study|Withdrawal by Subject|7|||
146417221|NCT01992107|528031930|FG002|Overall Study|Withdrawal by Subject|8|||
146417222|NCT02022007|528031931|FG000|Overall Study|Withdrawal by Subject|1|||
146417223|NCT02022007|528031932|FG001|Overall Study|Withdrawal by Subject|1|||
146417224|NCT02022007|528031933|FG002|Overall Study|Withdrawal by Subject|1|||
146417225|NCT02022007|528031931|FG000|Overall Study|Noncompliant|0|||
146417226|NCT02022007|528031932|FG001|Overall Study|Noncompliant|0|||
146417227|NCT02022007|528031933|FG002|Overall Study|Noncompliant|1|||
146417228|NCT01214603|528031934|FG000|Overall Study|Adverse Event|0|||
146417229|NCT01214603|528031935|FG001|Overall Study|Adverse Event|0|||
146417230|NCT01214603|528031936|FG002|Overall Study|Adverse Event|1|||
146417231|NCT01214603|528031934|FG000|Overall Study|Death|1|||
146417232|NCT01214603|528031935|FG001|Overall Study|Death|0|||
146417233|NCT01214603|528031936|FG002|Overall Study|Death|0|||
146417234|NCT01214603|528031934|FG000|Overall Study|Progressive Disease|4|||
146417235|NCT01214603|528031935|FG001|Overall Study|Progressive Disease|1|||
146417236|NCT01214603|528031936|FG002|Overall Study|Progressive Disease|3|||
146417237|NCT01507896|528031937|FG000|Overall Study|Withdrawal by Subject|1|||
146417238|NCT01507896|528031937|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
146417239|NCT00617461|528031948|FG000|First Treatment Intervention Period|Adverse Event|2|||
146417240|NCT00617461|528031949|FG001|First Treatment Intervention Period|Adverse Event|0|||
146417241|NCT00617461|528031948|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
146417242|NCT00617461|528031949|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
146417243|NCT00617461|528031948|FG000|First Treatment Intervention Period|Protocol Violation|2|||
146193493|NCT02974010|527219907|FG000|Overall Study|Adverse Event|0|||
146417244|NCT00617461|528031949|FG001|First Treatment Intervention Period|Protocol Violation|1|||
146417245|NCT00617461|528031948|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
146417246|NCT00617461|528031949|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
146417247|NCT00617461|528031948|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
146417248|NCT00617461|528031949|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
146417249|NCT00617461|528031948|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
146417250|NCT00617461|528031949|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
146417251|NCT00617461|528031948|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
146417252|NCT00617461|528031949|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
146417253|NCT00617461|528031948|FG000|Second Treatment Intervention Period|Adverse Event|0|||
146417254|NCT00617461|528031949|FG001|Second Treatment Intervention Period|Adverse Event|1|||
146417255|NCT00617461|528031948|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
146417256|NCT00617461|528031949|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
146417257|NCT00617461|528031948|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
146417258|NCT00617461|528031949|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
146417259|NCT00617461|528031948|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
146417260|NCT00617461|528031949|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
146417261|NCT00358826|528031950|FG000|Core Study|Adverse Event|1|||
146417262|NCT00358826|528031951|FG001|Core Study|Adverse Event|3|||
146417263|NCT00358826|528031952|FG002|Core Study|Adverse Event|1|||
146417264|NCT00358826|528031953|FG003|Core Study|Adverse Event|1|||
146417265|NCT00358826|528031954|FG004|Core Study|Adverse Event|0|||
146417266|NCT00358826|528031955|FG005|Core Study|Adverse Event|0|||
146417267|NCT00358826|528031956|FG006|Core Study|Adverse Event|0|||
146417268|NCT00358826|528031957|FG007|Core Study|Adverse Event|0|||
146417269|NCT00358826|528031950|FG000|Core Study|Withdrawal by Subject|2|||
146417270|NCT00358826|528031951|FG001|Core Study|Withdrawal by Subject|2|||
146417271|NCT00358826|528031952|FG002|Core Study|Withdrawal by Subject|0|||
146417272|NCT00358826|528031953|FG003|Core Study|Withdrawal by Subject|0|||
146417273|NCT00358826|528031954|FG004|Core Study|Withdrawal by Subject|0|||
146417274|NCT00358826|528031955|FG005|Core Study|Withdrawal by Subject|0|||
146417275|NCT00358826|528031956|FG006|Core Study|Withdrawal by Subject|0|||
146417276|NCT00358826|528031957|FG007|Core Study|Withdrawal by Subject|0|||
146417277|NCT00358826|528031950|FG000|Core Study|Lost to Follow-up|0|||
146417278|NCT00358826|528031951|FG001|Core Study|Lost to Follow-up|0|||
146417279|NCT00358826|528031952|FG002|Core Study|Lost to Follow-up|0|||
146417280|NCT00358826|528031953|FG003|Core Study|Lost to Follow-up|1|||
146417281|NCT00358826|528031954|FG004|Core Study|Lost to Follow-up|0|||
146417282|NCT00358826|528031955|FG005|Core Study|Lost to Follow-up|0|||
146417283|NCT00358826|528031956|FG006|Core Study|Lost to Follow-up|0|||
146417284|NCT00358826|528031957|FG007|Core Study|Lost to Follow-up|0|||
146417285|NCT00358826|528031950|FG000|Core Study|Physician Decision|0|||
146417286|NCT00358826|528031951|FG001|Core Study|Physician Decision|0|||
146417287|NCT00358826|528031952|FG002|Core Study|Physician Decision|1|||
146417288|NCT00358826|528031953|FG003|Core Study|Physician Decision|0|||
146417289|NCT00358826|528031954|FG004|Core Study|Physician Decision|0|||
146417290|NCT00358826|528031955|FG005|Core Study|Physician Decision|0|||
146417291|NCT00358826|528031956|FG006|Core Study|Physician Decision|0|||
146417292|NCT00358826|528031957|FG007|Core Study|Physician Decision|0|||
146417293|NCT00358826|528031950|FG000|MDCT Substudy|Adverse Event|0|||
146417294|NCT00358826|528031951|FG001|MDCT Substudy|Adverse Event|0|||
146417295|NCT00358826|528031952|FG002|MDCT Substudy|Adverse Event|0|||
146417296|NCT00358826|528031953|FG003|MDCT Substudy|Adverse Event|0|||
146417297|NCT00358826|528031954|FG004|MDCT Substudy|Adverse Event|1|||
146417298|NCT00358826|528031955|FG005|MDCT Substudy|Adverse Event|0|||
146417299|NCT00358826|528031956|FG006|MDCT Substudy|Adverse Event|0|||
146417300|NCT00358826|528031957|FG007|MDCT Substudy|Adverse Event|0|||
146417301|NCT00358826|528031950|FG000|MDCT Substudy|Lost to Follow-up|0|||
146417302|NCT00358826|528031951|FG001|MDCT Substudy|Lost to Follow-up|0|||
146417303|NCT00358826|528031952|FG002|MDCT Substudy|Lost to Follow-up|0|||
146417304|NCT00358826|528031953|FG003|MDCT Substudy|Lost to Follow-up|0|||
146417305|NCT00358826|528031954|FG004|MDCT Substudy|Lost to Follow-up|0|||
146417306|NCT00358826|528031955|FG005|MDCT Substudy|Lost to Follow-up|1|||
146417307|NCT00358826|528031956|FG006|MDCT Substudy|Lost to Follow-up|0|||
146417308|NCT00358826|528031957|FG007|MDCT Substudy|Lost to Follow-up|0|||
146417309|NCT00358826|528031950|FG000|MDCT Substudy|Withdrawal by Subject|0|||
146417310|NCT00358826|528031951|FG001|MDCT Substudy|Withdrawal by Subject|0|||
146417311|NCT00358826|528031952|FG002|MDCT Substudy|Withdrawal by Subject|0|||
146417312|NCT00358826|528031953|FG003|MDCT Substudy|Withdrawal by Subject|0|||
146417313|NCT00358826|528031954|FG004|MDCT Substudy|Withdrawal by Subject|0|||
146417314|NCT00358826|528031955|FG005|MDCT Substudy|Withdrawal by Subject|1|||
146417315|NCT00358826|528031956|FG006|MDCT Substudy|Withdrawal by Subject|0|||
146417316|NCT00358826|528031957|FG007|MDCT Substudy|Withdrawal by Subject|0|||
146193494|NCT02974010|527219908|FG001|Overall Study|Adverse Event|1|||
146193495|NCT02974010|527219909|FG002|Overall Study|Adverse Event|0|||
146193496|NCT02974010|527219910|FG003|Overall Study|Adverse Event|0|||
146193497|NCT02974010|527219907|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
146417317|NCT01821625|528031959|FG000|Overall Study|Withdrawal by Subject|2|||
146417318|NCT01821625|528031959|FG000|Overall Study|Lack of Efficacy|2|||
146417319|NCT01821625|528031959|FG000|Overall Study|Adverse Event|1|||
146417320|NCT01821625|528031959|FG000|Overall Study|Medical contraindication|1|||
146417321|NCT00321711|528031967|FG000|Part A|Adverse Event|3|||
146417322|NCT00321711|528031968|FG001|Part A|Adverse Event|3|||
146417323|NCT00321711|528031969|FG002|Part A|Adverse Event|2|||
146417324|NCT00321711|528031970|FG003|Part A|Adverse Event|0|||
146417325|NCT00321711|528031971|FG004|Part A|Adverse Event|0|||
146417326|NCT00321711|528031967|FG000|Part A|Withdrawal by Subject|1|||
146417327|NCT00321711|528031968|FG001|Part A|Withdrawal by Subject|1|||
146193498|NCT02974010|527219908|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
146417328|NCT00321711|528031969|FG002|Part A|Withdrawal by Subject|1|||
146417329|NCT00321711|528031970|FG003|Part A|Withdrawal by Subject|0|||
146417330|NCT00321711|528031971|FG004|Part A|Withdrawal by Subject|0|||
146417331|NCT00321711|528031967|FG000|Part A|Disease progression|0|||
146417332|NCT00321711|528031968|FG001|Part A|Disease progression|1|||
146417333|NCT00321711|528031969|FG002|Part A|Disease progression|0|||
146417334|NCT00321711|528031970|FG003|Part A|Disease progression|0|||
146417335|NCT00321711|528031971|FG004|Part A|Disease progression|0|||
146417336|NCT00321711|528031967|FG000|Part A|Requirement for alternative therapy|0|||
146417337|NCT00321711|528031968|FG001|Part A|Requirement for alternative therapy|2|||
146417338|NCT00321711|528031969|FG002|Part A|Requirement for alternative therapy|1|||
146417339|NCT00321711|528031970|FG003|Part A|Requirement for alternative therapy|0|||
146417340|NCT00321711|528031971|FG004|Part A|Requirement for alternative therapy|0|||
146417341|NCT00321711|528031967|FG000|Part A|Physician Decision|0|||
146417342|NCT00321711|528031968|FG001|Part A|Physician Decision|1|||
146417343|NCT00321711|528031969|FG002|Part A|Physician Decision|3|||
146417344|NCT00321711|528031970|FG003|Part A|Physician Decision|0|||
146417345|NCT00321711|528031971|FG004|Part A|Physician Decision|0|||
146417346|NCT00321711|528031967|FG000|Part A|Other|1|||
146417347|NCT00321711|528031968|FG001|Part A|Other|2|||
146417348|NCT00321711|528031969|FG002|Part A|Other|3|||
146417349|NCT00321711|528031970|FG003|Part A|Other|0|||
146417350|NCT00321711|528031971|FG004|Part A|Other|0|||
146417351|NCT00321711|528031967|FG000|Part A|Protocol deviation|0|||
146417352|NCT00321711|528031968|FG001|Part A|Protocol deviation|0|||
146417353|NCT00321711|528031969|FG002|Part A|Protocol deviation|1|||
146417354|NCT00321711|528031970|FG003|Part A|Protocol deviation|0|||
146417355|NCT00321711|528031971|FG004|Part A|Protocol deviation|0|||
146417356|NCT00321711|528031967|FG000|Part B|Noncompliance|0|||
146417357|NCT00321711|528031968|FG001|Part B|Noncompliance|0|||
146417358|NCT00321711|528031969|FG002|Part B|Noncompliance|0|||
146417359|NCT00321711|528031970|FG003|Part B|Noncompliance|0|||
146417360|NCT00321711|528031971|FG004|Part B|Noncompliance|1|||
146417361|NCT00321711|528031967|FG000|Part B|Adverse Event|0|||
146417362|NCT00321711|528031968|FG001|Part B|Adverse Event|0|||
146417363|NCT00321711|528031969|FG002|Part B|Adverse Event|0|||
146417364|NCT00321711|528031970|FG003|Part B|Adverse Event|2|||
146417365|NCT00321711|528031971|FG004|Part B|Adverse Event|1|||
146417366|NCT00321711|528031967|FG000|Part B|Disease progression|0|||
146417367|NCT00321711|528031968|FG001|Part B|Disease progression|0|||
146417368|NCT00321711|528031969|FG002|Part B|Disease progression|0|||
146417369|NCT00321711|528031970|FG003|Part B|Disease progression|1|||
146417370|NCT00321711|528031971|FG004|Part B|Disease progression|0|||
146417371|NCT00321711|528031967|FG000|Part B|Physician Decision|0|||
146417372|NCT00321711|528031968|FG001|Part B|Physician Decision|0|||
146417373|NCT00321711|528031969|FG002|Part B|Physician Decision|0|||
146417374|NCT00321711|528031970|FG003|Part B|Physician Decision|1|||
146417375|NCT00321711|528031971|FG004|Part B|Physician Decision|2|||
146417376|NCT00321711|528031967|FG000|Part B|Death|0|||
146417377|NCT00321711|528031968|FG001|Part B|Death|0|||
146417378|NCT00321711|528031969|FG002|Part B|Death|0|||
146417379|NCT00321711|528031970|FG003|Part B|Death|2|||
146417380|NCT00321711|528031971|FG004|Part B|Death|1|||
146417381|NCT01186978|528031972|FG000|Overall Study|Withdrawal by Subject|1|||
146417382|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
146417383|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
146417384|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
146417385|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
146417386|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
146417387|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
146417388|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
146417389|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
146417390|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
146417391|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
146417392|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
146417393|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
146417394|NCT01227668|528031973|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
146417395|NCT01227668|528031974|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
146417396|NCT01227668|528031973|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
146417397|NCT01227668|528031974|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
146417398|NCT01227668|528031973|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
146417399|NCT01227668|528031974|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
146417400|NCT01227668|528031973|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
146417401|NCT01227668|528031974|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
146417402|NCT01227668|528031973|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
146417403|NCT01227668|528031974|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
146417404|NCT01227668|528031973|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
146417405|NCT01227668|528031974|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
146417406|NCT02115256|528031979|FG000|Overall Study|Withdrawal by Subject|0|||
146417407|NCT02115256|528031980|FG001|Overall Study|Withdrawal by Subject|1|||
146417408|NCT01626859|528031983|FG000|Overall Study|Adverse Event|1|||
146417409|NCT01626859|528031984|FG001|Overall Study|Adverse Event|3|||
146417410|NCT01626859|528031985|FG002|Overall Study|Adverse Event|2|||
146417411|NCT01626859|528031983|FG000|Overall Study|Physician Decision|0|||
146417412|NCT01626859|528031984|FG001|Overall Study|Physician Decision|1|||
146417413|NCT01626859|528031985|FG002|Overall Study|Physician Decision|0|||
146417414|NCT01626859|528031983|FG000|Overall Study|Withdrawal by Subject|1|||
146417415|NCT01626859|528031984|FG001|Overall Study|Withdrawal by Subject|4|||
146417416|NCT01626859|528031985|FG002|Overall Study|Withdrawal by Subject|2|||
146417417|NCT02826603|528031986|FG000|Overall Study|Adverse Event|17|||
146417418|NCT02826603|528031987|FG001|Overall Study|Adverse Event|9|||
146417419|NCT02826603|528031986|FG000|Overall Study|Lack of Efficacy|4|||
146417420|NCT02826603|528031987|FG001|Overall Study|Lack of Efficacy|9|||
146417421|NCT02826603|528031986|FG000|Overall Study|Lost to Follow-up|13|||
146417422|NCT02826603|528031987|FG001|Overall Study|Lost to Follow-up|12|||
146417423|NCT02826603|528031986|FG000|Overall Study|Noncompliance with treatment|0|||
146417424|NCT02826603|528031987|FG001|Overall Study|Noncompliance with treatment|2|||
146417425|NCT02826603|528031986|FG000|Overall Study|Physician Decision|1|||
146417426|NCT02826603|528031987|FG001|Overall Study|Physician Decision|7|||
146417427|NCT02826603|528031986|FG000|Overall Study|Pregnancy|1|||
146417428|NCT02826603|528031987|FG001|Overall Study|Pregnancy|2|||
146417429|NCT02826603|528031986|FG000|Overall Study|Protocol Violation|3|||
146417430|NCT02826603|528031987|FG001|Overall Study|Protocol Violation|3|||
146417431|NCT02826603|528031986|FG000|Overall Study|Withdrawal by Subject|20|||
146417432|NCT02826603|528031987|FG001|Overall Study|Withdrawal by Subject|19|||
146417433|NCT02826603|528031986|FG000|Overall Study|Death|2|||
146417434|NCT02826603|528031987|FG001|Overall Study|Death|0|||
146082372|NCT04449029|526822777|FG004|Overall Study|Physician Decision|0|||
146082373|NCT04449029|526822778|FG005|Overall Study|Physician Decision|1|||
146082374|NCT04449029|526822779|FG006|Overall Study|Physician Decision|0|||
146082375|NCT04449029|526822780|FG007|Overall Study|Physician Decision|0|||
146417435|NCT02826603|528031986|FG000|Overall Study|New therapy for study indication|0|||
146417436|NCT02826603|528031987|FG001|Overall Study|New therapy for study indication|1|||
146417437|NCT00905489|528031988|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
146417438|NCT00905489|528031988|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
146417439|NCT00905489|528031988|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
146417440|NCT00583596|528031989|FG000|Overall Study|Lost to Follow-up|110|||
146417441|NCT00583596|528031989|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
146417442|NCT00583596|528031989|FG000|Overall Study|Death|2|||
146417443|NCT00583596|528031989|FG000|Overall Study|Withdrawal by Subject|6|||
146417444|NCT00583596|528031989|FG000|Overall Study|Lost to Follow-up|94|||
146417445|NCT00583596|528031989|FG000|Overall Study|Data not complete|1|||
146082376|NCT04449029|526822773|FG000|Overall Study|Withdrawal by Subject|3|||
146417446|NCT00583596|528031989|FG000|Overall Study|Not consented|15|||
146193499|NCT02974010|527219909|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
146193500|NCT02974010|527219910|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
146193501|NCT02974010|527219907|FG000|Overall Study|Lack of Efficacy|0|||
146193502|NCT02974010|527219908|FG001|Overall Study|Lack of Efficacy|0|||
146193503|NCT02974010|527219909|FG002|Overall Study|Lack of Efficacy|1|||
146193504|NCT02974010|527219910|FG003|Overall Study|Lack of Efficacy|0|||
146193505|NCT04088188|527219911|FG000|Overall Study|Withdrawal by Subject|2|||
146193506|NCT04088188|527219912|FG001|Overall Study|Withdrawal by Subject|0|||
146193507|NCT04088188|527219911|FG000|Overall Study|Adverse Event|2|||
146193508|NCT04088188|527219912|FG001|Overall Study|Adverse Event|0|||
146193509|NCT03124108|527219913|FG000|Overall Study|Adverse Event|0|||
146193510|NCT03124108|527219914|FG001|Overall Study|Adverse Event|1|||
146193511|NCT03124108|527219915|FG002|Overall Study|Adverse Event|0|||
146193512|NCT05650333|527219918|FG000|Treatment Period (7 Days)|Adverse Event|1|||
145948188|NCT02028169|526319601|FG000|Overall Study|Withdrawal by Subject|2|||
146193513|NCT02524288|527219920|FG000|Overall Study|Adverse Event|115|||
146417447|NCT00583596|528031989|FG000|Overall Study|Outside f-up window|26|||
146417448|NCT01855126|528031990|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
146417449|NCT01855126|528031991|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
146417450|NCT01855126|528031990|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146417451|NCT01855126|528031991|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
146417452|NCT01078090|528032003|FG000|Overall Study|Lost to Follow-up|2363|||
146417453|NCT01078090|528032003|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
146417454|NCT01078090|528032003|FG000|Overall Study|Lack of Efficacy|1193|||
146417455|NCT01078090|528032003|FG000|Overall Study|ADR and lack of efficacy|61|||
146417456|NCT01078090|528032003|FG000|Overall Study|Other|523|||
146417457|NCT04535583|528032004|FG000|Overall Study|Lost to Follow-up|1|||
146417458|NCT04535583|528032004|FG000|Overall Study|Physician Decision|1|||
146417459|NCT04535583|528032004|FG000|Overall Study|Withdrawal by Subject|1|||
146417460|NCT01748890|528032006|FG000|Overall Study|Insufficient recruitment for analysis|4|||
146417461|NCT00526890|528032007|FG000|Overall Study|Adverse Event|2|||
146417462|NCT03035227|528032008|FG000|Overall Study|study stopped due to PI leaving institut|1|||
146417463|NCT03035227|528032009|FG001|Overall Study|study stopped due to PI leaving institut|1|||
146417464|NCT00859469|528032010|FG000|Overall Study|Adverse Event|2|||
146417465|NCT00859469|528032010|FG000|Overall Study|Lack of Efficacy|9|||
146417466|NCT00859469|528032010|FG000|Overall Study|Withdrawal by Subject|1|||
146417467|NCT00859469|528032010|FG000|Overall Study|Death|16|||
146417468|NCT02220907|528032011|FG000|Overall Study|Adverse Event|7|||
146417469|NCT02220907|528032011|FG000|Overall Study|Physician Decision|1|||
146417470|NCT02220907|528032011|FG000|Overall Study|Withdrawal by Subject|2|||
146417471|NCT02220907|528032011|FG000|Overall Study|Conflict with the stopping criteria|1|||
146417472|NCT01098240|528032016|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
146417473|NCT01098240|528032017|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
146417474|NCT01098240|528032018|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
146417475|NCT01098240|528032016|FG000|Open-Label Phase|Protocol Violation|4|||
146417476|NCT01098240|528032017|FG001|Open-Label Phase|Protocol Violation|0|||
146417477|NCT01098240|528032018|FG002|Open-Label Phase|Protocol Violation|0|||
146417478|NCT01098240|528032016|FG000|Open-Label Phase|Lost to Follow-up|13|||
146417479|NCT01098240|528032017|FG001|Open-Label Phase|Lost to Follow-up|0|||
146417480|NCT01098240|528032018|FG002|Open-Label Phase|Lost to Follow-up|0|||
146417481|NCT01098240|528032016|FG000|Open-Label Phase|Other|19|||
146417482|NCT01098240|528032017|FG001|Open-Label Phase|Other|0|||
146417483|NCT01098240|528032018|FG002|Open-Label Phase|Other|0|||
146417484|NCT01098240|528032016|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
146417485|NCT01098240|528032017|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146417486|NCT01098240|528032018|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
146417487|NCT01098240|528032016|FG000|Open-Label Phase|Pregnancy|1|||
146417488|NCT01098240|528032017|FG001|Open-Label Phase|Pregnancy|0|||
146417489|NCT01098240|528032018|FG002|Open-Label Phase|Pregnancy|0|||
146417490|NCT01098240|528032016|FG000|Open-Label Phase|Withdrawal by Subject|9|||
146417491|NCT01098240|528032017|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146417492|NCT01098240|528032018|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146417493|NCT01098240|528032016|FG000|Open-Label Phase|Adverse Event|12|||
146417494|NCT01098240|528032017|FG001|Open-Label Phase|Adverse Event|0|||
146417495|NCT01098240|528032018|FG002|Open-Label Phase|Adverse Event|0|||
146417496|NCT01098240|528032016|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
146417497|NCT01098240|528032017|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
146417498|NCT01098240|528032018|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
146417499|NCT01098240|528032016|FG000|Double-Blind Phase|Protocol Violation|0|||
146417500|NCT01098240|528032017|FG001|Double-Blind Phase|Protocol Violation|2|||
146417501|NCT01098240|528032018|FG002|Double-Blind Phase|Protocol Violation|4|||
146417502|NCT01098240|528032016|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146417503|NCT01098240|528032017|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146193514|NCT02524288|527219920|FG000|Overall Study|Lost to Follow-up|216|||
146193515|NCT02524288|527219920|FG000|Overall Study|Non-Compliance With Protocol|32|||
146417504|NCT01098240|528032018|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146417505|NCT01098240|528032016|FG000|Double-Blind Phase|Other|0|||
146417506|NCT01098240|528032017|FG001|Double-Blind Phase|Other|2|||
146417507|NCT01098240|528032018|FG002|Double-Blind Phase|Other|2|||
146417508|NCT01098240|528032016|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
146417509|NCT01098240|528032017|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
146417510|NCT01098240|528032018|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
146417511|NCT01098240|528032016|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
146193516|NCT02524288|527219920|FG000|Overall Study|Non-Compliance With Study Drug|14|||
146193517|NCT02524288|527219920|FG000|Overall Study|Pregnancy Wish|6|||
146193518|NCT02524288|527219920|FG000|Overall Study|Protocol Violation|6|||
146193519|NCT02524288|527219920|FG000|Overall Study|Screen Failure|2|||
146193520|NCT02524288|527219920|FG000|Overall Study|Site Discontinued Study Participation|1|||
146193521|NCT02524288|527219920|FG000|Overall Study|Study Terminated By Sponsor|1417|||
146417512|NCT01098240|528032017|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
146417513|NCT01098240|528032018|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
146417514|NCT01098240|528032016|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146417515|NCT01098240|528032017|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
146417516|NCT01098240|528032018|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
146417517|NCT01098240|528032016|FG000|Double-Blind Phase|Adverse Event|0|||
146417518|NCT01098240|528032017|FG001|Double-Blind Phase|Adverse Event|3|||
146417519|NCT01098240|528032018|FG002|Double-Blind Phase|Adverse Event|3|||
146417520|NCT03280537|528032019|FG000|Overall Study|Withdrawal by Subject|2|||
146417521|NCT03280537|528032020|FG001|Overall Study|Withdrawal by Subject|4|||
146417522|NCT01588106|528032021|FG000|Overall Study|Withdrawal by Subject|5|||
146417523|NCT01588106|528032022|FG001|Overall Study|Withdrawal by Subject|4|||
146417524|NCT02995837|528032023|FG000|Overall Study|Lost to Follow-up|9|||
146417525|NCT02995837|528032024|FG001|Overall Study|Lost to Follow-up|8|||
146417526|NCT00458302|528033700|FG000|Overall Study|Adverse Event|4|||
146417527|NCT00458302|528033701|FG001|Overall Study|Adverse Event|14|||
146417528|NCT00458302|528033700|FG000|Overall Study|Pregnancy|2|||
146417529|NCT00458302|528033701|FG001|Overall Study|Pregnancy|1|||
146417530|NCT00458302|528033700|FG000|Overall Study|Protocol Violation|0|||
146417531|NCT00458302|528033701|FG001|Overall Study|Protocol Violation|2|||
146193522|NCT02524288|527219920|FG000|Overall Study|Subject Moved|32|||
145948189|NCT02028169|526319601|FG000|Overall Study|Adverse Event|1|||
146193523|NCT02524288|527219920|FG000|Overall Study|Withdrawal by Subject|76|||
146417532|NCT00458302|528033700|FG000|Overall Study|Withdrawal by Subject|6|||
146417533|NCT00458302|528033701|FG001|Overall Study|Withdrawal by Subject|4|||
146417534|NCT00458302|528033700|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
146417535|NCT00458302|528033701|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
146417536|NCT00458302|528033700|FG000|Overall Study|Study Termination By Sponsor|1|||
146417537|NCT00458302|528033701|FG001|Overall Study|Study Termination By Sponsor|0|||
146417538|NCT00458302|528033700|FG000|Overall Study|Lost to Follow-up|2|||
146417539|NCT00458302|528033701|FG001|Overall Study|Lost to Follow-up|0|||
146417540|NCT00458302|528033700|FG000|Overall Study|Other|4|||
146417541|NCT00458302|528033701|FG001|Overall Study|Other|2|||
146417542|NCT02224456|528033702|FG000|Overall Study|Lack of Efficacy|1|||
146417543|NCT02224456|528033702|FG000|Overall Study|Lost to Follow-up|15|||
146417544|NCT02224456|528033702|FG000|Overall Study|Withdrawal by Subject|9|||
146417545|NCT02224456|528033702|FG000|Overall Study|Physician Decision|3|||
146417546|NCT02224456|528033702|FG000|Overall Study|Death|2|||
146417547|NCT02224456|528033702|FG000|Overall Study|Pregnancy|4|||
146417548|NCT02224456|528033702|FG000|Overall Study|Protocol Violation|1|||
146417549|NCT02224456|528033702|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
146417550|NCT01241461|528033703|FG000|Overall Study|Progressive Disease|3|||
146417551|NCT01241461|528033704|FG001|Overall Study|Progressive Disease|6|||
146417552|NCT01379781|528033708|FG000|Overall Study|Lost to Follow-up|11|||
146417553|NCT01379781|528033709|FG001|Overall Study|Lost to Follow-up|8|||
146417554|NCT01162499|528033721|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
146417555|NCT01162499|528033722|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
146417556|NCT00832078|528033723|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
146417557|NCT00832078|528033724|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
146417558|NCT00832078|528033723|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
146417559|NCT00832078|528033724|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
146417560|NCT01628120|528033731|FG000|Overall Study|Withdrawal by Subject|7|||
146417561|NCT01628120|528033731|FG000|Overall Study|Adverse Event|12|||
146417562|NCT01628120|528033731|FG000|Overall Study|Lost to Follow-up|1|||
146417563|NCT01628120|528033731|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
146417564|NCT01628120|528033731|FG000|Overall Study|Non-compliant with Study Procedures|1|||
146417565|NCT01628120|528033731|FG000|Overall Study|Not Treated|3|||
146417566|NCT01628120|528033731|FG000|Overall Study|Sponsor Decision|5|||
146417567|NCT01628120|528033731|FG000|Overall Study|Switched Dialysis Method|2|||
146417568|NCT01628120|528033731|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
146417569|NCT01628120|528033731|FG000|Overall Study|Moved or Relocated|5|||
146417570|NCT01628120|528033731|FG000|Overall Study|Kidney Transplant|2|||
146417571|NCT01628120|528033731|FG000|Overall Study|Use of Standard of Care|1|||
146417572|NCT01165996|528033735|FG000|Overall Study|Death|1|||
146417573|NCT01165996|528033735|FG000|Overall Study|Physician Decision|1|||
146417574|NCT00096265|528033736|FG000|Overall Study|Ineligible|1|||
146417575|NCT00096265|528033737|FG001|Overall Study|Ineligible|0|||
146417576|NCT00096265|528033738|FG002|Overall Study|Ineligible|0|||
146417577|NCT01506323|528033739|FG000|Overall Study|Lost to Follow-up|5|||
146417578|NCT01506323|528033740|FG001|Overall Study|Lost to Follow-up|4|||
146417579|NCT01506323|528033739|FG000|Overall Study|Withdrawal by Subject|4|||
146417580|NCT01506323|528033740|FG001|Overall Study|Withdrawal by Subject|4|||
146417581|NCT01506323|528033739|FG000|Overall Study|Lack of Efficacy|1|||
146417582|NCT01506323|528033740|FG001|Overall Study|Lack of Efficacy|3|||
146417583|NCT01506323|528033739|FG000|Overall Study|Moved out of area|5|||
146417584|NCT01506323|528033740|FG001|Overall Study|Moved out of area|2|||
146417585|NCT01506323|528033739|FG000|Overall Study|Schedule or Transportation conflict|8|||
146417586|NCT01506323|528033740|FG001|Overall Study|Schedule or Transportation conflict|0|||
146417587|NCT01506323|528033739|FG000|Overall Study|Started another treatment|1|||
146417588|NCT01506323|528033740|FG001|Overall Study|Started another treatment|0|||
146417589|NCT00704418|528033742|FG000|Overall Study|Withdrawal by Subject|2|||
146417590|NCT00704418|528033743|FG001|Overall Study|Withdrawal by Subject|0|||
146417591|NCT00704418|528033742|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
146417592|NCT00704418|528033743|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
146417593|NCT01579474|528033744|FG000|Overall Study|Adverse Event|1|||
146417594|NCT01579474|528033745|FG001|Overall Study|Adverse Event|13|||
146417595|NCT01579474|528033746|FG002|Overall Study|Adverse Event|2|||
146417596|NCT01579474|528033747|FG003|Overall Study|Adverse Event|0|||
146417597|NCT01579474|528033748|FG004|Overall Study|Adverse Event|0|||
146417598|NCT01579474|528033749|FG005|Overall Study|Adverse Event|1|||
146417599|NCT01579474|528033744|FG000|Overall Study|Lack of Efficacy|1|||
146417600|NCT01579474|528033745|FG001|Overall Study|Lack of Efficacy|0|||
146417601|NCT01579474|528033746|FG002|Overall Study|Lack of Efficacy|0|||
146417602|NCT01579474|528033747|FG003|Overall Study|Lack of Efficacy|0|||
146417603|NCT01579474|528033748|FG004|Overall Study|Lack of Efficacy|1|||
146417604|NCT01579474|528033749|FG005|Overall Study|Lack of Efficacy|0|||
146417605|NCT01579474|528033744|FG000|Overall Study|Withdrawal by Subject|1|||
146417606|NCT01579474|528033745|FG001|Overall Study|Withdrawal by Subject|0|||
146417607|NCT01579474|528033746|FG002|Overall Study|Withdrawal by Subject|0|||
146417608|NCT01579474|528033747|FG003|Overall Study|Withdrawal by Subject|0|||
146417609|NCT01579474|528033748|FG004|Overall Study|Withdrawal by Subject|0|||
146417610|NCT01579474|528033749|FG005|Overall Study|Withdrawal by Subject|0|||
146417611|NCT01075763|528033750|FG000|Overall Study|Lost to Follow-up|2|||
146417612|NCT01075763|528033751|FG001|Overall Study|Lost to Follow-up|1|||
146417613|NCT01075763|528033750|FG000|Overall Study|Lack of Efficacy|0|||
146417614|NCT01075763|528033751|FG001|Overall Study|Lack of Efficacy|1|||
146417615|NCT01075763|528033750|FG000|Overall Study|Withdrawal by Subject|2|||
146417616|NCT01075763|528033751|FG001|Overall Study|Withdrawal by Subject|2|||
146417617|NCT00586521|528033752|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
146417618|NCT03734237|528033756|FG000|Overall Study|Lost to Follow-up|1|||
146417619|NCT03734237|528033757|FG001|Overall Study|Lost to Follow-up|3|||
146417620|NCT03734237|528033758|FG002|Overall Study|Lost to Follow-up|0|||
146417621|NCT03734237|528033756|FG000|Overall Study|Withdrawal by Subject|7|||
146417622|NCT03734237|528033757|FG001|Overall Study|Withdrawal by Subject|9|||
146417623|NCT03734237|528033758|FG002|Overall Study|Withdrawal by Subject|10|||
146417624|NCT00818623|528033763|FG000|Overall Study|Adverse Event|1|||
146417625|NCT00818623|528033764|FG001|Overall Study|Adverse Event|0|||
146417626|NCT00818623|528033765|FG002|Overall Study|Adverse Event|1|||
146417627|NCT00818623|528033766|FG003|Overall Study|Adverse Event|0|||
146417628|NCT00818623|528033767|FG004|Overall Study|Adverse Event|0|||
146417629|NCT00818623|528033768|FG005|Overall Study|Adverse Event|1|||
146417630|NCT00818623|528033769|FG006|Overall Study|Adverse Event|0|||
146417631|NCT00818623|528033770|FG007|Overall Study|Adverse Event|0|||
146417632|NCT00818623|528033763|FG000|Overall Study|Bad prostate specific antigen response|0|||
146417633|NCT00818623|528033764|FG001|Overall Study|Bad prostate specific antigen response|3|||
146417634|NCT00818623|528033765|FG002|Overall Study|Bad prostate specific antigen response|2|||
146417635|NCT00818623|528033766|FG003|Overall Study|Bad prostate specific antigen response|5|||
146417636|NCT00818623|528033767|FG004|Overall Study|Bad prostate specific antigen response|0|||
146417637|NCT00818623|528033768|FG005|Overall Study|Bad prostate specific antigen response|1|||
146417638|NCT00818623|528033769|FG006|Overall Study|Bad prostate specific antigen response|0|||
146417639|NCT00818623|528033770|FG007|Overall Study|Bad prostate specific antigen response|0|||
146417640|NCT00818623|528033763|FG000|Overall Study|Withdrawal by Subject|0|||
146417641|NCT00818623|528033764|FG001|Overall Study|Withdrawal by Subject|1|||
146417642|NCT00818623|528033765|FG002|Overall Study|Withdrawal by Subject|1|||
146417643|NCT00818623|528033766|FG003|Overall Study|Withdrawal by Subject|0|||
146417644|NCT00818623|528033767|FG004|Overall Study|Withdrawal by Subject|0|||
146417645|NCT00818623|528033768|FG005|Overall Study|Withdrawal by Subject|1|||
146417646|NCT00818623|528033769|FG006|Overall Study|Withdrawal by Subject|1|||
146417647|NCT00818623|528033770|FG007|Overall Study|Withdrawal by Subject|1|||
146417648|NCT00818623|528033763|FG000|Overall Study|Protocol Violation|1|||
146417649|NCT00818623|528033764|FG001|Overall Study|Protocol Violation|0|||
146417650|NCT00818623|528033765|FG002|Overall Study|Protocol Violation|0|||
146417651|NCT00818623|528033766|FG003|Overall Study|Protocol Violation|0|||
146417652|NCT00818623|528033767|FG004|Overall Study|Protocol Violation|1|||
146417653|NCT00818623|528033768|FG005|Overall Study|Protocol Violation|0|||
146417654|NCT00818623|528033769|FG006|Overall Study|Protocol Violation|1|||
146417655|NCT00818623|528033770|FG007|Overall Study|Protocol Violation|0|||
146417656|NCT00818623|528033763|FG000|Overall Study|Need of additional treatment|0|||
146417657|NCT00818623|528033764|FG001|Overall Study|Need of additional treatment|0|||
146417658|NCT00818623|528033765|FG002|Overall Study|Need of additional treatment|0|||
146417659|NCT00818623|528033766|FG003|Overall Study|Need of additional treatment|0|||
146417660|NCT00818623|528033767|FG004|Overall Study|Need of additional treatment|1|||
146417661|NCT00818623|528033768|FG005|Overall Study|Need of additional treatment|0|||
146417662|NCT00818623|528033769|FG006|Overall Study|Need of additional treatment|0|||
146417663|NCT00818623|528033770|FG007|Overall Study|Need of additional treatment|0|||
146417664|NCT00818623|528033763|FG000|Overall Study|Lack of trial drug at site|0|||
146417665|NCT00818623|528033764|FG001|Overall Study|Lack of trial drug at site|0|||
146417666|NCT00818623|528033765|FG002|Overall Study|Lack of trial drug at site|0|||
146417667|NCT00818623|528033766|FG003|Overall Study|Lack of trial drug at site|0|||
146417668|NCT00818623|528033767|FG004|Overall Study|Lack of trial drug at site|2|||
146417669|NCT00818623|528033768|FG005|Overall Study|Lack of trial drug at site|0|||
146417670|NCT00818623|528033769|FG006|Overall Study|Lack of trial drug at site|1|||
146417671|NCT00818623|528033770|FG007|Overall Study|Lack of trial drug at site|0|||
146417672|NCT00818623|528033763|FG000|Overall Study|Disease progression|0|||
146417673|NCT00818623|528033764|FG001|Overall Study|Disease progression|0|||
146417674|NCT00818623|528033765|FG002|Overall Study|Disease progression|0|||
146417675|NCT00818623|528033766|FG003|Overall Study|Disease progression|0|||
146417676|NCT00818623|528033767|FG004|Overall Study|Disease progression|0|||
146417677|NCT00818623|528033768|FG005|Overall Study|Disease progression|0|||
146417678|NCT00818623|528033769|FG006|Overall Study|Disease progression|1|||
146417679|NCT00818623|528033770|FG007|Overall Study|Disease progression|0|||
146417680|NCT00457665|528033771|FG000|12 Months|Drug allergy|1|||
146417681|NCT00457665|528033772|FG001|12 Months|Drug allergy|1|||
146417682|NCT00457665|528033771|FG000|12 Months|High HIV viral load|5|||
146417683|NCT00457665|528033772|FG001|12 Months|High HIV viral load|1|||
146417684|NCT00457665|528033771|FG000|12 Months|Lipodystrophy|2|||
146417685|NCT00457665|528033772|FG001|12 Months|Lipodystrophy|0|||
146417686|NCT00457665|528033771|FG000|12 Months|Withdrawal by Subject|0|||
146417687|NCT00457665|528033772|FG001|12 Months|Withdrawal by Subject|2|||
146417688|NCT00457665|528033771|FG000|12 Months|Abnormal Liver function tests|0|||
146417689|NCT00457665|528033772|FG001|12 Months|Abnormal Liver function tests|5|||
146417690|NCT00457665|528033771|FG000|24 Months|Withdrawal by Subject|3|||
146417691|NCT00457665|528033772|FG001|24 Months|Withdrawal by Subject|2|||
146417692|NCT00457665|528033771|FG000|24 Months|Lipodystrophy|1|||
146417693|NCT00457665|528033772|FG001|24 Months|Lipodystrophy|1|||
146417694|NCT00457665|528033771|FG000|24 Months|Abnormal liver function tests|1|||
146417695|NCT00457665|528033772|FG001|24 Months|Abnormal liver function tests|5|||
146417696|NCT02535000|528033773|FG000|Overall Study|Cancellation of surgery.|1|||
146417697|NCT02535000|528033774|FG001|Overall Study|Cancellation of surgery.|2|||
146417698|NCT01620489|528033779|FG000|Overall Study|Adverse Event|17|||
146417699|NCT01620489|528033780|FG001|Overall Study|Adverse Event|4|||
146417700|NCT01620489|528033779|FG000|Overall Study|Protocol Violation|0|||
146417701|NCT01620489|528033780|FG001|Overall Study|Protocol Violation|3|||
146417702|NCT01620489|528033779|FG000|Overall Study|Withdrawal Criteria|17|||
146417703|NCT01620489|528033780|FG001|Overall Study|Withdrawal Criteria|25|||
146417704|NCT01620489|528033779|FG000|Overall Study|Unclassified|1|||
146417705|NCT01620489|528033780|FG001|Overall Study|Unclassified|2|||
146417706|NCT01851590|528033782|FG000|Overall Study|Withdrawal by Subject|0|||
146417707|NCT01851590|528033783|FG001|Overall Study|Withdrawal by Subject|0|||
146417708|NCT01851590|528033784|FG002|Overall Study|Withdrawal by Subject|1|||
146417709|NCT01851590|528033782|FG000|Overall Study|Adverse Event|0|||
146417710|NCT01851590|528033783|FG001|Overall Study|Adverse Event|0|||
146417711|NCT01851590|528033784|FG002|Overall Study|Adverse Event|2|||
146417712|NCT01851590|528033782|FG000|Overall Study|Lack of Efficacy|0|||
146417713|NCT01851590|528033783|FG001|Overall Study|Lack of Efficacy|1|||
146417714|NCT01851590|528033784|FG002|Overall Study|Lack of Efficacy|0|||
146417715|NCT00696709|528033785|FG000|Overall Study|Withdrawal by Subject|1|||
146417716|NCT00696709|528033786|FG001|Overall Study|Withdrawal by Subject|2|||
146417717|NCT00696709|528033787|FG002|Overall Study|Withdrawal by Subject|1|||
146417718|NCT00696709|528033788|FG003|Overall Study|Withdrawal by Subject|4|||
146417719|NCT00696709|528033789|FG004|Overall Study|Withdrawal by Subject|3|||
146417720|NCT00696709|528033785|FG000|Overall Study|Protocol Violation|1|||
146417721|NCT00696709|528033786|FG001|Overall Study|Protocol Violation|0|||
146417722|NCT00696709|528033787|FG002|Overall Study|Protocol Violation|0|||
146417723|NCT00696709|528033788|FG003|Overall Study|Protocol Violation|0|||
146417724|NCT00696709|528033789|FG004|Overall Study|Protocol Violation|0|||
146417725|NCT00696709|528033785|FG000|Overall Study|Lost to Follow-up|1|||
146417726|NCT00696709|528033786|FG001|Overall Study|Lost to Follow-up|1|||
146417727|NCT00696709|528033787|FG002|Overall Study|Lost to Follow-up|0|||
146417728|NCT00696709|528033788|FG003|Overall Study|Lost to Follow-up|0|||
146417729|NCT00696709|528033789|FG004|Overall Study|Lost to Follow-up|0|||
146417730|NCT00696709|528033785|FG000|Overall Study|Adverse Event|0|||
146417731|NCT00696709|528033786|FG001|Overall Study|Adverse Event|0|||
146417732|NCT00696709|528033787|FG002|Overall Study|Adverse Event|0|||
146417733|NCT00696709|528033788|FG003|Overall Study|Adverse Event|1|||
146417734|NCT00696709|528033789|FG004|Overall Study|Adverse Event|0|||
146417735|NCT00310856|528033790|FG000|Overall Study|Withdrawal by Subject|2|||
146417736|NCT00310856|528033791|FG001|Overall Study|Withdrawal by Subject|2|||
146417737|NCT00310856|528033792|FG002|Overall Study|Withdrawal by Subject|2|||
146417738|NCT00310856|528033790|FG000|Overall Study|Lost to Follow-up|1|||
146417739|NCT00310856|528033791|FG001|Overall Study|Lost to Follow-up|2|||
146417740|NCT00310856|528033792|FG002|Overall Study|Lost to Follow-up|6|||
146417741|NCT00310856|528033790|FG000|Overall Study|Inappropriate enrollment|1|||
146417742|NCT00310856|528033791|FG001|Overall Study|Inappropriate enrollment|1|||
146417743|NCT00310856|528033792|FG002|Overall Study|Inappropriate enrollment|0|||
146417744|NCT00310856|528033790|FG000|Overall Study|Unable to classify|1|||
146417745|NCT00310856|528033791|FG001|Overall Study|Unable to classify|0|||
146417746|NCT00310856|528033792|FG002|Overall Study|Unable to classify|0|||
146417747|NCT01306253|528033799|FG000|Overall Study|Lost to Follow-up|1|||
146417748|NCT01306253|528033800|FG001|Overall Study|Lost to Follow-up|1|||
146417749|NCT00543439|528033801|FG000|Period 1|Adverse Event|0|||
146417750|NCT00543439|528033802|FG001|Period 1|Adverse Event|2|||
146417751|NCT00543439|528033803|FG002|Period 1|Adverse Event|1|||
146417752|NCT00543439|528033801|FG000|Period 1|Withdrawal by Subject|1|||
146417753|NCT00543439|528033802|FG001|Period 1|Withdrawal by Subject|1|||
146417754|NCT00543439|528033803|FG002|Period 1|Withdrawal by Subject|0|||
146417755|NCT00543439|528033801|FG000|Period 1|Physician Decision|0|||
146417756|NCT00543439|528033802|FG001|Period 1|Physician Decision|0|||
146417757|NCT00543439|528033803|FG002|Period 1|Physician Decision|1|||
146417758|NCT00543439|528033801|FG000|Period 2|Protocol Violation|1|||
146417759|NCT00543439|528033802|FG001|Period 2|Protocol Violation|0|||
146417760|NCT00543439|528033803|FG002|Period 2|Protocol Violation|1|||
146417761|NCT00543439|528033801|FG000|Period 2|Adverse Event|0|||
146417762|NCT00543439|528033802|FG001|Period 2|Adverse Event|1|||
146417763|NCT00543439|528033803|FG002|Period 2|Adverse Event|1|||
146417764|NCT01709383|528033808|FG000|Overall Study|Lost to Follow-up|1|||
146417765|NCT01709383|528033809|FG001|Overall Study|Lost to Follow-up|0|||
146417766|NCT03264066|528033810|FG000|Overall Study|Adverse Event|1|||
146417767|NCT03264066|528033811|FG001|Overall Study|Adverse Event|1|||
146417768|NCT03264066|528033812|FG002|Overall Study|Adverse Event|0|||
146417769|NCT03264066|528033813|FG003|Overall Study|Adverse Event|0|||
146417770|NCT03264066|528033814|FG004|Overall Study|Adverse Event|0|||
146417771|NCT03264066|528033815|FG005|Overall Study|Adverse Event|0|||
146417772|NCT03264066|528033810|FG000|Overall Study|Death|12|||
146417773|NCT03264066|528033811|FG001|Overall Study|Death|12|||
146417774|NCT03264066|528033812|FG002|Overall Study|Death|8|||
146417775|NCT03264066|528033813|FG003|Overall Study|Death|10|||
146417776|NCT03264066|528033814|FG004|Overall Study|Death|6|||
146417777|NCT03264066|528033815|FG005|Overall Study|Death|1|||
146417778|NCT03264066|528033810|FG000|Overall Study|Lost to Follow-up|1|||
146417779|NCT03264066|528033811|FG001|Overall Study|Lost to Follow-up|0|||
146417780|NCT03264066|528033812|FG002|Overall Study|Lost to Follow-up|0|||
146417781|NCT03264066|528033813|FG003|Overall Study|Lost to Follow-up|0|||
146417782|NCT03264066|528033814|FG004|Overall Study|Lost to Follow-up|0|||
146417783|NCT03264066|528033815|FG005|Overall Study|Lost to Follow-up|0|||
146417784|NCT03264066|528033810|FG000|Overall Study|Progressive Disease|0|||
146417785|NCT03264066|528033811|FG001|Overall Study|Progressive Disease|2|||
146417786|NCT03264066|528033812|FG002|Overall Study|Progressive Disease|1|||
146417787|NCT03264066|528033813|FG003|Overall Study|Progressive Disease|0|||
146417788|NCT03264066|528033814|FG004|Overall Study|Progressive Disease|0|||
146417789|NCT03264066|528033815|FG005|Overall Study|Progressive Disease|0|||
146417790|NCT03264066|528033810|FG000|Overall Study|Study Terminated by Sponsor|5|||
146417791|NCT03264066|528033811|FG001|Overall Study|Study Terminated by Sponsor|5|||
146417792|NCT03264066|528033812|FG002|Overall Study|Study Terminated by Sponsor|8|||
146417793|NCT03264066|528033813|FG003|Overall Study|Study Terminated by Sponsor|5|||
146417794|NCT03264066|528033814|FG004|Overall Study|Study Terminated by Sponsor|1|||
146417795|NCT03264066|528033815|FG005|Overall Study|Study Terminated by Sponsor|2|||
146417796|NCT03264066|528033810|FG000|Overall Study|Withdrawal by Subject|1|||
146417797|NCT03264066|528033811|FG001|Overall Study|Withdrawal by Subject|0|||
146417798|NCT03264066|528033812|FG002|Overall Study|Withdrawal by Subject|0|||
146417799|NCT03264066|528033813|FG003|Overall Study|Withdrawal by Subject|5|||
146417800|NCT03264066|528033814|FG004|Overall Study|Withdrawal by Subject|0|||
146417801|NCT03264066|528033815|FG005|Overall Study|Withdrawal by Subject|0|||
146417802|NCT01484028|528033816|FG000|Period 1|Lost to Follow-up|0|||
146417803|NCT01484028|528033817|FG001|Period 1|Lost to Follow-up|1|||
146417804|NCT01484028|528033818|FG002|Period 1|Lost to Follow-up|0|||
146417805|NCT01484028|528033819|FG003|Period 1|Lost to Follow-up|0|||
146082377|NCT04449029|526822774|FG001|Overall Study|Withdrawal by Subject|0|||
146417806|NCT01484028|528033816|FG000|Period 1|Non-Compliance to Protocol|0|||
146417807|NCT01484028|528033817|FG001|Period 1|Non-Compliance to Protocol|1|||
146417808|NCT01484028|528033818|FG002|Period 1|Non-Compliance to Protocol|0|||
146417809|NCT01484028|528033819|FG003|Period 1|Non-Compliance to Protocol|1|||
146417810|NCT01484028|528033816|FG000|Period 1|Lens Discomfort|0|||
146417811|NCT01484028|528033817|FG001|Period 1|Lens Discomfort|1|||
146417812|NCT01484028|528033818|FG002|Period 1|Lens Discomfort|0|||
146417813|NCT01484028|528033819|FG003|Period 1|Lens Discomfort|0|||
146417814|NCT01193517|528033820|FG000|Overall Study|Early Progression|1|||
146417815|NCT01193517|528033821|FG001|Overall Study|Early Progression|0|||
146417816|NCT01193517|528033822|FG002|Overall Study|Early Progression|0|||
146417817|NCT00146770|528033823|FG000|Overall Study|Adverse Event|2|||
146417818|NCT00146770|528033824|FG001|Overall Study|Adverse Event|0|||
146417819|NCT00146770|528033823|FG000|Overall Study|Pregnancy|1|||
146417820|NCT00146770|528033824|FG001|Overall Study|Pregnancy|0|||
146417821|NCT00146770|528033823|FG000|Overall Study|Withdrawal by Subject|2|||
146417822|NCT00146770|528033824|FG001|Overall Study|Withdrawal by Subject|0|||
146417823|NCT01626885|528033827|FG000|Overall Study|Adverse Event|8|||
146417824|NCT01626885|528033827|FG000|Overall Study|Withdrawal by Subject|4|||
146417825|NCT01533428|528033828|FG000|Overall Study|Adverse Event|0|||
146417826|NCT01533428|528033829|FG001|Overall Study|Adverse Event|1|||
146417827|NCT01533428|528033828|FG000|Overall Study|Lost to Follow-up|2|||
146417828|NCT01533428|528033829|FG001|Overall Study|Lost to Follow-up|1|||
146417829|NCT01533428|528033828|FG000|Overall Study|Withdrawal by Subject|7|||
146417830|NCT01533428|528033829|FG001|Overall Study|Withdrawal by Subject|6|||
146417831|NCT02669264|528033832|FG000|Overall Study|Death|5|||
146417832|NCT02669264|528033833|FG001|Overall Study|Death|5|||
146417833|NCT02669264|528033834|FG002|Overall Study|Death|3|||
146417834|NCT02669264|528033835|FG003|Overall Study|Death|3|||
146417835|NCT02669264|528033836|FG004|Overall Study|Death|3|||
146417836|NCT02669264|528033837|FG005|Overall Study|Death|6|||
146417837|NCT02669264|528033838|FG006|Overall Study|Death|3|||
146417838|NCT02669264|528033832|FG000|Overall Study|Withdrawal by Subject|0|||
146417839|NCT02669264|528033833|FG001|Overall Study|Withdrawal by Subject|1|||
146417840|NCT02669264|528033834|FG002|Overall Study|Withdrawal by Subject|0|||
146417841|NCT02669264|528033835|FG003|Overall Study|Withdrawal by Subject|0|||
146417842|NCT02669264|528033836|FG004|Overall Study|Withdrawal by Subject|1|||
146417843|NCT02669264|528033837|FG005|Overall Study|Withdrawal by Subject|0|||
146417844|NCT02669264|528033838|FG006|Overall Study|Withdrawal by Subject|0|||
146417845|NCT02669264|528033832|FG000|Overall Study|Lost to Follow-up|0|||
146417846|NCT02669264|528033833|FG001|Overall Study|Lost to Follow-up|0|||
146417847|NCT02669264|528033834|FG002|Overall Study|Lost to Follow-up|0|||
146417848|NCT02669264|528033835|FG003|Overall Study|Lost to Follow-up|0|||
146417849|NCT02669264|528033836|FG004|Overall Study|Lost to Follow-up|1|||
146417850|NCT02669264|528033837|FG005|Overall Study|Lost to Follow-up|0|||
146417851|NCT02669264|528033838|FG006|Overall Study|Lost to Follow-up|0|||
146417852|NCT02669264|528033832|FG000|Overall Study|Miscellaneous|0|||
146417853|NCT02669264|528033833|FG001|Overall Study|Miscellaneous|0|||
146417854|NCT02669264|528033834|FG002|Overall Study|Miscellaneous|0|||
146417855|NCT02669264|528033835|FG003|Overall Study|Miscellaneous|0|||
146417856|NCT02669264|528033836|FG004|Overall Study|Miscellaneous|0|||
146417857|NCT02669264|528033837|FG005|Overall Study|Miscellaneous|0|||
146417858|NCT02669264|528033838|FG006|Overall Study|Miscellaneous|2|||
146417859|NCT04345471|528033840|FG000|Overall Study|Adverse Event|8|||
146417860|NCT04345471|528033841|FG001|Overall Study|Adverse Event|5|||
146417861|NCT04345471|528033842|FG002|Overall Study|Adverse Event|6|||
146417862|NCT04345471|528033840|FG000|Overall Study|Lack of Efficacy|1|||
146417863|NCT04345471|528033841|FG001|Overall Study|Lack of Efficacy|1|||
146417864|NCT04345471|528033842|FG002|Overall Study|Lack of Efficacy|0|||
146417865|NCT04345471|528033840|FG000|Overall Study|Protocol Violation|0|||
146417866|NCT04345471|528033841|FG001|Overall Study|Protocol Violation|1|||
146417867|NCT04345471|528033842|FG002|Overall Study|Protocol Violation|2|||
146417868|NCT04345471|528033840|FG000|Overall Study|Withdrawal by Subject|10|||
146417869|NCT04345471|528033841|FG001|Overall Study|Withdrawal by Subject|5|||
146417870|NCT04345471|528033842|FG002|Overall Study|Withdrawal by Subject|10|||
146417871|NCT03083132|528033845|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
146417872|NCT03083132|528033846|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
146417873|NCT03083132|528033845|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
146417874|NCT03083132|528033846|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
146417875|NCT03083132|528033845|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
146417876|NCT03083132|528033846|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
146193524|NCT02524288|527219920|FG000|Overall Study|Pregnancy|22|||
146417877|NCT03118739|528033847|FG000|Overall Study|Physician Decision|0|||
146417878|NCT03118739|528033848|FG001|Overall Study|Physician Decision|1|||
146417879|NCT03118739|528033847|FG000|Overall Study|Withdrawal by Subject|5|||
146417880|NCT03118739|528033848|FG001|Overall Study|Withdrawal by Subject|3|||
146417881|NCT03118739|528033847|FG000|Overall Study|Lost to Follow-up|2|||
146417882|NCT03118739|528033848|FG001|Overall Study|Lost to Follow-up|0|||
146193525|NCT02524288|527219920|FG000|Overall Study|Physician Decision|2|||
146193526|NCT00517933|527219921|FG000|Period 1|Death|2|||
146193527|NCT00517933|527219922|FG001|Period 1|Death|1|||
146417883|NCT00669955|528033849|FG000|Overall Study|Adverse Event|3|||
146417884|NCT00669955|528033850|FG001|Overall Study|Adverse Event|5|||
146417885|NCT00669955|528033849|FG000|Overall Study|Death|0|||
146417886|NCT00669955|528033850|FG001|Overall Study|Death|1|||
146417887|NCT00669955|528033849|FG000|Overall Study|Withdrawal by Subject|2|||
146417888|NCT00669955|528033850|FG001|Overall Study|Withdrawal by Subject|3|||
146417889|NCT00669955|528033849|FG000|Overall Study|Lost to Follow-up|5|||
146417890|NCT00669955|528033850|FG001|Overall Study|Lost to Follow-up|7|||
146417891|NCT00669955|528033849|FG000|Overall Study|Protocol Violation|2|||
146417892|NCT00669955|528033850|FG001|Overall Study|Protocol Violation|7|||
146417893|NCT00669955|528033849|FG000|Overall Study|Investigator Sponsor Judgement|0|||
146417894|NCT00669955|528033850|FG001|Overall Study|Investigator Sponsor Judgement|1|||
146417895|NCT00669955|528033849|FG000|Overall Study|not compliant with study drug/visit|2|||
146417896|NCT00669955|528033850|FG001|Overall Study|not compliant with study drug/visit|3|||
146417897|NCT03507439|528033854|FG000|Overall Study|Other|2|||
146417898|NCT03507439|528033855|FG001|Overall Study|Other|1|||
146417899|NCT03507439|528033854|FG000|Overall Study|Withdrawal by Subject|1|||
146417900|NCT03507439|528033855|FG001|Overall Study|Withdrawal by Subject|0|||
146417901|NCT03507439|528033854|FG000|Overall Study|Death|1|||
146417902|NCT03507439|528033855|FG001|Overall Study|Death|1|||
146417903|NCT04274192|528033856|FG000|Overall Study|Protocol Violation|1|||
146417904|NCT04274192|528033857|FG001|Overall Study|Protocol Violation|0|||
146417905|NCT00289458|528033858|FG000|Overall Study|Death|1|||
146417906|NCT00289458|528033859|FG001|Overall Study|Death|0|||
146417907|NCT00289458|528033860|FG002|Overall Study|Death|0|||
146417908|NCT00289458|528033858|FG000|Overall Study|Physician Decision|3|||
146417909|NCT00289458|528033859|FG001|Overall Study|Physician Decision|4|||
146417910|NCT00289458|528033860|FG002|Overall Study|Physician Decision|2|||
146417911|NCT00289458|528033858|FG000|Overall Study|Withdrawal by Subject|2|||
146417912|NCT00289458|528033859|FG001|Overall Study|Withdrawal by Subject|2|||
146193528|NCT00517933|527219921|FG000|Period 1|Adverse Event|4|||
146193529|NCT00517933|527219922|FG001|Period 1|Adverse Event|4|||
146193530|NCT00517933|527219921|FG000|Period 1|Lost to Follow-up|2|||
146193531|NCT00517933|527219922|FG001|Period 1|Lost to Follow-up|0|||
146193532|NCT00517933|527219921|FG000|Period 1|Underwent lung transplant|0|||
146193533|NCT00517933|527219922|FG001|Period 1|Underwent lung transplant|1|||
146193534|NCT00517933|527219921|FG000|Period 2|Death|2|||
146193535|NCT00517933|527219922|FG001|Period 2|Death|4|||
146193536|NCT00517933|527219921|FG000|Period 2|Adverse Event|2|||
146193537|NCT00517933|527219922|FG001|Period 2|Adverse Event|4|||
146193538|NCT00517933|527219921|FG000|Period 2|Physician Decision|1|||
146417913|NCT00289458|528033860|FG002|Overall Study|Withdrawal by Subject|4|||
146417914|NCT00874757|528033861|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
146417915|NCT00982410|528035668|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
146417916|NCT00982410|528035669|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
146417917|NCT00982410|528035668|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
146417918|NCT00982410|528035669|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
146417919|NCT00982410|528035668|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
146417920|NCT00982410|528035669|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
146417921|NCT00982410|528035668|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
146417922|NCT00982410|528035669|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
146417923|NCT00982410|528035668|FG000|6-month Follow-up Assessment|participant no transportation|1|||
146193539|NCT00517933|527219922|FG001|Period 2|Physician Decision|0|||
146193540|NCT00517933|527219921|FG000|Period 2|Withdrawal by Subject|1|||
146193541|NCT00517933|527219922|FG001|Period 2|Withdrawal by Subject|3|||
146193542|NCT00517933|527219921|FG000|Period 2|Underwent lung transplant|0|||
146193543|NCT00517933|527219922|FG001|Period 2|Underwent lung transplant|2|||
146193544|NCT01649427|527219925|FG000|Overall Study|Adverse Event|1|||
146193545|NCT01649427|527219926|FG001|Overall Study|Adverse Event|1|||
146193546|NCT01649427|527219925|FG000|Overall Study|Withdrawal by Subject|8|||
146193547|NCT01649427|527219926|FG001|Overall Study|Withdrawal by Subject|7|||
146193548|NCT01649427|527219925|FG000|Overall Study|Lost to Follow-up|0|||
146193549|NCT01649427|527219926|FG001|Overall Study|Lost to Follow-up|1|||
146193550|NCT01649427|527219925|FG000|Overall Study|Graft loss|0|||
146193551|NCT01649427|527219926|FG001|Overall Study|Graft loss|1|||
146193552|NCT01649427|527219925|FG000|Overall Study|Surgical problems during nephrectomy|2|||
146193553|NCT01649427|527219926|FG001|Overall Study|Surgical problems during nephrectomy|2|||
146193554|NCT03717194|527219927|FG000|Overall Study|Withdrawal by Subject|2|||
146417924|NCT00982410|528035669|FG001|6-month Follow-up Assessment|participant no transportation|0|||
146417925|NCT00982410|528035668|FG000|6-month Follow-up Assessment|incarceration|0|||
146193555|NCT03717194|527219928|FG001|Overall Study|Withdrawal by Subject|4|||
146193556|NCT03717194|527219927|FG000|Overall Study|Adverse Event|1|||
146193557|NCT03717194|527219928|FG001|Overall Study|Adverse Event|1|||
146193558|NCT01836458|527219929|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146193559|NCT01836458|527219930|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146193560|NCT01836458|527219931|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146193561|NCT01836458|527219932|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
146193562|NCT00561574|527219934|FG000|Overall Study|Adverse Event|21|||
146417926|NCT00982410|528035669|FG001|6-month Follow-up Assessment|incarceration|2|||
146417927|NCT00982410|528035668|FG000|6-month Follow-up Assessment|patent surgery|0|||
146417928|NCT00982410|528035669|FG001|6-month Follow-up Assessment|patent surgery|1|||
146417929|NCT00982410|528035668|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
146417930|NCT00982410|528035669|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
146417931|NCT00982410|528035668|FG000|12-month Follow-up Assessment|Death|0|||
146417932|NCT00982410|528035669|FG001|12-month Follow-up Assessment|Death|2|||
146417933|NCT00982410|528035668|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
146417934|NCT00982410|528035669|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
146417935|NCT00982410|528035668|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
146417936|NCT00982410|528035669|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
146417937|NCT00982410|528035668|FG000|12-month Follow-up Assessment|incarceration|2|||
146417938|NCT00982410|528035669|FG001|12-month Follow-up Assessment|incarceration|1|||
146417939|NCT00982410|528035668|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
146417940|NCT00982410|528035669|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
146417941|NCT04014959|528035670|FG000|Baseline MRI and Assessments|Physician Decision|2|||
146417942|NCT04014959|528035670|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
146417943|NCT04014959|528035670|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
146417944|NCT02004847|528035671|FG000|Overall Study|Protocol Violation|1|||
146417945|NCT02004847|528035672|FG001|Overall Study|Protocol Violation|1|||
146417946|NCT03381248|528035676|FG000|0-6 Months|Withdrawal by Subject|4|||
146417947|NCT03381248|528035677|FG001|0-6 Months|Withdrawal by Subject|1|||
146417948|NCT03381248|528035676|FG000|0-6 Months|Lost to Follow-up|3|||
146417949|NCT03381248|528035677|FG001|0-6 Months|Lost to Follow-up|2|||
146417950|NCT03381248|528035676|FG000|0-6 Months|Lack of Efficacy|1|||
146417951|NCT03381248|528035677|FG001|0-6 Months|Lack of Efficacy|0|||
146417952|NCT03381248|528035676|FG000|0-6 Months|Adverse Event|1|||
146417953|NCT03381248|528035677|FG001|0-6 Months|Adverse Event|0|||
146417954|NCT03381248|528035676|FG000|0-6 Months|Protocol Violation|2|||
146417955|NCT03381248|528035677|FG001|0-6 Months|Protocol Violation|1|||
146417956|NCT03381248|528035676|FG000|0-6 Months|Physician Decision|1|||
146417957|NCT03381248|528035677|FG001|0-6 Months|Physician Decision|0|||
146417958|NCT03381248|528035676|FG000|0-6 Months|Planning another procedure|1|||
146417959|NCT03381248|528035677|FG001|0-6 Months|Planning another procedure|2|||
146417960|NCT03381248|528035676|FG000|6-12 Months|Withdrawal by Subject|1|||
146417961|NCT03381248|528035677|FG001|6-12 Months|Withdrawal by Subject|3|||
146417962|NCT03381248|528035676|FG000|6-12 Months|Lost to Follow-up|0|||
146417963|NCT03381248|528035677|FG001|6-12 Months|Lost to Follow-up|2|||
146417964|NCT03381248|528035676|FG000|6-12 Months|Protocol Violation|3|||
146417965|NCT03381248|528035677|FG001|6-12 Months|Protocol Violation|2|||
146417966|NCT03381248|528035676|FG000|6-12 Months|Planning another procedure|6|||
146417967|NCT03381248|528035677|FG001|6-12 Months|Planning another procedure|2|||
146417968|NCT03381248|528035676|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
146417969|NCT03381248|528035677|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
146417970|NCT03381248|528035676|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
146417971|NCT03381248|528035677|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
146417972|NCT03381248|528035676|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
146417973|NCT03381248|528035677|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
146417974|NCT00759148|528035678|FG000|Overall Study|Adverse Event|1|||
146417975|NCT00759148|528035679|FG001|Overall Study|Adverse Event|6|||
146417976|NCT00759148|528035678|FG000|Overall Study|Withdrawal by Subject|3|||
146417977|NCT00759148|528035679|FG001|Overall Study|Withdrawal by Subject|7|||
146417978|NCT00759148|528035678|FG000|Overall Study|Lost to Follow-up|3|||
146417979|NCT00759148|528035679|FG001|Overall Study|Lost to Follow-up|9|||
146417980|NCT00759148|528035678|FG000|Overall Study|Treatment Failure|6|||
146417981|NCT00759148|528035679|FG001|Overall Study|Treatment Failure|10|||
146417982|NCT00759148|528035678|FG000|Overall Study|Reason not given|1|||
146417983|NCT00759148|528035679|FG001|Overall Study|Reason not given|0|||
146417984|NCT05188521|528035680|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
146417985|NCT05188521|528035681|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
146417986|NCT01341639|528035682|FG000|Infant Series|Protocol Violation|1|||
146417987|NCT01341639|528035683|FG001|Infant Series|Protocol Violation|0|||
146417988|NCT01341639|528035682|FG000|Infant Series|Not Vaccinated|0|||
146417989|NCT01341639|528035683|FG001|Infant Series|Not Vaccinated|1|||
146417990|NCT01341639|528035682|FG000|Infant Series|Adverse Event|0|||
146417991|NCT01341639|528035683|FG001|Infant Series|Adverse Event|5|||
146417992|NCT01341639|528035682|FG000|Infant Series|Withdrawal by Subject|11|||
146417993|NCT01341639|528035683|FG001|Infant Series|Withdrawal by Subject|8|||
146417994|NCT01341639|528035682|FG000|Infant Series|Lost to Follow-up|0|||
146417995|NCT01341639|528035683|FG001|Infant Series|Lost to Follow-up|2|||
146417996|NCT01341639|528035682|FG000|Infant Series|Site 0048 Participants|17|||
146417997|NCT01341639|528035683|FG001|Infant Series|Site 0048 Participants|16|||
146417998|NCT01341639|528035682|FG000|Interim Period|Withdrawal by Subject|6|||
146417999|NCT01341639|528035683|FG001|Interim Period|Withdrawal by Subject|7|||
146418000|NCT01341639|528035682|FG000|Interim Period|Lost to Follow-up|2|||
146418001|NCT01341639|528035683|FG001|Interim Period|Lost to Follow-up|0|||
146418002|NCT01341639|528035682|FG000|Interim Period|Physician Decision|0|||
146418003|NCT01341639|528035683|FG001|Interim Period|Physician Decision|1|||
146418004|NCT01341639|528035682|FG000|Interim Period|Protocol Violation|0|||
146418005|NCT01341639|528035683|FG001|Interim Period|Protocol Violation|1|||
146418006|NCT01341639|528035682|FG000|Post-Treatment|Withdrawal by Subject|0|||
146418007|NCT01341639|528035683|FG001|Post-Treatment|Withdrawal by Subject|1|||
146418008|NCT01341639|528035682|FG000|Post-Treatment|Adverse Event|0|||
146418009|NCT01341639|528035683|FG001|Post-Treatment|Adverse Event|2|||
146418010|NCT04582266|528035684|FG000|Overall Study|Lost to Follow-up|7|||
146418011|NCT04582266|528035685|FG001|Overall Study|Lost to Follow-up|5|||
146418012|NCT04582266|528035684|FG000|Overall Study|Withdrawal by Subject|1|||
146418013|NCT04582266|528035685|FG001|Overall Study|Withdrawal by Subject|0|||
146418014|NCT04582266|528035684|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
146418015|NCT04582266|528035685|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
146418016|NCT02247479|528035686|FG000|Overall Study|Adverse Event|8|||
146418017|NCT02247479|528035687|FG001|Overall Study|Adverse Event|9|||
146418018|NCT02247479|528035688|FG002|Overall Study|Adverse Event|8|||
146418019|NCT02247479|528035686|FG000|Overall Study|Death|5|||
146418020|NCT02247479|528035687|FG001|Overall Study|Death|4|||
146418021|NCT02247479|528035688|FG002|Overall Study|Death|6|||
146418022|NCT02247479|528035686|FG000|Overall Study|Lost to Follow-up|3|||
146418023|NCT02247479|528035687|FG001|Overall Study|Lost to Follow-up|3|||
146418024|NCT02247479|528035688|FG002|Overall Study|Lost to Follow-up|1|||
146418025|NCT02247479|528035686|FG000|Overall Study|Non-compliance|0|||
146418026|NCT02247479|528035687|FG001|Overall Study|Non-compliance|0|||
146418027|NCT02247479|528035688|FG002|Overall Study|Non-compliance|1|||
146418028|NCT02247479|528035686|FG000|Overall Study|Withdrawal by Subject|25|||
146418029|NCT02247479|528035687|FG001|Overall Study|Withdrawal by Subject|29|||
146418030|NCT02247479|528035688|FG002|Overall Study|Withdrawal by Subject|24|||
146418031|NCT02247479|528035686|FG000|Overall Study|Study Terminated by Sponsor|98|||
146418032|NCT02247479|528035687|FG001|Overall Study|Study Terminated by Sponsor|88|||
146418033|NCT02247479|528035688|FG002|Overall Study|Study Terminated by Sponsor|94|||
146418034|NCT02247479|528035686|FG000|Overall Study|Physician Decision|1|||
146418035|NCT02247479|528035687|FG001|Overall Study|Physician Decision|0|||
146418036|NCT02247479|528035688|FG002|Overall Study|Physician Decision|2|||
146418037|NCT02247479|528035686|FG000|Overall Study|Unspecified Reason|2|||
146418038|NCT02247479|528035687|FG001|Overall Study|Unspecified Reason|5|||
146418039|NCT02247479|528035688|FG002|Overall Study|Unspecified Reason|2|||
146418040|NCT01132118|528035689|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
146418041|NCT01132118|528035690|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
146418042|NCT01132118|528035689|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146418043|NCT01132118|528035690|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
146418044|NCT01132118|528035689|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
146418045|NCT01132118|528035690|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
146418046|NCT01299038|528035693|FG000|Overall Study|Withdrawal by Subject|1|||
146418047|NCT01299038|528035694|FG001|Overall Study|Withdrawal by Subject|0|||
146418048|NCT00322556|528035695|FG000|Overall Study|Adverse Event|1|||
146418049|NCT00322556|528035695|FG000|Overall Study|Withdrawal by Subject|1|||
146418050|NCT00322556|528035695|FG000|Overall Study|Lost to Follow-up|3|||
146418051|NCT00322556|528035695|FG000|Overall Study|Other Reason|7|||
146418052|NCT01590433|528035696|FG000|Overall Study|Lost to Follow-up|20|||
146418053|NCT01590433|528035697|FG001|Overall Study|Lost to Follow-up|8|||
146418054|NCT01590433|528035696|FG000|Overall Study|Withdrawal by Subject|21|||
146418055|NCT01590433|528035697|FG001|Overall Study|Withdrawal by Subject|11|||
146418056|NCT01590433|528035696|FG000|Overall Study|Adverse Event|11|||
146418057|NCT01590433|528035697|FG001|Overall Study|Adverse Event|3|||
146418058|NCT00555009|528035698|FG000|Overall Study|Withdrawal by Subject|0|||
146418059|NCT00555009|528035699|FG001|Overall Study|Withdrawal by Subject|1|||
146418060|NCT00555009|528035698|FG000|Overall Study|Terminated by Sponsor|2|||
146418061|NCT00555009|528035699|FG001|Overall Study|Terminated by Sponsor|5|||
146418062|NCT02232074|528035700|FG000|Overall Study|Withdrawal by Subject|5|||
146418063|NCT02232074|528035701|FG001|Overall Study|Withdrawal by Subject|3|||
146418064|NCT02232074|528035700|FG000|Overall Study|No legal concerns at baseline|36|||
146418065|NCT02232074|528035701|FG001|Overall Study|No legal concerns at baseline|41|||
146418066|NCT02232074|528035700|FG000|Overall Study|deemed ineligible|0|||
146418067|NCT02232074|528035701|FG001|Overall Study|deemed ineligible|1|||
146418068|NCT02710071|528035705|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
146418069|NCT02710071|528035706|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
146418070|NCT02710071|528035705|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
146418071|NCT02710071|528035706|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
146418072|NCT02637557|528035709|FG000|Overall Study|Adverse Event|3|||
146418073|NCT02637557|528035710|FG001|Overall Study|Adverse Event|1|||
146418074|NCT02637557|528035711|FG002|Overall Study|Adverse Event|3|||
146418075|NCT02637557|528035712|FG003|Overall Study|Adverse Event|3|||
146418076|NCT02637557|528035709|FG000|Overall Study|Lost to Follow-up|1|||
146418077|NCT02637557|528035710|FG001|Overall Study|Lost to Follow-up|1|||
146418078|NCT02637557|528035711|FG002|Overall Study|Lost to Follow-up|0|||
146418079|NCT02637557|528035712|FG003|Overall Study|Lost to Follow-up|1|||
146418080|NCT02637557|528035709|FG000|Overall Study|Physician Decision|1|||
146418081|NCT02637557|528035710|FG001|Overall Study|Physician Decision|0|||
146418082|NCT02637557|528035711|FG002|Overall Study|Physician Decision|0|||
146418083|NCT02637557|528035712|FG003|Overall Study|Physician Decision|0|||
146418084|NCT02637557|528035709|FG000|Overall Study|Protocol Violation|2|||
146418085|NCT02637557|528035710|FG001|Overall Study|Protocol Violation|0|||
146418086|NCT02637557|528035711|FG002|Overall Study|Protocol Violation|2|||
146418087|NCT02637557|528035712|FG003|Overall Study|Protocol Violation|1|||
146418088|NCT02637557|528035709|FG000|Overall Study|Withdrawal by Subject|1|||
146418089|NCT02637557|528035710|FG001|Overall Study|Withdrawal by Subject|3|||
146418090|NCT02637557|528035711|FG002|Overall Study|Withdrawal by Subject|4|||
146418091|NCT02637557|528035712|FG003|Overall Study|Withdrawal by Subject|2|||
146418092|NCT01673009|528035717|FG000|Overall Study|Physician Decision|5|||
146418093|NCT01673009|528035717|FG000|Overall Study|Withdrawal by Subject|8|||
146418094|NCT01844583|528035718|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
146418095|NCT01844583|528035719|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
146418096|NCT00449072|528035723|FG000|Overall Study|Adverse Event|3|||
146193563|NCT00561574|527219935|FG001|Overall Study|Adverse Event|24|||
146193564|NCT00561574|527219934|FG000|Overall Study|Lack of Efficacy|11|||
146193565|NCT00561574|527219935|FG001|Overall Study|Lack of Efficacy|21|||
146193566|NCT00561574|527219934|FG000|Overall Study|Withdrawal by Subject|4|||
146193567|NCT00561574|527219935|FG001|Overall Study|Withdrawal by Subject|4|||
146193568|NCT00561574|527219934|FG000|Overall Study|Reason Unrelated to Trial|6|||
146193569|NCT00561574|527219935|FG001|Overall Study|Reason Unrelated to Trial|2|||
146418097|NCT00449072|528035724|FG001|Overall Study|Adverse Event|1|||
146418098|NCT00449072|528035723|FG000|Overall Study|Protocol Violation|14|||
146418099|NCT00449072|528035724|FG001|Overall Study|Protocol Violation|12|||
146418100|NCT00449072|528035723|FG000|Overall Study|Lost to Follow-up|5|||
146418101|NCT00449072|528035724|FG001|Overall Study|Lost to Follow-up|7|||
146418102|NCT00449072|528035723|FG000|Overall Study|Withdrawal by Subject|11|||
146418103|NCT00449072|528035724|FG001|Overall Study|Withdrawal by Subject|8|||
146418104|NCT00449072|528035723|FG000|Overall Study|Lack of Efficacy|1|||
146418105|NCT00449072|528035724|FG001|Overall Study|Lack of Efficacy|1|||
146418106|NCT00449072|528035723|FG000|Overall Study|Physician Decision|1|||
146418107|NCT00449072|528035724|FG001|Overall Study|Physician Decision|0|||
146418108|NCT00449072|528035723|FG000|Overall Study|Not treated|0|||
146418109|NCT00449072|528035724|FG001|Overall Study|Not treated|1|||
146418110|NCT00449072|528035723|FG000|Overall Study|Excluded medication|0|||
146418111|NCT00449072|528035724|FG001|Overall Study|Excluded medication|2|||
146418112|NCT00449072|528035723|FG000|Overall Study|Non-compliance|2|||
146418113|NCT00449072|528035724|FG001|Overall Study|Non-compliance|5|||
146418114|NCT00449072|528035723|FG000|Overall Study|Sponsor decision|1|||
146418115|NCT00449072|528035724|FG001|Overall Study|Sponsor decision|3|||
146418116|NCT00449072|528035723|FG000|Overall Study|Relocation|3|||
146418117|NCT00449072|528035724|FG001|Overall Study|Relocation|2|||
146418118|NCT01787825|528035725|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
146418119|NCT01787825|528035726|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
146418120|NCT01787825|528035725|FG000|Overall Study|Data Not Analyzable|5|||
146418121|NCT01787825|528035726|FG001|Overall Study|Data Not Analyzable|1|||
146418122|NCT00989261|528035732|FG000|Overall Study|Still in follow up|12|||
146418123|NCT00989261|528035733|FG001|Overall Study|Still in follow up|21|||
146418124|NCT00989261|528035732|FG000|Overall Study|Withdrawal by Subject|0|||
146418125|NCT00989261|528035733|FG001|Overall Study|Withdrawal by Subject|1|||
146418126|NCT00989261|528035732|FG000|Overall Study|Lost to Follow-up|3|||
146418127|NCT00989261|528035733|FG001|Overall Study|Lost to Follow-up|0|||
146418128|NCT01238848|528035734|FG000|Overall Study|Physician Decision|13|||
146418129|NCT01238848|528035735|FG001|Overall Study|Physician Decision|5|||
146418130|NCT00576901|528035736|FG000|Overall Study|Withdrawal by Subject|1|||
146418131|NCT00576901|528035736|FG000|Overall Study|Disease course|1|||
146418132|NCT00576901|528035736|FG000|Overall Study|Protocol Violation|1|||
146418133|NCT02398188|528035737|FG000|Overall Study|Adverse Event|2|||
146418134|NCT02398188|528035738|FG001|Overall Study|Adverse Event|3|||
146418135|NCT02398188|528035737|FG000|Overall Study|Lost to Follow-up|5|||
146418136|NCT02398188|528035738|FG001|Overall Study|Lost to Follow-up|0|||
146418137|NCT02398188|528035737|FG000|Overall Study|Non-compliance|4|||
146418138|NCT02398188|528035738|FG001|Overall Study|Non-compliance|4|||
146418139|NCT02398188|528035737|FG000|Overall Study|Protocol Violation|6|||
146418140|NCT02398188|528035738|FG001|Overall Study|Protocol Violation|10|||
146418141|NCT02398188|528035737|FG000|Overall Study|Sponsor Decision|2|||
146418142|NCT02398188|528035738|FG001|Overall Study|Sponsor Decision|1|||
146418143|NCT02398188|528035737|FG000|Overall Study|Pregnancy|1|||
146418144|NCT02398188|528035738|FG001|Overall Study|Pregnancy|0|||
146418145|NCT02398188|528035737|FG000|Overall Study|Withdrawal by Subject|7|||
146418146|NCT02398188|528035738|FG001|Overall Study|Withdrawal by Subject|16|||
146418147|NCT01259869|528035739|FG000|Overall Study|Duplicated registration|1|||
146418148|NCT03209570|528035744|FG000|Overall Study|Death|1|||
146193570|NCT00561574|527219934|FG000|Overall Study|Lost to Follow-up|1|||
146193571|NCT00561574|527219935|FG001|Overall Study|Lost to Follow-up|0|||
146193572|NCT00561574|527219934|FG000|Overall Study|Other|5|||
146193573|NCT00561574|527219935|FG001|Overall Study|Other|7|||
146193574|NCT00445692|527219936|FG000|Overall Study|Adverse Event|11|||
146193575|NCT00445692|527219936|FG000|Overall Study|Lack of Efficacy|5|||
146193576|NCT00430677|527219940|FG000|Short-term Period|Death|1|||
146193577|NCT00430677|527219941|FG001|Short-term Period|Death|1|||
146193578|NCT00430677|527219942|FG002|Short-term Period|Death|5|||
146193579|NCT00430677|527219940|FG000|Short-term Period|Adverse Event|15|||
146193580|NCT00430677|527219941|FG001|Short-term Period|Adverse Event|13|||
146193581|NCT00430677|527219942|FG002|Short-term Period|Adverse Event|9|||
146193582|NCT00430677|527219940|FG000|Short-term Period|Lack of Efficacy|5|||
146193583|NCT00430677|527219941|FG001|Short-term Period|Lack of Efficacy|6|||
146193584|NCT00430677|527219942|FG002|Short-term Period|Lack of Efficacy|4|||
146193585|NCT00430677|527219940|FG000|Short-term Period|Withdrawal by Subject|1|||
146193586|NCT00430677|527219941|FG001|Short-term Period|Withdrawal by Subject|1|||
146193587|NCT00430677|527219942|FG002|Short-term Period|Withdrawal by Subject|2|||
146193588|NCT00430677|527219940|FG000|Short-term Period|Participant no longer met study criteria|1|||
146193589|NCT00430677|527219941|FG001|Short-term Period|Participant no longer met study criteria|1|||
146193590|NCT00430677|527219942|FG002|Short-term Period|Participant no longer met study criteria|2|||
146193591|NCT00430677|527219940|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
146193592|NCT00430677|527219941|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
146193593|NCT00430677|527219942|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
146193594|NCT00430677|527219940|FG000|Short-term Period|Pregnancy|0|||
146193595|NCT00430677|527219941|FG001|Short-term Period|Pregnancy|2|||
146193596|NCT00430677|527219942|FG002|Short-term Period|Pregnancy|0|||
146193597|NCT00430677|527219940|FG000|Long-term Extension Period|Death|1|||
146193598|NCT00430677|527219941|FG001|Long-term Extension Period|Death|0|||
146193599|NCT00430677|527219942|FG002|Long-term Extension Period|Death|0|||
146193600|NCT00430677|527219940|FG000|Long-term Extension Period|Adverse Event|3|||
146193601|NCT00430677|527219941|FG001|Long-term Extension Period|Adverse Event|2|||
146193602|NCT00430677|527219942|FG002|Long-term Extension Period|Adverse Event|5|||
146193603|NCT00430677|527219940|FG000|Long-term Extension Period|Lack of Efficacy|5|||
146418149|NCT03209570|528035745|FG001|Overall Study|Death|0|||
146418150|NCT03209570|528035744|FG000|Overall Study|Incomplete Data|8|||
146418151|NCT03209570|528035745|FG001|Overall Study|Incomplete Data|10|||
146418152|NCT03209570|528035744|FG000|Overall Study|Protocol Violation|1|||
146418153|NCT03209570|528035745|FG001|Overall Study|Protocol Violation|0|||
146418154|NCT03209570|528035744|FG000|Overall Study|Withdrawal by Subject|0|||
146418155|NCT03209570|528035745|FG001|Overall Study|Withdrawal by Subject|3|||
146418156|NCT00220701|528035746|FG000|Overall Study|Lost to Follow-up|5|||
146193604|NCT00430677|527219941|FG001|Long-term Extension Period|Lack of Efficacy|3|||
146193605|NCT00430677|527219942|FG002|Long-term Extension Period|Lack of Efficacy|8|||
146193606|NCT00430677|527219940|FG000|Long-term Extension Period|Lost to Follow-up|1|||
146193607|NCT00430677|527219941|FG001|Long-term Extension Period|Lost to Follow-up|1|||
146418157|NCT00220701|528035747|FG001|Overall Study|Lost to Follow-up|4|||
146418158|NCT00755326|528035749|FG000|Overall Study|Lost to Follow-up|2|||
146418159|NCT00755326|528035750|FG001|Overall Study|Lost to Follow-up|3|||
146418160|NCT00368966|528035757|FG000|Infant Series|Withdrawal by Subject|11|||
146418161|NCT00368966|528035758|FG001|Infant Series|Withdrawal by Subject|6|||
146418162|NCT00368966|528035757|FG000|Infant Series|Protocol Violation|2|||
146193608|NCT00430677|527219942|FG002|Long-term Extension Period|Lost to Follow-up|1|||
146193609|NCT00430677|527219940|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
146193610|NCT00430677|527219941|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
146193611|NCT00430677|527219942|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
146193612|NCT00430677|527219940|FG000|Long-term Extension Period|Pregnancy|1|||
146418163|NCT00368966|528035758|FG001|Infant Series|Protocol Violation|1|||
146418164|NCT00368966|528035757|FG000|Infant Series|Lost to Follow-up|2|||
146418165|NCT00368966|528035758|FG001|Infant Series|Lost to Follow-up|0|||
146193613|NCT00430677|527219941|FG001|Long-term Extension Period|Pregnancy|1|||
146193614|NCT00430677|527219942|FG002|Long-term Extension Period|Pregnancy|0|||
146418166|NCT00368966|528035757|FG000|Infant Series|Randomization error|0|||
146418167|NCT00368966|528035758|FG001|Infant Series|Randomization error|1|||
146418168|NCT00368966|528035757|FG000|Infant Series|Failed to meet eligibility criteria|0|||
146418169|NCT00368966|528035758|FG001|Infant Series|Failed to meet eligibility criteria|1|||
146418170|NCT00368966|528035757|FG000|Infant Series|Adverse Event|0|||
146418171|NCT00368966|528035758|FG001|Infant Series|Adverse Event|1|||
146418172|NCT00368966|528035757|FG000|Infant Series|Failed to return|1|||
146418173|NCT00368966|528035758|FG001|Infant Series|Failed to return|0|||
146418174|NCT00368966|528035757|FG000|After Infant|Failed to return|3|||
146418175|NCT00368966|528035758|FG001|After Infant|Failed to return|1|||
146418176|NCT00368966|528035757|FG000|After Infant|Adverse Event|1|||
146418177|NCT00368966|528035758|FG001|After Infant|Adverse Event|2|||
146418178|NCT00368966|528035757|FG000|After Infant|Withdrawal by Subject|1|||
146418179|NCT00368966|528035758|FG001|After Infant|Withdrawal by Subject|1|||
146418180|NCT00368966|528035757|FG000|After Infant|Death|1|||
146418181|NCT00368966|528035758|FG001|After Infant|Death|0|||
146418182|NCT00368966|528035757|FG000|After Infant|Lost to Follow-up|0|||
146418183|NCT00368966|528035758|FG001|After Infant|Lost to Follow-up|1|||
146418184|NCT00368966|528035757|FG000|Toddler Dose|Withdrawal by Subject|1|||
146418185|NCT00368966|528035758|FG001|Toddler Dose|Withdrawal by Subject|1|||
146418186|NCT00368966|528035757|FG000|Toddler Dose|Lost to Follow-up|0|||
146418187|NCT00368966|528035758|FG001|Toddler Dose|Lost to Follow-up|2|||
146418188|NCT01689974|528035759|FG000|Overall Study|Termination of Study|5|||
146418189|NCT01689974|528035760|FG001|Overall Study|Termination of Study|5|||
146418190|NCT01333033|528035761|FG000|Overall Study|Ineligible|0|||
146418191|NCT01333033|528035762|FG001|Overall Study|Ineligible|0|||
146418192|NCT01333033|528035763|FG002|Overall Study|Ineligible|0|||
146418193|NCT01333033|528035764|FG003|Overall Study|Ineligible|0|||
146418194|NCT01333033|528035765|FG004|Overall Study|Ineligible|6|||
146418195|NCT01333033|528035766|FG005|Overall Study|Ineligible|8|||
146418196|NCT01333033|528035761|FG000|Overall Study|Withdrawal by Subject|0|||
146418197|NCT01333033|528035762|FG001|Overall Study|Withdrawal by Subject|0|||
146418198|NCT01333033|528035763|FG002|Overall Study|Withdrawal by Subject|0|||
146418199|NCT01333033|528035764|FG003|Overall Study|Withdrawal by Subject|0|||
146418200|NCT01333033|528035765|FG004|Overall Study|Withdrawal by Subject|4|||
146418201|NCT01333033|528035766|FG005|Overall Study|Withdrawal by Subject|2|||
146418202|NCT01333033|528035761|FG000|Overall Study|PET inevaluable|0|||
146418203|NCT01333033|528035762|FG001|Overall Study|PET inevaluable|0|||
146418204|NCT01333033|528035763|FG002|Overall Study|PET inevaluable|0|||
146418205|NCT01333033|528035764|FG003|Overall Study|PET inevaluable|0|||
146418206|NCT01333033|528035765|FG004|Overall Study|PET inevaluable|2|||
146418207|NCT01333033|528035766|FG005|Overall Study|PET inevaluable|4|||
146418208|NCT01333033|528035761|FG000|Overall Study|Adverse Event|0|||
146418209|NCT01333033|528035762|FG001|Overall Study|Adverse Event|0|||
146418210|NCT01333033|528035763|FG002|Overall Study|Adverse Event|0|||
146418211|NCT01333033|528035764|FG003|Overall Study|Adverse Event|0|||
146418212|NCT01333033|528035765|FG004|Overall Study|Adverse Event|2|||
146418213|NCT01333033|528035766|FG005|Overall Study|Adverse Event|1|||
146418214|NCT01333033|528035761|FG000|Overall Study|Progression|0|||
146418215|NCT01333033|528035762|FG001|Overall Study|Progression|0|||
146418216|NCT01333033|528035763|FG002|Overall Study|Progression|0|||
146418217|NCT01333033|528035764|FG003|Overall Study|Progression|0|||
146418218|NCT01333033|528035765|FG004|Overall Study|Progression|0|||
146418219|NCT01333033|528035766|FG005|Overall Study|Progression|1|||
146418220|NCT01333033|528035761|FG000|Overall Study|MD Decision|0|||
146418221|NCT01333033|528035762|FG001|Overall Study|MD Decision|0|||
146418222|NCT01333033|528035763|FG002|Overall Study|MD Decision|0|||
146418223|NCT01333033|528035764|FG003|Overall Study|MD Decision|0|||
146418224|NCT01333033|528035765|FG004|Overall Study|MD Decision|0|||
146418225|NCT01333033|528035766|FG005|Overall Study|MD Decision|2|||
146418226|NCT01388647|528035769|FG000|Overall Study|Adverse Event|1|||
146418227|NCT01388647|528035770|FG001|Overall Study|Adverse Event|2|||
146418228|NCT01336894|528035772|FG000|Follow-up|Study terminated prematurely|2|||
146418229|NCT01336894|528035773|FG001|Follow-up|Study terminated prematurely|7|||
146418230|NCT00903383|528035779|FG000|Overall Study|Adverse Event|1|||
146418231|NCT00903383|528035780|FG001|Overall Study|Adverse Event|2|||
146418232|NCT00903383|528035781|FG002|Overall Study|Adverse Event|3|||
146418233|NCT00903383|528035782|FG003|Overall Study|Adverse Event|1|||
146418234|NCT00903383|528035779|FG000|Overall Study|Physician Decision|1|||
146418235|NCT00903383|528035780|FG001|Overall Study|Physician Decision|2|||
146418236|NCT00903383|528035781|FG002|Overall Study|Physician Decision|0|||
146418237|NCT00903383|528035782|FG003|Overall Study|Physician Decision|0|||
146418238|NCT00903383|528035779|FG000|Overall Study|Lost to Follow-up|0|||
146418239|NCT00903383|528035780|FG001|Overall Study|Lost to Follow-up|0|||
146418240|NCT00903383|528035781|FG002|Overall Study|Lost to Follow-up|0|||
146418241|NCT00903383|528035782|FG003|Overall Study|Lost to Follow-up|1|||
146418242|NCT00903383|528035779|FG000|Overall Study|Decision of Sponsor|1|||
146418243|NCT00903383|528035780|FG001|Overall Study|Decision of Sponsor|0|||
146418244|NCT00903383|528035781|FG002|Overall Study|Decision of Sponsor|0|||
146418245|NCT00903383|528035782|FG003|Overall Study|Decision of Sponsor|0|||
146418246|NCT00903383|528035779|FG000|Overall Study|Withdrawal by Subject|4|||
146418247|NCT00903383|528035780|FG001|Overall Study|Withdrawal by Subject|1|||
146418248|NCT00903383|528035781|FG002|Overall Study|Withdrawal by Subject|0|||
146418249|NCT00903383|528035782|FG003|Overall Study|Withdrawal by Subject|2|||
146418250|NCT00903383|528035779|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
146418251|NCT00903383|528035780|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
146418252|NCT00903383|528035781|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
146418253|NCT00903383|528035782|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
146418254|NCT00903383|528035779|FG000|Overall Study|Patient Decision|0|||
146418255|NCT00903383|528035780|FG001|Overall Study|Patient Decision|0|||
146418256|NCT00903383|528035781|FG002|Overall Study|Patient Decision|0|||
146418257|NCT00903383|528035782|FG003|Overall Study|Patient Decision|1|||
146418258|NCT02015793|528035790|FG000|Overall Study|Adverse Event|3|||
146418259|NCT02015793|528035791|FG001|Overall Study|Adverse Event|3|||
146418260|NCT02015793|528035790|FG000|Overall Study|Withdrawal by Subject|1|||
146418261|NCT02015793|528035791|FG001|Overall Study|Withdrawal by Subject|1|||
146418262|NCT00320593|528035792|FG000|Overall Study|Lost to Follow-up|3|||
146418263|NCT00320593|528035793|FG001|Overall Study|Lost to Follow-up|0|||
146418264|NCT00320593|528035792|FG000|Overall Study|Moved to another state|1|||
146418265|NCT00320593|528035793|FG001|Overall Study|Moved to another state|0|||
146418266|NCT00320593|528035792|FG000|Overall Study|Withdrawal by Subject|2|||
146418267|NCT00320593|528035793|FG001|Overall Study|Withdrawal by Subject|1|||
146418268|NCT00320593|528035792|FG000|Overall Study|Withdrawal by clinical center|1|||
146418269|NCT00320593|528035793|FG001|Overall Study|Withdrawal by clinical center|0|||
146418270|NCT01076166|528035794|FG000|Overall Study|Adverse Event|3|||
146418271|NCT01076166|528035794|FG000|Overall Study|Symptoms improved/resolved|6|||
146418272|NCT00638157|528035797|FG000|Overall Study|Adverse Event|0|||
146418273|NCT00638157|528035798|FG001|Overall Study|Adverse Event|1|||
146418274|NCT00638157|528035797|FG000|Overall Study|Clinical (symptomatic) failure|1|||
146418275|NCT00638157|528035798|FG001|Overall Study|Clinical (symptomatic) failure|1|||
146418276|NCT00638157|528035797|FG000|Overall Study|Microbiological failure|1|||
146418277|NCT00638157|528035798|FG001|Overall Study|Microbiological failure|0|||
146418278|NCT00638157|528035797|FG000|Overall Study|Lost to Follow-up|1|||
146418279|NCT00638157|528035798|FG001|Overall Study|Lost to Follow-up|0|||
146418280|NCT00638157|528035797|FG000|Overall Study|Physician Decision|1|||
146418281|NCT00638157|528035798|FG001|Overall Study|Physician Decision|0|||
146418282|NCT00638157|528035797|FG000|Overall Study|Other|1|||
146418283|NCT00638157|528035798|FG001|Overall Study|Other|2|||
146418284|NCT00638157|528035797|FG000|Overall Study|Randomized, not treated|2|||
146418285|NCT00638157|528035798|FG001|Overall Study|Randomized, not treated|0|||
146418286|NCT02110706|528035799|FG000|Overall Study|Adverse Event|2|||
146418287|NCT02110706|528035800|FG001|Overall Study|Adverse Event|3|||
146418288|NCT02110706|528035799|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
146418289|NCT02110706|528035800|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
146418290|NCT02970669|528035805|FG000|Double-blind Period|Adverse Event|4|||
146418291|NCT02970669|528035806|FG001|Double-blind Period|Adverse Event|0|||
146418292|NCT02970669|528035805|FG000|Double-blind Period|Death|1|||
146418293|NCT02970669|528035806|FG001|Double-blind Period|Death|0|||
146418294|NCT02970669|528035805|FG000|Double-blind Period|Study terminated by sponsor|1|||
146418295|NCT02970669|528035806|FG001|Double-blind Period|Study terminated by sponsor|2|||
146418296|NCT02970669|528035805|FG000|Double-blind Period|Physician Decision|0|||
146082378|NCT04449029|526822775|FG002|Overall Study|Withdrawal by Subject|1|||
146418297|NCT02970669|528035806|FG001|Double-blind Period|Physician Decision|2|||
146418298|NCT02970669|528035805|FG000|Double-blind Period|Withdrawal by Subject|2|||
146082379|NCT04449029|526822776|FG003|Overall Study|Withdrawal by Subject|1|||
146418299|NCT02970669|528035806|FG001|Double-blind Period|Withdrawal by Subject|2|||
146418300|NCT02970669|528035805|FG000|Open-label Period|Withdrawal by Subject|2|||
146418301|NCT02970669|528035806|FG001|Open-label Period|Withdrawal by Subject|2|||
146418302|NCT02970669|528035805|FG000|Open-label Period|Adverse Event|1|||
146418303|NCT02970669|528035806|FG001|Open-label Period|Adverse Event|0|||
146082380|NCT04449029|526822777|FG004|Overall Study|Withdrawal by Subject|5|||
146418304|NCT02970669|528035805|FG000|Open-label Period|Physician Decision|1|||
146418305|NCT02970669|528035806|FG001|Open-label Period|Physician Decision|0|||
146418306|NCT00876733|528035809|FG000|Overall Study|Adverse Event|34|||
146418307|NCT00876733|528035810|FG001|Overall Study|Adverse Event|20|||
146418308|NCT00876733|528035811|FG002|Overall Study|Adverse Event|10|||
146418309|NCT00876733|528035812|FG003|Overall Study|Adverse Event|3|||
146418310|NCT00876733|528035809|FG000|Overall Study|Lack of Efficacy|17|||
146418311|NCT00876733|528035810|FG001|Overall Study|Lack of Efficacy|9|||
146418312|NCT00876733|528035811|FG002|Overall Study|Lack of Efficacy|10|||
146418313|NCT00876733|528035812|FG003|Overall Study|Lack of Efficacy|1|||
146418314|NCT00876733|528035809|FG000|Overall Study|Lost to Follow-up|26|||
146418315|NCT00876733|528035810|FG001|Overall Study|Lost to Follow-up|10|||
146418316|NCT00876733|528035811|FG002|Overall Study|Lost to Follow-up|3|||
146418317|NCT00876733|528035812|FG003|Overall Study|Lost to Follow-up|2|||
146418318|NCT00876733|528035809|FG000|Overall Study|Data not available|14|||
146418319|NCT00876733|528035810|FG001|Overall Study|Data not available|3|||
146418320|NCT00876733|528035811|FG002|Overall Study|Data not available|7|||
146418321|NCT00876733|528035812|FG003|Overall Study|Data not available|1|||
146418322|NCT02611752|528035815|FG000|Overall Study|Adverse Event|0|||
146418323|NCT02611752|528035816|FG001|Overall Study|Adverse Event|1|||
146418324|NCT02843074|528035817|FG000|Overall Study|Withdrawal by Subject|5|||
146418325|NCT02843074|528035817|FG000|Overall Study|Progressive disease|1|||
146418326|NCT02843074|528035817|FG000|Overall Study|Physician Decision|1|||
146418327|NCT02843074|528035817|FG000|Overall Study|Lost to Follow-up|1|||
146418328|NCT02843074|528035817|FG000|Overall Study|Death|9|||
146418329|NCT03521999|528035818|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
146418330|NCT03521999|528035819|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
146418331|NCT03521999|528035818|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
146418332|NCT03521999|528035819|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
146418333|NCT03521999|528035818|FG000|Completed 3 Month Follow up|Death|0|||
146418334|NCT03521999|528035819|FG001|Completed 3 Month Follow up|Death|1|||
146418335|NCT03521999|528035818|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
146418336|NCT03521999|528035819|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
146418337|NCT01564758|528035820|FG000|Overall Study|Death|8|||
146418338|NCT01564758|528035820|FG000|Overall Study|Adverse Event|3|||
146418339|NCT01564758|528035820|FG000|Overall Study|Other|3|||
146418340|NCT01185288|528035824|FG000|Overall Study|Adverse Event|7|||
146418341|NCT01185288|528035825|FG001|Overall Study|Adverse Event|6|||
146418342|NCT01185288|528035824|FG000|Overall Study|Withdrawal by Subject|6|||
146418343|NCT01185288|528035825|FG001|Overall Study|Withdrawal by Subject|4|||
146418344|NCT01185288|528035824|FG000|Overall Study|Lost to Follow-up|2|||
146418345|NCT01185288|528035825|FG001|Overall Study|Lost to Follow-up|5|||
146418346|NCT01185288|528035824|FG000|Overall Study|Lack of Efficacy|2|||
146418347|NCT01185288|528035825|FG001|Overall Study|Lack of Efficacy|0|||
146418348|NCT01185288|528035824|FG000|Overall Study|Investigator discretion|1|||
146418349|NCT01185288|528035825|FG001|Overall Study|Investigator discretion|0|||
146418350|NCT01185288|528035824|FG000|Overall Study|Did not meet inclusion criteria|1|||
146418351|NCT01185288|528035825|FG001|Overall Study|Did not meet inclusion criteria|0|||
146418352|NCT01185288|528035824|FG000|Overall Study|Noncompliance|0|||
146418353|NCT01185288|528035825|FG001|Overall Study|Noncompliance|1|||
146418354|NCT02427607|528035826|FG000|Overall Study|Withdrawal by Subject|1|||
146418355|NCT02277769|528035827|FG000|Overall Study|Protocol Violation|3|||
146418356|NCT02277769|528035828|FG001|Overall Study|Protocol Violation|3|||
146418357|NCT02277769|528035829|FG002|Overall Study|Protocol Violation|5|||
146418358|NCT02277769|528035827|FG000|Overall Study|Lack of Efficacy|17|||
146418359|NCT02277769|528035828|FG001|Overall Study|Lack of Efficacy|0|||
146418360|NCT02277769|528035829|FG002|Overall Study|Lack of Efficacy|4|||
146418361|NCT02277769|528035827|FG000|Overall Study|Adverse Event|14|||
146418362|NCT02277769|528035828|FG001|Overall Study|Adverse Event|2|||
146418363|NCT02277769|528035829|FG002|Overall Study|Adverse Event|4|||
146418364|NCT02277769|528035827|FG000|Overall Study|Other than specified above|12|||
146418365|NCT02277769|528035828|FG001|Overall Study|Other than specified above|8|||
146418366|NCT02277769|528035829|FG002|Overall Study|Other than specified above|5|||
146418367|NCT00656019|528035830|FG000|Overall Study|Not Eligible|10|||
146418368|NCT00656019|528035831|FG001|Overall Study|Not Eligible|0|||
146418369|NCT00656019|528035832|FG002|Overall Study|Not Eligible|0|||
146418370|NCT00656019|528035833|FG003|Overall Study|Not Eligible|0|||
146418371|NCT00656019|528035830|FG000|Overall Study|Withdrawal by Subject|2|||
146418372|NCT00656019|528035831|FG001|Overall Study|Withdrawal by Subject|0|||
146418373|NCT00656019|528035832|FG002|Overall Study|Withdrawal by Subject|0|||
146418374|NCT00656019|528035833|FG003|Overall Study|Withdrawal by Subject|0|||
146418375|NCT00656019|528035830|FG000|Overall Study|Lost to Follow-up|2|||
146418376|NCT00656019|528035831|FG001|Overall Study|Lost to Follow-up|1|||
146418377|NCT00656019|528035832|FG002|Overall Study|Lost to Follow-up|0|||
146418378|NCT00656019|528035833|FG003|Overall Study|Lost to Follow-up|0|||
146418379|NCT01326026|528035839|FG000|Overall Study|Adverse Event|4|||
146418380|NCT01326026|528035840|FG001|Overall Study|Adverse Event|3|||
146418381|NCT01326026|528035839|FG000|Overall Study|Withdrawal Criteria|5|||
146418382|NCT01326026|528035840|FG001|Overall Study|Withdrawal Criteria|7|||
146418383|NCT01326026|528035839|FG000|Overall Study|Other|3|||
146418384|NCT01326026|528035840|FG001|Overall Study|Other|3|||
146418385|NCT04317053|528035847|FG000|Overall Study|Withdrawn (screen failure)|4|||
146418386|NCT04317053|528035848|FG001|Overall Study|Withdrawn (screen failure)|2|||
146418387|NCT01073020|528037286|FG000|Overall Study|Withdrawal by Subject|6|||
146418388|NCT01073020|528037287|FG001|Overall Study|Withdrawal by Subject|4|||
146418389|NCT01073020|528037288|FG002|Overall Study|Withdrawal by Subject|1|||
146418390|NCT01073020|528037289|FG003|Overall Study|Withdrawal by Subject|2|||
146418391|NCT01073020|528037286|FG000|Overall Study|Physician Decision|1|||
146418392|NCT01073020|528037287|FG001|Overall Study|Physician Decision|0|||
146418393|NCT01073020|528037288|FG002|Overall Study|Physician Decision|2|||
146418394|NCT01073020|528037289|FG003|Overall Study|Physician Decision|0|||
146418395|NCT01073020|528037286|FG000|Overall Study|Death|0|||
146418396|NCT01073020|528037287|FG001|Overall Study|Death|1|||
146418397|NCT01073020|528037288|FG002|Overall Study|Death|0|||
146418398|NCT01073020|528037289|FG003|Overall Study|Death|0|||
146418399|NCT01644890|528037290|FG000|Overall Study|Adverse Event|7|||
146418400|NCT01644890|528037291|FG001|Overall Study|Adverse Event|20|||
146418401|NCT01644890|528037290|FG000|Overall Study|Death|1|||
146418402|NCT01644890|528037291|FG001|Overall Study|Death|3|||
146418403|NCT01644890|528037290|FG000|Overall Study|Physician Decision|3|||
146418404|NCT01644890|528037291|FG001|Overall Study|Physician Decision|9|||
146418405|NCT01644890|528037290|FG000|Overall Study|Protocol Violation|6|||
146418406|NCT01644890|528037291|FG001|Overall Study|Protocol Violation|7|||
146418407|NCT01644890|528037290|FG000|Overall Study|Withdrawal by Subject|19|||
146418408|NCT01644890|528037291|FG001|Overall Study|Withdrawal by Subject|27|||
146418409|NCT01644890|528037290|FG000|Overall Study|Progression Disease|160|||
146418410|NCT01644890|528037291|FG001|Overall Study|Progression Disease|131|||
146418411|NCT01644890|528037290|FG000|Overall Study|Clinical Progression|6|||
146418412|NCT01644890|528037291|FG001|Overall Study|Clinical Progression|6|||
146418413|NCT01644890|528037290|FG000|Overall Study|> 28 days since last dose of study drug|6|||
146418414|NCT01644890|528037291|FG001|Overall Study|> 28 days since last dose of study drug|3|||
146418415|NCT01644890|528037290|FG000|Overall Study|Other|8|||
146418416|NCT01644890|528037291|FG001|Overall Study|Other|9|||
146418417|NCT03031899|528037296|FG000|Overall Study|Protocol Violation|1|||
146418418|NCT03031899|528037296|FG000|Overall Study|lesion disappeared after stopping habit|1|||
146418419|NCT01060670|528037297|FG000|Run In|screen failure|0|||
146418420|NCT01060670|528037298|FG001|Run In|screen failure|238|||
146418421|NCT00094302|528037299|FG000|Overall Study|Lost to Follow-up|43|||
146418422|NCT00094302|528037300|FG001|Overall Study|Lost to Follow-up|41|||
146418423|NCT00094302|528037299|FG000|Overall Study|Physician Decision|5|||
146418424|NCT00094302|528037300|FG001|Overall Study|Physician Decision|8|||
146418425|NCT00094302|528037299|FG000|Overall Study|Withdrawal by Subject|103|||
146418426|NCT00094302|528037300|FG001|Overall Study|Withdrawal by Subject|111|||
146418427|NCT00094302|528037299|FG000|Overall Study|Death|266|||
146418428|NCT00094302|528037300|FG001|Overall Study|Death|246|||
146418429|NCT03705351|528037306|FG000|Overall Study|Study termination|3|||
146418430|NCT03705351|528037306|FG000|Overall Study|Death|1|||
146418431|NCT03705351|528037306|FG000|Overall Study|Lack of Efficacy|2|||
146418432|NCT03705351|528037306|FG000|Overall Study|Withdrawal by Subject|1|||
146418433|NCT01907087|528037311|FG000|Overall Study|Withdrawal by Subject|1|||
146418434|NCT02180061|528037312|FG000|Overall Study|Adverse Event|4|||
146418435|NCT02180061|528037313|FG001|Overall Study|Adverse Event|2|||
146418436|NCT02180061|528037312|FG000|Overall Study|Clinical Progression|5|||
146418437|NCT02180061|528037313|FG001|Overall Study|Clinical Progression|1|||
146418438|NCT02180061|528037312|FG000|Overall Study|Progressive Disease|15|||
146082381|NCT04449029|526822778|FG005|Overall Study|Withdrawal by Subject|1|||
146418439|NCT02180061|528037313|FG001|Overall Study|Progressive Disease|5|||
146418440|NCT02180061|528037312|FG000|Overall Study|Physician Decision|1|||
146418441|NCT02180061|528037313|FG001|Overall Study|Physician Decision|0|||
146418442|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
146418443|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
146285351|NCT01293487|527557843|FG005|Overall Study|Lost to Follow-up|0|||
146418444|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
146418445|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
146418446|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
146418447|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
146418448|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
146418449|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
146418450|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
146418451|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
146418452|NCT00056160|528037316|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
146418453|NCT00056160|528037317|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
146418454|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
146193615|NCT00430677|527219940|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
146193616|NCT00430677|527219941|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
146193617|NCT00430677|527219942|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
146193618|NCT00430677|527219940|FG000|Long-term Extension Period|Other|2|||
146418455|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
146418456|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
146418457|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
146418458|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
146418459|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
146418460|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
146418461|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
146418462|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
146418463|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
146418464|NCT00056160|528037316|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
146418465|NCT00056160|528037317|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
146418466|NCT00056160|528037316|FG000|Final Follow-up|Transferred into expanded access study.|3|||
146418467|NCT00056160|528037317|FG001|Final Follow-up|Transferred into expanded access study.|0|||
146418468|NCT00056160|528037316|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
146418469|NCT00056160|528037317|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
146418470|NCT00056160|528037316|FG000|Final Follow-up|Adverse Event|1|||
146418471|NCT00056160|528037317|FG001|Final Follow-up|Adverse Event|0|||
146418472|NCT01469364|528037319|FG000|Overall Study|Adverse Event|1|||
146193619|NCT00430677|527219941|FG001|Long-term Extension Period|Other|1|||
146193620|NCT00430677|527219942|FG002|Long-term Extension Period|Other|1|||
146193621|NCT00430677|527219940|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
146193622|NCT00430677|527219941|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
146193623|NCT00430677|527219942|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
146193624|NCT02040844|527219945|FG000|Overall Study|Adverse Event|0|||
146193625|NCT02040844|527219946|FG001|Overall Study|Adverse Event|0|||
146193626|NCT02040844|527219947|FG002|Overall Study|Adverse Event|1|||
146193627|NCT02040844|527219945|FG000|Overall Study|Withdrawal by Subject|16|||
146193628|NCT02040844|527219946|FG001|Overall Study|Withdrawal by Subject|22|||
146193629|NCT02040844|527219947|FG002|Overall Study|Withdrawal by Subject|25|||
146193630|NCT02040844|527219945|FG000|Overall Study|Lost to Follow-up|12|||
146193631|NCT02040844|527219946|FG001|Overall Study|Lost to Follow-up|9|||
146193632|NCT02040844|527219947|FG002|Overall Study|Lost to Follow-up|13|||
146193633|NCT02040844|527219945|FG000|Overall Study|Missing|13|||
146193634|NCT02040844|527219946|FG001|Overall Study|Missing|3|||
146193635|NCT02040844|527219947|FG002|Overall Study|Missing|2|||
146193636|NCT02040844|527219945|FG000|Overall Study|Non-specified|8|||
146193637|NCT02040844|527219946|FG001|Overall Study|Non-specified|2|||
146193638|NCT02040844|527219947|FG002|Overall Study|Non-specified|5|||
146193639|NCT02040844|527219945|FG000|Overall Study|Concomitant medication|1|||
146193640|NCT02040844|527219946|FG001|Overall Study|Concomitant medication|3|||
146193641|NCT02040844|527219947|FG002|Overall Study|Concomitant medication|1|||
146193642|NCT02068885|527219952|FG000|Overall Study|Withdrew|3|||
146418473|NCT01469364|528037319|FG000|Overall Study|Withdrawal by Subject|1|||
146418474|NCT02742090|528037320|FG000|Overall Study|Adverse Event|10|||
146418475|NCT02742090|528037320|FG000|Overall Study|Death|3|||
146418476|NCT02742090|528037320|FG000|Overall Study|Disease Progression|25|||
146193643|NCT02068885|527219953|FG001|Overall Study|Withdrew|5|||
146193644|NCT02068885|527219954|FG002|Overall Study|Withdrew|8|||
146193645|NCT00681811|527219955|FG000|Overall Study|Adverse Event|1|||
146193646|NCT00681811|527219956|FG001|Overall Study|Adverse Event|1|||
146193647|NCT00681811|527219955|FG000|Overall Study|Withdrawal by Subject|2|||
146193648|NCT00681811|527219956|FG001|Overall Study|Withdrawal by Subject|2|||
146418477|NCT02742090|528037320|FG000|Overall Study|Investigator's Decision|1|||
146418478|NCT02742090|528037320|FG000|Overall Study|Lost to Follow-up|1|||
146418479|NCT02742090|528037320|FG000|Overall Study|Non-compliance with Study|1|||
146418480|NCT02742090|528037320|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
146418481|NCT02742090|528037320|FG000|Overall Study|Withdrawal by Subject|4|||
146418482|NCT02742090|528037320|FG000|Overall Study|Reason Not Specified|1|||
146418483|NCT01767597|528037321|FG000|Overall Study|Incomplete intervention|3|||
146418484|NCT01767597|528037322|FG001|Overall Study|Incomplete intervention|1|||
146418485|NCT01767597|528037321|FG000|Overall Study|Withdrawal by Subject|1|||
146418486|NCT01767597|528037322|FG001|Overall Study|Withdrawal by Subject|0|||
146418487|NCT03355742|528037323|FG000|Overall Study|Lost to Follow-up|4|||
146418488|NCT03355742|528037323|FG000|Overall Study|Withdrawal by Subject|29|||
146418489|NCT03355742|528037323|FG000|Overall Study|Physician Decision|6|||
146418490|NCT03355742|528037323|FG000|Overall Study|Death|55|||
146418491|NCT03355742|528037323|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
146418492|NCT00836927|528037324|FG000|Overall Study|Progressive disease|2|||
146418493|NCT00836927|528037325|FG001|Overall Study|Progressive disease|0|||
146418494|NCT00836927|528037326|FG002|Overall Study|Progressive disease|0|||
146418495|NCT00836927|528037327|FG003|Overall Study|Progressive disease|1|||
146418496|NCT00836927|528037328|FG004|Overall Study|Progressive disease|1|||
146418497|NCT00836927|528037324|FG000|Overall Study|Withdrawal by Subject|1|||
146418498|NCT00836927|528037325|FG001|Overall Study|Withdrawal by Subject|0|||
146418499|NCT00836927|528037326|FG002|Overall Study|Withdrawal by Subject|0|||
146418500|NCT00836927|528037327|FG003|Overall Study|Withdrawal by Subject|0|||
146418501|NCT00836927|528037328|FG004|Overall Study|Withdrawal by Subject|0|||
146418502|NCT00614055|528037334|FG000|Overall Study|Adverse Event|1|||
146418503|NCT00614055|528037335|FG001|Overall Study|Adverse Event|0|||
146418504|NCT00614055|528037336|FG002|Overall Study|Adverse Event|0|||
146418505|NCT00614055|528037334|FG000|Overall Study|Protocol Violation|2|||
146418506|NCT00614055|528037335|FG001|Overall Study|Protocol Violation|2|||
146418507|NCT00614055|528037336|FG002|Overall Study|Protocol Violation|1|||
146418508|NCT00614055|528037334|FG000|Overall Study|Lack of Efficacy|0|||
146418509|NCT00614055|528037335|FG001|Overall Study|Lack of Efficacy|0|||
146418510|NCT00614055|528037336|FG002|Overall Study|Lack of Efficacy|2|||
146418511|NCT00614055|528037334|FG000|Overall Study|Unclassified|1|||
146418512|NCT00614055|528037335|FG001|Overall Study|Unclassified|4|||
146418513|NCT00614055|528037336|FG002|Overall Study|Unclassified|2|||
146418514|NCT00952484|528037339|FG000|Overall Study|Withdrawal by Subject|0|||
146418515|NCT00952484|528037340|FG001|Overall Study|Withdrawal by Subject|1|||
146418516|NCT00952484|528037341|FG002|Overall Study|Withdrawal by Subject|0|||
146418517|NCT02750306|528037342|FG000|Overall Study|Withdrawal by Subject|5|||
146418518|NCT02750306|528037343|FG001|Overall Study|Withdrawal by Subject|2|||
146418519|NCT02750306|528037342|FG000|Overall Study|Protocol Violation|1|||
146418520|NCT02750306|528037343|FG001|Overall Study|Protocol Violation|0|||
146418521|NCT00192296|528037346|FG000|Overall Study|Withdrawal by Subject|0|||
146418522|NCT00192296|528037347|FG001|Overall Study|Withdrawal by Subject|1|||
146418523|NCT00192296|528037348|FG002|Overall Study|Withdrawal by Subject|0|||
146418524|NCT00192296|528037349|FG003|Overall Study|Withdrawal by Subject|0|||
146418525|NCT01829477|528037350|FG000|Overall Study|Study Terminated by Sponsor|15|||
146418526|NCT01829477|528037351|FG001|Overall Study|Study Terminated by Sponsor|15|||
146418527|NCT01829477|528037350|FG000|Overall Study|Withdrawal by Subject|1|||
146418528|NCT01829477|528037351|FG001|Overall Study|Withdrawal by Subject|0|||
146418529|NCT03361423|528037352|FG000|Overall Study|Withdrawal by Subject|4|||
146418530|NCT03361423|528037353|FG001|Overall Study|Withdrawal by Subject|3|||
146418531|NCT03361423|528037352|FG000|Overall Study|Did not treat|19|||
146418532|NCT03361423|528037353|FG001|Overall Study|Did not treat|18|||
146418533|NCT03361423|528037352|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
146418534|NCT03361423|528037353|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
146418535|NCT03361423|528037352|FG000|Overall Study|Missing data|4|||
146418536|NCT03361423|528037353|FG001|Overall Study|Missing data|1|||
146418537|NCT05034731|528037354|FG000|Overall Study|Screen fail|1|||
146418538|NCT05034731|528037355|FG001|Overall Study|Screen fail|1|||
146418539|NCT00299156|528037356|FG000|Period 2 (Randomized)|Screen Failure|0|||
146418540|NCT00299156|528037357|FG001|Period 2 (Randomized)|Screen Failure|1|||
146418541|NCT00299156|528037358|FG002|Period 2 (Randomized)|Screen Failure|0|||
146082382|NCT04449029|526822779|FG006|Overall Study|Withdrawal by Subject|4|||
146418542|NCT01725451|528037359|FG000|Period 1|Withdrawal by Subject|1|||
146418543|NCT01725451|528037360|FG001|Period 1|Withdrawal by Subject|0|||
146418544|NCT01725451|528037361|FG002|Period 1|Withdrawal by Subject|0|||
146418545|NCT01725451|528037362|FG003|Period 1|Withdrawal by Subject|0|||
146418546|NCT01725451|528037359|FG000|Washout From Period 3|Protocol Violation|0|||
146418547|NCT01725451|528037360|FG001|Washout From Period 3|Protocol Violation|0|||
146418548|NCT01725451|528037361|FG002|Washout From Period 3|Protocol Violation|1|||
146418549|NCT01725451|528037362|FG003|Washout From Period 3|Protocol Violation|0|||
146418550|NCT01725451|528037359|FG000|Washout From Period 3|Adverse Event|0|||
146418551|NCT01725451|528037360|FG001|Washout From Period 3|Adverse Event|1|||
146418552|NCT01725451|528037361|FG002|Washout From Period 3|Adverse Event|0|||
146418553|NCT01725451|528037362|FG003|Washout From Period 3|Adverse Event|0|||
146418554|NCT01725451|528037359|FG000|Period 4|Adverse Event|0|||
146418555|NCT01725451|528037360|FG001|Period 4|Adverse Event|0|||
146418556|NCT01725451|528037361|FG002|Period 4|Adverse Event|1|||
146418557|NCT01725451|528037362|FG003|Period 4|Adverse Event|0|||
146418558|NCT00283686|528037365|FG000|Overall Study|Death|1|||
146418559|NCT00283686|528037366|FG001|Overall Study|Death|1|||
146418560|NCT00283686|528037367|FG002|Overall Study|Death|1|||
146418561|NCT00283686|528037368|FG003|Overall Study|Death|0|||
146418562|NCT00283686|528037365|FG000|Overall Study|Lost to Follow-up|21|||
146418563|NCT00283686|528037366|FG001|Overall Study|Lost to Follow-up|31|||
146418564|NCT00283686|528037367|FG002|Overall Study|Lost to Follow-up|26|||
146418565|NCT00283686|528037368|FG003|Overall Study|Lost to Follow-up|20|||
146418566|NCT00283686|528037365|FG000|Overall Study|Less than full participation|7|||
146418567|NCT00283686|528037366|FG001|Overall Study|Less than full participation|9|||
146418568|NCT00283686|528037367|FG002|Overall Study|Less than full participation|6|||
146418569|NCT00283686|528037368|FG003|Overall Study|Less than full participation|12|||
146418570|NCT00481247|528037369|FG000|Overall Study|Death|0|||
146418571|NCT00481247|528037370|FG001|Overall Study|Death|1|||
146418572|NCT00481247|528037369|FG000|Overall Study|Disease progression|18|||
146418573|NCT00481247|528037370|FG001|Overall Study|Disease progression|22|||
146418574|NCT00481247|528037369|FG000|Overall Study|Intolerance|42|||
146418575|NCT00481247|528037370|FG001|Overall Study|Intolerance|17|||
146418576|NCT00481247|528037369|FG000|Overall Study|Treatment failure|10|||
146418577|NCT00481247|528037370|FG001|Overall Study|Treatment failure|14|||
146418578|NCT00481247|528037369|FG000|Overall Study|AE unrelated to study drug|13|||
146418579|NCT00481247|528037370|FG001|Overall Study|AE unrelated to study drug|4|||
146418580|NCT00481247|528037369|FG000|Overall Study|Withdrawal by Subject|8|||
146418581|NCT00481247|528037370|FG001|Overall Study|Withdrawal by Subject|13|||
146418582|NCT00481247|528037369|FG000|Overall Study|Pregnancy|2|||
146418583|NCT00481247|528037370|FG001|Overall Study|Pregnancy|1|||
146418584|NCT00481247|528037369|FG000|Overall Study|Lost to Follow-up|1|||
146418585|NCT00481247|528037370|FG001|Overall Study|Lost to Follow-up|2|||
146418586|NCT00481247|528037369|FG000|Overall Study|Poor compliance/noncompliance|1|||
146418587|NCT00481247|528037370|FG001|Overall Study|Poor compliance/noncompliance|7|||
146418588|NCT00481247|528037369|FG000|Overall Study|Administrative reason by sponsor|157|||
146418589|NCT00481247|528037370|FG001|Overall Study|Administrative reason by sponsor|162|||
146418590|NCT00481247|528037369|FG000|Overall Study|Varied|6|||
146418591|NCT00481247|528037370|FG001|Overall Study|Varied|15|||
146418592|NCT00481247|528037369|FG000|Overall Study|Did not receive treatment|1|||
146418593|NCT00481247|528037370|FG001|Overall Study|Did not receive treatment|2|||
146418594|NCT01716754|528037371|FG000|Overall Study|Death|0|||
146418595|NCT01716754|528037372|FG001|Overall Study|Death|0|||
146418596|NCT01716754|528037373|FG002|Overall Study|Death|0|||
146418597|NCT01716754|528037374|FG003|Overall Study|Death|1|||
146418598|NCT01716754|528037371|FG000|Overall Study|Protocol deviation|0|||
146418599|NCT01716754|528037372|FG001|Overall Study|Protocol deviation|2|||
146418600|NCT01716754|528037373|FG002|Overall Study|Protocol deviation|7|||
146418601|NCT01716754|528037374|FG003|Overall Study|Protocol deviation|2|||
146418602|NCT01716754|528037371|FG000|Overall Study|Non-compliance with study treatment|0|||
146418603|NCT01716754|528037372|FG001|Overall Study|Non-compliance with study treatment|0|||
146418604|NCT01716754|528037373|FG002|Overall Study|Non-compliance with study treatment|1|||
146418605|NCT01716754|528037374|FG003|Overall Study|Non-compliance with study treatment|0|||
146418606|NCT01716754|528037371|FG000|Overall Study|Physician Decision|1|||
146418607|NCT01716754|528037372|FG001|Overall Study|Physician Decision|0|||
146418608|NCT01716754|528037373|FG002|Overall Study|Physician Decision|0|||
146418609|NCT01716754|528037374|FG003|Overall Study|Physician Decision|0|||
146418610|NCT01716754|528037371|FG000|Overall Study|Lost to Follow-up|1|||
146418611|NCT01716754|528037372|FG001|Overall Study|Lost to Follow-up|0|||
146418612|NCT01716754|528037373|FG002|Overall Study|Lost to Follow-up|0|||
146418613|NCT01716754|528037374|FG003|Overall Study|Lost to Follow-up|1|||
146418614|NCT01716754|528037371|FG000|Overall Study|Adverse Event|4|||
146418615|NCT01716754|528037372|FG001|Overall Study|Adverse Event|2|||
146418616|NCT01716754|528037373|FG002|Overall Study|Adverse Event|2|||
146418617|NCT01716754|528037374|FG003|Overall Study|Adverse Event|1|||
146418618|NCT01716754|528037371|FG000|Overall Study|Withdrawal by Subject|5|||
146418619|NCT01716754|528037372|FG001|Overall Study|Withdrawal by Subject|0|||
146418620|NCT01716754|528037373|FG002|Overall Study|Withdrawal by Subject|4|||
146418621|NCT01716754|528037374|FG003|Overall Study|Withdrawal by Subject|3|||
146418622|NCT04317781|528037375|FG000|Overall Study|Adverse Event|1|||
146418623|NCT04317781|528037375|FG000|Overall Study|Disease relapse|1|||
146418624|NCT04317781|528037375|FG000|Overall Study|Withdrawal by Subject|1|||
146418625|NCT02649231|528037395|FG000|Overall Study|Adverse Event|0|||
146418626|NCT02649231|528037396|FG001|Overall Study|Adverse Event|0|||
146418627|NCT02649231|528037397|FG002|Overall Study|Adverse Event|0|||
146418628|NCT02649231|528037398|FG003|Overall Study|Adverse Event|1|||
146418629|NCT02649231|528037395|FG000|Overall Study|Lost to Follow-up|2|||
146418630|NCT02649231|528037396|FG001|Overall Study|Lost to Follow-up|1|||
146418631|NCT02649231|528037397|FG002|Overall Study|Lost to Follow-up|1|||
146418632|NCT02649231|528037398|FG003|Overall Study|Lost to Follow-up|0|||
146418633|NCT02649231|528037395|FG000|Overall Study|Withdrawal by Subject|0|||
146418634|NCT02649231|528037396|FG001|Overall Study|Withdrawal by Subject|1|||
146418635|NCT02649231|528037397|FG002|Overall Study|Withdrawal by Subject|0|||
146418636|NCT02649231|528037398|FG003|Overall Study|Withdrawal by Subject|1|||
146418637|NCT02649231|528037395|FG000|Overall Study|Protocol Violation|2|||
146418638|NCT02649231|528037396|FG001|Overall Study|Protocol Violation|1|||
146418639|NCT02649231|528037397|FG002|Overall Study|Protocol Violation|1|||
146418640|NCT02649231|528037398|FG003|Overall Study|Protocol Violation|0|||
146418641|NCT01211769|528037399|FG000|Overall Study|Lost to Follow-up|7|||
146418642|NCT01211769|528037400|FG001|Overall Study|Lost to Follow-up|9|||
146418643|NCT01211769|528037401|FG002|Overall Study|Lost to Follow-up|5|||
146418644|NCT01211769|528037402|FG003|Overall Study|Lost to Follow-up|9|||
146418645|NCT01211769|528037399|FG000|Overall Study|Physician Decision|2|||
146418646|NCT01211769|528037400|FG001|Overall Study|Physician Decision|0|||
146418647|NCT01211769|528037401|FG002|Overall Study|Physician Decision|2|||
146418648|NCT01211769|528037402|FG003|Overall Study|Physician Decision|1|||
146418649|NCT01211769|528037399|FG000|Overall Study|Adverse Event|0|||
146418650|NCT01211769|528037400|FG001|Overall Study|Adverse Event|1|||
146418651|NCT01211769|528037401|FG002|Overall Study|Adverse Event|1|||
146418652|NCT01211769|528037402|FG003|Overall Study|Adverse Event|1|||
146418653|NCT01214330|528037403|FG000|Overall Study|Withdrawal by Subject|2|||
146418654|NCT01214330|528037403|FG000|Overall Study|Withdrawal by Subject|2|||
146418655|NCT00947427|528037404|FG000|Overall Study|Withdrawal by Subject|1|||
146418656|NCT00947427|528037405|FG001|Overall Study|Withdrawal by Subject|3|||
146418657|NCT00947427|528037404|FG000|Overall Study|Protocol Violation|0|||
146418658|NCT00947427|528037405|FG001|Overall Study|Protocol Violation|1|||
146418659|NCT03402893|528037406|FG000|Overall Study|Withdrawal by Subject|1|||
146418660|NCT00686036|528037411|FG000|Overall Study|Adverse Event|3|||
146418661|NCT00686036|528037412|FG001|Overall Study|Adverse Event|0|||
146418662|NCT00686036|528037411|FG000|Overall Study|Withdrawal by Subject|3|||
146418663|NCT00686036|528037412|FG001|Overall Study|Withdrawal by Subject|1|||
146418664|NCT00686036|528037411|FG000|Overall Study|Study terminated by AstraZeneca|2|||
146418665|NCT00686036|528037412|FG001|Overall Study|Study terminated by AstraZeneca|1|||
146418666|NCT00686036|528037411|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
146418667|NCT00686036|528037412|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
146418668|NCT00686036|528037411|FG000|Overall Study|Other reasons not identified|0|||
146418669|NCT00686036|528037412|FG001|Overall Study|Other reasons not identified|4|||
146418670|NCT01411995|528037413|FG000|Overall Study|Failed IUD insertion|0|||
146418671|NCT01411995|528037414|FG001|Overall Study|Failed IUD insertion|1|||
146418672|NCT01754259|528037423|FG000|Overall Study|Withdrawal by Subject|2|||
146418673|NCT01754259|528037424|FG001|Overall Study|Withdrawal by Subject|4|||
146418674|NCT01754259|528037423|FG000|Overall Study|Adverse Event|3|||
146418675|NCT01754259|528037424|FG001|Overall Study|Adverse Event|1|||
146418676|NCT01754259|528037423|FG000|Overall Study|Lost to Follow-up|0|||
146418677|NCT01754259|528037424|FG001|Overall Study|Lost to Follow-up|1|||
146418678|NCT01364870|528037429|FG000|Overall Study|Withdrawal by Subject|13|||
146418679|NCT01364870|528037430|FG001|Overall Study|Withdrawal by Subject|24|||
146418680|NCT01364870|528037431|FG002|Overall Study|Withdrawal by Subject|10|||
146418681|NCT01364870|528037429|FG000|Overall Study|Adverse Event|8|||
146418682|NCT01364870|528037430|FG001|Overall Study|Adverse Event|6|||
146418683|NCT01364870|528037431|FG002|Overall Study|Adverse Event|4|||
146418684|NCT01364870|528037429|FG000|Overall Study|Protocol Violation|1|||
146418685|NCT01364870|528037430|FG001|Overall Study|Protocol Violation|0|||
146418686|NCT01364870|528037431|FG002|Overall Study|Protocol Violation|0|||
146418687|NCT02102490|528037434|FG000|Overall Study|Death|6|||
146418688|NCT02102490|528037434|FG000|Overall Study|Lost to Follow-up|1|||
146418689|NCT00095199|528037437|FG000|Overall Study|Adverse Event|40|||
146418690|NCT00095199|528037438|FG001|Overall Study|Adverse Event|22|||
146418691|NCT00095199|528037439|FG002|Overall Study|Adverse Event|26|||
146418692|NCT00095199|528037440|FG003|Overall Study|Adverse Event|11|||
146418693|NCT00095199|528037437|FG000|Overall Study|Progressive disease|213|||
146418694|NCT00095199|528037438|FG001|Overall Study|Progressive disease|179|||
146418695|NCT00095199|528037439|FG002|Overall Study|Progressive disease|105|||
146418696|NCT00095199|528037440|FG003|Overall Study|Progressive disease|98|||
146418697|NCT00095199|528037437|FG000|Overall Study|Death|10|||
146418698|NCT00095199|528037438|FG001|Overall Study|Death|6|||
146418699|NCT00095199|528037439|FG002|Overall Study|Death|11|||
146418700|NCT00095199|528037440|FG003|Overall Study|Death|9|||
146418701|NCT00095199|528037437|FG000|Overall Study|Withdrawal by Subject|21|||
146418702|NCT00095199|528037438|FG001|Overall Study|Withdrawal by Subject|16|||
146418703|NCT00095199|528037439|FG002|Overall Study|Withdrawal by Subject|13|||
146418704|NCT00095199|528037440|FG003|Overall Study|Withdrawal by Subject|22|||
146418705|NCT00095199|528037437|FG000|Overall Study|Protocol Violation|4|||
146418706|NCT00095199|528037438|FG001|Overall Study|Protocol Violation|4|||
146418707|NCT00095199|528037439|FG002|Overall Study|Protocol Violation|2|||
146418708|NCT00095199|528037440|FG003|Overall Study|Protocol Violation|0|||
146418709|NCT00095199|528037437|FG000|Overall Study|Liver function test results elevated|0|||
146418710|NCT00095199|528037438|FG001|Overall Study|Liver function test results elevated|0|||
146418711|NCT00095199|528037439|FG002|Overall Study|Liver function test results elevated|1|||
146418712|NCT00095199|528037440|FG003|Overall Study|Liver function test results elevated|1|||
146418713|NCT00095199|528037437|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
146418714|NCT00095199|528037438|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
146418715|NCT00095199|528037439|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
146418716|NCT00095199|528037440|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
146418717|NCT00095199|528037437|FG000|Overall Study|Physician Decision|5|||
146418718|NCT00095199|528037438|FG001|Overall Study|Physician Decision|6|||
146418719|NCT00095199|528037439|FG002|Overall Study|Physician Decision|1|||
146418720|NCT00095199|528037440|FG003|Overall Study|Physician Decision|1|||
146418721|NCT00095199|528037437|FG000|Overall Study|Not eligible|1|||
146418722|NCT00095199|528037438|FG001|Overall Study|Not eligible|7|||
146418723|NCT00095199|528037439|FG002|Overall Study|Not eligible|0|||
146418724|NCT00095199|528037440|FG003|Overall Study|Not eligible|1|||
146418725|NCT00095199|528037437|FG000|Overall Study|Started Palliative Radiotherapy|1|||
146418726|NCT00095199|528037438|FG001|Overall Study|Started Palliative Radiotherapy|0|||
146418727|NCT00095199|528037439|FG002|Overall Study|Started Palliative Radiotherapy|0|||
146418728|NCT00095199|528037440|FG003|Overall Study|Started Palliative Radiotherapy|0|||
146418729|NCT00095199|528037437|FG000|Overall Study|Started radiotherapy regimen|0|||
146418730|NCT00095199|528037438|FG001|Overall Study|Started radiotherapy regimen|1|||
146418731|NCT00095199|528037439|FG002|Overall Study|Started radiotherapy regimen|0|||
146418732|NCT00095199|528037440|FG003|Overall Study|Started radiotherapy regimen|0|||
146418733|NCT00095199|528037437|FG000|Overall Study|Primary tumor removed in other surgery|0|||
146418734|NCT00095199|528037438|FG001|Overall Study|Primary tumor removed in other surgery|1|||
146418735|NCT00095199|528037439|FG002|Overall Study|Primary tumor removed in other surgery|0|||
146418736|NCT00095199|528037440|FG003|Overall Study|Primary tumor removed in other surgery|0|||
146418737|NCT00095199|528037437|FG000|Overall Study|Data inadvertently lost by site|1|||
146418738|NCT00095199|528037438|FG001|Overall Study|Data inadvertently lost by site|0|||
146418739|NCT00095199|528037439|FG002|Overall Study|Data inadvertently lost by site|0|||
146418740|NCT00095199|528037440|FG003|Overall Study|Data inadvertently lost by site|0|||
146418741|NCT03896490|528037475|FG000|Overall Study|Withdrawal by Subject|1|||
146418742|NCT03896490|528037476|FG001|Overall Study|Withdrawal by Subject|1|||
146418743|NCT01736553|528037481|FG000|Overall Study|Death|12|||
146418744|NCT01736553|528037482|FG001|Overall Study|Death|0|||
146418745|NCT01736553|528037481|FG000|Overall Study|Withdrawal by Subject|5|||
146418746|NCT01736553|528037482|FG001|Overall Study|Withdrawal by Subject|2|||
146418747|NCT01736553|528037481|FG000|Overall Study|Lost to Follow-up|2|||
146418748|NCT01736553|528037482|FG001|Overall Study|Lost to Follow-up|2|||
146418749|NCT01896297|528037483|FG000|Overall Study|Died in post treatment phase|1|||
146418750|NCT00003782|528037484|FG000|Overall Study|No follow up data|30|||
146418751|NCT00003782|528037485|FG001|Overall Study|No follow up data|31|||
146418752|NCT00003782|528037486|FG002|Overall Study|No follow up data|26|||
146418753|NCT01890707|528037487|FG000|Overall Study|Lost to Follow-up|1|||
146418754|NCT01890707|528037488|FG001|Overall Study|Lost to Follow-up|1|||
146418755|NCT00385541|528037490|FG000|Overall Study|severe pain, clinician requested unblind|0|||
146418756|NCT00385541|528037491|FG001|Overall Study|severe pain, clinician requested unblind|1|||
146418757|NCT00929708|528037492|FG000|Overall Study|Protocol Violation|2|||
146418758|NCT00929708|528037493|FG001|Overall Study|Protocol Violation|1|||
146418759|NCT00929708|528037494|FG002|Overall Study|Protocol Violation|1|||
146418760|NCT00929708|528037495|FG003|Overall Study|Protocol Violation|1|||
146418761|NCT00929708|528037496|FG004|Overall Study|Protocol Violation|1|||
146418762|NCT00929708|528037492|FG000|Overall Study|Withdrawal by Subject|2|||
146418763|NCT00929708|528037493|FG001|Overall Study|Withdrawal by Subject|0|||
146418764|NCT00929708|528037494|FG002|Overall Study|Withdrawal by Subject|0|||
146418765|NCT00929708|528037495|FG003|Overall Study|Withdrawal by Subject|2|||
146418766|NCT00929708|528037496|FG004|Overall Study|Withdrawal by Subject|1|||
146418767|NCT00929708|528037492|FG000|Overall Study|Adverse Event|0|||
146418768|NCT00929708|528037493|FG001|Overall Study|Adverse Event|0|||
146418769|NCT00929708|528037494|FG002|Overall Study|Adverse Event|0|||
146418770|NCT00929708|528037495|FG003|Overall Study|Adverse Event|0|||
146418771|NCT00929708|528037496|FG004|Overall Study|Adverse Event|3|||
146418772|NCT00929708|528037492|FG000|Overall Study|Physician Decision|0|||
146418773|NCT00929708|528037493|FG001|Overall Study|Physician Decision|2|||
146418774|NCT00929708|528037494|FG002|Overall Study|Physician Decision|2|||
146418775|NCT00929708|528037495|FG003|Overall Study|Physician Decision|2|||
146418776|NCT00929708|528037496|FG004|Overall Study|Physician Decision|1|||
146418777|NCT00929708|528037492|FG000|Overall Study|Lost to Follow-up|0|||
146418778|NCT00929708|528037493|FG001|Overall Study|Lost to Follow-up|0|||
146418779|NCT00929708|528037494|FG002|Overall Study|Lost to Follow-up|0|||
146418780|NCT00929708|528037495|FG003|Overall Study|Lost to Follow-up|1|||
146418781|NCT00929708|528037496|FG004|Overall Study|Lost to Follow-up|0|||
146418782|NCT01893138|528037497|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146418783|NCT01893138|528037498|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146418784|NCT01893138|528037497|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
146418785|NCT01893138|528037498|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
146418786|NCT01893138|528037497|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
146418787|NCT01893138|528037498|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
146418788|NCT01893138|528037497|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
146418789|NCT01893138|528037498|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
146418790|NCT01893138|528037497|FG000|Open Label - Unblinded Period|Adverse Event|1|||
146418791|NCT01893138|528037498|FG001|Open Label - Unblinded Period|Adverse Event|0|||
146418792|NCT02154529|528037499|FG000|Overall Study|Death|1|||
146418793|NCT02154529|528037500|FG001|Overall Study|Death|1|||
146418794|NCT02154529|528037501|FG002|Overall Study|Death|5|||
146418795|NCT02154529|528037502|FG003|Overall Study|Death|1|||
146418796|NCT02154529|528037499|FG000|Overall Study|Termination of study by sponsor|2|||
146418797|NCT02154529|528037500|FG001|Overall Study|Termination of study by sponsor|2|||
146418798|NCT02154529|528037501|FG002|Overall Study|Termination of study by sponsor|3|||
146418799|NCT02154529|528037502|FG003|Overall Study|Termination of study by sponsor|1|||
146418800|NCT02154529|528037499|FG000|Overall Study|Lost to Follow-up|1|||
146418801|NCT02154529|528037500|FG001|Overall Study|Lost to Follow-up|0|||
146418802|NCT02154529|528037501|FG002|Overall Study|Lost to Follow-up|0|||
146418803|NCT02154529|528037502|FG003|Overall Study|Lost to Follow-up|0|||
146418804|NCT02761980|528039483|FG000|Overall Study|Adverse Event|4|||
146418805|NCT02761980|528039484|FG001|Overall Study|Adverse Event|6|||
146418806|NCT02761980|528039485|FG002|Overall Study|Adverse Event|5|||
146418807|NCT02761980|528039486|FG003|Overall Study|Adverse Event|6|||
146418808|NCT02761980|528039483|FG000|Overall Study|Withdrawal by Subject|0|||
146418809|NCT02761980|528039484|FG001|Overall Study|Withdrawal by Subject|1|||
146418810|NCT02761980|528039485|FG002|Overall Study|Withdrawal by Subject|0|||
146418811|NCT02761980|528039486|FG003|Overall Study|Withdrawal by Subject|0|||
146418812|NCT02761980|528039483|FG000|Overall Study|Other|0|||
146418813|NCT02761980|528039484|FG001|Overall Study|Other|0|||
146418814|NCT02761980|528039485|FG002|Overall Study|Other|1|||
146418815|NCT02761980|528039486|FG003|Overall Study|Other|0|||
146418816|NCT02192905|528039493|FG000|Overall Study|Lost to Follow-up|1|||
146418817|NCT04820842|528039494|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146418818|NCT04820842|528039495|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
146418819|NCT04820842|528039496|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
146418820|NCT04820842|528039497|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146418821|NCT04820842|528039498|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146418822|NCT04820842|528039499|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146418823|NCT04820842|528039500|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
146418824|NCT04820842|528039494|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
146418825|NCT04820842|528039495|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
146418826|NCT04820842|528039496|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
146418827|NCT04820842|528039497|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418828|NCT04820842|528039498|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418829|NCT04820842|528039499|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418830|NCT04820842|528039500|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418831|NCT04820842|528039494|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418832|NCT04820842|528039495|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
146418833|NCT04820842|528039496|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418834|NCT04820842|528039497|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418835|NCT04820842|528039498|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418836|NCT04820842|528039499|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418837|NCT04820842|528039500|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
146418838|NCT04820842|528039494|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418839|NCT04820842|528039495|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418840|NCT04820842|528039496|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146193649|NCT00681811|527219955|FG000|Overall Study|Non-compliance|0|||
146193650|NCT00681811|527219956|FG001|Overall Study|Non-compliance|1|||
146193651|NCT00828919|527219957|FG000|Overall Study|Death|0|||
146193652|NCT00828919|527219958|FG001|Overall Study|Death|1|||
146193653|NCT00828919|527219959|FG002|Overall Study|Death|2|||
146193654|NCT00828919|527219960|FG003|Overall Study|Death|0|||
146193655|NCT00828919|527219961|FG004|Overall Study|Death|0|||
146193656|NCT00828919|527219957|FG000|Overall Study|Adverse Event|2|||
146193657|NCT00828919|527219958|FG001|Overall Study|Adverse Event|2|||
146193658|NCT00828919|527219959|FG002|Overall Study|Adverse Event|2|||
146193659|NCT00828919|527219960|FG003|Overall Study|Adverse Event|1|||
146193660|NCT00828919|527219961|FG004|Overall Study|Adverse Event|3|||
146193661|NCT00828919|527219957|FG000|Overall Study|Objective progression or relapse|4|||
146193662|NCT00828919|527219958|FG001|Overall Study|Objective progression or relapse|4|||
146193663|NCT00828919|527219959|FG002|Overall Study|Objective progression or relapse|11|||
146193664|NCT00828919|527219960|FG003|Overall Study|Objective progression or relapse|0|||
146193665|NCT00828919|527219961|FG004|Overall Study|Objective progression or relapse|5|||
146193666|NCT00828919|527219957|FG000|Overall Study|No longer willing to participate in study|0|||
146193667|NCT00828919|527219958|FG001|Overall Study|No longer willing to participate in study|0|||
146193668|NCT00828919|527219959|FG002|Overall Study|No longer willing to participate in study|2|||
146193669|NCT00828919|527219960|FG003|Overall Study|No longer willing to participate in study|0|||
146193670|NCT00828919|527219961|FG004|Overall Study|No longer willing to participate in study|0|||
146193671|NCT00828919|527219957|FG000|Overall Study|Insufficient Clinical Response|0|||
146193672|NCT00828919|527219958|FG001|Overall Study|Insufficient Clinical Response|1|||
146193673|NCT00828919|527219959|FG002|Overall Study|Insufficient Clinical Response|2|||
146193674|NCT00828919|527219960|FG003|Overall Study|Insufficient Clinical Response|0|||
146193675|NCT00828919|527219961|FG004|Overall Study|Insufficient Clinical Response|0|||
146193676|NCT00828919|527219957|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146193677|NCT00828919|527219958|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146193678|NCT00828919|527219959|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146193679|NCT00828919|527219960|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
146193680|NCT00828919|527219961|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
146193681|NCT00828919|527219957|FG000|Overall Study|Other|1|||
146193682|NCT00828919|527219958|FG001|Overall Study|Other|0|||
146193683|NCT00828919|527219959|FG002|Overall Study|Other|1|||
146418841|NCT04820842|528039497|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
146418842|NCT04820842|528039498|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418843|NCT04820842|528039499|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
146418844|NCT04820842|528039500|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
146418845|NCT01296932|528039501|FG000|Overall Study|Dose limiting toxicity|0|||
146418846|NCT01296932|528039502|FG001|Overall Study|Dose limiting toxicity|0|||
146418847|NCT01296932|528039503|FG002|Overall Study|Dose limiting toxicity|0|||
146418848|NCT01296932|528039504|FG003|Overall Study|Dose limiting toxicity|0|||
146418849|NCT01296932|528039505|FG004|Overall Study|Dose limiting toxicity|0|||
146418850|NCT01296932|528039506|FG005|Overall Study|Dose limiting toxicity|0|||
146418851|NCT01296932|528039507|FG006|Overall Study|Dose limiting toxicity|1|||
146418852|NCT01296932|528039508|FG007|Overall Study|Dose limiting toxicity|0|||
146418853|NCT01296932|528039509|FG008|Overall Study|Dose limiting toxicity|1|||
146418854|NCT01296932|528039501|FG000|Overall Study|Progressive disease|2|||
146418855|NCT01296932|528039502|FG001|Overall Study|Progressive disease|0|||
146418856|NCT01296932|528039503|FG002|Overall Study|Progressive disease|1|||
146418857|NCT01296932|528039504|FG003|Overall Study|Progressive disease|1|||
146418858|NCT01296932|528039505|FG004|Overall Study|Progressive disease|2|||
146418859|NCT01296932|528039506|FG005|Overall Study|Progressive disease|3|||
146418860|NCT01296932|528039507|FG006|Overall Study|Progressive disease|1|||
146193684|NCT00828919|527219960|FG003|Overall Study|Other|1|||
146193685|NCT00828919|527219961|FG004|Overall Study|Other|0|||
146193686|NCT00828919|527219957|FG000|Overall Study|Lost to Follow-up|0|||
146193687|NCT00828919|527219958|FG001|Overall Study|Lost to Follow-up|1|||
146193688|NCT00828919|527219959|FG002|Overall Study|Lost to Follow-up|0|||
146193689|NCT00828919|527219960|FG003|Overall Study|Lost to Follow-up|0|||
146193690|NCT00828919|527219961|FG004|Overall Study|Lost to Follow-up|0|||
146193691|NCT05567159|527219962|FG000|Overall Study|Adverse Event|4|||
146193692|NCT05567159|527219962|FG000|Overall Study|Physician Decision|3|||
146193693|NCT05567159|527219962|FG000|Overall Study|Protocol deviation|1|||
146193694|NCT02501811|527219964|FG000|Overall Study|Death|1|||
146193695|NCT02501811|527219965|FG001|Overall Study|Death|3|||
146193696|NCT02501811|527219966|FG002|Overall Study|Death|2|||
146193697|NCT02501811|527219967|FG003|Overall Study|Death|3|||
146193698|NCT02501811|527219964|FG000|Overall Study|Withdrawal by Subject|3|||
146193699|NCT02501811|527219965|FG001|Overall Study|Withdrawal by Subject|3|||
146193700|NCT02501811|527219966|FG002|Overall Study|Withdrawal by Subject|2|||
146193701|NCT02501811|527219967|FG003|Overall Study|Withdrawal by Subject|3|||
146193702|NCT02501811|527219964|FG000|Overall Study|Lost to Follow-up|0|||
146193703|NCT02501811|527219965|FG001|Overall Study|Lost to Follow-up|0|||
146193704|NCT02501811|527219966|FG002|Overall Study|Lost to Follow-up|2|||
146193705|NCT02501811|527219967|FG003|Overall Study|Lost to Follow-up|1|||
146193706|NCT01268891|527221392|FG000|Overall Study|Adverse Event|3|||
146193707|NCT01268891|527221393|FG001|Overall Study|Adverse Event|7|||
146193708|NCT01268891|527221392|FG000|Overall Study|Lack of Efficacy|1|||
146193709|NCT01268891|527221393|FG001|Overall Study|Lack of Efficacy|0|||
146193710|NCT01268891|527221392|FG000|Overall Study|Withdrawal of Consent|3|||
146193711|NCT01268891|527221393|FG001|Overall Study|Withdrawal of Consent|1|||
146193712|NCT01268891|527221392|FG000|Overall Study|Administrative or other reason(s)|1|||
146193713|NCT01268891|527221393|FG001|Overall Study|Administrative or other reason(s)|0|||
146193714|NCT00991276|527221394|FG000|First Intervention Period|Adverse Event|0|||
146193715|NCT00991276|527221395|FG001|First Intervention Period|Adverse Event|1|||
146193716|NCT00991276|527221396|FG002|First Intervention Period|Adverse Event|0|||
146193717|NCT00991276|527221397|FG003|First Intervention Period|Adverse Event|1|||
146193718|NCT00991276|527221398|FG004|First Intervention Period|Adverse Event|0|||
146193719|NCT00991276|527221399|FG005|First Intervention Period|Adverse Event|0|||
146193720|NCT00991276|527221394|FG000|First Intervention Period|Protocol Violation|0|||
146193721|NCT00991276|527221395|FG001|First Intervention Period|Protocol Violation|0|||
146193722|NCT00991276|527221396|FG002|First Intervention Period|Protocol Violation|0|||
146418861|NCT01296932|528039508|FG007|Overall Study|Progressive disease|0|||
146418862|NCT01296932|528039509|FG008|Overall Study|Progressive disease|0|||
146418863|NCT01296932|528039501|FG000|Overall Study|Withdrawal by Subject|0|||
146418864|NCT01296932|528039502|FG001|Overall Study|Withdrawal by Subject|0|||
146418865|NCT01296932|528039503|FG002|Overall Study|Withdrawal by Subject|1|||
146418866|NCT01296932|528039504|FG003|Overall Study|Withdrawal by Subject|1|||
146193723|NCT00991276|527221397|FG003|First Intervention Period|Protocol Violation|0|||
146193724|NCT00991276|527221398|FG004|First Intervention Period|Protocol Violation|2|||
146418867|NCT01296932|528039505|FG004|Overall Study|Withdrawal by Subject|0|||
146193725|NCT00991276|527221399|FG005|First Intervention Period|Protocol Violation|0|||
146193726|NCT00991276|527221394|FG000|First Intervention Period|Insufficient clinical response|0|||
146193727|NCT00991276|527221395|FG001|First Intervention Period|Insufficient clinical response|0|||
146193728|NCT00991276|527221396|FG002|First Intervention Period|Insufficient clinical response|0|||
146193729|NCT00991276|527221397|FG003|First Intervention Period|Insufficient clinical response|0|||
146418868|NCT01296932|528039506|FG005|Overall Study|Withdrawal by Subject|0|||
146418869|NCT01296932|528039507|FG006|Overall Study|Withdrawal by Subject|3|||
146418870|NCT01296932|528039508|FG007|Overall Study|Withdrawal by Subject|0|||
146418871|NCT01296932|528039509|FG008|Overall Study|Withdrawal by Subject|0|||
146418872|NCT01296932|528039501|FG000|Overall Study|Adverse Event|1|||
146418873|NCT01296932|528039502|FG001|Overall Study|Adverse Event|1|||
146418874|NCT01296932|528039503|FG002|Overall Study|Adverse Event|1|||
146418875|NCT01296932|528039504|FG003|Overall Study|Adverse Event|2|||
146418876|NCT01296932|528039505|FG004|Overall Study|Adverse Event|1|||
146418877|NCT01296932|528039506|FG005|Overall Study|Adverse Event|0|||
146418878|NCT01296932|528039507|FG006|Overall Study|Adverse Event|0|||
146418879|NCT01296932|528039508|FG007|Overall Study|Adverse Event|0|||
146418880|NCT01296932|528039509|FG008|Overall Study|Adverse Event|1|||
146418881|NCT01296932|528039501|FG000|Overall Study|Investigator decision|0|||
146418882|NCT01296932|528039502|FG001|Overall Study|Investigator decision|1|||
146418883|NCT01296932|528039503|FG002|Overall Study|Investigator decision|0|||
146418884|NCT01296932|528039504|FG003|Overall Study|Investigator decision|1|||
146418885|NCT01296932|528039505|FG004|Overall Study|Investigator decision|0|||
146418886|NCT01296932|528039506|FG005|Overall Study|Investigator decision|0|||
146418887|NCT01296932|528039507|FG006|Overall Study|Investigator decision|1|||
146418888|NCT01296932|528039508|FG007|Overall Study|Investigator decision|0|||
146418889|NCT01296932|528039509|FG008|Overall Study|Investigator decision|1|||
146418890|NCT01296932|528039501|FG000|Overall Study|No clinical benefit anymore|0|||
146418891|NCT01296932|528039502|FG001|Overall Study|No clinical benefit anymore|1|||
146082383|NCT04449029|526822780|FG007|Overall Study|Withdrawal by Subject|0|||
146082384|NCT02025556|526822785|FG000|Overall Study|Adverse Event|0|||
146082385|NCT02025556|526822786|FG001|Overall Study|Adverse Event|4|||
146082386|NCT02025556|526822787|FG002|Overall Study|Adverse Event|2|||
146082387|NCT02025556|526822785|FG000|Overall Study|Lack of Efficacy|2|||
146082388|NCT02025556|526822786|FG001|Overall Study|Lack of Efficacy|1|||
146082389|NCT02025556|526822787|FG002|Overall Study|Lack of Efficacy|0|||
146082390|NCT02025556|526822785|FG000|Overall Study|Protocol Violation|2|||
146082391|NCT02025556|526822786|FG001|Overall Study|Protocol Violation|1|||
146082392|NCT02025556|526822787|FG002|Overall Study|Protocol Violation|0|||
146082393|NCT02025556|526822785|FG000|Overall Study|Withdrawal by Subject|0|||
146082394|NCT02025556|526822786|FG001|Overall Study|Withdrawal by Subject|3|||
146082395|NCT02025556|526822787|FG002|Overall Study|Withdrawal by Subject|6|||
146082396|NCT02025556|526822785|FG000|Overall Study|Lost to Follow-up|2|||
146082397|NCT02025556|526822786|FG001|Overall Study|Lost to Follow-up|4|||
146082398|NCT02025556|526822787|FG002|Overall Study|Lost to Follow-up|0|||
146082399|NCT02025556|526822785|FG000|Overall Study|Reason not reported|0|||
146082400|NCT02025556|526822786|FG001|Overall Study|Reason not reported|0|||
146082401|NCT02025556|526822787|FG002|Overall Study|Reason not reported|1|||
146082402|NCT02486627|526822788|FG000|Overall Study|Death|1|||
146082403|NCT02486627|526822789|FG001|Overall Study|Death|0|||
146082404|NCT02486627|526822788|FG000|Overall Study|Other Unspecified|0|||
146082405|NCT02486627|526822789|FG001|Overall Study|Other Unspecified|2|||
146082406|NCT02486627|526822788|FG000|Overall Study|Consent Withdrawn by Participant|4|||
146082407|NCT02486627|526822789|FG001|Overall Study|Consent Withdrawn by Participant|3|||
146082408|NCT02486627|526822788|FG000|Overall Study|Significant Participant Noncompliance|1|||
146082409|NCT02486627|526822789|FG001|Overall Study|Significant Participant Noncompliance|1|||
146418892|NCT01296932|528039503|FG002|Overall Study|No clinical benefit anymore|0|||
146418893|NCT01296932|528039504|FG003|Overall Study|No clinical benefit anymore|0|||
146418894|NCT01296932|528039505|FG004|Overall Study|No clinical benefit anymore|0|||
146418895|NCT01296932|528039506|FG005|Overall Study|No clinical benefit anymore|0|||
146418896|NCT01296932|528039507|FG006|Overall Study|No clinical benefit anymore|0|||
146418897|NCT01296932|528039508|FG007|Overall Study|No clinical benefit anymore|0|||
146418898|NCT01296932|528039509|FG008|Overall Study|No clinical benefit anymore|0|||
146418899|NCT01296932|528039501|FG000|Overall Study|Physician Decision|0|||
146418900|NCT01296932|528039502|FG001|Overall Study|Physician Decision|0|||
146418901|NCT01296932|528039503|FG002|Overall Study|Physician Decision|1|||
146418902|NCT01296932|528039504|FG003|Overall Study|Physician Decision|0|||
146418903|NCT01296932|528039505|FG004|Overall Study|Physician Decision|0|||
146418904|NCT01296932|528039506|FG005|Overall Study|Physician Decision|0|||
146418905|NCT01296932|528039507|FG006|Overall Study|Physician Decision|0|||
146418906|NCT01296932|528039508|FG007|Overall Study|Physician Decision|0|||
146193730|NCT00991276|527221398|FG004|First Intervention Period|Insufficient clinical response|1|||
146193731|NCT00991276|527221399|FG005|First Intervention Period|Insufficient clinical response|0|||
146193732|NCT00991276|527221394|FG000|First Intervention Period|Other|0|||
146193733|NCT00991276|527221395|FG001|First Intervention Period|Other|0|||
146193734|NCT00991276|527221396|FG002|First Intervention Period|Other|0|||
146193735|NCT00991276|527221397|FG003|First Intervention Period|Other|1|||
146193736|NCT00991276|527221398|FG004|First Intervention Period|Other|1|||
146193737|NCT00991276|527221399|FG005|First Intervention Period|Other|0|||
146193738|NCT00991276|527221394|FG000|First Intervention Period|Withdrawal by Subject|0|||
146193739|NCT00991276|527221395|FG001|First Intervention Period|Withdrawal by Subject|1|||
146193740|NCT00991276|527221396|FG002|First Intervention Period|Withdrawal by Subject|0|||
146193741|NCT00991276|527221397|FG003|First Intervention Period|Withdrawal by Subject|1|||
146193742|NCT00991276|527221398|FG004|First Intervention Period|Withdrawal by Subject|0|||
146193743|NCT00991276|527221399|FG005|First Intervention Period|Withdrawal by Subject|1|||
146193744|NCT00991276|527221394|FG000|First Intervention Period|Lost to Follow-up|0|||
146193745|NCT00991276|527221395|FG001|First Intervention Period|Lost to Follow-up|1|||
146193746|NCT00991276|527221396|FG002|First Intervention Period|Lost to Follow-up|0|||
146193747|NCT00991276|527221397|FG003|First Intervention Period|Lost to Follow-up|1|||
146193748|NCT00991276|527221398|FG004|First Intervention Period|Lost to Follow-up|0|||
146193749|NCT00991276|527221399|FG005|First Intervention Period|Lost to Follow-up|0|||
146193750|NCT00991276|527221394|FG000|Second Intervention Period|Adverse Event|0|||
146193751|NCT00991276|527221395|FG001|Second Intervention Period|Adverse Event|2|||
146193752|NCT00991276|527221396|FG002|Second Intervention Period|Adverse Event|0|||
146193753|NCT00991276|527221397|FG003|Second Intervention Period|Adverse Event|1|||
146193754|NCT00991276|527221398|FG004|Second Intervention Period|Adverse Event|1|||
146193755|NCT00991276|527221399|FG005|Second Intervention Period|Adverse Event|0|||
146193756|NCT00991276|527221394|FG000|Second Intervention Period|Protocol Violation|1|||
146193757|NCT00991276|527221395|FG001|Second Intervention Period|Protocol Violation|0|||
146193758|NCT00991276|527221396|FG002|Second Intervention Period|Protocol Violation|0|||
146193759|NCT00991276|527221397|FG003|Second Intervention Period|Protocol Violation|0|||
146193760|NCT00991276|527221398|FG004|Second Intervention Period|Protocol Violation|0|||
146193761|NCT00991276|527221399|FG005|Second Intervention Period|Protocol Violation|0|||
146193762|NCT00991276|527221394|FG000|Second Intervention Period|Other|0|||
146193763|NCT00991276|527221395|FG001|Second Intervention Period|Other|0|||
146193764|NCT00991276|527221396|FG002|Second Intervention Period|Other|0|||
146193765|NCT00991276|527221397|FG003|Second Intervention Period|Other|1|||
146193766|NCT00991276|527221398|FG004|Second Intervention Period|Other|0|||
146193767|NCT00991276|527221399|FG005|Second Intervention Period|Other|1|||
146193768|NCT00991276|527221394|FG000|Third Intervention Period|Protocol Violation|1|||
146193769|NCT00991276|527221395|FG001|Third Intervention Period|Protocol Violation|0|||
146193770|NCT00991276|527221396|FG002|Third Intervention Period|Protocol Violation|0|||
146193771|NCT00991276|527221397|FG003|Third Intervention Period|Protocol Violation|0|||
146193772|NCT00991276|527221398|FG004|Third Intervention Period|Protocol Violation|0|||
146193773|NCT00991276|527221399|FG005|Third Intervention Period|Protocol Violation|0|||
146193774|NCT00991276|527221394|FG000|Third Intervention Period|Other|0|||
146193775|NCT00991276|527221395|FG001|Third Intervention Period|Other|0|||
146418907|NCT01296932|528039509|FG008|Overall Study|Physician Decision|0|||
146193776|NCT00991276|527221396|FG002|Third Intervention Period|Other|0|||
146193777|NCT00991276|527221397|FG003|Third Intervention Period|Other|0|||
146193778|NCT00991276|527221398|FG004|Third Intervention Period|Other|0|||
146193779|NCT00991276|527221399|FG005|Third Intervention Period|Other|1|||
146193780|NCT00991276|527221394|FG000|Third Intervention Period|Adverse Event|0|||
146193781|NCT00991276|527221395|FG001|Third Intervention Period|Adverse Event|0|||
146418908|NCT01296932|528039501|FG000|Overall Study|IV problems, administration not possible|0|||
146418909|NCT01296932|528039502|FG001|Overall Study|IV problems, administration not possible|0|||
146418910|NCT01296932|528039503|FG002|Overall Study|IV problems, administration not possible|1|||
146193782|NCT00991276|527221396|FG002|Third Intervention Period|Adverse Event|1|||
146193783|NCT00991276|527221397|FG003|Third Intervention Period|Adverse Event|0|||
146418911|NCT01296932|528039504|FG003|Overall Study|IV problems, administration not possible|0|||
146418912|NCT01296932|528039505|FG004|Overall Study|IV problems, administration not possible|0|||
146418913|NCT01296932|528039506|FG005|Overall Study|IV problems, administration not possible|0|||
146418914|NCT01296932|528039507|FG006|Overall Study|IV problems, administration not possible|0|||
146418915|NCT01296932|528039508|FG007|Overall Study|IV problems, administration not possible|0|||
146418916|NCT01296932|528039509|FG008|Overall Study|IV problems, administration not possible|0|||
146418917|NCT01296932|528039501|FG000|Overall Study|per protocol|0|||
146418918|NCT01296932|528039502|FG001|Overall Study|per protocol|0|||
146418919|NCT01296932|528039503|FG002|Overall Study|per protocol|1|||
146418920|NCT01296932|528039504|FG003|Overall Study|per protocol|1|||
146418921|NCT01296932|528039505|FG004|Overall Study|per protocol|0|||
146418922|NCT01296932|528039506|FG005|Overall Study|per protocol|0|||
146418923|NCT01296932|528039507|FG006|Overall Study|per protocol|0|||
146418924|NCT01296932|528039508|FG007|Overall Study|per protocol|0|||
146418925|NCT01296932|528039509|FG008|Overall Study|per protocol|0|||
146418926|NCT01296932|528039501|FG000|Overall Study|Low benefit and too many side effects|0|||
146418927|NCT01296932|528039502|FG001|Overall Study|Low benefit and too many side effects|0|||
146418928|NCT01296932|528039503|FG002|Overall Study|Low benefit and too many side effects|0|||
146418929|NCT01296932|528039504|FG003|Overall Study|Low benefit and too many side effects|0|||
146418930|NCT01296932|528039505|FG004|Overall Study|Low benefit and too many side effects|0|||
146418931|NCT01296932|528039506|FG005|Overall Study|Low benefit and too many side effects|0|||
146418932|NCT01296932|528039507|FG006|Overall Study|Low benefit and too many side effects|0|||
146418933|NCT01296932|528039508|FG007|Overall Study|Low benefit and too many side effects|1|||
146418934|NCT01296932|528039509|FG008|Overall Study|Low benefit and too many side effects|0|||
146418935|NCT01296932|528039501|FG000|Overall Study|No adequate treatment response|0|||
146418936|NCT01296932|528039502|FG001|Overall Study|No adequate treatment response|0|||
146418937|NCT01296932|528039503|FG002|Overall Study|No adequate treatment response|0|||
146418938|NCT01296932|528039504|FG003|Overall Study|No adequate treatment response|0|||
146418939|NCT01296932|528039505|FG004|Overall Study|No adequate treatment response|0|||
146418940|NCT01296932|528039506|FG005|Overall Study|No adequate treatment response|0|||
146418941|NCT01296932|528039507|FG006|Overall Study|No adequate treatment response|0|||
146418942|NCT01296932|528039508|FG007|Overall Study|No adequate treatment response|1|||
146418943|NCT01296932|528039509|FG008|Overall Study|No adequate treatment response|0|||
146418944|NCT01296932|528039501|FG000|Overall Study|Dosage already reduced, AE still present|0|||
146193784|NCT00991276|527221398|FG004|Third Intervention Period|Adverse Event|0|||
146193785|NCT00991276|527221399|FG005|Third Intervention Period|Adverse Event|0|||
146193786|NCT00991276|527221394|FG000|Third Intervention Period|Withdrawal by Subject|0|||
146193787|NCT00991276|527221395|FG001|Third Intervention Period|Withdrawal by Subject|0|||
146193788|NCT00991276|527221396|FG002|Third Intervention Period|Withdrawal by Subject|0|||
146193789|NCT00991276|527221397|FG003|Third Intervention Period|Withdrawal by Subject|1|||
146193790|NCT00991276|527221398|FG004|Third Intervention Period|Withdrawal by Subject|0|||
146193791|NCT00991276|527221399|FG005|Third Intervention Period|Withdrawal by Subject|0|||
146193792|NCT02534896|527221408|FG000|Overall Study|Adverse Event|2|||
146193793|NCT02534896|527221409|FG001|Overall Study|Adverse Event|1|||
146193794|NCT02534896|527221410|FG002|Overall Study|Adverse Event|1|||
146193795|NCT02534896|527221408|FG000|Overall Study|Insufficient therapeutic response|2|||
146193796|NCT02534896|527221409|FG001|Overall Study|Insufficient therapeutic response|0|||
146193797|NCT02534896|527221410|FG002|Overall Study|Insufficient therapeutic response|0|||
146193798|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
146193799|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
146193800|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
146193801|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
146193802|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Adverse Event|198|||
146418945|NCT01296932|528039502|FG001|Overall Study|Dosage already reduced, AE still present|0|||
146418946|NCT01296932|528039503|FG002|Overall Study|Dosage already reduced, AE still present|0|||
146418947|NCT01296932|528039504|FG003|Overall Study|Dosage already reduced, AE still present|0|||
146418948|NCT01296932|528039505|FG004|Overall Study|Dosage already reduced, AE still present|0|||
146418949|NCT01296932|528039506|FG005|Overall Study|Dosage already reduced, AE still present|0|||
146418950|NCT01296932|528039507|FG006|Overall Study|Dosage already reduced, AE still present|0|||
146193803|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Adverse Event|0|||
146193804|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Adverse Event|0|||
146193805|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Adverse Event|0|||
146193806|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Death|62|||
146418951|NCT01296932|528039508|FG007|Overall Study|Dosage already reduced, AE still present|0|||
146418952|NCT01296932|528039509|FG008|Overall Study|Dosage already reduced, AE still present|1|||
146418953|NCT04161144|528039514|FG000|Overall Study|Withdrawal by Subject|0|||
146418954|NCT04161144|528039515|FG001|Overall Study|Withdrawal by Subject|1|||
146418955|NCT04161144|528039514|FG000|Overall Study|Protocol Violation|1|||
146418956|NCT04161144|528039515|FG001|Overall Study|Protocol Violation|0|||
146418957|NCT00634907|528039518|FG000|Overall Study|Withdrawal by Subject|3|||
146418958|NCT00634907|528039519|FG001|Overall Study|Withdrawal by Subject|0|||
146418959|NCT00634907|528039518|FG000|Overall Study|Physician Decision|3|||
146418960|NCT00634907|528039519|FG001|Overall Study|Physician Decision|9|||
146418961|NCT00634907|528039518|FG000|Overall Study|Withdrawal by Subject|11|||
146418962|NCT00634907|528039519|FG001|Overall Study|Withdrawal by Subject|8|||
146418963|NCT04041570|528039520|FG000|Overall Study|Moved from Area|0|||
146418964|NCT04041570|528039521|FG001|Overall Study|Moved from Area|2|||
146418965|NCT01338636|528039522|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
146418966|NCT02385526|528039523|FG000|Overall Study|Withdrawal by Subject|0|||
146418967|NCT02385526|528039524|FG001|Overall Study|Withdrawal by Subject|2|||
146418968|NCT02385526|528039525|FG002|Overall Study|Withdrawal by Subject|0|||
146418969|NCT02385526|528039523|FG000|Overall Study|Lost to Follow-up|0|||
146418970|NCT02385526|528039524|FG001|Overall Study|Lost to Follow-up|1|||
146418971|NCT02385526|528039525|FG002|Overall Study|Lost to Follow-up|0|||
146418972|NCT02385526|528039523|FG000|Overall Study|Physician Decision|1|||
146418973|NCT02385526|528039524|FG001|Overall Study|Physician Decision|0|||
146418974|NCT02385526|528039525|FG002|Overall Study|Physician Decision|0|||
146418975|NCT02385526|528039523|FG000|Overall Study|Protocol Violation|1|||
146418976|NCT02385526|528039524|FG001|Overall Study|Protocol Violation|0|||
146418977|NCT02385526|528039525|FG002|Overall Study|Protocol Violation|0|||
146418978|NCT03532009|528039528|FG000|Overall Study|Other|1|||
146418979|NCT03532009|528039529|FG001|Overall Study|Other|1|||
146418980|NCT03532009|528039528|FG000|Overall Study|Death|1|||
146418981|NCT03532009|528039529|FG001|Overall Study|Death|1|||
146418982|NCT03532009|528039528|FG000|Overall Study|Withdrawal by Patient|0|||
146418983|NCT03532009|528039529|FG001|Overall Study|Withdrawal by Patient|2|||
146418984|NCT02866175|528039530|FG000|Overall Study|Adverse Event|56|||
146418985|NCT02866175|528039531|FG001|Overall Study|Adverse Event|54|||
146418986|NCT02866175|528039530|FG000|Overall Study|Withdrawal by Subject|31|||
146418987|NCT02866175|528039531|FG001|Overall Study|Withdrawal by Subject|52|||
146418988|NCT02866175|528039530|FG000|Overall Study|Death|30|||
146418989|NCT02866175|528039531|FG001|Overall Study|Death|23|||
146418990|NCT02866175|528039530|FG000|Overall Study|Other|7|||
146418991|NCT02866175|528039531|FG001|Overall Study|Other|14|||
146418992|NCT02866175|528039530|FG000|Overall Study|Progressive disease|1|||
146418993|NCT02866175|528039531|FG001|Overall Study|Progressive disease|1|||
146418994|NCT02866175|528039530|FG000|Overall Study|Lost to Follow-up|2|||
146418995|NCT02866175|528039531|FG001|Overall Study|Lost to Follow-up|0|||
146418996|NCT02866175|528039530|FG000|Overall Study|Lack of Efficacy|0|||
146418997|NCT02866175|528039531|FG001|Overall Study|Lack of Efficacy|1|||
146418998|NCT02866175|528039530|FG000|Overall Study|Physician Decision|3|||
146418999|NCT02866175|528039531|FG001|Overall Study|Physician Decision|15|||
146419000|NCT02866175|528039530|FG000|Overall Study|Did not receive treatment|5|||
146419001|NCT02866175|528039531|FG001|Overall Study|Did not receive treatment|15|||
146419002|NCT01694485|528039536|FG000|Overall Study|Withdrawal by Subject|20|||
146419003|NCT01694485|528039537|FG001|Overall Study|Withdrawal by Subject|6|||
146419004|NCT01694485|528039538|FG002|Overall Study|Withdrawal by Subject|7|||
146419005|NCT01694485|528039539|FG003|Overall Study|Withdrawal by Subject|25|||
146419006|NCT01694485|528039540|FG004|Overall Study|Withdrawal by Subject|18|||
146419007|NCT01694485|528039536|FG000|Overall Study|Sponsor Decision|3|||
146419008|NCT01694485|528039537|FG001|Overall Study|Sponsor Decision|0|||
146419009|NCT01694485|528039538|FG002|Overall Study|Sponsor Decision|0|||
146419010|NCT01694485|528039539|FG003|Overall Study|Sponsor Decision|2|||
146419011|NCT01694485|528039540|FG004|Overall Study|Sponsor Decision|0|||
146419012|NCT01694485|528039536|FG000|Overall Study|Lost to Follow-up|9|||
146419013|NCT01694485|528039537|FG001|Overall Study|Lost to Follow-up|1|||
146419014|NCT01694485|528039538|FG002|Overall Study|Lost to Follow-up|6|||
146419015|NCT01694485|528039539|FG003|Overall Study|Lost to Follow-up|10|||
146419016|NCT01694485|528039540|FG004|Overall Study|Lost to Follow-up|7|||
146419017|NCT01694485|528039536|FG000|Overall Study|Death|1|||
146419018|NCT01694485|528039537|FG001|Overall Study|Death|0|||
146419019|NCT01694485|528039538|FG002|Overall Study|Death|0|||
146419020|NCT01694485|528039539|FG003|Overall Study|Death|1|||
146419021|NCT01694485|528039540|FG004|Overall Study|Death|0|||
146419022|NCT02907203|528039541|FG000|Overall Study|Death|1|||
146419023|NCT02907203|528039541|FG000|Overall Study|Lost to Follow-up|3|||
146419024|NCT02907203|528039541|FG000|Overall Study|Withdrawal by Subject|3|||
146419025|NCT02907203|528039541|FG000|Overall Study|Surgical bypass|1|||
146419026|NCT00681863|528039543|FG000|Overall Study|Adverse Event|1|||
146419027|NCT00681863|528039543|FG000|Overall Study|Lost to Follow-up|2|||
146419028|NCT00681863|528039543|FG000|Overall Study|Lack of Efficacy|2|||
146419029|NCT00681863|528039543|FG000|Overall Study|Other|18|||
146419030|NCT00384033|528039553|FG000|Overall Study|Adverse Event|10|||
146419031|NCT00384033|528039554|FG001|Overall Study|Adverse Event|8|||
146419032|NCT00384033|528039555|FG002|Overall Study|Adverse Event|11|||
146419033|NCT00384033|528039556|FG003|Overall Study|Adverse Event|20|||
146419034|NCT00384033|528039553|FG000|Overall Study|Failed to return|1|||
146419035|NCT00384033|528039554|FG001|Overall Study|Failed to return|3|||
146419036|NCT00384033|528039555|FG002|Overall Study|Failed to return|2|||
146419037|NCT00384033|528039556|FG003|Overall Study|Failed to return|2|||
146419038|NCT00384033|528039553|FG000|Overall Study|Physician Decision|1|||
146419039|NCT00384033|528039554|FG001|Overall Study|Physician Decision|0|||
146419040|NCT00384033|528039555|FG002|Overall Study|Physician Decision|0|||
146419041|NCT00384033|528039556|FG003|Overall Study|Physician Decision|0|||
146419042|NCT00384033|528039553|FG000|Overall Study|Lost to Follow-up|6|||
146419043|NCT00384033|528039554|FG001|Overall Study|Lost to Follow-up|12|||
146419044|NCT00384033|528039555|FG002|Overall Study|Lost to Follow-up|7|||
146419045|NCT00384033|528039556|FG003|Overall Study|Lost to Follow-up|7|||
146419046|NCT00384033|528039553|FG000|Overall Study|Other|2|||
146419047|NCT00384033|528039554|FG001|Overall Study|Other|0|||
146419048|NCT00384033|528039555|FG002|Overall Study|Other|0|||
146419049|NCT00384033|528039556|FG003|Overall Study|Other|0|||
146419050|NCT00384033|528039553|FG000|Overall Study|Protocol Violation|5|||
146419051|NCT00384033|528039554|FG001|Overall Study|Protocol Violation|0|||
146419052|NCT00384033|528039555|FG002|Overall Study|Protocol Violation|5|||
146419053|NCT00384033|528039556|FG003|Overall Study|Protocol Violation|6|||
146419054|NCT00384033|528039553|FG000|Overall Study|Withdrawal by Subject|6|||
146419055|NCT00384033|528039554|FG001|Overall Study|Withdrawal by Subject|2|||
146419056|NCT00384033|528039555|FG002|Overall Study|Withdrawal by Subject|5|||
146419057|NCT00384033|528039556|FG003|Overall Study|Withdrawal by Subject|2|||
146419058|NCT00384033|528039553|FG000|Overall Study|Lack of Efficacy|7|||
146419059|NCT00384033|528039554|FG001|Overall Study|Lack of Efficacy|3|||
146419060|NCT00384033|528039555|FG002|Overall Study|Lack of Efficacy|3|||
146419061|NCT00384033|528039556|FG003|Overall Study|Lack of Efficacy|1|||
146419062|NCT00384033|528039553|FG000|Overall Study|Randomized but not treated|3|||
146419063|NCT00384033|528039554|FG001|Overall Study|Randomized but not treated|7|||
146419064|NCT00384033|528039555|FG002|Overall Study|Randomized but not treated|10|||
146419065|NCT00384033|528039556|FG003|Overall Study|Randomized but not treated|2|||
146419066|NCT01006707|528039557|FG000|Study Session 1|Lost to Follow-up|2|||
146419067|NCT01006707|528039558|FG001|Study Session 1|Lost to Follow-up|0|||
146419068|NCT01006707|528039559|FG002|Study Session 1|Lost to Follow-up|0|||
146419069|NCT01006707|528039557|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
146419070|NCT01006707|528039558|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
146419071|NCT01006707|528039559|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
146419072|NCT00760383|528039560|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
146419073|NCT00760383|528039561|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
146419074|NCT01842958|528039562|FG000|Overall Study|Lost to Follow-up|1|||
146419075|NCT01842958|528039563|FG001|Overall Study|Lost to Follow-up|1|||
146419076|NCT03465891|528039565|FG000|Overall Study|Withdrawal by Subject|0|||
146419077|NCT03465891|528039566|FG001|Overall Study|Withdrawal by Subject|1|||
146419078|NCT03465891|528039565|FG000|Overall Study|Disease progression|1|||
146419079|NCT03465891|528039566|FG001|Overall Study|Disease progression|0|||
146419080|NCT02737306|528039568|FG000|Overall Study|Adverse Event|3|||
146419081|NCT02737306|528039569|FG001|Overall Study|Adverse Event|0|||
146419082|NCT02737306|528039568|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
146419083|NCT02737306|528039569|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
146419084|NCT00622908|528039570|FG000|Overall Study|Protocol Violation|1|||
146419085|NCT00622908|528039571|FG001|Overall Study|Protocol Violation|0|||
146419086|NCT00622908|528039570|FG000|Overall Study|Adverse Event|0|||
146419087|NCT00622908|528039571|FG001|Overall Study|Adverse Event|1|||
146419088|NCT00622908|528039570|FG000|Overall Study|Lack of Efficacy|1|||
146082410|NCT02486627|526822788|FG000|Overall Study|Lost to Follow-up|1|||
146082411|NCT02486627|526822789|FG001|Overall Study|Lost to Follow-up|3|||
146082412|NCT00796991|526822799|FG000|Overall Study|Adverse Event|0|||
146082413|NCT00796991|526822800|FG001|Overall Study|Adverse Event|0|||
146082414|NCT00796991|526822801|FG002|Overall Study|Adverse Event|1|||
146193807|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Death|0|||
146193808|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Death|0|||
146193809|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Death|0|||
146193810|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
146193811|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146193812|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146193813|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
146193814|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Complicating disease|13|||
146193815|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Complicating disease|0|||
146193816|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Complicating disease|0|||
146193817|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Complicating disease|0|||
146193818|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
146193819|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
146193820|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
146193821|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
146193822|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
146193823|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146193824|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146193825|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
146193826|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Non-compliance|4|||
146193827|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Non-compliance|0|||
146193828|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Non-compliance|0|||
146193829|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Non-compliance|0|||
146193830|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Pain|4|||
146193831|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Pain|0|||
146193832|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Pain|0|||
146193833|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Pain|0|||
146193834|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
146193835|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
146193836|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
146193837|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
146193838|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Hospice care|1|||
146193839|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Hospice care|0|||
146193840|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Hospice care|0|||
146193841|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Hospice care|0|||
146193842|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Physician Decision|1|||
146193843|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Physician Decision|0|||
146193844|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Physician Decision|0|||
146193845|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Physician Decision|0|||
146193846|NCT01107626|527221413|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
146193847|NCT01107626|527221414|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146193848|NCT01107626|527221415|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146193849|NCT01107626|527221416|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
146193850|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
146082415|NCT00796991|526822799|FG000|Overall Study|Death|2|||
146082416|NCT00796991|526822800|FG001|Overall Study|Death|0|||
146082417|NCT00796991|526822801|FG002|Overall Study|Death|0|||
146082418|NCT00796991|526822799|FG000|Overall Study|Disease Progression|10|||
146082419|NCT00796991|526822800|FG001|Overall Study|Disease Progression|9|||
146082420|NCT00796991|526822801|FG002|Overall Study|Disease Progression|7|||
146193851|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
146193852|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
146193853|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
146193854|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
146193855|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
146193856|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
146193857|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
146193858|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Death|0|||
146193859|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Death|8|||
146193860|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Death|2|||
146193861|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Death|13|||
146193862|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
146193863|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
146193864|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
146193865|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
146193866|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
146082421|NCT00796991|526822799|FG000|Overall Study|Study Drug Toxicity|3|||
146082422|NCT00796991|526822800|FG001|Overall Study|Study Drug Toxicity|3|||
146082423|NCT00796991|526822801|FG002|Overall Study|Study Drug Toxicity|5|||
146193867|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
146193868|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
146193869|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
146193870|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
146193871|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
146193872|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
146193873|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
146193874|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
146193875|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
146193876|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
146193877|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
146193878|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
146419089|NCT00622908|528039571|FG001|Overall Study|Lack of Efficacy|7|||
146419090|NCT00622908|528039570|FG000|Overall Study|Lost to Follow-up|1|||
146419091|NCT00622908|528039571|FG001|Overall Study|Lost to Follow-up|0|||
146419092|NCT00622908|528039570|FG000|Overall Study|Refusal|0|||
146419093|NCT00622908|528039571|FG001|Overall Study|Refusal|1|||
146419094|NCT00622908|528039570|FG000|Overall Study|Termination by study sponser|0|||
146419095|NCT00622908|528039571|FG001|Overall Study|Termination by study sponser|1|||
146419096|NCT03305055|528039572|FG000|Overall Study|Withdrawal by Subject|0|||
146419097|NCT03305055|528039573|FG001|Overall Study|Withdrawal by Subject|1|||
146419098|NCT03305055|528039572|FG000|Overall Study|Adverse Event|1|||
146419099|NCT03305055|528039573|FG001|Overall Study|Adverse Event|1|||
146419100|NCT03937466|528039574|FG000|Overall Study|not eligbile after the 2-week diary|9|||
146419101|NCT03937466|528039574|FG000|Overall Study|never returned their diary|6|||
146419102|NCT03937466|528039574|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
146419103|NCT03937466|528039574|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
146419104|NCT03213210|528039575|FG000|Overall Study|Lost to Follow-up|2|||
146419105|NCT03213210|528039575|FG000|Overall Study|Study termination|3|||
146419106|NCT02540356|528039576|FG000|Overall Study|Terminated due to disease progression|1|||
146419107|NCT02540356|528039577|FG001|Overall Study|Terminated due to disease progression|0|||
146419108|NCT01166568|528039583|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
146419109|NCT01166568|528039584|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
146419110|NCT01166568|528039585|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
146419111|NCT01166568|528039583|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
146419112|NCT01166568|528039584|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
146419113|NCT01166568|528039585|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
146419114|NCT01166568|528039583|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
146419115|NCT01166568|528039584|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146419116|NCT01166568|528039585|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
146419117|NCT03335371|528039586|FG000|Overall Study|Lost to Follow-up|0|||
146419118|NCT03335371|528039587|FG001|Overall Study|Lost to Follow-up|0|||
146419119|NCT03335371|528039588|FG002|Overall Study|Lost to Follow-up|0|||
146419120|NCT03335371|528039589|FG003|Overall Study|Lost to Follow-up|0|||
146419121|NCT03335371|528039590|FG004|Overall Study|Lost to Follow-up|1|||
146419122|NCT03335371|528039586|FG000|Overall Study|Withdrawal by Subject|0|||
146419123|NCT03335371|528039587|FG001|Overall Study|Withdrawal by Subject|0|||
146419124|NCT03335371|528039588|FG002|Overall Study|Withdrawal by Subject|0|||
146419125|NCT03335371|528039589|FG003|Overall Study|Withdrawal by Subject|0|||
146419126|NCT03335371|528039590|FG004|Overall Study|Withdrawal by Subject|1|||
146419127|NCT03335371|528039586|FG000|Overall Study|Randomization Error|0|||
146419128|NCT03335371|528039587|FG001|Overall Study|Randomization Error|0|||
146419129|NCT03335371|528039588|FG002|Overall Study|Randomization Error|1|||
146419130|NCT03335371|528039589|FG003|Overall Study|Randomization Error|0|||
146419131|NCT03335371|528039590|FG004|Overall Study|Randomization Error|0|||
146419132|NCT00684671|528039591|FG000|Overall Study|Adverse Event|1|||
146419133|NCT00684671|528039592|FG001|Overall Study|Adverse Event|0|||
146419134|NCT00684671|528039593|FG002|Overall Study|Adverse Event|0|||
146419135|NCT00684671|528039591|FG000|Overall Study|Lost to Follow-up|1|||
146419136|NCT00684671|528039592|FG001|Overall Study|Lost to Follow-up|0|||
146419137|NCT00684671|528039593|FG002|Overall Study|Lost to Follow-up|0|||
146419138|NCT00684671|528039591|FG000|Overall Study|Alcoholic dependance|1|||
146193879|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
146193880|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
146193881|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
146419139|NCT00684671|528039592|FG001|Overall Study|Alcoholic dependance|0|||
146419140|NCT00684671|528039593|FG002|Overall Study|Alcoholic dependance|0|||
146419141|NCT00437281|528039594|FG000|Overall Study|Adverse Event|0|||
146419142|NCT00437281|528039595|FG001|Overall Study|Adverse Event|0|||
146285352|NCT01293487|527557844|FG006|Overall Study|Lost to Follow-up|0|||
146082424|NCT00796991|526822799|FG000|Overall Study|Withdrawal by Subject|0|||
146082425|NCT00796991|526822800|FG001|Overall Study|Withdrawal by Subject|0|||
146082426|NCT00796991|526822801|FG002|Overall Study|Withdrawal by Subject|1|||
146082427|NCT00171834|526822803|FG000|Overall Study|Adverse Event|2|||
146082428|NCT00171834|526822804|FG001|Overall Study|Adverse Event|1|||
146082429|NCT00171834|526822805|FG002|Overall Study|Adverse Event|3|||
146082430|NCT00171834|526822806|FG003|Overall Study|Adverse Event|2|||
146082431|NCT00171834|526822807|FG004|Overall Study|Adverse Event|2|||
146193882|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
146419143|NCT00437281|528039596|FG002|Overall Study|Adverse Event|0|||
146419144|NCT00437281|528039597|FG003|Overall Study|Adverse Event|1|||
146419145|NCT00437281|528039598|FG004|Overall Study|Adverse Event|0|||
146419146|NCT00437281|528039599|FG005|Overall Study|Adverse Event|1|||
146419147|NCT00437281|528039600|FG006|Overall Study|Adverse Event|0|||
146419148|NCT00437281|528039601|FG007|Overall Study|Adverse Event|0|||
146419149|NCT00437281|528039602|FG008|Overall Study|Adverse Event|0|||
146419150|NCT00437281|528039603|FG009|Overall Study|Adverse Event|1|||
146419151|NCT00437281|528039604|FG010|Overall Study|Adverse Event|0|||
146419152|NCT00437281|528039605|FG011|Overall Study|Adverse Event|0|||
146419153|NCT00437281|528039606|FG012|Overall Study|Adverse Event|0|||
146193883|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
146193884|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
146193885|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
146193886|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
146193887|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
146193888|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
146193889|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
146193890|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
146193891|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
146193892|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
146193893|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
146193894|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
146193895|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
146193896|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
146193897|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
146193898|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
146193899|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
146193900|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
146193901|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
146193902|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Pain|0|||
146193903|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Pain|0|||
146193904|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Pain|0|||
146419154|NCT00437281|528039607|FG013|Overall Study|Adverse Event|1|||
146419155|NCT00437281|528039608|FG014|Overall Study|Adverse Event|1|||
146082432|NCT00171834|526822808|FG005|Overall Study|Adverse Event|15|||
146193905|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Pain|1|||
146193906|NCT01107626|527221413|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
146419156|NCT00437281|528039609|FG015|Overall Study|Adverse Event|0|||
146419157|NCT00437281|528039610|FG016|Overall Study|Adverse Event|0|||
146419158|NCT00437281|528039611|FG017|Overall Study|Adverse Event|0|||
146419159|NCT00437281|528039612|FG018|Overall Study|Adverse Event|1|||
146082433|NCT00171834|526822809|FG006|Overall Study|Adverse Event|1|||
146082434|NCT00171834|526822803|FG000|Overall Study|Withdrawal by Subject|0|||
146419160|NCT00437281|528039613|FG019|Overall Study|Adverse Event|0|||
146419161|NCT00437281|528039594|FG000|Overall Study|Lost to Follow-up|0|||
146419162|NCT00437281|528039595|FG001|Overall Study|Lost to Follow-up|0|||
146419163|NCT00437281|528039596|FG002|Overall Study|Lost to Follow-up|0|||
146419164|NCT00437281|528039597|FG003|Overall Study|Lost to Follow-up|0|||
146419165|NCT00437281|528039598|FG004|Overall Study|Lost to Follow-up|0|||
146419166|NCT00437281|528039599|FG005|Overall Study|Lost to Follow-up|0|||
146419167|NCT00437281|528039600|FG006|Overall Study|Lost to Follow-up|0|||
146419168|NCT00437281|528039601|FG007|Overall Study|Lost to Follow-up|0|||
146419169|NCT00437281|528039602|FG008|Overall Study|Lost to Follow-up|0|||
146419170|NCT00437281|528039603|FG009|Overall Study|Lost to Follow-up|0|||
146419171|NCT00437281|528039604|FG010|Overall Study|Lost to Follow-up|0|||
146419172|NCT00437281|528039605|FG011|Overall Study|Lost to Follow-up|0|||
146419173|NCT00437281|528039606|FG012|Overall Study|Lost to Follow-up|0|||
146419174|NCT00437281|528039607|FG013|Overall Study|Lost to Follow-up|0|||
146419175|NCT00437281|528039608|FG014|Overall Study|Lost to Follow-up|0|||
146419176|NCT00437281|528039609|FG015|Overall Study|Lost to Follow-up|0|||
146419177|NCT00437281|528039610|FG016|Overall Study|Lost to Follow-up|0|||
146419178|NCT00437281|528039611|FG017|Overall Study|Lost to Follow-up|0|||
146419179|NCT00437281|528039612|FG018|Overall Study|Lost to Follow-up|0|||
146419180|NCT00437281|528039613|FG019|Overall Study|Lost to Follow-up|1|||
146419181|NCT00249821|528039616|FG000|Overall Study|Technical problem|0|||
146419182|NCT00249821|528039617|FG001|Overall Study|Technical problem|1|||
146419183|NCT01348542|528039621|FG000|Overall Study|Withdrawal by Subject|3|||
146419184|NCT01348542|528039622|FG001|Overall Study|Withdrawal by Subject|0|||
146419185|NCT00467584|528039623|FG000|Overall Study|Withdrawal by Subject|4|||
146419186|NCT00467584|528039624|FG001|Overall Study|Withdrawal by Subject|5|||
146419187|NCT00467584|528039625|FG002|Overall Study|Withdrawal by Subject|1|||
146419188|NCT00926289|528039626|FG000|Overall Study|Adverse Event|9|||
146419189|NCT00926289|528039627|FG001|Overall Study|Adverse Event|11|||
146419190|NCT00926289|528039626|FG000|Overall Study|Protocol Violation|8|||
146419191|NCT00926289|528039627|FG001|Overall Study|Protocol Violation|12|||
146419192|NCT00926289|528039626|FG000|Overall Study|Lost to Follow-up|3|||
146419193|NCT00926289|528039627|FG001|Overall Study|Lost to Follow-up|6|||
146419194|NCT00926289|528039626|FG000|Overall Study|Withdrawal by Subject|4|||
146419195|NCT00926289|528039627|FG001|Overall Study|Withdrawal by Subject|4|||
146419196|NCT00926289|528039626|FG000|Overall Study|Other|1|||
146419197|NCT00926289|528039627|FG001|Overall Study|Other|3|||
146419198|NCT00319956|528039628|FG000|Overall Study|Death|20|||
146419199|NCT00319956|528039629|FG001|Overall Study|Death|24|||
146419200|NCT00753714|528039630|FG000|Overall Study|Lack of Efficacy|21|||
146419201|NCT00753714|528039631|FG001|Overall Study|Lack of Efficacy|34|||
146419202|NCT00753714|528039630|FG000|Overall Study|Adverse Event|26|||
146419203|NCT00753714|528039631|FG001|Overall Study|Adverse Event|18|||
146419204|NCT00753714|528039630|FG000|Overall Study|Protocol Violation|1|||
146193907|NCT01107626|527221414|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
146419205|NCT00753714|528039631|FG001|Overall Study|Protocol Violation|0|||
146419206|NCT00753714|528039630|FG000|Overall Study|Lost to Follow-up|0|||
146419207|NCT00753714|528039631|FG001|Overall Study|Lost to Follow-up|1|||
146419208|NCT00753714|528039630|FG000|Overall Study|Withdrawal by Subject|2|||
146419209|NCT00753714|528039631|FG001|Overall Study|Withdrawal by Subject|1|||
146419210|NCT00753714|528039630|FG000|Overall Study|Death|3|||
146419211|NCT00753714|528039631|FG001|Overall Study|Death|3|||
146419212|NCT00753714|528039630|FG000|Overall Study|Other|7|||
146419213|NCT00753714|528039631|FG001|Overall Study|Other|5|||
146419214|NCT01202747|528039632|FG000|Overall Study|Withdrawal by Subject|1|||
146419215|NCT01446913|528039633|FG000|Overall Study|Significant illness|1|||
146419216|NCT01446913|528039634|FG001|Overall Study|Significant illness|1|||
146419217|NCT01446913|528039635|FG002|Overall Study|Significant illness|1|||
146419218|NCT01446913|528039633|FG000|Overall Study|Withdrawal by Subject|5|||
146419219|NCT01446913|528039634|FG001|Overall Study|Withdrawal by Subject|3|||
146419220|NCT01446913|528039635|FG002|Overall Study|Withdrawal by Subject|5|||
146419221|NCT01446913|528039633|FG000|Overall Study|Physician Decision|0|||
146419222|NCT01446913|528039634|FG001|Overall Study|Physician Decision|0|||
146419223|NCT01446913|528039635|FG002|Overall Study|Physician Decision|2|||
146419224|NCT01446913|528039633|FG000|Overall Study|Lost to Follow-up|3|||
146419225|NCT01446913|528039634|FG001|Overall Study|Lost to Follow-up|5|||
146419226|NCT01446913|528039635|FG002|Overall Study|Lost to Follow-up|3|||
146419227|NCT04000009|528039636|FG000|Overall Study|Adverse Event|13|||
146419228|NCT04000009|528039636|FG000|Overall Study|Lack of Efficacy|7|||
146419229|NCT04000009|528039636|FG000|Overall Study|Lost to Follow-up|8|||
146419230|NCT04000009|528039636|FG000|Overall Study|Noncompliance with study drug|4|||
146419231|NCT04000009|528039636|FG000|Overall Study|Physician Decision|1|||
146419232|NCT04000009|528039636|FG000|Overall Study|Use of prohibited medication|3|||
146419233|NCT04000009|528039636|FG000|Overall Study|Pregnancy|1|||
146419234|NCT04000009|528039636|FG000|Overall Study|Withdrawal by Subject|22|||
146419235|NCT04000009|528039636|FG000|Overall Study|Study terminated by sponsor|98|||
146419236|NCT04000009|528039636|FG000|Overall Study|Not further specified|8|||
146419237|NCT02292238|528039637|FG000|Overall Study|Protocol Violation|1|||
146419238|NCT02292238|528039638|FG001|Overall Study|Protocol Violation|2|||
146419239|NCT02292238|528039637|FG000|Overall Study|Withdrawal by Subject|2|||
146419240|NCT02292238|528039638|FG001|Overall Study|Withdrawal by Subject|1|||
146419241|NCT02292238|528039637|FG000|Overall Study|Lost to Follow-up|1|||
146419242|NCT02292238|528039638|FG001|Overall Study|Lost to Follow-up|0|||
146419243|NCT02292238|528039637|FG000|Overall Study|Physician Decision|0|||
146419244|NCT02292238|528039638|FG001|Overall Study|Physician Decision|1|||
146419245|NCT02041702|528039643|FG000|Overall Study|Lost to Follow-up|1|||
146419246|NCT02041702|528039644|FG001|Overall Study|Lost to Follow-up|6|||
146419247|NCT02041702|528039643|FG000|Overall Study|Death|4|||
146419248|NCT02041702|528039644|FG001|Overall Study|Death|0|||
146419249|NCT02041702|528039643|FG000|Overall Study|Withdrawal by Subject|4|||
146419250|NCT02041702|528039644|FG001|Overall Study|Withdrawal by Subject|3|||
146419251|NCT02041702|528039643|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
146419252|NCT02041702|528039644|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
146419253|NCT02041702|528039643|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
146419254|NCT02041702|528039644|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
146419255|NCT00203307|528039645|FG000|First Intervention|Adverse Event|2|||
146419256|NCT00203307|528039646|FG001|First Intervention|Adverse Event|0|||
146419257|NCT01618305|528039647|FG000|Overall Study|Death|0|||
146419258|NCT01618305|528039648|FG001|Overall Study|Death|1|||
146419259|NCT01618305|528039647|FG000|Overall Study|Lost to Follow-up|11|||
146419260|NCT01618305|528039648|FG001|Overall Study|Lost to Follow-up|7|||
146419261|NCT01618305|528039647|FG000|Overall Study|Protocol Violation|1|||
146419262|NCT01618305|528039648|FG001|Overall Study|Protocol Violation|0|||
146419263|NCT01618305|528039647|FG000|Overall Study|Withdrawal by Subject|3|||
146419264|NCT01618305|528039648|FG001|Overall Study|Withdrawal by Subject|2|||
146419265|NCT01960816|528039649|FG000|Overall Study|Lost to Follow-up|1|||
146419266|NCT01309919|528039665|FG000|Overall Study|Did not receive a postpartum IUD|17|||
146419267|NCT01309919|528039666|FG001|Overall Study|Did not receive a postpartum IUD|48|||
146419268|NCT04583579|528041320|FG000|Overall Study|Lost to Follow-up|4|||
146419269|NCT01691859|528041321|FG000|Overall Study|Adverse Event|19|||
146419270|NCT01691859|528041321|FG000|Overall Study|Lack of Efficacy|11|||
146419271|NCT01691859|528041321|FG000|Overall Study|Protocol Violation|4|||
146419272|NCT01691859|528041321|FG000|Overall Study|Product commercially available|221|||
146419273|NCT01691859|528041321|FG000|Overall Study|Study closed/terminated|50|||
146419274|NCT01691859|528041321|FG000|Overall Study|Lost to Follow-up|5|||
146419275|NCT01691859|528041321|FG000|Overall Study|Physician Decision|6|||
146419276|NCT01691859|528041321|FG000|Overall Study|Withdrawal by Subject|31|||
146419277|NCT01691508|528041322|FG000|Overall Study|Adverse Event|3|||
146419278|NCT01691508|528041323|FG001|Overall Study|Adverse Event|3|||
146419279|NCT01691508|528041322|FG000|Overall Study|Withdrawal by Subject|1|||
146419280|NCT01691508|528041323|FG001|Overall Study|Withdrawal by Subject|0|||
146419281|NCT03731182|528041327|FG000|Overall Study|Lost to Follow-up|2|||
146419282|NCT03731182|528041328|FG001|Overall Study|Lost to Follow-up|0|||
146419283|NCT03731182|528041327|FG000|Overall Study|Physician Decision|1|||
146419284|NCT03731182|528041328|FG001|Overall Study|Physician Decision|0|||
146419285|NCT03731182|528041327|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
146419286|NCT03731182|528041328|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
146419287|NCT02006706|528041329|FG000|Overall Study|Lost to Follow-up|1|||
146419288|NCT02207621|528041331|FG000|Overall Study|Adverse Event|71|||
146419289|NCT02207621|528041332|FG001|Overall Study|Adverse Event|15|||
146419290|NCT02207621|528041333|FG002|Overall Study|Adverse Event|132|||
146419291|NCT02207621|528041331|FG000|Overall Study|Withdrawal by Subject|9|||
146419292|NCT02207621|528041332|FG001|Overall Study|Withdrawal by Subject|9|||
146419293|NCT02207621|528041333|FG002|Overall Study|Withdrawal by Subject|13|||
146419294|NCT02207621|528041331|FG000|Overall Study|Non-Compliant|3|||
146419295|NCT02207621|528041332|FG001|Overall Study|Non-Compliant|3|||
146419296|NCT02207621|528041333|FG002|Overall Study|Non-Compliant|1|||
146419297|NCT02207621|528041331|FG000|Overall Study|Lost to Follow-up|1|||
146419298|NCT02207621|528041332|FG001|Overall Study|Lost to Follow-up|0|||
146419299|NCT02207621|528041333|FG002|Overall Study|Lost to Follow-up|3|||
146419300|NCT02207621|528041331|FG000|Overall Study|Lack of Efficacy|10|||
146419301|NCT02207621|528041332|FG001|Overall Study|Lack of Efficacy|2|||
146419302|NCT02207621|528041333|FG002|Overall Study|Lack of Efficacy|4|||
146419303|NCT02207621|528041331|FG000|Overall Study|Disallowed Concurrent Medication|2|||
146419304|NCT02207621|528041332|FG001|Overall Study|Disallowed Concurrent Medication|5|||
146419305|NCT02207621|528041333|FG002|Overall Study|Disallowed Concurrent Medication|2|||
146419306|NCT02207621|528041331|FG000|Overall Study|Physician Decision|1|||
146419307|NCT02207621|528041332|FG001|Overall Study|Physician Decision|2|||
146419308|NCT02207621|528041333|FG002|Overall Study|Physician Decision|2|||
146419309|NCT02207621|528041331|FG000|Overall Study|Protocol Violation|4|||
146419310|NCT02207621|528041332|FG001|Overall Study|Protocol Violation|10|||
146419311|NCT02207621|528041333|FG002|Overall Study|Protocol Violation|6|||
146419312|NCT02207621|528041331|FG000|Overall Study|Death|2|||
146419313|NCT02207621|528041332|FG001|Overall Study|Death|0|||
146419314|NCT02207621|528041333|FG002|Overall Study|Death|0|||
146193908|NCT01107626|527221415|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
146193909|NCT01107626|527221416|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
146193910|NCT04310579|527221424|FG000|Overall Study|Adverse Event|0|||
146193911|NCT04310579|527221425|FG001|Overall Study|Adverse Event|0|||
146193912|NCT04310579|527221426|FG002|Overall Study|Adverse Event|0|||
146193913|NCT04310579|527221427|FG003|Overall Study|Adverse Event|0|||
146193914|NCT04310579|527221428|FG004|Overall Study|Adverse Event|0|||
146193915|NCT04310579|527221429|FG005|Overall Study|Adverse Event|0|||
146193916|NCT04310579|527221430|FG006|Overall Study|Adverse Event|2|||
146193917|NCT04310579|527221431|FG007|Overall Study|Adverse Event|0|||
146193918|NCT04310579|527221432|FG008|Overall Study|Adverse Event|1|||
146193919|NCT04310579|527221433|FG009|Overall Study|Adverse Event|1|||
146193920|NCT04310579|527221434|FG010|Overall Study|Adverse Event|0|||
146193921|NCT04310579|527221424|FG000|Overall Study|Withdrawal by Subject|0|||
146193922|NCT04310579|527221425|FG001|Overall Study|Withdrawal by Subject|0|||
146193923|NCT04310579|527221426|FG002|Overall Study|Withdrawal by Subject|0|||
146419315|NCT02207621|528041331|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
146419316|NCT02207621|528041332|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
146419317|NCT02207621|528041333|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
146419318|NCT00958256|528041335|FG000|Overall Study|Adverse Event|3|||
146419319|NCT03036579|528041338|FG000|2 Years|Lost to Follow-up|1|||
146419320|NCT03036579|528041339|FG001|2 Years|Lost to Follow-up|0|||
146419321|NCT03036579|528041338|FG000|3 Years|Lost to Follow-up|0|||
146419322|NCT03036579|528041339|FG001|3 Years|Lost to Follow-up|1|||
146419323|NCT02848599|528041340|FG000|Overall Study|Protocol Violation|7|||
146419324|NCT02848599|528041341|FG001|Overall Study|Protocol Violation|9|||
146419325|NCT03519256|528041342|FG000|Overall Study|Disease recurrence|4|||
146419326|NCT03519256|528041343|FG001|Overall Study|Disease recurrence|4|||
146419327|NCT03519256|528041344|FG002|Overall Study|Disease recurrence|5|||
146419328|NCT03519256|528041345|FG003|Overall Study|Disease recurrence|2|||
146419329|NCT03519256|528041342|FG000|Overall Study|Study drug toxicity|0|||
146419330|NCT03519256|528041343|FG001|Overall Study|Study drug toxicity|2|||
146419331|NCT03519256|528041344|FG002|Overall Study|Study drug toxicity|5|||
146419332|NCT03519256|528041345|FG003|Overall Study|Study drug toxicity|2|||
146419333|NCT03519256|528041342|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146419334|NCT03519256|528041343|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146193924|NCT04310579|527221427|FG003|Overall Study|Withdrawal by Subject|0|||
146419335|NCT03519256|528041344|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146419336|NCT03519256|528041345|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146419337|NCT03519256|528041342|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146419338|NCT03519256|528041343|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146419339|NCT03519256|528041344|FG002|Overall Study|Participant request to discontinue study treatment|0|||
145948190|NCT02028169|526319601|FG000|Overall Study|Cessation of Drug|1|||
146193925|NCT04310579|527221428|FG004|Overall Study|Withdrawal by Subject|0|||
146193926|NCT04310579|527221429|FG005|Overall Study|Withdrawal by Subject|1|||
146193927|NCT04310579|527221430|FG006|Overall Study|Withdrawal by Subject|0|||
146193928|NCT04310579|527221431|FG007|Overall Study|Withdrawal by Subject|0|||
146285353|NCT01293487|527557845|FG007|Overall Study|Lost to Follow-up|0|||
146419340|NCT03519256|528041345|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146419341|NCT03519256|528041342|FG000|Overall Study|Other reasons|0|||
146419342|NCT03519256|528041343|FG001|Overall Study|Other reasons|0|||
146419343|NCT03519256|528041344|FG002|Overall Study|Other reasons|2|||
146419344|NCT03519256|528041345|FG003|Overall Study|Other reasons|0|||
146193929|NCT04310579|527221432|FG008|Overall Study|Withdrawal by Subject|0|||
146193930|NCT04310579|527221433|FG009|Overall Study|Withdrawal by Subject|0|||
146193931|NCT04310579|527221434|FG010|Overall Study|Withdrawal by Subject|0|||
146419345|NCT03519256|528041342|FG000|Overall Study|Disease progression|6|||
146419346|NCT03519256|528041343|FG001|Overall Study|Disease progression|3|||
146419347|NCT03519256|528041344|FG002|Overall Study|Disease progression|2|||
146419348|NCT03519256|528041345|FG003|Overall Study|Disease progression|1|||
146419349|NCT03519256|528041342|FG000|Overall Study|Lost to Follow-up|0|||
146419350|NCT03519256|528041343|FG001|Overall Study|Lost to Follow-up|1|||
146419351|NCT03519256|528041344|FG002|Overall Study|Lost to Follow-up|0|||
146419352|NCT03519256|528041345|FG003|Overall Study|Lost to Follow-up|0|||
146419353|NCT04828161|528041346|FG000|Overall Study|Withdrawal by Subject|0|||
146419354|NCT04828161|528041347|FG001|Overall Study|Withdrawal by Subject|3|||
146419355|NCT04828161|528041348|FG002|Overall Study|Withdrawal by Subject|3|||
146419356|NCT04828161|528041349|FG003|Overall Study|Withdrawal by Subject|4|||
146419357|NCT04828161|528041346|FG000|Overall Study|Lost to Follow-up|1|||
146419358|NCT04828161|528041347|FG001|Overall Study|Lost to Follow-up|4|||
146419359|NCT04828161|528041348|FG002|Overall Study|Lost to Follow-up|2|||
146419360|NCT04828161|528041349|FG003|Overall Study|Lost to Follow-up|2|||
146419361|NCT04828161|528041346|FG000|Overall Study|Other|2|||
146419362|NCT04828161|528041347|FG001|Overall Study|Other|0|||
146419363|NCT04828161|528041348|FG002|Overall Study|Other|2|||
146193932|NCT04310579|527221424|FG000|Overall Study|Positive COVID-19 test|0|||
146193933|NCT04310579|527221425|FG001|Overall Study|Positive COVID-19 test|0|||
146193934|NCT04310579|527221426|FG002|Overall Study|Positive COVID-19 test|0|||
146193935|NCT04310579|527221427|FG003|Overall Study|Positive COVID-19 test|0|||
146193936|NCT04310579|527221428|FG004|Overall Study|Positive COVID-19 test|0|||
146193937|NCT04310579|527221429|FG005|Overall Study|Positive COVID-19 test|0|||
146193938|NCT04310579|527221430|FG006|Overall Study|Positive COVID-19 test|0|||
146193939|NCT04310579|527221431|FG007|Overall Study|Positive COVID-19 test|0|||
146193940|NCT04310579|527221432|FG008|Overall Study|Positive COVID-19 test|0|||
146193941|NCT04310579|527221433|FG009|Overall Study|Positive COVID-19 test|0|||
146193942|NCT04310579|527221434|FG010|Overall Study|Positive COVID-19 test|1|||
146193943|NCT03467724|527221435|FG000|Overall Study|Lost to Follow-up|5|||
146193944|NCT03467724|527221435|FG000|Overall Study|Withdrawal by Subject|1|||
146193945|NCT03467724|527221435|FG000|Overall Study|Protocol Violation|1|||
146193946|NCT03467724|527221435|FG000|Overall Study|Adverse Event|1|||
146193947|NCT02236559|527221439|FG000|Overall Study|Met Exclusion|3|||
146193948|NCT02236559|527221440|FG001|Overall Study|Met Exclusion|6|||
146193949|NCT02236559|527221439|FG000|Overall Study|Did not Meet Inclusion|3|||
146193950|NCT02236559|527221440|FG001|Overall Study|Did not Meet Inclusion|3|||
146193951|NCT02236559|527221439|FG000|Overall Study|Subject Did Not Consent|4|||
146193952|NCT02236559|527221440|FG001|Overall Study|Subject Did Not Consent|2|||
146193953|NCT02236559|527221439|FG000|Overall Study|Physician Decision|1|||
146193954|NCT02236559|527221440|FG001|Overall Study|Physician Decision|1|||
146193955|NCT02236559|527221439|FG000|Overall Study|Withdrawal by Subject|1|||
146193956|NCT02236559|527221440|FG001|Overall Study|Withdrawal by Subject|0|||
146193957|NCT02049866|527221441|FG000|Overall Study|Withdrawal by Subject|1|||
146193958|NCT01117480|527221442|FG000|Overall Study|Protocol Violation|8|||
146193959|NCT01117480|527221442|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
146193960|NCT03721016|527221443|FG000|Overall Study|Adverse Event|0|||
146193961|NCT03721016|527221444|FG001|Overall Study|Adverse Event|1|||
146193962|NCT03721016|527221445|FG002|Overall Study|Adverse Event|1|||
146193963|NCT03721016|527221443|FG000|Overall Study|Withdrawal by Subject|8|||
146193964|NCT03721016|527221444|FG001|Overall Study|Withdrawal by Subject|16|||
146193965|NCT03721016|527221445|FG002|Overall Study|Withdrawal by Subject|13|||
146419364|NCT04828161|528041349|FG003|Overall Study|Other|0|||
146419365|NCT04828161|528041346|FG000|Overall Study|Death|0|||
146193966|NCT03721016|527221443|FG000|Overall Study|Lost to Follow-up|4|||
146193967|NCT03721016|527221444|FG001|Overall Study|Lost to Follow-up|6|||
146193968|NCT03721016|527221445|FG002|Overall Study|Lost to Follow-up|5|||
146193969|NCT03721016|527221443|FG000|Overall Study|Physician Decision|0|||
146193970|NCT03721016|527221444|FG001|Overall Study|Physician Decision|1|||
146193971|NCT03721016|527221445|FG002|Overall Study|Physician Decision|2|||
146193972|NCT03721016|527221443|FG000|Overall Study|Protocol Violation|0|||
146193973|NCT03721016|527221444|FG001|Overall Study|Protocol Violation|1|||
146419366|NCT04828161|528041347|FG001|Overall Study|Death|0|||
146419367|NCT04828161|528041348|FG002|Overall Study|Death|0|||
146193974|NCT03721016|527221445|FG002|Overall Study|Protocol Violation|0|||
146193975|NCT03721016|527221443|FG000|Overall Study|Site terminated by sponsor|3|||
146193976|NCT03721016|527221444|FG001|Overall Study|Site terminated by sponsor|7|||
146193977|NCT03721016|527221445|FG002|Overall Study|Site terminated by sponsor|6|||
146193978|NCT03721016|527221443|FG000|Overall Study|Subject exited early due to COVID-19|1|||
146193979|NCT03721016|527221444|FG001|Overall Study|Subject exited early due to COVID-19|0|||
146419368|NCT04828161|528041349|FG003|Overall Study|Death|2|||
146419369|NCT05431153|528041350|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146419370|NCT05431153|528041351|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146419371|NCT05431153|528041352|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146193980|NCT03721016|527221445|FG002|Overall Study|Subject exited early due to COVID-19|0|||
146193981|NCT02232178|527221449|FG000|Overall Study|Lost to Follow-up|0|||
146193982|NCT02232178|527221450|FG001|Overall Study|Lost to Follow-up|1|||
146193983|NCT02232178|527221451|FG002|Overall Study|Lost to Follow-up|0|||
146193984|NCT02232178|527221449|FG000|Overall Study|ineligibility|0|||
146193985|NCT02232178|527221450|FG001|Overall Study|ineligibility|0|||
146193986|NCT02232178|527221451|FG002|Overall Study|ineligibility|1|||
146193987|NCT02232178|527221449|FG000|Overall Study|surgical complication|1|||
146419372|NCT05431153|528041353|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146419373|NCT05431153|528041354|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146419374|NCT05431153|528041355|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146419375|NCT02352337|528041356|FG000|Overall Study|Patients never treated|4|||
146419376|NCT02352337|528041357|FG001|Overall Study|Patients never treated|1|||
146419377|NCT02352337|528041358|FG002|Overall Study|Patients never treated|2|||
146419378|NCT02458638|528041359|FG000|Overall Study|Death|309|||
146419379|NCT02458638|528041359|FG000|Overall Study|End of Cohort/End of Study|67|||
146419380|NCT02458638|528041359|FG000|Overall Study|Lost to Follow-up|31|||
146419381|NCT02458638|528041359|FG000|Overall Study|Other Reasons|4|||
146419382|NCT02458638|528041359|FG000|Overall Study|Physician Decision|1|||
146419383|NCT02458638|528041359|FG000|Overall Study|Withdrawal by Subject|47|||
146419384|NCT00135707|528041373|FG000|Overall Study|Lost to Follow-up|94|||
146419385|NCT00135707|528041374|FG001|Overall Study|Lost to Follow-up|89|||
146419386|NCT00135707|528041373|FG000|Overall Study|Withdrawal by Subject|0|||
146419387|NCT00135707|528041374|FG001|Overall Study|Withdrawal by Subject|1|||
146419388|NCT00135707|528041373|FG000|Overall Study|Institutional review board request|1|||
146419389|NCT00135707|528041374|FG001|Overall Study|Institutional review board request|0|||
146419390|NCT03093454|528041377|FG000|Overall Study|Withdrawal by Subject|1|||
146419391|NCT03093454|528041378|FG001|Overall Study|Withdrawal by Subject|1|||
146419392|NCT03093454|528041377|FG000|Overall Study|Scheduling conflict|3|||
146419393|NCT03093454|528041378|FG001|Overall Study|Scheduling conflict|1|||
146419394|NCT03093454|528041377|FG000|Overall Study|Physician Decision|2|||
146419395|NCT03093454|528041378|FG001|Overall Study|Physician Decision|1|||
146419396|NCT04540497|528041379|FG000|Overall Study|Adverse Event|0|||
146419397|NCT04540497|528041380|FG001|Overall Study|Adverse Event|2|||
146419398|NCT04540497|528041379|FG000|Overall Study|Lost to Follow-up|1|||
146419399|NCT04540497|528041380|FG001|Overall Study|Lost to Follow-up|0|||
146419400|NCT04540497|528041379|FG000|Overall Study|Withdrawal by Subject|1|||
146419401|NCT04540497|528041380|FG001|Overall Study|Withdrawal by Subject|1|||
146419402|NCT04540497|528041379|FG000|Overall Study|Miscellaneous|2|||
146419403|NCT04540497|528041380|FG001|Overall Study|Miscellaneous|1|||
146419404|NCT00421174|528041382|FG000|Overall Study|Withdrawal by Subject|0|||
146419405|NCT00421174|528041383|FG001|Overall Study|Withdrawal by Subject|1|||
146419406|NCT00421174|528041382|FG000|Overall Study|Ineligible due to infection|2|||
146419407|NCT00421174|528041383|FG001|Overall Study|Ineligible due to infection|0|||
146419408|NCT01829464|528041387|FG000|Overall Study|Adverse Event|1|||
146419409|NCT01829464|528041388|FG001|Overall Study|Adverse Event|0|||
146419410|NCT01829464|528041389|FG002|Overall Study|Adverse Event|0|||
146419411|NCT01829464|528041387|FG000|Overall Study|Lost to Follow-up|0|||
146419412|NCT01829464|528041388|FG001|Overall Study|Lost to Follow-up|0|||
146419413|NCT01829464|528041389|FG002|Overall Study|Lost to Follow-up|1|||
146419414|NCT01829464|528041387|FG000|Overall Study|Withdrawal by Subject|2|||
146419415|NCT01829464|528041388|FG001|Overall Study|Withdrawal by Subject|0|||
146419416|NCT01829464|528041389|FG002|Overall Study|Withdrawal by Subject|0|||
146419417|NCT01829464|528041387|FG000|Overall Study|Study terminated by sponsor|25|||
146419418|NCT01829464|528041388|FG001|Overall Study|Study terminated by sponsor|28|||
146419419|NCT01829464|528041389|FG002|Overall Study|Study terminated by sponsor|25|||
146419420|NCT01829464|528041387|FG000|Overall Study|Lack of Efficacy|0|||
146419421|NCT01829464|528041388|FG001|Overall Study|Lack of Efficacy|1|||
146419422|NCT01829464|528041389|FG002|Overall Study|Lack of Efficacy|0|||
146419423|NCT00992407|528041394|FG000|Overall Study|Protocol Violation|2|||
146419424|NCT00992407|528041395|FG001|Overall Study|Protocol Violation|1|||
146419425|NCT00992407|528041394|FG000|Overall Study|Lost to Follow-up|3|||
146419426|NCT00992407|528041395|FG001|Overall Study|Lost to Follow-up|3|||
146419427|NCT00992407|528041394|FG000|Overall Study|Adverse Event|3|||
146419428|NCT00992407|528041395|FG001|Overall Study|Adverse Event|2|||
146419429|NCT00992407|528041394|FG000|Overall Study|protocol Violation & Adverse events|2|||
146419430|NCT00992407|528041395|FG001|Overall Study|protocol Violation & Adverse events|4|||
146419431|NCT00992407|528041394|FG000|Overall Study|Other|2|||
146419432|NCT00992407|528041395|FG001|Overall Study|Other|0|||
146419433|NCT00992407|528041394|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
146419434|NCT00992407|528041395|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
146419435|NCT00992407|528041394|FG000|Overall Study|Study medication not administered|17|||
146193988|NCT02232178|527221450|FG001|Overall Study|surgical complication|0|||
146193989|NCT02232178|527221451|FG002|Overall Study|surgical complication|0|||
146419436|NCT00992407|528041395|FG001|Overall Study|Study medication not administered|13|||
146419437|NCT03738332|528041400|FG000|Overall Study|Withdrawal by Subject|1|||
146419438|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
146419439|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
146419440|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
146419441|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
146419442|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
146419443|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
146419444|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
146419445|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
146419446|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146419447|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146419448|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
146419449|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
146419450|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
146419451|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146419452|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146419453|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
146419454|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
146419455|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
146419456|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
146419457|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
146419458|NCT04700449|528041401|FG000|Stage 1: Double-Blind Period|Other|0|||
146419459|NCT04700449|528041402|FG001|Stage 1: Double-Blind Period|Other|0|||
146419460|NCT04700449|528041403|FG002|Stage 1: Double-Blind Period|Other|1|||
146419461|NCT04700449|528041404|FG003|Stage 1: Double-Blind Period|Other|0|||
146419462|NCT04700449|528041401|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
146419463|NCT04700449|528041402|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
146419464|NCT04700449|528041403|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
146419465|NCT04700449|528041404|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
146419466|NCT04700449|528041401|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146419467|NCT04700449|528041402|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146419468|NCT04700449|528041403|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
146419469|NCT04700449|528041404|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
146419470|NCT04700449|528041401|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146419471|NCT04700449|528041402|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146419472|NCT04700449|528041403|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
146419473|NCT04700449|528041404|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
146419474|NCT04700449|528041401|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146419475|NCT04700449|528041402|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146419476|NCT04700449|528041403|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
146419477|NCT04700449|528041404|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
146419478|NCT04700449|528041401|FG000|Stage 2 Sub-study 1|Other|1|||
146419479|NCT04700449|528041402|FG001|Stage 2 Sub-study 1|Other|2|||
146419480|NCT04700449|528041403|FG002|Stage 2 Sub-study 1|Other|0|||
146419481|NCT04700449|528041404|FG003|Stage 2 Sub-study 1|Other|0|||
146419482|NCT04700449|528041401|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
146419483|NCT04700449|528041402|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
146419484|NCT04700449|528041403|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
146419485|NCT04700449|528041404|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
146419486|NCT04700449|528041401|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146419487|NCT04700449|528041402|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146419488|NCT04700449|528041403|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
146419489|NCT04700449|528041404|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
146419490|NCT04700449|528041401|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146419491|NCT04700449|528041402|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146419492|NCT04700449|528041403|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
146419493|NCT04700449|528041404|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
146419494|NCT04700449|528041401|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146419495|NCT04700449|528041402|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146419496|NCT04700449|528041403|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
146193990|NCT00817635|527221452|FG000|Overall Study|Adverse Event|1|||
146419497|NCT04700449|528041404|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
146419498|NCT04700449|528041401|FG000|Stage 2 Sub-study 2|Other|0|||
146419499|NCT04700449|528041402|FG001|Stage 2 Sub-study 2|Other|0|||
146419500|NCT04700449|528041403|FG002|Stage 2 Sub-study 2|Other|0|||
146419501|NCT04700449|528041404|FG003|Stage 2 Sub-study 2|Other|5|||
146419502|NCT02336737|528041405|FG000|Overall Study|Withdrawal by Subject|5|||
146419503|NCT02336737|528041405|FG000|Overall Study|Physician Decision|8|||
146419504|NCT02396381|528041406|FG000|Overall Study|Adverse Event|3|||
146419505|NCT02396381|528041407|FG001|Overall Study|Adverse Event|2|||
146419506|NCT02396381|528041406|FG000|Overall Study|Withdrawal by Subject|33|||
146419507|NCT02396381|528041407|FG001|Overall Study|Withdrawal by Subject|24|||
146419508|NCT02396381|528041406|FG000|Overall Study|Lost to Follow-up|49|||
146419509|NCT02396381|528041407|FG001|Overall Study|Lost to Follow-up|31|||
146419510|NCT02396381|528041406|FG000|Overall Study|Protocol Violation|1|||
146419511|NCT02396381|528041407|FG001|Overall Study|Protocol Violation|0|||
146419512|NCT02396381|528041406|FG000|Overall Study|Site terminated by sponsor|7|||
146419513|NCT02396381|528041407|FG001|Overall Study|Site terminated by sponsor|8|||
146419514|NCT02396381|528041406|FG000|Overall Study|Physician Decision|5|||
146419515|NCT02396381|528041407|FG001|Overall Study|Physician Decision|5|||
146419516|NCT02396381|528041406|FG000|Overall Study|Pregnancy|2|||
146419517|NCT02396381|528041407|FG001|Overall Study|Pregnancy|0|||
146419518|NCT02396381|528041406|FG000|Overall Study|Non-compliance with study procedures|1|||
146419519|NCT02396381|528041407|FG001|Overall Study|Non-compliance with study procedures|0|||
146419520|NCT02396381|528041406|FG000|Overall Study|Moved out of town/state|1|||
146419521|NCT02396381|528041407|FG001|Overall Study|Moved out of town/state|3|||
146419522|NCT02396381|528041406|FG000|Overall Study|Could not complete visit|1|||
146419523|NCT02396381|528041407|FG001|Overall Study|Could not complete visit|0|||
146419524|NCT02396381|528041406|FG000|Overall Study|Possible conflict of interest|1|||
146419525|NCT02396381|528041407|FG001|Overall Study|Possible conflict of interest|0|||
146419526|NCT02396381|528041406|FG000|Overall Study|Randomization/Screening Error|3|||
146419527|NCT02396381|528041407|FG001|Overall Study|Randomization/Screening Error|1|||
146419528|NCT00356200|528041409|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
146419529|NCT00356200|528041410|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
146419530|NCT00356200|528041409|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
146419531|NCT00356200|528041410|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
146419532|NCT00635778|528041411|FG000|Overall Study|Adverse Event|1|||
146419533|NCT00635778|528041412|FG001|Overall Study|Adverse Event|0|||
146419534|NCT00635778|528041413|FG002|Overall Study|Adverse Event|0|||
146419535|NCT00635778|528041414|FG003|Overall Study|Adverse Event|3|||
146419536|NCT00635778|528041415|FG004|Overall Study|Adverse Event|3|||
146419537|NCT00635778|528041416|FG005|Overall Study|Adverse Event|6|||
146419538|NCT00635778|528041417|FG006|Overall Study|Adverse Event|1|||
146419539|NCT00635778|528041411|FG000|Overall Study|Withdrawal by Subject|0|||
146419540|NCT00635778|528041412|FG001|Overall Study|Withdrawal by Subject|0|||
146419541|NCT00635778|528041413|FG002|Overall Study|Withdrawal by Subject|0|||
146419542|NCT00635778|528041414|FG003|Overall Study|Withdrawal by Subject|1|||
146419543|NCT00635778|528041415|FG004|Overall Study|Withdrawal by Subject|0|||
146419544|NCT00635778|528041416|FG005|Overall Study|Withdrawal by Subject|1|||
146419545|NCT00635778|528041417|FG006|Overall Study|Withdrawal by Subject|1|||
146419546|NCT00635778|528041411|FG000|Overall Study|Progressive disease|0|||
146419547|NCT00635778|528041412|FG001|Overall Study|Progressive disease|3|||
146419548|NCT00635778|528041413|FG002|Overall Study|Progressive disease|3|||
146419549|NCT00635778|528041414|FG003|Overall Study|Progressive disease|4|||
146419550|NCT00635778|528041415|FG004|Overall Study|Progressive disease|5|||
146419551|NCT00635778|528041416|FG005|Overall Study|Progressive disease|14|||
146419552|NCT00635778|528041417|FG006|Overall Study|Progressive disease|4|||
146419553|NCT01000337|528041423|FG000|Overall Study|Lost to Follow-up|4|||
146419554|NCT01000337|528041424|FG001|Overall Study|Lost to Follow-up|3|||
146419555|NCT02227862|528041425|FG000|Overall Study|Protocol Violation|7|||
146419556|NCT02227862|528041426|FG001|Overall Study|Protocol Violation|9|||
146419557|NCT02227862|528041425|FG000|Overall Study|Other|0|||
146419558|NCT02227862|528041426|FG001|Overall Study|Other|2|||
146419559|NCT02227862|528041425|FG000|Overall Study|Adverse Event|4|||
146419560|NCT02227862|528041426|FG001|Overall Study|Adverse Event|3|||
146419561|NCT02227862|528041425|FG000|Overall Study|Withdrawal by Subject|7|||
146419562|NCT02227862|528041426|FG001|Overall Study|Withdrawal by Subject|6|||
146419563|NCT02227862|528041425|FG000|Overall Study|Lost to Follow-up|1|||
146419564|NCT02227862|528041426|FG001|Overall Study|Lost to Follow-up|2|||
146419565|NCT01612000|528041428|FG000|Overall Study|Lost to Follow-up|6|||
146419566|NCT01612000|528041429|FG001|Overall Study|Lost to Follow-up|4|||
146419567|NCT01612000|528041430|FG002|Overall Study|Lost to Follow-up|4|||
146419568|NCT01612000|528041431|FG003|Overall Study|Lost to Follow-up|8|||
146419569|NCT01612000|528041428|FG000|Overall Study|Physician Decision|0|||
146419570|NCT01612000|528041429|FG001|Overall Study|Physician Decision|0|||
146419571|NCT01612000|528041430|FG002|Overall Study|Physician Decision|1|||
146419572|NCT01612000|528041431|FG003|Overall Study|Physician Decision|0|||
146419573|NCT01612000|528041428|FG000|Overall Study|Withdrawal by Subject|3|||
146419574|NCT01612000|528041429|FG001|Overall Study|Withdrawal by Subject|1|||
146419575|NCT01612000|528041430|FG002|Overall Study|Withdrawal by Subject|2|||
146419576|NCT01612000|528041431|FG003|Overall Study|Withdrawal by Subject|2|||
146419577|NCT02173704|528041432|FG000|Overall Study|Adverse Event|1|||
146419578|NCT02173704|528041433|FG001|Overall Study|Adverse Event|0|||
146419579|NCT02173704|528041432|FG000|Overall Study|Lost to Follow-up|1|||
146419580|NCT02173704|528041433|FG001|Overall Study|Lost to Follow-up|0|||
146419581|NCT02173704|528041432|FG000|Overall Study|Other|1|||
146419582|NCT02173704|528041433|FG001|Overall Study|Other|0|||
146419583|NCT02173704|528041432|FG000|Overall Study|Protocol Violation|1|||
146419584|NCT02173704|528041433|FG001|Overall Study|Protocol Violation|0|||
146419585|NCT02173704|528041432|FG000|Overall Study|Withdrawal by Subject|9|||
146419586|NCT02173704|528041433|FG001|Overall Study|Withdrawal by Subject|4|||
146419587|NCT00419926|528041434|FG000|Overall Study|Withdrawal by Subject|7|||
146419588|NCT00419926|528041435|FG001|Overall Study|Withdrawal by Subject|3|||
146419589|NCT00419926|528041434|FG000|Overall Study|Administrative Problem|4|||
146419590|NCT00419926|528041435|FG001|Overall Study|Administrative Problem|4|||
146419591|NCT00419926|528041434|FG000|Overall Study|Lost to Follow-up|1|||
146419592|NCT00419926|528041435|FG001|Overall Study|Lost to Follow-up|2|||
146419593|NCT00419926|528041434|FG000|Overall Study|Death|2|||
146419594|NCT00419926|528041435|FG001|Overall Study|Death|1|||
146419595|NCT01180244|528041446|FG000|Overall Study|Lack of Efficacy|0|||
146419596|NCT01180244|528041447|FG001|Overall Study|Lack of Efficacy|7|||
146419597|NCT01180244|528041446|FG000|Overall Study|Physician Decision|3|||
146419598|NCT01180244|528041447|FG001|Overall Study|Physician Decision|0|||
146419599|NCT01180244|528041446|FG000|Overall Study|Adverse Event|1|||
146419600|NCT01180244|528041447|FG001|Overall Study|Adverse Event|0|||
146419601|NCT01180244|528041446|FG000|Overall Study|Withdrawal by Subject|0|||
146419602|NCT01180244|528041447|FG001|Overall Study|Withdrawal by Subject|1|||
146419603|NCT01180244|528041446|FG000|Overall Study|Protocol Violation|1|||
146419604|NCT01180244|528041447|FG001|Overall Study|Protocol Violation|0|||
146419605|NCT01180244|528041446|FG000|Overall Study|Lost to Follow-up|1|||
146419606|NCT01180244|528041447|FG001|Overall Study|Lost to Follow-up|0|||
146419607|NCT00620763|528041450|FG000|Period: First Intervention|Withdrawal by Subject|0|||
146419608|NCT00620763|528041451|FG001|Period: First Intervention|Withdrawal by Subject|2|||
146419609|NCT00620763|528041450|FG000|Period: First Intervention|Protocol Violation|0|||
146419610|NCT00620763|528041451|FG001|Period: First Intervention|Protocol Violation|3|||
146419611|NCT00620763|528041450|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
146419612|NCT00620763|528041451|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
146419613|NCT01595009|528041452|FG000|Core|Patients completed per protocol|85|||
146419614|NCT01595009|528041453|FG001|Core|Patients completed per protocol|44|||
146419615|NCT01595009|528041454|FG002|Core|Patients completed per protocol|0|||
146419616|NCT01595009|528041455|FG003|Core|Patients completed per protocol|0|||
146419617|NCT01595009|528041452|FG000|Core|Adverse Event|19|||
146419618|NCT01595009|528041453|FG001|Core|Adverse Event|23|||
146419619|NCT01595009|528041454|FG002|Core|Adverse Event|0|||
146419620|NCT01595009|528041455|FG003|Core|Adverse Event|0|||
146419621|NCT01595009|528041452|FG000|Core|Disease progression|14|||
146419622|NCT01595009|528041453|FG001|Core|Disease progression|26|||
146419623|NCT01595009|528041454|FG002|Core|Disease progression|0|||
146419624|NCT01595009|528041455|FG003|Core|Disease progression|0|||
146419625|NCT01595009|528041452|FG000|Core|Withdrawal by Subject|4|||
146419626|NCT01595009|528041453|FG001|Core|Withdrawal by Subject|17|||
146419627|NCT01595009|528041454|FG002|Core|Withdrawal by Subject|0|||
146419628|NCT01595009|528041455|FG003|Core|Withdrawal by Subject|0|||
146419629|NCT01595009|528041452|FG000|Core|Death|3|||
146419630|NCT01595009|528041453|FG001|Core|Death|6|||
146419631|NCT01595009|528041454|FG002|Core|Death|0|||
146419632|NCT01595009|528041455|FG003|Core|Death|0|||
146419633|NCT01595009|528041452|FG000|Core|Lost to Follow-up|1|||
146419634|NCT01595009|528041453|FG001|Core|Lost to Follow-up|2|||
146419635|NCT01595009|528041454|FG002|Core|Lost to Follow-up|0|||
146419636|NCT01595009|528041455|FG003|Core|Lost to Follow-up|0|||
146419637|NCT01595009|528041452|FG000|Core|Protocol deviation|0|||
146419638|NCT01595009|528041453|FG001|Core|Protocol deviation|1|||
146419639|NCT01595009|528041454|FG002|Core|Protocol deviation|0|||
146419640|NCT01595009|528041455|FG003|Core|Protocol deviation|0|||
146419641|NCT01595009|528041452|FG000|Core|Administrative problems|0|||
146419642|NCT01595009|528041453|FG001|Core|Administrative problems|1|||
146419643|NCT01595009|528041454|FG002|Core|Administrative problems|0|||
146419644|NCT01595009|528041455|FG003|Core|Administrative problems|0|||
146419645|NCT01595009|528041452|FG000|Extension|Administrative problems|0|||
146419646|NCT01595009|528041453|FG001|Extension|Administrative problems|0|||
146419647|NCT01595009|528041454|FG002|Extension|Administrative problems|0|||
146419648|NCT01595009|528041455|FG003|Extension|Administrative problems|1|||
146419649|NCT01595009|528041452|FG000|Extension|Patients completed per protocol|0|||
146419650|NCT01595009|528041453|FG001|Extension|Patients completed per protocol|0|||
146419651|NCT01595009|528041454|FG002|Extension|Patients completed per protocol|0|||
146419652|NCT01595009|528041455|FG003|Extension|Patients completed per protocol|2|||
146419653|NCT01595009|528041452|FG000|Extension|Disease progression|0|||
146419654|NCT01595009|528041453|FG001|Extension|Disease progression|0|||
146419655|NCT01595009|528041454|FG002|Extension|Disease progression|4|||
146419656|NCT01595009|528041455|FG003|Extension|Disease progression|7|||
146419657|NCT01595009|528041452|FG000|Extension|Adverse Event|0|||
146419658|NCT01595009|528041453|FG001|Extension|Adverse Event|0|||
146419659|NCT01595009|528041454|FG002|Extension|Adverse Event|0|||
146419660|NCT01595009|528041455|FG003|Extension|Adverse Event|1|||
146419661|NCT04956666|528041457|FG000|Overall Study|Adverse Event|18|||
146419662|NCT04956666|528041457|FG000|Overall Study|Physician Decision|5|||
146419663|NCT00783796|528041458|FG000|Overall Study|Did not receive any stent|4|||
146419664|NCT00783796|528041458|FG000|Overall Study|Received non-XIENCE V stent|1|||
146419665|NCT00783796|528041458|FG000|Overall Study|Received commercial XIENCE V stent|1|||
146419666|NCT00626925|528041463|FG000|Overall Study|Lost to Follow-up|1|||
146419667|NCT00626925|528041464|FG001|Overall Study|Lost to Follow-up|2|||
146419668|NCT00626925|528041463|FG000|Overall Study|relapse|1|||
146419669|NCT00626925|528041464|FG001|Overall Study|relapse|0|||
146419670|NCT00626925|528041463|FG000|Overall Study|Adverse effect|6|||
146419671|NCT00626925|528041464|FG001|Overall Study|Adverse effect|2|||
146419672|NCT00626925|528041463|FG000|Overall Study|Lack of Efficacy|1|||
146419673|NCT00626925|528041464|FG001|Overall Study|Lack of Efficacy|4|||
146419674|NCT00626925|528041463|FG000|Overall Study|Time constraints|3|||
146419675|NCT00626925|528041464|FG001|Overall Study|Time constraints|1|||
146419676|NCT01215942|528041467|FG000|Treatment Period|Adverse Event|15|||
146419677|NCT01215942|528041468|FG001|Treatment Period|Adverse Event|26|||
146419678|NCT01215942|528041467|FG000|Treatment Period|Death|2|||
146419679|NCT01215942|528041468|FG001|Treatment Period|Death|4|||
146419680|NCT01215942|528041467|FG000|Treatment Period|Lack of Efficacy|23|||
146419681|NCT01215942|528041468|FG001|Treatment Period|Lack of Efficacy|62|||
146419682|NCT01215942|528041467|FG000|Treatment Period|Lost to Follow-up|3|||
146419683|NCT01215942|528041468|FG001|Treatment Period|Lost to Follow-up|4|||
146419684|NCT01215942|528041467|FG000|Treatment Period|Withdrawal by Subject|17|||
146419685|NCT01215942|528041468|FG001|Treatment Period|Withdrawal by Subject|40|||
146419686|NCT01215942|528041467|FG000|Treatment Period|Physician Decision|5|||
146419687|NCT01215942|528041468|FG001|Treatment Period|Physician Decision|5|||
146419688|NCT01215942|528041467|FG000|Treatment Period|Protocol Violation|0|||
146419689|NCT01215942|528041468|FG001|Treatment Period|Protocol Violation|1|||
146419690|NCT01215942|528041467|FG000|Treatment Period|Sponsor Decision|349|||
146419691|NCT01215942|528041468|FG001|Treatment Period|Sponsor Decision|530|||
146419692|NCT01215942|528041467|FG000|Post-Treatment Follow-Up Period|Death|0|||
146419693|NCT01215942|528041468|FG001|Post-Treatment Follow-Up Period|Death|1|||
146419694|NCT01215942|528041467|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
146419695|NCT01215942|528041468|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
146419696|NCT01215942|528041467|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
146419697|NCT01215942|528041468|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
146419698|NCT01215942|528041467|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
146419699|NCT01215942|528041468|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
146419700|NCT01215942|528041467|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
146419701|NCT01215942|528041468|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
146419702|NCT02162758|528041469|FG000|Overall Study|Study termination|0|||
146419703|NCT02162758|528041470|FG001|Overall Study|Study termination|1|||
146419704|NCT00313703|528043212|FG000|Overall Study|Lost to Follow-up|11|||
146419705|NCT00313703|528043213|FG001|Overall Study|Lost to Follow-up|2|||
146419706|NCT00313703|528043214|FG002|Overall Study|Lost to Follow-up|5|||
146419707|NCT00313703|528043215|FG003|Overall Study|Lost to Follow-up|12|||
146419708|NCT03329027|528043218|FG000|Overall Study|Lost to Follow-up|1|||
146419709|NCT03329027|528043219|FG001|Overall Study|Lost to Follow-up|0|||
146193991|NCT00817635|527221453|FG001|Overall Study|Adverse Event|0|||
146193992|NCT00817635|527221454|FG002|Overall Study|Adverse Event|0|||
146193993|NCT00817635|527221455|FG003|Overall Study|Adverse Event|1|||
146193994|NCT00817635|527221456|FG004|Overall Study|Adverse Event|1|||
146193995|NCT00817635|527221452|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146193996|NCT00817635|527221453|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
146419710|NCT03329027|528043220|FG002|Overall Study|Lost to Follow-up|1|||
146193997|NCT00817635|527221454|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146419711|NCT03329027|528043218|FG000|Overall Study|Protocol Violation|9|||
146419712|NCT03329027|528043219|FG001|Overall Study|Protocol Violation|5|||
146419713|NCT03329027|528043220|FG002|Overall Study|Protocol Violation|7|||
146419714|NCT04849988|528043221|FG000|Overall Study|Lack of Efficacy|3|||
146419715|NCT04849988|528043222|FG001|Overall Study|Lack of Efficacy|4|||
146419716|NCT04849988|528043223|FG002|Overall Study|Lack of Efficacy|1|||
146419717|NCT04849988|528043224|FG003|Overall Study|Lack of Efficacy|4|||
146419718|NCT04849988|528043221|FG000|Overall Study|Other reasons|1|||
146419719|NCT04849988|528043222|FG001|Overall Study|Other reasons|2|||
146419720|NCT04849988|528043223|FG002|Overall Study|Other reasons|2|||
146419721|NCT04849988|528043224|FG003|Overall Study|Other reasons|1|||
146419722|NCT02146430|528043229|FG000|Overall Study|Protocol Violation|5|||
146419723|NCT02146430|528043230|FG001|Overall Study|Protocol Violation|4|||
146419724|NCT02146430|528043231|FG002|Overall Study|Protocol Violation|8|||
146193998|NCT00817635|527221455|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146419725|NCT02146430|528043232|FG003|Overall Study|Protocol Violation|6|||
146419726|NCT02146430|528043229|FG000|Overall Study|Lack of Efficacy|13|||
146193999|NCT00817635|527221456|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
146194000|NCT00817635|527221452|FG000|Overall Study|Withdrawal by Subject|2|||
146194001|NCT00817635|527221453|FG001|Overall Study|Withdrawal by Subject|1|||
146194002|NCT00817635|527221454|FG002|Overall Study|Withdrawal by Subject|0|||
146194003|NCT00817635|527221455|FG003|Overall Study|Withdrawal by Subject|1|||
146194004|NCT00817635|527221456|FG004|Overall Study|Withdrawal by Subject|2|||
146194005|NCT00817635|527221452|FG000|Overall Study|Lost to Follow-up|0|||
146194006|NCT00817635|527221453|FG001|Overall Study|Lost to Follow-up|1|||
146194007|NCT00817635|527221454|FG002|Overall Study|Lost to Follow-up|0|||
146194008|NCT00817635|527221455|FG003|Overall Study|Lost to Follow-up|1|||
146194009|NCT00817635|527221456|FG004|Overall Study|Lost to Follow-up|0|||
146194010|NCT00817635|527221452|FG000|Overall Study|Administrative Problems|0|||
146194011|NCT00817635|527221453|FG001|Overall Study|Administrative Problems|0|||
146194012|NCT00817635|527221454|FG002|Overall Study|Administrative Problems|0|||
146194013|NCT00817635|527221455|FG003|Overall Study|Administrative Problems|0|||
146194014|NCT00817635|527221456|FG004|Overall Study|Administrative Problems|1|||
146194015|NCT00817635|527221452|FG000|Overall Study|Protocol Violation|5|||
146194016|NCT00817635|527221453|FG001|Overall Study|Protocol Violation|1|||
146419727|NCT02146430|528043230|FG001|Overall Study|Lack of Efficacy|11|||
146419728|NCT02146430|528043231|FG002|Overall Study|Lack of Efficacy|8|||
146419729|NCT02146430|528043232|FG003|Overall Study|Lack of Efficacy|5|||
146419730|NCT02146430|528043229|FG000|Overall Study|Adverse Event|20|||
146419731|NCT02146430|528043230|FG001|Overall Study|Adverse Event|40|||
146419732|NCT02146430|528043231|FG002|Overall Study|Adverse Event|32|||
146419733|NCT02146430|528043232|FG003|Overall Study|Adverse Event|49|||
146419734|NCT02146430|528043229|FG000|Overall Study|Reason missing or not reported|2|||
146419735|NCT02146430|528043230|FG001|Overall Study|Reason missing or not reported|3|||
146419736|NCT02146430|528043231|FG002|Overall Study|Reason missing or not reported|4|||
146419737|NCT02146430|528043232|FG003|Overall Study|Reason missing or not reported|5|||
146419738|NCT02146430|528043229|FG000|Overall Study|Withdrawal by Subject|27|||
146419739|NCT02146430|528043230|FG001|Overall Study|Withdrawal by Subject|29|||
146419740|NCT02146430|528043231|FG002|Overall Study|Withdrawal by Subject|30|||
146419741|NCT02146430|528043232|FG003|Overall Study|Withdrawal by Subject|34|||
146419742|NCT03312530|528043233|FG000|Overall Study|Death|5|||
146419743|NCT03312530|528043234|FG001|Overall Study|Death|5|||
146419744|NCT03312530|528043235|FG002|Overall Study|Death|4|||
146419745|NCT03312530|528043236|FG003|Overall Study|Death|10|||
146419746|NCT03312530|528043237|FG004|Overall Study|Death|8|||
146419747|NCT03312530|528043233|FG000|Overall Study|Lost to Follow-up|0|||
146419748|NCT03312530|528043234|FG001|Overall Study|Lost to Follow-up|0|||
146419749|NCT03312530|528043235|FG002|Overall Study|Lost to Follow-up|0|||
146419750|NCT03312530|528043236|FG003|Overall Study|Lost to Follow-up|1|||
146419751|NCT03312530|528043237|FG004|Overall Study|Lost to Follow-up|0|||
146419752|NCT03312530|528043233|FG000|Overall Study|Participant in another sponsor study.|0|||
146419753|NCT03312530|528043234|FG001|Overall Study|Participant in another sponsor study.|0|||
146419754|NCT03312530|528043235|FG002|Overall Study|Participant in another sponsor study.|0|||
146419755|NCT03312530|528043236|FG003|Overall Study|Participant in another sponsor study.|1|||
146419756|NCT03312530|528043237|FG004|Overall Study|Participant in another sponsor study.|0|||
146419757|NCT03312530|528043233|FG000|Overall Study|Study terminated by sponsor|1|||
146419758|NCT03312530|528043234|FG001|Overall Study|Study terminated by sponsor|0|||
146419759|NCT03312530|528043235|FG002|Overall Study|Study terminated by sponsor|2|||
146419760|NCT03312530|528043236|FG003|Overall Study|Study terminated by sponsor|3|||
146419761|NCT03312530|528043237|FG004|Overall Study|Study terminated by sponsor|7|||
146419762|NCT03312530|528043233|FG000|Overall Study|Withdrawal by Subject|0|||
146419763|NCT03312530|528043234|FG001|Overall Study|Withdrawal by Subject|1|||
146419764|NCT03312530|528043235|FG002|Overall Study|Withdrawal by Subject|0|||
146419765|NCT03312530|528043236|FG003|Overall Study|Withdrawal by Subject|0|||
146419766|NCT03312530|528043237|FG004|Overall Study|Withdrawal by Subject|0|||
146419767|NCT03312530|528043233|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146419768|NCT03312530|528043234|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146419769|NCT03312530|528043235|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146419770|NCT03312530|528043236|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
146419771|NCT03312530|528043237|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
146419772|NCT02524379|528043245|FG000|Overall Study|Death|1|||
146419773|NCT00812253|528043246|FG000|Overall Study|Withdrawal by Subject|3|||
146419774|NCT00812253|528043247|FG001|Overall Study|Withdrawal by Subject|2|||
146419775|NCT00812253|528043246|FG000|Overall Study|Protocol Violation|1|||
146419776|NCT00812253|528043247|FG001|Overall Study|Protocol Violation|1|||
146419777|NCT00812253|528043246|FG000|Overall Study|Lost to Follow-up|2|||
146419778|NCT00812253|528043247|FG001|Overall Study|Lost to Follow-up|0|||
146419779|NCT01884025|528043248|FG000|Overall Study|Lost to Follow-up|3|||
146419780|NCT01884025|528043249|FG001|Overall Study|Lost to Follow-up|4|||
146419781|NCT02655237|528043250|FG000|Overall Study|Adverse Event|10|||
146419782|NCT02655237|528043251|FG001|Overall Study|Adverse Event|7|||
146419783|NCT02655237|528043250|FG000|Overall Study|Protocol Deviation|2|||
146419784|NCT02655237|528043251|FG001|Overall Study|Protocol Deviation|0|||
146419785|NCT02655237|528043250|FG000|Overall Study|Withdrawal by Participant|1|||
146419786|NCT02655237|528043251|FG001|Overall Study|Withdrawal by Participant|2|||
146419787|NCT02655237|528043250|FG000|Overall Study|Lack of Efficacy|0|||
146419788|NCT02655237|528043251|FG001|Overall Study|Lack of Efficacy|1|||
146419789|NCT02655237|528043250|FG000|Overall Study|Recovery Leading to Surgery|2|||
146419790|NCT02655237|528043251|FG001|Overall Study|Recovery Leading to Surgery|1|||
146419791|NCT02655237|528043250|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
146419792|NCT02655237|528043251|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
146419793|NCT02655237|528043250|FG000|Overall Study|Randomized but Not Treated|1|||
146419794|NCT02655237|528043251|FG001|Overall Study|Randomized but Not Treated|0|||
146419795|NCT03679741|528043252|FG000|Period 1|No longer meet eligibility criteria|1|||
146419796|NCT03679741|528043253|FG001|Period 1|No longer meet eligibility criteria|0|||
146419797|NCT03679741|528043252|FG000|Period 1|Lost to Follow-up|0|||
146419798|NCT03679741|528043253|FG001|Period 1|Lost to Follow-up|1|||
146419799|NCT03679741|528043252|FG000|Period 1|Adverse Event|1|||
146419800|NCT03679741|528043253|FG001|Period 1|Adverse Event|1|||
146419801|NCT03679741|528043252|FG000|Period 1|Withdrawal by Subject|0|||
146419802|NCT03679741|528043253|FG001|Period 1|Withdrawal by Subject|1|||
146419803|NCT03679741|528043252|FG000|Period 2|Adverse Event|2|||
146419804|NCT03679741|528043253|FG001|Period 2|Adverse Event|1|||
146419805|NCT03679741|528043252|FG000|Period 2|Withdrawal by Subject|1|||
146419806|NCT03679741|528043253|FG001|Period 2|Withdrawal by Subject|1|||
146419807|NCT02750761|528043258|FG000|Overall Study|Lost to Follow-up|0|||
146419808|NCT02750761|528043259|FG001|Overall Study|Lost to Follow-up|0|||
146419809|NCT02750761|528043260|FG002|Overall Study|Lost to Follow-up|1|||
146419810|NCT02750761|528043261|FG003|Overall Study|Lost to Follow-up|0|||
146419811|NCT02750761|528043262|FG004|Overall Study|Lost to Follow-up|0|||
146419812|NCT02750761|528043263|FG005|Overall Study|Lost to Follow-up|0|||
146419813|NCT00729859|528043264|FG000|Overall Study|Adverse Event|0|||
146419814|NCT00729859|528043265|FG001|Overall Study|Adverse Event|1|||
146419815|NCT00729859|528043266|FG002|Overall Study|Adverse Event|0|||
146419816|NCT00729859|528043264|FG000|Overall Study|Withdrawal by Subject|0|||
146419817|NCT00729859|528043265|FG001|Overall Study|Withdrawal by Subject|1|||
146419818|NCT00729859|528043266|FG002|Overall Study|Withdrawal by Subject|0|||
146419819|NCT02623829|528043273|FG000|Overall Study|Lost to Follow-up|1|||
146419820|NCT02623829|528043274|FG001|Overall Study|Lost to Follow-up|1|||
146419821|NCT00662025|528043275|FG000|Overall Study|Objective progression or relapse|51|||
146419822|NCT00662025|528043275|FG000|Overall Study|Adverse Event|7|||
146419823|NCT00662025|528043275|FG000|Overall Study|Withdrawal by Subject|1|||
146419824|NCT00662025|528043275|FG000|Overall Study|Results of other clinical study|2|||
146419825|NCT00662025|528043275|FG000|Overall Study|Target lesion cannot be evaluated|1|||
146419826|NCT00662025|528043275|FG000|Overall Study|Domestic circumstances|1|||
146419827|NCT01700621|528043276|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
146419828|NCT01700621|528043277|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
146419829|NCT01700621|528043276|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
146419830|NCT01700621|528043277|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
146419831|NCT01700621|528043276|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
146419832|NCT01700621|528043277|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
146419833|NCT02035137|528043280|FG000|Overall Study|Physician Decision|0|||
146419834|NCT02035137|528043281|FG001|Overall Study|Physician Decision|0|||
146419835|NCT02035137|528043282|FG002|Overall Study|Physician Decision|1|||
146419836|NCT02035137|528043280|FG000|Overall Study|Withdrawal by Subject|0|||
146419837|NCT02035137|528043281|FG001|Overall Study|Withdrawal by Subject|1|||
146419838|NCT02035137|528043282|FG002|Overall Study|Withdrawal by Subject|2|||
146419839|NCT02035137|528043280|FG000|Overall Study|Ineligible|0|||
146419840|NCT02035137|528043281|FG001|Overall Study|Ineligible|1|||
146419841|NCT02035137|528043282|FG002|Overall Study|Ineligible|2|||
146419842|NCT02035137|528043280|FG000|Overall Study|Disease progression prior to treatment start|2|||
146419843|NCT02035137|528043281|FG001|Overall Study|Disease progression prior to treatment start|0|||
146419844|NCT02035137|528043282|FG002|Overall Study|Disease progression prior to treatment start|0|||
146419845|NCT03349333|528043289|FG000|Overall Study|Progression of Disease|36|||
146419846|NCT03349333|528043289|FG000|Overall Study|Adverse Event|11|||
146419847|NCT03349333|528043289|FG000|Overall Study|Other|6|||
146419848|NCT03349333|528043289|FG000|Overall Study|Withdrawal by Subject|5|||
146419849|NCT03349333|528043289|FG000|Overall Study|Conditions interfere with participation|2|||
146419850|NCT03349333|528043289|FG000|Overall Study|Physician Decision|2|||
146419851|NCT03349333|528043289|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
146419852|NCT03349333|528043289|FG000|Overall Study|Patients in treatment less than 24 month|8|||
146419853|NCT02985151|528043290|FG000|Original Randomization|Withdrawal by Subject|0|||
146419854|NCT02985151|528043291|FG001|Original Randomization|Withdrawal by Subject|1|||
146419855|NCT00290745|528043292|FG000|Overall Study|Withdrawal by Subject|4|||
146419856|NCT00290745|528043292|FG000|Overall Study|Physician Decision|2|||
146419857|NCT00290745|528043292|FG000|Overall Study|Surgery after 3 months for progression|3|||
146419858|NCT00290745|528043292|FG000|Overall Study|Baseline MRI not available|3|||
146194017|NCT00817635|527221454|FG002|Overall Study|Protocol Violation|3|||
146419859|NCT00113490|528043296|FG000|Overall Study|Withdrawal by Subject|1|||
146419860|NCT00113490|528043297|FG001|Overall Study|Withdrawal by Subject|3|||
146419861|NCT00113490|528043296|FG000|Overall Study|Lost to Follow-up|1|||
146419862|NCT00113490|528043297|FG001|Overall Study|Lost to Follow-up|0|||
146419863|NCT00819247|528043298|FG000|Overall Study|Adverse Event|0|||
146419864|NCT00819247|528043299|FG001|Overall Study|Adverse Event|5|||
146419865|NCT00819247|528043300|FG002|Overall Study|Adverse Event|3|||
146419866|NCT00819247|528043298|FG000|Overall Study|Insufficient testosterone response|5|||
146419867|NCT00819247|528043299|FG001|Overall Study|Insufficient testosterone response|8|||
146419868|NCT00819247|528043300|FG002|Overall Study|Insufficient testosterone response|10|||
146419869|NCT00819247|528043298|FG000|Overall Study|Withdrawal by Subject|1|||
146419870|NCT00819247|528043299|FG001|Overall Study|Withdrawal by Subject|0|||
146419871|NCT00819247|528043300|FG002|Overall Study|Withdrawal by Subject|0|||
146194018|NCT00817635|527221455|FG003|Overall Study|Protocol Violation|2|||
146194019|NCT00817635|527221456|FG004|Overall Study|Protocol Violation|3|||
146194020|NCT01167426|527221457|FG000|Overall Study|Lost to Follow-up|6|||
146194021|NCT01167426|527221457|FG000|Overall Study|Protocol Violation|1|||
146194022|NCT01167426|527221457|FG000|Overall Study|Withdrawal by Subject|2|||
146194023|NCT01167426|527221457|FG000|Overall Study|Sponsor Decision|1|||
146419872|NCT00819247|528043298|FG000|Overall Study|Protocol Violation|1|||
146419873|NCT00819247|528043299|FG001|Overall Study|Protocol Violation|0|||
146194024|NCT04176458|527221459|FG000|Overall Study|Covid 19|4|||
146194025|NCT02131324|527221460|FG000|Overall Study|Withdrawal by Subject|1|||
146419874|NCT00819247|528043300|FG002|Overall Study|Protocol Violation|1|||
146419875|NCT00819247|528043298|FG000|Overall Study|Mistakenly withdrawn|0|||
146419876|NCT00819247|528043299|FG001|Overall Study|Mistakenly withdrawn|1|||
146419877|NCT00819247|528043300|FG002|Overall Study|Mistakenly withdrawn|0|||
146419878|NCT00819247|528043298|FG000|Overall Study|Bad prostate-specific antigen response|3|||
146419879|NCT00819247|528043299|FG001|Overall Study|Bad prostate-specific antigen response|2|||
146419880|NCT00819247|528043300|FG002|Overall Study|Bad prostate-specific antigen response|0|||
146419881|NCT00819247|528043298|FG000|Overall Study|Other|1|||
146419882|NCT00819247|528043299|FG001|Overall Study|Other|0|||
146419883|NCT00819247|528043300|FG002|Overall Study|Other|0|||
146419884|NCT04471935|528043301|FG000|Overall Study|Withdrawal by Subject|1|||
146419885|NCT04471935|528043301|FG000|Overall Study|Deemed ineligible to participate|1|||
146419886|NCT01766921|528043304|FG000|Overall Study|Administrative Reason|5|||
146419887|NCT01766921|528043305|FG001|Overall Study|Administrative Reason|5|||
146419888|NCT01766921|528043304|FG000|Overall Study|Death|1|||
146419889|NCT01766921|528043305|FG001|Overall Study|Death|1|||
146419890|NCT01766921|528043304|FG000|Overall Study|Lost to Follow-up|1|||
146419891|NCT01766921|528043305|FG001|Overall Study|Lost to Follow-up|3|||
146419892|NCT01766921|528043304|FG000|Overall Study|Unclassified|2|||
146419893|NCT01766921|528043305|FG001|Overall Study|Unclassified|2|||
146419894|NCT01766921|528043304|FG000|Overall Study|Protocol Violation|1|||
146419895|NCT01766921|528043305|FG001|Overall Study|Protocol Violation|1|||
146419896|NCT01766921|528043304|FG000|Overall Study|Withdrawal by Subject|14|||
146419897|NCT01766921|528043305|FG001|Overall Study|Withdrawal by Subject|5|||
146419898|NCT00708422|528043308|FG000|Overall Study|Adverse Event|3|||
146419899|NCT00708422|528043309|FG001|Overall Study|Adverse Event|1|||
146419900|NCT00708422|528043308|FG000|Overall Study|Withdrawal by Subject|1|||
146419901|NCT00708422|528043309|FG001|Overall Study|Withdrawal by Subject|0|||
146419902|NCT05476679|528043313|FG000|Overall Study|Withdrawal by Subject|0|||
146419903|NCT05476679|528043314|FG001|Overall Study|Withdrawal by Subject|0|||
146419904|NCT05476679|528043315|FG002|Overall Study|Withdrawal by Subject|0|||
146419905|NCT05476679|528043316|FG003|Overall Study|Withdrawal by Subject|1|||
146419906|NCT05476679|528043317|FG004|Overall Study|Withdrawal by Subject|0|||
146419907|NCT05476679|528043313|FG000|Overall Study|Lost to Follow-up|0|||
146419908|NCT05476679|528043314|FG001|Overall Study|Lost to Follow-up|0|||
146419909|NCT05476679|528043315|FG002|Overall Study|Lost to Follow-up|0|||
146419910|NCT05476679|528043316|FG003|Overall Study|Lost to Follow-up|1|||
146419911|NCT05476679|528043317|FG004|Overall Study|Lost to Follow-up|0|||
146419912|NCT00601354|528043318|FG000|Overall Study|Lost to Follow-up|4|||
146419913|NCT00601354|528043319|FG001|Overall Study|Lost to Follow-up|5|||
146419914|NCT00278512|528043321|FG000|Overall Study|Death|1|||
146419915|NCT00278512|528043322|FG001|Overall Study|Death|0|||
146419916|NCT01620177|528043323|FG000|Overall Study|Failure at Screening Visit|43|||
146419917|NCT01620177|528043323|FG000|Overall Study|Withdrawal by Subject|26|||
146419918|NCT01620177|528043323|FG000|Overall Study|Lost to Follow-up|7|||
146419919|NCT01620177|528043323|FG000|Overall Study|Physician Decision|2|||
146419920|NCT01620177|528043323|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
146419921|NCT01789320|528043327|FG000|Overall Study|Re-enrolled into study|1|||
146419922|NCT01789320|528043327|FG000|Overall Study|Lost to Follow-up|1|||
146419923|NCT00619385|528043332|FG000|Overall Study|Adverse Event|0|||
146419924|NCT00619385|528043333|FG001|Overall Study|Adverse Event|0|||
146419925|NCT00619385|528043334|FG002|Overall Study|Adverse Event|3|||
146419926|NCT00619385|528043332|FG000|Overall Study|Other|1|||
146419927|NCT00619385|528043333|FG001|Overall Study|Other|2|||
146419928|NCT00619385|528043334|FG002|Overall Study|Other|1|||
146419929|NCT03730103|528043335|FG000|Overall Study|Did not meet inclusion criteria|0|||
146419930|NCT03730103|528043336|FG001|Overall Study|Did not meet inclusion criteria|5|||
146419931|NCT02626949|528043337|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
146419932|NCT02626949|528043338|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
146194026|NCT02131324|527221461|FG001|Overall Study|Withdrawal by Subject|2|||
146194027|NCT02131324|527221460|FG000|Overall Study|Lost to Follow-up|1|||
146419933|NCT02626949|528043337|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
146419934|NCT02626949|528043338|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
146419935|NCT02626949|528043337|FG000|Enrolled|Lost to Follow-up|7|||
146419936|NCT02626949|528043338|FG001|Enrolled|Lost to Follow-up|6|||
146419937|NCT02626949|528043337|FG000|Enrolled|Withdrawal by Subject|3|||
146419938|NCT02626949|528043338|FG001|Enrolled|Withdrawal by Subject|2|||
146419939|NCT02789111|528043339|FG000|Overall Study|Withdrawal by Subject|1|||
146419940|NCT02789111|528043340|FG001|Overall Study|Withdrawal by Subject|4|||
146419941|NCT01488578|528043341|FG000|Overall Study|Protocol Violation|1836|||
146419942|NCT02308111|528043342|FG000|Overall Study|Adverse Event|31|||
146419943|NCT02308111|528043343|FG001|Overall Study|Adverse Event|19|||
146419944|NCT02308111|528043342|FG000|Overall Study|Death|9|||
146419945|NCT02308111|528043343|FG001|Overall Study|Death|6|||
146419946|NCT02308111|528043342|FG000|Overall Study|Lost to Follow-up|2|||
146419947|NCT02308111|528043343|FG001|Overall Study|Lost to Follow-up|7|||
146419948|NCT02308111|528043342|FG000|Overall Study|Physician Decision|6|||
146419949|NCT02308111|528043343|FG001|Overall Study|Physician Decision|17|||
146419950|NCT02308111|528043342|FG000|Overall Study|Protocol Violation|0|||
146419951|NCT02308111|528043343|FG001|Overall Study|Protocol Violation|1|||
146419952|NCT02308111|528043342|FG000|Overall Study|Withdrawal by Subject|28|||
146419953|NCT02308111|528043343|FG001|Overall Study|Withdrawal by Subject|38|||
146419954|NCT02308111|528043342|FG000|Overall Study|Study Terminated by Sponsor|72|||
146419955|NCT02308111|528043343|FG001|Overall Study|Study Terminated by Sponsor|61|||
146419956|NCT02308111|528043342|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
146419957|NCT02308111|528043343|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
146419958|NCT02308111|528043342|FG000|Overall Study|Site Closure|3|||
146419959|NCT02308111|528043343|FG001|Overall Study|Site Closure|3|||
146419960|NCT02308111|528043342|FG000|Overall Study|Non-compliance with Study Drug|3|||
146419961|NCT02308111|528043343|FG001|Overall Study|Non-compliance with Study Drug|1|||
146419962|NCT02308111|528043342|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
146419963|NCT02308111|528043343|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
146419964|NCT02308111|528043342|FG000|Overall Study|Liver Transplant|3|||
146419965|NCT02308111|528043343|FG001|Overall Study|Liver Transplant|3|||
146419966|NCT02308111|528043342|FG000|Overall Study|Liver Transplant Waitlist|2|||
146419967|NCT02308111|528043343|FG001|Overall Study|Liver Transplant Waitlist|2|||
146419968|NCT02308111|528043342|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
146419969|NCT02308111|528043343|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
146419970|NCT03271528|528043344|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
146419971|NCT03271528|528043345|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
146419972|NCT03271528|528043344|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
146419973|NCT03271528|528043345|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
146419974|NCT03271528|528043344|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
146419975|NCT03271528|528043345|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
146419976|NCT03271528|528043344|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
146419977|NCT03271528|528043345|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
146419978|NCT03271528|528043344|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
146419979|NCT03271528|528043345|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
146419980|NCT03271528|528043344|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
146419981|NCT03271528|528043345|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
146419982|NCT03271528|528043344|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
146419983|NCT03271528|528043345|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
146419984|NCT00717756|528043347|FG000|Overall Study|Withdrawal by Subject|1|||
146194028|NCT02131324|527221461|FG001|Overall Study|Lost to Follow-up|1|||
146419985|NCT00673790|528043348|FG000|Overall Study|Adverse Event|23|||
146419986|NCT00673790|528043349|FG001|Overall Study|Adverse Event|14|||
146419987|NCT00673790|528043350|FG002|Overall Study|Adverse Event|2|||
146419988|NCT00673790|528043348|FG000|Overall Study|Lack of Efficacy|2|||
146419989|NCT00673790|528043349|FG001|Overall Study|Lack of Efficacy|2|||
146419990|NCT00673790|528043350|FG002|Overall Study|Lack of Efficacy|2|||
146419991|NCT00673790|528043348|FG000|Overall Study|Protocol Violation|6|||
146419992|NCT00673790|528043349|FG001|Overall Study|Protocol Violation|9|||
146419993|NCT00673790|528043350|FG002|Overall Study|Protocol Violation|1|||
146419994|NCT00673790|528043348|FG000|Overall Study|Withdrawal by Subject|7|||
146419995|NCT00673790|528043349|FG001|Overall Study|Withdrawal by Subject|4|||
146419996|NCT00673790|528043350|FG002|Overall Study|Withdrawal by Subject|1|||
146419997|NCT00673790|528043348|FG000|Overall Study|Lost to Follow-up|6|||
146419998|NCT00673790|528043349|FG001|Overall Study|Lost to Follow-up|6|||
146419999|NCT00673790|528043350|FG002|Overall Study|Lost to Follow-up|5|||
146420000|NCT00673790|528043348|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
146420001|NCT00673790|528043349|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
146420002|NCT00673790|528043350|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
146420003|NCT00673790|528043348|FG000|Overall Study|Poor compliance|1|||
146420004|NCT00673790|528043349|FG001|Overall Study|Poor compliance|0|||
146420005|NCT00673790|528043350|FG002|Overall Study|Poor compliance|0|||
146420006|NCT00673790|528043348|FG000|Overall Study|Participated in two Nebivolol studies|0|||
146420007|NCT00673790|528043349|FG001|Overall Study|Participated in two Nebivolol studies|0|||
146420008|NCT00673790|528043350|FG002|Overall Study|Participated in two Nebivolol studies|1|||
146420009|NCT00673790|528043348|FG000|Overall Study|Unconfirmed pregnancy|0|||
146420010|NCT00673790|528043349|FG001|Overall Study|Unconfirmed pregnancy|1|||
146420011|NCT00673790|528043350|FG002|Overall Study|Unconfirmed pregnancy|0|||
146420012|NCT00673790|528043348|FG000|Overall Study|Randomization criteria not met|0|||
146420013|NCT00673790|528043349|FG001|Overall Study|Randomization criteria not met|1|||
146420014|NCT00673790|528043350|FG002|Overall Study|Randomization criteria not met|0|||
146420015|NCT00306384|528043351|FG000|Overall Study|Adverse Event|103|||
146082435|NCT00171834|526822804|FG001|Overall Study|Withdrawal by Subject|2|||
146082436|NCT00171834|526822805|FG002|Overall Study|Withdrawal by Subject|0|||
146082437|NCT00171834|526822806|FG003|Overall Study|Withdrawal by Subject|1|||
146082438|NCT00171834|526822807|FG004|Overall Study|Withdrawal by Subject|1|||
146082439|NCT00171834|526822808|FG005|Overall Study|Withdrawal by Subject|1|||
146082440|NCT00171834|526822809|FG006|Overall Study|Withdrawal by Subject|0|||
146082441|NCT00171834|526822803|FG000|Overall Study|Death from study indication|0|||
146082442|NCT00171834|526822804|FG001|Overall Study|Death from study indication|1|||
146082443|NCT00171834|526822805|FG002|Overall Study|Death from study indication|0|||
146082444|NCT00171834|526822806|FG003|Overall Study|Death from study indication|0|||
146082445|NCT00171834|526822807|FG004|Overall Study|Death from study indication|1|||
146082446|NCT00171834|526822808|FG005|Overall Study|Death from study indication|0|||
146082447|NCT00171834|526822809|FG006|Overall Study|Death from study indication|0|||
146082448|NCT00171834|526822803|FG000|Overall Study|Disease Progression|4|||
146082449|NCT00171834|526822804|FG001|Overall Study|Disease Progression|8|||
146082450|NCT00171834|526822805|FG002|Overall Study|Disease Progression|8|||
146082451|NCT00171834|526822806|FG003|Overall Study|Disease Progression|9|||
146082452|NCT00171834|526822807|FG004|Overall Study|Disease Progression|2|||
146082453|NCT00171834|526822808|FG005|Overall Study|Disease Progression|18|||
146082454|NCT00171834|526822809|FG006|Overall Study|Disease Progression|3|||
146082455|NCT00171834|526822803|FG000|Overall Study|Treatment Duration Completed|0|||
146082456|NCT00171834|526822804|FG001|Overall Study|Treatment Duration Completed|0|||
146082457|NCT00171834|526822805|FG002|Overall Study|Treatment Duration Completed|1|||
146082458|NCT00171834|526822806|FG003|Overall Study|Treatment Duration Completed|0|||
146082459|NCT00171834|526822807|FG004|Overall Study|Treatment Duration Completed|2|||
146082460|NCT00171834|526822808|FG005|Overall Study|Treatment Duration Completed|1|||
146082461|NCT00171834|526822809|FG006|Overall Study|Treatment Duration Completed|0|||
146082462|NCT02431260|526822810|FG000|Overall Study|Subject Decision|0|||
146082463|NCT02431260|526822811|FG001|Overall Study|Subject Decision|1|||
146082464|NCT02431260|526822812|FG002|Overall Study|Subject Decision|1|||
146082465|NCT02431260|526822813|FG003|Overall Study|Subject Decision|0|||
146082466|NCT02431260|526822814|FG004|Overall Study|Subject Decision|0|||
146082467|NCT02431260|526822815|FG005|Overall Study|Subject Decision|0|||
146082468|NCT02431260|526822816|FG006|Overall Study|Subject Decision|0|||
146082469|NCT02431260|526822817|FG007|Overall Study|Subject Decision|0|||
146082470|NCT02431260|526822818|FG008|Overall Study|Subject Decision|1|||
146082471|NCT02431260|526822819|FG009|Overall Study|Subject Decision|1|||
146082472|NCT02431260|526822820|FG010|Overall Study|Subject Decision|0|||
146082473|NCT02431260|526822821|FG011|Overall Study|Subject Decision|1|||
146082474|NCT02431260|526822822|FG012|Overall Study|Subject Decision|0|||
146082475|NCT02431260|526822823|FG013|Overall Study|Subject Decision|0|||
146082476|NCT02431260|526822810|FG000|Overall Study|Death|4|||
146082477|NCT02431260|526822811|FG001|Overall Study|Death|4|||
146082478|NCT02431260|526822812|FG002|Overall Study|Death|3|||
146420016|NCT00306384|528043352|FG001|Overall Study|Adverse Event|87|||
146420017|NCT00306384|528043353|FG002|Overall Study|Adverse Event|40|||
146420018|NCT00306384|528043351|FG000|Overall Study|Major protocol deviation|43|||
146420019|NCT00306384|528043352|FG001|Overall Study|Major protocol deviation|51|||
146420020|NCT00306384|528043353|FG002|Overall Study|Major protocol deviation|18|||
146420021|NCT00306384|528043351|FG000|Overall Study|Lost to Follow-up|57|||
146420022|NCT00306384|528043352|FG001|Overall Study|Lost to Follow-up|41|||
146420023|NCT00306384|528043353|FG002|Overall Study|Lost to Follow-up|35|||
146420024|NCT00306384|528043351|FG000|Overall Study|Voluntary withdrawal|199|||
146420025|NCT00306384|528043352|FG001|Overall Study|Voluntary withdrawal|187|||
146420026|NCT00306384|528043353|FG002|Overall Study|Voluntary withdrawal|91|||
146420027|NCT00306384|528043351|FG000|Overall Study|Study termination|1|||
146420028|NCT00306384|528043352|FG001|Overall Study|Study termination|0|||
146420029|NCT00306384|528043353|FG002|Overall Study|Study termination|1|||
146420030|NCT00306384|528043351|FG000|Overall Study|Pregnancy|3|||
146420031|NCT00306384|528043352|FG001|Overall Study|Pregnancy|1|||
146420032|NCT00306384|528043353|FG002|Overall Study|Pregnancy|1|||
146420033|NCT00306384|528043351|FG000|Overall Study|Lack of Efficacy|26|||
146420034|NCT00306384|528043352|FG001|Overall Study|Lack of Efficacy|40|||
146420035|NCT00306384|528043353|FG002|Overall Study|Lack of Efficacy|38|||
146420036|NCT00306384|528043351|FG000|Overall Study|Investigator discretion|28|||
146420037|NCT00306384|528043352|FG001|Overall Study|Investigator discretion|31|||
146420038|NCT00306384|528043353|FG002|Overall Study|Investigator discretion|21|||
146420039|NCT00306384|528043351|FG000|Overall Study|Other|80|||
146420040|NCT00306384|528043352|FG001|Overall Study|Other|70|||
146420041|NCT00306384|528043353|FG002|Overall Study|Other|32|||
146420042|NCT00306384|528043351|FG000|Overall Study|Site closure|2|||
146420043|NCT00306384|528043352|FG001|Overall Study|Site closure|0|||
146420044|NCT00306384|528043353|FG002|Overall Study|Site closure|0|||
146420045|NCT01873859|528043358|FG000|Overall Study|Withdrawal by Subject|0|||
146420046|NCT01873859|528043359|FG001|Overall Study|Withdrawal by Subject|4|||
146420047|NCT00601484|528043361|FG000|Overall Study|Adverse Event|0|||
146420048|NCT00601484|528043362|FG001|Overall Study|Adverse Event|1|||
146420049|NCT00601484|528043361|FG000|Overall Study|Lost to Follow-up|4|||
146194029|NCT00891618|527221462|FG000|Overall Study|Withdrawal by Subject|1|||
146420050|NCT00601484|528043362|FG001|Overall Study|Lost to Follow-up|3|||
146420051|NCT00601484|528043361|FG000|Overall Study|Lack of Efficacy|0|||
146420052|NCT00601484|528043362|FG001|Overall Study|Lack of Efficacy|2|||
146420053|NCT00601484|528043361|FG000|Overall Study|Withdrawal by Subject|1|||
146420054|NCT00601484|528043362|FG001|Overall Study|Withdrawal by Subject|1|||
146420055|NCT00601484|528043361|FG000|Overall Study|Randomized, but not treated|0|||
146420056|NCT00601484|528043362|FG001|Overall Study|Randomized, but not treated|1|||
146420057|NCT03977584|528043363|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
146420058|NCT03977584|528043364|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
146420059|NCT03977584|528043365|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
146420060|NCT03504852|528043369|FG000|Overall Study|Withdrawal of informed consent|2|||
146420061|NCT03504852|528043370|FG001|Overall Study|Withdrawal of informed consent|1|||
146420062|NCT03504852|528043371|FG002|Overall Study|Withdrawal of informed consent|0|||
146420063|NCT03504852|528043369|FG000|Overall Study|Withdrawal by Subject|5|||
146420064|NCT03504852|528043370|FG001|Overall Study|Withdrawal by Subject|5|||
146420065|NCT03504852|528043371|FG002|Overall Study|Withdrawal by Subject|1|||
146420066|NCT03504852|528043369|FG000|Overall Study|Lost to Follow-up|4|||
146420067|NCT03504852|528043370|FG001|Overall Study|Lost to Follow-up|1|||
146420068|NCT03504852|528043371|FG002|Overall Study|Lost to Follow-up|0|||
146420069|NCT03504852|528043369|FG000|Overall Study|New therapy for study indication|1|||
146420070|NCT03504852|528043370|FG001|Overall Study|New therapy for study indication|0|||
146420071|NCT03504852|528043371|FG002|Overall Study|New therapy for study indication|0|||
146420072|NCT03504852|528043369|FG000|Overall Study|Lack of Efficacy|1|||
146420073|NCT03504852|528043370|FG001|Overall Study|Lack of Efficacy|2|||
146420074|NCT03504852|528043371|FG002|Overall Study|Lack of Efficacy|0|||
146420075|NCT03504852|528043369|FG000|Overall Study|Death|0|||
146420076|NCT03504852|528043370|FG001|Overall Study|Death|1|||
146420077|NCT03504852|528043371|FG002|Overall Study|Death|0|||
146420078|NCT03504852|528043369|FG000|Overall Study|Adverse Event|4|||
146420079|NCT03504852|528043370|FG001|Overall Study|Adverse Event|8|||
146420080|NCT03504852|528043371|FG002|Overall Study|Adverse Event|2|||
146420081|NCT00745251|528043372|FG000|Overall Study|Adverse Event|1|||
146420082|NCT00745251|528043373|FG001|Overall Study|Adverse Event|2|||
146194030|NCT00920686|527221463|FG000|Overall Study|Lost to Follow-up|2|||
146194031|NCT00920686|527221464|FG001|Overall Study|Lost to Follow-up|3|||
146420083|NCT00745251|528043372|FG000|Overall Study|Withdrawal by Subject|1|||
146420084|NCT00745251|528043373|FG001|Overall Study|Withdrawal by Subject|1|||
146420085|NCT02928848|528043374|FG000|Arm 2|Withdrawal by Subject|1|||
146420086|NCT02928848|528043375|FG001|Arm 2|Withdrawal by Subject|0|||
146420087|NCT03850509|528043376|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
146420088|NCT03850509|528043377|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
146420089|NCT00969332|528043378|FG000|Overall Study|Physician Decision|8|||
146420090|NCT00969332|528043378|FG000|Overall Study|Withdrawal by Subject|3|||
146420091|NCT02666430|528043379|FG000|Period 1|Lost to Follow-up|1|||
146420092|NCT02666430|528043380|FG001|Period 1|Lost to Follow-up|0|||
146420093|NCT02666430|528043379|FG000|Period 1|Adverse Event|0|||
146420094|NCT02666430|528043380|FG001|Period 1|Adverse Event|1|||
146420095|NCT02666430|528043379|FG000|Period 2|Withdrawal by Subject|1|||
146420096|NCT02666430|528043380|FG001|Period 2|Withdrawal by Subject|4|||
146420097|NCT02666430|528043379|FG000|Period 3|Lost to Follow-up|1|||
146420098|NCT02666430|528043380|FG001|Period 3|Lost to Follow-up|0|||
146420099|NCT03828461|528043381|FG000|Overall Study|Lost to Follow-up|1|||
146420100|NCT03828461|528043381|FG000|Overall Study|Withdrawal by Subject|3|||
146420101|NCT00576199|528043382|FG000|Overall Study|Adverse Event|12|||
146420102|NCT00576199|528043382|FG000|Overall Study|Insufficient Therapeutic Response|14|||
146420103|NCT00576199|528043382|FG000|Overall Study|Refused Treatment|2|||
146420104|NCT00576199|528043382|FG000|Overall Study|Reason Unspecified|2|||
146420105|NCT03111147|528043384|FG000|Overall Study|Lost to Follow-up|2|||
146420106|NCT03111147|528043385|FG001|Overall Study|Lost to Follow-up|5|||
146420107|NCT03111147|528043384|FG000|Overall Study|Withdrawal by Subject|4|||
146420108|NCT03111147|528043385|FG001|Overall Study|Withdrawal by Subject|3|||
146420109|NCT03111147|528043384|FG000|Overall Study|Protocol Violation|2|||
146420110|NCT03111147|528043385|FG001|Overall Study|Protocol Violation|1|||
146420111|NCT03111147|528043384|FG000|Overall Study|Death|1|||
146420112|NCT03111147|528043385|FG001|Overall Study|Death|1|||
146420113|NCT01463683|528043386|FG000|Overall Study|Adverse Event|2|||
146420114|NCT01463683|528043387|FG001|Overall Study|Adverse Event|0|||
146420115|NCT01463683|528043388|FG002|Overall Study|Adverse Event|0|||
146420116|NCT01463683|528043386|FG000|Overall Study|Lost to Follow-up|10|||
146420117|NCT01463683|528043387|FG001|Overall Study|Lost to Follow-up|9|||
146420118|NCT01463683|528043388|FG002|Overall Study|Lost to Follow-up|7|||
146420119|NCT01463683|528043386|FG000|Overall Study|Physician Decision|0|||
146420120|NCT01463683|528043387|FG001|Overall Study|Physician Decision|3|||
146420121|NCT01463683|528043388|FG002|Overall Study|Physician Decision|1|||
146420122|NCT01463683|528043386|FG000|Overall Study|Pregnancy|2|||
146420123|NCT01463683|528043387|FG001|Overall Study|Pregnancy|2|||
146420124|NCT01463683|528043388|FG002|Overall Study|Pregnancy|1|||
146194032|NCT00920686|527221465|FG002|Overall Study|Lost to Follow-up|1|||
146194033|NCT00920686|527221463|FG000|Overall Study|Study drug dosing criteria not met|17|||
146420125|NCT01463683|528043386|FG000|Overall Study|Withdrawal by Subject|5|||
146420126|NCT01463683|528043387|FG001|Overall Study|Withdrawal by Subject|17|||
146420127|NCT01463683|528043388|FG002|Overall Study|Withdrawal by Subject|2|||
146420128|NCT01565083|528043389|FG000|Overall Study|Withdrawal by Subject|6|||
146420129|NCT01565083|528043390|FG001|Overall Study|Withdrawal by Subject|4|||
146420130|NCT01565083|528043389|FG000|Overall Study|Lost to Follow-up|2|||
146420131|NCT01565083|528043390|FG001|Overall Study|Lost to Follow-up|7|||
146420132|NCT01565083|528043389|FG000|Overall Study|Death|22|||
146420133|NCT01565083|528043390|FG001|Overall Study|Death|23|||
146420134|NCT01565083|528043389|FG000|Overall Study|Other|3|||
146420135|NCT01565083|528043390|FG001|Overall Study|Other|5|||
146420136|NCT01118728|528043391|FG000|Overall Study|Adverse Event|17|||
146420137|NCT01118728|528043391|FG000|Overall Study|Lack of Efficacy|27|||
146420138|NCT01118728|528043391|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
146420139|NCT01118728|528043391|FG000|Overall Study|Withdrawal by Subject|3|||
146420140|NCT01118728|528043391|FG000|Overall Study|Lost to Follow-up|4|||
146420141|NCT05328375|528045169|FG000|Overall Study|Withdrawal by Subject|0|||
146420142|NCT05328375|528045170|FG001|Overall Study|Withdrawal by Subject|1|||
146420143|NCT02178709|528045172|FG000|Overall Study|Adverse Event|5|||
146420144|NCT02178709|528045172|FG000|Overall Study|Death|2|||
146420145|NCT02178709|528045172|FG000|Overall Study|Withdrawal by Subject|2|||
146420146|NCT02178709|528045172|FG000|Overall Study|Physician Decision|2|||
146420147|NCT02178709|528045172|FG000|Overall Study|Disease Progression|5|||
146420148|NCT02946385|528045173|FG000|Overall Study|Lost to Follow-up|0|||
146420149|NCT02946385|528045174|FG001|Overall Study|Lost to Follow-up|0|||
146420150|NCT02946385|528045175|FG002|Overall Study|Lost to Follow-up|3|||
146420151|NCT02946385|528045176|FG003|Overall Study|Lost to Follow-up|0|||
146420152|NCT02946385|528045177|FG004|Overall Study|Lost to Follow-up|2|||
146420153|NCT02946385|528045178|FG005|Overall Study|Lost to Follow-up|1|||
146420154|NCT00101582|528045183|FG000|Overall Study|Ineligibility determined|0|||
146420155|NCT00101582|528045184|FG001|Overall Study|Ineligibility determined|1|||
146420156|NCT00101582|528045183|FG000|Overall Study|Adverse Event|1|||
146420157|NCT00101582|528045184|FG001|Overall Study|Adverse Event|4|||
146420158|NCT00101582|528045183|FG000|Overall Study|Withdrawal by Subject|6|||
146420159|NCT00101582|528045184|FG001|Overall Study|Withdrawal by Subject|4|||
146194034|NCT00920686|527221464|FG001|Overall Study|Study drug dosing criteria not met|19|||
146194035|NCT00920686|527221465|FG002|Overall Study|Study drug dosing criteria not met|12|||
146194036|NCT00003656|527221466|FG000|Overall Study|Adverse Event|0|||
146194037|NCT00003656|527221467|FG001|Overall Study|Adverse Event|1|||
146194038|NCT02219490|527221469|FG000|Overall Study|Adverse Event|24|||
146194039|NCT02219490|527221469|FG000|Overall Study|Withdrew consent|96|||
146194040|NCT02219490|527221469|FG000|Overall Study|Lost to Follow-up|126|||
146194041|NCT02219490|527221469|FG000|Overall Study|COVID-19 infection|2|||
146194042|NCT02219490|527221469|FG000|Overall Study|COVID-19 logistical restrictions|33|||
146194043|NCT02219490|527221469|FG000|Overall Study|Other, not specified|57|||
146194044|NCT00335556|527221470|FG000|Overall Study|Death|0|||
146194045|NCT00335556|527221471|FG001|Overall Study|Death|5|||
146194046|NCT00335556|527221472|FG002|Overall Study|Death|0|||
146194047|NCT00335556|527221473|FG003|Overall Study|Death|0|||
146194048|NCT00335556|527221474|FG004|Overall Study|Death|1|||
146194049|NCT00335556|527221475|FG005|Overall Study|Death|0|||
146194050|NCT00335556|527221470|FG000|Overall Study|Lack of Efficacy|0|||
146194051|NCT00335556|527221471|FG001|Overall Study|Lack of Efficacy|19|||
146194052|NCT00335556|527221472|FG002|Overall Study|Lack of Efficacy|3|||
146194053|NCT00335556|527221473|FG003|Overall Study|Lack of Efficacy|3|||
146194054|NCT00335556|527221474|FG004|Overall Study|Lack of Efficacy|0|||
146420160|NCT00101582|528045183|FG000|Overall Study|Physician Decision|1|||
146420161|NCT00101582|528045184|FG001|Overall Study|Physician Decision|0|||
146420162|NCT00101582|528045183|FG000|Overall Study|Death|3|||
146194055|NCT00335556|527221475|FG005|Overall Study|Lack of Efficacy|1|||
146194056|NCT00335556|527221470|FG000|Overall Study|Physician Decision|0|||
146194057|NCT00335556|527221471|FG001|Overall Study|Physician Decision|6|||
146194058|NCT00335556|527221472|FG002|Overall Study|Physician Decision|2|||
146194059|NCT00335556|527221473|FG003|Overall Study|Physician Decision|1|||
146194060|NCT00335556|527221474|FG004|Overall Study|Physician Decision|0|||
146194061|NCT00335556|527221475|FG005|Overall Study|Physician Decision|0|||
146194062|NCT00335556|527221470|FG000|Overall Study|Ineligible|2|||
146420163|NCT00101582|528045184|FG001|Overall Study|Death|5|||
146420164|NCT00101582|528045183|FG000|Overall Study|Other|0|||
146420165|NCT00101582|528045184|FG001|Overall Study|Other|1|||
146420166|NCT01919190|528045185|FG000|Overall Study|Intra-op findings, etc.|3|||
146420167|NCT01919190|528045186|FG001|Overall Study|Intra-op findings, etc.|0|||
146420168|NCT01893905|528045187|FG000|Overall Study|Withdrawal by Subject|1|||
146420169|NCT01893905|528045188|FG001|Overall Study|Withdrawal by Subject|0|||
146420170|NCT01893905|528045187|FG000|Overall Study|Adverse Event|9|||
146420171|NCT01893905|528045188|FG001|Overall Study|Adverse Event|3|||
146420172|NCT01893905|528045187|FG000|Overall Study|Lack of Efficacy|5|||
146420173|NCT01893905|528045188|FG001|Overall Study|Lack of Efficacy|7|||
146194063|NCT00335556|527221471|FG001|Overall Study|Ineligible|0|||
146194064|NCT00335556|527221472|FG002|Overall Study|Ineligible|0|||
146194065|NCT00335556|527221473|FG003|Overall Study|Ineligible|0|||
146194066|NCT00335556|527221474|FG004|Overall Study|Ineligible|0|||
146194067|NCT00335556|527221475|FG005|Overall Study|Ineligible|0|||
146194068|NCT00335556|527221470|FG000|Overall Study|Refusal of further protocol therapy|0|||
146420174|NCT01893905|528045187|FG000|Overall Study|Lost to Follow-up|1|||
146420175|NCT01893905|528045188|FG001|Overall Study|Lost to Follow-up|0|||
146420176|NCT01893905|528045187|FG000|Overall Study|Protocol Violation|6|||
146194069|NCT00335556|527221471|FG001|Overall Study|Refusal of further protocol therapy|4|||
146420177|NCT01893905|528045188|FG001|Overall Study|Protocol Violation|1|||
146420178|NCT01893905|528045187|FG000|Overall Study|Lack of adherence to treatment|2|||
146420179|NCT01893905|528045188|FG001|Overall Study|Lack of adherence to treatment|0|||
146420180|NCT01893905|528045187|FG000|Overall Study|Other reason|1|||
146420181|NCT01893905|528045188|FG001|Overall Study|Other reason|3|||
146420182|NCT01768858|528045189|FG000|Overall Study|Lost to Follow-up|9|||
146420183|NCT01768858|528045189|FG000|Overall Study|Lack of Efficacy|8|||
146420184|NCT01768858|528045189|FG000|Overall Study|Serious Adverse Event|1|||
146420185|NCT01768858|528045189|FG000|Overall Study|Participant moved to Germany|1|||
146420186|NCT01768858|528045189|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
146420187|NCT01768858|528045189|FG000|Overall Study|Exanthema|1|||
146420188|NCT01768858|528045189|FG000|Overall Study|Withdrawal by Subject|1|||
146420189|NCT03093324|528045191|FG000|Overall Study|Adverse Event|4|||
146420190|NCT03093324|528045192|FG001|Overall Study|Adverse Event|15|||
146420191|NCT03093324|528045191|FG000|Overall Study|Lost to Follow-up|1|||
146420192|NCT03093324|528045192|FG001|Overall Study|Lost to Follow-up|0|||
146420193|NCT03093324|528045191|FG000|Overall Study|Protocol Deviation|2|||
146420194|NCT03093324|528045192|FG001|Overall Study|Protocol Deviation|2|||
146420195|NCT03093324|528045191|FG000|Overall Study|Withdrawal by Subject|2|||
146420196|NCT03093324|528045192|FG001|Overall Study|Withdrawal by Subject|2|||
146420197|NCT02688400|528045198|FG000|Overall Study|Protocol Violation|2|||
146194070|NCT00335556|527221472|FG002|Overall Study|Refusal of further protocol therapy|0|||
146194071|NCT00335556|527221473|FG003|Overall Study|Refusal of further protocol therapy|1|||
146194072|NCT00335556|527221474|FG004|Overall Study|Refusal of further protocol therapy|0|||
146194073|NCT00335556|527221475|FG005|Overall Study|Refusal of further protocol therapy|0|||
146194074|NCT01670019|527221485|FG000|Overall Study|Adverse Event|3|||
146194075|NCT01670019|527221486|FG001|Overall Study|Adverse Event|0|||
146194076|NCT01670019|527221485|FG000|Overall Study|Withdrawal by Subject|6|||
146194077|NCT01670019|527221486|FG001|Overall Study|Withdrawal by Subject|0|||
146194078|NCT02595398|527221487|FG000|Overall Study|Non-compliance|1|||
146194079|NCT02595398|527221488|FG001|Overall Study|Non-compliance|0|||
146194080|NCT02595398|527221487|FG000|Overall Study|Withdrawal by Subject|2|||
146194081|NCT02595398|527221488|FG001|Overall Study|Withdrawal by Subject|1|||
146194082|NCT02595398|527221487|FG000|Overall Study|Lost to Follow-up|1|||
146194083|NCT02595398|527221488|FG001|Overall Study|Lost to Follow-up|0|||
146194084|NCT03601507|527221489|FG000|Overall Study|Adverse Event|1|||
146194085|NCT01664104|527221490|FG000|Overall Study|Adverse Event|6|||
146194086|NCT01664104|527221490|FG000|Overall Study|Lack of Efficacy|2|||
146194087|NCT01664104|527221490|FG000|Overall Study|Withdrawal by Subject|1|||
146194088|NCT01664104|527221490|FG000|Overall Study|Lost to Follow-up|4|||
146194089|NCT01664104|527221490|FG000|Overall Study|Other|1|||
146194090|NCT01664104|527221490|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
146194091|NCT02107014|527221494|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
146194092|NCT03761784|527221495|FG000|Overall Study|Adverse Event|4|||
146194093|NCT03761784|527221496|FG001|Overall Study|Adverse Event|0|||
146194094|NCT03761784|527221495|FG000|Overall Study|Lost to Follow-up|10|||
146194095|NCT03761784|527221496|FG001|Overall Study|Lost to Follow-up|7|||
146194096|NCT03761784|527221495|FG000|Overall Study|Pregnancy|1|||
146194097|NCT03761784|527221496|FG001|Overall Study|Pregnancy|0|||
146194098|NCT03761784|527221495|FG000|Overall Study|Protocol Violation|2|||
146194099|NCT03761784|527221496|FG001|Overall Study|Protocol Violation|0|||
146194100|NCT03761784|527221495|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
146194101|NCT03761784|527221496|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
146194102|NCT03761784|527221495|FG000|Overall Study|Withdrawal by Subject|9|||
146194103|NCT03761784|527221496|FG001|Overall Study|Withdrawal by Subject|4|||
146194104|NCT03761784|527221495|FG000|Overall Study|Physician Decision|1|||
146194105|NCT03761784|527221496|FG001|Overall Study|Physician Decision|0|||
146194106|NCT03761784|527221495|FG000|Overall Study|Other Than Specified|1|||
146420198|NCT02688400|528045199|FG001|Overall Study|Protocol Violation|5|||
146420199|NCT02688400|528045198|FG000|Overall Study|Lack of Efficacy|7|||
146194107|NCT03761784|527221496|FG001|Overall Study|Other Than Specified|0|||
146194108|NCT00586339|527221499|FG000|Overall Study|Withdrawal by Subject|1|||
146420200|NCT02688400|528045199|FG001|Overall Study|Lack of Efficacy|7|||
146194109|NCT00586339|527221500|FG001|Overall Study|Withdrawal by Subject|3|||
146194110|NCT00586339|527221501|FG002|Overall Study|Withdrawal by Subject|1|||
146194111|NCT00586339|527221499|FG000|Overall Study|Migrated/moved from study area|3|||
146420201|NCT02688400|528045198|FG000|Overall Study|Adverse Event|21|||
146194112|NCT00586339|527221500|FG001|Overall Study|Migrated/moved from study area|2|||
146194113|NCT00586339|527221501|FG002|Overall Study|Migrated/moved from study area|4|||
146194114|NCT00586339|527221499|FG000|Overall Study|Lost to Follow-up|3|||
146194115|NCT00586339|527221500|FG001|Overall Study|Lost to Follow-up|2|||
146194116|NCT00586339|527221501|FG002|Overall Study|Lost to Follow-up|1|||
146194117|NCT03852433|527221503|FG000|Overall Study|Withdrawal of consent|5|||
146194118|NCT03852433|527221504|FG001|Overall Study|Withdrawal of consent|8|||
146194119|NCT03852433|527221505|FG002|Overall Study|Withdrawal of consent|1|||
146194120|NCT03852433|527221506|FG003|Overall Study|Withdrawal of consent|1|||
146194121|NCT03852433|527221503|FG000|Overall Study|Adverse Event|1|||
146194122|NCT03852433|527221504|FG001|Overall Study|Adverse Event|1|||
146194123|NCT03852433|527221505|FG002|Overall Study|Adverse Event|1|||
146194124|NCT03852433|527221506|FG003|Overall Study|Adverse Event|1|||
146194125|NCT03852433|527221503|FG000|Overall Study|Lost to Follow-up|0|||
146194126|NCT03852433|527221504|FG001|Overall Study|Lost to Follow-up|1|||
146194127|NCT03852433|527221505|FG002|Overall Study|Lost to Follow-up|0|||
146194128|NCT03852433|527221506|FG003|Overall Study|Lost to Follow-up|1|||
146194129|NCT03852433|527221503|FG000|Overall Study|Pregnancy|0|||
146194130|NCT03852433|527221504|FG001|Overall Study|Pregnancy|1|||
146194131|NCT03852433|527221505|FG002|Overall Study|Pregnancy|1|||
146194132|NCT03852433|527221506|FG003|Overall Study|Pregnancy|0|||
146194133|NCT03852433|527221503|FG000|Overall Study|Protocol Violation|0|||
146194134|NCT03852433|527221504|FG001|Overall Study|Protocol Violation|0|||
146194135|NCT03852433|527221505|FG002|Overall Study|Protocol Violation|1|||
146194136|NCT03852433|527221506|FG003|Overall Study|Protocol Violation|1|||
146194137|NCT03852433|527221503|FG000|Overall Study|Death|0|||
146194138|NCT03852433|527221504|FG001|Overall Study|Death|0|||
146194139|NCT03852433|527221505|FG002|Overall Study|Death|1|||
146194140|NCT03852433|527221506|FG003|Overall Study|Death|0|||
146194141|NCT03852433|527221503|FG000|Overall Study|Lack of Efficacy|0|||
146194142|NCT03852433|527221504|FG001|Overall Study|Lack of Efficacy|1|||
146194143|NCT03852433|527221505|FG002|Overall Study|Lack of Efficacy|0|||
146194144|NCT03852433|527221506|FG003|Overall Study|Lack of Efficacy|0|||
146194145|NCT03852433|527221503|FG000|Overall Study|Non-compliance with study drug|0|||
146194146|NCT03852433|527221504|FG001|Overall Study|Non-compliance with study drug|0|||
146194147|NCT03852433|527221505|FG002|Overall Study|Non-compliance with study drug|0|||
146194148|NCT03852433|527221506|FG003|Overall Study|Non-compliance with study drug|1|||
146194149|NCT03852433|527221503|FG000|Overall Study|Physician Decision|1|||
146194150|NCT03852433|527221504|FG001|Overall Study|Physician Decision|0|||
146194151|NCT03852433|527221505|FG002|Overall Study|Physician Decision|0|||
146194152|NCT03852433|527221506|FG003|Overall Study|Physician Decision|0|||
146194153|NCT03852433|527221503|FG000|Overall Study|Randomized but never treated|1|||
146194154|NCT03852433|527221504|FG001|Overall Study|Randomized but never treated|0|||
146194155|NCT03852433|527221505|FG002|Overall Study|Randomized but never treated|0|||
146194156|NCT03852433|527221506|FG003|Overall Study|Randomized but never treated|0|||
146194157|NCT01981850|527221507|FG000|Main Phase Stage 1|Death|2|||
146194158|NCT01981850|527221508|FG001|Main Phase Stage 1|Death|0|||
146194159|NCT01981850|527221509|FG002|Main Phase Stage 1|Death|0|||
146194160|NCT01981850|527221510|FG003|Main Phase Stage 1|Death|0|||
146194161|NCT01981850|527221511|FG004|Main Phase Stage 1|Death|0|||
146194162|NCT01981850|527221512|FG005|Main Phase Stage 1|Death|0|||
146194163|NCT01981850|527221513|FG006|Main Phase Stage 1|Death|0|||
146194164|NCT01981850|527221514|FG007|Main Phase Stage 1|Death|0|||
146194165|NCT01981850|527221515|FG008|Main Phase Stage 1|Death|0|||
146194166|NCT01981850|527221516|FG009|Main Phase Stage 1|Death|0|||
146194167|NCT01981850|527221507|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
146194168|NCT01981850|527221508|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194169|NCT01981850|527221509|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194170|NCT01981850|527221510|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194171|NCT01981850|527221511|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194172|NCT01981850|527221512|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194173|NCT01981850|527221513|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194174|NCT01981850|527221514|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194175|NCT01981850|527221515|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194176|NCT01981850|527221516|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
146194177|NCT01981850|527221507|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
146194178|NCT01981850|527221508|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
146194179|NCT01981850|527221509|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
146194180|NCT01981850|527221510|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
146194181|NCT01981850|527221511|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
146194182|NCT01981850|527221512|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
146194183|NCT01981850|527221513|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
146194184|NCT01981850|527221514|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
146194185|NCT01981850|527221515|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
146194186|NCT01981850|527221516|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
146194187|NCT01981850|527221507|FG000|Main Phase Stage 1|Various reasons|0|||
146194188|NCT01981850|527221508|FG001|Main Phase Stage 1|Various reasons|0|||
146194189|NCT01981850|527221509|FG002|Main Phase Stage 1|Various reasons|2|||
146194190|NCT01981850|527221510|FG003|Main Phase Stage 1|Various reasons|0|||
146194191|NCT01981850|527221511|FG004|Main Phase Stage 1|Various reasons|0|||
146194192|NCT01981850|527221512|FG005|Main Phase Stage 1|Various reasons|0|||
146420202|NCT02688400|528045199|FG001|Overall Study|Adverse Event|12|||
146420203|NCT02688400|528045198|FG000|Overall Study|Withdrawal by Subject|15|||
146420204|NCT02688400|528045199|FG001|Overall Study|Withdrawal by Subject|13|||
146420205|NCT02688400|528045198|FG000|Overall Study|No study medication intake|1|||
146420206|NCT02688400|528045199|FG001|Overall Study|No study medication intake|4|||
146420207|NCT02688400|528045198|FG000|Overall Study|Lost to Follow-up|0|||
146420208|NCT02688400|528045199|FG001|Overall Study|Lost to Follow-up|3|||
146420209|NCT00275002|528045205|FG000|Overall Study|Death|1|||
146420210|NCT00275002|528045206|FG001|Overall Study|Death|0|||
146420211|NCT00275002|528045205|FG000|Overall Study|Disease progression|21|||
146420212|NCT00275002|528045206|FG001|Overall Study|Disease progression|15|||
146420213|NCT00275002|528045205|FG000|Overall Study|Adverse Event|0|||
146420214|NCT00275002|528045206|FG001|Overall Study|Adverse Event|1|||
146420215|NCT05456529|528045207|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
146420216|NCT05456529|528045207|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
146420217|NCT05456529|528045207|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
146420218|NCT05456529|528045207|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
146420219|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
146420220|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
146420221|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Physician Decision|2|||
146420222|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
146420223|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
146420224|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
146420225|NCT05456529|528045207|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
146420226|NCT02374918|528045208|FG000|Overall Study|Protocol Violation|2|||
146420227|NCT02374918|528045209|FG001|Overall Study|Protocol Violation|0|||
146420228|NCT02374918|528045210|FG002|Overall Study|Protocol Violation|2|||
146420229|NCT02374918|528045211|FG003|Overall Study|Protocol Violation|1|||
146420230|NCT02374918|528045208|FG000|Overall Study|Withdrawal by Subject|1|||
146420231|NCT02374918|528045209|FG001|Overall Study|Withdrawal by Subject|1|||
146194193|NCT01981850|527221513|FG006|Main Phase Stage 1|Various reasons|0|||
146420232|NCT02374918|528045210|FG002|Overall Study|Withdrawal by Subject|1|||
146420233|NCT02374918|528045211|FG003|Overall Study|Withdrawal by Subject|0|||
146420234|NCT02374918|528045208|FG000|Overall Study|Lack of Efficacy|0|||
146420235|NCT02374918|528045209|FG001|Overall Study|Lack of Efficacy|0|||
146420236|NCT02374918|528045210|FG002|Overall Study|Lack of Efficacy|1|||
146420237|NCT02374918|528045211|FG003|Overall Study|Lack of Efficacy|1|||
146420238|NCT01506947|528045212|FG000|Overall Study|Lost to Follow-up|7|||
146420239|NCT01506947|528045212|FG000|Overall Study|Adverse Event|5|||
146194194|NCT01981850|527221514|FG007|Main Phase Stage 1|Various reasons|0|||
146194195|NCT01981850|527221515|FG008|Main Phase Stage 1|Various reasons|0|||
146420240|NCT01506947|528045212|FG000|Overall Study|Death|1|||
146420241|NCT01506947|528045212|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
146420242|NCT02752776|528045215|FG000|Overall Study|Adverse Event|15|||
146420243|NCT02752776|528045216|FG001|Overall Study|Adverse Event|23|||
146420244|NCT02752776|528045217|FG002|Overall Study|Adverse Event|11|||
146420245|NCT02752776|528045215|FG000|Overall Study|Lack of Efficacy|2|||
146420246|NCT02752776|528045216|FG001|Overall Study|Lack of Efficacy|6|||
146420247|NCT02752776|528045217|FG002|Overall Study|Lack of Efficacy|14|||
146420248|NCT02752776|528045215|FG000|Overall Study|Lost to Follow-up|11|||
146420249|NCT02752776|528045216|FG001|Overall Study|Lost to Follow-up|12|||
146420250|NCT02752776|528045217|FG002|Overall Study|Lost to Follow-up|4|||
146420251|NCT02752776|528045215|FG000|Overall Study|Non-compliance with study treatment|0|||
146420252|NCT02752776|528045216|FG001|Overall Study|Non-compliance with study treatment|0|||
146420253|NCT02752776|528045217|FG002|Overall Study|Non-compliance with study treatment|1|||
146420254|NCT02752776|528045215|FG000|Overall Study|Physician Decision|2|||
146420255|NCT02752776|528045216|FG001|Overall Study|Physician Decision|6|||
146420256|NCT02752776|528045217|FG002|Overall Study|Physician Decision|2|||
146420257|NCT02752776|528045215|FG000|Overall Study|Pregnancy|1|||
146420258|NCT02752776|528045216|FG001|Overall Study|Pregnancy|6|||
146420259|NCT02752776|528045217|FG002|Overall Study|Pregnancy|3|||
146420260|NCT02752776|528045215|FG000|Overall Study|Protocol Violation|10|||
146420261|NCT02752776|528045216|FG001|Overall Study|Protocol Violation|13|||
146420262|NCT02752776|528045217|FG002|Overall Study|Protocol Violation|6|||
146420263|NCT02752776|528045215|FG000|Overall Study|Subject/guardian decision|8|||
146420264|NCT02752776|528045216|FG001|Overall Study|Subject/guardian decision|6|||
146420265|NCT02752776|528045217|FG002|Overall Study|Subject/guardian decision|4|||
146420266|NCT02752776|528045215|FG000|Overall Study|Death|0|||
146420267|NCT02752776|528045216|FG001|Overall Study|Death|0|||
146420268|NCT02752776|528045217|FG002|Overall Study|Death|1|||
146420269|NCT02752776|528045215|FG000|Overall Study|Withdrawal by Subject|3|||
146420270|NCT02752776|528045216|FG001|Overall Study|Withdrawal by Subject|4|||
146420271|NCT02752776|528045217|FG002|Overall Study|Withdrawal by Subject|2|||
146420272|NCT01816477|528045218|FG000|Overall Study|Withdrawal by Subject|13|||
146420273|NCT01816477|528045219|FG001|Overall Study|Withdrawal by Subject|1|||
146420274|NCT01816477|528045218|FG000|Overall Study|Unable to tolerate catheter placement|3|||
146420275|NCT01816477|528045219|FG001|Overall Study|Unable to tolerate catheter placement|0|||
146420276|NCT00108732|528045220|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
146420277|NCT00108732|528045220|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
146420278|NCT00108732|528045220|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
146420279|NCT00108732|528045220|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
146420280|NCT00108732|528045220|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
146420281|NCT00108732|528045220|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
146420282|NCT00108732|528045220|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
146420283|NCT02116803|528045222|FG000|Overall Study|Adverse Event|2|||
146420284|NCT02116803|528045223|FG001|Overall Study|Adverse Event|1|||
146420285|NCT02116803|528045222|FG000|Overall Study|Physician Decision|1|||
146420286|NCT02116803|528045223|FG001|Overall Study|Physician Decision|0|||
146420287|NCT02116803|528045222|FG000|Overall Study|Progressive disease|4|||
146420288|NCT02116803|528045223|FG001|Overall Study|Progressive disease|0|||
146420289|NCT02116803|528045222|FG000|Overall Study|Study terminated by sponsor|2|||
146420290|NCT02116803|528045223|FG001|Overall Study|Study terminated by sponsor|1|||
146420291|NCT02116803|528045222|FG000|Overall Study|Death|1|||
146420292|NCT02116803|528045223|FG001|Overall Study|Death|0|||
146420293|NCT01946165|528045224|FG000|Overall Study|Physician Decision|2|||
146420294|NCT01946165|528045225|FG001|Overall Study|Physician Decision|0|||
146420295|NCT01946165|528045224|FG000|Overall Study|Withdrawal by Subject|0|||
146420296|NCT01946165|528045225|FG001|Overall Study|Withdrawal by Subject|2|||
146420297|NCT01901055|528045226|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
146420298|NCT01901055|528045227|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
146420299|NCT01901055|528045226|FG000|Randomization But Not Titrated|Physician Decision|0|||
146420300|NCT01901055|528045227|FG001|Randomization But Not Titrated|Physician Decision|1|||
146420301|NCT01901055|528045226|FG000|Started Protocol to Week 6|Physician Decision|2|||
146420302|NCT01901055|528045227|FG001|Started Protocol to Week 6|Physician Decision|1|||
146420303|NCT01901055|528045226|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
146420304|NCT01901055|528045227|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
146420305|NCT01901055|528045226|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
146420306|NCT01901055|528045227|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
146420307|NCT01901055|528045226|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
146420308|NCT01901055|528045227|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
146420309|NCT01901055|528045226|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
146420310|NCT01901055|528045227|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
146420311|NCT01901055|528045226|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
146420312|NCT01901055|528045227|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
146420313|NCT01901055|528045226|FG000|Week 24|Withdrawal by Subject|13|||
146420314|NCT01901055|528045227|FG001|Week 24|Withdrawal by Subject|19|||
146420315|NCT01901055|528045226|FG000|Week 24|Physician Decision|1|||
146420316|NCT01901055|528045227|FG001|Week 24|Physician Decision|0|||
146420317|NCT01901055|528045226|FG000|Week 36|Withdrawal by Subject|0|||
146420318|NCT01901055|528045227|FG001|Week 36|Withdrawal by Subject|5|||
146420319|NCT03019965|528045230|FG000|Overall Study|Withdrawal by Subject|1|||
146420320|NCT03019965|528045231|FG001|Overall Study|Withdrawal by Subject|0|||
146420321|NCT03019965|528045230|FG000|Overall Study|Protocol Violation|1|||
146420322|NCT03019965|528045231|FG001|Overall Study|Protocol Violation|3|||
146420323|NCT03019965|528045230|FG000|Overall Study|viral or fungal infection|3|||
146420324|NCT03019965|528045231|FG001|Overall Study|viral or fungal infection|4|||
146420325|NCT03019965|528045230|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
146420326|NCT03019965|528045231|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
146420327|NCT03019965|528045230|FG000|Overall Study|Physician Decision|1|||
146420328|NCT03019965|528045231|FG001|Overall Study|Physician Decision|1|||
146420329|NCT01659567|528045232|FG000|Overall Study|Lack of Efficacy|22|||
146420330|NCT01659567|528045232|FG000|Overall Study|Switched to Pegferon|6|||
146420331|NCT01659567|528045232|FG000|Overall Study|Adverse Event|12|||
146420332|NCT01659567|528045232|FG000|Overall Study|Good result at early stage of treatment|5|||
146420333|NCT01659567|528045232|FG000|Overall Study|Withdrawal by Subject|64|||
146420334|NCT01659567|528045232|FG000|Overall Study|Progression of the main disease|1|||
146420335|NCT01659567|528045232|FG000|Overall Study|Other|13|||
146420336|NCT01915732|528045240|FG000|Overall Study|Withdrawal by Subject|18|||
146420337|NCT01915732|528045241|FG001|Overall Study|Withdrawal by Subject|18|||
146420338|NCT01915732|528045240|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
146420339|NCT01915732|528045241|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146420340|NCT01915732|528045240|FG000|Overall Study|Adverse Event|12|||
146420341|NCT01915732|528045241|FG001|Overall Study|Adverse Event|4|||
146420342|NCT01915732|528045240|FG000|Overall Study|Protocol Violation|5|||
146420343|NCT01915732|528045241|FG001|Overall Study|Protocol Violation|5|||
146420344|NCT01915732|528045240|FG000|Overall Study|Lack of Efficacy|6|||
146420345|NCT01915732|528045241|FG001|Overall Study|Lack of Efficacy|11|||
146420346|NCT01915732|528045240|FG000|Overall Study|Lost to Follow-up|22|||
146420347|NCT01915732|528045241|FG001|Overall Study|Lost to Follow-up|26|||
146420348|NCT01915732|528045240|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
146420349|NCT01915732|528045241|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
146420350|NCT01915732|528045240|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
146420351|NCT01915732|528045241|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
146420352|NCT01915732|528045240|FG000|Overall Study|Drug Release Error|1|||
146420353|NCT01915732|528045241|FG001|Overall Study|Drug Release Error|0|||
146420354|NCT01915732|528045240|FG000|Overall Study|Recovered|1|||
146420355|NCT01915732|528045241|FG001|Overall Study|Recovered|0|||
146420356|NCT01915732|528045240|FG000|Overall Study|Pregnancy|1|||
146420357|NCT01915732|528045241|FG001|Overall Study|Pregnancy|0|||
146420358|NCT01915732|528045240|FG000|Overall Study|Poor Perceived Efficacy|1|||
146420359|NCT01915732|528045241|FG001|Overall Study|Poor Perceived Efficacy|0|||
146420360|NCT01915732|528045240|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
146420361|NCT01915732|528045241|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
146420362|NCT01915732|528045240|FG000|Overall Study|Got Well|0|||
146420363|NCT01915732|528045241|FG001|Overall Study|Got Well|1|||
146420364|NCT01915732|528045240|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
146420365|NCT01915732|528045241|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
146420366|NCT01915732|528045240|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
146420367|NCT01915732|528045241|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
146420368|NCT01915732|528045240|FG000|Overall Study|Job Transfer|0|||
146420369|NCT01915732|528045241|FG001|Overall Study|Job Transfer|1|||
146420370|NCT01915732|528045240|FG000|Overall Study|Improper Facial Procedure|0|||
146420371|NCT01915732|528045241|FG001|Overall Study|Improper Facial Procedure|1|||
146420372|NCT01915732|528045240|FG000|Overall Study|Poor Conscious Effect|0|||
146420373|NCT01915732|528045241|FG001|Overall Study|Poor Conscious Effect|1|||
146420374|NCT01325207|528045242|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146420375|NCT01325207|528045243|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146420376|NCT01325207|528045244|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146420377|NCT01325207|528045245|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146420378|NCT01325207|528045246|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
146420379|NCT01325207|528045247|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
146420380|NCT01325207|528045242|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
146420381|NCT01325207|528045243|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
146420382|NCT01325207|528045244|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
146420383|NCT01325207|528045245|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
146420384|NCT01325207|528045246|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
146420385|NCT01325207|528045247|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
146194196|NCT01981850|527221516|FG009|Main Phase Stage 1|Various reasons|0|||
146194197|NCT01981850|527221507|FG000|Main Phase Stage 2|Adverse Event|0|||
146194198|NCT01981850|527221508|FG001|Main Phase Stage 2|Adverse Event|0|||
146420386|NCT01325207|528045242|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146420387|NCT01325207|528045243|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146420388|NCT01325207|528045244|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146420389|NCT01325207|528045245|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
146420390|NCT01325207|528045246|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
146420391|NCT01325207|528045247|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
146420392|NCT01325207|528045242|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146420393|NCT01325207|528045243|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
146420394|NCT01325207|528045244|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146420395|NCT01325207|528045245|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146420396|NCT01325207|528045246|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146420397|NCT01325207|528045247|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
146420398|NCT01325207|528045242|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146420399|NCT01325207|528045243|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146420400|NCT01325207|528045244|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146420401|NCT01325207|528045245|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146420402|NCT01325207|528045246|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
146420403|NCT01325207|528045247|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
146420404|NCT01325207|528045242|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146420405|NCT01325207|528045243|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146420406|NCT01325207|528045244|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146420407|NCT01325207|528045245|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146420408|NCT01325207|528045246|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
146420409|NCT01325207|528045247|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
146420410|NCT01325207|528045242|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146420411|NCT01325207|528045243|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146420412|NCT01325207|528045244|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146420413|NCT01325207|528045245|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146420414|NCT01325207|528045246|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
146420415|NCT01325207|528045247|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
146420416|NCT01254409|528045248|FG000|Overall Study|Adverse Event|0|||
146420417|NCT01254409|528045249|FG001|Overall Study|Adverse Event|1|||
146420418|NCT01254409|528045250|FG002|Overall Study|Adverse Event|0|||
146420419|NCT01254409|528045251|FG003|Overall Study|Adverse Event|0|||
146420420|NCT01974895|528045259|FG000|Overall Study|Protocol Violation|1|||
146420421|NCT01974895|528045260|FG001|Overall Study|Protocol Violation|0|||
146420422|NCT01974895|528045259|FG000|Overall Study|Lost to Follow-up|4|||
146420423|NCT01974895|528045260|FG001|Overall Study|Lost to Follow-up|6|||
146420424|NCT01974895|528045259|FG000|Overall Study|Withdrawal by Subject|0|||
146420425|NCT01974895|528045260|FG001|Overall Study|Withdrawal by Subject|1|||
146420426|NCT01974895|528045259|FG000|Overall Study|Other (Missed Visit)|1|||
146420427|NCT01974895|528045260|FG001|Overall Study|Other (Missed Visit)|0|||
146420428|NCT01974895|528045259|FG000|Overall Study|Other (Reason unknown)|9|||
146420429|NCT01974895|528045260|FG001|Overall Study|Other (Reason unknown)|8|||
146420430|NCT00635154|528045261|FG000|Overall Study|Alternative Treatment|8|||
146420431|NCT00635154|528045261|FG000|Overall Study|Other|4|||
146420432|NCT00635154|528045261|FG000|Overall Study|Still on treatment|21|||
146420433|NCT01399736|528045262|FG000|Overall Study|Withdrawal by Subject|4|||
146420434|NCT01399736|528045263|FG001|Overall Study|Withdrawal by Subject|2|||
146420435|NCT01399736|528045262|FG000|Overall Study|Lost to Follow-up|0|||
146420436|NCT01399736|528045263|FG001|Overall Study|Lost to Follow-up|2|||
146420437|NCT03500484|528045264|FG000|Overall Study|Adverse Event|2|||
146420438|NCT03500484|528045265|FG001|Overall Study|Adverse Event|0|||
146420439|NCT03500484|528045264|FG000|Overall Study|Physician Decision|1|||
146420440|NCT03500484|528045265|FG001|Overall Study|Physician Decision|0|||
146420441|NCT03500484|528045264|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
146420442|NCT03500484|528045265|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
146194199|NCT01981850|527221509|FG002|Main Phase Stage 2|Adverse Event|0|||
146420443|NCT04652453|528045269|FG000|Overall Study|Death|8|||
146420444|NCT04652453|528045270|FG001|Overall Study|Death|2|||
146420445|NCT04652453|528045271|FG002|Overall Study|Death|0|||
146420446|NCT04652453|528045269|FG000|Overall Study|Hospice|5|||
146420447|NCT04652453|528045270|FG001|Overall Study|Hospice|5|||
146420448|NCT04652453|528045271|FG002|Overall Study|Hospice|0|||
146420449|NCT04652453|528045269|FG000|Overall Study|Withdrawal by Subject|2|||
146420450|NCT04652453|528045270|FG001|Overall Study|Withdrawal by Subject|0|||
146194200|NCT01981850|527221510|FG003|Main Phase Stage 2|Adverse Event|0|||
146420451|NCT04652453|528045271|FG002|Overall Study|Withdrawal by Subject|0|||
146420452|NCT04543136|528045272|FG000|Overall Study|Withdrawal by Subject|0|||
146420453|NCT04543136|528045273|FG001|Overall Study|Withdrawal by Subject|1|||
146420454|NCT04543136|528045274|FG002|Overall Study|Withdrawal by Subject|0|||
146420455|NCT04543136|528045275|FG003|Overall Study|Withdrawal by Subject|1|||
146420456|NCT04543136|528045276|FG004|Overall Study|Withdrawal by Subject|0|||
146420457|NCT04543136|528045277|FG005|Overall Study|Withdrawal by Subject|0|||
146420458|NCT02192099|528045278|FG000|Overall Study|Adverse Event|1|||
146420459|NCT02192099|528045278|FG000|Overall Study|Lost to Follow-up|2|||
146420460|NCT02192099|528045278|FG000|Overall Study|Physician Decision|1|||
146420461|NCT02192099|528045278|FG000|Overall Study|Pregnancy|1|||
146420462|NCT02192099|528045278|FG000|Overall Study|Protocol Violation|8|||
146420463|NCT02192099|528045278|FG000|Overall Study|Study Terminated by Sponsor|32|||
146420464|NCT02192099|528045278|FG000|Overall Study|Withdrawal by Subject|11|||
146420465|NCT02192099|528045278|FG000|Overall Study|Miscellaneous Reasons|5|||
146420466|NCT00386009|528045279|FG000|Overall Study|Adverse Event|0|||
146420467|NCT00386009|528045280|FG001|Overall Study|Adverse Event|2|||
146420468|NCT00386009|528045279|FG000|Overall Study|Death|1|||
146420469|NCT00386009|528045280|FG001|Overall Study|Death|0|||
146420470|NCT00386009|528045279|FG000|Overall Study|Entry Criteria Not Met|0|||
146420471|NCT00386009|528045280|FG001|Overall Study|Entry Criteria Not Met|2|||
146420472|NCT00386009|528045279|FG000|Overall Study|Lost to Follow-up|1|||
146420473|NCT00386009|528045280|FG001|Overall Study|Lost to Follow-up|1|||
146420474|NCT00386009|528045279|FG000|Overall Study|Protocol Violation|1|||
146420475|NCT00386009|528045280|FG001|Overall Study|Protocol Violation|0|||
146420476|NCT00386009|528045279|FG000|Overall Study|Sponsor Decision|1|||
146420477|NCT00386009|528045280|FG001|Overall Study|Sponsor Decision|1|||
146420478|NCT00386009|528045279|FG000|Overall Study|Withdrawal by Subject|5|||
146420479|NCT00386009|528045280|FG001|Overall Study|Withdrawal by Subject|4|||
146420480|NCT01862328|528045291|FG000|Overall Study|Progressive Disease|3|||
146420481|NCT01862328|528045292|FG001|Overall Study|Progressive Disease|11|||
146420482|NCT01862328|528045293|FG002|Overall Study|Progressive Disease|5|||
146420483|NCT01862328|528045294|FG003|Overall Study|Progressive Disease|6|||
146420484|NCT01862328|528045295|FG004|Overall Study|Progressive Disease|7|||
146420485|NCT01862328|528045296|FG005|Overall Study|Progressive Disease|4|||
146420486|NCT01862328|528045297|FG006|Overall Study|Progressive Disease|3|||
146420487|NCT01862328|528045291|FG000|Overall Study|Adverse Event|0|||
146420488|NCT01862328|528045292|FG001|Overall Study|Adverse Event|4|||
146420489|NCT01862328|528045293|FG002|Overall Study|Adverse Event|0|||
146420490|NCT01862328|528045294|FG003|Overall Study|Adverse Event|1|||
146420491|NCT01862328|528045295|FG004|Overall Study|Adverse Event|0|||
146420492|NCT01862328|528045296|FG005|Overall Study|Adverse Event|2|||
146420493|NCT01862328|528045297|FG006|Overall Study|Adverse Event|4|||
146420494|NCT01862328|528045291|FG000|Overall Study|Other|0|||
146420495|NCT01862328|528045292|FG001|Overall Study|Other|2|||
146420496|NCT01862328|528045293|FG002|Overall Study|Other|1|||
146420497|NCT01862328|528045294|FG003|Overall Study|Other|0|||
146420498|NCT01862328|528045295|FG004|Overall Study|Other|4|||
146420499|NCT01862328|528045296|FG005|Overall Study|Other|0|||
146420500|NCT01862328|528045297|FG006|Overall Study|Other|1|||
146420501|NCT01862328|528045291|FG000|Overall Study|Withdrawal by Subject|1|||
146194201|NCT01981850|527221511|FG004|Main Phase Stage 2|Adverse Event|6|||
146194202|NCT01981850|527221512|FG005|Main Phase Stage 2|Adverse Event|5|||
146420502|NCT01862328|528045292|FG001|Overall Study|Withdrawal by Subject|1|||
146420503|NCT01862328|528045293|FG002|Overall Study|Withdrawal by Subject|0|||
146194203|NCT01981850|527221513|FG006|Main Phase Stage 2|Adverse Event|7|||
146194204|NCT01981850|527221514|FG007|Main Phase Stage 2|Adverse Event|0|||
146420504|NCT01862328|528045294|FG003|Overall Study|Withdrawal by Subject|0|||
146420505|NCT01862328|528045295|FG004|Overall Study|Withdrawal by Subject|1|||
146420506|NCT01862328|528045296|FG005|Overall Study|Withdrawal by Subject|1|||
146420507|NCT01862328|528045297|FG006|Overall Study|Withdrawal by Subject|1|||
146420508|NCT01862328|528045291|FG000|Overall Study|Symptomatic Deterioration|0|||
146420509|NCT01862328|528045292|FG001|Overall Study|Symptomatic Deterioration|0|||
146420510|NCT01862328|528045293|FG002|Overall Study|Symptomatic Deterioration|0|||
146420511|NCT01862328|528045294|FG003|Overall Study|Symptomatic Deterioration|0|||
146420512|NCT01862328|528045295|FG004|Overall Study|Symptomatic Deterioration|0|||
146420513|NCT01862328|528045296|FG005|Overall Study|Symptomatic Deterioration|0|||
146420514|NCT01862328|528045297|FG006|Overall Study|Symptomatic Deterioration|1|||
146420515|NCT00936975|528045298|FG000|Overall Study|Withdrawal by Subject|1|||
146420516|NCT00936975|528045298|FG000|Overall Study|Disease progression|3|||
146420517|NCT00936975|528045298|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
146420518|NCT02482571|528045299|FG000|Overall Study|Adverse Event|1|||
146420519|NCT02482571|528045299|FG000|Overall Study|Scanner or Respiract failure|3|||
146420520|NCT02482571|528045299|FG000|Overall Study|Withdrawal by Subject|4|||
146420521|NCT03922477|528045300|FG000|Overall Study|Death|9|||
146420522|NCT03922477|528045300|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
146420523|NCT03922477|528045300|FG000|Overall Study|Physician Decision|1|||
146420524|NCT03922477|528045300|FG000|Overall Study|Withdrawal by Subject|2|||
146420525|NCT01498484|528045302|FG000|Overall Study|Death|6|||
146420526|NCT01498484|528045303|FG001|Overall Study|Death|3|||
146420527|NCT01498484|528045304|FG002|Overall Study|Death|1|||
146420528|NCT01498484|528045305|FG003|Overall Study|Death|1|||
146420529|NCT01498484|528045306|FG004|Overall Study|Death|0|||
146420530|NCT01498484|528045307|FG005|Overall Study|Death|0|||
146420531|NCT01498484|528045308|FG006|Overall Study|Death|10|||
146420532|NCT01498484|528045309|FG007|Overall Study|Death|1|||
146420533|NCT01498484|528045310|FG008|Overall Study|Death|0|||
146420534|NCT01498484|528045302|FG000|Overall Study|Physician Decision|3|||
146420535|NCT01498484|528045303|FG001|Overall Study|Physician Decision|2|||
146420536|NCT01498484|528045304|FG002|Overall Study|Physician Decision|1|||
146420537|NCT01498484|528045305|FG003|Overall Study|Physician Decision|1|||
146420538|NCT01498484|528045306|FG004|Overall Study|Physician Decision|0|||
146420539|NCT01498484|528045307|FG005|Overall Study|Physician Decision|0|||
146420540|NCT01498484|528045308|FG006|Overall Study|Physician Decision|8|||
146420541|NCT01498484|528045309|FG007|Overall Study|Physician Decision|13|||
146420542|NCT01498484|528045310|FG008|Overall Study|Physician Decision|1|||
146420543|NCT01498484|528045302|FG000|Overall Study|Adverse Event|0|||
146420544|NCT01498484|528045303|FG001|Overall Study|Adverse Event|0|||
146194205|NCT01981850|527221515|FG008|Main Phase Stage 2|Adverse Event|0|||
146194206|NCT01981850|527221516|FG009|Main Phase Stage 2|Adverse Event|0|||
146420545|NCT01498484|528045304|FG002|Overall Study|Adverse Event|0|||
146194207|NCT01981850|527221507|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194208|NCT01981850|527221508|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194209|NCT01981850|527221509|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194210|NCT01981850|527221510|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194211|NCT01981850|527221511|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
146194212|NCT01981850|527221512|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
146194213|NCT01981850|527221513|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
146194214|NCT01981850|527221514|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194215|NCT01981850|527221515|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194216|NCT01981850|527221516|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
146194217|NCT01981850|527221507|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
146194218|NCT01981850|527221508|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
146194219|NCT01981850|527221509|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
146194220|NCT01981850|527221510|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
146194221|NCT01981850|527221511|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
146194222|NCT01981850|527221512|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
146194223|NCT01981850|527221513|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
146194224|NCT01981850|527221514|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
146194225|NCT01981850|527221515|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
146194226|NCT01981850|527221516|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
146194227|NCT01981850|527221507|FG000|Main Phase Stage 2|Various reasons|0|||
146420546|NCT01498484|528045305|FG003|Overall Study|Adverse Event|0|||
146194228|NCT01981850|527221508|FG001|Main Phase Stage 2|Various reasons|0|||
146420547|NCT01498484|528045306|FG004|Overall Study|Adverse Event|0|||
146420548|NCT01498484|528045307|FG005|Overall Study|Adverse Event|1|||
146194229|NCT01981850|527221509|FG002|Main Phase Stage 2|Various reasons|0|||
146194230|NCT01981850|527221510|FG003|Main Phase Stage 2|Various reasons|0|||
146420549|NCT01498484|528045308|FG006|Overall Study|Adverse Event|0|||
146420550|NCT01498484|528045309|FG007|Overall Study|Adverse Event|0|||
146420551|NCT01498484|528045310|FG008|Overall Study|Adverse Event|0|||
146420552|NCT01498484|528045302|FG000|Overall Study|Withdrawal by Subject|0|||
146420553|NCT01498484|528045303|FG001|Overall Study|Withdrawal by Subject|0|||
146420554|NCT01498484|528045304|FG002|Overall Study|Withdrawal by Subject|0|||
146420555|NCT01498484|528045305|FG003|Overall Study|Withdrawal by Subject|1|||
146420556|NCT01498484|528045306|FG004|Overall Study|Withdrawal by Subject|0|||
146420557|NCT01498484|528045307|FG005|Overall Study|Withdrawal by Subject|0|||
146420558|NCT01498484|528045308|FG006|Overall Study|Withdrawal by Subject|1|||
146420559|NCT01498484|528045309|FG007|Overall Study|Withdrawal by Subject|0|||
146420560|NCT01498484|528045310|FG008|Overall Study|Withdrawal by Subject|0|||
146420561|NCT01498484|528045302|FG000|Overall Study|Other|5|||
146420562|NCT01498484|528045303|FG001|Overall Study|Other|2|||
146420563|NCT01498484|528045304|FG002|Overall Study|Other|0|||
146420564|NCT01498484|528045305|FG003|Overall Study|Other|0|||
146420565|NCT01498484|528045306|FG004|Overall Study|Other|1|||
146420566|NCT01498484|528045307|FG005|Overall Study|Other|0|||
146420567|NCT01498484|528045308|FG006|Overall Study|Other|3|||
146420568|NCT01498484|528045309|FG007|Overall Study|Other|0|||
146420569|NCT01498484|528045310|FG008|Overall Study|Other|1|||
146420570|NCT01199601|528045311|FG000|Overall Study|Lost to Follow-up|47|||
146420571|NCT01199601|528045312|FG001|Overall Study|Lost to Follow-up|66|||
146420572|NCT01199601|528045311|FG000|Overall Study|Withdrawal by Subject|15|||
146420573|NCT01199601|528045312|FG001|Overall Study|Withdrawal by Subject|3|||
146420574|NCT01199601|528045311|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
146420575|NCT01199601|528045312|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
146420576|NCT03387098|528045313|FG000|Overall Study|progressive disease|1|||
146420577|NCT03387098|528045313|FG000|Overall Study|Withdrawal by Subject|2|||
146420578|NCT03387098|528045313|FG000|Overall Study|study terminated by sponsor|1|||
146420579|NCT02486796|528045314|FG000|Overall Study|Withdrawal by Subject|1|||
146420580|NCT02486796|528045315|FG001|Overall Study|Withdrawal by Subject|1|||
146420581|NCT02486796|528045314|FG000|Overall Study|Physician Decision|1|||
146420582|NCT02486796|528045315|FG001|Overall Study|Physician Decision|0|||
146420583|NCT02974153|528045316|FG000|Overall Study|Adverse Event|6|||
146420584|NCT02974153|528045317|FG001|Overall Study|Adverse Event|0|||
146420585|NCT02974153|528045318|FG002|Overall Study|Adverse Event|1|||
146420586|NCT02974153|528045316|FG000|Overall Study|Lack of Efficacy|6|||
146420587|NCT02974153|528045317|FG001|Overall Study|Lack of Efficacy|5|||
146420588|NCT02974153|528045318|FG002|Overall Study|Lack of Efficacy|10|||
146420589|NCT02974153|528045316|FG000|Overall Study|Lost to Follow-up|9|||
146420590|NCT02974153|528045317|FG001|Overall Study|Lost to Follow-up|10|||
146420591|NCT02974153|528045318|FG002|Overall Study|Lost to Follow-up|17|||
146420592|NCT02974153|528045316|FG000|Overall Study|Physician Decision|0|||
146420593|NCT02974153|528045317|FG001|Overall Study|Physician Decision|2|||
146420594|NCT02974153|528045318|FG002|Overall Study|Physician Decision|1|||
146420595|NCT02974153|528045316|FG000|Overall Study|Withdrawal by Subject|9|||
146420596|NCT02974153|528045317|FG001|Overall Study|Withdrawal by Subject|16|||
146420597|NCT02974153|528045318|FG002|Overall Study|Withdrawal by Subject|11|||
146420598|NCT02974153|528045316|FG000|Overall Study|Study Burden|8|||
146420599|NCT02974153|528045317|FG001|Overall Study|Study Burden|7|||
146420600|NCT02974153|528045318|FG002|Overall Study|Study Burden|3|||
146420601|NCT02974153|528045316|FG000|Overall Study|Other|14|||
146420602|NCT02974153|528045317|FG001|Overall Study|Other|8|||
146420603|NCT02974153|528045318|FG002|Overall Study|Other|7|||
146420604|NCT02521948|528045319|FG000|Overall Study|Adverse Event|2|||
146420605|NCT02521948|528045319|FG000|Overall Study|Death|4|||
146420606|NCT02521948|528045319|FG000|Overall Study|Lost to Follow-up|1|||
146420607|NCT02521948|528045319|FG000|Overall Study|Did not attend one or both follow-ups|6|||
146420608|NCT00423800|528045320|FG000|Overall Study|Protocol Violation|0|||
146420609|NCT00423800|528045321|FG001|Overall Study|Protocol Violation|1|||
146420610|NCT00679783|528045323|FG000|Overall Study|Adverse Event|0|||
146420611|NCT00679783|528045324|FG001|Overall Study|Adverse Event|0|||
146420612|NCT00679783|528045325|FG002|Overall Study|Adverse Event|0|||
146420613|NCT00679783|528045326|FG003|Overall Study|Adverse Event|3|||
146420614|NCT00679783|528045327|FG004|Overall Study|Adverse Event|0|||
146420615|NCT00679783|528045328|FG005|Overall Study|Adverse Event|0|||
146082479|NCT02431260|526822813|FG003|Overall Study|Death|4|||
146420616|NCT00679783|528045329|FG006|Overall Study|Adverse Event|1|||
146420617|NCT00679783|528045323|FG000|Overall Study|Lack of Efficacy|0|||
146420618|NCT00679783|528045324|FG001|Overall Study|Lack of Efficacy|1|||
146420619|NCT00679783|528045325|FG002|Overall Study|Lack of Efficacy|0|||
146420620|NCT00679783|528045326|FG003|Overall Study|Lack of Efficacy|2|||
146420621|NCT00679783|528045327|FG004|Overall Study|Lack of Efficacy|0|||
146420622|NCT00679783|528045328|FG005|Overall Study|Lack of Efficacy|0|||
146420623|NCT00679783|528045329|FG006|Overall Study|Lack of Efficacy|0|||
146420624|NCT00679783|528045323|FG000|Overall Study|Withdrawal by Subject|0|||
146420625|NCT00679783|528045324|FG001|Overall Study|Withdrawal by Subject|0|||
146420626|NCT00679783|528045325|FG002|Overall Study|Withdrawal by Subject|1|||
146420627|NCT00679783|528045326|FG003|Overall Study|Withdrawal by Subject|1|||
146420628|NCT00679783|528045327|FG004|Overall Study|Withdrawal by Subject|0|||
146420629|NCT00679783|528045328|FG005|Overall Study|Withdrawal by Subject|0|||
146420630|NCT00679783|528045329|FG006|Overall Study|Withdrawal by Subject|0|||
146420631|NCT00679783|528045323|FG000|Overall Study|Not Captured|0|||
146420632|NCT00679783|528045324|FG001|Overall Study|Not Captured|0|||
146420633|NCT00679783|528045325|FG002|Overall Study|Not Captured|0|||
146420634|NCT00679783|528045326|FG003|Overall Study|Not Captured|5|||
146420635|NCT00679783|528045327|FG004|Overall Study|Not Captured|0|||
146420636|NCT00679783|528045328|FG005|Overall Study|Not Captured|0|||
146420637|NCT00679783|528045329|FG006|Overall Study|Not Captured|0|||
146420638|NCT00679783|528045323|FG000|Overall Study|Ongoing at data cut-off|2|||
146420639|NCT00679783|528045324|FG001|Overall Study|Ongoing at data cut-off|2|||
146420640|NCT00679783|528045325|FG002|Overall Study|Ongoing at data cut-off|0|||
146420641|NCT00679783|528045326|FG003|Overall Study|Ongoing at data cut-off|9|||
146420642|NCT00679783|528045327|FG004|Overall Study|Ongoing at data cut-off|1|||
146420643|NCT00679783|528045328|FG005|Overall Study|Ongoing at data cut-off|0|||
146420644|NCT00679783|528045329|FG006|Overall Study|Ongoing at data cut-off|0|||
146420645|NCT00814320|528045330|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
146420646|NCT00814320|528045331|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
146420647|NCT00814320|528045330|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
146420648|NCT00814320|528045331|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
146420649|NCT00814320|528045330|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
146420650|NCT00814320|528045331|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
146420651|NCT00814320|528045330|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
146420652|NCT00814320|528045331|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
146420653|NCT00814320|528045330|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
146420654|NCT00814320|528045331|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
146420655|NCT00814320|528045330|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
146420656|NCT00814320|528045331|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
146420657|NCT00814320|528045330|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
146194231|NCT01981850|527221511|FG004|Main Phase Stage 2|Various reasons|2|||
146194232|NCT01981850|527221512|FG005|Main Phase Stage 2|Various reasons|0|||
146194233|NCT01981850|527221513|FG006|Main Phase Stage 2|Various reasons|1|||
146194234|NCT01981850|527221514|FG007|Main Phase Stage 2|Various reasons|0|||
146194235|NCT01981850|527221515|FG008|Main Phase Stage 2|Various reasons|0|||
146420658|NCT00814320|528045331|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
146420659|NCT00814320|528045330|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
146420660|NCT00814320|528045331|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
146420661|NCT00814320|528045330|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
146420662|NCT00814320|528045331|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
146420663|NCT00814320|528045330|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
146420664|NCT00814320|528045331|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
146082480|NCT02431260|526822814|FG004|Overall Study|Death|2|||
146082481|NCT02431260|526822815|FG005|Overall Study|Death|2|||
146420665|NCT00491504|528045332|FG000|Overall Study|Adverse Event|0|||
146420666|NCT00491504|528045333|FG001|Overall Study|Adverse Event|1|||
146420667|NCT00491504|528045334|FG002|Overall Study|Adverse Event|0|||
146420668|NCT00491504|528045335|FG003|Overall Study|Adverse Event|0|||
146420669|NCT00491504|528045332|FG000|Overall Study|Withdrawal by Subject|0|||
146420670|NCT00491504|528045333|FG001|Overall Study|Withdrawal by Subject|0|||
146420671|NCT00491504|528045334|FG002|Overall Study|Withdrawal by Subject|1|||
146420672|NCT00491504|528045335|FG003|Overall Study|Withdrawal by Subject|2|||
146420673|NCT00491504|528045332|FG000|Overall Study|Protocol Violation|0|||
146194236|NCT01981850|527221516|FG009|Main Phase Stage 2|Various reasons|0|||
146420674|NCT00491504|528045333|FG001|Overall Study|Protocol Violation|0|||
146420675|NCT00491504|528045334|FG002|Overall Study|Protocol Violation|3|||
146420676|NCT00491504|528045335|FG003|Overall Study|Protocol Violation|2|||
146420677|NCT02568384|528045338|FG000|Overall Study|Mobile devices incompatible with App|2|||
146420678|NCT01485536|528045339|FG000|Overall Study|Withdrawal by Subject|3|||
146420679|NCT01485536|528045339|FG000|Overall Study|Adverse Event|1|||
146420680|NCT02799602|528045340|FG000|Overall Study|Protocol Violation|1|||
146194237|NCT01981850|527221507|FG000|Main Phase Stage 2|Progressive Disease|0|||
146420681|NCT02799602|528045341|FG001|Overall Study|Protocol Violation|0|||
146420682|NCT02799602|528045340|FG000|Overall Study|Physician Decision|5|||
146082482|NCT02431260|526822816|FG006|Overall Study|Death|3|||
146082483|NCT02431260|526822817|FG007|Overall Study|Death|1|||
146194238|NCT01981850|527221508|FG001|Main Phase Stage 2|Progressive Disease|0|||
146420683|NCT02799602|528045341|FG001|Overall Study|Physician Decision|6|||
146194239|NCT01981850|527221509|FG002|Main Phase Stage 2|Progressive Disease|0|||
146194240|NCT01981850|527221510|FG003|Main Phase Stage 2|Progressive Disease|0|||
146194241|NCT01981850|527221511|FG004|Main Phase Stage 2|Progressive Disease|0|||
146194242|NCT01981850|527221512|FG005|Main Phase Stage 2|Progressive Disease|6|||
146194243|NCT01981850|527221513|FG006|Main Phase Stage 2|Progressive Disease|6|||
146194244|NCT01981850|527221514|FG007|Main Phase Stage 2|Progressive Disease|0|||
146194245|NCT01981850|527221515|FG008|Main Phase Stage 2|Progressive Disease|0|||
146194246|NCT01981850|527221516|FG009|Main Phase Stage 2|Progressive Disease|0|||
146194247|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Adverse Event|0|||
146194248|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Adverse Event|0|||
146194249|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Adverse Event|0|||
146194250|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Adverse Event|0|||
146194251|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Adverse Event|0|||
146194252|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Adverse Event|0|||
146194253|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Adverse Event|0|||
146194254|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Adverse Event|2|||
146194255|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Adverse Event|1|||
146194256|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Adverse Event|8|||
146194257|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194258|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194259|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194260|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194261|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194262|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194263|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
146194264|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
146194265|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
146194266|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
146194267|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Various reasons|0|||
146194268|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Various reasons|0|||
146194269|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Various reasons|0|||
146194270|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Various reasons|0|||
146194271|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Various reasons|0|||
146194272|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Various reasons|0|||
146194273|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Various reasons|0|||
146194274|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Various reasons|3|||
146194275|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Various reasons|1|||
146194276|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Various reasons|3|||
146194277|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
146194278|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
146194279|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
146194280|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
146194281|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
146194282|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
146194283|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
146194284|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
146194285|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
146194286|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
146194287|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194288|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194289|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146420684|NCT02799602|528045340|FG000|Overall Study|Lost to Follow-up|4|||
146420685|NCT02799602|528045341|FG001|Overall Study|Lost to Follow-up|2|||
146420686|NCT02799602|528045340|FG000|Overall Study|Additional primary malignancy|11|||
146420687|NCT02799602|528045341|FG001|Overall Study|Additional primary malignancy|6|||
146420688|NCT02799602|528045340|FG000|Overall Study|Non-compliance with study drug|14|||
146420689|NCT02799602|528045341|FG001|Overall Study|Non-compliance with study drug|12|||
146420690|NCT02799602|528045340|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
146420691|NCT02799602|528045341|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
146420692|NCT02799602|528045340|FG000|Overall Study|Withdrawal by Subject|26|||
146420693|NCT02799602|528045341|FG001|Overall Study|Withdrawal by Subject|40|||
146420694|NCT02799602|528045340|FG000|Overall Study|Progressive disease - clinical progression|131|||
146420695|NCT02799602|528045341|FG001|Overall Study|Progressive disease - clinical progression|276|||
146420696|NCT02799602|528045340|FG000|Overall Study|Progressive disease - radiological progression|90|||
145948191|NCT02028169|526319601|FG000|Overall Study|Concomitant Medication Usage|1|||
146082484|NCT02431260|526822818|FG008|Overall Study|Death|6|||
146082485|NCT02431260|526822819|FG009|Overall Study|Death|6|||
146194290|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194291|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194292|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146420697|NCT02799602|528045341|FG001|Overall Study|Progressive disease - radiological progression|133|||
146420698|NCT02799602|528045340|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
146420699|NCT02799602|528045341|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
146420700|NCT02799602|528045340|FG000|Overall Study|Death|9|||
146420701|NCT02799602|528045341|FG001|Overall Study|Death|5|||
146420702|NCT02799602|528045340|FG000|Overall Study|Other|287|||
146420703|NCT02799602|528045341|FG001|Overall Study|Other|118|||
146420704|NCT02799602|528045340|FG000|Overall Study|Study drug never administered|0|||
146420705|NCT02799602|528045341|FG001|Overall Study|Study drug never administered|3|||
146420706|NCT01048333|528045342|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146420707|NCT01048333|528045343|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
146420708|NCT01048333|528045344|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146420709|NCT01048333|528045345|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146420710|NCT01048333|528045346|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146420711|NCT01048333|528045347|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
146420712|NCT03131999|528045348|FG000|Overall Study|Withdrawal by Subject|0|||
146420713|NCT03131999|528045349|FG001|Overall Study|Withdrawal by Subject|1|||
146420714|NCT02260492|528045350|FG000|Overall Study|Adverse Event|6|||
146420715|NCT02260492|528045351|FG001|Overall Study|Adverse Event|1|||
146420716|NCT02260492|528045352|FG002|Overall Study|Adverse Event|2|||
146420717|NCT02260492|528045350|FG000|Overall Study|Death|0|||
146420718|NCT02260492|528045351|FG001|Overall Study|Death|1|||
146420719|NCT02260492|528045352|FG002|Overall Study|Death|0|||
146420720|NCT02260492|528045350|FG000|Overall Study|Lost to Follow-up|12|||
146420721|NCT02260492|528045351|FG001|Overall Study|Lost to Follow-up|9|||
146420722|NCT02260492|528045352|FG002|Overall Study|Lost to Follow-up|0|||
146420723|NCT02260492|528045350|FG000|Overall Study|Physician Decision|2|||
146420724|NCT02260492|528045351|FG001|Overall Study|Physician Decision|0|||
146420725|NCT02260492|528045352|FG002|Overall Study|Physician Decision|1|||
146420726|NCT02260492|528045350|FG000|Overall Study|Withdrawal by Subject|3|||
146420727|NCT02260492|528045351|FG001|Overall Study|Withdrawal by Subject|2|||
146420728|NCT02260492|528045352|FG002|Overall Study|Withdrawal by Subject|2|||
146420729|NCT01052116|528047096|FG000|Overall Study|Lost to Follow-up|11|||
146420730|NCT01052116|528047097|FG001|Overall Study|Lost to Follow-up|17|||
146420731|NCT01052116|528047096|FG000|Overall Study|Withdrawal by Subject|3|||
146420732|NCT01052116|528047097|FG001|Overall Study|Withdrawal by Subject|6|||
146420733|NCT01052116|528047096|FG000|Overall Study|Spirometry not performed|0|||
146420734|NCT01052116|528047097|FG001|Overall Study|Spirometry not performed|4|||
146420735|NCT00266409|528047102|FG000|Overall Study|Lack of Efficacy|2|||
146420736|NCT00266409|528047103|FG001|Overall Study|Lack of Efficacy|6|||
146420737|NCT00266409|528047104|FG002|Overall Study|Lack of Efficacy|1|||
146420738|NCT00266409|528047105|FG003|Overall Study|Lack of Efficacy|2|||
146420739|NCT00266409|528047102|FG000|Overall Study|Adverse Event|7|||
146420740|NCT00266409|528047103|FG001|Overall Study|Adverse Event|2|||
146420741|NCT00266409|528047104|FG002|Overall Study|Adverse Event|1|||
146420742|NCT00266409|528047105|FG003|Overall Study|Adverse Event|1|||
146420743|NCT00266409|528047102|FG000|Overall Study|Lost to Follow-up|18|||
146420744|NCT00266409|528047103|FG001|Overall Study|Lost to Follow-up|21|||
146420745|NCT00266409|528047104|FG002|Overall Study|Lost to Follow-up|6|||
146420746|NCT00266409|528047105|FG003|Overall Study|Lost to Follow-up|8|||
146420747|NCT00266409|528047102|FG000|Overall Study|Withdrawal by Subject|6|||
146420748|NCT00266409|528047103|FG001|Overall Study|Withdrawal by Subject|10|||
146420749|NCT00266409|528047104|FG002|Overall Study|Withdrawal by Subject|3|||
146420750|NCT00266409|528047105|FG003|Overall Study|Withdrawal by Subject|9|||
146420751|NCT00266409|528047102|FG000|Overall Study|Protocol Violation|5|||
146420752|NCT00266409|528047103|FG001|Overall Study|Protocol Violation|3|||
146420753|NCT00266409|528047104|FG002|Overall Study|Protocol Violation|4|||
146420754|NCT00266409|528047105|FG003|Overall Study|Protocol Violation|2|||
146420755|NCT00266409|528047102|FG000|Overall Study|Other|7|||
146420756|NCT00266409|528047103|FG001|Overall Study|Other|4|||
146420757|NCT00266409|528047104|FG002|Overall Study|Other|2|||
146420758|NCT00266409|528047105|FG003|Overall Study|Other|0|||
146420759|NCT00712010|528047106|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
146194293|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194294|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194295|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
146194296|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
146194297|NCT01981850|527221507|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194298|NCT01981850|527221508|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194299|NCT01981850|527221509|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194300|NCT01981850|527221510|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194301|NCT01981850|527221511|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194302|NCT01981850|527221512|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194303|NCT01981850|527221513|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194304|NCT01981850|527221514|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194305|NCT01981850|527221515|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
146194306|NCT01981850|527221516|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
146194307|NCT01311648|527223976|FG000|Main Study|Protocol Violation|0|||
146194308|NCT01311648|527223977|FG001|Main Study|Protocol Violation|1|||
146194309|NCT01311648|527223976|FG000|Main Study|Adverse Event|0|||
146194310|NCT01311648|527223977|FG001|Main Study|Adverse Event|1|||
146194311|NCT01311648|527223976|FG000|Main Study|Inhibitor management|0|||
146194312|NCT01311648|527223977|FG001|Main Study|Inhibitor management|17|||
146194313|NCT01311648|527223976|FG000|Main Study|Withdrawal by Subject|0|||
146194314|NCT01311648|527223977|FG001|Main Study|Withdrawal by Subject|2|||
146194315|NCT01311648|527223976|FG000|Extension Study|Physician Decision|0|||
146194316|NCT01311648|527223977|FG001|Extension Study|Physician Decision|1|||
146194317|NCT01311648|527223976|FG000|Extension Study|ITI therapy with marketed product|0|||
146194318|NCT01311648|527223977|FG001|Extension Study|ITI therapy with marketed product|1|||
146194319|NCT01311648|527223976|FG000|Extension Study|Incorrect visit planning|0|||
146194320|NCT01311648|527223977|FG001|Extension Study|Incorrect visit planning|1|||
146194321|NCT01311648|527223976|FG000|Extension Study|Family's decision|0|||
146194322|NCT01311648|527223977|FG001|Extension Study|Family's decision|1|||
146194323|NCT01311648|527223976|FG000|Extension Study|Failure of ITI therapy|0|||
146194324|NCT01311648|527223977|FG001|Extension Study|Failure of ITI therapy|3|||
146194325|NCT01311648|527223976|FG000|Extension Study|Long travel|0|||
146194326|NCT01311648|527223977|FG001|Extension Study|Long travel|1|||
146194327|NCT01311648|527223976|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
146194328|NCT01311648|527223977|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
146194329|NCT01311648|527223976|FG000|Extension Study|Withdrawal by Subject|0|||
146194330|NCT01311648|527223977|FG001|Extension Study|Withdrawal by Subject|1|||
146194331|NCT01311648|527223976|FG000|Extension Study|Inhibitor management|0|||
146194332|NCT01311648|527223977|FG001|Extension Study|Inhibitor management|2|||
146194333|NCT00763282|527223978|FG000|Overall Study|Withdrawal by Subject|6|||
146194334|NCT00763282|527223979|FG001|Overall Study|Withdrawal by Subject|5|||
146194335|NCT00763282|527223978|FG000|Overall Study|Death|4|||
146194336|NCT00763282|527223979|FG001|Overall Study|Death|3|||
146194337|NCT00763282|527223978|FG000|Overall Study|Lost to Follow-up|22|||
146194338|NCT00763282|527223979|FG001|Overall Study|Lost to Follow-up|26|||
146194339|NCT03736785|527223980|FG000|Overall Study|Adverse Event|1|||
146194340|NCT03736785|527223981|FG001|Overall Study|Adverse Event|1|||
146194341|NCT03736785|527223982|FG002|Overall Study|Adverse Event|1|||
146194342|NCT03736785|527223980|FG000|Overall Study|Death|1|||
146194343|NCT03736785|527223981|FG001|Overall Study|Death|0|||
146194344|NCT03736785|527223982|FG002|Overall Study|Death|1|||
146194345|NCT03736785|527223980|FG000|Overall Study|Lost to Follow-up|0|||
146194346|NCT03736785|527223981|FG001|Overall Study|Lost to Follow-up|2|||
146194347|NCT03736785|527223982|FG002|Overall Study|Lost to Follow-up|3|||
146194348|NCT03736785|527223980|FG000|Overall Study|Non compliance with study drug|1|||
146194349|NCT03736785|527223981|FG001|Overall Study|Non compliance with study drug|1|||
146194350|NCT03736785|527223982|FG002|Overall Study|Non compliance with study drug|0|||
146194351|NCT03736785|527223980|FG000|Overall Study|Physician Decision|0|||
146194352|NCT03736785|527223981|FG001|Overall Study|Physician Decision|1|||
146194353|NCT03736785|527223982|FG002|Overall Study|Physician Decision|1|||
146194354|NCT03736785|527223980|FG000|Overall Study|Protocol Violation|1|||
146194355|NCT03736785|527223981|FG001|Overall Study|Protocol Violation|4|||
146194356|NCT03736785|527223982|FG002|Overall Study|Protocol Violation|3|||
146194357|NCT03736785|527223980|FG000|Overall Study|Sponsor Decision|1|||
146194358|NCT03736785|527223981|FG001|Overall Study|Sponsor Decision|0|||
146194359|NCT03736785|527223982|FG002|Overall Study|Sponsor Decision|0|||
146420760|NCT01179919|528047107|FG000|Overall Study|Protocol Violation|1|||
146420761|NCT01179919|528047107|FG000|Overall Study|Adverse Event|1|||
146420762|NCT00698685|528047111|FG000|Overall Study|Sister withdrew as donor|1|||
146420763|NCT00698685|528047111|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
146420764|NCT01513148|528047113|FG000|Overall Study|Protocol Violation|2|||
146420765|NCT01513148|528047114|FG001|Overall Study|Protocol Violation|2|||
146420766|NCT02795104|528047115|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
146420767|NCT02795104|528047116|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
146420768|NCT02795104|528047117|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
146420769|NCT02795104|528047115|FG000|Overall Study|Withdrawal by Subject|0|||
146420770|NCT02795104|528047116|FG001|Overall Study|Withdrawal by Subject|2|||
146420771|NCT02795104|528047117|FG002|Overall Study|Withdrawal by Subject|0|||
146420772|NCT02795104|528047115|FG000|Overall Study|Lost to Follow-up|0|||
146420773|NCT02795104|528047116|FG001|Overall Study|Lost to Follow-up|0|||
146420774|NCT02795104|528047117|FG002|Overall Study|Lost to Follow-up|1|||
146420775|NCT01654380|528047118|FG000|Part B, Period 1|Physician Decision|0|||
146420776|NCT01654380|528047119|FG001|Part B, Period 1|Physician Decision|0|||
146420777|NCT01654380|528047120|FG002|Part B, Period 1|Physician Decision|1|||
146420778|NCT01654380|528047121|FG003|Part B, Period 1|Physician Decision|0|||
146420779|NCT04128007|528047124|FG000|Overall Study|Withdrawal by Subject|9|||
146420780|NCT04128007|528047125|FG001|Overall Study|Withdrawal by Subject|6|||
146420781|NCT04128007|528047124|FG000|Overall Study|Protocol Violation|1|||
146420782|NCT04128007|528047125|FG001|Overall Study|Protocol Violation|0|||
146420783|NCT04128007|528047124|FG000|Overall Study|Lost to Follow-up|8|||
146420784|NCT04128007|528047125|FG001|Overall Study|Lost to Follow-up|7|||
146420785|NCT04128007|528047124|FG000|Overall Study|Adverse Event|5|||
146420786|NCT04128007|528047125|FG001|Overall Study|Adverse Event|2|||
146420787|NCT04128007|528047124|FG000|Overall Study|Not reported|0|||
146420788|NCT04128007|528047125|FG001|Overall Study|Not reported|2|||
146420789|NCT00429923|528047132|FG000|Overall Study|Adverse Event|0|||
146420790|NCT00429923|528047133|FG001|Overall Study|Adverse Event|2|||
146420791|NCT00429923|528047134|FG002|Overall Study|Adverse Event|3|||
146420792|NCT00429923|528047132|FG000|Overall Study|Lack of Efficacy|4|||
146420793|NCT00429923|528047133|FG001|Overall Study|Lack of Efficacy|1|||
146420794|NCT00429923|528047134|FG002|Overall Study|Lack of Efficacy|33|||
146420795|NCT00429923|528047132|FG000|Overall Study|Lost to Follow-up|0|||
146420796|NCT00429923|528047133|FG001|Overall Study|Lost to Follow-up|0|||
146420797|NCT00429923|528047134|FG002|Overall Study|Lost to Follow-up|2|||
146420798|NCT00429923|528047132|FG000|Overall Study|Withdrew Consent|1|||
146420799|NCT00429923|528047133|FG001|Overall Study|Withdrew Consent|0|||
146420800|NCT00429923|528047134|FG002|Overall Study|Withdrew Consent|1|||
146420801|NCT00429923|528047132|FG000|Overall Study|Early Termination|0|||
146420802|NCT00429923|528047133|FG001|Overall Study|Early Termination|1|||
146420803|NCT00429923|528047134|FG002|Overall Study|Early Termination|0|||
146420804|NCT01265784|528047135|FG000|Overall Study|Lost to Follow-up|5|||
146420805|NCT01265784|528047136|FG001|Overall Study|Lost to Follow-up|3|||
146420806|NCT01265784|528047137|FG002|Overall Study|Lost to Follow-up|2|||
146420807|NCT01265784|528047135|FG000|Overall Study|Withdrawal by Subject|0|||
146420808|NCT01265784|528047136|FG001|Overall Study|Withdrawal by Subject|5|||
146420809|NCT01265784|528047137|FG002|Overall Study|Withdrawal by Subject|0|||
146420810|NCT01265784|528047135|FG000|Overall Study|Physician Decision|1|||
146420811|NCT01265784|528047136|FG001|Overall Study|Physician Decision|0|||
146420812|NCT01265784|528047137|FG002|Overall Study|Physician Decision|1|||
146420813|NCT01265784|528047135|FG000|Overall Study|Adverse Event|1|||
146420814|NCT01265784|528047136|FG001|Overall Study|Adverse Event|0|||
146420815|NCT01265784|528047137|FG002|Overall Study|Adverse Event|0|||
146420816|NCT01265784|528047135|FG000|Overall Study|Death|3|||
146420817|NCT01265784|528047136|FG001|Overall Study|Death|0|||
146420818|NCT01265784|528047137|FG002|Overall Study|Death|0|||
146420819|NCT01265784|528047135|FG000|Overall Study|Protocol Violation|2|||
146420820|NCT01265784|528047136|FG001|Overall Study|Protocol Violation|0|||
146420821|NCT01265784|528047137|FG002|Overall Study|Protocol Violation|0|||
146420822|NCT01265784|528047135|FG000|Overall Study|Incorrectly Randomized|0|||
146420823|NCT01265784|528047136|FG001|Overall Study|Incorrectly Randomized|0|||
146420824|NCT01265784|528047137|FG002|Overall Study|Incorrectly Randomized|1|||
146420825|NCT01937364|528047138|FG000|Overall Study|Adverse Event|2|||
146420826|NCT01937364|528047139|FG001|Overall Study|Adverse Event|1|||
146420827|NCT04799158|528047140|FG000|Run-In Period|Adverse Event|6|||
146420828|NCT04799158|528047141|FG001|Run-In Period|Adverse Event|0|||
146420829|NCT04799158|528047142|FG002|Run-In Period|Adverse Event|0|||
146420830|NCT04799158|528047143|FG003|Run-In Period|Adverse Event|0|||
146420831|NCT04799158|528047144|FG004|Run-In Period|Adverse Event|0|||
146420832|NCT04799158|528047140|FG000|Run-In Period|Lost to Follow-up|4|||
146420833|NCT04799158|528047141|FG001|Run-In Period|Lost to Follow-up|0|||
146420834|NCT04799158|528047142|FG002|Run-In Period|Lost to Follow-up|0|||
146420835|NCT04799158|528047143|FG003|Run-In Period|Lost to Follow-up|0|||
146420836|NCT04799158|528047144|FG004|Run-In Period|Lost to Follow-up|0|||
146420837|NCT04799158|528047140|FG000|Run-In Period|Significant Protocol Deviation|1|||
146420838|NCT04799158|528047141|FG001|Run-In Period|Significant Protocol Deviation|0|||
146420839|NCT04799158|528047142|FG002|Run-In Period|Significant Protocol Deviation|0|||
146420840|NCT04799158|528047143|FG003|Run-In Period|Significant Protocol Deviation|0|||
146420841|NCT04799158|528047144|FG004|Run-In Period|Significant Protocol Deviation|0|||
146420842|NCT04799158|528047140|FG000|Run-In Period|Withdrawal by Subject|11|||
146420843|NCT04799158|528047141|FG001|Run-In Period|Withdrawal by Subject|0|||
146420844|NCT04799158|528047142|FG002|Run-In Period|Withdrawal by Subject|0|||
146420845|NCT04799158|528047143|FG003|Run-In Period|Withdrawal by Subject|0|||
146420846|NCT04799158|528047144|FG004|Run-In Period|Withdrawal by Subject|0|||
146420847|NCT04799158|528047140|FG000|Run-In Period|Miscellaneous|3|||
146420848|NCT04799158|528047141|FG001|Run-In Period|Miscellaneous|0|||
146420849|NCT04799158|528047142|FG002|Run-In Period|Miscellaneous|0|||
146420850|NCT04799158|528047143|FG003|Run-In Period|Miscellaneous|0|||
146420851|NCT04799158|528047144|FG004|Run-In Period|Miscellaneous|0|||
146420852|NCT04799158|528047140|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
146420853|NCT04799158|528047141|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146420854|NCT04799158|528047142|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146420855|NCT04799158|528047143|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
145948192|NCT02258334|526319602|FG000|Overall Study|Adverse Event|1|||
146420856|NCT04799158|528047144|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
146420857|NCT04799158|528047140|FG000|On-Demand Treatment Period|Adverse Event|0|||
146420858|NCT04799158|528047141|FG001|On-Demand Treatment Period|Adverse Event|1|||
146420859|NCT04799158|528047142|FG002|On-Demand Treatment Period|Adverse Event|0|||
146420860|NCT04799158|528047143|FG003|On-Demand Treatment Period|Adverse Event|0|||
146420861|NCT04799158|528047144|FG004|On-Demand Treatment Period|Adverse Event|1|||
146420862|NCT04799158|528047140|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
146420863|NCT04799158|528047141|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
146420864|NCT04799158|528047142|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
146420865|NCT04799158|528047143|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
146420866|NCT04799158|528047144|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
146420867|NCT04799158|528047140|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146420868|NCT04799158|528047141|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146420869|NCT04799158|528047142|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146420870|NCT04799158|528047143|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
146420871|NCT04799158|528047144|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
146420872|NCT04799158|528047140|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
146420873|NCT04799158|528047141|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
146420874|NCT04799158|528047142|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
146420875|NCT04799158|528047143|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
146420876|NCT04799158|528047144|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
146420877|NCT04799158|528047140|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
146420878|NCT04799158|528047141|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
146420879|NCT04799158|528047142|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
146420880|NCT04799158|528047143|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
146420881|NCT04799158|528047144|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
146420882|NCT04799158|528047140|FG000|On-Demand Treatment Period|Miscellaneous|0|||
146420883|NCT04799158|528047141|FG001|On-Demand Treatment Period|Miscellaneous|0|||
146420884|NCT04799158|528047142|FG002|On-Demand Treatment Period|Miscellaneous|0|||
146420885|NCT04799158|528047143|FG003|On-Demand Treatment Period|Miscellaneous|0|||
146420886|NCT04799158|528047144|FG004|On-Demand Treatment Period|Miscellaneous|1|||
146420887|NCT04104646|528047147|FG000|Overall Study|Withdrawal by Subject|1|||
146420888|NCT04104646|528047148|FG001|Overall Study|Withdrawal by Subject|1|||
146420889|NCT04104646|528047147|FG000|Overall Study|Lost to Follow-up|1|||
146420890|NCT04104646|528047148|FG001|Overall Study|Lost to Follow-up|0|||
146420891|NCT04104646|528047147|FG000|Overall Study|Physician Decision|2|||
146420892|NCT04104646|528047148|FG001|Overall Study|Physician Decision|0|||
146420893|NCT02607800|528047149|FG000|Overall Study|Lost to Follow-up|7|||
146420894|NCT02607800|528047150|FG001|Overall Study|Lost to Follow-up|10|||
146420895|NCT02607800|528047149|FG000|Overall Study|Withdrew Consent|2|||
146420896|NCT02607800|528047150|FG001|Overall Study|Withdrew Consent|0|||
145948193|NCT02258334|526319603|FG001|Overall Study|Adverse Event|0|||
145948194|NCT02258334|526319604|FG002|Overall Study|Adverse Event|0|||
145948195|NCT02258334|526319605|FG003|Overall Study|Adverse Event|0|||
145948196|NCT00564395|526319608|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
145948197|NCT00564395|526319609|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
145948198|NCT00564395|526319608|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
145948199|NCT00564395|526319609|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
145948200|NCT04776018|526319616|FG000|Overall Study|Death|0|||
145948201|NCT04776018|526319617|FG001|Overall Study|Death|1|||
145948202|NCT04776018|526319618|FG002|Overall Study|Death|4|||
145948203|NCT04776018|526319619|FG003|Overall Study|Death|1|||
145948204|NCT04776018|526319620|FG004|Overall Study|Death|4|||
145948205|NCT04776018|526319621|FG005|Overall Study|Death|0|||
145948206|NCT04776018|526319622|FG006|Overall Study|Death|0|||
145948207|NCT04776018|526319616|FG000|Overall Study|Study terminated by sponsor|2|||
145948208|NCT04776018|526319617|FG001|Overall Study|Study terminated by sponsor|1|||
145948209|NCT04776018|526319618|FG002|Overall Study|Study terminated by sponsor|4|||
145948210|NCT04776018|526319619|FG003|Overall Study|Study terminated by sponsor|0|||
145948211|NCT04776018|526319620|FG004|Overall Study|Study terminated by sponsor|3|||
145948212|NCT04776018|526319621|FG005|Overall Study|Study terminated by sponsor|0|||
146194360|NCT03736785|527223980|FG000|Overall Study|Unknown/Missing data|3|||
146194361|NCT03736785|527223981|FG001|Overall Study|Unknown/Missing data|2|||
145948213|NCT04776018|526319622|FG006|Overall Study|Study terminated by sponsor|0|||
145948214|NCT04776018|526319616|FG000|Overall Study|Withdrawal by Subject|1|||
145948215|NCT04776018|526319617|FG001|Overall Study|Withdrawal by Subject|0|||
145948216|NCT04776018|526319618|FG002|Overall Study|Withdrawal by Subject|0|||
145948217|NCT04776018|526319619|FG003|Overall Study|Withdrawal by Subject|2|||
145948218|NCT04776018|526319620|FG004|Overall Study|Withdrawal by Subject|1|||
146420897|NCT02607800|528047149|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
146420898|NCT02607800|528047150|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
146420899|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
146420900|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
146420901|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Death|0|||
146420902|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Death|1|||
145948219|NCT04776018|526319621|FG005|Overall Study|Withdrawal by Subject|0|||
145948220|NCT04776018|526319622|FG006|Overall Study|Withdrawal by Subject|0|||
146194362|NCT03736785|527223982|FG002|Overall Study|Unknown/Missing data|1|||
146420903|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
146420904|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
146420905|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
146420906|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
146420907|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
146420908|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
146420909|NCT01656889|528047151|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
146420910|NCT01656889|528047152|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
146420911|NCT01656889|528047151|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
146420912|NCT01656889|528047152|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
146420913|NCT01656889|528047151|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
146420914|NCT01656889|528047152|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
146420915|NCT01656889|528047151|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
146420916|NCT01656889|528047152|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
146420917|NCT01656889|528047151|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
146420918|NCT01656889|528047152|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
146420919|NCT01734772|528047156|FG000|Overall Study|Adverse Event|1|||
146420920|NCT01734772|528047157|FG001|Overall Study|Adverse Event|2|||
146420921|NCT01734772|528047156|FG000|Overall Study|Withdrawal by Subject|0|||
146420922|NCT01734772|528047157|FG001|Overall Study|Withdrawal by Subject|1|||
146420923|NCT00329602|528047159|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
146420924|NCT00329602|528047160|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
146420925|NCT00329602|528047161|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
146420926|NCT00329602|528047159|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
146420927|NCT00329602|528047160|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
146420928|NCT00329602|528047161|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
146420929|NCT00329602|528047159|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
146420930|NCT00329602|528047160|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
146420931|NCT00329602|528047161|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
146420932|NCT00329602|528047159|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
146420933|NCT00329602|528047160|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
146420934|NCT00329602|528047161|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
146420935|NCT00329602|528047159|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
146420936|NCT00329602|528047160|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
146420937|NCT00329602|528047161|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
146420938|NCT00329602|528047159|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
146420939|NCT00329602|528047160|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
146420940|NCT00329602|528047161|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
146420941|NCT02275364|528047162|FG000|Period 1|Withdrawal by Subject|1|||
146420942|NCT02275364|528047163|FG001|Period 1|Withdrawal by Subject|0|||
146420943|NCT02275364|528047162|FG000|Period 1|Other reason|1|||
146420944|NCT02275364|528047163|FG001|Period 1|Other reason|0|||
146420945|NCT00510510|528047164|FG000|Overall Study|Adverse Event|4|||
146420946|NCT00510510|528047165|FG001|Overall Study|Adverse Event|3|||
146420947|NCT00510510|528047166|FG002|Overall Study|Adverse Event|6|||
146420948|NCT00510510|528047164|FG000|Overall Study|Lack of Efficacy|0|||
146194363|NCT03736785|527223980|FG000|Overall Study|Withdrawal by Subject|9|||
146194364|NCT03736785|527223981|FG001|Overall Study|Withdrawal by Subject|6|||
146194365|NCT03736785|527223982|FG002|Overall Study|Withdrawal by Subject|4|||
146194366|NCT00320489|527223985|FG000|Overall Study|Adverse Event|26|||
146194367|NCT00320489|527223986|FG001|Overall Study|Adverse Event|25|||
146194368|NCT00320489|527223985|FG000|Overall Study|Clinical Relapse|26|||
146194369|NCT00320489|527223986|FG001|Overall Study|Clinical Relapse|20|||
146194370|NCT00320489|527223985|FG000|Overall Study|Death|0|||
146194371|NCT00320489|527223986|FG001|Overall Study|Death|2|||
146194372|NCT00320489|527223985|FG000|Overall Study|Entry Criteria Exclusion|2|||
146194373|NCT00320489|527223986|FG001|Overall Study|Entry Criteria Exclusion|4|||
146194374|NCT00320489|527223985|FG000|Overall Study|Lack of Efficacy|16|||
146194375|NCT00320489|527223986|FG001|Overall Study|Lack of Efficacy|7|||
146194376|NCT00320489|527223985|FG000|Overall Study|Lost to Follow-up|21|||
146194377|NCT00320489|527223986|FG001|Overall Study|Lost to Follow-up|22|||
146194378|NCT00320489|527223985|FG000|Overall Study|Physician Decision|8|||
146194379|NCT00320489|527223986|FG001|Overall Study|Physician Decision|8|||
146420949|NCT00510510|528047165|FG001|Overall Study|Lack of Efficacy|1|||
146420950|NCT00510510|528047166|FG002|Overall Study|Lack of Efficacy|1|||
146420951|NCT00510510|528047164|FG000|Overall Study|Subjects no longer requires study drug|0|||
146420952|NCT00510510|528047165|FG001|Overall Study|Subjects no longer requires study drug|0|||
146420953|NCT00510510|528047166|FG002|Overall Study|Subjects no longer requires study drug|2|||
146194380|NCT00320489|527223985|FG000|Overall Study|Protocol Violation|4|||
146420954|NCT00510510|528047164|FG000|Overall Study|Withdrawal by Subject|1|||
146420955|NCT00510510|528047165|FG001|Overall Study|Withdrawal by Subject|2|||
146420956|NCT00510510|528047166|FG002|Overall Study|Withdrawal by Subject|3|||
146420957|NCT00510510|528047164|FG000|Overall Study|Lost to Follow-up|0|||
146420958|NCT00510510|528047165|FG001|Overall Study|Lost to Follow-up|0|||
146420959|NCT00510510|528047166|FG002|Overall Study|Lost to Follow-up|1|||
146420960|NCT00510510|528047164|FG000|Overall Study|Protocol Violation|0|||
146420961|NCT00510510|528047165|FG001|Overall Study|Protocol Violation|3|||
146420962|NCT00510510|528047166|FG002|Overall Study|Protocol Violation|4|||
146420963|NCT03595657|528047167|FG000|Overall Study|Adverse Event|14|||
146420964|NCT03595657|528047167|FG000|Overall Study|Death|1|||
146420965|NCT03595657|528047167|FG000|Overall Study|Lack of Efficacy|40|||
146420966|NCT03595657|528047167|FG000|Overall Study|Withdrawal by Subject|10|||
146420967|NCT03595657|528047167|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
146420968|NCT03595657|528047167|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
146420969|NCT01066052|528047168|FG000|Overall Study|Enrolled But Not Treated|3|||
146420970|NCT01066052|528047169|FG001|Overall Study|Enrolled But Not Treated|0|||
146420971|NCT01200394|528047170|FG000|Overall Study|Adverse Event|0|||
146420972|NCT01200394|528047171|FG001|Overall Study|Adverse Event|14|||
146420973|NCT01200394|528047170|FG000|Overall Study|Death|1|||
146420974|NCT01200394|528047171|FG001|Overall Study|Death|0|||
146420975|NCT01200394|528047170|FG000|Overall Study|Lost to Follow-up|0|||
146420976|NCT01200394|528047171|FG001|Overall Study|Lost to Follow-up|1|||
146420977|NCT01200394|528047170|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146420978|NCT01200394|528047171|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
146420979|NCT01200394|528047170|FG000|Overall Study|Protocol Violation|0|||
146420980|NCT01200394|528047171|FG001|Overall Study|Protocol Violation|3|||
146420981|NCT01200394|528047170|FG000|Overall Study|Withdrawal by Subject|0|||
146420982|NCT01200394|528047171|FG001|Overall Study|Withdrawal by Subject|5|||
146420983|NCT01200394|528047170|FG000|Overall Study|Other|0|||
146420984|NCT01200394|528047171|FG001|Overall Study|Other|1|||
146420985|NCT02729896|528047176|FG000|Overall Study|Death|0|||
146420986|NCT02729896|528047177|FG001|Overall Study|Death|2|||
146420987|NCT02729896|528047178|FG002|Overall Study|Death|13|||
146194381|NCT00320489|527223986|FG001|Overall Study|Protocol Violation|4|||
146420988|NCT02729896|528047176|FG000|Overall Study|Lost to Follow-up|0|||
146420989|NCT02729896|528047177|FG001|Overall Study|Lost to Follow-up|2|||
146420990|NCT02729896|528047178|FG002|Overall Study|Lost to Follow-up|3|||
146420991|NCT02729896|528047176|FG000|Overall Study|Other|0|||
146420992|NCT02729896|528047177|FG001|Overall Study|Other|2|||
146420993|NCT02729896|528047178|FG002|Overall Study|Other|0|||
146420994|NCT02729896|528047176|FG000|Overall Study|Physician Decision|1|||
146420995|NCT02729896|528047177|FG001|Overall Study|Physician Decision|2|||
146194382|NCT00320489|527223985|FG000|Overall Study|Sponsor Decision|3|||
146194383|NCT00320489|527223986|FG001|Overall Study|Sponsor Decision|3|||
146420996|NCT02729896|528047178|FG002|Overall Study|Physician Decision|3|||
146420997|NCT02729896|528047176|FG000|Overall Study|Progressive Disease|0|||
146420998|NCT02729896|528047177|FG001|Overall Study|Progressive Disease|1|||
146420999|NCT02729896|528047178|FG002|Overall Study|Progressive Disease|0|||
146421000|NCT02729896|528047176|FG000|Overall Study|Withdrawal by Subject|1|||
146421001|NCT02729896|528047177|FG001|Overall Study|Withdrawal by Subject|0|||
146421002|NCT02729896|528047178|FG002|Overall Study|Withdrawal by Subject|3|||
146421003|NCT01835145|528047179|FG000|Overall Study|Ineligible prior to treatment|1|||
146421004|NCT01835145|528047180|FG001|Overall Study|Ineligible prior to treatment|0|||
146421005|NCT00582309|528047181|FG000|Overall Study|Protocol Violation|0|||
146421006|NCT00582309|528047182|FG001|Overall Study|Protocol Violation|0|||
146421007|NCT00582309|528047183|FG002|Overall Study|Protocol Violation|2|||
146421008|NCT04094870|528047187|FG000|Overall Study|Lost to Follow-up|1|||
146194384|NCT00320489|527223985|FG000|Overall Study|Withdrawal by Subject|39|||
146194385|NCT00320489|527223986|FG001|Overall Study|Withdrawal by Subject|41|||
146194386|NCT03441984|527223988|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194387|NCT03441984|527223989|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194388|NCT03441984|527223990|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
146194389|NCT03441984|527223991|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194390|NCT03441984|527223992|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194391|NCT03441984|527223993|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194392|NCT03441984|527223994|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194393|NCT03441984|527223995|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194394|NCT03441984|527223996|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194395|NCT03441984|527223997|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194396|NCT03441984|527223998|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146421009|NCT04094870|528047188|FG001|Overall Study|Lost to Follow-up|1|||
146421010|NCT02708277|528047190|FG000|Overall Study|Lost to Follow-up|7|||
145948221|NCT04776018|526319616|FG000|Overall Study|Other|0|||
145948222|NCT04776018|526319617|FG001|Overall Study|Other|1|||
146421011|NCT02708277|528047191|FG001|Overall Study|Lost to Follow-up|4|||
146421012|NCT01058421|528047192|FG000|1 Month Outcomes|Death|10|||
146421013|NCT01058421|528047193|FG001|1 Month Outcomes|Death|6|||
146421014|NCT01058421|528047192|FG000|1 Month Outcomes|Lost to Follow-up|8|||
146421015|NCT01058421|528047193|FG001|1 Month Outcomes|Lost to Follow-up|7|||
146421016|NCT01058421|528047192|FG000|1 Month Outcomes|Remained in Hospital|5|||
146421017|NCT01058421|528047193|FG001|1 Month Outcomes|Remained in Hospital|12|||
146421018|NCT01058421|528047192|FG000|1 Month Outcomes|Remained in Other Facility|16|||
146421019|NCT01058421|528047193|FG001|1 Month Outcomes|Remained in Other Facility|17|||
146421020|NCT01058421|528047192|FG000|3 Month Outcomes|Death|3|||
146421021|NCT01058421|528047193|FG001|3 Month Outcomes|Death|5|||
146421022|NCT01058421|528047192|FG000|3 Month Outcomes|Lost to Follow-up|12|||
146421023|NCT01058421|528047193|FG001|3 Month Outcomes|Lost to Follow-up|11|||
146421024|NCT01058421|528047192|FG000|3 Month Outcomes|Remained in Hospital|0|||
146421025|NCT01058421|528047193|FG001|3 Month Outcomes|Remained in Hospital|2|||
146421026|NCT01058421|528047192|FG000|3 Month Outcomes|Remained in Other Facility|5|||
146421027|NCT01058421|528047193|FG001|3 Month Outcomes|Remained in Other Facility|8|||
146421028|NCT01058421|528047192|FG000|6 Month Outcomes|Death|2|||
146421029|NCT01058421|528047193|FG001|6 Month Outcomes|Death|2|||
146421030|NCT01058421|528047192|FG000|6 Month Outcomes|Lost to Follow-up|16|||
146421031|NCT01058421|528047193|FG001|6 Month Outcomes|Lost to Follow-up|21|||
146421032|NCT01058421|528047192|FG000|6 Month Outcomes|Remained in Other Facility|1|||
146421033|NCT01058421|528047193|FG001|6 Month Outcomes|Remained in Other Facility|3|||
146421034|NCT02984683|528047196|FG000|Overall Study|Adverse Event|3|||
146421035|NCT02984683|528047197|FG001|Overall Study|Adverse Event|3|||
146421036|NCT02984683|528047196|FG000|Overall Study|Withdrawal by Subject|1|||
146421037|NCT02984683|528047197|FG001|Overall Study|Withdrawal by Subject|0|||
146421038|NCT02984683|528047196|FG000|Overall Study|Disease progression|7|||
146421039|NCT02984683|528047197|FG001|Overall Study|Disease progression|9|||
146421040|NCT02415959|528047202|FG000|Overall Study|Adverse Event|0|||
146421041|NCT02415959|528047203|FG001|Overall Study|Adverse Event|1|||
146421042|NCT02415959|528047204|FG002|Overall Study|Adverse Event|0|||
146421043|NCT02415959|528047205|FG003|Overall Study|Adverse Event|0|||
146421044|NCT02415959|528047206|FG004|Overall Study|Adverse Event|0|||
146421045|NCT02415959|528047202|FG000|Overall Study|Protocol Violation|0|||
146421046|NCT02415959|528047203|FG001|Overall Study|Protocol Violation|0|||
146421047|NCT02415959|528047204|FG002|Overall Study|Protocol Violation|0|||
146421048|NCT02415959|528047205|FG003|Overall Study|Protocol Violation|1|||
146421049|NCT02415959|528047206|FG004|Overall Study|Protocol Violation|0|||
146421050|NCT03008460|528047211|FG000|Overall Study|Protocol deviation|0|||
146421051|NCT03008460|528047212|FG001|Overall Study|Protocol deviation|2|||
146421052|NCT03008460|528047211|FG000|Overall Study|Study drug not dispensed|0|||
146421053|NCT03008460|528047212|FG001|Overall Study|Study drug not dispensed|1|||
146421054|NCT03008460|528047211|FG000|Overall Study|Adverse Event|0|||
146421055|NCT03008460|528047212|FG001|Overall Study|Adverse Event|1|||
146421056|NCT03008460|528047211|FG000|Overall Study|Withdrawal by Subject|5|||
146421057|NCT03008460|528047212|FG001|Overall Study|Withdrawal by Subject|6|||
146421058|NCT03008460|528047211|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
146421059|NCT03008460|528047212|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
146421060|NCT03008460|528047211|FG000|Overall Study|End of study visit outside permitted time window|0|||
146421061|NCT03008460|528047212|FG001|Overall Study|End of study visit outside permitted time window|1|||
146421062|NCT03008460|528047211|FG000|Overall Study|Lost to Follow-up|1|||
146421063|NCT03008460|528047212|FG001|Overall Study|Lost to Follow-up|3|||
146421064|NCT03495869|528047219|FG000|Overall Study|Lost to Follow-up|4|||
146421065|NCT03495869|528047220|FG001|Overall Study|Lost to Follow-up|17|||
146421066|NCT03495869|528047221|FG002|Overall Study|Lost to Follow-up|8|||
146421067|NCT03495869|528047222|FG003|Overall Study|Lost to Follow-up|14|||
146421068|NCT03495869|528047219|FG000|Overall Study|Withdrawal by Subject|0|||
146421069|NCT03495869|528047220|FG001|Overall Study|Withdrawal by Subject|3|||
146421070|NCT03495869|528047221|FG002|Overall Study|Withdrawal by Subject|0|||
146421071|NCT03495869|528047222|FG003|Overall Study|Withdrawal by Subject|3|||
146421072|NCT03495869|528047219|FG000|Overall Study|Dropped from study|0|||
146421073|NCT03495869|528047220|FG001|Overall Study|Dropped from study|7|||
146421074|NCT03495869|528047221|FG002|Overall Study|Dropped from study|2|||
146421075|NCT03495869|528047222|FG003|Overall Study|Dropped from study|4|||
146421076|NCT04634409|528047223|FG000|Overall Study|Death|0|||
146421077|NCT04634409|528047224|FG001|Overall Study|Death|0|||
146421078|NCT04634409|528047225|FG002|Overall Study|Death|0|||
146421079|NCT04634409|528047226|FG003|Overall Study|Death|0|||
146421080|NCT04634409|528047227|FG004|Overall Study|Death|0|||
146421081|NCT04634409|528047228|FG005|Overall Study|Death|0|||
146421082|NCT04634409|528047229|FG006|Overall Study|Death|0|||
146421083|NCT04634409|528047230|FG007|Overall Study|Death|0|||
146421084|NCT04634409|528047231|FG008|Overall Study|Death|0|||
146421085|NCT04634409|528047232|FG009|Overall Study|Death|0|||
146421086|NCT04634409|528047233|FG010|Overall Study|Death|1|||
146421087|NCT04634409|528047234|FG011|Overall Study|Death|0|||
146421088|NCT04634409|528047235|FG012|Overall Study|Death|1|||
146421089|NCT04634409|528047236|FG013|Overall Study|Death|0|||
146421090|NCT04634409|528047237|FG014|Overall Study|Death|0|||
146421091|NCT04634409|528047238|FG015|Overall Study|Death|0|||
146421092|NCT04634409|528047239|FG016|Overall Study|Death|0|||
146421093|NCT04634409|528047240|FG017|Overall Study|Death|0|||
146421094|NCT04634409|528047241|FG018|Overall Study|Death|0|||
146421095|NCT04634409|528047242|FG019|Overall Study|Death|0|||
146421096|NCT04634409|528047243|FG020|Overall Study|Death|0|||
146421097|NCT04634409|528047244|FG021|Overall Study|Death|0|||
146421098|NCT04634409|528047245|FG022|Overall Study|Death|0|||
146421099|NCT04634409|528047246|FG023|Overall Study|Death|0|||
146421100|NCT04634409|528047247|FG024|Overall Study|Death|0|||
146421101|NCT04634409|528047248|FG025|Overall Study|Death|0|||
146421102|NCT04634409|528047249|FG026|Overall Study|Death|0|||
146421103|NCT04634409|528047223|FG000|Overall Study|Adverse Event|0|||
146421104|NCT04634409|528047224|FG001|Overall Study|Adverse Event|0|||
146421105|NCT04634409|528047225|FG002|Overall Study|Adverse Event|1|||
146421106|NCT04634409|528047226|FG003|Overall Study|Adverse Event|0|||
146421107|NCT04634409|528047227|FG004|Overall Study|Adverse Event|0|||
146421108|NCT04634409|528047228|FG005|Overall Study|Adverse Event|1|||
146421109|NCT04634409|528047229|FG006|Overall Study|Adverse Event|0|||
146194397|NCT03441984|527223999|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
146194398|NCT01190150|527224003|FG000|First Treatment|Withdrawal by Subject|1|||
146194399|NCT01190150|527224004|FG001|First Treatment|Withdrawal by Subject|0|||
146421110|NCT04634409|528047230|FG007|Overall Study|Adverse Event|0|||
146421111|NCT04634409|528047231|FG008|Overall Study|Adverse Event|0|||
146421112|NCT04634409|528047232|FG009|Overall Study|Adverse Event|0|||
146421113|NCT04634409|528047233|FG010|Overall Study|Adverse Event|0|||
146421114|NCT04634409|528047234|FG011|Overall Study|Adverse Event|0|||
146421115|NCT04634409|528047235|FG012|Overall Study|Adverse Event|0|||
146421116|NCT04634409|528047236|FG013|Overall Study|Adverse Event|0|||
146421117|NCT04634409|528047237|FG014|Overall Study|Adverse Event|0|||
146421118|NCT04634409|528047238|FG015|Overall Study|Adverse Event|0|||
146421119|NCT04634409|528047239|FG016|Overall Study|Adverse Event|0|||
146421120|NCT04634409|528047240|FG017|Overall Study|Adverse Event|0|||
146421121|NCT04634409|528047241|FG018|Overall Study|Adverse Event|0|||
146421122|NCT04634409|528047242|FG019|Overall Study|Adverse Event|0|||
146421123|NCT04634409|528047243|FG020|Overall Study|Adverse Event|0|||
146421124|NCT04634409|528047244|FG021|Overall Study|Adverse Event|0|||
146421125|NCT04634409|528047245|FG022|Overall Study|Adverse Event|0|||
146421126|NCT04634409|528047246|FG023|Overall Study|Adverse Event|0|||
146421127|NCT04634409|528047247|FG024|Overall Study|Adverse Event|0|||
146421128|NCT04634409|528047248|FG025|Overall Study|Adverse Event|0|||
146421129|NCT04634409|528047249|FG026|Overall Study|Adverse Event|0|||
146421130|NCT04634409|528047223|FG000|Overall Study|Lost to Follow-up|3|||
146421131|NCT04634409|528047224|FG001|Overall Study|Lost to Follow-up|1|||
146421132|NCT04634409|528047225|FG002|Overall Study|Lost to Follow-up|1|||
146421133|NCT04634409|528047226|FG003|Overall Study|Lost to Follow-up|3|||
146421134|NCT04634409|528047227|FG004|Overall Study|Lost to Follow-up|1|||
146421135|NCT04634409|528047228|FG005|Overall Study|Lost to Follow-up|1|||
146421136|NCT04634409|528047229|FG006|Overall Study|Lost to Follow-up|1|||
146421137|NCT04634409|528047230|FG007|Overall Study|Lost to Follow-up|3|||
146421138|NCT04634409|528047231|FG008|Overall Study|Lost to Follow-up|3|||
146421139|NCT04634409|528047232|FG009|Overall Study|Lost to Follow-up|11|||
146421140|NCT04634409|528047233|FG010|Overall Study|Lost to Follow-up|8|||
146421141|NCT04634409|528047234|FG011|Overall Study|Lost to Follow-up|15|||
146421142|NCT04634409|528047235|FG012|Overall Study|Lost to Follow-up|3|||
146421143|NCT04634409|528047236|FG013|Overall Study|Lost to Follow-up|2|||
146421144|NCT04634409|528047237|FG014|Overall Study|Lost to Follow-up|7|||
146421145|NCT04634409|528047238|FG015|Overall Study|Lost to Follow-up|0|||
146421146|NCT04634409|528047239|FG016|Overall Study|Lost to Follow-up|0|||
146421147|NCT04634409|528047240|FG017|Overall Study|Lost to Follow-up|0|||
146421148|NCT04634409|528047241|FG018|Overall Study|Lost to Follow-up|0|||
146421149|NCT04634409|528047242|FG019|Overall Study|Lost to Follow-up|0|||
146421150|NCT04634409|528047243|FG020|Overall Study|Lost to Follow-up|0|||
145948223|NCT04776018|526319618|FG002|Overall Study|Other|1|||
146421151|NCT04634409|528047244|FG021|Overall Study|Lost to Follow-up|0|||
146421152|NCT04634409|528047245|FG022|Overall Study|Lost to Follow-up|0|||
146421153|NCT04634409|528047246|FG023|Overall Study|Lost to Follow-up|0|||
146421154|NCT04634409|528047247|FG024|Overall Study|Lost to Follow-up|0|||
146421155|NCT04634409|528047248|FG025|Overall Study|Lost to Follow-up|0|||
146421156|NCT04634409|528047249|FG026|Overall Study|Lost to Follow-up|0|||
146421157|NCT04634409|528047223|FG000|Overall Study|Withdrawal by Subject|3|||
146421158|NCT04634409|528047224|FG001|Overall Study|Withdrawal by Subject|1|||
146421159|NCT04634409|528047225|FG002|Overall Study|Withdrawal by Subject|6|||
146421160|NCT04634409|528047226|FG003|Overall Study|Withdrawal by Subject|4|||
146421161|NCT04634409|528047227|FG004|Overall Study|Withdrawal by Subject|2|||
146421162|NCT04634409|528047228|FG005|Overall Study|Withdrawal by Subject|0|||
146421163|NCT04634409|528047229|FG006|Overall Study|Withdrawal by Subject|0|||
146421164|NCT04634409|528047230|FG007|Overall Study|Withdrawal by Subject|2|||
146421165|NCT04634409|528047231|FG008|Overall Study|Withdrawal by Subject|3|||
146421166|NCT04634409|528047232|FG009|Overall Study|Withdrawal by Subject|2|||
146421167|NCT04634409|528047233|FG010|Overall Study|Withdrawal by Subject|3|||
146421168|NCT04634409|528047234|FG011|Overall Study|Withdrawal by Subject|2|||
146421169|NCT04634409|528047235|FG012|Overall Study|Withdrawal by Subject|2|||
146421170|NCT04634409|528047236|FG013|Overall Study|Withdrawal by Subject|1|||
146421171|NCT04634409|528047237|FG014|Overall Study|Withdrawal by Subject|5|||
146421172|NCT04634409|528047238|FG015|Overall Study|Withdrawal by Subject|0|||
146421173|NCT04634409|528047239|FG016|Overall Study|Withdrawal by Subject|0|||
146421174|NCT04634409|528047240|FG017|Overall Study|Withdrawal by Subject|1|||
146421175|NCT04634409|528047241|FG018|Overall Study|Withdrawal by Subject|0|||
146421176|NCT04634409|528047242|FG019|Overall Study|Withdrawal by Subject|0|||
146421177|NCT04634409|528047243|FG020|Overall Study|Withdrawal by Subject|0|||
146421178|NCT04634409|528047244|FG021|Overall Study|Withdrawal by Subject|0|||
146421179|NCT04634409|528047245|FG022|Overall Study|Withdrawal by Subject|0|||
146421180|NCT04634409|528047246|FG023|Overall Study|Withdrawal by Subject|1|||
146421181|NCT04634409|528047247|FG024|Overall Study|Withdrawal by Subject|0|||
146421182|NCT04634409|528047248|FG025|Overall Study|Withdrawal by Subject|0|||
146421183|NCT04634409|528047249|FG026|Overall Study|Withdrawal by Subject|0|||
146421184|NCT04634409|528047223|FG000|Overall Study|Other - As reported by Investigator|1|||
146421185|NCT04634409|528047224|FG001|Overall Study|Other - As reported by Investigator|0|||
146421186|NCT04634409|528047225|FG002|Overall Study|Other - As reported by Investigator|0|||
146421187|NCT04634409|528047226|FG003|Overall Study|Other - As reported by Investigator|0|||
146421188|NCT04634409|528047227|FG004|Overall Study|Other - As reported by Investigator|0|||
146082486|NCT02431260|526822820|FG010|Overall Study|Death|3|||
146082487|NCT02431260|526822821|FG011|Overall Study|Death|2|||
146082488|NCT02431260|526822822|FG012|Overall Study|Death|5|||
146082489|NCT02431260|526822823|FG013|Overall Study|Death|1|||
146082490|NCT02431260|526822810|FG000|Overall Study|Lost to Follow-up|0|||
146082491|NCT02431260|526822811|FG001|Overall Study|Lost to Follow-up|0|||
146082492|NCT02431260|526822812|FG002|Overall Study|Lost to Follow-up|0|||
146082493|NCT02431260|526822813|FG003|Overall Study|Lost to Follow-up|0|||
146082494|NCT02431260|526822814|FG004|Overall Study|Lost to Follow-up|0|||
146082495|NCT02431260|526822815|FG005|Overall Study|Lost to Follow-up|1|||
146082496|NCT02431260|526822816|FG006|Overall Study|Lost to Follow-up|0|||
146082497|NCT02431260|526822817|FG007|Overall Study|Lost to Follow-up|0|||
146082498|NCT02431260|526822818|FG008|Overall Study|Lost to Follow-up|0|||
146194400|NCT01190150|527224003|FG000|Washout|Withdrawal by Subject|0|||
146194401|NCT01190150|527224004|FG001|Washout|Withdrawal by Subject|1|||
146194402|NCT01190150|527224003|FG000|Washout|Difficulty in adherence|0|||
146194403|NCT01190150|527224004|FG001|Washout|Difficulty in adherence|1|||
146194404|NCT00746330|527224006|FG000|Period 1|Abnormal test procedure result|0|||
146194405|NCT00746330|527224007|FG001|Period 1|Abnormal test procedure result|0|||
146194406|NCT00746330|527224008|FG002|Period 1|Abnormal test procedure result|1|||
146194407|NCT00746330|527224009|FG003|Period 1|Abnormal test procedure result|0|||
146194408|NCT01467700|527224010|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
146194409|NCT01467700|527224011|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
146194410|NCT01467700|527224012|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
146194411|NCT01467700|527224013|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
146194412|NCT01467700|527224010|FG000|Overall Study|Major Protocol Deviation|3|||
146194413|NCT01467700|527224011|FG001|Overall Study|Major Protocol Deviation|3|||
146194414|NCT01467700|527224012|FG002|Overall Study|Major Protocol Deviation|2|||
146194415|NCT01467700|527224013|FG003|Overall Study|Major Protocol Deviation|3|||
146194416|NCT01467700|527224010|FG000|Overall Study|Lost to Follow-up|6|||
146194417|NCT01467700|527224011|FG001|Overall Study|Lost to Follow-up|5|||
146194418|NCT01467700|527224012|FG002|Overall Study|Lost to Follow-up|2|||
146194419|NCT01467700|527224013|FG003|Overall Study|Lost to Follow-up|3|||
146194420|NCT01467700|527224010|FG000|Overall Study|Voluntary Withdrawal|5|||
146194421|NCT01467700|527224011|FG001|Overall Study|Voluntary Withdrawal|7|||
146194422|NCT01467700|527224012|FG002|Overall Study|Voluntary Withdrawal|6|||
146194423|NCT01467700|527224013|FG003|Overall Study|Voluntary Withdrawal|2|||
146194424|NCT01467700|527224010|FG000|Overall Study|Study Termination|6|||
146194425|NCT01467700|527224011|FG001|Overall Study|Study Termination|5|||
146194426|NCT01467700|527224012|FG002|Overall Study|Study Termination|10|||
146194427|NCT01467700|527224013|FG003|Overall Study|Study Termination|7|||
146194428|NCT01467700|527224010|FG000|Overall Study|Pregnancy|0|||
146194429|NCT01467700|527224011|FG001|Overall Study|Pregnancy|1|||
146194430|NCT01467700|527224012|FG002|Overall Study|Pregnancy|1|||
146194431|NCT01467700|527224013|FG003|Overall Study|Pregnancy|0|||
146194432|NCT01467700|527224010|FG000|Overall Study|Lack of Efficacy|2|||
146194433|NCT01467700|527224011|FG001|Overall Study|Lack of Efficacy|0|||
146194434|NCT01467700|527224012|FG002|Overall Study|Lack of Efficacy|2|||
146194435|NCT01467700|527224013|FG003|Overall Study|Lack of Efficacy|1|||
146194436|NCT01467700|527224010|FG000|Overall Study|Reason not Specified|1|||
146194437|NCT01467700|527224011|FG001|Overall Study|Reason not Specified|3|||
146194438|NCT01467700|527224012|FG002|Overall Study|Reason not Specified|2|||
146194439|NCT01467700|527224013|FG003|Overall Study|Reason not Specified|8|||
146194440|NCT03523962|527224014|FG000|Closed Fractures|Death|86|||
146194441|NCT03523962|527224015|FG001|Closed Fractures|Death|71|||
146194442|NCT03523962|527224016|FG002|Closed Fractures|Death|0|||
146194443|NCT03523962|527224017|FG003|Closed Fractures|Death|0|||
146194444|NCT03523962|527224014|FG000|Closed Fractures|Lost to Follow-up|62|||
146194445|NCT03523962|527224015|FG001|Closed Fractures|Lost to Follow-up|36|||
146194446|NCT03523962|527224016|FG002|Closed Fractures|Lost to Follow-up|0|||
146194447|NCT03523962|527224017|FG003|Closed Fractures|Lost to Follow-up|0|||
146194448|NCT03523962|527224014|FG000|Closed Fractures|Withdrawal by Subject|19|||
146194449|NCT03523962|527224015|FG001|Closed Fractures|Withdrawal by Subject|29|||
146194450|NCT03523962|527224016|FG002|Closed Fractures|Withdrawal by Subject|0|||
146194451|NCT03523962|527224017|FG003|Closed Fractures|Withdrawal by Subject|0|||
146194452|NCT03523962|527224014|FG000|Closed Fractures|Incarceration|1|||
146194453|NCT03523962|527224015|FG001|Closed Fractures|Incarceration|4|||
146194454|NCT03523962|527224016|FG002|Closed Fractures|Incarceration|0|||
146194455|NCT03523962|527224017|FG003|Closed Fractures|Incarceration|0|||
146194456|NCT03523962|527224014|FG000|Open Fractures|Death|0|||
146194457|NCT03523962|527224015|FG001|Open Fractures|Death|0|||
146194458|NCT03523962|527224016|FG002|Open Fractures|Death|11|||
146194459|NCT03523962|527224017|FG003|Open Fractures|Death|6|||
146082499|NCT02431260|526822819|FG009|Overall Study|Lost to Follow-up|0|||
146082500|NCT02431260|526822820|FG010|Overall Study|Lost to Follow-up|0|||
146082501|NCT02431260|526822821|FG011|Overall Study|Lost to Follow-up|0|||
146082502|NCT02431260|526822822|FG012|Overall Study|Lost to Follow-up|0|||
146194460|NCT03523962|527224014|FG000|Open Fractures|Lost to Follow-up|0|||
146194461|NCT03523962|527224015|FG001|Open Fractures|Lost to Follow-up|0|||
146194462|NCT03523962|527224016|FG002|Open Fractures|Lost to Follow-up|15|||
146421189|NCT04634409|528047228|FG005|Overall Study|Other - As reported by Investigator|0|||
146421190|NCT04634409|528047229|FG006|Overall Study|Other - As reported by Investigator|0|||
146421191|NCT04634409|528047230|FG007|Overall Study|Other - As reported by Investigator|6|||
146421192|NCT04634409|528047231|FG008|Overall Study|Other - As reported by Investigator|4|||
146421193|NCT04634409|528047232|FG009|Overall Study|Other - As reported by Investigator|0|||
146421194|NCT04634409|528047233|FG010|Overall Study|Other - As reported by Investigator|1|||
146421195|NCT04634409|528047234|FG011|Overall Study|Other - As reported by Investigator|2|||
146421196|NCT04634409|528047235|FG012|Overall Study|Other - As reported by Investigator|2|||
146421197|NCT04634409|528047236|FG013|Overall Study|Other - As reported by Investigator|1|||
146421198|NCT04634409|528047237|FG014|Overall Study|Other - As reported by Investigator|0|||
146421199|NCT04634409|528047238|FG015|Overall Study|Other - As reported by Investigator|0|||
146421200|NCT04634409|528047239|FG016|Overall Study|Other - As reported by Investigator|0|||
146421201|NCT04634409|528047240|FG017|Overall Study|Other - As reported by Investigator|0|||
146421202|NCT04634409|528047241|FG018|Overall Study|Other - As reported by Investigator|0|||
146421203|NCT04634409|528047242|FG019|Overall Study|Other - As reported by Investigator|0|||
146421204|NCT04634409|528047243|FG020|Overall Study|Other - As reported by Investigator|0|||
146421205|NCT04634409|528047244|FG021|Overall Study|Other - As reported by Investigator|0|||
146421206|NCT04634409|528047245|FG022|Overall Study|Other - As reported by Investigator|0|||
146421207|NCT04634409|528047246|FG023|Overall Study|Other - As reported by Investigator|0|||
146421208|NCT04634409|528047247|FG024|Overall Study|Other - As reported by Investigator|0|||
146421209|NCT04634409|528047248|FG025|Overall Study|Other - As reported by Investigator|0|||
146421210|NCT04634409|528047249|FG026|Overall Study|Other - As reported by Investigator|0|||
146421211|NCT01497938|528047250|FG000|Overall Study|Adverse Event|0|||
146421212|NCT01497938|528047251|FG001|Overall Study|Adverse Event|1|||
146421213|NCT01497938|528047250|FG000|Overall Study|Physician Decision|0|||
146421214|NCT01497938|528047251|FG001|Overall Study|Physician Decision|1|||
146421215|NCT01497938|528047250|FG000|Overall Study|Withdrawal by Subject|4|||
146421216|NCT01497938|528047251|FG001|Overall Study|Withdrawal by Subject|0|||
146421217|NCT01497938|528047250|FG000|Overall Study|Device Violation|1|||
146421218|NCT01497938|528047251|FG001|Overall Study|Device Violation|0|||
146421219|NCT00365352|528047252|FG000|Overall Study|Adverse Event|6|||
146421220|NCT00365352|528047253|FG001|Overall Study|Adverse Event|7|||
146421221|NCT00365352|528047254|FG002|Overall Study|Adverse Event|8|||
146421222|NCT00365352|528047252|FG000|Overall Study|Participant Withdrew Consent|8|||
146421223|NCT00365352|528047253|FG001|Overall Study|Participant Withdrew Consent|3|||
146421224|NCT00365352|528047254|FG002|Overall Study|Participant Withdrew Consent|4|||
146421225|NCT00365352|528047252|FG000|Overall Study|Lack of Efficacy|3|||
146421226|NCT00365352|528047253|FG001|Overall Study|Lack of Efficacy|0|||
146421227|NCT00365352|528047254|FG002|Overall Study|Lack of Efficacy|0|||
146421228|NCT00365352|528047252|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
146421229|NCT00365352|528047253|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
146421230|NCT00365352|528047254|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
146421231|NCT00365352|528047252|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
146421232|NCT00365352|528047253|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
146421233|NCT00365352|528047254|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
146421234|NCT00365352|528047252|FG000|Overall Study|Lost to Follow-up|1|||
146421235|NCT00365352|528047253|FG001|Overall Study|Lost to Follow-up|1|||
146421236|NCT00365352|528047254|FG002|Overall Study|Lost to Follow-up|0|||
146421237|NCT00365352|528047252|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
146421238|NCT00365352|528047253|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
146421239|NCT00365352|528047254|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
146421240|NCT00462982|528047259|FG000|Overall Study|Adverse Event|1|||
146421241|NCT00462982|528047259|FG000|Overall Study|Patient Not Treated|2|||
146421242|NCT02448771|528047262|FG000|Overall Study|Disease Progression|30|||
146421243|NCT02448771|528047262|FG000|Overall Study|Unacceptable Toxicity|1|||
146421244|NCT02448771|528047262|FG000|Overall Study|Physician Decision|3|||
146421245|NCT02448771|528047262|FG000|Overall Study|Started new therapy|2|||
146421246|NCT02683187|528047264|FG000|Overall Study|Failed IV access|3|||
146421247|NCT02683187|528047264|FG000|Overall Study|Withdrawal by Subject|5|||
146421248|NCT00770315|528047265|FG000|Overall Study|Adverse Event|11|||
146421249|NCT00770315|528047266|FG001|Overall Study|Adverse Event|17|||
146421250|NCT00770315|528047267|FG002|Overall Study|Adverse Event|16|||
146421251|NCT00770315|528047268|FG003|Overall Study|Adverse Event|6|||
146421252|NCT00770315|528047265|FG000|Overall Study|Lost to Follow-up|9|||
146421253|NCT00770315|528047266|FG001|Overall Study|Lost to Follow-up|5|||
146421254|NCT00770315|528047267|FG002|Overall Study|Lost to Follow-up|10|||
146421255|NCT00770315|528047268|FG003|Overall Study|Lost to Follow-up|3|||
146421256|NCT00770315|528047265|FG000|Overall Study|Withdrawal by Subject|13|||
146421257|NCT00770315|528047266|FG001|Overall Study|Withdrawal by Subject|17|||
146421258|NCT00770315|528047267|FG002|Overall Study|Withdrawal by Subject|24|||
146421259|NCT00770315|528047268|FG003|Overall Study|Withdrawal by Subject|20|||
146421260|NCT00770315|528047265|FG000|Overall Study|Noncompliance with Protocol|7|||
146421261|NCT00770315|528047266|FG001|Overall Study|Noncompliance with Protocol|4|||
146421262|NCT00770315|528047267|FG002|Overall Study|Noncompliance with Protocol|7|||
146194463|NCT03523962|527224017|FG003|Open Fractures|Lost to Follow-up|8|||
146194464|NCT03523962|527224014|FG000|Open Fractures|Withdrawal by Subject|0|||
146194465|NCT03523962|527224015|FG001|Open Fractures|Withdrawal by Subject|0|||
146194466|NCT03523962|527224016|FG002|Open Fractures|Withdrawal by Subject|6|||
146194467|NCT03523962|527224017|FG003|Open Fractures|Withdrawal by Subject|2|||
146421263|NCT00770315|528047268|FG003|Overall Study|Noncompliance with Protocol|9|||
146421264|NCT04256421|528047271|FG000|Overall Study|Death|171|||
146421265|NCT04256421|528047272|FG001|Overall Study|Death|180|||
146421266|NCT04256421|528047271|FG000|Overall Study|Lost to Follow-up|1|||
146421267|NCT04256421|528047272|FG001|Overall Study|Lost to Follow-up|1|||
146421268|NCT04256421|528047271|FG000|Overall Study|Withdrawal by Subject|9|||
146421269|NCT04256421|528047272|FG001|Overall Study|Withdrawal by Subject|10|||
146421270|NCT04256421|528047271|FG000|Overall Study|Ongoing in Study|66|||
146421271|NCT04256421|528047272|FG001|Overall Study|Ongoing in Study|52|||
146194468|NCT03523962|527224014|FG000|Open Fractures|Incarceration|0|||
145948224|NCT04776018|526319619|FG003|Overall Study|Other|0|||
145948225|NCT04776018|526319620|FG004|Overall Study|Other|0|||
145948226|NCT04776018|526319621|FG005|Overall Study|Other|0|||
145948227|NCT04776018|526319622|FG006|Overall Study|Other|0|||
145948228|NCT04776018|526319616|FG000|Overall Study|Lost to Follow-up|0|||
145948229|NCT04776018|526319617|FG001|Overall Study|Lost to Follow-up|0|||
145948230|NCT04776018|526319618|FG002|Overall Study|Lost to Follow-up|1|||
145948231|NCT04776018|526319619|FG003|Overall Study|Lost to Follow-up|0|||
145948232|NCT04776018|526319620|FG004|Overall Study|Lost to Follow-up|0|||
145948233|NCT04776018|526319621|FG005|Overall Study|Lost to Follow-up|0|||
145948234|NCT04776018|526319622|FG006|Overall Study|Lost to Follow-up|0|||
145948235|NCT00594386|526319623|FG000|Overall Study|Major protocol violation|2|||
145948236|NCT00594386|526319623|FG000|Overall Study|Lack of Efficacy|12|||
145948237|NCT00594386|526319623|FG000|Overall Study|Adverse Event|68|||
145948238|NCT00594386|526319623|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
145948239|NCT00594386|526319623|FG000|Overall Study|Subject withdrew consent|35|||
145948240|NCT00594386|526319623|FG000|Overall Study|Study ended per sponsor|115|||
145948241|NCT00594386|526319623|FG000|Overall Study|Lost to Follow-up|6|||
145948242|NCT00594386|526319623|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
145948243|NCT00594386|526319623|FG000|Overall Study|Other: Subject moved to Seattle|1|||
145948244|NCT00594386|526319623|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
145948245|NCT00594386|526319623|FG000|Overall Study|Other: Study terminated per investigator|2|||
145948246|NCT00594386|526319623|FG000|Overall Study|Other: Sponsor closure of study|1|||
145948247|NCT00594386|526319623|FG000|Overall Study|Other: Site terminated participation|1|||
145948248|NCT00594386|526319623|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
145948249|NCT00594386|526319623|FG000|Overall Study|Other: Loss of drivers license|1|||
145948250|NCT02195427|526319624|FG000|Overall Study|Did not consent to study extension|13|||
145948251|NCT02195427|526319625|FG001|Overall Study|Did not consent to study extension|9|||
145948252|NCT02195427|526319624|FG000|Overall Study|Withdrawal by Subject|4|||
145948253|NCT02195427|526319625|FG001|Overall Study|Withdrawal by Subject|2|||
145948254|NCT02195427|526319624|FG000|Overall Study|Lost to Follow-up|0|||
145948255|NCT02195427|526319625|FG001|Overall Study|Lost to Follow-up|1|||
145948256|NCT02195427|526319624|FG000|Overall Study|Protocol Violation|7|||
145948257|NCT02195427|526319625|FG001|Overall Study|Protocol Violation|14|||
145948258|NCT02195427|526319624|FG000|Overall Study|Conditional re-treatment at W52|2|||
145948259|NCT02195427|526319625|FG001|Overall Study|Conditional re-treatment at W52|1|||
145948260|NCT01210144|526319629|FG000|Overall Study|Lack of ovarian response|1|||
145948261|NCT01210144|526319630|FG001|Overall Study|Lack of ovarian response|0|||
145948262|NCT01210144|526319629|FG000|Overall Study|No fertilization|1|||
145948263|NCT01210144|526319630|FG001|Overall Study|No fertilization|0|||
145948264|NCT01210144|526319629|FG000|Overall Study|No transfer|1|||
145948265|NCT01210144|526319630|FG001|Overall Study|No transfer|0|||
145948266|NCT02678000|526319631|FG000|PART 2|Adverse Event|0|||
145948267|NCT02678000|526319632|FG001|PART 2|Adverse Event|0|||
145948268|NCT02678000|526319633|FG002|PART 2|Adverse Event|2|||
145948269|NCT02678000|526319634|FG003|PART 2|Adverse Event|1|||
145948270|NCT02678000|526319635|FG004|PART 2|Adverse Event|0|||
145948271|NCT02678000|526319631|FG000|PART 2|Withdrawal by Subject|0|||
145948272|NCT02678000|526319632|FG001|PART 2|Withdrawal by Subject|0|||
145948273|NCT02678000|526319633|FG002|PART 2|Withdrawal by Subject|1|||
145948274|NCT02678000|526319634|FG003|PART 2|Withdrawal by Subject|0|||
145948275|NCT02678000|526319635|FG004|PART 2|Withdrawal by Subject|0|||
145948276|NCT02360475|526319636|FG000|Overall Study|Lost to Follow-up|4|||
145948277|NCT02360475|526319637|FG001|Overall Study|Lost to Follow-up|12|||
145948278|NCT02360475|526319638|FG002|Overall Study|Lost to Follow-up|6|||
145948279|NCT02360475|526319639|FG003|Overall Study|Lost to Follow-up|4|||
145948280|NCT02360475|526319636|FG000|Overall Study|Withdrawal by Subject|0|||
145948281|NCT02360475|526319637|FG001|Overall Study|Withdrawal by Subject|1|||
145948282|NCT02360475|526319638|FG002|Overall Study|Withdrawal by Subject|2|||
145948283|NCT02360475|526319639|FG003|Overall Study|Withdrawal by Subject|0|||
145948284|NCT02360475|526319636|FG000|Overall Study|Migrated/moved from study area|0|||
145948285|NCT02360475|526319637|FG001|Overall Study|Migrated/moved from study area|0|||
145948286|NCT02360475|526319638|FG002|Overall Study|Migrated/moved from study area|0|||
145948287|NCT02360475|526319639|FG003|Overall Study|Migrated/moved from study area|1|||
145948288|NCT03759366|526319641|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
145948289|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
145948290|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
145948291|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
145948292|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
145948293|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
145948294|NCT03759366|526319641|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
145948295|NCT04226495|526319642|FG000|Overall Study|Withdrawal by Subject|3|||
145948296|NCT04226495|526319643|FG001|Overall Study|Withdrawal by Subject|3|||
145948297|NCT04226495|526319642|FG000|Overall Study|PI discretion|3|||
145948298|NCT04226495|526319643|FG001|Overall Study|PI discretion|4|||
145948299|NCT00435019|526319644|FG000|Overall Study|Adverse Event|1|||
145948300|NCT00435019|526319645|FG001|Overall Study|Adverse Event|0|||
145948301|NCT00435019|526319644|FG000|Overall Study|Lack of Efficacy|1|||
145948302|NCT00435019|526319645|FG001|Overall Study|Lack of Efficacy|2|||
145948303|NCT00435019|526319644|FG000|Overall Study|Protocol Violation|3|||
145948304|NCT00435019|526319645|FG001|Overall Study|Protocol Violation|1|||
145948305|NCT00435019|526319644|FG000|Overall Study|Personal reasons for withdrawal|8|||
145948306|NCT00435019|526319645|FG001|Overall Study|Personal reasons for withdrawal|7|||
145948307|NCT00505661|526319650|FG000|Overall Study|Not Eligible|4|||
145948308|NCT04459598|526319653|FG000|Overall Study|Adverse Event|1|||
145948309|NCT04459598|526319654|FG001|Overall Study|Adverse Event|1|||
145948310|NCT01907217|526319655|FG000|Overall Study|Withdrawal by Subject|0|||
145948311|NCT01907217|526319656|FG001|Overall Study|Withdrawal by Subject|2|||
145948312|NCT00866333|526319663|FG000|Overall Study|Withdrawal of consent|0|||
145948313|NCT00866333|526319664|FG001|Overall Study|Withdrawal of consent|1|||
145948314|NCT00866333|526319665|FG002|Overall Study|Withdrawal of consent|2|||
145948315|NCT00866333|526319663|FG000|Overall Study|Reason not Specified|3|||
145948316|NCT00866333|526319664|FG001|Overall Study|Reason not Specified|1|||
145948317|NCT00866333|526319665|FG002|Overall Study|Reason not Specified|1|||
145948318|NCT00866333|526319663|FG000|Overall Study|Study Terminated by Sponsor|2|||
145948319|NCT00866333|526319664|FG001|Overall Study|Study Terminated by Sponsor|5|||
146194469|NCT03523962|527224015|FG001|Open Fractures|Incarceration|0|||
146194470|NCT03523962|527224016|FG002|Open Fractures|Incarceration|1|||
146194471|NCT03523962|527224017|FG003|Open Fractures|Incarceration|0|||
146194472|NCT01081145|527224027|FG000|Open-Label Phase|Lack of Efficacy|56|||
146194473|NCT01081145|527224028|FG001|Open-Label Phase|Lack of Efficacy|0|||
145948320|NCT00866333|526319665|FG002|Overall Study|Study Terminated by Sponsor|9|||
145948321|NCT01764659|526319666|FG000|Overall Study|Death|1|||
145948322|NCT01764659|526319666|FG000|Overall Study|Physician Decision|1|||
145948323|NCT01210352|526319667|FG000|Overall Study|Adverse Event|0|||
145948324|NCT01210352|526319668|FG001|Overall Study|Adverse Event|0|||
145948325|NCT01210352|526319669|FG002|Overall Study|Adverse Event|0|||
145948326|NCT01210352|526319670|FG003|Overall Study|Adverse Event|0|||
145948327|NCT01210352|526319671|FG004|Overall Study|Adverse Event|0|||
145948328|NCT01210352|526319672|FG005|Overall Study|Adverse Event|0|||
145948329|NCT01210352|526319673|FG006|Overall Study|Adverse Event|0|||
145948330|NCT01210352|526319674|FG007|Overall Study|Adverse Event|2|||
145948331|NCT01210352|526319675|FG008|Overall Study|Adverse Event|1|||
145948332|NCT01210352|526319667|FG000|Overall Study|Lack of Efficacy|0|||
145948333|NCT01210352|526319668|FG001|Overall Study|Lack of Efficacy|0|||
145948334|NCT01210352|526319669|FG002|Overall Study|Lack of Efficacy|0|||
145948335|NCT01210352|526319670|FG003|Overall Study|Lack of Efficacy|0|||
145948336|NCT01210352|526319671|FG004|Overall Study|Lack of Efficacy|0|||
145948337|NCT01210352|526319672|FG005|Overall Study|Lack of Efficacy|0|||
145948338|NCT01210352|526319673|FG006|Overall Study|Lack of Efficacy|1|||
145948339|NCT01210352|526319674|FG007|Overall Study|Lack of Efficacy|0|||
145948340|NCT01210352|526319675|FG008|Overall Study|Lack of Efficacy|0|||
145948341|NCT01210352|526319667|FG000|Overall Study|Physician Decision|0|||
145948342|NCT01210352|526319668|FG001|Overall Study|Physician Decision|0|||
145948343|NCT01210352|526319669|FG002|Overall Study|Physician Decision|0|||
145948344|NCT01210352|526319670|FG003|Overall Study|Physician Decision|0|||
145948345|NCT01210352|526319671|FG004|Overall Study|Physician Decision|0|||
145948346|NCT01210352|526319672|FG005|Overall Study|Physician Decision|0|||
145948347|NCT01210352|526319673|FG006|Overall Study|Physician Decision|0|||
145948348|NCT01210352|526319674|FG007|Overall Study|Physician Decision|1|||
145948349|NCT01210352|526319675|FG008|Overall Study|Physician Decision|2|||
145948350|NCT01210352|526319667|FG000|Overall Study|Withdrawal by Subject|0|||
146194474|NCT01081145|527224027|FG000|Open-Label Phase|Response criteria not met|46|||
146194475|NCT01081145|527224028|FG001|Open-Label Phase|Response criteria not met|0|||
146194476|NCT01081145|527224027|FG000|Open-Label Phase|Adverse Event|42|||
146194477|NCT01081145|527224028|FG001|Open-Label Phase|Adverse Event|0|||
146194478|NCT01081145|527224027|FG000|Open-Label Phase|Withdrawal by Subject|41|||
145948351|NCT01210352|526319668|FG001|Overall Study|Withdrawal by Subject|0|||
145948352|NCT01210352|526319669|FG002|Overall Study|Withdrawal by Subject|1|||
145948353|NCT01210352|526319670|FG003|Overall Study|Withdrawal by Subject|0|||
145948354|NCT01210352|526319671|FG004|Overall Study|Withdrawal by Subject|0|||
145948355|NCT01210352|526319672|FG005|Overall Study|Withdrawal by Subject|0|||
145948356|NCT01210352|526319673|FG006|Overall Study|Withdrawal by Subject|1|||
145948357|NCT01210352|526319674|FG007|Overall Study|Withdrawal by Subject|0|||
145948358|NCT01210352|526319675|FG008|Overall Study|Withdrawal by Subject|1|||
145948359|NCT01210352|526319667|FG000|Overall Study|Patient Discharged Early|0|||
145948360|NCT01210352|526319668|FG001|Overall Study|Patient Discharged Early|0|||
145948361|NCT01210352|526319669|FG002|Overall Study|Patient Discharged Early|1|||
145948362|NCT01210352|526319670|FG003|Overall Study|Patient Discharged Early|0|||
146082503|NCT02431260|526822823|FG013|Overall Study|Lost to Follow-up|0|||
146421298|NCT05514119|528049059|FG000|Overall Study|Ineligible due to disease progression|1|||
146421299|NCT00278200|528049060|FG000|Overall Study|Death|1|||
146421300|NCT00278200|528049061|FG001|Overall Study|Death|3|||
146421301|NCT00278200|528049060|FG000|Overall Study|Physician Decision|0|||
146421302|NCT00278200|528049061|FG001|Overall Study|Physician Decision|1|||
146421303|NCT05568225|528049062|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
146421304|NCT05568225|528049063|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
146421305|NCT05568225|528049064|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
146421306|NCT05568225|528049062|FG000|Primary Treatment Period|Physician Decision|0|||
146421307|NCT05568225|528049063|FG001|Primary Treatment Period|Physician Decision|1|||
146421308|NCT05568225|528049064|FG002|Primary Treatment Period|Physician Decision|0|||
146421309|NCT05568225|528049062|FG000|Primary Treatment Period|Disease progression|0|||
146421310|NCT05568225|528049063|FG001|Primary Treatment Period|Disease progression|1|||
146421311|NCT05568225|528049064|FG002|Primary Treatment Period|Disease progression|0|||
146421312|NCT05568225|528049062|FG000|Primary Treatment Period|Lack of Efficacy|0|||
146421313|NCT05568225|528049063|FG001|Primary Treatment Period|Lack of Efficacy|1|||
146421314|NCT05568225|528049064|FG002|Primary Treatment Period|Lack of Efficacy|0|||
146421315|NCT05568225|528049062|FG000|Primary Treatment Period|Withdrawal of conset|1|||
146421316|NCT05568225|528049063|FG001|Primary Treatment Period|Withdrawal of conset|0|||
146421317|NCT05568225|528049064|FG002|Primary Treatment Period|Withdrawal of conset|4|||
146421318|NCT05568225|528049062|FG000|Primary Treatment Period|Adverse Event|1|||
146421319|NCT05568225|528049063|FG001|Primary Treatment Period|Adverse Event|0|||
146421320|NCT05568225|528049064|FG002|Primary Treatment Period|Adverse Event|0|||
146421321|NCT05568225|528049062|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
146421322|NCT05568225|528049063|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
146421323|NCT05568225|528049064|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
146421324|NCT05568225|528049062|FG000|Extension Treatment Period|Protocol Violation|0|||
146421325|NCT05568225|528049063|FG001|Extension Treatment Period|Protocol Violation|0|||
146421326|NCT05568225|528049064|FG002|Extension Treatment Period|Protocol Violation|1|||
146421327|NCT05568225|528049062|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146421328|NCT05568225|528049063|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146421329|NCT05568225|528049064|FG002|Extension Treatment Period|Lack of Efficacy|1|||
146421330|NCT01290263|528049065|FG000|Overall Study|Adverse Event|0|||
146421331|NCT01290263|528049066|FG001|Overall Study|Adverse Event|0|||
146421332|NCT01290263|528049067|FG002|Overall Study|Adverse Event|0|||
146421333|NCT01290263|528049068|FG003|Overall Study|Adverse Event|1|||
146421334|NCT01290263|528049069|FG004|Overall Study|Adverse Event|1|||
146421335|NCT01290263|528049065|FG000|Overall Study|Lack of Efficacy|8|||
146421336|NCT01290263|528049066|FG001|Overall Study|Lack of Efficacy|2|||
146421337|NCT01290263|528049067|FG002|Overall Study|Lack of Efficacy|7|||
146421338|NCT01290263|528049068|FG003|Overall Study|Lack of Efficacy|24|||
146421339|NCT01290263|528049069|FG004|Overall Study|Lack of Efficacy|33|||
146421340|NCT01290263|528049065|FG000|Overall Study|Withdrawal by Subject|3|||
146421341|NCT01290263|528049066|FG001|Overall Study|Withdrawal by Subject|1|||
146421342|NCT01290263|528049067|FG002|Overall Study|Withdrawal by Subject|0|||
146421343|NCT01290263|528049068|FG003|Overall Study|Withdrawal by Subject|1|||
146421344|NCT01290263|528049069|FG004|Overall Study|Withdrawal by Subject|2|||
146421345|NCT01290263|528049065|FG000|Overall Study|Participant Non-Compliance|0|||
146421346|NCT01290263|528049066|FG001|Overall Study|Participant Non-Compliance|0|||
146194479|NCT01081145|527224028|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146194480|NCT01081145|527224027|FG000|Open-Label Phase|Other|12|||
146421347|NCT01290263|528049067|FG002|Overall Study|Participant Non-Compliance|0|||
146194481|NCT01081145|527224028|FG001|Open-Label Phase|Other|0|||
146194482|NCT01081145|527224027|FG000|Open-Label Phase|Lost to Follow-up|11|||
146194483|NCT01081145|527224028|FG001|Open-Label Phase|Lost to Follow-up|0|||
146194484|NCT01081145|527224027|FG000|Open-Label Phase|Protocol Violation|4|||
146194485|NCT01081145|527224028|FG001|Open-Label Phase|Protocol Violation|0|||
146194486|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
146194487|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
146194488|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
146194489|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
146194490|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
146194491|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
146194492|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
146194493|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
146194494|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
146194495|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
146421348|NCT01290263|528049068|FG003|Overall Study|Participant Non-Compliance|1|||
146421349|NCT01290263|528049069|FG004|Overall Study|Participant Non-Compliance|1|||
146421350|NCT01521559|528049070|FG000|Overall Study|Adverse Event|0|||
146421351|NCT01521559|528049071|FG001|Overall Study|Adverse Event|4|||
146421352|NCT01521559|528049070|FG000|Overall Study|Death|1|||
146421353|NCT01521559|528049071|FG001|Overall Study|Death|0|||
146421354|NCT01521559|528049070|FG000|Overall Study|Withdrawal by Subject|9|||
146421355|NCT01521559|528049071|FG001|Overall Study|Withdrawal by Subject|11|||
146421356|NCT01521559|528049070|FG000|Overall Study|Lost to Follow-up|3|||
146421357|NCT01521559|528049071|FG001|Overall Study|Lost to Follow-up|1|||
146421358|NCT01521559|528049070|FG000|Overall Study|Protocol Violation|1|||
146421359|NCT01521559|528049071|FG001|Overall Study|Protocol Violation|0|||
146421360|NCT01521559|528049070|FG000|Overall Study|Other|1|||
146421361|NCT01521559|528049071|FG001|Overall Study|Other|2|||
146421362|NCT02228382|528049072|FG000|Overall Study|Death|5|||
146421363|NCT02228382|528049073|FG001|Overall Study|Death|7|||
146421364|NCT02228382|528049074|FG002|Overall Study|Death|5|||
146421365|NCT02228382|528049075|FG003|Overall Study|Death|0|||
146421366|NCT02228382|528049076|FG004|Overall Study|Death|2|||
146421367|NCT02228382|528049072|FG000|Overall Study|Participant refused further follow-up|0|||
146421368|NCT02228382|528049073|FG001|Overall Study|Participant refused further follow-up|0|||
146421369|NCT02228382|528049074|FG002|Overall Study|Participant refused further follow-up|1|||
146421370|NCT02228382|528049075|FG003|Overall Study|Participant refused further follow-up|0|||
146421371|NCT02228382|528049076|FG004|Overall Study|Participant refused further follow-up|0|||
146421372|NCT02228382|528049072|FG000|Overall Study|Study terminated by sponsor|3|||
146421373|NCT02228382|528049073|FG001|Overall Study|Study terminated by sponsor|5|||
146421374|NCT02228382|528049074|FG002|Overall Study|Study terminated by sponsor|7|||
146421375|NCT02228382|528049075|FG003|Overall Study|Study terminated by sponsor|0|||
146421376|NCT02228382|528049076|FG004|Overall Study|Study terminated by sponsor|0|||
146421377|NCT02228382|528049072|FG000|Overall Study|Lost to Follow-up|0|||
146421378|NCT02228382|528049073|FG001|Overall Study|Lost to Follow-up|0|||
146421379|NCT02228382|528049074|FG002|Overall Study|Lost to Follow-up|3|||
146421380|NCT02228382|528049075|FG003|Overall Study|Lost to Follow-up|1|||
146421381|NCT02228382|528049076|FG004|Overall Study|Lost to Follow-up|0|||
146421382|NCT02228382|528049072|FG000|Overall Study|Withdrawal by Subject|0|||
146421383|NCT02228382|528049073|FG001|Overall Study|Withdrawal by Subject|3|||
146421384|NCT02228382|528049074|FG002|Overall Study|Withdrawal by Subject|2|||
146421385|NCT02228382|528049075|FG003|Overall Study|Withdrawal by Subject|1|||
146421386|NCT02228382|528049076|FG004|Overall Study|Withdrawal by Subject|0|||
146421387|NCT02228382|528049072|FG000|Overall Study|Other|2|||
146421388|NCT02228382|528049073|FG001|Overall Study|Other|3|||
146421389|NCT02228382|528049074|FG002|Overall Study|Other|3|||
146421390|NCT02228382|528049075|FG003|Overall Study|Other|0|||
146421391|NCT02228382|528049076|FG004|Overall Study|Other|0|||
146421392|NCT02918162|528049078|FG000|Overall Study|Withdrawal by Subject|1|||
146421393|NCT02918162|528049078|FG000|Overall Study|Omental Disease|1|||
146421394|NCT00395226|528049079|FG000|Overall Study|Adverse Event|4|||
146421395|NCT00395226|528049080|FG001|Overall Study|Adverse Event|3|||
146421396|NCT00395226|528049079|FG000|Overall Study|Withdrawal by Subject|0|||
146421397|NCT00395226|528049080|FG001|Overall Study|Withdrawal by Subject|1|||
146421398|NCT00395226|528049079|FG000|Overall Study|Lost to Follow-up|0|||
146421399|NCT00395226|528049080|FG001|Overall Study|Lost to Follow-up|1|||
146421400|NCT00576381|528049084|FG000|Overall Study|Reoperation|3|||
146421401|NCT00576381|528049084|FG000|Overall Study|Adverse Event|4|||
146421402|NCT02324465|528049088|FG000|Overall Study|device failure|0|||
146421403|NCT02324465|528049089|FG001|Overall Study|device failure|1|||
146421404|NCT01031537|528049090|FG000|Overall Study|medical reasons not related to study|3|||
146421405|NCT01031537|528049090|FG000|Overall Study|Lack of Efficacy|1|||
146421406|NCT01031537|528049090|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
146421407|NCT01031537|528049090|FG000|Overall Study|moved, met exclusion criteria|10|||
146421408|NCT01031537|528049090|FG000|Overall Study|Withdrawal by Subject|5|||
146421409|NCT01031537|528049090|FG000|Overall Study|PI removal, no longer met eligibility|12|||
146421410|NCT02492958|528049098|FG000|Overall Study|Withdrawal by Subject|0|||
146421411|NCT02492958|528049099|FG001|Overall Study|Withdrawal by Subject|0|||
146421412|NCT02492958|528049100|FG002|Overall Study|Withdrawal by Subject|1|||
146421413|NCT02492958|528049101|FG003|Overall Study|Withdrawal by Subject|0|||
146421414|NCT02492958|528049098|FG000|Overall Study|Adverse Event|1|||
146421415|NCT02492958|528049099|FG001|Overall Study|Adverse Event|0|||
146421416|NCT02492958|528049100|FG002|Overall Study|Adverse Event|1|||
146421417|NCT02492958|528049101|FG003|Overall Study|Adverse Event|0|||
146421418|NCT03522948|528049102|FG000|Overall Study|Lost to Follow-up|1|||
146421419|NCT02187042|528049105|FG000|Overall Study|Death|1|||
146421420|NCT02187042|528049106|FG001|Overall Study|Death|1|||
146421421|NCT02187042|528049105|FG000|Overall Study|Toxicity|6|||
146421422|NCT02187042|528049106|FG001|Overall Study|Toxicity|5|||
146421423|NCT02187042|528049105|FG000|Overall Study|Participant choice|1|||
146421424|NCT02187042|528049106|FG001|Overall Study|Participant choice|0|||
146421425|NCT02187042|528049105|FG000|Overall Study|Doctor choice|1|||
146194496|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
146194497|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
146194498|NCT01081145|527224027|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
146194499|NCT01081145|527224028|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
146194500|NCT00121199|527224030|FG000|Overall Study|Adverse Event|11|||
146194501|NCT00121199|527224030|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146194502|NCT00121199|527224030|FG000|Overall Study|Progression/Relapse|1|||
146194503|NCT00121199|527224030|FG000|Overall Study|Death|3|||
146194504|NCT00121199|527224030|FG000|Overall Study|Other - Not Protocol Specified|3|||
146194505|NCT00121199|527224030|FG000|Overall Study|Ineligible|9|||
146194506|NCT03168438|527224031|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
146194507|NCT03168438|527224032|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
146194508|NCT03235349|527224037|FG000|Overall Study|Adverse Event|1|||
146194509|NCT03235349|527224037|FG000|Overall Study|Other|1|||
146194510|NCT01018511|527224039|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
146194511|NCT01018511|527224040|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
146194512|NCT01018511|527224041|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
146194513|NCT01018511|527224042|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
146194514|NCT01018511|527224039|FG000|Overall Study|Adverse Event|5|||
146194515|NCT01018511|527224040|FG001|Overall Study|Adverse Event|9|||
146194516|NCT01018511|527224041|FG002|Overall Study|Adverse Event|13|||
146194517|NCT01018511|527224042|FG003|Overall Study|Adverse Event|10|||
146194518|NCT01018511|527224039|FG000|Overall Study|Lack of Efficacy|4|||
146194519|NCT01018511|527224040|FG001|Overall Study|Lack of Efficacy|1|||
146194520|NCT01018511|527224041|FG002|Overall Study|Lack of Efficacy|1|||
146194521|NCT01018511|527224042|FG003|Overall Study|Lack of Efficacy|2|||
146194522|NCT01018511|527224039|FG000|Overall Study|Withdrawal by Subject|6|||
146194523|NCT01018511|527224040|FG001|Overall Study|Withdrawal by Subject|5|||
146194524|NCT01018511|527224041|FG002|Overall Study|Withdrawal by Subject|11|||
146194525|NCT01018511|527224042|FG003|Overall Study|Withdrawal by Subject|9|||
146194526|NCT01018511|527224039|FG000|Overall Study|Lost to Follow-up|0|||
146194527|NCT01018511|527224040|FG001|Overall Study|Lost to Follow-up|0|||
146194528|NCT01018511|527224041|FG002|Overall Study|Lost to Follow-up|1|||
146194529|NCT01018511|527224042|FG003|Overall Study|Lost to Follow-up|0|||
146194530|NCT01018511|527224039|FG000|Overall Study|Protocol Violation|5|||
146194531|NCT01018511|527224040|FG001|Overall Study|Protocol Violation|8|||
146194532|NCT01018511|527224041|FG002|Overall Study|Protocol Violation|7|||
146194533|NCT01018511|527224042|FG003|Overall Study|Protocol Violation|9|||
146194534|NCT01018511|527224039|FG000|Overall Study|Miscellaneous|0|||
146194535|NCT01018511|527224040|FG001|Overall Study|Miscellaneous|2|||
146194536|NCT01018511|527224041|FG002|Overall Study|Miscellaneous|0|||
146194537|NCT01018511|527224042|FG003|Overall Study|Miscellaneous|0|||
146194538|NCT04523181|527224043|FG000|Overall Study|Withdrawal by Subject|4|||
146194539|NCT04523181|527224044|FG001|Overall Study|Withdrawal by Subject|5|||
146194540|NCT04523181|527224043|FG000|Overall Study|Lost to Follow-up|2|||
146194541|NCT04523181|527224044|FG001|Overall Study|Lost to Follow-up|3|||
146194542|NCT04523181|527224043|FG000|Overall Study|Physician Decision|1|||
146194543|NCT04523181|527224044|FG001|Overall Study|Physician Decision|0|||
146194544|NCT04523181|527224043|FG000|Overall Study|Transferred to external facility.|1|||
146194545|NCT04523181|527224044|FG001|Overall Study|Transferred to external facility.|1|||
146194546|NCT04305912|527224045|FG000|First Intervention|COVID-19 Suspension|2|||
146421426|NCT02187042|528049106|FG001|Overall Study|Doctor choice|0|||
146421427|NCT02187042|528049105|FG000|Overall Study|Progressive disease|4|||
146421428|NCT02187042|528049106|FG001|Overall Study|Progressive disease|8|||
146421429|NCT00337571|528049110|FG000|Overall Study|Lack of Efficacy|3|||
146421430|NCT00337571|528049111|FG001|Overall Study|Lack of Efficacy|0|||
146421431|NCT00337571|528049112|FG002|Overall Study|Lack of Efficacy|0|||
146421432|NCT00337571|528049113|FG003|Overall Study|Lack of Efficacy|0|||
146421433|NCT00337571|528049110|FG000|Overall Study|Adverse Event|4|||
146421434|NCT00337571|528049111|FG001|Overall Study|Adverse Event|5|||
146421435|NCT00337571|528049112|FG002|Overall Study|Adverse Event|8|||
146421436|NCT00337571|528049113|FG003|Overall Study|Adverse Event|4|||
146421437|NCT00337571|528049110|FG000|Overall Study|Withdrawal by Subject|2|||
146421438|NCT00337571|528049111|FG001|Overall Study|Withdrawal by Subject|2|||
146421439|NCT00337571|528049112|FG002|Overall Study|Withdrawal by Subject|1|||
146421440|NCT00337571|528049113|FG003|Overall Study|Withdrawal by Subject|0|||
146421441|NCT00337571|528049110|FG000|Overall Study|Lost to Follow-up|3|||
146421442|NCT00337571|528049111|FG001|Overall Study|Lost to Follow-up|1|||
146421443|NCT00337571|528049112|FG002|Overall Study|Lost to Follow-up|0|||
146421444|NCT00337571|528049113|FG003|Overall Study|Lost to Follow-up|1|||
146421445|NCT00337571|528049110|FG000|Overall Study|Poor/noncompliance|1|||
146421446|NCT00337571|528049111|FG001|Overall Study|Poor/noncompliance|1|||
146421447|NCT00337571|528049112|FG002|Overall Study|Poor/noncompliance|1|||
146421448|NCT00337571|528049113|FG003|Overall Study|Poor/noncompliance|1|||
146421449|NCT00337571|528049110|FG000|Overall Study|No longer met study criteria|1|||
146421450|NCT00337571|528049111|FG001|Overall Study|No longer met study criteria|0|||
146421451|NCT00337571|528049112|FG002|Overall Study|No longer met study criteria|0|||
146421452|NCT00337571|528049113|FG003|Overall Study|No longer met study criteria|0|||
146421453|NCT00337571|528049110|FG000|Overall Study|High Potassium level|0|||
146421454|NCT00337571|528049111|FG001|Overall Study|High Potassium level|0|||
146421455|NCT00337571|528049112|FG002|Overall Study|High Potassium level|0|||
146421456|NCT00337571|528049113|FG003|Overall Study|High Potassium level|1|||
146421457|NCT00948675|528049114|FG000|Overall Study|Lost to Follow-up|1|||
146421458|NCT00948675|528049115|FG001|Overall Study|Lost to Follow-up|0|||
146421459|NCT00449150|528049116|FG000|Overall Study|Adverse Event|11|||
146421460|NCT00449150|528049117|FG001|Overall Study|Adverse Event|18|||
146421461|NCT00449150|528049118|FG002|Overall Study|Adverse Event|9|||
146421462|NCT00449150|528049116|FG000|Overall Study|Lack of Efficacy|1|||
146421463|NCT00449150|528049117|FG001|Overall Study|Lack of Efficacy|2|||
146421464|NCT00449150|528049118|FG002|Overall Study|Lack of Efficacy|2|||
146421465|NCT00449150|528049116|FG000|Overall Study|Other|16|||
146421466|NCT00449150|528049117|FG001|Overall Study|Other|13|||
146421467|NCT00449150|528049118|FG002|Overall Study|Other|14|||
146421468|NCT00449150|528049116|FG000|Overall Study|Withdrawal by Subject|17|||
146421469|NCT00449150|528049117|FG001|Overall Study|Withdrawal by Subject|18|||
146421470|NCT00449150|528049118|FG002|Overall Study|Withdrawal by Subject|21|||
146421471|NCT00449150|528049116|FG000|Overall Study|Protocol Violation|1|||
146421472|NCT00449150|528049117|FG001|Overall Study|Protocol Violation|2|||
146421473|NCT00449150|528049118|FG002|Overall Study|Protocol Violation|1|||
146421474|NCT03552757|528049119|FG000|Overall Study|Withdrawal by Subject|10|||
146421475|NCT03552757|528049120|FG001|Overall Study|Withdrawal by Subject|5|||
146421476|NCT03552757|528049121|FG002|Overall Study|Withdrawal by Subject|12|||
146421477|NCT03552757|528049119|FG000|Overall Study|Lost to Follow-up|2|||
146421478|NCT03552757|528049120|FG001|Overall Study|Lost to Follow-up|7|||
146421479|NCT03552757|528049121|FG002|Overall Study|Lost to Follow-up|7|||
146421480|NCT03552757|528049119|FG000|Overall Study|Death|1|||
146421481|NCT03552757|528049120|FG001|Overall Study|Death|1|||
146421482|NCT03552757|528049121|FG002|Overall Study|Death|1|||
146421483|NCT06331156|528049122|FG000|Overall Study|Adverse Event|1|||
146421484|NCT06331156|528049123|FG001|Overall Study|Adverse Event|0|||
146421485|NCT06331156|528049122|FG000|Overall Study|Lost to Follow-up|1|||
146421486|NCT06331156|528049123|FG001|Overall Study|Lost to Follow-up|0|||
146421487|NCT06331156|528049122|FG000|Overall Study|Migrated / Moved from the study area|4|||
146421488|NCT06331156|528049123|FG001|Overall Study|Migrated / Moved from the study area|3|||
146421489|NCT06331156|528049122|FG000|Overall Study|Other|7|||
146421490|NCT06331156|528049123|FG001|Overall Study|Other|0|||
146421491|NCT06331156|528049122|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
146421492|NCT06331156|528049123|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
146421493|NCT02978326|528049124|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
146421494|NCT02978326|528049125|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
146421495|NCT02978326|528049126|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
146421496|NCT02978326|528049124|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
146421497|NCT02978326|528049125|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
146421498|NCT02978326|528049126|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
146421499|NCT02978326|528049124|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
146421500|NCT02978326|528049125|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
146421501|NCT02978326|528049126|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
146421502|NCT02978326|528049124|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
146421503|NCT02978326|528049125|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
146421504|NCT02978326|528049126|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
146421505|NCT00865709|528049136|FG000|Treatment|Adverse Event|9|||
146421506|NCT00865709|528049137|FG001|Treatment|Adverse Event|6|||
146421507|NCT00865709|528049136|FG000|Treatment|Withdrawal by Subject|10|||
146421508|NCT00865709|528049137|FG001|Treatment|Withdrawal by Subject|7|||
146421509|NCT00865709|528049136|FG000|Treatment|Physician Decision|3|||
146421510|NCT00865709|528049137|FG001|Treatment|Physician Decision|2|||
146421511|NCT00865709|528049136|FG000|Treatment|Surgery|8|||
146421512|NCT00865709|528049137|FG001|Treatment|Surgery|3|||
146421513|NCT03276975|528049138|FG000|Overall Study|Withdrawal by Subject|1|||
146421514|NCT03276975|528049139|FG001|Overall Study|Withdrawal by Subject|0|||
146421515|NCT00662129|528049140|FG000|Overall Study|Protocol Violation|1|||
146421516|NCT00662129|528049140|FG000|Overall Study|Cancel prior to beginning treatment|1|||
146421517|NCT00662129|528049140|FG000|Overall Study|Ineligible|1|||
146421518|NCT02153736|528049145|FG000|Overall Study|Lost to Follow-up|1|||
146421519|NCT02153736|528049146|FG001|Overall Study|Lost to Follow-up|0|||
146421520|NCT02153736|528049145|FG000|Overall Study|Medical status change made ineligible|1|||
146421521|NCT02153736|528049146|FG001|Overall Study|Medical status change made ineligible|0|||
146421522|NCT02153736|528049145|FG000|Overall Study|Death|0|||
146421523|NCT02153736|528049146|FG001|Overall Study|Death|1|||
146421524|NCT02153736|528049145|FG000|Overall Study|Withdrawal by Subject|0|||
146421525|NCT02153736|528049146|FG001|Overall Study|Withdrawal by Subject|1|||
146421526|NCT00796510|528049155|FG000|Overall Study|Death|1|||
146421527|NCT00796510|528049156|FG001|Overall Study|Death|0|||
146421528|NCT00796510|528049155|FG000|Overall Study|Study Terminated|2|||
146421529|NCT00796510|528049156|FG001|Overall Study|Study Terminated|0|||
146421530|NCT05030753|528049157|FG000|9-week|Lost to Follow-up|10|||
146421531|NCT05030753|528049158|FG001|9-week|Lost to Follow-up|7|||
146421532|NCT05030753|528049157|FG000|9-week|Withdrawal by Subject|1|||
146421533|NCT05030753|528049158|FG001|9-week|Withdrawal by Subject|0|||
146421534|NCT05030753|528049157|FG000|9-week|Excluded from analysis due to missing covariates|2|||
146421535|NCT05030753|528049158|FG001|9-week|Excluded from analysis due to missing covariates|1|||
146421536|NCT05030753|528049157|FG000|6-month post intervention|Lost to Follow-up|5|||
146421537|NCT05030753|528049158|FG001|6-month post intervention|Lost to Follow-up|4|||
146421538|NCT05030753|528049157|FG000|6-month post intervention|Withdrawal by Subject|4|||
146421539|NCT05030753|528049158|FG001|6-month post intervention|Withdrawal by Subject|0|||
146421540|NCT05030753|528049157|FG000|18-month post intervention|Lost to Follow-up|3|||
146421541|NCT05030753|528049158|FG001|18-month post intervention|Lost to Follow-up|1|||
146421542|NCT00720122|528049166|FG000|Overall Study|Lost to Follow-up|1|||
146421543|NCT00720122|528049166|FG000|Overall Study|Physician Decision|1|||
146082504|NCT02431260|526822810|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146421544|NCT00720122|528049166|FG000|Overall Study|Withdrawal by Subject|7|||
146421545|NCT03072459|528049167|FG000|Overall Study|Device revised/removed|1|||
146421546|NCT03072459|528049167|FG000|Overall Study|Subject not able to return|1|||
146421547|NCT00663871|528049172|FG000|Overall Study|Lost to Follow-up|5|||
146421548|NCT00663871|528049173|FG001|Overall Study|Lost to Follow-up|5|||
146421549|NCT00663871|528049172|FG000|Overall Study|Withdrawal by Subject|5|||
146421550|NCT00663871|528049173|FG001|Overall Study|Withdrawal by Subject|2|||
146421551|NCT03384745|528049174|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146421552|NCT03384745|528049175|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146421553|NCT03384745|528049176|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
146421554|NCT03384745|528049177|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
146421555|NCT03384745|528049178|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146421556|NCT03384745|528049179|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
146421557|NCT03384745|528049174|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146421558|NCT03384745|528049175|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146421559|NCT03384745|528049176|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146421560|NCT03384745|528049177|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
146421561|NCT03384745|528049178|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
146421562|NCT03384745|528049179|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
146421563|NCT03384745|528049174|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146421564|NCT03384745|528049175|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146421565|NCT03384745|528049176|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146421566|NCT03384745|528049177|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146421567|NCT03384745|528049178|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
146421568|NCT03384745|528049179|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
146421569|NCT03384745|528049174|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146421570|NCT03384745|528049175|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146421571|NCT03384745|528049176|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
146421572|NCT03384745|528049177|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146421573|NCT03384745|528049178|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146421574|NCT03384745|528049179|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
146421575|NCT03384745|528049174|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146421576|NCT03384745|528049175|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146421577|NCT03384745|528049176|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146421578|NCT03384745|528049177|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
146421579|NCT03384745|528049178|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
146421580|NCT03384745|528049179|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
146421581|NCT03384745|528049174|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146421582|NCT03384745|528049175|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146421583|NCT03384745|528049176|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146421584|NCT03384745|528049177|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146421585|NCT03384745|528049178|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
146421586|NCT03384745|528049179|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
146421587|NCT03384745|528049174|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146421588|NCT03384745|528049175|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146421589|NCT03384745|528049176|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
146421590|NCT03384745|528049177|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
146421591|NCT03384745|528049178|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
146421592|NCT03384745|528049179|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
145948363|NCT01210352|526319671|FG004|Overall Study|Patient Discharged Early|0|||
146421593|NCT03384745|528049174|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146421594|NCT03384745|528049175|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146421595|NCT03384745|528049176|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
146421596|NCT03384745|528049177|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
146421597|NCT03384745|528049178|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
146421598|NCT03384745|528049179|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
146421599|NCT03384745|528049174|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
146421600|NCT03384745|528049175|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
146421601|NCT03384745|528049176|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
146421602|NCT03384745|528049177|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
146421603|NCT03384745|528049178|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
146421604|NCT03384745|528049179|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
146421605|NCT03384745|528049174|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146421606|NCT03384745|528049175|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146421607|NCT03384745|528049176|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146421608|NCT03384745|528049177|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
146421609|NCT03384745|528049178|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146421610|NCT03384745|528049179|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
146421611|NCT03384745|528049174|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
146421612|NCT03384745|528049175|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
146421613|NCT03384745|528049176|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
146421614|NCT03384745|528049177|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
146421615|NCT03384745|528049178|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
146421616|NCT03384745|528049179|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
146421617|NCT01592370|528049182|FG000|Overall Study|Disease Progression|62|||
146421618|NCT01592370|528049183|FG001|Overall Study|Disease Progression|16|||
146421619|NCT01592370|528049184|FG002|Overall Study|Disease Progression|52|||
146421620|NCT01592370|528049185|FG003|Overall Study|Disease Progression|3|||
146421621|NCT01592370|528049186|FG004|Overall Study|Disease Progression|3|||
146421622|NCT01592370|528049187|FG005|Overall Study|Disease Progression|31|||
146421623|NCT01592370|528049188|FG006|Overall Study|Disease Progression|14|||
146421624|NCT01592370|528049182|FG000|Overall Study|Study Drug Toxicity|14|||
146421625|NCT01592370|528049183|FG001|Overall Study|Study Drug Toxicity|3|||
146421626|NCT01592370|528049184|FG002|Overall Study|Study Drug Toxicity|0|||
146421627|NCT01592370|528049185|FG003|Overall Study|Study Drug Toxicity|0|||
146421628|NCT01592370|528049186|FG004|Overall Study|Study Drug Toxicity|0|||
146421629|NCT01592370|528049187|FG005|Overall Study|Study Drug Toxicity|0|||
146421630|NCT01592370|528049188|FG006|Overall Study|Study Drug Toxicity|1|||
146421631|NCT01592370|528049182|FG000|Overall Study|AE unrelated to study drug|4|||
146421632|NCT01592370|528049183|FG001|Overall Study|AE unrelated to study drug|3|||
146421633|NCT01592370|528049184|FG002|Overall Study|AE unrelated to study drug|0|||
146421634|NCT01592370|528049185|FG003|Overall Study|AE unrelated to study drug|0|||
146421635|NCT01592370|528049186|FG004|Overall Study|AE unrelated to study drug|0|||
146421636|NCT01592370|528049187|FG005|Overall Study|AE unrelated to study drug|0|||
146421637|NCT01592370|528049188|FG006|Overall Study|AE unrelated to study drug|1|||
146421638|NCT01592370|528049182|FG000|Overall Study|Request to discontinue study treatment|5|||
146421639|NCT01592370|528049183|FG001|Overall Study|Request to discontinue study treatment|0|||
146421640|NCT01592370|528049184|FG002|Overall Study|Request to discontinue study treatment|2|||
146421641|NCT01592370|528049185|FG003|Overall Study|Request to discontinue study treatment|0|||
146421642|NCT01592370|528049186|FG004|Overall Study|Request to discontinue study treatment|1|||
146421643|NCT01592370|528049187|FG005|Overall Study|Request to discontinue study treatment|2|||
146421644|NCT01592370|528049188|FG006|Overall Study|Request to discontinue study treatment|0|||
146421645|NCT01592370|528049182|FG000|Overall Study|Withdrew consent|1|||
146421646|NCT01592370|528049183|FG001|Overall Study|Withdrew consent|2|||
146421647|NCT01592370|528049184|FG002|Overall Study|Withdrew consent|1|||
146421648|NCT01592370|528049185|FG003|Overall Study|Withdrew consent|1|||
146421649|NCT01592370|528049186|FG004|Overall Study|Withdrew consent|0|||
146421650|NCT01592370|528049187|FG005|Overall Study|Withdrew consent|0|||
146421651|NCT01592370|528049188|FG006|Overall Study|Withdrew consent|0|||
146421652|NCT01592370|528049182|FG000|Overall Study|Maximum clinical benefit|11|||
146421653|NCT01592370|528049183|FG001|Overall Study|Maximum clinical benefit|1|||
146421654|NCT01592370|528049184|FG002|Overall Study|Maximum clinical benefit|7|||
146421655|NCT01592370|528049185|FG003|Overall Study|Maximum clinical benefit|1|||
146421656|NCT01592370|528049186|FG004|Overall Study|Maximum clinical benefit|0|||
146421657|NCT01592370|528049187|FG005|Overall Study|Maximum clinical benefit|0|||
146421658|NCT01592370|528049188|FG006|Overall Study|Maximum clinical benefit|0|||
146421659|NCT01592370|528049182|FG000|Overall Study|No longer meets study criteria|1|||
146421660|NCT01592370|528049183|FG001|Overall Study|No longer meets study criteria|0|||
146421661|NCT01592370|528049184|FG002|Overall Study|No longer meets study criteria|0|||
146421662|NCT01592370|528049185|FG003|Overall Study|No longer meets study criteria|0|||
146421663|NCT01592370|528049186|FG004|Overall Study|No longer meets study criteria|0|||
146421664|NCT01592370|528049187|FG005|Overall Study|No longer meets study criteria|0|||
146421665|NCT01592370|528049188|FG006|Overall Study|No longer meets study criteria|0|||
146421666|NCT01592370|528049182|FG000|Overall Study|Other Reasons|6|||
146421667|NCT01592370|528049183|FG001|Overall Study|Other Reasons|0|||
146421668|NCT01592370|528049184|FG002|Overall Study|Other Reasons|10|||
146421669|NCT01592370|528049185|FG003|Overall Study|Other Reasons|0|||
146421670|NCT01592370|528049186|FG004|Overall Study|Other Reasons|0|||
146421671|NCT01592370|528049187|FG005|Overall Study|Other Reasons|1|||
146421672|NCT01592370|528049188|FG006|Overall Study|Other Reasons|0|||
146421673|NCT01592370|528049182|FG000|Overall Study|Not Treated|0|||
146421674|NCT01592370|528049183|FG001|Overall Study|Not Treated|0|||
146421675|NCT01592370|528049184|FG002|Overall Study|Not Treated|0|||
146421676|NCT01592370|528049185|FG003|Overall Study|Not Treated|0|||
146421677|NCT01592370|528049186|FG004|Overall Study|Not Treated|2|||
146421678|NCT01592370|528049187|FG005|Overall Study|Not Treated|2|||
146421679|NCT01592370|528049188|FG006|Overall Study|Not Treated|0|||
146421680|NCT00319449|528049191|FG000|Overall Study|Subject did not wish to continue|1|||
146421681|NCT00319449|528049192|FG001|Overall Study|Subject did not wish to continue|0|||
146421682|NCT00319449|528049191|FG000|Overall Study|Noncompliance with the protocol|1|||
146421683|NCT00319449|528049192|FG001|Overall Study|Noncompliance with the protocol|0|||
146421684|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
146421685|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
146421686|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
146421687|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
146421688|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
146421689|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
146421690|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
146421691|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
146421692|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
146421693|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
146194547|NCT04305912|527224046|FG001|First Intervention|COVID-19 Suspension|0|||
146194548|NCT04305912|527224045|FG000|First Intervention|Withdrawal by Subject|0|||
146421694|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
146421695|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
146194549|NCT04305912|527224046|FG001|First Intervention|Withdrawal by Subject|1|||
146194550|NCT04305912|527224045|FG000|Second Intervention|Adverse Event|0|||
146194551|NCT04305912|527224046|FG001|Second Intervention|Adverse Event|1|||
146421696|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
146421697|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
146194552|NCT02138916|527224051|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
146421698|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
146421699|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
146194553|NCT02138916|527224052|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
146194554|NCT02138916|527224053|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
146194555|NCT02138916|527224051|FG000|Overall Study|Death|14|||
146421700|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
146421701|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
146421702|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
146421703|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
146421704|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
146421705|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
146421706|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
146421707|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
146421708|NCT00455533|528049193|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
146421709|NCT00455533|528049194|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
146421710|NCT00455533|528049195|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
146421711|NCT00455533|528049193|FG000|Period Two: Randomized Period|Death|0|||
146421712|NCT00455533|528049194|FG001|Period Two: Randomized Period|Death|0|||
146421713|NCT00455533|528049195|FG002|Period Two: Randomized Period|Death|3|||
146421714|NCT00455533|528049193|FG000|Period Two: Randomized Period|Disease Progression|0|||
146421715|NCT00455533|528049194|FG001|Period Two: Randomized Period|Disease Progression|1|||
146421716|NCT00455533|528049195|FG002|Period Two: Randomized Period|Disease Progression|1|||
146421717|NCT00455533|528049193|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
146421718|NCT00455533|528049194|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
146421719|NCT00455533|528049195|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
146421720|NCT00455533|528049193|FG000|Period Two: Randomized Period|Other - need reasons|0|||
146421721|NCT00455533|528049194|FG001|Period Two: Randomized Period|Other - need reasons|1|||
146421722|NCT00455533|528049195|FG002|Period Two: Randomized Period|Other - need reasons|0|||
146421723|NCT00455533|528049193|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
146421724|NCT00455533|528049194|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
146421725|NCT00455533|528049195|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
146421726|NCT00455533|528049193|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
146421727|NCT00455533|528049194|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
146421728|NCT00455533|528049195|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
146421729|NCT02739984|528049196|FG000|Overall Study|Sponsor Decision|1|||
146421730|NCT02739984|528049197|FG001|Overall Study|Sponsor Decision|0|||
146421731|NCT02739984|528049196|FG000|Overall Study|Withdrawal by Subject|1|||
146421732|NCT02739984|528049197|FG001|Overall Study|Withdrawal by Subject|1|||
146421733|NCT02739984|528049196|FG000|Overall Study|Death|0|||
146421734|NCT02739984|528049197|FG001|Overall Study|Death|1|||
146421735|NCT02739984|528049196|FG000|Overall Study|Lost to Follow-up|3|||
146421736|NCT02739984|528049197|FG001|Overall Study|Lost to Follow-up|0|||
146421737|NCT00767325|528049199|FG000|Overall Study|Lack of Efficacy|2|||
146421738|NCT00767325|528049199|FG000|Overall Study|Adverse Event|7|||
146421739|NCT00767325|528049199|FG000|Overall Study|Lost to Follow-up|3|||
146421740|NCT00767325|528049199|FG000|Overall Study|No longer met study criteria|2|||
146421741|NCT00767325|528049199|FG000|Overall Study|Missed visit due to family reasons|1|||
146421742|NCT03538756|528049200|FG000|Long-Term Follow-up|Adverse Event|0|||
146421743|NCT03538756|528049201|FG001|Long-Term Follow-up|Adverse Event|0|||
146421744|NCT03538756|528049202|FG002|Long-Term Follow-up|Adverse Event|6|||
146421745|NCT03538756|528049200|FG000|Long-Term Follow-up|Death|0|||
145948364|NCT01210352|526319672|FG005|Overall Study|Patient Discharged Early|0|||
146421746|NCT03538756|528049201|FG001|Long-Term Follow-up|Death|0|||
146421747|NCT03538756|528049202|FG002|Long-Term Follow-up|Death|1|||
146421748|NCT03538756|528049200|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
146194556|NCT02138916|527224052|FG001|Overall Study|Death|11|||
146194557|NCT02138916|527224053|FG002|Overall Study|Death|12|||
146194558|NCT02138916|527224051|FG000|Overall Study|Withdrawal by Subject|27|||
146194559|NCT02138916|527224052|FG001|Overall Study|Withdrawal by Subject|31|||
146194560|NCT02138916|527224053|FG002|Overall Study|Withdrawal by Subject|32|||
146194561|NCT02138916|527224051|FG000|Overall Study|Study specific withdrawal criteria|0|||
146194562|NCT02138916|527224052|FG001|Overall Study|Study specific withdrawal criteria|0|||
146194563|NCT02138916|527224053|FG002|Overall Study|Study specific withdrawal criteria|1|||
146194564|NCT02138916|527224051|FG000|Overall Study|incorrect enrolment|1|||
146194565|NCT02138916|527224052|FG001|Overall Study|incorrect enrolment|1|||
146194566|NCT02138916|527224053|FG002|Overall Study|incorrect enrolment|0|||
146194567|NCT02138916|527224051|FG000|Overall Study|Severe non-compliance|1|||
146194568|NCT02138916|527224052|FG001|Overall Study|Severe non-compliance|2|||
146194569|NCT02138916|527224053|FG002|Overall Study|Severe non-compliance|1|||
146194570|NCT02138916|527224051|FG000|Overall Study|Lost to Follow-up|4|||
146194571|NCT02138916|527224052|FG001|Overall Study|Lost to Follow-up|2|||
146194572|NCT02138916|527224053|FG002|Overall Study|Lost to Follow-up|3|||
146194573|NCT02138916|527224051|FG000|Overall Study|Adverse Event|4|||
146194574|NCT02138916|527224052|FG001|Overall Study|Adverse Event|4|||
146194575|NCT02138916|527224053|FG002|Overall Study|Adverse Event|3|||
146194576|NCT01348087|527224054|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
146194577|NCT01348087|527224054|FG000|Overall Study|Administrative problems|79|||
146421749|NCT03538756|528049201|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
146421750|NCT03538756|528049202|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
146421751|NCT03538756|528049200|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
146421752|NCT03538756|528049201|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
146421753|NCT03538756|528049202|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
146421754|NCT03538756|528049200|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
146194578|NCT01348087|527224054|FG000|Overall Study|protocol deviation|1|||
146194579|NCT01348087|527224054|FG000|Overall Study|Lost to Follow-up|1|||
146194580|NCT01348087|527224054|FG000|Overall Study|Subject withdrew consent|7|||
146194581|NCT01348087|527224054|FG000|Overall Study|Adverse Event|25|||
146194582|NCT00117988|527224059|FG000|Overall Study|Death|3|||
146194583|NCT00117988|527224059|FG000|Overall Study|Adverse Event|1|||
146194584|NCT02482233|527224066|FG000|Overall Study|Lost to Follow-up|1|||
146421755|NCT03538756|528049201|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
146421756|NCT03538756|528049202|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
146421757|NCT00752856|528049203|FG000|Overall Study|randomized but did not do viral kinetics|0|||
146421758|NCT00752856|528049204|FG001|Overall Study|randomized but did not do viral kinetics|1|||
146421759|NCT00996736|528049205|FG000|Overall Study|Death|1|||
146421760|NCT00996736|528049206|FG001|Overall Study|Death|1|||
146421761|NCT00996736|528049205|FG000|Overall Study|Lost to Follow-up|15|||
146421762|NCT00996736|528049206|FG001|Overall Study|Lost to Follow-up|14|||
146421763|NCT00996736|528049205|FG000|Overall Study|Visit not within 3-month window|5|||
146421764|NCT00996736|528049206|FG001|Overall Study|Visit not within 3-month window|3|||
146421765|NCT02688608|528049207|FG000|Overall Study|Lost to Follow-up|1|||
146421766|NCT02346201|528049209|FG000|Overall Study|Adverse Event|3|||
146421767|NCT02346201|528049210|FG001|Overall Study|Adverse Event|2|||
146421768|NCT02346201|528049209|FG000|Overall Study|Lost to Follow-up|1|||
146421769|NCT02346201|528049210|FG001|Overall Study|Lost to Follow-up|0|||
146421770|NCT02346201|528049209|FG000|Overall Study|Withdrawal by Subject|6|||
146421771|NCT02346201|528049210|FG001|Overall Study|Withdrawal by Subject|3|||
146421772|NCT02346201|528049209|FG000|Overall Study|Unavailable for future follow-up|0|||
146421773|NCT02346201|528049210|FG001|Overall Study|Unavailable for future follow-up|1|||
146421774|NCT02346201|528049209|FG000|Overall Study|Physician Decision|0|||
146421775|NCT02346201|528049210|FG001|Overall Study|Physician Decision|1|||
146421776|NCT02346201|528049209|FG000|Overall Study|Missed final visit|0|||
146421777|NCT02346201|528049210|FG001|Overall Study|Missed final visit|2|||
146421778|NCT03708211|528049212|FG000|Overall Study|Progressive Disease|10|||
146421779|NCT03708211|528049213|FG001|Overall Study|Progressive Disease|7|||
146421780|NCT03708211|528049212|FG000|Overall Study|Withdrawal by Subject|0|||
146421781|NCT03708211|528049213|FG001|Overall Study|Withdrawal by Subject|1|||
146421782|NCT03708211|528049212|FG000|Overall Study|Other|2|||
146421783|NCT03708211|528049213|FG001|Overall Study|Other|0|||
146421784|NCT00409578|528049216|FG000|Overall Study|Adverse Event|27|||
146421785|NCT00409578|528049217|FG001|Overall Study|Adverse Event|37|||
146421786|NCT00409578|528049218|FG002|Overall Study|Adverse Event|25|||
146421787|NCT00409578|528049219|FG003|Overall Study|Adverse Event|33|||
146421788|NCT00409578|528049216|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146421789|NCT00409578|528049217|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146421790|NCT00409578|528049218|FG002|Overall Study|Abnormal laboratory value(s)|2|||
146421791|NCT00409578|528049219|FG003|Overall Study|Abnormal laboratory value(s)|4|||
146421792|NCT00409578|528049216|FG000|Overall Study|Lack of Efficacy|0|||
146421793|NCT00409578|528049217|FG001|Overall Study|Lack of Efficacy|0|||
146194585|NCT02482233|527224067|FG001|Overall Study|Lost to Follow-up|1|||
146194586|NCT04888585|527224068|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146194587|NCT04888585|527224069|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146421794|NCT00409578|528049218|FG002|Overall Study|Lack of Efficacy|0|||
146421795|NCT00409578|528049219|FG003|Overall Study|Lack of Efficacy|2|||
146421796|NCT00409578|528049216|FG000|Overall Study|Subject no longer requires study drug|0|||
146421797|NCT00409578|528049217|FG001|Overall Study|Subject no longer requires study drug|0|||
146421798|NCT00409578|528049218|FG002|Overall Study|Subject no longer requires study drug|0|||
146421799|NCT00409578|528049219|FG003|Overall Study|Subject no longer requires study drug|1|||
146421800|NCT00409578|528049216|FG000|Overall Study|Withdrawal by Subject|8|||
146421801|NCT00409578|528049217|FG001|Overall Study|Withdrawal by Subject|15|||
146421802|NCT00409578|528049218|FG002|Overall Study|Withdrawal by Subject|16|||
146421803|NCT00409578|528049219|FG003|Overall Study|Withdrawal by Subject|17|||
146421804|NCT00409578|528049216|FG000|Overall Study|Lost to Follow-up|2|||
146421805|NCT00409578|528049217|FG001|Overall Study|Lost to Follow-up|0|||
146421806|NCT00409578|528049218|FG002|Overall Study|Lost to Follow-up|2|||
146421807|NCT00409578|528049219|FG003|Overall Study|Lost to Follow-up|2|||
146421808|NCT00409578|528049216|FG000|Overall Study|Administrative problems|8|||
146421809|NCT00409578|528049217|FG001|Overall Study|Administrative problems|9|||
146421810|NCT00409578|528049218|FG002|Overall Study|Administrative problems|2|||
146421811|NCT00409578|528049219|FG003|Overall Study|Administrative problems|4|||
146421812|NCT00409578|528049216|FG000|Overall Study|Death|2|||
146421813|NCT00409578|528049217|FG001|Overall Study|Death|4|||
146421814|NCT00409578|528049218|FG002|Overall Study|Death|4|||
146421815|NCT00409578|528049219|FG003|Overall Study|Death|2|||
146421816|NCT00409578|528049216|FG000|Overall Study|Protocol Violation|3|||
146421817|NCT00409578|528049217|FG001|Overall Study|Protocol Violation|2|||
146421818|NCT00409578|528049218|FG002|Overall Study|Protocol Violation|3|||
146421819|NCT00409578|528049219|FG003|Overall Study|Protocol Violation|1|||
146421820|NCT00409578|528049216|FG000|Overall Study|Missing|0|||
146421821|NCT00409578|528049217|FG001|Overall Study|Missing|1|||
146421822|NCT00409578|528049218|FG002|Overall Study|Missing|0|||
146421823|NCT00409578|528049219|FG003|Overall Study|Missing|1|||
146421824|NCT02109133|528049220|FG000|Overall Study|Lost to Follow-up|1|||
146421825|NCT02109133|528049221|FG001|Overall Study|Lost to Follow-up|0|||
146421826|NCT05200858|528049222|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
146421827|NCT05200858|528049223|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
146421828|NCT05200858|528049224|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
146421829|NCT05200858|528049225|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
146421830|NCT01739790|528050630|FG000|Overall Study|Early Trial Termination|2|||
146421831|NCT01739790|528050631|FG001|Overall Study|Early Trial Termination|4|||
146421832|NCT02309099|528050635|FG000|Overall Study|Adverse Event|2|||
146421833|NCT02309099|528050636|FG001|Overall Study|Adverse Event|0|||
146421834|NCT02819362|528050638|FG000|Overall Study|On-site MRI could not be performed|70|||
146421835|NCT05301751|528050639|FG000|Overall Study|Withdrawal by Subject|0|||
146421836|NCT05301751|528050640|FG001|Overall Study|Withdrawal by Subject|0|||
146421837|NCT05301751|528050641|FG002|Overall Study|Withdrawal by Subject|1|||
146421838|NCT05301751|528050642|FG003|Overall Study|Withdrawal by Subject|0|||
146421839|NCT02132247|528050643|FG000|Overall Study|Protocol Violation|1|||
146421840|NCT02132247|528050644|FG001|Overall Study|Protocol Violation|0|||
146421841|NCT00520741|528050651|FG000|Overall Study|Adverse Event|16|||
146421842|NCT00520741|528050652|FG001|Overall Study|Adverse Event|56|||
146421843|NCT00520741|528050651|FG000|Overall Study|Lack of Efficacy|11|||
146421844|NCT00520741|528050652|FG001|Overall Study|Lack of Efficacy|30|||
146421845|NCT00520741|528050651|FG000|Overall Study|Withdrawal by Subject|0|||
146421846|NCT00520741|528050652|FG001|Overall Study|Withdrawal by Subject|11|||
146421847|NCT00520741|528050651|FG000|Overall Study|Protocol Violation|2|||
146421848|NCT00520741|528050652|FG001|Overall Study|Protocol Violation|15|||
146421849|NCT00520741|528050651|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
146421850|NCT00520741|528050652|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
146421851|NCT00520741|528050651|FG000|Overall Study|Lost to Follow-up|4|||
146421852|NCT00520741|528050652|FG001|Overall Study|Lost to Follow-up|4|||
146421853|NCT00520741|528050651|FG000|Overall Study|Other reasons for premature termination|0|||
146421854|NCT00520741|528050652|FG001|Overall Study|Other reasons for premature termination|6|||
146421855|NCT03702621|528050653|FG000|Overall Study|Physician Decision|6|||
146421856|NCT03702621|528050654|FG001|Overall Study|Physician Decision|6|||
146421857|NCT01860976|528050661|FG000|Blinded Treatment|Adverse Event|1|||
146421858|NCT01860976|528050662|FG001|Blinded Treatment|Adverse Event|3|||
146421859|NCT01860976|528050661|FG000|Blinded Treatment|Lack of Efficacy|5|||
146421860|NCT01860976|528050662|FG001|Blinded Treatment|Lack of Efficacy|12|||
146421861|NCT01860976|528050661|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
146421862|NCT01860976|528050662|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
146421863|NCT01860976|528050661|FG000|Blinded Treatment|Withdrawal by Subject|3|||
146421864|NCT01860976|528050662|FG001|Blinded Treatment|Withdrawal by Subject|5|||
146421865|NCT01860976|528050661|FG000|Blinded Treatment|Subject no longer met criteria|1|||
146421866|NCT01860976|528050662|FG001|Blinded Treatment|Subject no longer met criteria|0|||
146421867|NCT01860976|528050661|FG000|Blinded Treatment|Entered Open-Label in error|0|||
146421868|NCT01860976|528050662|FG001|Blinded Treatment|Entered Open-Label in error|1|||
146421869|NCT01860976|528050661|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
146421870|NCT01860976|528050662|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
146421871|NCT01860976|528050661|FG000|Open-Label|Adverse Event|2|||
146421872|NCT01860976|528050662|FG001|Open-Label|Adverse Event|4|||
146421873|NCT01860976|528050661|FG000|Open-Label|Lack of Efficacy|16|||
146421874|NCT01860976|528050662|FG001|Open-Label|Lack of Efficacy|8|||
146421875|NCT01860976|528050661|FG000|Open-Label|Lost to Follow-up|1|||
146421876|NCT01860976|528050662|FG001|Open-Label|Lost to Follow-up|2|||
146421877|NCT01860976|528050661|FG000|Open-Label|Subject request discontinue treatment|4|||
146421878|NCT01860976|528050662|FG001|Open-Label|Subject request discontinue treatment|3|||
146421879|NCT01860976|528050661|FG000|Open-Label|Withdrawal by Subject|4|||
146421880|NCT01860976|528050662|FG001|Open-Label|Withdrawal by Subject|1|||
146421881|NCT01860976|528050661|FG000|Open-Label|Other Reasons|1|||
146421882|NCT01860976|528050662|FG001|Open-Label|Other Reasons|1|||
146421883|NCT01860976|528050661|FG000|Long Term Extension|Adverse Event|4|||
146421884|NCT01860976|528050662|FG001|Long Term Extension|Adverse Event|0|||
146421885|NCT01860976|528050661|FG000|Long Term Extension|Lack of Efficacy|2|||
146421886|NCT01860976|528050662|FG001|Long Term Extension|Lack of Efficacy|0|||
146421887|NCT01860976|528050661|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
146421888|NCT01860976|528050662|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
146421889|NCT01860976|528050661|FG000|Long Term Extension|Lost to Follow-up|2|||
146421890|NCT01860976|528050662|FG001|Long Term Extension|Lost to Follow-up|0|||
146421891|NCT01860976|528050661|FG000|Long Term Extension|subject withdrew consent|7|||
146421892|NCT01860976|528050662|FG001|Long Term Extension|subject withdrew consent|0|||
146421893|NCT02354586|528050665|FG000|Overall Study|Death|230|||
146421894|NCT02354586|528050665|FG000|Overall Study|Withdrawal by Subject|59|||
146421895|NCT02354586|528050665|FG000|Overall Study|Lost to Follow-up|11|||
146421896|NCT02354586|528050665|FG000|Overall Study|Sponsor decision|51|||
146421897|NCT02354586|528050665|FG000|Overall Study|Site closure|2|||
146421898|NCT02354586|528050665|FG000|Overall Study|Intercurrent illness|1|||
146421899|NCT02354586|528050665|FG000|Overall Study|Protocol Violation|3|||
146421900|NCT02354586|528050665|FG000|Overall Study|Physician Decision|13|||
146421901|NCT02354586|528050665|FG000|Overall Study|Lack of Efficacy|86|||
146421902|NCT02354586|528050665|FG000|Overall Study|Adverse Event|7|||
146421903|NCT02402166|528050666|FG000|Overall Study|Adverse Event|2|||
146421904|NCT02402166|528050666|FG000|Overall Study|Withdrawal by Subject|2|||
146421905|NCT02402166|528050666|FG000|Overall Study|Lost to Follow-up|1|||
146421906|NCT02204371|528050668|FG000|Overall Study|Adverse Event|1|||
146421907|NCT03803943|528050677|FG000|Overall Study|Withdrawal by Subject|2|||
146421908|NCT03803943|528050678|FG001|Overall Study|Withdrawal by Subject|2|||
146421909|NCT03803943|528050679|FG002|Overall Study|Withdrawal by Subject|2|||
146421910|NCT03803943|528050680|FG003|Overall Study|Withdrawal by Subject|2|||
146421911|NCT01574248|528050681|FG000|Overall Study|Withdrawal by Subject|2|||
146421912|NCT01574248|528050682|FG001|Overall Study|Withdrawal by Subject|0|||
146421913|NCT01574248|528050681|FG000|Overall Study|Missing primary endpoint data|1|||
146421914|NCT01574248|528050682|FG001|Overall Study|Missing primary endpoint data|0|||
146421915|NCT01781286|528050685|FG000|Overall Study|Lost to Follow-up|0|||
146421916|NCT01781286|528050686|FG001|Overall Study|Lost to Follow-up|0|||
146421917|NCT01781286|528050687|FG002|Overall Study|Lost to Follow-up|0|||
146421918|NCT01781286|528050688|FG003|Overall Study|Lost to Follow-up|0|||
146421919|NCT01781286|528050689|FG004|Overall Study|Lost to Follow-up|0|||
146421920|NCT01781286|528050690|FG005|Overall Study|Lost to Follow-up|1|||
146421921|NCT01781286|528050685|FG000|Overall Study|Time Constraints|2|||
146421922|NCT01781286|528050686|FG001|Overall Study|Time Constraints|0|||
146421923|NCT01781286|528050687|FG002|Overall Study|Time Constraints|2|||
146421924|NCT01781286|528050688|FG003|Overall Study|Time Constraints|0|||
146421925|NCT01781286|528050689|FG004|Overall Study|Time Constraints|0|||
146421926|NCT01781286|528050690|FG005|Overall Study|Time Constraints|0|||
146421927|NCT01781286|528050685|FG000|Overall Study|Noncompliance|0|||
146421928|NCT01781286|528050686|FG001|Overall Study|Noncompliance|0|||
146421929|NCT01781286|528050687|FG002|Overall Study|Noncompliance|0|||
146421930|NCT01781286|528050688|FG003|Overall Study|Noncompliance|1|||
146421931|NCT01781286|528050689|FG004|Overall Study|Noncompliance|0|||
146421932|NCT01781286|528050690|FG005|Overall Study|Noncompliance|0|||
146421933|NCT00995410|528050691|FG000|Overall Study|Adverse Event|51|||
146421934|NCT00995410|528050691|FG000|Overall Study|Withdrawal by Subject|7|||
146421935|NCT00995410|528050691|FG000|Overall Study|Lost to Follow-up|2|||
146421936|NCT00995410|528050691|FG000|Overall Study|Misc|28|||
146421937|NCT03594123|528050692|FG000|Overall Study|Lost to Follow-up|0|||
146421938|NCT03594123|528050693|FG001|Overall Study|Lost to Follow-up|1|||
146421939|NCT03594123|528050692|FG000|Overall Study|Adverse Event|8|||
146421940|NCT03594123|528050693|FG001|Overall Study|Adverse Event|5|||
146421941|NCT03594123|528050692|FG000|Overall Study|Site Terminated by Sponsor|4|||
146421942|NCT03594123|528050693|FG001|Overall Study|Site Terminated by Sponsor|1|||
146421943|NCT03594123|528050692|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
146421944|NCT03594123|528050693|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
146421945|NCT03594123|528050692|FG000|Overall Study|Lack of Efficacy|1|||
146421946|NCT03594123|528050693|FG001|Overall Study|Lack of Efficacy|0|||
146421947|NCT03594123|528050692|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
146421948|NCT03594123|528050693|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
146421949|NCT03365375|528050694|FG000|Overall Study|Withdrawal by Subject|0|||
146421950|NCT03365375|528050695|FG001|Overall Study|Withdrawal by Subject|1|||
146421951|NCT03365375|528050694|FG000|Overall Study|Lost to Follow-up|0|||
146421952|NCT03365375|528050695|FG001|Overall Study|Lost to Follow-up|4|||
146421953|NCT02483975|528050696|FG000|Overall Study|Adverse Event|0|||
146421954|NCT02483975|528050697|FG001|Overall Study|Adverse Event|1|||
146194588|NCT04888585|527224070|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
146194589|NCT04888585|527224071|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
146421955|NCT02483975|528050696|FG000|Overall Study|Lost to Follow-up|0|||
146421956|NCT02483975|528050697|FG001|Overall Study|Lost to Follow-up|1|||
146421957|NCT02483975|528050696|FG000|Overall Study|Physician Decision|2|||
146421958|NCT02483975|528050697|FG001|Overall Study|Physician Decision|0|||
146194590|NCT04888585|527224072|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
146194591|NCT04888585|527224073|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146421959|NCT02166697|528050698|FG000|Overall Study|Protocol Violation|347|||
146421960|NCT01505530|528050702|FG000|Overall Study|Progressive Disease|19|||
146421961|NCT01505530|528050703|FG001|Overall Study|Progressive Disease|17|||
145948365|NCT01210352|526319673|FG006|Overall Study|Patient Discharged Early|0|||
145948366|NCT01210352|526319674|FG007|Overall Study|Patient Discharged Early|0|||
145948367|NCT01210352|526319675|FG008|Overall Study|Patient Discharged Early|0|||
145948368|NCT02669082|526319676|FG000|Overall Study|Adverse Event|1|||
145948369|NCT04918355|526319677|FG000|Overall Study|no qualifying health encounter|497|||
145948370|NCT04918355|526319678|FG001|Overall Study|no qualifying health encounter|192|||
145948371|NCT04918355|526319679|FG002|Overall Study|no qualifying health encounter|438|||
145948372|NCT04918355|526319680|FG003|Overall Study|no qualifying health encounter|424|||
146194592|NCT04888585|527224074|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146194593|NCT04888585|527224075|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145948373|NCT01890759|526321472|FG000|Overall Study|Protocol Violation|0|||
145948374|NCT01890759|526321473|FG001|Overall Study|Protocol Violation|2|||
145948375|NCT01890759|526321472|FG000|Overall Study|Lost to Follow-up|0|||
145948376|NCT01890759|526321473|FG001|Overall Study|Lost to Follow-up|2|||
145948377|NCT01890759|526321472|FG000|Overall Study|Withdrawal by Subject|2|||
145948378|NCT01890759|526321473|FG001|Overall Study|Withdrawal by Subject|8|||
145948379|NCT00703326|526321474|FG000|Overall Study|Lost to Follow-up|47|||
145948380|NCT00703326|526321475|FG001|Overall Study|Lost to Follow-up|18|||
145948381|NCT00703326|526321474|FG000|Overall Study|Withdrawal by Subject|54|||
145948382|NCT00703326|526321475|FG001|Overall Study|Withdrawal by Subject|20|||
145948383|NCT00703326|526321474|FG000|Overall Study|Adverse Event|1|||
145948384|NCT00703326|526321475|FG001|Overall Study|Adverse Event|0|||
145948385|NCT03041467|526321477|FG000|Overall Study|Death|46|||
145948386|NCT03041467|526321478|FG001|Overall Study|Death|39|||
145948387|NCT03041467|526321477|FG000|Overall Study|Withdrawal by Subject|36|||
145948388|NCT03041467|526321478|FG001|Overall Study|Withdrawal by Subject|37|||
145948389|NCT03041467|526321477|FG000|Overall Study|Lost to Follow-up|6|||
145948390|NCT03041467|526321478|FG001|Overall Study|Lost to Follow-up|8|||
145948391|NCT03041467|526321477|FG000|Overall Study|Declined consent for study extension|21|||
145948392|NCT03041467|526321478|FG001|Overall Study|Declined consent for study extension|33|||
145948393|NCT03041467|526321477|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
145948394|NCT03041467|526321478|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
145948395|NCT05437640|526321479|FG000|Washout (1 Week)|Adverse Event|1|||
145948396|NCT05437640|526321480|FG001|Washout (1 Week)|Adverse Event|0|||
145948397|NCT04228965|526321483|FG000|Overall Study|Lost to Follow-up|26|||
145948398|NCT04228965|526321484|FG001|Overall Study|Lost to Follow-up|11|||
145948399|NCT04228965|526321483|FG000|Overall Study|Withdrawal by Subject|18|||
145948400|NCT04228965|526321484|FG001|Overall Study|Withdrawal by Subject|5|||
145948401|NCT03915626|526321488|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
145948402|NCT03015194|526321491|FG000|Overall Study|Death|10|||
145948403|NCT03015194|526321491|FG000|Overall Study|Withdrawal by Subject|2|||
145948404|NCT01754766|526321492|FG000|Overall Study|Personal reasons|1|||
145948405|NCT01754766|526321493|FG001|Overall Study|Personal reasons|1|||
145948406|NCT01754766|526321494|FG002|Overall Study|Personal reasons|0|||
145948407|NCT00433017|526321495|FG000|Overall Study|Adverse Event|5|||
145948408|NCT00433017|526321496|FG001|Overall Study|Adverse Event|3|||
145948409|NCT00433017|526321495|FG000|Overall Study|Withdrawal by Subject|4|||
145948410|NCT00433017|526321496|FG001|Overall Study|Withdrawal by Subject|5|||
145948411|NCT00433017|526321495|FG000|Overall Study|Lost to Follow-up|3|||
145948412|NCT00433017|526321496|FG001|Overall Study|Lost to Follow-up|4|||
145948413|NCT00433017|526321495|FG000|Overall Study|Administrative problems|80|||
145948414|NCT00433017|526321496|FG001|Overall Study|Administrative problems|86|||
145948415|NCT00433017|526321495|FG000|Overall Study|Protocol Violation|1|||
145948416|NCT00433017|526321496|FG001|Overall Study|Protocol Violation|0|||
145948417|NCT00433017|526321495|FG000|Overall Study|Death|2|||
145948418|NCT00433017|526321496|FG001|Overall Study|Death|2|||
145948419|NCT00433017|526321495|FG000|Overall Study|Subject no longer requires study drug|1|||
145948420|NCT00433017|526321496|FG001|Overall Study|Subject no longer requires study drug|1|||
145948421|NCT05025332|526321497|FG000|Screening|Screen failure|12|||
145948422|NCT05025332|526321497|FG000|Treatment & Follow Up|Protocol Violation|1|||
145948423|NCT05025332|526321497|FG000|Treatment & Follow Up|Adverse Event|4|||
145948424|NCT01306214|526321498|FG000|Overall Study|Death|0|||
145948425|NCT01306214|526321499|FG001|Overall Study|Death|0|||
145948426|NCT01306214|526321500|FG002|Overall Study|Death|1|||
146421962|NCT01505530|528050704|FG002|Overall Study|Progressive Disease|18|||
145948427|NCT01306214|526321498|FG000|Overall Study|Lost to Follow-up|3|||
145948428|NCT01306214|526321499|FG001|Overall Study|Lost to Follow-up|5|||
145948429|NCT01306214|526321500|FG002|Overall Study|Lost to Follow-up|4|||
145948430|NCT01306214|526321498|FG000|Overall Study|Withdrawal by Subject|24|||
145948431|NCT01306214|526321499|FG001|Overall Study|Withdrawal by Subject|22|||
145948432|NCT01306214|526321500|FG002|Overall Study|Withdrawal by Subject|16|||
145948433|NCT01306214|526321498|FG000|Overall Study|Not treated|1|||
145948434|NCT01306214|526321499|FG001|Overall Study|Not treated|1|||
145948435|NCT01306214|526321500|FG002|Overall Study|Not treated|1|||
145948436|NCT01026818|526321501|FG000|Screening Period|Entry Criteria Not Met|105|||
145948437|NCT01026818|526321502|FG001|Screening Period|Entry Criteria Not Met|0|||
145948438|NCT01026818|526321503|FG002|Screening Period|Entry Criteria Not Met|0|||
146421963|NCT01505530|528050702|FG000|Overall Study|Adverse Event|1|||
146421964|NCT01505530|528050703|FG001|Overall Study|Adverse Event|1|||
146421965|NCT01505530|528050704|FG002|Overall Study|Adverse Event|0|||
146421966|NCT01505530|528050702|FG000|Overall Study|Withdrawal by Subject|7|||
146421967|NCT01505530|528050703|FG001|Overall Study|Withdrawal by Subject|8|||
146421968|NCT01505530|528050704|FG002|Overall Study|Withdrawal by Subject|6|||
146421969|NCT01505530|528050702|FG000|Overall Study|Physician Decision|6|||
146421970|NCT01505530|528050703|FG001|Overall Study|Physician Decision|2|||
146421971|NCT01505530|528050704|FG002|Overall Study|Physician Decision|5|||
146421972|NCT01505530|528050702|FG000|Overall Study|Sponsor Decision|1|||
146421973|NCT01505530|528050703|FG001|Overall Study|Sponsor Decision|8|||
146421974|NCT01505530|528050704|FG002|Overall Study|Sponsor Decision|7|||
146421975|NCT01505530|528050702|FG000|Overall Study|Death|7|||
146421976|NCT01505530|528050703|FG001|Overall Study|Death|6|||
146421977|NCT01505530|528050704|FG002|Overall Study|Death|5|||
146421978|NCT01505530|528050702|FG000|Overall Study|entry criteria not met|0|||
146421979|NCT01505530|528050703|FG001|Overall Study|entry criteria not met|1|||
146421980|NCT01505530|528050704|FG002|Overall Study|entry criteria not met|0|||
146421981|NCT02720510|528050710|FG000|Overall Study|Study Terminated by the sponsor|2|||
146421982|NCT02720510|528050711|FG001|Overall Study|Study Terminated by the sponsor|0|||
146421983|NCT02720510|528050710|FG000|Overall Study|Adverse Event|0|||
146421984|NCT02720510|528050711|FG001|Overall Study|Adverse Event|1|||
146421985|NCT02720510|528050710|FG000|Overall Study|Physician Decision|1|||
146421986|NCT02720510|528050711|FG001|Overall Study|Physician Decision|2|||
146421987|NCT01618266|528050720|FG000|Overall Study|Lost to Follow-up|9|||
146421988|NCT01618266|528050720|FG000|Overall Study|Treatment satisfaction|10|||
146421989|NCT01618266|528050720|FG000|Overall Study|Other reasons|11|||
146421990|NCT01618266|528050720|FG000|Overall Study|Lack of Efficacy|23|||
146421991|NCT01618266|528050720|FG000|Overall Study|Protocol Violation|43|||
146421992|NCT00625807|528050721|FG000|Overall Study|schedule conflict|2|||
146421993|NCT00625807|528050722|FG001|Overall Study|schedule conflict|8|||
146421994|NCT01966042|528050723|FG000|Overall Study|Death|2|||
146421995|NCT03267264|528050724|FG000|Overall Study|Withdrawal by Subject|1|||
146421996|NCT03267264|528050725|FG001|Overall Study|Withdrawal by Subject|0|||
146421997|NCT03267264|528050726|FG002|Overall Study|Withdrawal by Subject|2|||
146421998|NCT03267264|528050727|FG003|Overall Study|Withdrawal by Subject|4|||
146421999|NCT02224391|528050728|FG000|Overall Study|Lost to Follow-up|26|||
146422000|NCT02224391|528050729|FG001|Overall Study|Lost to Follow-up|19|||
146422001|NCT02224391|528050728|FG000|Overall Study|Withdrawal by Subject|6|||
146422002|NCT02224391|528050729|FG001|Overall Study|Withdrawal by Subject|5|||
146422003|NCT00084084|528050730|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
146422004|NCT00084084|528050730|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
146422005|NCT01802879|528050731|FG000|Overall Study|Administrative problems|2|||
146422006|NCT01802879|528050731|FG000|Overall Study|Disease progression|6|||
146422007|NCT01047345|528050736|FG000|Base Study|Adverse Event|3|||
146422008|NCT01047345|528050737|FG001|Base Study|Adverse Event|0|||
146422009|NCT01047345|528050738|FG002|Base Study|Adverse Event|0|||
146422010|NCT01047345|528050736|FG000|Base Study|Lost to Follow-up|4|||
146422011|NCT01047345|528050737|FG001|Base Study|Lost to Follow-up|1|||
146422012|NCT01047345|528050738|FG002|Base Study|Lost to Follow-up|0|||
146422013|NCT01047345|528050736|FG000|Base Study|Protocol Violation|3|||
146422014|NCT01047345|528050737|FG001|Base Study|Protocol Violation|1|||
146422015|NCT01047345|528050738|FG002|Base Study|Protocol Violation|0|||
146422016|NCT01047345|528050736|FG000|Base Study|Withdrawal by Subject|12|||
146422017|NCT01047345|528050737|FG001|Base Study|Withdrawal by Subject|4|||
146422018|NCT01047345|528050738|FG002|Base Study|Withdrawal by Subject|0|||
146422019|NCT01047345|528050736|FG000|Extension|Withdrawal by Subject|0|||
146422020|NCT01047345|528050737|FG001|Extension|Withdrawal by Subject|0|||
146422021|NCT01047345|528050738|FG002|Extension|Withdrawal by Subject|1|||
146422022|NCT01047345|528050736|FG000|Extension|Lost to Follow-up|0|||
146422023|NCT01047345|528050737|FG001|Extension|Lost to Follow-up|0|||
146422024|NCT01047345|528050738|FG002|Extension|Lost to Follow-up|5|||
146422025|NCT00454636|528050739|FG000|Overall Study|Adverse Event|10|||
146422026|NCT00454636|528050740|FG001|Overall Study|Adverse Event|6|||
146422027|NCT00454636|528050741|FG002|Overall Study|Adverse Event|9|||
146422028|NCT00454636|528050742|FG003|Overall Study|Adverse Event|15|||
146422029|NCT00454636|528050739|FG000|Overall Study|Disease Progression|11|||
146422030|NCT00454636|528050740|FG001|Overall Study|Disease Progression|12|||
146422031|NCT00454636|528050741|FG002|Overall Study|Disease Progression|4|||
146422032|NCT00454636|528050742|FG003|Overall Study|Disease Progression|11|||
146422033|NCT00454636|528050739|FG000|Overall Study|Protocol Violation|3|||
146422034|NCT00454636|528050740|FG001|Overall Study|Protocol Violation|2|||
146422035|NCT00454636|528050741|FG002|Overall Study|Protocol Violation|3|||
146422036|NCT00454636|528050742|FG003|Overall Study|Protocol Violation|3|||
146422037|NCT00454636|528050739|FG000|Overall Study|Death|6|||
146422038|NCT00454636|528050740|FG001|Overall Study|Death|1|||
146422039|NCT00454636|528050741|FG002|Overall Study|Death|1|||
146422040|NCT00454636|528050742|FG003|Overall Study|Death|1|||
146422041|NCT00454636|528050739|FG000|Overall Study|Patient refusal|1|||
146422042|NCT00454636|528050740|FG001|Overall Study|Patient refusal|1|||
146422043|NCT00454636|528050741|FG002|Overall Study|Patient refusal|3|||
146422044|NCT00454636|528050742|FG003|Overall Study|Patient refusal|2|||
146422045|NCT00454636|528050739|FG000|Overall Study|Lost to Follow-up|0|||
146422046|NCT00454636|528050740|FG001|Overall Study|Lost to Follow-up|1|||
146422047|NCT00454636|528050741|FG002|Overall Study|Lost to Follow-up|0|||
146422048|NCT00454636|528050742|FG003|Overall Study|Lost to Follow-up|0|||
146194594|NCT04888585|527224076|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146422049|NCT01400113|528050743|FG000|Overall Study|Withdrawal by Subject|1|||
146422050|NCT01400113|528050744|FG001|Overall Study|Withdrawal by Subject|1|||
146422051|NCT00282256|528050745|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
146422052|NCT00282256|528050745|FG000|Extension Treatment Period|Adverse Event|2|||
146422053|NCT01890915|528050750|FG000|Overall Study|Adverse Event|1|||
146422054|NCT01890915|528050751|FG001|Overall Study|Adverse Event|0|||
146422055|NCT01890915|528050750|FG000|Overall Study|Protocol Violation|2|||
146422056|NCT01890915|528050751|FG001|Overall Study|Protocol Violation|0|||
146422057|NCT01890915|528050750|FG000|Overall Study|Equipment Malfunction|0|||
146422058|NCT01890915|528050751|FG001|Overall Study|Equipment Malfunction|1|||
146422059|NCT02114697|528050752|FG000|Overall Study|Study terminated|5|||
146422060|NCT02114697|528050753|FG001|Overall Study|Study terminated|4|||
146422061|NCT01984242|528050754|FG000|Overall Study|Death|52|||
146422062|NCT01984242|528050755|FG001|Overall Study|Death|50|||
146422063|NCT01984242|528050756|FG002|Overall Study|Death|52|||
146422064|NCT01984242|528050754|FG000|Overall Study|Withdrawal by Subject|5|||
146422065|NCT01984242|528050755|FG001|Overall Study|Withdrawal by Subject|3|||
146422066|NCT01984242|528050756|FG002|Overall Study|Withdrawal by Subject|10|||
146422067|NCT01984242|528050754|FG000|Overall Study|Physician Decision|0|||
146422068|NCT01984242|528050755|FG001|Overall Study|Physician Decision|0|||
146422069|NCT01984242|528050756|FG002|Overall Study|Physician Decision|1|||
146422070|NCT01984242|528050754|FG000|Overall Study|Lost to Follow-up|4|||
146422071|NCT01984242|528050755|FG001|Overall Study|Lost to Follow-up|0|||
146422072|NCT01984242|528050756|FG002|Overall Study|Lost to Follow-up|3|||
146422073|NCT01984242|528050754|FG000|Overall Study|Sponsor Decision|1|||
146422074|NCT01984242|528050755|FG001|Overall Study|Sponsor Decision|0|||
146422075|NCT01984242|528050756|FG002|Overall Study|Sponsor Decision|0|||
146422076|NCT01984242|528050754|FG000|Overall Study|Non-Compliance|1|||
146422077|NCT01984242|528050755|FG001|Overall Study|Non-Compliance|0|||
146422078|NCT01984242|528050756|FG002|Overall Study|Non-Compliance|0|||
146422079|NCT01984242|528050754|FG000|Overall Study|Study terminated by Sponsor|38|||
146422080|NCT01984242|528050755|FG001|Overall Study|Study terminated by Sponsor|50|||
146422081|NCT01984242|528050756|FG002|Overall Study|Study terminated by Sponsor|34|||
146422082|NCT01984242|528050754|FG000|Overall Study|Disease Progression|0|||
146194595|NCT04888585|527224077|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146422083|NCT01984242|528050755|FG001|Overall Study|Disease Progression|0|||
146422084|NCT01984242|528050756|FG002|Overall Study|Disease Progression|1|||
146422085|NCT00770510|528050757|FG000|Overall Study|Lost to Follow-up|2|||
146422086|NCT00770510|528050757|FG000|Overall Study|Pregnancy|1|||
146422087|NCT00770510|528050757|FG000|Overall Study|Withdrawal by Subject|2|||
146422088|NCT02246478|528050760|FG000|Multiple-dose Phase|Protocol Violation|1|||
146422089|NCT02246478|528050761|FG001|Multiple-dose Phase|Protocol Violation|0|||
146422090|NCT02246478|528050762|FG002|Multiple-dose Phase|Protocol Violation|0|||
146422091|NCT02246478|528050763|FG003|Multiple-dose Phase|Protocol Violation|1|||
146422092|NCT01457053|528050770|FG000|Overall Study|Unable to undergo selected treatment|1|||
146422093|NCT01457053|528050771|FG001|Overall Study|Unable to undergo selected treatment|1|||
146422094|NCT04333095|528050772|FG000|Overall Study|Protocol Violation|4|||
146422095|NCT04333095|528050773|FG001|Overall Study|Protocol Violation|0|||
146422096|NCT04333095|528050772|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
146422097|NCT04333095|528050773|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
146422098|NCT04333095|528050772|FG000|Overall Study|Mini Sternotomy|4|||
146422099|NCT04333095|528050773|FG001|Overall Study|Mini Sternotomy|5|||
146422100|NCT00984295|528050774|FG000|Overall Study|Lost to Follow-up|31|||
146422101|NCT00984295|528050775|FG001|Overall Study|Lost to Follow-up|12|||
146422102|NCT00984295|528050776|FG002|Overall Study|Lost to Follow-up|13|||
146422103|NCT00984295|528050774|FG000|Overall Study|Protocol Violation|2|||
146422104|NCT00984295|528050775|FG001|Overall Study|Protocol Violation|1|||
146082505|NCT02431260|526822811|FG001|Overall Study|Study Terminated by the Sponsor|0|||
146082506|NCT02431260|526822812|FG002|Overall Study|Study Terminated by the Sponsor|2|||
146194596|NCT04888585|527224078|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
146194597|NCT04888585|527224068|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194598|NCT04888585|527224069|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
146422105|NCT00984295|528050776|FG002|Overall Study|Protocol Violation|4|||
146422106|NCT00984295|528050774|FG000|Overall Study|Withdrawal by Subject|18|||
146422107|NCT00984295|528050775|FG001|Overall Study|Withdrawal by Subject|9|||
146422108|NCT00984295|528050776|FG002|Overall Study|Withdrawal by Subject|12|||
146422109|NCT00984295|528050774|FG000|Overall Study|CAE - discontinued test vaccine|0|||
146422110|NCT00984295|528050775|FG001|Overall Study|CAE - discontinued test vaccine|1|||
146422111|NCT00984295|528050776|FG002|Overall Study|CAE - discontinued test vaccine|3|||
146422112|NCT00984295|528050774|FG000|Overall Study|Missed one or more blood samplings|3|||
146422113|NCT00984295|528050775|FG001|Overall Study|Missed one or more blood samplings|7|||
146422114|NCT00984295|528050776|FG002|Overall Study|Missed one or more blood samplings|2|||
146422115|NCT00984295|528050774|FG000|Overall Study|Incomplete safety follow-up|11|||
146422116|NCT00984295|528050775|FG001|Overall Study|Incomplete safety follow-up|2|||
146422117|NCT00984295|528050776|FG002|Overall Study|Incomplete safety follow-up|3|||
146422118|NCT02742181|528050779|FG000|Overall Study|Physician Decision|1|||
146422119|NCT02742181|528050780|FG001|Overall Study|Physician Decision|0|||
146422120|NCT01346410|528050781|FG000|Overall Study|Death|1|||
146422121|NCT02576990|528050782|FG000|Overall Study|Death|29|||
146422122|NCT02576990|528050783|FG001|Overall Study|Death|18|||
146422123|NCT02576990|528050782|FG000|Overall Study|Physician Decision|1|||
146422124|NCT02576990|528050783|FG001|Overall Study|Physician Decision|0|||
146422125|NCT02576990|528050782|FG000|Overall Study|Screen failure|2|||
146422126|NCT02576990|528050783|FG001|Overall Study|Screen failure|0|||
146422127|NCT02576990|528050782|FG000|Overall Study|Sponsor's decision|24|||
146422128|NCT02576990|528050783|FG001|Overall Study|Sponsor's decision|4|||
146422129|NCT02576990|528050782|FG000|Overall Study|Withdrawal by Subject|0|||
146194599|NCT04888585|527224070|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
146422130|NCT02576990|528050783|FG001|Overall Study|Withdrawal by Subject|2|||
146422131|NCT00979628|528050784|FG000|Overall Study|received regimen < 24 hours|7|||
146422132|NCT00979628|528050785|FG001|Overall Study|received regimen < 24 hours|6|||
146422133|NCT00979628|528050786|FG002|Overall Study|received regimen < 24 hours|5|||
146422134|NCT00979628|528050784|FG000|Overall Study|received steroids|1|||
145948439|NCT01026818|526321504|FG003|Screening Period|Entry Criteria Not Met|0|||
145948440|NCT01026818|526321501|FG000|Screening Period|Withdrawal by Subject|49|||
145948441|NCT01026818|526321502|FG001|Screening Period|Withdrawal by Subject|0|||
145948442|NCT01026818|526321503|FG002|Screening Period|Withdrawal by Subject|0|||
145948443|NCT01026818|526321504|FG003|Screening Period|Withdrawal by Subject|0|||
145948444|NCT01026818|526321501|FG000|Screening Period|Protocol Deviation|3|||
145948445|NCT01026818|526321502|FG001|Screening Period|Protocol Deviation|0|||
145948446|NCT01026818|526321503|FG002|Screening Period|Protocol Deviation|0|||
145948447|NCT01026818|526321504|FG003|Screening Period|Protocol Deviation|0|||
145948448|NCT01026818|526321501|FG000|Screening Period|Adverse Event|2|||
145948449|NCT01026818|526321502|FG001|Screening Period|Adverse Event|0|||
145948450|NCT01026818|526321503|FG002|Screening Period|Adverse Event|0|||
145948451|NCT01026818|526321504|FG003|Screening Period|Adverse Event|0|||
145948452|NCT01026818|526321501|FG000|Screening Period|Physician Decision|1|||
145948453|NCT01026818|526321502|FG001|Screening Period|Physician Decision|0|||
145948454|NCT01026818|526321503|FG002|Screening Period|Physician Decision|0|||
145948455|NCT01026818|526321504|FG003|Screening Period|Physician Decision|0|||
145948456|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
145948457|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
145948458|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
146422135|NCT00979628|528050785|FG001|Overall Study|received steroids|1|||
146422136|NCT00979628|528050786|FG002|Overall Study|received steroids|0|||
146422137|NCT00979628|528050784|FG000|Overall Study|transferred to ICU|1|||
146422138|NCT00979628|528050785|FG001|Overall Study|transferred to ICU|2|||
146422139|NCT00979628|528050786|FG002|Overall Study|transferred to ICU|1|||
146422140|NCT00911859|528050787|FG000|Treatment Period|Adverse Event|3|||
146422141|NCT00911859|528050788|FG001|Treatment Period|Adverse Event|3|||
146422142|NCT00911859|528050789|FG002|Treatment Period|Adverse Event|7|||
146422143|NCT00911859|528050787|FG000|Treatment Period|Death|1|||
146422144|NCT00911859|528050788|FG001|Treatment Period|Death|3|||
146422145|NCT00911859|528050789|FG002|Treatment Period|Death|5|||
145948459|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
145948460|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
145948461|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
145948462|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
145948463|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
145948464|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
145948465|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
145948466|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
145948467|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
145948468|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
145948469|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
145948470|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
145948471|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
145948472|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
145948473|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
145948474|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
145948475|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
145948476|NCT01026818|526321501|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
145948477|NCT01026818|526321502|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
145948478|NCT01026818|526321503|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
146422146|NCT00911859|528050787|FG000|Treatment Period|Lack of Efficacy|1|||
145948479|NCT01026818|526321504|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
145948480|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
145948481|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
146082507|NCT02431260|526822813|FG003|Overall Study|Study Terminated by the Sponsor|1|||
145948482|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
146422147|NCT00911859|528050788|FG001|Treatment Period|Lack of Efficacy|7|||
146422148|NCT00911859|528050789|FG002|Treatment Period|Lack of Efficacy|5|||
146422149|NCT00911859|528050787|FG000|Treatment Period|Physician Decision|3|||
145948483|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
145948484|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
145948485|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
145948486|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
145948487|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
145948488|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145948489|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
145948490|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145948491|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145948492|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
145948493|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
145948494|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
146422150|NCT00911859|528050788|FG001|Treatment Period|Physician Decision|3|||
146422151|NCT00911859|528050789|FG002|Treatment Period|Physician Decision|3|||
146422152|NCT00911859|528050787|FG000|Treatment Period|Withdrawal by Subject|0|||
146422153|NCT00911859|528050788|FG001|Treatment Period|Withdrawal by Subject|4|||
146422154|NCT00911859|528050789|FG002|Treatment Period|Withdrawal by Subject|5|||
146422155|NCT00911859|528050787|FG000|Treatment Period|Did not receive study treatment|0|||
146422156|NCT00911859|528050788|FG001|Treatment Period|Did not receive study treatment|1|||
146422157|NCT00911859|528050789|FG002|Treatment Period|Did not receive study treatment|0|||
146422158|NCT00911859|528050787|FG000|Maintainance Period|Lack of Efficacy|0|||
145948495|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
145948496|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
145948497|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
145948498|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
145948499|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
145948500|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145948501|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
145948502|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145948503|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145948504|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
145948505|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
145948506|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
145948507|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
145948508|NCT01026818|526321501|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145948509|NCT01026818|526321502|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145948510|NCT01026818|526321503|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145948511|NCT01026818|526321504|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
145948512|NCT01026818|526321501|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145948513|NCT01026818|526321502|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
145948514|NCT01026818|526321503|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145948515|NCT01026818|526321504|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145948516|NCT01026818|526321501|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145948517|NCT01026818|526321502|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
145948518|NCT01026818|526321503|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145948519|NCT01026818|526321504|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145948520|NCT01026818|526321501|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
145948521|NCT01026818|526321502|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
145948522|NCT01026818|526321503|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
145948523|NCT01026818|526321504|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
145948524|NCT01026818|526321501|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
145948525|NCT01026818|526321502|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
146422159|NCT00911859|528050788|FG001|Maintainance Period|Lack of Efficacy|0|||
146422160|NCT00911859|528050789|FG002|Maintainance Period|Lack of Efficacy|9|||
146082508|NCT02431260|526822814|FG004|Overall Study|Study Terminated by the Sponsor|1|||
146082509|NCT02431260|526822815|FG005|Overall Study|Study Terminated by the Sponsor|0|||
146422161|NCT00911859|528050787|FG000|Maintainance Period|Physician Decision|0|||
146422162|NCT00911859|528050788|FG001|Maintainance Period|Physician Decision|0|||
146422163|NCT00911859|528050789|FG002|Maintainance Period|Physician Decision|9|||
146422164|NCT00911859|528050787|FG000|Maintainance Period|Withdrawal by Subject|0|||
146194600|NCT04888585|527224071|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
146194601|NCT04888585|527224072|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
146194602|NCT04888585|527224073|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194603|NCT04888585|527224074|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194604|NCT04888585|527224075|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194605|NCT04888585|527224076|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194606|NCT04888585|527224077|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194607|NCT04888585|527224078|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
146194608|NCT04888585|527224068|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194609|NCT04888585|527224069|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194610|NCT04888585|527224070|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
146194611|NCT04888585|527224071|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194612|NCT04888585|527224072|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
146194613|NCT04888585|527224073|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194614|NCT04888585|527224074|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194615|NCT04888585|527224075|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194616|NCT04888585|527224076|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194617|NCT04888585|527224077|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194618|NCT04888585|527224078|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
146194619|NCT04888585|527224068|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194620|NCT04888585|527224069|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194621|NCT04888585|527224070|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194622|NCT04888585|527224071|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194623|NCT04888585|527224072|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194624|NCT04888585|527224073|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194625|NCT04888585|527224074|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194626|NCT04888585|527224075|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
146194627|NCT04888585|527224076|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194628|NCT04888585|527224077|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
146194629|NCT04888585|527224078|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
146194630|NCT04888585|527224068|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146194631|NCT04888585|527224069|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146194632|NCT04888585|527224070|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146194633|NCT04888585|527224071|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146194634|NCT04888585|527224072|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
146194635|NCT04888585|527224073|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
146422165|NCT00911859|528050788|FG001|Maintainance Period|Withdrawal by Subject|0|||
146422166|NCT00911859|528050789|FG002|Maintainance Period|Withdrawal by Subject|3|||
146422167|NCT00911859|528050787|FG000|Follow-up Period|Death|5|||
146422168|NCT00911859|528050788|FG001|Follow-up Period|Death|8|||
146422169|NCT00911859|528050789|FG002|Follow-up Period|Death|10|||
146422170|NCT00911859|528050787|FG000|Follow-up Period|Lost to Follow-up|1|||
146422171|NCT00911859|528050788|FG001|Follow-up Period|Lost to Follow-up|1|||
146422172|NCT00911859|528050789|FG002|Follow-up Period|Lost to Follow-up|0|||
146422173|NCT00911859|528050787|FG000|Follow-up Period|Withdrawal by Subject|0|||
146422174|NCT00911859|528050788|FG001|Follow-up Period|Withdrawal by Subject|4|||
146422175|NCT00911859|528050789|FG002|Follow-up Period|Withdrawal by Subject|4|||
146422176|NCT00911859|528050787|FG000|Follow-up Period|Study terminated by sponsor|5|||
146422177|NCT00911859|528050788|FG001|Follow-up Period|Study terminated by sponsor|33|||
146082510|NCT02431260|526822816|FG006|Overall Study|Study Terminated by the Sponsor|1|||
146082511|NCT02431260|526822817|FG007|Overall Study|Study Terminated by the Sponsor|2|||
146082512|NCT02431260|526822818|FG008|Overall Study|Study Terminated by the Sponsor|1|||
146422178|NCT00911859|528050789|FG002|Follow-up Period|Study terminated by sponsor|27|||
146422179|NCT02785913|528053620|FG000|Overall Study|Adverse Event|5|||
146422180|NCT02785913|528053620|FG000|Overall Study|Death|2|||
145948526|NCT01026818|526321503|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
145948527|NCT01026818|526321504|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
145948528|NCT01026818|526321501|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
145948529|NCT01026818|526321502|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
145948530|NCT01026818|526321503|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
145948531|NCT01026818|526321504|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
145948532|NCT02634801|526321505|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
145948533|NCT02634801|526321506|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
145948534|NCT02634801|526321507|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
145948535|NCT02634801|526321505|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
145948536|NCT02634801|526321506|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
145948537|NCT02634801|526321507|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
145948538|NCT02634801|526321505|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
145948539|NCT02634801|526321506|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
145948540|NCT02634801|526321507|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
145948541|NCT02634801|526321505|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
145948542|NCT02634801|526321506|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
145948543|NCT02634801|526321507|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
145948544|NCT02634801|526321505|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
145948545|NCT02634801|526321506|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
145948546|NCT02634801|526321507|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
145948547|NCT02634801|526321505|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
145948548|NCT02634801|526321506|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
145948549|NCT02634801|526321507|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
145948550|NCT02634801|526321505|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
145948551|NCT02634801|526321506|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
145948552|NCT02634801|526321507|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
145948553|NCT02634801|526321505|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145948554|NCT02634801|526321506|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145948555|NCT02634801|526321507|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145948556|NCT02634801|526321505|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
145948557|NCT02634801|526321506|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
145948558|NCT02634801|526321507|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
145948559|NCT02634801|526321505|FG000|Follow-up Period|Lost to Follow-up|3|||
145948560|NCT02634801|526321506|FG001|Follow-up Period|Lost to Follow-up|1|||
145948561|NCT02634801|526321507|FG002|Follow-up Period|Lost to Follow-up|2|||
145948562|NCT02634801|526321505|FG000|Follow-up Period|Physician Decision|0|||
145948563|NCT02634801|526321506|FG001|Follow-up Period|Physician Decision|0|||
145948564|NCT02634801|526321507|FG002|Follow-up Period|Physician Decision|1|||
145948565|NCT02634801|526321505|FG000|Follow-up Period|Withdrawal by Subject|1|||
145948566|NCT02634801|526321506|FG001|Follow-up Period|Withdrawal by Subject|2|||
145948567|NCT02634801|526321507|FG002|Follow-up Period|Withdrawal by Subject|5|||
145948568|NCT02634801|526321505|FG000|Follow-up Period|Adverse Event|1|||
145948569|NCT02634801|526321506|FG001|Follow-up Period|Adverse Event|5|||
145948570|NCT02634801|526321507|FG002|Follow-up Period|Adverse Event|0|||
146194636|NCT04888585|527224074|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
146194637|NCT04888585|527224075|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146194638|NCT04888585|527224076|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146194639|NCT04888585|527224077|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
146194640|NCT04888585|527224078|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
146194641|NCT04888585|527224068|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146194642|NCT04888585|527224069|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146194643|NCT04888585|527224070|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146194644|NCT04888585|527224071|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146194645|NCT04888585|527224072|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
146194646|NCT04888585|527224073|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
146194647|NCT04888585|527224074|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
146194648|NCT04888585|527224075|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
146194649|NCT04888585|527224076|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
146422181|NCT02785913|528053620|FG000|Overall Study|Progression|18|||
146422182|NCT02785913|528053620|FG000|Overall Study|Not protocol specified|1|||
146422183|NCT02841709|528053621|FG000|5th Intervention|Adverse Event|2|||
145948571|NCT02907619|526321510|FG000|Overall Study|Study terminated by sponsor|18|||
145948572|NCT02907619|526321511|FG001|Overall Study|Study terminated by sponsor|18|||
145948573|NCT02907619|526321512|FG002|Overall Study|Study terminated by sponsor|19|||
145948574|NCT02907619|526321510|FG000|Overall Study|Death|0|||
145948575|NCT02907619|526321511|FG001|Overall Study|Death|0|||
145948576|NCT02907619|526321512|FG002|Overall Study|Death|1|||
145948577|NCT02907619|526321510|FG000|Overall Study|Withdrawal by Subject|1|||
146422184|NCT02841709|528053622|FG001|5th Intervention|Adverse Event|0|||
146422185|NCT02841709|528053623|FG002|5th Intervention|Adverse Event|0|||
146422186|NCT02841709|528053624|FG003|5th Intervention|Adverse Event|0|||
146422187|NCT02841709|528053625|FG004|5th Intervention|Adverse Event|2|||
146422188|NCT01929109|528053626|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
146422189|NCT01929109|528053627|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
145948578|NCT02907619|526321511|FG001|Overall Study|Withdrawal by Subject|1|||
145948579|NCT02907619|526321512|FG002|Overall Study|Withdrawal by Subject|0|||
146194650|NCT04888585|527224077|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
146194651|NCT04888585|527224078|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
146422190|NCT01929109|528053628|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
146422191|NCT01929109|528053629|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
146422192|NCT01929109|528053630|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
146422193|NCT01402908|528053631|FG000|Overall Study|Withdrawal by Subject|30|||
146422194|NCT01402908|528053632|FG001|Overall Study|Withdrawal by Subject|17|||
146422195|NCT01402908|528053631|FG000|Overall Study|Lost to Follow-up|3|||
146422196|NCT01402908|528053632|FG001|Overall Study|Lost to Follow-up|1|||
146422197|NCT01402908|528053631|FG000|Overall Study|Physician Decision|1|||
146422198|NCT01402908|528053632|FG001|Overall Study|Physician Decision|0|||
146422199|NCT02581345|528053633|FG000|Part 1: up to Week 16|Adverse Event|3|||
146422200|NCT02581345|528053634|FG001|Part 1: up to Week 16|Adverse Event|8|||
146422201|NCT02581345|528053635|FG002|Part 1: up to Week 16|Adverse Event|0|||
146422202|NCT02581345|528053636|FG003|Part 1: up to Week 16|Adverse Event|0|||
146422203|NCT02581345|528053633|FG000|Part 1: up to Week 16|Physician Decision|2|||
146422204|NCT02581345|528053634|FG001|Part 1: up to Week 16|Physician Decision|4|||
146422205|NCT02581345|528053635|FG002|Part 1: up to Week 16|Physician Decision|0|||
146422206|NCT02581345|528053636|FG003|Part 1: up to Week 16|Physician Decision|0|||
146422207|NCT02581345|528053633|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
146422208|NCT02581345|528053634|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
146422209|NCT02581345|528053635|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
146422210|NCT02581345|528053636|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
146422211|NCT02581345|528053633|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
146422212|NCT02581345|528053634|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
146422213|NCT02581345|528053635|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
146422214|NCT02581345|528053636|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
146422215|NCT02581345|528053633|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
146422216|NCT02581345|528053634|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
146422217|NCT02581345|528053635|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
145948580|NCT02907619|526321510|FG000|Overall Study|Other|0|||
146422218|NCT02581345|528053636|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
146082513|NCT02431260|526822819|FG009|Overall Study|Study Terminated by the Sponsor|1|||
146422219|NCT02581345|528053633|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
146422220|NCT02581345|528053634|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
146422221|NCT02581345|528053635|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
146194652|NCT04888585|527224068|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
146194653|NCT04888585|527224069|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
146194654|NCT04888585|527224070|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
146194655|NCT04888585|527224071|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
146194656|NCT04888585|527224072|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
146194657|NCT04888585|527224073|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
146422222|NCT02581345|528053636|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
146422223|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
146422224|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
146194658|NCT04888585|527224074|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
146422225|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
146422226|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
146422227|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
146422228|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
146422229|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
146422230|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
146422231|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
146422232|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
146422233|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
146422234|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
146422235|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
146422236|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
146422237|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
146422238|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
146422239|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
146422240|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
146422241|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
146422242|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
146422243|NCT02581345|528053633|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
146422244|NCT02581345|528053634|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
146422245|NCT02581345|528053635|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
146422246|NCT02581345|528053636|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
146422247|NCT03471078|528053643|FG000|Overall Study|Withdrawal by Subject|9|||
146422248|NCT03471078|528053644|FG001|Overall Study|Withdrawal by Subject|1|||
146422249|NCT03471078|528053643|FG000|Overall Study|Adverse Event|4|||
146422250|NCT03471078|528053644|FG001|Overall Study|Adverse Event|1|||
146422251|NCT03471078|528053643|FG000|Overall Study|Physician Decision|3|||
146422252|NCT03471078|528053644|FG001|Overall Study|Physician Decision|2|||
146422253|NCT03471078|528053643|FG000|Overall Study|Death|2|||
146422254|NCT03471078|528053644|FG001|Overall Study|Death|0|||
146422255|NCT03471078|528053643|FG000|Overall Study|Other|3|||
146422256|NCT03471078|528053644|FG001|Overall Study|Other|2|||
146422257|NCT00862979|528053650|FG000|Overall Study|Adverse Event|6|||
146422258|NCT00862979|528053651|FG001|Overall Study|Adverse Event|3|||
146422259|NCT00862979|528053650|FG000|Overall Study|Protocol Violation|0|||
146422260|NCT00862979|528053651|FG001|Overall Study|Protocol Violation|1|||
146422261|NCT00862979|528053650|FG000|Overall Study|Patient withdrew consent|2|||
146422262|NCT00862979|528053651|FG001|Overall Study|Patient withdrew consent|1|||
146422263|NCT00862979|528053650|FG000|Overall Study|Administrative problems|0|||
146422264|NCT00862979|528053651|FG001|Overall Study|Administrative problems|1|||
146422265|NCT00862979|528053650|FG000|Overall Study|Death|0|||
146422266|NCT00862979|528053651|FG001|Overall Study|Death|1|||
146422267|NCT01027143|528053654|FG000|Overall Study|Lost to Follow-up|9|||
146422268|NCT01027143|528053655|FG001|Overall Study|Lost to Follow-up|4|||
146422269|NCT00797108|528053664|FG000|Overall Study|Adverse Event|1|||
146422270|NCT00797108|528053665|FG001|Overall Study|Adverse Event|0|||
146422271|NCT00797108|528053666|FG002|Overall Study|Adverse Event|3|||
146422272|NCT00797108|528053664|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
146422273|NCT00797108|528053665|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
146422274|NCT00797108|528053666|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
146422275|NCT00797108|528053664|FG000|Overall Study|Global Deterioration of Health Status|0|||
146422276|NCT00797108|528053665|FG001|Overall Study|Global Deterioration of Health Status|1|||
146422277|NCT00797108|528053666|FG002|Overall Study|Global Deterioration of Health Status|0|||
146422278|NCT00797108|528053664|FG000|Overall Study|Lack of Efficacy|1|||
146422279|NCT00797108|528053665|FG001|Overall Study|Lack of Efficacy|0|||
146422280|NCT00797108|528053666|FG002|Overall Study|Lack of Efficacy|1|||
146422281|NCT00797108|528053664|FG000|Overall Study|Other|0|||
146422282|NCT00797108|528053665|FG001|Overall Study|Other|0|||
146422283|NCT00797108|528053666|FG002|Overall Study|Other|2|||
146422284|NCT00797108|528053664|FG000|Overall Study|Randomized but not Treated|2|||
146422285|NCT00797108|528053665|FG001|Overall Study|Randomized but not Treated|0|||
146422286|NCT00797108|528053666|FG002|Overall Study|Randomized but not Treated|0|||
146422287|NCT02518113|528053667|FG000|Overall Study|Adverse Event|1|||
146422288|NCT02518113|528053668|FG001|Overall Study|Adverse Event|0|||
146422289|NCT02518113|528053669|FG002|Overall Study|Adverse Event|1|||
145948581|NCT02907619|526321511|FG001|Overall Study|Other|1|||
145948582|NCT02907619|526321512|FG002|Overall Study|Other|0|||
145948583|NCT01375374|526321513|FG000|Overall Study|Adverse Event|1|||
145948584|NCT01908582|526321514|FG000|Period 2|Physician Decision|1|||
145948585|NCT01908582|526321514|FG000|Period 2|Withdrawal by Subject|1|||
145948586|NCT03594955|526321515|FG000|Overall Study|Adverse Event|1|||
145948587|NCT03594955|526321515|FG000|Overall Study|Progressive disease|5|||
145948588|NCT03594955|526321515|FG000|Overall Study|Sponsor's decision|1|||
145948589|NCT02065518|526321517|FG000|Overall Study|Lost to Follow-up|3|||
145948590|NCT02065518|526321518|FG001|Overall Study|Lost to Follow-up|4|||
145948591|NCT02065518|526321519|FG002|Overall Study|Lost to Follow-up|0|||
145948592|NCT02065518|526321520|FG003|Overall Study|Lost to Follow-up|3|||
145948593|NCT02065518|526321517|FG000|Overall Study|Withdrawal by Subject|3|||
145948594|NCT02065518|526321518|FG001|Overall Study|Withdrawal by Subject|4|||
145948595|NCT02065518|526321519|FG002|Overall Study|Withdrawal by Subject|9|||
145948596|NCT02065518|526321520|FG003|Overall Study|Withdrawal by Subject|2|||
145948597|NCT00564278|526321522|FG000|Overall Study|Lost to Follow-up|35|||
145948598|NCT00564278|526321523|FG001|Overall Study|Lost to Follow-up|33|||
145948599|NCT00564278|526321522|FG000|Overall Study|Physician Decision|1|||
145948600|NCT00564278|526321523|FG001|Overall Study|Physician Decision|2|||
145948601|NCT00564278|526321522|FG000|Overall Study|Withdrawal by Subject|11|||
145948602|NCT00564278|526321523|FG001|Overall Study|Withdrawal by Subject|7|||
145948603|NCT00560703|526321524|FG000|Overall Study|Adverse Event|0|||
145948604|NCT00560703|526321525|FG001|Overall Study|Adverse Event|2|||
145948605|NCT00560703|526321524|FG000|Overall Study|Protocol Violation|0|||
145948606|NCT00560703|526321525|FG001|Overall Study|Protocol Violation|2|||
145948607|NCT00560703|526321524|FG000|Overall Study|Withdrawal by Subject|0|||
145948608|NCT00560703|526321525|FG001|Overall Study|Withdrawal by Subject|1|||
145948609|NCT00560703|526321524|FG000|Overall Study|non-compliance|0|||
145948610|NCT00560703|526321525|FG001|Overall Study|non-compliance|1|||
145948611|NCT06439095|526321526|FG000|Overall Study|Lost to Follow-up|2|||
145948612|NCT03484403|526321528|FG000|Overall Study|Withdrawal by Subject|6|||
145948613|NCT03484403|526321529|FG001|Overall Study|Withdrawal by Subject|4|||
145948614|NCT02570750|526321535|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
145948615|NCT02570750|526321536|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
145948616|NCT02570750|526321535|FG000|Overall Study|Protocol deviation|4|||
145948617|NCT02570750|526321536|FG001|Overall Study|Protocol deviation|2|||
145948618|NCT02570750|526321535|FG000|Overall Study|Withdrawal by Subject|5|||
145948619|NCT02570750|526321536|FG001|Overall Study|Withdrawal by Subject|0|||
145948620|NCT02570750|526321535|FG000|Overall Study|Lost to Follow-up|2|||
145948621|NCT02570750|526321536|FG001|Overall Study|Lost to Follow-up|2|||
145948622|NCT02570750|526321535|FG000|Overall Study|Adverse Event|2|||
145948623|NCT02570750|526321536|FG001|Overall Study|Adverse Event|1|||
145948624|NCT04348500|526321537|FG000|Overall Study|Death|2|||
145948625|NCT04348500|526321538|FG001|Overall Study|Death|2|||
146422290|NCT02518113|528053670|FG003|Overall Study|Adverse Event|0|||
146422291|NCT02518113|528053667|FG000|Overall Study|Death|1|||
146422292|NCT02518113|528053668|FG001|Overall Study|Death|2|||
146422293|NCT02518113|528053669|FG002|Overall Study|Death|0|||
146422294|NCT02518113|528053670|FG003|Overall Study|Death|0|||
146422295|NCT02518113|528053667|FG000|Overall Study|Physician Decision|0|||
146422296|NCT02518113|528053668|FG001|Overall Study|Physician Decision|1|||
145948626|NCT04348500|526321537|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
145948627|NCT04348500|526321538|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
145948628|NCT01410240|526321539|FG000|Overall Study|Physician Decision|0|||
145948629|NCT01410240|526321540|FG001|Overall Study|Physician Decision|0|||
145948630|NCT01410240|526321541|FG002|Overall Study|Physician Decision|1|||
145948631|NCT01410240|526321539|FG000|Overall Study|Missed week 6 assessments|1|||
145948632|NCT01410240|526321540|FG001|Overall Study|Missed week 6 assessments|1|||
146082514|NCT02431260|526822820|FG010|Overall Study|Study Terminated by the Sponsor|1|||
146422297|NCT02518113|528053669|FG002|Overall Study|Physician Decision|0|||
146422298|NCT02518113|528053670|FG003|Overall Study|Physician Decision|0|||
146422299|NCT02518113|528053667|FG000|Overall Study|Progressive Disease|1|||
146422300|NCT02518113|528053668|FG001|Overall Study|Progressive Disease|2|||
146422301|NCT02518113|528053669|FG002|Overall Study|Progressive Disease|3|||
146422302|NCT02518113|528053670|FG003|Overall Study|Progressive Disease|0|||
145948633|NCT01410240|526321541|FG002|Overall Study|Missed week 6 assessments|1|||
145948634|NCT02776670|526321542|FG000|Overall Study|Adverse Event|0|||
145948635|NCT02776670|526321543|FG001|Overall Study|Adverse Event|2|||
145948636|NCT02776670|526321542|FG000|Overall Study|Protocol Violation|0|||
145948637|NCT02776670|526321543|FG001|Overall Study|Protocol Violation|2|||
145948638|NCT02776670|526321542|FG000|Overall Study|Withdrawal by Subject|0|||
145948639|NCT02776670|526321543|FG001|Overall Study|Withdrawal by Subject|1|||
145948640|NCT02776670|526321542|FG000|Overall Study|Other - Reason not given|0|||
145948641|NCT02776670|526321543|FG001|Overall Study|Other - Reason not given|1|||
145948642|NCT03699540|526321544|FG000|Overall Study|Lost to Follow-up|1|||
145948643|NCT02636699|526321547|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
145948644|NCT02636699|526321548|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
146422303|NCT00287118|528053671|FG000|Overall Study|Adverse Event|30|||
146422304|NCT00287118|528053671|FG000|Overall Study|Death|1|||
146422305|NCT00287118|528053671|FG000|Overall Study|Lack of Efficacy|11|||
146422306|NCT00287118|528053671|FG000|Overall Study|Lost to Follow-up|1|||
146422307|NCT00287118|528053671|FG000|Overall Study|Protocol Violation|2|||
146422308|NCT00287118|528053671|FG000|Overall Study|Other|7|||
146422309|NCT01631864|528053672|FG000|Overall Study|Withdrawal by Subject|0|||
146422310|NCT01631864|528053673|FG001|Overall Study|Withdrawal by Subject|1|||
146422311|NCT01631864|528053672|FG000|Overall Study|Adverse Event|2|||
146422312|NCT01631864|528053673|FG001|Overall Study|Adverse Event|3|||
146422313|NCT04471207|528053678|FG000|Overall Study|Lost to Follow-up|4|||
146422314|NCT04471207|528053679|FG001|Overall Study|Lost to Follow-up|1|||
146422315|NCT04471207|528053678|FG000|Overall Study|Medication Contraindication|0|||
146422316|NCT04471207|528053679|FG001|Overall Study|Medication Contraindication|1|||
146422317|NCT04471207|528053678|FG000|Overall Study|Loss of Interest|2|||
146422318|NCT04471207|528053679|FG001|Overall Study|Loss of Interest|1|||
146422319|NCT04471207|528053678|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
145948645|NCT02636699|526321549|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
145948646|NCT02636699|526321547|FG000|Screening Period|Withdrawal by Subject|0|||
145948647|NCT02636699|526321548|FG001|Screening Period|Withdrawal by Subject|0|||
145948648|NCT02636699|526321549|FG002|Screening Period|Withdrawal by Subject|23|||
145948649|NCT02636699|526321547|FG000|Screening Period|Adverse Event|0|||
146422320|NCT04471207|528053679|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
146422321|NCT04471207|528053678|FG000|Overall Study|Scheduling Conflicts|3|||
146422322|NCT04471207|528053679|FG001|Overall Study|Scheduling Conflicts|1|||
146422323|NCT04471207|528053678|FG000|Overall Study|Physician Decision|1|||
145948650|NCT02636699|526321548|FG001|Screening Period|Adverse Event|0|||
146422324|NCT04471207|528053679|FG001|Overall Study|Physician Decision|0|||
145948651|NCT02636699|526321549|FG002|Screening Period|Adverse Event|1|||
145948652|NCT02636699|526321547|FG000|Screening Period|Other not specified|0|||
145948653|NCT02636699|526321548|FG001|Screening Period|Other not specified|0|||
145948654|NCT02636699|526321549|FG002|Screening Period|Other not specified|3|||
145948655|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
145948656|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
145948657|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
145948658|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
145948659|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
145948660|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
145948661|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
145948662|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
145948663|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
145948664|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
145948665|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
145948666|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
145948667|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
145948668|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
145948669|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
145948670|NCT02636699|526321547|FG000|Treatment and Follow-up Periods|Other|3|||
145948671|NCT02636699|526321548|FG001|Treatment and Follow-up Periods|Other|1|||
145948672|NCT02636699|526321549|FG002|Treatment and Follow-up Periods|Other|0|||
145948673|NCT00438256|526321557|FG000|Overall Study|Ineligible for Resection|2|||
145948674|NCT00438256|526321558|FG001|Overall Study|Ineligible for Resection|1|||
145948675|NCT00438256|526321559|FG002|Overall Study|Ineligible for Resection|1|||
145948676|NCT00438256|526321560|FG003|Overall Study|Ineligible for Resection|7|||
145948677|NCT00438256|526321557|FG000|Overall Study|Excluded final Diagnosis|0|||
145948678|NCT00438256|526321558|FG001|Overall Study|Excluded final Diagnosis|0|||
145948679|NCT00438256|526321559|FG002|Overall Study|Excluded final Diagnosis|0|||
145948680|NCT00438256|526321560|FG003|Overall Study|Excluded final Diagnosis|2|||
145948681|NCT04933617|526321566|FG000|Dose Escalation|Early closure of study|0|||
145948682|NCT04933617|526321567|FG001|Dose Escalation|Early closure of study|3|||
145948683|NCT04933617|526321568|FG002|Dose Escalation|Early closure of study|0|||
145948684|NCT04933617|526321569|FG003|Dose Escalation|Early closure of study|0|||
145948685|NCT04933617|526321570|FG004|Dose Escalation|Early closure of study|0|||
145948686|NCT02191046|526321579|FG000|Overall Study|low compliance|5|||
145948687|NCT02191046|526321580|FG001|Overall Study|low compliance|1|||
145948688|NCT03913104|526321585|FG000|Overall Study|Lost to Follow-up|20|||
145948689|NCT03913104|526321585|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
145948690|NCT03913104|526321585|FG000|Overall Study|Withdrawal by Subject|2|||
145948691|NCT01490697|526321589|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
145948692|NCT01490697|526321590|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
145948693|NCT00379808|526321591|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
145948694|NCT00379808|526321592|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
145948695|NCT01048099|526321600|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
145948696|NCT01048099|526321600|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
145948697|NCT01731470|526321602|FG000|Overall Study|Withdrawal by Subject|1|||
145948698|NCT01731470|526321602|FG000|Overall Study|Did not meet study criteria|1|||
145948699|NCT01625689|526321605|FG000|Overall Study|Migration|2|||
145948700|NCT01625689|526321606|FG001|Overall Study|Migration|1|||
145948701|NCT01333956|526321615|FG000|Overall Study|Lost to Follow-up|1|||
145948702|NCT01333956|526321616|FG001|Overall Study|Lost to Follow-up|2|||
145948703|NCT01333956|526321617|FG002|Overall Study|Lost to Follow-up|0|||
145948704|NCT01333956|526321618|FG003|Overall Study|Lost to Follow-up|1|||
145948705|NCT01333956|526321615|FG000|Overall Study|Unable to complete study procedure|1|||
145948706|NCT01333956|526321616|FG001|Overall Study|Unable to complete study procedure|0|||
145948707|NCT01333956|526321617|FG002|Overall Study|Unable to complete study procedure|0|||
145948708|NCT01333956|526321618|FG003|Overall Study|Unable to complete study procedure|1|||
145948709|NCT01333956|526321615|FG000|Overall Study|Withdrawal by Subject|0|||
145948710|NCT01333956|526321616|FG001|Overall Study|Withdrawal by Subject|2|||
145948711|NCT01333956|526321617|FG002|Overall Study|Withdrawal by Subject|1|||
145948712|NCT01333956|526321618|FG003|Overall Study|Withdrawal by Subject|0|||
145948713|NCT02134353|526321619|FG000|Overall Study|Adverse Event|10|||
145948714|NCT02134353|526321620|FG001|Overall Study|Adverse Event|6|||
145948715|NCT02134353|526321619|FG000|Overall Study|Lost to Follow-up|1|||
145948716|NCT02134353|526321620|FG001|Overall Study|Lost to Follow-up|1|||
145948717|NCT02134353|526321619|FG000|Overall Study|Lack of Efficacy|2|||
145948718|NCT02134353|526321620|FG001|Overall Study|Lack of Efficacy|1|||
145948719|NCT02134353|526321619|FG000|Overall Study|Withdrawal by Subject|12|||
145948720|NCT02134353|526321620|FG001|Overall Study|Withdrawal by Subject|13|||
145948721|NCT02134353|526321619|FG000|Overall Study|Death|0|||
145948722|NCT02134353|526321620|FG001|Overall Study|Death|1|||
145948723|NCT02134353|526321619|FG000|Overall Study|Pregnancy|0|||
145948724|NCT02134353|526321620|FG001|Overall Study|Pregnancy|1|||
145948725|NCT02134353|526321619|FG000|Overall Study|Relocation|1|||
145948726|NCT02134353|526321620|FG001|Overall Study|Relocation|0|||
145948727|NCT02134353|526321619|FG000|Overall Study|Other - Patient's Choice|0|||
145948728|NCT02134353|526321620|FG001|Overall Study|Other - Patient's Choice|1|||
145948729|NCT03426436|526321621|FG000|Overall Study|Incorrect lead placement|12|||
145948730|NCT03426436|526321621|FG000|Overall Study|Withdrawal by Subject|2|||
145948731|NCT03426436|526321621|FG000|Overall Study|Consent issue|1|||
145948732|NCT03426436|526321621|FG000|Overall Study|ECGs not saved|4|||
145948733|NCT03611582|526321622|FG000|Overall Study|Adverse Event|26|||
145948734|NCT03611582|526321623|FG001|Overall Study|Adverse Event|6|||
145948735|NCT03611582|526321622|FG000|Overall Study|Protocol Violation|0|||
145948736|NCT03611582|526321623|FG001|Overall Study|Protocol Violation|1|||
145948737|NCT03611582|526321622|FG000|Overall Study|Pregnancy|1|||
145948738|NCT03611582|526321623|FG001|Overall Study|Pregnancy|2|||
145948739|NCT03611582|526321622|FG000|Overall Study|Lack of Efficacy|0|||
145948740|NCT03611582|526321623|FG001|Overall Study|Lack of Efficacy|1|||
145948741|NCT03611582|526321622|FG000|Overall Study|At the discretion of the investigator|1|||
145948742|NCT03611582|526321623|FG001|Overall Study|At the discretion of the investigator|0|||
145948743|NCT03611582|526321622|FG000|Overall Study|Safety concern as judged by the investigator|1|||
145948744|NCT03611582|526321623|FG001|Overall Study|Safety concern as judged by the investigator|2|||
145948745|NCT03611582|526321622|FG000|Overall Study|Withdrawal by Subject|4|||
145948746|NCT03611582|526321623|FG001|Overall Study|Withdrawal by Subject|3|||
145948747|NCT03611582|526321622|FG000|Overall Study|Lost to Follow-up|18|||
145948748|NCT03611582|526321623|FG001|Overall Study|Lost to Follow-up|7|||
145948749|NCT03611582|526321622|FG000|Overall Study|other|17|||
145948750|NCT03611582|526321623|FG001|Overall Study|other|16|||
145948751|NCT01783821|526321624|FG000|Overall Study|Screen Failure|1|||
145948752|NCT01783821|526321625|FG001|Overall Study|Screen Failure|1|||
146422325|NCT04471207|528053678|FG000|Overall Study|Unwilling to Use System|0|||
146422326|NCT04471207|528053679|FG001|Overall Study|Unwilling to Use System|1|||
146422327|NCT00561730|528053682|FG000|Overall Study|Adverse Event|2|||
146422328|NCT00561730|528053682|FG000|Overall Study|Handling of the drug|1|||
145948753|NCT00422292|526321626|FG000|Overall Study|Serious adverse events|1|||
145948754|NCT00422292|526321627|FG001|Overall Study|Serious adverse events|4|||
145948755|NCT00422292|526321628|FG002|Overall Study|Serious adverse events|0|||
145948756|NCT00422292|526321629|FG003|Overall Study|Serious adverse events|0|||
145948757|NCT00422292|526321626|FG000|Overall Study|Adverse Event|1|||
146194659|NCT04888585|527224075|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
146194660|NCT04888585|527224076|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
146194661|NCT04888585|527224077|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
146194662|NCT04888585|527224078|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
146194663|NCT04888585|527224068|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194664|NCT04888585|527224069|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194665|NCT04888585|527224070|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194666|NCT04888585|527224071|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194667|NCT04888585|527224072|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194668|NCT04888585|527224073|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194669|NCT04888585|527224074|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
146194670|NCT04888585|527224075|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
146194671|NCT04888585|527224076|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
146194672|NCT04888585|527224077|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
146194673|NCT04888585|527224078|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
146194674|NCT04927975|527224079|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
146194675|NCT04927975|527224080|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
146422329|NCT00561730|528053682|FG000|Overall Study|Lost to Follow-up|5|||
146422330|NCT00561730|528053682|FG000|Overall Study|Not specified reasons|1|||
146422331|NCT04373434|528053699|FG000|Overall Study|Lost to Follow-up|37|||
146422332|NCT04373434|528053700|FG001|Overall Study|Lost to Follow-up|32|||
146422333|NCT04373434|528053699|FG000|Overall Study|Refused at 9 months|1|||
146422334|NCT04373434|528053700|FG001|Overall Study|Refused at 9 months|2|||
146422335|NCT04373434|528053699|FG000|Overall Study|Refused at 4 months|7|||
146422336|NCT04373434|528053700|FG001|Overall Study|Refused at 4 months|3|||
145948758|NCT00422292|526321627|FG001|Overall Study|Adverse Event|0|||
145948759|NCT00422292|526321628|FG002|Overall Study|Adverse Event|1|||
145948760|NCT00422292|526321629|FG003|Overall Study|Adverse Event|0|||
145948761|NCT00422292|526321626|FG000|Overall Study|Protocol Violation|4|||
145948762|NCT00422292|526321627|FG001|Overall Study|Protocol Violation|25|||
145948763|NCT00422292|526321628|FG002|Overall Study|Protocol Violation|8|||
145948764|NCT00422292|526321629|FG003|Overall Study|Protocol Violation|5|||
145948765|NCT00422292|526321626|FG000|Overall Study|Lost to Follow-up|6|||
145948766|NCT00422292|526321627|FG001|Overall Study|Lost to Follow-up|12|||
146422337|NCT04373434|528053699|FG000|Overall Study|Excluded|2|||
146422338|NCT04373434|528053700|FG001|Overall Study|Excluded|0|||
145948767|NCT00422292|526321628|FG002|Overall Study|Lost to Follow-up|6|||
145948768|NCT00422292|526321629|FG003|Overall Study|Lost to Follow-up|6|||
145948769|NCT00422292|526321626|FG000|Overall Study|Withdrawal by Subject|6|||
145948770|NCT00422292|526321627|FG001|Overall Study|Withdrawal by Subject|25|||
145948771|NCT00422292|526321628|FG002|Overall Study|Withdrawal by Subject|7|||
145948772|NCT00422292|526321629|FG003|Overall Study|Withdrawal by Subject|13|||
145948773|NCT02440854|526321630|FG000|Overall Study|Relocation of patient|1|||
145948774|NCT02440854|526321630|FG000|Overall Study|Death|6|||
145948775|NCT02440854|526321630|FG000|Overall Study|Lost to Follow-up|10|||
145948776|NCT02440854|526321630|FG000|Overall Study|Afatinib discontinuation|46|||
145948777|NCT02440854|526321630|FG000|Overall Study|stopped study at earlier timepoint|14|||
145948778|NCT02440854|526321630|FG000|Overall Study|Study medication not received|1|||
145948779|NCT02440854|526321630|FG000|Overall Study|Violation of inclusion criteria|2|||
145948780|NCT03338569|526321631|FG000|Overall Study|Physician Decision|8|||
145948781|NCT03338569|526321632|FG001|Overall Study|Physician Decision|3|||
145948782|NCT03338569|526321631|FG000|Overall Study|Withdrawal by Subject|0|||
145948783|NCT03338569|526321632|FG001|Overall Study|Withdrawal by Subject|1|||
145948784|NCT03338569|526321631|FG000|Overall Study|Lost to Follow-up|0|||
145948785|NCT03338569|526321632|FG001|Overall Study|Lost to Follow-up|1|||
145948786|NCT02243046|526321633|FG000|Overall Study|Lost to Follow-up|1|||
145948787|NCT02243046|526321634|FG001|Overall Study|Lost to Follow-up|1|||
145948788|NCT02243046|526321635|FG002|Overall Study|Lost to Follow-up|4|||
145948789|NCT04607980|526321636|FG000|Overall Study|Adverse Event|3|||
145948790|NCT04607980|526321637|FG001|Overall Study|Adverse Event|4|||
145948791|NCT04607980|526321636|FG000|Overall Study|Death|0|||
145948792|NCT04607980|526321637|FG001|Overall Study|Death|1|||
145948793|NCT04607980|526321636|FG000|Overall Study|Withdrawal by Subject|2|||
145948794|NCT04607980|526321637|FG001|Overall Study|Withdrawal by Subject|5|||
145948795|NCT04607980|526321636|FG000|Overall Study|Lost to Follow-up|4|||
145948796|NCT04607980|526321637|FG001|Overall Study|Lost to Follow-up|8|||
145948797|NCT04607980|526321636|FG000|Overall Study|Protocol Violation|0|||
145948798|NCT04607980|526321637|FG001|Overall Study|Protocol Violation|3|||
145948799|NCT04607980|526321636|FG000|Overall Study|Other|3|||
145948800|NCT04607980|526321637|FG001|Overall Study|Other|0|||
145948801|NCT01854879|526321638|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
145948802|NCT01854879|526321638|FG000|Overall Study|screen fail|3|||
145948803|NCT01854879|526321638|FG000|Overall Study|incomplete data set|1|||
145948804|NCT02012959|526321639|FG000|Treatment Phase A|Adverse Event|2|||
145948805|NCT02012959|526321640|FG001|Treatment Phase A|Adverse Event|0|||
145948806|NCT02012959|526321641|FG002|Treatment Phase A|Adverse Event|0|||
145948807|NCT02012959|526321642|FG003|Treatment Phase A|Adverse Event|0|||
145948808|NCT02012959|526321643|FG004|Treatment Phase A|Adverse Event|0|||
145948809|NCT04494425|526323054|FG000|Overall Study|Death|160|||
145948810|NCT04494425|526323055|FG001|Overall Study|Death|166|||
145948811|NCT04494425|526323054|FG000|Overall Study|Withdrawal by Subject|10|||
145948812|NCT04494425|526323055|FG001|Overall Study|Withdrawal by Subject|40|||
145948813|NCT04494425|526323054|FG000|Overall Study|Other|1|||
145948814|NCT04494425|526323055|FG001|Overall Study|Other|1|||
145948815|NCT04494425|526323054|FG000|Overall Study|Ongoing at the time of PCD|265|||
145948816|NCT04494425|526323055|FG001|Overall Study|Ongoing at the time of PCD|223|||
145948817|NCT01270321|526323056|FG000|Overall Study|Death|3|||
145948818|NCT01270321|526323057|FG001|Overall Study|Death|1|||
145948819|NCT01270321|526323058|FG002|Overall Study|Death|4|||
145948820|NCT01270321|526323056|FG000|Overall Study|Adverse Event|7|||
145948821|NCT01270321|526323057|FG001|Overall Study|Adverse Event|9|||
145948822|NCT01270321|526323058|FG002|Overall Study|Adverse Event|5|||
145948823|NCT04003623|526323062|FG000|Overall Study|Withdrawal by Subject|1|||
145948824|NCT04003623|526323063|FG001|Overall Study|Withdrawal by Subject|0|||
145948825|NCT01744483|526323069|FG000|Overall Study|Death|9|||
146194676|NCT04927975|527224081|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
146194677|NCT04927975|527224082|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
146194678|NCT04927975|527224083|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
146194679|NCT04927975|527224084|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
146194680|NCT04927975|527224079|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
145948826|NCT01744483|526323070|FG001|Overall Study|Death|4|||
145948827|NCT01744483|526323071|FG002|Overall Study|Death|11|||
145948828|NCT01744483|526323069|FG000|Overall Study|Lost to Follow-up|8|||
145948829|NCT01744483|526323070|FG001|Overall Study|Lost to Follow-up|9|||
145948830|NCT01744483|526323071|FG002|Overall Study|Lost to Follow-up|11|||
145948831|NCT01744483|526323069|FG000|Overall Study|Protocol Violation|1|||
146194681|NCT04927975|527224080|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146194682|NCT04927975|527224081|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146194683|NCT04927975|527224082|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
146194684|NCT04927975|527224083|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
146194685|NCT04927975|527224084|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
146194686|NCT04927975|527224079|FG000|Period 1 (Baseline-Week 24)|Death|0|||
146194687|NCT04927975|527224080|FG001|Period 1 (Baseline-Week 24)|Death|0|||
146194688|NCT04927975|527224081|FG002|Period 1 (Baseline-Week 24)|Death|0|||
146194689|NCT04927975|527224082|FG003|Period 1 (Baseline-Week 24)|Death|0|||
146194690|NCT04927975|527224083|FG004|Period 1 (Baseline-Week 24)|Death|0|||
146194691|NCT04927975|527224084|FG005|Period 1 (Baseline-Week 24)|Death|1|||
146194692|NCT04927975|527224079|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
146194693|NCT04927975|527224080|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
146194694|NCT04927975|527224081|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
146194695|NCT04927975|527224082|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
146194696|NCT04927975|527224083|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
146194697|NCT04927975|527224084|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
146194698|NCT04927975|527224079|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
146194699|NCT04927975|527224080|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146194700|NCT04927975|527224081|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146194701|NCT04927975|527224082|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
146194702|NCT04927975|527224083|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146194703|NCT04927975|527224084|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
146194704|NCT03822351|527224085|FG000|Overall Study|Death|27|||
146194705|NCT03822351|527224086|FG001|Overall Study|Death|23|||
146194706|NCT03822351|527224087|FG002|Overall Study|Death|24|||
146194707|NCT03822351|527224085|FG000|Overall Study|Lost to Follow-up|6|||
146194708|NCT03822351|527224086|FG001|Overall Study|Lost to Follow-up|2|||
146194709|NCT03822351|527224087|FG002|Overall Study|Lost to Follow-up|1|||
146194710|NCT03822351|527224085|FG000|Overall Study|Withdrawal by Subject|10|||
146194711|NCT03822351|527224086|FG001|Overall Study|Withdrawal by Subject|4|||
146194712|NCT03822351|527224087|FG002|Overall Study|Withdrawal by Subject|6|||
146194713|NCT03822351|527224085|FG000|Overall Study|Progressive Disease|2|||
146194714|NCT03822351|527224086|FG001|Overall Study|Progressive Disease|1|||
146194715|NCT03822351|527224087|FG002|Overall Study|Progressive Disease|0|||
146194716|NCT03822351|527224085|FG000|Overall Study|Not Treated|1|||
146194717|NCT03822351|527224086|FG001|Overall Study|Not Treated|1|||
146194718|NCT03822351|527224087|FG002|Overall Study|Not Treated|1|||
146194719|NCT03563053|527224096|FG000|Overall Study|Withdrawal by Subject|17|||
146194720|NCT03563053|527224096|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
146194721|NCT03563053|527224096|FG000|Overall Study|Adverse Event|3|||
146194722|NCT03563053|527224096|FG000|Overall Study|Physician Decision|1|||
146194723|NCT03563053|527224096|FG000|Overall Study|study terminated by sponsor|71|||
146194724|NCT02081391|527224097|FG000|12-hour Treatment|Withdrawal by Subject|3|||
146194725|NCT02081391|527224098|FG001|12-hour Treatment|Withdrawal by Subject|2|||
146194726|NCT02081391|527224099|FG002|12-hour Treatment|Withdrawal by Subject|0|||
146194727|NCT02081391|527224100|FG003|12-hour Treatment|Withdrawal by Subject|0|||
146194728|NCT02081391|527224097|FG000|12-hour Treatment|Physician Decision|4|||
146422339|NCT00527423|528053701|FG000|Overall Study|Protocol Violation|1|||
146422340|NCT00527423|528053701|FG000|Overall Study|Adverse Event|5|||
146422341|NCT00527423|528053701|FG000|Overall Study|Physician Decision|4|||
146422342|NCT00527423|528053701|FG000|Overall Study|Withdrawal by Subject|10|||
146422343|NCT00527423|528053701|FG000|Overall Study|Lost to Follow-up|4|||
146422344|NCT00527423|528053701|FG000|Overall Study|OTHER|4|||
146422345|NCT00527423|528053701|FG000|Overall Study|Death|9|||
146422346|NCT03194464|528053705|FG000|Overall Study|data not usable|2|||
146422347|NCT02153398|528053706|FG000|Overall Study|Withdrawal by Subject|1|||
146422348|NCT02153398|528053707|FG001|Overall Study|Withdrawal by Subject|0|||
146422349|NCT02153398|528053708|FG002|Overall Study|Withdrawal by Subject|0|||
146422350|NCT02153398|528053709|FG003|Overall Study|Withdrawal by Subject|0|||
146422351|NCT02153398|528053710|FG004|Overall Study|Withdrawal by Subject|0|||
146422352|NCT02153398|528053706|FG000|Overall Study|Adverse Event|0|||
146422353|NCT02153398|528053707|FG001|Overall Study|Adverse Event|0|||
146422354|NCT02153398|528053708|FG002|Overall Study|Adverse Event|1|||
146422355|NCT02153398|528053709|FG003|Overall Study|Adverse Event|1|||
146422356|NCT02153398|528053710|FG004|Overall Study|Adverse Event|0|||
146422357|NCT01400425|528053711|FG000|Overall Study|Withdrawal by Subject|10|||
146422358|NCT00818883|528053712|FG000|Overall Study|Adverse Event|28|||
146422359|NCT00818883|528053713|FG001|Overall Study|Adverse Event|19|||
146422360|NCT00818883|528053712|FG000|Overall Study|Protocol Violation|2|||
146422361|NCT00818883|528053713|FG001|Overall Study|Protocol Violation|2|||
146422362|NCT00818883|528053712|FG000|Overall Study|Lost to Follow-up|3|||
146422363|NCT00818883|528053713|FG001|Overall Study|Lost to Follow-up|2|||
146422364|NCT00818883|528053712|FG000|Overall Study|Withdrawal by Subject|16|||
146422365|NCT00818883|528053713|FG001|Overall Study|Withdrawal by Subject|14|||
146422366|NCT00818883|528053712|FG000|Overall Study|Lack of Efficacy|0|||
146422367|NCT00818883|528053713|FG001|Overall Study|Lack of Efficacy|2|||
146422368|NCT00818883|528053712|FG000|Overall Study|Other|2|||
146422369|NCT00818883|528053713|FG001|Overall Study|Other|7|||
146422370|NCT00973700|528053714|FG000|Overall Study|Withdrawal by Subject|2|||
145948832|NCT01744483|526323070|FG001|Overall Study|Protocol Violation|2|||
146422371|NCT00973700|528053715|FG001|Overall Study|Withdrawal by Subject|2|||
146422372|NCT00973700|528053716|FG002|Overall Study|Withdrawal by Subject|8|||
146422373|NCT00973700|528053717|FG003|Overall Study|Withdrawal by Subject|4|||
146422374|NCT00973700|528053718|FG004|Overall Study|Withdrawal by Subject|4|||
146422375|NCT00973700|528053714|FG000|Overall Study|Lost to Follow-up|5|||
146422376|NCT00973700|528053715|FG001|Overall Study|Lost to Follow-up|0|||
146422377|NCT00973700|528053716|FG002|Overall Study|Lost to Follow-up|1|||
146422378|NCT00973700|528053717|FG003|Overall Study|Lost to Follow-up|8|||
146422379|NCT00973700|528053718|FG004|Overall Study|Lost to Follow-up|5|||
146422380|NCT00973700|528053714|FG000|Overall Study|Inappropriate enrolment|0|||
146422381|NCT00973700|528053715|FG001|Overall Study|Inappropriate enrolment|0|||
146422382|NCT00973700|528053716|FG002|Overall Study|Inappropriate enrolment|0|||
146422383|NCT00973700|528053717|FG003|Overall Study|Inappropriate enrolment|4|||
146422384|NCT00973700|528053718|FG004|Overall Study|Inappropriate enrolment|0|||
146422385|NCT00973700|528053714|FG000|Overall Study|Unable to Classify|0|||
146422386|NCT00973700|528053715|FG001|Overall Study|Unable to Classify|0|||
146422387|NCT00973700|528053716|FG002|Overall Study|Unable to Classify|1|||
146422388|NCT00973700|528053717|FG003|Overall Study|Unable to Classify|2|||
146422389|NCT00973700|528053718|FG004|Overall Study|Unable to Classify|1|||
146194729|NCT02081391|527224098|FG001|12-hour Treatment|Physician Decision|1|||
146194730|NCT02081391|527224099|FG002|12-hour Treatment|Physician Decision|0|||
146194731|NCT02081391|527224100|FG003|12-hour Treatment|Physician Decision|0|||
146194732|NCT02081391|527224097|FG000|12-hour Treatment|Lack of Efficacy|3|||
146194733|NCT02081391|527224098|FG001|12-hour Treatment|Lack of Efficacy|0|||
146194734|NCT02081391|527224099|FG002|12-hour Treatment|Lack of Efficacy|0|||
146194735|NCT02081391|527224100|FG003|12-hour Treatment|Lack of Efficacy|0|||
146194736|NCT02081391|527224097|FG000|12-hour Treatment|Adverse Event|4|||
146194737|NCT02081391|527224098|FG001|12-hour Treatment|Adverse Event|2|||
146194738|NCT02081391|527224099|FG002|12-hour Treatment|Adverse Event|0|||
146194739|NCT02081391|527224100|FG003|12-hour Treatment|Adverse Event|0|||
146194740|NCT02081391|527224097|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
146422390|NCT00806156|528053720|FG000|Overall Study|Death|35|||
146422391|NCT00806156|528053721|FG001|Overall Study|Death|95|||
146422392|NCT00806156|528053720|FG000|Overall Study|Did not meet eligibility criteria|1|||
146422393|NCT00806156|528053721|FG001|Overall Study|Did not meet eligibility criteria|0|||
146422394|NCT00806156|528053720|FG000|Overall Study|Study terminated by Sponsor|2|||
146422395|NCT00806156|528053721|FG001|Overall Study|Study terminated by Sponsor|40|||
146422396|NCT00806156|528053720|FG000|Overall Study|Consent withdrawn by subject|1|||
146422397|NCT00806156|528053721|FG001|Overall Study|Consent withdrawn by subject|3|||
146422398|NCT00806156|528053720|FG000|Overall Study|Lost to Follow-up|0|||
146194741|NCT02081391|527224098|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
146194742|NCT02081391|527224099|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
146194743|NCT02081391|527224100|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
146194744|NCT02081391|527224097|FG000|12-hour Treatment|Further reasons|2|||
146194745|NCT02081391|527224098|FG001|12-hour Treatment|Further reasons|1|||
146194746|NCT02081391|527224099|FG002|12-hour Treatment|Further reasons|0|||
146194747|NCT02081391|527224100|FG003|12-hour Treatment|Further reasons|0|||
146194748|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
146194749|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
146194750|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
146194751|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
146194752|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
146194753|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
146194754|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
146194755|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
146194756|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
146194757|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
146422399|NCT00806156|528053721|FG001|Overall Study|Lost to Follow-up|1|||
146422400|NCT00424489|528053725|FG000|Overall Study|Death|3|||
146422401|NCT00536575|528053730|FG000|Overall Study|Withdrawal by Subject|1|||
146194758|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
146194759|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
146194760|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
146422402|NCT00536575|528053730|FG000|Overall Study|Death|1|||
146422403|NCT01089647|528053731|FG000|Overall Study|Lost to Follow-up|2|||
146422404|NCT01089647|528053732|FG001|Overall Study|Lost to Follow-up|2|||
146194761|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
146194762|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
146194763|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
146194764|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
146422405|NCT01089647|528053731|FG000|Overall Study|Withdrawal by Subject|2|||
146422406|NCT01089647|528053732|FG001|Overall Study|Withdrawal by Subject|1|||
146422407|NCT01089647|528053731|FG000|Overall Study|Adverse Event|0|||
146422408|NCT01089647|528053732|FG001|Overall Study|Adverse Event|1|||
146194765|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
146194766|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
146194767|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
146194768|NCT02081391|527224097|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
146194769|NCT02081391|527224098|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
146194770|NCT02081391|527224099|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
146194771|NCT02081391|527224100|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
146194772|NCT01458275|527224101|FG000|Overall Study|Adverse Event|3|||
146194773|NCT01458275|527224102|FG001|Overall Study|Adverse Event|4|||
146194774|NCT01458275|527224103|FG002|Overall Study|Adverse Event|1|||
146194775|NCT01458275|527224101|FG000|Overall Study|Lost to Follow-up|3|||
146194776|NCT01458275|527224102|FG001|Overall Study|Lost to Follow-up|2|||
146194777|NCT01458275|527224103|FG002|Overall Study|Lost to Follow-up|5|||
146194778|NCT01458275|527224101|FG000|Overall Study|Protocol Violation|5|||
146194779|NCT01458275|527224102|FG001|Overall Study|Protocol Violation|5|||
146194780|NCT01458275|527224103|FG002|Overall Study|Protocol Violation|2|||
146194781|NCT01458275|527224101|FG000|Overall Study|Withdrawal by Subject|3|||
146194782|NCT01458275|527224102|FG001|Overall Study|Withdrawal by Subject|2|||
146194783|NCT01458275|527224103|FG002|Overall Study|Withdrawal by Subject|1|||
146422409|NCT00927810|528053733|FG000|Overall Study|Withdrawal by Subject|0|||
146194784|NCT00813488|527224104|FG000|Titration Period 1|Adverse Event|6|||
146194785|NCT00813488|527224105|FG001|Titration Period 1|Adverse Event|1|||
146194786|NCT00813488|527224104|FG000|Titration Period 1|Lack of Efficacy|9|||
146194787|NCT00813488|527224105|FG001|Titration Period 1|Lack of Efficacy|7|||
146194788|NCT00813488|527224104|FG000|Titration Period 1|Withdrawal by Subject|2|||
146194789|NCT00813488|527224105|FG001|Titration Period 1|Withdrawal by Subject|2|||
146194790|NCT00813488|527224104|FG000|Titration Period 1|Protocol Violation|4|||
146194791|NCT00813488|527224105|FG001|Titration Period 1|Protocol Violation|3|||
146194792|NCT00813488|527224104|FG000|Titration Period 1|Non-compliance to study medication|4|||
146194793|NCT00813488|527224105|FG001|Titration Period 1|Non-compliance to study medication|1|||
146194794|NCT00813488|527224104|FG000|Titration Period 1|Non-compliance to study procedures|2|||
146194795|NCT00813488|527224105|FG001|Titration Period 1|Non-compliance to study procedures|2|||
146422410|NCT00927810|528053734|FG001|Overall Study|Withdrawal by Subject|3|||
146422411|NCT00927810|528053735|FG002|Overall Study|Withdrawal by Subject|0|||
146422412|NCT00927810|528053736|FG003|Overall Study|Withdrawal by Subject|1|||
146422413|NCT00927810|528053733|FG000|Overall Study|Lost to Follow-up|0|||
146422414|NCT00927810|528053734|FG001|Overall Study|Lost to Follow-up|2|||
146422415|NCT00927810|528053735|FG002|Overall Study|Lost to Follow-up|1|||
146422416|NCT00927810|528053736|FG003|Overall Study|Lost to Follow-up|1|||
146422417|NCT00927810|528053733|FG000|Overall Study|Death|0|||
146422418|NCT00927810|528053734|FG001|Overall Study|Death|2|||
146422419|NCT00927810|528053735|FG002|Overall Study|Death|0|||
146422420|NCT00927810|528053736|FG003|Overall Study|Death|0|||
146422421|NCT00927810|528053733|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146422422|NCT00927810|528053734|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146422423|NCT00927810|528053735|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146422424|NCT00927810|528053736|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146422425|NCT00198029|528053737|FG000|Overall Study|Withdrawal by Subject|4|||
146422426|NCT02465567|528053738|FG000|Overall Study|Adverse Event|118|||
146422427|NCT02465567|528053739|FG001|Overall Study|Adverse Event|113|||
146422428|NCT02465567|528053740|FG002|Overall Study|Adverse Event|147|||
146422429|NCT02465567|528053741|FG003|Overall Study|Adverse Event|138|||
146422430|NCT02465567|528053738|FG000|Overall Study|Lack of Efficacy|103|||
146422431|NCT02465567|528053739|FG001|Overall Study|Lack of Efficacy|102|||
146422432|NCT02465567|528053740|FG002|Overall Study|Lack of Efficacy|171|||
146422433|NCT02465567|528053741|FG003|Overall Study|Lack of Efficacy|135|||
146422434|NCT02465567|528053738|FG000|Overall Study|Withdrawal by Subject|104|||
146422435|NCT02465567|528053739|FG001|Overall Study|Withdrawal by Subject|94|||
146422436|NCT02465567|528053740|FG002|Overall Study|Withdrawal by Subject|123|||
146422437|NCT02465567|528053741|FG003|Overall Study|Withdrawal by Subject|130|||
146422438|NCT02465567|528053738|FG000|Overall Study|Physician Decision|23|||
146422439|NCT02465567|528053739|FG001|Overall Study|Physician Decision|33|||
146422440|NCT02465567|528053740|FG002|Overall Study|Physician Decision|38|||
146422441|NCT02465567|528053741|FG003|Overall Study|Physician Decision|28|||
146422442|NCT02465567|528053738|FG000|Overall Study|Major Protocol Deviation|24|||
146422443|NCT02465567|528053739|FG001|Overall Study|Major Protocol Deviation|26|||
146422444|NCT02465567|528053740|FG002|Overall Study|Major Protocol Deviation|22|||
146422445|NCT02465567|528053741|FG003|Overall Study|Major Protocol Deviation|25|||
146422446|NCT02465567|528053738|FG000|Overall Study|Lost to Follow-up|25|||
146422447|NCT02465567|528053739|FG001|Overall Study|Lost to Follow-up|21|||
146422448|NCT02465567|528053740|FG002|Overall Study|Lost to Follow-up|19|||
146422449|NCT02465567|528053741|FG003|Overall Study|Lost to Follow-up|15|||
146422450|NCT02465567|528053738|FG000|Overall Study|Protocol Specified Criteria|20|||
146422451|NCT02465567|528053739|FG001|Overall Study|Protocol Specified Criteria|10|||
146422452|NCT02465567|528053740|FG002|Overall Study|Protocol Specified Criteria|9|||
146422453|NCT02465567|528053741|FG003|Overall Study|Protocol Specified Criteria|12|||
146422454|NCT02465567|528053738|FG000|Overall Study|Administrative Reasons|12|||
146422455|NCT02465567|528053739|FG001|Overall Study|Administrative Reasons|9|||
146422456|NCT02465567|528053740|FG002|Overall Study|Administrative Reasons|11|||
146422457|NCT02465567|528053741|FG003|Overall Study|Administrative Reasons|5|||
146422458|NCT02465567|528053738|FG000|Overall Study|Randomized but not treated|1|||
145948833|NCT01744483|526323071|FG002|Overall Study|Protocol Violation|1|||
145948834|NCT01744483|526323069|FG000|Overall Study|Withdrawal by Subject|4|||
145948835|NCT01744483|526323070|FG001|Overall Study|Withdrawal by Subject|6|||
145948836|NCT01744483|526323071|FG002|Overall Study|Withdrawal by Subject|2|||
146194796|NCT00813488|527224104|FG000|Titration Period 1|Technical Difficulties|0|||
146194797|NCT00813488|527224105|FG001|Titration Period 1|Technical Difficulties|1|||
146194798|NCT00813488|527224104|FG000|Titration Period 2|Adverse Event|2|||
146422459|NCT02465567|528053739|FG001|Overall Study|Randomized but not treated|5|||
146422460|NCT02465567|528053740|FG002|Overall Study|Randomized but not treated|4|||
146422461|NCT02465567|528053741|FG003|Overall Study|Randomized but not treated|5|||
146422462|NCT02465567|528053738|FG000|Overall Study|enrolled in >1 studies|18|||
146422463|NCT02465567|528053739|FG001|Overall Study|enrolled in >1 studies|11|||
146422464|NCT02465567|528053740|FG002|Overall Study|enrolled in >1 studies|19|||
146422465|NCT02465567|528053741|FG003|Overall Study|enrolled in >1 studies|15|||
146422466|NCT02465567|528053738|FG000|Overall Study|missing PI Signature|1|||
146422467|NCT02465567|528053739|FG001|Overall Study|missing PI Signature|0|||
146422468|NCT02465567|528053740|FG002|Overall Study|missing PI Signature|0|||
145948837|NCT01744483|526323069|FG000|Overall Study|No ICU Admit|5|||
146194799|NCT00813488|527224105|FG001|Titration Period 2|Adverse Event|3|||
146422469|NCT02465567|528053741|FG003|Overall Study|missing PI Signature|0|||
146422470|NCT02001558|528053742|FG000|Overall Study|Lost to Follow-up|8|||
146422471|NCT02001558|528053743|FG001|Overall Study|Lost to Follow-up|14|||
146422472|NCT04117607|528053744|FG000|Overall Study|Early Termination|0|||
146422473|NCT04117607|528053745|FG001|Overall Study|Early Termination|1|||
146422474|NCT04117607|528053746|FG002|Overall Study|Early Termination|0|||
146422475|NCT04117607|528053747|FG003|Overall Study|Early Termination|0|||
146422476|NCT04117607|528053748|FG004|Overall Study|Early Termination|0|||
146422477|NCT04117607|528053749|FG005|Overall Study|Early Termination|0|||
146422478|NCT04117607|528053750|FG006|Overall Study|Early Termination|1|||
146422479|NCT04117607|528053751|FG007|Overall Study|Early Termination|0|||
146422480|NCT04117607|528053752|FG008|Overall Study|Early Termination|0|||
146422481|NCT04117607|528053753|FG009|Overall Study|Early Termination|0|||
146422482|NCT04117607|528053754|FG010|Overall Study|Early Termination|0|||
146422483|NCT04117607|528053755|FG011|Overall Study|Early Termination|0|||
146422484|NCT04117607|528053756|FG012|Overall Study|Early Termination|0|||
146422485|NCT04117607|528053757|FG013|Overall Study|Early Termination|0|||
146422486|NCT01626079|528053759|FG000|Overall Study|Death|167|||
146422487|NCT01626079|528053760|FG001|Overall Study|Death|192|||
146422488|NCT01626079|528053761|FG002|Overall Study|Death|39|||
146422489|NCT01626079|528053759|FG000|Overall Study|Withdrawal by Subject|23|||
146422490|NCT01626079|528053760|FG001|Overall Study|Withdrawal by Subject|37|||
146422491|NCT01626079|528053761|FG002|Overall Study|Withdrawal by Subject|5|||
146422492|NCT01626079|528053759|FG000|Overall Study|Lost to Follow-up|7|||
146422493|NCT01626079|528053760|FG001|Overall Study|Lost to Follow-up|4|||
146422494|NCT01626079|528053761|FG002|Overall Study|Lost to Follow-up|2|||
146422495|NCT01626079|528053759|FG000|Overall Study|Missed Visits|1|||
146422496|NCT01626079|528053760|FG001|Overall Study|Missed Visits|4|||
146422497|NCT01626079|528053761|FG002|Overall Study|Missed Visits|6|||
146422498|NCT00814463|528053763|FG000|Overall Study|Lost to Follow-up|1|||
146422499|NCT02430870|528053765|FG000|Part 2|Voluntary Withdrawal|0|||
146422500|NCT02430870|528053766|FG001|Part 2|Voluntary Withdrawal|0|||
146422501|NCT02430870|528053767|FG002|Part 2|Voluntary Withdrawal|0|||
146422502|NCT02430870|528053768|FG003|Part 2|Voluntary Withdrawal|0|||
146422503|NCT02430870|528053769|FG004|Part 2|Voluntary Withdrawal|0|||
146422504|NCT02430870|528053770|FG005|Part 2|Voluntary Withdrawal|0|||
146422505|NCT02430870|528053771|FG006|Part 2|Voluntary Withdrawal|1|||
146422506|NCT02430870|528053772|FG007|Part 2|Voluntary Withdrawal|0|||
146422507|NCT02430870|528053765|FG000|Part 2|Other Reason Not Specified|0|||
146422508|NCT02430870|528053766|FG001|Part 2|Other Reason Not Specified|0|||
146422509|NCT02430870|528053767|FG002|Part 2|Other Reason Not Specified|0|||
146422510|NCT02430870|528053768|FG003|Part 2|Other Reason Not Specified|0|||
146422511|NCT02430870|528053769|FG004|Part 2|Other Reason Not Specified|0|||
146422512|NCT02430870|528053770|FG005|Part 2|Other Reason Not Specified|0|||
146422513|NCT02430870|528053771|FG006|Part 2|Other Reason Not Specified|0|||
146422514|NCT02430870|528053772|FG007|Part 2|Other Reason Not Specified|1|||
146422515|NCT02780687|528053773|FG000|Overall Study|Adverse Event|1|||
146422516|NCT02780687|528053774|FG001|Overall Study|Adverse Event|1|||
146422517|NCT02780687|528053773|FG000|Overall Study|Withdrawal by Subject|2|||
146422518|NCT02780687|528053774|FG001|Overall Study|Withdrawal by Subject|1|||
146422519|NCT02780687|528053773|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
146422520|NCT02780687|528053774|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
146422521|NCT02780687|528053773|FG000|Overall Study|progressive disease|29|||
146422522|NCT02780687|528053774|FG001|Overall Study|progressive disease|6|||
146422523|NCT03982433|528053775|FG000|Overall Study|Lost to Follow-up|1|||
146422524|NCT04257929|528053778|FG000|Overall Study|Adverse Event|1|||
146422525|NCT04257929|528053779|FG001|Overall Study|Adverse Event|0|||
146194800|NCT00813488|527224104|FG000|Titration Period 2|Lack of Efficacy|8|||
146194801|NCT00813488|527224105|FG001|Titration Period 2|Lack of Efficacy|4|||
146194802|NCT00813488|527224104|FG000|Titration Period 2|Protocol Violation|3|||
146194803|NCT00813488|527224105|FG001|Titration Period 2|Protocol Violation|2|||
146194804|NCT00813488|527224104|FG000|Titration Period 2|Lost to Follow-up|1|||
146194805|NCT00813488|527224105|FG001|Titration Period 2|Lost to Follow-up|0|||
146194806|NCT00813488|527224104|FG000|Titration Period 2|Non-compliance with study procedures|2|||
146422526|NCT04257929|528053780|FG002|Overall Study|Adverse Event|1|||
146422527|NCT04257929|528053778|FG000|Overall Study|Withdrawal by Subject|1|||
146422528|NCT04257929|528053779|FG001|Overall Study|Withdrawal by Subject|0|||
146422529|NCT04257929|528053780|FG002|Overall Study|Withdrawal by Subject|0|||
146422530|NCT04257929|528053778|FG000|Overall Study|COVID-19|0|||
146422531|NCT04257929|528053779|FG001|Overall Study|COVID-19|1|||
146422532|NCT04257929|528053780|FG002|Overall Study|COVID-19|1|||
146422533|NCT04257929|528053778|FG000|Overall Study|Lost to Follow-up|0|||
146422534|NCT04257929|528053779|FG001|Overall Study|Lost to Follow-up|0|||
146422535|NCT04257929|528053780|FG002|Overall Study|Lost to Follow-up|1|||
146422536|NCT05049460|528053781|FG000|Overall Study|Withdrawal by Subject|2|||
146422537|NCT05049460|528053782|FG001|Overall Study|Withdrawal by Subject|2|||
146422538|NCT05049460|528053781|FG000|Overall Study|Lost to Follow-up|2|||
146422539|NCT05049460|528053782|FG001|Overall Study|Lost to Follow-up|2|||
146422540|NCT03740165|528053787|FG000|Overall Study|Death|232|||
146422541|NCT03740165|528053788|FG001|Overall Study|Death|242|||
146422542|NCT03740165|528053789|FG002|Overall Study|Death|229|||
146422543|NCT03740165|528053787|FG000|Overall Study|Lost to Follow-up|0|||
146422544|NCT03740165|528053788|FG001|Overall Study|Lost to Follow-up|0|||
146422545|NCT03740165|528053789|FG002|Overall Study|Lost to Follow-up|1|||
146422546|NCT03740165|528053787|FG000|Overall Study|Withdrawal by Subject|7|||
146422547|NCT03740165|528053788|FG001|Overall Study|Withdrawal by Subject|4|||
146422548|NCT03740165|528053789|FG002|Overall Study|Withdrawal by Subject|3|||
146422549|NCT03740165|528053787|FG000|Overall Study|Ongoing in Study|216|||
146422550|NCT03740165|528053788|FG001|Overall Study|Ongoing in Study|212|||
146422551|NCT03740165|528053789|FG002|Overall Study|Ongoing in Study|221|||
146422552|NCT03049618|528053790|FG000|Overall Study|Death|1|||
146422553|NCT03049618|528053791|FG001|Overall Study|Death|0|||
146422554|NCT03049618|528053790|FG000|Overall Study|Lack of Efficacy|1|||
146422555|NCT03049618|528053791|FG001|Overall Study|Lack of Efficacy|2|||
146422556|NCT04582539|528053792|FG000|Overall Study|Death|1|||
146422557|NCT04582539|528053793|FG001|Overall Study|Death|1|||
146422558|NCT04582539|528053794|FG002|Overall Study|Death|0|||
146422559|NCT04582539|528053795|FG003|Overall Study|Death|1|||
146422560|NCT04582539|528053796|FG004|Overall Study|Death|0|||
146422561|NCT04582539|528053792|FG000|Overall Study|Lost to Follow-up|1|||
146422562|NCT04582539|528053793|FG001|Overall Study|Lost to Follow-up|0|||
146422563|NCT04582539|528053794|FG002|Overall Study|Lost to Follow-up|0|||
146422564|NCT04582539|528053795|FG003|Overall Study|Lost to Follow-up|0|||
146422565|NCT04582539|528053796|FG004|Overall Study|Lost to Follow-up|0|||
146422566|NCT04582539|528053792|FG000|Overall Study|Study Terminated by Sponsor|1|||
146422567|NCT04582539|528053793|FG001|Overall Study|Study Terminated by Sponsor|3|||
146422568|NCT04582539|528053794|FG002|Overall Study|Study Terminated by Sponsor|2|||
146422569|NCT04582539|528053795|FG003|Overall Study|Study Terminated by Sponsor|2|||
146422570|NCT04582539|528053796|FG004|Overall Study|Study Terminated by Sponsor|3|||
146422571|NCT04582539|528053792|FG000|Overall Study|Physician Decision|0|||
146422572|NCT04582539|528053793|FG001|Overall Study|Physician Decision|1|||
146422573|NCT04582539|528053794|FG002|Overall Study|Physician Decision|0|||
146422574|NCT04582539|528053795|FG003|Overall Study|Physician Decision|0|||
146422575|NCT04582539|528053796|FG004|Overall Study|Physician Decision|0|||
146422576|NCT04582539|528053792|FG000|Overall Study|Withdrawal by Subject|1|||
146422577|NCT04582539|528053793|FG001|Overall Study|Withdrawal by Subject|0|||
146422578|NCT04582539|528053794|FG002|Overall Study|Withdrawal by Subject|2|||
146422579|NCT04582539|528053795|FG003|Overall Study|Withdrawal by Subject|1|||
146422580|NCT04582539|528053796|FG004|Overall Study|Withdrawal by Subject|0|||
146422581|NCT04582539|528053792|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146422582|NCT04582539|528053793|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146422583|NCT04582539|528053794|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146422584|NCT04582539|528053795|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
146422585|NCT04582539|528053796|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
146422586|NCT00788957|528053805|FG000|Part 1|Death|8|||
146422587|NCT00788957|528053806|FG001|Part 1|Death|0|||
146422588|NCT00788957|528053807|FG002|Part 1|Death|0|||
146422589|NCT00788957|528053808|FG003|Part 1|Death|0|||
146422590|NCT00788957|528053809|FG004|Part 1|Death|0|||
146422591|NCT00788957|528053810|FG005|Part 1|Death|0|||
146422592|NCT00788957|528053805|FG000|Part 1|Lost to Follow-up|1|||
146422593|NCT00788957|528053806|FG001|Part 1|Lost to Follow-up|0|||
146422594|NCT00788957|528053807|FG002|Part 1|Lost to Follow-up|0|||
146422595|NCT00788957|528053808|FG003|Part 1|Lost to Follow-up|0|||
146422596|NCT00788957|528053809|FG004|Part 1|Lost to Follow-up|0|||
146422597|NCT00788957|528053810|FG005|Part 1|Lost to Follow-up|0|||
146422598|NCT00788957|528053805|FG000|Part 2|Withdrawal by Subject|0|||
146422599|NCT00788957|528053806|FG001|Part 2|Withdrawal by Subject|9|||
146422600|NCT00788957|528053807|FG002|Part 2|Withdrawal by Subject|5|||
146422601|NCT00788957|528053808|FG003|Part 2|Withdrawal by Subject|3|||
146422602|NCT00788957|528053809|FG004|Part 2|Withdrawal by Subject|0|||
146194807|NCT00813488|527224105|FG001|Titration Period 2|Non-compliance with study procedures|1|||
146194808|NCT00813488|527224104|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
146422603|NCT00788957|528053810|FG005|Part 2|Withdrawal by Subject|0|||
146422604|NCT00788957|528053805|FG000|Part 2|Death|0|||
146422605|NCT00788957|528053806|FG001|Part 2|Death|32|||
146422606|NCT00788957|528053807|FG002|Part 2|Death|35|||
146422607|NCT00788957|528053808|FG003|Part 2|Death|37|||
146082515|NCT02431260|526822821|FG011|Overall Study|Study Terminated by the Sponsor|0|||
146422608|NCT00788957|528053809|FG004|Part 2|Death|0|||
146422609|NCT00788957|528053810|FG005|Part 2|Death|0|||
146422610|NCT00788957|528053805|FG000|Part 2|Lost to Follow-up|0|||
146422611|NCT00788957|528053806|FG001|Part 2|Lost to Follow-up|0|||
146422612|NCT00788957|528053807|FG002|Part 2|Lost to Follow-up|3|||
146422613|NCT00788957|528053808|FG003|Part 2|Lost to Follow-up|0|||
146422614|NCT00788957|528053809|FG004|Part 2|Lost to Follow-up|0|||
146422615|NCT00788957|528053810|FG005|Part 2|Lost to Follow-up|0|||
146422616|NCT00788957|528053805|FG000|Part 2|On-study at time of data cut-off|0|||
146422617|NCT00788957|528053806|FG001|Part 2|On-study at time of data cut-off|1|||
146422618|NCT00788957|528053807|FG002|Part 2|On-study at time of data cut-off|1|||
146422619|NCT00788957|528053808|FG003|Part 2|On-study at time of data cut-off|1|||
146422620|NCT00788957|528053809|FG004|Part 2|On-study at time of data cut-off|0|||
146422621|NCT00788957|528053810|FG005|Part 2|On-study at time of data cut-off|0|||
146422622|NCT00788957|528053805|FG000|Part 3|Withdrawal by Subject|0|||
146422623|NCT00788957|528053806|FG001|Part 3|Withdrawal by Subject|0|||
146422624|NCT00788957|528053807|FG002|Part 3|Withdrawal by Subject|0|||
146422625|NCT00788957|528053808|FG003|Part 3|Withdrawal by Subject|0|||
146422626|NCT00788957|528053809|FG004|Part 3|Withdrawal by Subject|0|||
146422627|NCT00788957|528053810|FG005|Part 3|Withdrawal by Subject|2|||
146422628|NCT00788957|528053805|FG000|Part 3|Death|0|||
146422629|NCT00788957|528053806|FG001|Part 3|Death|0|||
146422630|NCT00788957|528053807|FG002|Part 3|Death|0|||
146422631|NCT00788957|528053808|FG003|Part 3|Death|0|||
146422632|NCT00788957|528053809|FG004|Part 3|Death|8|||
146422633|NCT00788957|528053810|FG005|Part 3|Death|8|||
146422634|NCT00788957|528053805|FG000|Part 3|On-study at time of data cut-off|0|||
146422635|NCT00788957|528053806|FG001|Part 3|On-study at time of data cut-off|0|||
146422636|NCT00788957|528053807|FG002|Part 3|On-study at time of data cut-off|0|||
146422637|NCT00788957|528053808|FG003|Part 3|On-study at time of data cut-off|0|||
146422638|NCT00788957|528053809|FG004|Part 3|On-study at time of data cut-off|1|||
146422639|NCT00788957|528053810|FG005|Part 3|On-study at time of data cut-off|0|||
146422640|NCT02579096|528053811|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
146422641|NCT02579096|528053812|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
146422642|NCT02579096|528053811|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
146422643|NCT02579096|528053812|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
146422644|NCT02579096|528053811|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
146422645|NCT02579096|528053812|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
146422646|NCT02579096|528053811|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
146422647|NCT02579096|528053812|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
146422648|NCT02579096|528053811|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
146422649|NCT02579096|528053812|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
146422650|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Death|2|||
146422651|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Death|4|||
146422652|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
146422653|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
146422654|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
146422655|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
146422656|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
146422657|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
146422658|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
146422659|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
146422660|NCT02579096|528053811|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
146422661|NCT02579096|528053812|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
146422662|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Death|3|||
146422663|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Death|2|||
146422664|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
146422665|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
146422666|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
146422667|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
146422668|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
146422669|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
146422670|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
146422671|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
146422672|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
146422673|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
146422674|NCT02579096|528053811|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
146422675|NCT02579096|528053812|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
146422676|NCT02097121|528053813|FG000|Overall Study|Other, not specified|4|||
146422677|NCT02097121|528053814|FG001|Overall Study|Other, not specified|2|||
146422678|NCT02097121|528053815|FG002|Overall Study|Other, not specified|3|||
146422679|NCT02097121|528053813|FG000|Overall Study|Lack of Efficacy|2|||
146422680|NCT02097121|528053814|FG001|Overall Study|Lack of Efficacy|1|||
146422681|NCT02097121|528053815|FG002|Overall Study|Lack of Efficacy|3|||
146422682|NCT02097121|528053813|FG000|Overall Study|Withdrawal by Subject|0|||
146422683|NCT02097121|528053814|FG001|Overall Study|Withdrawal by Subject|1|||
146422684|NCT02097121|528053815|FG002|Overall Study|Withdrawal by Subject|2|||
146422685|NCT02097121|528053813|FG000|Overall Study|Adverse Event|0|||
146422686|NCT02097121|528053814|FG001|Overall Study|Adverse Event|1|||
146422687|NCT02097121|528053815|FG002|Overall Study|Adverse Event|0|||
146422688|NCT02097121|528053813|FG000|Overall Study|Lost to Follow-up|1|||
146422689|NCT02097121|528053814|FG001|Overall Study|Lost to Follow-up|1|||
146422690|NCT02097121|528053815|FG002|Overall Study|Lost to Follow-up|2|||
146422691|NCT00661999|528053816|FG000|Overall Study|Adverse Event|11|||
146422692|NCT00661999|528053817|FG001|Overall Study|Adverse Event|5|||
146422693|NCT00661999|528053818|FG002|Overall Study|Adverse Event|8|||
146422694|NCT00661999|528053816|FG000|Overall Study|Death|8|||
146422695|NCT00661999|528053817|FG001|Overall Study|Death|6|||
146422696|NCT00661999|528053818|FG002|Overall Study|Death|3|||
146422697|NCT00661999|528053816|FG000|Overall Study|Other Reasons|5|||
146422698|NCT00661999|528053817|FG001|Overall Study|Other Reasons|12|||
146422699|NCT00661999|528053818|FG002|Overall Study|Other Reasons|23|||
146422700|NCT00661999|528053816|FG000|Overall Study|Withdrawal by Subject|30|||
146422701|NCT00661999|528053817|FG001|Overall Study|Withdrawal by Subject|23|||
146422702|NCT00661999|528053818|FG002|Overall Study|Withdrawal by Subject|14|||
146422703|NCT00661999|528053816|FG000|Overall Study|Alternative Treatment|1|||
146422704|NCT00661999|528053817|FG001|Overall Study|Alternative Treatment|0|||
146422705|NCT00661999|528053818|FG002|Overall Study|Alternative Treatment|0|||
146422706|NCT00661999|528053816|FG000|Overall Study|Other Medical Problems|4|||
146422707|NCT00661999|528053817|FG001|Overall Study|Other Medical Problems|4|||
146422708|NCT00661999|528053818|FG002|Overall Study|Other Medical Problems|9|||
146422709|NCT03066999|528053819|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
146422710|NCT03066999|528053820|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
146422711|NCT01790568|528053821|FG000|Overall Study|Progression prior to transplant|0|||
146422712|NCT01790568|528053822|FG001|Overall Study|Progression prior to transplant|1|||
146422713|NCT01361126|528053823|FG000|Overall Study|Sponsor decision|0|||
146422714|NCT01361126|528053824|FG001|Overall Study|Sponsor decision|2|||
146422715|NCT02994056|528053825|FG000|Overall Study|Death|8|||
146422716|NCT02994056|528053825|FG000|Overall Study|Withdrew Consent|1|||
146422717|NCT01508936|528053827|FG000|Overall Study|Adverse Event|11|||
146422718|NCT01508936|528053828|FG001|Overall Study|Adverse Event|32|||
146422719|NCT01508936|528053827|FG000|Overall Study|Lack of Efficacy|0|||
146422720|NCT01508936|528053828|FG001|Overall Study|Lack of Efficacy|1|||
146422721|NCT01508936|528053827|FG000|Overall Study|Withdrawal by Subject|4|||
146422722|NCT01508936|528053828|FG001|Overall Study|Withdrawal by Subject|18|||
146422723|NCT01508936|528053827|FG000|Overall Study|Protocol Violation|2|||
146422724|NCT01508936|528053828|FG001|Overall Study|Protocol Violation|3|||
146422725|NCT01508936|528053827|FG000|Overall Study|Lost to Follow-up|2|||
146422726|NCT01508936|528053828|FG001|Overall Study|Lost to Follow-up|9|||
146422727|NCT01508936|528053827|FG000|Overall Study|Other|0|||
146422728|NCT01508936|528053828|FG001|Overall Study|Other|5|||
146422729|NCT01508936|528053827|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
146422730|NCT01508936|528053828|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
146422731|NCT00679367|528053829|FG000|Overall Study|Adverse Event|7|||
146422732|NCT00679367|528053829|FG000|Overall Study|inability to swallow oral drugs|1|||
146422733|NCT00679367|528053829|FG000|Overall Study|Lack of Efficacy|3|||
146422734|NCT00679367|528053829|FG000|Overall Study|Withdrawal by Subject|1|||
146422735|NCT03365947|528053830|FG000|Overall Study|Lost to Follow-up|0|||
146422736|NCT03365947|528053831|FG001|Overall Study|Lost to Follow-up|0|||
146422737|NCT03365947|528053832|FG002|Overall Study|Lost to Follow-up|0|||
146422738|NCT03365947|528053833|FG003|Overall Study|Lost to Follow-up|0|||
146422739|NCT03365947|528053834|FG004|Overall Study|Lost to Follow-up|0|||
146422740|NCT03365947|528053835|FG005|Overall Study|Lost to Follow-up|1|||
145948838|NCT01744483|526323070|FG001|Overall Study|No ICU Admit|1|||
145948839|NCT01744483|526323071|FG002|Overall Study|No ICU Admit|2|||
145948840|NCT01744483|526323069|FG000|Overall Study|Routed to OSH|2|||
145948841|NCT01744483|526323070|FG001|Overall Study|Routed to OSH|0|||
146422741|NCT03365947|528053836|FG006|Overall Study|Lost to Follow-up|0|||
146422742|NCT03365947|528053837|FG007|Overall Study|Lost to Follow-up|0|||
146422743|NCT03365947|528053838|FG008|Overall Study|Lost to Follow-up|0|||
146422744|NCT03365947|528053839|FG009|Overall Study|Lost to Follow-up|0|||
146422745|NCT03365947|528053840|FG010|Overall Study|Lost to Follow-up|0|||
146422746|NCT03365947|528053841|FG011|Overall Study|Lost to Follow-up|0|||
146422747|NCT03365947|528053842|FG012|Overall Study|Lost to Follow-up|0|||
146422748|NCT03365947|528053843|FG013|Overall Study|Lost to Follow-up|0|||
146422749|NCT03365947|528053844|FG014|Overall Study|Lost to Follow-up|0|||
146422750|NCT03365947|528053845|FG015|Overall Study|Lost to Follow-up|0|||
146422751|NCT03365947|528053846|FG016|Overall Study|Lost to Follow-up|0|||
146422752|NCT03365947|528053847|FG017|Overall Study|Lost to Follow-up|0|||
146422753|NCT03365947|528053848|FG018|Overall Study|Lost to Follow-up|0|||
146422754|NCT02518685|528053849|FG000|Overall Study|Adverse Event|29|||
145948842|NCT01744483|526323071|FG002|Overall Study|Routed to OSH|1|||
145948843|NCT01190189|526323072|FG000|Overall Study|Lost to Follow-up|4|||
145948844|NCT01190189|526323072|FG000|Overall Study|Withdrawal by Subject|1|||
146422755|NCT02518685|528053850|FG001|Overall Study|Adverse Event|1|||
145948845|NCT01190189|526323072|FG000|Overall Study|Migrated/moved from study area|1|||
145948846|NCT04575584|526323073|FG000|Overall Study|Death|6|||
145948847|NCT04575584|526323074|FG001|Overall Study|Death|4|||
145948848|NCT04575584|526323075|FG002|Overall Study|Death|6|||
145948849|NCT04575584|526323076|FG003|Overall Study|Death|2|||
146422756|NCT02518685|528053849|FG000|Overall Study|Withdrawal by Subject|10|||
146422757|NCT02518685|528053850|FG001|Overall Study|Withdrawal by Subject|3|||
146422758|NCT02518685|528053849|FG000|Overall Study|relocation, study fatigue|7|||
146422759|NCT02518685|528053850|FG001|Overall Study|relocation, study fatigue|2|||
146422760|NCT02518685|528053849|FG000|Overall Study|Pregnancy|1|||
146422761|NCT02518685|528053850|FG001|Overall Study|Pregnancy|0|||
146422762|NCT02518685|528053849|FG000|Overall Study|Physician Decision|1|||
146422763|NCT02518685|528053850|FG001|Overall Study|Physician Decision|0|||
146422764|NCT02518685|528053849|FG000|Overall Study|Lost to Follow-up|1|||
146422765|NCT02518685|528053850|FG001|Overall Study|Lost to Follow-up|4|||
146422766|NCT05665595|528055784|FG000|Overall Study|Ongoing|692|||
146422767|NCT05665595|528055785|FG001|Overall Study|Ongoing|698|||
146422768|NCT05665595|528055784|FG000|Overall Study|Withdrawal by Subject|2|||
146422769|NCT05665595|528055785|FG001|Overall Study|Withdrawal by Subject|2|||
146422770|NCT05665595|528055784|FG000|Overall Study|Lost to Follow-up|1|||
146422771|NCT05665595|528055785|FG001|Overall Study|Lost to Follow-up|0|||
146422772|NCT05665595|528055784|FG000|Overall Study|Death|6|||
146422773|NCT05665595|528055785|FG001|Overall Study|Death|1|||
146422774|NCT05771428|528055786|FG000|Overall Study|Adverse Event|0|||
146422775|NCT05771428|528055787|FG001|Overall Study|Adverse Event|1|||
146422776|NCT05771428|528055788|FG002|Overall Study|Adverse Event|1|||
146422777|NCT05771428|528055789|FG003|Overall Study|Adverse Event|1|||
146422778|NCT05771428|528055786|FG000|Overall Study|Withdrawal by Subject|3|||
146422779|NCT05771428|528055787|FG001|Overall Study|Withdrawal by Subject|2|||
146422780|NCT05771428|528055788|FG002|Overall Study|Withdrawal by Subject|1|||
146422781|NCT05771428|528055789|FG003|Overall Study|Withdrawal by Subject|4|||
146422782|NCT05771428|528055786|FG000|Overall Study|Other|0|||
146422783|NCT05771428|528055787|FG001|Overall Study|Other|1|||
146422784|NCT05771428|528055788|FG002|Overall Study|Other|2|||
146422785|NCT05771428|528055789|FG003|Overall Study|Other|1|||
146422786|NCT05771428|528055786|FG000|Overall Study|Randomized but Not Treated|0|||
146422787|NCT05771428|528055787|FG001|Overall Study|Randomized but Not Treated|0|||
146422788|NCT05771428|528055788|FG002|Overall Study|Randomized but Not Treated|1|||
146422789|NCT05771428|528055789|FG003|Overall Study|Randomized but Not Treated|0|||
146422790|NCT04025229|528055790|FG000|Overall Study|Adverse Event|1|||
146422791|NCT04025229|528055791|FG001|Overall Study|Adverse Event|0|||
146422792|NCT04025229|528055790|FG000|Overall Study|Withdrawal by Subject|0|||
146422793|NCT04025229|528055791|FG001|Overall Study|Withdrawal by Subject|2|||
146422794|NCT04025229|528055790|FG000|Overall Study|Death|0|||
146422795|NCT04025229|528055791|FG001|Overall Study|Death|1|||
146422796|NCT04025229|528055790|FG000|Overall Study|Physician Decision|0|||
146422797|NCT04025229|528055791|FG001|Overall Study|Physician Decision|1|||
146422798|NCT03815942|528055792|FG000|Overall Study|Withdrawal by Subject|0|||
146422799|NCT03815942|528055793|FG001|Overall Study|Withdrawal by Subject|17|||
146422800|NCT01298570|528055794|FG000|Overall Study|Disease progression, relapse during acti|64|||
146422801|NCT01298570|528055795|FG001|Overall Study|Disease progression, relapse during acti|40|||
146422802|NCT01298570|528055794|FG000|Overall Study|Adverse Event|20|||
146422803|NCT01298570|528055795|FG001|Overall Study|Adverse Event|2|||
146422804|NCT01298570|528055794|FG000|Overall Study|Withdrawal by Subject|21|||
146422805|NCT01298570|528055795|FG001|Overall Study|Withdrawal by Subject|6|||
146422806|NCT01298570|528055794|FG000|Overall Study|Treatment delay > 4 weeks|4|||
146422807|NCT01298570|528055795|FG001|Overall Study|Treatment delay > 4 weeks|5|||
146422808|NCT01298570|528055794|FG000|Overall Study|Physician Decision|4|||
146422809|NCT01298570|528055795|FG001|Overall Study|Physician Decision|2|||
146422810|NCT01298570|528055794|FG000|Overall Study|Other complicating disease|2|||
145948850|NCT04575584|526323077|FG004|Overall Study|Death|0|||
145948851|NCT04575584|526323078|FG005|Overall Study|Death|0|||
145948852|NCT04575584|526323073|FG000|Overall Study|Lost to Follow-up|1|||
145948853|NCT04575584|526323074|FG001|Overall Study|Lost to Follow-up|1|||
145948854|NCT04575584|526323075|FG002|Overall Study|Lost to Follow-up|1|||
145948855|NCT04575584|526323076|FG003|Overall Study|Lost to Follow-up|1|||
145948856|NCT04575584|526323077|FG004|Overall Study|Lost to Follow-up|0|||
145948857|NCT04575584|526323078|FG005|Overall Study|Lost to Follow-up|0|||
145948858|NCT04575584|526323073|FG000|Overall Study|Physician Decision|0|||
145948859|NCT04575584|526323074|FG001|Overall Study|Physician Decision|1|||
145948860|NCT04575584|526323075|FG002|Overall Study|Physician Decision|1|||
146422811|NCT01298570|528055795|FG001|Overall Study|Other complicating disease|1|||
146422812|NCT01298570|528055794|FG000|Overall Study|Surgery|2|||
146422813|NCT01298570|528055795|FG001|Overall Study|Surgery|1|||
146422814|NCT01298570|528055794|FG000|Overall Study|Symptomatic progression/deterioration|3|||
146422815|NCT01298570|528055795|FG001|Overall Study|Symptomatic progression/deterioration|2|||
146422816|NCT01298570|528055794|FG000|Overall Study|Death|0|||
146422817|NCT01298570|528055795|FG001|Overall Study|Death|1|||
146422818|NCT01298570|528055794|FG000|Overall Study|Ineligibility|0|||
146422819|NCT01298570|528055795|FG001|Overall Study|Ineligibility|1|||
146422820|NCT00076102|528055796|FG000|Overall Study|Clinical progression|1|||
146422821|NCT00076102|528055796|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
146422822|NCT00076102|528055796|FG000|Overall Study|plexiform neurofibroma surgery|1|||
146422823|NCT00076102|528055796|FG000|Overall Study|refusal of further therapy|2|||
145948861|NCT04575584|526323076|FG003|Overall Study|Physician Decision|1|||
145948862|NCT04575584|526323077|FG004|Overall Study|Physician Decision|0|||
146422824|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
145948863|NCT04575584|526323078|FG005|Overall Study|Physician Decision|0|||
146422825|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
146422826|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
146194809|NCT00813488|527224105|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
146194810|NCT00813488|527224104|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
146194811|NCT00813488|527224105|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
146194812|NCT00813488|527224104|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
146194813|NCT00813488|527224105|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
146194814|NCT00813488|527224104|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
146194815|NCT00813488|527224105|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
146194816|NCT00813488|527224104|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
146194817|NCT00813488|527224105|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
146194818|NCT00813488|527224104|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
146194819|NCT00813488|527224105|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
146194820|NCT00813488|527224104|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
146194821|NCT00813488|527224105|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
146194822|NCT00813488|527224104|FG000|Double-blind Treatment Period 2|Other|1|||
146194823|NCT00813488|527224105|FG001|Double-blind Treatment Period 2|Other|0|||
146194824|NCT00813488|527224104|FG000|Open-label Extension|Adverse Event|1|||
146194825|NCT00813488|527224105|FG001|Open-label Extension|Adverse Event|2|||
146194826|NCT00813488|527224104|FG000|Open-label Extension|Lack of Efficacy|3|||
146194827|NCT00813488|527224105|FG001|Open-label Extension|Lack of Efficacy|0|||
146194828|NCT00813488|527224104|FG000|Open-label Extension|Withdrawal by Subject|0|||
146194829|NCT00813488|527224105|FG001|Open-label Extension|Withdrawal by Subject|2|||
146194830|NCT00813488|527224104|FG000|Open-label Extension|Protocol Violation|1|||
146194831|NCT00813488|527224105|FG001|Open-label Extension|Protocol Violation|2|||
146194832|NCT00813488|527224104|FG000|Open-label Extension|Non-compliance study medication|4|||
146194833|NCT00813488|527224105|FG001|Open-label Extension|Non-compliance study medication|0|||
146194834|NCT00813488|527224104|FG000|Open-label Extension|Non-compliance study procedures|2|||
146194835|NCT00813488|527224105|FG001|Open-label Extension|Non-compliance study procedures|1|||
146194836|NCT00813488|527224104|FG000|Open-label Extension|Other|1|||
146194837|NCT00813488|527224105|FG001|Open-label Extension|Other|0|||
146194838|NCT02926937|527224106|FG000|Overall Study|Adverse Event|0|||
146194839|NCT02926937|527224107|FG001|Overall Study|Adverse Event|1|||
146194840|NCT02926937|527224108|FG002|Overall Study|Adverse Event|1|||
146194841|NCT02926937|527224106|FG000|Overall Study|Poor Compliance to Protocol|1|||
146194842|NCT02926937|527224107|FG001|Overall Study|Poor Compliance to Protocol|0|||
146194843|NCT02926937|527224108|FG002|Overall Study|Poor Compliance to Protocol|0|||
146194844|NCT02926937|527224106|FG000|Overall Study|Lost to Follow-up|4|||
146194845|NCT02926937|527224107|FG001|Overall Study|Lost to Follow-up|5|||
146194846|NCT02926937|527224108|FG002|Overall Study|Lost to Follow-up|0|||
146194847|NCT02926937|527224106|FG000|Overall Study|At the Participant's own Request|11|||
146194848|NCT02926937|527224107|FG001|Overall Study|At the Participant's own Request|5|||
146194849|NCT02926937|527224108|FG002|Overall Study|At the Participant's own Request|8|||
146194850|NCT02926937|527224106|FG000|Overall Study|Reason not Specified|3|||
146194851|NCT02926937|527224107|FG001|Overall Study|Reason not Specified|4|||
146194852|NCT02926937|527224108|FG002|Overall Study|Reason not Specified|2|||
146194853|NCT01559090|527224109|FG000|Stage I|Withdrawal by Subject|2|||
146194854|NCT01559090|527224110|FG001|Stage I|Withdrawal by Subject|2|||
146194855|NCT01559090|527224111|FG002|Stage I|Withdrawal by Subject|3|||
146194856|NCT01559090|527224109|FG000|Stage II|Withdrawal by Subject|1|||
146194857|NCT01559090|527224110|FG001|Stage II|Withdrawal by Subject|0|||
146194858|NCT01559090|527224111|FG002|Stage II|Withdrawal by Subject|0|||
146194859|NCT03677375|527224113|FG000|Overall Study|Incomplete procedure|8|||
146194860|NCT03677375|527224113|FG000|Overall Study|Adverse Event|3|||
146194861|NCT03677375|527224113|FG000|Overall Study|Physician Decision|1|||
146194862|NCT03971357|527224116|FG000|Overall Study|Lack of Efficacy|0|||
146194863|NCT03971357|527224117|FG001|Overall Study|Lack of Efficacy|1|||
146194864|NCT01729871|527224118|FG000|Overall Study|Adverse Event|7|||
146194865|NCT01729871|527224119|FG001|Overall Study|Adverse Event|7|||
146194866|NCT01729871|527224118|FG000|Overall Study|Death|0|||
146194867|NCT01729871|527224119|FG001|Overall Study|Death|1|||
146194868|NCT01729871|527224118|FG000|Overall Study|Lack of Efficacy|0|||
146194869|NCT01729871|527224119|FG001|Overall Study|Lack of Efficacy|1|||
146194870|NCT01729871|527224118|FG000|Overall Study|Physician Decision|0|||
146194871|NCT01729871|527224119|FG001|Overall Study|Physician Decision|2|||
146194872|NCT01729871|527224118|FG000|Overall Study|Protocol Violation|1|||
146194873|NCT01729871|527224119|FG001|Overall Study|Protocol Violation|0|||
146194874|NCT01729871|527224118|FG000|Overall Study|Withdrawal by Subject|0|||
146194875|NCT01729871|527224119|FG001|Overall Study|Withdrawal by Subject|3|||
146194876|NCT01729871|527224118|FG000|Overall Study|Other|4|||
146194877|NCT01729871|527224119|FG001|Overall Study|Other|9|||
146194878|NCT01143077|527224120|FG000|Overall Study|Lack of Efficacy|0|||
146194879|NCT01143077|527224121|FG001|Overall Study|Lack of Efficacy|2|||
146194880|NCT01143077|527224122|FG002|Overall Study|Lack of Efficacy|1|||
146194881|NCT01143077|527224120|FG000|Overall Study|Adverse Event|5|||
146194882|NCT01143077|527224121|FG001|Overall Study|Adverse Event|6|||
146194883|NCT01143077|527224122|FG002|Overall Study|Adverse Event|5|||
146194884|NCT01143077|527224120|FG000|Overall Study|Lost to Follow-up|2|||
146422827|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
146422828|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
146422829|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
146422830|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
146422831|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
146422832|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146422833|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146422834|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
146422835|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
146422836|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
146422837|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
146422838|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
146422839|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
146422840|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146422841|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146422842|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
146422843|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
146422844|NCT02207231|528055798|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
146422845|NCT02207231|528055799|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
146422846|NCT02207231|528055800|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
146422847|NCT02207231|528055801|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
146422848|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
146422849|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
146422850|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
146422851|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
146422852|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146422853|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146422854|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
146422855|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
146422856|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
146422857|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
146422858|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
146422859|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
146422860|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
146422861|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
146422862|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
146422863|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
146422864|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
146422865|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
146422866|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
146422867|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
146422868|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146422869|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
146422870|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146422871|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
146422872|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
146422873|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
146422874|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
146422875|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
146422876|NCT02207231|528055798|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
146422877|NCT02207231|528055799|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
146422878|NCT02207231|528055800|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
146422879|NCT02207231|528055801|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
146422880|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
146422881|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
146422882|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
146422883|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
146422884|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
146422885|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
146422886|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
146422887|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
146422888|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
146422889|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
146422890|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
146422891|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
146422892|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
146422893|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
146422894|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
146422895|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
146422896|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
146422897|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
146422898|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
146422899|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
146422900|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
146422901|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
146422902|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
146422903|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
146422904|NCT02207231|528055798|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
146422905|NCT02207231|528055799|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
146422906|NCT02207231|528055800|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
146422907|NCT02207231|528055801|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
146422908|NCT00502775|528055805|FG000|Overall Study|Adverse Event|1|||
146422909|NCT00502775|528055806|FG001|Overall Study|Adverse Event|2|||
146422910|NCT00502775|528055807|FG002|Overall Study|Adverse Event|1|||
146422911|NCT00502775|528055805|FG000|Overall Study|Protocol Violation|1|||
146422912|NCT00502775|528055806|FG001|Overall Study|Protocol Violation|5|||
146422913|NCT00502775|528055807|FG002|Overall Study|Protocol Violation|2|||
146422914|NCT00502775|528055805|FG000|Overall Study|Withdrawal by Subject|1|||
146422915|NCT00502775|528055806|FG001|Overall Study|Withdrawal by Subject|1|||
146422916|NCT00502775|528055807|FG002|Overall Study|Withdrawal by Subject|2|||
146422917|NCT00502775|528055805|FG000|Overall Study|Sponsor Terminated Study|1|||
146422918|NCT00502775|528055806|FG001|Overall Study|Sponsor Terminated Study|0|||
146422919|NCT00502775|528055807|FG002|Overall Study|Sponsor Terminated Study|1|||
146422920|NCT00502775|528055805|FG000|Overall Study|Non-compliance with eDiary|4|||
146422921|NCT00502775|528055806|FG001|Overall Study|Non-compliance with eDiary|1|||
146422922|NCT00502775|528055807|FG002|Overall Study|Non-compliance with eDiary|1|||
146422923|NCT00502775|528055805|FG000|Overall Study|Subject unable to swallow capsule|1|||
146422924|NCT00502775|528055806|FG001|Overall Study|Subject unable to swallow capsule|0|||
146422925|NCT00502775|528055807|FG002|Overall Study|Subject unable to swallow capsule|1|||
146422926|NCT00502775|528055805|FG000|Overall Study|Logpad compliance <80%|1|||
146422927|NCT00502775|528055806|FG001|Overall Study|Logpad compliance <80%|0|||
146422928|NCT00502775|528055807|FG002|Overall Study|Logpad compliance <80%|0|||
146422929|NCT00502775|528055805|FG000|Overall Study|Randomized in error|0|||
146422930|NCT00502775|528055806|FG001|Overall Study|Randomized in error|1|||
146422931|NCT00502775|528055807|FG002|Overall Study|Randomized in error|1|||
146422932|NCT00502775|528055805|FG000|Overall Study|Non-compliance|0|||
146422933|NCT00502775|528055806|FG001|Overall Study|Non-compliance|2|||
146422934|NCT00502775|528055807|FG002|Overall Study|Non-compliance|2|||
146422935|NCT00502775|528055805|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
146422936|NCT00502775|528055806|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
146422937|NCT00502775|528055807|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
146422938|NCT00502775|528055805|FG000|Overall Study|Declining pollen counts|0|||
146422939|NCT00502775|528055806|FG001|Overall Study|Declining pollen counts|1|||
146194885|NCT01143077|527224121|FG001|Overall Study|Lost to Follow-up|3|||
146194886|NCT01143077|527224122|FG002|Overall Study|Lost to Follow-up|4|||
146194887|NCT01143077|527224120|FG000|Overall Study|Protocol Violation|2|||
146082516|NCT02431260|526822822|FG012|Overall Study|Study Terminated by the Sponsor|4|||
146194888|NCT01143077|527224121|FG001|Overall Study|Protocol Violation|0|||
146194889|NCT01143077|527224122|FG002|Overall Study|Protocol Violation|0|||
146422940|NCT00502775|528055807|FG002|Overall Study|Declining pollen counts|1|||
146422941|NCT00502775|528055805|FG000|Overall Study|Subject in jail|0|||
146422942|NCT00502775|528055806|FG001|Overall Study|Subject in jail|1|||
146422943|NCT00502775|528055807|FG002|Overall Study|Subject in jail|0|||
146422944|NCT00502775|528055805|FG000|Overall Study|Subject took disallowed drug|0|||
146422945|NCT00502775|528055806|FG001|Overall Study|Subject took disallowed drug|0|||
146082517|NCT02431260|526822823|FG013|Overall Study|Study Terminated by the Sponsor|0|||
146194890|NCT01143077|527224120|FG000|Overall Study|Withdrawal by Subject|4|||
146422946|NCT00502775|528055807|FG002|Overall Study|Subject took disallowed drug|1|||
146422947|NCT02016300|528055815|FG000|Overall Study|Lost to Follow-up|0|||
146422948|NCT02016300|528055816|FG001|Overall Study|Lost to Follow-up|3|||
146422949|NCT06165744|528055819|FG000|Overall Study|Non device-related adverse event|1|||
146422950|NCT01545076|528055820|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
146422951|NCT01545076|528055821|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
146422952|NCT01545076|528055822|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
146422953|NCT01545076|528055823|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
146422954|NCT01545076|528055824|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
146422955|NCT01545076|528055820|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
146422956|NCT01545076|528055821|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
146422957|NCT01545076|528055822|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
146422958|NCT01545076|528055823|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
146422959|NCT01545076|528055824|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
146422960|NCT01545076|528055820|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
146422961|NCT01545076|528055821|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
146422962|NCT01545076|528055822|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
146422963|NCT01545076|528055823|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
146422964|NCT01545076|528055824|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
146422965|NCT01545076|528055820|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
146422966|NCT01545076|528055821|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146422967|NCT01545076|528055822|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146422968|NCT01545076|528055823|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146422969|NCT01545076|528055824|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
146422970|NCT01545076|528055820|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
146422971|NCT01545076|528055821|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146422972|NCT01545076|528055822|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146422973|NCT01545076|528055823|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146422974|NCT01545076|528055824|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
146422975|NCT01545076|528055820|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146422976|NCT01545076|528055821|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146422977|NCT01545076|528055822|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146422978|NCT01545076|528055823|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
146422979|NCT01545076|528055824|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
146422980|NCT01545076|528055820|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
146422981|NCT01545076|528055821|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
146422982|NCT01545076|528055822|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
146422983|NCT01545076|528055823|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
146422984|NCT01545076|528055824|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
146422985|NCT01545076|528055820|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146422986|NCT01545076|528055821|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
146422987|NCT01545076|528055822|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
146422988|NCT01545076|528055823|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146422989|NCT01545076|528055824|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
146422990|NCT01545076|528055820|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
146422991|NCT01545076|528055821|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
146422992|NCT01545076|528055822|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
146422993|NCT01545076|528055823|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
146422994|NCT01545076|528055824|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
146422995|NCT01546987|528055825|FG000|Overall Study|Protocol Violation|3|||
146422996|NCT01546987|528055826|FG001|Overall Study|Protocol Violation|4|||
146422997|NCT02270736|528055827|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146422998|NCT02270736|528055828|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
146422999|NCT02270736|528055829|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146423000|NCT02270736|528055830|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146423001|NCT02270736|528055831|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
146194891|NCT01143077|527224121|FG001|Overall Study|Withdrawal by Subject|3|||
146194892|NCT01143077|527224122|FG002|Overall Study|Withdrawal by Subject|3|||
146423002|NCT02270736|528055827|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
146423003|NCT02270736|528055828|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146194893|NCT01143077|527224120|FG000|Overall Study|Non-compliance with study drug|0|||
146194894|NCT01143077|527224121|FG001|Overall Study|Non-compliance with study drug|1|||
146194895|NCT01143077|527224122|FG002|Overall Study|Non-compliance with study drug|1|||
146194896|NCT01143077|527224120|FG000|Overall Study|Administrative|1|||
146194897|NCT01143077|527224121|FG001|Overall Study|Administrative|0|||
146194898|NCT01143077|527224122|FG002|Overall Study|Administrative|0|||
146194899|NCT01143077|527224120|FG000|Overall Study|Principal Investigator Decision|2|||
146194900|NCT01143077|527224121|FG001|Overall Study|Principal Investigator Decision|0|||
146194901|NCT01143077|527224122|FG002|Overall Study|Principal Investigator Decision|1|||
146194902|NCT00124982|527224123|FG000|Short-term Period|Death|1|||
146194903|NCT00124982|527224124|FG001|Short-term Period|Death|1|||
146194904|NCT00124982|527224125|FG002|Short-term Period|Death|0|||
146194905|NCT00124982|527224123|FG000|Short-term Period|Adverse Event|17|||
146194906|NCT00124982|527224124|FG001|Short-term Period|Adverse Event|22|||
146194907|NCT00124982|527224125|FG002|Short-term Period|Adverse Event|0|||
146194908|NCT00124982|527224123|FG000|Short-term Period|Lack of Efficacy|32|||
146423004|NCT02270736|528055829|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
146194909|NCT00124982|527224124|FG001|Short-term Period|Lack of Efficacy|73|||
146194910|NCT00124982|527224125|FG002|Short-term Period|Lack of Efficacy|0|||
146194911|NCT00124982|527224123|FG000|Short-term Period|Lost to Follow-up|8|||
146194912|NCT00124982|527224124|FG001|Short-term Period|Lost to Follow-up|5|||
146194913|NCT00124982|527224125|FG002|Short-term Period|Lost to Follow-up|0|||
146194914|NCT00124982|527224123|FG000|Short-term Period|Withdrawal of Consent|7|||
146194915|NCT00124982|527224124|FG001|Short-term Period|Withdrawal of Consent|9|||
146194916|NCT00124982|527224125|FG002|Short-term Period|Withdrawal of Consent|0|||
146194917|NCT00124982|527224123|FG000|Short-term Period|Poor/Non-compliance|3|||
146194918|NCT00124982|527224124|FG001|Short-term Period|Poor/Non-compliance|1|||
146194919|NCT00124982|527224125|FG002|Short-term Period|Poor/Non-compliance|0|||
146194920|NCT00124982|527224123|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
146194921|NCT00124982|527224124|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
146194922|NCT00124982|527224125|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
146194923|NCT00124982|527224123|FG000|Short-term Period|Participant Decision|1|||
146194924|NCT00124982|527224124|FG001|Short-term Period|Participant Decision|0|||
146194925|NCT00124982|527224125|FG002|Short-term Period|Participant Decision|0|||
146194926|NCT00124982|527224123|FG000|Short-term Period|Participant Chose Own Doctor|0|||
146194927|NCT00124982|527224124|FG001|Short-term Period|Participant Chose Own Doctor|1|||
146194928|NCT00124982|527224125|FG002|Short-term Period|Participant Chose Own Doctor|0|||
146194929|NCT00124982|527224123|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
146194930|NCT00124982|527224124|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
146194931|NCT00124982|527224125|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
146194932|NCT00124982|527224123|FG000|Short-term Period|Participant Had Lymphopenia|1|||
146194933|NCT00124982|527224124|FG001|Short-term Period|Participant Had Lymphopenia|0|||
146194934|NCT00124982|527224125|FG002|Short-term Period|Participant Had Lymphopenia|0|||
146194935|NCT00124982|527224123|FG000|Long-term Period|Death|0|||
146194936|NCT00124982|527224124|FG001|Long-term Period|Death|0|||
146194937|NCT00124982|527224125|FG002|Long-term Period|Death|1|||
146194938|NCT00124982|527224123|FG000|Long-term Period|Adverse Event|0|||
146194939|NCT00124982|527224124|FG001|Long-term Period|Adverse Event|0|||
146194940|NCT00124982|527224125|FG002|Long-term Period|Adverse Event|17|||
146194941|NCT00124982|527224123|FG000|Long-term Period|Lack of Efficacy|0|||
146194942|NCT00124982|527224124|FG001|Long-term Period|Lack of Efficacy|0|||
146194943|NCT00124982|527224125|FG002|Long-term Period|Lack of Efficacy|46|||
146194944|NCT00124982|527224123|FG000|Long-term Period|Lost to Follow-up|0|||
146194945|NCT00124982|527224124|FG001|Long-term Period|Lost to Follow-up|0|||
146194946|NCT00124982|527224125|FG002|Long-term Period|Lost to Follow-up|4|||
146194947|NCT00124982|527224123|FG000|Long-term Period|Withdrawal by Subject|0|||
146423005|NCT02270736|528055830|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146423006|NCT02270736|528055831|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
146194948|NCT00124982|527224124|FG001|Long-term Period|Withdrawal by Subject|0|||
146194949|NCT00124982|527224125|FG002|Long-term Period|Withdrawal by Subject|16|||
146194950|NCT00124982|527224123|FG000|Long-term Period|Pregnancy|0|||
146194951|NCT00124982|527224124|FG001|Long-term Period|Pregnancy|0|||
146194952|NCT00124982|527224125|FG002|Long-term Period|Pregnancy|1|||
146194953|NCT00124982|527224123|FG000|Long-term Period|Poor/Non-compliance|0|||
146194954|NCT00124982|527224124|FG001|Long-term Period|Poor/Non-compliance|0|||
146194955|NCT00124982|527224125|FG002|Long-term Period|Poor/Non-compliance|2|||
146194956|NCT00124982|527224123|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
146194957|NCT00124982|527224124|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
146194958|NCT00124982|527224125|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
146194959|NCT00124982|527224123|FG000|Long-term Period|Neurologist Recommendation|0|||
146194960|NCT00124982|527224124|FG001|Long-term Period|Neurologist Recommendation|0|||
146194961|NCT00124982|527224125|FG002|Long-term Period|Neurologist Recommendation|1|||
146194962|NCT00630864|527224126|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
146194963|NCT00630864|527224126|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
146194964|NCT01555762|527224127|FG000|Overall Study|No information on Bevacizumab intake|11|||
146194965|NCT01555762|527224127|FG000|Overall Study|Missing start date of infusion|8|||
146194966|NCT01555762|527224127|FG000|Overall Study|75 years old or more ticked No|1|||
146194967|NCT01555762|527224127|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
146194968|NCT01555762|527224127|FG000|Overall Study|Death linked to progression of disease|165|||
146194969|NCT01555762|527224127|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
146194970|NCT01555762|527224127|FG000|Overall Study|Investigator's decision|10|||
146194971|NCT01555762|527224127|FG000|Overall Study|Participant not wishing to continue|5|||
146194972|NCT01555762|527224127|FG000|Overall Study|Missing data|1|||
146194973|NCT01555762|527224127|FG000|Overall Study|Death linked to an adverse event|14|||
146194974|NCT01333514|527224128|FG000|Overall Study|Withdrawal by Subject|1|||
146194975|NCT01333514|527224129|FG001|Overall Study|Withdrawal by Subject|0|||
146194976|NCT00836810|527224130|FG000|Overall Study|New diagnosis|1|||
146194977|NCT00836810|527224131|FG001|Overall Study|New diagnosis|0|||
146194978|NCT00819910|527224132|FG000|Overall Study|Adverse Event|0|||
146194979|NCT00819910|527224133|FG001|Overall Study|Adverse Event|0|||
146194980|NCT00819910|527224134|FG002|Overall Study|Adverse Event|2|||
146194981|NCT00819910|527224135|FG003|Overall Study|Adverse Event|1|||
146194982|NCT00819910|527224132|FG000|Overall Study|Withdrawal by Subject|1|||
146194983|NCT00819910|527224133|FG001|Overall Study|Withdrawal by Subject|1|||
146194984|NCT00819910|527224134|FG002|Overall Study|Withdrawal by Subject|1|||
146194985|NCT00819910|527224135|FG003|Overall Study|Withdrawal by Subject|0|||
146194986|NCT00819910|527224132|FG000|Overall Study|Lost to Follow-up|1|||
146194987|NCT00819910|527224133|FG001|Overall Study|Lost to Follow-up|0|||
146194988|NCT00819910|527224134|FG002|Overall Study|Lost to Follow-up|0|||
146194989|NCT00819910|527224135|FG003|Overall Study|Lost to Follow-up|0|||
146194990|NCT00871429|527224139|FG000|Overall Study|Lost to Follow-up|6|||
146194991|NCT00871429|527224139|FG000|Overall Study|Withdrawal by Subject|17|||
146194992|NCT00871429|527224139|FG000|Overall Study|Questionnaire not completed|1|||
146194993|NCT03102242|527224140|FG000|Overall Study|Adverse Event|2|||
146194994|NCT01137292|527224141|FG000|Overall Study|Death|30|||
146194995|NCT01137292|527224141|FG000|Overall Study|Adverse Event|3|||
146194996|NCT01137292|527224141|FG000|Overall Study|Lack of Efficacy|13|||
146194997|NCT01137292|527224141|FG000|Overall Study|Lost to Follow-up|1|||
146194998|NCT01137292|527224141|FG000|Overall Study|Other|7|||
146194999|NCT01772719|527224146|FG000|Overall Study|Withdrawal by Subject|3|||
146195000|NCT01772719|527224146|FG000|Overall Study|Adverse Event|2|||
146195001|NCT01772719|527224146|FG000|Overall Study|Protocol Violation|1|||
146195002|NCT01772719|527224146|FG000|Overall Study|Lost to Follow-up|1|||
146195003|NCT01311713|527224149|FG000|Overall Study|Death|0|||
146195004|NCT01311713|527224150|FG001|Overall Study|Death|0|||
146195005|NCT01311713|527224151|FG002|Overall Study|Death|1|||
146195006|NCT01311713|527224152|FG003|Overall Study|Death|1|||
146195007|NCT01311713|527224153|FG004|Overall Study|Death|0|||
146195008|NCT01311713|527224154|FG005|Overall Study|Death|1|||
146195009|NCT01311713|527224155|FG006|Overall Study|Death|0|||
146195010|NCT01311713|527224149|FG000|Overall Study|Adverse Event|0|||
146195011|NCT01311713|527224150|FG001|Overall Study|Adverse Event|1|||
146195012|NCT01311713|527224151|FG002|Overall Study|Adverse Event|0|||
146195013|NCT01311713|527224152|FG003|Overall Study|Adverse Event|2|||
146195014|NCT01311713|527224153|FG004|Overall Study|Adverse Event|0|||
146195015|NCT01311713|527224154|FG005|Overall Study|Adverse Event|0|||
146195016|NCT01311713|527224155|FG006|Overall Study|Adverse Event|2|||
146195017|NCT01311713|527224149|FG000|Overall Study|Withdrawal by Subject|0|||
146195018|NCT01311713|527224150|FG001|Overall Study|Withdrawal by Subject|1|||
146195019|NCT01311713|527224151|FG002|Overall Study|Withdrawal by Subject|1|||
146195020|NCT01311713|527224152|FG003|Overall Study|Withdrawal by Subject|0|||
146195021|NCT01311713|527224153|FG004|Overall Study|Withdrawal by Subject|0|||
146195022|NCT01311713|527224154|FG005|Overall Study|Withdrawal by Subject|1|||
146195023|NCT01311713|527224155|FG006|Overall Study|Withdrawal by Subject|2|||
146195024|NCT01311713|527224149|FG000|Overall Study|Disease progression|3|||
146195025|NCT01311713|527224150|FG001|Overall Study|Disease progression|4|||
146195026|NCT01311713|527224151|FG002|Overall Study|Disease progression|3|||
146195027|NCT01311713|527224152|FG003|Overall Study|Disease progression|2|||
146195028|NCT01311713|527224153|FG004|Overall Study|Disease progression|4|||
146195029|NCT01311713|527224154|FG005|Overall Study|Disease progression|4|||
146082518|NCT02431260|526822810|FG000|Overall Study|Physician Decision|0|||
146195030|NCT01311713|527224155|FG006|Overall Study|Disease progression|5|||
146195031|NCT01311713|527224149|FG000|Overall Study|Lost to Follow-up|0|||
146195032|NCT01311713|527224150|FG001|Overall Study|Lost to Follow-up|0|||
146195033|NCT01311713|527224151|FG002|Overall Study|Lost to Follow-up|1|||
146195034|NCT01311713|527224152|FG003|Overall Study|Lost to Follow-up|0|||
146195035|NCT01311713|527224153|FG004|Overall Study|Lost to Follow-up|0|||
146195036|NCT01311713|527224154|FG005|Overall Study|Lost to Follow-up|0|||
146195037|NCT01311713|527224155|FG006|Overall Study|Lost to Follow-up|0|||
146195038|NCT01311713|527224149|FG000|Overall Study|Stopped taking study medication|0|||
146195039|NCT01311713|527224150|FG001|Overall Study|Stopped taking study medication|0|||
146195040|NCT01311713|527224151|FG002|Overall Study|Stopped taking study medication|0|||
146195041|NCT01311713|527224152|FG003|Overall Study|Stopped taking study medication|1|||
146195042|NCT01311713|527224153|FG004|Overall Study|Stopped taking study medication|1|||
146195043|NCT01311713|527224154|FG005|Overall Study|Stopped taking study medication|0|||
146195044|NCT01311713|527224155|FG006|Overall Study|Stopped taking study medication|0|||
146195045|NCT01311713|527224149|FG000|Overall Study|Enrolled but not treated|0|||
146195046|NCT01311713|527224150|FG001|Overall Study|Enrolled but not treated|0|||
146195047|NCT01311713|527224151|FG002|Overall Study|Enrolled but not treated|1|||
146195048|NCT01311713|527224152|FG003|Overall Study|Enrolled but not treated|0|||
146195049|NCT01311713|527224153|FG004|Overall Study|Enrolled but not treated|0|||
146195050|NCT01311713|527224154|FG005|Overall Study|Enrolled but not treated|0|||
146195051|NCT01311713|527224155|FG006|Overall Study|Enrolled but not treated|0|||
146195052|NCT01311713|527224149|FG000|Overall Study|Other than specified|0|||
146195053|NCT01311713|527224150|FG001|Overall Study|Other than specified|1|||
146195054|NCT01311713|527224151|FG002|Overall Study|Other than specified|2|||
146195055|NCT01311713|527224152|FG003|Overall Study|Other than specified|0|||
146195056|NCT01311713|527224153|FG004|Overall Study|Other than specified|0|||
146195057|NCT01311713|527224154|FG005|Overall Study|Other than specified|0|||
146195058|NCT01311713|527224155|FG006|Overall Study|Other than specified|0|||
146195059|NCT00477412|527224156|FG000|Overall Study|Death|0|||
146195060|NCT00477412|527224157|FG001|Overall Study|Death|0|||
146195061|NCT00477412|527224158|FG002|Overall Study|Death|0|||
146195062|NCT00477412|527224159|FG003|Overall Study|Death|4|||
146195063|NCT00477412|527224156|FG000|Overall Study|Lost to Follow-up|0|||
146195064|NCT00477412|527224157|FG001|Overall Study|Lost to Follow-up|0|||
146195065|NCT00477412|527224158|FG002|Overall Study|Lost to Follow-up|0|||
146195066|NCT00477412|527224159|FG003|Overall Study|Lost to Follow-up|1|||
146195067|NCT00477412|527224156|FG000|Overall Study|Withdrawal by Subject|0|||
146195068|NCT00477412|527224157|FG001|Overall Study|Withdrawal by Subject|0|||
146195069|NCT00477412|527224158|FG002|Overall Study|Withdrawal by Subject|0|||
146195070|NCT00477412|527224159|FG003|Overall Study|Withdrawal by Subject|2|||
146195071|NCT00477412|527224156|FG000|Overall Study|Second Malignancy|0|||
146195072|NCT00477412|527224157|FG001|Overall Study|Second Malignancy|0|||
146195073|NCT00477412|527224158|FG002|Overall Study|Second Malignancy|0|||
146195074|NCT00477412|527224159|FG003|Overall Study|Second Malignancy|1|||
146195075|NCT00477412|527224156|FG000|Overall Study|Adverse Event|1|||
146195076|NCT00477412|527224157|FG001|Overall Study|Adverse Event|0|||
146195077|NCT00477412|527224158|FG002|Overall Study|Adverse Event|1|||
146195078|NCT00477412|527224159|FG003|Overall Study|Adverse Event|0|||
146195079|NCT02931396|527224161|FG000|Overall Study|Lost to Follow-up|3|||
146195080|NCT02931396|527224162|FG001|Overall Study|Lost to Follow-up|0|||
146195081|NCT02931396|527224161|FG000|Overall Study|Withdrawal by Subject|2|||
146195082|NCT02931396|527224162|FG001|Overall Study|Withdrawal by Subject|0|||
146195083|NCT05460663|527224163|FG000|Overall Study|Withdrawal by Subject|2|||
146195084|NCT05460663|527224164|FG001|Overall Study|Withdrawal by Subject|5|||
146195085|NCT01645111|527225672|FG000|Overall Study|Did not require Clevidipine|15|||
146195086|NCT04057196|527225673|FG000|Overall Study|Withdrawal by Subject|3|||
146195087|NCT04057196|527225673|FG000|Overall Study|Death|3|||
146195088|NCT03068468|527225674|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
146195089|NCT03068468|527225675|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
146195090|NCT03068468|527225676|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
146195091|NCT03068468|527225677|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
146195092|NCT03068468|527225674|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
146423007|NCT02270736|528055827|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146423008|NCT02270736|528055828|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
146423009|NCT02270736|528055829|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146195093|NCT03068468|527225675|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
146195094|NCT03068468|527225676|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
146195095|NCT03068468|527225677|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
146195096|NCT03068468|527225674|FG000|Placebo-Controlled Period|Adverse Event|16|||
146195097|NCT03068468|527225675|FG001|Placebo-Controlled Period|Adverse Event|21|||
146195098|NCT03068468|527225676|FG002|Placebo-Controlled Period|Adverse Event|0|||
146195099|NCT03068468|527225677|FG003|Placebo-Controlled Period|Adverse Event|0|||
146195100|NCT03068468|527225674|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
146195101|NCT03068468|527225675|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
146195102|NCT03068468|527225676|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
146195103|NCT03068468|527225677|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
146195104|NCT03068468|527225674|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146195105|NCT03068468|527225675|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
146195106|NCT03068468|527225676|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146195107|NCT03068468|527225677|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146195108|NCT03068468|527225674|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
146195109|NCT03068468|527225675|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
146195110|NCT03068468|527225676|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
146195111|NCT03068468|527225677|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
146195112|NCT03068468|527225674|FG000|Placebo-Controlled Period|Death|0|||
146195113|NCT03068468|527225675|FG001|Placebo-Controlled Period|Death|1|||
146195114|NCT03068468|527225676|FG002|Placebo-Controlled Period|Death|0|||
146195115|NCT03068468|527225677|FG003|Placebo-Controlled Period|Death|0|||
146195116|NCT03068468|527225674|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
146195117|NCT03068468|527225675|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146195118|NCT03068468|527225676|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
146195119|NCT03068468|527225677|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
146195120|NCT03068468|527225674|FG000|Open-Label Extension Period|Adverse Event|0|||
146195121|NCT03068468|527225675|FG001|Open-Label Extension Period|Adverse Event|0|||
146195122|NCT03068468|527225676|FG002|Open-Label Extension Period|Adverse Event|13|||
146195123|NCT03068468|527225677|FG003|Open-Label Extension Period|Adverse Event|17|||
146195124|NCT03068468|527225674|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
146195125|NCT03068468|527225675|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
146195126|NCT03068468|527225676|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
146195127|NCT03068468|527225677|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
146195128|NCT03068468|527225674|FG000|Open-Label Extension Period|Death|0|||
146195129|NCT03068468|527225675|FG001|Open-Label Extension Period|Death|0|||
146195130|NCT03068468|527225676|FG002|Open-Label Extension Period|Death|0|||
146195131|NCT03068468|527225677|FG003|Open-Label Extension Period|Death|1|||
146195132|NCT03068468|527225674|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
146195133|NCT03068468|527225675|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
146195134|NCT03068468|527225676|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
146195135|NCT03068468|527225677|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
146195136|NCT03068468|527225674|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146195137|NCT03068468|527225675|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146195138|NCT03068468|527225676|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
146195139|NCT03068468|527225677|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
146195140|NCT03068468|527225674|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
146195141|NCT03068468|527225675|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
146195142|NCT03068468|527225676|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
146195143|NCT03068468|527225677|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
146195144|NCT03068468|527225674|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146082519|NCT02431260|526822811|FG001|Overall Study|Physician Decision|0|||
146082520|NCT02431260|526822812|FG002|Overall Study|Physician Decision|0|||
146082521|NCT02431260|526822813|FG003|Overall Study|Physician Decision|0|||
146082522|NCT02431260|526822814|FG004|Overall Study|Physician Decision|0|||
146082523|NCT02431260|526822815|FG005|Overall Study|Physician Decision|1|||
146195145|NCT03068468|527225675|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146423010|NCT02270736|528055830|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146082524|NCT02431260|526822816|FG006|Overall Study|Physician Decision|0|||
146082525|NCT02431260|526822817|FG007|Overall Study|Physician Decision|0|||
146082526|NCT02431260|526822818|FG008|Overall Study|Physician Decision|0|||
146195146|NCT03068468|527225676|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
146195147|NCT03068468|527225677|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
146195148|NCT03068468|527225674|FG000|Open-Label Extension Period|Reason not Specified|0|||
146195149|NCT03068468|527225675|FG001|Open-Label Extension Period|Reason not Specified|0|||
146195150|NCT03068468|527225676|FG002|Open-Label Extension Period|Reason not Specified|1|||
146423011|NCT02270736|528055831|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
146082527|NCT02431260|526822819|FG009|Overall Study|Physician Decision|0|||
146082528|NCT02431260|526822820|FG010|Overall Study|Physician Decision|0|||
146082529|NCT02431260|526822821|FG011|Overall Study|Physician Decision|0|||
146082530|NCT02431260|526822822|FG012|Overall Study|Physician Decision|0|||
146082531|NCT02431260|526822823|FG013|Overall Study|Physician Decision|0|||
146082532|NCT02431260|526822810|FG000|Overall Study|Other Unspecified|0|||
146082533|NCT02431260|526822811|FG001|Overall Study|Other Unspecified|0|||
146082534|NCT02431260|526822812|FG002|Overall Study|Other Unspecified|0|||
146082535|NCT02431260|526822813|FG003|Overall Study|Other Unspecified|0|||
146082536|NCT02431260|526822814|FG004|Overall Study|Other Unspecified|0|||
146082537|NCT02431260|526822815|FG005|Overall Study|Other Unspecified|0|||
146082538|NCT02431260|526822816|FG006|Overall Study|Other Unspecified|0|||
146082539|NCT02431260|526822817|FG007|Overall Study|Other Unspecified|0|||
146082540|NCT02431260|526822818|FG008|Overall Study|Other Unspecified|0|||
146082541|NCT02431260|526822819|FG009|Overall Study|Other Unspecified|0|||
146082542|NCT02431260|526822820|FG010|Overall Study|Other Unspecified|0|||
146082543|NCT02431260|526822821|FG011|Overall Study|Other Unspecified|1|||
146082544|NCT02431260|526822822|FG012|Overall Study|Other Unspecified|1|||
146082545|NCT02431260|526822823|FG013|Overall Study|Other Unspecified|0|||
146082546|NCT00439738|526822825|FG000|Overall Study|Withdrawal by Subject|16|||
146082547|NCT00439738|526822826|FG001|Overall Study|Withdrawal by Subject|13|||
146082548|NCT00439738|526822825|FG000|Overall Study|Adverse Event|6|||
146082549|NCT00439738|526822826|FG001|Overall Study|Adverse Event|4|||
146082550|NCT00439738|526822825|FG000|Overall Study|Lost to Follow-up|5|||
146082551|NCT00439738|526822826|FG001|Overall Study|Lost to Follow-up|6|||
146082552|NCT00439738|526822825|FG000|Overall Study|Protocol Violation|6|||
146082553|NCT00439738|526822826|FG001|Overall Study|Protocol Violation|3|||
146082554|NCT00439738|526822825|FG000|Overall Study|Lack of Efficacy|2|||
146082555|NCT00439738|526822826|FG001|Overall Study|Lack of Efficacy|2|||
146082556|NCT00439738|526822825|FG000|Overall Study|Abnormal Lab Values|1|||
146082557|NCT00439738|526822826|FG001|Overall Study|Abnormal Lab Values|0|||
146082558|NCT00392379|526822827|FG000|Overall Study|Withdrawal by Subject|17|||
146082559|NCT00392379|526822828|FG001|Overall Study|Withdrawal by Subject|28|||
146082560|NCT00392379|526822827|FG000|Overall Study|Lost to Follow-up|4|||
146082561|NCT00392379|526822828|FG001|Overall Study|Lost to Follow-up|9|||
146082562|NCT00392379|526822827|FG000|Overall Study|Adverse Event|1|||
146082563|NCT00392379|526822828|FG001|Overall Study|Adverse Event|1|||
146082564|NCT01978938|526822829|FG000|Overall Study|Lost to Follow-up|12|||
146082565|NCT01978938|526822830|FG001|Overall Study|Lost to Follow-up|6|||
146082566|NCT01978938|526822829|FG000|Overall Study|Withdrawal by Subject|8|||
146082567|NCT01978938|526822830|FG001|Overall Study|Withdrawal by Subject|4|||
146082568|NCT01978938|526822829|FG000|Overall Study|Adverse Event, non-fatal|2|||
146082569|NCT01978938|526822830|FG001|Overall Study|Adverse Event, non-fatal|1|||
146082570|NCT01978938|526822829|FG000|Overall Study|Participant noncompliance|1|||
146082571|NCT01978938|526822830|FG001|Overall Study|Participant noncompliance|1|||
146082572|NCT01978938|526822829|FG000|Overall Study|Did not meet inclusion criteria|0|||
146082573|NCT01978938|526822830|FG001|Overall Study|Did not meet inclusion criteria|1|||
146082574|NCT01978938|526822829|FG000|Overall Study|Previously scheduled procedure|0|||
146082575|NCT01978938|526822830|FG001|Overall Study|Previously scheduled procedure|1|||
146082576|NCT01806662|526822834|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
146082577|NCT01806662|526822835|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
146082578|NCT01806662|526822834|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
146082579|NCT01806662|526822835|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
146082580|NCT01806662|526822834|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
146082581|NCT01806662|526822835|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
146082582|NCT01806662|526822834|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
146082583|NCT01806662|526822835|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
146082584|NCT00043550|526822838|FG000|Overall Study|Withdrawal by Subject|22|||
146195151|NCT03068468|527225677|FG003|Open-Label Extension Period|Reason not Specified|4|||
146195152|NCT02466516|527225679|FG000|Overall Study|Adverse Event|1|||
146195153|NCT02466516|527225680|FG001|Overall Study|Adverse Event|1|||
146082585|NCT00043550|526822839|FG001|Overall Study|Withdrawal by Subject|12|||
146082586|NCT00043550|526822840|FG002|Overall Study|Withdrawal by Subject|20|||
146082587|NCT00710762|526822845|FG000|Overall Study|Progressive disease|27|||
146082588|NCT00710762|526822846|FG001|Overall Study|Progressive disease|30|||
146082589|NCT00710762|526822845|FG000|Overall Study|Adverse Event other disease worsening|2|||
146082590|NCT00710762|526822846|FG001|Overall Study|Adverse Event other disease worsening|1|||
146082591|NCT00710762|526822845|FG000|Overall Study|Other Adverse Event|7|||
146082592|NCT00710762|526822846|FG001|Overall Study|Other Adverse Event|7|||
146082593|NCT00710762|526822845|FG000|Overall Study|Lost to Follow-up|1|||
146082594|NCT00710762|526822846|FG001|Overall Study|Lost to Follow-up|0|||
146082595|NCT00710762|526822845|FG000|Overall Study|Reason other than listed above|2|||
146195154|NCT02466516|527225681|FG002|Overall Study|Adverse Event|0|||
146082596|NCT00710762|526822846|FG001|Overall Study|Reason other than listed above|2|||
146082597|NCT01375075|526822847|FG000|Overall Study|Adverse Event|0|||
146195155|NCT02466516|527225682|FG003|Overall Study|Adverse Event|0|||
146195156|NCT02466516|527225683|FG004|Overall Study|Adverse Event|0|||
146195157|NCT02466516|527225679|FG000|Overall Study|Withdrew Consent|1|||
146195158|NCT02466516|527225680|FG001|Overall Study|Withdrew Consent|0|||
146195159|NCT02466516|527225681|FG002|Overall Study|Withdrew Consent|0|||
146195160|NCT02466516|527225682|FG003|Overall Study|Withdrew Consent|0|||
146195161|NCT02466516|527225683|FG004|Overall Study|Withdrew Consent|0|||
146195162|NCT02466516|527225679|FG000|Overall Study|Lost to Follow-up|2|||
146195163|NCT02466516|527225680|FG001|Overall Study|Lost to Follow-up|0|||
146195164|NCT02466516|527225681|FG002|Overall Study|Lost to Follow-up|1|||
146195165|NCT02466516|527225682|FG003|Overall Study|Lost to Follow-up|0|||
146195166|NCT02466516|527225683|FG004|Overall Study|Lost to Follow-up|0|||
146195167|NCT03712930|527225684|FG000|Overall Study|Death|7|||
146195168|NCT03712930|527225684|FG000|Overall Study|Physician Decision|1|||
146195169|NCT03712930|527225684|FG000|Overall Study|Study Terminated by Sponsor|3|||
146195170|NCT03712930|527225684|FG000|Overall Study|Progressive Disease|2|||
146195171|NCT03895034|527225685|FG000|Overall Study|Lost to Follow-up|2|||
146195172|NCT01118377|527225686|FG000|Overall Study|Did Not Receive Study Medication|1|||
146195173|NCT01118377|527225686|FG000|Overall Study|Death|38|||
146195174|NCT01118377|527225686|FG000|Overall Study|Failure to Return|3|||
146195175|NCT00739102|527225691|FG000|Overall Study|Death|5|||
146195176|NCT00739102|527225691|FG000|Overall Study|Withdrawal by Subject|10|||
146195177|NCT01062126|527225692|FG000|Overall Study|Death|209|||
146195178|NCT01062126|527225692|FG000|Overall Study|All Withdrawals|324|||
146195179|NCT00646451|527225693|FG000|Overall Study|Adverse Event|3|||
146195180|NCT00646451|527225694|FG001|Overall Study|Adverse Event|0|||
146195181|NCT00646451|527225693|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
146195182|NCT00646451|527225694|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
146195183|NCT03784963|527225695|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
146195184|NCT03784963|527225696|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
146195185|NCT03784963|527225697|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
146195186|NCT03784963|527225698|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
146195187|NCT01510912|527225699|FG000|Overall Study|Adverse Event|99|||
146195188|NCT01510912|527225699|FG000|Overall Study|Lack of Efficacy|12|||
146195189|NCT01510912|527225699|FG000|Overall Study|Non-compliance with trial drug|23|||
146195190|NCT01510912|527225699|FG000|Overall Study|Withdrawal by Subject|49|||
146195191|NCT01510912|527225699|FG000|Overall Study|Physician Decision|1|||
146195192|NCT01510912|527225699|FG000|Overall Study|Protocol Violation|27|||
146195193|NCT01510912|527225699|FG000|Overall Study|Lost to Follow-up|26|||
146195194|NCT01510912|527225699|FG000|Overall Study|Other, including joint replacement|5|||
146195195|NCT03181958|527225700|FG000|Overall Study|Lost to Follow-up|17|||
146195196|NCT03181958|527225701|FG001|Overall Study|Lost to Follow-up|21|||
146195197|NCT03181958|527225702|FG002|Overall Study|Lost to Follow-up|15|||
146195198|NCT00349908|527225706|FG000|Overall Study|Withdrawal by Subject|0|||
146195199|NCT00349908|527225707|FG001|Overall Study|Withdrawal by Subject|4|||
146195200|NCT00109967|527225712|FG000|Overall Study|Cancel Prior to Treatment|2|||
146195201|NCT00109967|527225713|FG001|Overall Study|Cancel Prior to Treatment|0|||
146195202|NCT00109967|527225712|FG000|Overall Study|Adverse Event|12|||
146195203|NCT00109967|527225713|FG001|Overall Study|Adverse Event|1|||
146195204|NCT00109967|527225712|FG000|Overall Study|Withdrawal by Subject|5|||
146195205|NCT00109967|527225713|FG001|Overall Study|Withdrawal by Subject|0|||
146195206|NCT00109967|527225712|FG000|Overall Study|Physician Decision|1|||
146195207|NCT00109967|527225713|FG001|Overall Study|Physician Decision|3|||
146195208|NCT00109967|527225712|FG000|Overall Study|Death|0|||
146195209|NCT00109967|527225713|FG001|Overall Study|Death|2|||
146195210|NCT01977612|527225716|FG000|Overall Study|Lost to Follow-up|1|||
146195211|NCT01977612|527225717|FG001|Overall Study|Lost to Follow-up|1|||
146195212|NCT02715258|527225718|FG000|Overall Study|Withdrawal by Subject|6|||
146195213|NCT02715258|527225719|FG001|Overall Study|Withdrawal by Subject|1|||
146195214|NCT02715258|527225718|FG000|Overall Study|Lost to Follow-up|7|||
146195215|NCT02715258|527225719|FG001|Overall Study|Lost to Follow-up|1|||
146195216|NCT02715258|527225718|FG000|Overall Study|Terminated by Sponsor|0|||
146195217|NCT02715258|527225719|FG001|Overall Study|Terminated by Sponsor|1|||
146195218|NCT02715258|527225718|FG000|Overall Study|Death|0|||
146195219|NCT02715258|527225719|FG001|Overall Study|Death|1|||
146195220|NCT02715258|527225718|FG000|Overall Study|Subject non-compliant|1|||
146195221|NCT02715258|527225719|FG001|Overall Study|Subject non-compliant|1|||
146195222|NCT02715258|527225718|FG000|Overall Study|GCP violation|2|||
146195223|NCT02715258|527225719|FG001|Overall Study|GCP violation|1|||
146195224|NCT02955069|527225721|FG000|Overall Study|Adverse Event|7|||
146195225|NCT02955069|527225722|FG001|Overall Study|Adverse Event|2|||
146195226|NCT02955069|527225721|FG000|Overall Study|Death|7|||
146195227|NCT02955069|527225722|FG001|Overall Study|Death|3|||
146195228|NCT02955069|527225721|FG000|Overall Study|Physician Decision|10|||
146195229|NCT02955069|527225722|FG001|Overall Study|Physician Decision|2|||
146195230|NCT02955069|527225721|FG000|Overall Study|Progressive disease|64|||
146195231|NCT02955069|527225722|FG001|Overall Study|Progressive disease|13|||
146195232|NCT02955069|527225721|FG000|Overall Study|Study terminated by sponsor|4|||
146195233|NCT02955069|527225722|FG001|Overall Study|Study terminated by sponsor|0|||
146195234|NCT02955069|527225721|FG000|Overall Study|Subject/Guardian decision|3|||
146195235|NCT02955069|527225722|FG001|Overall Study|Subject/Guardian decision|1|||
146195236|NCT00943605|527225723|FG000|Overall Study|Study termination|30|||
146195237|NCT00943605|527225724|FG001|Overall Study|Study termination|30|||
146195238|NCT04148937|527225725|FG000|Overall Study|Withdrawal by Subject|0|||
146195239|NCT04148937|527225726|FG001|Overall Study|Withdrawal by Subject|0|||
146195240|NCT04148937|527225727|FG002|Overall Study|Withdrawal by Subject|0|||
146195241|NCT04148937|527225728|FG003|Overall Study|Withdrawal by Subject|1|||
146195242|NCT04148937|527225729|FG004|Overall Study|Withdrawal by Subject|0|||
146195243|NCT04148937|527225730|FG005|Overall Study|Withdrawal by Subject|1|||
146195244|NCT04148937|527225731|FG006|Overall Study|Withdrawal by Subject|1|||
146195245|NCT04148937|527225732|FG007|Overall Study|Withdrawal by Subject|0|||
146195246|NCT04148937|527225725|FG000|Overall Study|Lost to Follow-up|0|||
146195247|NCT04148937|527225726|FG001|Overall Study|Lost to Follow-up|0|||
146195248|NCT04148937|527225727|FG002|Overall Study|Lost to Follow-up|1|||
146195249|NCT04148937|527225728|FG003|Overall Study|Lost to Follow-up|0|||
146195250|NCT04148937|527225729|FG004|Overall Study|Lost to Follow-up|0|||
146195251|NCT04148937|527225730|FG005|Overall Study|Lost to Follow-up|2|||
146195252|NCT04148937|527225731|FG006|Overall Study|Lost to Follow-up|0|||
146195253|NCT04148937|527225732|FG007|Overall Study|Lost to Follow-up|0|||
146195254|NCT01149681|527225733|FG000|Overall Study|Withdrawal by Subject|7|||
146195255|NCT01149681|527225733|FG000|Overall Study|Progressive disease|1|||
146195256|NCT01149681|527225733|FG000|Overall Study|Physician Decision|2|||
146195257|NCT01149681|527225733|FG000|Overall Study|adverse events nonrelated study drug|2|||
146195258|NCT03107611|527225735|FG000|Overall Study|Adverse Event|1|||
146195259|NCT03107611|527225736|FG001|Overall Study|Adverse Event|0|||
146195260|NCT03107611|527225737|FG002|Overall Study|Adverse Event|2|||
146195261|NCT03107611|527225735|FG000|Overall Study|Lost to Follow-up|3|||
146195262|NCT03107611|527225736|FG001|Overall Study|Lost to Follow-up|3|||
146195263|NCT03107611|527225737|FG002|Overall Study|Lost to Follow-up|3|||
146195264|NCT03107611|527225735|FG000|Overall Study|Protocol Violation|0|||
146195265|NCT03107611|527225736|FG001|Overall Study|Protocol Violation|0|||
146195266|NCT03107611|527225737|FG002|Overall Study|Protocol Violation|1|||
146195267|NCT03107611|527225735|FG000|Overall Study|Withdrawal by Subject|1|||
146195268|NCT03107611|527225736|FG001|Overall Study|Withdrawal by Subject|0|||
146195269|NCT03107611|527225737|FG002|Overall Study|Withdrawal by Subject|1|||
146195270|NCT03107611|527225735|FG000|Overall Study|Worsening signs/symptoms|2|||
146195271|NCT03107611|527225736|FG001|Overall Study|Worsening signs/symptoms|1|||
146195272|NCT03107611|527225737|FG002|Overall Study|Worsening signs/symptoms|2|||
146195273|NCT01908634|527225742|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
146195274|NCT01908634|527225742|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
146195275|NCT01570751|527225743|FG000|Period A (16 Weeks)|Protocol Violation|1|||
146195276|NCT01570751|527225744|FG001|Period A (16 Weeks)|Protocol Violation|1|||
146423012|NCT02270736|528055827|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146423013|NCT02270736|528055828|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146195277|NCT01570751|527225743|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
146195278|NCT01570751|527225744|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
146195279|NCT01570751|527225743|FG000|Period A (16 Weeks)|Unclassified|2|||
146195280|NCT01570751|527225744|FG001|Period A (16 Weeks)|Unclassified|3|||
146195281|NCT01570751|527225743|FG000|Period B (16 Weeks)|Adverse Event|1|||
146195282|NCT01570751|527225744|FG001|Period B (16 Weeks)|Adverse Event|0|||
146195283|NCT01570751|527225743|FG000|Period B (16 Weeks)|Protocol Violation|0|||
146195284|NCT01570751|527225744|FG001|Period B (16 Weeks)|Protocol Violation|1|||
146195285|NCT01876511|527225745|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
146195286|NCT01876511|527225746|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
146195287|NCT01876511|527225747|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
146195288|NCT01876511|527225745|FG000|Overall Study|Death (unrelated)|3|||
146195289|NCT01876511|527225746|FG001|Overall Study|Death (unrelated)|0|||
146195290|NCT01876511|527225747|FG002|Overall Study|Death (unrelated)|2|||
146195291|NCT01876511|527225745|FG000|Overall Study|Drug-related Toxicity|5|||
146195292|NCT01876511|527225746|FG001|Overall Study|Drug-related Toxicity|1|||
146195293|NCT01876511|527225747|FG002|Overall Study|Drug-related Toxicity|6|||
146195294|NCT01876511|527225745|FG000|Overall Study|Patient Decision|3|||
146195295|NCT01876511|527225746|FG001|Overall Study|Patient Decision|0|||
146195296|NCT01876511|527225747|FG002|Overall Study|Patient Decision|6|||
146195297|NCT01876511|527225745|FG000|Overall Study|Physician Decision|1|||
146195298|NCT01876511|527225746|FG001|Overall Study|Physician Decision|0|||
146195299|NCT01876511|527225747|FG002|Overall Study|Physician Decision|1|||
146195300|NCT02145182|527225752|FG000|Overall Study|Adverse Event|4|||
146195301|NCT02145182|527225753|FG001|Overall Study|Adverse Event|1|||
146195302|NCT02145182|527225752|FG000|Overall Study|Death|7|||
146195303|NCT02145182|527225753|FG001|Overall Study|Death|7|||
146195304|NCT02145182|527225752|FG000|Overall Study|Lost to Follow-up|2|||
146195305|NCT02145182|527225753|FG001|Overall Study|Lost to Follow-up|2|||
146195306|NCT02145182|527225752|FG000|Overall Study|Pre-transplant Withdrawal|0|||
146195307|NCT02145182|527225753|FG001|Overall Study|Pre-transplant Withdrawal|2|||
146195308|NCT02145182|527225752|FG000|Overall Study|Withdrawal by Subject|5|||
146195309|NCT02145182|527225753|FG001|Overall Study|Withdrawal by Subject|4|||
146195310|NCT05419557|527225755|FG000|Overall Study|Lost to Follow-up|11|||
146195311|NCT05419557|527225756|FG001|Overall Study|Lost to Follow-up|4|||
146195312|NCT01196988|527225757|FG000|Overall Study|Adverse Event|1|||
146195313|NCT01196988|527225758|FG001|Overall Study|Adverse Event|2|||
146195314|NCT01196988|527225759|FG002|Overall Study|Adverse Event|0|||
146195315|NCT01196988|527225760|FG003|Overall Study|Adverse Event|0|||
146195316|NCT01196988|527225757|FG000|Overall Study|Withdrawal by Subject|5|||
146195317|NCT01196988|527225758|FG001|Overall Study|Withdrawal by Subject|1|||
146195318|NCT01196988|527225759|FG002|Overall Study|Withdrawal by Subject|4|||
146195319|NCT01196988|527225760|FG003|Overall Study|Withdrawal by Subject|0|||
146195320|NCT01196988|527225757|FG000|Overall Study|Lost to Follow-up|16|||
146195321|NCT01196988|527225758|FG001|Overall Study|Lost to Follow-up|29|||
146195322|NCT01196988|527225759|FG002|Overall Study|Lost to Follow-up|21|||
146195323|NCT01196988|527225760|FG003|Overall Study|Lost to Follow-up|1|||
146195324|NCT01196988|527225757|FG000|Overall Study|Other|2|||
146195325|NCT01196988|527225758|FG001|Overall Study|Other|0|||
146195326|NCT01196988|527225759|FG002|Overall Study|Other|0|||
146195327|NCT01196988|527225760|FG003|Overall Study|Other|0|||
146195328|NCT00588666|527225761|FG000|Overall Study|Adverse Event|4|||
146195329|NCT01233050|527225762|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
146195330|NCT01233050|527225763|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
146195331|NCT03999554|527225766|FG000|Overall Study|Lost to Follow-up|4|||
146195332|NCT03999554|527225767|FG001|Overall Study|Lost to Follow-up|5|||
146195333|NCT03999554|527225768|FG002|Overall Study|Lost to Follow-up|4|||
146195334|NCT03999554|527225769|FG003|Overall Study|Lost to Follow-up|5|||
146195335|NCT03999554|527225770|FG004|Overall Study|Lost to Follow-up|8|||
146195336|NCT03999554|527225766|FG000|Overall Study|Protocol Violation|0|||
146195337|NCT03999554|527225767|FG001|Overall Study|Protocol Violation|0|||
146195338|NCT03999554|527225768|FG002|Overall Study|Protocol Violation|5|||
146195339|NCT03999554|527225769|FG003|Overall Study|Protocol Violation|0|||
146195340|NCT03999554|527225770|FG004|Overall Study|Protocol Violation|0|||
146195341|NCT03999554|527225766|FG000|Overall Study|Pregnancy|0|||
146195342|NCT03999554|527225767|FG001|Overall Study|Pregnancy|0|||
146195343|NCT03999554|527225768|FG002|Overall Study|Pregnancy|1|||
146195344|NCT03999554|527225769|FG003|Overall Study|Pregnancy|0|||
146195345|NCT03999554|527225770|FG004|Overall Study|Pregnancy|0|||
146195346|NCT03999554|527225766|FG000|Overall Study|Withdrawal by Subject|2|||
146195347|NCT03999554|527225767|FG001|Overall Study|Withdrawal by Subject|2|||
146195348|NCT03999554|527225768|FG002|Overall Study|Withdrawal by Subject|2|||
146195349|NCT03999554|527225769|FG003|Overall Study|Withdrawal by Subject|1|||
146423014|NCT02270736|528055829|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
146423015|NCT02270736|528055830|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
145948864|NCT04575584|526323073|FG000|Overall Study|Withdrawal by Subject|7|||
146195350|NCT03999554|527225770|FG004|Overall Study|Withdrawal by Subject|1|||
146195351|NCT03999554|527225766|FG000|Overall Study|failure to comply with protocol requirements|0|||
146195352|NCT03999554|527225767|FG001|Overall Study|failure to comply with protocol requirements|0|||
146195353|NCT03999554|527225768|FG002|Overall Study|failure to comply with protocol requirements|0|||
146195354|NCT03999554|527225769|FG003|Overall Study|failure to comply with protocol requirements|1|||
146195355|NCT03999554|527225770|FG004|Overall Study|failure to comply with protocol requirements|0|||
146195356|NCT04582877|527225771|FG000|Overall Study|Did not use device measurement|5|||
146195357|NCT04582877|527225771|FG000|Overall Study|No fractional flow reserve test results|2|||
146195358|NCT04582877|527225771|FG000|Overall Study|Protocol Violation|1|||
146195359|NCT04304534|527225772|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
146195360|NCT04304534|527225773|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
146195361|NCT04304534|527225774|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
146195362|NCT04304534|527225775|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
146423016|NCT02270736|528055831|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
146195363|NCT04304534|527225772|FG000|Overall Study|Non-Compliance with study drug|0|||
146195364|NCT04304534|527225773|FG001|Overall Study|Non-Compliance with study drug|1|||
146195365|NCT04304534|527225774|FG002|Overall Study|Non-Compliance with study drug|1|||
146195366|NCT04304534|527225775|FG003|Overall Study|Non-Compliance with study drug|1|||
146195367|NCT04304534|527225772|FG000|Overall Study|Lost to Follow-up|0|||
146195368|NCT04304534|527225773|FG001|Overall Study|Lost to Follow-up|1|||
146195369|NCT04304534|527225774|FG002|Overall Study|Lost to Follow-up|2|||
146195370|NCT04304534|527225775|FG003|Overall Study|Lost to Follow-up|3|||
146195371|NCT04304534|527225772|FG000|Overall Study|Unspecific|4|||
146195372|NCT04304534|527225773|FG001|Overall Study|Unspecific|2|||
146195373|NCT04304534|527225774|FG002|Overall Study|Unspecific|2|||
146195374|NCT04304534|527225775|FG003|Overall Study|Unspecific|2|||
146195375|NCT04304534|527225772|FG000|Overall Study|Technical Problems|2|||
146195376|NCT04304534|527225773|FG001|Overall Study|Technical Problems|2|||
146195377|NCT04304534|527225774|FG002|Overall Study|Technical Problems|3|||
146195378|NCT04304534|527225775|FG003|Overall Study|Technical Problems|4|||
146195379|NCT04304534|527225772|FG000|Overall Study|Death|7|||
146195380|NCT04304534|527225773|FG001|Overall Study|Death|2|||
146195381|NCT04304534|527225774|FG002|Overall Study|Death|4|||
146195382|NCT04304534|527225775|FG003|Overall Study|Death|3|||
146195383|NCT04304534|527225772|FG000|Overall Study|Withdrawal by Subject|7|||
146195384|NCT04304534|527225773|FG001|Overall Study|Withdrawal by Subject|2|||
146195385|NCT04304534|527225774|FG002|Overall Study|Withdrawal by Subject|7|||
146195386|NCT04304534|527225775|FG003|Overall Study|Withdrawal by Subject|4|||
146195387|NCT04304534|527225772|FG000|Overall Study|Physician Decision|4|||
146195388|NCT04304534|527225773|FG001|Overall Study|Physician Decision|9|||
146195389|NCT04304534|527225774|FG002|Overall Study|Physician Decision|9|||
146195390|NCT04304534|527225775|FG003|Overall Study|Physician Decision|5|||
146195391|NCT04304534|527225772|FG000|Overall Study|Subject Decision|34|||
146195392|NCT04304534|527225773|FG001|Overall Study|Subject Decision|25|||
146423017|NCT02270736|528055827|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146423018|NCT02270736|528055828|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146423019|NCT02270736|528055829|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146423020|NCT02270736|528055830|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
146423021|NCT02270736|528055831|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
146423022|NCT02270736|528055827|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146423023|NCT02270736|528055828|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146082598|NCT01375075|526822848|FG001|Overall Study|Adverse Event|0|||
146082599|NCT01375075|526822849|FG002|Overall Study|Adverse Event|3|||
146082600|NCT01375075|526822850|FG003|Overall Study|Adverse Event|1|||
146082601|NCT01375075|526822851|FG004|Overall Study|Adverse Event|0|||
146195393|NCT04304534|527225774|FG002|Overall Study|Subject Decision|25|||
146195394|NCT04304534|527225775|FG003|Overall Study|Subject Decision|26|||
146195395|NCT04304534|527225772|FG000|Overall Study|Adverse Event|35|||
146195396|NCT04304534|527225773|FG001|Overall Study|Adverse Event|40|||
146195397|NCT04304534|527225774|FG002|Overall Study|Adverse Event|39|||
146195398|NCT04304534|527225775|FG003|Overall Study|Adverse Event|44|||
146195399|NCT00464672|527225776|FG000|Overall Study|withdrawal of consent|0|||
146195400|NCT00464672|527225777|FG001|Overall Study|withdrawal of consent|0|||
146195401|NCT00464672|527225778|FG002|Overall Study|withdrawal of consent|0|||
146195402|NCT00464672|527225779|FG003|Overall Study|withdrawal of consent|1|||
146195403|NCT00464672|527225780|FG004|Overall Study|withdrawal of consent|9|||
146195404|NCT00464672|527225781|FG005|Overall Study|withdrawal of consent|4|||
146195405|NCT00464672|527225776|FG000|Overall Study|Lost to Follow-up|25|||
146195406|NCT00464672|527225777|FG001|Overall Study|Lost to Follow-up|10|||
146195407|NCT00464672|527225778|FG002|Overall Study|Lost to Follow-up|0|||
146195408|NCT00464672|527225779|FG003|Overall Study|Lost to Follow-up|0|||
146195409|NCT00464672|527225780|FG004|Overall Study|Lost to Follow-up|1|||
146195410|NCT00464672|527225781|FG005|Overall Study|Lost to Follow-up|0|||
146195411|NCT02299635|527225782|FG000|Overall Study|Adverse Event|2|||
146195412|NCT02299635|527225782|FG000|Overall Study|Death|1|||
146195413|NCT02299635|527225782|FG000|Overall Study|Global deterioration of health status|1|||
146195414|NCT02299635|527225782|FG000|Overall Study|Objective progression or relapse|10|||
146195415|NCT02299635|527225782|FG000|Overall Study|Withdrawal by Subject|2|||
146195416|NCT02299635|527225782|FG000|Overall Study|Other|3|||
146195417|NCT00601640|527225783|FG000|Overall Study|Withdrawal by Subject|3|||
146423024|NCT02270736|528055829|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146082602|NCT01375075|526822852|FG005|Overall Study|Adverse Event|1|||
146195418|NCT00601640|527225784|FG001|Overall Study|Withdrawal by Subject|0|||
146195419|NCT00601640|527225785|FG002|Overall Study|Withdrawal by Subject|7|||
146195420|NCT00601640|527225783|FG000|Overall Study|Death|1|||
146195421|NCT00601640|527225784|FG001|Overall Study|Death|0|||
146195422|NCT00601640|527225785|FG002|Overall Study|Death|0|||
146195423|NCT00601640|527225783|FG000|Overall Study|Adverse Event|0|||
146195424|NCT00601640|527225784|FG001|Overall Study|Adverse Event|4|||
146195425|NCT00601640|527225785|FG002|Overall Study|Adverse Event|2|||
146195426|NCT00601640|527225783|FG000|Overall Study|intercurrent illness|1|||
146195427|NCT00601640|527225784|FG001|Overall Study|intercurrent illness|0|||
145948865|NCT04575584|526323074|FG001|Overall Study|Withdrawal by Subject|9|||
145948866|NCT04575584|526323075|FG002|Overall Study|Withdrawal by Subject|5|||
145948867|NCT04575584|526323076|FG003|Overall Study|Withdrawal by Subject|3|||
145948868|NCT04575584|526323077|FG004|Overall Study|Withdrawal by Subject|0|||
145948869|NCT04575584|526323078|FG005|Overall Study|Withdrawal by Subject|0|||
145948870|NCT04575584|526323073|FG000|Overall Study|Not recorded|0|||
145948871|NCT04575584|526323074|FG001|Overall Study|Not recorded|0|||
145948872|NCT04575584|526323075|FG002|Overall Study|Not recorded|0|||
145948873|NCT04575584|526323076|FG003|Overall Study|Not recorded|1|||
145948874|NCT04575584|526323077|FG004|Overall Study|Not recorded|0|||
145948875|NCT04575584|526323078|FG005|Overall Study|Not recorded|0|||
145948876|NCT02335346|526323079|FG000|Overall Study|Adverse Event|11|||
145948877|NCT02335346|526323079|FG000|Overall Study|Withdrawal by Subject|1|||
145948878|NCT01548768|526323080|FG000|Overall Study|Withdrawal by Subject|0|||
145948879|NCT01548768|526323081|FG001|Overall Study|Withdrawal by Subject|2|||
145948880|NCT01548768|526323082|FG002|Overall Study|Withdrawal by Subject|1|||
145948881|NCT01548768|526323083|FG003|Overall Study|Withdrawal by Subject|0|||
145948882|NCT01548768|526323080|FG000|Overall Study|Physician Decision|1|||
145948883|NCT01548768|526323081|FG001|Overall Study|Physician Decision|0|||
145948884|NCT01548768|526323082|FG002|Overall Study|Physician Decision|0|||
145948885|NCT01548768|526323083|FG003|Overall Study|Physician Decision|0|||
145948886|NCT01548768|526323080|FG000|Overall Study|Adverse Event|0|||
145948887|NCT01548768|526323081|FG001|Overall Study|Adverse Event|0|||
145948888|NCT01548768|526323082|FG002|Overall Study|Adverse Event|0|||
145948889|NCT01548768|526323083|FG003|Overall Study|Adverse Event|1|||
145948890|NCT01548768|526323080|FG000|Overall Study|Non-Compliance|0|||
145948891|NCT01548768|526323081|FG001|Overall Study|Non-Compliance|0|||
145948892|NCT01548768|526323082|FG002|Overall Study|Non-Compliance|0|||
145948893|NCT01548768|526323083|FG003|Overall Study|Non-Compliance|3|||
145948894|NCT04847232|526323084|FG000|Overall Study|Death|123|||
145948895|NCT04847232|526323085|FG001|Overall Study|Death|115|||
145948896|NCT04847232|526323084|FG000|Overall Study|Lost to Follow-up|3|||
145948897|NCT04847232|526323085|FG001|Overall Study|Lost to Follow-up|10|||
145948898|NCT04847232|526323084|FG000|Overall Study|Withdrawal by Subject|73|||
145948899|NCT04847232|526323085|FG001|Overall Study|Withdrawal by Subject|101|||
145948900|NCT04847232|526323084|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
145948901|NCT04847232|526323085|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
145948902|NCT02476916|526323090|FG000|Core Period|Adverse Event|2|||
146195428|NCT00601640|527225785|FG002|Overall Study|intercurrent illness|0|||
146423025|NCT02270736|528055830|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
146423026|NCT02270736|528055831|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
146423027|NCT02270736|528055827|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145948903|NCT02476916|526323091|FG001|Core Period|Adverse Event|2|||
145948904|NCT02476916|526323090|FG000|Core Period|Investigator decision|1|||
145948905|NCT02476916|526323091|FG001|Core Period|Investigator decision|1|||
145948906|NCT02476916|526323090|FG000|Core Period|Withdrawal by Subject|3|||
145948907|NCT02476916|526323091|FG001|Core Period|Withdrawal by Subject|0|||
146195429|NCT00601640|527225783|FG000|Overall Study|change in eligibility status|0|||
146195430|NCT00601640|527225784|FG001|Overall Study|change in eligibility status|1|||
146195431|NCT00601640|527225785|FG002|Overall Study|change in eligibility status|1|||
146195432|NCT00015457|527225789|FG000|First Intervention|Adverse Event|0|||
146195433|NCT00015457|527225790|FG001|First Intervention|Adverse Event|2|||
146195434|NCT00015457|527225789|FG000|First Intervention|Lack of Efficacy|0|||
146195435|NCT00015457|527225790|FG001|First Intervention|Lack of Efficacy|1|||
146195436|NCT00015457|527225789|FG000|Second Intervention|Withdrawal by Subject|1|||
146195437|NCT00015457|527225790|FG001|Second Intervention|Withdrawal by Subject|0|||
146195438|NCT00544440|527225799|FG000|Overall Study|Other|1|||
146195439|NCT00544440|527225799|FG000|Overall Study|Adverse Event|1|||
146195440|NCT00544440|527225799|FG000|Overall Study|Withdrawal by Subject|2|||
146195441|NCT00544440|527225799|FG000|Overall Study|Subject Non-compliance|1|||
146195442|NCT00544440|527225799|FG000|Overall Study|Progressive Disease|47|||
146195443|NCT00544440|527225799|FG000|Overall Study|Other|5|||
146195444|NCT03586167|527225800|FG000|Overall Study|Other|1|||
146195445|NCT03586167|527225801|FG001|Overall Study|Other|0|||
146195446|NCT02512042|527225802|FG000|Overall Study|Adverse Event|0|||
146195447|NCT02512042|527225803|FG001|Overall Study|Adverse Event|4|||
146195448|NCT02512042|527225802|FG000|Overall Study|Withdrawal by Subject|6|||
146195449|NCT02512042|527225803|FG001|Overall Study|Withdrawal by Subject|6|||
146423028|NCT02270736|528055828|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146423029|NCT02270736|528055829|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145948908|NCT02476916|526323090|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
145948909|NCT02476916|526323091|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
145948910|NCT02476916|526323090|FG000|Extension Period|On Treatment|12|||
145948911|NCT02476916|526323091|FG001|Extension Period|On Treatment|17|||
145948912|NCT04401202|526323092|FG000|Overall Study|Lost to Follow-up|2|||
145948913|NCT04401202|526323093|FG001|Overall Study|Lost to Follow-up|2|||
146195450|NCT02512042|527225802|FG000|Overall Study|Non-compliance with study drug|1|||
146195451|NCT02512042|527225803|FG001|Overall Study|Non-compliance with study drug|2|||
146195452|NCT02512042|527225802|FG000|Overall Study|Lost to Follow-up|5|||
146195453|NCT02512042|527225803|FG001|Overall Study|Lost to Follow-up|2|||
146195454|NCT02512042|527225802|FG000|Overall Study|Other|11|||
146195455|NCT02512042|527225803|FG001|Overall Study|Other|11|||
146195456|NCT04109118|527225806|FG000|Overall Study|Lost to Follow-up|3|||
146195457|NCT03394027|527225807|FG000|Overall Study|Ineligible|3|||
146195458|NCT03394027|527225808|FG001|Overall Study|Ineligible|1|||
146195459|NCT03394027|527225809|FG002|Overall Study|Ineligible|3|||
146195460|NCT03394027|527225807|FG000|Overall Study|Participant declined to participate before treatment started|0|||
146195461|NCT03394027|527225808|FG001|Overall Study|Participant declined to participate before treatment started|0|||
146195462|NCT03394027|527225809|FG002|Overall Study|Participant declined to participate before treatment started|1|||
146195463|NCT01268566|527225819|FG000|Overall Study|Lost to Follow-up|1|||
146195464|NCT01268566|527225819|FG000|Overall Study|Withdrawal by Subject|12|||
146195465|NCT01268566|527225819|FG000|Overall Study|Death|30|||
146195466|NCT05273801|527225820|FG000|Overall Study|Physician Decision|1|||
146195467|NCT01249092|527227879|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
146195468|NCT01249092|527227879|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
146195469|NCT00151996|527227882|FG000|Overall Study|Adverse Event|3|||
146195470|NCT00151996|527227883|FG001|Overall Study|Adverse Event|2|||
146195471|NCT00151996|527227882|FG000|Overall Study|Withdrawal by Subject|1|||
146195472|NCT00151996|527227883|FG001|Overall Study|Withdrawal by Subject|1|||
146195473|NCT00151996|527227882|FG000|Overall Study|Protocol Violation|1|||
146195474|NCT00151996|527227883|FG001|Overall Study|Protocol Violation|2|||
146195475|NCT00151996|527227882|FG000|Overall Study|Sponsor's decision|0|||
146195476|NCT00151996|527227883|FG001|Overall Study|Sponsor's decision|2|||
146195477|NCT01259102|527227886|FG000|Overall Study|Adverse Event|1|||
146195478|NCT01259102|527227887|FG001|Overall Study|Adverse Event|0|||
146195479|NCT01259102|527227888|FG002|Overall Study|Adverse Event|1|||
146195480|NCT01259102|527227889|FG003|Overall Study|Adverse Event|1|||
146195481|NCT01259102|527227890|FG004|Overall Study|Adverse Event|0|||
146195482|NCT01259102|527227886|FG000|Overall Study|Other|0|||
146195483|NCT01259102|527227887|FG001|Overall Study|Other|0|||
146195484|NCT01259102|527227888|FG002|Overall Study|Other|1|||
146195485|NCT01259102|527227889|FG003|Overall Study|Other|1|||
146195486|NCT01259102|527227890|FG004|Overall Study|Other|1|||
146195487|NCT01720446|527227891|FG000|Overall Study|Lost to Follow-up|12|||
146195488|NCT01720446|527227892|FG001|Overall Study|Lost to Follow-up|6|||
146195489|NCT01720446|527227893|FG002|Overall Study|Lost to Follow-up|16|||
146195490|NCT01720446|527227894|FG003|Overall Study|Lost to Follow-up|16|||
146195491|NCT01720446|527227891|FG000|Overall Study|Withdrawal by Subject|2|||
146195492|NCT01720446|527227892|FG001|Overall Study|Withdrawal by Subject|5|||
146195493|NCT01720446|527227893|FG002|Overall Study|Withdrawal by Subject|4|||
146195494|NCT01720446|527227894|FG003|Overall Study|Withdrawal by Subject|4|||
146195495|NCT04464421|527227895|FG000|Overall Study|Lost to Follow-up|2|||
146195496|NCT04464421|527227896|FG001|Overall Study|Lost to Follow-up|2|||
146195497|NCT01020838|527227897|FG000|Overall Study|Death|90|||
146195498|NCT01020838|527227897|FG000|Overall Study|Adverse Event|1|||
146195499|NCT01020838|527227897|FG000|Overall Study|Withdrawal by Subject|9|||
146195500|NCT01020838|527227897|FG000|Overall Study|Lost to Follow-up|6|||
145948914|NCT04401202|526323092|FG000|Overall Study|Adverse Event|0|||
145948915|NCT04401202|526323093|FG001|Overall Study|Adverse Event|1|||
145948916|NCT04401202|526323092|FG000|Overall Study|Hospitalized|4|||
145948917|NCT04401202|526323093|FG001|Overall Study|Hospitalized|1|||
145948918|NCT02714036|526323094|FG000|Overall Study|Adverse Event|9|||
145948919|NCT02714036|526323095|FG001|Overall Study|Adverse Event|2|||
145948920|NCT02714036|526323094|FG000|Overall Study|Withdrawal by Subject|3|||
145948921|NCT02714036|526323095|FG001|Overall Study|Withdrawal by Subject|2|||
146082603|NCT01375075|526822847|FG000|Overall Study|Entry Criterion Not Met|1|||
146082604|NCT01375075|526822848|FG001|Overall Study|Entry Criterion Not Met|0|||
146195501|NCT01020838|527227897|FG000|Overall Study|Most common: Study ended by sponsor|77|||
146195502|NCT01956669|527227898|FG000|Overall Study|Disease Progression|12|||
146195503|NCT01956669|527227899|FG001|Overall Study|Disease Progression|7|||
146195504|NCT01956669|527227900|FG002|Overall Study|Disease Progression|7|||
146195505|NCT01956669|527227901|FG003|Overall Study|Disease Progression|8|||
146195506|NCT01956669|527227902|FG004|Overall Study|Disease Progression|4|||
146195507|NCT01956669|527227903|FG005|Overall Study|Disease Progression|3|||
146195508|NCT01956669|527227904|FG006|Overall Study|Disease Progression|5|||
146082605|NCT01375075|526822849|FG002|Overall Study|Entry Criterion Not Met|0|||
146195509|NCT01956669|527227898|FG000|Overall Study|Adverse Event|0|||
146195510|NCT01956669|527227899|FG001|Overall Study|Adverse Event|2|||
146195511|NCT01956669|527227900|FG002|Overall Study|Adverse Event|2|||
145948922|NCT01006590|526323097|FG000|Overall Study|Adverse Event|2|||
145948923|NCT01006590|526323098|FG001|Overall Study|Adverse Event|3|||
146195512|NCT01956669|527227901|FG003|Overall Study|Adverse Event|1|||
146195513|NCT01956669|527227902|FG004|Overall Study|Adverse Event|0|||
146195514|NCT01956669|527227903|FG005|Overall Study|Adverse Event|0|||
146195515|NCT01956669|527227904|FG006|Overall Study|Adverse Event|0|||
146195516|NCT01956669|527227898|FG000|Overall Study|Physician Decision|0|||
146195517|NCT01956669|527227899|FG001|Overall Study|Physician Decision|2|||
146195518|NCT01956669|527227900|FG002|Overall Study|Physician Decision|0|||
146195519|NCT01956669|527227901|FG003|Overall Study|Physician Decision|0|||
146195520|NCT01956669|527227902|FG004|Overall Study|Physician Decision|0|||
146195521|NCT01956669|527227903|FG005|Overall Study|Physician Decision|1|||
146195522|NCT01956669|527227904|FG006|Overall Study|Physician Decision|0|||
146195523|NCT01956669|527227898|FG000|Overall Study|Withdrawal by Subject|0|||
146195524|NCT01956669|527227899|FG001|Overall Study|Withdrawal by Subject|0|||
146195525|NCT01956669|527227900|FG002|Overall Study|Withdrawal by Subject|1|||
146195526|NCT01956669|527227901|FG003|Overall Study|Withdrawal by Subject|1|||
146195527|NCT01956669|527227902|FG004|Overall Study|Withdrawal by Subject|0|||
146195528|NCT01956669|527227903|FG005|Overall Study|Withdrawal by Subject|0|||
146195529|NCT01956669|527227904|FG006|Overall Study|Withdrawal by Subject|1|||
146195530|NCT01072357|527227905|FG000|Overall Study|Lost to Follow-up|0|||
146195531|NCT01072357|527227906|FG001|Overall Study|Lost to Follow-up|1|||
146195532|NCT00930813|527227907|FG000|Overall Study|Death|4|||
146195533|NCT00930813|527227908|FG001|Overall Study|Death|5|||
146195534|NCT00930813|527227907|FG000|Overall Study|Withdrawal by Subject|2|||
146195535|NCT00930813|527227908|FG001|Overall Study|Withdrawal by Subject|5|||
146195536|NCT00930813|527227907|FG000|Overall Study|Lost to Follow-up|2|||
146195537|NCT00930813|527227908|FG001|Overall Study|Lost to Follow-up|4|||
146195538|NCT01048788|527227909|FG000|Overall Study|Adverse Event|5|||
146195539|NCT01048788|527227910|FG001|Overall Study|Adverse Event|1|||
146195540|NCT01048788|527227911|FG002|Overall Study|Adverse Event|1|||
146195541|NCT01048788|527227909|FG000|Overall Study|Lack of Efficacy|0|||
146195542|NCT01048788|527227910|FG001|Overall Study|Lack of Efficacy|0|||
146423030|NCT02270736|528055830|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
146423031|NCT02270736|528055831|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
146423032|NCT02270736|528055827|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146423033|NCT02270736|528055828|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146082606|NCT01375075|526822850|FG003|Overall Study|Entry Criterion Not Met|0|||
146082607|NCT01375075|526822851|FG004|Overall Study|Entry Criterion Not Met|0|||
146082608|NCT01375075|526822852|FG005|Overall Study|Entry Criterion Not Met|1|||
146082609|NCT01375075|526822847|FG000|Overall Study|Withdrawal by Subject|0|||
146082610|NCT01375075|526822848|FG001|Overall Study|Withdrawal by Subject|1|||
146082611|NCT01375075|526822849|FG002|Overall Study|Withdrawal by Subject|0|||
146195543|NCT01048788|527227911|FG002|Overall Study|Lack of Efficacy|1|||
146195544|NCT01048788|527227909|FG000|Overall Study|Withdrawal by Subject|0|||
146423034|NCT02270736|528055829|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146082612|NCT01375075|526822850|FG003|Overall Study|Withdrawal by Subject|0|||
146082613|NCT01375075|526822851|FG004|Overall Study|Withdrawal by Subject|0|||
146195545|NCT01048788|527227910|FG001|Overall Study|Withdrawal by Subject|1|||
146195546|NCT01048788|527227911|FG002|Overall Study|Withdrawal by Subject|0|||
146082614|NCT01375075|526822852|FG005|Overall Study|Withdrawal by Subject|1|||
146195547|NCT01131494|527227912|FG000|Overall Study|Withdrawal by Subject|2|||
146195548|NCT04012853|527227914|FG000|Overall Study|Withdrawal by Subject|1|||
146195549|NCT04012853|527227915|FG001|Overall Study|Withdrawal by Subject|1|||
146195550|NCT04012853|527227914|FG000|Overall Study|Protocol Violation|1|||
146195551|NCT04012853|527227915|FG001|Overall Study|Protocol Violation|0|||
146195552|NCT04012853|527227914|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
146195553|NCT04012853|527227915|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
146195554|NCT03055767|527227916|FG000|Open-Label Period|Lost to Follow-up|0|||
146195555|NCT03055767|527227917|FG001|Open-Label Period|Lost to Follow-up|0|||
146195556|NCT03055767|527227918|FG002|Open-Label Period|Lost to Follow-up|2|||
146195557|NCT03055767|527227919|FG003|Open-Label Period|Lost to Follow-up|0|||
146195558|NCT03055767|527227916|FG000|Open-Label Period|Withdrawal by Subject|0|||
146195559|NCT03055767|527227917|FG001|Open-Label Period|Withdrawal by Subject|0|||
146195560|NCT03055767|527227918|FG002|Open-Label Period|Withdrawal by Subject|0|||
146195561|NCT03055767|527227919|FG003|Open-Label Period|Withdrawal by Subject|1|||
146195562|NCT02759731|527227920|FG000|Overall Study|Did not complete treatment.|8|||
146195563|NCT01466881|527227921|FG000|Overall Study|Ineligible|5|||
146195564|NCT01466881|527227921|FG000|Overall Study|Adverse Event|6|||
146195565|NCT01466881|527227921|FG000|Overall Study|Progression/relapse|20|||
146195566|NCT01466881|527227921|FG000|Overall Study|Death|4|||
146195567|NCT01466881|527227921|FG000|Overall Study|Other reason not protocol specified|5|||
146195568|NCT00927823|527227924|FG000|Continuous Dosing Period|Death|0|||
146195569|NCT00927823|527227925|FG001|Continuous Dosing Period|Death|0|||
146195570|NCT00927823|527227926|FG002|Continuous Dosing Period|Death|6|||
146195571|NCT00927823|527227927|FG003|Continuous Dosing Period|Death|0|||
146195572|NCT00927823|527227924|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
146195573|NCT00927823|527227925|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
146195574|NCT00927823|527227926|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
146195575|NCT00927823|527227927|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
146195576|NCT00927823|527227924|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
146195577|NCT00927823|527227925|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
146195578|NCT00927823|527227926|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
146195579|NCT00927823|527227927|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
146195580|NCT00927823|527227924|FG000|Continuous Dosing Period|Other|1|||
146195581|NCT00927823|527227925|FG001|Continuous Dosing Period|Other|2|||
146195582|NCT00927823|527227926|FG002|Continuous Dosing Period|Other|9|||
146195583|NCT00927823|527227927|FG003|Continuous Dosing Period|Other|3|||
146195584|NCT01674569|527227933|FG000|Overall Study|Adverse Event|0|||
146195585|NCT01674569|527227934|FG001|Overall Study|Adverse Event|2|||
146195586|NCT01674569|527227935|FG002|Overall Study|Adverse Event|0|||
146195587|NCT01674569|527227936|FG003|Overall Study|Adverse Event|1|||
145948924|NCT01006590|526323097|FG000|Overall Study|Death|1|||
145948925|NCT01006590|526323098|FG001|Overall Study|Death|1|||
145948926|NCT01006590|526323097|FG000|Overall Study|Lost to Follow-up|1|||
145948927|NCT01006590|526323098|FG001|Overall Study|Lost to Follow-up|1|||
146195588|NCT01674569|527227937|FG004|Overall Study|Adverse Event|2|||
146195589|NCT01674569|527227938|FG005|Overall Study|Adverse Event|2|||
146195590|NCT01674569|527227933|FG000|Overall Study|Protocol Violation|0|||
146195591|NCT01674569|527227934|FG001|Overall Study|Protocol Violation|1|||
145948928|NCT01006590|526323097|FG000|Overall Study|Protocol Violation|1|||
145948929|NCT01006590|526323098|FG001|Overall Study|Protocol Violation|0|||
145948930|NCT01006590|526323097|FG000|Overall Study|Withdrawal by Subject|4|||
145948931|NCT01006590|526323098|FG001|Overall Study|Withdrawal by Subject|2|||
145948932|NCT01006590|526323097|FG000|Overall Study|Study specific discontinuation criteria|16|||
145948933|NCT01006590|526323098|FG001|Overall Study|Study specific discontinuation criteria|23|||
145948934|NCT01006590|526323097|FG000|Overall Study|Other|3|||
145948935|NCT01006590|526323098|FG001|Overall Study|Other|2|||
145948936|NCT03332095|526323099|FG000|Overall Study|Lost to Follow-up|1|||
145948937|NCT03332095|526323100|FG001|Overall Study|Lost to Follow-up|0|||
145948938|NCT03332095|526323099|FG000|Overall Study|Pregnancy|0|||
146195592|NCT01674569|527227935|FG002|Overall Study|Protocol Violation|1|||
146195593|NCT01674569|527227936|FG003|Overall Study|Protocol Violation|0|||
146195594|NCT01674569|527227937|FG004|Overall Study|Protocol Violation|0|||
146195595|NCT01674569|527227938|FG005|Overall Study|Protocol Violation|0|||
146195596|NCT01674569|527227933|FG000|Overall Study|Withdrawal by Subject|0|||
146195597|NCT01674569|527227934|FG001|Overall Study|Withdrawal by Subject|0|||
146195598|NCT01674569|527227935|FG002|Overall Study|Withdrawal by Subject|1|||
146195599|NCT01674569|527227936|FG003|Overall Study|Withdrawal by Subject|0|||
146195600|NCT01674569|527227937|FG004|Overall Study|Withdrawal by Subject|0|||
145948939|NCT03332095|526323100|FG001|Overall Study|Pregnancy|1|||
145948940|NCT00624832|526323101|FG000|Overall Study|Adverse Event|0|||
146195601|NCT01674569|527227938|FG005|Overall Study|Withdrawal by Subject|0|||
146195602|NCT01599325|527227939|FG000|Primary Parent Phase|Adverse Event|5|||
146195603|NCT01599325|527227939|FG000|Primary Parent Phase|Disease Progression|7|||
145948941|NCT00624832|526323102|FG001|Overall Study|Adverse Event|1|||
145948942|NCT00624832|526323103|FG002|Overall Study|Adverse Event|0|||
145948943|NCT00624832|526323104|FG003|Overall Study|Adverse Event|1|||
145948944|NCT00624832|526323101|FG000|Overall Study|Abnormal Laboratory Value|2|||
146195604|NCT01599325|527227939|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
146195605|NCT01599325|527227939|FG000|Primary Parent Phase|Death|13|||
146195606|NCT01599325|527227939|FG000|Primary Parent Phase|Protocol Violation|1|||
146195607|NCT01599325|527227939|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
146195608|NCT01599325|527227939|FG000|Primary Parent Phase|Other|2|||
146195609|NCT01599325|527227939|FG000|Extension Phase|Study Closure|1|||
146195610|NCT01599325|527227939|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
146195611|NCT01599325|527227939|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
146195612|NCT01599325|527227939|FG000|Extension Phase|Disease Progression|1|||
146195613|NCT01599325|527227939|FG000|Extension Phase|Withdrawal by Subject|8|||
146195614|NCT01878890|527227940|FG000|Overall Study|Protocol Violation|0|||
146195615|NCT01878890|527227941|FG001|Overall Study|Protocol Violation|1|||
146195616|NCT01878890|527227942|FG002|Overall Study|Protocol Violation|0|||
146195617|NCT01878890|527227943|FG003|Overall Study|Protocol Violation|0|||
146195618|NCT01710514|527227949|FG000|Overall Study|Adverse Event|6|||
146195619|NCT01710514|527227950|FG001|Overall Study|Adverse Event|7|||
146195620|NCT01710514|527227949|FG000|Overall Study|Withdrawal by Subject|1|||
146195621|NCT01710514|527227950|FG001|Overall Study|Withdrawal by Subject|0|||
146195622|NCT03404843|527227951|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
146195623|NCT03404843|527227952|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
146195624|NCT00567164|527227953|FG000|Overall Study|Withdrawal by Subject|171|||
146195625|NCT00567164|527227954|FG001|Overall Study|Withdrawal by Subject|21|||
146195626|NCT00567164|527227955|FG002|Overall Study|Withdrawal by Subject|17|||
146195627|NCT00567164|527227953|FG000|Overall Study|Protocol Violation|23|||
146195628|NCT00567164|527227954|FG001|Overall Study|Protocol Violation|4|||
146195629|NCT00567164|527227955|FG002|Overall Study|Protocol Violation|2|||
146195630|NCT00567164|527227953|FG000|Overall Study|Adverse Event|92|||
146195631|NCT00567164|527227954|FG001|Overall Study|Adverse Event|13|||
146195632|NCT00567164|527227955|FG002|Overall Study|Adverse Event|9|||
146195633|NCT00567164|527227953|FG000|Overall Study|Death|0|||
146195634|NCT00567164|527227954|FG001|Overall Study|Death|0|||
146195635|NCT00567164|527227955|FG002|Overall Study|Death|1|||
146195636|NCT00567164|527227953|FG000|Overall Study|Lost to Follow-up|202|||
146195637|NCT00567164|527227954|FG001|Overall Study|Lost to Follow-up|23|||
146195638|NCT00567164|527227955|FG002|Overall Study|Lost to Follow-up|21|||
146195639|NCT00567164|527227953|FG000|Overall Study|Pregnancy|20|||
146195640|NCT00567164|527227954|FG001|Overall Study|Pregnancy|4|||
146195641|NCT00567164|527227955|FG002|Overall Study|Pregnancy|6|||
146195642|NCT00567164|527227953|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
146195643|NCT00567164|527227954|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
146195644|NCT00567164|527227955|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
146195645|NCT00567164|527227953|FG000|Overall Study|Missing|1|||
146195646|NCT00567164|527227954|FG001|Overall Study|Missing|0|||
146195647|NCT00567164|527227955|FG002|Overall Study|Missing|0|||
146195648|NCT04044664|527227956|FG000|Stage 1|Adverse Event|3|||
145948945|NCT00624832|526323102|FG001|Overall Study|Abnormal Laboratory Value|0|||
145948946|NCT00624832|526323103|FG002|Overall Study|Abnormal Laboratory Value|0|||
145948947|NCT00624832|526323104|FG003|Overall Study|Abnormal Laboratory Value|0|||
146195649|NCT04044664|527227957|FG001|Stage 1|Adverse Event|3|||
146195650|NCT04044664|527227958|FG002|Stage 1|Adverse Event|1|||
146195651|NCT04044664|527227956|FG000|Stage 1|Lost to Follow-up|3|||
146195652|NCT04044664|527227957|FG001|Stage 1|Lost to Follow-up|2|||
146195653|NCT04044664|527227958|FG002|Stage 1|Lost to Follow-up|2|||
146195654|NCT04044664|527227956|FG000|Stage 1|Withdrawal by Subject|9|||
146195655|NCT04044664|527227957|FG001|Stage 1|Withdrawal by Subject|1|||
146195656|NCT04044664|527227958|FG002|Stage 1|Withdrawal by Subject|0|||
146195657|NCT04044664|527227956|FG000|Stage 1|noncompliance, personal reason|2|||
146195658|NCT04044664|527227957|FG001|Stage 1|noncompliance, personal reason|0|||
146195659|NCT04044664|527227958|FG002|Stage 1|noncompliance, personal reason|0|||
146195660|NCT04044664|527227956|FG000|Stage 1|randomization error|0|||
145948948|NCT01939223|526323105|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
146195661|NCT04044664|527227957|FG001|Stage 1|randomization error|1|||
146195662|NCT04044664|527227958|FG002|Stage 1|randomization error|0|||
146195663|NCT04044664|527227956|FG000|Stage 2|Adverse Event|2|||
146195664|NCT04044664|527227957|FG001|Stage 2|Adverse Event|0|||
146195665|NCT04044664|527227958|FG002|Stage 2|Adverse Event|0|||
146195666|NCT04044664|527227956|FG000|Stage 2|Lost to Follow-up|3|||
146195667|NCT04044664|527227957|FG001|Stage 2|Lost to Follow-up|2|||
145948949|NCT01939223|526323106|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
145948950|NCT01939223|526323105|FG000|Overall Study|Disease recurrence (radiological)|1|||
145948951|NCT01939223|526323106|FG001|Overall Study|Disease recurrence (radiological)|3|||
145948952|NCT01939223|526323105|FG000|Overall Study|Study stopped by Sponsor|5|||
145948953|NCT01939223|526323106|FG001|Overall Study|Study stopped by Sponsor|7|||
145948954|NCT01939223|526323105|FG000|Overall Study|Withdrawal by Subject|6|||
145948955|NCT01939223|526323106|FG001|Overall Study|Withdrawal by Subject|0|||
145948956|NCT00957424|526323108|FG000|Overall Study|Lost to Follow-up|19|||
145948957|NCT00957424|526323108|FG000|Overall Study|Protocol Violation|3|||
145948958|NCT00957424|526323108|FG000|Overall Study|Withdrawal by Subject|1|||
145948959|NCT02700698|526323109|FG000|Overall Study|Withdrawal by Subject|1|||
145948960|NCT02700698|526323110|FG001|Overall Study|Withdrawal by Subject|0|||
145948961|NCT00703118|526323111|FG000|Overall Study|Adverse Event|1|||
145948962|NCT00703118|526323112|FG001|Overall Study|Adverse Event|2|||
145948963|NCT00703118|526323113|FG002|Overall Study|Adverse Event|2|||
145948964|NCT00703118|526323111|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
145948965|NCT00703118|526323112|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
145948966|NCT00703118|526323113|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
145948967|NCT00703118|526323111|FG000|Overall Study|Lost to Follow-up|6|||
145948968|NCT00703118|526323112|FG001|Overall Study|Lost to Follow-up|4|||
145948969|NCT00703118|526323113|FG002|Overall Study|Lost to Follow-up|4|||
145948970|NCT00703118|526323111|FG000|Overall Study|Withdrawal by Subject|8|||
145948971|NCT00703118|526323112|FG001|Overall Study|Withdrawal by Subject|7|||
145948972|NCT00703118|526323113|FG002|Overall Study|Withdrawal by Subject|13|||
145948973|NCT00703118|526323111|FG000|Overall Study|Other|0|||
145948974|NCT00703118|526323112|FG001|Overall Study|Other|0|||
145948975|NCT00703118|526323113|FG002|Overall Study|Other|1|||
145948976|NCT04165135|526323114|FG000|Overall Study|Protocol Violation|10|||
146195668|NCT04044664|527227958|FG002|Stage 2|Lost to Follow-up|1|||
146195669|NCT04044664|527227956|FG000|Stage 2|Withdrawal by Subject|3|||
145948977|NCT04165135|526323114|FG000|Overall Study|Participants withdrawal of consent|5|||
145948978|NCT00530790|526323115|FG000|Overall Study|Adverse Event|2|||
145948979|NCT00530790|526323115|FG000|Overall Study|Withdrawal by Subject|2|||
145948980|NCT00530790|526323115|FG000|Overall Study|Physician Decision|1|||
145948981|NCT05053035|526323120|FG000|Overall Study|Withdrawal by Subject|1|||
145948982|NCT05053035|526323121|FG001|Overall Study|Withdrawal by Subject|0|||
145948983|NCT01618916|526323123|FG000|Overall Study|Adverse Event|1|||
145948984|NCT01618916|526323124|FG001|Overall Study|Adverse Event|0|||
145948985|NCT01618916|526323125|FG002|Overall Study|Adverse Event|0|||
145948986|NCT01618916|526323126|FG003|Overall Study|Adverse Event|0|||
145948987|NCT01618916|526323127|FG004|Overall Study|Adverse Event|0|||
145948988|NCT01618916|526323128|FG005|Overall Study|Adverse Event|0|||
145948989|NCT01618916|526323123|FG000|Overall Study|Withdrawal by Subject|0|||
145948990|NCT01618916|526323124|FG001|Overall Study|Withdrawal by Subject|1|||
146195670|NCT04044664|527227957|FG001|Stage 2|Withdrawal by Subject|0|||
146195671|NCT04044664|527227958|FG002|Stage 2|Withdrawal by Subject|0|||
146195672|NCT04044664|527227956|FG000|Stage 2|protocol deviation|1|||
146195673|NCT04044664|527227957|FG001|Stage 2|protocol deviation|0|||
146195674|NCT04044664|527227958|FG002|Stage 2|protocol deviation|0|||
146195675|NCT01744691|527227965|FG000|Overall Study|Progressive Disease|18|||
146195676|NCT01744691|527227965|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
146195677|NCT01744691|527227965|FG000|Overall Study|Withdrawal of consent for treatment|3|||
146195678|NCT01744691|527227965|FG000|Overall Study|Physician Decision|4|||
146195679|NCT02701361|527227967|FG000|Overall Study|Lost to Follow-up|5|||
146195680|NCT02701361|527227968|FG001|Overall Study|Lost to Follow-up|2|||
146195681|NCT02701361|527227969|FG002|Overall Study|Lost to Follow-up|1|||
145948991|NCT01618916|526323125|FG002|Overall Study|Withdrawal by Subject|1|||
145948992|NCT01618916|526323126|FG003|Overall Study|Withdrawal by Subject|0|||
145948993|NCT01618916|526323127|FG004|Overall Study|Withdrawal by Subject|1|||
145948994|NCT01618916|526323128|FG005|Overall Study|Withdrawal by Subject|0|||
145948995|NCT01618916|526323123|FG000|Overall Study|Lost to Follow-up|1|||
145948996|NCT01618916|526323124|FG001|Overall Study|Lost to Follow-up|0|||
145948997|NCT01618916|526323125|FG002|Overall Study|Lost to Follow-up|0|||
145948998|NCT01618916|526323126|FG003|Overall Study|Lost to Follow-up|2|||
145948999|NCT01618916|526323127|FG004|Overall Study|Lost to Follow-up|0|||
145949000|NCT01618916|526323128|FG005|Overall Study|Lost to Follow-up|0|||
146195682|NCT02701361|527227967|FG000|Overall Study|Withdrawal by Subject|4|||
146195683|NCT02701361|527227968|FG001|Overall Study|Withdrawal by Subject|0|||
146195684|NCT02701361|527227969|FG002|Overall Study|Withdrawal by Subject|0|||
146195685|NCT02701361|527227967|FG000|Overall Study|timed out in rehab center|0|||
146195686|NCT02701361|527227968|FG001|Overall Study|timed out in rehab center|1|||
146195687|NCT02701361|527227969|FG002|Overall Study|timed out in rehab center|0|||
146195688|NCT02701361|527227967|FG000|Overall Study|incarceration|0|||
145949001|NCT01853696|526323129|FG000|Overall Study|Withdrawal by Subject|1|||
145949002|NCT01853696|526323130|FG001|Overall Study|Withdrawal by Subject|1|||
146195689|NCT02701361|527227968|FG001|Overall Study|incarceration|0|||
146195690|NCT02701361|527227969|FG002|Overall Study|incarceration|1|||
146195691|NCT04588480|527227970|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
146195692|NCT04588480|527227971|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
146195693|NCT04588480|527227972|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
146195694|NCT04588480|527227970|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
146195695|NCT04588480|527227971|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
146195696|NCT04588480|527227972|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
146195697|NCT02430532|527227979|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
146195698|NCT02430532|527227980|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
146195699|NCT02430532|527227979|FG000|Overall Study|Consent Withdrawn|0|||
146195700|NCT02430532|527227980|FG001|Overall Study|Consent Withdrawn|2|||
146195701|NCT02430532|527227979|FG000|Overall Study|Adverse Event|0|||
146195702|NCT02430532|527227980|FG001|Overall Study|Adverse Event|1|||
146195703|NCT02750709|527227983|FG000|Treatment Period 1|Adverse Event|0|||
146195704|NCT02750709|527227984|FG001|Treatment Period 1|Adverse Event|0|||
146195705|NCT02750709|527227985|FG002|Treatment Period 1|Adverse Event|0|||
146195706|NCT02750709|527227986|FG003|Treatment Period 1|Adverse Event|0|||
146195707|NCT02750709|527227987|FG004|Treatment Period 1|Adverse Event|0|||
146195708|NCT02750709|527227988|FG005|Treatment Period 1|Adverse Event|1|||
146195709|NCT03256344|527227989|FG000|Overall Study|Death|6|||
146195710|NCT03256344|527227990|FG001|Overall Study|Death|22|||
146195711|NCT03256344|527227989|FG000|Overall Study|Withdrawal by Subject|3|||
146195712|NCT03256344|527227990|FG001|Overall Study|Withdrawal by Subject|3|||
146195713|NCT03256344|527227989|FG000|Overall Study|Sponsor Decision|1|||
146195714|NCT03256344|527227990|FG001|Overall Study|Sponsor Decision|0|||
146195715|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Other|4|||
146195716|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Other|0|||
146195717|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
146195718|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
146195719|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
146195720|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
146195721|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
146195722|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
146195723|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
146195724|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
146195725|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
146195726|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
146195727|NCT00853827|527227994|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
146195728|NCT00853827|527227995|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
146195729|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
146195730|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
146195731|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
146195732|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
146195733|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
146195734|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
146195735|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
146195736|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
146195737|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
145949003|NCT01853696|526323129|FG000|Overall Study|Lost to Follow-up|5|||
146195738|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
146195739|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
146195740|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
146195741|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
146195742|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
146195743|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
146195744|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
146195745|NCT00853827|527227994|FG000|Double Blind Period (103 Weeks)|Death|1|||
146195746|NCT00853827|527227995|FG001|Double Blind Period (103 Weeks)|Death|6|||
146195747|NCT00290732|527228003|FG000|Overall Study|Inability to instill drug intraductally.|0|||
146195748|NCT00290732|527228004|FG001|Overall Study|Inability to instill drug intraductally.|1|||
146195749|NCT00290732|527228005|FG002|Overall Study|Inability to instill drug intraductally.|1|||
146195750|NCT00290732|527228006|FG003|Overall Study|Inability to instill drug intraductally.|0|||
146195751|NCT00290732|527228007|FG004|Overall Study|Inability to instill drug intraductally.|0|||
146195752|NCT00580801|527228008|FG000|Overall Study|Physician Decision|1|||
146195753|NCT00580801|527228009|FG001|Overall Study|Physician Decision|0|||
146195754|NCT00580801|527228010|FG002|Overall Study|Physician Decision|0|||
146195755|NCT00580801|527228008|FG000|Overall Study|Adverse Event|2|||
146195756|NCT00580801|527228009|FG001|Overall Study|Adverse Event|0|||
146195757|NCT00580801|527228010|FG002|Overall Study|Adverse Event|0|||
146195758|NCT00580801|527228008|FG000|Overall Study|Lost to Follow-up|2|||
146195759|NCT00580801|527228009|FG001|Overall Study|Lost to Follow-up|0|||
146195760|NCT00580801|527228010|FG002|Overall Study|Lost to Follow-up|0|||
146195761|NCT00580801|527228008|FG000|Overall Study|Reached a virologic endpoint|0|||
146195762|NCT00580801|527228009|FG001|Overall Study|Reached a virologic endpoint|1|||
146195763|NCT00580801|527228010|FG002|Overall Study|Reached a virologic endpoint|2|||
146195764|NCT00580801|527228008|FG000|Overall Study|Participant non-compliant|0|||
146195765|NCT00580801|527228009|FG001|Overall Study|Participant non-compliant|0|||
146195766|NCT00580801|527228010|FG002|Overall Study|Participant non-compliant|1|||
146195767|NCT00580801|527228008|FG000|Overall Study|Travel|1|||
146195768|NCT00580801|527228009|FG001|Overall Study|Travel|0|||
146195769|NCT00580801|527228010|FG002|Overall Study|Travel|0|||
146195770|NCT00502593|527228011|FG000|Overall Study|Withdrawn unspecified reason|1|||
146195771|NCT00502593|527228012|FG001|Overall Study|Withdrawn unspecified reason|1|||
146195772|NCT00502593|527228013|FG002|Overall Study|Withdrawn unspecified reason|3|||
146195773|NCT00502593|527228014|FG003|Overall Study|Withdrawn unspecified reason|1|||
146195774|NCT00502593|527228015|FG004|Overall Study|Withdrawn unspecified reason|2|||
146195775|NCT00502593|527228016|FG005|Overall Study|Withdrawn unspecified reason|0|||
146195776|NCT00502593|527228017|FG006|Overall Study|Withdrawn unspecified reason|2|||
146195777|NCT00502593|527228018|FG007|Overall Study|Withdrawn unspecified reason|0|||
146195778|NCT00502593|527228019|FG008|Overall Study|Withdrawn unspecified reason|0|||
146195779|NCT00502593|527228020|FG009|Overall Study|Withdrawn unspecified reason|0|||
146195780|NCT00502593|527228021|FG010|Overall Study|Withdrawn unspecified reason|0|||
146195781|NCT00502593|527228022|FG011|Overall Study|Withdrawn unspecified reason|0|||
146195782|NCT00502593|527228011|FG000|Overall Study|Withdrawal by Subject|0|||
146195783|NCT00502593|527228012|FG001|Overall Study|Withdrawal by Subject|0|||
146195784|NCT00502593|527228013|FG002|Overall Study|Withdrawal by Subject|6|||
146195785|NCT00502593|527228014|FG003|Overall Study|Withdrawal by Subject|2|||
146195786|NCT00502593|527228015|FG004|Overall Study|Withdrawal by Subject|2|||
146195787|NCT00502593|527228016|FG005|Overall Study|Withdrawal by Subject|0|||
146195788|NCT00502593|527228017|FG006|Overall Study|Withdrawal by Subject|3|||
146195789|NCT00502593|527228018|FG007|Overall Study|Withdrawal by Subject|0|||
146195790|NCT00502593|527228019|FG008|Overall Study|Withdrawal by Subject|3|||
146195791|NCT00502593|527228020|FG009|Overall Study|Withdrawal by Subject|0|||
146195792|NCT00502593|527228021|FG010|Overall Study|Withdrawal by Subject|1|||
146195793|NCT00502593|527228022|FG011|Overall Study|Withdrawal by Subject|0|||
146195794|NCT00502593|527228011|FG000|Overall Study|Lost to Follow-up|2|||
146195795|NCT00502593|527228012|FG001|Overall Study|Lost to Follow-up|1|||
146195796|NCT00502593|527228013|FG002|Overall Study|Lost to Follow-up|1|||
146195797|NCT00502593|527228014|FG003|Overall Study|Lost to Follow-up|1|||
146195798|NCT00502593|527228015|FG004|Overall Study|Lost to Follow-up|0|||
146195799|NCT00502593|527228016|FG005|Overall Study|Lost to Follow-up|0|||
146195800|NCT00502593|527228017|FG006|Overall Study|Lost to Follow-up|0|||
146195801|NCT00502593|527228018|FG007|Overall Study|Lost to Follow-up|0|||
146195802|NCT00502593|527228019|FG008|Overall Study|Lost to Follow-up|3|||
146195803|NCT00502593|527228020|FG009|Overall Study|Lost to Follow-up|0|||
146195804|NCT00502593|527228021|FG010|Overall Study|Lost to Follow-up|1|||
146195805|NCT00502593|527228022|FG011|Overall Study|Lost to Follow-up|0|||
146195806|NCT00843193|527228023|FG000|Overall Study|Adverse Event|2|||
146195807|NCT00843193|527228024|FG001|Overall Study|Adverse Event|4|||
146195808|NCT00843193|527228023|FG000|Overall Study|Lack of Efficacy|1|||
146195809|NCT00843193|527228024|FG001|Overall Study|Lack of Efficacy|1|||
146195810|NCT00843193|527228023|FG000|Overall Study|Protocol Violation|1|||
146195811|NCT00843193|527228024|FG001|Overall Study|Protocol Violation|2|||
146195812|NCT00843193|527228023|FG000|Overall Study|Lost to Follow-up|1|||
146195813|NCT00843193|527228024|FG001|Overall Study|Lost to Follow-up|0|||
146195814|NCT00843193|527228023|FG000|Overall Study|Physician Decision|0|||
146195815|NCT00843193|527228024|FG001|Overall Study|Physician Decision|1|||
146195816|NCT00843193|527228023|FG000|Overall Study|Withdrawal by Subject|3|||
146195817|NCT00843193|527228024|FG001|Overall Study|Withdrawal by Subject|3|||
146195818|NCT00542386|527228025|FG000|Overall Study|Adverse Event|1|||
146195819|NCT00542386|527228026|FG001|Overall Study|Adverse Event|7|||
146195820|NCT00542386|527228027|FG002|Overall Study|Adverse Event|7|||
146195821|NCT00542386|527228028|FG003|Overall Study|Adverse Event|8|||
146195822|NCT00542386|527228029|FG004|Overall Study|Adverse Event|13|||
146195823|NCT00542386|527228030|FG005|Overall Study|Adverse Event|4|||
146195824|NCT00542386|527228025|FG000|Overall Study|Death|0|||
146195825|NCT00542386|527228026|FG001|Overall Study|Death|0|||
146195826|NCT00542386|527228027|FG002|Overall Study|Death|1|||
146195827|NCT00542386|527228028|FG003|Overall Study|Death|2|||
146195828|NCT00542386|527228029|FG004|Overall Study|Death|1|||
146195829|NCT00542386|527228030|FG005|Overall Study|Death|2|||
146195830|NCT00542386|527228025|FG000|Overall Study|Lack of Efficacy|32|||
146195831|NCT00542386|527228026|FG001|Overall Study|Lack of Efficacy|12|||
146195832|NCT00542386|527228027|FG002|Overall Study|Lack of Efficacy|10|||
146195833|NCT00542386|527228028|FG003|Overall Study|Lack of Efficacy|13|||
146195834|NCT00542386|527228029|FG004|Overall Study|Lack of Efficacy|7|||
146195835|NCT00542386|527228030|FG005|Overall Study|Lack of Efficacy|31|||
146195836|NCT00542386|527228025|FG000|Overall Study|Physician Decision|1|||
146195837|NCT00542386|527228026|FG001|Overall Study|Physician Decision|0|||
146195838|NCT00542386|527228027|FG002|Overall Study|Physician Decision|0|||
146195839|NCT00542386|527228028|FG003|Overall Study|Physician Decision|1|||
146195840|NCT00542386|527228029|FG004|Overall Study|Physician Decision|0|||
145949004|NCT01853696|526323130|FG001|Overall Study|Lost to Follow-up|4|||
145949005|NCT03004924|526323131|FG000|Overall Study|Adverse Event|6|||
145949006|NCT03004924|526323132|FG001|Overall Study|Adverse Event|5|||
145949007|NCT03004924|526323133|FG002|Overall Study|Adverse Event|10|||
145949008|NCT03004924|526323131|FG000|Overall Study|Protocol Violation|4|||
145949009|NCT03004924|526323132|FG001|Overall Study|Protocol Violation|0|||
145949010|NCT03004924|526323133|FG002|Overall Study|Protocol Violation|1|||
145949011|NCT03004924|526323131|FG000|Overall Study|Withdrawal by Subject|5|||
145949012|NCT03004924|526323132|FG001|Overall Study|Withdrawal by Subject|3|||
145949013|NCT03004924|526323133|FG002|Overall Study|Withdrawal by Subject|5|||
145949014|NCT03004924|526323131|FG000|Overall Study|Lost to Follow-up|6|||
145949015|NCT03004924|526323132|FG001|Overall Study|Lost to Follow-up|1|||
145949016|NCT03004924|526323133|FG002|Overall Study|Lost to Follow-up|4|||
145949017|NCT03004924|526323131|FG000|Overall Study|Lack of Efficacy|2|||
145949018|NCT03004924|526323132|FG001|Overall Study|Lack of Efficacy|4|||
145949019|NCT03004924|526323133|FG002|Overall Study|Lack of Efficacy|2|||
145949020|NCT03004924|526323131|FG000|Overall Study|Physician Decision|1|||
145949021|NCT03004924|526323132|FG001|Overall Study|Physician Decision|0|||
145949022|NCT03004924|526323133|FG002|Overall Study|Physician Decision|1|||
145949023|NCT03004924|526323131|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145949024|NCT03004924|526323132|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145949025|NCT03004924|526323133|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145949026|NCT03004924|526323131|FG000|Overall Study|Screen Failure|1|||
145949027|NCT03004924|526323132|FG001|Overall Study|Screen Failure|0|||
145949028|NCT03004924|526323133|FG002|Overall Study|Screen Failure|0|||
145949029|NCT03004924|526323131|FG000|Overall Study|Pregnancy|0|||
145949030|NCT03004924|526323132|FG001|Overall Study|Pregnancy|1|||
145949031|NCT03004924|526323133|FG002|Overall Study|Pregnancy|0|||
145949032|NCT03004924|526323131|FG000|Overall Study|Terminated by Sponsor|0|||
145949033|NCT03004924|526323132|FG001|Overall Study|Terminated by Sponsor|0|||
145949034|NCT03004924|526323133|FG002|Overall Study|Terminated by Sponsor|1|||
145949035|NCT03004924|526323131|FG000|Overall Study|Missed Study Visit|0|||
145949036|NCT03004924|526323132|FG001|Overall Study|Missed Study Visit|0|||
145949037|NCT03004924|526323133|FG002|Overall Study|Missed Study Visit|2|||
145949038|NCT03004924|526323131|FG000|Overall Study|HSV1 Positive|1|||
145949039|NCT03004924|526323132|FG001|Overall Study|HSV1 Positive|0|||
145949040|NCT03004924|526323133|FG002|Overall Study|HSV1 Positive|0|||
145949041|NCT02005627|526323136|FG000|Overall Study|Lost to Follow-up|1|||
145949042|NCT02005627|526323137|FG001|Overall Study|Lost to Follow-up|2|||
145949043|NCT02005627|526323136|FG000|Overall Study|Withdrawal by Subject|1|||
145949044|NCT02005627|526323137|FG001|Overall Study|Withdrawal by Subject|2|||
145949045|NCT03003000|526323140|FG000|Overall Study|Adverse Event|1|||
145949046|NCT03003000|526323141|FG001|Overall Study|Adverse Event|2|||
145949047|NCT03003000|526323142|FG002|Overall Study|Adverse Event|3|||
145949048|NCT03003000|526323140|FG000|Overall Study|Lack of Efficacy|1|||
145949049|NCT03003000|526323141|FG001|Overall Study|Lack of Efficacy|0|||
145949050|NCT03003000|526323142|FG002|Overall Study|Lack of Efficacy|0|||
145949051|NCT03003000|526323140|FG000|Overall Study|Non-compliant with protocol|0|||
145949052|NCT03003000|526323141|FG001|Overall Study|Non-compliant with protocol|1|||
145949053|NCT03003000|526323142|FG002|Overall Study|Non-compliant with protocol|1|||
145949054|NCT03003000|526323140|FG000|Overall Study|Refused to continue medication|2|||
145949055|NCT03003000|526323141|FG001|Overall Study|Refused to continue medication|0|||
145949056|NCT03003000|526323142|FG002|Overall Study|Refused to continue medication|0|||
145949057|NCT03003000|526323140|FG000|Overall Study|Other than listed|1|||
145949058|NCT03003000|526323141|FG001|Overall Study|Other than listed|1|||
145949059|NCT03003000|526323142|FG002|Overall Study|Other than listed|1|||
145949060|NCT01964716|526323144|FG000|Overall Study|Withdrawal by Subject|2|||
145949061|NCT01964716|526323145|FG001|Overall Study|Withdrawal by Subject|3|||
145949062|NCT01964716|526323144|FG000|Overall Study|Lost to Follow-up|1|||
145949063|NCT01964716|526323145|FG001|Overall Study|Lost to Follow-up|2|||
145949064|NCT01964716|526323144|FG000|Overall Study|No longer met eligibility criteria|1|||
145949065|NCT01964716|526323145|FG001|Overall Study|No longer met eligibility criteria|1|||
145949066|NCT01964716|526323144|FG000|Overall Study|Death|1|||
145949067|NCT01964716|526323145|FG001|Overall Study|Death|0|||
145949068|NCT01119846|526323146|FG000|Overall Study|Adverse Event|1|||
145949069|NCT01119846|526323147|FG001|Overall Study|Adverse Event|0|||
145949070|NCT01119846|526323148|FG002|Overall Study|Adverse Event|6|||
145949071|NCT01119846|526323146|FG000|Overall Study|Physician Decision|1|||
145949072|NCT01119846|526323147|FG001|Overall Study|Physician Decision|0|||
145949073|NCT01119846|526323148|FG002|Overall Study|Physician Decision|0|||
145949074|NCT01119846|526323146|FG000|Overall Study|Protocol Violation|0|||
145949075|NCT01119846|526323147|FG001|Overall Study|Protocol Violation|0|||
145949076|NCT01119846|526323148|FG002|Overall Study|Protocol Violation|1|||
145949077|NCT01119846|526323146|FG000|Overall Study|Withdrawal by Subject|0|||
145949078|NCT01119846|526323147|FG001|Overall Study|Withdrawal by Subject|0|||
145949079|NCT01119846|526323148|FG002|Overall Study|Withdrawal by Subject|4|||
145949080|NCT00048997|526323149|FG000|Overall Study|Protocol Violation|7|||
145949081|NCT00048997|526323150|FG001|Overall Study|Protocol Violation|2|||
145949082|NCT00048997|526323149|FG000|Overall Study|Withdrawal by Subject|6|||
146195841|NCT00542386|527228030|FG005|Overall Study|Physician Decision|0|||
146195842|NCT00542386|527228025|FG000|Overall Study|Protocol Violation|0|||
146195843|NCT00542386|527228026|FG001|Overall Study|Protocol Violation|0|||
146195844|NCT00542386|527228027|FG002|Overall Study|Protocol Violation|1|||
146195845|NCT00542386|527228028|FG003|Overall Study|Protocol Violation|0|||
146195846|NCT00542386|527228029|FG004|Overall Study|Protocol Violation|0|||
146195847|NCT00542386|527228030|FG005|Overall Study|Protocol Violation|4|||
146195848|NCT00542386|527228025|FG000|Overall Study|Withdrawal by Subject|5|||
146195849|NCT00542386|527228026|FG001|Overall Study|Withdrawal by Subject|8|||
146195850|NCT00542386|527228027|FG002|Overall Study|Withdrawal by Subject|10|||
146195851|NCT00542386|527228028|FG003|Overall Study|Withdrawal by Subject|11|||
146195852|NCT00542386|527228029|FG004|Overall Study|Withdrawal by Subject|15|||
146195853|NCT00542386|527228030|FG005|Overall Study|Withdrawal by Subject|7|||
146195854|NCT00542386|527228025|FG000|Overall Study|Other Reasons|4|||
146195855|NCT00542386|527228026|FG001|Overall Study|Other Reasons|1|||
146195856|NCT00542386|527228027|FG002|Overall Study|Other Reasons|4|||
146195857|NCT00542386|527228028|FG003|Overall Study|Other Reasons|3|||
146195858|NCT00542386|527228029|FG004|Overall Study|Other Reasons|4|||
146195859|NCT00542386|527228030|FG005|Overall Study|Other Reasons|2|||
146195860|NCT00880906|527228032|FG000|Overall Study|Lost to Follow-up|0|||
146195861|NCT00880906|527228033|FG001|Overall Study|Lost to Follow-up|1|||
146195862|NCT00880906|527228032|FG000|Overall Study|Did not meet criteria following patholog|12|||
146195863|NCT00880906|527228033|FG001|Overall Study|Did not meet criteria following patholog|6|||
146195864|NCT01460342|527228036|FG000|Overall Study|Adverse Event|5|||
146195865|NCT01460342|527228037|FG001|Overall Study|Adverse Event|4|||
146195866|NCT01460342|527228036|FG000|Overall Study|Lost to Follow-up|1|||
146195867|NCT01460342|527228037|FG001|Overall Study|Lost to Follow-up|2|||
146195868|NCT01460342|527228036|FG000|Overall Study|Protocol Violation|0|||
146195869|NCT01460342|527228037|FG001|Overall Study|Protocol Violation|1|||
146195870|NCT01460342|527228036|FG000|Overall Study|Withdrawal by Subject|3|||
146195871|NCT01460342|527228037|FG001|Overall Study|Withdrawal by Subject|4|||
146195872|NCT01460342|527228036|FG000|Overall Study|Physician Decision|1|||
146195873|NCT01460342|527228037|FG001|Overall Study|Physician Decision|3|||
146195874|NCT01460342|527228036|FG000|Overall Study|Lack of Efficacy|1|||
146195875|NCT01460342|527228037|FG001|Overall Study|Lack of Efficacy|0|||
145949083|NCT00048997|526323150|FG001|Overall Study|Withdrawal by Subject|1|||
145949084|NCT00048165|526323151|FG000|Completed 6 Months Study|Administration/Other|8|||
145949085|NCT00048165|526323152|FG001|Completed 6 Months Study|Administration/Other|8|||
145949086|NCT00048165|526323151|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
145949087|NCT00048165|526323152|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
145949088|NCT00048165|526323151|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
145949089|NCT00048165|526323152|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
145949090|NCT00048165|526323151|FG000|Completed 6 Months Study|Death|12|||
145949091|NCT00048165|526323152|FG001|Completed 6 Months Study|Death|6|||
145949092|NCT00048165|526323151|FG000|Completed 6 Months Study|Insufficient therapy|1|||
145949093|NCT00048165|526323152|FG001|Completed 6 Months Study|Insufficient therapy|4|||
145949094|NCT00048165|526323151|FG000|Completed 6 Months Study|Other violation|4|||
145949095|NCT00048165|526323152|FG001|Completed 6 Months Study|Other violation|6|||
145949096|NCT00048165|526323151|FG000|Completed 6 Months Study|Refused treatment|5|||
145949097|NCT00048165|526323152|FG001|Completed 6 Months Study|Refused treatment|5|||
145949098|NCT00048165|526323151|FG000|Completed 6 Months Study|Violation criteria|0|||
145949099|NCT00048165|526323152|FG001|Completed 6 Months Study|Violation criteria|2|||
145949100|NCT00048165|526323151|FG000|Completed 6 Months Study|Did not receive study drug|6|||
145949101|NCT00048165|526323152|FG001|Completed 6 Months Study|Did not receive study drug|6|||
145949102|NCT00048165|526323151|FG000|Completed 12 Months Study|Administration/Other|0|||
145949103|NCT00048165|526323152|FG001|Completed 12 Months Study|Administration/Other|2|||
145949104|NCT00048165|526323151|FG000|Completed 12 Months Study|Death|2|||
145949105|NCT00048165|526323152|FG001|Completed 12 Months Study|Death|1|||
146082615|NCT00545129|526822853|FG000|Overall Study|Lack of Efficacy|2|||
146195876|NCT00591838|527228038|FG000|Overall Study|Withdrawal by Subject|0|||
146195877|NCT00591838|527228039|FG001|Overall Study|Withdrawal by Subject|0|||
146195878|NCT00591838|527228040|FG002|Overall Study|Withdrawal by Subject|0|||
146195879|NCT00591838|527228041|FG003|Overall Study|Withdrawal by Subject|1|||
146195880|NCT00591838|527228042|FG004|Overall Study|Withdrawal by Subject|0|||
146195881|NCT02982213|527228044|FG000|Overall Study|Did not complete follow up questionnaire|5|||
146195882|NCT02982213|527228045|FG001|Overall Study|Did not complete follow up questionnaire|1|||
146195883|NCT04163458|527228048|FG000|Overall Study|Protocol Deviation|7|||
146195884|NCT04163458|527228049|FG001|Overall Study|Protocol Deviation|13|||
146195885|NCT04163458|527228048|FG000|Overall Study|Adverse Event|5|||
146195886|NCT04163458|527228049|FG001|Overall Study|Adverse Event|8|||
146195887|NCT04163458|527228048|FG000|Overall Study|Due to COVID-19 pandemic|4|||
146195888|NCT04163458|527228049|FG001|Overall Study|Due to COVID-19 pandemic|2|||
146195889|NCT04163458|527228048|FG000|Overall Study|Participant withdrew consent|2|||
146195890|NCT04163458|527228049|FG001|Overall Study|Participant withdrew consent|3|||
146423035|NCT02270736|528055830|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
146195891|NCT04163458|527228048|FG000|Overall Study|Randomization failure|2|||
146195892|NCT04163458|527228049|FG001|Overall Study|Randomization failure|2|||
146195893|NCT04163458|527228048|FG000|Overall Study|Other|4|||
146195894|NCT04163458|527228049|FG001|Overall Study|Other|2|||
146195895|NCT03247543|527228052|FG000|Overall Study|Adverse Event|3|||
146195896|NCT03247543|527228053|FG001|Overall Study|Adverse Event|6|||
146195897|NCT03247543|527228054|FG002|Overall Study|Adverse Event|4|||
146195898|NCT03247543|527228052|FG000|Overall Study|Lost to Follow-up|10|||
146195899|NCT03247543|527228053|FG001|Overall Study|Lost to Follow-up|7|||
146195900|NCT03247543|527228054|FG002|Overall Study|Lost to Follow-up|8|||
146195901|NCT03247543|527228052|FG000|Overall Study|Consent withdrawn by caregiver|2|||
146195902|NCT03247543|527228053|FG001|Overall Study|Consent withdrawn by caregiver|2|||
146195903|NCT03247543|527228054|FG002|Overall Study|Consent withdrawn by caregiver|9|||
146195904|NCT03247543|527228052|FG000|Overall Study|Withdrawal by Subject|0|||
146195905|NCT03247543|527228053|FG001|Overall Study|Withdrawal by Subject|0|||
146195906|NCT03247543|527228054|FG002|Overall Study|Withdrawal by Subject|1|||
146195907|NCT03247543|527228052|FG000|Overall Study|Failure to Follow study procedures|1|||
146195908|NCT03247543|527228053|FG001|Overall Study|Failure to Follow study procedures|3|||
146195909|NCT03247543|527228054|FG002|Overall Study|Failure to Follow study procedures|1|||
146195910|NCT03247543|527228052|FG000|Overall Study|Lack of Efficacy|1|||
146195911|NCT03247543|527228053|FG001|Overall Study|Lack of Efficacy|0|||
146195912|NCT03247543|527228054|FG002|Overall Study|Lack of Efficacy|0|||
146195913|NCT03247543|527228052|FG000|Overall Study|Non-compliance with study visits|0|||
146195914|NCT03247543|527228053|FG001|Overall Study|Non-compliance with study visits|1|||
146195915|NCT03247543|527228054|FG002|Overall Study|Non-compliance with study visits|0|||
146195916|NCT02059980|527228058|FG000|Overall Study|Lost to Follow-up|2|||
146195917|NCT02059980|527228059|FG001|Overall Study|Lost to Follow-up|1|||
146195918|NCT01104415|527228060|FG000|Core Phase|Consent withdrawn by subjects|1|||
146195919|NCT01104415|527228061|FG001|Core Phase|Consent withdrawn by subjects|0|||
146195920|NCT01104415|527228060|FG000|Extension Period|Progressive disease|0|||
146195921|NCT01104415|527228061|FG001|Extension Period|Progressive disease|4|||
146195922|NCT01104415|527228060|FG000|Extension Period|Death|0|||
146195923|NCT01104415|527228061|FG001|Extension Period|Death|1|||
146195924|NCT01104415|527228060|FG000|Extension Period|Physician Decision|0|||
146195925|NCT01104415|527228061|FG001|Extension Period|Physician Decision|1|||
146195926|NCT01104415|527228060|FG000|Extension Period|Transition to Study LX1606.302|0|||
146195927|NCT01104415|527228061|FG001|Extension Period|Transition to Study LX1606.302|4|||
146195928|NCT01104415|527228060|FG000|Extension Period|Heart surgery/feeling miserable|0|||
146195929|NCT01104415|527228061|FG001|Extension Period|Heart surgery/feeling miserable|1|||
146195930|NCT04257058|527229560|FG000|Overall Study|Lost to Follow-up|31|||
146195931|NCT03227757|527229561|FG000|Overall Study|Death|25|||
146195932|NCT03227757|527229561|FG000|Overall Study|Withdrawal|10|||
146195933|NCT03227757|527229561|FG000|Overall Study|Missed visits|1|||
146195934|NCT03227757|527229561|FG000|Overall Study|Lost to Follow-up|2|||
146195935|NCT01144468|527229563|FG000|Overall Study|Lost to Follow-up|4|||
146195936|NCT01144468|527229564|FG001|Overall Study|Lost to Follow-up|7|||
146195937|NCT01144468|527229563|FG000|Overall Study|Adverse Event|3|||
146195938|NCT01144468|527229564|FG001|Overall Study|Adverse Event|2|||
146195939|NCT01144468|527229563|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
146195940|NCT01144468|527229564|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
146195941|NCT02960659|527229565|FG000|Overall Study|Withdrawal by Subject|1|||
146195942|NCT02960659|527229566|FG001|Overall Study|Withdrawal by Subject|0|||
146195943|NCT02960659|527229565|FG000|Overall Study|Poor compliance|0|||
146195944|NCT02960659|527229566|FG001|Overall Study|Poor compliance|1|||
146195945|NCT04199728|527229570|FG000|Overall Study|Adverse Event|1|||
146195946|NCT04199728|527229571|FG001|Overall Study|Adverse Event|0|||
146195947|NCT04199728|527229570|FG000|Overall Study|Withdrawal by Subject|8|||
146195948|NCT04199728|527229571|FG001|Overall Study|Withdrawal by Subject|3|||
146195949|NCT04199728|527229570|FG000|Overall Study|Screen fail after consent|0|||
146195950|NCT04199728|527229571|FG001|Overall Study|Screen fail after consent|1|||
146195951|NCT04199728|527229570|FG000|Overall Study|Early withdraw criteria met|0|||
146195952|NCT04199728|527229571|FG001|Overall Study|Early withdraw criteria met|1|||
146195953|NCT04199728|527229570|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
146195954|NCT04199728|527229571|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
146195955|NCT01331824|527229576|FG000|Overall Study|Adverse Event|2|||
146195956|NCT01331824|527229576|FG000|Overall Study|Death|1|||
146195957|NCT01331824|527229576|FG000|Overall Study|Disease Progression|9|||
146195958|NCT01331824|527229576|FG000|Overall Study|Withdrawal by Subject|1|||
146195959|NCT03179787|527229580|FG000|Overall Study|Lost to Follow-up|15|||
146195960|NCT03179787|527229580|FG000|Overall Study|Case report failures|2|||
146195961|NCT03179787|527229580|FG000|Overall Study|Treatment not administered|1|||
146195962|NCT02030028|527229581|FG000|Overall Study|Withdrawal by Subject|4|||
146195963|NCT02030028|527229581|FG000|Overall Study|lack of transportation|1|||
146195964|NCT00661778|527229582|FG000|Overall Study|Disease Progression|23|||
146195965|NCT00661778|527229582|FG000|Overall Study|Adverse Event|18|||
146195966|NCT00661778|527229582|FG000|Overall Study|Reason not Specified|6|||
146195967|NCT00661778|527229582|FG000|Overall Study|Protocol Violation|2|||
146195968|NCT00661778|527229582|FG000|Overall Study|Withdrawal of Consent|1|||
146195969|NCT01090024|527229587|FG000|Period 1|Met exclusion criteria|0|||
146195970|NCT01090024|527229588|FG001|Period 1|Met exclusion criteria|0|||
146195971|NCT01090024|527229589|FG002|Period 1|Met exclusion criteria|0|||
146195972|NCT01090024|527229590|FG003|Period 1|Met exclusion criteria|0|||
146195973|NCT01090024|527229591|FG004|Period 1|Met exclusion criteria|0|||
146195974|NCT01090024|527229592|FG005|Period 1|Met exclusion criteria|0|||
146195975|NCT01090024|527229593|FG006|Period 1|Met exclusion criteria|0|||
146195976|NCT01090024|527229594|FG007|Period 1|Met exclusion criteria|0|||
146195977|NCT01090024|527229595|FG008|Period 1|Met exclusion criteria|0|||
146195978|NCT01090024|527229596|FG009|Period 1|Met exclusion criteria|0|||
146195979|NCT01090024|527229597|FG010|Period 1|Met exclusion criteria|0|||
146195980|NCT01090024|527229598|FG011|Period 1|Met exclusion criteria|0|||
146195981|NCT01090024|527229599|FG012|Period 1|Met exclusion criteria|0|||
146195982|NCT01090024|527229600|FG013|Period 1|Met exclusion criteria|0|||
146195983|NCT01090024|527229601|FG014|Period 1|Met exclusion criteria|1|||
146195984|NCT01090024|527229602|FG015|Period 1|Met exclusion criteria|0|||
146195985|NCT01090024|527229603|FG016|Period 1|Met exclusion criteria|0|||
146195986|NCT01090024|527229604|FG017|Period 1|Met exclusion criteria|0|||
146195987|NCT01090024|527229587|FG000|Period 1|Adverse Event|0|||
146195988|NCT01090024|527229588|FG001|Period 1|Adverse Event|0|||
146195989|NCT01090024|527229589|FG002|Period 1|Adverse Event|0|||
146195990|NCT01090024|527229590|FG003|Period 1|Adverse Event|0|||
146195991|NCT01090024|527229591|FG004|Period 1|Adverse Event|0|||
146195992|NCT01090024|527229592|FG005|Period 1|Adverse Event|0|||
146195993|NCT01090024|527229593|FG006|Period 1|Adverse Event|0|||
146195994|NCT01090024|527229594|FG007|Period 1|Adverse Event|0|||
146195995|NCT01090024|527229595|FG008|Period 1|Adverse Event|0|||
146195996|NCT01090024|527229596|FG009|Period 1|Adverse Event|1|||
146195997|NCT01090024|527229597|FG010|Period 1|Adverse Event|0|||
146195998|NCT01090024|527229598|FG011|Period 1|Adverse Event|1|||
146195999|NCT01090024|527229599|FG012|Period 1|Adverse Event|0|||
146196000|NCT01090024|527229600|FG013|Period 1|Adverse Event|0|||
146196001|NCT01090024|527229601|FG014|Period 1|Adverse Event|0|||
146196002|NCT01090024|527229602|FG015|Period 1|Adverse Event|0|||
146196003|NCT01090024|527229603|FG016|Period 1|Adverse Event|0|||
146196004|NCT01090024|527229604|FG017|Period 1|Adverse Event|1|||
146196005|NCT01090024|527229587|FG000|Period 1|Withdrawal by Subject|0|||
146196006|NCT01090024|527229588|FG001|Period 1|Withdrawal by Subject|0|||
146196007|NCT01090024|527229589|FG002|Period 1|Withdrawal by Subject|0|||
146196008|NCT01090024|527229590|FG003|Period 1|Withdrawal by Subject|1|||
146196009|NCT01090024|527229591|FG004|Period 1|Withdrawal by Subject|0|||
146196010|NCT01090024|527229592|FG005|Period 1|Withdrawal by Subject|0|||
146196011|NCT01090024|527229593|FG006|Period 1|Withdrawal by Subject|0|||
146196012|NCT01090024|527229594|FG007|Period 1|Withdrawal by Subject|0|||
146196013|NCT01090024|527229595|FG008|Period 1|Withdrawal by Subject|0|||
146196014|NCT01090024|527229596|FG009|Period 1|Withdrawal by Subject|0|||
146196015|NCT01090024|527229597|FG010|Period 1|Withdrawal by Subject|0|||
146196016|NCT01090024|527229598|FG011|Period 1|Withdrawal by Subject|0|||
146196017|NCT01090024|527229599|FG012|Period 1|Withdrawal by Subject|0|||
146196018|NCT01090024|527229600|FG013|Period 1|Withdrawal by Subject|0|||
146196019|NCT01090024|527229601|FG014|Period 1|Withdrawal by Subject|0|||
146196020|NCT01090024|527229602|FG015|Period 1|Withdrawal by Subject|0|||
146196021|NCT01090024|527229603|FG016|Period 1|Withdrawal by Subject|0|||
146196022|NCT01090024|527229604|FG017|Period 1|Withdrawal by Subject|0|||
146196023|NCT01090024|527229587|FG000|Period 1|Lost to Follow-up|0|||
146196024|NCT01090024|527229588|FG001|Period 1|Lost to Follow-up|1|||
146196025|NCT01090024|527229589|FG002|Period 1|Lost to Follow-up|0|||
146196026|NCT01090024|527229590|FG003|Period 1|Lost to Follow-up|0|||
146196027|NCT01090024|527229591|FG004|Period 1|Lost to Follow-up|0|||
146196028|NCT01090024|527229592|FG005|Period 1|Lost to Follow-up|0|||
146196029|NCT01090024|527229593|FG006|Period 1|Lost to Follow-up|0|||
146196030|NCT01090024|527229594|FG007|Period 1|Lost to Follow-up|0|||
146196031|NCT01090024|527229595|FG008|Period 1|Lost to Follow-up|0|||
146196032|NCT01090024|527229596|FG009|Period 1|Lost to Follow-up|0|||
146196033|NCT01090024|527229597|FG010|Period 1|Lost to Follow-up|0|||
146196034|NCT01090024|527229598|FG011|Period 1|Lost to Follow-up|0|||
146196035|NCT01090024|527229599|FG012|Period 1|Lost to Follow-up|0|||
146196036|NCT01090024|527229600|FG013|Period 1|Lost to Follow-up|0|||
146196037|NCT01090024|527229601|FG014|Period 1|Lost to Follow-up|0|||
146196038|NCT01090024|527229602|FG015|Period 1|Lost to Follow-up|0|||
146196039|NCT01090024|527229603|FG016|Period 1|Lost to Follow-up|0|||
146196040|NCT01090024|527229604|FG017|Period 1|Lost to Follow-up|0|||
146196041|NCT01090024|527229587|FG000|Period 2|Lost to Follow-up|0|||
146196042|NCT01090024|527229588|FG001|Period 2|Lost to Follow-up|0|||
146196043|NCT01090024|527229589|FG002|Period 2|Lost to Follow-up|0|||
146196044|NCT01090024|527229590|FG003|Period 2|Lost to Follow-up|1|||
146196045|NCT01090024|527229591|FG004|Period 2|Lost to Follow-up|0|||
146196046|NCT01090024|527229592|FG005|Period 2|Lost to Follow-up|0|||
146196047|NCT01090024|527229593|FG006|Period 2|Lost to Follow-up|0|||
146196048|NCT01090024|527229594|FG007|Period 2|Lost to Follow-up|0|||
146196049|NCT01090024|527229595|FG008|Period 2|Lost to Follow-up|0|||
146196050|NCT01090024|527229596|FG009|Period 2|Lost to Follow-up|0|||
146196051|NCT01090024|527229597|FG010|Period 2|Lost to Follow-up|0|||
146196052|NCT01090024|527229598|FG011|Period 2|Lost to Follow-up|0|||
146196053|NCT01090024|527229599|FG012|Period 2|Lost to Follow-up|0|||
146196054|NCT01090024|527229600|FG013|Period 2|Lost to Follow-up|0|||
146196055|NCT01090024|527229601|FG014|Period 2|Lost to Follow-up|0|||
146196056|NCT01090024|527229602|FG015|Period 2|Lost to Follow-up|0|||
146196057|NCT01090024|527229603|FG016|Period 2|Lost to Follow-up|0|||
146196058|NCT01090024|527229604|FG017|Period 2|Lost to Follow-up|0|||
146196059|NCT01090024|527229587|FG000|Period 2|Adverse Event|1|||
146196060|NCT01090024|527229588|FG001|Period 2|Adverse Event|0|||
146196061|NCT01090024|527229589|FG002|Period 2|Adverse Event|0|||
146196062|NCT01090024|527229590|FG003|Period 2|Adverse Event|0|||
146196063|NCT01090024|527229591|FG004|Period 2|Adverse Event|0|||
146196064|NCT01090024|527229592|FG005|Period 2|Adverse Event|0|||
146196065|NCT01090024|527229593|FG006|Period 2|Adverse Event|0|||
146196066|NCT01090024|527229594|FG007|Period 2|Adverse Event|0|||
146196067|NCT01090024|527229595|FG008|Period 2|Adverse Event|0|||
146196068|NCT01090024|527229596|FG009|Period 2|Adverse Event|0|||
146196069|NCT01090024|527229597|FG010|Period 2|Adverse Event|0|||
146196070|NCT01090024|527229598|FG011|Period 2|Adverse Event|0|||
146196071|NCT01090024|527229599|FG012|Period 2|Adverse Event|0|||
146196072|NCT01090024|527229600|FG013|Period 2|Adverse Event|0|||
146196073|NCT01090024|527229601|FG014|Period 2|Adverse Event|0|||
146196074|NCT01090024|527229602|FG015|Period 2|Adverse Event|0|||
146196075|NCT01090024|527229603|FG016|Period 2|Adverse Event|0|||
146196076|NCT01090024|527229604|FG017|Period 2|Adverse Event|0|||
146196077|NCT01090024|527229587|FG000|Period 3|Withdrawal by Subject|0|||
146196078|NCT01090024|527229588|FG001|Period 3|Withdrawal by Subject|0|||
146196079|NCT01090024|527229589|FG002|Period 3|Withdrawal by Subject|0|||
146196080|NCT01090024|527229590|FG003|Period 3|Withdrawal by Subject|0|||
146196081|NCT01090024|527229591|FG004|Period 3|Withdrawal by Subject|0|||
146196082|NCT01090024|527229592|FG005|Period 3|Withdrawal by Subject|0|||
146196083|NCT01090024|527229593|FG006|Period 3|Withdrawal by Subject|0|||
146196084|NCT01090024|527229594|FG007|Period 3|Withdrawal by Subject|0|||
146196085|NCT01090024|527229595|FG008|Period 3|Withdrawal by Subject|0|||
146196086|NCT01090024|527229596|FG009|Period 3|Withdrawal by Subject|0|||
146196087|NCT01090024|527229597|FG010|Period 3|Withdrawal by Subject|0|||
146196088|NCT01090024|527229598|FG011|Period 3|Withdrawal by Subject|0|||
146196089|NCT01090024|527229599|FG012|Period 3|Withdrawal by Subject|0|||
146196090|NCT01090024|527229600|FG013|Period 3|Withdrawal by Subject|0|||
146196091|NCT01090024|527229601|FG014|Period 3|Withdrawal by Subject|0|||
146196092|NCT01090024|527229602|FG015|Period 3|Withdrawal by Subject|1|||
146196093|NCT01090024|527229603|FG016|Period 3|Withdrawal by Subject|0|||
146196094|NCT01090024|527229604|FG017|Period 3|Withdrawal by Subject|0|||
146196095|NCT01090024|527229587|FG000|Period 3|Protocol Violation|0|||
146196096|NCT01090024|527229588|FG001|Period 3|Protocol Violation|0|||
146196097|NCT01090024|527229589|FG002|Period 3|Protocol Violation|0|||
146196098|NCT01090024|527229590|FG003|Period 3|Protocol Violation|0|||
146196099|NCT01090024|527229591|FG004|Period 3|Protocol Violation|0|||
146196100|NCT01090024|527229592|FG005|Period 3|Protocol Violation|0|||
146196101|NCT01090024|527229593|FG006|Period 3|Protocol Violation|0|||
146196102|NCT01090024|527229594|FG007|Period 3|Protocol Violation|0|||
146196103|NCT01090024|527229595|FG008|Period 3|Protocol Violation|1|||
146196104|NCT01090024|527229596|FG009|Period 3|Protocol Violation|0|||
146196105|NCT01090024|527229597|FG010|Period 3|Protocol Violation|0|||
146196106|NCT01090024|527229598|FG011|Period 3|Protocol Violation|0|||
146423036|NCT02270736|528055831|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
146423037|NCT02270736|528055827|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146423038|NCT02270736|528055828|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
146196107|NCT01090024|527229599|FG012|Period 3|Protocol Violation|0|||
146196108|NCT01090024|527229600|FG013|Period 3|Protocol Violation|0|||
146196109|NCT01090024|527229601|FG014|Period 3|Protocol Violation|0|||
146196110|NCT01090024|527229602|FG015|Period 3|Protocol Violation|0|||
146196111|NCT01090024|527229603|FG016|Period 3|Protocol Violation|0|||
146196112|NCT01090024|527229604|FG017|Period 3|Protocol Violation|0|||
146196113|NCT01090024|527229587|FG000|Period 3|Adverse Event|0|||
146196114|NCT01090024|527229588|FG001|Period 3|Adverse Event|0|||
146196115|NCT01090024|527229589|FG002|Period 3|Adverse Event|0|||
146196116|NCT01090024|527229590|FG003|Period 3|Adverse Event|0|||
146196117|NCT01090024|527229591|FG004|Period 3|Adverse Event|0|||
146196118|NCT01090024|527229592|FG005|Period 3|Adverse Event|1|||
146196119|NCT01090024|527229593|FG006|Period 3|Adverse Event|0|||
146196120|NCT01090024|527229594|FG007|Period 3|Adverse Event|0|||
146196121|NCT01090024|527229595|FG008|Period 3|Adverse Event|0|||
146196122|NCT01090024|527229596|FG009|Period 3|Adverse Event|0|||
146196123|NCT01090024|527229597|FG010|Period 3|Adverse Event|0|||
146196124|NCT01090024|527229598|FG011|Period 3|Adverse Event|0|||
146196125|NCT01090024|527229599|FG012|Period 3|Adverse Event|0|||
146196126|NCT01090024|527229600|FG013|Period 3|Adverse Event|0|||
146196127|NCT01090024|527229601|FG014|Period 3|Adverse Event|0|||
146196128|NCT01090024|527229602|FG015|Period 3|Adverse Event|0|||
146196129|NCT01090024|527229603|FG016|Period 3|Adverse Event|0|||
146196130|NCT01090024|527229604|FG017|Period 3|Adverse Event|0|||
146196131|NCT00149630|527229607|FG000|Overall Study|Incarceration|2|||
146196132|NCT00149630|527229608|FG001|Overall Study|Incarceration|0|||
145949106|NCT00048165|526323151|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
145949107|NCT00048165|526323152|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
145949108|NCT01370616|526323153|FG000|Overall Study|Adverse Event|11|||
145949109|NCT01370616|526323154|FG001|Overall Study|Adverse Event|16|||
145949110|NCT01370616|526323153|FG000|Overall Study|Death|1|||
145949111|NCT01370616|526323154|FG001|Overall Study|Death|0|||
146196133|NCT00149630|527229607|FG000|Overall Study|Treatment Programs|4|||
146196134|NCT00149630|527229608|FG001|Overall Study|Treatment Programs|5|||
146196135|NCT00149630|527229607|FG000|Overall Study|Adverse Event|2|||
146196136|NCT00149630|527229608|FG001|Overall Study|Adverse Event|0|||
146196137|NCT00567879|527229612|FG000|Overall Study|Adverse Event|2|||
146196138|NCT00567879|527229613|FG001|Overall Study|Adverse Event|0|||
146196139|NCT00567879|527229614|FG002|Overall Study|Adverse Event|1|||
146196140|NCT00567879|527229615|FG003|Overall Study|Adverse Event|0|||
146196141|NCT00567879|527229616|FG004|Overall Study|Adverse Event|1|||
146196142|NCT00567879|527229617|FG005|Overall Study|Adverse Event|0|||
146196143|NCT00567879|527229612|FG000|Overall Study|Abnormal test procedure(s)|0|||
146196144|NCT00567879|527229613|FG001|Overall Study|Abnormal test procedure(s)|0|||
146196145|NCT00567879|527229614|FG002|Overall Study|Abnormal test procedure(s)|1|||
146196146|NCT00567879|527229615|FG003|Overall Study|Abnormal test procedure(s)|0|||
146196147|NCT00567879|527229616|FG004|Overall Study|Abnormal test procedure(s)|0|||
146196148|NCT00567879|527229617|FG005|Overall Study|Abnormal test procedure(s)|0|||
146196149|NCT00567879|527229612|FG000|Overall Study|Withdrawal by Subject|0|||
146196150|NCT00567879|527229613|FG001|Overall Study|Withdrawal by Subject|0|||
146196151|NCT00567879|527229614|FG002|Overall Study|Withdrawal by Subject|3|||
146196152|NCT00567879|527229615|FG003|Overall Study|Withdrawal by Subject|1|||
146196153|NCT00567879|527229616|FG004|Overall Study|Withdrawal by Subject|0|||
145949112|NCT01370616|526323153|FG000|Overall Study|Lack of Efficacy|6|||
145949113|NCT01370616|526323154|FG001|Overall Study|Lack of Efficacy|2|||
145949114|NCT01370616|526323153|FG000|Overall Study|Lost to Follow-up|0|||
145949115|NCT01370616|526323154|FG001|Overall Study|Lost to Follow-up|3|||
145949116|NCT01370616|526323153|FG000|Overall Study|Physician Decision|6|||
145949117|NCT01370616|526323154|FG001|Overall Study|Physician Decision|6|||
145949118|NCT01370616|526323153|FG000|Overall Study|Progressive Disease|0|||
145949119|NCT01370616|526323154|FG001|Overall Study|Progressive Disease|1|||
145949120|NCT01370616|526323153|FG000|Overall Study|Recovery|1|||
145949121|NCT01370616|526323154|FG001|Overall Study|Recovery|0|||
145949122|NCT01370616|526323153|FG000|Overall Study|Technical Problems|3|||
145949123|NCT01370616|526323154|FG001|Overall Study|Technical Problems|5|||
145949124|NCT01370616|526323153|FG000|Overall Study|Withdrawal by Subject|34|||
145949125|NCT01370616|526323154|FG001|Overall Study|Withdrawal by Subject|34|||
145949126|NCT02906033|526323157|FG000|Baseline|Protocol Violation|37|||
145949127|NCT02906033|526323158|FG001|Baseline|Protocol Violation|33|||
145949128|NCT02906033|526323157|FG000|Follow-up|Lost to Follow-up|46|||
145949129|NCT02906033|526323158|FG001|Follow-up|Lost to Follow-up|62|||
145949130|NCT00358956|526323163|FG000|Overall Study|Adverse Event|3|||
145949131|NCT00358956|526323163|FG000|Overall Study|condition under investigation worsened|4|||
145949132|NCT00358956|526323163|FG000|Overall Study|Withdrawal by Subject|1|||
145949133|NCT01859949|526325103|FG000|Overall Study|Family Matters|0|||
145949134|NCT01859949|526325104|FG001|Overall Study|Family Matters|1|||
146196154|NCT00567879|527229617|FG005|Overall Study|Withdrawal by Subject|0|||
146196155|NCT00567879|527229612|FG000|Overall Study|New cancer therapy|0|||
146196156|NCT00567879|527229613|FG001|Overall Study|New cancer therapy|0|||
146196157|NCT00567879|527229614|FG002|Overall Study|New cancer therapy|1|||
145949135|NCT01859949|526325103|FG000|Overall Study|Physician Decision|2|||
145949136|NCT01859949|526325104|FG001|Overall Study|Physician Decision|4|||
145949137|NCT01859949|526325103|FG000|Overall Study|Withdrawal by Subject|11|||
145949138|NCT01859949|526325104|FG001|Overall Study|Withdrawal by Subject|10|||
145949139|NCT01859949|526325103|FG000|Overall Study|Protocol Violation|1|||
145949140|NCT01859949|526325104|FG001|Overall Study|Protocol Violation|1|||
145949141|NCT01859949|526325103|FG000|Overall Study|Adverse Event|0|||
145949142|NCT01859949|526325104|FG001|Overall Study|Adverse Event|1|||
145949143|NCT01344759|526325105|FG000|Overall Study|Patients failed to reach sedation level|0|||
146196158|NCT00567879|527229615|FG003|Overall Study|New cancer therapy|0|||
146196159|NCT00567879|527229616|FG004|Overall Study|New cancer therapy|0|||
146196160|NCT00567879|527229617|FG005|Overall Study|New cancer therapy|0|||
146196161|NCT00567879|527229612|FG000|Overall Study|Disease progression|5|||
146196162|NCT00567879|527229613|FG001|Overall Study|Disease progression|7|||
146196163|NCT00567879|527229614|FG002|Overall Study|Disease progression|15|||
146196164|NCT00567879|527229615|FG003|Overall Study|Disease progression|5|||
145949144|NCT01344759|526325106|FG001|Overall Study|Patients failed to reach sedation level|2|||
145949145|NCT01709409|526325111|FG000|Overall Study|Protocol Violation|1|||
145949146|NCT01709409|526325112|FG001|Overall Study|Protocol Violation|0|||
146423039|NCT02270736|528055829|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145949147|NCT02412878|526325113|FG000|Overall Study|Withdrawal by Subject|19|||
145949148|NCT02412878|526325114|FG001|Overall Study|Withdrawal by Subject|10|||
145949149|NCT02412878|526325113|FG000|Overall Study|Lost to Follow-up|2|||
145949150|NCT02412878|526325114|FG001|Overall Study|Lost to Follow-up|3|||
145949151|NCT02190721|526325115|FG000|Overall Study|Patient was out of the city|0|||
145949152|NCT02190721|526325116|FG001|Overall Study|Patient was out of the city|1|||
145949153|NCT02190721|526325117|FG002|Overall Study|Patient was out of the city|0|||
145949154|NCT04571385|526325118|FG000|Overall Study|Participant non-compliance|1|||
145949155|NCT04571385|526325119|FG001|Overall Study|Participant non-compliance|0|||
145949156|NCT04571385|526325120|FG002|Overall Study|Participant non-compliance|0|||
145949157|NCT04571385|526325118|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
145949158|NCT04571385|526325119|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
145949159|NCT04571385|526325120|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
145949160|NCT04571385|526325118|FG000|Overall Study|Screen failure|0|||
145949161|NCT04571385|526325119|FG001|Overall Study|Screen failure|0|||
145949162|NCT04571385|526325120|FG002|Overall Study|Screen failure|1|||
145949163|NCT01928199|526325122|FG000|Overall Study|Lost to Follow-up|2|||
145949164|NCT01928199|526325123|FG001|Overall Study|Lost to Follow-up|1|||
145949165|NCT01928199|526325122|FG000|Overall Study|Withdrawal by Subject|3|||
145949166|NCT01928199|526325123|FG001|Overall Study|Withdrawal by Subject|5|||
145949167|NCT03300050|526325150|FG000|Overall Study|Lost to Follow-up|2|||
145949168|NCT03300050|526325151|FG001|Overall Study|Lost to Follow-up|1|||
145949169|NCT03300050|526325152|FG002|Overall Study|Lost to Follow-up|0|||
145949170|NCT03300050|526325153|FG003|Overall Study|Lost to Follow-up|0|||
145949171|NCT03300050|526325154|FG004|Overall Study|Lost to Follow-up|1|||
145949172|NCT03300050|526325150|FG000|Overall Study|Withdrawal by Subject|1|||
145949173|NCT03300050|526325151|FG001|Overall Study|Withdrawal by Subject|1|||
145949174|NCT03300050|526325152|FG002|Overall Study|Withdrawal by Subject|1|||
145949175|NCT03300050|526325153|FG003|Overall Study|Withdrawal by Subject|0|||
145949176|NCT03300050|526325154|FG004|Overall Study|Withdrawal by Subject|0|||
145949177|NCT03300050|526325150|FG000|Overall Study|Death|0|||
145949178|NCT03300050|526325151|FG001|Overall Study|Death|0|||
145949179|NCT03300050|526325152|FG002|Overall Study|Death|1|||
145949180|NCT03300050|526325153|FG003|Overall Study|Death|0|||
145949181|NCT03300050|526325154|FG004|Overall Study|Death|0|||
145949182|NCT03300050|526325150|FG000|Overall Study|Not Eligible at Randomization|0|||
145949183|NCT03300050|526325151|FG001|Overall Study|Not Eligible at Randomization|0|||
145949184|NCT03300050|526325152|FG002|Overall Study|Not Eligible at Randomization|1|||
146196165|NCT00567879|527229616|FG004|Overall Study|Disease progression|11|||
146196166|NCT00567879|527229617|FG005|Overall Study|Disease progression|3|||
146196167|NCT02380742|527229620|FG000|Overall Study|Withdrawal by Subject|1|||
146196168|NCT02380742|527229621|FG001|Overall Study|Withdrawal by Subject|0|||
146196169|NCT01729819|527229625|FG000|Overall Study|Adverse Event|2|||
146196170|NCT01729819|527229626|FG001|Overall Study|Adverse Event|4|||
146423040|NCT02270736|528055830|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
146423041|NCT02270736|528055831|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145949185|NCT03300050|526325153|FG003|Overall Study|Not Eligible at Randomization|1|||
145949186|NCT03300050|526325154|FG004|Overall Study|Not Eligible at Randomization|0|||
145949187|NCT03326518|526325155|FG000|Overall Study|Protocol Violation|1|||
145949188|NCT03326518|526325156|FG001|Overall Study|Protocol Violation|0|||
145949189|NCT03326518|526325157|FG002|Overall Study|Protocol Violation|0|||
145949190|NCT03326518|526325155|FG000|Overall Study|Withdrawal by Subject|1|||
145949191|NCT03326518|526325156|FG001|Overall Study|Withdrawal by Subject|0|||
145949192|NCT03326518|526325157|FG002|Overall Study|Withdrawal by Subject|0|||
145949193|NCT03326518|526325155|FG000|Overall Study|Lost to Follow-up|1|||
145949194|NCT03326518|526325156|FG001|Overall Study|Lost to Follow-up|0|||
146196171|NCT01729819|527229625|FG000|Overall Study|Lack of Efficacy|1|||
146196172|NCT01729819|527229626|FG001|Overall Study|Lack of Efficacy|0|||
146196173|NCT01729819|527229625|FG000|Overall Study|Lost to Follow-up|2|||
146196174|NCT01729819|527229626|FG001|Overall Study|Lost to Follow-up|0|||
146423042|NCT00262600|528055832|FG000|Overall Study|Lost to Follow-up|17|||
145949195|NCT03326518|526325157|FG002|Overall Study|Lost to Follow-up|1|||
145949196|NCT06010732|526325159|FG000|Crossover Period 1|Protocol Violation|0|||
145949197|NCT06010732|526325160|FG001|Crossover Period 1|Protocol Violation|0|||
145949198|NCT06010732|526325161|FG002|Crossover Period 1|Protocol Violation|1|||
145949199|NCT06010732|526325162|FG003|Crossover Period 1|Protocol Violation|0|||
145949200|NCT06010732|526325163|FG004|Crossover Period 1|Protocol Violation|1|||
145949201|NCT06010732|526325164|FG005|Crossover Period 1|Protocol Violation|0|||
145949202|NCT06010732|526325159|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145949203|NCT06010732|526325160|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
145949204|NCT06010732|526325161|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145949205|NCT06010732|526325162|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145949206|NCT06010732|526325163|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
146196175|NCT01729819|527229625|FG000|Overall Study|Other reason|1|||
146423043|NCT00262600|528055833|FG001|Overall Study|Lost to Follow-up|31|||
146196176|NCT01729819|527229626|FG001|Overall Study|Other reason|0|||
146196177|NCT01729819|527229625|FG000|Overall Study|Protocol Violation|0|||
146196178|NCT01729819|527229626|FG001|Overall Study|Protocol Violation|1|||
146196179|NCT01729819|527229625|FG000|Overall Study|Withdrawal by Subject|0|||
146196180|NCT01729819|527229626|FG001|Overall Study|Withdrawal by Subject|2|||
146196181|NCT02987543|527229627|FG000|Overall Study|Ongoing study at data cut off|49|||
146196182|NCT02987543|527229628|FG001|Overall Study|Ongoing study at data cut off|21|||
146196183|NCT02987543|527229629|FG002|Overall Study|Ongoing study at data cut off|19|||
146196184|NCT02987543|527229630|FG003|Overall Study|Ongoing study at data cut off|12|||
146196185|NCT02987543|527229627|FG000|Overall Study|Death|88|||
146196186|NCT02987543|527229628|FG001|Overall Study|Death|54|||
146196187|NCT02987543|527229629|FG002|Overall Study|Death|67|||
146196188|NCT02987543|527229630|FG003|Overall Study|Death|28|||
146196189|NCT02987543|527229627|FG000|Overall Study|Lost to Follow-up|3|||
146423044|NCT00262600|528055834|FG002|Overall Study|Lost to Follow-up|41|||
146423045|NCT00262600|528055832|FG000|Overall Study|Withdrawal by Subject|128|||
146423046|NCT00262600|528055833|FG001|Overall Study|Withdrawal by Subject|145|||
146423047|NCT00262600|528055834|FG002|Overall Study|Withdrawal by Subject|139|||
146196190|NCT02987543|527229628|FG001|Overall Study|Lost to Follow-up|0|||
146196191|NCT02987543|527229629|FG002|Overall Study|Lost to Follow-up|1|||
146196192|NCT02987543|527229630|FG003|Overall Study|Lost to Follow-up|0|||
146196193|NCT02987543|527229627|FG000|Overall Study|Screen failure|0|||
146196194|NCT02987543|527229628|FG001|Overall Study|Screen failure|0|||
146196195|NCT02987543|527229629|FG002|Overall Study|Screen failure|0|||
146196196|NCT02987543|527229630|FG003|Overall Study|Screen failure|1|||
146196197|NCT02987543|527229627|FG000|Overall Study|Withdrawal by Subject|21|||
146196198|NCT02987543|527229628|FG001|Overall Study|Withdrawal by Subject|7|||
146196199|NCT02987543|527229629|FG002|Overall Study|Withdrawal by Subject|7|||
146196200|NCT02987543|527229630|FG003|Overall Study|Withdrawal by Subject|6|||
146196201|NCT02987543|527229627|FG000|Overall Study|Study terminated by sponsor|1|||
146196202|NCT02987543|527229628|FG001|Overall Study|Study terminated by sponsor|0|||
146196203|NCT02987543|527229629|FG002|Overall Study|Study terminated by sponsor|0|||
146196204|NCT02987543|527229630|FG003|Overall Study|Study terminated by sponsor|0|||
146196205|NCT02987543|527229627|FG000|Overall Study|Investigator decision|0|||
146196206|NCT02987543|527229628|FG001|Overall Study|Investigator decision|1|||
146196207|NCT02987543|527229629|FG002|Overall Study|Investigator decision|0|||
146196208|NCT02987543|527229630|FG003|Overall Study|Investigator decision|0|||
146196209|NCT02987543|527229627|FG000|Overall Study|Disease progression|0|||
146196210|NCT02987543|527229628|FG001|Overall Study|Disease progression|0|||
146196211|NCT02987543|527229629|FG002|Overall Study|Disease progression|0|||
146196212|NCT02987543|527229630|FG003|Overall Study|Disease progression|1|||
146196213|NCT02001623|527229631|FG000|Overall Study|Disease Progression|2|||
146196214|NCT02001623|527229632|FG001|Overall Study|Disease Progression|2|||
146196215|NCT02001623|527229633|FG002|Overall Study|Disease Progression|3|||
146196216|NCT02001623|527229634|FG003|Overall Study|Disease Progression|2|||
146196217|NCT02001623|527229635|FG004|Overall Study|Disease Progression|3|||
146196218|NCT02001623|527229636|FG005|Overall Study|Disease Progression|2|||
146196219|NCT02001623|527229637|FG006|Overall Study|Disease Progression|3|||
146196220|NCT02001623|527229638|FG007|Overall Study|Disease Progression|3|||
146196221|NCT02001623|527229639|FG008|Overall Study|Disease Progression|7|||
146196222|NCT02001623|527229640|FG009|Overall Study|Disease Progression|40|||
146196223|NCT02001623|527229641|FG010|Overall Study|Disease Progression|5|||
146196224|NCT02001623|527229642|FG011|Overall Study|Disease Progression|9|||
146196225|NCT02001623|527229643|FG012|Overall Study|Disease Progression|9|||
146196226|NCT02001623|527229644|FG013|Overall Study|Disease Progression|20|||
146196227|NCT02001623|527229645|FG014|Overall Study|Disease Progression|9|||
146196228|NCT02001623|527229631|FG000|Overall Study|Physician Decision|0|||
146196229|NCT02001623|527229632|FG001|Overall Study|Physician Decision|0|||
146196230|NCT02001623|527229633|FG002|Overall Study|Physician Decision|0|||
146196231|NCT02001623|527229634|FG003|Overall Study|Physician Decision|0|||
146196232|NCT02001623|527229635|FG004|Overall Study|Physician Decision|0|||
146196233|NCT02001623|527229636|FG005|Overall Study|Physician Decision|0|||
146423048|NCT00262600|528055832|FG000|Overall Study|Not Treated|32|||
146196234|NCT02001623|527229637|FG006|Overall Study|Physician Decision|0|||
146196235|NCT02001623|527229638|FG007|Overall Study|Physician Decision|0|||
146196236|NCT02001623|527229639|FG008|Overall Study|Physician Decision|3|||
146196237|NCT02001623|527229640|FG009|Overall Study|Physician Decision|2|||
146196238|NCT02001623|527229641|FG010|Overall Study|Physician Decision|3|||
146196239|NCT02001623|527229642|FG011|Overall Study|Physician Decision|3|||
146196240|NCT02001623|527229643|FG012|Overall Study|Physician Decision|1|||
146196241|NCT02001623|527229644|FG013|Overall Study|Physician Decision|2|||
146196242|NCT02001623|527229645|FG014|Overall Study|Physician Decision|1|||
146196243|NCT02001623|527229631|FG000|Overall Study|Death|0|||
146196244|NCT02001623|527229632|FG001|Overall Study|Death|1|||
146196245|NCT02001623|527229633|FG002|Overall Study|Death|0|||
146196246|NCT02001623|527229634|FG003|Overall Study|Death|0|||
146196247|NCT02001623|527229635|FG004|Overall Study|Death|0|||
146423049|NCT00262600|528055833|FG001|Overall Study|Not Treated|17|||
146196248|NCT02001623|527229636|FG005|Overall Study|Death|0|||
146196249|NCT02001623|527229637|FG006|Overall Study|Death|0|||
146196250|NCT02001623|527229638|FG007|Overall Study|Death|0|||
146196251|NCT02001623|527229639|FG008|Overall Study|Death|0|||
146196252|NCT02001623|527229640|FG009|Overall Study|Death|0|||
146196253|NCT02001623|527229641|FG010|Overall Study|Death|0|||
146196254|NCT02001623|527229642|FG011|Overall Study|Death|0|||
146196255|NCT02001623|527229643|FG012|Overall Study|Death|0|||
146196256|NCT02001623|527229644|FG013|Overall Study|Death|0|||
146196257|NCT02001623|527229645|FG014|Overall Study|Death|0|||
146196258|NCT02001623|527229631|FG000|Overall Study|Adverse Event|0|||
146196259|NCT02001623|527229632|FG001|Overall Study|Adverse Event|0|||
146196260|NCT02001623|527229633|FG002|Overall Study|Adverse Event|0|||
146196261|NCT02001623|527229634|FG003|Overall Study|Adverse Event|0|||
146196262|NCT02001623|527229635|FG004|Overall Study|Adverse Event|0|||
146196263|NCT02001623|527229636|FG005|Overall Study|Adverse Event|1|||
146196264|NCT02001623|527229637|FG006|Overall Study|Adverse Event|0|||
146196265|NCT02001623|527229638|FG007|Overall Study|Adverse Event|3|||
146196266|NCT02001623|527229639|FG008|Overall Study|Adverse Event|4|||
146196267|NCT02001623|527229640|FG009|Overall Study|Adverse Event|6|||
146196268|NCT02001623|527229641|FG010|Overall Study|Adverse Event|4|||
146196269|NCT02001623|527229642|FG011|Overall Study|Adverse Event|0|||
146196270|NCT02001623|527229643|FG012|Overall Study|Adverse Event|3|||
146196271|NCT02001623|527229644|FG013|Overall Study|Adverse Event|5|||
146196272|NCT02001623|527229645|FG014|Overall Study|Adverse Event|6|||
146196273|NCT02001623|527229631|FG000|Overall Study|Other - Miscellaneous|0|||
146196274|NCT02001623|527229632|FG001|Overall Study|Other - Miscellaneous|0|||
146196275|NCT02001623|527229633|FG002|Overall Study|Other - Miscellaneous|0|||
146196276|NCT02001623|527229634|FG003|Overall Study|Other - Miscellaneous|0|||
146196277|NCT02001623|527229635|FG004|Overall Study|Other - Miscellaneous|0|||
146196278|NCT02001623|527229636|FG005|Overall Study|Other - Miscellaneous|0|||
146196279|NCT02001623|527229637|FG006|Overall Study|Other - Miscellaneous|0|||
146196280|NCT02001623|527229638|FG007|Overall Study|Other - Miscellaneous|0|||
146196281|NCT02001623|527229639|FG008|Overall Study|Other - Miscellaneous|0|||
146196282|NCT02001623|527229640|FG009|Overall Study|Other - Miscellaneous|1|||
146196283|NCT02001623|527229641|FG010|Overall Study|Other - Miscellaneous|0|||
146196284|NCT02001623|527229642|FG011|Overall Study|Other - Miscellaneous|0|||
146196285|NCT02001623|527229643|FG012|Overall Study|Other - Miscellaneous|0|||
146196286|NCT02001623|527229644|FG013|Overall Study|Other - Miscellaneous|1|||
146196287|NCT02001623|527229645|FG014|Overall Study|Other - Miscellaneous|0|||
146196288|NCT02001623|527229631|FG000|Overall Study|Withdrawal by Subject|1|||
146196289|NCT02001623|527229632|FG001|Overall Study|Withdrawal by Subject|0|||
146196290|NCT02001623|527229633|FG002|Overall Study|Withdrawal by Subject|0|||
146196291|NCT02001623|527229634|FG003|Overall Study|Withdrawal by Subject|0|||
146196292|NCT02001623|527229635|FG004|Overall Study|Withdrawal by Subject|0|||
146196293|NCT02001623|527229636|FG005|Overall Study|Withdrawal by Subject|0|||
146196294|NCT02001623|527229637|FG006|Overall Study|Withdrawal by Subject|0|||
146196295|NCT02001623|527229638|FG007|Overall Study|Withdrawal by Subject|0|||
146196296|NCT02001623|527229639|FG008|Overall Study|Withdrawal by Subject|1|||
146196297|NCT02001623|527229640|FG009|Overall Study|Withdrawal by Subject|3|||
146196298|NCT02001623|527229641|FG010|Overall Study|Withdrawal by Subject|2|||
146196299|NCT02001623|527229642|FG011|Overall Study|Withdrawal by Subject|2|||
146196300|NCT02001623|527229643|FG012|Overall Study|Withdrawal by Subject|1|||
146196301|NCT02001623|527229644|FG013|Overall Study|Withdrawal by Subject|5|||
146196302|NCT02001623|527229645|FG014|Overall Study|Withdrawal by Subject|2|||
146196303|NCT02001623|527229631|FG000|Overall Study|Lost to Follow-up|0|||
146196304|NCT02001623|527229632|FG001|Overall Study|Lost to Follow-up|0|||
146196305|NCT02001623|527229633|FG002|Overall Study|Lost to Follow-up|0|||
146196306|NCT02001623|527229634|FG003|Overall Study|Lost to Follow-up|0|||
146196307|NCT02001623|527229635|FG004|Overall Study|Lost to Follow-up|0|||
146196308|NCT02001623|527229636|FG005|Overall Study|Lost to Follow-up|0|||
146196309|NCT02001623|527229637|FG006|Overall Study|Lost to Follow-up|0|||
146196310|NCT02001623|527229638|FG007|Overall Study|Lost to Follow-up|0|||
146196311|NCT02001623|527229639|FG008|Overall Study|Lost to Follow-up|0|||
146196312|NCT02001623|527229640|FG009|Overall Study|Lost to Follow-up|1|||
146196313|NCT02001623|527229641|FG010|Overall Study|Lost to Follow-up|0|||
146196314|NCT02001623|527229642|FG011|Overall Study|Lost to Follow-up|0|||
146196315|NCT02001623|527229643|FG012|Overall Study|Lost to Follow-up|0|||
146196316|NCT02001623|527229644|FG013|Overall Study|Lost to Follow-up|0|||
146196317|NCT02001623|527229645|FG014|Overall Study|Lost to Follow-up|0|||
146196318|NCT02001623|527229631|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
146196319|NCT02001623|527229632|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
146196320|NCT02001623|527229633|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
146196321|NCT02001623|527229634|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
146196322|NCT02001623|527229635|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
146196323|NCT02001623|527229636|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
146196324|NCT02001623|527229637|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
146196325|NCT02001623|527229638|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
146196326|NCT02001623|527229639|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
146423050|NCT00262600|528055834|FG002|Overall Study|Not Treated|24|||
146196327|NCT02001623|527229640|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
146196328|NCT02001623|527229641|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
146196329|NCT02001623|527229642|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
146196330|NCT02001623|527229643|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
146196331|NCT02001623|527229644|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
146196332|NCT02001623|527229645|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
146196333|NCT02001623|527229631|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
146196334|NCT02001623|527229632|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
146196335|NCT02001623|527229633|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
146196336|NCT02001623|527229634|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
146196337|NCT02001623|527229635|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
146196338|NCT02001623|527229636|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
146196339|NCT02001623|527229637|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
146196340|NCT02001623|527229638|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
146196341|NCT02001623|527229639|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
146196342|NCT02001623|527229640|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
146196343|NCT02001623|527229641|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
146196344|NCT02001623|527229642|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
146196345|NCT02001623|527229643|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
146196346|NCT02001623|527229644|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
146196347|NCT02001623|527229645|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
146196348|NCT01063036|527229654|FG000|Participants Treated With Study Drug|Adverse Event|1|||
146196349|NCT01063036|527229654|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
146196350|NCT01063036|527229654|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
146196351|NCT01063036|527229654|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
146196352|NCT01063036|527229654|FG000|Participants Treated With Study Drug|Pregnancy|1|||
146196353|NCT01063036|527229654|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
146196354|NCT01063036|527229654|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
146196355|NCT01063036|527229654|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
146196356|NCT00918957|527229655|FG000|Overall Study|Adverse Event|2|||
146196357|NCT00918957|527229656|FG001|Overall Study|Adverse Event|0|||
146196358|NCT00918957|527229655|FG000|Overall Study|Withdrawal by Subject|1|||
146196359|NCT00918957|527229656|FG001|Overall Study|Withdrawal by Subject|0|||
146082616|NCT00545129|526822854|FG001|Overall Study|Lack of Efficacy|5|||
146196360|NCT05790408|527229657|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
146196361|NCT01064817|527229658|FG000|Study Completion|Physician Decision|1|||
146196362|NCT01064817|527229659|FG001|Study Completion|Physician Decision|0|||
146196363|NCT01064817|527229658|FG000|Study Completion|Withdrawal by Subject|1|||
146196364|NCT01064817|527229659|FG001|Study Completion|Withdrawal by Subject|0|||
146196365|NCT02274493|527229660|FG000|Overall Study|Withdrawal by Subject|1|||
146423051|NCT00262600|528055832|FG000|Overall Study|Other|58|||
146423052|NCT00262600|528055833|FG001|Overall Study|Other|59|||
146196366|NCT00558363|527229661|FG000|Overall Study|Physician Decision|18|||
146196367|NCT00558363|527229662|FG001|Overall Study|Physician Decision|4|||
146196368|NCT00558363|527229661|FG000|Overall Study|Withdrawal by Subject|11|||
146196369|NCT00558363|527229662|FG001|Overall Study|Withdrawal by Subject|4|||
146196370|NCT00558363|527229661|FG000|Overall Study|Adverse Event|5|||
146196371|NCT00558363|527229662|FG001|Overall Study|Adverse Event|5|||
146196372|NCT00558363|527229661|FG000|Overall Study|Lack of Efficacy|2|||
146196373|NCT00558363|527229662|FG001|Overall Study|Lack of Efficacy|2|||
146196374|NCT00558363|527229661|FG000|Overall Study|Protocol Violation|2|||
146196375|NCT00558363|527229662|FG001|Overall Study|Protocol Violation|1|||
146196376|NCT00558363|527229661|FG000|Overall Study|Lost to Follow-up|0|||
146196377|NCT00558363|527229662|FG001|Overall Study|Lost to Follow-up|1|||
146196378|NCT00558363|527229661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
146196379|NCT00558363|527229662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
146196380|NCT00558363|527229661|FG000|Overall Study|Randomized in Error|1|||
146196381|NCT00558363|527229662|FG001|Overall Study|Randomized in Error|2|||
146196382|NCT00558363|527229661|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
146196383|NCT00558363|527229662|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
146196384|NCT03102710|527229663|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
146196385|NCT03102710|527229664|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
146196386|NCT03102710|527229665|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
146196387|NCT03102710|527229663|FG000|Overall Study|Technical issues during final MRI scan|0|||
146196388|NCT03102710|527229664|FG001|Overall Study|Technical issues during final MRI scan|1|||
146196389|NCT03102710|527229665|FG002|Overall Study|Technical issues during final MRI scan|0|||
146196390|NCT03102710|527229663|FG000|Overall Study|Nausea during MRI scan|0|||
146196391|NCT03102710|527229664|FG001|Overall Study|Nausea during MRI scan|1|||
146196392|NCT03102710|527229665|FG002|Overall Study|Nausea during MRI scan|0|||
146196393|NCT03102710|527229663|FG000|Overall Study|Subject unable to attend final session|0|||
146196394|NCT03102710|527229664|FG001|Overall Study|Subject unable to attend final session|1|||
146196395|NCT03102710|527229665|FG002|Overall Study|Subject unable to attend final session|0|||
146196396|NCT01313182|527229666|FG000|Overall Study|Protocol Violation|66|||
146196397|NCT01313182|527229667|FG001|Overall Study|Protocol Violation|92|||
146196398|NCT01695317|527229668|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
146196399|NCT01695317|527229669|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
146196400|NCT01695317|527229668|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
146196401|NCT01695317|527229669|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
146196402|NCT00606580|527229673|FG000|Overall Study|Lost to Follow-up|1|||
146196403|NCT00606580|527229674|FG001|Overall Study|Lost to Follow-up|1|||
146196404|NCT00606580|527229675|FG002|Overall Study|Lost to Follow-up|4|||
146196405|NCT00606580|527229673|FG000|Overall Study|Clinical failures|1|||
146196406|NCT00606580|527229674|FG001|Overall Study|Clinical failures|0|||
146196407|NCT00606580|527229675|FG002|Overall Study|Clinical failures|12|||
146196408|NCT00606580|527229673|FG000|Overall Study|Withdrawal by investigator|0|||
146196409|NCT00606580|527229674|FG001|Overall Study|Withdrawal by investigator|1|||
146196410|NCT00606580|527229675|FG002|Overall Study|Withdrawal by investigator|6|||
146196411|NCT00606580|527229673|FG000|Overall Study|Withdrawal by Subject|0|||
146196412|NCT00606580|527229674|FG001|Overall Study|Withdrawal by Subject|1|||
146196413|NCT00606580|527229675|FG002|Overall Study|Withdrawal by Subject|0|||
146196414|NCT01101165|527229676|FG000|Period 1|Adverse Event|1|||
146196415|NCT01101165|527229677|FG001|Period 1|Adverse Event|2|||
146196416|NCT01101165|527229676|FG000|Period 1|Withdrawal by Subject|0|||
146196417|NCT01101165|527229677|FG001|Period 1|Withdrawal by Subject|2|||
146196418|NCT01101165|527229676|FG000|Period 1|Positive Drug Screen|0|||
146196419|NCT01101165|527229677|FG001|Period 1|Positive Drug Screen|1|||
146196420|NCT01101165|527229676|FG000|Period 1|Lost to Follow-up|1|||
146196421|NCT01101165|527229677|FG001|Period 1|Lost to Follow-up|0|||
146196422|NCT01101165|527229676|FG000|Period 2|Withdrawal by Subject|3|||
146196423|NCT01101165|527229677|FG001|Period 2|Withdrawal by Subject|1|||
146196424|NCT01101165|527229676|FG000|Period 2|Adverse Event|1|||
146196425|NCT01101165|527229677|FG001|Period 2|Adverse Event|0|||
146196426|NCT04580303|527229678|FG000|Overall Study|Adverse Event|0|||
146423053|NCT00262600|528055834|FG002|Overall Study|Other|62|||
146196427|NCT04580303|527229679|FG001|Overall Study|Adverse Event|1|||
146196428|NCT04580303|527229680|FG002|Overall Study|Adverse Event|0|||
146196429|NCT04580303|527229681|FG003|Overall Study|Adverse Event|0|||
146196430|NCT04580303|527229678|FG000|Overall Study|Withdrawal by Subject|0|||
146196431|NCT04580303|527229679|FG001|Overall Study|Withdrawal by Subject|0|||
146423054|NCT02710123|528055835|FG000|Overall Study|Lost to Follow-up|3|||
146423055|NCT02710123|528055836|FG001|Overall Study|Lost to Follow-up|4|||
145949207|NCT06010732|526325164|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145949208|NCT06010732|526325159|FG000|Crossover Period 2|Adverse Event|0|||
145949209|NCT06010732|526325160|FG001|Crossover Period 2|Adverse Event|1|||
145949210|NCT06010732|526325161|FG002|Crossover Period 2|Adverse Event|0|||
145949211|NCT06010732|526325162|FG003|Crossover Period 2|Adverse Event|0|||
145949212|NCT06010732|526325163|FG004|Crossover Period 2|Adverse Event|0|||
145949213|NCT06010732|526325164|FG005|Crossover Period 2|Adverse Event|0|||
145949214|NCT06010732|526325159|FG000|Crossover Period 2|broken denture|0|||
145949215|NCT06010732|526325160|FG001|Crossover Period 2|broken denture|0|||
145949216|NCT06010732|526325161|FG002|Crossover Period 2|broken denture|1|||
145949217|NCT06010732|526325162|FG003|Crossover Period 2|broken denture|0|||
145949218|NCT06010732|526325163|FG004|Crossover Period 2|broken denture|0|||
146196432|NCT04580303|527229680|FG002|Overall Study|Withdrawal by Subject|1|||
146196433|NCT04580303|527229681|FG003|Overall Study|Withdrawal by Subject|0|||
146196434|NCT01456936|527229683|FG000|Overall Study|Other reason|41|||
146196435|NCT01456936|527229684|FG001|Overall Study|Other reason|30|||
146196436|NCT01456936|527229685|FG002|Overall Study|Other reason|36|||
146196437|NCT01456936|527229686|FG003|Overall Study|Other reason|33|||
146196438|NCT01456936|527229683|FG000|Overall Study|No longer meets eligibility criteria|4|||
146196439|NCT01456936|527229684|FG001|Overall Study|No longer meets eligibility criteria|8|||
146196440|NCT01456936|527229685|FG002|Overall Study|No longer meets eligibility criteria|6|||
146196441|NCT01456936|527229686|FG003|Overall Study|No longer meets eligibility criteria|5|||
146196442|NCT01456936|527229683|FG000|Overall Study|Protocol Violation|4|||
146196443|NCT01456936|527229684|FG001|Overall Study|Protocol Violation|2|||
146196444|NCT01456936|527229685|FG002|Overall Study|Protocol Violation|5|||
146196445|NCT01456936|527229686|FG003|Overall Study|Protocol Violation|5|||
146196446|NCT01456936|527229683|FG000|Overall Study|Pregnancy|1|||
146196447|NCT01456936|527229684|FG001|Overall Study|Pregnancy|0|||
146196448|NCT01456936|527229685|FG002|Overall Study|Pregnancy|0|||
146196449|NCT01456936|527229686|FG003|Overall Study|Pregnancy|1|||
146196450|NCT01456936|527229683|FG000|Overall Study|Insufficient clinical response|4|||
146196451|NCT01456936|527229684|FG001|Overall Study|Insufficient clinical response|4|||
146196452|NCT01456936|527229685|FG002|Overall Study|Insufficient clinical response|14|||
146196453|NCT01456936|527229686|FG003|Overall Study|Insufficient clinical response|13|||
146196454|NCT01456936|527229683|FG000|Overall Study|No longer willing to participate|195|||
146196455|NCT01456936|527229684|FG001|Overall Study|No longer willing to participate|218|||
146196456|NCT01456936|527229685|FG002|Overall Study|No longer willing to participate|224|||
146196457|NCT01456936|527229686|FG003|Overall Study|No longer willing to participate|248|||
146196458|NCT01456936|527229683|FG000|Overall Study|Lost to Follow-up|135|||
146196459|NCT01456936|527229684|FG001|Overall Study|Lost to Follow-up|126|||
146196460|NCT01456936|527229685|FG002|Overall Study|Lost to Follow-up|144|||
146196461|NCT01456936|527229686|FG003|Overall Study|Lost to Follow-up|127|||
146196462|NCT01456936|527229683|FG000|Overall Study|Medication error|0|||
146196463|NCT01456936|527229684|FG001|Overall Study|Medication error|1|||
146196464|NCT01456936|527229685|FG002|Overall Study|Medication error|0|||
146196465|NCT01456936|527229686|FG003|Overall Study|Medication error|1|||
146196466|NCT01456936|527229683|FG000|Overall Study|Adverse event (study drug)|25|||
146196467|NCT01456936|527229684|FG001|Overall Study|Adverse event (study drug)|21|||
146196468|NCT01456936|527229685|FG002|Overall Study|Adverse event (study drug)|26|||
146196469|NCT01456936|527229686|FG003|Overall Study|Adverse event (study drug)|17|||
146196470|NCT01456936|527229683|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
146196471|NCT01456936|527229684|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
146196472|NCT01456936|527229685|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
146196473|NCT01456936|527229686|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
146196474|NCT01456936|527229683|FG000|Overall Study|Death|0|||
146196475|NCT01456936|527229684|FG001|Overall Study|Death|3|||
146196476|NCT01456936|527229685|FG002|Overall Study|Death|1|||
146423056|NCT02710123|528055835|FG000|Overall Study|Withdrawal by Subject|1|||
146423057|NCT02710123|528055836|FG001|Overall Study|Withdrawal by Subject|1|||
146423058|NCT02710123|528055835|FG000|Overall Study|Illness unrelated to study intervention|1|||
145949219|NCT06010732|526325164|FG005|Crossover Period 2|broken denture|0|||
146082617|NCT00545129|526822853|FG000|Overall Study|Death|2|||
146196477|NCT01456936|527229686|FG003|Overall Study|Death|3|||
146196478|NCT01456936|527229683|FG000|Overall Study|Randomized but not treated|21|||
146196479|NCT01456936|527229684|FG001|Overall Study|Randomized but not treated|28|||
146196480|NCT01456936|527229685|FG002|Overall Study|Randomized but not treated|16|||
146196481|NCT01456936|527229686|FG003|Overall Study|Randomized but not treated|21|||
146196482|NCT03095508|527229687|FG000|Overall Study|Adverse Event|0|||
146196483|NCT03095508|527229688|FG001|Overall Study|Adverse Event|1|||
146196484|NCT02317705|527229689|FG000|Overall Study|Withdrawal by Subject|3|||
146423059|NCT02710123|528055836|FG001|Overall Study|Illness unrelated to study intervention|0|||
145949220|NCT04942210|526325166|FG000|Overall Study|Adverse Event|0|||
145949221|NCT04942210|526325167|FG001|Overall Study|Adverse Event|1|||
145949222|NCT04942210|526325166|FG000|Overall Study|Protocol Deviation|4|||
145949223|NCT04942210|526325167|FG001|Overall Study|Protocol Deviation|1|||
146082618|NCT00545129|526822854|FG001|Overall Study|Death|1|||
146196485|NCT02317705|527229689|FG000|Overall Study|Physician Decision|1|||
146196486|NCT02317705|527229689|FG000|Overall Study|Drug not usable|1|||
146196487|NCT01549652|527229692|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
146196488|NCT01549652|527229693|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
146196489|NCT01549652|527229694|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
146196490|NCT01549652|527229695|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
146196491|NCT01549652|527229692|FG000|Overall Study|Study Drug Titration Failure|5|||
146196492|NCT01549652|527229693|FG001|Overall Study|Study Drug Titration Failure|6|||
146196493|NCT01549652|527229694|FG002|Overall Study|Study Drug Titration Failure|0|||
146196494|NCT01549652|527229695|FG003|Overall Study|Study Drug Titration Failure|0|||
146423060|NCT05381948|528055837|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
146423061|NCT05381948|528055838|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
146423062|NCT05381948|528055839|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
146423063|NCT05381948|528055837|FG000|Overall Study|Adverse Event: Non-ocular|0|||
146423064|NCT05381948|528055838|FG001|Overall Study|Adverse Event: Non-ocular|1|||
146423065|NCT05381948|528055839|FG002|Overall Study|Adverse Event: Non-ocular|0|||
146423066|NCT05381948|528055837|FG000|Overall Study|Lost to Follow-up|1|||
146423067|NCT05381948|528055838|FG001|Overall Study|Lost to Follow-up|0|||
146196495|NCT01549652|527229692|FG000|Overall Study|Withdrawal Effect|0|||
146196496|NCT01549652|527229693|FG001|Overall Study|Withdrawal Effect|2|||
146196497|NCT01549652|527229694|FG002|Overall Study|Withdrawal Effect|0|||
146196498|NCT01549652|527229695|FG003|Overall Study|Withdrawal Effect|0|||
146196499|NCT01549652|527229692|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
146196500|NCT01549652|527229693|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
146196501|NCT01549652|527229694|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
146196502|NCT01549652|527229695|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
146196503|NCT01549652|527229692|FG000|Overall Study|Problem with Infusion|1|||
146196504|NCT01549652|527229693|FG001|Overall Study|Problem with Infusion|0|||
146196505|NCT01549652|527229694|FG002|Overall Study|Problem with Infusion|0|||
146196506|NCT01549652|527229695|FG003|Overall Study|Problem with Infusion|0|||
146196507|NCT01549652|527229692|FG000|Overall Study|Titration Non-Compliance|1|||
146196508|NCT01549652|527229693|FG001|Overall Study|Titration Non-Compliance|3|||
146196509|NCT01549652|527229694|FG002|Overall Study|Titration Non-Compliance|4|||
146196510|NCT01549652|527229695|FG003|Overall Study|Titration Non-Compliance|5|||
146196511|NCT01549652|527229692|FG000|Overall Study|Titration Side Effects|0|||
146196512|NCT01549652|527229693|FG001|Overall Study|Titration Side Effects|0|||
146196513|NCT01549652|527229694|FG002|Overall Study|Titration Side Effects|6|||
146196514|NCT01549652|527229695|FG003|Overall Study|Titration Side Effects|3|||
146196515|NCT01549652|527229692|FG000|Overall Study|Withdrawal by Subject|0|||
146196516|NCT01549652|527229693|FG001|Overall Study|Withdrawal by Subject|0|||
146196517|NCT01549652|527229694|FG002|Overall Study|Withdrawal by Subject|5|||
146196518|NCT01549652|527229695|FG003|Overall Study|Withdrawal by Subject|3|||
146196519|NCT05196737|527229698|FG000|Non-intervention Week|Lost to Follow-up|2|||
146196520|NCT05196737|527229698|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
146196521|NCT03722446|527229699|FG000|Overall Study|Protocol Violation|15|||
146196522|NCT03722446|527229700|FG001|Overall Study|Protocol Violation|2|||
146196523|NCT02908464|527229705|FG000|Overall Study|Withdrawal by Subject|2|||
146196524|NCT02908464|527229706|FG001|Overall Study|Withdrawal by Subject|1|||
146196525|NCT02908464|527229705|FG000|Overall Study|Found ineligible after randomization|0|||
146196526|NCT02908464|527229706|FG001|Overall Study|Found ineligible after randomization|2|||
146196527|NCT02163915|527229707|FG000|Overall Study|Withdrawal by Subject|2|||
146196528|NCT02163915|527229708|FG001|Overall Study|Withdrawal by Subject|0|||
146196529|NCT02163915|527229709|FG002|Overall Study|Withdrawal by Subject|2|||
146196530|NCT02163915|527229710|FG003|Overall Study|Withdrawal by Subject|2|||
146196531|NCT02163915|527229711|FG004|Overall Study|Withdrawal by Subject|2|||
146196532|NCT02163915|527229707|FG000|Overall Study|Study termination|1|||
146196533|NCT02163915|527229708|FG001|Overall Study|Study termination|0|||
146196534|NCT02163915|527229709|FG002|Overall Study|Study termination|0|||
146196535|NCT02163915|527229710|FG003|Overall Study|Study termination|0|||
146196536|NCT02163915|527229711|FG004|Overall Study|Study termination|2|||
146196537|NCT02163915|527229707|FG000|Overall Study|Physician Decision|0|||
146196538|NCT02163915|527229708|FG001|Overall Study|Physician Decision|0|||
146423068|NCT05381948|528055839|FG002|Overall Study|Lost to Follow-up|0|||
146423069|NCT05381948|528055837|FG000|Overall Study|Protocol Deviation|0|||
146196539|NCT02163915|527229709|FG002|Overall Study|Physician Decision|0|||
146196540|NCT02163915|527229710|FG003|Overall Study|Physician Decision|1|||
146196541|NCT02163915|527229711|FG004|Overall Study|Physician Decision|0|||
146423070|NCT05381948|528055838|FG001|Overall Study|Protocol Deviation|2|||
146423071|NCT05381948|528055839|FG002|Overall Study|Protocol Deviation|0|||
146196542|NCT01091454|527231168|FG000|Overall Study|Ineligible|1|||
146196543|NCT00777556|527231171|FG000|Overall Study|Inappropriate self-selection|34|||
146423072|NCT05381948|528055837|FG000|Overall Study|Withdrawal by Subject|1|||
146196544|NCT00777556|527231171|FG000|Overall Study|Dispensed but did not use product|12|||
146196545|NCT00777556|527231171|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
146423073|NCT05381948|528055838|FG001|Overall Study|Withdrawal by Subject|0|||
145949224|NCT04942210|526325166|FG000|Overall Study|Withdrawal by Subject|5|||
145949225|NCT04942210|526325167|FG001|Overall Study|Withdrawal by Subject|2|||
145949226|NCT04942210|526325166|FG000|Overall Study|Lost to Follow-up|16|||
145949227|NCT04942210|526325167|FG001|Overall Study|Lost to Follow-up|7|||
145949228|NCT04942210|526325166|FG000|Overall Study|Ongoing at the time of DBL date|60|||
145949229|NCT04942210|526325167|FG001|Overall Study|Ongoing at the time of DBL date|25|||
145949230|NCT04942210|526325166|FG000|Overall Study|Randomized but did not receive vaccination|3|||
145949231|NCT04942210|526325167|FG001|Overall Study|Randomized but did not receive vaccination|0|||
145949232|NCT05697627|526325168|FG000|Overall Study|Adverse Event|1|||
145949233|NCT02722746|526325169|FG000|Overall Study|Withdrawal by Subject|0|||
145949234|NCT02722746|526325170|FG001|Overall Study|Withdrawal by Subject|1|||
145949235|NCT02722746|526325171|FG002|Overall Study|Withdrawal by Subject|0|||
145949236|NCT02722746|526325169|FG000|Overall Study|Protocol Violation|8|||
146196546|NCT05298111|527231173|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
146196547|NCT05298111|527231174|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
146196548|NCT03518112|527231175|FG000|Overall Study|Withdrawal by Subject|1|||
146196549|NCT01280591|527231178|FG000|Overall Study|Withdrawal by Subject|0|||
146196550|NCT01280591|527231179|FG001|Overall Study|Withdrawal by Subject|0|||
146196551|NCT01280591|527231180|FG002|Overall Study|Withdrawal by Subject|0|||
145949237|NCT02722746|526325170|FG001|Overall Study|Protocol Violation|4|||
145949238|NCT02722746|526325171|FG002|Overall Study|Protocol Violation|6|||
145949239|NCT01038752|526325172|FG000|Overall Study|Tumor Progression|2|||
145949240|NCT01038752|526325173|FG001|Overall Study|Tumor Progression|2|||
145949241|NCT01038752|526325172|FG000|Overall Study|Lost to Follow-up|3|||
145949242|NCT01038752|526325173|FG001|Overall Study|Lost to Follow-up|3|||
145949243|NCT02651688|526325193|FG000|Overall Study|Non-compliance|0|||
145949244|NCT02651688|526325194|FG001|Overall Study|Non-compliance|0|||
145949245|NCT02651688|526325195|FG002|Overall Study|Non-compliance|1|||
145949246|NCT02651688|526325193|FG000|Overall Study|Principal Investigator (PI) decision|0|||
145949247|NCT02651688|526325194|FG001|Overall Study|Principal Investigator (PI) decision|2|||
145949248|NCT02651688|526325195|FG002|Overall Study|Principal Investigator (PI) decision|0|||
145949249|NCT02651688|526325193|FG000|Overall Study|Lost to Follow-up|1|||
145949250|NCT02651688|526325194|FG001|Overall Study|Lost to Follow-up|3|||
145949251|NCT02651688|526325195|FG002|Overall Study|Lost to Follow-up|0|||
145949252|NCT02651688|526325193|FG000|Overall Study|Withdrawal by Subject|1|||
145949253|NCT02651688|526325194|FG001|Overall Study|Withdrawal by Subject|0|||
145949254|NCT02651688|526325195|FG002|Overall Study|Withdrawal by Subject|2|||
145949255|NCT04527978|526325196|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
145949256|NCT04527978|526325197|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
145949257|NCT02112877|526325198|FG000|Overall Study|Withdrawal by Subject|1|||
145949258|NCT02112877|526325199|FG001|Overall Study|Withdrawal by Subject|7|||
145949259|NCT02112877|526325198|FG000|Overall Study|Visit Missed|1|||
145949260|NCT02112877|526325199|FG001|Overall Study|Visit Missed|6|||
145949261|NCT01693185|526325200|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
145949262|NCT01693185|526325201|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
145949263|NCT01084538|526325212|FG000|Overall Study|Drug not available|30|||
145949264|NCT01084538|526325212|FG000|Overall Study|Adverse Event|9|||
145949265|NCT01084538|526325212|FG000|Overall Study|Kidney transplant|6|||
145949266|NCT01084538|526325212|FG000|Overall Study|Serious Adverse Event|3|||
145949267|NCT01084538|526325212|FG000|Overall Study|Lack of effectiveness|2|||
145949268|NCT01084538|526325212|FG000|Overall Study|Patient noncompliance|2|||
145949269|NCT01084538|526325212|FG000|Overall Study|Hyperphosphatemia|2|||
145949270|NCT01084538|526325212|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
145949271|NCT01084538|526325212|FG000|Overall Study|Change of residence|2|||
145949272|NCT01084538|526325212|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
145949273|NCT01084538|526325212|FG000|Overall Study|Reason unknown|8|||
145949274|NCT01429441|526325213|FG000|Overall Study|Adverse Event|5|||
145949275|NCT01429441|526325214|FG001|Overall Study|Adverse Event|1|||
145949276|NCT01429441|526325213|FG000|Overall Study|Death|0|||
145949277|NCT01429441|526325214|FG001|Overall Study|Death|2|||
146082619|NCT00545129|526822853|FG000|Overall Study|Adverse Event|1|||
146196552|NCT01280591|527231181|FG003|Overall Study|Withdrawal by Subject|2|||
146196553|NCT01280591|527231178|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
146196554|NCT01280591|527231179|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
146196555|NCT01280591|527231180|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
145949278|NCT01429441|526325213|FG000|Overall Study|Lost to Follow-up|5|||
145949279|NCT01429441|526325214|FG001|Overall Study|Lost to Follow-up|2|||
145949280|NCT01429441|526325213|FG000|Overall Study|Physician Decision|1|||
145949281|NCT01429441|526325214|FG001|Overall Study|Physician Decision|0|||
145949282|NCT01429441|526325213|FG000|Overall Study|Withdrawal by Subject|27|||
145949283|NCT01429441|526325214|FG001|Overall Study|Withdrawal by Subject|18|||
145949284|NCT00803205|526325219|FG000|Overall Study|Adverse Event|7|||
145949285|NCT00803205|526325220|FG001|Overall Study|Adverse Event|2|||
145949286|NCT00803205|526325219|FG000|Overall Study|Lost to Follow-up|1|||
145949287|NCT00803205|526325220|FG001|Overall Study|Lost to Follow-up|0|||
145949288|NCT00803205|526325219|FG000|Overall Study|Withdrawal by Subject|9|||
146196556|NCT01280591|527231181|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
146196557|NCT02263508|527231182|FG000|Overall Study|Withdrawal by Subject|1|||
146196558|NCT02263508|527231183|FG001|Overall Study|Withdrawal by Subject|23|||
146196559|NCT02263508|527231184|FG002|Overall Study|Withdrawal by Subject|17|||
146196560|NCT02263508|527231182|FG000|Overall Study|Sponsor Decision|12|||
146196561|NCT02263508|527231183|FG001|Overall Study|Sponsor Decision|165|||
146196562|NCT02263508|527231184|FG002|Overall Study|Sponsor Decision|182|||
146196563|NCT02263508|527231182|FG000|Overall Study|Lost to Follow-up|2|||
146196564|NCT02263508|527231183|FG001|Overall Study|Lost to Follow-up|7|||
146196565|NCT02263508|527231184|FG002|Overall Study|Lost to Follow-up|7|||
146196566|NCT02263508|527231182|FG000|Overall Study|Death|6|||
146196567|NCT02263508|527231183|FG001|Overall Study|Death|151|||
146196568|NCT02263508|527231184|FG002|Overall Study|Death|140|||
146196569|NCT03265210|527231187|FG000|Overall Study|Withdrawal by Subject|7|||
146196570|NCT03265210|527231188|FG001|Overall Study|Withdrawal by Subject|9|||
146196571|NCT03265210|527231187|FG000|Overall Study|Lost to Follow-up|2|||
146196572|NCT03265210|527231188|FG001|Overall Study|Lost to Follow-up|0|||
146196573|NCT03265210|527231187|FG000|Overall Study|Physician Decision|2|||
146196574|NCT03265210|527231188|FG001|Overall Study|Physician Decision|0|||
146196575|NCT03265210|527231187|FG000|Overall Study|Adverse Event|1|||
146196576|NCT03265210|527231188|FG001|Overall Study|Adverse Event|0|||
146196577|NCT03357341|527231191|FG000|Overall Study|Withdrawal by Subject|3|||
146196578|NCT03357341|527231192|FG001|Overall Study|Withdrawal by Subject|6|||
146196579|NCT03357341|527231191|FG000|Overall Study|Lost to Follow-up|4|||
146196580|NCT03357341|527231192|FG001|Overall Study|Lost to Follow-up|5|||
146196581|NCT03357341|527231191|FG000|Overall Study|Death|0|||
146196582|NCT03357341|527231192|FG001|Overall Study|Death|1|||
146196583|NCT00686517|527231193|FG000|Treatment|Serious Adverse Event|1|||
146196584|NCT00686517|527231194|FG001|Treatment|Serious Adverse Event|2|||
146196585|NCT00686517|527231195|FG002|Treatment|Serious Adverse Event|1|||
146196586|NCT00686517|527231193|FG000|Treatment|Adverse Event|2|||
146196587|NCT00686517|527231194|FG001|Treatment|Adverse Event|0|||
146196588|NCT00686517|527231195|FG002|Treatment|Adverse Event|0|||
146196589|NCT00686517|527231193|FG000|Treatment|Poor Protocol Compliance|1|||
146196590|NCT00686517|527231194|FG001|Treatment|Poor Protocol Compliance|0|||
146196591|NCT00686517|527231195|FG002|Treatment|Poor Protocol Compliance|0|||
146196592|NCT00686517|527231193|FG000|Treatment|Protocol Violation|2|||
146196593|NCT00686517|527231194|FG001|Treatment|Protocol Violation|1|||
146196594|NCT00686517|527231195|FG002|Treatment|Protocol Violation|0|||
146196595|NCT01803646|527231198|FG000|Overall Study|Protocol Violation|1|||
146196596|NCT01803646|527231199|FG001|Overall Study|Protocol Violation|0|||
146196597|NCT01803646|527231198|FG000|Overall Study|Adverse Event|1|||
146196598|NCT01803646|527231199|FG001|Overall Study|Adverse Event|1|||
146196599|NCT01803646|527231198|FG000|Overall Study|Withdrawal by Subject|9|||
146196600|NCT01803646|527231199|FG001|Overall Study|Withdrawal by Subject|6|||
146196601|NCT01803646|527231198|FG000|Overall Study|Randomization error|1|||
146196602|NCT01803646|527231199|FG001|Overall Study|Randomization error|2|||
146196603|NCT01803646|527231198|FG000|Overall Study|Lost to Follow-up|5|||
146196604|NCT01803646|527231199|FG001|Overall Study|Lost to Follow-up|1|||
146196605|NCT01693614|527231201|FG000|Overall Study|Adverse Event|7|||
146196606|NCT01693614|527231202|FG001|Overall Study|Adverse Event|11|||
146196607|NCT01693614|527231203|FG002|Overall Study|Adverse Event|5|||
146196608|NCT01693614|527231201|FG000|Overall Study|Disease progression|11|||
146196609|NCT01693614|527231202|FG001|Overall Study|Disease progression|8|||
146196610|NCT01693614|527231203|FG002|Overall Study|Disease progression|7|||
146196611|NCT01693614|527231201|FG000|Overall Study|Protocol Violation|5|||
146196612|NCT01693614|527231202|FG001|Overall Study|Protocol Violation|2|||
146196613|NCT01693614|527231203|FG002|Overall Study|Protocol Violation|1|||
146196614|NCT01693614|527231201|FG000|Overall Study|Death|1|||
146196615|NCT01693614|527231202|FG001|Overall Study|Death|0|||
146196616|NCT01693614|527231203|FG002|Overall Study|Death|0|||
146196617|NCT01693614|527231201|FG000|Overall Study|Physician Decision|1|||
146196618|NCT01693614|527231202|FG001|Overall Study|Physician Decision|1|||
146196619|NCT01693614|527231203|FG002|Overall Study|Physician Decision|4|||
146196620|NCT01693614|527231201|FG000|Overall Study|Withdrawal by subject/guardian|0|||
146196621|NCT01693614|527231202|FG001|Overall Study|Withdrawal by subject/guardian|0|||
146196622|NCT01693614|527231203|FG002|Overall Study|Withdrawal by subject/guardian|2|||
146196623|NCT01693614|527231201|FG000|Overall Study|Withdrawal by Subject|1|||
146196624|NCT01693614|527231202|FG001|Overall Study|Withdrawal by Subject|0|||
146196625|NCT01693614|527231203|FG002|Overall Study|Withdrawal by Subject|5|||
146196626|NCT00420316|527231206|FG000|Overall Study|Withdrawal by Subject|0|||
146196627|NCT00420316|527231207|FG001|Overall Study|Withdrawal by Subject|1|||
146196628|NCT00420316|527231206|FG000|Overall Study|Lost to Follow-up|12|||
146196629|NCT00420316|527231207|FG001|Overall Study|Lost to Follow-up|8|||
146196630|NCT02281318|527231208|FG000|Overall Study|Adverse Event|2|||
146196631|NCT02281318|527231209|FG001|Overall Study|Adverse Event|2|||
146196632|NCT02281318|527231208|FG000|Overall Study|Lack of Efficacy|2|||
146196633|NCT02281318|527231209|FG001|Overall Study|Lack of Efficacy|0|||
146196634|NCT02281318|527231208|FG000|Overall Study|Lost to Follow-up|2|||
146196635|NCT02281318|527231209|FG001|Overall Study|Lost to Follow-up|1|||
145949289|NCT00803205|526325220|FG001|Overall Study|Withdrawal by Subject|9|||
146196636|NCT02281318|527231208|FG000|Overall Study|Physician Decision|2|||
146196637|NCT02281318|527231209|FG001|Overall Study|Physician Decision|0|||
146196638|NCT02281318|527231208|FG000|Overall Study|Withdrawal by Subject|6|||
146196639|NCT02281318|527231209|FG001|Overall Study|Withdrawal by Subject|2|||
146196640|NCT01368406|527231210|FG000|Overall Study|Lost to Follow-up|8|||
146196641|NCT01368406|527231211|FG001|Overall Study|Lost to Follow-up|4|||
146196642|NCT01368406|527231210|FG000|Overall Study|Withdrawal by Subject|8|||
146196643|NCT01368406|527231211|FG001|Overall Study|Withdrawal by Subject|4|||
146196644|NCT01368406|527231210|FG000|Overall Study|relapse of the disease|3|||
146196645|NCT01368406|527231211|FG001|Overall Study|relapse of the disease|2|||
146196646|NCT01368406|527231210|FG000|Overall Study|started working|2|||
146196647|NCT01368406|527231211|FG001|Overall Study|started working|3|||
146196648|NCT00957229|527231212|FG000|Study Start|Adverse Event|0|||
146196649|NCT00957229|527231213|FG001|Study Start|Adverse Event|3|||
146196650|NCT00957229|527231212|FG000|Study Start|Disease Progression|1|||
146196651|NCT00957229|527231213|FG001|Study Start|Disease Progression|0|||
146196652|NCT00957229|527231212|FG000|Reallocated to or Continued Vismodegib|Death|1|||
146196653|NCT00957229|527231213|FG001|Reallocated to or Continued Vismodegib|Death|1|||
146196654|NCT00957229|527231212|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
146196655|NCT00957229|527231213|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
146196656|NCT01833065|527231214|FG000|Overall Study|Adverse Event|6|||
146196657|NCT01833065|527231215|FG001|Overall Study|Adverse Event|1|||
146196658|NCT01833065|527231216|FG002|Overall Study|Adverse Event|0|||
146196659|NCT01833065|527231217|FG003|Overall Study|Adverse Event|2|||
146196660|NCT01833065|527231218|FG004|Overall Study|Adverse Event|3|||
146196661|NCT01833065|527231214|FG000|Overall Study|Protocol Violation|1|||
146196662|NCT01833065|527231215|FG001|Overall Study|Protocol Violation|0|||
146196663|NCT01833065|527231216|FG002|Overall Study|Protocol Violation|0|||
146196664|NCT01833065|527231217|FG003|Overall Study|Protocol Violation|0|||
146196665|NCT01833065|527231218|FG004|Overall Study|Protocol Violation|2|||
146196666|NCT01833065|527231214|FG000|Overall Study|Lost to Follow-up|1|||
146196667|NCT01833065|527231215|FG001|Overall Study|Lost to Follow-up|0|||
146196668|NCT01833065|527231216|FG002|Overall Study|Lost to Follow-up|0|||
146196669|NCT01833065|527231217|FG003|Overall Study|Lost to Follow-up|0|||
146196670|NCT01833065|527231218|FG004|Overall Study|Lost to Follow-up|3|||
146196671|NCT01833065|527231214|FG000|Overall Study|Withdrawal by Subject|6|||
146196672|NCT01833065|527231215|FG001|Overall Study|Withdrawal by Subject|2|||
146196673|NCT01833065|527231216|FG002|Overall Study|Withdrawal by Subject|4|||
146196674|NCT01833065|527231217|FG003|Overall Study|Withdrawal by Subject|3|||
146196675|NCT01833065|527231218|FG004|Overall Study|Withdrawal by Subject|11|||
146196676|NCT01833065|527231214|FG000|Overall Study|Subject's substantial non-compliance|0|||
146196677|NCT01833065|527231215|FG001|Overall Study|Subject's substantial non-compliance|1|||
146196678|NCT01833065|527231216|FG002|Overall Study|Subject's substantial non-compliance|0|||
146196679|NCT01833065|527231217|FG003|Overall Study|Subject's substantial non-compliance|0|||
146196680|NCT01833065|527231218|FG004|Overall Study|Subject's substantial non-compliance|0|||
146196681|NCT01833065|527231214|FG000|Overall Study|Trial terminated by sponsor|8|||
146196682|NCT01833065|527231215|FG001|Overall Study|Trial terminated by sponsor|8|||
146196683|NCT01833065|527231216|FG002|Overall Study|Trial terminated by sponsor|7|||
146196684|NCT01833065|527231217|FG003|Overall Study|Trial terminated by sponsor|3|||
146196685|NCT01833065|527231218|FG004|Overall Study|Trial terminated by sponsor|13|||
146196686|NCT01833065|527231214|FG000|Overall Study|Others|2|||
146196687|NCT01833065|527231215|FG001|Overall Study|Others|1|||
146196688|NCT01833065|527231216|FG002|Overall Study|Others|1|||
146196689|NCT01833065|527231217|FG003|Overall Study|Others|1|||
146196690|NCT01833065|527231218|FG004|Overall Study|Others|4|||
146196691|NCT00828672|527231219|FG000|Study Treatment|Lost to Follow-up|1|||
146196692|NCT00828672|527231220|FG001|Study Treatment|Lost to Follow-up|0|||
146196693|NCT00828672|527231219|FG000|Study Treatment|Adverse Event|0|||
146196694|NCT00828672|527231220|FG001|Study Treatment|Adverse Event|1|||
146196695|NCT00828672|527231219|FG000|Study Treatment|Complete response, no surgery|1|||
146196696|NCT00828672|527231220|FG001|Study Treatment|Complete response, no surgery|1|||
146196697|NCT00828672|527231219|FG000|Post-surgery (<30 Days)|No central review materials|0|||
146196698|NCT00828672|527231220|FG001|Post-surgery (<30 Days)|No central review materials|1|||
146196699|NCT00906698|527231221|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
146196700|NCT00906698|527231222|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
146196701|NCT00906698|527231223|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
146196702|NCT00906698|527231224|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
146196703|NCT00906698|527231225|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
146196704|NCT00906698|527231226|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
146196705|NCT00906698|527231221|FG000|Overall Study|Adverse Event|0|||
146196706|NCT00906698|527231222|FG001|Overall Study|Adverse Event|0|||
146196707|NCT00906698|527231223|FG002|Overall Study|Adverse Event|2|||
146196708|NCT00906698|527231224|FG003|Overall Study|Adverse Event|0|||
146196709|NCT00906698|527231225|FG004|Overall Study|Adverse Event|4|||
146196710|NCT00906698|527231226|FG005|Overall Study|Adverse Event|1|||
146196711|NCT00906698|527231221|FG000|Overall Study|Disease progression|3|||
146196712|NCT00906698|527231222|FG001|Overall Study|Disease progression|12|||
146196713|NCT00906698|527231223|FG002|Overall Study|Disease progression|4|||
146196714|NCT00906698|527231224|FG003|Overall Study|Disease progression|4|||
146196715|NCT00906698|527231225|FG004|Overall Study|Disease progression|12|||
146196716|NCT00906698|527231226|FG005|Overall Study|Disease progression|4|||
146196717|NCT00906698|527231221|FG000|Overall Study|Withdrawal by Subject|0|||
146196718|NCT00906698|527231222|FG001|Overall Study|Withdrawal by Subject|0|||
146196719|NCT00906698|527231223|FG002|Overall Study|Withdrawal by Subject|0|||
146196720|NCT00906698|527231224|FG003|Overall Study|Withdrawal by Subject|0|||
146196721|NCT00906698|527231225|FG004|Overall Study|Withdrawal by Subject|1|||
146196722|NCT00906698|527231226|FG005|Overall Study|Withdrawal by Subject|0|||
146196723|NCT00906698|527231221|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
146196724|NCT00906698|527231222|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
146196725|NCT00906698|527231223|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
146196726|NCT00906698|527231224|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
146196727|NCT00906698|527231225|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
146196728|NCT00906698|527231226|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
146196729|NCT00001575|527231234|FG000|Overall Study|Screening failures-Ph I portion|22|||
146196730|NCT00001575|527231234|FG000|Overall Study|Withdrawn/deaths|23|||
146196731|NCT00831792|527231235|FG000|Overall Study|Not Eligible|3|||
146196732|NCT00831792|527231235|FG000|Overall Study|Adverse Event|1|||
146196733|NCT00831792|527231235|FG000|Overall Study|Death|1|||
146196734|NCT00831792|527231235|FG000|Overall Study|Lack of Efficacy|1|||
146196735|NCT01242085|527231236|FG000|Overall Study|Withdrawal by Subject|4|||
146196736|NCT01242085|527231237|FG001|Overall Study|Withdrawal by Subject|2|||
146196737|NCT01242085|527231238|FG002|Overall Study|Withdrawal by Subject|0|||
146196738|NCT01242085|527231236|FG000|Overall Study|medically unable to have surgery|4|||
146196739|NCT01242085|527231237|FG001|Overall Study|medically unable to have surgery|5|||
146196740|NCT01242085|527231238|FG002|Overall Study|medically unable to have surgery|0|||
146196741|NCT01178762|527231239|FG000|Overall Study|Lost to Follow-up|15|||
146196742|NCT02377362|527231240|FG000|Part A Second Treatment|Protocol Violation|0|||
146196743|NCT02377362|527231241|FG001|Part A Second Treatment|Protocol Violation|0|||
146196744|NCT02377362|527231242|FG002|Part A Second Treatment|Protocol Violation|0|||
146196745|NCT02377362|527231243|FG003|Part A Second Treatment|Protocol Violation|0|||
146196746|NCT02377362|527231244|FG004|Part A Second Treatment|Protocol Violation|1|||
146196747|NCT02377362|527231245|FG005|Part A Second Treatment|Protocol Violation|0|||
146196748|NCT02377362|527231246|FG006|Part A Second Treatment|Protocol Violation|0|||
146196749|NCT02377362|527231247|FG007|Part A Second Treatment|Protocol Violation|0|||
146196750|NCT02377362|527231248|FG008|Part A Second Treatment|Protocol Violation|0|||
146196751|NCT02377362|527231249|FG009|Part A Second Treatment|Protocol Violation|0|||
146196752|NCT02377362|527231250|FG010|Part A Second Treatment|Protocol Violation|0|||
146196753|NCT02377362|527231251|FG011|Part A Second Treatment|Protocol Violation|0|||
146196754|NCT02377362|527231252|FG012|Part A Second Treatment|Protocol Violation|0|||
146196755|NCT02377362|527231240|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196756|NCT02377362|527231241|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196757|NCT02377362|527231242|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196758|NCT02377362|527231243|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
146196759|NCT02377362|527231244|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
146196760|NCT02377362|527231245|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
146196761|NCT02377362|527231246|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196762|NCT02377362|527231247|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196763|NCT02377362|527231248|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196764|NCT02377362|527231249|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196765|NCT02377362|527231250|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196766|NCT02377362|527231251|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196767|NCT02377362|527231252|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
146196768|NCT02377362|527231240|FG000|Part B Overall|Protocol Violation|0|||
146196769|NCT02377362|527231241|FG001|Part B Overall|Protocol Violation|0|||
146196770|NCT02377362|527231242|FG002|Part B Overall|Protocol Violation|0|||
146196771|NCT02377362|527231243|FG003|Part B Overall|Protocol Violation|0|||
146196772|NCT02377362|527231244|FG004|Part B Overall|Protocol Violation|0|||
146196773|NCT02377362|527231245|FG005|Part B Overall|Protocol Violation|0|||
146196774|NCT02377362|527231246|FG006|Part B Overall|Protocol Violation|0|||
146196775|NCT02377362|527231247|FG007|Part B Overall|Protocol Violation|0|||
146196776|NCT02377362|527231248|FG008|Part B Overall|Protocol Violation|0|||
146196777|NCT02377362|527231249|FG009|Part B Overall|Protocol Violation|1|||
146196778|NCT02377362|527231250|FG010|Part B Overall|Protocol Violation|0|||
146196779|NCT02377362|527231251|FG011|Part B Overall|Protocol Violation|0|||
146196780|NCT02377362|527231252|FG012|Part B Overall|Protocol Violation|0|||
146196781|NCT02377362|527231240|FG000|Part B Overall|Adverse Event|0|||
146196782|NCT02377362|527231241|FG001|Part B Overall|Adverse Event|0|||
146196783|NCT02377362|527231242|FG002|Part B Overall|Adverse Event|0|||
146196784|NCT02377362|527231243|FG003|Part B Overall|Adverse Event|0|||
146196785|NCT02377362|527231244|FG004|Part B Overall|Adverse Event|0|||
146196786|NCT02377362|527231245|FG005|Part B Overall|Adverse Event|0|||
146196787|NCT02377362|527231246|FG006|Part B Overall|Adverse Event|1|||
146196788|NCT02377362|527231247|FG007|Part B Overall|Adverse Event|1|||
146196789|NCT02377362|527231248|FG008|Part B Overall|Adverse Event|0|||
146196790|NCT02377362|527231249|FG009|Part B Overall|Adverse Event|0|||
146196791|NCT02377362|527231250|FG010|Part B Overall|Adverse Event|0|||
146196792|NCT02377362|527231251|FG011|Part B Overall|Adverse Event|0|||
146196793|NCT02377362|527231252|FG012|Part B Overall|Adverse Event|0|||
146196794|NCT02377362|527231240|FG000|Part B Overall|Withdrawal by Subject|0|||
146196795|NCT02377362|527231241|FG001|Part B Overall|Withdrawal by Subject|0|||
146196796|NCT02377362|527231242|FG002|Part B Overall|Withdrawal by Subject|0|||
146196797|NCT02377362|527231243|FG003|Part B Overall|Withdrawal by Subject|0|||
146196798|NCT02377362|527231244|FG004|Part B Overall|Withdrawal by Subject|0|||
146196799|NCT02377362|527231245|FG005|Part B Overall|Withdrawal by Subject|0|||
146196800|NCT02377362|527231246|FG006|Part B Overall|Withdrawal by Subject|1|||
146196801|NCT02377362|527231247|FG007|Part B Overall|Withdrawal by Subject|0|||
146196802|NCT02377362|527231248|FG008|Part B Overall|Withdrawal by Subject|0|||
146196803|NCT02377362|527231249|FG009|Part B Overall|Withdrawal by Subject|0|||
146196804|NCT02377362|527231250|FG010|Part B Overall|Withdrawal by Subject|0|||
146196805|NCT02377362|527231251|FG011|Part B Overall|Withdrawal by Subject|1|||
146196806|NCT02377362|527231252|FG012|Part B Overall|Withdrawal by Subject|0|||
146196807|NCT02322216|527231255|FG000|Overall Study|Adverse Event|1|||
146196808|NCT02322216|527231256|FG001|Overall Study|Adverse Event|0|||
146196809|NCT02322216|527231255|FG000|Overall Study|Withdrawal by Subject|1|||
146196810|NCT02322216|527231256|FG001|Overall Study|Withdrawal by Subject|4|||
146196811|NCT01651949|527231258|FG000|Overall Study|Unknown status|4|||
146196812|NCT01651949|527231259|FG001|Overall Study|Unknown status|4|||
146196813|NCT01651949|527231260|FG002|Overall Study|Unknown status|0|||
146196814|NCT01651949|527231258|FG000|Overall Study|Lost to Follow-up|30|||
146196815|NCT01651949|527231259|FG001|Overall Study|Lost to Follow-up|56|||
146196816|NCT01651949|527231260|FG002|Overall Study|Lost to Follow-up|20|||
146196817|NCT01651949|527231258|FG000|Overall Study|Protocol Violation|0|||
146196818|NCT01651949|527231259|FG001|Overall Study|Protocol Violation|2|||
146196819|NCT01651949|527231260|FG002|Overall Study|Protocol Violation|1|||
146196820|NCT01651949|527231258|FG000|Overall Study|Physician Decision|0|||
146196821|NCT01651949|527231259|FG001|Overall Study|Physician Decision|2|||
146196822|NCT01651949|527231260|FG002|Overall Study|Physician Decision|0|||
146196823|NCT01651949|527231258|FG000|Overall Study|Adverse Event|0|||
146196824|NCT01651949|527231259|FG001|Overall Study|Adverse Event|2|||
146196825|NCT01651949|527231260|FG002|Overall Study|Adverse Event|1|||
146196826|NCT01651949|527231258|FG000|Overall Study|Screen failure|2|||
146196827|NCT01651949|527231259|FG001|Overall Study|Screen failure|2|||
146196828|NCT01651949|527231260|FG002|Overall Study|Screen failure|0|||
146196829|NCT01651949|527231258|FG000|Overall Study|Withdrawal by Subject|17|||
146196830|NCT01651949|527231259|FG001|Overall Study|Withdrawal by Subject|18|||
146196831|NCT01651949|527231260|FG002|Overall Study|Withdrawal by Subject|9|||
146196832|NCT01191086|527231261|FG000|Overall Study|Adverse Event|20|||
146196833|NCT01191086|527231261|FG000|Overall Study|Lack of Efficacy|10|||
145949290|NCT00803205|526325219|FG000|Overall Study|Physician Decision|1|||
146196834|NCT01191086|527231261|FG000|Overall Study|Lost to Follow-up|4|||
146196835|NCT01191086|527231261|FG000|Overall Study|Physician Decision|2|||
146196836|NCT01191086|527231261|FG000|Overall Study|Withdrawal by Subject|24|||
146196837|NCT01191086|527231261|FG000|Overall Study|Discontinuation criterion met|1|||
146196838|NCT01191086|527231261|FG000|Overall Study|Other|1|||
146196839|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
146196840|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
146196841|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
146196842|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
146196843|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
146196844|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
146196845|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
146196846|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
146196847|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
146196848|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
146196849|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
146196850|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
146196851|NCT02057718|527231264|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
146196852|NCT02057718|527231265|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
146196853|NCT02057718|527231264|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
146196854|NCT02057718|527231265|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
146196855|NCT02057718|527231264|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
146196856|NCT02057718|527231265|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
146196857|NCT02057718|527231264|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
146196858|NCT02057718|527231265|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
146196859|NCT02057718|527231264|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
146196860|NCT02057718|527231265|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
146196861|NCT00906035|527231270|FG000|Overall Study|Withdrawal by Subject|2|||
146196862|NCT00906035|527231271|FG001|Overall Study|Withdrawal by Subject|3|||
146196863|NCT00906035|527231272|FG002|Overall Study|Withdrawal by Subject|0|||
146196864|NCT00835380|527231273|FG000|Overall Study|Withdrawal by Subject|2|||
146196865|NCT01582945|527231274|FG000|Overall Study|Intolerable side-effects|1|||
146196866|NCT01582945|527231274|FG000|Overall Study|Scheduling conflicts|1|||
146196867|NCT04858425|527231277|FG000|Overall Study|Adverse Event|2|||
146196868|NCT04858425|527231278|FG001|Overall Study|Adverse Event|2|||
146196869|NCT04858425|527231277|FG000|Overall Study|Withdrawal by Subject|3|||
146196870|NCT04858425|527231278|FG001|Overall Study|Withdrawal by Subject|1|||
146196871|NCT04858425|527231277|FG000|Overall Study|Lost to Follow-up|4|||
146196872|NCT04858425|527231278|FG001|Overall Study|Lost to Follow-up|2|||
146196873|NCT04858425|527231277|FG000|Overall Study|Lost to Follow-up|1|||
146196874|NCT04858425|527231278|FG001|Overall Study|Lost to Follow-up|0|||
146196875|NCT04536077|527231280|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
146196876|NCT04536077|527231281|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
146196877|NCT04536077|527231280|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
146196878|NCT04536077|527231281|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
146196879|NCT04550039|527231286|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
146196880|NCT04550039|527231287|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
146196881|NCT04550039|527231286|FG000|Overall Study|patient self-withdrew from study|0|||
146196882|NCT04550039|527231287|FG001|Overall Study|patient self-withdrew from study|1|||
146196883|NCT01155869|527231293|FG000|Overall Study|Lost to Follow-up|3|||
146196884|NCT01155869|527231294|FG001|Overall Study|Lost to Follow-up|1|||
146196885|NCT02824432|527231298|FG000|Overall Study|Major Protocol Deviation|1|||
146196886|NCT02824432|527231299|FG001|Overall Study|Major Protocol Deviation|0|||
146196887|NCT05824351|527231300|FG000|Overall Study|Adverse Event|6|||
146196888|NCT00828945|527231301|FG000|Overall Study|Death|4|||
146196889|NCT00828945|527231301|FG000|Overall Study|Participant was missing|1|||
146196890|NCT00828945|527231301|FG000|Overall Study|Other|36|||
146196891|NCT02698241|527231304|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
146196892|NCT02698241|527231304|FG000|Overall Study|Screening not met|7|||
146196893|NCT02698241|527231304|FG000|Overall Study|Withdrawal by Subject|7|||
146196894|NCT02698241|527231304|FG000|Overall Study|Physician Decision|2|||
146196895|NCT02698241|527231304|FG000|Overall Study|Subject underwent system modification|2|||
146196896|NCT02698241|527231304|FG000|Overall Study|Lost to Follow-up|3|||
146196897|NCT02698241|527231304|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
146196898|NCT02698241|527231304|FG000|Overall Study|geographic and licensing issue|1|||
146196899|NCT02698241|527231304|FG000|Overall Study|Death|2|||
146196900|NCT01543685|527231305|FG000|Overall Study|Lack of Efficacy|1|||
146196901|NCT01543685|527231306|FG001|Overall Study|Lack of Efficacy|2|||
146196902|NCT01543685|527231307|FG002|Overall Study|Lack of Efficacy|2|||
146196903|NCT01543685|527231308|FG003|Overall Study|Lack of Efficacy|0|||
146196904|NCT01543685|527231309|FG004|Overall Study|Lack of Efficacy|2|||
146196905|NCT01543685|527231305|FG000|Overall Study|Adverse Event|2|||
146196906|NCT01543685|527231306|FG001|Overall Study|Adverse Event|1|||
146196907|NCT01543685|527231307|FG002|Overall Study|Adverse Event|0|||
146196908|NCT01543685|527231308|FG003|Overall Study|Adverse Event|0|||
146196909|NCT01543685|527231309|FG004|Overall Study|Adverse Event|2|||
146196910|NCT00708097|527231312|FG000|Period 1|Protocol Violation|0|||
146196911|NCT00708097|527231313|FG001|Period 1|Protocol Violation|1|||
146196912|NCT00708097|527231314|FG002|Period 1|Protocol Violation|0|||
146196913|NCT00708097|527231315|FG003|Period 1|Protocol Violation|2|||
146196914|NCT00708097|527231316|FG004|Period 1|Protocol Violation|0|||
146196915|NCT00708097|527231312|FG000|Period 1|Other Reason|0|||
146196916|NCT00708097|527231313|FG001|Period 1|Other Reason|0|||
146196917|NCT00708097|527231314|FG002|Period 1|Other Reason|0|||
146196918|NCT00708097|527231315|FG003|Period 1|Other Reason|0|||
146196919|NCT00708097|527231316|FG004|Period 1|Other Reason|1|||
146196920|NCT00708097|527231312|FG000|Period 2|Protocol Violation|0|||
146196921|NCT00708097|527231313|FG001|Period 2|Protocol Violation|1|||
146196922|NCT00708097|527231314|FG002|Period 2|Protocol Violation|1|||
146196923|NCT00708097|527231315|FG003|Period 2|Protocol Violation|1|||
146196924|NCT00708097|527231316|FG004|Period 2|Protocol Violation|0|||
146196925|NCT00603447|527231317|FG000|Overall Study|Adverse Event|0|||
146196926|NCT00603447|527231318|FG001|Overall Study|Adverse Event|1|||
146196927|NCT00603447|527231319|FG002|Overall Study|Adverse Event|1|||
146196928|NCT00603447|527231320|FG003|Overall Study|Adverse Event|2|||
146196929|NCT00603447|527231321|FG004|Overall Study|Adverse Event|1|||
146196930|NCT00603447|527231322|FG005|Overall Study|Adverse Event|2|||
146196931|NCT00603447|527231323|FG006|Overall Study|Adverse Event|10|||
146196932|NCT00603447|527231317|FG000|Overall Study|Other|0|||
146196933|NCT00603447|527231318|FG001|Overall Study|Other|0|||
146196934|NCT00603447|527231319|FG002|Overall Study|Other|1|||
146196935|NCT00603447|527231320|FG003|Overall Study|Other|0|||
146196936|NCT00603447|527231321|FG004|Overall Study|Other|3|||
146196937|NCT00603447|527231322|FG005|Overall Study|Other|0|||
146196938|NCT00603447|527231323|FG006|Overall Study|Other|13|||
146196939|NCT00603447|527231317|FG000|Overall Study|Withdrew Consent|0|||
146196940|NCT00603447|527231318|FG001|Overall Study|Withdrew Consent|2|||
146196941|NCT00603447|527231319|FG002|Overall Study|Withdrew Consent|0|||
146196942|NCT00603447|527231320|FG003|Overall Study|Withdrew Consent|0|||
146196943|NCT00603447|527231321|FG004|Overall Study|Withdrew Consent|1|||
146196944|NCT00603447|527231322|FG005|Overall Study|Withdrew Consent|0|||
146196945|NCT00603447|527231323|FG006|Overall Study|Withdrew Consent|1|||
146196946|NCT01838200|527231324|FG000|Overall Study|Adverse Event|0|||
146196947|NCT01838200|527231325|FG001|Overall Study|Adverse Event|2|||
146196948|NCT01838200|527231324|FG000|Overall Study|Progressive disease|3|||
146196949|NCT01838200|527231325|FG001|Overall Study|Progressive disease|0|||
146196950|NCT01875250|527232698|FG000|Overall Study|Adverse Event|2|||
146196951|NCT01875250|527232699|FG001|Overall Study|Adverse Event|0|||
146196952|NCT00482729|527232702|FG000|Overall Study|Adverse Event|29|||
146196953|NCT00482729|527232703|FG001|Overall Study|Adverse Event|33|||
146196954|NCT00482729|527232702|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
146196955|NCT00482729|527232703|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
146196956|NCT00482729|527232702|FG000|Overall Study|Hyperglycemia Criteria|7|||
146196957|NCT00482729|527232703|FG001|Overall Study|Hyperglycemia Criteria|5|||
146196958|NCT00482729|527232702|FG000|Overall Study|Lack of Efficacy|4|||
146196959|NCT00482729|527232703|FG001|Overall Study|Lack of Efficacy|16|||
146196960|NCT00482729|527232702|FG000|Overall Study|Lost to Follow-up|86|||
146196961|NCT00482729|527232703|FG001|Overall Study|Lost to Follow-up|66|||
146196962|NCT00482729|527232702|FG000|Overall Study|Physician Decision|10|||
146196963|NCT00482729|527232703|FG001|Overall Study|Physician Decision|7|||
146196964|NCT00482729|527232702|FG000|Overall Study|Pregnancy|4|||
146196965|NCT00482729|527232703|FG001|Overall Study|Pregnancy|2|||
146196966|NCT00482729|527232702|FG000|Overall Study|Protocol Violation|10|||
146196967|NCT00482729|527232703|FG001|Overall Study|Protocol Violation|18|||
146196968|NCT00482729|527232702|FG000|Overall Study|Withdrawal by Subject|67|||
146196969|NCT00482729|527232703|FG001|Overall Study|Withdrawal by Subject|69|||
146196970|NCT03140176|527232704|FG000|Overall Study|Reason missing|23|||
146196971|NCT03140176|527232704|FG000|Overall Study|Death|33|||
146196972|NCT03140176|527232704|FG000|Overall Study|Disease progression|1|||
146196973|NCT03140176|527232704|FG000|Overall Study|Physician Decision|1|||
146196974|NCT03140176|527232704|FG000|Overall Study|Withdrawal by Subject|1|||
146196975|NCT03140176|527232704|FG000|Overall Study|Lost to Follow-up|15|||
146196976|NCT00470626|527232707|FG000|Overall Study|Lost to Follow-up|10|||
146196977|NCT00470626|527232707|FG000|Overall Study|Withdrawal by Subject|7|||
146196978|NCT02689349|527232708|FG000|Overall Study|Not implanted|4|||
146196979|NCT02689349|527232709|FG001|Overall Study|Not implanted|0|||
146196980|NCT02689349|527232708|FG000|Overall Study|Withdrawal by Subject|9|||
146196981|NCT02689349|527232709|FG001|Overall Study|Withdrawal by Subject|0|||
146196982|NCT02930343|527232710|FG000|Overall Study|Lost to Follow-up|9|||
146196983|NCT02930343|527232711|FG001|Overall Study|Lost to Follow-up|7|||
146196984|NCT00486759|527232712|FG000|Treatment|Adverse event/intercurrent illness|86|||
146196985|NCT00486759|527232713|FG001|Treatment|Adverse event/intercurrent illness|39|||
146196986|NCT00486759|527232712|FG000|Treatment|Insufficient therapeutic response|37|||
146196987|NCT00486759|527232713|FG001|Treatment|Insufficient therapeutic response|39|||
146196988|NCT00486759|527232712|FG000|Treatment|Death|17|||
146196989|NCT00486759|527232713|FG001|Treatment|Death|10|||
146196990|NCT00486759|527232712|FG000|Treatment|Withdrew consent|15|||
146196991|NCT00486759|527232713|FG001|Treatment|Withdrew consent|12|||
146196992|NCT00486759|527232712|FG000|Treatment|Administrative/reason not specified|17|||
146196993|NCT00486759|527232713|FG001|Treatment|Administrative/reason not specified|21|||
146196994|NCT00486759|527232712|FG000|Treatment|Refused treatment|10|||
146196995|NCT00486759|527232713|FG001|Treatment|Refused treatment|7|||
146196996|NCT00486759|527232712|FG000|Treatment|Violation of selection criteria at entry|3|||
146196997|NCT00486759|527232713|FG001|Treatment|Violation of selection criteria at entry|3|||
146196998|NCT00486759|527232712|FG000|Treatment|Other protocol violation|1|||
145949291|NCT00803205|526325220|FG001|Overall Study|Physician Decision|0|||
145949292|NCT00803205|526325219|FG000|Overall Study|Protocol Violation|1|||
145949293|NCT00803205|526325220|FG001|Overall Study|Protocol Violation|1|||
145949294|NCT00803205|526325219|FG000|Overall Study|Medical Monitor Decision|1|||
145949295|NCT00803205|526325220|FG001|Overall Study|Medical Monitor Decision|0|||
146082620|NCT00545129|526822854|FG001|Overall Study|Adverse Event|1|||
146082621|NCT00545129|526822853|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
146082622|NCT00545129|526822854|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
146082623|NCT00545129|526822853|FG000|Overall Study|Other|3|||
146082624|NCT00545129|526822854|FG001|Overall Study|Other|3|||
146196999|NCT00486759|527232713|FG001|Treatment|Other protocol violation|5|||
146197000|NCT00486759|527232712|FG000|Treatment|Failure to return|1|||
146197001|NCT00486759|527232713|FG001|Treatment|Failure to return|1|||
146197002|NCT00486759|527232712|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
146197003|NCT00486759|527232713|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
146197004|NCT00486759|527232712|FG000|Safety Follow-up|Death|40|||
146197005|NCT00486759|527232713|FG001|Safety Follow-up|Death|29|||
146197006|NCT00486759|527232712|FG000|Safety Follow-up|Withdrew consent|32|||
146197007|NCT00486759|527232713|FG001|Safety Follow-up|Withdrew consent|23|||
146197008|NCT00486759|527232712|FG000|Safety Follow-up|Failure to return|9|||
146197009|NCT00486759|527232713|FG001|Safety Follow-up|Failure to return|6|||
146197010|NCT00486759|527232712|FG000|Safety Follow-up|Administrative/not specified|8|||
146197011|NCT00486759|527232713|FG001|Safety Follow-up|Administrative/not specified|6|||
146197012|NCT00486759|527232712|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
146197013|NCT00486759|527232713|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
146197014|NCT00486759|527232712|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
146197015|NCT00486759|527232713|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
146197016|NCT01025843|527232714|FG000|Washout 4|Withdrawal by Subject|0|||
146197017|NCT01025843|527232715|FG001|Washout 4|Withdrawal by Subject|0|||
146197018|NCT01025843|527232716|FG002|Washout 4|Withdrawal by Subject|1|||
146197019|NCT01025843|527232717|FG003|Washout 4|Withdrawal by Subject|1|||
146197020|NCT01025843|527232718|FG004|Washout 4|Withdrawal by Subject|0|||
146197021|NCT01025843|527232719|FG005|Washout 4|Withdrawal by Subject|0|||
146197022|NCT01025843|527232720|FG006|Washout 4|Withdrawal by Subject|0|||
146197023|NCT01025843|527232721|FG007|Washout 4|Withdrawal by Subject|0|||
146197024|NCT01025843|527232722|FG008|Washout 4|Withdrawal by Subject|0|||
146197025|NCT01025843|527232723|FG009|Washout 4|Withdrawal by Subject|0|||
146197026|NCT03646669|527232728|FG000|Overall Study|Withdrawal by Subject|5|||
146197027|NCT03646669|527232729|FG001|Overall Study|Withdrawal by Subject|0|||
146197028|NCT00377455|527232730|FG000|Overall Study|Withdrawal by Subject|1|||
146197029|NCT00309452|527232731|FG000|Overall Study|Withdrawal by Subject|3|||
146197030|NCT00309452|527232732|FG001|Overall Study|Withdrawal by Subject|0|||
146197031|NCT02814643|527232735|FG000|Overall Study|Lost to Follow-up|0|||
146197032|NCT02814643|527232736|FG001|Overall Study|Lost to Follow-up|1|||
146197033|NCT02814643|527232735|FG000|Overall Study|Withdrawal by Subject|1|||
146197034|NCT02814643|527232736|FG001|Overall Study|Withdrawal by Subject|2|||
146197035|NCT01883492|527232739|FG000|Overall Study|Lost to Follow-up|3|||
146197036|NCT01883492|527232740|FG001|Overall Study|Lost to Follow-up|4|||
146197037|NCT01883492|527232739|FG000|Overall Study|Surgery on contra-lateral hip|0|||
146197038|NCT01883492|527232740|FG001|Overall Study|Surgery on contra-lateral hip|1|||
146197039|NCT01883492|527232739|FG000|Overall Study|Poor X-ray quality|7|||
146197040|NCT01883492|527232740|FG001|Overall Study|Poor X-ray quality|4|||
146197041|NCT01883492|527232739|FG000|Overall Study|Withdrawal by Subject|1|||
146197042|NCT01883492|527232740|FG001|Overall Study|Withdrawal by Subject|0|||
146197043|NCT01883492|527232739|FG000|Overall Study|inappropriate implant used|1|||
146197044|NCT01883492|527232740|FG001|Overall Study|inappropriate implant used|1|||
146197045|NCT01883492|527232739|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
146197046|NCT01883492|527232740|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
146197047|NCT01281813|527232741|FG000|Overall Study|Adverse Event|0|||
146197048|NCT01281813|527232742|FG001|Overall Study|Adverse Event|0|||
146197049|NCT01281813|527232743|FG002|Overall Study|Adverse Event|10|||
146197050|NCT01281813|527232741|FG000|Overall Study|Lost to Follow-up|0|||
146197051|NCT01281813|527232742|FG001|Overall Study|Lost to Follow-up|0|||
146197052|NCT01281813|527232743|FG002|Overall Study|Lost to Follow-up|31|||
146197053|NCT01281813|527232741|FG000|Overall Study|Withdrawal by Subject|0|||
146197054|NCT01281813|527232742|FG001|Overall Study|Withdrawal by Subject|0|||
146197055|NCT01281813|527232743|FG002|Overall Study|Withdrawal by Subject|13|||
146197056|NCT01281813|527232741|FG000|Overall Study|Subject Non-Compliant|0|||
146197057|NCT01281813|527232742|FG001|Overall Study|Subject Non-Compliant|0|||
146197058|NCT01281813|527232743|FG002|Overall Study|Subject Non-Compliant|6|||
146197059|NCT01281813|527232741|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
146197060|NCT01281813|527232742|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
146197061|NCT01281813|527232743|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
146197062|NCT01281813|527232741|FG000|Overall Study|Sponsor's Decision|4|||
146082625|NCT00821509|526822855|FG000|Overall Study|Withdrawal by Subject|12|||
146197063|NCT01281813|527232742|FG001|Overall Study|Sponsor's Decision|3|||
146197064|NCT01281813|527232743|FG002|Overall Study|Sponsor's Decision|7|||
146197065|NCT01281813|527232741|FG000|Overall Study|Switched to Commercially Available Medication|0|||
146197066|NCT01281813|527232742|FG001|Overall Study|Switched to Commercially Available Medication|0|||
146197067|NCT01281813|527232743|FG002|Overall Study|Switched to Commercially Available Medication|26|||
146197068|NCT01281813|527232741|FG000|Overall Study|Other|0|||
146197069|NCT01281813|527232742|FG001|Overall Study|Other|1|||
146197070|NCT01281813|527232743|FG002|Overall Study|Other|39|||
146197071|NCT05257798|527232744|FG000|Follow-up Phase|Lost to Follow-up|1|||
146197072|NCT05257798|527232745|FG001|Follow-up Phase|Lost to Follow-up|0|||
146197073|NCT02614560|527232748|FG000|Overall Study|Death|6|||
146197074|NCT02614560|527232749|FG001|Overall Study|Death|2|||
146197075|NCT00703911|527232750|FG000|Overall Study|Death|1|||
146197076|NCT00703911|527232750|FG000|Overall Study|Physician Decision|6|||
146197077|NCT00703911|527232750|FG000|Overall Study|Lost to Follow-up|1|||
146197078|NCT00703911|527232750|FG000|Overall Study|Withdrawal by Subject|2|||
146197079|NCT02082158|527232751|FG000|Overall Study|Withdrawal by Subject|0|||
146197080|NCT02082158|527232752|FG001|Overall Study|Withdrawal by Subject|0|||
146197081|NCT02082158|527232753|FG002|Overall Study|Withdrawal by Subject|0|||
146197082|NCT02082158|527232754|FG003|Overall Study|Withdrawal by Subject|0|||
146197083|NCT02082158|527232755|FG004|Overall Study|Withdrawal by Subject|1|||
146197084|NCT02082158|527232756|FG005|Overall Study|Withdrawal by Subject|0|||
146197085|NCT02082158|527232751|FG000|Overall Study|Failed Fit-testing|8|||
146197086|NCT02082158|527232752|FG001|Overall Study|Failed Fit-testing|8|||
146197087|NCT02082158|527232753|FG002|Overall Study|Failed Fit-testing|14|||
146197088|NCT02082158|527232754|FG003|Overall Study|Failed Fit-testing|4|||
146197089|NCT02082158|527232755|FG004|Overall Study|Failed Fit-testing|3|||
146197090|NCT02082158|527232756|FG005|Overall Study|Failed Fit-testing|7|||
146197091|NCT00549848|527232757|FG000|Overall Study|Death|1|||
146197092|NCT00549848|527232758|FG001|Overall Study|Death|4|||
146197093|NCT00549848|527232759|FG002|Overall Study|Death|13|||
146197094|NCT00549848|527232757|FG000|Overall Study|Physician Decision|0|||
146197095|NCT00549848|527232758|FG001|Overall Study|Physician Decision|0|||
146197096|NCT00549848|527232759|FG002|Overall Study|Physician Decision|4|||
146197097|NCT00549848|527232757|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
146197098|NCT00549848|527232758|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
146197099|NCT00549848|527232759|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
146197100|NCT00549848|527232757|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
146197101|NCT00549848|527232758|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
146197102|NCT00549848|527232759|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
146197103|NCT00549848|527232757|FG000|Overall Study|Participant/Family Withdraw|2|||
146197104|NCT00549848|527232758|FG001|Overall Study|Participant/Family Withdraw|3|||
146197105|NCT00549848|527232759|FG002|Overall Study|Participant/Family Withdraw|5|||
146197106|NCT00549848|527232757|FG000|Overall Study|Second Malignancy|1|||
146197107|NCT00549848|527232758|FG001|Overall Study|Second Malignancy|0|||
146197108|NCT00549848|527232759|FG002|Overall Study|Second Malignancy|0|||
146197109|NCT00549848|527232757|FG000|Overall Study|Transplant|3|||
146197110|NCT00549848|527232758|FG001|Overall Study|Transplant|3|||
146197111|NCT00549848|527232759|FG002|Overall Study|Transplant|18|||
146197112|NCT00549848|527232757|FG000|Overall Study|Unacceptable Toxicity|1|||
146197113|NCT00549848|527232758|FG001|Overall Study|Unacceptable Toxicity|6|||
146197114|NCT00549848|527232759|FG002|Overall Study|Unacceptable Toxicity|6|||
146197115|NCT05193318|527232768|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
146197116|NCT05193318|527232768|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
146197117|NCT00543725|527232769|FG000|Overall Study|Adverse Event|18|||
146197118|NCT00543725|527232770|FG001|Overall Study|Adverse Event|27|||
146197119|NCT00543725|527232769|FG000|Overall Study|Sponsor's Decision|0|||
146197120|NCT00543725|527232770|FG001|Overall Study|Sponsor's Decision|1|||
146197121|NCT00543725|527232769|FG000|Overall Study|Subject Non-Compliant|4|||
146197122|NCT00543725|527232770|FG001|Overall Study|Subject Non-Compliant|4|||
146197123|NCT00543725|527232769|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146197124|NCT00543725|527232770|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
146197125|NCT00543725|527232769|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
146197126|NCT00543725|527232770|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
146197127|NCT00543725|527232769|FG000|Overall Study|Protocol Violation|0|||
146197128|NCT00543725|527232770|FG001|Overall Study|Protocol Violation|1|||
146197129|NCT00543725|527232769|FG000|Overall Study|Withdrawal by Subject|4|||
146197130|NCT00543725|527232770|FG001|Overall Study|Withdrawal by Subject|13|||
146197131|NCT00543725|527232769|FG000|Overall Study|Lost to Follow-up|15|||
146197132|NCT00543725|527232770|FG001|Overall Study|Lost to Follow-up|11|||
146197133|NCT00543725|527232769|FG000|Overall Study|Other|3|||
146197134|NCT00543725|527232770|FG001|Overall Study|Other|3|||
146197135|NCT01250002|527232771|FG000|Overall Study|Change to open surgical procedure|4|||
146197136|NCT01250002|527232772|FG001|Overall Study|Change to open surgical procedure|3|||
146197137|NCT02846415|527232773|FG000|Overall Study|Lost to Follow-up|2|||
146197138|NCT02846415|527232774|FG001|Overall Study|Lost to Follow-up|0|||
146197139|NCT02846415|527232773|FG000|Overall Study|Withdrawal by Subject|1|||
146197140|NCT02846415|527232774|FG001|Overall Study|Withdrawal by Subject|1|||
146197141|NCT03383887|527232777|FG000|Overall Study|Lost to Follow-up|0|||
146197142|NCT03383887|527232778|FG001|Overall Study|Lost to Follow-up|1|||
146197143|NCT00975806|527232789|FG000|Overall Study|Adverse Event|2|||
146197144|NCT00975806|527232790|FG001|Overall Study|Adverse Event|1|||
146197145|NCT00975806|527232791|FG002|Overall Study|Adverse Event|2|||
146197146|NCT00975806|527232789|FG000|Overall Study|Disease Progression|1|||
146197147|NCT00975806|527232790|FG001|Overall Study|Disease Progression|5|||
146197148|NCT00975806|527232791|FG002|Overall Study|Disease Progression|1|||
146197149|NCT00975806|527232789|FG000|Overall Study|Withdrawal by Subject|1|||
146197150|NCT00975806|527232790|FG001|Overall Study|Withdrawal by Subject|0|||
146197151|NCT00975806|527232791|FG002|Overall Study|Withdrawal by Subject|0|||
146197152|NCT00975806|527232789|FG000|Overall Study|Death|0|||
146197153|NCT00975806|527232790|FG001|Overall Study|Death|1|||
146197154|NCT00975806|527232791|FG002|Overall Study|Death|0|||
146197155|NCT00975806|527232789|FG000|Overall Study|Physician decision and disease related|1|||
146197156|NCT00975806|527232790|FG001|Overall Study|Physician decision and disease related|0|||
146197157|NCT00975806|527232791|FG002|Overall Study|Physician decision and disease related|1|||
146197158|NCT04889664|527232792|FG000|Screen|Lost to Follow-up|1|||
146197159|NCT04889664|527232792|FG000|Screen|Failed to meet screening criteria|1|||
146197160|NCT04889664|527232792|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
146197161|NCT01806714|527232797|FG000|Overall Study|No functioning phone number|200|||
146197162|NCT01806714|527232798|FG001|Overall Study|No functioning phone number|170|||
146197163|NCT02155829|527232799|FG000|Overall Study|Adverse Event|1|||
146197164|NCT02155829|527232800|FG001|Overall Study|Adverse Event|0|||
146197165|NCT02155829|527232799|FG000|Overall Study|Withdrawal by Subject|3|||
146197166|NCT02155829|527232800|FG001|Overall Study|Withdrawal by Subject|3|||
146197167|NCT02155829|527232799|FG000|Overall Study|Protocol Violation|2|||
146197168|NCT02155829|527232800|FG001|Overall Study|Protocol Violation|0|||
146197169|NCT00678795|527232801|FG000|Overall Study|Adverse Event|7|||
146197170|NCT00678795|527232802|FG001|Overall Study|Adverse Event|3|||
146197171|NCT00678795|527232801|FG000|Overall Study|Withdrawal by Subject|3|||
146197172|NCT00678795|527232802|FG001|Overall Study|Withdrawal by Subject|0|||
146197173|NCT00678795|527232801|FG000|Overall Study|Protocol Violation|0|||
146197174|NCT00678795|527232802|FG001|Overall Study|Protocol Violation|1|||
146197175|NCT00678795|527232801|FG000|Overall Study|Lost to Follow-up|0|||
146197176|NCT00678795|527232802|FG001|Overall Study|Lost to Follow-up|1|||
146197177|NCT00678795|527232801|FG000|Overall Study|Lack of Efficacy|1|||
146197178|NCT00678795|527232802|FG001|Overall Study|Lack of Efficacy|1|||
146197179|NCT00608907|527232804|FG000|Overall Study|Adverse Event|6|||
146197180|NCT00608907|527232805|FG001|Overall Study|Adverse Event|0|||
146197181|NCT00608907|527232806|FG002|Overall Study|Adverse Event|1|||
146197182|NCT00608907|527232804|FG000|Overall Study|Death|1|||
146197183|NCT00608907|527232805|FG001|Overall Study|Death|0|||
146197184|NCT00608907|527232806|FG002|Overall Study|Death|0|||
146197185|NCT00608907|527232804|FG000|Overall Study|Withdrawal by Subject|4|||
146197186|NCT00608907|527232805|FG001|Overall Study|Withdrawal by Subject|0|||
146197187|NCT00608907|527232806|FG002|Overall Study|Withdrawal by Subject|0|||
146197188|NCT00608907|527232804|FG000|Overall Study|Progressive Disease|1|||
146197189|NCT00608907|527232805|FG001|Overall Study|Progressive Disease|0|||
146197190|NCT00608907|527232806|FG002|Overall Study|Progressive Disease|0|||
146197191|NCT03058991|527232807|FG000|Overall Study|Lost to Follow-up|17|||
146197192|NCT03058991|527232808|FG001|Overall Study|Lost to Follow-up|12|||
146197193|NCT03058991|527232809|FG002|Overall Study|Lost to Follow-up|12|||
146197194|NCT03058991|527232807|FG000|Overall Study|Withdrawal by Subject|1|||
146197195|NCT03058991|527232808|FG001|Overall Study|Withdrawal by Subject|0|||
146197196|NCT03058991|527232809|FG002|Overall Study|Withdrawal by Subject|0|||
146197197|NCT01689519|527232810|FG000|Intent to Treat|Death|157|||
146197198|NCT01689519|527232811|FG001|Intent to Treat|Death|167|||
146197199|NCT01689519|527232810|FG000|Intent to Treat|Lost to Follow-up|4|||
146197200|NCT01689519|527232811|FG001|Intent to Treat|Lost to Follow-up|8|||
146197201|NCT01689519|527232810|FG000|Intent to Treat|Other|2|||
146197202|NCT01689519|527232811|FG001|Intent to Treat|Other|4|||
146197203|NCT01689519|527232810|FG000|Intent to Treat|Physician Decision|4|||
146197204|NCT01689519|527232811|FG001|Intent to Treat|Physician Decision|1|||
146197205|NCT01689519|527232810|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
146197206|NCT01689519|527232811|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
146197207|NCT01689519|527232810|FG000|Intent to Treat|Withdrawal by Subject|21|||
146197208|NCT01689519|527232811|FG001|Intent to Treat|Withdrawal by Subject|20|||
146197209|NCT01689519|527232810|FG000|Safety Population|Death|158|||
146197210|NCT01689519|527232811|FG001|Safety Population|Death|165|||
146197211|NCT01689519|527232810|FG000|Safety Population|Lost to Follow-up|4|||
146197212|NCT01689519|527232811|FG001|Safety Population|Lost to Follow-up|8|||
146197213|NCT01689519|527232810|FG000|Safety Population|Other|2|||
146197214|NCT01689519|527232811|FG001|Safety Population|Other|4|||
146197215|NCT01689519|527232810|FG000|Safety Population|Physician Decision|4|||
146197216|NCT01689519|527232811|FG001|Safety Population|Physician Decision|1|||
146197217|NCT01689519|527232810|FG000|Safety Population|Study Terminated By Sponsor|60|||
146197218|NCT01689519|527232811|FG001|Safety Population|Study Terminated By Sponsor|47|||
146197219|NCT01689519|527232810|FG000|Safety Population|Withdrawal by Subject|20|||
146197220|NCT01689519|527232811|FG001|Safety Population|Withdrawal by Subject|20|||
146197221|NCT00559949|527232816|FG000|Overall Study|Progressive Disease during cycle 1|1|||
146197222|NCT00559949|527232816|FG000|Overall Study|Adverse Event|1|||
146197223|NCT00559949|527232816|FG000|Overall Study|Withdrawal by Subject|4|||
146423074|NCT05381948|528055839|FG002|Overall Study|Withdrawal by Subject|1|||
146423075|NCT05381948|528055837|FG000|Overall Study|Death|0|||
146197224|NCT00559949|527232816|FG000|Overall Study|No disease evaluation per protocol|1|||
146197225|NCT04173572|527232821|FG000|Overall Study|Withdrawal by Subject|1|||
146197226|NCT04173572|527232822|FG001|Overall Study|Withdrawal by Subject|5|||
146197227|NCT04173572|527232821|FG000|Overall Study|Lost to Follow-up|3|||
146197228|NCT04173572|527232822|FG001|Overall Study|Lost to Follow-up|1|||
146197229|NCT01253226|527232824|FG000|Overall Study|Adverse Event|0|||
146197230|NCT01253226|527232825|FG001|Overall Study|Adverse Event|0|||
146197231|NCT01253226|527232826|FG002|Overall Study|Adverse Event|1|||
146197232|NCT01253226|527232827|FG003|Overall Study|Adverse Event|0|||
146197233|NCT01253226|527232828|FG004|Overall Study|Adverse Event|0|||
146197234|NCT01253226|527232824|FG000|Overall Study|Death|0|||
146197235|NCT01253226|527232825|FG001|Overall Study|Death|1|||
146197236|NCT01253226|527232826|FG002|Overall Study|Death|0|||
146197237|NCT01253226|527232827|FG003|Overall Study|Death|0|||
146197238|NCT01253226|527232828|FG004|Overall Study|Death|0|||
146197239|NCT01253226|527232824|FG000|Overall Study|Physician Decision|0|||
146197240|NCT01253226|527232825|FG001|Overall Study|Physician Decision|0|||
146197241|NCT01253226|527232826|FG002|Overall Study|Physician Decision|0|||
146197242|NCT01253226|527232827|FG003|Overall Study|Physician Decision|0|||
146197243|NCT01253226|527232828|FG004|Overall Study|Physician Decision|2|||
146197244|NCT01253226|527232824|FG000|Overall Study|Withdrawal by Subject|0|||
146197245|NCT01253226|527232825|FG001|Overall Study|Withdrawal by Subject|0|||
146197246|NCT01253226|527232826|FG002|Overall Study|Withdrawal by Subject|0|||
146197247|NCT01253226|527232827|FG003|Overall Study|Withdrawal by Subject|1|||
146197248|NCT01253226|527232828|FG004|Overall Study|Withdrawal by Subject|0|||
146197249|NCT00988637|527232829|FG000|Overall Study|Lost to Follow-up|2|||
146197250|NCT00988637|527232830|FG001|Overall Study|Lost to Follow-up|1|||
146197251|NCT00988637|527232829|FG000|Overall Study|Withdrawal by Subject|1|||
146197252|NCT00988637|527232830|FG001|Overall Study|Withdrawal by Subject|1|||
146197253|NCT00988637|527232829|FG000|Overall Study|non-compliance with study drug|0|||
146197254|NCT00988637|527232830|FG001|Overall Study|non-compliance with study drug|1|||
146197255|NCT01726023|527232835|FG000|Overall Study|Death|1|||
146197256|NCT01726023|527232836|FG001|Overall Study|Death|1|||
146197257|NCT01726023|527232835|FG000|Overall Study|Lost to Follow-up|5|||
146197258|NCT01726023|527232836|FG001|Overall Study|Lost to Follow-up|10|||
146197259|NCT01726023|527232835|FG000|Overall Study|Other Eligibility criteria|7|||
146197260|NCT01726023|527232836|FG001|Overall Study|Other Eligibility criteria|7|||
146197261|NCT01726023|527232835|FG000|Overall Study|Withdrawal by Subject|16|||
146197262|NCT01726023|527232836|FG001|Overall Study|Withdrawal by Subject|8|||
146197263|NCT03643211|527232837|FG000|Overall Study|Contract violation/deficiency|12|||
146197264|NCT03643211|527232837|FG000|Overall Study|Invalid registration|3|||
146197265|NCT03643211|527232837|FG000|Overall Study|No treatment information|2|||
146197266|NCT03643211|527232837|FG000|Overall Study|No adverse event information - No revisit|4|||
146197267|NCT02685033|527232838|FG000|Overall Study|Withdrawal of Consent|0|||
146197268|NCT02685033|527232839|FG001|Overall Study|Withdrawal of Consent|1|||
146197269|NCT02685033|527232838|FG000|Overall Study|Lost to Follow-up|2|||
146197270|NCT02685033|527232839|FG001|Overall Study|Lost to Follow-up|1|||
146197271|NCT02685033|527232838|FG000|Overall Study|Adverse Event|1|||
146197272|NCT02685033|527232839|FG001|Overall Study|Adverse Event|0|||
146197273|NCT03425643|527232842|FG000|Overall Study|Withdrawal by Subject|10|||
146197274|NCT03425643|527232843|FG001|Overall Study|Withdrawal by Subject|12|||
146197275|NCT03425643|527232842|FG000|Overall Study|Lost to Follow-up|2|||
146423076|NCT05381948|528055838|FG001|Overall Study|Death|2|||
146423077|NCT05381948|528055839|FG002|Overall Study|Death|0|||
146197276|NCT03425643|527232843|FG001|Overall Study|Lost to Follow-up|0|||
146197277|NCT03425643|527232842|FG000|Overall Study|Death|109|||
146197278|NCT03425643|527232843|FG001|Overall Study|Death|141|||
146197279|NCT03425643|527232842|FG000|Overall Study|Ongoing in study|276|||
146197280|NCT03425643|527232843|FG001|Overall Study|Ongoing in study|247|||
146197281|NCT03141788|527232844|FG000|Overall Study|Lost to Follow-up|1|||
146197282|NCT03141788|527232844|FG000|Overall Study|Protocol Violation|3|||
146197283|NCT03141788|527232844|FG000|Overall Study|Withdrawal by Subject|4|||
146197284|NCT04133363|527232845|FG000|Overall Study|Lost to Follow-up|2|||
146197285|NCT04133363|527232846|FG001|Overall Study|Lost to Follow-up|1|||
146197286|NCT04133363|527232847|FG002|Overall Study|Lost to Follow-up|4|||
146197287|NCT01546155|527234113|FG000|Overall Study|could not tolerate long scan duration|3|||
146197288|NCT00246012|527234118|FG000|Overall Study|Adverse Event|0|||
146197289|NCT00246012|527234119|FG001|Overall Study|Adverse Event|0|||
146197290|NCT00246012|527234120|FG002|Overall Study|Adverse Event|0|||
146197291|NCT00246012|527234121|FG003|Overall Study|Adverse Event|0|||
146423078|NCT05381948|528055837|FG000|Overall Study|Discontinued study without receiving study drug|0|||
146197292|NCT00246012|527234122|FG004|Overall Study|Adverse Event|0|||
146197293|NCT00246012|527234123|FG005|Overall Study|Adverse Event|1|||
146197294|NCT00246012|527234124|FG006|Overall Study|Adverse Event|0|||
146197295|NCT00246012|527234125|FG007|Overall Study|Adverse Event|0|||
146197296|NCT00246012|527234126|FG008|Overall Study|Adverse Event|2|||
146197297|NCT00246012|527234118|FG000|Overall Study|Withdrawal by Subject|0|||
146197298|NCT00246012|527234119|FG001|Overall Study|Withdrawal by Subject|0|||
146197299|NCT00246012|527234120|FG002|Overall Study|Withdrawal by Subject|0|||
146197300|NCT00246012|527234121|FG003|Overall Study|Withdrawal by Subject|0|||
146197301|NCT00246012|527234122|FG004|Overall Study|Withdrawal by Subject|0|||
146197302|NCT00246012|527234123|FG005|Overall Study|Withdrawal by Subject|1|||
146197303|NCT00246012|527234124|FG006|Overall Study|Withdrawal by Subject|0|||
146197304|NCT00246012|527234125|FG007|Overall Study|Withdrawal by Subject|0|||
146197305|NCT00246012|527234126|FG008|Overall Study|Withdrawal by Subject|0|||
146197306|NCT00246012|527234118|FG000|Overall Study|Disease progression|3|||
146197307|NCT00246012|527234119|FG001|Overall Study|Disease progression|1|||
146423079|NCT05381948|528055838|FG001|Overall Study|Discontinued study without receiving study drug|0|||
146423080|NCT05381948|528055839|FG002|Overall Study|Discontinued study without receiving study drug|1|||
146197308|NCT00246012|527234120|FG002|Overall Study|Disease progression|2|||
146197309|NCT00246012|527234121|FG003|Overall Study|Disease progression|3|||
146197310|NCT00246012|527234122|FG004|Overall Study|Disease progression|3|||
146197311|NCT00246012|527234123|FG005|Overall Study|Disease progression|25|||
146197312|NCT00246012|527234124|FG006|Overall Study|Disease progression|30|||
146197313|NCT00246012|527234125|FG007|Overall Study|Disease progression|27|||
146197314|NCT00246012|527234126|FG008|Overall Study|Disease progression|26|||
146197315|NCT00246012|527234118|FG000|Overall Study|Other|0|||
146197316|NCT00246012|527234119|FG001|Overall Study|Other|0|||
146197317|NCT00246012|527234120|FG002|Overall Study|Other|0|||
146197318|NCT00246012|527234121|FG003|Overall Study|Other|0|||
146197319|NCT00246012|527234122|FG004|Overall Study|Other|0|||
146197320|NCT00246012|527234123|FG005|Overall Study|Other|0|||
146197321|NCT00246012|527234124|FG006|Overall Study|Other|0|||
146197322|NCT00246012|527234125|FG007|Overall Study|Other|1|||
146197323|NCT00246012|527234126|FG008|Overall Study|Other|0|||
146197324|NCT00246012|527234118|FG000|Overall Study|Randomly assigned but not treated|0|||
146197325|NCT00246012|527234119|FG001|Overall Study|Randomly assigned but not treated|0|||
146197326|NCT00246012|527234120|FG002|Overall Study|Randomly assigned but not treated|0|||
146197327|NCT00246012|527234121|FG003|Overall Study|Randomly assigned but not treated|0|||
146197328|NCT00246012|527234122|FG004|Overall Study|Randomly assigned but not treated|0|||
146197329|NCT00246012|527234123|FG005|Overall Study|Randomly assigned but not treated|1|||
146197330|NCT00246012|527234124|FG006|Overall Study|Randomly assigned but not treated|1|||
146197331|NCT00246012|527234125|FG007|Overall Study|Randomly assigned but not treated|0|||
146197332|NCT00246012|527234126|FG008|Overall Study|Randomly assigned but not treated|0|||
146197333|NCT04107805|527234129|FG000|Overall Study|Adverse Event|0|||
146197334|NCT04107805|527234130|FG001|Overall Study|Adverse Event|0|||
146197335|NCT04107805|527234131|FG002|Overall Study|Adverse Event|0|||
146197336|NCT04107805|527234132|FG003|Overall Study|Adverse Event|1|||
146197337|NCT04107805|527234133|FG004|Overall Study|Adverse Event|0|||
146197338|NCT04107805|527234134|FG005|Overall Study|Adverse Event|1|||
146197339|NCT04107805|527234135|FG006|Overall Study|Adverse Event|0|||
146197340|NCT04107805|527234136|FG007|Overall Study|Adverse Event|0|||
146197341|NCT04107805|527234137|FG008|Overall Study|Adverse Event|1|||
146197342|NCT00404079|527234143|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
146197343|NCT00404079|527234144|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
146197344|NCT01120275|527234145|FG000|Overall Study|Adverse Event|3|||
146197345|NCT01120275|527234145|FG000|Overall Study|Progression|27|||
146197346|NCT01120275|527234145|FG000|Overall Study|Ineligible|3|||
146197347|NCT01120275|527234145|FG000|Overall Study|Withdrawal by Subject|1|||
146197348|NCT01120275|527234145|FG000|Overall Study|Refusal|1|||
146197349|NCT01120275|527234145|FG000|Overall Study|Not specific|1|||
146197350|NCT00771849|527234146|FG000|Overall Study|Lost to Follow-up|1|||
146197351|NCT00771849|527234147|FG001|Overall Study|Lost to Follow-up|2|||
146197352|NCT00771849|527234146|FG000|Overall Study|Withdrawal by Subject|1|||
146197353|NCT00771849|527234147|FG001|Overall Study|Withdrawal by Subject|1|||
146197354|NCT00771849|527234146|FG000|Overall Study|Not vaccinated|0|||
146197355|NCT00771849|527234147|FG001|Overall Study|Not vaccinated|1|||
146197356|NCT02736799|527234151|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146197357|NCT02736799|527234152|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146197358|NCT02736799|527234153|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
146197359|NCT02736799|527234154|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
146197360|NCT00197015|527234157|FG000|Overall Study|Adverse Event|3|||
146197361|NCT00197015|527234158|FG001|Overall Study|Adverse Event|0|||
146197362|NCT00197015|527234159|FG002|Overall Study|Adverse Event|1|||
146197363|NCT00197015|527234157|FG000|Overall Study|Protocol Violation|0|||
146197364|NCT00197015|527234158|FG001|Overall Study|Protocol Violation|3|||
146197365|NCT00197015|527234159|FG002|Overall Study|Protocol Violation|3|||
146197366|NCT00197015|527234157|FG000|Overall Study|Withdrawal by Subject|17|||
146197367|NCT00197015|527234158|FG001|Overall Study|Withdrawal by Subject|37|||
146197368|NCT00197015|527234159|FG002|Overall Study|Withdrawal by Subject|34|||
146197369|NCT00197015|527234157|FG000|Overall Study|Lost to Follow-up|28|||
146197370|NCT00197015|527234158|FG001|Overall Study|Lost to Follow-up|46|||
146197371|NCT00197015|527234159|FG002|Overall Study|Lost to Follow-up|37|||
146197372|NCT00197015|527234157|FG000|Overall Study|Other|2|||
146197373|NCT00197015|527234158|FG001|Overall Study|Other|3|||
146197374|NCT00197015|527234159|FG002|Overall Study|Other|2|||
146197375|NCT04511650|527234160|FG000|Overall Study|Lost to Follow-up|1|||
146197376|NCT04511650|527234161|FG001|Overall Study|Lost to Follow-up|0|||
146197377|NCT04511650|527234162|FG002|Overall Study|Lost to Follow-up|0|||
146197378|NCT04511650|527234160|FG000|Overall Study|Withdrawal by Subject|1|||
146197379|NCT04511650|527234161|FG001|Overall Study|Withdrawal by Subject|0|||
146197380|NCT04511650|527234162|FG002|Overall Study|Withdrawal by Subject|0|||
146197381|NCT04511650|527234160|FG000|Overall Study|reason not provided|0|||
146197382|NCT04511650|527234161|FG001|Overall Study|reason not provided|0|||
146197383|NCT04511650|527234162|FG002|Overall Study|reason not provided|1|||
146197384|NCT04511650|527234160|FG000|Overall Study|Death|1|||
146197385|NCT04511650|527234161|FG001|Overall Study|Death|1|||
146197386|NCT04511650|527234162|FG002|Overall Study|Death|1|||
146197387|NCT01972152|527234165|FG000|First Treatment Visit|Lost to Follow-up|0|||
146197388|NCT01972152|527234166|FG001|First Treatment Visit|Lost to Follow-up|1|||
146197389|NCT01972152|527234167|FG002|First Treatment Visit|Lost to Follow-up|0|||
146197390|NCT01972152|527234168|FG003|First Treatment Visit|Lost to Follow-up|0|||
146197391|NCT01972152|527234169|FG004|First Treatment Visit|Lost to Follow-up|0|||
146197392|NCT01972152|527234170|FG005|First Treatment Visit|Lost to Follow-up|0|||
146197393|NCT01972152|527234165|FG000|Second Treatment Visit|Protocol Violation|0|||
146197394|NCT01972152|527234166|FG001|Second Treatment Visit|Protocol Violation|1|||
146197395|NCT01972152|527234167|FG002|Second Treatment Visit|Protocol Violation|0|||
146197396|NCT01972152|527234168|FG003|Second Treatment Visit|Protocol Violation|0|||
146197397|NCT01972152|527234169|FG004|Second Treatment Visit|Protocol Violation|0|||
146197398|NCT01972152|527234170|FG005|Second Treatment Visit|Protocol Violation|0|||
146197399|NCT02596035|527234173|FG000|Overall Study|Disease Progression|64|||
146197400|NCT02596035|527234174|FG001|Overall Study|Disease Progression|32|||
146197401|NCT02596035|527234175|FG002|Overall Study|Disease Progression|1|||
146197402|NCT02596035|527234173|FG000|Overall Study|study drug toxicity|12|||
146197403|NCT02596035|527234174|FG001|Overall Study|study drug toxicity|3|||
146197404|NCT02596035|527234175|FG002|Overall Study|study drug toxicity|0|||
146197405|NCT02596035|527234173|FG000|Overall Study|AE unrelated to study drug|5|||
146197406|NCT02596035|527234174|FG001|Overall Study|AE unrelated to study drug|2|||
146197407|NCT02596035|527234175|FG002|Overall Study|AE unrelated to study drug|0|||
146197408|NCT02596035|527234173|FG000|Overall Study|participant request to discontinue study treatment|2|||
146197409|NCT02596035|527234174|FG001|Overall Study|participant request to discontinue study treatment|0|||
146197410|NCT02596035|527234175|FG002|Overall Study|participant request to discontinue study treatment|0|||
146197411|NCT02596035|527234173|FG000|Overall Study|participant withdrew consent|2|||
146197412|NCT02596035|527234174|FG001|Overall Study|participant withdrew consent|2|||
146197413|NCT02596035|527234175|FG002|Overall Study|participant withdrew consent|0|||
146197414|NCT02596035|527234173|FG000|Overall Study|Poor/Non Comlpiance|0|||
146197415|NCT02596035|527234174|FG001|Overall Study|Poor/Non Comlpiance|1|||
146197416|NCT02596035|527234175|FG002|Overall Study|Poor/Non Comlpiance|0|||
146197417|NCT02596035|527234173|FG000|Overall Study|participant no longer meets study criteria|1|||
146197418|NCT02596035|527234174|FG001|Overall Study|participant no longer meets study criteria|0|||
146197419|NCT02596035|527234175|FG002|Overall Study|participant no longer meets study criteria|0|||
146197420|NCT02596035|527234173|FG000|Overall Study|other reasons|11|||
146197421|NCT02596035|527234174|FG001|Overall Study|other reasons|4|||
146197422|NCT02596035|527234175|FG002|Overall Study|other reasons|0|||
146197423|NCT00509769|527234176|FG000|Overall Study|Progressive disease|77|||
146197424|NCT00509769|527234176|FG000|Overall Study|Adverse Event|4|||
146197425|NCT00509769|527234176|FG000|Overall Study|Patient's decision|1|||
146197426|NCT00509769|527234176|FG000|Overall Study|Physician Decision|8|||
146197427|NCT00509769|527234176|FG000|Overall Study|Use of prohibited therapies during study|1|||
146197428|NCT02873754|527234177|FG000|Overall Study|Lost to Follow-up|5|||
146197429|NCT02873754|527234177|FG000|Overall Study|Couldn't complete study procedures|1|||
146197430|NCT03593070|527234178|FG000|Overall Study|administrative withdrawal|1|||
146197431|NCT03593070|527234179|FG001|Overall Study|administrative withdrawal|1|||
146197432|NCT03310983|527234182|FG000|Overall Study|Lost to Follow-up|15|||
146197433|NCT03310983|527234183|FG001|Overall Study|Lost to Follow-up|17|||
146197434|NCT03612804|527234184|FG000|Overall Study|Death|0|||
146197435|NCT03612804|527234185|FG001|Overall Study|Death|7|||
146197436|NCT03612804|527234186|FG002|Overall Study|Death|0|||
146197437|NCT03612804|527234187|FG003|Overall Study|Death|8|||
146197438|NCT03612804|527234184|FG000|Overall Study|Medication copay coverage issues|0|||
146197439|NCT03612804|527234185|FG001|Overall Study|Medication copay coverage issues|0|||
146197440|NCT03612804|527234186|FG002|Overall Study|Medication copay coverage issues|0|||
146197441|NCT03612804|527234187|FG003|Overall Study|Medication copay coverage issues|17|||
146197442|NCT03612804|527234184|FG000|Overall Study|Not current smoker at time of screening|0|||
146197443|NCT03612804|527234185|FG001|Overall Study|Not current smoker at time of screening|1|||
146197444|NCT03612804|527234186|FG002|Overall Study|Not current smoker at time of screening|0|||
146197445|NCT03612804|527234187|FG003|Overall Study|Not current smoker at time of screening|3|||
146197446|NCT03612804|527234184|FG000|Overall Study|Non-veteran status|0|||
146197447|NCT03612804|527234185|FG001|Overall Study|Non-veteran status|1|||
146423081|NCT02446132|528055842|FG000|Overall Study|Adverse Event|10|||
146082626|NCT00821509|526822856|FG001|Overall Study|Withdrawal by Subject|11|||
146082627|NCT00821509|526822857|FG002|Overall Study|Withdrawal by Subject|34|||
146082628|NCT03104816|526822859|FG000|Overall Study|Lack of Efficacy|0|||
146197448|NCT03612804|527234186|FG002|Overall Study|Non-veteran status|0|||
146197449|NCT03612804|527234187|FG003|Overall Study|Non-veteran status|0|||
146197450|NCT03612804|527234184|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
146197451|NCT03612804|527234185|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
146197452|NCT03612804|527234186|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
146197453|NCT03612804|527234187|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
146197454|NCT03612804|527234184|FG000|Overall Study|Provider retired from VA|0|||
146197455|NCT03612804|527234185|FG001|Overall Study|Provider retired from VA|0|||
146197456|NCT03612804|527234186|FG002|Overall Study|Provider retired from VA|2|||
146197457|NCT03612804|527234187|FG003|Overall Study|Provider retired from VA|0|||
146197458|NCT03612804|527234184|FG000|Overall Study|Withdrawal by Subject|0|||
146197459|NCT03612804|527234185|FG001|Overall Study|Withdrawal by Subject|0|||
146197460|NCT03612804|527234186|FG002|Overall Study|Withdrawal by Subject|7|||
146197461|NCT03612804|527234187|FG003|Overall Study|Withdrawal by Subject|0|||
146197462|NCT03612804|527234184|FG000|Overall Study|Provider involved with study activities|1|||
146197463|NCT03612804|527234185|FG001|Overall Study|Provider involved with study activities|0|||
146197464|NCT03612804|527234186|FG002|Overall Study|Provider involved with study activities|0|||
146197465|NCT03612804|527234187|FG003|Overall Study|Provider involved with study activities|0|||
146197466|NCT01656304|527234188|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
146197467|NCT00881335|527234189|FG000|Overall Study|Lost to Follow-up|3|||
146197468|NCT00881335|527234190|FG001|Overall Study|Lost to Follow-up|2|||
146197469|NCT00554801|527234192|FG000|Overall Study|left area before completion|5|||
146197470|NCT00554801|527234193|FG001|Overall Study|left area before completion|0|||
146197471|NCT00554801|527234192|FG000|Overall Study|Withdrawal by Subject|14|||
146197472|NCT00554801|527234193|FG001|Overall Study|Withdrawal by Subject|0|||
146197473|NCT02104765|527234196|FG000|Overall Study|Lost to Follow-up|0|||
146197474|NCT02104765|527234197|FG001|Overall Study|Lost to Follow-up|0|||
146197475|NCT02104765|527234198|FG002|Overall Study|Lost to Follow-up|1|||
146197476|NCT02104765|527234199|FG003|Overall Study|Lost to Follow-up|0|||
146197477|NCT02104765|527234200|FG004|Overall Study|Lost to Follow-up|0|||
146197478|NCT02104765|527234201|FG005|Overall Study|Lost to Follow-up|0|||
146197479|NCT02104765|527234202|FG006|Overall Study|Lost to Follow-up|0|||
146197480|NCT02104765|527234196|FG000|Overall Study|Withdrawal by Subject|0|||
146197481|NCT02104765|527234197|FG001|Overall Study|Withdrawal by Subject|0|||
146197482|NCT02104765|527234198|FG002|Overall Study|Withdrawal by Subject|0|||
146197483|NCT02104765|527234199|FG003|Overall Study|Withdrawal by Subject|1|||
146197484|NCT02104765|527234200|FG004|Overall Study|Withdrawal by Subject|1|||
146197485|NCT02104765|527234201|FG005|Overall Study|Withdrawal by Subject|0|||
146197486|NCT02104765|527234202|FG006|Overall Study|Withdrawal by Subject|1|||
146197487|NCT02357784|527234203|FG000|Overall Study|Withdrawal by Subject|1|||
146197488|NCT00462943|527234204|FG000|Overall Study|Failure to achieve a response|5|||
146197489|NCT00462943|527234205|FG001|Overall Study|Failure to achieve a response|5|||
146197490|NCT00462943|527234206|FG002|Overall Study|Failure to achieve a response|1|||
146197491|NCT00462943|527234204|FG000|Overall Study|Adverse Event|6|||
146197492|NCT00462943|527234205|FG001|Overall Study|Adverse Event|4|||
146197493|NCT00462943|527234206|FG002|Overall Study|Adverse Event|1|||
146197494|NCT00462943|527234204|FG000|Overall Study|Protocol Violation|1|||
146197495|NCT00462943|527234205|FG001|Overall Study|Protocol Violation|0|||
146197496|NCT00462943|527234206|FG002|Overall Study|Protocol Violation|0|||
145949296|NCT00803205|526325219|FG000|Overall Study|Acquired a Lung Infection|0|||
146197497|NCT00462943|527234204|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
146197498|NCT00462943|527234205|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
146197499|NCT00462943|527234206|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
146197500|NCT00462943|527234204|FG000|Overall Study|Disease Progression|15|||
146197501|NCT00462943|527234205|FG001|Overall Study|Disease Progression|15|||
146197502|NCT00462943|527234206|FG002|Overall Study|Disease Progression|9|||
146197503|NCT00462943|527234204|FG000|Overall Study|Death|5|||
146197504|NCT00462943|527234205|FG001|Overall Study|Death|2|||
146197505|NCT00462943|527234206|FG002|Overall Study|Death|7|||
146197506|NCT00462943|527234204|FG000|Overall Study|Stem Cell Transplant|1|||
146197507|NCT00462943|527234205|FG001|Overall Study|Stem Cell Transplant|1|||
146197508|NCT00462943|527234206|FG002|Overall Study|Stem Cell Transplant|0|||
146197509|NCT00462943|527234204|FG000|Overall Study|Bone Marrow Transplant|1|||
146197510|NCT00462943|527234205|FG001|Overall Study|Bone Marrow Transplant|0|||
146197511|NCT00462943|527234206|FG002|Overall Study|Bone Marrow Transplant|0|||
146197512|NCT00462943|527234204|FG000|Overall Study|Required Lymphocyte Infusion|1|||
146197513|NCT00462943|527234205|FG001|Overall Study|Required Lymphocyte Infusion|0|||
146197514|NCT00462943|527234206|FG002|Overall Study|Required Lymphocyte Infusion|0|||
146197515|NCT00462943|527234204|FG000|Overall Study|Transplant - not specified|1|||
146197516|NCT00462943|527234205|FG001|Overall Study|Transplant - not specified|0|||
146197517|NCT00462943|527234206|FG002|Overall Study|Transplant - not specified|1|||
146197518|NCT00462943|527234204|FG000|Overall Study|Physician Decision|1|||
146197519|NCT00462943|527234205|FG001|Overall Study|Physician Decision|0|||
146197520|NCT00462943|527234206|FG002|Overall Study|Physician Decision|0|||
146197521|NCT00462943|527234204|FG000|Overall Study|Withdrawal by Subject|0|||
146197522|NCT00462943|527234205|FG001|Overall Study|Withdrawal by Subject|1|||
146197523|NCT00462943|527234206|FG002|Overall Study|Withdrawal by Subject|0|||
146197524|NCT01697319|527234207|FG000|Primary Phase|Withdrawal by Subject|1|||
146197525|NCT01697319|527234207|FG000|Extension Phase|Terminated by Sponsor|15|||
146197526|NCT00604721|527234212|FG000|Overall Study|Physician Decision|1|||
146197527|NCT00604721|527234212|FG000|Overall Study|Withdrawal by Subject|1|||
146197528|NCT01838551|527234216|FG000|Overall Study|Adverse Event|16|||
146197529|NCT01838551|527234216|FG000|Overall Study|Death|1|||
146197530|NCT01838551|527234216|FG000|Overall Study|Lack of Efficacy|10|||
146197531|NCT01838551|527234216|FG000|Overall Study|Physician Decision|4|||
146197532|NCT01838551|527234216|FG000|Overall Study|Withdrawal by Subject|10|||
146197533|NCT01838551|527234216|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
146197534|NCT00906282|527234217|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146197535|NCT00906282|527234217|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
146197536|NCT00906282|527234217|FG000|Preoperative Chemotherapy|Progressive disease|6|||
146197537|NCT00906282|527234217|FG000|Preoperative Chemotherapy|Toxicity|1|||
146197538|NCT00038103|527234220|FG000|Overall Study|Adverse Event|5|||
146197539|NCT00038103|527234221|FG001|Overall Study|Adverse Event|6|||
146197540|NCT00038103|527234220|FG000|Overall Study|Lack of Efficacy|48|||
146197541|NCT00038103|527234221|FG001|Overall Study|Lack of Efficacy|41|||
146197542|NCT00038103|527234220|FG000|Overall Study|Withdrawal by Subject|0|||
146197543|NCT00038103|527234221|FG001|Overall Study|Withdrawal by Subject|3|||
146197544|NCT00038103|527234220|FG000|Overall Study|Lost to Follow-up|0|||
146197545|NCT00038103|527234221|FG001|Overall Study|Lost to Follow-up|3|||
146197546|NCT00038103|527234220|FG000|Overall Study|Protocol Violation|0|||
146197547|NCT00038103|527234221|FG001|Overall Study|Protocol Violation|2|||
146197548|NCT00038103|527234220|FG000|Overall Study|Sponsor Decision|0|||
146197549|NCT00038103|527234221|FG001|Overall Study|Sponsor Decision|1|||
146197550|NCT00038103|527234220|FG000|Overall Study|Randomized/never treated|2|||
146197551|NCT00038103|527234221|FG001|Overall Study|Randomized/never treated|0|||
146197552|NCT01751724|527234225|FG000|Overall Study|extubated bef.start assigned treatment|1|||
146197553|NCT01751724|527234226|FG001|Overall Study|extubated bef.start assigned treatment|0|||
146197554|NCT01751724|527234225|FG000|Overall Study|withdrawn by parent|0|||
146197555|NCT01751724|527234226|FG001|Overall Study|withdrawn by parent|2|||
146197556|NCT02465359|527234231|FG000|Overall Study|Lack of Efficacy|1|||
146197557|NCT02465359|527234231|FG000|Overall Study|Withdrawal by Subject|1|||
146197558|NCT02465359|527234231|FG000|Overall Study|Adverse Event|1|||
146197559|NCT01278862|527234232|FG000|Overall Study|Lost to Follow-up|1|||
146197560|NCT01278862|527234233|FG001|Overall Study|Lost to Follow-up|1|||
146197561|NCT02952261|527234234|FG000|Overall Study|Withdrawal by Subject|4|||
146197562|NCT02952261|527234235|FG001|Overall Study|Withdrawal by Subject|5|||
146197563|NCT02952261|527234234|FG000|Overall Study|Protocol Violation|1|||
146197564|NCT02952261|527234235|FG001|Overall Study|Protocol Violation|0|||
146197565|NCT00798265|527234236|FG000|Overall Study|Lost to Follow-up|1|||
146197566|NCT00798265|527234237|FG001|Overall Study|Lost to Follow-up|10|||
146197567|NCT00798265|527234236|FG000|Overall Study|Study closing|7|||
146197568|NCT00798265|527234237|FG001|Overall Study|Study closing|6|||
146197569|NCT00798265|527234236|FG000|Overall Study|Withdrawal by Subject|0|||
146197570|NCT00798265|527234237|FG001|Overall Study|Withdrawal by Subject|1|||
146197571|NCT00798265|527234236|FG000|Overall Study|Screen failure|0|||
146197572|NCT00798265|527234237|FG001|Overall Study|Screen failure|1|||
146197573|NCT00954707|527235745|FG000|Overall Study|Death|34|||
146197574|NCT00954707|527235745|FG000|Overall Study|Withdrawal by Subject|100|||
146197575|NCT00954707|527235745|FG000|Overall Study|Lost to Follow-up|33|||
146197576|NCT01185522|527235746|FG000|Overall Study|Lack of Efficacy|28|||
146197577|NCT01185522|527235746|FG000|Overall Study|Lost to Follow-up|19|||
146197578|NCT01185522|527235746|FG000|Overall Study|Withdrawal by Subject|10|||
146197579|NCT01185522|527235746|FG000|Overall Study|Poor tolerance|39|||
146197580|NCT01185522|527235746|FG000|Overall Study|Other reasons|12|||
146197581|NCT01649791|527235747|FG000|Overall Study|Disease Progression|2|||
146197582|NCT01649791|527235747|FG000|Overall Study|Adverse Event|1|||
146197583|NCT00771667|527235748|FG000|Induction Phase|Adverse Event|5|||
146197584|NCT00771667|527235749|FG001|Induction Phase|Adverse Event|2|||
146197585|NCT00771667|527235750|FG002|Induction Phase|Adverse Event|4|||
146197586|NCT00771667|527235751|FG003|Induction Phase|Adverse Event|1|||
146197587|NCT00771667|527235752|FG004|Induction Phase|Adverse Event|0|||
146197588|NCT00771667|527235753|FG005|Induction Phase|Adverse Event|0|||
146197589|NCT00771667|527235754|FG006|Induction Phase|Adverse Event|0|||
146197590|NCT00771667|527235755|FG007|Induction Phase|Adverse Event|0|||
146197591|NCT00771667|527235756|FG008|Induction Phase|Adverse Event|0|||
146197592|NCT00771667|527235757|FG009|Induction Phase|Adverse Event|0|||
146197593|NCT00771667|527235748|FG000|Induction Phase|Lack of Efficacy|9|||
146197594|NCT00771667|527235749|FG001|Induction Phase|Lack of Efficacy|2|||
146197595|NCT00771667|527235750|FG002|Induction Phase|Lack of Efficacy|4|||
146197596|NCT00771667|527235751|FG003|Induction Phase|Lack of Efficacy|3|||
146197597|NCT00771667|527235752|FG004|Induction Phase|Lack of Efficacy|0|||
146197598|NCT00771667|527235753|FG005|Induction Phase|Lack of Efficacy|0|||
146197599|NCT00771667|527235754|FG006|Induction Phase|Lack of Efficacy|0|||
146197600|NCT00771667|527235755|FG007|Induction Phase|Lack of Efficacy|0|||
146197601|NCT00771667|527235756|FG008|Induction Phase|Lack of Efficacy|0|||
146197602|NCT00771667|527235757|FG009|Induction Phase|Lack of Efficacy|0|||
146197603|NCT00771667|527235748|FG000|Induction Phase|Lost to Follow-up|1|||
146197604|NCT00771667|527235749|FG001|Induction Phase|Lost to Follow-up|0|||
146197605|NCT00771667|527235750|FG002|Induction Phase|Lost to Follow-up|1|||
146197606|NCT00771667|527235751|FG003|Induction Phase|Lost to Follow-up|0|||
146197607|NCT00771667|527235752|FG004|Induction Phase|Lost to Follow-up|0|||
146197608|NCT00771667|527235753|FG005|Induction Phase|Lost to Follow-up|0|||
146197609|NCT00771667|527235754|FG006|Induction Phase|Lost to Follow-up|0|||
146197610|NCT00771667|527235755|FG007|Induction Phase|Lost to Follow-up|0|||
146197611|NCT00771667|527235756|FG008|Induction Phase|Lost to Follow-up|0|||
146197612|NCT00771667|527235757|FG009|Induction Phase|Lost to Follow-up|0|||
146197613|NCT00771667|527235748|FG000|Induction Phase|Other|4|||
146197614|NCT00771667|527235749|FG001|Induction Phase|Other|6|||
146197615|NCT00771667|527235750|FG002|Induction Phase|Other|3|||
146197616|NCT00771667|527235751|FG003|Induction Phase|Other|4|||
146197617|NCT00771667|527235752|FG004|Induction Phase|Other|0|||
146197618|NCT00771667|527235753|FG005|Induction Phase|Other|0|||
146197619|NCT00771667|527235754|FG006|Induction Phase|Other|0|||
146197620|NCT00771667|527235755|FG007|Induction Phase|Other|0|||
146197621|NCT00771667|527235756|FG008|Induction Phase|Other|0|||
146197622|NCT00771667|527235757|FG009|Induction Phase|Other|0|||
146197623|NCT00771667|527235748|FG000|Maintenance Phase|Adverse Event|0|||
146197624|NCT00771667|527235749|FG001|Maintenance Phase|Adverse Event|0|||
146197625|NCT00771667|527235750|FG002|Maintenance Phase|Adverse Event|0|||
146197626|NCT00771667|527235751|FG003|Maintenance Phase|Adverse Event|0|||
146197627|NCT00771667|527235752|FG004|Maintenance Phase|Adverse Event|1|||
146197628|NCT00771667|527235753|FG005|Maintenance Phase|Adverse Event|3|||
146197629|NCT00771667|527235754|FG006|Maintenance Phase|Adverse Event|5|||
146197630|NCT00771667|527235755|FG007|Maintenance Phase|Adverse Event|1|||
146197631|NCT00771667|527235756|FG008|Maintenance Phase|Adverse Event|8|||
146197632|NCT00771667|527235757|FG009|Maintenance Phase|Adverse Event|7|||
146197633|NCT00771667|527235748|FG000|Maintenance Phase|Lack of Efficacy|0|||
146197634|NCT00771667|527235749|FG001|Maintenance Phase|Lack of Efficacy|0|||
146197635|NCT00771667|527235750|FG002|Maintenance Phase|Lack of Efficacy|0|||
146197636|NCT00771667|527235751|FG003|Maintenance Phase|Lack of Efficacy|0|||
146197637|NCT00771667|527235752|FG004|Maintenance Phase|Lack of Efficacy|1|||
146197638|NCT00771667|527235753|FG005|Maintenance Phase|Lack of Efficacy|3|||
146197639|NCT00771667|527235754|FG006|Maintenance Phase|Lack of Efficacy|3|||
146197640|NCT00771667|527235755|FG007|Maintenance Phase|Lack of Efficacy|2|||
146197641|NCT00771667|527235756|FG008|Maintenance Phase|Lack of Efficacy|11|||
146197642|NCT00771667|527235757|FG009|Maintenance Phase|Lack of Efficacy|7|||
146197643|NCT00771667|527235748|FG000|Maintenance Phase|Other|0|||
146197644|NCT00771667|527235749|FG001|Maintenance Phase|Other|0|||
146197645|NCT00771667|527235750|FG002|Maintenance Phase|Other|0|||
146197646|NCT00771667|527235751|FG003|Maintenance Phase|Other|0|||
146197647|NCT00771667|527235752|FG004|Maintenance Phase|Other|0|||
146197648|NCT00771667|527235753|FG005|Maintenance Phase|Other|1|||
146197649|NCT00771667|527235754|FG006|Maintenance Phase|Other|2|||
146197650|NCT00771667|527235755|FG007|Maintenance Phase|Other|2|||
146197651|NCT00771667|527235756|FG008|Maintenance Phase|Other|3|||
146197652|NCT00771667|527235757|FG009|Maintenance Phase|Other|3|||
146197653|NCT01897233|527235758|FG000|Part B (24 Weeks)|Adverse Event|1|||
146197654|NCT01897233|527235758|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
146197655|NCT01897233|527235758|FG000|Part B (24 Weeks)|Physician Decision|1|||
146197656|NCT00628862|527235759|FG000|Overall Study|Adverse Event|6|||
146197657|NCT00628862|527235760|FG001|Overall Study|Adverse Event|8|||
146197658|NCT00628862|527235761|FG002|Overall Study|Adverse Event|10|||
146197659|NCT00628862|527235759|FG000|Overall Study|Withdrawal by Subject|4|||
146197660|NCT00628862|527235760|FG001|Overall Study|Withdrawal by Subject|6|||
146197661|NCT00628862|527235761|FG002|Overall Study|Withdrawal by Subject|11|||
146197662|NCT00628862|527235759|FG000|Overall Study|Lost to Follow-up|0|||
146197663|NCT00628862|527235760|FG001|Overall Study|Lost to Follow-up|2|||
146197664|NCT00628862|527235761|FG002|Overall Study|Lost to Follow-up|1|||
146197665|NCT00628862|527235759|FG000|Overall Study|Protocol Violation|1|||
146197666|NCT00628862|527235760|FG001|Overall Study|Protocol Violation|0|||
146197667|NCT00628862|527235761|FG002|Overall Study|Protocol Violation|0|||
146197668|NCT00628862|527235759|FG000|Overall Study|COPD Exacerbation|0|||
146197669|NCT00628862|527235760|FG001|Overall Study|COPD Exacerbation|1|||
146197670|NCT00628862|527235761|FG002|Overall Study|COPD Exacerbation|0|||
146197671|NCT04033432|527235782|FG000|Overall Study|Progressive Disease|8|||
146197672|NCT04033432|527235782|FG000|Overall Study|Adverse Event|4|||
146197673|NCT04033432|527235782|FG000|Overall Study|Death|1|||
146197674|NCT00738699|527235788|FG000|Overall Study|Withdrawal by Subject|5|||
146197675|NCT00738699|527235789|FG001|Overall Study|Withdrawal by Subject|0|||
146197676|NCT00738699|527235788|FG000|Overall Study|Lost to Follow-up|1|||
146197677|NCT00738699|527235789|FG001|Overall Study|Lost to Follow-up|0|||
146197678|NCT00738699|527235788|FG000|Overall Study|Death|144|||
146197679|NCT00738699|527235789|FG001|Overall Study|Death|68|||
146197680|NCT00738699|527235788|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
146197681|NCT00738699|527235789|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
146197682|NCT00738699|527235788|FG000|Overall Study|Other|2|||
146197683|NCT00738699|527235789|FG001|Overall Study|Other|0|||
146197684|NCT00868192|527235791|FG000|Overall Study|Ineligible|4|||
146197685|NCT02174562|527235792|FG000|Overall Study|Withdrawal by Subject|7|||
146197686|NCT02174562|527235793|FG001|Overall Study|Withdrawal by Subject|2|||
146197687|NCT02174562|527235792|FG000|Overall Study|Death|2|||
146197688|NCT02174562|527235793|FG001|Overall Study|Death|0|||
146197689|NCT02174562|527235792|FG000|Overall Study|Lost to Follow-up|0|||
146197690|NCT02174562|527235793|FG001|Overall Study|Lost to Follow-up|3|||
146197691|NCT00798096|527235795|FG000|Overall Study|Ongoing|2|||
146197692|NCT03670602|527235796|FG000|Overall Study|Lost to Follow-up|1|||
146197693|NCT03670602|527235797|FG001|Overall Study|Lost to Follow-up|0|||
146197694|NCT03670602|527235796|FG000|Overall Study|Withdrawal by Subject|0|||
146197695|NCT03670602|527235797|FG001|Overall Study|Withdrawal by Subject|3|||
146197696|NCT03201809|527235798|FG000|Overall Study|Lost to Follow-up|2|||
146197697|NCT03201809|527235799|FG001|Overall Study|Lost to Follow-up|0|||
146197698|NCT00957658|527235800|FG000|Overall Study|Death|1|||
146197699|NCT00957658|527235800|FG000|Overall Study|Lost to Follow-up|4|||
146197700|NCT00957658|527235800|FG000|Overall Study|Withdrawal by Subject|12|||
146197701|NCT00957658|527235800|FG000|Overall Study|Revision|1|||
146197702|NCT00957658|527235800|FG000|Overall Study|Incomplete 2 yr data|28|||
146197703|NCT00957658|527235800|FG000|Overall Study|Site termination|10|||
146197704|NCT00957658|527235800|FG000|Overall Study|unwilling/unable to return|2|||
146197705|NCT00957658|527235800|FG000|Overall Study|surgery cancelled|2|||
146197706|NCT00957658|527235800|FG000|Overall Study|Protocol Violation|5|||
146197707|NCT02469064|527235801|FG000|Overall Study|Request not to receive intervention.|1|||
146197708|NCT02469064|527235802|FG001|Overall Study|Request not to receive intervention.|3|||
146197709|NCT02046616|527235805|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
146197710|NCT02046616|527235805|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
146197711|NCT02046616|527235805|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
146197712|NCT02046616|527235805|FG000|24-Week Treatment Period|Physician Decision|3|||
146197713|NCT02046616|527235805|FG000|24-Week Treatment Period|Other|1|||
146197714|NCT02046616|527235805|FG000|8-Week FU Period|Lost to Follow-up|1|||
146197715|NCT01156116|527235806|FG000|Overall Study|Withdrawal by Subject|3|||
146197716|NCT01156116|527235807|FG001|Overall Study|Withdrawal by Subject|1|||
146197717|NCT01156116|527235806|FG000|Overall Study|CPAP intolerance|2|||
146197718|NCT01156116|527235807|FG001|Overall Study|CPAP intolerance|0|||
146197719|NCT01591616|527235809|FG000|Overall Study|Withdrawal by Subject|1|||
146197720|NCT01959412|527235810|FG000|Overall Study|Protocol deviation|1|||
146197721|NCT01959412|527235811|FG001|Overall Study|Protocol deviation|1|||
146197722|NCT01959412|527235812|FG002|Overall Study|Protocol deviation|0|||
146197723|NCT01959412|527235813|FG003|Overall Study|Protocol deviation|1|||
146423082|NCT02446132|528055843|FG001|Overall Study|Adverse Event|27|||
146197724|NCT01959412|527235814|FG004|Overall Study|Protocol deviation|3|||
146197725|NCT01959412|527235815|FG005|Overall Study|Protocol deviation|0|||
146197726|NCT01959412|527235810|FG000|Overall Study|Adverse Event|0|||
146197727|NCT01959412|527235811|FG001|Overall Study|Adverse Event|0|||
146197728|NCT01959412|527235812|FG002|Overall Study|Adverse Event|0|||
146197729|NCT01959412|527235813|FG003|Overall Study|Adverse Event|1|||
146197730|NCT01959412|527235814|FG004|Overall Study|Adverse Event|0|||
146197731|NCT01959412|527235815|FG005|Overall Study|Adverse Event|0|||
146197732|NCT01186848|527235816|FG000|Overall Study|Lost to Follow-up|4|||
146197733|NCT01186848|527235816|FG000|Overall Study|Withdrawal by Subject|2|||
146197734|NCT01186848|527235816|FG000|Overall Study|Adverse Event|2|||
146197735|NCT00158054|527235817|FG000|Overall Study|Refused to continue|3|||
146423083|NCT02446132|528055844|FG002|Overall Study|Adverse Event|27|||
146197736|NCT00158054|527235818|FG001|Overall Study|Refused to continue|0|||
146197737|NCT00158054|527235817|FG000|Overall Study|Unavailable for follow up|7|||
146197738|NCT00158054|527235818|FG001|Overall Study|Unavailable for follow up|3|||
146197739|NCT04567888|527235823|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
146197740|NCT04567888|527235824|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
146423084|NCT02446132|528055842|FG000|Overall Study|Death|2|||
145949297|NCT00803205|526325220|FG001|Overall Study|Acquired a Lung Infection|1|||
145949298|NCT00803205|526325219|FG000|Overall Study|Sponsor Decision|0|||
145949299|NCT00803205|526325220|FG001|Overall Study|Sponsor Decision|1|||
145949300|NCT00380718|526325223|FG000|Overall Study|Adverse Event|1|||
145949301|NCT00380718|526325223|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
145949302|NCT01606748|526325228|FG000|Overall Study|Adverse Event|1|||
145949303|NCT01606748|526325229|FG001|Overall Study|Adverse Event|0|||
145949304|NCT01606748|526325228|FG000|Overall Study|Progressive Disease|1|||
145949305|NCT01606748|526325229|FG001|Overall Study|Progressive Disease|0|||
145949306|NCT01606748|526325228|FG000|Overall Study|Withdrawal by Subject|1|||
145949307|NCT01606748|526325229|FG001|Overall Study|Withdrawal by Subject|0|||
145949308|NCT01706575|526325230|FG000|Overall Study|Participant Withdrew Consent|4|||
145949309|NCT01706575|526325230|FG000|Overall Study|Lost to Follow-up|2|||
145949310|NCT01706575|526325230|FG000|Overall Study|Started but not Treated|6|||
145949311|NCT02912455|526325231|FG000|Overall Study|Withdrawal by Subject|0|||
145949312|NCT02912455|526325232|FG001|Overall Study|Withdrawal by Subject|1|||
145949313|NCT02912455|526325231|FG000|Overall Study|Lack of Efficacy|0|||
145949314|NCT02912455|526325232|FG001|Overall Study|Lack of Efficacy|1|||
145949315|NCT02912455|526325231|FG000|Overall Study|Lost to Follow-up|2|||
145949316|NCT02912455|526325232|FG001|Overall Study|Lost to Follow-up|1|||
145949317|NCT00621517|526325238|FG000|Overall Study|Lost to Follow-up|3|||
146197741|NCT04567888|527235823|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
146197742|NCT04567888|527235824|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
146197743|NCT04567888|527235823|FG000|Overall Study|Reported Unusual Birth Year|2|||
146197744|NCT04567888|527235824|FG001|Overall Study|Reported Unusual Birth Year|3|||
146197745|NCT04567888|527235823|FG000|Overall Study|Duplicate Responses|0|||
146197746|NCT04567888|527235824|FG001|Overall Study|Duplicate Responses|1|||
146197747|NCT00414648|527235825|FG000|Overall Study|Adverse Event|5|||
146197748|NCT00414648|527235826|FG001|Overall Study|Adverse Event|5|||
146197749|NCT00414648|527235825|FG000|Overall Study|Death|0|||
146197750|NCT00414648|527235826|FG001|Overall Study|Death|1|||
146197751|NCT00414648|527235825|FG000|Overall Study|Lack of Efficacy|0|||
146197752|NCT00414648|527235826|FG001|Overall Study|Lack of Efficacy|2|||
146197753|NCT00414648|527235825|FG000|Overall Study|Withdrawal by Subject|0|||
146197754|NCT00414648|527235826|FG001|Overall Study|Withdrawal by Subject|1|||
146197755|NCT01194258|527235827|FG000|Titration Period|Withdrawal by Subject|6|||
146197756|NCT01194258|527235828|FG001|Titration Period|Withdrawal by Subject|0|||
146197757|NCT01194258|527235829|FG002|Titration Period|Withdrawal by Subject|0|||
146197758|NCT01194258|527235830|FG003|Titration Period|Withdrawal by Subject|0|||
146197759|NCT01194258|527235831|FG004|Titration Period|Withdrawal by Subject|0|||
146197760|NCT01194258|527235827|FG000|Titration Period|Lost to Follow-up|2|||
146197761|NCT01194258|527235828|FG001|Titration Period|Lost to Follow-up|0|||
146197762|NCT01194258|527235829|FG002|Titration Period|Lost to Follow-up|0|||
146197763|NCT01194258|527235830|FG003|Titration Period|Lost to Follow-up|0|||
146197764|NCT01194258|527235831|FG004|Titration Period|Lost to Follow-up|0|||
146197765|NCT01194258|527235827|FG000|Titration Period|Titration failure|3|||
146197766|NCT01194258|527235828|FG001|Titration Period|Titration failure|0|||
146197767|NCT01194258|527235829|FG002|Titration Period|Titration failure|0|||
146197768|NCT01194258|527235830|FG003|Titration Period|Titration failure|0|||
146197769|NCT01194258|527235831|FG004|Titration Period|Titration failure|0|||
146197770|NCT01194258|527235827|FG000|Period 1 (12 Weeks)|Death|0|||
146197771|NCT01194258|527235828|FG001|Period 1 (12 Weeks)|Death|0|||
146197772|NCT01194258|527235829|FG002|Period 1 (12 Weeks)|Death|0|||
146197773|NCT01194258|527235830|FG003|Period 1 (12 Weeks)|Death|0|||
146197774|NCT01194258|527235831|FG004|Period 1 (12 Weeks)|Death|1|||
146197775|NCT01194258|527235827|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146197776|NCT01194258|527235828|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146197777|NCT01194258|527235829|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146197778|NCT01194258|527235830|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146197779|NCT01194258|527235831|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
145949318|NCT00621517|526325239|FG001|Overall Study|Lost to Follow-up|3|||
145949319|NCT00621517|526325238|FG000|Overall Study|Withdrawal by Subject|3|||
145949320|NCT00621517|526325239|FG001|Overall Study|Withdrawal by Subject|4|||
146197780|NCT01194258|527235827|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
146197781|NCT01194258|527235828|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
146197782|NCT01194258|527235829|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
146197783|NCT01194258|527235830|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
145949321|NCT00621517|526325238|FG000|Overall Study|Adverse Event|1|||
145949322|NCT00621517|526325239|FG001|Overall Study|Adverse Event|0|||
146082629|NCT03104816|526822860|FG001|Overall Study|Lack of Efficacy|2|||
146197784|NCT01194258|527235831|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
146197785|NCT01194258|527235827|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146197786|NCT01194258|527235828|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146197787|NCT01194258|527235829|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146197788|NCT01194258|527235830|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146197789|NCT01194258|527235831|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146197790|NCT00619645|527235832|FG000|Overall Study|Adverse Event|1|||
146197791|NCT01490580|527235834|FG000|Overall Study|Parents withdrew consent|0|||
146197792|NCT01490580|527235835|FG001|Overall Study|Parents withdrew consent|2|||
146197793|NCT02026258|527235836|FG000|Randomized|Did not start treatment|2|||
146197794|NCT02026258|527235837|FG001|Randomized|Did not start treatment|1|||
146197795|NCT02026258|527235836|FG000|Randomized|Change in treatment plan|1|||
146197796|NCT02026258|527235837|FG001|Randomized|Change in treatment plan|0|||
146197797|NCT02026258|527235836|FG000|Randomized|Presence of periodontal disease|1|||
146197798|NCT02026258|527235837|FG001|Randomized|Presence of periodontal disease|1|||
146197799|NCT02026258|527235836|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
146197800|NCT02026258|527235837|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
146197801|NCT02026258|527235836|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
146197802|NCT02026258|527235837|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
146197803|NCT00383188|527235840|FG000|Overall Study|Adverse Event|4|||
146197804|NCT00383188|527235841|FG001|Overall Study|Adverse Event|7|||
146197805|NCT00383188|527235842|FG002|Overall Study|Adverse Event|9|||
146197806|NCT00383188|527235843|FG003|Overall Study|Adverse Event|8|||
146197807|NCT00383188|527235844|FG004|Overall Study|Adverse Event|8|||
146197808|NCT00383188|527235840|FG000|Overall Study|Lack of Efficacy|9|||
146197809|NCT00383188|527235841|FG001|Overall Study|Lack of Efficacy|3|||
146197810|NCT00383188|527235842|FG002|Overall Study|Lack of Efficacy|3|||
146197811|NCT00383188|527235843|FG003|Overall Study|Lack of Efficacy|2|||
146197812|NCT00383188|527235844|FG004|Overall Study|Lack of Efficacy|6|||
146197813|NCT00383188|527235840|FG000|Overall Study|Other|3|||
146197814|NCT00383188|527235841|FG001|Overall Study|Other|1|||
146197815|NCT00383188|527235842|FG002|Overall Study|Other|0|||
146197816|NCT00383188|527235843|FG003|Overall Study|Other|2|||
146197817|NCT00383188|527235844|FG004|Overall Study|Other|6|||
146197818|NCT00383188|527235840|FG000|Overall Study|No longer willing to participate|1|||
146197819|NCT00383188|527235841|FG001|Overall Study|No longer willing to participate|0|||
146197820|NCT00383188|527235842|FG002|Overall Study|No longer willing to participate|1|||
146197821|NCT00383188|527235843|FG003|Overall Study|No longer willing to participate|0|||
146197822|NCT00383188|527235844|FG004|Overall Study|No longer willing to participate|2|||
146197823|NCT00383188|527235840|FG000|Overall Study|Lost to Follow-up|0|||
146197824|NCT00383188|527235841|FG001|Overall Study|Lost to Follow-up|0|||
146197825|NCT00383188|527235842|FG002|Overall Study|Lost to Follow-up|0|||
146197826|NCT00383188|527235843|FG003|Overall Study|Lost to Follow-up|0|||
146197827|NCT00383188|527235844|FG004|Overall Study|Lost to Follow-up|1|||
146197828|NCT00597519|527235845|FG000|Overall Study|Death|1|||
146197829|NCT04246762|527235846|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
146197830|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
146197831|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
146197832|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
146197833|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
146197834|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
146197835|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
146197836|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
146197837|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
146197838|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
146197839|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
146197840|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
146197841|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
146197842|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Death|7|||
146197843|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Death|4|||
146197844|NCT00410124|527235847|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
146197845|NCT00410124|527235848|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
146197846|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
146197847|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
146197848|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
146197849|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
146197850|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
146197851|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
146197852|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
146197853|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
146197854|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
146197855|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
146197856|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
146423085|NCT02446132|528055843|FG001|Overall Study|Death|13|||
146197857|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
146197858|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
146197859|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
146197860|NCT00410124|527235847|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
146423086|NCT02446132|528055844|FG002|Overall Study|Death|10|||
145949323|NCT01863732|526325240|FG000|Overall Study|Adverse Event|2|||
145949324|NCT01863732|526325241|FG001|Overall Study|Adverse Event|0|||
145949325|NCT01863732|526325242|FG002|Overall Study|Adverse Event|3|||
145949326|NCT01863732|526325243|FG003|Overall Study|Adverse Event|3|||
145949327|NCT01863732|526325240|FG000|Overall Study|Lack of Efficacy|1|||
145949328|NCT01863732|526325241|FG001|Overall Study|Lack of Efficacy|0|||
145949329|NCT01863732|526325242|FG002|Overall Study|Lack of Efficacy|2|||
145949330|NCT01863732|526325243|FG003|Overall Study|Lack of Efficacy|1|||
145949331|NCT01863732|526325240|FG000|Overall Study|Lost to Follow-up|2|||
145949332|NCT01863732|526325241|FG001|Overall Study|Lost to Follow-up|2|||
145949333|NCT01863732|526325242|FG002|Overall Study|Lost to Follow-up|1|||
145949334|NCT01863732|526325243|FG003|Overall Study|Lost to Follow-up|1|||
145949335|NCT01863732|526325240|FG000|Overall Study|Physician Decision|1|||
145949336|NCT01863732|526325241|FG001|Overall Study|Physician Decision|0|||
145949337|NCT01863732|526325242|FG002|Overall Study|Physician Decision|1|||
145949338|NCT01863732|526325243|FG003|Overall Study|Physician Decision|0|||
145949339|NCT01863732|526325240|FG000|Overall Study|Pregnancy|0|||
145949340|NCT01863732|526325241|FG001|Overall Study|Pregnancy|0|||
145949341|NCT01863732|526325242|FG002|Overall Study|Pregnancy|0|||
145949342|NCT01863732|526325243|FG003|Overall Study|Pregnancy|1|||
145949343|NCT01863732|526325240|FG000|Overall Study|Technical problems|0|||
145949344|NCT01863732|526325241|FG001|Overall Study|Technical problems|1|||
145949345|NCT01863732|526325242|FG002|Overall Study|Technical problems|1|||
145949346|NCT01863732|526325243|FG003|Overall Study|Technical problems|0|||
145949347|NCT01863732|526325240|FG000|Overall Study|Subject/guardian decision|6|||
145949348|NCT01863732|526325241|FG001|Overall Study|Subject/guardian decision|9|||
145949349|NCT01863732|526325242|FG002|Overall Study|Subject/guardian decision|3|||
145949350|NCT01863732|526325243|FG003|Overall Study|Subject/guardian decision|1|||
145949351|NCT01863732|526325240|FG000|Overall Study|Death|1|||
145949352|NCT01863732|526325241|FG001|Overall Study|Death|0|||
145949353|NCT01863732|526325242|FG002|Overall Study|Death|0|||
145949354|NCT01863732|526325243|FG003|Overall Study|Death|1|||
145949355|NCT03084315|526325244|FG000|Overall Study|Lost to Follow-up|8|||
145949356|NCT03084315|526325245|FG001|Overall Study|Lost to Follow-up|7|||
145949357|NCT03084315|526325244|FG000|Overall Study|Withdrawal by Subject|2|||
145949358|NCT03084315|526325245|FG001|Overall Study|Withdrawal by Subject|2|||
145949359|NCT01810783|526325246|FG000|Overall Study|Adverse Event|32|||
145949360|NCT01810783|526325246|FG000|Overall Study|Withdrawal by Subject|22|||
145949361|NCT01810783|526325246|FG000|Overall Study|Lack of Efficacy|12|||
145949362|NCT01810783|526325246|FG000|Overall Study|Lost to Follow-up|10|||
145949363|NCT01810783|526325246|FG000|Overall Study|Protocol Violation|5|||
145949364|NCT01810783|526325246|FG000|Overall Study|Non-compliance with IMP|4|||
145949365|NCT01810783|526325246|FG000|Overall Study|Adminstrative or other reason(s)|23|||
145949366|NCT01810783|526325246|FG000|Overall Study|Enrolled, not treated|1|||
145949367|NCT00094536|526325251|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
145949368|NCT00094536|526325251|FG000|Treatment and Follow-up|Adverse Event|4|||
145949369|NCT00094536|526325251|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
145949370|NCT00094536|526325251|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
145949371|NCT00094536|526325251|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
145949372|NCT00094536|526325251|FG000|Treatment and Follow-up|Subject non-compliance|9|||
145949373|NCT00094536|526325251|FG000|Treatment and Follow-up|Unable to attend visits|1|||
146197861|NCT00410124|527235848|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
146197862|NCT03098030|527235849|FG000|Overall Study|Death|10|||
146197863|NCT03098030|527235850|FG001|Overall Study|Death|156|||
146197864|NCT03098030|527235851|FG002|Overall Study|Death|156|||
146197865|NCT03098030|527235852|FG003|Overall Study|Death|82|||
146197866|NCT03098030|527235849|FG000|Overall Study|Withdrawal by Subject|0|||
146197867|NCT03098030|527235850|FG001|Overall Study|Withdrawal by Subject|7|||
145949374|NCT02655419|526325252|FG000|Overall Study|Enrolled but not treated|1|||
145949375|NCT02655419|526325253|FG001|Overall Study|Enrolled but not treated|5|||
145949376|NCT02655419|526325252|FG000|Overall Study|Withdrawal by Subject|4|||
145949377|NCT02655419|526325253|FG001|Overall Study|Withdrawal by Subject|1|||
145949378|NCT02655419|526325252|FG000|Overall Study|Other|0|||
145949379|NCT02655419|526325253|FG001|Overall Study|Other|1|||
145949380|NCT01900431|526325254|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
145949381|NCT01900431|526325255|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
145949382|NCT01900431|526325256|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
145949383|NCT01900431|526325254|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
145949384|NCT01900431|526325255|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
145949385|NCT01900431|526325256|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
145949386|NCT01900431|526325254|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
145949387|NCT01900431|526325255|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
145949388|NCT01900431|526325256|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
145949389|NCT01900431|526325254|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
145949390|NCT01900431|526325255|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
145949391|NCT01900431|526325256|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
146197868|NCT03098030|527235851|FG002|Overall Study|Withdrawal by Subject|8|||
146197869|NCT03098030|527235852|FG003|Overall Study|Withdrawal by Subject|2|||
146197870|NCT03098030|527235849|FG000|Overall Study|Lost to Follow-up|0|||
146197871|NCT03098030|527235850|FG001|Overall Study|Lost to Follow-up|0|||
146197872|NCT03098030|527235851|FG002|Overall Study|Lost to Follow-up|2|||
146197873|NCT03098030|527235852|FG003|Overall Study|Lost to Follow-up|1|||
146197874|NCT05484726|527235853|FG000|Overall Study|Protocol Violation|3|||
146197875|NCT05484726|527235854|FG001|Overall Study|Protocol Violation|3|||
146197876|NCT05484726|527235853|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
146197877|NCT05484726|527235854|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
146197878|NCT05484726|527235853|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
146197879|NCT05484726|527235854|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
146197880|NCT05484726|527235853|FG000|Overall Study|continued need of mechanical ventilation|2|||
146197881|NCT05484726|527235854|FG001|Overall Study|continued need of mechanical ventilation|3|||
146197882|NCT05484726|527235853|FG000|Overall Study|Withdrawal by Subject|2|||
146197883|NCT05484726|527235854|FG001|Overall Study|Withdrawal by Subject|3|||
146197884|NCT05484726|527235853|FG000|Overall Study|IVH (G III & IV)|2|||
146197885|NCT05484726|527235854|FG001|Overall Study|IVH (G III & IV)|1|||
146197886|NCT05484726|527235853|FG000|Overall Study|NEC (stage II & III)|2|||
146197887|NCT05484726|527235854|FG001|Overall Study|NEC (stage II & III)|3|||
146197888|NCT04391309|527235855|FG000|Overall Study|Death|1|||
146197889|NCT04391309|527235856|FG001|Overall Study|Death|1|||
146197890|NCT04391309|527235855|FG000|Overall Study|Lost to Follow-up|3|||
146197891|NCT04391309|527235856|FG001|Overall Study|Lost to Follow-up|2|||
146197892|NCT04391309|527235855|FG000|Overall Study|Withdrawal by Subject|2|||
146197893|NCT04391309|527235856|FG001|Overall Study|Withdrawal by Subject|2|||
146197894|NCT03396913|527235857|FG000|Overall Study|Lost to Follow-up|0|||
146197895|NCT03396913|527235858|FG001|Overall Study|Lost to Follow-up|6|||
146197896|NCT02781584|527235859|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
146197897|NCT02781584|527235860|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
146197898|NCT02781584|527235861|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
146197899|NCT02781584|527235862|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
146197900|NCT02781584|527235863|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
146197901|NCT02781584|527235864|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
146197902|NCT02781584|527235865|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
146197903|NCT02781584|527235866|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
146197904|NCT02781584|527235867|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
146197905|NCT02781584|527235868|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
146197906|NCT02781584|527235869|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
146197907|NCT02781584|527235870|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
146197908|NCT02781584|527235871|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
146197909|NCT02781584|527235859|FG000|Pre-treatment Phase|Adverse Event|0|||
146197910|NCT02781584|527235860|FG001|Pre-treatment Phase|Adverse Event|0|||
146197911|NCT02781584|527235861|FG002|Pre-treatment Phase|Adverse Event|0|||
146197912|NCT02781584|527235862|FG003|Pre-treatment Phase|Adverse Event|0|||
146197913|NCT02781584|527235863|FG004|Pre-treatment Phase|Adverse Event|0|||
146197914|NCT02781584|527235864|FG005|Pre-treatment Phase|Adverse Event|0|||
146197915|NCT02781584|527235865|FG006|Pre-treatment Phase|Adverse Event|0|||
146197916|NCT02781584|527235866|FG007|Pre-treatment Phase|Adverse Event|0|||
146197917|NCT02781584|527235867|FG008|Pre-treatment Phase|Adverse Event|0|||
146197918|NCT02781584|527235868|FG009|Pre-treatment Phase|Adverse Event|0|||
146197919|NCT02781584|527235869|FG010|Pre-treatment Phase|Adverse Event|0|||
146197920|NCT02781584|527235870|FG011|Pre-treatment Phase|Adverse Event|1|||
146197921|NCT02781584|527235871|FG012|Pre-treatment Phase|Adverse Event|0|||
146197922|NCT02781584|527235859|FG000|Treatment Phase|Withdrew Consent|0|||
146197923|NCT02781584|527235860|FG001|Treatment Phase|Withdrew Consent|0|||
146197924|NCT02781584|527235861|FG002|Treatment Phase|Withdrew Consent|0|||
146197925|NCT02781584|527235862|FG003|Treatment Phase|Withdrew Consent|0|||
146197926|NCT02781584|527235863|FG004|Treatment Phase|Withdrew Consent|0|||
146197927|NCT02781584|527235864|FG005|Treatment Phase|Withdrew Consent|1|||
146197928|NCT02781584|527235865|FG006|Treatment Phase|Withdrew Consent|0|||
146197929|NCT02781584|527235866|FG007|Treatment Phase|Withdrew Consent|0|||
146197930|NCT02781584|527235867|FG008|Treatment Phase|Withdrew Consent|0|||
146197931|NCT02781584|527235868|FG009|Treatment Phase|Withdrew Consent|0|||
146197932|NCT02781584|527235869|FG010|Treatment Phase|Withdrew Consent|1|||
146197933|NCT02781584|527235870|FG011|Treatment Phase|Withdrew Consent|2|||
146197934|NCT02781584|527235871|FG012|Treatment Phase|Withdrew Consent|0|||
146197935|NCT02781584|527235859|FG000|Treatment Phase|Adverse Event|0|||
146197936|NCT02781584|527235860|FG001|Treatment Phase|Adverse Event|0|||
146197937|NCT02781584|527235861|FG002|Treatment Phase|Adverse Event|0|||
146197938|NCT02781584|527235862|FG003|Treatment Phase|Adverse Event|0|||
146197939|NCT02781584|527235863|FG004|Treatment Phase|Adverse Event|0|||
146197940|NCT02781584|527235864|FG005|Treatment Phase|Adverse Event|0|||
146197941|NCT02781584|527235865|FG006|Treatment Phase|Adverse Event|0|||
146197942|NCT02781584|527235866|FG007|Treatment Phase|Adverse Event|1|||
146197943|NCT02781584|527235867|FG008|Treatment Phase|Adverse Event|0|||
146197944|NCT02781584|527235868|FG009|Treatment Phase|Adverse Event|0|||
146197945|NCT02781584|527235869|FG010|Treatment Phase|Adverse Event|0|||
146423087|NCT02446132|528055842|FG000|Overall Study|Lack of Efficacy|1|||
146423088|NCT02446132|528055843|FG001|Overall Study|Lack of Efficacy|10|||
146197946|NCT02781584|527235870|FG011|Treatment Phase|Adverse Event|0|||
146197947|NCT02781584|527235871|FG012|Treatment Phase|Adverse Event|0|||
146197948|NCT05826431|527235872|FG000|Overall Study|Withdrawal by Subject|1|||
146197949|NCT04771273|527235875|FG000|Dose Escalation Period|Not treated with trial medication|0|||
146197950|NCT04771273|527235876|FG001|Dose Escalation Period|Not treated with trial medication|1|||
146197951|NCT04771273|527235877|FG002|Dose Escalation Period|Not treated with trial medication|1|||
146197952|NCT04771273|527235878|FG003|Dose Escalation Period|Not treated with trial medication|0|||
146197953|NCT04771273|527235875|FG000|Dose Escalation Period|Other reasons than listed|2|||
146197954|NCT04771273|527235876|FG001|Dose Escalation Period|Other reasons than listed|0|||
146197955|NCT04771273|527235877|FG002|Dose Escalation Period|Other reasons than listed|2|||
146197956|NCT04771273|527235878|FG003|Dose Escalation Period|Other reasons than listed|1|||
146197957|NCT04771273|527235875|FG000|Dose Escalation Period|Protocol Violation|0|||
146197958|NCT04771273|527235876|FG001|Dose Escalation Period|Protocol Violation|0|||
146197959|NCT04771273|527235877|FG002|Dose Escalation Period|Protocol Violation|3|||
146197960|NCT04771273|527235878|FG003|Dose Escalation Period|Protocol Violation|1|||
146197961|NCT04771273|527235875|FG000|Dose Escalation Period|Burden of study procedures|1|||
146197962|NCT04771273|527235876|FG001|Dose Escalation Period|Burden of study procedures|0|||
146197963|NCT04771273|527235877|FG002|Dose Escalation Period|Burden of study procedures|0|||
146197964|NCT04771273|527235878|FG003|Dose Escalation Period|Burden of study procedures|0|||
146197965|NCT04771273|527235875|FG000|Dose Escalation Period|Change of residence|0|||
146197966|NCT04771273|527235876|FG001|Dose Escalation Period|Change of residence|0|||
146197967|NCT04771273|527235877|FG002|Dose Escalation Period|Change of residence|0|||
146197968|NCT04771273|527235878|FG003|Dose Escalation Period|Change of residence|1|||
146197969|NCT04771273|527235875|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
146197970|NCT04771273|527235876|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
146197971|NCT04771273|527235877|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
146197972|NCT04771273|527235878|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
146197973|NCT04771273|527235875|FG000|Dose Escalation Period|Adverse Event|8|||
146197974|NCT04771273|527235876|FG001|Dose Escalation Period|Adverse Event|9|||
146197975|NCT04771273|527235877|FG002|Dose Escalation Period|Adverse Event|12|||
146197976|NCT04771273|527235878|FG003|Dose Escalation Period|Adverse Event|2|||
146197977|NCT04771273|527235875|FG000|Maintenance Period|Other than listed|4|||
146197978|NCT04771273|527235876|FG001|Maintenance Period|Other than listed|2|||
146197979|NCT04771273|527235877|FG002|Maintenance Period|Other than listed|0|||
146197980|NCT04771273|527235878|FG003|Maintenance Period|Other than listed|3|||
146197981|NCT04771273|527235875|FG000|Maintenance Period|Burden of study procedures|1|||
146197982|NCT04771273|527235876|FG001|Maintenance Period|Burden of study procedures|0|||
146197983|NCT04771273|527235877|FG002|Maintenance Period|Burden of study procedures|0|||
146197984|NCT04771273|527235878|FG003|Maintenance Period|Burden of study procedures|0|||
146197985|NCT04771273|527235875|FG000|Maintenance Period|Change of residence|0|||
146197986|NCT04771273|527235876|FG001|Maintenance Period|Change of residence|1|||
146197987|NCT04771273|527235877|FG002|Maintenance Period|Change of residence|3|||
146197988|NCT04771273|527235878|FG003|Maintenance Period|Change of residence|0|||
146197989|NCT04771273|527235875|FG000|Maintenance Period|Perceived lack of efficacy|0|||
146197990|NCT04771273|527235876|FG001|Maintenance Period|Perceived lack of efficacy|0|||
146197991|NCT04771273|527235877|FG002|Maintenance Period|Perceived lack of efficacy|0|||
146197992|NCT04771273|527235878|FG003|Maintenance Period|Perceived lack of efficacy|1|||
146197993|NCT04771273|527235875|FG000|Maintenance Period|Adverse Event|4|||
146197994|NCT04771273|527235876|FG001|Maintenance Period|Adverse Event|5|||
146197995|NCT04771273|527235877|FG002|Maintenance Period|Adverse Event|5|||
146197996|NCT04771273|527235878|FG003|Maintenance Period|Adverse Event|0|||
146197997|NCT04436120|527235882|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146197998|NCT04436120|527235883|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146197999|NCT04436120|527235884|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146198000|NCT04436120|527235885|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
146198001|NCT04436120|527235886|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146198002|NCT04436120|527235887|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
146198003|NCT04436120|527235888|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
146198004|NCT04222959|527235892|FG000|Overall Study|Lost to Follow-up|76|||
146198005|NCT04222959|527235893|FG001|Overall Study|Lost to Follow-up|28|||
146198006|NCT04776213|527235900|FG000|Overall Study|Other|1|||
146198007|NCT04776213|527235900|FG000|Overall Study|Withdrawal by Subject|7|||
146198008|NCT04776213|527235900|FG000|Overall Study|Protocol Violation|1|||
146198009|NCT04776213|527235900|FG000|Overall Study|Lost to Follow-up|2|||
146198010|NCT02540213|527235901|FG000|Overall Study|Death/adverse event|18|||
146198011|NCT02540213|527235901|FG000|Overall Study|Administrative reasons|3|||
146198012|NCT02540213|527235901|FG000|Overall Study|Kidney transplant|3|||
146198013|NCT02540213|527235901|FG000|Overall Study|Lack of Efficacy|6|||
146423089|NCT02446132|528055844|FG002|Overall Study|Lack of Efficacy|6|||
146423090|NCT02446132|528055842|FG000|Overall Study|Lost to Follow-up|2|||
146423091|NCT02446132|528055843|FG001|Overall Study|Lost to Follow-up|4|||
146423092|NCT02446132|528055844|FG002|Overall Study|Lost to Follow-up|5|||
146423093|NCT02446132|528055842|FG000|Overall Study|Non-compliance With Study Drug|2|||
146423094|NCT02446132|528055843|FG001|Overall Study|Non-compliance With Study Drug|2|||
146423095|NCT02446132|528055844|FG002|Overall Study|Non-compliance With Study Drug|3|||
146423096|NCT02446132|528055842|FG000|Overall Study|Physician Decision|1|||
146423097|NCT02446132|528055843|FG001|Overall Study|Physician Decision|8|||
146423098|NCT02446132|528055844|FG002|Overall Study|Physician Decision|13|||
146423099|NCT02446132|528055842|FG000|Overall Study|Protocol Deviation|0|||
146423100|NCT02446132|528055843|FG001|Overall Study|Protocol Deviation|0|||
146423101|NCT02446132|528055844|FG002|Overall Study|Protocol Deviation|1|||
146423102|NCT02446132|528055842|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
146423103|NCT02446132|528055843|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
146423104|NCT02446132|528055844|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
146423105|NCT02446132|528055842|FG000|Overall Study|Study Terminated by Sponsor|4|||
146423106|NCT02446132|528055843|FG001|Overall Study|Study Terminated by Sponsor|35|||
146423107|NCT02446132|528055844|FG002|Overall Study|Study Terminated by Sponsor|58|||
146423108|NCT02446132|528055842|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
146423109|NCT02446132|528055843|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
146423110|NCT02446132|528055844|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
146423111|NCT02446132|528055842|FG000|Overall Study|Withdrawal by Subject|11|||
146423112|NCT02446132|528055843|FG001|Overall Study|Withdrawal by Subject|29|||
146423113|NCT02446132|528055844|FG002|Overall Study|Withdrawal by Subject|25|||
146423114|NCT02446132|528055842|FG000|Overall Study|Reason not Specified|4|||
146423115|NCT02446132|528055843|FG001|Overall Study|Reason not Specified|16|||
146198014|NCT02540213|527235901|FG000|Overall Study|Consent withdrawn|7|||
146198015|NCT02540213|527235901|FG000|Overall Study|Enrolled but not treated|2|||
146198016|NCT02289560|527235902|FG000|Overall Study|Lost to Follow-up|6|||
146198017|NCT02289560|527235902|FG000|Overall Study|Alternative Treatment|4|||
146198018|NCT02289560|527235902|FG000|Overall Study|Inadequate Treatment|2|||
146423116|NCT02446132|528055844|FG002|Overall Study|Reason not Specified|10|||
146423117|NCT02446132|528055842|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
146423118|NCT02446132|528055843|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
146423119|NCT02446132|528055844|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
146423120|NCT05526248|528055845|FG000|Overall Study|Lost to Follow-up|1|||
146423121|NCT05526248|528055845|FG000|Overall Study|Adverse Event|2|||
146423122|NCT05526248|528055845|FG000|Overall Study|Withdrawal by Subject|1|||
146423123|NCT03444038|528055846|FG000|Overall Study|Adverse Event|12|||
146423124|NCT03444038|528055846|FG000|Overall Study|Withdrawal by Subject|7|||
146423125|NCT03444038|528055846|FG000|Overall Study|Lost to Follow-up|1|||
146423126|NCT03444038|528055846|FG000|Overall Study|Physician Decision|2|||
146198019|NCT02289560|527235902|FG000|Overall Study|Withdrawal by Subject|23|||
146198020|NCT01981356|527235910|FG000|Overall Study|Lost to Follow-up|4|||
146198021|NCT01981356|527235911|FG001|Overall Study|Lost to Follow-up|1|||
146198022|NCT01981356|527235910|FG000|Overall Study|Withdrawal by Subject|1|||
146198023|NCT01981356|527235911|FG001|Overall Study|Withdrawal by Subject|1|||
146198024|NCT01981356|527235910|FG000|Overall Study|Protocol Violation|2|||
146198025|NCT01981356|527235911|FG001|Overall Study|Protocol Violation|0|||
146198026|NCT03395353|527235912|FG000|Overall Study|Adverse Event|20|||
146198027|NCT03395353|527235912|FG000|Overall Study|Protocol Violation|1|||
146198028|NCT03395353|527235912|FG000|Overall Study|Lack of Efficacy|3|||
146198029|NCT03395353|527235912|FG000|Overall Study|Withdrawal by Subject|24|||
146198030|NCT03395353|527235912|FG000|Overall Study|Discontinued visit|1|||
146198031|NCT03395353|527235912|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
146198032|NCT03395353|527235912|FG000|Overall Study|Physician Decision|4|||
146198033|NCT03395353|527235912|FG000|Overall Study|Early termination of overall study|33|||
146198034|NCT02013037|527235914|FG000|Overall Study|Death|6|||
146198035|NCT02013037|527235914|FG000|Overall Study|Withdrawal by Subject|1|||
146198036|NCT02013037|527235914|FG000|Overall Study|Awaiting Transplantation|7|||
146198037|NCT02013037|527235914|FG000|Overall Study|Transplanted without DSA|2|||
146198038|NCT03354390|527235915|FG000|Level 1|Death|2|||
146423127|NCT03444038|528055846|FG000|Overall Study|Lack of Efficacy|7|||
146423128|NCT00977106|528055847|FG000|Overall Study|Adverse Event|5|||
146423129|NCT00977106|528055848|FG001|Overall Study|Adverse Event|6|||
146423130|NCT00977106|528055847|FG000|Overall Study|Withdrawal by Subject|2|||
146423131|NCT00977106|528055848|FG001|Overall Study|Withdrawal by Subject|2|||
146082630|NCT03104816|526822861|FG002|Overall Study|Lack of Efficacy|0|||
146198039|NCT03354390|527235916|FG001|Level 1|Death|0|||
146198040|NCT03354390|527235917|FG002|Level 1|Death|0|||
146198041|NCT03354390|527235918|FG003|Level 1|Death|0|||
146198042|NCT03354390|527235915|FG000|Level 1|Physician Decision|1|||
146198043|NCT03354390|527235916|FG001|Level 1|Physician Decision|0|||
146423132|NCT00977106|528055847|FG000|Overall Study|Lack of Efficacy|2|||
146423133|NCT00977106|528055848|FG001|Overall Study|Lack of Efficacy|2|||
146423134|NCT00977106|528055847|FG000|Overall Study|Protocol Violation|0|||
146423135|NCT00977106|528055848|FG001|Overall Study|Protocol Violation|1|||
146423136|NCT00977106|528055847|FG000|Overall Study|Other|1|||
146423137|NCT00977106|528055848|FG001|Overall Study|Other|0|||
146423138|NCT00436007|528055851|FG000|Overall Study|Withdrawal by Subject|5|||
146423139|NCT00436007|528055852|FG001|Overall Study|Withdrawal by Subject|3|||
146423140|NCT00436007|528055853|FG002|Overall Study|Withdrawal by Subject|4|||
146423141|NCT00436007|528055851|FG000|Overall Study|Lost to Follow-up|14|||
146423142|NCT00436007|528055852|FG001|Overall Study|Lost to Follow-up|10|||
146423143|NCT00436007|528055853|FG002|Overall Study|Lost to Follow-up|13|||
146423144|NCT00436007|528055851|FG000|Overall Study|Physician Decision|0|||
146423145|NCT00436007|528055852|FG001|Overall Study|Physician Decision|0|||
146423146|NCT00436007|528055853|FG002|Overall Study|Physician Decision|2|||
146423147|NCT00436007|528055851|FG000|Overall Study|Death|0|||
146423148|NCT00436007|528055852|FG001|Overall Study|Death|1|||
146423149|NCT00436007|528055853|FG002|Overall Study|Death|3|||
146423150|NCT00436007|528055851|FG000|Overall Study|Other|0|||
146423151|NCT00436007|528055852|FG001|Overall Study|Other|0|||
146423152|NCT00436007|528055853|FG002|Overall Study|Other|1|||
146423153|NCT00721409|528055855|FG000|Overall Study|Global deterioration of health status|2|||
146423154|NCT00721409|528055856|FG001|Overall Study|Global deterioration of health status|6|||
146423155|NCT00721409|528055857|FG002|Overall Study|Global deterioration of health status|3|||
146423156|NCT00721409|528055855|FG000|Overall Study|Death|0|||
146423157|NCT00721409|528055856|FG001|Overall Study|Death|1|||
146423158|NCT00721409|528055857|FG002|Overall Study|Death|0|||
146423159|NCT00721409|528055855|FG000|Overall Study|Randomized not Treated|0|||
146423160|NCT00721409|528055856|FG001|Overall Study|Randomized not Treated|1|||
146423161|NCT00721409|528055857|FG002|Overall Study|Randomized not Treated|4|||
146423162|NCT00721409|528055855|FG000|Overall Study|Reason not specified|1|||
146423163|NCT00721409|528055856|FG001|Overall Study|Reason not specified|0|||
146423164|NCT00721409|528055857|FG002|Overall Study|Reason not specified|2|||
146423165|NCT00721409|528055855|FG000|Overall Study|Adverse Event|0|||
146423166|NCT00721409|528055856|FG001|Overall Study|Adverse Event|13|||
146423167|NCT00721409|528055857|FG002|Overall Study|Adverse Event|2|||
146423168|NCT00721409|528055855|FG000|Overall Study|Lost to Follow-up|0|||
146423169|NCT00721409|528055856|FG001|Overall Study|Lost to Follow-up|0|||
146423170|NCT00721409|528055857|FG002|Overall Study|Lost to Follow-up|1|||
146198044|NCT03354390|527235917|FG002|Level 1|Physician Decision|0|||
146423171|NCT00721409|528055855|FG000|Overall Study|Withdrawal by Subject|1|||
146423172|NCT00721409|528055856|FG001|Overall Study|Withdrawal by Subject|6|||
146423173|NCT00721409|528055857|FG002|Overall Study|Withdrawal by Subject|5|||
146198045|NCT03354390|527235918|FG003|Level 1|Physician Decision|0|||
146198046|NCT03354390|527235915|FG000|Level 2|Physician Decision|0|||
146198047|NCT03354390|527235916|FG001|Level 2|Physician Decision|2|||
146198048|NCT03354390|527235917|FG002|Level 2|Physician Decision|0|||
146198049|NCT03354390|527235918|FG003|Level 2|Physician Decision|0|||
146198050|NCT03354390|527235915|FG000|Level 2|Lack of Efficacy|0|||
146198051|NCT03354390|527235916|FG001|Level 2|Lack of Efficacy|1|||
146198052|NCT03354390|527235917|FG002|Level 2|Lack of Efficacy|0|||
146198053|NCT03354390|527235918|FG003|Level 2|Lack of Efficacy|0|||
146198054|NCT03354390|527235915|FG000|Level 2|Lost to Follow-up|0|||
146198055|NCT03354390|527235916|FG001|Level 2|Lost to Follow-up|1|||
146198056|NCT03354390|527235917|FG002|Level 2|Lost to Follow-up|0|||
146198057|NCT03354390|527235918|FG003|Level 2|Lost to Follow-up|0|||
146198058|NCT03354390|527235915|FG000|Level 3|Death|0|||
146198059|NCT03354390|527235916|FG001|Level 3|Death|0|||
146198060|NCT03354390|527235917|FG002|Level 3|Death|1|||
146198061|NCT03354390|527235918|FG003|Level 3|Death|0|||
146198062|NCT03354390|527235915|FG000|Level 3|Physician Decision|0|||
146198063|NCT03354390|527235916|FG001|Level 3|Physician Decision|0|||
146198064|NCT03354390|527235917|FG002|Level 3|Physician Decision|2|||
146198065|NCT03354390|527235918|FG003|Level 3|Physician Decision|0|||
146198066|NCT03354390|527235915|FG000|Level 4|Death|0|||
146423174|NCT00721409|528055855|FG000|Overall Study|Objective progression or relapse|8|||
146423175|NCT00721409|528055856|FG001|Overall Study|Objective progression or relapse|55|||
146198067|NCT03354390|527235916|FG001|Level 4|Death|0|||
146198068|NCT03354390|527235917|FG002|Level 4|Death|0|||
146198069|NCT03354390|527235918|FG003|Level 4|Death|3|||
146198070|NCT00726596|527237051|FG000|Overall Study|Adverse Event|2|||
146423176|NCT00721409|528055857|FG002|Overall Study|Objective progression or relapse|62|||
146423177|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
146423178|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146423179|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
146423180|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
146198071|NCT00726596|527237052|FG001|Overall Study|Adverse Event|1|||
146198072|NCT00726596|527237051|FG000|Overall Study|Withdrawal by Subject|3|||
146198073|NCT00726596|527237052|FG001|Overall Study|Withdrawal by Subject|3|||
146423181|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146423182|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
146423183|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
146423184|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
146423185|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
146423186|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
146423187|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
146423188|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
146423189|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
146423190|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
146423191|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
146423192|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
146423193|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
146423194|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
146423195|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146423196|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146423197|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
146423198|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146423199|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
146423200|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
146423201|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146423202|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146423203|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146423204|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146423205|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
146198074|NCT02962674|527237055|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
146198075|NCT00364286|527237056|FG000|Overall Study|Withdrawal by Subject|1|||
146198076|NCT00364286|527237056|FG000|Overall Study|Adverse Event|2|||
146198077|NCT01227278|527237057|FG000|Overall Study|Withdrawal by Subject|4|||
146198078|NCT01227278|527237058|FG001|Overall Study|Withdrawal by Subject|4|||
146198079|NCT01227278|527237057|FG000|Overall Study|Death|0|||
146198080|NCT01227278|527237058|FG001|Overall Study|Death|2|||
146198081|NCT01227278|527237057|FG000|Overall Study|Other|1|||
146198082|NCT01227278|527237058|FG001|Overall Study|Other|2|||
146198083|NCT03546907|527237059|FG000|Overall Study|Lack of Efficacy|1|||
146198084|NCT03546907|527237060|FG001|Overall Study|Lack of Efficacy|1|||
146198085|NCT03546907|527237059|FG000|Overall Study|Withdrawal by Subject|8|||
146198086|NCT03546907|527237060|FG001|Overall Study|Withdrawal by Subject|9|||
146423206|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
146423207|NCT01957488|528055858|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
146423208|NCT01957488|528055859|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
146423209|NCT01957488|528055860|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
146423210|NCT01957488|528055861|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
146423211|NCT01957488|528055862|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
146423212|NCT01957488|528055863|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
146423213|NCT01957488|528055858|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
146423214|NCT01957488|528055859|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146423215|NCT01957488|528055860|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
146198087|NCT03546907|527237059|FG000|Overall Study|Adverse events (AEs)|7|||
146198088|NCT03546907|527237060|FG001|Overall Study|Adverse events (AEs)|10|||
146423216|NCT01957488|528055861|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
146423217|NCT01957488|528055862|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146423218|NCT01957488|528055863|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
146423219|NCT01957488|528055858|FG000|Test Period 2 (2 Weeks)|Other|1|||
146423220|NCT01957488|528055859|FG001|Test Period 2 (2 Weeks)|Other|0|||
146423221|NCT01957488|528055860|FG002|Test Period 2 (2 Weeks)|Other|0|||
146423222|NCT01957488|528055861|FG003|Test Period 2 (2 Weeks)|Other|0|||
146423223|NCT01957488|528055862|FG004|Test Period 2 (2 Weeks)|Other|0|||
146423224|NCT01957488|528055863|FG005|Test Period 2 (2 Weeks)|Other|0|||
146423225|NCT01957488|528055858|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146423226|NCT01957488|528055859|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
146423227|NCT01957488|528055860|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146423228|NCT01957488|528055861|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146423229|NCT01957488|528055862|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146423230|NCT01957488|528055863|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
146423231|NCT01957488|528055858|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
146423232|NCT01957488|528055859|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
146423233|NCT01957488|528055860|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
146423234|NCT01957488|528055861|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
146423235|NCT01957488|528055862|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
146423236|NCT01957488|528055863|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
146423237|NCT01957488|528055858|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146423238|NCT01957488|528055859|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146423239|NCT01957488|528055860|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146423240|NCT01957488|528055861|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146423241|NCT01957488|528055862|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
146423242|NCT01957488|528055863|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
146423243|NCT01957488|528055858|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
146423244|NCT01957488|528055859|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146423245|NCT01957488|528055860|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146423246|NCT01957488|528055861|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146423247|NCT01957488|528055862|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146423248|NCT01957488|528055863|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
146423249|NCT01957488|528055858|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146423250|NCT01957488|528055859|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
146423251|NCT01957488|528055860|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146198089|NCT03546907|527237059|FG000|Overall Study|Other-unspecified|1|||
146198090|NCT03546907|527237060|FG001|Overall Study|Other-unspecified|1|||
146198091|NCT03720210|527237061|FG000|Overall Study|Lost to Follow-up|1|||
146198092|NCT00864682|527237063|FG000|Overall Study|Protocol Violation|2|||
146198093|NCT00864682|527237064|FG001|Overall Study|Protocol Violation|1|||
146198094|NCT00864682|527237065|FG002|Overall Study|Protocol Violation|2|||
146198095|NCT01585038|527237066|FG000|Overall Study|Adverse Event|2|||
146198096|NCT01585038|527237067|FG001|Overall Study|Adverse Event|2|||
146198097|NCT01833832|527237073|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
146198098|NCT04842604|527237074|FG000|Overall Study|Death|1|||
146198099|NCT04842604|527237075|FG001|Overall Study|Death|0|||
146198100|NCT04842604|527237074|FG000|Overall Study|Other|4|||
146198101|NCT04842604|527237075|FG001|Overall Study|Other|4|||
146198102|NCT04842604|527237074|FG000|Overall Study|Randomized but not treated|1|||
146198103|NCT04842604|527237075|FG001|Overall Study|Randomized but not treated|0|||
146198104|NCT00344019|527237077|FG000|Overall Study|did not meet final inclusion criteria|0|||
146198105|NCT00344019|527237078|FG001|Overall Study|did not meet final inclusion criteria|0|||
146198106|NCT00344019|527237079|FG002|Overall Study|did not meet final inclusion criteria|74|||
146198107|NCT02503202|527237080|FG000|Base Study: Up to Month 6|Death|1|||
146198108|NCT02503202|527237081|FG001|Base Study: Up to Month 6|Death|1|||
146198109|NCT02503202|527237082|FG002|Base Study: Up to Month 6|Death|0|||
146198110|NCT02503202|527237083|FG003|Base Study: Up to Month 6|Death|0|||
146198111|NCT02503202|527237084|FG004|Base Study: Up to Month 6|Death|0|||
146198112|NCT02503202|527237080|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
146198113|NCT02503202|527237081|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
146198114|NCT02503202|527237082|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
146198115|NCT02503202|527237083|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
146423252|NCT01957488|528055861|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146423253|NCT01957488|528055862|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146423254|NCT01957488|528055863|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
146198116|NCT02503202|527237084|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
146198117|NCT02503202|527237080|FG000|Base Study: Up to Month 6|Physician Decision|0|||
146198118|NCT02503202|527237081|FG001|Base Study: Up to Month 6|Physician Decision|0|||
146198119|NCT02503202|527237082|FG002|Base Study: Up to Month 6|Physician Decision|0|||
146423255|NCT02419313|528055864|FG000|First Intervention|Lost to Follow-up|2|||
146423256|NCT02419313|528055865|FG001|First Intervention|Lost to Follow-up|0|||
146423257|NCT02419313|528055864|FG000|Second Intervention|Lost to Follow-up|1|||
146423258|NCT02419313|528055865|FG001|Second Intervention|Lost to Follow-up|0|||
146198120|NCT02503202|527237083|FG003|Base Study: Up to Month 6|Physician Decision|0|||
146198121|NCT02503202|527237084|FG004|Base Study: Up to Month 6|Physician Decision|1|||
146198122|NCT02503202|527237080|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
146198123|NCT02503202|527237081|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
146198124|NCT02503202|527237082|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
146198125|NCT02503202|527237083|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
146198126|NCT02503202|527237084|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
146198127|NCT02503202|527237080|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146198128|NCT02503202|527237081|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146198129|NCT02503202|527237082|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
146198130|NCT02503202|527237083|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
146198131|NCT02503202|527237084|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
146198132|NCT02503202|527237080|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
146198133|NCT02503202|527237081|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
146198134|NCT02503202|527237082|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
146198135|NCT02503202|527237083|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
146198136|NCT02503202|527237084|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
146198137|NCT02503202|527237080|FG000|Extension: Month 6 to 24|Death|1|||
146198138|NCT02503202|527237081|FG001|Extension: Month 6 to 24|Death|0|||
146198139|NCT02503202|527237082|FG002|Extension: Month 6 to 24|Death|0|||
146198140|NCT02503202|527237083|FG003|Extension: Month 6 to 24|Death|0|||
146198141|NCT02503202|527237084|FG004|Extension: Month 6 to 24|Death|0|||
146198142|NCT02503202|527237080|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
146198143|NCT02503202|527237081|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
146198144|NCT02503202|527237082|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
146198145|NCT02503202|527237083|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
146198146|NCT02503202|527237084|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
146198147|NCT02503202|527237080|FG000|Extension: Month 6 to 24|Physician Decision|1|||
146198148|NCT02503202|527237081|FG001|Extension: Month 6 to 24|Physician Decision|0|||
146198149|NCT02503202|527237082|FG002|Extension: Month 6 to 24|Physician Decision|1|||
146198150|NCT02503202|527237083|FG003|Extension: Month 6 to 24|Physician Decision|3|||
146198151|NCT02503202|527237084|FG004|Extension: Month 6 to 24|Physician Decision|0|||
146198152|NCT02503202|527237080|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
146198153|NCT02503202|527237081|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
146198154|NCT02503202|527237082|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
146198155|NCT02503202|527237083|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
146198156|NCT02503202|527237084|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
146198157|NCT00130637|527237087|FG000|Overall Study|Adverse Event|2|||
146198158|NCT00130637|527237087|FG000|Overall Study|Withdrawal by Subject|1|||
146198159|NCT01191788|527237088|FG000|Overall Study|Lost to Follow-up|21|||
146198160|NCT01191788|527237089|FG001|Overall Study|Lost to Follow-up|22|||
146198161|NCT00217672|527237093|FG000|Allocation|Ineligible|2|||
146198162|NCT00217672|527237094|FG001|Allocation|Ineligible|0|||
146198163|NCT00217672|527237093|FG000|Treatment|disease progression|33|||
146198164|NCT00217672|527237094|FG001|Treatment|disease progression|4|||
146198165|NCT00217672|527237093|FG000|Treatment|Adverse Event|18|||
146198166|NCT00217672|527237094|FG001|Treatment|Adverse Event|2|||
146198167|NCT00217672|527237093|FG000|Treatment|reqd treatment not permitted by protocol|6|||
146198168|NCT00217672|527237094|FG001|Treatment|reqd treatment not permitted by protocol|0|||
146198169|NCT00217672|527237093|FG000|Treatment|Physician Decision|6|||
146198170|NCT00217672|527237094|FG001|Treatment|Physician Decision|0|||
146198171|NCT00217672|527237093|FG000|Treatment|insurance issues|1|||
146198172|NCT00217672|527237094|FG001|Treatment|insurance issues|1|||
146198173|NCT00217672|527237093|FG000|Treatment|Death|2|||
146198174|NCT00217672|527237094|FG001|Treatment|Death|0|||
146198175|NCT00217672|527237093|FG000|Treatment|secondary malignancy|1|||
146198176|NCT00217672|527237094|FG001|Treatment|secondary malignancy|0|||
146198177|NCT00217672|527237093|FG000|Follow-up|Withdrawal by Subject|4|||
146198178|NCT00217672|527237094|FG001|Follow-up|Withdrawal by Subject|0|||
146198179|NCT00217672|527237093|FG000|Follow-up|Lost to Follow-up|1|||
146198180|NCT00217672|527237094|FG001|Follow-up|Lost to Follow-up|0|||
146198181|NCT00436644|527237105|FG000|Overall Study|Adverse Event|2|||
146198182|NCT00436644|527237105|FG000|Overall Study|Death|1|||
146198183|NCT04364269|527237106|FG000|Overall Study|Adverse Event|1|||
146198184|NCT04364269|527237107|FG001|Overall Study|Adverse Event|0|||
146198185|NCT04364269|527237108|FG002|Overall Study|Adverse Event|0|||
146198186|NCT04364269|527237106|FG000|Overall Study|Withdrawal by Subject|0|||
146198187|NCT04364269|527237107|FG001|Overall Study|Withdrawal by Subject|1|||
146198188|NCT04364269|527237108|FG002|Overall Study|Withdrawal by Subject|0|||
146198189|NCT00878722|527237109|FG000|Overall Study|Progressive disease|3|||
146423259|NCT00810368|528055866|FG000|Overall Study|Lost to Follow-up|4|||
146423260|NCT00810368|528055867|FG001|Overall Study|Lost to Follow-up|2|||
146423261|NCT00810368|528055866|FG000|Overall Study|Lack of Efficacy|2|||
146423262|NCT00810368|528055867|FG001|Overall Study|Lack of Efficacy|0|||
146423263|NCT00623103|528055868|FG000|Overall Study|Adverse Event|70|||
146423264|NCT00623103|528055869|FG001|Overall Study|Adverse Event|60|||
146423265|NCT00623103|528055868|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146423266|NCT00623103|528055869|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
146423267|NCT00623103|528055868|FG000|Overall Study|Withdrawal by Subject|18|||
146423268|NCT00623103|528055869|FG001|Overall Study|Withdrawal by Subject|24|||
146423269|NCT00623103|528055868|FG000|Overall Study|Lost to Follow-up|4|||
146423270|NCT00623103|528055869|FG001|Overall Study|Lost to Follow-up|1|||
146423271|NCT00623103|528055868|FG000|Overall Study|Administrative problems|2|||
146423272|NCT00623103|528055869|FG001|Overall Study|Administrative problems|4|||
146198190|NCT00878722|527237110|FG001|Overall Study|Progressive disease|3|||
146198191|NCT00878722|527237111|FG002|Overall Study|Progressive disease|3|||
146198192|NCT00878722|527237112|FG003|Overall Study|Progressive disease|7|||
146198193|NCT00878722|527237113|FG004|Overall Study|Progressive disease|7|||
146198194|NCT00878722|527237114|FG005|Overall Study|Progressive disease|1|||
146198195|NCT00878722|527237115|FG006|Overall Study|Progressive disease|4|||
146198196|NCT00878722|527237116|FG007|Overall Study|Progressive disease|3|||
146198197|NCT00878722|527237109|FG000|Overall Study|Death|0|||
146198198|NCT00878722|527237110|FG001|Overall Study|Death|0|||
146198199|NCT00878722|527237111|FG002|Overall Study|Death|0|||
146198200|NCT00878722|527237112|FG003|Overall Study|Death|1|||
146198201|NCT00878722|527237113|FG004|Overall Study|Death|0|||
146198202|NCT00878722|527237114|FG005|Overall Study|Death|1|||
146198203|NCT00878722|527237115|FG006|Overall Study|Death|0|||
146198204|NCT00878722|527237116|FG007|Overall Study|Death|2|||
146198205|NCT00878722|527237109|FG000|Overall Study|Adverse Event|0|||
146198206|NCT00878722|527237110|FG001|Overall Study|Adverse Event|0|||
146198207|NCT00878722|527237111|FG002|Overall Study|Adverse Event|0|||
146198208|NCT00878722|527237112|FG003|Overall Study|Adverse Event|0|||
146198209|NCT00878722|527237113|FG004|Overall Study|Adverse Event|0|||
146198210|NCT00878722|527237114|FG005|Overall Study|Adverse Event|0|||
146198211|NCT00878722|527237115|FG006|Overall Study|Adverse Event|2|||
146198212|NCT00878722|527237116|FG007|Overall Study|Adverse Event|0|||
146198213|NCT00878722|527237109|FG000|Overall Study|Withdrawal by Subject|0|||
146198214|NCT00878722|527237110|FG001|Overall Study|Withdrawal by Subject|0|||
146198215|NCT00878722|527237111|FG002|Overall Study|Withdrawal by Subject|0|||
146198216|NCT00878722|527237112|FG003|Overall Study|Withdrawal by Subject|0|||
146198217|NCT00878722|527237113|FG004|Overall Study|Withdrawal by Subject|0|||
146198218|NCT00878722|527237114|FG005|Overall Study|Withdrawal by Subject|0|||
146198219|NCT00878722|527237115|FG006|Overall Study|Withdrawal by Subject|0|||
146198220|NCT00878722|527237116|FG007|Overall Study|Withdrawal by Subject|2|||
146198221|NCT00878722|527237109|FG000|Overall Study|Relapse|0|||
146198222|NCT00878722|527237110|FG001|Overall Study|Relapse|0|||
146198223|NCT00878722|527237111|FG002|Overall Study|Relapse|0|||
146198224|NCT00878722|527237112|FG003|Overall Study|Relapse|1|||
146198225|NCT00878722|527237113|FG004|Overall Study|Relapse|0|||
146198226|NCT00878722|527237114|FG005|Overall Study|Relapse|0|||
146198227|NCT00878722|527237115|FG006|Overall Study|Relapse|0|||
146198228|NCT00878722|527237116|FG007|Overall Study|Relapse|0|||
146198229|NCT00972504|527237117|FG000|Overall Study|Adverse Event|2|||
146198230|NCT00972504|527237117|FG000|Overall Study|Investigator discretion|1|||
146198231|NCT02878330|527237118|FG000|Overall Study|Death|3|||
146198232|NCT02878330|527237119|FG001|Overall Study|Death|2|||
146198233|NCT02878330|527237118|FG000|Overall Study|Lost to Follow-up|11|||
146198234|NCT02878330|527237119|FG001|Overall Study|Lost to Follow-up|26|||
146198235|NCT02878330|527237118|FG000|Overall Study|Withdrawal by Subject|11|||
146198236|NCT02878330|527237119|FG001|Overall Study|Withdrawal by Subject|21|||
146198237|NCT02878330|527237118|FG000|Overall Study|Other|4|||
146198238|NCT02878330|527237119|FG001|Overall Study|Other|7|||
146423273|NCT00623103|528055868|FG000|Overall Study|Death|11|||
146423274|NCT00623103|528055869|FG001|Overall Study|Death|11|||
146423275|NCT00623103|528055868|FG000|Overall Study|Protocol deviation|2|||
146423276|NCT00623103|528055869|FG001|Overall Study|Protocol deviation|1|||
146423277|NCT00442936|528055873|FG000|Overall Study|Protocol Violation|1|||
146423278|NCT00442936|528055874|FG001|Overall Study|Protocol Violation|0|||
146198239|NCT00082810|527237124|FG000|Overall Study|Adverse Event|3|||
146198240|NCT00082810|527237124|FG000|Overall Study|Progressive disease|24|||
146198241|NCT00082810|527237124|FG000|Overall Study|Withdrawal by Subject|4|||
146198242|NCT01321606|527237130|FG000|Overall Study|Lost to Follow-up|0|||
146198243|NCT01321606|527237131|FG001|Overall Study|Lost to Follow-up|0|||
146198244|NCT01321606|527237132|FG002|Overall Study|Lost to Follow-up|0|||
146198245|NCT01321606|527237133|FG003|Overall Study|Lost to Follow-up|1|||
146198246|NCT02341625|527237141|FG000|Overall Study|Disease Progression|2|||
146198247|NCT02341625|527237142|FG001|Overall Study|Disease Progression|2|||
146198248|NCT02341625|527237143|FG002|Overall Study|Disease Progression|3|||
146198249|NCT02341625|527237144|FG003|Overall Study|Disease Progression|6|||
146423279|NCT00442936|528055875|FG002|Overall Study|Protocol Violation|1|||
146423280|NCT00442936|528055876|FG003|Overall Study|Protocol Violation|1|||
146423281|NCT00524459|528055878|FG000|Overall Study|Withdrawal by Subject|1|||
146423282|NCT00524459|528055878|FG000|Overall Study|Other|1|||
146423283|NCT02428699|528055879|FG000|Washout Period 1|Screen Failure|1|||
146423284|NCT02428699|528055880|FG001|Washout Period 1|Screen Failure|2|||
146423285|NCT02433678|528055881|FG000|Overall Study|Lost to Follow-up|1|||
146423286|NCT02433678|528055882|FG001|Overall Study|Lost to Follow-up|2|||
146423287|NCT04424407|528055883|FG000|Overall Study|Withdrawal by Subject|2|||
146423288|NCT04424407|528055883|FG000|Overall Study|Lost to Follow-up|1|||
146423289|NCT01424722|528055886|FG000|Overall Study|Sponsor terminated investigation|2258|||
146423290|NCT02684578|528055887|FG000|Overall Study|Withdrawal by Subject|10|||
146423291|NCT02684578|528055888|FG001|Overall Study|Withdrawal by Subject|7|||
146423292|NCT02684578|528055887|FG000|Overall Study|Lost to Follow-up|0|||
146423293|NCT02684578|528055888|FG001|Overall Study|Lost to Follow-up|3|||
146423294|NCT02684578|528055887|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
146423295|NCT02684578|528055888|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
146423296|NCT02684578|528055887|FG000|Overall Study|Missing follow-up data|0|||
146423297|NCT02684578|528055888|FG001|Overall Study|Missing follow-up data|1|||
146423298|NCT01153984|528055889|FG000|Overall Study|Withdrawal by Subject|1|||
146423299|NCT01153984|528055889|FG000|Overall Study|Adverse Event|1|||
146423300|NCT02460159|528055890|FG000|Overall Study|Adverse Event|4|||
146423301|NCT02460159|528055891|FG001|Overall Study|Adverse Event|1|||
146423302|NCT02460159|528055890|FG000|Overall Study|Withdrawal by Subject|2|||
146423303|NCT02460159|528055891|FG001|Overall Study|Withdrawal by Subject|0|||
146423304|NCT03499964|528055892|FG000|Overall Study|Lack of Efficacy|6|||
146423305|NCT03499964|528055893|FG001|Overall Study|Lack of Efficacy|26|||
146423306|NCT03499964|528055892|FG000|Overall Study|Adverse Event|1|||
146423307|NCT03499964|528055893|FG001|Overall Study|Adverse Event|0|||
146423308|NCT03499964|528055892|FG000|Overall Study|Death|1|||
146423309|NCT03499964|528055893|FG001|Overall Study|Death|0|||
146423310|NCT03499964|528055892|FG000|Overall Study|Withdrawal by Subject|2|||
146423311|NCT03499964|528055893|FG001|Overall Study|Withdrawal by Subject|1|||
146423312|NCT03499964|528055892|FG000|Overall Study|Lost to Follow-up|1|||
145949392|NCT01900431|526325254|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
145949393|NCT01900431|526325255|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
145949394|NCT01900431|526325256|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
145949395|NCT01900431|526325254|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
145949396|NCT01900431|526325255|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
145949397|NCT01900431|526325256|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
145949398|NCT01900431|526325254|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
145949399|NCT01900431|526325255|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
145949400|NCT01900431|526325256|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
145949401|NCT01900431|526325254|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
145949402|NCT01900431|526325255|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
145949403|NCT01900431|526325256|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
145949404|NCT01900431|526325254|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
145949405|NCT01900431|526325255|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
145949406|NCT01900431|526325256|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
145949407|NCT04503668|526325257|FG000|Overall Study|Incomplete data|4|||
145949408|NCT04503668|526325258|FG001|Overall Study|Incomplete data|3|||
145949409|NCT04503668|526325257|FG000|Overall Study|Withdrawal by Subject|1|||
145949410|NCT04503668|526325258|FG001|Overall Study|Withdrawal by Subject|1|||
145949411|NCT04503668|526325257|FG000|Overall Study|Adverse Event|2|||
145949412|NCT04503668|526325258|FG001|Overall Study|Adverse Event|0|||
145949413|NCT03403621|526325259|FG000|Overall Study|Withdrawal by Subject|2|||
145949414|NCT03403621|526325260|FG001|Overall Study|Withdrawal by Subject|2|||
145949415|NCT00395642|526325261|FG000|Overall Study|Death|4|||
145949416|NCT00395642|526325261|FG000|Overall Study|Lost to Follow-up|1|||
145949417|NCT00395642|526325261|FG000|Overall Study|Physician Decision|7|||
145949418|NCT00395642|526325261|FG000|Overall Study|Withdrawal by Subject|1|||
145949419|NCT00659776|526325263|FG000|Overall Study|Withdrawal by Subject|12|||
146423313|NCT03499964|528055893|FG001|Overall Study|Lost to Follow-up|0|||
146423314|NCT01193608|528055894|FG000|Overall Study|Other|0|||
146423315|NCT01193608|528055895|FG001|Overall Study|Other|1|||
146423316|NCT01193608|528055896|FG002|Overall Study|Other|0|||
145949420|NCT00659776|526325264|FG001|Overall Study|Withdrawal by Subject|2|||
145949421|NCT00659776|526325265|FG002|Overall Study|Withdrawal by Subject|0|||
145949422|NCT00448812|526325266|FG000|Year 2|Missed visit but remained in study|4|||
145949423|NCT00448812|526325267|FG001|Year 2|Missed visit but remained in study|1|||
146423317|NCT01193608|528055897|FG003|Overall Study|Other|0|||
146423318|NCT01193608|528055898|FG004|Overall Study|Other|0|||
146423319|NCT01193608|528055899|FG005|Overall Study|Other|0|||
146423320|NCT01193608|528055894|FG000|Overall Study|Withdrawal by Subject|0|||
146423321|NCT01193608|528055895|FG001|Overall Study|Withdrawal by Subject|1|||
146423322|NCT01193608|528055896|FG002|Overall Study|Withdrawal by Subject|2|||
146423323|NCT01193608|528055897|FG003|Overall Study|Withdrawal by Subject|3|||
146423324|NCT01193608|528055898|FG004|Overall Study|Withdrawal by Subject|3|||
146423325|NCT01193608|528055899|FG005|Overall Study|Withdrawal by Subject|0|||
146423326|NCT01193608|528055894|FG000|Overall Study|Lost to Follow-up|0|||
146198250|NCT02341625|527237145|FG004|Overall Study|Disease Progression|7|||
146423327|NCT01193608|528055895|FG001|Overall Study|Lost to Follow-up|0|||
146423328|NCT01193608|528055896|FG002|Overall Study|Lost to Follow-up|0|||
146423329|NCT01193608|528055897|FG003|Overall Study|Lost to Follow-up|0|||
146423330|NCT01193608|528055898|FG004|Overall Study|Lost to Follow-up|1|||
146423331|NCT01193608|528055899|FG005|Overall Study|Lost to Follow-up|2|||
146423332|NCT01193608|528055894|FG000|Overall Study|Adverse Event|0|||
146423333|NCT01193608|528055895|FG001|Overall Study|Adverse Event|0|||
146423334|NCT01193608|528055896|FG002|Overall Study|Adverse Event|0|||
146423335|NCT01193608|528055897|FG003|Overall Study|Adverse Event|0|||
146423336|NCT01193608|528055898|FG004|Overall Study|Adverse Event|1|||
146423337|NCT01193608|528055899|FG005|Overall Study|Adverse Event|0|||
146423338|NCT01025037|528055903|FG000|Overall Study|Adverse Event|3|||
146423339|NCT01025037|528055903|FG000|Overall Study|Lost to Follow-up|7|||
146423340|NCT01025037|528055903|FG000|Overall Study|Withdrawal by Subject|1|||
146423341|NCT02674334|528055906|FG000|Overall Study|Lost to Follow-up|5|||
146423342|NCT02674334|528055907|FG001|Overall Study|Lost to Follow-up|3|||
146423343|NCT02674334|528055906|FG000|Overall Study|participant difficulty breathing|1|||
146423344|NCT02674334|528055907|FG001|Overall Study|participant difficulty breathing|0|||
146423345|NCT02674334|528055906|FG000|Overall Study|NIRS not recording|1|||
146423346|NCT02674334|528055907|FG001|Overall Study|NIRS not recording|0|||
146423347|NCT02660242|528055913|FG000|Glucose Tabs|Lost to Follow-up|1|||
146423348|NCT02660242|528055913|FG000|Glucagon Injection|Lost to Follow-up|1|||
146423349|NCT02796664|528055915|FG000|Overall Study|Withdrawal by Subject|0|||
146423350|NCT02796664|528055916|FG001|Overall Study|Withdrawal by Subject|3|||
146423351|NCT02796664|528055915|FG000|Overall Study|Noncompliance|1|||
146423352|NCT02796664|528055916|FG001|Overall Study|Noncompliance|1|||
146423353|NCT02796664|528055915|FG000|Overall Study|Death|0|||
146423354|NCT02796664|528055916|FG001|Overall Study|Death|1|||
146198251|NCT02341625|527237146|FG005|Overall Study|Disease Progression|7|||
146198252|NCT02341625|527237147|FG006|Overall Study|Disease Progression|28|||
146198253|NCT02341625|527237148|FG007|Overall Study|Disease Progression|5|||
146198254|NCT02341625|527237149|FG008|Overall Study|Disease Progression|4|||
146198255|NCT02341625|527237150|FG009|Overall Study|Disease Progression|19|||
146198256|NCT02341625|527237141|FG000|Overall Study|Study Drug Toxicity|0|||
146198257|NCT02341625|527237142|FG001|Overall Study|Study Drug Toxicity|0|||
146198258|NCT02341625|527237143|FG002|Overall Study|Study Drug Toxicity|0|||
146198259|NCT02341625|527237144|FG003|Overall Study|Study Drug Toxicity|1|||
146198260|NCT02341625|527237145|FG004|Overall Study|Study Drug Toxicity|0|||
146198261|NCT02341625|527237146|FG005|Overall Study|Study Drug Toxicity|3|||
146198262|NCT02341625|527237147|FG006|Overall Study|Study Drug Toxicity|10|||
146198263|NCT02341625|527237148|FG007|Overall Study|Study Drug Toxicity|0|||
146198264|NCT02341625|527237149|FG008|Overall Study|Study Drug Toxicity|0|||
146198265|NCT02341625|527237150|FG009|Overall Study|Study Drug Toxicity|3|||
146198266|NCT02341625|527237141|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198267|NCT02341625|527237142|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198268|NCT02341625|527237143|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198269|NCT02341625|527237144|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198270|NCT02341625|527237145|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198271|NCT02341625|527237146|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198272|NCT02341625|527237147|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146198273|NCT02341625|527237148|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146198274|NCT02341625|527237149|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146198275|NCT02341625|527237150|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
146198276|NCT02341625|527237141|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198277|NCT02341625|527237142|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198278|NCT02341625|527237143|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146082631|NCT03104816|526822859|FG000|Overall Study|Protocol Violation|2|||
146198279|NCT02341625|527237144|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198280|NCT02341625|527237145|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198281|NCT02341625|527237146|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198282|NCT02341625|527237147|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
146198283|NCT02341625|527237148|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
146423355|NCT00995553|528055918|FG000|Overall Study|Withdrawal by Subject|2|||
146423356|NCT00995553|528055919|FG001|Overall Study|Withdrawal by Subject|6|||
146423357|NCT01531205|528055920|FG000|Overall Study|Did not proceed to surgery|1|||
146423358|NCT00918567|528055923|FG000|Overall Study|Lack of Efficacy|3|||
146423359|NCT00918567|528055924|FG001|Overall Study|Lack of Efficacy|1|||
146423360|NCT00918567|528055923|FG000|Overall Study|Withdrawal by Subject|1|||
145949424|NCT00448812|526325266|FG000|Year 3|Withdrawal by Subject|1|||
145949425|NCT00448812|526325267|FG001|Year 3|Withdrawal by Subject|3|||
145949426|NCT00448812|526325266|FG000|Year 3|Lost to Follow-up|1|||
145949427|NCT00448812|526325267|FG001|Year 3|Lost to Follow-up|0|||
145949428|NCT00448812|526325266|FG000|Year 3|Missed visit but remained in study|2|||
145949429|NCT00448812|526325267|FG001|Year 3|Missed visit but remained in study|0|||
145949430|NCT00448812|526325266|FG000|Year 5|Missed visit but remained in study|1|||
145949431|NCT00448812|526325267|FG001|Year 5|Missed visit but remained in study|0|||
145949432|NCT01687283|526326623|FG000|Overall Study|Adverse Event|11|||
145949433|NCT01687283|526326624|FG001|Overall Study|Adverse Event|4|||
145949434|NCT01687283|526326623|FG000|Overall Study|Lack of Efficacy|3|||
145949435|NCT01687283|526326624|FG001|Overall Study|Lack of Efficacy|1|||
145949436|NCT01687283|526326623|FG000|Overall Study|Protocol Violation|1|||
145949437|NCT01687283|526326624|FG001|Overall Study|Protocol Violation|3|||
145949438|NCT01687283|526326623|FG000|Overall Study|protocol defined stopping criteria|8|||
146198284|NCT02341625|527237149|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198285|NCT02341625|527237150|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
146198286|NCT02341625|527237141|FG000|Overall Study|Participant Withdrew Consent|0|||
146198287|NCT02341625|527237142|FG001|Overall Study|Participant Withdrew Consent|0|||
146198288|NCT02341625|527237143|FG002|Overall Study|Participant Withdrew Consent|0|||
146198289|NCT02341625|527237144|FG003|Overall Study|Participant Withdrew Consent|1|||
146198290|NCT02341625|527237145|FG004|Overall Study|Participant Withdrew Consent|0|||
146198291|NCT02341625|527237146|FG005|Overall Study|Participant Withdrew Consent|0|||
146198292|NCT02341625|527237147|FG006|Overall Study|Participant Withdrew Consent|0|||
146198293|NCT02341625|527237148|FG007|Overall Study|Participant Withdrew Consent|0|||
146198294|NCT02341625|527237149|FG008|Overall Study|Participant Withdrew Consent|0|||
146198295|NCT02341625|527237150|FG009|Overall Study|Participant Withdrew Consent|0|||
146198296|NCT02341625|527237141|FG000|Overall Study|Completed Treatment as per Protocol|0|||
146198297|NCT02341625|527237142|FG001|Overall Study|Completed Treatment as per Protocol|0|||
146198298|NCT02341625|527237143|FG002|Overall Study|Completed Treatment as per Protocol|0|||
146198299|NCT02341625|527237144|FG003|Overall Study|Completed Treatment as per Protocol|0|||
146198300|NCT02341625|527237145|FG004|Overall Study|Completed Treatment as per Protocol|0|||
146198301|NCT02341625|527237146|FG005|Overall Study|Completed Treatment as per Protocol|0|||
146198302|NCT02341625|527237147|FG006|Overall Study|Completed Treatment as per Protocol|0|||
146198303|NCT02341625|527237148|FG007|Overall Study|Completed Treatment as per Protocol|0|||
146198304|NCT02341625|527237149|FG008|Overall Study|Completed Treatment as per Protocol|0|||
146198305|NCT02341625|527237150|FG009|Overall Study|Completed Treatment as per Protocol|1|||
146198306|NCT02341625|527237141|FG000|Overall Study|Other Reasons|0|||
146198307|NCT02341625|527237142|FG001|Overall Study|Other Reasons|0|||
146198308|NCT02341625|527237143|FG002|Overall Study|Other Reasons|0|||
146198309|NCT02341625|527237144|FG003|Overall Study|Other Reasons|0|||
146198310|NCT02341625|527237145|FG004|Overall Study|Other Reasons|1|||
146198311|NCT02341625|527237146|FG005|Overall Study|Other Reasons|0|||
146198312|NCT02341625|527237147|FG006|Overall Study|Other Reasons|5|||
146198313|NCT02341625|527237148|FG007|Overall Study|Other Reasons|0|||
146198314|NCT02341625|527237149|FG008|Overall Study|Other Reasons|0|||
146198315|NCT02341625|527237150|FG009|Overall Study|Other Reasons|2|||
146198316|NCT02341625|527237141|FG000|Overall Study|Not Reported|0|||
146198317|NCT02341625|527237142|FG001|Overall Study|Not Reported|0|||
146198318|NCT02341625|527237143|FG002|Overall Study|Not Reported|0|||
146198319|NCT02341625|527237144|FG003|Overall Study|Not Reported|0|||
146198320|NCT02341625|527237145|FG004|Overall Study|Not Reported|0|||
146198321|NCT02341625|527237146|FG005|Overall Study|Not Reported|0|||
146198322|NCT02341625|527237147|FG006|Overall Study|Not Reported|0|||
146198323|NCT02341625|527237148|FG007|Overall Study|Not Reported|0|||
146198324|NCT02341625|527237149|FG008|Overall Study|Not Reported|0|||
146198325|NCT02341625|527237150|FG009|Overall Study|Not Reported|3|||
146198326|NCT01839877|527237153|FG000|Overall Study|Protocol Violation|1|||
146198327|NCT03368001|527237156|FG000|Allocation|Lost to Pretest|16|||
146198328|NCT03368001|527237157|FG001|Allocation|Lost to Pretest|25|||
146198329|NCT03368001|527237156|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
146198330|NCT03368001|527237157|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
146198331|NCT03368001|527237156|FG000|Posttest|Lost to Posttest|7|||
146198332|NCT03368001|527237157|FG001|Posttest|Lost to Posttest|11|||
146198333|NCT03368001|527237156|FG000|Posttest|Discontinued Intervention|6|||
146198334|NCT03368001|527237157|FG001|Posttest|Discontinued Intervention|19|||
146198335|NCT03368001|527237156|FG000|Follow-up|Lost to Follow-up|6|||
145949439|NCT01687283|526326624|FG001|Overall Study|protocol defined stopping criteria|10|||
145949440|NCT01687283|526326623|FG000|Overall Study|Lost to Follow-up|1|||
145949441|NCT01687283|526326624|FG001|Overall Study|Lost to Follow-up|1|||
145949442|NCT01687283|526326623|FG000|Overall Study|Investigator discretion|2|||
146198336|NCT03368001|527237157|FG001|Follow-up|Lost to Follow-up|3|||
146198337|NCT03008915|527237160|FG000|Treatment 1|Withdrawal by Subject|0|||
146198338|NCT03008915|527237161|FG001|Treatment 1|Withdrawal by Subject|1|||
146198339|NCT00712166|527237162|FG000|Overall Study|Noncompliance|0|||
146198340|NCT00712166|527237163|FG001|Overall Study|Noncompliance|1|||
146423361|NCT00918567|528055924|FG001|Overall Study|Withdrawal by Subject|1|||
146423362|NCT00918567|528055923|FG000|Overall Study|Adverse Event|1|||
146423363|NCT00918567|528055924|FG001|Overall Study|Adverse Event|0|||
146423364|NCT04803357|528055925|FG000|Overall Study|Withdrawal by Subject|31|||
146423365|NCT04803357|528055926|FG001|Overall Study|Withdrawal by Subject|5|||
146423366|NCT02879643|528055927|FG000|Overall Study|Adverse Event|0|||
146423367|NCT02879643|528055928|FG001|Overall Study|Adverse Event|0|||
146423368|NCT02879643|528055929|FG002|Overall Study|Adverse Event|1|||
146423369|NCT02879643|528055930|FG003|Overall Study|Adverse Event|1|||
146423370|NCT02879643|528055931|FG004|Overall Study|Adverse Event|0|||
146423371|NCT00182091|528055932|FG000|Overall Study|Withdrawal by Subject|1|||
146423372|NCT00182091|528055933|FG001|Overall Study|Withdrawal by Subject|0|||
146423373|NCT00182091|528055934|FG002|Overall Study|Withdrawal by Subject|0|||
146198341|NCT01773122|527237164|FG000|Overall Study|Due to amended age eligibility criteria|3|||
146423374|NCT00182091|528055935|FG003|Overall Study|Withdrawal by Subject|0|||
146423375|NCT05905783|528055937|FG000|Overall Study|Lost to Follow-up|12|||
146423376|NCT05905783|528055938|FG001|Overall Study|Lost to Follow-up|18|||
146423377|NCT05905783|528055937|FG000|Overall Study|Withdrawal by Subject|29|||
146423378|NCT05905783|528055938|FG001|Overall Study|Withdrawal by Subject|37|||
146198342|NCT01773122|527237165|FG001|Overall Study|Due to amended age eligibility criteria|1|||
146198343|NCT01773122|527237166|FG002|Overall Study|Due to amended age eligibility criteria|0|||
146198344|NCT01773122|527237167|FG003|Overall Study|Due to amended age eligibility criteria|1|||
146198345|NCT01769391|527237168|FG000|Overall Study|Death|10|||
146198346|NCT01769391|527237169|FG001|Overall Study|Death|1|||
146198347|NCT01769391|527237168|FG000|Overall Study|Adverse Event|0|||
146198348|NCT01769391|527237169|FG001|Overall Study|Adverse Event|3|||
146198349|NCT01769391|527237168|FG000|Overall Study|Progressive Disease|1|||
146198350|NCT01769391|527237169|FG001|Overall Study|Progressive Disease|2|||
146198351|NCT01769391|527237168|FG000|Overall Study|Withdrawal by Subject|4|||
146198352|NCT01769391|527237169|FG001|Overall Study|Withdrawal by Subject|3|||
146198353|NCT01769391|527237168|FG000|Overall Study|Investigator Decision|2|||
146198354|NCT01769391|527237169|FG001|Overall Study|Investigator Decision|0|||
146198355|NCT01066923|527237178|FG000|Overall Study|Withdrawal by Subject|3|||
146198356|NCT01066923|527237179|FG001|Overall Study|Withdrawal by Subject|3|||
146198357|NCT01066923|527237180|FG002|Overall Study|Withdrawal by Subject|8|||
146198358|NCT01066923|527237181|FG003|Overall Study|Withdrawal by Subject|8|||
146198359|NCT00357396|527238958|FG000|Overall Study|Adverse Event|1|||
146198360|NCT00357396|527238959|FG001|Overall Study|Adverse Event|0|||
146423379|NCT05905783|528055937|FG000|Overall Study|Decision by sponsor|69|||
146423380|NCT05905783|528055938|FG001|Overall Study|Decision by sponsor|65|||
146423381|NCT03968224|528055939|FG000|Overall Study|Lost to Follow-up|11|||
146423382|NCT03968224|528055940|FG001|Overall Study|Lost to Follow-up|18|||
146423383|NCT03717064|528057090|FG000|Period 2|Adverse Event|1|||
146198361|NCT02488980|527238961|FG000|Overall Study|Protocol Violation|2|||
146198362|NCT02488980|527238962|FG001|Overall Study|Protocol Violation|2|||
146423384|NCT03103100|528057091|FG000|Overall Study|Adverse Event|1|||
146423385|NCT03103100|528057092|FG001|Overall Study|Adverse Event|0|||
146423386|NCT03103100|528057093|FG002|Overall Study|Adverse Event|0|||
146423387|NCT03103100|528057091|FG000|Overall Study|Physician Decision|1|||
146423388|NCT03103100|528057092|FG001|Overall Study|Physician Decision|0|||
146423389|NCT03103100|528057093|FG002|Overall Study|Physician Decision|2|||
146423390|NCT00688064|528057096|FG000|Overall Study|Protocol Violation|0|||
146423391|NCT00688064|528057097|FG001|Overall Study|Protocol Violation|1|||
146423392|NCT00688064|528057096|FG000|Overall Study|Adverse Event|2|||
146423393|NCT00688064|528057097|FG001|Overall Study|Adverse Event|4|||
146423394|NCT00688064|528057096|FG000|Overall Study|Withdrawal by Subject|7|||
146423395|NCT00688064|528057097|FG001|Overall Study|Withdrawal by Subject|7|||
146423396|NCT00688064|528057096|FG000|Overall Study|Lost to Follow-up|10|||
146423397|NCT00688064|528057097|FG001|Overall Study|Lost to Follow-up|10|||
146423398|NCT00688064|528057096|FG000|Overall Study|Lack of Efficacy|0|||
146423399|NCT00688064|528057097|FG001|Overall Study|Lack of Efficacy|1|||
146423400|NCT00688064|528057096|FG000|Overall Study|Pregnancy|1|||
146423401|NCT00688064|528057097|FG001|Overall Study|Pregnancy|0|||
146423402|NCT00688064|528057096|FG000|Overall Study|Any other reasons|1|||
146423403|NCT00688064|528057097|FG001|Overall Study|Any other reasons|3|||
146423404|NCT00950807|528057104|FG000|Treatment Period 1|Lack of Efficacy|1|||
146423405|NCT00950807|528057105|FG001|Treatment Period 1|Lack of Efficacy|0|||
146423406|NCT00950807|528057106|FG002|Treatment Period 1|Lack of Efficacy|0|||
146423407|NCT00950807|528057107|FG003|Treatment Period 1|Lack of Efficacy|0|||
146423408|NCT00950807|528057108|FG004|Treatment Period 1|Lack of Efficacy|0|||
146423409|NCT00950807|528057109|FG005|Treatment Period 1|Lack of Efficacy|1|||
146423410|NCT00950807|528057110|FG006|Treatment Period 1|Lack of Efficacy|0|||
146423411|NCT00950807|528057111|FG007|Treatment Period 1|Lack of Efficacy|0|||
146423412|NCT00950807|528057112|FG008|Treatment Period 1|Lack of Efficacy|0|||
146423413|NCT00950807|528057113|FG009|Treatment Period 1|Lack of Efficacy|0|||
146423414|NCT00950807|528057104|FG000|Treatment Period 1|Protocol Violation|1|||
146423415|NCT00950807|528057105|FG001|Treatment Period 1|Protocol Violation|0|||
146423416|NCT00950807|528057106|FG002|Treatment Period 1|Protocol Violation|0|||
146423417|NCT00950807|528057107|FG003|Treatment Period 1|Protocol Violation|0|||
146423418|NCT00950807|528057108|FG004|Treatment Period 1|Protocol Violation|0|||
146423419|NCT00950807|528057109|FG005|Treatment Period 1|Protocol Violation|0|||
146423420|NCT00950807|528057110|FG006|Treatment Period 1|Protocol Violation|0|||
146423421|NCT00950807|528057111|FG007|Treatment Period 1|Protocol Violation|0|||
146423422|NCT00950807|528057112|FG008|Treatment Period 1|Protocol Violation|0|||
146423423|NCT00950807|528057113|FG009|Treatment Period 1|Protocol Violation|0|||
146423424|NCT00950807|528057104|FG000|Treatment Period 1|Lost to Follow-up|0|||
146423425|NCT00950807|528057105|FG001|Treatment Period 1|Lost to Follow-up|0|||
146423426|NCT00950807|528057106|FG002|Treatment Period 1|Lost to Follow-up|1|||
146423427|NCT00950807|528057107|FG003|Treatment Period 1|Lost to Follow-up|0|||
146423428|NCT00950807|528057108|FG004|Treatment Period 1|Lost to Follow-up|0|||
146423429|NCT00950807|528057109|FG005|Treatment Period 1|Lost to Follow-up|0|||
146423430|NCT00950807|528057110|FG006|Treatment Period 1|Lost to Follow-up|0|||
145949443|NCT01687283|526326624|FG001|Overall Study|Investigator discretion|0|||
145949444|NCT01687283|526326623|FG000|Overall Study|Withdrawal by Subject|9|||
145949445|NCT01687283|526326624|FG001|Overall Study|Withdrawal by Subject|8|||
145949446|NCT01153009|526326628|FG000|Overall Study|Adverse Event|4|||
145949447|NCT01153009|526326629|FG001|Overall Study|Adverse Event|14|||
146082632|NCT03104816|526822860|FG001|Overall Study|Protocol Violation|0|||
146198363|NCT02488980|527238963|FG002|Overall Study|Protocol Violation|2|||
146198364|NCT05174013|527238964|FG000|Overall Study|Lost to Follow-up|0|||
146198365|NCT05174013|527238965|FG001|Overall Study|Lost to Follow-up|0|||
146198366|NCT05174013|527238966|FG002|Overall Study|Lost to Follow-up|0|||
146198367|NCT05174013|527238967|FG003|Overall Study|Lost to Follow-up|1|||
146198368|NCT05174013|527238968|FG004|Overall Study|Lost to Follow-up|0|||
146198369|NCT05174013|527238969|FG005|Overall Study|Lost to Follow-up|0|||
146423431|NCT00950807|528057111|FG007|Treatment Period 1|Lost to Follow-up|0|||
146423432|NCT00950807|528057112|FG008|Treatment Period 1|Lost to Follow-up|0|||
146423433|NCT00950807|528057113|FG009|Treatment Period 1|Lost to Follow-up|0|||
146423434|NCT00950807|528057104|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146423435|NCT00950807|528057105|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146423436|NCT00950807|528057106|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146423437|NCT00950807|528057107|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146423438|NCT00950807|528057108|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146423439|NCT00950807|528057109|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146423440|NCT00950807|528057110|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146423441|NCT00950807|528057111|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146423442|NCT00950807|528057112|FG008|Treatment Period 1|Withdrawal by Subject|1|||
146082633|NCT03104816|526822861|FG002|Overall Study|Protocol Violation|2|||
146198370|NCT05174013|527238964|FG000|Overall Study|Withdrawal by Subject|0|||
146198371|NCT05174013|527238965|FG001|Overall Study|Withdrawal by Subject|0|||
146198372|NCT05174013|527238966|FG002|Overall Study|Withdrawal by Subject|1|||
146198373|NCT05174013|527238967|FG003|Overall Study|Withdrawal by Subject|0|||
146423443|NCT00950807|528057113|FG009|Treatment Period 1|Withdrawal by Subject|0|||
146423444|NCT00950807|528057104|FG000|Treatment Period 1|Adverse Event|0|||
146423445|NCT00950807|528057105|FG001|Treatment Period 1|Adverse Event|0|||
146423446|NCT00950807|528057106|FG002|Treatment Period 1|Adverse Event|0|||
146082634|NCT01894568|526822862|FG000|Overall Study|Adverse Event|2|||
146198374|NCT05174013|527238968|FG004|Overall Study|Withdrawal by Subject|0|||
146198375|NCT05174013|527238969|FG005|Overall Study|Withdrawal by Subject|0|||
146198376|NCT02034916|527238970|FG000|Overall Study|Death|39|||
146198377|NCT02034916|527238971|FG001|Overall Study|Death|28|||
146198378|NCT02034916|527238970|FG000|Overall Study|Withdrawal by Subject|2|||
146198379|NCT02034916|527238971|FG001|Overall Study|Withdrawal by Subject|1|||
146198380|NCT02034916|527238970|FG000|Overall Study|Lost to Follow-up|4|||
146198381|NCT02034916|527238971|FG001|Overall Study|Lost to Follow-up|1|||
146198382|NCT02034916|527238970|FG000|Overall Study|Study terminated by sponsor|4|||
146198383|NCT02034916|527238971|FG001|Overall Study|Study terminated by sponsor|5|||
146198384|NCT00753012|527238977|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
146198385|NCT00753012|527238978|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
146198386|NCT00753012|527238977|FG000|Overall Study|Adverse Event|2|||
146198387|NCT00753012|527238978|FG001|Overall Study|Adverse Event|0|||
146198388|NCT00753012|527238977|FG000|Overall Study|Withdrawal by Subject|0|||
146198389|NCT00753012|527238978|FG001|Overall Study|Withdrawal by Subject|1|||
146198390|NCT00753012|527238977|FG000|Overall Study|Lost to Follow-up|4|||
146198391|NCT00753012|527238978|FG001|Overall Study|Lost to Follow-up|0|||
146198392|NCT00753012|527238977|FG000|Overall Study|Confounded endpoint data|1|||
146198393|NCT00753012|527238978|FG001|Overall Study|Confounded endpoint data|0|||
146198394|NCT01027286|527238979|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
146198395|NCT01027286|527238980|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
146198396|NCT01027286|527238979|FG000|Overall Study|Lost to Follow-up|0|||
146198397|NCT01027286|527238980|FG001|Overall Study|Lost to Follow-up|1|||
146198398|NCT00545844|527238981|FG000|Overall Study|Lost to Follow-up|9|||
146198399|NCT00545844|527238981|FG000|Overall Study|Protocol Violation|1|||
146198400|NCT00545844|527238981|FG000|Overall Study|Withdrawal by Subject|2|||
146198401|NCT00094809|527238982|FG000|Overall Study|Protocol deviation|2|||
146198402|NCT00094809|527238983|FG001|Overall Study|Protocol deviation|2|||
146198403|NCT00094809|527238982|FG000|Overall Study|Noncompliance|1|||
146198404|NCT00094809|527238983|FG001|Overall Study|Noncompliance|0|||
146198405|NCT00094809|527238982|FG000|Overall Study|Adverse Event|3|||
146198406|NCT00094809|527238983|FG001|Overall Study|Adverse Event|1|||
146198407|NCT00094809|527238982|FG000|Overall Study|Withdrawal by Subject|8|||
146198408|NCT00094809|527238983|FG001|Overall Study|Withdrawal by Subject|9|||
146198409|NCT00094809|527238982|FG000|Overall Study|Disease progression|3|||
146198410|NCT00094809|527238983|FG001|Overall Study|Disease progression|3|||
146198411|NCT00094809|527238982|FG000|Overall Study|Physician Decision|3|||
146198412|NCT00094809|527238983|FG001|Overall Study|Physician Decision|5|||
146198413|NCT00094809|527238982|FG000|Overall Study|Lost to Follow-up|6|||
146198414|NCT00094809|527238983|FG001|Overall Study|Lost to Follow-up|6|||
146198415|NCT00094809|527238982|FG000|Overall Study|Death|19|||
146198416|NCT00094809|527238983|FG001|Overall Study|Death|25|||
146198417|NCT00094809|527238982|FG000|Overall Study|Protocol-specified criteria|1|||
146198418|NCT00094809|527238983|FG001|Overall Study|Protocol-specified criteria|1|||
146198419|NCT00094809|527238982|FG000|Overall Study|Other|2|||
146198420|NCT00094809|527238983|FG001|Overall Study|Other|4|||
146198421|NCT00094809|527238982|FG000|Overall Study|Informed consent signed after treatment|1|||
146198422|NCT00094809|527238983|FG001|Overall Study|Informed consent signed after treatment|0|||
146198423|NCT00094809|527238982|FG000|Overall Study|Study drug not received|2|||
146198424|NCT00094809|527238983|FG001|Overall Study|Study drug not received|8|||
146198425|NCT00094809|527238982|FG000|Overall Study|Other|1|||
146198426|NCT00094809|527238983|FG001|Overall Study|Other|1|||
146198427|NCT01565928|527238995|FG000|Overall Study|Adverse Event|3|||
146198428|NCT01565928|527238995|FG000|Overall Study|Other|3|||
145949448|NCT01153009|526326630|FG002|Overall Study|Adverse Event|14|||
146198429|NCT01565928|527238995|FG000|Overall Study|Progressive Disease|13|||
146198430|NCT01565928|527238995|FG000|Overall Study|Withdrawal by Subject|1|||
146198431|NCT01565928|527238995|FG000|Overall Study|Death|2|||
146198432|NCT03525119|527239003|FG000|Overall Study|Adverse Event|0|||
146198433|NCT03525119|527239004|FG001|Overall Study|Adverse Event|1|||
146198434|NCT03525119|527239005|FG002|Overall Study|Adverse Event|0|||
146198435|NCT03525119|527239003|FG000|Overall Study|Lost to Follow-up|32|||
146198436|NCT03525119|527239004|FG001|Overall Study|Lost to Follow-up|33|||
146198437|NCT03525119|527239005|FG002|Overall Study|Lost to Follow-up|37|||
146423447|NCT00950807|528057107|FG003|Treatment Period 1|Adverse Event|0|||
146423448|NCT00950807|528057108|FG004|Treatment Period 1|Adverse Event|0|||
146423449|NCT00950807|528057109|FG005|Treatment Period 1|Adverse Event|1|||
146423450|NCT00950807|528057110|FG006|Treatment Period 1|Adverse Event|0|||
146423451|NCT00950807|528057111|FG007|Treatment Period 1|Adverse Event|0|||
146423452|NCT00950807|528057112|FG008|Treatment Period 1|Adverse Event|0|||
146423453|NCT00950807|528057113|FG009|Treatment Period 1|Adverse Event|0|||
146423454|NCT00950807|528057104|FG000|Washout Period 1|Lack of Efficacy|0|||
146423455|NCT00950807|528057105|FG001|Washout Period 1|Lack of Efficacy|0|||
146423456|NCT00950807|528057106|FG002|Washout Period 1|Lack of Efficacy|0|||
146423457|NCT00950807|528057107|FG003|Washout Period 1|Lack of Efficacy|0|||
146423458|NCT00950807|528057108|FG004|Washout Period 1|Lack of Efficacy|0|||
146423459|NCT00950807|528057109|FG005|Washout Period 1|Lack of Efficacy|0|||
146423460|NCT00950807|528057110|FG006|Washout Period 1|Lack of Efficacy|1|||
146423461|NCT00950807|528057111|FG007|Washout Period 1|Lack of Efficacy|0|||
146423462|NCT00950807|528057112|FG008|Washout Period 1|Lack of Efficacy|0|||
146423463|NCT00950807|528057113|FG009|Washout Period 1|Lack of Efficacy|0|||
146423464|NCT00950807|528057104|FG000|Washout Period 1|Withdrawal by Subject|0|||
146423465|NCT00950807|528057105|FG001|Washout Period 1|Withdrawal by Subject|0|||
146423466|NCT00950807|528057106|FG002|Washout Period 1|Withdrawal by Subject|0|||
146423467|NCT00950807|528057107|FG003|Washout Period 1|Withdrawal by Subject|0|||
146423468|NCT00950807|528057108|FG004|Washout Period 1|Withdrawal by Subject|0|||
146423469|NCT00950807|528057109|FG005|Washout Period 1|Withdrawal by Subject|0|||
146423470|NCT00950807|528057110|FG006|Washout Period 1|Withdrawal by Subject|0|||
146423471|NCT00950807|528057111|FG007|Washout Period 1|Withdrawal by Subject|0|||
146423472|NCT00950807|528057112|FG008|Washout Period 1|Withdrawal by Subject|1|||
146423473|NCT00950807|528057113|FG009|Washout Period 1|Withdrawal by Subject|0|||
146423474|NCT00950807|528057104|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
146423475|NCT00950807|528057105|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423476|NCT00950807|528057106|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423477|NCT00950807|528057107|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423478|NCT00950807|528057108|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423479|NCT00950807|528057109|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423480|NCT00950807|528057110|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
146423481|NCT00950807|528057111|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
146423482|NCT00950807|528057112|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423483|NCT00950807|528057113|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
146423484|NCT00950807|528057104|FG000|Washout Period 1|Adverse Event|2|||
146423485|NCT00950807|528057105|FG001|Washout Period 1|Adverse Event|0|||
146423486|NCT00950807|528057106|FG002|Washout Period 1|Adverse Event|0|||
146423487|NCT00950807|528057107|FG003|Washout Period 1|Adverse Event|1|||
146423488|NCT00950807|528057108|FG004|Washout Period 1|Adverse Event|1|||
146423489|NCT00950807|528057109|FG005|Washout Period 1|Adverse Event|0|||
146423490|NCT00950807|528057110|FG006|Washout Period 1|Adverse Event|0|||
146423491|NCT00950807|528057111|FG007|Washout Period 1|Adverse Event|0|||
146423492|NCT00950807|528057112|FG008|Washout Period 1|Adverse Event|0|||
146423493|NCT00950807|528057113|FG009|Washout Period 1|Adverse Event|0|||
146423494|NCT00950807|528057104|FG000|Treatment Period 2|Lack of Efficacy|1|||
146423495|NCT00950807|528057105|FG001|Treatment Period 2|Lack of Efficacy|0|||
146423496|NCT00950807|528057106|FG002|Treatment Period 2|Lack of Efficacy|0|||
146423497|NCT00950807|528057107|FG003|Treatment Period 2|Lack of Efficacy|0|||
146423498|NCT00950807|528057108|FG004|Treatment Period 2|Lack of Efficacy|0|||
146423499|NCT00950807|528057109|FG005|Treatment Period 2|Lack of Efficacy|0|||
146423500|NCT00950807|528057110|FG006|Treatment Period 2|Lack of Efficacy|0|||
146423501|NCT00950807|528057111|FG007|Treatment Period 2|Lack of Efficacy|0|||
146423502|NCT00950807|528057112|FG008|Treatment Period 2|Lack of Efficacy|0|||
146423503|NCT00950807|528057113|FG009|Treatment Period 2|Lack of Efficacy|0|||
146423504|NCT00950807|528057104|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146423505|NCT00950807|528057105|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146423506|NCT00950807|528057106|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146423507|NCT00950807|528057107|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146423508|NCT00950807|528057108|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146423509|NCT00950807|528057109|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145949449|NCT01153009|526326631|FG003|Overall Study|Adverse Event|10|||
146423510|NCT00950807|528057110|FG006|Treatment Period 2|Withdrawal by Subject|1|||
146423511|NCT00950807|528057111|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146423512|NCT00950807|528057112|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146423513|NCT00950807|528057113|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146423514|NCT00950807|528057104|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
146423515|NCT00950807|528057105|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423516|NCT00950807|528057106|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423517|NCT00950807|528057107|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423518|NCT00950807|528057108|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423519|NCT00950807|528057109|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423520|NCT00950807|528057110|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146198438|NCT03525119|527239003|FG000|Overall Study|Withdrawal by Subject|5|||
146198439|NCT03525119|527239004|FG001|Overall Study|Withdrawal by Subject|4|||
146198440|NCT03525119|527239005|FG002|Overall Study|Withdrawal by Subject|2|||
146198441|NCT03525119|527239003|FG000|Overall Study|Reason not Specified|2|||
146198442|NCT03525119|527239004|FG001|Overall Study|Reason not Specified|1|||
146198443|NCT03525119|527239005|FG002|Overall Study|Reason not Specified|2|||
146198444|NCT03525119|527239003|FG000|Overall Study|Randomized but not Vaccinated|1|||
146198445|NCT03525119|527239004|FG001|Overall Study|Randomized but not Vaccinated|0|||
146198446|NCT03525119|527239005|FG002|Overall Study|Randomized but not Vaccinated|2|||
146198447|NCT01713530|527239006|FG000|Overall Study|Adverse Event|0|||
146198448|NCT01713530|527239007|FG001|Overall Study|Adverse Event|5|||
146198449|NCT01713530|527239006|FG000|Overall Study|Withdrawal criteria|21|||
146198450|NCT01713530|527239007|FG001|Overall Study|Withdrawal criteria|12|||
146198451|NCT01713530|527239006|FG000|Overall Study|Unclassified|4|||
146198452|NCT01713530|527239007|FG001|Overall Study|Unclassified|2|||
146198453|NCT04379713|527239015|FG000|Overall Study|Adverse Event|2|||
146198454|NCT04379713|527239016|FG001|Overall Study|Adverse Event|0|||
146198455|NCT04379713|527239015|FG000|Overall Study|Physician Decision|2|||
146198456|NCT04379713|527239016|FG001|Overall Study|Physician Decision|1|||
146198457|NCT04379713|527239015|FG000|Overall Study|Protocol Violation|11|||
146198458|NCT04379713|527239016|FG001|Overall Study|Protocol Violation|6|||
146198459|NCT04379713|527239015|FG000|Overall Study|No longer met eligibility criteria|14|||
146198460|NCT04379713|527239016|FG001|Overall Study|No longer met eligibility criteria|11|||
146198461|NCT04379713|527239015|FG000|Overall Study|Withdrawal by parent/guardian|36|||
146198462|NCT04379713|527239016|FG001|Overall Study|Withdrawal by parent/guardian|15|||
146198463|NCT04379713|527239015|FG000|Overall Study|Lost to Follow-up|31|||
146198464|NCT04379713|527239016|FG001|Overall Study|Lost to Follow-up|21|||
146198465|NCT03808883|527239017|FG000|Overall Study|Withdrawal by Subject|2|||
146198466|NCT03808883|527239018|FG001|Overall Study|Withdrawal by Subject|0|||
146198467|NCT03808883|527239017|FG000|Overall Study|Did not complete pre test or post test survey|4|||
146198468|NCT03808883|527239018|FG001|Overall Study|Did not complete pre test or post test survey|3|||
146198469|NCT02371746|527239029|FG000|Overall Study|Consent withdrawn|0|||
146198470|NCT02371746|527239030|FG001|Overall Study|Consent withdrawn|0|||
146198471|NCT02371746|527239031|FG002|Overall Study|Consent withdrawn|0|||
146198472|NCT02371746|527239032|FG003|Overall Study|Consent withdrawn|0|||
146198473|NCT02371746|527239033|FG004|Overall Study|Consent withdrawn|0|||
146198474|NCT02371746|527239034|FG005|Overall Study|Consent withdrawn|0|||
146198475|NCT02371746|527239035|FG006|Overall Study|Consent withdrawn|1|||
146198476|NCT02613364|527239036|FG000|Overall Study|Other|19|||
146198477|NCT02613364|527239037|FG001|Overall Study|Other|29|||
146198478|NCT02613364|527239038|FG002|Overall Study|Other|17|||
146198479|NCT02613364|527239036|FG000|Overall Study|Too time consuming|21|||
146198480|NCT02613364|527239037|FG001|Overall Study|Too time consuming|26|||
146198481|NCT02613364|527239038|FG002|Overall Study|Too time consuming|26|||
146198482|NCT02613364|527239036|FG000|Overall Study|Withdrawal by Subject|13|||
146198483|NCT02613364|527239037|FG001|Overall Study|Withdrawal by Subject|18|||
146198484|NCT02613364|527239038|FG002|Overall Study|Withdrawal by Subject|17|||
146198485|NCT02613364|527239036|FG000|Overall Study|Medical|12|||
146198486|NCT02613364|527239037|FG001|Overall Study|Medical|13|||
146198487|NCT02613364|527239038|FG002|Overall Study|Medical|9|||
146198488|NCT02613364|527239036|FG000|Overall Study|Disliked Study Procedure|1|||
146198489|NCT02613364|527239037|FG001|Overall Study|Disliked Study Procedure|1|||
146198490|NCT02613364|527239038|FG002|Overall Study|Disliked Study Procedure|4|||
146198491|NCT02613364|527239036|FG000|Overall Study|Disliked Intervention|0|||
146198492|NCT02613364|527239037|FG001|Overall Study|Disliked Intervention|3|||
146198493|NCT02613364|527239038|FG002|Overall Study|Disliked Intervention|3|||
146198494|NCT01909336|527239039|FG000|Overall Study|Lost to Follow-up|4|||
146198495|NCT01909336|527239040|FG001|Overall Study|Lost to Follow-up|2|||
146198496|NCT01909336|527239041|FG002|Overall Study|Lost to Follow-up|2|||
146198497|NCT01909336|527239039|FG000|Overall Study|Physician Decision|0|||
146198498|NCT01909336|527239040|FG001|Overall Study|Physician Decision|1|||
146198499|NCT01909336|527239041|FG002|Overall Study|Physician Decision|1|||
146198500|NCT01235949|527239042|FG000|Primary Phase|Migrated/moved from study area|1|||
146198501|NCT01235949|527239043|FG001|Primary Phase|Migrated/moved from study area|1|||
146198502|NCT01235949|527239044|FG002|Primary Phase|Migrated/moved from study area|0|||
146198503|NCT01235949|527239045|FG003|Primary Phase|Migrated/moved from study area|0|||
146198504|NCT01235949|527239046|FG004|Primary Phase|Migrated/moved from study area|1|||
146423521|NCT00950807|528057111|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146198505|NCT01235949|527239047|FG005|Primary Phase|Migrated/moved from study area|2|||
146198506|NCT01235949|527239048|FG006|Primary Phase|Migrated/moved from study area|0|||
146198507|NCT01235949|527239049|FG007|Primary Phase|Migrated/moved from study area|0|||
146198508|NCT01235949|527239050|FG008|Primary Phase|Migrated/moved from study area|0|||
146198509|NCT01235949|527239051|FG009|Primary Phase|Migrated/moved from study area|0|||
146198510|NCT01235949|527239052|FG010|Primary Phase|Migrated/moved from study area|0|||
146198511|NCT01235949|527239053|FG011|Primary Phase|Migrated/moved from study area|0|||
146198512|NCT01235949|527239054|FG012|Primary Phase|Migrated/moved from study area|0|||
146423522|NCT00950807|528057112|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423523|NCT00950807|528057113|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146423524|NCT00950807|528057104|FG000|Treatment Period 2|Adverse Event|0|||
146423525|NCT00950807|528057105|FG001|Treatment Period 2|Adverse Event|1|||
146423526|NCT00950807|528057106|FG002|Treatment Period 2|Adverse Event|0|||
146423527|NCT00950807|528057107|FG003|Treatment Period 2|Adverse Event|1|||
146423528|NCT00950807|528057108|FG004|Treatment Period 2|Adverse Event|0|||
146423529|NCT00950807|528057109|FG005|Treatment Period 2|Adverse Event|1|||
146423530|NCT00950807|528057110|FG006|Treatment Period 2|Adverse Event|0|||
146423531|NCT00950807|528057111|FG007|Treatment Period 2|Adverse Event|1|||
146423532|NCT00950807|528057112|FG008|Treatment Period 2|Adverse Event|0|||
146423533|NCT00950807|528057113|FG009|Treatment Period 2|Adverse Event|0|||
146423534|NCT00950807|528057104|FG000|Washout Period 2|Lack of Efficacy|1|||
146423535|NCT00950807|528057105|FG001|Washout Period 2|Lack of Efficacy|0|||
146423536|NCT00950807|528057106|FG002|Washout Period 2|Lack of Efficacy|0|||
146423537|NCT00950807|528057107|FG003|Washout Period 2|Lack of Efficacy|0|||
146423538|NCT00950807|528057108|FG004|Washout Period 2|Lack of Efficacy|0|||
146423539|NCT00950807|528057109|FG005|Washout Period 2|Lack of Efficacy|0|||
146423540|NCT00950807|528057110|FG006|Washout Period 2|Lack of Efficacy|0|||
146423541|NCT00950807|528057111|FG007|Washout Period 2|Lack of Efficacy|0|||
146423542|NCT00950807|528057112|FG008|Washout Period 2|Lack of Efficacy|0|||
146423543|NCT00950807|528057113|FG009|Washout Period 2|Lack of Efficacy|0|||
146423544|NCT00950807|528057104|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423545|NCT00950807|528057105|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146423546|NCT00950807|528057106|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423547|NCT00950807|528057107|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423548|NCT00950807|528057108|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146423549|NCT00950807|528057109|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423550|NCT00950807|528057110|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146423551|NCT00950807|528057111|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
146423552|NCT00950807|528057112|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423553|NCT00950807|528057113|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
146423554|NCT00950807|528057104|FG000|Washout Period 2|Adverse Event|3|||
146423555|NCT00950807|528057105|FG001|Washout Period 2|Adverse Event|0|||
146423556|NCT00950807|528057106|FG002|Washout Period 2|Adverse Event|0|||
146423557|NCT00950807|528057107|FG003|Washout Period 2|Adverse Event|1|||
146423558|NCT00950807|528057108|FG004|Washout Period 2|Adverse Event|0|||
146423559|NCT00950807|528057109|FG005|Washout Period 2|Adverse Event|0|||
146423560|NCT00950807|528057110|FG006|Washout Period 2|Adverse Event|0|||
146423561|NCT00950807|528057111|FG007|Washout Period 2|Adverse Event|0|||
146423562|NCT00950807|528057112|FG008|Washout Period 2|Adverse Event|0|||
146423563|NCT00950807|528057113|FG009|Washout Period 2|Adverse Event|0|||
146423564|NCT00950807|528057104|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146423565|NCT00950807|528057105|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146423566|NCT00950807|528057106|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146423567|NCT00950807|528057107|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146423568|NCT00950807|528057108|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146423569|NCT00950807|528057109|FG005|Treatment Period 3|Withdrawal by Subject|0|||
146423570|NCT00950807|528057110|FG006|Treatment Period 3|Withdrawal by Subject|0|||
146423571|NCT00950807|528057111|FG007|Treatment Period 3|Withdrawal by Subject|0|||
146423572|NCT00950807|528057112|FG008|Treatment Period 3|Withdrawal by Subject|0|||
146423573|NCT00950807|528057113|FG009|Treatment Period 3|Withdrawal by Subject|1|||
146423574|NCT00950807|528057104|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146423575|NCT00950807|528057105|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423576|NCT00950807|528057106|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423577|NCT00950807|528057107|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423578|NCT00950807|528057108|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423579|NCT00950807|528057109|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423580|NCT00950807|528057110|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146198513|NCT01235949|527239055|FG013|Primary Phase|Migrated/moved from study area|0|||
146198514|NCT01235949|527239056|FG014|Primary Phase|Migrated/moved from study area|0|||
146198515|NCT01235949|527239057|FG015|Primary Phase|Migrated/moved from study area|0|||
145949450|NCT01153009|526326628|FG000|Overall Study|Lack of Efficacy|9|||
145949451|NCT01153009|526326629|FG001|Overall Study|Lack of Efficacy|0|||
146198516|NCT01235949|527239058|FG016|Primary Phase|Migrated/moved from study area|0|||
146198517|NCT01235949|527239059|FG017|Primary Phase|Migrated/moved from study area|0|||
146198518|NCT01235949|527239042|FG000|Primary Phase|Adverse Event|0|||
146423581|NCT00950807|528057111|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146198519|NCT01235949|527239043|FG001|Primary Phase|Adverse Event|0|||
146423582|NCT00950807|528057112|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423583|NCT00950807|528057113|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146423584|NCT00950807|528057104|FG000|Treatment Period 3|Adverse Event|0|||
146423585|NCT00950807|528057105|FG001|Treatment Period 3|Adverse Event|0|||
146423586|NCT00950807|528057106|FG002|Treatment Period 3|Adverse Event|0|||
146423587|NCT00950807|528057107|FG003|Treatment Period 3|Adverse Event|0|||
146423588|NCT00950807|528057108|FG004|Treatment Period 3|Adverse Event|0|||
146423589|NCT00950807|528057109|FG005|Treatment Period 3|Adverse Event|0|||
146423590|NCT00950807|528057110|FG006|Treatment Period 3|Adverse Event|1|||
146423591|NCT00950807|528057111|FG007|Treatment Period 3|Adverse Event|0|||
146423592|NCT00950807|528057112|FG008|Treatment Period 3|Adverse Event|0|||
146423593|NCT00950807|528057113|FG009|Treatment Period 3|Adverse Event|0|||
146423594|NCT00337077|528057114|FG000|Overall Study|Progressive disease|25|||
146423595|NCT00337077|528057115|FG001|Overall Study|Progressive disease|37|||
146423596|NCT00337077|528057116|FG002|Overall Study|Progressive disease|19|||
146423597|NCT00337077|528057114|FG000|Overall Study|Adverse Event|7|||
146423598|NCT00337077|528057115|FG001|Overall Study|Adverse Event|7|||
146423599|NCT00337077|528057116|FG002|Overall Study|Adverse Event|1|||
146423600|NCT00337077|528057114|FG000|Overall Study|Death|0|||
146423601|NCT00337077|528057115|FG001|Overall Study|Death|1|||
146423602|NCT00337077|528057116|FG002|Overall Study|Death|0|||
146423603|NCT00337077|528057114|FG000|Overall Study|Withdrawal by Subject|7|||
146423604|NCT00337077|528057115|FG001|Overall Study|Withdrawal by Subject|2|||
146423605|NCT00337077|528057116|FG002|Overall Study|Withdrawal by Subject|2|||
146423606|NCT00337077|528057114|FG000|Overall Study|Alternative therapy|1|||
146423607|NCT00337077|528057115|FG001|Overall Study|Alternative therapy|0|||
146423608|NCT00337077|528057116|FG002|Overall Study|Alternative therapy|0|||
146423609|NCT00337077|528057114|FG000|Overall Study|Physician Decision|1|||
146423610|NCT00337077|528057115|FG001|Overall Study|Physician Decision|4|||
146423611|NCT00337077|528057116|FG002|Overall Study|Physician Decision|2|||
146082635|NCT01894568|526822863|FG001|Overall Study|Adverse Event|3|||
146198520|NCT01235949|527239044|FG002|Primary Phase|Adverse Event|0|||
146198521|NCT01235949|527239045|FG003|Primary Phase|Adverse Event|1|||
146198522|NCT01235949|527239046|FG004|Primary Phase|Adverse Event|0|||
146198523|NCT01235949|527239047|FG005|Primary Phase|Adverse Event|0|||
146198524|NCT01235949|527239048|FG006|Primary Phase|Adverse Event|0|||
146198525|NCT01235949|527239049|FG007|Primary Phase|Adverse Event|0|||
146198526|NCT01235949|527239050|FG008|Primary Phase|Adverse Event|0|||
146198527|NCT01235949|527239051|FG009|Primary Phase|Adverse Event|0|||
146198528|NCT01235949|527239052|FG010|Primary Phase|Adverse Event|0|||
146198529|NCT01235949|527239053|FG011|Primary Phase|Adverse Event|0|||
146198530|NCT01235949|527239054|FG012|Primary Phase|Adverse Event|0|||
146198531|NCT01235949|527239055|FG013|Primary Phase|Adverse Event|0|||
146198532|NCT01235949|527239056|FG014|Primary Phase|Adverse Event|0|||
146198533|NCT01235949|527239057|FG015|Primary Phase|Adverse Event|0|||
146198534|NCT01235949|527239058|FG016|Primary Phase|Adverse Event|0|||
146198535|NCT01235949|527239059|FG017|Primary Phase|Adverse Event|0|||
146198536|NCT01235949|527239042|FG000|Primary Phase|Withdrawal by Subject|3|||
146198537|NCT01235949|527239043|FG001|Primary Phase|Withdrawal by Subject|2|||
146198538|NCT01235949|527239044|FG002|Primary Phase|Withdrawal by Subject|2|||
146198539|NCT01235949|527239045|FG003|Primary Phase|Withdrawal by Subject|0|||
146198540|NCT01235949|527239046|FG004|Primary Phase|Withdrawal by Subject|0|||
146198541|NCT01235949|527239047|FG005|Primary Phase|Withdrawal by Subject|3|||
146198542|NCT01235949|527239048|FG006|Primary Phase|Withdrawal by Subject|0|||
146198543|NCT01235949|527239049|FG007|Primary Phase|Withdrawal by Subject|0|||
146198544|NCT01235949|527239050|FG008|Primary Phase|Withdrawal by Subject|0|||
146198545|NCT01235949|527239051|FG009|Primary Phase|Withdrawal by Subject|0|||
146198546|NCT01235949|527239052|FG010|Primary Phase|Withdrawal by Subject|0|||
146198547|NCT01235949|527239053|FG011|Primary Phase|Withdrawal by Subject|0|||
146423612|NCT00337077|528057114|FG000|Overall Study|Never started treatment|1|||
146423613|NCT00337077|528057115|FG001|Overall Study|Never started treatment|1|||
146423614|NCT00337077|528057116|FG002|Overall Study|Never started treatment|0|||
146423615|NCT00337077|528057114|FG000|Overall Study|Ineligible|1|||
146423616|NCT00337077|528057115|FG001|Overall Study|Ineligible|1|||
146198548|NCT01235949|527239054|FG012|Primary Phase|Withdrawal by Subject|0|||
146198549|NCT01235949|527239055|FG013|Primary Phase|Withdrawal by Subject|0|||
146198550|NCT01235949|527239056|FG014|Primary Phase|Withdrawal by Subject|0|||
146198551|NCT01235949|527239057|FG015|Primary Phase|Withdrawal by Subject|0|||
146198552|NCT01235949|527239058|FG016|Primary Phase|Withdrawal by Subject|0|||
146198553|NCT01235949|527239059|FG017|Primary Phase|Withdrawal by Subject|0|||
146198554|NCT01235949|527239042|FG000|Primary Phase|Lost to Follow-up|0|||
146198555|NCT01235949|527239043|FG001|Primary Phase|Lost to Follow-up|0|||
146423617|NCT00337077|528057116|FG002|Overall Study|Ineligible|1|||
146423618|NCT01492400|528057121|FG000|Overall Study|Miscellaneous Reasons|2|||
146423619|NCT01492400|528057122|FG001|Overall Study|Miscellaneous Reasons|3|||
146423620|NCT01492400|528057121|FG000|Overall Study|Personal Reasons|0|||
146423621|NCT01492400|528057122|FG001|Overall Study|Personal Reasons|5|||
146198556|NCT01235949|527239044|FG002|Primary Phase|Lost to Follow-up|1|||
146198557|NCT01235949|527239045|FG003|Primary Phase|Lost to Follow-up|1|||
146423622|NCT01492400|528057121|FG000|Overall Study|Lost to Follow-up|3|||
146423623|NCT01492400|528057122|FG001|Overall Study|Lost to Follow-up|1|||
146423624|NCT01492400|528057121|FG000|Overall Study|Pregnancy|0|||
146423625|NCT01492400|528057122|FG001|Overall Study|Pregnancy|1|||
146423626|NCT01492400|528057121|FG000|Overall Study|Lack of Efficacy|1|||
146423627|NCT01492400|528057122|FG001|Overall Study|Lack of Efficacy|1|||
146423628|NCT01492400|528057121|FG000|Overall Study|Adverse Event|10|||
146423629|NCT01492400|528057122|FG001|Overall Study|Adverse Event|5|||
146423630|NCT00659607|528057123|FG000|Overall Study|No blood pressure recorded|147|||
146423631|NCT00659607|528057123|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
146423632|NCT00659607|528057123|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
146423633|NCT00659607|528057123|FG000|Overall Study|No recorded efficacy data|15|||
146423634|NCT00659607|528057123|FG000|Overall Study|Inconsistent BP measuring date|2|||
146423635|NCT02899338|528057125|FG000|Overall Study|Adverse Event|1|||
145949452|NCT01153009|526326630|FG002|Overall Study|Lack of Efficacy|2|||
146198558|NCT01235949|527239046|FG004|Primary Phase|Lost to Follow-up|0|||
146198559|NCT01235949|527239047|FG005|Primary Phase|Lost to Follow-up|2|||
146198560|NCT01235949|527239048|FG006|Primary Phase|Lost to Follow-up|0|||
146198561|NCT01235949|527239049|FG007|Primary Phase|Lost to Follow-up|0|||
146198562|NCT01235949|527239050|FG008|Primary Phase|Lost to Follow-up|0|||
146198563|NCT01235949|527239051|FG009|Primary Phase|Lost to Follow-up|0|||
146198564|NCT01235949|527239052|FG010|Primary Phase|Lost to Follow-up|0|||
146198565|NCT01235949|527239053|FG011|Primary Phase|Lost to Follow-up|0|||
146198566|NCT01235949|527239054|FG012|Primary Phase|Lost to Follow-up|0|||
146198567|NCT01235949|527239055|FG013|Primary Phase|Lost to Follow-up|0|||
146198568|NCT01235949|527239056|FG014|Primary Phase|Lost to Follow-up|0|||
146198569|NCT01235949|527239057|FG015|Primary Phase|Lost to Follow-up|0|||
146198570|NCT01235949|527239058|FG016|Primary Phase|Lost to Follow-up|0|||
146198571|NCT01235949|527239059|FG017|Primary Phase|Lost to Follow-up|0|||
146198572|NCT01235949|527239042|FG000|Booster Phase|Migrated/moved from study area|0|||
146198573|NCT01235949|527239043|FG001|Booster Phase|Migrated/moved from study area|0|||
146198574|NCT01235949|527239044|FG002|Booster Phase|Migrated/moved from study area|0|||
146198575|NCT01235949|527239045|FG003|Booster Phase|Migrated/moved from study area|0|||
146198576|NCT01235949|527239046|FG004|Booster Phase|Migrated/moved from study area|0|||
146198577|NCT01235949|527239047|FG005|Booster Phase|Migrated/moved from study area|0|||
146198578|NCT01235949|527239048|FG006|Booster Phase|Migrated/moved from study area|0|||
146198579|NCT01235949|527239049|FG007|Booster Phase|Migrated/moved from study area|0|||
146198580|NCT01235949|527239050|FG008|Booster Phase|Migrated/moved from study area|0|||
146198581|NCT01235949|527239051|FG009|Booster Phase|Migrated/moved from study area|0|||
146198582|NCT01235949|527239052|FG010|Booster Phase|Migrated/moved from study area|0|||
146198583|NCT01235949|527239053|FG011|Booster Phase|Migrated/moved from study area|1|||
146198584|NCT01235949|527239054|FG012|Booster Phase|Migrated/moved from study area|1|||
146198585|NCT01235949|527239055|FG013|Booster Phase|Migrated/moved from study area|0|||
146198586|NCT01235949|527239056|FG014|Booster Phase|Migrated/moved from study area|0|||
146198587|NCT01235949|527239057|FG015|Booster Phase|Migrated/moved from study area|0|||
146198588|NCT01235949|527239058|FG016|Booster Phase|Migrated/moved from study area|0|||
146198589|NCT01235949|527239059|FG017|Booster Phase|Migrated/moved from study area|1|||
146198590|NCT01235949|527239042|FG000|Booster Phase|Adverse Event|0|||
146198591|NCT01235949|527239043|FG001|Booster Phase|Adverse Event|0|||
146198592|NCT01235949|527239044|FG002|Booster Phase|Adverse Event|0|||
146198593|NCT01235949|527239045|FG003|Booster Phase|Adverse Event|0|||
146198594|NCT01235949|527239046|FG004|Booster Phase|Adverse Event|0|||
146198595|NCT01235949|527239047|FG005|Booster Phase|Adverse Event|0|||
146198596|NCT01235949|527239048|FG006|Booster Phase|Adverse Event|0|||
146198597|NCT01235949|527239049|FG007|Booster Phase|Adverse Event|0|||
146198598|NCT01235949|527239050|FG008|Booster Phase|Adverse Event|0|||
146198599|NCT01235949|527239051|FG009|Booster Phase|Adverse Event|0|||
146198600|NCT01235949|527239052|FG010|Booster Phase|Adverse Event|0|||
146198601|NCT01235949|527239053|FG011|Booster Phase|Adverse Event|0|||
146198602|NCT01235949|527239054|FG012|Booster Phase|Adverse Event|0|||
146198603|NCT01235949|527239055|FG013|Booster Phase|Adverse Event|0|||
146198604|NCT01235949|527239056|FG014|Booster Phase|Adverse Event|0|||
146198605|NCT01235949|527239057|FG015|Booster Phase|Adverse Event|1|||
146198606|NCT01235949|527239058|FG016|Booster Phase|Adverse Event|0|||
146198607|NCT01235949|527239059|FG017|Booster Phase|Adverse Event|0|||
146423636|NCT02899338|528057126|FG001|Overall Study|Adverse Event|2|||
146423637|NCT02899338|528057125|FG000|Overall Study|Withdrawal by Subject|2|||
146198608|NCT01235949|527239042|FG000|Booster Phase|Withdrawal by Subject|0|||
146198609|NCT01235949|527239043|FG001|Booster Phase|Withdrawal by Subject|0|||
146198610|NCT01235949|527239044|FG002|Booster Phase|Withdrawal by Subject|0|||
146198611|NCT01235949|527239045|FG003|Booster Phase|Withdrawal by Subject|0|||
146198612|NCT01235949|527239046|FG004|Booster Phase|Withdrawal by Subject|0|||
146198613|NCT01235949|527239047|FG005|Booster Phase|Withdrawal by Subject|0|||
146198614|NCT01235949|527239048|FG006|Booster Phase|Withdrawal by Subject|0|||
146198615|NCT01235949|527239049|FG007|Booster Phase|Withdrawal by Subject|1|||
146198616|NCT01235949|527239050|FG008|Booster Phase|Withdrawal by Subject|1|||
146198617|NCT01235949|527239051|FG009|Booster Phase|Withdrawal by Subject|0|||
146423638|NCT02899338|528057126|FG001|Overall Study|Withdrawal by Subject|0|||
146423639|NCT06179108|528057127|FG000|Overall Study|Withdrawal by Subject|16|||
146423640|NCT06179108|528057128|FG001|Overall Study|Withdrawal by Subject|19|||
146423641|NCT06179108|528057129|FG002|Overall Study|Withdrawal by Subject|10|||
146423642|NCT06179108|528057130|FG003|Overall Study|Withdrawal by Subject|11|||
146423643|NCT06179108|528057127|FG000|Overall Study|Lost to Follow-up|12|||
146423644|NCT06179108|528057128|FG001|Overall Study|Lost to Follow-up|4|||
146423645|NCT06179108|528057129|FG002|Overall Study|Lost to Follow-up|1|||
146423646|NCT06179108|528057130|FG003|Overall Study|Lost to Follow-up|9|||
146423647|NCT06179108|528057127|FG000|Overall Study|Adverse Event|2|||
146423648|NCT06179108|528057128|FG001|Overall Study|Adverse Event|3|||
146423649|NCT06179108|528057129|FG002|Overall Study|Adverse Event|3|||
146423650|NCT06179108|528057130|FG003|Overall Study|Adverse Event|2|||
146423651|NCT06179108|528057127|FG000|Overall Study|Protocol Violation|0|||
146423652|NCT06179108|528057128|FG001|Overall Study|Protocol Violation|1|||
146423653|NCT06179108|528057129|FG002|Overall Study|Protocol Violation|0|||
146423654|NCT06179108|528057130|FG003|Overall Study|Protocol Violation|1|||
146423655|NCT06179108|528057127|FG000|Overall Study|Physician Decision|1|||
146423656|NCT06179108|528057128|FG001|Overall Study|Physician Decision|1|||
146423657|NCT06179108|528057129|FG002|Overall Study|Physician Decision|0|||
146423658|NCT06179108|528057130|FG003|Overall Study|Physician Decision|0|||
146423659|NCT06179108|528057127|FG000|Overall Study|Lack of Efficacy|0|||
146423660|NCT06179108|528057128|FG001|Overall Study|Lack of Efficacy|0|||
146423661|NCT06179108|528057129|FG002|Overall Study|Lack of Efficacy|0|||
146423662|NCT06179108|528057130|FG003|Overall Study|Lack of Efficacy|1|||
146423663|NCT06179108|528057127|FG000|Overall Study|Death|0|||
146423664|NCT06179108|528057128|FG001|Overall Study|Death|0|||
146423665|NCT06179108|528057129|FG002|Overall Study|Death|0|||
146423666|NCT06179108|528057130|FG003|Overall Study|Death|1|||
146423667|NCT01370408|528057131|FG000|Overall Study|treatment failure|9|||
146423668|NCT05014412|528057133|FG000|Overall Study|Death|11|||
146423669|NCT05014412|528057134|FG001|Overall Study|Death|7|||
146423670|NCT05014412|528057135|FG002|Overall Study|Death|4|||
146423671|NCT05014412|528057136|FG003|Overall Study|Death|7|||
146423672|NCT05014412|528057133|FG000|Overall Study|Withdrawal by Subject|1|||
146423673|NCT05014412|528057134|FG001|Overall Study|Withdrawal by Subject|1|||
146423674|NCT05014412|528057135|FG002|Overall Study|Withdrawal by Subject|1|||
146423675|NCT05014412|528057136|FG003|Overall Study|Withdrawal by Subject|2|||
146423676|NCT05014412|528057133|FG000|Overall Study|Ongoing|21|||
146423677|NCT05014412|528057134|FG001|Overall Study|Ongoing|4|||
146423678|NCT05014412|528057135|FG002|Overall Study|Ongoing|6|||
146423679|NCT05014412|528057136|FG003|Overall Study|Ongoing|20|||
146423680|NCT02353169|528057137|FG000|Overall Study|QTc > 450 msec|1|||
146423681|NCT02353169|528057138|FG001|Overall Study|QTc > 450 msec|1|||
146423682|NCT02353169|528057139|FG002|Overall Study|QTc > 450 msec|1|||
146423683|NCT02353169|528057140|FG003|Overall Study|QTc > 450 msec|1|||
145949453|NCT01153009|526326631|FG003|Overall Study|Lack of Efficacy|1|||
145949454|NCT01153009|526326628|FG000|Overall Study|Noncompliance with Study Medication|1|||
145949455|NCT01153009|526326629|FG001|Overall Study|Noncompliance with Study Medication|3|||
145949456|NCT01153009|526326630|FG002|Overall Study|Noncompliance with Study Medication|4|||
145949457|NCT01153009|526326631|FG003|Overall Study|Noncompliance with Study Medication|1|||
145949458|NCT01153009|526326628|FG000|Overall Study|Protocol Deviations|4|||
145949459|NCT01153009|526326629|FG001|Overall Study|Protocol Deviations|3|||
145949460|NCT01153009|526326630|FG002|Overall Study|Protocol Deviations|3|||
145949461|NCT01153009|526326631|FG003|Overall Study|Protocol Deviations|2|||
145949462|NCT01153009|526326628|FG000|Overall Study|Withdrawal of Consent|5|||
145949463|NCT01153009|526326629|FG001|Overall Study|Withdrawal of Consent|5|||
146082636|NCT01894568|526822862|FG000|Overall Study|Protocol required discontinuation|2|||
146198618|NCT01235949|527239052|FG010|Booster Phase|Withdrawal by Subject|1|||
146198619|NCT01235949|527239053|FG011|Booster Phase|Withdrawal by Subject|1|||
146198620|NCT01235949|527239054|FG012|Booster Phase|Withdrawal by Subject|2|||
146198621|NCT01235949|527239055|FG013|Booster Phase|Withdrawal by Subject|0|||
145949464|NCT01153009|526326630|FG002|Overall Study|Withdrawal of Consent|4|||
146198622|NCT01235949|527239056|FG014|Booster Phase|Withdrawal by Subject|2|||
146198623|NCT01235949|527239057|FG015|Booster Phase|Withdrawal by Subject|0|||
146198624|NCT01235949|527239058|FG016|Booster Phase|Withdrawal by Subject|0|||
145949465|NCT01153009|526326631|FG003|Overall Study|Withdrawal of Consent|6|||
146198625|NCT01235949|527239059|FG017|Booster Phase|Withdrawal by Subject|0|||
146198626|NCT01235949|527239042|FG000|Booster Phase|Lost to Follow-up|0|||
146423684|NCT02353169|528057137|FG000|Overall Study|OR team declined|2|||
146423685|NCT02353169|528057138|FG001|Overall Study|OR team declined|0|||
146423686|NCT02353169|528057139|FG002|Overall Study|OR team declined|0|||
146423687|NCT02353169|528057140|FG003|Overall Study|OR team declined|0|||
146423688|NCT02353169|528057137|FG000|Overall Study|Inhalational induction|0|||
146423689|NCT02353169|528057138|FG001|Overall Study|Inhalational induction|2|||
146423690|NCT02353169|528057139|FG002|Overall Study|Inhalational induction|0|||
146423691|NCT02353169|528057140|FG003|Overall Study|Inhalational induction|0|||
146423692|NCT02353169|528057137|FG000|Overall Study|ECG data error|0|||
146423693|NCT02353169|528057138|FG001|Overall Study|ECG data error|3|||
146423694|NCT02353169|528057139|FG002|Overall Study|ECG data error|2|||
146198627|NCT01235949|527239043|FG001|Booster Phase|Lost to Follow-up|0|||
146198628|NCT01235949|527239044|FG002|Booster Phase|Lost to Follow-up|0|||
146198629|NCT01235949|527239045|FG003|Booster Phase|Lost to Follow-up|0|||
146198630|NCT01235949|527239046|FG004|Booster Phase|Lost to Follow-up|0|||
146198631|NCT01235949|527239047|FG005|Booster Phase|Lost to Follow-up|0|||
146198632|NCT01235949|527239048|FG006|Booster Phase|Lost to Follow-up|0|||
146198633|NCT01235949|527239049|FG007|Booster Phase|Lost to Follow-up|0|||
146198634|NCT01235949|527239050|FG008|Booster Phase|Lost to Follow-up|1|||
146198635|NCT01235949|527239051|FG009|Booster Phase|Lost to Follow-up|1|||
146198636|NCT01235949|527239052|FG010|Booster Phase|Lost to Follow-up|1|||
146198637|NCT01235949|527239053|FG011|Booster Phase|Lost to Follow-up|1|||
146198638|NCT01235949|527239054|FG012|Booster Phase|Lost to Follow-up|0|||
146198639|NCT01235949|527239055|FG013|Booster Phase|Lost to Follow-up|0|||
146198640|NCT01235949|527239056|FG014|Booster Phase|Lost to Follow-up|0|||
146198641|NCT01235949|527239057|FG015|Booster Phase|Lost to Follow-up|0|||
146198642|NCT01235949|527239058|FG016|Booster Phase|Lost to Follow-up|0|||
146198643|NCT01235949|527239059|FG017|Booster Phase|Lost to Follow-up|1|||
146198644|NCT00754936|527239060|FG000|Overall Study|Lost to Follow-up|3|||
146198645|NCT00754936|527239060|FG000|Overall Study|Physician Decision|1|||
146198646|NCT00754936|527239060|FG000|Overall Study|Withdrawal by Subject|2|||
146198647|NCT00754936|527239060|FG000|Overall Study|Side Effects|3|||
146198648|NCT00754936|527239060|FG000|Overall Study|Inter-current medical events|3|||
146198649|NCT00371566|527239065|FG000|Treatment Phase|Withdrawal by Subject|0|||
146198650|NCT00371566|527239066|FG001|Treatment Phase|Withdrawal by Subject|1|||
146198651|NCT00371566|527239065|FG000|Treatment Phase|Adverse Event|0|||
146198652|NCT00371566|527239066|FG001|Treatment Phase|Adverse Event|1|||
146198653|NCT00371566|527239065|FG000|Treatment Phase|Protocol Violation|0|||
146198654|NCT00371566|527239066|FG001|Treatment Phase|Protocol Violation|1|||
146198655|NCT00371566|527239065|FG000|Chemoradiation Phase|Physician Decision|2|||
146198656|NCT00371566|527239066|FG001|Chemoradiation Phase|Physician Decision|0|||
146198657|NCT00371566|527239065|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
146198658|NCT00371566|527239066|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
146198659|NCT00371566|527239065|FG000|Chemoradiation Phase|Non compliant|0|||
146198660|NCT00371566|527239066|FG001|Chemoradiation Phase|Non compliant|1|||
146198661|NCT00371566|527239065|FG000|Chemoradiation Phase|Progressive Disease|1|||
146198662|NCT00371566|527239066|FG001|Chemoradiation Phase|Progressive Disease|1|||
146198663|NCT00371566|527239065|FG000|Chemoradiation Phase|Death|2|||
146198664|NCT00371566|527239066|FG001|Chemoradiation Phase|Death|0|||
146198665|NCT00371566|527239065|FG000|Follow Up Phase|Death|0|||
146198666|NCT00371566|527239066|FG001|Follow Up Phase|Death|5|||
146198667|NCT00371566|527239065|FG000|Follow Up Phase|Disease progression|1|||
146198668|NCT00371566|527239066|FG001|Follow Up Phase|Disease progression|0|||
146198669|NCT00371566|527239065|FG000|Follow Up Phase|Withdrawal by Subject|0|||
146198670|NCT00371566|527239066|FG001|Follow Up Phase|Withdrawal by Subject|1|||
146198671|NCT00371566|527239065|FG000|Follow Up Phase|Physician Decision|1|||
146198672|NCT00371566|527239066|FG001|Follow Up Phase|Physician Decision|1|||
146198673|NCT00371566|527239065|FG000|Follow Up Phase|Lost to Follow-up|1|||
146198674|NCT00371566|527239066|FG001|Follow Up Phase|Lost to Follow-up|0|||
146198675|NCT00177216|527239067|FG000|Overall Study|Withdrawal by Subject|6|||
146198676|NCT00177216|527239068|FG001|Overall Study|Withdrawal by Subject|3|||
146198677|NCT00177216|527239069|FG002|Overall Study|Withdrawal by Subject|1|||
146198678|NCT01093534|527239074|FG000|Overall Study|Adverse Event|2|||
146198679|NCT01093534|527239075|FG001|Overall Study|Adverse Event|5|||
146198680|NCT01093534|527239076|FG002|Overall Study|Adverse Event|2|||
146198681|NCT01093534|527239074|FG000|Overall Study|Lack of Efficacy|2|||
146198682|NCT01093534|527239075|FG001|Overall Study|Lack of Efficacy|1|||
146198683|NCT01093534|527239076|FG002|Overall Study|Lack of Efficacy|1|||
146198684|NCT01093534|527239074|FG000|Overall Study|Withdrawal by Subject|5|||
146198685|NCT01093534|527239075|FG001|Overall Study|Withdrawal by Subject|7|||
146198686|NCT01093534|527239076|FG002|Overall Study|Withdrawal by Subject|2|||
146198687|NCT01093534|527239074|FG000|Overall Study|Other|1|||
146198688|NCT01093534|527239075|FG001|Overall Study|Other|3|||
146198689|NCT01093534|527239076|FG002|Overall Study|Other|4|||
146198690|NCT00811057|527239077|FG000|Overall Study|Protocol Violation|5|||
146198691|NCT00811057|527239078|FG001|Overall Study|Protocol Violation|10|||
146198692|NCT00811057|527239079|FG002|Overall Study|Protocol Violation|10|||
145949466|NCT01153009|526326628|FG000|Overall Study|Lost to Follow-up|8|||
146198693|NCT00768651|527239080|FG000|Overall Study|Withdrawal by Subject|1|||
146198694|NCT00995709|527239085|FG000|Overall Study|Adverse Event|4|||
146198695|NCT00995709|527239086|FG001|Overall Study|Adverse Event|2|||
146198696|NCT00995709|527239087|FG002|Overall Study|Adverse Event|0|||
145949467|NCT01153009|526326629|FG001|Overall Study|Lost to Follow-up|8|||
146198697|NCT00995709|527239085|FG000|Overall Study|Lack of Efficacy|0|||
146198698|NCT00995709|527239086|FG001|Overall Study|Lack of Efficacy|1|||
146198699|NCT00995709|527239087|FG002|Overall Study|Lack of Efficacy|4|||
146198700|NCT00995709|527239085|FG000|Overall Study|Withdrawal by Subject|0|||
146198701|NCT00995709|527239086|FG001|Overall Study|Withdrawal by Subject|4|||
146198702|NCT00995709|527239087|FG002|Overall Study|Withdrawal by Subject|1|||
146198703|NCT00995709|527239085|FG000|Overall Study|Lost to Follow-up|1|||
146198704|NCT00995709|527239086|FG001|Overall Study|Lost to Follow-up|0|||
146198705|NCT00995709|527239087|FG002|Overall Study|Lost to Follow-up|0|||
146198706|NCT00995709|527239085|FG000|Overall Study|Death|0|||
146423695|NCT02353169|528057140|FG003|Overall Study|ECG data error|2|||
146423696|NCT02353169|528057137|FG000|Overall Study|Pre-op medication|0|||
146423697|NCT02353169|528057138|FG001|Overall Study|Pre-op medication|0|||
146423698|NCT02353169|528057139|FG002|Overall Study|Pre-op medication|1|||
146423699|NCT02353169|528057140|FG003|Overall Study|Pre-op medication|0|||
146423700|NCT00486837|528057143|FG000|Overall Study|Withdrawal by Subject|1|||
146423701|NCT00486837|528057144|FG001|Overall Study|Withdrawal by Subject|0|||
146423702|NCT00486837|528057143|FG000|Overall Study|Adverse Event|1|||
146423703|NCT00486837|528057144|FG001|Overall Study|Adverse Event|1|||
146423704|NCT00486837|528057143|FG000|Overall Study|Protocol Violation|4|||
146423705|NCT00486837|528057144|FG001|Overall Study|Protocol Violation|2|||
146423706|NCT00486837|528057143|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
146423707|NCT00486837|528057144|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
146423708|NCT02468778|528057145|FG000|Overall Study|Death|2|||
146423709|NCT02468778|528057146|FG001|Overall Study|Death|1|||
146423710|NCT02468778|528057147|FG002|Overall Study|Death|0|||
146423711|NCT02468778|528057145|FG000|Overall Study|Lost to Follow-up|1|||
146423712|NCT02468778|528057146|FG001|Overall Study|Lost to Follow-up|2|||
146423713|NCT02468778|528057147|FG002|Overall Study|Lost to Follow-up|2|||
146423714|NCT02468778|528057145|FG000|Overall Study|Withdrawal by Subject|0|||
146423715|NCT02468778|528057146|FG001|Overall Study|Withdrawal by Subject|1|||
146423716|NCT02468778|528057147|FG002|Overall Study|Withdrawal by Subject|1|||
146423717|NCT00414765|528057148|FG000|Overall Study|Adverse Event|5|||
146423718|NCT00414765|528057149|FG001|Overall Study|Adverse Event|9|||
146423719|NCT00414765|528057148|FG000|Overall Study|Withdrawal by Subject|1|||
146423720|NCT00414765|528057149|FG001|Overall Study|Withdrawal by Subject|1|||
146423721|NCT00414765|528057148|FG000|Overall Study|Disease Progression|0|||
146423722|NCT00414765|528057149|FG001|Overall Study|Disease Progression|1|||
146423723|NCT05295953|528057150|FG000|Overall Study|Withdrawal by Subject|0|||
146423724|NCT05295953|528057151|FG001|Overall Study|Withdrawal by Subject|1|||
146423725|NCT05694013|528057153|FG000|Overall Study|Death|6|||
146423726|NCT05694013|528057154|FG001|Overall Study|Death|2|||
146423727|NCT05694013|528057153|FG000|Overall Study|Participant Decision|0|||
146423728|NCT05694013|528057154|FG001|Overall Study|Participant Decision|1|||
146423729|NCT05694013|528057153|FG000|Overall Study|Physician Decision|1|||
146423730|NCT05694013|528057154|FG001|Overall Study|Physician Decision|0|||
146423731|NCT05694013|528057153|FG000|Overall Study|Progressive Disease|0|||
146423732|NCT05694013|528057154|FG001|Overall Study|Progressive Disease|1|||
146423733|NCT05694013|528057153|FG000|Overall Study|Study Terminated by Sponsor|12|||
146423734|NCT05694013|528057154|FG001|Overall Study|Study Terminated by Sponsor|17|||
146423735|NCT05694013|528057153|FG000|Overall Study|Withdrawal by Subject|3|||
146423736|NCT05694013|528057154|FG001|Overall Study|Withdrawal by Subject|0|||
146423737|NCT04817891|528057155|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
146423738|NCT04817891|528057155|FG000|Overall Study|Adverse Event|1|||
146423739|NCT04817891|528057155|FG000|Overall Study|Withdrawal by Subject|1|||
146423740|NCT04534283|528057156|FG000|Overall Study|Physician Decision|2|||
146423741|NCT04534283|528057156|FG000|Overall Study|Withdrawal by Subject|1|||
146423742|NCT04534283|528057156|FG000|Overall Study|Disease Progression|12|||
146423743|NCT04534283|528057156|FG000|Overall Study|Adverse Event|1|||
146423744|NCT03257462|528057159|FG000|Cohort A|Lost to Follow-up|1|||
146423745|NCT03257462|528057160|FG001|Cohort A|Lost to Follow-up|0|||
146423746|NCT03257462|528057161|FG002|Cohort A|Lost to Follow-up|0|||
146423747|NCT03257462|528057162|FG003|Cohort A|Lost to Follow-up|0|||
146423748|NCT03257462|528057159|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
146423749|NCT03257462|528057160|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
146423750|NCT03257462|528057161|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
146423751|NCT03257462|528057162|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
146423752|NCT00368277|528057163|FG000|Overall Study|Adverse Event|33|||
146198707|NCT00995709|527239086|FG001|Overall Study|Death|1|||
146423753|NCT00368277|528057164|FG001|Overall Study|Adverse Event|49|||
146198708|NCT00995709|527239087|FG002|Overall Study|Death|0|||
146423754|NCT00368277|528057163|FG000|Overall Study|Death|2|||
146423755|NCT00368277|528057164|FG001|Overall Study|Death|1|||
146423756|NCT00368277|528057163|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
146423757|NCT00368277|528057164|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
146423758|NCT00368277|528057163|FG000|Overall Study|Protocol deviation|7|||
146423759|NCT00368277|528057164|FG001|Overall Study|Protocol deviation|0|||
146423760|NCT00368277|528057163|FG000|Overall Study|Patient withdrew consent|32|||
146423761|NCT00368277|528057164|FG001|Overall Study|Patient withdrew consent|28|||
146423762|NCT00368277|528057163|FG000|Overall Study|Lost to Follow-up|8|||
146423763|NCT00368277|528057164|FG001|Overall Study|Lost to Follow-up|6|||
146423764|NCT04347239|528057165|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
146423765|NCT04347239|528057166|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
146423766|NCT04347239|528057167|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
146423767|NCT04347239|528057165|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
146423768|NCT04347239|528057166|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
146423769|NCT04347239|528057167|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
146423770|NCT03283709|528057177|FG000|Overall Study|trial terminated|0|||
146423771|NCT03283709|528057178|FG001|Overall Study|trial terminated|1|||
146423772|NCT05275998|528057179|FG000|Overall Study|Adverse Event|0|||
146423773|NCT05275998|528057180|FG001|Overall Study|Adverse Event|0|||
146423774|NCT05275998|528057181|FG002|Overall Study|Adverse Event|0|||
146423775|NCT05275998|528057182|FG003|Overall Study|Adverse Event|1|||
146423776|NCT05275998|528057179|FG000|Overall Study|Withdrawal by Subject|0|||
146423777|NCT05275998|528057180|FG001|Overall Study|Withdrawal by Subject|0|||
146423778|NCT05275998|528057181|FG002|Overall Study|Withdrawal by Subject|0|||
146423779|NCT05275998|528057182|FG003|Overall Study|Withdrawal by Subject|1|||
146423780|NCT05275998|528057179|FG000|Overall Study|Physician Decision|0|||
146423781|NCT05275998|528057180|FG001|Overall Study|Physician Decision|0|||
146423782|NCT05275998|528057181|FG002|Overall Study|Physician Decision|0|||
146423783|NCT05275998|528057182|FG003|Overall Study|Physician Decision|1|||
146423784|NCT05275998|528057179|FG000|Overall Study|Protocol Violation|0|||
146423785|NCT05275998|528057180|FG001|Overall Study|Protocol Violation|0|||
146423786|NCT05275998|528057181|FG002|Overall Study|Protocol Violation|1|||
146423787|NCT05275998|528057182|FG003|Overall Study|Protocol Violation|0|||
146423788|NCT01867242|528057185|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
146423789|NCT01867242|528057186|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
146423790|NCT01867242|528057187|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
146423791|NCT00264810|528057192|FG000|Baseline|Withdrawal by Subject|10|||
146423792|NCT00264810|528057193|FG001|Baseline|Withdrawal by Subject|10|||
146423793|NCT00264810|528057192|FG000|Baseline|Physician Decision|7|||
146423794|NCT00264810|528057193|FG001|Baseline|Physician Decision|8|||
146423795|NCT00264810|528057192|FG000|Baseline|Subject Compliance Failure|3|||
146423796|NCT00264810|528057193|FG001|Baseline|Subject Compliance Failure|3|||
146423797|NCT00264810|528057192|FG000|Baseline|Insufficient Seizure Frequency|2|||
146423798|NCT00264810|528057193|FG001|Baseline|Insufficient Seizure Frequency|2|||
146423799|NCT00264810|528057192|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
146423800|NCT00264810|528057193|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
146423801|NCT00264810|528057192|FG000|Baseline|Other|0|||
146423802|NCT00264810|528057193|FG001|Baseline|Other|1|||
146423803|NCT00264810|528057192|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
146423804|NCT00264810|528057193|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
146423805|NCT00264810|528057192|FG000|Stimulation Optimization Period|Death|0|||
146423806|NCT00264810|528057193|FG001|Stimulation Optimization Period|Death|1|||
146423807|NCT00264810|528057192|FG000|Blinded Evaluation Period|Explant due to infection|1|||
146423808|NCT00264810|528057193|FG001|Blinded Evaluation Period|Explant due to infection|1|||
146423809|NCT00264810|528057192|FG000|Open Label Evaluation Period|Explant due to infection|1|||
146423810|NCT00264810|528057193|FG001|Open Label Evaluation Period|Explant due to infection|1|||
146423811|NCT00264810|528057192|FG000|Open Label Evaluation Period|Death|3|||
146423812|NCT00264810|528057193|FG001|Open Label Evaluation Period|Death|2|||
146423813|NCT00264810|528057192|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
145949468|NCT01153009|526326630|FG002|Overall Study|Lost to Follow-up|11|||
146198709|NCT00995709|527239085|FG000|Overall Study|Protocol Violation|2|||
146198710|NCT00995709|527239086|FG001|Overall Study|Protocol Violation|1|||
146198711|NCT00995709|527239087|FG002|Overall Study|Protocol Violation|0|||
146198712|NCT01264718|527239090|FG000|Overall Study|Lost to Follow-up|3|||
146198713|NCT01264718|527239091|FG001|Overall Study|Lost to Follow-up|2|||
146198714|NCT01264718|527239090|FG000|Overall Study|Withdrawal by Subject|9|||
146198715|NCT01264718|527239091|FG001|Overall Study|Withdrawal by Subject|15|||
146198716|NCT01264718|527239090|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
146198717|NCT01264718|527239091|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
146423814|NCT00264810|528057193|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
146423815|NCT02199509|528057195|FG000|Overall Study|Suicidal Ideation|0|||
146423816|NCT02199509|528057196|FG001|Overall Study|Suicidal Ideation|1|||
146423817|NCT02199509|528057195|FG000|Overall Study|Misunderstood titration schedule|1|||
146423818|NCT02199509|528057196|FG001|Overall Study|Misunderstood titration schedule|0|||
145949469|NCT01153009|526326631|FG003|Overall Study|Lost to Follow-up|15|||
146423819|NCT02093689|528057198|FG000|Overall Study|Physician Decision|4|||
145949470|NCT01153009|526326628|FG000|Overall Study|Other|1|||
145949471|NCT01153009|526326629|FG001|Overall Study|Other|1|||
146423820|NCT02093689|528057199|FG001|Overall Study|Physician Decision|0|||
146423821|NCT02093689|528057200|FG002|Overall Study|Physician Decision|0|||
146423822|NCT04947579|528057204|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146423823|NCT04947579|528057205|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146423824|NCT04947579|528057206|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146423825|NCT04947579|528057207|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
146423826|NCT04947579|528057208|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146423827|NCT04947579|528057209|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
146423828|NCT04947579|528057204|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146423829|NCT04947579|528057205|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146423830|NCT04947579|528057206|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
146423831|NCT04947579|528057207|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146423832|NCT04947579|528057208|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146423833|NCT04947579|528057209|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
146423834|NCT04947579|528057204|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
146423835|NCT04947579|528057205|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
146423836|NCT04947579|528057206|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
146423837|NCT04947579|528057207|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
146423838|NCT04947579|528057208|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
146423839|NCT04947579|528057209|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
146423840|NCT04947579|528057204|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
146423841|NCT04947579|528057205|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
146423842|NCT04947579|528057206|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
146423843|NCT04947579|528057207|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
146423844|NCT04947579|528057208|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
146423845|NCT04947579|528057209|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
146423846|NCT04947579|528057204|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
146423847|NCT04947579|528057205|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146198718|NCT03386929|527239092|FG000|Overall Study|Death|0|||
146198719|NCT03386929|527239093|FG001|Overall Study|Death|0|||
146198720|NCT03386929|527239094|FG002|Overall Study|Death|1|||
146198721|NCT03386929|527239092|FG000|Overall Study|Withdrawal by Subject|0|||
146198722|NCT03386929|527239093|FG001|Overall Study|Withdrawal by Subject|1|||
146198723|NCT03386929|527239094|FG002|Overall Study|Withdrawal by Subject|0|||
146198724|NCT03386929|527239092|FG000|Overall Study|Physician Decision|0|||
146198725|NCT03386929|527239093|FG001|Overall Study|Physician Decision|0|||
146198726|NCT03386929|527239094|FG002|Overall Study|Physician Decision|1|||
146198727|NCT03386929|527239092|FG000|Overall Study|Progression|4|||
146198728|NCT03386929|527239093|FG001|Overall Study|Progression|4|||
146198729|NCT03386929|527239094|FG002|Overall Study|Progression|0|||
146198730|NCT03386929|527239092|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146198731|NCT03386929|527239093|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146198732|NCT03386929|527239094|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
146198733|NCT03386929|527239092|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
146198734|NCT03386929|527239093|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
146198735|NCT03386929|527239094|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
146198736|NCT01144182|527239095|FG000|Overall Study|Death|5|||
146198737|NCT01144182|527239096|FG001|Overall Study|Death|6|||
146198738|NCT01144182|527239095|FG000|Overall Study|Withdrawal by Subject|3|||
146198739|NCT01144182|527239096|FG001|Overall Study|Withdrawal by Subject|6|||
146198740|NCT01144182|527239095|FG000|Overall Study|Lost to Follow-up|9|||
146198741|NCT01144182|527239096|FG001|Overall Study|Lost to Follow-up|9|||
146198742|NCT02317016|527239101|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
146423848|NCT04947579|528057206|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146423849|NCT04947579|528057207|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146198743|NCT02317016|527239101|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
146198744|NCT02317016|527239101|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
146198745|NCT02317016|527239101|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
146198746|NCT02317016|527239101|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
146198747|NCT02317016|527239101|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
146198748|NCT02317016|527239101|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
146198749|NCT03545984|527239102|FG000|Overall Study|CSF cases not present during rotation|11|||
146198750|NCT03545984|527239103|FG001|Overall Study|CSF cases not present during rotation|9|||
146198751|NCT01768676|527239104|FG000|Overall Study|Adverse Event|3|||
146198752|NCT01768676|527239105|FG001|Overall Study|Adverse Event|3|||
146198753|NCT01768676|527239104|FG000|Overall Study|Lost to Follow-up|13|||
146198754|NCT01768676|527239105|FG001|Overall Study|Lost to Follow-up|16|||
146198755|NCT01768676|527239104|FG000|Overall Study|Protocol Violation|1|||
146198756|NCT01768676|527239105|FG001|Overall Study|Protocol Violation|1|||
146198757|NCT01768676|527239104|FG000|Overall Study|Physician Decision|4|||
146423850|NCT04947579|528057208|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146423851|NCT04947579|528057209|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
146423852|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146423853|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146423854|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
146423855|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146423856|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146423857|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
146423858|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146423859|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
146423860|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146423861|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146423862|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
146423863|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
146423864|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146423865|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146423866|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
146423867|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146423868|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146423869|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
146423870|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
146423871|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
146423872|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
146423873|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
146423874|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
146423875|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
146423876|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
146423877|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
146423878|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
146423879|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
146423880|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
146423881|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
146423882|NCT04947579|528057204|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146423883|NCT04947579|528057205|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
146423884|NCT04947579|528057206|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
146423885|NCT04947579|528057207|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146423886|NCT04947579|528057208|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
146423887|NCT04947579|528057209|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
146423888|NCT00634179|528057210|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
146423889|NCT04272801|528057213|FG000|Overall Study|Withdrawal by Subject|4|||
146423890|NCT04272801|528057213|FG000|Overall Study|Lost to Follow-up|4|||
146423891|NCT04272801|528057213|FG000|Overall Study|Ineligible|1|||
146423892|NCT00475020|528057214|FG000|Overall Study|Physician Decision|3|||
146423893|NCT00475020|528057214|FG000|Overall Study|Insurance Denial|1|||
146423894|NCT00475020|528057214|FG000|Overall Study|Donor not able to donate the last minute|1|||
146423895|NCT02456909|528057215|FG000|Overall Study|Did not receive allocated intervention|24|||
146423896|NCT02456909|528057216|FG001|Overall Study|Did not receive allocated intervention|26|||
146423897|NCT02456909|528057215|FG000|Overall Study|Did not complete the primary outcome|0|||
146423898|NCT02456909|528057216|FG001|Overall Study|Did not complete the primary outcome|1|||
146423899|NCT03481309|528057217|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
146423900|NCT03481309|528057218|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146423901|NCT03481309|528057219|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146423902|NCT03481309|528057220|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146423903|NCT03481309|528057221|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146423904|NCT03481309|528057222|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
146423905|NCT01575054|528057223|FG000|Overall Study|Other Reasons|5|||
146423906|NCT01575054|528057224|FG001|Overall Study|Other Reasons|3|||
146423907|NCT01575054|528057223|FG000|Overall Study|Protocol Violation|2|||
146423908|NCT01575054|528057224|FG001|Overall Study|Protocol Violation|1|||
146423909|NCT01575054|528057223|FG000|Overall Study|Personal Reasons|10|||
146423910|NCT01575054|528057224|FG001|Overall Study|Personal Reasons|11|||
146423911|NCT01575054|528057223|FG000|Overall Study|Lost to Follow-up|3|||
146423912|NCT01575054|528057224|FG001|Overall Study|Lost to Follow-up|3|||
146423913|NCT01575054|528057223|FG000|Overall Study|Adverse Event|9|||
146423914|NCT01575054|528057224|FG001|Overall Study|Adverse Event|8|||
146423915|NCT02768298|528057227|FG000|Overall Study|Adverse Event|1|||
146423916|NCT02768298|528057228|FG001|Overall Study|Adverse Event|4|||
146423917|NCT02768298|528057227|FG000|Overall Study|Death|2|||
146423918|NCT02768298|528057228|FG001|Overall Study|Death|1|||
146423919|NCT02768298|528057227|FG000|Overall Study|Non-compliance with study treatment|0|||
146423920|NCT02768298|528057228|FG001|Overall Study|Non-compliance with study treatment|1|||
146423921|NCT02768298|528057227|FG000|Overall Study|Subject/guardian decision|1|||
146423922|NCT02768298|528057228|FG001|Overall Study|Subject/guardian decision|0|||
146423923|NCT02768298|528057227|FG000|Overall Study|Withdrawal of informed consent|0|||
146423924|NCT02768298|528057228|FG001|Overall Study|Withdrawal of informed consent|1|||
146423925|NCT04603937|528057229|FG000|Overall Study|Adverse Event|9|||
146423926|NCT04603937|528057230|FG001|Overall Study|Adverse Event|10|||
146423927|NCT04603937|528057229|FG000|Overall Study|Withdrawal by Subject|7|||
146423928|NCT04603937|528057230|FG001|Overall Study|Withdrawal by Subject|6|||
146423929|NCT04603937|528057229|FG000|Overall Study|Lost to Follow-up|5|||
146423930|NCT04603937|528057230|FG001|Overall Study|Lost to Follow-up|6|||
146423931|NCT04603937|528057229|FG000|Overall Study|Physician Decision|0|||
146423932|NCT04603937|528057230|FG001|Overall Study|Physician Decision|1|||
146423933|NCT04603937|528057229|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
146423934|NCT04603937|528057230|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
146423935|NCT01611090|528057231|FG000|Randomized Period|Lost to Follow-up|8|||
146423936|NCT01611090|528057232|FG001|Randomized Period|Lost to Follow-up|3|||
146423937|NCT01611090|528057233|FG002|Randomized Period|Lost to Follow-up|0|||
146423938|NCT01611090|528057231|FG000|Randomized Period|Withdrawal by Subject|22|||
146423939|NCT01611090|528057232|FG001|Randomized Period|Withdrawal by Subject|26|||
146423940|NCT01611090|528057233|FG002|Randomized Period|Withdrawal by Subject|0|||
146423941|NCT01611090|528057231|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
146423942|NCT01611090|528057232|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
146423943|NCT01611090|528057233|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
146423944|NCT01611090|528057231|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
146423945|NCT01611090|528057232|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
146423946|NCT01611090|528057233|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
146423947|NCT05109234|528057234|FG000|Overall Study|Adverse Event|2|||
146423948|NCT05109234|528057235|FG001|Overall Study|Adverse Event|2|||
146423949|NCT05109234|528057234|FG000|Overall Study|Lack of Efficacy|5|||
146423950|NCT05109234|528057235|FG001|Overall Study|Lack of Efficacy|0|||
146423951|NCT05109234|528057234|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
146423952|NCT05109234|528057235|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
146423953|NCT05109234|528057234|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
146423954|NCT05109234|528057235|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
146423955|NCT05109234|528057234|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
146423956|NCT05109234|528057235|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
146423957|NCT05109234|528057234|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
146423958|NCT05109234|528057235|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
146423959|NCT00336024|528057237|FG000|Overall Study|Death|2|||
146423960|NCT00336024|528057238|FG001|Overall Study|Death|1|||
146423961|NCT00336024|528057237|FG000|Overall Study|Physician Decision|4|||
146423962|NCT00336024|528057238|FG001|Overall Study|Physician Decision|1|||
146423963|NCT00336024|528057237|FG000|Overall Study|Protocol Violation|1|||
146423964|NCT00336024|528057238|FG001|Overall Study|Protocol Violation|0|||
146423965|NCT00336024|528057237|FG000|Overall Study|Withdrawal by Subject|1|||
146423966|NCT00336024|528057238|FG001|Overall Study|Withdrawal by Subject|2|||
146423967|NCT00336024|528057237|FG000|Overall Study|Failure to fulfill consolidation|1|||
146423968|NCT00336024|528057238|FG001|Overall Study|Failure to fulfill consolidation|1|||
146423969|NCT00336024|528057237|FG000|Overall Study|Progressive Disease|4|||
146423970|NCT00336024|528057238|FG001|Overall Study|Progressive Disease|7|||
146198758|NCT01768676|527239105|FG001|Overall Study|Physician Decision|1|||
146198759|NCT01768676|527239104|FG000|Overall Study|Withdrawal by Subject|3|||
146198760|NCT01768676|527239105|FG001|Overall Study|Withdrawal by Subject|10|||
146198761|NCT03121950|527239106|FG000|Overall Study|Withdrawal by Subject|11|||
146198762|NCT03121950|527239107|FG001|Overall Study|Withdrawal by Subject|2|||
146423971|NCT00336024|528057237|FG000|Overall Study|Ineligible|7|||
146423972|NCT00336024|528057238|FG001|Overall Study|Ineligible|7|||
146423973|NCT02585258|528057239|FG000|Overall Study|Adverse Event|28|||
146423974|NCT02585258|528057240|FG001|Overall Study|Adverse Event|29|||
146423975|NCT02585258|528057239|FG000|Overall Study|Death|3|||
146423976|NCT02585258|528057240|FG001|Overall Study|Death|2|||
146423977|NCT02585258|528057239|FG000|Overall Study|Lack of Efficacy|7|||
146423978|NCT02585258|528057240|FG001|Overall Study|Lack of Efficacy|9|||
146423979|NCT02585258|528057239|FG000|Overall Study|includes covid-related access problems|42|||
146423980|NCT02585258|528057240|FG001|Overall Study|includes covid-related access problems|46|||
146423981|NCT02585258|528057239|FG000|Overall Study|Lost to Follow-up|5|||
146423982|NCT02585258|528057240|FG001|Overall Study|Lost to Follow-up|2|||
146423983|NCT05125952|528057241|FG000|Overall Study|Physician Decision|1|||
146423984|NCT03946449|528057242|FG000|Treatment Extension II|Rolled over to another study|0|||
146423985|NCT03946449|528057243|FG001|Treatment Extension II|Rolled over to another study|0|||
146423986|NCT03946449|528057244|FG002|Treatment Extension II|Rolled over to another study|2|||
146423987|NCT03946449|528057242|FG000|Treatment Extension II|Withdrawal by Subject|0|||
146423988|NCT03946449|528057243|FG001|Treatment Extension II|Withdrawal by Subject|0|||
146423989|NCT03946449|528057244|FG002|Treatment Extension II|Withdrawal by Subject|1|||
146423990|NCT01210001|528059167|FG000|Overall Study|Not treated|1|||
146423991|NCT01210001|528059168|FG001|Overall Study|Not treated|0|||
146423992|NCT01210001|528059169|FG002|Overall Study|Not treated|0|||
146423993|NCT01210001|528059167|FG000|Overall Study|Adverse Event|4|||
146423994|NCT01210001|528059168|FG001|Overall Study|Adverse Event|2|||
146423995|NCT01210001|528059169|FG002|Overall Study|Adverse Event|5|||
146423996|NCT01210001|528059167|FG000|Overall Study|Non compliant with protocol|2|||
146423997|NCT01210001|528059168|FG001|Overall Study|Non compliant with protocol|2|||
146423998|NCT01210001|528059169|FG002|Overall Study|Non compliant with protocol|3|||
146423999|NCT01210001|528059167|FG000|Overall Study|Lost to Follow-up|4|||
146424000|NCT01210001|528059168|FG001|Overall Study|Lost to Follow-up|3|||
146424001|NCT01210001|528059169|FG002|Overall Study|Lost to Follow-up|2|||
146424002|NCT01210001|528059167|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
146424003|NCT01210001|528059168|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
146424004|NCT01210001|528059169|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
146424005|NCT01210001|528059167|FG000|Overall Study|Other reason not defined above|2|||
146424006|NCT01210001|528059168|FG001|Overall Study|Other reason not defined above|2|||
146424007|NCT01210001|528059169|FG002|Overall Study|Other reason not defined above|1|||
146424008|NCT00788125|528059170|FG000|Overall Study|Death|6|||
146424009|NCT02180711|528059175|FG000|Overall Study|Death|0|||
146424010|NCT02180711|528059176|FG001|Overall Study|Death|1|||
146424011|NCT02180711|528059177|FG002|Overall Study|Death|0|||
146424012|NCT02180711|528059178|FG003|Overall Study|Death|0|||
146424013|NCT02180711|528059179|FG004|Overall Study|Death|7|||
146424014|NCT02180711|528059180|FG005|Overall Study|Death|0|||
146424015|NCT02180711|528059181|FG006|Overall Study|Death|1|||
146424016|NCT02180711|528059182|FG007|Overall Study|Death|3|||
146424017|NCT02180711|528059175|FG000|Overall Study|Lost to Follow-up|0|||
146424018|NCT02180711|528059176|FG001|Overall Study|Lost to Follow-up|1|||
146424019|NCT02180711|528059177|FG002|Overall Study|Lost to Follow-up|0|||
146424020|NCT02180711|528059178|FG003|Overall Study|Lost to Follow-up|0|||
146424021|NCT02180711|528059179|FG004|Overall Study|Lost to Follow-up|1|||
146424022|NCT02180711|528059180|FG005|Overall Study|Lost to Follow-up|1|||
146424023|NCT02180711|528059181|FG006|Overall Study|Lost to Follow-up|0|||
146424024|NCT02180711|528059182|FG007|Overall Study|Lost to Follow-up|3|||
146424025|NCT02180711|528059175|FG000|Overall Study|Withdrawal by Subject|2|||
146424026|NCT02180711|528059176|FG001|Overall Study|Withdrawal by Subject|1|||
146424027|NCT02180711|528059177|FG002|Overall Study|Withdrawal by Subject|0|||
146424028|NCT02180711|528059178|FG003|Overall Study|Withdrawal by Subject|4|||
146424029|NCT02180711|528059179|FG004|Overall Study|Withdrawal by Subject|3|||
146424030|NCT02180711|528059180|FG005|Overall Study|Withdrawal by Subject|0|||
146424031|NCT02180711|528059181|FG006|Overall Study|Withdrawal by Subject|3|||
146424032|NCT02180711|528059182|FG007|Overall Study|Withdrawal by Subject|2|||
145949472|NCT01153009|526326630|FG002|Overall Study|Other|3|||
145949473|NCT01153009|526326631|FG003|Overall Study|Other|2|||
145949474|NCT00410072|526326632|FG000|Day 1 to Week 48|Adverse Event|1|||
145949475|NCT00410072|526326633|FG001|Day 1 to Week 48|Adverse Event|2|||
145949476|NCT00410072|526326632|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
145949477|NCT00410072|526326633|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
145949478|NCT00410072|526326632|FG000|Day 1 to Week 48|Other|0|||
145949479|NCT00410072|526326633|FG001|Day 1 to Week 48|Other|1|||
145949480|NCT00410072|526326632|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
145949481|NCT00410072|526326633|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
145949482|NCT00410072|526326632|FG000|Day 1 to Week 48|Pregnancy|0|||
146082637|NCT01894568|526822863|FG001|Overall Study|Protocol required discontinuation|1|||
146198763|NCT03183518|527239111|FG000|Overall Study|Other (Not specified)|2|||
146424033|NCT02180711|528059175|FG000|Overall Study|- Disease Progression|0|||
146424034|NCT02180711|528059176|FG001|Overall Study|- Disease Progression|1|||
146424035|NCT02180711|528059177|FG002|Overall Study|- Disease Progression|0|||
145949483|NCT00410072|526326633|FG001|Day 1 to Week 48|Pregnancy|2|||
146082638|NCT01894568|526822862|FG000|Overall Study|Withdrawal by Subject|5|||
145949484|NCT00410072|526326632|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
146424036|NCT02180711|528059178|FG003|Overall Study|- Disease Progression|0|||
146424037|NCT02180711|528059179|FG004|Overall Study|- Disease Progression|0|||
146424038|NCT02180711|528059180|FG005|Overall Study|- Disease Progression|0|||
146424039|NCT02180711|528059181|FG006|Overall Study|- Disease Progression|0|||
146424040|NCT02180711|528059182|FG007|Overall Study|- Disease Progression|0|||
146424041|NCT02180711|528059175|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
146424042|NCT02180711|528059176|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
146424043|NCT02180711|528059177|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
146424044|NCT02180711|528059178|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
146424045|NCT02180711|528059179|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146424046|NCT02180711|528059180|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146424047|NCT02180711|528059181|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146424048|NCT02180711|528059182|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
146424049|NCT02180711|528059175|FG000|Overall Study|- Study Terminated by Sponsor|2|||
146424050|NCT02180711|528059176|FG001|Overall Study|- Study Terminated by Sponsor|3|||
146424051|NCT02180711|528059177|FG002|Overall Study|- Study Terminated by Sponsor|0|||
146424052|NCT02180711|528059178|FG003|Overall Study|- Study Terminated by Sponsor|5|||
146424053|NCT02180711|528059179|FG004|Overall Study|- Study Terminated by Sponsor|32|||
146424054|NCT02180711|528059180|FG005|Overall Study|- Study Terminated by Sponsor|0|||
146424055|NCT02180711|528059181|FG006|Overall Study|- Study Terminated by Sponsor|4|||
146424056|NCT02180711|528059182|FG007|Overall Study|- Study Terminated by Sponsor|13|||
146424057|NCT02180711|528059175|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
146424058|NCT02180711|528059176|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
146424059|NCT02180711|528059177|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
146424060|NCT02180711|528059178|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
146424061|NCT02180711|528059179|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
146424062|NCT02180711|528059180|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
146424063|NCT02180711|528059181|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
146424064|NCT02180711|528059182|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
146424065|NCT02180711|528059175|FG000|Overall Study|- Other|1|||
146424066|NCT02180711|528059176|FG001|Overall Study|- Other|0|||
146424067|NCT02180711|528059177|FG002|Overall Study|- Other|0|||
146424068|NCT02180711|528059178|FG003|Overall Study|- Other|1|||
146424069|NCT02180711|528059179|FG004|Overall Study|- Other|0|||
146424070|NCT02180711|528059180|FG005|Overall Study|- Other|0|||
146424071|NCT02180711|528059181|FG006|Overall Study|- Other|0|||
146424072|NCT02180711|528059182|FG007|Overall Study|- Other|0|||
146424073|NCT03805438|528059189|FG000|Overall Study|Lack of Efficacy|1|||
146424074|NCT03805438|528059189|FG000|Overall Study|Protocol Violation|1|||
146424075|NCT02684344|528059191|FG000|Overall Study|Withdrawal by Subject|0|||
146424076|NCT02684344|528059192|FG001|Overall Study|Withdrawal by Subject|1|||
146424077|NCT00863746|528059195|FG000|Treatment|Not treated|4|||
146424078|NCT00863746|528059196|FG001|Treatment|Not treated|2|||
146424079|NCT00863746|528059195|FG000|Treatment|Adverse Event|41|||
146424080|NCT00863746|528059196|FG001|Treatment|Adverse Event|16|||
146424081|NCT00863746|528059195|FG000|Treatment|non-compliant with study medication|4|||
146424082|NCT00863746|528059196|FG001|Treatment|non-compliant with study medication|0|||
146424083|NCT00863746|528059195|FG000|Treatment|Consent withdrawn|15|||
146424084|NCT00863746|528059196|FG001|Treatment|Consent withdrawn|14|||
146424085|NCT00863746|528059195|FG000|Treatment|Lost to Follow-up|1|||
146424086|NCT00863746|528059196|FG001|Treatment|Lost to Follow-up|0|||
146424087|NCT00863746|528059195|FG000|Treatment|Protocol Violation|5|||
146424088|NCT00863746|528059196|FG001|Treatment|Protocol Violation|3|||
146424089|NCT00863746|528059195|FG000|Treatment|Other|1|||
146424090|NCT00863746|528059196|FG001|Treatment|Other|0|||
146424091|NCT00863746|528059195|FG000|Survival Follow up|Death|244|||
146424092|NCT00863746|528059196|FG001|Survival Follow up|Death|271|||
146424093|NCT00863746|528059195|FG000|Survival Follow up|Lost to Follow-up|2|||
146424094|NCT00863746|528059196|FG001|Survival Follow up|Lost to Follow-up|1|||
146424095|NCT00863746|528059195|FG000|Survival Follow up|Consent Withdrawn|7|||
146424096|NCT00863746|528059196|FG001|Survival Follow up|Consent Withdrawn|8|||
146424097|NCT03292653|528059199|FG000|Overall Study|Adverse Event|0|||
146424098|NCT03292653|528059200|FG001|Overall Study|Adverse Event|0|||
146424099|NCT03292653|528059201|FG002|Overall Study|Adverse Event|1|||
146424100|NCT03292653|528059199|FG000|Overall Study|Did not Receive Treatment|1|||
146424101|NCT03292653|528059200|FG001|Overall Study|Did not Receive Treatment|0|||
146424102|NCT03292653|528059201|FG002|Overall Study|Did not Receive Treatment|0|||
146424103|NCT04720664|528059202|FG000|Overall Study|Adverse Event|2|||
146424104|NCT04720664|528059202|FG000|Overall Study|Lack of Efficacy|9|||
146424105|NCT05037097|528059203|FG000|Overall Study|Withdrawal by Subject|0|||
146424106|NCT05037097|528059204|FG001|Overall Study|Withdrawal by Subject|1|||
146424107|NCT05037097|528059205|FG002|Overall Study|Withdrawal by Subject|0|||
146424108|NCT05037097|528059206|FG003|Overall Study|Withdrawal by Subject|1|||
146424109|NCT05037097|528059207|FG004|Overall Study|Withdrawal by Subject|0|||
146424110|NCT05037097|528059208|FG005|Overall Study|Withdrawal by Subject|2|||
146424111|NCT05037097|528059209|FG006|Overall Study|Withdrawal by Subject|0|||
146424112|NCT05037097|528059210|FG007|Overall Study|Withdrawal by Subject|0|||
146424113|NCT05037097|528059203|FG000|Overall Study|Lost to Follow-up|0|||
146424114|NCT05037097|528059204|FG001|Overall Study|Lost to Follow-up|1|||
146424115|NCT05037097|528059205|FG002|Overall Study|Lost to Follow-up|0|||
146424116|NCT05037097|528059206|FG003|Overall Study|Lost to Follow-up|0|||
146424117|NCT05037097|528059207|FG004|Overall Study|Lost to Follow-up|1|||
146424118|NCT05037097|528059208|FG005|Overall Study|Lost to Follow-up|1|||
146424119|NCT05037097|528059209|FG006|Overall Study|Lost to Follow-up|0|||
146424120|NCT05037097|528059210|FG007|Overall Study|Lost to Follow-up|0|||
146424121|NCT02322047|528059211|FG000|Overall Study|Physician Decision|1|||
146424122|NCT02322047|528059212|FG001|Overall Study|Physician Decision|0|||
146424123|NCT02322047|528059213|FG002|Overall Study|Physician Decision|0|||
146424124|NCT02322047|528059214|FG003|Overall Study|Physician Decision|0|||
146424125|NCT02322047|528059211|FG000|Overall Study|Withdrawal by Subject|1|||
146424126|NCT02322047|528059212|FG001|Overall Study|Withdrawal by Subject|0|||
146424127|NCT02322047|528059213|FG002|Overall Study|Withdrawal by Subject|0|||
146424128|NCT02322047|528059214|FG003|Overall Study|Withdrawal by Subject|1|||
146424129|NCT02322047|528059211|FG000|Overall Study|Adverse Event|0|||
146424130|NCT02322047|528059212|FG001|Overall Study|Adverse Event|1|||
146424131|NCT02322047|528059213|FG002|Overall Study|Adverse Event|0|||
146424132|NCT02322047|528059214|FG003|Overall Study|Adverse Event|0|||
146424133|NCT02322047|528059211|FG000|Overall Study|Lost to Follow-up|0|||
146424134|NCT02322047|528059212|FG001|Overall Study|Lost to Follow-up|0|||
146424135|NCT02322047|528059213|FG002|Overall Study|Lost to Follow-up|1|||
146424136|NCT02322047|528059214|FG003|Overall Study|Lost to Follow-up|1|||
146424137|NCT00376220|528059219|FG000|Overall Study|Lost to Follow-up|7|||
146424138|NCT00376220|528059220|FG001|Overall Study|Lost to Follow-up|10|||
146424139|NCT00376220|528059219|FG000|Overall Study|Withdrawal by Subject|3|||
146424140|NCT00376220|528059220|FG001|Overall Study|Withdrawal by Subject|2|||
146424141|NCT03311646|528059221|FG000|Overall Study|Physician Decision|1|||
146424142|NCT03311646|528059221|FG000|Overall Study|Withdrawal by Subject|5|||
146424143|NCT03311646|528059221|FG000|Overall Study|Lost to Follow-up|5|||
146424144|NCT03311646|528059221|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
146424145|NCT00531206|528059222|FG000|Overall Study|Adverse Event related|5|||
146424146|NCT00531206|528059222|FG000|Overall Study|Lack of Efficacy|2|||
146424147|NCT00531206|528059222|FG000|Overall Study|Lost to Follow-up|5|||
146424148|NCT00531206|528059222|FG000|Overall Study|including non-related adverse events|8|||
146424149|NCT02906709|528059223|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
146424150|NCT02906709|528059224|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
146424151|NCT02906709|528059223|FG000|Phase A (Week 0 to Week 16)|Death|0|||
146424152|NCT02906709|528059224|FG001|Phase A (Week 0 to Week 16)|Death|1|||
146424153|NCT02906709|528059223|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
146424154|NCT02906709|528059224|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
146424155|NCT02906709|528059223|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
146424156|NCT02906709|528059224|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
146424157|NCT01124149|528059225|FG000|Acute Phase|Withdrawal by Subject|22|||
146424158|NCT01124149|528059225|FG000|Acute Phase|Adverse Event|21|||
146424159|NCT01124149|528059225|FG000|Acute Phase|Lack of Efficacy|17|||
146424160|NCT01124149|528059225|FG000|Acute Phase|Protocol Violation|14|||
146424161|NCT01124149|528059225|FG000|Acute Phase|Lost to Follow-up|2|||
146424162|NCT01124149|528059225|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
146424163|NCT01124149|528059225|FG000|Acute Phase|Sponsor request|1|||
146424164|NCT01124149|528059225|FG000|Acute Phase|UC symptoms not ameliorated|1|||
146424165|NCT01124149|528059225|FG000|Acute Phase|Non-compliance|1|||
146424166|NCT01124149|528059225|FG000|Acute Phase|Low hemoglobin|1|||
146424167|NCT01124149|528059225|FG000|Acute Phase|Travelling to another country|1|||
146424168|NCT01124149|528059225|FG000|Acute Phase|Sponsor decision|1|||
146424169|NCT01124149|528059225|FG000|Maintenance Phase|Lack of Efficacy|40|||
146198764|NCT03183518|527239111|FG000|Overall Study|Other (Withdrawal of consent)|1|||
146198765|NCT04248829|527239112|FG000|Overall Study|Disease progression|44|||
146198766|NCT04248829|527239113|FG001|Overall Study|Disease progression|109|||
146198767|NCT04248829|527239112|FG000|Overall Study|Adverse Event|19|||
146198768|NCT04248829|527239113|FG001|Overall Study|Adverse Event|18|||
146198769|NCT04248829|527239112|FG000|Overall Study|Withdrawal by Subject|11|||
146198770|NCT04248829|527239113|FG001|Overall Study|Withdrawal by Subject|2|||
146424170|NCT01124149|528059225|FG000|Maintenance Phase|Adverse Event|24|||
146424171|NCT01124149|528059225|FG000|Maintenance Phase|Lost to Follow-up|15|||
146424172|NCT01124149|528059225|FG000|Maintenance Phase|Withdrawal by Subject|10|||
146424173|NCT01124149|528059225|FG000|Maintenance Phase|Protocol Violation|5|||
146424174|NCT01124149|528059225|FG000|Maintenance Phase|Coordinator error|1|||
146424175|NCT01124149|528059225|FG000|Maintenance Phase|Non-compliance|1|||
146424176|NCT01644500|528059226|FG000|Overall Study|Adverse Event|6|||
146424177|NCT01644500|528059227|FG001|Overall Study|Adverse Event|1|||
146424178|NCT01644500|528059228|FG002|Overall Study|Adverse Event|2|||
146424179|NCT01644500|528059226|FG000|Overall Study|Death|0|||
146424180|NCT01644500|528059227|FG001|Overall Study|Death|1|||
146424181|NCT01644500|528059228|FG002|Overall Study|Death|0|||
146424182|NCT01644500|528059226|FG000|Overall Study|Lost to Follow-up|3|||
146198771|NCT04248829|527239112|FG000|Overall Study|Lost to Follow-up|0|||
146198772|NCT04248829|527239113|FG001|Overall Study|Lost to Follow-up|1|||
146198773|NCT04248829|527239112|FG000|Overall Study|Death|12|||
146424183|NCT01644500|528059227|FG001|Overall Study|Lost to Follow-up|8|||
146424184|NCT01644500|528059228|FG002|Overall Study|Lost to Follow-up|0|||
146424185|NCT01644500|528059226|FG000|Overall Study|Protocol Violation|1|||
146424186|NCT01644500|528059227|FG001|Overall Study|Protocol Violation|1|||
146424187|NCT01644500|528059228|FG002|Overall Study|Protocol Violation|0|||
146424188|NCT01644500|528059226|FG000|Overall Study|Withdrawal by Subject|11|||
146424189|NCT01644500|528059227|FG001|Overall Study|Withdrawal by Subject|12|||
146424190|NCT01644500|528059228|FG002|Overall Study|Withdrawal by Subject|12|||
146424191|NCT01644500|528059226|FG000|Overall Study|Physician Decision|1|||
146424192|NCT01644500|528059227|FG001|Overall Study|Physician Decision|1|||
146424193|NCT01644500|528059228|FG002|Overall Study|Physician Decision|1|||
146424194|NCT01439165|528059235|FG000|Overall Study|Protocol Violation|3|||
146424195|NCT01439165|528059236|FG001|Overall Study|Protocol Violation|0|||
146424196|NCT01439165|528059235|FG000|Overall Study|Lost to Follow-up|11|||
146424197|NCT01439165|528059236|FG001|Overall Study|Lost to Follow-up|1|||
146424198|NCT01439165|528059235|FG000|Overall Study|Withdrawal by Subject|7|||
146424199|NCT01439165|528059236|FG001|Overall Study|Withdrawal by Subject|1|||
146424200|NCT03331042|528059240|FG000|Overall Study|Protocol Violation|1|||
146424201|NCT03331042|528059241|FG001|Overall Study|Protocol Violation|0|||
146424202|NCT03331042|528059242|FG002|Overall Study|Protocol Violation|0|||
146424203|NCT03331042|528059243|FG003|Overall Study|Protocol Violation|0|||
146424204|NCT03331042|528059240|FG000|Overall Study|Physician Decision|0|||
146424205|NCT03331042|528059241|FG001|Overall Study|Physician Decision|0|||
146424206|NCT03331042|528059242|FG002|Overall Study|Physician Decision|1|||
146424207|NCT03331042|528059243|FG003|Overall Study|Physician Decision|0|||
146424208|NCT03331042|528059240|FG000|Overall Study|Lost to Follow-up|0|||
146424209|NCT03331042|528059241|FG001|Overall Study|Lost to Follow-up|0|||
146424210|NCT03331042|528059242|FG002|Overall Study|Lost to Follow-up|0|||
146424211|NCT03331042|528059243|FG003|Overall Study|Lost to Follow-up|1|||
146424212|NCT00322491|528059249|FG000|Overall Study|Adverse Event|1|||
146424213|NCT00322491|528059250|FG001|Overall Study|Adverse Event|0|||
146424214|NCT00322491|528059249|FG000|Overall Study|Death|1|||
146424215|NCT00322491|528059250|FG001|Overall Study|Death|2|||
146424216|NCT03992196|528059251|FG000|Enrollment|lost to follow-up prior dosing|1|||
146424217|NCT03992196|528059252|FG001|Enrollment|lost to follow-up prior dosing|0|||
146424218|NCT03992196|528059253|FG002|Enrollment|lost to follow-up prior dosing|0|||
146424219|NCT03992196|528059251|FG000|Treatment|Protocol Violation|0|||
146424220|NCT03992196|528059252|FG001|Treatment|Protocol Violation|0|||
146424221|NCT03992196|528059253|FG002|Treatment|Protocol Violation|1|||
146424222|NCT03992196|528059251|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
146424223|NCT03992196|528059252|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
146424224|NCT03992196|528059253|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
146424225|NCT03992196|528059251|FG000|Treatment|Withdrawal due to non-compliance|0|||
146424226|NCT03992196|528059252|FG001|Treatment|Withdrawal due to non-compliance|0|||
146424227|NCT03992196|528059253|FG002|Treatment|Withdrawal due to non-compliance|1|||
146424228|NCT03992196|528059251|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
146424229|NCT03992196|528059252|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
146424230|NCT03992196|528059253|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
146424231|NCT03992196|528059251|FG000|Treatment|Withdrawal by parent/guardian|0|||
146424232|NCT03992196|528059252|FG001|Treatment|Withdrawal by parent/guardian|0|||
146424233|NCT03992196|528059253|FG002|Treatment|Withdrawal by parent/guardian|2|||
146424234|NCT00048048|528059254|FG000|Core Treatment|Withdrawal by Subject|0|||
146198774|NCT04248829|527239113|FG001|Overall Study|Death|14|||
146198775|NCT04248829|527239112|FG000|Overall Study|Physician Decision|2|||
146198776|NCT04248829|527239113|FG001|Overall Study|Physician Decision|4|||
146198777|NCT04248829|527239112|FG000|Overall Study|Any reason not specifically recorded|0|||
146198778|NCT04248829|527239113|FG001|Overall Study|Any reason not specifically recorded|2|||
146198779|NCT02132702|527239114|FG000|Overall Study|Protocol Violation|2|||
146424235|NCT00048048|528059255|FG001|Core Treatment|Withdrawal by Subject|0|||
146424236|NCT00048048|528059256|FG002|Core Treatment|Withdrawal by Subject|1|||
146424237|NCT00048048|528059257|FG003|Core Treatment|Withdrawal by Subject|0|||
146424238|NCT00048048|528059258|FG004|Core Treatment|Withdrawal by Subject|0|||
146424239|NCT00048048|528059259|FG005|Core Treatment|Withdrawal by Subject|0|||
146424240|NCT00048048|528059260|FG006|Core Treatment|Withdrawal by Subject|0|||
146424241|NCT00048048|528059261|FG007|Core Treatment|Withdrawal by Subject|0|||
146424242|NCT00048048|528059262|FG008|Core Treatment|Withdrawal by Subject|0|||
146424243|NCT00048048|528059263|FG009|Core Treatment|Withdrawal by Subject|0|||
146424244|NCT00048048|528059264|FG010|Core Treatment|Withdrawal by Subject|0|||
146424245|NCT00048048|528059265|FG011|Core Treatment|Withdrawal by Subject|0|||
146198780|NCT02132702|527239114|FG000|Overall Study|Adverse Event|3|||
146424246|NCT00048048|528059254|FG000|Core Treatment|Adverse Event|0|||
146424247|NCT00048048|528059255|FG001|Core Treatment|Adverse Event|0|||
146424248|NCT00048048|528059256|FG002|Core Treatment|Adverse Event|0|||
146424249|NCT00048048|528059257|FG003|Core Treatment|Adverse Event|0|||
146424250|NCT00048048|528059258|FG004|Core Treatment|Adverse Event|0|||
146424251|NCT00048048|528059259|FG005|Core Treatment|Adverse Event|0|||
146424252|NCT00048048|528059260|FG006|Core Treatment|Adverse Event|0|||
146198781|NCT02132702|527239114|FG000|Overall Study|Withdrawal by Subject|3|||
146424253|NCT00048048|528059261|FG007|Core Treatment|Adverse Event|1|||
146424254|NCT00048048|528059262|FG008|Core Treatment|Adverse Event|0|||
146424255|NCT00048048|528059263|FG009|Core Treatment|Adverse Event|0|||
146424256|NCT00048048|528059264|FG010|Core Treatment|Adverse Event|0|||
146424257|NCT00048048|528059265|FG011|Core Treatment|Adverse Event|0|||
146198782|NCT01867580|527239116|FG000|Overall Study|Withdrawal by Subject|2|||
146198783|NCT01867580|527239117|FG001|Overall Study|Withdrawal by Subject|3|||
146198784|NCT01867580|527239116|FG000|Overall Study|Physician Decision|17|||
146198785|NCT01867580|527239117|FG001|Overall Study|Physician Decision|12|||
146198786|NCT01867580|527239116|FG000|Overall Study|Lost to Follow-up|3|||
146198787|NCT01867580|527239117|FG001|Overall Study|Lost to Follow-up|5|||
146198788|NCT01867580|527239116|FG000|Overall Study|Sponsor terminated study|1|||
146198789|NCT01867580|527239117|FG001|Overall Study|Sponsor terminated study|0|||
146198790|NCT01867580|527239116|FG000|Overall Study|Missed follow-up assessment|2|||
146198791|NCT01867580|527239117|FG001|Overall Study|Missed follow-up assessment|1|||
146198792|NCT01867580|527239116|FG000|Overall Study|Interruption to therapy|3|||
146424258|NCT00048048|528059254|FG000|Extension Year 1|Early withdrawals|0|||
146424259|NCT00048048|528059255|FG001|Extension Year 1|Early withdrawals|0|||
146424260|NCT00048048|528059256|FG002|Extension Year 1|Early withdrawals|0|||
146424261|NCT00048048|528059257|FG003|Extension Year 1|Early withdrawals|0|||
146424262|NCT00048048|528059258|FG004|Extension Year 1|Early withdrawals|0|||
146424263|NCT00048048|528059259|FG005|Extension Year 1|Early withdrawals|0|||
146424264|NCT00048048|528059260|FG006|Extension Year 1|Early withdrawals|0|||
146424265|NCT00048048|528059261|FG007|Extension Year 1|Early withdrawals|0|||
146424266|NCT00048048|528059262|FG008|Extension Year 1|Early withdrawals|0|||
146424267|NCT00048048|528059263|FG009|Extension Year 1|Early withdrawals|2|||
146424268|NCT00048048|528059264|FG010|Extension Year 1|Early withdrawals|2|||
146424269|NCT00048048|528059265|FG011|Extension Year 1|Early withdrawals|4|||
146424270|NCT00048048|528059254|FG000|Extension Year 2|Early withdrawals|0|||
146424271|NCT00048048|528059255|FG001|Extension Year 2|Early withdrawals|0|||
146424272|NCT00048048|528059256|FG002|Extension Year 2|Early withdrawals|0|||
146424273|NCT00048048|528059257|FG003|Extension Year 2|Early withdrawals|0|||
146424274|NCT00048048|528059258|FG004|Extension Year 2|Early withdrawals|0|||
146424275|NCT00048048|528059259|FG005|Extension Year 2|Early withdrawals|0|||
146424276|NCT00048048|528059260|FG006|Extension Year 2|Early withdrawals|0|||
146424277|NCT00048048|528059261|FG007|Extension Year 2|Early withdrawals|0|||
146424278|NCT00048048|528059262|FG008|Extension Year 2|Early withdrawals|0|||
146424279|NCT00048048|528059263|FG009|Extension Year 2|Early withdrawals|0|||
146424280|NCT00048048|528059264|FG010|Extension Year 2|Early withdrawals|4|||
146424281|NCT00048048|528059265|FG011|Extension Year 2|Early withdrawals|2|||
146424282|NCT02388763|528059268|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
146424283|NCT02388763|528059269|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
146424284|NCT02388763|528059268|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
146424285|NCT02388763|528059269|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
146424286|NCT05518487|528059270|FG000|Overall Study|Withdrawal by Subject|3|||
146424287|NCT02194998|528059273|FG000|On-HCV Treatment|Did not pick up study medication|0|||
146424288|NCT02194998|528059274|FG001|On-HCV Treatment|Did not pick up study medication|1|||
146424289|NCT02194998|528059275|FG002|On-HCV Treatment|Did not pick up study medication|0|||
146424290|NCT02194998|528059276|FG003|On-HCV Treatment|Did not pick up study medication|0|||
146424291|NCT02194998|528059273|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
146424292|NCT02194998|528059274|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
146424293|NCT02194998|528059275|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
146424294|NCT02194998|528059276|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
146424295|NCT01458405|528059277|FG000|Phase 1 (up to 12 Months)|Other|0|||
146424296|NCT01458405|528059278|FG001|Phase 1 (up to 12 Months)|Other|1|||
146424297|NCT01458405|528059279|FG002|Phase 1 (up to 12 Months)|Other|0|||
146424298|NCT01458405|528059280|FG003|Phase 1 (up to 12 Months)|Other|0|||
146198793|NCT01867580|527239117|FG001|Overall Study|Interruption to therapy|0|||
146198794|NCT01867580|527239116|FG000|Overall Study|Osteomyelitis|0|||
146424299|NCT01458405|528059277|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
146424300|NCT01458405|528059278|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
146198795|NCT01867580|527239117|FG001|Overall Study|Osteomyelitis|1|||
146424301|NCT01458405|528059279|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
146424302|NCT01458405|528059280|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
146424303|NCT01458405|528059277|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146424304|NCT01458405|528059278|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146198796|NCT01867580|527239116|FG000|Overall Study|Continuation of therapy|0|||
146424305|NCT01458405|528059279|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
146424306|NCT01458405|528059280|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
146424307|NCT01458405|528059277|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146424308|NCT01458405|528059278|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146424309|NCT01458405|528059279|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
146424310|NCT01458405|528059280|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
146424311|NCT02497781|528059283|FG000|Overall Study|Withdrawal by Subject|2|||
146424312|NCT02497781|528059284|FG001|Overall Study|Withdrawal by Subject|0|||
146424313|NCT02497781|528059283|FG000|Overall Study|Lack of Efficacy|0|||
146424314|NCT02497781|528059284|FG001|Overall Study|Lack of Efficacy|1|||
146424315|NCT02497781|528059283|FG000|Overall Study|Randomised but not treated|1|||
146424316|NCT02497781|528059284|FG001|Overall Study|Randomised but not treated|1|||
146424317|NCT02497781|528059283|FG000|Overall Study|Lost to Follow-up|1|||
146424318|NCT02497781|528059284|FG001|Overall Study|Lost to Follow-up|1|||
146424319|NCT02236130|528059285|FG000|Overall Study|Lost to Follow-up|7|||
146424320|NCT02236130|528059286|FG001|Overall Study|Lost to Follow-up|12|||
146424321|NCT00525590|528059287|FG000|Overall Study|Adverse Event|3|||
146424322|NCT00525590|528059287|FG000|Overall Study|Physician Decision|3|||
146424323|NCT00525590|528059287|FG000|Overall Study|Withdrawal by Subject|16|||
146424324|NCT00525590|528059287|FG000|Overall Study|Lost to Follow-up|1|||
146424325|NCT00525590|528059287|FG000|Overall Study|Death|9|||
146424326|NCT00525590|528059287|FG000|Overall Study|Other|13|||
146424327|NCT01345019|528059296|FG000|Blinded Treatment Phase|Death|147|||
146424328|NCT01345019|528059297|FG001|Blinded Treatment Phase|Death|137|||
146424329|NCT01345019|528059296|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
146424330|NCT01345019|528059297|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
146424331|NCT01345019|528059296|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
146424332|NCT01345019|528059297|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
146424333|NCT01345019|528059296|FG000|Blinded Treatment Phase|Disease Progression|12|||
146424334|NCT01345019|528059297|FG001|Blinded Treatment Phase|Disease Progression|10|||
146424335|NCT01345019|528059296|FG000|Blinded Treatment Phase|Adverse Event|6|||
146424336|NCT01345019|528059297|FG001|Blinded Treatment Phase|Adverse Event|13|||
146424337|NCT01345019|528059296|FG000|Blinded Treatment Phase|Administrative Decision|10|||
146424338|NCT01345019|528059297|FG001|Blinded Treatment Phase|Administrative Decision|8|||
146424339|NCT01345019|528059296|FG000|Blinded Treatment Phase|Noncompliance|5|||
146424340|NCT01345019|528059297|FG001|Blinded Treatment Phase|Noncompliance|3|||
146424341|NCT01345019|528059296|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
146424342|NCT01345019|528059297|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
146424343|NCT01345019|528059296|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
146424344|NCT01345019|528059297|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
146424345|NCT01345019|528059296|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
146424346|NCT01345019|528059297|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
146424347|NCT01345019|528059296|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
146424348|NCT01345019|528059297|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
146424349|NCT01345019|528059296|FG000|Open Label Treatment Phase|Death|49|||
146424350|NCT01345019|528059297|FG001|Open Label Treatment Phase|Death|48|||
146424351|NCT01345019|528059296|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
146424352|NCT01345019|528059297|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
146424353|NCT01345019|528059296|FG000|Open Label Treatment Phase|Adverse Event|30|||
146424354|NCT01345019|528059297|FG001|Open Label Treatment Phase|Adverse Event|51|||
146424355|NCT01345019|528059296|FG000|Open Label Treatment Phase|Administrative Decision|30|||
146424356|NCT01345019|528059297|FG001|Open Label Treatment Phase|Administrative Decision|15|||
146424357|NCT01345019|528059296|FG000|Open Label Treatment Phase|Disease Progression|17|||
146424358|NCT01345019|528059297|FG001|Open Label Treatment Phase|Disease Progression|18|||
146424359|NCT01345019|528059296|FG000|Open Label Treatment Phase|Noncompliance|5|||
146424360|NCT01345019|528059297|FG001|Open Label Treatment Phase|Noncompliance|4|||
146424361|NCT01345019|528059296|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
146424362|NCT01345019|528059297|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
146198797|NCT01867580|527239117|FG001|Overall Study|Continuation of therapy|1|||
146198798|NCT01867580|527239116|FG000|Overall Study|Wound recurrence|0|||
146198799|NCT01867580|527239117|FG001|Overall Study|Wound recurrence|1|||
146198800|NCT01304147|527239118|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
146198801|NCT01304147|527239119|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
146198802|NCT01244828|527239120|FG000|Overall Study|Adverse Event|37|||
146424363|NCT01345019|528059296|FG000|Open Label Treatment Phase|Pregnancy|1|||
146424364|NCT01345019|528059297|FG001|Open Label Treatment Phase|Pregnancy|0|||
146424365|NCT01345019|528059296|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
146424366|NCT01345019|528059297|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
146424367|NCT01345019|528059296|FG000|Open Label Treatment Phase|Protocol Violation|0|||
146424368|NCT01345019|528059297|FG001|Open Label Treatment Phase|Protocol Violation|1|||
146424369|NCT03830164|528059298|FG000|Overall Study|Adverse Event|0|||
146424370|NCT03830164|528059299|FG001|Overall Study|Adverse Event|2|||
146198803|NCT01244828|527239120|FG000|Overall Study|Withdrawal by Subject|31|||
146198804|NCT01244828|527239120|FG000|Overall Study|Lack of Efficacy|7|||
146198805|NCT01244828|527239120|FG000|Overall Study|Lost to Follow-up|2|||
146424371|NCT03830164|528059300|FG002|Overall Study|Adverse Event|0|||
146198806|NCT01244828|527239120|FG000|Overall Study|Other reason (not specified)|1|||
146424372|NCT03830164|528059298|FG000|Overall Study|Lack of Efficacy|1|||
146424373|NCT03830164|528059299|FG001|Overall Study|Lack of Efficacy|5|||
146424374|NCT03830164|528059300|FG002|Overall Study|Lack of Efficacy|0|||
146424375|NCT03830164|528059298|FG000|Overall Study|Lost to Follow-up|0|||
146424376|NCT03830164|528059299|FG001|Overall Study|Lost to Follow-up|1|||
146424377|NCT03830164|528059300|FG002|Overall Study|Lost to Follow-up|0|||
146424378|NCT03830164|528059298|FG000|Overall Study|Withdrawal by Subject|1|||
146424379|NCT03830164|528059299|FG001|Overall Study|Withdrawal by Subject|0|||
146424380|NCT03830164|528059300|FG002|Overall Study|Withdrawal by Subject|0|||
146424381|NCT00320112|528059301|FG000|Overall Study|Lost to Follow-up|3|||
146424382|NCT00320112|528059302|FG001|Overall Study|Lost to Follow-up|4|||
146424383|NCT00320112|528059301|FG000|Overall Study|Withdrawal by Subject|3|||
146424384|NCT00320112|528059302|FG001|Overall Study|Withdrawal by Subject|0|||
146424385|NCT00320112|528059301|FG000|Overall Study|Death|2|||
146424386|NCT00320112|528059302|FG001|Overall Study|Death|1|||
146424387|NCT01199861|528059304|FG000|Overall Study|Administrative problems|1|||
146424388|NCT01199861|528059305|FG001|Overall Study|Administrative problems|0|||
146424389|NCT01199861|528059304|FG000|Overall Study|Adverse Event|1|||
146424390|NCT01199861|528059305|FG001|Overall Study|Adverse Event|0|||
146424391|NCT04981912|528059306|FG000|Overall Study|Physician Decision|2|||
146424392|NCT00661505|528059307|FG000|Overall Study|Adverse Event|3|||
146424393|NCT00661505|528059307|FG000|Overall Study|Protocol Violation|14|||
146424394|NCT00661505|528059307|FG000|Overall Study|Withdrawal by Subject|8|||
146424395|NCT00661505|528059307|FG000|Overall Study|Lost to Follow-up|3|||
146424396|NCT00661505|528059307|FG000|Overall Study|Other|2|||
146424397|NCT05630547|528059308|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146424398|NCT05630547|528059309|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
146424399|NCT05630547|528059310|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146424400|NCT05630547|528059311|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
146424401|NCT05630547|528059308|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
146424402|NCT05630547|528059309|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
146424403|NCT05630547|528059310|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
146424404|NCT05630547|528059311|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
146424405|NCT05630547|528059308|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146424406|NCT05630547|528059309|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
146424407|NCT05630547|528059310|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146424408|NCT05630547|528059311|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
146424409|NCT05630547|528059308|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
146424410|NCT05630547|528059309|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
146424411|NCT05630547|528059310|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
146424412|NCT05630547|528059311|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
146424413|NCT05630547|528059308|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146424414|NCT05630547|528059309|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
146424415|NCT05630547|528059310|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146424416|NCT05630547|528059311|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
146424417|NCT05630547|528059308|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
146424418|NCT05630547|528059309|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
146424419|NCT05630547|528059310|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
146424420|NCT05630547|528059311|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
146424421|NCT05630547|528059308|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146424422|NCT05630547|528059309|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146424423|NCT05630547|528059310|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
146424424|NCT05630547|528059311|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
146424425|NCT05630547|528059308|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
146424426|NCT05630547|528059309|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
146424427|NCT05630547|528059310|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
145949485|NCT00410072|526326633|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
146424428|NCT05630547|528059311|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
145949486|NCT00410072|526326632|FG000|After Week 48 to Week 96|Adverse Event|1|||
146424429|NCT05630547|528059308|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
146424430|NCT05630547|528059309|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
146424431|NCT05630547|528059310|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
146424432|NCT05630547|528059311|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
146424433|NCT05630547|528059308|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
146424434|NCT05630547|528059309|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
146424435|NCT05630547|528059310|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
146424436|NCT05630547|528059311|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
146424437|NCT00977470|528059312|FG000|Overall Study|Lack of Efficacy|32|||
146424438|NCT00977470|528059313|FG001|Overall Study|Lack of Efficacy|30|||
146424439|NCT00977470|528059312|FG000|Overall Study|Physician Decision|2|||
146424440|NCT00977470|528059313|FG001|Overall Study|Physician Decision|0|||
146424441|NCT00977470|528059312|FG000|Overall Study|Adverse Event|1|||
146424442|NCT00977470|528059313|FG001|Overall Study|Adverse Event|2|||
146424443|NCT00977470|528059312|FG000|Overall Study|Protocol Violation|1|||
146424444|NCT00977470|528059313|FG001|Overall Study|Protocol Violation|0|||
146424445|NCT00977470|528059312|FG000|Overall Study|Withdrawal by Subject|0|||
146424446|NCT00977470|528059313|FG001|Overall Study|Withdrawal by Subject|2|||
146424447|NCT00977470|528059312|FG000|Overall Study|Death|0|||
146424448|NCT00977470|528059313|FG001|Overall Study|Death|2|||
146424449|NCT00977470|528059312|FG000|Overall Study|clinical decline|0|||
146424450|NCT00977470|528059313|FG001|Overall Study|clinical decline|1|||
146424451|NCT00977470|528059312|FG000|Overall Study|prolonged recovery post-surgery|0|||
146424452|NCT00977470|528059313|FG001|Overall Study|prolonged recovery post-surgery|1|||
146424453|NCT00977470|528059312|FG000|Overall Study|Still on-study|2|||
146424454|NCT00977470|528059313|FG001|Overall Study|Still on-study|0|||
146424455|NCT00796822|528059314|FG000|Overall Study|Lost to Follow-up|2|||
146424456|NCT00796822|528059315|FG001|Overall Study|Lost to Follow-up|0|||
146424457|NCT00796822|528059314|FG000|Overall Study|Adverse Event|1|||
146424458|NCT00796822|528059315|FG001|Overall Study|Adverse Event|0|||
146424459|NCT02364557|528059316|FG000|Overall Study|Protocol Violation|3|||
146424460|NCT02364557|528059317|FG001|Overall Study|Protocol Violation|1|||
146424461|NCT03978624|528059318|FG000|Overall Study|Protocol Violation|1|||
146424462|NCT03978624|528059319|FG001|Overall Study|Protocol Violation|0|||
146424463|NCT05097989|528059321|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424464|NCT05097989|528059322|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424465|NCT05097989|528059323|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424466|NCT05097989|528059324|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424467|NCT05097989|528059325|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424468|NCT05097989|528059326|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
146424469|NCT05097989|528059327|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424470|NCT05097989|528059328|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424471|NCT05097989|528059329|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
146424472|NCT05097989|528059321|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
146424473|NCT05097989|528059322|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
146424474|NCT05097989|528059323|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
146424475|NCT05097989|528059324|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
146424476|NCT05097989|528059325|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
146198807|NCT05233085|527239121|FG000|Overall Study|Adverse Event|1|||
146198808|NCT05233085|527239122|FG001|Overall Study|Adverse Event|0|||
146198809|NCT05233085|527239123|FG002|Overall Study|Adverse Event|0|||
146198810|NCT05233085|527239124|FG003|Overall Study|Adverse Event|0|||
146198811|NCT05052983|527239125|FG000|Overall Study|Lack of Efficacy|3|||
146198812|NCT05052983|527239126|FG001|Overall Study|Lack of Efficacy|12|||
146198813|NCT05052983|527239125|FG000|Overall Study|Adverse Event|1|||
146198814|NCT05052983|527239126|FG001|Overall Study|Adverse Event|0|||
146198815|NCT02812966|527239129|FG000|Overall Study|Death|1|||
146198816|NCT02812966|527239130|FG001|Overall Study|Death|0|||
146198817|NCT05147233|527240822|FG000|Overall Study|Adverse Event|0|||
146198818|NCT05147233|527240823|FG001|Overall Study|Adverse Event|1|||
146198819|NCT05147233|527240822|FG000|Overall Study|Lost to Follow-up|1|||
146198820|NCT05147233|527240823|FG001|Overall Study|Lost to Follow-up|1|||
146198821|NCT05147233|527240822|FG000|Overall Study|Protocol Violation|0|||
146198822|NCT05147233|527240823|FG001|Overall Study|Protocol Violation|1|||
146198823|NCT05147233|527240822|FG000|Overall Study|Withdrawal by Subject|2|||
146198824|NCT05147233|527240823|FG001|Overall Study|Withdrawal by Subject|1|||
146198825|NCT00589667|527240832|FG000|Overall Study|Adverse Event|2|||
146198826|NCT00589667|527240832|FG000|Overall Study|Withdrawal by Subject|1|||
146198827|NCT03538041|527240835|FG000|12-Week Treatment Period|Adverse Event|1|||
146198828|NCT03538041|527240836|FG001|12-Week Treatment Period|Adverse Event|1|||
146198829|NCT03538041|527240835|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
146424477|NCT05097989|528059326|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
146424478|NCT05097989|528059327|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
146424479|NCT05097989|528059328|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
146424480|NCT05097989|528059329|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
146424481|NCT05097989|528059321|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424482|NCT05097989|528059322|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424483|NCT05097989|528059323|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424484|NCT05097989|528059324|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424485|NCT05097989|528059325|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424486|NCT05097989|528059326|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
146424487|NCT05097989|528059327|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
146424488|NCT05097989|528059328|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
146424489|NCT05097989|528059329|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
146424490|NCT05097989|528059321|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424491|NCT05097989|528059322|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424492|NCT05097989|528059323|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
146424493|NCT05097989|528059324|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424494|NCT05097989|528059325|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424495|NCT05097989|528059326|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
146424496|NCT05097989|528059327|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424497|NCT05097989|528059328|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
146424498|NCT05097989|528059329|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
146424499|NCT05097989|528059321|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424500|NCT05097989|528059322|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424501|NCT05097989|528059323|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
146424502|NCT05097989|528059324|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424503|NCT05097989|528059325|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424504|NCT05097989|528059326|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424505|NCT05097989|528059327|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145949487|NCT00410072|526326633|FG001|After Week 48 to Week 96|Adverse Event|2|||
145949488|NCT00410072|526326632|FG000|After Week 48 to Week 96|Death|0|||
145949489|NCT00410072|526326633|FG001|After Week 48 to Week 96|Death|1|||
145949490|NCT00410072|526326632|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
145949491|NCT00410072|526326633|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
145949492|NCT00410072|526326632|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
145949493|NCT00410072|526326633|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
145949494|NCT00410072|526326632|FG000|After Week 48 to Week 96|Other|2|||
145949495|NCT00410072|526326633|FG001|After Week 48 to Week 96|Other|0|||
145949496|NCT00410072|526326632|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
145949497|NCT00410072|526326633|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
145949498|NCT00410072|526326632|FG000|After Week 48 to Week 96|Pregnancy|0|||
145949499|NCT00410072|526326633|FG001|After Week 48 to Week 96|Pregnancy|2|||
145949500|NCT00410072|526326632|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
145949501|NCT00410072|526326633|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
145949502|NCT01212159|526326637|FG000|Overall Study|Withdrawal by Subject|12|||
145949503|NCT01212159|526326638|FG001|Overall Study|Withdrawal by Subject|12|||
145949504|NCT04676152|526326639|FG000|Overall Study|screen fail|9|||
145949505|NCT01066663|526326641|FG000|Overall Study|Adverse Event|0|||
145949506|NCT01066663|526326642|FG001|Overall Study|Adverse Event|0|||
145949507|NCT01066663|526326643|FG002|Overall Study|Adverse Event|1|||
145949508|NCT01090050|526326644|FG000|Overall Study|Lost to Follow-up|0|||
145949509|NCT01090050|526326645|FG001|Overall Study|Lost to Follow-up|1|||
145949510|NCT01090050|526326644|FG000|Overall Study|Lack of Efficacy|1|||
145949511|NCT01090050|526326645|FG001|Overall Study|Lack of Efficacy|5|||
145949512|NCT01090050|526326644|FG000|Overall Study|Physician Decision|0|||
145949513|NCT01090050|526326645|FG001|Overall Study|Physician Decision|1|||
145949514|NCT03539484|526326646|FG000|Overall Study|Death|1|||
145949515|NCT03539484|526326647|FG001|Overall Study|Death|0|||
145949516|NCT03539484|526326648|FG002|Overall Study|Death|0|||
145949517|NCT03539484|526326649|FG003|Overall Study|Death|2|||
145949518|NCT03539484|526326650|FG004|Overall Study|Death|8|||
146424506|NCT05097989|528059328|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424507|NCT05097989|528059329|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
146424508|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145949519|NCT03539484|526326651|FG005|Overall Study|Death|3|||
145949520|NCT03539484|526326652|FG006|Overall Study|Death|0|||
145949521|NCT03539484|526326646|FG000|Overall Study|Lost to Follow-up|0|||
145949522|NCT03539484|526326647|FG001|Overall Study|Lost to Follow-up|1|||
145949523|NCT03539484|526326648|FG002|Overall Study|Lost to Follow-up|0|||
145949524|NCT03539484|526326649|FG003|Overall Study|Lost to Follow-up|0|||
145949525|NCT03539484|526326650|FG004|Overall Study|Lost to Follow-up|1|||
145949526|NCT03539484|526326651|FG005|Overall Study|Lost to Follow-up|0|||
145949527|NCT03539484|526326652|FG006|Overall Study|Lost to Follow-up|0|||
145949528|NCT03539484|526326646|FG000|Overall Study|Withdrawal by Subject|0|||
145949529|NCT03539484|526326647|FG001|Overall Study|Withdrawal by Subject|0|||
145949530|NCT03539484|526326648|FG002|Overall Study|Withdrawal by Subject|0|||
146424509|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
146424510|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424511|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424512|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424513|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424514|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424515|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424516|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
146424517|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424518|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424519|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424520|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424521|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146424522|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424523|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424524|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424525|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146424526|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424527|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424528|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424529|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424530|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
146198830|NCT03538041|527240836|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
146198831|NCT03538041|527240835|FG000|Treatment Extension Period|Adverse Event|4|||
146198832|NCT03538041|527240836|FG001|Treatment Extension Period|Adverse Event|1|||
146198833|NCT03538041|527240835|FG000|Treatment Extension Period|Physician Decision|1|||
146198834|NCT03538041|527240836|FG001|Treatment Extension Period|Physician Decision|1|||
146198835|NCT03538041|527240835|FG000|Treatment Extension Period|Lack of Efficacy|1|||
146198836|NCT03538041|527240836|FG001|Treatment Extension Period|Lack of Efficacy|4|||
146198837|NCT03538041|527240835|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
146198838|NCT03538041|527240836|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
146198839|NCT03538041|527240835|FG000|Treatment Extension Period|Death|0|||
146198840|NCT03538041|527240836|FG001|Treatment Extension Period|Death|1|||
146198841|NCT01070888|527240845|FG000|First Intervention (14 Days)|Adverse Event|0|||
146198842|NCT01070888|527240846|FG001|First Intervention (14 Days)|Adverse Event|1|||
146198843|NCT01070888|527240845|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
146198844|NCT01070888|527240846|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
146198845|NCT01070888|527240845|FG000|Washout (14 Days)|Physician Decision|1|||
146198846|NCT01070888|527240846|FG001|Washout (14 Days)|Physician Decision|0|||
146198847|NCT02577523|527240847|FG000|Overall Study|Adverse Event|1|||
146198848|NCT02577523|527240848|FG001|Overall Study|Adverse Event|1|||
146198849|NCT02577523|527240847|FG000|Overall Study|Lack of Efficacy|1|||
146198850|NCT02577523|527240848|FG001|Overall Study|Lack of Efficacy|1|||
146198851|NCT02577523|527240847|FG000|Overall Study|Withdrawal by Subject|1|||
146198852|NCT02577523|527240848|FG001|Overall Study|Withdrawal by Subject|0|||
146198853|NCT02631148|527240849|FG000|Overall Study|8 were ineligible|8|||
146198854|NCT02631148|527240850|FG001|Overall Study|8 were ineligible|0|||
146198855|NCT02631148|527240849|FG000|Overall Study|Withdrawal by Subject|1|||
146198856|NCT02631148|527240850|FG001|Overall Study|Withdrawal by Subject|0|||
146198857|NCT02631148|527240849|FG000|Overall Study|PAH not available to study participant|1|||
146198858|NCT02631148|527240850|FG001|Overall Study|PAH not available to study participant|0|||
146198859|NCT00028769|527240852|FG000|Overall Study|Adverse Event|2|||
146198860|NCT00028769|527240852|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
146198861|NCT00028769|527240852|FG000|Overall Study|Progression or Death|31|||
146198862|NCT00028769|527240852|FG000|Overall Study|Other - Not Protocol Specified|1|||
146198863|NCT00028769|527240852|FG000|Overall Study|Ineligible|5|||
146198864|NCT00028769|527240852|FG000|Overall Study|Not Analyzable|1|||
146198865|NCT00487578|527240853|FG000|Overall Study|Adverse Event|1|||
146198866|NCT00487578|527240854|FG001|Overall Study|Adverse Event|2|||
146198867|NCT00487578|527240853|FG000|Overall Study|Lack of Efficacy|0|||
146198868|NCT00487578|527240854|FG001|Overall Study|Lack of Efficacy|1|||
146198869|NCT00487578|527240853|FG000|Overall Study|Lost to Follow-up|0|||
146198870|NCT00487578|527240854|FG001|Overall Study|Lost to Follow-up|1|||
146198871|NCT02525796|527240859|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146198872|NCT02525796|527240860|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146424531|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424532|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146198873|NCT02525796|527240861|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
146082639|NCT01894568|526822863|FG001|Overall Study|Withdrawal by Subject|5|||
146198874|NCT02525796|527240859|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
146198875|NCT02525796|527240860|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
146198876|NCT02525796|527240861|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
146198877|NCT02525796|527240859|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
146198878|NCT02525796|527240860|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
146198879|NCT02525796|527240861|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
146198880|NCT02525796|527240859|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
146198881|NCT02525796|527240860|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
146198882|NCT02525796|527240861|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
146198883|NCT02525796|527240859|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
146198884|NCT02525796|527240860|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
146198885|NCT02525796|527240861|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
146198886|NCT00726999|527240864|FG000|Overall Study|Physician Decision|0|||
146198887|NCT00726999|527240865|FG001|Overall Study|Physician Decision|1|||
146198888|NCT00726999|527240864|FG000|Overall Study|Withdrawal by Subject|2|||
146198889|NCT00726999|527240865|FG001|Overall Study|Withdrawal by Subject|0|||
146198890|NCT00726999|527240864|FG000|Overall Study|Protocol Violation|1|||
146198891|NCT00726999|527240865|FG001|Overall Study|Protocol Violation|0|||
146198892|NCT00955825|527240866|FG000|Overall Study|Adverse Event|15|||
146198893|NCT00955825|527240867|FG001|Overall Study|Adverse Event|2|||
146198894|NCT00955825|527240866|FG000|Overall Study|Withdrawal by Subject|4|||
146198895|NCT00955825|527240867|FG001|Overall Study|Withdrawal by Subject|6|||
146198896|NCT00955825|527240866|FG000|Overall Study|Any other reason not above-mentioned|7|||
146198897|NCT00955825|527240867|FG001|Overall Study|Any other reason not above-mentioned|9|||
146198898|NCT01198275|527240868|FG000|Overall Study|Adverse Event|2|||
146198899|NCT01198275|527240869|FG001|Overall Study|Adverse Event|3|||
146198900|NCT01198275|527240868|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
146198901|NCT01198275|527240869|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
146198902|NCT00150176|527240870|FG000|Overall Study|Adverse Event|16|||
146198903|NCT00150176|527240871|FG001|Overall Study|Adverse Event|53|||
146198904|NCT00150176|527240870|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
146198905|NCT00150176|527240871|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
146198906|NCT00150176|527240870|FG000|Overall Study|Withdrawal by Subject|19|||
146198907|NCT00150176|527240871|FG001|Overall Study|Withdrawal by Subject|12|||
146198908|NCT00150176|527240870|FG000|Overall Study|Lost to Follow-up|3|||
146198909|NCT00150176|527240871|FG001|Overall Study|Lost to Follow-up|3|||
146198910|NCT00150176|527240870|FG000|Overall Study|OTHER|11|||
146198911|NCT00150176|527240871|FG001|Overall Study|OTHER|13|||
146198912|NCT02385669|527240875|FG000|Overall Study|Adverse Event|2|||
146198913|NCT00970307|527240876|FG000|Overall Study|Serious Adverse Event|1|||
146198914|NCT00970307|527240877|FG001|Overall Study|Serious Adverse Event|0|||
146198915|NCT00970307|527240878|FG002|Overall Study|Serious Adverse Event|0|||
146198916|NCT00970307|527240876|FG000|Overall Study|Withdrawal by Subject|2|||
146198917|NCT00970307|527240877|FG001|Overall Study|Withdrawal by Subject|3|||
146198918|NCT00970307|527240878|FG002|Overall Study|Withdrawal by Subject|2|||
146198919|NCT02810080|527240879|FG000|Overall Study|Adverse Event|3|||
146198920|NCT02810080|527240880|FG001|Overall Study|Adverse Event|0|||
146198921|NCT02810080|527240879|FG000|Overall Study|Death|0|||
146198922|NCT02810080|527240880|FG001|Overall Study|Death|2|||
146198923|NCT02810080|527240879|FG000|Overall Study|Physician Decision|4|||
146198924|NCT02810080|527240880|FG001|Overall Study|Physician Decision|0|||
146198925|NCT02810080|527240879|FG000|Overall Study|Withdrawal by Subject|0|||
146198926|NCT02810080|527240880|FG001|Overall Study|Withdrawal by Subject|2|||
146198927|NCT00393848|527240884|FG000|Overall Study|Surgical schedule|0|||
146198928|NCT00393848|527240885|FG001|Overall Study|Surgical schedule|0|||
146198929|NCT00393848|527240886|FG002|Overall Study|Surgical schedule|0|||
146198930|NCT00393848|527240887|FG003|Overall Study|Surgical schedule|1|||
146198931|NCT00393848|527240884|FG000|Overall Study|Personal reasons|0|||
146198932|NCT00393848|527240885|FG001|Overall Study|Personal reasons|0|||
146198933|NCT00393848|527240886|FG002|Overall Study|Personal reasons|2|||
146198934|NCT00393848|527240887|FG003|Overall Study|Personal reasons|0|||
146198935|NCT02192606|527240888|FG000|Overall Study|surgery type was changed|1|||
146198936|NCT02192606|527240889|FG001|Overall Study|surgery type was changed|1|||
146198937|NCT02192606|527240888|FG000|Overall Study|Physician Decision|1|||
146198938|NCT02192606|527240889|FG001|Overall Study|Physician Decision|2|||
146082640|NCT01894568|526822862|FG000|Overall Study|Physician Decision|1|||
146198939|NCT02192606|527240888|FG000|Overall Study|3D equipment rep unable to join|0|||
146198940|NCT02192606|527240889|FG001|Overall Study|3D equipment rep unable to join|1|||
146198941|NCT02224924|527240896|FG000|Overall Study|Withdrawal by Subject|7|||
146198942|NCT02224924|527240897|FG001|Overall Study|Withdrawal by Subject|6|||
146198943|NCT02224924|527240896|FG000|Overall Study|Biopsy cancelled|20|||
146198944|NCT02224924|527240897|FG001|Overall Study|Biopsy cancelled|14|||
146198945|NCT02224924|527240896|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
146198946|NCT02224924|527240897|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
146198947|NCT02224924|527240896|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
146198948|NCT02224924|527240897|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
146198949|NCT01458210|527240898|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
146198950|NCT01458210|527240898|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
146198951|NCT01458210|527240898|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
146198952|NCT01458210|527240898|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
146198953|NCT01616654|527240899|FG000|Overall Study|Lack of Efficacy|1|||
146198954|NCT01616654|527240900|FG001|Overall Study|Lack of Efficacy|0|||
146198955|NCT01616654|527240901|FG002|Overall Study|Lack of Efficacy|0|||
146198956|NCT01616654|527240902|FG003|Overall Study|Lack of Efficacy|0|||
146198957|NCT01616654|527240903|FG004|Overall Study|Lack of Efficacy|1|||
146198958|NCT01616654|527240899|FG000|Overall Study|Adverse Event|0|||
146198959|NCT01616654|527240900|FG001|Overall Study|Adverse Event|1|||
146198960|NCT01616654|527240901|FG002|Overall Study|Adverse Event|2|||
146198961|NCT01616654|527240902|FG003|Overall Study|Adverse Event|1|||
146198962|NCT01616654|527240903|FG004|Overall Study|Adverse Event|0|||
146198963|NCT01616654|527240899|FG000|Overall Study|Withdrawal by Subject|2|||
146198964|NCT01616654|527240900|FG001|Overall Study|Withdrawal by Subject|2|||
146198965|NCT01616654|527240901|FG002|Overall Study|Withdrawal by Subject|3|||
146198966|NCT01616654|527240902|FG003|Overall Study|Withdrawal by Subject|1|||
146198967|NCT01616654|527240903|FG004|Overall Study|Withdrawal by Subject|5|||
146198968|NCT01616654|527240899|FG000|Overall Study|Protocol Violation|0|||
146198969|NCT01616654|527240900|FG001|Overall Study|Protocol Violation|5|||
146198970|NCT01616654|527240901|FG002|Overall Study|Protocol Violation|2|||
146198971|NCT01616654|527240902|FG003|Overall Study|Protocol Violation|4|||
146198972|NCT01616654|527240903|FG004|Overall Study|Protocol Violation|4|||
146198973|NCT01616654|527240899|FG000|Overall Study|Lost to Follow-up|1|||
146198974|NCT01616654|527240900|FG001|Overall Study|Lost to Follow-up|0|||
146198975|NCT01616654|527240901|FG002|Overall Study|Lost to Follow-up|3|||
146198976|NCT01616654|527240902|FG003|Overall Study|Lost to Follow-up|2|||
146198977|NCT01616654|527240903|FG004|Overall Study|Lost to Follow-up|1|||
146198978|NCT01616654|527240899|FG000|Overall Study|Pregnancy|1|||
146198979|NCT01616654|527240900|FG001|Overall Study|Pregnancy|0|||
146198980|NCT01616654|527240901|FG002|Overall Study|Pregnancy|0|||
146198981|NCT01616654|527240902|FG003|Overall Study|Pregnancy|0|||
146198982|NCT01616654|527240903|FG004|Overall Study|Pregnancy|1|||
146198983|NCT01329328|527240907|FG000|Overall Study|Withdrawal by Subject|2|||
146198984|NCT01329328|527240908|FG001|Overall Study|Withdrawal by Subject|4|||
146198985|NCT01329328|527240909|FG002|Overall Study|Withdrawal by Subject|3|||
146198986|NCT00964366|527240910|FG000|Overall Study|Did not qualify at Day 1|1|||
146198987|NCT00964366|527240911|FG001|Overall Study|Did not qualify at Day 1|0|||
146198988|NCT00964366|527240910|FG000|Overall Study|Withdrawal by Subject|0|||
146198989|NCT00964366|527240911|FG001|Overall Study|Withdrawal by Subject|1|||
146198990|NCT01370694|527240912|FG000|Overall Study|Switched to rituximab|4|||
146198991|NCT01370694|527240912|FG000|Overall Study|Progressive disease|2|||
146198992|NCT02393716|527240913|FG000|Overall Study|Death|29|||
146198993|NCT02393716|527240913|FG000|Overall Study|Withdrawal by Subject|8|||
146198994|NCT02393716|527240913|FG000|Overall Study|Device Explanted|8|||
146198995|NCT02393716|527240913|FG000|Overall Study|Missed visit|16|||
146198996|NCT02957539|527240914|FG000|Baseline to Week 16|Lost to Follow-up|8|||
146198997|NCT02957539|527240915|FG001|Baseline to Week 16|Lost to Follow-up|10|||
146198998|NCT02957539|527240916|FG002|Baseline to Week 16|Lost to Follow-up|16|||
146198999|NCT02957539|527240914|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
146199000|NCT02957539|527240915|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
146199001|NCT02957539|527240916|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
146199002|NCT02957539|527240914|FG000|Week 16 to 32|Withdrawal by Subject|3|||
146199003|NCT02957539|527240915|FG001|Week 16 to 32|Withdrawal by Subject|3|||
146199004|NCT02957539|527240916|FG002|Week 16 to 32|Withdrawal by Subject|1|||
146199005|NCT02957539|527240914|FG000|Week 16 to 32|Lost to Follow-up|8|||
146424533|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146199006|NCT02957539|527240915|FG001|Week 16 to 32|Lost to Follow-up|7|||
146199007|NCT02957539|527240916|FG002|Week 16 to 32|Lost to Follow-up|5|||
146199008|NCT02957539|527240914|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
146199009|NCT02957539|527240915|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
146199010|NCT02957539|527240916|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
146082641|NCT01894568|526822863|FG001|Overall Study|Physician Decision|0|||
146199011|NCT02957539|527240914|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
146199012|NCT02957539|527240915|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
146199013|NCT02957539|527240916|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
146199014|NCT01119950|527240918|FG000|Overall Study|Adverse Event|25|||
146199015|NCT01119950|527240918|FG000|Overall Study|Withdrawal by Subject|9|||
146199016|NCT01119950|527240918|FG000|Overall Study|Protocol Violation|5|||
146199017|NCT01119950|527240918|FG000|Overall Study|Lost to Follow-up|4|||
146199018|NCT01119950|527240918|FG000|Overall Study|Administrative|2|||
146199019|NCT01119950|527240918|FG000|Overall Study|Abnormal lab value|1|||
146199020|NCT01119950|527240918|FG000|Overall Study|Death|1|||
146199021|NCT00139737|527240919|FG000|Overall Study|Withdrawal by Subject|190|||
146199022|NCT00139737|527240919|FG000|Overall Study|Adverse Event|58|||
146199023|NCT00139737|527240919|FG000|Overall Study|Lack of Efficacy|40|||
146199024|NCT00139737|527240919|FG000|Overall Study|Lost to Follow-up|8|||
146199025|NCT00139737|527240919|FG000|Overall Study|Death|3|||
146199026|NCT00139737|527240919|FG000|Overall Study|Laboratory Abnormality|2|||
146199027|NCT00139737|527240919|FG000|Overall Study|Protocol Violation|18|||
146199028|NCT00139737|527240919|FG000|Overall Study|Withdrew During Screening Phase|8|||
146199029|NCT00139737|527240919|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146199030|NCT00139737|527240919|FG000|Overall Study|Screened, Not Treated|13|||
146199031|NCT00758602|527240925|FG000|Overall Study|Adverse Event|11|||
146199032|NCT00758602|527240926|FG001|Overall Study|Adverse Event|10|||
146199033|NCT00758602|527240925|FG000|Overall Study|Lost to Follow-up|4|||
146199034|NCT00758602|527240926|FG001|Overall Study|Lost to Follow-up|3|||
146199035|NCT00758602|527240925|FG000|Overall Study|Withdrawal by Subject|1|||
146199036|NCT00758602|527240926|FG001|Overall Study|Withdrawal by Subject|3|||
146199037|NCT00758602|527240925|FG000|Overall Study|Protocol Violation|0|||
146199038|NCT00758602|527240926|FG001|Overall Study|Protocol Violation|2|||
146199039|NCT00758602|527240925|FG000|Overall Study|Death|0|||
146199040|NCT00758602|527240926|FG001|Overall Study|Death|1|||
146199041|NCT00758602|527240925|FG000|Overall Study|Reason not specified|3|||
146199042|NCT00758602|527240926|FG001|Overall Study|Reason not specified|3|||
146199043|NCT03939819|527240927|FG000|Overall Study|Death|2|||
146199044|NCT03939819|527240928|FG001|Overall Study|Death|0|||
146199045|NCT05046132|527240929|FG000|Overall Study|Adverse Event|4|||
146199046|NCT05046132|527240930|FG001|Overall Study|Adverse Event|0|||
146199047|NCT05046132|527240931|FG002|Overall Study|Adverse Event|0|||
146199048|NCT05046132|527240929|FG000|Overall Study|Withdrawal by Subject|3|||
146199049|NCT05046132|527240930|FG001|Overall Study|Withdrawal by Subject|0|||
146199050|NCT05046132|527240931|FG002|Overall Study|Withdrawal by Subject|0|||
146199051|NCT05046132|527240929|FG000|Overall Study|Positive Covid19 Result.|0|||
146199052|NCT05046132|527240930|FG001|Overall Study|Positive Covid19 Result.|1|||
146199053|NCT05046132|527240931|FG002|Overall Study|Positive Covid19 Result.|0|||
146199054|NCT02148133|527240933|FG000|Overall Study|Investigator discretion|1|||
146199055|NCT02148133|527240933|FG000|Overall Study|Lack of Efficacy|1|||
146199056|NCT02148133|527240933|FG000|Overall Study|Protocol deviation|1|||
146199057|NCT02148133|527240933|FG000|Overall Study|Protocol-defined stopping criteria|2|||
146199058|NCT00855465|527240935|FG000|Treatment Period|Adverse Event|4|||
146199059|NCT00855465|527240936|FG001|Treatment Period|Adverse Event|2|||
146424534|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
146424535|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424536|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146424537|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424538|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146424539|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424540|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424541|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424542|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424543|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146424544|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
146424545|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
146424546|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146424547|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
146424548|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
146424549|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146424550|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
146424551|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
146424552|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
146424553|NCT05097989|528059321|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
146424554|NCT05097989|528059322|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
146424555|NCT05097989|528059323|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
146424556|NCT05097989|528059324|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
146424557|NCT05097989|528059325|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
146424558|NCT05097989|528059326|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
146424559|NCT05097989|528059327|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
146424560|NCT05097989|528059328|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
146424561|NCT05097989|528059329|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
146424562|NCT05097989|528059321|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424563|NCT05097989|528059322|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424564|NCT05097989|528059323|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424565|NCT05097989|528059324|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
146199060|NCT00855465|527240935|FG000|Treatment Period|Death|2|||
146199061|NCT00855465|527240936|FG001|Treatment Period|Death|2|||
146199062|NCT00855465|527240935|FG000|Treatment Period|Lack of Efficacy|2|||
146199063|NCT00855465|527240936|FG001|Treatment Period|Lack of Efficacy|1|||
146199064|NCT00855465|527240935|FG000|Treatment Period|Non-compliance|1|||
146199065|NCT00855465|527240936|FG001|Treatment Period|Non-compliance|0|||
146424566|NCT05097989|528059325|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
146424567|NCT05097989|528059326|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424568|NCT05097989|528059327|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424569|NCT05097989|528059328|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424570|NCT05097989|528059329|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
146424571|NCT05097989|528059321|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
146424572|NCT05097989|528059322|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
146424573|NCT05097989|528059323|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424574|NCT05097989|528059324|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424575|NCT05097989|528059325|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424576|NCT05097989|528059326|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424577|NCT05097989|528059327|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424578|NCT05097989|528059328|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424579|NCT05097989|528059329|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
146424580|NCT05097989|528059321|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
146424581|NCT05097989|528059322|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
146424582|NCT05097989|528059323|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
146424583|NCT05097989|528059324|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
146424584|NCT05097989|528059325|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
146424585|NCT05097989|528059326|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
146424586|NCT05097989|528059327|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
146424587|NCT05097989|528059328|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
146424588|NCT05097989|528059329|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
146424589|NCT00117949|528059337|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
146424590|NCT00117949|528059338|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
146424591|NCT00117949|528059339|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
146424592|NCT00117949|528059340|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
146424593|NCT00117949|528059337|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
146424594|NCT00117949|528059338|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
146424595|NCT00117949|528059339|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
146424596|NCT00117949|528059340|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
146424597|NCT00117949|528059337|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
146424598|NCT00117949|528059338|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
146424599|NCT00117949|528059339|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
146424600|NCT00117949|528059340|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
146424601|NCT00117949|528059337|FG000|Overall Study|PSA increase >=10ng/mL|0|||
146424602|NCT00117949|528059338|FG001|Overall Study|PSA increase >=10ng/mL|1|||
146424603|NCT00117949|528059339|FG002|Overall Study|PSA increase >=10ng/mL|1|||
146424604|NCT00117949|528059340|FG003|Overall Study|PSA increase >=10ng/mL|0|||
146424605|NCT00117949|528059337|FG000|Overall Study|PSA reduction <=50%|0|||
146424606|NCT00117949|528059338|FG001|Overall Study|PSA reduction <=50%|2|||
146424607|NCT00117949|528059339|FG002|Overall Study|PSA reduction <=50%|2|||
146424608|NCT00117949|528059340|FG003|Overall Study|PSA reduction <=50%|4|||
146424609|NCT00117949|528059337|FG000|Overall Study|Hepatic abnormalities|0|||
146424610|NCT00117949|528059338|FG001|Overall Study|Hepatic abnormalities|1|||
146424611|NCT00117949|528059339|FG002|Overall Study|Hepatic abnormalities|0|||
146424612|NCT00117949|528059340|FG003|Overall Study|Hepatic abnormalities|1|||
146424613|NCT01658943|528059343|FG000|Overall Study|Adverse Event|6|||
146424614|NCT01658943|528059344|FG001|Overall Study|Adverse Event|13|||
146424615|NCT01658943|528059343|FG000|Overall Study|Withdrawal by Subject|9|||
146424616|NCT01658943|528059344|FG001|Overall Study|Withdrawal by Subject|2|||
146424617|NCT01658943|528059343|FG000|Overall Study|Progression/Relapse|39|||
146424618|NCT01658943|528059344|FG001|Overall Study|Progression/Relapse|40|||
146424619|NCT01658943|528059343|FG000|Overall Study|Death|4|||
146424620|NCT01658943|528059344|FG001|Overall Study|Death|2|||
146424621|NCT01658943|528059343|FG000|Overall Study|not protocol specified|4|||
146424622|NCT01658943|528059344|FG001|Overall Study|not protocol specified|1|||
146424623|NCT01658943|528059343|FG000|Overall Study|Not eligible|7|||
146424624|NCT01658943|528059344|FG001|Overall Study|Not eligible|9|||
146424625|NCT01658943|528059343|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
146424626|NCT01658943|528059344|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
146424627|NCT03309956|528059345|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
146082642|NCT01894568|526822862|FG000|Overall Study|Lost to Follow-up|0|||
146424628|NCT02130466|528059346|FG000|Overall Study|Death|4|||
146424629|NCT02130466|528059347|FG001|Overall Study|Death|1|||
146424630|NCT02130466|528059348|FG002|Overall Study|Death|1|||
146424631|NCT02130466|528059349|FG003|Overall Study|Death|3|||
146424632|NCT02130466|528059350|FG004|Overall Study|Death|2|||
146424633|NCT02130466|528059351|FG005|Overall Study|Death|30|||
146424634|NCT02130466|528059352|FG006|Overall Study|Death|45|||
146424635|NCT02130466|528059353|FG007|Overall Study|Death|2|||
146424636|NCT02130466|528059354|FG008|Overall Study|Death|3|||
146424637|NCT02130466|528059355|FG009|Overall Study|Death|4|||
146199066|NCT00855465|527240935|FG000|Treatment Period|Protocol Violation|2|||
146199067|NCT00855465|527240936|FG001|Treatment Period|Protocol Violation|0|||
146199068|NCT00855465|527240935|FG000|Treatment Period|Withdrawal by Subject|2|||
146199069|NCT00855465|527240936|FG001|Treatment Period|Withdrawal by Subject|0|||
146424638|NCT02130466|528059356|FG010|Overall Study|Death|5|||
146424639|NCT02130466|528059357|FG011|Overall Study|Death|3|||
146424640|NCT02130466|528059358|FG012|Overall Study|Death|11|||
146424641|NCT02130466|528059359|FG013|Overall Study|Death|7|||
146424642|NCT02130466|528059346|FG000|Overall Study|Lost to Follow-up|1|||
146424643|NCT02130466|528059347|FG001|Overall Study|Lost to Follow-up|0|||
146424644|NCT02130466|528059348|FG002|Overall Study|Lost to Follow-up|0|||
146424645|NCT02130466|528059349|FG003|Overall Study|Lost to Follow-up|0|||
146424646|NCT02130466|528059350|FG004|Overall Study|Lost to Follow-up|0|||
146424647|NCT02130466|528059351|FG005|Overall Study|Lost to Follow-up|1|||
146424648|NCT02130466|528059352|FG006|Overall Study|Lost to Follow-up|0|||
146424649|NCT02130466|528059353|FG007|Overall Study|Lost to Follow-up|0|||
146424650|NCT02130466|528059354|FG008|Overall Study|Lost to Follow-up|0|||
146424651|NCT02130466|528059355|FG009|Overall Study|Lost to Follow-up|0|||
146424652|NCT02130466|528059356|FG010|Overall Study|Lost to Follow-up|0|||
146424653|NCT02130466|528059357|FG011|Overall Study|Lost to Follow-up|0|||
146424654|NCT02130466|528059358|FG012|Overall Study|Lost to Follow-up|1|||
146424655|NCT02130466|528059359|FG013|Overall Study|Lost to Follow-up|0|||
146424656|NCT02130466|528059346|FG000|Overall Study|Physician Decision|0|||
146424657|NCT02130466|528059347|FG001|Overall Study|Physician Decision|0|||
146424658|NCT02130466|528059348|FG002|Overall Study|Physician Decision|0|||
146424659|NCT02130466|528059349|FG003|Overall Study|Physician Decision|0|||
146424660|NCT02130466|528059350|FG004|Overall Study|Physician Decision|0|||
146424661|NCT02130466|528059351|FG005|Overall Study|Physician Decision|1|||
146424662|NCT02130466|528059352|FG006|Overall Study|Physician Decision|1|||
146424663|NCT02130466|528059353|FG007|Overall Study|Physician Decision|0|||
146424664|NCT02130466|528059354|FG008|Overall Study|Physician Decision|0|||
146424665|NCT02130466|528059355|FG009|Overall Study|Physician Decision|0|||
146424666|NCT02130466|528059356|FG010|Overall Study|Physician Decision|0|||
146424667|NCT02130466|528059357|FG011|Overall Study|Physician Decision|0|||
146424668|NCT02130466|528059358|FG012|Overall Study|Physician Decision|0|||
146424669|NCT02130466|528059359|FG013|Overall Study|Physician Decision|0|||
146424670|NCT02130466|528059346|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146424671|NCT02130466|528059347|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
146424672|NCT02130466|528059348|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146424673|NCT02130466|528059349|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
146424674|NCT02130466|528059350|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146424675|NCT02130466|528059351|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
146424676|NCT02130466|528059352|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
146424677|NCT02130466|528059353|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146424678|NCT02130466|528059354|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146424679|NCT02130466|528059355|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146424680|NCT02130466|528059356|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
146424681|NCT02130466|528059357|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146424682|NCT02130466|528059358|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
146424683|NCT02130466|528059359|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
146424684|NCT02130466|528059346|FG000|Overall Study|Withdrawal by Subject|1|||
146424685|NCT02130466|528059347|FG001|Overall Study|Withdrawal by Subject|0|||
146424686|NCT02130466|528059348|FG002|Overall Study|Withdrawal by Subject|0|||
146424687|NCT02130466|528059349|FG003|Overall Study|Withdrawal by Subject|0|||
146424688|NCT02130466|528059350|FG004|Overall Study|Withdrawal by Subject|0|||
146424689|NCT02130466|528059351|FG005|Overall Study|Withdrawal by Subject|1|||
146424690|NCT02130466|528059352|FG006|Overall Study|Withdrawal by Subject|0|||
146424691|NCT02130466|528059353|FG007|Overall Study|Withdrawal by Subject|0|||
146424692|NCT02130466|528059354|FG008|Overall Study|Withdrawal by Subject|1|||
146199070|NCT00855465|527240935|FG000|Treatment Period|Not treated|1|||
146199071|NCT00855465|527240936|FG001|Treatment Period|Not treated|0|||
146199072|NCT00855465|527240935|FG000|Follow-up Period (FUP)|Adverse Event|0|||
146199073|NCT00855465|527240936|FG001|Follow-up Period (FUP)|Adverse Event|1|||
146199074|NCT00855465|527240935|FG000|Follow-up Period (FUP)|Death|0|||
146199075|NCT00855465|527240936|FG001|Follow-up Period (FUP)|Death|1|||
146199076|NCT00855465|527240935|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
146199077|NCT00855465|527240936|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
146199078|NCT00855465|527240935|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
146199079|NCT00855465|527240936|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
146199080|NCT00855465|527240935|FG000|Follow-up Period (FUP)|Missing|1|||
146199081|NCT00855465|527240936|FG001|Follow-up Period (FUP)|Missing|0|||
146199082|NCT00079183|527240937|FG000|Overall Study|Withdrawal by Subject|4|||
146199083|NCT00079183|527240937|FG000|Overall Study|Study medication non-compliance|2|||
146199084|NCT00079183|527240937|FG000|Overall Study|Specimen collection non-compliance|1|||
146199085|NCT01157182|527240938|FG000|Washout of 28 Days|Adverse Event|2|||
146199086|NCT01157182|527240939|FG001|Washout of 28 Days|Adverse Event|0|||
146199087|NCT03743246|527240940|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146199088|NCT03743246|527240941|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146199089|NCT03743246|527240942|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
146199090|NCT03743246|527240943|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
146199091|NCT03743246|527240940|FG000|Pre-Treatment Period|Death|0|||
146199092|NCT03743246|527240941|FG001|Pre-Treatment Period|Death|1|||
146199093|NCT03743246|527240942|FG002|Pre-Treatment Period|Death|0|||
146199094|NCT03743246|527240943|FG003|Pre-Treatment Period|Death|1|||
146199095|NCT03743246|527240940|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
146199096|NCT03743246|527240941|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146199097|NCT03743246|527240942|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146199098|NCT03743246|527240943|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
146199099|NCT03743246|527240940|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
146199100|NCT03743246|527240941|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146199101|NCT03743246|527240942|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146199102|NCT03743246|527240943|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
146199103|NCT03743246|527240940|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
146199104|NCT03743246|527240941|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146199105|NCT03743246|527240942|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146199106|NCT03743246|527240943|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
146199107|NCT03743246|527240940|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146199108|NCT03743246|527240941|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
146199109|NCT03743246|527240942|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146199110|NCT03743246|527240943|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
146199111|NCT03743246|527240940|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
146199112|NCT03743246|527240941|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146199113|NCT03743246|527240942|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146199114|NCT03743246|527240943|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
146199115|NCT03743246|527240940|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
146199116|NCT03743246|527240941|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
146199117|NCT03743246|527240942|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
146199118|NCT03743246|527240943|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
146199119|NCT03743246|527240940|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
146199120|NCT03743246|527240941|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146199121|NCT03743246|527240942|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146199122|NCT03743246|527240943|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
146199123|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
146199124|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
146199125|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
146199126|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
146199127|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
146199128|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
146199129|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
146199130|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
146199131|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
146199132|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
146199133|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
146199134|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
146199135|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
146199136|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
146199137|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
146199138|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
146424693|NCT02130466|528059355|FG009|Overall Study|Withdrawal by Subject|0|||
146424694|NCT02130466|528059356|FG010|Overall Study|Withdrawal by Subject|0|||
146424695|NCT02130466|528059357|FG011|Overall Study|Withdrawal by Subject|0|||
146424696|NCT02130466|528059358|FG012|Overall Study|Withdrawal by Subject|0|||
146424697|NCT02130466|528059359|FG013|Overall Study|Withdrawal by Subject|0|||
146424698|NCT04529109|528059360|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146424699|NCT04529109|528059361|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146424700|NCT00922779|528059362|FG000|Overall Study|Adverse Event|67|||
146424701|NCT00922779|528059362|FG000|Overall Study|Pregnancy|7|||
146424702|NCT00922779|528059362|FG000|Overall Study|Withdrawal by Subject|308|||
146424703|NCT00922779|528059362|FG000|Overall Study|Lost to Follow-up|44|||
146424704|NCT00922779|528059362|FG000|Overall Study|Other|27|||
146424705|NCT00922779|528059362|FG000|Overall Study|Missing|1874|||
146424706|NCT01922349|528059363|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146424707|NCT01922349|528059364|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146424708|NCT01922349|528059365|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
146424709|NCT01922349|528059366|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
146424710|NCT00993616|528059367|FG000|Overall Study|No tumor at entry|1|||
146424711|NCT00993616|528059367|FG000|Overall Study|Never treated|1|||
146424712|NCT05067504|528059368|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
146424713|NCT05067504|528059369|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
146424714|NCT05067504|528059368|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
146424715|NCT05067504|528059369|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
146424716|NCT05067504|528059368|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
146424717|NCT05067504|528059369|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
146424718|NCT01374919|528060617|FG000|Overall Study|Withdrawal by Subject|2|||
146424719|NCT00366899|528060618|FG000|Infant Series|Withdrawal by Subject|4|||
146424720|NCT00366899|528060619|FG001|Infant Series|Withdrawal by Subject|7|||
146424721|NCT00366899|528060618|FG000|Infant Series|Protocol Violation|2|||
146424722|NCT00366899|528060619|FG001|Infant Series|Protocol Violation|1|||
146424723|NCT00366899|528060618|FG000|Infant Series|Failed to return|1|||
146424724|NCT00366899|528060619|FG001|Infant Series|Failed to return|1|||
146424725|NCT00366899|528060618|FG000|Infant Series|Lost to Follow-up|0|||
146424726|NCT00366899|528060619|FG001|Infant Series|Lost to Follow-up|2|||
146424727|NCT00366899|528060618|FG000|Infant Series|Adverse Event|0|||
146424728|NCT00366899|528060619|FG001|Infant Series|Adverse Event|1|||
146424729|NCT00366899|528060618|FG000|Infant Series|Physician Decision|1|||
146424730|NCT00366899|528060619|FG001|Infant Series|Physician Decision|0|||
146424731|NCT00366899|528060618|FG000|Infant Series|Randomized but not consented|1|||
146424732|NCT00366899|528060619|FG001|Infant Series|Randomized but not consented|0|||
146424733|NCT00366899|528060618|FG000|After Infant Series|Lost to Follow-up|4|||
146424734|NCT00366899|528060619|FG001|After Infant Series|Lost to Follow-up|3|||
145949531|NCT03539484|526326649|FG003|Overall Study|Withdrawal by Subject|0|||
146424735|NCT00366899|528060618|FG000|After Infant Series|Withdrawal by Subject|1|||
146424736|NCT00366899|528060619|FG001|After Infant Series|Withdrawal by Subject|4|||
146424737|NCT00366899|528060618|FG000|After Infant Series|Adverse Event|1|||
146424738|NCT00366899|528060619|FG001|After Infant Series|Adverse Event|2|||
146424739|NCT00366899|528060618|FG000|After Infant Series|Protocol Violation|1|||
146424740|NCT00366899|528060619|FG001|After Infant Series|Protocol Violation|0|||
146424741|NCT00366899|528060618|FG000|Toddler Dose|Withdrawal by Subject|1|||
146424742|NCT00366899|528060619|FG001|Toddler Dose|Withdrawal by Subject|1|||
146424743|NCT00366899|528060618|FG000|Toddler Dose|Protocol Violation|1|||
146424744|NCT00366899|528060619|FG001|Toddler Dose|Protocol Violation|0|||
146424745|NCT01619800|528060620|FG000|Overall Study|study terminated|2|||
146424746|NCT01619800|528060621|FG001|Overall Study|study terminated|0|||
146424747|NCT02848326|528060622|FG000|Treatment Period|Adverse Event|5|||
145949532|NCT03539484|526326650|FG004|Overall Study|Withdrawal by Subject|2|||
145949533|NCT03539484|526326651|FG005|Overall Study|Withdrawal by Subject|0|||
145949534|NCT03539484|526326652|FG006|Overall Study|Withdrawal by Subject|1|||
145949535|NCT03539484|526326646|FG000|Overall Study|Study Terminated by Sponsor|0|||
145949536|NCT03539484|526326647|FG001|Overall Study|Study Terminated by Sponsor|0|||
146424748|NCT02848326|528060623|FG001|Treatment Period|Adverse Event|4|||
146424749|NCT02848326|528060624|FG002|Treatment Period|Adverse Event|11|||
146424750|NCT02848326|528060625|FG003|Treatment Period|Adverse Event|6|||
146424751|NCT02848326|528060626|FG004|Treatment Period|Adverse Event|5|||
146424752|NCT02848326|528060627|FG005|Treatment Period|Adverse Event|7|||
146424753|NCT02848326|528060622|FG000|Treatment Period|Withdrawal of Consent|20|||
146424754|NCT02848326|528060623|FG001|Treatment Period|Withdrawal of Consent|6|||
145949537|NCT03539484|526326648|FG002|Overall Study|Study Terminated by Sponsor|1|||
145949538|NCT03539484|526326649|FG003|Overall Study|Study Terminated by Sponsor|1|||
146199139|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
146199140|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
146424755|NCT02848326|528060624|FG002|Treatment Period|Withdrawal of Consent|9|||
146424756|NCT02848326|528060625|FG003|Treatment Period|Withdrawal of Consent|6|||
146424757|NCT02848326|528060626|FG004|Treatment Period|Withdrawal of Consent|9|||
146424758|NCT02848326|528060627|FG005|Treatment Period|Withdrawal of Consent|6|||
146199141|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
146424759|NCT02848326|528060622|FG000|Treatment Period|Lost to Follow-up|5|||
146424760|NCT02848326|528060623|FG001|Treatment Period|Lost to Follow-up|1|||
146424761|NCT02848326|528060624|FG002|Treatment Period|Lost to Follow-up|11|||
146424762|NCT02848326|528060625|FG003|Treatment Period|Lost to Follow-up|7|||
146424763|NCT02848326|528060626|FG004|Treatment Period|Lost to Follow-up|2|||
146424764|NCT02848326|528060627|FG005|Treatment Period|Lost to Follow-up|3|||
146424765|NCT02848326|528060622|FG000|Treatment Period|Pregnancy|0|||
146424766|NCT02848326|528060623|FG001|Treatment Period|Pregnancy|0|||
146424767|NCT02848326|528060624|FG002|Treatment Period|Pregnancy|1|||
145949539|NCT03539484|526326650|FG004|Overall Study|Study Terminated by Sponsor|2|||
145949540|NCT03539484|526326651|FG005|Overall Study|Study Terminated by Sponsor|2|||
145949541|NCT03539484|526326652|FG006|Overall Study|Study Terminated by Sponsor|1|||
145949542|NCT02232061|526326653|FG000|Overall Study|Administrative problems|1|||
145949543|NCT02232061|526326653|FG000|Overall Study|Withdrawal by Subject|1|||
145949544|NCT00571103|526326654|FG000|Overall Study|Withdrawal by Subject|1|||
145949545|NCT00571103|526326654|FG000|Overall Study|Lost to Follow-up|1|||
145949546|NCT00948922|526326656|FG000|Overall Study|Did not start study treatment|2|||
145949547|NCT00948922|526326657|FG001|Overall Study|Did not start study treatment|5|||
145949548|NCT00948922|526326658|FG002|Overall Study|Did not start study treatment|0|||
145949549|NCT00948922|526326656|FG000|Overall Study|Withdrawal by Subject|0|||
145949550|NCT00948922|526326657|FG001|Overall Study|Withdrawal by Subject|2|||
145949551|NCT00948922|526326658|FG002|Overall Study|Withdrawal by Subject|1|||
145949552|NCT00948922|526326656|FG000|Overall Study|Death|3|||
145949553|NCT00948922|526326657|FG001|Overall Study|Death|0|||
145949554|NCT00948922|526326658|FG002|Overall Study|Death|0|||
145949555|NCT00948922|526326656|FG000|Overall Study|Disease progression|0|||
145949556|NCT00948922|526326657|FG001|Overall Study|Disease progression|1|||
145949557|NCT00948922|526326658|FG002|Overall Study|Disease progression|0|||
145949558|NCT00948922|526326656|FG000|Overall Study|Insurance issues|1|||
145949559|NCT00948922|526326657|FG001|Overall Study|Insurance issues|0|||
145949560|NCT00948922|526326658|FG002|Overall Study|Insurance issues|0|||
145949561|NCT00948922|526326656|FG000|Overall Study|Transplant eligibility issues|2|||
145949562|NCT00948922|526326657|FG001|Overall Study|Transplant eligibility issues|3|||
145949563|NCT00948922|526326658|FG002|Overall Study|Transplant eligibility issues|0|||
145949564|NCT00948922|526326656|FG000|Overall Study|Not evaluable at time of analysis|0|||
145949565|NCT00948922|526326657|FG001|Overall Study|Not evaluable at time of analysis|3|||
145949566|NCT00948922|526326658|FG002|Overall Study|Not evaluable at time of analysis|0|||
145949567|NCT02784288|526326659|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
145949568|NCT02757625|526326660|FG000|Overall Study|Investigator's discretion|0|||
145949569|NCT02757625|526326661|FG001|Overall Study|Investigator's discretion|0|||
145949570|NCT02757625|526326662|FG002|Overall Study|Investigator's discretion|1|||
145949571|NCT02757625|526326663|FG003|Overall Study|Investigator's discretion|0|||
145949572|NCT02757625|526326660|FG000|Overall Study|Adverse Event|0|||
145949573|NCT02757625|526326661|FG001|Overall Study|Adverse Event|0|||
145949574|NCT02757625|526326662|FG002|Overall Study|Adverse Event|1|||
145949575|NCT02757625|526326663|FG003|Overall Study|Adverse Event|0|||
145949576|NCT02131233|526326664|FG000|Overall Study|Not Treated|2|||
145949577|NCT02131233|526326665|FG001|Overall Study|Not Treated|3|||
145949578|NCT02131233|526326664|FG000|Overall Study|Adverse Event|7|||
146424768|NCT02848326|528060625|FG003|Treatment Period|Pregnancy|1|||
146424769|NCT02848326|528060626|FG004|Treatment Period|Pregnancy|0|||
146082643|NCT01894568|526822863|FG001|Overall Study|Lost to Follow-up|1|||
145949579|NCT02131233|526326665|FG001|Overall Study|Adverse Event|6|||
145949580|NCT02131233|526326664|FG000|Overall Study|Death|0|||
145949581|NCT02131233|526326665|FG001|Overall Study|Death|1|||
145949582|NCT02131233|526326664|FG000|Overall Study|Lack of Efficacy|6|||
145949583|NCT02131233|526326665|FG001|Overall Study|Lack of Efficacy|3|||
145949584|NCT02131233|526326664|FG000|Overall Study|Lost to Follow-up|14|||
146082644|NCT00807573|526822864|FG000|Overall Study|Withdrawal by Subject|1|||
146424770|NCT02848326|528060627|FG005|Treatment Period|Pregnancy|1|||
146424771|NCT02848326|528060622|FG000|Treatment Period|Protocol Violation|4|||
146424772|NCT02848326|528060623|FG001|Treatment Period|Protocol Violation|3|||
146424773|NCT02848326|528060624|FG002|Treatment Period|Protocol Violation|4|||
146424774|NCT02848326|528060625|FG003|Treatment Period|Protocol Violation|2|||
146424775|NCT02848326|528060626|FG004|Treatment Period|Protocol Violation|3|||
146424776|NCT02848326|528060627|FG005|Treatment Period|Protocol Violation|3|||
146424777|NCT02848326|528060622|FG000|Treatment Period|Non-compliance with Study Drug|4|||
146424778|NCT02848326|528060623|FG001|Treatment Period|Non-compliance with Study Drug|0|||
146424779|NCT02848326|528060624|FG002|Treatment Period|Non-compliance with Study Drug|0|||
146424780|NCT02848326|528060625|FG003|Treatment Period|Non-compliance with Study Drug|1|||
146424781|NCT02848326|528060626|FG004|Treatment Period|Non-compliance with Study Drug|0|||
146424782|NCT02848326|528060627|FG005|Treatment Period|Non-compliance with Study Drug|0|||
146424783|NCT02848326|528060622|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
146424784|NCT02848326|528060623|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
146424785|NCT02848326|528060624|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
146424786|NCT02848326|528060625|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
146424787|NCT02848326|528060626|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
146424788|NCT02848326|528060627|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
146424789|NCT02848326|528060622|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
146424790|NCT02848326|528060623|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
146424791|NCT02848326|528060624|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
146424792|NCT02848326|528060625|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
146424793|NCT02848326|528060626|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
146424794|NCT02848326|528060627|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
146424795|NCT00414466|528060628|FG000|Overall Study|Adverse Event|0|||
146424796|NCT00414466|528060629|FG001|Overall Study|Adverse Event|0|||
146424797|NCT00414466|528060630|FG002|Overall Study|Adverse Event|1|||
146424798|NCT00414466|528060631|FG003|Overall Study|Adverse Event|1|||
146424799|NCT00414466|528060628|FG000|Overall Study|Lack of Efficacy|1|||
146424800|NCT00414466|528060629|FG001|Overall Study|Lack of Efficacy|0|||
146424801|NCT00414466|528060630|FG002|Overall Study|Lack of Efficacy|0|||
146424802|NCT00414466|528060631|FG003|Overall Study|Lack of Efficacy|0|||
146424803|NCT00414466|528060628|FG000|Overall Study|Withdrawn by Sponsor|1|||
146424804|NCT00414466|528060629|FG001|Overall Study|Withdrawn by Sponsor|0|||
146424805|NCT00414466|528060630|FG002|Overall Study|Withdrawn by Sponsor|0|||
146424806|NCT00414466|528060631|FG003|Overall Study|Withdrawn by Sponsor|0|||
146424807|NCT03480425|528060633|FG000|Overall Study|Force transducer technical failure|1|||
146424808|NCT01451762|528060634|FG000|Overall Study|Lost to Follow-up|3|||
146424809|NCT01451762|528060635|FG001|Overall Study|Lost to Follow-up|6|||
146424810|NCT01451762|528060636|FG002|Overall Study|Lost to Follow-up|6|||
146424811|NCT00630305|528060640|FG000|Overall Study|Withdrawal by Subject|1|||
146424812|NCT00630305|528060640|FG000|Overall Study|Inability to insert contact lens|1|||
146424813|NCT01085045|528060641|FG000|Part A|Withdrawal by Subject|4|||
146424814|NCT01085045|528060641|FG000|Part A|Adverse Event|6|||
146424815|NCT01085045|528060641|FG000|Part A|Protocol Violation|1|||
146424816|NCT01085045|528060641|FG000|Part A|Protocol Specified Criteria|7|||
146424817|NCT01085045|528060641|FG000|Part B|Withdrawal by Subject|2|||
146424818|NCT01085045|528060641|FG000|Part B|Protocol Specified Criteria|6|||
146424819|NCT01085045|528060641|FG000|Part B|Lost to Follow-up|1|||
146424820|NCT01085045|528060641|FG000|Part B|Adverse Event|6|||
146424821|NCT02395822|528060645|FG000|Overall Study|Withdrawal by Subject|1|||
146424822|NCT02395822|528060645|FG000|Overall Study|Death|1|||
146424823|NCT02127281|528060646|FG000|Overall Study|Lost to Follow-up|1|||
146424824|NCT02127281|528060647|FG001|Overall Study|Lost to Follow-up|0|||
146424825|NCT04510857|528060648|FG000|Overall Study|Withdrawal by Subject|1|||
146424826|NCT04510857|528060649|FG001|Overall Study|Withdrawal by Subject|2|||
146424827|NCT02564263|528060652|FG000|Overall Study|Adverse Event|31|||
146424828|NCT02564263|528060653|FG001|Overall Study|Adverse Event|29|||
146424829|NCT02564263|528060652|FG000|Overall Study|Death|270|||
146424830|NCT02564263|528060653|FG001|Overall Study|Death|262|||
146424831|NCT02564263|528060652|FG000|Overall Study|Withdrawal by Subject|4|||
146424832|NCT02564263|528060653|FG001|Overall Study|Withdrawal by Subject|19|||
146424833|NCT02564263|528060652|FG000|Overall Study|Sponsor's decision|9|||
146424834|NCT02564263|528060653|FG001|Overall Study|Sponsor's decision|4|||
146424835|NCT00920140|528060654|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
146424836|NCT00920140|528060655|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
146424837|NCT00920140|528060656|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
146424838|NCT00920140|528060657|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
146424839|NCT00920140|528060658|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
146424840|NCT00920140|528060654|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
146424841|NCT00920140|528060655|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
146424842|NCT00920140|528060656|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146424843|NCT00920140|528060657|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146424844|NCT00920140|528060658|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
146424845|NCT00920140|528060654|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146424846|NCT00920140|528060655|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
146424847|NCT00920140|528060656|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146424848|NCT00920140|528060657|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146424849|NCT00920140|528060658|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146424850|NCT00920140|528060654|FG000|Phase 2|Adverse Event|0|||
146424851|NCT00920140|528060655|FG001|Phase 2|Adverse Event|0|||
146424852|NCT00920140|528060656|FG002|Phase 2|Adverse Event|14|||
146424853|NCT00920140|528060657|FG003|Phase 2|Adverse Event|2|||
146424854|NCT00920140|528060658|FG004|Phase 2|Adverse Event|3|||
146424855|NCT00920140|528060654|FG000|Phase 2|Lack of Efficacy|0|||
146424856|NCT00920140|528060655|FG001|Phase 2|Lack of Efficacy|0|||
146424857|NCT00920140|528060656|FG002|Phase 2|Lack of Efficacy|29|||
146424858|NCT00920140|528060657|FG003|Phase 2|Lack of Efficacy|14|||
146424859|NCT00920140|528060658|FG004|Phase 2|Lack of Efficacy|5|||
146424860|NCT00920140|528060654|FG000|Phase 2|Lost to Follow-up|0|||
146424861|NCT00920140|528060655|FG001|Phase 2|Lost to Follow-up|0|||
146424862|NCT00920140|528060656|FG002|Phase 2|Lost to Follow-up|0|||
146424863|NCT00920140|528060657|FG003|Phase 2|Lost to Follow-up|1|||
146424864|NCT00920140|528060658|FG004|Phase 2|Lost to Follow-up|0|||
146424865|NCT00920140|528060654|FG000|Phase 2|Physician Decision|0|||
146424866|NCT00920140|528060655|FG001|Phase 2|Physician Decision|0|||
146424867|NCT00920140|528060656|FG002|Phase 2|Physician Decision|3|||
146424868|NCT00920140|528060657|FG003|Phase 2|Physician Decision|3|||
146424869|NCT00920140|528060658|FG004|Phase 2|Physician Decision|2|||
146424870|NCT00920140|528060654|FG000|Phase 2|Withdrawal by Subject|0|||
146424871|NCT00920140|528060655|FG001|Phase 2|Withdrawal by Subject|0|||
146424872|NCT00920140|528060656|FG002|Phase 2|Withdrawal by Subject|4|||
146424873|NCT00920140|528060657|FG003|Phase 2|Withdrawal by Subject|2|||
146424874|NCT00920140|528060658|FG004|Phase 2|Withdrawal by Subject|1|||
146424875|NCT00720096|528060662|FG000|Overall Study|Withdrawal by Subject|0|||
146424876|NCT00720096|528060663|FG001|Overall Study|Withdrawal by Subject|2|||
146424877|NCT04557124|528060664|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
146424878|NCT04557124|528060665|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
146424879|NCT04557124|528060664|FG000|Mid-point (1 Month)|Missed testing|5|||
146424880|NCT04557124|528060665|FG001|Mid-point (1 Month)|Missed testing|4|||
146424881|NCT04557124|528060664|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
146424882|NCT04557124|528060665|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
146424883|NCT04557124|528060664|FG000|Post-testing (2 Months)|Missed testing|1|||
146424884|NCT04557124|528060665|FG001|Post-testing (2 Months)|Missed testing|5|||
146424885|NCT04557124|528060664|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
146424886|NCT04557124|528060665|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
146424887|NCT04557124|528060664|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
146424888|NCT04557124|528060665|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
146424889|NCT00001849|528060666|FG000|Overall Study|Death|4|||
146424890|NCT00001849|528060666|FG000|Overall Study|Lost to Follow-up|2|||
146424891|NCT00001849|528060666|FG000|Overall Study|Withdrawal by Subject|2|||
146424892|NCT00001849|528060666|FG000|Overall Study|tumor remained occult|6|||
146424893|NCT03127137|528060670|FG000|Overall Study|Requested sedation after consent|1|||
146424894|NCT03127137|528060671|FG001|Overall Study|Requested sedation after consent|0|||
146424895|NCT03127137|528060670|FG000|Overall Study|Malfunction in electronic data collection|1|||
146424896|NCT03127137|528060671|FG001|Overall Study|Malfunction in electronic data collection|0|||
146199142|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
146199143|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
146199144|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
146199145|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
146199146|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
146199147|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
146199148|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
146199149|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
146199150|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
146199151|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
146199152|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
146199153|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
146424897|NCT03127137|528060670|FG000|Overall Study|Post procedure testing could not be obtained|0|||
146424898|NCT03127137|528060671|FG001|Overall Study|Post procedure testing could not be obtained|1|||
146424899|NCT02319148|528060675|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
146424900|NCT02319148|528060676|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
146424901|NCT02319148|528060677|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
146424902|NCT02319148|528060678|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
146424903|NCT02319148|528060675|FG000|Second Intervention Period|No longer willing to participate|0|||
146424904|NCT02319148|528060676|FG001|Second Intervention Period|No longer willing to participate|1|||
146424905|NCT02319148|528060677|FG002|Second Intervention Period|No longer willing to participate|0|||
146424906|NCT02319148|528060678|FG003|Second Intervention Period|No longer willing to participate|0|||
146424907|NCT02319148|528060675|FG000|Second Intervention Period|Other|0|||
146424908|NCT02319148|528060676|FG001|Second Intervention Period|Other|0|||
146424909|NCT02319148|528060677|FG002|Second Intervention Period|Other|0|||
146424910|NCT02319148|528060678|FG003|Second Intervention Period|Other|1|||
146424911|NCT00264797|528060679|FG000|Overall Study|Withdrawal by Subject|11|||
146424912|NCT00264797|528060680|FG001|Overall Study|Withdrawal by Subject|11|||
146424913|NCT00264797|528060679|FG000|Overall Study|Lost to Follow-up|9|||
146424914|NCT00264797|528060680|FG001|Overall Study|Lost to Follow-up|17|||
146424915|NCT00264797|528060679|FG000|Overall Study|Moved from area|3|||
146424916|NCT00264797|528060680|FG001|Overall Study|Moved from area|1|||
146424917|NCT00264797|528060679|FG000|Overall Study|Practical Problems|2|||
146424918|NCT00264797|528060680|FG001|Overall Study|Practical Problems|3|||
146424919|NCT00264797|528060679|FG000|Overall Study|Incarceration|4|||
146424920|NCT00264797|528060680|FG001|Overall Study|Incarceration|5|||
146424921|NCT00264797|528060679|FG000|Overall Study|Pressure/advice from Outsiders|1|||
146424922|NCT00264797|528060680|FG001|Overall Study|Pressure/advice from Outsiders|1|||
146424923|NCT00264797|528060679|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
146424924|NCT00264797|528060680|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
146424925|NCT00264797|528060679|FG000|Overall Study|Other|3|||
146424926|NCT00264797|528060680|FG001|Overall Study|Other|4|||
146424927|NCT00755196|528060681|FG000|Overall Study|Lost to Follow-up|1|||
146424928|NCT00755196|528060681|FG000|Overall Study|Lack of Efficiency|1|||
146424929|NCT01604850|528060682|FG000|Overall Study|Enrolled but never treated|0|||
146424930|NCT01604850|528060683|FG001|Overall Study|Enrolled but never treated|1|||
146424931|NCT01604850|528060682|FG000|Overall Study|Efficacy Failure|50|||
146424932|NCT01604850|528060683|FG001|Overall Study|Efficacy Failure|29|||
146424933|NCT01604850|528060682|FG000|Overall Study|Lost to Follow-up|1|||
146424934|NCT01604850|528060683|FG001|Overall Study|Lost to Follow-up|0|||
146424935|NCT01604850|528060682|FG000|Overall Study|Subject withdrew consent|1|||
146199154|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
146199155|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
146199156|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199157|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
146199158|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
146199159|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
146199160|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199161|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199162|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199163|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199164|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199165|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199166|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
146199167|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199168|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199169|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199170|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199171|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
146199172|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199173|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199174|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199175|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199176|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199177|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
146199178|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
146199179|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199180|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199181|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199182|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146424936|NCT01604850|528060683|FG001|Overall Study|Subject withdrew consent|0|||
146424937|NCT01249664|528060684|FG000|Overall Study|Withdrawal by Subject|5|||
146424938|NCT01249664|528060685|FG001|Overall Study|Withdrawal by Subject|0|||
146424939|NCT01249664|528060684|FG000|Overall Study|Adverse Event|1|||
146424940|NCT01249664|528060685|FG001|Overall Study|Adverse Event|0|||
146424941|NCT00762086|528060688|FG000|Overall Study|Adverse Event|2|||
146199183|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146424942|NCT00762086|528060689|FG001|Overall Study|Adverse Event|0|||
146424943|NCT00762086|528060688|FG000|Overall Study|Lost to Follow-up|0|||
146424944|NCT00762086|528060689|FG001|Overall Study|Lost to Follow-up|2|||
146424945|NCT00762086|528060688|FG000|Overall Study|Non compliance|1|||
146424946|NCT00762086|528060689|FG001|Overall Study|Non compliance|0|||
146424947|NCT00762086|528060688|FG000|Overall Study|Withdrawal by Subject|2|||
146424948|NCT00762086|528060689|FG001|Overall Study|Withdrawal by Subject|2|||
146424949|NCT00762086|528060688|FG000|Overall Study|Ineligible to participate in the study|1|||
146424950|NCT00762086|528060689|FG001|Overall Study|Ineligible to participate in the study|0|||
146424951|NCT00860405|528060690|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
146424952|NCT00860405|528060691|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
146424953|NCT00497796|528060693|FG000|Overall Study|Adverse event (not related)|9|||
146424954|NCT00497796|528060694|FG001|Overall Study|Adverse event (not related)|9|||
146424955|NCT00497796|528060693|FG000|Overall Study|Adverse event (related)|5|||
146424956|NCT00497796|528060694|FG001|Overall Study|Adverse event (related)|4|||
146424957|NCT00497796|528060693|FG000|Overall Study|CMV infection or disease treatment|30|||
146424958|NCT00497796|528060694|FG001|Overall Study|CMV infection or disease treatment|4|||
146424959|NCT00497796|528060693|FG000|Overall Study|Consent withdrawn|10|||
146424960|NCT00497796|528060694|FG001|Overall Study|Consent withdrawn|3|||
146424961|NCT00497796|528060693|FG000|Overall Study|Investigator/sponsor discretion|31|||
146424962|NCT00497796|528060694|FG001|Overall Study|Investigator/sponsor discretion|34|||
146424963|NCT00497796|528060693|FG000|Overall Study|Lost to Follow-up|0|||
146424964|NCT00497796|528060694|FG001|Overall Study|Lost to Follow-up|1|||
146424965|NCT00497796|528060693|FG000|Overall Study|Not applicable (randomized not treated)|0|||
146424966|NCT00497796|528060694|FG001|Overall Study|Not applicable (randomized not treated)|4|||
146424967|NCT01074554|528060695|FG000|Overall Study|Adverse Event|3|||
146424968|NCT01074554|528060696|FG001|Overall Study|Adverse Event|3|||
146424969|NCT01074554|528060695|FG000|Overall Study|Lost to Follow-up|0|||
146424970|NCT01074554|528060696|FG001|Overall Study|Lost to Follow-up|1|||
146424971|NCT04276883|528060697|FG000|Overall Study|Withdrawal by Subject|2|||
146424972|NCT04276883|528060698|FG001|Overall Study|Withdrawal by Subject|3|||
146424973|NCT04276883|528060699|FG002|Overall Study|Withdrawal by Subject|6|||
146199184|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199185|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146424974|NCT04276883|528060697|FG000|Overall Study|Lost to Follow-up|1|||
146199186|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146424975|NCT04276883|528060698|FG001|Overall Study|Lost to Follow-up|3|||
146424976|NCT04276883|528060699|FG002|Overall Study|Lost to Follow-up|0|||
146424977|NCT04276883|528060697|FG000|Overall Study|Adverse Event|0|||
146424978|NCT04276883|528060698|FG001|Overall Study|Adverse Event|1|||
146424979|NCT04276883|528060699|FG002|Overall Study|Adverse Event|0|||
146424980|NCT04276883|528060697|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
146424981|NCT04276883|528060698|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
146424982|NCT04276883|528060699|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
146199187|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199188|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
146199189|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
146199190|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
146199191|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
146199192|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
146199193|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
146199194|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
146199195|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
146199196|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
146424983|NCT02073643|528060702|FG000|Overall Study|Lost to Follow-up|24|||
146424984|NCT01139164|528060708|FG000|Overall Study|Withdrawn prior to study start|0|||
146424985|NCT01139164|528060709|FG001|Overall Study|Withdrawn prior to study start|2|||
146424986|NCT01139164|528060710|FG002|Overall Study|Withdrawn prior to study start|0|||
146424987|NCT00406848|528060711|FG000|Overall Study|Withdrawal by Subject|27|||
146424988|NCT00406848|528060712|FG001|Overall Study|Withdrawal by Subject|22|||
146424989|NCT00406848|528060711|FG000|Overall Study|Adverse Event|38|||
146424990|NCT00406848|528060712|FG001|Overall Study|Adverse Event|7|||
146424991|NCT00406848|528060711|FG000|Overall Study|Lack of Efficacy|9|||
146424992|NCT00406848|528060712|FG001|Overall Study|Lack of Efficacy|14|||
146424993|NCT00406848|528060711|FG000|Overall Study|Protocol Violation|10|||
146424994|NCT00406848|528060712|FG001|Overall Study|Protocol Violation|6|||
146424995|NCT00406848|528060711|FG000|Overall Study|Lost to Follow-up|6|||
146424996|NCT00406848|528060712|FG001|Overall Study|Lost to Follow-up|2|||
146199197|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
146199198|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
146199199|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
146199200|NCT02914522|527240944|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146424997|NCT00406848|528060711|FG000|Overall Study|Physician Decision|2|||
146424998|NCT00406848|528060712|FG001|Overall Study|Physician Decision|2|||
146199201|NCT02914522|527240945|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146424999|NCT00406848|528060711|FG000|Overall Study|Sponsor Decision|1|||
146425000|NCT00406848|528060712|FG001|Overall Study|Sponsor Decision|1|||
146425001|NCT01355081|528060713|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
146425002|NCT01355081|528060714|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
146425003|NCT01355081|528060715|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
146425004|NCT01355081|528060713|FG000|Overall Study|Major Protocol Deviation|0|||
146425005|NCT01355081|528060714|FG001|Overall Study|Major Protocol Deviation|1|||
146425006|NCT01355081|528060715|FG002|Overall Study|Major Protocol Deviation|0|||
146425007|NCT01355081|528060713|FG000|Overall Study|Lost to Follow-up|0|||
146425008|NCT01355081|528060714|FG001|Overall Study|Lost to Follow-up|0|||
146425009|NCT01355081|528060715|FG002|Overall Study|Lost to Follow-up|1|||
146425010|NCT01355081|528060713|FG000|Overall Study|Withdrawal of Consent|2|||
146425011|NCT01355081|528060714|FG001|Overall Study|Withdrawal of Consent|3|||
146425012|NCT01355081|528060715|FG002|Overall Study|Withdrawal of Consent|3|||
146425013|NCT01355081|528060713|FG000|Overall Study|Lack of Efficacy|2|||
146425014|NCT01355081|528060714|FG001|Overall Study|Lack of Efficacy|1|||
146425015|NCT01355081|528060715|FG002|Overall Study|Lack of Efficacy|1|||
146425016|NCT01355081|528060713|FG000|Overall Study|Non Compliance with Study Medication|0|||
146425017|NCT01355081|528060714|FG001|Overall Study|Non Compliance with Study Medication|1|||
146425018|NCT01355081|528060715|FG002|Overall Study|Non Compliance with Study Medication|0|||
146425019|NCT02719522|528060716|FG000|Overall Study|Implant Failure|4|||
146425020|NCT02719522|528060716|FG000|Overall Study|Death|2|||
146199202|NCT02914522|527240946|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199203|NCT02914522|527240947|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146425021|NCT02719522|528060716|FG000|Overall Study|Lost to Follow-up|5|||
146425022|NCT03184441|528060717|FG000|Overall Study|Withdrawal by Subject|1|||
146425023|NCT00860028|528060720|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
146425024|NCT00860028|528060721|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
146425025|NCT00936390|528060722|FG000|Overall Study|Protocol Violation|21|||
146425026|NCT00936390|528060723|FG001|Overall Study|Protocol Violation|25|||
146425027|NCT02514174|528060727|FG000|Overall Study|Patient refused to continue medication|1|||
146425028|NCT02514174|528060727|FG000|Overall Study|Adverse Event|2|||
146425029|NCT02514174|528060727|FG000|Overall Study|Study closed by sponsor|9|||
146425030|NCT02514174|528060727|FG000|Overall Study|Progressive disease|11|||
146425031|NCT02514174|528060727|FG000|Overall Study|Treatment change|1|||
146425032|NCT02514174|528060727|FG000|Overall Study|Treated off study with Afatinib.|1|||
146425033|NCT00444145|528062498|FG000|Overall Study|Withdrawal by Subject|2|||
146425034|NCT00444145|528062498|FG000|Overall Study|Lost to Follow-up|1|||
146425035|NCT00444145|528062498|FG000|Overall Study|non-compliant|11|||
146425036|NCT00444145|528062498|FG000|Overall Study|Screen Failures|5|||
146425037|NCT00419770|528062502|FG000|Overall Study|Withdrawal by Subject|5|||
146425038|NCT00419770|528062503|FG001|Overall Study|Withdrawal by Subject|1|||
146425039|NCT04526210|528062510|FG000|Overall Study|Sponsor decision|7|||
146425040|NCT04526210|528062511|FG001|Overall Study|Sponsor decision|5|||
146425041|NCT04526210|528062510|FG000|Overall Study|Withdrawal by Subject|3|||
146425042|NCT04526210|528062511|FG001|Overall Study|Withdrawal by Subject|2|||
146425043|NCT02637232|528062512|FG000|Overall Study|Lost to Follow-up|42|||
146199204|NCT02914522|527240948|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146199205|NCT02914522|527240949|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
146199206|NCT02914522|527240950|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199207|NCT02914522|527240951|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199208|NCT02914522|527240952|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199209|NCT02914522|527240953|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199210|NCT02914522|527240954|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
146199211|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199212|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199213|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199214|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199215|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199216|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
146199217|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
146199218|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
146199219|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
146199220|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
146425044|NCT02637232|528062512|FG000|Overall Study|Adverse Event|11|||
146425045|NCT02637232|528062512|FG000|Overall Study|patient 's decision|2|||
146425046|NCT01781637|528062513|FG000|Overall Study|Adverse Event|1|||
146425047|NCT01781637|528062514|FG001|Overall Study|Adverse Event|0|||
146425048|NCT01781637|528062513|FG000|Overall Study|Lack of Efficacy|2|||
146425049|NCT01781637|528062514|FG001|Overall Study|Lack of Efficacy|6|||
146425050|NCT01781637|528062513|FG000|Overall Study|Withdrawal by Subject|1|||
146082645|NCT00807573|526822864|FG000|Overall Study|Adverse Event|1|||
146425051|NCT01781637|528062514|FG001|Overall Study|Withdrawal by Subject|0|||
146425052|NCT02999178|528062515|FG000|Overall Study|Adverse Event|85|||
146425053|NCT02999178|528062516|FG001|Overall Study|Adverse Event|62|||
146425054|NCT02999178|528062515|FG000|Overall Study|Protocol Violation|1|||
146425055|NCT02999178|528062516|FG001|Overall Study|Protocol Violation|2|||
146425056|NCT02999178|528062515|FG000|Overall Study|Lost to Follow-up|0|||
146425057|NCT02999178|528062516|FG001|Overall Study|Lost to Follow-up|2|||
146425058|NCT02999178|528062515|FG000|Overall Study|Withdrawal by Subject|21|||
146425059|NCT02999178|528062516|FG001|Overall Study|Withdrawal by Subject|21|||
146425060|NCT02999178|528062515|FG000|Overall Study|Other reason not defined above|7|||
146425061|NCT02999178|528062516|FG001|Overall Study|Other reason not defined above|13|||
146425062|NCT00090857|528062517|FG000|Overall Study|Lost to Follow-up|0|||
146425063|NCT00090857|528062518|FG001|Overall Study|Lost to Follow-up|1|||
146425064|NCT00090857|528062517|FG000|Overall Study|Withdrawal by Subject|2|||
146425065|NCT00090857|528062518|FG001|Overall Study|Withdrawal by Subject|0|||
146425066|NCT00090857|528062517|FG000|Overall Study|Adverse Event|2|||
146425067|NCT00090857|528062518|FG001|Overall Study|Adverse Event|2|||
146425068|NCT05097326|528062519|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
146425069|NCT05097326|528062520|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
146425070|NCT01244126|528062521|FG000|Overall Study|Protocol Violation|3|||
146425071|NCT01244126|528062522|FG001|Overall Study|Protocol Violation|3|||
146425072|NCT01244126|528062523|FG002|Overall Study|Protocol Violation|9|||
146425073|NCT02424188|528062528|FG000|Overall Study|Death|2|||
146425074|NCT02424188|528062529|FG001|Overall Study|Death|2|||
146425075|NCT02424188|528062528|FG000|Overall Study|Lost to Follow-up|1|||
146425076|NCT02424188|528062529|FG001|Overall Study|Lost to Follow-up|3|||
146425077|NCT02424188|528062528|FG000|Overall Study|Incarceration|1|||
146425078|NCT02424188|528062529|FG001|Overall Study|Incarceration|0|||
146425079|NCT01494506|528062538|FG000|Overall Study|Lack of Efficacy|77|||
146425080|NCT01494506|528062539|FG001|Overall Study|Lack of Efficacy|83|||
146425081|NCT01494506|528062540|FG002|Overall Study|Lack of Efficacy|57|||
146425082|NCT01494506|528062538|FG000|Overall Study|Adverse Event|17|||
146425083|NCT01494506|528062539|FG001|Overall Study|Adverse Event|10|||
146425084|NCT01494506|528062540|FG002|Overall Study|Adverse Event|11|||
146425085|NCT01494506|528062538|FG000|Overall Study|Death|9|||
146425086|NCT01494506|528062539|FG001|Overall Study|Death|5|||
146425087|NCT01494506|528062540|FG002|Overall Study|Death|2|||
146425088|NCT01494506|528062538|FG000|Overall Study|Physician Decision|7|||
146425089|NCT01494506|528062539|FG001|Overall Study|Physician Decision|5|||
146425090|NCT01494506|528062540|FG002|Overall Study|Physician Decision|4|||
146425091|NCT01494506|528062538|FG000|Overall Study|Withdrawal by Subject|17|||
146425092|NCT01494506|528062539|FG001|Overall Study|Withdrawal by Subject|20|||
146425093|NCT01494506|528062540|FG002|Overall Study|Withdrawal by Subject|14|||
146425094|NCT01494506|528062538|FG000|Overall Study|Clinical Deterioration|21|||
146425095|NCT01494506|528062539|FG001|Overall Study|Clinical Deterioration|17|||
146425096|NCT01494506|528062540|FG002|Overall Study|Clinical Deterioration|13|||
146425097|NCT01494506|528062538|FG000|Overall Study|Sponsor Decision|0|||
146425098|NCT01494506|528062539|FG001|Overall Study|Sponsor Decision|0|||
146425099|NCT01494506|528062540|FG002|Overall Study|Sponsor Decision|1|||
146425100|NCT01494506|528062538|FG000|Overall Study|Other|0|||
146425101|NCT01494506|528062539|FG001|Overall Study|Other|3|||
146425102|NCT01494506|528062540|FG002|Overall Study|Other|1|||
146425103|NCT01703832|528062544|FG000|Overall Study|Withdrawal by Subject|1|||
146425104|NCT01703832|528062545|FG001|Overall Study|Withdrawal by Subject|0|||
146425105|NCT00243932|528062546|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
146425106|NCT00243932|528062547|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
146425107|NCT00243932|528062548|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
146425108|NCT00543309|528062549|FG000|Overall Study|Physician Decision|0|||
146425109|NCT00543309|528062550|FG001|Overall Study|Physician Decision|1|||
146425110|NCT00543309|528062551|FG002|Overall Study|Physician Decision|0|||
146199221|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
146199222|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146199223|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146199224|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146199225|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146199226|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146425111|NCT04538170|528062563|FG000|Overall Study|Withdrawal by Subject|104|||
146425112|NCT04538170|528062564|FG001|Overall Study|Withdrawal by Subject|210|||
146425113|NCT01682083|528062569|FG000|Overall Study|Lost to Follow-up|11|||
146425114|NCT01682083|528062570|FG001|Overall Study|Lost to Follow-up|18|||
146425115|NCT01682083|528062569|FG000|Overall Study|Withdrawal by Subject|31|||
146425116|NCT01682083|528062570|FG001|Overall Study|Withdrawal by Subject|40|||
146425117|NCT01682083|528062569|FG000|Overall Study|Death|60|||
146425118|NCT01682083|528062570|FG001|Overall Study|Death|93|||
146425119|NCT01682083|528062569|FG000|Overall Study|Physician Decision|5|||
146425120|NCT01682083|528062570|FG001|Overall Study|Physician Decision|4|||
146425121|NCT00864097|528062571|FG000|Overall Study|Death|0|||
146425122|NCT00864097|528062572|FG001|Overall Study|Death|1|||
146425123|NCT00864097|528062573|FG002|Overall Study|Death|0|||
146425124|NCT00864097|528062574|FG003|Overall Study|Death|0|||
146425125|NCT00864097|528062571|FG000|Overall Study|Adverse Event|6|||
146425126|NCT00864097|528062572|FG001|Overall Study|Adverse Event|8|||
146425127|NCT00864097|528062573|FG002|Overall Study|Adverse Event|11|||
146425128|NCT00864097|528062574|FG003|Overall Study|Adverse Event|9|||
146425129|NCT00864097|528062571|FG000|Overall Study|Lack of Efficacy|9|||
146425130|NCT00864097|528062572|FG001|Overall Study|Lack of Efficacy|3|||
146425131|NCT00864097|528062573|FG002|Overall Study|Lack of Efficacy|7|||
146425132|NCT00864097|528062574|FG003|Overall Study|Lack of Efficacy|2|||
146425133|NCT00864097|528062571|FG000|Overall Study|Lost to Follow-up|0|||
146425134|NCT00864097|528062572|FG001|Overall Study|Lost to Follow-up|1|||
146425135|NCT00864097|528062573|FG002|Overall Study|Lost to Follow-up|0|||
146425136|NCT00864097|528062574|FG003|Overall Study|Lost to Follow-up|1|||
146425137|NCT00864097|528062571|FG000|Overall Study|Withdrawal by Subject|15|||
146425138|NCT00864097|528062572|FG001|Overall Study|Withdrawal by Subject|11|||
146425139|NCT00864097|528062573|FG002|Overall Study|Withdrawal by Subject|11|||
146425140|NCT00864097|528062574|FG003|Overall Study|Withdrawal by Subject|12|||
146425141|NCT00864097|528062571|FG000|Overall Study|Protocol Violation|2|||
146425142|NCT00864097|528062572|FG001|Overall Study|Protocol Violation|1|||
146425143|NCT00864097|528062573|FG002|Overall Study|Protocol Violation|0|||
146425144|NCT00864097|528062574|FG003|Overall Study|Protocol Violation|1|||
146425145|NCT00864097|528062571|FG000|Overall Study|Terminated by sponsor|105|||
146425146|NCT00864097|528062572|FG001|Overall Study|Terminated by sponsor|112|||
146425147|NCT00864097|528062573|FG002|Overall Study|Terminated by sponsor|102|||
146425148|NCT00864097|528062574|FG003|Overall Study|Terminated by sponsor|99|||
146425149|NCT00864097|528062571|FG000|Overall Study|Randomized but not treated|2|||
146425150|NCT00864097|528062572|FG001|Overall Study|Randomized but not treated|0|||
146425151|NCT00864097|528062573|FG002|Overall Study|Randomized but not treated|1|||
146425152|NCT00864097|528062574|FG003|Overall Study|Randomized but not treated|0|||
146425153|NCT00864097|528062571|FG000|Overall Study|Other|0|||
146425154|NCT00864097|528062572|FG001|Overall Study|Other|0|||
146425155|NCT00864097|528062573|FG002|Overall Study|Other|0|||
146425156|NCT00864097|528062574|FG003|Overall Study|Other|1|||
146425157|NCT05956665|528062586|FG000|Overall Study|Death|1|||
146425158|NCT05956665|528062586|FG000|Overall Study|Withdrawal by Subject|1|||
146425159|NCT01939197|528062587|FG000|Overall Study|Withdrawal by Subject|1|||
146425160|NCT01939197|528062588|FG001|Overall Study|Withdrawal by Subject|0|||
146425161|NCT01939197|528062589|FG002|Overall Study|Withdrawal by Subject|0|||
146425162|NCT01939197|528062590|FG003|Overall Study|Withdrawal by Subject|0|||
146425163|NCT01939197|528062591|FG004|Overall Study|Withdrawal by Subject|1|||
146425164|NCT01939197|528062592|FG005|Overall Study|Withdrawal by Subject|0|||
146425165|NCT01939197|528062593|FG006|Overall Study|Withdrawal by Subject|0|||
146425166|NCT01939197|528062587|FG000|Overall Study|Lost to Follow-up|0|||
146425167|NCT01939197|528062588|FG001|Overall Study|Lost to Follow-up|1|||
146425168|NCT01939197|528062589|FG002|Overall Study|Lost to Follow-up|0|||
146425169|NCT01939197|528062590|FG003|Overall Study|Lost to Follow-up|1|||
146425170|NCT01939197|528062591|FG004|Overall Study|Lost to Follow-up|3|||
146425171|NCT01939197|528062592|FG005|Overall Study|Lost to Follow-up|1|||
146425172|NCT01939197|528062593|FG006|Overall Study|Lost to Follow-up|2|||
146425173|NCT02545998|528062594|FG000|Overall Study|Lost to Follow-up|12|||
146425174|NCT02545998|528062595|FG001|Overall Study|Lost to Follow-up|3|||
146425175|NCT02545998|528062594|FG000|Overall Study|Withdrawal by Subject|3|||
146425176|NCT02545998|528062595|FG001|Overall Study|Withdrawal by Subject|2|||
146425177|NCT02603952|528062604|FG000|Overall Study|Withdrawal by Subject|1|||
146425178|NCT02603952|528062605|FG001|Overall Study|Withdrawal by Subject|0|||
146425179|NCT02603952|528062606|FG002|Overall Study|Withdrawal by Subject|0|||
146425180|NCT02603952|528062607|FG003|Overall Study|Withdrawal by Subject|0|||
146425181|NCT02603952|528062604|FG000|Overall Study|Received oseltamivir by error|0|||
146425182|NCT02603952|528062605|FG001|Overall Study|Received oseltamivir by error|0|||
146425183|NCT02603952|528062606|FG002|Overall Study|Received oseltamivir by error|0|||
146425184|NCT02603952|528062607|FG003|Overall Study|Received oseltamivir by error|1|||
146425185|NCT00958243|528062620|FG000|Overall Study|Withdrawal by Subject|0|||
146425186|NCT00958243|528062621|FG001|Overall Study|Withdrawal by Subject|1|||
146425187|NCT00958243|528062622|FG002|Overall Study|Withdrawal by Subject|3|||
146199227|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
146199228|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
146199229|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
146199230|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
146425188|NCT00958243|528062623|FG003|Overall Study|Withdrawal by Subject|1|||
146425189|NCT00958243|528062624|FG004|Overall Study|Withdrawal by Subject|1|||
146425190|NCT00958243|528062625|FG005|Overall Study|Withdrawal by Subject|5|||
146425191|NCT00958243|528062620|FG000|Overall Study|Lost to Follow-up|2|||
146425192|NCT00958243|528062621|FG001|Overall Study|Lost to Follow-up|5|||
146425193|NCT00958243|528062622|FG002|Overall Study|Lost to Follow-up|11|||
146425194|NCT00958243|528062623|FG003|Overall Study|Lost to Follow-up|2|||
146425195|NCT00958243|528062624|FG004|Overall Study|Lost to Follow-up|8|||
146425196|NCT00958243|528062625|FG005|Overall Study|Lost to Follow-up|5|||
146082646|NCT01426789|526822865|FG000|Part 1|Protocol deviation|0|||
146199231|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
146199232|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
146199233|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199234|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199235|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199236|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199237|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199238|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199239|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
146199240|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
146199241|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
146199242|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
146199243|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
146199244|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199245|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199246|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199247|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199248|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199249|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
146199250|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
146199251|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
146199252|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
146199253|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
146199254|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
146199255|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
146199256|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
146199257|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
146199258|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
146199259|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
146199260|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
146199261|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
146199262|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
146199263|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
146199264|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
146199265|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
146199266|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199267|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199268|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199269|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199270|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199271|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199272|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199273|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
146199274|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
146199275|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199276|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
146199277|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199278|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199279|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199280|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199281|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199282|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199283|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199284|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146199285|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
146199286|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
146199287|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
146425197|NCT04646109|528062626|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
146425198|NCT04646109|528062627|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
146425199|NCT06176768|528062628|FG000|Overall Study|Adverse Event|1|||
146425200|NCT06176768|528062629|FG001|Overall Study|Adverse Event|0|||
146425201|NCT06176768|528062628|FG000|Overall Study|Assigned treatment by mistake|1|||
146425202|NCT06176768|528062629|FG001|Overall Study|Assigned treatment by mistake|0|||
146425203|NCT06176768|528062628|FG000|Overall Study|Lost to Follow-up|0|||
146425204|NCT06176768|528062629|FG001|Overall Study|Lost to Follow-up|3|||
146425205|NCT06176768|528062628|FG000|Overall Study|Physician Decision|1|||
146425206|NCT06176768|528062629|FG001|Overall Study|Physician Decision|0|||
146425207|NCT06176768|528062628|FG000|Overall Study|Protocol deviation|3|||
146425208|NCT06176768|528062629|FG001|Overall Study|Protocol deviation|1|||
146425209|NCT06176768|528062628|FG000|Overall Study|Other|1|||
146425210|NCT06176768|528062629|FG001|Overall Study|Other|0|||
146425211|NCT06176768|528062628|FG000|Overall Study|Withdrawal by Subject|6|||
146425212|NCT06176768|528062629|FG001|Overall Study|Withdrawal by Subject|9|||
146425213|NCT01226797|528062632|FG000|Overall Study|Adverse Event|1|||
146425214|NCT01226797|528062633|FG001|Overall Study|Adverse Event|0|||
146425215|NCT01226797|528062632|FG000|Overall Study|No longer willing to participate|1|||
146425216|NCT01226797|528062633|FG001|Overall Study|No longer willing to participate|0|||
146425217|NCT01226797|528062632|FG000|Overall Study|Protocol Violation|0|||
146425218|NCT01226797|528062633|FG001|Overall Study|Protocol Violation|1|||
146425219|NCT00577460|528062634|FG000|Overall Study|Adverse Event|11|||
146425220|NCT00577460|528062635|FG001|Overall Study|Adverse Event|7|||
146425221|NCT00577460|528062636|FG002|Overall Study|Adverse Event|14|||
146425222|NCT00577460|528062634|FG000|Overall Study|Protocol Violation|0|||
146425223|NCT00577460|528062635|FG001|Overall Study|Protocol Violation|1|||
146425224|NCT00577460|528062636|FG002|Overall Study|Protocol Violation|1|||
146425225|NCT00577460|528062634|FG000|Overall Study|Lost to Follow-up|0|||
146425226|NCT00577460|528062635|FG001|Overall Study|Lost to Follow-up|3|||
146425227|NCT00577460|528062636|FG002|Overall Study|Lost to Follow-up|4|||
146425228|NCT00577460|528062634|FG000|Overall Study|Withdrawal by Subject|5|||
146425229|NCT00577460|528062635|FG001|Overall Study|Withdrawal by Subject|5|||
146425230|NCT00577460|528062636|FG002|Overall Study|Withdrawal by Subject|6|||
146425231|NCT00577460|528062634|FG000|Overall Study|Other|0|||
146425232|NCT00577460|528062635|FG001|Overall Study|Other|3|||
146425233|NCT00577460|528062636|FG002|Overall Study|Other|2|||
146425234|NCT01318499|528062639|FG000|Overall Study|Adverse Event|16|||
146425235|NCT01318499|528062640|FG001|Overall Study|Adverse Event|11|||
146425236|NCT01318499|528062641|FG002|Overall Study|Adverse Event|6|||
146425237|NCT01318499|528062639|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
146425238|NCT01318499|528062640|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
146425239|NCT01318499|528062641|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
146425240|NCT01318499|528062639|FG000|Overall Study|Noncompliance|2|||
146425241|NCT01318499|528062640|FG001|Overall Study|Noncompliance|3|||
146425242|NCT01318499|528062641|FG002|Overall Study|Noncompliance|0|||
146425243|NCT01318499|528062639|FG000|Overall Study|Treatment Failure|19|||
146425244|NCT01318499|528062640|FG001|Overall Study|Treatment Failure|19|||
146425245|NCT01318499|528062641|FG002|Overall Study|Treatment Failure|101|||
146425246|NCT01318499|528062639|FG000|Overall Study|Protocol Violation|2|||
146425247|NCT01318499|528062640|FG001|Overall Study|Protocol Violation|4|||
146425248|NCT01318499|528062641|FG002|Overall Study|Protocol Violation|2|||
146425249|NCT01318499|528062639|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
146425250|NCT01318499|528062640|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
146425251|NCT01318499|528062641|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
146425252|NCT01318499|528062639|FG000|Overall Study|Other|7|||
145949585|NCT02131233|526326665|FG001|Overall Study|Lost to Follow-up|13|||
145949586|NCT02131233|526326664|FG000|Overall Study|Non-Compliance With Study Drug|8|||
145949587|NCT02131233|526326665|FG001|Overall Study|Non-Compliance With Study Drug|5|||
145949588|NCT02131233|526326664|FG000|Overall Study|Physician Decision|7|||
145949589|NCT02131233|526326665|FG001|Overall Study|Physician Decision|0|||
146082647|NCT01426789|526822866|FG001|Part 1|Protocol deviation|1|||
146199288|NCT02914522|527240944|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199289|NCT02914522|527240945|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146425253|NCT01318499|528062640|FG001|Overall Study|Other|10|||
146425254|NCT01318499|528062641|FG002|Overall Study|Other|22|||
146425255|NCT01974141|528062647|FG000|Overall Study|Other Reasons|28|||
146425256|NCT01974141|528062648|FG001|Overall Study|Other Reasons|18|||
146425257|NCT01974141|528062647|FG000|Overall Study|Protocol Violation|2|||
146082648|NCT01426789|526822867|FG002|Part 1|Protocol deviation|0|||
146082649|NCT01426789|526822868|FG003|Part 1|Protocol deviation|0|||
146425258|NCT01974141|528062648|FG001|Overall Study|Protocol Violation|6|||
146425259|NCT01974141|528062647|FG000|Overall Study|Personal Reasons|21|||
146425260|NCT01974141|528062648|FG001|Overall Study|Personal Reasons|20|||
146425261|NCT01974141|528062647|FG000|Overall Study|Lost to Follow-up|38|||
145949590|NCT02131233|526326664|FG000|Overall Study|Pregnancy|4|||
145949591|NCT02131233|526326665|FG001|Overall Study|Pregnancy|0|||
146425262|NCT01974141|528062648|FG001|Overall Study|Lost to Follow-up|29|||
146425263|NCT01974141|528062647|FG000|Overall Study|Pregnancy|3|||
146425264|NCT01974141|528062648|FG001|Overall Study|Pregnancy|3|||
146425265|NCT01974141|528062647|FG000|Overall Study|Lack of Efficacy|0|||
146425266|NCT01974141|528062648|FG001|Overall Study|Lack of Efficacy|1|||
146425267|NCT01974141|528062647|FG000|Overall Study|Adverse Event|4|||
146425268|NCT01974141|528062648|FG001|Overall Study|Adverse Event|5|||
146425269|NCT04028843|528062651|FG000|Overall Study|Lost to Follow-up|32|||
146425270|NCT04028843|528062652|FG001|Overall Study|Lost to Follow-up|39|||
146425271|NCT04028843|528062651|FG000|Overall Study|Adverse Event|1|||
146425272|NCT04028843|528062652|FG001|Overall Study|Adverse Event|0|||
146425273|NCT04028843|528062651|FG000|Overall Study|Non-viable Pregnancy|0|||
146425274|NCT04028843|528062652|FG001|Overall Study|Non-viable Pregnancy|1|||
146425275|NCT04028843|528062651|FG000|Overall Study|Withdrawal by Subject|4|||
146425276|NCT04028843|528062652|FG001|Overall Study|Withdrawal by Subject|2|||
146425277|NCT04977336|528062653|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
146425278|NCT04977336|528062654|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146425279|NCT04977336|528062655|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146425280|NCT04977336|528062656|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
146425281|NCT04977336|528062657|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146425282|NCT04977336|528062653|FG000|Overall Study|Lost to Follow-up|0|||
146425283|NCT04977336|528062654|FG001|Overall Study|Lost to Follow-up|0|||
146425284|NCT04977336|528062655|FG002|Overall Study|Lost to Follow-up|1|||
146425285|NCT04977336|528062656|FG003|Overall Study|Lost to Follow-up|0|||
146425286|NCT04977336|528062657|FG004|Overall Study|Lost to Follow-up|0|||
146425287|NCT03298451|528062658|FG000|Overall Study|Death|275|||
146425288|NCT03298451|528062659|FG001|Overall Study|Death|260|||
146425289|NCT03298451|528062660|FG002|Overall Study|Death|122|||
146082650|NCT01426789|526822869|FG004|Part 1|Protocol deviation|0|||
146425290|NCT03298451|528062661|FG003|Overall Study|Death|280|||
146425291|NCT03298451|528062658|FG000|Overall Study|Lost to Follow-up|1|||
146425292|NCT03298451|528062659|FG001|Overall Study|Lost to Follow-up|1|||
146425293|NCT03298451|528062660|FG002|Overall Study|Lost to Follow-up|0|||
146425294|NCT03298451|528062661|FG003|Overall Study|Lost to Follow-up|7|||
146425295|NCT03298451|528062658|FG000|Overall Study|Withdrawal by Subject|9|||
146425296|NCT03298451|528062659|FG001|Overall Study|Withdrawal by Subject|7|||
146425297|NCT03298451|528062660|FG002|Overall Study|Withdrawal by Subject|1|||
146425298|NCT03298451|528062661|FG003|Overall Study|Withdrawal by Subject|20|||
146425299|NCT01347710|528062662|FG000|Overall Study|Withdrawal by Subject|2|||
146425300|NCT01347710|528062662|FG000|Overall Study|Adverse Event|4|||
146425301|NCT01347710|528062662|FG000|Overall Study|Angio or SPECT not completed|18|||
146425302|NCT01347710|528062662|FG000|Overall Study|issue with vitals prior to dosing|1|||
146425303|NCT01347710|528062662|FG000|Overall Study|Lost to Follow-up|1|||
146425304|NCT01347710|528062662|FG000|Overall Study|Physician Decision|2|||
146425305|NCT01347710|528062662|FG000|Overall Study|Other|3|||
146425306|NCT04591626|528062664|FG000|Overall Study|Adverse Event|4|||
146425307|NCT04591626|528062665|FG001|Overall Study|Adverse Event|0|||
146425308|NCT04591626|528062664|FG000|Overall Study|Withdrawal by Subject|5|||
146425309|NCT04591626|528062665|FG001|Overall Study|Withdrawal by Subject|3|||
146425310|NCT04591626|528062664|FG000|Overall Study|Physician Decision|0|||
146425311|NCT04591626|528062665|FG001|Overall Study|Physician Decision|1|||
146425312|NCT04591626|528062664|FG000|Overall Study|Death|0|||
146425313|NCT04591626|528062665|FG001|Overall Study|Death|1|||
146425314|NCT04591626|528062664|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146425315|NCT04591626|528062665|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146425316|NCT01004172|528062669|FG000|Overall Study|Progressive Disease in CNS Only|16|||
146425317|NCT01004172|528062669|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
146425318|NCT01004172|528062669|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
146425319|NCT01004172|528062669|FG000|Overall Study|Adverse Event|1|||
146425320|NCT01004172|528062669|FG000|Overall Study|Physician Decision|1|||
146425321|NCT01004172|528062669|FG000|Overall Study|Symptomatic Deterioration|2|||
146425322|NCT00878995|528062673|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
146425323|NCT00878995|528062674|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
146425324|NCT02480764|528062677|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146425325|NCT02480764|528062678|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146425326|NCT02480764|528062679|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
146425327|NCT02480764|528062677|FG000|Overall Study|Major Protocol Deviation|1|||
146425328|NCT02480764|528062678|FG001|Overall Study|Major Protocol Deviation|4|||
146425329|NCT02480764|528062679|FG002|Overall Study|Major Protocol Deviation|3|||
146425330|NCT02480764|528062677|FG000|Overall Study|Lost to Follow-up|0|||
146425331|NCT02480764|528062678|FG001|Overall Study|Lost to Follow-up|1|||
146425332|NCT02480764|528062679|FG002|Overall Study|Lost to Follow-up|2|||
146425333|NCT02480764|528062677|FG000|Overall Study|Voluntary Withdrawal|6|||
146425334|NCT02480764|528062678|FG001|Overall Study|Voluntary Withdrawal|5|||
146425335|NCT02480764|528062679|FG002|Overall Study|Voluntary Withdrawal|10|||
146425336|NCT02480764|528062677|FG000|Overall Study|Lack of Efficacy|0|||
146425337|NCT02480764|528062678|FG001|Overall Study|Lack of Efficacy|3|||
146425338|NCT02480764|528062679|FG002|Overall Study|Lack of Efficacy|3|||
146425339|NCT02480764|528062677|FG000|Overall Study|Reason not Specified|0|||
146425340|NCT02480764|528062678|FG001|Overall Study|Reason not Specified|1|||
146425341|NCT02480764|528062679|FG002|Overall Study|Reason not Specified|0|||
146425342|NCT02457832|528062680|FG000|Training|Lost to Follow-up|10|||
146425343|NCT02457832|528062681|FG001|Training|Lost to Follow-up|6|||
146425344|NCT02457832|528062682|FG002|Training|Lost to Follow-up|3|||
146425345|NCT02457832|528062680|FG000|One Month Washout|Lost to Follow-up|0|||
146425346|NCT02457832|528062681|FG001|One Month Washout|Lost to Follow-up|1|||
146425347|NCT02457832|528062682|FG002|One Month Washout|Lost to Follow-up|1|||
146425348|NCT01868009|528062685|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
146199290|NCT02914522|527240946|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199291|NCT02914522|527240947|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199292|NCT02914522|527240948|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199293|NCT02914522|527240949|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199294|NCT02914522|527240950|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199295|NCT02914522|527240951|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199296|NCT02914522|527240952|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199297|NCT02914522|527240953|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
146199298|NCT02914522|527240954|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
146199299|NCT01161498|527240955|FG000|Overall Study|Disease Progression|0|||
146199300|NCT01161498|527240956|FG001|Overall Study|Disease Progression|1|||
146425349|NCT01868009|528062686|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
146425350|NCT01868009|528062685|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
146425351|NCT01868009|528062686|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
146425352|NCT01868009|528062685|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
146425353|NCT01868009|528062686|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
146425354|NCT01691248|528062689|FG000|Overall Study|Protocol Violation|43|||
146425355|NCT01691248|528062690|FG001|Overall Study|Protocol Violation|27|||
146425356|NCT01691248|528062689|FG000|Overall Study|Adverse Event|24|||
146425357|NCT01691248|528062690|FG001|Overall Study|Adverse Event|22|||
146425358|NCT01691248|528062689|FG000|Overall Study|Withdrawal by Subject|20|||
146425359|NCT01691248|528062690|FG001|Overall Study|Withdrawal by Subject|18|||
146425360|NCT01691248|528062689|FG000|Overall Study|Confirmed CDAD|14|||
146425361|NCT01691248|528062690|FG001|Overall Study|Confirmed CDAD|31|||
146425362|NCT01691248|528062689|FG000|Overall Study|Lost to Follow-up|2|||
146425363|NCT01691248|528062690|FG001|Overall Study|Lost to Follow-up|5|||
146425364|NCT01691248|528062689|FG000|Overall Study|Reason not provided|4|||
146425365|NCT01691248|528062690|FG001|Overall Study|Reason not provided|4|||
146425366|NCT01691248|528062689|FG000|Overall Study|Not Treated|4|||
146425367|NCT01691248|528062690|FG001|Overall Study|Not Treated|7|||
146425368|NCT02924038|528063832|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
146425369|NCT02924038|528063833|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
146425370|NCT02473640|528063836|FG000|Treatment Period 1|Adverse Event|1|||
146425371|NCT02777528|528063839|FG000|Overall Study|Still in study|24|||
146425372|NCT02777528|528063840|FG001|Overall Study|Still in study|10|||
146425373|NCT02777528|528063841|FG002|Overall Study|Still in study|1|||
146425374|NCT02777528|528063839|FG000|Overall Study|Study Device Explanted|1|||
146425375|NCT02777528|528063840|FG001|Overall Study|Study Device Explanted|0|||
146425376|NCT02777528|528063841|FG002|Overall Study|Study Device Explanted|0|||
146425377|NCT02777528|528063839|FG000|Overall Study|Death|14|||
146425378|NCT02777528|528063840|FG001|Overall Study|Death|7|||
146425379|NCT02777528|528063841|FG002|Overall Study|Death|1|||
146425380|NCT02777528|528063839|FG000|Overall Study|Withdrawal by Subject|2|||
146425381|NCT02777528|528063840|FG001|Overall Study|Withdrawal by Subject|2|||
146425382|NCT02777528|528063841|FG002|Overall Study|Withdrawal by Subject|1|||
146425383|NCT02777528|528063839|FG000|Overall Study|Physician Decision|2|||
146425384|NCT02777528|528063840|FG001|Overall Study|Physician Decision|1|||
146425385|NCT02777528|528063841|FG002|Overall Study|Physician Decision|0|||
146425386|NCT02777528|528063839|FG000|Overall Study|Lost to Follow-up|2|||
146425387|NCT02777528|528063840|FG001|Overall Study|Lost to Follow-up|0|||
146425388|NCT02777528|528063841|FG002|Overall Study|Lost to Follow-up|0|||
146425389|NCT02777528|528063839|FG000|Overall Study|Discontinued due to Other|1|||
146425390|NCT02777528|528063840|FG001|Overall Study|Discontinued due to Other|0|||
146425391|NCT02777528|528063841|FG002|Overall Study|Discontinued due to Other|0|||
146425392|NCT00453362|528063844|FG000|Overall Study|Adverse Event|5|||
146425393|NCT00453362|528063844|FG000|Overall Study|Death|7|||
146425394|NCT00453362|528063844|FG000|Overall Study|Physician Decision|2|||
146425395|NCT00453362|528063844|FG000|Overall Study|Withdrawal by Subject|3|||
146425396|NCT00453362|528063844|FG000|Overall Study|Progression of disease|56|||
146425397|NCT00453362|528063844|FG000|Overall Study|Screening Failure|14|||
146425398|NCT04885296|528063845|FG000|Period 1|Covid-19 Related|1|||
146425399|NCT04885296|528063846|FG001|Period 1|Covid-19 Related|0|||
146425400|NCT04885296|528063845|FG000|Period 1|Adverse Event|0|||
146425401|NCT04885296|528063846|FG001|Period 1|Adverse Event|1|||
146425402|NCT04885296|528063845|FG000|Period 1|Withdrawal by Subject|1|||
146425403|NCT04885296|528063846|FG001|Period 1|Withdrawal by Subject|1|||
146425404|NCT04885296|528063845|FG000|Period 1|Test Article No Longer Available|1|||
146425405|NCT04885296|528063846|FG001|Period 1|Test Article No Longer Available|0|||
146425406|NCT04885296|528063845|FG000|Period 1|Dispensed Study lens in Error|1|||
146425407|NCT04885296|528063846|FG001|Period 1|Dispensed Study lens in Error|0|||
146425408|NCT04885296|528063845|FG000|Period 1|Lost to Follow-up|1|||
146425409|NCT04885296|528063846|FG001|Period 1|Lost to Follow-up|0|||
146425410|NCT04885296|528063845|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146425411|NCT04885296|528063846|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146425412|NCT00433147|528063848|FG000|Overall Study|Adverse Event|0|||
146425413|NCT00433147|528063849|FG001|Overall Study|Adverse Event|1|||
146425414|NCT00433147|528063850|FG002|Overall Study|Adverse Event|0|||
146425415|NCT00433147|528063851|FG003|Overall Study|Adverse Event|0|||
146199301|NCT02807493|527240957|FG000|Overall Study|Adverse Event|5|||
146199302|NCT02807493|527240958|FG001|Overall Study|Adverse Event|2|||
146199303|NCT02807493|527240957|FG000|Overall Study|Lost to Follow-up|6|||
146199304|NCT02807493|527240958|FG001|Overall Study|Lost to Follow-up|0|||
146425416|NCT01882647|528063852|FG000|Overall Study|Lost to Follow-up|2|||
146425417|NCT01882647|528063853|FG001|Overall Study|Lost to Follow-up|2|||
146425418|NCT01882647|528063852|FG000|Overall Study|Withdrawal by Subject|0|||
146425419|NCT01882647|528063853|FG001|Overall Study|Withdrawal by Subject|4|||
146425420|NCT02937701|528063854|FG000|Day 1 to Week 22|Adverse Event|11|||
146425421|NCT02937701|528063855|FG001|Day 1 to Week 22|Adverse Event|14|||
146425422|NCT02937701|528063856|FG002|Day 1 to Week 22|Adverse Event|0|||
146425423|NCT02937701|528063857|FG003|Day 1 to Week 22|Adverse Event|0|||
146425424|NCT02937701|528063858|FG004|Day 1 to Week 22|Adverse Event|0|||
146425425|NCT02937701|528063854|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
146425426|NCT02937701|528063855|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
146425427|NCT02937701|528063856|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
146425428|NCT02937701|528063857|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
145949592|NCT02131233|526326664|FG000|Overall Study|Withdrawal by Subject|18|||
146199305|NCT02807493|527240957|FG000|Overall Study|Physician Decision|4|||
146199306|NCT02807493|527240958|FG001|Overall Study|Physician Decision|1|||
146425429|NCT02937701|528063858|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
146425430|NCT02937701|528063854|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
146425431|NCT02937701|528063855|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
146425432|NCT02937701|528063856|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146425433|NCT02937701|528063857|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146425434|NCT02937701|528063858|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
146425435|NCT02937701|528063854|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
146425436|NCT02937701|528063855|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
146425437|NCT02937701|528063856|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
146425438|NCT02937701|528063857|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
146425439|NCT02937701|528063858|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
146425440|NCT02937701|528063854|FG000|Day 1 to Week 22|Death|1|||
146425441|NCT02937701|528063855|FG001|Day 1 to Week 22|Death|1|||
146425442|NCT02937701|528063856|FG002|Day 1 to Week 22|Death|0|||
146425443|NCT02937701|528063857|FG003|Day 1 to Week 22|Death|0|||
146425444|NCT02937701|528063858|FG004|Day 1 to Week 22|Death|0|||
146425445|NCT02937701|528063854|FG000|Day 1 to Week 22|Protocol Violation|1|||
146425446|NCT02937701|528063855|FG001|Day 1 to Week 22|Protocol Violation|1|||
146425447|NCT02937701|528063856|FG002|Day 1 to Week 22|Protocol Violation|0|||
146425448|NCT02937701|528063857|FG003|Day 1 to Week 22|Protocol Violation|0|||
146425449|NCT02937701|528063858|FG004|Day 1 to Week 22|Protocol Violation|0|||
146425450|NCT02937701|528063854|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
146425451|NCT02937701|528063855|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
146425452|NCT02937701|528063856|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
146425453|NCT02937701|528063857|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
146425454|NCT02937701|528063858|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
146425455|NCT02937701|528063854|FG000|Day 1 to Week 22|Physician Decision|2|||
146425456|NCT02937701|528063855|FG001|Day 1 to Week 22|Physician Decision|0|||
146425457|NCT02937701|528063856|FG002|Day 1 to Week 22|Physician Decision|0|||
146425458|NCT02937701|528063857|FG003|Day 1 to Week 22|Physician Decision|0|||
146425459|NCT02937701|528063858|FG004|Day 1 to Week 22|Physician Decision|0|||
146425460|NCT02937701|528063854|FG000|Day 1 to Week 22|Other|1|||
146425461|NCT02937701|528063855|FG001|Day 1 to Week 22|Other|0|||
146425462|NCT02937701|528063856|FG002|Day 1 to Week 22|Other|0|||
146425463|NCT02937701|528063857|FG003|Day 1 to Week 22|Other|0|||
146425464|NCT02937701|528063858|FG004|Day 1 to Week 22|Other|0|||
146425465|NCT02937701|528063854|FG000|Week 22 to Week 50|Adverse Event|0|||
146425466|NCT02937701|528063855|FG001|Week 22 to Week 50|Adverse Event|0|||
146425467|NCT02937701|528063856|FG002|Week 22 to Week 50|Adverse Event|10|||
146425468|NCT02937701|528063857|FG003|Week 22 to Week 50|Adverse Event|3|||
146425469|NCT02937701|528063858|FG004|Week 22 to Week 50|Adverse Event|3|||
146425470|NCT02937701|528063854|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
146425471|NCT02937701|528063855|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
146425472|NCT02937701|528063856|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
146425473|NCT02937701|528063857|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
146425474|NCT02937701|528063858|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
146425475|NCT02937701|528063854|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
146425476|NCT02937701|528063855|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
146425477|NCT02937701|528063856|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
146425478|NCT02937701|528063857|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
146425479|NCT02937701|528063858|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
146425480|NCT02937701|528063854|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
146425481|NCT02937701|528063855|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
146425482|NCT02937701|528063856|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
146425483|NCT02937701|528063857|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
146425484|NCT02937701|528063858|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
146425485|NCT02937701|528063854|FG000|Week 22 to Week 50|Physician Decision|0|||
146425486|NCT02937701|528063855|FG001|Week 22 to Week 50|Physician Decision|0|||
146425487|NCT02937701|528063856|FG002|Week 22 to Week 50|Physician Decision|2|||
146425488|NCT02937701|528063857|FG003|Week 22 to Week 50|Physician Decision|0|||
146425489|NCT02937701|528063858|FG004|Week 22 to Week 50|Physician Decision|1|||
146425490|NCT02937701|528063854|FG000|Week 22 to Week 50|Other|0|||
146425491|NCT02937701|528063855|FG001|Week 22 to Week 50|Other|0|||
146425492|NCT02937701|528063856|FG002|Week 22 to Week 50|Other|0|||
146199307|NCT02807493|527240957|FG000|Overall Study|Protocol Violation|7|||
146199308|NCT02807493|527240958|FG001|Overall Study|Protocol Violation|0|||
146425493|NCT02937701|528063857|FG003|Week 22 to Week 50|Other|0|||
146425494|NCT02937701|528063858|FG004|Week 22 to Week 50|Other|1|||
146425495|NCT00416520|528063860|FG000|Open-label Period|Adverse Event|28|||
146425496|NCT00416520|528063861|FG001|Open-label Period|Adverse Event|10|||
146425497|NCT00416520|528063862|FG002|Open-label Period|Adverse Event|0|||
146425498|NCT00416520|528063863|FG003|Open-label Period|Adverse Event|0|||
146425499|NCT00416520|528063860|FG000|Open-label Period|Death|2|||
146199309|NCT02807493|527240957|FG000|Overall Study|Withdrawal by Subject|17|||
146425500|NCT00416520|528063861|FG001|Open-label Period|Death|1|||
146425501|NCT00416520|528063862|FG002|Open-label Period|Death|0|||
146425502|NCT00416520|528063863|FG003|Open-label Period|Death|0|||
146425503|NCT00416520|528063860|FG000|Open-label Period|Lack of Efficacy|8|||
146425504|NCT00416520|528063861|FG001|Open-label Period|Lack of Efficacy|1|||
146425505|NCT00416520|528063862|FG002|Open-label Period|Lack of Efficacy|0|||
146425506|NCT00416520|528063863|FG003|Open-label Period|Lack of Efficacy|0|||
146425507|NCT00416520|528063860|FG000|Open-label Period|Protocol Violation|3|||
146425508|NCT00416520|528063861|FG001|Open-label Period|Protocol Violation|3|||
146425509|NCT00416520|528063862|FG002|Open-label Period|Protocol Violation|0|||
146425510|NCT00416520|528063863|FG003|Open-label Period|Protocol Violation|0|||
146425511|NCT00416520|528063860|FG000|Open-label Period|Withdrawal by Subject|16|||
146425512|NCT00416520|528063861|FG001|Open-label Period|Withdrawal by Subject|5|||
146425513|NCT00416520|528063862|FG002|Open-label Period|Withdrawal by Subject|0|||
146425514|NCT00416520|528063863|FG003|Open-label Period|Withdrawal by Subject|0|||
146425515|NCT00416520|528063860|FG000|Open-label Period|Other Reasons|3|||
146425516|NCT00416520|528063861|FG001|Open-label Period|Other Reasons|12|||
146425517|NCT00416520|528063862|FG002|Open-label Period|Other Reasons|0|||
146425518|NCT00416520|528063863|FG003|Open-label Period|Other Reasons|0|||
146425519|NCT00416520|528063860|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146425520|NCT00416520|528063861|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146425521|NCT00416520|528063862|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
146425522|NCT00416520|528063863|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
146425523|NCT00416520|528063860|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146425524|NCT00416520|528063861|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146425525|NCT00416520|528063862|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
146425526|NCT00416520|528063863|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
146425527|NCT00416520|528063860|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
146425528|NCT00416520|528063861|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
146425529|NCT00416520|528063862|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
145949593|NCT02131233|526326665|FG001|Overall Study|Withdrawal by Subject|11|||
145949594|NCT00645671|526326666|FG000|Overall Study|Protocol Violation|1|||
145949595|NCT00645671|526326667|FG001|Overall Study|Protocol Violation|0|||
145949596|NCT00645671|526326666|FG000|Overall Study|Withdrawal by Subject|0|||
145949597|NCT00645671|526326667|FG001|Overall Study|Withdrawal by Subject|4|||
145949598|NCT00645671|526326666|FG000|Overall Study|Adverse Event|0|||
145949599|NCT00645671|526326667|FG001|Overall Study|Adverse Event|1|||
145949600|NCT00645671|526326666|FG000|Overall Study|Physician Decision|0|||
145949601|NCT00645671|526326667|FG001|Overall Study|Physician Decision|1|||
145949602|NCT02095197|526326668|FG000|Overall Study|Lost to Follow-up|0|||
145949603|NCT02095197|526326669|FG001|Overall Study|Lost to Follow-up|3|||
145949604|NCT04379700|526326677|FG000|Overall Study|Withdrawal by Subject|10|||
145949605|NCT04379700|526326677|FG000|Overall Study|Screen Fail|4|||
145949606|NCT04379700|526326677|FG000|Overall Study|Lost to Follow-up|3|||
145949607|NCT03624569|526326678|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145949608|NCT03624569|526326679|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
145949609|NCT03624569|526326678|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
145949610|NCT03624569|526326679|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
145949611|NCT01404949|526326704|FG000|Overall Study|Not Treated|1|||
145949612|NCT00002525|526326705|FG000|Overall Study|Adverse Event|36|||
145949613|NCT00002525|526326706|FG001|Overall Study|Adverse Event|0|||
145949614|NCT00002525|526326705|FG000|Overall Study|Death|5|||
145949615|NCT00002525|526326706|FG001|Overall Study|Death|0|||
145949616|NCT00002525|526326705|FG000|Overall Study|Withdrawal by Subject|11|||
145949617|NCT00002525|526326706|FG001|Overall Study|Withdrawal by Subject|0|||
145949618|NCT00002525|526326705|FG000|Overall Study|Start non-protocol therapy|1|||
145949619|NCT00002525|526326706|FG001|Overall Study|Start non-protocol therapy|0|||
145949620|NCT00002525|526326705|FG000|Overall Study|Other complicating disease|1|||
145949621|NCT00002525|526326706|FG001|Overall Study|Other complicating disease|0|||
145949622|NCT00002525|526326705|FG000|Overall Study|Duke's A, B1, D disease|92|||
146199310|NCT02807493|527240958|FG001|Overall Study|Withdrawal by Subject|10|||
146425530|NCT00416520|528063863|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
145949623|NCT00002525|526326706|FG001|Overall Study|Duke's A, B1, D disease|0|||
145949624|NCT00002525|526326705|FG000|Overall Study|Error|6|||
145949625|NCT00002525|526326706|FG001|Overall Study|Error|0|||
145949626|NCT00002525|526326705|FG000|Overall Study|Other|26|||
145949627|NCT00002525|526326706|FG001|Overall Study|Other|0|||
145949628|NCT00002525|526326705|FG000|Overall Study|Never start protocol therapy|8|||
146199311|NCT02807493|527240957|FG000|Overall Study|Other withdrawal|17|||
146199312|NCT02807493|527240958|FG001|Overall Study|Other withdrawal|0|||
146199313|NCT02807493|527240957|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
145949629|NCT00002525|526326706|FG001|Overall Study|Never start protocol therapy|0|||
145949630|NCT00435188|526326711|FG000|Overall Study|Death|1|||
145949631|NCT00435188|526326712|FG001|Overall Study|Death|6|||
145949632|NCT00435188|526326711|FG000|Overall Study|Withdrawal by Subject|16|||
145949633|NCT00435188|526326712|FG001|Overall Study|Withdrawal by Subject|11|||
145949634|NCT00435188|526326711|FG000|Overall Study|Lost to Follow-up|5|||
146199314|NCT02807493|527240958|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
146199315|NCT01227707|527240959|FG000|Overall Study|Adverse Event|10|||
146199316|NCT01227707|527240959|FG000|Overall Study|Progression of disease|3|||
146199317|NCT01227707|527240959|FG000|Overall Study|Withdrawal by Subject|1|||
146199318|NCT01227707|527240959|FG000|Overall Study|Patient non-compliance|3|||
146199319|NCT01227707|527240959|FG000|Overall Study|Medical decision|6|||
146199320|NCT01227707|527240959|FG000|Overall Study|Death|1|||
146199321|NCT02351180|527240962|FG000|Overall Study|Withdrawal by Subject|1|||
146199322|NCT02351180|527240963|FG001|Overall Study|Withdrawal by Subject|0|||
146199323|NCT00208767|527240964|FG000|Overall Study|Adverse Event|9|||
146199324|NCT00208767|527240965|FG001|Overall Study|Adverse Event|1|||
146199325|NCT00208767|527240964|FG000|Overall Study|Withdrawal by Subject|14|||
146199326|NCT00208767|527240965|FG001|Overall Study|Withdrawal by Subject|3|||
146199327|NCT00208767|527240964|FG000|Overall Study|Death|1|||
146199328|NCT00208767|527240965|FG001|Overall Study|Death|0|||
146199329|NCT00208767|527240964|FG000|Overall Study|Lost to Follow-up|3|||
146199330|NCT00208767|527240965|FG001|Overall Study|Lost to Follow-up|3|||
146199331|NCT00536380|527240966|FG000|Overall Study|Adverse Event|0|||
146199332|NCT00536380|527240967|FG001|Overall Study|Adverse Event|2|||
146199333|NCT00536380|527240968|FG002|Overall Study|Adverse Event|2|||
146199334|NCT00536380|527240966|FG000|Overall Study|Lost to Follow-up|0|||
146199335|NCT00536380|527240967|FG001|Overall Study|Lost to Follow-up|0|||
146199336|NCT00536380|527240968|FG002|Overall Study|Lost to Follow-up|1|||
146199337|NCT00536380|527240966|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
146199338|NCT00536380|527240967|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
146199339|NCT00536380|527240968|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
146199340|NCT00536380|527240966|FG000|Overall Study|Withdrawal related to study drug|7|||
146199341|NCT00536380|527240967|FG001|Overall Study|Withdrawal related to study drug|5|||
146199342|NCT00536380|527240968|FG002|Overall Study|Withdrawal related to study drug|2|||
146199343|NCT00536380|527240966|FG000|Overall Study|Noncompliance with protocol|3|||
146199344|NCT00536380|527240967|FG001|Overall Study|Noncompliance with protocol|2|||
146199345|NCT00536380|527240968|FG002|Overall Study|Noncompliance with protocol|2|||
146199346|NCT00536380|527240966|FG000|Overall Study|Did not meet protocol eligibility|0|||
146199347|NCT00536380|527240967|FG001|Overall Study|Did not meet protocol eligibility|0|||
146199348|NCT00536380|527240968|FG002|Overall Study|Did not meet protocol eligibility|1|||
146199349|NCT00536380|527240966|FG000|Overall Study|Administrative|0|||
146199350|NCT00536380|527240967|FG001|Overall Study|Administrative|0|||
146199351|NCT00536380|527240968|FG002|Overall Study|Administrative|1|||
146199352|NCT03418324|527240969|FG000|Overall Study|Death|0|||
146199353|NCT03418324|527240970|FG001|Overall Study|Death|1|||
146199354|NCT03418324|527240969|FG000|Overall Study|Physician Decision|1|||
146199355|NCT03418324|527240970|FG001|Overall Study|Physician Decision|1|||
146199356|NCT00290706|527240974|FG000|Overall Study|Withdrawal by Subject|2|||
146199357|NCT00290706|527240975|FG001|Overall Study|Withdrawal by Subject|0|||
146199358|NCT00290706|527240976|FG002|Overall Study|Withdrawal by Subject|0|||
146199359|NCT00290706|527240977|FG003|Overall Study|Withdrawal by Subject|0|||
146199360|NCT00290706|527240974|FG000|Overall Study|Progressive Disease|3|||
146199361|NCT00290706|527240975|FG001|Overall Study|Progressive Disease|5|||
146199362|NCT00290706|527240976|FG002|Overall Study|Progressive Disease|4|||
146199363|NCT00290706|527240977|FG003|Overall Study|Progressive Disease|10|||
146199364|NCT00290706|527240974|FG000|Overall Study|Adverse Event|0|||
146199365|NCT00290706|527240975|FG001|Overall Study|Adverse Event|1|||
146199366|NCT00290706|527240976|FG002|Overall Study|Adverse Event|2|||
146199367|NCT00290706|527240977|FG003|Overall Study|Adverse Event|0|||
146425531|NCT03601637|528063864|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
146425532|NCT03601637|528063865|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
146199368|NCT00290706|527240974|FG000|Overall Study|Receive auto transplant or radiation|0|||
146199369|NCT00290706|527240975|FG001|Overall Study|Receive auto transplant or radiation|0|||
146199370|NCT00290706|527240976|FG002|Overall Study|Receive auto transplant or radiation|0|||
146199371|NCT00290706|527240977|FG003|Overall Study|Receive auto transplant or radiation|1|||
146199372|NCT00290706|527240974|FG000|Overall Study|Physician Decision|0|||
146199373|NCT00290706|527240975|FG001|Overall Study|Physician Decision|0|||
146199374|NCT00290706|527240976|FG002|Overall Study|Physician Decision|0|||
146199375|NCT00290706|527240977|FG003|Overall Study|Physician Decision|1|||
146199376|NCT01049503|527243134|FG000|Overall Study|Lost to Follow-up|11|||
146199377|NCT01049503|527243135|FG001|Overall Study|Lost to Follow-up|12|||
146199378|NCT01049503|527243136|FG002|Overall Study|Lost to Follow-up|24|||
146199379|NCT01049503|527243137|FG003|Overall Study|Lost to Follow-up|26|||
146199380|NCT01049503|527243138|FG004|Overall Study|Lost to Follow-up|27|||
146199381|NCT01049503|527243139|FG005|Overall Study|Lost to Follow-up|8|||
146199382|NCT02974634|527243140|FG000|Overall Study|Advanced disease|12|||
146199383|NCT02974634|527243141|FG001|Overall Study|Advanced disease|3|||
146199384|NCT02974634|527243140|FG000|Overall Study|Noncompliance|3|||
146199385|NCT02974634|527243141|FG001|Overall Study|Noncompliance|7|||
146199386|NCT02974634|527243140|FG000|Overall Study|intervention technology related issues|5|||
146199387|NCT02974634|527243141|FG001|Overall Study|intervention technology related issues|0|||
146199388|NCT02974634|527243140|FG000|Overall Study|Death|8|||
146199389|NCT02974634|527243141|FG001|Overall Study|Death|11|||
146199390|NCT02496702|527243144|FG000|Overall Study|Lost to Follow-up|8|||
146425533|NCT03601637|528063864|FG000|Overall Study|Adverse Event|1|||
146425534|NCT03601637|528063865|FG001|Overall Study|Adverse Event|1|||
146425535|NCT03601637|528063864|FG000|Overall Study|Other|0|||
146425536|NCT03601637|528063865|FG001|Overall Study|Other|1|||
146425537|NCT01108094|528063870|FG000|Overall Study|Adverse Event|2|||
146425538|NCT01108094|528063871|FG001|Overall Study|Adverse Event|0|||
146425539|NCT01108094|528063872|FG002|Overall Study|Adverse Event|0|||
146425540|NCT01108094|528063873|FG003|Overall Study|Adverse Event|0|||
146425541|NCT01108094|528063870|FG000|Overall Study|Withdrawal by Subject|1|||
146425542|NCT01108094|528063871|FG001|Overall Study|Withdrawal by Subject|0|||
146425543|NCT01108094|528063872|FG002|Overall Study|Withdrawal by Subject|0|||
146425544|NCT01108094|528063873|FG003|Overall Study|Withdrawal by Subject|0|||
146425545|NCT05818137|528063883|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
146425546|NCT05818137|528063883|FG000|Extension Treatment Period|Ongoing participants|44|||
146425547|NCT05346055|528063886|FG000|Overall Study|Withdrawal by Subject|1|||
146425548|NCT05346055|528063886|FG000|Overall Study|Protocol Violation|1|||
146425549|NCT05346055|528063886|FG000|Overall Study|Therapist decision|1|||
146425550|NCT00728949|528063887|FG000|Overall Study|Adverse Event|8|||
146425551|NCT00728949|528063888|FG001|Overall Study|Adverse Event|0|||
146425552|NCT00728949|528063887|FG000|Overall Study|Withdrawal by Subject|2|||
146425553|NCT00728949|528063888|FG001|Overall Study|Withdrawal by Subject|2|||
146425554|NCT00728949|528063887|FG000|Overall Study|Abnormal Lab Results|0|||
146425555|NCT00728949|528063888|FG001|Overall Study|Abnormal Lab Results|2|||
146425556|NCT00728949|528063887|FG000|Overall Study|On treatment at cutoff date|1|||
146425557|NCT00728949|528063888|FG001|Overall Study|On treatment at cutoff date|0|||
146425558|NCT01996033|528063889|FG000|Overall Study|Death|1|||
146425559|NCT01996033|528063889|FG000|Overall Study|Physician Decision|1|||
146425560|NCT01996033|528063889|FG000|Overall Study|Withdrawal by Subject|4|||
146425561|NCT01996033|528063889|FG000|Overall Study|Lost to Follow-up|3|||
146425562|NCT01087970|528063894|FG000|Overall Study|Protocol Violation|2|||
146425563|NCT02143102|528063897|FG000|Overall Study|Lost to Follow-up|11|||
146425564|NCT02143102|528063898|FG001|Overall Study|Lost to Follow-up|0|||
146425565|NCT02636907|528063901|FG000|Autoinjector Assessment Period|Adverse Event|2|||
146425566|NCT02636907|528063901|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
146425567|NCT02636907|528063901|FG000|Extension Phase|Adverse Event|2|||
146425568|NCT02636907|528063901|FG000|Extension Phase|Withdrawal by Subject|4|||
146425569|NCT02636907|528063901|FG000|Extension Phase|Physician Decision|1|||
146425570|NCT02636907|528063901|FG000|Extension Phase|Lost to Follow-up|2|||
146425571|NCT02636907|528063901|FG000|Extension Phase|Lack of Efficacy|1|||
146425572|NCT04099888|528063902|FG000|Overall Study|Study terminated by sponsor|9|||
146425573|NCT04099888|528063903|FG001|Overall Study|Study terminated by sponsor|11|||
146425574|NCT04099888|528063902|FG000|Overall Study|Lost to Follow-up|1|||
146425575|NCT04099888|528063903|FG001|Overall Study|Lost to Follow-up|1|||
146425576|NCT04099888|528063902|FG000|Overall Study|Withdrawal by Subject|5|||
146425577|NCT04099888|528063903|FG001|Overall Study|Withdrawal by Subject|6|||
146425578|NCT04099888|528063902|FG000|Overall Study|Death|5|||
146425579|NCT04099888|528063903|FG001|Overall Study|Death|2|||
146425580|NCT04099888|528063902|FG000|Overall Study|Other|1|||
146425581|NCT04099888|528063903|FG001|Overall Study|Other|0|||
146425582|NCT03952143|528063906|FG000|Lead-In Period|Adverse Event|2|||
146425583|NCT03952143|528063907|FG001|Lead-In Period|Adverse Event|0|||
146425584|NCT03952143|528063908|FG002|Lead-In Period|Adverse Event|0|||
146425585|NCT03952143|528063906|FG000|Lead-In Period|Lack of Efficacy|2|||
146425586|NCT03952143|528063907|FG001|Lead-In Period|Lack of Efficacy|0|||
146425587|NCT03952143|528063908|FG002|Lead-In Period|Lack of Efficacy|0|||
146082651|NCT01426789|526822870|FG005|Part 1|Protocol deviation|0|||
146199391|NCT02496702|527243145|FG001|Overall Study|Lost to Follow-up|6|||
146199392|NCT02496702|527243144|FG000|Overall Study|Only partially tested|0|||
146199393|NCT02496702|527243145|FG001|Overall Study|Only partially tested|2|||
146199394|NCT01499134|527243146|FG000|Overall Study|Withdrawal by Subject|0|||
146199395|NCT01499134|527243147|FG001|Overall Study|Withdrawal by Subject|1|||
146199396|NCT01400776|527243148|FG000|Overall Study|Adverse Event|7|||
146425588|NCT03952143|528063906|FG000|Lead-In Period|Physician Decision|5|||
146425589|NCT03952143|528063907|FG001|Lead-In Period|Physician Decision|0|||
146425590|NCT03952143|528063908|FG002|Lead-In Period|Physician Decision|0|||
146425591|NCT03952143|528063906|FG000|Lead-In Period|Protocol Violation|5|||
146425592|NCT03952143|528063907|FG001|Lead-In Period|Protocol Violation|0|||
146199397|NCT01400776|527243149|FG001|Overall Study|Adverse Event|2|||
146425593|NCT03952143|528063908|FG002|Lead-In Period|Protocol Violation|0|||
146425594|NCT03952143|528063906|FG000|Lead-In Period|Withdrawal by Subject|19|||
146425595|NCT03952143|528063907|FG001|Lead-In Period|Withdrawal by Subject|0|||
146425596|NCT03952143|528063908|FG002|Lead-In Period|Withdrawal by Subject|0|||
146425597|NCT03952143|528063906|FG000|Treatment Period|Adverse Event|0|||
146425598|NCT03952143|528063907|FG001|Treatment Period|Adverse Event|0|||
146425599|NCT03952143|528063908|FG002|Treatment Period|Adverse Event|1|||
146425600|NCT03952143|528063906|FG000|Treatment Period|Lost to Follow-up|0|||
146425601|NCT03952143|528063907|FG001|Treatment Period|Lost to Follow-up|2|||
146425602|NCT03952143|528063908|FG002|Treatment Period|Lost to Follow-up|0|||
146425603|NCT03952143|528063906|FG000|Treatment Period|Physician Decision|0|||
146425604|NCT03952143|528063907|FG001|Treatment Period|Physician Decision|0|||
146425605|NCT03952143|528063908|FG002|Treatment Period|Physician Decision|2|||
146425606|NCT03952143|528063906|FG000|Treatment Period|Protocol Violation|0|||
146425607|NCT03952143|528063907|FG001|Treatment Period|Protocol Violation|0|||
146425608|NCT03952143|528063908|FG002|Treatment Period|Protocol Violation|1|||
146425609|NCT03952143|528063906|FG000|Treatment Period|Withdrawal by Subject|0|||
146425610|NCT03952143|528063907|FG001|Treatment Period|Withdrawal by Subject|5|||
146425611|NCT03952143|528063908|FG002|Treatment Period|Withdrawal by Subject|26|||
146425612|NCT03952143|528063906|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
146425613|NCT03952143|528063907|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
146425614|NCT03952143|528063908|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
146425615|NCT03952143|528063906|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
146425616|NCT03952143|528063907|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
146425617|NCT03952143|528063908|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
146425618|NCT01225146|528063911|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
146425619|NCT01225146|528063912|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
146425620|NCT03661528|528063915|FG000|Overall Study|Death|1|||
146425621|NCT03661528|528063916|FG001|Overall Study|Death|0|||
146425622|NCT03661528|528063915|FG000|Overall Study|Physician Decision|3|||
146425623|NCT03661528|528063916|FG001|Overall Study|Physician Decision|1|||
146425624|NCT03661528|528063915|FG000|Overall Study|Other than Specified|5|||
146425625|NCT03661528|528063916|FG001|Overall Study|Other than Specified|2|||
146425626|NCT03661528|528063915|FG000|Overall Study|Withdrawal by Subject|5|||
146425627|NCT03661528|528063916|FG001|Overall Study|Withdrawal by Subject|3|||
146425628|NCT03661528|528063915|FG000|Overall Study|Disease Progression|8|||
146425629|NCT03661528|528063916|FG001|Overall Study|Disease Progression|13|||
146425630|NCT03661528|528063915|FG000|Overall Study|Adverse Event|61|||
146425631|NCT03661528|528063916|FG001|Overall Study|Adverse Event|55|||
146425632|NCT02732210|528063917|FG000|Overall Study|Site Closed|0|||
146425633|NCT02732210|528063918|FG001|Overall Study|Site Closed|11|||
146425634|NCT02732210|528063917|FG000|Overall Study|Study Ended|13|||
146425635|NCT02732210|528063918|FG001|Overall Study|Study Ended|13|||
146425636|NCT02732210|528063917|FG000|Overall Study|Withdrawal by Subject|28|||
146425637|NCT02732210|528063918|FG001|Overall Study|Withdrawal by Subject|87|||
146425638|NCT02732210|528063917|FG000|Overall Study|Lost to Follow-up|5|||
146425639|NCT02732210|528063918|FG001|Overall Study|Lost to Follow-up|57|||
146425640|NCT02732210|528063917|FG000|Overall Study|Death|4|||
146425641|NCT02732210|528063918|FG001|Overall Study|Death|15|||
146425642|NCT02732210|528063917|FG000|Overall Study|Other|35|||
146425643|NCT02732210|528063918|FG001|Overall Study|Other|103|||
146425644|NCT02732210|528063917|FG000|Overall Study|Missing|0|||
146425645|NCT02732210|528063918|FG001|Overall Study|Missing|8|||
146425646|NCT01876706|528063921|FG000|Overall Study|BPH Intervention|9|||
146425647|NCT01876706|528063921|FG000|Overall Study|Lost to Follow-up|7|||
146425648|NCT01876706|528063921|FG000|Overall Study|Withdrawals|6|||
146425649|NCT01876706|528063921|FG000|Overall Study|Death|3|||
146425650|NCT00604500|528063922|FG000|Overall Study|Adverse Event|2|||
146425651|NCT00604500|528063922|FG000|Overall Study|Protocol Violation|2|||
146425652|NCT00604500|528063922|FG000|Overall Study|Treatment Failure|1|||
146425653|NCT00604500|528063922|FG000|Overall Study|Withdrawal by Subject|4|||
146425654|NCT00604500|528063922|FG000|Overall Study|Administrative|1|||
146425655|NCT00604500|528063922|FG000|Overall Study|Did not meet protocol eligibility|1|||
145949635|NCT00435188|526326712|FG001|Overall Study|Lost to Follow-up|6|||
145949636|NCT00575510|526326713|FG000|Overall Study|Lost to Follow-up|4|||
145949637|NCT00575510|526326714|FG001|Overall Study|Lost to Follow-up|6|||
146199398|NCT01400776|527243150|FG002|Overall Study|Adverse Event|9|||
146199399|NCT01400776|527243151|FG003|Overall Study|Adverse Event|2|||
146199400|NCT01400776|527243148|FG000|Overall Study|Lost to Follow-up|1|||
145949638|NCT00575510|526326715|FG002|Overall Study|Lost to Follow-up|9|||
145949639|NCT00575510|526326713|FG000|Overall Study|Withdrawal by Subject|1|||
145949640|NCT00575510|526326714|FG001|Overall Study|Withdrawal by Subject|0|||
146425656|NCT02191891|528063924|FG000|Overall Study|Withdrawal by Subject|0|||
146425657|NCT02191891|528063925|FG001|Overall Study|Withdrawal by Subject|1|||
146425658|NCT02191891|528063926|FG002|Overall Study|Withdrawal by Subject|0|||
146425659|NCT02191891|528063927|FG003|Overall Study|Withdrawal by Subject|0|||
146425660|NCT02191891|528063928|FG004|Overall Study|Withdrawal by Subject|1|||
146425661|NCT02191891|528063924|FG000|Overall Study|Adverse Event|0|||
146425662|NCT02191891|528063925|FG001|Overall Study|Adverse Event|1|||
145949641|NCT00575510|526326715|FG002|Overall Study|Withdrawal by Subject|0|||
146199401|NCT01400776|527243149|FG001|Overall Study|Lost to Follow-up|0|||
146425663|NCT02191891|528063926|FG002|Overall Study|Adverse Event|0|||
146425664|NCT02191891|528063927|FG003|Overall Study|Adverse Event|0|||
146425665|NCT02191891|528063928|FG004|Overall Study|Adverse Event|2|||
146425666|NCT02191891|528063924|FG000|Overall Study|Disease Progression|4|||
146425667|NCT02191891|528063925|FG001|Overall Study|Disease Progression|10|||
146425668|NCT02191891|528063926|FG002|Overall Study|Disease Progression|4|||
146425669|NCT02191891|528063927|FG003|Overall Study|Disease Progression|2|||
146425670|NCT02191891|528063928|FG004|Overall Study|Disease Progression|7|||
146425671|NCT03883906|528063933|FG000|Overall Study|Withdrawal by Subject|2|||
146425672|NCT03883906|528063933|FG000|Overall Study|Physician Decision|5|||
146425673|NCT00874237|528063934|FG000|Overall Study|Physician Decision|0|||
146425674|NCT00874237|528063935|FG001|Overall Study|Physician Decision|1|||
146425675|NCT00874237|528063936|FG002|Overall Study|Physician Decision|0|||
146425676|NCT00874237|528063937|FG003|Overall Study|Physician Decision|0|||
146425677|NCT00874237|528063938|FG004|Overall Study|Physician Decision|0|||
146425678|NCT00874237|528063939|FG005|Overall Study|Physician Decision|0|||
146425679|NCT00874237|528063934|FG000|Overall Study|Withdrawal by Subject|0|||
146425680|NCT00874237|528063935|FG001|Overall Study|Withdrawal by Subject|0|||
146425681|NCT00874237|528063936|FG002|Overall Study|Withdrawal by Subject|1|||
146425682|NCT00874237|528063937|FG003|Overall Study|Withdrawal by Subject|0|||
146425683|NCT00874237|528063938|FG004|Overall Study|Withdrawal by Subject|0|||
146425684|NCT00874237|528063939|FG005|Overall Study|Withdrawal by Subject|0|||
146425685|NCT02458469|528063943|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146425686|NCT02458469|528063944|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146425687|NCT02458469|528063945|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146425688|NCT02458469|528063946|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146425689|NCT02458469|528063947|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146199402|NCT01400776|527243150|FG002|Overall Study|Lost to Follow-up|4|||
146199403|NCT01400776|527243151|FG003|Overall Study|Lost to Follow-up|1|||
146199404|NCT01400776|527243148|FG000|Overall Study|Withdrew Consent|4|||
146199405|NCT01400776|527243149|FG001|Overall Study|Withdrew Consent|2|||
146199406|NCT01400776|527243150|FG002|Overall Study|Withdrew Consent|6|||
146199407|NCT01400776|527243151|FG003|Overall Study|Withdrew Consent|1|||
146425690|NCT02458469|528063948|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146425691|NCT02458469|528063943|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
146425692|NCT02458469|528063944|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
146425693|NCT02458469|528063945|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
146425694|NCT02458469|528063946|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
146425695|NCT02458469|528063947|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
146425696|NCT02458469|528063948|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
146425697|NCT02458469|528063943|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146425698|NCT02458469|528063944|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146425699|NCT02458469|528063945|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146425700|NCT02458469|528063946|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146425701|NCT02458469|528063947|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146425702|NCT02458469|528063948|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
146425703|NCT03561883|528063951|FG000|Overall Study|Adverse Event|10|||
146425704|NCT03561883|528063952|FG001|Overall Study|Adverse Event|13|||
146425705|NCT03561883|528063951|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146425706|NCT03561883|528063952|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146425707|NCT03561883|528063951|FG000|Overall Study|Protocol Violation|2|||
146425708|NCT03561883|528063952|FG001|Overall Study|Protocol Violation|3|||
146425709|NCT03561883|528063951|FG000|Overall Study|Withdrawal by Subject|14|||
146425710|NCT03561883|528063952|FG001|Overall Study|Withdrawal by Subject|6|||
146425711|NCT03561883|528063951|FG000|Overall Study|Lost to Follow-up|2|||
146425712|NCT03561883|528063952|FG001|Overall Study|Lost to Follow-up|6|||
146425713|NCT03561883|528063951|FG000|Overall Study|Study Terminated by Sponsor|12|||
146199408|NCT01400776|527243148|FG000|Overall Study|Protocol Deviation|6|||
146199409|NCT01400776|527243149|FG001|Overall Study|Protocol Deviation|1|||
146199410|NCT01400776|527243150|FG002|Overall Study|Protocol Deviation|5|||
146425714|NCT03561883|528063952|FG001|Overall Study|Study Terminated by Sponsor|11|||
146425715|NCT03561883|528063951|FG000|Overall Study|Physician Decision|1|||
146425716|NCT03561883|528063952|FG001|Overall Study|Physician Decision|0|||
146425717|NCT03561883|528063951|FG000|Overall Study|Randomized by Mistake|1|||
146425718|NCT03561883|528063952|FG001|Overall Study|Randomized by Mistake|0|||
146199411|NCT01400776|527243151|FG003|Overall Study|Protocol Deviation|2|||
146199412|NCT01400776|527243148|FG000|Overall Study|Reason not Specified|3|||
146425719|NCT03561883|528063951|FG000|Overall Study|Other, Not Specified|3|||
146425720|NCT03561883|528063952|FG001|Overall Study|Other, Not Specified|2|||
146425721|NCT01471522|528063967|FG000|Overall Study|Withdrawal by Subject|28|||
146425722|NCT01471522|528063968|FG001|Overall Study|Withdrawal by Subject|22|||
146199413|NCT01400776|527243149|FG001|Overall Study|Reason not Specified|0|||
146425723|NCT01471522|528063967|FG000|Overall Study|Lost to Follow-up|36|||
146199414|NCT01400776|527243150|FG002|Overall Study|Reason not Specified|4|||
146199415|NCT01400776|527243151|FG003|Overall Study|Reason not Specified|3|||
146425724|NCT01471522|528063968|FG001|Overall Study|Lost to Follow-up|26|||
146425725|NCT02863575|528063969|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
146425726|NCT02863575|528063970|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
146425727|NCT02863575|528063971|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
146425728|NCT02863575|528063969|FG000|Overall Study|Withdrawal by Subject|0|||
146425729|NCT02863575|528063970|FG001|Overall Study|Withdrawal by Subject|1|||
146425730|NCT02863575|528063971|FG002|Overall Study|Withdrawal by Subject|1|||
146425731|NCT02863575|528063969|FG000|Overall Study|Adverse Event|0|||
146425732|NCT02863575|528063970|FG001|Overall Study|Adverse Event|1|||
146425733|NCT02863575|528063971|FG002|Overall Study|Adverse Event|0|||
146425734|NCT05628675|528065687|FG000|Overall Study|Lost to Follow-up|2|||
146425735|NCT05628675|528065687|FG000|Overall Study|Withdrawal by Subject|1|||
146425736|NCT02918877|528065690|FG000|Overall Study|Withdrawal by Subject|2|||
146425737|NCT02918877|528065691|FG001|Overall Study|Withdrawal by Subject|2|||
146425738|NCT02918877|528065690|FG000|Overall Study|Surgery cancelled|1|||
146425739|NCT02918877|528065691|FG001|Overall Study|Surgery cancelled|0|||
146425740|NCT02918877|528065690|FG000|Overall Study|Physician Decision|1|||
146425741|NCT02918877|528065691|FG001|Overall Study|Physician Decision|0|||
146425742|NCT02918877|528065690|FG000|Overall Study|Received intraoperative steroids|1|||
146425743|NCT02918877|528065691|FG001|Overall Study|Received intraoperative steroids|0|||
146425744|NCT02918877|528065690|FG000|Overall Study|Unable to obtain lab samples|1|||
146425745|NCT02918877|528065691|FG001|Overall Study|Unable to obtain lab samples|0|||
146425746|NCT02918877|528065690|FG000|Overall Study|Unsafe to perform BAL|0|||
146425747|NCT02918877|528065691|FG001|Overall Study|Unsafe to perform BAL|1|||
146425748|NCT01367275|528065692|FG000|Overall Study|Ineligible|1|||
146425749|NCT01367275|528065692|FG000|Overall Study|Disease Progression|2|||
146425750|NCT01648166|528065693|FG000|Overall Study|inadequate toenail samples|53|||
146425751|NCT01648166|528065694|FG001|Overall Study|inadequate toenail samples|100|||
146425752|NCT00883090|528065695|FG000|Overall Study|Sponsor's decision|1|||
146425753|NCT00883090|528065695|FG000|Overall Study|Withdrawal by Subject|1|||
146425754|NCT02532764|528065696|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425755|NCT02532764|528065697|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425756|NCT02532764|528065698|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425757|NCT02532764|528065699|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425758|NCT02532764|528065700|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425759|NCT02532764|528065701|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425760|NCT02532764|528065702|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
146425761|NCT02532764|528065703|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146425762|NCT02532764|528065704|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146425763|NCT02532764|528065705|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
146425764|NCT01717976|528065706|FG000|Overall Study|Protocol Violation|0|||
146425765|NCT01717976|528065707|FG001|Overall Study|Protocol Violation|1|||
146425766|NCT00262223|528065710|FG000|Treatment Phase|Withdrawal by Subject|3|||
146425767|NCT00262223|528065711|FG001|Treatment Phase|Withdrawal by Subject|6|||
146425768|NCT00262223|528065710|FG000|Treatment Phase|Adverse Event|1|||
146425769|NCT00262223|528065711|FG001|Treatment Phase|Adverse Event|2|||
146425770|NCT00262223|528065710|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
146425771|NCT00262223|528065711|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
146425772|NCT00262223|528065710|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
146425773|NCT00262223|528065711|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
146425774|NCT00262223|528065710|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
146425775|NCT00262223|528065711|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
146425776|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
146425777|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
146425778|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
146199416|NCT01376089|527243153|FG000|Overall Study|Patient received no contrast media|3|||
146199417|NCT01376089|527243154|FG001|Overall Study|Patient received no contrast media|4|||
146199418|NCT01811706|527243157|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
146199419|NCT01811706|527243158|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
146199420|NCT02057692|527243163|FG000|Overall Study|Adverse Event|1|||
146199421|NCT02057692|527243164|FG001|Overall Study|Adverse Event|0|||
146199422|NCT02057692|527243165|FG002|Overall Study|Adverse Event|0|||
146199423|NCT02057692|527243166|FG003|Overall Study|Adverse Event|0|||
146425779|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
146425780|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
146425781|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
146425782|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
146082652|NCT01426789|526822865|FG000|Part 1|Lost to Follow-up|1|||
146199424|NCT02057692|527243163|FG000|Overall Study|Lost to Follow-up|0|||
146425783|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
146199425|NCT02057692|527243164|FG001|Overall Study|Lost to Follow-up|0|||
146425784|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
146425785|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
146425786|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
146425787|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
146425788|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
146425789|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
146425790|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
146425791|NCT00437658|528065712|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
146425792|NCT00437658|528065713|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
146425793|NCT00437658|528065714|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
146425794|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
146425795|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
146425796|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
146425797|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
146425798|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
146425799|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
146425800|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
146425801|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
146425802|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
146425803|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
146425804|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
146425805|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
146425806|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
146425807|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
146425808|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
146425809|NCT00437658|528065712|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
146425810|NCT00437658|528065713|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
146425811|NCT00437658|528065714|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
146425812|NCT01866319|528065715|FG000|Overall Study|Adverse Event|12|||
146425813|NCT01866319|528065716|FG001|Overall Study|Adverse Event|5|||
146425814|NCT01866319|528065717|FG002|Overall Study|Adverse Event|9|||
146425815|NCT01866319|528065715|FG000|Overall Study|Clinical progression|3|||
146425816|NCT01866319|528065716|FG001|Overall Study|Clinical progression|2|||
146425817|NCT01866319|528065717|FG002|Overall Study|Clinical progression|2|||
146425818|NCT01866319|528065715|FG000|Overall Study|Death|153|||
146425819|NCT01866319|528065716|FG001|Overall Study|Death|154|||
146425820|NCT01866319|528065717|FG002|Overall Study|Death|147|||
146425821|NCT01866319|528065715|FG000|Overall Study|Lost to Follow-up|6|||
146425822|NCT01866319|528065716|FG001|Overall Study|Lost to Follow-up|3|||
146425823|NCT01866319|528065717|FG002|Overall Study|Lost to Follow-up|8|||
146199426|NCT02057692|527243165|FG002|Overall Study|Lost to Follow-up|0|||
146199427|NCT02057692|527243166|FG003|Overall Study|Lost to Follow-up|1|||
146199428|NCT03923491|527243167|FG000|Overall Study|Lost to Follow-up|5|||
146199429|NCT03923491|527243168|FG001|Overall Study|Lost to Follow-up|8|||
146199430|NCT03923491|527243167|FG000|Overall Study|Withdrawal by Subject|4|||
146199431|NCT03923491|527243168|FG001|Overall Study|Withdrawal by Subject|6|||
146199432|NCT01648140|527243175|FG000|Overall Study|Physician Decision|1|||
146199433|NCT01648140|527243176|FG001|Overall Study|Physician Decision|0|||
146199434|NCT01648140|527243177|FG002|Overall Study|Physician Decision|0|||
146199435|NCT01648140|527243178|FG003|Overall Study|Physician Decision|0|||
146082653|NCT01426789|526822866|FG001|Part 1|Lost to Follow-up|2|||
146199436|NCT01648140|527243175|FG000|Overall Study|Lack of Efficacy|4|||
146199437|NCT01648140|527243176|FG001|Overall Study|Lack of Efficacy|7|||
146199438|NCT01648140|527243177|FG002|Overall Study|Lack of Efficacy|1|||
146199439|NCT01648140|527243178|FG003|Overall Study|Lack of Efficacy|0|||
146199440|NCT01648140|527243175|FG000|Overall Study|Adverse Event|3|||
146199441|NCT01648140|527243176|FG001|Overall Study|Adverse Event|1|||
146199442|NCT01648140|527243177|FG002|Overall Study|Adverse Event|2|||
146199443|NCT01648140|527243178|FG003|Overall Study|Adverse Event|0|||
146199444|NCT01648140|527243175|FG000|Overall Study|Withdrawal by Subject|2|||
146199445|NCT01648140|527243176|FG001|Overall Study|Withdrawal by Subject|3|||
146199446|NCT01648140|527243177|FG002|Overall Study|Withdrawal by Subject|3|||
146199447|NCT01648140|527243178|FG003|Overall Study|Withdrawal by Subject|2|||
146199448|NCT01648140|527243175|FG000|Overall Study|Lost to Follow-up|2|||
146425824|NCT01866319|528065715|FG000|Overall Study|Physician Decision|1|||
146425825|NCT01866319|528065716|FG001|Overall Study|Physician Decision|0|||
146425826|NCT01866319|528065717|FG002|Overall Study|Physician Decision|1|||
146425827|NCT01866319|528065715|FG000|Overall Study|Protocol Violation|0|||
146082654|NCT01426789|526822867|FG002|Part 1|Lost to Follow-up|0|||
146199449|NCT01648140|527243176|FG001|Overall Study|Lost to Follow-up|1|||
146199450|NCT01648140|527243177|FG002|Overall Study|Lost to Follow-up|2|||
146425828|NCT01866319|528065716|FG001|Overall Study|Protocol Violation|0|||
146199451|NCT01648140|527243178|FG003|Overall Study|Lost to Follow-up|0|||
146199452|NCT00530842|527243185|FG000|Overall Study|Adverse Event|10|||
146425829|NCT01866319|528065717|FG002|Overall Study|Protocol Violation|1|||
146425830|NCT01866319|528065715|FG000|Overall Study|Withdrawal by Subject|32|||
146425831|NCT01866319|528065716|FG001|Overall Study|Withdrawal by Subject|14|||
146425832|NCT01866319|528065717|FG002|Overall Study|Withdrawal by Subject|12|||
146425833|NCT00623779|528065719|FG000|Overall Study|Adverse Event|1|||
146425834|NCT00623779|528065720|FG001|Overall Study|Adverse Event|3|||
146425835|NCT00623779|528065721|FG002|Overall Study|Adverse Event|0|||
146425836|NCT00623779|528065719|FG000|Overall Study|Criteria from CSR|2|||
146425837|NCT00623779|528065720|FG001|Overall Study|Criteria from CSR|0|||
146425838|NCT00623779|528065721|FG002|Overall Study|Criteria from CSR|1|||
146425839|NCT01856309|528065722|FG000|Overall Study|Death|4|||
146425840|NCT01856309|528065723|FG001|Overall Study|Death|6|||
146425841|NCT01856309|528065724|FG002|Overall Study|Death|11|||
146425842|NCT01856309|528065725|FG003|Overall Study|Death|6|||
146425843|NCT01856309|528065722|FG000|Overall Study|Lost to Follow-up|6|||
146425844|NCT01856309|528065723|FG001|Overall Study|Lost to Follow-up|2|||
146425845|NCT01856309|528065724|FG002|Overall Study|Lost to Follow-up|4|||
146425846|NCT01856309|528065725|FG003|Overall Study|Lost to Follow-up|8|||
146425847|NCT01856309|528065722|FG000|Overall Study|Withdrawal by Subject|11|||
146425848|NCT01856309|528065723|FG001|Overall Study|Withdrawal by Subject|13|||
146425849|NCT01856309|528065724|FG002|Overall Study|Withdrawal by Subject|28|||
146425850|NCT01856309|528065725|FG003|Overall Study|Withdrawal by Subject|26|||
146425851|NCT01856309|528065722|FG000|Overall Study|Other|227|||
146425852|NCT01856309|528065723|FG001|Overall Study|Other|225|||
146425853|NCT01856309|528065724|FG002|Overall Study|Other|447|||
146425854|NCT01856309|528065725|FG003|Overall Study|Other|469|||
146425855|NCT01856309|528065722|FG000|Overall Study|Lack of Efficacy|14|||
146425856|NCT01856309|528065723|FG001|Overall Study|Lack of Efficacy|9|||
146425857|NCT01856309|528065724|FG002|Overall Study|Lack of Efficacy|40|||
146425858|NCT01856309|528065725|FG003|Overall Study|Lack of Efficacy|25|||
146425859|NCT01856309|528065722|FG000|Overall Study|Adverse Event|31|||
146425860|NCT01856309|528065723|FG001|Overall Study|Adverse Event|31|||
146425861|NCT01856309|528065724|FG002|Overall Study|Adverse Event|55|||
146425862|NCT01856309|528065725|FG003|Overall Study|Adverse Event|65|||
146425863|NCT01856309|528065722|FG000|Overall Study|Pregnancy|0|||
146425864|NCT01856309|528065723|FG001|Overall Study|Pregnancy|0|||
146425865|NCT01856309|528065724|FG002|Overall Study|Pregnancy|0|||
146425866|NCT01856309|528065725|FG003|Overall Study|Pregnancy|1|||
146425867|NCT01856309|528065722|FG000|Overall Study|Physician Decision|6|||
146425868|NCT01856309|528065723|FG001|Overall Study|Physician Decision|1|||
146425869|NCT01856309|528065724|FG002|Overall Study|Physician Decision|6|||
146425870|NCT01856309|528065725|FG003|Overall Study|Physician Decision|8|||
146425871|NCT01856309|528065722|FG000|Overall Study|Noncompliance With Study Drug|0|||
146425872|NCT01856309|528065723|FG001|Overall Study|Noncompliance With Study Drug|1|||
146425873|NCT01856309|528065724|FG002|Overall Study|Noncompliance With Study Drug|4|||
146425874|NCT01856309|528065725|FG003|Overall Study|Noncompliance With Study Drug|1|||
146425875|NCT00220337|528065726|FG000|Overall Study|Adverse Event|70|||
146425876|NCT00220337|528065726|FG000|Overall Study|Lack of Efficacy|17|||
146425877|NCT00220337|528065726|FG000|Overall Study|Withdrawal by Subject|68|||
146425878|NCT00220337|528065726|FG000|Overall Study|Protocol Violation|2|||
146425879|NCT00220337|528065726|FG000|Overall Study|Lost to Follow-up|5|||
146425880|NCT00220337|528065726|FG000|Overall Study|Other|12|||
146199453|NCT00530842|527243186|FG001|Overall Study|Adverse Event|6|||
146199454|NCT00530842|527243185|FG000|Overall Study|Lack of Efficacy|2|||
146425881|NCT00220337|528065726|FG000|Overall Study|Unsatisfactory compliance|5|||
146425882|NCT00832377|528065727|FG000|Overall Study|Protocol Violation|1|||
146199455|NCT00530842|527243186|FG001|Overall Study|Lack of Efficacy|1|||
146199456|NCT00530842|527243185|FG000|Overall Study|Lost to Follow-up|0|||
146425883|NCT00944697|528065728|FG000|Overall Study|Withdrawal by Subject|1|||
146425884|NCT00944697|528065729|FG001|Overall Study|Withdrawal by Subject|1|||
146425885|NCT00944697|528065728|FG000|Overall Study|Adverse Event|0|||
146425886|NCT00944697|528065729|FG001|Overall Study|Adverse Event|3|||
146425887|NCT00944697|528065728|FG000|Overall Study|Administrative|1|||
146425888|NCT00944697|528065729|FG001|Overall Study|Administrative|1|||
146425889|NCT01273181|528065730|FG000|Phase I, Dose 1|Study termination|1|||
146425890|NCT01273181|528065731|FG001|Phase I, Dose 1|Study termination|0|||
146425891|NCT01273181|528065732|FG002|Phase I, Dose 1|Study termination|0|||
146425892|NCT01273181|528065733|FG003|Phase I, Dose 1|Study termination|0|||
146425893|NCT01273181|528065730|FG000|Phase I, Dose 2|Death during treatment|0|||
146425894|NCT01273181|528065731|FG001|Phase I, Dose 2|Death during treatment|1|||
146425895|NCT01273181|528065732|FG002|Phase I, Dose 2|Death during treatment|0|||
146425896|NCT01273181|528065733|FG003|Phase I, Dose 2|Death during treatment|0|||
146425897|NCT01273181|528065730|FG000|Phase 2, Dose 1|Study termination|0|||
146425898|NCT01273181|528065731|FG001|Phase 2, Dose 1|Study termination|0|||
146425899|NCT01273181|528065732|FG002|Phase 2, Dose 1|Study termination|1|||
146425900|NCT01273181|528065733|FG003|Phase 2, Dose 1|Study termination|0|||
146425901|NCT01273181|528065730|FG000|Phase 2, Dose 2|Death during treatment|0|||
146425902|NCT01273181|528065731|FG001|Phase 2, Dose 2|Death during treatment|0|||
146425903|NCT01273181|528065732|FG002|Phase 2, Dose 2|Death during treatment|0|||
146425904|NCT01273181|528065733|FG003|Phase 2, Dose 2|Death during treatment|1|||
146425905|NCT01062256|528065735|FG000|Overall Study|Adverse Event|1|||
146425906|NCT01062256|528065736|FG001|Overall Study|Adverse Event|0|||
146425907|NCT01062256|528065737|FG002|Overall Study|Adverse Event|0|||
146425908|NCT01062256|528065735|FG000|Overall Study|Withdrawal by Subject|1|||
146425909|NCT01062256|528065736|FG001|Overall Study|Withdrawal by Subject|1|||
146425910|NCT01062256|528065737|FG002|Overall Study|Withdrawal by Subject|1|||
146425911|NCT01062256|528065735|FG000|Overall Study|Ineligible|1|||
146425912|NCT01062256|528065736|FG001|Overall Study|Ineligible|4|||
146425913|NCT01062256|528065737|FG002|Overall Study|Ineligible|3|||
146425914|NCT01062256|528065735|FG000|Overall Study|Administrative|0|||
146425915|NCT01062256|528065736|FG001|Overall Study|Administrative|2|||
146425916|NCT01062256|528065737|FG002|Overall Study|Administrative|0|||
146425917|NCT03049488|528065738|FG000|Overall Study|Lost to Follow-up|1|||
146425918|NCT03049488|528065739|FG001|Overall Study|Lost to Follow-up|1|||
146425919|NCT03049488|528065740|FG002|Overall Study|Lost to Follow-up|0|||
146425920|NCT03049488|528065741|FG003|Overall Study|Lost to Follow-up|0|||
146425921|NCT03049488|528065742|FG004|Overall Study|Lost to Follow-up|0|||
146425922|NCT03049488|528065743|FG005|Overall Study|Lost to Follow-up|0|||
146425923|NCT03049488|528065738|FG000|Overall Study|Moved from Area|1|||
146425924|NCT03049488|528065739|FG001|Overall Study|Moved from Area|0|||
146425925|NCT03049488|528065740|FG002|Overall Study|Moved from Area|0|||
146425926|NCT03049488|528065741|FG003|Overall Study|Moved from Area|1|||
146425927|NCT03049488|528065742|FG004|Overall Study|Moved from Area|1|||
146425928|NCT03049488|528065743|FG005|Overall Study|Moved from Area|0|||
146425929|NCT03049488|528065738|FG000|Overall Study|Physician Decision|0|||
146425930|NCT03049488|528065739|FG001|Overall Study|Physician Decision|1|||
146425931|NCT03049488|528065740|FG002|Overall Study|Physician Decision|0|||
146425932|NCT03049488|528065741|FG003|Overall Study|Physician Decision|0|||
146425933|NCT03049488|528065742|FG004|Overall Study|Physician Decision|0|||
146425934|NCT03049488|528065743|FG005|Overall Study|Physician Decision|0|||
146425935|NCT03049488|528065738|FG000|Overall Study|Withdrawal by Subject|0|||
146425936|NCT03049488|528065739|FG001|Overall Study|Withdrawal by Subject|0|||
146425937|NCT03049488|528065740|FG002|Overall Study|Withdrawal by Subject|0|||
146425938|NCT03049488|528065741|FG003|Overall Study|Withdrawal by Subject|1|||
146199457|NCT00530842|527243186|FG001|Overall Study|Lost to Follow-up|4|||
146199458|NCT00530842|527243185|FG000|Overall Study|Protocol Violation|3|||
146199459|NCT00530842|527243186|FG001|Overall Study|Protocol Violation|2|||
146199460|NCT00530842|527243185|FG000|Overall Study|Withdrawal by Subject|4|||
146199461|NCT00530842|527243186|FG001|Overall Study|Withdrawal by Subject|5|||
146199462|NCT00530842|527243185|FG000|Overall Study|Individual different reasons|4|||
146199463|NCT00530842|527243186|FG001|Overall Study|Individual different reasons|3|||
146199464|NCT00530842|527243185|FG000|Period 1|Adverse Event|7|||
146199465|NCT00530842|527243186|FG001|Period 1|Adverse Event|3|||
146199466|NCT00530842|527243185|FG000|Period 1|Lack of Efficacy|1|||
146199467|NCT00530842|527243186|FG001|Period 1|Lack of Efficacy|1|||
146199468|NCT00530842|527243185|FG000|Period 1|Protocol Violation|2|||
146199469|NCT00530842|527243186|FG001|Period 1|Protocol Violation|1|||
146199470|NCT00530842|527243185|FG000|Period 1|Withdrawal by Subject|2|||
146199471|NCT00530842|527243186|FG001|Period 1|Withdrawal by Subject|3|||
146199472|NCT00530842|527243185|FG000|Period 1|Individual different reasons|2|||
146199473|NCT00530842|527243186|FG001|Period 1|Individual different reasons|3|||
146199474|NCT00530842|527243185|FG000|Period 2|Adverse Event|3|||
146199475|NCT00530842|527243186|FG001|Period 2|Adverse Event|3|||
146199476|NCT00530842|527243185|FG000|Period 2|Lack of Efficacy|1|||
146199477|NCT00530842|527243186|FG001|Period 2|Lack of Efficacy|0|||
146199478|NCT00530842|527243185|FG000|Period 2|Lost to Follow-up|0|||
146199479|NCT00530842|527243186|FG001|Period 2|Lost to Follow-up|4|||
146199480|NCT00530842|527243185|FG000|Period 2|Protocol Violation|1|||
146425939|NCT03049488|528065742|FG004|Overall Study|Withdrawal by Subject|1|||
146199481|NCT00530842|527243186|FG001|Period 2|Protocol Violation|0|||
146425940|NCT03049488|528065743|FG005|Overall Study|Withdrawal by Subject|0|||
146425941|NCT00891293|528065745|FG000|Overall Study|Adverse Event|2|||
146425942|NCT00891293|528065745|FG000|Overall Study|Protocol Violation|2|||
146425943|NCT00891293|528065745|FG000|Overall Study|Laboratory abnormality|4|||
146425944|NCT00891293|528065745|FG000|Overall Study|Lost to Follow-up|7|||
146425945|NCT00891293|528065745|FG000|Overall Study|Subject withdrew consent|7|||
146425946|NCT00891293|528065745|FG000|Overall Study|Sponsor termination|62|||
146199482|NCT00530842|527243185|FG000|Period 2|Withdrawal by Subject|1|||
146199483|NCT00530842|527243186|FG001|Period 2|Withdrawal by Subject|2|||
146199484|NCT00530842|527243185|FG000|Period 2|Individual different reasons|2|||
146199485|NCT00530842|527243186|FG001|Period 2|Individual different reasons|0|||
146199486|NCT02534350|527243187|FG000|Overall Study|Randomized But Not Treated|1|||
146199487|NCT02534350|527243188|FG001|Overall Study|Randomized But Not Treated|0|||
146199488|NCT02534350|527243187|FG000|Overall Study|Protocol Violation|1|||
146199489|NCT02534350|527243188|FG001|Overall Study|Protocol Violation|0|||
146425947|NCT01448057|528065746|FG000|Overall Study|Protocol Violation|3|||
146425948|NCT01448057|528065747|FG001|Overall Study|Protocol Violation|2|||
146425949|NCT01448057|528065746|FG000|Overall Study|Lost to Follow-up|3|||
146425950|NCT01448057|528065747|FG001|Overall Study|Lost to Follow-up|0|||
146425951|NCT01448057|528065746|FG000|Overall Study|Adverse Event|0|||
146425952|NCT01448057|528065747|FG001|Overall Study|Adverse Event|2|||
146425953|NCT01448057|528065746|FG000|Overall Study|Withdrawal by Subject|2|||
146425954|NCT01448057|528065747|FG001|Overall Study|Withdrawal by Subject|0|||
146425955|NCT03912337|528065763|FG000|Overall Study|Withdrawal of Consent From Study|1|||
146425956|NCT03912337|528065764|FG001|Overall Study|Withdrawal of Consent From Study|0|||
146425957|NCT03912337|528065763|FG000|Overall Study|Lost to Follow-up|1|||
146425958|NCT03912337|528065764|FG001|Overall Study|Lost to Follow-up|1|||
146425959|NCT00537030|528065765|FG000|Overall Study|Physician Decision|2|||
146425960|NCT00537030|528065765|FG000|Overall Study|Withdrawal by Subject|2|||
146425961|NCT00537030|528065765|FG000|Overall Study|≥ Grade 2 allergy|7|||
146425962|NCT00537030|528065765|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
146425963|NCT00537030|528065765|FG000|Overall Study|Ineligible|2|||
146425964|NCT00537030|528065765|FG000|Overall Study|Inevaluable|2|||
146425965|NCT01496183|528065767|FG000|Overall Study|Physician Decision|3|||
146425966|NCT01496183|528065768|FG001|Overall Study|Physician Decision|1|||
146425967|NCT01496183|528065767|FG000|Overall Study|Withdrawal by Subject|0|||
146425968|NCT01496183|528065768|FG001|Overall Study|Withdrawal by Subject|1|||
146425969|NCT03130699|528065769|FG000|Overall Study|Lost to Follow-up|34|||
146425970|NCT03130699|528065770|FG001|Overall Study|Lost to Follow-up|37|||
146425971|NCT03130699|528065771|FG002|Overall Study|Lost to Follow-up|26|||
146425972|NCT03130699|528065769|FG000|Overall Study|Withdrawal by Subject|5|||
146425973|NCT03130699|528065770|FG001|Overall Study|Withdrawal by Subject|1|||
146425974|NCT03130699|528065771|FG002|Overall Study|Withdrawal by Subject|0|||
146425975|NCT03130699|528065769|FG000|Overall Study|Withdrawal by PI|1|||
146425976|NCT03130699|528065770|FG001|Overall Study|Withdrawal by PI|2|||
146082655|NCT01426789|526822868|FG003|Part 1|Lost to Follow-up|0|||
146425977|NCT03130699|528065771|FG002|Overall Study|Withdrawal by PI|5|||
146425978|NCT03130699|528065769|FG000|Overall Study|Death|0|||
146425979|NCT03130699|528065770|FG001|Overall Study|Death|0|||
146425980|NCT03130699|528065771|FG002|Overall Study|Death|1|||
146425981|NCT00669864|528065774|FG000|Overall Study|Lost to Follow-up|2|||
146425982|NCT00669864|528065774|FG000|Overall Study|Protocol Violation|2|||
146425983|NCT00669864|528065774|FG000|Overall Study|Withdrawal by Subject|3|||
146425984|NCT00669864|528065774|FG000|Overall Study|Other|2|||
146082656|NCT01426789|526822869|FG004|Part 1|Lost to Follow-up|0|||
145949642|NCT00575510|526326713|FG000|Overall Study|Clinic Called Patient|7|||
145949643|NCT00575510|526326714|FG001|Overall Study|Clinic Called Patient|7|||
145949644|NCT00575510|526326715|FG002|Overall Study|Clinic Called Patient|7|||
145949645|NCT00575510|526326713|FG000|Overall Study|Pregnancy|0|||
145949646|NCT00575510|526326714|FG001|Overall Study|Pregnancy|0|||
145949647|NCT00575510|526326715|FG002|Overall Study|Pregnancy|1|||
145949648|NCT00055497|526326720|FG000|Overall Study|Adverse Event|1|||
145949649|NCT00055497|526326721|FG001|Overall Study|Adverse Event|1|||
145949650|NCT00055497|526326722|FG002|Overall Study|Adverse Event|1|||
145949651|NCT00055497|526326723|FG003|Overall Study|Adverse Event|28|||
145949652|NCT00055497|526326720|FG000|Overall Study|Withdrawal by Subject|3|||
145949653|NCT00055497|526326721|FG001|Overall Study|Withdrawal by Subject|1|||
145949654|NCT00055497|526326722|FG002|Overall Study|Withdrawal by Subject|1|||
145949655|NCT00055497|526326723|FG003|Overall Study|Withdrawal by Subject|15|||
145949656|NCT00055497|526326720|FG000|Overall Study|Lost to Follow-up|0|||
145949657|NCT00055497|526326721|FG001|Overall Study|Lost to Follow-up|1|||
145949658|NCT00055497|526326722|FG002|Overall Study|Lost to Follow-up|0|||
145949659|NCT00055497|526326723|FG003|Overall Study|Lost to Follow-up|5|||
146425985|NCT06354270|528065777|FG000|Overall Study|Withdrawal by Subject|1|||
146425986|NCT06354270|528065778|FG001|Overall Study|Withdrawal by Subject|0|||
146425987|NCT00680121|528065779|FG000|Overall Study|Lost to Follow-up|27|||
146425988|NCT00680121|528065780|FG001|Overall Study|Lost to Follow-up|23|||
146425989|NCT00162123|528065781|FG000|Overall Study|Disease progression|27|||
146425990|NCT00162123|528065782|FG001|Overall Study|Disease progression|19|||
146425991|NCT00162123|528065783|FG002|Overall Study|Disease progression|10|||
146425992|NCT00162123|528065784|FG003|Overall Study|Disease progression|4|||
146425993|NCT00162123|528065785|FG004|Overall Study|Disease progression|8|||
146425994|NCT00162123|528065786|FG005|Overall Study|Disease progression|3|||
146425995|NCT00162123|528065787|FG006|Overall Study|Disease progression|1|||
146425996|NCT00162123|528065788|FG007|Overall Study|Disease progression|0|||
146425997|NCT00162123|528065781|FG000|Overall Study|Study drug toxicity|6|||
146425998|NCT00162123|528065782|FG001|Overall Study|Study drug toxicity|1|||
146425999|NCT00162123|528065783|FG002|Overall Study|Study drug toxicity|5|||
146426000|NCT00162123|528065784|FG003|Overall Study|Study drug toxicity|0|||
146426001|NCT00162123|528065785|FG004|Overall Study|Study drug toxicity|4|||
145949660|NCT00055497|526326720|FG000|Overall Study|Protocol Violation|0|||
145949661|NCT00055497|526326721|FG001|Overall Study|Protocol Violation|0|||
145949662|NCT00055497|526326722|FG002|Overall Study|Protocol Violation|0|||
145949663|NCT00055497|526326723|FG003|Overall Study|Protocol Violation|3|||
145949664|NCT00055497|526326720|FG000|Overall Study|Lack of Efficacy|1|||
145949665|NCT00055497|526326721|FG001|Overall Study|Lack of Efficacy|0|||
145949666|NCT00055497|526326722|FG002|Overall Study|Lack of Efficacy|0|||
145949667|NCT00055497|526326723|FG003|Overall Study|Lack of Efficacy|27|||
145949668|NCT00055497|526326720|FG000|Overall Study|Administrative Reasons|0|||
145949669|NCT00055497|526326721|FG001|Overall Study|Administrative Reasons|0|||
145949670|NCT00055497|526326722|FG002|Overall Study|Administrative Reasons|0|||
145949671|NCT00055497|526326723|FG003|Overall Study|Administrative Reasons|1|||
145949672|NCT00055497|526326720|FG000|Overall Study|Other|0|||
145949673|NCT00055497|526326721|FG001|Overall Study|Other|0|||
145949674|NCT00055497|526326722|FG002|Overall Study|Other|0|||
145949675|NCT00055497|526326723|FG003|Overall Study|Other|11|||
145949676|NCT03816007|526326728|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
145949677|NCT03816007|526326729|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
145949678|NCT03816007|526326728|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
145949679|NCT03816007|526326729|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
145949680|NCT03816007|526326728|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
145949681|NCT03816007|526326729|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
145949682|NCT01428115|526326730|FG000|Overall Study|Lack of Efficacy|3|||
145949683|NCT01428115|526326730|FG000|Overall Study|Lost to Follow-up|10|||
146199490|NCT02534350|527243187|FG000|Overall Study|Withdrew Consent|2|||
146199491|NCT02534350|527243188|FG001|Overall Study|Withdrew Consent|0|||
145949684|NCT01428115|526326730|FG000|Overall Study|Pregnancy|1|||
145949685|NCT01428115|526326730|FG000|Overall Study|Protocol Violation|3|||
146199492|NCT00880048|527243193|FG000|Overall Study|Adverse Event|2|||
145949686|NCT01428115|526326730|FG000|Overall Study|Withdrawal by Subject|4|||
146199493|NCT00880048|527243194|FG001|Overall Study|Adverse Event|3|||
146199494|NCT00880048|527243195|FG002|Overall Study|Adverse Event|5|||
146426002|NCT00162123|528065786|FG005|Overall Study|Study drug toxicity|1|||
146426003|NCT00162123|528065787|FG006|Overall Study|Study drug toxicity|1|||
146426004|NCT00162123|528065788|FG007|Overall Study|Study drug toxicity|0|||
145949687|NCT02620384|526326731|FG000|Overall Study|Adverse Event|2|||
145949688|NCT02620384|526326732|FG001|Overall Study|Adverse Event|1|||
146426005|NCT00162123|528065781|FG000|Overall Study|Death|3|||
146426006|NCT00162123|528065782|FG001|Overall Study|Death|3|||
146426007|NCT00162123|528065783|FG002|Overall Study|Death|1|||
146426008|NCT00162123|528065784|FG003|Overall Study|Death|1|||
146082657|NCT01426789|526822870|FG005|Part 1|Lost to Follow-up|0|||
146426009|NCT00162123|528065785|FG004|Overall Study|Death|1|||
145949689|NCT02620384|526326731|FG000|Overall Study|Discharged prior to 2nd dose|2|||
146082658|NCT01426789|526822865|FG000|Part 1|Lack of Efficacy|2|||
146426010|NCT00162123|528065786|FG005|Overall Study|Death|1|||
146426011|NCT00162123|528065787|FG006|Overall Study|Death|0|||
146426012|NCT00162123|528065788|FG007|Overall Study|Death|0|||
146426013|NCT00162123|528065781|FG000|Overall Study|Withdrawal by Subject|2|||
146426014|NCT00162123|528065782|FG001|Overall Study|Withdrawal by Subject|0|||
146426015|NCT00162123|528065783|FG002|Overall Study|Withdrawal by Subject|2|||
146426016|NCT00162123|528065784|FG003|Overall Study|Withdrawal by Subject|1|||
146426017|NCT00162123|528065785|FG004|Overall Study|Withdrawal by Subject|1|||
146426018|NCT00162123|528065786|FG005|Overall Study|Withdrawal by Subject|2|||
146426019|NCT00162123|528065787|FG006|Overall Study|Withdrawal by Subject|1|||
146426020|NCT00162123|528065788|FG007|Overall Study|Withdrawal by Subject|0|||
146426021|NCT00162123|528065781|FG000|Overall Study|Deterioration without progression|2|||
146426022|NCT00162123|528065782|FG001|Overall Study|Deterioration without progression|2|||
146426023|NCT00162123|528065783|FG002|Overall Study|Deterioration without progression|3|||
146426024|NCT00162123|528065784|FG003|Overall Study|Deterioration without progression|0|||
146426025|NCT00162123|528065785|FG004|Overall Study|Deterioration without progression|1|||
146426026|NCT00162123|528065786|FG005|Overall Study|Deterioration without progression|0|||
146426027|NCT00162123|528065787|FG006|Overall Study|Deterioration without progression|0|||
146426028|NCT00162123|528065788|FG007|Overall Study|Deterioration without progression|0|||
146426029|NCT00162123|528065781|FG000|Overall Study|Adverse Event|1|||
146426030|NCT00162123|528065782|FG001|Overall Study|Adverse Event|2|||
146426031|NCT00162123|528065783|FG002|Overall Study|Adverse Event|0|||
146426032|NCT00162123|528065784|FG003|Overall Study|Adverse Event|2|||
146426033|NCT00162123|528065785|FG004|Overall Study|Adverse Event|1|||
146426034|NCT00162123|528065786|FG005|Overall Study|Adverse Event|0|||
146426035|NCT00162123|528065787|FG006|Overall Study|Adverse Event|0|||
146426036|NCT00162123|528065788|FG007|Overall Study|Adverse Event|0|||
146426037|NCT00162123|528065781|FG000|Overall Study|Not specified (before treatment)|2|||
146426038|NCT00162123|528065782|FG001|Overall Study|Not specified (before treatment)|0|||
146426039|NCT00162123|528065783|FG002|Overall Study|Not specified (before treatment)|0|||
146426040|NCT00162123|528065784|FG003|Overall Study|Not specified (before treatment)|0|||
146426041|NCT00162123|528065785|FG004|Overall Study|Not specified (before treatment)|12|||
146426042|NCT00162123|528065786|FG005|Overall Study|Not specified (before treatment)|1|||
146426043|NCT00162123|528065787|FG006|Overall Study|Not specified (before treatment)|0|||
146426044|NCT00162123|528065788|FG007|Overall Study|Not specified (before treatment)|0|||
146426045|NCT00162123|528065781|FG000|Overall Study|Not specified (after start of treatment)|0|||
146426046|NCT00162123|528065782|FG001|Overall Study|Not specified (after start of treatment)|0|||
146426047|NCT00162123|528065783|FG002|Overall Study|Not specified (after start of treatment)|0|||
146426048|NCT00162123|528065784|FG003|Overall Study|Not specified (after start of treatment)|0|||
146426049|NCT00162123|528065785|FG004|Overall Study|Not specified (after start of treatment)|3|||
146426050|NCT00162123|528065786|FG005|Overall Study|Not specified (after start of treatment)|0|||
146426051|NCT00162123|528065787|FG006|Overall Study|Not specified (after start of treatment)|0|||
146426052|NCT00162123|528065788|FG007|Overall Study|Not specified (after start of treatment)|0|||
146426053|NCT00162123|528065781|FG000|Overall Study|Physician Decision|1|||
146426054|NCT00162123|528065782|FG001|Overall Study|Physician Decision|2|||
146426055|NCT00162123|528065783|FG002|Overall Study|Physician Decision|0|||
146426056|NCT00162123|528065784|FG003|Overall Study|Physician Decision|0|||
146426057|NCT00162123|528065785|FG004|Overall Study|Physician Decision|0|||
146426058|NCT00162123|528065786|FG005|Overall Study|Physician Decision|1|||
146426059|NCT00162123|528065787|FG006|Overall Study|Physician Decision|1|||
146426060|NCT00162123|528065788|FG007|Overall Study|Physician Decision|0|||
146426061|NCT00162123|528065781|FG000|Overall Study|Tumor assessment only (not treated)|0|||
146426062|NCT00162123|528065782|FG001|Overall Study|Tumor assessment only (not treated)|0|||
146426063|NCT00162123|528065783|FG002|Overall Study|Tumor assessment only (not treated)|0|||
146426064|NCT00162123|528065784|FG003|Overall Study|Tumor assessment only (not treated)|0|||
146426065|NCT00162123|528065785|FG004|Overall Study|Tumor assessment only (not treated)|0|||
146426066|NCT00162123|528065786|FG005|Overall Study|Tumor assessment only (not treated)|0|||
146426067|NCT00162123|528065787|FG006|Overall Study|Tumor assessment only (not treated)|0|||
146199495|NCT00880048|527243193|FG000|Overall Study|Lack of Efficacy|1|||
146199496|NCT00880048|527243194|FG001|Overall Study|Lack of Efficacy|2|||
146199497|NCT00880048|527243195|FG002|Overall Study|Lack of Efficacy|2|||
146426068|NCT00162123|528065788|FG007|Overall Study|Tumor assessment only (not treated)|1|||
146426069|NCT00162123|528065781|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
146426070|NCT00162123|528065782|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
146426071|NCT00162123|528065783|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
146426072|NCT00162123|528065784|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
146426073|NCT00162123|528065785|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
146426074|NCT00162123|528065786|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
146426075|NCT00162123|528065787|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
146426076|NCT00162123|528065788|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
146426077|NCT02016170|528065789|FG000|Overall Study|Adverse Event|1|||
146426078|NCT02016170|528065790|FG001|Overall Study|Adverse Event|1|||
146426079|NCT02016170|528065791|FG002|Overall Study|Adverse Event|0|||
146199498|NCT00880048|527243193|FG000|Overall Study|Protocol Violation|4|||
146199499|NCT00880048|527243194|FG001|Overall Study|Protocol Violation|6|||
146199500|NCT00880048|527243195|FG002|Overall Study|Protocol Violation|5|||
146199501|NCT00880048|527243193|FG000|Overall Study|Lost to Follow-up|6|||
146199502|NCT00880048|527243194|FG001|Overall Study|Lost to Follow-up|6|||
146199503|NCT00880048|527243195|FG002|Overall Study|Lost to Follow-up|5|||
146199504|NCT00880048|527243193|FG000|Overall Study|Physician Decision|1|||
146199505|NCT00880048|527243194|FG001|Overall Study|Physician Decision|1|||
146199506|NCT00880048|527243195|FG002|Overall Study|Physician Decision|7|||
146199507|NCT00880048|527243193|FG000|Overall Study|Withdrawal by Subject|5|||
146199508|NCT00880048|527243194|FG001|Overall Study|Withdrawal by Subject|8|||
146199509|NCT00880048|527243195|FG002|Overall Study|Withdrawal by Subject|5|||
146199510|NCT00880048|527243193|FG000|Overall Study|Study closed/terminated|9|||
146199511|NCT00880048|527243194|FG001|Overall Study|Study closed/terminated|7|||
146199512|NCT00880048|527243195|FG002|Overall Study|Study closed/terminated|6|||
146199513|NCT01069341|527243196|FG000|Overall Study|Lost to Follow-up|1|||
146199514|NCT02950558|527243200|FG000|Overall Study|Lost to Follow-up|2|||
146199515|NCT02950558|527243201|FG001|Overall Study|Lost to Follow-up|0|||
146199516|NCT01184508|527243202|FG000|Overall Study|Adverse Event|4|||
146199517|NCT01184508|527243203|FG001|Overall Study|Adverse Event|6|||
146199518|NCT01184508|527243202|FG000|Overall Study|Lack of Efficacy|1|||
146199519|NCT01184508|527243203|FG001|Overall Study|Lack of Efficacy|1|||
146199520|NCT01184508|527243202|FG000|Overall Study|Lost to Follow-up|1|||
146199521|NCT01184508|527243203|FG001|Overall Study|Lost to Follow-up|1|||
146199522|NCT01184508|527243202|FG000|Overall Study|Physician Decision|1|||
146199523|NCT01184508|527243203|FG001|Overall Study|Physician Decision|0|||
146199524|NCT01184508|527243202|FG000|Overall Study|Protocol Violation|3|||
146199525|NCT01184508|527243203|FG001|Overall Study|Protocol Violation|1|||
146199526|NCT01184508|527243202|FG000|Overall Study|Sponsor Decision|5|||
146199527|NCT01184508|527243203|FG001|Overall Study|Sponsor Decision|2|||
146199528|NCT01184508|527243202|FG000|Overall Study|Withdrawal by Subject|1|||
146199529|NCT01184508|527243203|FG001|Overall Study|Withdrawal by Subject|3|||
146199530|NCT01184508|527243202|FG000|Overall Study|Randomized, Not Treated|0|||
146199531|NCT01184508|527243203|FG001|Overall Study|Randomized, Not Treated|1|||
146199532|NCT00319436|527243209|FG000|Overall Study|Withdrawal by Subject|6|||
146199533|NCT00319436|527243210|FG001|Overall Study|Withdrawal by Subject|7|||
146199534|NCT02000817|527243212|FG000|Overall Study|Withdrawal by Subject|2|||
146199535|NCT02000817|527243213|FG001|Overall Study|Withdrawal by Subject|0|||
146199536|NCT02000817|527243214|FG002|Overall Study|Withdrawal by Subject|0|||
146199537|NCT02000817|527243215|FG003|Overall Study|Withdrawal by Subject|0|||
146199538|NCT02000817|527243212|FG000|Overall Study|Adverse Event|0|||
146199539|NCT02000817|527243213|FG001|Overall Study|Adverse Event|1|||
146199540|NCT02000817|527243214|FG002|Overall Study|Adverse Event|0|||
146199541|NCT02000817|527243215|FG003|Overall Study|Adverse Event|0|||
146199542|NCT02000817|527243212|FG000|Overall Study|Lost to Follow-up|0|||
146199543|NCT02000817|527243213|FG001|Overall Study|Lost to Follow-up|0|||
146199544|NCT02000817|527243214|FG002|Overall Study|Lost to Follow-up|1|||
146199545|NCT02000817|527243215|FG003|Overall Study|Lost to Follow-up|0|||
146199546|NCT01493778|527243222|FG000|Overall Study|Withdrawal by Subject|8|||
146199547|NCT04210180|527243223|FG000|Overall Study|Withdrawal by Subject|2|||
146199548|NCT00823979|527243236|FG000|Overall Study|Lack of Efficacy|13|||
146199549|NCT00823979|527243237|FG001|Overall Study|Lack of Efficacy|16|||
146199550|NCT00823979|527243238|FG002|Overall Study|Lack of Efficacy|9|||
146199551|NCT00823979|527243236|FG000|Overall Study|Lost to Follow-up|2|||
146199552|NCT00823979|527243237|FG001|Overall Study|Lost to Follow-up|1|||
146199553|NCT00823979|527243238|FG002|Overall Study|Lost to Follow-up|0|||
146199554|NCT00823979|527243236|FG000|Overall Study|Withdrawal by Subject|2|||
146199555|NCT00823979|527243237|FG001|Overall Study|Withdrawal by Subject|3|||
146199556|NCT00823979|527243238|FG002|Overall Study|Withdrawal by Subject|2|||
146199557|NCT00823979|527243236|FG000|Overall Study|Protocol Violation|1|||
146199558|NCT00823979|527243237|FG001|Overall Study|Protocol Violation|1|||
146199559|NCT00823979|527243238|FG002|Overall Study|Protocol Violation|0|||
146199560|NCT00823979|527243236|FG000|Overall Study|Pregnancy|0|||
146199561|NCT00823979|527243237|FG001|Overall Study|Pregnancy|1|||
146199562|NCT00823979|527243238|FG002|Overall Study|Pregnancy|0|||
146199563|NCT00823979|527243236|FG000|Overall Study|Adverse Event|0|||
146199564|NCT00823979|527243237|FG001|Overall Study|Adverse Event|2|||
146199565|NCT00823979|527243238|FG002|Overall Study|Adverse Event|4|||
146199566|NCT00823979|527243236|FG000|Overall Study|Other|2|||
146199567|NCT00823979|527243237|FG001|Overall Study|Other|0|||
146199568|NCT00823979|527243238|FG002|Overall Study|Other|1|||
146426080|NCT02016170|528065789|FG000|Overall Study|Protocol Violation|1|||
146426081|NCT02016170|528065790|FG001|Overall Study|Protocol Violation|0|||
146426082|NCT02016170|528065791|FG002|Overall Study|Protocol Violation|0|||
146426083|NCT02365207|528065795|FG000|Overall Study|Withdrawal by Subject|1|||
146426084|NCT02365207|528065795|FG000|Overall Study|Physician Decision|1|||
146426085|NCT01936948|528065796|FG000|Overall Study|no 30-day follow-up data|0|||
146426086|NCT01936948|528065797|FG001|Overall Study|no 30-day follow-up data|3|||
146426087|NCT01936948|528065798|FG002|Overall Study|no 30-day follow-up data|3|||
146426088|NCT01936948|528065799|FG003|Overall Study|no 30-day follow-up data|3|||
146426089|NCT01395030|528065800|FG000|Overall Study|Did not complete FCH PET/CT|7|||
146426090|NCT01606306|528065803|FG000|Overall Study|Lack of Efficacy|2|||
146426091|NCT01606306|528065804|FG001|Overall Study|Lack of Efficacy|1|||
146426092|NCT01606306|528065805|FG002|Overall Study|Lack of Efficacy|4|||
146426093|NCT01606306|528065806|FG003|Overall Study|Lack of Efficacy|4|||
146426094|NCT01606306|528065807|FG004|Overall Study|Lack of Efficacy|1|||
146426095|NCT01606306|528065808|FG005|Overall Study|Lack of Efficacy|2|||
146426096|NCT01606306|528065803|FG000|Overall Study|Adverse Event|1|||
146426097|NCT01606306|528065804|FG001|Overall Study|Adverse Event|0|||
146426098|NCT01606306|528065805|FG002|Overall Study|Adverse Event|1|||
146426099|NCT01606306|528065806|FG003|Overall Study|Adverse Event|1|||
146426100|NCT01606306|528065807|FG004|Overall Study|Adverse Event|2|||
146426101|NCT01606306|528065808|FG005|Overall Study|Adverse Event|0|||
146426102|NCT01606306|528065803|FG000|Overall Study|Lost to Follow-up|7|||
146426103|NCT01606306|528065804|FG001|Overall Study|Lost to Follow-up|4|||
146426104|NCT01606306|528065805|FG002|Overall Study|Lost to Follow-up|5|||
146426105|NCT01606306|528065806|FG003|Overall Study|Lost to Follow-up|4|||
146426106|NCT01606306|528065807|FG004|Overall Study|Lost to Follow-up|3|||
146426107|NCT01606306|528065808|FG005|Overall Study|Lost to Follow-up|5|||
146426108|NCT01606306|528065803|FG000|Overall Study|Withdrawal by Subject|4|||
146426109|NCT01606306|528065804|FG001|Overall Study|Withdrawal by Subject|3|||
146426110|NCT01606306|528065805|FG002|Overall Study|Withdrawal by Subject|4|||
146426111|NCT01606306|528065806|FG003|Overall Study|Withdrawal by Subject|4|||
146426112|NCT01606306|528065807|FG004|Overall Study|Withdrawal by Subject|5|||
146426113|NCT01606306|528065808|FG005|Overall Study|Withdrawal by Subject|4|||
146426114|NCT01606306|528065803|FG000|Overall Study|Physician Decision|1|||
146426115|NCT01606306|528065804|FG001|Overall Study|Physician Decision|2|||
146426116|NCT01606306|528065805|FG002|Overall Study|Physician Decision|0|||
146426117|NCT01606306|528065806|FG003|Overall Study|Physician Decision|0|||
146426118|NCT01606306|528065807|FG004|Overall Study|Physician Decision|0|||
146426119|NCT01606306|528065808|FG005|Overall Study|Physician Decision|0|||
146426120|NCT00950872|528065809|FG000|Overall Study|Withdrawal by Subject|1|||
146426121|NCT00950872|528065809|FG000|Overall Study|Did not have surgery|2|||
146426122|NCT00408902|528065812|FG000|Overall Study|Lack of Efficacy|7|||
146426123|NCT00408902|528065812|FG000|Overall Study|Adverse Event|3|||
146426124|NCT00970281|528065815|FG000|Overall Study|Lack of Efficacy|1|||
146426125|NCT00970281|528065816|FG001|Overall Study|Lack of Efficacy|14|||
146426126|NCT00970281|528065815|FG000|Overall Study|Withdrawal by Subject|0|||
146426127|NCT00970281|528065816|FG001|Overall Study|Withdrawal by Subject|1|||
146426128|NCT00970281|528065815|FG000|Overall Study|Physician Decision|1|||
146426129|NCT00970281|528065816|FG001|Overall Study|Physician Decision|1|||
146426130|NCT01759290|528065817|FG000|Overall Study|Subjects withdrawn consent|5|||
146426131|NCT01759290|528065817|FG000|Overall Study|Physician Decision|2|||
146426132|NCT01759290|528065817|FG000|Overall Study|Death|17|||
146426133|NCT01759290|528065817|FG000|Overall Study|Lost to Follow-up|53|||
146426134|NCT01759290|528065817|FG000|Overall Study|Unknown reason|4|||
146426135|NCT00841100|528065818|FG000|Phase 1 (28 Days)|Adverse Event|1|||
146426136|NCT00841100|528065818|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
146426137|NCT03338972|528065819|FG000|Overall Study|Death|1|||
146426138|NCT03338972|528065820|FG001|Overall Study|Death|1|||
146426139|NCT03338972|528065821|FG002|Overall Study|Death|0|||
146426140|NCT03338972|528065822|FG003|Overall Study|Death|0|||
146426141|NCT03338972|528065819|FG000|Overall Study|Withdrawal by Subject|1|||
146426142|NCT03338972|528065820|FG001|Overall Study|Withdrawal by Subject|0|||
146426143|NCT03338972|528065821|FG002|Overall Study|Withdrawal by Subject|0|||
146426144|NCT03338972|528065822|FG003|Overall Study|Withdrawal by Subject|0|||
146426145|NCT03629249|528065823|FG000|Overall Study|Study terminated by sponsor|197|||
146426146|NCT03629249|528065824|FG001|Overall Study|Study terminated by sponsor|197|||
146426147|NCT03629249|528065825|FG002|Overall Study|Study terminated by sponsor|194|||
146426148|NCT03629249|528065823|FG000|Overall Study|Protocol deviation|0|||
146426149|NCT03629249|528065824|FG001|Overall Study|Protocol deviation|2|||
146082659|NCT01426789|526822866|FG001|Part 1|Lack of Efficacy|1|||
146426150|NCT03629249|528065825|FG002|Overall Study|Protocol deviation|5|||
146426151|NCT03629249|528065823|FG000|Overall Study|Subject decision|1|||
146426152|NCT03629249|528065824|FG001|Overall Study|Subject decision|1|||
146426153|NCT03629249|528065825|FG002|Overall Study|Subject decision|3|||
146426154|NCT03629249|528065823|FG000|Overall Study|Adverse Event|1|||
146426155|NCT03629249|528065824|FG001|Overall Study|Adverse Event|1|||
146426156|NCT03629249|528065825|FG002|Overall Study|Adverse Event|0|||
146426157|NCT03629249|528065823|FG000|Overall Study|Death|1|||
146426158|NCT03629249|528065824|FG001|Overall Study|Death|0|||
146426159|NCT03629249|528065825|FG002|Overall Study|Death|0|||
146426160|NCT03629249|528065823|FG000|Overall Study|Physician Decision|1|||
146426161|NCT03629249|528065824|FG001|Overall Study|Physician Decision|0|||
146426162|NCT03629249|528065825|FG002|Overall Study|Physician Decision|0|||
146426163|NCT00352690|528065826|FG000|Overall Study|Determined to be ineligible|2|||
146426164|NCT00352690|528065827|FG001|Overall Study|Determined to be ineligible|0|||
146082660|NCT01426789|526822867|FG002|Part 1|Lack of Efficacy|0|||
146426165|NCT03633721|528065832|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
146426166|NCT03633721|528065833|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
146426167|NCT03633721|528065834|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
146426168|NCT03633721|528065835|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
146426169|NCT01475474|528065839|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
146426170|NCT01475474|528065839|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
146426171|NCT05277389|528065840|FG000|Overall Study|Lost to Follow-up|1|||
146426172|NCT05277389|528065841|FG001|Overall Study|Lost to Follow-up|4|||
146426173|NCT03069937|528065842|FG000|Overall Study|Second primary malignancy noted|1|||
146426174|NCT06096168|528065843|FG000|Overall Study|Death|30|||
146426175|NCT06096168|528065843|FG000|Overall Study|Revision|2|||
146426176|NCT01046253|528065846|FG000|Second Intervention|Adverse Event|0|||
146426177|NCT01046253|528065847|FG001|Second Intervention|Adverse Event|1|||
146426178|NCT01046253|528065846|FG000|Second Intervention|Protocol Violation|0|||
146426179|NCT01046253|528065847|FG001|Second Intervention|Protocol Violation|1|||
146426180|NCT02339909|528065848|FG000|Overall Study|Became ineligible after randomisation|89|||
146426181|NCT02339909|528065849|FG001|Overall Study|Became ineligible after randomisation|63|||
146426182|NCT02339909|528065850|FG002|Overall Study|Became ineligible after randomisation|71|||
146426183|NCT01766778|528065855|FG000|Overall Study|Adverse Event|4|||
146426184|NCT01766778|528065856|FG001|Overall Study|Adverse Event|4|||
146426185|NCT01766778|528065855|FG000|Overall Study|Withdrawal by Subject|1|||
146426186|NCT01766778|528065856|FG001|Overall Study|Withdrawal by Subject|0|||
146426187|NCT01411332|528065857|FG000|Enrollment|Protocol Violation|0|||
146426188|NCT01411332|528065858|FG001|Enrollment|Protocol Violation|1|||
146426189|NCT01411332|528065857|FG000|Enrollment|Withdrawal by Subject|0|||
146426190|NCT01411332|528065858|FG001|Enrollment|Withdrawal by Subject|1|||
146426191|NCT01411332|528065857|FG000|Treatment|Lost to Follow-up|1|||
146199569|NCT00823979|527243236|FG000|Overall Study|Randomized but not Treated|4|||
146199570|NCT00823979|527243237|FG001|Overall Study|Randomized but not Treated|3|||
146426192|NCT01411332|528065858|FG001|Treatment|Lost to Follow-up|0|||
146426193|NCT02079532|528065859|FG000|Overall Study|Adverse Event|7|||
146426194|NCT02079532|528065859|FG000|Overall Study|Additional or changed therapy|2|||
146426195|NCT02079532|528065859|FG000|Overall Study|Lack of Efficacy|9|||
146426196|NCT02079532|528065859|FG000|Overall Study|Protocol Violation|3|||
146426197|NCT02079532|528065859|FG000|Overall Study|Withdrawal by Subject|1|||
146426198|NCT02079532|528065859|FG000|Overall Study|Administrative problems|1|||
146426199|NCT02079532|528065859|FG000|Overall Study|Inclusion into ReFIRST|3|||
146426200|NCT02079532|528065859|FG000|Overall Study|Other|3|||
146426201|NCT01432171|528065860|FG000|Overall Study|Death|1|||
146426202|NCT01432171|528065861|FG001|Overall Study|Death|2|||
146426203|NCT01432171|528065860|FG000|Overall Study|Lost to Follow-up|6|||
146426204|NCT01432171|528065861|FG001|Overall Study|Lost to Follow-up|5|||
146426205|NCT01432171|528065860|FG000|Overall Study|Withdrawal by Subject|3|||
146426206|NCT01432171|528065861|FG001|Overall Study|Withdrawal by Subject|1|||
146426207|NCT01432171|528065860|FG000|Overall Study|Noncompliance|2|||
146426208|NCT01432171|528065861|FG001|Overall Study|Noncompliance|3|||
146426209|NCT01432171|528065860|FG000|Overall Study|Insurance denial trial coverage|1|||
146426210|NCT01432171|528065861|FG001|Overall Study|Insurance denial trial coverage|0|||
146426211|NCT01432171|528065860|FG000|Overall Study|Patient moved to palliative care|1|||
146426212|NCT01432171|528065861|FG001|Overall Study|Patient moved to palliative care|0|||
146426213|NCT02289963|528067427|FG000|Overall Study|Adverse Event|1|||
146426214|NCT02289963|528067428|FG001|Overall Study|Adverse Event|2|||
146426215|NCT02289963|528067427|FG000|Overall Study|Poor compliance to protocol|1|||
146426216|NCT02289963|528067428|FG001|Overall Study|Poor compliance to protocol|0|||
146426217|NCT02289963|528067427|FG000|Overall Study|Withdrawal by Subject|1|||
146426218|NCT02289963|528067428|FG001|Overall Study|Withdrawal by Subject|0|||
146426219|NCT02289963|528067427|FG000|Overall Study|Last injection missed|2|||
146426220|NCT02289963|528067428|FG001|Overall Study|Last injection missed|2|||
146426221|NCT02289963|528067427|FG000|Overall Study|End treatment visit outside visit window|0|||
146426222|NCT02289963|528067428|FG001|Overall Study|End treatment visit outside visit window|4|||
146426223|NCT02289963|528067427|FG000|Overall Study|Other than specified above|0|||
146426224|NCT02289963|528067428|FG001|Overall Study|Other than specified above|2|||
146426225|NCT01101022|528067433|FG000|Overall Study|Adverse Event|6|||
146426226|NCT01101022|528067434|FG001|Overall Study|Adverse Event|2|||
146199571|NCT00823979|527243238|FG002|Overall Study|Randomized but not Treated|1|||
146426227|NCT01101022|528067433|FG000|Overall Study|Protocol Violation|4|||
146426228|NCT01101022|528067434|FG001|Overall Study|Protocol Violation|3|||
146199572|NCT00823979|527243236|FG000|Overall Study|Study Terminated by Sponsor|5|||
146199573|NCT00823979|527243237|FG001|Overall Study|Study Terminated by Sponsor|5|||
146199574|NCT00823979|527243238|FG002|Overall Study|Study Terminated by Sponsor|7|||
146426229|NCT01101022|528067433|FG000|Overall Study|Withdrawal by Subject|3|||
146426230|NCT01101022|528067434|FG001|Overall Study|Withdrawal by Subject|8|||
146426231|NCT01101022|528067433|FG000|Overall Study|Lost to Follow-up|1|||
146426232|NCT01101022|528067434|FG001|Overall Study|Lost to Follow-up|4|||
146426233|NCT01101022|528067433|FG000|Overall Study|Lack of Efficacy|0|||
146426234|NCT01101022|528067434|FG001|Overall Study|Lack of Efficacy|7|||
146426235|NCT01101022|528067433|FG000|Overall Study|Sponsor decision|1|||
146199575|NCT03523091|527243239|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
146426236|NCT01101022|528067434|FG001|Overall Study|Sponsor decision|1|||
146426237|NCT01101022|528067433|FG000|Overall Study|Non-compliance|1|||
146426238|NCT01101022|528067434|FG001|Overall Study|Non-compliance|0|||
146426239|NCT01101022|528067433|FG000|Overall Study|Work schedule|1|||
146426240|NCT01101022|528067434|FG001|Overall Study|Work schedule|1|||
146426241|NCT01101022|528067433|FG000|Overall Study|Vacation|0|||
146426242|NCT01101022|528067434|FG001|Overall Study|Vacation|1|||
146426243|NCT01519661|528067435|FG000|Overall Study|Protocol deviation|6|||
146426244|NCT01519661|528067435|FG000|Overall Study|Lost to Follow-up|3|||
146426245|NCT01519661|528067435|FG000|Overall Study|Withdrawal by Subject|17|||
146426246|NCT01519661|528067435|FG000|Overall Study|Lack of Efficacy|6|||
146426247|NCT01519661|528067435|FG000|Overall Study|Adverse Event|29|||
146426248|NCT01139047|528067436|FG000|Overall Study|Withdrawal by Subject|1|||
146426249|NCT00420303|528067437|FG000|Overall Study|Serious Adverse Event|1|||
146426250|NCT00420303|528067438|FG001|Overall Study|Serious Adverse Event|0|||
146426251|NCT00420303|528067437|FG000|Overall Study|Lack of Efficacy|0|||
146426252|NCT00420303|528067438|FG001|Overall Study|Lack of Efficacy|3|||
146426253|NCT00420303|528067437|FG000|Overall Study|Physician Decision|0|||
146426254|NCT00420303|528067438|FG001|Overall Study|Physician Decision|1|||
146426255|NCT00745420|528067439|FG000|Overall Study|Ineligible|1|||
146426256|NCT01941095|528067440|FG000|Overall Study|Insufficient therapeutic response|13|||
146426257|NCT01941095|528067440|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
146426258|NCT01941095|528067440|FG000|Overall Study|Adverse Event|11|||
146426259|NCT01941095|528067440|FG000|Overall Study|Physician Decision|3|||
146426260|NCT01941095|528067440|FG000|Overall Study|Withdrawal by Subject|17|||
146426261|NCT01941095|528067440|FG000|Overall Study|Lost to Follow-up|10|||
146426262|NCT00088829|528067448|FG000|Overall Study|PI left institution and study was close|22|||
146426263|NCT01475838|528067452|FG000|Randomized Phase|Randomized but Not Treated|0|||
146426264|NCT01475838|528067453|FG001|Randomized Phase|Randomized but Not Treated|5|||
146426265|NCT01475838|528067452|FG000|Randomized Phase|Adverse Event|6|||
146426266|NCT01475838|528067453|FG001|Randomized Phase|Adverse Event|1|||
146426267|NCT01475838|528067452|FG000|Randomized Phase|Pregnancy|0|||
146426268|NCT01475838|528067453|FG001|Randomized Phase|Pregnancy|1|||
146426269|NCT01475838|528067452|FG000|Randomized Phase|Investigators Discretion|1|||
146426270|NCT01475838|528067453|FG001|Randomized Phase|Investigators Discretion|2|||
146426271|NCT01475838|528067452|FG000|Randomized Phase|Withdrew Consent|10|||
146426272|NCT01475838|528067453|FG001|Randomized Phase|Withdrew Consent|14|||
146426273|NCT01475838|528067452|FG000|Randomized Phase|Lost to Follow-up|3|||
146426274|NCT01475838|528067453|FG001|Randomized Phase|Lost to Follow-up|4|||
146426275|NCT01475838|528067452|FG000|Randomized Phase|Participant Noncompliance|1|||
146426276|NCT01475838|528067453|FG001|Randomized Phase|Participant Noncompliance|5|||
146426277|NCT01475838|528067452|FG000|Randomized Phase|Protocol Violation|9|||
146426278|NCT01475838|528067453|FG001|Randomized Phase|Protocol Violation|4|||
146426279|NCT01475838|528067452|FG000|Extension Phase|Participant Noncompliance|1|||
146426280|NCT01475838|528067453|FG001|Extension Phase|Participant Noncompliance|0|||
146426281|NCT00048568|528067459|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
146426282|NCT00048568|528067460|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
146426283|NCT00048568|528067461|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
146426284|NCT00048568|528067459|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
146426285|NCT00048568|528067460|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
146426286|NCT00048568|528067461|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
146426287|NCT00048568|528067459|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
146426288|NCT00048568|528067460|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
145949690|NCT02620384|526326732|FG001|Overall Study|Discharged prior to 2nd dose|5|||
146199576|NCT03523091|527243240|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
146199577|NCT03523091|527243239|FG000|Overall Study|Withdrawal by Subject|0|||
146199578|NCT03523091|527243240|FG001|Overall Study|Withdrawal by Subject|3|||
146199579|NCT03523091|527243239|FG000|Overall Study|Increase Botox dose|0|||
146199580|NCT03523091|527243240|FG001|Overall Study|Increase Botox dose|1|||
146199581|NCT00741988|527243241|FG000|Overall Study|Adverse Event|2|||
146199582|NCT00741988|527243242|FG001|Overall Study|Adverse Event|4|||
146199583|NCT00741988|527243241|FG000|Overall Study|Lack of Efficacy|2|||
146199584|NCT00741988|527243242|FG001|Overall Study|Lack of Efficacy|0|||
146199585|NCT02685488|527243249|FG000|Overall Study|Withdrawal by Subject|0|||
146426289|NCT00048568|528067461|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
146426290|NCT00048568|528067459|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
146426291|NCT00048568|528067460|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
146426292|NCT00048568|528067461|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
146426293|NCT00048568|528067459|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
146426294|NCT00048568|528067460|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
146426295|NCT00048568|528067461|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
146426296|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Death|1|||
146426297|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Death|1|||
146426298|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Death|0|||
146426299|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
145949691|NCT02620384|526326731|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
145949692|NCT02620384|526326732|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
145949693|NCT02071082|526326733|FG000|Overall Study|Enrolled and Never Treated|1|||
145949694|NCT02071082|526326734|FG001|Overall Study|Enrolled and Never Treated|1|||
145949695|NCT02071082|526326733|FG000|Overall Study|Adverse Event|0|||
145949696|NCT02071082|526326734|FG001|Overall Study|Adverse Event|1|||
145949697|NCT02071082|526326733|FG000|Overall Study|Withdrew Consent|0|||
145949698|NCT02071082|526326734|FG001|Overall Study|Withdrew Consent|4|||
145949699|NCT02071082|526326733|FG000|Overall Study|Lost to Follow-up|1|||
145949700|NCT02071082|526326734|FG001|Overall Study|Lost to Follow-up|1|||
145949701|NCT00630747|526326737|FG000|Overall Study|Death|1|||
145949702|NCT00630747|526326737|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
145949703|NCT00630747|526326737|FG000|Overall Study|Returned to country of origin|1|||
145949704|NCT03782974|526326740|FG000|Overall Study|Withdrawal by Subject|7|||
145949705|NCT03782974|526326741|FG001|Overall Study|Withdrawal by Subject|7|||
145949706|NCT03782974|526326740|FG000|Overall Study|Pregnancy|1|||
145949707|NCT03782974|526326741|FG001|Overall Study|Pregnancy|0|||
145949708|NCT01078298|526326744|FG000|Overall Study|Lost to Follow-up|12|||
145949709|NCT01078298|526326745|FG001|Overall Study|Lost to Follow-up|13|||
145949710|NCT01078298|526326744|FG000|Overall Study|Withdrawal by Subject|31|||
145949711|NCT01078298|526326745|FG001|Overall Study|Withdrawal by Subject|33|||
145949712|NCT01078298|526326744|FG000|Overall Study|Protocol Violation|6|||
145949713|NCT01078298|526326745|FG001|Overall Study|Protocol Violation|6|||
145949714|NCT01078298|526326744|FG000|Overall Study|Adverse Event|6|||
145949715|NCT01078298|526326745|FG001|Overall Study|Adverse Event|5|||
145949716|NCT01078298|526326744|FG000|Overall Study|Death|2|||
145949717|NCT01078298|526326745|FG001|Overall Study|Death|0|||
145949718|NCT01078298|526326744|FG000|Overall Study|Did not meet entrance criteria|0|||
145949719|NCT01078298|526326745|FG001|Overall Study|Did not meet entrance criteria|1|||
145949720|NCT01078298|526326744|FG000|Overall Study|Other|24|||
145949721|NCT01078298|526326745|FG001|Overall Study|Other|32|||
145949722|NCT00628927|526326753|FG000|Overall Study|Problems performing blood draw|6|||
145949723|NCT00628927|526326754|FG001|Overall Study|Problems performing blood draw|0|||
145949724|NCT00628927|526326753|FG000|Overall Study|Lost to Follow-up|1|||
145949725|NCT00628927|526326754|FG001|Overall Study|Lost to Follow-up|0|||
145949726|NCT00628927|526326753|FG000|Overall Study|Equipment failure|1|||
145949727|NCT00628927|526326754|FG001|Overall Study|Equipment failure|0|||
145949728|NCT01298141|526326755|FG000|Overall Study|Adverse Event|3|||
145949729|NCT01298141|526326755|FG000|Overall Study|Refusal of Required Study Procedures|1|||
145949730|NCT01298141|526326755|FG000|Overall Study|Withdrawal by Subject|6|||
145949731|NCT01298141|526326755|FG000|Overall Study|Termination of Study by the Investigator|5|||
145949732|NCT01298141|526326755|FG000|Overall Study|Other|5|||
145949733|NCT01298141|526326755|FG000|Overall Study|Lost to Follow-up|1|||
145949734|NCT01298141|526326755|FG000|Overall Study|Death|6|||
145949735|NCT01298141|526326755|FG000|Overall Study|Not treated|4|||
145949736|NCT01421147|526328647|FG000|Treatment Period|Adverse Event|2|||
145949737|NCT01421147|526328648|FG001|Treatment Period|Adverse Event|3|||
145949738|NCT01421147|526328647|FG000|Treatment Period|Lost to Follow-up|2|||
145949739|NCT01421147|526328648|FG001|Treatment Period|Lost to Follow-up|1|||
145949740|NCT01421147|526328647|FG000|Treatment Period|Physician Decision|2|||
145949741|NCT01421147|526328648|FG001|Treatment Period|Physician Decision|2|||
145949742|NCT01421147|526328647|FG000|Treatment Period|Withdrawal by Subject|10|||
145949743|NCT01421147|526328648|FG001|Treatment Period|Withdrawal by Subject|5|||
145949744|NCT01421147|526328647|FG000|Extension Period|Adverse Event|0|||
145949745|NCT01421147|526328648|FG001|Extension Period|Adverse Event|2|||
145949746|NCT01421147|526328647|FG000|Extension Period|Death|0|||
145949747|NCT01421147|526328648|FG001|Extension Period|Death|1|||
145949748|NCT01421147|526328647|FG000|Extension Period|Lost to Follow-up|2|||
145949749|NCT01421147|526328648|FG001|Extension Period|Lost to Follow-up|5|||
145949750|NCT01421147|526328647|FG000|Extension Period|Physician Decision|1|||
145949751|NCT01421147|526328648|FG001|Extension Period|Physician Decision|0|||
145949752|NCT01421147|526328647|FG000|Extension Period|Withdrawal by Subject|5|||
145949753|NCT01421147|526328648|FG001|Extension Period|Withdrawal by Subject|3|||
145949754|NCT03307837|526328649|FG000|Overall Study|Withdrawal by Subject|0|||
145949755|NCT03307837|526328650|FG001|Overall Study|Withdrawal by Subject|0|||
145949756|NCT03307837|526328651|FG002|Overall Study|Withdrawal by Subject|1|||
145949757|NCT03307837|526328652|FG003|Overall Study|Withdrawal by Subject|0|||
145949758|NCT03307837|526328653|FG004|Overall Study|Withdrawal by Subject|0|||
145949759|NCT03307837|526328654|FG005|Overall Study|Withdrawal by Subject|1|||
145949760|NCT03307837|526328649|FG000|Overall Study|Lost to Follow-up|1|||
145949761|NCT03307837|526328650|FG001|Overall Study|Lost to Follow-up|1|||
145949762|NCT03307837|526328651|FG002|Overall Study|Lost to Follow-up|0|||
145949763|NCT03307837|526328652|FG003|Overall Study|Lost to Follow-up|0|||
145949764|NCT03307837|526328653|FG004|Overall Study|Lost to Follow-up|0|||
145949765|NCT03307837|526328654|FG005|Overall Study|Lost to Follow-up|1|||
145949766|NCT00904917|526328656|FG000|Overall Study|Lost to Follow-up|2|||
145949767|NCT00904917|526328657|FG001|Overall Study|Lost to Follow-up|2|||
145949768|NCT00904917|526328658|FG002|Overall Study|Lost to Follow-up|2|||
146426300|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
146426301|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
146426302|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
146426303|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
146426304|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
146426305|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
146426306|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
146426307|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
146426308|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
146426309|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
146426310|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
146426311|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
146426312|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
146426313|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
146426314|NCT00048568|528067459|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
146426315|NCT00048568|528067460|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
146426316|NCT00048568|528067461|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
146426317|NCT00048568|528067459|FG000|Open-Label Period|Death|0|||
146426318|NCT00048568|528067460|FG001|Open-Label Period|Death|0|||
146426319|NCT00048568|528067461|FG002|Open-Label Period|Death|13|||
146426320|NCT00048568|528067459|FG000|Open-Label Period|Adverse Event|0|||
146426321|NCT00048568|528067460|FG001|Open-Label Period|Adverse Event|0|||
146426322|NCT00048568|528067461|FG002|Open-Label Period|Adverse Event|49|||
146426323|NCT00048568|528067459|FG000|Open-Label Period|Lack of Efficacy|0|||
146426324|NCT00048568|528067460|FG001|Open-Label Period|Lack of Efficacy|0|||
146426325|NCT00048568|528067461|FG002|Open-Label Period|Lack of Efficacy|32|||
146426326|NCT00048568|528067459|FG000|Open-Label Period|Withdrawal by Subject|0|||
146426327|NCT00048568|528067460|FG001|Open-Label Period|Withdrawal by Subject|0|||
146426328|NCT00048568|528067461|FG002|Open-Label Period|Withdrawal by Subject|26|||
146426329|NCT00048568|528067459|FG000|Open-Label Period|Pregnancy|0|||
146426330|NCT00048568|528067460|FG001|Open-Label Period|Pregnancy|0|||
146426331|NCT00048568|528067461|FG002|Open-Label Period|Pregnancy|5|||
146426332|NCT00048568|528067459|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
146426333|NCT00048568|528067460|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
146426334|NCT00048568|528067461|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
146426335|NCT00048568|528067459|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
146426336|NCT00048568|528067460|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
146426337|NCT00048568|528067461|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
146426338|NCT00048568|528067459|FG000|Open-Label Period|Unknown Reasons|0|||
146426339|NCT00048568|528067460|FG001|Open-Label Period|Unknown Reasons|0|||
146426340|NCT00048568|528067461|FG002|Open-Label Period|Unknown Reasons|25|||
146426341|NCT00048568|528067459|FG000|Open-Label Period|Lost to Follow-up|0|||
146426342|NCT00048568|528067460|FG001|Open-Label Period|Lost to Follow-up|0|||
146426343|NCT00048568|528067461|FG002|Open-Label Period|Lost to Follow-up|7|||
146426344|NCT03831048|528067462|FG000|Overall Study|Protocol Violation|9|||
146426345|NCT03831048|528067463|FG001|Overall Study|Protocol Violation|3|||
146426346|NCT03831048|528067462|FG000|Overall Study|Death|4|||
146426347|NCT03831048|528067463|FG001|Overall Study|Death|9|||
146426348|NCT03831048|528067462|FG000|Overall Study|Re-transplant|0|||
146426349|NCT03831048|528067463|FG001|Overall Study|Re-transplant|2|||
146426350|NCT03831048|528067462|FG000|Overall Study|Protocol violation and death|1|||
146426351|NCT03831048|528067463|FG001|Overall Study|Protocol violation and death|1|||
146426352|NCT01315249|528067468|FG000|Overall Study|Adverse Event|22|||
146426353|NCT01315249|528067469|FG001|Overall Study|Adverse Event|26|||
146426354|NCT01315249|528067468|FG000|Overall Study|Withdrawal by Subject|11|||
146426355|NCT01315249|528067469|FG001|Overall Study|Withdrawal by Subject|10|||
146426356|NCT01315249|528067468|FG000|Overall Study|Protocol Violation|8|||
146426357|NCT01315249|528067469|FG001|Overall Study|Protocol Violation|5|||
146426358|NCT01315249|528067468|FG000|Overall Study|Abnormal test results|1|||
146426359|NCT01315249|528067469|FG001|Overall Study|Abnormal test results|2|||
146426360|NCT01315249|528067468|FG000|Overall Study|Administrative problems|1|||
146426361|NCT01315249|528067469|FG001|Overall Study|Administrative problems|0|||
146426362|NCT01315249|528067468|FG000|Overall Study|inability to use device|1|||
146426363|NCT01315249|528067469|FG001|Overall Study|inability to use device|0|||
146426364|NCT01315249|528067468|FG000|Overall Study|Lack of Efficacy|0|||
146426365|NCT01315249|528067469|FG001|Overall Study|Lack of Efficacy|1|||
146426366|NCT01315249|528067468|FG000|Overall Study|Lost to Follow-up|0|||
146426367|NCT01315249|528067469|FG001|Overall Study|Lost to Follow-up|2|||
146426368|NCT01315249|528067468|FG000|Overall Study|Death|0|||
146426369|NCT01315249|528067469|FG001|Overall Study|Death|1|||
146199586|NCT02685488|527243250|FG001|Overall Study|Withdrawal by Subject|1|||
146199587|NCT05019729|527243251|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146199588|NCT05019729|527243252|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146426370|NCT03227445|528067470|FG000|Period 1 (28 Days)|Adverse Event|1|||
146426371|NCT03227445|528067471|FG001|Period 1 (28 Days)|Adverse Event|2|||
146426372|NCT03227445|528067472|FG002|Period 1 (28 Days)|Adverse Event|0|||
146199589|NCT05019729|527243253|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146199590|NCT05019729|527243254|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146199591|NCT05019729|527243255|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
146199592|NCT05019729|527243256|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
146199593|NCT03538054|527243257|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
146199594|NCT03538054|527243257|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
146199595|NCT03538054|527243257|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
146199596|NCT03254394|527243258|FG000|Overall Study|Withdrawal by Subject|0|||
146199597|NCT03254394|527243259|FG001|Overall Study|Withdrawal by Subject|2|||
146199598|NCT00387465|527243268|FG000|Overall Study|Withdrawal by Subject|0|||
146199599|NCT00387465|527243269|FG001|Overall Study|Withdrawal by Subject|1|||
146199600|NCT00387465|527243270|FG002|Overall Study|Withdrawal by Subject|0|||
146199601|NCT00605033|527243272|FG000|Overall Study|Adverse Event|2|||
146199602|NCT00605033|527243273|FG001|Overall Study|Adverse Event|2|||
146199603|NCT00605033|527243272|FG000|Overall Study|Lost to Follow-up|1|||
146199604|NCT00605033|527243273|FG001|Overall Study|Lost to Follow-up|1|||
146199605|NCT00605033|527243272|FG000|Overall Study|Withdrawal by Subject|3|||
146199606|NCT00605033|527243273|FG001|Overall Study|Withdrawal by Subject|4|||
146199607|NCT00605033|527243272|FG000|Overall Study|Protocol Violation|1|||
146199608|NCT00605033|527243273|FG001|Overall Study|Protocol Violation|1|||
146199609|NCT01196429|527243274|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146199610|NCT01196429|527243275|FG001|Overall Study|Ineligible - inadequate pathology|0|||
146199611|NCT01196429|527243274|FG000|Overall Study|Ineligible - wrong cell type|1|||
146199612|NCT01196429|527243275|FG001|Overall Study|Ineligible - wrong cell type|0|||
146199613|NCT01196429|527243274|FG000|Overall Study|Refused - Never Treated|1|||
146199614|NCT01196429|527243275|FG001|Overall Study|Refused - Never Treated|0|||
146199615|NCT03768206|527243276|FG000|Overall Study|Lost to Follow-up|2|||
146199616|NCT03768206|527243277|FG001|Overall Study|Lost to Follow-up|1|||
146199617|NCT03768206|527243276|FG000|Overall Study|Withdrawal by Subject|0|||
146199618|NCT03768206|527243277|FG001|Overall Study|Withdrawal by Subject|1|||
146199619|NCT02754479|527243278|FG000|Overall Study|Lost to Follow-up|1|||
146199620|NCT02299336|527243283|FG000|Overall Study|Withdrawal by Subject|11|||
146199621|NCT02299336|527243283|FG000|Overall Study|Adverse Event|1|||
146199622|NCT02299336|527243283|FG000|Overall Study|Death|1|||
146199623|NCT02299336|527243283|FG000|Overall Study|Lost to Follow-up|1|||
146199624|NCT02106442|527243287|FG000|Overall Study|Case Report Forms Uncollected|7|||
146199625|NCT02106442|527243287|FG000|Overall Study|Protocol Deviation|30|||
146199626|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146199627|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
146199628|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
146199629|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199630|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199631|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199632|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199633|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199634|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146199635|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146199636|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146199637|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146199638|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199639|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199640|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199641|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199642|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199643|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146199644|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
146426373|NCT03227445|528067473|FG003|Period 1 (28 Days)|Adverse Event|1|||
146426374|NCT03227445|528067470|FG000|Period 1 (28 Days)|Protocol Violation|1|||
146426375|NCT03227445|528067471|FG001|Period 1 (28 Days)|Protocol Violation|0|||
146199645|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
146426376|NCT03227445|528067472|FG002|Period 1 (28 Days)|Protocol Violation|0|||
146426377|NCT03227445|528067473|FG003|Period 1 (28 Days)|Protocol Violation|0|||
146426378|NCT03227445|528067470|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
146426379|NCT03227445|528067471|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
146426380|NCT03227445|528067472|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
146426381|NCT03227445|528067473|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
146426382|NCT03227445|528067470|FG000|Period 2 (28 Days)|Adverse Event|1|||
146426383|NCT03227445|528067471|FG001|Period 2 (28 Days)|Adverse Event|0|||
146426384|NCT03227445|528067472|FG002|Period 2 (28 Days)|Adverse Event|2|||
146426385|NCT03227445|528067473|FG003|Period 2 (28 Days)|Adverse Event|1|||
146426386|NCT03227445|528067470|FG000|Period 2 (28 Days)|Protocol Violation|0|||
146426387|NCT03227445|528067471|FG001|Period 2 (28 Days)|Protocol Violation|0|||
146426388|NCT03227445|528067472|FG002|Period 2 (28 Days)|Protocol Violation|0|||
146426389|NCT03227445|528067473|FG003|Period 2 (28 Days)|Protocol Violation|1|||
146426390|NCT03227445|528067470|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
146426391|NCT03227445|528067471|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
146426392|NCT03227445|528067472|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
146426393|NCT03227445|528067473|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
146426394|NCT00365300|528067476|FG000|Open-label Phase|Adverse Event|4|||
146426395|NCT00365300|528067477|FG001|Open-label Phase|Adverse Event|0|||
146426396|NCT00365300|528067476|FG000|Open-label Phase|Failed to Return|1|||
146426397|NCT00365300|528067477|FG001|Open-label Phase|Failed to Return|0|||
146426398|NCT00365300|528067476|FG000|Open-label Phase|Physician Decision|1|||
146426399|NCT00365300|528067477|FG001|Open-label Phase|Physician Decision|0|||
146426400|NCT00365300|528067476|FG000|Open-label Phase|Noncompliance|9|||
146426401|NCT00365300|528067477|FG001|Open-label Phase|Noncompliance|0|||
146426402|NCT00365300|528067476|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
146426403|NCT00365300|528067477|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
146426404|NCT00365300|528067476|FG000|Open-label Phase|Protocol Violation|1|||
146426405|NCT00365300|528067477|FG001|Open-label Phase|Protocol Violation|0|||
146426406|NCT00365300|528067476|FG000|Open-label Phase|Lack of Efficacy|1|||
146426407|NCT00365300|528067477|FG001|Open-label Phase|Lack of Efficacy|0|||
146426408|NCT00365300|528067476|FG000|Open-label Phase|Patient skipped open label phase|1|||
146426409|NCT00365300|528067477|FG001|Open-label Phase|Patient skipped open label phase|0|||
146426410|NCT00365300|528067476|FG000|Double-blind Phase|Failed to return|1|||
146426411|NCT00365300|528067477|FG001|Double-blind Phase|Failed to return|0|||
146426412|NCT00365300|528067476|FG000|Double-blind Phase|Noncompliance|1|||
146426413|NCT00365300|528067477|FG001|Double-blind Phase|Noncompliance|1|||
146426414|NCT00365300|528067476|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146426415|NCT00365300|528067477|FG001|Double-blind Phase|Withdrawal by Subject|1|||
146426416|NCT00365300|528067476|FG000|Double-blind Phase|Protocol Violation|3|||
146426417|NCT00365300|528067477|FG001|Double-blind Phase|Protocol Violation|1|||
146426418|NCT00365300|528067476|FG000|Double-blind Phase|Lack of Efficacy|6|||
146426419|NCT00365300|528067477|FG001|Double-blind Phase|Lack of Efficacy|6|||
146426420|NCT01991470|528067478|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
146199646|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
146199647|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199648|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199649|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199650|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199651|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199652|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146199653|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
146199654|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199655|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
146199656|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199657|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199658|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199659|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199660|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199661|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146199662|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146426421|NCT01991470|528067478|FG000|Enlite 1 Period|Adverse Event|1|||
146426422|NCT01991470|528067478|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
146426423|NCT01991470|528067478|FG000|Enlite 3 Period|Lost to Follow-up|1|||
146426424|NCT01991470|528067478|FG000|Enlite 3 Period|Physician Decision|2|||
146426425|NCT01991470|528067478|FG000|Enlite 3 Period|Physician Decision|8|||
146426426|NCT01991470|528067478|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
146426427|NCT02896361|528067495|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
146426428|NCT02896361|528067496|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
146426429|NCT02896361|528067497|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
146426430|NCT02896361|528067495|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
146426431|NCT02896361|528067496|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
146199663|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146199664|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
146199665|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199666|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199667|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199668|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199669|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199670|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146199671|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199672|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146199673|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146199674|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199675|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199676|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199677|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199678|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199679|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146199680|NCT01212757|527243291|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
146199681|NCT01212757|527243292|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
146199682|NCT01212757|527243293|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199683|NCT01212757|527243294|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199684|NCT01212757|527243295|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199685|NCT01212757|527243296|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199686|NCT01212757|527243297|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199687|NCT01212757|527243298|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199688|NCT01212757|527243299|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146199689|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146199690|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
146199691|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
146199692|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
146199693|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146199694|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
146199695|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146199696|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146199697|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
146199698|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146199699|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
146199700|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
146199701|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
146199702|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146199703|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
146199704|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146199705|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146199706|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
146199707|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199708|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199709|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
146199710|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199711|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199712|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199713|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199714|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199715|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
146199716|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146199717|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146199718|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
146199719|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146199720|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
146199721|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
146199722|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146199723|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146199724|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
146199725|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199726|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
146199727|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146426432|NCT02896361|528067497|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
146426433|NCT03164772|528067498|FG000|Overall Study|Death|4|||
146426434|NCT03164772|528067499|FG001|Overall Study|Death|2|||
146426435|NCT03164772|528067498|FG000|Overall Study|Adverse Event|1|||
146426436|NCT03164772|528067499|FG001|Overall Study|Adverse Event|4|||
146426437|NCT03164772|528067498|FG000|Overall Study|Progressive Disease|11|||
146426438|NCT03164772|528067499|FG001|Overall Study|Progressive Disease|21|||
146426439|NCT03164772|528067498|FG000|Overall Study|Physician Decision|2|||
146426440|NCT03164772|528067499|FG001|Overall Study|Physician Decision|0|||
146426441|NCT03164772|528067498|FG000|Overall Study|Withdrawal by Subject|0|||
146426442|NCT03164772|528067499|FG001|Overall Study|Withdrawal by Subject|4|||
146426443|NCT01029353|528067501|FG000|Overall Study|Lost to Follow-up|4|||
146426444|NCT01029353|528067502|FG001|Overall Study|Lost to Follow-up|5|||
146426445|NCT01029353|528067503|FG002|Overall Study|Lost to Follow-up|5|||
146426446|NCT01029353|528067504|FG003|Overall Study|Lost to Follow-up|4|||
146426447|NCT01029353|528067501|FG000|Overall Study|Consent Withdrawn|2|||
146426448|NCT01029353|528067502|FG001|Overall Study|Consent Withdrawn|0|||
146426449|NCT01029353|528067503|FG002|Overall Study|Consent Withdrawn|0|||
146426450|NCT01029353|528067504|FG003|Overall Study|Consent Withdrawn|0|||
146426451|NCT01029353|528067501|FG000|Overall Study|Primary Outcome Indeterminate|1|||
146426452|NCT01029353|528067502|FG001|Overall Study|Primary Outcome Indeterminate|3|||
146426453|NCT01029353|528067503|FG002|Overall Study|Primary Outcome Indeterminate|2|||
146426454|NCT01029353|528067504|FG003|Overall Study|Primary Outcome Indeterminate|0|||
146426455|NCT02932878|528067507|FG000|Overall Study|Due to Lab Results|2|||
146426456|NCT02932878|528067508|FG001|Overall Study|Due to Lab Results|1|||
146426457|NCT00849901|528067509|FG000|Acute Treatment Phase|Adverse Event|9|||
146199728|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199729|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
146199730|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199731|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199732|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199733|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
146199734|NCT01212757|527243291|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199735|NCT01212757|527243292|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
146199736|NCT01212757|527243293|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
146199737|NCT01212757|527243294|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199738|NCT01212757|527243295|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199739|NCT01212757|527243296|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199740|NCT01212757|527243297|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199741|NCT01212757|527243298|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199742|NCT01212757|527243299|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
146199743|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199744|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199745|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199746|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199747|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199748|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199749|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199750|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
146199751|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
146199752|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146199753|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
146199754|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
146199755|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146199756|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146199757|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146199758|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
146199759|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
146426458|NCT00849901|528067510|FG001|Acute Treatment Phase|Adverse Event|1|||
146426459|NCT00849901|528067511|FG002|Acute Treatment Phase|Adverse Event|3|||
146426460|NCT00849901|528067509|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
146426461|NCT00849901|528067510|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
146426462|NCT00849901|528067511|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
146426463|NCT00849901|528067509|FG000|Acute Treatment Phase|Protocol Violation|0|||
146426464|NCT00849901|528067510|FG001|Acute Treatment Phase|Protocol Violation|2|||
146426465|NCT00849901|528067511|FG002|Acute Treatment Phase|Protocol Violation|1|||
146426466|NCT00849901|528067509|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
146199760|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
145949769|NCT00904917|526328659|FG003|Overall Study|Lost to Follow-up|2|||
145949770|NCT00762034|526328660|FG000|Induction Period|Protocol Violation|1|||
145949771|NCT00762034|526328661|FG001|Induction Period|Protocol Violation|2|||
145949772|NCT00762034|526328660|FG000|Induction Period|Entry Criterion Not Met|12|||
145949773|NCT00762034|526328661|FG001|Induction Period|Entry Criterion Not Met|11|||
145949774|NCT00762034|526328660|FG000|Induction Period|Adverse Event|27|||
145949775|NCT00762034|526328661|FG001|Induction Period|Adverse Event|38|||
145949776|NCT00762034|526328660|FG000|Induction Period|Lost to Follow-up|1|||
145949777|NCT00762034|526328661|FG001|Induction Period|Lost to Follow-up|1|||
145949778|NCT00762034|526328660|FG000|Induction Period|Progressive Disease|73|||
145949779|NCT00762034|526328661|FG001|Induction Period|Progressive Disease|55|||
145949780|NCT00762034|526328660|FG000|Induction Period|Physician Decision|21|||
145949781|NCT00762034|526328661|FG001|Induction Period|Physician Decision|20|||
145949782|NCT00762034|526328660|FG000|Induction Period|Withdrawal by Subject|15|||
145949783|NCT00762034|526328661|FG001|Induction Period|Withdrawal by Subject|19|||
145949784|NCT00762034|526328660|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
145949785|NCT00762034|526328661|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
145949786|NCT00762034|526328660|FG000|Induction Period|Deaths Due to Study Disease|9|||
145949787|NCT00762034|526328661|FG001|Induction Period|Deaths Due to Study Disease|9|||
145949788|NCT00762034|526328660|FG000|Maintenance Period|Protocol Violation|1|||
145949789|NCT00762034|526328661|FG001|Maintenance Period|Protocol Violation|3|||
145949790|NCT00762034|526328660|FG000|Maintenance Period|Entry Criterion Not Met|0|||
145949791|NCT00762034|526328661|FG001|Maintenance Period|Entry Criterion Not Met|2|||
145949792|NCT00762034|526328660|FG000|Maintenance Period|Adverse Event|42|||
145949793|NCT00762034|526328661|FG001|Maintenance Period|Adverse Event|26|||
145949794|NCT00762034|526328660|FG000|Maintenance Period|Progressive Disease|186|||
145949795|NCT00762034|526328661|FG001|Maintenance Period|Progressive Disease|224|||
145949796|NCT00762034|526328660|FG000|Maintenance Period|Physician Decision|25|||
145949797|NCT00762034|526328661|FG001|Maintenance Period|Physician Decision|20|||
145949798|NCT00762034|526328660|FG000|Maintenance Period|Withdrawal by Subject|34|||
145949799|NCT00762034|526328661|FG001|Maintenance Period|Withdrawal by Subject|14|||
145949800|NCT00762034|526328660|FG000|Maintenance Period|Death not due to study disease|2|||
145949801|NCT00762034|526328661|FG001|Maintenance Period|Death not due to study disease|5|||
145949802|NCT00762034|526328660|FG000|Maintenance Period|Death due to study disease|3|||
145949803|NCT00762034|526328661|FG001|Maintenance Period|Death due to study disease|3|||
145949804|NCT00762034|526328660|FG000|Maintenance Period|Other|1|||
145949805|NCT00762034|526328661|FG001|Maintenance Period|Other|1|||
145949806|NCT02442206|526328662|FG000|Period 1|Adverse Event|1|||
145949807|NCT02442206|526328663|FG001|Period 1|Adverse Event|1|||
145949808|NCT02442206|526328662|FG000|Period 1|withdrew consent|0|||
145949809|NCT02442206|526328663|FG001|Period 1|withdrew consent|1|||
145949810|NCT02442206|526328662|FG000|Period 1|COPD exacerbation|0|||
145949811|NCT02442206|526328663|FG001|Period 1|COPD exacerbation|1|||
145949812|NCT02442206|526328662|FG000|Period 2|Adverse Event|1|||
145949813|NCT02442206|526328663|FG001|Period 2|Adverse Event|0|||
145949814|NCT01471444|526328664|FG000|Overall Study|Physician Decision|3|||
145949815|NCT01471444|526328665|FG001|Overall Study|Physician Decision|2|||
145949816|NCT01471444|526328664|FG000|Overall Study|Withdrawal by Subject|0|||
145949817|NCT01471444|526328665|FG001|Overall Study|Withdrawal by Subject|1|||
145949818|NCT02107313|526328667|FG000|Overall Study|One participant did not do the FED cohor|0|||
145949819|NCT02107313|526328668|FG001|Overall Study|One participant did not do the FED cohor|1|||
145949820|NCT01031004|526328671|FG000|Overall Study|Protocol Violation|0|||
146199761|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146199762|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
146199763|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
146199764|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146199765|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146199766|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145949821|NCT01031004|526328672|FG001|Overall Study|Protocol Violation|1|||
145949822|NCT01031004|526328671|FG000|Overall Study|Lost to Follow-up|1|||
145949823|NCT01031004|526328672|FG001|Overall Study|Lost to Follow-up|0|||
145949824|NCT01641471|526328673|FG000|Overall Study|Withdrawal by Subject|19|||
145949825|NCT01641471|526328674|FG001|Overall Study|Withdrawal by Subject|19|||
145949826|NCT01641471|526328673|FG000|Overall Study|Lost to Follow-up|2|||
145949827|NCT01641471|526328674|FG001|Overall Study|Lost to Follow-up|4|||
145949828|NCT01641471|526328673|FG000|Overall Study|Protocol Violation|2|||
146199767|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145949829|NCT01641471|526328674|FG001|Overall Study|Protocol Violation|4|||
145949830|NCT01214668|526328680|FG000|Overall Study|Adverse Event|0|||
145949831|NCT01214668|526328681|FG001|Overall Study|Adverse Event|1|||
145949832|NCT01214668|526328682|FG002|Overall Study|Adverse Event|0|||
145949833|NCT01214668|526328683|FG003|Overall Study|Adverse Event|2|||
145949834|NCT01214668|526328684|FG004|Overall Study|Adverse Event|1|||
145949835|NCT01214668|526328685|FG005|Overall Study|Adverse Event|1|||
145949836|NCT01214668|526328680|FG000|Overall Study|Death|0|||
145949837|NCT01214668|526328681|FG001|Overall Study|Death|0|||
145949838|NCT01214668|526328682|FG002|Overall Study|Death|1|||
146199768|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
146199769|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
146199770|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146199771|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
146199772|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
146199773|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146199774|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146199775|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146426467|NCT00849901|528067510|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
146426468|NCT00849901|528067511|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
146426469|NCT00849901|528067509|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
146426470|NCT00849901|528067510|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
146426471|NCT00849901|528067511|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
146426472|NCT00849901|528067509|FG000|Acute Treatment Phase|Physician Decision|1|||
146426473|NCT00849901|528067510|FG001|Acute Treatment Phase|Physician Decision|1|||
146426474|NCT00849901|528067511|FG002|Acute Treatment Phase|Physician Decision|1|||
146426475|NCT00849901|528067509|FG000|Acute Treatment Phase|Sponsor Decision|1|||
146426476|NCT00849901|528067510|FG001|Acute Treatment Phase|Sponsor Decision|0|||
146426477|NCT00849901|528067511|FG002|Acute Treatment Phase|Sponsor Decision|0|||
146426478|NCT00849901|528067509|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
146426479|NCT00849901|528067510|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
146199776|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146199777|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146199778|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
146199779|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199780|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199781|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
146199782|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199783|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199784|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199785|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199786|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199787|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
146199788|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199789|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
146199790|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
146199791|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199792|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199793|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199794|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199795|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
146199796|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
146199797|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146199798|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
146199799|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
146199800|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146199801|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146199802|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146199803|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
146199804|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
146199805|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
146199806|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199807|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199808|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
146199809|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199810|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199811|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199812|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199813|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199814|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
146199815|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146199816|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
146199817|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146199818|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146199819|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146199820|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146199821|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146199822|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146199823|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146199824|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199825|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199826|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199827|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199828|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199829|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199830|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199831|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
146199832|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
146199833|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199834|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
146199835|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199836|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199837|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146082661|NCT01426789|526822868|FG003|Part 1|Lack of Efficacy|0|||
146082662|NCT01426789|526822869|FG004|Part 1|Lack of Efficacy|0|||
146199838|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199839|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199840|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199841|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
146199842|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199843|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199844|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
146199845|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199846|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199847|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199848|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199849|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
146199850|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
146199851|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199852|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
146199853|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199854|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199855|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199856|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199857|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199858|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
146199859|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
146199860|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146199861|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146199862|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
146199863|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146199864|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146199865|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146199866|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
146199867|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146199868|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
146199869|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146199870|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
146199871|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
146199872|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146199873|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146199874|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146199875|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
146199876|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
146199877|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
146199878|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146199879|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146199880|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
146199881|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146199882|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146199883|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146199884|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146199885|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
146199886|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
146199887|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
146199888|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
146199889|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
146199890|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
146199891|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
146199892|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
146199893|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
146199894|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
146199895|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
146199896|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199897|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145949839|NCT01214668|526328683|FG003|Overall Study|Death|0|||
146426480|NCT00849901|528067511|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
146426481|NCT00849901|528067509|FG000|Extension Phase|Adverse Event|2|||
146426482|NCT00849901|528067510|FG001|Extension Phase|Adverse Event|8|||
146426483|NCT00849901|528067511|FG002|Extension Phase|Adverse Event|4|||
146426484|NCT00849901|528067509|FG000|Extension Phase|Lost to Follow-up|3|||
146426485|NCT00849901|528067510|FG001|Extension Phase|Lost to Follow-up|0|||
146426486|NCT00849901|528067511|FG002|Extension Phase|Lost to Follow-up|1|||
146426487|NCT00849901|528067509|FG000|Extension Phase|Protocol Violation|2|||
146426488|NCT00849901|528067510|FG001|Extension Phase|Protocol Violation|2|||
146426489|NCT00849901|528067511|FG002|Extension Phase|Protocol Violation|4|||
146426490|NCT00849901|528067509|FG000|Extension Phase|Withdrawal by Subject|7|||
146426491|NCT00849901|528067510|FG001|Extension Phase|Withdrawal by Subject|6|||
146426492|NCT00849901|528067511|FG002|Extension Phase|Withdrawal by Subject|3|||
146426493|NCT00849901|528067509|FG000|Extension Phase|Parent or Caregiver Decision|10|||
146426494|NCT00849901|528067510|FG001|Extension Phase|Parent or Caregiver Decision|4|||
146426495|NCT00849901|528067511|FG002|Extension Phase|Parent or Caregiver Decision|4|||
146426496|NCT00849901|528067509|FG000|Extension Phase|Physician Decision|1|||
146426497|NCT00849901|528067510|FG001|Extension Phase|Physician Decision|2|||
146426498|NCT00849901|528067511|FG002|Extension Phase|Physician Decision|0|||
146426499|NCT00849901|528067509|FG000|Extension Phase|Lack of Efficacy|2|||
146426500|NCT00849901|528067510|FG001|Extension Phase|Lack of Efficacy|4|||
146426501|NCT00849901|528067511|FG002|Extension Phase|Lack of Efficacy|1|||
146426502|NCT02152566|528067514|FG000|Overall Study|Lost to Follow-up|1|||
146426503|NCT02152566|528067514|FG000|Overall Study|Withdrawal by Subject|2|||
146426504|NCT02731157|528067515|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
146426505|NCT02327130|528067516|FG000|Overall Study|Discharged in less than 5 days|5|||
146426506|NCT02327130|528067516|FG000|Overall Study|Physician Decision|2|||
146426507|NCT02327130|528067516|FG000|Overall Study|Unable to provide breath sample|1|||
146426508|NCT02327130|528067516|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
146426509|NCT02327130|528067516|FG000|Overall Study|Met exclusion criteria|3|||
146426510|NCT05214560|528067518|FG000|Overall Study|Screening Failure|1|||
146426511|NCT05214560|528067518|FG000|Overall Study|Physician Decision|4|||
146426512|NCT05214560|528067518|FG000|Overall Study|Withdrawal by Subject|1|||
146426513|NCT05214560|528067518|FG000|Overall Study|Lost to Follow-up|2|||
146426514|NCT05214560|528067518|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
146426515|NCT05214560|528067518|FG000|Overall Study|Study physician not available for the anesthesia|3|||
146426516|NCT05214560|528067518|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
146426517|NCT05214560|528067518|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
146426518|NCT05214560|528067518|FG000|Overall Study|Surgery not performed|3|||
146426519|NCT02672553|528067519|FG000|Overall Study|Death|3|||
146426520|NCT02672553|528067520|FG001|Overall Study|Death|5|||
146426521|NCT02672553|528067519|FG000|Overall Study|Valve Explant|1|||
146426522|NCT02672553|528067520|FG001|Overall Study|Valve Explant|0|||
146426523|NCT02672553|528067519|FG000|Overall Study|Conversion to Commercial Valve|3|||
146426524|NCT02672553|528067520|FG001|Overall Study|Conversion to Commercial Valve|0|||
146426525|NCT02672553|528067519|FG000|Overall Study|Withdrawal by Subject|3|||
146426526|NCT02672553|528067520|FG001|Overall Study|Withdrawal by Subject|3|||
146426527|NCT02672553|528067519|FG000|Overall Study|Intraoperative screen failure|2|||
146426528|NCT02672553|528067520|FG001|Overall Study|Intraoperative screen failure|0|||
146426529|NCT02003183|528067521|FG000|Overall Study|Lost to Follow-up|0|||
146426530|NCT02003183|528067522|FG001|Overall Study|Lost to Follow-up|2|||
146426531|NCT02343120|528067525|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
146426532|NCT02343120|528067526|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
146426533|NCT02343120|528067527|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
146426534|NCT02343120|528067528|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
146426535|NCT02343120|528067529|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
146426536|NCT02343120|528067525|FG000|Part 1: Dose Escalation|Death|1|||
146426537|NCT02343120|528067526|FG001|Part 1: Dose Escalation|Death|2|||
146426538|NCT02343120|528067527|FG002|Part 1: Dose Escalation|Death|2|||
146426539|NCT02343120|528067528|FG003|Part 1: Dose Escalation|Death|2|||
146426540|NCT02343120|528067529|FG004|Part 1: Dose Escalation|Death|1|||
146426541|NCT02343120|528067525|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
146426542|NCT02343120|528067526|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
145890965|NCT01207440|526107574|FG004|Overall Study|Site Terminated by Sponsor|3|||
146426543|NCT02343120|528067527|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146426544|NCT02343120|528067528|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146426545|NCT02343120|528067529|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146426546|NCT02343120|528067525|FG000|Part 2: Expansion|Sponsor decision|0|||
146426547|NCT02343120|528067526|FG001|Part 2: Expansion|Sponsor decision|0|||
146426548|NCT02343120|528067527|FG002|Part 2: Expansion|Sponsor decision|0|||
146426549|NCT02343120|528067528|FG003|Part 2: Expansion|Sponsor decision|165|||
146426550|NCT02343120|528067529|FG004|Part 2: Expansion|Sponsor decision|67|||
146426551|NCT02343120|528067525|FG000|Part 2: Expansion|Death|0|||
146426552|NCT02343120|528067526|FG001|Part 2: Expansion|Death|0|||
146426553|NCT02343120|528067527|FG002|Part 2: Expansion|Death|0|||
146426554|NCT02343120|528067528|FG003|Part 2: Expansion|Death|74|||
146426555|NCT02343120|528067529|FG004|Part 2: Expansion|Death|17|||
146426556|NCT02343120|528067525|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
146426557|NCT02343120|528067526|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
146426558|NCT02343120|528067527|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
146426559|NCT02343120|528067528|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
146426560|NCT02343120|528067529|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
146426561|NCT02343120|528067525|FG000|Part 2: Expansion|Lost to Follow-up|0|||
146426562|NCT02343120|528067526|FG001|Part 2: Expansion|Lost to Follow-up|0|||
146426563|NCT02343120|528067527|FG002|Part 2: Expansion|Lost to Follow-up|0|||
146426564|NCT02343120|528067528|FG003|Part 2: Expansion|Lost to Follow-up|5|||
146426565|NCT02343120|528067529|FG004|Part 2: Expansion|Lost to Follow-up|2|||
146426566|NCT02343120|528067525|FG000|Part 2: Expansion|Other|0|||
146426567|NCT02343120|528067526|FG001|Part 2: Expansion|Other|0|||
146426568|NCT02343120|528067527|FG002|Part 2: Expansion|Other|0|||
146426569|NCT02343120|528067528|FG003|Part 2: Expansion|Other|1|||
146426570|NCT02343120|528067529|FG004|Part 2: Expansion|Other|5|||
146426571|NCT02343120|528067525|FG000|Part 2: Expansion|Adverse Event|0|||
146426572|NCT02343120|528067526|FG001|Part 2: Expansion|Adverse Event|0|||
146426573|NCT02343120|528067527|FG002|Part 2: Expansion|Adverse Event|0|||
146426574|NCT02343120|528067528|FG003|Part 2: Expansion|Adverse Event|1|||
146426575|NCT02343120|528067529|FG004|Part 2: Expansion|Adverse Event|1|||
146426576|NCT02534493|528067530|FG000|Overall Study|Lost to Follow-up|1|||
146426577|NCT02534493|528067530|FG000|Overall Study|Withdrawal by Subject|1|||
146426578|NCT01054599|528067538|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
146426579|NCT01054599|528067539|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
146426580|NCT01054599|528067538|FG000|Overall Study|Protocol Violation|1|||
146426581|NCT01054599|528067539|FG001|Overall Study|Protocol Violation|0|||
146426582|NCT01054599|528067538|FG000|Overall Study|Spells/seizure-like episodes|1|||
146426583|NCT01054599|528067539|FG001|Overall Study|Spells/seizure-like episodes|1|||
146426584|NCT01054599|528067538|FG000|Overall Study|Timing/scheduling difficulties|1|||
146426585|NCT01054599|528067539|FG001|Overall Study|Timing/scheduling difficulties|1|||
146426586|NCT01054599|528067538|FG000|Overall Study|Visual impairment, WTAR <80|0|||
146426587|NCT01054599|528067539|FG001|Overall Study|Visual impairment, WTAR <80|1|||
146426588|NCT01054599|528067538|FG000|Overall Study|Lost to Follow-up|0|||
146426589|NCT01054599|528067539|FG001|Overall Study|Lost to Follow-up|2|||
146426590|NCT01054599|528067538|FG000|Overall Study|Adverse Event|0|||
146426591|NCT01054599|528067539|FG001|Overall Study|Adverse Event|1|||
146426592|NCT01054599|528067538|FG000|Overall Study|Withdrawal by Subject|0|||
146426593|NCT01054599|528067539|FG001|Overall Study|Withdrawal by Subject|1|||
146426594|NCT00743197|528067540|FG000|Overall Study|Study terminated due to departure of PI.|1|||
146426595|NCT00743197|528067541|FG001|Overall Study|Study terminated due to departure of PI.|2|||
146426596|NCT01104662|528067542|FG000|Overall Study|Adverse Event|2|||
146426597|NCT01104662|528067543|FG001|Overall Study|Adverse Event|2|||
146426598|NCT01104662|528067544|FG002|Overall Study|Adverse Event|0|||
146426599|NCT01104662|528067545|FG003|Overall Study|Adverse Event|1|||
146426600|NCT01104662|528067546|FG004|Overall Study|Adverse Event|1|||
146426601|NCT01104662|528067547|FG005|Overall Study|Adverse Event|1|||
146426602|NCT01104662|528067548|FG006|Overall Study|Adverse Event|0|||
146426603|NCT01104662|528067549|FG007|Overall Study|Adverse Event|0|||
146426604|NCT01104662|528067542|FG000|Overall Study|Clinical Failure|1|||
146426605|NCT01104662|528067543|FG001|Overall Study|Clinical Failure|0|||
146426606|NCT01104662|528067544|FG002|Overall Study|Clinical Failure|0|||
146426607|NCT01104662|528067545|FG003|Overall Study|Clinical Failure|0|||
146426608|NCT01104662|528067546|FG004|Overall Study|Clinical Failure|0|||
146426609|NCT01104662|528067547|FG005|Overall Study|Clinical Failure|1|||
146426610|NCT01104662|528067548|FG006|Overall Study|Clinical Failure|0|||
146426611|NCT01104662|528067549|FG007|Overall Study|Clinical Failure|0|||
146426612|NCT01104662|528067542|FG000|Overall Study|Participant left investigator's care|1|||
146426613|NCT01104662|528067543|FG001|Overall Study|Participant left investigator's care|1|||
146426614|NCT01104662|528067544|FG002|Overall Study|Participant left investigator's care|0|||
146426615|NCT01104662|528067545|FG003|Overall Study|Participant left investigator's care|0|||
146426616|NCT01104662|528067546|FG004|Overall Study|Participant left investigator's care|0|||
146426617|NCT01104662|528067547|FG005|Overall Study|Participant left investigator's care|0|||
146426618|NCT01104662|528067548|FG006|Overall Study|Participant left investigator's care|0|||
146426619|NCT01104662|528067549|FG007|Overall Study|Participant left investigator's care|0|||
146426620|NCT01104662|528067542|FG000|Overall Study|Reason not specified|3|||
146426621|NCT01104662|528067543|FG001|Overall Study|Reason not specified|3|||
146426622|NCT01104662|528067544|FG002|Overall Study|Reason not specified|0|||
146426623|NCT01104662|528067545|FG003|Overall Study|Reason not specified|0|||
146426624|NCT01104662|528067546|FG004|Overall Study|Reason not specified|0|||
146426625|NCT01104662|528067547|FG005|Overall Study|Reason not specified|1|||
146426626|NCT01104662|528067548|FG006|Overall Study|Reason not specified|0|||
146426627|NCT01104662|528067549|FG007|Overall Study|Reason not specified|0|||
146426628|NCT01104662|528067542|FG000|Overall Study|Randomized but not treated|3|||
146426629|NCT01104662|528067543|FG001|Overall Study|Randomized but not treated|4|||
146426630|NCT01104662|528067544|FG002|Overall Study|Randomized but not treated|1|||
146426631|NCT01104662|528067545|FG003|Overall Study|Randomized but not treated|0|||
146426632|NCT01104662|528067546|FG004|Overall Study|Randomized but not treated|0|||
146426633|NCT01104662|528067547|FG005|Overall Study|Randomized but not treated|1|||
146426634|NCT01104662|528067548|FG006|Overall Study|Randomized but not treated|0|||
146426635|NCT01104662|528067549|FG007|Overall Study|Randomized but not treated|0|||
146426636|NCT01478620|528067550|FG000|Overall Study|Lost to Follow-up|6|||
146426637|NCT02170688|528067555|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
146426638|NCT02170688|528067556|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
146426639|NCT02170688|528067557|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
146426640|NCT02170688|528067558|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
146426641|NCT02170688|528067559|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
146426642|NCT02170688|528067555|FG000|Overall Study|Full dose not received|0|||
146426643|NCT02170688|528067556|FG001|Overall Study|Full dose not received|1|||
146426644|NCT02170688|528067557|FG002|Overall Study|Full dose not received|0|||
146426645|NCT02170688|528067558|FG003|Overall Study|Full dose not received|0|||
146426646|NCT02170688|528067559|FG004|Overall Study|Full dose not received|0|||
146426647|NCT02170688|528067555|FG000|Overall Study|Physician Decision|0|||
146426648|NCT02170688|528067556|FG001|Overall Study|Physician Decision|0|||
146426649|NCT02170688|528067557|FG002|Overall Study|Physician Decision|1|||
146426650|NCT02170688|528067558|FG003|Overall Study|Physician Decision|0|||
146426651|NCT02170688|528067559|FG004|Overall Study|Physician Decision|0|||
146426652|NCT01402947|528067562|FG000|First Intervention|Adverse Event|0|||
146426653|NCT01402947|528067563|FG001|First Intervention|Adverse Event|1|||
146426654|NCT01706926|528067567|FG000|Overall Study|Lost to Follow-up|0|||
146426655|NCT01706926|528067568|FG001|Overall Study|Lost to Follow-up|0|||
146426656|NCT01706926|528067569|FG002|Overall Study|Lost to Follow-up|1|||
146426657|NCT01706926|528067570|FG003|Overall Study|Lost to Follow-up|0|||
146426658|NCT01706926|528067567|FG000|Overall Study|Withdrawal by Subject|2|||
146426659|NCT01706926|528067568|FG001|Overall Study|Withdrawal by Subject|0|||
146426660|NCT01706926|528067569|FG002|Overall Study|Withdrawal by Subject|1|||
146426661|NCT01706926|528067570|FG003|Overall Study|Withdrawal by Subject|2|||
146426662|NCT01706926|528067567|FG000|Overall Study|Other|4|||
146426663|NCT01706926|528067568|FG001|Overall Study|Other|4|||
146426664|NCT01706926|528067569|FG002|Overall Study|Other|4|||
146426665|NCT01706926|528067570|FG003|Overall Study|Other|3|||
146199898|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199899|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199900|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199901|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199902|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146199903|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
145949840|NCT01214668|526328684|FG004|Overall Study|Death|0|||
146082663|NCT01426789|526822870|FG005|Part 1|Lack of Efficacy|0|||
146199904|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
146426666|NCT04349917|528069345|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
146426667|NCT04349917|528069346|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
146426668|NCT04349917|528069345|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
146426669|NCT04349917|528069346|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
146426670|NCT04188106|528069347|FG000|Overall Study|Lost to Follow-up|5|||
146426671|NCT04188106|528069347|FG000|Overall Study|Non-Compliance|1|||
146426672|NCT00441467|528069348|FG000|Overall Study|Adverse Event|6|||
146426673|NCT00441467|528069348|FG000|Overall Study|Withdrawal by Subject|3|||
146426674|NCT00441467|528069348|FG000|Overall Study|Progressive disease|9|||
146426675|NCT01042522|528069349|FG000|Overall Study|Adverse Event|1|||
146426676|NCT01042522|528069350|FG001|Overall Study|Adverse Event|2|||
146426677|NCT01042522|528069349|FG000|Overall Study|Disease Progression|5|||
146426678|NCT01042522|528069350|FG001|Overall Study|Disease Progression|0|||
146426679|NCT01042522|528069349|FG000|Overall Study|Death|1|||
146426680|NCT01042522|528069350|FG001|Overall Study|Death|0|||
146426681|NCT01042522|528069349|FG000|Overall Study|Patient Refused|0|||
146426682|NCT01042522|528069350|FG001|Overall Study|Patient Refused|3|||
146426683|NCT01042522|528069349|FG000|Overall Study|Withdrawal by Subject|1|||
146426684|NCT01042522|528069350|FG001|Overall Study|Withdrawal by Subject|1|||
146426685|NCT01746017|528069353|FG000|Period 1|Withdrawal by Subject|0|||
146426686|NCT01746017|528069354|FG001|Period 1|Withdrawal by Subject|0|||
146426687|NCT01746017|528069355|FG002|Period 1|Withdrawal by Subject|0|||
146426688|NCT01746017|528069356|FG003|Period 1|Withdrawal by Subject|0|||
146426689|NCT01746017|528069357|FG004|Period 1|Withdrawal by Subject|0|||
146426690|NCT01746017|528069358|FG005|Period 1|Withdrawal by Subject|0|||
146426691|NCT01746017|528069359|FG006|Period 1|Withdrawal by Subject|1|||
146426692|NCT01746017|528069360|FG007|Period 1|Withdrawal by Subject|0|||
146426693|NCT01746017|528069361|FG008|Period 1|Withdrawal by Subject|0|||
146426694|NCT01746017|528069362|FG009|Period 1|Withdrawal by Subject|0|||
146426695|NCT01746017|528069363|FG010|Period 1|Withdrawal by Subject|0|||
146426696|NCT01746017|528069353|FG000|Period 3|Withdrawal by Subject|0|||
146426697|NCT01746017|528069354|FG001|Period 3|Withdrawal by Subject|0|||
146426698|NCT01746017|528069355|FG002|Period 3|Withdrawal by Subject|0|||
146426699|NCT01746017|528069356|FG003|Period 3|Withdrawal by Subject|0|||
146426700|NCT01746017|528069357|FG004|Period 3|Withdrawal by Subject|0|||
146426701|NCT01746017|528069358|FG005|Period 3|Withdrawal by Subject|1|||
146426702|NCT01746017|528069359|FG006|Period 3|Withdrawal by Subject|0|||
146426703|NCT01746017|528069360|FG007|Period 3|Withdrawal by Subject|0|||
146426704|NCT01746017|528069361|FG008|Period 3|Withdrawal by Subject|0|||
146426705|NCT01746017|528069362|FG009|Period 3|Withdrawal by Subject|0|||
146426706|NCT01746017|528069363|FG010|Period 3|Withdrawal by Subject|0|||
146426707|NCT01507051|528069364|FG000|Overall Study|Withdrawal by Subject|1|||
146426708|NCT01507051|528069365|FG001|Overall Study|Withdrawal by Subject|3|||
146426709|NCT01507051|528069366|FG002|Overall Study|Withdrawal by Subject|1|||
146426710|NCT01507051|528069367|FG003|Overall Study|Withdrawal by Subject|6|||
146426711|NCT01507051|528069364|FG000|Overall Study|Physician Decision|0|||
146426712|NCT01507051|528069365|FG001|Overall Study|Physician Decision|0|||
146199905|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146199906|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
146199907|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
146199908|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146199909|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146199910|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146199911|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146199912|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146199913|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146199914|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146426713|NCT01507051|528069366|FG002|Overall Study|Physician Decision|0|||
146426714|NCT01507051|528069367|FG003|Overall Study|Physician Decision|1|||
146426715|NCT01507051|528069364|FG000|Overall Study|Adverse Event|1|||
146199915|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146199916|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146199917|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146426716|NCT01507051|528069365|FG001|Overall Study|Adverse Event|0|||
146426717|NCT01507051|528069366|FG002|Overall Study|Adverse Event|0|||
146426718|NCT01507051|528069367|FG003|Overall Study|Adverse Event|0|||
146426719|NCT01675622|528069368|FG000|Overall Study|Withdrawal by Subject|2|||
146426720|NCT01675622|528069369|FG001|Overall Study|Withdrawal by Subject|2|||
146426721|NCT01675622|528069368|FG000|Overall Study|Adverse Event|12|||
146426722|NCT01675622|528069369|FG001|Overall Study|Adverse Event|10|||
146426723|NCT01675622|528069368|FG000|Overall Study|Protocol Violation|4|||
146426724|NCT01675622|528069369|FG001|Overall Study|Protocol Violation|1|||
146426725|NCT01675622|528069368|FG000|Overall Study|Lack of Efficacy|2|||
146426726|NCT01675622|528069369|FG001|Overall Study|Lack of Efficacy|4|||
146426727|NCT01675622|528069368|FG000|Overall Study|Lost to Follow-up|1|||
146426728|NCT01675622|528069369|FG001|Overall Study|Lost to Follow-up|3|||
146426729|NCT01675622|528069368|FG000|Overall Study|Other|5|||
146426730|NCT01675622|528069369|FG001|Overall Study|Other|4|||
146426731|NCT02311361|528069370|FG000|Overall Study|Did not receive treatment|0|||
146426732|NCT02311361|528069371|FG001|Overall Study|Did not receive treatment|1|||
146426733|NCT02311361|528069372|FG002|Overall Study|Did not receive treatment|0|||
146426734|NCT02311361|528069373|FG003|Overall Study|Did not receive treatment|1|||
146426735|NCT04455633|528069375|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
146426736|NCT04455633|528069376|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
146426737|NCT04455633|528069377|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
146426738|NCT04455633|528069375|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
146426739|NCT04455633|528069376|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
146426740|NCT04455633|528069377|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
146426741|NCT04455633|528069375|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
146426742|NCT04455633|528069376|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
146426743|NCT04455633|528069377|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
146426744|NCT04455633|528069375|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
146426745|NCT04455633|528069376|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
146426746|NCT04455633|528069377|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
146426747|NCT03527745|528069378|FG000|Overall Study|Lost to Follow-up|3|||
146426748|NCT03527745|528069379|FG001|Overall Study|Lost to Follow-up|6|||
146426749|NCT03527745|528069380|FG002|Overall Study|Lost to Follow-up|7|||
146426750|NCT03527745|528069381|FG003|Overall Study|Lost to Follow-up|9|||
146426751|NCT03527745|528069382|FG004|Overall Study|Lost to Follow-up|0|||
146426752|NCT03527745|528069383|FG005|Overall Study|Lost to Follow-up|2|||
146426753|NCT03527745|528069384|FG006|Overall Study|Lost to Follow-up|3|||
146426754|NCT03527745|528069385|FG007|Overall Study|Lost to Follow-up|2|||
146426755|NCT03527745|528069386|FG008|Overall Study|Lost to Follow-up|3|||
146426756|NCT03527745|528069387|FG009|Overall Study|Lost to Follow-up|2|||
146426757|NCT03527745|528069388|FG010|Overall Study|Lost to Follow-up|1|||
146426758|NCT03527745|528069389|FG011|Overall Study|Lost to Follow-up|1|||
146426759|NCT03527745|528069390|FG012|Overall Study|Lost to Follow-up|0|||
146426760|NCT03527745|528069391|FG013|Overall Study|Lost to Follow-up|0|||
146426761|NCT03527745|528069392|FG014|Overall Study|Lost to Follow-up|0|||
146426762|NCT03527745|528069393|FG015|Overall Study|Lost to Follow-up|0|||
146426763|NCT03527745|528069394|FG016|Overall Study|Lost to Follow-up|1|||
146426764|NCT03527745|528069395|FG017|Overall Study|Lost to Follow-up|0|||
146426765|NCT03527745|528069396|FG018|Overall Study|Lost to Follow-up|0|||
146426766|NCT03527745|528069397|FG019|Overall Study|Lost to Follow-up|1|||
146426767|NCT03527745|528069398|FG020|Overall Study|Lost to Follow-up|1|||
146426768|NCT03527745|528069399|FG021|Overall Study|Lost to Follow-up|5|||
146426769|NCT03527745|528069400|FG022|Overall Study|Lost to Follow-up|6|||
146426770|NCT03527745|528069401|FG023|Overall Study|Lost to Follow-up|8|||
146426771|NCT03527745|528069402|FG024|Overall Study|Lost to Follow-up|1|||
146426772|NCT03527745|528069403|FG025|Overall Study|Lost to Follow-up|3|||
146426773|NCT02942264|528069408|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426774|NCT02942264|528069409|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
146426775|NCT02942264|528069410|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426776|NCT02942264|528069411|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426777|NCT02942264|528069412|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426778|NCT02942264|528069413|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426779|NCT02942264|528069414|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
146426780|NCT02942264|528069415|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426781|NCT02942264|528069416|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
146426782|NCT02942264|528069408|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426783|NCT02942264|528069409|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426784|NCT02942264|528069410|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426785|NCT02942264|528069411|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426786|NCT02942264|528069412|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426787|NCT02942264|528069413|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146199918|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146199919|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146199920|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146199921|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
146199922|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
146199923|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146426788|NCT02942264|528069414|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426789|NCT02942264|528069415|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
146426790|NCT02942264|528069416|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
146426791|NCT01328093|528069417|FG000|Double-Blind Phase|Adverse Event|78|||
146426792|NCT01328093|528069418|FG001|Double-Blind Phase|Adverse Event|15|||
146199924|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
146199925|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
146426793|NCT01328093|528069417|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
146426794|NCT01328093|528069418|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
146426795|NCT01328093|528069417|FG000|Double-Blind Phase|Lost to Follow-up|39|||
146426796|NCT01328093|528069418|FG001|Double-Blind Phase|Lost to Follow-up|14|||
146426797|NCT01328093|528069417|FG000|Double-Blind Phase|Protocol Violation|30|||
146426798|NCT01328093|528069418|FG001|Double-Blind Phase|Protocol Violation|10|||
146426799|NCT01328093|528069417|FG000|Double-Blind Phase|Lack of Efficacy|55|||
146426800|NCT01328093|528069418|FG001|Double-Blind Phase|Lack of Efficacy|13|||
146426801|NCT01328093|528069417|FG000|Double-Blind Phase|Sponsor Decision|17|||
146426802|NCT01328093|528069418|FG001|Double-Blind Phase|Sponsor Decision|3|||
146426803|NCT01328093|528069417|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
146426804|NCT01328093|528069418|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
146426805|NCT01328093|528069417|FG000|Double-Blind Phase|Scheduling conflict|8|||
146426806|NCT01328093|528069418|FG001|Double-Blind Phase|Scheduling conflict|3|||
146426807|NCT01328093|528069417|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
146426808|NCT01328093|528069418|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
146426809|NCT01328093|528069417|FG000|Double-Blind Phase|Death|1|||
146426810|NCT01328093|528069418|FG001|Double-Blind Phase|Death|0|||
146426811|NCT01328093|528069417|FG000|Open-Label Phase|Sponsor Decision|98|||
146426812|NCT01328093|528069418|FG001|Open-Label Phase|Sponsor Decision|34|||
146426813|NCT01328093|528069417|FG000|Open-Label Phase|Protocol Violation|8|||
146426814|NCT01328093|528069418|FG001|Open-Label Phase|Protocol Violation|3|||
146426815|NCT01328093|528069417|FG000|Open-Label Phase|Lost to Follow-up|10|||
146426816|NCT01328093|528069418|FG001|Open-Label Phase|Lost to Follow-up|1|||
146426817|NCT01328093|528069417|FG000|Open-Label Phase|Adverse Event|10|||
146426818|NCT01328093|528069418|FG001|Open-Label Phase|Adverse Event|4|||
146426819|NCT01328093|528069417|FG000|Open-Label Phase|Lack of Efficacy|5|||
146426820|NCT01328093|528069418|FG001|Open-Label Phase|Lack of Efficacy|6|||
146426821|NCT01328093|528069417|FG000|Open-Label Phase|Withdrawal by Subject|4|||
146426822|NCT01328093|528069418|FG001|Open-Label Phase|Withdrawal by Subject|1|||
146426823|NCT01328093|528069417|FG000|Open-Label Phase|Scheduling conflict|2|||
146426824|NCT01328093|528069418|FG001|Open-Label Phase|Scheduling conflict|1|||
146426825|NCT01328093|528069417|FG000|Open-Label Phase|Subject is moving or has moved|2|||
146426826|NCT01328093|528069418|FG001|Open-Label Phase|Subject is moving or has moved|0|||
146426827|NCT01328093|528069417|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
146426828|NCT01328093|528069418|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
146426829|NCT03980483|528069421|FG000|Overall Study|Adverse Event|13|||
146426830|NCT03980483|528069422|FG001|Overall Study|Adverse Event|29|||
146426831|NCT03980483|528069423|FG002|Overall Study|Adverse Event|11|||
146426832|NCT03980483|528069424|FG003|Overall Study|Adverse Event|2|||
146426833|NCT03980483|528069425|FG004|Overall Study|Adverse Event|2|||
146426834|NCT03980483|528069426|FG005|Overall Study|Adverse Event|2|||
146426835|NCT03980483|528069421|FG000|Overall Study|Lack of Efficacy|7|||
146426836|NCT03980483|528069422|FG001|Overall Study|Lack of Efficacy|6|||
146426837|NCT03980483|528069423|FG002|Overall Study|Lack of Efficacy|0|||
146426838|NCT03980483|528069424|FG003|Overall Study|Lack of Efficacy|3|||
146426839|NCT03980483|528069425|FG004|Overall Study|Lack of Efficacy|1|||
146426840|NCT03980483|528069426|FG005|Overall Study|Lack of Efficacy|1|||
146426841|NCT03980483|528069421|FG000|Overall Study|Lost to Follow-up|2|||
146426842|NCT03980483|528069422|FG001|Overall Study|Lost to Follow-up|4|||
146426843|NCT03980483|528069423|FG002|Overall Study|Lost to Follow-up|2|||
146426844|NCT03980483|528069424|FG003|Overall Study|Lost to Follow-up|1|||
146426845|NCT03980483|528069425|FG004|Overall Study|Lost to Follow-up|2|||
146426846|NCT03980483|528069426|FG005|Overall Study|Lost to Follow-up|0|||
146426847|NCT03980483|528069421|FG000|Overall Study|Protocol Violation|4|||
146426848|NCT03980483|528069422|FG001|Overall Study|Protocol Violation|2|||
146426849|NCT03980483|528069423|FG002|Overall Study|Protocol Violation|1|||
146426850|NCT03980483|528069424|FG003|Overall Study|Protocol Violation|1|||
146426851|NCT03980483|528069425|FG004|Overall Study|Protocol Violation|0|||
146426852|NCT03980483|528069426|FG005|Overall Study|Protocol Violation|0|||
146426853|NCT03980483|528069421|FG000|Overall Study|Physician Decision|14|||
146426854|NCT03980483|528069422|FG001|Overall Study|Physician Decision|10|||
146426855|NCT03980483|528069423|FG002|Overall Study|Physician Decision|7|||
146426856|NCT03980483|528069424|FG003|Overall Study|Physician Decision|4|||
146426857|NCT03980483|528069425|FG004|Overall Study|Physician Decision|4|||
146426858|NCT03980483|528069426|FG005|Overall Study|Physician Decision|2|||
146426859|NCT03980483|528069421|FG000|Overall Study|Withdrawal by Subject|38|||
146426860|NCT03980483|528069422|FG001|Overall Study|Withdrawal by Subject|21|||
146426861|NCT03980483|528069423|FG002|Overall Study|Withdrawal by Subject|15|||
146426862|NCT03980483|528069424|FG003|Overall Study|Withdrawal by Subject|5|||
146426863|NCT03980483|528069425|FG004|Overall Study|Withdrawal by Subject|3|||
146426864|NCT03980483|528069426|FG005|Overall Study|Withdrawal by Subject|4|||
146426865|NCT03980483|528069421|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
146426866|NCT03980483|528069422|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
146426867|NCT03980483|528069423|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146426868|NCT03980483|528069424|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
146426869|NCT03980483|528069425|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146426870|NCT03980483|528069426|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
146426871|NCT03980483|528069421|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146426872|NCT03980483|528069422|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
146426873|NCT03980483|528069423|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146426874|NCT03980483|528069424|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146426875|NCT03980483|528069425|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146426876|NCT03980483|528069426|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
146426877|NCT03980483|528069421|FG000|Overall Study|Other|0|||
146426878|NCT03980483|528069422|FG001|Overall Study|Other|1|||
146426879|NCT03980483|528069423|FG002|Overall Study|Other|0|||
146426880|NCT03980483|528069424|FG003|Overall Study|Other|0|||
146426881|NCT03980483|528069425|FG004|Overall Study|Other|0|||
146426882|NCT03980483|528069426|FG005|Overall Study|Other|0|||
146426883|NCT00760266|528069429|FG000|Overall Study|Adverse Event|13|||
145949841|NCT01214668|526328685|FG005|Overall Study|Death|0|||
146199926|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146199927|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146199928|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146199929|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
146199930|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
146199931|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
146199932|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199933|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
146199934|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199935|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199936|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199937|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199938|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199939|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199940|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
146199941|NCT01212757|527243291|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199942|NCT01212757|527243292|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
146199943|NCT01212757|527243293|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
146199944|NCT01212757|527243294|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199945|NCT01212757|527243295|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199946|NCT01212757|527243296|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199947|NCT01212757|527243297|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199948|NCT01212757|527243298|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199949|NCT01212757|527243299|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
146199950|NCT00573833|527243300|FG000|Overall Study|Not Treated|2|||
146199951|NCT04493242|527243301|FG000|Overall Study|Death|10|||
146199952|NCT04493242|527243302|FG001|Overall Study|Death|14|||
146199953|NCT04493242|527243303|FG002|Overall Study|Death|16|||
146199954|NCT04493242|527243301|FG000|Overall Study|Lost to Follow-up|1|||
146199955|NCT04493242|527243302|FG001|Overall Study|Lost to Follow-up|1|||
146199956|NCT04493242|527243303|FG002|Overall Study|Lost to Follow-up|0|||
146199957|NCT04493242|527243301|FG000|Overall Study|Withdrawal by Subject|1|||
146199958|NCT04493242|527243302|FG001|Overall Study|Withdrawal by Subject|0|||
146199959|NCT04493242|527243303|FG002|Overall Study|Withdrawal by Subject|0|||
146199960|NCT04493242|527243301|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
146426884|NCT00760266|528069430|FG001|Overall Study|Adverse Event|7|||
146426885|NCT00760266|528069429|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146426886|NCT00760266|528069430|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146426887|NCT00760266|528069429|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146426888|NCT00760266|528069430|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146426889|NCT00760266|528069429|FG000|Overall Study|Lack of Efficacy|2|||
146426890|NCT00760266|528069430|FG001|Overall Study|Lack of Efficacy|2|||
146426891|NCT00760266|528069429|FG000|Overall Study|Protocol deviation|2|||
146426892|NCT00760266|528069430|FG001|Overall Study|Protocol deviation|4|||
146426893|NCT00760266|528069429|FG000|Overall Study|Patient withdrew consent|3|||
146426894|NCT00760266|528069430|FG001|Overall Study|Patient withdrew consent|3|||
146426895|NCT00760266|528069429|FG000|Overall Study|Lost to Follow-up|2|||
146426896|NCT00760266|528069430|FG001|Overall Study|Lost to Follow-up|1|||
146426897|NCT00760266|528069429|FG000|Overall Study|Administrative Problems|0|||
146426898|NCT00760266|528069430|FG001|Overall Study|Administrative Problems|1|||
146426899|NCT01239121|528069431|FG000|Overall Study|Withdrawal by Subject|2|||
146426900|NCT01239121|528069432|FG001|Overall Study|Withdrawal by Subject|4|||
146426901|NCT01239121|528069433|FG002|Overall Study|Withdrawal by Subject|0|||
146426902|NCT03657160|528069434|FG000|Overall Study|Adverse Event|5|||
146426903|NCT03657160|528069435|FG001|Overall Study|Adverse Event|6|||
146426904|NCT03657160|528069434|FG000|Overall Study|Protocol Deviation|3|||
146426905|NCT03657160|528069435|FG001|Overall Study|Protocol Deviation|0|||
146426906|NCT03657160|528069434|FG000|Overall Study|Withdrawal by Subject|18|||
146426907|NCT03657160|528069435|FG001|Overall Study|Withdrawal by Subject|16|||
146426908|NCT03657160|528069434|FG000|Overall Study|Site Termination|1|||
146426909|NCT03657160|528069435|FG001|Overall Study|Site Termination|0|||
146426910|NCT03657160|528069434|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
146426911|NCT03657160|528069435|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
146426912|NCT03657160|528069434|FG000|Overall Study|Death|33|||
146426913|NCT03657160|528069435|FG001|Overall Study|Death|26|||
146426914|NCT03657160|528069434|FG000|Overall Study|Death (COVID-19-Related)|1|||
146426915|NCT03657160|528069435|FG001|Overall Study|Death (COVID-19-Related)|0|||
146426916|NCT03657160|528069434|FG000|Overall Study|Reason Not Specified|5|||
146426917|NCT03657160|528069435|FG001|Overall Study|Reason Not Specified|5|||
146426918|NCT03657160|528069434|FG000|Overall Study|Other (COVID-19-Related)|0|||
146426919|NCT03657160|528069435|FG001|Overall Study|Other (COVID-19-Related)|1|||
146426920|NCT00686959|528069437|FG000|Overall Study|Participants censored (no death events)|124|||
146426921|NCT00686959|528069438|FG001|Overall Study|Participants censored (no death events)|117|||
146426922|NCT01449630|528069439|FG000|Period 1|Physician Decision|1|||
146426923|NCT01449630|528069440|FG001|Period 1|Physician Decision|0|||
146426924|NCT01449630|528069441|FG002|Period 1|Physician Decision|0|||
146426925|NCT01449630|528069442|FG003|Period 1|Physician Decision|1|||
146426926|NCT01449630|528069443|FG004|Period 1|Physician Decision|0|||
146426927|NCT01449630|528069444|FG005|Period 1|Physician Decision|0|||
146426928|NCT01449630|528069445|FG006|Period 1|Physician Decision|0|||
146426929|NCT01449630|528069446|FG007|Period 1|Physician Decision|0|||
146426930|NCT01449630|528069447|FG008|Period 1|Physician Decision|0|||
146426931|NCT01449630|528069439|FG000|Period 1|Sponsor Decision|0|||
146426932|NCT01449630|528069440|FG001|Period 1|Sponsor Decision|0|||
146426933|NCT01449630|528069441|FG002|Period 1|Sponsor Decision|0|||
146426934|NCT01449630|528069442|FG003|Period 1|Sponsor Decision|0|||
146426935|NCT01449630|528069443|FG004|Period 1|Sponsor Decision|0|||
146426936|NCT01449630|528069444|FG005|Period 1|Sponsor Decision|1|||
146426937|NCT01449630|528069445|FG006|Period 1|Sponsor Decision|0|||
146426938|NCT01449630|528069446|FG007|Period 1|Sponsor Decision|0|||
146426939|NCT01449630|528069447|FG008|Period 1|Sponsor Decision|0|||
146426940|NCT01449630|528069439|FG000|Period 2|Sponsor Decision|0|||
146426941|NCT01449630|528069440|FG001|Period 2|Sponsor Decision|0|||
146426942|NCT01449630|528069441|FG002|Period 2|Sponsor Decision|0|||
146426943|NCT01449630|528069442|FG003|Period 2|Sponsor Decision|0|||
146426944|NCT01449630|528069443|FG004|Period 2|Sponsor Decision|0|||
146426945|NCT01449630|528069444|FG005|Period 2|Sponsor Decision|0|||
146426946|NCT01449630|528069445|FG006|Period 2|Sponsor Decision|1|||
146426947|NCT01449630|528069446|FG007|Period 2|Sponsor Decision|0|||
146426948|NCT01449630|528069447|FG008|Period 2|Sponsor Decision|0|||
146426949|NCT01735630|528069449|FG000|Overall Study|Adverse Event|8|||
146426950|NCT01735630|528069450|FG001|Overall Study|Adverse Event|7|||
146426951|NCT01735630|528069449|FG000|Overall Study|Lost to Follow-up|1|||
146426952|NCT01735630|528069450|FG001|Overall Study|Lost to Follow-up|0|||
146426953|NCT01735630|528069449|FG000|Overall Study|Physician Decision|0|||
146426954|NCT01735630|528069450|FG001|Overall Study|Physician Decision|1|||
146426955|NCT01735630|528069449|FG000|Overall Study|Sponsor Decision|2|||
146426956|NCT01735630|528069450|FG001|Overall Study|Sponsor Decision|1|||
146426957|NCT01735630|528069449|FG000|Overall Study|Withdrawal by Subject|7|||
146426958|NCT01735630|528069450|FG001|Overall Study|Withdrawal by Subject|9|||
146426959|NCT01572948|528069451|FG000|Overall Study|Lost to Follow-up|1|||
146426960|NCT01572948|528069452|FG001|Overall Study|Lost to Follow-up|0|||
146426961|NCT01572948|528069451|FG000|Overall Study|unable to contact|0|||
146426962|NCT01572948|528069452|FG001|Overall Study|unable to contact|1|||
146426963|NCT01126736|528069457|FG000|Overall Study|Death|2|||
146426964|NCT01126736|528069458|FG001|Overall Study|Death|2|||
146426965|NCT01126736|528069459|FG002|Overall Study|Death|1|||
146426966|NCT01126736|528069460|FG003|Overall Study|Death|19|||
146426967|NCT01126736|528069461|FG004|Overall Study|Death|19|||
146426968|NCT01126736|528069457|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146426969|NCT01126736|528069458|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146426970|NCT01126736|528069459|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
146426971|NCT01126736|528069460|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
146426972|NCT01126736|528069461|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
146426973|NCT01126736|528069457|FG000|Overall Study|Lost to Follow-up|0|||
146426974|NCT01126736|528069458|FG001|Overall Study|Lost to Follow-up|0|||
146426975|NCT01126736|528069459|FG002|Overall Study|Lost to Follow-up|0|||
146426976|NCT01126736|528069460|FG003|Overall Study|Lost to Follow-up|1|||
146426977|NCT01126736|528069461|FG004|Overall Study|Lost to Follow-up|1|||
146426978|NCT01126736|528069457|FG000|Overall Study|Administrative reasons|0|||
146426979|NCT01126736|528069458|FG001|Overall Study|Administrative reasons|0|||
146426980|NCT01126736|528069459|FG002|Overall Study|Administrative reasons|0|||
146426981|NCT01126736|528069460|FG003|Overall Study|Administrative reasons|0|||
146426982|NCT01126736|528069461|FG004|Overall Study|Administrative reasons|1|||
146426983|NCT01126736|528069457|FG000|Overall Study|Progressive disease|0|||
146426984|NCT01126736|528069458|FG001|Overall Study|Progressive disease|0|||
146426985|NCT01126736|528069459|FG002|Overall Study|Progressive disease|0|||
146426986|NCT01126736|528069460|FG003|Overall Study|Progressive disease|2|||
146426987|NCT01126736|528069461|FG004|Overall Study|Progressive disease|1|||
146426988|NCT01126736|528069457|FG000|Overall Study|Withdrawal by Subject|0|||
146426989|NCT01126736|528069458|FG001|Overall Study|Withdrawal by Subject|0|||
146426990|NCT01126736|528069459|FG002|Overall Study|Withdrawal by Subject|0|||
146426991|NCT01126736|528069460|FG003|Overall Study|Withdrawal by Subject|1|||
146426992|NCT01126736|528069461|FG004|Overall Study|Withdrawal by Subject|1|||
146426993|NCT01126736|528069457|FG000|Overall Study|Other|2|||
146426994|NCT01126736|528069458|FG001|Overall Study|Other|4|||
146426995|NCT01126736|528069459|FG002|Overall Study|Other|4|||
146426996|NCT01126736|528069460|FG003|Overall Study|Other|16|||
146426997|NCT01126736|528069461|FG004|Overall Study|Other|15|||
146426998|NCT01720264|528069467|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
146426999|NCT01720264|528069467|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
146427000|NCT01720264|528069467|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
146427001|NCT03018249|528069479|FG000|Overall Study|Withdrawal by Subject|2|||
146427002|NCT03018249|528069480|FG001|Overall Study|Withdrawal by Subject|2|||
146427003|NCT01030965|528069482|FG000|Overall Study|Lack of Efficacy|3|||
146427004|NCT01030965|528069483|FG001|Overall Study|Lack of Efficacy|2|||
146427005|NCT01030965|528069484|FG002|Overall Study|Lack of Efficacy|0|||
146427006|NCT01030965|528069485|FG003|Overall Study|Lack of Efficacy|3|||
146427007|NCT01030965|528069482|FG000|Overall Study|Protocol Violation|1|||
146427008|NCT01030965|528069483|FG001|Overall Study|Protocol Violation|1|||
146427009|NCT01030965|528069484|FG002|Overall Study|Protocol Violation|1|||
146427010|NCT01030965|528069485|FG003|Overall Study|Protocol Violation|1|||
146427011|NCT01030965|528069482|FG000|Overall Study|Adverse Event|0|||
146427012|NCT01030965|528069483|FG001|Overall Study|Adverse Event|1|||
146427013|NCT01030965|528069484|FG002|Overall Study|Adverse Event|2|||
146427014|NCT01030965|528069485|FG003|Overall Study|Adverse Event|1|||
146427015|NCT01030965|528069482|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
146427016|NCT01030965|528069483|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
146427017|NCT01030965|528069484|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
146427018|NCT01030965|528069485|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
146427019|NCT01030965|528069482|FG000|Overall Study|Withdrawal by Subject|0|||
146427020|NCT01030965|528069483|FG001|Overall Study|Withdrawal by Subject|1|||
146427021|NCT01030965|528069484|FG002|Overall Study|Withdrawal by Subject|0|||
146427022|NCT01030965|528069485|FG003|Overall Study|Withdrawal by Subject|2|||
146427023|NCT02097290|528069486|FG000|Overall Study|Death|6|||
146427024|NCT02097290|528069486|FG000|Overall Study|Total Withdrawals|3|||
146427025|NCT02097290|528069486|FG000|Overall Study|Attempt|8|||
146427026|NCT00824265|528069487|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
146427027|NCT00824265|528069488|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
146427028|NCT00824265|528069487|FG000|Treatment Phase|Protocol Violation|1|||
146427029|NCT00824265|528069488|FG001|Treatment Phase|Protocol Violation|0|||
146427030|NCT00824265|528069487|FG000|Treatment Phase|Lost to Follow-up|1|||
146427031|NCT00824265|528069488|FG001|Treatment Phase|Lost to Follow-up|1|||
146427032|NCT00824265|528069487|FG000|Treatment Phase|Physician Decision|6|||
146427033|NCT00824265|528069488|FG001|Treatment Phase|Physician Decision|12|||
146427034|NCT00824265|528069487|FG000|Treatment Phase|Withdrawal by Subject|6|||
146427035|NCT00824265|528069488|FG001|Treatment Phase|Withdrawal by Subject|15|||
146427036|NCT00824265|528069487|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
146427037|NCT00824265|528069488|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
146427038|NCT00824265|528069487|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
146427039|NCT00824265|528069488|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
146427040|NCT02888171|528069489|FG000|Overall Study|Lost to Follow-up|2|||
146427041|NCT02888171|528069490|FG001|Overall Study|Lost to Follow-up|1|||
146427042|NCT02888171|528069489|FG000|Overall Study|Withdrawal by Subject|3|||
146427043|NCT02888171|528069490|FG001|Overall Study|Withdrawal by Subject|2|||
146427044|NCT02888171|528069489|FG000|Overall Study|Adverse Event|0|||
146427045|NCT02888171|528069490|FG001|Overall Study|Adverse Event|1|||
146427046|NCT02920996|528069491|FG000|Overall Study|Adverse Event|8|||
146427047|NCT02920996|528069492|FG001|Overall Study|Adverse Event|0|||
146427048|NCT02920996|528069491|FG000|Overall Study|Physician Decision|1|||
146427049|NCT02920996|528069492|FG001|Overall Study|Physician Decision|0|||
146427050|NCT02920996|528069491|FG000|Overall Study|Death|1|||
146427051|NCT02920996|528069492|FG001|Overall Study|Death|0|||
146427052|NCT02920996|528069491|FG000|Overall Study|Missing|1|||
146427053|NCT02920996|528069492|FG001|Overall Study|Missing|0|||
146427054|NCT02920996|528069491|FG000|Overall Study|Subject Non-Compliance|1|||
146427055|NCT02920996|528069492|FG001|Overall Study|Subject Non-Compliance|0|||
146427056|NCT00591630|528069493|FG000|Overall Study|Death|0|||
146235008|NCT00622700|527378447|FG000|Core Treatment Period|Randomized but Not Treated|0|||
146427057|NCT00591630|528069494|FG001|Overall Study|Death|0|||
146427058|NCT00591630|528069495|FG002|Overall Study|Death|1|||
146427059|NCT00591630|528069496|FG003|Overall Study|Death|0|||
146427060|NCT02158936|528069498|FG000|Overall Study|Study closed/ terminated|57|||
146427061|NCT02158936|528069499|FG001|Overall Study|Study closed/ terminated|77|||
146427062|NCT02158936|528069498|FG000|Overall Study|Azacitidine tx discontinued|53|||
146427063|NCT02158936|528069499|FG001|Overall Study|Azacitidine tx discontinued|46|||
146427064|NCT02158936|528069498|FG000|Overall Study|Adverse Event|39|||
146427065|NCT02158936|528069499|FG001|Overall Study|Adverse Event|24|||
146427066|NCT02158936|528069498|FG000|Overall Study|Withdrawal by Subject|15|||
146427067|NCT02158936|528069499|FG001|Overall Study|Withdrawal by Subject|16|||
146427068|NCT02158936|528069498|FG000|Overall Study|Physician Decision|15|||
146427069|NCT02158936|528069499|FG001|Overall Study|Physician Decision|13|||
146427070|NCT02158936|528069498|FG000|Overall Study|Lost to Follow-up|0|||
146427071|NCT02158936|528069499|FG001|Overall Study|Lost to Follow-up|1|||
146427072|NCT00522457|528069500|FG000|Overall Study|Due to disease progression|16|||
146427073|NCT00522457|528069500|FG000|Overall Study|Adverse Event|2|||
146427074|NCT00485472|528071147|FG000|Overall Study|Adverse Event|8|||
146427075|NCT00485472|528071148|FG001|Overall Study|Adverse Event|5|||
146427076|NCT00485472|528071147|FG000|Overall Study|Lack of Efficacy|5|||
146427077|NCT00485472|528071148|FG001|Overall Study|Lack of Efficacy|4|||
146427078|NCT00485472|528071147|FG000|Overall Study|Withdrawal by Subject|1|||
146427079|NCT00485472|528071148|FG001|Overall Study|Withdrawal by Subject|0|||
146427080|NCT00485472|528071147|FG000|Overall Study|Protocol Violation|0|||
146427081|NCT00485472|528071148|FG001|Overall Study|Protocol Violation|1|||
146427082|NCT00485472|528071147|FG000|Overall Study|Other|2|||
146427083|NCT00485472|528071148|FG001|Overall Study|Other|1|||
146427084|NCT00485472|528071147|FG000|Overall Study|Lost to Follow-up|0|||
146427085|NCT00485472|528071148|FG001|Overall Study|Lost to Follow-up|1|||
146427086|NCT01492361|528071149|FG000|Overall Study|Withdrawal by Subject|281|||
146427087|NCT01492361|528071150|FG001|Overall Study|Withdrawal by Subject|297|||
146427088|NCT01492361|528071149|FG000|Overall Study|Physician Decision|12|||
146427089|NCT01492361|528071150|FG001|Overall Study|Physician Decision|12|||
146427090|NCT01492361|528071149|FG000|Overall Study|Lost to Follow-up|6|||
146427091|NCT01492361|528071150|FG001|Overall Study|Lost to Follow-up|13|||
146427092|NCT01492361|528071149|FG000|Overall Study|Other than specified above|106|||
146427093|NCT01492361|528071150|FG001|Overall Study|Other than specified above|138|||
146427094|NCT04015232|528071151|FG000|Overall Study|Withdrawal by Subject|7|||
146427095|NCT04015232|528071152|FG001|Overall Study|Withdrawal by Subject|4|||
146427096|NCT04015232|528071151|FG000|Overall Study|Protocol Violation|1|||
146427097|NCT04015232|528071152|FG001|Overall Study|Protocol Violation|0|||
146427098|NCT04015232|528071151|FG000|Overall Study|Medical Grounds|3|||
146427099|NCT04015232|528071152|FG001|Overall Study|Medical Grounds|3|||
146427100|NCT05150964|528071157|FG000|Overall Study|Lost to Follow-up|2|||
146427101|NCT01434693|528071160|FG000|Overall Study|Adverse Event|1|||
146427102|NCT01434693|528071161|FG001|Overall Study|Adverse Event|0|||
146427103|NCT01434693|528071162|FG002|Overall Study|Adverse Event|0|||
146427104|NCT01434693|528071163|FG003|Overall Study|Adverse Event|0|||
146427105|NCT01434693|528071160|FG000|Overall Study|Withdrawal by Subject|1|||
146427106|NCT01434693|528071161|FG001|Overall Study|Withdrawal by Subject|0|||
146427107|NCT01434693|528071162|FG002|Overall Study|Withdrawal by Subject|1|||
146427108|NCT01434693|528071163|FG003|Overall Study|Withdrawal by Subject|1|||
146199961|NCT04493242|527243302|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
146199962|NCT04493242|527243303|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
146199963|NCT04493242|527243301|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
146199964|NCT04493242|527243302|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
146199965|NCT04493242|527243303|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
146199966|NCT00849147|527243304|FG000|Overall Study|Withdrawal by Subject|1|||
146427109|NCT01434693|528071160|FG000|Overall Study|Lost to Follow-up|1|||
146427110|NCT01434693|528071161|FG001|Overall Study|Lost to Follow-up|0|||
146427111|NCT01434693|528071162|FG002|Overall Study|Lost to Follow-up|0|||
146427112|NCT01434693|528071163|FG003|Overall Study|Lost to Follow-up|0|||
146427113|NCT04006171|528071164|FG000|Overall Study|Withdrawal by Subject|8|||
146427114|NCT04006171|528071165|FG001|Overall Study|Withdrawal by Subject|7|||
146427115|NCT04006171|528071164|FG000|Overall Study|missing serum samples|2|||
146427116|NCT04006171|528071165|FG001|Overall Study|missing serum samples|2|||
146427117|NCT04006171|528071164|FG000|Overall Study|insufficient sample volume|2|||
146199967|NCT00849147|527243304|FG000|Overall Study|Protocol Violation|2|||
146199968|NCT00849147|527243304|FG000|Overall Study|Disease Relapse/Progression|2|||
146235009|NCT00622700|527378448|FG001|Core Treatment Period|Randomized but Not Treated|2|||
146235010|NCT00622700|527378449|FG002|Core Treatment Period|Randomized but Not Treated|2|||
146235011|NCT00622700|527378450|FG003|Core Treatment Period|Randomized but Not Treated|0|||
146235012|NCT00622700|527378451|FG004|Core Treatment Period|Randomized but Not Treated|0|||
146235013|NCT00622700|527378452|FG005|Core Treatment Period|Randomized but Not Treated|0|||
146235014|NCT00622700|527378453|FG006|Core Treatment Period|Randomized but Not Treated|0|||
146235015|NCT00622700|527378447|FG000|Core Treatment Period|Adverse Event|18|||
146235016|NCT00622700|527378448|FG001|Core Treatment Period|Adverse Event|25|||
146235017|NCT00622700|527378449|FG002|Core Treatment Period|Adverse Event|18|||
146235018|NCT00622700|527378450|FG003|Core Treatment Period|Adverse Event|0|||
146235019|NCT00622700|527378451|FG004|Core Treatment Period|Adverse Event|0|||
146235020|NCT00622700|527378452|FG005|Core Treatment Period|Adverse Event|0|||
146235021|NCT00622700|527378453|FG006|Core Treatment Period|Adverse Event|0|||
146235022|NCT00622700|527378447|FG000|Core Treatment Period|Lack of Efficacy|19|||
146235023|NCT00622700|527378448|FG001|Core Treatment Period|Lack of Efficacy|6|||
146235024|NCT00622700|527378449|FG002|Core Treatment Period|Lack of Efficacy|12|||
146235025|NCT00622700|527378450|FG003|Core Treatment Period|Lack of Efficacy|0|||
146235026|NCT00622700|527378451|FG004|Core Treatment Period|Lack of Efficacy|0|||
146235027|NCT00622700|527378452|FG005|Core Treatment Period|Lack of Efficacy|0|||
146235028|NCT00622700|527378453|FG006|Core Treatment Period|Lack of Efficacy|0|||
146235029|NCT00622700|527378447|FG000|Core Treatment Period|Lost to Follow-up|1|||
146082664|NCT01426789|526822865|FG000|Part 1|Adverse Event|3|||
146082665|NCT01426789|526822866|FG001|Part 1|Adverse Event|0|||
146082666|NCT01426789|526822867|FG002|Part 1|Adverse Event|0|||
146082667|NCT01426789|526822868|FG003|Part 1|Adverse Event|0|||
146082668|NCT01426789|526822869|FG004|Part 1|Adverse Event|0|||
146235030|NCT00622700|527378448|FG001|Core Treatment Period|Lost to Follow-up|1|||
146235031|NCT00622700|527378449|FG002|Core Treatment Period|Lost to Follow-up|1|||
146235032|NCT00622700|527378450|FG003|Core Treatment Period|Lost to Follow-up|0|||
146235033|NCT00622700|527378451|FG004|Core Treatment Period|Lost to Follow-up|0|||
146235034|NCT00622700|527378452|FG005|Core Treatment Period|Lost to Follow-up|0|||
146235035|NCT00622700|527378453|FG006|Core Treatment Period|Lost to Follow-up|0|||
146235036|NCT00622700|527378447|FG000|Core Treatment Period|Death|1|||
146235037|NCT00622700|527378448|FG001|Core Treatment Period|Death|0|||
146235038|NCT00622700|527378449|FG002|Core Treatment Period|Death|0|||
146235039|NCT00622700|527378450|FG003|Core Treatment Period|Death|0|||
146235040|NCT00622700|527378451|FG004|Core Treatment Period|Death|0|||
146235041|NCT00622700|527378452|FG005|Core Treatment Period|Death|0|||
146235042|NCT00622700|527378453|FG006|Core Treatment Period|Death|0|||
146235043|NCT00622700|527378447|FG000|Core Treatment Period|Progressive Disease|3|||
146235044|NCT00622700|527378448|FG001|Core Treatment Period|Progressive Disease|1|||
146235045|NCT00622700|527378449|FG002|Core Treatment Period|Progressive Disease|0|||
146235046|NCT00622700|527378450|FG003|Core Treatment Period|Progressive Disease|0|||
146235047|NCT00622700|527378451|FG004|Core Treatment Period|Progressive Disease|0|||
146235048|NCT00622700|527378452|FG005|Core Treatment Period|Progressive Disease|0|||
146235049|NCT00622700|527378453|FG006|Core Treatment Period|Progressive Disease|0|||
146235050|NCT00622700|527378447|FG000|Core Treatment Period|Withdrawal by Subject|12|||
146235051|NCT00622700|527378448|FG001|Core Treatment Period|Withdrawal by Subject|18|||
146235052|NCT00622700|527378449|FG002|Core Treatment Period|Withdrawal by Subject|15|||
146235053|NCT00622700|527378450|FG003|Core Treatment Period|Withdrawal by Subject|0|||
146235054|NCT00622700|527378451|FG004|Core Treatment Period|Withdrawal by Subject|0|||
146235055|NCT00622700|527378452|FG005|Core Treatment Period|Withdrawal by Subject|0|||
146235056|NCT00622700|527378453|FG006|Core Treatment Period|Withdrawal by Subject|0|||
146235057|NCT00622700|527378447|FG000|Core Treatment Period|Other than specified above|2|||
146235058|NCT00622700|527378448|FG001|Core Treatment Period|Other than specified above|2|||
146427118|NCT04006171|528071165|FG001|Overall Study|insufficient sample volume|3|||
146427119|NCT00912288|528071166|FG000|Overall Study|Death|0|||
146427120|NCT00912288|528071167|FG001|Overall Study|Death|1|||
146082669|NCT01426789|526822870|FG005|Part 1|Adverse Event|0|||
146082670|NCT01426789|526822865|FG000|Part 2|Protocol deviation|0|||
146235059|NCT00622700|527378449|FG002|Core Treatment Period|Other than specified above|5|||
146235060|NCT00622700|527378450|FG003|Core Treatment Period|Other than specified above|0|||
146235061|NCT00622700|527378451|FG004|Core Treatment Period|Other than specified above|0|||
146235062|NCT00622700|527378452|FG005|Core Treatment Period|Other than specified above|0|||
146235063|NCT00622700|527378453|FG006|Core Treatment Period|Other than specified above|0|||
146235064|NCT00622700|527378447|FG000|Extension Treatment Period|Adverse Event|0|||
146427121|NCT00912288|528071166|FG000|Overall Study|Adverse Event|1|||
146235065|NCT00622700|527378448|FG001|Extension Treatment Period|Adverse Event|0|||
146235066|NCT00622700|527378449|FG002|Extension Treatment Period|Adverse Event|0|||
146427122|NCT00912288|528071167|FG001|Overall Study|Adverse Event|1|||
146199969|NCT04517864|527246205|FG000|Placebo-Controlled Phase|Adverse Event|1|||
146199970|NCT04517864|527246206|FG001|Placebo-Controlled Phase|Adverse Event|0|||
146199971|NCT04517864|527246207|FG002|Placebo-Controlled Phase|Adverse Event|0|||
146199972|NCT04517864|527246205|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
146199973|NCT04517864|527246206|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
146199974|NCT04517864|527246207|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
146199975|NCT04517864|527246205|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
146199976|NCT04517864|527246206|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
146199977|NCT04517864|527246207|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
146199978|NCT04517864|527246205|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
146199979|NCT04517864|527246206|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
146199980|NCT04517864|527246207|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
146199981|NCT04517864|527246205|FG000|Active Therapy Extension Phase|Adverse Event|1|||
146199982|NCT04517864|527246206|FG001|Active Therapy Extension Phase|Adverse Event|0|||
146199983|NCT04517864|527246207|FG002|Active Therapy Extension Phase|Adverse Event|0|||
146199984|NCT04517864|527246205|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
146082671|NCT01426789|526822866|FG001|Part 2|Protocol deviation|0|||
146082672|NCT01426789|526822867|FG002|Part 2|Protocol deviation|1|||
146082673|NCT01426789|526822868|FG003|Part 2|Protocol deviation|0|||
146082674|NCT01426789|526822869|FG004|Part 2|Protocol deviation|0|||
146082675|NCT01426789|526822870|FG005|Part 2|Protocol deviation|0|||
146082676|NCT01426789|526822865|FG000|Part 2|Death|0|||
146082677|NCT01426789|526822866|FG001|Part 2|Death|0|||
146082678|NCT01426789|526822867|FG002|Part 2|Death|1|||
146082679|NCT01426789|526822868|FG003|Part 2|Death|0|||
146082680|NCT01426789|526822869|FG004|Part 2|Death|1|||
146082681|NCT01426789|526822870|FG005|Part 2|Death|0|||
146082682|NCT01426789|526822865|FG000|Part 2|Administrative problems|0|||
146082683|NCT01426789|526822866|FG001|Part 2|Administrative problems|0|||
146082684|NCT01426789|526822867|FG002|Part 2|Administrative problems|2|||
146082685|NCT01426789|526822868|FG003|Part 2|Administrative problems|0|||
146082686|NCT01426789|526822869|FG004|Part 2|Administrative problems|1|||
146082687|NCT01426789|526822870|FG005|Part 2|Administrative problems|0|||
146082688|NCT01426789|526822865|FG000|Part 2|Lost to Follow-up|0|||
146082689|NCT01426789|526822866|FG001|Part 2|Lost to Follow-up|0|||
146082690|NCT01426789|526822867|FG002|Part 2|Lost to Follow-up|4|||
146082691|NCT01426789|526822868|FG003|Part 2|Lost to Follow-up|0|||
146082692|NCT01426789|526822869|FG004|Part 2|Lost to Follow-up|1|||
146082693|NCT01426789|526822870|FG005|Part 2|Lost to Follow-up|0|||
146082694|NCT01426789|526822865|FG000|Part 2|Withdrawal by Subject|0|||
146082695|NCT01426789|526822866|FG001|Part 2|Withdrawal by Subject|0|||
146082696|NCT01426789|526822867|FG002|Part 2|Withdrawal by Subject|0|||
146082697|NCT01426789|526822868|FG003|Part 2|Withdrawal by Subject|1|||
146082698|NCT01426789|526822869|FG004|Part 2|Withdrawal by Subject|2|||
146082699|NCT01426789|526822870|FG005|Part 2|Withdrawal by Subject|0|||
146082700|NCT01426789|526822865|FG000|Part 2|Lack of Efficacy|0|||
146082701|NCT01426789|526822866|FG001|Part 2|Lack of Efficacy|0|||
146082702|NCT01426789|526822867|FG002|Part 2|Lack of Efficacy|5|||
146082703|NCT01426789|526822868|FG003|Part 2|Lack of Efficacy|0|||
146082704|NCT01426789|526822869|FG004|Part 2|Lack of Efficacy|2|||
146082705|NCT01426789|526822870|FG005|Part 2|Lack of Efficacy|0|||
146082706|NCT01426789|526822865|FG000|Part 2|Adverse Event|0|||
146082707|NCT01426789|526822866|FG001|Part 2|Adverse Event|0|||
146082708|NCT01426789|526822867|FG002|Part 2|Adverse Event|2|||
146082709|NCT01426789|526822868|FG003|Part 2|Adverse Event|0|||
146082710|NCT01426789|526822869|FG004|Part 2|Adverse Event|1|||
146199985|NCT04517864|527246206|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
146199986|NCT04517864|527246207|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
146199987|NCT04517864|527246205|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
146199988|NCT04517864|527246206|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
146199989|NCT04517864|527246207|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
146082711|NCT01426789|526822870|FG005|Part 2|Adverse Event|0|||
146082712|NCT04054947|526822871|FG000|Overall Study|Withdrawal by Subject|1|||
146199990|NCT04517864|527246205|FG000|Active Therapy Extension Phase|Physician Decision|1|||
146199991|NCT04517864|527246206|FG001|Active Therapy Extension Phase|Physician Decision|0|||
146199992|NCT04517864|527246207|FG002|Active Therapy Extension Phase|Physician Decision|0|||
146082713|NCT04054947|526822872|FG001|Overall Study|Withdrawal by Subject|0|||
146427123|NCT00912288|528071166|FG000|Overall Study|Lost to Follow-up|1|||
146082714|NCT04054947|526822871|FG000|Overall Study|Lost to Follow-up|2|||
146082715|NCT04054947|526822872|FG001|Overall Study|Lost to Follow-up|5|||
146082716|NCT00311584|526822873|FG000|Overall Study|Death|1|||
146082717|NCT00311584|526822874|FG001|Overall Study|Death|0|||
146427124|NCT00912288|528071167|FG001|Overall Study|Lost to Follow-up|0|||
146427125|NCT00912288|528071166|FG000|Overall Study|Protocol Violation|1|||
146427126|NCT00912288|528071167|FG001|Overall Study|Protocol Violation|0|||
146427127|NCT00912288|528071166|FG000|Overall Study|Withdrawal by Subject|3|||
146427128|NCT00912288|528071167|FG001|Overall Study|Withdrawal by Subject|3|||
146427129|NCT00912288|528071166|FG000|Overall Study|Study terminated by sponsor|34|||
146427130|NCT00912288|528071167|FG001|Overall Study|Study terminated by sponsor|35|||
146427131|NCT00912288|528071166|FG000|Overall Study|Other|1|||
146427132|NCT00912288|528071167|FG001|Overall Study|Other|0|||
146427133|NCT02087904|528071174|FG000|Overall Study|Did Not Receive Study Drug|0|||
146427134|NCT02087904|528071175|FG001|Overall Study|Did Not Receive Study Drug|0|||
146427135|NCT02087904|528071176|FG002|Overall Study|Did Not Receive Study Drug|2|||
146427136|NCT02087904|528071177|FG003|Overall Study|Did Not Receive Study Drug|1|||
146427137|NCT02087904|528071174|FG000|Overall Study|Adverse Event|8|||
146427138|NCT02087904|528071175|FG001|Overall Study|Adverse Event|4|||
146427139|NCT02087904|528071176|FG002|Overall Study|Adverse Event|4|||
146427140|NCT02087904|528071177|FG003|Overall Study|Adverse Event|12|||
146427141|NCT02087904|528071174|FG000|Overall Study|Lack of Efficacy|3|||
146427142|NCT02087904|528071175|FG001|Overall Study|Lack of Efficacy|6|||
146427143|NCT02087904|528071176|FG002|Overall Study|Lack of Efficacy|3|||
146427144|NCT02087904|528071177|FG003|Overall Study|Lack of Efficacy|2|||
146427145|NCT02087904|528071174|FG000|Overall Study|Other|6|||
146427146|NCT02087904|528071175|FG001|Overall Study|Other|2|||
146427147|NCT02087904|528071176|FG002|Overall Study|Other|4|||
146427148|NCT02087904|528071177|FG003|Overall Study|Other|4|||
146082718|NCT00311584|526822873|FG000|Overall Study|Lack of Efficacy|12|||
146082719|NCT00311584|526822874|FG001|Overall Study|Lack of Efficacy|15|||
146427149|NCT02087904|528071174|FG000|Overall Study|Withdrawal by Subject|8|||
146427150|NCT02087904|528071175|FG001|Overall Study|Withdrawal by Subject|3|||
146427151|NCT02087904|528071176|FG002|Overall Study|Withdrawal by Subject|7|||
146427152|NCT02087904|528071177|FG003|Overall Study|Withdrawal by Subject|4|||
146427153|NCT02087904|528071174|FG000|Overall Study|Lost to Follow-up|0|||
146427154|NCT02087904|528071175|FG001|Overall Study|Lost to Follow-up|4|||
146427155|NCT02087904|528071176|FG002|Overall Study|Lost to Follow-up|2|||
146427156|NCT02087904|528071177|FG003|Overall Study|Lost to Follow-up|2|||
146427157|NCT01196052|528071178|FG000|Overall Study|Adverse Event|9|||
146427158|NCT01196052|528071178|FG000|Overall Study|Lost to Follow-up|1|||
146427159|NCT01196052|528071178|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
146427160|NCT01196052|528071178|FG000|Overall Study|Reason not Specified|5|||
146427161|NCT01196052|528071178|FG000|Overall Study|Withdrawal by Subject|6|||
146427162|NCT02178722|528071179|FG000|Overall Study|Withdrawal by Subject|0|||
146427163|NCT02178722|528071180|FG001|Overall Study|Withdrawal by Subject|0|||
146427164|NCT02178722|528071181|FG002|Overall Study|Withdrawal by Subject|0|||
146427165|NCT02178722|528071182|FG003|Overall Study|Withdrawal by Subject|2|||
146427166|NCT02178722|528071183|FG004|Overall Study|Withdrawal by Subject|33|||
146427167|NCT02178722|528071179|FG000|Overall Study|Death|2|||
146427168|NCT02178722|528071180|FG001|Overall Study|Death|13|||
146427169|NCT02178722|528071181|FG002|Overall Study|Death|12|||
146427170|NCT02178722|528071182|FG003|Overall Study|Death|12|||
146427171|NCT02178722|528071183|FG004|Overall Study|Death|205|||
146427172|NCT02178722|528071179|FG000|Overall Study|Lost to Follow-up|0|||
146427173|NCT02178722|528071180|FG001|Overall Study|Lost to Follow-up|0|||
146427174|NCT02178722|528071181|FG002|Overall Study|Lost to Follow-up|0|||
146427175|NCT02178722|528071182|FG003|Overall Study|Lost to Follow-up|2|||
146427176|NCT02178722|528071183|FG004|Overall Study|Lost to Follow-up|11|||
146427177|NCT02178722|528071179|FG000|Overall Study|Study terminated by Sponsor|2|||
146427178|NCT02178722|528071180|FG001|Overall Study|Study terminated by Sponsor|7|||
146427179|NCT02178722|528071181|FG002|Overall Study|Study terminated by Sponsor|6|||
146427180|NCT02178722|528071182|FG003|Overall Study|Study terminated by Sponsor|4|||
146427181|NCT02178722|528071183|FG004|Overall Study|Study terminated by Sponsor|128|||
146082720|NCT00311584|526822873|FG000|Overall Study|Physician Decision|4|||
146082721|NCT00311584|526822874|FG001|Overall Study|Physician Decision|5|||
146082722|NCT00311584|526822873|FG000|Overall Study|Withdrawal by Subject|1|||
146082723|NCT00311584|526822874|FG001|Overall Study|Withdrawal by Subject|1|||
146199993|NCT04517864|527246205|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
146427182|NCT02178722|528071179|FG000|Overall Study|Physician Decision|0|||
146427183|NCT02178722|528071180|FG001|Overall Study|Physician Decision|0|||
146427184|NCT02178722|528071181|FG002|Overall Study|Physician Decision|0|||
146427185|NCT02178722|528071182|FG003|Overall Study|Physician Decision|0|||
146427186|NCT02178722|528071183|FG004|Overall Study|Physician Decision|3|||
146427187|NCT02178722|528071179|FG000|Overall Study|Other|0|||
146427188|NCT02178722|528071180|FG001|Overall Study|Other|0|||
146427189|NCT02178722|528071181|FG002|Overall Study|Other|0|||
146427190|NCT02178722|528071182|FG003|Overall Study|Other|0|||
146082724|NCT00311584|526822873|FG000|Overall Study|ineligible|2|||
146427191|NCT02178722|528071183|FG004|Overall Study|Other|2|||
146427192|NCT03340727|528071184|FG000|Overall Study|Death|1|||
146427193|NCT03340727|528071185|FG001|Overall Study|Death|0|||
146082725|NCT00311584|526822874|FG001|Overall Study|ineligible|2|||
146082726|NCT03720652|526822875|FG000|Overall Study|Withdrawal by Subject|2|||
146082727|NCT03720652|526822876|FG001|Overall Study|Withdrawal by Subject|7|||
146082728|NCT03720652|526822875|FG000|Overall Study|Lost to Follow-up|0|||
146082729|NCT03720652|526822876|FG001|Overall Study|Lost to Follow-up|4|||
146082730|NCT03073733|526822883|FG000|Overall Study|Lost to Follow-up|1|||
146082731|NCT03073733|526822884|FG001|Overall Study|Lost to Follow-up|0|||
146082732|NCT03073733|526822885|FG002|Overall Study|Lost to Follow-up|0|||
146082733|NCT03073733|526822883|FG000|Overall Study|Physician Decision|0|||
146082734|NCT03073733|526822884|FG001|Overall Study|Physician Decision|1|||
146082735|NCT03073733|526822885|FG002|Overall Study|Physician Decision|0|||
146082736|NCT03073733|526822883|FG000|Overall Study|Withdrawal by Subject|0|||
146082737|NCT03073733|526822884|FG001|Overall Study|Withdrawal by Subject|0|||
146082738|NCT03073733|526822885|FG002|Overall Study|Withdrawal by Subject|1|||
146082739|NCT00835731|526822886|FG000|Overall Study|Withdrawal by Subject|1|||
146082740|NCT00835731|526822887|FG001|Overall Study|Withdrawal by Subject|0|||
146082741|NCT00835731|526822886|FG000|Overall Study|Physician Decision|1|||
146082742|NCT00835731|526822887|FG001|Overall Study|Physician Decision|1|||
146082743|NCT01227629|526822888|FG000|Overall Study|Adverse Event|2|||
146082744|NCT01227629|526822889|FG001|Overall Study|Adverse Event|2|||
146082745|NCT01227629|526822890|FG002|Overall Study|Adverse Event|1|||
146082746|NCT01227629|526822891|FG003|Overall Study|Adverse Event|6|||
146082747|NCT01227629|526822892|FG004|Overall Study|Adverse Event|1|||
146082748|NCT01227629|526822893|FG005|Overall Study|Adverse Event|1|||
146082749|NCT01227629|526822894|FG006|Overall Study|Adverse Event|6|||
146082750|NCT01227629|526822895|FG007|Overall Study|Adverse Event|6|||
146082751|NCT01227629|526822896|FG008|Overall Study|Adverse Event|4|||
146082752|NCT01227629|526822897|FG009|Overall Study|Adverse Event|0|||
146082753|NCT01227629|526822888|FG000|Overall Study|Protocol Violation|0|||
146082754|NCT01227629|526822889|FG001|Overall Study|Protocol Violation|0|||
146082755|NCT01227629|526822890|FG002|Overall Study|Protocol Violation|0|||
146082756|NCT01227629|526822891|FG003|Overall Study|Protocol Violation|1|||
146082757|NCT01227629|526822892|FG004|Overall Study|Protocol Violation|0|||
146082758|NCT01227629|526822893|FG005|Overall Study|Protocol Violation|0|||
146082759|NCT01227629|526822894|FG006|Overall Study|Protocol Violation|0|||
146082760|NCT01227629|526822895|FG007|Overall Study|Protocol Violation|0|||
146082761|NCT01227629|526822896|FG008|Overall Study|Protocol Violation|0|||
146082762|NCT01227629|526822897|FG009|Overall Study|Protocol Violation|0|||
146082763|NCT01227629|526822888|FG000|Overall Study|Lost to Follow-up|0|||
146082764|NCT01227629|526822889|FG001|Overall Study|Lost to Follow-up|0|||
146082765|NCT01227629|526822890|FG002|Overall Study|Lost to Follow-up|0|||
146082766|NCT01227629|526822891|FG003|Overall Study|Lost to Follow-up|0|||
146082767|NCT01227629|526822892|FG004|Overall Study|Lost to Follow-up|1|||
146082768|NCT01227629|526822893|FG005|Overall Study|Lost to Follow-up|0|||
146082769|NCT01227629|526822894|FG006|Overall Study|Lost to Follow-up|0|||
146082770|NCT01227629|526822895|FG007|Overall Study|Lost to Follow-up|0|||
146082771|NCT01227629|526822896|FG008|Overall Study|Lost to Follow-up|0|||
146082772|NCT01227629|526822897|FG009|Overall Study|Lost to Follow-up|0|||
146082773|NCT01227629|526822888|FG000|Overall Study|Withdrawal by Subject|0|||
146082774|NCT01227629|526822889|FG001|Overall Study|Withdrawal by Subject|0|||
146082775|NCT01227629|526822890|FG002|Overall Study|Withdrawal by Subject|0|||
146427194|NCT03340727|528071184|FG000|Overall Study|Lost to Follow-up|31|||
146427195|NCT03340727|528071185|FG001|Overall Study|Lost to Follow-up|35|||
146427196|NCT03340727|528071184|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
146427197|NCT03340727|528071185|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
146427198|NCT03340727|528071184|FG000|Overall Study|Transferred to another facility|10|||
146427199|NCT03340727|528071185|FG001|Overall Study|Transferred to another facility|7|||
146427200|NCT03340727|528071184|FG000|Overall Study|Withdrawal by Subject|28|||
146427201|NCT03340727|528071185|FG001|Overall Study|Withdrawal by Subject|17|||
146427202|NCT00440557|528071186|FG000|Overall Study|Withdrawal by Subject|10|||
146427203|NCT00440557|528071187|FG001|Overall Study|Withdrawal by Subject|5|||
146427204|NCT00440557|528071188|FG002|Overall Study|Withdrawal by Subject|11|||
146082776|NCT01227629|526822891|FG003|Overall Study|Withdrawal by Subject|0|||
146082777|NCT01227629|526822892|FG004|Overall Study|Withdrawal by Subject|0|||
146082778|NCT01227629|526822893|FG005|Overall Study|Withdrawal by Subject|0|||
146082779|NCT01227629|526822894|FG006|Overall Study|Withdrawal by Subject|2|||
146082780|NCT01227629|526822895|FG007|Overall Study|Withdrawal by Subject|0|||
146082781|NCT01227629|526822896|FG008|Overall Study|Withdrawal by Subject|0|||
146082782|NCT01227629|526822897|FG009|Overall Study|Withdrawal by Subject|1|||
146082783|NCT01227629|526822888|FG000|Overall Study|Other|0|||
146082784|NCT01227629|526822889|FG001|Overall Study|Other|0|||
146082785|NCT01227629|526822890|FG002|Overall Study|Other|0|||
146082786|NCT01227629|526822891|FG003|Overall Study|Other|1|||
146082787|NCT01227629|526822892|FG004|Overall Study|Other|0|||
146082788|NCT01227629|526822893|FG005|Overall Study|Other|0|||
146082789|NCT01227629|526822894|FG006|Overall Study|Other|0|||
146082790|NCT01227629|526822895|FG007|Overall Study|Other|0|||
146082791|NCT01227629|526822896|FG008|Overall Study|Other|2|||
146427205|NCT00440557|528071186|FG000|Overall Study|Lost to Follow-up|1|||
146427206|NCT00440557|528071187|FG001|Overall Study|Lost to Follow-up|2|||
146427207|NCT00440557|528071188|FG002|Overall Study|Lost to Follow-up|6|||
146427208|NCT00440557|528071186|FG000|Overall Study|Adverse Event|3|||
146427209|NCT00440557|528071187|FG001|Overall Study|Adverse Event|3|||
146427210|NCT00440557|528071188|FG002|Overall Study|Adverse Event|5|||
146427211|NCT00440557|528071186|FG000|Overall Study|Death|2|||
146427212|NCT00440557|528071187|FG001|Overall Study|Death|6|||
146427213|NCT00440557|528071188|FG002|Overall Study|Death|3|||
146427214|NCT00440557|528071186|FG000|Overall Study|Began Dialysis|4|||
146427215|NCT00440557|528071187|FG001|Overall Study|Began Dialysis|1|||
146427216|NCT00440557|528071188|FG002|Overall Study|Began Dialysis|4|||
146427217|NCT00440557|528071186|FG000|Overall Study|Principal Investigator decision|0|||
146427218|NCT00440557|528071187|FG001|Overall Study|Principal Investigator decision|3|||
146427219|NCT00440557|528071188|FG002|Overall Study|Principal Investigator decision|1|||
146427220|NCT00440557|528071186|FG000|Overall Study|Patient moved|1|||
146427221|NCT00440557|528071187|FG001|Overall Study|Patient moved|2|||
146427222|NCT00440557|528071188|FG002|Overall Study|Patient moved|1|||
146427223|NCT00440557|528071186|FG000|Overall Study|Principal Investigator's office closed|3|||
146427224|NCT00440557|528071187|FG001|Overall Study|Principal Investigator's office closed|6|||
146427225|NCT00440557|528071188|FG002|Overall Study|Principal Investigator's office closed|4|||
146427226|NCT00440557|528071186|FG000|Overall Study|Patient transferred to nursing home|0|||
146427227|NCT00440557|528071187|FG001|Overall Study|Patient transferred to nursing home|1|||
146427228|NCT00440557|528071188|FG002|Overall Study|Patient transferred to nursing home|0|||
146427229|NCT00440557|528071186|FG000|Overall Study|Patient had surgery|1|||
146427230|NCT00440557|528071187|FG001|Overall Study|Patient had surgery|0|||
146427231|NCT00440557|528071188|FG002|Overall Study|Patient had surgery|0|||
146427232|NCT00669942|528071189|FG000|Parts 2 and 3|Adverse Event|0|||
146427233|NCT00669942|528071190|FG001|Parts 2 and 3|Adverse Event|0|||
146427234|NCT00669942|528071191|FG002|Parts 2 and 3|Adverse Event|0|||
146427235|NCT00669942|528071192|FG003|Parts 2 and 3|Adverse Event|0|||
146427236|NCT00669942|528071193|FG004|Parts 2 and 3|Adverse Event|0|||
146427237|NCT00669942|528071194|FG005|Parts 2 and 3|Adverse Event|0|||
146427238|NCT00669942|528071195|FG006|Parts 2 and 3|Adverse Event|0|||
146427239|NCT00669942|528071196|FG007|Parts 2 and 3|Adverse Event|2|||
146427240|NCT00669942|528071197|FG008|Parts 2 and 3|Adverse Event|1|||
146427241|NCT00669942|528071198|FG009|Parts 2 and 3|Adverse Event|0|||
146427242|NCT00669942|528071199|FG010|Parts 2 and 3|Adverse Event|0|||
146427243|NCT00669942|528071200|FG011|Parts 2 and 3|Adverse Event|0|||
146427244|NCT00669942|528071189|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
146427245|NCT00669942|528071190|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
146427246|NCT00669942|528071191|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
146427247|NCT00669942|528071192|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
146427248|NCT00669942|528071193|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
146427249|NCT00669942|528071194|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
146427250|NCT00669942|528071195|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
146427251|NCT00669942|528071196|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
146427252|NCT00669942|528071197|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
146427253|NCT00669942|528071198|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
146427254|NCT00669942|528071199|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
146427255|NCT00669942|528071200|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
146427256|NCT00669942|528071189|FG000|Parts 2 and 3|Protocol Violation|0|||
146427257|NCT00669942|528071190|FG001|Parts 2 and 3|Protocol Violation|0|||
146427258|NCT00669942|528071191|FG002|Parts 2 and 3|Protocol Violation|0|||
146427259|NCT00669942|528071192|FG003|Parts 2 and 3|Protocol Violation|0|||
146427260|NCT00669942|528071193|FG004|Parts 2 and 3|Protocol Violation|0|||
146427261|NCT00669942|528071194|FG005|Parts 2 and 3|Protocol Violation|1|||
146427262|NCT00669942|528071195|FG006|Parts 2 and 3|Protocol Violation|0|||
146427263|NCT00669942|528071196|FG007|Parts 2 and 3|Protocol Violation|0|||
146427264|NCT00669942|528071197|FG008|Parts 2 and 3|Protocol Violation|0|||
146427265|NCT00669942|528071198|FG009|Parts 2 and 3|Protocol Violation|0|||
146427266|NCT00669942|528071199|FG010|Parts 2 and 3|Protocol Violation|0|||
146427267|NCT00669942|528071200|FG011|Parts 2 and 3|Protocol Violation|0|||
146427268|NCT02107092|528071201|FG000|Overall Study|Miscellaneous|3|||
146427269|NCT02107092|528071201|FG000|Overall Study|Subject compliance|3|||
146427270|NCT02107092|528071201|FG000|Overall Study|Hypo-or hyperkalemia|2|||
146427271|NCT02107092|528071201|FG000|Overall Study|Met ECG withdrawal criteria|3|||
146427272|NCT02107092|528071201|FG000|Overall Study|Physician Decision|3|||
146427273|NCT02107092|528071201|FG000|Overall Study|Lost to Follow-up|2|||
146427274|NCT02107092|528071201|FG000|Overall Study|Withdrawal by Subject|9|||
146427275|NCT02107092|528071201|FG000|Overall Study|Adverse Event|7|||
146427276|NCT02107092|528071201|FG000|Overall Study|Expected progression of CKD|12|||
146427277|NCT04213326|528071206|FG000|Overall Study|Consent withdrawn|51|||
146427278|NCT04213326|528071207|FG001|Overall Study|Consent withdrawn|241|||
146427279|NCT04213326|528071206|FG000|Overall Study|Lost to Follow-up|50|||
146427280|NCT04213326|528071207|FG001|Overall Study|Lost to Follow-up|902|||
146427281|NCT04213326|528071206|FG000|Overall Study|Protocol Violation|3|||
146427282|NCT04213326|528071207|FG001|Overall Study|Protocol Violation|25|||
146427283|NCT04213326|528071206|FG000|Overall Study|Participant eligibility changed|106|||
146427284|NCT04213326|528071207|FG001|Overall Study|Participant eligibility changed|19|||
146427285|NCT04213326|528071206|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
146427286|NCT04213326|528071207|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
146427287|NCT04213326|528071206|FG000|Overall Study|Incomplete study visit|0|||
146427288|NCT04213326|528071207|FG001|Overall Study|Incomplete study visit|367|||
146427289|NCT02549092|528071208|FG000|Treatment Period|Adverse Event|2|||
146427290|NCT02549092|528071209|FG001|Treatment Period|Adverse Event|2|||
146427291|NCT02549092|528071208|FG000|Treatment Period|Withdrawal by Subject|1|||
146427292|NCT02549092|528071209|FG001|Treatment Period|Withdrawal by Subject|3|||
146427293|NCT02549092|528071208|FG000|Treatment Period|Lack of Efficacy|0|||
146427294|NCT02549092|528071209|FG001|Treatment Period|Lack of Efficacy|2|||
146427295|NCT02549092|528071208|FG000|Extension/Transition Period|Adverse Event|1|||
146427296|NCT02549092|528071209|FG001|Extension/Transition Period|Adverse Event|1|||
146427297|NCT02549092|528071208|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
146427298|NCT02549092|528071209|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
146427299|NCT02549092|528071208|FG000|Extension/Transition Period|Other, Not Specified|4|||
146427300|NCT02549092|528071209|FG001|Extension/Transition Period|Other, Not Specified|2|||
146427301|NCT03002077|528071216|FG000|Overall Study|Non-compliance with Study Drug|4|||
146427302|NCT03002077|528071216|FG000|Overall Study|Non-compliance w/Background ADT|1|||
146427303|NCT03002077|528071216|FG000|Overall Study|Study Terminated by Sponsor|257|||
146427304|NCT03002077|528071216|FG000|Overall Study|Site Terminated by Sponsor|5|||
146427305|NCT03002077|528071216|FG000|Overall Study|Miscellaneous Reasons|10|||
146427306|NCT03002077|528071216|FG000|Overall Study|Adverse Event|23|||
146427307|NCT03002077|528071216|FG000|Overall Study|Lack of Efficacy|20|||
146082792|NCT01227629|526822897|FG009|Overall Study|Other|1|||
146427308|NCT03002077|528071216|FG000|Overall Study|Withdrawal by Subject|72|||
146427309|NCT03002077|528071216|FG000|Overall Study|Lost to Follow-up|21|||
146427310|NCT03002077|528071216|FG000|Overall Study|Pregnancy|4|||
146427311|NCT03002077|528071216|FG000|Overall Study|Protocol Violation|21|||
146427312|NCT04625114|528071227|FG000|Overall Study|Adverse Event|3|||
146427313|NCT04625114|528071228|FG001|Overall Study|Adverse Event|1|||
146427314|NCT04625114|528071227|FG000|Overall Study|Withdrawal by Subject|2|||
146427315|NCT04625114|528071228|FG001|Overall Study|Withdrawal by Subject|0|||
146427316|NCT01629381|528071229|FG000|Overall Study|Withdrawal by Subject|2|||
146427317|NCT01629381|528071230|FG001|Overall Study|Withdrawal by Subject|5|||
146427318|NCT00906347|528071233|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
146427319|NCT00906347|528071234|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
146427320|NCT00906347|528071233|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
146427321|NCT00906347|528071234|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
146427322|NCT00906347|528071233|FG000|Received Study Drug|Refused study drug|1|||
146427323|NCT00906347|528071234|FG001|Received Study Drug|Refused study drug|0|||
146427324|NCT00906347|528071233|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
146427325|NCT00906347|528071234|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
146427326|NCT02849652|528071242|FG000|Overall Study|Lost to Follow-up|104|||
146427327|NCT02849652|528071243|FG001|Overall Study|Lost to Follow-up|35|||
146427328|NCT02849652|528071244|FG002|Overall Study|Lost to Follow-up|116|||
146427329|NCT02849652|528071245|FG003|Overall Study|Lost to Follow-up|22|||
146427330|NCT02849652|528071242|FG000|Overall Study|Withdrawal by Subject|10|||
146427331|NCT02849652|528071243|FG001|Overall Study|Withdrawal by Subject|2|||
146427332|NCT02849652|528071244|FG002|Overall Study|Withdrawal by Subject|8|||
146427333|NCT02849652|528071245|FG003|Overall Study|Withdrawal by Subject|4|||
146427334|NCT00472290|528071246|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
146427335|NCT00472290|528071246|FG000|Overall Study|Protocol Specified Criteria|7|||
146427336|NCT00472290|528071246|FG000|Overall Study|Administrative Decision|37|||
146427337|NCT00472290|528071246|FG000|Overall Study|Death|3|||
146427338|NCT00472290|528071246|FG000|Overall Study|Lost to Follow-up|1|||
146427339|NCT00472290|528071246|FG000|Overall Study|Lack of Efficacy|1|||
146427340|NCT00472290|528071246|FG000|Overall Study|Disease Progression|4|||
146427341|NCT00472290|528071246|FG000|Overall Study|Withdrawal by Subject|5|||
146427342|NCT00472290|528071246|FG000|Overall Study|Adverse Event|6|||
146427343|NCT00472290|528071246|FG000|Overall Study|Requirement for alternative therapy|7|||
146427344|NCT00777829|528071247|FG000|Overall Study|Withdrawal by Subject|0|||
146427345|NCT00777829|528071248|FG001|Overall Study|Withdrawal by Subject|2|||
146427346|NCT00854308|528071257|FG000|Overall Study|Disease progression|42|||
146427347|NCT00854308|528071258|FG001|Overall Study|Disease progression|50|||
146427348|NCT00854308|528071257|FG000|Overall Study|Adverse Event|8|||
146427349|NCT00854308|528071258|FG001|Overall Study|Adverse Event|3|||
146427350|NCT00854308|528071257|FG000|Overall Study|Death|2|||
146427351|NCT00854308|528071258|FG001|Overall Study|Death|5|||
146427352|NCT00854308|528071257|FG000|Overall Study|Physician Decision|6|||
146427353|NCT00854308|528071258|FG001|Overall Study|Physician Decision|6|||
146427354|NCT00854308|528071257|FG000|Overall Study|Withdrawal by Subject|4|||
146427355|NCT00854308|528071258|FG001|Overall Study|Withdrawal by Subject|2|||
146427356|NCT00854308|528071257|FG000|Overall Study|Sponsor's decision to terminate study|0|||
146427357|NCT00854308|528071258|FG001|Overall Study|Sponsor's decision to terminate study|1|||
146427358|NCT01390844|528071259|FG000|Treatment Phase|Adverse Event|12|||
146427359|NCT01390844|528071260|FG001|Treatment Phase|Adverse Event|2|||
146427360|NCT01390844|528071261|FG002|Treatment Phase|Adverse Event|3|||
146427361|NCT01390844|528071262|FG003|Treatment Phase|Adverse Event|2|||
146427362|NCT01390844|528071259|FG000|Treatment Phase|Treatment Failure|23|||
146427363|NCT01390844|528071260|FG001|Treatment Phase|Treatment Failure|25|||
146427364|NCT01390844|528071261|FG002|Treatment Phase|Treatment Failure|10|||
146427365|NCT01390844|528071262|FG003|Treatment Phase|Treatment Failure|13|||
146427366|NCT01390844|528071259|FG000|Treatment Phase|Non-Medical Reasons|5|||
146427367|NCT01390844|528071260|FG001|Treatment Phase|Non-Medical Reasons|1|||
146427368|NCT01390844|528071261|FG002|Treatment Phase|Non-Medical Reasons|8|||
146427369|NCT01390844|528071262|FG003|Treatment Phase|Non-Medical Reasons|1|||
146427370|NCT01390844|528071259|FG000|Treatment Phase|Non-GCP Compliant|0|||
146427371|NCT01390844|528071260|FG001|Treatment Phase|Non-GCP Compliant|0|||
146427372|NCT01390844|528071261|FG002|Treatment Phase|Non-GCP Compliant|10|||
146427373|NCT01390844|528071262|FG003|Treatment Phase|Non-GCP Compliant|3|||
146427374|NCT01390844|528071259|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
146427375|NCT01390844|528071260|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
146427376|NCT01390844|528071261|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
146427377|NCT01390844|528071262|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
146427378|NCT00745095|528071263|FG000|Overall Study|Declined to participate|1|||
146427379|NCT00745095|528071264|FG001|Overall Study|Declined to participate|0|||
146427380|NCT00745095|528071265|FG002|Overall Study|Declined to participate|0|||
146427381|NCT00745095|528071266|FG003|Overall Study|Declined to participate|0|||
146427382|NCT00745095|528071267|FG004|Overall Study|Declined to participate|92|||
146427383|NCT00745095|528071268|FG005|Overall Study|Declined to participate|95|||
146427384|NCT00745095|528071263|FG000|Overall Study|Ineligible due to GFR criteria|0|||
146427385|NCT00745095|528071264|FG001|Overall Study|Ineligible due to GFR criteria|2|||
146427386|NCT00745095|528071265|FG002|Overall Study|Ineligible due to GFR criteria|3|||
146427387|NCT00745095|528071266|FG003|Overall Study|Ineligible due to GFR criteria|3|||
146427388|NCT00745095|528071267|FG004|Overall Study|Ineligible due to GFR criteria|30|||
146427389|NCT00745095|528071268|FG005|Overall Study|Ineligible due to GFR criteria|28|||
145949842|NCT01214668|526328680|FG000|Overall Study|Progressive Disease|4|||
146427390|NCT01479439|528071269|FG000|Overall Study|Adverse Event|1|||
146427391|NCT01479439|528071270|FG001|Overall Study|Adverse Event|0|||
146427392|NCT01479439|528071271|FG002|Overall Study|Adverse Event|0|||
146427393|NCT01479439|528071269|FG000|Overall Study|Lost to Follow-up|0|||
146427394|NCT01479439|528071270|FG001|Overall Study|Lost to Follow-up|1|||
146427395|NCT01479439|528071271|FG002|Overall Study|Lost to Follow-up|0|||
146427396|NCT01479439|528071269|FG000|Overall Study|Protocol Violation|0|||
146427397|NCT01479439|528071270|FG001|Overall Study|Protocol Violation|0|||
146427398|NCT01479439|528071271|FG002|Overall Study|Protocol Violation|2|||
146427399|NCT02079766|528071272|FG000|Overall Study|Physician Decision|1|||
146427400|NCT02079766|528071273|FG001|Overall Study|Physician Decision|0|||
146427401|NCT02079766|528071272|FG000|Overall Study|Withdrawal by Subject|1|||
146427402|NCT02079766|528071273|FG001|Overall Study|Withdrawal by Subject|0|||
146427403|NCT00304083|528071276|FG000|Overall Study|Withdrawal by Subject|4|||
146427404|NCT00304083|528071277|FG001|Overall Study|Withdrawal by Subject|2|||
146427405|NCT00304083|528071276|FG000|Overall Study|Physician Decision|8|||
146427406|NCT00304083|528071277|FG001|Overall Study|Physician Decision|3|||
146427407|NCT00304083|528071276|FG000|Overall Study|Disease Progression|5|||
146427408|NCT00304083|528071277|FG001|Overall Study|Disease Progression|1|||
146427409|NCT00304083|528071276|FG000|Overall Study|Other|5|||
146427410|NCT00304083|528071277|FG001|Overall Study|Other|2|||
146427411|NCT01044732|528071278|FG000|Overall Study|Lost to Follow-up|2|||
146427412|NCT01044732|528071279|FG001|Overall Study|Lost to Follow-up|1|||
146427413|NCT01044732|528071278|FG000|Overall Study|Physician Decision|5|||
146427414|NCT01044732|528071279|FG001|Overall Study|Physician Decision|3|||
146427415|NCT01044732|528071278|FG000|Overall Study|Protocol Violation|11|||
146427416|NCT01044732|528071279|FG001|Overall Study|Protocol Violation|12|||
146427417|NCT01044732|528071278|FG000|Overall Study|Withdrawal by Subject|0|||
146427418|NCT01044732|528071279|FG001|Overall Study|Withdrawal by Subject|1|||
146427419|NCT01044732|528071278|FG000|Overall Study|Inadequate bowel preparation|11|||
146427420|NCT01044732|528071279|FG001|Overall Study|Inadequate bowel preparation|17|||
146427421|NCT01044732|528071278|FG000|Overall Study|Inability to reach cecum|5|||
146427422|NCT01044732|528071279|FG001|Overall Study|Inability to reach cecum|2|||
146427423|NCT01044732|528071278|FG000|Overall Study|Technical error or malfunction|15|||
146427424|NCT01044732|528071279|FG001|Overall Study|Technical error or malfunction|14|||
146427425|NCT03991494|528071282|FG000|Overall Study|Progressive Disease|4|||
146427426|NCT03144687|528071289|FG000|Overall Study|Death|0|||
146427427|NCT03144687|528071290|FG001|Overall Study|Death|2|||
146427428|NCT03144687|528071289|FG000|Overall Study|Lost to Follow-up|0|||
146427429|NCT03144687|528071290|FG001|Overall Study|Lost to Follow-up|1|||
146427430|NCT03144687|528071289|FG000|Overall Study|Physician Decision|0|||
146427431|NCT03144687|528071290|FG001|Overall Study|Physician Decision|1|||
146427432|NCT03144687|528071289|FG000|Overall Study|Withdrawal by Subject|1|||
146427433|NCT03144687|528071290|FG001|Overall Study|Withdrawal by Subject|3|||
146427434|NCT03144687|528071289|FG000|Overall Study|Not Reported|2|||
146427435|NCT03144687|528071290|FG001|Overall Study|Not Reported|0|||
146427436|NCT00683293|528071293|FG000|Overall Study|Withdrawal by Subject|2|||
146427437|NCT00683293|528071294|FG001|Overall Study|Withdrawal by Subject|3|||
146427438|NCT02507375|528071301|FG000|Overall Study|Progressive Disease|4|||
146427439|NCT02507375|528071302|FG001|Overall Study|Progressive Disease|5|||
146427440|NCT02507375|528071301|FG000|Overall Study|Death|0|||
146427441|NCT02507375|528071302|FG001|Overall Study|Death|1|||
146427442|NCT02507375|528071301|FG000|Overall Study|Refused treatment|0|||
146427443|NCT02507375|528071302|FG001|Overall Study|Refused treatment|1|||
146427444|NCT02507375|528071301|FG000|Overall Study|Adverse Event|0|||
146427445|NCT02507375|528071302|FG001|Overall Study|Adverse Event|1|||
146427446|NCT01387737|528072857|FG000|Overall Study|Adverse Event|20|||
146427447|NCT01387737|528072858|FG001|Overall Study|Adverse Event|30|||
146427448|NCT01387737|528072857|FG000|Overall Study|Lack of Efficacy|1|||
146427449|NCT01387737|528072858|FG001|Overall Study|Lack of Efficacy|0|||
146427450|NCT01387737|528072857|FG000|Overall Study|Physician Decision|3|||
146427451|NCT01387737|528072858|FG001|Overall Study|Physician Decision|10|||
146427452|NCT01387737|528072857|FG000|Overall Study|Withdrawal by Subject|27|||
146427453|NCT01387737|528072858|FG001|Overall Study|Withdrawal by Subject|31|||
146427454|NCT01387737|528072857|FG000|Overall Study|Clearly not eligible for the study|1|||
146427455|NCT01387737|528072858|FG001|Overall Study|Clearly not eligible for the study|3|||
146427456|NCT01248247|528072859|FG000|Overall Study|Adverse Event|2|||
146427457|NCT01248247|528072860|FG001|Overall Study|Adverse Event|4|||
146427458|NCT01248247|528072861|FG002|Overall Study|Adverse Event|4|||
146427459|NCT01248247|528072862|FG003|Overall Study|Adverse Event|2|||
146427460|NCT01248247|528072859|FG000|Overall Study|Death|0|||
146427461|NCT01248247|528072860|FG001|Overall Study|Death|1|||
146427462|NCT01248247|528072861|FG002|Overall Study|Death|4|||
146427463|NCT01248247|528072862|FG003|Overall Study|Death|7|||
146427464|NCT01248247|528072859|FG000|Overall Study|Lost to Follow-up|0|||
146427465|NCT01248247|528072860|FG001|Overall Study|Lost to Follow-up|1|||
146427466|NCT01248247|528072861|FG002|Overall Study|Lost to Follow-up|1|||
146427467|NCT01248247|528072862|FG003|Overall Study|Lost to Follow-up|0|||
146427468|NCT01248247|528072859|FG000|Overall Study|Alternative treatment|0|||
146427469|NCT01248247|528072860|FG001|Overall Study|Alternative treatment|1|||
146427470|NCT01248247|528072861|FG002|Overall Study|Alternative treatment|0|||
146427471|NCT01248247|528072862|FG003|Overall Study|Alternative treatment|0|||
146427472|NCT01248247|528072859|FG000|Overall Study|Other|2|||
146427473|NCT01248247|528072860|FG001|Overall Study|Other|8|||
146427474|NCT01248247|528072861|FG002|Overall Study|Other|8|||
146427475|NCT01248247|528072862|FG003|Overall Study|Other|5|||
146427476|NCT01248247|528072859|FG000|Overall Study|Progression|18|||
146427477|NCT01248247|528072860|FG001|Overall Study|Progression|27|||
146427478|NCT01248247|528072861|FG002|Overall Study|Progression|56|||
146427479|NCT01248247|528072862|FG003|Overall Study|Progression|44|||
146427480|NCT01248247|528072859|FG000|Overall Study|Refuse further treatment|0|||
146427481|NCT01248247|528072860|FG001|Overall Study|Refuse further treatment|0|||
146427482|NCT01248247|528072861|FG002|Overall Study|Refuse further treatment|1|||
146427483|NCT01248247|528072862|FG003|Overall Study|Refuse further treatment|2|||
146427484|NCT01248247|528072859|FG000|Overall Study|Complicating disease|0|||
146427485|NCT01248247|528072860|FG001|Overall Study|Complicating disease|0|||
146427486|NCT01248247|528072861|FG002|Overall Study|Complicating disease|1|||
146427487|NCT01248247|528072862|FG003|Overall Study|Complicating disease|1|||
146427488|NCT00705536|528072864|FG000|Start Period 1|Withdrawal by Subject|0|||
146427489|NCT00705536|528072865|FG001|Start Period 1|Withdrawal by Subject|0|||
146427490|NCT00705536|528072866|FG002|Start Period 1|Withdrawal by Subject|0|||
146427491|NCT00705536|528072867|FG003|Start Period 1|Withdrawal by Subject|1|||
146427492|NCT00549718|528072868|FG000|Overall Study|Insufficient clinical response|20|||
146427493|NCT00549718|528072869|FG001|Overall Study|Insufficient clinical response|7|||
146427494|NCT00549718|528072870|FG002|Overall Study|Insufficient clinical response|18|||
146427495|NCT00549718|528072871|FG003|Overall Study|Insufficient clinical response|32|||
146427496|NCT00549718|528072868|FG000|Overall Study|Adverse Event|6|||
146427497|NCT00549718|528072869|FG001|Overall Study|Adverse Event|8|||
146427498|NCT00549718|528072870|FG002|Overall Study|Adverse Event|7|||
146427499|NCT00549718|528072871|FG003|Overall Study|Adverse Event|3|||
146427500|NCT00549718|528072868|FG000|Overall Study|Lost to Follow-up|4|||
146427501|NCT00549718|528072869|FG001|Overall Study|Lost to Follow-up|2|||
146427502|NCT00549718|528072870|FG002|Overall Study|Lost to Follow-up|0|||
146427503|NCT00549718|528072871|FG003|Overall Study|Lost to Follow-up|6|||
146427504|NCT00549718|528072868|FG000|Overall Study|Withdrawal by Subject|9|||
146427505|NCT00549718|528072869|FG001|Overall Study|Withdrawal by Subject|18|||
146427506|NCT00549718|528072870|FG002|Overall Study|Withdrawal by Subject|12|||
146427507|NCT00549718|528072871|FG003|Overall Study|Withdrawal by Subject|13|||
146427508|NCT00549718|528072868|FG000|Overall Study|Administrative|2|||
146427509|NCT00549718|528072869|FG001|Overall Study|Administrative|2|||
146427510|NCT00549718|528072870|FG002|Overall Study|Administrative|2|||
146427511|NCT00549718|528072871|FG003|Overall Study|Administrative|1|||
146427512|NCT04032977|528072872|FG000|Overall Study|Withdrawal by Subject|6|||
146427513|NCT04032977|528072873|FG001|Overall Study|Withdrawal by Subject|1|||
146427514|NCT04032977|528072872|FG000|Overall Study|Lost to Follow-up|2|||
146427515|NCT04032977|528072873|FG001|Overall Study|Lost to Follow-up|7|||
146427516|NCT04032977|528072872|FG000|Overall Study|Pregnancy|1|||
146427517|NCT04032977|528072873|FG001|Overall Study|Pregnancy|0|||
146427518|NCT02880761|528072875|FG000|Overall Study|Death|6|||
146427519|NCT02880761|528072876|FG001|Overall Study|Death|8|||
146427520|NCT02880761|528072875|FG000|Overall Study|Withdrawal by Subject|3|||
146427521|NCT02880761|528072876|FG001|Overall Study|Withdrawal by Subject|6|||
146427522|NCT02880761|528072875|FG000|Overall Study|Protocol Violation|4|||
146427523|NCT02880761|528072876|FG001|Overall Study|Protocol Violation|3|||
146427524|NCT02880761|528072875|FG000|Overall Study|Lost to Follow-up|3|||
146427525|NCT02880761|528072876|FG001|Overall Study|Lost to Follow-up|4|||
146427526|NCT03075761|528072877|FG000|Overall Study|Lost to Follow-up|1|||
146427527|NCT03075761|528072878|FG001|Overall Study|Lost to Follow-up|6|||
146427528|NCT03597256|528072879|FG000|Overall Study|Lost to Follow-up|3|||
146427529|NCT03597256|528072880|FG001|Overall Study|Lost to Follow-up|1|||
146427530|NCT03597256|528072879|FG000|Overall Study|Withdrawal by Subject|0|||
146427531|NCT03597256|528072880|FG001|Overall Study|Withdrawal by Subject|1|||
146427532|NCT03597256|528072879|FG000|Overall Study|Could not return for treatment|0|||
146427533|NCT03597256|528072880|FG001|Overall Study|Could not return for treatment|1|||
146427534|NCT03597256|528072879|FG000|Overall Study|Moved from location|0|||
146427535|NCT03597256|528072880|FG001|Overall Study|Moved from location|1|||
146427536|NCT03597256|528072879|FG000|Overall Study|Not accepted the treatment|0|||
146427537|NCT03597256|528072880|FG001|Overall Study|Not accepted the treatment|1|||
146427538|NCT02106156|528072881|FG000|Overall Study|Patient Died|19|||
146427539|NCT02106156|528072882|FG001|Overall Study|Patient Died|0|||
146427540|NCT02106156|528072883|FG002|Overall Study|Patient Died|0|||
146427541|NCT02106156|528072881|FG000|Overall Study|Lack of Tolerability|305|||
146427542|NCT02106156|528072882|FG001|Overall Study|Lack of Tolerability|3|||
146427543|NCT02106156|528072883|FG002|Overall Study|Lack of Tolerability|0|||
146427544|NCT02106156|528072881|FG000|Overall Study|Lack of Virological Response|1044|||
146427545|NCT02106156|528072882|FG001|Overall Study|Lack of Virological Response|8|||
146427546|NCT02106156|528072883|FG002|Overall Study|Lack of Virological Response|0|||
146427547|NCT02106156|528072881|FG000|Overall Study|Concomitant Disease|74|||
146427548|NCT02106156|528072882|FG001|Overall Study|Concomitant Disease|2|||
146427549|NCT02106156|528072883|FG002|Overall Study|Concomitant Disease|0|||
146427550|NCT02106156|528072881|FG000|Overall Study|Lack of Compliance|211|||
146427551|NCT02106156|528072882|FG001|Overall Study|Lack of Compliance|7|||
146427552|NCT02106156|528072883|FG002|Overall Study|Lack of Compliance|0|||
146427553|NCT02106156|528072881|FG000|Overall Study|Patients Request|307|||
146427554|NCT02106156|528072882|FG001|Overall Study|Patients Request|9|||
146427555|NCT02106156|528072883|FG002|Overall Study|Patients Request|0|||
146427556|NCT02106156|528072881|FG000|Overall Study|Lost to Follow-up|451|||
146427557|NCT02106156|528072882|FG001|Overall Study|Lost to Follow-up|8|||
146427558|NCT02106156|528072883|FG002|Overall Study|Lost to Follow-up|0|||
146427559|NCT02106156|528072881|FG000|Overall Study|Unplanned Event|82|||
146427560|NCT02106156|528072882|FG001|Overall Study|Unplanned Event|2|||
146427561|NCT02106156|528072883|FG002|Overall Study|Unplanned Event|0|||
146427562|NCT02106156|528072881|FG000|Overall Study|Change of Laboratory Parameter|10|||
146427563|NCT02106156|528072882|FG001|Overall Study|Change of Laboratory Parameter|0|||
146427564|NCT02106156|528072883|FG002|Overall Study|Change of Laboratory Parameter|0|||
146427565|NCT02106156|528072881|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
146427566|NCT02106156|528072882|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
146427567|NCT02106156|528072883|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
146427568|NCT02106156|528072881|FG000|Overall Study|Relocation/Change of Physician|40|||
146427569|NCT02106156|528072882|FG001|Overall Study|Relocation/Change of Physician|1|||
146427570|NCT02106156|528072883|FG002|Overall Study|Relocation/Change of Physician|0|||
146427571|NCT00560235|528072893|FG000|Phase 1|Discontinued|8|||
146427572|NCT00560235|528072894|FG001|Phase 1|Discontinued|0|||
146427573|NCT00560235|528072895|FG002|Phase 1|Discontinued|0|||
146427574|NCT00560235|528072893|FG000|Phase 1B|Discontinued|0|||
146427575|NCT00560235|528072894|FG001|Phase 1B|Discontinued|19|||
146427576|NCT00560235|528072895|FG002|Phase 1B|Discontinued|0|||
146427577|NCT00560235|528072893|FG000|Phase 2|Discontinued|0|||
146427578|NCT00560235|528072894|FG001|Phase 2|Discontinued|0|||
146427579|NCT00560235|528072895|FG002|Phase 2|Discontinued|96|||
146427580|NCT00560235|528072893|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
146427581|NCT00560235|528072894|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
146427582|NCT00560235|528072895|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
146427583|NCT03247556|528072899|FG000|Overall Study|Adverse Event|1|||
146427584|NCT03247556|528072900|FG001|Overall Study|Adverse Event|4|||
146427585|NCT03247556|528072901|FG002|Overall Study|Adverse Event|5|||
146427586|NCT03247556|528072899|FG000|Overall Study|Lost to Follow-up|5|||
146427587|NCT03247556|528072900|FG001|Overall Study|Lost to Follow-up|5|||
146427588|NCT03247556|528072901|FG002|Overall Study|Lost to Follow-up|4|||
146427589|NCT03247556|528072899|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
146427590|NCT03247556|528072900|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
146427591|NCT03247556|528072901|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
146427592|NCT03247556|528072899|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
146427593|NCT03247556|528072900|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
146427594|NCT03247556|528072901|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
146427595|NCT03247556|528072899|FG000|Overall Study|Protocol Violation|2|||
146427596|NCT03247556|528072900|FG001|Overall Study|Protocol Violation|0|||
146427597|NCT03247556|528072901|FG002|Overall Study|Protocol Violation|1|||
146427598|NCT03247556|528072899|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
146427599|NCT03247556|528072900|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
146427600|NCT03247556|528072901|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
146427601|NCT00051025|528072903|FG000|Overall Study|Progressive Disease|1|||
146427602|NCT00051025|528072904|FG001|Overall Study|Progressive Disease|1|||
146427603|NCT00051025|528072903|FG000|Overall Study|Adverse Event|1|||
146427604|NCT00051025|528072904|FG001|Overall Study|Adverse Event|1|||
145949843|NCT01214668|526328681|FG001|Overall Study|Progressive Disease|2|||
146427605|NCT00051025|528072903|FG000|Overall Study|Withdrawal by Subject|0|||
146427606|NCT00051025|528072904|FG001|Overall Study|Withdrawal by Subject|1|||
146427607|NCT00051025|528072903|FG000|Overall Study|Death|0|||
146427608|NCT00051025|528072904|FG001|Overall Study|Death|1|||
146427609|NCT00274937|528072905|FG000|Overall Study|Physician Decision|10|||
146427610|NCT00274937|528072905|FG000|Overall Study|Withdrawal by Subject|6|||
146427611|NCT00274937|528072905|FG000|Overall Study|Progressive Disease|4|||
146427612|NCT02189941|528072906|FG000|Overall Study|Non-compliance|0|||
146427613|NCT02189941|528072907|FG001|Overall Study|Non-compliance|0|||
146427614|NCT02189941|528072908|FG002|Overall Study|Non-compliance|1|||
146427615|NCT00445003|528072909|FG000|Overall Study|Death|1|||
146427616|NCT00445003|528072910|FG001|Overall Study|Death|2|||
146427617|NCT00445003|528072911|FG002|Overall Study|Death|1|||
146427618|NCT00445003|528072909|FG000|Overall Study|Missed Visit|3|||
146427619|NCT00445003|528072910|FG001|Overall Study|Missed Visit|5|||
146427620|NCT00445003|528072911|FG002|Overall Study|Missed Visit|1|||
146427621|NCT00445003|528072909|FG000|Overall Study|Dropped|1|||
146427622|NCT00445003|528072910|FG001|Overall Study|Dropped|3|||
146427623|NCT00445003|528072911|FG002|Overall Study|Dropped|2|||
146427624|NCT00528606|528072912|FG000|Overall Study|Withdrew consent|4|||
146427625|NCT00528606|528072913|FG001|Overall Study|Withdrew consent|3|||
146427626|NCT00528606|528072912|FG000|Overall Study|Lost to Follow-up|4|||
146427627|NCT00528606|528072913|FG001|Overall Study|Lost to Follow-up|1|||
146427628|NCT00528606|528072912|FG000|Overall Study|Adverse Event|3|||
146427629|NCT00528606|528072913|FG001|Overall Study|Adverse Event|0|||
146427630|NCT00528606|528072912|FG000|Overall Study|Other|2|||
146427631|NCT00528606|528072913|FG001|Overall Study|Other|0|||
146427632|NCT01471093|528072914|FG000|Overall Study|Adverse Event|1|||
146427633|NCT01471093|528072915|FG001|Overall Study|Adverse Event|0|||
146427634|NCT01471093|528072916|FG002|Overall Study|Adverse Event|0|||
146427635|NCT01471093|528072917|FG003|Overall Study|Adverse Event|0|||
146427636|NCT02475954|528072918|FG000|Overall Study|Withdrawal by Subject|2|||
146427637|NCT02475954|528072919|FG001|Overall Study|Withdrawal by Subject|2|||
146427638|NCT02475954|528072918|FG000|Overall Study|Lost to Follow-up|11|||
146427639|NCT02475954|528072919|FG001|Overall Study|Lost to Follow-up|9|||
146427640|NCT02475954|528072918|FG000|Overall Study|Death|1|||
146427641|NCT02475954|528072919|FG001|Overall Study|Death|1|||
146427642|NCT01918397|528072923|FG000|Overall Study|Never started treatment|2|||
146427643|NCT01918397|528072924|FG001|Overall Study|Never started treatment|1|||
146427644|NCT01918397|528072925|FG002|Overall Study|Never started treatment|0|||
146427645|NCT01918397|528072926|FG003|Overall Study|Never started treatment|0|||
146427646|NCT01918397|528072923|FG000|Overall Study|Adverse Event|1|||
146427647|NCT01918397|528072924|FG001|Overall Study|Adverse Event|1|||
146427648|NCT01918397|528072925|FG002|Overall Study|Adverse Event|1|||
146427649|NCT01918397|528072926|FG003|Overall Study|Adverse Event|0|||
146427650|NCT01918397|528072923|FG000|Overall Study|Lack of compliance|2|||
146427651|NCT01918397|528072924|FG001|Overall Study|Lack of compliance|2|||
146427652|NCT01918397|528072925|FG002|Overall Study|Lack of compliance|3|||
146427653|NCT01918397|528072926|FG003|Overall Study|Lack of compliance|0|||
146427654|NCT01918397|528072923|FG000|Overall Study|Pregnancy|0|||
146427655|NCT01918397|528072924|FG001|Overall Study|Pregnancy|1|||
146427656|NCT01918397|528072925|FG002|Overall Study|Pregnancy|0|||
146427657|NCT01918397|528072926|FG003|Overall Study|Pregnancy|0|||
146427658|NCT01918397|528072923|FG000|Overall Study|Rifampin susceptible|0|||
146427659|NCT01918397|528072924|FG001|Overall Study|Rifampin susceptible|0|||
146427660|NCT01918397|528072925|FG002|Overall Study|Rifampin susceptible|0|||
146427661|NCT01918397|528072926|FG003|Overall Study|Rifampin susceptible|2|||
146427662|NCT01918397|528072923|FG000|Overall Study|Treatment failure|0|||
146427663|NCT01918397|528072924|FG001|Overall Study|Treatment failure|0|||
146427664|NCT01918397|528072925|FG002|Overall Study|Treatment failure|0|||
146427665|NCT01918397|528072926|FG003|Overall Study|Treatment failure|1|||
146427666|NCT01918397|528072923|FG000|Overall Study|Withdrawal by Subject|3|||
146427667|NCT01918397|528072924|FG001|Overall Study|Withdrawal by Subject|2|||
146427668|NCT01918397|528072925|FG002|Overall Study|Withdrawal by Subject|1|||
146427669|NCT01918397|528072926|FG003|Overall Study|Withdrawal by Subject|1|||
146427670|NCT01918397|528072923|FG000|Overall Study|XDR at baseline|0|||
146427671|NCT01918397|528072924|FG001|Overall Study|XDR at baseline|0|||
146427672|NCT01918397|528072925|FG002|Overall Study|XDR at baseline|1|||
146427673|NCT01918397|528072926|FG003|Overall Study|XDR at baseline|0|||
146427674|NCT01918397|528072923|FG000|Overall Study|Lost to Follow-up|2|||
146427675|NCT01918397|528072924|FG001|Overall Study|Lost to Follow-up|1|||
146427676|NCT01918397|528072925|FG002|Overall Study|Lost to Follow-up|1|||
146427677|NCT01918397|528072926|FG003|Overall Study|Lost to Follow-up|1|||
146427678|NCT01918397|528072923|FG000|Overall Study|Increased QTc|1|||
146427679|NCT01918397|528072924|FG001|Overall Study|Increased QTc|0|||
146427680|NCT01918397|528072925|FG002|Overall Study|Increased QTc|0|||
146427681|NCT01918397|528072926|FG003|Overall Study|Increased QTc|1|||
146427682|NCT01918397|528072923|FG000|Overall Study|Death|0|||
146427683|NCT01918397|528072924|FG001|Overall Study|Death|0|||
146427684|NCT01918397|528072925|FG002|Overall Study|Death|1|||
146427685|NCT01918397|528072926|FG003|Overall Study|Death|0|||
146427686|NCT01918397|528072923|FG000|Overall Study|Involved in another investigative trial|0|||
146427687|NCT01918397|528072924|FG001|Overall Study|Involved in another investigative trial|0|||
146427688|NCT01918397|528072925|FG002|Overall Study|Involved in another investigative trial|0|||
146427689|NCT01918397|528072926|FG003|Overall Study|Involved in another investigative trial|1|||
146427690|NCT00880568|528072927|FG000|Overall Study|Disease progression|3|||
146427691|NCT00880568|528072928|FG001|Overall Study|Disease progression|3|||
146427692|NCT00880568|528072929|FG002|Overall Study|Disease progression|3|||
146427693|NCT00880568|528072930|FG003|Overall Study|Disease progression|1|||
146427694|NCT00880568|528072931|FG004|Overall Study|Disease progression|3|||
146427695|NCT00880568|528072932|FG005|Overall Study|Disease progression|3|||
146427696|NCT00880568|528072933|FG006|Overall Study|Disease progression|5|||
146427697|NCT00880568|528072934|FG007|Overall Study|Disease progression|0|||
146427698|NCT00880568|528072935|FG008|Overall Study|Disease progression|3|||
146427699|NCT00880568|528072927|FG000|Overall Study|Adverse Event|0|||
146427700|NCT00880568|528072928|FG001|Overall Study|Adverse Event|0|||
146427701|NCT00880568|528072929|FG002|Overall Study|Adverse Event|0|||
146427702|NCT00880568|528072930|FG003|Overall Study|Adverse Event|0|||
146427703|NCT00880568|528072931|FG004|Overall Study|Adverse Event|0|||
146427704|NCT00880568|528072932|FG005|Overall Study|Adverse Event|0|||
146427705|NCT00880568|528072933|FG006|Overall Study|Adverse Event|1|||
146427706|NCT00880568|528072934|FG007|Overall Study|Adverse Event|1|||
146427707|NCT00880568|528072935|FG008|Overall Study|Adverse Event|0|||
146427708|NCT00880568|528072927|FG000|Overall Study|Withdrawal by Subject|0|||
146427709|NCT00880568|528072928|FG001|Overall Study|Withdrawal by Subject|0|||
146427710|NCT00880568|528072929|FG002|Overall Study|Withdrawal by Subject|0|||
146427711|NCT00880568|528072930|FG003|Overall Study|Withdrawal by Subject|0|||
146427712|NCT00880568|528072931|FG004|Overall Study|Withdrawal by Subject|0|||
146427713|NCT00880568|528072932|FG005|Overall Study|Withdrawal by Subject|0|||
146427714|NCT00880568|528072933|FG006|Overall Study|Withdrawal by Subject|0|||
146427715|NCT00880568|528072934|FG007|Overall Study|Withdrawal by Subject|1|||
146427716|NCT00880568|528072935|FG008|Overall Study|Withdrawal by Subject|0|||
146427717|NCT00620022|528072936|FG000|Treatment Period 1|Adverse Event|4|||
146427718|NCT00620022|528072937|FG001|Treatment Period 1|Adverse Event|6|||
146427719|NCT00620022|528072936|FG000|Treatment Period 1|Subject withdrew consent|1|||
146427720|NCT00620022|528072937|FG001|Treatment Period 1|Subject withdrew consent|0|||
146427721|NCT00620022|528072936|FG000|Treatment Period 2|Adverse Event|2|||
146427722|NCT00620022|528072937|FG001|Treatment Period 2|Adverse Event|2|||
146427723|NCT00496964|528072944|FG000|Overall Study|Withdrawal by Subject|0|||
146427724|NCT00496964|528072945|FG001|Overall Study|Withdrawal by Subject|1|||
146427725|NCT02017964|528072949|FG000|Overall Study|Patient deemed ineligible|1|||
146427726|NCT00150462|528072953|FG000|Overall Study|Disease Progression or Relapse|3|||
146427727|NCT00150462|528072954|FG001|Overall Study|Disease Progression or Relapse|1|||
146427728|NCT00150462|528072955|FG002|Overall Study|Disease Progression or Relapse|2|||
146427729|NCT00150462|528072956|FG003|Overall Study|Disease Progression or Relapse|1|||
146427730|NCT00150462|528072957|FG004|Overall Study|Disease Progression or Relapse|2|||
146427731|NCT00150462|528072958|FG005|Overall Study|Disease Progression or Relapse|2|||
146427732|NCT00150462|528072959|FG006|Overall Study|Disease Progression or Relapse|3|||
146427733|NCT00150462|528072960|FG007|Overall Study|Disease Progression or Relapse|5|||
146427734|NCT00150462|528072961|FG008|Overall Study|Disease Progression or Relapse|5|||
146427735|NCT00150462|528072962|FG009|Overall Study|Disease Progression or Relapse|3|||
146427736|NCT00150462|528072963|FG010|Overall Study|Disease Progression or Relapse|2|||
146427737|NCT00150462|528072953|FG000|Overall Study|Withdrawal by Subject|0|||
146427738|NCT00150462|528072954|FG001|Overall Study|Withdrawal by Subject|1|||
146427739|NCT00150462|528072955|FG002|Overall Study|Withdrawal by Subject|1|||
146427740|NCT00150462|528072956|FG003|Overall Study|Withdrawal by Subject|0|||
146427741|NCT00150462|528072957|FG004|Overall Study|Withdrawal by Subject|1|||
146427742|NCT00150462|528072958|FG005|Overall Study|Withdrawal by Subject|2|||
146427743|NCT00150462|528072959|FG006|Overall Study|Withdrawal by Subject|0|||
146427744|NCT00150462|528072960|FG007|Overall Study|Withdrawal by Subject|1|||
146427745|NCT00150462|528072961|FG008|Overall Study|Withdrawal by Subject|0|||
146427746|NCT00150462|528072962|FG009|Overall Study|Withdrawal by Subject|1|||
146427747|NCT00150462|528072963|FG010|Overall Study|Withdrawal by Subject|0|||
146427748|NCT00150462|528072953|FG000|Overall Study|Death|0|||
146427749|NCT00150462|528072954|FG001|Overall Study|Death|1|||
146427750|NCT00150462|528072955|FG002|Overall Study|Death|0|||
146427751|NCT00150462|528072956|FG003|Overall Study|Death|0|||
146427752|NCT00150462|528072957|FG004|Overall Study|Death|0|||
146427753|NCT00150462|528072958|FG005|Overall Study|Death|0|||
146082793|NCT03976648|526822899|FG000|Overall Study|Adverse Event|0|||
146082794|NCT03976648|526822900|FG001|Overall Study|Adverse Event|2|||
146082795|NCT03976648|526822899|FG000|Overall Study|Study terminated by sponsor|21|||
146082796|NCT03976648|526822900|FG001|Overall Study|Study terminated by sponsor|8|||
146427754|NCT00150462|528072959|FG006|Overall Study|Death|0|||
146427755|NCT00150462|528072960|FG007|Overall Study|Death|0|||
146427756|NCT00150462|528072961|FG008|Overall Study|Death|1|||
146427757|NCT00150462|528072962|FG009|Overall Study|Death|0|||
146427758|NCT00150462|528072963|FG010|Overall Study|Death|0|||
146082797|NCT01155167|526822901|FG000|Overall Study|Insufficient ultrasound data|2|||
146427759|NCT00150462|528072953|FG000|Overall Study|Adverse Event|0|||
146427760|NCT00150462|528072954|FG001|Overall Study|Adverse Event|0|||
146427761|NCT00150462|528072955|FG002|Overall Study|Adverse Event|0|||
146427762|NCT00150462|528072956|FG003|Overall Study|Adverse Event|1|||
146427763|NCT00150462|528072957|FG004|Overall Study|Adverse Event|0|||
146427764|NCT00150462|528072958|FG005|Overall Study|Adverse Event|0|||
146427765|NCT00150462|528072959|FG006|Overall Study|Adverse Event|0|||
146427766|NCT00150462|528072960|FG007|Overall Study|Adverse Event|2|||
146427767|NCT00150462|528072961|FG008|Overall Study|Adverse Event|0|||
146427768|NCT00150462|528072962|FG009|Overall Study|Adverse Event|1|||
146427769|NCT00150462|528072963|FG010|Overall Study|Adverse Event|0|||
146427770|NCT00150462|528072953|FG000|Overall Study|Physician Decision|0|||
146427771|NCT00150462|528072954|FG001|Overall Study|Physician Decision|0|||
146427772|NCT00150462|528072955|FG002|Overall Study|Physician Decision|1|||
146427773|NCT00150462|528072956|FG003|Overall Study|Physician Decision|1|||
146427774|NCT00150462|528072957|FG004|Overall Study|Physician Decision|0|||
146427775|NCT00150462|528072958|FG005|Overall Study|Physician Decision|0|||
146427776|NCT00150462|528072959|FG006|Overall Study|Physician Decision|0|||
146427777|NCT00150462|528072960|FG007|Overall Study|Physician Decision|0|||
146427778|NCT00150462|528072961|FG008|Overall Study|Physician Decision|0|||
146427779|NCT00150462|528072962|FG009|Overall Study|Physician Decision|0|||
146427780|NCT00150462|528072963|FG010|Overall Study|Physician Decision|0|||
146427781|NCT00150462|528072953|FG000|Overall Study|Other|0|||
146427782|NCT00150462|528072954|FG001|Overall Study|Other|0|||
146427783|NCT00150462|528072955|FG002|Overall Study|Other|0|||
146427784|NCT00150462|528072956|FG003|Overall Study|Other|0|||
146427785|NCT00150462|528072957|FG004|Overall Study|Other|0|||
146427786|NCT00150462|528072958|FG005|Overall Study|Other|0|||
146427787|NCT00150462|528072959|FG006|Overall Study|Other|0|||
146427788|NCT00150462|528072960|FG007|Overall Study|Other|0|||
146427789|NCT00150462|528072961|FG008|Overall Study|Other|0|||
146427790|NCT00150462|528072962|FG009|Overall Study|Other|1|||
146427791|NCT00150462|528072963|FG010|Overall Study|Other|1|||
146427792|NCT00569374|528072964|FG000|Overall Study|Withdrawal by Subject|4|||
146427793|NCT04638153|528072967|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146427794|NCT04638153|528072968|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146427795|NCT04638153|528072969|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146427796|NCT04638153|528072967|FG000|Overall Study|Study terminated by sponsor|4|||
146427797|NCT04638153|528072968|FG001|Overall Study|Study terminated by sponsor|2|||
146427798|NCT04638153|528072969|FG002|Overall Study|Study terminated by sponsor|14|||
146427799|NCT01440283|528072972|FG000|Overall Study|Death|3|||
146427800|NCT01440283|528072972|FG000|Overall Study|Withdrawal by Subject|4|||
146427801|NCT01440283|528072972|FG000|Overall Study|Physician Decision|3|||
146427802|NCT03099538|528072976|FG000|Overall Study|Lack of Efficacy|3|||
146427803|NCT02015390|528072977|FG000|Overall Study|Lost to Follow-up|1|||
146427804|NCT02015390|528072978|FG001|Overall Study|Lost to Follow-up|0|||
146427805|NCT02015390|528072977|FG000|Overall Study|Adverse Event|0|||
146427806|NCT02015390|528072978|FG001|Overall Study|Adverse Event|3|||
146427807|NCT02015390|528072977|FG000|Overall Study|Physician Decision|0|||
146427808|NCT02015390|528072978|FG001|Overall Study|Physician Decision|1|||
146427809|NCT01661686|528072984|FG000|Overall Study|Lost to Follow-up|2|||
146427810|NCT01661686|528072985|FG001|Overall Study|Lost to Follow-up|1|||
146427811|NCT01661686|528072984|FG000|Overall Study|did not receive allocated intervention|0|||
146427812|NCT01661686|528072985|FG001|Overall Study|did not receive allocated intervention|1|||
146427813|NCT00877032|528072988|FG000|Overall Study|Did not meet entrance criteria|0|||
146427814|NCT00877032|528072989|FG001|Overall Study|Did not meet entrance criteria|0|||
146427815|NCT00877032|528072990|FG002|Overall Study|Did not meet entrance criteria|0|||
146427816|NCT00877032|528072991|FG003|Overall Study|Did not meet entrance criteria|1|||
146427817|NCT00877032|528072992|FG004|Overall Study|Did not meet entrance criteria|0|||
146427818|NCT00877032|528072993|FG005|Overall Study|Did not meet entrance criteria|0|||
146427819|NCT00877032|528072994|FG006|Overall Study|Did not meet entrance criteria|2|||
146427820|NCT03752528|528072995|FG000|Part A|Lost to Follow-up|1|||
146427821|NCT03752528|528072995|FG000|Part A|Protocol Violation|1|||
146427822|NCT03752528|528072995|FG000|Part B|Protocol Violation|1|||
146427823|NCT03752528|528072995|FG000|Part B|Study terminated by sponsor|3|||
146427824|NCT00259012|528072997|FG000|Overall Study|Adverse Event|0|||
146427825|NCT00259012|528072998|FG001|Overall Study|Adverse Event|1|||
146427826|NCT00259012|528072997|FG000|Overall Study|Withdrawal by Subject|1|||
146427827|NCT00259012|528072998|FG001|Overall Study|Withdrawal by Subject|0|||
146199994|NCT04517864|527246206|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
146427828|NCT00259012|528072997|FG000|Overall Study|Physician Decision|0|||
146427829|NCT00259012|528072998|FG001|Overall Study|Physician Decision|1|||
146427830|NCT00259012|528072997|FG000|Overall Study|Lost to Follow-up|0|||
146427831|NCT00259012|528072998|FG001|Overall Study|Lost to Follow-up|1|||
146427832|NCT00259012|528072997|FG000|Overall Study|Protocol Violation|1|||
146427833|NCT00259012|528072998|FG001|Overall Study|Protocol Violation|1|||
146427834|NCT02781727|528073001|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
146427835|NCT02781727|528073002|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
146427836|NCT02781727|528073001|FG000|Treatment Period|Withdrawal by Subject|1|||
146427837|NCT02781727|528073002|FG001|Treatment Period|Withdrawal by Subject|0|||
146427838|NCT02781727|528073001|FG000|Treatment Period|Lost to Follow-up|0|||
146427839|NCT02781727|528073002|FG001|Treatment Period|Lost to Follow-up|1|||
146427840|NCT01378975|528073004|FG000|Overall Study|Death|77|||
146427841|NCT01378975|528073005|FG001|Overall Study|Death|46|||
146427842|NCT01378975|528073004|FG000|Overall Study|Investigator Request|1|||
146427843|NCT01378975|528073005|FG001|Overall Study|Investigator Request|0|||
146427844|NCT01378975|528073004|FG000|Overall Study|Lost to Follow-up|4|||
146427845|NCT01378975|528073005|FG001|Overall Study|Lost to Follow-up|1|||
146427846|NCT01378975|528073004|FG000|Overall Study|Withdrew Consent|4|||
146427847|NCT01378975|528073005|FG001|Overall Study|Withdrew Consent|3|||
146427848|NCT03125200|528073010|FG000|Overall Study|Study Termination|0|||
146427849|NCT03125200|528073011|FG001|Overall Study|Study Termination|0|||
146427850|NCT03125200|528073012|FG002|Overall Study|Study Termination|0|||
146427851|NCT03125200|528073013|FG003|Overall Study|Study Termination|1|||
146427852|NCT03125200|528073014|FG004|Overall Study|Study Termination|1|||
146427853|NCT03125200|528073015|FG005|Overall Study|Study Termination|2|||
146427854|NCT03125200|528073016|FG006|Overall Study|Study Termination|1|||
146427855|NCT03125200|528073010|FG000|Overall Study|Clinical Progression|0|||
146427856|NCT03125200|528073011|FG001|Overall Study|Clinical Progression|0|||
146427857|NCT03125200|528073012|FG002|Overall Study|Clinical Progression|0|||
146427858|NCT03125200|528073013|FG003|Overall Study|Clinical Progression|1|||
146427859|NCT03125200|528073014|FG004|Overall Study|Clinical Progression|0|||
146427860|NCT03125200|528073015|FG005|Overall Study|Clinical Progression|1|||
146427861|NCT03125200|528073016|FG006|Overall Study|Clinical Progression|0|||
146427862|NCT03125200|528073010|FG000|Overall Study|Progressive Disease|2|||
146427863|NCT03125200|528073011|FG001|Overall Study|Progressive Disease|1|||
146427864|NCT03125200|528073012|FG002|Overall Study|Progressive Disease|2|||
146427865|NCT03125200|528073013|FG003|Overall Study|Progressive Disease|1|||
146427866|NCT03125200|528073014|FG004|Overall Study|Progressive Disease|2|||
146427867|NCT03125200|528073015|FG005|Overall Study|Progressive Disease|0|||
146427868|NCT03125200|528073016|FG006|Overall Study|Progressive Disease|1|||
146427869|NCT03125200|528073010|FG000|Overall Study|Lack of Efficacy|0|||
146427870|NCT03125200|528073011|FG001|Overall Study|Lack of Efficacy|0|||
146427871|NCT03125200|528073012|FG002|Overall Study|Lack of Efficacy|0|||
146427872|NCT03125200|528073013|FG003|Overall Study|Lack of Efficacy|1|||
146427873|NCT03125200|528073014|FG004|Overall Study|Lack of Efficacy|0|||
146427874|NCT03125200|528073015|FG005|Overall Study|Lack of Efficacy|0|||
146427875|NCT03125200|528073016|FG006|Overall Study|Lack of Efficacy|0|||
146427876|NCT03125200|528073010|FG000|Overall Study|Toxicity|0|||
146427877|NCT03125200|528073011|FG001|Overall Study|Toxicity|0|||
146427878|NCT03125200|528073012|FG002|Overall Study|Toxicity|0|||
146427879|NCT03125200|528073013|FG003|Overall Study|Toxicity|1|||
146427880|NCT03125200|528073014|FG004|Overall Study|Toxicity|0|||
146427881|NCT03125200|528073015|FG005|Overall Study|Toxicity|0|||
146427882|NCT03125200|528073016|FG006|Overall Study|Toxicity|0|||
146427883|NCT03125200|528073010|FG000|Overall Study|Consent Withdrawn by Subject|0|||
146427884|NCT03125200|528073011|FG001|Overall Study|Consent Withdrawn by Subject|1|||
146427885|NCT03125200|528073012|FG002|Overall Study|Consent Withdrawn by Subject|0|||
146427886|NCT03125200|528073013|FG003|Overall Study|Consent Withdrawn by Subject|0|||
146427887|NCT03125200|528073014|FG004|Overall Study|Consent Withdrawn by Subject|1|||
146427888|NCT03125200|528073015|FG005|Overall Study|Consent Withdrawn by Subject|0|||
146427889|NCT03125200|528073016|FG006|Overall Study|Consent Withdrawn by Subject|1|||
146427890|NCT00694551|528073020|FG000|Overall Study|Disease Progression|1|||
146427891|NCT00694551|528073021|FG001|Overall Study|Disease Progression|0|||
146427892|NCT00694551|528073022|FG002|Overall Study|Disease Progression|1|||
146427893|NCT01937390|528073023|FG000|Overall Study|Death|2|||
146427894|NCT01937390|528073023|FG000|Overall Study|Lost to Follow-up|7|||
146427895|NCT01937390|528073023|FG000|Overall Study|Withdrawal by Subject|5|||
146427896|NCT01937390|528073023|FG000|Overall Study|Fail to return|21|||
146427897|NCT02817841|528074363|FG000|Overall Study|Lost to Follow-up|287|||
146427898|NCT02817841|528074363|FG000|Overall Study|Withdrawal by Subject|183|||
146427899|NCT02817841|528074363|FG000|Overall Study|Adverse event not related to bleeding|131|||
146427900|NCT02817841|528074363|FG000|Overall Study|Adverse event related to bleeding|51|||
146427901|NCT02817841|528074363|FG000|Overall Study|Pregnancy|32|||
146427902|NCT02817841|528074363|FG000|Overall Study|Pregnancy wish|17|||
146427903|NCT02817841|528074363|FG000|Overall Study|Other reasons|53|||
146427904|NCT02817841|528074363|FG000|Overall Study|Protocol Violation|94|||
146427905|NCT00397488|528074364|FG000|Overall Study|Withdrawal by Subject|3|||
146427906|NCT00397488|528074364|FG000|Overall Study|Adverse Event|3|||
146427907|NCT00397488|528074364|FG000|Overall Study|Death|1|||
146427908|NCT02424097|528074367|FG000|Overall Study|Lost to Follow-up|1|||
146427909|NCT02424097|528074368|FG001|Overall Study|Lost to Follow-up|2|||
146427910|NCT01215981|528074371|FG000|Overall Study|Physician Decision|0|||
146427911|NCT01215981|528074372|FG001|Overall Study|Physician Decision|1|||
146427912|NCT01215981|528074371|FG000|Overall Study|Protocol Violation|1|||
146427913|NCT01215981|528074372|FG001|Overall Study|Protocol Violation|0|||
146427914|NCT01215981|528074371|FG000|Overall Study|Withdrawal by Subject|1|||
146427915|NCT01215981|528074372|FG001|Overall Study|Withdrawal by Subject|0|||
146427916|NCT02943447|528074373|FG000|Blinded Study Phase|Withdrew Consent|1|||
146427917|NCT02943447|528074374|FG001|Blinded Study Phase|Withdrew Consent|2|||
146427918|NCT02943447|528074375|FG002|Blinded Study Phase|Withdrew Consent|1|||
146427919|NCT02943447|528074373|FG000|Blinded Study Phase|Adverse Event|3|||
146427920|NCT02943447|528074374|FG001|Blinded Study Phase|Adverse Event|0|||
146427921|NCT02943447|528074375|FG002|Blinded Study Phase|Adverse Event|0|||
146427922|NCT02943447|528074373|FG000|Blinded Study Phase|Investigator's discretion|1|||
146427923|NCT02943447|528074374|FG001|Blinded Study Phase|Investigator's discretion|0|||
146427924|NCT02943447|528074375|FG002|Blinded Study Phase|Investigator's discretion|0|||
146427925|NCT02943447|528074373|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
146427926|NCT02943447|528074374|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
146427927|NCT02943447|528074375|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
146427928|NCT02943447|528074373|FG000|Open-Label Extension Phase|Adverse Event|4|||
146427929|NCT02943447|528074374|FG001|Open-Label Extension Phase|Adverse Event|7|||
146427930|NCT02943447|528074375|FG002|Open-Label Extension Phase|Adverse Event|3|||
146427931|NCT02943447|528074373|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
146427932|NCT02943447|528074374|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
146427933|NCT02943447|528074375|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
146427934|NCT02943447|528074373|FG000|Open-Label Extension Phase|Withdrew consent|1|||
146427935|NCT02943447|528074374|FG001|Open-Label Extension Phase|Withdrew consent|1|||
146427936|NCT02943447|528074375|FG002|Open-Label Extension Phase|Withdrew consent|1|||
146427937|NCT02943447|528074373|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146427938|NCT02943447|528074374|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146427939|NCT02943447|528074375|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146427940|NCT00840632|528074377|FG000|First Intervention|Withdrawal by Subject|0|||
146427941|NCT00840632|528074378|FG001|First Intervention|Withdrawal by Subject|1|||
146427942|NCT00840632|528074377|FG000|Washout|Withdrawal by Subject|1|||
146427943|NCT00840632|528074378|FG001|Washout|Withdrawal by Subject|1|||
146427944|NCT05017480|528074379|FG000|Stage 1 Study|Withdrawal by Subject|8|||
146427945|NCT05017480|528074380|FG001|Stage 1 Study|Withdrawal by Subject|6|||
146427946|NCT05017480|528074381|FG002|Stage 1 Study|Withdrawal by Subject|0|||
146427947|NCT05017480|528074382|FG003|Stage 1 Study|Withdrawal by Subject|0|||
146427948|NCT05017480|528074383|FG004|Stage 1 Study|Withdrawal by Subject|0|||
146427949|NCT05017480|528074379|FG000|Stage 1 Study|Adverse Event|1|||
146427950|NCT05017480|528074380|FG001|Stage 1 Study|Adverse Event|1|||
146427951|NCT05017480|528074381|FG002|Stage 1 Study|Adverse Event|0|||
146427952|NCT05017480|528074382|FG003|Stage 1 Study|Adverse Event|0|||
146427953|NCT05017480|528074383|FG004|Stage 1 Study|Adverse Event|0|||
146427954|NCT05017480|528074379|FG000|Stage 1 Study|Poor Compliance|1|||
146427955|NCT05017480|528074380|FG001|Stage 1 Study|Poor Compliance|1|||
146427956|NCT05017480|528074381|FG002|Stage 1 Study|Poor Compliance|0|||
146427957|NCT05017480|528074382|FG003|Stage 1 Study|Poor Compliance|0|||
146427958|NCT05017480|528074383|FG004|Stage 1 Study|Poor Compliance|0|||
146427959|NCT05017480|528074379|FG000|Stage 1 Study|Physician Decision|0|||
146427960|NCT05017480|528074380|FG001|Stage 1 Study|Physician Decision|1|||
146427961|NCT05017480|528074381|FG002|Stage 1 Study|Physician Decision|0|||
146427962|NCT05017480|528074382|FG003|Stage 1 Study|Physician Decision|0|||
146427963|NCT05017480|528074383|FG004|Stage 1 Study|Physician Decision|0|||
146427964|NCT05017480|528074379|FG000|Stage 2 Study|Withdrawal by Subject|0|||
146427965|NCT05017480|528074380|FG001|Stage 2 Study|Withdrawal by Subject|0|||
146427966|NCT05017480|528074381|FG002|Stage 2 Study|Withdrawal by Subject|6|||
146427967|NCT05017480|528074382|FG003|Stage 2 Study|Withdrawal by Subject|9|||
146427968|NCT05017480|528074383|FG004|Stage 2 Study|Withdrawal by Subject|11|||
146427969|NCT05017480|528074379|FG000|Stage 2 Study|Lost to Follow-up|0|||
146427970|NCT05017480|528074380|FG001|Stage 2 Study|Lost to Follow-up|0|||
146427971|NCT05017480|528074381|FG002|Stage 2 Study|Lost to Follow-up|0|||
146427972|NCT05017480|528074382|FG003|Stage 2 Study|Lost to Follow-up|2|||
146427973|NCT05017480|528074383|FG004|Stage 2 Study|Lost to Follow-up|1|||
146427974|NCT05017480|528074379|FG000|Stage 2 Study|Adverse Event|0|||
146427975|NCT05017480|528074380|FG001|Stage 2 Study|Adverse Event|0|||
146427976|NCT05017480|528074381|FG002|Stage 2 Study|Adverse Event|0|||
146427977|NCT05017480|528074382|FG003|Stage 2 Study|Adverse Event|1|||
146427978|NCT05017480|528074383|FG004|Stage 2 Study|Adverse Event|0|||
146427979|NCT05017480|528074379|FG000|Stage 2 Study|COVID-19|0|||
146427980|NCT05017480|528074380|FG001|Stage 2 Study|COVID-19|0|||
146427981|NCT05017480|528074381|FG002|Stage 2 Study|COVID-19|0|||
146427982|NCT05017480|528074382|FG003|Stage 2 Study|COVID-19|1|||
146427983|NCT05017480|528074383|FG004|Stage 2 Study|COVID-19|0|||
146427984|NCT05017480|528074379|FG000|Stage 2 Study|Pregnancy|0|||
146427985|NCT05017480|528074380|FG001|Stage 2 Study|Pregnancy|0|||
146427986|NCT05017480|528074381|FG002|Stage 2 Study|Pregnancy|0|||
146427987|NCT05017480|528074382|FG003|Stage 2 Study|Pregnancy|0|||
146082798|NCT01155167|526822902|FG001|Overall Study|Insufficient ultrasound data|0|||
146082799|NCT01155167|526822901|FG000|Overall Study|Access site changed to femoral artery|1|||
146082800|NCT01155167|526822902|FG001|Overall Study|Access site changed to femoral artery|0|||
146082801|NCT00881868|526822903|FG000|Overall Study|Adverse Event|0|||
146082802|NCT00881868|526822904|FG001|Overall Study|Adverse Event|1|||
146082803|NCT00881868|526822903|FG000|Overall Study|Lost to Follow-up|2|||
146082804|NCT00881868|526822904|FG001|Overall Study|Lost to Follow-up|1|||
146082805|NCT00881868|526822903|FG000|Overall Study|Physician Decision|4|||
146082806|NCT00881868|526822904|FG001|Overall Study|Physician Decision|0|||
146082807|NCT00881868|526822903|FG000|Overall Study|Protocol Violation|2|||
146082808|NCT00881868|526822904|FG001|Overall Study|Protocol Violation|0|||
146082809|NCT00960570|526822905|FG000|21 Day Washout Period|Adverse Event|1|||
146082810|NCT00960570|526822905|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
146082811|NCT00960570|526822905|FG000|1 Day Period Between Dosing|Adverse Event|2|||
146082812|NCT00960570|526822905|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
146082813|NCT01451437|526822906|FG000|Overall Study|Adverse Event|0|||
146427988|NCT05017480|528074383|FG004|Stage 2 Study|Pregnancy|1|||
146427989|NCT01136382|528074384|FG000|Overall Study|Other|8|||
146082814|NCT01451437|526822907|FG001|Overall Study|Adverse Event|0|||
146082815|NCT01451437|526822908|FG002|Overall Study|Adverse Event|0|||
146082816|NCT01451437|526822909|FG003|Overall Study|Adverse Event|0|||
146082817|NCT01451437|526822910|FG004|Overall Study|Adverse Event|0|||
146082818|NCT01451437|526822911|FG005|Overall Study|Adverse Event|1|||
146199995|NCT04517864|527246207|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
146199996|NCT04517864|527246205|FG000|Extension Phase|Adverse Event|0|||
146199997|NCT04517864|527246206|FG001|Extension Phase|Adverse Event|0|||
146199998|NCT04517864|527246207|FG002|Extension Phase|Adverse Event|1|||
146199999|NCT04517864|527246205|FG000|Extension Phase|Lack of Efficacy|0|||
146427990|NCT01136382|528074385|FG001|Overall Study|Other|3|||
146427991|NCT01136382|528074384|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
146427992|NCT01136382|528074385|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
146427993|NCT01136382|528074384|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
146427994|NCT01136382|528074385|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146427995|NCT01136382|528074384|FG000|Overall Study|Withdrawal by Subject|4|||
146200000|NCT04517864|527246206|FG001|Extension Phase|Lack of Efficacy|0|||
146200001|NCT04517864|527246207|FG002|Extension Phase|Lack of Efficacy|2|||
146427996|NCT01136382|528074385|FG001|Overall Study|Withdrawal by Subject|1|||
146427997|NCT01725529|528074395|FG000|Overall Study|Adverse Event|1|||
146427998|NCT01725529|528074396|FG001|Overall Study|Adverse Event|0|||
146427999|NCT01725529|528074397|FG002|Overall Study|Adverse Event|0|||
146428000|NCT01725529|528074395|FG000|Overall Study|Lost to Follow-up|2|||
146428001|NCT01725529|528074396|FG001|Overall Study|Lost to Follow-up|1|||
146200002|NCT04517864|527246205|FG000|Extension Phase|Study Terminated By Sponsor|0|||
146428002|NCT01725529|528074397|FG002|Overall Study|Lost to Follow-up|1|||
146428003|NCT01725529|528074395|FG000|Overall Study|Protocol Violation|0|||
146200003|NCT04517864|527246206|FG001|Extension Phase|Study Terminated By Sponsor|0|||
146200004|NCT04517864|527246207|FG002|Extension Phase|Study Terminated By Sponsor|32|||
146200005|NCT04517864|527246205|FG000|Extension Phase|Withdrawal by Subject|0|||
146428004|NCT01725529|528074396|FG001|Overall Study|Protocol Violation|1|||
146428005|NCT01725529|528074397|FG002|Overall Study|Protocol Violation|1|||
146428006|NCT01725529|528074395|FG000|Overall Study|Withdrawal by Subject|12|||
146428007|NCT01725529|528074396|FG001|Overall Study|Withdrawal by Subject|14|||
146428008|NCT01725529|528074397|FG002|Overall Study|Withdrawal by Subject|8|||
146428009|NCT02653664|528074403|FG000|Post-Treatment|Withdrawal by Subject|6|||
146428010|NCT02653664|528074404|FG001|Post-Treatment|Withdrawal by Subject|5|||
146428011|NCT02653664|528074405|FG002|Post-Treatment|Withdrawal by Subject|7|||
146200006|NCT04517864|527246206|FG001|Extension Phase|Withdrawal by Subject|0|||
146200007|NCT04517864|527246207|FG002|Extension Phase|Withdrawal by Subject|3|||
146200008|NCT04517864|527246205|FG000|Extension Phase|Approved Drug Available for Indication|0|||
146428012|NCT02653664|528074403|FG000|Post-Treatment|Lost to Follow-up|8|||
146428013|NCT02653664|528074404|FG001|Post-Treatment|Lost to Follow-up|1|||
146428014|NCT02653664|528074405|FG002|Post-Treatment|Lost to Follow-up|7|||
146428015|NCT02653664|528074403|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
146082819|NCT01451437|526822912|FG006|Overall Study|Adverse Event|1|||
146082820|NCT01451437|526822913|FG007|Overall Study|Adverse Event|2|||
146082821|NCT01451437|526822914|FG008|Overall Study|Adverse Event|1|||
146200009|NCT04517864|527246206|FG001|Extension Phase|Approved Drug Available for Indication|0|||
146428016|NCT02653664|528074404|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
146428017|NCT02653664|528074405|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
146428018|NCT02653664|528074403|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
146082822|NCT01451437|526822906|FG000|Overall Study|Physician Decision|1|||
146428019|NCT02653664|528074404|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
146428020|NCT02653664|528074405|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
146428021|NCT02653664|528074403|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146428022|NCT02653664|528074404|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
146428023|NCT02653664|528074405|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146428024|NCT02653664|528074403|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
146428025|NCT02653664|528074404|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
146428026|NCT02653664|528074405|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
146428027|NCT02653664|528074403|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
146428028|NCT02653664|528074404|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
146428029|NCT02653664|528074405|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
146428030|NCT02653664|528074403|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
146428031|NCT02653664|528074404|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
146428032|NCT02653664|528074405|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
146428033|NCT02653664|528074403|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146428034|NCT02653664|528074404|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
146428035|NCT02653664|528074405|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
146428036|NCT02653664|528074403|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
146428037|NCT02653664|528074404|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
146428038|NCT02653664|528074405|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
146428039|NCT04657770|528074406|FG000|Overall Study|Withdrawal by Subject|3|||
146428040|NCT04657770|528074406|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
146428041|NCT00746798|528074407|FG000|Overall Study|Protocol Violation|0|||
146428042|NCT00746798|528074408|FG001|Overall Study|Protocol Violation|1|||
146428043|NCT00746798|528074409|FG002|Overall Study|Protocol Violation|0|||
146428044|NCT00746798|528074410|FG003|Overall Study|Protocol Violation|0|||
146428045|NCT00746798|528074407|FG000|Overall Study|Withdrawal by Subject|0|||
146428046|NCT00746798|528074408|FG001|Overall Study|Withdrawal by Subject|1|||
146428047|NCT00746798|528074409|FG002|Overall Study|Withdrawal by Subject|1|||
146428048|NCT00746798|528074410|FG003|Overall Study|Withdrawal by Subject|0|||
146428049|NCT00746798|528074407|FG000|Overall Study|Death|0|||
146428050|NCT00746798|528074408|FG001|Overall Study|Death|0|||
146428051|NCT00746798|528074409|FG002|Overall Study|Death|2|||
146428052|NCT00746798|528074410|FG003|Overall Study|Death|0|||
146428053|NCT00746798|528074407|FG000|Overall Study|Participant unable to return for visit|1|||
146428054|NCT00746798|528074408|FG001|Overall Study|Participant unable to return for visit|0|||
146428055|NCT00746798|528074409|FG002|Overall Study|Participant unable to return for visit|0|||
146428056|NCT00746798|528074410|FG003|Overall Study|Participant unable to return for visit|0|||
146428057|NCT00633594|528074413|FG000|Overall Study|Adverse Event|0|||
146428058|NCT00633594|528074414|FG001|Overall Study|Adverse Event|4|||
146428059|NCT00633594|528074415|FG002|Overall Study|Adverse Event|7|||
146428060|NCT00633594|528074413|FG000|Overall Study|Death|0|||
146428061|NCT00633594|528074414|FG001|Overall Study|Death|1|||
146428062|NCT00633594|528074415|FG002|Overall Study|Death|2|||
146428063|NCT00633594|528074413|FG000|Overall Study|Disease Progression|0|||
146428064|NCT00633594|528074414|FG001|Overall Study|Disease Progression|0|||
146428065|NCT00633594|528074415|FG002|Overall Study|Disease Progression|1|||
146428066|NCT00727571|528074417|FG000|Overall Study|Ineligibility determined|1|||
146428067|NCT00727571|528074418|FG001|Overall Study|Ineligibility determined|1|||
146428068|NCT00727571|528074419|FG002|Overall Study|Ineligibility determined|1|||
146428069|NCT00727571|528074420|FG003|Overall Study|Ineligibility determined|0|||
146428070|NCT00727571|528074417|FG000|Overall Study|Death|0|||
146428071|NCT00727571|528074418|FG001|Overall Study|Death|19|||
146428072|NCT00727571|528074419|FG002|Overall Study|Death|5|||
146428073|NCT00727571|528074420|FG003|Overall Study|Death|1|||
146428074|NCT00727571|528074417|FG000|Overall Study|Physician Decision|0|||
146428075|NCT00727571|528074418|FG001|Overall Study|Physician Decision|5|||
146428076|NCT00727571|528074419|FG002|Overall Study|Physician Decision|0|||
146428077|NCT00727571|528074420|FG003|Overall Study|Physician Decision|0|||
146428078|NCT00727571|528074417|FG000|Overall Study|Withdrawal by Subject|0|||
146428079|NCT00727571|528074418|FG001|Overall Study|Withdrawal by Subject|10|||
146428080|NCT00727571|528074419|FG002|Overall Study|Withdrawal by Subject|11|||
146428081|NCT00727571|528074420|FG003|Overall Study|Withdrawal by Subject|0|||
146428082|NCT00727571|528074417|FG000|Overall Study|Subject Non Compliance|0|||
146428083|NCT00727571|528074418|FG001|Overall Study|Subject Non Compliance|6|||
146428084|NCT00727571|528074419|FG002|Overall Study|Subject Non Compliance|0|||
146428085|NCT00727571|528074420|FG003|Overall Study|Subject Non Compliance|4|||
146428086|NCT00727571|528074417|FG000|Overall Study|Dismissed from nursing home|0|||
146428087|NCT00727571|528074418|FG001|Overall Study|Dismissed from nursing home|9|||
146428088|NCT00727571|528074419|FG002|Overall Study|Dismissed from nursing home|5|||
146428089|NCT00727571|528074420|FG003|Overall Study|Dismissed from nursing home|0|||
146428090|NCT00727571|528074417|FG000|Overall Study|Hospitalization|0|||
146428091|NCT00727571|528074418|FG001|Overall Study|Hospitalization|1|||
146428092|NCT00727571|528074419|FG002|Overall Study|Hospitalization|0|||
146428093|NCT00727571|528074420|FG003|Overall Study|Hospitalization|1|||
146428094|NCT00727571|528074417|FG000|Overall Study|AE not leading to hospitalization|0|||
146428095|NCT00727571|528074418|FG001|Overall Study|AE not leading to hospitalization|0|||
146428096|NCT00727571|528074419|FG002|Overall Study|AE not leading to hospitalization|2|||
146428097|NCT00727571|528074420|FG003|Overall Study|AE not leading to hospitalization|0|||
146428098|NCT00727571|528074417|FG000|Overall Study|Other|0|||
146428099|NCT00727571|528074418|FG001|Overall Study|Other|4|||
146428100|NCT00727571|528074419|FG002|Overall Study|Other|6|||
146428101|NCT00727571|528074420|FG003|Overall Study|Other|0|||
146428102|NCT01287013|528074421|FG000|Overall Study|Non-evaluable|3|||
146428103|NCT01287013|528074422|FG001|Overall Study|Non-evaluable|5|||
146428104|NCT01287013|528074423|FG002|Overall Study|Non-evaluable|21|||
146428105|NCT01900730|528074424|FG000|Overall Study|Withdrawal by Subject|1|||
146428106|NCT01900730|528074425|FG001|Overall Study|Withdrawal by Subject|0|||
146428107|NCT01900730|528074424|FG000|Overall Study|Screen Failure|1|||
146428108|NCT01900730|528074425|FG001|Overall Study|Screen Failure|0|||
146428109|NCT01179048|528074426|FG000|Overall Study|Withdrawn - does not allow contact|4|||
146428110|NCT01179048|528074427|FG001|Overall Study|Withdrawn - does not allow contact|8|||
146428111|NCT01179048|528074426|FG000|Overall Study|Lost to Follow-up|8|||
146428112|NCT01179048|528074427|FG001|Overall Study|Lost to Follow-up|9|||
146428113|NCT01179048|528074426|FG000|Overall Study|Alive|127|||
146428114|NCT01179048|528074427|FG001|Overall Study|Alive|142|||
146428115|NCT02109042|528074428|FG000|Overall Study|Sponsor Decision|15|||
146428116|NCT03203447|528074433|FG000|Overall Study|Withdrawal by Subject|2|||
146428117|NCT03203447|528074434|FG001|Overall Study|Withdrawal by Subject|1|||
146428118|NCT03203447|528074433|FG000|Overall Study|Lost to Follow-up|1|||
146428119|NCT03203447|528074434|FG001|Overall Study|Lost to Follow-up|10|||
146428120|NCT03203447|528074433|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
146428121|NCT03203447|528074434|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
146428122|NCT00324168|528074435|FG000|Overall Study|Lost to Follow-up|19|||
146428123|NCT00324168|528074436|FG001|Overall Study|Lost to Follow-up|18|||
146428124|NCT00324168|528074435|FG000|Overall Study|Death|3|||
146428125|NCT00324168|528074436|FG001|Overall Study|Death|3|||
146428126|NCT00324168|528074435|FG000|Overall Study|Patient did not visit in f/u window|6|||
146428127|NCT00324168|528074436|FG001|Overall Study|Patient did not visit in f/u window|9|||
146428128|NCT01203878|528074437|FG000|Overall Study|Withdrawal by Subject|0|||
146428129|NCT01203878|528074438|FG001|Overall Study|Withdrawal by Subject|0|||
146428130|NCT01203878|528074439|FG002|Overall Study|Withdrawal by Subject|1|||
146428131|NCT01203878|528074437|FG000|Overall Study|Adverse Event|0|||
146428132|NCT01203878|528074438|FG001|Overall Study|Adverse Event|0|||
146428133|NCT01203878|528074439|FG002|Overall Study|Adverse Event|2|||
146428134|NCT00358449|528074441|FG000|Overall Study|Adverse Event|1|||
146200010|NCT04517864|527246207|FG002|Extension Phase|Approved Drug Available for Indication|7|||
146428135|NCT00358449|528074442|FG001|Overall Study|Adverse Event|0|||
146428136|NCT00358449|528074443|FG002|Overall Study|Adverse Event|1|||
146428137|NCT00358449|528074441|FG000|Overall Study|Lost to Follow-up|1|||
146428138|NCT00358449|528074442|FG001|Overall Study|Lost to Follow-up|0|||
146428139|NCT00358449|528074443|FG002|Overall Study|Lost to Follow-up|0|||
146428140|NCT00358449|528074441|FG000|Overall Study|Withdrawal by Subject|2|||
146428141|NCT00358449|528074442|FG001|Overall Study|Withdrawal by Subject|0|||
146428142|NCT00358449|528074443|FG002|Overall Study|Withdrawal by Subject|0|||
146428143|NCT00358449|528074441|FG000|Overall Study|Lack of Efficacy|0|||
146428144|NCT00358449|528074442|FG001|Overall Study|Lack of Efficacy|1|||
146428145|NCT00358449|528074443|FG002|Overall Study|Lack of Efficacy|0|||
146428146|NCT00358449|528074441|FG000|Overall Study|Steriod Inhaler was Increased|0|||
146428147|NCT00358449|528074442|FG001|Overall Study|Steriod Inhaler was Increased|0|||
146428148|NCT00358449|528074443|FG002|Overall Study|Steriod Inhaler was Increased|1|||
146428149|NCT01804270|528074444|FG000|Overall Study|Withdrawal by Subject|1|||
146428150|NCT01804270|528074445|FG001|Overall Study|Withdrawal by Subject|1|||
146428151|NCT04407806|528074450|FG000|Overall Study|Withdrawal by Subject|1|||
146428152|NCT04407806|528074451|FG001|Overall Study|Withdrawal by Subject|2|||
146428153|NCT03478397|528074454|FG000|Overall Study|Refused to participate|31|||
146428154|NCT03478397|528074455|FG001|Overall Study|Refused to participate|7|||
146428155|NCT05327491|528074456|FG000|Periods 1 & 2|Miscellaneous|0|||
146428156|NCT05327491|528074457|FG001|Periods 1 & 2|Miscellaneous|1|||
146428157|NCT05327491|528074458|FG002|Periods 1 & 2|Miscellaneous|0|||
146428158|NCT05327491|528074459|FG003|Periods 1 & 2|Miscellaneous|0|||
146428159|NCT05327491|528074456|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
146428160|NCT05327491|528074457|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
146428161|NCT05327491|528074458|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
146428162|NCT05327491|528074459|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
146428163|NCT04869787|528074460|FG000|Screening|Physician Decision|1|||
146428164|NCT04869787|528074460|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
146428165|NCT00813293|528074461|FG000|Overall Study|Intercurrent illness|1|||
146428166|NCT00813293|528074462|FG001|Overall Study|Intercurrent illness|0|||
146428167|NCT00813293|528074461|FG000|Overall Study|Adverse Event|0|||
146428168|NCT00813293|528074462|FG001|Overall Study|Adverse Event|1|||
146428169|NCT00533273|528074463|FG000|Double-blind|Withdrew consent|0|||
146428170|NCT00533273|528074464|FG001|Double-blind|Withdrew consent|2|||
146428171|NCT00533273|528074463|FG000|Open-label|Withdrawal by Subject|6|||
146428172|NCT00533273|528074464|FG001|Open-label|Withdrawal by Subject|0|||
146428173|NCT02794974|528074465|FG000|Overall Study|Physician Decision|0|||
146428174|NCT02794974|528074466|FG001|Overall Study|Physician Decision|1|||
146428175|NCT01873586|528074468|FG000|Overall Study|Lost to Follow-up|3|||
146428176|NCT02202850|528074469|FG000|Overall Study|Other|2|||
146428177|NCT02202850|528074470|FG001|Overall Study|Other|2|||
146428178|NCT02202850|528074469|FG000|Overall Study|Enbrel treatment discontinued|15|||
146428179|NCT02202850|528074470|FG001|Overall Study|Enbrel treatment discontinued|3|||
146428180|NCT02202850|528074469|FG000|Overall Study|Lost to Follow-up|7|||
146428181|NCT02202850|528074470|FG001|Overall Study|Lost to Follow-up|1|||
146428182|NCT00615069|528074471|FG000|Overall Study|Death|10|||
146428183|NCT00615069|528074471|FG000|Overall Study|Physician Decision|2|||
146428184|NCT00615069|528074471|FG000|Overall Study|Withdrawal by Subject|4|||
146428185|NCT00454909|528074472|FG000|Overall Study|Withdrawal by Subject|1|||
146428186|NCT00454909|528074473|FG001|Overall Study|Withdrawal by Subject|0|||
146428187|NCT00454909|528074474|FG002|Overall Study|Withdrawal by Subject|0|||
146428188|NCT00454909|528074472|FG000|Overall Study|Migrated/moved from study area|0|||
146428189|NCT00454909|528074473|FG001|Overall Study|Migrated/moved from study area|0|||
146428190|NCT00454909|528074474|FG002|Overall Study|Migrated/moved from study area|1|||
146428191|NCT00454909|528074472|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
146428192|NCT00454909|528074473|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
146428193|NCT00454909|528074474|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
146082823|NCT01451437|526822907|FG001|Overall Study|Physician Decision|1|||
146428194|NCT00454909|528074472|FG000|Overall Study|Others|1|||
146428195|NCT00454909|528074473|FG001|Overall Study|Others|0|||
146428196|NCT00454909|528074474|FG002|Overall Study|Others|0|||
146428197|NCT02996682|528074475|FG000|Overall Study|Death|0|||
146428198|NCT02996682|528074476|FG001|Overall Study|Death|3|||
146428199|NCT01981720|528074477|FG000|Overall Study|Adverse Event|1|||
146428200|NCT01981720|528074477|FG000|Overall Study|Withdrawal by Subject|3|||
146428201|NCT01981720|528074477|FG000|Overall Study|Pregnancy|1|||
146428202|NCT00282048|528074478|FG000|Overall Study|Lack of Efficacy|30|||
146428203|NCT00282048|528074478|FG000|Overall Study|Adverse Event|22|||
146428204|NCT00282048|528074478|FG000|Overall Study|Withdrawal by Subject|1|||
146428205|NCT00282048|528074478|FG000|Overall Study|Other|8|||
146428206|NCT00282048|528074478|FG000|Overall Study|Ongoing|1|||
146428207|NCT03048500|528074480|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
146428208|NCT03048500|528074480|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
146428209|NCT03048500|528074480|FG000|Reached 1st Response/Continued Treatment|Death|1|||
146428210|NCT03048500|528074480|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
146428211|NCT03048500|528074480|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
146428212|NCT03048500|528074480|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
146428213|NCT03048500|528074480|FG000|Follow up for 3 Years|Death|12|||
146428214|NCT01941030|528074483|FG000|Overall Study|Death|3|||
146428215|NCT01941030|528074484|FG001|Overall Study|Death|2|||
146428216|NCT01941030|528074483|FG000|Overall Study|Lost to Follow-up|6|||
146428217|NCT01941030|528074484|FG001|Overall Study|Lost to Follow-up|5|||
146428218|NCT01941030|528074483|FG000|Overall Study|Withdrawal by Subject|4|||
146428219|NCT01941030|528074484|FG001|Overall Study|Withdrawal by Subject|6|||
146428220|NCT00870870|528074487|FG000|Overall Study|Withdrawal by Subject|0|||
146428221|NCT00870870|528074488|FG001|Overall Study|Withdrawal by Subject|1|||
146428222|NCT00870870|528074489|FG002|Overall Study|Withdrawal by Subject|1|||
146428223|NCT00870870|528074490|FG003|Overall Study|Withdrawal by Subject|3|||
146428224|NCT00870870|528074487|FG000|Overall Study|Adverse Event|0|||
146428225|NCT00870870|528074488|FG001|Overall Study|Adverse Event|0|||
146428226|NCT00870870|528074489|FG002|Overall Study|Adverse Event|2|||
146428227|NCT00870870|528074490|FG003|Overall Study|Adverse Event|2|||
146428228|NCT03639311|528074495|FG000|Maintenance Phase|Lost to Follow-up|1|||
146428229|NCT03639311|528074496|FG001|Maintenance Phase|Lost to Follow-up|0|||
146428230|NCT03639311|528074497|FG002|Maintenance Phase|Lost to Follow-up|0|||
146428231|NCT03639311|528074495|FG000|Maintenance Phase|Adverse Event|1|||
146428232|NCT03639311|528074496|FG001|Maintenance Phase|Adverse Event|0|||
146428233|NCT03639311|528074497|FG002|Maintenance Phase|Adverse Event|0|||
146428234|NCT03639311|528074495|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
146428235|NCT03639311|528074496|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
146428236|NCT03639311|528074497|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
146428237|NCT03639311|528074495|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
146428238|NCT03639311|528074496|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
146428239|NCT03639311|528074497|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
146428240|NCT03639311|528074495|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
146428241|NCT03639311|528074496|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146428242|NCT03639311|528074497|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146428243|NCT03639311|528074495|FG000|Maintenance Phase|Lack of Efficacy|1|||
146428244|NCT03639311|528074496|FG001|Maintenance Phase|Lack of Efficacy|0|||
146428245|NCT03639311|528074497|FG002|Maintenance Phase|Lack of Efficacy|0|||
146428246|NCT00822926|528074498|FG000|Second Injection Visit|Lost to Follow-up|1|||
146428247|NCT00822926|528074499|FG001|Second Injection Visit|Lost to Follow-up|0|||
146428248|NCT00822926|528074498|FG000|Second Injection Visit|Withdrawal by Subject|0|||
146428249|NCT00822926|528074499|FG001|Second Injection Visit|Withdrawal by Subject|1|||
146428250|NCT03544138|528074503|FG000|Overall Study|Lost to Follow-up|29|||
146428251|NCT02028715|528075977|FG000|Overall Study|Adverse Event|2|||
146428252|NCT02028715|528075978|FG001|Overall Study|Adverse Event|2|||
146428253|NCT02028715|528075977|FG000|Overall Study|Physician Decision|1|||
146428254|NCT02028715|528075978|FG001|Overall Study|Physician Decision|0|||
146428255|NCT02028715|528075977|FG000|Overall Study|Did not complete satisfaction surveys|2|||
146428256|NCT02028715|528075978|FG001|Overall Study|Did not complete satisfaction surveys|2|||
146428257|NCT01710657|528075981|FG000|Overall Study|Lost to Follow-up|2|||
146428258|NCT01710657|528075982|FG001|Overall Study|Lost to Follow-up|0|||
146428259|NCT01710657|528075983|FG002|Overall Study|Lost to Follow-up|1|||
146428260|NCT01710657|528075981|FG000|Overall Study|Protocol Violation|2|||
146428261|NCT01710657|528075982|FG001|Overall Study|Protocol Violation|2|||
146428262|NCT01710657|528075983|FG002|Overall Study|Protocol Violation|0|||
146428263|NCT01710657|528075981|FG000|Overall Study|Adverse Event|14|||
146428264|NCT01710657|528075982|FG001|Overall Study|Adverse Event|8|||
146428265|NCT01710657|528075983|FG002|Overall Study|Adverse Event|28|||
146428266|NCT01710657|528075981|FG000|Overall Study|Withdrawal by Subject|0|||
146428267|NCT01710657|528075982|FG001|Overall Study|Withdrawal by Subject|1|||
146428268|NCT01710657|528075983|FG002|Overall Study|Withdrawal by Subject|2|||
146428269|NCT01710657|528075981|FG000|Overall Study|Lack of Efficacy|0|||
146428270|NCT01710657|528075982|FG001|Overall Study|Lack of Efficacy|1|||
146428271|NCT01710657|528075983|FG002|Overall Study|Lack of Efficacy|1|||
146428272|NCT02188303|528075984|FG000|Overall Study|Adverse Event|0|||
146428273|NCT02188303|528075985|FG001|Overall Study|Adverse Event|0|||
146428274|NCT02188303|528075986|FG002|Overall Study|Adverse Event|0|||
146428275|NCT02188303|528075987|FG003|Overall Study|Adverse Event|0|||
146428276|NCT02188303|528075988|FG004|Overall Study|Adverse Event|0|||
146428277|NCT02188303|528075989|FG005|Overall Study|Adverse Event|2|||
146428278|NCT02188303|528075990|FG006|Overall Study|Adverse Event|0|||
146428279|NCT02188303|528075991|FG007|Overall Study|Adverse Event|2|||
146428280|NCT02188303|528075984|FG000|Overall Study|Dose Termination Criteria Met|0|||
146428281|NCT02188303|528075985|FG001|Overall Study|Dose Termination Criteria Met|0|||
146428282|NCT02188303|528075986|FG002|Overall Study|Dose Termination Criteria Met|0|||
146428283|NCT02188303|528075987|FG003|Overall Study|Dose Termination Criteria Met|0|||
146428284|NCT02188303|528075988|FG004|Overall Study|Dose Termination Criteria Met|0|||
146428285|NCT02188303|528075989|FG005|Overall Study|Dose Termination Criteria Met|0|||
146428286|NCT02188303|528075990|FG006|Overall Study|Dose Termination Criteria Met|2|||
146428287|NCT02188303|528075991|FG007|Overall Study|Dose Termination Criteria Met|4|||
146428288|NCT04206332|528075993|FG000|Part A|Lost to Follow-up|0|||
146428289|NCT04206332|528075994|FG001|Part A|Lost to Follow-up|1|||
146428290|NCT04206332|528075995|FG002|Part A|Lost to Follow-up|0|||
146428291|NCT04206332|528075996|FG003|Part A|Lost to Follow-up|0|||
146428292|NCT04206332|528075997|FG004|Part A|Lost to Follow-up|0|||
146428293|NCT04206332|528075998|FG005|Part A|Lost to Follow-up|0|||
146428294|NCT04206332|528075999|FG006|Part A|Lost to Follow-up|0|||
146428295|NCT04206332|528076000|FG007|Part A|Lost to Follow-up|0|||
146428296|NCT04206332|528076001|FG008|Part A|Lost to Follow-up|0|||
146428297|NCT04206332|528076002|FG009|Part A|Lost to Follow-up|0|||
146428298|NCT04206332|528076003|FG010|Part A|Lost to Follow-up|0|||
146428299|NCT04206332|528076004|FG011|Part A|Lost to Follow-up|0|||
146428300|NCT04206332|528076005|FG012|Part A|Lost to Follow-up|0|||
146428301|NCT04206332|528076006|FG013|Part A|Lost to Follow-up|0|||
146428302|NCT04206332|528076007|FG014|Part A|Lost to Follow-up|0|||
146428303|NCT04206332|528076008|FG015|Part A|Lost to Follow-up|0|||
146428304|NCT04206332|528076009|FG016|Part A|Lost to Follow-up|0|||
146428305|NCT04206332|528075993|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428306|NCT04206332|528075994|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428307|NCT04206332|528075995|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428308|NCT04206332|528075996|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428309|NCT04206332|528075997|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428310|NCT04206332|528075998|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
146428311|NCT04206332|528075999|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428312|NCT04206332|528076000|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428313|NCT04206332|528076001|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428314|NCT04206332|528076002|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428315|NCT04206332|528076003|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428316|NCT04206332|528076004|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428317|NCT04206332|528076005|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428318|NCT04206332|528076006|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428319|NCT04206332|528076007|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428320|NCT04206332|528076008|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428321|NCT04206332|528076009|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
146428322|NCT04206332|528075993|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428323|NCT04206332|528075994|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428324|NCT04206332|528075995|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146200011|NCT04860258|527246208|FG000|Overall Study|Withdrawal by Subject|0|||
146428325|NCT04206332|528075996|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428326|NCT04206332|528075997|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428327|NCT04206332|528075998|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428328|NCT04206332|528075999|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428329|NCT04206332|528076000|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
146428330|NCT04206332|528076001|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428331|NCT04206332|528076002|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428332|NCT04206332|528076003|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
146428333|NCT04206332|528076004|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428334|NCT04206332|528076005|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428335|NCT04206332|528076006|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428336|NCT04206332|528076007|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428337|NCT04206332|528076008|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428338|NCT04206332|528076009|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428339|NCT04206332|528075993|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428340|NCT04206332|528075994|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428341|NCT04206332|528075995|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428342|NCT04206332|528075996|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428343|NCT04206332|528075997|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428344|NCT04206332|528075998|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428345|NCT04206332|528075999|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428346|NCT04206332|528076000|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428347|NCT04206332|528076001|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428348|NCT04206332|528076002|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428349|NCT04206332|528076003|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428350|NCT04206332|528076004|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428351|NCT04206332|528076005|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428352|NCT04206332|528076006|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428353|NCT04206332|528076007|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428354|NCT04206332|528076008|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
146428355|NCT04206332|528076009|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
146428356|NCT04206332|528075993|FG000|Part C|Withdrawal by Subject|0|||
146428357|NCT04206332|528075994|FG001|Part C|Withdrawal by Subject|0|||
146428358|NCT04206332|528075995|FG002|Part C|Withdrawal by Subject|0|||
146428359|NCT04206332|528075996|FG003|Part C|Withdrawal by Subject|0|||
146428360|NCT04206332|528075997|FG004|Part C|Withdrawal by Subject|0|||
146428361|NCT04206332|528075998|FG005|Part C|Withdrawal by Subject|0|||
146428362|NCT04206332|528075999|FG006|Part C|Withdrawal by Subject|0|||
146428363|NCT04206332|528076000|FG007|Part C|Withdrawal by Subject|0|||
146428364|NCT04206332|528076001|FG008|Part C|Withdrawal by Subject|0|||
146428365|NCT04206332|528076002|FG009|Part C|Withdrawal by Subject|0|||
146428366|NCT04206332|528076003|FG010|Part C|Withdrawal by Subject|0|||
146428367|NCT04206332|528076004|FG011|Part C|Withdrawal by Subject|0|||
146428368|NCT04206332|528076005|FG012|Part C|Withdrawal by Subject|0|||
146428369|NCT04206332|528076006|FG013|Part C|Withdrawal by Subject|0|||
146428370|NCT04206332|528076007|FG014|Part C|Withdrawal by Subject|2|||
146428371|NCT04206332|528076008|FG015|Part C|Withdrawal by Subject|0|||
146428372|NCT04206332|528076009|FG016|Part C|Withdrawal by Subject|0|||
146428373|NCT02334722|528076010|FG000|Overall Study|Lost to Follow-up|4|||
146428374|NCT02334722|528076011|FG001|Overall Study|Lost to Follow-up|0|||
146428375|NCT02334722|528076010|FG000|Overall Study|6 week questionnaire not completed|2|||
146428376|NCT02334722|528076011|FG001|Overall Study|6 week questionnaire not completed|0|||
146428377|NCT02334722|528076010|FG000|Overall Study|Unable to obtain medication|1|||
146428378|NCT02334722|528076011|FG001|Overall Study|Unable to obtain medication|1|||
146428379|NCT02334722|528076010|FG000|Overall Study|Withdrawal by Subject|0|||
146428380|NCT02334722|528076011|FG001|Overall Study|Withdrawal by Subject|3|||
146428381|NCT02334722|528076010|FG000|Overall Study|Adverse Event|0|||
146428382|NCT02334722|528076011|FG001|Overall Study|Adverse Event|2|||
146428383|NCT02334722|528076010|FG000|Overall Study|Physician Decision|0|||
146428384|NCT02334722|528076011|FG001|Overall Study|Physician Decision|1|||
146428385|NCT05612724|528076013|FG000|Overall Study|Lost to Follow-up|4|||
146428386|NCT04000815|528076020|FG000|Overall Study|Lost to Follow-up|9|||
146428387|NCT04000815|528076021|FG001|Overall Study|Lost to Follow-up|2|||
146428388|NCT04000815|528076022|FG002|Overall Study|Lost to Follow-up|3|||
146428389|NCT04000815|528076020|FG000|Overall Study|Withdrawal by Subject|4|||
146428390|NCT04000815|528076021|FG001|Overall Study|Withdrawal by Subject|3|||
146428391|NCT04000815|528076022|FG002|Overall Study|Withdrawal by Subject|2|||
146428392|NCT04000815|528076020|FG000|Overall Study|Right ovarian cyst occured|1|||
146428393|NCT04000815|528076021|FG001|Overall Study|Right ovarian cyst occured|0|||
146428394|NCT04000815|528076022|FG002|Overall Study|Right ovarian cyst occured|0|||
146428395|NCT04000815|528076020|FG000|Overall Study|Hypertension occured on follow up|0|||
146428396|NCT04000815|528076021|FG001|Overall Study|Hypertension occured on follow up|0|||
146428397|NCT04000815|528076022|FG002|Overall Study|Hypertension occured on follow up|2|||
146428398|NCT00239577|528076023|FG000|Primary Phase|Adverse Event|0|||
146428399|NCT00239577|528076024|FG001|Primary Phase|Adverse Event|0|||
146428400|NCT00239577|528076025|FG002|Primary Phase|Adverse Event|1|||
146428401|NCT00239577|528076026|FG003|Primary Phase|Adverse Event|0|||
146428402|NCT00239577|528076023|FG000|Primary Phase|Other|5|||
146428403|NCT00239577|528076024|FG001|Primary Phase|Other|3|||
146428404|NCT00239577|528076025|FG002|Primary Phase|Other|2|||
146428405|NCT00239577|528076026|FG003|Primary Phase|Other|0|||
146428406|NCT02422264|528076029|FG000|Overall Study|Serious Adverse Event|1|||
146428407|NCT02422264|528076030|FG001|Overall Study|Serious Adverse Event|0|||
146428408|NCT02422264|528076029|FG000|Overall Study|Withdrawal by Subject|1|||
146428409|NCT02422264|528076030|FG001|Overall Study|Withdrawal by Subject|2|||
146428410|NCT02422264|528076029|FG000|Overall Study|Migrated/moved from study area|3|||
146428411|NCT02422264|528076030|FG001|Overall Study|Migrated/moved from study area|1|||
146200012|NCT04860258|527246209|FG001|Overall Study|Withdrawal by Subject|0|||
146200013|NCT04860258|527246210|FG002|Overall Study|Withdrawal by Subject|4|||
146200014|NCT04860258|527246211|FG003|Overall Study|Withdrawal by Subject|1|||
146200015|NCT04860258|527246212|FG004|Overall Study|Withdrawal by Subject|4|||
146200016|NCT04860258|527246213|FG005|Overall Study|Withdrawal by Subject|1|||
146200017|NCT04860258|527246214|FG006|Overall Study|Withdrawal by Subject|0|||
146200018|NCT00391846|527246215|FG000|Overall Study|Adverse Event|4|||
146200019|NCT00391846|527246216|FG001|Overall Study|Adverse Event|1|||
146200020|NCT00391846|527246215|FG000|Overall Study|Did not meet the required elig. crit|2|||
146200021|NCT00391846|527246216|FG001|Overall Study|Did not meet the required elig. crit|2|||
146200022|NCT00391846|527246215|FG000|Overall Study|Withdrawal by Subject|2|||
146200023|NCT00391846|527246216|FG001|Overall Study|Withdrawal by Subject|3|||
146200024|NCT00391846|527246215|FG000|Overall Study|Developed study specific DC criteria|0|||
146200025|NCT00391846|527246216|FG001|Overall Study|Developed study specific DC criteria|1|||
146200026|NCT04035668|527246217|FG000|Overall Study|Adverse Event|3|||
146200027|NCT04035668|527246218|FG001|Overall Study|Adverse Event|4|||
146200028|NCT04035668|527246219|FG002|Overall Study|Adverse Event|2|||
146200029|NCT04035668|527246217|FG000|Overall Study|Lost to Follow-up|0|||
146200030|NCT04035668|527246218|FG001|Overall Study|Lost to Follow-up|1|||
146200031|NCT04035668|527246219|FG002|Overall Study|Lost to Follow-up|0|||
146200032|NCT04035668|527246217|FG000|Overall Study|Physician Decision|2|||
146200033|NCT04035668|527246218|FG001|Overall Study|Physician Decision|1|||
146200034|NCT04035668|527246219|FG002|Overall Study|Physician Decision|1|||
146200035|NCT04035668|527246217|FG000|Overall Study|Subject Decision|2|||
146200036|NCT04035668|527246218|FG001|Overall Study|Subject Decision|2|||
146200037|NCT04035668|527246219|FG002|Overall Study|Subject Decision|0|||
146200038|NCT02937831|527246220|FG000|Overall Study|Protocol Violation|4|||
146200039|NCT00419094|527246221|FG000|Overall Study|Adverse Event|3|||
146200040|NCT00419094|527246222|FG001|Overall Study|Adverse Event|7|||
146200041|NCT00419094|527246221|FG000|Overall Study|Lack of Efficacy|1|||
146200042|NCT00419094|527246222|FG001|Overall Study|Lack of Efficacy|0|||
146200043|NCT00419094|527246221|FG000|Overall Study|Lost to Follow-up|0|||
146200044|NCT00419094|527246222|FG001|Overall Study|Lost to Follow-up|2|||
146200045|NCT00419094|527246221|FG000|Overall Study|Protocol Violation|1|||
146200046|NCT00419094|527246222|FG001|Overall Study|Protocol Violation|14|||
146200047|NCT00419094|527246221|FG000|Overall Study|Withdrawal of consent|1|||
146200048|NCT00419094|527246222|FG001|Overall Study|Withdrawal of consent|5|||
146200049|NCT00419094|527246221|FG000|Overall Study|Other: Error determining exit criteria|1|||
146200050|NCT00419094|527246222|FG001|Overall Study|Other: Error determining exit criteria|0|||
146200051|NCT00419094|527246221|FG000|Overall Study|Other: Patient non-compliant|0|||
146200052|NCT00419094|527246222|FG001|Overall Study|Other: Patient non-compliant|1|||
146200053|NCT00419094|527246221|FG000|Overall Study|Other: No contact for extended period|0|||
146200054|NCT00419094|527246222|FG001|Overall Study|Other: No contact for extended period|1|||
146200055|NCT03020745|527246223|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200056|NCT03020745|527246224|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200057|NCT03020745|527246225|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200058|NCT03020745|527246226|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200059|NCT03020745|527246227|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200060|NCT03020745|527246228|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200061|NCT03020745|527246229|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200062|NCT03020745|527246230|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200063|NCT03020745|527246231|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
146200064|NCT03020745|527246232|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
146200065|NCT03020745|527246223|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200066|NCT03020745|527246224|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200067|NCT03020745|527246225|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200068|NCT03020745|527246226|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200069|NCT03020745|527246227|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200070|NCT03020745|527246228|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200071|NCT03020745|527246229|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200072|NCT03020745|527246230|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
146200073|NCT03020745|527246231|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200074|NCT03020745|527246232|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
146200075|NCT03020745|527246223|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200076|NCT03020745|527246224|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200077|NCT03020745|527246225|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200078|NCT03020745|527246226|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200079|NCT03020745|527246227|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200080|NCT03020745|527246228|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
146200081|NCT03020745|527246229|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200082|NCT03020745|527246230|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146200083|NCT03020745|527246231|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
146200084|NCT03020745|527246232|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
146428412|NCT02422264|528076029|FG000|Overall Study|Subject vaccinated outside of the study|0|||
146428413|NCT02422264|528076030|FG001|Overall Study|Subject vaccinated outside of the study|1|||
146428414|NCT03021018|528076031|FG000|Overall Study|Adverse Event|1|||
146428415|NCT03021018|528076032|FG001|Overall Study|Adverse Event|0|||
146428416|NCT03021018|528076033|FG002|Overall Study|Adverse Event|0|||
146428417|NCT03021018|528076031|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
146428418|NCT03021018|528076032|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
146428419|NCT03021018|528076033|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
146428420|NCT00856388|528076036|FG000|Overall Study|Other|1|||
146428421|NCT01617668|528076038|FG000|Overall Study|Adverse Event|7|||
146428422|NCT01617668|528076039|FG001|Overall Study|Adverse Event|0|||
146428423|NCT01617668|528076040|FG002|Overall Study|Adverse Event|12|||
146428424|NCT01617668|528076041|FG003|Overall Study|Adverse Event|5|||
146428425|NCT01617668|528076038|FG000|Overall Study|Physician Decision|1|||
146428426|NCT01617668|528076039|FG001|Overall Study|Physician Decision|2|||
146428427|NCT01617668|528076040|FG002|Overall Study|Physician Decision|3|||
146428428|NCT01617668|528076041|FG003|Overall Study|Physician Decision|0|||
146428429|NCT01617668|528076038|FG000|Overall Study|Progressive Disease|4|||
146428430|NCT01617668|528076039|FG001|Overall Study|Progressive Disease|4|||
146428431|NCT01617668|528076040|FG002|Overall Study|Progressive Disease|6|||
146428432|NCT01617668|528076041|FG003|Overall Study|Progressive Disease|9|||
146428433|NCT01617668|528076038|FG000|Overall Study|Subject/guardian decision|1|||
146428434|NCT01617668|528076039|FG001|Overall Study|Subject/guardian decision|3|||
146428435|NCT01617668|528076040|FG002|Overall Study|Subject/guardian decision|2|||
146428436|NCT01617668|528076041|FG003|Overall Study|Subject/guardian decision|1|||
146428437|NCT00925769|528076042|FG000|Overall Study|Major toxicity|1|||
146428438|NCT00925769|528076043|FG001|Overall Study|Major toxicity|0|||
146428439|NCT00925769|528076044|FG002|Overall Study|Major toxicity|1|||
146428440|NCT00925769|528076045|FG003|Overall Study|Major toxicity|1|||
146428441|NCT00925769|528076046|FG004|Overall Study|Major toxicity|0|||
146428442|NCT00925769|528076047|FG005|Overall Study|Major toxicity|0|||
146428443|NCT00925769|528076042|FG000|Overall Study|Disease progression|4|||
146428444|NCT00925769|528076043|FG001|Overall Study|Disease progression|5|||
146428445|NCT00925769|528076044|FG002|Overall Study|Disease progression|3|||
146428446|NCT00925769|528076045|FG003|Overall Study|Disease progression|4|||
146428447|NCT00925769|528076046|FG004|Overall Study|Disease progression|2|||
146428448|NCT00925769|528076047|FG005|Overall Study|Disease progression|3|||
146428449|NCT00925769|528076042|FG000|Overall Study|Death|0|||
146428450|NCT00925769|528076043|FG001|Overall Study|Death|0|||
146428451|NCT00925769|528076044|FG002|Overall Study|Death|1|||
146428452|NCT00925769|528076045|FG003|Overall Study|Death|0|||
146428453|NCT00925769|528076046|FG004|Overall Study|Death|0|||
146428454|NCT00925769|528076047|FG005|Overall Study|Death|0|||
146428455|NCT00925769|528076042|FG000|Overall Study|Physician Decision|1|||
146428456|NCT00925769|528076043|FG001|Overall Study|Physician Decision|0|||
146428457|NCT00925769|528076044|FG002|Overall Study|Physician Decision|0|||
146428458|NCT00925769|528076045|FG003|Overall Study|Physician Decision|0|||
146428459|NCT00925769|528076046|FG004|Overall Study|Physician Decision|0|||
146428460|NCT00925769|528076047|FG005|Overall Study|Physician Decision|0|||
146428461|NCT00925769|528076042|FG000|Overall Study|Missing documentation|0|||
146428462|NCT00925769|528076043|FG001|Overall Study|Missing documentation|1|||
146428463|NCT00925769|528076044|FG002|Overall Study|Missing documentation|0|||
146428464|NCT00925769|528076045|FG003|Overall Study|Missing documentation|0|||
146428465|NCT00925769|528076046|FG004|Overall Study|Missing documentation|0|||
146428466|NCT00925769|528076047|FG005|Overall Study|Missing documentation|0|||
146200085|NCT03020745|527246223|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200086|NCT03020745|527246224|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146428467|NCT00925769|528076042|FG000|Overall Study|End of study visit not done|0|||
146428468|NCT00925769|528076043|FG001|Overall Study|End of study visit not done|0|||
146428469|NCT00925769|528076044|FG002|Overall Study|End of study visit not done|1|||
146428470|NCT00925769|528076045|FG003|Overall Study|End of study visit not done|0|||
146428471|NCT00925769|528076046|FG004|Overall Study|End of study visit not done|0|||
146428472|NCT00925769|528076047|FG005|Overall Study|End of study visit not done|0|||
146428473|NCT00925769|528076042|FG000|Overall Study|Participant is unable to swallow drug|0|||
146428474|NCT00925769|528076043|FG001|Overall Study|Participant is unable to swallow drug|0|||
146428475|NCT00925769|528076044|FG002|Overall Study|Participant is unable to swallow drug|0|||
146428476|NCT00925769|528076045|FG003|Overall Study|Participant is unable to swallow drug|1|||
146428477|NCT00925769|528076046|FG004|Overall Study|Participant is unable to swallow drug|0|||
146428478|NCT00925769|528076047|FG005|Overall Study|Participant is unable to swallow drug|0|||
146428479|NCT00925769|528076042|FG000|Overall Study|Adverse Event|0|||
146428480|NCT00925769|528076043|FG001|Overall Study|Adverse Event|0|||
146428481|NCT00925769|528076044|FG002|Overall Study|Adverse Event|0|||
146428482|NCT00925769|528076045|FG003|Overall Study|Adverse Event|0|||
146428483|NCT00925769|528076046|FG004|Overall Study|Adverse Event|1|||
146428484|NCT00925769|528076047|FG005|Overall Study|Adverse Event|0|||
146428485|NCT01038856|528076050|FG000|Overall Study|Adverse Event|2|||
146428486|NCT02300103|528076051|FG000|Overall Study|Lack of Efficacy|3|||
146428487|NCT02300103|528076051|FG000|Overall Study|Protocol Violation|1|||
146428488|NCT02300103|528076051|FG000|Overall Study|Withdrew Consent|2|||
146428489|NCT04091971|528076052|FG000|Overall Study|Withdrawal by Subject|1|||
146428490|NCT04091971|528076052|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
146428491|NCT04091971|528076052|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
146428492|NCT01666730|528076054|FG000|Overall Study|Adverse Event|16|||
146428493|NCT01666730|528076054|FG000|Overall Study|Death|2|||
146428494|NCT01666730|528076054|FG000|Overall Study|Physician Decision|5|||
146428495|NCT01666730|528076054|FG000|Overall Study|Withdrawal by Subject|9|||
146428496|NCT01666730|528076054|FG000|Overall Study|Disease progression/relapse|18|||
146428497|NCT04466111|528076055|FG000|Prior to Trial Phase|Physician Decision|1|||
146428498|NCT03553823|528076056|FG000|Overall Study|Physician Decision|0|||
146428499|NCT03553823|528076057|FG001|Overall Study|Physician Decision|1|||
146428500|NCT03603314|528076058|FG000|Overall Study|Lost to Follow-up|0|||
146428501|NCT03603314|528076059|FG001|Overall Study|Lost to Follow-up|3|||
146428502|NCT03603314|528076060|FG002|Overall Study|Lost to Follow-up|0|||
146428503|NCT03603314|528076058|FG000|Overall Study|Protocol Violation|0|||
146428504|NCT03603314|528076059|FG001|Overall Study|Protocol Violation|1|||
146428505|NCT03603314|528076060|FG002|Overall Study|Protocol Violation|0|||
146428506|NCT03603314|528076058|FG000|Overall Study|Adverse Event|2|||
146428507|NCT03603314|528076059|FG001|Overall Study|Adverse Event|0|||
146428508|NCT03603314|528076060|FG002|Overall Study|Adverse Event|0|||
146428509|NCT03603314|528076058|FG000|Overall Study|Physician Decision|1|||
146428510|NCT03603314|528076059|FG001|Overall Study|Physician Decision|1|||
146428511|NCT03603314|528076060|FG002|Overall Study|Physician Decision|0|||
146428512|NCT03603314|528076058|FG000|Overall Study|Withdrawal by Subject|4|||
146428513|NCT03603314|528076059|FG001|Overall Study|Withdrawal by Subject|5|||
146428514|NCT03603314|528076060|FG002|Overall Study|Withdrawal by Subject|3|||
146428515|NCT03603314|528076058|FG000|Overall Study|Other|0|||
146428516|NCT03603314|528076059|FG001|Overall Study|Other|1|||
146428517|NCT03603314|528076060|FG002|Overall Study|Other|0|||
146428518|NCT01389102|528076061|FG000|Overall Study|Adverse Event|1|||
146428519|NCT01389102|528076062|FG001|Overall Study|Adverse Event|3|||
146428520|NCT01389102|528076063|FG002|Overall Study|Adverse Event|2|||
146428521|NCT01389102|528076064|FG003|Overall Study|Adverse Event|2|||
146428522|NCT01389102|528076065|FG004|Overall Study|Adverse Event|2|||
146428523|NCT01389102|528076066|FG005|Overall Study|Adverse Event|2|||
146428524|NCT01389102|528076061|FG000|Overall Study|Hurricane Katrina|4|||
146428525|NCT01389102|528076062|FG001|Overall Study|Hurricane Katrina|2|||
146428526|NCT01389102|528076063|FG002|Overall Study|Hurricane Katrina|3|||
146428527|NCT01389102|528076064|FG003|Overall Study|Hurricane Katrina|0|||
146428528|NCT01389102|528076065|FG004|Overall Study|Hurricane Katrina|3|||
146428529|NCT01389102|528076066|FG005|Overall Study|Hurricane Katrina|1|||
146428530|NCT01389102|528076061|FG000|Overall Study|Lost to Follow-up|4|||
146428531|NCT01389102|528076062|FG001|Overall Study|Lost to Follow-up|1|||
146428532|NCT01389102|528076063|FG002|Overall Study|Lost to Follow-up|1|||
146428533|NCT01389102|528076064|FG003|Overall Study|Lost to Follow-up|2|||
146428534|NCT01389102|528076065|FG004|Overall Study|Lost to Follow-up|4|||
146428535|NCT01389102|528076066|FG005|Overall Study|Lost to Follow-up|1|||
146200087|NCT03020745|527246225|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146428536|NCT01389102|528076061|FG000|Overall Study|Protocol Violation|0|||
146428537|NCT01389102|528076062|FG001|Overall Study|Protocol Violation|0|||
146428538|NCT01389102|528076063|FG002|Overall Study|Protocol Violation|3|||
146428539|NCT01389102|528076064|FG003|Overall Study|Protocol Violation|0|||
146428540|NCT01389102|528076065|FG004|Overall Study|Protocol Violation|1|||
146428541|NCT01389102|528076066|FG005|Overall Study|Protocol Violation|1|||
146428542|NCT01389102|528076061|FG000|Overall Study|Withdrawal by Subject|7|||
146428543|NCT01389102|528076062|FG001|Overall Study|Withdrawal by Subject|4|||
146428544|NCT01389102|528076063|FG002|Overall Study|Withdrawal by Subject|9|||
146428545|NCT01389102|528076064|FG003|Overall Study|Withdrawal by Subject|2|||
146428546|NCT01389102|528076065|FG004|Overall Study|Withdrawal by Subject|3|||
145949844|NCT01214668|526328682|FG002|Overall Study|Progressive Disease|5|||
145949845|NCT01214668|526328683|FG003|Overall Study|Progressive Disease|4|||
145949846|NCT01214668|526328684|FG004|Overall Study|Progressive Disease|4|||
145949847|NCT01214668|526328685|FG005|Overall Study|Progressive Disease|5|||
145949848|NCT01214668|526328680|FG000|Overall Study|Withdrawal by Subject|0|||
145949849|NCT01214668|526328681|FG001|Overall Study|Withdrawal by Subject|0|||
145949850|NCT01214668|526328682|FG002|Overall Study|Withdrawal by Subject|0|||
145949851|NCT01214668|526328683|FG003|Overall Study|Withdrawal by Subject|0|||
145949852|NCT01214668|526328684|FG004|Overall Study|Withdrawal by Subject|1|||
145949853|NCT01214668|526328685|FG005|Overall Study|Withdrawal by Subject|0|||
145949854|NCT02815267|526328686|FG000|Double-Blind Phase|Adverse Event|0|||
145949855|NCT02815267|526328687|FG001|Double-Blind Phase|Adverse Event|3|||
145949856|NCT02815267|526328686|FG000|Double-Blind Phase|Lost to Follow-up|17|||
146082824|NCT01451437|526822908|FG002|Overall Study|Physician Decision|2|||
146200088|NCT03020745|527246226|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200089|NCT03020745|527246227|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200090|NCT03020745|527246228|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200091|NCT03020745|527246229|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200092|NCT03020745|527246230|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200093|NCT03020745|527246231|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
146200094|NCT03020745|527246232|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
146200095|NCT03823300|527246233|FG000|Overall Study|Withdrawal by Subject|16|||
146200096|NCT03823300|527246234|FG001|Overall Study|Withdrawal by Subject|22|||
146200097|NCT03823300|527246233|FG000|Overall Study|Death|10|||
146200098|NCT03823300|527246234|FG001|Overall Study|Death|14|||
146200099|NCT03823300|527246233|FG000|Overall Study|Adverse Event|3|||
146200100|NCT03823300|527246234|FG001|Overall Study|Adverse Event|5|||
146200101|NCT03823300|527246233|FG000|Overall Study|Physician Decision|1|||
146200102|NCT03823300|527246234|FG001|Overall Study|Physician Decision|7|||
146200103|NCT03823300|527246233|FG000|Overall Study|Lost to Follow-up|1|||
146200104|NCT03823300|527246234|FG001|Overall Study|Lost to Follow-up|3|||
146200105|NCT03823300|527246233|FG000|Overall Study|Protocol Violation|1|||
146200106|NCT03823300|527246234|FG001|Overall Study|Protocol Violation|1|||
146200107|NCT03823300|527246233|FG000|Overall Study|Lack of Efficacy|1|||
146200108|NCT03823300|527246234|FG001|Overall Study|Lack of Efficacy|1|||
146200109|NCT03823300|527246233|FG000|Overall Study|Not Eligible|0|||
146200110|NCT03823300|527246234|FG001|Overall Study|Not Eligible|1|||
146200111|NCT03823300|527246233|FG000|Overall Study|Other|1|||
146200112|NCT03823300|527246234|FG001|Overall Study|Other|0|||
146200113|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
146200114|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
146200115|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
146200116|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
146200117|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
146200118|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
146200119|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
146200120|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
146200121|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
146200122|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
146200123|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
146200124|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
146200125|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
146200126|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
146200127|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
146200128|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
146200129|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
146200130|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
146200131|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
146200132|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
146200133|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
146200134|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
146200135|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
146200136|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
145949857|NCT02815267|526328687|FG001|Double-Blind Phase|Lost to Follow-up|9|||
145949858|NCT02815267|526328686|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
146082825|NCT01451437|526822909|FG003|Overall Study|Physician Decision|0|||
146200137|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146200138|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146200139|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
146200140|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
146200141|NCT00241644|527246236|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
146200142|NCT00241644|527246237|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
146428547|NCT01389102|528076066|FG005|Overall Study|Withdrawal by Subject|3|||
146428548|NCT01389102|528076061|FG000|Overall Study|Subject Traveling Out of Country|0|||
146428549|NCT01389102|528076062|FG001|Overall Study|Subject Traveling Out of Country|0|||
146428550|NCT01389102|528076063|FG002|Overall Study|Subject Traveling Out of Country|0|||
146428551|NCT01389102|528076064|FG003|Overall Study|Subject Traveling Out of Country|1|||
146428552|NCT01389102|528076065|FG004|Overall Study|Subject Traveling Out of Country|0|||
146428553|NCT01389102|528076066|FG005|Overall Study|Subject Traveling Out of Country|0|||
146428554|NCT01389102|528076061|FG000|Overall Study|Subject Moved|2|||
146428555|NCT01389102|528076062|FG001|Overall Study|Subject Moved|0|||
146428556|NCT01389102|528076063|FG002|Overall Study|Subject Moved|1|||
146428557|NCT01389102|528076064|FG003|Overall Study|Subject Moved|0|||
146428558|NCT01389102|528076065|FG004|Overall Study|Subject Moved|0|||
146428559|NCT01389102|528076066|FG005|Overall Study|Subject Moved|0|||
146428560|NCT01389102|528076061|FG000|Overall Study|Unavailable due to husband's illness|0|||
146428561|NCT01389102|528076062|FG001|Overall Study|Unavailable due to husband's illness|1|||
146428562|NCT01389102|528076063|FG002|Overall Study|Unavailable due to husband's illness|0|||
146428563|NCT01389102|528076064|FG003|Overall Study|Unavailable due to husband's illness|0|||
146428564|NCT01389102|528076065|FG004|Overall Study|Unavailable due to husband's illness|0|||
146428565|NCT01389102|528076066|FG005|Overall Study|Unavailable due to husband's illness|0|||
146428566|NCT01389102|528076061|FG000|Overall Study|Investigator Judgement|0|||
146428567|NCT01389102|528076062|FG001|Overall Study|Investigator Judgement|1|||
146428568|NCT01389102|528076063|FG002|Overall Study|Investigator Judgement|0|||
146428569|NCT01389102|528076064|FG003|Overall Study|Investigator Judgement|0|||
146428570|NCT01389102|528076065|FG004|Overall Study|Investigator Judgement|0|||
146428571|NCT01389102|528076066|FG005|Overall Study|Investigator Judgement|0|||
146428572|NCT03450070|528076067|FG000|Overall Study|Withdrawal by Subject|8|||
146428573|NCT00050778|528076068|FG000|Overall Study|Adverse Event|13|||
146428574|NCT00050778|528076069|FG001|Overall Study|Adverse Event|3|||
146428575|NCT00050778|528076070|FG002|Overall Study|Adverse Event|2|||
146428576|NCT00050778|528076068|FG000|Overall Study|Death|0|||
146428577|NCT00050778|528076069|FG001|Overall Study|Death|1|||
146428578|NCT00050778|528076070|FG002|Overall Study|Death|1|||
146428579|NCT00050778|528076068|FG000|Overall Study|Lack of Efficacy|16|||
146428580|NCT00050778|528076069|FG001|Overall Study|Lack of Efficacy|2|||
146428581|NCT00050778|528076070|FG002|Overall Study|Lack of Efficacy|2|||
146428582|NCT00050778|528076068|FG000|Overall Study|Lost to Follow-up|0|||
146428583|NCT00050778|528076069|FG001|Overall Study|Lost to Follow-up|2|||
146428584|NCT00050778|528076070|FG002|Overall Study|Lost to Follow-up|4|||
146428585|NCT00050778|528076068|FG000|Overall Study|Physician Decision|3|||
146428586|NCT00050778|528076069|FG001|Overall Study|Physician Decision|0|||
146428587|NCT00050778|528076070|FG002|Overall Study|Physician Decision|2|||
146428588|NCT00050778|528076068|FG000|Overall Study|Protocol Violation|2|||
146428589|NCT00050778|528076069|FG001|Overall Study|Protocol Violation|0|||
146428590|NCT00050778|528076070|FG002|Overall Study|Protocol Violation|1|||
146428591|NCT00050778|528076068|FG000|Overall Study|Withdrawal by Subject|6|||
146428592|NCT00050778|528076069|FG001|Overall Study|Withdrawal by Subject|8|||
146428593|NCT00050778|528076070|FG002|Overall Study|Withdrawal by Subject|4|||
146428594|NCT00050778|528076068|FG000|Overall Study|Randomized but not treated|4|||
146428595|NCT00050778|528076069|FG001|Overall Study|Randomized but not treated|5|||
146428596|NCT00050778|528076070|FG002|Overall Study|Randomized but not treated|2|||
146428597|NCT00050778|528076068|FG000|Overall Study|Familial and personal reasons|1|||
146428598|NCT00050778|528076069|FG001|Overall Study|Familial and personal reasons|0|||
146428599|NCT00050778|528076070|FG002|Overall Study|Familial and personal reasons|0|||
146428600|NCT02910037|528076071|FG000|Overall Study|Withdrawal by Subject|4|||
146428601|NCT02910037|528076071|FG000|Overall Study|Lost to Follow-up|6|||
146428602|NCT00436553|528076074|FG000|Overall Study|Adverse Event|4|||
146428603|NCT00436553|528076075|FG001|Overall Study|Adverse Event|3|||
146428604|NCT00436553|528076076|FG002|Overall Study|Adverse Event|4|||
146428605|NCT00436553|528076074|FG000|Overall Study|Death|3|||
146428606|NCT00436553|528076075|FG001|Overall Study|Death|1|||
146428607|NCT00436553|528076076|FG002|Overall Study|Death|3|||
146428608|NCT00436553|528076074|FG000|Overall Study|Lost to Follow-up|0|||
146428609|NCT00436553|528076075|FG001|Overall Study|Lost to Follow-up|2|||
146428610|NCT00436553|528076076|FG002|Overall Study|Lost to Follow-up|0|||
146428611|NCT00436553|528076074|FG000|Overall Study|Protocol Violation|1|||
146428612|NCT00436553|528076075|FG001|Overall Study|Protocol Violation|0|||
146428613|NCT00436553|528076076|FG002|Overall Study|Protocol Violation|0|||
146428614|NCT00436553|528076074|FG000|Overall Study|Withdrawal by Subject|5|||
146428615|NCT00436553|528076075|FG001|Overall Study|Withdrawal by Subject|6|||
146428616|NCT00436553|528076076|FG002|Overall Study|Withdrawal by Subject|3|||
146428617|NCT01035060|528076077|FG000|Overall Study|Lost to Follow-up|0|||
146428618|NCT01035060|528076078|FG001|Overall Study|Lost to Follow-up|7|||
146428619|NCT01035060|528076077|FG000|Overall Study|Did not quality after 2nd screening|14|||
146428620|NCT01035060|528076078|FG001|Overall Study|Did not quality after 2nd screening|1|||
146428621|NCT01035060|528076077|FG000|Overall Study|Withdrawal by Subject|8|||
146428622|NCT01035060|528076078|FG001|Overall Study|Withdrawal by Subject|6|||
146428623|NCT01035060|528076077|FG000|Overall Study|Physician Decision|2|||
146428624|NCT01035060|528076078|FG001|Overall Study|Physician Decision|0|||
146428625|NCT00064753|528076080|FG000|Overall Study|Death|251|||
146428626|NCT00064753|528076081|FG001|Overall Study|Death|242|||
146428627|NCT00064753|528076080|FG000|Overall Study|Withdrawal by Subject|198|||
146428628|NCT00064753|528076081|FG001|Overall Study|Withdrawal by Subject|171|||
146428629|NCT00064753|528076080|FG000|Overall Study|Lost to Follow-up|225|||
146428630|NCT00064753|528076081|FG001|Overall Study|Lost to Follow-up|235|||
146428631|NCT02193880|528076084|FG000|Overall Study|patients did not collect enough HPC|3|||
146428632|NCT03522675|528076085|FG000|Overall Study|Screen fail|1|||
146428633|NCT03522675|528076085|FG000|Overall Study|Non-reactive to histamine|1|||
146428634|NCT00707161|528076086|FG000|Overall Study|Physician Decision|6|||
146428635|NCT02674477|528076087|FG000|Overall Study|Protocol Violation|8|||
146428636|NCT02674477|528076088|FG001|Overall Study|Protocol Violation|2|||
146428637|NCT00296647|528076089|FG000|Overall Study|Death|4|||
146428638|NCT00296647|528076090|FG001|Overall Study|Death|1|||
146428639|NCT00296647|528076091|FG002|Overall Study|Death|2|||
146428640|NCT00296647|528076092|FG003|Overall Study|Death|1|||
146428641|NCT00296647|528076093|FG004|Overall Study|Death|1|||
146428642|NCT00296647|528076089|FG000|Overall Study|Withdrawal by Subject|28|||
146428643|NCT00296647|528076090|FG001|Overall Study|Withdrawal by Subject|27|||
146428644|NCT00296647|528076091|FG002|Overall Study|Withdrawal by Subject|32|||
146428645|NCT00296647|528076092|FG003|Overall Study|Withdrawal by Subject|16|||
146428646|NCT00296647|528076093|FG004|Overall Study|Withdrawal by Subject|19|||
146428647|NCT00565448|528076094|FG000|Overall Study|Adverse Event|1|||
146428648|NCT00565448|528076095|FG001|Overall Study|Adverse Event|2|||
146428649|NCT00565448|528076094|FG000|Overall Study|Disease progression|1|||
146428650|NCT00565448|528076095|FG001|Overall Study|Disease progression|0|||
146428651|NCT00565448|528076094|FG000|Overall Study|Withdrawal by Subject|1|||
146428652|NCT00565448|528076095|FG001|Overall Study|Withdrawal by Subject|0|||
146428653|NCT01863745|528076096|FG000|Overall Study|Disease Progression|9|||
146428654|NCT01863745|528076096|FG000|Overall Study|Adverse Event|2|||
146428655|NCT01863745|528076096|FG000|Overall Study|Death|1|||
145949859|NCT02815267|526328687|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
145949860|NCT02815267|526328686|FG000|Double-Blind Phase|Protocol Violation|3|||
145949861|NCT02815267|526328687|FG001|Double-Blind Phase|Protocol Violation|2|||
145949862|NCT02815267|526328686|FG000|Double-Blind Phase|Site withdrawal|1|||
145949863|NCT02815267|526328687|FG001|Double-Blind Phase|Site withdrawal|6|||
146082826|NCT01451437|526822910|FG004|Overall Study|Physician Decision|0|||
146428656|NCT01863745|528076096|FG000|Overall Study|Withdrawal by Subject|1|||
146428657|NCT00193609|528076097|FG000|Overall Study|Lack of Efficacy|2|||
146428658|NCT00193609|528076097|FG000|Overall Study|Adverse Event|2|||
146428659|NCT00735904|528076099|FG000|Overall Study|Adverse Event|3|||
146428660|NCT00735904|528076099|FG000|Overall Study|Death|20|||
146428661|NCT00735904|528076099|FG000|Overall Study|Protocol Violation|1|||
146428662|NCT00735904|528076099|FG000|Overall Study|Withdrawal by Subject|1|||
146428663|NCT00735904|528076099|FG000|Overall Study|Study Terminated by Sponsor|5|||
146428664|NCT00735904|528076099|FG000|Overall Study|Other|8|||
146428665|NCT03361228|528076103|FG000|Overall Study|Other|1|||
146428666|NCT03361228|528076104|FG001|Overall Study|Other|1|||
146428667|NCT03361228|528076103|FG000|Overall Study|Death|3|||
146428668|NCT03361228|528076104|FG001|Overall Study|Death|0|||
146428669|NCT03693430|528076112|FG000|Overall Study|Lost to Follow-up|3|||
146428670|NCT03693430|528076113|FG001|Overall Study|Lost to Follow-up|14|||
146428671|NCT03693430|528076112|FG000|Overall Study|Death|1|||
146428672|NCT03693430|528076113|FG001|Overall Study|Death|0|||
146428673|NCT03693430|528076112|FG000|Overall Study|Withdrawal by Subject|0|||
146428674|NCT03693430|528076113|FG001|Overall Study|Withdrawal by Subject|4|||
146428675|NCT00585689|528076114|FG000|Overall Study|Received different ABI-007 schedule|3|||
146428676|NCT00585689|528076114|FG000|Overall Study|Adverse Event|1|||
146428677|NCT00585689|528076114|FG000|Overall Study|Patient Declined Surgery|1|||
146428678|NCT00585689|528076114|FG000|Overall Study|Patient had unresectable disease|1|||
146428679|NCT00585689|528076114|FG000|Overall Study|Death|1|||
146428680|NCT02930005|528076115|FG000|Overall Study|Lost to Follow-up|1|||
146428681|NCT02930005|528076116|FG001|Overall Study|Lost to Follow-up|5|||
146428682|NCT02373098|528076117|FG000|Overall Study|Lost to Follow-up|1|||
146428683|NCT02373098|528076118|FG001|Overall Study|Lost to Follow-up|0|||
146428684|NCT02373098|528076117|FG000|Overall Study|Protocol Violation|3|||
146428685|NCT02373098|528076118|FG001|Overall Study|Protocol Violation|0|||
146428686|NCT02373098|528076117|FG000|Overall Study|Withdrawal by Subject|5|||
146428687|NCT02373098|528076118|FG001|Overall Study|Withdrawal by Subject|0|||
146428688|NCT02373098|528076117|FG000|Overall Study|Adverse Event|3|||
146428689|NCT02373098|528076118|FG001|Overall Study|Adverse Event|0|||
146428690|NCT00855738|528076125|FG000|Overall Study|Lost to Follow-up|2|||
146428691|NCT00855738|528076125|FG000|Overall Study|Adverse Event|1|||
146428692|NCT00855738|528076125|FG000|Overall Study|Subject Defaulted|1|||
146428693|NCT00855738|528076125|FG000|Overall Study|Death|1|||
146428694|NCT00319735|528076138|FG000|Overall Study|Death|2|||
146428695|NCT00119379|528076144|FG000|Overall Study|Adverse Event|4|||
146428696|NCT00119379|528076145|FG001|Overall Study|Adverse Event|1|||
146428697|NCT00154102|528076146|FG000|Overall Study|investigational study phase ongoing|7|||
146428698|NCT00154102|528076147|FG001|Overall Study|investigational study phase ongoing|2|||
146428699|NCT01811953|528077655|FG000|Overall Study|Adverse Event|0|||
146428700|NCT01811953|528077656|FG001|Overall Study|Adverse Event|0|||
146428701|NCT01811953|528077657|FG002|Overall Study|Adverse Event|0|||
146428702|NCT01811953|528077658|FG003|Overall Study|Adverse Event|1|||
146428703|NCT01811953|528077659|FG004|Overall Study|Adverse Event|0|||
146428704|NCT01811953|528077660|FG005|Overall Study|Adverse Event|1|||
146428705|NCT01811953|528077655|FG000|Overall Study|Protocol Violation|0|||
146428706|NCT01811953|528077656|FG001|Overall Study|Protocol Violation|0|||
146428707|NCT01811953|528077657|FG002|Overall Study|Protocol Violation|0|||
146428708|NCT01811953|528077658|FG003|Overall Study|Protocol Violation|0|||
146428709|NCT01811953|528077659|FG004|Overall Study|Protocol Violation|1|||
146428710|NCT01811953|528077660|FG005|Overall Study|Protocol Violation|0|||
146200143|NCT00241644|527246238|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
146200144|NCT00241644|527246239|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
146200145|NCT00241644|527246236|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
146200146|NCT00241644|527246237|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
146200147|NCT00241644|527246238|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
146200148|NCT00241644|527246239|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
146200149|NCT00241644|527246236|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
146200150|NCT00241644|527246237|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
146200151|NCT00241644|527246238|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
146200152|NCT00241644|527246239|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
146200153|NCT00241644|527246236|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
146428711|NCT02533258|528077665|FG000|Overall Study|Adverse Event|1|||
146428712|NCT02533258|528077665|FG000|Overall Study|Death|2|||
146428713|NCT02533258|528077665|FG000|Overall Study|Other|1|||
146428714|NCT02533258|528077665|FG000|Overall Study|Economic factor|1|||
146428715|NCT02533258|528077665|FG000|Overall Study|Progression of pleural effusion|1|||
146428716|NCT02533258|528077665|FG000|Overall Study|Lack of Efficacy|2|||
146428717|NCT03655106|528077666|FG000|Overall Study|Withdrawal by Subject|3|||
146428718|NCT03655106|528077667|FG001|Overall Study|Withdrawal by Subject|2|||
146428719|NCT03655106|528077666|FG000|Overall Study|Lost to Follow-up|2|||
146428720|NCT03655106|528077667|FG001|Overall Study|Lost to Follow-up|1|||
146428721|NCT03655106|528077666|FG000|Overall Study|Duplicate Enrollment|1|||
146428722|NCT03655106|528077667|FG001|Overall Study|Duplicate Enrollment|1|||
146428723|NCT03655106|528077666|FG000|Overall Study|Protocol Violation|3|||
146428724|NCT03655106|528077667|FG001|Overall Study|Protocol Violation|0|||
146428725|NCT01049334|528077669|FG000|Overall Study|Withdrawal by Subject|5|||
146428726|NCT01049334|528077670|FG001|Overall Study|Withdrawal by Subject|3|||
146428727|NCT01049334|528077669|FG000|Overall Study|Adverse Event|2|||
146428728|NCT01049334|528077670|FG001|Overall Study|Adverse Event|3|||
146428729|NCT01049334|528077669|FG000|Overall Study|Physician Decision|2|||
146428730|NCT01049334|528077670|FG001|Overall Study|Physician Decision|0|||
146428731|NCT01049334|528077669|FG000|Overall Study|Protocol Violation|0|||
146428732|NCT01049334|528077670|FG001|Overall Study|Protocol Violation|1|||
146428733|NCT01367457|528077673|FG000|Overall Study|Death|2|||
146428734|NCT01367457|528077674|FG001|Overall Study|Death|0|||
146428735|NCT01367457|528077675|FG002|Overall Study|Death|0|||
146428736|NCT01367457|528077673|FG000|Overall Study|Investigator's decision|2|||
146428737|NCT01367457|528077674|FG001|Overall Study|Investigator's decision|0|||
146428738|NCT01367457|528077675|FG002|Overall Study|Investigator's decision|0|||
146428739|NCT01367457|528077673|FG000|Overall Study|Clinical decline (CD)|2|||
146428740|NCT01367457|528077674|FG001|Overall Study|Clinical decline (CD)|0|||
146428741|NCT01367457|528077675|FG002|Overall Study|Clinical decline (CD)|0|||
146428742|NCT01367457|528077673|FG000|Overall Study|Progression and death|8|||
146428743|NCT01367457|528077674|FG001|Overall Study|Progression and death|0|||
146428744|NCT01367457|528077675|FG002|Overall Study|Progression and death|0|||
146428745|NCT01367457|528077673|FG000|Overall Study|Toxicity|16|||
146428746|NCT01367457|528077674|FG001|Overall Study|Toxicity|0|||
146428747|NCT01367457|528077675|FG002|Overall Study|Toxicity|0|||
146428748|NCT01367457|528077673|FG000|Overall Study|Progression|137|||
146428749|NCT01367457|528077674|FG001|Overall Study|Progression|0|||
146428750|NCT01367457|528077675|FG002|Overall Study|Progression|0|||
146428751|NCT01367457|528077673|FG000|Overall Study|Patient asks for rest + slow progression|1|||
146428752|NCT01367457|528077674|FG001|Overall Study|Patient asks for rest + slow progression|0|||
146428753|NCT01367457|528077675|FG002|Overall Study|Patient asks for rest + slow progression|0|||
146428754|NCT01367457|528077673|FG000|Overall Study|Investigator's opinion, stable disease|1|||
146428755|NCT01367457|528077674|FG001|Overall Study|Investigator's opinion, stable disease|0|||
146428756|NCT01367457|528077675|FG002|Overall Study|Investigator's opinion, stable disease|0|||
146428757|NCT01367457|528077673|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
146428758|NCT01367457|528077674|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
146428759|NCT01367457|528077675|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
146428760|NCT01367457|528077673|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
146428761|NCT01367457|528077674|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
146428762|NCT01367457|528077675|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
146428763|NCT01367457|528077673|FG000|Overall Study|low grade toxicities + stable disease|1|||
146428764|NCT01367457|528077674|FG001|Overall Study|low grade toxicities + stable disease|0|||
146428765|NCT01367457|528077675|FG002|Overall Study|low grade toxicities + stable disease|0|||
146428766|NCT01367457|528077673|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
146428767|NCT01367457|528077674|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
146428768|NCT01367457|528077675|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
146428769|NCT01367457|528077673|FG000|Overall Study|Withdrawal by Subject|1|||
146428770|NCT01367457|528077674|FG001|Overall Study|Withdrawal by Subject|0|||
146428771|NCT01367457|528077675|FG002|Overall Study|Withdrawal by Subject|0|||
146428772|NCT01367457|528077673|FG000|Overall Study|CD, associated leukaemia|1|||
146428773|NCT01367457|528077674|FG001|Overall Study|CD, associated leukaemia|0|||
146428774|NCT01367457|528077675|FG002|Overall Study|CD, associated leukaemia|0|||
146428775|NCT01367457|528077673|FG000|Overall Study|Uncontrolled pain|1|||
146428776|NCT01367457|528077674|FG001|Overall Study|Uncontrolled pain|0|||
146428777|NCT01367457|528077675|FG002|Overall Study|Uncontrolled pain|0|||
146428778|NCT01367457|528077673|FG000|Overall Study|Overall status worsens to grade 4|1|||
146428779|NCT01367457|528077674|FG001|Overall Study|Overall status worsens to grade 4|0|||
146428780|NCT01367457|528077675|FG002|Overall Study|Overall status worsens to grade 4|0|||
146428781|NCT01367457|528077673|FG000|Overall Study|Stabilisation + frequent infections|1|||
146428782|NCT01367457|528077674|FG001|Overall Study|Stabilisation + frequent infections|0|||
146428783|NCT01367457|528077675|FG002|Overall Study|Stabilisation + frequent infections|0|||
146428784|NCT01367457|528077673|FG000|Overall Study|No clinical benefit|1|||
146428785|NCT01367457|528077674|FG001|Overall Study|No clinical benefit|0|||
146428786|NCT01367457|528077675|FG002|Overall Study|No clinical benefit|0|||
146428787|NCT01367457|528077673|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
146428788|NCT01367457|528077674|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
146428789|NCT01367457|528077675|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
146428790|NCT01367457|528077673|FG000|Overall Study|Overall decline|1|||
145949864|NCT02815267|526328686|FG000|Double-Blind Phase|Received a disallowed medication|1|||
145949865|NCT02815267|526328687|FG001|Double-Blind Phase|Received a disallowed medication|1|||
145949866|NCT02815267|526328686|FG000|Open-Label Phase|Adverse Event|1|||
145949867|NCT02815267|526328687|FG001|Open-Label Phase|Adverse Event|1|||
145949868|NCT02815267|526328686|FG000|Open-Label Phase|Lost to Follow-up|23|||
145949869|NCT02815267|526328687|FG001|Open-Label Phase|Lost to Follow-up|9|||
146428791|NCT01367457|528077674|FG001|Overall Study|Overall decline|0|||
145949870|NCT02815267|526328686|FG000|Open-Label Phase|Withdrawal by Subject|24|||
146428792|NCT01367457|528077675|FG002|Overall Study|Overall decline|0|||
146428793|NCT01367457|528077673|FG000|Overall Study|Rejection of treatment|1|||
146428794|NCT01367457|528077674|FG001|Overall Study|Rejection of treatment|0|||
146428795|NCT01367457|528077675|FG002|Overall Study|Rejection of treatment|0|||
146428796|NCT01367457|528077673|FG000|Overall Study|Lost to Follow-up|1|||
146428797|NCT01367457|528077674|FG001|Overall Study|Lost to Follow-up|0|||
146428798|NCT01367457|528077675|FG002|Overall Study|Lost to Follow-up|0|||
146428799|NCT01367457|528077673|FG000|Overall Study|Death from septic shock|1|||
146428800|NCT01367457|528077674|FG001|Overall Study|Death from septic shock|0|||
146428801|NCT01367457|528077675|FG002|Overall Study|Death from septic shock|0|||
146428802|NCT01367457|528077673|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
146428803|NCT01367457|528077674|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
146428804|NCT01367457|528077675|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
146428805|NCT01367457|528077673|FG000|Overall Study|Patient's Wish|1|||
146428806|NCT01367457|528077674|FG001|Overall Study|Patient's Wish|0|||
146428807|NCT01367457|528077675|FG002|Overall Study|Patient's Wish|0|||
146428808|NCT01367457|528077673|FG000|Overall Study|Palliative. Overall decline|1|||
146428809|NCT01367457|528077674|FG001|Overall Study|Palliative. Overall decline|0|||
146428810|NCT01367457|528077675|FG002|Overall Study|Palliative. Overall decline|0|||
146428811|NCT01367457|528077673|FG000|Overall Study|Suspected DP/suspected active infection|1|||
146428812|NCT01367457|528077674|FG001|Overall Study|Suspected DP/suspected active infection|0|||
146428813|NCT01367457|528077675|FG002|Overall Study|Suspected DP/suspected active infection|0|||
146428814|NCT03447262|528077676|FG000|Overall Study|Adverse Event|7|||
146428815|NCT03447262|528077676|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146428816|NCT03447262|528077676|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
146428817|NCT03447262|528077676|FG000|Overall Study|Death|2|||
146428818|NCT03447262|528077676|FG000|Overall Study|Study Termination by Sponsor|455|||
146428819|NCT03447262|528077676|FG000|Overall Study|Other|4|||
146428820|NCT02058498|528077677|FG000|Overall Study|Withdrawal by Subject|4|||
146428821|NCT03988803|528077678|FG000|Period 2|Prematurely discontinued from medication|2|||
146428822|NCT03988803|528077678|FG000|Period 2|Adverse Event|1|||
146428823|NCT05038293|528077688|FG000|Overall Study|device was not operating properly for one subject.|1|||
146428824|NCT05038293|528077689|FG001|Overall Study|device was not operating properly for one subject.|0|||
146428825|NCT05038293|528077688|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
146428826|NCT05038293|528077689|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
146428827|NCT01171989|528077690|FG000|Overall Study|Lost to Follow-up|0|||
146428828|NCT01171989|528077691|FG001|Overall Study|Lost to Follow-up|0|||
146428829|NCT01171989|528077692|FG002|Overall Study|Lost to Follow-up|1|||
146428830|NCT02822235|528077693|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
146428831|NCT02822235|528077694|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
146428832|NCT02822235|528077693|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
146428833|NCT02822235|528077694|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
146428834|NCT02822235|528077693|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
146428835|NCT02822235|528077694|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
146428836|NCT02822235|528077693|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
146428837|NCT02822235|528077694|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
146428838|NCT02822235|528077693|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
146428839|NCT02822235|528077694|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
146428840|NCT02822235|528077693|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
146428841|NCT02822235|528077694|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
146428842|NCT00627016|528077695|FG000|Overall Study|Adverse Event|1|||
146428843|NCT00627016|528077696|FG001|Overall Study|Adverse Event|1|||
146428844|NCT00627016|528077695|FG000|Overall Study|Protocol Violation|0|||
146428845|NCT00627016|528077696|FG001|Overall Study|Protocol Violation|2|||
146200154|NCT00241644|527246237|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
146200155|NCT00241644|527246238|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
146200156|NCT00241644|527246239|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
146200157|NCT00241644|527246236|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
146200158|NCT00241644|527246237|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
146200159|NCT00241644|527246238|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
146200160|NCT00241644|527246239|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
146200161|NCT00241644|527246236|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
146200162|NCT00241644|527246237|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
146200163|NCT00241644|527246238|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
146200164|NCT00241644|527246239|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
146428846|NCT00627016|528077695|FG000|Overall Study|Lost to Follow-up|0|||
146200165|NCT00943735|527246240|FG000|Overall Study|Adverse Event|12|||
146428847|NCT00627016|528077696|FG001|Overall Study|Lost to Follow-up|1|||
146082827|NCT01451437|526822911|FG005|Overall Study|Physician Decision|0|||
146082828|NCT01451437|526822912|FG006|Overall Study|Physician Decision|0|||
146082829|NCT01451437|526822913|FG007|Overall Study|Physician Decision|0|||
146082830|NCT01451437|526822914|FG008|Overall Study|Physician Decision|0|||
146428848|NCT00627016|528077695|FG000|Overall Study|Withdrawal by Subject|2|||
146428849|NCT00627016|528077696|FG001|Overall Study|Withdrawal by Subject|1|||
146428850|NCT00627016|528077695|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146200166|NCT00943735|527246240|FG000|Overall Study|Withdrawal by Subject|8|||
146200167|NCT00943735|527246240|FG000|Overall Study|Death|1|||
146200168|NCT00943735|527246240|FG000|Overall Study|Other|8|||
146200169|NCT00943735|527246240|FG000|Overall Study|Other|3|||
146200170|NCT00486330|527246241|FG000|Overall Study|Adverse Event|2|||
146200171|NCT03804918|527246242|FG000|Overall Study|Participant did not use the app|1|||
146200172|NCT00813904|527246243|FG000|Overall Study|Death|1|||
146200173|NCT01087762|527246244|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
146200174|NCT01087762|527246245|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146200175|NCT01087762|527246246|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
146200176|NCT01087762|527246247|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146200177|NCT01087762|527246248|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
146200178|NCT01087762|527246244|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
146200179|NCT01087762|527246245|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146200180|NCT01087762|527246246|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
146428851|NCT00627016|528077696|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
146428852|NCT00627016|528077695|FG000|Overall Study|Lack of Efficacy|1|||
146428853|NCT00627016|528077696|FG001|Overall Study|Lack of Efficacy|0|||
146428854|NCT00627016|528077695|FG000|Overall Study|Placed on Excluded Drugs|1|||
146428855|NCT00627016|528077696|FG001|Overall Study|Placed on Excluded Drugs|0|||
146428856|NCT00627016|528077695|FG000|Overall Study|Pregnancy|1|||
146200181|NCT01087762|527246247|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146200182|NCT01087762|527246248|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
146200183|NCT01087762|527246244|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
146200184|NCT01087762|527246245|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
146200185|NCT01087762|527246246|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
146200186|NCT01087762|527246247|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
146200187|NCT01087762|527246248|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
146200188|NCT01087762|527246244|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
146200189|NCT01087762|527246245|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
146428857|NCT00627016|528077696|FG001|Overall Study|Pregnancy|0|||
146428858|NCT00829530|528077697|FG000|First Intervention|Adverse Event|0|||
146200190|NCT01087762|527246246|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
146200191|NCT01087762|527246247|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
146200192|NCT01087762|527246248|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
146200193|NCT01087762|527246244|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
146200194|NCT01087762|527246245|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
146200195|NCT01087762|527246246|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
146200196|NCT01087762|527246247|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
146200197|NCT01087762|527246248|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
146200198|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146200199|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146200200|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
146200201|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
146200202|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
146200203|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146200204|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146200205|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
146200206|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
146200207|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
146200208|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146200209|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146200210|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
146200211|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
146200212|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
146428859|NCT00829530|528077698|FG001|First Intervention|Adverse Event|1|||
146428860|NCT00829530|528077697|FG000|First Intervention|Intolerance to Venopuncture|0|||
146200213|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146200214|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146428861|NCT00829530|528077698|FG001|First Intervention|Intolerance to Venopuncture|1|||
146428862|NCT00829530|528077697|FG000|Second Intervention|Intolerance to Venopuncture|1|||
146428863|NCT00829530|528077698|FG001|Second Intervention|Intolerance to Venopuncture|0|||
146428864|NCT02511782|528077707|FG000|Overall Study|Withdrawal by Subject|1|||
146428865|NCT02511782|528077708|FG001|Overall Study|Withdrawal by Subject|0|||
146428866|NCT02511782|528077709|FG002|Overall Study|Withdrawal by Subject|0|||
146428867|NCT00112463|528077712|FG000|Overall Study|Physician Decision|1|||
146428868|NCT00112463|528077712|FG000|Overall Study|Progression|30|||
146428869|NCT00112463|528077712|FG000|Overall Study|Second Primary|1|||
146428870|NCT00112463|528077712|FG000|Overall Study|Toxicity|3|||
146428871|NCT00112463|528077712|FG000|Overall Study|Withdrawal by Subject|2|||
146428872|NCT00112463|528077712|FG000|Overall Study|Never started treatment|2|||
146200215|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
146200216|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
146200217|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
146200218|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
146200219|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
146200220|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
146200221|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
146200222|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
146200223|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146200224|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146200225|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
146200226|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
146200227|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
146200228|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146200229|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146200230|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
146200231|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
146200232|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
146200233|NCT01087762|527246244|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146200234|NCT01087762|527246245|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146200235|NCT01087762|527246246|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
146200236|NCT01087762|527246247|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
146200237|NCT01087762|527246248|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
146200238|NCT01405924|527246249|FG000|Overall Study|Protocol Violation|8|||
146200239|NCT01405924|527246249|FG000|Overall Study|Missing/Incomplete Data|2|||
146428873|NCT01171963|528077713|FG000|Overall Study|Adverse Event|10|||
146428874|NCT01171963|528077714|FG001|Overall Study|Adverse Event|15|||
145949871|NCT02815267|526328687|FG001|Open-Label Phase|Withdrawal by Subject|13|||
145949872|NCT02815267|526328686|FG000|Open-Label Phase|Protocol Violation|0|||
145949873|NCT02815267|526328687|FG001|Open-Label Phase|Protocol Violation|1|||
145949874|NCT02815267|526328686|FG000|Open-Label Phase|Administrative|21|||
145949875|NCT02815267|526328687|FG001|Open-Label Phase|Administrative|12|||
145949876|NCT02815267|526328686|FG000|Open-Label Phase|Other|2|||
145949877|NCT02815267|526328687|FG001|Open-Label Phase|Other|5|||
145949878|NCT01108237|526328688|FG000|Overall Study|No alignment data|2|||
145949879|NCT01108237|526328689|FG001|Overall Study|No alignment data|15|||
145949880|NCT01108237|526328688|FG000|Overall Study|Did not meet criteria for analysis|7|||
145949881|NCT01108237|526328689|FG001|Overall Study|Did not meet criteria for analysis|0|||
146428875|NCT01171963|528077713|FG000|Overall Study|Lost to Follow-up|23|||
146428876|NCT01171963|528077714|FG001|Overall Study|Lost to Follow-up|24|||
146428877|NCT01171963|528077713|FG000|Overall Study|Other - diarrhoea|1|||
146428878|NCT01171963|528077714|FG001|Overall Study|Other - diarrhoea|0|||
145949882|NCT02178358|526328694|FG000|Overall Study|Withdrawal by Subject|0|||
146428879|NCT01171963|528077713|FG000|Overall Study|Withdrawal by Subject|114|||
146200240|NCT02506257|527246250|FG000|Overall Study|Adverse Event|0|||
146200241|NCT02506257|527246251|FG001|Overall Study|Adverse Event|2|||
146200242|NCT02506257|527246252|FG002|Overall Study|Adverse Event|3|||
146428880|NCT01171963|528077714|FG001|Overall Study|Withdrawal by Subject|129|||
145949883|NCT02178358|526328695|FG001|Overall Study|Withdrawal by Subject|2|||
146428881|NCT05093205|528077715|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
146428882|NCT05093205|528077716|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
146428883|NCT05093205|528077717|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
146428884|NCT05093205|528077718|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
146428885|NCT05093205|528077719|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
146428886|NCT05093205|528077720|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
146428887|NCT05093205|528077721|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
146428888|NCT05093205|528077722|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
146428889|NCT05093205|528077723|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
146428890|NCT05093205|528077724|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
146428891|NCT05093205|528077725|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
146428892|NCT05093205|528077726|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
146428893|NCT05093205|528077727|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
146428894|NCT05093205|528077715|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428895|NCT05093205|528077716|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428896|NCT05093205|528077717|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
146428897|NCT05093205|528077718|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428898|NCT05093205|528077719|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428899|NCT05093205|528077720|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428900|NCT05093205|528077721|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428901|NCT05093205|528077722|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428902|NCT05093205|528077723|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428903|NCT05093205|528077724|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428904|NCT05093205|528077725|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428905|NCT05093205|528077726|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146200243|NCT02506257|527246253|FG003|Overall Study|Adverse Event|0|||
145949884|NCT02178358|526328696|FG002|Overall Study|Withdrawal by Subject|2|||
146200244|NCT02506257|527246250|FG000|Overall Study|Protocol Violation|0|||
146428906|NCT05093205|528077727|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
146428907|NCT05093205|528077715|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
146428908|NCT05093205|528077716|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
146200245|NCT02506257|527246251|FG001|Overall Study|Protocol Violation|0|||
146200246|NCT02506257|527246252|FG002|Overall Study|Protocol Violation|1|||
146200247|NCT02506257|527246253|FG003|Overall Study|Protocol Violation|0|||
146200248|NCT01924767|527246256|FG000|Overall Study|Adverse Event|1|||
146200249|NCT01924767|527246257|FG001|Overall Study|Adverse Event|0|||
146200250|NCT01924767|527246258|FG002|Overall Study|Adverse Event|1|||
146200251|NCT01924767|527246259|FG003|Overall Study|Adverse Event|0|||
146200252|NCT01924767|527246260|FG004|Overall Study|Adverse Event|0|||
146200253|NCT01193153|527246261|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
146200254|NCT01193153|527246262|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
146200255|NCT01193153|527246261|FG000|Open-label Lead in Period|Pregnancy|1|||
146200256|NCT01193153|527246262|FG001|Open-label Lead in Period|Pregnancy|0|||
146200257|NCT01193153|527246261|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
146200258|NCT01193153|527246262|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
146200259|NCT01193153|527246261|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
146200260|NCT01193153|527246262|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
146200261|NCT01193153|527246261|FG000|Open-label Lead in Period|Other|14|||
146200262|NCT01193153|527246262|FG001|Open-label Lead in Period|Other|0|||
146200263|NCT01193153|527246261|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
146200264|NCT01193153|527246262|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
146428909|NCT05093205|528077717|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
146428910|NCT05093205|528077718|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
146428911|NCT05093205|528077719|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
146428912|NCT05093205|528077720|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
146428913|NCT05093205|528077721|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
146428914|NCT05093205|528077722|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
146428915|NCT05093205|528077723|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
146428916|NCT05093205|528077724|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
146428917|NCT05093205|528077725|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
146428918|NCT05093205|528077726|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
146200265|NCT01193153|527246261|FG000|Open-label Lead in Period|Adverse Event|41|||
146200266|NCT01193153|527246262|FG001|Open-label Lead in Period|Adverse Event|0|||
146200267|NCT01193153|527246261|FG000|Open-label Lead in Period|Death|1|||
146200268|NCT01193153|527246262|FG001|Open-label Lead in Period|Death|0|||
146200269|NCT01193153|527246261|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
146200270|NCT01193153|527246262|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
146200271|NCT01193153|527246261|FG000|Open-label Stabilization Period|Adverse Event|9|||
146200272|NCT01193153|527246262|FG001|Open-label Stabilization Period|Adverse Event|0|||
146200273|NCT01193153|527246261|FG000|Open-label Stabilization Period|Death|2|||
146200274|NCT01193153|527246262|FG001|Open-label Stabilization Period|Death|0|||
146200275|NCT01193153|527246261|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
146200276|NCT01193153|527246262|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
146200277|NCT01193153|527246261|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
146200278|NCT01193153|527246262|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
146200279|NCT01193153|527246261|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
146200280|NCT01193153|527246262|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
146200281|NCT01193153|527246261|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
146200282|NCT01193153|527246262|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
146200283|NCT01193153|527246261|FG000|Open-label Stabilization Period|Other|8|||
146200284|NCT01193153|527246262|FG001|Open-label Stabilization Period|Other|0|||
146428919|NCT05093205|528077727|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
146428920|NCT05093205|528077715|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
146428921|NCT05093205|528077716|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
146428922|NCT05093205|528077717|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
146428923|NCT05093205|528077718|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
146428924|NCT05093205|528077719|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
146428925|NCT05093205|528077720|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
146428926|NCT05093205|528077721|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
146428927|NCT05093205|528077722|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
146428928|NCT05093205|528077723|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
146428929|NCT05093205|528077724|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
146428930|NCT05093205|528077725|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
146428931|NCT05093205|528077726|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
146428932|NCT05093205|528077727|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
146428933|NCT05093205|528077715|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
146428934|NCT05093205|528077716|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
146428935|NCT05093205|528077717|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
146428936|NCT05093205|528077718|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
146428937|NCT05093205|528077719|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
146428938|NCT05093205|528077720|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
146428939|NCT05093205|528077721|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
146428940|NCT05093205|528077722|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
146428941|NCT05093205|528077723|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
146200285|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Other|2|||
146200286|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Other|3|||
146200287|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
146200288|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
146200289|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Death|2|||
146428942|NCT05093205|528077724|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
146428943|NCT05093205|528077725|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
146428944|NCT05093205|528077726|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
146428945|NCT05093205|528077727|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
146428946|NCT05093205|528077715|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
146428947|NCT05093205|528077716|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
146428948|NCT05093205|528077717|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
146200290|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Death|0|||
146200291|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
146428949|NCT05093205|528077718|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
146428950|NCT05093205|528077719|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
146428951|NCT05093205|528077720|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
146428952|NCT05093205|528077721|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
146428953|NCT05093205|528077722|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
146428954|NCT05093205|528077723|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
146428955|NCT05093205|528077724|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
146428956|NCT05093205|528077725|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
146200292|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
146200293|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
146200294|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
146200295|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
146200296|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
146200297|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
146200298|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
146200299|NCT01193153|527246261|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
146200300|NCT01193153|527246262|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
146428957|NCT05093205|528077726|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
146428958|NCT05093205|528077727|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
146428959|NCT05093205|528077715|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
146428960|NCT05093205|528077716|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
145949885|NCT02178358|526328694|FG000|Overall Study|Lost to Follow-up|1|||
145949886|NCT02178358|526328695|FG001|Overall Study|Lost to Follow-up|0|||
145949887|NCT02178358|526328696|FG002|Overall Study|Lost to Follow-up|0|||
145949888|NCT00790556|526328697|FG000|Treatment Period 1|Physician Decision|1|||
145949889|NCT00790556|526328698|FG001|Treatment Period 1|Physician Decision|0|||
145949890|NCT00790556|526328697|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145949891|NCT00790556|526328698|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145949892|NCT00339833|526328701|FG000|Overall Study|Withdrawal by Subject|1|||
145949893|NCT00339833|526328702|FG001|Overall Study|Withdrawal by Subject|2|||
145949894|NCT00339833|526328701|FG000|Overall Study|toothache|0|||
145949895|NCT00339833|526328702|FG001|Overall Study|toothache|1|||
145949896|NCT00339833|526328701|FG000|Overall Study|indigestion|0|||
145949897|NCT00339833|526328702|FG001|Overall Study|indigestion|1|||
146200301|NCT01988233|527246265|FG000|Overall Study|Lost to Follow-up|64|||
146200302|NCT01988233|527246266|FG001|Overall Study|Lost to Follow-up|51|||
146428961|NCT05093205|528077717|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
146428962|NCT05093205|528077718|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
145949898|NCT00339833|526328701|FG000|Overall Study|Chest pain|0|||
145949899|NCT00339833|526328702|FG001|Overall Study|Chest pain|1|||
145949900|NCT00339833|526328701|FG000|Overall Study|minor infection|0|||
145949901|NCT00339833|526328702|FG001|Overall Study|minor infection|1|||
146200303|NCT03781336|527246271|FG000|Overall Study|Withdrawal by Subject|2|||
146200304|NCT03781336|527246272|FG001|Overall Study|Withdrawal by Subject|2|||
146200305|NCT03987451|527246273|FG000|Overall Study|Lost to Follow-up|1|||
146200306|NCT03987451|527246274|FG001|Overall Study|Lost to Follow-up|0|||
146200307|NCT03987451|527246273|FG000|Overall Study|Withdrawal by Subject|1|||
146200308|NCT03987451|527246274|FG001|Overall Study|Withdrawal by Subject|1|||
146200309|NCT01183780|527246275|FG000|Overall Study|Withdrawal by Subject|25|||
146200310|NCT01183780|527246276|FG001|Overall Study|Withdrawal by Subject|14|||
146200311|NCT01183780|527246275|FG000|Overall Study|Lost to Follow-up|6|||
146200312|NCT01183780|527246276|FG001|Overall Study|Lost to Follow-up|11|||
146200313|NCT00770965|527246277|FG000|Safety Set|Withdrawal by Subject|0|||
146200314|NCT00770965|527246278|FG001|Safety Set|Withdrawal by Subject|0|||
146200315|NCT00770965|527246279|FG002|Safety Set|Withdrawal by Subject|0|||
146200316|NCT00770965|527246280|FG003|Safety Set|Withdrawal by Subject|1|||
146200317|NCT00770965|527246277|FG000|Safety Set|Protocol deviation|0|||
146200318|NCT00770965|527246278|FG001|Safety Set|Protocol deviation|0|||
146200319|NCT00770965|527246279|FG002|Safety Set|Protocol deviation|1|||
146200320|NCT00770965|527246280|FG003|Safety Set|Protocol deviation|0|||
146200321|NCT00770965|527246277|FG000|Excluded Set|Administrative problems|14|||
146200322|NCT00770965|527246278|FG001|Excluded Set|Administrative problems|12|||
146200323|NCT00770965|527246279|FG002|Excluded Set|Administrative problems|12|||
146200324|NCT00770965|527246280|FG003|Excluded Set|Administrative problems|10|||
146200325|NCT00770965|527246277|FG000|Excluded Set|Withdrawal by Subject|1|||
146200326|NCT00770965|527246278|FG001|Excluded Set|Withdrawal by Subject|1|||
146200327|NCT00770965|527246279|FG002|Excluded Set|Withdrawal by Subject|2|||
146200328|NCT00770965|527246280|FG003|Excluded Set|Withdrawal by Subject|3|||
146200329|NCT00790790|527246293|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
146200330|NCT00790790|527246294|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
146200331|NCT00790790|527246295|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
146200332|NCT00790790|527246293|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
146200333|NCT00790790|527246294|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
146200334|NCT00790790|527246295|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
146200335|NCT00790790|527246293|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
146200336|NCT00790790|527246294|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
146200337|NCT00790790|527246295|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
146200338|NCT00790790|527246293|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
146200339|NCT00790790|527246294|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146200340|NCT00790790|527246295|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
146200341|NCT00790790|527246293|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
146200342|NCT00790790|527246294|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
146200343|NCT00790790|527246295|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
146200344|NCT02808338|527246296|FG000|Screening|Screen Failure|10|||
146200345|NCT02808338|527246296|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
146428963|NCT05093205|528077719|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
146428964|NCT05093205|528077720|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
146428965|NCT05093205|528077721|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
146428966|NCT05093205|528077722|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
146428967|NCT05093205|528077723|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
146428968|NCT05093205|528077724|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
146428969|NCT05093205|528077725|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
146428970|NCT05093205|528077726|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
146428971|NCT05093205|528077727|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
146428972|NCT05093205|528077715|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
146428973|NCT05093205|528077716|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
146428974|NCT05093205|528077717|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
146428975|NCT05093205|528077718|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
146428976|NCT05093205|528077719|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
146428977|NCT05093205|528077720|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
146428978|NCT05093205|528077721|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
146428979|NCT05093205|528077722|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
146428980|NCT05093205|528077723|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
146200346|NCT02808338|527246296|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
146428981|NCT05093205|528077724|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
146428982|NCT05093205|528077725|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
146428983|NCT05093205|528077726|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
146200347|NCT02194933|527246297|FG000|Overall Study|Lost to Follow-up|1|||
146200348|NCT02194933|527246298|FG001|Overall Study|Lost to Follow-up|2|||
146200349|NCT02194933|527246297|FG000|Overall Study|Participant met withdrawal criteria|1|||
146200350|NCT02194933|527246298|FG001|Overall Study|Participant met withdrawal criteria|3|||
146200351|NCT02194933|527246297|FG000|Overall Study|Withdrawal by Subject|0|||
146200352|NCT02194933|527246298|FG001|Overall Study|Withdrawal by Subject|2|||
146200353|NCT02194933|527246297|FG000|Overall Study|Lack of Efficacy|1|||
146428984|NCT05093205|528077727|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
146428985|NCT05093205|528077715|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428986|NCT05093205|528077716|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146200354|NCT02194933|527246298|FG001|Overall Study|Lack of Efficacy|2|||
146200355|NCT00756730|527246301|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
146200356|NCT00756730|527246302|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
146200357|NCT00756730|527246301|FG000|Overall Study|persistent low-level viremmia|0|||
146200358|NCT00756730|527246302|FG001|Overall Study|persistent low-level viremmia|1|||
146200359|NCT03383146|527246304|FG000|Overall Study|Screen Failure|1|||
146200360|NCT03383146|527246305|FG001|Overall Study|Screen Failure|0|||
146200361|NCT03383146|527246304|FG000|Overall Study|Adverse Event|6|||
146200362|NCT03383146|527246305|FG001|Overall Study|Adverse Event|18|||
146200363|NCT03383146|527246304|FG000|Overall Study|Lack of Efficacy|0|||
146200364|NCT03383146|527246305|FG001|Overall Study|Lack of Efficacy|3|||
146200365|NCT03383146|527246304|FG000|Overall Study|Withdrawal by Subject|20|||
146200366|NCT03383146|527246305|FG001|Overall Study|Withdrawal by Subject|36|||
146200367|NCT03383146|527246304|FG000|Overall Study|Lost to Follow-up|5|||
146200368|NCT03383146|527246305|FG001|Overall Study|Lost to Follow-up|15|||
146200369|NCT03383146|527246304|FG000|Overall Study|Death|0|||
146200370|NCT03383146|527246305|FG001|Overall Study|Death|2|||
146200371|NCT03383146|527246304|FG000|Overall Study|Physician Decision|0|||
146200372|NCT03383146|527246305|FG001|Overall Study|Physician Decision|1|||
146200373|NCT03383146|527246304|FG000|Overall Study|Protocol Deviation|1|||
146200374|NCT03383146|527246305|FG001|Overall Study|Protocol Deviation|8|||
146200375|NCT03383146|527246304|FG000|Overall Study|Study Terminated by the Sponsor|48|||
146200376|NCT03383146|527246305|FG001|Overall Study|Study Terminated by the Sponsor|95|||
146200377|NCT03383146|527246304|FG000|Overall Study|Reason not Specified|4|||
146428987|NCT05093205|528077717|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428988|NCT05093205|528077718|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428989|NCT05093205|528077719|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428990|NCT05093205|528077720|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428991|NCT05093205|528077721|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428992|NCT05093205|528077722|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428993|NCT05093205|528077723|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428994|NCT05093205|528077724|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
146428995|NCT05093205|528077725|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428996|NCT05093205|528077726|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146200378|NCT03383146|527246305|FG001|Overall Study|Reason not Specified|6|||
146200379|NCT05382104|527246306|FG000|Period 2 (2 Days)|Adverse Event|0|||
146200380|NCT05382104|527246307|FG001|Period 2 (2 Days)|Adverse Event|1|||
146200381|NCT05382104|527246308|FG002|Period 2 (2 Days)|Adverse Event|0|||
146200382|NCT05382104|527246309|FG003|Period 2 (2 Days)|Adverse Event|0|||
146200383|NCT05382104|527246310|FG004|Period 2 (2 Days)|Adverse Event|0|||
146200384|NCT05382104|527246311|FG005|Period 2 (2 Days)|Adverse Event|0|||
146428997|NCT05093205|528077727|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
146428998|NCT05093205|528077715|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
146428999|NCT05093205|528077716|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
146429000|NCT05093205|528077717|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
146429001|NCT05093205|528077718|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
145949902|NCT00339833|526328701|FG000|Overall Study|Poor venous access|2|||
145949903|NCT00339833|526328702|FG001|Overall Study|Poor venous access|2|||
145949904|NCT00339833|526328701|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
145949905|NCT00339833|526328702|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
145949906|NCT00339833|526328701|FG000|Overall Study|Error in data records|1|||
145949907|NCT00339833|526328702|FG001|Overall Study|Error in data records|0|||
146200385|NCT00639002|527246312|FG000|Overall Study|Death|1|||
146200386|NCT00639002|527246312|FG000|Overall Study|Adverse Event|1|||
146200387|NCT00639002|527246312|FG000|Overall Study|Protocol Violation|1|||
146200388|NCT00639002|527246312|FG000|Overall Study|Disease progression|3|||
146200389|NCT00639002|527246312|FG000|Overall Study|Physician Decision|6|||
146200390|NCT00639002|527246312|FG000|Overall Study|Lack of Efficacy|1|||
146200391|NCT01317420|527246318|FG000|Overall Study|Progressive disease according to RECIST|2|||
146200392|NCT01317420|527246319|FG001|Overall Study|Progressive disease according to RECIST|3|||
146200393|NCT01317420|527246320|FG002|Overall Study|Progressive disease according to RECIST|3|||
146200394|NCT01317420|527246321|FG003|Overall Study|Progressive disease according to RECIST|3|||
146200395|NCT01317420|527246322|FG004|Overall Study|Progressive disease according to RECIST|3|||
146429002|NCT05093205|528077719|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
146429003|NCT05093205|528077720|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
146200396|NCT01317420|527246323|FG005|Overall Study|Progressive disease according to RECIST|3|||
146200397|NCT01317420|527246324|FG006|Overall Study|Progressive disease according to RECIST|3|||
146200398|NCT01317420|527246325|FG007|Overall Study|Progressive disease according to RECIST|3|||
146200399|NCT01317420|527246326|FG008|Overall Study|Progressive disease according to RECIST|3|||
146200400|NCT01317420|527246327|FG009|Overall Study|Progressive disease according to RECIST|2|||
146200401|NCT01317420|527246328|FG010|Overall Study|Progressive disease according to RECIST|3|||
146200402|NCT01317420|527246329|FG011|Overall Study|Progressive disease according to RECIST|11|||
145949908|NCT00217581|526328703|FG000|Overall Study|Withdrawal by Subject|1|||
146200403|NCT01317420|527246330|FG012|Overall Study|Progressive disease according to RECIST|16|||
146200404|NCT01317420|527246318|FG000|Overall Study|Other adverse event|1|||
146200405|NCT01317420|527246319|FG001|Overall Study|Other adverse event|0|||
146200406|NCT01317420|527246320|FG002|Overall Study|Other adverse event|0|||
146200407|NCT01317420|527246321|FG003|Overall Study|Other adverse event|0|||
146200408|NCT01317420|527246322|FG004|Overall Study|Other adverse event|0|||
146200409|NCT01317420|527246323|FG005|Overall Study|Other adverse event|0|||
146200410|NCT01317420|527246324|FG006|Overall Study|Other adverse event|0|||
146200411|NCT01317420|527246325|FG007|Overall Study|Other adverse event|0|||
146200412|NCT01317420|527246326|FG008|Overall Study|Other adverse event|0|||
146200413|NCT01317420|527246327|FG009|Overall Study|Other adverse event|0|||
146200414|NCT01317420|527246328|FG010|Overall Study|Other adverse event|0|||
146200415|NCT01317420|527246329|FG011|Overall Study|Other adverse event|0|||
146200416|NCT01317420|527246330|FG012|Overall Study|Other adverse event|2|||
146200417|NCT01317420|527246318|FG000|Overall Study|Non-compliant with protocol|0|||
146200418|NCT01317420|527246319|FG001|Overall Study|Non-compliant with protocol|0|||
146200419|NCT01317420|527246320|FG002|Overall Study|Non-compliant with protocol|0|||
146200420|NCT01317420|527246321|FG003|Overall Study|Non-compliant with protocol|0|||
146200421|NCT01317420|527246322|FG004|Overall Study|Non-compliant with protocol|0|||
146200422|NCT01317420|527246323|FG005|Overall Study|Non-compliant with protocol|0|||
146200423|NCT01317420|527246324|FG006|Overall Study|Non-compliant with protocol|0|||
146200424|NCT01317420|527246325|FG007|Overall Study|Non-compliant with protocol|0|||
146200425|NCT01317420|527246326|FG008|Overall Study|Non-compliant with protocol|0|||
146200426|NCT01317420|527246327|FG009|Overall Study|Non-compliant with protocol|0|||
146200427|NCT01317420|527246328|FG010|Overall Study|Non-compliant with protocol|0|||
146200428|NCT01317420|527246329|FG011|Overall Study|Non-compliant with protocol|0|||
146200429|NCT01317420|527246330|FG012|Overall Study|Non-compliant with protocol|1|||
146200430|NCT01317420|527246318|FG000|Overall Study|Refused to cont. taking trial medication|0|||
146200431|NCT01317420|527246319|FG001|Overall Study|Refused to cont. taking trial medication|0|||
146200432|NCT01317420|527246320|FG002|Overall Study|Refused to cont. taking trial medication|0|||
146200433|NCT01317420|527246321|FG003|Overall Study|Refused to cont. taking trial medication|0|||
146200434|NCT01317420|527246322|FG004|Overall Study|Refused to cont. taking trial medication|0|||
146200435|NCT01317420|527246323|FG005|Overall Study|Refused to cont. taking trial medication|0|||
146200436|NCT01317420|527246324|FG006|Overall Study|Refused to cont. taking trial medication|0|||
146200437|NCT01317420|527246325|FG007|Overall Study|Refused to cont. taking trial medication|0|||
146200438|NCT01317420|527246326|FG008|Overall Study|Refused to cont. taking trial medication|0|||
146200439|NCT01317420|527246327|FG009|Overall Study|Refused to cont. taking trial medication|0|||
146200440|NCT01317420|527246328|FG010|Overall Study|Refused to cont. taking trial medication|0|||
146200441|NCT01317420|527246329|FG011|Overall Study|Refused to cont. taking trial medication|0|||
146200442|NCT01317420|527246330|FG012|Overall Study|Refused to cont. taking trial medication|1|||
146200443|NCT01317420|527246318|FG000|Overall Study|Reason other than those specified|0|||
146200444|NCT01317420|527246319|FG001|Overall Study|Reason other than those specified|0|||
146200445|NCT01317420|527246320|FG002|Overall Study|Reason other than those specified|0|||
146200446|NCT01317420|527246321|FG003|Overall Study|Reason other than those specified|0|||
146200447|NCT01317420|527246322|FG004|Overall Study|Reason other than those specified|0|||
146200448|NCT01317420|527246323|FG005|Overall Study|Reason other than those specified|0|||
146200449|NCT01317420|527246324|FG006|Overall Study|Reason other than those specified|0|||
146200450|NCT01317420|527246325|FG007|Overall Study|Reason other than those specified|0|||
146200451|NCT01317420|527246326|FG008|Overall Study|Reason other than those specified|0|||
146200452|NCT01317420|527246327|FG009|Overall Study|Reason other than those specified|1|||
146200453|NCT01317420|527246328|FG010|Overall Study|Reason other than those specified|0|||
146200454|NCT01317420|527246329|FG011|Overall Study|Reason other than those specified|0|||
146200455|NCT01317420|527246330|FG012|Overall Study|Reason other than those specified|0|||
146200456|NCT05686421|527246331|FG000|Overall Study|Screen failure|22|||
146200457|NCT05686421|527246332|FG001|Overall Study|Screen failure|0|||
146200458|NCT05686421|527246333|FG002|Overall Study|Screen failure|0|||
146200459|NCT05686421|527246334|FG003|Overall Study|Screen failure|0|||
146200460|NCT05082025|527246335|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
146200461|NCT00857649|527246336|FG000|Overall Study|Adverse Event|15|||
146200462|NCT00857649|527246337|FG001|Overall Study|Adverse Event|10|||
146200463|NCT00857649|527246336|FG000|Overall Study|Non-compliance|1|||
146200464|NCT00857649|527246337|FG001|Overall Study|Non-compliance|1|||
146200465|NCT00857649|527246336|FG000|Overall Study|Protocol Violation|2|||
146200466|NCT00857649|527246337|FG001|Overall Study|Protocol Violation|2|||
146200467|NCT00857649|527246336|FG000|Overall Study|Withdrawal of Consent|10|||
146200468|NCT00857649|527246337|FG001|Overall Study|Withdrawal of Consent|7|||
146200469|NCT00857649|527246336|FG000|Overall Study|Nursing Home Placement|2|||
146200470|NCT00857649|527246337|FG001|Overall Study|Nursing Home Placement|9|||
146200471|NCT00857649|527246336|FG000|Overall Study|Other Reasons|1|||
146200472|NCT00857649|527246337|FG001|Overall Study|Other Reasons|3|||
146200473|NCT05190419|527246340|FG000|Overall Study|Lack of Efficacy|8|||
146200474|NCT05190419|527246341|FG001|Overall Study|Lack of Efficacy|0|||
146200475|NCT05190419|527246342|FG002|Overall Study|Lack of Efficacy|1|||
146200476|NCT05190419|527246343|FG003|Overall Study|Lack of Efficacy|0|||
146200477|NCT05190419|527246340|FG000|Overall Study|Withdrawal by Subject|7|||
146200478|NCT05190419|527246341|FG001|Overall Study|Withdrawal by Subject|1|||
146200479|NCT05190419|527246342|FG002|Overall Study|Withdrawal by Subject|2|||
146200480|NCT05190419|527246343|FG003|Overall Study|Withdrawal by Subject|2|||
146200481|NCT05190419|527246340|FG000|Overall Study|Adverse Event|2|||
146200482|NCT05190419|527246341|FG001|Overall Study|Adverse Event|10|||
146200483|NCT05190419|527246342|FG002|Overall Study|Adverse Event|11|||
146200484|NCT05190419|527246343|FG003|Overall Study|Adverse Event|21|||
146200485|NCT05190419|527246340|FG000|Overall Study|Lost to Follow-up|1|||
146200486|NCT05190419|527246341|FG001|Overall Study|Lost to Follow-up|2|||
146200487|NCT05190419|527246342|FG002|Overall Study|Lost to Follow-up|3|||
146200488|NCT05190419|527246343|FG003|Overall Study|Lost to Follow-up|1|||
146200489|NCT05190419|527246340|FG000|Overall Study|Other|1|||
146200490|NCT05190419|527246341|FG001|Overall Study|Other|1|||
146200491|NCT05190419|527246342|FG002|Overall Study|Other|0|||
146200492|NCT05190419|527246343|FG003|Overall Study|Other|3|||
146200493|NCT00367055|527246344|FG000|Overall Study|Adverse Event|6|||
146200494|NCT00367055|527246345|FG001|Overall Study|Adverse Event|3|||
146200495|NCT00367055|527246344|FG000|Overall Study|Patient's Willing|3|||
146200496|NCT00367055|527246345|FG001|Overall Study|Patient's Willing|2|||
146200497|NCT00367055|527246344|FG000|Overall Study|Lack of Efficacy|1|||
146200498|NCT00367055|527246345|FG001|Overall Study|Lack of Efficacy|2|||
146200499|NCT00367055|527246344|FG000|Overall Study|Lost to Follow-up|1|||
146200500|NCT00367055|527246345|FG001|Overall Study|Lost to Follow-up|1|||
146200501|NCT00367055|527246344|FG000|Overall Study|Protocol Violation|0|||
146200502|NCT00367055|527246345|FG001|Overall Study|Protocol Violation|1|||
146200503|NCT00367055|527246344|FG000|Overall Study|Stopping Criterion Met|0|||
146200504|NCT00367055|527246345|FG001|Overall Study|Stopping Criterion Met|1|||
146200505|NCT00367055|527246344|FG000|Overall Study|Participant Living too Far from Hospital|0|||
146200506|NCT00367055|527246345|FG001|Overall Study|Participant Living too Far from Hospital|1|||
146200507|NCT03210402|527246346|FG000|Overall Study|Withdrawal by Subject|0|||
146200508|NCT03210402|527246347|FG001|Overall Study|Withdrawal by Subject|1|||
146200509|NCT02517307|527246362|FG000|Overall Study|Withdrawal by Subject|1|||
146200510|NCT02517307|527246363|FG001|Overall Study|Withdrawal by Subject|0|||
146200511|NCT02517307|527246364|FG002|Overall Study|Withdrawal by Subject|1|||
146200512|NCT02517307|527246365|FG003|Overall Study|Withdrawal by Subject|0|||
146200513|NCT02517307|527246362|FG000|Overall Study|Protocol Violation|0|||
146200514|NCT02517307|527246363|FG001|Overall Study|Protocol Violation|0|||
146200515|NCT02517307|527246364|FG002|Overall Study|Protocol Violation|1|||
146200516|NCT02517307|527246365|FG003|Overall Study|Protocol Violation|1|||
146200517|NCT03586544|527246366|FG000|First Intervention|Adverse Event|0|||
146200518|NCT03586544|527246367|FG001|First Intervention|Adverse Event|1|||
146200519|NCT03586544|527246366|FG000|Second Intervention|Withdrawal by Subject|0|||
146200520|NCT03586544|527246367|FG001|Second Intervention|Withdrawal by Subject|1|||
146200521|NCT03863834|527246371|FG000|Overall Study|Lost to Follow-up|3|||
146200522|NCT02770248|527246373|FG000|Overall Study|Adverse Event|0|||
146200523|NCT02770248|527246374|FG001|Overall Study|Adverse Event|1|||
146200524|NCT02770248|527246373|FG000|Overall Study|Randomized in error, prior to treatment|0|||
146200525|NCT02770248|527246374|FG001|Overall Study|Randomized in error, prior to treatment|1|||
146200526|NCT01837641|527246375|FG000|Overall Study|Sponsor decision|1|||
146200527|NCT01837641|527246376|FG001|Overall Study|Sponsor decision|0|||
146200528|NCT01837641|527246377|FG002|Overall Study|Sponsor decision|0|||
146200529|NCT01837641|527246378|FG003|Overall Study|Sponsor decision|0|||
146200530|NCT01837641|527246379|FG004|Overall Study|Sponsor decision|0|||
146200531|NCT01837641|527246380|FG005|Overall Study|Sponsor decision|1|||
146200532|NCT01837641|527246381|FG006|Overall Study|Sponsor decision|0|||
146200533|NCT01837641|527246382|FG007|Overall Study|Sponsor decision|0|||
146200534|NCT01837641|527246375|FG000|Overall Study|Adverse Event|0|||
146200535|NCT01837641|527246376|FG001|Overall Study|Adverse Event|0|||
146200536|NCT01837641|527246377|FG002|Overall Study|Adverse Event|0|||
145949909|NCT02829047|526328704|FG000|Overall Study|Withdrawal by Subject|1|||
145949910|NCT01597492|526328705|FG000|Overall Study|Withdrawal by Subject|1|||
146200537|NCT01837641|527246378|FG003|Overall Study|Adverse Event|0|||
146200538|NCT01837641|527246379|FG004|Overall Study|Adverse Event|0|||
146200539|NCT01837641|527246380|FG005|Overall Study|Adverse Event|1|||
146200540|NCT01837641|527246381|FG006|Overall Study|Adverse Event|0|||
146200541|NCT01837641|527246382|FG007|Overall Study|Adverse Event|0|||
146200542|NCT01837641|527246375|FG000|Overall Study|Withdrawal by Subject|0|||
146200543|NCT01837641|527246376|FG001|Overall Study|Withdrawal by Subject|0|||
146200544|NCT01837641|527246377|FG002|Overall Study|Withdrawal by Subject|0|||
146200545|NCT01837641|527246378|FG003|Overall Study|Withdrawal by Subject|0|||
146200546|NCT01837641|527246379|FG004|Overall Study|Withdrawal by Subject|1|||
146200547|NCT01837641|527246380|FG005|Overall Study|Withdrawal by Subject|0|||
146200548|NCT01837641|527246381|FG006|Overall Study|Withdrawal by Subject|1|||
146200549|NCT01837641|527246382|FG007|Overall Study|Withdrawal by Subject|0|||
146200550|NCT01579916|527246383|FG000|Overall Study|Lost to Follow-up|6|||
146200551|NCT01579916|527246384|FG001|Overall Study|Lost to Follow-up|1|||
146200552|NCT01579916|527246383|FG000|Overall Study|Withdrawal by Subject|1|||
146200553|NCT01579916|527246384|FG001|Overall Study|Withdrawal by Subject|1|||
146200554|NCT01579916|527246383|FG000|Overall Study|Death|1|||
146200555|NCT01579916|527246384|FG001|Overall Study|Death|0|||
146200556|NCT03264456|527246385|FG000|Overall Study|Withdrawal by Subject|3|||
146200557|NCT03264456|527246385|FG000|Overall Study|Lost to Follow-up|1|||
146200558|NCT01123083|527246388|FG000|Overall Study|Investigator recommendation|1|||
146200559|NCT01123083|527246389|FG001|Overall Study|Investigator recommendation|1|||
146200560|NCT01123083|527246388|FG000|Overall Study|Administrative reasons|0|||
146200561|NCT01123083|527246389|FG001|Overall Study|Administrative reasons|4|||
146200562|NCT01123083|527246388|FG000|Overall Study|Lost to Follow-up|2|||
146200563|NCT01123083|527246389|FG001|Overall Study|Lost to Follow-up|6|||
146200564|NCT01123083|527246388|FG000|Overall Study|Adverse Event|1|||
146200565|NCT01123083|527246389|FG001|Overall Study|Adverse Event|0|||
146200566|NCT01123083|527246388|FG000|Overall Study|Withdrew for another reason not covered|0|||
146200567|NCT01123083|527246389|FG001|Overall Study|Withdrew for another reason not covered|1|||
146200568|NCT01123083|527246388|FG000|Overall Study|Participant/legal representative request|7|||
146200569|NCT01123083|527246389|FG001|Overall Study|Participant/legal representative request|3|||
146200570|NCT00961636|527246390|FG000|Overall Study|Adverse Event|35|||
146200571|NCT00961636|527246391|FG001|Overall Study|Adverse Event|54|||
146200572|NCT00961636|527246392|FG002|Overall Study|Adverse Event|13|||
146200573|NCT00961636|527246390|FG000|Overall Study|Flushing Symptoms|29|||
146200574|NCT00961636|527246391|FG001|Overall Study|Flushing Symptoms|46|||
146200575|NCT00961636|527246392|FG002|Overall Study|Flushing Symptoms|3|||
146200576|NCT00961636|527246390|FG000|Overall Study|Lost to Follow-up|2|||
146200577|NCT00961636|527246391|FG001|Overall Study|Lost to Follow-up|3|||
146200578|NCT00961636|527246392|FG002|Overall Study|Lost to Follow-up|1|||
146200579|NCT00961636|527246390|FG000|Overall Study|Physician Decision|3|||
146200580|NCT00961636|527246391|FG001|Overall Study|Physician Decision|1|||
146200581|NCT00961636|527246392|FG002|Overall Study|Physician Decision|1|||
146200582|NCT00961636|527246390|FG000|Overall Study|Protocol Violation|9|||
146200583|NCT00961636|527246391|FG001|Overall Study|Protocol Violation|5|||
146200584|NCT00961636|527246392|FG002|Overall Study|Protocol Violation|1|||
146200585|NCT00961636|527246390|FG000|Overall Study|Withdrawal by Subject|29|||
146200586|NCT00961636|527246391|FG001|Overall Study|Withdrawal by Subject|22|||
146200587|NCT00961636|527246392|FG002|Overall Study|Withdrawal by Subject|13|||
146200588|NCT02486588|527246395|FG000|Overall Study|Randomized in error- ineligible|738|||
146200589|NCT02486588|527246396|FG001|Overall Study|Randomized in error- ineligible|750|||
146200590|NCT02486588|527246397|FG002|Overall Study|Randomized in error- ineligible|755|||
146200591|NCT02486588|527246398|FG003|Overall Study|Randomized in error- ineligible|738|||
146200592|NCT02486588|527246399|FG004|Overall Study|Randomized in error- ineligible|746|||
146200593|NCT02486588|527246400|FG005|Overall Study|Randomized in error- ineligible|746|||
146200594|NCT02551055|527246403|FG000|Overall Study|Death|2|||
146200595|NCT02551055|527246404|FG001|Overall Study|Death|4|||
146200596|NCT02551055|527246405|FG002|Overall Study|Death|2|||
146200597|NCT02551055|527246406|FG003|Overall Study|Death|2|||
146200598|NCT02551055|527246407|FG004|Overall Study|Death|2|||
146200599|NCT02551055|527246408|FG005|Overall Study|Death|1|||
146200600|NCT02551055|527246409|FG006|Overall Study|Death|2|||
146200601|NCT02551055|527246410|FG007|Overall Study|Death|0|||
146200602|NCT02551055|527246403|FG000|Overall Study|Study Terminated by Sponsor|1|||
146200603|NCT02551055|527246404|FG001|Overall Study|Study Terminated by Sponsor|1|||
146200604|NCT02551055|527246405|FG002|Overall Study|Study Terminated by Sponsor|0|||
146200605|NCT02551055|527246406|FG003|Overall Study|Study Terminated by Sponsor|2|||
146200606|NCT02551055|527246407|FG004|Overall Study|Study Terminated by Sponsor|2|||
146200607|NCT02551055|527246408|FG005|Overall Study|Study Terminated by Sponsor|0|||
146200608|NCT02551055|527246409|FG006|Overall Study|Study Terminated by Sponsor|0|||
146200609|NCT02551055|527246410|FG007|Overall Study|Study Terminated by Sponsor|0|||
146200610|NCT02551055|527246403|FG000|Overall Study|Withdrawal by Subject|1|||
146200611|NCT02551055|527246404|FG001|Overall Study|Withdrawal by Subject|1|||
146200612|NCT02551055|527246405|FG002|Overall Study|Withdrawal by Subject|0|||
146200613|NCT02551055|527246406|FG003|Overall Study|Withdrawal by Subject|1|||
146200614|NCT02551055|527246407|FG004|Overall Study|Withdrawal by Subject|2|||
146200615|NCT02551055|527246408|FG005|Overall Study|Withdrawal by Subject|0|||
146200616|NCT02551055|527246409|FG006|Overall Study|Withdrawal by Subject|0|||
146200617|NCT02551055|527246410|FG007|Overall Study|Withdrawal by Subject|0|||
146200618|NCT02551055|527246403|FG000|Overall Study|Reason not specified|0|||
146200619|NCT02551055|527246404|FG001|Overall Study|Reason not specified|0|||
146200620|NCT02551055|527246405|FG002|Overall Study|Reason not specified|0|||
146200621|NCT02551055|527246406|FG003|Overall Study|Reason not specified|0|||
146200622|NCT02551055|527246407|FG004|Overall Study|Reason not specified|1|||
146200623|NCT02551055|527246408|FG005|Overall Study|Reason not specified|0|||
146200624|NCT02551055|527246409|FG006|Overall Study|Reason not specified|1|||
146200625|NCT02551055|527246410|FG007|Overall Study|Reason not specified|0|||
146200626|NCT00430300|527246411|FG000|Overall Study|Adverse Event|0|||
146200627|NCT00430300|527246412|FG001|Overall Study|Adverse Event|2|||
146200628|NCT00430300|527246413|FG002|Overall Study|Adverse Event|1|||
146200629|NCT00430300|527246414|FG003|Overall Study|Adverse Event|1|||
146200630|NCT00430300|527246411|FG000|Overall Study|Withdrawal by Subject|1|||
146200631|NCT00430300|527246412|FG001|Overall Study|Withdrawal by Subject|0|||
146200632|NCT00430300|527246413|FG002|Overall Study|Withdrawal by Subject|5|||
146200633|NCT00430300|527246414|FG003|Overall Study|Withdrawal by Subject|0|||
146200634|NCT00430300|527246411|FG000|Overall Study|Laboratory abnormality|1|||
146200635|NCT00430300|527246412|FG001|Overall Study|Laboratory abnormality|0|||
146200636|NCT00430300|527246413|FG002|Overall Study|Laboratory abnormality|0|||
146200637|NCT00430300|527246414|FG003|Overall Study|Laboratory abnormality|0|||
146200638|NCT00430300|527246411|FG000|Overall Study|Other|0|||
146200639|NCT00430300|527246412|FG001|Overall Study|Other|0|||
146200640|NCT00430300|527246413|FG002|Overall Study|Other|0|||
146200641|NCT00430300|527246414|FG003|Overall Study|Other|1|||
146200642|NCT02041104|527246417|FG000|Overall Study|Lost to Follow-up|1|||
146200643|NCT02041104|527246418|FG001|Overall Study|Lost to Follow-up|4|||
146200644|NCT02041104|527246417|FG000|Overall Study|discomfort during OGTT|0|||
146200645|NCT02041104|527246418|FG001|Overall Study|discomfort during OGTT|3|||
146200646|NCT00546871|527246419|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
146200647|NCT00546871|527246420|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
146200648|NCT00546871|527246419|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
146200649|NCT00546871|527246420|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
146200650|NCT00546871|527246419|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
146200651|NCT00546871|527246420|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
146200652|NCT00546871|527246419|FG000|Study Extension Period|Protocol Violation|1|||
146200653|NCT00546871|527246420|FG001|Study Extension Period|Protocol Violation|0|||
146200654|NCT00546871|527246419|FG000|Study Extension Period|Withdrawal by Subject|0|||
146200655|NCT00546871|527246420|FG001|Study Extension Period|Withdrawal by Subject|1|||
146200656|NCT01713946|527246421|FG000|Overall Study|Death|0|||
146200657|NCT01713946|527246422|FG001|Overall Study|Death|2|||
146200658|NCT01713946|527246423|FG002|Overall Study|Death|2|||
146200659|NCT01713946|527246421|FG000|Overall Study|Adverse Event|19|||
146200660|NCT01713946|527246422|FG001|Overall Study|Adverse Event|14|||
146200661|NCT01713946|527246423|FG002|Overall Study|Adverse Event|13|||
146200662|NCT01713946|527246421|FG000|Overall Study|Withdrawal by Subject|12|||
146200663|NCT01713946|527246422|FG001|Overall Study|Withdrawal by Subject|12|||
146200664|NCT01713946|527246423|FG002|Overall Study|Withdrawal by Subject|8|||
146200665|NCT01713946|527246421|FG000|Overall Study|Lack of Efficacy|8|||
146200666|NCT01713946|527246422|FG001|Overall Study|Lack of Efficacy|8|||
146200667|NCT01713946|527246423|FG002|Overall Study|Lack of Efficacy|14|||
146200668|NCT01713946|527246421|FG000|Overall Study|Protocol Violation|2|||
146200669|NCT01713946|527246422|FG001|Overall Study|Protocol Violation|4|||
146200670|NCT01713946|527246423|FG002|Overall Study|Protocol Violation|1|||
146200671|NCT01713946|527246421|FG000|Overall Study|Lost to Follow-up|0|||
146200672|NCT01713946|527246422|FG001|Overall Study|Lost to Follow-up|0|||
146200673|NCT01713946|527246423|FG002|Overall Study|Lost to Follow-up|1|||
146200674|NCT01713946|527246421|FG000|Overall Study|Administrative problems|1|||
146200675|NCT01713946|527246422|FG001|Overall Study|Administrative problems|0|||
146200676|NCT01713946|527246423|FG002|Overall Study|Administrative problems|0|||
146200677|NCT01713946|527246421|FG000|Overall Study|Did not continue in Ext|0|||
146200678|NCT01713946|527246422|FG001|Overall Study|Did not continue in Ext|3|||
146200679|NCT01713946|527246423|FG002|Overall Study|Did not continue in Ext|0|||
146200680|NCT01713946|527246421|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
146200681|NCT01713946|527246422|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
146200682|NCT01713946|527246423|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
146200683|NCT01713946|527246421|FG000|Overall Study|Patients never switched to everolimus|0|||
146200684|NCT01713946|527246422|FG001|Overall Study|Patients never switched to everolimus|0|||
146200685|NCT01713946|527246423|FG002|Overall Study|Patients never switched to everolimus|5|||
146200686|NCT04722003|527248255|FG000|Overall Study|Lost to Follow-up|2|||
146200687|NCT04722003|527248256|FG001|Overall Study|Lost to Follow-up|0|||
146200688|NCT04722003|527248255|FG000|Overall Study|Physician Decision|1|||
146200689|NCT04722003|527248256|FG001|Overall Study|Physician Decision|0|||
146200690|NCT03351075|527248257|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
146200691|NCT03351075|527248258|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
146200692|NCT03351075|527248257|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
146200693|NCT03351075|527248258|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
146200694|NCT03351075|527248257|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
146200695|NCT03351075|527248258|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
146200696|NCT03351075|527248257|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
146200697|NCT03351075|527248258|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
146200698|NCT03175172|527248259|FG000|Overall Study|Death|3|||
146200699|NCT03175172|527248259|FG000|Overall Study|Withdrawal by Subject|3|||
146200700|NCT03175172|527248259|FG000|Overall Study|Lost to Follow-up|1|||
146200701|NCT03175172|527248259|FG000|Overall Study|Study Terminated by Sponsor|3|||
146200702|NCT03169244|527248260|FG000|Overall Study|Lost to Follow-up|1|||
146200703|NCT03169244|527248261|FG001|Overall Study|Lost to Follow-up|2|||
146200704|NCT03169244|527248260|FG000|Overall Study|Adverse Event|1|||
146200705|NCT03169244|527248261|FG001|Overall Study|Adverse Event|0|||
146200706|NCT03169244|527248260|FG000|Overall Study|Withdrawal by Subject|2|||
146200707|NCT03169244|527248261|FG001|Overall Study|Withdrawal by Subject|2|||
146200708|NCT03169244|527248260|FG000|Overall Study|Physician Decision|1|||
146200709|NCT03169244|527248261|FG001|Overall Study|Physician Decision|0|||
146200710|NCT02027558|527248264|FG000|Overall Study|Death|0|||
146200711|NCT02027558|527248265|FG001|Overall Study|Death|1|||
146200712|NCT02027558|527248264|FG000|Overall Study|Withdrawal by Subject|2|||
146200713|NCT02027558|527248265|FG001|Overall Study|Withdrawal by Subject|0|||
146200714|NCT02027558|527248264|FG000|Overall Study|Lost to Follow-up|4|||
146200715|NCT02027558|527248265|FG001|Overall Study|Lost to Follow-up|1|||
146200716|NCT02027558|527248264|FG000|Overall Study|Refused assessment|3|||
146200717|NCT02027558|527248265|FG001|Overall Study|Refused assessment|0|||
146200718|NCT00114244|527248270|FG000|Overall Study|Adverse Event|2|||
146200719|NCT00114244|527248271|FG001|Overall Study|Adverse Event|5|||
146200720|NCT00114244|527248270|FG000|Overall Study|Withdrawal by Subject|0|||
146200721|NCT00114244|527248271|FG001|Overall Study|Withdrawal by Subject|2|||
146200722|NCT02694978|527248272|FG000|Overall Study|Adverse Event|10|||
146200723|NCT02694978|527248273|FG001|Overall Study|Adverse Event|9|||
146200724|NCT02694978|527248272|FG000|Overall Study|Withdrawal by Subject|22|||
146200725|NCT02694978|527248273|FG001|Overall Study|Withdrawal by Subject|19|||
146200726|NCT02694978|527248272|FG000|Overall Study|Lost to Follow-up|14|||
146200727|NCT02694978|527248273|FG001|Overall Study|Lost to Follow-up|17|||
146200728|NCT02694978|527248272|FG000|Overall Study|Death|4|||
146200729|NCT02694978|527248273|FG001|Overall Study|Death|1|||
146200730|NCT02694978|527248272|FG000|Overall Study|Other-Decision of Participant|6|||
146200731|NCT02694978|527248273|FG001|Overall Study|Other-Decision of Participant|1|||
146200732|NCT02694978|527248272|FG000|Overall Study|Other-Investigator's decision|1|||
146200733|NCT02694978|527248273|FG001|Overall Study|Other-Investigator's decision|0|||
146200734|NCT02694978|527248272|FG000|Overall Study|Other-Unable to be reached|0|||
146200735|NCT02694978|527248273|FG001|Overall Study|Other-Unable to be reached|1|||
146200736|NCT02694978|527248272|FG000|Overall Study|Other-Protocol noncompliant|2|||
146200737|NCT02694978|527248273|FG001|Overall Study|Other-Protocol noncompliant|1|||
146200738|NCT02694978|527248272|FG000|Overall Study|Other-Personal reasons|3|||
146200739|NCT02694978|527248273|FG001|Overall Study|Other-Personal reasons|3|||
146200740|NCT02694978|527248272|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
146200741|NCT02694978|527248273|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
146200742|NCT01613716|527248274|FG000|Overall Study|screen failures|3|||
146200743|NCT01613716|527248274|FG000|Overall Study|Lost to Follow-up|4|||
146200744|NCT03262935|527248276|FG000|Overall Study|Withdrawal by Subject|6|||
146200745|NCT03262935|527248277|FG001|Overall Study|Withdrawal by Subject|7|||
146200746|NCT03262935|527248276|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
146200747|NCT03262935|527248277|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
146200748|NCT03262935|527248276|FG000|Overall Study|Death|181|||
146200749|NCT03262935|527248277|FG001|Overall Study|Death|94|||
146200750|NCT03262935|527248276|FG000|Overall Study|Lost to Follow-up|9|||
146200751|NCT03262935|527248277|FG001|Overall Study|Lost to Follow-up|4|||
146200752|NCT03262935|527248276|FG000|Overall Study|Other reason|5|||
146200753|NCT03262935|527248277|FG001|Overall Study|Other reason|0|||
146200754|NCT00743444|527248280|FG000|First Intervention|Catheter placement problems|0|||
146200755|NCT00743444|527248281|FG001|First Intervention|Catheter placement problems|1|||
146200756|NCT00743444|527248280|FG000|Washout Period|Adverse Event|0|||
146200757|NCT00743444|527248281|FG001|Washout Period|Adverse Event|1|||
146200758|NCT02567656|527248284|FG000|Overall Study|Premature discontinuation due to PD|1|||
146200759|NCT02567656|527248285|FG001|Overall Study|Premature discontinuation due to PD|1|||
146200760|NCT02567656|527248286|FG002|Overall Study|Premature discontinuation due to PD|2|||
146200761|NCT02567656|527248287|FG003|Overall Study|Premature discontinuation due to PD|0|||
146200762|NCT02567656|527248288|FG004|Overall Study|Premature discontinuation due to PD|0|||
146200763|NCT02567656|527248289|FG005|Overall Study|Premature discontinuation due to PD|0|||
146200764|NCT03287622|527248290|FG000|Overall Study|Withdrawal by Subject|1|||
146200765|NCT03287622|527248291|FG001|Overall Study|Withdrawal by Subject|0|||
146200766|NCT03287622|527248290|FG000|Overall Study|Lost to Follow-up|27|||
146200767|NCT03287622|527248291|FG001|Overall Study|Lost to Follow-up|15|||
146200768|NCT03287622|527248290|FG000|Overall Study|No prescripion after surgery|28|||
146200769|NCT03287622|527248291|FG001|Overall Study|No prescripion after surgery|31|||
146200770|NCT03287622|527248290|FG000|Overall Study|prolonged Length of stay|2|||
146200771|NCT03287622|527248291|FG001|Overall Study|prolonged Length of stay|0|||
146200772|NCT03287622|527248290|FG000|Overall Study|surgery related|0|||
146200773|NCT03287622|527248291|FG001|Overall Study|surgery related|2|||
146200774|NCT03622580|527248294|FG000|Overall Study|Death|16|||
146200775|NCT03622580|527248295|FG001|Overall Study|Death|21|||
146200776|NCT03622580|527248296|FG002|Overall Study|Death|13|||
146200777|NCT03622580|527248294|FG000|Overall Study|Adverse Event|6|||
146200778|NCT03622580|527248295|FG001|Overall Study|Adverse Event|6|||
146200779|NCT03622580|527248296|FG002|Overall Study|Adverse Event|5|||
146200780|NCT03622580|527248294|FG000|Overall Study|Withdrawal by Subject|12|||
146200781|NCT03622580|527248295|FG001|Overall Study|Withdrawal by Subject|7|||
146200782|NCT03622580|527248296|FG002|Overall Study|Withdrawal by Subject|19|||
146200783|NCT03622580|527248294|FG000|Overall Study|Lost to Follow-up|12|||
146200784|NCT03622580|527248295|FG001|Overall Study|Lost to Follow-up|9|||
146200785|NCT03622580|527248296|FG002|Overall Study|Lost to Follow-up|9|||
146200786|NCT03622580|527248294|FG000|Overall Study|Protocol Violation|1|||
146200787|NCT03622580|527248295|FG001|Overall Study|Protocol Violation|0|||
146200788|NCT03622580|527248296|FG002|Overall Study|Protocol Violation|1|||
146200789|NCT03622580|527248294|FG000|Overall Study|Physician Decision|3|||
146200790|NCT03622580|527248295|FG001|Overall Study|Physician Decision|0|||
146200791|NCT03622580|527248296|FG002|Overall Study|Physician Decision|1|||
146200792|NCT03622580|527248294|FG000|Overall Study|Pregnancy|0|||
146429004|NCT05093205|528077721|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
146429005|NCT05093205|528077722|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
146082831|NCT01451437|526822906|FG000|Overall Study|Disease Progression|0|||
146200793|NCT03622580|527248295|FG001|Overall Study|Pregnancy|1|||
146200794|NCT03622580|527248296|FG002|Overall Study|Pregnancy|0|||
146200795|NCT03622580|527248294|FG000|Overall Study|Lack of Efficacy|0|||
146200796|NCT03622580|527248295|FG001|Overall Study|Lack of Efficacy|0|||
146200797|NCT03622580|527248296|FG002|Overall Study|Lack of Efficacy|1|||
146200798|NCT03622580|527248294|FG000|Overall Study|Other|2|||
146200799|NCT03622580|527248295|FG001|Overall Study|Other|0|||
146200800|NCT03622580|527248296|FG002|Overall Study|Other|3|||
146429006|NCT05093205|528077723|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
146429007|NCT05093205|528077724|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
146429008|NCT05093205|528077725|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
146200801|NCT01930045|527248299|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146200802|NCT01930045|527248300|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146200803|NCT01930045|527248301|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146200804|NCT01930045|527248302|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146200805|NCT01930045|527248303|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
146200806|NCT01930045|527248304|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
146200807|NCT01930045|527248299|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
146200808|NCT01930045|527248300|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
146200809|NCT01930045|527248301|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
146200810|NCT01930045|527248302|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
146200811|NCT01930045|527248303|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
146200812|NCT01930045|527248304|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
146200813|NCT01563354|527248307|FG000|Core Phase|Adverse Event|5|||
146200814|NCT01563354|527248308|FG001|Core Phase|Adverse Event|15|||
146200815|NCT01563354|527248309|FG002|Core Phase|Adverse Event|13|||
146200816|NCT01563354|527248307|FG000|Core Phase|Withdrawal by Subject|1|||
146200817|NCT01563354|527248308|FG001|Core Phase|Withdrawal by Subject|0|||
146200818|NCT01563354|527248309|FG002|Core Phase|Withdrawal by Subject|3|||
146200819|NCT01563354|527248307|FG000|Core Phase|Lost to Follow-up|1|||
146200820|NCT01563354|527248308|FG001|Core Phase|Lost to Follow-up|0|||
146200821|NCT01563354|527248309|FG002|Core Phase|Lost to Follow-up|0|||
146429009|NCT05093205|528077726|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
146429010|NCT05093205|528077727|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
146429011|NCT05093205|528077715|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429012|NCT05093205|528077716|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429013|NCT05093205|528077717|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429014|NCT05093205|528077718|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429015|NCT05093205|528077719|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429016|NCT05093205|528077720|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429017|NCT05093205|528077721|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429018|NCT05093205|528077722|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429019|NCT05093205|528077723|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429020|NCT05093205|528077724|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429021|NCT05093205|528077725|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
146429022|NCT05093205|528077726|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429023|NCT05093205|528077727|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
146429024|NCT05093205|528077715|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429025|NCT05093205|528077716|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146200822|NCT01563354|527248307|FG000|Core Phase|Death|1|||
146200823|NCT01563354|527248308|FG001|Core Phase|Death|5|||
146200824|NCT01563354|527248309|FG002|Core Phase|Death|2|||
146200825|NCT01563354|527248307|FG000|Core Phase|Diseasse progression|18|||
146200826|NCT01563354|527248308|FG001|Core Phase|Diseasse progression|7|||
146200827|NCT01563354|527248309|FG002|Core Phase|Diseasse progression|8|||
146200828|NCT01563354|527248307|FG000|Core Phase|Protocol deviation|2|||
146200829|NCT01563354|527248308|FG001|Core Phase|Protocol deviation|0|||
146200830|NCT01563354|527248309|FG002|Core Phase|Protocol deviation|0|||
146200831|NCT01563354|527248307|FG000|Core Phase|PI decision - did not enter extension|0|||
146200832|NCT01563354|527248308|FG001|Core Phase|PI decision - did not enter extension|1|||
146200833|NCT01563354|527248309|FG002|Core Phase|PI decision - did not enter extension|0|||
146200834|NCT01563354|527248307|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
146200835|NCT01563354|527248308|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
146200836|NCT01563354|527248309|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
146200837|NCT01563354|527248307|FG000|Extension Phase|Adverse Event|0|||
146200838|NCT01563354|527248308|FG001|Extension Phase|Adverse Event|3|||
146200839|NCT01563354|527248309|FG002|Extension Phase|Adverse Event|2|||
146200840|NCT01563354|527248307|FG000|Extension Phase|Withdrawal by Subject|0|||
146200841|NCT01563354|527248308|FG001|Extension Phase|Withdrawal by Subject|1|||
146200842|NCT01563354|527248309|FG002|Extension Phase|Withdrawal by Subject|0|||
146200843|NCT01563354|527248307|FG000|Extension Phase|Administration problems|3|||
146200844|NCT01563354|527248308|FG001|Extension Phase|Administration problems|2|||
146200845|NCT01563354|527248309|FG002|Extension Phase|Administration problems|3|||
146200846|NCT01563354|527248307|FG000|Extension Phase|Disease progression|9|||
146200847|NCT01563354|527248308|FG001|Extension Phase|Disease progression|8|||
146200848|NCT01563354|527248309|FG002|Extension Phase|Disease progression|10|||
146429026|NCT05093205|528077717|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146200849|NCT03621761|527248311|FG000|Overall Study|Lost to Follow-up|1|||
146200850|NCT03621761|527248312|FG001|Overall Study|Lost to Follow-up|1|||
146429027|NCT05093205|528077718|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146200851|NCT03621761|527248313|FG002|Overall Study|Lost to Follow-up|2|||
146200852|NCT03621761|527248311|FG000|Overall Study|Withdrawal by Subject|2|||
146200853|NCT03621761|527248312|FG001|Overall Study|Withdrawal by Subject|1|||
146200854|NCT03621761|527248313|FG002|Overall Study|Withdrawal by Subject|1|||
146429028|NCT05093205|528077719|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146200855|NCT03621761|527248311|FG000|Overall Study|Became Ineligible|0|||
146200856|NCT03621761|527248312|FG001|Overall Study|Became Ineligible|2|||
146200857|NCT03621761|527248313|FG002|Overall Study|Became Ineligible|0|||
146200858|NCT01050569|527248314|FG000|Overall Study|Lost to Follow-up|20|||
146200859|NCT01050569|527248315|FG001|Overall Study|Lost to Follow-up|14|||
146200860|NCT01050569|527248316|FG002|Overall Study|Lost to Follow-up|16|||
146200861|NCT01050569|527248314|FG000|Overall Study|Withdrawal by Subject|9|||
146200862|NCT01050569|527248315|FG001|Overall Study|Withdrawal by Subject|3|||
146200863|NCT01050569|527248316|FG002|Overall Study|Withdrawal by Subject|11|||
146200864|NCT01050569|527248314|FG000|Overall Study|Lack of Efficacy|5|||
146200865|NCT01050569|527248315|FG001|Overall Study|Lack of Efficacy|4|||
146200866|NCT01050569|527248316|FG002|Overall Study|Lack of Efficacy|3|||
146200867|NCT01050569|527248314|FG000|Overall Study|Adverse Event|1|||
146200868|NCT01050569|527248315|FG001|Overall Study|Adverse Event|0|||
146200869|NCT01050569|527248316|FG002|Overall Study|Adverse Event|0|||
146200870|NCT01050569|527248314|FG000|Overall Study|Physician Decision|3|||
146200871|NCT01050569|527248315|FG001|Overall Study|Physician Decision|3|||
146200872|NCT01050569|527248316|FG002|Overall Study|Physician Decision|3|||
146200873|NCT02441036|527248321|FG000|Overall Study|No tissue resected|0|||
146200874|NCT02441036|527248322|FG001|Overall Study|No tissue resected|1|||
146200875|NCT02441036|527248323|FG002|Overall Study|No tissue resected|0|||
146200876|NCT02441036|527248324|FG003|Overall Study|No tissue resected|1|||
146200877|NCT02441036|527248325|FG004|Overall Study|No tissue resected|0|||
146200878|NCT00612586|527248328|FG000|Overall Study|Adverse Event|6|||
146200879|NCT00612586|527248329|FG001|Overall Study|Adverse Event|2|||
146200880|NCT00612586|527248328|FG000|Overall Study|Death|1|||
146200881|NCT00612586|527248329|FG001|Overall Study|Death|0|||
146200882|NCT00612586|527248328|FG000|Overall Study|Entry Criteria Not Met|0|||
146200883|NCT00612586|527248329|FG001|Overall Study|Entry Criteria Not Met|2|||
146200884|NCT00612586|527248328|FG000|Overall Study|Withdrawal by Subject|7|||
146200885|NCT00612586|527248329|FG001|Overall Study|Withdrawal by Subject|9|||
146200886|NCT00612586|527248328|FG000|Overall Study|Physician Decision|1|||
146200887|NCT00612586|527248329|FG001|Overall Study|Physician Decision|2|||
146200888|NCT00612586|527248328|FG000|Overall Study|Sponsor Decision|1|||
146200889|NCT00612586|527248329|FG001|Overall Study|Sponsor Decision|1|||
146200890|NCT00612586|527248328|FG000|Overall Study|Progressive Disease|26|||
146200891|NCT00612586|527248329|FG001|Overall Study|Progressive Disease|24|||
146200892|NCT00612586|527248328|FG000|Overall Study|Randomized and Not Treated|1|||
146200893|NCT00612586|527248329|FG001|Overall Study|Randomized and Not Treated|1|||
146200894|NCT01194154|527248330|FG000|Overall Study|Adverse Event|12|||
146200895|NCT01194154|527248331|FG001|Overall Study|Adverse Event|7|||
146200896|NCT01194154|527248330|FG000|Overall Study|Lost to Follow-up|2|||
146200897|NCT01194154|527248331|FG001|Overall Study|Lost to Follow-up|3|||
146200898|NCT01194154|527248330|FG000|Overall Study|Protocol Violation|0|||
146200899|NCT01194154|527248331|FG001|Overall Study|Protocol Violation|1|||
146200900|NCT01194154|527248330|FG000|Overall Study|Withdrawal by Subject|5|||
146200901|NCT01194154|527248331|FG001|Overall Study|Withdrawal by Subject|6|||
146200902|NCT01194154|527248330|FG000|Overall Study|Blood pressure increase|5|||
146200903|NCT01194154|527248331|FG001|Overall Study|Blood pressure increase|3|||
146200904|NCT01194154|527248330|FG000|Overall Study|Hemoglobin decrease|0|||
146200905|NCT01194154|527248331|FG001|Overall Study|Hemoglobin decrease|1|||
146200906|NCT01194154|527248330|FG000|Overall Study|Hemoglobin increase|12|||
146200907|NCT01194154|527248331|FG001|Overall Study|Hemoglobin increase|3|||
146200908|NCT01194154|527248330|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
146200909|NCT01194154|527248331|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
146200910|NCT01194154|527248330|FG000|Overall Study|Treatment with prohibited medication|4|||
146200911|NCT01194154|527248331|FG001|Overall Study|Treatment with prohibited medication|5|||
146200912|NCT01194154|527248330|FG000|Overall Study|Other|4|||
146200913|NCT01194154|527248331|FG001|Overall Study|Other|0|||
146200914|NCT01194154|527248330|FG000|Overall Study|Did not receive study medication|2|||
146200915|NCT01194154|527248331|FG001|Overall Study|Did not receive study medication|4|||
146200916|NCT01505881|527248332|FG000|Overall Study|Adverse Event|0|||
146200917|NCT01505881|527248333|FG001|Overall Study|Adverse Event|1|||
146200918|NCT01505881|527248332|FG000|Overall Study|Lost to Follow-up|2|||
146200919|NCT01505881|527248333|FG001|Overall Study|Lost to Follow-up|0|||
146200920|NCT01505881|527248332|FG000|Overall Study|Withdrawal by Subject|2|||
146200921|NCT01505881|527248333|FG001|Overall Study|Withdrawal by Subject|0|||
146200922|NCT01596504|527248334|FG000|Overall Study|Participant's Private Reason|0|||
146200923|NCT01596504|527248335|FG001|Overall Study|Participant's Private Reason|1|||
146200924|NCT01596504|527248336|FG002|Overall Study|Participant's Private Reason|0|||
146200925|NCT01596504|527248334|FG000|Overall Study|Adverse Event|1|||
146200926|NCT01596504|527248335|FG001|Overall Study|Adverse Event|2|||
146200927|NCT01596504|527248336|FG002|Overall Study|Adverse Event|1|||
146200928|NCT01596504|527248334|FG000|Overall Study|Withdrawal by Subject|1|||
146200929|NCT01596504|527248335|FG001|Overall Study|Withdrawal by Subject|0|||
146200930|NCT01596504|527248336|FG002|Overall Study|Withdrawal by Subject|0|||
146200931|NCT01901276|527248337|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
146200932|NCT01901276|527248338|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
146200933|NCT00395018|527248339|FG000|On-Treatment|Death|4|||
146200934|NCT00395018|527248339|FG000|On-Treatment|Other Reason|2|||
146200935|NCT00395018|527248339|FG000|On-Treatment|Poor/non-compliance|2|||
146200936|NCT00395018|527248339|FG000|On-Treatment|Subject no longer meets study criteria|2|||
146200937|NCT00395018|527248339|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
146200938|NCT00395018|527248339|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
146200939|NCT00395018|527248339|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
146200940|NCT02314117|527248340|FG000|Overall Study|Lost to Follow-up|9|||
146200941|NCT02314117|527248341|FG001|Overall Study|Lost to Follow-up|14|||
146200942|NCT02314117|527248340|FG000|Overall Study|Withdrawal by Subject|3|||
146200943|NCT02314117|527248341|FG001|Overall Study|Withdrawal by Subject|2|||
146200944|NCT04439799|527248342|FG000|Overall Study|Lost to Follow-up|6|||
146200945|NCT04439799|527248343|FG001|Overall Study|Lost to Follow-up|6|||
146200946|NCT04439799|527248342|FG000|Overall Study|Withdrawal by Subject|2|||
146200947|NCT04439799|527248343|FG001|Overall Study|Withdrawal by Subject|6|||
146200948|NCT04439799|527248342|FG000|Overall Study|Adverse Event|2|||
146200949|NCT04439799|527248343|FG001|Overall Study|Adverse Event|5|||
146200950|NCT00949975|527248344|FG000|Overall Study|Voluntary discontinuation|6|||
146200951|NCT00949975|527248345|FG001|Overall Study|Voluntary discontinuation|5|||
146200952|NCT00949975|527248346|FG002|Overall Study|Voluntary discontinuation|3|||
146200953|NCT00949975|527248347|FG003|Overall Study|Voluntary discontinuation|6|||
146200954|NCT00949975|527248344|FG000|Overall Study|Adverse Event|11|||
146200955|NCT00949975|527248345|FG001|Overall Study|Adverse Event|11|||
146200956|NCT00949975|527248346|FG002|Overall Study|Adverse Event|10|||
146200957|NCT00949975|527248347|FG003|Overall Study|Adverse Event|10|||
146200958|NCT00949975|527248344|FG000|Overall Study|Safety reason|0|||
146200959|NCT00949975|527248345|FG001|Overall Study|Safety reason|1|||
146429029|NCT05093205|528077720|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429030|NCT05093205|528077721|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429031|NCT05093205|528077722|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429032|NCT05093205|528077723|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429033|NCT05093205|528077724|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429034|NCT05093205|528077725|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429035|NCT05093205|528077726|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
146429036|NCT05093205|528077727|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
146429037|NCT05093205|528077715|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
146429038|NCT05093205|528077716|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
146429039|NCT05093205|528077717|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
146429040|NCT05093205|528077718|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
146429041|NCT05093205|528077719|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
146429042|NCT05093205|528077720|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
146429043|NCT05093205|528077721|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
146429044|NCT05093205|528077722|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
146429045|NCT05093205|528077723|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
146429046|NCT05093205|528077724|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
146429047|NCT05093205|528077725|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
146429048|NCT05093205|528077726|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
146429049|NCT05093205|528077727|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
146429050|NCT05093205|528077715|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429051|NCT05093205|528077716|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429052|NCT05093205|528077717|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429053|NCT05093205|528077718|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429054|NCT05093205|528077719|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429055|NCT05093205|528077720|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429056|NCT05093205|528077721|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429057|NCT05093205|528077722|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146200960|NCT00949975|527248346|FG002|Overall Study|Safety reason|0|||
146200961|NCT00949975|527248347|FG003|Overall Study|Safety reason|0|||
146200962|NCT00949975|527248344|FG000|Overall Study|Study-specific criteria|0|||
146200963|NCT00949975|527248345|FG001|Overall Study|Study-specific criteria|1|||
146200964|NCT00949975|527248346|FG002|Overall Study|Study-specific criteria|1|||
146200965|NCT00949975|527248347|FG003|Overall Study|Study-specific criteria|0|||
146200966|NCT00949975|527248344|FG000|Overall Study|Incorrect enrolment|5|||
146429058|NCT05093205|528077723|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146429059|NCT05093205|528077724|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146200967|NCT00949975|527248345|FG001|Overall Study|Incorrect enrolment|10|||
146200968|NCT00949975|527248346|FG002|Overall Study|Incorrect enrolment|4|||
146200969|NCT00949975|527248347|FG003|Overall Study|Incorrect enrolment|7|||
146200970|NCT00949975|527248344|FG000|Overall Study|Severe non-compliance|3|||
146200971|NCT00949975|527248345|FG001|Overall Study|Severe non-compliance|1|||
146200972|NCT00949975|527248346|FG002|Overall Study|Severe non-compliance|0|||
146429060|NCT05093205|528077725|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146200973|NCT00949975|527248347|FG003|Overall Study|Severe non-compliance|2|||
146200974|NCT00949975|527248344|FG000|Overall Study|Lost to Follow-up|1|||
146200975|NCT00949975|527248345|FG001|Overall Study|Lost to Follow-up|0|||
146200976|NCT00949975|527248346|FG002|Overall Study|Lost to Follow-up|1|||
146200977|NCT00949975|527248347|FG003|Overall Study|Lost to Follow-up|3|||
146200978|NCT00949975|527248344|FG000|Overall Study|Other|1|||
146200979|NCT00949975|527248345|FG001|Overall Study|Other|0|||
146200980|NCT00949975|527248346|FG002|Overall Study|Other|0|||
146200981|NCT00949975|527248347|FG003|Overall Study|Other|0|||
146200982|NCT04347954|527248348|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
146200983|NCT04347954|527248349|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
146200984|NCT04347954|527248350|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
146200985|NCT04347954|527248348|FG000|Overall Study|Lost to Follow-up|0|||
146200986|NCT04347954|527248349|FG001|Overall Study|Lost to Follow-up|1|||
146200987|NCT04347954|527248350|FG002|Overall Study|Lost to Follow-up|0|||
146200988|NCT03478696|527248354|FG000|Overall Study|Adverse Event|1|||
146200989|NCT03478696|527248355|FG001|Overall Study|Adverse Event|5|||
146200990|NCT03478696|527248354|FG000|Overall Study|Lost to Follow-up|1|||
146200991|NCT03478696|527248355|FG001|Overall Study|Lost to Follow-up|0|||
146200992|NCT03478696|527248354|FG000|Overall Study|Physician Decision|6|||
146200993|NCT03478696|527248355|FG001|Overall Study|Physician Decision|3|||
146200994|NCT03478696|527248354|FG000|Overall Study|Withdrawal by Subject|9|||
146200995|NCT03478696|527248355|FG001|Overall Study|Withdrawal by Subject|4|||
146200996|NCT03257813|527248356|FG000|Overall Study|Protocol Violation|6|||
146200997|NCT03257813|527248357|FG001|Overall Study|Protocol Violation|3|||
146200998|NCT03615924|527248358|FG000|Overall Study|Withdrawal by Subject|2|||
146200999|NCT03615924|527248359|FG001|Overall Study|Withdrawal by Subject|5|||
146201000|NCT03615924|527248358|FG000|Overall Study|Death|3|||
146201001|NCT03615924|527248359|FG001|Overall Study|Death|1|||
146201002|NCT03615924|527248358|FG000|Overall Study|Lost to Follow-up|1|||
146201003|NCT03615924|527248359|FG001|Overall Study|Lost to Follow-up|0|||
146201004|NCT03615924|527248358|FG000|Overall Study|Randomized in error|1|||
146201005|NCT03615924|527248359|FG001|Overall Study|Randomized in error|0|||
146201006|NCT03615924|527248358|FG000|Overall Study|Study termination by Sponsor|94|||
146201007|NCT03615924|527248359|FG001|Overall Study|Study termination by Sponsor|86|||
146201008|NCT00716144|527248360|FG000|Overall Study|Withdrawal by Subject|4|||
146201009|NCT00716144|527248361|FG001|Overall Study|Withdrawal by Subject|2|||
146201010|NCT00716144|527248362|FG002|Overall Study|Withdrawal by Subject|6|||
146201011|NCT00716144|527248363|FG003|Overall Study|Withdrawal by Subject|6|||
146201012|NCT00716144|527248360|FG000|Overall Study|Lost to Follow-up|2|||
146201013|NCT00716144|527248361|FG001|Overall Study|Lost to Follow-up|2|||
146201014|NCT00716144|527248362|FG002|Overall Study|Lost to Follow-up|1|||
146201015|NCT00716144|527248363|FG003|Overall Study|Lost to Follow-up|2|||
146201016|NCT00716144|527248360|FG000|Overall Study|Adverse Event|0|||
146201017|NCT00716144|527248361|FG001|Overall Study|Adverse Event|0|||
146201018|NCT00716144|527248362|FG002|Overall Study|Adverse Event|0|||
146201019|NCT00716144|527248363|FG003|Overall Study|Adverse Event|2|||
146201020|NCT00716144|527248360|FG000|Overall Study|Non-compliance|1|||
146201021|NCT00716144|527248361|FG001|Overall Study|Non-compliance|0|||
146201022|NCT00716144|527248362|FG002|Overall Study|Non-compliance|0|||
146201023|NCT00716144|527248363|FG003|Overall Study|Non-compliance|0|||
146201024|NCT00716144|527248360|FG000|Overall Study|Protocol Violation|2|||
146201025|NCT00716144|527248361|FG001|Overall Study|Protocol Violation|0|||
146201026|NCT00716144|527248362|FG002|Overall Study|Protocol Violation|1|||
146201027|NCT00716144|527248363|FG003|Overall Study|Protocol Violation|0|||
146201028|NCT00716144|527248360|FG000|Overall Study|Physician Decision|0|||
146201029|NCT00716144|527248361|FG001|Overall Study|Physician Decision|1|||
146201030|NCT00716144|527248362|FG002|Overall Study|Physician Decision|2|||
145949911|NCT01597492|526328706|FG001|Overall Study|Withdrawal by Subject|2|||
145949912|NCT01597492|526328705|FG000|Overall Study|Adverse Event|3|||
146201031|NCT00716144|527248363|FG003|Overall Study|Physician Decision|2|||
146201032|NCT00716144|527248360|FG000|Overall Study|Intercurrent illness|0|||
146201033|NCT00716144|527248361|FG001|Overall Study|Intercurrent illness|0|||
146201034|NCT00716144|527248362|FG002|Overall Study|Intercurrent illness|1|||
146201035|NCT00716144|527248363|FG003|Overall Study|Intercurrent illness|0|||
146201036|NCT00716144|527248360|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
146201037|NCT00716144|527248361|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
146201038|NCT00716144|527248362|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
146201039|NCT00716144|527248363|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
146201040|NCT00716144|527248360|FG000|Overall Study|Adverse event: left foot pain|0|||
146201041|NCT00716144|527248361|FG001|Overall Study|Adverse event: left foot pain|1|||
146201042|NCT00716144|527248362|FG002|Overall Study|Adverse event: left foot pain|0|||
146201043|NCT00716144|527248363|FG003|Overall Study|Adverse event: left foot pain|0|||
146201044|NCT00716144|527248360|FG000|Overall Study|Clinical Depression|0|||
146201045|NCT00716144|527248361|FG001|Overall Study|Clinical Depression|1|||
146201046|NCT00716144|527248362|FG002|Overall Study|Clinical Depression|0|||
146201047|NCT00716144|527248363|FG003|Overall Study|Clinical Depression|0|||
146429061|NCT05093205|528077726|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
146429062|NCT05093205|528077727|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
146201048|NCT00909363|527248364|FG000|Overall Study|Withdrawal by Subject|1|||
146201049|NCT00909363|527248365|FG001|Overall Study|Withdrawal by Subject|0|||
146429063|NCT02979353|528077732|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
146429064|NCT02979353|528077733|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
146429065|NCT02979353|528077732|FG000|Overall Study|Withdrawal by Subject|16|||
146201050|NCT00909363|527248366|FG002|Overall Study|Withdrawal by Subject|0|||
146201051|NCT00909363|527248364|FG000|Overall Study|Lack of Efficacy|1|||
146201052|NCT00909363|527248365|FG001|Overall Study|Lack of Efficacy|0|||
146201053|NCT00909363|527248366|FG002|Overall Study|Lack of Efficacy|0|||
146201054|NCT02954848|527248376|FG000|Overall Study|Randomized but Not Treated|0|||
146201055|NCT02954848|527248377|FG001|Overall Study|Randomized but Not Treated|1|||
146201056|NCT02954848|527248376|FG000|Overall Study|Adverse Event|2|||
146201057|NCT02954848|527248377|FG001|Overall Study|Adverse Event|3|||
146201058|NCT02954848|527248376|FG000|Overall Study|Withdrawal by Participant|0|||
146201059|NCT02954848|527248377|FG001|Overall Study|Withdrawal by Participant|1|||
146201060|NCT01802632|527248378|FG000|Overall Study|Death|28|||
146201061|NCT01802632|527248379|FG001|Overall Study|Death|1|||
146201062|NCT01802632|527248380|FG002|Overall Study|Death|38|||
146201063|NCT01802632|527248381|FG003|Overall Study|Death|0|||
146201064|NCT01802632|527248382|FG004|Overall Study|Death|2|||
146201065|NCT01802632|527248383|FG005|Overall Study|Death|0|||
146201066|NCT01802632|527248378|FG000|Overall Study|Withdrawal by Subject|4|||
146201067|NCT01802632|527248379|FG001|Overall Study|Withdrawal by Subject|2|||
146201068|NCT01802632|527248380|FG002|Overall Study|Withdrawal by Subject|7|||
146201069|NCT01802632|527248381|FG003|Overall Study|Withdrawal by Subject|3|||
146201070|NCT01802632|527248382|FG004|Overall Study|Withdrawal by Subject|0|||
146201071|NCT01802632|527248383|FG005|Overall Study|Withdrawal by Subject|1|||
146201072|NCT01802632|527248378|FG000|Overall Study|Objective Disease Progression|1|||
146201073|NCT01802632|527248379|FG001|Overall Study|Objective Disease Progression|12|||
146201074|NCT01802632|527248380|FG002|Overall Study|Objective Disease Progression|104|||
146201075|NCT01802632|527248381|FG003|Overall Study|Objective Disease Progression|6|||
146201076|NCT01802632|527248382|FG004|Overall Study|Objective Disease Progression|4|||
146201077|NCT01802632|527248383|FG005|Overall Study|Objective Disease Progression|4|||
146201078|NCT01802632|527248378|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
146201079|NCT01802632|527248379|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
146201080|NCT01802632|527248380|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
146201081|NCT01802632|527248381|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
146201082|NCT01802632|527248382|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
146201083|NCT01802632|527248383|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
146201084|NCT01802632|527248378|FG000|Overall Study|Other (not specified)|0|||
146201085|NCT01802632|527248379|FG001|Overall Study|Other (not specified)|0|||
146201086|NCT01802632|527248380|FG002|Overall Study|Other (not specified)|7|||
146201087|NCT01802632|527248381|FG003|Overall Study|Other (not specified)|1|||
146429066|NCT02979353|528077733|FG001|Overall Study|Withdrawal by Subject|12|||
146429067|NCT02979353|528077732|FG000|Overall Study|Death|10|||
146429068|NCT02979353|528077733|FG001|Overall Study|Death|11|||
146429069|NCT02979353|528077732|FG000|Overall Study|Transfer to Hospice Care|19|||
146429070|NCT02979353|528077733|FG001|Overall Study|Transfer to Hospice Care|14|||
146429071|NCT02979353|528077732|FG000|Overall Study|Lost to Follow-up|1|||
146429072|NCT02979353|528077733|FG001|Overall Study|Lost to Follow-up|5|||
146201088|NCT01802632|527248382|FG004|Overall Study|Other (not specified)|0|||
146201089|NCT01802632|527248383|FG005|Overall Study|Other (not specified)|1|||
146429073|NCT01722877|528077736|FG000|Overall Study|Death|1|||
146429074|NCT01722877|528077736|FG000|Overall Study|Lost to Follow-up|1|||
146429075|NCT05067647|528077739|FG000|Overall Study|Lost to Follow-up|1|||
146429076|NCT03897088|528077740|FG000|Overall Study|Withdrawal by Subject|12|||
146429077|NCT03897088|528077741|FG001|Overall Study|Withdrawal by Subject|12|||
146429078|NCT03897088|528077740|FG000|Overall Study|Lost to Follow-up|7|||
146429079|NCT03897088|528077741|FG001|Overall Study|Lost to Follow-up|15|||
146201090|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
146201091|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
146201092|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
146201093|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
146201094|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
146201095|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
146429080|NCT03897088|528077740|FG000|Overall Study|Sponsor Decision|1|||
146429081|NCT03897088|528077741|FG001|Overall Study|Sponsor Decision|2|||
146429082|NCT03897088|528077740|FG000|Overall Study|COVID-19|2|||
146429083|NCT03897088|528077741|FG001|Overall Study|COVID-19|0|||
146429084|NCT03897088|528077740|FG000|Overall Study|Other|3|||
146429085|NCT03897088|528077741|FG001|Overall Study|Other|0|||
146201096|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
146201097|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
146201098|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
146201099|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146201100|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146201101|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146201102|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
146201103|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
146201104|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
146201105|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201106|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201107|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
146201108|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201109|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201110|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201111|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201112|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201113|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201114|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201115|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
146201116|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
146201117|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
146201118|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
146201119|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
146201120|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
146201121|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146201122|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
146201123|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146201124|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
146201125|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146201126|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146429086|NCT03897088|528077740|FG000|Overall Study|Non-compliance with Study Drug|1|||
146429087|NCT03897088|528077741|FG001|Overall Study|Non-compliance with Study Drug|1|||
146429088|NCT03897088|528077740|FG000|Overall Study|Pregnancy|0|||
146429089|NCT03897088|528077741|FG001|Overall Study|Pregnancy|1|||
146429090|NCT04320849|528077746|FG000|Overall Study|Withdrawal by Subject|4|||
146429091|NCT04320849|528077746|FG000|Overall Study|Imaging data unavailable|2|||
146429092|NCT04320849|528077746|FG000|Overall Study|Incomplete imaging|2|||
146429093|NCT03929393|528077749|FG000|Overall Study|Death|1|||
146429094|NCT03929393|528077750|FG001|Overall Study|Death|0|||
146429095|NCT03929393|528077749|FG000|Overall Study|Time Commitment|2|||
146429096|NCT03929393|528077750|FG001|Overall Study|Time Commitment|5|||
146429097|NCT03929393|528077749|FG000|Overall Study|Motor Vehicle Accident|0|||
146429098|NCT03929393|528077750|FG001|Overall Study|Motor Vehicle Accident|1|||
146429099|NCT03929393|528077749|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
146429100|NCT03929393|528077750|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
146429101|NCT03929393|528077749|FG000|Overall Study|Other|1|||
146429102|NCT03929393|528077750|FG001|Overall Study|Other|3|||
146429103|NCT01569152|528077757|FG000|Phase IIa, Period 1|Early Escape|5|||
146429104|NCT01569152|528077758|FG001|Phase IIa, Period 1|Early Escape|22|||
146429105|NCT01569152|528077759|FG002|Phase IIa, Period 1|Early Escape|0|||
146429106|NCT01569152|528077757|FG000|Phase IIa, Period 1|Adverse Event|4|||
146429107|NCT01569152|528077758|FG001|Phase IIa, Period 1|Adverse Event|0|||
146429108|NCT01569152|528077759|FG002|Phase IIa, Period 1|Adverse Event|0|||
146429109|NCT01569152|528077757|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
146429110|NCT01569152|528077758|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
146429111|NCT01569152|528077759|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
146429112|NCT01569152|528077757|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
146429113|NCT01569152|528077758|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
146201127|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146201128|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
146201129|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201130|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
146082832|NCT01451437|526822907|FG001|Overall Study|Disease Progression|0|||
146201131|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
146429114|NCT01569152|528077759|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
146429115|NCT01569152|528077757|FG000|Phase IIa, Period 1|Protocol Violation|0|||
146082833|NCT01451437|526822908|FG002|Overall Study|Disease Progression|1|||
146429116|NCT01569152|528077758|FG001|Phase IIa, Period 1|Protocol Violation|1|||
146429117|NCT01569152|528077759|FG002|Phase IIa, Period 1|Protocol Violation|0|||
145949913|NCT01597492|526328706|FG001|Overall Study|Adverse Event|0|||
146429118|NCT01569152|528077757|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
146429119|NCT01569152|528077758|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
146429120|NCT01569152|528077759|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
146429121|NCT01569152|528077757|FG000|Safety Extension, Period 3|Adverse Event|0|||
146429122|NCT01569152|528077758|FG001|Safety Extension, Period 3|Adverse Event|0|||
146429123|NCT01569152|528077759|FG002|Safety Extension, Period 3|Adverse Event|4|||
146429124|NCT01569152|528077757|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
146429125|NCT01569152|528077758|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
146429126|NCT01569152|528077759|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
146429127|NCT01569152|528077757|FG000|Safety Extension, Period 3|Physician Decision|0|||
146429128|NCT01569152|528077758|FG001|Safety Extension, Period 3|Physician Decision|0|||
145949914|NCT01597492|526328705|FG000|Overall Study|Lost to Follow-up|0|||
145949915|NCT01597492|526328706|FG001|Overall Study|Lost to Follow-up|2|||
145949916|NCT01597492|526328705|FG000|Overall Study|Other Reason|2|||
145949917|NCT01597492|526328706|FG001|Overall Study|Other Reason|0|||
146201132|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201133|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
146201134|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201135|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201136|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201137|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201138|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201139|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201140|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201141|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
146201142|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146201143|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
146201144|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
145949918|NCT00482170|526328707|FG000|Overall Study|Adverse Event|5|||
146082834|NCT01451437|526822909|FG003|Overall Study|Disease Progression|1|||
146201145|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146201146|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
146201147|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201148|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201149|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201150|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
146201151|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201152|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201153|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201154|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
146201155|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146201156|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201157|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201158|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201159|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145949919|NCT00482170|526328708|FG001|Overall Study|Adverse Event|14|||
145949920|NCT00482170|526328707|FG000|Overall Study|Withdrawal by Subject|6|||
145949921|NCT00482170|526328708|FG001|Overall Study|Withdrawal by Subject|1|||
145949922|NCT00482170|526328707|FG000|Overall Study|Protocol Violation|2|||
146201160|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146201161|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
146201162|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
146201163|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201164|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201165|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201166|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201167|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
146201168|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
146201169|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
146201170|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
146201171|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
146201172|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
146201173|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146201174|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
146201175|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146201176|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
146201177|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146201178|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146201179|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146201180|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
146201181|NCT04707313|527248385|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201182|NCT04707313|527248386|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201183|NCT04707313|527248387|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
146201184|NCT04707313|527248388|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201185|NCT04707313|527248389|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201186|NCT04707313|527248390|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201187|NCT04707313|527248391|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201188|NCT04707313|527248392|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
146201189|NCT04707313|527248393|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201190|NCT04707313|527248394|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201191|NCT04707313|527248395|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201192|NCT04707313|527248396|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201193|NCT04707313|527248397|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
146201194|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201195|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201196|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201197|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201198|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201199|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201200|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201201|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201202|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201203|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
146201204|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
146201205|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
146201206|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
146201207|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201208|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201209|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201210|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201211|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201212|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201213|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201214|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201215|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201216|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
146201217|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
146201218|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
146201219|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
146201220|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201221|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201222|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201223|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201224|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201225|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201226|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201227|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201228|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
146201229|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
146201230|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
146201231|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
146201232|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
146201233|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201234|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201235|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201236|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201237|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201238|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201239|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201240|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201241|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201242|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201243|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
146201244|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
146201245|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
146201246|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201247|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201248|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201249|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201250|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201251|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201252|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201253|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201254|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201255|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
146201256|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
146201257|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201258|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
146201259|NCT04707313|527248385|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201260|NCT04707313|527248386|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201261|NCT04707313|527248387|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201262|NCT04707313|527248388|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201263|NCT04707313|527248389|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201264|NCT04707313|527248390|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201265|NCT04707313|527248391|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201266|NCT04707313|527248392|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201267|NCT04707313|527248393|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
146201268|NCT04707313|527248394|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
146201269|NCT04707313|527248395|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
146201270|NCT04707313|527248396|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
146201271|NCT04707313|527248397|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
146201272|NCT02459899|527248398|FG000|Overall Study|Adverse Event|1|||
146201273|NCT02459899|527248399|FG001|Overall Study|Adverse Event|1|||
146201274|NCT02459899|527248400|FG002|Overall Study|Adverse Event|0|||
146201275|NCT02459899|527248401|FG003|Overall Study|Adverse Event|0|||
146201276|NCT02459899|527248398|FG000|Overall Study|Lost to Follow-up|1|||
146201277|NCT02459899|527248399|FG001|Overall Study|Lost to Follow-up|2|||
146201278|NCT02459899|527248400|FG002|Overall Study|Lost to Follow-up|0|||
146201279|NCT02459899|527248401|FG003|Overall Study|Lost to Follow-up|1|||
146201280|NCT02459899|527248398|FG000|Overall Study|Non-compliance with the treatment|0|||
146201281|NCT02459899|527248399|FG001|Overall Study|Non-compliance with the treatment|0|||
146201282|NCT02459899|527248400|FG002|Overall Study|Non-compliance with the treatment|0|||
146201283|NCT02459899|527248401|FG003|Overall Study|Non-compliance with the treatment|1|||
146201284|NCT02459899|527248398|FG000|Overall Study|Withdrawal by Subject|1|||
146201285|NCT02459899|527248399|FG001|Overall Study|Withdrawal by Subject|3|||
146201286|NCT02459899|527248400|FG002|Overall Study|Withdrawal by Subject|0|||
146201287|NCT02459899|527248401|FG003|Overall Study|Withdrawal by Subject|0|||
146201288|NCT02020616|527248406|FG000|Overall Study|Adverse Event|0|||
146201289|NCT02020616|527248407|FG001|Overall Study|Adverse Event|0|||
146201290|NCT02020616|527248408|FG002|Overall Study|Adverse Event|0|||
146201291|NCT02020616|527248409|FG003|Overall Study|Adverse Event|0|||
146201292|NCT02020616|527248410|FG004|Overall Study|Adverse Event|0|||
146201293|NCT02020616|527248411|FG005|Overall Study|Adverse Event|1|||
146201294|NCT02020616|527248412|FG006|Overall Study|Adverse Event|1|||
146201295|NCT02020616|527248406|FG000|Overall Study|Physician Decision|0|||
146201296|NCT02020616|527248407|FG001|Overall Study|Physician Decision|0|||
146201297|NCT02020616|527248408|FG002|Overall Study|Physician Decision|0|||
146201298|NCT02020616|527248409|FG003|Overall Study|Physician Decision|0|||
146201299|NCT02020616|527248410|FG004|Overall Study|Physician Decision|0|||
146201300|NCT02020616|527248411|FG005|Overall Study|Physician Decision|1|||
146201301|NCT02020616|527248412|FG006|Overall Study|Physician Decision|2|||
146201302|NCT02020616|527248406|FG000|Overall Study|Withdrawal by Subject|0|||
146201303|NCT02020616|527248407|FG001|Overall Study|Withdrawal by Subject|0|||
146201304|NCT02020616|527248408|FG002|Overall Study|Withdrawal by Subject|1|||
146201305|NCT02020616|527248409|FG003|Overall Study|Withdrawal by Subject|0|||
146201306|NCT02020616|527248410|FG004|Overall Study|Withdrawal by Subject|0|||
146201307|NCT02020616|527248411|FG005|Overall Study|Withdrawal by Subject|1|||
146201308|NCT02020616|527248412|FG006|Overall Study|Withdrawal by Subject|1|||
146201309|NCT02020616|527248406|FG000|Overall Study|Lost to Follow-up|0|||
146201310|NCT02020616|527248407|FG001|Overall Study|Lost to Follow-up|1|||
146201311|NCT02020616|527248408|FG002|Overall Study|Lost to Follow-up|0|||
146201312|NCT02020616|527248409|FG003|Overall Study|Lost to Follow-up|1|||
146201313|NCT02020616|527248410|FG004|Overall Study|Lost to Follow-up|1|||
146201314|NCT02020616|527248411|FG005|Overall Study|Lost to Follow-up|1|||
146201315|NCT02020616|527248412|FG006|Overall Study|Lost to Follow-up|0|||
146201316|NCT02020616|527248406|FG000|Overall Study|Early Termination Criteria Met|0|||
146201317|NCT02020616|527248407|FG001|Overall Study|Early Termination Criteria Met|0|||
146201318|NCT02020616|527248408|FG002|Overall Study|Early Termination Criteria Met|1|||
146201319|NCT02020616|527248409|FG003|Overall Study|Early Termination Criteria Met|0|||
146201320|NCT02020616|527248410|FG004|Overall Study|Early Termination Criteria Met|0|||
146201321|NCT02020616|527248411|FG005|Overall Study|Early Termination Criteria Met|1|||
146201322|NCT02020616|527248412|FG006|Overall Study|Early Termination Criteria Met|0|||
146201323|NCT02020616|527248406|FG000|Overall Study|Randomized in Error|0|||
146201324|NCT02020616|527248407|FG001|Overall Study|Randomized in Error|0|||
146201325|NCT02020616|527248408|FG002|Overall Study|Randomized in Error|0|||
146201326|NCT02020616|527248409|FG003|Overall Study|Randomized in Error|1|||
146201327|NCT02020616|527248410|FG004|Overall Study|Randomized in Error|0|||
146201328|NCT02020616|527248411|FG005|Overall Study|Randomized in Error|0|||
146201329|NCT02020616|527248412|FG006|Overall Study|Randomized in Error|0|||
146201330|NCT02020616|527248406|FG000|Overall Study|Lack of Efficacy|0|||
146201331|NCT02020616|527248407|FG001|Overall Study|Lack of Efficacy|0|||
146201332|NCT02020616|527248408|FG002|Overall Study|Lack of Efficacy|0|||
146201333|NCT02020616|527248409|FG003|Overall Study|Lack of Efficacy|0|||
146201334|NCT02020616|527248410|FG004|Overall Study|Lack of Efficacy|1|||
146201335|NCT02020616|527248411|FG005|Overall Study|Lack of Efficacy|0|||
146201336|NCT02020616|527248412|FG006|Overall Study|Lack of Efficacy|0|||
146201337|NCT03070483|527248418|FG000|Overall Study|Lost to Follow-up|2|||
146201338|NCT02031471|527248419|FG000|24 Week Treatment Period|Adverse Event|6|||
146201339|NCT02031471|527248419|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
146201340|NCT02031471|527248419|FG000|24 Week Treatment Period|Protocol Violation|1|||
146201341|NCT02031471|527248419|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
146201342|NCT02031471|527248419|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
146201343|NCT02031471|527248419|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
146201344|NCT02031471|527248419|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
146201345|NCT00361283|527248423|FG000|Overall Study|Lost to Follow-up|27|||
146201346|NCT01063517|527248424|FG000|Overall Study|Consent withdrawal|1|||
146201347|NCT01063517|527248425|FG001|Overall Study|Consent withdrawal|0|||
146201348|NCT01063517|527248424|FG000|Overall Study|Study reached data cut-off|19|||
146201349|NCT01063517|527248425|FG001|Overall Study|Study reached data cut-off|7|||
146201350|NCT01063517|527248424|FG000|Overall Study|Lost to Follow-up|4|||
146201351|NCT01063517|527248425|FG001|Overall Study|Lost to Follow-up|3|||
146201352|NCT01063517|527248424|FG000|Overall Study|Withdrawal by Subject|1|||
146201353|NCT01063517|527248425|FG001|Overall Study|Withdrawal by Subject|2|||
146201354|NCT01063517|527248424|FG000|Overall Study|Death|33|||
146201355|NCT01063517|527248425|FG001|Overall Study|Death|48|||
146201356|NCT05328297|527250030|FG000|Overall Study|Adverse Event|5|||
146201357|NCT05328297|527250031|FG001|Overall Study|Adverse Event|7|||
146429129|NCT01569152|528077759|FG002|Safety Extension, Period 3|Physician Decision|2|||
146201358|NCT05328297|527250030|FG000|Overall Study|Withdrawal by Subject|4|||
146429130|NCT01569152|528077757|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
146429131|NCT01569152|528077758|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
146201359|NCT05328297|527250031|FG001|Overall Study|Withdrawal by Subject|3|||
146201360|NCT05328297|527250030|FG000|Overall Study|Lack of Efficacy|1|||
146201361|NCT05328297|527250031|FG001|Overall Study|Lack of Efficacy|0|||
146201362|NCT05328297|527250030|FG000|Overall Study|Lost to Follow-up|1|||
146201363|NCT05328297|527250031|FG001|Overall Study|Lost to Follow-up|0|||
146201364|NCT05328297|527250030|FG000|Overall Study|Protocol Violation|1|||
146201365|NCT05328297|527250031|FG001|Overall Study|Protocol Violation|0|||
146201366|NCT05328297|527250030|FG000|Overall Study|Randomized but not treated|1|||
146201367|NCT05328297|527250031|FG001|Overall Study|Randomized but not treated|1|||
146201368|NCT04513522|527250032|FG000|Overall Study|Other reasons|1|||
146201369|NCT04513522|527250032|FG000|Overall Study|Adverse event unrelated to study drug|9|||
146201370|NCT04513522|527250032|FG000|Overall Study|Study drug toxicity|14|||
146201371|NCT04513522|527250032|FG000|Overall Study|Disease progression|39|||
146201372|NCT04513522|527250032|FG000|Overall Study|Participants withdrew consent|2|||
146201373|NCT05219253|527250044|FG000|Overall Study|Withdrawal by Subject|1|||
146201374|NCT05219253|527250045|FG001|Overall Study|Withdrawal by Subject|2|||
146201375|NCT03086369|527250046|FG000|Overall Study|Lost to Follow-up|1|||
146201376|NCT03086369|527250047|FG001|Overall Study|Lost to Follow-up|0|||
146201377|NCT03086369|527250048|FG002|Overall Study|Lost to Follow-up|0|||
146201378|NCT03086369|527250049|FG003|Overall Study|Lost to Follow-up|2|||
145949923|NCT00482170|526328708|FG001|Overall Study|Protocol Violation|3|||
145949924|NCT00482170|526328707|FG000|Overall Study|Lost to Follow-up|2|||
146082835|NCT01451437|526822910|FG004|Overall Study|Disease Progression|3|||
146201379|NCT03086369|527250050|FG004|Overall Study|Lost to Follow-up|1|||
146201380|NCT03086369|527250046|FG000|Overall Study|Physician Decision|0|||
146201381|NCT03086369|527250047|FG001|Overall Study|Physician Decision|0|||
146201382|NCT03086369|527250048|FG002|Overall Study|Physician Decision|0|||
146201383|NCT03086369|527250049|FG003|Overall Study|Physician Decision|1|||
146201384|NCT03086369|527250050|FG004|Overall Study|Physician Decision|2|||
146201385|NCT03086369|527250046|FG000|Overall Study|Withdrawal by Subject|0|||
146201386|NCT03086369|527250047|FG001|Overall Study|Withdrawal by Subject|0|||
146201387|NCT03086369|527250048|FG002|Overall Study|Withdrawal by Subject|0|||
146201388|NCT03086369|527250049|FG003|Overall Study|Withdrawal by Subject|5|||
146201389|NCT03086369|527250050|FG004|Overall Study|Withdrawal by Subject|3|||
146201390|NCT03086369|527250046|FG000|Overall Study|Progressive Disease|0|||
146201391|NCT03086369|527250047|FG001|Overall Study|Progressive Disease|0|||
146201392|NCT03086369|527250048|FG002|Overall Study|Progressive Disease|0|||
146201393|NCT03086369|527250049|FG003|Overall Study|Progressive Disease|1|||
146201394|NCT03086369|527250050|FG004|Overall Study|Progressive Disease|1|||
146201395|NCT04668339|527250051|FG000|Overall Study|Physician Decision|1|||
146201396|NCT04668339|527250052|FG001|Overall Study|Physician Decision|0|||
146201397|NCT04668339|527250053|FG002|Overall Study|Physician Decision|1|||
146201398|NCT04668339|527250054|FG003|Overall Study|Physician Decision|1|||
146201399|NCT04668339|527250051|FG000|Overall Study|Lost to Follow-up|14|||
146201400|NCT04668339|527250052|FG001|Overall Study|Lost to Follow-up|12|||
146201401|NCT04668339|527250053|FG002|Overall Study|Lost to Follow-up|8|||
146201402|NCT04668339|527250054|FG003|Overall Study|Lost to Follow-up|5|||
146201403|NCT04668339|527250051|FG000|Overall Study|Adverse Event|0|||
146201404|NCT04668339|527250052|FG001|Overall Study|Adverse Event|0|||
146201405|NCT04668339|527250053|FG002|Overall Study|Adverse Event|1|||
146201406|NCT04668339|527250054|FG003|Overall Study|Adverse Event|0|||
146201407|NCT04668339|527250051|FG000|Overall Study|Other than specified|3|||
146201408|NCT04668339|527250052|FG001|Overall Study|Other than specified|0|||
146201409|NCT04668339|527250053|FG002|Overall Study|Other than specified|1|||
146201410|NCT04668339|527250054|FG003|Overall Study|Other than specified|0|||
146201411|NCT04668339|527250051|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
146201412|NCT04668339|527250052|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
146201413|NCT04668339|527250053|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
146201414|NCT04668339|527250054|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
146201415|NCT04668339|527250051|FG000|Overall Study|Vaccine not Administered|0|||
145949925|NCT00482170|526328708|FG001|Overall Study|Lost to Follow-up|0|||
145949926|NCT00482170|526328707|FG000|Overall Study|Unspecified reason|0|||
146201416|NCT04668339|527250052|FG001|Overall Study|Vaccine not Administered|0|||
146201417|NCT04668339|527250053|FG002|Overall Study|Vaccine not Administered|1|||
146201418|NCT04668339|527250054|FG003|Overall Study|Vaccine not Administered|0|||
146201419|NCT04668339|527250051|FG000|Overall Study|Protocol Violation|18|||
146201420|NCT04668339|527250052|FG001|Overall Study|Protocol Violation|23|||
146201421|NCT04668339|527250053|FG002|Overall Study|Protocol Violation|12|||
146201422|NCT04668339|527250054|FG003|Overall Study|Protocol Violation|20|||
146201423|NCT04668339|527250051|FG000|Overall Study|Withdrawal by Subject|45|||
146201424|NCT04668339|527250052|FG001|Overall Study|Withdrawal by Subject|46|||
146201425|NCT04668339|527250053|FG002|Overall Study|Withdrawal by Subject|46|||
146201426|NCT04668339|527250054|FG003|Overall Study|Withdrawal by Subject|27|||
146201427|NCT04668339|527250051|FG000|Overall Study|Study Terminated by Sponsor|59|||
146201428|NCT04668339|527250052|FG001|Overall Study|Study Terminated by Sponsor|59|||
146201429|NCT04668339|527250053|FG002|Overall Study|Study Terminated by Sponsor|71|||
146201430|NCT04668339|527250054|FG003|Overall Study|Study Terminated by Sponsor|1|||
146201431|NCT00178399|527250058|FG000|Overall Study|Physician Decision|4|||
146201432|NCT00178399|527250058|FG000|Overall Study|Withdrawal by Subject|8|||
146201433|NCT00178399|527250058|FG000|Overall Study|Lost to Follow-up|1|||
146201434|NCT01134562|527250063|FG000|Overall Study|Adverse Event|0|||
146201435|NCT01134562|527250064|FG001|Overall Study|Adverse Event|1|||
146201436|NCT01134562|527250065|FG002|Overall Study|Adverse Event|0|||
146201437|NCT01134562|527250066|FG003|Overall Study|Adverse Event|0|||
146201438|NCT01134562|527250067|FG004|Overall Study|Adverse Event|0|||
146201439|NCT00768664|527250068|FG000|Overall Study|Death|57|||
146201440|NCT00768664|527250068|FG000|Overall Study|Lost to Follow-up|2|||
146201441|NCT00768664|527250068|FG000|Overall Study|Other|9|||
146201442|NCT00768664|527250068|FG000|Overall Study|Participant refused|1|||
146201443|NCT00708032|527250071|FG000|Overall Study|Adverse Event|0|||
146201444|NCT00708032|527250072|FG001|Overall Study|Adverse Event|2|||
146201445|NCT00708032|527250071|FG000|Overall Study|Lost to Follow-up|1|||
146201446|NCT00708032|527250072|FG001|Overall Study|Lost to Follow-up|2|||
146201447|NCT00708032|527250071|FG000|Overall Study|Pregnancy|0|||
146201448|NCT00708032|527250072|FG001|Overall Study|Pregnancy|1|||
146201449|NCT00708032|527250071|FG000|Overall Study|Poor vision|0|||
146201450|NCT00708032|527250072|FG001|Overall Study|Poor vision|6|||
146201451|NCT00708032|527250071|FG000|Overall Study|Visit out of range at month 12|4|||
146201452|NCT00708032|527250072|FG001|Overall Study|Visit out of range at month 12|1|||
146201453|NCT00708032|527250071|FG000|Overall Study|Did not meet protocol criteria|1|||
146201454|NCT00708032|527250072|FG001|Overall Study|Did not meet protocol criteria|2|||
146201455|NCT00708032|527250071|FG000|Overall Study|Protocol Violation|4|||
146201456|NCT00708032|527250072|FG001|Overall Study|Protocol Violation|1|||
146201457|NCT00708032|527250071|FG000|Overall Study|Withdrawal by Subject|0|||
146201458|NCT00708032|527250072|FG001|Overall Study|Withdrawal by Subject|1|||
146201459|NCT02320123|527250076|FG000|Overall Study|Lost to Follow-up|4|||
146201460|NCT02320123|527250077|FG001|Overall Study|Lost to Follow-up|6|||
146201461|NCT02320123|527250076|FG000|Overall Study|Death|6|||
146201462|NCT02320123|527250077|FG001|Overall Study|Death|5|||
146201463|NCT00941655|527250086|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
146201464|NCT00941655|527250087|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
146201465|NCT00941655|527250086|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
146201466|NCT00941655|527250087|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
146201467|NCT00941655|527250086|FG000|Overall Study|progressed while on chemo|0|||
146201468|NCT00941655|527250087|FG001|Overall Study|progressed while on chemo|2|||
146201469|NCT00941655|527250086|FG000|Overall Study|refused further treatment|0|||
146201470|NCT00941655|527250087|FG001|Overall Study|refused further treatment|1|||
146201471|NCT00941655|527250086|FG000|Overall Study|withdrew consent|0|||
146201472|NCT00941655|527250087|FG001|Overall Study|withdrew consent|1|||
146201473|NCT00941655|527250086|FG000|Overall Study|non-compliant|0|||
146201474|NCT00941655|527250087|FG001|Overall Study|non-compliant|1|||
146201475|NCT02477670|527250091|FG000|Stage 1|Adverse Event|2|||
146201476|NCT02477670|527250092|FG001|Stage 1|Adverse Event|7|||
146201477|NCT02477670|527250093|FG002|Stage 1|Adverse Event|0|||
146201478|NCT02477670|527250094|FG003|Stage 1|Adverse Event|0|||
146201479|NCT02477670|527250095|FG004|Stage 1|Adverse Event|0|||
146201480|NCT02477670|527250096|FG005|Stage 1|Adverse Event|0|||
146201481|NCT02477670|527250097|FG006|Stage 1|Adverse Event|0|||
146201482|NCT02477670|527250091|FG000|Stage 1|Lost to Follow-up|0|||
146201483|NCT02477670|527250092|FG001|Stage 1|Lost to Follow-up|2|||
146201484|NCT02477670|527250093|FG002|Stage 1|Lost to Follow-up|0|||
146201485|NCT02477670|527250094|FG003|Stage 1|Lost to Follow-up|0|||
146201486|NCT02477670|527250095|FG004|Stage 1|Lost to Follow-up|0|||
146201487|NCT02477670|527250096|FG005|Stage 1|Lost to Follow-up|0|||
146201488|NCT02477670|527250097|FG006|Stage 1|Lost to Follow-up|0|||
146201489|NCT02477670|527250091|FG000|Stage 1|Withdrawal by Subject|1|||
146201490|NCT02477670|527250092|FG001|Stage 1|Withdrawal by Subject|2|||
146201491|NCT02477670|527250093|FG002|Stage 1|Withdrawal by Subject|0|||
146201492|NCT02477670|527250094|FG003|Stage 1|Withdrawal by Subject|0|||
146201493|NCT02477670|527250095|FG004|Stage 1|Withdrawal by Subject|0|||
146201494|NCT02477670|527250096|FG005|Stage 1|Withdrawal by Subject|0|||
146201495|NCT02477670|527250097|FG006|Stage 1|Withdrawal by Subject|0|||
146201496|NCT02477670|527250091|FG000|Stage 1|Non-compliance with Study Drug|1|||
146201497|NCT02477670|527250092|FG001|Stage 1|Non-compliance with Study Drug|2|||
146201498|NCT02477670|527250093|FG002|Stage 1|Non-compliance with Study Drug|0|||
146201499|NCT02477670|527250094|FG003|Stage 1|Non-compliance with Study Drug|0|||
146201500|NCT02477670|527250095|FG004|Stage 1|Non-compliance with Study Drug|0|||
146201501|NCT02477670|527250096|FG005|Stage 1|Non-compliance with Study Drug|0|||
146201502|NCT02477670|527250097|FG006|Stage 1|Non-compliance with Study Drug|0|||
146201503|NCT02477670|527250091|FG000|Stage 2|Adverse Event|0|||
146201504|NCT02477670|527250092|FG001|Stage 2|Adverse Event|0|||
146201505|NCT02477670|527250093|FG002|Stage 2|Adverse Event|1|||
146201506|NCT02477670|527250094|FG003|Stage 2|Adverse Event|0|||
146201507|NCT02477670|527250095|FG004|Stage 2|Adverse Event|0|||
146201508|NCT02477670|527250096|FG005|Stage 2|Adverse Event|0|||
146201509|NCT02477670|527250097|FG006|Stage 2|Adverse Event|0|||
146201510|NCT02477670|527250091|FG000|Stage 2|Antipsychotic Medication Changed|0|||
146201511|NCT02477670|527250092|FG001|Stage 2|Antipsychotic Medication Changed|0|||
146201512|NCT02477670|527250093|FG002|Stage 2|Antipsychotic Medication Changed|1|||
146201513|NCT02477670|527250094|FG003|Stage 2|Antipsychotic Medication Changed|0|||
146201514|NCT02477670|527250095|FG004|Stage 2|Antipsychotic Medication Changed|0|||
146201515|NCT02477670|527250096|FG005|Stage 2|Antipsychotic Medication Changed|0|||
146201516|NCT02477670|527250097|FG006|Stage 2|Antipsychotic Medication Changed|0|||
146201517|NCT02477670|527250091|FG000|Stage 2|Withdrawal by Subject|0|||
146201518|NCT02477670|527250092|FG001|Stage 2|Withdrawal by Subject|0|||
146201519|NCT02477670|527250093|FG002|Stage 2|Withdrawal by Subject|0|||
146201520|NCT02477670|527250094|FG003|Stage 2|Withdrawal by Subject|1|||
146201521|NCT02477670|527250095|FG004|Stage 2|Withdrawal by Subject|0|||
146201522|NCT02477670|527250096|FG005|Stage 2|Withdrawal by Subject|0|||
146201523|NCT02477670|527250097|FG006|Stage 2|Withdrawal by Subject|0|||
146201524|NCT00004124|527250099|FG000|Overall Study|Received no protocol therapy|12|||
146201525|NCT00004124|527250100|FG001|Overall Study|Received no protocol therapy|20|||
146201526|NCT00446550|527250101|FG000|Overall Study|Adverse Event|1|||
146201527|NCT00446550|527250102|FG001|Overall Study|Adverse Event|0|||
146201528|NCT01759264|527250103|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
146201529|NCT01759264|527250103|FG000|Overall Study|Adverse Event|1|||
146201530|NCT01759264|527250103|FG000|Overall Study|Other|2|||
146201531|NCT01759264|527250103|FG000|Overall Study|Lost to Follow-up|2|||
146201532|NCT01759264|527250103|FG000|Overall Study|Withdrawal by Subject|3|||
146201533|NCT01759264|527250103|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
146201534|NCT00516386|527250106|FG000|Overall Study|not interested in the study|4|||
146201535|NCT00516386|527250106|FG000|Overall Study|Lost to Follow-up|2|||
146201536|NCT02698891|527250107|FG000|Overall Study|Withdrawal by Subject|2|||
146201537|NCT02698891|527250107|FG000|Overall Study|deemed ineligible|1|||
146201538|NCT02698891|527250107|FG000|Overall Study|Adverse Event|9|||
146201539|NCT02383472|527250108|FG000|Overall Study|Withdrawal by Subject|1|||
146201540|NCT02383472|527250109|FG001|Overall Study|Withdrawal by Subject|1|||
146201541|NCT01111526|527250110|FG000|Overall Study|GVHD Disease Progression|0|||
146201542|NCT01111526|527250111|FG001|Overall Study|GVHD Disease Progression|1|||
146201543|NCT01111526|527250112|FG002|Overall Study|GVHD Disease Progression|2|||
146201544|NCT02013830|527250113|FG000|Overall Study|Adverse Event|3|||
146201545|NCT02013830|527250113|FG000|Overall Study|Death|1|||
146429132|NCT01569152|528077759|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
146201546|NCT02013830|527250113|FG000|Overall Study|Insufficient therapeutic response|25|||
146201547|NCT02013830|527250113|FG000|Overall Study|Refused treatment|1|||
146201548|NCT04424641|527250116|FG000|Overall Study|Death|1|||
146201549|NCT04424641|527250117|FG001|Overall Study|Death|2|||
146201550|NCT04424641|527250118|FG002|Overall Study|Death|3|||
146201551|NCT04424641|527250119|FG003|Overall Study|Death|0|||
146201552|NCT04424641|527250120|FG004|Overall Study|Death|3|||
146201553|NCT04424641|527250121|FG005|Overall Study|Death|0|||
146201554|NCT04424641|527250122|FG006|Overall Study|Death|1|||
146201555|NCT04424641|527250123|FG007|Overall Study|Death|2|||
146201556|NCT04424641|527250116|FG000|Overall Study|Sponsor decision|0|||
146201557|NCT04424641|527250117|FG001|Overall Study|Sponsor decision|2|||
146201558|NCT04424641|527250118|FG002|Overall Study|Sponsor decision|3|||
146429133|NCT01706536|528077760|FG000|Overall Study|Withdrawal by Subject|1|||
146429134|NCT01706536|528077761|FG001|Overall Study|Withdrawal by Subject|0|||
146429135|NCT01706536|528077762|FG002|Overall Study|Withdrawal by Subject|1|||
146429136|NCT01706536|528077763|FG003|Overall Study|Withdrawal by Subject|0|||
146429137|NCT01706536|528077764|FG004|Overall Study|Withdrawal by Subject|0|||
146201559|NCT04424641|527250119|FG003|Overall Study|Sponsor decision|7|||
146201560|NCT04424641|527250120|FG004|Overall Study|Sponsor decision|2|||
146429138|NCT01706536|528077760|FG000|Overall Study|Adverse Event|2|||
146429139|NCT01706536|528077761|FG001|Overall Study|Adverse Event|3|||
146429140|NCT01706536|528077762|FG002|Overall Study|Adverse Event|4|||
146429141|NCT01706536|528077763|FG003|Overall Study|Adverse Event|3|||
146201561|NCT04424641|527250121|FG005|Overall Study|Sponsor decision|2|||
146429142|NCT01706536|528077764|FG004|Overall Study|Adverse Event|2|||
146429143|NCT01706536|528077760|FG000|Overall Study|Lack of Efficacy|1|||
146201562|NCT04424641|527250122|FG006|Overall Study|Sponsor decision|3|||
146201563|NCT04424641|527250123|FG007|Overall Study|Sponsor decision|4|||
146201564|NCT04424641|527250116|FG000|Overall Study|Withdrawal by Subject|0|||
146201565|NCT04424641|527250117|FG001|Overall Study|Withdrawal by Subject|0|||
146201566|NCT04424641|527250118|FG002|Overall Study|Withdrawal by Subject|0|||
146201567|NCT04424641|527250119|FG003|Overall Study|Withdrawal by Subject|0|||
146201568|NCT04424641|527250120|FG004|Overall Study|Withdrawal by Subject|1|||
146429144|NCT01706536|528077761|FG001|Overall Study|Lack of Efficacy|0|||
146429145|NCT01706536|528077762|FG002|Overall Study|Lack of Efficacy|0|||
146201569|NCT04424641|527250121|FG005|Overall Study|Withdrawal by Subject|0|||
146201570|NCT04424641|527250122|FG006|Overall Study|Withdrawal by Subject|0|||
146201571|NCT04424641|527250123|FG007|Overall Study|Withdrawal by Subject|0|||
146201572|NCT04424641|527250116|FG000|Overall Study|Other|0|||
146201573|NCT04424641|527250117|FG001|Overall Study|Other|0|||
146201574|NCT04424641|527250118|FG002|Overall Study|Other|1|||
146201575|NCT04424641|527250119|FG003|Overall Study|Other|0|||
146201576|NCT04424641|527250120|FG004|Overall Study|Other|0|||
146201577|NCT04424641|527250121|FG005|Overall Study|Other|0|||
146201578|NCT04424641|527250122|FG006|Overall Study|Other|0|||
146201579|NCT04424641|527250123|FG007|Overall Study|Other|0|||
146201580|NCT01171625|527250130|FG000|Overall Study|On-Protocol|67|||
146201581|NCT01171625|527250130|FG000|Overall Study|Death|38|||
146201582|NCT01171625|527250130|FG000|Overall Study|Withdrawal by Subject|31|||
146201583|NCT01171625|527250130|FG000|Overall Study|Explanted|10|||
146201584|NCT01171625|527250130|FG000|Overall Study|Lost to Follow-up|5|||
146201585|NCT01171625|527250130|FG000|Overall Study|Patient received valve-in-valve|3|||
146201586|NCT01171625|527250130|FG000|Overall Study|Other|1|||
146201587|NCT01171625|527250130|FG000|Overall Study|Consented but did not receive device|25|||
146201588|NCT03557008|527250131|FG000|Overall Study|Withdrawal by Subject|2|||
146201589|NCT03557008|527250132|FG001|Overall Study|Withdrawal by Subject|2|||
146201590|NCT03557008|527250131|FG000|Overall Study|Early termination from study|3|||
146201591|NCT03557008|527250132|FG001|Overall Study|Early termination from study|1|||
146201592|NCT02969863|527250135|FG000|Overall Study|Physician Decision|1|||
146201593|NCT02969863|527250136|FG001|Overall Study|Physician Decision|0|||
146201594|NCT02969863|527250137|FG002|Overall Study|Physician Decision|0|||
146201595|NCT02969863|527250138|FG003|Overall Study|Physician Decision|0|||
146201596|NCT02969863|527250139|FG004|Overall Study|Physician Decision|0|||
146201597|NCT02969863|527250140|FG005|Overall Study|Physician Decision|0|||
146201598|NCT02705586|527250147|FG000|Overall Study|Health Issues|2|||
146201599|NCT02705586|527250147|FG000|Overall Study|Transportation Difficulties|5|||
146201600|NCT02705586|527250147|FG000|Overall Study|Vacation/Planned Absence|1|||
146201601|NCT02045836|527250151|FG000|Overall Study|Adverse Event|4|||
146201602|NCT02045836|527250152|FG001|Overall Study|Adverse Event|4|||
146201603|NCT02045836|527250151|FG000|Overall Study|Withdrawal by Subject|1|||
146201604|NCT02045836|527250152|FG001|Overall Study|Withdrawal by Subject|1|||
146201605|NCT02045836|527250151|FG000|Overall Study|Lost to Follow-up|4|||
146201606|NCT02045836|527250152|FG001|Overall Study|Lost to Follow-up|7|||
146201607|NCT02045836|527250151|FG000|Overall Study|Migrated from study area|0|||
146201608|NCT02045836|527250152|FG001|Overall Study|Migrated from study area|2|||
146201609|NCT03920215|527250154|FG000|Overall Study|Lost to Follow-up|1|||
146201610|NCT03920215|527250155|FG001|Overall Study|Lost to Follow-up|2|||
146201611|NCT03920215|527250156|FG002|Overall Study|Lost to Follow-up|0|||
146201612|NCT03920215|527250157|FG003|Overall Study|Lost to Follow-up|0|||
146201613|NCT03920215|527250154|FG000|Overall Study|Death|0|||
146201614|NCT03920215|527250155|FG001|Overall Study|Death|0|||
146201615|NCT03920215|527250156|FG002|Overall Study|Death|0|||
146201616|NCT03920215|527250157|FG003|Overall Study|Death|1|||
146201617|NCT02798835|527250158|FG000|Overall Study|Protocol Violation|0|||
146201618|NCT02798835|527250159|FG001|Overall Study|Protocol Violation|0|||
146201619|NCT02798835|527250160|FG002|Overall Study|Protocol Violation|3|||
146201620|NCT03024606|527250165|FG000|Overall Study|Withdrawal by Subject|9|||
146201621|NCT03024606|527250166|FG001|Overall Study|Withdrawal by Subject|10|||
146201622|NCT02547922|527250173|FG000|Overall Study|Withdrawal by Subject|9|||
146201623|NCT02547922|527250174|FG001|Overall Study|Withdrawal by Subject|6|||
146201624|NCT02547922|527250175|FG002|Overall Study|Withdrawal by Subject|10|||
146201625|NCT02547922|527250173|FG000|Overall Study|Adverse Event|3|||
146201626|NCT02547922|527250174|FG001|Overall Study|Adverse Event|1|||
146201627|NCT02547922|527250175|FG002|Overall Study|Adverse Event|2|||
146201628|NCT02547922|527250173|FG000|Overall Study|Lost to Follow-up|1|||
146201629|NCT02547922|527250174|FG001|Overall Study|Lost to Follow-up|0|||
146201630|NCT02547922|527250175|FG002|Overall Study|Lost to Follow-up|0|||
146201631|NCT02547922|527250173|FG000|Overall Study|Lack of Efficacy|5|||
146201632|NCT02547922|527250174|FG001|Overall Study|Lack of Efficacy|7|||
146201633|NCT02547922|527250175|FG002|Overall Study|Lack of Efficacy|4|||
146201634|NCT02547922|527250173|FG000|Overall Study|Death|1|||
146201635|NCT02547922|527250174|FG001|Overall Study|Death|0|||
146201636|NCT02547922|527250175|FG002|Overall Study|Death|0|||
146201637|NCT02547922|527250173|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
146201638|NCT02547922|527250174|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
146201639|NCT02547922|527250175|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
146201640|NCT02547922|527250173|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
146201641|NCT02547922|527250174|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
146201642|NCT02547922|527250175|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
146201643|NCT02547922|527250173|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
146201644|NCT02547922|527250174|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
146201645|NCT02547922|527250175|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
146201646|NCT02547922|527250173|FG000|Overall Study|Physician Decision|2|||
146201647|NCT02547922|527250174|FG001|Overall Study|Physician Decision|1|||
146201648|NCT02547922|527250175|FG002|Overall Study|Physician Decision|2|||
146201649|NCT02547922|527250173|FG000|Overall Study|Patients did not receive IP|1|||
146201650|NCT02547922|527250174|FG001|Overall Study|Patients did not receive IP|1|||
146201651|NCT02547922|527250175|FG002|Overall Study|Patients did not receive IP|0|||
146201652|NCT00102063|527250180|FG000|Overall Study|Lack of Efficacy|5|||
146201653|NCT00102063|527250181|FG001|Overall Study|Lack of Efficacy|1|||
146429146|NCT01706536|528077763|FG003|Overall Study|Lack of Efficacy|1|||
146429147|NCT01706536|528077764|FG004|Overall Study|Lack of Efficacy|0|||
146429148|NCT01706536|528077760|FG000|Overall Study|non compliance|0|||
146429149|NCT01706536|528077761|FG001|Overall Study|non compliance|1|||
146429150|NCT01706536|528077762|FG002|Overall Study|non compliance|0|||
146429151|NCT01706536|528077763|FG003|Overall Study|non compliance|0|||
146429152|NCT01706536|528077764|FG004|Overall Study|non compliance|0|||
146429153|NCT03262012|528077765|FG000|Overall Study|Withdrawal by Subject|15|||
146429154|NCT03262012|528077766|FG001|Overall Study|Withdrawal by Subject|13|||
146429155|NCT03262012|528077767|FG002|Overall Study|Withdrawal by Subject|8|||
146429156|NCT03262012|528077768|FG003|Overall Study|Withdrawal by Subject|7|||
146429157|NCT03262012|528077765|FG000|Overall Study|Adverse Event|10|||
146429158|NCT03262012|528077766|FG001|Overall Study|Adverse Event|12|||
146429159|NCT03262012|528077767|FG002|Overall Study|Adverse Event|4|||
146429160|NCT03262012|528077768|FG003|Overall Study|Adverse Event|6|||
146429161|NCT03262012|528077765|FG000|Overall Study|Physician Decision|2|||
146429162|NCT03262012|528077766|FG001|Overall Study|Physician Decision|5|||
146429163|NCT03262012|528077767|FG002|Overall Study|Physician Decision|1|||
146429164|NCT03262012|528077768|FG003|Overall Study|Physician Decision|0|||
146429165|NCT03262012|528077765|FG000|Overall Study|Lack of Efficacy|0|||
146429166|NCT03262012|528077766|FG001|Overall Study|Lack of Efficacy|5|||
146429167|NCT03262012|528077767|FG002|Overall Study|Lack of Efficacy|1|||
146429168|NCT03262012|528077768|FG003|Overall Study|Lack of Efficacy|2|||
146429169|NCT03262012|528077765|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
146201654|NCT00102063|527250182|FG002|Overall Study|Lack of Efficacy|1|||
146201655|NCT00102063|527250180|FG000|Overall Study|Adverse Event|7|||
146201656|NCT00102063|527250181|FG001|Overall Study|Adverse Event|4|||
146201657|NCT00102063|527250182|FG002|Overall Study|Adverse Event|2|||
146201658|NCT00102063|527250180|FG000|Overall Study|Withdrawal by Subject|4|||
146201659|NCT00102063|527250181|FG001|Overall Study|Withdrawal by Subject|12|||
146201660|NCT00102063|527250182|FG002|Overall Study|Withdrawal by Subject|5|||
146201661|NCT00102063|527250180|FG000|Overall Study|Lost to Follow-up|0|||
146201662|NCT00102063|527250181|FG001|Overall Study|Lost to Follow-up|0|||
146201663|NCT00102063|527250182|FG002|Overall Study|Lost to Follow-up|1|||
146201664|NCT00102063|527250180|FG000|Overall Study|Protocol Violation|0|||
146201665|NCT00102063|527250181|FG001|Overall Study|Protocol Violation|1|||
146201666|NCT00102063|527250182|FG002|Overall Study|Protocol Violation|1|||
146201667|NCT02739035|527250185|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
146201668|NCT02739035|527250186|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
146201669|NCT02739035|527250185|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
146201670|NCT02739035|527250186|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
146201671|NCT02739035|527250185|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
146201672|NCT02739035|527250186|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
146201673|NCT02739035|527250185|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
146201674|NCT02739035|527250186|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
146201675|NCT00940992|527250189|FG000|Overall Study|Adverse Event|2|||
146201676|NCT00940992|527250190|FG001|Overall Study|Adverse Event|0|||
146429170|NCT03262012|528077766|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
146429171|NCT03262012|528077767|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
146429172|NCT03262012|528077768|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
146429173|NCT01469546|528077771|FG000|Received 5 mg Dose|Adverse Event|13|||
146429174|NCT01469546|528077771|FG000|Received 5 mg Dose|Death|2|||
146201677|NCT00940992|527250191|FG002|Overall Study|Adverse Event|1|||
146201678|NCT00940992|527250189|FG000|Overall Study|subject request|2|||
146201679|NCT00940992|527250190|FG001|Overall Study|subject request|1|||
146201680|NCT00940992|527250191|FG002|Overall Study|subject request|0|||
146201681|NCT00940992|527250189|FG000|Overall Study|Lost to Follow-up|0|||
146201682|NCT00940992|527250190|FG001|Overall Study|Lost to Follow-up|1|||
146201683|NCT00940992|527250191|FG002|Overall Study|Lost to Follow-up|1|||
146201684|NCT00539292|527250195|FG000|Overall Study|Physician Decision|1|||
146201685|NCT00539292|527250196|FG001|Overall Study|Physician Decision|0|||
146429175|NCT01469546|528077771|FG000|Received 5 mg Dose|Protocol Violation|2|||
146429176|NCT01469546|528077771|FG000|Received 5 mg Dose|Progressive Disease|3|||
146429177|NCT01469546|528077771|FG000|Received 5 mg Dose|Physician Decision|3|||
146429178|NCT00385684|528077774|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
146201686|NCT00630786|527250197|FG000|Overall Study|Physician Decision|0|||
146429179|NCT00385684|528077775|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
146429180|NCT00385684|528077774|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
146429181|NCT00385684|528077775|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
146429182|NCT00385684|528077774|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
146429183|NCT00385684|528077775|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
146429184|NCT02801877|528077776|FG000|Overall Study|Lost to Follow-up|1|||
146429185|NCT02801877|528077777|FG001|Overall Study|Lost to Follow-up|1|||
146429186|NCT02801877|528077778|FG002|Overall Study|Lost to Follow-up|2|||
146429187|NCT02801877|528077779|FG003|Overall Study|Lost to Follow-up|0|||
146429188|NCT02801877|528077776|FG000|Overall Study|Never Started Treatment|2|||
146429189|NCT02801877|528077777|FG001|Overall Study|Never Started Treatment|0|||
146429190|NCT02801877|528077778|FG002|Overall Study|Never Started Treatment|4|||
146429191|NCT02801877|528077779|FG003|Overall Study|Never Started Treatment|0|||
146429192|NCT00463606|528077780|FG000|Overall Study|Adverse Event|21|||
146429193|NCT00463606|528077781|FG001|Overall Study|Adverse Event|18|||
146429194|NCT00463606|528077782|FG002|Overall Study|Adverse Event|11|||
146429195|NCT00463606|528077780|FG000|Overall Study|Withdrawal by Subject|11|||
146429196|NCT00463606|528077781|FG001|Overall Study|Withdrawal by Subject|11|||
146429197|NCT00463606|528077782|FG002|Overall Study|Withdrawal by Subject|5|||
146429198|NCT00463606|528077780|FG000|Overall Study|Lost to Follow-up|2|||
146429199|NCT00463606|528077781|FG001|Overall Study|Lost to Follow-up|2|||
146429200|NCT00463606|528077782|FG002|Overall Study|Lost to Follow-up|3|||
146429201|NCT00463606|528077780|FG000|Overall Study|Subject noncompliance|1|||
146429202|NCT00463606|528077781|FG001|Overall Study|Subject noncompliance|1|||
146429203|NCT00463606|528077782|FG002|Overall Study|Subject noncompliance|0|||
146429204|NCT00463606|528077780|FG000|Overall Study|Subject moved out of town|1|||
146429205|NCT00463606|528077781|FG001|Overall Study|Subject moved out of town|0|||
146429206|NCT00463606|528077782|FG002|Overall Study|Subject moved out of town|0|||
146429207|NCT00463606|528077780|FG000|Overall Study|Physician Decision|0|||
146429208|NCT00463606|528077781|FG001|Overall Study|Physician Decision|1|||
146429209|NCT00463606|528077782|FG002|Overall Study|Physician Decision|0|||
146429210|NCT00463606|528077780|FG000|Overall Study|Sponsor request|0|||
146429211|NCT00463606|528077781|FG001|Overall Study|Sponsor request|1|||
146429212|NCT00463606|528077782|FG002|Overall Study|Sponsor request|0|||
146429213|NCT00463606|528077780|FG000|Overall Study|Exclusion criteria violation|2|||
146429214|NCT00463606|528077781|FG001|Overall Study|Exclusion criteria violation|0|||
146429215|NCT00463606|528077782|FG002|Overall Study|Exclusion criteria violation|0|||
146429216|NCT00463606|528077780|FG000|Overall Study|Coordinator error|1|||
146429217|NCT00463606|528077781|FG001|Overall Study|Coordinator error|0|||
146429218|NCT00463606|528077782|FG002|Overall Study|Coordinator error|0|||
146429219|NCT00463606|528077780|FG000|Overall Study|Patient randomized in error|1|||
146429220|NCT00463606|528077781|FG001|Overall Study|Patient randomized in error|0|||
146429221|NCT00463606|528077782|FG002|Overall Study|Patient randomized in error|0|||
146429222|NCT00463606|528077780|FG000|Overall Study|Participation in another ABT-335 trial|1|||
146429223|NCT00463606|528077781|FG001|Overall Study|Participation in another ABT-335 trial|0|||
145949927|NCT00482170|526328708|FG001|Overall Study|Unspecified reason|2|||
145949928|NCT01134263|526328709|FG000|Overall Study|Serious adverse event|2|||
145949929|NCT01134263|526328710|FG001|Overall Study|Serious adverse event|1|||
145949930|NCT01134263|526328711|FG002|Overall Study|Serious adverse event|1|||
145949931|NCT01134263|526328712|FG003|Overall Study|Serious adverse event|1|||
145949932|NCT01134263|526328713|FG004|Overall Study|Serious adverse event|1|||
145949933|NCT01134263|526328709|FG000|Overall Study|Other adverse event|1|||
146201687|NCT00630786|527250198|FG001|Overall Study|Physician Decision|0|||
146201688|NCT00630786|527250199|FG002|Overall Study|Physician Decision|1|||
146201689|NCT00630786|527250197|FG000|Overall Study|Withdrawal by Subject|0|||
145949934|NCT01134263|526328710|FG001|Overall Study|Other adverse event|2|||
145949935|NCT01134263|526328711|FG002|Overall Study|Other adverse event|5|||
145949936|NCT01134263|526328712|FG003|Overall Study|Other adverse event|3|||
146201690|NCT00630786|527250198|FG001|Overall Study|Withdrawal by Subject|1|||
146201691|NCT00630786|527250199|FG002|Overall Study|Withdrawal by Subject|1|||
146429224|NCT00463606|528077782|FG002|Overall Study|Participation in another ABT-335 trial|0|||
146429225|NCT00463606|528077780|FG000|Overall Study|Protocol Violation|0|||
146429226|NCT00463606|528077781|FG001|Overall Study|Protocol Violation|0|||
146429227|NCT00463606|528077782|FG002|Overall Study|Protocol Violation|1|||
146429228|NCT01223365|528077783|FG000|Open-label Titration Period|Enrolled but not treated|1|||
146429229|NCT01223365|528077783|FG000|Open-label Titration Period|Adverse Event|23|||
145949937|NCT01134263|526328713|FG004|Overall Study|Other adverse event|0|||
146201692|NCT00630786|527250197|FG000|Overall Study|Lost to Follow-up|0|||
146429230|NCT01223365|528077783|FG000|Open-label Titration Period|Lack of Efficacy|3|||
146429231|NCT01223365|528077783|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
146429232|NCT01223365|528077783|FG000|Open-label Titration Period|Protocol Violation|1|||
146429233|NCT01223365|528077783|FG000|Open-label Titration Period|Lost to Follow-up|2|||
146429234|NCT01223365|528077783|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
146429235|NCT01223365|528077783|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
146429236|NCT01223365|528077783|FG000|Open-label Titration Period|Starting physical therapy|1|||
146429237|NCT01223365|528077783|FG000|Open-label Treatment Period|Adverse Event|39|||
146429238|NCT01223365|528077783|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
146429239|NCT01223365|528077783|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
146429240|NCT01223365|528077783|FG000|Open-label Treatment Period|Protocol Violation|15|||
146429241|NCT01223365|528077783|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
146429242|NCT01223365|528077783|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
146429243|NCT01223365|528077783|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
146429244|NCT01223365|528077783|FG000|Open-label Treatment Period|Moved out of area|2|||
146429245|NCT01223365|528077783|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
146429246|NCT01223365|528077783|FG000|Open-label Treatment Period|"Out of window"|1|||
146429247|NCT01223365|528077783|FG000|Open-label Treatment Period|Starting physical therapy|1|||
146429248|NCT01223365|528077783|FG000|Open-label Treatment Period|Physician Decision|2|||
146429249|NCT02682602|528077784|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
146429250|NCT02682602|528077785|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
146429251|NCT02682602|528077784|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
146429252|NCT02682602|528077785|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
146429253|NCT02140060|528077786|FG000|Overall Study|Adverse Event|0|||
146429254|NCT02140060|528077787|FG001|Overall Study|Adverse Event|0|||
146429255|NCT02140060|528077788|FG002|Overall Study|Adverse Event|0|||
146429256|NCT02140060|528077789|FG003|Overall Study|Adverse Event|1|||
146429257|NCT02140060|528077790|FG004|Overall Study|Adverse Event|1|||
146429258|NCT02140060|528077791|FG005|Overall Study|Adverse Event|1|||
146429259|NCT02140060|528077786|FG000|Overall Study|Lack of Efficacy|0|||
146201693|NCT00630786|527250198|FG001|Overall Study|Lost to Follow-up|1|||
146201694|NCT00630786|527250199|FG002|Overall Study|Lost to Follow-up|0|||
146201695|NCT00630786|527250197|FG000|Overall Study|Other|1|||
146201696|NCT00630786|527250198|FG001|Overall Study|Other|0|||
146201697|NCT00630786|527250199|FG002|Overall Study|Other|0|||
146201698|NCT00324038|527250205|FG000|Overall Study|Adverse Event|38|||
146201699|NCT00324038|527250206|FG001|Overall Study|Adverse Event|23|||
146201700|NCT00324038|527250205|FG000|Overall Study|Lack of Efficacy|5|||
146201701|NCT00324038|527250206|FG001|Overall Study|Lack of Efficacy|13|||
146201702|NCT00324038|527250205|FG000|Overall Study|Lost to Follow-up|0|||
146201703|NCT00324038|527250206|FG001|Overall Study|Lost to Follow-up|2|||
146201704|NCT00324038|527250205|FG000|Overall Study|Other|6|||
146201705|NCT00324038|527250206|FG001|Overall Study|Other|13|||
146201706|NCT00688519|527250207|FG000|Overall Study|Adverse Event|2|||
146201707|NCT00688519|527250208|FG001|Overall Study|Adverse Event|3|||
146201708|NCT00688519|527250207|FG000|Overall Study|Lost to Follow-up|3|||
146201709|NCT00688519|527250208|FG001|Overall Study|Lost to Follow-up|3|||
146201710|NCT00688519|527250207|FG000|Overall Study|Lack of Efficacy|3|||
146201711|NCT00688519|527250208|FG001|Overall Study|Lack of Efficacy|1|||
146201712|NCT00688519|527250207|FG000|Overall Study|Withdrawal by Subject|7|||
146201713|NCT00688519|527250208|FG001|Overall Study|Withdrawal by Subject|6|||
146201714|NCT00688519|527250207|FG000|Overall Study|Prohibited medication|1|||
146201715|NCT00688519|527250208|FG001|Overall Study|Prohibited medication|0|||
146201716|NCT00688519|527250207|FG000|Overall Study|Non-compliance|0|||
146201717|NCT00688519|527250208|FG001|Overall Study|Non-compliance|1|||
146201718|NCT00688519|527250207|FG000|Overall Study|Subject moved out of state|1|||
146201719|NCT00688519|527250208|FG001|Overall Study|Subject moved out of state|0|||
146201720|NCT00688519|527250207|FG000|Overall Study|Investigator decision|1|||
146201721|NCT00688519|527250208|FG001|Overall Study|Investigator decision|0|||
146201722|NCT00688519|527250207|FG000|Overall Study|Subject moved out of area|1|||
146201723|NCT00688519|527250208|FG001|Overall Study|Subject moved out of area|0|||
146201724|NCT00688519|527250207|FG000|Overall Study|Pregnancy|0|||
146201725|NCT00688519|527250208|FG001|Overall Study|Pregnancy|1|||
146201726|NCT03284957|527252133|FG000|Overall Study|Adverse Event|0|||
146429260|NCT02140060|528077787|FG001|Overall Study|Lack of Efficacy|0|||
146429261|NCT02140060|528077788|FG002|Overall Study|Lack of Efficacy|0|||
146429262|NCT02140060|528077789|FG003|Overall Study|Lack of Efficacy|1|||
146429263|NCT02140060|528077790|FG004|Overall Study|Lack of Efficacy|0|||
146429264|NCT02140060|528077791|FG005|Overall Study|Lack of Efficacy|0|||
146429265|NCT00520130|528079899|FG000|Overall Study|Disease progression on study|4|||
146429266|NCT00520130|528079900|FG001|Overall Study|Disease progression on study|0|||
146429267|NCT00520130|528079899|FG000|Overall Study|Physician Decision|1|||
146429268|NCT00520130|528079900|FG001|Overall Study|Physician Decision|1|||
146429269|NCT04915755|528079901|FG000|Overall Study|Physician Decision|3|||
146429270|NCT04915755|528079902|FG001|Overall Study|Physician Decision|2|||
146429271|NCT04915755|528079901|FG000|Overall Study|Withdrawal by Subject|1|||
146429272|NCT04915755|528079902|FG001|Overall Study|Withdrawal by Subject|1|||
146429273|NCT04915755|528079901|FG000|Overall Study|Ongoing for PACT|3|||
146429274|NCT04915755|528079902|FG001|Overall Study|Ongoing for PACT|2|||
146429275|NCT04915755|528079901|FG000|Overall Study|Other|7|||
146429276|NCT04915755|528079902|FG001|Overall Study|Other|11|||
146429277|NCT01993030|528079906|FG000|Overall Study|Adverse Event|0|||
146429278|NCT01993030|528079907|FG001|Overall Study|Adverse Event|4|||
146429279|NCT02736721|528079908|FG000|Overall Study|Adverse Event|8|||
146429280|NCT02736721|528079908|FG000|Overall Study|Lost to Follow-up|3|||
146429281|NCT02736721|528079908|FG000|Overall Study|Other|5|||
146429282|NCT01034358|528079909|FG000|Overall Study|Withdrawal by Subject|1|||
146429283|NCT01034358|528079909|FG000|Overall Study|Protocol Violation|1|||
146429284|NCT01838941|528079910|FG000|Overall Study|Adverse Event|1|||
146429285|NCT01838941|528079910|FG000|Overall Study|Withdrawal by Subject|1|||
146429286|NCT01534663|528079913|FG000|Overall Study|Lost to Follow-up|0|||
146429287|NCT01534663|528079914|FG001|Overall Study|Lost to Follow-up|2|||
146429288|NCT01534663|528079913|FG000|Overall Study|Adverse Event|2|||
146429289|NCT01534663|528079914|FG001|Overall Study|Adverse Event|1|||
146429290|NCT04088760|528079917|FG000|Overall Study|Physician Decision|1|||
146429291|NCT00377260|528079918|FG000|Overall Study|Lost to Follow-up|0|||
146429292|NCT00377260|528079919|FG001|Overall Study|Lost to Follow-up|1|||
146429293|NCT00377260|528079918|FG000|Overall Study|Withdrawal by Subject|2|||
146429294|NCT00377260|528079919|FG001|Overall Study|Withdrawal by Subject|4|||
146429295|NCT01391793|528079920|FG000|Overall Study|Ineligible|3|||
146429296|NCT01391793|528079921|FG001|Overall Study|Ineligible|0|||
146429297|NCT01391793|528079920|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
146429298|NCT01391793|528079921|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
146429299|NCT01391793|528079920|FG000|Overall Study|No DMSA|73|||
146429300|NCT01391793|528079921|FG001|Overall Study|No DMSA|57|||
146429301|NCT01015625|528079922|FG000|Overall Study|Lost to Follow-up|3|||
146429302|NCT01015625|528079923|FG001|Overall Study|Lost to Follow-up|1|||
146429303|NCT01015625|528079922|FG000|Overall Study|Withdrawal by Subject|2|||
146429304|NCT01015625|528079923|FG001|Overall Study|Withdrawal by Subject|3|||
146429305|NCT01015625|528079922|FG000|Overall Study|Physician Decision|2|||
146429306|NCT01015625|528079923|FG001|Overall Study|Physician Decision|0|||
146429307|NCT01015625|528079922|FG000|Overall Study|Death|30|||
146429308|NCT01015625|528079923|FG001|Overall Study|Death|22|||
146429309|NCT03136380|528079925|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146429310|NCT03136380|528079926|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
146429311|NCT03136380|528079927|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146429312|NCT03136380|528079928|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146429313|NCT03136380|528079929|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
146429314|NCT02419937|528079933|FG000|Overall Study|Lost to Follow-up|1|||
146429315|NCT02419937|528079934|FG001|Overall Study|Lost to Follow-up|0|||
146429316|NCT00286754|528079935|FG000|Overall Study|Adverse Event|2|||
146429317|NCT00286754|528079936|FG001|Overall Study|Adverse Event|2|||
146429318|NCT00286754|528079937|FG002|Overall Study|Adverse Event|3|||
146429319|NCT00286754|528079935|FG000|Overall Study|Withdrawal by Subject|6|||
145949938|NCT01134263|526328709|FG000|Overall Study|Protocol Violation|8|||
145949939|NCT01134263|526328710|FG001|Overall Study|Protocol Violation|7|||
146429320|NCT00286754|528079936|FG001|Overall Study|Withdrawal by Subject|2|||
146429321|NCT00286754|528079937|FG002|Overall Study|Withdrawal by Subject|0|||
146429322|NCT00286754|528079935|FG000|Overall Study|Lost to Follow-up|12|||
146429323|NCT00286754|528079936|FG001|Overall Study|Lost to Follow-up|14|||
146429324|NCT00286754|528079937|FG002|Overall Study|Lost to Follow-up|6|||
146429325|NCT00286754|528079935|FG000|Overall Study|Moved out of state|0|||
146429326|NCT00286754|528079936|FG001|Overall Study|Moved out of state|0|||
146429327|NCT00286754|528079937|FG002|Overall Study|Moved out of state|1|||
146429328|NCT02661295|528079938|FG000|Overall Study|Death|1|||
146429329|NCT02661295|528079938|FG000|Overall Study|Transferred Out|1|||
146429330|NCT02661295|528079938|FG000|Overall Study|Kidney Transplant|1|||
146429331|NCT02661295|528079938|FG000|Overall Study|Withdrawn due to side effects|8|||
146429332|NCT02661295|528079938|FG000|Overall Study|Withdrawn due to access type|1|||
146429333|NCT02661295|528079938|FG000|Overall Study|Withdrawn due to allergies|1|||
146429334|NCT02661295|528079938|FG000|Overall Study|Withdrawn due to non-compliance|1|||
146429335|NCT02661295|528079938|FG000|Overall Study|Withdrawal by Subject|3|||
146429336|NCT02661295|528079938|FG000|Overall Study|Failed screening|2|||
146429337|NCT00910663|528079939|FG000|Period 1|Withdrawal by Subject|0|||
146429338|NCT00910663|528079940|FG001|Period 1|Withdrawal by Subject|1|||
146429339|NCT02726581|528079941|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146429340|NCT02726581|528079942|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
146429341|NCT02726581|528079943|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146429342|NCT02726581|528079941|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
146429343|NCT02726581|528079942|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
146429344|NCT02726581|528079943|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
146429345|NCT02726581|528079941|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146429346|NCT02726581|528079942|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146429347|NCT02726581|528079943|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146429348|NCT02726581|528079941|FG000|Treatment Period|Disease progression|47|||
146429349|NCT02726581|528079942|FG001|Treatment Period|Disease progression|50|||
146429350|NCT02726581|528079943|FG002|Treatment Period|Disease progression|16|||
146429351|NCT02726581|528079941|FG000|Treatment Period|Other reasons|9|||
146429352|NCT02726581|528079942|FG001|Treatment Period|Other reasons|8|||
146429353|NCT02726581|528079943|FG002|Treatment Period|Other reasons|2|||
146429354|NCT02726581|528079941|FG000|Treatment Period|Study drug toxicity|6|||
146429355|NCT02726581|528079942|FG001|Treatment Period|Study drug toxicity|3|||
146429356|NCT02726581|528079943|FG002|Treatment Period|Study drug toxicity|2|||
146429357|NCT02726581|528079941|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
146429358|NCT02726581|528079942|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
146429359|NCT02726581|528079943|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
146429360|NCT02726581|528079941|FG000|Treatment Period|Participant withdrew consent|3|||
146429361|NCT02726581|528079942|FG001|Treatment Period|Participant withdrew consent|1|||
146429362|NCT02726581|528079943|FG002|Treatment Period|Participant withdrew consent|1|||
146429363|NCT02726581|528079941|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
146429364|NCT02726581|528079942|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
146429365|NCT02726581|528079943|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
146429366|NCT02726581|528079941|FG000|Treatment Period|Maximum clinical benefit|0|||
146429367|NCT02726581|528079942|FG001|Treatment Period|Maximum clinical benefit|2|||
146429368|NCT02726581|528079943|FG002|Treatment Period|Maximum clinical benefit|0|||
146429369|NCT02726581|528079941|FG000|Treatment Period|Death|1|||
146429370|NCT02726581|528079942|FG001|Treatment Period|Death|0|||
146429371|NCT02726581|528079943|FG002|Treatment Period|Death|0|||
146429372|NCT02726581|528079941|FG000|Treatment Period|Poor/non-compliance|1|||
146429373|NCT02726581|528079942|FG001|Treatment Period|Poor/non-compliance|0|||
146429374|NCT02726581|528079943|FG002|Treatment Period|Poor/non-compliance|0|||
146429375|NCT02726581|528079941|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146429376|NCT02726581|528079942|FG001|Treatment Period|Participant no longer meets study criteria|1|||
146429377|NCT02726581|528079943|FG002|Treatment Period|Participant no longer meets study criteria|0|||
146429378|NCT02865850|528079944|FG000|Overall Study|Death|15|||
146429379|NCT02865850|528079945|FG001|Overall Study|Death|19|||
146429380|NCT02865850|528079944|FG000|Overall Study|Withdrawal by Subject|3|||
146429381|NCT02865850|528079945|FG001|Overall Study|Withdrawal by Subject|2|||
146429382|NCT02865850|528079944|FG000|Overall Study|Lost to Follow-up|3|||
146429383|NCT02865850|528079945|FG001|Overall Study|Lost to Follow-up|2|||
146429384|NCT01844375|528079949|FG000|Overall Study|Protocol Violation|1|||
146429385|NCT01844375|528079950|FG001|Overall Study|Protocol Violation|1|||
146429386|NCT01772537|528079952|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
146429387|NCT01772537|528079953|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
146429388|NCT01772537|528079954|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
146429389|NCT03627091|528079955|FG000|Overall Study|Adverse Event|0|||
146429390|NCT03627091|528079956|FG001|Overall Study|Adverse Event|0|||
146429391|NCT03627091|528079957|FG002|Overall Study|Adverse Event|2|||
146429392|NCT03627091|528079955|FG000|Overall Study|Withdrawal by Subject|2|||
146201727|NCT03284957|527252134|FG001|Overall Study|Adverse Event|0|||
146201728|NCT03284957|527252135|FG002|Overall Study|Adverse Event|0|||
146201729|NCT03284957|527252136|FG003|Overall Study|Adverse Event|0|||
146429393|NCT03627091|528079956|FG001|Overall Study|Withdrawal by Subject|0|||
146429394|NCT03627091|528079957|FG002|Overall Study|Withdrawal by Subject|2|||
146429395|NCT03627091|528079955|FG000|Overall Study|Physician Decision|2|||
145949940|NCT01134263|526328711|FG002|Overall Study|Protocol Violation|2|||
146429396|NCT03627091|528079956|FG001|Overall Study|Physician Decision|0|||
146429397|NCT03627091|528079957|FG002|Overall Study|Physician Decision|0|||
146429398|NCT03627091|528079955|FG000|Overall Study|Site terminated by sponsor|0|||
146429399|NCT03627091|528079956|FG001|Overall Study|Site terminated by sponsor|1|||
146429400|NCT03627091|528079957|FG002|Overall Study|Site terminated by sponsor|0|||
146429401|NCT03627091|528079955|FG000|Overall Study|Disease relapse|7|||
146429402|NCT03627091|528079956|FG001|Overall Study|Disease relapse|5|||
146429403|NCT03627091|528079957|FG002|Overall Study|Disease relapse|1|||
146429404|NCT03627091|528079955|FG000|Overall Study|Other|1|||
146429405|NCT03627091|528079956|FG001|Overall Study|Other|0|||
146429406|NCT03627091|528079957|FG002|Overall Study|Other|0|||
146429407|NCT00450190|528079958|FG000|Overall Study|Withdrawal by Subject|2|||
146429408|NCT01536574|528079959|FG000|Overall Study|Adverse Event|4|||
146429409|NCT01536574|528079960|FG001|Overall Study|Adverse Event|5|||
146429410|NCT01536574|528079959|FG000|Overall Study|Withdrawal by Subject|1|||
146429411|NCT01536574|528079960|FG001|Overall Study|Withdrawal by Subject|2|||
146429412|NCT01536574|528079959|FG000|Overall Study|Lack of Efficacy|1|||
146429413|NCT01536574|528079960|FG001|Overall Study|Lack of Efficacy|0|||
146429414|NCT01376167|528079961|FG000|Overall Study|Lost to Follow-up|2|||
146429415|NCT01376167|528079962|FG001|Overall Study|Lost to Follow-up|4|||
146429416|NCT01376167|528079963|FG002|Overall Study|Lost to Follow-up|2|||
146429417|NCT01376167|528079961|FG000|Overall Study|Physician Decision|1|||
146429418|NCT01376167|528079962|FG001|Overall Study|Physician Decision|1|||
146429419|NCT01376167|528079963|FG002|Overall Study|Physician Decision|0|||
146429420|NCT01376167|528079961|FG000|Overall Study|Withdrawal by Subject|1|||
146429421|NCT01376167|528079962|FG001|Overall Study|Withdrawal by Subject|5|||
146429422|NCT01376167|528079963|FG002|Overall Study|Withdrawal by Subject|4|||
146429423|NCT00834756|528079964|FG000|First Intervention|Adverse Event|1|||
146429424|NCT00834756|528079965|FG001|First Intervention|Adverse Event|0|||
146429425|NCT00834756|528079964|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
146429426|NCT00834756|528079965|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
146429427|NCT02193165|528079968|FG000|4 Week Product Use|Lost to Follow-up|1|||
146429428|NCT02193165|528079969|FG001|4 Week Product Use|Lost to Follow-up|1|||
146429429|NCT02193165|528079970|FG002|4 Week Product Use|Lost to Follow-up|1|||
146429430|NCT02193165|528079968|FG000|6 Week Product Use|Lost to Follow-up|0|||
146429431|NCT02193165|528079969|FG001|6 Week Product Use|Lost to Follow-up|1|||
146429432|NCT02193165|528079970|FG002|6 Week Product Use|Lost to Follow-up|0|||
146429433|NCT04239872|528079971|FG000|Overall Study|Lost to Follow-up|0|||
146429434|NCT04239872|528079972|FG001|Overall Study|Lost to Follow-up|1|||
146429435|NCT01498120|528079976|FG000|Overall Study|Lost to Follow-up|1|||
146429436|NCT01498120|528079976|FG000|Overall Study|Withdrawal by Subject|5|||
146429437|NCT01498120|528079976|FG000|Overall Study|AE, non-serious non-fatal|3|||
146429438|NCT01498120|528079976|FG000|Overall Study|Other|4|||
146429439|NCT01173692|528079977|FG000|Overall Study|Adverse Event|1|||
146429440|NCT01173692|528079978|FG001|Overall Study|Adverse Event|2|||
146429441|NCT01173692|528079977|FG000|Overall Study|Withdrawal by Subject|1|||
146429442|NCT01173692|528079978|FG001|Overall Study|Withdrawal by Subject|3|||
146429443|NCT01472341|528079979|FG000|Overall Study|Started insulin therapy|55|||
145949941|NCT01134263|526328712|FG003|Overall Study|Protocol Violation|4|||
145949942|NCT01134263|526328713|FG004|Overall Study|Protocol Violation|2|||
145949943|NCT01134263|526328709|FG000|Overall Study|Lost to Follow-up|4|||
145949944|NCT01134263|526328710|FG001|Overall Study|Lost to Follow-up|3|||
146429444|NCT01472341|528079979|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
145949945|NCT01134263|526328711|FG002|Overall Study|Lost to Follow-up|5|||
145949946|NCT01134263|526328712|FG003|Overall Study|Lost to Follow-up|3|||
145949947|NCT01134263|526328713|FG004|Overall Study|Lost to Follow-up|1|||
145949948|NCT01134263|526328709|FG000|Overall Study|Withdrawal by Subject|8|||
145949949|NCT01134263|526328710|FG001|Overall Study|Withdrawal by Subject|6|||
145949950|NCT01134263|526328711|FG002|Overall Study|Withdrawal by Subject|16|||
145949951|NCT01134263|526328712|FG003|Overall Study|Withdrawal by Subject|7|||
145949952|NCT01134263|526328713|FG004|Overall Study|Withdrawal by Subject|5|||
145949953|NCT01134263|526328709|FG000|Overall Study|Enrolled, but not treated|1|||
145949954|NCT01134263|526328710|FG001|Overall Study|Enrolled, but not treated|1|||
146429445|NCT01472341|528079979|FG000|Overall Study|Withdrawal by Subject|39|||
145949955|NCT01134263|526328711|FG002|Overall Study|Enrolled, but not treated|0|||
146429446|NCT01472341|528079979|FG000|Overall Study|Lost to Follow-up|52|||
145949956|NCT01134263|526328712|FG003|Overall Study|Enrolled, but not treated|1|||
145949957|NCT01134263|526328713|FG004|Overall Study|Enrolled, but not treated|0|||
146429447|NCT01472341|528079979|FG000|Overall Study|Laboratory parameters unavailable|25|||
146429448|NCT01472341|528079979|FG000|Overall Study|Death|9|||
146429449|NCT00579670|528079980|FG000|Overall Study|Death|1|||
146429450|NCT00579670|528079981|FG001|Overall Study|Death|0|||
146429451|NCT00579670|528079982|FG002|Overall Study|Death|0|||
146429452|NCT00579670|528079983|FG003|Overall Study|Death|0|||
146429453|NCT00579670|528079984|FG004|Overall Study|Death|0|||
146429454|NCT00579670|528079980|FG000|Overall Study|Adverse Event|1|||
146429455|NCT00579670|528079981|FG001|Overall Study|Adverse Event|0|||
146429456|NCT00579670|528079982|FG002|Overall Study|Adverse Event|1|||
146429457|NCT00579670|528079983|FG003|Overall Study|Adverse Event|2|||
146429458|NCT00579670|528079984|FG004|Overall Study|Adverse Event|0|||
146429459|NCT00579670|528079980|FG000|Overall Study|Lack of Efficacy|0|||
146429460|NCT00579670|528079981|FG001|Overall Study|Lack of Efficacy|0|||
146429461|NCT00579670|528079982|FG002|Overall Study|Lack of Efficacy|1|||
146429462|NCT00579670|528079983|FG003|Overall Study|Lack of Efficacy|14|||
146429463|NCT00579670|528079984|FG004|Overall Study|Lack of Efficacy|0|||
146429464|NCT00579670|528079980|FG000|Overall Study|Lost to Follow-up|0|||
146429465|NCT00579670|528079981|FG001|Overall Study|Lost to Follow-up|1|||
146429466|NCT00579670|528079982|FG002|Overall Study|Lost to Follow-up|0|||
146429467|NCT00579670|528079983|FG003|Overall Study|Lost to Follow-up|4|||
146429468|NCT00579670|528079984|FG004|Overall Study|Lost to Follow-up|0|||
146429469|NCT00579670|528079980|FG000|Overall Study|Other|0|||
146429470|NCT00579670|528079981|FG001|Overall Study|Other|0|||
146429471|NCT00579670|528079982|FG002|Overall Study|Other|1|||
146429472|NCT00579670|528079983|FG003|Overall Study|Other|2|||
146429473|NCT00579670|528079984|FG004|Overall Study|Other|0|||
146429474|NCT00579670|528079980|FG000|Overall Study|Withdrawal by Subject|0|||
146429475|NCT00579670|528079981|FG001|Overall Study|Withdrawal by Subject|0|||
146429476|NCT00579670|528079982|FG002|Overall Study|Withdrawal by Subject|1|||
146429477|NCT00579670|528079983|FG003|Overall Study|Withdrawal by Subject|0|||
146429478|NCT00579670|528079984|FG004|Overall Study|Withdrawal by Subject|0|||
146429479|NCT01118312|528079988|FG000|Overall Study|Lost to Follow-up|33|||
146429480|NCT01118312|528079989|FG001|Overall Study|Lost to Follow-up|32|||
146429481|NCT01118312|528079988|FG000|Overall Study|Withdrawal by Subject|1|||
146429482|NCT01118312|528079989|FG001|Overall Study|Withdrawal by Subject|3|||
146429483|NCT00678639|528079990|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
146429484|NCT00678639|528079991|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
146429485|NCT01546545|528079994|FG000|Overall Study|Withdrawal by Subject|1|||
146429486|NCT04060147|528079995|FG000|Overall Study|Withdrew consent|1|||
146429487|NCT00986245|528079996|FG000|First Intervention|Poor compliance|8|||
146429488|NCT00986245|528079997|FG001|First Intervention|Poor compliance|4|||
146429489|NCT00986245|528079996|FG000|First Intervention|Lack of Efficacy|1|||
146429490|NCT00986245|528079997|FG001|First Intervention|Lack of Efficacy|2|||
146429491|NCT00986245|528079996|FG000|First Intervention|Withdrawal by Subject|0|||
146429492|NCT00986245|528079997|FG001|First Intervention|Withdrawal by Subject|1|||
146429493|NCT00986245|528079996|FG000|First Intervention|Protocol Violation|0|||
146429494|NCT00986245|528079997|FG001|First Intervention|Protocol Violation|1|||
146429495|NCT00986245|528079996|FG000|First Intervention|Out of indication|1|||
146429496|NCT00986245|528079997|FG001|First Intervention|Out of indication|0|||
146429497|NCT00986245|528079996|FG000|Second Intervention|Poor compliance|1|||
146429498|NCT00986245|528079997|FG001|Second Intervention|Poor compliance|0|||
146429499|NCT00986245|528079996|FG000|Second Intervention|Lost to Follow-up|1|||
146429500|NCT00986245|528079997|FG001|Second Intervention|Lost to Follow-up|0|||
146429501|NCT00986245|528079996|FG000|Second Intervention|Protocol Violation|0|||
146429502|NCT00986245|528079997|FG001|Second Intervention|Protocol Violation|1|||
146429503|NCT01214850|528079998|FG000|Overall Study|Withdrawal by Subject|38|||
146429504|NCT01214850|528079999|FG001|Overall Study|Withdrawal by Subject|31|||
146429505|NCT01214850|528080000|FG002|Overall Study|Withdrawal by Subject|28|||
146429506|NCT01214850|528079998|FG000|Overall Study|Lost to Follow-up|124|||
146429507|NCT01214850|528079999|FG001|Overall Study|Lost to Follow-up|98|||
146429508|NCT01214850|528080000|FG002|Overall Study|Lost to Follow-up|123|||
146429509|NCT01214850|528079998|FG000|Overall Study|Protocol Violation|5|||
146429510|NCT01214850|528079999|FG001|Overall Study|Protocol Violation|5|||
146429511|NCT01214850|528080000|FG002|Overall Study|Protocol Violation|6|||
146429512|NCT01214850|528079998|FG000|Overall Study|Adverse event or death|11|||
146429513|NCT01214850|528079999|FG001|Overall Study|Adverse event or death|8|||
145949958|NCT03517449|526328716|FG000|Overall Study|Death|184|||
145949959|NCT03517449|526328717|FG001|Overall Study|Death|236|||
145949960|NCT03517449|526328716|FG000|Overall Study|Lost to Follow-up|0|||
145949961|NCT03517449|526328717|FG001|Overall Study|Lost to Follow-up|2|||
145949962|NCT03517449|526328716|FG000|Overall Study|Withdrawal by Subject|7|||
145949963|NCT03517449|526328717|FG001|Overall Study|Withdrawal by Subject|26|||
146429514|NCT01214850|528080000|FG002|Overall Study|Adverse event or death|3|||
146429515|NCT01214850|528079998|FG000|Overall Study|Inappropriate enrollment|2|||
146429516|NCT01214850|528079999|FG001|Overall Study|Inappropriate enrollment|1|||
146429517|NCT01214850|528080000|FG002|Overall Study|Inappropriate enrollment|0|||
145949964|NCT03517449|526328716|FG000|Overall Study|Participants Ongoing|220|||
145949965|NCT03517449|526328717|FG001|Overall Study|Participants Ongoing|152|||
146429518|NCT01214850|528079998|FG000|Overall Study|Administrative reason|1|||
146429519|NCT01214850|528079999|FG001|Overall Study|Administrative reason|0|||
146429520|NCT01214850|528080000|FG002|Overall Study|Administrative reason|0|||
146429521|NCT01214850|528079998|FG000|Overall Study|Unable to classify|2|||
146429522|NCT01214850|528079999|FG001|Overall Study|Unable to classify|1|||
146429523|NCT01214850|528080000|FG002|Overall Study|Unable to classify|1|||
146429524|NCT00610363|528080001|FG000|Overall Study|Non-compliance with protocol|0|||
146429525|NCT00610363|528080002|FG001|Overall Study|Non-compliance with protocol|1|||
146429526|NCT00610363|528080001|FG000|Overall Study|Adverse Event|3|||
146429527|NCT00610363|528080002|FG001|Overall Study|Adverse Event|1|||
145949966|NCT00269477|526328718|FG000|Overall Study|Protocol Violation|5|||
145949967|NCT00269477|526328719|FG001|Overall Study|Protocol Violation|5|||
145949968|NCT00269477|526328720|FG002|Overall Study|Protocol Violation|1|||
145949969|NCT00269477|526328721|FG003|Overall Study|Protocol Violation|0|||
145949970|NCT00269477|526328718|FG000|Overall Study|Missed post-vaccination blood draw|0|||
145949971|NCT00269477|526328719|FG001|Overall Study|Missed post-vaccination blood draw|1|||
145949972|NCT00269477|526328720|FG002|Overall Study|Missed post-vaccination blood draw|0|||
145949973|NCT00269477|526328721|FG003|Overall Study|Missed post-vaccination blood draw|0|||
145949974|NCT00431067|526328722|FG000|Overall Study|Other Adverse Event|9|||
145949975|NCT00431067|526328722|FG000|Overall Study|Progressive disease|30|||
145949976|NCT00431067|526328722|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
145949977|NCT00548249|526328723|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
145949978|NCT00548249|526328724|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
145949979|NCT00548249|526328725|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
145949980|NCT00548249|526328726|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
145949981|NCT00548249|526328727|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
146429528|NCT00610363|528080001|FG000|Overall Study|Lack of Efficacy|2|||
145949982|NCT00548249|526328723|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
145949983|NCT00548249|526328724|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
145949984|NCT00548249|526328725|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
145949985|NCT00548249|526328726|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
145949986|NCT00548249|526328727|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
145949987|NCT00548249|526328723|FG000|Overall Study|Protocol Violation|1|||
145949988|NCT00548249|526328724|FG001|Overall Study|Protocol Violation|1|||
145949989|NCT00548249|526328725|FG002|Overall Study|Protocol Violation|4|||
145949990|NCT00548249|526328726|FG003|Overall Study|Protocol Violation|0|||
145949991|NCT00548249|526328727|FG004|Overall Study|Protocol Violation|3|||
145949992|NCT00548249|526328723|FG000|Overall Study|Miscellaneous|2|||
145949993|NCT00548249|526328724|FG001|Overall Study|Miscellaneous|3|||
145949994|NCT00548249|526328725|FG002|Overall Study|Miscellaneous|2|||
145949995|NCT00548249|526328726|FG003|Overall Study|Miscellaneous|0|||
145949996|NCT00548249|526328727|FG004|Overall Study|Miscellaneous|2|||
145949997|NCT00548249|526328723|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
145949998|NCT00548249|526328724|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
145949999|NCT00548249|526328725|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
145950000|NCT00548249|526328726|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
145950001|NCT00548249|526328727|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
146201730|NCT03284957|527252137|FG004|Overall Study|Adverse Event|0|||
146429529|NCT00610363|528080002|FG001|Overall Study|Lack of Efficacy|0|||
146429530|NCT00610363|528080001|FG000|Overall Study|Lost to Follow-up|4|||
146429531|NCT00610363|528080002|FG001|Overall Study|Lost to Follow-up|0|||
146429532|NCT00610363|528080001|FG000|Overall Study|Withdrawal by Subject|1|||
146429533|NCT00610363|528080002|FG001|Overall Study|Withdrawal by Subject|0|||
146429534|NCT00610363|528080001|FG000|Overall Study|Other than specified above|1|||
146429535|NCT00610363|528080002|FG001|Overall Study|Other than specified above|1|||
146429536|NCT03204539|528080003|FG000|Overall Study|Loss of funding|0|||
146429537|NCT03204539|528080004|FG001|Overall Study|Loss of funding|1|||
146429538|NCT00302952|528080018|FG000|Overall Study|Physician Decision|1|||
146429539|NCT00302952|528080019|FG001|Overall Study|Physician Decision|1|||
146429540|NCT00302952|528080018|FG000|Overall Study|Withdrawal by Subject|2|||
146429541|NCT00302952|528080019|FG001|Overall Study|Withdrawal by Subject|3|||
146429542|NCT00302952|528080018|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
146429543|NCT00302952|528080019|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
146429544|NCT00336479|528080020|FG000|Overall Study|Adverse Event|8|||
146429545|NCT00336479|528080021|FG001|Overall Study|Adverse Event|11|||
146429546|NCT00336479|528080022|FG002|Overall Study|Adverse Event|18|||
146429547|NCT00336479|528080023|FG003|Overall Study|Adverse Event|4|||
146429548|NCT00336479|528080020|FG000|Overall Study|Noncompliant|1|||
146429549|NCT00336479|528080021|FG001|Overall Study|Noncompliant|7|||
146429550|NCT00336479|528080022|FG002|Overall Study|Noncompliant|3|||
146429551|NCT00336479|528080023|FG003|Overall Study|Noncompliant|0|||
146429552|NCT00336479|528080020|FG000|Overall Study|Physician Decision|2|||
145950002|NCT00548249|526328723|FG000|Overall Study|Adverse Event|2|||
145950003|NCT00548249|526328724|FG001|Overall Study|Adverse Event|2|||
146201731|NCT03284957|527252138|FG005|Overall Study|Adverse Event|1|||
146201732|NCT03284957|527252139|FG006|Overall Study|Adverse Event|1|||
146201733|NCT03284957|527252140|FG007|Overall Study|Adverse Event|1|||
145950004|NCT00548249|526328725|FG002|Overall Study|Adverse Event|0|||
145950005|NCT00548249|526328726|FG003|Overall Study|Adverse Event|1|||
145950006|NCT00548249|526328727|FG004|Overall Study|Adverse Event|1|||
145950007|NCT00548249|526328723|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
145950008|NCT00548249|526328724|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
146201734|NCT03284957|527252141|FG008|Overall Study|Adverse Event|0|||
146429553|NCT00336479|528080021|FG001|Overall Study|Physician Decision|3|||
146429554|NCT00336479|528080022|FG002|Overall Study|Physician Decision|1|||
146429555|NCT00336479|528080023|FG003|Overall Study|Physician Decision|0|||
146429556|NCT00336479|528080020|FG000|Overall Study|Lost to Follow-up|3|||
146429557|NCT00336479|528080021|FG001|Overall Study|Lost to Follow-up|2|||
146429558|NCT00336479|528080022|FG002|Overall Study|Lost to Follow-up|0|||
146429559|NCT00336479|528080023|FG003|Overall Study|Lost to Follow-up|0|||
146429560|NCT00336479|528080020|FG000|Overall Study|Withdrawal by Subject|3|||
146429561|NCT00336479|528080021|FG001|Overall Study|Withdrawal by Subject|2|||
146429562|NCT00336479|528080022|FG002|Overall Study|Withdrawal by Subject|3|||
146429563|NCT00336479|528080023|FG003|Overall Study|Withdrawal by Subject|0|||
146429564|NCT00336479|528080020|FG000|Overall Study|Other|0|||
146429565|NCT00336479|528080021|FG001|Overall Study|Other|0|||
146429566|NCT00336479|528080022|FG002|Overall Study|Other|1|||
146429567|NCT00336479|528080023|FG003|Overall Study|Other|0|||
146429568|NCT00336479|528080020|FG000|Overall Study|Virologic Stopping Rule|20|||
146429569|NCT00336479|528080021|FG001|Overall Study|Virologic Stopping Rule|0|||
146429570|NCT00336479|528080022|FG002|Overall Study|Virologic Stopping Rule|0|||
146429571|NCT00336479|528080023|FG003|Overall Study|Virologic Stopping Rule|0|||
146429572|NCT00550537|528080024|FG000|Overall Study|Death|18|||
146429573|NCT00550537|528080024|FG000|Overall Study|Adverse Event|20|||
146429574|NCT00550537|528080024|FG000|Overall Study|Disease progression before|46|||
146429575|NCT00550537|528080024|FG000|Overall Study|Withdrawal by Subject|7|||
146429576|NCT00550537|528080024|FG000|Overall Study|Change in treatment plan|4|||
146429577|NCT00550537|528080024|FG000|Overall Study|Other complicating ilness|3|||
146429578|NCT00550537|528080024|FG000|Overall Study|Declining performance status|2|||
146429579|NCT00550537|528080024|FG000|Overall Study|Treated closer to home|4|||
146429580|NCT02008565|528080025|FG000|Overall Study|Protocol Violation|1|||
146429581|NCT02008565|528080026|FG001|Overall Study|Protocol Violation|1|||
146429582|NCT02008565|528080027|FG002|Overall Study|Protocol Violation|2|||
146429583|NCT02008565|528080028|FG003|Overall Study|Protocol Violation|0|||
146429584|NCT00268905|528080029|FG000|Overall Study|Adverse Event|3|||
146429585|NCT00268905|528080030|FG001|Overall Study|Adverse Event|0|||
146429586|NCT00268905|528080031|FG002|Overall Study|Adverse Event|4|||
146429587|NCT00268905|528080029|FG000|Overall Study|Lost to Follow-up|0|||
146429588|NCT00268905|528080030|FG001|Overall Study|Lost to Follow-up|1|||
146429589|NCT00268905|528080031|FG002|Overall Study|Lost to Follow-up|0|||
146429590|NCT00268905|528080029|FG000|Overall Study|Withdrawal by Subject|0|||
146429591|NCT00268905|528080030|FG001|Overall Study|Withdrawal by Subject|0|||
146429592|NCT00268905|528080031|FG002|Overall Study|Withdrawal by Subject|3|||
146429593|NCT00268905|528080029|FG000|Overall Study|Progressive Disease|28|||
145950009|NCT00548249|526328725|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
145950010|NCT00548249|526328726|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
146082836|NCT01451437|526822911|FG005|Overall Study|Disease Progression|2|||
146429594|NCT00268905|528080030|FG001|Overall Study|Progressive Disease|4|||
146429595|NCT00268905|528080031|FG002|Overall Study|Progressive Disease|3|||
146429596|NCT00268905|528080029|FG000|Overall Study|Physician Decision|3|||
146429597|NCT00268905|528080030|FG001|Overall Study|Physician Decision|0|||
146429598|NCT00268905|528080031|FG002|Overall Study|Physician Decision|1|||
146429599|NCT00268905|528080029|FG000|Overall Study|Clinical Progression|9|||
146429600|NCT00268905|528080030|FG001|Overall Study|Clinical Progression|4|||
146429601|NCT00268905|528080031|FG002|Overall Study|Clinical Progression|1|||
146429602|NCT00617305|528080032|FG000|Overall Study|Adverse Event|4|||
146429603|NCT00617305|528080033|FG001|Overall Study|Adverse Event|0|||
146201735|NCT03284957|527252142|FG009|Overall Study|Adverse Event|4|||
146201736|NCT03284957|527252143|FG010|Overall Study|Adverse Event|1|||
146201737|NCT03284957|527252144|FG011|Overall Study|Adverse Event|1|||
146201738|NCT03284957|527252145|FG012|Overall Study|Adverse Event|0|||
146201739|NCT03284957|527252146|FG013|Overall Study|Adverse Event|0|||
146201740|NCT03284957|527252147|FG014|Overall Study|Adverse Event|0|||
146201741|NCT03284957|527252148|FG015|Overall Study|Adverse Event|0|||
146201742|NCT03284957|527252133|FG000|Overall Study|Progressive Disease|3|||
146201743|NCT03284957|527252134|FG001|Overall Study|Progressive Disease|3|||
146201744|NCT03284957|527252135|FG002|Overall Study|Progressive Disease|4|||
146201745|NCT03284957|527252136|FG003|Overall Study|Progressive Disease|3|||
146201746|NCT03284957|527252137|FG004|Overall Study|Progressive Disease|3|||
146201747|NCT03284957|527252138|FG005|Overall Study|Progressive Disease|5|||
146201748|NCT03284957|527252139|FG006|Overall Study|Progressive Disease|45|||
146201749|NCT03284957|527252140|FG007|Overall Study|Progressive Disease|8|||
146201750|NCT03284957|527252141|FG008|Overall Study|Progressive Disease|5|||
146201751|NCT03284957|527252142|FG009|Overall Study|Progressive Disease|18|||
146201752|NCT03284957|527252143|FG010|Overall Study|Progressive Disease|7|||
146201753|NCT03284957|527252144|FG011|Overall Study|Progressive Disease|2|||
146201754|NCT03284957|527252145|FG012|Overall Study|Progressive Disease|3|||
146201755|NCT03284957|527252146|FG013|Overall Study|Progressive Disease|1|||
146201756|NCT03284957|527252147|FG014|Overall Study|Progressive Disease|1|||
146201757|NCT03284957|527252148|FG015|Overall Study|Progressive Disease|2|||
146201758|NCT03284957|527252133|FG000|Overall Study|Withdrawal by Subject|0|||
146201759|NCT03284957|527252134|FG001|Overall Study|Withdrawal by Subject|0|||
146201760|NCT03284957|527252135|FG002|Overall Study|Withdrawal by Subject|0|||
146201761|NCT03284957|527252136|FG003|Overall Study|Withdrawal by Subject|0|||
146201762|NCT03284957|527252137|FG004|Overall Study|Withdrawal by Subject|0|||
146201763|NCT03284957|527252138|FG005|Overall Study|Withdrawal by Subject|0|||
146201764|NCT03284957|527252139|FG006|Overall Study|Withdrawal by Subject|0|||
146201765|NCT03284957|527252140|FG007|Overall Study|Withdrawal by Subject|0|||
146201766|NCT03284957|527252141|FG008|Overall Study|Withdrawal by Subject|0|||
146201767|NCT03284957|527252142|FG009|Overall Study|Withdrawal by Subject|2|||
146201768|NCT03284957|527252143|FG010|Overall Study|Withdrawal by Subject|0|||
146201769|NCT03284957|527252144|FG011|Overall Study|Withdrawal by Subject|0|||
146201770|NCT03284957|527252145|FG012|Overall Study|Withdrawal by Subject|0|||
146201771|NCT03284957|527252146|FG013|Overall Study|Withdrawal by Subject|0|||
146201772|NCT03284957|527252147|FG014|Overall Study|Withdrawal by Subject|0|||
146201773|NCT03284957|527252148|FG015|Overall Study|Withdrawal by Subject|0|||
146201774|NCT03284957|527252133|FG000|Overall Study|Other|0|||
146201775|NCT03284957|527252134|FG001|Overall Study|Other|0|||
146201776|NCT03284957|527252135|FG002|Overall Study|Other|0|||
146201777|NCT03284957|527252136|FG003|Overall Study|Other|0|||
146201778|NCT03284957|527252137|FG004|Overall Study|Other|0|||
146201779|NCT03284957|527252138|FG005|Overall Study|Other|0|||
146201780|NCT03284957|527252139|FG006|Overall Study|Other|3|||
146201781|NCT03284957|527252140|FG007|Overall Study|Other|0|||
146201782|NCT03284957|527252141|FG008|Overall Study|Other|1|||
146201783|NCT03284957|527252142|FG009|Overall Study|Other|6|||
146201784|NCT03284957|527252143|FG010|Overall Study|Other|0|||
146201785|NCT03284957|527252144|FG011|Overall Study|Other|0|||
146201786|NCT03284957|527252145|FG012|Overall Study|Other|0|||
146201787|NCT03284957|527252146|FG013|Overall Study|Other|0|||
146201788|NCT03284957|527252147|FG014|Overall Study|Other|2|||
146201789|NCT03284957|527252148|FG015|Overall Study|Other|0|||
146201790|NCT03544515|527252151|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
146201791|NCT03544515|527252152|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
146201792|NCT03544515|527252151|FG000|Overall Study|Lost to Follow-up|2|||
146201793|NCT03544515|527252152|FG001|Overall Study|Lost to Follow-up|0|||
146201794|NCT03622593|527252153|FG000|Overall Study|Withdrawal by Subject|11|||
146201795|NCT03622593|527252154|FG001|Overall Study|Withdrawal by Subject|9|||
146201796|NCT03622593|527252155|FG002|Overall Study|Withdrawal by Subject|13|||
146201797|NCT03622593|527252153|FG000|Overall Study|Death|12|||
146201798|NCT03622593|527252154|FG001|Overall Study|Death|9|||
146201799|NCT03622593|527252155|FG002|Overall Study|Death|10|||
146201800|NCT03622593|527252153|FG000|Overall Study|Lost to Follow-up|11|||
146201801|NCT03622593|527252154|FG001|Overall Study|Lost to Follow-up|5|||
146201802|NCT03622593|527252155|FG002|Overall Study|Lost to Follow-up|8|||
146201803|NCT03622593|527252153|FG000|Overall Study|Adverse Event|4|||
146201804|NCT03622593|527252154|FG001|Overall Study|Adverse Event|5|||
146201805|NCT03622593|527252155|FG002|Overall Study|Adverse Event|6|||
146201806|NCT03622593|527252153|FG000|Overall Study|Physician Decision|2|||
146201807|NCT03622593|527252154|FG001|Overall Study|Physician Decision|1|||
146201808|NCT03622593|527252155|FG002|Overall Study|Physician Decision|6|||
146429604|NCT00617305|528080034|FG002|Overall Study|Adverse Event|0|||
146429605|NCT00617305|528080032|FG000|Overall Study|Death|1|||
146429606|NCT00617305|528080033|FG001|Overall Study|Death|0|||
146429607|NCT00617305|528080034|FG002|Overall Study|Death|0|||
146429608|NCT00617305|528080032|FG000|Overall Study|Physician Decision|1|||
146429609|NCT00617305|528080033|FG001|Overall Study|Physician Decision|0|||
146429610|NCT00617305|528080034|FG002|Overall Study|Physician Decision|0|||
146429611|NCT00617305|528080032|FG000|Overall Study|Protocol Violation|1|||
146429612|NCT00617305|528080033|FG001|Overall Study|Protocol Violation|0|||
146429613|NCT00617305|528080034|FG002|Overall Study|Protocol Violation|1|||
146429614|NCT00617305|528080032|FG000|Overall Study|Withdrawal by Subject|1|||
146429615|NCT00617305|528080033|FG001|Overall Study|Withdrawal by Subject|0|||
146429616|NCT00617305|528080034|FG002|Overall Study|Withdrawal by Subject|0|||
146429617|NCT02193178|528080035|FG000|Overall Study|Lost to Follow-up|1|||
146429618|NCT02193178|528080035|FG000|Overall Study|Dry eyes|1|||
146429619|NCT03435081|528080036|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
146429620|NCT03435081|528080037|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
146429621|NCT03435081|528080038|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
146429622|NCT03435081|528080036|FG000|Week 0 to Week 16|Adverse Event|2|||
146429623|NCT03435081|528080037|FG001|Week 0 to Week 16|Adverse Event|2|||
146429624|NCT03435081|528080038|FG002|Week 0 to Week 16|Adverse Event|2|||
146429625|NCT03435081|528080036|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
146429626|NCT03435081|528080037|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
146429627|NCT03435081|528080038|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
146429628|NCT03435081|528080036|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
146429629|NCT03435081|528080037|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
146429630|NCT03435081|528080038|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
146429631|NCT03435081|528080036|FG000|Week 0 to Week 16|Pregnancy|1|||
146429632|NCT03435081|528080037|FG001|Week 0 to Week 16|Pregnancy|0|||
146429633|NCT03435081|528080038|FG002|Week 0 to Week 16|Pregnancy|0|||
146429634|NCT03435081|528080036|FG000|Week 0 to Week 16|Non-compliance|1|||
146429635|NCT03435081|528080037|FG001|Week 0 to Week 16|Non-compliance|0|||
146429636|NCT03435081|528080038|FG002|Week 0 to Week 16|Non-compliance|2|||
146429637|NCT03435081|528080036|FG000|Week 0 to Week 16|Inadequate Response|0|||
146429638|NCT03435081|528080037|FG001|Week 0 to Week 16|Inadequate Response|1|||
146429639|NCT03435081|528080038|FG002|Week 0 to Week 16|Inadequate Response|0|||
146429640|NCT03435081|528080036|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
146429641|NCT03435081|528080037|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
146429642|NCT03435081|528080038|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
146429643|NCT03435081|528080036|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
146429644|NCT03435081|528080037|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
146429645|NCT03435081|528080038|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
146429646|NCT03435081|528080036|FG000|Week 16 to Week 104|Adverse Event|1|||
146429647|NCT03435081|528080037|FG001|Week 16 to Week 104|Adverse Event|0|||
146429648|NCT03435081|528080038|FG002|Week 16 to Week 104|Adverse Event|2|||
146429649|NCT03435081|528080036|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
146429650|NCT03435081|528080037|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
146429651|NCT03435081|528080038|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
146429652|NCT03435081|528080036|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
146429653|NCT03435081|528080037|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
146429654|NCT03435081|528080038|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
146429655|NCT03435081|528080036|FG000|Week 16 to Week 104|Non--Compliance|0|||
146429656|NCT03435081|528080037|FG001|Week 16 to Week 104|Non--Compliance|0|||
146429657|NCT03435081|528080038|FG002|Week 16 to Week 104|Non--Compliance|1|||
146429658|NCT00420238|528080039|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
146429659|NCT00420238|528080040|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
146429660|NCT00420238|528080039|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
146429661|NCT00420238|528080040|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
146429662|NCT00420238|528080039|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
146429663|NCT00420238|528080040|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
146429664|NCT00420238|528080039|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
146201809|NCT03622593|527252153|FG000|Overall Study|Other|2|||
146201810|NCT03622593|527252154|FG001|Overall Study|Other|2|||
146429665|NCT00420238|528080040|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
146429666|NCT00420238|528080039|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
146429667|NCT00420238|528080040|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
146429668|NCT00420238|528080039|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
146429669|NCT00420238|528080040|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
146429670|NCT00048581|528080041|FG000|Double-Blind Period|Adverse Event|9|||
146429671|NCT00048581|528080042|FG001|Double-Blind Period|Adverse Event|5|||
146201811|NCT03622593|527252155|FG002|Overall Study|Other|3|||
146201812|NCT03622593|527252153|FG000|Overall Study|Protocol Violation|0|||
146201813|NCT03622593|527252154|FG001|Overall Study|Protocol Violation|0|||
146201814|NCT03622593|527252155|FG002|Overall Study|Protocol Violation|1|||
146201815|NCT03622593|527252153|FG000|Overall Study|Pregnancy|0|||
146201816|NCT03622593|527252154|FG001|Overall Study|Pregnancy|0|||
146201817|NCT03622593|527252155|FG002|Overall Study|Pregnancy|1|||
146201818|NCT01393119|527252156|FG000|Overall Study|Adverse Event|1|||
146201819|NCT01393119|527252157|FG001|Overall Study|Adverse Event|1|||
146201820|NCT01393119|527252158|FG002|Overall Study|Adverse Event|0|||
146201821|NCT01393119|527252159|FG003|Overall Study|Adverse Event|1|||
146201822|NCT01393119|527252156|FG000|Overall Study|Withdrawal by Subject|0|||
146201823|NCT01393119|527252157|FG001|Overall Study|Withdrawal by Subject|1|||
146201824|NCT01393119|527252158|FG002|Overall Study|Withdrawal by Subject|1|||
146201825|NCT01393119|527252159|FG003|Overall Study|Withdrawal by Subject|0|||
146201826|NCT01393119|527252156|FG000|Overall Study|Lack of Efficacy|1|||
146201827|NCT01393119|527252157|FG001|Overall Study|Lack of Efficacy|0|||
146201828|NCT01393119|527252158|FG002|Overall Study|Lack of Efficacy|2|||
146201829|NCT01393119|527252159|FG003|Overall Study|Lack of Efficacy|1|||
146201830|NCT01393119|527252156|FG000|Overall Study|Protocol Violation|0|||
146201831|NCT01393119|527252157|FG001|Overall Study|Protocol Violation|0|||
146201832|NCT01393119|527252158|FG002|Overall Study|Protocol Violation|1|||
146201833|NCT01393119|527252159|FG003|Overall Study|Protocol Violation|0|||
146201834|NCT01393119|527252156|FG000|Overall Study|Death|0|||
146201835|NCT01393119|527252157|FG001|Overall Study|Death|0|||
146201836|NCT01393119|527252158|FG002|Overall Study|Death|0|||
146201837|NCT01393119|527252159|FG003|Overall Study|Death|1|||
146201838|NCT01393119|527252156|FG000|Overall Study|Randomized but Not treated|1|||
146201839|NCT01393119|527252157|FG001|Overall Study|Randomized but Not treated|0|||
146201840|NCT01393119|527252158|FG002|Overall Study|Randomized but Not treated|1|||
146201841|NCT01393119|527252159|FG003|Overall Study|Randomized but Not treated|1|||
146201842|NCT01393119|527252156|FG000|Overall Study|Sponsor Termination of Study|11|||
146201843|NCT01393119|527252157|FG001|Overall Study|Sponsor Termination of Study|12|||
146201844|NCT01393119|527252158|FG002|Overall Study|Sponsor Termination of Study|9|||
146201845|NCT01393119|527252159|FG003|Overall Study|Sponsor Termination of Study|12|||
146201846|NCT01266265|527252160|FG000|Overall Study|Death|95|||
146201847|NCT01266265|527252161|FG001|Overall Study|Death|73|||
146201848|NCT01266265|527252160|FG000|Overall Study|Lost to Follow-up|23|||
146201849|NCT01266265|527252161|FG001|Overall Study|Lost to Follow-up|28|||
146201850|NCT01266265|527252160|FG000|Overall Study|Withdrawal by Subject|13|||
146201851|NCT01266265|527252161|FG001|Overall Study|Withdrawal by Subject|11|||
146201852|NCT01266265|527252160|FG000|Overall Study|Respiratory-related adverse event|2|||
146201853|NCT01266265|527252161|FG001|Overall Study|Respiratory-related adverse event|1|||
146201854|NCT01266265|527252160|FG000|Overall Study|Transferred care to another provider|22|||
146201855|NCT01266265|527252161|FG001|Overall Study|Transferred care to another provider|28|||
146201856|NCT01266265|527252160|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
146201857|NCT01266265|527252161|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
146201858|NCT01266265|527252160|FG000|Overall Study|Enrolled in another clinical study|15|||
146201859|NCT01266265|527252161|FG001|Overall Study|Enrolled in another clinical study|26|||
146201860|NCT01266265|527252160|FG000|Overall Study|Non-compliance|8|||
146201861|NCT01266265|527252161|FG001|Overall Study|Non-compliance|5|||
146201862|NCT01266265|527252160|FG000|Overall Study|Lung transplant|6|||
146201863|NCT01266265|527252161|FG001|Overall Study|Lung transplant|5|||
146201864|NCT01266265|527252160|FG000|Overall Study|Site closed early|4|||
146201865|NCT01266265|527252161|FG001|Overall Study|Site closed early|3|||
146201866|NCT01266265|527252160|FG000|Overall Study|Clinical worsening|1|||
146201867|NCT01266265|527252161|FG001|Overall Study|Clinical worsening|1|||
145950011|NCT00548249|526328727|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
146201868|NCT01580293|527252162|FG000|Part A_Main Trial|Adverse Event|0|||
146201869|NCT01580293|527252163|FG001|Part A_Main Trial|Adverse Event|2|||
146201870|NCT01580293|527252164|FG002|Part A_Main Trial|Adverse Event|0|||
146201871|NCT01580293|527252162|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
146201872|NCT01580293|527252163|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
146201873|NCT01580293|527252164|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
145950012|NCT00548249|526328723|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
146201874|NCT01580293|527252162|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
146201875|NCT01580293|527252163|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
146201876|NCT01580293|527252164|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
146201877|NCT01580293|527252162|FG000|Part A_Extension|Adverse Event|0|||
146201878|NCT01580293|527252163|FG001|Part A_Extension|Adverse Event|2|||
146201879|NCT01580293|527252164|FG002|Part A_Extension|Adverse Event|0|||
146201880|NCT01580293|527252162|FG000|Part A_Extension|Withdrawal by Subject|0|||
146201881|NCT01580293|527252163|FG001|Part A_Extension|Withdrawal by Subject|3|||
146201882|NCT01580293|527252164|FG002|Part A_Extension|Withdrawal by Subject|0|||
146429672|NCT00048581|528080043|FG002|Double-Blind Period|Adverse Event|0|||
146429673|NCT00048581|528080041|FG000|Double-Blind Period|Lack of Efficacy|14|||
146429674|NCT00048581|528080042|FG001|Double-Blind Period|Lack of Efficacy|27|||
146429675|NCT00048581|528080043|FG002|Double-Blind Period|Lack of Efficacy|0|||
146429676|NCT00048581|528080041|FG000|Double-Blind Period|Lost to Follow-up|5|||
146429677|NCT00048581|528080042|FG001|Double-Blind Period|Lost to Follow-up|0|||
146429678|NCT00048581|528080043|FG002|Double-Blind Period|Lost to Follow-up|0|||
146429679|NCT00048581|528080041|FG000|Double-Blind Period|Withdrawal by Subject|5|||
146429680|NCT00048581|528080042|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146429681|NCT00048581|528080043|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146429682|NCT00048581|528080041|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
146429683|NCT00048581|528080042|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
146429684|NCT00048581|528080043|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
146429685|NCT00048581|528080041|FG000|Double-Blind Period|Investigator Decision|1|||
146429686|NCT00048581|528080042|FG001|Double-Blind Period|Investigator Decision|0|||
146429687|NCT00048581|528080043|FG002|Double-Blind Period|Investigator Decision|0|||
146429688|NCT00048581|528080041|FG000|Open-Label Period|Death|0|||
146429689|NCT00048581|528080042|FG001|Open-Label Period|Death|0|||
146429690|NCT00048581|528080043|FG002|Open-Label Period|Death|4|||
146429691|NCT00048581|528080041|FG000|Open-Label Period|Adverse Event|0|||
146429692|NCT00048581|528080042|FG001|Open-Label Period|Adverse Event|0|||
146429693|NCT00048581|528080043|FG002|Open-Label Period|Adverse Event|37|||
146429694|NCT00048581|528080041|FG000|Open-Label Period|Lack of Efficacy|0|||
146429695|NCT00048581|528080042|FG001|Open-Label Period|Lack of Efficacy|0|||
146429696|NCT00048581|528080043|FG002|Open-Label Period|Lack of Efficacy|69|||
146429697|NCT00048581|528080041|FG000|Open-Label Period|Lost to Follow-up|0|||
146429698|NCT00048581|528080042|FG001|Open-Label Period|Lost to Follow-up|0|||
146429699|NCT00048581|528080043|FG002|Open-Label Period|Lost to Follow-up|14|||
146429700|NCT00048581|528080041|FG000|Open-Label Period|Withdrawal by Subject|0|||
146429701|NCT00048581|528080042|FG001|Open-Label Period|Withdrawal by Subject|0|||
146429702|NCT00048581|528080043|FG002|Open-Label Period|Withdrawal by Subject|20|||
146429703|NCT00048581|528080041|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
146429704|NCT00048581|528080042|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
146429705|NCT00048581|528080043|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
146429706|NCT00048581|528080041|FG000|Open-Label Period|Poor/Non-compliance|0|||
146429707|NCT00048581|528080042|FG001|Open-Label Period|Poor/Non-compliance|0|||
146429708|NCT00048581|528080043|FG002|Open-Label Period|Poor/Non-compliance|5|||
146429709|NCT00048581|528080041|FG000|Open-Label Period|Pregnancy|0|||
146429710|NCT00048581|528080042|FG001|Open-Label Period|Pregnancy|0|||
146429711|NCT00048581|528080043|FG002|Open-Label Period|Pregnancy|7|||
146429712|NCT00048581|528080041|FG000|Open-Label Period|Study Site Closure|0|||
146429713|NCT00048581|528080042|FG001|Open-Label Period|Study Site Closure|0|||
146429714|NCT00048581|528080043|FG002|Open-Label Period|Study Site Closure|2|||
146429715|NCT00048581|528080041|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
146429716|NCT00048581|528080042|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
146429717|NCT00048581|528080043|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
146429718|NCT00048581|528080041|FG000|Open-Label Period|Problem With Transportation To Site|0|||
146429719|NCT00048581|528080042|FG001|Open-Label Period|Problem With Transportation To Site|0|||
146429720|NCT00048581|528080043|FG002|Open-Label Period|Problem With Transportation To Site|1|||
146429721|NCT00048581|528080041|FG000|Open-Label Period|Primary Investigator Retired|0|||
146429722|NCT00048581|528080042|FG001|Open-Label Period|Primary Investigator Retired|0|||
146429723|NCT00048581|528080043|FG002|Open-Label Period|Primary Investigator Retired|2|||
146429724|NCT00048581|528080041|FG000|Open-Label Period|Study Ended By Sponsor|0|||
146429725|NCT00048581|528080042|FG001|Open-Label Period|Study Ended By Sponsor|0|||
146429726|NCT00048581|528080043|FG002|Open-Label Period|Study Ended By Sponsor|1|||
146429727|NCT01406795|528080044|FG000|Overall Study|Withdrawal by Subject|1|||
146429728|NCT03966365|528080045|FG000|Overall Study|Protocol Violation|1|||
146429729|NCT03966365|528080046|FG001|Overall Study|Protocol Violation|0|||
146429730|NCT03567174|528080048|FG000|Overall Study|Death|24|||
146429731|NCT03567174|528080049|FG001|Overall Study|Death|31|||
146429732|NCT03567174|528080048|FG000|Overall Study|Lost to Follow-up|165|||
146429733|NCT03567174|528080049|FG001|Overall Study|Lost to Follow-up|174|||
146429734|NCT06358820|528081692|FG000|Overall Study|Adverse Event|11|||
146429735|NCT06358820|528081692|FG000|Overall Study|kidney transplantation|3|||
146429736|NCT06358820|528081692|FG000|Overall Study|patient voluntary withdrawal|6|||
146429737|NCT06358820|528081692|FG000|Overall Study|Physician Decision|1|||
146429738|NCT05376319|528081697|FG000|Overall Study|Funding termination|2|||
146429739|NCT05376319|528081698|FG001|Overall Study|Funding termination|4|||
146429740|NCT01124175|528081699|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
146429741|NCT01124175|528081700|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
146429742|NCT00942968|528081701|FG000|Overall Study|Adverse Event|60|||
146429743|NCT00942968|528081701|FG000|Overall Study|Death|76|||
146429744|NCT00942968|528081701|FG000|Overall Study|Protocol Violation|9|||
146429745|NCT00942968|528081701|FG000|Overall Study|Lost to Follow-up|4|||
146429746|NCT00942968|528081701|FG000|Overall Study|Withdrawal by Subject|44|||
146201883|NCT01580293|527252162|FG000|Part A_Extension|Lost to Follow-up|0|||
146429747|NCT00942968|528081701|FG000|Overall Study|Sponsor request|5|||
146429748|NCT00942968|528081701|FG000|Overall Study|Physician Decision|11|||
146429749|NCT00942968|528081701|FG000|Overall Study|Progression of disease|12|||
146429750|NCT00942968|528081701|FG000|Overall Study|Inferior vena cava filter placement|4|||
146429751|NCT00942968|528081701|FG000|Overall Study|Pulmonary embolism (PE)|1|||
146429752|NCT00942968|528081701|FG000|Overall Study|Participant required pancreatic biopsy|1|||
146429753|NCT00942968|528081701|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
146429754|NCT01340495|528081706|FG000|Overall Study|Withdrawal by Subject|1|||
146429755|NCT00070291|528081707|FG000|Step 1|Withdrawal by Subject|1|||
146429756|NCT00070291|528081707|FG000|Step 1|Adverse Event|1|||
146429757|NCT00070291|528081707|FG000|Step 2|Adverse Event|1|||
146429758|NCT02262377|528081708|FG000|Overall Study|Lost to Follow-up|5|||
146429759|NCT02262377|528081709|FG001|Overall Study|Lost to Follow-up|6|||
146429760|NCT02262377|528081708|FG000|Overall Study|Found ineligible after enrollment|3|||
146429761|NCT02262377|528081709|FG001|Overall Study|Found ineligible after enrollment|0|||
146429762|NCT02262377|528081708|FG000|Overall Study|Withdrawal by Subject|4|||
146429763|NCT02262377|528081709|FG001|Overall Study|Withdrawal by Subject|0|||
146429764|NCT01045096|528081710|FG000|Overall Study|Withdrawal by Subject|2|||
146429765|NCT01045096|528081711|FG001|Overall Study|Withdrawal by Subject|0|||
146429766|NCT01045096|528081712|FG002|Overall Study|Withdrawal by Subject|0|||
146429767|NCT01045096|528081710|FG000|Overall Study|Other|1|||
146429768|NCT01045096|528081711|FG001|Overall Study|Other|0|||
146429769|NCT01045096|528081712|FG002|Overall Study|Other|0|||
146429770|NCT01511939|528081714|FG000|Overall Study|Withdrawal by Subject|2|||
146429771|NCT01511939|528081715|FG001|Overall Study|Withdrawal by Subject|1|||
146429772|NCT01511939|528081716|FG002|Overall Study|Withdrawal by Subject|0|||
146429773|NCT03497897|528081720|FG000|Overall Study|Adverse Event|1|||
146429774|NCT03497897|528081721|FG001|Overall Study|Adverse Event|1|||
146429775|NCT03497897|528081722|FG002|Overall Study|Adverse Event|1|||
146429776|NCT03497897|528081720|FG000|Overall Study|Lost to Follow-up|2|||
145950013|NCT00548249|526328724|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
145950014|NCT00548249|526328725|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
146201884|NCT01580293|527252163|FG001|Part A_Extension|Lost to Follow-up|1|||
146201885|NCT01580293|527252164|FG002|Part A_Extension|Lost to Follow-up|0|||
146201886|NCT01580293|527252162|FG000|Part A_Extension|Other Reason|0|||
146201887|NCT01580293|527252163|FG001|Part A_Extension|Other Reason|1|||
146201888|NCT01580293|527252164|FG002|Part A_Extension|Other Reason|0|||
146201889|NCT01580293|527252162|FG000|Part A_Extension|Completed Japan only|0|||
146201890|NCT01580293|527252163|FG001|Part A_Extension|Completed Japan only|5|||
146201891|NCT01580293|527252164|FG002|Part A_Extension|Completed Japan only|0|||
146201892|NCT01580293|527252162|FG000|Part B|Withdrawal by Subject|0|||
146201893|NCT01580293|527252163|FG001|Part B|Withdrawal by Subject|0|||
146201894|NCT01580293|527252164|FG002|Part B|Withdrawal by Subject|1|||
146201895|NCT01580293|527252162|FG000|Part B|Other reason|0|||
145950015|NCT00548249|526328726|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
145950016|NCT00548249|526328727|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
146201896|NCT01580293|527252163|FG001|Part B|Other reason|0|||
146201897|NCT01580293|527252164|FG002|Part B|Other reason|1|||
146201898|NCT02544152|527252165|FG000|Overall Study|Adverse Event|0|||
146201899|NCT02544152|527252166|FG001|Overall Study|Adverse Event|4|||
146429777|NCT03497897|528081721|FG001|Overall Study|Lost to Follow-up|0|||
146429778|NCT03497897|528081722|FG002|Overall Study|Lost to Follow-up|2|||
146429779|NCT03497897|528081720|FG000|Overall Study|Physician Decision|1|||
146429780|NCT03497897|528081721|FG001|Overall Study|Physician Decision|0|||
146429781|NCT03497897|528081722|FG002|Overall Study|Physician Decision|0|||
146429782|NCT03497897|528081720|FG000|Overall Study|Subject/Guardian Decision|2|||
146201900|NCT02544152|527252165|FG000|Overall Study|Withdrawal by Subject|0|||
146201901|NCT02544152|527252166|FG001|Overall Study|Withdrawal by Subject|3|||
146201902|NCT02544152|527252165|FG000|Overall Study|Other|1|||
146429783|NCT03497897|528081721|FG001|Overall Study|Subject/Guardian Decision|1|||
146429784|NCT03497897|528081722|FG002|Overall Study|Subject/Guardian Decision|3|||
146429785|NCT00723528|528081725|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
146201903|NCT02544152|527252166|FG001|Overall Study|Other|0|||
146201904|NCT00423098|527252167|FG000|Overall Study|Adverse Event|1|||
146201905|NCT00423098|527252168|FG001|Overall Study|Adverse Event|2|||
146429786|NCT00723528|528081726|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
146429787|NCT00723528|528081727|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
146429788|NCT00723528|528081728|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
146429789|NCT00723528|528081729|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
146429790|NCT00723528|528081730|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
146429791|NCT00723528|528081731|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
146429792|NCT00723528|528081725|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
146429793|NCT00723528|528081726|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429794|NCT00723528|528081727|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429795|NCT00723528|528081728|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429796|NCT00723528|528081729|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429797|NCT00723528|528081730|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429798|NCT00723528|528081731|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
146429799|NCT00723528|528081725|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429800|NCT00723528|528081726|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429801|NCT00723528|528081727|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
146429802|NCT00723528|528081728|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429803|NCT00723528|528081729|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429804|NCT00723528|528081730|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429805|NCT00723528|528081731|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
146429806|NCT00723528|528081725|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429807|NCT00723528|528081726|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429808|NCT00723528|528081727|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
146429809|NCT00723528|528081728|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429810|NCT00723528|528081729|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429811|NCT00723528|528081730|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429812|NCT00723528|528081731|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
146429813|NCT00723528|528081725|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
146429814|NCT00723528|528081726|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146429815|NCT00723528|528081727|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
146429816|NCT00723528|528081728|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146429817|NCT00723528|528081729|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146201906|NCT00423098|527252167|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146201907|NCT00423098|527252168|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146082837|NCT01451437|526822912|FG006|Overall Study|Disease Progression|3|||
146429818|NCT00723528|528081730|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146429819|NCT00723528|528081731|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
146429820|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146429821|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146429822|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146429823|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146429824|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
146429825|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146429826|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
146429827|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429828|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429829|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429830|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429831|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429832|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
146429833|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
146429834|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Other|0|||
146429835|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Other|0|||
146429836|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Other|0|||
146429837|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Other|0|||
146429838|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Other|1|||
146429839|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Other|4|||
146429840|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Other|0|||
146429841|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Adverse Event|0|||
146429842|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Adverse Event|0|||
146429843|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Adverse Event|0|||
146429844|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Adverse Event|0|||
146429845|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Adverse Event|1|||
146429846|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Adverse Event|0|||
146429847|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Adverse Event|1|||
146429848|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429849|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429850|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429851|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429852|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429853|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
146429854|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
146429855|NCT00723528|528081725|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429856|NCT00723528|528081726|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429857|NCT00723528|528081727|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429858|NCT00723528|528081728|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429859|NCT00723528|528081729|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429860|NCT00723528|528081730|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
146429861|NCT00723528|528081731|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
146429862|NCT03785548|528081735|FG000|Overall Study|age > 80|1|||
146429863|NCT03785548|528081736|FG001|Overall Study|age > 80|0|||
146429864|NCT03785548|528081735|FG000|Overall Study|no Postop queries|1|||
146429865|NCT03785548|528081736|FG001|Overall Study|no Postop queries|0|||
146429866|NCT01591785|528081738|FG000|Overall Study|worsening condition|1|||
146429867|NCT01591785|528081739|FG001|Overall Study|worsening condition|2|||
146429868|NCT01591785|528081738|FG000|Overall Study|Protocol Violation|2|||
146429869|NCT01591785|528081739|FG001|Overall Study|Protocol Violation|0|||
146429870|NCT01591785|528081738|FG000|Overall Study|Lost to Follow-up|1|||
146082838|NCT01451437|526822913|FG007|Overall Study|Disease Progression|1|||
146082839|NCT01451437|526822914|FG008|Overall Study|Disease Progression|3|||
146429871|NCT01591785|528081739|FG001|Overall Study|Lost to Follow-up|0|||
146429872|NCT00667862|528081740|FG000|Overall Study|Adverse Event|9|||
146429873|NCT00667862|528081740|FG000|Overall Study|Death|1|||
146429874|NCT00667862|528081740|FG000|Overall Study|Disease Progression|22|||
146429875|NCT00667862|528081740|FG000|Overall Study|Withdrawal by Subject|3|||
146429876|NCT02495857|528081747|FG000|Overall Study|Adverse Event|5|||
146429877|NCT02495857|528081748|FG001|Overall Study|Adverse Event|0|||
146429878|NCT02495857|528081749|FG002|Overall Study|Adverse Event|1|||
146429879|NCT02495857|528081747|FG000|Overall Study|Withdrawal by Subject|9|||
146429880|NCT02495857|528081748|FG001|Overall Study|Withdrawal by Subject|6|||
146429881|NCT02495857|528081749|FG002|Overall Study|Withdrawal by Subject|10|||
146429882|NCT02495857|528081747|FG000|Overall Study|Physician Decision|0|||
146429883|NCT02495857|528081748|FG001|Overall Study|Physician Decision|1|||
146429884|NCT02495857|528081749|FG002|Overall Study|Physician Decision|0|||
146429885|NCT02495857|528081747|FG000|Overall Study|Protocol Violation|1|||
146429886|NCT02495857|528081748|FG001|Overall Study|Protocol Violation|1|||
146429887|NCT02495857|528081749|FG002|Overall Study|Protocol Violation|2|||
146429888|NCT02495857|528081747|FG000|Overall Study|Lost to Follow-up|4|||
146429889|NCT02495857|528081748|FG001|Overall Study|Lost to Follow-up|5|||
146429890|NCT02495857|528081749|FG002|Overall Study|Lost to Follow-up|3|||
146429891|NCT02495857|528081747|FG000|Overall Study|Other|3|||
146429892|NCT02495857|528081748|FG001|Overall Study|Other|3|||
146429893|NCT02495857|528081749|FG002|Overall Study|Other|2|||
146429894|NCT00396279|528081750|FG000|Overall Study|Ongoing in study|26|||
146429895|NCT00396279|528081750|FG000|Overall Study|Disease progression|2|||
146429896|NCT00396279|528081750|FG000|Overall Study|Withdrawal by Subject|1|||
146429897|NCT00396279|528081750|FG000|Overall Study|Physician Decision|1|||
146429898|NCT02883452|528081752|FG000|Overall Study|Withdrawal by Subject|1|||
146429899|NCT02883452|528081753|FG001|Overall Study|Withdrawal by Subject|1|||
146429900|NCT02883452|528081754|FG002|Overall Study|Withdrawal by Subject|3|||
146429901|NCT02883452|528081755|FG003|Overall Study|Withdrawal by Subject|0|||
146429902|NCT02883452|528081756|FG004|Overall Study|Withdrawal by Subject|2|||
146429903|NCT02883452|528081757|FG005|Overall Study|Withdrawal by Subject|5|||
146429904|NCT02883452|528081752|FG000|Overall Study|Disease progression|1|||
146429905|NCT02883452|528081753|FG001|Overall Study|Disease progression|0|||
146429906|NCT02883452|528081754|FG002|Overall Study|Disease progression|0|||
146429907|NCT02883452|528081755|FG003|Overall Study|Disease progression|1|||
146429908|NCT02883452|528081756|FG004|Overall Study|Disease progression|4|||
146429909|NCT02883452|528081757|FG005|Overall Study|Disease progression|5|||
146429910|NCT02883452|528081752|FG000|Overall Study|Adverse Event|2|||
146429911|NCT02883452|528081753|FG001|Overall Study|Adverse Event|1|||
146429912|NCT02883452|528081754|FG002|Overall Study|Adverse Event|1|||
146429913|NCT02883452|528081755|FG003|Overall Study|Adverse Event|1|||
146429914|NCT02883452|528081756|FG004|Overall Study|Adverse Event|1|||
146429915|NCT02883452|528081757|FG005|Overall Study|Adverse Event|3|||
146429916|NCT02883452|528081752|FG000|Overall Study|Physician Decision|0|||
146429917|NCT02883452|528081753|FG001|Overall Study|Physician Decision|0|||
146429918|NCT02883452|528081754|FG002|Overall Study|Physician Decision|0|||
146429919|NCT02883452|528081755|FG003|Overall Study|Physician Decision|0|||
146429920|NCT02883452|528081756|FG004|Overall Study|Physician Decision|4|||
146429921|NCT02883452|528081757|FG005|Overall Study|Physician Decision|1|||
146429922|NCT02883452|528081752|FG000|Overall Study|Death|1|||
146429923|NCT02883452|528081753|FG001|Overall Study|Death|0|||
146429924|NCT02883452|528081754|FG002|Overall Study|Death|1|||
146429925|NCT02883452|528081755|FG003|Overall Study|Death|0|||
146429926|NCT02883452|528081756|FG004|Overall Study|Death|0|||
146429927|NCT02883452|528081757|FG005|Overall Study|Death|0|||
146429928|NCT02883452|528081752|FG000|Overall Study|Other|0|||
146429929|NCT02883452|528081753|FG001|Overall Study|Other|0|||
146082840|NCT01451437|526822906|FG000|Overall Study|Protocol Violation|0|||
146201908|NCT00423098|527252167|FG000|Overall Study|Administrative problems|0|||
146201909|NCT00423098|527252168|FG001|Overall Study|Administrative problems|1|||
146201910|NCT00423098|527252167|FG000|Overall Study|Death|2|||
146429930|NCT02883452|528081754|FG002|Overall Study|Other|0|||
146429931|NCT02883452|528081755|FG003|Overall Study|Other|0|||
146429932|NCT02883452|528081756|FG004|Overall Study|Other|0|||
146429933|NCT02883452|528081757|FG005|Overall Study|Other|1|||
146429934|NCT00667095|528081767|FG000|Overall Study|Withdrawal by Subject|0|||
146429935|NCT00667095|528081768|FG001|Overall Study|Withdrawal by Subject|1|||
146429936|NCT01520909|528081769|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
146429937|NCT01520909|528081770|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
146429938|NCT01520909|528081771|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
146429939|NCT01520909|528081769|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
146429940|NCT01520909|528081770|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
146429941|NCT01520909|528081771|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
146429942|NCT01520909|528081769|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
146429943|NCT01520909|528081770|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
146429944|NCT01520909|528081771|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
146429945|NCT01520909|528081769|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
146429946|NCT01520909|528081770|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
146429947|NCT01520909|528081771|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
146429948|NCT01882257|528081773|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
146201911|NCT00423098|527252168|FG001|Overall Study|Death|0|||
146201912|NCT02983617|527252171|FG000|Overall Study|Adverse Event|0|||
146201913|NCT02983617|527252172|FG001|Overall Study|Adverse Event|7|||
146201914|NCT02983617|527252171|FG000|Overall Study|Death|0|||
146201915|NCT02983617|527252172|FG001|Overall Study|Death|1|||
146201916|NCT02983617|527252171|FG000|Overall Study|Investigator's Discretion|0|||
146201917|NCT02983617|527252172|FG001|Overall Study|Investigator's Discretion|1|||
146201918|NCT00711958|527252175|FG000|Overall Study|Withdrawal by Subject|6|||
146201919|NCT00711958|527252176|FG001|Overall Study|Withdrawal by Subject|8|||
146201920|NCT00711958|527252175|FG000|Overall Study|Lack of Efficacy|3|||
146201921|NCT00711958|527252176|FG001|Overall Study|Lack of Efficacy|1|||
146201922|NCT00711958|527252175|FG000|Overall Study|Clinical deterioration|1|||
146201923|NCT00711958|527252176|FG001|Overall Study|Clinical deterioration|0|||
146201924|NCT00711958|527252175|FG000|Overall Study|Adverse Event|9|||
146201925|NCT00711958|527252176|FG001|Overall Study|Adverse Event|7|||
146201926|NCT00711958|527252175|FG000|Overall Study|Protocol Violation|1|||
146201927|NCT00711958|527252176|FG001|Overall Study|Protocol Violation|0|||
146201928|NCT00711958|527252175|FG000|Overall Study|Lost to Follow-up|2|||
146201929|NCT00711958|527252176|FG001|Overall Study|Lost to Follow-up|2|||
146201930|NCT00711958|527252175|FG000|Overall Study|Death|10|||
146201931|NCT00711958|527252176|FG001|Overall Study|Death|5|||
146201932|NCT00711958|527252175|FG000|Overall Study|Progression of disease|1|||
146201933|NCT00711958|527252176|FG001|Overall Study|Progression of disease|0|||
146201934|NCT02296424|527252180|FG000|Part 1|New therapy for study indication|0|||
146201935|NCT02296424|527252181|FG001|Part 1|New therapy for study indication|1|||
146201936|NCT02296424|527252182|FG002|Part 1|New therapy for study indication|0|||
146201937|NCT02296424|527252183|FG003|Part 1|New therapy for study indication|0|||
146201938|NCT02296424|527252180|FG000|Part 1|Protocol Violation|0|||
146201939|NCT02296424|527252181|FG001|Part 1|Protocol Violation|1|||
146429949|NCT01882257|528081774|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
146429950|NCT01882257|528081775|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
146429951|NCT01882257|528081773|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
146429952|NCT01882257|528081774|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
146429953|NCT01882257|528081775|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
146201940|NCT02296424|527252182|FG002|Part 1|Protocol Violation|0|||
146201941|NCT02296424|527252183|FG003|Part 1|Protocol Violation|0|||
146201942|NCT02296424|527252180|FG000|Part 1|Withdrawal by Subject|0|||
146201943|NCT02296424|527252181|FG001|Part 1|Withdrawal by Subject|2|||
146201944|NCT02296424|527252182|FG002|Part 1|Withdrawal by Subject|0|||
146201945|NCT02296424|527252183|FG003|Part 1|Withdrawal by Subject|0|||
146201946|NCT02296424|527252180|FG000|Part 1|Study terminated by sponsor|0|||
146201947|NCT02296424|527252181|FG001|Part 1|Study terminated by sponsor|1|||
146201948|NCT02296424|527252182|FG002|Part 1|Study terminated by sponsor|0|||
146201949|NCT02296424|527252183|FG003|Part 1|Study terminated by sponsor|0|||
146201950|NCT02296424|527252180|FG000|Part 1|Adverse Event|2|||
146201951|NCT02296424|527252181|FG001|Part 1|Adverse Event|11|||
146201952|NCT02296424|527252182|FG002|Part 1|Adverse Event|0|||
146201953|NCT02296424|527252183|FG003|Part 1|Adverse Event|0|||
146201954|NCT02296424|527252180|FG000|Part 1|Lack of Efficacy|5|||
146201955|NCT02296424|527252181|FG001|Part 1|Lack of Efficacy|17|||
146201956|NCT02296424|527252182|FG002|Part 1|Lack of Efficacy|0|||
146201957|NCT02296424|527252183|FG003|Part 1|Lack of Efficacy|0|||
146201958|NCT02296424|527252180|FG000|Part 1|16 directly started part II|16|||
146201959|NCT02296424|527252181|FG001|Part 1|16 directly started part II|0|||
146201960|NCT02296424|527252182|FG002|Part 1|16 directly started part II|0|||
146201961|NCT02296424|527252183|FG003|Part 1|16 directly started part II|0|||
146201962|NCT02296424|527252180|FG000|Part 2|Lack of Efficacy|0|||
146201963|NCT02296424|527252181|FG001|Part 2|Lack of Efficacy|0|||
146201964|NCT02296424|527252182|FG002|Part 2|Lack of Efficacy|1|||
146201965|NCT02296424|527252183|FG003|Part 2|Lack of Efficacy|0|||
146201966|NCT02296424|527252180|FG000|Part 2|Adverse Event|0|||
146201967|NCT02296424|527252181|FG001|Part 2|Adverse Event|0|||
146429954|NCT00830206|528081777|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
146201968|NCT02296424|527252182|FG002|Part 2|Adverse Event|1|||
146201969|NCT02296424|527252183|FG003|Part 2|Adverse Event|0|||
146082841|NCT01451437|526822907|FG001|Overall Study|Protocol Violation|0|||
146201970|NCT02296424|527252180|FG000|Part 2|Lost to Follow-up|0|||
146201971|NCT02296424|527252181|FG001|Part 2|Lost to Follow-up|0|||
146201972|NCT02296424|527252182|FG002|Part 2|Lost to Follow-up|1|||
146201973|NCT02296424|527252183|FG003|Part 2|Lost to Follow-up|0|||
146201974|NCT00186186|527252184|FG000|Overall Study|Lack of Efficacy|3|||
146201975|NCT00186186|527252184|FG000|Overall Study|Withdrawal by Subject|3|||
146201976|NCT00186186|527252184|FG000|Overall Study|Not reported as to reason|2|||
146201977|NCT00807144|527252185|FG000|Overall Study|Lost to Follow-up|0|||
146201978|NCT00807144|527252186|FG001|Overall Study|Lost to Follow-up|1|||
146201979|NCT00071799|527252190|FG000|Overall Study|Adverse Event|19|||
146201980|NCT00071799|527252191|FG001|Overall Study|Adverse Event|10|||
146201981|NCT00071799|527252190|FG000|Overall Study|Protocol Violation|1|||
146201982|NCT00071799|527252191|FG001|Overall Study|Protocol Violation|7|||
146201983|NCT00071799|527252190|FG000|Overall Study|Lost to Follow-up|1|||
146201984|NCT00071799|527252191|FG001|Overall Study|Lost to Follow-up|1|||
146201985|NCT00071799|527252190|FG000|Overall Study|Withdrawal by Subject|15|||
146201986|NCT00071799|527252191|FG001|Overall Study|Withdrawal by Subject|37|||
146201987|NCT00071799|527252190|FG000|Overall Study|Physician Decision|0|||
146201988|NCT00071799|527252191|FG001|Overall Study|Physician Decision|2|||
146201989|NCT00071799|527252190|FG000|Overall Study|Lack of Efficacy|11|||
146201990|NCT00071799|527252191|FG001|Overall Study|Lack of Efficacy|18|||
146201991|NCT00071799|527252190|FG000|Overall Study|Disease Progression|23|||
146201992|NCT00071799|527252191|FG001|Overall Study|Disease Progression|20|||
146201993|NCT00071799|527252190|FG000|Overall Study|Different Central+Local Pathology Review|0|||
146201994|NCT00071799|527252191|FG001|Overall Study|Different Central+Local Pathology Review|1|||
146201995|NCT00071799|527252190|FG000|Overall Study|Not Documented|0|||
146201996|NCT00071799|527252191|FG001|Overall Study|Not Documented|2|||
146201997|NCT00814346|527252192|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
146201998|NCT00814346|527252193|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
146201999|NCT00814346|527252192|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
146202000|NCT00814346|527252193|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
146202001|NCT00814346|527252192|FG000|Open Phase (17 Months)|Adverse Event|5|||
146202002|NCT00814346|527252193|FG001|Open Phase (17 Months)|Adverse Event|0|||
146202003|NCT00814346|527252192|FG000|Open Phase (17 Months)|Consent|2|||
146202004|NCT00814346|527252193|FG001|Open Phase (17 Months)|Consent|0|||
146202005|NCT00814346|527252192|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
146202006|NCT00814346|527252193|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
146202007|NCT00814346|527252192|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
146202008|NCT00814346|527252193|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
146202009|NCT05136443|527252195|FG000|Overall Study|Lost to Follow-up|2|||
146202010|NCT05136443|527252195|FG000|Overall Study|Adverse Event|2|||
146202011|NCT03959241|527252206|FG000|Overall Study|Withdrawal by Subject|7|||
146202012|NCT03959241|527252207|FG001|Overall Study|Withdrawal by Subject|8|||
146202013|NCT03959241|527252206|FG000|Overall Study|Lost to Follow-up|1|||
146202014|NCT03959241|527252207|FG001|Overall Study|Lost to Follow-up|0|||
146202015|NCT03959241|527252206|FG000|Overall Study|Move to Hospice Care|1|||
146202016|NCT03959241|527252207|FG001|Overall Study|Move to Hospice Care|0|||
146202017|NCT03959241|527252206|FG000|Overall Study|Screen Failure|1|||
146202018|NCT03959241|527252207|FG001|Overall Study|Screen Failure|0|||
146202019|NCT03959241|527252206|FG000|Overall Study|Disease Relapse|0|||
146202020|NCT03959241|527252207|FG001|Overall Study|Disease Relapse|1|||
146202021|NCT03959241|527252206|FG000|Overall Study|Off Study|1|||
146202022|NCT03959241|527252207|FG001|Overall Study|Off Study|0|||
146202023|NCT03192046|527252208|FG000|Overall Study|Withdrawal by Subject|1|||
146202024|NCT03192046|527252209|FG001|Overall Study|Withdrawal by Subject|1|||
146202025|NCT00762606|527252210|FG000|Overall Study|Lost to Follow-up|18|||
146202026|NCT00762606|527252211|FG001|Overall Study|Lost to Follow-up|13|||
146202027|NCT00842257|527252214|FG000|Overall Study|Adverse Event|1|||
146202028|NCT01147341|527252215|FG000|Double Blind Period|Lack of Efficacy|1|||
146202029|NCT01147341|527252216|FG001|Double Blind Period|Lack of Efficacy|1|||
146202030|NCT01147341|527252215|FG000|Double Blind Period|Withdrawal by Subject|0|||
146202031|NCT01147341|527252216|FG001|Double Blind Period|Withdrawal by Subject|1|||
146202032|NCT01147341|527252215|FG000|Open Label Period|Lack of Efficacy|3|||
146202033|NCT01147341|527252216|FG001|Open Label Period|Lack of Efficacy|0|||
146202034|NCT01147341|527252215|FG000|Open Label Period|Subject moved|1|||
146202035|NCT01147341|527252216|FG001|Open Label Period|Subject moved|0|||
146202036|NCT05641311|527252224|FG000|Dosing Period 1|Adverse Event|1|||
146202037|NCT05641311|527252225|FG001|Dosing Period 1|Adverse Event|0|||
146202038|NCT00922207|527252228|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
146202039|NCT00922207|527252229|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
146202040|NCT00922207|527252230|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
146202041|NCT00922207|527252228|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146202042|NCT00922207|527252229|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146202043|NCT00922207|527252230|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146202044|NCT00922207|527252228|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146202045|NCT00922207|527252229|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146202046|NCT00922207|527252230|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146202047|NCT00922207|527252228|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
146202048|NCT00922207|527252229|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146202049|NCT00922207|527252230|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146202050|NCT00922207|527252228|FG000|Overall Study|Withdrew Consent|2|||
146202051|NCT00922207|527252229|FG001|Overall Study|Withdrew Consent|5|||
146202052|NCT00922207|527252230|FG002|Overall Study|Withdrew Consent|2|||
146202053|NCT00922207|527252228|FG000|Overall Study|Abnormality of Laboratory Test|0|||
146202054|NCT00922207|527252229|FG001|Overall Study|Abnormality of Laboratory Test|1|||
146202055|NCT00922207|527252230|FG002|Overall Study|Abnormality of Laboratory Test|1|||
146202056|NCT03299816|527252231|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
146429955|NCT00830206|528081778|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
146429956|NCT00905346|528081785|FG000|Period 1|Withdrawal by Subject|1|||
146429957|NCT00905346|528081786|FG001|Period 1|Withdrawal by Subject|0|||
146429958|NCT01435265|528081787|FG000|Overall Study|Lost to Follow-up|0|||
146429959|NCT01435265|528081788|FG001|Overall Study|Lost to Follow-up|1|||
146429960|NCT00909610|528081791|FG000|Period: First Intervention|Adverse Event|0|||
146429961|NCT00909610|528081792|FG001|Period: First Intervention|Adverse Event|1|||
146429962|NCT00909610|528081791|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
146429963|NCT00909610|528081792|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
146429964|NCT00909610|528081791|FG000|Period: Second Intervention|Adverse Event|1|||
146429965|NCT00909610|528081792|FG001|Period: Second Intervention|Adverse Event|0|||
146429966|NCT04123548|528081796|FG000|Overall Study|Withdrawal by Subject|1|||
146429967|NCT04123548|528081796|FG000|Overall Study|Lost to Follow-up|8|||
146429968|NCT04123548|528081796|FG000|Overall Study|Death|4|||
146429969|NCT04123548|528081796|FG000|Overall Study|Reason Not Specified|1|||
146429970|NCT04166630|528081798|FG000|Overall Study|Withdrawal by Subject|0|||
146429971|NCT04166630|528081799|FG001|Overall Study|Withdrawal by Subject|1|||
146429972|NCT03107091|528081800|FG000|Overall Study|Physician Decision|1|||
146429973|NCT00105196|528081805|FG000|Overall Study|Lack of Efficacy|2|||
146429974|NCT00105196|528081806|FG001|Overall Study|Lack of Efficacy|3|||
146429975|NCT00105196|528081805|FG000|Overall Study|Adverse Event|11|||
146429976|NCT00105196|528081806|FG001|Overall Study|Adverse Event|3|||
146429977|NCT00105196|528081805|FG000|Overall Study|Withdrawal by Subject|6|||
146429978|NCT00105196|528081806|FG001|Overall Study|Withdrawal by Subject|6|||
146429979|NCT00105196|528081805|FG000|Overall Study|Lost to Follow-up|3|||
146429980|NCT00105196|528081806|FG001|Overall Study|Lost to Follow-up|2|||
146429981|NCT00105196|528081805|FG000|Overall Study|Poor/noncompliance|3|||
146429982|NCT00105196|528081806|FG001|Overall Study|Poor/noncompliance|4|||
146429983|NCT00105196|528081805|FG000|Overall Study|Protocol Violation|5|||
146429984|NCT00105196|528081806|FG001|Overall Study|Protocol Violation|2|||
146429985|NCT00105196|528081805|FG000|Overall Study|pending surgery|0|||
146429986|NCT00105196|528081806|FG001|Overall Study|pending surgery|1|||
146429987|NCT00105196|528081805|FG000|Overall Study|marijuana use|0|||
146429988|NCT00105196|528081806|FG001|Overall Study|marijuana use|1|||
146429989|NCT00105196|528081805|FG000|Overall Study|Subject became unblinded|0|||
146429990|NCT00105196|528081806|FG001|Overall Study|Subject became unblinded|1|||
146429991|NCT00893464|528081807|FG000|Overall Study|Did not complete therapy/experience PD|0|||
146429992|NCT00893464|528081808|FG001|Overall Study|Did not complete therapy/experience PD|0|||
146429993|NCT00893464|528081809|FG002|Overall Study|Did not complete therapy/experience PD|0|||
146429994|NCT00893464|528081810|FG003|Overall Study|Did not complete therapy/experience PD|0|||
146429995|NCT00893464|528081811|FG004|Overall Study|Did not complete therapy/experience PD|0|||
146429996|NCT00893464|528081812|FG005|Overall Study|Did not complete therapy/experience PD|0|||
146429997|NCT00893464|528081813|FG006|Overall Study|Did not complete therapy/experience PD|2|||
146429998|NCT00893464|528081814|FG007|Overall Study|Did not complete therapy/experience PD|2|||
146429999|NCT01544127|528081815|FG000|Overall Study|Lost to Follow-up|4|||
146430000|NCT01544127|528081816|FG001|Overall Study|Lost to Follow-up|2|||
146430001|NCT01544127|528081817|FG002|Overall Study|Lost to Follow-up|9|||
146430002|NCT01544127|528081815|FG000|Overall Study|Withdrawal by Subject|2|||
146430003|NCT01544127|528081816|FG001|Overall Study|Withdrawal by Subject|2|||
146430004|NCT01544127|528081817|FG002|Overall Study|Withdrawal by Subject|1|||
146430005|NCT01544127|528081815|FG000|Overall Study|Discharged out of catchment area|1|||
146430006|NCT01544127|528081816|FG001|Overall Study|Discharged out of catchment area|1|||
146430007|NCT01544127|528081817|FG002|Overall Study|Discharged out of catchment area|1|||
146430008|NCT01544127|528081815|FG000|Overall Study|Death|1|||
146430009|NCT01544127|528081816|FG001|Overall Study|Death|0|||
146202057|NCT03299816|527252232|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
146202058|NCT03299816|527252231|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
146430010|NCT01544127|528081817|FG002|Overall Study|Death|0|||
146430011|NCT01544127|528081815|FG000|Overall Study|Jail or Prison|1|||
146430012|NCT01544127|528081816|FG001|Overall Study|Jail or Prison|1|||
146430013|NCT01544127|528081817|FG002|Overall Study|Jail or Prison|2|||
146430014|NCT01544127|528081815|FG000|Overall Study|Became Psychotic|1|||
146430015|NCT01544127|528081816|FG001|Overall Study|Became Psychotic|0|||
146202059|NCT03299816|527252232|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
146202060|NCT03299816|527252231|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
146202061|NCT03299816|527252232|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
146202062|NCT00367991|527252234|FG000|Overall Study|Withdrawal by Subject|1|||
146430016|NCT01544127|528081817|FG002|Overall Study|Became Psychotic|0|||
146430017|NCT01544127|528081815|FG000|Overall Study|Researcher withdrew|1|||
146430018|NCT01544127|528081816|FG001|Overall Study|Researcher withdrew|0|||
146430019|NCT01544127|528081817|FG002|Overall Study|Researcher withdrew|0|||
146430020|NCT01544127|528081815|FG000|Overall Study|Went active duty|0|||
146430021|NCT01544127|528081816|FG001|Overall Study|Went active duty|0|||
146430022|NCT01544127|528081817|FG002|Overall Study|Went active duty|1|||
146430023|NCT01256684|528081818|FG000|Overall Study|Adverse Event|1|||
146430024|NCT01256684|528081819|FG001|Overall Study|Adverse Event|4|||
146430025|NCT01256684|528081820|FG002|Overall Study|Adverse Event|2|||
146430026|NCT01256684|528081818|FG000|Overall Study|Withdrawal by Subject|4|||
146430027|NCT01256684|528081819|FG001|Overall Study|Withdrawal by Subject|0|||
146430028|NCT01256684|528081820|FG002|Overall Study|Withdrawal by Subject|2|||
146430029|NCT01256684|528081818|FG000|Overall Study|Physician Decision|0|||
146430030|NCT01256684|528081819|FG001|Overall Study|Physician Decision|1|||
146430031|NCT01256684|528081820|FG002|Overall Study|Physician Decision|0|||
146430032|NCT01256684|528081818|FG000|Overall Study|Lack of Efficacy|0|||
146430033|NCT01256684|528081819|FG001|Overall Study|Lack of Efficacy|1|||
146430034|NCT01256684|528081820|FG002|Overall Study|Lack of Efficacy|1|||
146430035|NCT01256684|528081818|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
146430036|NCT01256684|528081819|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
146430037|NCT01256684|528081820|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
146430038|NCT02914600|528081821|FG000|Overall Study|Adverse Event|298|||
146430039|NCT02914600|528081822|FG001|Overall Study|Adverse Event|35|||
146430040|NCT02914600|528081823|FG002|Overall Study|Adverse Event|25|||
146430041|NCT02914600|528081821|FG000|Overall Study|Sponsors decision|287|||
146430042|NCT02914600|528081822|FG001|Overall Study|Sponsors decision|41|||
146430043|NCT02914600|528081823|FG002|Overall Study|Sponsors decision|12|||
146430044|NCT02914600|528081821|FG000|Overall Study|Withdrawal by Subject|158|||
146430045|NCT02914600|528081822|FG001|Overall Study|Withdrawal by Subject|20|||
146430046|NCT02914600|528081823|FG002|Overall Study|Withdrawal by Subject|18|||
146430047|NCT02914600|528081821|FG000|Overall Study|Investigators discretion|169|||
146430048|NCT02914600|528081822|FG001|Overall Study|Investigators discretion|14|||
146430049|NCT02914600|528081823|FG002|Overall Study|Investigators discretion|13|||
146430050|NCT02914600|528081821|FG000|Overall Study|Lost to Follow-up|10|||
146430051|NCT02914600|528081822|FG001|Overall Study|Lost to Follow-up|4|||
146430052|NCT02914600|528081823|FG002|Overall Study|Lost to Follow-up|0|||
146430053|NCT02914600|528081821|FG000|Overall Study|Pregnancy|8|||
146430054|NCT02914600|528081822|FG001|Overall Study|Pregnancy|0|||
146430055|NCT02914600|528081823|FG002|Overall Study|Pregnancy|0|||
146430056|NCT02914600|528081821|FG000|Overall Study|Protocol Violation|5|||
146430057|NCT02914600|528081822|FG001|Overall Study|Protocol Violation|3|||
146430058|NCT02914600|528081823|FG002|Overall Study|Protocol Violation|0|||
146430059|NCT02914600|528081821|FG000|Overall Study|Non-compliance with study drug|6|||
146430060|NCT02914600|528081822|FG001|Overall Study|Non-compliance with study drug|1|||
146430061|NCT02914600|528081823|FG002|Overall Study|Non-compliance with study drug|0|||
146430062|NCT02914600|528081821|FG000|Overall Study|Death|3|||
146430063|NCT02914600|528081822|FG001|Overall Study|Death|1|||
146430064|NCT02914600|528081823|FG002|Overall Study|Death|1|||
146430065|NCT02914600|528081821|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
146430066|NCT02914600|528081822|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
146430067|NCT02914600|528081823|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
146430068|NCT02914600|528081821|FG000|Overall Study|Enrolled but not treated|1|||
146430069|NCT02914600|528081822|FG001|Overall Study|Enrolled but not treated|0|||
146430070|NCT02914600|528081823|FG002|Overall Study|Enrolled but not treated|0|||
146430071|NCT02457520|528081824|FG000|Active Treatment Phase|Adverse Event|10|||
146430072|NCT02457520|528081824|FG000|Active Treatment Phase|Lost to Follow-up|8|||
146430073|NCT02457520|528081824|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
146430074|NCT02457520|528081824|FG000|Active Treatment Phase|other|4|||
146430075|NCT02457520|528081824|FG000|Active Treatment Phase|Physician Decision|1|||
146430076|NCT02457520|528081824|FG000|Active Treatment Phase|Protocol Violation|1|||
146430077|NCT02457520|528081824|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
146430078|NCT02457520|528081824|FG000|Post-treatment Period|Other: Retreatment Required|7|||
146430079|NCT02457520|528081824|FG000|Post-treatment Period|Lost to Follow-up|23|||
146430080|NCT02457520|528081824|FG000|Post-treatment Period|Other|3|||
146430081|NCT02457520|528081824|FG000|Post-treatment Period|Physician Decision|1|||
146430082|NCT02457520|528081824|FG000|Post-treatment Period|Withdrawal by Subject|14|||
146430083|NCT01185548|528081825|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
146430084|NCT00184600|528081828|FG000|Overall Study|Adverse Event|9|||
146430085|NCT00184600|528081829|FG001|Overall Study|Adverse Event|0|||
146430086|NCT00184600|528081830|FG002|Overall Study|Adverse Event|5|||
146430087|NCT00184600|528081828|FG000|Overall Study|Death|3|||
146202063|NCT00367991|527252235|FG001|Overall Study|Withdrawal by Subject|1|||
146430088|NCT00184600|528081829|FG001|Overall Study|Death|9|||
146430089|NCT00184600|528081830|FG002|Overall Study|Death|7|||
146430090|NCT00184600|528081828|FG000|Overall Study|Lack of Efficacy|3|||
146430091|NCT00184600|528081829|FG001|Overall Study|Lack of Efficacy|1|||
146430092|NCT00184600|528081830|FG002|Overall Study|Lack of Efficacy|3|||
146430093|NCT00184600|528081828|FG000|Overall Study|Lost to Follow-up|4|||
146430094|NCT00184600|528081829|FG001|Overall Study|Lost to Follow-up|6|||
146430095|NCT00184600|528081830|FG002|Overall Study|Lost to Follow-up|1|||
146430096|NCT00184600|528081828|FG000|Overall Study|Protocol Violation|2|||
146430097|NCT00184600|528081829|FG001|Overall Study|Protocol Violation|2|||
146430098|NCT00184600|528081830|FG002|Overall Study|Protocol Violation|3|||
146202064|NCT00367991|527252234|FG000|Overall Study|Adverse Event|1|||
146430099|NCT00184600|528081828|FG000|Overall Study|Withdrawal by Subject|20|||
146430100|NCT00184600|528081829|FG001|Overall Study|Withdrawal by Subject|28|||
146430101|NCT00184600|528081830|FG002|Overall Study|Withdrawal by Subject|12|||
146430102|NCT00184600|528081828|FG000|Overall Study|Unclassified|4|||
146430103|NCT00184600|528081829|FG001|Overall Study|Unclassified|5|||
146430104|NCT00184600|528081830|FG002|Overall Study|Unclassified|3|||
146430105|NCT00696020|528081833|FG000|Overall Study|Adverse Event|3|||
146430106|NCT00696020|528081834|FG001|Overall Study|Adverse Event|1|||
146430107|NCT00696020|528081835|FG002|Overall Study|Adverse Event|2|||
146430108|NCT00696020|528081836|FG003|Overall Study|Adverse Event|1|||
146430109|NCT00696020|528081833|FG000|Overall Study|Lack of Efficacy|1|||
146430110|NCT00696020|528081834|FG001|Overall Study|Lack of Efficacy|0|||
146430111|NCT00696020|528081835|FG002|Overall Study|Lack of Efficacy|0|||
146430112|NCT00696020|528081836|FG003|Overall Study|Lack of Efficacy|0|||
146430113|NCT00696020|528081833|FG000|Overall Study|Protocol Violation|0|||
146430114|NCT00696020|528081834|FG001|Overall Study|Protocol Violation|0|||
146430115|NCT00696020|528081835|FG002|Overall Study|Protocol Violation|0|||
146430116|NCT00696020|528081836|FG003|Overall Study|Protocol Violation|1|||
146430117|NCT00696020|528081833|FG000|Overall Study|Withdrawal by Subject|0|||
146430118|NCT00696020|528081834|FG001|Overall Study|Withdrawal by Subject|1|||
146430119|NCT00696020|528081835|FG002|Overall Study|Withdrawal by Subject|0|||
146430120|NCT00696020|528081836|FG003|Overall Study|Withdrawal by Subject|1|||
146430121|NCT00696020|528081833|FG000|Overall Study|Other not stated above|0|||
146430122|NCT00696020|528081834|FG001|Overall Study|Other not stated above|0|||
146430123|NCT00696020|528081835|FG002|Overall Study|Other not stated above|1|||
146430124|NCT00696020|528081836|FG003|Overall Study|Other not stated above|1|||
146430125|NCT00624065|528081837|FG000|Overall Study|Adverse Event|5|||
146430126|NCT00624065|528081838|FG001|Overall Study|Adverse Event|6|||
146430127|NCT00624065|528081837|FG000|Overall Study|Lost to Follow-up|4|||
146430128|NCT00624065|528081838|FG001|Overall Study|Lost to Follow-up|1|||
146430129|NCT00624065|528081837|FG000|Overall Study|Consent withdrawn|6|||
146430130|NCT00624065|528081838|FG001|Overall Study|Consent withdrawn|5|||
146430131|NCT00624065|528081837|FG000|Overall Study|Lack of Efficacy|0|||
146430132|NCT00624065|528081838|FG001|Overall Study|Lack of Efficacy|3|||
146430133|NCT00624065|528081837|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
146430134|NCT00624065|528081838|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
146430135|NCT01387022|528081840|FG000|Overall Study|Death|1|||
146430136|NCT01387022|528081841|FG001|Overall Study|Death|1|||
146430137|NCT01387022|528081840|FG000|Overall Study|Lost to Follow-up|0|||
146430138|NCT01387022|528081841|FG001|Overall Study|Lost to Follow-up|3|||
146430139|NCT02076022|528081842|FG000|Overall Study|Withdrawal by Subject|2|||
146430140|NCT02076022|528081843|FG001|Overall Study|Withdrawal by Subject|0|||
146430141|NCT00312663|528081846|FG000|Immunization Phase|Adverse Event|0|||
146430142|NCT00312663|528081847|FG001|Immunization Phase|Adverse Event|1|||
146430143|NCT00312663|528081848|FG002|Immunization Phase|Adverse Event|0|||
146430144|NCT02336165|528081852|FG000|Overall Study|Death|3|||
146430145|NCT02336165|528081853|FG001|Overall Study|Death|0|||
146430146|NCT02336165|528081854|FG002|Overall Study|Death|0|||
146430147|NCT02336165|528081855|FG003|Overall Study|Death|0|||
146430148|NCT02336165|528081856|FG004|Overall Study|Death|1|||
146430149|NCT02336165|528081852|FG000|Overall Study|Physician Decision|2|||
146430150|NCT02336165|528081853|FG001|Overall Study|Physician Decision|2|||
146430151|NCT02336165|528081854|FG002|Overall Study|Physician Decision|1|||
146430152|NCT02336165|528081855|FG003|Overall Study|Physician Decision|1|||
146430153|NCT02336165|528081856|FG004|Overall Study|Physician Decision|0|||
146202065|NCT00367991|527252235|FG001|Overall Study|Adverse Event|1|||
146202066|NCT01585558|527252246|FG000|Overall Study|Withdrawal by Subject|4|||
146202067|NCT01585558|527252247|FG001|Overall Study|Withdrawal by Subject|5|||
146202068|NCT01585558|527252248|FG002|Overall Study|Withdrawal by Subject|8|||
146202069|NCT01585558|527252246|FG000|Overall Study|Lost to Follow-up|2|||
146202070|NCT01585558|527252247|FG001|Overall Study|Lost to Follow-up|0|||
146430154|NCT02336165|528081852|FG000|Overall Study|Withdrawal by Subject|0|||
146430155|NCT02336165|528081853|FG001|Overall Study|Withdrawal by Subject|0|||
146430156|NCT02336165|528081854|FG002|Overall Study|Withdrawal by Subject|1|||
146430157|NCT02336165|528081855|FG003|Overall Study|Withdrawal by Subject|0|||
146430158|NCT02336165|528081856|FG004|Overall Study|Withdrawal by Subject|1|||
146430159|NCT02336165|528081852|FG000|Overall Study|Adverse Event|4|||
146430160|NCT02336165|528081853|FG001|Overall Study|Adverse Event|1|||
146430161|NCT02336165|528081854|FG002|Overall Study|Adverse Event|2|||
146430162|NCT02336165|528081855|FG003|Overall Study|Adverse Event|4|||
146430163|NCT02336165|528081856|FG004|Overall Study|Adverse Event|1|||
146430164|NCT02336165|528081852|FG000|Overall Study|Progressive disease|23|||
146202071|NCT01585558|527252248|FG002|Overall Study|Lost to Follow-up|3|||
146202072|NCT01585558|527252246|FG000|Overall Study|Adverse Event|3|||
146430165|NCT02336165|528081853|FG001|Overall Study|Progressive disease|22|||
146430166|NCT02336165|528081854|FG002|Overall Study|Progressive disease|27|||
146430167|NCT02336165|528081855|FG003|Overall Study|Progressive disease|24|||
146430168|NCT02336165|528081856|FG004|Overall Study|Progressive disease|19|||
146430169|NCT02336165|528081852|FG000|Overall Study|Non-compliance|1|||
146430170|NCT02336165|528081853|FG001|Overall Study|Non-compliance|0|||
146430171|NCT02336165|528081854|FG002|Overall Study|Non-compliance|0|||
146430172|NCT02336165|528081855|FG003|Overall Study|Non-compliance|1|||
146430173|NCT02336165|528081856|FG004|Overall Study|Non-compliance|0|||
146430174|NCT02336165|528081852|FG000|Overall Study|Other|1|||
146430175|NCT02336165|528081853|FG001|Overall Study|Other|0|||
146430176|NCT02336165|528081854|FG002|Overall Study|Other|0|||
146430177|NCT02336165|528081855|FG003|Overall Study|Other|1|||
146430178|NCT02336165|528081856|FG004|Overall Study|Other|0|||
146430179|NCT01010542|528081861|FG000|Overall Study|Adverse Event|0|||
146430180|NCT01010542|528081862|FG001|Overall Study|Adverse Event|1|||
146430181|NCT01010542|528081863|FG002|Overall Study|Adverse Event|0|||
146430182|NCT01010542|528081861|FG000|Overall Study|Lost to Follow-up|0|||
146430183|NCT01010542|528081862|FG001|Overall Study|Lost to Follow-up|1|||
146430184|NCT01010542|528081863|FG002|Overall Study|Lost to Follow-up|0|||
146430185|NCT01010542|528081861|FG000|Overall Study|Withdrawal by Subject|0|||
146430186|NCT01010542|528081862|FG001|Overall Study|Withdrawal by Subject|3|||
146430187|NCT01010542|528081863|FG002|Overall Study|Withdrawal by Subject|2|||
146430188|NCT04185909|528081864|FG000|Overall Study|Lost to Follow-up|1|||
146430189|NCT00857623|528081865|FG000|Overall Study|Adverse Event|5|||
146430190|NCT00857623|528081866|FG001|Overall Study|Adverse Event|2|||
146430191|NCT00857623|528081865|FG000|Overall Study|Study-specific discontinuation criteria|5|||
146430192|NCT00857623|528081866|FG001|Overall Study|Study-specific discontinuation criteria|3|||
146430193|NCT00857623|528081865|FG000|Overall Study|Withdrawal by Subject|2|||
146430194|NCT00857623|528081866|FG001|Overall Study|Withdrawal by Subject|1|||
146430195|NCT00857623|528081865|FG000|Overall Study|Lack of Efficacy|1|||
146430196|NCT00857623|528081866|FG001|Overall Study|Lack of Efficacy|1|||
146430197|NCT00857623|528081865|FG000|Overall Study|Severe non-compliance to protocol|1|||
146430198|NCT00857623|528081866|FG001|Overall Study|Severe non-compliance to protocol|1|||
146430199|NCT00857623|528081865|FG000|Overall Study|Intake of prohibited medication|0|||
146430200|NCT00857623|528081866|FG001|Overall Study|Intake of prohibited medication|1|||
146430201|NCT00857623|528081865|FG000|Overall Study|Positive for HEP C|0|||
146430202|NCT00857623|528081866|FG001|Overall Study|Positive for HEP C|1|||
146430203|NCT04510285|528081869|FG000|Overall Study|Death|1|||
146430204|NCT00626548|528081870|FG000|Overall Study|Adverse Event|164|||
146430205|NCT00626548|528081871|FG001|Overall Study|Adverse Event|44|||
146430206|NCT00626548|528081870|FG000|Overall Study|Withdrawal by Subject|42|||
146430207|NCT00626548|528081871|FG001|Overall Study|Withdrawal by Subject|46|||
146430208|NCT00626548|528081870|FG000|Overall Study|Protocol Violation|4|||
146430209|NCT00626548|528081871|FG001|Overall Study|Protocol Violation|11|||
146430210|NCT00626548|528081870|FG000|Overall Study|Lost to Follow-up|2|||
146430211|NCT00626548|528081871|FG001|Overall Study|Lost to Follow-up|2|||
146430212|NCT00626548|528081870|FG000|Overall Study|Other termination reason|493|||
146430213|NCT00626548|528081871|FG001|Overall Study|Other termination reason|613|||
146430214|NCT01066143|528083783|FG000|Overall Study|ineligible for the study|8|||
146430215|NCT01294787|528083784|FG000|Period 1|Adverse Event|0|||
146430216|NCT01294787|528083785|FG001|Period 1|Adverse Event|0|||
146430217|NCT01294787|528083786|FG002|Period 1|Adverse Event|0|||
146430218|NCT01294787|528083787|FG003|Period 1|Adverse Event|0|||
146430219|NCT01294787|528083788|FG004|Period 1|Adverse Event|1|||
146430220|NCT01294787|528083789|FG005|Period 1|Adverse Event|0|||
146430221|NCT01294787|528083784|FG000|Period 1|Withdrawal by Subject|0|||
146430222|NCT01294787|528083785|FG001|Period 1|Withdrawal by Subject|0|||
146430223|NCT01294787|528083786|FG002|Period 1|Withdrawal by Subject|0|||
146430224|NCT01294787|528083787|FG003|Period 1|Withdrawal by Subject|1|||
146430225|NCT01294787|528083788|FG004|Period 1|Withdrawal by Subject|1|||
146430226|NCT01294787|528083789|FG005|Period 1|Withdrawal by Subject|1|||
146430227|NCT01294787|528083784|FG000|Period 1|Administrative problem|0|||
146430228|NCT01294787|528083785|FG001|Period 1|Administrative problem|0|||
145950017|NCT00548249|526328723|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145950018|NCT00548249|526328724|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146082842|NCT01451437|526822908|FG002|Overall Study|Protocol Violation|0|||
146082843|NCT01451437|526822909|FG003|Overall Study|Protocol Violation|0|||
146202073|NCT01585558|527252247|FG001|Overall Study|Adverse Event|4|||
146202074|NCT01585558|527252248|FG002|Overall Study|Adverse Event|1|||
146430229|NCT01294787|528083786|FG002|Period 1|Administrative problem|1|||
146430230|NCT01294787|528083787|FG003|Period 1|Administrative problem|0|||
146430231|NCT01294787|528083788|FG004|Period 1|Administrative problem|0|||
146430232|NCT01294787|528083789|FG005|Period 1|Administrative problem|1|||
146430233|NCT01294787|528083784|FG000|Period 2|Adverse Event|0|||
146430234|NCT01294787|528083785|FG001|Period 2|Adverse Event|3|||
146430235|NCT01294787|528083786|FG002|Period 2|Adverse Event|0|||
146430236|NCT01294787|528083787|FG003|Period 2|Adverse Event|1|||
146430237|NCT01294787|528083788|FG004|Period 2|Adverse Event|0|||
146430238|NCT01294787|528083789|FG005|Period 2|Adverse Event|0|||
146430239|NCT01294787|528083784|FG000|Period 2|No longer needs study drug|0|||
146082844|NCT01451437|526822910|FG004|Overall Study|Protocol Violation|0|||
146430240|NCT01294787|528083785|FG001|Period 2|No longer needs study drug|0|||
146430241|NCT01294787|528083786|FG002|Period 2|No longer needs study drug|0|||
146430242|NCT01294787|528083787|FG003|Period 2|No longer needs study drug|1|||
146430243|NCT01294787|528083788|FG004|Period 2|No longer needs study drug|0|||
146430244|NCT01294787|528083789|FG005|Period 2|No longer needs study drug|0|||
146430245|NCT01294787|528083784|FG000|Period 3|Adverse Event|0|||
146430246|NCT01294787|528083785|FG001|Period 3|Adverse Event|0|||
146202075|NCT01585558|527252246|FG000|Overall Study|Protocol Violation|4|||
146202076|NCT01585558|527252247|FG001|Overall Study|Protocol Violation|3|||
146430247|NCT01294787|528083786|FG002|Period 3|Adverse Event|0|||
146430248|NCT01294787|528083787|FG003|Period 3|Adverse Event|0|||
146202077|NCT01585558|527252248|FG002|Overall Study|Protocol Violation|2|||
146202078|NCT01585558|527252246|FG000|Overall Study|Lack of Efficacy|0|||
146202079|NCT01585558|527252247|FG001|Overall Study|Lack of Efficacy|0|||
146202080|NCT01585558|527252248|FG002|Overall Study|Lack of Efficacy|1|||
146202081|NCT00997386|527252249|FG000|Overall Study|Death|7|||
146202082|NCT00617201|527252252|FG000|Overall Study|Lost to Follow-up|9|||
146202083|NCT00617201|527252253|FG001|Overall Study|Lost to Follow-up|13|||
146202084|NCT01350804|527252254|FG000|Core Study|Withdrawal by Subject|11|||
146202085|NCT01350804|527252255|FG001|Core Study|Withdrawal by Subject|17|||
146202086|NCT01350804|527252256|FG002|Core Study|Withdrawal by Subject|16|||
146202087|NCT01350804|527252257|FG003|Core Study|Withdrawal by Subject|7|||
146202088|NCT01350804|527252254|FG000|Core Study|Study terminated by Sponsor|0|||
146202089|NCT01350804|527252255|FG001|Core Study|Study terminated by Sponsor|0|||
146202090|NCT01350804|527252256|FG002|Core Study|Study terminated by Sponsor|0|||
146202091|NCT01350804|527252257|FG003|Core Study|Study terminated by Sponsor|2|||
146202092|NCT01350804|527252254|FG000|Core Study|Protocol deviation|1|||
146202093|NCT01350804|527252255|FG001|Core Study|Protocol deviation|0|||
146202094|NCT01350804|527252256|FG002|Core Study|Protocol deviation|1|||
146202095|NCT01350804|527252257|FG003|Core Study|Protocol deviation|0|||
146202096|NCT01350804|527252254|FG000|Core Study|Physician Decision|1|||
146202097|NCT01350804|527252255|FG001|Core Study|Physician Decision|0|||
146202098|NCT01350804|527252256|FG002|Core Study|Physician Decision|1|||
146430249|NCT01294787|528083788|FG004|Period 3|Adverse Event|1|||
146430250|NCT01294787|528083789|FG005|Period 3|Adverse Event|0|||
146430251|NCT03351335|528083790|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
146430252|NCT03351335|528083791|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
146430253|NCT03351335|528083792|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
146202099|NCT01350804|527252257|FG003|Core Study|Physician Decision|3|||
146202100|NCT01350804|527252254|FG000|Core Study|Lost to Follow-up|3|||
146430254|NCT04605094|528083793|FG000|Overall Study|Adverse Event|2|||
146430255|NCT04605094|528083794|FG001|Overall Study|Adverse Event|2|||
146202101|NCT01350804|527252255|FG001|Core Study|Lost to Follow-up|0|||
146202102|NCT01350804|527252256|FG002|Core Study|Lost to Follow-up|2|||
146202103|NCT01350804|527252257|FG003|Core Study|Lost to Follow-up|1|||
146202104|NCT01350804|527252254|FG000|Core Study|Lack of Efficacy|16|||
146202105|NCT01350804|527252255|FG001|Core Study|Lack of Efficacy|19|||
146430256|NCT04605094|528083793|FG000|Overall Study|Lost to Follow-up|1|||
146430257|NCT04605094|528083794|FG001|Overall Study|Lost to Follow-up|4|||
146430258|NCT04605094|528083793|FG000|Overall Study|Physician Decision|2|||
146430259|NCT04605094|528083794|FG001|Overall Study|Physician Decision|2|||
146430260|NCT04605094|528083793|FG000|Overall Study|Study terminated by Sponsor|31|||
146430261|NCT04605094|528083794|FG001|Overall Study|Study terminated by Sponsor|33|||
146430262|NCT04605094|528083793|FG000|Overall Study|Withdrawal by Subject|22|||
146430263|NCT04605094|528083794|FG001|Overall Study|Withdrawal by Subject|19|||
146430264|NCT04605094|528083793|FG000|Overall Study|Other|1|||
146430265|NCT04605094|528083794|FG001|Overall Study|Other|1|||
146430266|NCT01900691|528083795|FG000|Overall Study|Death|7|||
146430267|NCT01900691|528083795|FG000|Overall Study|Lost to Follow-up|4|||
146430268|NCT01900691|528083795|FG000|Overall Study|Study Device Not Placed|3|||
146430269|NCT01900691|528083795|FG000|Overall Study|Non study stent placed|2|||
146430270|NCT01900691|528083795|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
146430271|NCT01900691|528083795|FG000|Overall Study|Complete stent migration through digestive tract|1|||
146430272|NCT02724462|528083796|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
146202106|NCT01350804|527252256|FG002|Core Study|Lack of Efficacy|18|||
146202107|NCT01350804|527252257|FG003|Core Study|Lack of Efficacy|5|||
146430273|NCT02724462|528083797|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
146202108|NCT01350804|527252254|FG000|Core Study|Death|1|||
146202109|NCT01350804|527252255|FG001|Core Study|Death|1|||
146202110|NCT01350804|527252256|FG002|Core Study|Death|1|||
146202111|NCT01350804|527252257|FG003|Core Study|Death|0|||
146202112|NCT01350804|527252254|FG000|Core Study|Adverse Event|8|||
146202113|NCT01350804|527252255|FG001|Core Study|Adverse Event|10|||
146202114|NCT01350804|527252256|FG002|Core Study|Adverse Event|8|||
146202115|NCT01350804|527252257|FG003|Core Study|Adverse Event|8|||
146202116|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
146202117|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
146430274|NCT02724462|528083796|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146430275|NCT02724462|528083797|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146202118|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
146202119|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
146430276|NCT02724462|528083796|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
146430277|NCT02724462|528083797|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
146430278|NCT02724462|528083796|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146430279|NCT02724462|528083797|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146430280|NCT02724462|528083796|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
146430281|NCT02724462|528083797|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
146430282|NCT02724462|528083796|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
146430283|NCT02724462|528083797|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
146430284|NCT00469417|528083798|FG000|Overall Study|Treatment failure all lesions|18|||
146202120|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
146202121|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
146202122|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
146202123|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
146202124|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
146202125|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
146202126|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
146430285|NCT00469417|528083799|FG001|Overall Study|Treatment failure all lesions|11|||
146430286|NCT00469417|528083798|FG000|Overall Study|Consent withdrawn|1|||
146430287|NCT00469417|528083799|FG001|Overall Study|Consent withdrawn|1|||
146430288|NCT00469417|528083798|FG000|Overall Study|Adverse Event|8|||
146430289|NCT00469417|528083799|FG001|Overall Study|Adverse Event|2|||
146430290|NCT00469417|528083798|FG000|Overall Study|Lost to Follow-up|1|||
146430291|NCT00469417|528083799|FG001|Overall Study|Lost to Follow-up|2|||
146430292|NCT00469417|528083798|FG000|Overall Study|Intercurrent disease|0|||
146430293|NCT00469417|528083799|FG001|Overall Study|Intercurrent disease|1|||
146430294|NCT00469417|528083798|FG000|Overall Study|Randomized but not treated|2|||
146430295|NCT00469417|528083799|FG001|Overall Study|Randomized but not treated|0|||
146430296|NCT01954394|528083802|FG000|Overall Study|Enrolled but not treated|1|||
146430297|NCT01954394|528083803|FG001|Overall Study|Enrolled but not treated|0|||
146430298|NCT01954394|528083802|FG000|Overall Study|Adverse Event|10|||
146430299|NCT01954394|528083803|FG001|Overall Study|Adverse Event|23|||
146430300|NCT01954394|528083802|FG000|Overall Study|Poor compliance to protocol|7|||
146430301|NCT01954394|528083803|FG001|Overall Study|Poor compliance to protocol|7|||
146202127|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
146202128|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146202129|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
146202130|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146202131|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
146202132|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
146430302|NCT01954394|528083802|FG000|Overall Study|Participant Moved|0|||
146430303|NCT01954394|528083803|FG001|Overall Study|Participant Moved|4|||
146430304|NCT01954394|528083802|FG000|Overall Study|Related to Study Drug administration|2|||
146430305|NCT01954394|528083803|FG001|Overall Study|Related to Study Drug administration|2|||
146430306|NCT01954394|528083802|FG000|Overall Study|Other than specified above|10|||
146202133|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
146202134|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
146202135|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
146430307|NCT01954394|528083803|FG001|Overall Study|Other than specified above|21|||
146430308|NCT04089735|528083806|FG000|Overall Study|Adverse Event|1|||
146430309|NCT04089735|528083807|FG001|Overall Study|Adverse Event|0|||
146202136|NCT01350804|527252254|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
146202137|NCT01350804|527252255|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
146202138|NCT01350804|527252256|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
146202139|NCT01350804|527252257|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
146202140|NCT01286272|527253880|FG000|Overall Study|Ineligible after beginning treatment|1|||
146430310|NCT04089735|528083808|FG002|Overall Study|Adverse Event|1|||
146430311|NCT04089735|528083809|FG003|Overall Study|Adverse Event|1|||
146430312|NCT04089735|528083810|FG004|Overall Study|Adverse Event|0|||
146430313|NCT04089735|528083811|FG005|Overall Study|Adverse Event|0|||
146430314|NCT04089735|528083806|FG000|Overall Study|Physician Decision|0|||
146430315|NCT04089735|528083807|FG001|Overall Study|Physician Decision|3|||
146430316|NCT04089735|528083808|FG002|Overall Study|Physician Decision|0|||
146430317|NCT04089735|528083809|FG003|Overall Study|Physician Decision|0|||
146430318|NCT04089735|528083810|FG004|Overall Study|Physician Decision|0|||
146430319|NCT04089735|528083811|FG005|Overall Study|Physician Decision|0|||
146430320|NCT04089735|528083806|FG000|Overall Study|Withdrawal by Subject|0|||
146430321|NCT04089735|528083807|FG001|Overall Study|Withdrawal by Subject|0|||
146430322|NCT04089735|528083808|FG002|Overall Study|Withdrawal by Subject|1|||
146430323|NCT04089735|528083809|FG003|Overall Study|Withdrawal by Subject|0|||
146430324|NCT04089735|528083810|FG004|Overall Study|Withdrawal by Subject|0|||
146430325|NCT04089735|528083811|FG005|Overall Study|Withdrawal by Subject|0|||
146430326|NCT04089735|528083806|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
146430327|NCT04089735|528083807|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
146430328|NCT04089735|528083808|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
146430329|NCT04089735|528083809|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
146430330|NCT04089735|528083810|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
146430331|NCT04089735|528083811|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
146430332|NCT02128997|528083815|FG000|Overall Study|Lost to Follow-up|6|||
146430333|NCT02128997|528083816|FG001|Overall Study|Lost to Follow-up|11|||
146430334|NCT00418184|528083823|FG000|Double-blind Phase|Withdrawal by Subject|22|||
146430335|NCT00418184|528083824|FG001|Double-blind Phase|Withdrawal by Subject|9|||
146430336|NCT00418184|528083823|FG000|Double-blind Phase|Adverse Event|2|||
146430337|NCT00418184|528083824|FG001|Double-blind Phase|Adverse Event|1|||
146430338|NCT00418184|528083823|FG000|Double-blind Phase|Poor compliance|3|||
146430339|NCT00418184|528083824|FG001|Double-blind Phase|Poor compliance|1|||
146430340|NCT01247701|528083826|FG000|Overall Study|Death|2|||
146430341|NCT01247701|528083826|FG000|Overall Study|Relapsed|8|||
146430342|NCT00096447|528083827|FG000|Overall Study|Never treated|1|||
146430343|NCT02246166|528083830|FG000|Overall Study|Protocol Violation|1|||
146430344|NCT02246166|528083831|FG001|Overall Study|Protocol Violation|0|||
146430345|NCT00834743|528083832|FG000|Second Intervention|Withdrawal by Subject|1|||
146430346|NCT00834743|528083833|FG001|Second Intervention|Withdrawal by Subject|0|||
146430347|NCT04112823|528083836|FG000|Overall Study|Lost to Follow-up|2|||
146430348|NCT04112823|528083837|FG001|Overall Study|Lost to Follow-up|3|||
146430349|NCT03025880|528083840|FG000|Overall Study|Adverse Event|1|||
146430350|NCT03025880|528083841|FG001|Overall Study|Adverse Event|0|||
146430351|NCT03025880|528083840|FG000|Overall Study|Death|1|||
146430352|NCT03025880|528083841|FG001|Overall Study|Death|1|||
146430353|NCT03025880|528083840|FG000|Overall Study|Withdrawal by Subject|0|||
146202141|NCT01286272|527253881|FG001|Overall Study|Ineligible after beginning treatment|3|||
146202142|NCT04001829|527253882|FG000|Overall Study|Never start protocol therapy|5|||
146202143|NCT04001829|527253883|FG001|Overall Study|Never start protocol therapy|5|||
146202144|NCT04001829|527253882|FG000|Overall Study|Adverse Event|11|||
146202145|NCT04001829|527253883|FG001|Overall Study|Adverse Event|7|||
146202146|NCT04001829|527253882|FG000|Overall Study|Alternative therapy|1|||
146202147|NCT04001829|527253883|FG001|Overall Study|Alternative therapy|2|||
146202148|NCT04001829|527253882|FG000|Overall Study|Disease progression/relapse|2|||
146430354|NCT03025880|528083841|FG001|Overall Study|Withdrawal by Subject|1|||
146430355|NCT03025880|528083840|FG000|Overall Study|Physician Decision|0|||
146430356|NCT03025880|528083841|FG001|Overall Study|Physician Decision|1|||
146430357|NCT03025880|528083840|FG000|Overall Study|Progressive Disease|12|||
146430358|NCT03025880|528083841|FG001|Overall Study|Progressive Disease|19|||
146430359|NCT00625443|528083843|FG000|Overall Study|Adverse Event|1|||
146430360|NCT00625443|528083844|FG001|Overall Study|Adverse Event|4|||
146430361|NCT00625443|528083845|FG002|Overall Study|Adverse Event|0|||
146430362|NCT00625443|528083843|FG000|Overall Study|Non-compliance with protocol|0|||
146430363|NCT00625443|528083844|FG001|Overall Study|Non-compliance with protocol|1|||
146430364|NCT00625443|528083845|FG002|Overall Study|Non-compliance with protocol|0|||
146430365|NCT00625443|528083843|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
146430366|NCT00625443|528083844|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
146430367|NCT00625443|528083845|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
146430368|NCT00625443|528083843|FG000|Overall Study|Withdrawal by Subject|0|||
146430369|NCT00625443|528083844|FG001|Overall Study|Withdrawal by Subject|1|||
146430370|NCT00625443|528083845|FG002|Overall Study|Withdrawal by Subject|2|||
146202149|NCT04001829|527253883|FG001|Overall Study|Disease progression/relapse|1|||
146202150|NCT04001829|527253882|FG000|Overall Study|Other complicating disease|1|||
146202151|NCT04001829|527253883|FG001|Overall Study|Other complicating disease|0|||
146202152|NCT04001829|527253882|FG000|Overall Study|Withdrawal by Subject|1|||
146202153|NCT04001829|527253883|FG001|Overall Study|Withdrawal by Subject|4|||
146202154|NCT04001829|527253882|FG000|Overall Study|Ineligible|2|||
146430371|NCT00625443|528083843|FG000|Overall Study|Physician Decision|0|||
146430372|NCT00625443|528083844|FG001|Overall Study|Physician Decision|4|||
146430373|NCT00625443|528083845|FG002|Overall Study|Physician Decision|2|||
146430374|NCT00625443|528083843|FG000|Overall Study|Other|0|||
146430375|NCT00625443|528083844|FG001|Overall Study|Other|1|||
146430376|NCT00625443|528083845|FG002|Overall Study|Other|1|||
146430377|NCT02728102|528083846|FG000|Overall Study|Death|3|||
146430378|NCT02728102|528083847|FG001|Overall Study|Death|0|||
146430379|NCT02728102|528083848|FG002|Overall Study|Death|1|||
146430380|NCT02728102|528083846|FG000|Overall Study|Withdrawal by Subject|0|||
146430381|NCT02728102|528083847|FG001|Overall Study|Withdrawal by Subject|2|||
146430382|NCT02728102|528083848|FG002|Overall Study|Withdrawal by Subject|3|||
146430383|NCT02728102|528083846|FG000|Overall Study|Physician Decision|1|||
146430384|NCT02728102|528083847|FG001|Overall Study|Physician Decision|1|||
146430385|NCT02728102|528083848|FG002|Overall Study|Physician Decision|0|||
146430386|NCT02728102|528083846|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
146430387|NCT02728102|528083847|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
146430388|NCT02728102|528083848|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
146430389|NCT02728102|528083846|FG000|Overall Study|Covid|0|||
146430390|NCT02728102|528083847|FG001|Overall Study|Covid|0|||
146430391|NCT02728102|528083848|FG002|Overall Study|Covid|1|||
146430392|NCT02924883|528083850|FG000|Overall Study|Death|39|||
146430393|NCT02924883|528083851|FG001|Overall Study|Death|20|||
146430394|NCT02924883|528083850|FG000|Overall Study|Lost to Follow-up|1|||
146430395|NCT02924883|528083851|FG001|Overall Study|Lost to Follow-up|0|||
146430396|NCT02924883|528083850|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
146430397|NCT02924883|528083851|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
146430398|NCT02924883|528083850|FG000|Overall Study|Protocol Violation|1|||
146430399|NCT02924883|528083851|FG001|Overall Study|Protocol Violation|0|||
146430400|NCT02924883|528083850|FG000|Overall Study|Withdrawal by Subject|22|||
146430401|NCT02924883|528083851|FG001|Overall Study|Withdrawal by Subject|16|||
146430402|NCT02924883|528083850|FG000|Overall Study|Progressive Disease|1|||
146430403|NCT02924883|528083851|FG001|Overall Study|Progressive Disease|0|||
146430404|NCT02924883|528083850|FG000|Overall Study|Study Terminated by Sponsor|69|||
146430405|NCT02924883|528083851|FG001|Overall Study|Study Terminated by Sponsor|32|||
146430406|NCT00553280|528083852|FG000|Overall Study|Adverse Event|19|||
146430407|NCT00553280|528083852|FG000|Overall Study|Lack of Efficacy|3|||
146430408|NCT00553280|528083852|FG000|Overall Study|Withdrawal by Subject|3|||
146430409|NCT00553280|528083852|FG000|Overall Study|Physician Decision|1|||
146430410|NCT01182415|528083853|FG000|Overall Study|Lost to Follow-up|1|||
146430411|NCT02587962|528083858|FG000|Overall Study|Adverse Event|0|||
146430412|NCT02587962|528083859|FG001|Overall Study|Adverse Event|0|||
146430413|NCT02587962|528083860|FG002|Overall Study|Adverse Event|1|||
146430414|NCT02587962|528083861|FG003|Overall Study|Adverse Event|0|||
146430415|NCT02587962|528083862|FG004|Overall Study|Adverse Event|0|||
146430416|NCT02587962|528083858|FG000|Overall Study|Withdrawal by Subject|0|||
146430417|NCT02587962|528083859|FG001|Overall Study|Withdrawal by Subject|0|||
146430418|NCT02587962|528083860|FG002|Overall Study|Withdrawal by Subject|1|||
146430419|NCT02587962|528083861|FG003|Overall Study|Withdrawal by Subject|1|||
146430420|NCT02587962|528083862|FG004|Overall Study|Withdrawal by Subject|4|||
146430421|NCT02587962|528083858|FG000|Overall Study|Radiological progression|2|||
146202155|NCT04001829|527253883|FG001|Overall Study|Ineligible|2|||
146202156|NCT04001829|527253882|FG000|Overall Study|Reason missing due to delinquent data|1|||
146202157|NCT04001829|527253883|FG001|Overall Study|Reason missing due to delinquent data|0|||
146202158|NCT05011396|527253884|FG000|Overall Study|Lost to Follow-up|3|||
146202159|NCT05011396|527253885|FG001|Overall Study|Lost to Follow-up|1|||
146430422|NCT02587962|528083859|FG001|Overall Study|Radiological progression|2|||
146430423|NCT02587962|528083860|FG002|Overall Study|Radiological progression|2|||
146430424|NCT02587962|528083861|FG003|Overall Study|Radiological progression|5|||
146430425|NCT02587962|528083862|FG004|Overall Study|Radiological progression|10|||
146430426|NCT02587962|528083858|FG000|Overall Study|Clinical progression|0|||
146430427|NCT02587962|528083859|FG001|Overall Study|Clinical progression|1|||
146430428|NCT02587962|528083860|FG002|Overall Study|Clinical progression|2|||
146430429|NCT02587962|528083861|FG003|Overall Study|Clinical progression|0|||
146430430|NCT02587962|528083862|FG004|Overall Study|Clinical progression|1|||
146430431|NCT01422538|528083865|FG000|Overall Study|Lost to Follow-up|0|||
146430432|NCT01422538|528083866|FG001|Overall Study|Lost to Follow-up|1|||
146430433|NCT01422538|528083867|FG002|Overall Study|Lost to Follow-up|1|||
146430434|NCT01422538|528083865|FG000|Overall Study|Missed visit|0|||
146430435|NCT01422538|528083866|FG001|Overall Study|Missed visit|1|||
146430436|NCT01422538|528083867|FG002|Overall Study|Missed visit|1|||
146430437|NCT01536405|528083868|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
146430438|NCT01536405|528083869|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
146430439|NCT01536405|528083868|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
146430440|NCT01536405|528083869|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
146430441|NCT01536405|528083868|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
146430442|NCT01536405|528083869|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
146430443|NCT01536405|528083868|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
146430444|NCT01536405|528083869|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
146430445|NCT01536405|528083868|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
146430446|NCT01536405|528083869|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
146430447|NCT01536405|528083868|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
146430448|NCT01536405|528083869|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
146430449|NCT01536405|528083868|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
146430450|NCT01536405|528083869|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
146430451|NCT01536405|528083868|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
146430452|NCT01536405|528083869|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
146430453|NCT01536405|528083868|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
146430454|NCT01536405|528083869|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
146430455|NCT01536405|528083868|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
146430456|NCT01536405|528083869|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
146430457|NCT01536405|528083868|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
146430458|NCT01536405|528083869|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
146430459|NCT01536405|528083868|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
146430460|NCT01536405|528083869|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
146430461|NCT01536405|528083868|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
146430462|NCT01536405|528083869|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
146430463|NCT01263704|528083872|FG000|Overall Study|Progressive disease|18|||
146430464|NCT01263704|528083872|FG000|Overall Study|Adverse Event|3|||
146430465|NCT01263704|528083872|FG000|Overall Study|Death|2|||
146430466|NCT01263704|528083872|FG000|Overall Study|Patient withdrew consent|2|||
146430467|NCT01263704|528083872|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
146430468|NCT01263704|528083872|FG000|Overall Study|Lost to Follow-up|1|||
146430469|NCT01263704|528083872|FG000|Overall Study|Colon metastases|1|||
146430470|NCT01263704|528083872|FG000|Overall Study|Principal Investigator (PI) decision|1|||
146430471|NCT01061866|528083873|FG000|Overall Study|Adverse Event|2|||
146430472|NCT02255097|528083874|FG000|Overall Study|Death|151|||
146430473|NCT02255097|528083874|FG000|Overall Study|Lost to Follow-up|5|||
146430474|NCT02255097|528083874|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
146430475|NCT02255097|528083874|FG000|Overall Study|Withdrawal by Subject|7|||
146430476|NCT02255097|528083874|FG000|Overall Study|Allocated but not treated|1|||
146430477|NCT02514122|528083875|FG000|Overall Study|Withdrawal by Subject|2|||
146430478|NCT02514122|528083876|FG001|Overall Study|Withdrawal by Subject|0|||
146430479|NCT01675765|528083877|FG000|Overall Study|Progressive disease|4|||
146430480|NCT01675765|528083878|FG001|Overall Study|Progressive disease|4|||
146430481|NCT01675765|528083877|FG000|Overall Study|Adverse Event|1|||
146430482|NCT01675765|528083878|FG001|Overall Study|Adverse Event|2|||
146430483|NCT01675765|528083877|FG000|Overall Study|Withdrawal by Subject|2|||
146430484|NCT01675765|528083878|FG001|Overall Study|Withdrawal by Subject|0|||
146430485|NCT01675765|528083877|FG000|Overall Study|Death|1|||
146430486|NCT01675765|528083878|FG001|Overall Study|Death|0|||
146430487|NCT01675765|528083877|FG000|Overall Study|Clinical progression|3|||
146430488|NCT01675765|528083878|FG001|Overall Study|Clinical progression|2|||
146430489|NCT03965091|528083879|FG000|Overall Study|Adverse Event|0|||
146430490|NCT03965091|528083880|FG001|Overall Study|Adverse Event|2|||
146430491|NCT03965091|528083881|FG002|Overall Study|Adverse Event|3|||
146430492|NCT03965091|528083879|FG000|Overall Study|Withdrawal by Subject|11|||
146430493|NCT03965091|528083880|FG001|Overall Study|Withdrawal by Subject|3|||
146430494|NCT03965091|528083881|FG002|Overall Study|Withdrawal by Subject|5|||
146430495|NCT03965091|528083879|FG000|Overall Study|Non-compliance with study drug|0|||
146430496|NCT03965091|528083880|FG001|Overall Study|Non-compliance with study drug|0|||
146430497|NCT03965091|528083881|FG002|Overall Study|Non-compliance with study drug|1|||
146430498|NCT03965091|528083879|FG000|Overall Study|Lost to Follow-up|1|||
146430499|NCT03965091|528083880|FG001|Overall Study|Lost to Follow-up|1|||
146430500|NCT03965091|528083881|FG002|Overall Study|Lost to Follow-up|1|||
146430501|NCT03965091|528083879|FG000|Overall Study|Lack of Efficacy|2|||
146430502|NCT03965091|528083880|FG001|Overall Study|Lack of Efficacy|0|||
146430503|NCT03965091|528083881|FG002|Overall Study|Lack of Efficacy|0|||
146430504|NCT03965091|528083879|FG000|Overall Study|Other than specified|9|||
146430505|NCT03965091|528083880|FG001|Overall Study|Other than specified|11|||
146430506|NCT03965091|528083881|FG002|Overall Study|Other than specified|8|||
146430507|NCT01534520|528083884|FG000|Overall Study|Adverse Event|0|||
146430508|NCT01534520|528083885|FG001|Overall Study|Adverse Event|1|||
146430509|NCT01417078|528083886|FG000|Overall Study|Withdrawal by Subject|1|||
146430510|NCT01059903|528083888|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
146430511|NCT01059903|528083889|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
146430512|NCT03725605|528083890|FG000|Overall Study|Unsuccessful TIL expansion|2|||
146430513|NCT03555305|528083891|FG000|Period 1|Physician Decision|0|||
146430514|NCT03555305|528083892|FG001|Period 1|Physician Decision|1|||
146430515|NCT03555305|528083891|FG000|Period 1|Adverse Event|0|||
146430516|NCT03555305|528083892|FG001|Period 1|Adverse Event|1|||
146430517|NCT03135834|528083898|FG000|Stage 1|Adverse Event|1|||
146430518|NCT03135834|528083899|FG001|Stage 1|Adverse Event|2|||
146430519|NCT03135834|528083900|FG002|Stage 1|Adverse Event|2|||
146430520|NCT03135834|528083901|FG003|Stage 1|Adverse Event|1|||
146430521|NCT03135834|528083898|FG000|Stage 1|Death|1|||
146430522|NCT03135834|528083899|FG001|Stage 1|Death|0|||
146430523|NCT03135834|528083900|FG002|Stage 1|Death|0|||
146430524|NCT03135834|528083901|FG003|Stage 1|Death|0|||
146430525|NCT03135834|528083898|FG000|Stage 1|Lost to Follow-up|17|||
146430526|NCT03135834|528083899|FG001|Stage 1|Lost to Follow-up|24|||
146430527|NCT03135834|528083900|FG002|Stage 1|Lost to Follow-up|21|||
146430528|NCT03135834|528083901|FG003|Stage 1|Lost to Follow-up|38|||
146430529|NCT03135834|528083898|FG000|Stage 1|No longer met eligibility criteria|1|||
146430530|NCT03135834|528083899|FG001|Stage 1|No longer met eligibility criteria|6|||
146430531|NCT03135834|528083900|FG002|Stage 1|No longer met eligibility criteria|2|||
146430532|NCT03135834|528083901|FG003|Stage 1|No longer met eligibility criteria|5|||
146430533|NCT03135834|528083898|FG000|Stage 1|Other|0|||
146430534|NCT03135834|528083899|FG001|Stage 1|Other|2|||
146430535|NCT03135834|528083900|FG002|Stage 1|Other|1|||
146430536|NCT03135834|528083901|FG003|Stage 1|Other|0|||
146430537|NCT03135834|528083898|FG000|Stage 1|Physician Decision|0|||
146430538|NCT03135834|528083899|FG001|Stage 1|Physician Decision|1|||
146430539|NCT03135834|528083900|FG002|Stage 1|Physician Decision|0|||
146430540|NCT03135834|528083901|FG003|Stage 1|Physician Decision|0|||
146430541|NCT03135834|528083898|FG000|Stage 1|Pregnancy|0|||
146430542|NCT03135834|528083899|FG001|Stage 1|Pregnancy|4|||
146430543|NCT03135834|528083900|FG002|Stage 1|Pregnancy|2|||
146430544|NCT03135834|528083901|FG003|Stage 1|Pregnancy|4|||
146430545|NCT03135834|528083898|FG000|Stage 1|Protocol Violation|1|||
146430546|NCT03135834|528083899|FG001|Stage 1|Protocol Violation|1|||
146430547|NCT03135834|528083900|FG002|Stage 1|Protocol Violation|2|||
146430548|NCT03135834|528083901|FG003|Stage 1|Protocol Violation|1|||
146430549|NCT03135834|528083898|FG000|Stage 1|Withdrawal by parent/guardian|2|||
146430550|NCT03135834|528083899|FG001|Stage 1|Withdrawal by parent/guardian|10|||
146430551|NCT03135834|528083900|FG002|Stage 1|Withdrawal by parent/guardian|2|||
146430552|NCT03135834|528083901|FG003|Stage 1|Withdrawal by parent/guardian|1|||
146430553|NCT03135834|528083898|FG000|Stage 1|Withdrawal by Subject|16|||
146430554|NCT03135834|528083899|FG001|Stage 1|Withdrawal by Subject|22|||
146430555|NCT03135834|528083900|FG002|Stage 1|Withdrawal by Subject|7|||
146430556|NCT03135834|528083901|FG003|Stage 1|Withdrawal by Subject|10|||
146430557|NCT03135834|528083898|FG000|Stage 1|Randomized but not Vaccinated|0|||
146430558|NCT03135834|528083899|FG001|Stage 1|Randomized but not Vaccinated|3|||
146430559|NCT03135834|528083900|FG002|Stage 1|Randomized but not Vaccinated|1|||
146202160|NCT05011396|527253884|FG000|Overall Study|Withdrawal by Subject|0|||
146430560|NCT03135834|528083901|FG003|Stage 1|Randomized but not Vaccinated|6|||
146430561|NCT03135834|528083898|FG000|Stage 2|Lost to Follow-up|0|||
146430562|NCT03135834|528083899|FG001|Stage 2|Lost to Follow-up|1|||
146430563|NCT03135834|528083900|FG002|Stage 2|Lost to Follow-up|0|||
146430564|NCT03135834|528083901|FG003|Stage 2|Lost to Follow-up|0|||
146430565|NCT03135834|528083898|FG000|Stage 2|Withdrawal by Subject|0|||
146430566|NCT03135834|528083899|FG001|Stage 2|Withdrawal by Subject|1|||
146430567|NCT03135834|528083900|FG002|Stage 2|Withdrawal by Subject|0|||
146430568|NCT03135834|528083901|FG003|Stage 2|Withdrawal by Subject|0|||
146430569|NCT03135834|528083898|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
146430570|NCT03135834|528083899|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
146430571|NCT03135834|528083900|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
146430572|NCT03135834|528083901|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
146430573|NCT03135834|528083898|FG000|Stage 2|Did not receive Booster Vaccination|1|||
146430574|NCT03135834|528083899|FG001|Stage 2|Did not receive Booster Vaccination|1|||
146202161|NCT05011396|527253885|FG001|Overall Study|Withdrawal by Subject|1|||
146202162|NCT05011396|527253884|FG000|Overall Study|Positive Drug Screen|0|||
146430575|NCT03135834|528083900|FG002|Stage 2|Did not receive Booster Vaccination|0|||
146430576|NCT03135834|528083901|FG003|Stage 2|Did not receive Booster Vaccination|0|||
146430577|NCT02100228|528083902|FG000|Overall Study|Other|19|||
146430578|NCT02100228|528083903|FG001|Overall Study|Other|19|||
146430579|NCT02100228|528083902|FG000|Overall Study|Administrative reason|0|||
146430580|NCT02100228|528083903|FG001|Overall Study|Administrative reason|1|||
146430581|NCT02100228|528083902|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
146430582|NCT02100228|528083903|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
146430583|NCT02100228|528083902|FG000|Overall Study|Non-compliance|0|||
146430584|NCT02100228|528083903|FG001|Overall Study|Non-compliance|3|||
146430585|NCT02100228|528083902|FG000|Overall Study|Lost to Follow-up|0|||
146430586|NCT02100228|528083903|FG001|Overall Study|Lost to Follow-up|1|||
146430587|NCT02100228|528083902|FG000|Overall Study|Withdrawal by Subject|27|||
146430588|NCT02100228|528083903|FG001|Overall Study|Withdrawal by Subject|37|||
146430589|NCT02100228|528083902|FG000|Overall Study|Adverse Event|16|||
146430590|NCT02100228|528083903|FG001|Overall Study|Adverse Event|12|||
146430591|NCT02100228|528083902|FG000|Overall Study|Death|1|||
146430592|NCT02100228|528083903|FG001|Overall Study|Death|1|||
146430593|NCT00214422|528083904|FG000|Overall Study|Physician Decision|2|||
146430594|NCT00214422|528083905|FG001|Overall Study|Physician Decision|0|||
146430595|NCT00214422|528083906|FG002|Overall Study|Physician Decision|0|||
146430596|NCT00214422|528083904|FG000|Overall Study|Developed esophageal ca|1|||
146430597|NCT00214422|528083905|FG001|Overall Study|Developed esophageal ca|0|||
146430598|NCT00214422|528083906|FG002|Overall Study|Developed esophageal ca|0|||
146430599|NCT00214422|528083904|FG000|Overall Study|Pt taken off study|1|||
145950019|NCT00548249|526328725|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145950020|NCT00548249|526328726|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
146202163|NCT05011396|527253885|FG001|Overall Study|Positive Drug Screen|1|||
146430600|NCT00214422|528083905|FG001|Overall Study|Pt taken off study|1|||
146430601|NCT00214422|528083906|FG002|Overall Study|Pt taken off study|0|||
146430602|NCT00214422|528083904|FG000|Overall Study|Disease progression on study|1|||
146430603|NCT00214422|528083905|FG001|Overall Study|Disease progression on study|0|||
146430604|NCT00214422|528083906|FG002|Overall Study|Disease progression on study|0|||
146430605|NCT00214422|528083904|FG000|Overall Study|Unable to make a radiation treatment|0|||
146430606|NCT00214422|528083905|FG001|Overall Study|Unable to make a radiation treatment|0|||
146430607|NCT00214422|528083906|FG002|Overall Study|Unable to make a radiation treatment|1|||
146430608|NCT02612337|528083908|FG000|Overall Study|Lack of Efficacy|1|||
146430609|NCT02612337|528083909|FG001|Overall Study|Lack of Efficacy|0|||
146430610|NCT02612337|528083908|FG000|Overall Study|Withdrawal by Subject|2|||
146430611|NCT02612337|528083909|FG001|Overall Study|Withdrawal by Subject|2|||
146430612|NCT02612337|528083908|FG000|Overall Study|Did not receive study drug|0|||
146430613|NCT02612337|528083909|FG001|Overall Study|Did not receive study drug|1|||
146430614|NCT02421952|528083912|FG000|Overall Study|Diary Not Returned|93|||
146430615|NCT02421952|528083912|FG000|Overall Study|Failed seriation task|13|||
146430616|NCT02421952|528083912|FG000|Overall Study|Subject uncooperative for baseline test|2|||
146430617|NCT02421952|528083912|FG000|Overall Study|Surgery cancelled|1|||
146430618|NCT00854100|528083915|FG000|Overall Study|Inability to complete the study visits|0|||
146430619|NCT00854100|528083916|FG001|Overall Study|Inability to complete the study visits|0|||
146430620|NCT00854100|528083917|FG002|Overall Study|Inability to complete the study visits|1|||
146430621|NCT00854100|528083915|FG000|Overall Study|Lost to Follow-up|2|||
146430622|NCT00854100|528083916|FG001|Overall Study|Lost to Follow-up|0|||
146430623|NCT00854100|528083917|FG002|Overall Study|Lost to Follow-up|3|||
146430624|NCT00854100|528083915|FG000|Overall Study|Withdrawal by Subject|3|||
146430625|NCT00854100|528083916|FG001|Overall Study|Withdrawal by Subject|1|||
146430626|NCT00854100|528083917|FG002|Overall Study|Withdrawal by Subject|2|||
146430627|NCT00854100|528083915|FG000|Overall Study|Protocol Violation|2|||
146430628|NCT00854100|528083916|FG001|Overall Study|Protocol Violation|4|||
146430629|NCT00854100|528083917|FG002|Overall Study|Protocol Violation|3|||
146430630|NCT00854100|528083915|FG000|Overall Study|Adverse Event|2|||
146430631|NCT00854100|528083916|FG001|Overall Study|Adverse Event|1|||
146430632|NCT00854100|528083917|FG002|Overall Study|Adverse Event|2|||
146430633|NCT02216071|528083927|FG000|Overall Study|Withdrawal by Subject|7|||
146430634|NCT02216071|528083928|FG001|Overall Study|Withdrawal by Subject|2|||
146430635|NCT02216071|528083927|FG000|Overall Study|Lost to Follow-up|3|||
146430636|NCT02216071|528083928|FG001|Overall Study|Lost to Follow-up|3|||
146430637|NCT02216071|528083927|FG000|Overall Study|Protocol Violation|3|||
146430638|NCT02216071|528083928|FG001|Overall Study|Protocol Violation|5|||
146430639|NCT02216071|528083927|FG000|Overall Study|Other|2|||
146430640|NCT02216071|528083928|FG001|Overall Study|Other|2|||
146430641|NCT04753437|528083929|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146430642|NCT04753437|528083930|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146430643|NCT04753437|528083929|FG000|Overall Study|Liver Function Test Abnormalities|2|||
146430644|NCT04753437|528083930|FG001|Overall Study|Liver Function Test Abnormalities|4|||
146430645|NCT02865122|528083931|FG000|Overall Study|Adverse Event|1|||
146430646|NCT02865122|528083932|FG001|Overall Study|Adverse Event|0|||
146430647|NCT02865122|528083933|FG002|Overall Study|Adverse Event|0|||
146430648|NCT01948258|528085130|FG000|Overall Study|Pregnancy|41|||
146430649|NCT01948258|528085130|FG000|Overall Study|Did not complete by cut-off date|35|||
146202164|NCT03253848|527253886|FG000|Overall Study|Adverse Event|7|||
146202165|NCT03253848|527253886|FG000|Overall Study|Death|5|||
146430650|NCT01948258|528085130|FG000|Overall Study|Lost to Follow-up|27|||
146430651|NCT01948258|528085130|FG000|Overall Study|Withdrawal by SPD|8|||
146430652|NCT01948258|528085130|FG000|Overall Study|Withdrawal by Subject|6|||
146430653|NCT01948258|528085130|FG000|Overall Study|Health Care Professional|43|||
146430654|NCT01948258|528085130|FG000|Overall Study|Removed from statistical analysis|2|||
146430655|NCT01466166|528085134|FG000|Overall Study|Death|1|||
146430656|NCT01466166|528085134|FG000|Overall Study|Lost to Follow-up|7|||
146430657|NCT01466166|528085134|FG000|Overall Study|Infusion Reaction (IR)|27|||
146430658|NCT01466166|528085134|FG000|Overall Study|Adverse Event (Other than IR)|11|||
146430659|NCT01466166|528085134|FG000|Overall Study|Elevated Serum Uric Acid|78|||
146430660|NCT01466166|528085134|FG000|Overall Study|Withdrawal by Subject|13|||
146430661|NCT01466166|528085134|FG000|Overall Study|Sponsor Decision|4|||
146430662|NCT01466166|528085134|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
146202166|NCT03253848|527253886|FG000|Overall Study|initiation of other treatments|3|||
146202167|NCT03253848|527253886|FG000|Overall Study|Other complicating disease|1|||
146202168|NCT03253848|527253886|FG000|Overall Study|Withdrawal by Subject|1|||
146202169|NCT03253848|527253886|FG000|Overall Study|Declining health|1|||
146202170|NCT04480827|527253888|FG000|Overall Study|Adverse Event|0|||
146202171|NCT04480827|527253889|FG001|Overall Study|Adverse Event|0|||
146202172|NCT04480827|527253890|FG002|Overall Study|Adverse Event|0|||
146430663|NCT01466166|528085134|FG000|Overall Study|Other|20|||
146430664|NCT00851877|528085142|FG000|Phase I-1|Death|1|||
146430665|NCT00851877|528085143|FG001|Phase I-1|Death|0|||
146430666|NCT00851877|528085144|FG002|Phase I-1|Death|0|||
146430667|NCT00851877|528085142|FG000|Phase II|Withdrawal by Subject|0|||
146430668|NCT00851877|528085143|FG001|Phase II|Withdrawal by Subject|0|||
146430669|NCT00851877|528085144|FG002|Phase II|Withdrawal by Subject|3|||
146430670|NCT00620074|528085145|FG000|Overall Study|Adverse Event|1|||
146430671|NCT00829673|528085146|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146202173|NCT04480827|527253891|FG003|Overall Study|Adverse Event|0|||
146202174|NCT04480827|527253892|FG004|Overall Study|Adverse Event|0|||
146202175|NCT04480827|527253893|FG005|Overall Study|Adverse Event|1|||
146202176|NCT04480827|527253894|FG006|Overall Study|Adverse Event|0|||
146202177|NCT04218110|527253895|FG000|Overall Study|Withdrawal by Subject|0|||
146202178|NCT04218110|527253896|FG001|Overall Study|Withdrawal by Subject|0|||
146202179|NCT04218110|527253897|FG002|Overall Study|Withdrawal by Subject|0|||
146430672|NCT00829673|528085147|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146430673|NCT00829790|528085148|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
146430674|NCT00829790|528085149|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
146430675|NCT03214952|528085150|FG000|Overall Study|Protocol Deviation|45|||
146430676|NCT03214952|528085150|FG000|Overall Study|Case Report Forms Uncollected|13|||
146430677|NCT03769896|528085151|FG000|Open-label Phase|Lack of Efficacy|5|||
146430678|NCT03769896|528085152|FG001|Open-label Phase|Lack of Efficacy|0|||
146430679|NCT03769896|528085151|FG000|Open-label Phase|Adverse Event|3|||
146430680|NCT03769896|528085152|FG001|Open-label Phase|Adverse Event|0|||
146430681|NCT03769896|528085151|FG000|Open-label Phase|Withdrawal by Subject|1|||
146430682|NCT03769896|528085152|FG001|Open-label Phase|Withdrawal by Subject|0|||
146430683|NCT00086996|528085156|FG000|Overall Study|Adverse Event|29|||
146430684|NCT00086996|528085156|FG000|Overall Study|Death|4|||
146430685|NCT00086996|528085156|FG000|Overall Study|progression/relapse|7|||
146430686|NCT00086996|528085156|FG000|Overall Study|Withdrawal by Subject|13|||
146430687|NCT00086996|528085156|FG000|Overall Study|Other|6|||
146430688|NCT00086996|528085156|FG000|Overall Study|not eligible|5|||
146430689|NCT00004562|528085157|FG000|Overall Study|Lost to Follow-up|102|||
146430690|NCT00004562|528085158|FG001|Overall Study|Lost to Follow-up|91|||
146430691|NCT02770820|528085159|FG000|Overall Study|Death|1|||
146430692|NCT02770820|528085159|FG000|Overall Study|Physician Decision|2|||
146430693|NCT00301366|528085160|FG000|Overall Study|Adverse Event|1|||
146430694|NCT00552669|528085163|FG000|Overall Study|Death|3|||
146430695|NCT00552669|528085164|FG001|Overall Study|Death|7|||
146430696|NCT03195491|528085165|FG000|Overall Study|Study drug toxicity|25|||
146430697|NCT03195491|528085166|FG001|Overall Study|Study drug toxicity|3|||
146430698|NCT03195491|528085165|FG000|Overall Study|Maximum clinical benefit|5|||
146430699|NCT03195491|528085166|FG001|Overall Study|Maximum clinical benefit|0|||
146430700|NCT03195491|528085165|FG000|Overall Study|Lost to Follow-up|1|||
146430701|NCT03195491|528085166|FG001|Overall Study|Lost to Follow-up|0|||
146430702|NCT03195491|528085165|FG000|Overall Study|Death|3|||
146430703|NCT03195491|528085166|FG001|Overall Study|Death|0|||
146430704|NCT03195491|528085165|FG000|Overall Study|Adverse event unrelated to study drug|19|||
146430705|NCT03195491|528085166|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146430706|NCT03195491|528085165|FG000|Overall Study|Disease progression|266|||
146430707|NCT03195491|528085166|FG001|Overall Study|Disease progression|8|||
146430708|NCT03195491|528085165|FG000|Overall Study|Other reasons|10|||
146430709|NCT03195491|528085166|FG001|Overall Study|Other reasons|0|||
146430710|NCT03195491|528085165|FG000|Overall Study|Participant withdrew consent|8|||
146430711|NCT03195491|528085166|FG001|Overall Study|Participant withdrew consent|1|||
146430712|NCT03195491|528085165|FG000|Overall Study|Participant no longer meets study criteria|0|||
146430713|NCT03195491|528085166|FG001|Overall Study|Participant no longer meets study criteria|1|||
146430714|NCT03195491|528085165|FG000|Overall Study|Participant request to discontinue study treatment|10|||
146430715|NCT03195491|528085166|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146430716|NCT01270503|528085167|FG000|Overall Study|Lost to Follow-up|1|||
146430717|NCT02459951|528085168|FG000|Overall Study|Unable to meet holding requirement|1|||
146430718|NCT00252720|528085170|FG000|Overall Study|Withdrawal by Subject|95|||
146430719|NCT00252720|528085171|FG001|Overall Study|Withdrawal by Subject|97|||
146430720|NCT00252720|528085170|FG000|Overall Study|Death|7|||
146430721|NCT00252720|528085171|FG001|Overall Study|Death|8|||
146430722|NCT00252720|528085170|FG000|Overall Study|Moving|23|||
146430723|NCT00252720|528085171|FG001|Overall Study|Moving|42|||
146430724|NCT00252720|528085170|FG000|Overall Study|Mainly patients lost to follow-up|7|||
146202180|NCT04218110|527253898|FG003|Overall Study|Withdrawal by Subject|1|||
146202181|NCT00002842|527253899|FG000|Overall Study|ineligible for surgical resection|27|||
146202182|NCT02015546|527253900|FG000|Overall Study|Withdrawal by Subject|1|||
146202183|NCT02015546|527253901|FG001|Overall Study|Withdrawal by Subject|1|||
146430725|NCT00252720|528085171|FG001|Overall Study|Mainly patients lost to follow-up|18|||
146430726|NCT00102440|528085172|FG000|Overall Study|Lost to Follow-up|25|||
146430727|NCT00102440|528085173|FG001|Overall Study|Lost to Follow-up|18|||
146430728|NCT00102440|528085174|FG002|Overall Study|Lost to Follow-up|21|||
146430729|NCT00102440|528085172|FG000|Overall Study|Adverse Event|16|||
146430730|NCT00102440|528085173|FG001|Overall Study|Adverse Event|23|||
146430731|NCT00102440|528085174|FG002|Overall Study|Adverse Event|8|||
146202184|NCT02015546|527253902|FG002|Overall Study|Withdrawal by Subject|1|||
146202185|NCT02015546|527253900|FG000|Overall Study|Screem Failure|2|||
146430732|NCT00102440|528085172|FG000|Overall Study|Gout Flare|10|||
146430733|NCT00102440|528085173|FG001|Overall Study|Gout Flare|28|||
146202186|NCT02015546|527253901|FG001|Overall Study|Screem Failure|1|||
146202187|NCT02015546|527253902|FG002|Overall Study|Screem Failure|3|||
146202188|NCT05855655|527253903|FG000|Overall Study|Withdrawal by Subject|0|||
146202189|NCT05855655|527253904|FG001|Overall Study|Withdrawal by Subject|1|||
146202190|NCT05855655|527253903|FG000|Overall Study|Lost to Follow-up|4|||
146202191|NCT05855655|527253904|FG001|Overall Study|Lost to Follow-up|0|||
146430734|NCT00102440|528085174|FG002|Overall Study|Gout Flare|9|||
146430735|NCT00102440|528085172|FG000|Overall Study|Personal Reason(s)|19|||
146430736|NCT00102440|528085173|FG001|Overall Study|Personal Reason(s)|13|||
146430737|NCT00102440|528085174|FG002|Overall Study|Personal Reason(s)|13|||
146430738|NCT00102440|528085172|FG000|Overall Study|Other|11|||
146430739|NCT00102440|528085173|FG001|Overall Study|Other|14|||
146430740|NCT00102440|528085174|FG002|Overall Study|Other|14|||
146430741|NCT00102440|528085172|FG000|Overall Study|Protocol Violation|7|||
146430742|NCT00102440|528085173|FG001|Overall Study|Protocol Violation|2|||
146430743|NCT00102440|528085174|FG002|Overall Study|Protocol Violation|1|||
146430744|NCT00772941|528085175|FG000|Overall Study|CRFs not available|195|||
146430745|NCT00772941|528085175|FG000|Overall Study|Study not completed|16|||
146430746|NCT00772941|528085175|FG000|Overall Study|Missed Visits|374|||
146430747|NCT00772941|528085175|FG000|Overall Study|Poor Compliance|7|||
146430748|NCT00772941|528085175|FG000|Overall Study|GPSP Violation|90|||
146430749|NCT04786184|528085177|FG000|Overall Study|Adverse Event|4|||
146430750|NCT04786184|528085178|FG001|Overall Study|Adverse Event|0|||
146430751|NCT04786184|528085177|FG000|Overall Study|Withdrawal by Subject|3|||
146430752|NCT04786184|528085178|FG001|Overall Study|Withdrawal by Subject|1|||
146202192|NCT01337635|527253905|FG000|Overall Study|Lost to Follow-up|0|||
146202193|NCT01337635|527253906|FG001|Overall Study|Lost to Follow-up|1|||
146202194|NCT01113931|527253909|FG000|Overall Study|Adverse Event|2|||
146202195|NCT01113931|527253910|FG001|Overall Study|Adverse Event|2|||
146202196|NCT01113931|527253909|FG000|Overall Study|Physician Decision|0|||
146202197|NCT01113931|527253910|FG001|Overall Study|Physician Decision|2|||
146202198|NCT01113931|527253909|FG000|Overall Study|Lost to Follow-up|12|||
146202199|NCT01113931|527253910|FG001|Overall Study|Lost to Follow-up|9|||
146202200|NCT01113931|527253909|FG000|Overall Study|Various|2|||
146202201|NCT01113931|527253910|FG001|Overall Study|Various|4|||
146430753|NCT04786184|528085177|FG000|Overall Study|Lost to Follow-up|4|||
146202202|NCT01113931|527253909|FG000|Overall Study|Withdrawal by Subject|3|||
146430754|NCT04786184|528085178|FG001|Overall Study|Lost to Follow-up|2|||
146430755|NCT01745120|528085179|FG000|Overall Study|Investigator decision|1|||
146430756|NCT01745120|528085180|FG001|Overall Study|Investigator decision|0|||
146430757|NCT01185821|528085183|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146430758|NCT01185821|528085184|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146202203|NCT01113931|527253910|FG001|Overall Study|Withdrawal by Subject|0|||
146202204|NCT01307267|527253911|FG000|Overall Study|Death|4|||
146202205|NCT01307267|527253912|FG001|Overall Study|Death|3|||
146202206|NCT01307267|527253913|FG002|Overall Study|Death|5|||
146202207|NCT01307267|527253914|FG003|Overall Study|Death|3|||
146202208|NCT01307267|527253915|FG004|Overall Study|Death|1|||
146202209|NCT01307267|527253916|FG005|Overall Study|Death|26|||
146202210|NCT01307267|527253917|FG006|Overall Study|Death|2|||
146202211|NCT01307267|527253918|FG007|Overall Study|Death|2|||
146202212|NCT01307267|527253919|FG008|Overall Study|Death|21|||
146202213|NCT01307267|527253920|FG009|Overall Study|Death|2|||
146202214|NCT01307267|527253921|FG010|Overall Study|Death|3|||
146202215|NCT01307267|527253922|FG011|Overall Study|Death|9|||
146202216|NCT01307267|527253923|FG012|Overall Study|Death|0|||
146202217|NCT01307267|527253924|FG013|Overall Study|Death|0|||
146202218|NCT01307267|527253925|FG014|Overall Study|Death|0|||
146202219|NCT01307267|527253926|FG015|Overall Study|Death|0|||
146202220|NCT01307267|527253927|FG016|Overall Study|Death|1|||
146202221|NCT01307267|527253928|FG017|Overall Study|Death|1|||
146430759|NCT01185821|528085185|FG002|Overall Study|Abnormal laboratory value(s)|1|||
146430760|NCT01185821|528085186|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146430761|NCT01185821|528085187|FG004|Overall Study|Abnormal laboratory value(s)|0|||
146430762|NCT01185821|528085183|FG000|Overall Study|Protocol Violation|0|||
146430763|NCT01185821|528085184|FG001|Overall Study|Protocol Violation|0|||
146430764|NCT01185821|528085185|FG002|Overall Study|Protocol Violation|0|||
146430765|NCT01185821|528085186|FG003|Overall Study|Protocol Violation|1|||
146430766|NCT01185821|528085187|FG004|Overall Study|Protocol Violation|1|||
146430767|NCT01185821|528085183|FG000|Overall Study|Abnormal test procedure result|0|||
146430768|NCT01185821|528085184|FG001|Overall Study|Abnormal test procedure result|0|||
146430769|NCT01185821|528085185|FG002|Overall Study|Abnormal test procedure result|0|||
146430770|NCT01185821|528085186|FG003|Overall Study|Abnormal test procedure result|0|||
146430771|NCT01185821|528085187|FG004|Overall Study|Abnormal test procedure result|1|||
146430772|NCT01185821|528085183|FG000|Overall Study|Death|0|||
146430773|NCT01185821|528085184|FG001|Overall Study|Death|1|||
146430774|NCT01185821|528085185|FG002|Overall Study|Death|0|||
146430775|NCT01185821|528085186|FG003|Overall Study|Death|0|||
146430776|NCT01185821|528085187|FG004|Overall Study|Death|0|||
146430777|NCT01185821|528085183|FG000|Overall Study|Condition no longer required study drug|0|||
146430778|NCT01185821|528085184|FG001|Overall Study|Condition no longer required study drug|0|||
146430779|NCT01185821|528085185|FG002|Overall Study|Condition no longer required study drug|0|||
146430780|NCT01185821|528085186|FG003|Overall Study|Condition no longer required study drug|0|||
146202222|NCT01307267|527253929|FG018|Overall Study|Death|2|||
146202223|NCT01307267|527253930|FG019|Overall Study|Death|8|||
146430781|NCT01185821|528085187|FG004|Overall Study|Condition no longer required study drug|1|||
146430782|NCT01185821|528085183|FG000|Overall Study|Adverse Event|2|||
146430783|NCT01185821|528085184|FG001|Overall Study|Adverse Event|3|||
146430784|NCT01185821|528085185|FG002|Overall Study|Adverse Event|1|||
146202224|NCT01307267|527253931|FG020|Overall Study|Death|1|||
146202225|NCT01307267|527253932|FG021|Overall Study|Death|2|||
146202226|NCT01307267|527253933|FG022|Overall Study|Death|2|||
146202227|NCT01307267|527253911|FG000|Overall Study|Lost to Follow-up|0|||
146202228|NCT01307267|527253912|FG001|Overall Study|Lost to Follow-up|0|||
146202229|NCT01307267|527253913|FG002|Overall Study|Lost to Follow-up|0|||
146430785|NCT01185821|528085186|FG003|Overall Study|Adverse Event|2|||
146430786|NCT01185821|528085187|FG004|Overall Study|Adverse Event|5|||
146430787|NCT01185821|528085183|FG000|Overall Study|Lack of Efficacy|0|||
146430788|NCT01185821|528085184|FG001|Overall Study|Lack of Efficacy|0|||
146430789|NCT01185821|528085185|FG002|Overall Study|Lack of Efficacy|3|||
146430790|NCT01185821|528085186|FG003|Overall Study|Lack of Efficacy|0|||
146430791|NCT01185821|528085187|FG004|Overall Study|Lack of Efficacy|9|||
146430792|NCT01185821|528085183|FG000|Overall Study|Withdrawal by Subject|3|||
146430793|NCT01185821|528085184|FG001|Overall Study|Withdrawal by Subject|2|||
146430794|NCT01185821|528085185|FG002|Overall Study|Withdrawal by Subject|2|||
146430795|NCT01185821|528085186|FG003|Overall Study|Withdrawal by Subject|1|||
146430796|NCT01185821|528085187|FG004|Overall Study|Withdrawal by Subject|3|||
146430797|NCT01185821|528085183|FG000|Overall Study|Lost to Follow-up|1|||
146430798|NCT01185821|528085184|FG001|Overall Study|Lost to Follow-up|1|||
146430799|NCT01185821|528085185|FG002|Overall Study|Lost to Follow-up|2|||
146202230|NCT01307267|527253914|FG003|Overall Study|Lost to Follow-up|0|||
146202231|NCT01307267|527253915|FG004|Overall Study|Lost to Follow-up|0|||
146202232|NCT01307267|527253916|FG005|Overall Study|Lost to Follow-up|7|||
146202233|NCT01307267|527253917|FG006|Overall Study|Lost to Follow-up|0|||
146202234|NCT01307267|527253918|FG007|Overall Study|Lost to Follow-up|0|||
146202235|NCT01307267|527253919|FG008|Overall Study|Lost to Follow-up|1|||
146202236|NCT01307267|527253920|FG009|Overall Study|Lost to Follow-up|2|||
146202237|NCT01307267|527253921|FG010|Overall Study|Lost to Follow-up|1|||
146202238|NCT01307267|527253922|FG011|Overall Study|Lost to Follow-up|0|||
146202239|NCT01307267|527253923|FG012|Overall Study|Lost to Follow-up|0|||
146202240|NCT01307267|527253924|FG013|Overall Study|Lost to Follow-up|0|||
146202241|NCT01307267|527253925|FG014|Overall Study|Lost to Follow-up|0|||
146202242|NCT01307267|527253926|FG015|Overall Study|Lost to Follow-up|0|||
146202243|NCT01307267|527253927|FG016|Overall Study|Lost to Follow-up|0|||
146202244|NCT01307267|527253928|FG017|Overall Study|Lost to Follow-up|0|||
146202245|NCT01307267|527253929|FG018|Overall Study|Lost to Follow-up|0|||
146202246|NCT01307267|527253930|FG019|Overall Study|Lost to Follow-up|2|||
146202247|NCT01307267|527253931|FG020|Overall Study|Lost to Follow-up|0|||
146202248|NCT01307267|527253932|FG021|Overall Study|Lost to Follow-up|0|||
146202249|NCT01307267|527253933|FG022|Overall Study|Lost to Follow-up|0|||
146202250|NCT01307267|527253911|FG000|Overall Study|Withdrawal by Subject|0|||
146202251|NCT01307267|527253912|FG001|Overall Study|Withdrawal by Subject|0|||
146202252|NCT01307267|527253913|FG002|Overall Study|Withdrawal by Subject|0|||
146202253|NCT01307267|527253914|FG003|Overall Study|Withdrawal by Subject|0|||
146202254|NCT01307267|527253915|FG004|Overall Study|Withdrawal by Subject|0|||
146202255|NCT01307267|527253916|FG005|Overall Study|Withdrawal by Subject|1|||
146202256|NCT01307267|527253917|FG006|Overall Study|Withdrawal by Subject|0|||
146202257|NCT01307267|527253918|FG007|Overall Study|Withdrawal by Subject|1|||
146202258|NCT01307267|527253919|FG008|Overall Study|Withdrawal by Subject|5|||
146202259|NCT01307267|527253920|FG009|Overall Study|Withdrawal by Subject|1|||
146202260|NCT01307267|527253921|FG010|Overall Study|Withdrawal by Subject|1|||
146202261|NCT01307267|527253922|FG011|Overall Study|Withdrawal by Subject|1|||
146202262|NCT01307267|527253923|FG012|Overall Study|Withdrawal by Subject|0|||
146202263|NCT01307267|527253924|FG013|Overall Study|Withdrawal by Subject|0|||
146202264|NCT01307267|527253925|FG014|Overall Study|Withdrawal by Subject|0|||
146430800|NCT01185821|528085186|FG003|Overall Study|Lost to Follow-up|1|||
146430801|NCT01185821|528085187|FG004|Overall Study|Lost to Follow-up|2|||
146430802|NCT01185821|528085183|FG000|Overall Study|Administrative problems|0|||
146430803|NCT01185821|528085184|FG001|Overall Study|Administrative problems|0|||
146430804|NCT01185821|528085185|FG002|Overall Study|Administrative problems|1|||
146430805|NCT01185821|528085186|FG003|Overall Study|Administrative problems|1|||
146430806|NCT01185821|528085187|FG004|Overall Study|Administrative problems|2|||
146430807|NCT02392000|528085199|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
146430808|NCT02392000|528085199|FG000|Overall Study|Withdrawal by Subject|1|||
146430809|NCT02392000|528085199|FG000|Overall Study|Lost to Follow-up|8|||
146430810|NCT00385593|528085200|FG000|Overall Study|Adverse Event|3|||
146430811|NCT00385593|528085201|FG001|Overall Study|Adverse Event|2|||
146430812|NCT00385593|528085200|FG000|Overall Study|Withdrawal by Subject|17|||
146430813|NCT00385593|528085201|FG001|Overall Study|Withdrawal by Subject|7|||
146430814|NCT00385593|528085200|FG000|Overall Study|Lost to Follow-up|12|||
146430815|NCT00385593|528085201|FG001|Overall Study|Lost to Follow-up|8|||
146430816|NCT00385593|528085200|FG000|Overall Study|Protocol Violation|7|||
146430817|NCT00385593|528085201|FG001|Overall Study|Protocol Violation|4|||
146430818|NCT00385593|528085200|FG000|Overall Study|Several reasons|17|||
146202265|NCT01307267|527253926|FG015|Overall Study|Withdrawal by Subject|0|||
146430819|NCT00385593|528085201|FG001|Overall Study|Several reasons|15|||
146430820|NCT00385593|528085200|FG000|Overall Study|Incorrect inclusion|2|||
146430821|NCT00385593|528085201|FG001|Overall Study|Incorrect inclusion|0|||
146430822|NCT00385593|528085200|FG000|Overall Study|Incorrect randomization|0|||
146430823|NCT00385593|528085201|FG001|Overall Study|Incorrect randomization|1|||
146430824|NCT04384978|528085202|FG000|Overall Study|Withdrawal by Subject|4|||
146430825|NCT04384978|528085203|FG001|Overall Study|Withdrawal by Subject|0|||
146430826|NCT03586726|528085208|FG000|Overall Study|Withdrawal by Subject|1|||
146202266|NCT01307267|527253927|FG016|Overall Study|Withdrawal by Subject|0|||
146202267|NCT01307267|527253928|FG017|Overall Study|Withdrawal by Subject|0|||
146202268|NCT01307267|527253929|FG018|Overall Study|Withdrawal by Subject|0|||
146430827|NCT00965185|528085209|FG000|Overall Study|Lost to Follow-up|2|||
146430828|NCT00965185|528085210|FG001|Overall Study|Lost to Follow-up|0|||
146430829|NCT00965185|528085209|FG000|Overall Study|Withdrawal by Subject|0|||
146430830|NCT00965185|528085210|FG001|Overall Study|Withdrawal by Subject|1|||
146430831|NCT03197883|528085211|FG000|Overall Study|Adverse Event|1|||
146430832|NCT03197883|528085212|FG001|Overall Study|Adverse Event|1|||
146430833|NCT03197883|528085211|FG000|Overall Study|Lost to Follow-up|1|||
146430834|NCT03197883|528085212|FG001|Overall Study|Lost to Follow-up|0|||
146430835|NCT03197883|528085211|FG000|Overall Study|Protocol Violation|1|||
146430836|NCT03197883|528085212|FG001|Overall Study|Protocol Violation|0|||
146202269|NCT01307267|527253930|FG019|Overall Study|Withdrawal by Subject|3|||
146202270|NCT01307267|527253931|FG020|Overall Study|Withdrawal by Subject|0|||
146202271|NCT01307267|527253932|FG021|Overall Study|Withdrawal by Subject|0|||
146202272|NCT01307267|527253933|FG022|Overall Study|Withdrawal by Subject|0|||
146202273|NCT01307267|527253911|FG000|Overall Study|Other|0|||
146202274|NCT01307267|527253912|FG001|Overall Study|Other|0|||
146202275|NCT01307267|527253913|FG002|Overall Study|Other|0|||
146202276|NCT01307267|527253914|FG003|Overall Study|Other|0|||
146202277|NCT01307267|527253915|FG004|Overall Study|Other|0|||
146202278|NCT01307267|527253916|FG005|Overall Study|Other|7|||
146202279|NCT01307267|527253917|FG006|Overall Study|Other|0|||
146430837|NCT03197883|528085211|FG000|Overall Study|Other (Not Specified)|0|||
146430838|NCT03197883|528085212|FG001|Overall Study|Other (Not Specified)|5|||
146430839|NCT00389064|528085219|FG000|Overall Study|Adverse Event|11|||
146430840|NCT00389064|528085220|FG001|Overall Study|Adverse Event|3|||
146082845|NCT01451437|526822911|FG005|Overall Study|Protocol Violation|0|||
146082846|NCT01451437|526822912|FG006|Overall Study|Protocol Violation|1|||
146202280|NCT01307267|527253918|FG007|Overall Study|Other|1|||
146202281|NCT01307267|527253919|FG008|Overall Study|Other|3|||
146202282|NCT01307267|527253920|FG009|Overall Study|Other|0|||
146202283|NCT01307267|527253921|FG010|Overall Study|Other|1|||
146430841|NCT00389064|528085219|FG000|Overall Study|Lack of Efficacy|3|||
146202284|NCT01307267|527253922|FG011|Overall Study|Other|1|||
146430842|NCT00389064|528085220|FG001|Overall Study|Lack of Efficacy|14|||
146430843|NCT00389064|528085219|FG000|Overall Study|Withdrawal by Subject|17|||
146202285|NCT01307267|527253923|FG012|Overall Study|Other|1|||
146202286|NCT01307267|527253924|FG013|Overall Study|Other|0|||
146202287|NCT01307267|527253925|FG014|Overall Study|Other|2|||
146202288|NCT01307267|527253926|FG015|Overall Study|Other|1|||
146202289|NCT01307267|527253927|FG016|Overall Study|Other|0|||
146202290|NCT01307267|527253928|FG017|Overall Study|Other|0|||
146202291|NCT01307267|527253929|FG018|Overall Study|Other|0|||
146202292|NCT01307267|527253930|FG019|Overall Study|Other|19|||
146202293|NCT01307267|527253931|FG020|Overall Study|Other|2|||
146202294|NCT01307267|527253932|FG021|Overall Study|Other|3|||
146202295|NCT01307267|527253933|FG022|Overall Study|Other|2|||
146202296|NCT04956575|527253937|FG000|Overall Study|Death|1|||
146202297|NCT04956575|527253938|FG001|Overall Study|Death|0|||
146202298|NCT04956575|527253939|FG002|Overall Study|Death|0|||
146202299|NCT04956575|527253940|FG003|Overall Study|Death|0|||
146202300|NCT04956575|527253941|FG004|Overall Study|Death|0|||
146202301|NCT04956575|527253942|FG005|Overall Study|Death|0|||
146202302|NCT04956575|527253943|FG006|Overall Study|Death|0|||
146202303|NCT04956575|527253944|FG007|Overall Study|Death|1|||
146202304|NCT04956575|527253945|FG008|Overall Study|Death|0|||
146202305|NCT04956575|527253946|FG009|Overall Study|Death|1|||
146202306|NCT04956575|527253947|FG010|Overall Study|Death|0|||
146202307|NCT04956575|527253948|FG011|Overall Study|Death|0|||
146202308|NCT04956575|527253937|FG000|Overall Study|Lost to Follow-up|3|||
146202309|NCT04956575|527253938|FG001|Overall Study|Lost to Follow-up|4|||
146202310|NCT04956575|527253939|FG002|Overall Study|Lost to Follow-up|2|||
146202311|NCT04956575|527253940|FG003|Overall Study|Lost to Follow-up|3|||
146202312|NCT04956575|527253941|FG004|Overall Study|Lost to Follow-up|1|||
146202313|NCT04956575|527253942|FG005|Overall Study|Lost to Follow-up|10|||
146202314|NCT04956575|527253943|FG006|Overall Study|Lost to Follow-up|11|||
146202315|NCT04956575|527253944|FG007|Overall Study|Lost to Follow-up|7|||
146202316|NCT04956575|527253945|FG008|Overall Study|Lost to Follow-up|4|||
146202317|NCT04956575|527253946|FG009|Overall Study|Lost to Follow-up|2|||
146202318|NCT04956575|527253947|FG010|Overall Study|Lost to Follow-up|3|||
146202319|NCT04956575|527253948|FG011|Overall Study|Lost to Follow-up|8|||
146202320|NCT04956575|527253937|FG000|Overall Study|Withdrawal by Subject|1|||
146202321|NCT04956575|527253938|FG001|Overall Study|Withdrawal by Subject|2|||
146202322|NCT04956575|527253939|FG002|Overall Study|Withdrawal by Subject|1|||
146202323|NCT04956575|527253940|FG003|Overall Study|Withdrawal by Subject|4|||
146202324|NCT04956575|527253941|FG004|Overall Study|Withdrawal by Subject|2|||
146202325|NCT04956575|527253942|FG005|Overall Study|Withdrawal by Subject|8|||
146202326|NCT04956575|527253943|FG006|Overall Study|Withdrawal by Subject|5|||
146202327|NCT04956575|527253944|FG007|Overall Study|Withdrawal by Subject|1|||
146202328|NCT04956575|527253945|FG008|Overall Study|Withdrawal by Subject|1|||
146202329|NCT04956575|527253946|FG009|Overall Study|Withdrawal by Subject|0|||
146202330|NCT04956575|527253947|FG010|Overall Study|Withdrawal by Subject|3|||
146202331|NCT04956575|527253948|FG011|Overall Study|Withdrawal by Subject|1|||
146202332|NCT03593876|527253949|FG000|Overall Study|Withdrawal by Subject|1|||
146202333|NCT03593876|527253949|FG000|Overall Study|Discharged home before intervention completion|2|||
146202334|NCT00854906|527253952|FG000|Overall Study|One person had no ocular history|1|||
146202335|NCT04527549|527253956|FG000|Overall Study|Withdrawal by Subject|1|||
146202336|NCT04527549|527253957|FG001|Overall Study|Withdrawal by Subject|1|||
146202337|NCT05764161|527253960|FG000|12-week DBVC Period|Lack of Efficacy|2|||
146430844|NCT00389064|528085220|FG001|Overall Study|Withdrawal by Subject|27|||
146430845|NCT00389064|528085219|FG000|Overall Study|Physician Decision|2|||
146430846|NCT00389064|528085220|FG001|Overall Study|Physician Decision|2|||
146430847|NCT00389064|528085219|FG000|Overall Study|Lost to Follow-up|1|||
146430848|NCT00389064|528085220|FG001|Overall Study|Lost to Follow-up|2|||
146430849|NCT00389064|528085219|FG000|Overall Study|Protocol Violation|2|||
146430850|NCT00389064|528085220|FG001|Overall Study|Protocol Violation|0|||
146202338|NCT05764161|527253961|FG001|12-week DBVC Period|Lack of Efficacy|1|||
146202339|NCT05764161|527253960|FG000|12-week DBVC Period|Lost to Follow-up|0|||
146202340|NCT05764161|527253961|FG001|12-week DBVC Period|Lost to Follow-up|2|||
146430851|NCT00389064|528085219|FG000|Overall Study|Multiple Reasons|9|||
146202341|NCT05764161|527253960|FG000|12-week DBVC Period|Protocol Violation|2|||
146202342|NCT05764161|527253961|FG001|12-week DBVC Period|Protocol Violation|4|||
146202343|NCT05764161|527253960|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
146202344|NCT05764161|527253961|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
146202345|NCT05764161|527253960|FG000|40-week OLE Period|Lack of Efficacy|0|||
146202346|NCT05764161|527253961|FG001|40-week OLE Period|Lack of Efficacy|1|||
146202347|NCT05764161|527253960|FG000|40-week OLE Period|Lost to Follow-up|1|||
146202348|NCT05764161|527253961|FG001|40-week OLE Period|Lost to Follow-up|4|||
146202349|NCT05764161|527253960|FG000|40-week OLE Period|Withdrawal by Subject|2|||
146202350|NCT05764161|527253961|FG001|40-week OLE Period|Withdrawal by Subject|7|||
146430852|NCT00389064|528085220|FG001|Overall Study|Multiple Reasons|11|||
146430853|NCT05275205|528085229|FG000|Overall Study|Adverse Event|1|||
146430854|NCT05275205|528085230|FG001|Overall Study|Adverse Event|2|||
146430855|NCT05275205|528085229|FG000|Overall Study|Physician Decision|1|||
146430856|NCT05275205|528085230|FG001|Overall Study|Physician Decision|1|||
146430857|NCT05275205|528085229|FG000|Overall Study|Withdrawal by Subject|2|||
146430858|NCT05275205|528085230|FG001|Overall Study|Withdrawal by Subject|3|||
146430859|NCT05275205|528085229|FG000|Overall Study|Death|1|||
146430860|NCT05275205|528085230|FG001|Overall Study|Death|0|||
146430861|NCT05275205|528085229|FG000|Overall Study|Patient unable to attend visits|1|||
146430862|NCT05275205|528085230|FG001|Overall Study|Patient unable to attend visits|0|||
146430863|NCT02963259|528085233|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
146430864|NCT02963259|528085233|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
146430865|NCT02963259|528085233|FG000|Overall Study|Death|1|||
146082847|NCT01451437|526822913|FG007|Overall Study|Protocol Violation|0|||
146082848|NCT01451437|526822914|FG008|Overall Study|Protocol Violation|0|||
146082849|NCT01451437|526822906|FG000|Overall Study|Withdrawal by Subject|0|||
146082850|NCT01451437|526822907|FG001|Overall Study|Withdrawal by Subject|0|||
146082851|NCT01451437|526822908|FG002|Overall Study|Withdrawal by Subject|0|||
146430866|NCT02963259|528085233|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
146430867|NCT03243630|528085234|FG000|Overall Study|Protocol Violation|1|||
146430868|NCT03243630|528085234|FG000|Overall Study|Physician Decision|1|||
146430869|NCT00939003|528085236|FG000|Double-blind Treatment Period|Adverse Event|1|||
146430870|NCT00939003|528085237|FG001|Double-blind Treatment Period|Adverse Event|1|||
146430871|NCT00939003|528085236|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146202351|NCT05764161|527253960|FG000|40-week OLE Period|Extended Travel|0|||
146202352|NCT05764161|527253961|FG001|40-week OLE Period|Extended Travel|1|||
146202353|NCT05764161|527253960|FG000|40-week OLE Period|Ongoing|66|||
146202354|NCT05764161|527253961|FG001|40-week OLE Period|Ongoing|59|||
146202355|NCT03718767|527253962|FG000|Overall Study|Declined to participate (before treatment started)|0|||
146202356|NCT03718767|527253963|FG001|Overall Study|Declined to participate (before treatment started)|0|||
146202357|NCT03718767|527253964|FG002|Overall Study|Declined to participate (before treatment started)|7|||
146202358|NCT03718767|527253962|FG000|Overall Study|Ineligible|0|||
146202359|NCT03718767|527253963|FG001|Overall Study|Ineligible|0|||
146202360|NCT03718767|527253964|FG002|Overall Study|Ineligible|17|||
146202361|NCT00831415|527253965|FG000|Overall Study|Adverse Event|14|||
146202362|NCT00831415|527253965|FG000|Overall Study|Failed to return|3|||
146202363|NCT00831415|527253965|FG000|Overall Study|Physician Decision|6|||
146202364|NCT00831415|527253965|FG000|Overall Study|Lost to Follow-up|9|||
146202365|NCT00831415|527253965|FG000|Overall Study|Protocol Violation|3|||
146202366|NCT00831415|527253965|FG000|Overall Study|Withdrawal by Subject|35|||
146430872|NCT00939003|528085237|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146430873|NCT00939003|528085236|FG000|Double-blind Treatment Period|Pregnancy|0|||
146430874|NCT00939003|528085237|FG001|Double-blind Treatment Period|Pregnancy|1|||
146430875|NCT00939003|528085236|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
146202367|NCT00831415|527253965|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
146202368|NCT00831415|527253965|FG000|Overall Study|Death|1|||
146202369|NCT01290224|527253966|FG000|Overall Study|Adverse Event|1|||
146202370|NCT01290224|527253966|FG000|Overall Study|Refused Further Treatment|4|||
146202371|NCT05694065|527253967|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
146202372|NCT05694065|527253967|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
146202373|NCT05694065|527253967|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
146202374|NCT03861767|527253968|FG000|Overall Study|Withdrawal by Subject|2|||
146202375|NCT03861767|527253969|FG001|Overall Study|Withdrawal by Subject|1|||
146202376|NCT03861767|527253970|FG002|Overall Study|Withdrawal by Subject|0|||
146202377|NCT03861767|527253971|FG003|Overall Study|Withdrawal by Subject|5|||
146202378|NCT03861767|527253972|FG004|Overall Study|Withdrawal by Subject|2|||
146202379|NCT03861767|527253973|FG005|Overall Study|Withdrawal by Subject|1|||
146202380|NCT03861767|527253974|FG006|Overall Study|Withdrawal by Subject|3|||
146202381|NCT03861767|527253975|FG007|Overall Study|Withdrawal by Subject|1|||
146202382|NCT03861767|527253976|FG008|Overall Study|Withdrawal by Subject|0|||
146202383|NCT03861767|527253977|FG009|Overall Study|Withdrawal by Subject|5|||
146202384|NCT00346333|527253978|FG000|Overall Study|Death|1|||
146202385|NCT00346333|527253979|FG001|Overall Study|Death|0|||
146202386|NCT00346333|527253978|FG000|Overall Study|unwilling or unable to continue|4|||
146202387|NCT00346333|527253979|FG001|Overall Study|unwilling or unable to continue|8|||
146202388|NCT03184558|527253980|FG000|Overall Study|Withdrawal by Subject|2|||
146202389|NCT03184558|527253980|FG000|Overall Study|Death|16|||
146202390|NCT03184558|527253980|FG000|Overall Study|Lost to Follow-up|2|||
146202391|NCT03184558|527253980|FG000|Overall Study|Other|9|||
146202392|NCT05299606|527253981|FG000|Overall Study|Death|1|||
146202393|NCT03460756|527253982|FG000|Overall Study|Adverse Event|0|||
146202394|NCT03460756|527253983|FG001|Overall Study|Adverse Event|0|||
146202395|NCT03460756|527253984|FG002|Overall Study|Adverse Event|0|||
146202396|NCT03460756|527253985|FG003|Overall Study|Adverse Event|1|||
146202397|NCT03460756|527253982|FG000|Overall Study|Lack of Efficacy|0|||
146202398|NCT03460756|527253983|FG001|Overall Study|Lack of Efficacy|0|||
146202399|NCT03460756|527253984|FG002|Overall Study|Lack of Efficacy|0|||
146202400|NCT03460756|527253985|FG003|Overall Study|Lack of Efficacy|2|||
146430876|NCT00939003|528085237|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
146430877|NCT00939003|528085236|FG000|Open-label Treatment Period|Adverse Event|4|||
146430878|NCT00939003|528085237|FG001|Open-label Treatment Period|Adverse Event|8|||
146202401|NCT03460756|527253982|FG000|Overall Study|Lost to Follow-up|0|||
146202402|NCT03460756|527253983|FG001|Overall Study|Lost to Follow-up|1|||
146202403|NCT03460756|527253984|FG002|Overall Study|Lost to Follow-up|2|||
146202404|NCT03460756|527253985|FG003|Overall Study|Lost to Follow-up|1|||
146202405|NCT03460756|527253982|FG000|Overall Study|Pregnancy|0|||
146202406|NCT03460756|527253983|FG001|Overall Study|Pregnancy|0|||
146202407|NCT03460756|527253984|FG002|Overall Study|Pregnancy|0|||
146202408|NCT03460756|527253985|FG003|Overall Study|Pregnancy|1|||
146202409|NCT03460756|527253982|FG000|Overall Study|Protocol Violation|0|||
146202410|NCT03460756|527253983|FG001|Overall Study|Protocol Violation|0|||
146202411|NCT03460756|527253984|FG002|Overall Study|Protocol Violation|0|||
146202412|NCT03460756|527253985|FG003|Overall Study|Protocol Violation|1|||
146430879|NCT00939003|528085236|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
146202413|NCT03460756|527253982|FG000|Overall Study|Withdrawal by Subject|0|||
146202414|NCT03460756|527253983|FG001|Overall Study|Withdrawal by Subject|4|||
146202415|NCT03460756|527253984|FG002|Overall Study|Withdrawal by Subject|7|||
146202416|NCT03460756|527253985|FG003|Overall Study|Withdrawal by Subject|3|||
146202417|NCT03515304|527253992|FG000|Overall Study|Lost to Follow-up|0|||
146430880|NCT00939003|528085237|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
146430881|NCT00939003|528085236|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
146430882|NCT00939003|528085237|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
146430883|NCT00939003|528085236|FG000|Open-label Treatment Period|Pregnancy|1|||
146430884|NCT00939003|528085237|FG001|Open-label Treatment Period|Pregnancy|1|||
146430885|NCT00939003|528085236|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
146202418|NCT03515304|527253993|FG001|Overall Study|Lost to Follow-up|3|||
146202419|NCT03946670|527253998|FG000|Overall Study|Progressive Disease|34|||
146202420|NCT03946670|527253999|FG001|Overall Study|Progressive Disease|27|||
146202421|NCT03946670|527253998|FG000|Overall Study|Adverse Event|7|||
146202422|NCT03946670|527253999|FG001|Overall Study|Adverse Event|10|||
146202423|NCT03946670|527253998|FG000|Overall Study|Physician Decision|6|||
146202424|NCT03946670|527253999|FG001|Overall Study|Physician Decision|5|||
146202425|NCT03946670|527253998|FG000|Overall Study|Death|5|||
146202426|NCT03946670|527253999|FG001|Overall Study|Death|8|||
146202427|NCT03946670|527253998|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
146202428|NCT03946670|527253999|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
146202429|NCT03946670|527253998|FG000|Overall Study|Subject Decision|4|||
146202430|NCT03946670|527253999|FG001|Overall Study|Subject Decision|5|||
146202431|NCT03946670|527253998|FG000|Overall Study|Study Terminated By Sponsor|2|||
146202432|NCT03946670|527253999|FG001|Overall Study|Study Terminated By Sponsor|0|||
146202433|NCT03946670|527253998|FG000|Overall Study|New Therapy For Study Indication|1|||
146202434|NCT03946670|527253999|FG001|Overall Study|New Therapy For Study Indication|0|||
146202435|NCT03946670|527253998|FG000|Overall Study|Not Treated|1|||
146202436|NCT03946670|527253999|FG001|Overall Study|Not Treated|1|||
146202437|NCT04221438|527254003|FG000|Overall Study|Adverse Event|1|||
146202438|NCT04221438|527254003|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
146202439|NCT00588770|527254006|FG000|Overall Study|Disease progression|85|||
146202440|NCT00588770|527254007|FG001|Overall Study|Disease progression|68|||
146202441|NCT00588770|527254006|FG000|Overall Study|Adverse Event|29|||
146202442|NCT00588770|527254007|FG001|Overall Study|Adverse Event|58|||
146202443|NCT00588770|527254006|FG000|Overall Study|Death|13|||
146202444|NCT00588770|527254007|FG001|Overall Study|Death|22|||
146430886|NCT00939003|528085237|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
146202445|NCT00588770|527254006|FG000|Overall Study|Withdrawal by Subject|15|||
146202446|NCT00588770|527254007|FG001|Overall Study|Withdrawal by Subject|25|||
146202447|NCT00588770|527254006|FG000|Overall Study|Alternative therapy|2|||
146202448|NCT00588770|527254007|FG001|Overall Study|Alternative therapy|4|||
146202449|NCT00588770|527254006|FG000|Overall Study|Other complicating disease|3|||
146202450|NCT00588770|527254007|FG001|Overall Study|Other complicating disease|2|||
146202451|NCT00588770|527254006|FG000|Overall Study|Not start protocol therapy|0|||
146202452|NCT00588770|527254007|FG001|Overall Study|Not start protocol therapy|9|||
145950021|NCT00548249|526328727|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
145950022|NCT00548249|526328723|FG000|Overall Study|Prolonged hospitalization|0|||
145950023|NCT00548249|526328724|FG001|Overall Study|Prolonged hospitalization|0|||
146430887|NCT00939003|528085236|FG000|Open-label Treatment Period|Site Closure|3|||
146430888|NCT00939003|528085237|FG001|Open-label Treatment Period|Site Closure|4|||
146430889|NCT02131129|528085238|FG000|Overall Study|Withdrawal by Subject|1|||
146430890|NCT02131129|528085239|FG001|Overall Study|Withdrawal by Subject|0|||
145950024|NCT00548249|526328725|FG002|Overall Study|Prolonged hospitalization|2|||
145950025|NCT00548249|526328726|FG003|Overall Study|Prolonged hospitalization|1|||
145950026|NCT00548249|526328727|FG004|Overall Study|Prolonged hospitalization|0|||
145950027|NCT00548249|526328723|FG000|Overall Study|Withdrawal by Subject|2|||
145950028|NCT00548249|526328724|FG001|Overall Study|Withdrawal by Subject|0|||
145950029|NCT00548249|526328725|FG002|Overall Study|Withdrawal by Subject|0|||
146430891|NCT03707912|528085240|FG000|Overall Study|Violation of inclusion criteria|1|||
145950030|NCT00548249|526328726|FG003|Overall Study|Withdrawal by Subject|0|||
145950031|NCT00548249|526328727|FG004|Overall Study|Withdrawal by Subject|0|||
145950032|NCT00548249|526328723|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145950033|NCT00548249|526328724|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
146202453|NCT00588770|527254006|FG000|Overall Study|Lack of Efficacy|8|||
146430892|NCT03707912|528085241|FG001|Overall Study|Violation of inclusion criteria|0|||
146202454|NCT00588770|527254007|FG001|Overall Study|Lack of Efficacy|10|||
146202455|NCT00588770|527254006|FG000|Overall Study|Physician discretion|2|||
146202456|NCT00588770|527254007|FG001|Overall Study|Physician discretion|0|||
146202457|NCT00588770|527254006|FG000|Overall Study|Patient non-compliance|2|||
146202458|NCT00588770|527254007|FG001|Overall Study|Patient non-compliance|2|||
146430893|NCT03880266|528085242|FG000|Overall Study|Withdrawal by Subject|0|||
146430894|NCT03880266|528085243|FG001|Overall Study|Withdrawal by Subject|1|||
146430895|NCT03880266|528085244|FG002|Overall Study|Withdrawal by Subject|1|||
146430896|NCT03880266|528085245|FG003|Overall Study|Withdrawal by Subject|0|||
146430897|NCT03880266|528085246|FG004|Overall Study|Withdrawal by Subject|0|||
146430898|NCT03880266|528085247|FG005|Overall Study|Withdrawal by Subject|0|||
146430899|NCT03880266|528085248|FG006|Overall Study|Withdrawal by Subject|0|||
146430900|NCT03880266|528085249|FG007|Overall Study|Withdrawal by Subject|0|||
146430901|NCT05369208|528086596|FG000|Core Phase|Prohibited Medication Required|2|||
146430902|NCT05369208|528086596|FG000|Core Phase|Adverse Event|1|||
146430903|NCT05369208|528086596|FG000|Core Phase|Lack of Efficacy|1|||
146202459|NCT02425111|527254488|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
146202460|NCT02425111|527254488|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
146430904|NCT04934722|528086597|FG000|Overall Study|Death|4|||
146430905|NCT04934722|528086598|FG001|Overall Study|Death|3|||
146202461|NCT02425111|527254488|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
146202462|NCT02425111|527254488|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
146202463|NCT02425111|527254488|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
146202464|NCT02425111|527254488|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
146202465|NCT00843882|527254489|FG000|Step 1|Lack of Efficacy|14|||
146202466|NCT00843882|527254490|FG001|Step 1|Lack of Efficacy|10|||
146202467|NCT00843882|527254491|FG002|Step 1|Lack of Efficacy|21|||
146202468|NCT00843882|527254489|FG000|Step 1|Adverse Event|8|||
146202469|NCT00843882|527254490|FG001|Step 1|Adverse Event|17|||
146202470|NCT00843882|527254491|FG002|Step 1|Adverse Event|20|||
146430906|NCT04934722|528086597|FG000|Overall Study|Participants Ongoing|88|||
146430907|NCT04934722|528086598|FG001|Overall Study|Participants Ongoing|91|||
146430908|NCT00371839|528086599|FG000|Overall Study|Death|4|||
146430909|NCT00371839|528086600|FG001|Overall Study|Death|0|||
146430910|NCT00371839|528086601|FG002|Overall Study|Death|0|||
146430911|NCT00371839|528086599|FG000|Overall Study|Withdrawal by Subject|7|||
146430912|NCT00371839|528086600|FG001|Overall Study|Withdrawal by Subject|4|||
145950034|NCT00548249|526328725|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145950035|NCT00548249|526328726|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145950036|NCT00548249|526328727|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
145950037|NCT00548249|526328723|FG000|Overall Study|Sponsor's request|0|||
146202471|NCT00843882|527254489|FG000|Step 1|Death|1|||
146202472|NCT00843882|527254490|FG001|Step 1|Death|2|||
146202473|NCT00843882|527254491|FG002|Step 1|Death|4|||
146430913|NCT00371839|528086601|FG002|Overall Study|Withdrawal by Subject|0|||
146430914|NCT00371839|528086599|FG000|Overall Study|Lost to Follow-up|6|||
145950038|NCT00548249|526328724|FG001|Overall Study|Sponsor's request|0|||
146202474|NCT00843882|527254489|FG000|Step 1|Withdrawal by Subject|6|||
146202475|NCT00843882|527254490|FG001|Step 1|Withdrawal by Subject|12|||
146202476|NCT00843882|527254491|FG002|Step 1|Withdrawal by Subject|9|||
146202477|NCT00843882|527254489|FG000|Step 1|Physician Decision|0|||
146202478|NCT00843882|527254490|FG001|Step 1|Physician Decision|5|||
146202479|NCT00843882|527254491|FG002|Step 1|Physician Decision|1|||
146202480|NCT00843882|527254489|FG000|Step 1|Patient and physician's decision|0|||
146430915|NCT00371839|528086600|FG001|Overall Study|Lost to Follow-up|3|||
146430916|NCT00371839|528086601|FG002|Overall Study|Lost to Follow-up|2|||
146430917|NCT01149473|528086602|FG000|First Intervention|Adverse Event|1|||
146430918|NCT01149473|528086603|FG001|First Intervention|Adverse Event|1|||
146430919|NCT01149473|528086602|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146430920|NCT01149473|528086603|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146430921|NCT00834249|528086607|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146430922|NCT00834249|528086608|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
146430923|NCT00834249|528086607|FG000|Second Intervention|Adverse Event|1|||
146430924|NCT00834249|528086608|FG001|Second Intervention|Adverse Event|0|||
146430925|NCT03450057|528086609|FG000|Overall Study|Death|17|||
146430926|NCT03450057|528086609|FG000|Overall Study|ICF withdrawal|4|||
146430927|NCT03450057|528086609|FG000|Overall Study|Lost to Follow-up|2|||
146430928|NCT00573066|528086610|FG000|Overall Study|Exclusion criteria|18|||
146430929|NCT00573066|528086610|FG000|Overall Study|IV malfunction|1|||
146430930|NCT00573066|528086610|FG000|Overall Study|Postoperative bleeding|1|||
146430931|NCT05755282|528086611|FG000|Overall Study|Protocol Violation|0|||
146430932|NCT05755282|528086612|FG001|Overall Study|Protocol Violation|1|||
146430933|NCT01015703|528086613|FG000|Overall Study|Withdrawal by Subject|0|||
146430934|NCT01015703|528086614|FG001|Overall Study|Withdrawal by Subject|1|||
146430935|NCT01015703|528086615|FG002|Overall Study|Withdrawal by Subject|0|||
146430936|NCT01015703|528086616|FG003|Overall Study|Withdrawal by Subject|0|||
146430937|NCT01015703|528086617|FG004|Overall Study|Withdrawal by Subject|0|||
146430938|NCT01015703|528086613|FG000|Overall Study|Adverse Event|1|||
146430939|NCT01015703|528086614|FG001|Overall Study|Adverse Event|0|||
146430940|NCT01015703|528086615|FG002|Overall Study|Adverse Event|0|||
146430941|NCT01015703|528086616|FG003|Overall Study|Adverse Event|0|||
146430942|NCT01015703|528086617|FG004|Overall Study|Adverse Event|0|||
146430943|NCT01015703|528086613|FG000|Overall Study|Protocol Violation|1|||
146430944|NCT01015703|528086614|FG001|Overall Study|Protocol Violation|0|||
146430945|NCT01015703|528086615|FG002|Overall Study|Protocol Violation|0|||
146430946|NCT01015703|528086616|FG003|Overall Study|Protocol Violation|0|||
146430947|NCT01015703|528086617|FG004|Overall Study|Protocol Violation|0|||
146202481|NCT00843882|527254490|FG001|Step 1|Patient and physician's decision|0|||
146202482|NCT00843882|527254491|FG002|Step 1|Patient and physician's decision|1|||
146202483|NCT00843882|527254489|FG000|Step 1|Other complicating disease|1|||
146202484|NCT00843882|527254490|FG001|Step 1|Other complicating disease|3|||
146202485|NCT00843882|527254491|FG002|Step 1|Other complicating disease|4|||
146202486|NCT00843882|527254489|FG000|Step 1|Alternative therapy|0|||
146202487|NCT00843882|527254490|FG001|Step 1|Alternative therapy|1|||
146202488|NCT00843882|527254491|FG002|Step 1|Alternative therapy|1|||
146202489|NCT00843882|527254489|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
146202490|NCT00843882|527254490|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
146202491|NCT00843882|527254491|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
146430948|NCT01693523|528086618|FG000|Overall Study|Adverse Event|2|||
146430949|NCT01693523|528086619|FG001|Overall Study|Adverse Event|1|||
146430950|NCT01693523|528086620|FG002|Overall Study|Adverse Event|0|||
146202492|NCT00843882|527254489|FG000|Step 1|Off treatment reason unknown|0|||
146202493|NCT00843882|527254490|FG001|Step 1|Off treatment reason unknown|1|||
146202494|NCT00843882|527254491|FG002|Step 1|Off treatment reason unknown|4|||
146430951|NCT01693523|528086618|FG000|Overall Study|Death|0|||
146430952|NCT01693523|528086619|FG001|Overall Study|Death|1|||
146430953|NCT01693523|528086620|FG002|Overall Study|Death|1|||
146430954|NCT01693523|528086618|FG000|Overall Study|Lost to Follow-up|0|||
146430955|NCT01693523|528086619|FG001|Overall Study|Lost to Follow-up|0|||
146430956|NCT01693523|528086620|FG002|Overall Study|Lost to Follow-up|4|||
146430957|NCT01693523|528086618|FG000|Overall Study|Physician Decision|0|||
146082852|NCT01451437|526822909|FG003|Overall Study|Withdrawal by Subject|0|||
146430958|NCT01693523|528086619|FG001|Overall Study|Physician Decision|0|||
146430959|NCT01693523|528086620|FG002|Overall Study|Physician Decision|1|||
146430960|NCT01693523|528086618|FG000|Overall Study|Withdrawal by Subject|1|||
146430961|NCT01693523|528086619|FG001|Overall Study|Withdrawal by Subject|2|||
146430962|NCT01693523|528086620|FG002|Overall Study|Withdrawal by Subject|2|||
146202495|NCT00843882|527254489|FG000|Step 1|Never started treatment|2|||
146202496|NCT00843882|527254490|FG001|Step 1|Never started treatment|0|||
146202497|NCT00843882|527254491|FG002|Step 1|Never started treatment|0|||
146202498|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
146202499|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
146202500|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
146202501|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
146202502|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
146202503|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
146202504|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
146202505|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
146202506|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
146202507|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
146202508|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
146202509|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
146202510|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
146202511|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
146202512|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
146202513|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
146202514|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
146202515|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
146202516|NCT00843882|527254489|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
146202517|NCT00843882|527254490|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
146430963|NCT01693523|528086618|FG000|Overall Study|Lack of compliance study medication|1|||
146430964|NCT01693523|528086619|FG001|Overall Study|Lack of compliance study medication|2|||
146430965|NCT01693523|528086620|FG002|Overall Study|Lack of compliance study medication|0|||
146202518|NCT00843882|527254491|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
146202519|NCT00256243|527254492|FG000|Overall Study|Lost to Follow-up|2|||
146202520|NCT00256243|527254492|FG000|Overall Study|Death|7|||
146202521|NCT00256243|527254492|FG000|Overall Study|Not treated|1|||
146202522|NCT02248480|527254493|FG000|Overall Study|Lack of Efficacy|4|||
146202523|NCT02248480|527254494|FG001|Overall Study|Lack of Efficacy|6|||
146202524|NCT02248480|527254493|FG000|Overall Study|Adverse Event|11|||
146202525|NCT02248480|527254494|FG001|Overall Study|Adverse Event|2|||
146202526|NCT02248480|527254493|FG000|Overall Study|Withdrawal by Subject|2|||
146202527|NCT02248480|527254494|FG001|Overall Study|Withdrawal by Subject|4|||
146202528|NCT02248480|527254493|FG000|Overall Study|Entry Criteria Not Met|0|||
146202529|NCT02248480|527254494|FG001|Overall Study|Entry Criteria Not Met|1|||
146202530|NCT02248480|527254493|FG000|Overall Study|Other:Physician Decision|0|||
146430966|NCT01693523|528086618|FG000|Overall Study|Chemotherapy was held|1|||
145950039|NCT00548249|526328725|FG002|Overall Study|Sponsor's request|0|||
145950040|NCT00548249|526328726|FG003|Overall Study|Sponsor's request|1|||
145950041|NCT00548249|526328727|FG004|Overall Study|Sponsor's request|0|||
145950042|NCT00938587|526328728|FG000|Overall Study|Adverse Event|2|||
145950043|NCT00938587|526328729|FG001|Overall Study|Adverse Event|0|||
145950044|NCT00938587|526328730|FG002|Overall Study|Adverse Event|0|||
145950045|NCT00938587|526328731|FG003|Overall Study|Adverse Event|2|||
145950046|NCT00938587|526328728|FG000|Overall Study|Did not meet entrance criteria|0|||
145950047|NCT00938587|526328729|FG001|Overall Study|Did not meet entrance criteria|0|||
145950048|NCT00938587|526328730|FG002|Overall Study|Did not meet entrance criteria|1|||
145950049|NCT00938587|526328731|FG003|Overall Study|Did not meet entrance criteria|0|||
145950050|NCT00938587|526328728|FG000|Overall Study|Withdrawal by Subject|1|||
145950051|NCT00938587|526328729|FG001|Overall Study|Withdrawal by Subject|1|||
145950052|NCT00938587|526328730|FG002|Overall Study|Withdrawal by Subject|0|||
145950053|NCT00938587|526328731|FG003|Overall Study|Withdrawal by Subject|0|||
145950054|NCT03760458|526328733|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
145950055|NCT03760458|526328734|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
146202531|NCT02248480|527254494|FG001|Overall Study|Other:Physician Decision|1|||
146202532|NCT04795752|527254495|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
146202533|NCT04795752|527254496|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
146430967|NCT01693523|528086619|FG001|Overall Study|Chemotherapy was held|2|||
146430968|NCT01693523|528086620|FG002|Overall Study|Chemotherapy was held|0|||
146430969|NCT00834418|528086621|FG000|Overall Study|Adverse Event|0|||
146430970|NCT00834418|528086622|FG001|Overall Study|Adverse Event|2|||
146430971|NCT02331394|528086624|FG000|Overall Study|Disease progression|1|||
145950056|NCT03760458|526328735|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145950057|NCT03760458|526328736|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145950058|NCT03760458|526328737|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145950059|NCT01464619|526328738|FG000|Overall Study|Lost to Follow-up|3|||
145950060|NCT01464619|526328739|FG001|Overall Study|Lost to Follow-up|4|||
145950061|NCT00750919|526328740|FG000|Overall Study|Adverse Event|9|||
145950062|NCT00750919|526328740|FG000|Overall Study|Withdrawal by Subject|1|||
145950063|NCT00750919|526328740|FG000|Overall Study|Lack of Efficacy|8|||
145950064|NCT00750919|526328740|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
145950065|NCT00750919|526328740|FG000|Overall Study|Other|36|||
145950066|NCT00080483|526328743|FG000|Overall Study|Lost to Follow-up|1|||
145950067|NCT00080483|526328744|FG001|Overall Study|Lost to Follow-up|1|||
145950068|NCT00080483|526328743|FG000|Overall Study|Physician Decision|1|||
145950069|NCT00080483|526328744|FG001|Overall Study|Physician Decision|1|||
145950070|NCT02819440|526328745|FG000|Overall Study|Adverse Event|3|||
145950071|NCT02819440|526328746|FG001|Overall Study|Adverse Event|1|||
145950072|NCT02819440|526328745|FG000|Overall Study|Lost to Follow-up|1|||
145950073|NCT02819440|526328746|FG001|Overall Study|Lost to Follow-up|3|||
145950074|NCT02819440|526328745|FG000|Overall Study|Withdrawal by Subject|9|||
145950075|NCT02819440|526328746|FG001|Overall Study|Withdrawal by Subject|8|||
145950076|NCT03230838|526328752|FG000|Overall Study|Withdrawal by Subject|3|||
145950077|NCT03230838|526328753|FG001|Overall Study|Withdrawal by Subject|0|||
146202534|NCT04795752|527254495|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
146202535|NCT04795752|527254496|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
146202536|NCT04795752|527254495|FG000|Primary Endpoint Phase|Physician Decision|2|||
145950078|NCT03230838|526328752|FG000|Overall Study|Temperature excursion|1|||
145950079|NCT03230838|526328753|FG001|Overall Study|Temperature excursion|0|||
145950080|NCT03304184|526328754|FG000|Overall Study|Withdrawal by Subject|1|||
145950081|NCT03304184|526328755|FG001|Overall Study|Withdrawal by Subject|2|||
146202537|NCT04795752|527254496|FG001|Primary Endpoint Phase|Physician Decision|0|||
146430972|NCT02098876|528086627|FG000|Overall Study|Withdrawal by Subject|5|||
146202538|NCT04795752|527254495|FG000|Primary Endpoint Phase|Other|4|||
146202539|NCT04795752|527254496|FG001|Primary Endpoint Phase|Other|1|||
146202540|NCT04795752|527254495|FG000|Primary Endpoint Phase|Protocol Violation|1|||
146202541|NCT04795752|527254496|FG001|Primary Endpoint Phase|Protocol Violation|0|||
146202542|NCT04795752|527254495|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
146202543|NCT04795752|527254496|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
146202544|NCT04795752|527254495|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
146202545|NCT04795752|527254496|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
146202546|NCT04795752|527254495|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
146202547|NCT04795752|527254496|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
146202548|NCT04795752|527254495|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
146202549|NCT04795752|527254496|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
146202550|NCT04795752|527254495|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
146202551|NCT04795752|527254496|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
146202552|NCT00792948|527254497|FG000|Overall Study|Adverse Event|6|||
146202553|NCT00792948|527254497|FG000|Overall Study|Death|4|||
146202554|NCT00792948|527254497|FG000|Overall Study|Withdrawal by Subject|3|||
146202555|NCT00792948|527254497|FG000|Overall Study|Ineligible|2|||
146202556|NCT00792948|527254497|FG000|Overall Study|Insurance denial - not treated|1|||
146202557|NCT00792948|527254497|FG000|Overall Study|Physician Decision|11|||
146202558|NCT00792948|527254497|FG000|Overall Study|Protocol Violation|1|||
146202559|NCT06129045|527254498|FG000|Overall Study|Lost to Follow-up|1|||
146430973|NCT02098876|528086628|FG001|Overall Study|Withdrawal by Subject|5|||
146430974|NCT01602419|528086631|FG000|Overall Study|Not treated with Wilate|9|||
146202560|NCT06129045|527254499|FG001|Overall Study|Lost to Follow-up|1|||
146202561|NCT06129045|527254500|FG002|Overall Study|Lost to Follow-up|4|||
146202562|NCT01582269|527254503|FG000|Overall Study|Withdrawal by Subject|1|||
146202563|NCT01582269|527254504|FG001|Overall Study|Withdrawal by Subject|0|||
146202564|NCT01582269|527254505|FG002|Overall Study|Withdrawal by Subject|0|||
146202565|NCT06218251|527254506|FG000|Overall Study|Lost to Follow-up|4|||
146202566|NCT05076266|527254507|FG000|Overall Study|Survey not complete - Participant refusal|2|||
146202567|NCT05076266|527254508|FG001|Overall Study|Survey not complete - Participant refusal|0|||
146202568|NCT05797155|527254509|FG000|Overall Study|Lost to Follow-up|33|||
146202569|NCT05797155|527254510|FG001|Overall Study|Lost to Follow-up|12|||
146202570|NCT00026312|527254511|FG000|Overall Study|Adverse Event|0|||
146202571|NCT00026312|527254512|FG001|Overall Study|Adverse Event|32|||
146202572|NCT00026312|527254511|FG000|Overall Study|Death|1|||
146202573|NCT00026312|527254512|FG001|Overall Study|Death|7|||
146202574|NCT00026312|527254511|FG000|Overall Study|Lack of Efficacy|19|||
146202575|NCT00026312|527254512|FG001|Overall Study|Lack of Efficacy|114|||
146202576|NCT00026312|527254511|FG000|Overall Study|Lost to Follow-up|0|||
146202577|NCT00026312|527254512|FG001|Overall Study|Lost to Follow-up|5|||
146202578|NCT00026312|527254511|FG000|Overall Study|Physician Decision|1|||
145950082|NCT02334384|526328756|FG000|Overall Study|Lost to Follow-up|1|||
146202579|NCT00026312|527254512|FG001|Overall Study|Physician Decision|37|||
146202580|NCT00026312|527254511|FG000|Overall Study|Protocol Violation|0|||
146202581|NCT00026312|527254512|FG001|Overall Study|Protocol Violation|3|||
146202582|NCT00026312|527254511|FG000|Overall Study|Withdrawal by Subject|1|||
146202583|NCT00026312|527254512|FG001|Overall Study|Withdrawal by Subject|6|||
146202584|NCT00026312|527254511|FG000|Overall Study|Ineligible|4|||
146202585|NCT00026312|527254512|FG001|Overall Study|Ineligible|5|||
146202586|NCT00026312|527254511|FG000|Overall Study|Entry onto another COG study|0|||
146202587|NCT00026312|527254512|FG001|Overall Study|Entry onto another COG study|1|||
146202588|NCT00026312|527254511|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
146430975|NCT01602419|528086631|FG000|Overall Study|Adverse Drug Reaction|4|||
146202589|NCT00026312|527254512|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
146202590|NCT02445391|527254513|FG000|Overall Study|No active protocol treatment|3|||
145950083|NCT02334384|526328757|FG001|Overall Study|Lost to Follow-up|1|||
145950084|NCT00731731|526328758|FG000|Overall Study|Protocol Violation|0|||
145950085|NCT00731731|526328759|FG001|Overall Study|Protocol Violation|0|||
145950086|NCT00731731|526328760|FG002|Overall Study|Protocol Violation|1|||
145950087|NCT00731731|526328758|FG000|Overall Study|Cancel prior to treatment|0|||
145950088|NCT00731731|526328759|FG001|Overall Study|Cancel prior to treatment|0|||
145950089|NCT00731731|526328760|FG002|Overall Study|Cancel prior to treatment|2|||
145950090|NCT00625183|526328761|FG000|Overall Study|Disease Progression|1|||
145950091|NCT01578499|526328763|FG000|Overall Study|Reason not Specified|0|||
145950092|NCT01578499|526328764|FG001|Overall Study|Reason not Specified|1|||
145950093|NCT01578499|526328763|FG000|Overall Study|Lost to Follow-up|2|||
145950094|NCT01578499|526328764|FG001|Overall Study|Lost to Follow-up|1|||
145950095|NCT01578499|526328763|FG000|Overall Study|Withdrawal by Subject|10|||
145950096|NCT01578499|526328764|FG001|Overall Study|Withdrawal by Subject|16|||
145950097|NCT01578499|526328763|FG000|Overall Study|Death|20|||
145950098|NCT01578499|526328764|FG001|Overall Study|Death|25|||
145950099|NCT01578499|526328763|FG000|Overall Study|Died and End of Study Page not Completed|2|||
145950100|NCT01578499|526328764|FG001|Overall Study|Died and End of Study Page not Completed|0|||
145950101|NCT02670382|526328767|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
145950102|NCT02670382|526328768|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
145950103|NCT03244618|526328771|FG000|Overall Study|Lost to Follow-up|3|||
145950104|NCT03244618|526328772|FG001|Overall Study|Lost to Follow-up|4|||
145950105|NCT03244618|526328771|FG000|Overall Study|Protocol Violation|4|||
145950106|NCT03244618|526328772|FG001|Overall Study|Protocol Violation|3|||
145950107|NCT03244618|526328771|FG000|Overall Study|Withdrawal by Subject|0|||
145950108|NCT03244618|526328772|FG001|Overall Study|Withdrawal by Subject|2|||
145950109|NCT00394771|526328773|FG000|Overall Study|Did not meet protocol requirements|1|||
145950110|NCT00394771|526328774|FG001|Overall Study|Did not meet protocol requirements|0|||
145950111|NCT00394771|526328775|FG002|Overall Study|Did not meet protocol requirements|2|||
145950112|NCT00394771|526328776|FG003|Overall Study|Did not meet protocol requirements|0|||
145950113|NCT00394771|526328773|FG000|Overall Study|Protocol Violation|2|||
145950114|NCT00394771|526328774|FG001|Overall Study|Protocol Violation|4|||
145950115|NCT00394771|526328775|FG002|Overall Study|Protocol Violation|9|||
145950116|NCT00394771|526328776|FG003|Overall Study|Protocol Violation|7|||
145950117|NCT00394771|526328773|FG000|Overall Study|Withdrawal by Subject|10|||
146202591|NCT02445391|527254514|FG001|Overall Study|No active protocol treatment|0|||
146202592|NCT02445391|527254515|FG002|Overall Study|No active protocol treatment|0|||
146202593|NCT02445391|527254513|FG000|Overall Study|Adverse Event|0|||
146202594|NCT02445391|527254514|FG001|Overall Study|Adverse Event|21|||
145950118|NCT00394771|526328774|FG001|Overall Study|Withdrawal by Subject|6|||
145950119|NCT00394771|526328775|FG002|Overall Study|Withdrawal by Subject|8|||
145950120|NCT00394771|526328776|FG003|Overall Study|Withdrawal by Subject|12|||
145950121|NCT00394771|526328773|FG000|Overall Study|Adverse Event|10|||
145950122|NCT00394771|526328774|FG001|Overall Study|Adverse Event|5|||
145950123|NCT00394771|526328775|FG002|Overall Study|Adverse Event|12|||
145950124|NCT00394771|526328776|FG003|Overall Study|Adverse Event|8|||
145950125|NCT00394771|526328773|FG000|Overall Study|Participant pregnant|0|||
145950126|NCT00394771|526328774|FG001|Overall Study|Participant pregnant|1|||
145950127|NCT00394771|526328775|FG002|Overall Study|Participant pregnant|2|||
145950128|NCT00394771|526328776|FG003|Overall Study|Participant pregnant|2|||
146202595|NCT02445391|527254515|FG002|Overall Study|Adverse Event|12|||
146202596|NCT02445391|527254513|FG000|Overall Study|Alternative therapy|0|||
146202597|NCT02445391|527254514|FG001|Overall Study|Alternative therapy|0|||
146202598|NCT02445391|527254515|FG002|Overall Study|Alternative therapy|1|||
146202599|NCT02445391|527254513|FG000|Overall Study|Disease progression|0|||
146202600|NCT02445391|527254514|FG001|Overall Study|Disease progression|7|||
146202601|NCT02445391|527254515|FG002|Overall Study|Disease progression|22|||
146202602|NCT02445391|527254513|FG000|Overall Study|Complicating disease|0|||
146202603|NCT02445391|527254514|FG001|Overall Study|Complicating disease|2|||
146202604|NCT02445391|527254515|FG002|Overall Study|Complicating disease|1|||
146202605|NCT02445391|527254513|FG000|Overall Study|Withdrawal by Subject|0|||
146202606|NCT02445391|527254514|FG001|Overall Study|Withdrawal by Subject|4|||
146202607|NCT02445391|527254515|FG002|Overall Study|Withdrawal by Subject|9|||
146202608|NCT02445391|527254513|FG000|Overall Study|Financial issue|0|||
146202609|NCT02445391|527254514|FG001|Overall Study|Financial issue|0|||
146202610|NCT02445391|527254515|FG002|Overall Study|Financial issue|2|||
146430976|NCT01602419|528086631|FG000|Overall Study|Insurance issues|3|||
146202611|NCT02445391|527254513|FG000|Overall Study|Still on treatment|0|||
146202612|NCT02445391|527254514|FG001|Overall Study|Still on treatment|7|||
146430977|NCT01602419|528086631|FG000|Overall Study|Changed treatment centre|1|||
146430978|NCT01602419|528086631|FG000|Overall Study|Treatment centre closed|1|||
146430979|NCT01602419|528086631|FG000|Overall Study|Withdrawal by Subject|5|||
146430980|NCT01602419|528086631|FG000|Overall Study|Lost to Follow-up|6|||
146430981|NCT01792635|528086632|FG000|Part B|Adverse Event|0|||
146430982|NCT01792635|528086633|FG001|Part B|Adverse Event|0|||
146430983|NCT01792635|528086634|FG002|Part B|Adverse Event|1|||
146430984|NCT01792635|528086632|FG000|Part B|Study terminated|0|||
146430985|NCT01792635|528086633|FG001|Part B|Study terminated|4|||
146430986|NCT01792635|528086634|FG002|Part B|Study terminated|3|||
146430987|NCT03956862|528086638|FG000|Overall Study|Lost to Follow-up|1|||
146430988|NCT03956862|528086639|FG001|Overall Study|Lost to Follow-up|1|||
146430989|NCT03956862|528086638|FG000|Overall Study|Withdrawal by Subject|1|||
146430990|NCT03956862|528086639|FG001|Overall Study|Withdrawal by Subject|1|||
146430991|NCT02714062|528086640|FG000|Overall Study|Adverse Event|0|||
146430992|NCT02714062|528086641|FG001|Overall Study|Adverse Event|0|||
146202613|NCT02445391|527254515|FG002|Overall Study|Still on treatment|16|||
146202614|NCT02445391|527254513|FG000|Overall Study|Not start protocol therapy|0|||
146202615|NCT02445391|527254514|FG001|Overall Study|Not start protocol therapy|12|||
146202616|NCT02445391|527254515|FG002|Overall Study|Not start protocol therapy|9|||
146202617|NCT03516942|527254524|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
146202618|NCT03516942|527254524|FG000|Registration through baseline survey com|Death|8|||
146202619|NCT03516942|527254524|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
146202620|NCT03516942|527254524|FG000|T0: Baseline|LOST|13|||
146430993|NCT02714062|528086642|FG002|Overall Study|Adverse Event|2|||
146430994|NCT02714062|528086640|FG000|Overall Study|Withdrawal by Subject|1|||
146430995|NCT02714062|528086641|FG001|Overall Study|Withdrawal by Subject|0|||
146430996|NCT02714062|528086642|FG002|Overall Study|Withdrawal by Subject|1|||
146082853|NCT01451437|526822910|FG004|Overall Study|Withdrawal by Subject|1|||
146202621|NCT03516942|527254524|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
146202622|NCT03516942|527254524|FG000|T1: 3 Months Survey|Death|10|||
146202623|NCT03516942|527254524|FG000|T1: 3 Months Survey|Lost|163|||
146202624|NCT03516942|527254524|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
146202625|NCT03516942|527254524|FG000|T2: 6 Month Survey|Death|14|||
146202626|NCT03516942|527254524|FG000|T2: 6 Month Survey|Lost|180|||
146202627|NCT03516942|527254524|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
146202628|NCT03516942|527254524|FG000|T3: 12 Month Survey|Death|19|||
146202629|NCT03516942|527254524|FG000|T3: 12 Month Survey|Lost|209|||
146202630|NCT03215927|527255520|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
146202631|NCT03215927|527255521|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
146202632|NCT03215927|527255520|FG000|Open Label Extension|Adverse Event|1|||
146202633|NCT03215927|527255521|FG001|Open Label Extension|Adverse Event|0|||
146202634|NCT03215927|527255520|FG000|Open Label Extension|Lack of Efficacy|1|||
146202635|NCT03215927|527255521|FG001|Open Label Extension|Lack of Efficacy|0|||
146202636|NCT03215927|527255520|FG000|Open Label Extension|Death|0|||
146202637|NCT03215927|527255521|FG001|Open Label Extension|Death|1|||
146202638|NCT00465816|527255522|FG000|Overall Study|Lost to Follow-up|0|||
146202639|NCT00465816|527255523|FG001|Overall Study|Lost to Follow-up|0|||
146202640|NCT00465816|527255524|FG002|Overall Study|Lost to Follow-up|2|||
146202641|NCT01426269|527255527|FG000|Period 1: 12 Weeks|Adverse Event|5|||
146202642|NCT01426269|527255528|FG001|Period 1: 12 Weeks|Adverse Event|0|||
146202643|NCT01426269|527255529|FG002|Period 1: 12 Weeks|Adverse Event|0|||
146202644|NCT01426269|527255527|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
146202645|NCT01426269|527255528|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
146202646|NCT01426269|527255529|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
146202647|NCT01426269|527255527|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
146202648|NCT01426269|527255528|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
146202649|NCT01426269|527255529|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
146202650|NCT01426269|527255527|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
146202651|NCT01426269|527255528|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
146202652|NCT01426269|527255529|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
146202653|NCT01426269|527255527|FG000|Period 1: 12 Weeks|Pregnancy|1|||
146202654|NCT01426269|527255528|FG001|Period 1: 12 Weeks|Pregnancy|0|||
146202655|NCT01426269|527255529|FG002|Period 1: 12 Weeks|Pregnancy|0|||
146202656|NCT01426269|527255527|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
146202657|NCT01426269|527255528|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
146202658|NCT01426269|527255529|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
146202659|NCT01426269|527255527|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
146202660|NCT01426269|527255528|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
146202661|NCT01426269|527255529|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
146202662|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Adverse Event|0|||
146202663|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Adverse Event|1|||
146202664|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Adverse Event|2|||
146202665|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
146202666|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
146202667|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
146202668|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
146202669|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
146202670|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
146202671|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
145950129|NCT00394771|526328773|FG000|Overall Study|Lost to Follow-up|15|||
145950130|NCT00394771|526328774|FG001|Overall Study|Lost to Follow-up|15|||
145950131|NCT00394771|526328775|FG002|Overall Study|Lost to Follow-up|13|||
146202672|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
146202673|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
146202674|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Site closed|0|||
146202675|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Site closed|6|||
146202676|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Site closed|5|||
146202677|NCT01426269|527255527|FG000|Period 2: 40 Weeks|Relapsed|0|||
145950132|NCT00394771|526328776|FG003|Overall Study|Lost to Follow-up|10|||
145950133|NCT00394771|526328773|FG000|Overall Study|Other|3|||
145950134|NCT00394771|526328774|FG001|Overall Study|Other|3|||
145950135|NCT00394771|526328775|FG002|Overall Study|Other|1|||
145950136|NCT00394771|526328776|FG003|Overall Study|Other|0|||
145950137|NCT02839876|526328777|FG000|Overall Study|Protocol Violation|10|||
145950138|NCT02839876|526328778|FG001|Overall Study|Protocol Violation|11|||
145950139|NCT00494221|526328782|FG000|Overall Study|Death|15|||
145950140|NCT00494221|526328783|FG001|Overall Study|Death|9|||
145950141|NCT00494221|526328784|FG002|Overall Study|Death|14|||
145950142|NCT00494221|526328782|FG000|Overall Study|Withdrawal by Subject|1|||
145950143|NCT00494221|526328783|FG001|Overall Study|Withdrawal by Subject|2|||
145950144|NCT00494221|526328784|FG002|Overall Study|Withdrawal by Subject|0|||
145950145|NCT03172364|526328789|FG000|Overall Study|Adverse Event|1|||
145950146|NCT03172364|526328790|FG001|Overall Study|Adverse Event|1|||
145950147|NCT03172364|526328789|FG000|Overall Study|Protocol Violation|1|||
145950148|NCT03172364|526328790|FG001|Overall Study|Protocol Violation|0|||
145950149|NCT03755518|526328791|FG000|Overall Study|Lack of Efficacy|10|||
145950150|NCT03755518|526328791|FG000|Overall Study|Adverse Event|7|||
145950151|NCT03755518|526328791|FG000|Overall Study|Study Terminated by Sponsor|5|||
145950152|NCT03755518|526328791|FG000|Overall Study|Death|1|||
145950153|NCT03755518|526328791|FG000|Overall Study|Withdrawal by Subject|3|||
145950154|NCT03755518|526328791|FG000|Overall Study|Progressive Disease|4|||
145950155|NCT03755518|526328791|FG000|Overall Study|Bone Marrow Transplant|4|||
145950156|NCT03755518|526328791|FG000|Overall Study|Physicians Decision|1|||
145950157|NCT03755518|526328791|FG000|Overall Study|Relapse|1|||
145950158|NCT03755518|526328791|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
145950159|NCT03755518|526328791|FG000|Overall Study|Withdrawal by PI|1|||
145950160|NCT01714609|526328792|FG000|Overall Study|Protocol Violation|1|||
145950161|NCT01714609|526328793|FG001|Overall Study|Protocol Violation|0|||
146202678|NCT01426269|527255528|FG001|Period 2: 40 Weeks|Relapsed|9|||
146202679|NCT01426269|527255529|FG002|Period 2: 40 Weeks|Relapsed|18|||
146202680|NCT00818454|527255530|FG000|Treatment Period 1|Adverse Event|0|||
146202681|NCT00818454|527255531|FG001|Treatment Period 1|Adverse Event|1|||
145950162|NCT02732327|526328794|FG000|Overall Study|Protocol Violation|0|||
145950163|NCT02732327|526328795|FG001|Overall Study|Protocol Violation|1|||
145950164|NCT02306694|526328796|FG000|Overall Study|Withdrawal by Subject|3|||
146202682|NCT00818454|527255532|FG002|Treatment Period 1|Adverse Event|0|||
146202683|NCT00818454|527255533|FG003|Treatment Period 1|Adverse Event|0|||
146202684|NCT00818454|527255530|FG000|Treatment Period 1|Other|3|||
146202685|NCT00818454|527255531|FG001|Treatment Period 1|Other|0|||
146202686|NCT00818454|527255532|FG002|Treatment Period 1|Other|0|||
146202687|NCT00818454|527255533|FG003|Treatment Period 1|Other|0|||
146202688|NCT00818454|527255530|FG000|Washout Period of 1 Week|Adverse Event|1|||
146202689|NCT00818454|527255531|FG001|Washout Period of 1 Week|Adverse Event|1|||
146202690|NCT00818454|527255532|FG002|Washout Period of 1 Week|Adverse Event|0|||
146202691|NCT00818454|527255533|FG003|Washout Period of 1 Week|Adverse Event|0|||
146202692|NCT00818454|527255530|FG000|Washout Period of 1 Week|Protocol Violation|2|||
146202693|NCT00818454|527255531|FG001|Washout Period of 1 Week|Protocol Violation|0|||
145950165|NCT02306694|526328796|FG000|Overall Study|Lost to Follow-up|1|||
146082854|NCT01451437|526822911|FG005|Overall Study|Withdrawal by Subject|0|||
146202694|NCT00818454|527255532|FG002|Washout Period of 1 Week|Protocol Violation|0|||
146202695|NCT00818454|527255533|FG003|Washout Period of 1 Week|Protocol Violation|0|||
146082855|NCT01451437|526822912|FG006|Overall Study|Withdrawal by Subject|1|||
146202696|NCT00818454|527255530|FG000|Washout Period of 1 Week|Other|1|||
146202697|NCT00818454|527255531|FG001|Washout Period of 1 Week|Other|2|||
145950166|NCT00603382|526328797|FG000|Overall Study|Adverse Event|0|||
145950167|NCT00603382|526328798|FG001|Overall Study|Adverse Event|1|||
145950168|NCT00603382|526328799|FG002|Overall Study|Adverse Event|1|||
145950169|NCT00603382|526328800|FG003|Overall Study|Adverse Event|2|||
145950170|NCT00603382|526328801|FG004|Overall Study|Adverse Event|1|||
145950171|NCT00603382|526328802|FG005|Overall Study|Adverse Event|2|||
145950172|NCT00603382|526328797|FG000|Overall Study|Lack of Efficacy|14|||
145950173|NCT00603382|526328798|FG001|Overall Study|Lack of Efficacy|9|||
145950174|NCT00603382|526328799|FG002|Overall Study|Lack of Efficacy|3|||
145950175|NCT00603382|526328800|FG003|Overall Study|Lack of Efficacy|6|||
145950176|NCT00603382|526328801|FG004|Overall Study|Lack of Efficacy|6|||
145950177|NCT00603382|526328802|FG005|Overall Study|Lack of Efficacy|11|||
145950178|NCT00603382|526328797|FG000|Overall Study|Protocol Violation|1|||
145950179|NCT00603382|526328798|FG001|Overall Study|Protocol Violation|0|||
145950180|NCT00603382|526328799|FG002|Overall Study|Protocol Violation|1|||
145950181|NCT00603382|526328800|FG003|Overall Study|Protocol Violation|2|||
145950182|NCT00603382|526328801|FG004|Overall Study|Protocol Violation|1|||
145950183|NCT00603382|526328802|FG005|Overall Study|Protocol Violation|0|||
145950184|NCT00603382|526328797|FG000|Overall Study|Lost to Follow-up|0|||
145950185|NCT00603382|526328798|FG001|Overall Study|Lost to Follow-up|1|||
145950186|NCT00603382|526328799|FG002|Overall Study|Lost to Follow-up|1|||
145950187|NCT00603382|526328800|FG003|Overall Study|Lost to Follow-up|1|||
145950188|NCT00603382|526328801|FG004|Overall Study|Lost to Follow-up|0|||
145950189|NCT00603382|526328802|FG005|Overall Study|Lost to Follow-up|1|||
145950190|NCT00603382|526328797|FG000|Overall Study|Physician Decision|0|||
145950191|NCT00603382|526328798|FG001|Overall Study|Physician Decision|0|||
145950192|NCT00603382|526328799|FG002|Overall Study|Physician Decision|2|||
145950193|NCT00603382|526328800|FG003|Overall Study|Physician Decision|0|||
145950194|NCT00603382|526328801|FG004|Overall Study|Physician Decision|1|||
145950195|NCT00603382|526328802|FG005|Overall Study|Physician Decision|3|||
145950196|NCT00603382|526328797|FG000|Overall Study|Withdrawal by Subject|3|||
145950197|NCT00603382|526328798|FG001|Overall Study|Withdrawal by Subject|3|||
145950198|NCT00603382|526328799|FG002|Overall Study|Withdrawal by Subject|1|||
145950199|NCT00603382|526328800|FG003|Overall Study|Withdrawal by Subject|1|||
145950200|NCT00603382|526328801|FG004|Overall Study|Withdrawal by Subject|0|||
145950201|NCT00603382|526328802|FG005|Overall Study|Withdrawal by Subject|1|||
145950202|NCT00583102|526328803|FG000|Overall Study|Adverse Event|3|||
145950203|NCT00171158|526330353|FG000|Core Study|Death|27|||
145950204|NCT00171158|526330353|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
145950205|NCT00171158|526330353|FG000|Core Study|Protocol Violation|4|||
145950206|NCT00171158|526330353|FG000|Core Study|Administrative problems|1|||
145950207|NCT00171158|526330353|FG000|Core Study|Adverse event, non-fatal|21|||
145950208|NCT00171158|526330353|FG000|Core Study|Consent withdrawn by subject|6|||
145950209|NCT00171158|526330353|FG000|Core Study|No longer required drug (BMT)|14|||
145950210|NCT00171158|526330353|FG000|Core Study|Abnormal Laboratory Values|2|||
145950211|NCT00171158|526330353|FG000|Core Study|Lost to Follow-up|1|||
145950212|NCT00171158|526330353|FG000|E2 Extension|Other|7|||
145950213|NCT02757352|526330357|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
145950214|NCT02757352|526330358|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950215|NCT02757352|526330359|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
145950216|NCT02757352|526330360|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950217|NCT02757352|526330361|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950218|NCT02757352|526330362|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950219|NCT02757352|526330363|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950220|NCT02757352|526330364|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950221|NCT02757352|526330365|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950222|NCT02757352|526330366|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145950223|NCT02757352|526330357|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950224|NCT02757352|526330358|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950225|NCT02757352|526330359|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
145950226|NCT02757352|526330360|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950227|NCT02757352|526330361|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950228|NCT02757352|526330362|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146202698|NCT00818454|527255532|FG002|Washout Period of 1 Week|Other|0|||
146202699|NCT00818454|527255533|FG003|Washout Period of 1 Week|Other|0|||
145950229|NCT02757352|526330363|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950230|NCT02757352|526330364|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950231|NCT02757352|526330365|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
146202700|NCT00818454|527255530|FG000|Treatment Period 2|Other|2|||
146202701|NCT00818454|527255531|FG001|Treatment Period 2|Other|1|||
145950232|NCT02757352|526330366|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145950233|NCT02757352|526330357|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
145950234|NCT02757352|526330358|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
146202702|NCT00818454|527255532|FG002|Treatment Period 2|Other|0|||
146202703|NCT00818454|527255533|FG003|Treatment Period 2|Other|0|||
145950235|NCT02757352|526330359|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
146202704|NCT00818454|527255530|FG000|Treatment Period 3|Adverse Event|0|||
146202705|NCT00818454|527255531|FG001|Treatment Period 3|Adverse Event|0|||
146202706|NCT00818454|527255532|FG002|Treatment Period 3|Adverse Event|0|||
146202707|NCT00818454|527255533|FG003|Treatment Period 3|Adverse Event|1|||
146202708|NCT00799396|527255535|FG000|Clopidogrel Treatment|Adverse Event|6|||
146202709|NCT00799396|527255535|FG000|Clopidogrel Treatment|Physician Decision|5|||
146202710|NCT00799396|527255535|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
146202711|NCT00799396|527255535|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
146082856|NCT01451437|526822913|FG007|Overall Study|Withdrawal by Subject|0|||
146082857|NCT01451437|526822914|FG008|Overall Study|Withdrawal by Subject|0|||
146202712|NCT00799396|527255535|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
146202713|NCT01867216|527255536|FG000|Overall Study|Withdrawal by Subject|2|||
146202714|NCT01867216|527255537|FG001|Overall Study|Withdrawal by Subject|0|||
146202715|NCT01867216|527255538|FG002|Overall Study|Withdrawal by Subject|0|||
146202716|NCT01867216|527255539|FG003|Overall Study|Withdrawal by Subject|0|||
146202717|NCT01867216|527255540|FG004|Overall Study|Withdrawal by Subject|1|||
146202718|NCT01867216|527255541|FG005|Overall Study|Withdrawal by Subject|0|||
146202719|NCT01867216|527255542|FG006|Overall Study|Withdrawal by Subject|1|||
146202720|NCT01867216|527255536|FG000|Overall Study|Physician Decision|1|||
146202721|NCT01867216|527255537|FG001|Overall Study|Physician Decision|0|||
146202722|NCT01867216|527255538|FG002|Overall Study|Physician Decision|0|||
146202723|NCT01867216|527255539|FG003|Overall Study|Physician Decision|0|||
146202724|NCT01867216|527255540|FG004|Overall Study|Physician Decision|0|||
146202725|NCT01867216|527255541|FG005|Overall Study|Physician Decision|0|||
146202726|NCT01867216|527255542|FG006|Overall Study|Physician Decision|0|||
146202727|NCT01867216|527255536|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
146202728|NCT01867216|527255537|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146202729|NCT01867216|527255538|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146202730|NCT01867216|527255539|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146202731|NCT01867216|527255540|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146202732|NCT01867216|527255541|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145950236|NCT02757352|526330360|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950237|NCT02757352|526330361|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950238|NCT02757352|526330362|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950239|NCT02757352|526330363|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950240|NCT02757352|526330364|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950241|NCT02757352|526330365|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950242|NCT02757352|526330366|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145950243|NCT02757352|526330357|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950244|NCT02757352|526330358|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
145950245|NCT02757352|526330359|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950246|NCT02757352|526330360|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950247|NCT02757352|526330361|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950248|NCT02757352|526330362|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950249|NCT02757352|526330363|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
146202733|NCT01867216|527255542|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
146202734|NCT01765543|527255553|FG000|Overall Study|Death|1|||
145950250|NCT02757352|526330364|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950251|NCT02757352|526330365|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950252|NCT02757352|526330366|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145950253|NCT02757352|526330357|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950254|NCT02757352|526330358|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145950255|NCT02757352|526330359|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950256|NCT02757352|526330360|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950257|NCT02757352|526330361|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950258|NCT02757352|526330362|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950259|NCT02757352|526330363|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950260|NCT02757352|526330364|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950261|NCT02757352|526330365|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950262|NCT02757352|526330366|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950263|NCT02757352|526330357|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145950264|NCT02757352|526330358|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145950265|NCT02757352|526330359|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
145950266|NCT02757352|526330360|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950267|NCT02757352|526330361|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950268|NCT02757352|526330362|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950269|NCT02757352|526330363|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950270|NCT02757352|526330364|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950271|NCT02757352|526330365|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950272|NCT02757352|526330366|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950273|NCT02757352|526330357|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
145950274|NCT02757352|526330358|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
145950275|NCT02757352|526330359|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
145950276|NCT02757352|526330360|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
146202735|NCT01765543|527255553|FG000|Overall Study|Withdrawal by Subject|2|||
146202736|NCT03454529|527255554|FG000|Overall Study|Did not receive treatment|6|||
146202737|NCT03454529|527255554|FG000|Overall Study|Received < 80% doses|1|||
146202738|NCT00507689|527255555|FG000|Pre-Randomization Period|Adverse Event|1|||
146202739|NCT00507689|527255556|FG001|Pre-Randomization Period|Adverse Event|0|||
146202740|NCT00507689|527255555|FG000|Pre-Randomization Period|Physician Decision|1|||
146202741|NCT00507689|527255556|FG001|Pre-Randomization Period|Physician Decision|0|||
146202742|NCT00507689|527255555|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
146202743|NCT00507689|527255556|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
146202744|NCT00507689|527255555|FG000|Randomized Period|Adverse Event|1|||
146202745|NCT00507689|527255556|FG001|Randomized Period|Adverse Event|1|||
146202746|NCT00507689|527255555|FG000|Randomized Period|Withdrawal by Subject|0|||
145950277|NCT02757352|526330361|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950278|NCT02757352|526330362|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950279|NCT02757352|526330363|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950280|NCT02757352|526330364|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950281|NCT02757352|526330365|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950282|NCT02757352|526330366|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145950283|NCT02757352|526330357|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950284|NCT02757352|526330358|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950285|NCT02757352|526330359|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950286|NCT02757352|526330360|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
145950287|NCT02757352|526330361|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950288|NCT02757352|526330362|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
145950289|NCT02757352|526330363|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950290|NCT02757352|526330364|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950291|NCT02757352|526330365|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950292|NCT02757352|526330366|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145950293|NCT02757352|526330357|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950294|NCT02757352|526330358|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950295|NCT02757352|526330359|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950296|NCT02757352|526330360|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
145950297|NCT02757352|526330361|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145950298|NCT02757352|526330362|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
145950299|NCT02757352|526330363|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950300|NCT02757352|526330364|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950301|NCT02757352|526330365|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950302|NCT02757352|526330366|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145950303|NCT02757352|526330357|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950304|NCT02757352|526330358|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950305|NCT02757352|526330359|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950306|NCT02757352|526330360|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950307|NCT02757352|526330361|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
145950308|NCT02757352|526330362|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950309|NCT02757352|526330363|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950310|NCT02757352|526330364|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950311|NCT02757352|526330365|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950312|NCT02757352|526330366|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145950313|NCT02757352|526330357|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950314|NCT02757352|526330358|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950315|NCT02757352|526330359|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950316|NCT02757352|526330360|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950317|NCT02757352|526330361|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950318|NCT02757352|526330362|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
145950319|NCT02757352|526330363|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950320|NCT02757352|526330364|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950321|NCT02757352|526330365|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950322|NCT02757352|526330366|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145950323|NCT02757352|526330357|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950324|NCT02757352|526330358|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950325|NCT02757352|526330359|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950326|NCT02757352|526330360|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
145950327|NCT02757352|526330361|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145950328|NCT02757352|526330362|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
146202747|NCT00507689|527255556|FG001|Randomized Period|Withdrawal by Subject|1|||
146202748|NCT00424762|527255564|FG000|Overall Study|Withdrawal by Subject|18|||
146202749|NCT00424762|527255565|FG001|Overall Study|Withdrawal by Subject|19|||
145950329|NCT02757352|526330363|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950330|NCT02757352|526330364|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950331|NCT02757352|526330365|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950332|NCT02757352|526330366|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145950333|NCT02757352|526330357|FG000|Follow-Up Period|Adverse Event|0|||
146202750|NCT00424762|527255564|FG000|Overall Study|Lost to Follow-up|2|||
146202751|NCT00424762|527255565|FG001|Overall Study|Lost to Follow-up|3|||
145950334|NCT02757352|526330358|FG001|Follow-Up Period|Adverse Event|0|||
145950335|NCT02757352|526330359|FG002|Follow-Up Period|Adverse Event|0|||
145950336|NCT02757352|526330360|FG003|Follow-Up Period|Adverse Event|0|||
145950337|NCT02757352|526330361|FG004|Follow-Up Period|Adverse Event|0|||
145950338|NCT02757352|526330362|FG005|Follow-Up Period|Adverse Event|0|||
145950339|NCT02757352|526330363|FG006|Follow-Up Period|Adverse Event|1|||
145950340|NCT02757352|526330364|FG007|Follow-Up Period|Adverse Event|0|||
145950341|NCT02757352|526330365|FG008|Follow-Up Period|Adverse Event|2|||
145950342|NCT02757352|526330366|FG009|Follow-Up Period|Adverse Event|0|||
145950343|NCT02757352|526330357|FG000|Follow-Up Period|Lost to Follow-up|0|||
145950344|NCT02757352|526330358|FG001|Follow-Up Period|Lost to Follow-up|0|||
145950345|NCT02757352|526330359|FG002|Follow-Up Period|Lost to Follow-up|0|||
145950346|NCT02757352|526330360|FG003|Follow-Up Period|Lost to Follow-up|0|||
145950347|NCT02757352|526330361|FG004|Follow-Up Period|Lost to Follow-up|0|||
145950348|NCT02757352|526330362|FG005|Follow-Up Period|Lost to Follow-up|0|||
145950349|NCT02757352|526330363|FG006|Follow-Up Period|Lost to Follow-up|0|||
145950350|NCT02757352|526330364|FG007|Follow-Up Period|Lost to Follow-up|0|||
145950351|NCT02757352|526330365|FG008|Follow-Up Period|Lost to Follow-up|1|||
145950352|NCT02757352|526330366|FG009|Follow-Up Period|Lost to Follow-up|0|||
145950353|NCT02757352|526330357|FG000|Follow-Up Period|Lack of Efficacy|0|||
145950354|NCT02757352|526330358|FG001|Follow-Up Period|Lack of Efficacy|0|||
145950355|NCT02757352|526330359|FG002|Follow-Up Period|Lack of Efficacy|0|||
145950356|NCT02757352|526330360|FG003|Follow-Up Period|Lack of Efficacy|0|||
145950357|NCT02757352|526330361|FG004|Follow-Up Period|Lack of Efficacy|0|||
145950358|NCT02757352|526330362|FG005|Follow-Up Period|Lack of Efficacy|0|||
145950359|NCT02757352|526330363|FG006|Follow-Up Period|Lack of Efficacy|0|||
145950360|NCT02757352|526330364|FG007|Follow-Up Period|Lack of Efficacy|0|||
145950361|NCT02757352|526330365|FG008|Follow-Up Period|Lack of Efficacy|1|||
145950362|NCT02757352|526330366|FG009|Follow-Up Period|Lack of Efficacy|1|||
145950363|NCT02757352|526330357|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145950364|NCT02757352|526330358|FG001|Follow-Up Period|Withdrawal by Subject|0|||
145950365|NCT02757352|526330359|FG002|Follow-Up Period|Withdrawal by Subject|0|||
145950366|NCT02757352|526330360|FG003|Follow-Up Period|Withdrawal by Subject|0|||
145950367|NCT02757352|526330361|FG004|Follow-Up Period|Withdrawal by Subject|0|||
145950368|NCT02757352|526330362|FG005|Follow-Up Period|Withdrawal by Subject|0|||
145950369|NCT02757352|526330363|FG006|Follow-Up Period|Withdrawal by Subject|0|||
145950370|NCT02757352|526330364|FG007|Follow-Up Period|Withdrawal by Subject|1|||
145950371|NCT02757352|526330365|FG008|Follow-Up Period|Withdrawal by Subject|6|||
145950372|NCT02757352|526330366|FG009|Follow-Up Period|Withdrawal by Subject|2|||
145950373|NCT03536663|526330367|FG000|Endexo|Protocol Violation|1|||
146202752|NCT01145885|527255566|FG000|Overall Study|Progressive Disease|7|||
146202753|NCT00723450|527255567|FG000|Open-Label Phase|Adverse Event|26|||
146202754|NCT00723450|527255568|FG001|Open-Label Phase|Adverse Event|0|||
146202755|NCT00723450|527255569|FG002|Open-Label Phase|Adverse Event|0|||
146202756|NCT00723450|527255567|FG000|Open-Label Phase|Lack of Efficacy|18|||
146202757|NCT00723450|527255568|FG001|Open-Label Phase|Lack of Efficacy|0|||
146202758|NCT00723450|527255569|FG002|Open-Label Phase|Lack of Efficacy|0|||
146202759|NCT00723450|527255567|FG000|Open-Label Phase|Protocol Violation|35|||
146202760|NCT00723450|527255568|FG001|Open-Label Phase|Protocol Violation|0|||
146202761|NCT00723450|527255569|FG002|Open-Label Phase|Protocol Violation|0|||
146202762|NCT00723450|527255567|FG000|Open-Label Phase|Lost to Follow-up|7|||
146202763|NCT00723450|527255568|FG001|Open-Label Phase|Lost to Follow-up|0|||
146202764|NCT00723450|527255569|FG002|Open-Label Phase|Lost to Follow-up|0|||
145950374|NCT00497146|526330369|FG000|Treatment Period|Adverse Event|6|||
145950375|NCT00497146|526330370|FG001|Treatment Period|Adverse Event|2|||
145950376|NCT00497146|526330369|FG000|Treatment Period|Withdrawal by Subject|5|||
145950377|NCT00497146|526330370|FG001|Treatment Period|Withdrawal by Subject|9|||
145950378|NCT00497146|526330369|FG000|Treatment Period|Lost to Follow-up|1|||
145950379|NCT00497146|526330370|FG001|Treatment Period|Lost to Follow-up|3|||
145950380|NCT00497146|526330369|FG000|Treatment Period|Required dialysis|4|||
145950381|NCT00497146|526330370|FG001|Treatment Period|Required dialysis|1|||
145950382|NCT00497146|526330369|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
145950383|NCT00497146|526330370|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
146202765|NCT00723450|527255567|FG000|Open-Label Phase|Physician Decision|2|||
145950384|NCT00497146|526330369|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
145950385|NCT00497146|526330370|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
146202766|NCT00723450|527255568|FG001|Open-Label Phase|Physician Decision|0|||
146202767|NCT00723450|527255569|FG002|Open-Label Phase|Physician Decision|0|||
146202768|NCT00723450|527255567|FG000|Open-Label Phase|Withdrawal by Subject|37|||
146202769|NCT00723450|527255568|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146202770|NCT00723450|527255569|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146202771|NCT00723450|527255567|FG000|Randomized Phase|Adverse Event|0|||
145950386|NCT00497146|526330369|FG000|Treatment Period|Other Reason|2|||
145950387|NCT00497146|526330370|FG001|Treatment Period|Other Reason|3|||
145950388|NCT00497146|526330369|FG000|Long-term Follow-up Period|Adverse Event|2|||
146202772|NCT00723450|527255568|FG001|Randomized Phase|Adverse Event|26|||
146202773|NCT00723450|527255569|FG002|Randomized Phase|Adverse Event|17|||
145950389|NCT00497146|526330370|FG001|Long-term Follow-up Period|Adverse Event|2|||
145950390|NCT00497146|526330369|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
146202774|NCT00723450|527255567|FG000|Randomized Phase|Lack of Efficacy|0|||
146202775|NCT00723450|527255568|FG001|Randomized Phase|Lack of Efficacy|11|||
146202776|NCT00723450|527255569|FG002|Randomized Phase|Lack of Efficacy|11|||
146202777|NCT00723450|527255567|FG000|Randomized Phase|Protocol Violation|0|||
146202778|NCT00723450|527255568|FG001|Randomized Phase|Protocol Violation|9|||
146202779|NCT00723450|527255569|FG002|Randomized Phase|Protocol Violation|13|||
146202780|NCT00723450|527255567|FG000|Randomized Phase|Lost to Follow-up|0|||
146202781|NCT00723450|527255568|FG001|Randomized Phase|Lost to Follow-up|2|||
146202782|NCT00723450|527255569|FG002|Randomized Phase|Lost to Follow-up|3|||
146202783|NCT00723450|527255567|FG000|Randomized Phase|Physician Decision|0|||
146202784|NCT00723450|527255568|FG001|Randomized Phase|Physician Decision|3|||
146202785|NCT00723450|527255569|FG002|Randomized Phase|Physician Decision|1|||
146202786|NCT00723450|527255567|FG000|Randomized Phase|Withdrawal by Subject|0|||
146202787|NCT00723450|527255568|FG001|Randomized Phase|Withdrawal by Subject|14|||
146202788|NCT00723450|527255569|FG002|Randomized Phase|Withdrawal by Subject|22|||
146202789|NCT01135511|527255570|FG000|Overall Study|Adverse Event|0|||
146202790|NCT01135511|527255571|FG001|Overall Study|Adverse Event|1|||
146202791|NCT01135511|527255572|FG002|Overall Study|Adverse Event|2|||
146202792|NCT01135511|527255573|FG003|Overall Study|Adverse Event|0|||
146082858|NCT02081859|526822917|FG000|Overall Study|No fertilization|2|||
146082859|NCT02081859|526822918|FG001|Overall Study|No fertilization|2|||
146082860|NCT02081859|526822917|FG000|Overall Study|No sperm|1|||
146082861|NCT02081859|526822918|FG001|Overall Study|No sperm|0|||
146082862|NCT02081859|526822917|FG000|Overall Study|Unanticipated freeze all cycle|2|||
146082863|NCT02081859|526822918|FG001|Overall Study|Unanticipated freeze all cycle|6|||
146082864|NCT02081859|526822917|FG000|Overall Study|< 4 embryos|27|||
146082865|NCT02081859|526822918|FG001|Overall Study|< 4 embryos|23|||
146082866|NCT02081859|526822917|FG000|Overall Study|Other reasons|2|||
146082867|NCT02081859|526822918|FG001|Overall Study|Other reasons|0|||
146082868|NCT03658876|526824694|FG000|Overall Study|Protocol Violation|3|||
146082869|NCT03658876|526824695|FG001|Overall Study|Protocol Violation|2|||
146082870|NCT03658876|526824694|FG000|Overall Study|Withdrawal by Subject|2|||
146082871|NCT03658876|526824695|FG001|Overall Study|Withdrawal by Subject|0|||
146082872|NCT03658876|526824694|FG000|Overall Study|Death|0|||
146082873|NCT03658876|526824695|FG001|Overall Study|Death|1|||
146082874|NCT03658876|526824694|FG000|Overall Study|Intercurrent illness|6|||
146082875|NCT03658876|526824695|FG001|Overall Study|Intercurrent illness|4|||
146082876|NCT03658876|526824694|FG000|Overall Study|Transplantation/other operation|1|||
146082877|NCT03658876|526824695|FG001|Overall Study|Transplantation/other operation|5|||
146082878|NCT02616146|526824696|FG000|Overall Study|Adverse Event|64|||
146082879|NCT02616146|526824697|FG001|Overall Study|Adverse Event|24|||
146202793|NCT01135511|527255574|FG004|Overall Study|Adverse Event|0|||
146202794|NCT01135511|527255575|FG005|Overall Study|Adverse Event|1|||
146202795|NCT01135511|527255576|FG006|Overall Study|Adverse Event|0|||
146202796|NCT01135511|527255577|FG007|Overall Study|Adverse Event|1|||
146202797|NCT01135511|527255578|FG008|Overall Study|Adverse Event|0|||
146082880|NCT02616146|526824696|FG000|Overall Study|Lost to Follow-up|23|||
146082881|NCT02616146|526824697|FG001|Overall Study|Lost to Follow-up|13|||
146082882|NCT02616146|526824696|FG000|Overall Study|Non-compliance with study protocol|2|||
145950391|NCT00497146|526330370|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
145950392|NCT00497146|526330369|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
145950393|NCT00497146|526330370|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
145950394|NCT00497146|526330369|FG000|Long-term Follow-up Period|Other|0|||
145950395|NCT00497146|526330370|FG001|Long-term Follow-up Period|Other|1|||
145950396|NCT01964989|526330385|FG000|Overall Study|Protocol Violation|3|||
145950397|NCT01964989|526330386|FG001|Overall Study|Protocol Violation|4|||
145950398|NCT01964989|526330385|FG000|Overall Study|Administrative Reason|103|||
145950399|NCT01964989|526330386|FG001|Overall Study|Administrative Reason|95|||
145950400|NCT01964989|526330385|FG000|Overall Study|Adverse Event|0|||
145950401|NCT01964989|526330386|FG001|Overall Study|Adverse Event|1|||
145950402|NCT01964989|526330385|FG000|Overall Study|Death|1|||
145950403|NCT01964989|526330386|FG001|Overall Study|Death|3|||
145950404|NCT01964989|526330385|FG000|Overall Study|Withdrawal by Subject|156|||
145950405|NCT01964989|526330386|FG001|Overall Study|Withdrawal by Subject|160|||
145950406|NCT01964989|526330385|FG000|Overall Study|Lost to Follow-up|254|||
145950407|NCT01964989|526330386|FG001|Overall Study|Lost to Follow-up|232|||
146202798|NCT01135511|527255570|FG000|Overall Study|Lack of Efficacy|0|||
146202799|NCT01135511|527255571|FG001|Overall Study|Lack of Efficacy|1|||
146202800|NCT01135511|527255572|FG002|Overall Study|Lack of Efficacy|1|||
145950408|NCT01964989|526330385|FG000|Overall Study|Other|267|||
145950409|NCT01964989|526330386|FG001|Overall Study|Other|252|||
145950410|NCT02769312|526330387|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
146202801|NCT01135511|527255573|FG003|Overall Study|Lack of Efficacy|2|||
146202802|NCT01135511|527255574|FG004|Overall Study|Lack of Efficacy|0|||
146202803|NCT01135511|527255575|FG005|Overall Study|Lack of Efficacy|0|||
146202804|NCT01135511|527255576|FG006|Overall Study|Lack of Efficacy|0|||
146202805|NCT01135511|527255577|FG007|Overall Study|Lack of Efficacy|0|||
146202806|NCT01135511|527255578|FG008|Overall Study|Lack of Efficacy|0|||
146202807|NCT01135511|527255570|FG000|Overall Study|Protocol Violation|0|||
146202808|NCT01135511|527255571|FG001|Overall Study|Protocol Violation|0|||
146202809|NCT01135511|527255572|FG002|Overall Study|Protocol Violation|3|||
146202810|NCT01135511|527255573|FG003|Overall Study|Protocol Violation|0|||
146202811|NCT01135511|527255574|FG004|Overall Study|Protocol Violation|0|||
146202812|NCT01135511|527255575|FG005|Overall Study|Protocol Violation|0|||
146202813|NCT01135511|527255576|FG006|Overall Study|Protocol Violation|0|||
146202814|NCT01135511|527255577|FG007|Overall Study|Protocol Violation|0|||
146202815|NCT01135511|527255578|FG008|Overall Study|Protocol Violation|0|||
146202816|NCT01135511|527255570|FG000|Overall Study|Pregnancy|0|||
146202817|NCT01135511|527255571|FG001|Overall Study|Pregnancy|0|||
146202818|NCT01135511|527255572|FG002|Overall Study|Pregnancy|0|||
146202819|NCT01135511|527255573|FG003|Overall Study|Pregnancy|1|||
146202820|NCT01135511|527255574|FG004|Overall Study|Pregnancy|0|||
146202821|NCT01135511|527255575|FG005|Overall Study|Pregnancy|0|||
146202822|NCT01135511|527255576|FG006|Overall Study|Pregnancy|0|||
146202823|NCT01135511|527255577|FG007|Overall Study|Pregnancy|0|||
146202824|NCT01135511|527255578|FG008|Overall Study|Pregnancy|0|||
146202825|NCT01135511|527255570|FG000|Overall Study|could not visit the clinic|0|||
146202826|NCT01135511|527255571|FG001|Overall Study|could not visit the clinic|1|||
146202827|NCT01135511|527255572|FG002|Overall Study|could not visit the clinic|2|||
146202828|NCT01135511|527255573|FG003|Overall Study|could not visit the clinic|0|||
146202829|NCT01135511|527255574|FG004|Overall Study|could not visit the clinic|0|||
146202830|NCT01135511|527255575|FG005|Overall Study|could not visit the clinic|0|||
146202831|NCT01135511|527255576|FG006|Overall Study|could not visit the clinic|0|||
146202832|NCT01135511|527255577|FG007|Overall Study|could not visit the clinic|0|||
146202833|NCT01135511|527255578|FG008|Overall Study|could not visit the clinic|0|||
146202834|NCT01135511|527255570|FG000|Overall Study|noncompliance with study drug taken|0|||
146202835|NCT01135511|527255571|FG001|Overall Study|noncompliance with study drug taken|0|||
146202836|NCT01135511|527255572|FG002|Overall Study|noncompliance with study drug taken|0|||
146202837|NCT01135511|527255573|FG003|Overall Study|noncompliance with study drug taken|0|||
145950411|NCT02769312|526330388|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
146202838|NCT01135511|527255574|FG004|Overall Study|noncompliance with study drug taken|1|||
146202839|NCT01135511|527255575|FG005|Overall Study|noncompliance with study drug taken|0|||
146202840|NCT01135511|527255576|FG006|Overall Study|noncompliance with study drug taken|0|||
146202841|NCT01135511|527255577|FG007|Overall Study|noncompliance with study drug taken|0|||
146202842|NCT01135511|527255578|FG008|Overall Study|noncompliance with study drug taken|0|||
146202843|NCT01135511|527255570|FG000|Overall Study|Withdrawal by Subject|0|||
146202844|NCT01135511|527255571|FG001|Overall Study|Withdrawal by Subject|0|||
146202845|NCT01135511|527255572|FG002|Overall Study|Withdrawal by Subject|0|||
145950412|NCT02769312|526330387|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
145950413|NCT02769312|526330388|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
145950414|NCT02769312|526330387|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
146202846|NCT01135511|527255573|FG003|Overall Study|Withdrawal by Subject|0|||
146202847|NCT01135511|527255574|FG004|Overall Study|Withdrawal by Subject|0|||
146202848|NCT01135511|527255575|FG005|Overall Study|Withdrawal by Subject|0|||
146202849|NCT01135511|527255576|FG006|Overall Study|Withdrawal by Subject|1|||
146202850|NCT01135511|527255577|FG007|Overall Study|Withdrawal by Subject|0|||
146202851|NCT01135511|527255578|FG008|Overall Study|Withdrawal by Subject|1|||
146202852|NCT02880241|527255579|FG000|Overall Study|Lack of Efficacy|1|||
146202853|NCT02880241|527255580|FG001|Overall Study|Lack of Efficacy|0|||
146202854|NCT02880241|527255581|FG002|Overall Study|Lack of Efficacy|0|||
146202855|NCT02880241|527255582|FG003|Overall Study|Lack of Efficacy|0|||
146202856|NCT02880241|527255583|FG004|Overall Study|Lack of Efficacy|0|||
146202857|NCT02880241|527255584|FG005|Overall Study|Lack of Efficacy|0|||
146202858|NCT00057837|527255585|FG000|Overall Study|Progression/relapse|12|||
146202859|NCT00057837|527255586|FG001|Overall Study|Progression/relapse|14|||
146202860|NCT00057837|527255585|FG000|Overall Study|Adverse Event|2|||
146202861|NCT00057837|527255586|FG001|Overall Study|Adverse Event|12|||
146202862|NCT00057837|527255585|FG000|Overall Study|Death|5|||
146202863|NCT00057837|527255586|FG001|Overall Study|Death|4|||
146202864|NCT00057837|527255585|FG000|Overall Study|Withdrawal by Subject|5|||
146202865|NCT00057837|527255586|FG001|Overall Study|Withdrawal by Subject|3|||
146202866|NCT00057837|527255585|FG000|Overall Study|Alternative therapy|0|||
146202867|NCT00057837|527255586|FG001|Overall Study|Alternative therapy|1|||
146202868|NCT00057837|527255585|FG000|Overall Study|Other complicating disease|2|||
146202869|NCT00057837|527255586|FG001|Overall Study|Other complicating disease|1|||
146202870|NCT00057837|527255585|FG000|Overall Study|Physician Decision|1|||
146202871|NCT00057837|527255586|FG001|Overall Study|Physician Decision|0|||
146202872|NCT00057837|527255585|FG000|Overall Study|Ineligible|3|||
146202873|NCT00057837|527255586|FG001|Overall Study|Ineligible|3|||
146202874|NCT00057837|527255585|FG000|Overall Study|Never started treatment|1|||
146202875|NCT00057837|527255586|FG001|Overall Study|Never started treatment|1|||
146202876|NCT02537522|527255587|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
146202877|NCT02537522|527255588|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
146202878|NCT02537522|527255589|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
146202879|NCT02537522|527255590|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
146202880|NCT02537522|527255587|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
146202881|NCT02537522|527255588|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
146202882|NCT02537522|527255589|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
146202883|NCT02537522|527255590|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
146202884|NCT02537522|527255587|FG000|Phase I - Contralateral|incorrect randomization|0|||
146202885|NCT02537522|527255588|FG001|Phase I - Contralateral|incorrect randomization|1|||
146202886|NCT02537522|527255589|FG002|Phase I - Contralateral|incorrect randomization|0|||
146202887|NCT02537522|527255590|FG003|Phase I - Contralateral|incorrect randomization|0|||
146202888|NCT02537522|527255587|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146202889|NCT02537522|527255588|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
146202890|NCT02537522|527255589|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146202891|NCT02537522|527255590|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
146202892|NCT02537522|527255587|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
146202893|NCT02537522|527255588|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
146202894|NCT02537522|527255589|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
146202895|NCT02537522|527255590|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
146202896|NCT02570711|527255594|FG000|Overall Study|Death|1|||
146202897|NCT02570711|527255595|FG001|Overall Study|Death|0|||
146202898|NCT02570711|527255594|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
146202899|NCT02570711|527255595|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
146202900|NCT05001945|527255596|FG000|Overall Study|Adverse Event|0|||
146202901|NCT05001945|527255597|FG001|Overall Study|Adverse Event|0|||
146202902|NCT05001945|527255598|FG002|Overall Study|Adverse Event|0|||
146202903|NCT05001945|527255599|FG003|Overall Study|Adverse Event|1|||
146202904|NCT05001945|527255600|FG004|Overall Study|Adverse Event|0|||
146202905|NCT05001945|527255601|FG005|Overall Study|Adverse Event|0|||
146202906|NCT05001945|527255602|FG006|Overall Study|Adverse Event|0|||
146202907|NCT05001945|527255603|FG007|Overall Study|Adverse Event|0|||
146202908|NCT05001945|527255596|FG000|Overall Study|Lost to Follow-up|0|||
146202909|NCT05001945|527255597|FG001|Overall Study|Lost to Follow-up|1|||
146202910|NCT05001945|527255598|FG002|Overall Study|Lost to Follow-up|1|||
146202911|NCT05001945|527255599|FG003|Overall Study|Lost to Follow-up|2|||
146202912|NCT05001945|527255600|FG004|Overall Study|Lost to Follow-up|0|||
146202913|NCT05001945|527255601|FG005|Overall Study|Lost to Follow-up|1|||
146202914|NCT05001945|527255602|FG006|Overall Study|Lost to Follow-up|0|||
146202915|NCT05001945|527255603|FG007|Overall Study|Lost to Follow-up|0|||
146202916|NCT05001945|527255596|FG000|Overall Study|Protocol Violation|1|||
146202917|NCT05001945|527255597|FG001|Overall Study|Protocol Violation|0|||
146202918|NCT05001945|527255598|FG002|Overall Study|Protocol Violation|1|||
146202919|NCT05001945|527255599|FG003|Overall Study|Protocol Violation|1|||
146202920|NCT05001945|527255600|FG004|Overall Study|Protocol Violation|0|||
146202921|NCT05001945|527255601|FG005|Overall Study|Protocol Violation|1|||
146202922|NCT05001945|527255602|FG006|Overall Study|Protocol Violation|0|||
146202923|NCT05001945|527255603|FG007|Overall Study|Protocol Violation|0|||
146202924|NCT05001945|527255596|FG000|Overall Study|Withdrawal by Subject|0|||
146202925|NCT05001945|527255597|FG001|Overall Study|Withdrawal by Subject|0|||
146202926|NCT05001945|527255598|FG002|Overall Study|Withdrawal by Subject|0|||
146202927|NCT05001945|527255599|FG003|Overall Study|Withdrawal by Subject|1|||
146202928|NCT05001945|527255600|FG004|Overall Study|Withdrawal by Subject|1|||
146202929|NCT05001945|527255601|FG005|Overall Study|Withdrawal by Subject|1|||
146202930|NCT05001945|527255602|FG006|Overall Study|Withdrawal by Subject|0|||
146202931|NCT05001945|527255603|FG007|Overall Study|Withdrawal by Subject|1|||
146202932|NCT05001945|527255596|FG000|Overall Study|Not specified by Investigator|0|||
146202933|NCT05001945|527255597|FG001|Overall Study|Not specified by Investigator|3|||
146202934|NCT05001945|527255598|FG002|Overall Study|Not specified by Investigator|0|||
146202935|NCT05001945|527255599|FG003|Overall Study|Not specified by Investigator|0|||
146202936|NCT05001945|527255600|FG004|Overall Study|Not specified by Investigator|1|||
146202937|NCT05001945|527255601|FG005|Overall Study|Not specified by Investigator|0|||
146202938|NCT05001945|527255602|FG006|Overall Study|Not specified by Investigator|0|||
146202939|NCT05001945|527255603|FG007|Overall Study|Not specified by Investigator|0|||
146202940|NCT00585533|527255604|FG000|Overall Study|objective or symptomatic progression|9|||
146202941|NCT03482011|527255605|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
146202942|NCT03482011|527255606|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
146202943|NCT03482011|527255607|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146202944|NCT03482011|527255608|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
146202945|NCT03482011|527255609|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146202946|NCT03482011|527255610|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146202947|NCT03482011|527255611|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146202948|NCT03482011|527255612|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146202949|NCT03482011|527255605|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
146202950|NCT03482011|527255606|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
146202951|NCT03482011|527255607|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202952|NCT03482011|527255608|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202953|NCT03482011|527255609|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202954|NCT03482011|527255610|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202955|NCT03482011|527255611|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202956|NCT03482011|527255612|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146202957|NCT03482011|527255605|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202958|NCT03482011|527255606|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
146202959|NCT03482011|527255607|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202960|NCT03482011|527255608|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202961|NCT03482011|527255609|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202962|NCT03482011|527255610|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202963|NCT03482011|527255611|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202964|NCT03482011|527255612|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
146202965|NCT03482011|527255605|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
146202966|NCT03482011|527255606|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
146202967|NCT03482011|527255607|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
146202968|NCT03482011|527255608|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
146202969|NCT03482011|527255609|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
146202970|NCT03482011|527255610|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
146202971|NCT03482011|527255611|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
146202972|NCT03482011|527255612|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
146202973|NCT03482011|527255605|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146202974|NCT03482011|527255606|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
146202975|NCT03482011|527255607|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202976|NCT03482011|527255608|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202977|NCT03482011|527255609|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202978|NCT03482011|527255610|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202979|NCT03482011|527255611|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202980|NCT03482011|527255612|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146202981|NCT03482011|527255605|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
146202982|NCT03482011|527255606|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
146202983|NCT03482011|527255607|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
146202984|NCT03482011|527255608|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
146202985|NCT03482011|527255609|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
146202986|NCT03482011|527255610|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
146202987|NCT03482011|527255611|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
146202988|NCT03482011|527255612|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
146202989|NCT03482011|527255605|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146202990|NCT03482011|527255606|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146202991|NCT03482011|527255607|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146202992|NCT03482011|527255608|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
146202993|NCT03482011|527255609|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146202994|NCT03482011|527255610|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
146202995|NCT03482011|527255611|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146202996|NCT03482011|527255612|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
146202997|NCT03482011|527255605|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146202998|NCT03482011|527255606|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146202999|NCT03482011|527255607|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146203000|NCT03482011|527255608|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146203001|NCT03482011|527255609|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
146203002|NCT03482011|527255610|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146203003|NCT03482011|527255611|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146203004|NCT03482011|527255612|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
146203005|NCT03482011|527255605|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
146203006|NCT03482011|527255606|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
146203007|NCT03482011|527255607|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
146203008|NCT03482011|527255608|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
146203009|NCT03482011|527255609|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
145950415|NCT02769312|526330388|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
146203010|NCT03482011|527255610|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
146203011|NCT03482011|527255611|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
145950416|NCT02769312|526330387|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
145950417|NCT02769312|526330388|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
145950418|NCT02769312|526330387|FG000|Follow-up|Lost to Follow-up|1|||
145950419|NCT02769312|526330388|FG001|Follow-up|Lost to Follow-up|1|||
145950420|NCT02496039|526330389|FG000|Overall Study|Adverse Event|3|||
145950421|NCT02496039|526330389|FG000|Overall Study|Protocol Violation|1|||
145950422|NCT05114564|526330391|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
146203012|NCT03482011|527255612|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
146203013|NCT03482011|527255605|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146203014|NCT03482011|527255606|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146203015|NCT03482011|527255607|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146203016|NCT03482011|527255608|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
146203017|NCT03482011|527255609|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
145950423|NCT05114564|526330392|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
145950424|NCT05114564|526330391|FG000|First Intervention|Adverse Event|0|||
145950425|NCT05114564|526330392|FG001|First Intervention|Adverse Event|1|||
146203018|NCT03482011|527255610|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
146203019|NCT03482011|527255611|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146203020|NCT03482011|527255612|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146203021|NCT03482011|527255605|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146203022|NCT03482011|527255606|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146203023|NCT03482011|527255607|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146203024|NCT03482011|527255608|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
146203025|NCT03482011|527255609|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146203026|NCT03482011|527255610|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146203027|NCT03482011|527255611|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146203028|NCT03482011|527255612|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
146203029|NCT03482011|527255605|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203030|NCT03482011|527255606|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203031|NCT03482011|527255607|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203032|NCT03482011|527255608|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203033|NCT03482011|527255609|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203034|NCT03482011|527255610|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
146203035|NCT03482011|527255611|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
146203036|NCT03482011|527255612|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
146203037|NCT03482011|527255605|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146203038|NCT03482011|527255606|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146203039|NCT03482011|527255607|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
146203040|NCT03482011|527255608|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
146203041|NCT03482011|527255609|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146203042|NCT03482011|527255610|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146203043|NCT03482011|527255611|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
146203044|NCT03482011|527255612|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
146203045|NCT03482011|527255605|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203046|NCT03482011|527255606|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203047|NCT03482011|527255607|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203048|NCT03482011|527255608|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203049|NCT03482011|527255609|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203050|NCT03482011|527255610|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203051|NCT03482011|527255611|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
146203052|NCT03482011|527255612|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
146203053|NCT03482011|527255605|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145950426|NCT00493311|526330393|FG000|Overall Study|Need for rescue medication|2|||
145950427|NCT00493311|526330394|FG001|Overall Study|Need for rescue medication|2|||
146203054|NCT03482011|527255606|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203055|NCT03482011|527255607|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203056|NCT03482011|527255608|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203057|NCT03482011|527255609|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203058|NCT03482011|527255610|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203059|NCT03482011|527255611|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146203060|NCT03482011|527255612|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
146203061|NCT00468052|527255613|FG000|Overall Study|Protocol Violation|7|||
146203062|NCT00468052|527255614|FG001|Overall Study|Protocol Violation|8|||
146203063|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
146203064|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146203065|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146203066|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146203067|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
146203068|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
146203069|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146203070|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146203071|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146203072|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
146203073|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
146203074|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146203075|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146203076|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146203077|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
146203078|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
146203079|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146203080|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146203081|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146203082|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
146203083|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
146430997|NCT02714062|528086640|FG000|Overall Study|Protocol Violation|0|||
146430998|NCT02714062|528086641|FG001|Overall Study|Protocol Violation|1|||
146430999|NCT02714062|528086642|FG002|Overall Study|Protocol Violation|0|||
146431000|NCT00850174|528086645|FG000|Washout: One Week|Withdrawal by Subject|0|||
146203084|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146203085|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146431001|NCT00850174|528086646|FG001|Washout: One Week|Withdrawal by Subject|2|||
146431002|NCT00850174|528086645|FG000|Second Intervention|Withdrawal by Subject|1|||
146431003|NCT00850174|528086646|FG001|Second Intervention|Withdrawal by Subject|0|||
146431004|NCT01363765|528086649|FG000|Overall Study|non-diagnostic|2621|||
146203086|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146203087|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
146203088|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
146203089|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146203090|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146203091|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146203092|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
146203093|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
146431005|NCT01363765|528086650|FG001|Overall Study|non-diagnostic|1124|||
145950428|NCT02779075|526330395|FG000|Overall Study|Withdrawal by Subject|1|||
145950429|NCT02779075|526330396|FG001|Overall Study|Withdrawal by Subject|3|||
146431006|NCT01363765|528086649|FG000|Overall Study|duplicate records|736|||
145950430|NCT02779075|526330395|FG000|Overall Study|IV lost during 2nd study|1|||
145950431|NCT02779075|526330396|FG001|Overall Study|IV lost during 2nd study|0|||
145950432|NCT00255840|526330397|FG000|Overall Study|Lost to Follow-up|10|||
145950433|NCT00255840|526330398|FG001|Overall Study|Lost to Follow-up|14|||
145950434|NCT00255840|526330397|FG000|Overall Study|Discontinued intervention|53|||
145950435|NCT00255840|526330398|FG001|Overall Study|Discontinued intervention|56|||
145950436|NCT00496587|526330399|FG000|Overall Study|Adverse Event|2|||
145950437|NCT00496587|526330399|FG000|Overall Study|Progressive Disease|24|||
145950438|NCT00496587|526330399|FG000|Overall Study|Withdrawal by Subject|2|||
145950439|NCT00496587|526330399|FG000|Overall Study|Death|1|||
145950440|NCT00496587|526330399|FG000|Overall Study|Complications unrelated|2|||
145950441|NCT05259917|526330404|FG000|Overall Study|Protocol Violation|0|||
145950442|NCT05259917|526330405|FG001|Overall Study|Protocol Violation|0|||
145950443|NCT05259917|526330406|FG002|Overall Study|Protocol Violation|1|||
145950444|NCT05259917|526330407|FG003|Overall Study|Protocol Violation|0|||
145950445|NCT05259917|526330408|FG004|Overall Study|Protocol Violation|0|||
145950446|NCT05259917|526330409|FG005|Overall Study|Protocol Violation|0|||
145950447|NCT05259917|526330404|FG000|Overall Study|Lost to Follow-up|0|||
145950448|NCT05259917|526330405|FG001|Overall Study|Lost to Follow-up|0|||
145950449|NCT05259917|526330406|FG002|Overall Study|Lost to Follow-up|1|||
145950450|NCT05259917|526330407|FG003|Overall Study|Lost to Follow-up|0|||
145950451|NCT05259917|526330408|FG004|Overall Study|Lost to Follow-up|0|||
145950452|NCT05259917|526330409|FG005|Overall Study|Lost to Follow-up|1|||
145950453|NCT05259917|526330404|FG000|Overall Study|Physician Decision|0|||
145950454|NCT05259917|526330405|FG001|Overall Study|Physician Decision|1|||
145950455|NCT05259917|526330406|FG002|Overall Study|Physician Decision|0|||
145950456|NCT05259917|526330407|FG003|Overall Study|Physician Decision|0|||
145950457|NCT05259917|526330408|FG004|Overall Study|Physician Decision|0|||
145950458|NCT05259917|526330409|FG005|Overall Study|Physician Decision|0|||
145950459|NCT05259917|526330404|FG000|Overall Study|Withdrawal by Subject|0|||
145950460|NCT05259917|526330405|FG001|Overall Study|Withdrawal by Subject|1|||
145950461|NCT05259917|526330406|FG002|Overall Study|Withdrawal by Subject|0|||
145950462|NCT05259917|526330407|FG003|Overall Study|Withdrawal by Subject|0|||
145950463|NCT05259917|526330408|FG004|Overall Study|Withdrawal by Subject|1|||
145950464|NCT05259917|526330409|FG005|Overall Study|Withdrawal by Subject|1|||
145950465|NCT05259917|526330404|FG000|Overall Study|Trial Termination by Sponsor|7|||
145950466|NCT05259917|526330405|FG001|Overall Study|Trial Termination by Sponsor|2|||
145950467|NCT05259917|526330406|FG002|Overall Study|Trial Termination by Sponsor|3|||
145950468|NCT05259917|526330407|FG003|Overall Study|Trial Termination by Sponsor|5|||
145950469|NCT05259917|526330408|FG004|Overall Study|Trial Termination by Sponsor|11|||
145950470|NCT05259917|526330409|FG005|Overall Study|Trial Termination by Sponsor|4|||
145950471|NCT05259917|526330404|FG000|Overall Study|Other|1|||
145950472|NCT05259917|526330405|FG001|Overall Study|Other|0|||
145950473|NCT05259917|526330406|FG002|Overall Study|Other|2|||
145950474|NCT05259917|526330407|FG003|Overall Study|Other|0|||
145950475|NCT05259917|526330408|FG004|Overall Study|Other|0|||
145950476|NCT05259917|526330409|FG005|Overall Study|Other|0|||
145950477|NCT00592592|526330410|FG000|Overall Study|Patient found ineligible upon chart review|1|||
145950478|NCT01557517|526330411|FG000|Overall Study|Death|1|||
145950479|NCT01557517|526330412|FG001|Overall Study|Death|0|||
145950480|NCT01557517|526330411|FG000|Overall Study|Refused further treatment|0|||
145950481|NCT01557517|526330412|FG001|Overall Study|Refused further treatment|2|||
145950482|NCT01557517|526330411|FG000|Overall Study|Adverse Event|0|||
145950483|NCT01557517|526330412|FG001|Overall Study|Adverse Event|2|||
145950484|NCT01557517|526330411|FG000|Overall Study|Pt declined before treatment started|1|||
145950485|NCT01557517|526330412|FG001|Overall Study|Pt declined before treatment started|0|||
145950486|NCT00162097|526330413|FG000|Overall Study|Participant no longer met study criteria|0|||
145950487|NCT00162097|526330414|FG001|Overall Study|Participant no longer met study criteria|0|||
145950488|NCT00162097|526330415|FG002|Overall Study|Participant no longer met study criteria|0|||
145950489|NCT00162097|526330416|FG003|Overall Study|Participant no longer met study criteria|1|||
145950490|NCT01204918|526330417|FG000|Overall Study|Withdrawal by Subject|4|||
145950491|NCT01204918|526330418|FG001|Overall Study|Withdrawal by Subject|10|||
145950492|NCT01204918|526330419|FG002|Overall Study|Withdrawal by Subject|5|||
145950493|NCT03585712|526330422|FG000|Treatment Period 1|Protocol Violation|1|||
145950494|NCT03585712|526330423|FG001|Treatment Period 1|Protocol Violation|0|||
145950495|NCT03585712|526330424|FG002|Treatment Period 1|Protocol Violation|0|||
145950496|NCT03585712|526330422|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
145950497|NCT03585712|526330423|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
145950498|NCT03585712|526330424|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
146082883|NCT02616146|526824697|FG001|Overall Study|Non-compliance with study protocol|0|||
146082884|NCT02616146|526824696|FG000|Overall Study|Non-compliance with study drug|4|||
145950499|NCT03585712|526330422|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
145950500|NCT03585712|526330423|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
145950501|NCT03585712|526330424|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
145950502|NCT03585712|526330422|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
145950503|NCT03585712|526330423|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
145950504|NCT03585712|526330424|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
145950505|NCT01280682|526330425|FG000|Overall Study|Lost to Follow-up|0|||
145950506|NCT01280682|526330426|FG001|Overall Study|Lost to Follow-up|6|||
145950507|NCT01280682|526330425|FG000|Overall Study|Withdrawal by Subject|0|||
145950508|NCT01280682|526330426|FG001|Overall Study|Withdrawal by Subject|7|||
145950509|NCT00849290|526330427|FG000|Overall Study|Adverse Event|3|||
145950510|NCT00849290|526330427|FG000|Overall Study|Death|14|||
145950511|NCT00849290|526330427|FG000|Overall Study|Withdrawal by Subject|11|||
145950512|NCT00849290|526330427|FG000|Overall Study|Lost to Follow-up|2|||
145950513|NCT00849290|526330427|FG000|Overall Study|Protocol Violation|5|||
145950514|NCT00849290|526330427|FG000|Overall Study|Disease Progression|20|||
145950515|NCT02007278|526330428|FG000|Overall Study|Failure to comply with an eligibility|0|||
145950516|NCT02007278|526330429|FG001|Overall Study|Failure to comply with an eligibility|1|||
145950517|NCT02007278|526330428|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
145950518|NCT02007278|526330429|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
145950519|NCT02007278|526330428|FG000|Overall Study|Incorrect medication administration|1|||
145950520|NCT02007278|526330429|FG001|Overall Study|Incorrect medication administration|0|||
145950521|NCT02007278|526330428|FG000|Overall Study|Mis-randomization|1|||
145950522|NCT02007278|526330429|FG001|Overall Study|Mis-randomization|1|||
145950523|NCT01915771|526330432|FG000|Day 1|Withdrawal by Subject|1|||
145950524|NCT01915771|526330432|FG000|Day 15|Withdrawal by Subject|1|||
145950525|NCT03420222|526330435|FG000|Overall Study|Withdrawal by Subject|5|||
145950526|NCT03420222|526330436|FG001|Overall Study|Withdrawal by Subject|0|||
145950527|NCT03420222|526330435|FG000|Overall Study|Physician Decision|0|||
145950528|NCT03420222|526330436|FG001|Overall Study|Physician Decision|1|||
145950529|NCT02279745|526330437|FG000|Overall Study|Adverse Event|7|||
145950530|NCT02279745|526330437|FG000|Overall Study|Death|6|||
145950531|NCT02279745|526330437|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
145950532|NCT02279745|526330437|FG000|Overall Study|Withdrawal by Subject|2|||
145950533|NCT02279745|526330437|FG000|Overall Study|Pregnancy|1|||
145950534|NCT02279745|526330437|FG000|Overall Study|Study Non-compliance|1|||
145950535|NCT02279745|526330437|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
145950536|NCT03469999|526330441|FG000|Overall Study|Lost to Follow-up|2|||
145950537|NCT04424914|526330445|FG000|Overall Study|Other|0|||
145950538|NCT04424914|526330446|FG001|Overall Study|Other|0|||
145950539|NCT04424914|526330447|FG002|Overall Study|Other|28|||
145950540|NCT04424914|526330445|FG000|Overall Study|Withdrawal by Subject|3|||
145950541|NCT04424914|526330446|FG001|Overall Study|Withdrawal by Subject|0|||
145950542|NCT04424914|526330447|FG002|Overall Study|Withdrawal by Subject|0|||
145950543|NCT04424914|526330445|FG000|Overall Study|Study terminated by sponsor|23|||
145950544|NCT04424914|526330446|FG001|Overall Study|Study terminated by sponsor|7|||
145950545|NCT04424914|526330447|FG002|Overall Study|Study terminated by sponsor|0|||
145950546|NCT04424914|526330445|FG000|Overall Study|Lost to Follow-up|0|||
145950547|NCT04424914|526330446|FG001|Overall Study|Lost to Follow-up|0|||
145950548|NCT04424914|526330447|FG002|Overall Study|Lost to Follow-up|1|||
145950549|NCT04424914|526330445|FG000|Overall Study|Death|3|||
145950550|NCT04424914|526330446|FG001|Overall Study|Death|1|||
145950551|NCT04424914|526330447|FG002|Overall Study|Death|0|||
145950552|NCT02791438|526330448|FG000|Treatment Period|Adverse Event|1|||
145950553|NCT02791438|526330449|FG001|Treatment Period|Adverse Event|0|||
145950554|NCT02791438|526330448|FG000|Treatment Period|Withdrawal by Subject|0|||
145950555|NCT02791438|526330449|FG001|Treatment Period|Withdrawal by Subject|1|||
145950556|NCT02791438|526330448|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
145950557|NCT02791438|526330449|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
145950558|NCT02669667|526330450|FG000|Overall Study|Lost to Follow-up|0|||
145950559|NCT02669667|526330451|FG001|Overall Study|Lost to Follow-up|0|||
145950560|NCT02669667|526330452|FG002|Overall Study|Lost to Follow-up|0|||
145950561|NCT02669667|526330453|FG003|Overall Study|Lost to Follow-up|0|||
145950562|NCT02669667|526330454|FG004|Overall Study|Lost to Follow-up|0|||
146431007|NCT01363765|528086650|FG001|Overall Study|duplicate records|3177|||
146431008|NCT01363765|528086649|FG000|Overall Study|non-resident|156|||
145950563|NCT02669667|526330455|FG005|Overall Study|Lost to Follow-up|1|||
145950564|NCT02669667|526330456|FG006|Overall Study|Lost to Follow-up|0|||
145950565|NCT01215435|526330457|FG000|Overall Study|Adverse Event|1|||
145950566|NCT01215435|526330458|FG001|Overall Study|Adverse Event|0|||
145950567|NCT01215435|526330457|FG000|Overall Study|Protocol Violation|2|||
145950568|NCT01215435|526330458|FG001|Overall Study|Protocol Violation|0|||
145950569|NCT01215435|526330457|FG000|Overall Study|Withdrawal Criteria|8|||
145950570|NCT01215435|526330458|FG001|Overall Study|Withdrawal Criteria|11|||
145950571|NCT01215435|526330457|FG000|Overall Study|Lost to Follow-up|3|||
145950572|NCT01215435|526330458|FG001|Overall Study|Lost to Follow-up|0|||
145950573|NCT01215435|526330457|FG000|Overall Study|Unclassified|5|||
145950574|NCT01215435|526330458|FG001|Overall Study|Unclassified|5|||
145950575|NCT00840034|526330459|FG000|Acute Treatment Phase|Adverse Event|6|||
145950576|NCT00840034|526330460|FG001|Acute Treatment Phase|Adverse Event|8|||
145950577|NCT00840034|526330459|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
146431009|NCT01363765|528086650|FG001|Overall Study|non-resident|76|||
146431010|NCT01363765|528086649|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
145950578|NCT00840034|526330460|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
145950579|NCT00840034|526330459|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
145950580|NCT00840034|526330460|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
145950581|NCT00840034|526330459|FG000|Acute Treatment Phase|Physician Decision|0|||
145950582|NCT00840034|526330460|FG001|Acute Treatment Phase|Physician Decision|1|||
145950583|NCT00840034|526330459|FG000|Acute Treatment Phase|Protocol Violation|2|||
145950584|NCT00840034|526330460|FG001|Acute Treatment Phase|Protocol Violation|4|||
145950585|NCT00840034|526330459|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
145950586|NCT00840034|526330460|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
145950587|NCT00840034|526330459|FG000|Taper Phase|Adverse Event|1|||
145950588|NCT00840034|526330460|FG001|Taper Phase|Adverse Event|0|||
145950589|NCT00840034|526330459|FG000|Taper Phase|Lost to Follow-up|1|||
145950590|NCT00840034|526330460|FG001|Taper Phase|Lost to Follow-up|1|||
145950591|NCT00840034|526330459|FG000|Taper Phase|Withdrawal by Subject|1|||
145950592|NCT00840034|526330460|FG001|Taper Phase|Withdrawal by Subject|1|||
145950593|NCT01156051|526330473|FG000|Overall Study|Lost to Follow-up|1|||
145950594|NCT01156051|526330474|FG001|Overall Study|Lost to Follow-up|0|||
145950595|NCT01156051|526330473|FG000|Overall Study|patient not compliant with protocol|0|||
145950596|NCT01156051|526330474|FG001|Overall Study|patient not compliant with protocol|1|||
145950597|NCT00793546|526330477|FG000|Overall Study|Death|3|||
145950598|NCT00793546|526330478|FG001|Overall Study|Death|0|||
145950599|NCT00793546|526330477|FG000|Overall Study|Lost to Follow-up|1|||
145950600|NCT00793546|526330478|FG001|Overall Study|Lost to Follow-up|0|||
145950601|NCT00793546|526330477|FG000|Overall Study|Withdrawal by Subject|1|||
145950602|NCT00793546|526330478|FG001|Overall Study|Withdrawal by Subject|1|||
145950603|NCT00793546|526330477|FG000|Overall Study|Study Terminated by Sponsor|8|||
145950604|NCT00793546|526330478|FG001|Overall Study|Study Terminated by Sponsor|27|||
145950605|NCT00793546|526330477|FG000|Overall Study|Other|1|||
145950606|NCT00793546|526330478|FG001|Overall Study|Other|0|||
145950607|NCT02101359|526330479|FG000|Overall Study|Not included|23|||
145950608|NCT02101359|526330480|FG001|Overall Study|Not included|13|||
145950609|NCT02101359|526330479|FG000|Overall Study|Withdrawal by Subject|5|||
145950610|NCT02101359|526330480|FG001|Overall Study|Withdrawal by Subject|4|||
145950611|NCT02101359|526330479|FG000|Overall Study|Lost to Follow-up|1|||
145950612|NCT02101359|526330480|FG001|Overall Study|Lost to Follow-up|0|||
145950613|NCT02101359|526330479|FG000|Overall Study|Protocol Violation|0|||
145950614|NCT02101359|526330480|FG001|Overall Study|Protocol Violation|2|||
145950615|NCT00742027|526330481|FG000|Overall Study|Disease Progression|76|||
145950616|NCT00742027|526330481|FG000|Overall Study|New Cancer Therapy|19|||
145950617|NCT00742027|526330481|FG000|Overall Study|Withdrawal by Subject|18|||
145950618|NCT00742027|526330481|FG000|Overall Study|Death|7|||
145950619|NCT00742027|526330481|FG000|Overall Study|Lost to Follow-up|4|||
145950620|NCT00742027|526330481|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
145950621|NCT00742027|526330481|FG000|Overall Study|Missing|2|||
145950622|NCT00742027|526330481|FG000|Overall Study|Administrative Problems|1|||
145950623|NCT01994902|526330482|FG000|Test Period 1|Withdrawal by Subject|3|||
145950624|NCT01994902|526330483|FG001|Test Period 1|Withdrawal by Subject|0|||
145950625|NCT01994902|526330482|FG000|Test Period 1|device deficiency with adverse event|0|||
145950626|NCT01994902|526330483|FG001|Test Period 1|device deficiency with adverse event|1|||
145950627|NCT01994902|526330482|FG000|Test Period 1|Adverse Event|2|||
145950628|NCT01994902|526330483|FG001|Test Period 1|Adverse Event|1|||
145950629|NCT01994902|526330482|FG000|Test Period 1|Lack of Efficacy|0|||
145950630|NCT01994902|526330483|FG001|Test Period 1|Lack of Efficacy|1|||
145950631|NCT01994902|526330482|FG000|Test Period 1|bag too small|1|||
145950632|NCT01994902|526330483|FG001|Test Period 1|bag too small|0|||
145950633|NCT01994902|526330482|FG000|Test Period 2|Withdrawal by Subject|0|||
145950634|NCT01994902|526330483|FG001|Test Period 2|Withdrawal by Subject|2|||
145950635|NCT01994902|526330482|FG000|Test Period 2|Lack of Efficacy|0|||
145950636|NCT01994902|526330483|FG001|Test Period 2|Lack of Efficacy|1|||
145950637|NCT01994902|526330482|FG000|Test Period 2|Other|0|||
145950638|NCT01994902|526330483|FG001|Test Period 2|Other|3|||
145950639|NCT01180049|526330484|FG000|Overall Study|Other|9|||
146082885|NCT02616146|526824697|FG001|Overall Study|Non-compliance with study drug|2|||
145950640|NCT01180049|526330485|FG001|Overall Study|Other|7|||
145950641|NCT01180049|526330484|FG000|Overall Study|Lost to Follow-up|8|||
145950642|NCT01180049|526330485|FG001|Overall Study|Lost to Follow-up|6|||
145950643|NCT01180049|526330484|FG000|Overall Study|Death|36|||
145950644|NCT01180049|526330485|FG001|Overall Study|Death|35|||
145950645|NCT01738191|526330486|FG000|Overall Study|Withdrawal by Subject|4|||
145950646|NCT01738191|526330487|FG001|Overall Study|Withdrawal by Subject|1|||
146082886|NCT02616146|526824696|FG000|Overall Study|Pregnancy|2|||
145950647|NCT02483572|526330488|FG000|Overall Study|Withdrawal by Subject|1|||
145950648|NCT02483572|526330489|FG001|Overall Study|Withdrawal by Subject|0|||
145950649|NCT02483572|526330488|FG000|Overall Study|Lost to Follow-up|1|||
145950650|NCT02483572|526330489|FG001|Overall Study|Lost to Follow-up|0|||
145950651|NCT02483572|526330488|FG000|Overall Study|Physician Decision|0|||
145950652|NCT02483572|526330489|FG001|Overall Study|Physician Decision|1|||
145950653|NCT00350779|526330493|FG000|Overall Study|Adverse Event|4|||
145950654|NCT00350779|526330494|FG001|Overall Study|Adverse Event|2|||
145950655|NCT00350779|526330493|FG000|Overall Study|Lack of Efficacy|0|||
145950656|NCT00350779|526330494|FG001|Overall Study|Lack of Efficacy|4|||
145950657|NCT00350779|526330493|FG000|Overall Study|Lost to Follow-up|2|||
145950658|NCT00350779|526330494|FG001|Overall Study|Lost to Follow-up|0|||
145950659|NCT00350779|526330493|FG000|Overall Study|Physician Decision|2|||
145950660|NCT00350779|526330494|FG001|Overall Study|Physician Decision|4|||
145950661|NCT00350779|526330493|FG000|Overall Study|Protocol Violation|3|||
145950662|NCT00350779|526330494|FG001|Overall Study|Protocol Violation|1|||
145950663|NCT00350779|526330493|FG000|Overall Study|Withdrawal by Subject|9|||
145950664|NCT00350779|526330494|FG001|Overall Study|Withdrawal by Subject|8|||
145950665|NCT00350779|526330493|FG000|Overall Study|Patient Moved|2|||
145950666|NCT00350779|526330494|FG001|Overall Study|Patient Moved|1|||
145950667|NCT00350779|526330493|FG000|Overall Study|Non-compliance with study procedures|0|||
145950668|NCT00350779|526330494|FG001|Overall Study|Non-compliance with study procedures|1|||
145950669|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
145950670|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950671|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950672|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950673|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950674|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950675|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950676|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950677|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145950678|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145950679|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
145950680|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
145950681|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
145950682|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145950683|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
145950684|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
145950685|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145950686|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145950687|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
145950688|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
145950689|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
145950690|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
145950691|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
145950692|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
145950693|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
145950694|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
145950695|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
145950696|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
145950697|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
145950698|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
145950699|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145950700|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145950701|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
145950702|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
146431011|NCT01363765|528086650|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
145950703|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145950704|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
145950705|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950706|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950707|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950708|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
145950709|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950710|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
145950711|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950712|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950713|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145950714|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145950715|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950716|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145950717|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950718|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950719|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145950720|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950721|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950722|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145950723|NCT00528372|526330495|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
145950724|NCT00528372|526330496|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950725|NCT00528372|526330497|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950726|NCT00528372|526330498|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
145950727|NCT00528372|526330499|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950728|NCT00528372|526330500|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950729|NCT00528372|526330501|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950730|NCT00528372|526330502|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
145950731|NCT00528372|526330503|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145950732|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
145950733|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
145950734|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
145950735|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145950736|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145950737|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145950738|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
145950739|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
145950740|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
145950741|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
145950742|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
145950743|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
145950744|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145950745|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
145950746|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
145950747|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
145950748|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145950749|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145950750|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
145950751|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
145950752|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
145950753|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
145950754|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
145950755|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
145950756|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
145950757|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
145950758|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
145950759|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
145950760|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
145950761|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145950762|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145950763|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
145950764|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
145950765|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
145950766|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
145950767|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145950768|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145950769|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145950770|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145950771|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145950772|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145950773|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
146082887|NCT02616146|526824697|FG001|Overall Study|Pregnancy|2|||
146203094|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146203095|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146203096|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146203097|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
146203098|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
146203099|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146203100|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146431012|NCT01363765|528086649|FG000|Overall Study|smear during intervention|2170|||
146431013|NCT01363765|528086650|FG001|Overall Study|smear during intervention|0|||
146431014|NCT02682784|528086658|FG000|Overall Study|Withdrawal by Subject|0|||
146203101|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146203102|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
146431015|NCT02682784|528086659|FG001|Overall Study|Withdrawal by Subject|2|||
146431016|NCT02682784|528086660|FG002|Overall Study|Withdrawal by Subject|1|||
146431017|NCT02682784|528086661|FG003|Overall Study|Withdrawal by Subject|2|||
146431018|NCT02682784|528086658|FG000|Overall Study|Physician Decision|1|||
146431019|NCT02682784|528086659|FG001|Overall Study|Physician Decision|0|||
146431020|NCT02682784|528086660|FG002|Overall Study|Physician Decision|1|||
146431021|NCT02682784|528086661|FG003|Overall Study|Physician Decision|1|||
146431022|NCT01702987|528086662|FG000|Overall Study|Withdrawal by Subject|1|||
146431023|NCT01702987|528086663|FG001|Overall Study|Withdrawal by Subject|0|||
146431024|NCT02017223|528086664|FG000|Overall Study|Algorithm problems|2|||
146431025|NCT01401647|528086665|FG000|Overall Study|Withdrawal by Subject|1|||
146203103|NCT02709655|527255615|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
146203104|NCT02709655|527255616|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146431026|NCT01401647|528086666|FG001|Overall Study|Withdrawal by Subject|5|||
146203105|NCT02709655|527255617|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146203106|NCT02709655|527255618|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146082888|NCT02616146|526824696|FG000|Overall Study|Pregnancy wish|3|||
146082889|NCT02616146|526824697|FG001|Overall Study|Pregnancy wish|0|||
146203107|NCT02709655|527255619|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
146431027|NCT01401647|528086667|FG002|Overall Study|Withdrawal by Subject|2|||
146431028|NCT01401647|528086665|FG000|Overall Study|Lost to Follow-up|3|||
146431029|NCT01401647|528086666|FG001|Overall Study|Lost to Follow-up|3|||
146431030|NCT01401647|528086667|FG002|Overall Study|Lost to Follow-up|1|||
146431031|NCT00365846|528086672|FG000|Overall Study|Lost to Follow-up|1|||
146203108|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
146203109|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
146203110|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
146203111|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
146203112|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
146203113|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146203114|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
146203115|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146203116|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
146203117|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
146203118|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
146203119|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
146203120|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
146203121|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
146203122|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
146203123|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146203124|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
146203125|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146203126|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146203127|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
146203128|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
146203129|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146203130|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146203131|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
146203132|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
146203133|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146203134|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
146203135|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146203136|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
146203137|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
146203138|NCT02709655|527255615|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
146203139|NCT02709655|527255616|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
146203140|NCT02709655|527255617|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
146203141|NCT02709655|527255618|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
146203142|NCT02709655|527255619|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
146203143|NCT03779048|527256719|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
146203144|NCT03779048|527256720|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
146203145|NCT03779048|527256721|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
146203146|NCT03779048|527256719|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
146203147|NCT03779048|527256720|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
146203148|NCT03779048|527256721|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
146203149|NCT03779048|527256719|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
146203150|NCT03779048|527256720|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
146203151|NCT03779048|527256721|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
146203152|NCT03762668|527256722|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
146203153|NCT03762668|527256723|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
146203154|NCT00686855|527256724|FG000|Overall Study|Lost to Follow-up|1|||
146203155|NCT00686855|527256725|FG001|Overall Study|Lost to Follow-up|0|||
146203156|NCT00686855|527256724|FG000|Overall Study|Progressive GVHD|0|||
146203157|NCT00686855|527256725|FG001|Overall Study|Progressive GVHD|1|||
146203158|NCT05876949|527256728|FG000|Overall Study|Withdrawal by Subject|1|||
146203159|NCT05876949|527256729|FG001|Overall Study|Withdrawal by Subject|3|||
146203160|NCT05876949|527256728|FG000|Overall Study|Physician Decision|0|||
146203161|NCT05876949|527256729|FG001|Overall Study|Physician Decision|2|||
146203162|NCT05876949|527256728|FG000|Overall Study|Death|0|||
146203163|NCT05876949|527256729|FG001|Overall Study|Death|1|||
146203164|NCT02613871|527256736|FG000|Overall Study|Death|2|||
146203165|NCT02613871|527256736|FG000|Overall Study|Withdrew Consent|1|||
146203166|NCT01786564|527256737|FG000|Overall Study|Lost to Follow-up|47|||
146203167|NCT01786564|527256737|FG000|Overall Study|Ineligible|17|||
146203168|NCT00494442|527256738|FG000|Overall Study|Death|1|||
146203169|NCT00494442|527256739|FG001|Overall Study|Death|1|||
146203170|NCT00494442|527256738|FG000|Overall Study|Lack of Efficacy|16|||
146203171|NCT00494442|527256739|FG001|Overall Study|Lack of Efficacy|10|||
146203172|NCT00494442|527256738|FG000|Overall Study|Adverse Event|0|||
146203173|NCT00494442|527256739|FG001|Overall Study|Adverse Event|2|||
146203174|NCT00494442|527256738|FG000|Overall Study|Physician Decision|0|||
146203175|NCT00494442|527256739|FG001|Overall Study|Physician Decision|1|||
146203176|NCT00494442|527256738|FG000|Overall Study|Non-compliance|0|||
146203177|NCT00494442|527256739|FG001|Overall Study|Non-compliance|1|||
146203178|NCT00494442|527256738|FG000|Overall Study|Intercurrent illness|0|||
146431032|NCT02057458|528086677|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
146431033|NCT02057458|528086678|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
146431034|NCT02057458|528086679|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
146431035|NCT02057458|528086677|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
146431036|NCT02057458|528086678|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
146431037|NCT02057458|528086679|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
146431038|NCT02057458|528086677|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
146431039|NCT02057458|528086678|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
146431040|NCT02057458|528086679|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
146431041|NCT04263649|528086680|FG000|Overall Study|Adverse Event|53|||
146431042|NCT04263649|528086680|FG000|Overall Study|Lost to Follow-up|3|||
146431043|NCT04263649|528086680|FG000|Overall Study|Death|29|||
146431044|NCT04263649|528086680|FG000|Overall Study|Device deficiency|19|||
146431045|NCT04263649|528086680|FG000|Overall Study|other reasons|11|||
146431046|NCT05169710|528086684|FG000|Overall Study|Adverse Event|1|||
146431047|NCT05169710|528086685|FG001|Overall Study|Adverse Event|2|||
146431048|NCT05169710|528086686|FG002|Overall Study|Adverse Event|2|||
145950774|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145950775|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145950776|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145950777|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950778|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950779|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950780|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950781|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
145950782|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
145950783|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950784|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950785|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145950786|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950787|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145950788|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950789|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950790|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950791|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950792|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145950793|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145950794|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145950795|NCT00528372|526330495|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145950796|NCT00528372|526330496|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145950797|NCT00528372|526330497|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
145950798|NCT00528372|526330498|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145950799|NCT00528372|526330499|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
145950800|NCT00528372|526330500|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
145950801|NCT00528372|526330501|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
145950802|NCT00528372|526330502|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
145950803|NCT00528372|526330503|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
145950804|NCT02432144|526330508|FG000|Overall Study|Participant Non-Compliance|1|||
145950805|NCT01483599|526330509|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
145950806|NCT01483599|526330510|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950807|NCT01483599|526330511|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950808|NCT01483599|526330512|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
145950809|NCT01483599|526330513|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
145950810|NCT01483599|526330514|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
146203179|NCT00494442|527256739|FG001|Overall Study|Intercurrent illness|1|||
146203180|NCT01241292|527256742|FG000|Overall Study|Administrative Reason by Sponsor|1|||
146203181|NCT01241292|527256743|FG001|Overall Study|Administrative Reason by Sponsor|0|||
146203182|NCT01241292|527256742|FG000|Overall Study|Disease Progression|2|||
146203183|NCT01241292|527256743|FG001|Overall Study|Disease Progression|0|||
146431049|NCT05169710|528086684|FG000|Overall Study|Lost to Follow-up|0|||
146431050|NCT05169710|528086685|FG001|Overall Study|Lost to Follow-up|0|||
146431051|NCT05169710|528086686|FG002|Overall Study|Lost to Follow-up|1|||
146431052|NCT05169710|528086684|FG000|Overall Study|Withdrawal by Subject|2|||
146431053|NCT05169710|528086685|FG001|Overall Study|Withdrawal by Subject|1|||
146431054|NCT05169710|528086686|FG002|Overall Study|Withdrawal by Subject|0|||
146431055|NCT05169710|528086684|FG000|Overall Study|Other Study Discontinuation Reason|0|||
146431056|NCT05169710|528086685|FG001|Overall Study|Other Study Discontinuation Reason|2|||
146431057|NCT05169710|528086686|FG002|Overall Study|Other Study Discontinuation Reason|0|||
146431058|NCT04400890|528086687|FG000|Overall Study|Withdrawal by Subject|3|||
146431059|NCT04400890|528086688|FG001|Overall Study|Withdrawal by Subject|2|||
146431060|NCT00846495|528086693|FG000|Overall Study|Lost to Follow-up|1|||
146431061|NCT00846495|528086694|FG001|Overall Study|Lost to Follow-up|0|||
146203184|NCT01241292|527256742|FG000|Overall Study|Study Drug Toxicity|0|||
146203185|NCT01241292|527256743|FG001|Overall Study|Study Drug Toxicity|1|||
146431062|NCT00846495|528086693|FG000|Overall Study|Adverse Event|5|||
146431063|NCT00846495|528086694|FG001|Overall Study|Adverse Event|1|||
146203186|NCT01241292|527256742|FG000|Overall Study|Participant Discontinued Treatment|0|||
146203187|NCT01241292|527256743|FG001|Overall Study|Participant Discontinued Treatment|2|||
146203188|NCT03034915|527256746|FG000|Overall Study|Adverse Event|29|||
146203189|NCT03034915|527256747|FG001|Overall Study|Adverse Event|32|||
146203190|NCT03034915|527256748|FG002|Overall Study|Adverse Event|22|||
146203191|NCT03034915|527256746|FG000|Overall Study|Lost to Follow-up|5|||
146203192|NCT03034915|527256747|FG001|Overall Study|Lost to Follow-up|13|||
146203193|NCT03034915|527256748|FG002|Overall Study|Lost to Follow-up|3|||
146203194|NCT03034915|527256746|FG000|Overall Study|Withdrawal by Subject|29|||
146203195|NCT03034915|527256747|FG001|Overall Study|Withdrawal by Subject|46|||
146203196|NCT03034915|527256748|FG002|Overall Study|Withdrawal by Subject|41|||
146203197|NCT03034915|527256746|FG000|Overall Study|Protocol Deviation|2|||
146203198|NCT03034915|527256747|FG001|Overall Study|Protocol Deviation|14|||
146203199|NCT03034915|527256748|FG002|Overall Study|Protocol Deviation|7|||
146203200|NCT03034915|527256746|FG000|Overall Study|Lack of Efficacy|8|||
146203201|NCT03034915|527256747|FG001|Overall Study|Lack of Efficacy|16|||
146203202|NCT03034915|527256748|FG002|Overall Study|Lack of Efficacy|18|||
146203203|NCT03034915|527256746|FG000|Overall Study|Site closed|2|||
146203204|NCT03034915|527256747|FG001|Overall Study|Site closed|2|||
146203205|NCT03034915|527256748|FG002|Overall Study|Site closed|4|||
146203206|NCT03034915|527256746|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
146203207|NCT03034915|527256747|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
146203208|NCT03034915|527256748|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
146203209|NCT03034915|527256746|FG000|Overall Study|Physician Decision|1|||
146203210|NCT03034915|527256747|FG001|Overall Study|Physician Decision|5|||
146203211|NCT03034915|527256748|FG002|Overall Study|Physician Decision|2|||
146203212|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
146203213|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146203214|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146203215|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
146203216|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
146203217|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146203218|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146203219|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
146203220|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
146203221|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146203222|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146203223|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
146203224|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
146203225|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146203226|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146203227|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
146203228|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
146203229|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
146203230|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
146203231|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
146082890|NCT02616146|526824696|FG000|Overall Study|Protocol Violation|6|||
146203232|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
146203233|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146203234|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146203235|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
146203236|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
146431064|NCT00846495|528086693|FG000|Overall Study|Lack of Efficacy|1|||
146431065|NCT00846495|528086694|FG001|Overall Study|Lack of Efficacy|2|||
146203237|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146203238|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146431066|NCT00846495|528086693|FG000|Overall Study|Physician Decision|1|||
146431067|NCT00846495|528086694|FG001|Overall Study|Physician Decision|0|||
146203239|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
146431068|NCT01265056|528086695|FG000|Initial Study Period|Withdrawal by Subject|1|||
146431069|NCT01265056|528086696|FG001|Initial Study Period|Withdrawal by Subject|1|||
146431070|NCT01265056|528086695|FG000|Initial Study Period|Withdrawal by Subject|1|||
146203240|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
146203241|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146203242|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146203243|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
146431071|NCT01265056|528086696|FG001|Initial Study Period|Withdrawal by Subject|1|||
146431072|NCT01265056|528086695|FG000|Follow up|Lost to Follow-up|7|||
146431073|NCT01265056|528086696|FG001|Follow up|Lost to Follow-up|3|||
146431074|NCT00537979|528086702|FG000|Overall Study|Adverse Event|2|||
146431075|NCT00537979|528086703|FG001|Overall Study|Adverse Event|2|||
146203244|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
146203245|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146431076|NCT00537979|528086702|FG000|Overall Study|Withdrawal by Subject|1|||
146431077|NCT00537979|528086703|FG001|Overall Study|Withdrawal by Subject|4|||
146431078|NCT00537979|528086702|FG000|Overall Study|Lost to Follow-up|1|||
146431079|NCT00537979|528086703|FG001|Overall Study|Lost to Follow-up|4|||
146431080|NCT00537979|528086702|FG000|Overall Study|Lack of Efficacy|0|||
146431081|NCT00537979|528086703|FG001|Overall Study|Lack of Efficacy|1|||
146203246|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146203247|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
146431082|NCT00537979|528086702|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
146431083|NCT00537979|528086703|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
146431084|NCT00537979|528086702|FG000|Overall Study|Death|0|||
146431085|NCT00537979|528086703|FG001|Overall Study|Death|3|||
146203248|NCT03593213|527256749|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
146203249|NCT03593213|527256750|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146203250|NCT03593213|527256751|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146203251|NCT03593213|527256752|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
146203252|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
146203253|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
146203254|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
146203255|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
146431086|NCT00537979|528086702|FG000|Overall Study|Kidney transplant|0|||
146431087|NCT00537979|528086703|FG001|Overall Study|Kidney transplant|3|||
146203256|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
146203257|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
146203258|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
146203259|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
146203260|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
146203261|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
146203262|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
146203263|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
146203264|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
146203265|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
146203266|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
146203267|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
146203268|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146203269|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146203270|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
146203271|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
146203272|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
146203273|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
146203274|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
146203275|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
146203276|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
146203277|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
146203278|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
146203279|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
146203280|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
146203281|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
146203282|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
146203283|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
146203284|NCT03593213|527256749|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
146203285|NCT03593213|527256750|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
146203286|NCT03593213|527256751|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
146203287|NCT03593213|527256752|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
146203288|NCT01831791|527256753|FG000|Overall Study|Withdrawal by Subject|10|||
146203289|NCT00494780|527256754|FG000|Overall Study|Adverse Event|1|||
146203290|NCT00494780|527256755|FG001|Overall Study|Adverse Event|0|||
146203291|NCT00494780|527256754|FG000|Overall Study|Withdrew before Dosed|0|||
146203292|NCT00494780|527256755|FG001|Overall Study|Withdrew before Dosed|1|||
146203293|NCT00494780|527256754|FG000|Overall Study|Progression of Study Disease|7|||
146203294|NCT00494780|527256755|FG001|Overall Study|Progression of Study Disease|8|||
146203295|NCT00494780|527256754|FG000|Overall Study|New Treatment|2|||
146203296|NCT00494780|527256755|FG001|Overall Study|New Treatment|2|||
146203297|NCT00494780|527256754|FG000|Overall Study|Non-compliance|1|||
146203298|NCT00494780|527256755|FG001|Overall Study|Non-compliance|0|||
146203299|NCT00494780|527256754|FG000|Overall Study|Residual Tumour Mass|0|||
146203300|NCT00494780|527256755|FG001|Overall Study|Residual Tumour Mass|1|||
146203301|NCT00494780|527256754|FG000|Overall Study|Insurance Issues|0|||
146203302|NCT00494780|527256755|FG001|Overall Study|Insurance Issues|1|||
146203303|NCT01190007|527256756|FG000|Overall Study|Withdrawal by Subject|4|||
146203304|NCT01190007|527256756|FG000|Overall Study|Adverse Event|8|||
146203305|NCT01190007|527256756|FG000|Overall Study|Difficulty of visit for complications|1|||
146203306|NCT01190007|527256756|FG000|Overall Study|Participant was arrested|1|||
146203307|NCT01254019|527256757|FG000|Overall Study|Adverse Event|0|||
146203308|NCT01254019|527256758|FG001|Overall Study|Adverse Event|2|||
146203309|NCT01254019|527256757|FG000|Overall Study|Protocol Violation|1|||
146203310|NCT01254019|527256758|FG001|Overall Study|Protocol Violation|0|||
146203311|NCT01254019|527256757|FG000|Overall Study|Withdrawal by Subject|0|||
146203312|NCT01254019|527256758|FG001|Overall Study|Withdrawal by Subject|2|||
146203313|NCT03061474|527256759|FG000|Overall Study|Adverse Event|2|||
146203314|NCT03061474|527256760|FG001|Overall Study|Adverse Event|0|||
146203315|NCT03061474|527256759|FG000|Overall Study|Safety Risk|0|||
146203316|NCT03061474|527256760|FG001|Overall Study|Safety Risk|1|||
146203317|NCT03061474|527256759|FG000|Overall Study|Participant unwilling or unable to participate|0|||
146203318|NCT03061474|527256760|FG001|Overall Study|Participant unwilling or unable to participate|2|||
146203319|NCT03061474|527256759|FG000|Overall Study|Lost to Follow-up|0|||
146203320|NCT03061474|527256760|FG001|Overall Study|Lost to Follow-up|1|||
146203321|NCT01391130|527256763|FG000|Overall Study|Withdrawal by Subject|3|||
146203322|NCT01391130|527256764|FG001|Overall Study|Withdrawal by Subject|2|||
146203323|NCT01391130|527256763|FG000|Overall Study|Physician Decision|2|||
146203324|NCT01391130|527256764|FG001|Overall Study|Physician Decision|3|||
146203325|NCT01391130|527256763|FG000|Overall Study|Did not Receive Drug|1|||
146203326|NCT01391130|527256764|FG001|Overall Study|Did not Receive Drug|1|||
146203327|NCT00189202|527256765|FG000|Overall Study|Physician Decision|5|||
146203328|NCT00545077|527256766|FG000|Overall Study|Treatment not received|5|||
146203329|NCT00545077|527256767|FG001|Overall Study|Treatment not received|1|||
146203330|NCT00545077|527256766|FG000|Overall Study|Disease Progression|131|||
146203331|NCT00545077|527256767|FG001|Overall Study|Disease Progression|98|||
146203332|NCT00545077|527256766|FG000|Overall Study|Withdrawal by Subject|3|||
146203333|NCT00545077|527256767|FG001|Overall Study|Withdrawal by Subject|14|||
146203334|NCT00545077|527256766|FG000|Overall Study|Physician Decision|6|||
146203335|NCT00545077|527256767|FG001|Overall Study|Physician Decision|3|||
146203336|NCT00545077|527256766|FG000|Overall Study|Lost to Follow-up|2|||
146203337|NCT00545077|527256767|FG001|Overall Study|Lost to Follow-up|0|||
146203338|NCT00545077|527256766|FG000|Overall Study|Protocol Violation|1|||
146203339|NCT00545077|527256767|FG001|Overall Study|Protocol Violation|0|||
146203340|NCT00545077|527256766|FG000|Overall Study|Adverse Event|0|||
146203341|NCT00545077|527256767|FG001|Overall Study|Adverse Event|31|||
146203342|NCT00545077|527256766|FG000|Overall Study|Death|0|||
146203343|NCT00545077|527256767|FG001|Overall Study|Death|8|||
146203344|NCT03260140|527256768|FG000|Overall Study|Death|4|||
146203345|NCT03260140|527256769|FG001|Overall Study|Death|1|||
146203346|NCT03260140|527256768|FG000|Overall Study|Withdrawal by Subject|1|||
146203347|NCT03260140|527256769|FG001|Overall Study|Withdrawal by Subject|4|||
146203348|NCT05283395|527256772|FG000|Overall Study|Adverse Event|4|||
146203349|NCT05283395|527256773|FG001|Overall Study|Adverse Event|4|||
146203350|NCT05283395|527256774|FG002|Overall Study|Adverse Event|0|||
146203351|NCT05283395|527256772|FG000|Overall Study|Patient Lost to Follow-Up|0|||
146203352|NCT05283395|527256773|FG001|Overall Study|Patient Lost to Follow-Up|0|||
146203353|NCT05283395|527256774|FG002|Overall Study|Patient Lost to Follow-Up|1|||
146203354|NCT05283395|527256772|FG000|Overall Study|Patient Withdrawal|2|||
146203355|NCT05283395|527256773|FG001|Overall Study|Patient Withdrawal|4|||
146203356|NCT05283395|527256774|FG002|Overall Study|Patient Withdrawal|2|||
146203357|NCT05283395|527256772|FG000|Overall Study|Investigator Decision|1|||
146203358|NCT05283395|527256773|FG001|Overall Study|Investigator Decision|0|||
146203359|NCT05283395|527256774|FG002|Overall Study|Investigator Decision|1|||
146203360|NCT05283395|527256772|FG000|Overall Study|Enrolled in error|0|||
146203361|NCT05283395|527256773|FG001|Overall Study|Enrolled in error|0|||
146203362|NCT05283395|527256774|FG002|Overall Study|Enrolled in error|1|||
146203363|NCT01063972|527256775|FG000|Overall Study|Death|12|||
146203364|NCT01063972|527256776|FG001|Overall Study|Death|11|||
146203365|NCT01063972|527256775|FG000|Overall Study|Incarcerated|2|||
146203366|NCT01063972|527256776|FG001|Overall Study|Incarcerated|1|||
146203367|NCT00712335|527256777|FG000|Overall Study|Withdrawal by Subject|0|||
146203368|NCT00712335|527256778|FG001|Overall Study|Withdrawal by Subject|7|||
146203369|NCT00712335|527256779|FG002|Overall Study|Withdrawal by Subject|2|||
146203370|NCT00712335|527256780|FG003|Overall Study|Withdrawal by Subject|3|||
146203371|NCT00712335|527256781|FG004|Overall Study|Withdrawal by Subject|0|||
146203372|NCT00712335|527256777|FG000|Overall Study|Lost to Follow-up|2|||
146203373|NCT00712335|527256778|FG001|Overall Study|Lost to Follow-up|5|||
146203374|NCT00712335|527256779|FG002|Overall Study|Lost to Follow-up|0|||
146203375|NCT00712335|527256780|FG003|Overall Study|Lost to Follow-up|1|||
146203376|NCT00712335|527256781|FG004|Overall Study|Lost to Follow-up|0|||
146203377|NCT00712335|527256777|FG000|Overall Study|Protocol Violation|1|||
146203378|NCT00712335|527256778|FG001|Overall Study|Protocol Violation|2|||
146203379|NCT00712335|527256779|FG002|Overall Study|Protocol Violation|1|||
146203380|NCT00712335|527256780|FG003|Overall Study|Protocol Violation|0|||
146203381|NCT00712335|527256781|FG004|Overall Study|Protocol Violation|0|||
146203382|NCT00712335|527256777|FG000|Overall Study|Lack of Efficacy|0|||
146203383|NCT00712335|527256778|FG001|Overall Study|Lack of Efficacy|0|||
146203384|NCT00712335|527256779|FG002|Overall Study|Lack of Efficacy|1|||
146203385|NCT00712335|527256780|FG003|Overall Study|Lack of Efficacy|1|||
146203386|NCT00712335|527256781|FG004|Overall Study|Lack of Efficacy|0|||
146203387|NCT00712335|527256777|FG000|Overall Study|Other Reason|0|||
146203388|NCT00712335|527256778|FG001|Overall Study|Other Reason|3|||
146203389|NCT00712335|527256779|FG002|Overall Study|Other Reason|1|||
146203390|NCT00712335|527256780|FG003|Overall Study|Other Reason|0|||
146203391|NCT00712335|527256781|FG004|Overall Study|Other Reason|0|||
146203392|NCT03401112|527256782|FG000|Overall Study|Adverse Event|1|||
146203393|NCT03401112|527256783|FG001|Overall Study|Adverse Event|2|||
146203394|NCT03401112|527256784|FG002|Overall Study|Adverse Event|3|||
146431088|NCT00537979|528086702|FG000|Overall Study|Heart failure|0|||
146431089|NCT00537979|528086703|FG001|Overall Study|Heart failure|1|||
146431090|NCT02601560|528086704|FG000|Overall Study|Other|0|||
146431091|NCT02601560|528086705|FG001|Overall Study|Other|0|||
146431092|NCT02601560|528086706|FG002|Overall Study|Other|0|||
146431093|NCT02601560|528086707|FG003|Overall Study|Other|0|||
146203395|NCT03401112|527256785|FG003|Overall Study|Adverse Event|2|||
146203396|NCT03401112|527256786|FG004|Overall Study|Adverse Event|0|||
146203397|NCT03401112|527256782|FG000|Overall Study|Lost to Follow-up|1|||
146203398|NCT03401112|527256783|FG001|Overall Study|Lost to Follow-up|0|||
146082891|NCT02616146|526824697|FG001|Overall Study|Protocol Violation|3|||
146082892|NCT02616146|526824696|FG000|Overall Study|Study terminated by sponsor|1372|||
146203399|NCT03401112|527256784|FG002|Overall Study|Lost to Follow-up|0|||
146203400|NCT03401112|527256785|FG003|Overall Study|Lost to Follow-up|0|||
146203401|NCT03401112|527256786|FG004|Overall Study|Lost to Follow-up|0|||
146203402|NCT03401112|527256782|FG000|Overall Study|Noncompliance|1|||
146203403|NCT03401112|527256783|FG001|Overall Study|Noncompliance|2|||
146203404|NCT03401112|527256784|FG002|Overall Study|Noncompliance|3|||
146203405|NCT03401112|527256785|FG003|Overall Study|Noncompliance|0|||
146203406|NCT03401112|527256786|FG004|Overall Study|Noncompliance|0|||
146203407|NCT03401112|527256782|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
146203408|NCT03401112|527256783|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
146203409|NCT03401112|527256784|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
146203410|NCT03401112|527256785|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
146203411|NCT03401112|527256786|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
146203412|NCT03401112|527256782|FG000|Overall Study|Withdrawal by Subject|0|||
146203413|NCT03401112|527256783|FG001|Overall Study|Withdrawal by Subject|3|||
146203414|NCT03401112|527256784|FG002|Overall Study|Withdrawal by Subject|2|||
146203415|NCT03401112|527256785|FG003|Overall Study|Withdrawal by Subject|1|||
146431094|NCT02601560|528086708|FG004|Overall Study|Other|0|||
146431095|NCT02601560|528086709|FG005|Overall Study|Other|0|||
146203416|NCT03401112|527256786|FG004|Overall Study|Withdrawal by Subject|0|||
146203417|NCT03401112|527256782|FG000|Overall Study|Physician Decision|0|||
146203418|NCT03401112|527256783|FG001|Overall Study|Physician Decision|0|||
146203419|NCT03401112|527256784|FG002|Overall Study|Physician Decision|0|||
146203420|NCT03401112|527256785|FG003|Overall Study|Physician Decision|2|||
146203421|NCT03401112|527256786|FG004|Overall Study|Physician Decision|0|||
146203422|NCT03401112|527256782|FG000|Overall Study|Study was Terminated by Sponsor|0|||
146203423|NCT03401112|527256783|FG001|Overall Study|Study was Terminated by Sponsor|0|||
146203424|NCT03401112|527256784|FG002|Overall Study|Study was Terminated by Sponsor|0|||
146203425|NCT03401112|527256785|FG003|Overall Study|Study was Terminated by Sponsor|1|||
146203426|NCT03401112|527256786|FG004|Overall Study|Study was Terminated by Sponsor|0|||
146203427|NCT03401112|527256782|FG000|Overall Study|Day 1 Assessment not Done|1|||
146203428|NCT03401112|527256783|FG001|Overall Study|Day 1 Assessment not Done|0|||
146203429|NCT03401112|527256784|FG002|Overall Study|Day 1 Assessment not Done|0|||
146203430|NCT03401112|527256785|FG003|Overall Study|Day 1 Assessment not Done|0|||
146203431|NCT03401112|527256786|FG004|Overall Study|Day 1 Assessment not Done|0|||
146203432|NCT03401112|527256782|FG000|Overall Study|Not Dosed|0|||
146203433|NCT03401112|527256783|FG001|Overall Study|Not Dosed|0|||
146203434|NCT03401112|527256784|FG002|Overall Study|Not Dosed|1|||
146203435|NCT03401112|527256785|FG003|Overall Study|Not Dosed|0|||
146203436|NCT03401112|527256786|FG004|Overall Study|Not Dosed|0|||
146203437|NCT03401112|527256782|FG000|Overall Study|Missed Clinical Visit|0|||
146203438|NCT03401112|527256783|FG001|Overall Study|Missed Clinical Visit|0|||
146203439|NCT03401112|527256784|FG002|Overall Study|Missed Clinical Visit|1|||
146203440|NCT03401112|527256785|FG003|Overall Study|Missed Clinical Visit|0|||
146203441|NCT03401112|527256786|FG004|Overall Study|Missed Clinical Visit|0|||
146203442|NCT03401112|527256782|FG000|Overall Study|Missed Doses|0|||
146203443|NCT03401112|527256783|FG001|Overall Study|Missed Doses|0|||
146203444|NCT03401112|527256784|FG002|Overall Study|Missed Doses|1|||
146203445|NCT03401112|527256785|FG003|Overall Study|Missed Doses|0|||
146203446|NCT03401112|527256786|FG004|Overall Study|Missed Doses|0|||
146203447|NCT01264679|527256787|FG000|Overall Study|Participation in Another Clinical Trial|1|||
146203448|NCT01264679|527256787|FG000|Overall Study|Physician Decision|1|||
146203449|NCT01264679|527256787|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
146203450|NCT01264679|527256787|FG000|Overall Study|Withdrawal by Subject|1|||
146203451|NCT03475316|527256788|FG000|6 Month Intervention|Adverse Event|2|||
146203452|NCT03475316|527256789|FG001|6 Month Intervention|Adverse Event|1|||
146203453|NCT03475316|527256788|FG000|6 Month Intervention|Withdrawal by Subject|2|||
146203454|NCT03475316|527256789|FG001|6 Month Intervention|Withdrawal by Subject|0|||
146203455|NCT03475316|527256788|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
146203456|NCT03475316|527256789|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
146203457|NCT03475316|527256788|FG000|9 Months|Study stopped due to COVID pandemic|3|||
145950811|NCT01483599|526330515|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
145950812|NCT01483599|526330516|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950813|NCT01483599|526330517|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950814|NCT01483599|526330518|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950815|NCT01483599|526330519|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950816|NCT01483599|526330520|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950817|NCT01483599|526330521|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
146203458|NCT03475316|527256789|FG001|9 Months|Study stopped due to COVID pandemic|4|||
146203459|NCT00424645|527256790|FG000|Overall Study|Death|1|||
146203460|NCT00424645|527256791|FG001|Overall Study|Death|0|||
146203461|NCT01179334|527256792|FG000|Treatment Period|Adverse Event|1|||
146203462|NCT01179334|527256793|FG001|Treatment Period|Adverse Event|0|||
146203463|NCT01179334|527256792|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
146203464|NCT01179334|527256793|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
146203465|NCT01179334|527256792|FG000|Long-term Extension (LTE) Period|Death|3|||
146203466|NCT01179334|527256793|FG001|Long-term Extension (LTE) Period|Death|0|||
145950818|NCT01483599|526330522|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145950819|NCT01483599|526330509|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146203467|NCT01179334|527256792|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
146203468|NCT01179334|527256793|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
146203469|NCT04177394|527256794|FG000|Overall Study|Death|16|||
146203470|NCT04177394|527256794|FG000|Overall Study|Withdrawal by Subject|19|||
146203471|NCT04177394|527256794|FG000|Overall Study|Missed visits|61|||
146203472|NCT04177394|527256794|FG000|Overall Study|Expected Visits|15|||
146203473|NCT00258895|527256795|FG000|Overall Study|Lost to Follow-up|3|||
146203474|NCT00258895|527256796|FG001|Overall Study|Lost to Follow-up|1|||
146203475|NCT00258895|527256795|FG000|Overall Study|Protocol Violation|6|||
146203476|NCT00258895|527256796|FG001|Overall Study|Protocol Violation|2|||
146203477|NCT00258895|527256795|FG000|Overall Study|Withdrawal by Subject|1|||
146203478|NCT00258895|527256796|FG001|Overall Study|Withdrawal by Subject|0|||
146203479|NCT00547118|527256799|FG000|Overall Study|Did not qualify prior to starting drug|1|||
146203480|NCT00547118|527256800|FG001|Overall Study|Did not qualify prior to starting drug|1|||
146203481|NCT00547118|527256799|FG000|Overall Study|Study suspended|7|||
146203482|NCT00547118|527256800|FG001|Overall Study|Study suspended|8|||
146203483|NCT01595321|527256801|FG000|Overall Study|Adverse Event|1|||
146203484|NCT01595321|527256802|FG001|Overall Study|Adverse Event|1|||
146203485|NCT01595321|527256803|FG002|Overall Study|Adverse Event|1|||
146203486|NCT01595321|527256801|FG000|Overall Study|Lack of Efficacy|0|||
146203487|NCT01595321|527256802|FG001|Overall Study|Lack of Efficacy|0|||
146203488|NCT01595321|527256803|FG002|Overall Study|Lack of Efficacy|4|||
146203489|NCT00834834|527256804|FG000|Overall Study|Withdrawal by Subject|4|||
146203490|NCT00834834|527256805|FG001|Overall Study|Withdrawal by Subject|3|||
146203491|NCT00373529|527256806|FG000|Overall Study|Physician Decision|19|||
146203492|NCT00373529|527256806|FG000|Overall Study|Withdrawal by Subject|7|||
146203493|NCT00373529|527256806|FG000|Overall Study|Adverse Event|7|||
146203494|NCT00373529|527256806|FG000|Overall Study|Treatment failure|36|||
146203495|NCT00373529|527256806|FG000|Overall Study|Disease recurrence|10|||
146203496|NCT00373529|527256806|FG000|Overall Study|Death|16|||
146203497|NCT00373529|527256806|FG000|Overall Study|Need for treatment prohibited by study|1|||
146203498|NCT00373529|527256806|FG000|Overall Study|Other|8|||
146203499|NCT00373529|527256806|FG000|Overall Study|Failed independent confirmation of AML|3|||
146203500|NCT00373529|527256806|FG000|Overall Study|Consent violation|1|||
146203501|NCT00442117|527256807|FG000|Overall Study|Adverse Event|3|||
146203502|NCT00442117|527256808|FG001|Overall Study|Adverse Event|2|||
146203503|NCT00442117|527256807|FG000|Overall Study|Lack of Efficacy|2|||
146203504|NCT00442117|527256808|FG001|Overall Study|Lack of Efficacy|6|||
146203505|NCT00442117|527256807|FG000|Overall Study|Lost to Follow-up|1|||
146203506|NCT00442117|527256808|FG001|Overall Study|Lost to Follow-up|2|||
146203507|NCT00442117|527256807|FG000|Overall Study|Withdrawal by Subject|2|||
146203508|NCT00442117|527256808|FG001|Overall Study|Withdrawal by Subject|2|||
146203509|NCT00442117|527256807|FG000|Overall Study|Major Deviation|25|||
146203510|NCT00442117|527256808|FG001|Overall Study|Major Deviation|20|||
146203511|NCT00442117|527256807|FG000|Overall Study|Non compliance with protocol|3|||
146203512|NCT00442117|527256808|FG001|Overall Study|Non compliance with protocol|5|||
146203513|NCT00442117|527256807|FG000|Overall Study|Met Withdrawal Criteria|2|||
146203514|NCT00442117|527256808|FG001|Overall Study|Met Withdrawal Criteria|1|||
146203515|NCT04009577|527256809|FG000|Core Study|Adverse Event|1|||
146203516|NCT04009577|527256810|FG001|Core Study|Adverse Event|0|||
146203517|NCT04009577|527256811|FG002|Core Study|Adverse Event|2|||
146203518|NCT04009577|527256812|FG003|Core Study|Adverse Event|4|||
146203519|NCT04009577|527256809|FG000|Core Study|Withdrawal by Subject|0|||
146203520|NCT04009577|527256810|FG001|Core Study|Withdrawal by Subject|0|||
146203521|NCT04009577|527256811|FG002|Core Study|Withdrawal by Subject|2|||
146203522|NCT04009577|527256812|FG003|Core Study|Withdrawal by Subject|0|||
146203523|NCT04009577|527256809|FG000|Core Study|Other|0|||
146203524|NCT04009577|527256810|FG001|Core Study|Other|0|||
146431096|NCT02601560|528086710|FG006|Overall Study|Other|1|||
146431097|NCT02601560|528086711|FG007|Overall Study|Other|0|||
146431098|NCT03459807|528086715|FG000|Overall Study|Withdrawal due to transplant|0|||
146431099|NCT03459807|528086716|FG001|Overall Study|Withdrawal due to transplant|1|||
146203525|NCT04009577|527256811|FG002|Core Study|Other|0|||
146203526|NCT04009577|527256812|FG003|Core Study|Other|1|||
146203527|NCT04009577|527256809|FG000|Extension Phase|Adverse Event|0|||
146203528|NCT04009577|527256810|FG001|Extension Phase|Adverse Event|0|||
146203529|NCT04009577|527256811|FG002|Extension Phase|Adverse Event|0|||
146203530|NCT04009577|527256812|FG003|Extension Phase|Adverse Event|1|||
146203531|NCT04009577|527256809|FG000|Extension Phase|Inadequate therapeutic effect|0|||
146203532|NCT04009577|527256810|FG001|Extension Phase|Inadequate therapeutic effect|0|||
146203533|NCT04009577|527256811|FG002|Extension Phase|Inadequate therapeutic effect|1|||
146203534|NCT04009577|527256812|FG003|Extension Phase|Inadequate therapeutic effect|0|||
146203535|NCT04009577|527256809|FG000|Extension Phase|Withdrawal by Subject|0|||
146203536|NCT04009577|527256810|FG001|Extension Phase|Withdrawal by Subject|0|||
146203537|NCT04009577|527256811|FG002|Extension Phase|Withdrawal by Subject|1|||
146203538|NCT04009577|527256812|FG003|Extension Phase|Withdrawal by Subject|0|||
146203539|NCT04009577|527256809|FG000|Extension Phase|Not Treated|0|||
146203540|NCT04009577|527256810|FG001|Extension Phase|Not Treated|0|||
146203541|NCT04009577|527256811|FG002|Extension Phase|Not Treated|2|||
146203542|NCT04009577|527256812|FG003|Extension Phase|Not Treated|0|||
146203543|NCT00305695|527256818|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
146203544|NCT00305695|527256819|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
146203545|NCT00305695|527256818|FG000|Overall Study|Did not have baseline scan|1|||
146203546|NCT00305695|527256819|FG001|Overall Study|Did not have baseline scan|1|||
146203547|NCT00841035|527256821|FG000|Phase 1 Overall Study|Physician Decision|13|||
146203548|NCT02994654|527256832|FG000|Overall Study|Lost to Follow-up|1|||
146203549|NCT01810263|527256841|FG000|Overall Study|Lost to Follow-up|8|||
146203550|NCT01810263|527256842|FG001|Overall Study|Lost to Follow-up|7|||
146203551|NCT01390402|527256843|FG000|Overall Study|Death|1|||
146203552|NCT01390402|527256843|FG000|Overall Study|Disease Progression|4|||
146203553|NCT01353963|527256844|FG000|Overall Study|Adverse Event|2|||
146203554|NCT01121549|527256845|FG000|Overall Study|Adverse Event|10|||
146203555|NCT01121549|527256845|FG000|Overall Study|Lack of Efficacy|11|||
146203556|NCT01121549|527256845|FG000|Overall Study|Lost to Follow-up|12|||
146203557|NCT01121549|527256845|FG000|Overall Study|Did not meet entrance criteria|9|||
146203558|NCT01121549|527256845|FG000|Overall Study|Study terminated by sponsor|197|||
146203559|NCT01121549|527256845|FG000|Overall Study|Pregnancy|1|||
146203560|NCT01121549|527256845|FG000|Overall Study|Protocol Violation|33|||
146203561|NCT01121549|527256845|FG000|Overall Study|Withdrawal by Subject|16|||
146203562|NCT01121549|527256845|FG000|Overall Study|Other|58|||
146203563|NCT04789408|527256846|FG000|Overall Study|Death|4|||
146203564|NCT04789408|527256847|FG001|Overall Study|Death|3|||
146203565|NCT04789408|527256848|FG002|Overall Study|Death|6|||
146203566|NCT04789408|527256846|FG000|Overall Study|Did not meet eligibility criteria|1|||
146203567|NCT04789408|527256847|FG001|Overall Study|Did not meet eligibility criteria|0|||
146203568|NCT04789408|527256848|FG002|Overall Study|Did not meet eligibility criteria|0|||
146203569|NCT04789408|527256846|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
146203570|NCT04789408|527256847|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
146203571|NCT04789408|527256848|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
146203572|NCT01170026|527257954|FG000|Overall Study|Lost to Follow-up|4|||
146203573|NCT01170026|527257955|FG001|Overall Study|Lost to Follow-up|2|||
146203574|NCT03785782|527257967|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
146203575|NCT03785782|527257968|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
145950820|NCT01483599|526330510|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145950821|NCT01483599|526330511|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950822|NCT01483599|526330512|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145950823|NCT01483599|526330513|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950824|NCT01483599|526330514|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950825|NCT01483599|526330515|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145950826|NCT01483599|526330516|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950827|NCT01483599|526330517|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950828|NCT01483599|526330518|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950829|NCT01483599|526330519|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950830|NCT01483599|526330520|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146082893|NCT02616146|526824697|FG001|Overall Study|Study terminated by sponsor|432|||
146203576|NCT03785782|527257967|FG000|Overall Study|Withdrawal by Subject|1|||
146203577|NCT03785782|527257968|FG001|Overall Study|Withdrawal by Subject|1|||
146203578|NCT03785782|527257967|FG000|Overall Study|insufficient image quality.|3|||
146203579|NCT03785782|527257968|FG001|Overall Study|insufficient image quality.|0|||
146203580|NCT03889925|527257969|FG000|Overall Study|Lost to Follow-up|11|||
146203581|NCT03889925|527257970|FG001|Overall Study|Lost to Follow-up|10|||
146203582|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
146203583|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
146203584|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
146203585|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
146203586|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
146203587|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
146203588|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
145950831|NCT01483599|526330521|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145950832|NCT01483599|526330522|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
146203589|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
146203590|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
146203591|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
146203592|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
146203593|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
146203594|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
146203595|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
146203596|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
146203597|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
146203598|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
146203599|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
146203600|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
146203601|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
146203602|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
146203603|NCT00304031|527257972|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
146203604|NCT00304031|527257973|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
146203605|NCT00304031|527257974|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
146203606|NCT00304031|527257972|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
146203607|NCT00304031|527257973|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
146203608|NCT00304031|527257974|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
146203609|NCT00493649|527257975|FG000|Overall Study|Adverse Event|44|||
146203610|NCT00493649|527257975|FG000|Overall Study|Patient Request|21|||
146203611|NCT00493649|527257975|FG000|Overall Study|Investigator Request|2|||
146203612|NCT00493649|527257975|FG000|Overall Study|Disease Progression|1|||
146203613|NCT00493649|527257975|FG000|Overall Study|Lost to Follow-up|1|||
146203614|NCT00493649|527257975|FG000|Overall Study|Other|13|||
146203615|NCT01662336|527257988|FG000|Overall Study|Adverse Event|1|||
146203616|NCT01662336|527257988|FG000|Overall Study|No longer on LPV/r|30|||
146203617|NCT01662336|527257988|FG000|Overall Study|Other|29|||
146203618|NCT01662336|527257988|FG000|Overall Study|Withdrawal by Subject|6|||
146203619|NCT02189252|527257989|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146203620|NCT02189252|527257990|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
146203621|NCT02189252|527257991|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146203622|NCT02189252|527257992|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
146203623|NCT02189252|527257989|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146203624|NCT02189252|527257990|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
146203625|NCT02189252|527257991|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146203626|NCT02189252|527257992|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
146203627|NCT00566735|527257993|FG000|Overall Study|Withdrawal by Subject|0|||
146203628|NCT00566735|527257994|FG001|Overall Study|Withdrawal by Subject|1|||
146203629|NCT00566735|527257993|FG000|Overall Study|Refused neuropsychological testing|2|||
146203630|NCT00566735|527257994|FG001|Overall Study|Refused neuropsychological testing|5|||
146203631|NCT00566735|527257993|FG000|Overall Study|Switched into a manic episode|0|||
146203632|NCT00566735|527257994|FG001|Overall Study|Switched into a manic episode|1|||
146203633|NCT04603924|527257995|FG000|Overall Study|Not Dosed|2|||
146203634|NCT04603924|527257996|FG001|Overall Study|Not Dosed|1|||
146203635|NCT04603924|527257995|FG000|Overall Study|Withdrawal by Subject|6|||
146203636|NCT04603924|527257996|FG001|Overall Study|Withdrawal by Subject|6|||
146203637|NCT04603924|527257995|FG000|Overall Study|Adverse Event|2|||
146203638|NCT04603924|527257996|FG001|Overall Study|Adverse Event|2|||
146203639|NCT02731755|527258008|FG000|First Intervention|Withdrawal by Subject|0|||
146203640|NCT02731755|527258009|FG001|First Intervention|Withdrawal by Subject|2|||
146203641|NCT01460446|527258010|FG000|Overall Study|Non-compliance|2|||
146203642|NCT01460446|527258011|FG001|Overall Study|Non-compliance|9|||
146203643|NCT01460446|527258010|FG000|Overall Study|Consent Withdrawn|0|||
146203644|NCT01460446|527258011|FG001|Overall Study|Consent Withdrawn|4|||
146203645|NCT01460446|527258010|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
146203646|NCT01460446|527258011|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
146203647|NCT01460446|527258010|FG000|Overall Study|Surgery/Illness|1|||
146203648|NCT01460446|527258011|FG001|Overall Study|Surgery/Illness|1|||
146203649|NCT01460446|527258010|FG000|Overall Study|Pregnancy|1|||
146203650|NCT01460446|527258011|FG001|Overall Study|Pregnancy|0|||
146203651|NCT01460446|527258010|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
146203652|NCT01460446|527258011|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
146203653|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
146203654|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
146203655|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
146203656|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
146203657|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
146203658|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
146203659|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
146203660|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
146203661|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
146203662|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
146203663|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
146203664|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
146203665|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
146203666|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
146203667|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
146203668|NCT00516321|527258012|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
146203669|NCT00516321|527258013|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
146203670|NCT00516321|527258014|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
146203671|NCT00516321|527258012|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
146203672|NCT00516321|527258013|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
146203673|NCT00516321|527258014|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
146203674|NCT00516321|527258012|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
146203675|NCT00516321|527258013|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
146203676|NCT00516321|527258014|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
146203677|NCT00516321|527258012|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
146203678|NCT00516321|527258013|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
146203679|NCT00516321|527258014|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
146203680|NCT00516321|527258012|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
146203681|NCT00516321|527258013|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
146203682|NCT00516321|527258014|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
146203683|NCT00516321|527258012|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
146203684|NCT00516321|527258013|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
146203685|NCT00516321|527258014|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
146203686|NCT02139046|527258015|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146203687|NCT02139046|527258016|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
146203688|NCT02139046|527258017|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
146203689|NCT02139046|527258018|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
146203690|NCT02139046|527258019|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
146203691|NCT02139046|527258015|FG000|Overall Study|Major Protocol Deviation|9|||
146203692|NCT02139046|527258016|FG001|Overall Study|Major Protocol Deviation|10|||
146203693|NCT02139046|527258017|FG002|Overall Study|Major Protocol Deviation|16|||
146203694|NCT02139046|527258018|FG003|Overall Study|Major Protocol Deviation|12|||
146203695|NCT02139046|527258019|FG004|Overall Study|Major Protocol Deviation|6|||
146203696|NCT02139046|527258015|FG000|Overall Study|Lost to Follow-up|13|||
146203697|NCT02139046|527258016|FG001|Overall Study|Lost to Follow-up|16|||
146203698|NCT02139046|527258017|FG002|Overall Study|Lost to Follow-up|16|||
146203699|NCT02139046|527258018|FG003|Overall Study|Lost to Follow-up|18|||
146203700|NCT02139046|527258019|FG004|Overall Study|Lost to Follow-up|13|||
146203701|NCT02139046|527258015|FG000|Overall Study|Voluntary Withdrawal|20|||
146203702|NCT02139046|527258016|FG001|Overall Study|Voluntary Withdrawal|8|||
146203703|NCT02139046|527258017|FG002|Overall Study|Voluntary Withdrawal|10|||
146203704|NCT02139046|527258018|FG003|Overall Study|Voluntary Withdrawal|15|||
146203705|NCT02139046|527258019|FG004|Overall Study|Voluntary Withdrawal|16|||
146203706|NCT02139046|527258015|FG000|Overall Study|Lack of Efficacy|0|||
146203707|NCT02139046|527258016|FG001|Overall Study|Lack of Efficacy|1|||
146203708|NCT02139046|527258017|FG002|Overall Study|Lack of Efficacy|2|||
146203709|NCT02139046|527258018|FG003|Overall Study|Lack of Efficacy|1|||
146203710|NCT02139046|527258019|FG004|Overall Study|Lack of Efficacy|2|||
146203711|NCT02139046|527258015|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
146203712|NCT02139046|527258016|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
146203713|NCT02139046|527258017|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
146203714|NCT02139046|527258018|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
146203715|NCT02139046|527258019|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
146203716|NCT02139046|527258015|FG000|Overall Study|Other Miscellaneous Reasons|10|||
146203717|NCT02139046|527258016|FG001|Overall Study|Other Miscellaneous Reasons|9|||
146203718|NCT02139046|527258017|FG002|Overall Study|Other Miscellaneous Reasons|4|||
146203719|NCT02139046|527258018|FG003|Overall Study|Other Miscellaneous Reasons|9|||
146203720|NCT02139046|527258019|FG004|Overall Study|Other Miscellaneous Reasons|12|||
146203721|NCT01582100|527258028|FG000|Overall Study|Adverse Event|1|||
146203722|NCT01582100|527258028|FG000|Overall Study|Withdrawal by Subject|1|||
146203723|NCT01040689|527258029|FG000|Overall Study|Adverse Event|0|||
146431100|NCT00576056|528086717|FG000|Overall Study|Adverse Event|1|||
146431101|NCT00576056|528086717|FG000|Overall Study|Death|1|||
146431102|NCT00576056|528086717|FG000|Overall Study|Lack of Efficacy|1|||
146431103|NCT00576056|528086717|FG000|Overall Study|Withdrawal by Subject|2|||
146431104|NCT00576056|528086717|FG000|Overall Study|did not meet eligibility criteria|8|||
146431105|NCT00576056|528086717|FG000|Overall Study|Physician Decision|1|||
146431106|NCT00858845|528086718|FG000|Overall Study|Patient underwent heart transplant.|0|||
146431107|NCT00858845|528086719|FG001|Overall Study|Patient underwent heart transplant.|1|||
146431108|NCT03420300|528086725|FG000|Overall Study|Death|2|||
146431109|NCT03500692|528086729|FG000|Overall Study|Death|163|||
146431110|NCT03500692|528086729|FG000|Overall Study|Lost to Follow-up|75|||
146431111|NCT03500692|528086729|FG000|Overall Study|Termination Reasons|3|||
146431112|NCT04149964|528086730|FG000|Overall Study|Lost to Follow-up|19|||
146431113|NCT04149964|528086731|FG001|Overall Study|Lost to Follow-up|18|||
146203724|NCT01040689|527258030|FG001|Overall Study|Adverse Event|0|||
146203725|NCT01040689|527258031|FG002|Overall Study|Adverse Event|2|||
146203726|NCT01040689|527258032|FG003|Overall Study|Adverse Event|4|||
146203727|NCT01040689|527258029|FG000|Overall Study|Lack of Efficacy|0|||
146203728|NCT01040689|527258030|FG001|Overall Study|Lack of Efficacy|0|||
146203729|NCT01040689|527258031|FG002|Overall Study|Lack of Efficacy|1|||
146203730|NCT01040689|527258032|FG003|Overall Study|Lack of Efficacy|0|||
146431114|NCT03041025|528086734|FG000|Overall Study|Adverse Event|0|||
146431115|NCT03041025|528086735|FG001|Overall Study|Adverse Event|0|||
146431116|NCT03041025|528086736|FG002|Overall Study|Adverse Event|1|||
146431117|NCT03041025|528086734|FG000|Overall Study|Lost to Follow-up|1|||
146431118|NCT03041025|528086735|FG001|Overall Study|Lost to Follow-up|0|||
146431119|NCT03041025|528086736|FG002|Overall Study|Lost to Follow-up|0|||
146203731|NCT01040689|527258029|FG000|Overall Study|Lost to Follow-up|1|||
146203732|NCT01040689|527258030|FG001|Overall Study|Lost to Follow-up|0|||
146203733|NCT01040689|527258031|FG002|Overall Study|Lost to Follow-up|0|||
146203734|NCT01040689|527258032|FG003|Overall Study|Lost to Follow-up|0|||
146203735|NCT01040689|527258029|FG000|Overall Study|Withdrawal by Subject|2|||
146203736|NCT01040689|527258030|FG001|Overall Study|Withdrawal by Subject|1|||
146431120|NCT03041025|528086734|FG000|Overall Study|Withdrawal by Subject|0|||
146431121|NCT03041025|528086735|FG001|Overall Study|Withdrawal by Subject|0|||
146431122|NCT03041025|528086736|FG002|Overall Study|Withdrawal by Subject|1|||
146431123|NCT01577381|528086739|FG000|Overall Study|Discontinued|2|||
146431124|NCT01577381|528086740|FG001|Overall Study|Discontinued|1|||
146431125|NCT01577381|528086741|FG002|Overall Study|Discontinued|2|||
146203737|NCT01040689|527258031|FG002|Overall Study|Withdrawal by Subject|1|||
146203738|NCT01040689|527258032|FG003|Overall Study|Withdrawal by Subject|0|||
146203739|NCT01040689|527258029|FG000|Overall Study|Other reasons not listed above|0|||
146203740|NCT01040689|527258030|FG001|Overall Study|Other reasons not listed above|1|||
146203741|NCT01040689|527258031|FG002|Overall Study|Other reasons not listed above|0|||
146203742|NCT01040689|527258032|FG003|Overall Study|Other reasons not listed above|0|||
146203743|NCT01185561|527258033|FG000|Overall Study|Lost to Follow-up|0|||
146203744|NCT01185561|527258034|FG001|Overall Study|Lost to Follow-up|4|||
146203745|NCT01185561|527258033|FG000|Overall Study|Withdrawal by Subject|2|||
146203746|NCT01185561|527258034|FG001|Overall Study|Withdrawal by Subject|8|||
146203747|NCT01078116|527258035|FG000|Overall Study|Lost to Follow-up|17|||
146203748|NCT01078116|527258035|FG000|Overall Study|Adverse Event|5|||
146203749|NCT01078116|527258035|FG000|Overall Study|Withdrawal by Subject|8|||
146203750|NCT01078116|527258035|FG000|Overall Study|Lack of effectiveness|15|||
146431126|NCT01577381|528086742|FG003|Overall Study|Discontinued|2|||
146431127|NCT01577381|528086739|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
146203751|NCT01078116|527258035|FG000|Overall Study|Case report form not completed|3|||
146203752|NCT02616900|527258036|FG000|Overall Study|Lack of Efficacy|7|||
146203753|NCT02616900|527258036|FG000|Overall Study|Lost to Follow-up|2|||
146203754|NCT02616900|527258036|FG000|Overall Study|Protocol Violation|5|||
146203755|NCT02616900|527258036|FG000|Overall Study|Withdrawal by Subject|3|||
146203756|NCT02616900|527258036|FG000|Overall Study|Incomplete data|6|||
146203757|NCT00845832|527258037|FG000|Treatment Period|Adverse Event|0|||
146203758|NCT00845832|527258038|FG001|Treatment Period|Adverse Event|2|||
146203759|NCT00845832|527258039|FG002|Treatment Period|Adverse Event|0|||
146203760|NCT00845832|527258037|FG000|Treatment Period|Protocol Violation|1|||
146203761|NCT00845832|527258038|FG001|Treatment Period|Protocol Violation|1|||
146203762|NCT00845832|527258039|FG002|Treatment Period|Protocol Violation|0|||
146203763|NCT00845832|527258037|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
146203764|NCT00845832|527258038|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
146203765|NCT00845832|527258039|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
146203766|NCT00845832|527258037|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
146203767|NCT00845832|527258038|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
146203768|NCT00845832|527258039|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
146203769|NCT00668863|527258040|FG000|Overall Study|Objective Progression or Relapse|42|||
146203770|NCT00668863|527258040|FG000|Overall Study|Adverse Event|13|||
146203771|NCT00668863|527258040|FG000|Overall Study|Study Terminated by Sponsor|8|||
146203772|NCT00668863|527258040|FG000|Overall Study|Global Deterioration of Health Status|4|||
146203773|NCT00668863|527258040|FG000|Overall Study|Withdrawal by Subject|1|||
146203774|NCT00668863|527258040|FG000|Overall Study|Surgery|1|||
146203775|NCT00668863|527258040|FG000|Overall Study|Subject's work scheduling problem|1|||
146203776|NCT00668863|527258040|FG000|Overall Study|Physician Decision|1|||
146203777|NCT00869323|527258043|FG000|Maintenance Therapy|concurrent illness|1|||
146203778|NCT01068743|527258048|FG000|Period 3|Adverse Event|0|||
146203779|NCT01068743|527258049|FG001|Period 3|Adverse Event|1|||
146203780|NCT01068743|527258050|FG002|Period 3|Adverse Event|0|||
146203781|NCT01068743|527258051|FG003|Period 3|Adverse Event|0|||
146203782|NCT00638963|527258052|FG000|Overall Study|Withdrawal by Subject|1|||
146203783|NCT00638963|527258053|FG001|Overall Study|Withdrawal by Subject|0|||
146203784|NCT00463788|527258057|FG000|Overall Study|Progressive Disease|86|||
146203785|NCT00463788|527258058|FG001|Overall Study|Progressive Disease|42|||
146203786|NCT00463788|527258057|FG000|Overall Study|Adverse Event|6|||
146203787|NCT00463788|527258058|FG001|Overall Study|Adverse Event|2|||
146203788|NCT00463788|527258057|FG000|Overall Study|Withdrawal by Subject|6|||
146203789|NCT00463788|527258058|FG001|Overall Study|Withdrawal by Subject|2|||
146203790|NCT00463788|527258057|FG000|Overall Study|Death|4|||
146203791|NCT00463788|527258058|FG001|Overall Study|Death|3|||
146203792|NCT00463788|527258057|FG000|Overall Study|Symptomatic Deterioration|2|||
146203793|NCT00463788|527258058|FG001|Overall Study|Symptomatic Deterioration|3|||
146203794|NCT00463788|527258057|FG000|Overall Study|Lost to Follow-up|1|||
146203795|NCT00463788|527258058|FG001|Overall Study|Lost to Follow-up|0|||
146203796|NCT00463788|527258057|FG000|Overall Study|Protocol Violation|0|||
146203797|NCT00463788|527258058|FG001|Overall Study|Protocol Violation|1|||
146203798|NCT00463788|527258057|FG000|Overall Study|Other|3|||
146203799|NCT00463788|527258058|FG001|Overall Study|Other|0|||
146203800|NCT00463788|527258057|FG000|Overall Study|Randomized but not treated|1|||
146203801|NCT00463788|527258058|FG001|Overall Study|Randomized but not treated|1|||
146203802|NCT00360698|527258059|FG000|Run-In|Physician Decision|0|||
146203803|NCT00360698|527258060|FG001|Run-In|Physician Decision|1|||
146203804|NCT00360698|527258059|FG000|Run-In|Withdrawal by Subject|0|||
146203805|NCT00360698|527258060|FG001|Run-In|Withdrawal by Subject|2|||
146203806|NCT00360698|527258059|FG000|Run-In|Non compliance with treatment procedure|0|||
146203807|NCT00360698|527258060|FG001|Run-In|Non compliance with treatment procedure|1|||
146203808|NCT00360698|527258059|FG000|Run-In|Sponsor request|0|||
146203809|NCT00360698|527258060|FG001|Run-In|Sponsor request|2|||
146203810|NCT00360698|527258059|FG000|Run-In|Patient did not meet inclusion criteria|0|||
146203811|NCT00360698|527258060|FG001|Run-In|Patient did not meet inclusion criteria|1|||
146203812|NCT00360698|527258059|FG000|Run-In|Patient personal reasons|0|||
146203813|NCT00360698|527258060|FG001|Run-In|Patient personal reasons|2|||
146203814|NCT00360698|527258059|FG000|Run-In|Need of insulin with meals|0|||
146203815|NCT00360698|527258060|FG001|Run-In|Need of insulin with meals|1|||
146203816|NCT00360698|527258059|FG000|Treatment Period|Non compliance with treatment procedure|1|||
146203817|NCT00360698|527258060|FG001|Treatment Period|Non compliance with treatment procedure|0|||
146203818|NCT00360698|527258059|FG000|Treatment Period|Early termination by error|0|||
146203819|NCT00360698|527258060|FG001|Treatment Period|Early termination by error|1|||
146203820|NCT01692938|527258068|FG000|Overall Study|Protocol Deviation|1|||
146203821|NCT01692938|527258069|FG001|Overall Study|Protocol Deviation|1|||
146431128|NCT01577381|528086740|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
146431129|NCT01577381|528086741|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
146431130|NCT01577381|528086742|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
146203822|NCT01692938|527258068|FG000|Overall Study|Study completed prior to site completion|3|||
146431131|NCT02186821|528086743|FG000|Overall Study|Adverse Event|9|||
146203823|NCT01692938|527258069|FG001|Overall Study|Study completed prior to site completion|3|||
146203824|NCT02755116|527258070|FG000|Overall Study|surgery converted to open, pt admitted|3|||
146203825|NCT02755116|527258071|FG001|Overall Study|surgery converted to open, pt admitted|1|||
146203826|NCT02423291|527258072|FG000|Overall Study|Lack of Efficacy|14|||
146203827|NCT02423291|527258072|FG000|Overall Study|Adverse Event|1|||
146203828|NCT04975308|527258077|FG000|Overall Study|Withdrawal by Subject|6|||
146203829|NCT04975308|527258078|FG001|Overall Study|Withdrawal by Subject|16|||
146203830|NCT04975308|527258079|FG002|Overall Study|Withdrawal by Subject|6|||
146203831|NCT04975308|527258077|FG000|Overall Study|Physician Decision|0|||
146203832|NCT04975308|527258078|FG001|Overall Study|Physician Decision|3|||
146203833|NCT04975308|527258079|FG002|Overall Study|Physician Decision|1|||
146203834|NCT04975308|527258077|FG000|Overall Study|Adverse Event|10|||
146203835|NCT04975308|527258078|FG001|Overall Study|Adverse Event|1|||
146203836|NCT04975308|527258079|FG002|Overall Study|Adverse Event|12|||
146203837|NCT04975308|527258077|FG000|Overall Study|On study treatment (Ongoing)|65|||
146203838|NCT04975308|527258078|FG001|Overall Study|On study treatment (Ongoing)|43|||
146203839|NCT04975308|527258079|FG002|Overall Study|On study treatment (Ongoing)|75|||
146203840|NCT04975308|527258077|FG000|Overall Study|Protocol Deviation|4|||
146203841|NCT04975308|527258078|FG001|Overall Study|Protocol Deviation|3|||
146203842|NCT04975308|527258079|FG002|Overall Study|Protocol Deviation|2|||
146203843|NCT00658996|527258080|FG000|First Intervention|Positive slit lamp finding|1|||
146203844|NCT00658996|527258081|FG001|First Intervention|Positive slit lamp finding|0|||
146203845|NCT00658996|527258080|FG000|First Intervention|Lack of lenses|0|||
146203846|NCT00658996|527258081|FG001|First Intervention|Lack of lenses|1|||
146203847|NCT00658996|527258080|FG000|Crossover Period|Physician Decision|1|||
146203848|NCT00658996|527258081|FG001|Crossover Period|Physician Decision|0|||
146203849|NCT00658996|527258080|FG000|Crossover Period|Ineligible|1|||
146203850|NCT00658996|527258081|FG001|Crossover Period|Ineligible|1|||
146203851|NCT00658996|527258080|FG000|Second Intervention|Developed a stye on upper lid|1|||
146203852|NCT00658996|527258081|FG001|Second Intervention|Developed a stye on upper lid|0|||
146203853|NCT00658996|527258080|FG000|Second Intervention|Positive slit lamp finding|0|||
146203854|NCT00658996|527258081|FG001|Second Intervention|Positive slit lamp finding|1|||
146203855|NCT02242487|527259296|FG000|Overall Study|Adverse Event|13|||
146203856|NCT02242487|527259297|FG001|Overall Study|Adverse Event|15|||
146203857|NCT02242487|527259296|FG000|Overall Study|Lack of Efficacy|4|||
146203858|NCT02242487|527259297|FG001|Overall Study|Lack of Efficacy|6|||
146203859|NCT02242487|527259296|FG000|Overall Study|Protocol Violation|2|||
146203860|NCT02242487|527259297|FG001|Overall Study|Protocol Violation|0|||
146203861|NCT02242487|527259296|FG000|Overall Study|Lost to Follow-up|2|||
146203862|NCT02242487|527259297|FG001|Overall Study|Lost to Follow-up|1|||
146203863|NCT02242487|527259296|FG000|Overall Study|Other - Miscellaneous|4|||
146203864|NCT02242487|527259297|FG001|Overall Study|Other - Miscellaneous|6|||
146431132|NCT02186821|528086743|FG000|Overall Study|Death|2|||
146431133|NCT02186821|528086743|FG000|Overall Study|Disease progression|32|||
146431134|NCT02186821|528086743|FG000|Overall Study|Protocol Violation|1|||
146431135|NCT02186821|528086743|FG000|Overall Study|Physician Decision|1|||
146431136|NCT02186821|528086743|FG000|Overall Study|Study terminated by sponsor|2|||
146431137|NCT01313780|528086744|FG000|Overall Study|Lack of Efficacy|4|||
146431138|NCT01313780|528086745|FG001|Overall Study|Lack of Efficacy|2|||
146431139|NCT01313780|528086744|FG000|Overall Study|Adverse Event|6|||
146431140|NCT01313780|528086745|FG001|Overall Study|Adverse Event|11|||
146431141|NCT01313780|528086744|FG000|Overall Study|Withdrawal by Subject|2|||
146431142|NCT01313780|528086745|FG001|Overall Study|Withdrawal by Subject|8|||
146431143|NCT01313780|528086744|FG000|Overall Study|Protocol Violation|10|||
146431144|NCT01313780|528086745|FG001|Overall Study|Protocol Violation|4|||
146203865|NCT02242487|527259296|FG000|Overall Study|Withdrawal by Subject|37|||
146203866|NCT02242487|527259297|FG001|Overall Study|Withdrawal by Subject|19|||
146203867|NCT02755805|527259298|FG000|Overall Study|Lost to Follow-up|1|||
146203868|NCT02755805|527259299|FG001|Overall Study|Lost to Follow-up|2|||
146203869|NCT02755805|527259298|FG000|Overall Study|Refused assessments|1|||
146203870|NCT02755805|527259299|FG001|Overall Study|Refused assessments|0|||
146203871|NCT02755805|527259298|FG000|Overall Study|Withdrawal by Subject|0|||
146203872|NCT02755805|527259299|FG001|Overall Study|Withdrawal by Subject|2|||
146203873|NCT02252042|527259302|FG000|Overall Study|Adverse Event|9|||
146203874|NCT02252042|527259303|FG001|Overall Study|Adverse Event|6|||
146431145|NCT01313780|528086744|FG000|Overall Study|missing data|3|||
146431146|NCT01313780|528086745|FG001|Overall Study|missing data|3|||
146431147|NCT00467896|528088163|FG000|Overall Study|Consent Withdrawal|18|||
146431148|NCT00467896|528088163|FG000|Overall Study|Adverse Event|7|||
146431149|NCT00467896|528088163|FG000|Overall Study|Serious Adverse Event|13|||
146431150|NCT00467896|528088163|FG000|Overall Study|Non-compliance|3|||
146431151|NCT00467896|528088163|FG000|Overall Study|Changed therapy|2|||
146431152|NCT00467896|528088163|FG000|Overall Study|Patient received transplant|2|||
146203875|NCT02252042|527259302|FG000|Overall Study|Death|209|||
146203876|NCT02252042|527259303|FG001|Overall Study|Death|217|||
146203877|NCT02252042|527259302|FG000|Overall Study|Physician Decision|0|||
146203878|NCT02252042|527259303|FG001|Overall Study|Physician Decision|2|||
146203879|NCT02252042|527259302|FG000|Overall Study|Transferred to Extension Study|7|||
146203880|NCT02252042|527259303|FG001|Overall Study|Transferred to Extension Study|1|||
146203881|NCT02252042|527259302|FG000|Overall Study|Did Not Continue on Extension Study|7|||
146203882|NCT02252042|527259303|FG001|Overall Study|Did Not Continue on Extension Study|2|||
146203883|NCT02252042|527259302|FG000|Overall Study|Withdrawal by Subject|15|||
146203884|NCT02252042|527259303|FG001|Overall Study|Withdrawal by Subject|20|||
146203885|NCT02593149|527259304|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
146203886|NCT02593149|527259305|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
146203887|NCT02593149|527259304|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
146203888|NCT02593149|527259305|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
146203889|NCT00979992|527259306|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146203890|NCT00979992|527259306|FG000|Overall Study|Ineligible - wrong cell type|2|||
146203891|NCT00979992|527259306|FG000|Overall Study|Refused - Never Treated|2|||
146203892|NCT03691428|527259309|FG000|Overall Study|Withdrawal by Subject|6|||
146203893|NCT03691428|527259310|FG001|Overall Study|Withdrawal by Subject|8|||
146203894|NCT01460290|527259311|FG000|Overall Study|Adverse Event|3|||
146203895|NCT01460290|527259311|FG000|Overall Study|Elevated liver function|1|||
146203896|NCT02527148|527259312|FG000|Overall Study|Did not receive study intervention|1|||
146431153|NCT00467896|528088163|FG000|Overall Study|Patient had atrial septostomy|1|||
146203897|NCT02527148|527259313|FG001|Overall Study|Did not receive study intervention|0|||
146203898|NCT02448446|527259322|FG000|Overall Study|Withdrawal by Subject|1|||
146203899|NCT02448446|527259323|FG001|Overall Study|Withdrawal by Subject|0|||
146203900|NCT01254188|527259324|FG000|Overall Study|Disease Progression|6|||
146203901|NCT01254188|527259324|FG000|Overall Study|Protocol Violation|6|||
146203902|NCT01254188|527259324|FG000|Overall Study|Pregnancy|2|||
146203903|NCT01254188|527259324|FG000|Overall Study|Death|4|||
146203904|NCT01254188|527259324|FG000|Overall Study|Lost to Follow-up|5|||
146203905|NCT01254188|527259324|FG000|Overall Study|Withdrawal by Subject|7|||
146203906|NCT01254188|527259324|FG000|Overall Study|Adverse Event|43|||
146203907|NCT01254188|527259324|FG000|Overall Study|per investigator discretion|20|||
146203908|NCT02202499|527259329|FG000|Overall Study|Cancer diagnosis|0|||
146203909|NCT02202499|527259330|FG001|Overall Study|Cancer diagnosis|0|||
146203910|NCT02202499|527259331|FG002|Overall Study|Cancer diagnosis|1|||
146203911|NCT02202499|527259329|FG000|Overall Study|Moved from area|0|||
146203912|NCT02202499|527259330|FG001|Overall Study|Moved from area|0|||
146203913|NCT02202499|527259331|FG002|Overall Study|Moved from area|1|||
146203914|NCT02202499|527259329|FG000|Overall Study|Declined before randomization|1|||
146203915|NCT02202499|527259330|FG001|Overall Study|Declined before randomization|0|||
146203916|NCT02202499|527259331|FG002|Overall Study|Declined before randomization|0|||
146203917|NCT02202499|527259329|FG000|Overall Study|Auto accident|1|||
146203918|NCT02202499|527259330|FG001|Overall Study|Auto accident|0|||
146203919|NCT02202499|527259331|FG002|Overall Study|Auto accident|0|||
146203920|NCT02957136|527259335|FG000|Overall Study|Withdrawal by Subject|2|||
146203921|NCT02957136|527259336|FG001|Overall Study|Withdrawal by Subject|1|||
146203922|NCT00439569|527259339|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
146203923|NCT00439569|527259339|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
146203924|NCT00439569|527259339|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
146203925|NCT02200770|527259341|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
146203926|NCT02200770|527259342|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
146203927|NCT02200770|527259341|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
146203928|NCT02200770|527259342|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
146203929|NCT02200770|527259341|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
146203930|NCT02200770|527259342|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
146203931|NCT02200770|527259341|FG000|Randomized-controlled Period (RCP)|Other|1|||
146203932|NCT02200770|527259342|FG001|Randomized-controlled Period (RCP)|Other|2|||
146203933|NCT02200770|527259341|FG000|Open-label Period (OLP)|Adverse Event|1|||
146203934|NCT02200770|527259342|FG001|Open-label Period (OLP)|Adverse Event|2|||
146203935|NCT02200770|527259341|FG000|Open-label Period (OLP)|Death|1|||
146203936|NCT02200770|527259342|FG001|Open-label Period (OLP)|Death|2|||
146203937|NCT02200770|527259341|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
146203938|NCT02200770|527259342|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
146203939|NCT02200770|527259341|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
146203940|NCT02200770|527259342|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
146203941|NCT02200770|527259341|FG000|Open-label Period (OLP)|Other|6|||
146203942|NCT02200770|527259342|FG001|Open-label Period (OLP)|Other|15|||
146203943|NCT01124734|527259343|FG000|Overall Study|Disease progression|13|||
146203944|NCT01124734|527259343|FG000|Overall Study|Adverse Event|1|||
146203945|NCT01124734|527259343|FG000|Overall Study|Withdrawal by Subject|1|||
146203946|NCT01124734|527259343|FG000|Overall Study|Elected for alternative treatment|2|||
146203947|NCT01510717|527259348|FG000|Overall Study|Adverse Event|1|||
146203948|NCT01510717|527259349|FG001|Overall Study|Adverse Event|2|||
146203949|NCT01510717|527259348|FG000|Overall Study|Death|1|||
146203950|NCT01510717|527259349|FG001|Overall Study|Death|0|||
146203951|NCT01510717|527259348|FG000|Overall Study|Lost to Follow-up|0|||
146203952|NCT01510717|527259349|FG001|Overall Study|Lost to Follow-up|1|||
146203953|NCT01510717|527259348|FG000|Overall Study|Withdrawal by Subject|0|||
146203954|NCT01510717|527259349|FG001|Overall Study|Withdrawal by Subject|2|||
146203955|NCT02555215|527259352|FG000|Overall Study|Other|1|||
146203956|NCT02555215|527259352|FG000|Overall Study|Investigator Decision|2|||
146203957|NCT01595061|527259353|FG000|Overall Study|Never Treated|3|||
146203958|NCT01595061|527259353|FG000|Overall Study|Inadequate Pathology|1|||
146203959|NCT00529789|527259354|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
146203960|NCT00529789|527259354|FG000|Study Period II/III|Adverse Event|3|||
146203961|NCT00529789|527259354|FG000|Study Period II/III|Lack of Efficacy|2|||
146203962|NCT00529789|527259354|FG000|Study Period II/III|Withdrawal by Subject|1|||
146203963|NCT00529789|527259354|FG000|Study Period II/III|Protocol Violation|3|||
146203964|NCT00529789|527259354|FG000|Study Period II/III|Physician Decision|3|||
146203965|NCT00529789|527259354|FG000|Study Period II/III|Lost to Follow-up|3|||
146203966|NCT00529789|527259354|FG000|Study Period IV|Parent/Caregiver Decision|1|||
146203967|NCT00529789|527259354|FG000|Study Period IV|Adverse Event|1|||
146203968|NCT00529789|527259354|FG000|Study Period IV|Lack of Efficacy|1|||
146203969|NCT00529789|527259354|FG000|Study Period IV|Lost to Follow-up|3|||
146203970|NCT03194958|527259357|FG000|Overall Study|Death|0|||
146203971|NCT03194958|527259358|FG001|Overall Study|Death|1|||
146203972|NCT03194958|527259359|FG002|Overall Study|Death|1|||
146203973|NCT03194958|527259360|FG003|Overall Study|Death|1|||
146203974|NCT03194958|527259357|FG000|Overall Study|Withdrawal by Subject|24|||
146203975|NCT03194958|527259358|FG001|Overall Study|Withdrawal by Subject|27|||
146203976|NCT03194958|527259359|FG002|Overall Study|Withdrawal by Subject|7|||
146203977|NCT03194958|527259360|FG003|Overall Study|Withdrawal by Subject|22|||
146203978|NCT03194958|527259357|FG000|Overall Study|Lost to Follow-up|168|||
146203979|NCT03194958|527259358|FG001|Overall Study|Lost to Follow-up|196|||
146203980|NCT03194958|527259359|FG002|Overall Study|Lost to Follow-up|174|||
146203981|NCT03194958|527259360|FG003|Overall Study|Lost to Follow-up|186|||
146203982|NCT00959946|527259362|FG000|Overall Study|Adverse Event|0|||
146203983|NCT00959946|527259363|FG001|Overall Study|Adverse Event|0|||
146203984|NCT00959946|527259364|FG002|Overall Study|Adverse Event|2|||
146203985|NCT00959946|527259365|FG003|Overall Study|Adverse Event|1|||
146203986|NCT00959946|527259366|FG004|Overall Study|Adverse Event|0|||
146203987|NCT00959946|527259367|FG005|Overall Study|Adverse Event|1|||
146203988|NCT00959946|527259368|FG006|Overall Study|Adverse Event|0|||
146203989|NCT00959946|527259369|FG007|Overall Study|Adverse Event|0|||
146203990|NCT00959946|527259362|FG000|Overall Study|Death|0|||
146203991|NCT00959946|527259363|FG001|Overall Study|Death|0|||
146203992|NCT00959946|527259364|FG002|Overall Study|Death|0|||
146203993|NCT00959946|527259365|FG003|Overall Study|Death|0|||
146203994|NCT00959946|527259366|FG004|Overall Study|Death|0|||
146203995|NCT00959946|527259367|FG005|Overall Study|Death|1|||
146203996|NCT00959946|527259368|FG006|Overall Study|Death|0|||
146203997|NCT00959946|527259369|FG007|Overall Study|Death|0|||
146203998|NCT00959946|527259362|FG000|Overall Study|Disease Progression|2|||
146203999|NCT00959946|527259363|FG001|Overall Study|Disease Progression|4|||
146204000|NCT00959946|527259364|FG002|Overall Study|Disease Progression|2|||
146204001|NCT00959946|527259365|FG003|Overall Study|Disease Progression|4|||
146204002|NCT00959946|527259366|FG004|Overall Study|Disease Progression|4|||
146204003|NCT00959946|527259367|FG005|Overall Study|Disease Progression|6|||
146204004|NCT00959946|527259368|FG006|Overall Study|Disease Progression|2|||
146204005|NCT00959946|527259369|FG007|Overall Study|Disease Progression|2|||
146204006|NCT00959946|527259362|FG000|Overall Study|Withdrawal by Subject|0|||
146204007|NCT00959946|527259363|FG001|Overall Study|Withdrawal by Subject|0|||
146204008|NCT00959946|527259364|FG002|Overall Study|Withdrawal by Subject|0|||
146204009|NCT00959946|527259365|FG003|Overall Study|Withdrawal by Subject|0|||
146204010|NCT00959946|527259366|FG004|Overall Study|Withdrawal by Subject|0|||
146204011|NCT00959946|527259367|FG005|Overall Study|Withdrawal by Subject|1|||
146204012|NCT00959946|527259368|FG006|Overall Study|Withdrawal by Subject|0|||
146204013|NCT00959946|527259369|FG007|Overall Study|Withdrawal by Subject|0|||
146204014|NCT00356265|527259370|FG000|Overall Study|Withdrawal by Subject|0|||
146204015|NCT00356265|527259371|FG001|Overall Study|Withdrawal by Subject|0|||
146204016|NCT00356265|527259372|FG002|Overall Study|Withdrawal by Subject|1|||
146204017|NCT00159783|527259381|FG000|Overall Study|Adverse Event|5|||
146204018|NCT00159783|527259382|FG001|Overall Study|Adverse Event|7|||
146204019|NCT00159783|527259383|FG002|Overall Study|Adverse Event|9|||
146204020|NCT00159783|527259381|FG000|Overall Study|Lack of Efficacy|1|||
146204021|NCT00159783|527259382|FG001|Overall Study|Lack of Efficacy|2|||
146204022|NCT00159783|527259383|FG002|Overall Study|Lack of Efficacy|3|||
146204023|NCT00159783|527259381|FG000|Overall Study|Withdrawal by Subject|7|||
146204024|NCT00159783|527259382|FG001|Overall Study|Withdrawal by Subject|11|||
146204025|NCT00159783|527259383|FG002|Overall Study|Withdrawal by Subject|12|||
146204026|NCT00159783|527259381|FG000|Overall Study|Lost to Follow-up|6|||
146204027|NCT00159783|527259382|FG001|Overall Study|Lost to Follow-up|5|||
146204028|NCT00159783|527259383|FG002|Overall Study|Lost to Follow-up|11|||
146204029|NCT00159783|527259381|FG000|Overall Study|Other|0|||
146204030|NCT00159783|527259382|FG001|Overall Study|Other|2|||
146204031|NCT00159783|527259383|FG002|Overall Study|Other|4|||
146204032|NCT02538107|527259384|FG000|Overall Study|Did not receive any Mircera dose|11|||
146204033|NCT02538107|527259384|FG000|Overall Study|Missing|5|||
146204034|NCT02538107|527259384|FG000|Overall Study|Necessity of dialysis|20|||
146204035|NCT02538107|527259384|FG000|Overall Study|Administration of other ESA|11|||
146204036|NCT02538107|527259384|FG000|Overall Study|No further treatment necessary|18|||
146204037|NCT02538107|527259384|FG000|Overall Study|Withdrawal by Subject|17|||
146204038|NCT02538107|527259384|FG000|Overall Study|Death|4|||
146204039|NCT02538107|527259384|FG000|Overall Study|Administrative reason|5|||
146204040|NCT02538107|527259384|FG000|Overall Study|Adverse Event|4|||
146204041|NCT02538107|527259384|FG000|Overall Study|Surgery|1|||
146204042|NCT02538107|527259384|FG000|Overall Study|Other|7|||
146204043|NCT02538107|527259384|FG000|Overall Study|Not recorded|7|||
146204044|NCT01278394|527259385|FG000|Overall Study|Lost to Follow-up|1|||
146204045|NCT01236560|527259388|FG000|Overall Study|Adverse Event|0|||
146204046|NCT01236560|527259389|FG001|Overall Study|Adverse Event|2|||
146204047|NCT01236560|527259390|FG002|Overall Study|Adverse Event|1|||
146204048|NCT01236560|527259391|FG003|Overall Study|Adverse Event|3|||
146204049|NCT01236560|527259392|FG004|Overall Study|Adverse Event|0|||
146204050|NCT01236560|527259393|FG005|Overall Study|Adverse Event|0|||
146204051|NCT01236560|527259388|FG000|Overall Study|Death|0|||
146204052|NCT01236560|527259389|FG001|Overall Study|Death|1|||
146204053|NCT01236560|527259390|FG002|Overall Study|Death|0|||
146204054|NCT01236560|527259391|FG003|Overall Study|Death|1|||
146204055|NCT01236560|527259392|FG004|Overall Study|Death|0|||
146204056|NCT01236560|527259393|FG005|Overall Study|Death|0|||
146204057|NCT01236560|527259388|FG000|Overall Study|Lost to Follow-up|0|||
146204058|NCT01236560|527259389|FG001|Overall Study|Lost to Follow-up|1|||
146204059|NCT01236560|527259390|FG002|Overall Study|Lost to Follow-up|1|||
146204060|NCT01236560|527259391|FG003|Overall Study|Lost to Follow-up|0|||
146204061|NCT01236560|527259392|FG004|Overall Study|Lost to Follow-up|0|||
146204062|NCT01236560|527259393|FG005|Overall Study|Lost to Follow-up|0|||
146204063|NCT01236560|527259388|FG000|Overall Study|Physician Decision|0|||
146204064|NCT01236560|527259389|FG001|Overall Study|Physician Decision|1|||
146204065|NCT01236560|527259390|FG002|Overall Study|Physician Decision|8|||
146204066|NCT01236560|527259391|FG003|Overall Study|Physician Decision|0|||
146204067|NCT01236560|527259392|FG004|Overall Study|Physician Decision|0|||
146204068|NCT01236560|527259393|FG005|Overall Study|Physician Decision|0|||
146204069|NCT01236560|527259388|FG000|Overall Study|Withdrawal by Subject|0|||
146204070|NCT01236560|527259389|FG001|Overall Study|Withdrawal by Subject|0|||
146204071|NCT01236560|527259390|FG002|Overall Study|Withdrawal by Subject|1|||
146204072|NCT01236560|527259391|FG003|Overall Study|Withdrawal by Subject|2|||
146204073|NCT01236560|527259392|FG004|Overall Study|Withdrawal by Subject|0|||
146204074|NCT01236560|527259393|FG005|Overall Study|Withdrawal by Subject|0|||
146204075|NCT01236560|527259388|FG000|Overall Study|Progressive disease|5|||
146204076|NCT01236560|527259389|FG001|Overall Study|Progressive disease|19|||
146204077|NCT01236560|527259390|FG002|Overall Study|Progressive disease|9|||
146204078|NCT01236560|527259391|FG003|Overall Study|Progressive disease|16|||
146204079|NCT01236560|527259392|FG004|Overall Study|Progressive disease|0|||
146204080|NCT01236560|527259393|FG005|Overall Study|Progressive disease|0|||
146204081|NCT00468910|527259394|FG000|Overall Study|Lost to Follow-up|2|||
146204082|NCT00468910|527259395|FG001|Overall Study|Lost to Follow-up|1|||
146204083|NCT00468910|527259394|FG000|Overall Study|Withdrawal by Subject|2|||
146204084|NCT00468910|527259395|FG001|Overall Study|Withdrawal by Subject|1|||
146204085|NCT00468910|527259394|FG000|Overall Study|Medical Contraindication|0|||
146204086|NCT00468910|527259395|FG001|Overall Study|Medical Contraindication|1|||
146204087|NCT01909778|527259396|FG000|Overall Study|failed screening|1|||
146204088|NCT00919763|527259397|FG000|Overall Study|Adverse Event|7|||
146204089|NCT00919763|527259398|FG001|Overall Study|Adverse Event|1|||
146204090|NCT00919763|527259397|FG000|Overall Study|Lost to Follow-up|1|||
146204091|NCT00919763|527259398|FG001|Overall Study|Lost to Follow-up|0|||
146204092|NCT00919763|527259397|FG000|Overall Study|Protocol Violation|1|||
146204093|NCT00919763|527259398|FG001|Overall Study|Protocol Violation|1|||
146204094|NCT00919763|527259397|FG000|Overall Study|Withdrawal by Subject|3|||
146204095|NCT00919763|527259398|FG001|Overall Study|Withdrawal by Subject|1|||
146204096|NCT00919763|527259397|FG000|Overall Study|Non-compliance|0|||
146204097|NCT00919763|527259398|FG001|Overall Study|Non-compliance|1|||
146204098|NCT02471755|527259400|FG000|Overall Study|Withdrawal by Subject|1|||
146204099|NCT02471755|527259401|FG001|Overall Study|Withdrawal by Subject|0|||
146204100|NCT02471755|527259400|FG000|Overall Study|Lost to Follow-up|0|||
146204101|NCT02471755|527259401|FG001|Overall Study|Lost to Follow-up|1|||
146204102|NCT04740164|527259402|FG000|Overall Study|Lack of Efficacy|4|||
146204103|NCT04740164|527259403|FG001|Overall Study|Lack of Efficacy|0|||
146204104|NCT04740164|527259402|FG000|Overall Study|Physician Decision|3|||
146204105|NCT04740164|527259403|FG001|Overall Study|Physician Decision|3|||
146204106|NCT05323734|527259407|FG000|Overall Study|Adverse Event|5|||
146204107|NCT05323734|527259408|FG001|Overall Study|Adverse Event|2|||
146204108|NCT05323734|527259407|FG000|Overall Study|Physician Decision|1|||
146204109|NCT05323734|527259408|FG001|Overall Study|Physician Decision|0|||
146204110|NCT05323734|527259407|FG000|Overall Study|Lack of Efficacy|1|||
146204111|NCT05323734|527259408|FG001|Overall Study|Lack of Efficacy|2|||
146204112|NCT05323734|527259407|FG000|Overall Study|Withdrawal by Subject|2|||
146204113|NCT05323734|527259408|FG001|Overall Study|Withdrawal by Subject|0|||
146204114|NCT05323734|527259407|FG000|Overall Study|Participant Withdrawn Due|0|||
146204115|NCT05323734|527259408|FG001|Overall Study|Participant Withdrawn Due|1|||
146204116|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146204117|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146204118|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
146204119|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204120|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204121|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204122|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204123|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204124|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204125|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204126|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204127|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
146204128|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
146204129|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
146204130|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
146204131|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
146204132|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
146204133|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
146204134|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
146204135|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
146204136|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
146204137|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
146204138|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
146204139|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
146204140|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
146204141|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204142|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204143|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204144|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204145|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204146|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204147|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204148|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204149|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204150|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204151|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
146204152|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204153|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204154|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
146204155|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204156|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204157|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204158|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204159|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204160|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204161|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204162|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204163|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
146204164|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146204165|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146204166|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
146204167|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
146204168|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204169|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204170|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204171|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204172|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204173|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204174|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204175|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
146204176|NCT05061693|527259409|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146204177|NCT05061693|527259410|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
146204178|NCT05061693|527259411|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146204179|NCT05061693|527259412|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
146204180|NCT05061693|527259413|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204181|NCT05061693|527259414|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204182|NCT05061693|527259415|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204183|NCT05061693|527259416|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204184|NCT05061693|527259417|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204185|NCT05061693|527259418|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204186|NCT05061693|527259419|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204187|NCT05061693|527259420|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
146204188|NCT05061693|527259409|FG000|24-week Extension Period|Adverse Event|0|||
146204189|NCT05061693|527259410|FG001|24-week Extension Period|Adverse Event|0|||
146204190|NCT05061693|527259411|FG002|24-week Extension Period|Adverse Event|0|||
146204191|NCT05061693|527259412|FG003|24-week Extension Period|Adverse Event|0|||
146204192|NCT05061693|527259413|FG004|24-week Extension Period|Adverse Event|0|||
146204193|NCT05061693|527259414|FG005|24-week Extension Period|Adverse Event|0|||
146204194|NCT05061693|527259415|FG006|24-week Extension Period|Adverse Event|0|||
146204195|NCT05061693|527259416|FG007|24-week Extension Period|Adverse Event|2|||
146431154|NCT00467896|528088163|FG000|Overall Study|Patient weaned off iloprost|1|||
146082894|NCT02616146|526824696|FG000|Overall Study|Participant moved|4|||
146204196|NCT05061693|527259417|FG008|24-week Extension Period|Adverse Event|2|||
146204197|NCT05061693|527259418|FG009|24-week Extension Period|Adverse Event|0|||
146204198|NCT05061693|527259419|FG010|24-week Extension Period|Adverse Event|1|||
146204199|NCT05061693|527259420|FG011|24-week Extension Period|Adverse Event|3|||
146204200|NCT05061693|527259409|FG000|24-week Extension Period|Lack of Efficacy|0|||
146204201|NCT05061693|527259410|FG001|24-week Extension Period|Lack of Efficacy|0|||
146204202|NCT05061693|527259411|FG002|24-week Extension Period|Lack of Efficacy|0|||
146204203|NCT05061693|527259412|FG003|24-week Extension Period|Lack of Efficacy|0|||
146204204|NCT05061693|527259413|FG004|24-week Extension Period|Lack of Efficacy|0|||
146204205|NCT05061693|527259414|FG005|24-week Extension Period|Lack of Efficacy|0|||
146204206|NCT05061693|527259415|FG006|24-week Extension Period|Lack of Efficacy|0|||
146204207|NCT05061693|527259416|FG007|24-week Extension Period|Lack of Efficacy|0|||
146204208|NCT05061693|527259417|FG008|24-week Extension Period|Lack of Efficacy|0|||
146204209|NCT05061693|527259418|FG009|24-week Extension Period|Lack of Efficacy|0|||
146204210|NCT05061693|527259419|FG010|24-week Extension Period|Lack of Efficacy|2|||
146204211|NCT05061693|527259420|FG011|24-week Extension Period|Lack of Efficacy|0|||
146204212|NCT05061693|527259409|FG000|24-week Extension Period|Lost to Follow-up|0|||
146204213|NCT05061693|527259410|FG001|24-week Extension Period|Lost to Follow-up|0|||
146204214|NCT05061693|527259411|FG002|24-week Extension Period|Lost to Follow-up|0|||
146204215|NCT05061693|527259412|FG003|24-week Extension Period|Lost to Follow-up|0|||
146204216|NCT05061693|527259413|FG004|24-week Extension Period|Lost to Follow-up|0|||
146204217|NCT05061693|527259414|FG005|24-week Extension Period|Lost to Follow-up|0|||
146204218|NCT05061693|527259415|FG006|24-week Extension Period|Lost to Follow-up|1|||
146204219|NCT05061693|527259416|FG007|24-week Extension Period|Lost to Follow-up|0|||
146204220|NCT05061693|527259417|FG008|24-week Extension Period|Lost to Follow-up|1|||
146204221|NCT05061693|527259418|FG009|24-week Extension Period|Lost to Follow-up|1|||
146204222|NCT05061693|527259419|FG010|24-week Extension Period|Lost to Follow-up|0|||
146204223|NCT05061693|527259420|FG011|24-week Extension Period|Lost to Follow-up|0|||
146204224|NCT05061693|527259409|FG000|24-week Extension Period|Withdrawal by Subject|0|||
146204225|NCT05061693|527259410|FG001|24-week Extension Period|Withdrawal by Subject|0|||
146204226|NCT05061693|527259411|FG002|24-week Extension Period|Withdrawal by Subject|0|||
146204227|NCT05061693|527259412|FG003|24-week Extension Period|Withdrawal by Subject|0|||
146204228|NCT05061693|527259413|FG004|24-week Extension Period|Withdrawal by Subject|0|||
146204229|NCT05061693|527259414|FG005|24-week Extension Period|Withdrawal by Subject|0|||
146204230|NCT05061693|527259415|FG006|24-week Extension Period|Withdrawal by Subject|0|||
146204231|NCT05061693|527259416|FG007|24-week Extension Period|Withdrawal by Subject|0|||
146204232|NCT05061693|527259417|FG008|24-week Extension Period|Withdrawal by Subject|1|||
146204233|NCT05061693|527259418|FG009|24-week Extension Period|Withdrawal by Subject|2|||
146204234|NCT05061693|527259419|FG010|24-week Extension Period|Withdrawal by Subject|2|||
146204235|NCT05061693|527259420|FG011|24-week Extension Period|Withdrawal by Subject|1|||
146204236|NCT05061693|527259409|FG000|24-week Extension Period|Sponsor Decision|0|||
146204237|NCT05061693|527259410|FG001|24-week Extension Period|Sponsor Decision|0|||
146204238|NCT05061693|527259411|FG002|24-week Extension Period|Sponsor Decision|0|||
146204239|NCT05061693|527259412|FG003|24-week Extension Period|Sponsor Decision|0|||
146204240|NCT05061693|527259413|FG004|24-week Extension Period|Sponsor Decision|0|||
146204241|NCT05061693|527259414|FG005|24-week Extension Period|Sponsor Decision|0|||
146204242|NCT05061693|527259415|FG006|24-week Extension Period|Sponsor Decision|0|||
146204243|NCT05061693|527259416|FG007|24-week Extension Period|Sponsor Decision|1|||
146204244|NCT05061693|527259417|FG008|24-week Extension Period|Sponsor Decision|0|||
146204245|NCT05061693|527259418|FG009|24-week Extension Period|Sponsor Decision|0|||
146204246|NCT05061693|527259419|FG010|24-week Extension Period|Sponsor Decision|0|||
146204247|NCT05061693|527259420|FG011|24-week Extension Period|Sponsor Decision|0|||
146204248|NCT05061693|527259409|FG000|24-week Extension Period|Site Closure|0|||
146204249|NCT05061693|527259410|FG001|24-week Extension Period|Site Closure|0|||
146204250|NCT05061693|527259411|FG002|24-week Extension Period|Site Closure|0|||
146204251|NCT05061693|527259412|FG003|24-week Extension Period|Site Closure|0|||
146204252|NCT05061693|527259413|FG004|24-week Extension Period|Site Closure|0|||
146204253|NCT05061693|527259414|FG005|24-week Extension Period|Site Closure|0|||
146204254|NCT05061693|527259415|FG006|24-week Extension Period|Site Closure|0|||
146204255|NCT05061693|527259416|FG007|24-week Extension Period|Site Closure|0|||
146204256|NCT05061693|527259417|FG008|24-week Extension Period|Site Closure|1|||
146204257|NCT05061693|527259418|FG009|24-week Extension Period|Site Closure|0|||
146204258|NCT05061693|527259419|FG010|24-week Extension Period|Site Closure|0|||
146204259|NCT05061693|527259420|FG011|24-week Extension Period|Site Closure|1|||
146204260|NCT01152190|527259421|FG000|Overall Study|Adverse Event|2|||
146204261|NCT01152190|527259422|FG001|Overall Study|Adverse Event|4|||
146204262|NCT01152190|527259421|FG000|Overall Study|Death|1|||
146204263|NCT01152190|527259422|FG001|Overall Study|Death|0|||
146204264|NCT01152190|527259421|FG000|Overall Study|Protocol Violation|1|||
146204265|NCT01152190|527259422|FG001|Overall Study|Protocol Violation|1|||
146204266|NCT01152190|527259421|FG000|Overall Study|Withdrawal by Subject|1|||
146204267|NCT01152190|527259422|FG001|Overall Study|Withdrawal by Subject|3|||
146204268|NCT03603717|527259429|FG000|Overall Study|Lost to Follow-up|20|||
146204269|NCT03603717|527259430|FG001|Overall Study|Lost to Follow-up|20|||
146204270|NCT03603717|527259429|FG000|Overall Study|Withdrawal by Subject|16|||
146204271|NCT03603717|527259430|FG001|Overall Study|Withdrawal by Subject|10|||
146204272|NCT00732381|527259433|FG000|Overall Study|Adverse Event|1|||
146204273|NCT00732381|527259434|FG001|Overall Study|Adverse Event|0|||
146204274|NCT00732381|527259433|FG000|Overall Study|Treatment Failure|1|||
146204275|NCT00732381|527259434|FG001|Overall Study|Treatment Failure|1|||
146204276|NCT00457691|527259435|FG000|Overall Study|Adverse Event|4|||
146204277|NCT00457691|527259436|FG001|Overall Study|Adverse Event|1|||
146204278|NCT00457691|527259435|FG000|Overall Study|Death|163|||
146204279|NCT00457691|527259436|FG001|Overall Study|Death|148|||
146204280|NCT00457691|527259435|FG000|Overall Study|Protocol Violation|1|||
146204281|NCT00457691|527259436|FG001|Overall Study|Protocol Violation|3|||
146204282|NCT00457691|527259435|FG000|Overall Study|Lost to Follow-up|23|||
146204283|NCT00457691|527259436|FG001|Overall Study|Lost to Follow-up|14|||
146204284|NCT00457691|527259435|FG000|Overall Study|Study terminated by Sponsor|1|||
146204285|NCT00457691|527259436|FG001|Overall Study|Study terminated by Sponsor|1|||
146204286|NCT00457691|527259435|FG000|Overall Study|Subject refused (reason other than AE)|14|||
146204287|NCT00457691|527259436|FG001|Overall Study|Subject refused (reason other than AE)|19|||
146204288|NCT00457691|527259435|FG000|Overall Study|Disease progression, study terminated|180|||
146204289|NCT00457691|527259436|FG001|Overall Study|Disease progression, study terminated|196|||
146204290|NCT01420549|527259437|FG000|Overall Study|Adverse Event|1|||
146204291|NCT01420549|527259438|FG001|Overall Study|Adverse Event|1|||
146204292|NCT01420549|527259437|FG000|Overall Study|Lost to Follow-up|2|||
146204293|NCT01420549|527259438|FG001|Overall Study|Lost to Follow-up|2|||
146204294|NCT01420549|527259437|FG000|Overall Study|Protocol Violation|0|||
146204295|NCT01420549|527259438|FG001|Overall Study|Protocol Violation|1|||
146204296|NCT01420549|527259437|FG000|Overall Study|Non-adherence to medication|4|||
146204297|NCT01420549|527259438|FG001|Overall Study|Non-adherence to medication|1|||
146204298|NCT05777785|527260587|FG000|Overall Study|Withdrawal by Subject|5|||
146204299|NCT05777785|527260587|FG000|Overall Study|Lost to Follow-up|1|||
146204300|NCT05644444|527260592|FG000|Tolerance Phase|Adverse Event|0|||
146204301|NCT05644444|527260593|FG001|Tolerance Phase|Adverse Event|2|||
146204302|NCT05644444|527260592|FG000|Treatment Phase|Adverse Event|0|||
146204303|NCT05644444|527260593|FG001|Treatment Phase|Adverse Event|2|||
146204304|NCT04817670|527260594|FG000|Overall Study|Withdrawal by Subject|1|||
146204305|NCT04817670|527260595|FG001|Overall Study|Withdrawal by Subject|0|||
146204306|NCT04817670|527260596|FG002|Overall Study|Withdrawal by Subject|0|||
146204307|NCT04817670|527260597|FG003|Overall Study|Withdrawal by Subject|0|||
146204308|NCT04817670|527260598|FG004|Overall Study|Withdrawal by Subject|0|||
146204309|NCT04817670|527260594|FG000|Overall Study|Lost to Follow-up|0|||
146204310|NCT04817670|527260595|FG001|Overall Study|Lost to Follow-up|0|||
146204311|NCT04817670|527260596|FG002|Overall Study|Lost to Follow-up|1|||
146204312|NCT04817670|527260597|FG003|Overall Study|Lost to Follow-up|0|||
146204313|NCT04817670|527260598|FG004|Overall Study|Lost to Follow-up|0|||
146204314|NCT02396316|527260599|FG000|Overall Study|Physician Decision|1|||
146204315|NCT02396316|527260600|FG001|Overall Study|Physician Decision|0|||
146204316|NCT02396316|527260599|FG000|Overall Study|Progressive disease|6|||
146204317|NCT02396316|527260600|FG001|Overall Study|Progressive disease|3|||
146204318|NCT02396316|527260599|FG000|Overall Study|Protocol Violation|0|||
146204319|NCT02396316|527260600|FG001|Overall Study|Protocol Violation|1|||
146204320|NCT02396316|527260599|FG000|Overall Study|Treatment unblinded|0|||
146204321|NCT02396316|527260600|FG001|Overall Study|Treatment unblinded|1|||
146204322|NCT00714714|527260602|FG000|Overall Study|Adverse Event|1|||
146204323|NCT01149369|527260603|FG000|Overall Study|Adverse Event|6|||
146204324|NCT01149369|527260604|FG001|Overall Study|Adverse Event|3|||
146204325|NCT03644849|527260607|FG000|Overall Study|Lost to Follow-up|1|||
146204326|NCT03644849|527260608|FG001|Overall Study|Lost to Follow-up|3|||
146204327|NCT00508924|527260609|FG000|Overall Study|Protocol Violation|0|||
146204328|NCT00508924|527260610|FG001|Overall Study|Protocol Violation|0|||
146204329|NCT00508924|527260611|FG002|Overall Study|Protocol Violation|1|||
146204330|NCT00508924|527260612|FG003|Overall Study|Protocol Violation|1|||
146204331|NCT04532528|527260613|FG000|Overall Study|Adverse Event|12|||
146204332|NCT04532528|527260614|FG001|Overall Study|Adverse Event|17|||
146204333|NCT04532528|527260613|FG000|Overall Study|Withdrawal of consent|16|||
146204334|NCT04532528|527260614|FG001|Overall Study|Withdrawal of consent|17|||
146204335|NCT04532528|527260613|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
146204336|NCT04532528|527260614|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
146204337|NCT04532528|527260613|FG000|Overall Study|Lost to Follow-up|69|||
146204338|NCT04532528|527260614|FG001|Overall Study|Lost to Follow-up|68|||
146204339|NCT04532528|527260613|FG000|Overall Study|Administrative problems|12|||
146204340|NCT04532528|527260614|FG001|Overall Study|Administrative problems|14|||
146204341|NCT04532528|527260613|FG000|Overall Study|Death|3|||
146204342|NCT04532528|527260614|FG001|Overall Study|Death|3|||
146204343|NCT04532528|527260613|FG000|Overall Study|Other|38|||
146204344|NCT04532528|527260614|FG001|Overall Study|Other|46|||
146204345|NCT01837966|527260620|FG000|Overall Study|Withdrawal by Subject|2|||
146204346|NCT01837966|527260621|FG001|Overall Study|Withdrawal by Subject|1|||
146204347|NCT01202955|527260622|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
146204348|NCT01202955|527260623|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
146204349|NCT02928224|527260626|FG000|Overall Study|Lost to Follow-up|1|||
146204350|NCT02928224|527260627|FG001|Overall Study|Lost to Follow-up|1|||
146204351|NCT02928224|527260628|FG002|Overall Study|Lost to Follow-up|3|||
146204352|NCT02928224|527260629|FG003|Overall Study|Lost to Follow-up|0|||
146204353|NCT02928224|527260626|FG000|Overall Study|Death|30|||
146204354|NCT02928224|527260627|FG001|Overall Study|Death|209|||
146204355|NCT02928224|527260628|FG002|Overall Study|Death|193|||
146204356|NCT02928224|527260629|FG003|Overall Study|Death|198|||
146204357|NCT02928224|527260626|FG000|Overall Study|Withdrawal by Subject|0|||
146204358|NCT02928224|527260627|FG001|Overall Study|Withdrawal by Subject|3|||
146204359|NCT02928224|527260628|FG002|Overall Study|Withdrawal by Subject|7|||
146204360|NCT02928224|527260629|FG003|Overall Study|Withdrawal by Subject|20|||
146204361|NCT02928224|527260626|FG000|Overall Study|Study participation terminated by sponsor|3|||
146204362|NCT02928224|527260627|FG001|Overall Study|Study participation terminated by sponsor|8|||
146204363|NCT02928224|527260628|FG002|Overall Study|Study participation terminated by sponsor|12|||
146204364|NCT02928224|527260629|FG003|Overall Study|Study participation terminated by sponsor|3|||
146204365|NCT02928224|527260626|FG000|Overall Study|Other|3|||
146204366|NCT02928224|527260627|FG001|Overall Study|Other|3|||
146204367|NCT02928224|527260628|FG002|Overall Study|Other|5|||
146204368|NCT02928224|527260629|FG003|Overall Study|Other|0|||
146204369|NCT02115139|527260630|FG000|Overall Study|Protocol Violation|1|||
146204370|NCT02115139|527260630|FG000|Overall Study|treatment discontinuation|6|||
146204371|NCT01943916|527260631|FG000|Overall Study|Technically invalid images|10|||
146204372|NCT01943916|527260631|FG000|Overall Study|Enrollment Failure|23|||
146204373|NCT01943916|527260631|FG000|Overall Study|Pilot Phase exclusion|100|||
146204374|NCT01943916|527260631|FG000|Overall Study|Quality Assurance Reader Fail|130|||
146204375|NCT01943916|527260631|FG000|Overall Study|Technical Failure|39|||
146204376|NCT01943916|527260631|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
146204377|NCT01943916|527260631|FG000|Overall Study|No Truth Panel Review|38|||
146204378|NCT01943916|527260631|FG000|Overall Study|Protocol Deviation|1|||
146204379|NCT01576484|527260632|FG000|Overall Study|Adverse Event|1|||
146204380|NCT01576484|527260633|FG001|Overall Study|Adverse Event|1|||
146204381|NCT01576484|527260632|FG000|Overall Study|Protocol Violation|0|||
146204382|NCT01576484|527260633|FG001|Overall Study|Protocol Violation|2|||
146204383|NCT01576484|527260632|FG000|Overall Study|Sponsor Decision|2|||
146204384|NCT01576484|527260633|FG001|Overall Study|Sponsor Decision|8|||
146204385|NCT01576484|527260632|FG000|Overall Study|Withdrawal by Subject|0|||
146204386|NCT01576484|527260633|FG001|Overall Study|Withdrawal by Subject|3|||
146204387|NCT01576484|527260632|FG000|Overall Study|Other|2|||
146204388|NCT01576484|527260633|FG001|Overall Study|Other|5|||
146204389|NCT03823911|527260637|FG000|Overall Study|Lost to Follow-up|1|||
146204390|NCT03823911|527260638|FG001|Overall Study|Lost to Follow-up|5|||
146204391|NCT03823911|527260639|FG002|Overall Study|Lost to Follow-up|2|||
146204392|NCT03823911|527260637|FG000|Overall Study|Did not meet eligibility criteria|13|||
146204393|NCT03823911|527260638|FG001|Overall Study|Did not meet eligibility criteria|7|||
146204394|NCT03823911|527260639|FG002|Overall Study|Did not meet eligibility criteria|4|||
146204395|NCT03823911|527260637|FG000|Overall Study|Death|0|||
146204396|NCT03823911|527260638|FG001|Overall Study|Death|1|||
146204397|NCT03823911|527260639|FG002|Overall Study|Death|0|||
146204398|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
146204399|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
146204400|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
146204401|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
146082895|NCT02616146|526824697|FG001|Overall Study|Participant moved|3|||
146204402|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
146204403|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
146204404|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
146204405|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
146204406|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
146204407|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
146204408|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
146204409|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
146204410|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
146204411|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
146204412|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
146204413|NCT00958633|527260644|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
146204414|NCT00958633|527260645|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
146204415|NCT00958633|527260646|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
146204416|NCT00958633|527260644|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
146204417|NCT00958633|527260645|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
146204418|NCT00958633|527260646|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
146204419|NCT00433199|527260654|FG000|Double-Blind Period|Adverse Event|0|||
146204420|NCT00433199|527260655|FG001|Double-Blind Period|Adverse Event|25|||
146204421|NCT00433199|527260654|FG000|Double-Blind Period|Lack of Efficacy|0|||
146204422|NCT00433199|527260655|FG001|Double-Blind Period|Lack of Efficacy|2|||
146204423|NCT00433199|527260654|FG000|Double-Blind Period|Lost to Follow-up|2|||
146204424|NCT00433199|527260655|FG001|Double-Blind Period|Lost to Follow-up|5|||
146204425|NCT00433199|527260654|FG000|Double-Blind Period|Withdrawal by Subject|8|||
146204426|NCT00433199|527260655|FG001|Double-Blind Period|Withdrawal by Subject|19|||
146204427|NCT00433199|527260654|FG000|Double-Blind Period|Protocol Violation|1|||
146204428|NCT00433199|527260655|FG001|Double-Blind Period|Protocol Violation|10|||
146204429|NCT00433199|527260654|FG000|Double-Blind Period|Administrative|1|||
146204430|NCT00433199|527260655|FG001|Double-Blind Period|Administrative|5|||
146204431|NCT00433199|527260654|FG000|Open-Label Period|Adverse Event|0|||
146204432|NCT00433199|527260655|FG001|Open-Label Period|Adverse Event|19|||
146204433|NCT00433199|527260654|FG000|Open-Label Period|Lack of Efficacy|0|||
146204434|NCT00433199|527260655|FG001|Open-Label Period|Lack of Efficacy|2|||
146204435|NCT00433199|527260654|FG000|Open-Label Period|Lost to Follow-up|0|||
146204436|NCT00433199|527260655|FG001|Open-Label Period|Lost to Follow-up|3|||
146204437|NCT00433199|527260654|FG000|Open-Label Period|Withdrawal by Subject|0|||
146204438|NCT00433199|527260655|FG001|Open-Label Period|Withdrawal by Subject|7|||
146204439|NCT00433199|527260654|FG000|Open-Label Period|Protocol Violation|0|||
146204440|NCT00433199|527260655|FG001|Open-Label Period|Protocol Violation|2|||
146204441|NCT00433199|527260654|FG000|Open-Label Period|Administrative|0|||
146204442|NCT00433199|527260655|FG001|Open-Label Period|Administrative|1|||
146204443|NCT00357097|527260656|FG000|Overall Study|Did not meet inclusion criteria|5|||
146204444|NCT00357097|527260657|FG001|Overall Study|Did not meet inclusion criteria|3|||
146204445|NCT00357097|527260656|FG000|Overall Study|Adverse Event|34|||
146204446|NCT00357097|527260657|FG001|Overall Study|Adverse Event|6|||
146204447|NCT00357097|527260656|FG000|Overall Study|Withdrawal by Subject|8|||
146204448|NCT00357097|527260657|FG001|Overall Study|Withdrawal by Subject|7|||
146204449|NCT00357097|527260656|FG000|Overall Study|Non-compliance|1|||
146204450|NCT00357097|527260657|FG001|Overall Study|Non-compliance|2|||
146204451|NCT00357097|527260656|FG000|Overall Study|Lack of Efficacy|2|||
146204452|NCT00357097|527260657|FG001|Overall Study|Lack of Efficacy|8|||
146204453|NCT00357097|527260656|FG000|Overall Study|Met Exclusion Criteria|3|||
146204454|NCT00357097|527260657|FG001|Overall Study|Met Exclusion Criteria|1|||
146204455|NCT00357097|527260656|FG000|Overall Study|Other|1|||
146204456|NCT00357097|527260657|FG001|Overall Study|Other|1|||
146204457|NCT00357097|527260656|FG000|Overall Study|Increase of RLS Symptoms|0|||
146204458|NCT00357097|527260657|FG001|Overall Study|Increase of RLS Symptoms|1|||
146204459|NCT00094575|527260658|FG000|Overall Study|Death|146|||
146204460|NCT00094575|527260659|FG001|Overall Study|Death|146|||
146204461|NCT04305405|527260660|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146204462|NCT04305405|527260661|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146204463|NCT00206375|527260663|FG000|Overall Study|Lost to Follow-up|1|||
146204464|NCT00206375|527260664|FG001|Overall Study|Lost to Follow-up|0|||
146204465|NCT00206375|527260665|FG002|Overall Study|Lost to Follow-up|0|||
146204466|NCT00206375|527260663|FG000|Overall Study|Withdrawal by Subject|2|||
146204467|NCT00206375|527260664|FG001|Overall Study|Withdrawal by Subject|1|||
146204468|NCT00206375|527260665|FG002|Overall Study|Withdrawal by Subject|3|||
146204469|NCT00206375|527260663|FG000|Overall Study|Study terminated due to lack of funds|0|||
146204470|NCT00206375|527260664|FG001|Overall Study|Study terminated due to lack of funds|1|||
146204471|NCT00206375|527260665|FG002|Overall Study|Study terminated due to lack of funds|1|||
146204472|NCT00837616|527260668|FG000|Overall Study|Withdrawal by Subject|0|||
146204473|NCT00837616|527260669|FG001|Overall Study|Withdrawal by Subject|1|||
146204474|NCT02674750|527260670|FG000|Overall Study|Death|4|||
146204475|NCT02674750|527260671|FG001|Overall Study|Death|5|||
146204476|NCT02674750|527260672|FG002|Overall Study|Death|8|||
146204477|NCT02674750|527260670|FG000|Overall Study|Lost to Follow-up|0|||
146204478|NCT02674750|527260671|FG001|Overall Study|Lost to Follow-up|8|||
146204479|NCT02674750|527260672|FG002|Overall Study|Lost to Follow-up|0|||
146204480|NCT02674750|527260670|FG000|Overall Study|Lack of Efficacy|1|||
146204481|NCT02674750|527260671|FG001|Overall Study|Lack of Efficacy|17|||
146204482|NCT02674750|527260672|FG002|Overall Study|Lack of Efficacy|3|||
146204483|NCT02674750|527260670|FG000|Overall Study|Withdrawal by Subject|0|||
146204484|NCT02674750|527260671|FG001|Overall Study|Withdrawal by Subject|7|||
146204485|NCT02674750|527260672|FG002|Overall Study|Withdrawal by Subject|1|||
146204486|NCT02674750|527260670|FG000|Overall Study|Other|0|||
146204487|NCT02674750|527260671|FG001|Overall Study|Other|8|||
146204488|NCT02674750|527260672|FG002|Overall Study|Other|0|||
146204489|NCT01685606|527260673|FG000|Overall Study|Withdrawal by Subject|1|||
146204490|NCT01787760|527260674|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
146204491|NCT01787760|527260675|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
146204492|NCT01787760|527260676|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
146204493|NCT01787760|527260674|FG000|Overall Study|Decompensated on left exotropia|0|||
146204494|NCT01787760|527260675|FG001|Overall Study|Decompensated on left exotropia|0|||
146204495|NCT01787760|527260676|FG002|Overall Study|Decompensated on left exotropia|1|||
146204496|NCT01787760|527260674|FG000|Overall Study|Dryness|0|||
146204497|NCT01787760|527260675|FG001|Overall Study|Dryness|1|||
146204498|NCT01787760|527260676|FG002|Overall Study|Dryness|0|||
146204499|NCT01787760|527260674|FG000|Overall Study|Relocation|1|||
146204500|NCT01787760|527260675|FG001|Overall Study|Relocation|1|||
146204501|NCT01787760|527260676|FG002|Overall Study|Relocation|0|||
146204502|NCT01787760|527260674|FG000|Overall Study|Lens discomfort|3|||
146204503|NCT01787760|527260675|FG001|Overall Study|Lens discomfort|0|||
146204504|NCT01787760|527260676|FG002|Overall Study|Lens discomfort|0|||
146204505|NCT01787760|527260674|FG000|Overall Study|Lens handling difficulty|1|||
146204506|NCT01787760|527260675|FG001|Overall Study|Lens handling difficulty|2|||
146204507|NCT01787760|527260676|FG002|Overall Study|Lens handling difficulty|0|||
146204508|NCT01787760|527260674|FG000|Overall Study|Protocol Violation|6|||
146204509|NCT01787760|527260675|FG001|Overall Study|Protocol Violation|0|||
146204510|NCT01787760|527260676|FG002|Overall Study|Protocol Violation|1|||
146204511|NCT01787760|527260674|FG000|Overall Study|Withdrawal by Subject|5|||
146204512|NCT01787760|527260675|FG001|Overall Study|Withdrawal by Subject|1|||
146204513|NCT01787760|527260676|FG002|Overall Study|Withdrawal by Subject|2|||
146204514|NCT01787760|527260674|FG000|Overall Study|Lost to Follow-up|1|||
146204515|NCT01787760|527260675|FG001|Overall Study|Lost to Follow-up|0|||
146204516|NCT01787760|527260676|FG002|Overall Study|Lost to Follow-up|1|||
146204517|NCT01787760|527260674|FG000|Overall Study|Stroke|1|||
146204518|NCT01787760|527260675|FG001|Overall Study|Stroke|0|||
146204519|NCT01787760|527260676|FG002|Overall Study|Stroke|0|||
146204520|NCT01787760|527260674|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
146204521|NCT01787760|527260675|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
146204522|NCT01787760|527260676|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
146204523|NCT01787760|527260674|FG000|Overall Study|Unsatisfactory physiological response|2|||
146204524|NCT01787760|527260675|FG001|Overall Study|Unsatisfactory physiological response|4|||
146204525|NCT01787760|527260676|FG002|Overall Study|Unsatisfactory physiological response|0|||
146204526|NCT01787760|527260674|FG000|Overall Study|Unsatisfactory visual response|1|||
146204527|NCT01787760|527260675|FG001|Overall Study|Unsatisfactory visual response|1|||
146204528|NCT01787760|527260676|FG002|Overall Study|Unsatisfactory visual response|0|||
146204529|NCT01787760|527260674|FG000|Overall Study|Near vision blur|1|||
146204530|NCT01787760|527260675|FG001|Overall Study|Near vision blur|0|||
146204531|NCT01787760|527260676|FG002|Overall Study|Near vision blur|0|||
146204532|NCT03512756|527260677|FG000|Part 1|Death|23|||
146204533|NCT03512756|527260678|FG001|Part 1|Death|18|||
146204534|NCT03512756|527260679|FG002|Part 1|Death|0|||
146204535|NCT03512756|527260680|FG003|Part 1|Death|0|||
146204536|NCT03512756|527260677|FG000|Part 1|Lost to Follow-up|0|||
146204537|NCT03512756|527260678|FG001|Part 1|Lost to Follow-up|3|||
146204538|NCT03512756|527260679|FG002|Part 1|Lost to Follow-up|0|||
146204539|NCT03512756|527260680|FG003|Part 1|Lost to Follow-up|0|||
146204540|NCT03512756|527260677|FG000|Part 1|Physician Decision|0|||
146204541|NCT03512756|527260678|FG001|Part 1|Physician Decision|1|||
146204542|NCT03512756|527260679|FG002|Part 1|Physician Decision|0|||
146204543|NCT03512756|527260680|FG003|Part 1|Physician Decision|0|||
146204544|NCT03512756|527260677|FG000|Part 1|Withdrawal by Subject|2|||
146204545|NCT03512756|527260678|FG001|Part 1|Withdrawal by Subject|2|||
146204546|NCT03512756|527260679|FG002|Part 1|Withdrawal by Subject|0|||
146204547|NCT03512756|527260680|FG003|Part 1|Withdrawal by Subject|0|||
146204548|NCT03512756|527260677|FG000|Part 2|Death|0|||
146204549|NCT03512756|527260678|FG001|Part 2|Death|0|||
146204550|NCT03512756|527260679|FG002|Part 2|Death|32|||
146204551|NCT03512756|527260680|FG003|Part 2|Death|21|||
146204552|NCT03512756|527260677|FG000|Part 2|Lost to Follow-up|0|||
146204553|NCT03512756|527260678|FG001|Part 2|Lost to Follow-up|0|||
146204554|NCT03512756|527260679|FG002|Part 2|Lost to Follow-up|1|||
146204555|NCT03512756|527260680|FG003|Part 2|Lost to Follow-up|0|||
146204556|NCT03512756|527260677|FG000|Part 2|Physician Decision|0|||
146204557|NCT03512756|527260678|FG001|Part 2|Physician Decision|0|||
146204558|NCT03512756|527260679|FG002|Part 2|Physician Decision|2|||
146204559|NCT03512756|527260680|FG003|Part 2|Physician Decision|4|||
146204560|NCT03512756|527260677|FG000|Part 2|Study Terminated by Sponsor|0|||
146204561|NCT03512756|527260678|FG001|Part 2|Study Terminated by Sponsor|0|||
146204562|NCT03512756|527260679|FG002|Part 2|Study Terminated by Sponsor|2|||
146204563|NCT03512756|527260680|FG003|Part 2|Study Terminated by Sponsor|6|||
146204564|NCT03512756|527260677|FG000|Part 2|Protocol Violation|0|||
146204565|NCT03512756|527260678|FG001|Part 2|Protocol Violation|0|||
146204566|NCT03512756|527260679|FG002|Part 2|Protocol Violation|1|||
146204567|NCT03512756|527260680|FG003|Part 2|Protocol Violation|0|||
146204568|NCT03512756|527260677|FG000|Part 2|Withdrawal by Subject|0|||
146204569|NCT03512756|527260678|FG001|Part 2|Withdrawal by Subject|0|||
146204570|NCT03512756|527260679|FG002|Part 2|Withdrawal by Subject|3|||
146204571|NCT03512756|527260680|FG003|Part 2|Withdrawal by Subject|9|||
146204572|NCT03073941|527262409|FG000|Overall Study|Received non-study device intraoperatively|0|||
146204573|NCT03073941|527262410|FG001|Overall Study|Received non-study device intraoperatively|2|||
146204574|NCT03073941|527262409|FG000|Overall Study|Death|1|||
146204575|NCT03073941|527262410|FG001|Overall Study|Death|0|||
146204576|NCT03073941|527262409|FG000|Overall Study|Withdrawal by Subject|1|||
146204577|NCT03073941|527262410|FG001|Overall Study|Withdrawal by Subject|3|||
146204578|NCT03073941|527262409|FG000|Overall Study|Lost to Follow-up|5|||
146204579|NCT03073941|527262410|FG001|Overall Study|Lost to Follow-up|4|||
146204580|NCT03073941|527262409|FG000|Overall Study|Adverse Event|4|||
146204581|NCT03073941|527262410|FG001|Overall Study|Adverse Event|2|||
146204582|NCT03073941|527262409|FG000|Overall Study|Met an exclusion criterion|0|||
146204583|NCT03073941|527262410|FG001|Overall Study|Met an exclusion criterion|1|||
146204584|NCT04588259|527262411|FG000|Run-in Period|Run-in failure|0|||
146204585|NCT04588259|527262412|FG001|Run-in Period|Run-in failure|23|||
146204586|NCT04588259|527262411|FG000|Run-in Period|Withdrawn before randomisation|0|||
146204587|NCT04588259|527262412|FG001|Run-in Period|Withdrawn before randomisation|8|||
146204588|NCT04588259|527262411|FG000|Treatment Period|Withdrawal by Subject|6|||
146204589|NCT04588259|527262412|FG001|Treatment Period|Withdrawal by Subject|6|||
146204590|NCT01188655|527262416|FG000|Overall Study|Lack of Efficacy|1|||
146204591|NCT01188655|527262416|FG000|Overall Study|Lost to Follow-up|1|||
146204592|NCT01188655|527262416|FG000|Overall Study|Other|11|||
146204593|NCT00925899|527262417|FG000|Part 1|Death|1|||
146204594|NCT00925899|527262418|FG001|Part 1|Death|2|||
146204595|NCT00925899|527262417|FG000|Part 1|Withdrawal by Subject|10|||
146204596|NCT00925899|527262418|FG001|Part 1|Withdrawal by Subject|9|||
146204597|NCT00089544|527262419|FG000|Overall Study|Ineligible|1|||
146204598|NCT00089544|527262420|FG001|Overall Study|Ineligible|0|||
146204599|NCT00683696|527262421|FG000|Overall Study|Withdrawn due to study closure|337|||
146204600|NCT00683696|527262422|FG001|Overall Study|Withdrawn due to study closure|338|||
146204601|NCT00683696|527262421|FG000|Overall Study|Withdrawn prior to study closure|13|||
146204602|NCT00683696|527262422|FG001|Overall Study|Withdrawn prior to study closure|28|||
146204603|NCT00683696|527262421|FG000|Overall Study|Lost to Follow-up|5|||
146204604|NCT00683696|527262422|FG001|Overall Study|Lost to Follow-up|6|||
146204605|NCT00683696|527262421|FG000|Overall Study|Vital status follow-up only|3|||
146204606|NCT00683696|527262422|FG001|Overall Study|Vital status follow-up only|3|||
146204607|NCT00683696|527262421|FG000|Overall Study|Death|46|||
146204608|NCT00683696|527262422|FG001|Overall Study|Death|30|||
146204609|NCT01823536|527262425|FG000|Overall Study|Lost to Follow-up|1|||
146204610|NCT01823536|527262426|FG001|Overall Study|Lost to Follow-up|0|||
146204611|NCT01823536|527262427|FG002|Overall Study|Lost to Follow-up|0|||
146204612|NCT01823536|527262428|FG003|Overall Study|Lost to Follow-up|1|||
146204613|NCT01823536|527262429|FG004|Overall Study|Lost to Follow-up|1|||
146204614|NCT01823536|527262430|FG005|Overall Study|Lost to Follow-up|0|||
146204615|NCT01823536|527262425|FG000|Overall Study|Protocol Violation|0|||
146204616|NCT01823536|527262426|FG001|Overall Study|Protocol Violation|1|||
146204617|NCT01823536|527262427|FG002|Overall Study|Protocol Violation|0|||
146204618|NCT01823536|527262428|FG003|Overall Study|Protocol Violation|0|||
146204619|NCT01823536|527262429|FG004|Overall Study|Protocol Violation|0|||
146204620|NCT01823536|527262430|FG005|Overall Study|Protocol Violation|0|||
146204621|NCT01823536|527262425|FG000|Overall Study|Withdrawal by Subject|1|||
146204622|NCT01823536|527262426|FG001|Overall Study|Withdrawal by Subject|1|||
146204623|NCT01823536|527262427|FG002|Overall Study|Withdrawal by Subject|0|||
146204624|NCT01823536|527262428|FG003|Overall Study|Withdrawal by Subject|0|||
146204625|NCT01823536|527262429|FG004|Overall Study|Withdrawal by Subject|0|||
146204626|NCT01823536|527262430|FG005|Overall Study|Withdrawal by Subject|0|||
146204627|NCT01823536|527262425|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146204628|NCT01823536|527262426|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146204629|NCT01823536|527262427|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
146204630|NCT01823536|527262428|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146204631|NCT01823536|527262429|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146204632|NCT01823536|527262430|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
146204633|NCT01823536|527262425|FG000|Overall Study|Met exclusion criterion No 6|0|||
146204634|NCT01823536|527262426|FG001|Overall Study|Met exclusion criterion No 6|0|||
146204635|NCT01823536|527262427|FG002|Overall Study|Met exclusion criterion No 6|0|||
146204636|NCT01823536|527262428|FG003|Overall Study|Met exclusion criterion No 6|1|||
146204637|NCT01823536|527262429|FG004|Overall Study|Met exclusion criterion No 6|0|||
146204638|NCT01823536|527262430|FG005|Overall Study|Met exclusion criterion No 6|0|||
146204639|NCT01823536|527262425|FG000|Overall Study|Subject moved out of the state|0|||
146204640|NCT01823536|527262426|FG001|Overall Study|Subject moved out of the state|0|||
146204641|NCT01823536|527262427|FG002|Overall Study|Subject moved out of the state|0|||
146204642|NCT01823536|527262428|FG003|Overall Study|Subject moved out of the state|0|||
146204643|NCT01823536|527262429|FG004|Overall Study|Subject moved out of the state|1|||
146204644|NCT01823536|527262430|FG005|Overall Study|Subject moved out of the state|0|||
146204645|NCT03648762|527262431|FG000|Overall Study|Lost to Follow-up|1|||
146204646|NCT03648762|527262432|FG001|Overall Study|Lost to Follow-up|2|||
146204647|NCT03648762|527262433|FG002|Overall Study|Lost to Follow-up|0|||
146204648|NCT03648762|527262431|FG000|Overall Study|Withdrawal by Subject|5|||
146204649|NCT03648762|527262432|FG001|Overall Study|Withdrawal by Subject|2|||
146204650|NCT03648762|527262433|FG002|Overall Study|Withdrawal by Subject|1|||
146204651|NCT01391832|527262436|FG000|Overall Study|Withdrawal by Subject|21|||
146204652|NCT01391832|527262437|FG001|Overall Study|Withdrawal by Subject|22|||
146204653|NCT01391832|527262436|FG000|Overall Study|Lost to Follow-up|0|||
146204654|NCT01391832|527262437|FG001|Overall Study|Lost to Follow-up|1|||
146204655|NCT03345901|527262443|FG000|Overall Study|The study was terminated|18|||
146204656|NCT00722046|527262444|FG000|Overall Study|Adverse Event|0|||
146204657|NCT00722046|527262445|FG001|Overall Study|Adverse Event|1|||
146204658|NCT00722046|527262446|FG002|Overall Study|Adverse Event|2|||
146204659|NCT00722046|527262447|FG003|Overall Study|Adverse Event|1|||
146204660|NCT00722046|527262448|FG004|Overall Study|Adverse Event|2|||
146204661|NCT00722046|527262449|FG005|Overall Study|Adverse Event|1|||
146204662|NCT00722046|527262450|FG006|Overall Study|Adverse Event|0|||
146204663|NCT00722046|527262444|FG000|Overall Study|Death|0|||
146204664|NCT00722046|527262445|FG001|Overall Study|Death|1|||
146204665|NCT00722046|527262446|FG002|Overall Study|Death|0|||
146204666|NCT00722046|527262447|FG003|Overall Study|Death|0|||
146204667|NCT00722046|527262448|FG004|Overall Study|Death|0|||
146204668|NCT00722046|527262449|FG005|Overall Study|Death|0|||
146204669|NCT00722046|527262450|FG006|Overall Study|Death|2|||
146204670|NCT00722046|527262444|FG000|Overall Study|Protocol Violation|1|||
146204671|NCT00722046|527262445|FG001|Overall Study|Protocol Violation|0|||
146204672|NCT00722046|527262446|FG002|Overall Study|Protocol Violation|0|||
146204673|NCT00722046|527262447|FG003|Overall Study|Protocol Violation|0|||
146204674|NCT00722046|527262448|FG004|Overall Study|Protocol Violation|0|||
146204675|NCT00722046|527262449|FG005|Overall Study|Protocol Violation|1|||
146204676|NCT00722046|527262450|FG006|Overall Study|Protocol Violation|0|||
146204677|NCT00722046|527262444|FG000|Overall Study|Withdrawal by Subject|3|||
146204678|NCT00722046|527262445|FG001|Overall Study|Withdrawal by Subject|3|||
146204679|NCT00722046|527262446|FG002|Overall Study|Withdrawal by Subject|4|||
146204680|NCT00722046|527262447|FG003|Overall Study|Withdrawal by Subject|4|||
146204681|NCT00722046|527262448|FG004|Overall Study|Withdrawal by Subject|4|||
146204682|NCT00722046|527262449|FG005|Overall Study|Withdrawal by Subject|7|||
146204683|NCT00722046|527262450|FG006|Overall Study|Withdrawal by Subject|3|||
146204684|NCT00722046|527262444|FG000|Overall Study|Randomized, but not treated|1|||
146204685|NCT00722046|527262445|FG001|Overall Study|Randomized, but not treated|1|||
146204686|NCT00722046|527262446|FG002|Overall Study|Randomized, but not treated|0|||
146204687|NCT00722046|527262447|FG003|Overall Study|Randomized, but not treated|2|||
146204688|NCT00722046|527262448|FG004|Overall Study|Randomized, but not treated|0|||
146204689|NCT00722046|527262449|FG005|Overall Study|Randomized, but not treated|0|||
146204690|NCT00722046|527262450|FG006|Overall Study|Randomized, but not treated|0|||
146204691|NCT00722046|527262444|FG000|Overall Study|Other|0|||
146204692|NCT00722046|527262445|FG001|Overall Study|Other|0|||
146204693|NCT00722046|527262446|FG002|Overall Study|Other|1|||
146204694|NCT00722046|527262447|FG003|Overall Study|Other|1|||
146204695|NCT00722046|527262448|FG004|Overall Study|Other|3|||
146204696|NCT00722046|527262449|FG005|Overall Study|Other|2|||
146204697|NCT00722046|527262450|FG006|Overall Study|Other|1|||
146204698|NCT00925587|527262451|FG000|Overall Study|Protocol Specified Criteria|6|||
146204699|NCT00925587|527262452|FG001|Overall Study|Protocol Specified Criteria|6|||
146204700|NCT00925587|527262451|FG000|Overall Study|Physician Decision|4|||
146204701|NCT00925587|527262452|FG001|Overall Study|Physician Decision|1|||
146204702|NCT00925587|527262451|FG000|Overall Study|Protocol Violation|6|||
146204703|NCT00925587|527262452|FG001|Overall Study|Protocol Violation|4|||
146204704|NCT00925587|527262451|FG000|Overall Study|Withdrawal by Subject|9|||
146204705|NCT00925587|527262452|FG001|Overall Study|Withdrawal by Subject|6|||
146204706|NCT00925587|527262451|FG000|Overall Study|Death|5|||
146204707|NCT00925587|527262452|FG001|Overall Study|Death|5|||
146204708|NCT00925587|527262451|FG000|Overall Study|Adverse Event|6|||
146204709|NCT00925587|527262452|FG001|Overall Study|Adverse Event|2|||
146204710|NCT00925587|527262451|FG000|Overall Study|Lost to Follow-up|0|||
146204711|NCT00925587|527262452|FG001|Overall Study|Lost to Follow-up|1|||
146285354|NCT01293487|527557838|FG000|Overall Study|Withdrawal by Subject|0|||
146285355|NCT01293487|527557839|FG001|Overall Study|Withdrawal by Subject|0|||
146285356|NCT01293487|527557840|FG002|Overall Study|Withdrawal by Subject|0|||
146285357|NCT01293487|527557841|FG003|Overall Study|Withdrawal by Subject|0|||
146204712|NCT01140048|527262462|FG000|Overall Study|Physician Decision|1|||
146204713|NCT01140048|527262462|FG000|Overall Study|Withdrawal by Subject|13|||
146204714|NCT01140048|527262462|FG000|Overall Study|Lost to Follow-up|31|||
146204715|NCT02888080|527262463|FG000|Overall Study|Subject / Guardian decision|1|||
146204716|NCT02888080|527262464|FG001|Overall Study|Subject / Guardian decision|3|||
146204717|NCT02888080|527262463|FG000|Overall Study|New Therapy for study indication|1|||
146204718|NCT02888080|527262464|FG001|Overall Study|New Therapy for study indication|0|||
146204719|NCT02888080|527262463|FG000|Overall Study|Lack of Efficacy|0|||
146204720|NCT02888080|527262464|FG001|Overall Study|Lack of Efficacy|1|||
146204721|NCT02888080|527262463|FG000|Overall Study|Adverse Event|0|||
146204722|NCT02888080|527262464|FG001|Overall Study|Adverse Event|1|||
146204723|NCT00980330|527262465|FG000|Overall Study|Adverse Event|0|||
146204724|NCT00980330|527262466|FG001|Overall Study|Adverse Event|0|||
146204725|NCT00980330|527262467|FG002|Overall Study|Adverse Event|0|||
146204726|NCT00980330|527262468|FG003|Overall Study|Adverse Event|1|||
146204727|NCT00980330|527262469|FG004|Overall Study|Adverse Event|0|||
146204728|NCT00980330|527262470|FG005|Overall Study|Adverse Event|0|||
146204729|NCT00980330|527262471|FG006|Overall Study|Adverse Event|0|||
146204730|NCT00980330|527262465|FG000|Overall Study|Lost to Follow-up|1|||
146204731|NCT00980330|527262466|FG001|Overall Study|Lost to Follow-up|1|||
146204732|NCT00980330|527262467|FG002|Overall Study|Lost to Follow-up|4|||
146204733|NCT00980330|527262468|FG003|Overall Study|Lost to Follow-up|2|||
146204734|NCT00980330|527262469|FG004|Overall Study|Lost to Follow-up|1|||
146204735|NCT00980330|527262470|FG005|Overall Study|Lost to Follow-up|1|||
146204736|NCT00980330|527262471|FG006|Overall Study|Lost to Follow-up|2|||
146204737|NCT00980330|527262465|FG000|Overall Study|Withdrawal by Subject|2|||
146204738|NCT00980330|527262466|FG001|Overall Study|Withdrawal by Subject|4|||
146204739|NCT00980330|527262467|FG002|Overall Study|Withdrawal by Subject|4|||
146204740|NCT00980330|527262468|FG003|Overall Study|Withdrawal by Subject|1|||
146204741|NCT00980330|527262469|FG004|Overall Study|Withdrawal by Subject|3|||
146204742|NCT00980330|527262470|FG005|Overall Study|Withdrawal by Subject|2|||
146204743|NCT00980330|527262471|FG006|Overall Study|Withdrawal by Subject|5|||
146204744|NCT00980330|527262465|FG000|Overall Study|(not specified)|2|||
146204745|NCT00980330|527262466|FG001|Overall Study|(not specified)|0|||
146204746|NCT00980330|527262467|FG002|Overall Study|(not specified)|0|||
146204747|NCT00980330|527262468|FG003|Overall Study|(not specified)|1|||
146204748|NCT00980330|527262469|FG004|Overall Study|(not specified)|1|||
146204749|NCT00980330|527262470|FG005|Overall Study|(not specified)|1|||
146204750|NCT00980330|527262471|FG006|Overall Study|(not specified)|0|||
146204751|NCT00666276|527262474|FG000|Overall Study|Protocol Violation|34|||
146204752|NCT01039688|527262475|FG000|Overall Study|Adverse Event|38|||
146204753|NCT01039688|527262476|FG001|Overall Study|Adverse Event|39|||
146204754|NCT01039688|527262477|FG002|Overall Study|Adverse Event|24|||
146204755|NCT01039688|527262475|FG000|Overall Study|Lack of Efficacy|20|||
146204756|NCT01039688|527262476|FG001|Overall Study|Lack of Efficacy|11|||
146204757|NCT01039688|527262477|FG002|Overall Study|Lack of Efficacy|26|||
146204758|NCT01039688|527262475|FG000|Overall Study|Lost to Follow-up|11|||
146204759|NCT01039688|527262476|FG001|Overall Study|Lost to Follow-up|9|||
146204760|NCT01039688|527262477|FG002|Overall Study|Lost to Follow-up|5|||
146204761|NCT01039688|527262475|FG000|Overall Study|Other|13|||
146204762|NCT01039688|527262476|FG001|Overall Study|Other|25|||
145950833|NCT01483599|526330509|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
145950834|NCT01483599|526330510|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950835|NCT01483599|526330511|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950836|NCT01483599|526330512|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146204763|NCT01039688|527262477|FG002|Overall Study|Other|12|||
145950837|NCT01483599|526330513|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146204764|NCT01039688|527262475|FG000|Overall Study|Withdrawal by Subject|23|||
146204765|NCT01039688|527262476|FG001|Overall Study|Withdrawal by Subject|27|||
146285358|NCT01293487|527557842|FG004|Overall Study|Withdrawal by Subject|0|||
145950838|NCT01483599|526330514|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950839|NCT01483599|526330515|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146204766|NCT01039688|527262477|FG002|Overall Study|Withdrawal by Subject|13|||
146204767|NCT01039688|527262475|FG000|Overall Study|Death|2|||
146204768|NCT01039688|527262476|FG001|Overall Study|Death|0|||
146204769|NCT01039688|527262477|FG002|Overall Study|Death|0|||
146204770|NCT02594735|527262478|FG000|Overall Study|Adverse Event|1|||
146204771|NCT03844269|527262482|FG000|Overall Study|Withdrawal pre-intervention|1|||
146204772|NCT03844269|527262482|FG000|Overall Study|Did not complete the intervention|2|||
146204773|NCT00665444|527262486|FG000|Overall Study|Physician Decision|1|||
146204774|NCT00665444|527262486|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
146204775|NCT03520413|527262487|FG000|Overall Study|Lost to Follow-up|1|||
146204776|NCT03520413|527262488|FG001|Overall Study|Lost to Follow-up|1|||
146204777|NCT03520413|527262487|FG000|Overall Study|Withdrawal by Subject|1|||
146204778|NCT03520413|527262488|FG001|Overall Study|Withdrawal by Subject|2|||
146204779|NCT03520413|527262487|FG000|Overall Study|Death|0|||
146204780|NCT03520413|527262488|FG001|Overall Study|Death|1|||
146204781|NCT03520413|527262487|FG000|Overall Study|Physician Decision|3|||
146204782|NCT03520413|527262488|FG001|Overall Study|Physician Decision|3|||
146204783|NCT03520413|527262487|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
146204784|NCT03520413|527262488|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
146204785|NCT00101010|527262489|FG000|Overall Study|Physician Decision|1|||
146204786|NCT00346151|527262490|FG000|Overall Study|Withdrawal by Subject|3|||
146204787|NCT04054635|527262491|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
146204788|NCT04054635|527262492|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
146204789|NCT04054635|527262493|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
146204790|NCT04054635|527262491|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
146204791|NCT04054635|527262492|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
146204792|NCT04054635|527262493|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
146204793|NCT00891930|527262494|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
146204794|NCT00891930|527262494|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
146204795|NCT00891930|527262494|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
146204796|NCT00891930|527262494|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
146204797|NCT00891930|527262494|FG000|Part 2 Panitumumab + AMG479|Death|30|||
146204798|NCT02507752|527262499|FG000|Overall Study|Adverse Event|1|||
146204799|NCT02507752|527262499|FG000|Overall Study|Protocol Violation|6|||
146204800|NCT02507752|527262499|FG000|Overall Study|Lost to Follow-up|7|||
146204801|NCT02507752|527262499|FG000|Overall Study|Infusion reaction at first infusion|1|||
146204802|NCT02507752|527262499|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
146204803|NCT02507752|527262499|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
146204804|NCT00535145|527262504|FG000|Phase I|Adverse Event|3|||
146204805|NCT00535145|527262504|FG000|Phase I|Lost to Follow-up|7|||
146204806|NCT00535145|527262504|FG000|Phase I|Withdrawal by Subject|6|||
146204807|NCT00535145|527262504|FG000|Phase I|(eligibility)|8|||
146204808|NCT00535145|527262504|FG000|Phase I|(protocol violation)|1|||
146204809|NCT00535145|527262504|FG000|Phase I|(PI decision)|1|||
146204810|NCT00535145|527262504|FG000|Phase I|(diagnosis)|3|||
146204811|NCT00535145|527262504|FG000|Phase II|Adverse Event|2|||
146204812|NCT00535145|527262504|FG000|Phase II|Lack of Efficacy|1|||
146204813|NCT00535145|527262504|FG000|Phase II|Lost to Follow-up|5|||
146204814|NCT00535145|527262504|FG000|Phase II|Withdrawal by Subject|5|||
146204815|NCT00535145|527262504|FG000|Phase II|Subject non-compliance|2|||
146204816|NCT02423798|527262505|FG000|Overall Study|Withdrawal by Subject|3|||
146204817|NCT02204982|527262507|FG000|Overall Study|Patient ineligible-medical monitor|1|||
146204818|NCT02204982|527262508|FG001|Overall Study|Patient ineligible-medical monitor|0|||
146204819|NCT02204982|527262507|FG000|Overall Study|Withdrawal by Subject|1|||
146204820|NCT02204982|527262508|FG001|Overall Study|Withdrawal by Subject|0|||
146204821|NCT02204982|527262507|FG000|Overall Study|Adverse Event|1|||
146204822|NCT02204982|527262508|FG001|Overall Study|Adverse Event|0|||
146204823|NCT02204982|527262507|FG000|Overall Study|Adverse Event and Investigator decision|1|||
146204824|NCT02204982|527262508|FG001|Overall Study|Adverse Event and Investigator decision|0|||
146204825|NCT02204982|527262507|FG000|Overall Study|Physician Decision|0|||
146431155|NCT00467896|528088163|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
146431156|NCT00467896|528088163|FG000|Overall Study|Started intravenous prostacyclin|1|||
146204826|NCT02204982|527262508|FG001|Overall Study|Physician Decision|2|||
146204827|NCT02204982|527262507|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
146204828|NCT02204982|527262508|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
146204829|NCT02204982|527262507|FG000|Overall Study|Termination of Study bySponsor|0|||
146204830|NCT02204982|527262508|FG001|Overall Study|Termination of Study bySponsor|1|||
146204831|NCT01968226|527262509|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
146204832|NCT00566527|527262510|FG000|Overall Study|Reason not provided|3|||
146204833|NCT00566527|527262511|FG001|Overall Study|Reason not provided|11|||
146204834|NCT00566527|527262512|FG002|Overall Study|Reason not provided|10|||
146204835|NCT00566527|527262510|FG000|Overall Study|Adverse Event|2|||
146431157|NCT00467896|528088163|FG000|Overall Study|Started inhaled Remodulin|1|||
146431158|NCT00467896|528088163|FG000|Overall Study|Patient had no improvement|1|||
146431159|NCT03772522|528088164|FG000|Pre-intervention|Withdrawal by Subject|3|||
146431160|NCT03772522|528088165|FG001|Pre-intervention|Withdrawal by Subject|4|||
146431161|NCT03772522|528088164|FG000|Intervention|Withdrawal by Subject|1|||
146431162|NCT03772522|528088165|FG001|Intervention|Withdrawal by Subject|0|||
146431163|NCT03772522|528088164|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
146204836|NCT00566527|527262511|FG001|Overall Study|Adverse Event|0|||
146204837|NCT00566527|527262512|FG002|Overall Study|Adverse Event|1|||
146204838|NCT00566527|527262510|FG000|Overall Study|Physician Decision|3|||
146204839|NCT00566527|527262511|FG001|Overall Study|Physician Decision|8|||
146431164|NCT03772522|528088165|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
146431165|NCT03818581|528088168|FG000|Overall Study|Adverse Event|1|||
146431166|NCT03818581|528088169|FG001|Overall Study|Adverse Event|0|||
146431167|NCT03818581|528088170|FG002|Overall Study|Adverse Event|0|||
146431168|NCT03818581|528088171|FG003|Overall Study|Adverse Event|0|||
146431169|NCT03818581|528088172|FG004|Overall Study|Adverse Event|0|||
146431170|NCT03818581|528088168|FG000|Overall Study|Covid-19|2|||
146431171|NCT03818581|528088169|FG001|Overall Study|Covid-19|0|||
146431172|NCT03818581|528088170|FG002|Overall Study|Covid-19|0|||
146431173|NCT03818581|528088171|FG003|Overall Study|Covid-19|0|||
146204840|NCT00566527|527262512|FG002|Overall Study|Physician Decision|20|||
146204841|NCT00566527|527262510|FG000|Overall Study|Lost to Follow-up|3|||
146204842|NCT00566527|527262511|FG001|Overall Study|Lost to Follow-up|4|||
146204843|NCT00566527|527262512|FG002|Overall Study|Lost to Follow-up|4|||
146204844|NCT00566527|527262510|FG000|Overall Study|Withdrawal by Subject|6|||
146204845|NCT00566527|527262511|FG001|Overall Study|Withdrawal by Subject|43|||
146204846|NCT00566527|527262512|FG002|Overall Study|Withdrawal by Subject|43|||
146204847|NCT00457743|527262513|FG000|Overall Study|Adverse Event|0|||
146204848|NCT00457743|527262514|FG001|Overall Study|Adverse Event|4|||
146204849|NCT00457743|527262515|FG002|Overall Study|Adverse Event|0|||
146204850|NCT00457743|527262513|FG000|Overall Study|Lack of Efficacy|3|||
146204851|NCT00457743|527262514|FG001|Overall Study|Lack of Efficacy|23|||
146204852|NCT00457743|527262515|FG002|Overall Study|Lack of Efficacy|3|||
146204853|NCT02079844|527262519|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
146204854|NCT02079844|527262520|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
146204855|NCT02079844|527262521|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
146204856|NCT02079844|527262519|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
146204857|NCT02079844|527262520|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
146204858|NCT02079844|527262521|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
146204859|NCT00203411|527262526|FG000|Follow-up|Progressive Disease|4|||
146204860|NCT00632424|527262529|FG000|Overall Study|Disease Progression|17|||
146204861|NCT00632424|527262529|FG000|Overall Study|Study Drug Toxicity|1|||
146204862|NCT02531113|527262530|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
146204863|NCT02531113|527262530|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
146204864|NCT02531113|527262530|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
146204865|NCT02531113|527262530|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
146204866|NCT02531113|527262530|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
146204867|NCT02531113|527262530|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
146204868|NCT02531113|527262530|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
146204869|NCT02531113|527262530|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
146204870|NCT05135000|527262535|FG000|Overall Study|Adverse Event|2|||
146204871|NCT05135000|527262536|FG001|Overall Study|Adverse Event|0|||
146204872|NCT05135000|527262535|FG000|Overall Study|Lost to Follow-up|1|||
146204873|NCT05135000|527262536|FG001|Overall Study|Lost to Follow-up|0|||
146204874|NCT05135000|527262535|FG000|Overall Study|Study Terminated by Sponsor|6|||
146204875|NCT05135000|527262536|FG001|Overall Study|Study Terminated by Sponsor|3|||
146204876|NCT04250883|527264452|FG000|Overall Study|Lost to Follow-up|1|||
146204877|NCT04250883|527264453|FG001|Overall Study|Lost to Follow-up|0|||
146204878|NCT01318382|527264455|FG000|Overall Study|Physician Decision|2|||
146204879|NCT01318382|527264455|FG000|Overall Study|Device Malfunction|10|||
146204880|NCT01318382|527264455|FG000|Overall Study|Protocol Violation|1|||
146204881|NCT01599104|527264456|FG000|Overall Study|Withdrawal by Subject|1|||
146204882|NCT01599104|527264457|FG001|Overall Study|Withdrawal by Subject|1|||
146204883|NCT01599104|527264458|FG002|Overall Study|Withdrawal by Subject|2|||
146204884|NCT01599104|527264456|FG000|Overall Study|Technical Problems|1|||
146204885|NCT01599104|527264457|FG001|Overall Study|Technical Problems|0|||
146204886|NCT01599104|527264458|FG002|Overall Study|Technical Problems|0|||
146204887|NCT01599104|527264456|FG000|Overall Study|Physician Decision|3|||
146204888|NCT01599104|527264457|FG001|Overall Study|Physician Decision|2|||
146204889|NCT01599104|527264458|FG002|Overall Study|Physician Decision|2|||
146204890|NCT01599104|527264456|FG000|Overall Study|Non-compliance with study treatment|0|||
146204891|NCT01599104|527264457|FG001|Overall Study|Non-compliance with study treatment|1|||
146204892|NCT01599104|527264458|FG002|Overall Study|Non-compliance with study treatment|0|||
146204893|NCT01599104|527264456|FG000|Overall Study|Lack of Efficacy|4|||
146204894|NCT01599104|527264457|FG001|Overall Study|Lack of Efficacy|4|||
146204895|NCT01599104|527264458|FG002|Overall Study|Lack of Efficacy|10|||
146204896|NCT01599104|527264456|FG000|Overall Study|Adverse Event|7|||
146204897|NCT01599104|527264457|FG001|Overall Study|Adverse Event|6|||
146204898|NCT01599104|527264458|FG002|Overall Study|Adverse Event|12|||
146204899|NCT02271854|527264463|FG000|Overall Study|Withdrawal by Subject|2|||
146204900|NCT02271854|527264463|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
146204901|NCT02271854|527264463|FG000|Overall Study|Lost to Follow-up|1|||
146204902|NCT01308567|527264464|FG000|Overall Study|Lost to Follow-up|2|||
146204903|NCT01308567|527264465|FG001|Overall Study|Lost to Follow-up|4|||
146204904|NCT01308567|527264466|FG002|Overall Study|Lost to Follow-up|4|||
146204905|NCT01571596|527264469|FG000|Overall Study|Adverse Event|2|||
146204906|NCT01571596|527264470|FG001|Overall Study|Adverse Event|0|||
146204907|NCT01571596|527264471|FG002|Overall Study|Adverse Event|0|||
146204908|NCT01571596|527264469|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146204909|NCT01571596|527264470|FG001|Overall Study|Study Terminated by the Sponsor|1|||
146204910|NCT01571596|527264471|FG002|Overall Study|Study Terminated by the Sponsor|1|||
146204911|NCT00434304|527264474|FG000|Overall Study|Adverse Event|14|||
146204912|NCT00434304|527264474|FG000|Overall Study|Lack of Efficacy|2|||
146204913|NCT00434304|527264474|FG000|Overall Study|Withdrawal by Subject|4|||
146204914|NCT05262738|527264475|FG000|Overall Study|Withdrawal by Subject|1|||
146204915|NCT05262738|527264476|FG001|Overall Study|Withdrawal by Subject|0|||
146204916|NCT02374463|527264479|FG000|Overall Study|Withdrawal by Subject|3|||
146204917|NCT02374463|527264480|FG001|Overall Study|Withdrawal by Subject|3|||
146204918|NCT01424397|527264481|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204919|NCT01424397|527264482|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204920|NCT01424397|527264483|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
146204921|NCT01424397|527264484|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204922|NCT01424397|527264485|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204923|NCT01424397|527264486|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204924|NCT01424397|527264487|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204925|NCT01424397|527264488|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204926|NCT01424397|527264489|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204927|NCT01424397|527264490|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204928|NCT01424397|527264491|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204929|NCT01424397|527264492|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
146204930|NCT00774397|527264502|FG000|Overall Study|Adverse Event|1|||
146204931|NCT00774397|527264503|FG001|Overall Study|Adverse Event|3|||
146204932|NCT00774397|527264504|FG002|Overall Study|Adverse Event|16|||
146204933|NCT00774397|527264505|FG003|Overall Study|Adverse Event|8|||
146204934|NCT00774397|527264506|FG004|Overall Study|Adverse Event|8|||
146204935|NCT00774397|527264507|FG005|Overall Study|Adverse Event|3|||
146204936|NCT00774397|527264508|FG006|Overall Study|Adverse Event|16|||
146204937|NCT00774397|527264502|FG000|Overall Study|Lack of Efficacy|11|||
146204938|NCT00774397|527264503|FG001|Overall Study|Lack of Efficacy|4|||
146204939|NCT00774397|527264504|FG002|Overall Study|Lack of Efficacy|5|||
146204940|NCT00774397|527264505|FG003|Overall Study|Lack of Efficacy|3|||
146204941|NCT00774397|527264506|FG004|Overall Study|Lack of Efficacy|27|||
146204942|NCT00774397|527264507|FG005|Overall Study|Lack of Efficacy|15|||
146204943|NCT00774397|527264508|FG006|Overall Study|Lack of Efficacy|9|||
146204944|NCT00774397|527264502|FG000|Overall Study|Protocol Violation|0|||
146204945|NCT00774397|527264503|FG001|Overall Study|Protocol Violation|1|||
146204946|NCT00774397|527264504|FG002|Overall Study|Protocol Violation|3|||
146204947|NCT00774397|527264505|FG003|Overall Study|Protocol Violation|1|||
146204948|NCT00774397|527264506|FG004|Overall Study|Protocol Violation|2|||
146204949|NCT00774397|527264507|FG005|Overall Study|Protocol Violation|1|||
146204950|NCT00774397|527264508|FG006|Overall Study|Protocol Violation|0|||
146204951|NCT00774397|527264502|FG000|Overall Study|Lost to Follow-up|0|||
146204952|NCT00774397|527264503|FG001|Overall Study|Lost to Follow-up|1|||
146204953|NCT00774397|527264504|FG002|Overall Study|Lost to Follow-up|1|||
146204954|NCT00774397|527264505|FG003|Overall Study|Lost to Follow-up|1|||
146204955|NCT00774397|527264506|FG004|Overall Study|Lost to Follow-up|0|||
146204956|NCT00774397|527264507|FG005|Overall Study|Lost to Follow-up|1|||
146204957|NCT00774397|527264508|FG006|Overall Study|Lost to Follow-up|0|||
146204958|NCT00774397|527264502|FG000|Overall Study|Refused to continue trial medication|1|||
146204959|NCT00774397|527264503|FG001|Overall Study|Refused to continue trial medication|3|||
146204960|NCT00774397|527264504|FG002|Overall Study|Refused to continue trial medication|2|||
146204961|NCT00774397|527264505|FG003|Overall Study|Refused to continue trial medication|2|||
146204962|NCT00774397|527264506|FG004|Overall Study|Refused to continue trial medication|6|||
146204963|NCT00774397|527264507|FG005|Overall Study|Refused to continue trial medication|2|||
146204964|NCT00774397|527264508|FG006|Overall Study|Refused to continue trial medication|3|||
146204965|NCT00774397|527264502|FG000|Overall Study|Not treated|0|||
146204966|NCT00774397|527264503|FG001|Overall Study|Not treated|0|||
146204967|NCT00774397|527264504|FG002|Overall Study|Not treated|0|||
146204968|NCT00774397|527264505|FG003|Overall Study|Not treated|0|||
146204969|NCT00774397|527264506|FG004|Overall Study|Not treated|1|||
146204970|NCT00774397|527264507|FG005|Overall Study|Not treated|0|||
146204971|NCT00774397|527264508|FG006|Overall Study|Not treated|1|||
146204972|NCT00774397|527264502|FG000|Overall Study|Other than those stated above|1|||
146204973|NCT00774397|527264503|FG001|Overall Study|Other than those stated above|1|||
146204974|NCT00774397|527264504|FG002|Overall Study|Other than those stated above|3|||
146204975|NCT00774397|527264505|FG003|Overall Study|Other than those stated above|2|||
146204976|NCT00774397|527264506|FG004|Overall Study|Other than those stated above|2|||
146204977|NCT00774397|527264507|FG005|Overall Study|Other than those stated above|0|||
146204978|NCT00774397|527264508|FG006|Overall Study|Other than those stated above|1|||
146204979|NCT00858117|527264510|FG000|Treatment on Study|Adverse Event|2|||
146204980|NCT00858117|527264510|FG000|Follow up for 5 Years|Death|4|||
146204981|NCT00858117|527264510|FG000|Follow up for 5 Years|No further data collected for study|9|||
146204982|NCT00077675|527264513|FG000|Overall Study|Adverse Event|1|||
146204983|NCT00077675|527264514|FG001|Overall Study|Adverse Event|2|||
146204984|NCT00077675|527264513|FG000|Overall Study|Lost to Follow-up|6|||
146204985|NCT00077675|527264514|FG001|Overall Study|Lost to Follow-up|3|||
146204986|NCT00077675|527264513|FG000|Overall Study|Withdrawal by Subject|1|||
146204987|NCT00077675|527264514|FG001|Overall Study|Withdrawal by Subject|0|||
146204988|NCT00077675|527264513|FG000|Overall Study|Other|0|||
146204989|NCT00077675|527264514|FG001|Overall Study|Other|1|||
146204990|NCT00077675|527264513|FG000|Overall Study|Never received study treatment|3|||
146204991|NCT00077675|527264514|FG001|Overall Study|Never received study treatment|3|||
146204992|NCT02499159|527264515|FG000|Randomization|Protocol Violation|1|||
146204993|NCT02499159|527264516|FG001|Randomization|Protocol Violation|1|||
146204994|NCT02499159|527264515|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
146204995|NCT02499159|527264516|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
146204996|NCT02499159|527264515|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
146204997|NCT02499159|527264516|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
146204998|NCT02499159|527264515|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
146204999|NCT02499159|527264516|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
146205000|NCT02499159|527264515|FG000|30-Day Follow-Up Phone Call|Other|1|||
146205001|NCT02499159|527264516|FG001|30-Day Follow-Up Phone Call|Other|0|||
146205002|NCT04425863|527264518|FG000|Overall Study|Death|0|||
146205003|NCT04425863|527264519|FG001|Overall Study|Death|0|||
146205004|NCT04425863|527264520|FG002|Overall Study|Death|1|||
146205005|NCT02601820|527264521|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
146205006|NCT02601820|527264521|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
146205007|NCT02601820|527264521|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
146205008|NCT02601820|527264521|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
146205009|NCT01599793|527264522|FG000|Overall Study|Adverse Event|2|||
146205010|NCT02564744|527264524|FG000|Overall Study|Investigator decision|0|||
146205011|NCT02564744|527264525|FG001|Overall Study|Investigator decision|0|||
146205012|NCT02564744|527264526|FG002|Overall Study|Investigator decision|0|||
146205013|NCT02564744|527264527|FG003|Overall Study|Investigator decision|0|||
146205014|NCT02564744|527264528|FG004|Overall Study|Investigator decision|1|||
146205015|NCT02564744|527264524|FG000|Overall Study|Death|10|||
146205016|NCT02564744|527264525|FG001|Overall Study|Death|5|||
146205017|NCT02564744|527264526|FG002|Overall Study|Death|4|||
146205018|NCT02564744|527264527|FG003|Overall Study|Death|16|||
146205019|NCT02564744|527264528|FG004|Overall Study|Death|16|||
146205020|NCT02564744|527264524|FG000|Overall Study|End of study Page Missing|0|||
146205021|NCT02564744|527264525|FG001|Overall Study|End of study Page Missing|0|||
146205022|NCT02564744|527264526|FG002|Overall Study|End of study Page Missing|3|||
146205023|NCT02564744|527264527|FG003|Overall Study|End of study Page Missing|3|||
146205024|NCT02564744|527264528|FG004|Overall Study|End of study Page Missing|0|||
146205025|NCT02564744|527264524|FG000|Overall Study|Subject Withdrew Consent|1|||
146205026|NCT02564744|527264525|FG001|Overall Study|Subject Withdrew Consent|1|||
146205027|NCT02564744|527264526|FG002|Overall Study|Subject Withdrew Consent|1|||
146205028|NCT02564744|527264527|FG003|Overall Study|Subject Withdrew Consent|0|||
146205029|NCT02564744|527264528|FG004|Overall Study|Subject Withdrew Consent|2|||
146205030|NCT02564744|527264524|FG000|Overall Study|Lost to Follow-up|0|||
146205031|NCT02564744|527264525|FG001|Overall Study|Lost to Follow-up|1|||
146205032|NCT02564744|527264526|FG002|Overall Study|Lost to Follow-up|0|||
146205033|NCT02564744|527264527|FG003|Overall Study|Lost to Follow-up|0|||
146205034|NCT02564744|527264528|FG004|Overall Study|Lost to Follow-up|1|||
146205035|NCT02564744|527264524|FG000|Overall Study|Reason not specified|1|||
146205036|NCT02564744|527264525|FG001|Overall Study|Reason not specified|0|||
146205037|NCT02564744|527264526|FG002|Overall Study|Reason not specified|0|||
146205038|NCT02564744|527264527|FG003|Overall Study|Reason not specified|0|||
146205039|NCT02564744|527264528|FG004|Overall Study|Reason not specified|0|||
146205040|NCT01177670|527264542|FG000|Overall Study|Study Terminated|115|||
146205041|NCT01177670|527264542|FG000|Overall Study|Physician Decision|50|||
146205042|NCT01177670|527264542|FG000|Overall Study|Withdrawal by Subject|4|||
146205043|NCT00391898|527264543|FG000|Overall Study|Adverse Event|3|||
146205044|NCT00391898|527264544|FG001|Overall Study|Adverse Event|0|||
146205045|NCT00391898|527264543|FG000|Overall Study|Other|8|||
146205046|NCT00391898|527264544|FG001|Overall Study|Other|10|||
146205047|NCT01636687|527264550|FG000|Induction Period|Withdrawal by Subject|1|||
146205048|NCT01636687|527264551|FG001|Induction Period|Withdrawal by Subject|0|||
146205049|NCT01636687|527264552|FG002|Induction Period|Withdrawal by Subject|0|||
146205050|NCT01636687|527264553|FG003|Induction Period|Withdrawal by Subject|0|||
146205051|NCT01636687|527264554|FG004|Induction Period|Withdrawal by Subject|0|||
146205052|NCT01636687|527264550|FG000|Induction Period|Adverse Event|1|||
146205053|NCT01636687|527264551|FG001|Induction Period|Adverse Event|0|||
146205054|NCT01636687|527264552|FG002|Induction Period|Adverse Event|0|||
146205055|NCT01636687|527264553|FG003|Induction Period|Adverse Event|0|||
146205056|NCT01636687|527264554|FG004|Induction Period|Adverse Event|1|||
146205057|NCT01636687|527264550|FG000|Induction Period|Lack of Efficacy|0|||
146205058|NCT01636687|527264551|FG001|Induction Period|Lack of Efficacy|0|||
146205059|NCT01636687|527264552|FG002|Induction Period|Lack of Efficacy|0|||
146205060|NCT01636687|527264553|FG003|Induction Period|Lack of Efficacy|0|||
146205061|NCT01636687|527264554|FG004|Induction Period|Lack of Efficacy|1|||
146205062|NCT01636687|527264550|FG000|Induction Period|Physician Decision|1|||
146205063|NCT01636687|527264551|FG001|Induction Period|Physician Decision|0|||
146205064|NCT01636687|527264552|FG002|Induction Period|Physician Decision|0|||
146205065|NCT01636687|527264553|FG003|Induction Period|Physician Decision|0|||
146205066|NCT01636687|527264554|FG004|Induction Period|Physician Decision|0|||
146205067|NCT01636687|527264550|FG000|Maintenance Period|Withdrawal by Subject|2|||
146205068|NCT01636687|527264551|FG001|Maintenance Period|Withdrawal by Subject|0|||
146205069|NCT01636687|527264552|FG002|Maintenance Period|Withdrawal by Subject|2|||
146205070|NCT01636687|527264553|FG003|Maintenance Period|Withdrawal by Subject|0|||
146205071|NCT01636687|527264554|FG004|Maintenance Period|Withdrawal by Subject|0|||
146205072|NCT01636687|527264550|FG000|Maintenance Period|Adverse Event|1|||
146205073|NCT01636687|527264551|FG001|Maintenance Period|Adverse Event|0|||
146205074|NCT01636687|527264552|FG002|Maintenance Period|Adverse Event|0|||
146205075|NCT01636687|527264553|FG003|Maintenance Period|Adverse Event|0|||
146205076|NCT01636687|527264554|FG004|Maintenance Period|Adverse Event|0|||
146205077|NCT01636687|527264550|FG000|Maintenance Period|Lack of Efficacy|4|||
146205078|NCT01636687|527264551|FG001|Maintenance Period|Lack of Efficacy|1|||
146205079|NCT01636687|527264552|FG002|Maintenance Period|Lack of Efficacy|0|||
146205080|NCT01636687|527264553|FG003|Maintenance Period|Lack of Efficacy|0|||
146205081|NCT01636687|527264554|FG004|Maintenance Period|Lack of Efficacy|0|||
146205082|NCT01636687|527264550|FG000|Maintenance Period|Lost to Follow-up|1|||
146205083|NCT01636687|527264551|FG001|Maintenance Period|Lost to Follow-up|1|||
146205084|NCT01636687|527264552|FG002|Maintenance Period|Lost to Follow-up|0|||
146205085|NCT01636687|527264553|FG003|Maintenance Period|Lost to Follow-up|0|||
146205086|NCT01636687|527264554|FG004|Maintenance Period|Lost to Follow-up|1|||
146205087|NCT01636687|527264550|FG000|Maintenance Period|Physician Decision|0|||
146205088|NCT01636687|527264551|FG001|Maintenance Period|Physician Decision|0|||
146205089|NCT01636687|527264552|FG002|Maintenance Period|Physician Decision|0|||
146205090|NCT01636687|527264553|FG003|Maintenance Period|Physician Decision|0|||
146285359|NCT01293487|527557843|FG005|Overall Study|Withdrawal by Subject|0|||
146205091|NCT01636687|527264554|FG004|Maintenance Period|Physician Decision|1|||
146205092|NCT01636687|527264550|FG000|Extension Period|technical problems|0|||
146205093|NCT01636687|527264551|FG001|Extension Period|technical problems|1|||
146205094|NCT01636687|527264552|FG002|Extension Period|technical problems|2|||
146205095|NCT01636687|527264553|FG003|Extension Period|technical problems|1|||
146205096|NCT01636687|527264554|FG004|Extension Period|technical problems|0|||
146205097|NCT01636687|527264550|FG000|Extension Period|Adverse Event|4|||
146205098|NCT01636687|527264551|FG001|Extension Period|Adverse Event|3|||
146205099|NCT01636687|527264552|FG002|Extension Period|Adverse Event|2|||
146205100|NCT01636687|527264553|FG003|Extension Period|Adverse Event|1|||
146205101|NCT01636687|527264554|FG004|Extension Period|Adverse Event|0|||
146205102|NCT01636687|527264550|FG000|Extension Period|Lack of Efficacy|7|||
146205103|NCT01636687|527264551|FG001|Extension Period|Lack of Efficacy|0|||
146205104|NCT01636687|527264552|FG002|Extension Period|Lack of Efficacy|2|||
146205105|NCT01636687|527264553|FG003|Extension Period|Lack of Efficacy|1|||
146205106|NCT01636687|527264554|FG004|Extension Period|Lack of Efficacy|0|||
146205107|NCT01636687|527264550|FG000|Extension Period|Lost to Follow-up|1|||
146205108|NCT01636687|527264551|FG001|Extension Period|Lost to Follow-up|0|||
146205109|NCT01636687|527264552|FG002|Extension Period|Lost to Follow-up|1|||
146205110|NCT01636687|527264553|FG003|Extension Period|Lost to Follow-up|0|||
146205111|NCT01636687|527264554|FG004|Extension Period|Lost to Follow-up|0|||
146205112|NCT01636687|527264550|FG000|Extension Period|Physician Decision|1|||
146205113|NCT01636687|527264551|FG001|Extension Period|Physician Decision|0|||
146205114|NCT01636687|527264552|FG002|Extension Period|Physician Decision|0|||
146205115|NCT01636687|527264553|FG003|Extension Period|Physician Decision|1|||
146205116|NCT01636687|527264554|FG004|Extension Period|Physician Decision|0|||
146205117|NCT01636687|527264550|FG000|Extension Period|study terminated by sponsor|33|||
146205118|NCT01636687|527264551|FG001|Extension Period|study terminated by sponsor|50|||
146205119|NCT01636687|527264552|FG002|Extension Period|study terminated by sponsor|17|||
146205120|NCT01636687|527264553|FG003|Extension Period|study terminated by sponsor|23|||
146205121|NCT01636687|527264554|FG004|Extension Period|study terminated by sponsor|0|||
146205122|NCT01636687|527264550|FG000|Extension Period|Withdrawal by Subject|1|||
146205123|NCT01636687|527264551|FG001|Extension Period|Withdrawal by Subject|0|||
146205124|NCT01636687|527264552|FG002|Extension Period|Withdrawal by Subject|1|||
146205125|NCT01636687|527264553|FG003|Extension Period|Withdrawal by Subject|1|||
146205126|NCT01636687|527264554|FG004|Extension Period|Withdrawal by Subject|0|||
146205127|NCT01636687|527264550|FG000|Follow-up Period|Withdrawal by Subject|1|||
146205128|NCT01636687|527264551|FG001|Follow-up Period|Withdrawal by Subject|0|||
146205129|NCT01636687|527264552|FG002|Follow-up Period|Withdrawal by Subject|0|||
146205130|NCT01636687|527264553|FG003|Follow-up Period|Withdrawal by Subject|0|||
146205131|NCT01636687|527264554|FG004|Follow-up Period|Withdrawal by Subject|1|||
146205132|NCT02918279|527264557|FG000|Overall Study|Lost to Follow-up|3|||
146205133|NCT02918279|527264558|FG001|Overall Study|Lost to Follow-up|6|||
146205134|NCT02918279|527264557|FG000|Overall Study|Withdrawal by Subject|5|||
146205135|NCT02918279|527264558|FG001|Overall Study|Withdrawal by Subject|15|||
146205136|NCT02918279|527264557|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146205137|NCT02918279|527264558|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146205138|NCT02918279|527264557|FG000|Overall Study|Other|3|||
146205139|NCT02918279|527264558|FG001|Overall Study|Other|1|||
146205140|NCT00244855|527264563|FG000|Overall Study|Withdrawal by Subject|0|||
146205141|NCT00244855|527264564|FG001|Overall Study|Withdrawal by Subject|1|||
146205142|NCT00869258|527264565|FG000|Overall Study|Physician Decision|1|||
146205143|NCT00636207|527264566|FG000|Overall Study|Adverse Event|1|||
146205144|NCT00636207|527264567|FG001|Overall Study|Adverse Event|0|||
146205145|NCT00636207|527264568|FG002|Overall Study|Adverse Event|0|||
146205146|NCT00636207|527264569|FG003|Overall Study|Adverse Event|0|||
146205147|NCT00636207|527264570|FG004|Overall Study|Adverse Event|0|||
146205148|NCT00636207|527264571|FG005|Overall Study|Adverse Event|0|||
146205149|NCT00636207|527264572|FG006|Overall Study|Adverse Event|0|||
146205150|NCT00636207|527264566|FG000|Overall Study|Withdrawal by Subject|0|||
146205151|NCT00636207|527264567|FG001|Overall Study|Withdrawal by Subject|1|||
146205152|NCT00636207|527264568|FG002|Overall Study|Withdrawal by Subject|0|||
146205153|NCT00636207|527264569|FG003|Overall Study|Withdrawal by Subject|0|||
146205154|NCT00636207|527264570|FG004|Overall Study|Withdrawal by Subject|1|||
146205155|NCT00636207|527264571|FG005|Overall Study|Withdrawal by Subject|0|||
146205156|NCT00636207|527264572|FG006|Overall Study|Withdrawal by Subject|0|||
146205157|NCT01641198|527264573|FG000|After 12 Months of Function|Lost to Follow-up|3|||
146205158|NCT01641198|527264574|FG001|After 12 Months of Function|Lost to Follow-up|2|||
146285360|NCT01293487|527557844|FG006|Overall Study|Withdrawal by Subject|0|||
146205159|NCT01641198|527264575|FG002|After 12 Months of Function|Lost to Follow-up|2|||
146205160|NCT01641198|527264573|FG000|After 12 Months of Function|Protocol Violation|1|||
146205161|NCT01641198|527264574|FG001|After 12 Months of Function|Protocol Violation|0|||
146205162|NCT01641198|527264575|FG002|After 12 Months of Function|Protocol Violation|0|||
146205163|NCT01641198|527264573|FG000|After 12 Months of Function|Adverse Event|0|||
146205164|NCT01641198|527264574|FG001|After 12 Months of Function|Adverse Event|1|||
146205165|NCT01641198|527264575|FG002|After 12 Months of Function|Adverse Event|0|||
146205166|NCT01641198|527264573|FG000|After 24 Months of Function|Lost to Follow-up|4|||
146205167|NCT01641198|527264574|FG001|After 24 Months of Function|Lost to Follow-up|9|||
146205168|NCT01641198|527264575|FG002|After 24 Months of Function|Lost to Follow-up|6|||
146205169|NCT01641198|527264573|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
146205170|NCT01641198|527264574|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
146205171|NCT01641198|527264575|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
146205172|NCT01641198|527264573|FG000|At 15-20 Years of Function|Death|1|||
146205173|NCT01641198|527264574|FG001|At 15-20 Years of Function|Death|0|||
146205174|NCT01641198|527264575|FG002|At 15-20 Years of Function|Death|1|||
146205175|NCT02529995|527264577|FG000|Part A|Ongoing Study at Data Cut-off|14|||
146205176|NCT02529995|527264578|FG001|Part A|Ongoing Study at Data Cut-off|16|||
146205177|NCT02529995|527264577|FG000|Part A|Discontinued Study|1|||
146205178|NCT02529995|527264578|FG001|Part A|Discontinued Study|0|||
146205179|NCT02529995|527264577|FG000|Part B|Ongoing Study at Data Cut-off|0|||
146205180|NCT02529995|527264578|FG001|Part B|Ongoing Study at Data Cut-off|7|||
146205181|NCT02529995|527264577|FG000|Part B|Discontinued Study|6|||
146205182|NCT02529995|527264578|FG001|Part B|Discontinued Study|5|||
146205183|NCT03737240|527264587|FG000|Overall Study|Lost to Follow-up|16|||
146205184|NCT03737240|527264588|FG001|Overall Study|Lost to Follow-up|15|||
146205185|NCT00364013|527264589|FG000|Overall Study|Ineligibility determined|4|||
146205186|NCT00364013|527264590|FG001|Overall Study|Ineligibility determined|2|||
146205187|NCT00364013|527264589|FG000|Overall Study|Adverse Event|4|||
146205188|NCT00364013|527264590|FG001|Overall Study|Adverse Event|3|||
146205189|NCT00364013|527264589|FG000|Overall Study|Withdrawal by Subject|13|||
146205190|NCT00364013|527264590|FG001|Overall Study|Withdrawal by Subject|18|||
146205191|NCT00364013|527264589|FG000|Overall Study|Physician Decision|3|||
146205192|NCT00364013|527264590|FG001|Overall Study|Physician Decision|3|||
146205193|NCT00364013|527264589|FG000|Overall Study|Lost to Follow-up|10|||
146205194|NCT00364013|527264590|FG001|Overall Study|Lost to Follow-up|3|||
146205195|NCT00364013|527264589|FG000|Overall Study|Protocol-specified criteria|6|||
146205196|NCT00364013|527264590|FG001|Overall Study|Protocol-specified criteria|6|||
146205197|NCT00364013|527264589|FG000|Overall Study|Other|41|||
146205198|NCT00364013|527264590|FG001|Overall Study|Other|47|||
146205199|NCT00364013|527264589|FG000|Overall Study|Ongoing|20|||
146205200|NCT00364013|527264590|FG001|Overall Study|Ongoing|13|||
146205201|NCT01369498|527264595|FG000|Overall Study|Lack of Efficacy|9|||
146205202|NCT01369498|527264596|FG001|Overall Study|Lack of Efficacy|9|||
146205203|NCT01369498|527264597|FG002|Overall Study|Lack of Efficacy|1|||
146205204|NCT01369498|527264598|FG003|Overall Study|Lack of Efficacy|3|||
146205205|NCT01369498|527264595|FG000|Overall Study|Adverse Event|1|||
146205206|NCT01369498|527264596|FG001|Overall Study|Adverse Event|2|||
146205207|NCT01369498|527264597|FG002|Overall Study|Adverse Event|0|||
146205208|NCT01369498|527264598|FG003|Overall Study|Adverse Event|1|||
146205209|NCT01369498|527264595|FG000|Overall Study|Withdrawal of Consent|0|||
146205210|NCT01369498|527264596|FG001|Overall Study|Withdrawal of Consent|1|||
146205211|NCT01369498|527264597|FG002|Overall Study|Withdrawal of Consent|1|||
146205212|NCT01369498|527264598|FG003|Overall Study|Withdrawal of Consent|1|||
146205213|NCT01369498|527264595|FG000|Overall Study|Death|0|||
146205214|NCT01369498|527264596|FG001|Overall Study|Death|0|||
146205215|NCT01369498|527264597|FG002|Overall Study|Death|1|||
146205216|NCT01369498|527264598|FG003|Overall Study|Death|0|||
146205217|NCT01369498|527264595|FG000|Overall Study|Investigator's Discretion|1|||
146205218|NCT01369498|527264596|FG001|Overall Study|Investigator's Discretion|0|||
146205219|NCT01369498|527264597|FG002|Overall Study|Investigator's Discretion|1|||
146205220|NCT01369498|527264598|FG003|Overall Study|Investigator's Discretion|3|||
146205221|NCT01369498|527264595|FG000|Overall Study|Unknown Reason|1|||
146205222|NCT01369498|527264596|FG001|Overall Study|Unknown Reason|0|||
146205223|NCT01369498|527264597|FG002|Overall Study|Unknown Reason|11|||
146205224|NCT01369498|527264598|FG003|Overall Study|Unknown Reason|6|||
146205225|NCT01369498|527264595|FG000|Overall Study|Disease Progression|0|||
146205226|NCT01369498|527264596|FG001|Overall Study|Disease Progression|0|||
146205227|NCT01369498|527264597|FG002|Overall Study|Disease Progression|0|||
146205228|NCT01369498|527264598|FG003|Overall Study|Disease Progression|1|||
146205229|NCT01444417|527264601|FG000|Overall Study|Ineligibility Determined|0|||
146205230|NCT01444417|527264602|FG001|Overall Study|Ineligibility Determined|1|||
146205231|NCT01444417|527264601|FG000|Overall Study|Withdrawal by Subject|2|||
146205232|NCT01444417|527264602|FG001|Overall Study|Withdrawal by Subject|0|||
146205233|NCT02214160|527264604|FG000|Overall Study|Withdrawal by Subject|1|||
146205234|NCT02214160|527264605|FG001|Overall Study|Withdrawal by Subject|0|||
146205235|NCT02214160|527264606|FG002|Overall Study|Withdrawal by Subject|6|||
146205236|NCT02214160|527264604|FG000|Overall Study|Death|2|||
146205237|NCT02214160|527264605|FG001|Overall Study|Death|2|||
146205238|NCT02214160|527264606|FG002|Overall Study|Death|1|||
146205239|NCT02214160|527264604|FG000|Overall Study|Subject Non-Compliance|0|||
146205240|NCT02214160|527264605|FG001|Overall Study|Subject Non-Compliance|3|||
146205241|NCT02214160|527264606|FG002|Overall Study|Subject Non-Compliance|1|||
146205242|NCT02214160|527264604|FG000|Overall Study|Adverse Event|0|||
146205243|NCT02214160|527264605|FG001|Overall Study|Adverse Event|1|||
146205244|NCT02214160|527264606|FG002|Overall Study|Adverse Event|1|||
146205245|NCT02214160|527264604|FG000|Overall Study|Sponsor Decision|0|||
146205246|NCT02214160|527264605|FG001|Overall Study|Sponsor Decision|2|||
146205247|NCT02214160|527264606|FG002|Overall Study|Sponsor Decision|0|||
146205248|NCT02214160|527264604|FG000|Overall Study|Protocol Violation|1|||
146205249|NCT02214160|527264605|FG001|Overall Study|Protocol Violation|0|||
146205250|NCT02214160|527264606|FG002|Overall Study|Protocol Violation|0|||
146205251|NCT02214160|527264604|FG000|Overall Study|Physician Decision|0|||
146205252|NCT02214160|527264605|FG001|Overall Study|Physician Decision|0|||
146205253|NCT02214160|527264606|FG002|Overall Study|Physician Decision|1|||
146205254|NCT01430611|527264609|FG000|Overall Study|Adverse Event|0|||
146205255|NCT01430611|527264610|FG001|Overall Study|Adverse Event|1|||
146205256|NCT01430611|527264609|FG000|Overall Study|Protocol Violation|1|||
146205257|NCT01430611|527264610|FG001|Overall Study|Protocol Violation|0|||
146205258|NCT01430611|527264609|FG000|Overall Study|Lost to Follow-up|1|||
146205259|NCT01430611|527264610|FG001|Overall Study|Lost to Follow-up|0|||
146205260|NCT01430611|527264609|FG000|Overall Study|Withdrawal by Subject|15|||
146205261|NCT01430611|527264610|FG001|Overall Study|Withdrawal by Subject|14|||
146205262|NCT02261467|527264611|FG000|Overall Study|Enrolled in Error|1|||
146205263|NCT02261467|527264612|FG001|Overall Study|Enrolled in Error|0|||
146205264|NCT02261467|527264611|FG000|Overall Study|Protocol Violation|0|||
146205265|NCT02261467|527264612|FG001|Overall Study|Protocol Violation|1|||
146205266|NCT02261467|527264611|FG000|Overall Study|Personal Reasons|17|||
146205267|NCT02261467|527264612|FG001|Overall Study|Personal Reasons|22|||
146205268|NCT02261467|527264611|FG000|Overall Study|Lost to Follow-up|2|||
146205269|NCT02261467|527264612|FG001|Overall Study|Lost to Follow-up|13|||
146205270|NCT02261467|527264611|FG000|Overall Study|Adverse Event|1|||
146205271|NCT02261467|527264612|FG001|Overall Study|Adverse Event|1|||
146205272|NCT00794118|527264615|FG000|Overall Study|Lost to Follow-up|16|||
146205273|NCT00794118|527264615|FG000|Overall Study|Withdrawal by Subject|9|||
146205274|NCT00794118|527264615|FG000|Overall Study|Changed hospital center|2|||
146205275|NCT01597258|527264621|FG000|Overall Study|No Drug Administration|1|||
146205276|NCT00933400|527264622|FG000|Overall Study|Withdrawal by Subject|21|||
146205277|NCT00933400|527264623|FG001|Overall Study|Withdrawal by Subject|1|||
146205278|NCT01415349|527264624|FG000|Treatment Period 1|Adverse Event|0|||
146205279|NCT01415349|527264625|FG001|Treatment Period 1|Adverse Event|1|||
146205280|NCT01415349|527264624|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146205281|NCT01415349|527264625|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146205282|NCT01041417|527264626|FG000|Overall Study|Adverse Event|5|||
146205283|NCT01041417|527264627|FG001|Overall Study|Adverse Event|2|||
146205284|NCT01041417|527264626|FG000|Overall Study|Lost to Follow-up|1|||
146205285|NCT01041417|527264627|FG001|Overall Study|Lost to Follow-up|1|||
146205286|NCT01041417|527264626|FG000|Overall Study|Death|1|||
146205287|NCT01041417|527264627|FG001|Overall Study|Death|0|||
146205288|NCT01764464|527264628|FG000|First Intervention|Withdrawal by Subject|1|||
146205289|NCT01764464|527264629|FG001|First Intervention|Withdrawal by Subject|0|||
146205290|NCT01764464|527264628|FG000|First Intervention|Lost to Follow-up|1|||
146205291|NCT01764464|527264629|FG001|First Intervention|Lost to Follow-up|0|||
146205292|NCT01764464|527264628|FG000|First Intervention|Adverse Event|0|||
146205293|NCT01764464|527264629|FG001|First Intervention|Adverse Event|2|||
146205294|NCT01764464|527264628|FG000|First Intervention|did not receive study drug|0|||
146205295|NCT01764464|527264629|FG001|First Intervention|did not receive study drug|1|||
146205296|NCT01764464|527264628|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
146205297|NCT01764464|527264629|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
146205298|NCT03473340|527264630|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
146205299|NCT03473340|527264631|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
146205300|NCT03473340|527264630|FG000|Overall Study|Withdrawal by Subject|1|||
146205301|NCT03473340|527264631|FG001|Overall Study|Withdrawal by Subject|0|||
145950840|NCT01483599|526330516|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
146205302|NCT03473340|527264630|FG000|Overall Study|Lost to Follow-up|1|||
146205303|NCT03473340|527264631|FG001|Overall Study|Lost to Follow-up|2|||
146205304|NCT04623008|527266495|FG000|Baseline to T2|Withdrawal by Subject|4|||
146205305|NCT04623008|527266496|FG001|Baseline to T2|Withdrawal by Subject|2|||
146205306|NCT04623008|527266495|FG000|Baseline to T3|Withdrawal by Subject|4|||
146205307|NCT04623008|527266496|FG001|Baseline to T3|Withdrawal by Subject|2|||
146205308|NCT02763319|527266500|FG000|Overall Study|Adverse Event|12|||
146205309|NCT02763319|527266501|FG001|Overall Study|Adverse Event|3|||
146205310|NCT02763319|527266500|FG000|Overall Study|Death|123|||
146205311|NCT02763319|527266501|FG001|Overall Study|Death|123|||
146205312|NCT02763319|527266500|FG000|Overall Study|Lost to Follow-up|6|||
146205313|NCT02763319|527266501|FG001|Overall Study|Lost to Follow-up|7|||
146205314|NCT02763319|527266500|FG000|Overall Study|Noncompliance with Study Drug|2|||
146205315|NCT02763319|527266501|FG001|Overall Study|Noncompliance with Study Drug|0|||
146205316|NCT02763319|527266500|FG000|Overall Study|"Captured as Other in Database"|29|||
146205317|NCT02763319|527266501|FG001|Overall Study|"Captured as Other in Database"|34|||
146205318|NCT02763319|527266500|FG000|Overall Study|Physician Decision|1|||
146205319|NCT02763319|527266501|FG001|Overall Study|Physician Decision|7|||
146205320|NCT02763319|527266500|FG000|Overall Study|Progressive Disease|24|||
146205321|NCT02763319|527266501|FG001|Overall Study|Progressive Disease|27|||
146205322|NCT02763319|527266500|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
146205323|NCT02763319|527266501|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
146205324|NCT02763319|527266500|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
146205325|NCT02763319|527266501|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
146205326|NCT02763319|527266500|FG000|Overall Study|Withdrawal by Subject|26|||
146205327|NCT02763319|527266501|FG001|Overall Study|Withdrawal by Subject|25|||
146205328|NCT03936660|527266503|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
146205329|NCT03936660|527266504|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
146205330|NCT01875848|527266508|FG000|Overall Study|Withdrawal by Subject|2|||
146205331|NCT01875848|527266509|FG001|Overall Study|Withdrawal by Subject|0|||
146205332|NCT02407249|527266510|FG000|Overall Study|Did not complete 12-month follow-up|13|||
146205333|NCT02407249|527266510|FG000|Overall Study|Not treated|13|||
146205334|NCT00840177|527266511|FG000|Overall Study|Adverse Event|5|||
146205335|NCT00840177|527266512|FG001|Overall Study|Adverse Event|1|||
146205336|NCT00840177|527266513|FG002|Overall Study|Adverse Event|1|||
146205337|NCT00840177|527266511|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146205338|NCT00840177|527266512|FG001|Overall Study|Refusal unrelated to adverse events|0|||
146205339|NCT00840177|527266513|FG002|Overall Study|Refusal unrelated to adverse events|1|||
146205340|NCT00840177|527266511|FG000|Overall Study|Progression/relapse|2|||
146205341|NCT00840177|527266512|FG001|Overall Study|Progression/relapse|0|||
146205342|NCT00840177|527266513|FG002|Overall Study|Progression/relapse|0|||
146205343|NCT00840177|527266511|FG000|Overall Study|Death|4|||
146205344|NCT00840177|527266512|FG001|Overall Study|Death|5|||
146205345|NCT00840177|527266513|FG002|Overall Study|Death|5|||
146205346|NCT00840177|527266511|FG000|Overall Study|not protocol specified|6|||
146205347|NCT00840177|527266512|FG001|Overall Study|not protocol specified|3|||
146205348|NCT00840177|527266513|FG002|Overall Study|not protocol specified|0|||
146205349|NCT00840177|527266511|FG000|Overall Study|Ineligible|0|||
146205350|NCT00840177|527266512|FG001|Overall Study|Ineligible|0|||
146205351|NCT00840177|527266513|FG002|Overall Study|Ineligible|3|||
146205352|NCT00840177|527266511|FG000|Overall Study|Did not start treatment|0|||
146205353|NCT00840177|527266512|FG001|Overall Study|Did not start treatment|0|||
146205354|NCT00840177|527266513|FG002|Overall Study|Did not start treatment|1|||
146205355|NCT01622868|527266514|FG000|Overall Study|Protocol Violation|7|||
145950841|NCT01483599|526330517|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950842|NCT01483599|526330518|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950843|NCT01483599|526330519|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950844|NCT01483599|526330520|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950845|NCT01483599|526330521|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950846|NCT01483599|526330522|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145950847|NCT01483599|526330509|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
145950848|NCT01483599|526330510|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
146205356|NCT01622868|527266515|FG001|Overall Study|Protocol Violation|0|||
146205357|NCT00542789|527266516|FG000|Overall Study|Adverse Event|18|||
146205358|NCT00542789|527266517|FG001|Overall Study|Adverse Event|17|||
146205359|NCT00542789|527266516|FG000|Overall Study|Withdrawal by Subject|7|||
146205360|NCT00542789|527266517|FG001|Overall Study|Withdrawal by Subject|3|||
146205361|NCT00542789|527266516|FG000|Overall Study|Protocol Violation|8|||
146205362|NCT00542789|527266517|FG001|Overall Study|Protocol Violation|1|||
146205363|NCT00542789|527266516|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
146205364|NCT00542789|527266517|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
146205365|NCT02584829|527266518|FG000|Overall Study|Physician Decision|1|||
146205366|NCT02584829|527266519|FG001|Overall Study|Physician Decision|0|||
146205367|NCT02584829|527266518|FG000|Overall Study|Withdrawal by Subject|0|||
146205368|NCT02584829|527266519|FG001|Overall Study|Withdrawal by Subject|1|||
146205369|NCT02584829|527266518|FG000|Overall Study|Progressive Disease|0|||
146205370|NCT02584829|527266519|FG001|Overall Study|Progressive Disease|3|||
146205371|NCT02767765|527266521|FG000|Overall Study|Adverse Event|4|||
146205372|NCT02767765|527266521|FG000|Overall Study|Death|1|||
146205373|NCT02767765|527266521|FG000|Overall Study|Insufficient response|1|||
146205374|NCT02767765|527266521|FG000|Overall Study|Lost to Follow-up|2|||
146205375|NCT02767765|527266521|FG000|Overall Study|Investigator decision|1|||
146205376|NCT02767765|527266521|FG000|Overall Study|Non-Compliance|1|||
146205377|NCT02767765|527266521|FG000|Overall Study|Withdrawal by Subject|1|||
146205378|NCT01951170|527266522|FG000|Overall Study|Investigator decision|1|||
146205379|NCT00585052|527266531|FG000|Overall Study|Withdrawal by Subject|1|||
146205380|NCT00446459|527266534|FG000|8 Months|Protocol Violation|12|||
146205381|NCT00446459|527266534|FG000|12 Months|Protocol Violation|4|||
146205382|NCT00446459|527266534|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
146205383|NCT00277355|527266540|FG000|Overall Study|Withdrawal by Subject|3|||
146205384|NCT00277355|527266541|FG001|Overall Study|Withdrawal by Subject|3|||
146205385|NCT00277355|527266540|FG000|Overall Study|Lost to Follow-up|2|||
146205386|NCT00277355|527266541|FG001|Overall Study|Lost to Follow-up|2|||
146205387|NCT00277355|527266540|FG000|Overall Study|Adverse Event|5|||
146205388|NCT00277355|527266541|FG001|Overall Study|Adverse Event|0|||
146205389|NCT00277355|527266540|FG000|Overall Study|Death|3|||
146205390|NCT00277355|527266541|FG001|Overall Study|Death|0|||
146205391|NCT00277355|527266540|FG000|Overall Study|Physician Decision|1|||
146205392|NCT00277355|527266541|FG001|Overall Study|Physician Decision|0|||
146205393|NCT02765100|527266542|FG000|Overall Study|subject found ineligible after baseline|1|||
146205394|NCT02765100|527266543|FG001|Overall Study|subject found ineligible after baseline|1|||
146205395|NCT02765100|527266542|FG000|Overall Study|Lost to Follow-up|0|||
146205396|NCT02765100|527266543|FG001|Overall Study|Lost to Follow-up|1|||
146205397|NCT02675244|527266546|FG000|Overall Study|Death|9|||
146205398|NCT02675244|527266547|FG001|Overall Study|Death|6|||
146205399|NCT02675244|527266546|FG000|Overall Study|Withdrawal by Subject|3|||
146205400|NCT02675244|527266547|FG001|Overall Study|Withdrawal by Subject|6|||
146205401|NCT02675244|527266546|FG000|Overall Study|Lost to Follow-up|1|||
146205402|NCT02675244|527266547|FG001|Overall Study|Lost to Follow-up|1|||
146205403|NCT02675244|527266546|FG000|Overall Study|Ongoing at 2 Years|190|||
146205404|NCT02675244|527266547|FG001|Overall Study|Ongoing at 2 Years|185|||
146205405|NCT02652442|527266551|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
146205406|NCT00309907|527266552|FG000|Overall Study|Death|4|||
146205407|NCT00309907|527266552|FG000|Overall Study|Physician Decision|1|||
146205408|NCT00309907|527266552|FG000|Overall Study|Ineligible|11|||
146205409|NCT00309907|527266552|FG000|Overall Study|Major infectious event|4|||
146205410|NCT01075217|527266553|FG000|Overall Study|Adverse Event|1|||
146205411|NCT01075217|527266554|FG001|Overall Study|Adverse Event|1|||
146205412|NCT01075217|527266553|FG000|Overall Study|Physician Decision|1|||
146205413|NCT01075217|527266554|FG001|Overall Study|Physician Decision|0|||
146205414|NCT00293293|527266557|FG000|Overall Study|Withdrawal by Subject|1|||
146205415|NCT00293293|527266558|FG001|Overall Study|Withdrawal by Subject|1|||
146205416|NCT00293293|527266557|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
146205417|NCT00293293|527266558|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
146205418|NCT00293293|527266557|FG000|Overall Study|Patient discontinued chemotherapy|0|||
146205419|NCT00293293|527266558|FG001|Overall Study|Patient discontinued chemotherapy|1|||
146082896|NCT02616146|526824696|FG000|Overall Study|Withdrawal by Subject|30|||
146205420|NCT02512965|527266561|FG000|Overall Study|Withdrawal by Subject|0|||
146205421|NCT02512965|527266562|FG001|Overall Study|Withdrawal by Subject|4|||
146205422|NCT00835770|527266563|FG000|Overall Study|MS Relapse|17|||
146205423|NCT00835770|527266564|FG001|Overall Study|MS Relapse|23|||
146205424|NCT00835770|527266563|FG000|Overall Study|MS Progression|14|||
146205425|NCT00835770|527266564|FG001|Overall Study|MS Progression|9|||
146205426|NCT00835770|527266563|FG000|Overall Study|Adverse Event|113|||
146205427|NCT00835770|527266564|FG001|Overall Study|Adverse Event|124|||
146082897|NCT02616146|526824697|FG001|Overall Study|Withdrawal by Subject|24|||
146205428|NCT00835770|527266563|FG000|Overall Study|Lost to Follow-up|22|||
146205429|NCT00835770|527266564|FG001|Overall Study|Lost to Follow-up|19|||
146205430|NCT00835770|527266563|FG000|Overall Study|Consent Withdrawn|144|||
146205431|NCT00835770|527266564|FG001|Overall Study|Consent Withdrawn|156|||
146205432|NCT00835770|527266563|FG000|Overall Study|Investigator Decision|42|||
146205433|NCT00835770|527266564|FG001|Overall Study|Investigator Decision|42|||
146205434|NCT00835770|527266563|FG000|Overall Study|Participant Non-Compliance|11|||
146205435|NCT00835770|527266564|FG001|Overall Study|Participant Non-Compliance|9|||
146205436|NCT00835770|527266563|FG000|Overall Study|Death|4|||
146205437|NCT00835770|527266564|FG001|Overall Study|Death|6|||
146205438|NCT00835770|527266563|FG000|Overall Study|Other|115|||
146205439|NCT00835770|527266564|FG001|Overall Study|Other|104|||
146205440|NCT00835770|527266563|FG000|Overall Study|Other|2|||
146082898|NCT02616146|526824696|FG000|Overall Study|Physician Decision|2|||
146205441|NCT00835770|527266564|FG001|Overall Study|Other|1|||
146205442|NCT01185782|527266565|FG000|Overall Study|Adverse Event|0|||
146205443|NCT01185782|527266566|FG001|Overall Study|Adverse Event|1|||
146205444|NCT01185782|527266565|FG000|Overall Study|Protocol Violation|1|||
146205445|NCT01185782|527266566|FG001|Overall Study|Protocol Violation|0|||
146205446|NCT01185782|527266565|FG000|Overall Study|Poor Response to Treatment|3|||
146205447|NCT01185782|527266566|FG001|Overall Study|Poor Response to Treatment|1|||
146205448|NCT01185782|527266565|FG000|Overall Study|Other|2|||
146205449|NCT01185782|527266566|FG001|Overall Study|Other|5|||
146205450|NCT01185782|527266565|FG000|Overall Study|Randomized but not treated|0|||
146205451|NCT01185782|527266566|FG001|Overall Study|Randomized but not treated|4|||
146205452|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
146205453|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
146205454|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
146205455|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
146205456|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
146205457|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
146205458|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
146205459|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
146205460|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
146205461|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
146205462|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
146205463|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
146205464|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
146285361|NCT01293487|527557845|FG007|Overall Study|Withdrawal by Subject|2|||
146431174|NCT03818581|528088172|FG004|Overall Study|Covid-19|1|||
146431175|NCT03818581|528088168|FG000|Overall Study|Withdrawal by Subject|0|||
146431176|NCT03818581|528088169|FG001|Overall Study|Withdrawal by Subject|0|||
146431177|NCT03818581|528088170|FG002|Overall Study|Withdrawal by Subject|0|||
146431178|NCT03818581|528088171|FG003|Overall Study|Withdrawal by Subject|0|||
146431179|NCT03818581|528088172|FG004|Overall Study|Withdrawal by Subject|1|||
146431180|NCT03818581|528088168|FG000|Overall Study|No longer met study criteria|0|||
146431181|NCT03818581|528088169|FG001|Overall Study|No longer met study criteria|0|||
146431182|NCT03818581|528088170|FG002|Overall Study|No longer met study criteria|0|||
146431183|NCT03818581|528088171|FG003|Overall Study|No longer met study criteria|0|||
146431184|NCT03818581|528088172|FG004|Overall Study|No longer met study criteria|1|||
146431185|NCT00218257|528088175|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
146431186|NCT00218257|528088176|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
146431187|NCT02096211|528088177|FG000|Overall Study|Death|2|||
146431188|NCT02096211|528088177|FG000|Overall Study|Withdrawal by Subject|8|||
146431189|NCT02096211|528088177|FG000|Overall Study|Revision of implant|7|||
146431190|NCT02096211|528088177|FG000|Overall Study|Lost to Follow-up|43|||
146431191|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
146431192|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
146431193|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Death|2|||
146431194|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Death|1|||
146431195|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
146431196|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
146431197|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
146431198|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
146431199|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Other|8|||
146431200|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Other|13|||
146431201|NCT01439880|528088182|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
146431202|NCT01439880|528088183|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
146431203|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
146431204|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
146431205|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
146431206|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
146431207|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Death|3|||
146431208|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Death|13|||
146431209|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
146431210|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
146431211|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Other|14|||
146431212|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Other|31|||
146205465|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
146205466|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
146285362|NCT00528645|527557846|FG000|Overall Study|Adverse Event|3|||
146431213|NCT01439880|528088182|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
146431214|NCT01439880|528088183|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
146431215|NCT03874715|528088184|FG000|Overall Study|Adverse Event|2|||
146431216|NCT03874715|528088185|FG001|Overall Study|Adverse Event|0|||
146431217|NCT03874715|528088184|FG000|Overall Study|Poor compliance to protocol|5|||
146431218|NCT03874715|528088185|FG001|Overall Study|Poor compliance to protocol|1|||
146431219|NCT03874715|528088184|FG000|Overall Study|Withdrawal by Subject|1|||
146431220|NCT03874715|528088185|FG001|Overall Study|Withdrawal by Subject|0|||
146431221|NCT03874715|528088184|FG000|Overall Study|Other-unspecified|1|||
146431222|NCT03874715|528088185|FG001|Overall Study|Other-unspecified|0|||
146431223|NCT00328926|528088188|FG000|Overall Study|Pregnancy|2|||
146205467|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
146205468|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
146205469|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
146205470|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
146205471|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
146205472|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
146205473|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
146205474|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
146205475|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
146205476|NCT01061151|527266568|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
146205477|NCT01061151|527266569|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
146205478|NCT01061151|527266570|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
146205479|NCT01061151|527266571|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
146205480|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
146205481|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
146205482|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
146205483|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
146205484|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
146205485|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146205486|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146205487|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
146205488|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
146205489|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
146205490|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
146205491|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
146205492|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
146205493|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
146205494|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
146205495|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
146205496|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
146205497|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
146205498|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
146205499|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
146205500|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
146431224|NCT00328926|528088189|FG001|Overall Study|Pregnancy|1|||
146431225|NCT00328926|528088190|FG002|Overall Study|Pregnancy|0|||
146431226|NCT00328926|528088188|FG000|Overall Study|Lost to Follow-up|0|||
146205501|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
146205502|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
146431227|NCT00328926|528088189|FG001|Overall Study|Lost to Follow-up|1|||
146431228|NCT00328926|528088190|FG002|Overall Study|Lost to Follow-up|0|||
146431229|NCT00328926|528088188|FG000|Overall Study|Death|0|||
146431230|NCT00328926|528088189|FG001|Overall Study|Death|0|||
146431231|NCT00328926|528088190|FG002|Overall Study|Death|1|||
146431232|NCT00328926|528088188|FG000|Overall Study|In vitro fertilization treatment|0|||
146431233|NCT00328926|528088189|FG001|Overall Study|In vitro fertilization treatment|0|||
146431234|NCT00328926|528088190|FG002|Overall Study|In vitro fertilization treatment|1|||
146431235|NCT00328926|528088188|FG000|Overall Study|Lack of ovarian response|0|||
146431236|NCT00328926|528088189|FG001|Overall Study|Lack of ovarian response|1|||
146431237|NCT00328926|528088190|FG002|Overall Study|Lack of ovarian response|0|||
146431238|NCT02269657|528088191|FG000|Overall Study|Protocol Violation|3|||
146431239|NCT02956460|528088194|FG000|Lens 1|Lost to Follow-up|1|||
146431240|NCT02956460|528088195|FG001|Lens 1|Lost to Follow-up|0|||
146431241|NCT02440711|528088196|FG000|Second Intervention|Lost to Follow-up|1|||
145950849|NCT01483599|526330511|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
145950850|NCT01483599|526330512|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
145950851|NCT01483599|526330513|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
146205503|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
146205504|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
146431242|NCT02440711|528088197|FG001|Second Intervention|Lost to Follow-up|0|||
146431243|NCT04129346|528088200|FG000|Overall Study|Death|1|||
146431244|NCT04129346|528088201|FG001|Overall Study|Death|0|||
146431245|NCT02646124|528088202|FG000|Overall Study|Lost to Follow-up|0|||
146431246|NCT02646124|528088203|FG001|Overall Study|Lost to Follow-up|2|||
146431247|NCT03154047|528088204|FG000|Overall Study|Death|1|||
146431248|NCT03154047|528088204|FG000|Overall Study|Study terminated by sponsor|76|||
146431249|NCT03154047|528088204|FG000|Overall Study|Withdrawal by Subject|3|||
146431250|NCT00857454|528088205|FG000|Overall Study|Withdrawal by Subject|2|||
146431251|NCT00857454|528088205|FG000|Overall Study|Lost to Follow-up|1|||
146431252|NCT00857454|528088205|FG000|Overall Study|Adverse Event|2|||
146431253|NCT00857454|528088205|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
146431254|NCT00857454|528088205|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
146205505|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
146205506|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
146205507|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
146205508|NCT01061151|527266568|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
146205509|NCT01061151|527266569|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
146205510|NCT01061151|527266570|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
146205511|NCT01061151|527266571|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
146205512|NCT03451721|527266574|FG000|Overall Study|Death|1|||
146205513|NCT00960141|527266575|FG000|Overall Study|Adverse Event|4|||
146205514|NCT00960141|527266576|FG001|Overall Study|Adverse Event|8|||
146205515|NCT00960141|527266577|FG002|Overall Study|Adverse Event|2|||
146205516|NCT00960141|527266575|FG000|Overall Study|Lack of Efficacy|3|||
146431255|NCT00857454|528088205|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
146431256|NCT00365365|528088206|FG000|Overall Study|Randomized but not treated|0|||
146431257|NCT00365365|528088207|FG001|Overall Study|Randomized but not treated|2|||
146431258|NCT00365365|528088208|FG002|Overall Study|Randomized but not treated|0|||
146431259|NCT00365365|528088206|FG000|Overall Study|Poor compliance to protocol|0|||
146431260|NCT00365365|528088207|FG001|Overall Study|Poor compliance to protocol|1|||
146205517|NCT00960141|527266576|FG001|Overall Study|Lack of Efficacy|4|||
146205518|NCT00960141|527266577|FG002|Overall Study|Lack of Efficacy|2|||
146205519|NCT00960141|527266575|FG000|Overall Study|Lost to Follow-up|1|||
146205520|NCT00960141|527266576|FG001|Overall Study|Lost to Follow-up|0|||
145950852|NCT01483599|526330514|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
145950853|NCT01483599|526330515|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
145950854|NCT01483599|526330516|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
145950855|NCT01483599|526330517|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
146431261|NCT00365365|528088208|FG002|Overall Study|Poor compliance to protocol|0|||
145950856|NCT01483599|526330518|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
145950857|NCT01483599|526330519|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
146205521|NCT00960141|527266577|FG002|Overall Study|Lost to Follow-up|0|||
146205522|NCT00960141|527266575|FG000|Overall Study|Protocol Violation|1|||
146205523|NCT00960141|527266576|FG001|Overall Study|Protocol Violation|3|||
146205524|NCT00960141|527266577|FG002|Overall Study|Protocol Violation|2|||
146205525|NCT00960141|527266575|FG000|Overall Study|Withdrawal by Subject|1|||
145950858|NCT01483599|526330520|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
145950859|NCT01483599|526330521|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
145950860|NCT01483599|526330522|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
145950861|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
145950862|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
145950863|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
145950864|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
145950865|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
145950866|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
145950867|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
145950868|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
145950869|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
146205526|NCT00960141|527266576|FG001|Overall Study|Withdrawal by Subject|2|||
146205527|NCT00960141|527266577|FG002|Overall Study|Withdrawal by Subject|1|||
146205528|NCT00939510|527266578|FG000|Overall Study|Withdrawal by Subject|1|||
146205529|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
146205530|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
146205531|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
146205532|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
146205533|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
146205534|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
146431262|NCT00365365|528088206|FG000|Overall Study|Lost to Follow-up|3|||
145950870|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
145950871|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
146431263|NCT00365365|528088207|FG001|Overall Study|Lost to Follow-up|3|||
146431264|NCT00365365|528088208|FG002|Overall Study|Lost to Follow-up|3|||
146082899|NCT02616146|526824697|FG001|Overall Study|Physician Decision|1|||
146205535|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
146205536|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
146205537|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205538|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205539|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205540|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205541|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
146205542|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
146205543|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205544|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
146205545|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146205546|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146205547|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146205548|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146431265|NCT00365365|528088206|FG000|Overall Study|Death|1|||
146431266|NCT00365365|528088207|FG001|Overall Study|Death|3|||
146205549|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146205550|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
146205551|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
146205552|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
146205553|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205554|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
146205555|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205556|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205557|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205558|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205559|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205560|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
146205561|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205562|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205563|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205564|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
146205565|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
146205566|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205567|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205568|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
146205569|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205570|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205571|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205572|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
146205573|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205574|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205575|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205576|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
146205577|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146205578|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
146205579|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146205580|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146205581|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
146205582|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
146205583|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
146205584|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
146205585|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
146205586|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205587|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205588|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205589|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205590|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
146205591|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205592|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
146205593|NCT03903822|527266581|FG000|Treatment Phase (6 Weeks)|Other|2|||
146205594|NCT03903822|527266582|FG001|Treatment Phase (6 Weeks)|Other|1|||
146205595|NCT03903822|527266583|FG002|Treatment Phase (6 Weeks)|Other|0|||
146205596|NCT03903822|527266584|FG003|Treatment Phase (6 Weeks)|Other|0|||
146205597|NCT03903822|527266585|FG004|Treatment Phase (6 Weeks)|Other|1|||
145950872|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
146205598|NCT03903822|527266586|FG005|Treatment Phase (6 Weeks)|Other|1|||
146082900|NCT03039621|526824698|FG000|Overall Study|Violation of inclusion criteria|3|||
146205599|NCT03903822|527266587|FG006|Treatment Phase (6 Weeks)|Other|0|||
146205600|NCT03903822|527266588|FG007|Treatment Phase (6 Weeks)|Other|0|||
146205601|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
146205602|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
146205603|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
146205604|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
146205605|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
146205606|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
146205607|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
146205608|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
146205609|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205610|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205611|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205612|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205613|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
146205614|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205615|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205616|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
146205617|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
146205618|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146205619|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146205620|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146205621|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146205622|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
146205623|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
146205624|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
146205625|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205626|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205627|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205628|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
146205629|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
146205630|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205631|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205632|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
146205633|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146205634|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
146205635|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146205636|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146205637|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146205638|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
146205639|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146205640|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
146205641|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146205642|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146205643|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146205644|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146205645|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146431267|NCT00365365|528088208|FG002|Overall Study|Death|0|||
146431268|NCT00365365|528088206|FG000|Overall Study|Subject's request|11|||
146431269|NCT00365365|528088207|FG001|Overall Study|Subject's request|13|||
146431270|NCT00365365|528088208|FG002|Overall Study|Subject's request|1|||
146431271|NCT00365365|528088206|FG000|Overall Study|Disease progression/relapse|9|||
146431272|NCT00365365|528088207|FG001|Overall Study|Disease progression/relapse|6|||
146431273|NCT00365365|528088208|FG002|Overall Study|Disease progression/relapse|7|||
146431274|NCT00365365|528088206|FG000|Overall Study|Adverse Event|6|||
146431275|NCT00365365|528088207|FG001|Overall Study|Adverse Event|6|||
146431276|NCT00365365|528088208|FG002|Overall Study|Adverse Event|3|||
146431277|NCT00365365|528088206|FG000|Overall Study|Moved|2|||
145950873|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
145950874|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
145950875|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950876|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950877|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950878|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950879|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950880|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950881|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146431278|NCT00365365|528088207|FG001|Overall Study|Moved|0|||
146431279|NCT00365365|528088208|FG002|Overall Study|Moved|0|||
146431280|NCT00365365|528088206|FG000|Overall Study|New cancer|1|||
146431281|NCT00365365|528088207|FG001|Overall Study|New cancer|0|||
146431282|NCT00365365|528088208|FG002|Overall Study|New cancer|0|||
146431283|NCT00365365|528088206|FG000|Overall Study|Withdrew consent|1|||
146431284|NCT00365365|528088207|FG001|Overall Study|Withdrew consent|1|||
146431285|NCT00365365|528088208|FG002|Overall Study|Withdrew consent|0|||
146431286|NCT00365365|528088206|FG000|Overall Study|Second malignancy|0|||
146431287|NCT00365365|528088207|FG001|Overall Study|Second malignancy|1|||
146205646|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
146205647|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146205648|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
146431288|NCT00365365|528088208|FG002|Overall Study|Second malignancy|0|||
146431289|NCT00365365|528088206|FG000|Overall Study|Patient/physician decision|0|||
146431290|NCT00365365|528088207|FG001|Overall Study|Patient/physician decision|0|||
146431291|NCT00365365|528088208|FG002|Overall Study|Patient/physician decision|1|||
146431292|NCT01083693|528088211|FG000|Overall Study|Adverse Event|1|||
146431293|NCT01083693|528088212|FG001|Overall Study|Adverse Event|1|||
146431294|NCT01083693|528088213|FG002|Overall Study|Adverse Event|0|||
146431295|NCT01083693|528088211|FG000|Overall Study|Lost to Follow-up|2|||
146431296|NCT01083693|528088212|FG001|Overall Study|Lost to Follow-up|0|||
146431297|NCT01083693|528088213|FG002|Overall Study|Lost to Follow-up|2|||
146431298|NCT01083693|528088211|FG000|Overall Study|Lack of effectiveness|13|||
146431299|NCT01083693|528088212|FG001|Overall Study|Lack of effectiveness|2|||
146431300|NCT01083693|528088213|FG002|Overall Study|Lack of effectiveness|2|||
146431301|NCT01083693|528088211|FG000|Overall Study|Patient Moved|0|||
146431302|NCT01083693|528088212|FG001|Overall Study|Patient Moved|1|||
146431303|NCT01083693|528088213|FG002|Overall Study|Patient Moved|0|||
146431304|NCT01083693|528088211|FG000|Overall Study|Complete remission|0|||
146431305|NCT01083693|528088212|FG001|Overall Study|Complete remission|1|||
146431306|NCT01083693|528088213|FG002|Overall Study|Complete remission|0|||
146431307|NCT01083693|528088211|FG000|Overall Study|Other medical condition/surgery|1|||
146431308|NCT01083693|528088212|FG001|Overall Study|Other medical condition/surgery|1|||
146431309|NCT01083693|528088213|FG002|Overall Study|Other medical condition/surgery|0|||
146431310|NCT01083693|528088211|FG000|Overall Study|Withdrawal by Subject|3|||
146431311|NCT01083693|528088212|FG001|Overall Study|Withdrawal by Subject|0|||
146431312|NCT01083693|528088213|FG002|Overall Study|Withdrawal by Subject|2|||
146431313|NCT01083693|528088211|FG000|Overall Study|Reason unknown|0|||
146205649|NCT03903822|527266581|FG000|Follow up Phase (4 Weeks)|Other|1|||
146205650|NCT03903822|527266582|FG001|Follow up Phase (4 Weeks)|Other|1|||
146205651|NCT03903822|527266583|FG002|Follow up Phase (4 Weeks)|Other|0|||
146205652|NCT03903822|527266584|FG003|Follow up Phase (4 Weeks)|Other|0|||
146205653|NCT03903822|527266585|FG004|Follow up Phase (4 Weeks)|Other|0|||
146205654|NCT03903822|527266586|FG005|Follow up Phase (4 Weeks)|Other|0|||
146205655|NCT03903822|527266587|FG006|Follow up Phase (4 Weeks)|Other|0|||
146205656|NCT03903822|527266588|FG007|Follow up Phase (4 Weeks)|Other|0|||
146205657|NCT05274217|527266610|FG000|Overall Study|Study terminated.|11|||
146205658|NCT05274217|527266611|FG001|Overall Study|Study terminated.|0|||
146205659|NCT04594759|527266612|FG000|Overall Study|Lost to Follow-up|3|||
146205660|NCT03144674|527266621|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
146205661|NCT03144674|527266622|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
146205662|NCT03144674|527266623|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
146205663|NCT03144674|527266624|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
146205664|NCT03144674|527266621|FG000|Overall Study|Death|3|||
146205665|NCT03144674|527266622|FG001|Overall Study|Death|2|||
146205666|NCT03144674|527266623|FG002|Overall Study|Death|6|||
146205667|NCT03144674|527266624|FG003|Overall Study|Death|24|||
146205668|NCT03144674|527266621|FG000|Overall Study|Lost to Follow-up|0|||
146205669|NCT03144674|527266622|FG001|Overall Study|Lost to Follow-up|1|||
146205670|NCT03144674|527266623|FG002|Overall Study|Lost to Follow-up|0|||
146205671|NCT03144674|527266624|FG003|Overall Study|Lost to Follow-up|4|||
146205672|NCT03144674|527266621|FG000|Overall Study|Withdrawal by Participant|0|||
146205673|NCT03144674|527266622|FG001|Overall Study|Withdrawal by Participant|0|||
146205674|NCT03144674|527266623|FG002|Overall Study|Withdrawal by Participant|2|||
146205675|NCT03144674|527266624|FG003|Overall Study|Withdrawal by Participant|6|||
146205676|NCT03144674|527266621|FG000|Overall Study|Discharged from the Trust|0|||
146205677|NCT03144674|527266622|FG001|Overall Study|Discharged from the Trust|0|||
146205678|NCT03144674|527266623|FG002|Overall Study|Discharged from the Trust|1|||
146205679|NCT03144674|527266624|FG003|Overall Study|Discharged from the Trust|0|||
146205680|NCT03144674|527266621|FG000|Overall Study|Exclusion Criteria Met|0|||
146205681|NCT03144674|527266622|FG001|Overall Study|Exclusion Criteria Met|0|||
146205682|NCT03144674|527266623|FG002|Overall Study|Exclusion Criteria Met|1|||
146205683|NCT03144674|527266624|FG003|Overall Study|Exclusion Criteria Met|0|||
146205684|NCT03144674|527266621|FG000|Overall Study|Changed Physicians|0|||
146205685|NCT03144674|527266622|FG001|Overall Study|Changed Physicians|0|||
146205686|NCT03144674|527266623|FG002|Overall Study|Changed Physicians|0|||
146205687|NCT03144674|527266624|FG003|Overall Study|Changed Physicians|1|||
146205688|NCT03144674|527266621|FG000|Overall Study|Removed for Safety|0|||
146205689|NCT03144674|527266622|FG001|Overall Study|Removed for Safety|0|||
146205690|NCT03144674|527266623|FG002|Overall Study|Removed for Safety|0|||
146205691|NCT03144674|527266624|FG003|Overall Study|Removed for Safety|1|||
146205692|NCT03144674|527266621|FG000|Overall Study|Site Closed|0|||
146205693|NCT03144674|527266622|FG001|Overall Study|Site Closed|0|||
146205694|NCT03144674|527266623|FG002|Overall Study|Site Closed|0|||
146205695|NCT03144674|527266624|FG003|Overall Study|Site Closed|1|||
146205696|NCT03144674|527266621|FG000|Overall Study|Histological Criteria Not Met|0|||
146205697|NCT03144674|527266622|FG001|Overall Study|Histological Criteria Not Met|0|||
146205698|NCT03144674|527266623|FG002|Overall Study|Histological Criteria Not Met|0|||
146205699|NCT03144674|527266624|FG003|Overall Study|Histological Criteria Not Met|1|||
146205700|NCT03144674|527266621|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
146205701|NCT03144674|527266622|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
146205702|NCT03144674|527266623|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
146205703|NCT03144674|527266624|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
146205704|NCT03144674|527266621|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146205705|NCT03144674|527266622|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146205706|NCT03144674|527266623|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
146205707|NCT03144674|527266624|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
146205708|NCT01395758|527266625|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
146205709|NCT01395758|527266626|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146205710|NCT01395758|527266627|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146205711|NCT03942042|527266631|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
146205712|NCT03942042|527266632|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
146205713|NCT03942042|527266631|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
146205714|NCT03942042|527266632|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
146205715|NCT00736853|527266633|FG000|Open-Label Period|Physician Decision|2|||
146205716|NCT00736853|527266634|FG001|Open-Label Period|Physician Decision|0|||
146205717|NCT00736853|527266635|FG002|Open-Label Period|Physician Decision|0|||
146205718|NCT00736853|527266633|FG000|Open-Label Period|Adverse Event|31|||
146205719|NCT00736853|527266634|FG001|Open-Label Period|Adverse Event|0|||
146205720|NCT00736853|527266635|FG002|Open-Label Period|Adverse Event|0|||
146205721|NCT00736853|527266633|FG000|Open-Label Period|Withdrawal by Subject|16|||
146205722|NCT00736853|527266634|FG001|Open-Label Period|Withdrawal by Subject|0|||
146205723|NCT00736853|527266635|FG002|Open-Label Period|Withdrawal by Subject|0|||
146205724|NCT00736853|527266633|FG000|Open-Label Period|Started but not treated|42|||
146205725|NCT00736853|527266634|FG001|Open-Label Period|Started but not treated|0|||
146205726|NCT00736853|527266635|FG002|Open-Label Period|Started but not treated|0|||
146205727|NCT00736853|527266633|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
146205728|NCT00736853|527266634|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
146205729|NCT00736853|527266635|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
146205730|NCT00736853|527266633|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
146205731|NCT00736853|527266634|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
146205732|NCT00736853|527266635|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
146205733|NCT00736853|527266633|FG000|Double-Blind Period|Lack of Efficacy|0|||
146205734|NCT00736853|527266634|FG001|Double-Blind Period|Lack of Efficacy|19|||
146205735|NCT00736853|527266635|FG002|Double-Blind Period|Lack of Efficacy|42|||
146205736|NCT00736853|527266633|FG000|Double-Blind Period|Adverse Event|0|||
146205737|NCT00736853|527266634|FG001|Double-Blind Period|Adverse Event|3|||
146205738|NCT00736853|527266635|FG002|Double-Blind Period|Adverse Event|2|||
146205739|NCT00736853|527266633|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146205740|NCT00736853|527266634|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146205741|NCT00736853|527266635|FG002|Double-Blind Period|Withdrawal by Subject|4|||
146205742|NCT00736853|527266633|FG000|Double-Blind Period|Ineligible to participate the study|0|||
146205743|NCT00736853|527266634|FG001|Double-Blind Period|Ineligible to participate the study|1|||
146205744|NCT00736853|527266635|FG002|Double-Blind Period|Ineligible to participate the study|0|||
146205745|NCT01199705|527266636|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
146205746|NCT04980755|527266637|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
146205747|NCT04980755|527266637|FG000|Body Reprogramming Courses|Work commitment|2|||
146205748|NCT04980755|527266637|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
146205749|NCT04980755|527266637|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
146205750|NCT01212991|527266638|FG000|Double-blind|Lost to Follow-up|8|||
146205751|NCT01212991|527266639|FG001|Double-blind|Lost to Follow-up|4|||
146205752|NCT01212991|527266640|FG002|Double-blind|Lost to Follow-up|0|||
146205753|NCT01212991|527266638|FG000|Double-blind|Death|699|||
146205754|NCT01212991|527266639|FG001|Double-blind|Death|550|||
146205755|NCT01212991|527266640|FG002|Double-blind|Death|0|||
146205756|NCT01212991|527266638|FG000|Double-blind|Withdrawal by Subject|16|||
146205757|NCT01212991|527266639|FG001|Double-blind|Withdrawal by Subject|19|||
146205758|NCT01212991|527266640|FG002|Double-blind|Withdrawal by Subject|0|||
146205759|NCT01212991|527266638|FG000|Double-blind|Other|7|||
146205760|NCT01212991|527266639|FG001|Double-blind|Other|0|||
146205761|NCT01212991|527266640|FG002|Double-blind|Other|0|||
146205762|NCT01212991|527266638|FG000|Double-blind|Sponsor decision|142|||
146205763|NCT01212991|527266639|FG001|Double-blind|Sponsor decision|38|||
146205764|NCT01212991|527266640|FG002|Double-blind|Sponsor decision|0|||
146205765|NCT01212991|527266638|FG000|Open-label|Death|0|||
146205766|NCT01212991|527266639|FG001|Open-label|Death|0|||
146205767|NCT01212991|527266640|FG002|Open-label|Death|166|||
146205768|NCT01212991|527266638|FG000|Open-label|Lost to Follow-up|0|||
146205769|NCT01212991|527266639|FG001|Open-label|Lost to Follow-up|0|||
146205770|NCT01212991|527266640|FG002|Open-label|Lost to Follow-up|5|||
146205771|NCT01212991|527266638|FG000|Open-label|Withdrawal by Subject|0|||
146205772|NCT01212991|527266639|FG001|Open-label|Withdrawal by Subject|0|||
146205773|NCT01212991|527266640|FG002|Open-label|Withdrawal by Subject|7|||
146205774|NCT01212991|527266638|FG000|Open-label|Sponsor decision|0|||
146205775|NCT01212991|527266639|FG001|Open-label|Sponsor decision|0|||
146205776|NCT01212991|527266640|FG002|Open-label|Sponsor decision|53|||
146205777|NCT01212991|527266638|FG000|Open-label|Other|0|||
146205778|NCT01212991|527266639|FG001|Open-label|Other|0|||
146205779|NCT01212991|527266640|FG002|Open-label|Other|3|||
146205780|NCT04411056|527268121|FG000|Overall Study|surgery cancelled|1|||
146205781|NCT04411056|527268122|FG001|Overall Study|surgery cancelled|0|||
146205782|NCT04411056|527268121|FG000|Overall Study|Equipment problem during intubation|0|||
146205783|NCT04411056|527268122|FG001|Overall Study|Equipment problem during intubation|1|||
146205784|NCT03122886|527268134|FG000|Overall Study|Withdrawal by Subject|1|||
146205785|NCT03122886|527268135|FG001|Overall Study|Withdrawal by Subject|2|||
146205786|NCT05985044|527268136|FG000|Overall Study|Death|6|||
146205787|NCT05985044|527268136|FG000|Overall Study|Lost to Follow-up|4|||
146205788|NCT05985044|527268136|FG000|Overall Study|Incapacitation|3|||
146205789|NCT05985044|527268136|FG000|Overall Study|Withdrawal by Subject|2|||
146205790|NCT03312907|527268139|FG000|Overall Study|Adverse Event|1|||
146205791|NCT03312907|527268140|FG001|Overall Study|Adverse Event|6|||
146205792|NCT03312907|527268141|FG002|Overall Study|Adverse Event|1|||
146205793|NCT03312907|527268139|FG000|Overall Study|Protocol Violation|2|||
146205794|NCT03312907|527268140|FG001|Overall Study|Protocol Violation|3|||
146205795|NCT03312907|527268141|FG002|Overall Study|Protocol Violation|4|||
146205796|NCT03312907|527268139|FG000|Overall Study|Lost to Follow-up|2|||
146205797|NCT03312907|527268140|FG001|Overall Study|Lost to Follow-up|3|||
146205798|NCT03312907|527268141|FG002|Overall Study|Lost to Follow-up|2|||
146205799|NCT03312907|527268139|FG000|Overall Study|Physician Decision|3|||
146205800|NCT03312907|527268140|FG001|Overall Study|Physician Decision|4|||
146205801|NCT03312907|527268141|FG002|Overall Study|Physician Decision|2|||
146205802|NCT03312907|527268139|FG000|Overall Study|Withdrawal by Subject|9|||
146205803|NCT03312907|527268140|FG001|Overall Study|Withdrawal by Subject|14|||
146205804|NCT03312907|527268141|FG002|Overall Study|Withdrawal by Subject|10|||
146205805|NCT04252586|527268143|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146205806|NCT04252586|527268143|FG000|Overall Study|Adverse Event|1|||
146205807|NCT04252586|527268143|FG000|Overall Study|Death|2|||
146205808|NCT04252586|527268143|FG000|Overall Study|Study terminated by sponsor|4|||
146205809|NCT04252586|527268143|FG000|Overall Study|Sponsor request|10|||
146205810|NCT04252586|527268143|FG000|Overall Study|Did not complete treatment period|1|||
146205811|NCT01236001|527268145|FG000|Overall Study|Adverse Event|5|||
146205812|NCT01236001|527268146|FG001|Overall Study|Adverse Event|14|||
146205813|NCT01236001|527268145|FG000|Overall Study|Lack of Efficacy|6|||
146205814|NCT01236001|527268146|FG001|Overall Study|Lack of Efficacy|6|||
146205815|NCT01236001|527268145|FG000|Overall Study|Lost to Follow-up|6|||
146431314|NCT01083693|528088212|FG001|Overall Study|Reason unknown|0|||
146431315|NCT01083693|528088213|FG002|Overall Study|Reason unknown|1|||
146205816|NCT01236001|527268146|FG001|Overall Study|Lost to Follow-up|1|||
146205817|NCT01236001|527268145|FG000|Overall Study|Incompliance|1|||
146205818|NCT01236001|527268146|FG001|Overall Study|Incompliance|0|||
146205819|NCT01236001|527268145|FG000|Overall Study|Planned Visit After End of Study|0|||
146205820|NCT01236001|527268146|FG001|Overall Study|Planned Visit After End of Study|1|||
146431316|NCT04567186|528088214|FG000|Period 1|COVID-19 related|1|||
146431317|NCT04567186|528088215|FG001|Period 1|COVID-19 related|0|||
146431318|NCT04567186|528088214|FG000|Period 1|Protocol Violation|0|||
146431319|NCT04567186|528088215|FG001|Period 1|Protocol Violation|1|||
146082901|NCT03039621|526824699|FG001|Overall Study|Violation of inclusion criteria|2|||
146431320|NCT04567186|528088214|FG000|Period 1|Adverse Event|0|||
146205821|NCT02988817|527268147|FG000|Overall Study|Withdrawal by Subject|1|||
146205822|NCT02988817|527268148|FG001|Overall Study|Withdrawal by Subject|0|||
146431321|NCT04567186|528088215|FG001|Period 1|Adverse Event|2|||
146205823|NCT02988817|527268149|FG002|Overall Study|Withdrawal by Subject|0|||
146205824|NCT02988817|527268150|FG003|Overall Study|Withdrawal by Subject|1|||
146205825|NCT02988817|527268151|FG004|Overall Study|Withdrawal by Subject|3|||
146431322|NCT04567186|528088214|FG000|Period 2|COVID-19 Related|0|||
146205826|NCT02988817|527268152|FG005|Overall Study|Withdrawal by Subject|1|||
146431323|NCT04567186|528088215|FG001|Period 2|COVID-19 Related|1|||
146431324|NCT04567186|528088214|FG000|Period 2|Protocol Violation|0|||
146431325|NCT04567186|528088215|FG001|Period 2|Protocol Violation|1|||
146431326|NCT04567186|528088214|FG000|Period 2|Lost to Follow-up|0|||
146431327|NCT04567186|528088215|FG001|Period 2|Lost to Follow-up|1|||
146205827|NCT02988817|527268153|FG006|Overall Study|Withdrawal by Subject|2|||
146205828|NCT02988817|527268154|FG007|Overall Study|Withdrawal by Subject|1|||
146205829|NCT02988817|527268155|FG008|Overall Study|Withdrawal by Subject|1|||
146205830|NCT02988817|527268156|FG009|Overall Study|Withdrawal by Subject|1|||
146205831|NCT02988817|527268157|FG010|Overall Study|Withdrawal by Subject|1|||
146205832|NCT02988817|527268158|FG011|Overall Study|Withdrawal by Subject|12|||
146205833|NCT02988817|527268159|FG012|Overall Study|Withdrawal by Subject|6|||
146205834|NCT02988817|527268160|FG013|Overall Study|Withdrawal by Subject|6|||
146205835|NCT02988817|527268161|FG014|Overall Study|Withdrawal by Subject|4|||
146205836|NCT02988817|527268162|FG015|Overall Study|Withdrawal by Subject|5|||
146205837|NCT02988817|527268163|FG016|Overall Study|Withdrawal by Subject|4|||
146205838|NCT02988817|527268164|FG017|Overall Study|Withdrawal by Subject|11|||
146205839|NCT02988817|527268165|FG018|Overall Study|Withdrawal by Subject|4|||
146205840|NCT02988817|527268166|FG019|Overall Study|Withdrawal by Subject|2|||
146205841|NCT02988817|527268147|FG000|Overall Study|Death|0|||
146205842|NCT02988817|527268148|FG001|Overall Study|Death|1|||
146205843|NCT02988817|527268149|FG002|Overall Study|Death|3|||
146205844|NCT02988817|527268150|FG003|Overall Study|Death|1|||
146205845|NCT02988817|527268151|FG004|Overall Study|Death|6|||
146205846|NCT02988817|527268152|FG005|Overall Study|Death|10|||
146205847|NCT02988817|527268153|FG006|Overall Study|Death|1|||
146205848|NCT02988817|527268154|FG007|Overall Study|Death|2|||
146205849|NCT02988817|527268155|FG008|Overall Study|Death|1|||
146205850|NCT02988817|527268156|FG009|Overall Study|Death|5|||
146205851|NCT02988817|527268157|FG010|Overall Study|Death|1|||
146205852|NCT02988817|527268158|FG011|Overall Study|Death|8|||
146205853|NCT02988817|527268159|FG012|Overall Study|Death|9|||
146205854|NCT02988817|527268160|FG013|Overall Study|Death|17|||
146205855|NCT02988817|527268161|FG014|Overall Study|Death|18|||
146205856|NCT02988817|527268162|FG015|Overall Study|Death|30|||
146205857|NCT02988817|527268163|FG016|Overall Study|Death|17|||
146205858|NCT02988817|527268164|FG017|Overall Study|Death|38|||
146205859|NCT02988817|527268165|FG018|Overall Study|Death|14|||
146205860|NCT02988817|527268166|FG019|Overall Study|Death|16|||
146205861|NCT02988817|527268147|FG000|Overall Study|Other|0|||
146431328|NCT04567186|528088214|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
146431329|NCT04567186|528088215|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
146431330|NCT04274686|528088216|FG000|Overall Study|Physician Decision|1|||
146431331|NCT04274686|528088217|FG001|Overall Study|Physician Decision|0|||
146431332|NCT00376623|528088218|FG000|Overall Study|Progressive disease|35|||
146431333|NCT00376623|528088219|FG001|Overall Study|Progressive disease|22|||
146431334|NCT00376623|528088220|FG002|Overall Study|Progressive disease|17|||
146431335|NCT00376623|528088218|FG000|Overall Study|Lost to Follow-up|0|||
146431336|NCT00376623|528088219|FG001|Overall Study|Lost to Follow-up|1|||
146431337|NCT00376623|528088220|FG002|Overall Study|Lost to Follow-up|0|||
146431338|NCT00376623|528088218|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
146431339|NCT00376623|528088219|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
146431340|NCT00376623|528088220|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
146431341|NCT00376623|528088218|FG000|Overall Study|Not treated with BI 2536|1|||
146431342|NCT00376623|528088219|FG001|Overall Study|Not treated with BI 2536|0|||
146431343|NCT00376623|528088220|FG002|Overall Study|Not treated with BI 2536|0|||
146431344|NCT00376623|528088218|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
146431345|NCT00376623|528088219|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146431346|NCT00376623|528088220|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146431347|NCT00376623|528088218|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
146431348|NCT00376623|528088219|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
146431349|NCT00376623|528088220|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
146431350|NCT00376623|528088218|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
146431351|NCT00376623|528088219|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
146431352|NCT00376623|528088220|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
146431353|NCT00376623|528088218|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
146431354|NCT00376623|528088219|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
146431355|NCT00376623|528088220|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
146431356|NCT00376623|528088218|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146205862|NCT02988817|527268148|FG001|Overall Study|Other|0|||
146205863|NCT02988817|527268149|FG002|Overall Study|Other|0|||
146431357|NCT00376623|528088219|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
146431358|NCT00376623|528088220|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
146205864|NCT02988817|527268150|FG003|Overall Study|Other|1|||
146205865|NCT02988817|527268151|FG004|Overall Study|Other|1|||
146205866|NCT02988817|527268152|FG005|Overall Study|Other|0|||
146205867|NCT02988817|527268153|FG006|Overall Study|Other|0|||
146205868|NCT02988817|527268154|FG007|Overall Study|Other|0|||
146205869|NCT02988817|527268155|FG008|Overall Study|Other|0|||
146431359|NCT00376623|528088218|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
146431360|NCT00376623|528088219|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
146431361|NCT00376623|528088220|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
146431362|NCT00376623|528088218|FG000|Overall Study|Increase of tumour markers|0|||
146431363|NCT00376623|528088219|FG001|Overall Study|Increase of tumour markers|1|||
146431364|NCT00376623|528088220|FG002|Overall Study|Increase of tumour markers|0|||
146431365|NCT00376623|528088218|FG000|Overall Study|Bone metastasis|1|||
146431366|NCT00376623|528088219|FG001|Overall Study|Bone metastasis|0|||
146431367|NCT00376623|528088220|FG002|Overall Study|Bone metastasis|0|||
146431368|NCT04247282|528088221|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
146431369|NCT04247282|528088222|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
146431370|NCT04247282|528088223|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
146431371|NCT04247282|528088224|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
146431372|NCT04247282|528088221|FG000|Overall Study|Refused further treatment|0|||
146431373|NCT04247282|528088222|FG001|Overall Study|Refused further treatment|1|||
146431374|NCT04247282|528088223|FG002|Overall Study|Refused further treatment|0|||
146431375|NCT04247282|528088224|FG003|Overall Study|Refused further treatment|0|||
146431376|NCT01313273|528088225|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
146431377|NCT01313273|528088226|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
146431378|NCT01313273|528088225|FG000|Overall Study|Withdrawal by Subject|1|||
146431379|NCT01313273|528088226|FG001|Overall Study|Withdrawal by Subject|0|||
146431380|NCT01313273|528088225|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
146431381|NCT01313273|528088226|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
146431382|NCT03687736|528088227|FG000|Overall Study|Lost to Follow-up|7|||
146431383|NCT03687736|528088227|FG000|Overall Study|Withdrawal by Subject|3|||
146431384|NCT03496623|528088230|FG000|Run-In Period (2 Weeks)|Death|1|||
146431385|NCT03496623|528088231|FG001|Run-In Period (2 Weeks)|Death|0|||
146431386|NCT03496623|528088232|FG002|Run-In Period (2 Weeks)|Death|0|||
146431387|NCT03496623|528088233|FG003|Run-In Period (2 Weeks)|Death|0|||
146431388|NCT03496623|528088234|FG004|Run-In Period (2 Weeks)|Death|0|||
146431389|NCT03496623|528088230|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
146431390|NCT03496623|528088231|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146431391|NCT03496623|528088232|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146431392|NCT03496623|528088233|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146431393|NCT03496623|528088234|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
146431394|NCT03496623|528088230|FG000|Period 1 (12 Weeks)|Death|0|||
146431395|NCT03496623|528088231|FG001|Period 1 (12 Weeks)|Death|3|||
146431396|NCT03496623|528088232|FG002|Period 1 (12 Weeks)|Death|0|||
146431397|NCT03496623|528088233|FG003|Period 1 (12 Weeks)|Death|0|||
146431398|NCT03496623|528088234|FG004|Period 1 (12 Weeks)|Death|0|||
146431399|NCT03496623|528088230|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146431400|NCT03496623|528088231|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146431401|NCT03496623|528088232|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
146431402|NCT03496623|528088233|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
146431403|NCT03496623|528088234|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
146431404|NCT03496623|528088230|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146431405|NCT03496623|528088231|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146431406|NCT03496623|528088232|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
146431407|NCT03496623|528088233|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146431408|NCT03496623|528088234|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146431409|NCT03496623|528088230|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146431410|NCT03496623|528088231|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
146431411|NCT03496623|528088232|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
146431412|NCT03496623|528088233|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146431413|NCT03496623|528088234|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
146431414|NCT03496623|528088230|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146431415|NCT03496623|528088231|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146431416|NCT03496623|528088232|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
146205870|NCT02988817|527268156|FG009|Overall Study|Other|0|||
146205871|NCT02988817|527268157|FG010|Overall Study|Other|0|||
146205872|NCT02988817|527268158|FG011|Overall Study|Other|0|||
146205873|NCT02988817|527268159|FG012|Overall Study|Other|0|||
146431417|NCT03496623|528088233|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146431418|NCT03496623|528088234|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
146431419|NCT03496623|528088230|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146431420|NCT03496623|528088231|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146431421|NCT03496623|528088232|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
146431422|NCT03496623|528088233|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146431423|NCT03496623|528088234|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
146431424|NCT03496623|528088230|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146431425|NCT03496623|528088231|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
146431426|NCT03496623|528088232|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146431427|NCT03496623|528088233|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146431428|NCT03496623|528088234|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146431429|NCT02543203|528088235|FG000|Overall Study|Unpalatable Fragrance|2|||
146431430|NCT02543203|528088236|FG001|Overall Study|Unpalatable Fragrance|2|||
146431431|NCT02543203|528088235|FG000|Overall Study|Lost to Follow-up|1|||
146431432|NCT02543203|528088236|FG001|Overall Study|Lost to Follow-up|0|||
146431433|NCT02543203|528088235|FG000|Overall Study|Increased Irritability|1|||
146431434|NCT02543203|528088236|FG001|Overall Study|Increased Irritability|0|||
146431435|NCT02543203|528088235|FG000|Overall Study|Family|1|||
146431436|NCT02543203|528088236|FG001|Overall Study|Family|2|||
146431437|NCT02543203|528088235|FG000|Overall Study|Negative Behavior|1|||
146431438|NCT02543203|528088236|FG001|Overall Study|Negative Behavior|0|||
146431439|NCT02543203|528088235|FG000|Overall Study|Withdrawal by Subject|0|||
146431440|NCT02543203|528088236|FG001|Overall Study|Withdrawal by Subject|1|||
146431441|NCT03020615|528088237|FG000|Overall Study|Physician Decision|3|||
146431442|NCT03020615|528088238|FG001|Overall Study|Physician Decision|1|||
146431443|NCT03020615|528088239|FG002|Overall Study|Physician Decision|2|||
146431444|NCT03020615|528088237|FG000|Overall Study|Parent/guardian/patient choice|3|||
146431445|NCT03020615|528088238|FG001|Overall Study|Parent/guardian/patient choice|0|||
146431446|NCT03020615|528088239|FG002|Overall Study|Parent/guardian/patient choice|4|||
146431447|NCT03020615|528088237|FG000|Overall Study|Screen failure|0|||
146431448|NCT03020615|528088238|FG001|Overall Study|Screen failure|0|||
146431449|NCT03020615|528088239|FG002|Overall Study|Screen failure|1|||
146431450|NCT03020615|528088237|FG000|Overall Study|Death|1|||
146431451|NCT03020615|528088238|FG001|Overall Study|Death|0|||
146431452|NCT03020615|528088239|FG002|Overall Study|Death|0|||
146431453|NCT03020615|528088237|FG000|Overall Study|Lost to Follow-up|0|||
146431454|NCT03020615|528088238|FG001|Overall Study|Lost to Follow-up|1|||
146431455|NCT03020615|528088239|FG002|Overall Study|Lost to Follow-up|0|||
146431456|NCT00089661|528088240|FG000|Overall Study|Adverse Event|0|||
146431457|NCT00089661|528088241|FG001|Overall Study|Adverse Event|2|||
146431458|NCT00089661|528088240|FG000|Overall Study|Death|1|||
146431459|NCT00089661|528088241|FG001|Overall Study|Death|0|||
146431460|NCT00089661|528088240|FG000|Overall Study|Lost to Follow-up|0|||
146431461|NCT00089661|528088241|FG001|Overall Study|Lost to Follow-up|3|||
146431462|NCT00089661|528088240|FG000|Overall Study|Withdrawal by Subject|11|||
146431463|NCT00089661|528088241|FG001|Overall Study|Withdrawal by Subject|9|||
146431464|NCT00089661|528088240|FG000|Overall Study|Disease progression|1|||
146431465|NCT00089661|528088241|FG001|Overall Study|Disease progression|3|||
146431466|NCT00089661|528088240|FG000|Overall Study|Ineligibility determined|4|||
146431467|NCT00089661|528088241|FG001|Overall Study|Ineligibility determined|4|||
146431468|NCT00089661|528088240|FG000|Overall Study|Noncompliance|2|||
146431469|NCT00089661|528088241|FG001|Overall Study|Noncompliance|4|||
146431470|NCT00089661|528088240|FG000|Overall Study|Other|2|||
146431471|NCT00089661|528088241|FG001|Overall Study|Other|1|||
146431472|NCT02077465|528088245|FG000|Overall Study|Withdrew Consent|0|||
146431473|NCT02077465|528088246|FG001|Overall Study|Withdrew Consent|1|||
146431474|NCT02077465|528088245|FG000|Overall Study|Lost to Follow-up|1|||
146431475|NCT02077465|528088246|FG001|Overall Study|Lost to Follow-up|0|||
146431476|NCT02481830|528088248|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
146431477|NCT02481830|528088249|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
146431478|NCT02481830|528088248|FG000|Pre-treatment|Withdrawal by Subject|0|||
146431479|NCT02481830|528088249|FG001|Pre-treatment|Withdrawal by Subject|10|||
146431480|NCT02481830|528088248|FG000|Pre-treatment|Disease Progression|1|||
146431481|NCT02481830|528088249|FG001|Pre-treatment|Disease Progression|1|||
146431482|NCT02481830|528088248|FG000|Pre-treatment|Other reasons|0|||
146431483|NCT02481830|528088249|FG001|Pre-treatment|Other reasons|1|||
146431484|NCT02481830|528088248|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
146431485|NCT02481830|528088249|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
146431486|NCT02481830|528088248|FG000|Treatment|Disease Progression|233|||
146431487|NCT02481830|528088249|FG001|Treatment|Disease Progression|171|||
146431488|NCT02481830|528088248|FG000|Treatment|Study drug toxicity|18|||
146431489|NCT02481830|528088249|FG001|Treatment|Study drug toxicity|38|||
146431490|NCT02481830|528088248|FG000|Treatment|Death|1|||
146431491|NCT02481830|528088249|FG001|Treatment|Death|1|||
146431492|NCT02481830|528088248|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
146431493|NCT02481830|528088249|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
146431494|NCT02481830|528088248|FG000|Treatment|Participants request to discontinue Study treatment|6|||
146431495|NCT02481830|528088249|FG001|Treatment|Participants request to discontinue Study treatment|34|||
146431496|NCT02481830|528088248|FG000|Treatment|Withdrawal by Subject|2|||
146431497|NCT02481830|528088249|FG001|Treatment|Withdrawal by Subject|3|||
146431498|NCT02481830|528088248|FG000|Treatment|Lost to Follow-up|1|||
146431499|NCT02481830|528088249|FG001|Treatment|Lost to Follow-up|0|||
146431500|NCT02481830|528088248|FG000|Treatment|Maximum Clinical Benefit|0|||
146431501|NCT02481830|528088249|FG001|Treatment|Maximum Clinical Benefit|5|||
146431502|NCT02481830|528088248|FG000|Treatment|Administrative reason by sponsor|1|||
146431503|NCT02481830|528088249|FG001|Treatment|Administrative reason by sponsor|1|||
146431504|NCT02481830|528088248|FG000|Treatment|Other reasons|6|||
146431505|NCT02481830|528088249|FG001|Treatment|Other reasons|1|||
146431506|NCT04627038|528088250|FG000|Overall Study|Adverse Event|36|||
146431507|NCT04627038|528088251|FG001|Overall Study|Adverse Event|8|||
146431508|NCT04627038|528088250|FG000|Overall Study|Lost to Follow-up|1|||
146431509|NCT04627038|528088251|FG001|Overall Study|Lost to Follow-up|0|||
146431510|NCT04627038|528088250|FG000|Overall Study|Physician Decision|0|||
146431511|NCT04627038|528088251|FG001|Overall Study|Physician Decision|1|||
146431512|NCT04627038|528088250|FG000|Overall Study|Protocol Violation|3|||
146431513|NCT04627038|528088251|FG001|Overall Study|Protocol Violation|1|||
146431514|NCT04627038|528088250|FG000|Overall Study|Withdrawal by Subject|13|||
146431515|NCT04627038|528088251|FG001|Overall Study|Withdrawal by Subject|3|||
146431516|NCT04627038|528088250|FG000|Overall Study|Non-compliance with study drug|0|||
146431517|NCT04627038|528088251|FG001|Overall Study|Non-compliance with study drug|1|||
146431518|NCT04627038|528088250|FG000|Overall Study|Prohibited Concomitant Medication|1|||
146431519|NCT04627038|528088251|FG001|Overall Study|Prohibited Concomitant Medication|0|||
146431520|NCT00794963|528088256|FG000|Overall Study|Withdrawal by Subject|1|||
146431521|NCT00794963|528088257|FG001|Overall Study|Withdrawal by Subject|4|||
146431522|NCT03375463|528088258|FG000|Period 1|Lost to Follow-up|0|||
146431523|NCT03375463|528088259|FG001|Period 1|Lost to Follow-up|0|||
146431524|NCT03375463|528088260|FG002|Period 1|Lost to Follow-up|1|||
146431525|NCT03375463|528088261|FG003|Period 1|Lost to Follow-up|0|||
145950882|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145950883|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145950884|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950885|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145950886|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
146431526|NCT03375463|528088262|FG004|Period 1|Lost to Follow-up|0|||
145950887|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145950888|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145950889|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950890|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950891|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950892|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950893|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950894|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950895|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950896|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950897|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145950898|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950899|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950900|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145950901|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145950902|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145950903|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950904|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
146205874|NCT02988817|527268160|FG013|Overall Study|Other|0|||
146205875|NCT02988817|527268161|FG014|Overall Study|Other|0|||
146205876|NCT02988817|527268162|FG015|Overall Study|Other|1|||
146431527|NCT03375463|528088263|FG005|Period 1|Lost to Follow-up|0|||
146431528|NCT03375463|528088258|FG000|Period 1|Adverse Event|0|||
146431529|NCT03375463|528088259|FG001|Period 1|Adverse Event|0|||
146431530|NCT03375463|528088260|FG002|Period 1|Adverse Event|0|||
146431531|NCT03375463|528088261|FG003|Period 1|Adverse Event|0|||
146431532|NCT03375463|528088262|FG004|Period 1|Adverse Event|1|||
146431533|NCT03375463|528088263|FG005|Period 1|Adverse Event|0|||
146431534|NCT03375463|528088258|FG000|Period 2|Lost to Follow-up|1|||
146431535|NCT03375463|528088259|FG001|Period 2|Lost to Follow-up|1|||
146431536|NCT03375463|528088260|FG002|Period 2|Lost to Follow-up|0|||
146431537|NCT03375463|528088261|FG003|Period 2|Lost to Follow-up|0|||
146431538|NCT03375463|528088262|FG004|Period 2|Lost to Follow-up|0|||
146431539|NCT03375463|528088263|FG005|Period 2|Lost to Follow-up|0|||
146431540|NCT01827163|528088264|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
146431541|NCT01827163|528088264|FG000|Overall Study|Adverse Event|9|||
146431542|NCT01037114|528088265|FG000|Year 20|Others|1|||
146431543|NCT02294604|528088271|FG000|Overall Study|Did not provide samples for culture|0|||
146431544|NCT02294604|528088272|FG001|Overall Study|Did not provide samples for culture|1|||
146431545|NCT02294604|528088273|FG002|Overall Study|Did not provide samples for culture|0|||
146431546|NCT02294604|528088271|FG000|Overall Study|Culture contamination|1|||
146431547|NCT02294604|528088272|FG001|Overall Study|Culture contamination|2|||
146431548|NCT02294604|528088273|FG002|Overall Study|Culture contamination|0|||
146431549|NCT01513174|528088276|FG000|Overall Study|Inclusion Error|1|||
146431550|NCT01513174|528088277|FG001|Overall Study|Inclusion Error|7|||
146431551|NCT01513174|528088276|FG000|Overall Study|Not receive study treatment|3|||
146431552|NCT01513174|528088277|FG001|Overall Study|Not receive study treatment|1|||
146431553|NCT01900626|528088278|FG000|Overall Study|study was closed due to low enrollment|1|||
146431554|NCT01900626|528088279|FG001|Overall Study|study was closed due to low enrollment|1|||
146431555|NCT04533594|528088280|FG000|Overall Study|Death|26|||
146431556|NCT01975948|528088284|FG000|Overall Study|Withdrawal by Subject|17|||
146431557|NCT01975948|528088285|FG001|Overall Study|Withdrawal by Subject|21|||
146431558|NCT01975948|528088286|FG002|Overall Study|Withdrawal by Subject|7|||
146431559|NCT01975948|528088287|FG003|Overall Study|Withdrawal by Subject|6|||
146431560|NCT00836056|528088291|FG000|First Intervention|Adverse Event|1|||
146431561|NCT00836056|528088292|FG001|First Intervention|Adverse Event|0|||
146431562|NCT02158663|528088293|FG000|Overall Study|Withdrawal by Subject|5|||
146431563|NCT02158663|528088294|FG001|Overall Study|Withdrawal by Subject|4|||
146431564|NCT02711852|528088295|FG000|Overall Study|Death|5|||
146431565|NCT02711852|528088295|FG000|Overall Study|Lost to Follow-up|1|||
146431566|NCT02711852|528088295|FG000|Overall Study|Completed follow-up|3|||
146431567|NCT02711852|528088295|FG000|Overall Study|Withdrawal by Subject|1|||
146431568|NCT03616106|528088297|FG000|Overall Study|Removed by PI|6|||
146431569|NCT03616106|528088298|FG001|Overall Study|Removed by PI|0|||
146431570|NCT03616106|528088297|FG000|Overall Study|Withdrawal by Subject|1|||
146431571|NCT03616106|528088298|FG001|Overall Study|Withdrawal by Subject|1|||
146431572|NCT03616106|528088297|FG000|Overall Study|Lost to Follow-up|7|||
146431573|NCT03616106|528088298|FG001|Overall Study|Lost to Follow-up|0|||
146431574|NCT01880593|528088299|FG000|Overall Study|Adverse Event|1|||
146431575|NCT01880593|528088300|FG001|Overall Study|Adverse Event|0|||
146431576|NCT01880593|528088299|FG000|Overall Study|Lack of Efficacy|1|||
146431577|NCT01880593|528088300|FG001|Overall Study|Lack of Efficacy|5|||
146431578|NCT01880593|528088299|FG000|Overall Study|Withdrawal by Subject|6|||
146431579|NCT01880593|528088300|FG001|Overall Study|Withdrawal by Subject|1|||
146431580|NCT02272777|528088301|FG000|Overall Study|Adverse Event|0|||
146431581|NCT02272777|528088302|FG001|Overall Study|Adverse Event|1|||
146431582|NCT02272777|528088301|FG000|Overall Study|Withdrawal by Subject|0|||
146205877|NCT02988817|527268163|FG016|Overall Study|Other|0|||
146205878|NCT02988817|527268164|FG017|Overall Study|Other|0|||
146205879|NCT02988817|527268165|FG018|Overall Study|Other|0|||
146205880|NCT02988817|527268166|FG019|Overall Study|Other|0|||
146205881|NCT02988817|527268147|FG000|Overall Study|Lost to Follow-up|0|||
146205882|NCT02988817|527268148|FG001|Overall Study|Lost to Follow-up|0|||
146205883|NCT02988817|527268149|FG002|Overall Study|Lost to Follow-up|0|||
146205884|NCT02988817|527268150|FG003|Overall Study|Lost to Follow-up|0|||
146205885|NCT02988817|527268151|FG004|Overall Study|Lost to Follow-up|0|||
146205886|NCT02988817|527268152|FG005|Overall Study|Lost to Follow-up|0|||
146205887|NCT02988817|527268153|FG006|Overall Study|Lost to Follow-up|0|||
146205888|NCT02988817|527268154|FG007|Overall Study|Lost to Follow-up|0|||
146205889|NCT02988817|527268155|FG008|Overall Study|Lost to Follow-up|1|||
146205890|NCT02988817|527268156|FG009|Overall Study|Lost to Follow-up|0|||
146205891|NCT02988817|527268157|FG010|Overall Study|Lost to Follow-up|1|||
146205892|NCT02988817|527268158|FG011|Overall Study|Lost to Follow-up|1|||
146205893|NCT02988817|527268159|FG012|Overall Study|Lost to Follow-up|0|||
146205894|NCT02988817|527268160|FG013|Overall Study|Lost to Follow-up|0|||
146205895|NCT02988817|527268161|FG014|Overall Study|Lost to Follow-up|1|||
146205896|NCT02988817|527268162|FG015|Overall Study|Lost to Follow-up|1|||
146205897|NCT02988817|527268163|FG016|Overall Study|Lost to Follow-up|2|||
146205898|NCT02988817|527268164|FG017|Overall Study|Lost to Follow-up|3|||
146205899|NCT02988817|527268165|FG018|Overall Study|Lost to Follow-up|0|||
146205900|NCT02988817|527268166|FG019|Overall Study|Lost to Follow-up|0|||
146205901|NCT02988817|527268147|FG000|Overall Study|Sponsor decision|0|||
146431583|NCT02272777|528088302|FG001|Overall Study|Withdrawal by Subject|3|||
146431584|NCT02272777|528088301|FG000|Overall Study|Lost to Follow-up|2|||
146431585|NCT02272777|528088302|FG001|Overall Study|Lost to Follow-up|0|||
146431586|NCT02272777|528088301|FG000|Overall Study|Other|2|||
146205902|NCT02988817|527268148|FG001|Overall Study|Sponsor decision|0|||
146205903|NCT02988817|527268149|FG002|Overall Study|Sponsor decision|0|||
146205904|NCT02988817|527268150|FG003|Overall Study|Sponsor decision|0|||
146205905|NCT02988817|527268151|FG004|Overall Study|Sponsor decision|0|||
146205906|NCT02988817|527268152|FG005|Overall Study|Sponsor decision|0|||
146285363|NCT01445301|527557847|FG000|Overall Study|Adverse Event|15|||
146205907|NCT02988817|527268153|FG006|Overall Study|Sponsor decision|0|||
146431587|NCT02272777|528088302|FG001|Overall Study|Other|0|||
146431588|NCT00440297|528088306|FG000|Overall Study|Adverse Event|8|||
146431589|NCT00440297|528088307|FG001|Overall Study|Adverse Event|5|||
146431590|NCT00440297|528088306|FG000|Overall Study|Lost to Follow-up|1|||
146431591|NCT00440297|528088307|FG001|Overall Study|Lost to Follow-up|0|||
146431592|NCT00440297|528088306|FG000|Overall Study|Physician Decision|1|||
146431593|NCT00440297|528088307|FG001|Overall Study|Physician Decision|0|||
146431594|NCT00440297|528088306|FG000|Overall Study|Protocol Violation|11|||
146431595|NCT00440297|528088307|FG001|Overall Study|Protocol Violation|7|||
146431596|NCT00440297|528088306|FG000|Overall Study|Withdrawal by Subject|1|||
146431597|NCT00440297|528088307|FG001|Overall Study|Withdrawal by Subject|6|||
146431598|NCT00440297|528088306|FG000|Overall Study|Randomized by mistake|1|||
146431599|NCT00440297|528088307|FG001|Overall Study|Randomized by mistake|0|||
146431600|NCT03206177|528088308|FG000|Overall Study|Withdrawal by Subject|1|||
146431601|NCT02024932|528088309|FG000|Overall Study|Adverse Event|2|||
146431602|NCT02024932|528088310|FG001|Overall Study|Adverse Event|3|||
146431603|NCT02024932|528088311|FG002|Overall Study|Adverse Event|0|||
146431604|NCT02024932|528088312|FG003|Overall Study|Adverse Event|0|||
146431605|NCT02024932|528088313|FG004|Overall Study|Adverse Event|2|||
146431606|NCT02024932|528088314|FG005|Overall Study|Adverse Event|0|||
146431607|NCT02024932|528088309|FG000|Overall Study|Abnormal laboratory value|0|||
146431608|NCT02024932|528088310|FG001|Overall Study|Abnormal laboratory value|0|||
146431609|NCT02024932|528088311|FG002|Overall Study|Abnormal laboratory value|0|||
146431610|NCT02024932|528088312|FG003|Overall Study|Abnormal laboratory value|2|||
146431611|NCT02024932|528088313|FG004|Overall Study|Abnormal laboratory value|0|||
146431612|NCT02024932|528088314|FG005|Overall Study|Abnormal laboratory value|0|||
146431613|NCT02445339|528088315|FG000|Overall Study|Physician Decision|1|||
146431614|NCT02445339|528088316|FG001|Overall Study|Physician Decision|0|||
146431615|NCT02445339|528088315|FG000|Overall Study|Lost to Follow-up|11|||
146431616|NCT02445339|528088316|FG001|Overall Study|Lost to Follow-up|15|||
146431617|NCT03020641|528088317|FG000|Overall Study|Lost to Follow-up|0|||
146431618|NCT03020641|528088318|FG001|Overall Study|Lost to Follow-up|1|||
146431619|NCT03020641|528088317|FG000|Overall Study|Converted to open surgery|2|||
146431620|NCT03020641|528088318|FG001|Overall Study|Converted to open surgery|1|||
146431621|NCT03020641|528088317|FG000|Overall Study|for surgery not performed|0|||
146431622|NCT03020641|528088318|FG001|Overall Study|for surgery not performed|1|||
146431623|NCT04611789|528088319|FG000|Overall Study|Lost to Follow-up|1|||
146431624|NCT04611789|528088320|FG001|Overall Study|Lost to Follow-up|0|||
146431625|NCT04611789|528088321|FG002|Overall Study|Lost to Follow-up|0|||
146431626|NCT05472038|528090064|FG000|Overall Study|Adverse Event|0|||
146431627|NCT05472038|528090065|FG001|Overall Study|Adverse Event|0|||
146431628|NCT05472038|528090066|FG002|Overall Study|Adverse Event|1|||
146431629|NCT05472038|528090067|FG003|Overall Study|Adverse Event|0|||
146431630|NCT05472038|528090068|FG004|Overall Study|Adverse Event|0|||
146431631|NCT05472038|528090069|FG005|Overall Study|Adverse Event|0|||
146431632|NCT05472038|528090070|FG006|Overall Study|Adverse Event|0|||
146431633|NCT05472038|528090071|FG007|Overall Study|Adverse Event|0|||
146431634|NCT05472038|528090072|FG008|Overall Study|Adverse Event|0|||
146431635|NCT05472038|528090073|FG009|Overall Study|Adverse Event|0|||
146431636|NCT05472038|528090074|FG010|Overall Study|Adverse Event|0|||
146431637|NCT05472038|528090075|FG011|Overall Study|Adverse Event|0|||
146431638|NCT05472038|528090064|FG000|Overall Study|Death|0|||
146431639|NCT05472038|528090065|FG001|Overall Study|Death|0|||
146431640|NCT05472038|528090066|FG002|Overall Study|Death|0|||
146431641|NCT05472038|528090067|FG003|Overall Study|Death|0|||
146431642|NCT05472038|528090068|FG004|Overall Study|Death|0|||
146431643|NCT05472038|528090069|FG005|Overall Study|Death|1|||
146431644|NCT05472038|528090070|FG006|Overall Study|Death|0|||
146431645|NCT05472038|528090071|FG007|Overall Study|Death|0|||
146431646|NCT05472038|528090072|FG008|Overall Study|Death|0|||
146431647|NCT05472038|528090073|FG009|Overall Study|Death|0|||
146431648|NCT05472038|528090074|FG010|Overall Study|Death|0|||
146431649|NCT05472038|528090075|FG011|Overall Study|Death|0|||
146431650|NCT05472038|528090064|FG000|Overall Study|Lost to Follow-up|1|||
146431651|NCT05472038|528090065|FG001|Overall Study|Lost to Follow-up|3|||
146431652|NCT05472038|528090066|FG002|Overall Study|Lost to Follow-up|3|||
146431653|NCT05472038|528090067|FG003|Overall Study|Lost to Follow-up|9|||
146431654|NCT05472038|528090068|FG004|Overall Study|Lost to Follow-up|2|||
146431655|NCT05472038|528090069|FG005|Overall Study|Lost to Follow-up|2|||
146431656|NCT05472038|528090070|FG006|Overall Study|Lost to Follow-up|1|||
146431657|NCT05472038|528090071|FG007|Overall Study|Lost to Follow-up|0|||
146431658|NCT05472038|528090072|FG008|Overall Study|Lost to Follow-up|1|||
146431659|NCT05472038|528090073|FG009|Overall Study|Lost to Follow-up|0|||
146431660|NCT05472038|528090074|FG010|Overall Study|Lost to Follow-up|2|||
146431661|NCT05472038|528090075|FG011|Overall Study|Lost to Follow-up|1|||
146431662|NCT05472038|528090064|FG000|Overall Study|Physician Decision|0|||
146431663|NCT05472038|528090065|FG001|Overall Study|Physician Decision|0|||
146431664|NCT05472038|528090066|FG002|Overall Study|Physician Decision|0|||
146431665|NCT05472038|528090067|FG003|Overall Study|Physician Decision|0|||
146431666|NCT05472038|528090068|FG004|Overall Study|Physician Decision|1|||
146431667|NCT05472038|528090069|FG005|Overall Study|Physician Decision|0|||
146431668|NCT05472038|528090070|FG006|Overall Study|Physician Decision|0|||
146431669|NCT05472038|528090071|FG007|Overall Study|Physician Decision|0|||
146431670|NCT05472038|528090072|FG008|Overall Study|Physician Decision|0|||
146431671|NCT05472038|528090073|FG009|Overall Study|Physician Decision|0|||
146431672|NCT05472038|528090074|FG010|Overall Study|Physician Decision|0|||
146431673|NCT05472038|528090075|FG011|Overall Study|Physician Decision|0|||
146431674|NCT05472038|528090064|FG000|Overall Study|Withdrawal by Subject|1|||
146431675|NCT05472038|528090065|FG001|Overall Study|Withdrawal by Subject|3|||
146431676|NCT05472038|528090066|FG002|Overall Study|Withdrawal by Subject|1|||
146431677|NCT05472038|528090067|FG003|Overall Study|Withdrawal by Subject|6|||
146431678|NCT05472038|528090068|FG004|Overall Study|Withdrawal by Subject|1|||
146431679|NCT05472038|528090069|FG005|Overall Study|Withdrawal by Subject|3|||
146431680|NCT05472038|528090070|FG006|Overall Study|Withdrawal by Subject|0|||
146431681|NCT05472038|528090071|FG007|Overall Study|Withdrawal by Subject|2|||
146431682|NCT05472038|528090072|FG008|Overall Study|Withdrawal by Subject|3|||
146431683|NCT05472038|528090073|FG009|Overall Study|Withdrawal by Subject|1|||
146431684|NCT05472038|528090074|FG010|Overall Study|Withdrawal by Subject|2|||
146431685|NCT05472038|528090075|FG011|Overall Study|Withdrawal by Subject|2|||
146431686|NCT05472038|528090064|FG000|Overall Study|Protocol Violation|0|||
146431687|NCT05472038|528090065|FG001|Overall Study|Protocol Violation|0|||
146431688|NCT05472038|528090066|FG002|Overall Study|Protocol Violation|0|||
146431689|NCT05472038|528090067|FG003|Overall Study|Protocol Violation|0|||
146431690|NCT05472038|528090068|FG004|Overall Study|Protocol Violation|0|||
146431691|NCT05472038|528090069|FG005|Overall Study|Protocol Violation|0|||
146431692|NCT05472038|528090070|FG006|Overall Study|Protocol Violation|0|||
146431693|NCT05472038|528090071|FG007|Overall Study|Protocol Violation|1|||
146431694|NCT05472038|528090072|FG008|Overall Study|Protocol Violation|1|||
146431695|NCT05472038|528090073|FG009|Overall Study|Protocol Violation|1|||
146431696|NCT05472038|528090074|FG010|Overall Study|Protocol Violation|1|||
146205908|NCT02988817|527268154|FG007|Overall Study|Sponsor decision|0|||
146205909|NCT02988817|527268155|FG008|Overall Study|Sponsor decision|0|||
146205910|NCT02988817|527268156|FG009|Overall Study|Sponsor decision|0|||
146205911|NCT02988817|527268157|FG010|Overall Study|Sponsor decision|0|||
146205912|NCT02988817|527268158|FG011|Overall Study|Sponsor decision|1|||
146205913|NCT02988817|527268159|FG012|Overall Study|Sponsor decision|1|||
146205914|NCT02988817|527268160|FG013|Overall Study|Sponsor decision|2|||
146205915|NCT02988817|527268161|FG014|Overall Study|Sponsor decision|2|||
146205916|NCT02988817|527268162|FG015|Overall Study|Sponsor decision|6|||
146205917|NCT02988817|527268163|FG016|Overall Study|Sponsor decision|2|||
146205918|NCT02988817|527268164|FG017|Overall Study|Sponsor decision|3|||
146205919|NCT02988817|527268165|FG018|Overall Study|Sponsor decision|2|||
146205920|NCT02988817|527268166|FG019|Overall Study|Sponsor decision|7|||
146205921|NCT02988817|527268147|FG000|Overall Study|Physician Decision|0|||
146205922|NCT02988817|527268148|FG001|Overall Study|Physician Decision|0|||
146431697|NCT05472038|528090075|FG011|Overall Study|Protocol Violation|1|||
146431698|NCT05472038|528090064|FG000|Overall Study|Not vaccinated|0|||
146431699|NCT05472038|528090065|FG001|Overall Study|Not vaccinated|0|||
146431700|NCT05472038|528090066|FG002|Overall Study|Not vaccinated|0|||
146431701|NCT05472038|528090067|FG003|Overall Study|Not vaccinated|1|||
146431702|NCT05472038|528090068|FG004|Overall Study|Not vaccinated|0|||
146431703|NCT05472038|528090069|FG005|Overall Study|Not vaccinated|0|||
146431704|NCT05472038|528090070|FG006|Overall Study|Not vaccinated|0|||
146431705|NCT05472038|528090071|FG007|Overall Study|Not vaccinated|0|||
146205923|NCT02988817|527268149|FG002|Overall Study|Physician Decision|0|||
146205924|NCT02988817|527268150|FG003|Overall Study|Physician Decision|0|||
146431706|NCT05472038|528090072|FG008|Overall Study|Not vaccinated|0|||
146431707|NCT05472038|528090073|FG009|Overall Study|Not vaccinated|0|||
146431708|NCT05472038|528090074|FG010|Overall Study|Not vaccinated|0|||
146431709|NCT05472038|528090075|FG011|Overall Study|Not vaccinated|0|||
146431710|NCT03235739|528090078|FG000|Overall Study|Withdrawal by Subject|2|||
146431711|NCT03235739|528090079|FG001|Overall Study|Withdrawal by Subject|2|||
146431712|NCT03235739|528090078|FG000|Overall Study|Physician Decision|0|||
146431713|NCT03235739|528090079|FG001|Overall Study|Physician Decision|1|||
146431714|NCT02847650|528090080|FG000|Overall Study|Adverse Event|2|||
146431715|NCT02847650|528090081|FG001|Overall Study|Adverse Event|4|||
146431716|NCT02847650|528090080|FG000|Overall Study|Lost to Follow-up|1|||
146431717|NCT02847650|528090081|FG001|Overall Study|Lost to Follow-up|0|||
146431718|NCT02847650|528090080|FG000|Overall Study|Protocol Violation|0|||
146431719|NCT02847650|528090081|FG001|Overall Study|Protocol Violation|1|||
146431720|NCT02847650|528090080|FG000|Overall Study|Withdrawal by Subject|1|||
146431721|NCT02847650|528090081|FG001|Overall Study|Withdrawal by Subject|1|||
146431722|NCT02175095|528090084|FG000|Overall Study|Withdrawal by Subject|3|||
146431723|NCT00462345|528090085|FG000|Overall Study|Withdrawal by Subject|2|||
146431724|NCT00462345|528090085|FG000|Overall Study|Did not complete second course|1|||
146431725|NCT03255733|528090086|FG000|Overall Study|Lost to Follow-up|4|||
146431726|NCT02869867|528090087|FG000|Overall Study|Protocol Violation|1|||
146431727|NCT02869867|528090088|FG001|Overall Study|Protocol Violation|0|||
146431728|NCT02869867|528090087|FG000|Overall Study|Lost to Follow-up|5|||
146431729|NCT02869867|528090088|FG001|Overall Study|Lost to Follow-up|5|||
146431730|NCT00461786|528090092|FG000|Overall Study|Entry Criteria Not Met|2|||
146431731|NCT00461786|528090092|FG000|Overall Study|Inevaluable (Never Treated)|1|||
146431732|NCT00835991|528090095|FG000|First Intervention|Adverse Event|0|||
146431733|NCT00835991|528090096|FG001|First Intervention|Adverse Event|1|||
146431734|NCT00835991|528090095|FG000|Washout|Protocol Violation|0|||
146431735|NCT00835991|528090096|FG001|Washout|Protocol Violation|2|||
146431736|NCT00835991|528090095|FG000|Washout|Withdrawal by Subject|3|||
146431737|NCT00835991|528090096|FG001|Washout|Withdrawal by Subject|1|||
146431738|NCT02378935|528090097|FG000|Overall Study|Lack of Efficacy|10|||
146431739|NCT02378935|528090098|FG001|Overall Study|Lack of Efficacy|0|||
146431740|NCT02378935|528090099|FG002|Overall Study|Lack of Efficacy|2|||
146431741|NCT02378935|528090100|FG003|Overall Study|Lack of Efficacy|6|||
146431742|NCT02378935|528090101|FG004|Overall Study|Lack of Efficacy|0|||
146431743|NCT02378935|528090102|FG005|Overall Study|Lack of Efficacy|0|||
146431744|NCT02378935|528090103|FG006|Overall Study|Lack of Efficacy|0|||
146431745|NCT02378935|528090097|FG000|Overall Study|Death|0|||
146431746|NCT02378935|528090098|FG001|Overall Study|Death|0|||
146431747|NCT02378935|528090099|FG002|Overall Study|Death|1|||
146431748|NCT02378935|528090100|FG003|Overall Study|Death|0|||
146431749|NCT02378935|528090101|FG004|Overall Study|Death|0|||
146431750|NCT02378935|528090102|FG005|Overall Study|Death|0|||
146431751|NCT02378935|528090103|FG006|Overall Study|Death|0|||
146431752|NCT00272779|528090104|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
146431753|NCT00272779|528090105|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
146431754|NCT00272779|528090104|FG000|Baseline Through Week 48|Death before Week 48|4|||
146431755|NCT00272779|528090105|FG001|Baseline Through Week 48|Death before Week 48|4|||
146431756|NCT00272779|528090104|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
146431757|NCT00272779|528090105|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
146431758|NCT00272779|528090104|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
146431759|NCT00272779|528090105|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
146431760|NCT00272779|528090104|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
146431761|NCT00272779|528090105|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
146431762|NCT00272779|528090104|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
146431763|NCT00272779|528090105|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
146431764|NCT00272779|528090104|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
146431765|NCT00272779|528090105|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
146431766|NCT00272779|528090104|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
146431767|NCT00272779|528090105|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
146431768|NCT00272779|528090104|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
146431769|NCT00272779|528090105|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
146431770|NCT00272779|528090104|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
146431771|NCT00272779|528090105|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
146431772|NCT00272779|528090104|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
146431773|NCT00272779|528090105|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
146431774|NCT00272779|528090104|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
146431775|NCT00272779|528090105|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
146431776|NCT00272779|528090104|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
146431777|NCT00272779|528090105|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
146431778|NCT00272779|528090104|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
146431779|NCT00272779|528090105|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
146431780|NCT00272779|528090104|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
146431781|NCT00272779|528090105|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
146431782|NCT00272779|528090104|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
146431783|NCT00272779|528090105|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
146431784|NCT00272779|528090104|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
146431785|NCT00272779|528090105|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
146431786|NCT00272779|528090104|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
146431787|NCT00272779|528090105|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
146431788|NCT00272779|528090104|FG000|Baseline Through Week 48|Continuing treatment|385|||
146431789|NCT00272779|528090105|FG001|Baseline Through Week 48|Continuing treatment|368|||
146431790|NCT00272779|528090104|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
146431791|NCT00272779|528090105|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
146431792|NCT00272779|528090104|FG000|Baseline Through Week 48|Never treated|2|||
146431793|NCT00272779|528090105|FG001|Baseline Through Week 48|Never treated|3|||
146431794|NCT00272779|528090104|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
146431795|NCT00272779|528090105|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
146431796|NCT00272779|528090104|FG000|Baseline Through Week 96|Death before Week 96|6|||
146431797|NCT00272779|528090105|FG001|Baseline Through Week 96|Death before Week 96|5|||
146431798|NCT00272779|528090104|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
146431799|NCT00272779|528090105|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
146431800|NCT00272779|528090104|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
146431801|NCT00272779|528090105|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
146431802|NCT00272779|528090104|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
146431803|NCT00272779|528090105|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
146431804|NCT00272779|528090104|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
146431805|NCT00272779|528090105|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
146431806|NCT00272779|528090104|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
146431807|NCT00272779|528090105|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
146431808|NCT00272779|528090104|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
146431809|NCT00272779|528090105|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
146431810|NCT00272779|528090104|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
146431811|NCT00272779|528090105|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
146431812|NCT00272779|528090104|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
146431813|NCT00272779|528090105|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
146431814|NCT00272779|528090104|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
146431815|NCT00272779|528090105|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
146431816|NCT00272779|528090104|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
146431817|NCT00272779|528090105|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
146431818|NCT00272779|528090104|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
146431819|NCT00272779|528090105|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
146431820|NCT00272779|528090104|FG000|Baseline Through Week 96|Never treated|2|||
146431821|NCT00272779|528090105|FG001|Baseline Through Week 96|Never treated|3|||
146431822|NCT00272779|528090104|FG000|Baseline Through Week 96|Continuing on treatment|61|||
146431823|NCT00272779|528090105|FG001|Baseline Through Week 96|Continuing on treatment|38|||
146431824|NCT02146105|528090108|FG000|Overall Study|Adverse Event|1|||
146431825|NCT02146105|528090108|FG000|Overall Study|Withdrawal by Subject|5|||
146431826|NCT03935880|528090112|FG000|Overall Study|Lost to Follow-up|0|||
146431827|NCT03935880|528090113|FG001|Overall Study|Lost to Follow-up|1|||
146431828|NCT02476994|528090114|FG000|Overall Study|Based on feedback from FDA|1|||
146431829|NCT02476994|528090115|FG001|Overall Study|Based on feedback from FDA|0|||
146431830|NCT02563561|528090116|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
146431831|NCT02563561|528090117|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
146431832|NCT02563561|528090118|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
146431833|NCT02563561|528090116|FG000|Overall Study|Withdrew of Consent|1|||
146431834|NCT02563561|528090117|FG001|Overall Study|Withdrew of Consent|1|||
146431835|NCT02563561|528090118|FG002|Overall Study|Withdrew of Consent|2|||
146431836|NCT02563561|528090116|FG000|Overall Study|Lost to Follow-up|1|||
146431837|NCT02563561|528090117|FG001|Overall Study|Lost to Follow-up|1|||
146431838|NCT02563561|528090118|FG002|Overall Study|Lost to Follow-up|0|||
146431839|NCT02563561|528090116|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
146431840|NCT02563561|528090117|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
146431841|NCT02563561|528090118|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
146431842|NCT02563561|528090116|FG000|Overall Study|Investigator Decision|3|||
146431843|NCT02563561|528090117|FG001|Overall Study|Investigator Decision|4|||
146431844|NCT02563561|528090118|FG002|Overall Study|Investigator Decision|2|||
146431845|NCT02563561|528090116|FG000|Overall Study|Sponsor Decision|5|||
146431846|NCT02563561|528090117|FG001|Overall Study|Sponsor Decision|2|||
146431847|NCT02563561|528090118|FG002|Overall Study|Sponsor Decision|4|||
146431848|NCT02563561|528090116|FG000|Overall Study|Other|1|||
146431849|NCT02563561|528090117|FG001|Overall Study|Other|5|||
146431850|NCT02563561|528090118|FG002|Overall Study|Other|2|||
146431851|NCT02718326|528090121|FG000|Overall Study|Adverse Event|4|||
146431852|NCT02718326|528090122|FG001|Overall Study|Adverse Event|9|||
146431853|NCT02718326|528090123|FG002|Overall Study|Adverse Event|0|||
146431854|NCT02718326|528090121|FG000|Overall Study|Death|8|||
146431855|NCT02718326|528090122|FG001|Overall Study|Death|1|||
146431856|NCT02718326|528090123|FG002|Overall Study|Death|2|||
146431857|NCT02718326|528090121|FG000|Overall Study|Withdrawal by Subject|4|||
146431858|NCT02718326|528090122|FG001|Overall Study|Withdrawal by Subject|9|||
146431859|NCT02718326|528090123|FG002|Overall Study|Withdrawal by Subject|6|||
146431860|NCT02718326|528090121|FG000|Overall Study|Lost to Follow-up|18|||
146431861|NCT02718326|528090122|FG001|Overall Study|Lost to Follow-up|5|||
146431862|NCT02718326|528090123|FG002|Overall Study|Lost to Follow-up|14|||
146431863|NCT02718326|528090121|FG000|Overall Study|Protocol Deviation|1|||
146431864|NCT02718326|528090122|FG001|Overall Study|Protocol Deviation|0|||
146431865|NCT02718326|528090123|FG002|Overall Study|Protocol Deviation|0|||
146431866|NCT02718326|528090121|FG000|Overall Study|Pregnancy|1|||
146431867|NCT02718326|528090122|FG001|Overall Study|Pregnancy|0|||
146431868|NCT02718326|528090123|FG002|Overall Study|Pregnancy|0|||
146431869|NCT03122535|528090124|FG000|Overall Study|Lost to Follow-up|68|||
146431870|NCT03122535|528090125|FG001|Overall Study|Lost to Follow-up|68|||
146431871|NCT03122535|528090124|FG000|Overall Study|Physician Decision|3|||
146431872|NCT03122535|528090125|FG001|Overall Study|Physician Decision|3|||
146431873|NCT03122535|528090124|FG000|Overall Study|Withdrawal by Subject|2|||
146431874|NCT03122535|528090125|FG001|Overall Study|Withdrawal by Subject|2|||
146431875|NCT00984022|528090129|FG000|Overall Study|Lost to Follow-up|10|||
146431876|NCT00984022|528090130|FG001|Overall Study|Lost to Follow-up|14|||
146431877|NCT00573443|528090131|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146431878|NCT00573443|528090132|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146431879|NCT00573443|528090133|FG002|Double-Blind Phase|Lost to Follow-up|2|||
146431880|NCT00573443|528090131|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
146431881|NCT00573443|528090132|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
146431882|NCT00573443|528090133|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
145950905|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950906|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950907|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950908|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950909|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950910|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950911|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
145950912|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950913|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
146431883|NCT00573443|528090131|FG000|Double-Blind Phase|Adverse Event|1|||
146431884|NCT00573443|528090132|FG001|Double-Blind Phase|Adverse Event|5|||
146431885|NCT00573443|528090133|FG002|Double-Blind Phase|Adverse Event|0|||
145950914|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950915|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145950916|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
145950917|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146431886|NCT00573443|528090131|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
146431887|NCT00573443|528090132|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
146431888|NCT00573443|528090133|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
146431889|NCT00573443|528090131|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
146431890|NCT00573443|528090132|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
145950918|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950919|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950920|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950921|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950922|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950923|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
146205925|NCT02988817|527268151|FG004|Overall Study|Physician Decision|0|||
146431891|NCT00573443|528090133|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
146431892|NCT00573443|528090131|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146431893|NCT00573443|528090132|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146431894|NCT00573443|528090133|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
146431895|NCT00573443|528090131|FG000|Double-Blind Phase|Protocol Violation|0|||
146431896|NCT00573443|528090132|FG001|Double-Blind Phase|Protocol Violation|2|||
146431897|NCT00573443|528090133|FG002|Double-Blind Phase|Protocol Violation|1|||
146431898|NCT00573443|528090131|FG000|Double-Blind Phase|Other|0|||
146431899|NCT00573443|528090132|FG001|Double-Blind Phase|Other|2|||
146431900|NCT00573443|528090133|FG002|Double-Blind Phase|Other|3|||
146431901|NCT00573443|528090131|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
146431902|NCT00573443|528090132|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146431903|NCT00573443|528090133|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146431904|NCT00573443|528090131|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
146431905|NCT00573443|528090132|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
146431906|NCT00573443|528090133|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
146431907|NCT00573443|528090131|FG000|Open-Label Extension Phase|Adverse Event|3|||
146431908|NCT00573443|528090132|FG001|Open-Label Extension Phase|Adverse Event|0|||
146431909|NCT00573443|528090133|FG002|Open-Label Extension Phase|Adverse Event|0|||
146431910|NCT00573443|528090131|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
146431911|NCT00573443|528090132|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
146431912|NCT00573443|528090133|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
146431913|NCT00573443|528090131|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
146431914|NCT00573443|528090132|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
146431915|NCT00573443|528090133|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146431916|NCT00573443|528090131|FG000|Open-Label Extension Phase|Protocol Violation|2|||
146431917|NCT00573443|528090132|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146431918|NCT00573443|528090133|FG002|Open-Label Extension Phase|Protocol Violation|0|||
146431919|NCT00573443|528090131|FG000|Open-Label Extension Phase|Other|2|||
146431920|NCT00573443|528090132|FG001|Open-Label Extension Phase|Other|0|||
146431921|NCT00573443|528090133|FG002|Open-Label Extension Phase|Other|0|||
146431922|NCT00418561|528090139|FG000|Overall Study|Participant's (guardian's) decision|0|||
146431923|NCT00418561|528090140|FG001|Overall Study|Participant's (guardian's) decision|1|||
146431924|NCT00418561|528090141|FG002|Overall Study|Participant's (guardian's) decision|0|||
146431925|NCT01796171|528090142|FG000|Enrolled|Death|0|||
146431926|NCT01796171|528090143|FG001|Enrolled|Death|0|||
146431927|NCT01796171|528090144|FG002|Enrolled|Death|0|||
146431928|NCT01796171|528090145|FG003|Enrolled|Death|0|||
146431929|NCT01796171|528090146|FG004|Enrolled|Death|0|||
146431930|NCT01796171|528090147|FG005|Enrolled|Death|0|||
146431931|NCT01796171|528090148|FG006|Enrolled|Death|0|||
146431932|NCT01796171|528090149|FG007|Enrolled|Death|0|||
146431933|NCT01796171|528090150|FG008|Enrolled|Death|0|||
146431934|NCT01796171|528090151|FG009|Enrolled|Death|0|||
146431935|NCT01796171|528090152|FG010|Enrolled|Death|0|||
146431936|NCT01796171|528090153|FG011|Enrolled|Death|0|||
146431937|NCT01796171|528090154|FG012|Enrolled|Death|0|||
146431938|NCT01796171|528090155|FG013|Enrolled|Death|0|||
146431939|NCT01796171|528090156|FG014|Enrolled|Death|1|||
146431940|NCT01796171|528090142|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
146431941|NCT01796171|528090143|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
146431942|NCT01796171|528090144|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
146431943|NCT01796171|528090145|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
146431944|NCT01796171|528090146|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
146431945|NCT01796171|528090147|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
146431946|NCT01796171|528090148|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
146431947|NCT01796171|528090149|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
146431948|NCT01796171|528090150|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
146431949|NCT01796171|528090151|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
146431950|NCT01796171|528090152|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
146431951|NCT01796171|528090153|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
146431952|NCT01796171|528090154|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
146431953|NCT01796171|528090155|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
146431954|NCT01796171|528090156|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
146431955|NCT01796171|528090142|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431956|NCT01796171|528090143|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431957|NCT01796171|528090144|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431958|NCT01796171|528090145|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431959|NCT01796171|528090146|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431960|NCT01796171|528090147|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431961|NCT01796171|528090148|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431962|NCT01796171|528090149|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431963|NCT01796171|528090150|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431964|NCT01796171|528090151|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431965|NCT01796171|528090152|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431966|NCT01796171|528090153|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431967|NCT01796171|528090154|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431968|NCT01796171|528090155|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
146431969|NCT01796171|528090156|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
146431970|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Progressive disease|0|||
146431971|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Progressive disease|1|||
146431972|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Progressive disease|0|||
146431973|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Progressive disease|0|||
146205926|NCT02988817|527268152|FG005|Overall Study|Physician Decision|0|||
146431974|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Progressive disease|0|||
146431975|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Progressive disease|0|||
146431976|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Progressive disease|0|||
146431977|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Progressive disease|0|||
146431978|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Progressive disease|0|||
146431979|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Progressive disease|0|||
146431980|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Progressive disease|0|||
146431981|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Progressive disease|0|||
146431982|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Progressive disease|0|||
146431983|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Progressive disease|0|||
146431984|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Progressive disease|0|||
146431985|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431986|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431987|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431988|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431989|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431990|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431991|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431992|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431993|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146431994|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431995|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146431996|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
146431997|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431998|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146431999|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
146432000|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Physician Decision|0|||
146432001|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Physician Decision|0|||
146432002|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Physician Decision|0|||
146432003|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Physician Decision|0|||
146432004|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Physician Decision|0|||
146432005|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Physician Decision|0|||
146432006|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Physician Decision|0|||
146432007|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Physician Decision|0|||
146432008|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Physician Decision|0|||
145950924|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950925|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
145950926|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950927|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950928|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145950929|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
145950930|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
145950931|NCT01483599|526330509|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
145950932|NCT01483599|526330510|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
145950933|NCT01483599|526330511|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
145950934|NCT01483599|526330512|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
145950935|NCT01483599|526330513|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
145950936|NCT01483599|526330514|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
145950937|NCT01483599|526330515|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
145950938|NCT01483599|526330516|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
145950939|NCT01483599|526330517|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
146205927|NCT02988817|527268153|FG006|Overall Study|Physician Decision|0|||
146205928|NCT02988817|527268154|FG007|Overall Study|Physician Decision|0|||
146205929|NCT02988817|527268155|FG008|Overall Study|Physician Decision|0|||
146205930|NCT02988817|527268156|FG009|Overall Study|Physician Decision|0|||
146205931|NCT02988817|527268157|FG010|Overall Study|Physician Decision|0|||
146205932|NCT02988817|527268158|FG011|Overall Study|Physician Decision|0|||
146205933|NCT02988817|527268159|FG012|Overall Study|Physician Decision|0|||
146205934|NCT02988817|527268160|FG013|Overall Study|Physician Decision|0|||
146432009|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Physician Decision|0|||
145950940|NCT01483599|526330518|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
145950941|NCT01483599|526330519|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
146205935|NCT02988817|527268161|FG014|Overall Study|Physician Decision|0|||
146205936|NCT02988817|527268162|FG015|Overall Study|Physician Decision|1|||
146205937|NCT02988817|527268163|FG016|Overall Study|Physician Decision|0|||
146205938|NCT02988817|527268164|FG017|Overall Study|Physician Decision|0|||
146432010|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Physician Decision|5|||
146432011|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Physician Decision|1|||
146432012|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Physician Decision|1|||
146432013|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Physician Decision|0|||
146432014|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Physician Decision|0|||
146432015|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Death|0|||
146432016|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Death|0|||
146432017|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Death|0|||
146432018|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Death|0|||
146432019|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Death|0|||
146432020|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Death|0|||
146432021|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Death|0|||
146432022|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Death|0|||
146432023|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Death|0|||
146432024|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Death|0|||
146432025|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Death|2|||
146432026|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Death|0|||
146432027|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Death|0|||
146432028|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Death|0|||
146432029|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Death|0|||
146432030|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
145950942|NCT01483599|526330520|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
145950943|NCT01483599|526330521|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
145950944|NCT01483599|526330522|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
145950945|NCT02109445|526330523|FG000|Overall Study|Symptomatic deterioration|2|||
145950946|NCT02109445|526330523|FG000|Overall Study|Adverse Event|1|||
145950947|NCT00958412|526330524|FG000|Overall Study|Study prematurely terminated|18|||
145950948|NCT00385827|526332111|FG000|Part 1|Adverse Event|1|||
145950949|NCT00385827|526332112|FG001|Part 1|Adverse Event|0|||
146432031|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
146432032|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
146432033|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
146432034|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
146432035|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
146432036|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
146432037|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
146432038|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
146432039|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
146432040|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
146432041|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
146432042|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
146432043|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
146432044|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
146432045|NCT01796171|528090142|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432046|NCT01796171|528090143|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432047|NCT01796171|528090144|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432048|NCT01796171|528090145|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432049|NCT01796171|528090146|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432050|NCT01796171|528090147|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432051|NCT01796171|528090148|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432052|NCT01796171|528090149|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432053|NCT01796171|528090150|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432054|NCT01796171|528090151|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432055|NCT01796171|528090152|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
146432056|NCT01796171|528090153|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
146432057|NCT01796171|528090154|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432058|NCT01796171|528090155|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432059|NCT01796171|528090156|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
146432060|NCT01796171|528090142|FG000|Follow-up Period|Start of further anticancer therapy|4|||
146432061|NCT01796171|528090143|FG001|Follow-up Period|Start of further anticancer therapy|25|||
146432062|NCT01796171|528090144|FG002|Follow-up Period|Start of further anticancer therapy|2|||
146432063|NCT01796171|528090145|FG003|Follow-up Period|Start of further anticancer therapy|1|||
146432064|NCT01796171|528090146|FG004|Follow-up Period|Start of further anticancer therapy|2|||
145950950|NCT00385827|526332113|FG002|Part 1|Adverse Event|0|||
145950951|NCT00385827|526332111|FG000|Part 1|Death|2|||
145950952|NCT00385827|526332112|FG001|Part 1|Death|0|||
146205939|NCT02988817|527268165|FG018|Overall Study|Physician Decision|1|||
146205940|NCT02988817|527268166|FG019|Overall Study|Physician Decision|1|||
146432065|NCT01796171|528090147|FG005|Follow-up Period|Start of further anticancer therapy|2|||
146432066|NCT01796171|528090148|FG006|Follow-up Period|Start of further anticancer therapy|1|||
146432067|NCT01796171|528090149|FG007|Follow-up Period|Start of further anticancer therapy|15|||
146432068|NCT01796171|528090150|FG008|Follow-up Period|Start of further anticancer therapy|2|||
146432069|NCT01796171|528090151|FG009|Follow-up Period|Start of further anticancer therapy|0|||
146432070|NCT01796171|528090152|FG010|Follow-up Period|Start of further anticancer therapy|0|||
146432071|NCT01796171|528090153|FG011|Follow-up Period|Start of further anticancer therapy|0|||
146432072|NCT01796171|528090154|FG012|Follow-up Period|Start of further anticancer therapy|0|||
146432073|NCT01796171|528090155|FG013|Follow-up Period|Start of further anticancer therapy|0|||
146432074|NCT01796171|528090156|FG014|Follow-up Period|Start of further anticancer therapy|0|||
146432075|NCT01796171|528090142|FG000|Follow-up Period|Progressive disease|0|||
146432076|NCT01796171|528090143|FG001|Follow-up Period|Progressive disease|1|||
146432077|NCT01796171|528090144|FG002|Follow-up Period|Progressive disease|0|||
146432078|NCT01796171|528090145|FG003|Follow-up Period|Progressive disease|0|||
146432079|NCT01796171|528090146|FG004|Follow-up Period|Progressive disease|0|||
146432080|NCT01796171|528090147|FG005|Follow-up Period|Progressive disease|0|||
146432081|NCT01796171|528090148|FG006|Follow-up Period|Progressive disease|0|||
146432082|NCT01796171|528090149|FG007|Follow-up Period|Progressive disease|3|||
146432083|NCT01796171|528090150|FG008|Follow-up Period|Progressive disease|0|||
146432084|NCT01796171|528090151|FG009|Follow-up Period|Progressive disease|0|||
146432085|NCT01796171|528090152|FG010|Follow-up Period|Progressive disease|0|||
146432086|NCT01796171|528090153|FG011|Follow-up Period|Progressive disease|0|||
146432087|NCT01796171|528090154|FG012|Follow-up Period|Progressive disease|0|||
146432088|NCT01796171|528090155|FG013|Follow-up Period|Progressive disease|0|||
146432089|NCT01796171|528090156|FG014|Follow-up Period|Progressive disease|0|||
146432090|NCT01796171|528090142|FG000|Follow-up Period|Physician Decision|0|||
146432091|NCT01796171|528090143|FG001|Follow-up Period|Physician Decision|2|||
146432092|NCT01796171|528090144|FG002|Follow-up Period|Physician Decision|0|||
146432093|NCT01796171|528090145|FG003|Follow-up Period|Physician Decision|0|||
146432094|NCT01796171|528090146|FG004|Follow-up Period|Physician Decision|0|||
146432095|NCT01796171|528090147|FG005|Follow-up Period|Physician Decision|0|||
146432096|NCT01796171|528090148|FG006|Follow-up Period|Physician Decision|0|||
146432097|NCT01796171|528090149|FG007|Follow-up Period|Physician Decision|0|||
146432098|NCT01796171|528090150|FG008|Follow-up Period|Physician Decision|0|||
146432099|NCT01796171|528090151|FG009|Follow-up Period|Physician Decision|0|||
146432100|NCT01796171|528090152|FG010|Follow-up Period|Physician Decision|5|||
146432101|NCT01796171|528090153|FG011|Follow-up Period|Physician Decision|0|||
146432102|NCT01796171|528090154|FG012|Follow-up Period|Physician Decision|0|||
146432103|NCT01796171|528090155|FG013|Follow-up Period|Physician Decision|0|||
146432104|NCT01796171|528090156|FG014|Follow-up Period|Physician Decision|0|||
146432105|NCT01796171|528090142|FG000|Follow-up Period|Withdrawal by Subject|0|||
146432106|NCT01796171|528090143|FG001|Follow-up Period|Withdrawal by Subject|1|||
146432107|NCT01796171|528090144|FG002|Follow-up Period|Withdrawal by Subject|0|||
146432108|NCT01796171|528090145|FG003|Follow-up Period|Withdrawal by Subject|0|||
146432109|NCT01796171|528090146|FG004|Follow-up Period|Withdrawal by Subject|0|||
146432110|NCT01796171|528090147|FG005|Follow-up Period|Withdrawal by Subject|1|||
146432111|NCT01796171|528090148|FG006|Follow-up Period|Withdrawal by Subject|0|||
146432112|NCT01796171|528090149|FG007|Follow-up Period|Withdrawal by Subject|0|||
146432113|NCT01796171|528090150|FG008|Follow-up Period|Withdrawal by Subject|0|||
146432114|NCT01796171|528090151|FG009|Follow-up Period|Withdrawal by Subject|0|||
146432115|NCT01796171|528090152|FG010|Follow-up Period|Withdrawal by Subject|3|||
146432116|NCT01796171|528090153|FG011|Follow-up Period|Withdrawal by Subject|1|||
146432117|NCT01796171|528090154|FG012|Follow-up Period|Withdrawal by Subject|0|||
146432118|NCT01796171|528090155|FG013|Follow-up Period|Withdrawal by Subject|0|||
146432119|NCT01796171|528090156|FG014|Follow-up Period|Withdrawal by Subject|0|||
146432120|NCT01796171|528090142|FG000|Follow-up Period|Death|0|||
146432121|NCT01796171|528090143|FG001|Follow-up Period|Death|0|||
146432122|NCT01796171|528090144|FG002|Follow-up Period|Death|0|||
146432123|NCT01796171|528090145|FG003|Follow-up Period|Death|0|||
146432124|NCT01796171|528090146|FG004|Follow-up Period|Death|0|||
146432125|NCT01796171|528090147|FG005|Follow-up Period|Death|0|||
146432126|NCT01796171|528090148|FG006|Follow-up Period|Death|1|||
146432127|NCT01796171|528090149|FG007|Follow-up Period|Death|0|||
146432128|NCT01796171|528090150|FG008|Follow-up Period|Death|0|||
146432129|NCT01796171|528090151|FG009|Follow-up Period|Death|0|||
146432130|NCT01796171|528090152|FG010|Follow-up Period|Death|17|||
146432131|NCT01796171|528090153|FG011|Follow-up Period|Death|9|||
146432132|NCT01796171|528090154|FG012|Follow-up Period|Death|1|||
146432133|NCT01796171|528090155|FG013|Follow-up Period|Death|0|||
146432134|NCT01796171|528090156|FG014|Follow-up Period|Death|0|||
146432135|NCT01796171|528090142|FG000|Follow-up Period|Patient transferred to other hospital|0|||
146432136|NCT01796171|528090143|FG001|Follow-up Period|Patient transferred to other hospital|1|||
146432137|NCT01796171|528090144|FG002|Follow-up Period|Patient transferred to other hospital|0|||
146432138|NCT01796171|528090145|FG003|Follow-up Period|Patient transferred to other hospital|0|||
146432139|NCT01796171|528090146|FG004|Follow-up Period|Patient transferred to other hospital|0|||
146432140|NCT01796171|528090147|FG005|Follow-up Period|Patient transferred to other hospital|0|||
146432141|NCT01796171|528090148|FG006|Follow-up Period|Patient transferred to other hospital|0|||
146432142|NCT01796171|528090149|FG007|Follow-up Period|Patient transferred to other hospital|0|||
146432143|NCT01796171|528090150|FG008|Follow-up Period|Patient transferred to other hospital|0|||
146432144|NCT01796171|528090151|FG009|Follow-up Period|Patient transferred to other hospital|0|||
146432145|NCT01796171|528090152|FG010|Follow-up Period|Patient transferred to other hospital|0|||
146432146|NCT01796171|528090153|FG011|Follow-up Period|Patient transferred to other hospital|0|||
146432147|NCT01796171|528090154|FG012|Follow-up Period|Patient transferred to other hospital|0|||
146432148|NCT01796171|528090155|FG013|Follow-up Period|Patient transferred to other hospital|0|||
146432149|NCT01796171|528090156|FG014|Follow-up Period|Patient transferred to other hospital|0|||
146432150|NCT01796171|528090142|FG000|Follow-up Period|Sponsor Decision|0|||
146432151|NCT01796171|528090143|FG001|Follow-up Period|Sponsor Decision|0|||
146432152|NCT01796171|528090144|FG002|Follow-up Period|Sponsor Decision|0|||
146432153|NCT01796171|528090145|FG003|Follow-up Period|Sponsor Decision|0|||
146432154|NCT01796171|528090146|FG004|Follow-up Period|Sponsor Decision|0|||
146432155|NCT01796171|528090147|FG005|Follow-up Period|Sponsor Decision|0|||
146432156|NCT01796171|528090148|FG006|Follow-up Period|Sponsor Decision|0|||
146432157|NCT01796171|528090149|FG007|Follow-up Period|Sponsor Decision|0|||
146432158|NCT01796171|528090150|FG008|Follow-up Period|Sponsor Decision|0|||
146432159|NCT01796171|528090151|FG009|Follow-up Period|Sponsor Decision|0|||
146432160|NCT01796171|528090152|FG010|Follow-up Period|Sponsor Decision|40|||
146432161|NCT01796171|528090153|FG011|Follow-up Period|Sponsor Decision|15|||
146432162|NCT01796171|528090154|FG012|Follow-up Period|Sponsor Decision|7|||
146432163|NCT01796171|528090155|FG013|Follow-up Period|Sponsor Decision|0|||
146432164|NCT01796171|528090156|FG014|Follow-up Period|Sponsor Decision|0|||
146432165|NCT00829309|528090157|FG000|Washout: 7 Days|Protocol Violation|1|||
146432166|NCT00829309|528090158|FG001|Washout: 7 Days|Protocol Violation|0|||
146432167|NCT01705574|528090159|FG000|Double-Blind Phase|Lost to Follow-up|12|||
146432168|NCT01705574|528090160|FG001|Double-Blind Phase|Lost to Follow-up|16|||
146432169|NCT01705574|528090161|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146432170|NCT01705574|528090162|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146432171|NCT01705574|528090159|FG000|Double-Blind Phase|Adverse Event|3|||
146432172|NCT01705574|528090160|FG001|Double-Blind Phase|Adverse Event|10|||
146432173|NCT01705574|528090161|FG002|Double-Blind Phase|Adverse Event|0|||
146432174|NCT01705574|528090162|FG003|Double-Blind Phase|Adverse Event|0|||
146432175|NCT01705574|528090159|FG000|Double-Blind Phase|Withdrew Consent|8|||
146432176|NCT01705574|528090160|FG001|Double-Blind Phase|Withdrew Consent|5|||
146432177|NCT01705574|528090161|FG002|Double-Blind Phase|Withdrew Consent|0|||
146432178|NCT01705574|528090162|FG003|Double-Blind Phase|Withdrew Consent|0|||
146432179|NCT01705574|528090159|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
146432180|NCT01705574|528090160|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
146432181|NCT01705574|528090161|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
146432182|NCT01705574|528090162|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
146432183|NCT01705574|528090159|FG000|Double-Blind Phase|Pregnancy|1|||
146432184|NCT01705574|528090160|FG001|Double-Blind Phase|Pregnancy|1|||
146432185|NCT01705574|528090161|FG002|Double-Blind Phase|Pregnancy|0|||
146432186|NCT01705574|528090162|FG003|Double-Blind Phase|Pregnancy|0|||
146432187|NCT01705574|528090159|FG000|Double-Blind Phase|Protocol Violation|1|||
146432188|NCT01705574|528090160|FG001|Double-Blind Phase|Protocol Violation|0|||
146432189|NCT01705574|528090161|FG002|Double-Blind Phase|Protocol Violation|0|||
146432190|NCT01705574|528090162|FG003|Double-Blind Phase|Protocol Violation|0|||
146432191|NCT01705574|528090159|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
146432192|NCT01705574|528090160|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
146432193|NCT01705574|528090161|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
145950953|NCT00385827|526332113|FG002|Part 1|Death|0|||
145950954|NCT00385827|526332111|FG000|Part 1|Lack of Efficacy|5|||
145950955|NCT00385827|526332112|FG001|Part 1|Lack of Efficacy|0|||
146205941|NCT05082935|527268173|FG000|Overall Study|Lost to Follow-up|549|||
146205942|NCT05082935|527268174|FG001|Overall Study|Lost to Follow-up|631|||
146205943|NCT05082935|527268173|FG000|Overall Study|Withdrawal by Subject|27|||
146205944|NCT05082935|527268174|FG001|Overall Study|Withdrawal by Subject|58|||
146205945|NCT04530747|527268178|FG000|Overall Study|Withdrawal by Subject|1|||
146205946|NCT04530747|527268179|FG001|Overall Study|Withdrawal by Subject|0|||
146205947|NCT03292913|527268180|FG000|Overall Study|Death|9|||
146432194|NCT01705574|528090162|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
146432195|NCT01705574|528090159|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
146432196|NCT01705574|528090160|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146432197|NCT01705574|528090161|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
146432198|NCT01705574|528090162|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
146432199|NCT01705574|528090159|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
146432200|NCT01705574|528090160|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
146432201|NCT01705574|528090161|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
146432202|NCT01705574|528090162|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
146432203|NCT01705574|528090159|FG000|Open-Label Extension Phase|Adverse Event|3|||
146432204|NCT01705574|528090160|FG001|Open-Label Extension Phase|Adverse Event|0|||
146432205|NCT01705574|528090161|FG002|Open-Label Extension Phase|Adverse Event|0|||
146432206|NCT01705574|528090162|FG003|Open-Label Extension Phase|Adverse Event|1|||
145950956|NCT00385827|526332113|FG002|Part 1|Lack of Efficacy|0|||
146205948|NCT03292913|527268181|FG001|Overall Study|Death|3|||
146432207|NCT01705574|528090159|FG000|Open-Label Extension Phase|Death|2|||
146432208|NCT01705574|528090160|FG001|Open-Label Extension Phase|Death|0|||
146432209|NCT01705574|528090161|FG002|Open-Label Extension Phase|Death|1|||
146432210|NCT01705574|528090162|FG003|Open-Label Extension Phase|Death|0|||
146432211|NCT01705574|528090159|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146432212|NCT01705574|528090160|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146432213|NCT01705574|528090161|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
146432214|NCT01705574|528090162|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
146432215|NCT01705574|528090159|FG000|Open-Label Extension Phase|Physician Decision|0|||
146432216|NCT01705574|528090160|FG001|Open-Label Extension Phase|Physician Decision|0|||
146432217|NCT01705574|528090161|FG002|Open-Label Extension Phase|Physician Decision|2|||
146432218|NCT01705574|528090162|FG003|Open-Label Extension Phase|Physician Decision|0|||
146432219|NCT01705574|528090159|FG000|Open-Label Extension Phase|Pregnancy|0|||
146432220|NCT01705574|528090160|FG001|Open-Label Extension Phase|Pregnancy|0|||
146432221|NCT01705574|528090161|FG002|Open-Label Extension Phase|Pregnancy|1|||
146432222|NCT01705574|528090162|FG003|Open-Label Extension Phase|Pregnancy|1|||
146432223|NCT00777023|528090163|FG000|Overall Study|Adverse Event|15|||
146432224|NCT00777023|528090164|FG001|Overall Study|Adverse Event|21|||
146432225|NCT00777023|528090165|FG002|Overall Study|Adverse Event|8|||
146432226|NCT00777023|528090163|FG000|Overall Study|Lack of Efficacy|1|||
146432227|NCT00777023|528090164|FG001|Overall Study|Lack of Efficacy|0|||
146432228|NCT00777023|528090165|FG002|Overall Study|Lack of Efficacy|14|||
146432229|NCT00777023|528090163|FG000|Overall Study|Protocol Violation|2|||
146432230|NCT00777023|528090164|FG001|Overall Study|Protocol Violation|1|||
146432231|NCT00777023|528090165|FG002|Overall Study|Protocol Violation|1|||
146432232|NCT00777023|528090163|FG000|Overall Study|Lost to Follow-up|2|||
146432233|NCT00777023|528090164|FG001|Overall Study|Lost to Follow-up|3|||
146432234|NCT00777023|528090165|FG002|Overall Study|Lost to Follow-up|3|||
146432235|NCT00777023|528090163|FG000|Overall Study|Death|0|||
146432236|NCT00777023|528090164|FG001|Overall Study|Death|1|||
146432237|NCT00777023|528090165|FG002|Overall Study|Death|0|||
146432238|NCT00777023|528090163|FG000|Overall Study|Withdrawal by Subject|7|||
146432239|NCT00777023|528090164|FG001|Overall Study|Withdrawal by Subject|7|||
146432240|NCT00777023|528090165|FG002|Overall Study|Withdrawal by Subject|8|||
146432241|NCT00777023|528090163|FG000|Overall Study|Missing data|1|||
146432242|NCT00777023|528090164|FG001|Overall Study|Missing data|1|||
146432243|NCT00777023|528090165|FG002|Overall Study|Missing data|0|||
146432244|NCT00777023|528090163|FG000|Overall Study|Reasons not specified|4|||
146432245|NCT00777023|528090164|FG001|Overall Study|Reasons not specified|4|||
146432246|NCT00777023|528090165|FG002|Overall Study|Reasons not specified|2|||
146432247|NCT00777023|528090163|FG000|Overall Study|Last dose date unknown|3|||
146432248|NCT00777023|528090164|FG001|Overall Study|Last dose date unknown|3|||
146432249|NCT00777023|528090165|FG002|Overall Study|Last dose date unknown|1|||
146432250|NCT02659150|528090168|FG000|Subject Enrollment|Physician Decision|3|||
146432251|NCT02659150|528090168|FG000|Subject Enrollment|Withdrawal by Subject|2|||
146432252|NCT02659150|528090168|FG000|Baseline Imaging|Withdrawal by Subject|1|||
146432253|NCT02659150|528090168|FG000|Baseline Imaging|Physician Decision|1|||
146432254|NCT02659150|528090168|FG000|Study Drug Dosing|Adverse Event|1|||
146432255|NCT02472366|528090171|FG000|Overall Study|Lost to Follow-up|1|||
146432256|NCT02472366|528090172|FG001|Overall Study|Lost to Follow-up|0|||
146432257|NCT03699020|528090175|FG000|Overall Study|Withdrawal by Subject|3|||
146432258|NCT03699020|528090176|FG001|Overall Study|Withdrawal by Subject|2|||
146432259|NCT03620747|528090180|FG000|Overall Study|Participant decision|7|||
146205949|NCT03292913|527268180|FG000|Overall Study|Lost to Follow-up|49|||
146432260|NCT03620747|528090180|FG000|Overall Study|Adverse Event|6|||
146205950|NCT03292913|527268181|FG001|Overall Study|Lost to Follow-up|49|||
146205951|NCT03292913|527268180|FG000|Overall Study|Withdrawal by Subject|2|||
146205952|NCT03292913|527268181|FG001|Overall Study|Withdrawal by Subject|0|||
146432261|NCT03620747|528090180|FG000|Overall Study|Lack of Efficacy|1|||
146432262|NCT03620747|528090180|FG000|Overall Study|Poor compliance to protocol|2|||
146432263|NCT03620747|528090180|FG000|Overall Study|Other-unspecified|3|||
146432264|NCT00635492|528090189|FG000|Overall Study|Death|12|||
146432265|NCT00635492|528090190|FG001|Overall Study|Death|40|||
146432266|NCT00635492|528090189|FG000|Overall Study|Lost to Follow-up|151|||
146432267|NCT00635492|528090190|FG001|Overall Study|Lost to Follow-up|172|||
146205953|NCT03292913|527268180|FG000|Overall Study|Clinic closed due to COVID|22|||
146432268|NCT00635492|528090189|FG000|Overall Study|Physician Decision|32|||
146432269|NCT00635492|528090190|FG001|Overall Study|Physician Decision|22|||
146432270|NCT00635492|528090189|FG000|Overall Study|Sponsor decision|2|||
146432271|NCT00635492|528090190|FG001|Overall Study|Sponsor decision|3|||
146432272|NCT00635492|528090189|FG000|Overall Study|Withdrawal by Subject|82|||
146432273|NCT00635492|528090190|FG001|Overall Study|Withdrawal by Subject|45|||
146432274|NCT00467363|528090196|FG000|Overall Study|Lost to Follow-up|80|||
146432275|NCT00467363|528090197|FG001|Overall Study|Lost to Follow-up|70|||
146432276|NCT00473330|528090198|FG000|Core Study|Adverse Event|4|||
146432277|NCT00473330|528090199|FG001|Core Study|Adverse Event|4|||
146432278|NCT00473330|528090200|FG002|Core Study|Adverse Event|1|||
146432279|NCT00473330|528090198|FG000|Core Study|Death|6|||
146432280|NCT00473330|528090199|FG001|Core Study|Death|4|||
146432281|NCT00473330|528090200|FG002|Core Study|Death|4|||
146432282|NCT00473330|528090198|FG000|Core Study|Lost to Follow-up|5|||
146432283|NCT00473330|528090199|FG001|Core Study|Lost to Follow-up|5|||
146432284|NCT00473330|528090200|FG002|Core Study|Lost to Follow-up|10|||
146432285|NCT00473330|528090198|FG000|Core Study|Physician Decision|2|||
146432286|NCT00473330|528090199|FG001|Core Study|Physician Decision|1|||
146432287|NCT00473330|528090200|FG002|Core Study|Physician Decision|3|||
146432288|NCT00473330|528090198|FG000|Core Study|Subject Non-compliance|1|||
146432289|NCT00473330|528090199|FG001|Core Study|Subject Non-compliance|2|||
146432290|NCT00473330|528090200|FG002|Core Study|Subject Non-compliance|1|||
146432291|NCT00473330|528090198|FG000|Core Study|Subject Required Other Therapy|0|||
146432292|NCT00473330|528090199|FG001|Core Study|Subject Required Other Therapy|1|||
146432293|NCT00473330|528090200|FG002|Core Study|Subject Required Other Therapy|3|||
146432294|NCT00473330|528090198|FG000|Core Study|Subject's Decision|9|||
146432295|NCT00473330|528090199|FG001|Core Study|Subject's Decision|8|||
146432296|NCT00473330|528090200|FG002|Core Study|Subject's Decision|19|||
146432297|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
146432298|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
146432299|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
146432300|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Death|2|||
146432301|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Death|0|||
146432302|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Death|0|||
146432303|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
146432304|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
146432305|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
146432306|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
146432307|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
146432308|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
146432309|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
146432310|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
146432311|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
146432312|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
146432313|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
146432314|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
146432315|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
146432316|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
146432317|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
146432318|NCT00473330|528090198|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
146432319|NCT00473330|528090199|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
146432320|NCT00473330|528090200|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
146432321|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
146432322|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
146432323|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
146432324|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Death|2|||
146432325|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Death|2|||
146432326|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Death|1|||
146432327|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
146432328|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
146432329|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
146432330|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
146432331|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
146432332|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
146432333|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
146432334|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
146432335|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
146432336|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
146432337|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
146432338|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
146432339|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
146432340|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
146432341|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
146432342|NCT00473330|528090198|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
146432343|NCT00473330|528090199|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
146432344|NCT00473330|528090200|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
146432345|NCT05615935|528090201|FG000|Overall Study|Lost to Follow-up|1|||
146432346|NCT05615935|528090202|FG001|Overall Study|Lost to Follow-up|1|||
146432347|NCT03925532|528090203|FG000|Overall Study|Lost to Follow-up|1|||
146432348|NCT01079988|528090204|FG000|Overall Study|Lost to Follow-up|0|||
146432349|NCT01079988|528090205|FG001|Overall Study|Lost to Follow-up|0|||
146432350|NCT01079988|528090206|FG002|Overall Study|Lost to Follow-up|0|||
146432351|NCT01079988|528090207|FG003|Overall Study|Lost to Follow-up|1|||
146432352|NCT01079988|528090208|FG004|Overall Study|Lost to Follow-up|0|||
146432353|NCT01079988|528090204|FG000|Overall Study|Lack of Efficacy|1|||
146432354|NCT01079988|528090205|FG001|Overall Study|Lack of Efficacy|0|||
146432355|NCT01079988|528090206|FG002|Overall Study|Lack of Efficacy|0|||
146432356|NCT01079988|528090207|FG003|Overall Study|Lack of Efficacy|0|||
146432357|NCT01079988|528090208|FG004|Overall Study|Lack of Efficacy|0|||
146432358|NCT01079988|528090204|FG000|Overall Study|Other|0|||
146432359|NCT01079988|528090205|FG001|Overall Study|Other|0|||
146432360|NCT01079988|528090206|FG002|Overall Study|Other|0|||
146432361|NCT01079988|528090207|FG003|Overall Study|Other|2|||
146432362|NCT01079988|528090208|FG004|Overall Study|Other|1|||
146432363|NCT01001208|528090209|FG000|Overall Study|Adverse Event|10|||
146432364|NCT01001208|528090210|FG001|Overall Study|Adverse Event|5|||
146432365|NCT01001208|528090209|FG000|Overall Study|Lost to Follow-up|5|||
146432366|NCT01001208|528090210|FG001|Overall Study|Lost to Follow-up|9|||
146432367|NCT01001208|528090209|FG000|Overall Study|Physician Decision|1|||
146432368|NCT01001208|528090210|FG001|Overall Study|Physician Decision|0|||
146432369|NCT01001208|528090209|FG000|Overall Study|Withdrawal by Subject|4|||
146432370|NCT01001208|528090210|FG001|Overall Study|Withdrawal by Subject|5|||
146432371|NCT01001208|528090209|FG000|Overall Study|Ineligibility Determined|4|||
146432372|NCT01001208|528090210|FG001|Overall Study|Ineligibility Determined|2|||
146432373|NCT01001208|528090209|FG000|Overall Study|Noncompliance|4|||
146432374|NCT01001208|528090210|FG001|Overall Study|Noncompliance|7|||
146432375|NCT01001208|528090209|FG000|Overall Study|Disease Progression|0|||
146432376|NCT01001208|528090210|FG001|Overall Study|Disease Progression|3|||
146432377|NCT01001208|528090209|FG000|Overall Study|Other|0|||
146432378|NCT01001208|528090210|FG001|Overall Study|Other|2|||
146432379|NCT00833937|528090211|FG000|Washout|Withdrawal by Subject|1|||
146432380|NCT00833937|528090212|FG001|Washout|Withdrawal by Subject|0|||
146432381|NCT00095212|528090213|FG000|Overall Study|Withdrawal by Subject|1|||
146432382|NCT00095212|528090214|FG001|Overall Study|Withdrawal by Subject|3|||
146432383|NCT02032888|528090218|FG000|Treatment Period|Poor compliance/noncompliance|1|||
146432384|NCT02032888|528090219|FG001|Treatment Period|Poor compliance/noncompliance|1|||
146432385|NCT02032888|528090220|FG002|Treatment Period|Poor compliance/noncompliance|0|||
146432386|NCT02032888|528090218|FG000|Treatment Period|Other|1|||
146432387|NCT02032888|528090219|FG001|Treatment Period|Other|1|||
146432388|NCT02032888|528090220|FG002|Treatment Period|Other|0|||
146432389|NCT02032888|528090218|FG000|Follow-up Period|Lost to Follow-up|1|||
146432390|NCT02032888|528090219|FG001|Follow-up Period|Lost to Follow-up|1|||
146432391|NCT02032888|528090220|FG002|Follow-up Period|Lost to Follow-up|0|||
146432392|NCT02032888|528090218|FG000|Follow-up Period|Death|1|||
146432393|NCT02032888|528090219|FG001|Follow-up Period|Death|1|||
146432394|NCT02032888|528090220|FG002|Follow-up Period|Death|0|||
146432395|NCT02032888|528090218|FG000|Follow-up Period|Other|1|||
146432396|NCT02032888|528090219|FG001|Follow-up Period|Other|0|||
146432397|NCT02032888|528090220|FG002|Follow-up Period|Other|0|||
146432398|NCT01697696|528090221|FG000|Overall Study|Study terminated by sponsor|0|||
146432399|NCT01697696|528090222|FG001|Overall Study|Study terminated by sponsor|3|||
146432400|NCT01697696|528090221|FG000|Overall Study|Protocol deviation|1|||
146432401|NCT01697696|528090222|FG001|Overall Study|Protocol deviation|0|||
146432402|NCT01697696|528090221|FG000|Overall Study|Physician Decision|1|||
146432403|NCT01697696|528090222|FG001|Overall Study|Physician Decision|0|||
146432404|NCT01697696|528090221|FG000|Overall Study|Death|4|||
146432405|NCT01697696|528090222|FG001|Overall Study|Death|2|||
146432406|NCT01697696|528090221|FG000|Overall Study|Lost to Follow-up|10|||
146432407|NCT01697696|528090222|FG001|Overall Study|Lost to Follow-up|7|||
146432408|NCT01697696|528090221|FG000|Overall Study|Subject/guardian decision|31|||
146432409|NCT01697696|528090222|FG001|Overall Study|Subject/guardian decision|35|||
146432410|NCT02066922|528090223|FG000|Overall Study|Adverse Event|1|||
146432411|NCT00727961|528090225|FG000|Overall Study|Lost to Follow-up|1|||
146432412|NCT00727961|528090225|FG000|Overall Study|Adverse Event|4|||
146432413|NCT00727961|528090225|FG000|Overall Study|Patient's refusal|2|||
146432414|NCT00727961|528090225|FG000|Overall Study|Progression|30|||
146432415|NCT03238781|528090226|FG000|Overall Study|Adverse Event|1|||
146432416|NCT03238781|528090227|FG001|Overall Study|Adverse Event|1|||
146432417|NCT03238781|528090228|FG002|Overall Study|Adverse Event|2|||
146432418|NCT03238781|528090226|FG000|Overall Study|Lost to Follow-up|2|||
146432419|NCT03238781|528090227|FG001|Overall Study|Lost to Follow-up|1|||
146432420|NCT03238781|528090228|FG002|Overall Study|Lost to Follow-up|2|||
146432421|NCT03238781|528090226|FG000|Overall Study|Withdrawal by Subject|23|||
146432422|NCT03238781|528090227|FG001|Overall Study|Withdrawal by Subject|14|||
146432423|NCT03238781|528090228|FG002|Overall Study|Withdrawal by Subject|16|||
146432424|NCT03238781|528090226|FG000|Overall Study|Decision by sponsor|0|||
146432425|NCT03238781|528090227|FG001|Overall Study|Decision by sponsor|1|||
146432426|NCT03238781|528090228|FG002|Overall Study|Decision by sponsor|0|||
146432427|NCT03161405|528090229|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
146432428|NCT00837486|528090230|FG000|Blinded-treatment Phase|Physician Decision|1|||
146432429|NCT00837486|528090231|FG001|Blinded-treatment Phase|Physician Decision|0|||
146432430|NCT00837486|528090230|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
146432431|NCT00837486|528090231|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
146432432|NCT00837486|528090230|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
146432433|NCT00837486|528090231|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
146432434|NCT00837486|528090230|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
146432435|NCT00837486|528090231|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
146432436|NCT02655679|528090232|FG000|Overall Study|Adverse Event|0|||
146432437|NCT02655679|528090233|FG001|Overall Study|Adverse Event|1|||
146432438|NCT02655679|528090234|FG002|Overall Study|Adverse Event|0|||
146432439|NCT02655679|528090235|FG003|Overall Study|Adverse Event|0|||
146432440|NCT02655679|528090236|FG004|Overall Study|Adverse Event|0|||
146432441|NCT02655679|528090232|FG000|Overall Study|Withdrawal by Subject|1|||
146432442|NCT02655679|528090233|FG001|Overall Study|Withdrawal by Subject|1|||
146432443|NCT02655679|528090234|FG002|Overall Study|Withdrawal by Subject|0|||
146432444|NCT02655679|528090235|FG003|Overall Study|Withdrawal by Subject|3|||
146432445|NCT02655679|528090236|FG004|Overall Study|Withdrawal by Subject|1|||
146432446|NCT02655679|528090232|FG000|Overall Study|Inability to Comply with the Protocol|1|||
146432447|NCT02655679|528090233|FG001|Overall Study|Inability to Comply with the Protocol|0|||
146432448|NCT02655679|528090234|FG002|Overall Study|Inability to Comply with the Protocol|0|||
146432449|NCT02655679|528090235|FG003|Overall Study|Inability to Comply with the Protocol|0|||
146432450|NCT02655679|528090236|FG004|Overall Study|Inability to Comply with the Protocol|0|||
146432451|NCT02655679|528090232|FG000|Overall Study|Lost to Follow-up|0|||
146432452|NCT02655679|528090233|FG001|Overall Study|Lost to Follow-up|1|||
146432453|NCT02655679|528090234|FG002|Overall Study|Lost to Follow-up|1|||
146432454|NCT02655679|528090235|FG003|Overall Study|Lost to Follow-up|1|||
146432455|NCT02655679|528090236|FG004|Overall Study|Lost to Follow-up|0|||
146432456|NCT02655679|528090232|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146432457|NCT02655679|528090233|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146432458|NCT02655679|528090234|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146432459|NCT02655679|528090235|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146432460|NCT02655679|528090236|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146432461|NCT01421277|528090237|FG000|Overall Study|Lack of qualifying event|0|||
146432462|NCT01421277|528090238|FG001|Overall Study|Lack of qualifying event|61|||
146432463|NCT01421277|528090237|FG000|Overall Study|Incomplete baseline data|0|||
146432464|NCT01421277|528090238|FG001|Overall Study|Incomplete baseline data|31|||
146432465|NCT02039908|528090239|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
146432466|NCT02039908|528090240|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
146432467|NCT02039908|528090241|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
146432468|NCT02039908|528090242|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
146432469|NCT02039908|528090239|FG000|Phase 1-Summer|Protocol Violation|6|||
146432470|NCT02039908|528090240|FG001|Phase 1-Summer|Protocol Violation|0|||
146432471|NCT02039908|528090241|FG002|Phase 1-Summer|Protocol Violation|0|||
146432472|NCT02039908|528090242|FG003|Phase 1-Summer|Protocol Violation|0|||
146432473|NCT02039908|528090239|FG000|Phase 2-School Year|Lost to Follow-up|0|||
146432474|NCT02039908|528090240|FG001|Phase 2-School Year|Lost to Follow-up|0|||
146432475|NCT02039908|528090241|FG002|Phase 2-School Year|Lost to Follow-up|1|||
146432476|NCT02039908|528090242|FG003|Phase 2-School Year|Lost to Follow-up|3|||
146432477|NCT02039908|528090239|FG000|Phase 2-School Year|Protocol Violation|0|||
146432478|NCT02039908|528090240|FG001|Phase 2-School Year|Protocol Violation|0|||
146432479|NCT02039908|528090241|FG002|Phase 2-School Year|Protocol Violation|3|||
146205954|NCT03292913|527268181|FG001|Overall Study|Clinic closed due to COVID|36|||
146432480|NCT02039908|528090242|FG003|Phase 2-School Year|Protocol Violation|0|||
146432481|NCT02039908|528090239|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
146432482|NCT02039908|528090240|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
146432483|NCT02039908|528090241|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
146432484|NCT02039908|528090242|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
146432485|NCT02246920|528091696|FG000|Overall Study|Adverse Event|3|||
146432486|NCT02246920|528091697|FG001|Overall Study|Adverse Event|1|||
146432487|NCT02246920|528091698|FG002|Overall Study|Adverse Event|1|||
146432488|NCT02246920|528091696|FG000|Overall Study|Lost to Follow-up|2|||
146432489|NCT02246920|528091697|FG001|Overall Study|Lost to Follow-up|1|||
146432490|NCT02246920|528091698|FG002|Overall Study|Lost to Follow-up|0|||
146432491|NCT02246920|528091696|FG000|Overall Study|Protocol Violation|2|||
146432492|NCT02246920|528091697|FG001|Overall Study|Protocol Violation|5|||
146432493|NCT02246920|528091698|FG002|Overall Study|Protocol Violation|1|||
146432494|NCT02246920|528091696|FG000|Overall Study|Withdrawal by Subject|0|||
146432495|NCT02246920|528091697|FG001|Overall Study|Withdrawal by Subject|0|||
146432496|NCT02246920|528091698|FG002|Overall Study|Withdrawal by Subject|1|||
146432497|NCT02678286|528091699|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
146432498|NCT02678286|528091700|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
146432499|NCT02678286|528091699|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
146432500|NCT02678286|528091700|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
146432501|NCT02678286|528091699|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
146432502|NCT02678286|528091700|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
146432503|NCT02678286|528091699|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
146432504|NCT02678286|528091700|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
146432505|NCT02678286|528091699|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
146432506|NCT02678286|528091700|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
146432507|NCT00448019|528091701|FG000|Overall Study|Withdrawal by Subject|3|||
146432508|NCT00448019|528091701|FG000|Overall Study|Disease progression|1|||
146432509|NCT00448019|528091701|FG000|Overall Study|Death|2|||
146432510|NCT00448019|528091701|FG000|Overall Study|Insurance Issues|1|||
146432511|NCT01273805|528091702|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
146432512|NCT01273805|528091703|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
146432513|NCT02647944|528091708|FG000|Overall Study|Withdrawal by Subject|0|||
146432514|NCT02647944|528091709|FG001|Overall Study|Withdrawal by Subject|3|||
146432515|NCT02647944|528091708|FG000|Overall Study|Adverse Event|2|||
146432516|NCT02647944|528091709|FG001|Overall Study|Adverse Event|0|||
146432517|NCT02760368|528091711|FG000|Overall Study|Withdrawal by Subject|8|||
146432518|NCT02760368|528091712|FG001|Overall Study|Withdrawal by Subject|12|||
146432519|NCT02760368|528091713|FG002|Overall Study|Withdrawal by Subject|9|||
146432520|NCT02760368|528091711|FG000|Overall Study|Screen Failure|0|||
146432521|NCT02760368|528091712|FG001|Overall Study|Screen Failure|0|||
146432522|NCT02760368|528091713|FG002|Overall Study|Screen Failure|1|||
146432523|NCT02760368|528091711|FG000|Overall Study|Death|0|||
146432524|NCT02760368|528091712|FG001|Overall Study|Death|1|||
146432525|NCT02760368|528091713|FG002|Overall Study|Death|0|||
146432526|NCT02760368|528091711|FG000|Overall Study|Withdrawal by Sponsor|0|||
146432527|NCT02760368|528091712|FG001|Overall Study|Withdrawal by Sponsor|0|||
146432528|NCT02760368|528091713|FG002|Overall Study|Withdrawal by Sponsor|1|||
146432529|NCT02902211|528091721|FG000|First Three Months|Withdrawal by Subject|7|||
146432530|NCT02902211|528091722|FG001|First Three Months|Withdrawal by Subject|3|||
146432531|NCT01200810|528091723|FG000|Overall Study|Physician Decision|1|||
146432532|NCT01200810|528091724|FG001|Overall Study|Physician Decision|0|||
146432533|NCT01200810|528091723|FG000|Overall Study|Withdrawal by Subject|1|||
146432534|NCT01200810|528091724|FG001|Overall Study|Withdrawal by Subject|2|||
146432535|NCT01200810|528091723|FG000|Overall Study|Sponsor stopped making study drug|3|||
146432536|NCT01200810|528091724|FG001|Overall Study|Sponsor stopped making study drug|3|||
146205955|NCT03950622|527268182|FG000|Overall Study|Withdrawal by Subject|1|||
146205956|NCT03950622|527268183|FG001|Overall Study|Withdrawal by Subject|0|||
146205957|NCT03950622|527268182|FG000|Overall Study|Protocol Deviation|0|||
146205958|NCT03950622|527268183|FG001|Overall Study|Protocol Deviation|1|||
146205959|NCT03950622|527268182|FG000|Overall Study|Physician Decision|1|||
146205960|NCT03950622|527268183|FG001|Overall Study|Physician Decision|0|||
146205961|NCT03950622|527268182|FG000|Overall Study|Lost to Follow-up|5|||
146205962|NCT03950622|527268183|FG001|Overall Study|Lost to Follow-up|5|||
146205963|NCT03950622|527268182|FG000|Overall Study|Death|1|||
146205964|NCT03950622|527268183|FG001|Overall Study|Death|1|||
146432537|NCT00904215|528091726|FG000|Overall Study|Adverse Event|25|||
146432538|NCT00904215|528091726|FG000|Overall Study|Protocol Violation|10|||
146432539|NCT00904215|528091726|FG000|Overall Study|Lost to Follow-up|63|||
146205965|NCT02379819|527268184|FG000|Overall Study|Withdrawal by Subject|10|||
146205966|NCT02379819|527268184|FG000|Overall Study|Death|2|||
146205967|NCT02379819|527268184|FG000|Overall Study|Lack of Efficacy|1|||
146205968|NCT02379819|527268184|FG000|Overall Study|Lost to Follow-up|1|||
146432540|NCT00904215|528091726|FG000|Overall Study|Withdrawal by Subject|9|||
146432541|NCT00904215|528091726|FG000|Overall Study|Other|28|||
146432542|NCT00838630|528091727|FG000|First Intervention|Adverse Event|1|||
146432543|NCT00838630|528091728|FG001|First Intervention|Adverse Event|0|||
146432544|NCT00838630|528091727|FG000|Washout: 7 Days|Protocol Violation|1|||
146432545|NCT00838630|528091728|FG001|Washout: 7 Days|Protocol Violation|0|||
146432546|NCT00640562|528091729|FG000|Overall Study|Adverse Event|8|||
146432547|NCT00640562|528091730|FG001|Overall Study|Adverse Event|5|||
146432548|NCT00640562|528091729|FG000|Overall Study|Lack of Efficacy|1|||
146432549|NCT00640562|528091730|FG001|Overall Study|Lack of Efficacy|4|||
146432550|NCT00640562|528091729|FG000|Overall Study|Protocol Violation|2|||
146432551|NCT00640562|528091730|FG001|Overall Study|Protocol Violation|4|||
146432552|NCT00640562|528091729|FG000|Overall Study|Withdrawal by Subject|6|||
146432553|NCT00640562|528091730|FG001|Overall Study|Withdrawal by Subject|10|||
146432554|NCT00640562|528091729|FG000|Overall Study|Known risperidone intolerance|0|||
146432555|NCT00640562|528091730|FG001|Overall Study|Known risperidone intolerance|1|||
146432556|NCT00640562|528091729|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
146432557|NCT00640562|528091730|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
146432558|NCT00640562|528091729|FG000|Overall Study|Low study drug dose|0|||
146432559|NCT00640562|528091730|FG001|Overall Study|Low study drug dose|1|||
146432560|NCT00640562|528091729|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
146432561|NCT00640562|528091730|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
146432562|NCT00448591|528091731|FG000|Overall Study|Withdrawal by Subject|178|||
146432563|NCT00448591|528091731|FG000|Overall Study|Progressive Disease|1382|||
146432564|NCT00448591|528091731|FG000|Overall Study|Adverse Event|382|||
146432565|NCT00448591|528091731|FG000|Overall Study|Protocol Violation|41|||
146432566|NCT00448591|528091731|FG000|Overall Study|Lost to Follow-up|19|||
146432567|NCT00448591|528091731|FG000|Overall Study|Treatment Regimen Completed|70|||
146432568|NCT00448591|528091731|FG000|Overall Study|Other|154|||
146432569|NCT00448591|528091731|FG000|Overall Study|Termination of Study|70|||
146432570|NCT02937870|528091732|FG000|Overall Study|Adverse Event|1|||
146432571|NCT02937870|528091732|FG000|Overall Study|Protocol Deviation|2|||
146432572|NCT03098394|528091736|FG000|Overall Study|Pregnancy|0|||
146432573|NCT03098394|528091737|FG001|Overall Study|Pregnancy|1|||
146432574|NCT00609674|528091738|FG000|Overall Study|Adverse Event|1|||
146432575|NCT00609674|528091739|FG001|Overall Study|Adverse Event|1|||
146432576|NCT00609674|528091738|FG000|Overall Study|Protocol Violation|3|||
146432577|NCT00609674|528091739|FG001|Overall Study|Protocol Violation|5|||
146432578|NCT00609674|528091738|FG000|Overall Study|Lost to Follow-up|1|||
146432579|NCT00609674|528091739|FG001|Overall Study|Lost to Follow-up|0|||
146432580|NCT00609674|528091738|FG000|Overall Study|Withdrew consent|2|||
146432581|NCT00609674|528091739|FG001|Overall Study|Withdrew consent|1|||
146432582|NCT00244764|528091743|FG000|Overall Study|Adverse Event|37|||
146432583|NCT00244764|528091743|FG000|Overall Study|Lost to Follow-up|23|||
146432584|NCT00244764|528091743|FG000|Overall Study|Withdrawal by Subject|12|||
146432585|NCT00244764|528091743|FG000|Overall Study|Disease Progression|13|||
146432586|NCT00244764|528091743|FG000|Overall Study|Protocol Violation|2|||
146432587|NCT00244764|528091743|FG000|Overall Study|Death|1|||
146432588|NCT00244764|528091743|FG000|Overall Study|Off Study Medication for >21 Days|1|||
146432589|NCT00244764|528091743|FG000|Overall Study|Declining Performance Status|1|||
146432590|NCT00244764|528091743|FG000|Overall Study|Participant was Hospitalized until Death|1|||
146432591|NCT00244764|528091743|FG000|Overall Study|Primary Investigator Discretion|2|||
146432592|NCT00244764|528091743|FG000|Overall Study|Sponsor Terminated Study|2|||
146432593|NCT00244764|528091743|FG000|Overall Study|Developed Secondary Malignancy|1|||
146432594|NCT02648438|528091749|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146432595|NCT02648438|528091750|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
146432596|NCT02648438|528091751|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146432597|NCT02648438|528091749|FG000|Overall Study|Protocol Violation|2|||
146432598|NCT02648438|528091750|FG001|Overall Study|Protocol Violation|0|||
146432599|NCT02648438|528091751|FG002|Overall Study|Protocol Violation|0|||
146432600|NCT02648438|528091749|FG000|Overall Study|Withdrawal by Subject|1|||
146432601|NCT02648438|528091750|FG001|Overall Study|Withdrawal by Subject|1|||
146432602|NCT02648438|528091751|FG002|Overall Study|Withdrawal by Subject|0|||
146432603|NCT03138967|528091752|FG000|Overall Study|Death|0|||
146432604|NCT03138967|528091753|FG001|Overall Study|Death|1|||
146432605|NCT03138967|528091752|FG000|Overall Study|Physician Decision|1|||
146432606|NCT03138967|528091753|FG001|Overall Study|Physician Decision|3|||
146432607|NCT04604275|528091754|FG000|Washout-1 Week|Withdrawal by Subject|1|||
146432608|NCT04604275|528091755|FG001|Washout-1 Week|Withdrawal by Subject|0|||
146432609|NCT02689505|528091756|FG000|Overall Study|Progressive disease|2|||
146432610|NCT02689505|528091757|FG001|Overall Study|Progressive disease|2|||
146432611|NCT02689505|528091758|FG002|Overall Study|Progressive disease|3|||
146432612|NCT02689505|528091759|FG003|Overall Study|Progressive disease|9|||
146432613|NCT02689505|528091760|FG004|Overall Study|Progressive disease|1|||
146432614|NCT02689505|528091756|FG000|Overall Study|Dose Limiting Toxicity|0|||
145950957|NCT00385827|526332111|FG000|Part 1|Other|1|||
146432615|NCT02689505|528091757|FG001|Overall Study|Dose Limiting Toxicity|1|||
146432616|NCT02689505|528091758|FG002|Overall Study|Dose Limiting Toxicity|0|||
146432617|NCT02689505|528091759|FG003|Overall Study|Dose Limiting Toxicity|0|||
146432618|NCT02689505|528091760|FG004|Overall Study|Dose Limiting Toxicity|2|||
146432619|NCT02689505|528091756|FG000|Overall Study|Other AE or clinical progression|0|||
146432620|NCT02689505|528091757|FG001|Overall Study|Other AE or clinical progression|2|||
146432621|NCT02689505|528091758|FG002|Overall Study|Other AE or clinical progression|0|||
146432622|NCT02689505|528091759|FG003|Overall Study|Other AE or clinical progression|2|||
146432623|NCT02689505|528091760|FG004|Overall Study|Other AE or clinical progression|0|||
146432624|NCT00723710|528091764|FG000|Overall Study|Disease progression|48|||
146432625|NCT00723710|528091764|FG000|Overall Study|Adverse Event|88|||
146432626|NCT00723710|528091764|FG000|Overall Study|Withdrawal by Subject|36|||
146432627|NCT00723710|528091764|FG000|Overall Study|Physician Decision|2|||
146432628|NCT04405570|528091765|FG000|Overall Study|Adverse Event|0|||
146432629|NCT04405570|528091766|FG001|Overall Study|Adverse Event|1|||
146432630|NCT04405570|528091767|FG002|Overall Study|Adverse Event|1|||
146432631|NCT04405570|528091768|FG003|Overall Study|Adverse Event|1|||
146432632|NCT04405570|528091765|FG000|Overall Study|Lost to Follow-up|0|||
146432633|NCT04405570|528091766|FG001|Overall Study|Lost to Follow-up|1|||
146432634|NCT04405570|528091767|FG002|Overall Study|Lost to Follow-up|0|||
146432635|NCT04405570|528091768|FG003|Overall Study|Lost to Follow-up|0|||
146432636|NCT04405570|528091765|FG000|Overall Study|Physician Decision|0|||
146432637|NCT04405570|528091766|FG001|Overall Study|Physician Decision|0|||
146432638|NCT04405570|528091767|FG002|Overall Study|Physician Decision|1|||
146432639|NCT04405570|528091768|FG003|Overall Study|Physician Decision|0|||
146432640|NCT04405570|528091765|FG000|Overall Study|Withdrawal by Subject|0|||
146432641|NCT04405570|528091766|FG001|Overall Study|Withdrawal by Subject|1|||
146432642|NCT04405570|528091767|FG002|Overall Study|Withdrawal by Subject|1|||
146432643|NCT04405570|528091768|FG003|Overall Study|Withdrawal by Subject|0|||
146432644|NCT04405570|528091765|FG000|Overall Study|Randomized not dosed|0|||
146432645|NCT04405570|528091766|FG001|Overall Study|Randomized not dosed|2|||
146432646|NCT04405570|528091767|FG002|Overall Study|Randomized not dosed|0|||
146432647|NCT04405570|528091768|FG003|Overall Study|Randomized not dosed|0|||
146432648|NCT04499963|528091769|FG000|Overall Study|Adverse Event|3|||
146432649|NCT04499963|528091770|FG001|Overall Study|Adverse Event|0|||
146432650|NCT04499963|528091769|FG000|Overall Study|Death|3|||
146432651|NCT04499963|528091770|FG001|Overall Study|Death|0|||
146432652|NCT04499963|528091769|FG000|Overall Study|Lack of Efficacy|7|||
146432653|NCT04499963|528091770|FG001|Overall Study|Lack of Efficacy|0|||
146432654|NCT04499963|528091769|FG000|Overall Study|Lost to Follow-up|2|||
146432655|NCT04499963|528091770|FG001|Overall Study|Lost to Follow-up|0|||
146432656|NCT03546842|528091771|FG000|Overall Study|Protocol Violation|1|||
146432657|NCT03546842|528091771|FG000|Overall Study|Withdrawal by Subject|2|||
146432658|NCT03031847|528091782|FG000|Overall Study|Death|1|||
146432659|NCT03031847|528091783|FG001|Overall Study|Death|1|||
146432660|NCT03031847|528091784|FG002|Overall Study|Death|2|||
146432661|NCT03031847|528091785|FG003|Overall Study|Death|3|||
146432662|NCT03031847|528091782|FG000|Overall Study|Lost to Follow-up|1|||
146432663|NCT03031847|528091783|FG001|Overall Study|Lost to Follow-up|1|||
146432664|NCT03031847|528091784|FG002|Overall Study|Lost to Follow-up|2|||
146432665|NCT03031847|528091785|FG003|Overall Study|Lost to Follow-up|3|||
146432666|NCT01353664|528091786|FG000|Overall Study|Other|3|||
146432667|NCT01353664|528091786|FG000|Overall Study|Disease Progression|16|||
146432668|NCT03273153|528091787|FG000|Overall Study|Adverse Event|1|||
146432669|NCT03273153|528091788|FG001|Overall Study|Adverse Event|2|||
146432670|NCT03273153|528091787|FG000|Overall Study|Missing|0|||
146432671|NCT03273153|528091788|FG001|Overall Study|Missing|2|||
146432672|NCT03273153|528091787|FG000|Overall Study|Other|3|||
146432673|NCT03273153|528091788|FG001|Overall Study|Other|2|||
146432674|NCT03273153|528091787|FG000|Overall Study|Symptomatic Deterioration|0|||
146432675|NCT03273153|528091788|FG001|Overall Study|Symptomatic Deterioration|1|||
146432676|NCT03273153|528091787|FG000|Overall Study|Progressive Disease|6|||
146432677|NCT03273153|528091788|FG001|Overall Study|Progressive Disease|5|||
146432678|NCT03273153|528091787|FG000|Overall Study|Physician Decision|1|||
146432679|NCT03273153|528091788|FG001|Overall Study|Physician Decision|3|||
146432680|NCT03273153|528091787|FG000|Overall Study|Study Terminated by Sponsor|112|||
146432681|NCT03273153|528091788|FG001|Overall Study|Study Terminated by Sponsor|102|||
146432682|NCT03273153|528091787|FG000|Overall Study|Withdrawal by Subject|26|||
146432683|NCT03273153|528091788|FG001|Overall Study|Withdrawal by Subject|25|||
146432684|NCT03273153|528091787|FG000|Overall Study|Protocol Deviation|3|||
146432685|NCT03273153|528091788|FG001|Overall Study|Protocol Deviation|0|||
146432686|NCT03273153|528091787|FG000|Overall Study|Lost to Follow-up|6|||
146432687|NCT03273153|528091788|FG001|Overall Study|Lost to Follow-up|11|||
146432688|NCT03273153|528091787|FG000|Overall Study|Death|66|||
146432689|NCT03273153|528091788|FG001|Overall Study|Death|69|||
146432690|NCT01237054|528091791|FG000|Overall Study|imaging 10C0096|1|||
146432691|NCT00838539|528091792|FG000|Overall Study|Disease Progression|2|||
146432692|NCT00838539|528091793|FG001|Overall Study|Disease Progression|4|||
146432693|NCT00838539|528091794|FG002|Overall Study|Disease Progression|3|||
146432694|NCT00838539|528091795|FG003|Overall Study|Disease Progression|2|||
146432695|NCT00838539|528091796|FG004|Overall Study|Disease Progression|4|||
146432696|NCT00838539|528091797|FG005|Overall Study|Disease Progression|2|||
146432697|NCT00838539|528091798|FG006|Overall Study|Disease Progression|3|||
146432698|NCT00838539|528091799|FG007|Overall Study|Disease Progression|4|||
146432699|NCT00838539|528091800|FG008|Overall Study|Disease Progression|4|||
146432700|NCT00838539|528091801|FG009|Overall Study|Disease Progression|5|||
146432701|NCT00838539|528091802|FG010|Overall Study|Disease Progression|1|||
146432702|NCT00838539|528091803|FG011|Overall Study|Disease Progression|4|||
146432703|NCT00838539|528091792|FG000|Overall Study|Adverse Event|1|||
146432704|NCT00838539|528091793|FG001|Overall Study|Adverse Event|1|||
146432705|NCT00838539|528091794|FG002|Overall Study|Adverse Event|1|||
146432706|NCT00838539|528091795|FG003|Overall Study|Adverse Event|1|||
146432707|NCT00838539|528091796|FG004|Overall Study|Adverse Event|2|||
146432708|NCT00838539|528091797|FG005|Overall Study|Adverse Event|1|||
146432709|NCT00838539|528091798|FG006|Overall Study|Adverse Event|0|||
146432710|NCT00838539|528091799|FG007|Overall Study|Adverse Event|2|||
146432711|NCT00838539|528091800|FG008|Overall Study|Adverse Event|0|||
146432712|NCT00838539|528091801|FG009|Overall Study|Adverse Event|1|||
146432713|NCT00838539|528091802|FG010|Overall Study|Adverse Event|2|||
146432714|NCT00838539|528091803|FG011|Overall Study|Adverse Event|0|||
146432715|NCT00838539|528091792|FG000|Overall Study|Withdrawal by Subject|0|||
146432716|NCT00838539|528091793|FG001|Overall Study|Withdrawal by Subject|1|||
146432717|NCT00838539|528091794|FG002|Overall Study|Withdrawal by Subject|0|||
146432718|NCT00838539|528091795|FG003|Overall Study|Withdrawal by Subject|0|||
146432719|NCT00838539|528091796|FG004|Overall Study|Withdrawal by Subject|0|||
146432720|NCT00838539|528091797|FG005|Overall Study|Withdrawal by Subject|0|||
146432721|NCT00838539|528091798|FG006|Overall Study|Withdrawal by Subject|0|||
146432722|NCT00838539|528091799|FG007|Overall Study|Withdrawal by Subject|0|||
146432723|NCT00838539|528091800|FG008|Overall Study|Withdrawal by Subject|0|||
146432724|NCT00838539|528091801|FG009|Overall Study|Withdrawal by Subject|1|||
146432725|NCT00838539|528091802|FG010|Overall Study|Withdrawal by Subject|2|||
146432726|NCT00838539|528091803|FG011|Overall Study|Withdrawal by Subject|0|||
146432727|NCT00838539|528091792|FG000|Overall Study|Death|0|||
146432728|NCT00838539|528091793|FG001|Overall Study|Death|0|||
146432729|NCT00838539|528091794|FG002|Overall Study|Death|0|||
146432730|NCT00838539|528091795|FG003|Overall Study|Death|0|||
146432731|NCT00838539|528091796|FG004|Overall Study|Death|0|||
146432732|NCT00838539|528091797|FG005|Overall Study|Death|0|||
146432733|NCT00838539|528091798|FG006|Overall Study|Death|1|||
146432734|NCT00838539|528091799|FG007|Overall Study|Death|0|||
146432735|NCT00838539|528091800|FG008|Overall Study|Death|0|||
146432736|NCT00838539|528091801|FG009|Overall Study|Death|0|||
146432737|NCT00838539|528091802|FG010|Overall Study|Death|0|||
146432738|NCT00838539|528091803|FG011|Overall Study|Death|0|||
146432739|NCT00838539|528091792|FG000|Overall Study|Physician Decision|0|||
146432740|NCT00838539|528091793|FG001|Overall Study|Physician Decision|0|||
146432741|NCT00838539|528091794|FG002|Overall Study|Physician Decision|0|||
146432742|NCT00838539|528091795|FG003|Overall Study|Physician Decision|0|||
146432743|NCT00838539|528091796|FG004|Overall Study|Physician Decision|0|||
146432744|NCT00838539|528091797|FG005|Overall Study|Physician Decision|0|||
146432745|NCT00838539|528091798|FG006|Overall Study|Physician Decision|0|||
146432746|NCT00838539|528091799|FG007|Overall Study|Physician Decision|0|||
146432747|NCT00838539|528091800|FG008|Overall Study|Physician Decision|1|||
146432748|NCT00838539|528091801|FG009|Overall Study|Physician Decision|0|||
146432749|NCT00838539|528091802|FG010|Overall Study|Physician Decision|0|||
146432750|NCT00838539|528091803|FG011|Overall Study|Physician Decision|0|||
146432751|NCT00838539|528091792|FG000|Overall Study|Clinical Progression|0|||
146432752|NCT00838539|528091793|FG001|Overall Study|Clinical Progression|0|||
146432753|NCT00838539|528091794|FG002|Overall Study|Clinical Progression|0|||
146432754|NCT00838539|528091795|FG003|Overall Study|Clinical Progression|0|||
146432755|NCT00838539|528091796|FG004|Overall Study|Clinical Progression|0|||
146432756|NCT00838539|528091797|FG005|Overall Study|Clinical Progression|0|||
146432757|NCT00838539|528091798|FG006|Overall Study|Clinical Progression|1|||
146432758|NCT00838539|528091799|FG007|Overall Study|Clinical Progression|0|||
146432759|NCT00838539|528091800|FG008|Overall Study|Clinical Progression|0|||
146432760|NCT00838539|528091801|FG009|Overall Study|Clinical Progression|0|||
146432761|NCT00838539|528091802|FG010|Overall Study|Clinical Progression|0|||
146432762|NCT00838539|528091803|FG011|Overall Study|Clinical Progression|0|||
146432763|NCT00838539|528091792|FG000|Overall Study|Symptomatic Deterioration|0|||
146432764|NCT00838539|528091793|FG001|Overall Study|Symptomatic Deterioration|0|||
146432765|NCT00838539|528091794|FG002|Overall Study|Symptomatic Deterioration|1|||
146432766|NCT00838539|528091795|FG003|Overall Study|Symptomatic Deterioration|1|||
146432767|NCT00838539|528091796|FG004|Overall Study|Symptomatic Deterioration|0|||
146432768|NCT00838539|528091797|FG005|Overall Study|Symptomatic Deterioration|1|||
146432769|NCT00838539|528091798|FG006|Overall Study|Symptomatic Deterioration|0|||
146432770|NCT00838539|528091799|FG007|Overall Study|Symptomatic Deterioration|0|||
146432771|NCT00838539|528091800|FG008|Overall Study|Symptomatic Deterioration|0|||
146432772|NCT00838539|528091801|FG009|Overall Study|Symptomatic Deterioration|1|||
146432773|NCT00838539|528091802|FG010|Overall Study|Symptomatic Deterioration|0|||
146432774|NCT00838539|528091803|FG011|Overall Study|Symptomatic Deterioration|0|||
146432775|NCT01908205|528091804|FG000|Overall Study|Lost to Follow-up|2|||
146432776|NCT01908205|528091805|FG001|Overall Study|Lost to Follow-up|0|||
146432777|NCT01908205|528091804|FG000|Overall Study|Withdrawal by Subject|3|||
146432778|NCT01908205|528091805|FG001|Overall Study|Withdrawal by Subject|1|||
146432779|NCT05323396|528091806|FG000|Overall Study|Lost to Follow-up|1|||
146432780|NCT05323396|528091807|FG001|Overall Study|Lost to Follow-up|35|||
146432781|NCT05323396|528091806|FG000|Overall Study|Pregnancy|1|||
146432782|NCT05323396|528091807|FG001|Overall Study|Pregnancy|0|||
146432783|NCT03134222|528091808|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
146432784|NCT03134222|528091809|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
146432785|NCT03134222|528091810|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
145950958|NCT00385827|526332112|FG001|Part 1|Other|0|||
145950959|NCT00385827|526332113|FG002|Part 1|Other|0|||
145950960|NCT00385827|526332111|FG000|Part 2|Adverse Event|0|||
145950961|NCT00385827|526332112|FG001|Part 2|Adverse Event|6|||
146205969|NCT01839331|527268185|FG000|Overall Study|Early Termination|3|||
146205970|NCT01839331|527268186|FG001|Overall Study|Early Termination|0|||
146205971|NCT01839331|527268187|FG002|Overall Study|Early Termination|1|||
146205972|NCT01839331|527268188|FG003|Overall Study|Early Termination|2|||
146205973|NCT01839331|527268185|FG000|Overall Study|Protocol Violation|1|||
146205974|NCT01839331|527268186|FG001|Overall Study|Protocol Violation|6|||
146432786|NCT03134222|528091811|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
146432787|NCT03134222|528091812|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
146432788|NCT03134222|528091808|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146205975|NCT01839331|527268187|FG002|Overall Study|Protocol Violation|4|||
146205976|NCT01839331|527268188|FG003|Overall Study|Protocol Violation|3|||
146205977|NCT04056624|527268189|FG000|Overall Study|Withdrawal by Subject|0|||
146432789|NCT03134222|528091809|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146432790|NCT03134222|528091810|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
146432791|NCT03134222|528091811|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
146432792|NCT03134222|528091812|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
146432793|NCT03134222|528091808|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146432794|NCT03134222|528091809|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
146432795|NCT03134222|528091810|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146432796|NCT03134222|528091811|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146432797|NCT03134222|528091812|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
146432798|NCT03134222|528091808|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146432799|NCT03134222|528091809|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
146432800|NCT03134222|528091810|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
146432801|NCT03134222|528091811|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146432802|NCT03134222|528091812|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
146432803|NCT03134222|528091808|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146432804|NCT03134222|528091809|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
146432805|NCT03134222|528091810|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146432806|NCT03134222|528091811|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
146432807|NCT03134222|528091812|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
146432808|NCT03134222|528091808|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
146432809|NCT03134222|528091809|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146432810|NCT03134222|528091810|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146432811|NCT03134222|528091811|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146432812|NCT03134222|528091812|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
146432813|NCT03134222|528091808|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146432814|NCT03134222|528091809|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146432815|NCT03134222|528091810|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146432816|NCT03134222|528091811|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
146432817|NCT03134222|528091812|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
146432818|NCT03134222|528091808|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146432819|NCT03134222|528091809|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
146432820|NCT03134222|528091810|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146432821|NCT03134222|528091811|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146432822|NCT03134222|528091812|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
146432823|NCT02089997|528091821|FG000|Overall Study|Case report forms uncollected|99|||
146432824|NCT02089997|528091821|FG000|Overall Study|Protocol Violation|147|||
146432825|NCT02242201|528091826|FG000|Overall Study|preoperative identified neuropathy|2|||
146432826|NCT02242201|528091827|FG001|Overall Study|preoperative identified neuropathy|0|||
146432827|NCT02242201|528091828|FG002|Overall Study|preoperative identified neuropathy|0|||
146432828|NCT02242201|528091826|FG000|Overall Study|planned post-op anticoagulation|1|||
146432829|NCT02242201|528091827|FG001|Overall Study|planned post-op anticoagulation|0|||
145950962|NCT00385827|526332113|FG002|Part 2|Adverse Event|10|||
145950963|NCT00385827|526332111|FG000|Part 2|Death|0|||
145950964|NCT00385827|526332112|FG001|Part 2|Death|0|||
146205978|NCT04056624|527268190|FG001|Overall Study|Withdrawal by Subject|0|||
146285364|NCT01445301|527557848|FG001|Overall Study|Adverse Event|25|||
146432830|NCT02242201|528091828|FG002|Overall Study|planned post-op anticoagulation|0|||
146432831|NCT02242201|528091826|FG000|Overall Study|changed surgical procedure|1|||
146432832|NCT02242201|528091827|FG001|Overall Study|changed surgical procedure|0|||
146432833|NCT02242201|528091828|FG002|Overall Study|changed surgical procedure|0|||
146432834|NCT02242201|528091826|FG000|Overall Study|postponed surgery|0|||
146432835|NCT02242201|528091827|FG001|Overall Study|postponed surgery|0|||
146432836|NCT02242201|528091828|FG002|Overall Study|postponed surgery|1|||
146432837|NCT02242201|528091826|FG000|Overall Study|preoperative opioid consumption|0|||
146432838|NCT02242201|528091827|FG001|Overall Study|preoperative opioid consumption|1|||
146432839|NCT02242201|528091828|FG002|Overall Study|preoperative opioid consumption|0|||
146432840|NCT02335658|528091829|FG000|Overall Study|Adverse Event|18|||
146432841|NCT02335658|528091830|FG001|Overall Study|Adverse Event|12|||
146432842|NCT02335658|528091829|FG000|Overall Study|Lack of Efficacy|4|||
146432843|NCT02335658|528091830|FG001|Overall Study|Lack of Efficacy|5|||
146432844|NCT02335658|528091829|FG000|Overall Study|Pregnancy|1|||
146432845|NCT02335658|528091830|FG001|Overall Study|Pregnancy|0|||
146432846|NCT02335658|528091829|FG000|Overall Study|Withdrawal by Subject|13|||
146432847|NCT02335658|528091830|FG001|Overall Study|Withdrawal by Subject|21|||
146432848|NCT02335658|528091829|FG000|Overall Study|non-compliance|2|||
146432849|NCT02335658|528091830|FG001|Overall Study|non-compliance|3|||
146432850|NCT02335658|528091829|FG000|Overall Study|other reason|2|||
146432851|NCT02335658|528091830|FG001|Overall Study|other reason|3|||
146432852|NCT01424644|528091831|FG000|Overall Study|Adverse Event|2|||
146432853|NCT01424644|528091832|FG001|Overall Study|Adverse Event|0|||
146432854|NCT01424644|528091831|FG000|Overall Study|Withdrawal by Subject|9|||
146432855|NCT01424644|528091832|FG001|Overall Study|Withdrawal by Subject|12|||
146432856|NCT01424644|528091831|FG000|Overall Study|Lost to Follow-up|16|||
146432857|NCT01424644|528091832|FG001|Overall Study|Lost to Follow-up|12|||
146432858|NCT01424644|528091831|FG000|Overall Study|Protocol Violation|4|||
146432859|NCT01424644|528091832|FG001|Overall Study|Protocol Violation|3|||
146432860|NCT01424644|528091831|FG000|Overall Study|Administrative Reason|1|||
146432861|NCT01424644|528091832|FG001|Overall Study|Administrative Reason|0|||
146432862|NCT01424644|528091831|FG000|Overall Study|Unable to Classify|1|||
146432863|NCT01424644|528091832|FG001|Overall Study|Unable to Classify|0|||
146432864|NCT05593965|528091835|FG000|1st Intervention (1 Day)|Technical error|1|||
146432865|NCT05593965|528091836|FG001|1st Intervention (1 Day)|Technical error|0|||
146432866|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
146432867|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
146432868|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
146432869|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
146432870|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432871|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432872|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432873|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432874|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432875|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432876|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432877|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432878|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432879|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432880|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432881|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432882|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432883|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432884|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146205979|NCT04056624|527268191|FG002|Overall Study|Withdrawal by Subject|1|||
146205980|NCT04056624|527268189|FG000|Overall Study|Protocol Violation|1|||
146205981|NCT04056624|527268190|FG001|Overall Study|Protocol Violation|2|||
146205982|NCT04056624|527268191|FG002|Overall Study|Protocol Violation|0|||
146432885|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432886|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
146432887|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
146432888|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
146432889|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
146432890|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
146432891|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432892|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146205983|NCT03531840|527268196|FG000|Overall Study|Death on study|3|||
146432893|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432894|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432895|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432896|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432897|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432898|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432899|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432900|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432901|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432902|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432903|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432904|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432905|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432906|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432907|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
146432908|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
146432909|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
146432910|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
146432911|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
146432912|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432913|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432914|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432915|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432916|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432917|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432918|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432919|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432920|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432921|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432922|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432923|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432924|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432925|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432926|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432927|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432928|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
146432929|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
146432930|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
146432931|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
146432932|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432933|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432934|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432935|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432936|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145950965|NCT00385827|526332113|FG002|Part 2|Death|2|||
146432937|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432938|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145950966|NCT00385827|526332111|FG000|Part 2|Lack of Efficacy|0|||
145950967|NCT00385827|526332112|FG001|Part 2|Lack of Efficacy|14|||
145950968|NCT00385827|526332113|FG002|Part 2|Lack of Efficacy|13|||
145950969|NCT00385827|526332111|FG000|Part 2|Randomized but not treated|0|||
145950970|NCT00385827|526332112|FG001|Part 2|Randomized but not treated|2|||
145950971|NCT00385827|526332113|FG002|Part 2|Randomized but not treated|2|||
145950972|NCT00385827|526332111|FG000|Part 2|Other|0|||
145950973|NCT00385827|526332112|FG001|Part 2|Other|11|||
145950974|NCT00385827|526332113|FG002|Part 2|Other|21|||
145950975|NCT04227405|526332114|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
145950976|NCT04227405|526332115|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
145950977|NCT04227405|526332114|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
145950978|NCT04227405|526332115|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
145950979|NCT04227405|526332114|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
145950980|NCT04227405|526332115|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
145950981|NCT04985942|526332116|FG000|Overall Study|Adverse Event|14|||
145950982|NCT04985942|526332117|FG001|Overall Study|Adverse Event|2|||
145950983|NCT04985942|526332116|FG000|Overall Study|Lack of Efficacy|0|||
145950984|NCT04985942|526332117|FG001|Overall Study|Lack of Efficacy|3|||
145950985|NCT04985942|526332116|FG000|Overall Study|Lost to Follow-up|1|||
145950986|NCT04985942|526332117|FG001|Overall Study|Lost to Follow-up|1|||
145950987|NCT04985942|526332116|FG000|Overall Study|Protocol Violation|1|||
145950988|NCT04985942|526332117|FG001|Overall Study|Protocol Violation|1|||
145950989|NCT04985942|526332116|FG000|Overall Study|Withdrawal by Subject|5|||
145950990|NCT04985942|526332117|FG001|Overall Study|Withdrawal by Subject|4|||
145950991|NCT03252145|526332118|FG000|Overall Study|Withdrawal by Subject|1|||
145950992|NCT03252145|526332119|FG001|Overall Study|Withdrawal by Subject|0|||
145950993|NCT03252145|526332118|FG000|Overall Study|Complicating Disease|1|||
145950994|NCT03252145|526332119|FG001|Overall Study|Complicating Disease|2|||
145950995|NCT03488563|526332120|FG000|Overall Study|Lost to Follow-up|7|||
145950996|NCT03488563|526332121|FG001|Overall Study|Lost to Follow-up|6|||
145950997|NCT03488563|526332122|FG002|Overall Study|Lost to Follow-up|7|||
145950998|NCT03488563|526332120|FG000|Overall Study|Withdrawal by Subject|8|||
145950999|NCT03488563|526332121|FG001|Overall Study|Withdrawal by Subject|7|||
145951000|NCT03488563|526332122|FG002|Overall Study|Withdrawal by Subject|7|||
145951001|NCT03488563|526332120|FG000|Overall Study|Physician Decision|0|||
145951002|NCT03488563|526332121|FG001|Overall Study|Physician Decision|0|||
145951003|NCT03488563|526332122|FG002|Overall Study|Physician Decision|1|||
145951004|NCT03488563|526332120|FG000|Overall Study|Protocol Violation|3|||
145951005|NCT03488563|526332121|FG001|Overall Study|Protocol Violation|2|||
145951006|NCT03488563|526332122|FG002|Overall Study|Protocol Violation|6|||
145951007|NCT03488563|526332120|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
145951008|NCT03488563|526332121|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
145951009|NCT03488563|526332122|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
145951010|NCT03488563|526332120|FG000|Overall Study|Use of prohibited medication|2|||
145951011|NCT03488563|526332121|FG001|Overall Study|Use of prohibited medication|0|||
145951012|NCT03488563|526332122|FG002|Overall Study|Use of prohibited medication|0|||
145951013|NCT03488563|526332120|FG000|Overall Study|Adverse Event|1|||
146432939|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432940|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145951014|NCT03488563|526332121|FG001|Overall Study|Adverse Event|0|||
145951015|NCT03488563|526332122|FG002|Overall Study|Adverse Event|1|||
145951016|NCT03488563|526332120|FG000|Overall Study|Subject returned for ET visit|0|||
146432941|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432942|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432943|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145951017|NCT03488563|526332121|FG001|Overall Study|Subject returned for ET visit|1|||
145951018|NCT03488563|526332122|FG002|Overall Study|Subject returned for ET visit|0|||
145951019|NCT03488563|526332120|FG000|Overall Study|Sponsor's decision|0|||
145951020|NCT03488563|526332121|FG001|Overall Study|Sponsor's decision|0|||
145951021|NCT03488563|526332122|FG002|Overall Study|Sponsor's decision|1|||
145951022|NCT00582426|526332127|FG000|Overall Study|Lost to Follow-up|0|||
145951023|NCT00582426|526332128|FG001|Overall Study|Lost to Follow-up|2|||
145951024|NCT00582426|526332127|FG000|Overall Study|Adverse Event|4|||
145951025|NCT00582426|526332128|FG001|Overall Study|Adverse Event|2|||
146432944|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432945|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432946|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432947|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432948|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432949|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
146432950|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
146432951|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432952|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432953|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
146432954|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432955|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432956|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432957|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432958|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432959|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432960|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432961|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432962|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146205984|NCT03531840|527268197|FG001|Overall Study|Death on study|2|||
146205985|NCT03531840|527268198|FG002|Overall Study|Death on study|1|||
146205986|NCT03531840|527268199|FG003|Overall Study|Death on study|2|||
146205987|NCT03531840|527268196|FG000|Overall Study|Death during follow up|2|||
146205988|NCT03531840|527268197|FG001|Overall Study|Death during follow up|3|||
146432963|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432964|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432965|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432966|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432967|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432968|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432969|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432970|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
146432971|NCT01597245|528091837|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
146432972|NCT01597245|528091838|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
146432973|NCT01597245|528091839|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
146432974|NCT01597245|528091840|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432975|NCT01597245|528091841|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432976|NCT01597245|528091842|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432977|NCT01597245|528091843|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432978|NCT01597245|528091844|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432979|NCT01597245|528091845|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432980|NCT01597245|528091846|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432981|NCT01597245|528091847|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432982|NCT01597245|528091848|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432983|NCT01597245|528091849|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432984|NCT01597245|528091850|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432985|NCT01597245|528091851|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432986|NCT01597245|528091852|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432987|NCT01597245|528091853|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432988|NCT01597245|528091854|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432989|NCT01597245|528091855|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432990|NCT01597245|528091856|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432991|NCT01597245|528091857|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
146432992|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146432993|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146432994|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146432995|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146432996|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146432997|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
146432998|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
146432999|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433000|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433001|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433002|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433003|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433004|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433005|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433006|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433007|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433008|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433009|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433010|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433011|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433012|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
146433013|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433014|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433015|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146205989|NCT03531840|527268198|FG002|Overall Study|Death during follow up|4|||
146285365|NCT01445301|527557849|FG002|Overall Study|Adverse Event|4|||
146433016|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433017|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
146433018|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
146433019|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
146433020|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
146433021|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433022|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
146433023|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433024|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433025|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433026|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433027|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433028|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433029|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433030|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433031|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433032|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433033|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
146433034|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433035|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433036|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433037|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433038|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433039|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
146433040|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433041|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433042|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
146433043|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146205990|NCT03531840|527268199|FG003|Overall Study|Death during follow up|1|||
146205991|NCT02092116|527268200|FG000|Overall Study|Withdrawal by Subject|0|||
146205992|NCT02092116|527268201|FG001|Overall Study|Withdrawal by Subject|3|||
146205993|NCT02092116|527268200|FG000|Overall Study|Adverse Event|0|||
146205994|NCT02092116|527268201|FG001|Overall Study|Adverse Event|1|||
146205995|NCT02267824|527268202|FG000|Overall Study|Pregnancy|1|||
146205996|NCT02267824|527268203|FG001|Overall Study|Pregnancy|1|||
146205997|NCT02267824|527268202|FG000|Overall Study|Lost to Follow-up|4|||
146205998|NCT02267824|527268203|FG001|Overall Study|Lost to Follow-up|0|||
146205999|NCT02267824|527268202|FG000|Overall Study|Protocol Violation|3|||
146206000|NCT02267824|527268203|FG001|Overall Study|Protocol Violation|0|||
146206001|NCT02267824|527268202|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
146206002|NCT02267824|527268203|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
146206003|NCT03074331|527268204|FG000|Overall Study|Enrolled but Not Treated|1|||
146206004|NCT03074331|527268204|FG000|Overall Study|Lost to Follow-up|5|||
146206005|NCT03074331|527268204|FG000|Overall Study|Withdrew Consent|1|||
146206006|NCT01792830|527268208|FG000|Overall Study|Withdrawal by Subject|22|||
146206007|NCT01792830|527268209|FG001|Overall Study|Withdrawal by Subject|0|||
146206008|NCT01792830|527268210|FG002|Overall Study|Withdrawal by Subject|0|||
146206009|NCT01792830|527268211|FG003|Overall Study|Withdrawal by Subject|2|||
146206010|NCT01792830|527268212|FG004|Overall Study|Withdrawal by Subject|1|||
146206011|NCT01792830|527268213|FG005|Overall Study|Withdrawal by Subject|1|||
146206012|NCT01792830|527268214|FG006|Overall Study|Withdrawal by Subject|1|||
146206013|NCT01792830|527268215|FG007|Overall Study|Withdrawal by Subject|1|||
146206014|NCT01792830|527268216|FG008|Overall Study|Withdrawal by Subject|7|||
146206015|NCT01792830|527268217|FG009|Overall Study|Withdrawal by Subject|0|||
146206016|NCT01792830|527268218|FG010|Overall Study|Withdrawal by Subject|2|||
146206017|NCT01792830|527268208|FG000|Overall Study|Death|3|||
146206018|NCT01792830|527268209|FG001|Overall Study|Death|0|||
146206019|NCT01792830|527268210|FG002|Overall Study|Death|0|||
146206020|NCT01792830|527268211|FG003|Overall Study|Death|1|||
146206021|NCT01792830|527268212|FG004|Overall Study|Death|0|||
146206022|NCT01792830|527268213|FG005|Overall Study|Death|0|||
146206023|NCT01792830|527268214|FG006|Overall Study|Death|1|||
146206024|NCT01792830|527268215|FG007|Overall Study|Death|0|||
146206025|NCT01792830|527268216|FG008|Overall Study|Death|1|||
146206026|NCT01792830|527268217|FG009|Overall Study|Death|0|||
146206027|NCT01792830|527268218|FG010|Overall Study|Death|1|||
146206028|NCT01792830|527268208|FG000|Overall Study|Adverse Event|0|||
146206029|NCT01792830|527268209|FG001|Overall Study|Adverse Event|0|||
146206030|NCT01792830|527268210|FG002|Overall Study|Adverse Event|0|||
146206031|NCT01792830|527268211|FG003|Overall Study|Adverse Event|0|||
146206032|NCT01792830|527268212|FG004|Overall Study|Adverse Event|0|||
146206033|NCT01792830|527268213|FG005|Overall Study|Adverse Event|0|||
146206034|NCT01792830|527268214|FG006|Overall Study|Adverse Event|0|||
146206035|NCT01792830|527268215|FG007|Overall Study|Adverse Event|0|||
146206036|NCT01792830|527268216|FG008|Overall Study|Adverse Event|1|||
146206037|NCT01792830|527268217|FG009|Overall Study|Adverse Event|0|||
146206038|NCT01792830|527268218|FG010|Overall Study|Adverse Event|0|||
146206039|NCT01943799|527268219|FG000|Overall Study|Lost to Follow-up|0|||
146206040|NCT01943799|527268220|FG001|Overall Study|Lost to Follow-up|1|||
146206041|NCT01943799|527268221|FG002|Overall Study|Lost to Follow-up|1|||
146206042|NCT01943799|527268222|FG003|Overall Study|Lost to Follow-up|0|||
146206043|NCT01943799|527268219|FG000|Overall Study|Protocol Violation|1|||
146206044|NCT01943799|527268220|FG001|Overall Study|Protocol Violation|0|||
146206045|NCT01943799|527268221|FG002|Overall Study|Protocol Violation|0|||
146206046|NCT01943799|527268222|FG003|Overall Study|Protocol Violation|0|||
146206047|NCT01943799|527268219|FG000|Overall Study|Withdrawal by Subject|4|||
146206048|NCT01943799|527268220|FG001|Overall Study|Withdrawal by Subject|2|||
146206049|NCT01943799|527268221|FG002|Overall Study|Withdrawal by Subject|1|||
146206050|NCT01943799|527268222|FG003|Overall Study|Withdrawal by Subject|0|||
146206051|NCT03811574|527268225|FG000|Overall Study|Withdrawal by Subject|2|||
146206052|NCT03811574|527268226|FG001|Overall Study|Withdrawal by Subject|4|||
146206053|NCT03811574|527268227|FG002|Overall Study|Withdrawal by Subject|0|||
146206054|NCT01832480|527268228|FG000|Overall Study|Lost to Follow-up|33|||
146206055|NCT01832480|527268229|FG001|Overall Study|Lost to Follow-up|30|||
146206056|NCT01832480|527268228|FG000|Overall Study|Withdrawal by Subject|0|||
146206057|NCT01832480|527268229|FG001|Overall Study|Withdrawal by Subject|2|||
146206058|NCT01832480|527268228|FG000|Overall Study|post randomization ineligible|8|||
146206059|NCT01832480|527268229|FG001|Overall Study|post randomization ineligible|10|||
146433044|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
146433045|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
146433046|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
146433047|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145951026|NCT00582426|526332127|FG000|Overall Study|Protocol Violation|6|||
145951027|NCT00582426|526332128|FG001|Overall Study|Protocol Violation|2|||
145951028|NCT00582426|526332127|FG000|Overall Study|Death|4|||
145951029|NCT00582426|526332128|FG001|Overall Study|Death|3|||
145951030|NCT00582426|526332127|FG000|Overall Study|Withdrawal by Subject|3|||
145951031|NCT00582426|526332128|FG001|Overall Study|Withdrawal by Subject|2|||
145951032|NCT00582426|526332127|FG000|Overall Study|Disease Progression|2|||
145951033|NCT00582426|526332128|FG001|Overall Study|Disease Progression|2|||
145951034|NCT00582426|526332127|FG000|Overall Study|Use of illicit drugs|1|||
145951035|NCT00582426|526332128|FG001|Overall Study|Use of illicit drugs|0|||
145951036|NCT02626000|526332129|FG000|Overall Study|Decision by Sponsor|1|||
145951037|NCT02626000|526332129|FG000|Overall Study|Death|29|||
145951038|NCT02164318|526332130|FG000|Overall Study|Withdrawal by Subject|0|||
145951039|NCT02164318|526332131|FG001|Overall Study|Withdrawal by Subject|1|||
145951040|NCT02164318|526332132|FG002|Overall Study|Withdrawal by Subject|0|||
145951041|NCT02164318|526332133|FG003|Overall Study|Withdrawal by Subject|1|||
145951042|NCT00662311|526332134|FG000|Overall Study|Respiratory Infection|1|||
145951043|NCT00662311|526332135|FG001|Overall Study|Respiratory Infection|0|||
145951044|NCT00662311|526332136|FG002|Overall Study|Respiratory Infection|0|||
145951045|NCT01467271|526332139|FG000|Overall Study|Death|84|||
145951046|NCT01467271|526332139|FG000|Overall Study|Lost to Follow-up|83|||
145951047|NCT01467271|526332139|FG000|Overall Study|Retraction of patient's consent|21|||
145951048|NCT01467271|526332139|FG000|Overall Study|Other reason|14|||
145951049|NCT03084302|526332144|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
145951050|NCT03084302|526332144|FG000|Overall Study|No valid objective monitor data|6|||
145951051|NCT01411319|526332145|FG000|Overall Study|Lost to Follow-up|1|||
145951052|NCT02499263|526332146|FG000|Overall Study|Lost to Follow-up|9|||
145951053|NCT02499263|526332146|FG000|Overall Study|Participant's withdrawal of consent|4|||
145951054|NCT02499263|526332146|FG000|Overall Study|Lack of Efficacy|22|||
145951055|NCT02499263|526332146|FG000|Overall Study|investigator's judgment|12|||
145951056|NCT02499263|526332146|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
145951057|NCT02499263|526332146|FG000|Overall Study|Participant's decision|3|||
145951058|NCT02499263|526332146|FG000|Overall Study|Pregnancy|1|||
145951059|NCT04126317|526332165|FG000|Overall Study|Adverse Event|0|||
145951060|NCT04126317|526332166|FG001|Overall Study|Adverse Event|1|||
145951061|NCT04126317|526332165|FG000|Overall Study|Withdrawal by Subject|4|||
145951062|NCT04126317|526332166|FG001|Overall Study|Withdrawal by Subject|1|||
145951063|NCT00424593|526332169|FG000|Acute Double-Blind Period|Adverse Event|16|||
145951064|NCT00424593|526332170|FG001|Acute Double-Blind Period|Adverse Event|7|||
145951065|NCT00424593|526332169|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
145951066|NCT00424593|526332170|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
145951067|NCT00424593|526332169|FG000|Acute Double-Blind Period|Protocol Violation|2|||
145951068|NCT00424593|526332170|FG001|Acute Double-Blind Period|Protocol Violation|2|||
145951069|NCT00424593|526332169|FG000|Acute Double-Blind Period|Physician Decision|1|||
145951070|NCT00424593|526332170|FG001|Acute Double-Blind Period|Physician Decision|2|||
145951071|NCT00424593|526332169|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
145951072|NCT00424593|526332170|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
145951073|NCT00424593|526332169|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
145951074|NCT00424593|526332170|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
145951075|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
145951076|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
145951077|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Adverse Event|18|||
145951078|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Adverse Event|0|||
145951079|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
146082902|NCT03039621|526824698|FG000|Overall Study|Non-compliance with protocol requirement|4|||
146082903|NCT03039621|526824699|FG001|Overall Study|Non-compliance with protocol requirement|5|||
146082904|NCT03039621|526824698|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
146206060|NCT05609032|527268235|FG000|Overall Study|Lost to Follow-up|3|||
146206061|NCT05609032|527268236|FG001|Overall Study|Lost to Follow-up|1|||
146206062|NCT05609032|527268235|FG000|Overall Study|Withdrawal by Subject|1|||
146206063|NCT05609032|527268236|FG001|Overall Study|Withdrawal by Subject|0|||
146433048|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433049|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145951080|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
145951081|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
145951082|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
146206064|NCT01170962|527268241|FG000|Treatment Period|Lack of Efficacy|96|||
146433050|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145951083|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
145951084|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
146206065|NCT01170962|527268242|FG001|Treatment Period|Lack of Efficacy|91|||
146206066|NCT01170962|527268243|FG002|Treatment Period|Lack of Efficacy|7|||
146206067|NCT01170962|527268241|FG000|Treatment Period|Adverse Event|11|||
146206068|NCT01170962|527268242|FG001|Treatment Period|Adverse Event|12|||
146206069|NCT01170962|527268243|FG002|Treatment Period|Adverse Event|3|||
146206070|NCT01170962|527268241|FG000|Treatment Period|Withdrawal by Subject|2|||
146206071|NCT01170962|527268242|FG001|Treatment Period|Withdrawal by Subject|1|||
146206072|NCT01170962|527268243|FG002|Treatment Period|Withdrawal by Subject|0|||
146206073|NCT01170962|527268241|FG000|Treatment Period|Lost to Follow-up|1|||
146206074|NCT01170962|527268242|FG001|Treatment Period|Lost to Follow-up|1|||
146206075|NCT01170962|527268243|FG002|Treatment Period|Lost to Follow-up|1|||
146206076|NCT01170962|527268241|FG000|Treatment Period|Participant no longer meets criteria|0|||
146206077|NCT01170962|527268242|FG001|Treatment Period|Participant no longer meets criteria|1|||
146206078|NCT01170962|527268243|FG002|Treatment Period|Participant no longer meets criteria|0|||
146206079|NCT01170962|527268241|FG000|Treatment Period|Request to discontinue treatment|7|||
146206080|NCT01170962|527268242|FG001|Treatment Period|Request to discontinue treatment|3|||
146206081|NCT01170962|527268243|FG002|Treatment Period|Request to discontinue treatment|1|||
146206082|NCT01170962|527268241|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
146206083|NCT01170962|527268242|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
146206084|NCT01170962|527268243|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
146206085|NCT01170962|527268241|FG000|Follow up Period|Withdrawal by Subject|14|||
146206086|NCT01170962|527268242|FG001|Follow up Period|Withdrawal by Subject|10|||
146206087|NCT01170962|527268243|FG002|Follow up Period|Withdrawal by Subject|2|||
146206088|NCT01170962|527268241|FG000|Follow up Period|Lost to Follow-up|13|||
146206089|NCT01170962|527268242|FG001|Follow up Period|Lost to Follow-up|8|||
146206090|NCT01170962|527268243|FG002|Follow up Period|Lost to Follow-up|1|||
146206091|NCT01170962|527268241|FG000|Follow up Period|Death|2|||
146206092|NCT01170962|527268242|FG001|Follow up Period|Death|2|||
146206093|NCT01170962|527268243|FG002|Follow up Period|Death|0|||
146206094|NCT01170962|527268241|FG000|Follow up Period|Others|10|||
146206095|NCT01170962|527268242|FG001|Follow up Period|Others|7|||
146206096|NCT01170962|527268243|FG002|Follow up Period|Others|3|||
146206097|NCT02918071|527268244|FG000|Overall Study|Withdrawal by Subject|2|||
146206098|NCT02918071|527268244|FG000|Overall Study|Lost to Follow-up|1|||
146206099|NCT01616459|527268245|FG000|Overall Study|Adverse Event|1|||
146206100|NCT01616459|527268246|FG001|Overall Study|Adverse Event|1|||
146206101|NCT01616459|527268247|FG002|Overall Study|Adverse Event|2|||
146206102|NCT01616459|527268248|FG003|Overall Study|Adverse Event|0|||
146206103|NCT01616459|527268245|FG000|Overall Study|Lost to Follow-up|1|||
146206104|NCT01616459|527268246|FG001|Overall Study|Lost to Follow-up|11|||
146206105|NCT01616459|527268247|FG002|Overall Study|Lost to Follow-up|3|||
146206106|NCT01616459|527268248|FG003|Overall Study|Lost to Follow-up|2|||
146206107|NCT01616459|527268245|FG000|Overall Study|Protocol Violation|0|||
146206108|NCT01616459|527268246|FG001|Overall Study|Protocol Violation|0|||
146206109|NCT01616459|527268247|FG002|Overall Study|Protocol Violation|0|||
146206110|NCT01616459|527268248|FG003|Overall Study|Protocol Violation|2|||
146206111|NCT01616459|527268245|FG000|Overall Study|Withdrawal by Subject|2|||
146206112|NCT01616459|527268246|FG001|Overall Study|Withdrawal by Subject|4|||
146206113|NCT01616459|527268247|FG002|Overall Study|Withdrawal by Subject|4|||
146206114|NCT01616459|527268248|FG003|Overall Study|Withdrawal by Subject|4|||
146206115|NCT01616459|527268245|FG000|Overall Study|Other reason|0|||
146206116|NCT01616459|527268246|FG001|Overall Study|Other reason|1|||
146206117|NCT01616459|527268247|FG002|Overall Study|Other reason|1|||
146206118|NCT01616459|527268248|FG003|Overall Study|Other reason|0|||
146206119|NCT03394885|527268249|FG000|Overall Study|Adverse Event|4|||
146206120|NCT03394885|527268249|FG000|Overall Study|Lack of Efficacy|1|||
146206121|NCT03394885|527268249|FG000|Overall Study|Physician Decision|1|||
146206122|NCT03394885|527268249|FG000|Overall Study|Withdrawal by Subject|8|||
146206123|NCT03394885|527268249|FG000|Overall Study|Alternative Therapy|1|||
146206124|NCT00801983|527268250|FG000|Period 1|Lost to Follow-up|2|||
146206125|NCT00801983|527268251|FG001|Period 1|Lost to Follow-up|0|||
146206126|NCT00801983|527268250|FG000|Period 1|Withdrawal by Subject|2|||
146206127|NCT00801983|527268251|FG001|Period 1|Withdrawal by Subject|8|||
146206128|NCT00801983|527268250|FG000|Period 2|Withdrawal by Subject|2|||
146206129|NCT00801983|527268251|FG001|Period 2|Withdrawal by Subject|1|||
146206130|NCT04688450|527270139|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
146206131|NCT04688450|527270139|FG000|Overall Study|Withdrawal by Subject|1|||
146206132|NCT02544074|527270140|FG000|Overall Study|Withdrawal by Subject|0|||
146206133|NCT02544074|527270141|FG001|Overall Study|Withdrawal by Subject|1|||
146206134|NCT02544074|527270142|FG002|Overall Study|Withdrawal by Subject|0|||
146433051|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146206135|NCT02544074|527270143|FG003|Overall Study|Withdrawal by Subject|0|||
146206136|NCT02544074|527270144|FG004|Overall Study|Withdrawal by Subject|0|||
146206137|NCT02544074|527270145|FG005|Overall Study|Withdrawal by Subject|0|||
146206138|NCT02544074|527270146|FG006|Overall Study|Withdrawal by Subject|0|||
146206139|NCT02544074|527270147|FG007|Overall Study|Withdrawal by Subject|0|||
146206140|NCT02544074|527270148|FG008|Overall Study|Withdrawal by Subject|0|||
146206141|NCT02544074|527270149|FG009|Overall Study|Withdrawal by Subject|0|||
146206142|NCT02544074|527270150|FG010|Overall Study|Withdrawal by Subject|0|||
146206143|NCT02544074|527270151|FG011|Overall Study|Withdrawal by Subject|0|||
146206144|NCT02544074|527270152|FG012|Overall Study|Withdrawal by Subject|0|||
146206145|NCT02544074|527270153|FG013|Overall Study|Withdrawal by Subject|0|||
146206146|NCT02544074|527270154|FG014|Overall Study|Withdrawal by Subject|0|||
146206147|NCT02544074|527270155|FG015|Overall Study|Withdrawal by Subject|0|||
146206148|NCT02544074|527270156|FG016|Overall Study|Withdrawal by Subject|0|||
146206149|NCT02544074|527270157|FG017|Overall Study|Withdrawal by Subject|0|||
146206150|NCT02544074|527270158|FG018|Overall Study|Withdrawal by Subject|0|||
146206151|NCT02544074|527270159|FG019|Overall Study|Withdrawal by Subject|0|||
146206152|NCT02544074|527270160|FG020|Overall Study|Withdrawal by Subject|0|||
146206153|NCT02544074|527270140|FG000|Overall Study|Tablet error|0|||
146206154|NCT02544074|527270141|FG001|Overall Study|Tablet error|0|||
146206155|NCT02544074|527270142|FG002|Overall Study|Tablet error|0|||
146206156|NCT02544074|527270143|FG003|Overall Study|Tablet error|0|||
146206157|NCT02544074|527270144|FG004|Overall Study|Tablet error|0|||
146206158|NCT02544074|527270145|FG005|Overall Study|Tablet error|1|||
146206159|NCT02544074|527270146|FG006|Overall Study|Tablet error|0|||
146206160|NCT02544074|527270147|FG007|Overall Study|Tablet error|0|||
146206161|NCT02544074|527270148|FG008|Overall Study|Tablet error|0|||
146206162|NCT02544074|527270149|FG009|Overall Study|Tablet error|1|||
146206163|NCT02544074|527270150|FG010|Overall Study|Tablet error|0|||
146206164|NCT02544074|527270151|FG011|Overall Study|Tablet error|0|||
146206165|NCT02544074|527270152|FG012|Overall Study|Tablet error|0|||
146206166|NCT02544074|527270153|FG013|Overall Study|Tablet error|0|||
146206167|NCT02544074|527270154|FG014|Overall Study|Tablet error|0|||
146206168|NCT02544074|527270155|FG015|Overall Study|Tablet error|0|||
146206169|NCT02544074|527270156|FG016|Overall Study|Tablet error|0|||
146206170|NCT02544074|527270157|FG017|Overall Study|Tablet error|0|||
146206171|NCT02544074|527270158|FG018|Overall Study|Tablet error|0|||
146206172|NCT02544074|527270159|FG019|Overall Study|Tablet error|0|||
146206173|NCT02544074|527270160|FG020|Overall Study|Tablet error|0|||
146206174|NCT03189524|527270162|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
146206175|NCT03189524|527270163|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
146206176|NCT03189524|527270164|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
146206177|NCT03189524|527270162|FG000|Overall Study|Death|2|||
146206178|NCT03189524|527270163|FG001|Overall Study|Death|2|||
146206179|NCT03189524|527270164|FG002|Overall Study|Death|1|||
146206180|NCT03189524|527270162|FG000|Overall Study|Lost to Follow-up|1|||
146206181|NCT03189524|527270163|FG001|Overall Study|Lost to Follow-up|0|||
146206182|NCT03189524|527270164|FG002|Overall Study|Lost to Follow-up|8|||
146206183|NCT03189524|527270162|FG000|Overall Study|Withdrawal by Subject|1|||
146206184|NCT03189524|527270163|FG001|Overall Study|Withdrawal by Subject|1|||
146206185|NCT03189524|527270164|FG002|Overall Study|Withdrawal by Subject|3|||
146206186|NCT03189524|527270162|FG000|Overall Study|Progressive Disease|0|||
146206187|NCT03189524|527270163|FG001|Overall Study|Progressive Disease|2|||
146206188|NCT03189524|527270164|FG002|Overall Study|Progressive Disease|0|||
146206189|NCT01780298|527270166|FG000|Overall Study|Physician Decision|1|||
146206190|NCT01780298|527270167|FG001|Overall Study|Physician Decision|5|||
146206191|NCT01780298|527270168|FG002|Overall Study|Physician Decision|1|||
146206192|NCT01780298|527270169|FG003|Overall Study|Physician Decision|1|||
146206193|NCT01780298|527270166|FG000|Overall Study|Subject not matched|1|||
146206194|NCT01780298|527270167|FG001|Overall Study|Subject not matched|0|||
146206195|NCT01780298|527270168|FG002|Overall Study|Subject not matched|1|||
146206196|NCT01780298|527270169|FG003|Overall Study|Subject not matched|0|||
146206197|NCT01780298|527270166|FG000|Overall Study|Adverse Event|0|||
146433052|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433053|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433054|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
146433055|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433056|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433057|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433058|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146206198|NCT01780298|527270167|FG001|Overall Study|Adverse Event|0|||
146206199|NCT01780298|527270168|FG002|Overall Study|Adverse Event|2|||
146206200|NCT01780298|527270169|FG003|Overall Study|Adverse Event|0|||
146206201|NCT03873779|527270170|FG000|Overall Study|Withdrawal by Subject|1|||
146206202|NCT02566902|527270174|FG000|Overall Study|Protocol Violation|2|||
146206203|NCT02566902|527270175|FG001|Overall Study|Protocol Violation|1|||
146206204|NCT04425629|527270180|FG000|Overall Study|Adverse Event|0|||
146206205|NCT04425629|527270181|FG001|Overall Study|Adverse Event|0|||
146206206|NCT04425629|527270182|FG002|Overall Study|Adverse Event|0|||
146206207|NCT04425629|527270183|FG003|Overall Study|Adverse Event|0|||
146206208|NCT04425629|527270184|FG004|Overall Study|Adverse Event|1|||
146206209|NCT04425629|527270185|FG005|Overall Study|Adverse Event|0|||
145951085|NCT00424593|526332169|FG000|Dose-Blind Extension Period|Physician Decision|3|||
145951086|NCT00424593|526332170|FG001|Dose-Blind Extension Period|Physician Decision|0|||
145951087|NCT02985021|526332171|FG000|Overall Study|Inability to comply with study procedures|1|||
145951088|NCT03297021|526332172|FG000|Overall Study|Incomplete/illegible data sheet|4|||
145951089|NCT03297021|526332173|FG001|Overall Study|Incomplete/illegible data sheet|2|||
145951090|NCT03297021|526332174|FG002|Overall Study|Incomplete/illegible data sheet|3|||
145951091|NCT03297021|526332172|FG000|Overall Study|Missing Post-Op Data|1|||
145951092|NCT03297021|526332173|FG001|Overall Study|Missing Post-Op Data|2|||
145951093|NCT03297021|526332174|FG002|Overall Study|Missing Post-Op Data|1|||
145951094|NCT02734862|526332176|FG000|Part A|Death|3|||
145951095|NCT02734862|526332177|FG001|Part A|Death|4|||
145951096|NCT02734862|526332178|FG002|Part A|Death|6|||
145951097|NCT02734862|526332176|FG000|Part A|Lost to Follow-up|2|||
145951098|NCT02734862|526332177|FG001|Part A|Lost to Follow-up|1|||
145951099|NCT02734862|526332178|FG002|Part A|Lost to Follow-up|1|||
145951100|NCT02734862|526332176|FG000|Part A|Withdrawal by Subject|1|||
145951101|NCT02734862|526332177|FG001|Part A|Withdrawal by Subject|1|||
145951102|NCT02734862|526332178|FG002|Part A|Withdrawal by Subject|2|||
145951103|NCT02734862|526332176|FG000|Part A|Physician Decision|2|||
145951104|NCT02734862|526332177|FG001|Part A|Physician Decision|0|||
145951105|NCT02734862|526332178|FG002|Part A|Physician Decision|1|||
145951106|NCT02734862|526332176|FG000|Part A|Adverse Event|2|||
145951107|NCT02734862|526332177|FG001|Part A|Adverse Event|0|||
145951108|NCT02734862|526332178|FG002|Part A|Adverse Event|1|||
146206210|NCT04425629|527270186|FG006|Overall Study|Adverse Event|0|||
146433059|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
146433060|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
146433061|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
146433062|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
146433063|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
146433064|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
146433065|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
146433066|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
146433067|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
146433068|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433069|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433070|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145951109|NCT02734862|526332176|FG000|Part A|Noncompliance|1|||
145951110|NCT02734862|526332177|FG001|Part A|Noncompliance|1|||
145951111|NCT02734862|526332178|FG002|Part A|Noncompliance|0|||
146082905|NCT03039621|526824699|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
146082906|NCT03039621|526824698|FG000|Overall Study|Violation of non-inclusion criteria|1|||
146082907|NCT03039621|526824699|FG001|Overall Study|Violation of non-inclusion criteria|2|||
146082908|NCT00603590|526824703|FG000|Overall Study|Did not attend study clinic|39|||
146082909|NCT00603590|526824704|FG001|Overall Study|Did not attend study clinic|30|||
146206211|NCT04425629|527270187|FG007|Overall Study|Adverse Event|0|||
146206212|NCT04425629|527270188|FG008|Overall Study|Adverse Event|0|||
146433071|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433072|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433073|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145951112|NCT02734862|526332176|FG000|Part A|Other|1|||
145951113|NCT02734862|526332177|FG001|Part A|Other|1|||
145951114|NCT02734862|526332178|FG002|Part A|Other|3|||
145951115|NCT02734862|526332176|FG000|Part B|Death|8|||
145951116|NCT02734862|526332177|FG001|Part B|Death|3|||
146082910|NCT00603590|526824703|FG000|Overall Study|Refused blood test|5|||
146082911|NCT00603590|526824704|FG001|Overall Study|Refused blood test|1|||
146082912|NCT00603590|526824703|FG000|Overall Study|Patient discontinued study drug|22|||
146082913|NCT00603590|526824704|FG001|Overall Study|Patient discontinued study drug|15|||
146082914|NCT00603590|526824703|FG000|Overall Study|Adverse Event|2|||
146082915|NCT00603590|526824704|FG001|Overall Study|Adverse Event|0|||
146082916|NCT00603590|526824703|FG000|Overall Study|Lost to Follow-up|8|||
146082917|NCT00603590|526824704|FG001|Overall Study|Lost to Follow-up|4|||
146082918|NCT00603590|526824703|FG000|Overall Study|Cardiovascular event|0|||
146082919|NCT00603590|526824704|FG001|Overall Study|Cardiovascular event|1|||
146082920|NCT05338671|526824705|FG000|Overall Study|Lost to Follow-up|2|||
146082921|NCT05338671|526824706|FG001|Overall Study|Lost to Follow-up|2|||
146082922|NCT05338671|526824705|FG000|Overall Study|Root canal completed in a single visit|1|||
146082923|NCT05338671|526824706|FG001|Overall Study|Root canal completed in a single visit|0|||
146082924|NCT03085914|526824709|FG000|Overall Study|Death|6|||
146082925|NCT03085914|526824710|FG001|Overall Study|Death|6|||
146082926|NCT03085914|526824711|FG002|Overall Study|Death|4|||
146082927|NCT03085914|526824712|FG003|Overall Study|Death|1|||
146082928|NCT03085914|526824713|FG004|Overall Study|Death|5|||
146433074|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433075|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
146433076|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433077|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433078|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433079|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433080|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
146433081|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
146433082|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
146433083|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433084|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
146433085|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
146433086|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
146433087|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
146433088|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
146082929|NCT03085914|526824714|FG005|Overall Study|Death|2|||
146082930|NCT03085914|526824715|FG006|Overall Study|Death|2|||
146082931|NCT03085914|526824709|FG000|Overall Study|Withdrawal by Subject|1|||
146082932|NCT03085914|526824710|FG001|Overall Study|Withdrawal by Subject|1|||
146082933|NCT03085914|526824711|FG002|Overall Study|Withdrawal by Subject|2|||
146206213|NCT04425629|527270189|FG009|Overall Study|Adverse Event|3|||
146206214|NCT04425629|527270190|FG010|Overall Study|Adverse Event|2|||
146206215|NCT04425629|527270191|FG011|Overall Study|Adverse Event|1|||
146206216|NCT04425629|527270192|FG012|Overall Study|Adverse Event|1|||
146206217|NCT04425629|527270193|FG013|Overall Study|Adverse Event|0|||
146206218|NCT04425629|527270194|FG014|Overall Study|Adverse Event|0|||
146206219|NCT04425629|527270195|FG015|Overall Study|Adverse Event|0|||
146206220|NCT04425629|527270196|FG016|Overall Study|Adverse Event|0|||
146206221|NCT04425629|527270197|FG017|Overall Study|Adverse Event|0|||
146206222|NCT04425629|527270198|FG018|Overall Study|Adverse Event|0|||
146206223|NCT04425629|527270180|FG000|Overall Study|Lost to Follow-up|1|||
146206224|NCT04425629|527270181|FG001|Overall Study|Lost to Follow-up|3|||
146206225|NCT04425629|527270182|FG002|Overall Study|Lost to Follow-up|1|||
146206226|NCT04425629|527270183|FG003|Overall Study|Lost to Follow-up|7|||
146206227|NCT04425629|527270184|FG004|Overall Study|Lost to Follow-up|1|||
146206228|NCT04425629|527270185|FG005|Overall Study|Lost to Follow-up|2|||
146206229|NCT04425629|527270186|FG006|Overall Study|Lost to Follow-up|1|||
146206230|NCT04425629|527270187|FG007|Overall Study|Lost to Follow-up|0|||
146206231|NCT04425629|527270188|FG008|Overall Study|Lost to Follow-up|1|||
146433089|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433090|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433091|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433092|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433093|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146206232|NCT04425629|527270189|FG009|Overall Study|Lost to Follow-up|64|||
146206233|NCT04425629|527270190|FG010|Overall Study|Lost to Follow-up|70|||
146206234|NCT04425629|527270191|FG011|Overall Study|Lost to Follow-up|98|||
146206235|NCT04425629|527270192|FG012|Overall Study|Lost to Follow-up|30|||
146206236|NCT04425629|527270193|FG013|Overall Study|Lost to Follow-up|0|||
146206237|NCT04425629|527270194|FG014|Overall Study|Lost to Follow-up|5|||
146206238|NCT04425629|527270195|FG015|Overall Study|Lost to Follow-up|4|||
146206239|NCT04425629|527270196|FG016|Overall Study|Lost to Follow-up|0|||
146206240|NCT04425629|527270197|FG017|Overall Study|Lost to Follow-up|3|||
146206241|NCT04425629|527270198|FG018|Overall Study|Lost to Follow-up|1|||
146206242|NCT04425629|527270180|FG000|Overall Study|Subject Decision|0|||
146206243|NCT04425629|527270181|FG001|Overall Study|Subject Decision|2|||
146206244|NCT04425629|527270182|FG002|Overall Study|Subject Decision|1|||
146206245|NCT04425629|527270183|FG003|Overall Study|Subject Decision|3|||
146206246|NCT04425629|527270184|FG004|Overall Study|Subject Decision|6|||
146206247|NCT04425629|527270185|FG005|Overall Study|Subject Decision|6|||
146206248|NCT04425629|527270186|FG006|Overall Study|Subject Decision|3|||
146206249|NCT04425629|527270187|FG007|Overall Study|Subject Decision|3|||
146206250|NCT04425629|527270188|FG008|Overall Study|Subject Decision|1|||
146206251|NCT04425629|527270189|FG009|Overall Study|Subject Decision|70|||
146206252|NCT04425629|527270190|FG010|Overall Study|Subject Decision|95|||
146206253|NCT04425629|527270191|FG011|Overall Study|Subject Decision|124|||
146206254|NCT04425629|527270192|FG012|Overall Study|Subject Decision|25|||
146206255|NCT04425629|527270193|FG013|Overall Study|Subject Decision|0|||
146206256|NCT04425629|527270194|FG014|Overall Study|Subject Decision|1|||
146206257|NCT04425629|527270195|FG015|Overall Study|Subject Decision|4|||
146206258|NCT04425629|527270196|FG016|Overall Study|Subject Decision|1|||
146206259|NCT04425629|527270197|FG017|Overall Study|Subject Decision|0|||
146206260|NCT04425629|527270198|FG018|Overall Study|Subject Decision|2|||
146206261|NCT04425629|527270180|FG000|Overall Study|Death|0|||
146206262|NCT04425629|527270181|FG001|Overall Study|Death|0|||
146206263|NCT04425629|527270182|FG002|Overall Study|Death|0|||
146206264|NCT04425629|527270183|FG003|Overall Study|Death|0|||
146206265|NCT04425629|527270184|FG004|Overall Study|Death|0|||
146206266|NCT04425629|527270185|FG005|Overall Study|Death|0|||
146206267|NCT04425629|527270186|FG006|Overall Study|Death|0|||
146206268|NCT04425629|527270187|FG007|Overall Study|Death|0|||
146433094|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146433095|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
146206269|NCT04425629|527270188|FG008|Overall Study|Death|0|||
146206270|NCT04425629|527270189|FG009|Overall Study|Death|11|||
146206271|NCT04425629|527270190|FG010|Overall Study|Death|2|||
146206272|NCT04425629|527270191|FG011|Overall Study|Death|4|||
146433096|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145951117|NCT02734862|526332178|FG002|Part B|Death|5|||
146206273|NCT04425629|527270192|FG012|Overall Study|Death|0|||
146206274|NCT04425629|527270193|FG013|Overall Study|Death|0|||
146206275|NCT04425629|527270194|FG014|Overall Study|Death|0|||
146433097|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146206276|NCT04425629|527270195|FG015|Overall Study|Death|0|||
146206277|NCT04425629|527270196|FG016|Overall Study|Death|0|||
146206278|NCT04425629|527270197|FG017|Overall Study|Death|0|||
145951118|NCT02734862|526332176|FG000|Part B|Lost to Follow-up|2|||
146206279|NCT04425629|527270198|FG018|Overall Study|Death|0|||
146206280|NCT04425629|527270180|FG000|Overall Study|Sponsor Request|0|||
146206281|NCT04425629|527270181|FG001|Overall Study|Sponsor Request|0|||
146433098|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433099|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433100|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433101|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
145890966|NCT01207440|526107575|FG005|Overall Study|Site Terminated by Sponsor|0|||
145890967|NCT01207440|526107576|FG006|Overall Study|Site Terminated by Sponsor|2|||
145890968|NCT01207440|526107570|FG000|Overall Study|Withdrawal by Subject|29|||
145890969|NCT01207440|526107571|FG001|Overall Study|Withdrawal by Subject|4|||
145890970|NCT01207440|526107572|FG002|Overall Study|Withdrawal by Subject|5|||
145951119|NCT02734862|526332177|FG001|Part B|Lost to Follow-up|2|||
145951120|NCT02734862|526332178|FG002|Part B|Lost to Follow-up|0|||
145951121|NCT02734862|526332176|FG000|Part B|Withdrawal by Subject|3|||
145951122|NCT02734862|526332177|FG001|Part B|Withdrawal by Subject|1|||
145951123|NCT02734862|526332178|FG002|Part B|Withdrawal by Subject|0|||
145951124|NCT02734862|526332176|FG000|Part B|Other|0|||
145951125|NCT02734862|526332177|FG001|Part B|Other|1|||
145951126|NCT02734862|526332178|FG002|Part B|Other|0|||
145951127|NCT04854057|526332179|FG000|Overall Study|Adverse Event|0|||
145951128|NCT04854057|526332180|FG001|Overall Study|Adverse Event|1|||
145951129|NCT01951573|526332183|FG000|Washout Period|Adverse Event|0|||
145951130|NCT01951573|526332184|FG001|Washout Period|Adverse Event|1|||
145951131|NCT01005901|526332203|FG000|Overall Study|Withdrawal by Subject|38|||
145951132|NCT01005901|526332204|FG001|Overall Study|Withdrawal by Subject|14|||
145951133|NCT01005901|526332203|FG000|Overall Study|Adverse Event|30|||
145951134|NCT01005901|526332204|FG001|Overall Study|Adverse Event|16|||
145951135|NCT01005901|526332203|FG000|Overall Study|Administrative problems|21|||
145951136|NCT01005901|526332204|FG001|Overall Study|Administrative problems|13|||
145951137|NCT01005901|526332203|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145951138|NCT01005901|526332204|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
145951139|NCT01005901|526332203|FG000|Overall Study|Protocol Violation|4|||
145951140|NCT01005901|526332204|FG001|Overall Study|Protocol Violation|3|||
145951141|NCT01005901|526332203|FG000|Overall Study|Death|2|||
145951142|NCT01005901|526332204|FG001|Overall Study|Death|3|||
145951143|NCT01005901|526332203|FG000|Overall Study|Lost to Follow-up|1|||
145951144|NCT01005901|526332204|FG001|Overall Study|Lost to Follow-up|2|||
145951145|NCT01005901|526332203|FG000|Overall Study|Patient's inability to use the device|1|||
145951146|NCT01005901|526332204|FG001|Overall Study|Patient's inability to use the device|1|||
145951147|NCT01005901|526332203|FG000|Overall Study|No longer requires study drug|0|||
145951148|NCT01005901|526332204|FG001|Overall Study|No longer requires study drug|1|||
145951149|NCT00760487|526332205|FG000|Overall Study|Unilateral implantation|3|||
145951150|NCT02087943|526332211|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
145951151|NCT02087943|526332212|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
145951152|NCT02087943|526332213|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
145951153|NCT02087943|526332214|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
145951154|NCT02087943|526332215|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
145951155|NCT02087943|526332211|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
145951156|NCT02087943|526332212|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
145951157|NCT02087943|526332213|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
145951158|NCT02087943|526332214|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
145951159|NCT02087943|526332215|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
145951160|NCT02087943|526332211|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
145951161|NCT02087943|526332212|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
145951162|NCT02087943|526332213|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
145951163|NCT02087943|526332214|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
145951164|NCT02087943|526332215|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
145951165|NCT02087943|526332211|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
145951166|NCT02087943|526332212|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145951167|NCT02087943|526332213|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
145951168|NCT02087943|526332214|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145951169|NCT02087943|526332215|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145951170|NCT02087943|526332211|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145951171|NCT02087943|526332212|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
145951172|NCT02087943|526332213|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145951173|NCT02087943|526332214|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145951174|NCT02087943|526332215|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145951175|NCT02087943|526332211|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
145951176|NCT02087943|526332212|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
145951177|NCT02087943|526332213|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
145951178|NCT02087943|526332214|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
145951179|NCT02087943|526332215|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
145951180|NCT02087943|526332211|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
146206282|NCT04425629|527270182|FG002|Overall Study|Sponsor Request|0|||
146206283|NCT04425629|527270183|FG003|Overall Study|Sponsor Request|2|||
145951181|NCT02087943|526332212|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
145951182|NCT02087943|526332213|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
145951183|NCT02087943|526332214|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
145951184|NCT02087943|526332215|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
145951185|NCT02087943|526332211|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145951186|NCT02087943|526332212|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145951187|NCT02087943|526332213|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
146206284|NCT04425629|527270184|FG004|Overall Study|Sponsor Request|2|||
146206285|NCT04425629|527270185|FG005|Overall Study|Sponsor Request|2|||
146206286|NCT04425629|527270186|FG006|Overall Study|Sponsor Request|1|||
146206287|NCT04425629|527270187|FG007|Overall Study|Sponsor Request|0|||
146206288|NCT04425629|527270188|FG008|Overall Study|Sponsor Request|0|||
146206289|NCT04425629|527270189|FG009|Overall Study|Sponsor Request|9|||
146206290|NCT04425629|527270190|FG010|Overall Study|Sponsor Request|9|||
146206291|NCT04425629|527270191|FG011|Overall Study|Sponsor Request|10|||
146206292|NCT04425629|527270192|FG012|Overall Study|Sponsor Request|8|||
146206293|NCT04425629|527270193|FG013|Overall Study|Sponsor Request|0|||
146206294|NCT04425629|527270194|FG014|Overall Study|Sponsor Request|0|||
146206295|NCT04425629|527270195|FG015|Overall Study|Sponsor Request|1|||
146206296|NCT04425629|527270196|FG016|Overall Study|Sponsor Request|0|||
146206297|NCT04425629|527270197|FG017|Overall Study|Sponsor Request|0|||
146206298|NCT04425629|527270198|FG018|Overall Study|Sponsor Request|0|||
146206299|NCT04425629|527270180|FG000|Overall Study|Physician Decision|0|||
146206300|NCT04425629|527270181|FG001|Overall Study|Physician Decision|0|||
146206301|NCT04425629|527270182|FG002|Overall Study|Physician Decision|0|||
146206302|NCT04425629|527270183|FG003|Overall Study|Physician Decision|0|||
146206303|NCT04425629|527270184|FG004|Overall Study|Physician Decision|0|||
146206304|NCT04425629|527270185|FG005|Overall Study|Physician Decision|0|||
146206305|NCT04425629|527270186|FG006|Overall Study|Physician Decision|0|||
146206306|NCT04425629|527270187|FG007|Overall Study|Physician Decision|0|||
146206307|NCT04425629|527270188|FG008|Overall Study|Physician Decision|0|||
146206308|NCT04425629|527270189|FG009|Overall Study|Physician Decision|4|||
146206309|NCT04425629|527270190|FG010|Overall Study|Physician Decision|3|||
146206310|NCT04425629|527270191|FG011|Overall Study|Physician Decision|5|||
146206311|NCT04425629|527270192|FG012|Overall Study|Physician Decision|1|||
146206312|NCT04425629|527270193|FG013|Overall Study|Physician Decision|0|||
146206313|NCT04425629|527270194|FG014|Overall Study|Physician Decision|0|||
146206314|NCT04425629|527270195|FG015|Overall Study|Physician Decision|1|||
146206315|NCT04425629|527270196|FG016|Overall Study|Physician Decision|0|||
146206316|NCT04425629|527270197|FG017|Overall Study|Physician Decision|0|||
146206317|NCT04425629|527270198|FG018|Overall Study|Physician Decision|0|||
146206318|NCT04425629|527270180|FG000|Overall Study|Lack of Efficacy|0|||
146433102|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433103|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433104|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433105|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
146433106|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
146433107|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
146433108|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433109|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
146433110|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433111|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433112|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433113|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433114|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433115|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433116|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433117|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
146433118|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433119|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433120|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433121|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433122|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
146433123|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
146433124|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
146433125|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433126|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
146082934|NCT03085914|526824712|FG003|Overall Study|Withdrawal by Subject|2|||
146433127|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
146082935|NCT03085914|526824713|FG004|Overall Study|Withdrawal by Subject|2|||
146082936|NCT03085914|526824714|FG005|Overall Study|Withdrawal by Subject|0|||
146082937|NCT03085914|526824715|FG006|Overall Study|Withdrawal by Subject|1|||
146206319|NCT04425629|527270181|FG001|Overall Study|Lack of Efficacy|0|||
146206320|NCT04425629|527270182|FG002|Overall Study|Lack of Efficacy|0|||
146206321|NCT04425629|527270183|FG003|Overall Study|Lack of Efficacy|0|||
146206322|NCT04425629|527270184|FG004|Overall Study|Lack of Efficacy|0|||
146206323|NCT04425629|527270185|FG005|Overall Study|Lack of Efficacy|0|||
146206324|NCT04425629|527270186|FG006|Overall Study|Lack of Efficacy|0|||
146206325|NCT04425629|527270187|FG007|Overall Study|Lack of Efficacy|0|||
146206326|NCT04425629|527270188|FG008|Overall Study|Lack of Efficacy|0|||
146206327|NCT04425629|527270189|FG009|Overall Study|Lack of Efficacy|0|||
146206328|NCT04425629|527270190|FG010|Overall Study|Lack of Efficacy|1|||
146206329|NCT04425629|527270191|FG011|Overall Study|Lack of Efficacy|0|||
146206330|NCT04425629|527270192|FG012|Overall Study|Lack of Efficacy|0|||
146206331|NCT04425629|527270193|FG013|Overall Study|Lack of Efficacy|0|||
146206332|NCT04425629|527270194|FG014|Overall Study|Lack of Efficacy|0|||
146206333|NCT04425629|527270195|FG015|Overall Study|Lack of Efficacy|0|||
146206334|NCT04425629|527270196|FG016|Overall Study|Lack of Efficacy|0|||
146206335|NCT04425629|527270197|FG017|Overall Study|Lack of Efficacy|0|||
146206336|NCT04425629|527270198|FG018|Overall Study|Lack of Efficacy|0|||
146206337|NCT00610649|527270199|FG000|Overall Study|Adverse Event|1|||
146206338|NCT00610649|527270200|FG001|Overall Study|Adverse Event|0|||
146206339|NCT00610649|527270201|FG002|Overall Study|Adverse Event|0|||
146206340|NCT00610649|527270202|FG003|Overall Study|Adverse Event|0|||
146206341|NCT00610649|527270203|FG004|Overall Study|Adverse Event|0|||
146206342|NCT00610649|527270204|FG005|Overall Study|Adverse Event|0|||
146206343|NCT00610649|527270205|FG006|Overall Study|Adverse Event|0|||
146206344|NCT00610649|527270206|FG007|Overall Study|Adverse Event|0|||
146206345|NCT00610649|527270207|FG008|Overall Study|Adverse Event|0|||
146206346|NCT00610649|527270208|FG009|Overall Study|Adverse Event|0|||
146206347|NCT00610649|527270209|FG010|Overall Study|Adverse Event|1|||
146206348|NCT00610649|527270199|FG000|Overall Study|Family Emergency|0|||
146206349|NCT00610649|527270200|FG001|Overall Study|Family Emergency|1|||
146206350|NCT00610649|527270201|FG002|Overall Study|Family Emergency|0|||
146206351|NCT00610649|527270202|FG003|Overall Study|Family Emergency|0|||
146206352|NCT00610649|527270203|FG004|Overall Study|Family Emergency|0|||
146206353|NCT00610649|527270204|FG005|Overall Study|Family Emergency|0|||
146206354|NCT00610649|527270205|FG006|Overall Study|Family Emergency|0|||
146206355|NCT00610649|527270206|FG007|Overall Study|Family Emergency|0|||
146206356|NCT00610649|527270207|FG008|Overall Study|Family Emergency|0|||
146206357|NCT00610649|527270208|FG009|Overall Study|Family Emergency|0|||
146206358|NCT00610649|527270209|FG010|Overall Study|Family Emergency|0|||
146206359|NCT00610649|527270199|FG000|Overall Study|Withdrawal by Subject|0|||
146206360|NCT00610649|527270200|FG001|Overall Study|Withdrawal by Subject|0|||
146206361|NCT00610649|527270201|FG002|Overall Study|Withdrawal by Subject|0|||
146206362|NCT00610649|527270202|FG003|Overall Study|Withdrawal by Subject|0|||
146206363|NCT00610649|527270203|FG004|Overall Study|Withdrawal by Subject|0|||
146206364|NCT00610649|527270204|FG005|Overall Study|Withdrawal by Subject|0|||
146206365|NCT00610649|527270205|FG006|Overall Study|Withdrawal by Subject|0|||
146206366|NCT00610649|527270206|FG007|Overall Study|Withdrawal by Subject|0|||
146206367|NCT00610649|527270207|FG008|Overall Study|Withdrawal by Subject|0|||
146206368|NCT00610649|527270208|FG009|Overall Study|Withdrawal by Subject|1|||
146082938|NCT03085914|526824709|FG000|Overall Study|Lost to Follow-up|0|||
146206369|NCT00610649|527270209|FG010|Overall Study|Withdrawal by Subject|0|||
146206370|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Death|186|||
146206371|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Death|222|||
146206372|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Death|0|||
146206373|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
146206374|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
146206375|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
146206376|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
146206377|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
146206378|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
146206379|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
146206380|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
146206381|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
146206382|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Adverse Event|83|||
146206383|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Adverse Event|100|||
146206384|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Adverse Event|0|||
146206385|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Other|70|||
146206386|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Other|75|||
146206387|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Other|0|||
146206388|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
146206389|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
146206390|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
146206391|NCT00232180|527270210|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
146206392|NCT00232180|527270211|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
146206393|NCT00232180|527270212|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
146206394|NCT00232180|527270210|FG000|Open Label Phase|Death|0|||
146206395|NCT00232180|527270211|FG001|Open Label Phase|Death|0|||
146206396|NCT00232180|527270212|FG002|Open Label Phase|Death|48|||
146206397|NCT00232180|527270210|FG000|Open Label Phase|Lost to Follow-up|0|||
146206398|NCT00232180|527270211|FG001|Open Label Phase|Lost to Follow-up|0|||
146206399|NCT00232180|527270212|FG002|Open Label Phase|Lost to Follow-up|5|||
146206400|NCT00232180|527270210|FG000|Open Label Phase|Protocol Violation|0|||
146206401|NCT00232180|527270211|FG001|Open Label Phase|Protocol Violation|0|||
146206402|NCT00232180|527270212|FG002|Open Label Phase|Protocol Violation|3|||
146206403|NCT00232180|527270210|FG000|Open Label Phase|Study terminated by sponsor|0|||
146206404|NCT00232180|527270211|FG001|Open Label Phase|Study terminated by sponsor|0|||
146206405|NCT00232180|527270212|FG002|Open Label Phase|Study terminated by sponsor|3|||
146206406|NCT00232180|527270210|FG000|Open Label Phase|Withdrawal by Subject|0|||
146206407|NCT00232180|527270211|FG001|Open Label Phase|Withdrawal by Subject|0|||
146206408|NCT00232180|527270212|FG002|Open Label Phase|Withdrawal by Subject|37|||
146206409|NCT00232180|527270210|FG000|Open Label Phase|Other|0|||
146206410|NCT00232180|527270211|FG001|Open Label Phase|Other|0|||
146206411|NCT00232180|527270212|FG002|Open Label Phase|Other|16|||
146206412|NCT00232180|527270210|FG000|Open Label Phase|Adverse Event|0|||
146206413|NCT00232180|527270211|FG001|Open Label Phase|Adverse Event|0|||
146206414|NCT00232180|527270212|FG002|Open Label Phase|Adverse Event|25|||
146206415|NCT00232180|527270210|FG000|Open Label Phase|Laboratory abnormality|0|||
146206416|NCT00232180|527270211|FG001|Open Label Phase|Laboratory abnormality|0|||
146433128|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
146433129|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
146433130|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
146433131|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146206417|NCT00232180|527270212|FG002|Open Label Phase|Laboratory abnormality|10|||
146433132|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146206418|NCT00232180|527270210|FG000|Open Label Phase|Randomized but not treated|0|||
146433133|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433134|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146206419|NCT00232180|527270211|FG001|Open Label Phase|Randomized but not treated|0|||
146206420|NCT00232180|527270212|FG002|Open Label Phase|Randomized but not treated|1|||
146206421|NCT02748317|527270213|FG000|Overall Study|Withdrawal by Subject|14|||
146206422|NCT02748317|527270213|FG000|Overall Study|Lost to Follow-up|8|||
146206423|NCT02748317|527270213|FG000|Overall Study|Death|1|||
146206424|NCT00414544|527270214|FG000|Overall Study|Lost to Follow-up|14|||
146206425|NCT04259450|527270215|FG000|Overall Study|Adverse event/ Toxicity|0|||
146206426|NCT04259450|527270216|FG001|Overall Study|Adverse event/ Toxicity|3|||
146206427|NCT04259450|527270217|FG002|Overall Study|Adverse event/ Toxicity|0|||
146206428|NCT04259450|527270218|FG003|Overall Study|Adverse event/ Toxicity|1|||
146433135|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433136|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433137|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433138|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
146433139|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433140|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433141|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433142|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433143|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433144|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
146433145|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433146|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433147|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
146433148|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
146433149|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
146433150|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
146433151|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433152|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433153|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433154|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433155|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433156|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433157|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433158|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433159|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
146433160|NCT01597245|528091837|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433161|NCT01597245|528091838|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433162|NCT01597245|528091839|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433163|NCT01597245|528091840|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433164|NCT01597245|528091841|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433165|NCT01597245|528091842|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433166|NCT01597245|528091843|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433167|NCT01597245|528091844|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433168|NCT01597245|528091845|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433169|NCT01597245|528091846|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433170|NCT01597245|528091847|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
146433171|NCT01597245|528091848|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433172|NCT01597245|528091849|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433173|NCT01597245|528091850|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433174|NCT01597245|528091851|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433175|NCT01597245|528091852|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433176|NCT01597245|528091853|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433177|NCT01597245|528091854|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433178|NCT01597245|528091855|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433179|NCT01597245|528091856|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433180|NCT01597245|528091857|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
146433181|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433182|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433183|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433184|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433185|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433186|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433187|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433188|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433189|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433190|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433191|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433192|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433193|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433194|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
146433195|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
146433196|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
146433197|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433198|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433199|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433200|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433201|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
146433202|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433203|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433204|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433205|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433206|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433207|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433208|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433209|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433210|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433211|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433212|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433213|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433214|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433215|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
146433216|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
146433217|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
146433218|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433219|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433220|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433221|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433222|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
146433223|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433224|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433225|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433226|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433227|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433228|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433229|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433230|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433231|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433232|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433233|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433234|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433235|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433236|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433237|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
146433238|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
146433239|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433240|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433241|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433242|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145951188|NCT02087943|526332214|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146433243|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
146433244|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433245|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433246|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433247|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433248|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433249|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433250|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433251|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433252|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433253|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433254|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433255|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146206429|NCT04259450|527270219|FG004|Overall Study|Adverse event/ Toxicity|0|||
146206430|NCT04259450|527270220|FG005|Overall Study|Adverse event/ Toxicity|0|||
146206431|NCT04259450|527270221|FG006|Overall Study|Adverse event/ Toxicity|0|||
146206432|NCT04259450|527270222|FG007|Overall Study|Adverse event/ Toxicity|1|||
146206433|NCT04259450|527270223|FG008|Overall Study|Adverse event/ Toxicity|0|||
146206434|NCT04259450|527270224|FG009|Overall Study|Adverse event/ Toxicity|3|||
146206435|NCT04259450|527270215|FG000|Overall Study|Disease progression|2|||
146206436|NCT04259450|527270216|FG001|Overall Study|Disease progression|3|||
146433256|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433257|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146206437|NCT04259450|527270217|FG002|Overall Study|Disease progression|4|||
146206438|NCT04259450|527270218|FG003|Overall Study|Disease progression|4|||
146206439|NCT04259450|527270219|FG004|Overall Study|Disease progression|6|||
146206440|NCT04259450|527270220|FG005|Overall Study|Disease progression|6|||
146206441|NCT04259450|527270221|FG006|Overall Study|Disease progression|6|||
146206442|NCT04259450|527270222|FG007|Overall Study|Disease progression|15|||
146206443|NCT04259450|527270223|FG008|Overall Study|Disease progression|6|||
146206444|NCT04259450|527270224|FG009|Overall Study|Disease progression|18|||
146206445|NCT04259450|527270215|FG000|Overall Study|Death|0|||
146206446|NCT04259450|527270216|FG001|Overall Study|Death|0|||
146206447|NCT04259450|527270217|FG002|Overall Study|Death|0|||
146206448|NCT04259450|527270218|FG003|Overall Study|Death|0|||
146206449|NCT04259450|527270219|FG004|Overall Study|Death|0|||
146206450|NCT04259450|527270220|FG005|Overall Study|Death|0|||
146206451|NCT04259450|527270221|FG006|Overall Study|Death|0|||
146206452|NCT04259450|527270222|FG007|Overall Study|Death|1|||
146206453|NCT04259450|527270223|FG008|Overall Study|Death|1|||
146206454|NCT04259450|527270224|FG009|Overall Study|Death|0|||
146206455|NCT04259450|527270215|FG000|Overall Study|Withdrawal by Subject|0|||
146206456|NCT04259450|527270216|FG001|Overall Study|Withdrawal by Subject|0|||
146206457|NCT04259450|527270217|FG002|Overall Study|Withdrawal by Subject|0|||
146206458|NCT04259450|527270218|FG003|Overall Study|Withdrawal by Subject|0|||
146206459|NCT04259450|527270219|FG004|Overall Study|Withdrawal by Subject|0|||
146206460|NCT04259450|527270220|FG005|Overall Study|Withdrawal by Subject|0|||
146206461|NCT04259450|527270221|FG006|Overall Study|Withdrawal by Subject|0|||
146206462|NCT04259450|527270222|FG007|Overall Study|Withdrawal by Subject|1|||
146206463|NCT04259450|527270223|FG008|Overall Study|Withdrawal by Subject|0|||
146206464|NCT04259450|527270224|FG009|Overall Study|Withdrawal by Subject|0|||
146206465|NCT04259450|527270215|FG000|Overall Study|Other than listed|0|||
146206466|NCT04259450|527270216|FG001|Overall Study|Other than listed|0|||
146206467|NCT04259450|527270217|FG002|Overall Study|Other than listed|0|||
146206468|NCT04259450|527270218|FG003|Overall Study|Other than listed|0|||
146206469|NCT04259450|527270219|FG004|Overall Study|Other than listed|0|||
146206470|NCT04259450|527270220|FG005|Overall Study|Other than listed|0|||
146206471|NCT04259450|527270221|FG006|Overall Study|Other than listed|0|||
146206472|NCT04259450|527270222|FG007|Overall Study|Other than listed|1|||
146206473|NCT04259450|527270223|FG008|Overall Study|Other than listed|1|||
146206474|NCT04259450|527270224|FG009|Overall Study|Other than listed|2|||
146433258|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
146433259|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
146433260|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433261|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433262|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433263|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433264|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
146433265|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433266|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146206475|NCT03452189|527270225|FG000|First Intervention (3 Months)|Adverse Event|1|||
146206476|NCT03452189|527270226|FG001|First Intervention (3 Months)|Adverse Event|0|||
146206477|NCT03452189|527270225|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
146206478|NCT03452189|527270226|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
146206479|NCT00332241|527270227|FG000|Overall Study|Lack of Efficacy|6|||
146206480|NCT00332241|527270228|FG001|Overall Study|Lack of Efficacy|1|||
146206481|NCT00332241|527270227|FG000|Overall Study|Adverse Event|3|||
146206482|NCT00332241|527270228|FG001|Overall Study|Adverse Event|5|||
146206483|NCT00332241|527270227|FG000|Overall Study|Withdrawal by Subject|2|||
146206484|NCT00332241|527270228|FG001|Overall Study|Withdrawal by Subject|1|||
146206485|NCT00332241|527270227|FG000|Overall Study|Lost to Follow-up|4|||
146206486|NCT00332241|527270228|FG001|Overall Study|Lost to Follow-up|1|||
146206487|NCT02724592|527270235|FG000|Overall Study|Lost to Follow-up|4|||
146206488|NCT02724592|527270236|FG001|Overall Study|Lost to Follow-up|1|||
146206489|NCT00371787|527270239|FG000|Overall Study|Withdrawal by Subject|3|||
146206490|NCT00371787|527270240|FG001|Overall Study|Withdrawal by Subject|1|||
146206491|NCT01972724|527270241|FG000|Double-Blind|Rescue Criteria Met|1|||
146206492|NCT01972724|527270242|FG001|Double-Blind|Rescue Criteria Met|0|||
146206493|NCT01972724|527270243|FG002|Double-Blind|Rescue Criteria Met|0|||
146206494|NCT01972724|527270241|FG000|Double-Blind|Adverse Event|1|||
146206495|NCT01972724|527270242|FG001|Double-Blind|Adverse Event|0|||
146206496|NCT01972724|527270243|FG002|Double-Blind|Adverse Event|0|||
146206497|NCT01972724|527270241|FG000|Double-Blind|Withdrawal of Consent|2|||
146082939|NCT03085914|526824710|FG001|Overall Study|Lost to Follow-up|0|||
146206498|NCT01972724|527270242|FG001|Double-Blind|Withdrawal of Consent|1|||
146206499|NCT01972724|527270243|FG002|Double-Blind|Withdrawal of Consent|0|||
146206500|NCT01972724|527270241|FG000|Double-Blind|Significant Protocol Deviation|5|||
146206501|NCT01972724|527270242|FG001|Double-Blind|Significant Protocol Deviation|8|||
146206502|NCT01972724|527270243|FG002|Double-Blind|Significant Protocol Deviation|0|||
146206503|NCT01972724|527270241|FG000|Open-Label|Withdrew Consent|0|||
146206504|NCT01972724|527270242|FG001|Open-Label|Withdrew Consent|0|||
146206505|NCT01972724|527270243|FG002|Open-Label|Withdrew Consent|3|||
146206506|NCT01972724|527270241|FG000|Open-Label|Significant Protocol Deviation|0|||
146206507|NCT01972724|527270242|FG001|Open-Label|Significant Protocol Deviation|0|||
146206508|NCT01972724|527270243|FG002|Open-Label|Significant Protocol Deviation|2|||
146206509|NCT03740009|527270251|FG000|Overall Study|Physician Decision|9|||
146206510|NCT03740009|527270251|FG000|Overall Study|Lost to Follow-up|1|||
146206511|NCT03752151|527270253|FG000|Overall Study|Withdrawal by Subject|1|||
146206512|NCT03752151|527270253|FG000|Overall Study|Protocol Violation|1|||
146206513|NCT00350792|527270256|FG000|Overall Study|Adverse Event|11|||
146206514|NCT00350792|527270256|FG000|Overall Study|Death from Study Disease|1|||
146206515|NCT00350792|527270256|FG000|Overall Study|Death from Study Drug Toxicity|1|||
146206516|NCT00350792|527270256|FG000|Overall Study|Death Not Study Drug Related|2|||
146206517|NCT00350792|527270256|FG000|Overall Study|Protocol Violation|1|||
146206518|NCT00350792|527270256|FG000|Overall Study|Withdrawal by Subject|4|||
146433267|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433268|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433269|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433270|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433271|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433272|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433273|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433274|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433275|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433276|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433277|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433278|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
146433279|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
146433280|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
146433281|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433282|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433283|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433284|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433285|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
146433286|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433287|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
145951189|NCT02087943|526332215|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
146206519|NCT00350792|527270256|FG000|Overall Study|Physician Decision|2|||
146206520|NCT00350792|527270256|FG000|Overall Study|Lack of Efficacy|11|||
146206521|NCT03764475|527270257|FG000|Overall Study|Adverse Event|11|||
146206522|NCT03764475|527270258|FG001|Overall Study|Adverse Event|2|||
146206523|NCT03764475|527270257|FG000|Overall Study|Lost to Follow-up|24|||
146206524|NCT03764475|527270258|FG001|Overall Study|Lost to Follow-up|10|||
146206525|NCT03764475|527270257|FG000|Overall Study|Withdrawal by Subject|26|||
146206526|NCT03764475|527270258|FG001|Overall Study|Withdrawal by Subject|10|||
146206527|NCT03764475|527270257|FG000|Overall Study|Lack of Efficacy|3|||
146206528|NCT03764475|527270258|FG001|Overall Study|Lack of Efficacy|0|||
146206529|NCT03764475|527270257|FG000|Overall Study|COVID-19 Disruption|2|||
146206530|NCT03764475|527270258|FG001|Overall Study|COVID-19 Disruption|0|||
146206531|NCT05510245|527270259|FG000|Overall Study|Withdrawal by Subject|1|||
146206532|NCT05510245|527270260|FG001|Overall Study|Withdrawal by Subject|0|||
146206533|NCT05510245|527270261|FG002|Overall Study|Withdrawal by Subject|0|||
146206534|NCT01373346|527270267|FG000|Overall Study|Death|1|||
146206535|NCT01198028|527270268|FG000|Overall Study|Adverse Event|5|||
146206536|NCT01198028|527270268|FG000|Overall Study|Death|3|||
145951190|NCT02087943|526332211|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
146206537|NCT01198028|527270268|FG000|Overall Study|Physician Decision|2|||
146206538|NCT00970359|527270272|FG000|Overall Study|Not Treated|4|||
146206539|NCT01565148|527270273|FG000|Overall Study|Withdrawal by Subject|1|||
146206540|NCT01565148|527270274|FG001|Overall Study|Withdrawal by Subject|1|||
146206541|NCT01565148|527270275|FG002|Overall Study|Withdrawal by Subject|1|||
146206542|NCT01565148|527270276|FG003|Overall Study|Withdrawal by Subject|2|||
146206543|NCT01565148|527270273|FG000|Overall Study|Lost to Follow-up|4|||
146206544|NCT01565148|527270274|FG001|Overall Study|Lost to Follow-up|4|||
146206545|NCT01565148|527270275|FG002|Overall Study|Lost to Follow-up|0|||
146206546|NCT01565148|527270276|FG003|Overall Study|Lost to Follow-up|3|||
146206547|NCT01565148|527270273|FG000|Overall Study|Rescue Therapy|8|||
146206548|NCT01565148|527270274|FG001|Overall Study|Rescue Therapy|5|||
146206549|NCT01565148|527270275|FG002|Overall Study|Rescue Therapy|5|||
146206550|NCT01565148|527270276|FG003|Overall Study|Rescue Therapy|8|||
146206551|NCT01565148|527270273|FG000|Overall Study|Death|0|||
146206552|NCT01565148|527270274|FG001|Overall Study|Death|0|||
146206553|NCT01565148|527270275|FG002|Overall Study|Death|1|||
146206554|NCT01565148|527270276|FG003|Overall Study|Death|0|||
146206555|NCT01565148|527270273|FG000|Overall Study|Physician Decision|2|||
146206556|NCT01565148|527270274|FG001|Overall Study|Physician Decision|5|||
146206557|NCT01565148|527270275|FG002|Overall Study|Physician Decision|0|||
146206558|NCT01565148|527270276|FG003|Overall Study|Physician Decision|0|||
146206559|NCT01759771|527270277|FG000|Overall Study|Withdrawal by Subject|1|||
146206560|NCT01759771|527270278|FG001|Overall Study|Withdrawal by Subject|1|||
146206561|NCT02528188|527270279|FG000|Overall Study|Adverse Event|23|||
146206562|NCT02528188|527270280|FG001|Overall Study|Adverse Event|22|||
146206563|NCT02528188|527270281|FG002|Overall Study|Adverse Event|8|||
146206564|NCT02528188|527270279|FG000|Overall Study|Protocol Violation|4|||
146206565|NCT02528188|527270280|FG001|Overall Study|Protocol Violation|6|||
146206566|NCT02528188|527270281|FG002|Overall Study|Protocol Violation|4|||
146206567|NCT02528188|527270279|FG000|Overall Study|Lack of Efficacy|19|||
146206568|NCT02528188|527270280|FG001|Overall Study|Lack of Efficacy|21|||
146206569|NCT02528188|527270281|FG002|Overall Study|Lack of Efficacy|22|||
146206570|NCT02528188|527270279|FG000|Overall Study|Withdrawal by Subject|97|||
146206571|NCT02528188|527270280|FG001|Overall Study|Withdrawal by Subject|104|||
146206572|NCT02528188|527270281|FG002|Overall Study|Withdrawal by Subject|100|||
146206573|NCT02528188|527270279|FG000|Overall Study|Lost to Follow-up|25|||
146206574|NCT02528188|527270280|FG001|Overall Study|Lost to Follow-up|21|||
146206575|NCT02528188|527270281|FG002|Overall Study|Lost to Follow-up|31|||
146206576|NCT02528188|527270279|FG000|Overall Study|Death|4|||
146206577|NCT02528188|527270280|FG001|Overall Study|Death|4|||
146206578|NCT02528188|527270281|FG002|Overall Study|Death|0|||
146206579|NCT02528188|527270279|FG000|Overall Study|Other|89|||
146206580|NCT02528188|527270280|FG001|Overall Study|Other|91|||
146433288|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433289|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433290|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433291|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433292|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433293|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433294|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433295|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433296|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433297|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433298|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433299|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433300|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
146433301|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
146433302|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433303|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433304|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433305|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433306|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
146433307|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433308|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433309|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433310|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433311|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433312|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433313|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433314|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433315|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433316|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433317|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433318|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433319|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433320|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433321|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
146433322|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
146433323|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433324|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433325|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433326|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433327|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
146433328|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433329|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433330|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433331|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433332|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433333|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433334|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433335|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433336|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433337|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433338|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145951191|NCT02087943|526332212|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145951192|NCT02087943|526332213|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145951193|NCT02087943|526332214|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145951194|NCT02087943|526332215|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
145951195|NCT02087943|526332211|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
145951196|NCT02087943|526332212|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
146433339|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433340|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433341|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433342|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
145951197|NCT02087943|526332213|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
146206581|NCT02528188|527270281|FG002|Overall Study|Other|74|||
146082940|NCT03085914|526824711|FG002|Overall Study|Lost to Follow-up|1|||
146433343|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
146433344|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433345|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433346|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433347|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433348|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
146433349|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433350|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145951198|NCT02087943|526332214|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
145951199|NCT02087943|526332215|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
145951200|NCT02886884|526332221|FG000|Follow-up|Withdrawal by Subject|0|||
145951201|NCT02886884|526332222|FG001|Follow-up|Withdrawal by Subject|0|||
145951202|NCT02886884|526332223|FG002|Follow-up|Withdrawal by Subject|0|||
145951203|NCT02886884|526332224|FG003|Follow-up|Withdrawal by Subject|1|||
145951204|NCT02697734|526332230|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
145951205|NCT02697734|526332231|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
145951206|NCT02697734|526332230|FG000|Core Phase - up to Week 48|Adverse Event|1|||
145951207|NCT02697734|526332231|FG001|Core Phase - up to Week 48|Adverse Event|2|||
145951208|NCT02697734|526332230|FG000|Core Phase - up to Week 48|Physician Decision|1|||
145951209|NCT02697734|526332231|FG001|Core Phase - up to Week 48|Physician Decision|0|||
145951210|NCT02697734|526332230|FG000|Optional Extension Phase|Adverse Event|5|||
145951211|NCT02697734|526332231|FG001|Optional Extension Phase|Adverse Event|1|||
145951212|NCT02697734|526332230|FG000|Optional Extension Phase|Physician Decision|0|||
145951213|NCT02697734|526332231|FG001|Optional Extension Phase|Physician Decision|1|||
145951214|NCT02324699|526332232|FG000|Overall Study|study terminated|1|||
145951215|NCT03970200|526332233|FG000|Overall Study|Death|2|||
145951216|NCT03970200|526332234|FG001|Overall Study|Death|2|||
145951217|NCT03970200|526332235|FG002|Overall Study|Death|1|||
145951218|NCT03970200|526332233|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
145951219|NCT03970200|526332234|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
145951220|NCT03970200|526332235|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
145951221|NCT01607346|526332236|FG000|Overall Study|Adverse Event|3|||
145951222|NCT01098162|526332237|FG000|Overall Study|Adverse Event|37|||
145951223|NCT01098162|526332237|FG000|Overall Study|Lack of Efficacy|4|||
145951224|NCT01098162|526332237|FG000|Overall Study|Wish of Patient|7|||
145951225|NCT01098162|526332237|FG000|Overall Study|Lost to Follow-up|9|||
145951226|NCT01098162|526332237|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
145951227|NCT01098162|526332237|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
145951228|NCT01098162|526332237|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
145951229|NCT01098162|526332237|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
145951230|NCT01098162|526332237|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
145951231|NCT01098162|526332237|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
145951232|NCT01098162|526332237|FG000|Overall Study|Other Reason|1|||
145951233|NCT01098162|526332237|FG000|Overall Study|Reason Unknown|26|||
145951234|NCT01605825|526332238|FG000|Overall Study|Adverse Event|4|||
145951235|NCT01605825|526332239|FG001|Overall Study|Adverse Event|2|||
145951236|NCT01605825|526332238|FG000|Overall Study|Withdrawal by Subject|0|||
145951237|NCT01605825|526332239|FG001|Overall Study|Withdrawal by Subject|1|||
145951238|NCT01605825|526332238|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
145951239|NCT01605825|526332239|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
145951240|NCT01605825|526332238|FG000|Overall Study|Non-Compliance with Protocol|3|||
145951241|NCT01605825|526332239|FG001|Overall Study|Non-Compliance with Protocol|0|||
145951242|NCT00830518|526332240|FG000|Overall Study|Progressive Disease|18|||
145951243|NCT00830518|526332241|FG001|Overall Study|Progressive Disease|8|||
145951244|NCT00830518|526332240|FG000|Overall Study|Symptomatic Deterioration|4|||
146206582|NCT02528188|527270279|FG000|Overall Study|Randomized but not treated|6|||
146206583|NCT02528188|527270280|FG001|Overall Study|Randomized but not treated|7|||
146206584|NCT02528188|527270281|FG002|Overall Study|Randomized but not treated|12|||
146206585|NCT05368831|527270282|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
146206586|NCT00529659|527270283|FG000|Overall Study|Adverse Event|8|||
146433351|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145951245|NCT00830518|526332241|FG001|Overall Study|Symptomatic Deterioration|1|||
146206587|NCT00529659|527270284|FG001|Overall Study|Adverse Event|7|||
146433352|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433353|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433354|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433355|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433356|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433357|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433358|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145951246|NCT00830518|526332240|FG000|Overall Study|Adverse Event|14|||
145951247|NCT00830518|526332241|FG001|Overall Study|Adverse Event|1|||
146206588|NCT00529659|527270283|FG000|Overall Study|Lost to Follow-up|0|||
145951248|NCT00830518|526332240|FG000|Overall Study|Withdrawal by Patient|2|||
145951249|NCT00830518|526332241|FG001|Overall Study|Withdrawal by Patient|0|||
145951250|NCT00830518|526332240|FG000|Overall Study|Reason not Specified|8|||
145951251|NCT00830518|526332241|FG001|Overall Study|Reason not Specified|1|||
145951252|NCT02155322|526332242|FG000|Overall Study|Adverse Event|1|||
145951253|NCT02155322|526332242|FG000|Overall Study|Physician Decision|1|||
145951254|NCT02155322|526332242|FG000|Overall Study|Relapse/Recurrence|8|||
145951255|NCT02155322|526332242|FG000|Overall Study|Withdrawal by Subject|4|||
145951256|NCT00460746|526332245|FG000|Overall Study|Adverse Event|1|||
145951257|NCT00460746|526332245|FG000|Overall Study|Lost to Follow-up|1|||
145951258|NCT01778751|526332246|FG000|Overall Study|Lost to Follow-up|1|||
146433359|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433360|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433361|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433362|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433363|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
146433364|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
146433365|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433366|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145951259|NCT01778751|526332247|FG001|Overall Study|Lost to Follow-up|0|||
145951260|NCT01778751|526332246|FG000|Overall Study|Withdrawal by Subject|0|||
145951261|NCT01778751|526332247|FG001|Overall Study|Withdrawal by Subject|2|||
145951262|NCT01778751|526332246|FG000|Overall Study|Transfered care|1|||
145951263|NCT01778751|526332247|FG001|Overall Study|Transfered care|0|||
145951264|NCT01603394|526332254|FG000|Overall Study|Adverse Event|1|||
145951265|NCT03383692|526332259|FG000|Overall Study|Progressive disease as per RECIST|3|||
145951266|NCT03383692|526332260|FG001|Overall Study|Progressive disease as per RECIST|3|||
145951267|NCT03383692|526332259|FG000|Overall Study|Clinical progression|0|||
145951268|NCT03383692|526332260|FG001|Overall Study|Clinical progression|1|||
145951269|NCT03383692|526332259|FG000|Overall Study|Adverse Event|3|||
145951270|NCT03383692|526332260|FG001|Overall Study|Adverse Event|0|||
145951271|NCT00586898|526332261|FG000|Overall Study|Adverse Event|1|||
145951272|NCT00586898|526332261|FG000|Overall Study|Patiemt Non-compliance|1|||
145951273|NCT00586898|526332261|FG000|Overall Study|Evaluable for Toxicity Only|5|||
145951274|NCT00966355|526332267|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
145951275|NCT00966355|526332268|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
145951276|NCT00966355|526332269|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
145951277|NCT00966355|526332267|FG000|Overall Study|newly diagnosed advanced HCC|11|||
145951278|NCT00966355|526332268|FG001|Overall Study|newly diagnosed advanced HCC|12|||
145951279|NCT00966355|526332269|FG002|Overall Study|newly diagnosed advanced HCC|10|||
145951280|NCT00966355|526332267|FG000|Overall Study|Lost to Follow-up|5|||
145951281|NCT00966355|526332268|FG001|Overall Study|Lost to Follow-up|4|||
145951282|NCT00966355|526332269|FG002|Overall Study|Lost to Follow-up|3|||
145951283|NCT02552888|526332270|FG000|Overall Study|Lost to Follow-up|1|||
145951284|NCT02552888|526332271|FG001|Overall Study|Lost to Follow-up|1|||
145951285|NCT00824655|526333832|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
145951286|NCT00824655|526333833|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
145951287|NCT00824655|526333832|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
145951288|NCT00824655|526333833|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
145951289|NCT03504189|526333834|FG000|Overall Study|Withdrawal by Subject|1|||
145951290|NCT03504189|526333834|FG000|Overall Study|Screening Failure|1|||
145951291|NCT03504189|526333834|FG000|Overall Study|Device Failure|2|||
145951292|NCT03091738|526333835|FG000|Overall Study|Adverse Event|1|||
145951293|NCT03091738|526333835|FG000|Overall Study|Lost to Follow-up|1|||
145951294|NCT01148459|526333836|FG000|Overall Study|Serious Adverse Event|5|||
145951295|NCT01148459|526333837|FG001|Overall Study|Serious Adverse Event|4|||
145951296|NCT01148459|526333836|FG000|Overall Study|Withdrawal by Subject|1|||
145951297|NCT01148459|526333837|FG001|Overall Study|Withdrawal by Subject|0|||
146206589|NCT00529659|527270284|FG001|Overall Study|Lost to Follow-up|2|||
146433367|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145951298|NCT01148459|526333836|FG000|Overall Study|Migrated/moved from study area|3|||
145951299|NCT01148459|526333837|FG001|Overall Study|Migrated/moved from study area|6|||
145951300|NCT01148459|526333836|FG000|Overall Study|Lost to Follow-up|2|||
145951301|NCT01148459|526333837|FG001|Overall Study|Lost to Follow-up|0|||
145951302|NCT01148459|526333836|FG000|Overall Study|Refusal|1|||
145951303|NCT01148459|526333837|FG001|Overall Study|Refusal|0|||
145951304|NCT01148459|526333836|FG000|Overall Study|Failure to comply with study procedures|0|||
145951305|NCT01148459|526333837|FG001|Overall Study|Failure to comply with study procedures|1|||
145951306|NCT03077607|526333844|FG000|Period 1 (15 Days)|Adverse Event|1|||
145951307|NCT03077607|526333845|FG001|Period 1 (15 Days)|Adverse Event|0|||
145951308|NCT03077607|526333844|FG000|Period 1 (15 Days)|Death|1|||
145951309|NCT03077607|526333845|FG001|Period 1 (15 Days)|Death|0|||
145951310|NCT03077607|526333844|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
145951311|NCT03077607|526333845|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
146082941|NCT03085914|526824712|FG003|Overall Study|Lost to Follow-up|0|||
146206590|NCT00529659|527270283|FG000|Overall Study|Physician Decision|0|||
146206591|NCT00529659|527270284|FG001|Overall Study|Physician Decision|2|||
146206592|NCT00529659|527270283|FG000|Overall Study|Protocol Violation|2|||
146206593|NCT00529659|527270284|FG001|Overall Study|Protocol Violation|6|||
146206594|NCT00529659|527270283|FG000|Overall Study|Withdrawal by Subject|1|||
146206595|NCT00529659|527270284|FG001|Overall Study|Withdrawal by Subject|6|||
146206596|NCT03887650|527270285|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
146206597|NCT03887650|527270286|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
146206598|NCT03887650|527270285|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
146206599|NCT03887650|527270286|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
146206600|NCT03887650|527270285|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
146206601|NCT03887650|527270286|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
146206602|NCT01692730|527270290|FG000|Overall Study|Lost to Follow-up|225|||
146206603|NCT01692730|527270291|FG001|Overall Study|Lost to Follow-up|227|||
146206604|NCT01849055|527270292|FG000|Overall Study|Withdrawal by Subject|0|||
146206605|NCT01849055|527270293|FG001|Overall Study|Withdrawal by Subject|0|||
146206606|NCT01849055|527270294|FG002|Overall Study|Withdrawal by Subject|1|||
146206607|NCT01849055|527270295|FG003|Overall Study|Withdrawal by Subject|0|||
146206608|NCT01849055|527270296|FG004|Overall Study|Withdrawal by Subject|0|||
146206609|NCT01849055|527270297|FG005|Overall Study|Withdrawal by Subject|0|||
146206610|NCT00223795|527270302|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
146206611|NCT00223795|527270303|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
146206612|NCT00223795|527270302|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
146206613|NCT00223795|527270303|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
146206614|NCT02299375|527270304|FG000|Overall Study|Adverse Event, serious fatal|1|||
146206615|NCT02299375|527270305|FG001|Overall Study|Adverse Event, serious fatal|3|||
146206616|NCT02299375|527270304|FG000|Overall Study|Adverse Event, non-fatal|8|||
146206617|NCT02299375|527270305|FG001|Overall Study|Adverse Event, non-fatal|9|||
146206618|NCT02299375|527270304|FG000|Overall Study|Lack of Efficacy|1|||
146206619|NCT02299375|527270305|FG001|Overall Study|Lack of Efficacy|3|||
146206620|NCT02299375|527270304|FG000|Overall Study|Protocol Violation|1|||
146206621|NCT02299375|527270305|FG001|Overall Study|Protocol Violation|3|||
146206622|NCT02299375|527270304|FG000|Overall Study|Other: Met stopping criteria|1|||
146206623|NCT02299375|527270305|FG001|Overall Study|Other: Met stopping criteria|0|||
146206624|NCT02299375|527270304|FG000|Overall Study|Other: Study closed/terminated|66|||
146206625|NCT02299375|527270305|FG001|Overall Study|Other: Study closed/terminated|55|||
146206626|NCT02299375|527270304|FG000|Overall Study|Lost to Follow-up|0|||
146206627|NCT02299375|527270305|FG001|Overall Study|Lost to Follow-up|2|||
146206628|NCT02299375|527270304|FG000|Overall Study|Physician Decision|1|||
146206629|NCT02299375|527270305|FG001|Overall Study|Physician Decision|1|||
146206630|NCT02299375|527270304|FG000|Overall Study|Withdrawal by Subject|1|||
146206631|NCT02299375|527270305|FG001|Overall Study|Withdrawal by Subject|4|||
146206632|NCT00704184|527270310|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
146206633|NCT00704184|527270311|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
146206634|NCT00704184|527270312|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
146206635|NCT00704184|527270313|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
146206636|NCT00704184|527270314|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
146206637|NCT00704184|527270310|FG000|Open-Label Treatment|Adverse Event|0|||
146206638|NCT00704184|527270311|FG001|Open-Label Treatment|Adverse Event|0|||
146206639|NCT00704184|527270312|FG002|Open-Label Treatment|Adverse Event|2|||
146206640|NCT00704184|527270313|FG003|Open-Label Treatment|Adverse Event|0|||
146206641|NCT00704184|527270314|FG004|Open-Label Treatment|Adverse Event|1|||
146206642|NCT00704184|527270310|FG000|Open-Label Treatment|Lack of Efficacy|0|||
146206643|NCT00704184|527270311|FG001|Open-Label Treatment|Lack of Efficacy|2|||
146206644|NCT00704184|527270312|FG002|Open-Label Treatment|Lack of Efficacy|2|||
146206645|NCT00704184|527270313|FG003|Open-Label Treatment|Lack of Efficacy|2|||
146206646|NCT00704184|527270314|FG004|Open-Label Treatment|Lack of Efficacy|1|||
146206647|NCT00704184|527270310|FG000|Open-Label Treatment|Physician Decision|0|||
146206648|NCT00704184|527270311|FG001|Open-Label Treatment|Physician Decision|0|||
146206649|NCT00704184|527270312|FG002|Open-Label Treatment|Physician Decision|0|||
146433368|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146206650|NCT00704184|527270313|FG003|Open-Label Treatment|Physician Decision|0|||
146206651|NCT00704184|527270314|FG004|Open-Label Treatment|Physician Decision|1|||
146206652|NCT00704184|527270310|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
146433369|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
146433370|NCT01597245|528091837|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146206653|NCT00704184|527270311|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146206654|NCT00704184|527270312|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
146206655|NCT00704184|527270313|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
146206656|NCT00704184|527270314|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
146206657|NCT00716859|527270315|FG000|Overall Study|Adverse Event|4|||
146206658|NCT00716859|527270316|FG001|Overall Study|Adverse Event|1|||
146206659|NCT00716859|527270315|FG000|Overall Study|Lack of Efficacy|3|||
145951312|NCT03077607|526333844|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
145951313|NCT03077607|526333845|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
145951314|NCT00460239|526333846|FG000|Overall Study|Physician Decision|0|||
145951315|NCT00460239|526333847|FG001|Overall Study|Physician Decision|1|||
145951316|NCT00460239|526333848|FG002|Overall Study|Physician Decision|0|||
145951317|NCT00460239|526333849|FG003|Overall Study|Physician Decision|0|||
145951318|NCT00460239|526333850|FG004|Overall Study|Physician Decision|0|||
145951319|NCT00460239|526333851|FG005|Overall Study|Physician Decision|2|||
145951320|NCT00460239|526333852|FG006|Overall Study|Physician Decision|0|||
145951321|NCT00460239|526333853|FG007|Overall Study|Physician Decision|0|||
145951322|NCT00460239|526333854|FG008|Overall Study|Physician Decision|0|||
145951323|NCT00460239|526333846|FG000|Overall Study|Withdrawal by Subject|0|||
145951324|NCT00460239|526333847|FG001|Overall Study|Withdrawal by Subject|0|||
145951325|NCT00460239|526333848|FG002|Overall Study|Withdrawal by Subject|0|||
145951326|NCT00460239|526333849|FG003|Overall Study|Withdrawal by Subject|0|||
145951327|NCT00460239|526333850|FG004|Overall Study|Withdrawal by Subject|0|||
145951328|NCT00460239|526333851|FG005|Overall Study|Withdrawal by Subject|1|||
145951329|NCT00460239|526333852|FG006|Overall Study|Withdrawal by Subject|0|||
145951330|NCT00460239|526333853|FG007|Overall Study|Withdrawal by Subject|0|||
145951331|NCT00460239|526333854|FG008|Overall Study|Withdrawal by Subject|0|||
145951332|NCT04217317|526333856|FG000|Overall Study|Lack of Efficacy|4|||
145951333|NCT04217317|526333856|FG000|Overall Study|Physician Decision|1|||
145951334|NCT03836209|526333857|FG000|Overall Study|Adverse Event|5|||
145951335|NCT03836209|526333858|FG001|Overall Study|Adverse Event|2|||
145951336|NCT03836209|526333857|FG000|Overall Study|Death|4|||
145951337|NCT03836209|526333858|FG001|Overall Study|Death|1|||
145951338|NCT03836209|526333857|FG000|Overall Study|Lack of Efficacy|7|||
145951339|NCT03836209|526333858|FG001|Overall Study|Lack of Efficacy|10|||
145951340|NCT03836209|526333857|FG000|Overall Study|Physician Decision|7|||
145951341|NCT03836209|526333858|FG001|Overall Study|Physician Decision|11|||
145951342|NCT03836209|526333857|FG000|Overall Study|Protocol Violation|0|||
145951343|NCT03836209|526333858|FG001|Overall Study|Protocol Violation|3|||
145951344|NCT03836209|526333857|FG000|Overall Study|Withdrawal by Subject|2|||
145951345|NCT03836209|526333858|FG001|Overall Study|Withdrawal by Subject|10|||
145951346|NCT03836209|526333857|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
145951347|NCT03836209|526333858|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
145951348|NCT03739710|526333859|FG000|Overall Study|Screen Failed|81|||
145951349|NCT01753115|526333860|FG000|Overall Study|Lost to Follow-up|3|||
145951350|NCT01753115|526333861|FG001|Overall Study|Lost to Follow-up|6|||
145951351|NCT01753115|526333862|FG002|Overall Study|Lost to Follow-up|8|||
145951352|NCT01753115|526333860|FG000|Overall Study|Withdrawal by Subject|6|||
145951353|NCT01753115|526333861|FG001|Overall Study|Withdrawal by Subject|5|||
145951354|NCT01753115|526333862|FG002|Overall Study|Withdrawal by Subject|6|||
145951355|NCT01753115|526333860|FG000|Overall Study|Subject non-compliant|3|||
145951356|NCT01753115|526333861|FG001|Overall Study|Subject non-compliant|3|||
145951357|NCT01753115|526333862|FG002|Overall Study|Subject non-compliant|0|||
145951358|NCT01753115|526333860|FG000|Overall Study|Used excluded drug|0|||
145951359|NCT01753115|526333861|FG001|Overall Study|Used excluded drug|1|||
145951360|NCT01753115|526333862|FG002|Overall Study|Used excluded drug|0|||
145951361|NCT04313400|526333868|FG000|Overall Study|Withdrawal by Subject|0|||
145951362|NCT04313400|526333869|FG001|Overall Study|Withdrawal by Subject|0|||
145951363|NCT04313400|526333870|FG002|Overall Study|Withdrawal by Subject|0|||
145951364|NCT04313400|526333871|FG003|Overall Study|Withdrawal by Subject|0|||
145951365|NCT04313400|526333872|FG004|Overall Study|Withdrawal by Subject|0|||
145951366|NCT04313400|526333873|FG005|Overall Study|Withdrawal by Subject|4|||
145951367|NCT04313400|526333874|FG006|Overall Study|Withdrawal by Subject|1|||
145951368|NCT04313400|526333868|FG000|Overall Study|Adverse Event|0|||
145951369|NCT04313400|526333869|FG001|Overall Study|Adverse Event|0|||
145951370|NCT04313400|526333870|FG002|Overall Study|Adverse Event|0|||
145951371|NCT04313400|526333871|FG003|Overall Study|Adverse Event|0|||
145951372|NCT04313400|526333872|FG004|Overall Study|Adverse Event|0|||
145951373|NCT04313400|526333873|FG005|Overall Study|Adverse Event|1|||
145951374|NCT04313400|526333874|FG006|Overall Study|Adverse Event|0|||
145951375|NCT04313400|526333868|FG000|Overall Study|Lost to Follow-up|0|||
145951376|NCT04313400|526333869|FG001|Overall Study|Lost to Follow-up|0|||
145951377|NCT04313400|526333870|FG002|Overall Study|Lost to Follow-up|0|||
145951378|NCT04313400|526333871|FG003|Overall Study|Lost to Follow-up|0|||
145951379|NCT04313400|526333872|FG004|Overall Study|Lost to Follow-up|0|||
145951380|NCT04313400|526333873|FG005|Overall Study|Lost to Follow-up|1|||
145951381|NCT04313400|526333874|FG006|Overall Study|Lost to Follow-up|0|||
145951382|NCT00329745|526333881|FG000|Overall Study|Protocol Violation|1|||
145951383|NCT00329745|526333882|FG001|Overall Study|Protocol Violation|0|||
145951384|NCT00329745|526333881|FG000|Overall Study|Withdrawal by Subject|0|||
145951385|NCT00329745|526333882|FG001|Overall Study|Withdrawal by Subject|1|||
145951386|NCT00329745|526333881|FG000|Overall Study|Lost to Follow-up|86|||
145951387|NCT00329745|526333882|FG001|Overall Study|Lost to Follow-up|101|||
145951388|NCT03224624|526333885|FG000|Overall Study|Lost to Follow-up|9|||
146433371|NCT01597245|528091838|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433372|NCT01597245|528091839|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433373|NCT01597245|528091840|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433374|NCT01597245|528091841|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433375|NCT01597245|528091842|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433376|NCT01597245|528091843|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433377|NCT01597245|528091844|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433378|NCT01597245|528091845|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433379|NCT01597245|528091846|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433380|NCT01597245|528091847|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433381|NCT01597245|528091848|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433382|NCT01597245|528091849|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433383|NCT01597245|528091850|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
146433384|NCT01597245|528091851|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433385|NCT01597245|528091852|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433386|NCT01597245|528091853|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433387|NCT01597245|528091854|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433388|NCT01597245|528091855|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146082942|NCT03085914|526824713|FG004|Overall Study|Lost to Follow-up|0|||
146206660|NCT00716859|527270316|FG001|Overall Study|Lack of Efficacy|0|||
146206661|NCT00716859|527270315|FG000|Overall Study|Withdrawal by Subject|1|||
146206662|NCT00716859|527270316|FG001|Overall Study|Withdrawal by Subject|3|||
146206663|NCT00716859|527270315|FG000|Overall Study|Not treated|1|||
146433389|NCT01597245|528091856|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433390|NCT01597245|528091857|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
146433391|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433392|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433393|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433394|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433395|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433396|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433397|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433398|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433399|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433400|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433401|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433402|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433403|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433404|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433405|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433406|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
146433407|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
146433408|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
146433409|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
146433410|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
146433411|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
146433412|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433413|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433414|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433415|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433416|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433417|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433418|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433419|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433420|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433421|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433422|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433423|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433424|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433425|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433426|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433427|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146206664|NCT00716859|527270316|FG001|Overall Study|Not treated|1|||
146206665|NCT04139668|527272020|FG000|Overall Study|Withdrawal by Subject|1|||
146433428|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
146433429|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
146433430|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
146433431|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
146433432|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
146433433|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433434|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433435|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433436|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433437|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433438|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433439|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433440|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433441|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433442|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433443|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433444|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433445|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433446|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433447|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433448|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433449|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
146433450|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433451|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
146433452|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
146433453|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
146433454|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433455|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433456|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433457|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433458|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433459|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433460|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433461|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433462|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433463|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433464|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433465|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433466|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433467|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433468|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433469|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433470|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433471|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
146433472|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
146433473|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
146433474|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
146433475|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433476|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433477|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433478|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433479|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433480|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433481|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433482|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433483|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433484|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433485|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433486|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433487|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433488|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433489|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433490|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433491|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
146433492|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433493|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
146433494|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
146433495|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
146433496|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433497|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433498|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433499|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433500|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433501|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433502|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433503|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433504|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433505|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433506|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433507|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433508|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433509|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433510|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433511|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433512|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
146433513|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433514|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
146433515|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
146433516|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
146433517|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433518|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433519|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433520|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433521|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433522|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433523|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433524|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433525|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433526|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433527|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433528|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433529|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146206666|NCT04907474|527272031|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
146206667|NCT04907474|527272032|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
146206668|NCT02581215|527272033|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
146433530|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433531|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433532|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433533|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
146433534|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433535|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433536|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
146433537|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
146433538|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433539|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433540|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433541|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433542|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433543|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433544|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433545|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433546|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433547|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433548|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433549|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433550|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433551|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433552|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433553|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433554|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
146433555|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433556|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433557|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
146433558|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
146433559|NCT01597245|528091837|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433560|NCT01597245|528091838|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433561|NCT01597245|528091839|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433562|NCT01597245|528091840|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433563|NCT01597245|528091841|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433564|NCT01597245|528091842|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433565|NCT01597245|528091843|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433566|NCT01597245|528091844|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433567|NCT01597245|528091845|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433568|NCT01597245|528091846|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433569|NCT01597245|528091847|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433570|NCT01597245|528091848|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433571|NCT01597245|528091849|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433572|NCT01597245|528091850|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433573|NCT01597245|528091851|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433574|NCT01597245|528091852|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433575|NCT01597245|528091853|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433576|NCT01597245|528091854|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433577|NCT01597245|528091855|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433578|NCT01597245|528091856|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
146433579|NCT01597245|528091857|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
146433580|NCT00731783|528091858|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
146433581|NCT00731783|528091859|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
146433582|NCT00731783|528091858|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
146433583|NCT00731783|528091859|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
146433584|NCT00731783|528091858|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
146433585|NCT00731783|528091859|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
146433586|NCT00731783|528091858|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
146433587|NCT00731783|528091859|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
146433588|NCT01802320|528091860|FG000|Overall Study|Death|1|||
146433589|NCT01802320|528091860|FG000|Overall Study|Withdrawal by Subject|1|||
146433590|NCT02222818|528093365|FG000|Period 1|Eligibility criteria not met|0|||
146433591|NCT02222818|528093366|FG001|Period 1|Eligibility criteria not met|3|||
146433592|NCT00934050|528093367|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
146433593|NCT00934050|528093368|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
146433594|NCT00934050|528093369|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
145951389|NCT03224624|526333886|FG001|Overall Study|Lost to Follow-up|4|||
145951390|NCT03224624|526333885|FG000|Overall Study|Death|1|||
145951391|NCT03224624|526333886|FG001|Overall Study|Death|0|||
145951392|NCT01884545|526333887|FG000|Overall Study|Lost to Follow-up|6|||
145951393|NCT01884545|526333888|FG001|Overall Study|Lost to Follow-up|4|||
145951394|NCT01884545|526333889|FG002|Overall Study|Lost to Follow-up|9|||
145951395|NCT01884545|526333890|FG003|Overall Study|Lost to Follow-up|4|||
145951396|NCT01884545|526333887|FG000|Overall Study|Patient withdrawn|7|||
145951397|NCT01884545|526333888|FG001|Overall Study|Patient withdrawn|12|||
145951398|NCT01884545|526333889|FG002|Overall Study|Patient withdrawn|5|||
145951399|NCT01884545|526333890|FG003|Overall Study|Patient withdrawn|5|||
145951400|NCT01884545|526333887|FG000|Overall Study|Non-adherence|0|||
145951401|NCT01884545|526333888|FG001|Overall Study|Non-adherence|2|||
145951402|NCT01884545|526333889|FG002|Overall Study|Non-adherence|0|||
146082943|NCT03085914|526824714|FG005|Overall Study|Lost to Follow-up|1|||
146082944|NCT03085914|526824715|FG006|Overall Study|Lost to Follow-up|1|||
146082945|NCT03085914|526824709|FG000|Overall Study|Reason was not specified,|2|||
146433595|NCT00934050|528093370|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
146433596|NCT00934050|528093371|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
146433597|NCT00934050|528093372|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
146433598|NCT00934050|528093367|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
146433599|NCT00934050|528093368|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
146433600|NCT00934050|528093369|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
146433601|NCT00934050|528093370|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
146433602|NCT00934050|528093371|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
146433603|NCT00934050|528093372|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
146433604|NCT00934050|528093367|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
146433605|NCT00934050|528093368|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
146433606|NCT00934050|528093369|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
146433607|NCT00934050|528093370|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
146433608|NCT00934050|528093371|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
146433609|NCT00934050|528093372|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
146433610|NCT00934050|528093367|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
146433611|NCT00934050|528093368|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
146433612|NCT00934050|528093369|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
146433613|NCT00934050|528093370|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
146433614|NCT00934050|528093371|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
146433615|NCT00934050|528093372|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
146433616|NCT00934050|528093367|FG000|Enrolled After 15 Dec 2009|Death|0|||
146433617|NCT00934050|528093368|FG001|Enrolled After 15 Dec 2009|Death|0|||
146433618|NCT00934050|528093369|FG002|Enrolled After 15 Dec 2009|Death|0|||
146433619|NCT00934050|528093370|FG003|Enrolled After 15 Dec 2009|Death|0|||
146433620|NCT00934050|528093371|FG004|Enrolled After 15 Dec 2009|Death|0|||
146433621|NCT00934050|528093372|FG005|Enrolled After 15 Dec 2009|Death|1|||
146433622|NCT00934050|528093367|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
146433623|NCT00934050|528093368|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
146433624|NCT00934050|528093369|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
146433625|NCT00934050|528093370|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
146433626|NCT00934050|528093371|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
146433627|NCT00934050|528093372|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
146433628|NCT00934050|528093367|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
146433629|NCT00934050|528093368|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
146433630|NCT00934050|528093369|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
146433631|NCT00934050|528093370|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
146433632|NCT00934050|528093371|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
146433633|NCT00934050|528093372|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
146433634|NCT02149420|528093375|FG000|Core Study|Administrative problems|0|||
146433635|NCT02149420|528093376|FG001|Core Study|Administrative problems|1|||
146433636|NCT02149420|528093377|FG002|Core Study|Administrative problems|2|||
146433637|NCT02149420|528093375|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
146433638|NCT02149420|528093376|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
146433639|NCT02149420|528093377|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
146433640|NCT03181594|528093378|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
146433641|NCT03181594|528093378|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
146433642|NCT03181594|528093378|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
146433643|NCT03181594|528093378|FG000|Initial Study Protocol (12-month FU)|Death|1|||
145951403|NCT01884545|526333890|FG003|Overall Study|Non-adherence|0|||
145951404|NCT01424241|526333891|FG000|Overall Study|Withdrawal by Subject|1|||
145951405|NCT01424241|526333891|FG000|Overall Study|Time constraints|2|||
145951406|NCT02782377|526333892|FG000|Overall Study|Physician Decision|5|||
146082946|NCT03085914|526824710|FG001|Overall Study|Reason was not specified,|2|||
145951407|NCT04318132|526333893|FG000|Overall Study|Protocol Violation|0|||
145951408|NCT04318132|526333894|FG001|Overall Study|Protocol Violation|0|||
146433644|NCT03181594|528093378|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
146433645|NCT03181594|528093378|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
146433646|NCT00960297|528093381|FG000|Overall Study|Physician Decision|1|||
146433647|NCT00960297|528093381|FG000|Overall Study|Venous port infection|1|||
146433648|NCT00960297|528093381|FG000|Overall Study|Disease progression|1|||
146433649|NCT03247972|528093391|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
146433650|NCT03247972|528093391|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
146433651|NCT02576938|528093394|FG000|Overall Study|Adverse Event|5|||
146433652|NCT02576938|528093395|FG001|Overall Study|Adverse Event|3|||
146433653|NCT02576938|528093396|FG002|Overall Study|Adverse Event|6|||
146433654|NCT02576938|528093394|FG000|Overall Study|Protocol Violation|1|||
146433655|NCT02576938|528093395|FG001|Overall Study|Protocol Violation|1|||
146433656|NCT02576938|528093396|FG002|Overall Study|Protocol Violation|1|||
146433657|NCT02576938|528093394|FG000|Overall Study|Withdrawal by Subject|3|||
146433658|NCT02576938|528093395|FG001|Overall Study|Withdrawal by Subject|2|||
146433659|NCT02576938|528093396|FG002|Overall Study|Withdrawal by Subject|4|||
146433660|NCT02576938|528093394|FG000|Overall Study|Lack of Efficacy|9|||
146433661|NCT02576938|528093395|FG001|Overall Study|Lack of Efficacy|4|||
146433662|NCT02576938|528093396|FG002|Overall Study|Lack of Efficacy|0|||
146433663|NCT02576938|528093394|FG000|Overall Study|Lost to Follow-up|2|||
146433664|NCT02576938|528093395|FG001|Overall Study|Lost to Follow-up|0|||
146433665|NCT02576938|528093396|FG002|Overall Study|Lost to Follow-up|1|||
146433666|NCT02576938|528093394|FG000|Overall Study|Physician Decision|0|||
146433667|NCT02576938|528093395|FG001|Overall Study|Physician Decision|1|||
146433668|NCT02576938|528093396|FG002|Overall Study|Physician Decision|0|||
146433669|NCT02576938|528093394|FG000|Overall Study|Met Exclusion Criteria|0|||
146433670|NCT02576938|528093395|FG001|Overall Study|Met Exclusion Criteria|1|||
146433671|NCT02576938|528093396|FG002|Overall Study|Met Exclusion Criteria|0|||
146433672|NCT03500341|528093397|FG000|Overall Study|Withdrawn prior to Completion|2|||
146433673|NCT00968812|528093398|FG000|Overall Study|Adverse Event|30|||
146433674|NCT00968812|528093399|FG001|Overall Study|Adverse Event|46|||
146433675|NCT00968812|528093400|FG002|Overall Study|Adverse Event|33|||
146433676|NCT00968812|528093398|FG000|Overall Study|Death|2|||
146433677|NCT00968812|528093399|FG001|Overall Study|Death|2|||
146433678|NCT00968812|528093400|FG002|Overall Study|Death|1|||
146433679|NCT00968812|528093398|FG000|Overall Study|Lack of Efficacy|9|||
146206669|NCT02581215|527272034|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
146206670|NCT02581215|527272033|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146206671|NCT02581215|527272034|FG001|Overall Study|Eligibility Criteria Not Met|1|||
146206672|NCT04279574|527272040|FG000|Overall Study|Death|1|||
146206673|NCT04279574|527272041|FG001|Overall Study|Death|0|||
146433680|NCT00968812|528093399|FG001|Overall Study|Lack of Efficacy|7|||
146433681|NCT00968812|528093400|FG002|Overall Study|Lack of Efficacy|16|||
146433682|NCT00968812|528093398|FG000|Overall Study|Lost to Follow-up|17|||
146433683|NCT00968812|528093399|FG001|Overall Study|Lost to Follow-up|12|||
146433684|NCT00968812|528093400|FG002|Overall Study|Lost to Follow-up|11|||
146433685|NCT00968812|528093398|FG000|Overall Study|Physician Decision|8|||
146433686|NCT00968812|528093399|FG001|Overall Study|Physician Decision|5|||
146433687|NCT00968812|528093400|FG002|Overall Study|Physician Decision|9|||
146433688|NCT00968812|528093398|FG000|Overall Study|Protocol Violation|7|||
146433689|NCT00968812|528093399|FG001|Overall Study|Protocol Violation|4|||
146433690|NCT00968812|528093400|FG002|Overall Study|Protocol Violation|3|||
146433691|NCT00968812|528093398|FG000|Overall Study|Withdrawal by Subject|17|||
146433692|NCT00968812|528093399|FG001|Overall Study|Withdrawal by Subject|23|||
146433693|NCT00968812|528093400|FG002|Overall Study|Withdrawal by Subject|25|||
146433694|NCT00968812|528093398|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
146433695|NCT00968812|528093399|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
146433696|NCT00968812|528093400|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
146433697|NCT00968812|528093398|FG000|Overall Study|Noncompliance with study drug|4|||
146433698|NCT00968812|528093399|FG001|Overall Study|Noncompliance with study drug|1|||
146433699|NCT00968812|528093400|FG002|Overall Study|Noncompliance with study drug|6|||
146433700|NCT00968812|528093398|FG000|Overall Study|Unable to take rescue therapy|12|||
146433701|NCT00968812|528093399|FG001|Overall Study|Unable to take rescue therapy|12|||
146433702|NCT00968812|528093400|FG002|Overall Study|Unable to take rescue therapy|17|||
146433703|NCT00968812|528093398|FG000|Overall Study|Other|25|||
146433704|NCT00968812|528093399|FG001|Overall Study|Other|37|||
146433705|NCT00968812|528093400|FG002|Overall Study|Other|40|||
146433706|NCT00571064|528093403|FG000|Overall Study|Adverse Event|13|||
146433707|NCT00571064|528093403|FG000|Overall Study|Protocol Violation|4|||
146433708|NCT00571064|528093403|FG000|Overall Study|Withdrawal by Subject|2|||
146433709|NCT00571064|528093403|FG000|Overall Study|Other|2|||
146433710|NCT00003659|528093410|FG000|Overall Study|Withdrawal by Subject|3|||
146433711|NCT04022954|528093411|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
146433712|NCT04022954|528093411|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
146433713|NCT04022954|528093411|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
146433714|NCT03017885|528093412|FG000|Overall Study|Adverse Event|2|||
146433715|NCT03017885|528093413|FG001|Overall Study|Adverse Event|0|||
146433716|NCT03017885|528093414|FG002|Overall Study|Adverse Event|0|||
146433717|NCT03017885|528093415|FG003|Overall Study|Adverse Event|0|||
146206674|NCT04279574|527272040|FG000|Overall Study|lost restoration, tooth fracture|1|||
146206675|NCT04279574|527272041|FG001|Overall Study|lost restoration, tooth fracture|0|||
146206676|NCT04279574|527272040|FG000|Overall Study|Lost to Follow-up|0|||
146433718|NCT03017885|528093416|FG004|Overall Study|Adverse Event|0|||
146433719|NCT03017885|528093417|FG005|Overall Study|Adverse Event|0|||
146433720|NCT03017885|528093412|FG000|Overall Study|Progression of disease|4|||
146433721|NCT03017885|528093413|FG001|Overall Study|Progression of disease|3|||
146433722|NCT03017885|528093414|FG002|Overall Study|Progression of disease|4|||
146433723|NCT03017885|528093415|FG003|Overall Study|Progression of disease|0|||
146433724|NCT03017885|528093416|FG004|Overall Study|Progression of disease|0|||
146433725|NCT03017885|528093417|FG005|Overall Study|Progression of disease|0|||
146433726|NCT03017885|528093412|FG000|Overall Study|Other than listed|1|||
146206677|NCT04279574|527272041|FG001|Overall Study|Lost to Follow-up|1|||
146206678|NCT03112174|527272043|FG000|Overall Study|Withdrawal by Subject|3|||
146206679|NCT03112174|527272044|FG001|Overall Study|Withdrawal by Subject|0|||
146206680|NCT03112174|527272045|FG002|Overall Study|Withdrawal by Subject|11|||
146206681|NCT03112174|527272046|FG003|Overall Study|Withdrawal by Subject|9|||
146206682|NCT03112174|527272047|FG004|Overall Study|Withdrawal by Subject|7|||
146206683|NCT03112174|527272043|FG000|Overall Study|Lost to Follow-up|1|||
146206684|NCT03112174|527272044|FG001|Overall Study|Lost to Follow-up|1|||
146206685|NCT03112174|527272045|FG002|Overall Study|Lost to Follow-up|2|||
146206686|NCT03112174|527272046|FG003|Overall Study|Lost to Follow-up|3|||
146206687|NCT03112174|527272047|FG004|Overall Study|Lost to Follow-up|2|||
146206688|NCT03112174|527272043|FG000|Overall Study|Death|8|||
146206689|NCT03112174|527272044|FG001|Overall Study|Death|3|||
146206690|NCT03112174|527272045|FG002|Overall Study|Death|67|||
146206691|NCT03112174|527272046|FG003|Overall Study|Death|73|||
146206692|NCT03112174|527272047|FG004|Overall Study|Death|18|||
146206693|NCT03112174|527272043|FG000|Overall Study|Other, Not Specified|1|||
146206694|NCT03112174|527272044|FG001|Overall Study|Other, Not Specified|0|||
146206695|NCT03112174|527272045|FG002|Overall Study|Other, Not Specified|1|||
146206696|NCT03112174|527272046|FG003|Overall Study|Other, Not Specified|2|||
146206697|NCT03112174|527272047|FG004|Overall Study|Other, Not Specified|0|||
146206698|NCT00802464|527272049|FG000|Month 0 - Month 8|Adverse Event|0|||
146206699|NCT00802464|527272050|FG001|Month 0 - Month 8|Adverse Event|1|||
146206700|NCT00802464|527272051|FG002|Month 0 - Month 8|Adverse Event|1|||
146206701|NCT00802464|527272052|FG003|Month 0 - Month 8|Adverse Event|2|||
146206702|NCT00802464|527272049|FG000|Month 0 - Month 8|Protocol Violation|0|||
146206703|NCT00802464|527272050|FG001|Month 0 - Month 8|Protocol Violation|0|||
146206704|NCT00802464|527272051|FG002|Month 0 - Month 8|Protocol Violation|1|||
146206705|NCT00802464|527272052|FG003|Month 0 - Month 8|Protocol Violation|0|||
146206706|NCT00802464|527272049|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
146206707|NCT00802464|527272050|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
146206708|NCT00802464|527272051|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
146206709|NCT00802464|527272052|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
146206710|NCT00802464|527272049|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
146206711|NCT00802464|527272050|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
146206712|NCT00802464|527272051|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
146206713|NCT00802464|527272052|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
146206714|NCT00802464|527272049|FG000|Month 0 - Month 8|Other|0|||
146206715|NCT00802464|527272050|FG001|Month 0 - Month 8|Other|0|||
146206716|NCT00802464|527272051|FG002|Month 0 - Month 8|Other|1|||
146206717|NCT00802464|527272052|FG003|Month 0 - Month 8|Other|0|||
146206718|NCT00802464|527272049|FG000|Month 8 - Month 14|Adverse Event|0|||
146206719|NCT00802464|527272050|FG001|Month 8 - Month 14|Adverse Event|1|||
146206720|NCT00802464|527272051|FG002|Month 8 - Month 14|Adverse Event|0|||
146206721|NCT00802464|527272052|FG003|Month 8 - Month 14|Adverse Event|0|||
146433727|NCT03017885|528093413|FG001|Overall Study|Other than listed|2|||
146206722|NCT00802464|527272049|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
146206723|NCT00802464|527272050|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
146206724|NCT00802464|527272051|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
146206725|NCT00802464|527272052|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
146206726|NCT00802464|527272049|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
146206727|NCT00802464|527272050|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
146206728|NCT00802464|527272051|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
146206729|NCT00802464|527272052|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
146206730|NCT04512482|527272062|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
146206731|NCT04512482|527272063|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
146206732|NCT01939899|527272064|FG000|Lead-in Dose Finding Phase|Death|0|||
146206733|NCT01939899|527272065|FG001|Lead-in Dose Finding Phase|Death|3|||
146206734|NCT01939899|527272066|FG002|Lead-in Dose Finding Phase|Death|1|||
146206735|NCT01939899|527272067|FG003|Lead-in Dose Finding Phase|Death|0|||
146206736|NCT01939899|527272068|FG004|Lead-in Dose Finding Phase|Death|0|||
146206737|NCT01939899|527272064|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
146433728|NCT03017885|528093414|FG002|Overall Study|Other than listed|1|||
146433729|NCT03017885|528093415|FG003|Overall Study|Other than listed|0|||
146206738|NCT01939899|527272065|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
146206739|NCT01939899|527272066|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
146206740|NCT01939899|527272067|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
146433730|NCT03017885|528093416|FG004|Overall Study|Other than listed|0|||
146433731|NCT03017885|528093417|FG005|Overall Study|Other than listed|0|||
146433732|NCT03017885|528093412|FG000|Overall Study|Lost to Follow-up|2|||
146433733|NCT03017885|528093413|FG001|Overall Study|Lost to Follow-up|0|||
146433734|NCT03017885|528093414|FG002|Overall Study|Lost to Follow-up|3|||
146433735|NCT03017885|528093415|FG003|Overall Study|Lost to Follow-up|0|||
146433736|NCT03017885|528093416|FG004|Overall Study|Lost to Follow-up|0|||
146433737|NCT03017885|528093417|FG005|Overall Study|Lost to Follow-up|0|||
146433738|NCT03017885|528093412|FG000|Overall Study|Change to other anti-cancer therapy|0|||
146433739|NCT03017885|528093413|FG001|Overall Study|Change to other anti-cancer therapy|0|||
146433740|NCT03017885|528093414|FG002|Overall Study|Change to other anti-cancer therapy|1|||
146433741|NCT03017885|528093415|FG003|Overall Study|Change to other anti-cancer therapy|0|||
146433742|NCT03017885|528093416|FG004|Overall Study|Change to other anti-cancer therapy|0|||
146433743|NCT03017885|528093417|FG005|Overall Study|Change to other anti-cancer therapy|0|||
146433744|NCT02258074|528093419|FG000|Overall Study|Withdrawal by Subject|1|||
146433745|NCT02258074|528093420|FG001|Overall Study|Withdrawal by Subject|0|||
146433746|NCT02258074|528093421|FG002|Overall Study|Withdrawal by Subject|0|||
146433747|NCT02258074|528093422|FG003|Overall Study|Withdrawal by Subject|0|||
146433748|NCT05446870|528093423|FG000|Overall Study|Death|6|||
146433749|NCT05446870|528093424|FG001|Overall Study|Death|5|||
146433750|NCT05446870|528093423|FG000|Overall Study|Lost to Follow-up|0|||
146433751|NCT05446870|528093424|FG001|Overall Study|Lost to Follow-up|1|||
146433752|NCT05446870|528093423|FG000|Overall Study|Physician Decision|52|||
146433753|NCT05446870|528093424|FG001|Overall Study|Physician Decision|53|||
146433754|NCT05446870|528093423|FG000|Overall Study|Withdrawal by Subject|3|||
146433755|NCT05446870|528093424|FG001|Overall Study|Withdrawal by Subject|3|||
146433756|NCT04108858|528093426|FG000|Overall Study|Adverse Event|1|||
146433757|NCT01005745|528093427|FG000|Overall Study|No TIL growth|1|||
146433758|NCT01005745|528093427|FG000|Overall Study|Disease progressed during TIL growth|3|||
146433759|NCT01005745|528093427|FG000|Overall Study|Death prior to treatment|1|||
146206741|NCT01939899|527272068|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
146433760|NCT01005745|528093427|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
146433761|NCT01208337|528093432|FG000|Overall Study|Death|3|||
146433762|NCT03663179|528093436|FG000|Overall Study|Withdrawal by Subject|2|||
146206742|NCT01939899|527272064|FG000|Lead-in Dose Finding Phase|Other|0|||
146206743|NCT01939899|527272065|FG001|Lead-in Dose Finding Phase|Other|0|||
146433763|NCT03663179|528093437|FG001|Overall Study|Withdrawal by Subject|0|||
146433764|NCT03663179|528093436|FG000|Overall Study|Lost to Follow-up|1|||
146433765|NCT03663179|528093437|FG001|Overall Study|Lost to Follow-up|1|||
146082947|NCT03085914|526824711|FG002|Overall Study|Reason was not specified,|2|||
146206744|NCT01939899|527272066|FG002|Lead-in Dose Finding Phase|Other|1|||
146206745|NCT01939899|527272067|FG003|Lead-in Dose Finding Phase|Other|0|||
146433766|NCT03663179|528093436|FG000|Overall Study|Revealed exclusionary condition|1|||
146433767|NCT03663179|528093437|FG001|Overall Study|Revealed exclusionary condition|0|||
146433768|NCT01615198|528093441|FG000|Overall Study|Withdrawal by Subject|5|||
146433769|NCT01615198|528093442|FG001|Overall Study|Withdrawal by Subject|5|||
146433770|NCT01615198|528093441|FG000|Overall Study|Protocol deviation|1|||
146433771|NCT01615198|528093442|FG001|Overall Study|Protocol deviation|1|||
146433772|NCT01615198|528093441|FG000|Overall Study|Physician Decision|5|||
146433773|NCT01615198|528093442|FG001|Overall Study|Physician Decision|1|||
146433774|NCT01615198|528093441|FG000|Overall Study|Lost to Follow-up|1|||
146433775|NCT01615198|528093442|FG001|Overall Study|Lost to Follow-up|1|||
146433776|NCT01615198|528093441|FG000|Overall Study|Lack of Efficacy|1|||
146433777|NCT01615198|528093442|FG001|Overall Study|Lack of Efficacy|6|||
146433778|NCT01615198|528093441|FG000|Overall Study|Adverse Event|11|||
146433779|NCT01615198|528093442|FG001|Overall Study|Adverse Event|5|||
146433780|NCT01686438|528093443|FG000|Overall Study|Lost to Follow-up|8|||
146433781|NCT01686438|528093444|FG001|Overall Study|Lost to Follow-up|9|||
146433782|NCT01686438|528093445|FG002|Overall Study|Lost to Follow-up|10|||
146433783|NCT01686438|528093443|FG000|Overall Study|Adverse Event|0|||
146433784|NCT01686438|528093444|FG001|Overall Study|Adverse Event|0|||
146433785|NCT01686438|528093445|FG002|Overall Study|Adverse Event|1|||
146206746|NCT01939899|527272068|FG004|Lead-in Dose Finding Phase|Other|0|||
146433786|NCT01686438|528093443|FG000|Overall Study|Protocol Violation|0|||
146433787|NCT01686438|528093444|FG001|Overall Study|Protocol Violation|0|||
146433788|NCT01686438|528093445|FG002|Overall Study|Protocol Violation|1|||
146433789|NCT01686438|528093443|FG000|Overall Study|Withdrawal by Subject|0|||
146433790|NCT01686438|528093444|FG001|Overall Study|Withdrawal by Subject|0|||
146433791|NCT01686438|528093445|FG002|Overall Study|Withdrawal by Subject|1|||
146433792|NCT00984126|528093446|FG000|Overall Study|Protocol Violation|0|||
146433793|NCT00984126|528093447|FG001|Overall Study|Protocol Violation|0|||
146433794|NCT00984126|528093448|FG002|Overall Study|Protocol Violation|1|||
146433795|NCT00984126|528093449|FG003|Overall Study|Protocol Violation|2|||
146433796|NCT00984126|528093446|FG000|Overall Study|Adverse Event|0|||
146433797|NCT00984126|528093447|FG001|Overall Study|Adverse Event|0|||
146433798|NCT00984126|528093448|FG002|Overall Study|Adverse Event|0|||
146433799|NCT00984126|528093449|FG003|Overall Study|Adverse Event|2|||
146433800|NCT00984126|528093446|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
146433801|NCT00984126|528093447|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
146433802|NCT00984126|528093448|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
146433803|NCT00984126|528093449|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
146433804|NCT00984126|528093446|FG000|Overall Study|Withdrawal criteria|0|||
146433805|NCT00984126|528093447|FG001|Overall Study|Withdrawal criteria|1|||
146433806|NCT00984126|528093448|FG002|Overall Study|Withdrawal criteria|3|||
146433807|NCT00984126|528093449|FG003|Overall Study|Withdrawal criteria|9|||
146433808|NCT01029340|528093453|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
146433809|NCT01029340|528093454|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
146433810|NCT01029340|528093455|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
146433811|NCT01029340|528093456|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
146433812|NCT01029340|528093457|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
146433813|NCT01029340|528093458|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
146433814|NCT01029340|528093453|FG000|Part B Treatment Period|Protocol Violation|0|||
146433815|NCT01029340|528093454|FG001|Part B Treatment Period|Protocol Violation|0|||
146433816|NCT01029340|528093455|FG002|Part B Treatment Period|Protocol Violation|1|||
146433817|NCT01029340|528093456|FG003|Part B Treatment Period|Protocol Violation|0|||
146433818|NCT01029340|528093457|FG004|Part B Treatment Period|Protocol Violation|0|||
146433819|NCT01029340|528093458|FG005|Part B Treatment Period|Protocol Violation|0|||
146433820|NCT01029340|528093453|FG000|Extension Period|Adverse Event|0|||
146433821|NCT01029340|528093454|FG001|Extension Period|Adverse Event|0|||
146433822|NCT01029340|528093455|FG002|Extension Period|Adverse Event|0|||
146433823|NCT01029340|528093456|FG003|Extension Period|Adverse Event|0|||
146433824|NCT01029340|528093457|FG004|Extension Period|Adverse Event|0|||
146433825|NCT01029340|528093458|FG005|Extension Period|Adverse Event|1|||
146433826|NCT01029340|528093453|FG000|Extension Period|starting another study|0|||
146433827|NCT01029340|528093454|FG001|Extension Period|starting another study|0|||
146433828|NCT01029340|528093455|FG002|Extension Period|starting another study|0|||
146433829|NCT01029340|528093456|FG003|Extension Period|starting another study|0|||
146433830|NCT01029340|528093457|FG004|Extension Period|starting another study|0|||
146433831|NCT01029340|528093458|FG005|Extension Period|starting another study|8|||
146433832|NCT01029340|528093453|FG000|Extension Period|non-compliance|0|||
146206747|NCT01939899|527272064|FG000|Phase 2|Withdrawal by Subject|0|||
146433833|NCT01029340|528093454|FG001|Extension Period|non-compliance|0|||
146433834|NCT01029340|528093455|FG002|Extension Period|non-compliance|0|||
146433835|NCT01029340|528093456|FG003|Extension Period|non-compliance|0|||
146206748|NCT01939899|527272065|FG001|Phase 2|Withdrawal by Subject|0|||
146206749|NCT01939899|527272066|FG002|Phase 2|Withdrawal by Subject|0|||
146206750|NCT01939899|527272067|FG003|Phase 2|Withdrawal by Subject|2|||
146206751|NCT01939899|527272068|FG004|Phase 2|Withdrawal by Subject|0|||
146206752|NCT01939899|527272064|FG000|Phase 2|Disease Progression|0|||
146206753|NCT01939899|527272065|FG001|Phase 2|Disease Progression|0|||
146206754|NCT01939899|527272066|FG002|Phase 2|Disease Progression|0|||
146206755|NCT01939899|527272067|FG003|Phase 2|Disease Progression|9|||
146206756|NCT01939899|527272068|FG004|Phase 2|Disease Progression|1|||
146206757|NCT04723394|527272069|FG000|Overall Study|Adverse Event|0|||
146206758|NCT04723394|527272070|FG001|Overall Study|Adverse Event|3|||
146206759|NCT04723394|527272069|FG000|Overall Study|Death|8|||
146206760|NCT04723394|527272070|FG001|Overall Study|Death|8|||
146206761|NCT04723394|527272069|FG000|Overall Study|Lost to Follow-up|20|||
146206762|NCT04723394|527272070|FG001|Overall Study|Lost to Follow-up|17|||
146206763|NCT04723394|527272069|FG000|Overall Study|Physician Decision|1|||
146206764|NCT04723394|527272070|FG001|Overall Study|Physician Decision|0|||
146206765|NCT04723394|527272069|FG000|Overall Study|Withdrawal by Subject|20|||
146206766|NCT04723394|527272070|FG001|Overall Study|Withdrawal by Subject|34|||
146206767|NCT04723394|527272069|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
146206768|NCT04723394|527272070|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
146206769|NCT02706717|527272073|FG000|Overall Study|Withdrawal by Subject|1|||
146206770|NCT02706717|527272074|FG001|Overall Study|Withdrawal by Subject|8|||
146206771|NCT02706717|527272073|FG000|Overall Study|Lost to Follow-up|0|||
146206772|NCT02706717|527272074|FG001|Overall Study|Lost to Follow-up|1|||
146206773|NCT02706717|527272073|FG000|Overall Study|Physician Decision|0|||
146206774|NCT02706717|527272074|FG001|Overall Study|Physician Decision|1|||
146206775|NCT02706717|527272073|FG000|Overall Study|Death|0|||
146206776|NCT02706717|527272074|FG001|Overall Study|Death|1|||
146206777|NCT00106080|527272078|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
146206778|NCT00106080|527272079|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
146206779|NCT01414738|527272081|FG000|Overall Study|Death|26|||
146206780|NCT01414738|527272081|FG000|Overall Study|Refused testing|5|||
146206781|NCT01414738|527272081|FG000|Overall Study|Lost to Follow-up|2|||
146206782|NCT01414738|527272081|FG000|Overall Study|Refused, disease progression|8|||
146206783|NCT01414738|527272081|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
146206784|NCT01266122|527272083|FG000|Overall Study|Lost to Follow-up|6|||
146206785|NCT01266122|527272084|FG001|Overall Study|Lost to Follow-up|6|||
146206786|NCT00421889|527272085|FG000|Overall Study|Adverse Event|1|||
146206787|NCT00421889|527272086|FG001|Overall Study|Adverse Event|0|||
146206788|NCT00421889|527272087|FG002|Overall Study|Adverse Event|1|||
146206789|NCT00421889|527272088|FG003|Overall Study|Adverse Event|1|||
146206790|NCT00421889|527272089|FG004|Overall Study|Adverse Event|1|||
146206791|NCT00421889|527272090|FG005|Overall Study|Adverse Event|4|||
146206792|NCT00421889|527272091|FG006|Overall Study|Adverse Event|1|||
146206793|NCT00421889|527272092|FG007|Overall Study|Adverse Event|0|||
146206794|NCT00421889|527272093|FG008|Overall Study|Adverse Event|2|||
146206795|NCT00421889|527272085|FG000|Overall Study|Withdrawal by Subject|1|||
146206796|NCT00421889|527272086|FG001|Overall Study|Withdrawal by Subject|3|||
146206797|NCT00421889|527272087|FG002|Overall Study|Withdrawal by Subject|0|||
146206798|NCT00421889|527272088|FG003|Overall Study|Withdrawal by Subject|0|||
146206799|NCT00421889|527272089|FG004|Overall Study|Withdrawal by Subject|2|||
146206800|NCT00421889|527272090|FG005|Overall Study|Withdrawal by Subject|0|||
146206801|NCT00421889|527272091|FG006|Overall Study|Withdrawal by Subject|0|||
146206802|NCT00421889|527272092|FG007|Overall Study|Withdrawal by Subject|0|||
146206803|NCT00421889|527272093|FG008|Overall Study|Withdrawal by Subject|0|||
146206804|NCT00421889|527272085|FG000|Overall Study|Death|0|||
146206805|NCT00421889|527272086|FG001|Overall Study|Death|0|||
146206806|NCT00421889|527272087|FG002|Overall Study|Death|0|||
146206807|NCT00421889|527272088|FG003|Overall Study|Death|0|||
146206808|NCT00421889|527272089|FG004|Overall Study|Death|1|||
146206809|NCT00421889|527272090|FG005|Overall Study|Death|1|||
146206810|NCT00421889|527272091|FG006|Overall Study|Death|0|||
146206811|NCT00421889|527272092|FG007|Overall Study|Death|0|||
146206812|NCT00421889|527272093|FG008|Overall Study|Death|0|||
146206813|NCT00421889|527272085|FG000|Overall Study|Progressive disease|3|||
146206814|NCT00421889|527272086|FG001|Overall Study|Progressive disease|2|||
146206815|NCT00421889|527272087|FG002|Overall Study|Progressive disease|2|||
146206816|NCT00421889|527272088|FG003|Overall Study|Progressive disease|3|||
146206817|NCT00421889|527272089|FG004|Overall Study|Progressive disease|2|||
146206818|NCT00421889|527272090|FG005|Overall Study|Progressive disease|21|||
146206819|NCT00421889|527272091|FG006|Overall Study|Progressive disease|3|||
146206820|NCT00421889|527272092|FG007|Overall Study|Progressive disease|1|||
146206821|NCT00421889|527272093|FG008|Overall Study|Progressive disease|5|||
146206822|NCT00421889|527272085|FG000|Overall Study|Patient/Investigator request|0|||
146206823|NCT00421889|527272086|FG001|Overall Study|Patient/Investigator request|0|||
146206824|NCT00421889|527272087|FG002|Overall Study|Patient/Investigator request|0|||
146206825|NCT00421889|527272088|FG003|Overall Study|Patient/Investigator request|0|||
146206826|NCT00421889|527272089|FG004|Overall Study|Patient/Investigator request|0|||
146206827|NCT00421889|527272090|FG005|Overall Study|Patient/Investigator request|9|||
146206828|NCT00421889|527272091|FG006|Overall Study|Patient/Investigator request|0|||
146206829|NCT00421889|527272092|FG007|Overall Study|Patient/Investigator request|1|||
146206830|NCT00421889|527272093|FG008|Overall Study|Patient/Investigator request|3|||
146206831|NCT00421889|527272085|FG000|Overall Study|Lost to Follow-up|0|||
146206832|NCT00421889|527272086|FG001|Overall Study|Lost to Follow-up|0|||
146206833|NCT00421889|527272087|FG002|Overall Study|Lost to Follow-up|0|||
146206834|NCT00421889|527272088|FG003|Overall Study|Lost to Follow-up|0|||
146206835|NCT00421889|527272089|FG004|Overall Study|Lost to Follow-up|0|||
146433836|NCT01029340|528093457|FG004|Extension Period|non-compliance|0|||
146433837|NCT01029340|528093458|FG005|Extension Period|non-compliance|1|||
146433838|NCT01029340|528093453|FG000|Extension Period|Withdrawal by Subject|0|||
146433839|NCT01029340|528093454|FG001|Extension Period|Withdrawal by Subject|0|||
146433840|NCT01029340|528093455|FG002|Extension Period|Withdrawal by Subject|0|||
146433841|NCT01029340|528093456|FG003|Extension Period|Withdrawal by Subject|0|||
146433842|NCT01029340|528093457|FG004|Extension Period|Withdrawal by Subject|0|||
146433843|NCT01029340|528093458|FG005|Extension Period|Withdrawal by Subject|1|||
146433844|NCT01029340|528093453|FG000|Extension Period|Physician Decision|0|||
146433845|NCT01029340|528093454|FG001|Extension Period|Physician Decision|0|||
146433846|NCT01029340|528093455|FG002|Extension Period|Physician Decision|0|||
146433847|NCT01029340|528093456|FG003|Extension Period|Physician Decision|0|||
146433848|NCT01029340|528093457|FG004|Extension Period|Physician Decision|0|||
146206836|NCT00421889|527272090|FG005|Overall Study|Lost to Follow-up|0|||
146206837|NCT00421889|527272091|FG006|Overall Study|Lost to Follow-up|0|||
146206838|NCT00421889|527272092|FG007|Overall Study|Lost to Follow-up|0|||
146206839|NCT00421889|527272093|FG008|Overall Study|Lost to Follow-up|1|||
146206840|NCT00978042|527272094|FG000|Initial Treatment Period|Treated in Error|0|||
146206841|NCT00978042|527272095|FG001|Initial Treatment Period|Treated in Error|3|||
146206842|NCT00978042|527272094|FG000|Initial Treatment Period|Ineligibility|1|||
146206843|NCT00978042|527272095|FG001|Initial Treatment Period|Ineligibility|0|||
146206844|NCT00978042|527272094|FG000|Initial Treatment Period|Lost to Follow-up|21|||
146206845|NCT00978042|527272095|FG001|Initial Treatment Period|Lost to Follow-up|3|||
146206846|NCT00978042|527272094|FG000|Initial Treatment Period|Adverse Event|2|||
146206847|NCT00978042|527272095|FG001|Initial Treatment Period|Adverse Event|0|||
146433849|NCT01029340|528093458|FG005|Extension Period|Physician Decision|1|||
146206848|NCT00978042|527272094|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
146206849|NCT00978042|527272095|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
146206850|NCT00978042|527272094|FG000|Initial Treatment Period|Consent withdrawn|22|||
146206851|NCT00978042|527272095|FG001|Initial Treatment Period|Consent withdrawn|9|||
146206852|NCT00978042|527272094|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
146206853|NCT00978042|527272095|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
146206854|NCT00529516|527272096|FG000|Overall Study|Adverse Event|2|||
146206855|NCT00529516|527272097|FG001|Overall Study|Adverse Event|1|||
146206856|NCT00529516|527272098|FG002|Overall Study|Adverse Event|0|||
146206857|NCT00529516|527272096|FG000|Overall Study|Withdrawal by Subject|1|||
146206858|NCT00529516|527272097|FG001|Overall Study|Withdrawal by Subject|1|||
146206859|NCT00529516|527272098|FG002|Overall Study|Withdrawal by Subject|0|||
146206860|NCT00529516|527272096|FG000|Overall Study|Lost to Follow-up|0|||
146206861|NCT00529516|527272097|FG001|Overall Study|Lost to Follow-up|0|||
146206862|NCT00529516|527272098|FG002|Overall Study|Lost to Follow-up|1|||
146206863|NCT00703820|527272101|FG000|Overall Study|Adverse Event|12|||
146206864|NCT00703820|527272102|FG001|Overall Study|Adverse Event|17|||
146206865|NCT00703820|527272101|FG000|Overall Study|Death|5|||
146206866|NCT00703820|527272102|FG001|Overall Study|Death|0|||
146206867|NCT00703820|527272101|FG000|Overall Study|Lack of Efficacy|11|||
146206868|NCT00703820|527272102|FG001|Overall Study|Lack of Efficacy|11|||
146206869|NCT00703820|527272101|FG000|Overall Study|Received non-protocol therapy|1|||
146206870|NCT00703820|527272102|FG001|Overall Study|Received non-protocol therapy|0|||
146206871|NCT00703820|527272101|FG000|Overall Study|Physician Decision|4|||
146206872|NCT00703820|527272102|FG001|Overall Study|Physician Decision|5|||
146433850|NCT01864174|528093459|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
146433851|NCT01864174|528093460|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
146433852|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
146433853|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
146433854|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
146433855|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
146433856|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
146433857|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
146433858|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Death|1|||
146433859|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Death|0|||
146433860|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
146433861|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
146433862|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
146433863|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
145951409|NCT04318132|526333895|FG002|Overall Study|Protocol Violation|3|||
146206873|NCT00703820|527272101|FG000|Overall Study|Withdrawal by Subject|2|||
146206874|NCT00703820|527272102|FG001|Overall Study|Withdrawal by Subject|1|||
146206875|NCT00761605|527272107|FG000|Overall Study|Adverse Event|26|||
146206876|NCT00761605|527272107|FG000|Overall Study|Death|2|||
146206877|NCT00761605|527272107|FG000|Overall Study|Lack of Efficacy|26|||
146206878|NCT00761605|527272107|FG000|Overall Study|Lost to Follow-up|29|||
146433864|NCT01864174|528093459|FG000|Double Blind - Compliant Randomized|Other|6|||
146433865|NCT01864174|528093460|FG001|Double Blind - Compliant Randomized|Other|10|||
146433866|NCT01864174|528093459|FG000|Off Treatment Follow-Up|Other|2|||
146433867|NCT01864174|528093460|FG001|Off Treatment Follow-Up|Other|0|||
146433868|NCT01864174|528093459|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
146433869|NCT01864174|528093460|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
146433870|NCT02648347|528093461|FG000|Overall Study|Death|174|||
146433871|NCT02648347|528093462|FG001|Overall Study|Death|167|||
146433872|NCT02648347|528093461|FG000|Overall Study|Withdrawal by Subject|16|||
146433873|NCT02648347|528093462|FG001|Overall Study|Withdrawal by Subject|9|||
146433874|NCT02648347|528093461|FG000|Overall Study|Lost to Follow-up|18|||
146433875|NCT02648347|528093462|FG001|Overall Study|Lost to Follow-up|21|||
146433876|NCT02648347|528093461|FG000|Overall Study|Missing|1|||
146433877|NCT02648347|528093462|FG001|Overall Study|Missing|0|||
146433878|NCT02739997|528093467|FG000|Overall Study|Death|1|||
146433879|NCT02739997|528093467|FG000|Overall Study|Withdrawal by Subject|1|||
146433880|NCT01723397|528093471|FG000|Study Period 1|Protocol Violation|0|||
146433881|NCT01723397|528093472|FG001|Study Period 1|Protocol Violation|1|||
146433882|NCT01723397|528093471|FG000|Study Period 2|Protocol Violation|0|||
146433883|NCT01723397|528093472|FG001|Study Period 2|Protocol Violation|1|||
146433884|NCT00468286|528093475|FG000|Overall Study|Adverse Event|1|||
146433885|NCT00468286|528093476|FG001|Overall Study|Adverse Event|6|||
146433886|NCT00468286|528093475|FG000|Overall Study|Protocol Violation|2|||
146433887|NCT00468286|528093476|FG001|Overall Study|Protocol Violation|2|||
146433888|NCT00468286|528093475|FG000|Overall Study|Withdrawal by Subject|4|||
146433889|NCT00468286|528093476|FG001|Overall Study|Withdrawal by Subject|3|||
146433890|NCT00468286|528093475|FG000|Overall Study|Physician Decision|0|||
146433891|NCT00468286|528093476|FG001|Overall Study|Physician Decision|1|||
146433892|NCT02196675|528093477|FG000|Overall Study|Withdrawal by Subject|1|||
146433893|NCT02196675|528093478|FG001|Overall Study|Withdrawal by Subject|0|||
146433894|NCT02196675|528093479|FG002|Overall Study|Withdrawal by Subject|0|||
146433895|NCT02196675|528093477|FG000|Overall Study|Intra-operative surgical exclusion|1|||
146433896|NCT02196675|528093478|FG001|Overall Study|Intra-operative surgical exclusion|1|||
146433897|NCT02196675|528093479|FG002|Overall Study|Intra-operative surgical exclusion|0|||
146433898|NCT02196675|528093477|FG000|Overall Study|Protocol Violation|0|||
146433899|NCT02196675|528093478|FG001|Overall Study|Protocol Violation|1|||
146433900|NCT02196675|528093479|FG002|Overall Study|Protocol Violation|0|||
146433901|NCT02196675|528093477|FG000|Overall Study|Death|0|||
146433902|NCT02196675|528093478|FG001|Overall Study|Death|0|||
146433903|NCT02196675|528093479|FG002|Overall Study|Death|1|||
146433904|NCT00359281|528093480|FG000|Overall Study|Adverse Event|1|||
146433905|NCT00359281|528093481|FG001|Overall Study|Adverse Event|0|||
146433906|NCT00359281|528093482|FG002|Overall Study|Adverse Event|0|||
146433907|NCT00359281|528093483|FG003|Overall Study|Adverse Event|0|||
146433908|NCT00359281|528093484|FG004|Overall Study|Adverse Event|0|||
146433909|NCT00359281|528093485|FG005|Overall Study|Adverse Event|0|||
146433910|NCT00359281|528093486|FG006|Overall Study|Adverse Event|1|||
146433911|NCT00359281|528093487|FG007|Overall Study|Adverse Event|0|||
146433912|NCT00359281|528093488|FG008|Overall Study|Adverse Event|0|||
146433913|NCT00359281|528093480|FG000|Overall Study|Withdrawal by Subject|0|||
146433914|NCT00359281|528093481|FG001|Overall Study|Withdrawal by Subject|0|||
146433915|NCT00359281|528093482|FG002|Overall Study|Withdrawal by Subject|0|||
146433916|NCT00359281|528093483|FG003|Overall Study|Withdrawal by Subject|0|||
146433917|NCT00359281|528093484|FG004|Overall Study|Withdrawal by Subject|0|||
146433918|NCT00359281|528093485|FG005|Overall Study|Withdrawal by Subject|0|||
146433919|NCT00359281|528093486|FG006|Overall Study|Withdrawal by Subject|1|||
146433920|NCT00359281|528093487|FG007|Overall Study|Withdrawal by Subject|0|||
146433921|NCT00359281|528093488|FG008|Overall Study|Withdrawal by Subject|0|||
146433922|NCT01474551|528093489|FG000|Overall Study|Death|1|||
146433923|NCT03686033|528093501|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
146433924|NCT03686033|528093502|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
146433925|NCT03686033|528093503|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
146433926|NCT03686033|528093504|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
146433927|NCT03686033|528093505|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
146433928|NCT03686033|528093506|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
146206879|NCT00761605|527272107|FG000|Overall Study|Withdrawal by Subject|37|||
146206880|NCT00761605|527272107|FG000|Overall Study|Other|21|||
146206881|NCT01985334|527272112|FG000|Overall Study|Administrative problems|1|||
146206882|NCT01985334|527272113|FG001|Overall Study|Administrative problems|1|||
146206883|NCT01985334|527272114|FG002|Overall Study|Administrative problems|0|||
146206884|NCT01985334|527272115|FG003|Overall Study|Administrative problems|2|||
146206885|NCT01985334|527272116|FG004|Overall Study|Administrative problems|0|||
146433929|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
146433930|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
146433931|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
146433932|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
146433933|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
146433934|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
146433935|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
146433936|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
146433937|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
146433938|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
146433939|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
146433940|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
146433941|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
146433942|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
146433943|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
146433944|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
146433945|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
146433946|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
146433947|NCT01045161|528093507|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
146433948|NCT01045161|528093508|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
146433949|NCT01045161|528093509|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
146433950|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
146433951|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
146433952|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
146433953|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
146433954|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
146433955|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
146433956|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
146433957|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
146433958|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
146433959|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
146433960|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
146433961|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
146433962|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
146433963|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
146433964|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
146433965|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
146433966|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
146433967|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
146433968|NCT01045161|528093507|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
146433969|NCT01045161|528093508|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
146433970|NCT01045161|528093509|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
146433971|NCT01854047|528093510|FG000|Overall Study|Lack of Efficacy|1|||
146433972|NCT01854047|528093511|FG001|Overall Study|Lack of Efficacy|0|||
146433973|NCT01854047|528093512|FG002|Overall Study|Lack of Efficacy|0|||
146433974|NCT01854047|528093513|FG003|Overall Study|Lack of Efficacy|0|||
146433975|NCT01854047|528093514|FG004|Overall Study|Lack of Efficacy|0|||
146433976|NCT01854047|528093510|FG000|Overall Study|Poor compliance to protocol|3|||
146433977|NCT01854047|528093511|FG001|Overall Study|Poor compliance to protocol|0|||
146433978|NCT01854047|528093512|FG002|Overall Study|Poor compliance to protocol|2|||
146433979|NCT01854047|528093513|FG003|Overall Study|Poor compliance to protocol|0|||
146433980|NCT01854047|528093514|FG004|Overall Study|Poor compliance to protocol|0|||
146433981|NCT01854047|528093510|FG000|Overall Study|Adverse Event|5|||
146433982|NCT01854047|528093511|FG001|Overall Study|Adverse Event|4|||
146433983|NCT01854047|528093512|FG002|Overall Study|Adverse Event|6|||
146433984|NCT01854047|528093513|FG003|Overall Study|Adverse Event|10|||
146206886|NCT01985334|527272117|FG005|Overall Study|Administrative problems|1|||
146206887|NCT01985334|527272118|FG006|Overall Study|Administrative problems|1|||
146206888|NCT01985334|527272119|FG007|Overall Study|Administrative problems|3|||
146206889|NCT01985334|527272112|FG000|Overall Study|Death|1|||
146433985|NCT01854047|528093514|FG004|Overall Study|Adverse Event|7|||
146433986|NCT01854047|528093510|FG000|Overall Study|Randomized but not treated|0|||
146433987|NCT01854047|528093511|FG001|Overall Study|Randomized but not treated|1|||
146433988|NCT01854047|528093512|FG002|Overall Study|Randomized but not treated|2|||
146433989|NCT01854047|528093513|FG003|Overall Study|Randomized but not treated|0|||
146433990|NCT01854047|528093514|FG004|Overall Study|Randomized but not treated|4|||
146433991|NCT01854047|528093510|FG000|Overall Study|Other than specified above|3|||
146433992|NCT01854047|528093511|FG001|Overall Study|Other than specified above|3|||
146433993|NCT01854047|528093512|FG002|Overall Study|Other than specified above|3|||
146433994|NCT01854047|528093513|FG003|Overall Study|Other than specified above|5|||
146433995|NCT01854047|528093514|FG004|Overall Study|Other than specified above|8|||
146433996|NCT04659603|528093520|FG000|Overall Study|Study terminated by sponsor|0|||
146433997|NCT04659603|528093521|FG001|Overall Study|Study terminated by sponsor|0|||
146433998|NCT04659603|528093522|FG002|Overall Study|Study terminated by sponsor|2|||
146433999|NCT04659603|528093520|FG000|Overall Study|Withdrawal by Subject|0|||
146434000|NCT04659603|528093521|FG001|Overall Study|Withdrawal by Subject|5|||
146434001|NCT04659603|528093522|FG002|Overall Study|Withdrawal by Subject|0|||
146434002|NCT04659603|528093520|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
146434003|NCT04659603|528093521|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
146434004|NCT04659603|528093522|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
146434005|NCT02374853|528093525|FG000|Overall Study|Surgery Cancelled|5|||
146434006|NCT02374853|528093526|FG001|Overall Study|Surgery Cancelled|11|||
146434007|NCT02281084|528093527|FG000|Overall Study|Death|21|||
146434008|NCT02281084|528093528|FG001|Overall Study|Death|18|||
146434009|NCT02281084|528093529|FG002|Overall Study|Death|3|||
146434010|NCT02281084|528093530|FG003|Overall Study|Death|5|||
146434011|NCT02281084|528093527|FG000|Overall Study|Adverse Event|1|||
146434012|NCT02281084|528093528|FG001|Overall Study|Adverse Event|0|||
146434013|NCT02281084|528093529|FG002|Overall Study|Adverse Event|0|||
146434014|NCT02281084|528093530|FG003|Overall Study|Adverse Event|0|||
146434015|NCT02281084|528093527|FG000|Overall Study|Withdrawal by Subject|2|||
146434016|NCT02281084|528093528|FG001|Overall Study|Withdrawal by Subject|2|||
146434017|NCT02281084|528093529|FG002|Overall Study|Withdrawal by Subject|0|||
146434018|NCT02281084|528093530|FG003|Overall Study|Withdrawal by Subject|0|||
146434019|NCT02281084|528093527|FG000|Overall Study|Site Closure by Sponsor|5|||
146434020|NCT02281084|528093528|FG001|Overall Study|Site Closure by Sponsor|1|||
146434021|NCT02281084|528093529|FG002|Overall Study|Site Closure by Sponsor|2|||
146434022|NCT02281084|528093530|FG003|Overall Study|Site Closure by Sponsor|0|||
146434023|NCT03681470|528093531|FG000|Overall Study|Lack of Efficacy|3|||
146434024|NCT03681470|528093531|FG000|Overall Study|Lost to Follow-up|1|||
146434025|NCT03681470|528093531|FG000|Overall Study|Protocol Violation|3|||
146434026|NCT03681470|528093531|FG000|Overall Study|Withdrawal by Subject|1|||
146434027|NCT02305758|528093532|FG000|Overall Study|Death|27|||
146434028|NCT02305758|528093533|FG001|Overall Study|Death|27|||
146434029|NCT02305758|528093532|FG000|Overall Study|Withdrew consent|9|||
146434030|NCT02305758|528093533|FG001|Overall Study|Withdrew consent|2|||
146434031|NCT02305758|528093532|FG000|Overall Study|Lost to Follow-up|6|||
146434032|NCT02305758|528093533|FG001|Overall Study|Lost to Follow-up|1|||
146434033|NCT02305758|528093532|FG000|Overall Study|Study Terminated by Sponsor|21|||
146434034|NCT02305758|528093533|FG001|Overall Study|Study Terminated by Sponsor|34|||
146434035|NCT02305758|528093532|FG000|Overall Study|Other, not specified|2|||
146434036|NCT02305758|528093533|FG001|Overall Study|Other, not specified|1|||
146434037|NCT00811655|528093548|FG000|Overall Study|Physician Decision|1|||
146434038|NCT02820350|528093549|FG000|Overall Study|Withdrawal by Subject|3|||
146434039|NCT02820350|528093549|FG000|Overall Study|Death|4|||
146434040|NCT01754597|528093550|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
146434041|NCT01754597|528093551|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
146434042|NCT02674152|528095084|FG000|Overall Study|Personal Reasons|1|||
146434043|NCT02674152|528095085|FG001|Overall Study|Personal Reasons|0|||
146434044|NCT02674152|528095086|FG002|Overall Study|Personal Reasons|0|||
146434045|NCT02674152|528095087|FG003|Overall Study|Personal Reasons|1|||
146434046|NCT02674152|528095088|FG004|Overall Study|Personal Reasons|1|||
146434047|NCT02674152|528095084|FG000|Overall Study|Other adverse event or clinical progression|0|||
146434048|NCT02674152|528095085|FG001|Overall Study|Other adverse event or clinical progression|1|||
146434049|NCT02674152|528095086|FG002|Overall Study|Other adverse event or clinical progression|0|||
146434050|NCT02674152|528095087|FG003|Overall Study|Other adverse event or clinical progression|3|||
146434051|NCT02674152|528095088|FG004|Overall Study|Other adverse event or clinical progression|0|||
146434052|NCT02674152|528095084|FG000|Overall Study|Dose-limiting toxicity|0|||
146434053|NCT02674152|528095085|FG001|Overall Study|Dose-limiting toxicity|0|||
146434054|NCT02674152|528095086|FG002|Overall Study|Dose-limiting toxicity|0|||
146434055|NCT02674152|528095087|FG003|Overall Study|Dose-limiting toxicity|0|||
146434056|NCT02674152|528095088|FG004|Overall Study|Dose-limiting toxicity|1|||
146434057|NCT02674152|528095084|FG000|Overall Study|Progressive Disease|2|||
146434058|NCT02674152|528095085|FG001|Overall Study|Progressive Disease|1|||
146434059|NCT02674152|528095086|FG002|Overall Study|Progressive Disease|1|||
146434060|NCT02674152|528095087|FG003|Overall Study|Progressive Disease|13|||
146434061|NCT02674152|528095088|FG004|Overall Study|Progressive Disease|2|||
146434062|NCT02674152|528095084|FG000|Overall Study|Adverse Event|0|||
146434063|NCT02674152|528095085|FG001|Overall Study|Adverse Event|0|||
146206890|NCT01985334|527272113|FG001|Overall Study|Death|0|||
146206891|NCT01985334|527272114|FG002|Overall Study|Death|0|||
146206892|NCT01985334|527272115|FG003|Overall Study|Death|3|||
146206893|NCT01985334|527272116|FG004|Overall Study|Death|0|||
146206894|NCT01985334|527272117|FG005|Overall Study|Death|0|||
146206895|NCT01985334|527272118|FG006|Overall Study|Death|1|||
146206896|NCT01985334|527272119|FG007|Overall Study|Death|2|||
146206897|NCT01985334|527272112|FG000|Overall Study|Worsening of disease|0|||
146206898|NCT01985334|527272113|FG001|Overall Study|Worsening of disease|0|||
146206899|NCT01985334|527272114|FG002|Overall Study|Worsening of disease|0|||
146206900|NCT01985334|527272115|FG003|Overall Study|Worsening of disease|1|||
146206901|NCT01985334|527272116|FG004|Overall Study|Worsening of disease|0|||
146206902|NCT01985334|527272117|FG005|Overall Study|Worsening of disease|3|||
146206903|NCT01985334|527272118|FG006|Overall Study|Worsening of disease|0|||
146206904|NCT01985334|527272119|FG007|Overall Study|Worsening of disease|1|||
146206905|NCT01985334|527272112|FG000|Overall Study|Other|2|||
146206906|NCT01985334|527272113|FG001|Overall Study|Other|9|||
146206907|NCT01985334|527272114|FG002|Overall Study|Other|7|||
146206908|NCT01985334|527272115|FG003|Overall Study|Other|17|||
146206909|NCT01985334|527272116|FG004|Overall Study|Other|4|||
146434064|NCT02674152|528095086|FG002|Overall Study|Adverse Event|1|||
146206910|NCT01985334|527272117|FG005|Overall Study|Other|8|||
146206911|NCT01985334|527272118|FG006|Overall Study|Other|4|||
146206912|NCT01985334|527272119|FG007|Overall Study|Other|7|||
146206913|NCT01985334|527272112|FG000|Overall Study|Protocol deviation|6|||
146434065|NCT02674152|528095087|FG003|Overall Study|Adverse Event|0|||
146434066|NCT02674152|528095088|FG004|Overall Study|Adverse Event|1|||
146434067|NCT05265624|528095089|FG000|Overall Study|Lost to Follow-up|3|||
146434068|NCT05265624|528095090|FG001|Overall Study|Lost to Follow-up|0|||
146434069|NCT05265624|528095089|FG000|Overall Study|Withdrawal by Subject|1|||
146434070|NCT05265624|528095090|FG001|Overall Study|Withdrawal by Subject|0|||
146434071|NCT00001703|528095091|FG000|Overall Study|progressed disease|2|||
146434072|NCT00001703|528095091|FG000|Overall Study|No evidence of disease|1|||
146434073|NCT00001703|528095091|FG000|Overall Study|recurrent disease|2|||
146434074|NCT03071575|528095092|FG000|Overall Study|Death|0|||
146434075|NCT03071575|528095093|FG001|Overall Study|Death|1|||
146434076|NCT03071575|528095092|FG000|Overall Study|Lost to Follow-up|5|||
146434077|NCT03071575|528095093|FG001|Overall Study|Lost to Follow-up|11|||
146434078|NCT03071575|528095092|FG000|Overall Study|Withdrawal by Subject|4|||
146434079|NCT03071575|528095093|FG001|Overall Study|Withdrawal by Subject|2|||
146434080|NCT00834795|528095098|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
146434081|NCT00834795|528095099|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
146434082|NCT00834795|528095098|FG000|Second Intervention|Adverse Event|1|||
146434083|NCT00834795|528095099|FG001|Second Intervention|Adverse Event|0|||
146434084|NCT00579345|528095100|FG000|Overall Study|Withdrawal by Subject|2|||
146434085|NCT00579345|528095101|FG001|Overall Study|Withdrawal by Subject|0|||
146434086|NCT00579345|528095102|FG002|Overall Study|Withdrawal by Subject|0|||
146434087|NCT00579345|528095103|FG003|Overall Study|Withdrawal by Subject|0|||
146434088|NCT00579345|528095104|FG004|Overall Study|Withdrawal by Subject|0|||
146434089|NCT00579345|528095105|FG005|Overall Study|Withdrawal by Subject|0|||
146434090|NCT00579345|528095106|FG006|Overall Study|Withdrawal by Subject|0|||
146434091|NCT00579345|528095107|FG007|Overall Study|Withdrawal by Subject|1|||
146434092|NCT00579345|528095100|FG000|Overall Study|Lost to Follow-up|1|||
146434093|NCT00579345|528095101|FG001|Overall Study|Lost to Follow-up|0|||
146434094|NCT00579345|528095102|FG002|Overall Study|Lost to Follow-up|0|||
146434095|NCT00579345|528095103|FG003|Overall Study|Lost to Follow-up|0|||
146434096|NCT00579345|528095104|FG004|Overall Study|Lost to Follow-up|0|||
146434097|NCT00579345|528095105|FG005|Overall Study|Lost to Follow-up|0|||
146434098|NCT00579345|528095106|FG006|Overall Study|Lost to Follow-up|0|||
146434099|NCT00579345|528095107|FG007|Overall Study|Lost to Follow-up|0|||
146434100|NCT00579345|528095100|FG000|Overall Study|Adverse Event|0|||
146434101|NCT00579345|528095101|FG001|Overall Study|Adverse Event|0|||
146434102|NCT00579345|528095102|FG002|Overall Study|Adverse Event|1|||
146434103|NCT00579345|528095103|FG003|Overall Study|Adverse Event|0|||
146434104|NCT00579345|528095104|FG004|Overall Study|Adverse Event|0|||
146434105|NCT00579345|528095105|FG005|Overall Study|Adverse Event|0|||
146434106|NCT00579345|528095106|FG006|Overall Study|Adverse Event|0|||
146434107|NCT00579345|528095107|FG007|Overall Study|Adverse Event|0|||
146434108|NCT00579345|528095100|FG000|Overall Study|Protocol Violation|1|||
146434109|NCT00579345|528095101|FG001|Overall Study|Protocol Violation|0|||
146434110|NCT00579345|528095102|FG002|Overall Study|Protocol Violation|0|||
146434111|NCT00579345|528095103|FG003|Overall Study|Protocol Violation|0|||
146434112|NCT00579345|528095104|FG004|Overall Study|Protocol Violation|0|||
146434113|NCT00579345|528095105|FG005|Overall Study|Protocol Violation|0|||
146434114|NCT00579345|528095106|FG006|Overall Study|Protocol Violation|0|||
146434115|NCT00579345|528095107|FG007|Overall Study|Protocol Violation|1|||
146434116|NCT00579345|528095100|FG000|Overall Study|Death|1|||
146434117|NCT00579345|528095101|FG001|Overall Study|Death|1|||
146434118|NCT00579345|528095102|FG002|Overall Study|Death|1|||
146434119|NCT00579345|528095103|FG003|Overall Study|Death|1|||
146434120|NCT00579345|528095104|FG004|Overall Study|Death|0|||
146434121|NCT00579345|528095105|FG005|Overall Study|Death|0|||
146434122|NCT00579345|528095106|FG006|Overall Study|Death|0|||
146434123|NCT00579345|528095107|FG007|Overall Study|Death|0|||
146434124|NCT03447353|528095111|FG000|Overall Study|Failure at Screening Visit|2|||
146434125|NCT03447353|528095111|FG000|Overall Study|Lost to Follow-up|4|||
146434126|NCT03447353|528095111|FG000|Overall Study|Scheduling Conflicts|3|||
146434127|NCT03447353|528095111|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
146434128|NCT02057835|528095112|FG000|Overall Study|Withdrawal by Subject|0|||
146434129|NCT02057835|528095113|FG001|Overall Study|Withdrawal by Subject|2|||
146434130|NCT02057835|528095114|FG002|Overall Study|Withdrawal by Subject|0|||
146434131|NCT02057835|528095115|FG003|Overall Study|Withdrawal by Subject|0|||
146434132|NCT02057835|528095116|FG004|Overall Study|Withdrawal by Subject|0|||
146434133|NCT02057835|528095117|FG005|Overall Study|Withdrawal by Subject|0|||
146434134|NCT02057835|528095118|FG006|Overall Study|Withdrawal by Subject|0|||
146434135|NCT02057835|528095119|FG007|Overall Study|Withdrawal by Subject|0|||
146434136|NCT02057835|528095120|FG008|Overall Study|Withdrawal by Subject|0|||
146434137|NCT02057835|528095121|FG009|Overall Study|Withdrawal by Subject|0|||
146434138|NCT02267187|528095122|FG000|Overall Study|Physician Decision|2|||
146434139|NCT02267187|528095122|FG000|Overall Study|Screen fail|3|||
146434140|NCT04299087|528095123|FG000|Overall Study|Lost to Follow-up|2|||
146434141|NCT04299087|528095124|FG001|Overall Study|Lost to Follow-up|1|||
146434142|NCT03025087|528095125|FG000|Overall Study|Physician Decision|3|||
146434143|NCT03025087|528095126|FG001|Overall Study|Physician Decision|3|||
146434144|NCT03025087|528095127|FG002|Overall Study|Physician Decision|0|||
146434145|NCT03025087|528095128|FG003|Overall Study|Physician Decision|0|||
146434146|NCT03025087|528095129|FG004|Overall Study|Physician Decision|0|||
146434147|NCT03025087|528095125|FG000|Overall Study|Withdrawal by Subject|1|||
146434148|NCT03025087|528095126|FG001|Overall Study|Withdrawal by Subject|1|||
146434149|NCT03025087|528095127|FG002|Overall Study|Withdrawal by Subject|0|||
146434150|NCT03025087|528095128|FG003|Overall Study|Withdrawal by Subject|0|||
146434151|NCT03025087|528095129|FG004|Overall Study|Withdrawal by Subject|0|||
145951410|NCT04318132|526333896|FG003|Overall Study|Protocol Violation|0|||
145951411|NCT00073008|526333897|FG000|Overall Study|Missing|6|||
145951412|NCT00073008|526333898|FG001|Overall Study|Missing|6|||
145951413|NCT00073008|526333897|FG000|Overall Study|Withdrawal by Subject|2|||
145951414|NCT00073008|526333898|FG001|Overall Study|Withdrawal by Subject|2|||
145951415|NCT00073008|526333897|FG000|Overall Study|Lost to Follow-up|1|||
145951416|NCT00073008|526333898|FG001|Overall Study|Lost to Follow-up|3|||
145951417|NCT00073008|526333897|FG000|Overall Study|Death|46|||
145951418|NCT00073008|526333898|FG001|Overall Study|Death|47|||
145951419|NCT00073008|526333897|FG000|Overall Study|"Other selected on Case Report Form"|7|||
145951420|NCT00073008|526333898|FG001|Overall Study|"Other selected on Case Report Form"|5|||
145951421|NCT00636961|526333910|FG000|Period 1|Administrative problems|1|||
145951422|NCT00636961|526333911|FG001|Period 1|Administrative problems|1|||
145951423|NCT00636961|526333910|FG000|Period 2|Adverse Event|1|||
145951424|NCT00636961|526333911|FG001|Period 2|Adverse Event|0|||
145951425|NCT01926197|526333913|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
145951426|NCT01926197|526333914|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
145951427|NCT01926197|526333913|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
145951428|NCT01926197|526333914|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
145951429|NCT03628716|526333915|FG000|Overall Study|Adverse Event|1|||
145951430|NCT03628716|526333916|FG001|Overall Study|Adverse Event|1|||
145951431|NCT03628716|526333915|FG000|Overall Study|Death|1|||
145951432|NCT03628716|526333916|FG001|Overall Study|Death|0|||
145951433|NCT03628716|526333915|FG000|Overall Study|Lack of Efficacy|15|||
145951434|NCT03628716|526333916|FG001|Overall Study|Lack of Efficacy|20|||
145951435|NCT03628716|526333915|FG000|Overall Study|Withdrawal by Subject|1|||
145951436|NCT03628716|526333916|FG001|Overall Study|Withdrawal by Subject|2|||
145951437|NCT03628716|526333915|FG000|Overall Study|Study Terminated by Sponsor|1|||
145951438|NCT03628716|526333916|FG001|Overall Study|Study Terminated by Sponsor|0|||
145951439|NCT00856843|526333917|FG000|Overall Study|Withdrawal by Subject|1|||
145951440|NCT00856843|526333918|FG001|Overall Study|Withdrawal by Subject|5|||
145951441|NCT00856843|526333917|FG000|Overall Study|Lack of Efficacy|1|||
145951442|NCT00856843|526333918|FG001|Overall Study|Lack of Efficacy|0|||
145951443|NCT02179749|526333919|FG000|Overall Study|Adverse Event|0|||
145951444|NCT02179749|526333920|FG001|Overall Study|Adverse Event|0|||
145951445|NCT02179749|526333921|FG002|Overall Study|Adverse Event|1|||
145951446|NCT02179749|526333919|FG000|Overall Study|Withdrawal by Subject|0|||
145951447|NCT02179749|526333920|FG001|Overall Study|Withdrawal by Subject|0|||
145951448|NCT02179749|526333921|FG002|Overall Study|Withdrawal by Subject|1|||
145951449|NCT01841567|526333922|FG000|Overall Study|Adverse Event|3|||
145951450|NCT01573754|526333927|FG000|Overall Study|Noncompliance or remission not achieved|3|||
145951451|NCT01573754|526333928|FG001|Overall Study|Noncompliance or remission not achieved|15|||
146206914|NCT01985334|527272113|FG001|Overall Study|Protocol deviation|31|||
145951452|NCT00829829|526333929|FG000|Overall Study|Protocol Violation|0|||
145951453|NCT00829829|526333930|FG001|Overall Study|Protocol Violation|3|||
145951454|NCT00829829|526333931|FG002|Overall Study|Protocol Violation|0|||
145951455|NCT00829829|526333929|FG000|Overall Study|Adverse Event|4|||
145951456|NCT00829829|526333930|FG001|Overall Study|Adverse Event|4|||
145951457|NCT00829829|526333931|FG002|Overall Study|Adverse Event|3|||
145951458|NCT00829829|526333929|FG000|Overall Study|Withdrawal by Subject|8|||
146206915|NCT01985334|527272114|FG002|Overall Study|Protocol deviation|25|||
146434152|NCT03025087|528095125|FG000|Overall Study|Unable to complete MRI|2|||
146434153|NCT03025087|528095126|FG001|Overall Study|Unable to complete MRI|2|||
146434154|NCT03025087|528095127|FG002|Overall Study|Unable to complete MRI|0|||
146434155|NCT03025087|528095128|FG003|Overall Study|Unable to complete MRI|0|||
145951459|NCT00829829|526333930|FG001|Overall Study|Withdrawal by Subject|4|||
146206916|NCT01985334|527272115|FG003|Overall Study|Protocol deviation|84|||
146206917|NCT01985334|527272116|FG004|Overall Study|Protocol deviation|17|||
145951460|NCT00829829|526333931|FG002|Overall Study|Withdrawal by Subject|2|||
145951461|NCT00829829|526333929|FG000|Overall Study|Decision by the Sponsor|1|||
146434156|NCT03025087|528095129|FG004|Overall Study|Unable to complete MRI|0|||
146434157|NCT00508651|528095130|FG000|Overall Study|Lost to Follow-up|3|||
146434158|NCT00508651|528095131|FG001|Overall Study|Lost to Follow-up|1|||
146434159|NCT00508651|528095130|FG000|Overall Study|Withdrawal by Subject|1|||
146434160|NCT00508651|528095131|FG001|Overall Study|Withdrawal by Subject|1|||
146434161|NCT01376037|528095133|FG000|Overall Study|Lost to Follow-up|0|||
146434162|NCT01376037|528095134|FG001|Overall Study|Lost to Follow-up|2|||
146434163|NCT01111461|528095135|FG000|Overall Study|Adverse Event|32|||
146434164|NCT01111461|528095135|FG000|Overall Study|Participant choice|11|||
146434165|NCT01111461|528095135|FG000|Overall Study|Lost to Follow-up|1|||
146434166|NCT01111461|528095135|FG000|Overall Study|Withdrawal by Subject|1|||
146434167|NCT01111461|528095135|FG000|Overall Study|Other|6|||
146434168|NCT00834067|528095138|FG000|Washout of 21 Days|Protocol Violation|0|||
146434169|NCT00834067|528095139|FG001|Washout of 21 Days|Protocol Violation|1|||
146434170|NCT00440518|528095140|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
146434171|NCT00440518|528095141|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
146434172|NCT00440518|528095142|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
146434173|NCT00440518|528095140|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
146434174|NCT00440518|528095141|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
146434175|NCT00440518|528095142|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
146434176|NCT00440518|528095140|FG000|Randomized /Titration Period|Protocol Deviation|1|||
146434177|NCT00440518|528095141|FG001|Randomized /Titration Period|Protocol Deviation|0|||
146434178|NCT00440518|528095142|FG002|Randomized /Titration Period|Protocol Deviation|0|||
146434179|NCT00440518|528095140|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
146434180|NCT00440518|528095141|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
146434181|NCT00440518|528095142|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
146434182|NCT00440518|528095140|FG000|Randomized /Titration Period|Other|1|||
146434183|NCT00440518|528095141|FG001|Randomized /Titration Period|Other|0|||
146434184|NCT00440518|528095142|FG002|Randomized /Titration Period|Other|0|||
146434185|NCT00440518|528095140|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
146434186|NCT00440518|528095141|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
146434187|NCT00440518|528095142|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
146434188|NCT00440518|528095140|FG000|Randomized /Titration Period|Adverse Event|2|||
146434189|NCT00440518|528095141|FG001|Randomized /Titration Period|Adverse Event|3|||
146434190|NCT00440518|528095142|FG002|Randomized /Titration Period|Adverse Event|0|||
146434191|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
146434192|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
146434193|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
146434194|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
146434195|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
146434196|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
146434197|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
146434198|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
146434199|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
146434200|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
146434201|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
146434202|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
146434203|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
146434204|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
146434205|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
146434206|NCT00440518|528095140|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
146434207|NCT00440518|528095141|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
146434208|NCT00440518|528095142|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
146434209|NCT03570749|528095144|FG000|Overall Study|Ongoing|26|||
146434210|NCT03570749|528095145|FG001|Overall Study|Ongoing|25|||
146434211|NCT03570749|528095146|FG002|Overall Study|Ongoing|25|||
146434212|NCT03570749|528095147|FG003|Overall Study|Ongoing|26|||
146434213|NCT03570749|528095148|FG004|Overall Study|Ongoing|140|||
146434214|NCT03570749|528095149|FG005|Overall Study|Ongoing|142|||
146434215|NCT03570749|528095150|FG006|Overall Study|Ongoing|220|||
146434216|NCT03570749|528095144|FG000|Overall Study|Adverse Event|0|||
146434217|NCT03570749|528095145|FG001|Overall Study|Adverse Event|0|||
146434218|NCT03570749|528095146|FG002|Overall Study|Adverse Event|0|||
146434219|NCT03570749|528095147|FG003|Overall Study|Adverse Event|0|||
146206918|NCT01985334|527272117|FG005|Overall Study|Protocol deviation|47|||
146206919|NCT01985334|527272118|FG006|Overall Study|Protocol deviation|15|||
146206920|NCT01985334|527272119|FG007|Overall Study|Protocol deviation|42|||
146434220|NCT03570749|528095148|FG004|Overall Study|Adverse Event|2|||
146434221|NCT03570749|528095149|FG005|Overall Study|Adverse Event|3|||
146434222|NCT03570749|528095150|FG006|Overall Study|Adverse Event|6|||
146434223|NCT03570749|528095144|FG000|Overall Study|Lack of Efficacy|0|||
146434224|NCT03570749|528095145|FG001|Overall Study|Lack of Efficacy|0|||
146434225|NCT03570749|528095146|FG002|Overall Study|Lack of Efficacy|0|||
146434226|NCT03570749|528095147|FG003|Overall Study|Lack of Efficacy|0|||
146206921|NCT01985334|527272112|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
146434227|NCT03570749|528095148|FG004|Overall Study|Lack of Efficacy|8|||
146434228|NCT03570749|528095149|FG005|Overall Study|Lack of Efficacy|2|||
146434229|NCT03570749|528095150|FG006|Overall Study|Lack of Efficacy|7|||
146434230|NCT03570749|528095144|FG000|Overall Study|Lost to Follow-up|0|||
146082948|NCT03085914|526824712|FG003|Overall Study|Reason was not specified,|3|||
146082949|NCT03085914|526824713|FG004|Overall Study|Reason was not specified,|3|||
146082950|NCT03085914|526824714|FG005|Overall Study|Reason was not specified,|3|||
146082951|NCT03085914|526824715|FG006|Overall Study|Reason was not specified,|6|||
146082952|NCT03085914|526824709|FG000|Overall Study|Progressive Disease|0|||
146434231|NCT03570749|528095145|FG001|Overall Study|Lost to Follow-up|0|||
146434232|NCT03570749|528095146|FG002|Overall Study|Lost to Follow-up|0|||
146434233|NCT03570749|528095147|FG003|Overall Study|Lost to Follow-up|0|||
146434234|NCT03570749|528095148|FG004|Overall Study|Lost to Follow-up|5|||
146434235|NCT03570749|528095149|FG005|Overall Study|Lost to Follow-up|10|||
146434236|NCT03570749|528095150|FG006|Overall Study|Lost to Follow-up|10|||
146434237|NCT03570749|528095144|FG000|Overall Study|Pregnancy|0|||
146434238|NCT03570749|528095145|FG001|Overall Study|Pregnancy|0|||
146434239|NCT03570749|528095146|FG002|Overall Study|Pregnancy|0|||
146434240|NCT03570749|528095147|FG003|Overall Study|Pregnancy|0|||
146434241|NCT03570749|528095148|FG004|Overall Study|Pregnancy|0|||
146434242|NCT03570749|528095149|FG005|Overall Study|Pregnancy|1|||
146434243|NCT03570749|528095150|FG006|Overall Study|Pregnancy|1|||
146434244|NCT03570749|528095144|FG000|Overall Study|Screen Fail|0|||
146434245|NCT03570749|528095145|FG001|Overall Study|Screen Fail|0|||
146434246|NCT03570749|528095146|FG002|Overall Study|Screen Fail|0|||
146434247|NCT03570749|528095147|FG003|Overall Study|Screen Fail|0|||
146434248|NCT03570749|528095148|FG004|Overall Study|Screen Fail|0|||
146434249|NCT03570749|528095149|FG005|Overall Study|Screen Fail|0|||
146434250|NCT03570749|528095150|FG006|Overall Study|Screen Fail|1|||
146434251|NCT03570749|528095144|FG000|Overall Study|Withdrawal by Subject|2|||
146434252|NCT03570749|528095145|FG001|Overall Study|Withdrawal by Subject|3|||
146434253|NCT03570749|528095146|FG002|Overall Study|Withdrawal by Subject|2|||
146434254|NCT03570749|528095147|FG003|Overall Study|Withdrawal by Subject|1|||
146434255|NCT03570749|528095148|FG004|Overall Study|Withdrawal by Subject|17|||
146434256|NCT03570749|528095149|FG005|Overall Study|Withdrawal by Subject|12|||
146434257|NCT03570749|528095150|FG006|Overall Study|Withdrawal by Subject|15|||
146434258|NCT03570749|528095144|FG000|Overall Study|Other|0|||
146434259|NCT03570749|528095145|FG001|Overall Study|Other|0|||
146434260|NCT03570749|528095146|FG002|Overall Study|Other|0|||
146434261|NCT03570749|528095147|FG003|Overall Study|Other|0|||
146434262|NCT03570749|528095148|FG004|Overall Study|Other|17|||
146434263|NCT03570749|528095149|FG005|Overall Study|Other|14|||
146434264|NCT03570749|528095150|FG006|Overall Study|Other|21|||
146434265|NCT00561015|528095151|FG000|Overall Study|Adverse Event|0|||
146434266|NCT00561015|528095152|FG001|Overall Study|Adverse Event|0|||
146434267|NCT00561015|528095153|FG002|Overall Study|Adverse Event|0|||
146434268|NCT00561015|528095154|FG003|Overall Study|Adverse Event|0|||
146434269|NCT00561015|528095155|FG004|Overall Study|Adverse Event|1|||
146434270|NCT00561015|528095156|FG005|Overall Study|Adverse Event|0|||
146434271|NCT00561015|528095151|FG000|Overall Study|Lost to Follow-up|2|||
146434272|NCT00561015|528095152|FG001|Overall Study|Lost to Follow-up|0|||
146434273|NCT00561015|528095153|FG002|Overall Study|Lost to Follow-up|0|||
146434274|NCT00561015|528095154|FG003|Overall Study|Lost to Follow-up|1|||
146434275|NCT00561015|528095155|FG004|Overall Study|Lost to Follow-up|0|||
146434276|NCT00561015|528095156|FG005|Overall Study|Lost to Follow-up|3|||
146434277|NCT00561015|528095151|FG000|Overall Study|Participant non-compliance|2|||
146434278|NCT00561015|528095152|FG001|Overall Study|Participant non-compliance|0|||
146434279|NCT00561015|528095153|FG002|Overall Study|Participant non-compliance|0|||
146434280|NCT00561015|528095154|FG003|Overall Study|Participant non-compliance|0|||
146082953|NCT03085914|526824710|FG001|Overall Study|Progressive Disease|0|||
146082954|NCT03085914|526824711|FG002|Overall Study|Progressive Disease|2|||
146082955|NCT03085914|526824712|FG003|Overall Study|Progressive Disease|2|||
146434281|NCT00561015|528095155|FG004|Overall Study|Participant non-compliance|0|||
146434282|NCT00561015|528095156|FG005|Overall Study|Participant non-compliance|0|||
146434283|NCT03616535|528095157|FG000|Overall Study|Death|2|||
146434284|NCT03616535|528095158|FG001|Overall Study|Death|0|||
146434285|NCT03616535|528095159|FG002|Overall Study|Death|0|||
146434286|NCT03616535|528095160|FG003|Overall Study|Death|1|||
146434287|NCT03616535|528095157|FG000|Overall Study|Lost to Follow-up|2|||
146434288|NCT03616535|528095158|FG001|Overall Study|Lost to Follow-up|1|||
146434289|NCT03616535|528095159|FG002|Overall Study|Lost to Follow-up|0|||
146434290|NCT03616535|528095160|FG003|Overall Study|Lost to Follow-up|2|||
146434291|NCT03616535|528095157|FG000|Overall Study|Withdrawal by Subject|1|||
146434292|NCT03616535|528095158|FG001|Overall Study|Withdrawal by Subject|2|||
146434293|NCT03616535|528095159|FG002|Overall Study|Withdrawal by Subject|5|||
146434294|NCT03616535|528095160|FG003|Overall Study|Withdrawal by Subject|1|||
146434295|NCT03616535|528095157|FG000|Overall Study|Not specified or change in eligibility|2|||
146434296|NCT03616535|528095158|FG001|Overall Study|Not specified or change in eligibility|3|||
146434297|NCT03616535|528095159|FG002|Overall Study|Not specified or change in eligibility|3|||
146434298|NCT03616535|528095160|FG003|Overall Study|Not specified or change in eligibility|1|||
146434299|NCT00804856|528095161|FG000|Overall Study|Progressive Disease|3|||
146434300|NCT00804856|528095162|FG001|Overall Study|Progressive Disease|2|||
146434301|NCT00804856|528095163|FG002|Overall Study|Progressive Disease|4|||
146434302|NCT00804856|528095164|FG003|Overall Study|Progressive Disease|6|||
146434303|NCT00804856|528095165|FG004|Overall Study|Progressive Disease|4|||
146434304|NCT00804856|528095166|FG005|Overall Study|Progressive Disease|1|||
146434305|NCT00804856|528095167|FG006|Overall Study|Progressive Disease|8|||
146434306|NCT00804856|528095168|FG007|Overall Study|Progressive Disease|2|||
146434307|NCT00804856|528095169|FG008|Overall Study|Progressive Disease|4|||
146434308|NCT00804856|528095170|FG009|Overall Study|Progressive Disease|5|||
146434309|NCT00804856|528095171|FG010|Overall Study|Progressive Disease|12|||
146434310|NCT00804856|528095172|FG011|Overall Study|Progressive Disease|2|||
146434311|NCT00804856|528095173|FG012|Overall Study|Progressive Disease|2|||
146434312|NCT00804856|528095174|FG013|Overall Study|Progressive Disease|26|||
146082956|NCT03085914|526824713|FG004|Overall Study|Progressive Disease|1|||
146082957|NCT03085914|526824714|FG005|Overall Study|Progressive Disease|1|||
146082958|NCT03085914|526824715|FG006|Overall Study|Progressive Disease|1|||
146082959|NCT03085914|526824709|FG000|Overall Study|Study Terminated by the Sponsor|0|||
146434313|NCT00804856|528095175|FG014|Overall Study|Progressive Disease|20|||
146082960|NCT03085914|526824710|FG001|Overall Study|Study Terminated by the Sponsor|0|||
146206922|NCT01985334|527272113|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
146434314|NCT00804856|528095161|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434315|NCT00804856|528095162|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434316|NCT00804856|528095163|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434317|NCT00804856|528095164|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434318|NCT00804856|528095165|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146434319|NCT00804856|528095166|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434320|NCT00804856|528095167|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146082961|NCT03085914|526824711|FG002|Overall Study|Study Terminated by the Sponsor|0|||
146082962|NCT03085914|526824712|FG003|Overall Study|Study Terminated by the Sponsor|1|||
146434321|NCT00804856|528095168|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434322|NCT00804856|528095169|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434323|NCT00804856|528095170|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434324|NCT00804856|528095171|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434325|NCT00804856|528095172|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434326|NCT00804856|528095173|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434327|NCT00804856|528095174|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146434328|NCT00804856|528095175|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146434329|NCT00804856|528095161|FG000|Overall Study|Other Adverse Event|1|||
146434330|NCT00804856|528095162|FG001|Overall Study|Other Adverse Event|1|||
146434331|NCT00804856|528095163|FG002|Overall Study|Other Adverse Event|1|||
146434332|NCT00804856|528095164|FG003|Overall Study|Other Adverse Event|2|||
146434333|NCT00804856|528095165|FG004|Overall Study|Other Adverse Event|2|||
146434334|NCT00804856|528095166|FG005|Overall Study|Other Adverse Event|1|||
146434335|NCT00804856|528095167|FG006|Overall Study|Other Adverse Event|3|||
146434336|NCT00804856|528095168|FG007|Overall Study|Other Adverse Event|0|||
146434337|NCT00804856|528095169|FG008|Overall Study|Other Adverse Event|0|||
146434338|NCT00804856|528095170|FG009|Overall Study|Other Adverse Event|1|||
146434339|NCT00804856|528095171|FG010|Overall Study|Other Adverse Event|5|||
146434340|NCT00804856|528095172|FG011|Overall Study|Other Adverse Event|2|||
146434341|NCT00804856|528095173|FG012|Overall Study|Other Adverse Event|0|||
146434342|NCT00804856|528095174|FG013|Overall Study|Other Adverse Event|6|||
146434343|NCT00804856|528095175|FG014|Overall Study|Other Adverse Event|13|||
146434344|NCT00804856|528095161|FG000|Overall Study|Non compliance with protocol|0|||
146434345|NCT00804856|528095162|FG001|Overall Study|Non compliance with protocol|0|||
146434346|NCT00804856|528095163|FG002|Overall Study|Non compliance with protocol|0|||
146434347|NCT00804856|528095164|FG003|Overall Study|Non compliance with protocol|0|||
146434348|NCT00804856|528095165|FG004|Overall Study|Non compliance with protocol|0|||
146434349|NCT00804856|528095166|FG005|Overall Study|Non compliance with protocol|0|||
146434350|NCT00804856|528095167|FG006|Overall Study|Non compliance with protocol|0|||
146434351|NCT00804856|528095168|FG007|Overall Study|Non compliance with protocol|0|||
146434352|NCT00804856|528095169|FG008|Overall Study|Non compliance with protocol|0|||
146434353|NCT00804856|528095170|FG009|Overall Study|Non compliance with protocol|0|||
146434354|NCT00804856|528095171|FG010|Overall Study|Non compliance with protocol|0|||
146434355|NCT00804856|528095172|FG011|Overall Study|Non compliance with protocol|0|||
146434356|NCT00804856|528095173|FG012|Overall Study|Non compliance with protocol|0|||
146434357|NCT00804856|528095174|FG013|Overall Study|Non compliance with protocol|2|||
146434358|NCT00804856|528095175|FG014|Overall Study|Non compliance with protocol|0|||
146434359|NCT00804856|528095161|FG000|Overall Study|Refused to continue medication|0|||
146434360|NCT00804856|528095162|FG001|Overall Study|Refused to continue medication|0|||
146434361|NCT00804856|528095163|FG002|Overall Study|Refused to continue medication|0|||
146434362|NCT00804856|528095164|FG003|Overall Study|Refused to continue medication|1|||
146434363|NCT00804856|528095165|FG004|Overall Study|Refused to continue medication|1|||
146434364|NCT00804856|528095166|FG005|Overall Study|Refused to continue medication|0|||
146434365|NCT00804856|528095167|FG006|Overall Study|Refused to continue medication|0|||
146434366|NCT00804856|528095168|FG007|Overall Study|Refused to continue medication|0|||
146434367|NCT00804856|528095169|FG008|Overall Study|Refused to continue medication|0|||
146434368|NCT00804856|528095170|FG009|Overall Study|Refused to continue medication|0|||
146434369|NCT00804856|528095171|FG010|Overall Study|Refused to continue medication|3|||
146434370|NCT00804856|528095172|FG011|Overall Study|Refused to continue medication|0|||
146434371|NCT00804856|528095173|FG012|Overall Study|Refused to continue medication|1|||
146434372|NCT00804856|528095174|FG013|Overall Study|Refused to continue medication|1|||
146434373|NCT00804856|528095175|FG014|Overall Study|Refused to continue medication|5|||
146434374|NCT00804856|528095161|FG000|Overall Study|Other reason than listed above|0|||
146434375|NCT00804856|528095162|FG001|Overall Study|Other reason than listed above|0|||
146434376|NCT00804856|528095163|FG002|Overall Study|Other reason than listed above|0|||
146434377|NCT00804856|528095164|FG003|Overall Study|Other reason than listed above|0|||
146434378|NCT00804856|528095165|FG004|Overall Study|Other reason than listed above|0|||
146434379|NCT00804856|528095166|FG005|Overall Study|Other reason than listed above|1|||
146434380|NCT00804856|528095167|FG006|Overall Study|Other reason than listed above|0|||
146434381|NCT00804856|528095168|FG007|Overall Study|Other reason than listed above|0|||
146434382|NCT00804856|528095169|FG008|Overall Study|Other reason than listed above|1|||
146434383|NCT00804856|528095170|FG009|Overall Study|Other reason than listed above|0|||
146434384|NCT00804856|528095171|FG010|Overall Study|Other reason than listed above|3|||
146434385|NCT00804856|528095172|FG011|Overall Study|Other reason than listed above|1|||
146434386|NCT00804856|528095173|FG012|Overall Study|Other reason than listed above|1|||
146434387|NCT00804856|528095174|FG013|Overall Study|Other reason than listed above|10|||
146434388|NCT00804856|528095175|FG014|Overall Study|Other reason than listed above|3|||
146434389|NCT00455312|528095176|FG000|Overall Study|Death|0|||
146434390|NCT00455312|528095177|FG001|Overall Study|Death|1|||
146434391|NCT03343535|528095178|FG000|Overall Study|Lost to Follow-up|1|||
146434392|NCT03343535|528095178|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
146434393|NCT03343535|528095178|FG000|Overall Study|Death|12|||
146434394|NCT03868891|528095179|FG000|Overall Study|Adverse Event|1|||
146434395|NCT03868891|528095180|FG001|Overall Study|Adverse Event|0|||
146434396|NCT03868891|528095179|FG000|Overall Study|Lost to Follow-up|2|||
146434397|NCT03868891|528095180|FG001|Overall Study|Lost to Follow-up|1|||
146434398|NCT03868891|528095179|FG000|Overall Study|COVID-19 Restrictions|1|||
146206923|NCT01985334|527272114|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
146206924|NCT01985334|527272115|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
146206925|NCT01985334|527272116|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
146206926|NCT01985334|527272117|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
146206927|NCT01985334|527272118|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
146082963|NCT03085914|526824713|FG004|Overall Study|Study Terminated by the Sponsor|2|||
146206928|NCT01985334|527272119|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
146206929|NCT01985334|527272112|FG000|Overall Study|Subject withdrawal of consent|3|||
146206930|NCT01985334|527272113|FG001|Overall Study|Subject withdrawal of consent|6|||
146206931|NCT01985334|527272114|FG002|Overall Study|Subject withdrawal of consent|2|||
146206932|NCT01985334|527272115|FG003|Overall Study|Subject withdrawal of consent|28|||
146206933|NCT01985334|527272116|FG004|Overall Study|Subject withdrawal of consent|4|||
146206934|NCT01985334|527272117|FG005|Overall Study|Subject withdrawal of consent|19|||
146206935|NCT01985334|527272118|FG006|Overall Study|Subject withdrawal of consent|0|||
146206936|NCT01985334|527272119|FG007|Overall Study|Subject withdrawal of consent|20|||
146206937|NCT01985334|527272112|FG000|Overall Study|Adverse Event|0|||
146206938|NCT01985334|527272113|FG001|Overall Study|Adverse Event|8|||
146206939|NCT01985334|527272114|FG002|Overall Study|Adverse Event|2|||
146206940|NCT01985334|527272115|FG003|Overall Study|Adverse Event|26|||
146206941|NCT01985334|527272116|FG004|Overall Study|Adverse Event|3|||
146206942|NCT01985334|527272117|FG005|Overall Study|Adverse Event|18|||
146206943|NCT01985334|527272118|FG006|Overall Study|Adverse Event|3|||
146206944|NCT01985334|527272119|FG007|Overall Study|Adverse Event|15|||
146206945|NCT01985334|527272112|FG000|Overall Study|Other|4|||
146206946|NCT01985334|527272113|FG001|Overall Study|Other|2|||
146206947|NCT01985334|527272114|FG002|Overall Study|Other|3|||
146206948|NCT01985334|527272115|FG003|Overall Study|Other|10|||
146206949|NCT01985334|527272116|FG004|Overall Study|Other|1|||
146206950|NCT01985334|527272117|FG005|Overall Study|Other|6|||
146206951|NCT01985334|527272118|FG006|Overall Study|Other|2|||
146206952|NCT01985334|527272119|FG007|Overall Study|Other|2|||
146206953|NCT01985334|527272112|FG000|Overall Study|Medication non-compliance|0|||
146206954|NCT01985334|527272113|FG001|Overall Study|Medication non-compliance|4|||
146206955|NCT01985334|527272114|FG002|Overall Study|Medication non-compliance|1|||
146206956|NCT01985334|527272115|FG003|Overall Study|Medication non-compliance|6|||
146206957|NCT01985334|527272116|FG004|Overall Study|Medication non-compliance|2|||
146206958|NCT01985334|527272117|FG005|Overall Study|Medication non-compliance|3|||
146206959|NCT01985334|527272118|FG006|Overall Study|Medication non-compliance|1|||
146434399|NCT03868891|528095180|FG001|Overall Study|COVID-19 Restrictions|2|||
145951462|NCT00829829|526333930|FG001|Overall Study|Decision by the Sponsor|0|||
145951463|NCT00829829|526333931|FG002|Overall Study|Decision by the Sponsor|2|||
145951464|NCT00829829|526333929|FG000|Overall Study|Lost to Follow-up|7|||
145951465|NCT00829829|526333930|FG001|Overall Study|Lost to Follow-up|3|||
145951466|NCT00829829|526333931|FG002|Overall Study|Lost to Follow-up|3|||
145951467|NCT00829829|526333929|FG000|Overall Study|Other than specified above|2|||
145951468|NCT00829829|526333930|FG001|Overall Study|Other than specified above|2|||
145951469|NCT00829829|526333931|FG002|Overall Study|Other than specified above|1|||
145951470|NCT02984267|526333932|FG000|Overall Study|Protocol Violation|1|||
145951471|NCT02984267|526333933|FG001|Overall Study|Protocol Violation|0|||
145951472|NCT02984267|526333932|FG000|Overall Study|Withdrawal by Subject|0|||
145951473|NCT02984267|526333933|FG001|Overall Study|Withdrawal by Subject|1|||
145951474|NCT02685072|526333934|FG000|Treatment Period|Lost to Follow-up|12|||
145951475|NCT02685072|526333935|FG001|Treatment Period|Lost to Follow-up|6|||
145951476|NCT02685072|526333934|FG000|Treatment Period|Withdrawal by Subject|1|||
145951477|NCT02685072|526333935|FG001|Treatment Period|Withdrawal by Subject|3|||
145951478|NCT02685072|526333934|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
145951479|NCT02685072|526333935|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
145951481|NCT01249833|526333938|FG000|Overall Study|Lost to Follow-up|0|||
145951482|NCT01249833|526333939|FG001|Overall Study|Lost to Follow-up|1|||
145951483|NCT03796676|526333940|FG000|Overall Study|Adverse Event|2|||
145951484|NCT03796676|526333941|FG001|Overall Study|Adverse Event|1|||
145951485|NCT03796676|526333942|FG002|Overall Study|Adverse Event|2|||
145951486|NCT03796676|526333940|FG000|Overall Study|Lost to Follow-up|2|||
145951487|NCT03796676|526333941|FG001|Overall Study|Lost to Follow-up|1|||
145951488|NCT03796676|526333942|FG002|Overall Study|Lost to Follow-up|0|||
146206960|NCT01985334|527272119|FG007|Overall Study|Medication non-compliance|3|||
146206961|NCT01985334|527272112|FG000|Overall Study|Use of prohibited treatment|1|||
146206962|NCT01985334|527272113|FG001|Overall Study|Use of prohibited treatment|4|||
146206963|NCT01985334|527272114|FG002|Overall Study|Use of prohibited treatment|1|||
146206964|NCT01985334|527272115|FG003|Overall Study|Use of prohibited treatment|2|||
146285366|NCT01445301|527557847|FG000|Overall Study|Lack of Efficacy|0|||
145951489|NCT03796676|526333940|FG000|Overall Study|Protocol Violation|0|||
145951490|NCT03796676|526333941|FG001|Overall Study|Protocol Violation|0|||
145951491|NCT03796676|526333942|FG002|Overall Study|Protocol Violation|1|||
145951492|NCT03796676|526333940|FG000|Overall Study|Withdrawal by Subject|1|||
145951493|NCT03796676|526333941|FG001|Overall Study|Withdrawal by Subject|1|||
146285367|NCT01445301|527557848|FG001|Overall Study|Lack of Efficacy|1|||
146285368|NCT01445301|527557849|FG002|Overall Study|Lack of Efficacy|0|||
146285369|NCT01445301|527557847|FG000|Overall Study|Protocol Violation|1|||
146285370|NCT01445301|527557848|FG001|Overall Study|Protocol Violation|0|||
146285371|NCT01445301|527557849|FG002|Overall Study|Protocol Violation|0|||
146285372|NCT01445301|527557847|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
146285373|NCT01445301|527557848|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
146285374|NCT01445301|527557849|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
146285375|NCT01445301|527557847|FG000|Overall Study|Physician Decision|0|||
146285376|NCT01445301|527557848|FG001|Overall Study|Physician Decision|2|||
146285377|NCT01445301|527557849|FG002|Overall Study|Physician Decision|0|||
146285378|NCT01445301|527557847|FG000|Overall Study|Withdrawal by Subject|5|||
146285379|NCT01445301|527557848|FG001|Overall Study|Withdrawal by Subject|6|||
146285380|NCT01445301|527557849|FG002|Overall Study|Withdrawal by Subject|4|||
146434400|NCT01518972|528095181|FG000|Overall Study|Lost to Follow-up|2|||
146434401|NCT01518972|528095182|FG001|Overall Study|Lost to Follow-up|1|||
146434402|NCT01518972|528095181|FG000|Overall Study|Withdrawal by Subject|1|||
146434403|NCT01518972|528095182|FG001|Overall Study|Withdrawal by Subject|0|||
146434404|NCT01518972|528095181|FG000|Overall Study|Moved from area|1|||
146434405|NCT01518972|528095182|FG001|Overall Study|Moved from area|0|||
146434406|NCT01518972|528095181|FG000|Overall Study|Transportation problems|1|||
146434407|NCT01518972|528095182|FG001|Overall Study|Transportation problems|0|||
146434408|NCT01518972|528095181|FG000|Overall Study|Exclusionary medical condition|1|||
146434409|NCT01518972|528095182|FG001|Overall Study|Exclusionary medical condition|0|||
146434410|NCT01518972|528095181|FG000|Overall Study|Missed safety visits|0|||
146434411|NCT01518972|528095182|FG001|Overall Study|Missed safety visits|1|||
146434412|NCT01518972|528095181|FG000|Overall Study|Exclusionary medication|0|||
146434413|NCT01518972|528095182|FG001|Overall Study|Exclusionary medication|1|||
146434414|NCT01518972|528095181|FG000|Overall Study|Declined medication starting on day 12|0|||
146434415|NCT01518972|528095182|FG001|Overall Study|Declined medication starting on day 12|1|||
146434416|NCT02159950|528095187|FG000|Overall Study|Adverse Event|0|||
146434417|NCT02159950|528095188|FG001|Overall Study|Adverse Event|1|||
146434418|NCT02159950|528095187|FG000|Overall Study|Progression|0|||
146434419|NCT02159950|528095188|FG001|Overall Study|Progression|1|||
146434420|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
146434421|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
146434422|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
146434423|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
146434424|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
146434425|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
146434426|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
146434427|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
146434428|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
146434429|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
146434430|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
146434431|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
146434432|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
146434433|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
146434434|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
146434435|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
146434436|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
146434437|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
146434438|NCT02009163|528095194|FG000|Open-label Period (Non-randomized)|Other|13|||
146434439|NCT02009163|528095195|FG001|Open-label Period (Non-randomized)|Other|0|||
146434440|NCT02009163|528095196|FG002|Open-label Period (Non-randomized)|Other|0|||
146434441|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
146434442|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
146434443|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
146434444|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
146434445|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
146434446|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
146434447|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Adverse Event|0|||
146434448|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Adverse Event|0|||
146434449|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Adverse Event|6|||
146434450|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
146434451|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
146434452|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
146434453|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
146434454|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
146434455|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
146285381|NCT00752557|527557850|FG000|Overall Study|Withdrawal by Subject|4|||
146285382|NCT00752557|527557851|FG001|Overall Study|Withdrawal by Subject|3|||
146206965|NCT01985334|527272116|FG004|Overall Study|Use of prohibited treatment|1|||
146206966|NCT01985334|527272117|FG005|Overall Study|Use of prohibited treatment|6|||
146206967|NCT01985334|527272118|FG006|Overall Study|Use of prohibited treatment|2|||
146206968|NCT01985334|527272119|FG007|Overall Study|Use of prohibited treatment|0|||
146206969|NCT01985334|527272112|FG000|Overall Study|Investigator decision|0|||
146206970|NCT01985334|527272113|FG001|Overall Study|Investigator decision|3|||
146206971|NCT01985334|527272114|FG002|Overall Study|Investigator decision|0|||
146206972|NCT01985334|527272115|FG003|Overall Study|Investigator decision|7|||
146206973|NCT01985334|527272116|FG004|Overall Study|Investigator decision|1|||
146206974|NCT01985334|527272117|FG005|Overall Study|Investigator decision|1|||
146206975|NCT01985334|527272118|FG006|Overall Study|Investigator decision|0|||
146206976|NCT01985334|527272119|FG007|Overall Study|Investigator decision|4|||
146206977|NCT01985334|527272112|FG000|Overall Study|Lost to Follow-up|0|||
146206978|NCT01985334|527272113|FG001|Overall Study|Lost to Follow-up|2|||
146206979|NCT01985334|527272114|FG002|Overall Study|Lost to Follow-up|0|||
146206980|NCT01985334|527272115|FG003|Overall Study|Lost to Follow-up|3|||
146206981|NCT01985334|527272116|FG004|Overall Study|Lost to Follow-up|1|||
146206982|NCT01985334|527272117|FG005|Overall Study|Lost to Follow-up|4|||
146206983|NCT01985334|527272118|FG006|Overall Study|Lost to Follow-up|0|||
146206984|NCT01985334|527272119|FG007|Overall Study|Lost to Follow-up|3|||
146285383|NCT00752557|527557852|FG002|Overall Study|Withdrawal by Subject|3|||
146206985|NCT01546753|527272120|FG000|Overall Study|anxiety|1|||
146206986|NCT01546753|527272121|FG001|Overall Study|anxiety|1|||
146206987|NCT01546753|527272120|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
146206988|NCT01546753|527272121|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
146206989|NCT03036813|527272122|FG000|Overall Study|Adverse Event|6|||
146434456|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Pregnancy|0|||
146434457|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Pregnancy|0|||
146434458|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Pregnancy|2|||
146434459|NCT02009163|528095194|FG000|Randomized-withdrawal Period|Other|0|||
146434460|NCT02009163|528095195|FG001|Randomized-withdrawal Period|Other|9|||
146434461|NCT02009163|528095196|FG002|Randomized-withdrawal Period|Other|5|||
146434462|NCT02453386|528095199|FG000|Overall Study|Adverse Event|22|||
146434463|NCT02453386|528095200|FG001|Overall Study|Adverse Event|30|||
146434464|NCT02453386|528095201|FG002|Overall Study|Adverse Event|15|||
146434465|NCT02453386|528095199|FG000|Overall Study|Protocol Violation|1|||
146434466|NCT02453386|528095200|FG001|Overall Study|Protocol Violation|0|||
146434467|NCT02453386|528095201|FG002|Overall Study|Protocol Violation|1|||
146434468|NCT02453386|528095199|FG000|Overall Study|Withdrawal by Subject|10|||
146434469|NCT02453386|528095200|FG001|Overall Study|Withdrawal by Subject|9|||
146434470|NCT02453386|528095201|FG002|Overall Study|Withdrawal by Subject|9|||
146434471|NCT02453386|528095199|FG000|Overall Study|Sponsor Terminated Study|14|||
146434472|NCT02453386|528095200|FG001|Overall Study|Sponsor Terminated Study|8|||
146434473|NCT02453386|528095201|FG002|Overall Study|Sponsor Terminated Study|11|||
146434474|NCT02453386|528095199|FG000|Overall Study|Subject Terminated by Sponsor|1|||
146206990|NCT03036813|527272123|FG001|Overall Study|Adverse Event|11|||
146206991|NCT03036813|527272124|FG002|Overall Study|Adverse Event|6|||
146206992|NCT03036813|527272122|FG000|Overall Study|Withdrawal by Subject|12|||
146206993|NCT03036813|527272123|FG001|Overall Study|Withdrawal by Subject|6|||
146434475|NCT02453386|528095200|FG001|Overall Study|Subject Terminated by Sponsor|1|||
146434476|NCT02453386|528095201|FG002|Overall Study|Subject Terminated by Sponsor|1|||
146434477|NCT02453386|528095199|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
146434478|NCT02453386|528095200|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
146434479|NCT02453386|528095201|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
146434480|NCT02453386|528095199|FG000|Overall Study|Lost to Follow-up|0|||
146434481|NCT02453386|528095200|FG001|Overall Study|Lost to Follow-up|0|||
146434482|NCT02453386|528095201|FG002|Overall Study|Lost to Follow-up|1|||
146434483|NCT02453386|528095199|FG000|Overall Study|Other|1|||
146206994|NCT03036813|527272124|FG002|Overall Study|Withdrawal by Subject|10|||
146434484|NCT02453386|528095200|FG001|Overall Study|Other|0|||
146206995|NCT03036813|527272122|FG000|Overall Study|Lost to Follow-up|1|||
146434485|NCT02453386|528095201|FG002|Overall Study|Other|1|||
146434486|NCT02601625|528095202|FG000|Overall Study|Lost to Follow-up|0|||
146434487|NCT02601625|528095203|FG001|Overall Study|Lost to Follow-up|0|||
146434488|NCT02601625|528095204|FG002|Overall Study|Lost to Follow-up|1|||
146434489|NCT02601625|528095205|FG003|Overall Study|Lost to Follow-up|1|||
146206996|NCT03036813|527272123|FG001|Overall Study|Lost to Follow-up|1|||
146434490|NCT00838279|528095210|FG000|Washout|Protocol Violation|1|||
146434491|NCT00838279|528095211|FG001|Washout|Protocol Violation|0|||
146434492|NCT00838279|528095210|FG000|Washout|Withdrawal by Subject|0|||
146434493|NCT00838279|528095211|FG001|Washout|Withdrawal by Subject|1|||
146434494|NCT01415986|528095212|FG000|Overall Study|Lost to Follow-up|1|||
146434495|NCT03792477|528095215|FG000|Overall Study|Adverse Event|0|||
146434496|NCT03792477|528095216|FG001|Overall Study|Adverse Event|0|||
146434497|NCT03792477|528095217|FG002|Overall Study|Adverse Event|0|||
146434498|NCT03792477|528095218|FG003|Overall Study|Adverse Event|1|||
146434499|NCT03792477|528095219|FG004|Overall Study|Adverse Event|0|||
146434500|NCT03792477|528095215|FG000|Overall Study|Lost to Follow-up|0|||
146434501|NCT03792477|528095216|FG001|Overall Study|Lost to Follow-up|0|||
146434502|NCT03792477|528095217|FG002|Overall Study|Lost to Follow-up|2|||
146434503|NCT03792477|528095218|FG003|Overall Study|Lost to Follow-up|0|||
146434504|NCT03792477|528095219|FG004|Overall Study|Lost to Follow-up|0|||
146434505|NCT03792477|528095215|FG000|Overall Study|Other|0|||
146434506|NCT03792477|528095216|FG001|Overall Study|Other|0|||
146434507|NCT03792477|528095217|FG002|Overall Study|Other|0|||
146434508|NCT03792477|528095218|FG003|Overall Study|Other|0|||
146434509|NCT03792477|528095219|FG004|Overall Study|Other|1|||
146434510|NCT00840411|528095221|FG000|First Intervention|Adverse Event|1|||
146434511|NCT00840411|528095222|FG001|First Intervention|Adverse Event|0|||
146434512|NCT00840411|528095221|FG000|Washout|Withdrawal by Subject|1|||
146434513|NCT00840411|528095222|FG001|Washout|Withdrawal by Subject|0|||
146434514|NCT04419311|528095223|FG000|Overall Study|Lost to Follow-up|1|||
146434515|NCT04419311|528095224|FG001|Overall Study|Lost to Follow-up|0|||
146434516|NCT00465270|528095225|FG000|Overall Study|Death|7|||
146434517|NCT00465270|528095226|FG001|Overall Study|Death|11|||
146434518|NCT00465270|528095225|FG000|Overall Study|Withdrawal by Subject|34|||
146434519|NCT00465270|528095226|FG001|Overall Study|Withdrawal by Subject|78|||
146434520|NCT00465270|528095225|FG000|Overall Study|Lost to Follow-up|60|||
146434521|NCT00465270|528095226|FG001|Overall Study|Lost to Follow-up|67|||
146434522|NCT00465270|528095225|FG000|Overall Study|Investigator request|3|||
146434523|NCT00465270|528095226|FG001|Overall Study|Investigator request|4|||
146434524|NCT03122457|528095228|FG000|Overall Study|Withdrawal by Subject|6|||
146434525|NCT02388191|528095229|FG000|Overall Study|Patient did not receive IUD|1|||
146434526|NCT02388191|528095230|FG001|Overall Study|Patient did not receive IUD|0|||
146434527|NCT01921062|528095231|FG000|Overall Study|Withdrawal by Subject|0|||
146434528|NCT01921062|528095232|FG001|Overall Study|Withdrawal by Subject|7|||
146434529|NCT01921062|528095231|FG000|Overall Study|Adverse Event|5|||
146434530|NCT01921062|528095232|FG001|Overall Study|Adverse Event|6|||
146434531|NCT01921062|528095231|FG000|Overall Study|Protocol Violation|0|||
146434532|NCT01921062|528095232|FG001|Overall Study|Protocol Violation|1|||
146434533|NCT01921062|528095231|FG000|Overall Study|VMIQ score > 72|4|||
146434534|NCT01921062|528095232|FG001|Overall Study|VMIQ score > 72|1|||
146434535|NCT01921062|528095231|FG000|Overall Study|Logistic error|0|||
146434536|NCT01921062|528095232|FG001|Overall Study|Logistic error|1|||
146434537|NCT01911676|528095233|FG000|Period 1 of Study|Withdrawal by Subject|4|||
146434538|NCT01911676|528095234|FG001|Period 1 of Study|Withdrawal by Subject|2|||
146434539|NCT01911676|528095235|FG002|Period 1 of Study|Withdrawal by Subject|1|||
146434540|NCT01911676|528095236|FG003|Period 1 of Study|Withdrawal by Subject|2|||
146434541|NCT01911676|528095233|FG000|Period 1 of Study|Physician Decision|2|||
146434542|NCT01911676|528095234|FG001|Period 1 of Study|Physician Decision|0|||
146434543|NCT01911676|528095235|FG002|Period 1 of Study|Physician Decision|0|||
146434544|NCT01911676|528095236|FG003|Period 1 of Study|Physician Decision|1|||
146434545|NCT01911676|528095233|FG000|Period 2 of Study|Physician Decision|2|||
146434546|NCT01911676|528095234|FG001|Period 2 of Study|Physician Decision|0|||
146434547|NCT01911676|528095235|FG002|Period 2 of Study|Physician Decision|0|||
146206997|NCT03036813|527272124|FG002|Overall Study|Lost to Follow-up|0|||
146206998|NCT03036813|527272122|FG000|Overall Study|Physician Decision|2|||
146434548|NCT01911676|528095236|FG003|Period 2 of Study|Physician Decision|1|||
146434549|NCT01911676|528095233|FG000|Period 2 of Study|Lost to Follow-up|0|||
146206999|NCT03036813|527272123|FG001|Overall Study|Physician Decision|1|||
146207000|NCT03036813|527272124|FG002|Overall Study|Physician Decision|1|||
146434550|NCT01911676|528095234|FG001|Period 2 of Study|Lost to Follow-up|0|||
146434551|NCT01911676|528095235|FG002|Period 2 of Study|Lost to Follow-up|0|||
146434552|NCT01911676|528095236|FG003|Period 2 of Study|Lost to Follow-up|1|||
146434553|NCT00657553|528095239|FG000|Overall Study|low accrual, no analysis run|5|||
146434554|NCT00657553|528095240|FG001|Overall Study|low accrual, no analysis run|5|||
146207001|NCT03036813|527272122|FG000|Overall Study|Non-Compliance|1|||
146434555|NCT03173547|528095241|FG000|Overall Study|Adverse Event|2|||
146434556|NCT03173547|528095242|FG001|Overall Study|Adverse Event|0|||
146434557|NCT03173547|528095241|FG000|Overall Study|Withdrawal by Subject|2|||
146434558|NCT03173547|528095242|FG001|Overall Study|Withdrawal by Subject|2|||
146207002|NCT03036813|527272123|FG001|Overall Study|Non-Compliance|5|||
146434559|NCT01169558|528095243|FG000|Overall Study|Disease progression|98|||
146434560|NCT01169558|528095243|FG000|Overall Study|Adverse Event|25|||
146434561|NCT01169558|528095243|FG000|Overall Study|Withdrawal of Consent|8|||
146207003|NCT03036813|527272124|FG002|Overall Study|Non-Compliance|3|||
146207004|NCT03036813|527272122|FG000|Overall Study|Pregnancy|0|||
146207005|NCT03036813|527272123|FG001|Overall Study|Pregnancy|0|||
146207006|NCT03036813|527272124|FG002|Overall Study|Pregnancy|1|||
146207007|NCT03036813|527272122|FG000|Overall Study|Other|0|||
146207008|NCT03036813|527272123|FG001|Overall Study|Other|3|||
146207009|NCT03036813|527272124|FG002|Overall Study|Other|5|||
146207010|NCT01102231|527272125|FG000|Overall Study|Protocol Violation|3|||
146207011|NCT01102231|527272125|FG000|Overall Study|Lack of Efficacy|2|||
146207012|NCT01102231|527272125|FG000|Overall Study|Death|2|||
146207013|NCT01102231|527272125|FG000|Overall Study|Adverse Event|3|||
146207014|NCT01102231|527272125|FG000|Overall Study|Withdrawal by Subject|1|||
146207015|NCT01102231|527272125|FG000|Overall Study|Did not received the treatment|4|||
146207016|NCT00546754|527272126|FG000|Overall Study|Serious Adverse Event|1|||
146434562|NCT01169558|528095243|FG000|Overall Study|Medical Decision|7|||
146434563|NCT01169558|528095243|FG000|Overall Study|Stable Disease|4|||
146207017|NCT00546754|527272127|FG001|Overall Study|Serious Adverse Event|1|||
146207018|NCT00546754|527272126|FG000|Overall Study|Adverse Event|11|||
146207019|NCT00546754|527272127|FG001|Overall Study|Adverse Event|16|||
146207020|NCT00546754|527272126|FG000|Overall Study|Lack of Efficacy|1|||
146207021|NCT00546754|527272127|FG001|Overall Study|Lack of Efficacy|1|||
146207022|NCT00546754|527272126|FG000|Overall Study|Lost to Follow-up|9|||
146207023|NCT00546754|527272127|FG001|Overall Study|Lost to Follow-up|15|||
146207024|NCT00546754|527272126|FG000|Overall Study|Protocol Violation|3|||
146434564|NCT01169558|528095243|FG000|Overall Study|Lost to Follow-up|4|||
146434565|NCT01169558|528095243|FG000|Overall Study|Need for Surgery|4|||
146434566|NCT01169558|528095243|FG000|Overall Study|Non-compliance|2|||
146434567|NCT01169558|528095243|FG000|Overall Study|Protocol Violation|2|||
146434568|NCT01169558|528095243|FG000|Overall Study|Partial response|2|||
146434569|NCT03482882|528095248|FG000|Overall Study|Adverse Event|3|||
146434570|NCT03482882|528095248|FG000|Overall Study|Lost to Follow-up|1|||
146434571|NCT03482882|528095248|FG000|Overall Study|Protocol Violation|2|||
146434572|NCT03482882|528095248|FG000|Overall Study|Not further specified|1|||
146434573|NCT01110005|528095251|FG000|Overall Study|ineligible|1|||
146434574|NCT01110005|528095252|FG001|Overall Study|ineligible|2|||
146434575|NCT01110005|528095251|FG000|Overall Study|missing consent|3|||
146434576|NCT01110005|528095252|FG001|Overall Study|missing consent|2|||
146434577|NCT01110005|528095251|FG000|Overall Study|Withdrawal by Subject|0|||
146434578|NCT01110005|528095252|FG001|Overall Study|Withdrawal by Subject|1|||
146434579|NCT01136174|528095253|FG000|Overall Study|Adverse Event|0|||
146434580|NCT01136174|528095254|FG001|Overall Study|Adverse Event|0|||
146434581|NCT01136174|528095255|FG002|Overall Study|Adverse Event|0|||
146434582|NCT01136174|528095256|FG003|Overall Study|Adverse Event|4|||
146434583|NCT00819741|528095259|FG000|Overall Study|Adverse Event|5|||
146434584|NCT00819741|528095260|FG001|Overall Study|Adverse Event|2|||
146434585|NCT00819741|528095259|FG000|Overall Study|Lack of Efficacy|0|||
146434586|NCT00819741|528095260|FG001|Overall Study|Lack of Efficacy|2|||
146434587|NCT00819741|528095259|FG000|Overall Study|Lost to Follow-up|3|||
146434588|NCT00819741|528095260|FG001|Overall Study|Lost to Follow-up|1|||
146434589|NCT00819741|528095259|FG000|Overall Study|Protocol Violation|3|||
146434590|NCT00819741|528095260|FG001|Overall Study|Protocol Violation|4|||
146434591|NCT00819741|528095259|FG000|Overall Study|Withdrawal by Subject|2|||
146434592|NCT00819741|528095260|FG001|Overall Study|Withdrawal by Subject|2|||
146434593|NCT00819741|528095259|FG000|Overall Study|Unclassified|6|||
146434594|NCT00819741|528095260|FG001|Overall Study|Unclassified|0|||
146434595|NCT00819741|528095259|FG000|Overall Study|Reasons unknown|3|||
146434596|NCT00819741|528095260|FG001|Overall Study|Reasons unknown|3|||
146434597|NCT00119015|528095261|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
146434598|NCT00119015|528095262|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
146434599|NCT00119015|528095263|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
146434600|NCT05604170|528096866|FG000|Overall Study|Lack of Efficacy|5|||
146434601|NCT05604170|528096866|FG000|Overall Study|Adverse Event|6|||
146434602|NCT05604170|528096866|FG000|Overall Study|Physician Decision|6|||
146434603|NCT05604170|528096866|FG000|Overall Study|Lost to Follow-up|6|||
146207025|NCT00546754|527272127|FG001|Overall Study|Protocol Violation|0|||
146207026|NCT00546754|527272126|FG000|Overall Study|Withdrawal by Subject|6|||
146207027|NCT00546754|527272127|FG001|Overall Study|Withdrawal by Subject|7|||
146207028|NCT00546754|527272126|FG000|Overall Study|Dyspnea|1|||
146207029|NCT00546754|527272127|FG001|Overall Study|Dyspnea|0|||
146207030|NCT00546754|527272126|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
146434604|NCT05604170|528096866|FG000|Overall Study|Withdrawal by Subject|11|||
146434605|NCT05604170|528096866|FG000|Overall Study|Early study termination by sponsor|77|||
146434606|NCT05604170|528096866|FG000|Overall Study|Other|6|||
146434607|NCT03697109|528096867|FG000|Open-label (OL) Phase|Adverse Event|24|||
146434608|NCT03697109|528096868|FG001|Open-label (OL) Phase|Adverse Event|0|||
146434609|NCT03697109|528096869|FG002|Open-label (OL) Phase|Adverse Event|0|||
146434610|NCT03697109|528096867|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
146434611|NCT03697109|528096868|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
146207031|NCT00546754|527272127|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
146434612|NCT03697109|528096869|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
146434613|NCT03697109|528096867|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
146434614|NCT03697109|528096868|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
146434615|NCT03697109|528096869|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
146434616|NCT03697109|528096867|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
146434617|NCT03697109|528096868|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
146434618|NCT03697109|528096869|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
146434619|NCT03697109|528096867|FG000|Open-label (OL) Phase|Physician Decision|2|||
146434620|NCT03697109|528096868|FG001|Open-label (OL) Phase|Physician Decision|0|||
146434621|NCT03697109|528096869|FG002|Open-label (OL) Phase|Physician Decision|0|||
146434622|NCT03697109|528096867|FG000|Open-label (OL) Phase|Death|2|||
146434623|NCT03697109|528096868|FG001|Open-label (OL) Phase|Death|0|||
146434624|NCT03697109|528096869|FG002|Open-label (OL) Phase|Death|0|||
146434625|NCT03697109|528096867|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
146434626|NCT03697109|528096868|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
146434627|NCT03697109|528096869|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
146434628|NCT03697109|528096867|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
146434629|NCT03697109|528096868|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
146434630|NCT03697109|528096869|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
146434631|NCT03697109|528096867|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
146434632|NCT03697109|528096868|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
146434633|NCT03697109|528096869|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
146434634|NCT03032172|528096870|FG000|Treatment Period|Adverse Event|0|||
146434635|NCT03032172|528096871|FG001|Treatment Period|Adverse Event|1|||
146434636|NCT03032172|528096872|FG002|Treatment Period|Adverse Event|0|||
146434637|NCT03032172|528096873|FG003|Treatment Period|Adverse Event|0|||
146434638|NCT03032172|528096874|FG004|Treatment Period|Adverse Event|0|||
146434639|NCT03032172|528096875|FG005|Treatment Period|Adverse Event|0|||
146434640|NCT03032172|528096876|FG006|Treatment Period|Adverse Event|0|||
146434641|NCT03032172|528096877|FG007|Treatment Period|Adverse Event|0|||
146434642|NCT03032172|528096870|FG000|Treatment Period|Lack of Efficacy|0|||
146434643|NCT03032172|528096871|FG001|Treatment Period|Lack of Efficacy|1|||
146434644|NCT03032172|528096872|FG002|Treatment Period|Lack of Efficacy|0|||
146434645|NCT03032172|528096873|FG003|Treatment Period|Lack of Efficacy|0|||
146434646|NCT03032172|528096874|FG004|Treatment Period|Lack of Efficacy|0|||
146434647|NCT03032172|528096875|FG005|Treatment Period|Lack of Efficacy|0|||
146434648|NCT03032172|528096876|FG006|Treatment Period|Lack of Efficacy|0|||
146434649|NCT03032172|528096877|FG007|Treatment Period|Lack of Efficacy|0|||
146434650|NCT03032172|528096870|FG000|Treatment Period|Non-compliance With Study Drug|0|||
146434651|NCT03032172|528096871|FG001|Treatment Period|Non-compliance With Study Drug|1|||
146434652|NCT03032172|528096872|FG002|Treatment Period|Non-compliance With Study Drug|0|||
146434653|NCT03032172|528096873|FG003|Treatment Period|Non-compliance With Study Drug|0|||
146434654|NCT03032172|528096874|FG004|Treatment Period|Non-compliance With Study Drug|0|||
146434655|NCT03032172|528096875|FG005|Treatment Period|Non-compliance With Study Drug|0|||
146207032|NCT00546754|527272126|FG000|Overall Study|Hip Replacement|1|||
146207033|NCT00546754|527272127|FG001|Overall Study|Hip Replacement|0|||
146207034|NCT00546754|527272126|FG000|Overall Study|Suicide|1|||
146207035|NCT00546754|527272127|FG001|Overall Study|Suicide|0|||
146207036|NCT00546754|527272126|FG000|Overall Study|Missing Cooperation|1|||
146207037|NCT00546754|527272127|FG001|Overall Study|Missing Cooperation|0|||
146207038|NCT00546754|527272126|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
146207039|NCT00546754|527272127|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
146207040|NCT00546754|527272126|FG000|Overall Study|Patient's Decision|0|||
146207041|NCT00546754|527272127|FG001|Overall Study|Patient's Decision|1|||
146207042|NCT00546754|527272126|FG000|Overall Study|Missing|14|||
146207043|NCT00546754|527272127|FG001|Overall Study|Missing|7|||
146434656|NCT03032172|528096876|FG006|Treatment Period|Non-compliance With Study Drug|0|||
146434657|NCT03032172|528096877|FG007|Treatment Period|Non-compliance With Study Drug|0|||
146434658|NCT03032172|528096870|FG000|Treatment Period|Reason Not Specified|0|||
146434659|NCT03032172|528096871|FG001|Treatment Period|Reason Not Specified|4|||
146434660|NCT03032172|528096872|FG002|Treatment Period|Reason Not Specified|1|||
146434661|NCT03032172|528096873|FG003|Treatment Period|Reason Not Specified|0|||
146082964|NCT03085914|526824714|FG005|Overall Study|Study Terminated by the Sponsor|1|||
146285384|NCT00752557|527557850|FG000|Overall Study|Unspecified resaons|0|||
146434662|NCT03032172|528096874|FG004|Treatment Period|Reason Not Specified|0|||
146434663|NCT03032172|528096875|FG005|Treatment Period|Reason Not Specified|0|||
146207044|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
146207045|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
146207046|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
146207047|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
146207048|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
146207049|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
146207050|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
146207051|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
146207052|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
146207053|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
146207054|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
146207055|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
146207056|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
146207057|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
146207058|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
146207059|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
146207060|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
146207061|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
146207062|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
146207063|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
146207064|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
146207065|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
146207066|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
146207067|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
146207068|NCT00311363|527272130|FG000|24-Week Single-Blind Treatment Period|Death|1|||
146207069|NCT00311363|527272131|FG001|24-Week Single-Blind Treatment Period|Death|0|||
146207070|NCT00311363|527272132|FG002|24-Week Single-Blind Treatment Period|Death|0|||
146207071|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
146207072|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
146207073|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
146207074|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146207075|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146207076|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146207077|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
146207078|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
146207079|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
146207080|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
146207081|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
146207082|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
146207083|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
146207084|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
146207085|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
146207086|NCT00311363|527272130|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
146207087|NCT00311363|527272131|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
146207088|NCT00311363|527272132|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
146207089|NCT00396084|527272133|FG000|Overall Study|Adverse Event|0|||
146207090|NCT00396084|527272134|FG001|Overall Study|Adverse Event|0|||
146207091|NCT00396084|527272135|FG002|Overall Study|Adverse Event|0|||
146207092|NCT00396084|527272136|FG003|Overall Study|Adverse Event|0|||
146207093|NCT00396084|527272137|FG004|Overall Study|Adverse Event|1|||
146207094|NCT00396084|527272138|FG005|Overall Study|Adverse Event|2|||
146207095|NCT00396084|527272133|FG000|Overall Study|Withdrawal by Subject|0|||
146207096|NCT00396084|527272134|FG001|Overall Study|Withdrawal by Subject|0|||
146207097|NCT00396084|527272135|FG002|Overall Study|Withdrawal by Subject|0|||
146434664|NCT03032172|528096876|FG006|Treatment Period|Reason Not Specified|0|||
146434665|NCT03032172|528096877|FG007|Treatment Period|Reason Not Specified|0|||
146434666|NCT03032172|528096870|FG000|Treatment Period|Physician Decision|0|||
146207098|NCT00396084|527272136|FG003|Overall Study|Withdrawal by Subject|1|||
146207099|NCT00396084|527272137|FG004|Overall Study|Withdrawal by Subject|0|||
146207100|NCT00396084|527272138|FG005|Overall Study|Withdrawal by Subject|0|||
146207101|NCT01697969|527272139|FG000|Overall Study|Did not meet inc/exc criteria|3|||
146207102|NCT04200365|527272140|FG000|Overall Study|Adverse Event|2|||
146434667|NCT03032172|528096871|FG001|Treatment Period|Physician Decision|2|||
146434668|NCT03032172|528096872|FG002|Treatment Period|Physician Decision|1|||
146434669|NCT03032172|528096873|FG003|Treatment Period|Physician Decision|0|||
146434670|NCT03032172|528096874|FG004|Treatment Period|Physician Decision|0|||
146434671|NCT03032172|528096875|FG005|Treatment Period|Physician Decision|0|||
145951494|NCT03796676|526333942|FG002|Overall Study|Withdrawal by Subject|0|||
145951495|NCT03796676|526333940|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
145951496|NCT03796676|526333941|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
145951497|NCT03796676|526333942|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
145951498|NCT01085084|526333946|FG000|Overall Study|Withdrawal by Subject|1|||
145951499|NCT01085084|526333947|FG001|Overall Study|Withdrawal by Subject|0|||
145951500|NCT01085084|526333948|FG002|Overall Study|Withdrawal by Subject|0|||
145951501|NCT01085084|526333946|FG000|Overall Study|Lost to Follow-up|2|||
145951502|NCT01085084|526333947|FG001|Overall Study|Lost to Follow-up|1|||
145951503|NCT01085084|526333948|FG002|Overall Study|Lost to Follow-up|1|||
145951504|NCT01085084|526333946|FG000|Overall Study|Adverse Event|4|||
145951505|NCT01085084|526333947|FG001|Overall Study|Adverse Event|3|||
145951506|NCT01085084|526333948|FG002|Overall Study|Adverse Event|6|||
145951507|NCT01085084|526333946|FG000|Overall Study|Treatment Failure|0|||
145951508|NCT01085084|526333947|FG001|Overall Study|Treatment Failure|1|||
145951509|NCT01085084|526333948|FG002|Overall Study|Treatment Failure|2|||
145951510|NCT02749799|526333949|FG000|Overall Study|Adverse Event|2|||
145951511|NCT02749799|526333949|FG000|Overall Study|Lost to Follow-up|4|||
145951512|NCT02749799|526333949|FG000|Overall Study|Protocol Violation|1|||
145951513|NCT02749799|526333949|FG000|Overall Study|Withdrawal by Subject|1|||
145951514|NCT02070978|526333950|FG000|Overall Study|Adverse Event|6|||
145951515|NCT02070978|526333951|FG001|Overall Study|Adverse Event|2|||
145951516|NCT02070978|526333952|FG002|Overall Study|Adverse Event|0|||
145951517|NCT02070978|526333950|FG000|Overall Study|Lost to Follow-up|1|||
145951518|NCT02070978|526333951|FG001|Overall Study|Lost to Follow-up|3|||
145951519|NCT02070978|526333952|FG002|Overall Study|Lost to Follow-up|4|||
145951520|NCT02070978|526333950|FG000|Overall Study|Withdrawal by Subject|3|||
145951521|NCT02070978|526333951|FG001|Overall Study|Withdrawal by Subject|5|||
145951522|NCT02070978|526333952|FG002|Overall Study|Withdrawal by Subject|3|||
145951523|NCT02070978|526333950|FG000|Overall Study|Protocol Violation|1|||
145951524|NCT02070978|526333951|FG001|Overall Study|Protocol Violation|0|||
145951525|NCT02070978|526333952|FG002|Overall Study|Protocol Violation|3|||
145951526|NCT02070978|526333950|FG000|Overall Study|Lack of Efficacy|0|||
145951527|NCT02070978|526333951|FG001|Overall Study|Lack of Efficacy|1|||
145951528|NCT02070978|526333952|FG002|Overall Study|Lack of Efficacy|0|||
145951529|NCT02070978|526333950|FG000|Overall Study|Death|0|||
145951530|NCT02070978|526333951|FG001|Overall Study|Death|0|||
145951531|NCT02070978|526333952|FG002|Overall Study|Death|2|||
145951532|NCT02070978|526333950|FG000|Overall Study|Un-specified|3|||
145951533|NCT02070978|526333951|FG001|Overall Study|Un-specified|2|||
145951534|NCT02070978|526333952|FG002|Overall Study|Un-specified|2|||
145951535|NCT02070978|526333950|FG000|Overall Study|Terminated by Sponsor|33|||
145951536|NCT02070978|526333951|FG001|Overall Study|Terminated by Sponsor|40|||
145951537|NCT02070978|526333952|FG002|Overall Study|Terminated by Sponsor|39|||
145951538|NCT03951753|526333953|FG000|Overall Study|Adverse Event|1|||
145951539|NCT03951753|526333954|FG001|Overall Study|Adverse Event|0|||
145951540|NCT03951753|526333955|FG002|Overall Study|Adverse Event|3|||
145951541|NCT03951753|526333953|FG000|Overall Study|Withdrawal by Subject|3|||
145951542|NCT03951753|526333954|FG001|Overall Study|Withdrawal by Subject|1|||
145951543|NCT03951753|526333955|FG002|Overall Study|Withdrawal by Subject|0|||
146207103|NCT04200365|527272140|FG000|Overall Study|Progressive Disease|4|||
146207104|NCT04200365|527272140|FG000|Overall Study|Lack of Efficacy|1|||
146434672|NCT03032172|528096876|FG006|Treatment Period|Physician Decision|0|||
146434673|NCT03032172|528096877|FG007|Treatment Period|Physician Decision|0|||
146434674|NCT03032172|528096870|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146434675|NCT03032172|528096871|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
146434676|NCT03032172|528096872|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
146434677|NCT03032172|528096873|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
146434678|NCT03032172|528096874|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145951544|NCT03951753|526333953|FG000|Overall Study|Lost to Follow-up|0|||
145951545|NCT03951753|526333954|FG001|Overall Study|Lost to Follow-up|0|||
145951546|NCT03951753|526333955|FG002|Overall Study|Lost to Follow-up|1|||
145951547|NCT01905592|526333958|FG000|Overall Study|Disease Progression|51|||
145951548|NCT01905592|526333959|FG001|Overall Study|Disease Progression|110|||
145951549|NCT01905592|526333958|FG000|Overall Study|Toxicity|1|||
145951550|NCT01905592|526333959|FG001|Overall Study|Toxicity|16|||
145951551|NCT01905592|526333958|FG000|Overall Study|Physician Decision|0|||
145951552|NCT01905592|526333959|FG001|Overall Study|Physician Decision|2|||
145951553|NCT01905592|526333958|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
145951554|NCT01905592|526333959|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
146434679|NCT03032172|528096875|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146434680|NCT03032172|528096876|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146434681|NCT03032172|528096877|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
146434682|NCT03032172|528096870|FG000|Treatment Period|Withdrawal by Subject|2|||
146434683|NCT03032172|528096871|FG001|Treatment Period|Withdrawal by Subject|0|||
146434684|NCT03032172|528096872|FG002|Treatment Period|Withdrawal by Subject|3|||
145951555|NCT01905592|526333958|FG000|Overall Study|Protocol Violation|0|||
146207105|NCT04200365|527272140|FG000|Overall Study|Study Closure|4|||
146207106|NCT01499199|527272143|FG000|Overall Study|Adverse Event|1|||
146207107|NCT01499199|527272143|FG000|Overall Study|Lack of Efficacy|1|||
146207108|NCT01199575|527272144|FG000|Overall Study|Withdrawal by Subject|5|||
146207109|NCT02139943|527272145|FG000|Overall Study|Adverse Event|0|||
146207110|NCT02139943|527272146|FG001|Overall Study|Adverse Event|1|||
146207111|NCT02139943|527272147|FG002|Overall Study|Adverse Event|2|||
146207112|NCT02139943|527272145|FG000|Overall Study|Lost to Follow-up|3|||
146207113|NCT02139943|527272146|FG001|Overall Study|Lost to Follow-up|2|||
146207114|NCT02139943|527272147|FG002|Overall Study|Lost to Follow-up|2|||
146207115|NCT02139943|527272145|FG000|Overall Study|Withdrawal by Subject|4|||
146207116|NCT02139943|527272146|FG001|Overall Study|Withdrawal by Subject|3|||
146207117|NCT02139943|527272147|FG002|Overall Study|Withdrawal by Subject|0|||
146207118|NCT02139943|527272145|FG000|Overall Study|Other|0|||
146207119|NCT02139943|527272146|FG001|Overall Study|Other|0|||
146207120|NCT02139943|527272147|FG002|Overall Study|Other|1|||
146207121|NCT02139943|527272145|FG000|Overall Study|Participant wishes to discontinue|2|||
146207122|NCT02139943|527272146|FG001|Overall Study|Participant wishes to discontinue|0|||
146207123|NCT02139943|527272147|FG002|Overall Study|Participant wishes to discontinue|0|||
146207124|NCT02139943|527272145|FG000|Overall Study|Participant in Poor Compliance|1|||
146207125|NCT02139943|527272146|FG001|Overall Study|Participant in Poor Compliance|0|||
146207126|NCT02139943|527272147|FG002|Overall Study|Participant in Poor Compliance|1|||
146207127|NCT02139943|527272145|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
146207128|NCT02139943|527272146|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
146207129|NCT02139943|527272147|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
146207130|NCT00411216|527272160|FG000|Overall Study|Ten participants were entered into the c|0|||
146207131|NCT00411216|527272161|FG001|Overall Study|Ten participants were entered into the c|2|||
146207132|NCT01251354|527272165|FG000|Overall Study|Adverse Event|1|||
146207133|NCT01251354|527272165|FG000|Overall Study|Investigator's Decision|1|||
146207134|NCT01251354|527272165|FG000|Overall Study|Disease Progression|4|||
146207135|NCT03422276|527273531|FG000|Overall Study|Withdrawal by Subject|21|||
146207136|NCT03422276|527273532|FG001|Overall Study|Withdrawal by Subject|25|||
146207137|NCT03422276|527273533|FG002|Overall Study|Withdrawal by Subject|14|||
146207138|NCT03422276|527273534|FG003|Overall Study|Withdrawal by Subject|16|||
146207139|NCT03422276|527273531|FG000|Overall Study|Death|14|||
146207140|NCT03422276|527273532|FG001|Overall Study|Death|21|||
146207141|NCT03422276|527273533|FG002|Overall Study|Death|3|||
146207142|NCT03422276|527273534|FG003|Overall Study|Death|1|||
146207143|NCT03422276|527273531|FG000|Overall Study|Discontinued, ineligible|4|||
146207144|NCT03422276|527273532|FG001|Overall Study|Discontinued, ineligible|3|||
146207145|NCT03422276|527273533|FG002|Overall Study|Discontinued, ineligible|0|||
146207146|NCT03422276|527273534|FG003|Overall Study|Discontinued, ineligible|0|||
146207147|NCT03422276|527273531|FG000|Overall Study|Lost to Follow-up|15|||
146207148|NCT03422276|527273532|FG001|Overall Study|Lost to Follow-up|8|||
146207149|NCT03422276|527273533|FG002|Overall Study|Lost to Follow-up|13|||
146207150|NCT03422276|527273534|FG003|Overall Study|Lost to Follow-up|4|||
146285385|NCT00752557|527557851|FG001|Overall Study|Unspecified resaons|2|||
146207151|NCT03422276|527273531|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
146207152|NCT03422276|527273532|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
146207153|NCT03422276|527273533|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
146207154|NCT03422276|527273534|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
146207155|NCT03422276|527273531|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
146207156|NCT03422276|527273532|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
146207157|NCT03422276|527273533|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
146207158|NCT03422276|527273534|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
146207159|NCT03422276|527273531|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
146207160|NCT03422276|527273532|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
146207161|NCT03422276|527273533|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
146207162|NCT03422276|527273534|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
146207163|NCT03422276|527273531|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
146207164|NCT03422276|527273532|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
146207165|NCT03422276|527273533|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
146207166|NCT03422276|527273534|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
146207167|NCT03422276|527273531|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146207168|NCT03422276|527273532|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146207169|NCT03422276|527273533|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
146207170|NCT03422276|527273534|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
146207171|NCT02279095|527273540|FG000|Overall Study|Non-Compliance|1|||
146207172|NCT02279095|527273540|FG000|Overall Study|Withdrawal by Subject|8|||
146207173|NCT02279095|527273540|FG000|Overall Study|Adverse Event|2|||
146207174|NCT02279095|527273540|FG000|Overall Study|Other|7|||
146207175|NCT02279095|527273540|FG000|Overall Study|Lost to Follow-up|1|||
146207176|NCT05938413|527273541|FG000|Overall Study|Lost to Follow-up|1|||
146207177|NCT05938413|527273542|FG001|Overall Study|Lost to Follow-up|7|||
146207178|NCT05938413|527273541|FG000|Overall Study|Withdrawal by Subject|1|||
146207179|NCT05938413|527273542|FG001|Overall Study|Withdrawal by Subject|1|||
146207180|NCT04922021|527273543|FG000|Overall Study|Withdrawal by Subject|4|||
146207181|NCT04922021|527273544|FG001|Overall Study|Withdrawal by Subject|10|||
146207182|NCT04922021|527273543|FG000|Overall Study|Adverse Event|2|||
146207183|NCT04922021|527273544|FG001|Overall Study|Adverse Event|2|||
146207184|NCT04922021|527273543|FG000|Overall Study|Lack of Efficacy|0|||
146207185|NCT04922021|527273544|FG001|Overall Study|Lack of Efficacy|1|||
146207186|NCT04922021|527273543|FG000|Overall Study|Multiple reasons|1|||
146207187|NCT04922021|527273544|FG001|Overall Study|Multiple reasons|0|||
146082965|NCT03085914|526824715|FG006|Overall Study|Study Terminated by the Sponsor|0|||
146082966|NCT01215916|526824716|FG000|Overall Study|Progressive Disease|0|||
146207188|NCT03237481|527273553|FG000|Overall Study|Lost to Follow-up|1|||
146207189|NCT03237481|527273554|FG001|Overall Study|Lost to Follow-up|0|||
146207190|NCT03237481|527273555|FG002|Overall Study|Lost to Follow-up|0|||
146207191|NCT03237481|527273553|FG000|Overall Study|Protocol Violation|1|||
146207192|NCT03237481|527273554|FG001|Overall Study|Protocol Violation|0|||
146207193|NCT03237481|527273555|FG002|Overall Study|Protocol Violation|0|||
146207194|NCT03237481|527273553|FG000|Overall Study|Withdrawal by Subject|3|||
146207195|NCT03237481|527273554|FG001|Overall Study|Withdrawal by Subject|2|||
146207196|NCT03237481|527273555|FG002|Overall Study|Withdrawal by Subject|1|||
146207197|NCT03481777|527273556|FG000|Overall Study|Withdrawal by Subject|36|||
146207198|NCT03481777|527273557|FG001|Overall Study|Withdrawal by Subject|31|||
146207199|NCT03481777|527273556|FG000|Overall Study|Non stroke = non target population|277|||
146207200|NCT03481777|527273557|FG001|Overall Study|Non stroke = non target population|254|||
146082967|NCT01215916|526824717|FG001|Overall Study|Progressive Disease|2|||
146207201|NCT04300647|527273562|FG000|Pre-Crossover|Death|19|||
146207202|NCT04300647|527273563|FG001|Pre-Crossover|Death|58|||
146207203|NCT04300647|527273564|FG002|Pre-Crossover|Death|0|||
146207204|NCT04300647|527273562|FG000|Pre-Crossover|Lost to Follow-up|0|||
146207205|NCT04300647|527273563|FG001|Pre-Crossover|Lost to Follow-up|3|||
146207206|NCT04300647|527273564|FG002|Pre-Crossover|Lost to Follow-up|0|||
146207207|NCT04300647|527273562|FG000|Pre-Crossover|Withdrawal by Subject|2|||
146207208|NCT04300647|527273563|FG001|Pre-Crossover|Withdrawal by Subject|4|||
146207209|NCT04300647|527273564|FG002|Pre-Crossover|Withdrawal by Subject|0|||
146207210|NCT04300647|527273562|FG000|Pre-Crossover|On-going in Study|24|||
146207211|NCT04300647|527273563|FG001|Pre-Crossover|On-going in Study|61|||
146207212|NCT04300647|527273564|FG002|Pre-Crossover|On-going in Study|0|||
146207213|NCT04300647|527273562|FG000|Post-Crossover|Death|0|||
146207214|NCT04300647|527273563|FG001|Post-Crossover|Death|0|||
146207215|NCT04300647|527273564|FG002|Post-Crossover|Death|3|||
146207216|NCT04300647|527273562|FG000|Post-Crossover|Lost to Follow-up|0|||
146207217|NCT04300647|527273563|FG001|Post-Crossover|Lost to Follow-up|0|||
146207218|NCT04300647|527273564|FG002|Post-Crossover|Lost to Follow-up|1|||
146207219|NCT04300647|527273562|FG000|Post-Crossover|Withdrawal by Subject|0|||
146207220|NCT04300647|527273563|FG001|Post-Crossover|Withdrawal by Subject|0|||
146207221|NCT04300647|527273564|FG002|Post-Crossover|Withdrawal by Subject|1|||
146207222|NCT04300647|527273562|FG000|Post-Crossover|On-going in Study|0|||
146207223|NCT04300647|527273563|FG001|Post-Crossover|On-going in Study|0|||
146207224|NCT04300647|527273564|FG002|Post-Crossover|On-going in Study|8|||
146207225|NCT05386238|527273565|FG000|Overall Study|Lost to Follow-up|3|||
146207226|NCT05386238|527273566|FG001|Overall Study|Lost to Follow-up|2|||
146207227|NCT05386238|527273565|FG000|Overall Study|Withdrawal by Subject|0|||
146207228|NCT05386238|527273566|FG001|Overall Study|Withdrawal by Subject|1|||
146434685|NCT03032172|528096873|FG003|Treatment Period|Withdrawal by Subject|0|||
146434686|NCT03032172|528096874|FG004|Treatment Period|Withdrawal by Subject|0|||
146434687|NCT03032172|528096875|FG005|Treatment Period|Withdrawal by Subject|0|||
146434688|NCT03032172|528096876|FG006|Treatment Period|Withdrawal by Subject|0|||
146207229|NCT04714320|527273572|FG000|Overall Study|Voluntary Withdrawal|4|||
146207230|NCT04714320|527273573|FG001|Overall Study|Voluntary Withdrawal|1|||
146207231|NCT04714320|527273574|FG002|Overall Study|Voluntary Withdrawal|2|||
146207232|NCT04714320|527273572|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
146207233|NCT04714320|527273573|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
146207234|NCT04714320|527273574|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
146207235|NCT04714320|527273572|FG000|Overall Study|Reason Not Specified|1|||
146207236|NCT04714320|527273573|FG001|Overall Study|Reason Not Specified|3|||
146207237|NCT04714320|527273574|FG002|Overall Study|Reason Not Specified|3|||
146207238|NCT05057897|527273575|FG000|Overall Study|Site closure|2|||
146207239|NCT05057897|527273576|FG001|Overall Study|Site closure|2|||
146207240|NCT05057897|527273575|FG000|Overall Study|Death|1|||
146207241|NCT05057897|527273576|FG001|Overall Study|Death|0|||
146207242|NCT01353313|527273577|FG000|Overall Study|Lost to Follow-up|22|||
146207243|NCT01353313|527273578|FG001|Overall Study|Lost to Follow-up|23|||
146207244|NCT01353313|527273577|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
146207245|NCT01353313|527273578|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
146207246|NCT04755660|527273579|FG000|Overall Study|Lost to Follow-up|1|||
146207247|NCT04755660|527273580|FG001|Overall Study|Lost to Follow-up|1|||
146207248|NCT04755660|527273581|FG002|Overall Study|Lost to Follow-up|0|||
146207249|NCT04755660|527273579|FG000|Overall Study|Withdrawal by Subject|0|||
146207250|NCT04755660|527273580|FG001|Overall Study|Withdrawal by Subject|1|||
146207251|NCT04755660|527273581|FG002|Overall Study|Withdrawal by Subject|1|||
146207252|NCT04755660|527273579|FG000|Overall Study|Physician Decision|0|||
146434689|NCT03032172|528096877|FG007|Treatment Period|Withdrawal by Subject|0|||
146207253|NCT04755660|527273580|FG001|Overall Study|Physician Decision|0|||
146207254|NCT04755660|527273581|FG002|Overall Study|Physician Decision|1|||
146207255|NCT02824029|527273583|FG000|Overall Study|Didn't receive treatment|2|||
146207256|NCT02824029|527273583|FG000|Overall Study|Patient decision to discontinue treatment|3|||
146207257|NCT02824029|527273583|FG000|Overall Study|Non-compliant|5|||
146207258|NCT02824029|527273583|FG000|Overall Study|Progression of disease|15|||
146207259|NCT02824029|527273583|FG000|Overall Study|Inadequate response to therapy|2|||
146434690|NCT03032172|528096870|FG000|Open-label Extension Period|Death|0|||
146434691|NCT03032172|528096871|FG001|Open-label Extension Period|Death|0|||
146434692|NCT03032172|528096872|FG002|Open-label Extension Period|Death|0|||
146434693|NCT03032172|528096873|FG003|Open-label Extension Period|Death|0|||
146434694|NCT03032172|528096874|FG004|Open-label Extension Period|Death|0|||
146434695|NCT03032172|528096875|FG005|Open-label Extension Period|Death|0|||
146434696|NCT03032172|528096876|FG006|Open-label Extension Period|Death|0|||
146434697|NCT03032172|528096877|FG007|Open-label Extension Period|Death|2|||
146434698|NCT03032172|528096870|FG000|Open-label Extension Period|Reason Not Specified|0|||
146434699|NCT03032172|528096871|FG001|Open-label Extension Period|Reason Not Specified|0|||
146434700|NCT03032172|528096872|FG002|Open-label Extension Period|Reason Not Specified|0|||
146434701|NCT03032172|528096873|FG003|Open-label Extension Period|Reason Not Specified|0|||
146434702|NCT03032172|528096874|FG004|Open-label Extension Period|Reason Not Specified|0|||
146434703|NCT03032172|528096875|FG005|Open-label Extension Period|Reason Not Specified|5|||
146434704|NCT03032172|528096876|FG006|Open-label Extension Period|Reason Not Specified|3|||
146434705|NCT03032172|528096877|FG007|Open-label Extension Period|Reason Not Specified|0|||
146434706|NCT03032172|528096870|FG000|Open-label Extension Period|Pregnancy|0|||
146434707|NCT03032172|528096871|FG001|Open-label Extension Period|Pregnancy|0|||
146434708|NCT03032172|528096872|FG002|Open-label Extension Period|Pregnancy|0|||
146434709|NCT03032172|528096873|FG003|Open-label Extension Period|Pregnancy|0|||
146434710|NCT03032172|528096874|FG004|Open-label Extension Period|Pregnancy|0|||
146434711|NCT03032172|528096875|FG005|Open-label Extension Period|Pregnancy|0|||
146434712|NCT03032172|528096876|FG006|Open-label Extension Period|Pregnancy|1|||
146434713|NCT03032172|528096877|FG007|Open-label Extension Period|Pregnancy|0|||
146434714|NCT03032172|528096870|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146434715|NCT03032172|528096871|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
146434716|NCT03032172|528096872|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
146434717|NCT03032172|528096873|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
146434718|NCT03032172|528096874|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
146434719|NCT03032172|528096875|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
146434720|NCT03032172|528096876|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
146434721|NCT03032172|528096877|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
146434722|NCT06284525|528096878|FG000|Overall Study|Withdrawal by Subject|1|||
146434723|NCT02545283|528096881|FG000|Overall Study|Lost to Follow-up|2|||
146434724|NCT02545283|528096882|FG001|Overall Study|Lost to Follow-up|4|||
146434725|NCT02545283|528096881|FG000|Overall Study|Withdrawal by Subject|5|||
146434726|NCT02545283|528096882|FG001|Overall Study|Withdrawal by Subject|9|||
146434727|NCT02545283|528096881|FG000|Overall Study|Death|109|||
146434728|NCT02545283|528096882|FG001|Overall Study|Death|211|||
146434729|NCT02545283|528096881|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
146434730|NCT02545283|528096882|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
146434731|NCT02545283|528096881|FG000|Overall Study|Study Terminated By Sponsor|33|||
146434732|NCT02545283|528096882|FG001|Overall Study|Study Terminated By Sponsor|71|||
146434733|NCT02436005|528096883|FG000|Second Intervention|Adverse Event|0|||
146434734|NCT02436005|528096884|FG001|Second Intervention|Adverse Event|1|||
146434735|NCT00583453|528096885|FG000|Overall Study|discontinued intervention|0|||
146434736|NCT00583453|528096886|FG001|Overall Study|discontinued intervention|2|||
146434737|NCT00905606|528096887|FG000|Period 1|Adverse Event|0|||
146434738|NCT00905606|528096888|FG001|Period 1|Adverse Event|1|||
146434739|NCT00905606|528096887|FG000|Washout|Withdrawal by Subject|1|||
146434740|NCT00905606|528096888|FG001|Washout|Withdrawal by Subject|0|||
146434741|NCT03635320|528096889|FG000|Overall Study|not implanted the device|1|||
146434742|NCT03635320|528096890|FG001|Overall Study|not implanted the device|2|||
146434743|NCT03635320|528096889|FG000|Overall Study|Withdrawal by Subject|11|||
146434744|NCT03635320|528096890|FG001|Overall Study|Withdrawal by Subject|6|||
146434745|NCT01558635|528096894|FG000|Overall Study|Death|1|||
146434746|NCT01558635|528096894|FG000|Overall Study|Withdrawal by Subject|2|||
146434747|NCT01558635|528096894|FG000|Overall Study|Physician Decision|1|||
146434748|NCT01558635|528096894|FG000|Overall Study|Subject received other treatment|1|||
146434749|NCT01558635|528096894|FG000|Overall Study|Reveal XT was explanted|1|||
146434750|NCT04994535|528096895|FG000|Overall Study|Lost to Follow-up|7|||
146434751|NCT04994535|528096896|FG001|Overall Study|Lost to Follow-up|7|||
146434752|NCT04994535|528096895|FG000|Overall Study|Withdrawal by Subject|10|||
146434753|NCT04994535|528096896|FG001|Overall Study|Withdrawal by Subject|7|||
146434754|NCT04994535|528096895|FG000|Overall Study|Other|1|||
146434755|NCT04994535|528096896|FG001|Overall Study|Other|1|||
146434756|NCT01158118|528096897|FG000|Overall Study|Screen failure|1|||
146434757|NCT01158118|528096898|FG001|Overall Study|Screen failure|0|||
146434758|NCT01158118|528096897|FG000|Overall Study|Donor match was a screen failure|0|||
146434759|NCT01158118|528096898|FG001|Overall Study|Donor match was a screen failure|1|||
146434760|NCT01158118|528096897|FG000|Overall Study|Suffered stroke prior to transplant|0|||
146434761|NCT01158118|528096898|FG001|Overall Study|Suffered stroke prior to transplant|1|||
146434762|NCT01158118|528096897|FG000|Overall Study|Death|0|||
146434763|NCT01158118|528096898|FG001|Overall Study|Death|1|||
146434764|NCT00905840|528096901|FG000|Overall Study|Lost to Follow-up|11|||
146434765|NCT00905840|528096901|FG000|Overall Study|Death|3|||
146434766|NCT00905840|528096901|FG000|Overall Study|Withdrawal by Subject|1|||
146434767|NCT00905840|528096901|FG000|Overall Study|Adverse Event|1|||
146434768|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
146434769|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
146434770|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
146434771|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
146434772|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
146434773|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
146434774|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
146434775|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
146434776|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
146434777|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
146434778|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
146434779|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
146434780|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
146434781|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
146434782|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
146434783|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
146434784|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
146434785|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
146434786|NCT01667679|528096907|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
146434787|NCT01667679|528096908|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
146434788|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
146434789|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
146434790|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
146434791|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
146434792|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
146434793|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
146434794|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
146434795|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
146434796|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
146434797|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
146434798|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
146434799|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
146434800|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
146434801|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
146434802|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
146434803|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
146434804|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
146434805|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
146434806|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
146434807|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
146434808|NCT01667679|528096907|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
146434809|NCT01667679|528096908|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
146434810|NCT03872128|528096912|FG000|Overall Study|Dropped out before treatment|1|||
146434811|NCT03872128|528096913|FG001|Overall Study|Dropped out before treatment|0|||
146434812|NCT03872128|528096914|FG002|Overall Study|Dropped out before treatment|4|||
146434813|NCT03872128|528096912|FG000|Overall Study|Lost to Follow-up|2|||
146434814|NCT03872128|528096913|FG001|Overall Study|Lost to Follow-up|5|||
146434815|NCT03872128|528096914|FG002|Overall Study|Lost to Follow-up|8|||
146434816|NCT03419403|528096923|FG000|Overall Study|Withdrawal by Subject|5|||
146434817|NCT03419403|528096924|FG001|Overall Study|Withdrawal by Subject|2|||
146434818|NCT03419403|528096925|FG002|Overall Study|Withdrawal by Subject|5|||
146434819|NCT03419403|528096926|FG003|Overall Study|Withdrawal by Subject|1|||
146434820|NCT03419403|528096923|FG000|Overall Study|Progressive disease (per protocol)|0|||
146434821|NCT03419403|528096924|FG001|Overall Study|Progressive disease (per protocol)|2|||
146434822|NCT03419403|528096925|FG002|Overall Study|Progressive disease (per protocol)|2|||
146434823|NCT03419403|528096926|FG003|Overall Study|Progressive disease (per protocol)|0|||
146434824|NCT03419403|528096923|FG000|Overall Study|Other, not specified|6|||
146207260|NCT02824029|527273583|FG000|Overall Study|Possible progression per treating physician|1|||
146207261|NCT04524390|527273584|FG000|Double Blind|Consent Withdrawal by subject|2|||
146207262|NCT04524390|527273585|FG001|Double Blind|Consent Withdrawal by subject|1|||
146207263|NCT04524390|527273586|FG002|Double Blind|Consent Withdrawal by subject|0|||
146434825|NCT03419403|528096924|FG001|Overall Study|Other, not specified|4|||
146434826|NCT03419403|528096925|FG002|Overall Study|Other, not specified|5|||
146434827|NCT03419403|528096926|FG003|Overall Study|Other, not specified|1|||
146434828|NCT03419403|528096923|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
146434829|NCT03419403|528096924|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
146434830|NCT03419403|528096925|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
146434831|NCT03419403|528096926|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
146434832|NCT03552393|528096929|FG000|Core Period|Kidney Transplant|1|||
146434833|NCT03552393|528096929|FG000|Core Period|Prohibited Medication|1|||
146434834|NCT03552393|528096929|FG000|Safety Extension Period|Kidney Transplant|4|||
146434835|NCT01289262|528096931|FG000|Overall Study|Lost to Follow-up|29|||
146434836|NCT01289262|528096932|FG001|Overall Study|Lost to Follow-up|16|||
146434837|NCT01289262|528096931|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
145951556|NCT01905592|526333959|FG001|Overall Study|Protocol Violation|1|||
145951557|NCT01905592|526333958|FG000|Overall Study|Sponsor's decision|1|||
145951558|NCT01905592|526333959|FG001|Overall Study|Sponsor's decision|1|||
145951559|NCT01905592|526333958|FG000|Overall Study|Not treated|7|||
145951560|NCT01905592|526333959|FG001|Overall Study|Not treated|3|||
145951561|NCT01905592|526333958|FG000|Overall Study|Withdrawal by Subject|10|||
145951562|NCT01905592|526333959|FG001|Overall Study|Withdrawal by Subject|2|||
145951563|NCT02669043|526333960|FG000|Overall Study|Didn't meet I/E criteria|4|||
145951564|NCT00467558|526333965|FG000|Overall Study|Lost to Follow-up|2|||
145951565|NCT00467558|526333966|FG001|Overall Study|Lost to Follow-up|0|||
145951566|NCT02636439|526333968|FG000|Overall Study|Adverse Event|2|||
145951567|NCT02636439|526333969|FG001|Overall Study|Adverse Event|2|||
146434838|NCT01289262|528096932|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
146434839|NCT04887415|528096933|FG000|Overall Study|Lost to Follow-up|2|||
146434840|NCT04608188|528096934|FG000|Overall Study|Withdrawal by Subject|4|||
146434841|NCT04608188|528096935|FG001|Overall Study|Withdrawal by Subject|8|||
146434842|NCT01250912|528096939|FG000|Overall Study|Lost to Follow-up|1|||
146434843|NCT05646251|528096942|FG000|Overall Study|Physician Decision|1|||
146434844|NCT05646251|528096943|FG001|Overall Study|Physician Decision|0|||
146434845|NCT05646251|528096944|FG002|Overall Study|Physician Decision|2|||
146434846|NCT01218867|528096945|FG000|Overall Study|Death during treatment|0|||
146434847|NCT01218867|528096946|FG001|Overall Study|Death during treatment|0|||
146434848|NCT01218867|528096947|FG002|Overall Study|Death during treatment|0|||
145951568|NCT02636439|526333968|FG000|Overall Study|Lost to Follow-up|1|||
145951569|NCT02636439|526333969|FG001|Overall Study|Lost to Follow-up|0|||
145951570|NCT02636439|526333968|FG000|Overall Study|Non-compliance|1|||
145951571|NCT02636439|526333969|FG001|Overall Study|Non-compliance|1|||
145951572|NCT02636439|526333968|FG000|Overall Study|Personal reasons|2|||
145951573|NCT02636439|526333969|FG001|Overall Study|Personal reasons|0|||
146207264|NCT04524390|527273584|FG000|Double Blind|Adverse Event|5|||
146207265|NCT04524390|527273585|FG001|Double Blind|Adverse Event|3|||
146207266|NCT04524390|527273586|FG002|Double Blind|Adverse Event|0|||
146207267|NCT04524390|527273584|FG000|Double Blind|Liver Transplant|5|||
146207268|NCT04524390|527273585|FG001|Double Blind|Liver Transplant|6|||
146207269|NCT04524390|527273586|FG002|Double Blind|Liver Transplant|0|||
146207270|NCT04524390|527273584|FG000|Double Blind|Disease Progression|0|||
146207271|NCT04524390|527273585|FG001|Double Blind|Disease Progression|1|||
146207272|NCT04524390|527273586|FG002|Double Blind|Disease Progression|0|||
146207273|NCT04524390|527273584|FG000|Open-Label|Drug interruption criteria|0|||
146207274|NCT04524390|527273585|FG001|Open-Label|Drug interruption criteria|0|||
146207275|NCT04524390|527273586|FG002|Open-Label|Drug interruption criteria|1|||
146207276|NCT04524390|527273584|FG000|Open-Label|Liver Transplant|0|||
146207277|NCT04524390|527273585|FG001|Open-Label|Liver Transplant|0|||
146207278|NCT04524390|527273586|FG002|Open-Label|Liver Transplant|1|||
146434849|NCT01218867|528096948|FG003|Overall Study|Death during treatment|0|||
146434850|NCT01218867|528096949|FG004|Overall Study|Death during treatment|0|||
146082968|NCT01215916|526824718|FG002|Overall Study|Progressive Disease|1|||
146207279|NCT04524390|527273584|FG000|Open-Label|Disease Progression|0|||
146207280|NCT04524390|527273585|FG001|Open-Label|Disease Progression|0|||
146207281|NCT04524390|527273586|FG002|Open-Label|Disease Progression|1|||
146207282|NCT04524390|527273584|FG000|Open-Label|Adverse Event|0|||
146434851|NCT01218867|528096950|FG005|Overall Study|Death during treatment|0|||
146434852|NCT01218867|528096951|FG006|Overall Study|Death during treatment|1|||
146434853|NCT01218867|528096952|FG007|Overall Study|Death during treatment|0|||
145951574|NCT04378569|526335673|FG000|Overall Study|Adverse Event|0|||
145951575|NCT04378569|526335674|FG001|Overall Study|Adverse Event|0|||
145951576|NCT04378569|526335675|FG002|Overall Study|Adverse Event|2|||
145951577|NCT04378569|526335676|FG003|Overall Study|Adverse Event|0|||
146082969|NCT01215916|526824719|FG003|Overall Study|Progressive Disease|2|||
145951578|NCT04378569|526335677|FG004|Overall Study|Adverse Event|3|||
145951579|NCT04378569|526335678|FG005|Overall Study|Adverse Event|3|||
146434854|NCT01218867|528096953|FG008|Overall Study|Death during treatment|0|||
146434855|NCT01218867|528096954|FG009|Overall Study|Death during treatment|0|||
146434856|NCT01218867|528096955|FG010|Overall Study|Death during treatment|0|||
146434857|NCT03233724|528096959|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
146434858|NCT03233724|528096960|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
146434859|NCT03233724|528096961|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
146434860|NCT03233724|528096962|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
146434861|NCT03233724|528096963|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
146434862|NCT03233724|528096959|FG000|Phase I Dose Escalation|Best interest of participant|1|||
146434863|NCT03233724|528096960|FG001|Phase I Dose Escalation|Best interest of participant|1|||
145951580|NCT04378569|526335673|FG000|Overall Study|Lost to Follow-up|0|||
145951581|NCT04378569|526335674|FG001|Overall Study|Lost to Follow-up|3|||
146434864|NCT03233724|528096961|FG002|Phase I Dose Escalation|Best interest of participant|1|||
146434865|NCT03233724|528096962|FG003|Phase I Dose Escalation|Best interest of participant|0|||
146434866|NCT03233724|528096963|FG004|Phase I Dose Escalation|Best interest of participant|0|||
146434867|NCT03233724|528096959|FG000|Phase I Dose Escalation|Physician Decision|0|||
146434868|NCT03233724|528096960|FG001|Phase I Dose Escalation|Physician Decision|0|||
145951582|NCT04378569|526335675|FG002|Overall Study|Lost to Follow-up|1|||
145951583|NCT04378569|526335676|FG003|Overall Study|Lost to Follow-up|0|||
145951584|NCT04378569|526335677|FG004|Overall Study|Lost to Follow-up|1|||
145951585|NCT04378569|526335678|FG005|Overall Study|Lost to Follow-up|1|||
145951586|NCT04378569|526335673|FG000|Overall Study|Protocol Violation|0|||
145951587|NCT04378569|526335674|FG001|Overall Study|Protocol Violation|0|||
145951588|NCT04378569|526335675|FG002|Overall Study|Protocol Violation|0|||
145951589|NCT04378569|526335676|FG003|Overall Study|Protocol Violation|0|||
145951590|NCT04378569|526335677|FG004|Overall Study|Protocol Violation|0|||
145951591|NCT04378569|526335678|FG005|Overall Study|Protocol Violation|1|||
145951592|NCT04378569|526335673|FG000|Overall Study|Withdrawal by Subject|0|||
145951593|NCT04378569|526335674|FG001|Overall Study|Withdrawal by Subject|6|||
145951594|NCT04378569|526335675|FG002|Overall Study|Withdrawal by Subject|7|||
145951595|NCT04378569|526335676|FG003|Overall Study|Withdrawal by Subject|4|||
145951596|NCT04378569|526335677|FG004|Overall Study|Withdrawal by Subject|5|||
145951597|NCT04378569|526335678|FG005|Overall Study|Withdrawal by Subject|4|||
145951598|NCT04378569|526335673|FG000|Overall Study|Lack of response|0|||
145951599|NCT04378569|526335674|FG001|Overall Study|Lack of response|0|||
145951600|NCT04378569|526335675|FG002|Overall Study|Lack of response|1|||
145951601|NCT04378569|526335676|FG003|Overall Study|Lack of response|0|||
145951602|NCT04378569|526335677|FG004|Overall Study|Lack of response|1|||
145951603|NCT04378569|526335678|FG005|Overall Study|Lack of response|1|||
145951604|NCT01844817|526335679|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
145951605|NCT01844817|526335680|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
145951606|NCT01844817|526335679|FG000|Treatment|Progressive Disease|27|||
145951607|NCT01844817|526335680|FG001|Treatment|Progressive Disease|36|||
145951608|NCT01844817|526335679|FG000|Treatment|Adverse Event|17|||
145951609|NCT01844817|526335680|FG001|Treatment|Adverse Event|9|||
145951610|NCT01844817|526335679|FG000|Treatment|Withdrawal by Subject|10|||
145951611|NCT01844817|526335680|FG001|Treatment|Withdrawal by Subject|6|||
145951612|NCT01844817|526335679|FG000|Treatment|Death|10|||
146207283|NCT04524390|527273585|FG001|Open-Label|Adverse Event|0|||
146207284|NCT04524390|527273586|FG002|Open-Label|Adverse Event|3|||
146207285|NCT04524390|527273584|FG000|Open-Label|Study Termination by sponsor|0|||
146207286|NCT04524390|527273585|FG001|Open-Label|Study Termination by sponsor|0|||
146207287|NCT04524390|527273586|FG002|Open-Label|Study Termination by sponsor|45|||
146207288|NCT03088813|527273589|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146207289|NCT03088813|527273590|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
146207290|NCT03088813|527273591|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146207291|NCT03088813|527273592|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
146207292|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146207293|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146082970|NCT01215916|526824720|FG004|Overall Study|Progressive Disease|5|||
145951613|NCT01844817|526335680|FG001|Treatment|Death|8|||
145951614|NCT01844817|526335679|FG000|Treatment|Lost to Follow-up|0|||
145951615|NCT01844817|526335680|FG001|Treatment|Lost to Follow-up|1|||
145951616|NCT01844817|526335679|FG000|Treatment|Other|0|||
145951617|NCT01844817|526335680|FG001|Treatment|Other|3|||
145951618|NCT02207400|526335681|FG000|Overall Study|Adverse Event|1|||
145951619|NCT02207400|526335682|FG001|Overall Study|Adverse Event|1|||
145951620|NCT02207400|526335681|FG000|Overall Study|Lost to Follow-up|6|||
145951621|NCT02207400|526335682|FG001|Overall Study|Lost to Follow-up|7|||
145951622|NCT02207400|526335681|FG000|Overall Study|Protocol Violation|1|||
145951623|NCT02207400|526335682|FG001|Overall Study|Protocol Violation|1|||
145951624|NCT02207400|526335681|FG000|Overall Study|Withdrawal by Subject|8|||
145951625|NCT02207400|526335682|FG001|Overall Study|Withdrawal by Subject|4|||
145951626|NCT02207400|526335681|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
145951627|NCT02207400|526335682|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
145951628|NCT03630705|526335683|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
145951629|NCT03630705|526335684|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
145951630|NCT03630705|526335685|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145951631|NCT03630705|526335686|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145951632|NCT03630705|526335683|FG000|Overall Study|Lost to Follow-up|1|||
145951633|NCT03630705|526335684|FG001|Overall Study|Lost to Follow-up|2|||
145951634|NCT03630705|526335685|FG002|Overall Study|Lost to Follow-up|0|||
145951635|NCT03630705|526335686|FG003|Overall Study|Lost to Follow-up|0|||
145951636|NCT03638466|526335689|FG000|Overall Study|Early Termination|0|||
145951637|NCT03638466|526335690|FG001|Overall Study|Early Termination|1|||
145951638|NCT01128400|526335691|FG000|Overall Study|Lost to Follow-up|1|||
145951639|NCT01128400|526335692|FG001|Overall Study|Lost to Follow-up|0|||
145951640|NCT01128400|526335693|FG002|Overall Study|Lost to Follow-up|1|||
146434869|NCT03233724|528096961|FG002|Phase I Dose Escalation|Physician Decision|1|||
146434870|NCT03233724|528096962|FG003|Phase I Dose Escalation|Physician Decision|0|||
146434871|NCT03233724|528096963|FG004|Phase I Dose Escalation|Physician Decision|0|||
146434872|NCT03233724|528096959|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
146434873|NCT03233724|528096960|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
146434874|NCT03233724|528096961|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
146434875|NCT03233724|528096962|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
146434876|NCT03233724|528096963|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
146434877|NCT00651820|528096966|FG000|Overall Study|Lost to Follow-up|2|||
146434878|NCT00773253|528096967|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
146434879|NCT00773253|528096968|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
146434880|NCT01566721|528096969|FG000|Treatment Period|Withdrawal by Subject|35|||
146434881|NCT01566721|528096970|FG001|Treatment Period|Withdrawal by Subject|9|||
146434882|NCT01566721|528096969|FG000|Treatment Period|Disease Progression/Recurrence|37|||
146434883|NCT01566721|528096970|FG001|Treatment Period|Disease Progression/Recurrence|13|||
146434884|NCT01566721|528096969|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
146434885|NCT01566721|528096970|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
146434886|NCT01566721|528096969|FG000|Treatment Period|Other|13|||
146434887|NCT01566721|528096970|FG001|Treatment Period|Other|2|||
146434888|NCT01566721|528096969|FG000|Treatment Period|Lack of Compliance|5|||
146434889|NCT01566721|528096970|FG001|Treatment Period|Lack of Compliance|1|||
146434890|NCT01566721|528096969|FG000|Treatment Period|Adverse Event|100|||
146434891|NCT01566721|528096970|FG001|Treatment Period|Adverse Event|30|||
146434892|NCT01566721|528096969|FG000|Treatment Period|Pregnancy|1|||
146434893|NCT01566721|528096970|FG001|Treatment Period|Pregnancy|0|||
146434894|NCT01566721|528096969|FG000|Safety Follow-up|Physician Decision|6|||
146434895|NCT01566721|528096970|FG001|Safety Follow-up|Physician Decision|4|||
146434896|NCT01566721|528096969|FG000|Safety Follow-up|Lost to Follow-up|101|||
146434897|NCT01566721|528096970|FG001|Safety Follow-up|Lost to Follow-up|48|||
146434898|NCT01566721|528096969|FG000|Safety Follow-up|Withdrawal by Subject|155|||
146434899|NCT01566721|528096970|FG001|Safety Follow-up|Withdrawal by Subject|49|||
146434900|NCT01566721|528096969|FG000|Safety Follow-up|Death|28|||
146434901|NCT01566721|528096970|FG001|Safety Follow-up|Death|4|||
146434902|NCT01566721|528096969|FG000|Safety Follow-up|Non-compliance|7|||
146434903|NCT01566721|528096970|FG001|Safety Follow-up|Non-compliance|3|||
146434904|NCT01566721|528096969|FG000|Safety Follow-up|Protocol Violation|7|||
146434905|NCT01566721|528096970|FG001|Safety Follow-up|Protocol Violation|0|||
146434906|NCT01566721|528096969|FG000|Safety Follow-up|Site closure|2|||
146434907|NCT01566721|528096970|FG001|Safety Follow-up|Site closure|3|||
146434908|NCT01566721|528096969|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
146434909|NCT01566721|528096970|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
146434910|NCT01566721|528096969|FG000|Safety Follow-up|Missing|7|||
146434911|NCT01566721|528096970|FG001|Safety Follow-up|Missing|2|||
146434912|NCT01566721|528096969|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
146082971|NCT01215916|526824721|FG005|Overall Study|Progressive Disease|4|||
146082972|NCT01215916|526824722|FG006|Overall Study|Progressive Disease|5|||
146082973|NCT01215916|526824723|FG007|Overall Study|Progressive Disease|3|||
146434913|NCT01566721|528096970|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
146434914|NCT01566721|528096969|FG000|Safety Follow-up|Sponsor decision|1|||
146434915|NCT01566721|528096970|FG001|Safety Follow-up|Sponsor decision|0|||
146434916|NCT01566721|528096969|FG000|Safety Follow-up|Adverse Event|8|||
146434917|NCT01566721|528096970|FG001|Safety Follow-up|Adverse Event|4|||
146434918|NCT00446563|528096971|FG000|Overall Study|Adverse Event|4|||
146434919|NCT00446563|528096972|FG001|Overall Study|Adverse Event|3|||
145951641|NCT01128400|526335691|FG000|Overall Study|Screening failure|1|||
145951642|NCT01128400|526335692|FG001|Overall Study|Screening failure|0|||
145951643|NCT01128400|526335693|FG002|Overall Study|Screening failure|0|||
146434920|NCT00446563|528096971|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145951644|NCT01128400|526335691|FG000|Overall Study|were not invited to participate on taste|0|||
146082974|NCT01215916|526824724|FG008|Overall Study|Progressive Disease|1|||
146082975|NCT01215916|526824716|FG000|Overall Study|Adverse Event|1|||
146207294|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
146207295|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
146207296|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
146207297|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
146207298|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
146207299|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
146207300|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
146207301|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
146207302|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
146207303|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
146207304|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
146207305|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
146207306|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
146207307|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
146207308|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146207309|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146207310|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
146207311|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
146207312|NCT03088813|527273589|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146207313|NCT03088813|527273590|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146207314|NCT03088813|527273591|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
146207315|NCT03088813|527273592|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
146207316|NCT03756571|527273595|FG000|Overall Study|Lost to Follow-up|1|||
146207317|NCT03756571|527273596|FG001|Overall Study|Lost to Follow-up|1|||
146207318|NCT00785512|527273603|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
146207319|NCT00785512|527273604|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
146434921|NCT00446563|528096972|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146434922|NCT00446563|528096971|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146434923|NCT00446563|528096972|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146434924|NCT00446563|528096971|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146434925|NCT00446563|528096972|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146434926|NCT00446563|528096971|FG000|Overall Study|Withdrawal by Subject|2|||
146434927|NCT00446563|528096972|FG001|Overall Study|Withdrawal by Subject|1|||
146434928|NCT00446563|528096971|FG000|Overall Study|Administrative problems|0|||
146434929|NCT00446563|528096972|FG001|Overall Study|Administrative problems|1|||
146434930|NCT02911701|528096973|FG000|Overall Study|Withdrawal by Subject|2|||
146434931|NCT02911701|528096974|FG001|Overall Study|Withdrawal by Subject|4|||
145951645|NCT01128400|526335692|FG001|Overall Study|were not invited to participate on taste|0|||
146207320|NCT00785512|527273603|FG000|Overall Study|Adverse Event|0|||
146207321|NCT00785512|527273604|FG001|Overall Study|Adverse Event|0|||
146207322|NCT00785512|527273603|FG000|Overall Study|Lack of Efficacy|0|||
146207323|NCT00785512|527273604|FG001|Overall Study|Lack of Efficacy|2|||
146207324|NCT00785512|527273603|FG000|Overall Study|Withdrawal by Subject|0|||
146207325|NCT00785512|527273604|FG001|Overall Study|Withdrawal by Subject|1|||
146285386|NCT00752557|527557852|FG002|Overall Study|Unspecified resaons|2|||
146434932|NCT02911701|528096973|FG000|Overall Study|Adverse Event|1|||
146434933|NCT02911701|528096974|FG001|Overall Study|Adverse Event|0|||
146434934|NCT01302548|528096975|FG000|Overall Study|Lost to Follow-up|2|||
146434935|NCT01302548|528096976|FG001|Overall Study|Lost to Follow-up|1|||
146434936|NCT02409355|528096979|FG000|Overall Study|Withdrawal by Subject|1|||
146207326|NCT00785512|527273603|FG000|Overall Study|Lost to Follow-up|3|||
146207327|NCT00785512|527273604|FG001|Overall Study|Lost to Follow-up|0|||
146207328|NCT00785512|527273603|FG000|Overall Study|Precedure Refused|0|||
146207329|NCT00785512|527273604|FG001|Overall Study|Precedure Refused|0|||
146207330|NCT00785512|527273603|FG000|Overall Study|IVRS Programing Error|0|||
146207331|NCT00785512|527273604|FG001|Overall Study|IVRS Programing Error|0|||
146207332|NCT00785512|527273603|FG000|Overall Study|Physician Decision|0|||
146207333|NCT00785512|527273604|FG001|Overall Study|Physician Decision|0|||
146207334|NCT00785512|527273603|FG000|Overall Study|Lack of compliance|0|||
146207335|NCT00785512|527273604|FG001|Overall Study|Lack of compliance|1|||
146207336|NCT00603954|527273617|FG000|Overall Study|Protocol Violation|1|||
146207337|NCT00603954|527273618|FG001|Overall Study|Protocol Violation|2|||
146207338|NCT02568683|527273619|FG000|Overall Study|Death|0|||
146207339|NCT02568683|527273620|FG001|Overall Study|Death|2|||
146207340|NCT02568683|527273619|FG000|Overall Study|Withdrew Consent|1|||
146207341|NCT02568683|527273620|FG001|Overall Study|Withdrew Consent|0|||
146207342|NCT02568683|527273619|FG000|Overall Study|Study Terminated By Sponsor|5|||
146207343|NCT02568683|527273620|FG001|Overall Study|Study Terminated By Sponsor|2|||
146207344|NCT04556981|527273632|FG000|Overall Study|Death|0|||
146207345|NCT04556981|527273633|FG001|Overall Study|Death|1|||
146207346|NCT04556981|527273632|FG000|Overall Study|Lost to Follow-up|2|||
146207347|NCT04556981|527273633|FG001|Overall Study|Lost to Follow-up|11|||
146207348|NCT04556981|527273632|FG000|Overall Study|Moved from the study area|1|||
146207349|NCT04556981|527273633|FG001|Overall Study|Moved from the study area|4|||
146207350|NCT04556981|527273632|FG000|Overall Study|Withdrawal by Subject|2|||
146207351|NCT04556981|527273633|FG001|Overall Study|Withdrawal by Subject|2|||
146207352|NCT04556981|527273632|FG000|Overall Study|Other|2|||
146207353|NCT04556981|527273633|FG001|Overall Study|Other|1|||
146207354|NCT02477605|527273637|FG000|Overall Study|Discontinued prior to treatment|1|||
146207355|NCT02477605|527273638|FG001|Overall Study|Discontinued prior to treatment|0|||
146207356|NCT02477605|527273637|FG000|Overall Study|Lost to Follow-up|0|||
146207357|NCT02477605|527273638|FG001|Overall Study|Lost to Follow-up|2|||
146207358|NCT02477605|527273637|FG000|Overall Study|Withdrawal by Subject|0|||
146207359|NCT02477605|527273638|FG001|Overall Study|Withdrawal by Subject|1|||
146207360|NCT02477605|527273637|FG000|Overall Study|Administered gas during surgery|0|||
146207361|NCT02477605|527273638|FG001|Overall Study|Administered gas during surgery|1|||
146207362|NCT02574455|527273639|FG000|Overall Study|Death|197|||
146207363|NCT02574455|527273640|FG001|Overall Study|Death|210|||
146207364|NCT02574455|527273639|FG000|Overall Study|Withdrawal of Consent|11|||
146207365|NCT02574455|527273640|FG001|Overall Study|Withdrawal of Consent|28|||
146207366|NCT02574455|527273639|FG000|Overall Study|Lost to Follow-up|4|||
146207367|NCT02574455|527273640|FG001|Overall Study|Lost to Follow-up|4|||
146207368|NCT02574455|527273639|FG000|Overall Study|Sponsor's Decision|55|||
146207369|NCT02574455|527273640|FG001|Overall Study|Sponsor's Decision|20|||
146207370|NCT01388361|527273642|FG000|Overall Study|Adverse Event|0|||
146207371|NCT01388361|527273643|FG001|Overall Study|Adverse Event|5|||
146207372|NCT01388361|527273644|FG002|Overall Study|Adverse Event|1|||
146207373|NCT01388361|527273642|FG000|Overall Study|Protocol Violation|0|||
146207374|NCT01388361|527273643|FG001|Overall Study|Protocol Violation|0|||
146207375|NCT01388361|527273644|FG002|Overall Study|Protocol Violation|2|||
146207376|NCT01388361|527273642|FG000|Overall Study|Withdrawal criteria|12|||
146207377|NCT01388361|527273643|FG001|Overall Study|Withdrawal criteria|7|||
146207378|NCT01388361|527273644|FG002|Overall Study|Withdrawal criteria|10|||
146207379|NCT01388361|527273642|FG000|Overall Study|Unclassified|0|||
146207380|NCT01388361|527273643|FG001|Overall Study|Unclassified|0|||
146207381|NCT01388361|527273644|FG002|Overall Study|Unclassified|1|||
146207382|NCT03565315|527273650|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146207383|NCT03565315|527273651|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146207384|NCT03565315|527273652|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
146207385|NCT03565315|527273653|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
146207386|NCT00440011|527273654|FG000|Overall Study|Adverse Event|2|||
146207387|NCT00440011|527273655|FG001|Overall Study|Adverse Event|0|||
146207388|NCT00440011|527273654|FG000|Overall Study|Lost to Follow-up|0|||
146207389|NCT00440011|527273655|FG001|Overall Study|Lost to Follow-up|2|||
146207390|NCT00440011|527273654|FG000|Overall Study|Protocol Violation|1|||
146207391|NCT00440011|527273655|FG001|Overall Study|Protocol Violation|1|||
146207392|NCT00440011|527273654|FG000|Overall Study|Withdrawal by Subject|1|||
146207393|NCT00440011|527273655|FG001|Overall Study|Withdrawal by Subject|0|||
146207394|NCT01083316|527273656|FG000|Overall Study|Adverse Event|2|||
146207395|NCT01083316|527273656|FG000|Overall Study|Withdrawal by Subject|1|||
146207396|NCT01239316|527273664|FG000|Overall Study|Progression/Relapse|11|||
146207397|NCT01239316|527273664|FG000|Overall Study|Adverse Event|1|||
146207398|NCT03960463|527275100|FG000|Overall Study|Withdrawal by Subject|2|||
146207399|NCT03960463|527275101|FG001|Overall Study|Withdrawal by Subject|0|||
146207400|NCT05568615|527275102|FG000|Overall Study|Death|1|||
146207401|NCT05568615|527275102|FG000|Overall Study|Physician Decision|1|||
146207402|NCT05194917|527275103|FG000|Overall Study|Lost to Follow-up|7|||
146207403|NCT05194917|527275104|FG001|Overall Study|Lost to Follow-up|5|||
146207404|NCT05194917|527275105|FG002|Overall Study|Lost to Follow-up|6|||
146207405|NCT05194917|527275106|FG003|Overall Study|Lost to Follow-up|5|||
146207406|NCT05505045|527275110|FG000|Overall Study|Withdrawal by Subject|2|||
146207407|NCT05505045|527275111|FG001|Overall Study|Withdrawal by Subject|1|||
146207408|NCT03346538|527275116|FG000|Overall Study|Physician Decision|0|||
146207409|NCT03346538|527275117|FG001|Overall Study|Physician Decision|1|||
146207410|NCT03346538|527275118|FG002|Overall Study|Physician Decision|0|||
146207411|NCT03346538|527275116|FG000|Overall Study|Withdrawal by Subject|3|||
146207412|NCT03346538|527275117|FG001|Overall Study|Withdrawal by Subject|2|||
146207413|NCT03346538|527275118|FG002|Overall Study|Withdrawal by Subject|0|||
146207414|NCT03346538|527275116|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
146207415|NCT03346538|527275117|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
146207416|NCT03346538|527275118|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
146434937|NCT02409355|528096980|FG001|Overall Study|Withdrawal by Subject|0|||
146434938|NCT02409355|528096979|FG000|Overall Study|Death|1|||
146434939|NCT02409355|528096980|FG001|Overall Study|Death|1|||
146434940|NCT02409355|528096979|FG000|Overall Study|Study terminated by Sponsor|2|||
146434941|NCT02409355|528096980|FG001|Overall Study|Study terminated by Sponsor|3|||
146434942|NCT02605928|528096981|FG000|Overall Study|Model tuning phase|28|||
146207417|NCT05672667|527275119|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
146207418|NCT01903811|527275127|FG000|Overall Study|No measurable disease|1|||
146207419|NCT01903811|527275128|FG001|Overall Study|No measurable disease|1|||
146207420|NCT01903811|527275127|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
146207421|NCT01903811|527275128|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
146434943|NCT02605928|528096981|FG000|Overall Study|Lack of Efficacy|5|||
146434944|NCT02530905|528096984|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
146434945|NCT02530905|528096985|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
146434946|NCT02530905|528096986|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
146434947|NCT01231906|528096988|FG000|Overall Study|Lack of Efficacy|75|||
146434948|NCT01231906|528096989|FG001|Overall Study|Lack of Efficacy|68|||
146434949|NCT01231906|528096988|FG000|Overall Study|Lost to Follow-up|1|||
146434950|NCT01231906|528096989|FG001|Overall Study|Lost to Follow-up|0|||
146434951|NCT01231906|528096988|FG000|Overall Study|Physician Decision|34|||
146434952|NCT01231906|528096989|FG001|Overall Study|Physician Decision|24|||
146434953|NCT01231906|528096988|FG000|Overall Study|Withdrawal by Subject|0|||
146434954|NCT01231906|528096989|FG001|Overall Study|Withdrawal by Subject|4|||
146434955|NCT01231906|528096988|FG000|Overall Study|Ineligible|10|||
146434956|NCT01231906|528096989|FG001|Overall Study|Ineligible|3|||
146434957|NCT01231906|528096988|FG000|Overall Study|No treatment|1|||
146434958|NCT01231906|528096989|FG001|Overall Study|No treatment|2|||
146434959|NCT04646213|528096990|FG000|Overall Study|Physician Decision|3|||
146434960|NCT04646213|528096990|FG000|Overall Study|Withdrawal by Subject|2|||
146434961|NCT02441309|528096993|FG000|Overall Study|Disease progression|2|||
146434962|NCT02441309|528096994|FG001|Overall Study|Disease progression|1|||
146434963|NCT02441309|528096995|FG002|Overall Study|Disease progression|2|||
146434964|NCT02441309|528096993|FG000|Overall Study|Adverse Event|0|||
146434965|NCT02441309|528096994|FG001|Overall Study|Adverse Event|1|||
146434966|NCT02441309|528096995|FG002|Overall Study|Adverse Event|0|||
146434967|NCT02441309|528096993|FG000|Overall Study|Withdrawal by Subject|1|||
146434968|NCT02441309|528096994|FG001|Overall Study|Withdrawal by Subject|0|||
146434969|NCT02441309|528096995|FG002|Overall Study|Withdrawal by Subject|1|||
146434970|NCT00415363|528096996|FG000|Overall Study|Withdrawal by Subject|4|||
146434971|NCT00415363|528096997|FG001|Overall Study|Withdrawal by Subject|4|||
146434972|NCT00415363|528096996|FG000|Overall Study|Adverse Event|4|||
146434973|NCT00415363|528096997|FG001|Overall Study|Adverse Event|4|||
146434974|NCT00415363|528096996|FG000|Overall Study|Lost to Follow-up|2|||
146434975|NCT00415363|528096997|FG001|Overall Study|Lost to Follow-up|1|||
146434976|NCT00415363|528096996|FG000|Overall Study|Physician Decision|3|||
146434977|NCT00415363|528096997|FG001|Overall Study|Physician Decision|1|||
146434978|NCT00415363|528096996|FG000|Overall Study|Death|16|||
146434979|NCT00415363|528096997|FG001|Overall Study|Death|12|||
146434980|NCT00415363|528096996|FG000|Overall Study|Progressive disease|26|||
146434981|NCT00415363|528096997|FG001|Overall Study|Progressive disease|32|||
146434982|NCT02658084|528097002|FG000|Overall Study|Withdrawal by Subject|1|||
146434983|NCT02658084|528097003|FG001|Overall Study|Withdrawal by Subject|0|||
146434984|NCT02658084|528097002|FG000|Overall Study|Study Termination|1|||
146434985|NCT02658084|528097003|FG001|Overall Study|Study Termination|0|||
145951646|NCT01128400|526335693|FG002|Overall Study|were not invited to participate on taste|15|||
146434986|NCT03290781|528097005|FG000|Overall Study|Adverse Event|5|||
146434987|NCT03290781|528097006|FG001|Overall Study|Adverse Event|7|||
146434988|NCT03290781|528097007|FG002|Overall Study|Adverse Event|4|||
146434989|NCT03290781|528097008|FG003|Overall Study|Adverse Event|1|||
146434990|NCT03290781|528097009|FG004|Overall Study|Adverse Event|0|||
146434991|NCT03290781|528097010|FG005|Overall Study|Adverse Event|0|||
146434992|NCT03290781|528097011|FG006|Overall Study|Adverse Event|0|||
146434993|NCT03290781|528097005|FG000|Overall Study|Death|0|||
146434994|NCT03290781|528097006|FG001|Overall Study|Death|0|||
146434995|NCT03290781|528097007|FG002|Overall Study|Death|1|||
146434996|NCT03290781|528097008|FG003|Overall Study|Death|0|||
146207422|NCT01903811|527275127|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
146207423|NCT01903811|527275128|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
145951647|NCT01128400|526335691|FG000|Overall Study|Excluded due to sinus problems|0|||
146207424|NCT01903811|527275127|FG000|Overall Study|Withdrawal by Subject|0|||
146207425|NCT01903811|527275128|FG001|Overall Study|Withdrawal by Subject|1|||
146207426|NCT04540913|527275129|FG000|Overall Study|Withdrawal by Subject|14|||
146207427|NCT04540913|527275130|FG001|Overall Study|Withdrawal by Subject|3|||
146207428|NCT03613740|527275134|FG000|Overall Study|Lost to Follow-up|1|||
146207429|NCT03613740|527275135|FG001|Overall Study|Lost to Follow-up|1|||
146207430|NCT03575052|527275136|FG000|Overall Study|Adverse Event|6|||
146207431|NCT03575052|527275137|FG001|Overall Study|Adverse Event|10|||
146207432|NCT03575052|527275136|FG000|Overall Study|Not further specified|5|||
146207433|NCT03575052|527275137|FG001|Overall Study|Not further specified|7|||
146207434|NCT03575052|527275136|FG000|Overall Study|Withdrawal by Subject|5|||
146207435|NCT03575052|527275137|FG001|Overall Study|Withdrawal by Subject|6|||
146207436|NCT03575052|527275136|FG000|Overall Study|Lost to Follow-up|3|||
146207437|NCT03575052|527275137|FG001|Overall Study|Lost to Follow-up|0|||
146207438|NCT03575052|527275136|FG000|Overall Study|Death|2|||
146207439|NCT03575052|527275137|FG001|Overall Study|Death|1|||
146207440|NCT03575052|527275136|FG000|Overall Study|Lack of Efficacy|2|||
146207441|NCT03575052|527275137|FG001|Overall Study|Lack of Efficacy|1|||
146207442|NCT03575052|527275136|FG000|Overall Study|Study drug noncompliance|1|||
146207443|NCT03575052|527275137|FG001|Overall Study|Study drug noncompliance|2|||
146207444|NCT03575052|527275136|FG000|Overall Study|Protocol Violation|0|||
146207445|NCT03575052|527275137|FG001|Overall Study|Protocol Violation|2|||
146207446|NCT03575052|527275136|FG000|Overall Study|Physician Decision|1|||
146207447|NCT03575052|527275137|FG001|Overall Study|Physician Decision|0|||
146207448|NCT04188379|527275138|FG000|Overall Study|Withdrawal by Subject|10|||
146207449|NCT04188379|527275139|FG001|Overall Study|Withdrawal by Subject|3|||
146207450|NCT04188379|527275138|FG000|Overall Study|Physician Decision|0|||
146207451|NCT04188379|527275139|FG001|Overall Study|Physician Decision|1|||
146207452|NCT04188379|527275138|FG000|Overall Study|Adverse Event|3|||
146207453|NCT04188379|527275139|FG001|Overall Study|Adverse Event|1|||
146207454|NCT04188379|527275138|FG000|Overall Study|Pregnancy|1|||
146207455|NCT04188379|527275139|FG001|Overall Study|Pregnancy|0|||
146207456|NCT04188379|527275138|FG000|Overall Study|Lack of Efficacy|8|||
146207457|NCT04188379|527275139|FG001|Overall Study|Lack of Efficacy|5|||
146207458|NCT04188379|527275138|FG000|Overall Study|Other|0|||
146207459|NCT04188379|527275139|FG001|Overall Study|Other|3|||
146434997|NCT03290781|528097009|FG004|Overall Study|Death|1|||
146434998|NCT03290781|528097010|FG005|Overall Study|Death|0|||
145951648|NCT01128400|526335692|FG001|Overall Study|Excluded due to sinus problems|1|||
145951649|NCT01128400|526335693|FG002|Overall Study|Excluded due to sinus problems|0|||
145951650|NCT02362425|526335694|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
146207460|NCT01693120|527275141|FG000|Enrollment|Lost to Follow-up|1|||
146207461|NCT01693120|527275141|FG000|Enrollment|Withdrawal by Subject|10|||
146207462|NCT01693120|527275141|FG000|Enrollment|Protocol Violation|46|||
146207463|NCT01693120|527275141|FG000|Enrollment|Physician Decision|3|||
146434999|NCT03290781|528097011|FG006|Overall Study|Death|0|||
145951651|NCT02362425|526335695|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
146435000|NCT03290781|528097005|FG000|Overall Study|Withdrawal by Subject|6|||
146435001|NCT03290781|528097006|FG001|Overall Study|Withdrawal by Subject|5|||
146435002|NCT03290781|528097007|FG002|Overall Study|Withdrawal by Subject|9|||
146207464|NCT01693120|527275141|FG000|Enrollment|Adverse Event|1|||
146207465|NCT01693120|527275141|FG000|Enrollment|Study closed|8|||
146207466|NCT01693120|527275141|FG000|Enrollment|Other|1|||
146207467|NCT01693120|527275141|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
146207468|NCT01693120|527275141|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
146207469|NCT01693120|527275141|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
146207470|NCT01693120|527275141|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
146207471|NCT01693120|527275141|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
146207472|NCT02411084|527275151|FG000|Overall Study|Lack of Efficacy|6|||
146435003|NCT03290781|528097008|FG003|Overall Study|Withdrawal by Subject|10|||
146207473|NCT02411084|527275152|FG001|Overall Study|Lack of Efficacy|3|||
146207474|NCT02411084|527275151|FG000|Overall Study|Death|5|||
146207475|NCT02411084|527275152|FG001|Overall Study|Death|4|||
146207476|NCT02411084|527275151|FG000|Overall Study|Adverse Event|2|||
146207477|NCT02411084|527275152|FG001|Overall Study|Adverse Event|1|||
146207478|NCT02411084|527275151|FG000|Overall Study|Other reasons|0|||
146207479|NCT02411084|527275152|FG001|Overall Study|Other reasons|5|||
146207480|NCT03624972|527275153|FG000|Overall Study|Lost to Follow-up|2|||
146207481|NCT03624972|527275154|FG001|Overall Study|Lost to Follow-up|0|||
146207482|NCT03624972|527275155|FG002|Overall Study|Lost to Follow-up|0|||
146207483|NCT03624972|527275153|FG000|Overall Study|Withdrawal by Subject|0|||
146207484|NCT03624972|527275154|FG001|Overall Study|Withdrawal by Subject|2|||
146207485|NCT03624972|527275155|FG002|Overall Study|Withdrawal by Subject|0|||
146207486|NCT01534494|527275158|FG000|Overall Study|Withdrawal by Subject|1|||
146207487|NCT05137236|527275159|FG000|Part A|Other than Specified|1|||
146207488|NCT05137236|527275160|FG001|Part A|Other than Specified|0|||
146207489|NCT05137236|527275161|FG002|Part A|Other than Specified|0|||
146207490|NCT05137236|527275162|FG003|Part A|Other than Specified|0|||
146207491|NCT05137236|527275163|FG004|Part A|Other than Specified|0|||
146207492|NCT05137236|527275164|FG005|Part A|Other than Specified|0|||
146207493|NCT05137236|527275165|FG006|Part A|Other than Specified|0|||
146207494|NCT05137236|527275166|FG007|Part A|Other than Specified|0|||
146207495|NCT05137236|527275159|FG000|Part A|Withdrawal by Subject|0|||
146207496|NCT05137236|527275160|FG001|Part A|Withdrawal by Subject|4|||
146207497|NCT05137236|527275161|FG002|Part A|Withdrawal by Subject|1|||
146207498|NCT05137236|527275162|FG003|Part A|Withdrawal by Subject|1|||
146207499|NCT05137236|527275163|FG004|Part A|Withdrawal by Subject|3|||
146207500|NCT05137236|527275164|FG005|Part A|Withdrawal by Subject|2|||
146207501|NCT05137236|527275165|FG006|Part A|Withdrawal by Subject|0|||
146207502|NCT05137236|527275166|FG007|Part A|Withdrawal by Subject|0|||
146207503|NCT05137236|527275159|FG000|Part A|Lost to Follow-up|5|||
146207504|NCT05137236|527275160|FG001|Part A|Lost to Follow-up|7|||
146207505|NCT05137236|527275161|FG002|Part A|Lost to Follow-up|1|||
146207506|NCT05137236|527275162|FG003|Part A|Lost to Follow-up|3|||
146207507|NCT05137236|527275163|FG004|Part A|Lost to Follow-up|3|||
146207508|NCT05137236|527275164|FG005|Part A|Lost to Follow-up|8|||
146207509|NCT05137236|527275165|FG006|Part A|Lost to Follow-up|0|||
146207510|NCT05137236|527275166|FG007|Part A|Lost to Follow-up|0|||
146207511|NCT05137236|527275159|FG000|Part B|Withdrawal by Subject|0|||
146207512|NCT05137236|527275160|FG001|Part B|Withdrawal by Subject|0|||
146207513|NCT05137236|527275161|FG002|Part B|Withdrawal by Subject|0|||
146207514|NCT05137236|527275162|FG003|Part B|Withdrawal by Subject|0|||
146207515|NCT05137236|527275163|FG004|Part B|Withdrawal by Subject|0|||
146207516|NCT05137236|527275164|FG005|Part B|Withdrawal by Subject|0|||
146207517|NCT05137236|527275165|FG006|Part B|Withdrawal by Subject|0|||
146207518|NCT05137236|527275166|FG007|Part B|Withdrawal by Subject|2|||
146207519|NCT05137236|527275159|FG000|Part B|Lost to Follow-up|0|||
146207520|NCT05137236|527275160|FG001|Part B|Lost to Follow-up|0|||
146207521|NCT05137236|527275161|FG002|Part B|Lost to Follow-up|0|||
146207522|NCT05137236|527275162|FG003|Part B|Lost to Follow-up|0|||
146207523|NCT05137236|527275163|FG004|Part B|Lost to Follow-up|0|||
146207524|NCT05137236|527275164|FG005|Part B|Lost to Follow-up|0|||
146207525|NCT05137236|527275165|FG006|Part B|Lost to Follow-up|5|||
146207526|NCT05137236|527275166|FG007|Part B|Lost to Follow-up|5|||
146207527|NCT05137236|527275159|FG000|Part B|Death|0|||
146207528|NCT05137236|527275160|FG001|Part B|Death|0|||
146207529|NCT05137236|527275161|FG002|Part B|Death|0|||
146207530|NCT05137236|527275162|FG003|Part B|Death|0|||
146207531|NCT05137236|527275163|FG004|Part B|Death|0|||
146207532|NCT05137236|527275164|FG005|Part B|Death|0|||
146207533|NCT05137236|527275165|FG006|Part B|Death|0|||
146207534|NCT05137236|527275166|FG007|Part B|Death|2|||
146207535|NCT00431834|527275168|FG000|Overall Study|Withdrawal by Subject|7|||
146207536|NCT00431834|527275168|FG000|Overall Study|Death|3|||
146207537|NCT00431834|527275168|FG000|Overall Study|Missed Endpoint Visit|2|||
146207538|NCT00431834|527275168|FG000|Overall Study|Lost to Follow-up|1|||
146207539|NCT02622568|527275171|FG000|Overall Study|Lost to Follow-up|5|||
146207540|NCT02622568|527275172|FG001|Overall Study|Lost to Follow-up|5|||
146207541|NCT02647905|527275175|FG000|Overall Study|Lost to Follow-up|1|||
146207542|NCT02647905|527275175|FG000|Overall Study|Withdrawal by Subject|2|||
146207543|NCT05119855|527275178|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
146207544|NCT05119855|527275179|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
146207545|NCT05119855|527275178|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
146207546|NCT05119855|527275179|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
146207547|NCT05119855|527275178|FG000|Overall Study|Lost to Follow-up|6|||
146207548|NCT05119855|527275179|FG001|Overall Study|Lost to Follow-up|8|||
146207549|NCT02597920|527275183|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146207550|NCT02597920|527275184|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146207551|NCT02597920|527275185|FG002|Overall Study|Worsening of other pre-existing disease|0|||
146207552|NCT02597920|527275183|FG000|Overall Study|Other adverse event|20|||
146207553|NCT02597920|527275184|FG001|Overall Study|Other adverse event|30|||
146207554|NCT02597920|527275185|FG002|Overall Study|Other adverse event|0|||
146435004|NCT03290781|528097009|FG004|Overall Study|Withdrawal by Subject|1|||
146435005|NCT03290781|528097010|FG005|Overall Study|Withdrawal by Subject|2|||
146435006|NCT03290781|528097011|FG006|Overall Study|Withdrawal by Subject|0|||
146435007|NCT03290781|528097005|FG000|Overall Study|Physician Decision|0|||
146435008|NCT03290781|528097006|FG001|Overall Study|Physician Decision|1|||
146435009|NCT03290781|528097007|FG002|Overall Study|Physician Decision|0|||
146435010|NCT03290781|528097008|FG003|Overall Study|Physician Decision|0|||
146435011|NCT03290781|528097009|FG004|Overall Study|Physician Decision|0|||
146435012|NCT03290781|528097010|FG005|Overall Study|Physician Decision|0|||
146435013|NCT03290781|528097011|FG006|Overall Study|Physician Decision|0|||
146435014|NCT03290781|528097005|FG000|Overall Study|Site Terminated by Sponsor|1|||
146435015|NCT03290781|528097006|FG001|Overall Study|Site Terminated by Sponsor|0|||
146435016|NCT03290781|528097007|FG002|Overall Study|Site Terminated by Sponsor|2|||
146435017|NCT03290781|528097008|FG003|Overall Study|Site Terminated by Sponsor|1|||
146435018|NCT03290781|528097009|FG004|Overall Study|Site Terminated by Sponsor|0|||
146435019|NCT03290781|528097010|FG005|Overall Study|Site Terminated by Sponsor|0|||
146435020|NCT03290781|528097011|FG006|Overall Study|Site Terminated by Sponsor|0|||
146435021|NCT03290781|528097005|FG000|Overall Study|Lost to Follow-up|0|||
146435022|NCT03290781|528097006|FG001|Overall Study|Lost to Follow-up|0|||
146435023|NCT03290781|528097007|FG002|Overall Study|Lost to Follow-up|0|||
146435024|NCT03290781|528097008|FG003|Overall Study|Lost to Follow-up|1|||
146435025|NCT03290781|528097009|FG004|Overall Study|Lost to Follow-up|0|||
146435026|NCT03290781|528097010|FG005|Overall Study|Lost to Follow-up|0|||
146435027|NCT03290781|528097011|FG006|Overall Study|Lost to Follow-up|0|||
146435028|NCT03290781|528097005|FG000|Overall Study|Protocol Deviation|2|||
146435029|NCT03290781|528097006|FG001|Overall Study|Protocol Deviation|0|||
146435030|NCT03290781|528097007|FG002|Overall Study|Protocol Deviation|0|||
146435031|NCT03290781|528097008|FG003|Overall Study|Protocol Deviation|1|||
146435032|NCT03290781|528097009|FG004|Overall Study|Protocol Deviation|0|||
146435033|NCT03290781|528097010|FG005|Overall Study|Protocol Deviation|0|||
146435034|NCT03290781|528097011|FG006|Overall Study|Protocol Deviation|0|||
146435035|NCT03290781|528097005|FG000|Overall Study|Disease Relapse|32|||
146435036|NCT03290781|528097006|FG001|Overall Study|Disease Relapse|5|||
146435037|NCT03290781|528097007|FG002|Overall Study|Disease Relapse|38|||
146435038|NCT03290781|528097008|FG003|Overall Study|Disease Relapse|7|||
146435039|NCT03290781|528097009|FG004|Overall Study|Disease Relapse|3|||
146435040|NCT03290781|528097010|FG005|Overall Study|Disease Relapse|1|||
146435041|NCT03290781|528097011|FG006|Overall Study|Disease Relapse|4|||
146435042|NCT03290781|528097005|FG000|Overall Study|Other|3|||
146435043|NCT03290781|528097006|FG001|Overall Study|Other|0|||
146285387|NCT00752557|527557850|FG000|Overall Study|Lost to Follow-up|1|||
146435044|NCT03290781|528097007|FG002|Overall Study|Other|2|||
146435045|NCT03290781|528097008|FG003|Overall Study|Other|2|||
146435046|NCT03290781|528097009|FG004|Overall Study|Other|0|||
146435047|NCT03290781|528097010|FG005|Overall Study|Other|0|||
146435048|NCT03290781|528097011|FG006|Overall Study|Other|0|||
146435049|NCT01588236|528097020|FG000|Overall Study|Adverse Event|5|||
146435050|NCT01588236|528097021|FG001|Overall Study|Adverse Event|4|||
146435051|NCT01588236|528097022|FG002|Overall Study|Adverse Event|1|||
146435052|NCT01588236|528097020|FG000|Overall Study|Lost to Follow-up|8|||
146435053|NCT01588236|528097021|FG001|Overall Study|Lost to Follow-up|13|||
146285388|NCT00752557|527557851|FG001|Overall Study|Lost to Follow-up|0|||
146435054|NCT01588236|528097022|FG002|Overall Study|Lost to Follow-up|6|||
146435055|NCT01588236|528097020|FG000|Overall Study|Physician Decision|1|||
146435056|NCT01588236|528097021|FG001|Overall Study|Physician Decision|2|||
146435057|NCT01588236|528097022|FG002|Overall Study|Physician Decision|0|||
146435058|NCT01588236|528097020|FG000|Overall Study|Protocol Violation|0|||
146435059|NCT01588236|528097021|FG001|Overall Study|Protocol Violation|1|||
146435060|NCT01588236|528097022|FG002|Overall Study|Protocol Violation|1|||
146435061|NCT01588236|528097020|FG000|Overall Study|Withdrawal by Subject|14|||
146435062|NCT01588236|528097021|FG001|Overall Study|Withdrawal by Subject|16|||
146435063|NCT01588236|528097022|FG002|Overall Study|Withdrawal by Subject|18|||
146435064|NCT01588236|528097020|FG000|Overall Study|Exclusion Criteria met during study|2|||
146435065|NCT01588236|528097021|FG001|Overall Study|Exclusion Criteria met during study|1|||
146435066|NCT01588236|528097022|FG002|Overall Study|Exclusion Criteria met during study|0|||
146435067|NCT01588236|528097020|FG000|Overall Study|sponsor decision|1|||
146435068|NCT01588236|528097021|FG001|Overall Study|sponsor decision|6|||
146435069|NCT01588236|528097022|FG002|Overall Study|sponsor decision|2|||
146207555|NCT02597920|527275183|FG000|Overall Study|Lost to Follow-up|7|||
146207556|NCT02597920|527275184|FG001|Overall Study|Lost to Follow-up|9|||
146207557|NCT02597920|527275185|FG002|Overall Study|Lost to Follow-up|0|||
146207558|NCT02597920|527275183|FG000|Overall Study|Refuse to continue in the study|3|||
146207559|NCT02597920|527275184|FG001|Overall Study|Refuse to continue in the study|13|||
146207560|NCT02597920|527275185|FG002|Overall Study|Refuse to continue in the study|1|||
146207561|NCT02597920|527275183|FG000|Overall Study|Other than specified|10|||
146207562|NCT02597920|527275184|FG001|Overall Study|Other than specified|31|||
146207563|NCT02597920|527275185|FG002|Overall Study|Other than specified|5|||
146207564|NCT02597920|527275183|FG000|Overall Study|Other|1|||
146207565|NCT02597920|527275184|FG001|Overall Study|Other|0|||
146207566|NCT02597920|527275185|FG002|Overall Study|Other|0|||
146207567|NCT00642850|527275186|FG000|Overall Study|Death|7|||
146435070|NCT04115293|528098502|FG000|Overall Study|Adverse Event|0|||
146435071|NCT04115293|528098503|FG001|Overall Study|Adverse Event|2|||
146435072|NCT04115293|528098502|FG000|Overall Study|Withdrawal by Subject|2|||
146435073|NCT04115293|528098503|FG001|Overall Study|Withdrawal by Subject|1|||
146435074|NCT04115293|528098502|FG000|Overall Study|Physician Decision|1|||
146207568|NCT00642850|527275186|FG000|Overall Study|Adverse Event|2|||
146207569|NCT00642850|527275186|FG000|Overall Study|Lack of Efficacy|1|||
146207570|NCT00642850|527275186|FG000|Overall Study|Protocol Violation|2|||
146435075|NCT04115293|528098503|FG001|Overall Study|Physician Decision|0|||
146207571|NCT00642850|527275186|FG000|Overall Study|Kidney transplantation|8|||
146207572|NCT00642850|527275186|FG000|Overall Study|Blood transfusion|6|||
146207573|NCT00642850|527275186|FG000|Overall Study|Other reasons|7|||
146207574|NCT05489484|527275193|FG000|Overall Study|withdrawn|1|||
146207575|NCT00444600|527275194|FG000|Overall Study|Death|7|||
146207576|NCT00444600|527275195|FG001|Overall Study|Death|5|||
146207577|NCT00444600|527275196|FG002|Overall Study|Death|3|||
146082976|NCT01215916|526824717|FG001|Overall Study|Adverse Event|1|||
146082977|NCT01215916|526824718|FG002|Overall Study|Adverse Event|0|||
146082978|NCT01215916|526824719|FG003|Overall Study|Adverse Event|1|||
146082979|NCT01215916|526824720|FG004|Overall Study|Adverse Event|0|||
146082980|NCT01215916|526824721|FG005|Overall Study|Adverse Event|0|||
146207578|NCT00444600|527275197|FG003|Overall Study|Death|2|||
146207579|NCT00444600|527275194|FG000|Overall Study|Dropped|11|||
146207580|NCT00444600|527275195|FG001|Overall Study|Dropped|11|||
146207581|NCT00444600|527275196|FG002|Overall Study|Dropped|7|||
146207582|NCT00444600|527275197|FG003|Overall Study|Dropped|7|||
146207583|NCT00444600|527275194|FG000|Overall Study|Missed visit|1|||
146207584|NCT00444600|527275195|FG001|Overall Study|Missed visit|0|||
146207585|NCT00444600|527275196|FG002|Overall Study|Missed visit|0|||
146207586|NCT00444600|527275197|FG003|Overall Study|Missed visit|1|||
146207587|NCT05132478|527275198|FG000|Overall Study|did not complete survey after consent|1|||
146207588|NCT05132478|527275199|FG001|Overall Study|did not complete survey after consent|1|||
146207589|NCT05132478|527275198|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
146207590|NCT05132478|527275199|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
146207591|NCT02549170|527275202|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
146207592|NCT02549170|527275203|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
146207593|NCT02549170|527275204|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146207594|NCT02549170|527275205|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146207595|NCT02549170|527275206|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
146207596|NCT02549170|527275202|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
146207597|NCT02549170|527275203|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
146082981|NCT01215916|526824722|FG006|Overall Study|Adverse Event|3|||
146082982|NCT01215916|526824723|FG007|Overall Study|Adverse Event|0|||
146207598|NCT02549170|527275204|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146207599|NCT02549170|527275205|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146207600|NCT02549170|527275206|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
146082983|NCT01215916|526824724|FG008|Overall Study|Adverse Event|0|||
146082984|NCT01215916|526824716|FG000|Overall Study|Withdrawal by Subject|0|||
146082985|NCT01215916|526824717|FG001|Overall Study|Withdrawal by Subject|1|||
146207601|NCT02549170|527275202|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
146285389|NCT00752557|527557852|FG002|Overall Study|Lost to Follow-up|1|||
146207602|NCT02549170|527275203|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
146207603|NCT02549170|527275204|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146207604|NCT02549170|527275205|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146207605|NCT02549170|527275206|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
146207606|NCT03051165|527275207|FG000|Overall Study|Withdrawal by Subject|1|||
146207607|NCT03051165|527275207|FG000|Overall Study|Early termination of study|12|||
146082986|NCT01215916|526824718|FG002|Overall Study|Withdrawal by Subject|1|||
146082987|NCT01215916|526824719|FG003|Overall Study|Withdrawal by Subject|2|||
146082988|NCT01215916|526824720|FG004|Overall Study|Withdrawal by Subject|0|||
146435076|NCT04115293|528098502|FG000|Overall Study|Death|1|||
146435077|NCT04115293|528098503|FG001|Overall Study|Death|1|||
146435078|NCT02571907|528098504|FG000|Overall Study|Death|4|||
146435079|NCT02571907|528098504|FG000|Overall Study|Lost to Follow-up|3|||
146435080|NCT02571907|528098504|FG000|Overall Study|Withdrawal by Subject|3|||
146435081|NCT02286739|528098505|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
146435082|NCT02286739|528098506|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
146435083|NCT02286739|528098505|FG000|Overall Study|No Verasense type documented|0|||
146435084|NCT02286739|528098506|FG001|Overall Study|No Verasense type documented|23|||
146435085|NCT02286739|528098505|FG000|Overall Study|Adverse Event|1|||
146435086|NCT02286739|528098506|FG001|Overall Study|Adverse Event|2|||
146435087|NCT02286739|528098505|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
146435088|NCT02286739|528098506|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
146435089|NCT02635750|528098511|FG000|Part 1, Period 2|Adverse Event|1|||
146435090|NCT02635750|528098512|FG001|Part 1, Period 2|Adverse Event|0|||
146435091|NCT02635750|528098513|FG002|Part 1, Period 2|Adverse Event|0|||
146435092|NCT02642653|528098517|FG000|Overall Study|Adverse Event|2|||
146435093|NCT02642653|528098518|FG001|Overall Study|Adverse Event|0|||
146435094|NCT02875392|528098519|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
146435095|NCT02875392|528098520|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
146435096|NCT00834717|528098526|FG000|First Intervention|Adverse Event|1|||
146435097|NCT00834717|528098527|FG001|First Intervention|Adverse Event|0|||
146435098|NCT00834717|528098526|FG000|First Intervention|Withdrawal by Subject|0|||
146435099|NCT00834717|528098527|FG001|First Intervention|Withdrawal by Subject|1|||
146435100|NCT01701674|528098528|FG000|Overall Study|Unable to safely complete treatment|1|||
146435101|NCT00834522|528098531|FG000|Washout|Adverse Event|1|||
146435102|NCT00834522|528098532|FG001|Washout|Adverse Event|0|||
146435103|NCT00834522|528098531|FG000|Washout|Withdrawal by Subject|2|||
146435104|NCT00834522|528098532|FG001|Washout|Withdrawal by Subject|1|||
146435105|NCT04516967|528098533|FG000|Core Phase|Adverse Event|2|||
146435106|NCT04516967|528098534|FG001|Core Phase|Adverse Event|1|||
146435107|NCT04516967|528098535|FG002|Core Phase|Adverse Event|0|||
146435108|NCT04516967|528098533|FG000|Core Phase|Physician Decision|1|||
146435109|NCT04516967|528098534|FG001|Core Phase|Physician Decision|1|||
146435110|NCT04516967|528098535|FG002|Core Phase|Physician Decision|0|||
146435111|NCT04516967|528098533|FG000|Core Phase|Lack of Efficacy|7|||
146435112|NCT04516967|528098534|FG001|Core Phase|Lack of Efficacy|18|||
146435113|NCT04516967|528098535|FG002|Core Phase|Lack of Efficacy|0|||
146435114|NCT00519194|528098536|FG000|Overall Study|Withdrawal by Subject|9|||
146435115|NCT00519194|528098536|FG000|Overall Study|Death|9|||
146435116|NCT00519194|528098536|FG000|Overall Study|Lost to Follow-up|3|||
146435117|NCT03165994|528098537|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
146435118|NCT03165994|528098537|FG000|Overall Study|Death|2|||
146435119|NCT03165994|528098537|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
146435120|NCT03165994|528098537|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
146435121|NCT03165994|528098537|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
146435122|NCT03165994|528098537|FG000|Overall Study|Miscellaneous|1|||
146207608|NCT01290341|527275208|FG000|Overall Study|Protocol Violation|7|||
146207609|NCT01290341|527275209|FG001|Overall Study|Protocol Violation|3|||
146207610|NCT01290341|527275208|FG000|Overall Study|Adverse Event|1|||
146207611|NCT01290341|527275209|FG001|Overall Study|Adverse Event|0|||
146207612|NCT01290341|527275208|FG000|Overall Study|Lost to Follow-up|21|||
146207613|NCT01290341|527275209|FG001|Overall Study|Lost to Follow-up|10|||
146207614|NCT01290341|527275208|FG000|Overall Study|Withdrawal by Subject|19|||
146207615|NCT01290341|527275209|FG001|Overall Study|Withdrawal by Subject|5|||
146207616|NCT01290341|527275208|FG000|Overall Study|Negative baseline culture and others|44|||
146207617|NCT01290341|527275209|FG001|Overall Study|Negative baseline culture and others|11|||
146207618|NCT00529100|527275210|FG000|Overall Study|Adverse Event|0|||
146207619|NCT00529100|527275211|FG001|Overall Study|Adverse Event|5|||
146207620|NCT00529100|527275210|FG000|Overall Study|Protocol Violation|0|||
146207621|NCT00529100|527275211|FG001|Overall Study|Protocol Violation|1|||
146207622|NCT00529100|527275210|FG000|Overall Study|Progressive Disease|0|||
146207623|NCT00529100|527275211|FG001|Overall Study|Progressive Disease|1|||
146207624|NCT00529100|527275210|FG000|Overall Study|Withdrawal by Subject|0|||
146207625|NCT00529100|527275211|FG001|Overall Study|Withdrawal by Subject|1|||
146207626|NCT00529100|527275210|FG000|Overall Study|Participant Ineligibility|0|||
146207627|NCT00529100|527275211|FG001|Overall Study|Participant Ineligibility|1|||
146207628|NCT03684044|527275213|FG000|Overall Study|Adverse Event|3|||
146207629|NCT03684044|527275214|FG001|Overall Study|Adverse Event|0|||
146207630|NCT03684044|527275213|FG000|Overall Study|Death|4|||
146207631|NCT03684044|527275214|FG001|Overall Study|Death|7|||
146207632|NCT03684044|527275213|FG000|Overall Study|Lost to Follow-up|3|||
146207633|NCT03684044|527275214|FG001|Overall Study|Lost to Follow-up|2|||
146207634|NCT03684044|527275213|FG000|Overall Study|Patient Not Available|0|||
146207635|NCT03684044|527275214|FG001|Overall Study|Patient Not Available|2|||
146207636|NCT03684044|527275213|FG000|Overall Study|Physician Decision|1|||
146207637|NCT03684044|527275214|FG001|Overall Study|Physician Decision|0|||
146207638|NCT03684044|527275213|FG000|Overall Study|Withdrawal by Subject|11|||
146207639|NCT03684044|527275214|FG001|Overall Study|Withdrawal by Subject|9|||
146207640|NCT03703336|527275215|FG000|Overall Study|Parent withdrew consent|29|||
146207641|NCT03703336|527275216|FG001|Overall Study|Parent withdrew consent|8|||
146207642|NCT03703336|527275215|FG000|Overall Study|Migration|3|||
146207643|NCT03703336|527275216|FG001|Overall Study|Migration|3|||
146207644|NCT03703336|527275215|FG000|Overall Study|Protocol Violation|3|||
146207645|NCT03703336|527275216|FG001|Overall Study|Protocol Violation|1|||
146207646|NCT03703336|527275215|FG000|Overall Study|Physician Decision|2|||
146207647|NCT03703336|527275216|FG001|Overall Study|Physician Decision|0|||
146207648|NCT03703336|527275215|FG000|Overall Study|Adverse Event|0|||
146207649|NCT03703336|527275216|FG001|Overall Study|Adverse Event|2|||
146207650|NCT03703336|527275215|FG000|Overall Study|Lost to Follow-up|1|||
146207651|NCT03703336|527275216|FG001|Overall Study|Lost to Follow-up|0|||
146207652|NCT02708108|527275217|FG000|Overall Study|Death|1|||
146207653|NCT02708108|527275218|FG001|Overall Study|Death|2|||
146207654|NCT02708108|527275217|FG000|Overall Study|Regimen change|1|||
146207655|NCT02708108|527275218|FG001|Overall Study|Regimen change|0|||
146207656|NCT02708108|527275217|FG000|Overall Study|No MRD and no imaging available|0|||
146207657|NCT02708108|527275218|FG001|Overall Study|No MRD and no imaging available|1|||
146207658|NCT01061671|527275223|FG000|Overall Study|Withdrawal by Subject|16|||
146207659|NCT01061671|527275224|FG001|Overall Study|Withdrawal by Subject|20|||
146207660|NCT01061671|527275223|FG000|Overall Study|Lost to Follow-up|3|||
146207661|NCT01061671|527275224|FG001|Overall Study|Lost to Follow-up|5|||
146207662|NCT01061671|527275223|FG000|Overall Study|Death|28|||
146207663|NCT01061671|527275224|FG001|Overall Study|Death|30|||
146207664|NCT00419341|527275228|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
146207665|NCT00419341|527275228|FG000|Wash in/Wash Out Period|Adverse Event|2|||
146207666|NCT00419341|527275228|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
146207667|NCT00419341|527275228|FG000|Efficacy Period|Withdrawal by Subject|6|||
146207668|NCT00419341|527275228|FG000|Efficacy Period|Protocol Violation|1|||
146207669|NCT00419341|527275228|FG000|Efficacy Period|Lost to Follow-up|1|||
146207670|NCT00419341|527275228|FG000|Efficacy Period|Non-compliance|1|||
146207671|NCT00419341|527275228|FG000|Efficacy Period|Termination of study site|1|||
146207672|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
146207673|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
146207674|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
146207675|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
146207676|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
146207677|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
146207678|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
146207679|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
146207680|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
146207681|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
146207682|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
146207683|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
146207684|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146207685|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
146207686|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
146207687|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146207688|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146207689|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
146207690|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
146207691|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
146207692|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
146207693|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146207694|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146207695|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
146207696|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146207697|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
146207698|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146207699|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146207700|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146207701|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
146207702|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
146207703|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146207704|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146207705|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146207706|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146207707|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
146207708|NCT04043455|527276365|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146207709|NCT04043455|527276366|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
146207710|NCT04043455|527276367|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146207711|NCT04043455|527276368|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146207712|NCT04043455|527276369|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146207713|NCT04043455|527276370|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
146207714|NCT04043455|527276365|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
146207715|NCT04043455|527276366|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
146207716|NCT04043455|527276367|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
146207717|NCT04043455|527276368|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
146207718|NCT04043455|527276369|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
146207719|NCT04043455|527276370|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
146207720|NCT04043455|527276365|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146207721|NCT04043455|527276366|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146207722|NCT04043455|527276367|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146207723|NCT04043455|527276368|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
146207724|NCT04043455|527276369|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
146207725|NCT04043455|527276370|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
146207726|NCT04043455|527276365|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146207727|NCT04043455|527276366|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146207728|NCT04043455|527276367|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146207729|NCT04043455|527276368|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146207730|NCT04043455|527276369|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
146207731|NCT04043455|527276370|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
146207732|NCT04043455|527276365|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146207733|NCT04043455|527276366|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146207734|NCT04043455|527276367|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146207735|NCT04043455|527276368|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
146207736|NCT04043455|527276369|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
146207737|NCT04043455|527276370|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
146207738|NCT00111813|527276371|FG000|Overall Study|Adverse Event|1|||
146207739|NCT00111813|527276372|FG001|Overall Study|Adverse Event|2|||
146207740|NCT00111813|527276373|FG002|Overall Study|Adverse Event|4|||
146207741|NCT00111813|527276374|FG003|Overall Study|Adverse Event|2|||
146207742|NCT00111813|527276375|FG004|Overall Study|Adverse Event|2|||
146435123|NCT01175018|528098544|FG000|Overall Study|Adverse Event|3|||
146435124|NCT01175018|528098545|FG001|Overall Study|Adverse Event|1|||
146435125|NCT03285594|528098546|FG000|Overall Study|At the Participant's Own Request|10|||
146435126|NCT03285594|528098547|FG001|Overall Study|At the Participant's Own Request|5|||
146435127|NCT03285594|528098548|FG002|Overall Study|At the Participant's Own Request|21|||
146435128|NCT03285594|528098546|FG000|Overall Study|Adverse Event|2|||
146435129|NCT03285594|528098547|FG001|Overall Study|Adverse Event|2|||
146435130|NCT03285594|528098548|FG002|Overall Study|Adverse Event|6|||
146435131|NCT03285594|528098546|FG000|Overall Study|Poor Compliance to Protocol|0|||
146435132|NCT03285594|528098547|FG001|Overall Study|Poor Compliance to Protocol|0|||
146435133|NCT03285594|528098548|FG002|Overall Study|Poor Compliance to Protocol|1|||
146435134|NCT03285594|528098546|FG000|Overall Study|Lost to Follow-up|0|||
146435135|NCT03285594|528098547|FG001|Overall Study|Lost to Follow-up|0|||
146435136|NCT03285594|528098548|FG002|Overall Study|Lost to Follow-up|1|||
146435137|NCT03285594|528098546|FG000|Overall Study|Reason Not Specified|3|||
146435138|NCT03285594|528098547|FG001|Overall Study|Reason Not Specified|4|||
146435139|NCT03285594|528098548|FG002|Overall Study|Reason Not Specified|8|||
146435140|NCT02558491|528098549|FG000|First Invention|Withdrawal by Subject|3|||
146435141|NCT02558491|528098550|FG001|First Invention|Withdrawal by Subject|1|||
146435142|NCT02558491|528098549|FG000|First Invention|Data collection issues|1|||
146207743|NCT00111813|527276376|FG005|Overall Study|Adverse Event|2|||
146207744|NCT00111813|527276371|FG000|Overall Study|Progressive disease|2|||
146207745|NCT00111813|527276372|FG001|Overall Study|Progressive disease|1|||
146207746|NCT00111813|527276373|FG002|Overall Study|Progressive disease|5|||
146207747|NCT00111813|527276374|FG003|Overall Study|Progressive disease|3|||
146207748|NCT00111813|527276375|FG004|Overall Study|Progressive disease|4|||
146207749|NCT00111813|527276376|FG005|Overall Study|Progressive disease|3|||
146207750|NCT00111813|527276371|FG000|Overall Study|Lack of Efficacy|0|||
146207751|NCT00111813|527276372|FG001|Overall Study|Lack of Efficacy|0|||
146207752|NCT00111813|527276373|FG002|Overall Study|Lack of Efficacy|0|||
146207753|NCT00111813|527276374|FG003|Overall Study|Lack of Efficacy|0|||
146207754|NCT00111813|527276375|FG004|Overall Study|Lack of Efficacy|0|||
146207755|NCT00111813|527276376|FG005|Overall Study|Lack of Efficacy|1|||
146207756|NCT00111813|527276371|FG000|Overall Study|Other|0|||
146207757|NCT00111813|527276372|FG001|Overall Study|Other|0|||
146207758|NCT00111813|527276373|FG002|Overall Study|Other|1|||
146207759|NCT00111813|527276374|FG003|Overall Study|Other|0|||
146207760|NCT00111813|527276375|FG004|Overall Study|Other|0|||
146207761|NCT00111813|527276376|FG005|Overall Study|Other|0|||
146207762|NCT00409838|527276380|FG000|Short-term Period|Adverse Event|0|||
146207763|NCT00409838|527276381|FG001|Short-term Period|Adverse Event|1|||
146207764|NCT00409838|527276380|FG000|Short-term Period|Lost to Follow-up|0|||
146207765|NCT00409838|527276381|FG001|Short-term Period|Lost to Follow-up|1|||
146207766|NCT00409838|527276380|FG000|Short-term Period|Withdrawal by Subject|2|||
146207767|NCT00409838|527276381|FG001|Short-term Period|Withdrawal by Subject|3|||
146207768|NCT00409838|527276380|FG000|Short-term Period|Never Treated|1|||
146207769|NCT00409838|527276381|FG001|Short-term Period|Never Treated|0|||
146207770|NCT00409838|527276380|FG000|Long-term Extension Period|Adverse Event|10|||
146207771|NCT00409838|527276381|FG001|Long-term Extension Period|Adverse Event|0|||
146207772|NCT00409838|527276380|FG000|Long-term Extension Period|Death|1|||
146207773|NCT00409838|527276381|FG001|Long-term Extension Period|Death|0|||
146207774|NCT00409838|527276380|FG000|Long-term Extension Period|Lack of Efficacy|2|||
146207775|NCT00409838|527276381|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146207776|NCT00409838|527276380|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
146207777|NCT00409838|527276381|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
146207778|NCT00409838|527276380|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
146207779|NCT00409838|527276381|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
146207780|NCT00409838|527276380|FG000|Long-term Extension Period|Pregnancy|1|||
146207781|NCT00409838|527276381|FG001|Long-term Extension Period|Pregnancy|0|||
146207782|NCT04788641|527276382|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146207783|NCT04788641|527276383|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146207784|NCT04788641|527276384|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
146207785|NCT04788641|527276385|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
146207786|NCT04788641|527276382|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
146207787|NCT04788641|527276383|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146207788|NCT04788641|527276384|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146207789|NCT04788641|527276385|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
146207790|NCT04788641|527276382|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
146207791|NCT04788641|527276383|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
146435143|NCT02558491|528098550|FG001|First Invention|Data collection issues|0|||
146207792|NCT04788641|527276384|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
146207793|NCT04788641|527276385|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
146207794|NCT01250769|527276386|FG000|Overall Study|Withdrawal by Subject|0|||
146207795|NCT01250769|527276387|FG001|Overall Study|Withdrawal by Subject|1|||
146207796|NCT01250769|527276388|FG002|Overall Study|Withdrawal by Subject|1|||
146435144|NCT02558491|528098549|FG000|First Invention|Stopping criteria|0|||
146435145|NCT02558491|528098550|FG001|First Invention|Stopping criteria|1|||
146435146|NCT02558491|528098549|FG000|First Invention|Changed parameters during trial|1|||
146435147|NCT02558491|528098550|FG001|First Invention|Changed parameters during trial|0|||
146435148|NCT02558491|528098549|FG000|Second Intervention|Withdrawal by Subject|1|||
146435149|NCT02558491|528098550|FG001|Second Intervention|Withdrawal by Subject|0|||
146435150|NCT02558491|528098549|FG000|Second Intervention|Stopping Criteria|1|||
146435151|NCT02558491|528098550|FG001|Second Intervention|Stopping Criteria|0|||
146435152|NCT00834431|528098551|FG000|First Intervention|Adverse Event|0|||
146435153|NCT00834431|528098552|FG001|First Intervention|Adverse Event|1|||
146435154|NCT00834431|528098551|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
146435155|NCT00834431|528098552|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146435156|NCT03733444|528098555|FG000|Overall Study|Adverse Event|8|||
146435157|NCT03733444|528098556|FG001|Overall Study|Adverse Event|10|||
146435158|NCT03733444|528098557|FG002|Overall Study|Adverse Event|5|||
146435159|NCT03733444|528098555|FG000|Overall Study|Death|20|||
146435160|NCT03733444|528098556|FG001|Overall Study|Death|19|||
146435161|NCT03733444|528098557|FG002|Overall Study|Death|11|||
146435162|NCT03733444|528098555|FG000|Overall Study|Lost to Follow-up|3|||
146435163|NCT03733444|528098556|FG001|Overall Study|Lost to Follow-up|0|||
146435164|NCT03733444|528098557|FG002|Overall Study|Lost to Follow-up|1|||
146435165|NCT03733444|528098555|FG000|Overall Study|Lack of Efficacy|0|||
146435166|NCT03733444|528098556|FG001|Overall Study|Lack of Efficacy|1|||
146435167|NCT03733444|528098557|FG002|Overall Study|Lack of Efficacy|1|||
146435168|NCT03733444|528098555|FG000|Overall Study|Physician Decision|2|||
146435169|NCT03733444|528098556|FG001|Overall Study|Physician Decision|1|||
146435170|NCT03733444|528098557|FG002|Overall Study|Physician Decision|0|||
146435171|NCT03733444|528098555|FG000|Overall Study|Protocol Violation|2|||
146435172|NCT03733444|528098556|FG001|Overall Study|Protocol Violation|1|||
146435173|NCT03733444|528098557|FG002|Overall Study|Protocol Violation|0|||
146435174|NCT03733444|528098555|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
146435175|NCT03733444|528098556|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
146435176|NCT03733444|528098557|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
146435177|NCT03733444|528098555|FG000|Overall Study|Study Terminated by Sponsor|203|||
146435178|NCT03733444|528098556|FG001|Overall Study|Study Terminated by Sponsor|209|||
146435179|NCT03733444|528098557|FG002|Overall Study|Study Terminated by Sponsor|221|||
146435180|NCT03733444|528098555|FG000|Overall Study|Withdrawal by Subject|19|||
146435181|NCT03733444|528098556|FG001|Overall Study|Withdrawal by Subject|18|||
146435182|NCT03733444|528098557|FG002|Overall Study|Withdrawal by Subject|16|||
146435183|NCT03733444|528098555|FG000|Overall Study|Miscellaneous|1|||
146435184|NCT03733444|528098556|FG001|Overall Study|Miscellaneous|0|||
146435185|NCT03733444|528098557|FG002|Overall Study|Miscellaneous|1|||
146435186|NCT03733444|528098555|FG000|Overall Study|Not Treated|1|||
146435187|NCT03733444|528098556|FG001|Overall Study|Not Treated|2|||
146435188|NCT03733444|528098557|FG002|Overall Study|Not Treated|1|||
146435189|NCT03637764|528098558|FG000|Overall Study|Adverse Event|2|||
146435190|NCT03637764|528098559|FG001|Overall Study|Adverse Event|0|||
146435191|NCT03637764|528098560|FG002|Overall Study|Adverse Event|0|||
146435192|NCT03637764|528098561|FG003|Overall Study|Adverse Event|1|||
146435193|NCT03637764|528098558|FG000|Overall Study|Progressive Disease|23|||
146435194|NCT03637764|528098559|FG001|Overall Study|Progressive Disease|23|||
146435195|NCT03637764|528098560|FG002|Overall Study|Progressive Disease|18|||
146435196|NCT03637764|528098561|FG003|Overall Study|Progressive Disease|31|||
146435197|NCT03637764|528098558|FG000|Overall Study|Withdrawal by Subject|1|||
146435198|NCT03637764|528098559|FG001|Overall Study|Withdrawal by Subject|3|||
146435199|NCT03637764|528098560|FG002|Overall Study|Withdrawal by Subject|0|||
146435200|NCT03637764|528098561|FG003|Overall Study|Withdrawal by Subject|1|||
146435201|NCT00835263|528098562|FG000|Second Intervention|Adverse Event|1|||
146435202|NCT00835263|528098563|FG001|Second Intervention|Adverse Event|0|||
146435203|NCT03987191|528098564|FG000|Overall Study|COVID-19 related research disruption|0|||
146435204|NCT03987191|528098565|FG001|Overall Study|COVID-19 related research disruption|2|||
146435205|NCT01020474|528098566|FG000|Overall Study|Adverse Event|4|||
146435206|NCT01020474|528098567|FG001|Overall Study|Adverse Event|4|||
146435207|NCT01020474|528098566|FG000|Overall Study|Protocol Violation|0|||
146435208|NCT01020474|528098567|FG001|Overall Study|Protocol Violation|2|||
146435209|NCT01020474|528098566|FG000|Overall Study|Withdrawal by Subject|5|||
146435210|NCT01020474|528098567|FG001|Overall Study|Withdrawal by Subject|7|||
146435211|NCT01020474|528098566|FG000|Overall Study|Other Reasons|1|||
146435212|NCT01020474|528098567|FG001|Overall Study|Other Reasons|1|||
146435213|NCT01020474|528098566|FG000|Overall Study|Insufficient Clinical Response|0|||
146435214|NCT01020474|528098567|FG001|Overall Study|Insufficient Clinical Response|3|||
146435215|NCT02838420|528098570|FG000|Overall Study|Ongoing in Study|113|||
146435216|NCT02838420|528098571|FG001|Overall Study|Ongoing in Study|45|||
146435217|NCT02838420|528098570|FG000|Overall Study|Lost to Follow-up|1|||
146435218|NCT02838420|528098571|FG001|Overall Study|Lost to Follow-up|0|||
146435219|NCT02838420|528098570|FG000|Overall Study|Withdrawal by Subject|3|||
146435220|NCT02838420|528098571|FG001|Overall Study|Withdrawal by Subject|4|||
146435221|NCT02838420|528098570|FG000|Overall Study|Death|8|||
146207797|NCT01250769|527276389|FG003|Overall Study|Withdrawal by Subject|0|||
146207798|NCT01250769|527276386|FG000|Overall Study|Adverse Event|0|||
146207799|NCT01250769|527276387|FG001|Overall Study|Adverse Event|0|||
146207800|NCT01250769|527276388|FG002|Overall Study|Adverse Event|1|||
146207801|NCT01250769|527276389|FG003|Overall Study|Adverse Event|0|||
146207802|NCT03283371|527276390|FG000|Placebo-controlled|Adverse Event|1|||
146207803|NCT03283371|527276391|FG001|Placebo-controlled|Adverse Event|1|||
146207804|NCT03283371|527276392|FG002|Placebo-controlled|Adverse Event|0|||
146207805|NCT03283371|527276393|FG003|Placebo-controlled|Adverse Event|0|||
146207806|NCT03283371|527276390|FG000|Placebo-controlled|Lack of Efficacy|1|||
146207807|NCT03283371|527276391|FG001|Placebo-controlled|Lack of Efficacy|0|||
146207808|NCT03283371|527276392|FG002|Placebo-controlled|Lack of Efficacy|0|||
146207809|NCT03283371|527276393|FG003|Placebo-controlled|Lack of Efficacy|0|||
146207810|NCT03283371|527276390|FG000|Placebo-controlled|Withdrawal by Subject|1|||
146207811|NCT03283371|527276391|FG001|Placebo-controlled|Withdrawal by Subject|1|||
146207812|NCT03283371|527276392|FG002|Placebo-controlled|Withdrawal by Subject|0|||
146207813|NCT03283371|527276393|FG003|Placebo-controlled|Withdrawal by Subject|0|||
146207814|NCT03283371|527276390|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146285390|NCT00190749|527557853|FG000|Overall Study|Lost to Follow-up|8|||
146285391|NCT00190749|527557854|FG001|Overall Study|Lost to Follow-up|11|||
146435222|NCT02838420|528098571|FG001|Overall Study|Death|13|||
146435223|NCT00796653|528098572|FG000|Overall Study|Adverse Event|19|||
146435224|NCT00796653|528098573|FG001|Overall Study|Adverse Event|16|||
146435225|NCT00796653|528098574|FG002|Overall Study|Adverse Event|16|||
146435226|NCT00796653|528098575|FG003|Overall Study|Adverse Event|16|||
146435227|NCT00796653|528098572|FG000|Overall Study|Lost to Follow-up|2|||
146435228|NCT00796653|528098573|FG001|Overall Study|Lost to Follow-up|1|||
146435229|NCT00796653|528098574|FG002|Overall Study|Lost to Follow-up|2|||
146435230|NCT00796653|528098575|FG003|Overall Study|Lost to Follow-up|3|||
146435231|NCT00796653|528098572|FG000|Overall Study|Withdrawal by Subject|16|||
146435232|NCT00796653|528098573|FG001|Overall Study|Withdrawal by Subject|8|||
146435233|NCT00796653|528098574|FG002|Overall Study|Withdrawal by Subject|8|||
146435234|NCT00796653|528098575|FG003|Overall Study|Withdrawal by Subject|13|||
146435235|NCT00796653|528098572|FG000|Overall Study|Lack of Efficacy|8|||
146435236|NCT00796653|528098573|FG001|Overall Study|Lack of Efficacy|1|||
146435237|NCT00796653|528098574|FG002|Overall Study|Lack of Efficacy|3|||
146435238|NCT00796653|528098575|FG003|Overall Study|Lack of Efficacy|2|||
146435239|NCT00796653|528098572|FG000|Overall Study|Non compliance with protocol|2|||
146435240|NCT00796653|528098573|FG001|Overall Study|Non compliance with protocol|2|||
146435241|NCT00796653|528098574|FG002|Overall Study|Non compliance with protocol|0|||
146435242|NCT00796653|528098575|FG003|Overall Study|Non compliance with protocol|2|||
146435243|NCT00796653|528098572|FG000|Overall Study|Other reason not described above|4|||
146435244|NCT00796653|528098573|FG001|Overall Study|Other reason not described above|9|||
146435245|NCT00796653|528098574|FG002|Overall Study|Other reason not described above|7|||
146435246|NCT00796653|528098575|FG003|Overall Study|Other reason not described above|4|||
146285392|NCT00190749|527557853|FG000|Overall Study|Withdrawal by Subject|10|||
146285393|NCT00190749|527557854|FG001|Overall Study|Withdrawal by Subject|6|||
146285394|NCT00190749|527557853|FG000|Overall Study|Protocol Violation|5|||
146285395|NCT00190749|527557854|FG001|Overall Study|Protocol Violation|4|||
146435247|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
146435248|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
146435249|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
146435250|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
146207815|NCT03283371|527276391|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
146207816|NCT03283371|527276392|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146207817|NCT03283371|527276393|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
146207818|NCT03283371|527276390|FG000|Open-label Phase|Adverse Event|0|||
146207819|NCT03283371|527276391|FG001|Open-label Phase|Adverse Event|0|||
146285396|NCT00190749|527557853|FG000|Overall Study|Adverse Event|0|||
146207820|NCT03283371|527276392|FG002|Open-label Phase|Adverse Event|2|||
146207821|NCT03283371|527276393|FG003|Open-label Phase|Adverse Event|0|||
146207822|NCT03283371|527276390|FG000|Open-label Phase|Withdrawal by Subject|0|||
146207823|NCT03283371|527276391|FG001|Open-label Phase|Withdrawal by Subject|0|||
146285397|NCT00190749|527557854|FG001|Overall Study|Adverse Event|5|||
146285398|NCT00190749|527557853|FG000|Overall Study|Lack of Efficacy|2|||
146435251|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
146435252|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
146435253|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146435254|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146435255|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
146435256|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
146435257|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
146435258|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
146435259|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
146435260|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
146435261|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146435262|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146435263|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
146435264|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
146435265|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
146435266|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
146435267|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Death|0|||
145951652|NCT02362425|526335696|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
145951653|NCT02362425|526335697|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
145951654|NCT02362425|526335694|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
145951655|NCT02362425|526335695|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145951656|NCT02362425|526335696|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145951657|NCT02362425|526335697|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145951658|NCT02362425|526335694|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
145951659|NCT02362425|526335695|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
145951660|NCT02362425|526335696|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
145951661|NCT02362425|526335697|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
145951662|NCT02362425|526335694|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
145951663|NCT02362425|526335695|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
145951664|NCT02362425|526335696|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
146285399|NCT00190749|527557854|FG001|Overall Study|Lack of Efficacy|3|||
146435268|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Death|1|||
146435269|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Death|0|||
146435270|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Death|0|||
146435271|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
146435272|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
146435273|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
146435274|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
146435275|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
146435276|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
146435277|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
146435278|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
146435279|NCT01940341|528098578|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146435280|NCT01940341|528098579|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
146435281|NCT01940341|528098580|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146435282|NCT01940341|528098581|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146435283|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146435284|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146435285|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
146435286|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
146435287|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146435288|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146435289|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
146435290|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
146435291|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146435292|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145951665|NCT02362425|526335697|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
146285400|NCT00190749|527557853|FG000|Overall Study|Reason Not Specified|0|||
146207824|NCT03283371|527276392|FG002|Open-label Phase|Withdrawal by Subject|1|||
146207825|NCT03283371|527276393|FG003|Open-label Phase|Withdrawal by Subject|0|||
146435293|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
146435294|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146435295|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
146435296|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
146435297|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
146435298|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
146435299|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146435300|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146435301|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
146435302|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146207826|NCT03283371|527276390|FG000|Open-label Phase|Other|0|||
146207827|NCT03283371|527276391|FG001|Open-label Phase|Other|0|||
146207828|NCT03283371|527276392|FG002|Open-label Phase|Other|1|||
146207829|NCT03283371|527276393|FG003|Open-label Phase|Other|1|||
146207830|NCT00243503|527276394|FG000|Overall Study|Adverse Event|11|||
146435303|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
146435304|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
146435305|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
146435306|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
146435307|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146435308|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146435309|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
146435310|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146435311|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146435312|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146435313|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146435314|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
146435315|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146435316|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146435317|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146435318|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
146435319|NCT01940341|528098578|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
146435320|NCT01940341|528098579|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
146435321|NCT01940341|528098580|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
146435322|NCT01940341|528098581|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
146207831|NCT00243503|527276394|FG000|Overall Study|Withdrawal by Subject|1|||
146207832|NCT00243503|527276394|FG000|Overall Study|Lack of Efficacy|44|||
146207833|NCT00243503|527276394|FG000|Overall Study|Death|1|||
146207834|NCT00243503|527276394|FG000|Overall Study|Other|1|||
146207835|NCT00914589|527276395|FG000|Overall Study|Adverse Event|1|||
146207836|NCT00914589|527276396|FG001|Overall Study|Adverse Event|0|||
146207837|NCT00914589|527276397|FG002|Overall Study|Adverse Event|1|||
146207838|NCT00914589|527276395|FG000|Overall Study|Protocol Violation|8|||
146207839|NCT00914589|527276396|FG001|Overall Study|Protocol Violation|6|||
146207840|NCT00914589|527276397|FG002|Overall Study|Protocol Violation|3|||
146207841|NCT00914589|527276395|FG000|Overall Study|unclassified|16|||
146207842|NCT00914589|527276396|FG001|Overall Study|unclassified|9|||
146207843|NCT00914589|527276397|FG002|Overall Study|unclassified|7|||
146207844|NCT00914589|527276395|FG000|Overall Study|Death|0|||
146207845|NCT00914589|527276396|FG001|Overall Study|Death|1|||
146207846|NCT00914589|527276397|FG002|Overall Study|Death|1|||
146207847|NCT00093015|527276402|FG000|Overall Study|Withdrawal by Subject|194|||
146207848|NCT00093015|527276403|FG001|Overall Study|Withdrawal by Subject|171|||
146435323|NCT02414152|528098582|FG000|Overall Study|Withdrawal by Subject|1|||
146435324|NCT02414152|528098582|FG000|Overall Study|Lack of Efficacy|1|||
146435325|NCT01576042|528098586|FG000|Overall Study|Physician Decision|2|||
146435326|NCT01576042|528098587|FG001|Overall Study|Physician Decision|0|||
146435327|NCT03769025|528098593|FG000|Overall Study|Withdrawal by Subject|1|||
146435328|NCT03769025|528098594|FG001|Overall Study|Withdrawal by Subject|1|||
146435329|NCT03769025|528098593|FG000|Overall Study|Lost to Follow-up|4|||
146435330|NCT03769025|528098594|FG001|Overall Study|Lost to Follow-up|3|||
146082989|NCT01215916|526824721|FG005|Overall Study|Withdrawal by Subject|0|||
146207849|NCT00093015|527276402|FG000|Overall Study|Lost to Follow-up|96|||
146207850|NCT00093015|527276403|FG001|Overall Study|Lost to Follow-up|108|||
146207851|NCT00093015|527276402|FG000|Overall Study|Death|375|||
146207852|NCT00093015|527276403|FG001|Overall Study|Death|385|||
146207853|NCT00520546|527276406|FG000|Overall Study|Withdrawal by Subject|1|||
146207854|NCT00520546|527276406|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
146207855|NCT03076515|527276407|FG000|Overall Study|DMC decision based on interim analysis|25|||
146207856|NCT03076515|527276408|FG001|Overall Study|DMC decision based on interim analysis|29|||
146207857|NCT03988023|527276412|FG000|Overall Study|Non-compliance|3|||
146207858|NCT03988023|527276413|FG001|Overall Study|Non-compliance|0|||
146435331|NCT05341622|528098603|FG000|Overall Study|Death|0|||
146435332|NCT05341622|528098604|FG001|Overall Study|Death|0|||
146207859|NCT03988023|527276412|FG000|Overall Study|Withdrawal by Subject|39|||
146435333|NCT05341622|528098605|FG002|Overall Study|Death|0|||
146207860|NCT03988023|527276413|FG001|Overall Study|Withdrawal by Subject|37|||
146207861|NCT03988023|527276412|FG000|Overall Study|Adverse Event|0|||
146207862|NCT03988023|527276413|FG001|Overall Study|Adverse Event|2|||
146207863|NCT03988023|527276412|FG000|Overall Study|Physician Decision|0|||
146207864|NCT03988023|527276413|FG001|Overall Study|Physician Decision|1|||
146207865|NCT03988023|527276412|FG000|Overall Study|Lost to Follow-up|5|||
146207866|NCT03988023|527276413|FG001|Overall Study|Lost to Follow-up|8|||
146207867|NCT03988023|527276412|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
146207868|NCT03988023|527276413|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
146207869|NCT03988023|527276412|FG000|Overall Study|Lack of Efficacy|3|||
146207870|NCT03988023|527276413|FG001|Overall Study|Lack of Efficacy|1|||
146207871|NCT03988023|527276412|FG000|Overall Study|COVID-19 pandemic|225|||
146207872|NCT03988023|527276413|FG001|Overall Study|COVID-19 pandemic|227|||
146207873|NCT02101281|527276414|FG000|Overall Study|Adverse Event|0|||
146207874|NCT02101281|527276415|FG001|Overall Study|Adverse Event|1|||
146207875|NCT00174382|527276416|FG000|Overall Study|Death|2|||
146207876|NCT00174382|527276416|FG000|Overall Study|Adverse Event|19|||
146207877|NCT00174382|527276416|FG000|Overall Study|Withdrawal by Subject|6|||
146207878|NCT00174382|527276416|FG000|Overall Study|Protocol Violation|3|||
146207879|NCT00174382|527276416|FG000|Overall Study|Arrived early for last visit in error|1|||
146207880|NCT00174382|527276416|FG000|Overall Study|Subject felt pill not effective enough|1|||
146207881|NCT00174382|527276416|FG000|Overall Study|Lost to Follow-up|1|||
146207882|NCT03733119|527276418|FG000|Overall Study|Physician Decision|2|||
146207883|NCT03733119|527276419|FG001|Overall Study|Physician Decision|1|||
146207884|NCT03733119|527276418|FG000|Overall Study|ineligible to treat per protocol|0|||
146207885|NCT03733119|527276419|FG001|Overall Study|ineligible to treat per protocol|1|||
146207886|NCT00595413|527276420|FG000|Overall Study|Adverse Event|0|||
146207887|NCT00595413|527276421|FG001|Overall Study|Adverse Event|2|||
146207888|NCT00595413|527276422|FG002|Overall Study|Adverse Event|1|||
146207889|NCT00595413|527276423|FG003|Overall Study|Adverse Event|1|||
146207890|NCT00595413|527276420|FG000|Overall Study|Lost to Follow-up|2|||
145951666|NCT02362425|526335694|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
145951667|NCT02362425|526335695|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
145951668|NCT02362425|526335696|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
145951669|NCT02362425|526335697|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
145951670|NCT02362425|526335694|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145951671|NCT02362425|526335695|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145951672|NCT02362425|526335696|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145951673|NCT02362425|526335697|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
145951674|NCT02362425|526335694|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145951675|NCT02362425|526335695|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145951676|NCT02362425|526335696|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145951677|NCT02362425|526335697|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
145951678|NCT02362425|526335694|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145951679|NCT02362425|526335695|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145951680|NCT02362425|526335696|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
145951681|NCT02362425|526335697|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145951682|NCT02155309|526335700|FG000|Overall Study|Protocol Violation|0|||
145951683|NCT02155309|526335701|FG001|Overall Study|Protocol Violation|0|||
145951684|NCT02155309|526335702|FG002|Overall Study|Protocol Violation|1|||
145951685|NCT00314808|526335708|FG000|Overall Study|Disease Progression without AE|4|||
145951686|NCT00314808|526335708|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
145951687|NCT04304508|526335709|FG000|Overall Study|Subject Decision|29|||
145951688|NCT04304508|526335710|FG001|Overall Study|Subject Decision|39|||
145951689|NCT04304508|526335711|FG002|Overall Study|Subject Decision|37|||
145951690|NCT04304508|526335712|FG003|Overall Study|Subject Decision|48|||
145951691|NCT04304508|526335709|FG000|Overall Study|Death|6|||
145951692|NCT04304508|526335710|FG001|Overall Study|Death|1|||
146207891|NCT00595413|527276421|FG001|Overall Study|Lost to Follow-up|2|||
146207892|NCT00595413|527276422|FG002|Overall Study|Lost to Follow-up|1|||
146207893|NCT00595413|527276423|FG003|Overall Study|Lost to Follow-up|3|||
146207894|NCT00595413|527276420|FG000|Overall Study|Death|0|||
146207895|NCT00595413|527276421|FG001|Overall Study|Death|0|||
146207896|NCT00595413|527276422|FG002|Overall Study|Death|1|||
146207897|NCT00595413|527276423|FG003|Overall Study|Death|0|||
146207898|NCT00595413|527276420|FG000|Overall Study|Other|5|||
146207899|NCT00595413|527276421|FG001|Overall Study|Other|1|||
146207900|NCT00595413|527276422|FG002|Overall Study|Other|5|||
146207901|NCT00595413|527276423|FG003|Overall Study|Other|0|||
146207902|NCT00807937|527276424|FG000|Overall Study|Adverse Event|12|||
146207903|NCT00807937|527276425|FG001|Overall Study|Adverse Event|12|||
146207904|NCT00807937|527276426|FG002|Overall Study|Adverse Event|5|||
146207905|NCT00807937|527276427|FG003|Overall Study|Adverse Event|4|||
146207906|NCT00807937|527276424|FG000|Overall Study|Protocol Violation|4|||
146207907|NCT00807937|527276425|FG001|Overall Study|Protocol Violation|5|||
146207908|NCT00807937|527276426|FG002|Overall Study|Protocol Violation|3|||
146435334|NCT05341622|528098606|FG003|Overall Study|Death|0|||
146435335|NCT05341622|528098607|FG004|Overall Study|Death|1|||
146435336|NCT05341622|528098608|FG005|Overall Study|Death|0|||
146435337|NCT05341622|528098609|FG006|Overall Study|Death|0|||
146435338|NCT05341622|528098610|FG007|Overall Study|Death|1|||
146435339|NCT05341622|528098603|FG000|Overall Study|Invalid Address|0|||
146435340|NCT05341622|528098604|FG001|Overall Study|Invalid Address|1|||
146435341|NCT05341622|528098605|FG002|Overall Study|Invalid Address|0|||
146435342|NCT05341622|528098606|FG003|Overall Study|Invalid Address|0|||
146435343|NCT05341622|528098607|FG004|Overall Study|Invalid Address|0|||
146207909|NCT00807937|527276427|FG003|Overall Study|Protocol Violation|3|||
146207910|NCT00807937|527276424|FG000|Overall Study|Withdrawal by Subject|5|||
146207911|NCT00807937|527276425|FG001|Overall Study|Withdrawal by Subject|4|||
146207912|NCT00807937|527276426|FG002|Overall Study|Withdrawal by Subject|1|||
146207913|NCT00807937|527276427|FG003|Overall Study|Withdrawal by Subject|4|||
146435344|NCT05341622|528098608|FG005|Overall Study|Invalid Address|0|||
146435345|NCT05341622|528098609|FG006|Overall Study|Invalid Address|0|||
146435346|NCT05341622|528098610|FG007|Overall Study|Invalid Address|0|||
146435347|NCT05341622|528098603|FG000|Overall Study|Ineligible|26|||
146435348|NCT05341622|528098604|FG001|Overall Study|Ineligible|21|||
146435349|NCT05341622|528098605|FG002|Overall Study|Ineligible|28|||
146435350|NCT05341622|528098606|FG003|Overall Study|Ineligible|24|||
146435351|NCT05341622|528098607|FG004|Overall Study|Ineligible|29|||
146435352|NCT05341622|528098608|FG005|Overall Study|Ineligible|31|||
146435353|NCT05341622|528098609|FG006|Overall Study|Ineligible|28|||
146435354|NCT05341622|528098610|FG007|Overall Study|Ineligible|26|||
146435355|NCT02957942|528098611|FG000|Overall Study|Withdrawal by Subject|0|||
146435356|NCT02957942|528098612|FG001|Overall Study|Withdrawal by Subject|1|||
146435357|NCT02957942|528098611|FG000|Overall Study|Practicing experiment protocol|0|||
146435358|NCT02957942|528098612|FG001|Overall Study|Practicing experiment protocol|6|||
146435359|NCT03801707|528098623|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
146435360|NCT00787254|528098626|FG000|Overall Study|Adverse Event|24|||
146435361|NCT00787254|528098627|FG001|Overall Study|Adverse Event|23|||
146435362|NCT00787254|528098626|FG000|Overall Study|Protocol Violation|26|||
146435363|NCT00787254|528098627|FG001|Overall Study|Protocol Violation|23|||
146435364|NCT00787254|528098626|FG000|Overall Study|Withdrawal by Subject|16|||
146435365|NCT00787254|528098627|FG001|Overall Study|Withdrawal by Subject|11|||
146435366|NCT00787254|528098626|FG000|Overall Study|Lack of Efficacy|4|||
146435367|NCT00787254|528098627|FG001|Overall Study|Lack of Efficacy|15|||
146435368|NCT00787254|528098626|FG000|Overall Study|NSAIDs discontinuation|1|||
146435369|NCT00787254|528098627|FG001|Overall Study|NSAIDs discontinuation|2|||
146435370|NCT00787254|528098626|FG000|Overall Study|Institution closed|1|||
146435371|NCT00787254|528098627|FG001|Overall Study|Institution closed|0|||
146435372|NCT00787254|528098626|FG000|Overall Study|Physician Decision|4|||
146435373|NCT00787254|528098627|FG001|Overall Study|Physician Decision|8|||
146435374|NCT03761173|528098628|FG000|Overall Study|Lost to Follow-up|93|||
146435375|NCT03761173|528098628|FG000|Overall Study|Withdrawal by Subject|74|||
146435376|NCT03761173|528098628|FG000|Overall Study|Death|45|||
146435377|NCT03761173|528098628|FG000|Overall Study|Withdrawal for Other Reasons|29|||
146435378|NCT03761173|528098628|FG000|Overall Study|Protocol Violation|1|||
146435379|NCT00316186|528098629|FG000|Overall Study|Adverse Event|6|||
146435380|NCT00316186|528098629|FG000|Overall Study|Disease Progression|4|||
146435381|NCT00316186|528098629|FG000|Overall Study|Lost to Follow-up|1|||
146435382|NCT00316186|528098629|FG000|Overall Study|Other|1|||
146435383|NCT00594035|528100510|FG000|Overall Study|Lost to Follow-up|1|||
146435384|NCT00594035|528100511|FG001|Overall Study|Lost to Follow-up|1|||
146435385|NCT00594035|528100510|FG000|Overall Study|Withdrawal by Subject|1|||
146435386|NCT00594035|528100511|FG001|Overall Study|Withdrawal by Subject|0|||
146435387|NCT00594035|528100510|FG000|Overall Study|Subject transferred to nursing home|0|||
146435388|NCT00594035|528100511|FG001|Overall Study|Subject transferred to nursing home|1|||
146435389|NCT00594035|528100510|FG000|Overall Study|Subject couldn't return due to job|0|||
146435390|NCT00594035|528100511|FG001|Overall Study|Subject couldn't return due to job|1|||
146435391|NCT00795821|528100512|FG000|Acute Treatment Phase|Adverse Event|23|||
146435392|NCT00795821|528100513|FG001|Acute Treatment Phase|Adverse Event|4|||
146435393|NCT00795821|528100512|FG000|Acute Treatment Phase|Death|1|||
146435394|NCT00795821|528100513|FG001|Acute Treatment Phase|Death|0|||
146435395|NCT00795821|528100512|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
146435396|NCT00795821|528100513|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
146435397|NCT00795821|528100512|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
146435398|NCT00795821|528100513|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
146435399|NCT00795821|528100512|FG000|Acute Treatment Phase|Physician Decision|1|||
146435400|NCT00795821|528100513|FG001|Acute Treatment Phase|Physician Decision|1|||
146435401|NCT00795821|528100512|FG000|Acute Treatment Phase|Protocol Violation|1|||
146435402|NCT00795821|528100513|FG001|Acute Treatment Phase|Protocol Violation|2|||
146435403|NCT00795821|528100512|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
146435404|NCT00795821|528100513|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
146435405|NCT00795821|528100512|FG000|Long-term Extension Phase|Adverse Event|25|||
146435406|NCT00795821|528100513|FG001|Long-term Extension Phase|Adverse Event|32|||
146435407|NCT00795821|528100512|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
146435408|NCT00795821|528100513|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
146435409|NCT00795821|528100512|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
146435410|NCT00795821|528100513|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
145951693|NCT04304508|526335711|FG002|Overall Study|Death|8|||
146435411|NCT00795821|528100512|FG000|Long-term Extension Phase|Physician Decision|1|||
146435412|NCT00795821|528100513|FG001|Long-term Extension Phase|Physician Decision|2|||
146435413|NCT00795821|528100512|FG000|Long-term Extension Phase|Protocol Violation|3|||
146435414|NCT00795821|528100513|FG001|Long-term Extension Phase|Protocol Violation|5|||
146435415|NCT00795821|528100512|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
146435416|NCT00795821|528100513|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
146435417|NCT00795821|528100512|FG000|Taper Phase|Adverse Event|2|||
146435418|NCT00795821|528100513|FG001|Taper Phase|Adverse Event|0|||
146435419|NCT00795821|528100512|FG000|Taper Phase|Lost to Follow-up|1|||
146435420|NCT00795821|528100513|FG001|Taper Phase|Lost to Follow-up|0|||
146435421|NCT00795821|528100512|FG000|Taper Phase|Physician Decision|2|||
146435422|NCT00795821|528100513|FG001|Taper Phase|Physician Decision|0|||
146435423|NCT00795821|528100512|FG000|Taper Phase|Withdrawal by Subject|4|||
146435424|NCT00795821|528100513|FG001|Taper Phase|Withdrawal by Subject|0|||
146435425|NCT00712959|528100520|FG000|Overall Study|Protocol Violation|3|||
146435426|NCT00712959|528100521|FG001|Overall Study|Protocol Violation|1|||
146435427|NCT00712959|528100520|FG000|Overall Study|Lost to Follow-up|13|||
146435428|NCT00712959|528100521|FG001|Overall Study|Lost to Follow-up|2|||
146435429|NCT00712959|528100520|FG000|Overall Study|Withdrawal by Subject|3|||
146435430|NCT00712959|528100521|FG001|Overall Study|Withdrawal by Subject|0|||
146435431|NCT02255149|528100522|FG000|Overall Study|Lost to Follow-up|2|||
146435432|NCT02255149|528100522|FG000|Overall Study|Withdrawal by Subject|1|||
146435433|NCT02255149|528100522|FG000|Overall Study|Withdrawal by PI|1|||
146435434|NCT02255149|528100522|FG000|Overall Study|Implant Failure|1|||
146435435|NCT02301975|528100532|FG000|Overall Study|Adverse Event|8|||
146435436|NCT02301975|528100533|FG001|Overall Study|Adverse Event|3|||
146435437|NCT02301975|528100534|FG002|Overall Study|Adverse Event|2|||
146435438|NCT02301975|528100532|FG000|Overall Study|Lack of Efficacy|1|||
146435439|NCT02301975|528100533|FG001|Overall Study|Lack of Efficacy|1|||
146435440|NCT02301975|528100534|FG002|Overall Study|Lack of Efficacy|1|||
146435441|NCT02301975|528100532|FG000|Overall Study|Protocol Violation|3|||
146435442|NCT02301975|528100533|FG001|Overall Study|Protocol Violation|5|||
146435443|NCT02301975|528100534|FG002|Overall Study|Protocol Violation|3|||
146435444|NCT02301975|528100532|FG000|Overall Study|Lost to Follow-up|0|||
146207914|NCT00807937|527276424|FG000|Overall Study|Lost to Follow-up|4|||
146435445|NCT02301975|528100533|FG001|Overall Study|Lost to Follow-up|2|||
146435446|NCT02301975|528100534|FG002|Overall Study|Lost to Follow-up|2|||
146435447|NCT02301975|528100532|FG000|Overall Study|Physician Decision|4|||
146435448|NCT02301975|528100533|FG001|Overall Study|Physician Decision|2|||
146435449|NCT02301975|528100534|FG002|Overall Study|Physician Decision|3|||
146435450|NCT02301975|528100532|FG000|Overall Study|Withdrawal by Subject|15|||
146435451|NCT02301975|528100533|FG001|Overall Study|Withdrawal by Subject|12|||
146435452|NCT02301975|528100534|FG002|Overall Study|Withdrawal by Subject|11|||
146435453|NCT04278560|528100536|FG000|Overall Study|Adverse Event|1|||
146435454|NCT04278560|528100537|FG001|Overall Study|Adverse Event|2|||
146435455|NCT04278560|528100536|FG000|Overall Study|Withdrawal by Subject|0|||
146435456|NCT04278560|528100537|FG001|Overall Study|Withdrawal by Subject|1|||
146435457|NCT00163657|528100538|FG000|Overall Study|Death|12|||
146207915|NCT00807937|527276425|FG001|Overall Study|Lost to Follow-up|0|||
146207916|NCT00807937|527276426|FG002|Overall Study|Lost to Follow-up|2|||
146207917|NCT00807937|527276427|FG003|Overall Study|Lost to Follow-up|1|||
146207918|NCT00807937|527276424|FG000|Overall Study|Lack of Efficacy|0|||
146435458|NCT00163657|528100539|FG001|Overall Study|Death|14|||
146435459|NCT00163657|528100540|FG002|Overall Study|Death|19|||
146207919|NCT00807937|527276425|FG001|Overall Study|Lack of Efficacy|0|||
146207920|NCT00807937|527276426|FG002|Overall Study|Lack of Efficacy|1|||
146435460|NCT00163657|528100538|FG000|Overall Study|graft loss|4|||
146435461|NCT00163657|528100539|FG001|Overall Study|graft loss|1|||
146435462|NCT00163657|528100540|FG002|Overall Study|graft loss|2|||
146207921|NCT00807937|527276427|FG003|Overall Study|Lack of Efficacy|2|||
146207922|NCT00807937|527276424|FG000|Overall Study|Intake of prohibited medicine|0|||
146435463|NCT00163657|528100538|FG000|Overall Study|Withdrawal by Subject|2|||
146435464|NCT00163657|528100539|FG001|Overall Study|Withdrawal by Subject|3|||
146435465|NCT00163657|528100540|FG002|Overall Study|Withdrawal by Subject|2|||
146435466|NCT00163657|528100538|FG000|Overall Study|Physician Decision|0|||
146435467|NCT00163657|528100539|FG001|Overall Study|Physician Decision|1|||
146435468|NCT00163657|528100540|FG002|Overall Study|Physician Decision|1|||
146435469|NCT00163657|528100538|FG000|Overall Study|Non Compliance|1|||
146435470|NCT00163657|528100539|FG001|Overall Study|Non Compliance|0|||
146435471|NCT00163657|528100540|FG002|Overall Study|Non Compliance|0|||
146435472|NCT00163657|528100538|FG000|Overall Study|Lost to Follow-up|1|||
146435473|NCT00163657|528100539|FG001|Overall Study|Lost to Follow-up|3|||
146435474|NCT00163657|528100540|FG002|Overall Study|Lost to Follow-up|10|||
146435475|NCT00163657|528100538|FG000|Overall Study|Other reason|0|||
146435476|NCT00163657|528100539|FG001|Overall Study|Other reason|1|||
146435477|NCT00163657|528100540|FG002|Overall Study|Other reason|3|||
146435478|NCT01319383|528100543|FG000|Overall Study|No ex vivo or in vivo response|4|||
146435479|NCT01319383|528100544|FG001|Overall Study|No ex vivo or in vivo response|0|||
146435480|NCT01319383|528100543|FG000|Overall Study|Physician Decision|3|||
146435481|NCT01319383|528100544|FG001|Overall Study|Physician Decision|0|||
146435482|NCT01319383|528100543|FG000|Overall Study|Lack of Efficacy|5|||
146435483|NCT01319383|528100544|FG001|Overall Study|Lack of Efficacy|9|||
146435484|NCT01319383|528100543|FG000|Overall Study|No in vivo response to interval doses|0|||
146435485|NCT01319383|528100544|FG001|Overall Study|No in vivo response to interval doses|1|||
146435486|NCT01531894|528100547|FG000|Overall Study|Physician Decision|8|||
146435487|NCT01531894|528100547|FG000|Overall Study|Death|1|||
146435488|NCT03086460|528100548|FG000|Study Participants|Lost to Follow-up|2|||
146435489|NCT03086460|528100548|FG000|Study Participants|Protocol Violation|1|||
146435490|NCT03086460|528100548|FG000|Study Participants|Withdrawal by Subject|6|||
146435491|NCT03086460|528100548|FG000|Treatment A|Lost to Follow-up|1|||
146435492|NCT03086460|528100548|FG000|Treatment A|Protocol Violation|1|||
146435493|NCT03086460|528100548|FG000|Treatment A|Withdrawal by Subject|2|||
146435494|NCT03086460|528100548|FG000|Treatment C|Withdrawal by Subject|2|||
146435495|NCT03086460|528100548|FG000|Treatment E|Lost to Follow-up|1|||
146435496|NCT03086460|528100548|FG000|Treatment E|Withdrawal by Subject|3|||
146435497|NCT03600805|528100557|FG000|Overall Study|Adverse Event|2|||
146435498|NCT03600805|528100558|FG001|Overall Study|Adverse Event|1|||
146435499|NCT03600805|528100559|FG002|Overall Study|Adverse Event|1|||
146435500|NCT03600805|528100560|FG003|Overall Study|Adverse Event|7|||
146435501|NCT03600805|528100557|FG000|Overall Study|Lack of Efficacy|2|||
146435502|NCT03600805|528100558|FG001|Overall Study|Lack of Efficacy|1|||
146435503|NCT03600805|528100559|FG002|Overall Study|Lack of Efficacy|0|||
146435504|NCT03600805|528100560|FG003|Overall Study|Lack of Efficacy|0|||
146435505|NCT03600805|528100557|FG000|Overall Study|Withdrawal by Subject|1|||
146435506|NCT03600805|528100558|FG001|Overall Study|Withdrawal by Subject|0|||
146435507|NCT03600805|528100559|FG002|Overall Study|Withdrawal by Subject|0|||
146435508|NCT03600805|528100560|FG003|Overall Study|Withdrawal by Subject|1|||
146435509|NCT03600805|528100557|FG000|Overall Study|Other unspecified|14|||
146435510|NCT03600805|528100558|FG001|Overall Study|Other unspecified|6|||
146435511|NCT03600805|528100559|FG002|Overall Study|Other unspecified|7|||
146435512|NCT03600805|528100560|FG003|Overall Study|Other unspecified|11|||
146435513|NCT06195579|528100561|FG000|Overall Study|Withdrawal by Subject|1|||
146435514|NCT03123094|528100563|FG000|Overall Study|Withdrawal by Subject|0|||
146435515|NCT03123094|528100564|FG001|Overall Study|Withdrawal by Subject|2|||
146435516|NCT03123094|528100565|FG002|Overall Study|Withdrawal by Subject|1|||
146435517|NCT03123094|528100566|FG003|Overall Study|Withdrawal by Subject|0|||
146435518|NCT03123094|528100567|FG004|Overall Study|Withdrawal by Subject|1|||
146435519|NCT01735994|528100568|FG000|Overall Study|Withdrawal by Subject|6|||
145951694|NCT04304508|526335712|FG003|Overall Study|Death|5|||
145951695|NCT04304508|526335709|FG000|Overall Study|Non-compliance With Study Drug|3|||
145951696|NCT04304508|526335710|FG001|Overall Study|Non-compliance With Study Drug|1|||
145951697|NCT04304508|526335711|FG002|Overall Study|Non-compliance With Study Drug|2|||
145951698|NCT04304508|526335712|FG003|Overall Study|Non-compliance With Study Drug|0|||
145951699|NCT04304508|526335709|FG000|Overall Study|Switching To Other Therapy|1|||
145951700|NCT04304508|526335710|FG001|Overall Study|Switching To Other Therapy|1|||
145951701|NCT04304508|526335711|FG002|Overall Study|Switching To Other Therapy|1|||
145951702|NCT04304508|526335712|FG003|Overall Study|Switching To Other Therapy|2|||
145951703|NCT04304508|526335709|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
145951704|NCT04304508|526335710|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
146435520|NCT01735994|528100569|FG001|Overall Study|Withdrawal by Subject|4|||
146435521|NCT01735994|528100568|FG000|Overall Study|Injury|2|||
146435522|NCT01735994|528100569|FG001|Overall Study|Injury|0|||
146435523|NCT01735994|528100568|FG000|Overall Study|Kicked off team|5|||
146435524|NCT01735994|528100569|FG001|Overall Study|Kicked off team|0|||
146435525|NCT01735994|528100568|FG000|Overall Study|Lost to Follow-up|50|||
146435526|NCT01735994|528100569|FG001|Overall Study|Lost to Follow-up|62|||
146435527|NCT00736190|528100571|FG000|Overall Study|Pregnancy|1|||
145951705|NCT04304508|526335711|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
146435528|NCT00736190|528100571|FG000|Overall Study|Withdrawal by Subject|1|||
146435529|NCT00736190|528100571|FG000|Overall Study|Adverse Event|1|||
146435530|NCT03128723|528100575|FG000|Overall Study|Withdrawal by Subject|2|||
146207923|NCT00807937|527276425|FG001|Overall Study|Intake of prohibited medicine|0|||
146207924|NCT00807937|527276426|FG002|Overall Study|Intake of prohibited medicine|2|||
146207925|NCT00807937|527276427|FG003|Overall Study|Intake of prohibited medicine|0|||
146435531|NCT02909907|528100577|FG000|Overall Study|Withdrawal by Subject|0|||
146435532|NCT02909907|528100578|FG001|Overall Study|Withdrawal by Subject|1|||
146435533|NCT00395694|528100584|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
146435534|NCT00395694|528100585|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
146435535|NCT00395694|528100584|FG000|Continuation Phase|Adverse Event|1|||
146435536|NCT00395694|528100585|FG001|Continuation Phase|Adverse Event|0|||
146435537|NCT00395694|528100584|FG000|Continuation Phase|Lack of Efficacy|12|||
146435538|NCT00395694|528100585|FG001|Continuation Phase|Lack of Efficacy|11|||
146435539|NCT00395694|528100584|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
146435540|NCT00395694|528100585|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
146435541|NCT00395694|528100584|FG000|Continuation Phase|Poor Compliance|1|||
146435542|NCT00395694|528100585|FG001|Continuation Phase|Poor Compliance|0|||
146435543|NCT00395694|528100584|FG000|Continuation Phase|Withdrawal by Subject|0|||
146435544|NCT00395694|528100585|FG001|Continuation Phase|Withdrawal by Subject|2|||
146435545|NCT02849457|528100586|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
146435546|NCT02849457|528100587|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
146435547|NCT02849457|528100588|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
146435548|NCT02849457|528100589|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
146435549|NCT02699866|528100590|FG000|Overall Study|Withdrawal by Subject|3|||
146435550|NCT02699866|528100590|FG000|Overall Study|Physician Decision|2|||
146435551|NCT02699866|528100590|FG000|Overall Study|Adverse Event|3|||
146435552|NCT04238754|528100594|FG000|Washout - 1 Week|Lost to Follow-up|1|||
146435553|NCT04238754|528100595|FG001|Washout - 1 Week|Lost to Follow-up|0|||
146435554|NCT01294917|528100598|FG000|Overall Study|Relocation|5|||
146435555|NCT01294917|528100598|FG000|Overall Study|Inconvenience|1|||
146207926|NCT00807937|527276424|FG000|Overall Study|All other reasons (not provided)|2|||
146207927|NCT00807937|527276425|FG001|Overall Study|All other reasons (not provided)|4|||
146435556|NCT03406156|528100600|FG000|Overall Study|Death|9|||
146435557|NCT03406156|528100601|FG001|Overall Study|Death|3|||
146435558|NCT03406156|528100600|FG000|Overall Study|Withdrawal by Subject|1|||
146435559|NCT03406156|528100601|FG001|Overall Study|Withdrawal by Subject|2|||
146435560|NCT03406156|528100600|FG000|Overall Study|COVID-19 infection|1|||
146435561|NCT03406156|528100601|FG001|Overall Study|COVID-19 infection|0|||
146435562|NCT03406156|528100600|FG000|Overall Study|Non-compliance with study procedures|1|||
146435563|NCT03406156|528100601|FG001|Overall Study|Non-compliance with study procedures|1|||
146435564|NCT03406156|528100600|FG000|Overall Study|Lost to Follow-up|0|||
146435565|NCT03406156|528100601|FG001|Overall Study|Lost to Follow-up|2|||
146435566|NCT03406156|528100600|FG000|Overall Study|Other, not specified|72|||
146435567|NCT03406156|528100601|FG001|Overall Study|Other, not specified|28|||
146435568|NCT00835536|528100602|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
146435569|NCT00835536|528100603|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
146435570|NCT03123471|528100604|FG000|Placebo-controlled Phase|Adverse Event|3|||
146435571|NCT03123471|528100605|FG001|Placebo-controlled Phase|Adverse Event|8|||
146435572|NCT03123471|528100604|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
146435573|NCT03123471|528100605|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
146435574|NCT03123471|528100604|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
146435575|NCT03123471|528100605|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
146435576|NCT03123471|528100604|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
146435577|NCT03123471|528100605|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
146435578|NCT03123471|528100604|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
146435579|NCT03123471|528100605|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
146435580|NCT03123471|528100604|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
146435581|NCT03123471|528100605|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
146435582|NCT03123471|528100604|FG000|Placebo-controlled Phase|Miscellaneous|0|||
146435583|NCT03123471|528100605|FG001|Placebo-controlled Phase|Miscellaneous|1|||
146435584|NCT03123471|528100604|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
146435585|NCT03123471|528100605|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
146435586|NCT03123471|528100604|FG000|Apremilast Extension Phase|Adverse Event|1|||
146435587|NCT03123471|528100605|FG001|Apremilast Extension Phase|Adverse Event|5|||
146435588|NCT03123471|528100604|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
146435589|NCT03123471|528100605|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
146435590|NCT03123471|528100604|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
146435591|NCT03123471|528100605|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
145951706|NCT04304508|526335712|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
146435592|NCT01686477|528100608|FG000|Feeding Intervention|Death|1|||
146435593|NCT01686477|528100609|FG001|Feeding Intervention|Death|0|||
146435594|NCT01686477|528100610|FG002|Feeding Intervention|Death|1|||
146435595|NCT01686477|528100608|FG000|Feeding Intervention|Withdrawal by Subject|0|||
146435596|NCT01686477|528100609|FG001|Feeding Intervention|Withdrawal by Subject|6|||
146435597|NCT01686477|528100610|FG002|Feeding Intervention|Withdrawal by Subject|0|||
146435598|NCT01686477|528100608|FG000|Feeding Intervention|Physician Decision|1|||
146435599|NCT01686477|528100609|FG001|Feeding Intervention|Physician Decision|2|||
146435600|NCT01686477|528100610|FG002|Feeding Intervention|Physician Decision|0|||
146435601|NCT01686477|528100608|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
146435602|NCT01686477|528100609|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
146435603|NCT01686477|528100610|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
146435604|NCT01686477|528100608|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
146435605|NCT01686477|528100609|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
146435606|NCT01686477|528100610|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
146435607|NCT01686477|528100608|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
146435608|NCT01686477|528100609|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
146435609|NCT01686477|528100610|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
146435610|NCT01686477|528100608|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
146435611|NCT01686477|528100609|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
146435612|NCT01686477|528100610|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
146435613|NCT01686477|528100608|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
146435614|NCT01686477|528100609|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
146435615|NCT01686477|528100610|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
146435616|NCT01686477|528100608|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
146435617|NCT01686477|528100609|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
146435618|NCT01686477|528100610|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
146435619|NCT01686477|528100608|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
146435620|NCT01686477|528100609|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
146435621|NCT01686477|528100610|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
146435622|NCT01249651|528100615|FG000|Overall Study|Withdrawal by Subject|4|||
146435623|NCT01249651|528100615|FG000|Overall Study|Adverse Event|1|||
146435624|NCT01249651|528100615|FG000|Overall Study|Protocol Violation|1|||
146435625|NCT01249651|528100615|FG000|Overall Study|Sponsor Decision|1|||
146435626|NCT00813592|528100616|FG000|Overall Study|Disease assessment was not completed per|2|||
146435627|NCT03873272|528100619|FG000|Overall Study|Withdrawal by Subject|2|||
146435628|NCT03873272|528100620|FG001|Overall Study|Withdrawal by Subject|0|||
146435629|NCT03873272|528100621|FG002|Overall Study|Withdrawal by Subject|1|||
146435630|NCT03873272|528100619|FG000|Overall Study|Death|0|||
146435631|NCT03873272|528100620|FG001|Overall Study|Death|2|||
146435632|NCT03873272|528100621|FG002|Overall Study|Death|1|||
146435633|NCT04544410|528100622|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146435634|NCT04544410|528100623|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146435635|NCT04544410|528100622|FG000|Double-blind Treatment Period|Adverse Event|1|||
146435636|NCT04544410|528100623|FG001|Double-blind Treatment Period|Adverse Event|0|||
146435637|NCT04544410|528100622|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146435638|NCT04544410|528100623|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146435639|NCT04544410|528100622|FG000|Double-blind Treatment Period|Protocol Violation|1|||
146435640|NCT04544410|528100623|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146435641|NCT04544410|528100622|FG000|Open-Label Treatment Period|Study Terminated|15|||
146435642|NCT04544410|528100623|FG001|Open-Label Treatment Period|Study Terminated|19|||
146435643|NCT04544410|528100622|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
146435644|NCT04544410|528100623|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
146435645|NCT04544410|528100622|FG000|Open-Label Treatment Period|Adverse Event|0|||
146435646|NCT04544410|528100623|FG001|Open-Label Treatment Period|Adverse Event|1|||
146435647|NCT04544410|528100622|FG000|Open-Label Treatment Period|Physician Decision|1|||
146435648|NCT04544410|528100623|FG001|Open-Label Treatment Period|Physician Decision|0|||
146435649|NCT04544410|528100622|FG000|Open-Label Treatment Period|Other|0|||
146435650|NCT04544410|528100623|FG001|Open-Label Treatment Period|Other|1|||
146435651|NCT02430480|528100624|FG000|Overall Study|Death|1|||
146435652|NCT02430480|528100624|FG000|Overall Study|Anesthesia concerns|1|||
146435653|NCT02430480|528100624|FG000|Overall Study|Progressed on treatment|1|||
146435654|NCT04493684|528100625|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
146435655|NCT04493684|528100626|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435656|NCT04493684|528100627|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
146435657|NCT04493684|528100628|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435658|NCT04493684|528100629|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435659|NCT04493684|528100630|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
146435660|NCT04493684|528100631|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435661|NCT04493684|528100632|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435662|NCT04493684|528100633|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435663|NCT04493684|528100634|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435664|NCT04493684|528100635|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435665|NCT04493684|528100636|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435666|NCT04493684|528100637|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435667|NCT04493684|528100638|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435668|NCT04493684|528100639|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435669|NCT04493684|528100640|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435670|NCT04493684|528100641|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
146435671|NCT04493684|528100625|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
146435672|NCT04493684|528100626|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435673|NCT04493684|528100627|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435674|NCT04493684|528100628|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435675|NCT04493684|528100629|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435676|NCT04493684|528100630|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435677|NCT04493684|528100631|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435678|NCT04493684|528100632|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435679|NCT04493684|528100633|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435680|NCT04493684|528100634|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435681|NCT04493684|528100635|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435682|NCT04493684|528100636|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435683|NCT04493684|528100637|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435684|NCT04493684|528100638|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435685|NCT04493684|528100639|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435686|NCT04493684|528100640|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435687|NCT04493684|528100641|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
146435688|NCT04493684|528100625|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435689|NCT04493684|528100626|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435690|NCT04493684|528100627|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146207928|NCT00807937|527276426|FG002|Overall Study|All other reasons (not provided)|0|||
146435691|NCT04493684|528100628|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435692|NCT04493684|528100629|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435693|NCT04493684|528100630|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435694|NCT04493684|528100631|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
146435695|NCT04493684|528100632|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435696|NCT04493684|528100633|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435697|NCT04493684|528100634|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146207929|NCT00807937|527276427|FG003|Overall Study|All other reasons (not provided)|1|||
146207930|NCT04629950|527276430|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
146435698|NCT04493684|528100635|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435699|NCT04493684|528100636|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435700|NCT04493684|528100637|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435701|NCT04493684|528100638|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435702|NCT04493684|528100639|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435703|NCT04493684|528100640|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435704|NCT04493684|528100641|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
146435705|NCT04493684|528100625|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
146435706|NCT04493684|528100626|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146207931|NCT04629950|527276431|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
146207932|NCT04629950|527276432|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
145951707|NCT04304508|526335709|FG000|Overall Study|Withdrawal by Subject|7|||
145951708|NCT04304508|526335710|FG001|Overall Study|Withdrawal by Subject|5|||
145951709|NCT04304508|526335711|FG002|Overall Study|Withdrawal by Subject|11|||
145951710|NCT04304508|526335712|FG003|Overall Study|Withdrawal by Subject|6|||
145951711|NCT04304508|526335709|FG000|Overall Study|Logistical Difficulties|2|||
145951712|NCT04304508|526335710|FG001|Overall Study|Logistical Difficulties|2|||
145951713|NCT04304508|526335711|FG002|Overall Study|Logistical Difficulties|3|||
145951714|NCT04304508|526335712|FG003|Overall Study|Logistical Difficulties|2|||
145951715|NCT04304508|526335709|FG000|Overall Study|Missing Information|1|||
145951716|NCT04304508|526335710|FG001|Overall Study|Missing Information|2|||
145951717|NCT04304508|526335711|FG002|Overall Study|Missing Information|1|||
145951718|NCT04304508|526335712|FG003|Overall Study|Missing Information|3|||
145951719|NCT04304508|526335709|FG000|Overall Study|Other|7|||
145951720|NCT04304508|526335710|FG001|Overall Study|Other|6|||
145951721|NCT04304508|526335711|FG002|Overall Study|Other|5|||
145951722|NCT04304508|526335712|FG003|Overall Study|Other|4|||
145951723|NCT04304508|526335709|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
145951724|NCT04304508|526335710|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145951725|NCT04304508|526335711|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145951726|NCT04304508|526335712|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145951727|NCT04304508|526335709|FG000|Overall Study|Physician Decision|3|||
145951728|NCT04304508|526335710|FG001|Overall Study|Physician Decision|4|||
145951729|NCT04304508|526335711|FG002|Overall Study|Physician Decision|9|||
145951730|NCT04304508|526335712|FG003|Overall Study|Physician Decision|7|||
145951731|NCT04304508|526335709|FG000|Overall Study|Study drug never administered|10|||
145951732|NCT04304508|526335710|FG001|Overall Study|Study drug never administered|4|||
145951733|NCT04304508|526335711|FG002|Overall Study|Study drug never administered|4|||
145951734|NCT04304508|526335712|FG003|Overall Study|Study drug never administered|4|||
145951735|NCT04304508|526335709|FG000|Overall Study|Adverse Event|49|||
145951736|NCT04304508|526335710|FG001|Overall Study|Adverse Event|50|||
145951737|NCT04304508|526335711|FG002|Overall Study|Adverse Event|51|||
145951738|NCT04304508|526335712|FG003|Overall Study|Adverse Event|56|||
145951739|NCT04304508|526335709|FG000|Overall Study|Lost to Follow-up|1|||
145951740|NCT04304508|526335710|FG001|Overall Study|Lost to Follow-up|5|||
145951741|NCT04304508|526335711|FG002|Overall Study|Lost to Follow-up|2|||
145951742|NCT04304508|526335712|FG003|Overall Study|Lost to Follow-up|3|||
145951743|NCT02688764|526335719|FG000|Overall Study|Adverse Event|3|||
145951744|NCT02688764|526335720|FG001|Overall Study|Adverse Event|3|||
145951745|NCT02688764|526335719|FG000|Overall Study|AE/Kidney transplant|1|||
145951746|NCT02688764|526335720|FG001|Overall Study|AE/Kidney transplant|0|||
145951747|NCT02688764|526335719|FG000|Overall Study|AE/Lack of efficacy|1|||
145951748|NCT02688764|526335720|FG001|Overall Study|AE/Lack of efficacy|0|||
145951749|NCT02688764|526335719|FG000|Overall Study|AE/Non-compl.|1|||
145951750|NCT02688764|526335720|FG001|Overall Study|AE/Non-compl.|0|||
145951751|NCT02688764|526335719|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
145951752|NCT02688764|526335720|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
145951753|NCT02688764|526335719|FG000|Overall Study|AE/Other|0|||
145951754|NCT02688764|526335720|FG001|Overall Study|AE/Other|1|||
145951755|NCT02688764|526335719|FG000|Overall Study|AE/Physician decision|1|||
145951756|NCT02688764|526335720|FG001|Overall Study|AE/Physician decision|0|||
145951757|NCT02688764|526335719|FG000|Overall Study|AE/Withd. parent|3|||
145951758|NCT02688764|526335720|FG001|Overall Study|AE/Withd. parent|0|||
145951759|NCT02688764|526335719|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
145951760|NCT02688764|526335720|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
145951761|NCT02688764|526335719|FG000|Overall Study|AE/Withd. subject|1|||
145951762|NCT02688764|526335720|FG001|Overall Study|AE/Withd. subject|0|||
145951763|NCT02688764|526335719|FG000|Overall Study|Kidney transplant|10|||
145951764|NCT02688764|526335720|FG001|Overall Study|Kidney transplant|4|||
145951765|NCT02688764|526335719|FG000|Overall Study|Lack of Efficacy|3|||
145951766|NCT02688764|526335720|FG001|Overall Study|Lack of Efficacy|2|||
145951767|NCT02688764|526335719|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
145951768|NCT02688764|526335720|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
145951769|NCT02688764|526335719|FG000|Overall Study|Non-compliance with study drug|4|||
145951770|NCT02688764|526335720|FG001|Overall Study|Non-compliance with study drug|0|||
145951771|NCT02688764|526335719|FG000|Overall Study|Non-compl./Physician decision|2|||
145951772|NCT02688764|526335720|FG001|Overall Study|Non-compl./Physician decision|0|||
145951773|NCT02688764|526335719|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
146435707|NCT04493684|528100627|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145951774|NCT02688764|526335720|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
145951775|NCT02688764|526335719|FG000|Overall Study|Non-compl./Withd. subject|0|||
145951776|NCT02688764|526335720|FG001|Overall Study|Non-compl./Withd. subject|2|||
145951777|NCT02688764|526335719|FG000|Overall Study|Phosphorus level outside safe range|0|||
145951778|NCT02688764|526335720|FG001|Overall Study|Phosphorus level outside safe range|1|||
145951779|NCT02688764|526335719|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
145951780|NCT02688764|526335720|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
146435708|NCT04493684|528100628|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145951781|NCT02688764|526335719|FG000|Overall Study|Study drug taste/Withd. parent|1|||
145951782|NCT02688764|526335720|FG001|Overall Study|Study drug taste/Withd. parent|0|||
145951783|NCT02688764|526335719|FG000|Overall Study|Subject moving out|2|||
145951784|NCT02688764|526335720|FG001|Overall Study|Subject moving out|0|||
145951785|NCT02688764|526335719|FG000|Overall Study|Subject taken off dialysis|1|||
145951786|NCT02688764|526335720|FG001|Overall Study|Subject taken off dialysis|0|||
145951787|NCT02688764|526335719|FG000|Overall Study|Withdrawal by parent|3|||
145951788|NCT02688764|526335720|FG001|Overall Study|Withdrawal by parent|0|||
145951789|NCT02113007|526335721|FG000|Overall Study|Progressive disease|2|||
145951790|NCT00885378|526335722|FG000|Overall Study|Lack of Efficacy|2|||
145951791|NCT00885378|526335723|FG001|Overall Study|Lack of Efficacy|2|||
145951792|NCT00885378|526335722|FG000|Overall Study|Withdrawal by Subject|1|||
145951793|NCT00885378|526335723|FG001|Overall Study|Withdrawal by Subject|2|||
146435709|NCT04493684|528100629|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435710|NCT04493684|528100630|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435711|NCT04493684|528100631|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435712|NCT04493684|528100632|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435713|NCT04493684|528100633|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435714|NCT04493684|528100634|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435715|NCT04493684|528100635|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435716|NCT04493684|528100636|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435717|NCT04493684|528100637|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435718|NCT04493684|528100638|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435719|NCT04493684|528100639|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435720|NCT04493684|528100640|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435721|NCT04493684|528100641|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
146435722|NCT04493684|528100625|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435723|NCT04493684|528100626|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435724|NCT04493684|528100627|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435725|NCT04493684|528100628|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435726|NCT04493684|528100629|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435727|NCT04493684|528100630|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
146435728|NCT04493684|528100631|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435729|NCT04493684|528100632|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435730|NCT04493684|528100633|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435731|NCT04493684|528100634|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435732|NCT04493684|528100635|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435733|NCT04493684|528100636|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435734|NCT04493684|528100637|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435735|NCT04493684|528100638|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435736|NCT04493684|528100639|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435737|NCT04493684|528100640|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435738|NCT04493684|528100641|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
146435739|NCT04493684|528100625|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435740|NCT04493684|528100626|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435741|NCT04493684|528100627|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435742|NCT04493684|528100628|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435743|NCT04493684|528100629|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435744|NCT04493684|528100630|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435745|NCT04493684|528100631|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435746|NCT04493684|528100632|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435747|NCT04493684|528100633|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435748|NCT04493684|528100634|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435749|NCT04493684|528100635|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435750|NCT04493684|528100636|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
146435751|NCT04493684|528100637|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435752|NCT04493684|528100638|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145951794|NCT00885378|526335722|FG000|Overall Study|Lost to Follow-up|1|||
146082990|NCT01215916|526824722|FG006|Overall Study|Withdrawal by Subject|1|||
146082991|NCT01215916|526824723|FG007|Overall Study|Withdrawal by Subject|0|||
145951795|NCT00885378|526335723|FG001|Overall Study|Lost to Follow-up|2|||
145951796|NCT00885378|526335722|FG000|Overall Study|Poor/Noncompliance|2|||
145951797|NCT00885378|526335723|FG001|Overall Study|Poor/Noncompliance|2|||
145951798|NCT00885378|526335722|FG000|Overall Study|Protocol Violation|2|||
146082992|NCT01215916|526824724|FG008|Overall Study|Withdrawal by Subject|0|||
146435753|NCT04493684|528100639|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435754|NCT04493684|528100640|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435755|NCT04493684|528100641|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
146435756|NCT04493684|528100625|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435757|NCT04493684|528100626|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435758|NCT04493684|528100627|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435759|NCT04493684|528100628|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435760|NCT04493684|528100629|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435761|NCT04493684|528100630|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435762|NCT04493684|528100631|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435763|NCT04493684|528100632|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435764|NCT04493684|528100633|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435765|NCT04493684|528100634|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435766|NCT04493684|528100635|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435767|NCT04493684|528100636|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435768|NCT04493684|528100637|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435769|NCT04493684|528100638|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435770|NCT04493684|528100639|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435771|NCT04493684|528100640|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
146435772|NCT04493684|528100641|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
146435773|NCT04493684|528100625|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435774|NCT04493684|528100626|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435775|NCT04493684|528100627|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435776|NCT04493684|528100628|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435777|NCT04493684|528100629|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435778|NCT04493684|528100630|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435779|NCT04493684|528100631|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435780|NCT04493684|528100632|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435781|NCT04493684|528100633|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435782|NCT04493684|528100634|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435783|NCT04493684|528100635|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435784|NCT04493684|528100636|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435785|NCT04493684|528100637|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435786|NCT04493684|528100638|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435787|NCT04493684|528100639|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435788|NCT04493684|528100640|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
146082993|NCT01215916|526824716|FG000|Overall Study|Death|0|||
146435789|NCT04493684|528100641|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
146435790|NCT01963728|528100642|FG000|Overall Study|Study terminated early|0|||
146435791|NCT01963728|528100643|FG001|Overall Study|Study terminated early|1|||
146435792|NCT05152576|528100646|FG000|Overall Study|Lost to Follow-up|3|||
146435793|NCT05152576|528100647|FG001|Overall Study|Lost to Follow-up|0|||
146207933|NCT04629950|527276433|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
146435794|NCT05152576|528100648|FG002|Overall Study|Lost to Follow-up|0|||
145951799|NCT00885378|526335723|FG001|Overall Study|Protocol Violation|0|||
146435795|NCT05152576|528100649|FG003|Overall Study|Lost to Follow-up|1|||
146435796|NCT05152576|528100646|FG000|Overall Study|Withdrawal by Subject|0|||
146435797|NCT05152576|528100647|FG001|Overall Study|Withdrawal by Subject|1|||
146435798|NCT05152576|528100648|FG002|Overall Study|Withdrawal by Subject|0|||
146435799|NCT05152576|528100649|FG003|Overall Study|Withdrawal by Subject|1|||
146435800|NCT05152576|528100646|FG000|Overall Study|Other|2|||
146435801|NCT05152576|528100647|FG001|Overall Study|Other|0|||
146435802|NCT05152576|528100648|FG002|Overall Study|Other|0|||
146435803|NCT05152576|528100649|FG003|Overall Study|Other|0|||
146435804|NCT00859430|528100650|FG000|First Intervention|Withdrawal by Subject|0|||
146435805|NCT00859430|528100651|FG001|First Intervention|Withdrawal by Subject|1|||
146435806|NCT01660243|528102016|FG000|Overall Study|Adverse Event|1|||
146435807|NCT01660243|528102017|FG001|Overall Study|Adverse Event|0|||
146435808|NCT01660243|528102018|FG002|Overall Study|Adverse Event|1|||
146435809|NCT01660243|528102019|FG003|Overall Study|Adverse Event|0|||
146435810|NCT01660243|528102016|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
146435811|NCT01660243|528102017|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
146435812|NCT01660243|528102018|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
146435813|NCT01660243|528102019|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
146435814|NCT01660243|528102016|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
146435815|NCT01660243|528102017|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
146435816|NCT01660243|528102018|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
146207934|NCT04629950|527276430|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146207935|NCT04629950|527276431|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
146207936|NCT04629950|527276432|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146207937|NCT04629950|527276433|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
146207938|NCT04629950|527276430|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146207939|NCT04629950|527276431|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
146435817|NCT01660243|528102019|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
146435818|NCT01660243|528102016|FG000|Overall Study|Randomization error|0|||
145951800|NCT04750278|526335724|FG000|Overall Study|Death|9|||
145951801|NCT04750278|526335725|FG001|Overall Study|Death|10|||
145951802|NCT04750278|526335726|FG002|Overall Study|Death|10|||
145951803|NCT04750278|526335724|FG000|Overall Study|Withdrawal by Subject|4|||
145951804|NCT04750278|526335725|FG001|Overall Study|Withdrawal by Subject|1|||
145951805|NCT04750278|526335726|FG002|Overall Study|Withdrawal by Subject|2|||
146207940|NCT04629950|527276432|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146207941|NCT04629950|527276433|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
146207942|NCT04629950|527276430|FG000|Extension Study|Withdrawal by Subject|0|||
146207943|NCT04629950|527276431|FG001|Extension Study|Withdrawal by Subject|0|||
146207944|NCT04629950|527276432|FG002|Extension Study|Withdrawal by Subject|1|||
146207945|NCT04629950|527276433|FG003|Extension Study|Withdrawal by Subject|0|||
146207946|NCT04629950|527276430|FG000|Extension Study|Adverse Event|0|||
146435819|NCT01660243|528102017|FG001|Overall Study|Randomization error|0|||
145951806|NCT04750278|526335724|FG000|Overall Study|Lost to Follow-up|1|||
145951807|NCT04750278|526335725|FG001|Overall Study|Lost to Follow-up|1|||
146207947|NCT04629950|527276431|FG001|Extension Study|Adverse Event|0|||
146207948|NCT04629950|527276432|FG002|Extension Study|Adverse Event|0|||
146207949|NCT04629950|527276433|FG003|Extension Study|Adverse Event|1|||
146207950|NCT03233633|527276434|FG000|Overall Study|Adverse Event|2|||
146207951|NCT03233633|527276434|FG000|Overall Study|Less Than 3 Days of Data|6|||
146207952|NCT02088853|527276435|FG000|Overall Study|Pregnancy|1|||
146207953|NCT02088853|527276436|FG001|Overall Study|Pregnancy|0|||
146207954|NCT00580866|527276437|FG000|Overall Study|Lost to Follow-up|2|||
146207955|NCT00580866|527276438|FG001|Overall Study|Lost to Follow-up|2|||
146207956|NCT00609336|527276439|FG000|Overall Study|Protocol Violation|3|||
146207957|NCT00609336|527276439|FG000|Overall Study|Death|1|||
146435820|NCT01660243|528102018|FG002|Overall Study|Randomization error|0|||
146207958|NCT00609336|527276439|FG000|Overall Study|LA or Met at Surgery|9|||
146207959|NCT00068601|527276440|FG000|Overall Study|Ineligible|11|||
146207960|NCT00068601|527276441|FG001|Overall Study|Ineligible|13|||
146207961|NCT00068601|527276440|FG000|Overall Study|Not evaluable: withdrew consent|5|||
146207962|NCT00068601|527276441|FG001|Overall Study|Not evaluable: withdrew consent|4|||
146435821|NCT01660243|528102019|FG003|Overall Study|Randomization error|1|||
146207963|NCT00068601|527276440|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
146207964|NCT00068601|527276441|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
146207965|NCT00068601|527276440|FG000|Overall Study|Death|11|||
145951808|NCT04750278|526335726|FG002|Overall Study|Lost to Follow-up|1|||
145951809|NCT04750278|526335724|FG000|Overall Study|Pregnancy|1|||
145951810|NCT04750278|526335725|FG001|Overall Study|Pregnancy|0|||
145951811|NCT04750278|526335726|FG002|Overall Study|Pregnancy|0|||
145951812|NCT04750278|526335724|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
145951813|NCT04750278|526335725|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
145951814|NCT04750278|526335726|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
145951815|NCT04750278|526335724|FG000|Overall Study|Non-compliance|0|||
145951816|NCT04750278|526335725|FG001|Overall Study|Non-compliance|0|||
145951817|NCT04750278|526335726|FG002|Overall Study|Non-compliance|1|||
145951818|NCT04750278|526335724|FG000|Overall Study|Transfer to Outside Facility|0|||
145951819|NCT04750278|526335725|FG001|Overall Study|Transfer to Outside Facility|2|||
145951820|NCT04750278|526335726|FG002|Overall Study|Transfer to Outside Facility|1|||
145951821|NCT04750278|526335724|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
145951822|NCT04750278|526335725|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
145951823|NCT04750278|526335726|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
145951824|NCT04750278|526335724|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
145951825|NCT04750278|526335725|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
145951826|NCT04750278|526335726|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
145951827|NCT01775787|526335727|FG000|First 7-10 Days|Adverse Event|0|||
145951828|NCT01775787|526335728|FG001|First 7-10 Days|Adverse Event|1|||
145951829|NCT01775787|526335727|FG000|First 7-10 Days|family emergency|0|||
145951830|NCT01775787|526335728|FG001|First 7-10 Days|family emergency|1|||
145951831|NCT01775787|526335727|FG000|First 7-10 Days|time commitment|0|||
145951832|NCT01775787|526335728|FG001|First 7-10 Days|time commitment|2|||
145951833|NCT01775787|526335727|FG000|First 7-10 Days|concerns with using IV|1|||
145951834|NCT01775787|526335728|FG001|First 7-10 Days|concerns with using IV|2|||
145951835|NCT01775787|526335727|FG000|Second 7-10 Days|time commitment|0|||
145951836|NCT01775787|526335728|FG001|Second 7-10 Days|time commitment|1|||
145951837|NCT01775787|526335727|FG000|Second 7-10 Days|concerns with using IV|0|||
145951838|NCT01775787|526335728|FG001|Second 7-10 Days|concerns with using IV|1|||
145951839|NCT01299896|526335729|FG000|Overall Study|Withdrawal by Subject|1|||
145951840|NCT01299896|526335730|FG001|Overall Study|Withdrawal by Subject|7|||
145951841|NCT01299896|526335729|FG000|Overall Study|Lost to Follow-up|0|||
145951842|NCT01299896|526335730|FG001|Overall Study|Lost to Follow-up|11|||
145951843|NCT01502956|526335735|FG000|Overall Study|Death|0|||
145951844|NCT01502956|526335736|FG001|Overall Study|Death|2|||
145951845|NCT01502956|526335735|FG000|Overall Study|Lost to Follow-up|14|||
145951846|NCT01502956|526335736|FG001|Overall Study|Lost to Follow-up|11|||
145951847|NCT01502956|526335735|FG000|Overall Study|Physician Decision|2|||
145951848|NCT01502956|526335736|FG001|Overall Study|Physician Decision|3|||
145951849|NCT01502956|526335735|FG000|Overall Study|Withdrawal by Subject|8|||
145951850|NCT01502956|526335736|FG001|Overall Study|Withdrawal by Subject|10|||
145951851|NCT01616758|526335737|FG000|Overall Study|Adverse Event|1|||
145951852|NCT01616758|526335737|FG000|Overall Study|Withdrawal by Subject|2|||
145951853|NCT01616758|526335737|FG000|Overall Study|Disease progression|18|||
145951854|NCT01616758|526335737|FG000|Overall Study|Study termination by Sponsor|1|||
146207966|NCT00068601|527276441|FG001|Overall Study|Death|3|||
146207967|NCT00068601|527276440|FG000|Overall Study|Lost to Follow-up|3|||
146207968|NCT00068601|527276441|FG001|Overall Study|Lost to Follow-up|2|||
146207969|NCT00068601|527276440|FG000|Overall Study|Missing primary outcome data|30|||
146207970|NCT00068601|527276441|FG001|Overall Study|Missing primary outcome data|34|||
146207971|NCT02692417|527276452|FG000|Overall Study|Withdrawal by Subject|5|||
146207972|NCT02692417|527276453|FG001|Overall Study|Withdrawal by Subject|1|||
146207973|NCT02692417|527276452|FG000|Overall Study|Adverse Event|1|||
146207974|NCT02692417|527276453|FG001|Overall Study|Adverse Event|0|||
146207975|NCT01803555|527276461|FG000|Overall Study|Adverse Event|3|||
146207976|NCT01803555|527276462|FG001|Overall Study|Adverse Event|2|||
146207977|NCT01803555|527276461|FG000|Overall Study|Withdrawal by Subject|3|||
146207978|NCT01803555|527276462|FG001|Overall Study|Withdrawal by Subject|3|||
146207979|NCT01803555|527276461|FG000|Overall Study|Non-compliance|1|||
146207980|NCT01803555|527276462|FG001|Overall Study|Non-compliance|1|||
145951855|NCT03026283|526335738|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
146207981|NCT01803555|527276461|FG000|Overall Study|Protocol Violation|3|||
145951856|NCT03026283|526335739|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
145951857|NCT03026283|526335740|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
146207982|NCT01803555|527276462|FG001|Overall Study|Protocol Violation|5|||
146207983|NCT01803555|527276461|FG000|Overall Study|Lost to Follow-up|0|||
146207984|NCT01803555|527276462|FG001|Overall Study|Lost to Follow-up|2|||
145951858|NCT03026283|526335741|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
145951859|NCT03026283|526335742|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
146207985|NCT01803555|527276461|FG000|Overall Study|Other than specified|3|||
146207986|NCT01803555|527276462|FG001|Overall Study|Other than specified|5|||
146207987|NCT01551355|527276463|FG000|Overall Study|Lost to Follow-up|51|||
146207988|NCT01551355|527276464|FG001|Overall Study|Lost to Follow-up|49|||
146435822|NCT02328040|528102037|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
145951860|NCT03026283|526335743|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
145951861|NCT03026283|526335744|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
145951862|NCT03026283|526335745|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
145951863|NCT03026283|526335738|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
145951864|NCT03026283|526335739|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
145951865|NCT03026283|526335740|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
145951866|NCT03026283|526335741|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
145951867|NCT03026283|526335742|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
145951868|NCT03026283|526335743|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
145951869|NCT03026283|526335744|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
145951870|NCT03026283|526335745|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
145951871|NCT03026283|526335738|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951872|NCT03026283|526335739|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
146435823|NCT02328040|528102038|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
146435824|NCT00604162|528102039|FG000|Overall Study|Physician Decision|3|||
146435825|NCT00604162|528102039|FG000|Overall Study|Withdrawal by Subject|1|||
146435826|NCT02682238|528102046|FG000|Overall Study|Lost to Follow-up|0|||
146435827|NCT02682238|528102047|FG001|Overall Study|Lost to Follow-up|2|||
146435828|NCT02682238|528102046|FG000|Overall Study|Withdrawal by Subject|1|||
146435829|NCT02682238|528102047|FG001|Overall Study|Withdrawal by Subject|0|||
146435830|NCT02682238|528102046|FG000|Overall Study|Adverse Event|1|||
146435831|NCT02682238|528102047|FG001|Overall Study|Adverse Event|0|||
145951873|NCT03026283|526335740|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951874|NCT03026283|526335741|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951875|NCT03026283|526335742|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951876|NCT03026283|526335743|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951877|NCT03026283|526335744|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951878|NCT03026283|526335745|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145951879|NCT03026283|526335738|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951880|NCT03026283|526335739|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951881|NCT03026283|526335740|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
145951882|NCT03026283|526335741|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951883|NCT03026283|526335742|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951884|NCT03026283|526335743|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951885|NCT03026283|526335744|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951886|NCT03026283|526335745|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145951887|NCT03026283|526335738|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951888|NCT03026283|526335739|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951889|NCT03026283|526335740|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951890|NCT03026283|526335741|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
145951891|NCT03026283|526335742|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
145951892|NCT03026283|526335743|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951893|NCT03026283|526335744|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951894|NCT03026283|526335745|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145951895|NCT03026283|526335738|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145951896|NCT03026283|526335739|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145951897|NCT03026283|526335740|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145951898|NCT03026283|526335741|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
145951899|NCT03026283|526335742|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
145951900|NCT03026283|526335743|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
145951901|NCT03026283|526335744|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145951902|NCT03026283|526335745|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145951903|NCT03026283|526335738|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951904|NCT03026283|526335739|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951905|NCT03026283|526335740|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951906|NCT03026283|526335741|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
145951907|NCT03026283|526335742|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951908|NCT03026283|526335743|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
145951909|NCT03026283|526335744|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951910|NCT03026283|526335745|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145951911|NCT03026283|526335738|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951912|NCT03026283|526335739|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
146207989|NCT01551355|527276465|FG002|Overall Study|Lost to Follow-up|34|||
146207990|NCT01551355|527276466|FG003|Overall Study|Lost to Follow-up|24|||
146435832|NCT02682238|528102046|FG000|Overall Study|Non-compliance with Study Drug|1|||
146435833|NCT02682238|528102047|FG001|Overall Study|Non-compliance with Study Drug|0|||
146435834|NCT02682238|528102046|FG000|Overall Study|Non-compliance with Protocol|0|||
145951913|NCT03026283|526335740|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951914|NCT03026283|526335741|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
145951915|NCT03026283|526335742|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951916|NCT03026283|526335743|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951917|NCT03026283|526335744|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951918|NCT03026283|526335745|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145951919|NCT03026283|526335738|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951920|NCT03026283|526335739|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951921|NCT03026283|526335740|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951922|NCT03026283|526335741|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951923|NCT03026283|526335742|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
145951924|NCT03026283|526335743|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
145951925|NCT03026283|526335744|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951926|NCT03026283|526335745|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145951927|NCT04076319|526335750|FG000|Overall Study|Withdrawal by Subject|2|||
145951928|NCT04076319|526335751|FG001|Overall Study|Withdrawal by Subject|0|||
145951929|NCT04076319|526335750|FG000|Overall Study|Death|1|||
145951930|NCT04076319|526335751|FG001|Overall Study|Death|0|||
145951931|NCT01054222|526335752|FG000|Overall Study|Lack of Efficacy|1|||
145951932|NCT01054222|526335752|FG000|Overall Study|Lost to Follow-up|4|||
145951933|NCT01054222|526335752|FG000|Overall Study|Withdrawal by Subject|6|||
145951934|NCT03782571|526335753|FG000|Period 1|Withdrawal by Subject|1|||
145951935|NCT03782571|526335754|FG001|Period 1|Withdrawal by Subject|0|||
145951936|NCT03782571|526335755|FG002|Period 1|Withdrawal by Subject|0|||
145951937|NCT03782571|526335756|FG003|Period 1|Withdrawal by Subject|0|||
145951938|NCT03782571|526335753|FG000|Period 3|Subject Unable to Attend V5|1|||
145951939|NCT03782571|526335754|FG001|Period 3|Subject Unable to Attend V5|0|||
145951940|NCT03782571|526335755|FG002|Period 3|Subject Unable to Attend V5|0|||
145951941|NCT03782571|526335756|FG003|Period 3|Subject Unable to Attend V5|0|||
145951942|NCT03782571|526335753|FG000|Period 3|Adverse Event|1|||
145951943|NCT03782571|526335754|FG001|Period 3|Adverse Event|0|||
145951944|NCT03782571|526335755|FG002|Period 3|Adverse Event|0|||
145951945|NCT03782571|526335756|FG003|Period 3|Adverse Event|0|||
145951946|NCT00199849|526335763|FG000|Overall Study|Unrelated illness or complication|0|||
145951947|NCT00199849|526335764|FG001|Overall Study|Unrelated illness or complication|1|||
145951948|NCT00199849|526335765|FG002|Overall Study|Unrelated illness or complication|0|||
145951949|NCT00199849|526335763|FG000|Overall Study|Progressive disease requiring intervention|0|||
145951950|NCT00199849|526335764|FG001|Overall Study|Progressive disease requiring intervention|0|||
145951951|NCT00199849|526335765|FG002|Overall Study|Progressive disease requiring intervention|1|||
145951952|NCT00199849|526335763|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
145951953|NCT00199849|526335764|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
145951954|NCT00199849|526335765|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
145951955|NCT04727528|526335766|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
145951956|NCT04727528|526335767|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
145951957|NCT04727528|526335766|FG000|Open-label Period|Randomized who did not receive treatment|1|||
145951958|NCT04727528|526335767|FG001|Open-label Period|Randomized who did not receive treatment|0|||
145951959|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145951960|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Adverse Event|1|||
145951961|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Death|0|||
145951962|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Death|1|||
145951963|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
145951964|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
145951965|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
145951966|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
145951967|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Physician Decision|0|||
146435835|NCT02682238|528102047|FG001|Overall Study|Non-compliance with Protocol|2|||
146435836|NCT01370317|528102048|FG000|Overall Study|Participant withdrew consent|1|||
146435837|NCT01370317|528102049|FG001|Overall Study|Participant withdrew consent|0|||
146435838|NCT01370317|528102048|FG000|Overall Study|Protocol deviation|0|||
146435839|NCT01370317|528102049|FG001|Overall Study|Protocol deviation|1|||
146435840|NCT00075478|528102050|FG000|Overall Study|not eligible|1|||
146435841|NCT00075478|528102051|FG001|Overall Study|not eligible|0|||
145951968|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Physician Decision|1|||
146082994|NCT01215916|526824717|FG001|Overall Study|Death|1|||
146207991|NCT01551355|527276467|FG004|Overall Study|Lost to Follow-up|9|||
146207992|NCT01551355|527276468|FG005|Overall Study|Lost to Follow-up|6|||
146435842|NCT00075478|528102050|FG000|Overall Study|Physician Decision|0|||
146435843|NCT00075478|528102051|FG001|Overall Study|Physician Decision|1|||
145951969|NCT04727528|526335766|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
145951970|NCT04727528|526335767|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145951971|NCT01826981|526335781|FG000|Overall Study|Lack of Efficacy|0|||
145951972|NCT01826981|526335782|FG001|Overall Study|Lack of Efficacy|1|||
145951973|NCT01826981|526335783|FG002|Overall Study|Lack of Efficacy|0|||
145951974|NCT01826981|526335784|FG003|Overall Study|Lack of Efficacy|0|||
145951975|NCT01826981|526335785|FG004|Overall Study|Lack of Efficacy|5|||
145951976|NCT01826981|526335786|FG005|Overall Study|Lack of Efficacy|0|||
145951977|NCT01826981|526335787|FG006|Overall Study|Lack of Efficacy|0|||
145951978|NCT01826981|526335788|FG007|Overall Study|Lack of Efficacy|8|||
145951979|NCT01826981|526335789|FG008|Overall Study|Lack of Efficacy|7|||
145951980|NCT01826981|526335790|FG009|Overall Study|Lack of Efficacy|0|||
145951981|NCT01826981|526335791|FG010|Overall Study|Lack of Efficacy|1|||
145951982|NCT01826981|526335792|FG011|Overall Study|Lack of Efficacy|0|||
145951983|NCT01826981|526335793|FG012|Overall Study|Lack of Efficacy|0|||
145951984|NCT01826981|526335794|FG013|Overall Study|Lack of Efficacy|3|||
145951985|NCT01826981|526335795|FG014|Overall Study|Lack of Efficacy|0|||
145951986|NCT01826981|526335781|FG000|Overall Study|Lost to Follow-up|0|||
145951987|NCT01826981|526335782|FG001|Overall Study|Lost to Follow-up|0|||
145951988|NCT01826981|526335783|FG002|Overall Study|Lost to Follow-up|0|||
145951989|NCT01826981|526335784|FG003|Overall Study|Lost to Follow-up|0|||
145951990|NCT01826981|526335785|FG004|Overall Study|Lost to Follow-up|1|||
145951991|NCT01826981|526335786|FG005|Overall Study|Lost to Follow-up|1|||
145951992|NCT01826981|526335787|FG006|Overall Study|Lost to Follow-up|0|||
145951993|NCT01826981|526335788|FG007|Overall Study|Lost to Follow-up|1|||
145951994|NCT01826981|526335789|FG008|Overall Study|Lost to Follow-up|0|||
145951995|NCT01826981|526335790|FG009|Overall Study|Lost to Follow-up|1|||
145951996|NCT01826981|526335791|FG010|Overall Study|Lost to Follow-up|1|||
145951997|NCT01826981|526335792|FG011|Overall Study|Lost to Follow-up|1|||
145951998|NCT01826981|526335793|FG012|Overall Study|Lost to Follow-up|1|||
145951999|NCT01826981|526335794|FG013|Overall Study|Lost to Follow-up|0|||
145952000|NCT01826981|526335795|FG014|Overall Study|Lost to Follow-up|0|||
145952001|NCT01826981|526335781|FG000|Overall Study|Withdrew Consent|0|||
145952002|NCT01826981|526335782|FG001|Overall Study|Withdrew Consent|0|||
145952003|NCT01826981|526335783|FG002|Overall Study|Withdrew Consent|0|||
145952004|NCT01826981|526335784|FG003|Overall Study|Withdrew Consent|0|||
145952005|NCT01826981|526335785|FG004|Overall Study|Withdrew Consent|0|||
145952006|NCT01826981|526335786|FG005|Overall Study|Withdrew Consent|0|||
145952007|NCT01826981|526335787|FG006|Overall Study|Withdrew Consent|1|||
145952008|NCT01826981|526335788|FG007|Overall Study|Withdrew Consent|1|||
145952009|NCT01826981|526335789|FG008|Overall Study|Withdrew Consent|0|||
145952010|NCT01826981|526335790|FG009|Overall Study|Withdrew Consent|0|||
145952011|NCT01826981|526335791|FG010|Overall Study|Withdrew Consent|0|||
145952012|NCT01826981|526335792|FG011|Overall Study|Withdrew Consent|1|||
145952013|NCT01826981|526335793|FG012|Overall Study|Withdrew Consent|0|||
145952014|NCT01826981|526335794|FG013|Overall Study|Withdrew Consent|1|||
145952015|NCT01826981|526335795|FG014|Overall Study|Withdrew Consent|0|||
145952016|NCT01826981|526335781|FG000|Overall Study|Adverse Event|0|||
145952017|NCT01826981|526335782|FG001|Overall Study|Adverse Event|0|||
145952018|NCT01826981|526335783|FG002|Overall Study|Adverse Event|0|||
145952019|NCT01826981|526335784|FG003|Overall Study|Adverse Event|0|||
145952020|NCT01826981|526335785|FG004|Overall Study|Adverse Event|1|||
145952021|NCT01826981|526335786|FG005|Overall Study|Adverse Event|0|||
145952022|NCT01826981|526335787|FG006|Overall Study|Adverse Event|0|||
145952023|NCT01826981|526335788|FG007|Overall Study|Adverse Event|0|||
145952024|NCT01826981|526335789|FG008|Overall Study|Adverse Event|0|||
145952025|NCT01826981|526335790|FG009|Overall Study|Adverse Event|0|||
145952026|NCT01826981|526335791|FG010|Overall Study|Adverse Event|0|||
145952027|NCT01826981|526335792|FG011|Overall Study|Adverse Event|0|||
145952028|NCT01826981|526335793|FG012|Overall Study|Adverse Event|0|||
145952029|NCT01826981|526335794|FG013|Overall Study|Adverse Event|0|||
145952030|NCT01826981|526335795|FG014|Overall Study|Adverse Event|0|||
145952031|NCT01826981|526335781|FG000|Overall Study|Upper G-I Haemorrhage|0|||
145952032|NCT01826981|526335782|FG001|Overall Study|Upper G-I Haemorrhage|0|||
145952033|NCT01826981|526335783|FG002|Overall Study|Upper G-I Haemorrhage|0|||
145952034|NCT01826981|526335784|FG003|Overall Study|Upper G-I Haemorrhage|0|||
146082995|NCT01215916|526824718|FG002|Overall Study|Death|0|||
146082996|NCT01215916|526824719|FG003|Overall Study|Death|0|||
146082997|NCT01215916|526824720|FG004|Overall Study|Death|1|||
145952035|NCT01826981|526335785|FG004|Overall Study|Upper G-I Haemorrhage|0|||
145952036|NCT01826981|526335786|FG005|Overall Study|Upper G-I Haemorrhage|0|||
145952037|NCT01826981|526335787|FG006|Overall Study|Upper G-I Haemorrhage|0|||
145952038|NCT01826981|526335788|FG007|Overall Study|Upper G-I Haemorrhage|0|||
145952039|NCT01826981|526335789|FG008|Overall Study|Upper G-I Haemorrhage|0|||
145952040|NCT01826981|526335790|FG009|Overall Study|Upper G-I Haemorrhage|0|||
145952041|NCT01826981|526335791|FG010|Overall Study|Upper G-I Haemorrhage|0|||
146082998|NCT01215916|526824721|FG005|Overall Study|Death|0|||
146082999|NCT01215916|526824722|FG006|Overall Study|Death|0|||
145952042|NCT01826981|526335792|FG011|Overall Study|Upper G-I Haemorrhage|0|||
145952043|NCT01826981|526335793|FG012|Overall Study|Upper G-I Haemorrhage|0|||
145952044|NCT01826981|526335794|FG013|Overall Study|Upper G-I Haemorrhage|1|||
146083000|NCT01215916|526824723|FG007|Overall Study|Death|0|||
146083001|NCT01215916|526824724|FG008|Overall Study|Death|1|||
146435844|NCT02075463|528102054|FG000|Overall Study|Adverse Event|3|||
145952045|NCT01826981|526335795|FG014|Overall Study|Upper G-I Haemorrhage|0|||
145952046|NCT01826981|526335781|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952047|NCT01826981|526335782|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952048|NCT01826981|526335783|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952049|NCT01826981|526335784|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952050|NCT01826981|526335785|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952051|NCT01826981|526335786|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952052|NCT01826981|526335787|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952053|NCT01826981|526335788|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
145952054|NCT01826981|526335789|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952055|NCT01826981|526335790|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952056|NCT01826981|526335791|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952057|NCT01826981|526335792|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952058|NCT01826981|526335793|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952059|NCT01826981|526335794|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952060|NCT01826981|526335795|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
145952061|NCT03479008|526335800|FG000|Overall Study|Withdrawal by Subject|3|||
145952062|NCT01796301|526335801|FG000|Overall Study|Withdrawal by Subject|15|||
145952063|NCT01796301|526335802|FG001|Overall Study|Withdrawal by Subject|15|||
145952064|NCT01796301|526335801|FG000|Overall Study|Lost to Follow-up|3|||
145952065|NCT01796301|526335802|FG001|Overall Study|Lost to Follow-up|3|||
145952066|NCT01796301|526335801|FG000|Overall Study|Death|0|||
145952067|NCT01796301|526335802|FG001|Overall Study|Death|1|||
145952068|NCT01796301|526335801|FG000|Overall Study|Decision by Sponsor|0|||
145952069|NCT01796301|526335802|FG001|Overall Study|Decision by Sponsor|1|||
145952070|NCT01704755|526335803|FG000|Overall Study|Adverse Event|4|||
145952071|NCT01704755|526335804|FG001|Overall Study|Adverse Event|1|||
145952072|NCT01704755|526335803|FG000|Overall Study|Lost to Follow-up|3|||
145952073|NCT01704755|526335804|FG001|Overall Study|Lost to Follow-up|4|||
145952074|NCT01704755|526335803|FG000|Overall Study|Withdrew consent|1|||
145952075|NCT01704755|526335804|FG001|Overall Study|Withdrew consent|1|||
145952076|NCT01704755|526335803|FG000|Overall Study|Other (not specified)|3|||
145952077|NCT01704755|526335804|FG001|Overall Study|Other (not specified)|1|||
145952078|NCT01704755|526335803|FG000|Overall Study|Withdrew consent and personal issues|1|||
145952079|NCT01704755|526335804|FG001|Overall Study|Withdrew consent and personal issues|0|||
145952080|NCT00667563|526335805|FG000|Overall Study|Protocol Violation|24|||
145952081|NCT00660595|526335808|FG000|Overall Study|Lost to Follow-up|0|||
145952082|NCT00660595|526335809|FG001|Overall Study|Lost to Follow-up|1|||
145952083|NCT00660595|526335808|FG000|Overall Study|Did not consent to participate in study|12|||
145952084|NCT00660595|526335809|FG001|Overall Study|Did not consent to participate in study|8|||
145952085|NCT00660595|526335808|FG000|Overall Study|Participant left hospital|1|||
145952086|NCT00660595|526335809|FG001|Overall Study|Participant left hospital|0|||
145952087|NCT00660595|526335808|FG000|Overall Study|Non Specified reasons|5|||
145952088|NCT00660595|526335809|FG001|Overall Study|Non Specified reasons|0|||
145952089|NCT00264290|526335824|FG000|Intervention (8 Weeks)|Adverse Event|1|||
145952090|NCT00264290|526335825|FG001|Intervention (8 Weeks)|Adverse Event|0|||
145952091|NCT04399889|526335826|FG000|Overall Study|Death|5|||
145952092|NCT04399889|526335827|FG001|Overall Study|Death|1|||
145952093|NCT04399889|526335828|FG002|Overall Study|Death|1|||
145952094|NCT01152996|526335832|FG000|Overall Study|Withdrawal by Subject|142|||
145952095|NCT01152996|526335832|FG000|Overall Study|Adverse Event|115|||
145952096|NCT01152996|526335832|FG000|Overall Study|Lost to Follow-up|112|||
145952097|NCT01152996|526335832|FG000|Overall Study|Lack of Efficacy|68|||
145952098|NCT01152996|526335832|FG000|Overall Study|Noncompliance|41|||
145952099|NCT01152996|526335832|FG000|Overall Study|Other|36|||
145952100|NCT01152996|526335832|FG000|Overall Study|Protocol Violation|22|||
145952101|NCT01152996|526335832|FG000|Overall Study|Elevated liver enzymes|1|||
145952102|NCT02347072|526335842|FG000|Overall Study|Adverse Event|2|||
145952103|NCT02347072|526335842|FG000|Overall Study|Withdrawal by Subject|6|||
145952104|NCT02347072|526335842|FG000|Overall Study|Physician Decision|1|||
145952105|NCT02347072|526335842|FG000|Overall Study|Lost to Follow-up|2|||
145952106|NCT02347072|526335842|FG000|Overall Study|Protocol Violation|1|||
145952107|NCT02347072|526335842|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
145952108|NCT01808222|526335843|FG000|Overall Study|mpMR scan was not performed|1|||
145952109|NCT01146561|526335844|FG000|Overall Study|Withdrawal by Subject|1|||
145952110|NCT01146561|526335844|FG000|Overall Study|Lost to Follow-up|1|||
145952111|NCT02774005|526335850|FG000|Overall Study|Adverse Event|8|||
145952112|NCT02774005|526335850|FG000|Overall Study|Withdrawal by Subject|23|||
146435845|NCT02075463|528102054|FG000|Overall Study|Par. reached stopping criteria|4|||
146435846|NCT02075463|528102054|FG000|Overall Study|Withdrawal by Subject|1|||
145952113|NCT02774005|526335850|FG000|Overall Study|Lost to Follow-up|7|||
145952114|NCT02774005|526335850|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
145952115|NCT02774005|526335850|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
145952116|NCT02774005|526335850|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
145952117|NCT02774005|526335850|FG000|Overall Study|Death|1|||
146207993|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
146207994|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146207995|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146207996|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146207997|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
146207998|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
146207999|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146208000|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146208001|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146208002|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
146208003|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
146208004|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146208005|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146208006|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146208007|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
146208008|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
146208009|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146208010|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146208011|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146208012|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
146208013|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
146208014|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146208015|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146208016|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146208017|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
146208018|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
146208019|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146208020|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146208021|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146208022|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
146208023|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
146208024|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146208025|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146435847|NCT00673660|528102055|FG000|Overall Study|Lost to Follow-up|107|||
146208026|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146208027|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
146208028|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
146208029|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146208030|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146208031|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146435848|NCT01527006|528102056|FG000|Core Study|Adverse Event|0|||
146435849|NCT01527006|528102057|FG001|Core Study|Adverse Event|2|||
146435850|NCT01527006|528102056|FG000|Core Study|Lost to Follow-up|0|||
146208032|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
146208033|NCT02409667|527276469|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
146208034|NCT02409667|527276470|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146208035|NCT02409667|527276471|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146208036|NCT02409667|527276472|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146208037|NCT02409667|527276473|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
146208038|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
146208039|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
146208040|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
146208041|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
146208042|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
146208043|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146208044|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146208045|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146208046|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
146208047|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
146208048|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
146208049|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
146208050|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
146208051|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
146208052|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
146208053|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146208054|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
146208055|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
146208056|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146208057|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
146208058|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
146208059|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
146208060|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
146208061|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
146208062|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
146208063|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146208064|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146208065|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
146208066|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
146208067|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
146208068|NCT02409667|527276469|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146208069|NCT02409667|527276470|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146208070|NCT02409667|527276471|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
146208071|NCT02409667|527276472|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
146208072|NCT02409667|527276473|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
145952118|NCT02774005|526335850|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
145952119|NCT02774005|526335850|FG000|Overall Study|Lack of compliance with study medication|4|||
145952120|NCT02774005|526335850|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
145952121|NCT02774005|526335850|FG000|Overall Study|another study|1|||
145952122|NCT02774005|526335850|FG000|Overall Study|cardiologist imposed travel restriction|1|||
145952123|NCT00723697|526335851|FG000|Overall Study|Physician questionnaires not received|2|||
145952124|NCT00723697|526335851|FG000|Overall Study|Missing Informed Consent Form|10|||
145952125|NCT00723697|526335851|FG000|Overall Study|Other exclusion criteria applied|6|||
145952126|NCT01289574|526335852|FG000|Overall Study|Lack of Efficacy|4|||
145952127|NCT01289574|526335853|FG001|Overall Study|Lack of Efficacy|0|||
145952128|NCT01289574|526335854|FG002|Overall Study|Lack of Efficacy|1|||
146208073|NCT01925339|527276474|FG000|Overall Study|Adverse Event|2|||
146208074|NCT01925339|527276475|FG001|Overall Study|Adverse Event|0|||
146208075|NCT01205048|527276478|FG000|Overall Study|Withdrawal by Subject|14|||
146208076|NCT01205048|527276478|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
146208077|NCT01205048|527276478|FG000|Overall Study|Lost to Follow-up|4|||
146208078|NCT01205048|527276478|FG000|Overall Study|Other|2|||
146208079|NCT01255670|527276479|FG000|Overall Study|Adverse Event|10|||
146208080|NCT01255670|527276480|FG001|Overall Study|Adverse Event|10|||
146208081|NCT01255670|527276479|FG000|Overall Study|Lost to Follow-up|16|||
146208082|NCT01255670|527276480|FG001|Overall Study|Lost to Follow-up|10|||
146208083|NCT03892564|527276481|FG000|Overall Study|Withdrawal by Subject|2|||
145952129|NCT01289574|526335852|FG000|Overall Study|Lost to Follow-up|2|||
146083002|NCT01215916|526824716|FG000|Overall Study|Physician Decision|0|||
146083003|NCT01215916|526824717|FG001|Overall Study|Physician Decision|0|||
146083004|NCT01215916|526824718|FG002|Overall Study|Physician Decision|1|||
145952130|NCT01289574|526335853|FG001|Overall Study|Lost to Follow-up|0|||
146083005|NCT01215916|526824719|FG003|Overall Study|Physician Decision|1|||
146083006|NCT01215916|526824720|FG004|Overall Study|Physician Decision|0|||
146083007|NCT01215916|526824721|FG005|Overall Study|Physician Decision|0|||
146083008|NCT01215916|526824722|FG006|Overall Study|Physician Decision|0|||
146083009|NCT01215916|526824723|FG007|Overall Study|Physician Decision|0|||
146083010|NCT01215916|526824724|FG008|Overall Study|Physician Decision|0|||
146083011|NCT02353143|526824725|FG000|Overall Study|Withdrawal by Subject|1|||
146083012|NCT02353143|526824726|FG001|Overall Study|Withdrawal by Subject|0|||
146083013|NCT02353143|526824727|FG002|Overall Study|Withdrawal by Subject|0|||
146083014|NCT02353143|526824728|FG003|Overall Study|Withdrawal by Subject|0|||
146083015|NCT02353143|526824729|FG004|Overall Study|Withdrawal by Subject|1|||
146083016|NCT02353143|526824730|FG005|Overall Study|Withdrawal by Subject|0|||
146083017|NCT02353143|526824731|FG006|Overall Study|Withdrawal by Subject|0|||
146083018|NCT02353143|526824732|FG007|Overall Study|Withdrawal by Subject|1|||
146083019|NCT02353143|526824733|FG008|Overall Study|Withdrawal by Subject|1|||
146083020|NCT02353143|526824725|FG000|Overall Study|Lack of Efficacy|2|||
146083021|NCT02353143|526824726|FG001|Overall Study|Lack of Efficacy|1|||
146083022|NCT02353143|526824727|FG002|Overall Study|Lack of Efficacy|2|||
146083023|NCT02353143|526824728|FG003|Overall Study|Lack of Efficacy|4|||
146083024|NCT02353143|526824729|FG004|Overall Study|Lack of Efficacy|13|||
146083025|NCT02353143|526824730|FG005|Overall Study|Lack of Efficacy|2|||
146083026|NCT02353143|526824731|FG006|Overall Study|Lack of Efficacy|2|||
146083027|NCT02353143|526824732|FG007|Overall Study|Lack of Efficacy|2|||
146083028|NCT02353143|526824733|FG008|Overall Study|Lack of Efficacy|1|||
146083029|NCT02353143|526824725|FG000|Overall Study|reason not specified|1|||
146083030|NCT02353143|526824726|FG001|Overall Study|reason not specified|2|||
146083031|NCT02353143|526824727|FG002|Overall Study|reason not specified|0|||
146083032|NCT02353143|526824728|FG003|Overall Study|reason not specified|0|||
146083033|NCT02353143|526824729|FG004|Overall Study|reason not specified|6|||
145952131|NCT01289574|526335854|FG002|Overall Study|Lost to Follow-up|1|||
145952132|NCT01289574|526335852|FG000|Overall Study|Withdrawal by Subject|1|||
145952133|NCT01289574|526335853|FG001|Overall Study|Withdrawal by Subject|1|||
145952134|NCT01289574|526335854|FG002|Overall Study|Withdrawal by Subject|1|||
145952135|NCT01289574|526335852|FG000|Overall Study|Adverse Event|0|||
145952136|NCT01289574|526335853|FG001|Overall Study|Adverse Event|1|||
145952137|NCT01289574|526335854|FG002|Overall Study|Adverse Event|0|||
145952138|NCT01289574|526335852|FG000|Overall Study|Subject wanted alternate treatment|0|||
145952139|NCT01289574|526335853|FG001|Overall Study|Subject wanted alternate treatment|1|||
145952140|NCT01289574|526335854|FG002|Overall Study|Subject wanted alternate treatment|0|||
145952141|NCT00262002|526335855|FG000|Overall Study|Adverse Event|2|||
145952142|NCT00262002|526335856|FG001|Overall Study|Adverse Event|1|||
145952143|NCT00262002|526335857|FG002|Overall Study|Adverse Event|0|||
145952144|NCT00262002|526335858|FG003|Overall Study|Adverse Event|0|||
145952145|NCT00262002|526335859|FG004|Overall Study|Adverse Event|0|||
145952146|NCT00262002|526335860|FG005|Overall Study|Adverse Event|1|||
145952147|NCT00262002|526335861|FG006|Overall Study|Adverse Event|0|||
146083034|NCT02353143|526824730|FG005|Overall Study|reason not specified|1|||
146083035|NCT02353143|526824731|FG006|Overall Study|reason not specified|0|||
146083036|NCT02353143|526824732|FG007|Overall Study|reason not specified|3|||
146083037|NCT02353143|526824733|FG008|Overall Study|reason not specified|1|||
146083038|NCT02353143|526824725|FG000|Overall Study|Physician Decision|0|||
146083039|NCT02353143|526824726|FG001|Overall Study|Physician Decision|4|||
146083040|NCT02353143|526824727|FG002|Overall Study|Physician Decision|2|||
146083041|NCT02353143|526824728|FG003|Overall Study|Physician Decision|3|||
146083042|NCT02353143|526824729|FG004|Overall Study|Physician Decision|4|||
145952148|NCT00262002|526335855|FG000|Overall Study|Withdrawal by Subject|4|||
145952149|NCT00262002|526335856|FG001|Overall Study|Withdrawal by Subject|2|||
145952150|NCT00262002|526335857|FG002|Overall Study|Withdrawal by Subject|0|||
145952151|NCT00262002|526335858|FG003|Overall Study|Withdrawal by Subject|1|||
145952152|NCT00262002|526335859|FG004|Overall Study|Withdrawal by Subject|2|||
146083043|NCT02353143|526824730|FG005|Overall Study|Physician Decision|0|||
146285401|NCT00190749|527557854|FG001|Overall Study|Reason Not Specified|2|||
146435851|NCT01527006|528102057|FG001|Core Study|Lost to Follow-up|1|||
146435852|NCT01527006|528102056|FG000|Core Study|Subject Choice|1|||
146435853|NCT01527006|528102057|FG001|Core Study|Subject Choice|0|||
146435854|NCT01527006|528102056|FG000|Core Study|Inadequate Therapeutic Effect|1|||
146435855|NCT01527006|528102057|FG001|Core Study|Inadequate Therapeutic Effect|0|||
146435856|NCT01527006|528102056|FG000|Core Study|Withdrawal by Subject|0|||
146435857|NCT01527006|528102057|FG001|Core Study|Withdrawal by Subject|1|||
146435858|NCT01527006|528102056|FG000|Core Study|Other|0|||
146435859|NCT01527006|528102057|FG001|Core Study|Other|2|||
146435860|NCT01527006|528102056|FG000|Extension Phase|Adverse Event|4|||
146435861|NCT01527006|528102057|FG001|Extension Phase|Adverse Event|2|||
146435862|NCT01527006|528102056|FG000|Extension Phase|Lost to Follow-up|0|||
146435863|NCT01527006|528102057|FG001|Extension Phase|Lost to Follow-up|1|||
146435864|NCT01527006|528102056|FG000|Extension Phase|Subject Choice|1|||
146435865|NCT01527006|528102057|FG001|Extension Phase|Subject Choice|1|||
146435866|NCT01527006|528102056|FG000|Extension Phase|Inadequate therapeutic effect|1|||
146435867|NCT01527006|528102057|FG001|Extension Phase|Inadequate therapeutic effect|1|||
146435868|NCT01527006|528102056|FG000|Extension Phase|Other|0|||
146435869|NCT01527006|528102057|FG001|Extension Phase|Other|3|||
146435870|NCT00834340|528102059|FG000|Washout|Adverse Event|1|||
146435871|NCT00834340|528102060|FG001|Washout|Adverse Event|0|||
146435872|NCT00834340|528102059|FG000|Washout|Withdrawal by Subject|1|||
146435873|NCT00834340|528102060|FG001|Washout|Withdrawal by Subject|0|||
146435874|NCT00392665|528102061|FG000|Overall Study|Death|16|||
146435875|NCT00392665|528102062|FG001|Overall Study|Death|14|||
146435876|NCT00392665|528102061|FG000|Overall Study|Lost to Follow-up|1|||
146285402|NCT00190749|527557853|FG000|Overall Study|Sponsor Decision|1|||
146435877|NCT00392665|528102062|FG001|Overall Study|Lost to Follow-up|1|||
146435878|NCT03673670|528102065|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
146435879|NCT03673670|528102066|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
146435880|NCT03673670|528102067|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
146435881|NCT03673670|528102068|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
146435882|NCT03673670|528102069|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
146435883|NCT03673670|528102070|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
146435884|NCT03673670|528102065|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
146435885|NCT03673670|528102066|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
146435886|NCT03673670|528102067|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
146435887|NCT03673670|528102068|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
146285403|NCT00190749|527557854|FG001|Overall Study|Sponsor Decision|0|||
146435888|NCT03673670|528102069|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
146435889|NCT03673670|528102070|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
146435890|NCT03673670|528102065|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
146435891|NCT03673670|528102066|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
146435892|NCT03673670|528102067|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
146435893|NCT03673670|528102068|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
146435894|NCT03673670|528102069|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
146435895|NCT03673670|528102070|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
146435896|NCT03673670|528102065|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
146435897|NCT03673670|528102066|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
146435898|NCT03673670|528102067|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
146435899|NCT03673670|528102068|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
146435900|NCT03673670|528102069|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
146435901|NCT03673670|528102070|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
146435902|NCT03673670|528102065|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
146435903|NCT03673670|528102066|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
146435904|NCT03673670|528102067|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
146435905|NCT03673670|528102068|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
146435906|NCT03673670|528102069|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
146435907|NCT03673670|528102070|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
146435908|NCT03673670|528102065|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
146435909|NCT03673670|528102066|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
146435910|NCT03673670|528102067|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145952153|NCT00262002|526335860|FG005|Overall Study|Withdrawal by Subject|2|||
146208084|NCT03664960|527276482|FG000|Overall Study|Adverse Event|0|||
146208085|NCT03664960|527276483|FG001|Overall Study|Adverse Event|3|||
146208086|NCT03664960|527276482|FG000|Overall Study|Lost to Follow-up|3|||
146208087|NCT03664960|527276483|FG001|Overall Study|Lost to Follow-up|2|||
146208088|NCT03664960|527276482|FG000|Overall Study|Physician Decision|1|||
146208089|NCT03664960|527276483|FG001|Overall Study|Physician Decision|0|||
146435911|NCT03673670|528102068|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
146435912|NCT03673670|528102069|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
146435913|NCT03673670|528102070|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
146435914|NCT03673670|528102065|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
146435915|NCT03673670|528102066|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
146435916|NCT03673670|528102067|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
146435917|NCT03673670|528102068|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
146435918|NCT03673670|528102069|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
146435919|NCT03673670|528102070|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
146435920|NCT03437265|528102073|FG000|Overall Study|Protocol Violation|6|||
146435921|NCT02294786|528102074|FG000|Overall Study|Withdrawal by Subject|0|||
146435922|NCT02294786|528102075|FG001|Overall Study|Withdrawal by Subject|1|||
146435923|NCT02294786|528102074|FG000|Overall Study|Physician Decision|6|||
146435924|NCT02294786|528102075|FG001|Overall Study|Physician Decision|7|||
146435925|NCT02294786|528102074|FG000|Overall Study|Lost to Follow-up|1|||
146435926|NCT02294786|528102075|FG001|Overall Study|Lost to Follow-up|2|||
146435927|NCT02294786|528102074|FG000|Overall Study|Protocol Violation|1|||
146435928|NCT02294786|528102075|FG001|Overall Study|Protocol Violation|0|||
146435929|NCT02294786|528102074|FG000|Overall Study|Adverse Event|1|||
146435930|NCT02294786|528102075|FG001|Overall Study|Adverse Event|1|||
146435931|NCT02294786|528102074|FG000|Overall Study|Death|2|||
146435932|NCT02294786|528102075|FG001|Overall Study|Death|3|||
146435933|NCT01778010|528102076|FG000|Overall Study|Withdrawal by Subject|2|||
146435934|NCT01778010|528102076|FG000|Overall Study|abnormal ECG before meds|1|||
146435935|NCT01778010|528102076|FG000|Overall Study|Arrested|1|||
146435936|NCT01778010|528102076|FG000|Overall Study|rash while on placebo|1|||
146435937|NCT02159183|528102084|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
146435938|NCT02159183|528102085|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
146435939|NCT02159183|528102084|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
146435940|NCT02159183|528102085|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
146208090|NCT03664960|527276482|FG000|Overall Study|Withdrawal by Subject|3|||
146208091|NCT03664960|527276483|FG001|Overall Study|Withdrawal by Subject|14|||
146208092|NCT03664960|527276482|FG000|Overall Study|Sponsor Decision|1|||
146208093|NCT03664960|527276483|FG001|Overall Study|Sponsor Decision|1|||
146435941|NCT02159183|528102084|FG000|Analysis After the 36 Months Follow-up|Death|0|||
146435942|NCT02159183|528102085|FG001|Analysis After the 36 Months Follow-up|Death|1|||
146435943|NCT02159183|528102084|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
146435944|NCT02159183|528102085|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
146208094|NCT03664960|527276482|FG000|Overall Study|Other|1|||
146208095|NCT03664960|527276483|FG001|Overall Study|Other|2|||
146435945|NCT02159183|528102084|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
146435946|NCT02159183|528102085|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
146435947|NCT01244620|528102089|FG000|Overall Study|Study terminated|4|||
146435948|NCT01244620|528102090|FG001|Overall Study|Study terminated|4|||
146435949|NCT01244620|528102091|FG002|Overall Study|Study terminated|4|||
146435950|NCT01244620|528102092|FG003|Overall Study|Study terminated|4|||
146435951|NCT00840073|528102094|FG000|Second Intervention|Missed 72 hour blood draw|1|||
146208096|NCT00823472|527276484|FG000|Overall Study|Physician Decision|24|||
146208097|NCT00823472|527276485|FG001|Overall Study|Physician Decision|28|||
146208098|NCT04019444|527276486|FG000|Overall Study|Withdrawal by Subject|0|||
146208099|NCT04019444|527276487|FG001|Overall Study|Withdrawal by Subject|1|||
146208100|NCT04019444|527276488|FG002|Overall Study|Withdrawal by Subject|0|||
146208101|NCT04019444|527276489|FG003|Overall Study|Withdrawal by Subject|1|||
146208102|NCT04019444|527276486|FG000|Overall Study|Solicited Event|0|||
146208103|NCT04019444|527276487|FG001|Overall Study|Solicited Event|0|||
146208104|NCT04019444|527276488|FG002|Overall Study|Solicited Event|2|||
146208105|NCT04019444|527276489|FG003|Overall Study|Solicited Event|0|||
146208106|NCT03997916|527276498|FG000|Overall Study|Protocol Violation|35|||
146208107|NCT03807778|527276501|FG000|Overall Study|Adverse Event|0|||
146208108|NCT03807778|527276502|FG001|Overall Study|Adverse Event|0|||
146208109|NCT03807778|527276503|FG002|Overall Study|Adverse Event|3|||
146208110|NCT03807778|527276504|FG003|Overall Study|Adverse Event|5|||
146208111|NCT03807778|527276501|FG000|Overall Study|Progressive Disease|4|||
146208112|NCT03807778|527276502|FG001|Overall Study|Progressive Disease|2|||
146208113|NCT03807778|527276503|FG002|Overall Study|Progressive Disease|8|||
146208114|NCT03807778|527276504|FG003|Overall Study|Progressive Disease|15|||
146208115|NCT03807778|527276501|FG000|Overall Study|Symptomatic Deterioration|0|||
146208116|NCT03807778|527276502|FG001|Overall Study|Symptomatic Deterioration|1|||
146208117|NCT03807778|527276503|FG002|Overall Study|Symptomatic Deterioration|0|||
146208118|NCT03807778|527276504|FG003|Overall Study|Symptomatic Deterioration|1|||
146208119|NCT03807778|527276501|FG000|Overall Study|Withdrawal by Subject|0|||
146208120|NCT03807778|527276502|FG001|Overall Study|Withdrawal by Subject|1|||
146208121|NCT03807778|527276503|FG002|Overall Study|Withdrawal by Subject|0|||
146208122|NCT03807778|527276504|FG003|Overall Study|Withdrawal by Subject|1|||
146208123|NCT03807778|527276501|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
146208124|NCT03807778|527276502|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
146208125|NCT03807778|527276503|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
146208126|NCT03807778|527276504|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
146208127|NCT01207492|527276505|FG000|Overall Study|Still on study|1|||
146208128|NCT01207492|527276505|FG000|Overall Study|Withdrawal by Subject|9|||
146208129|NCT01207492|527276505|FG000|Overall Study|Physician Decision|1|||
146208130|NCT01207492|527276505|FG000|Overall Study|Progressive disease|3|||
146208131|NCT01207492|527276505|FG000|Overall Study|Toxicity|1|||
146208132|NCT02769858|527276506|FG000|Overall Study|Withdrawal by Subject|2|||
146208133|NCT03783026|527277715|FG000|Treatment Phase|Adverse Event|15|||
146208134|NCT03783026|527277715|FG000|Treatment Phase|Lack of Efficacy|11|||
146208135|NCT03783026|527277715|FG000|Treatment Phase|Withdrawal by Subject|6|||
146208136|NCT03783026|527277715|FG000|Treatment Phase|Lost to Follow-up|2|||
146435952|NCT00840073|528102095|FG001|Second Intervention|Missed 72 hour blood draw|1|||
146435953|NCT01663233|528102096|FG000|Overall Study|Withdrawal by Subject|3|||
146435954|NCT01663233|528102097|FG001|Overall Study|Withdrawal by Subject|2|||
146435955|NCT01663233|528102096|FG000|Overall Study|Protocol Deviation|1|||
146435956|NCT01663233|528102097|FG001|Overall Study|Protocol Deviation|4|||
146435957|NCT01663233|528102096|FG000|Overall Study|Lost to Follow-up|0|||
146435958|NCT01663233|528102097|FG001|Overall Study|Lost to Follow-up|1|||
146435959|NCT02321098|528102098|FG000|12 Weeks Treament|Lost to Follow-up|1|||
146435960|NCT02321098|528102099|FG001|12 Weeks Treament|Lost to Follow-up|1|||
146435961|NCT02321098|528102100|FG002|12 Weeks Treament|Lost to Follow-up|0|||
146435962|NCT02321098|528102098|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
146435963|NCT02321098|528102099|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
146435964|NCT02321098|528102100|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
146435965|NCT02321098|528102098|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
146435966|NCT02321098|528102099|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
146435967|NCT02321098|528102100|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
146435968|NCT02321098|528102098|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
146435969|NCT02321098|528102099|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
146435970|NCT02321098|528102100|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
146435971|NCT01788423|528102103|FG000|Overall Study|See Comments in Completed (above)|0|||
146208137|NCT03783026|527277715|FG000|Treatment Phase|Protocol Deviation|8|||
146208138|NCT03783026|527277715|FG000|Treatment Phase|Did Not Receive Treatment|1|||
146208139|NCT03783026|527277715|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
146208140|NCT01853748|527277719|FG000|Allocation|Withdrawal by Subject|1|||
146208141|NCT01853748|527277720|FG001|Allocation|Withdrawal by Subject|13|||
146208142|NCT01853748|527277719|FG000|Allocation|not sufficient to receive intervention|0|||
146208143|NCT01853748|527277720|FG001|Allocation|not sufficient to receive intervention|1|||
146208144|NCT01853748|527277719|FG000|Follow-Up|Withdrawal by Subject|7|||
146208145|NCT01853748|527277720|FG001|Follow-Up|Withdrawal by Subject|6|||
146208146|NCT01853748|527277719|FG000|Follow-Up|Adverse Event|67|||
146208147|NCT01853748|527277720|FG001|Follow-Up|Adverse Event|7|||
146208148|NCT01853748|527277719|FG000|Follow-Up|not available for data collection|16|||
146208149|NCT01853748|527277720|FG001|Follow-Up|not available for data collection|4|||
146208150|NCT01643070|527277723|FG000|Overall Study|Withdrawal by Subject|3|||
146208151|NCT01643070|527277724|FG001|Overall Study|Withdrawal by Subject|1|||
146208152|NCT01643070|527277723|FG000|Overall Study|Death|1|||
146208153|NCT01643070|527277724|FG001|Overall Study|Death|0|||
146208154|NCT01643070|527277723|FG000|Overall Study|Pregressive disease|0|||
146208155|NCT01643070|527277724|FG001|Overall Study|Pregressive disease|2|||
146208156|NCT04941287|527277725|FG000|Overall Study|Rapid decline before starting treatment|3|||
146208157|NCT04941287|527277726|FG001|Overall Study|Rapid decline before starting treatment|1|||
146208158|NCT02980276|527277727|FG000|Overall Study|Withdrawal by Subject|4|||
146208159|NCT02980276|527277728|FG001|Overall Study|Withdrawal by Subject|4|||
146208160|NCT02980276|527277727|FG000|Overall Study|Physician Decision|0|||
146208161|NCT02980276|527277728|FG001|Overall Study|Physician Decision|1|||
146208162|NCT02980276|527277727|FG000|Overall Study|Lost to Follow-up|18|||
146208163|NCT02980276|527277728|FG001|Overall Study|Lost to Follow-up|18|||
146208164|NCT02980276|527277727|FG000|Overall Study|Death|1|||
146208165|NCT02980276|527277728|FG001|Overall Study|Death|0|||
146208166|NCT02980276|527277727|FG000|Overall Study|Miscellaneous other|10|||
146208167|NCT02980276|527277728|FG001|Overall Study|Miscellaneous other|4|||
146208168|NCT01998984|527277729|FG000|Overall Study|Adverse Event|0|||
146208169|NCT01998984|527277730|FG001|Overall Study|Adverse Event|0|||
146208170|NCT01998984|527277731|FG002|Overall Study|Adverse Event|0|||
146208171|NCT01998984|527277732|FG003|Overall Study|Adverse Event|1|||
146208172|NCT01998984|527277729|FG000|Overall Study|Lost to Follow-up|0|||
146208173|NCT01998984|527277730|FG001|Overall Study|Lost to Follow-up|1|||
146208174|NCT01998984|527277731|FG002|Overall Study|Lost to Follow-up|0|||
146208175|NCT01998984|527277732|FG003|Overall Study|Lost to Follow-up|1|||
146208176|NCT01998984|527277729|FG000|Overall Study|Withdrawal by Subject|0|||
146208177|NCT01998984|527277730|FG001|Overall Study|Withdrawal by Subject|0|||
146208178|NCT01998984|527277731|FG002|Overall Study|Withdrawal by Subject|1|||
146208179|NCT01998984|527277732|FG003|Overall Study|Withdrawal by Subject|0|||
146208180|NCT01998984|527277729|FG000|Overall Study|Other|0|||
146208181|NCT01998984|527277730|FG001|Overall Study|Other|0|||
146208182|NCT01998984|527277731|FG002|Overall Study|Other|0|||
146208183|NCT01998984|527277732|FG003|Overall Study|Other|1|||
146208184|NCT03025789|527277733|FG000|Overall Study|Lack of Efficacy|6|||
146208185|NCT03025789|527277734|FG001|Overall Study|Lack of Efficacy|1|||
146208186|NCT03025789|527277733|FG000|Overall Study|Death|1|||
146208187|NCT03025789|527277734|FG001|Overall Study|Death|0|||
146208188|NCT03025789|527277733|FG000|Overall Study|Withdrawal by Subject|0|||
146208189|NCT03025789|527277734|FG001|Overall Study|Withdrawal by Subject|2|||
146208190|NCT04440176|527277738|FG000|Overall Study|Withdrawal by Subject|5|||
146208191|NCT04440176|527277739|FG001|Overall Study|Withdrawal by Subject|3|||
146208192|NCT04440176|527277738|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146208193|NCT04440176|527277739|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146208194|NCT04440176|527277738|FG000|Overall Study|Adverse Event|2|||
146208195|NCT04440176|527277739|FG001|Overall Study|Adverse Event|6|||
146208196|NCT04440176|527277738|FG000|Overall Study|Lost to Follow-up|22|||
146208197|NCT04440176|527277739|FG001|Overall Study|Lost to Follow-up|23|||
146208198|NCT04440176|527277738|FG000|Overall Study|Medication error without associated adverse event|0|||
146208199|NCT04440176|527277739|FG001|Overall Study|Medication error without associated adverse event|1|||
146208200|NCT04440176|527277738|FG000|Overall Study|No longer met eligibility criteria|7|||
146208201|NCT04440176|527277739|FG001|Overall Study|No longer met eligibility criteria|1|||
146208202|NCT04440176|527277738|FG000|Overall Study|Other|1|||
146208203|NCT04440176|527277739|FG001|Overall Study|Other|2|||
146208204|NCT04440176|527277738|FG000|Overall Study|Protocol deviation|6|||
146208205|NCT04440176|527277739|FG001|Overall Study|Protocol deviation|8|||
146208206|NCT04440176|527277738|FG000|Overall Study|Randomized but not vaccinated|6|||
146208207|NCT04440176|527277739|FG001|Overall Study|Randomized but not vaccinated|3|||
146208208|NCT01631214|527277740|FG000|Overall Study|Withdrawal by Subject|276|||
146208209|NCT01631214|527277741|FG001|Overall Study|Withdrawal by Subject|290|||
146208210|NCT01631214|527277740|FG000|Overall Study|Death|113|||
146208211|NCT01631214|527277741|FG001|Overall Study|Death|106|||
146208212|NCT01631214|527277740|FG000|Overall Study|Lost to Follow-up|54|||
146208213|NCT01631214|527277741|FG001|Overall Study|Lost to Follow-up|40|||
146208214|NCT01631214|527277740|FG000|Overall Study|Adverse Event|45|||
146208215|NCT01631214|527277741|FG001|Overall Study|Adverse Event|45|||
146208216|NCT01631214|527277740|FG000|Overall Study|Other|22|||
146208217|NCT01631214|527277741|FG001|Overall Study|Other|19|||
146208218|NCT01631214|527277740|FG000|Overall Study|Noncompliance|16|||
146208219|NCT01631214|527277741|FG001|Overall Study|Noncompliance|15|||
146208220|NCT01631214|527277740|FG000|Overall Study|Requirement for Alternative Therapy|8|||
146208221|NCT01631214|527277741|FG001|Overall Study|Requirement for Alternative Therapy|3|||
146208222|NCT01631214|527277740|FG000|Overall Study|Protocol Deviation|4|||
146208223|NCT01631214|527277741|FG001|Overall Study|Protocol Deviation|3|||
146208224|NCT01631214|527277740|FG000|Overall Study|Ineligibility determined|5|||
146208225|NCT01631214|527277741|FG001|Overall Study|Ineligibility determined|2|||
146208226|NCT01631214|527277740|FG000|Overall Study|Administrative Decision|1|||
146208227|NCT01631214|527277741|FG001|Overall Study|Administrative Decision|0|||
146208228|NCT05288283|527277742|FG000|Overall Study|Study Terminated Early|1|||
146208229|NCT05288283|527277743|FG001|Overall Study|Study Terminated Early|1|||
145952154|NCT00262002|526335861|FG006|Overall Study|Withdrawal by Subject|2|||
145952155|NCT00262002|526335855|FG000|Overall Study|Lost to Follow-up|2|||
145952156|NCT00262002|526335856|FG001|Overall Study|Lost to Follow-up|0|||
145952157|NCT00262002|526335857|FG002|Overall Study|Lost to Follow-up|0|||
145952158|NCT00262002|526335858|FG003|Overall Study|Lost to Follow-up|2|||
145952159|NCT00262002|526335859|FG004|Overall Study|Lost to Follow-up|0|||
145952160|NCT00262002|526335860|FG005|Overall Study|Lost to Follow-up|1|||
145952161|NCT00262002|526335861|FG006|Overall Study|Lost to Follow-up|0|||
145952162|NCT00262002|526335855|FG000|Overall Study|Inapropriate enrollment|0|||
145952163|NCT00262002|526335856|FG001|Overall Study|Inapropriate enrollment|1|||
145952164|NCT00262002|526335857|FG002|Overall Study|Inapropriate enrollment|0|||
145952165|NCT00262002|526335858|FG003|Overall Study|Inapropriate enrollment|0|||
145952166|NCT00262002|526335859|FG004|Overall Study|Inapropriate enrollment|0|||
145952167|NCT00262002|526335860|FG005|Overall Study|Inapropriate enrollment|0|||
145952168|NCT00262002|526335861|FG006|Overall Study|Inapropriate enrollment|0|||
145952169|NCT00262002|526335855|FG000|Overall Study|Protocol Violation|3|||
145952170|NCT00262002|526335856|FG001|Overall Study|Protocol Violation|2|||
145952171|NCT00262002|526335857|FG002|Overall Study|Protocol Violation|0|||
145952172|NCT00262002|526335858|FG003|Overall Study|Protocol Violation|2|||
145952173|NCT00262002|526335859|FG004|Overall Study|Protocol Violation|5|||
146208230|NCT04153565|527277744|FG000|Overall Study|Death|13|||
146208231|NCT02991807|527277745|FG000|Overall Study|Withdrawal by Subject|2|||
146208232|NCT02991807|527277746|FG001|Overall Study|Withdrawal by Subject|1|||
146208233|NCT02991807|527277745|FG000|Overall Study|Physician Decision|0|||
146208234|NCT02991807|527277746|FG001|Overall Study|Physician Decision|1|||
146208235|NCT02991807|527277745|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
146208236|NCT02991807|527277746|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
146208237|NCT02300298|527277747|FG000|Disposition for Nintedanib|Progressive disease|10|||
146208238|NCT02300298|527277748|FG001|Disposition for Nintedanib|Progressive disease|0|||
146208239|NCT02300298|527277747|FG000|Disposition for Docetaxel|Progressive disease|0|||
146208240|NCT02300298|527277748|FG001|Disposition for Docetaxel|Progressive disease|6|||
146208241|NCT02300298|527277747|FG000|Disposition for Docetaxel|other adverse event|0|||
146208242|NCT02300298|527277748|FG001|Disposition for Docetaxel|other adverse event|4|||
146208243|NCT03285763|527277749|FG000|Overall Study|Death|470|||
146208244|NCT03285763|527277749|FG000|Overall Study|Lost to Follow-up|18|||
146208245|NCT03285763|527277749|FG000|Overall Study|Physician Decision|2|||
146208246|NCT03285763|527277749|FG000|Overall Study|Study Terminated By Sponsor|79|||
146208247|NCT03285763|527277749|FG000|Overall Study|Withdrawal by Subject|33|||
146208248|NCT00402246|527277750|FG000|Overall Study|Death|62|||
146208249|NCT00402246|527277751|FG001|Overall Study|Death|58|||
146208250|NCT00402246|527277750|FG000|Overall Study|Lost to Follow-up|20|||
146208251|NCT00402246|527277751|FG001|Overall Study|Lost to Follow-up|28|||
146208252|NCT00402246|527277750|FG000|Overall Study|Withdrawal by Subject|72|||
146208253|NCT00402246|527277751|FG001|Overall Study|Withdrawal by Subject|87|||
146208254|NCT00402246|527277750|FG000|Overall Study|Physician Decision|24|||
146208255|NCT00402246|527277751|FG001|Overall Study|Physician Decision|26|||
146208256|NCT00402246|527277750|FG000|Overall Study|Protocol Violation|25|||
146208257|NCT00402246|527277751|FG001|Overall Study|Protocol Violation|24|||
146208258|NCT00402246|527277750|FG000|Overall Study|Missed Final Visit|1|||
146208259|NCT00402246|527277751|FG001|Overall Study|Missed Final Visit|2|||
146208260|NCT00402246|527277750|FG000|Overall Study|Insurance Issues|2|||
146208261|NCT00402246|527277751|FG001|Overall Study|Insurance Issues|1|||
146208262|NCT00402246|527277750|FG000|Overall Study|Heart Transplant|0|||
146208263|NCT00402246|527277751|FG001|Overall Study|Heart Transplant|1|||
146285404|NCT01605916|527557857|FG000|Overall Study|Adverse Event|1|||
146285405|NCT01605916|527557858|FG001|Overall Study|Adverse Event|0|||
145952174|NCT00262002|526335860|FG005|Overall Study|Protocol Violation|3|||
145952175|NCT00262002|526335861|FG006|Overall Study|Protocol Violation|2|||
145952176|NCT00262002|526335855|FG000|Overall Study|Unable to classify|0|||
145952177|NCT00262002|526335856|FG001|Overall Study|Unable to classify|0|||
145952178|NCT00262002|526335857|FG002|Overall Study|Unable to classify|0|||
145952179|NCT00262002|526335858|FG003|Overall Study|Unable to classify|0|||
146435972|NCT01788423|528102104|FG001|Overall Study|See Comments in Completed (above)|4|||
146435973|NCT01788423|528102105|FG002|Overall Study|See Comments in Completed (above)|5|||
146435974|NCT03249454|528102106|FG000|Overall Study|Withdrawal by Subject|0|||
146435975|NCT03249454|528102107|FG001|Overall Study|Withdrawal by Subject|0|||
146435976|NCT03249454|528102108|FG002|Overall Study|Withdrawal by Subject|0|||
146435977|NCT03249454|528102109|FG003|Overall Study|Withdrawal by Subject|0|||
146435978|NCT03249454|528102110|FG004|Overall Study|Withdrawal by Subject|0|||
146435979|NCT03249454|528102111|FG005|Overall Study|Withdrawal by Subject|0|||
146435980|NCT03249454|528102112|FG006|Overall Study|Withdrawal by Subject|0|||
146435981|NCT03249454|528102113|FG007|Overall Study|Withdrawal by Subject|0|||
146435982|NCT03249454|528102114|FG008|Overall Study|Withdrawal by Subject|0|||
146435983|NCT03249454|528102115|FG009|Overall Study|Withdrawal by Subject|1|||
146435984|NCT03249454|528102116|FG010|Overall Study|Withdrawal by Subject|1|||
146435985|NCT01913405|528102117|FG000|Overall Study|Withdrawal by Subject|1|||
146435986|NCT01913405|528102117|FG000|Overall Study|Adverse Event|1|||
146435987|NCT00705666|528102122|FG000|Overall Study|No post-treatment questionnaire|279|||
146435988|NCT00705666|528102122|FG000|Overall Study|Withdrawal by Subject|21|||
146435989|NCT00705666|528102122|FG000|Overall Study|Physician Decision|7|||
146435990|NCT00705666|528102122|FG000|Overall Study|Lost to Follow-up|5|||
146435991|NCT00705666|528102122|FG000|Overall Study|Death|1|||
146435992|NCT00705666|528102122|FG000|Overall Study|Adverse Event|4|||
146435993|NCT00705666|528102122|FG000|Overall Study|Other|12|||
146435994|NCT00705666|528102122|FG000|Overall Study|Other|2|||
146435995|NCT00705666|528102122|FG000|Overall Study|Lack of data|3|||
146435996|NCT00705666|528102122|FG000|Overall Study|Untreated|5|||
146435997|NCT02105272|528102123|FG000|Overall Study|Adverse Event|1|||
146435998|NCT02105272|528102124|FG001|Overall Study|Adverse Event|2|||
146435999|NCT02105272|528102123|FG000|Overall Study|Physician Decision|0|||
146436000|NCT02105272|528102124|FG001|Overall Study|Physician Decision|1|||
146436001|NCT02105272|528102123|FG000|Overall Study|Protocol Violation|2|||
146436002|NCT02105272|528102124|FG001|Overall Study|Protocol Violation|0|||
146436003|NCT02105272|528102123|FG000|Overall Study|Withdrawal by Subject|2|||
146436004|NCT02105272|528102124|FG001|Overall Study|Withdrawal by Subject|0|||
146436005|NCT02964039|528102135|FG000|Overall Study|Medical reason unrelated to study participation|1|||
146436006|NCT02964039|528102136|FG001|Overall Study|Medical reason unrelated to study participation|0|||
146436007|NCT02964039|528102137|FG002|Overall Study|Medical reason unrelated to study participation|3|||
146436008|NCT02964039|528102135|FG000|Overall Study|Research shutdown due to pandemic|2|||
146436009|NCT02964039|528102136|FG001|Overall Study|Research shutdown due to pandemic|0|||
146436010|NCT02964039|528102137|FG002|Overall Study|Research shutdown due to pandemic|1|||
145952180|NCT00262002|526335859|FG004|Overall Study|Unable to classify|0|||
145952181|NCT00262002|526335860|FG005|Overall Study|Unable to classify|0|||
145952182|NCT00262002|526335861|FG006|Overall Study|Unable to classify|2|||
145952183|NCT03885999|526335862|FG000|Overall Study|Adverse Event|1|||
145952184|NCT02452554|526335863|FG000|Overall Study|Death|2|||
145952185|NCT02452554|526335864|FG001|Overall Study|Death|1|||
145952186|NCT02452554|526335865|FG002|Overall Study|Death|0|||
146083044|NCT02353143|526824731|FG006|Overall Study|Physician Decision|1|||
146083045|NCT02353143|526824732|FG007|Overall Study|Physician Decision|2|||
146083046|NCT02353143|526824733|FG008|Overall Study|Physician Decision|0|||
146083047|NCT02353143|526824725|FG000|Overall Study|Adverse Event|0|||
146083048|NCT02353143|526824726|FG001|Overall Study|Adverse Event|0|||
146083049|NCT02353143|526824727|FG002|Overall Study|Adverse Event|1|||
146083050|NCT02353143|526824728|FG003|Overall Study|Adverse Event|0|||
146083051|NCT02353143|526824729|FG004|Overall Study|Adverse Event|1|||
146083052|NCT02353143|526824730|FG005|Overall Study|Adverse Event|1|||
146083053|NCT02353143|526824731|FG006|Overall Study|Adverse Event|0|||
146436011|NCT02964039|528102135|FG000|Overall Study|Withdrawal by Subject|0|||
146436012|NCT02964039|528102136|FG001|Overall Study|Withdrawal by Subject|1|||
146083054|NCT02353143|526824732|FG007|Overall Study|Adverse Event|0|||
146083055|NCT02353143|526824733|FG008|Overall Study|Adverse Event|0|||
146436013|NCT02964039|528102137|FG002|Overall Study|Withdrawal by Subject|0|||
146436014|NCT02964039|528102135|FG000|Overall Study|Lost to Follow-up|1|||
146083056|NCT02353143|526824725|FG000|Overall Study|patient receiving other treatment for AML|0|||
146083057|NCT02353143|526824726|FG001|Overall Study|patient receiving other treatment for AML|0|||
146436015|NCT02964039|528102136|FG001|Overall Study|Lost to Follow-up|0|||
146436016|NCT02964039|528102137|FG002|Overall Study|Lost to Follow-up|1|||
146436017|NCT05479058|528102138|FG000|Overall Study|Withdrawal by Subject|1|||
146436018|NCT05479058|528102139|FG001|Overall Study|Withdrawal by Subject|1|||
146436019|NCT05479058|528102138|FG000|Overall Study|Study terminated by sponsor|10|||
146436020|NCT05479058|528102139|FG001|Overall Study|Study terminated by sponsor|10|||
146436021|NCT05630885|528102140|FG000|Study Completion|Took prohibited medications|2|||
146436022|NCT05630885|528102141|FG001|Study Completion|Took prohibited medications|0|||
146436023|NCT05630885|528102140|FG000|Study Completion|Non-compliance with study drug|1|||
145952187|NCT02452554|526335866|FG003|Overall Study|Death|0|||
145952188|NCT02452554|526335867|FG004|Overall Study|Death|0|||
145952189|NCT02452554|526335868|FG005|Overall Study|Death|0|||
146083058|NCT02353143|526824727|FG002|Overall Study|patient receiving other treatment for AML|1|||
146436024|NCT05630885|528102141|FG001|Study Completion|Non-compliance with study drug|0|||
146436025|NCT05630885|528102140|FG000|Study Completion|Adverse Event|1|||
146436026|NCT05630885|528102141|FG001|Study Completion|Adverse Event|0|||
146436027|NCT05630885|528102140|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
146436028|NCT05630885|528102141|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
146436029|NCT05630885|528102140|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
146436030|NCT05630885|528102141|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
146436031|NCT01103713|528102142|FG000|Overall Study|Lost to Follow-up|2|||
146436032|NCT01103713|528102142|FG000|Overall Study|Withdrawal by Subject|8|||
146436033|NCT01103713|528102142|FG000|Overall Study|Study terminated by sponsor|2|||
146436034|NCT01103713|528102142|FG000|Overall Study|Other|1|||
146436035|NCT01929863|528102145|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
146436036|NCT01929863|528102146|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
146436037|NCT01929863|528102145|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
146436038|NCT01929863|528102146|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
146436039|NCT01929863|528102145|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
146436040|NCT01929863|528102146|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
146436041|NCT00251979|528102147|FG000|Overall Study|Protocol Violation|3|||
146436042|NCT00251979|528102148|FG001|Overall Study|Protocol Violation|5|||
146436043|NCT00251979|528102147|FG000|Overall Study|Adverse Event|11|||
146436044|NCT00251979|528102148|FG001|Overall Study|Adverse Event|17|||
146436045|NCT00251979|528102147|FG000|Overall Study|Withdrawal by Subject|13|||
146436046|NCT00251979|528102148|FG001|Overall Study|Withdrawal by Subject|7|||
146436047|NCT00251979|528102147|FG000|Overall Study|Lost to Follow-up|8|||
146436048|NCT00251979|528102148|FG001|Overall Study|Lost to Follow-up|6|||
146436049|NCT00251979|528102147|FG000|Overall Study|Death|3|||
146436050|NCT00251979|528102148|FG001|Overall Study|Death|5|||
146436051|NCT01878292|528102149|FG000|Randomized|Protocol Violation|1|||
145952190|NCT02452554|526335863|FG000|Overall Study|Lack of Efficacy|13|||
145952191|NCT02452554|526335864|FG001|Overall Study|Lack of Efficacy|14|||
145952192|NCT02452554|526335865|FG002|Overall Study|Lack of Efficacy|9|||
146436052|NCT01878292|528102150|FG001|Randomized|Protocol Violation|0|||
146436053|NCT01878292|528102151|FG002|Randomized|Protocol Violation|0|||
146436054|NCT01878292|528102149|FG000|Randomized|Lost to Follow-up|1|||
146436055|NCT01878292|528102150|FG001|Randomized|Lost to Follow-up|0|||
146436056|NCT01878292|528102151|FG002|Randomized|Lost to Follow-up|0|||
146436057|NCT01878292|528102149|FG000|Randomized|Adverse Event|1|||
146436058|NCT01878292|528102150|FG001|Randomized|Adverse Event|0|||
146436059|NCT01878292|528102151|FG002|Randomized|Adverse Event|0|||
146436060|NCT01878292|528102149|FG000|Double-blind Treatment Period|Other Reasons|2|||
145952193|NCT02452554|526335866|FG003|Overall Study|Lack of Efficacy|1|||
145952194|NCT02452554|526335867|FG004|Overall Study|Lack of Efficacy|5|||
145952195|NCT02452554|526335868|FG005|Overall Study|Lack of Efficacy|8|||
145952196|NCT02452554|526335863|FG000|Overall Study|Physician Decision|0|||
145952197|NCT02452554|526335864|FG001|Overall Study|Physician Decision|1|||
145952198|NCT02452554|526335865|FG002|Overall Study|Physician Decision|0|||
145952199|NCT02452554|526335866|FG003|Overall Study|Physician Decision|0|||
145952200|NCT02452554|526335867|FG004|Overall Study|Physician Decision|0|||
145952201|NCT02452554|526335868|FG005|Overall Study|Physician Decision|0|||
145952202|NCT02452554|526335863|FG000|Overall Study|Withdrawal by Subject|1|||
145952203|NCT02452554|526335864|FG001|Overall Study|Withdrawal by Subject|0|||
145952204|NCT02452554|526335865|FG002|Overall Study|Withdrawal by Subject|2|||
145952205|NCT02452554|526335866|FG003|Overall Study|Withdrawal by Subject|0|||
145952206|NCT02452554|526335867|FG004|Overall Study|Withdrawal by Subject|0|||
145952207|NCT02452554|526335868|FG005|Overall Study|Withdrawal by Subject|1|||
145952208|NCT02452554|526335863|FG000|Overall Study|Ineligible|0|||
146436061|NCT01878292|528102150|FG001|Double-blind Treatment Period|Other Reasons|0|||
145952209|NCT02452554|526335864|FG001|Overall Study|Ineligible|1|||
145952210|NCT02452554|526335865|FG002|Overall Study|Ineligible|0|||
145952211|NCT02452554|526335866|FG003|Overall Study|Ineligible|0|||
145952212|NCT02452554|526335867|FG004|Overall Study|Ineligible|0|||
146436062|NCT01878292|528102151|FG002|Double-blind Treatment Period|Other Reasons|0|||
146436063|NCT01878292|528102149|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
146436064|NCT01878292|528102150|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
146436065|NCT01878292|528102151|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146436066|NCT01878292|528102149|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
146436067|NCT01878292|528102150|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
146436068|NCT01878292|528102151|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
146436069|NCT01878292|528102149|FG000|Double-blind Treatment Period|Protocol Violation|3|||
146436070|NCT01878292|528102150|FG001|Double-blind Treatment Period|Protocol Violation|4|||
146436071|NCT01878292|528102151|FG002|Double-blind Treatment Period|Protocol Violation|2|||
146436072|NCT01878292|528102149|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
146436073|NCT01878292|528102150|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
146436074|NCT01878292|528102151|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146436075|NCT01878292|528102149|FG000|Double-blind Treatment Period|Adverse Event|4|||
146436076|NCT01878292|528102150|FG001|Double-blind Treatment Period|Adverse Event|9|||
146436077|NCT01878292|528102151|FG002|Double-blind Treatment Period|Adverse Event|8|||
146436078|NCT01878292|528102149|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
146436079|NCT01878292|528102150|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
146436080|NCT01878292|528102151|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
146436081|NCT01983969|528102153|FG000|Overall Study|Disease Progression|0|||
146436082|NCT01983969|528102154|FG001|Overall Study|Disease Progression|1|||
146436083|NCT01983969|528102155|FG002|Overall Study|Disease Progression|0|||
146436084|NCT00268203|528102156|FG000|Overall Study|Lost to Follow-up|92|||
146436085|NCT00268203|528102156|FG000|Overall Study|Withdrawal by Subject|9|||
146436086|NCT00268203|528102156|FG000|Overall Study|Received Other NHL Therapy|7|||
146436087|NCT00268203|528102156|FG000|Overall Study|Progressive Disease|359|||
146436088|NCT00268203|528102156|FG000|Overall Study|Death|84|||
146436089|NCT00268203|528102156|FG000|Overall Study|Reason Not Specified|34|||
146436090|NCT00268203|528102156|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
146436091|NCT00950989|528102157|FG000|Overall Study|Death|0|||
146436092|NCT00950989|528102158|FG001|Overall Study|Death|0|||
146436093|NCT00950989|528102159|FG002|Overall Study|Death|1|||
146436094|NCT00950989|528102160|FG003|Overall Study|Death|0|||
146436095|NCT00950989|528102157|FG000|Overall Study|Administrative Decision|0|||
146436096|NCT00950989|528102158|FG001|Overall Study|Administrative Decision|1|||
146436097|NCT00950989|528102159|FG002|Overall Study|Administrative Decision|0|||
146436098|NCT00950989|528102160|FG003|Overall Study|Administrative Decision|0|||
146436099|NCT00950989|528102157|FG000|Overall Study|Disease Progression|0|||
146436100|NCT00950989|528102158|FG001|Overall Study|Disease Progression|0|||
146436101|NCT00950989|528102159|FG002|Overall Study|Disease Progression|1|||
146436102|NCT00950989|528102160|FG003|Overall Study|Disease Progression|0|||
146436103|NCT00950989|528102157|FG000|Overall Study|Withdrawal by Subject|2|||
146436104|NCT00950989|528102158|FG001|Overall Study|Withdrawal by Subject|1|||
146436105|NCT00950989|528102159|FG002|Overall Study|Withdrawal by Subject|0|||
146436106|NCT00950989|528102160|FG003|Overall Study|Withdrawal by Subject|0|||
146436107|NCT00950989|528102157|FG000|Overall Study|Adverse Event|2|||
146436108|NCT00950989|528102158|FG001|Overall Study|Adverse Event|1|||
146436109|NCT00950989|528102159|FG002|Overall Study|Adverse Event|1|||
146436110|NCT00950989|528102160|FG003|Overall Study|Adverse Event|0|||
146436111|NCT00730691|528102161|FG000|Overall Study|Adverse Event|4|||
146436112|NCT00730691|528102162|FG001|Overall Study|Adverse Event|8|||
146436113|NCT00730691|528102163|FG002|Overall Study|Adverse Event|11|||
146436114|NCT00730691|528102164|FG003|Overall Study|Adverse Event|11|||
146436115|NCT00730691|528102165|FG004|Overall Study|Adverse Event|23|||
146436116|NCT00730691|528102161|FG000|Overall Study|Lack of Efficacy|4|||
146436117|NCT00730691|528102162|FG001|Overall Study|Lack of Efficacy|4|||
146436118|NCT00730691|528102163|FG002|Overall Study|Lack of Efficacy|2|||
146436119|NCT00730691|528102164|FG003|Overall Study|Lack of Efficacy|1|||
146436120|NCT00730691|528102165|FG004|Overall Study|Lack of Efficacy|1|||
146436121|NCT00730691|528102161|FG000|Overall Study|Non-compliance with Study Drug|6|||
146436122|NCT00730691|528102162|FG001|Overall Study|Non-compliance with Study Drug|1|||
146436123|NCT00730691|528102163|FG002|Overall Study|Non-compliance with Study Drug|6|||
146436124|NCT00730691|528102164|FG003|Overall Study|Non-compliance with Study Drug|3|||
146436125|NCT00730691|528102165|FG004|Overall Study|Non-compliance with Study Drug|3|||
146436126|NCT00730691|528102161|FG000|Overall Study|Protocol Deviations|3|||
145952213|NCT02452554|526335868|FG005|Overall Study|Ineligible|0|||
146436127|NCT00730691|528102162|FG001|Overall Study|Protocol Deviations|5|||
146436128|NCT00730691|528102163|FG002|Overall Study|Protocol Deviations|3|||
146436129|NCT00730691|528102164|FG003|Overall Study|Protocol Deviations|7|||
146436130|NCT00730691|528102165|FG004|Overall Study|Protocol Deviations|5|||
146436131|NCT00730691|528102161|FG000|Overall Study|Withdrawal of Consent|7|||
146436132|NCT00730691|528102162|FG001|Overall Study|Withdrawal of Consent|9|||
146436133|NCT00730691|528102163|FG002|Overall Study|Withdrawal of Consent|3|||
146436134|NCT00730691|528102164|FG003|Overall Study|Withdrawal of Consent|6|||
146436135|NCT00730691|528102165|FG004|Overall Study|Withdrawal of Consent|3|||
146436136|NCT00730691|528102161|FG000|Overall Study|Lost to Follow-up|11|||
146436137|NCT00730691|528102162|FG001|Overall Study|Lost to Follow-up|8|||
146436138|NCT00730691|528102163|FG002|Overall Study|Lost to Follow-up|13|||
146436139|NCT00730691|528102164|FG003|Overall Study|Lost to Follow-up|15|||
146436140|NCT00730691|528102165|FG004|Overall Study|Lost to Follow-up|13|||
146436141|NCT00730691|528102161|FG000|Overall Study|Other|1|||
146436142|NCT00730691|528102162|FG001|Overall Study|Other|1|||
146436143|NCT00730691|528102163|FG002|Overall Study|Other|1|||
146436144|NCT00730691|528102164|FG003|Overall Study|Other|2|||
146436145|NCT00730691|528102165|FG004|Overall Study|Other|2|||
146436146|NCT05776901|528103962|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
146436147|NCT00682461|528103964|FG000|Overall Study|Adverse Event|5|||
146436148|NCT00682461|528103965|FG001|Overall Study|Adverse Event|7|||
146436149|NCT00682461|528103964|FG000|Overall Study|Lost to Follow-up|8|||
146436150|NCT00682461|528103965|FG001|Overall Study|Lost to Follow-up|5|||
146436151|NCT00682461|528103964|FG000|Overall Study|Withdrawal by Subject|12|||
146436152|NCT00682461|528103965|FG001|Overall Study|Withdrawal by Subject|19|||
146436153|NCT00835705|528103966|FG000|First Intervention|Difficulty with vein|1|||
146436154|NCT00835705|528103967|FG001|First Intervention|Difficulty with vein|0|||
146436155|NCT00835705|528103966|FG000|Second Intervention|Difficulty with vein|1|||
146436156|NCT00835705|528103967|FG001|Second Intervention|Difficulty with vein|0|||
146436157|NCT00665925|528103968|FG000|Overall Study|Lack of Efficacy|10|||
146436158|NCT00665925|528103969|FG001|Overall Study|Lack of Efficacy|8|||
146436159|NCT00665925|528103970|FG002|Overall Study|Lack of Efficacy|9|||
146436160|NCT00665925|528103971|FG003|Overall Study|Lack of Efficacy|8|||
146436161|NCT00665925|528103968|FG000|Overall Study|Lost to Follow-up|1|||
146436162|NCT00665925|528103969|FG001|Overall Study|Lost to Follow-up|2|||
146436163|NCT00665925|528103970|FG002|Overall Study|Lost to Follow-up|2|||
146436164|NCT00665925|528103971|FG003|Overall Study|Lost to Follow-up|2|||
146436165|NCT00665925|528103968|FG000|Overall Study|Withdrawal by Subject|2|||
146436166|NCT00665925|528103969|FG001|Overall Study|Withdrawal by Subject|2|||
145952214|NCT02452554|526335863|FG000|Overall Study|Never Received Treatment|1|||
146436167|NCT00665925|528103970|FG002|Overall Study|Withdrawal by Subject|3|||
146436168|NCT00665925|528103971|FG003|Overall Study|Withdrawal by Subject|2|||
146436169|NCT00665925|528103968|FG000|Overall Study|Physician Decision|0|||
145952215|NCT02452554|526335864|FG001|Overall Study|Never Received Treatment|0|||
146436170|NCT00665925|528103969|FG001|Overall Study|Physician Decision|0|||
146436171|NCT00665925|528103970|FG002|Overall Study|Physician Decision|1|||
146436172|NCT00665925|528103971|FG003|Overall Study|Physician Decision|2|||
146436173|NCT00665925|528103968|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
146436174|NCT00665925|528103969|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
146436175|NCT00665925|528103970|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
146436176|NCT00665925|528103971|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
146436177|NCT00665925|528103968|FG000|Overall Study|Adverse Event|1|||
146436178|NCT00665925|528103969|FG001|Overall Study|Adverse Event|5|||
146436179|NCT00665925|528103970|FG002|Overall Study|Adverse Event|10|||
146436180|NCT00665925|528103971|FG003|Overall Study|Adverse Event|5|||
146436181|NCT00665925|528103968|FG000|Overall Study|Enrolled by mistake|0|||
146436182|NCT00665925|528103969|FG001|Overall Study|Enrolled by mistake|0|||
146436183|NCT00665925|528103970|FG002|Overall Study|Enrolled by mistake|0|||
146436184|NCT00665925|528103971|FG003|Overall Study|Enrolled by mistake|1|||
146436185|NCT00665925|528103968|FG000|Overall Study|Due to exclusion criteria|1|||
146436186|NCT00665925|528103969|FG001|Overall Study|Due to exclusion criteria|0|||
146436187|NCT00665925|528103970|FG002|Overall Study|Due to exclusion criteria|0|||
146436188|NCT00665925|528103971|FG003|Overall Study|Due to exclusion criteria|0|||
146436189|NCT04035187|528103972|FG000|Overall Study|Withdrawal by Subject|2|||
146436190|NCT04035187|528103973|FG001|Overall Study|Withdrawal by Subject|1|||
146436191|NCT04035187|528103974|FG002|Overall Study|Withdrawal by Subject|0|||
146436192|NCT04035187|528103975|FG003|Overall Study|Withdrawal by Subject|0|||
146436193|NCT04035187|528103972|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
146436194|NCT04035187|528103973|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
146436195|NCT04035187|528103974|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
146436196|NCT04035187|528103975|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
146436197|NCT01987765|528103984|FG000|Overall Study|Protocol Violation|65|||
146436198|NCT01987765|528103984|FG000|Overall Study|Lost to Follow-up|37|||
146436199|NCT03049748|528103987|FG000|Overall Study|Lost to Follow-up|1|||
146436200|NCT03049748|528103988|FG001|Overall Study|Lost to Follow-up|0|||
146436201|NCT03049748|528103987|FG000|Overall Study|Death|3|||
146436202|NCT03049748|528103988|FG001|Overall Study|Death|0|||
146436203|NCT03049748|528103987|FG000|Overall Study|Withdrawal by Subject|0|||
146436204|NCT03049748|528103988|FG001|Overall Study|Withdrawal by Subject|3|||
146436205|NCT03049748|528103987|FG000|Overall Study|Protocol Violation|0|||
146436206|NCT03049748|528103988|FG001|Overall Study|Protocol Violation|2|||
146436207|NCT03049748|528103987|FG000|Overall Study|Moved out of state (relocation)|0|||
146436208|NCT03049748|528103988|FG001|Overall Study|Moved out of state (relocation)|1|||
146436209|NCT03502811|528103991|FG000|Overall Study|Death|157|||
146436210|NCT03502811|528103991|FG000|Overall Study|Withdrawal by Subject|105|||
146436211|NCT03502811|528103991|FG000|Overall Study|Lost to Follow-up|26|||
146436212|NCT03502811|528103991|FG000|Overall Study|No Visits (Missed)|31|||
146436213|NCT01492439|528103992|FG000|Overall Study|Withdrew from RTE|4|||
146436214|NCT01492439|528103993|FG001|Overall Study|Withdrew from RTE|9|||
146436215|NCT00824291|528103996|FG000|Overall Study|Adverse Event|15|||
146436216|NCT00824291|528103997|FG001|Overall Study|Adverse Event|6|||
146436217|NCT00824291|528103996|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146436218|NCT00824291|528103997|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
146436219|NCT00824291|528103996|FG000|Overall Study|Lost to Follow-up|11|||
146436220|NCT00824291|528103997|FG001|Overall Study|Lost to Follow-up|9|||
146436221|NCT00824291|528103996|FG000|Overall Study|Non-compliance|1|||
146436222|NCT00824291|528103997|FG001|Overall Study|Non-compliance|1|||
146436223|NCT00824291|528103996|FG000|Overall Study|Protocol Violation|4|||
146436224|NCT00824291|528103997|FG001|Overall Study|Protocol Violation|1|||
146436225|NCT00824291|528103996|FG000|Overall Study|Withdrawal by Subject|14|||
146208264|NCT00402246|527277750|FG000|Overall Study|Patient's device explanted|6|||
146208265|NCT00402246|527277751|FG001|Overall Study|Patient's device explanted|2|||
146436226|NCT00824291|528103997|FG001|Overall Study|Withdrawal by Subject|8|||
146436227|NCT00824291|528103996|FG000|Overall Study|Lack of Efficacy|7|||
146208266|NCT00402246|527277750|FG000|Overall Study|Center Closure|5|||
146208267|NCT00402246|527277751|FG001|Overall Study|Center Closure|3|||
146208268|NCT00402246|527277750|FG000|Overall Study|Deterioriating Condition|3|||
146208269|NCT00402246|527277751|FG001|Overall Study|Deterioriating Condition|2|||
146208270|NCT01808339|527277757|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146436228|NCT00824291|528103997|FG001|Overall Study|Lack of Efficacy|8|||
146436229|NCT00824291|528103996|FG000|Overall Study|Participant on prohibited medication|1|||
146436230|NCT00824291|528103997|FG001|Overall Study|Participant on prohibited medication|0|||
146436231|NCT00123734|528103998|FG000|Overall Study|Death|3|||
146436232|NCT00123734|528103998|FG000|Overall Study|Lost to Follow-up|3|||
146436233|NCT00123734|528103998|FG000|Overall Study|Dropout|1|||
146436234|NCT00123734|528103998|FG000|Overall Study|Withdrawal by Subject|1|||
146436235|NCT00113386|528103999|FG000|Overall Study|Withdrawal by Subject|1|||
146436236|NCT00113386|528104000|FG001|Overall Study|Withdrawal by Subject|0|||
146436237|NCT00113386|528103999|FG000|Overall Study|Physician Decision|0|||
146436238|NCT00113386|528104000|FG001|Overall Study|Physician Decision|1|||
145952216|NCT02452554|526335865|FG002|Overall Study|Never Received Treatment|0|||
145952217|NCT02452554|526335866|FG003|Overall Study|Never Received Treatment|0|||
145952218|NCT02452554|526335867|FG004|Overall Study|Never Received Treatment|0|||
145952219|NCT02452554|526335868|FG005|Overall Study|Never Received Treatment|0|||
145952220|NCT02494401|526335869|FG000|Overall Study|Lost to Follow-up|22|||
145952221|NCT02494401|526335870|FG001|Overall Study|Lost to Follow-up|25|||
145952222|NCT02494401|526335869|FG000|Overall Study|Withdrawal by Subject|3|||
145952223|NCT02494401|526335870|FG001|Overall Study|Withdrawal by Subject|2|||
145952224|NCT01048944|526337869|FG000|Overall Study|Protocol Violation|8|||
145952225|NCT01048944|526337870|FG001|Overall Study|Protocol Violation|10|||
145952226|NCT01048944|526337871|FG002|Overall Study|Protocol Violation|10|||
145952227|NCT01048944|526337872|FG003|Overall Study|Protocol Violation|2|||
145952228|NCT00376532|526337873|FG000|Overall Study|Lack sufficient blood sample|6|||
145952229|NCT00376532|526337874|FG001|Overall Study|Lack sufficient blood sample|6|||
145952230|NCT01133704|526337875|FG000|Overall Study|Death|44|||
145952231|NCT01133704|526337876|FG001|Overall Study|Death|26|||
145952232|NCT01133704|526337875|FG000|Overall Study|Patient refused to continue|4|||
145952233|NCT01133704|526337876|FG001|Overall Study|Patient refused to continue|0|||
145952234|NCT01133704|526337875|FG000|Overall Study|Study Closure|1|||
145952235|NCT01133704|526337876|FG001|Overall Study|Study Closure|0|||
145952236|NCT03746405|526337881|FG000|Overall Study|Withdrawal by Subject|3|||
145952237|NCT03746405|526337882|FG001|Overall Study|Withdrawal by Subject|0|||
145952238|NCT03746405|526337881|FG000|Overall Study|technical difficulties|0|||
145952239|NCT03746405|526337882|FG001|Overall Study|technical difficulties|2|||
145952240|NCT02753816|526337883|FG000|Overall Study|Protocol Violation|0|||
145952241|NCT02753816|526337884|FG001|Overall Study|Protocol Violation|1|||
145952242|NCT02753816|526337885|FG002|Overall Study|Protocol Violation|0|||
145952243|NCT02372383|526337889|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
145952244|NCT02372383|526337890|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
145952245|NCT02372383|526337891|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
145952246|NCT04472494|526337892|FG000|Pre-treatment|Other reasons|2|||
145952247|NCT04472494|526337893|FG001|Pre-treatment|Other reasons|0|||
145952248|NCT04472494|526337892|FG000|Treatment|Death|5|||
145952249|NCT04472494|526337893|FG001|Treatment|Death|2|||
145952250|NCT04472494|526337892|FG000|Treatment|Hospital discharge|1|||
145952251|NCT04472494|526337893|FG001|Treatment|Hospital discharge|1|||
145952252|NCT00707980|526337894|FG000|Overall Study|Adverse Event|49|||
145952253|NCT00707980|526337894|FG000|Overall Study|Lack of Efficacy|35|||
145952254|NCT00707980|526337894|FG000|Overall Study|Non-Compliance with Study Drug|28|||
145952255|NCT00707980|526337894|FG000|Overall Study|Protocol Deviations|19|||
145952256|NCT00707980|526337894|FG000|Overall Study|Withdrawal of Consent|81|||
145952257|NCT00707980|526337894|FG000|Overall Study|Lost to Follow-up|59|||
145952258|NCT00707980|526337894|FG000|Overall Study|Other|39|||
145952259|NCT02768792|526337901|FG000|Overall Study|Adverse Event|1|||
145952260|NCT01188668|526337902|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
145952261|NCT01188668|526337902|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
145952262|NCT01188668|526337902|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
145952263|NCT00303472|526337903|FG000|Treatment Period|Adverse Event|0|||
145952264|NCT00303472|526337904|FG001|Treatment Period|Adverse Event|0|||
145952265|NCT00303472|526337905|FG002|Treatment Period|Adverse Event|0|||
145952266|NCT00303472|526337906|FG003|Treatment Period|Adverse Event|0|||
145952267|NCT00303472|526337907|FG004|Treatment Period|Adverse Event|1|||
145952268|NCT00303472|526337908|FG005|Treatment Period|Adverse Event|0|||
145952269|NCT00303472|526337909|FG006|Treatment Period|Adverse Event|0|||
146436239|NCT00113386|528103999|FG000|Overall Study|Toxicity|3|||
145952270|NCT00303472|526337903|FG000|Treatment Period|Death|0|||
145952271|NCT00303472|526337904|FG001|Treatment Period|Death|0|||
145952272|NCT00303472|526337905|FG002|Treatment Period|Death|0|||
146083059|NCT02353143|526824728|FG003|Overall Study|patient receiving other treatment for AML|0|||
146083060|NCT02353143|526824729|FG004|Overall Study|patient receiving other treatment for AML|0|||
146208271|NCT01808339|527277758|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208272|NCT01808339|527277759|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208273|NCT01808339|527277760|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146083061|NCT02353143|526824730|FG005|Overall Study|patient receiving other treatment for AML|0|||
146208274|NCT01808339|527277761|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
146436240|NCT00113386|528104000|FG001|Overall Study|Toxicity|0|||
145952273|NCT00303472|526337906|FG003|Treatment Period|Death|1|||
145952274|NCT00303472|526337907|FG004|Treatment Period|Death|0|||
145952275|NCT00303472|526337908|FG005|Treatment Period|Death|0|||
145952276|NCT00303472|526337909|FG006|Treatment Period|Death|1|||
145952277|NCT00303472|526337903|FG000|Treatment Period|Withdrawal by Subject|0|||
145952278|NCT00303472|526337904|FG001|Treatment Period|Withdrawal by Subject|0|||
145952279|NCT00303472|526337905|FG002|Treatment Period|Withdrawal by Subject|0|||
145952280|NCT00303472|526337906|FG003|Treatment Period|Withdrawal by Subject|1|||
145952281|NCT00303472|526337907|FG004|Treatment Period|Withdrawal by Subject|0|||
145952282|NCT00303472|526337908|FG005|Treatment Period|Withdrawal by Subject|1|||
145952283|NCT00303472|526337909|FG006|Treatment Period|Withdrawal by Subject|0|||
146436241|NCT00113386|528103999|FG000|Overall Study|Ineligible|1|||
146436242|NCT00113386|528104000|FG001|Overall Study|Ineligible|2|||
146436243|NCT00113386|528103999|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
146436244|NCT00113386|528104000|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
146436245|NCT01648582|528104001|FG000|Overall Study|Adverse Event|6|||
146436246|NCT01648582|528104002|FG001|Overall Study|Adverse Event|11|||
146436247|NCT01648582|528104003|FG002|Overall Study|Adverse Event|2|||
146436248|NCT01648582|528104001|FG000|Overall Study|Lost to Follow-up|9|||
146436249|NCT01648582|528104002|FG001|Overall Study|Lost to Follow-up|6|||
146436250|NCT01648582|528104003|FG002|Overall Study|Lost to Follow-up|8|||
146436251|NCT01648582|528104001|FG000|Overall Study|Protocol Violation|1|||
146436252|NCT01648582|528104002|FG001|Overall Study|Protocol Violation|2|||
146436253|NCT01648582|528104003|FG002|Overall Study|Protocol Violation|1|||
146436254|NCT01648582|528104001|FG000|Overall Study|Withdrawal by Subject|15|||
146436255|NCT01648582|528104002|FG001|Overall Study|Withdrawal by Subject|17|||
146436256|NCT01648582|528104003|FG002|Overall Study|Withdrawal by Subject|17|||
146436257|NCT01648582|528104001|FG000|Overall Study|Physician Decision|0|||
146436258|NCT01648582|528104002|FG001|Overall Study|Physician Decision|1|||
146436259|NCT01648582|528104003|FG002|Overall Study|Physician Decision|3|||
146436260|NCT01648582|528104001|FG000|Overall Study|Death|1|||
146436261|NCT01648582|528104002|FG001|Overall Study|Death|0|||
146436262|NCT01648582|528104003|FG002|Overall Study|Death|0|||
146436263|NCT01648582|528104001|FG000|Overall Study|Sponsor Decision|0|||
146436264|NCT01648582|528104002|FG001|Overall Study|Sponsor Decision|1|||
146436265|NCT01648582|528104003|FG002|Overall Study|Sponsor Decision|1|||
146436266|NCT04408794|528104004|FG000|Overall Study|Adverse Event|43|||
146436267|NCT04408794|528104004|FG000|Overall Study|Infrequent study drug usage|43|||
146436268|NCT04408794|528104004|FG000|Overall Study|Lack of Efficacy|61|||
146436269|NCT04408794|528104004|FG000|Overall Study|Lost to Follow-up|33|||
146436270|NCT04408794|528104004|FG000|Overall Study|Non-compliance|6|||
146436271|NCT04408794|528104004|FG000|Overall Study|Physician Decision|1|||
146436272|NCT04408794|528104004|FG000|Overall Study|Pregnancy|6|||
146436273|NCT04408794|528104004|FG000|Overall Study|Protocol Deviation|9|||
146436274|NCT04408794|528104004|FG000|Overall Study|Sheehan-STS Result|1|||
146436275|NCT04408794|528104004|FG000|Overall Study|Withdrawal by Subject|57|||
146436276|NCT04408794|528104004|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
146436277|NCT04408794|528104004|FG000|Overall Study|Never Treated Migraine|5|||
146436278|NCT01444378|528104009|FG000|Overall Study|Lost to Follow-up|1|||
146436279|NCT01444378|528104009|FG000|Overall Study|Withdrawal by Subject|1|||
146436280|NCT01444378|528104009|FG000|Overall Study|Death|3|||
146436281|NCT01444378|528104009|FG000|Overall Study|Administrative Closure Of The Study|2|||
146436282|NCT01444378|528104009|FG000|Overall Study|Missed Visits|10|||
146436283|NCT00556322|528104010|FG000|Overall Study|Insufficient therapeutic response|158|||
146436284|NCT00556322|528104011|FG001|Overall Study|Insufficient therapeutic response|168|||
146436285|NCT00556322|528104010|FG000|Overall Study|Adverse Event|7|||
146436286|NCT00556322|528104011|FG001|Overall Study|Adverse Event|4|||
146436287|NCT00556322|528104010|FG000|Overall Study|Other|4|||
146208275|NCT01808339|527277762|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146208276|NCT01808339|527277757|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146208277|NCT01808339|527277758|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146208278|NCT01808339|527277759|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146208279|NCT01808339|527277760|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146436288|NCT00556322|528104011|FG001|Overall Study|Other|1|||
146436289|NCT00556322|528104010|FG000|Overall Study|Lost to Follow-up|5|||
146436290|NCT00556322|528104011|FG001|Overall Study|Lost to Follow-up|3|||
146436291|NCT00556322|528104010|FG000|Overall Study|Withdrawal by Subject|19|||
146436292|NCT00556322|528104011|FG001|Overall Study|Withdrawal by Subject|7|||
146436293|NCT00556322|528104010|FG000|Overall Study|Protocol Violation|5|||
146436294|NCT00556322|528104011|FG001|Overall Study|Protocol Violation|1|||
146436295|NCT00556322|528104010|FG000|Overall Study|Ongoing at data cutoff|3|||
146436296|NCT00556322|528104011|FG001|Overall Study|Ongoing at data cutoff|5|||
146436297|NCT00556322|528104010|FG000|Overall Study|Death|20|||
146436298|NCT00556322|528104011|FG001|Overall Study|Death|14|||
146436299|NCT03261167|528104014|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
146436300|NCT03261167|528104015|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
146436301|NCT03261167|528104014|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
146436302|NCT03261167|528104015|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
146436303|NCT03261167|528104014|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
146436304|NCT03261167|528104015|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
145952284|NCT00303472|526337903|FG000|Treatment Period|Other|0|||
145952285|NCT00303472|526337904|FG001|Treatment Period|Other|0|||
145952286|NCT00303472|526337905|FG002|Treatment Period|Other|0|||
145952287|NCT00303472|526337906|FG003|Treatment Period|Other|0|||
145952288|NCT00303472|526337907|FG004|Treatment Period|Other|1|||
145952289|NCT00303472|526337908|FG005|Treatment Period|Other|0|||
145952290|NCT00303472|526337909|FG006|Treatment Period|Other|1|||
145952291|NCT00303472|526337903|FG000|Treatment Period|Disease Progression (to AML)|0|||
145952292|NCT00303472|526337904|FG001|Treatment Period|Disease Progression (to AML)|0|||
145952293|NCT00303472|526337905|FG002|Treatment Period|Disease Progression (to AML)|0|||
145952294|NCT00303472|526337906|FG003|Treatment Period|Disease Progression (to AML)|0|||
145952295|NCT00303472|526337907|FG004|Treatment Period|Disease Progression (to AML)|1|||
145952296|NCT00303472|526337908|FG005|Treatment Period|Disease Progression (to AML)|0|||
145952297|NCT00303472|526337909|FG006|Treatment Period|Disease Progression (to AML)|0|||
145952298|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Adverse Event|1|||
145952299|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Adverse Event|0|||
145952300|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Adverse Event|1|||
145952301|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Adverse Event|0|||
145952302|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Adverse Event|0|||
145952303|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Adverse Event|0|||
145952304|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Adverse Event|0|||
145952305|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Death|2|||
145952306|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Death|0|||
145952307|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Death|1|||
145952308|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Death|0|||
146436305|NCT03261167|528104014|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
146436306|NCT03261167|528104015|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
146436307|NCT03261167|528104014|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
146436308|NCT03261167|528104015|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
146436309|NCT03256695|528104018|FG000|Overall Study|Adverse Event|8|||
146436310|NCT03256695|528104018|FG000|Overall Study|Death|2|||
146436311|NCT03256695|528104018|FG000|Overall Study|Withdrawal by Subject|14|||
146436312|NCT03256695|528104018|FG000|Overall Study|Non-compliance with study drug|1|||
146436313|NCT03256695|528104018|FG000|Overall Study|Lost to Follow-up|3|||
146436314|NCT03256695|528104018|FG000|Overall Study|Lack of Efficacy|3|||
145952309|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Death|0|||
145952310|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Death|0|||
145952311|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Death|0|||
145952312|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
145952313|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
145952314|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
145952315|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
145952316|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
145952317|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
146436315|NCT03256695|528104018|FG000|Overall Study|Protocol Violation|5|||
146436316|NCT03256695|528104018|FG000|Overall Study|Other than specified|3|||
146436317|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Adverse Event|11|||
146436318|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Adverse Event|23|||
146436319|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Adverse Event|29|||
146436320|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Adverse Event|2|||
146436321|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Adverse Event|8|||
146436322|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
146436323|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
146436324|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
146436325|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
146436326|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
146436327|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
146436328|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
146436329|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
145952318|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
145952319|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Physician Decision|0|||
145952320|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Physician Decision|4|||
145952321|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Physician Decision|2|||
145952322|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Physician Decision|3|||
145952323|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Physician Decision|2|||
146083062|NCT02353143|526824731|FG006|Overall Study|patient receiving other treatment for AML|0|||
146436330|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
146436331|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
146436332|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
146436333|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
146436334|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
146436335|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
146436336|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
146436337|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
146436338|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
146436339|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
146436340|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
146436341|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
146436342|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
146436343|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
146436344|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
146436345|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
146436346|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
146436347|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
146436348|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
146436349|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
146436350|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
146436351|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
146436352|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Move|0|||
146436353|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Move|1|||
146436354|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Move|0|||
146436355|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Move|0|||
146436356|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Move|0|||
146436357|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
146208280|NCT01808339|527277761|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146436358|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
146436359|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
146436360|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
146436361|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
146436362|NCT00318461|528104019|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
146436363|NCT00318461|528104020|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
146436364|NCT00318461|528104021|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
146436365|NCT00318461|528104022|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
146436366|NCT00318461|528104023|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
146436367|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Work commitment|0|||
146436368|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Work commitment|0|||
146436369|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Work commitment|0|||
146436370|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Work commitment|0|||
146436371|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Work commitment|1|||
146436372|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Investigator decision|0|||
146436373|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Investigator decision|0|||
146436374|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Investigator decision|0|||
146436375|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Investigator decision|0|||
146436376|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Investigator decision|1|||
146436377|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Lack of time|1|||
146436378|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Lack of time|0|||
146436379|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Lack of time|0|||
146436380|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Lack of time|0|||
146436381|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Lack of time|0|||
146436382|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
146208281|NCT01808339|527277762|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146208282|NCT01808339|527277757|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208283|NCT01808339|527277758|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146436383|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
146436384|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
146436385|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
146436386|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
146436387|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
146436388|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
146436389|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
146436390|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
146436391|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
146436392|NCT00318461|528104019|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
146436393|NCT00318461|528104020|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
146436394|NCT00318461|528104021|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
146436395|NCT00318461|528104022|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
146436396|NCT00318461|528104023|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
146436397|NCT00318461|528104019|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
146436398|NCT00318461|528104020|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
146436399|NCT00318461|528104021|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
146436400|NCT00318461|528104022|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
146436401|NCT00318461|528104023|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
146436402|NCT00318461|528104019|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
146436403|NCT00318461|528104020|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
146436404|NCT00318461|528104021|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
146436405|NCT00318461|528104022|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
146436406|NCT00318461|528104023|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
146436407|NCT00318461|528104019|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
146436408|NCT00318461|528104020|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
146436409|NCT00318461|528104021|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
146436410|NCT00318461|528104022|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
146436411|NCT00318461|528104023|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
146436412|NCT00318461|528104019|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
146436413|NCT00318461|528104020|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
146436414|NCT00318461|528104021|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
146436415|NCT00318461|528104022|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
146436416|NCT00318461|528104023|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
146436417|NCT00318461|528104019|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
146436418|NCT00318461|528104020|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
146436419|NCT00318461|528104021|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
146436420|NCT00318461|528104022|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
146436421|NCT00318461|528104023|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
146436422|NCT01848938|528104032|FG000|Overall Study|Lost to Follow-up|1|||
146436423|NCT01848938|528104033|FG001|Overall Study|Lost to Follow-up|1|||
146436424|NCT01757392|528104034|FG000|Overall Study|Withdrawal by Subject|1|||
146436425|NCT01757392|528104034|FG000|Overall Study|Screen Fail|3|||
146436426|NCT00207090|528104039|FG000|Overall Study|Study drug toxicity|3|||
146436427|NCT00207090|528104039|FG000|Overall Study|Chest wall mass larger|1|||
146436428|NCT00207090|528104039|FG000|Overall Study|Disease progression/relapse|2|||
146436429|NCT00207090|528104039|FG000|Overall Study|Physician Decision|1|||
146436430|NCT00841698|528104042|FG000|First Intervention|Withdrawal by Subject|1|||
146436431|NCT00841698|528104043|FG001|First Intervention|Withdrawal by Subject|0|||
146436432|NCT01348789|528104055|FG000|Overall Study|Protocol Violation|2|||
146436433|NCT01348789|528104055|FG000|Overall Study|Withdrawal by Subject|2|||
146436434|NCT00323882|528104056|FG000|Overall Study|Adverse Event|2|||
146436435|NCT00323882|528104057|FG001|Overall Study|Adverse Event|1|||
146436436|NCT00323882|528104058|FG002|Overall Study|Adverse Event|1|||
146436437|NCT00323882|528104059|FG003|Overall Study|Adverse Event|1|||
146436438|NCT00323882|528104060|FG004|Overall Study|Adverse Event|3|||
146436439|NCT00323882|528104056|FG000|Overall Study|Disease Progression|6|||
146436440|NCT00323882|528104057|FG001|Overall Study|Disease Progression|4|||
146436441|NCT00323882|528104058|FG002|Overall Study|Disease Progression|10|||
146436442|NCT00323882|528104059|FG003|Overall Study|Disease Progression|5|||
146436443|NCT00323882|528104060|FG004|Overall Study|Disease Progression|22|||
146436444|NCT00323882|528104056|FG000|Overall Study|Death|0|||
146436445|NCT00323882|528104057|FG001|Overall Study|Death|1|||
146436446|NCT00323882|528104058|FG002|Overall Study|Death|1|||
146436447|NCT00323882|528104059|FG003|Overall Study|Death|0|||
146436448|NCT00323882|528104060|FG004|Overall Study|Death|5|||
146436449|NCT00323882|528104056|FG000|Overall Study|Lost to Follow-up|0|||
146436450|NCT00323882|528104057|FG001|Overall Study|Lost to Follow-up|0|||
146436451|NCT00323882|528104058|FG002|Overall Study|Lost to Follow-up|1|||
146436452|NCT00323882|528104059|FG003|Overall Study|Lost to Follow-up|0|||
145952324|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Physician Decision|0|||
145952325|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Physician Decision|0|||
145952326|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145952327|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145952328|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145952329|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
145952330|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145952331|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145952332|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145952333|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Other|0|||
146208284|NCT01808339|527277759|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
146208285|NCT01808339|527277760|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208286|NCT01808339|527277761|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208287|NCT01808339|527277762|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
146208288|NCT02932579|527277764|FG000|Overall Study|Withdrawal by Subject|4|||
146208289|NCT02932579|527277765|FG001|Overall Study|Withdrawal by Subject|1|||
146208290|NCT00818246|527277767|FG000|Overall Study|Impossible to match pictures|5|||
146208291|NCT02121002|527277769|FG000|Overall Study|Physician Decision|2|||
146208292|NCT02121002|527277770|FG001|Overall Study|Physician Decision|0|||
146208293|NCT02121002|527277771|FG002|Overall Study|Physician Decision|0|||
146208294|NCT02121002|527277769|FG000|Overall Study|Withdrawal by Subject|3|||
146208295|NCT02121002|527277770|FG001|Overall Study|Withdrawal by Subject|1|||
146208296|NCT02121002|527277771|FG002|Overall Study|Withdrawal by Subject|4|||
146208297|NCT02121002|527277769|FG000|Overall Study|Protocol Violation|1|||
146208298|NCT02121002|527277770|FG001|Overall Study|Protocol Violation|2|||
146208299|NCT02121002|527277771|FG002|Overall Study|Protocol Violation|4|||
146208300|NCT02121002|527277769|FG000|Overall Study|Concomitant therapy|0|||
146208301|NCT02121002|527277770|FG001|Overall Study|Concomitant therapy|1|||
146208302|NCT02121002|527277771|FG002|Overall Study|Concomitant therapy|1|||
146208303|NCT02121002|527277769|FG000|Overall Study|Others|1|||
146208304|NCT02121002|527277770|FG001|Overall Study|Others|0|||
146208305|NCT02121002|527277771|FG002|Overall Study|Others|1|||
146208306|NCT01007396|527277772|FG000|Overall Study|Lost to Follow-up|47|||
146208307|NCT00296036|527277773|FG000|Overall Study|Withdrawal by Subject|1|||
146208308|NCT00296036|527277774|FG001|Overall Study|Withdrawal by Subject|0|||
146208309|NCT00296036|527277775|FG002|Overall Study|Withdrawal by Subject|2|||
146208310|NCT00296036|527277776|FG003|Overall Study|Withdrawal by Subject|1|||
146208311|NCT00296036|527277777|FG004|Overall Study|Withdrawal by Subject|2|||
146208312|NCT00296036|527277778|FG005|Overall Study|Withdrawal by Subject|1|||
146208313|NCT00296036|527277773|FG000|Overall Study|Protocol Violation|0|||
146208314|NCT00296036|527277774|FG001|Overall Study|Protocol Violation|0|||
146208315|NCT00296036|527277775|FG002|Overall Study|Protocol Violation|0|||
146208316|NCT00296036|527277776|FG003|Overall Study|Protocol Violation|0|||
146208317|NCT00296036|527277777|FG004|Overall Study|Protocol Violation|0|||
146208318|NCT00296036|527277778|FG005|Overall Study|Protocol Violation|3|||
146208319|NCT03403413|527277779|FG000|Overall Study|Lack of Efficacy|2|||
146208320|NCT03655262|527277780|FG000|Overall Study|Withdrawal by Subject|0|||
146208321|NCT03655262|527277781|FG001|Overall Study|Withdrawal by Subject|0|||
146208322|NCT03655262|527277782|FG002|Overall Study|Withdrawal by Subject|1|||
146208323|NCT05052996|527277786|FG000|Overall Study|Still on study|0|||
146208324|NCT05052996|527277787|FG001|Overall Study|Still on study|0|||
146208325|NCT05052996|527277788|FG002|Overall Study|Still on study|47|||
146208326|NCT05052996|527277789|FG003|Overall Study|Still on study|44|||
146208327|NCT05052996|527277786|FG000|Overall Study|Cohort terminated by sponsor|21|||
146208328|NCT05052996|527277787|FG001|Overall Study|Cohort terminated by sponsor|12|||
146208329|NCT05052996|527277788|FG002|Overall Study|Cohort terminated by sponsor|0|||
146208330|NCT05052996|527277789|FG003|Overall Study|Cohort terminated by sponsor|0|||
146208331|NCT05052996|527277786|FG000|Overall Study|Withdrew consent|1|||
146208332|NCT05052996|527277787|FG001|Overall Study|Withdrew consent|0|||
146208333|NCT05052996|527277788|FG002|Overall Study|Withdrew consent|1|||
146285406|NCT01605916|527557859|FG002|Overall Study|Adverse Event|0|||
146285407|NCT01605916|527557860|FG003|Overall Study|Adverse Event|1|||
146436453|NCT00323882|528104060|FG004|Overall Study|Lost to Follow-up|1|||
146083063|NCT02353143|526824732|FG007|Overall Study|patient receiving other treatment for AML|0|||
146208334|NCT05052996|527277789|FG003|Overall Study|Withdrew consent|2|||
146208335|NCT05052996|527277786|FG000|Overall Study|Lost to Follow-up|1|||
146208336|NCT05052996|527277787|FG001|Overall Study|Lost to Follow-up|0|||
146208337|NCT05052996|527277788|FG002|Overall Study|Lost to Follow-up|0|||
146208338|NCT05052996|527277789|FG003|Overall Study|Lost to Follow-up|2|||
146208339|NCT05052996|527277786|FG000|Overall Study|Adverse Event|0|||
146208340|NCT05052996|527277787|FG001|Overall Study|Adverse Event|0|||
146208341|NCT05052996|527277788|FG002|Overall Study|Adverse Event|2|||
146208342|NCT05052996|527277789|FG003|Overall Study|Adverse Event|0|||
146208343|NCT05052996|527277786|FG000|Overall Study|Randomized but never treated|0|||
146208344|NCT05052996|527277787|FG001|Overall Study|Randomized but never treated|0|||
146436454|NCT00323882|528104056|FG000|Overall Study|Other|0|||
146436455|NCT00323882|528104057|FG001|Overall Study|Other|0|||
146436456|NCT00323882|528104058|FG002|Overall Study|Other|0|||
146436457|NCT00323882|528104059|FG003|Overall Study|Other|1|||
146436458|NCT00323882|528104060|FG004|Overall Study|Other|1|||
146436459|NCT00830024|528104067|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146436460|NCT00830024|528104068|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146436461|NCT00429416|528104069|FG000|Overall Study|Death|1|||
146436462|NCT02619682|528104070|FG000|Overall Study|Withdrawal by Subject|3|||
146436463|NCT02619682|528104070|FG000|Overall Study|Lack of Efficacy|8|||
146436464|NCT02619682|528104070|FG000|Overall Study|new secondary cancer|1|||
146436465|NCT02619682|528104070|FG000|Overall Study|post surgery complications|2|||
146436466|NCT03600376|528104071|FG000|Overall Study|Adverse Event|1|||
146436467|NCT03600376|528104072|FG001|Overall Study|Adverse Event|1|||
146436468|NCT03600376|528104071|FG000|Overall Study|Transferred to other facility|1|||
146436469|NCT03600376|528104072|FG001|Overall Study|Transferred to other facility|0|||
146436470|NCT03600376|528104071|FG000|Overall Study|Investigator Decision|0|||
146436471|NCT03600376|528104072|FG001|Overall Study|Investigator Decision|4|||
146436472|NCT03600376|528104071|FG000|Overall Study|Determined to be ineligible for study|0|||
146436473|NCT03600376|528104072|FG001|Overall Study|Determined to be ineligible for study|1|||
146436474|NCT02358538|528104073|FG000|Through Week 26|Adverse Event|0|||
146436475|NCT02358538|528104074|FG001|Through Week 26|Adverse Event|1|||
146436476|NCT02358538|528104075|FG002|Through Week 26|Adverse Event|1|||
146436477|NCT02358538|528104076|FG003|Through Week 26|Adverse Event|2|||
146436478|NCT02358538|528104073|FG000|Through Week 26|Lack of Efficacy|1|||
146436479|NCT02358538|528104074|FG001|Through Week 26|Lack of Efficacy|1|||
146436480|NCT02358538|528104075|FG002|Through Week 26|Lack of Efficacy|3|||
146436481|NCT02358538|528104076|FG003|Through Week 26|Lack of Efficacy|3|||
146436482|NCT02358538|528104073|FG000|Through Week 26|Withdrawal by Subject|1|||
146436483|NCT02358538|528104074|FG001|Through Week 26|Withdrawal by Subject|0|||
146436484|NCT02358538|528104075|FG002|Through Week 26|Withdrawal by Subject|0|||
146436485|NCT02358538|528104076|FG003|Through Week 26|Withdrawal by Subject|0|||
146436486|NCT02358538|528104073|FG000|Through Week 26|Non-Compliance|0|||
146436487|NCT02358538|528104074|FG001|Through Week 26|Non-Compliance|0|||
146436488|NCT02358538|528104075|FG002|Through Week 26|Non-Compliance|1|||
146436489|NCT02358538|528104076|FG003|Through Week 26|Non-Compliance|0|||
146436490|NCT02358538|528104073|FG000|Through Week 26|Family did not see benefit from IP|1|||
146436491|NCT02358538|528104074|FG001|Through Week 26|Family did not see benefit from IP|0|||
146436492|NCT02358538|528104075|FG002|Through Week 26|Family did not see benefit from IP|0|||
146436493|NCT02358538|528104076|FG003|Through Week 26|Family did not see benefit from IP|0|||
146436494|NCT02358538|528104073|FG000|52 Week Extension Period|Lack of Efficacy|0|||
146436495|NCT02358538|528104074|FG001|52 Week Extension Period|Lack of Efficacy|0|||
146436496|NCT02358538|528104075|FG002|52 Week Extension Period|Lack of Efficacy|2|||
146436497|NCT02358538|528104076|FG003|52 Week Extension Period|Lack of Efficacy|4|||
146436498|NCT06999265|528104077|FG000|Overall Study|Lost to Follow-up|1|||
146436499|NCT06999265|528104078|FG001|Overall Study|Lost to Follow-up|1|||
146436500|NCT02178787|528104079|FG000|Overall Study|Lost to Follow-up|1|||
146436501|NCT02178787|528104080|FG001|Overall Study|Lost to Follow-up|0|||
146436502|NCT02178787|528104079|FG000|Overall Study|Withdrawal by Subject|0|||
146436503|NCT02178787|528104080|FG001|Overall Study|Withdrawal by Subject|2|||
146436504|NCT02178787|528104079|FG000|Overall Study|No TCD window|3|||
146436505|NCT02178787|528104080|FG001|Overall Study|No TCD window|7|||
146436506|NCT02178787|528104079|FG000|Overall Study|Physician Decision|1|||
146436507|NCT02178787|528104080|FG001|Overall Study|Physician Decision|0|||
146436508|NCT02554890|528104081|FG000|Double-blind|Adverse Event|45|||
146436509|NCT02554890|528104082|FG001|Double-blind|Adverse Event|51|||
146436510|NCT02554890|528104081|FG000|Double-blind|Death|6|||
146436511|NCT02554890|528104082|FG001|Double-blind|Death|4|||
146436512|NCT02554890|528104081|FG000|Double-blind|Protocol Violation|1|||
146436513|NCT02554890|528104082|FG001|Double-blind|Protocol Violation|1|||
146436514|NCT02554890|528104081|FG000|Double-blind|Physician Decision|4|||
146436515|NCT02554890|528104082|FG001|Double-blind|Physician Decision|3|||
146436516|NCT02554890|528104081|FG000|Double-blind|Subject/Guardian decision|21|||
146436517|NCT02554890|528104082|FG001|Double-blind|Subject/Guardian decision|16|||
146436518|NCT02554890|528104081|FG000|Double-blind|Lost to Follow-up|7|||
146436519|NCT02554890|528104082|FG001|Double-blind|Lost to Follow-up|5|||
146436520|NCT02554890|528104081|FG000|Double-blind|Technical problems|1|||
146436521|NCT02554890|528104082|FG001|Double-blind|Technical problems|0|||
146436522|NCT02554890|528104081|FG000|Double-blind|Withdrawal by Subject|5|||
146436523|NCT02554890|528104082|FG001|Double-blind|Withdrawal by Subject|6|||
146436524|NCT02554890|528104081|FG000|Double-blind|Noncompliance with study treatment|6|||
146436525|NCT02554890|528104082|FG001|Double-blind|Noncompliance with study treatment|5|||
146436526|NCT02554890|528104081|FG000|Open-label|Adverse Event|0|||
146436527|NCT02554890|528104082|FG001|Open-label|Adverse Event|30|||
146436528|NCT02554890|528104081|FG000|Open-label|Death|0|||
146436529|NCT02554890|528104082|FG001|Open-label|Death|1|||
146436530|NCT02554890|528104081|FG000|Open-label|Physician Decision|0|||
146436531|NCT02554890|528104082|FG001|Open-label|Physician Decision|1|||
145952334|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Other|2|||
146208345|NCT05052996|527277788|FG002|Overall Study|Randomized but never treated|1|||
146208346|NCT05052996|527277789|FG003|Overall Study|Randomized but never treated|1|||
146208347|NCT05052996|527277786|FG000|Overall Study|Protocol Violation|1|||
146436532|NCT02554890|528104081|FG000|Open-label|Subject/Guardian decision|0|||
146436533|NCT02554890|528104082|FG001|Open-label|Subject/Guardian decision|11|||
146436534|NCT02554890|528104081|FG000|Open-label|Lost to Follow-up|0|||
145952335|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Other|4|||
146208348|NCT05052996|527277787|FG001|Overall Study|Protocol Violation|0|||
146208349|NCT05052996|527277788|FG002|Overall Study|Protocol Violation|0|||
146208350|NCT05052996|527277789|FG003|Overall Study|Protocol Violation|0|||
146208351|NCT03951805|527277790|FG000|Overall Study|Adverse Event|1|||
146436535|NCT02554890|528104082|FG001|Open-label|Lost to Follow-up|7|||
146436536|NCT02554890|528104081|FG000|Open-label|Technical problems|0|||
146436537|NCT02554890|528104082|FG001|Open-label|Technical problems|1|||
146436538|NCT02554890|528104081|FG000|Open-label|Withdrawal by Subject|0|||
146436539|NCT02554890|528104082|FG001|Open-label|Withdrawal by Subject|1|||
146436540|NCT03649477|528104088|FG000|Overall Study|Adverse Event|2|||
146436541|NCT03649477|528104089|FG001|Overall Study|Adverse Event|0|||
146436542|NCT03649477|528104090|FG002|Overall Study|Adverse Event|0|||
146436543|NCT01030133|528104091|FG000|Overall Study|failed to experience pain at level 7/10|2|||
146436544|NCT01030133|528104092|FG001|Overall Study|failed to experience pain at level 7/10|2|||
146436545|NCT01750294|528105403|FG000|Overall Study|Withdrawal by Subject|1|||
146436546|NCT01750294|528105403|FG000|Overall Study|Safety Endpoint|1|||
146436547|NCT01116739|528105404|FG000|Overall Study|Child had 2 years of HS|110|||
146436548|NCT01116739|528105405|FG001|Overall Study|Child had 2 years of HS|128|||
146436549|NCT01116739|528105404|FG000|Overall Study|Withdrawal by Subject|6|||
146436550|NCT01116739|528105405|FG001|Overall Study|Withdrawal by Subject|0|||
146436551|NCT01116739|528105404|FG000|Overall Study|child too young|2|||
146436552|NCT01116739|528105405|FG001|Overall Study|child too young|6|||
146436553|NCT01116739|528105404|FG000|Overall Study|child not enrolled in head start|10|||
146436554|NCT01116739|528105405|FG001|Overall Study|child not enrolled in head start|2|||
146436555|NCT01116739|528105404|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
146436556|NCT01116739|528105405|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
146436557|NCT01624233|528105406|FG000|Period 2 - Induction|Adverse Event|1|||
146436558|NCT01624233|528105406|FG000|Period 3 - Maintenance|Adverse Event|2|||
146436559|NCT01624233|528105406|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
146436560|NCT01624233|528105406|FG000|Period 3 - Maintenance|Physician Decision|2|||
146436561|NCT01624233|528105406|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
146436562|NCT01624233|528105406|FG000|Period 4 - Drug Free Period|Relapsed|61|||
146436563|NCT01624233|528105406|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
146436564|NCT01624233|528105406|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
146436565|NCT01624233|528105406|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
146436566|NCT01624233|528105406|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
146436567|NCT01624233|528105406|FG000|Period 6: Follow-up|Adverse Event|3|||
146436568|NCT01624233|528105406|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
146436569|NCT01624233|528105406|FG000|Period 6: Follow-up|Physician Decision|1|||
146436570|NCT01624233|528105406|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
146436571|NCT05090839|528105407|FG000|Overall Study|Lost to Follow-up|2|||
146436572|NCT05090839|528105408|FG001|Overall Study|Lost to Follow-up|3|||
146436573|NCT05090839|528105409|FG002|Overall Study|Lost to Follow-up|1|||
146436574|NCT05090839|528105410|FG003|Overall Study|Lost to Follow-up|1|||
146436575|NCT05710718|528105411|FG000|Overall Study|Withdrawal by Subject|5|||
146436576|NCT05710718|528105412|FG001|Overall Study|Withdrawal by Subject|1|||
146436577|NCT05710718|528105411|FG000|Overall Study|Lost to Follow-up|0|||
146436578|NCT05710718|528105412|FG001|Overall Study|Lost to Follow-up|1|||
146436579|NCT05710718|528105411|FG000|Overall Study|Death|0|||
146436580|NCT05710718|528105412|FG001|Overall Study|Death|1|||
146436581|NCT01528696|528105414|FG000|Overall Study|See detailed description|18|||
146436582|NCT01528696|528105415|FG001|Overall Study|See detailed description|19|||
146436583|NCT01056484|528105416|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
146436584|NCT01056484|528105417|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
146436585|NCT01056484|528105416|FG000|Randomized Controlled Trial|Physician Decision|1|||
146436586|NCT01056484|528105417|FG001|Randomized Controlled Trial|Physician Decision|0|||
146436587|NCT01056484|528105416|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
146436588|NCT01056484|528105417|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
146436589|NCT00835575|528105419|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
146436590|NCT00835575|528105420|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
146436591|NCT03606174|528105425|FG000|Overall Study|Death|37|||
146436592|NCT03606174|528105426|FG001|Overall Study|Death|15|||
146208352|NCT03951805|527277791|FG001|Overall Study|Adverse Event|0|||
146208353|NCT03951805|527277792|FG002|Overall Study|Adverse Event|0|||
146436593|NCT03606174|528105427|FG002|Overall Study|Death|15|||
146436594|NCT03606174|528105428|FG003|Overall Study|Death|7|||
146436595|NCT03606174|528105429|FG004|Overall Study|Death|35|||
146436596|NCT03606174|528105430|FG005|Overall Study|Death|12|||
146436597|NCT03606174|528105431|FG006|Overall Study|Death|35|||
146436598|NCT03606174|528105432|FG007|Overall Study|Death|8|||
146436599|NCT03606174|528105433|FG008|Overall Study|Death|5|||
146436600|NCT03606174|528105434|FG009|Overall Study|Death|3|||
146436601|NCT03606174|528105435|FG010|Overall Study|Death|0|||
146436602|NCT03606174|528105425|FG000|Overall Study|Lost to Follow-up|0|||
146436603|NCT03606174|528105426|FG001|Overall Study|Lost to Follow-up|0|||
146436604|NCT03606174|528105427|FG002|Overall Study|Lost to Follow-up|0|||
146436605|NCT03606174|528105428|FG003|Overall Study|Lost to Follow-up|0|||
146436606|NCT03606174|528105429|FG004|Overall Study|Lost to Follow-up|1|||
146436607|NCT03606174|528105430|FG005|Overall Study|Lost to Follow-up|1|||
146436608|NCT03606174|528105431|FG006|Overall Study|Lost to Follow-up|0|||
146436609|NCT03606174|528105432|FG007|Overall Study|Lost to Follow-up|0|||
146208354|NCT03951805|527277793|FG003|Overall Study|Adverse Event|0|||
146436610|NCT03606174|528105433|FG008|Overall Study|Lost to Follow-up|0|||
146436611|NCT03606174|528105434|FG009|Overall Study|Lost to Follow-up|0|||
146436612|NCT03606174|528105435|FG010|Overall Study|Lost to Follow-up|0|||
146436613|NCT03606174|528105425|FG000|Overall Study|Withdrawal by Subject|6|||
146436614|NCT03606174|528105426|FG001|Overall Study|Withdrawal by Subject|0|||
146436615|NCT03606174|528105427|FG002|Overall Study|Withdrawal by Subject|0|||
146436616|NCT03606174|528105428|FG003|Overall Study|Withdrawal by Subject|1|||
146436617|NCT03606174|528105429|FG004|Overall Study|Withdrawal by Subject|2|||
146436618|NCT03606174|528105430|FG005|Overall Study|Withdrawal by Subject|1|||
146436619|NCT03606174|528105431|FG006|Overall Study|Withdrawal by Subject|4|||
146436620|NCT03606174|528105432|FG007|Overall Study|Withdrawal by Subject|0|||
146436621|NCT03606174|528105433|FG008|Overall Study|Withdrawal by Subject|0|||
146436622|NCT03606174|528105434|FG009|Overall Study|Withdrawal by Subject|0|||
146436623|NCT03606174|528105435|FG010|Overall Study|Withdrawal by Subject|1|||
146436624|NCT03606174|528105425|FG000|Overall Study|Study Terminated by Sponsor|5|||
146436625|NCT03606174|528105426|FG001|Overall Study|Study Terminated by Sponsor|7|||
146436626|NCT03606174|528105427|FG002|Overall Study|Study Terminated by Sponsor|3|||
146436627|NCT03606174|528105428|FG003|Overall Study|Study Terminated by Sponsor|0|||
146436628|NCT03606174|528105429|FG004|Overall Study|Study Terminated by Sponsor|11|||
146436629|NCT03606174|528105430|FG005|Overall Study|Study Terminated by Sponsor|6|||
146436630|NCT03606174|528105431|FG006|Overall Study|Study Terminated by Sponsor|12|||
146436631|NCT03606174|528105432|FG007|Overall Study|Study Terminated by Sponsor|1|||
146436632|NCT03606174|528105433|FG008|Overall Study|Study Terminated by Sponsor|3|||
146436633|NCT03606174|528105434|FG009|Overall Study|Study Terminated by Sponsor|1|||
146436634|NCT03606174|528105435|FG010|Overall Study|Study Terminated by Sponsor|2|||
146436635|NCT03606174|528105425|FG000|Overall Study|Miscellaneous|1|||
146436636|NCT03606174|528105426|FG001|Overall Study|Miscellaneous|1|||
146208355|NCT05782231|527277795|FG000|Overall Study|Withdrawal by Subject|1|||
146436637|NCT03606174|528105427|FG002|Overall Study|Miscellaneous|0|||
146436638|NCT03606174|528105428|FG003|Overall Study|Miscellaneous|1|||
146208356|NCT01198145|527277796|FG000|Overall Study|Withdrawal by Subject|1|||
146208357|NCT01198145|527277797|FG001|Overall Study|Withdrawal by Subject|1|||
146208358|NCT03830866|527277798|FG000|Overall Study|Death|90|||
146436639|NCT03606174|528105429|FG004|Overall Study|Miscellaneous|4|||
146436640|NCT03606174|528105430|FG005|Overall Study|Miscellaneous|7|||
146436641|NCT03606174|528105431|FG006|Overall Study|Miscellaneous|5|||
146436642|NCT03606174|528105432|FG007|Overall Study|Miscellaneous|0|||
146436643|NCT03606174|528105433|FG008|Overall Study|Miscellaneous|0|||
146208359|NCT03830866|527277799|FG001|Overall Study|Death|111|||
146208360|NCT03830866|527277798|FG000|Overall Study|Lost to Follow-up|7|||
146436644|NCT03606174|528105434|FG009|Overall Study|Miscellaneous|0|||
146436645|NCT03606174|528105435|FG010|Overall Study|Miscellaneous|1|||
146436646|NCT03246503|528105438|FG000|Overall Study|Lost to Follow-up|23|||
146436647|NCT03246503|528105438|FG000|Overall Study|Withdrawal by Subject|20|||
146436648|NCT03246503|528105438|FG000|Overall Study|Physician Decision|5|||
146436649|NCT03246503|528105438|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
146436650|NCT01896934|528105446|FG000|Overall Study|Adverse Event|1|||
146436651|NCT01896934|528105446|FG000|Overall Study|Withdrawal by Subject|1|||
146436652|NCT02197416|528105447|FG000|Overall Study|Other reasons|0|||
146436653|NCT02197416|528105448|FG001|Overall Study|Other reasons|2|||
146436654|NCT02197416|528105449|FG002|Overall Study|Other reasons|5|||
146436655|NCT02197416|528105447|FG000|Overall Study|Withdrawal by Subject|0|||
146436656|NCT02197416|528105448|FG001|Overall Study|Withdrawal by Subject|2|||
146436657|NCT02197416|528105449|FG002|Overall Study|Withdrawal by Subject|1|||
146436658|NCT02197416|528105447|FG000|Overall Study|Protocol Violation|1|||
146436659|NCT02197416|528105448|FG001|Overall Study|Protocol Violation|0|||
146436660|NCT02197416|528105449|FG002|Overall Study|Protocol Violation|1|||
146436661|NCT02197416|528105447|FG000|Overall Study|Adverse Event|0|||
146436662|NCT02197416|528105448|FG001|Overall Study|Adverse Event|0|||
146436663|NCT02197416|528105449|FG002|Overall Study|Adverse Event|1|||
146436664|NCT00716625|528105450|FG000|Overall Study|Safety was not Assessable|1|||
146436665|NCT05014828|528105451|FG000|Overall Study|Study Completed by Sponsor|16|||
146436666|NCT05014828|528105452|FG001|Overall Study|Study Completed by Sponsor|16|||
146436667|NCT05014828|528105453|FG002|Overall Study|Study Completed by Sponsor|3|||
146436668|NCT05014828|528105454|FG003|Overall Study|Study Completed by Sponsor|3|||
146436669|NCT05014828|528105451|FG000|Overall Study|Death|11|||
146436670|NCT05014828|528105452|FG001|Overall Study|Death|6|||
146436671|NCT05014828|528105453|FG002|Overall Study|Death|0|||
146436672|NCT05014828|528105454|FG003|Overall Study|Death|0|||
146436673|NCT05014828|528105451|FG000|Overall Study|Lost to Follow-up|0|||
146436674|NCT05014828|528105452|FG001|Overall Study|Lost to Follow-up|0|||
146436675|NCT05014828|528105453|FG002|Overall Study|Lost to Follow-up|2|||
146436676|NCT05014828|528105454|FG003|Overall Study|Lost to Follow-up|0|||
146436677|NCT05014828|528105451|FG000|Overall Study|Miscellaneous.|0|||
146436678|NCT05014828|528105452|FG001|Overall Study|Miscellaneous.|1|||
146436679|NCT05014828|528105453|FG002|Overall Study|Miscellaneous.|0|||
146436680|NCT05014828|528105454|FG003|Overall Study|Miscellaneous.|0|||
146436681|NCT04590027|528105455|FG000|Overall Study|Lost to Follow-up|17|||
146208361|NCT03830866|527277799|FG001|Overall Study|Lost to Follow-up|7|||
146208362|NCT03830866|527277798|FG000|Overall Study|Withdrawal by Subject|19|||
146208363|NCT03830866|527277799|FG001|Overall Study|Withdrawal by Subject|16|||
146436682|NCT04590027|528105456|FG001|Overall Study|Lost to Follow-up|14|||
146436683|NCT04590027|528105455|FG000|Overall Study|Protocol Violation|0|||
146436684|NCT04590027|528105456|FG001|Overall Study|Protocol Violation|3|||
146436685|NCT00933686|528105457|FG000|Overall Study|Protocol Violation|0|||
146436686|NCT00933686|528105458|FG001|Overall Study|Protocol Violation|1|||
146436687|NCT00933686|528105457|FG000|Overall Study|Lost to Follow-up|2|||
146436688|NCT00933686|528105458|FG001|Overall Study|Lost to Follow-up|2|||
146436689|NCT00933686|528105457|FG000|Overall Study|Withdrawal by Subject|6|||
146436690|NCT00933686|528105458|FG001|Overall Study|Withdrawal by Subject|5|||
145952336|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Other|2|||
145952337|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Other|1|||
145952338|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Other|0|||
145952339|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Other|0|||
145952340|NCT00303472|526337903|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
145952341|NCT00303472|526337904|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145952342|NCT00303472|526337905|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145952343|NCT00303472|526337906|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145952344|NCT00303472|526337907|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145952345|NCT00303472|526337908|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
145952346|NCT00303472|526337909|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145952347|NCT02937636|526337914|FG000|Overall Study|Other (Not specified)|3|||
145952348|NCT02937636|526337915|FG001|Overall Study|Other (Not specified)|2|||
145952349|NCT00770913|526337916|FG000|Overall Study|Adverse Event|1|||
145952350|NCT00770913|526337917|FG001|Overall Study|Adverse Event|3|||
145952351|NCT00770913|526337918|FG002|Overall Study|Adverse Event|6|||
145952352|NCT00770913|526337916|FG000|Overall Study|Refusal to continue participation|6|||
145952353|NCT00770913|526337917|FG001|Overall Study|Refusal to continue participation|4|||
145952354|NCT00770913|526337918|FG002|Overall Study|Refusal to continue participation|5|||
145952355|NCT00770913|526337916|FG000|Overall Study|Physician Decision|0|||
145952356|NCT00770913|526337917|FG001|Overall Study|Physician Decision|1|||
145952357|NCT00770913|526337918|FG002|Overall Study|Physician Decision|1|||
145952358|NCT00770913|526337916|FG000|Overall Study|Protocol Violation|3|||
145952359|NCT00770913|526337917|FG001|Overall Study|Protocol Violation|0|||
145952360|NCT00770913|526337918|FG002|Overall Study|Protocol Violation|1|||
145952361|NCT00770913|526337916|FG000|Overall Study|Incorrect drug was allocated|1|||
145952362|NCT00770913|526337917|FG001|Overall Study|Incorrect drug was allocated|0|||
145952363|NCT00770913|526337918|FG002|Overall Study|Incorrect drug was allocated|0|||
145952364|NCT00359294|526337924|FG000|Overall Study|Progressive disease|1|||
145952365|NCT00359294|526337925|FG001|Overall Study|Progressive disease|1|||
145952366|NCT00359294|526337926|FG002|Overall Study|Progressive disease|2|||
146436691|NCT00933686|528105457|FG000|Overall Study|Adverse Event|1|||
145952367|NCT00359294|526337927|FG003|Overall Study|Progressive disease|3|||
145952368|NCT00359294|526337928|FG004|Overall Study|Progressive disease|2|||
145952369|NCT00359294|526337924|FG000|Overall Study|Withdrawal by Subject|0|||
145952370|NCT00359294|526337925|FG001|Overall Study|Withdrawal by Subject|0|||
145952371|NCT00359294|526337926|FG002|Overall Study|Withdrawal by Subject|0|||
145952372|NCT00359294|526337927|FG003|Overall Study|Withdrawal by Subject|0|||
145952373|NCT00359294|526337928|FG004|Overall Study|Withdrawal by Subject|1|||
145952374|NCT00359294|526337924|FG000|Overall Study|Not treated|0|||
145952375|NCT00359294|526337925|FG001|Overall Study|Not treated|0|||
145952376|NCT00359294|526337926|FG002|Overall Study|Not treated|0|||
145952377|NCT00359294|526337927|FG003|Overall Study|Not treated|1|||
145952378|NCT00359294|526337928|FG004|Overall Study|Not treated|0|||
145952379|NCT00359294|526337924|FG000|Overall Study|Physician Decision|0|||
145952380|NCT00359294|526337925|FG001|Overall Study|Physician Decision|0|||
145952381|NCT00359294|526337926|FG002|Overall Study|Physician Decision|1|||
145952382|NCT00359294|526337927|FG003|Overall Study|Physician Decision|0|||
145952383|NCT00359294|526337928|FG004|Overall Study|Physician Decision|0|||
145952384|NCT04208412|526337931|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
145952385|NCT04208412|526337932|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
145952386|NCT04208412|526337931|FG000|Overall Study|Withdrawal by Subject|1|||
145952387|NCT04208412|526337932|FG001|Overall Study|Withdrawal by Subject|0|||
145952388|NCT04208412|526337931|FG000|Overall Study|Lost to Follow-up|0|||
145952389|NCT04208412|526337932|FG001|Overall Study|Lost to Follow-up|1|||
145952390|NCT03853291|526337935|FG000|Overall Study|Lost to Follow-up|1|||
145952391|NCT03853291|526337936|FG001|Overall Study|Lost to Follow-up|2|||
145952392|NCT03853291|526337937|FG002|Overall Study|Lost to Follow-up|0|||
145952393|NCT03853291|526337938|FG003|Overall Study|Lost to Follow-up|0|||
145952394|NCT03853291|526337939|FG004|Overall Study|Lost to Follow-up|0|||
145952395|NCT03853291|526337940|FG005|Overall Study|Lost to Follow-up|0|||
145952396|NCT03853291|526337935|FG000|Overall Study|Determined to be ineligible|1|||
145952397|NCT03853291|526337936|FG001|Overall Study|Determined to be ineligible|1|||
145952398|NCT03853291|526337937|FG002|Overall Study|Determined to be ineligible|0|||
145952399|NCT03853291|526337938|FG003|Overall Study|Determined to be ineligible|0|||
145952400|NCT03853291|526337939|FG004|Overall Study|Determined to be ineligible|0|||
145952401|NCT03853291|526337940|FG005|Overall Study|Determined to be ineligible|0|||
145952402|NCT03882957|526337941|FG000|Overall Study|Did not complete all three arms|1|||
145952403|NCT01134393|526337944|FG000|Overall Study|Adverse Event|18|||
145952404|NCT01134393|526337944|FG000|Overall Study|Lack of Efficacy|2|||
145952405|NCT01134393|526337944|FG000|Overall Study|Protocol Violation|12|||
145952406|NCT01134393|526337944|FG000|Overall Study|Lost to Follow-up|3|||
145952407|NCT01134393|526337944|FG000|Overall Study|Withdrawal by Subject|11|||
145952408|NCT01134393|526337944|FG000|Overall Study|Other|6|||
146285408|NCT01605916|527557861|FG004|Overall Study|Adverse Event|0|||
146208364|NCT03830866|527277798|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
146208365|NCT03830866|527277799|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
146208366|NCT03830866|527277798|FG000|Overall Study|Other|1|||
146208367|NCT03830866|527277799|FG001|Overall Study|Other|1|||
146208368|NCT00510887|527277801|FG000|Overall Study|Lost to Follow-up|1|||
146208369|NCT01561989|527277802|FG000|Overall Study|accural target not met.|5|||
146436692|NCT00933686|528105458|FG001|Overall Study|Adverse Event|1|||
146436693|NCT00933686|528105457|FG000|Overall Study|Physician Decision|1|||
146436694|NCT00933686|528105458|FG001|Overall Study|Physician Decision|0|||
146436695|NCT00933686|528105457|FG000|Overall Study|Failure to show up at endpoint visits|0|||
146436696|NCT00933686|528105458|FG001|Overall Study|Failure to show up at endpoint visits|2|||
146436697|NCT01383486|528105459|FG000|Overall Study|Lost to Follow-up|10|||
146436698|NCT01383486|528105459|FG000|Overall Study|Incomplete information for analysis|2|||
146436699|NCT01383486|528105459|FG000|Overall Study|Did not take any product|6|||
146436700|NCT03276754|528105461|FG000|Overall Study|Withdrawal of informed consent|4|||
146436701|NCT03276754|528105461|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
146436702|NCT03276754|528105461|FG000|Overall Study|Lost to Follow-up|27|||
146436703|NCT03276754|528105461|FG000|Overall Study|No data reported at Month 24|31|||
146436704|NCT03276754|528105461|FG000|Overall Study|Death|39|||
146436705|NCT02911792|528105464|FG000|Overall Study|Lost to Follow-up|3|||
146436706|NCT02911792|528105465|FG001|Overall Study|Lost to Follow-up|3|||
146436707|NCT02911792|528105466|FG002|Overall Study|Lost to Follow-up|3|||
146436708|NCT02911792|528105467|FG003|Overall Study|Lost to Follow-up|3|||
146436709|NCT00927069|528105468|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
146436710|NCT00927069|528105469|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
146436711|NCT00927069|528105470|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
146436712|NCT00927069|528105471|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
146436713|NCT00927069|528105468|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
146436714|NCT00927069|528105469|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
146436715|NCT00927069|528105470|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
146436716|NCT00927069|528105471|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
146436717|NCT00927069|528105468|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
146436718|NCT00927069|528105469|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
146436719|NCT00927069|528105470|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
146436720|NCT00927069|528105471|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
146436721|NCT00927069|528105468|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
146436722|NCT00927069|528105469|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
146436723|NCT00927069|528105470|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
146436724|NCT00927069|528105471|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
146436725|NCT00927069|528105468|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
146436726|NCT00927069|528105469|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
146436727|NCT00927069|528105470|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
146436728|NCT00927069|528105471|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
146436729|NCT00796328|528105472|FG000|Overall Study|experienced hypotension requiring tx|6|||
146436730|NCT00466167|528105478|FG000|Overall Study|Adverse Event|8|||
146436731|NCT00466167|528105479|FG001|Overall Study|Adverse Event|8|||
146436732|NCT00466167|528105480|FG002|Overall Study|Adverse Event|7|||
146436733|NCT00466167|528105478|FG000|Overall Study|Lack of Efficacy|2|||
146436734|NCT00466167|528105479|FG001|Overall Study|Lack of Efficacy|0|||
146436735|NCT00466167|528105480|FG002|Overall Study|Lack of Efficacy|3|||
146436736|NCT00466167|528105478|FG000|Overall Study|Protocol Violation|1|||
146436737|NCT00466167|528105479|FG001|Overall Study|Protocol Violation|1|||
146436738|NCT00466167|528105480|FG002|Overall Study|Protocol Violation|2|||
146436739|NCT00466167|528105478|FG000|Overall Study|Lost to Follow-up|3|||
146436740|NCT00466167|528105479|FG001|Overall Study|Lost to Follow-up|2|||
146436741|NCT00466167|528105480|FG002|Overall Study|Lost to Follow-up|2|||
146436742|NCT00466167|528105478|FG000|Overall Study|Withdrawal by Subject|4|||
146436743|NCT00466167|528105479|FG001|Overall Study|Withdrawal by Subject|1|||
146436744|NCT00466167|528105480|FG002|Overall Study|Withdrawal by Subject|6|||
146436745|NCT00466167|528105478|FG000|Overall Study|patient did not meet inclusion criteria|1|||
146436746|NCT00466167|528105479|FG001|Overall Study|patient did not meet inclusion criteria|0|||
146436747|NCT00466167|528105480|FG002|Overall Study|patient did not meet inclusion criteria|1|||
146436748|NCT00466167|528105478|FG000|Overall Study|Not treated|1|||
146436749|NCT00466167|528105479|FG001|Overall Study|Not treated|0|||
146436750|NCT00466167|528105480|FG002|Overall Study|Not treated|0|||
146436751|NCT03199963|528105481|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
146436752|NCT03199963|528105482|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
146436753|NCT03199963|528105481|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
146436754|NCT03199963|528105482|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
146436755|NCT03199963|528105481|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
146436756|NCT03199963|528105482|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
146436757|NCT03199963|528105481|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
146436758|NCT03199963|528105482|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
146436759|NCT03199963|528105481|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
146436760|NCT03199963|528105482|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
146436761|NCT03199963|528105481|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
146436762|NCT03199963|528105482|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
146436763|NCT00107991|528105485|FG000|Eligibility Assessment|Disease not severe enough|7|||
146436764|NCT00107991|528105485|FG000|Eligibility Assessment|Unwilling to participate|7|||
146436765|NCT00107991|528105485|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
146436766|NCT00107991|528105485|FG000|Eligibility Assessment|Abnormal labs|2|||
146436767|NCT00107991|528105485|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
145952409|NCT01658904|526337945|FG000|Overall Study|Principal Investigator discretion|2|||
145952410|NCT01658904|526337946|FG001|Overall Study|Principal Investigator discretion|0|||
145952411|NCT01658904|526337947|FG002|Overall Study|Principal Investigator discretion|0|||
145952412|NCT00524680|526337949|FG000|Overall Study|progression|0|||
145952413|NCT00524680|526337950|FG001|Overall Study|progression|0|||
145952414|NCT00524680|526337951|FG002|Overall Study|progression|0|||
145952415|NCT00524680|526337952|FG003|Overall Study|progression|1|||
145952416|NCT00524680|526337949|FG000|Overall Study|Adverse Event|2|||
145952417|NCT00524680|526337950|FG001|Overall Study|Adverse Event|0|||
145952418|NCT00524680|526337951|FG002|Overall Study|Adverse Event|0|||
146208370|NCT01561989|527277803|FG001|Overall Study|accural target not met.|6|||
146208371|NCT01736215|527277804|FG000|Overall Study|Early termination of erythropoietin use|1|||
146436768|NCT00107991|528105485|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
146208372|NCT01736215|527277804|FG000|Overall Study|Adverse Event|4|||
146208373|NCT01736215|527277804|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
146436769|NCT00107991|528105485|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
146436770|NCT00107991|528105485|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
145952419|NCT00524680|526337952|FG003|Overall Study|Adverse Event|1|||
145952420|NCT00524680|526337949|FG000|Overall Study|Other|0|||
145952421|NCT00524680|526337950|FG001|Overall Study|Other|1|||
145952422|NCT00524680|526337951|FG002|Overall Study|Other|2|||
146436771|NCT00107991|528105485|FG000|12 Week Treatment Period|Adverse Event|1|||
146436772|NCT00107991|528105485|FG000|12 Week Treatment Period|Protocol Violation|1|||
145952423|NCT00524680|526337952|FG003|Overall Study|Other|3|||
146208374|NCT01736215|527277804|FG000|Overall Study|Insufficient data to perform analysis|8|||
146208375|NCT03447249|527277805|FG000|Overall Study|Adverse Event|1|||
145952424|NCT00524680|526337949|FG000|Overall Study|Withdrawal by Subject|1|||
146436773|NCT00107991|528105485|FG000|12 Week Treatment Period|Incarcerated|1|||
146436774|NCT00107991|528105485|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
146436775|NCT01535222|528105486|FG000|Overall Study|Inclusion/exclusion|0|||
146436776|NCT01535222|528105487|FG001|Overall Study|Inclusion/exclusion|0|||
146436777|NCT01535222|528105488|FG002|Overall Study|Inclusion/exclusion|1|||
146436778|NCT01535222|528105489|FG003|Overall Study|Inclusion/exclusion|0|||
146436779|NCT01535222|528105490|FG004|Overall Study|Inclusion/exclusion|0|||
146436780|NCT01535222|528105491|FG005|Overall Study|Inclusion/exclusion|0|||
146436781|NCT03669861|528105492|FG000|Overall Study|Disease Flare|5|||
146436782|NCT03669861|528105492|FG000|Overall Study|Lack of Efficacy|2|||
146436783|NCT02760927|528105493|FG000|Overall Study|Tube Slippage from Device|1|||
146436784|NCT03930732|528105494|FG000|Overall Study|Adverse Event|9|||
146436785|NCT03930732|528105495|FG001|Overall Study|Adverse Event|7|||
146436786|NCT03930732|528105494|FG000|Overall Study|Poor compliance to protocol|0|||
146436787|NCT03930732|528105495|FG001|Overall Study|Poor compliance to protocol|1|||
146436788|NCT03930732|528105494|FG000|Overall Study|Withdrawal by Subject|23|||
146436789|NCT03930732|528105495|FG001|Overall Study|Withdrawal by Subject|11|||
146436790|NCT03930732|528105494|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
146436791|NCT03930732|528105495|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
146436792|NCT03930732|528105494|FG000|Overall Study|Other reason not related to COVID-19|5|||
146436793|NCT03930732|528105495|FG001|Overall Study|Other reason not related to COVID-19|8|||
146436794|NCT02645409|528105504|FG000|Overall Study|Withdrawal by Subject|3|||
146436795|NCT02645409|528105505|FG001|Overall Study|Withdrawal by Subject|0|||
146436796|NCT02645409|528105504|FG000|Overall Study|Physician Decision|1|||
146436797|NCT02645409|528105505|FG001|Overall Study|Physician Decision|0|||
146436798|NCT02089685|528105510|FG000|Overall Study|Adverse Event|1|||
146436799|NCT02089685|528105511|FG001|Overall Study|Adverse Event|0|||
146436800|NCT02089685|528105512|FG002|Overall Study|Adverse Event|0|||
146436801|NCT02089685|528105513|FG003|Overall Study|Adverse Event|0|||
146436802|NCT02089685|528105514|FG004|Overall Study|Adverse Event|1|||
146436803|NCT02089685|528105515|FG005|Overall Study|Adverse Event|0|||
146436804|NCT02089685|528105510|FG000|Overall Study|Clinical Progression|4|||
146436805|NCT02089685|528105511|FG001|Overall Study|Clinical Progression|0|||
146436806|NCT02089685|528105512|FG002|Overall Study|Clinical Progression|0|||
146436807|NCT02089685|528105513|FG003|Overall Study|Clinical Progression|5|||
146436808|NCT02089685|528105514|FG004|Overall Study|Clinical Progression|1|||
146436809|NCT02089685|528105515|FG005|Overall Study|Clinical Progression|2|||
146436810|NCT02089685|528105510|FG000|Overall Study|Excluded Medication|1|||
146436811|NCT02089685|528105511|FG001|Overall Study|Excluded Medication|0|||
146436812|NCT02089685|528105512|FG002|Overall Study|Excluded Medication|0|||
146436813|NCT02089685|528105513|FG003|Overall Study|Excluded Medication|11|||
146436814|NCT02089685|528105514|FG004|Overall Study|Excluded Medication|2|||
146436815|NCT02089685|528105515|FG005|Overall Study|Excluded Medication|1|||
146436816|NCT02089685|528105510|FG000|Overall Study|Progressive disease|13|||
146436817|NCT02089685|528105511|FG001|Overall Study|Progressive disease|10|||
146436818|NCT02089685|528105512|FG002|Overall Study|Progressive disease|3|||
146436819|NCT02089685|528105513|FG003|Overall Study|Progressive disease|51|||
146436820|NCT02089685|528105514|FG004|Overall Study|Progressive disease|17|||
146436821|NCT02089685|528105515|FG005|Overall Study|Progressive disease|12|||
146436822|NCT02089685|528105510|FG000|Overall Study|Follow up ended by sponsor|2|||
146436823|NCT02089685|528105511|FG001|Overall Study|Follow up ended by sponsor|2|||
146436824|NCT02089685|528105512|FG002|Overall Study|Follow up ended by sponsor|0|||
146436825|NCT02089685|528105513|FG003|Overall Study|Follow up ended by sponsor|70|||
146436826|NCT02089685|528105514|FG004|Overall Study|Follow up ended by sponsor|26|||
146436827|NCT02089685|528105515|FG005|Overall Study|Follow up ended by sponsor|26|||
146436828|NCT02089685|528105510|FG000|Overall Study|Withdrawal by Subject|0|||
146436829|NCT02089685|528105511|FG001|Overall Study|Withdrawal by Subject|2|||
146436830|NCT02089685|528105512|FG002|Overall Study|Withdrawal by Subject|0|||
146436831|NCT02089685|528105513|FG003|Overall Study|Withdrawal by Subject|8|||
146436832|NCT02089685|528105514|FG004|Overall Study|Withdrawal by Subject|1|||
146436833|NCT02089685|528105515|FG005|Overall Study|Withdrawal by Subject|1|||
146436834|NCT02089685|528105510|FG000|Overall Study|Status not recorded|1|||
146436835|NCT02089685|528105511|FG001|Overall Study|Status not recorded|0|||
146436836|NCT02089685|528105512|FG002|Overall Study|Status not recorded|0|||
146436837|NCT02089685|528105513|FG003|Overall Study|Status not recorded|0|||
146436838|NCT02089685|528105514|FG004|Overall Study|Status not recorded|1|||
146208376|NCT03447249|527277806|FG001|Overall Study|Adverse Event|0|||
146208377|NCT03447249|527277805|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
146208378|NCT03447249|527277806|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146208379|NCT03447249|527277805|FG000|Overall Study|Other|3|||
146208380|NCT03447249|527277806|FG001|Overall Study|Other|0|||
146208381|NCT01248936|527277807|FG000|Overall Study|Sponsor Decision|259|||
146208382|NCT01248936|527277807|FG000|Overall Study|Progression of Disease|50|||
146208383|NCT01248936|527277807|FG000|Overall Study|Death|26|||
146208384|NCT01248936|527277807|FG000|Overall Study|Withdrawal of Consent|20|||
146208385|NCT01248936|527277807|FG000|Overall Study|Adverse Event|8|||
146208386|NCT01248936|527277807|FG000|Overall Study|Lost to Follow-up|7|||
146208387|NCT01248936|527277807|FG000|Overall Study|Refused Treatment|1|||
146208388|NCT01248936|527277807|FG000|Overall Study|Other reason|3|||
146208389|NCT03485950|527277808|FG000|Overall Study|Adverse Event|1|||
146208390|NCT03485950|527277809|FG001|Overall Study|Adverse Event|0|||
146208391|NCT03485950|527277808|FG000|Overall Study|Death|3|||
146208392|NCT03485950|527277809|FG001|Overall Study|Death|2|||
146208393|NCT03485950|527277808|FG000|Overall Study|Withdrawal by Subject|3|||
146208394|NCT03485950|527277809|FG001|Overall Study|Withdrawal by Subject|0|||
146208395|NCT00988858|527277810|FG000|Overall Study|Adverse Event|7|||
146208396|NCT00988858|527277810|FG000|Overall Study|Death|1|||
146208397|NCT00988858|527277810|FG000|Overall Study|Physician Decision|1|||
146208398|NCT00988858|527277810|FG000|Overall Study|Sponsor Decision|1|||
146208399|NCT00390299|527277811|FG000|Overall Study|Cancellation|1|||
146208400|NCT00390299|527277812|FG001|Overall Study|Cancellation|0|||
146208401|NCT00390299|527277813|FG002|Overall Study|Cancellation|0|||
146208402|NCT00390299|527277814|FG003|Overall Study|Cancellation|0|||
146208403|NCT00390299|527277815|FG004|Overall Study|Cancellation|0|||
146208404|NCT03750968|527277817|FG000|Overall Study|Adverse Event|2|||
146208405|NCT03750968|527277818|FG001|Overall Study|Adverse Event|0|||
146208406|NCT03750968|527277817|FG000|Overall Study|Lost to Follow-up|1|||
146208407|NCT03750968|527277818|FG001|Overall Study|Lost to Follow-up|3|||
146208408|NCT05094141|527277819|FG000|Overall Study|Death|0|||
146208409|NCT05094141|527277820|FG001|Overall Study|Death|0|||
146208410|NCT05094141|527277821|FG002|Overall Study|Death|1|||
146208411|NCT05094141|527277819|FG000|Overall Study|Withdrawal by Subject|0|||
146208412|NCT05094141|527277820|FG001|Overall Study|Withdrawal by Subject|0|||
146208413|NCT05094141|527277821|FG002|Overall Study|Withdrawal by Subject|1|||
146208414|NCT05094141|527277819|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
146208415|NCT05094141|527277820|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
146208416|NCT05094141|527277821|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
146208417|NCT05094141|527277819|FG000|Overall Study|Did not participate in randomization|0|||
146208418|NCT05094141|527277820|FG001|Overall Study|Did not participate in randomization|0|||
146208419|NCT05094141|527277821|FG002|Overall Study|Did not participate in randomization|33|||
146208420|NCT04814186|527280221|FG000|Treatment Phase|Adverse Event|1|||
146208421|NCT04814186|527280221|FG000|Treatment Phase|Death|6|||
146208422|NCT04814186|527280221|FG000|Treatment Phase|Withdrawal by Subject|2|||
146208423|NCT04814186|527280221|FG000|Treatment Phase|Other|1|||
146208424|NCT04814186|527280221|FG000|Follow-Up Phase|Adverse Event|1|||
146208425|NCT04814186|527280221|FG000|Follow-Up Phase|Death|6|||
146208426|NCT04814186|527280221|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
146208427|NCT04814186|527280221|FG000|Follow-Up Phase|Other|1|||
146208428|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
146208429|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
146208430|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
146208431|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
146208432|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
146208433|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
146208434|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
146208435|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
146208436|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
146208437|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
146285409|NCT01605916|527557857|FG000|Overall Study|Lack of Efficacy|2|||
146436839|NCT02089685|528105515|FG005|Overall Study|Status not recorded|0|||
146436840|NCT02089685|528105510|FG000|Overall Study|Death|0|||
146436841|NCT02089685|528105511|FG001|Overall Study|Death|0|||
146436842|NCT02089685|528105512|FG002|Overall Study|Death|0|||
146436843|NCT02089685|528105513|FG003|Overall Study|Death|7|||
146436844|NCT02089685|528105514|FG004|Overall Study|Death|2|||
146436845|NCT02089685|528105515|FG005|Overall Study|Death|5|||
146436846|NCT02089685|528105510|FG000|Overall Study|Lost to Follow-up|0|||
146436847|NCT02089685|528105511|FG001|Overall Study|Lost to Follow-up|0|||
146436848|NCT02089685|528105512|FG002|Overall Study|Lost to Follow-up|0|||
146436849|NCT02089685|528105513|FG003|Overall Study|Lost to Follow-up|1|||
146436850|NCT02089685|528105514|FG004|Overall Study|Lost to Follow-up|0|||
146436851|NCT02089685|528105515|FG005|Overall Study|Lost to Follow-up|0|||
146436852|NCT02089685|528105510|FG000|Overall Study|Physician Decision|0|||
146436853|NCT02089685|528105511|FG001|Overall Study|Physician Decision|0|||
146436854|NCT02089685|528105512|FG002|Overall Study|Physician Decision|0|||
146436855|NCT02089685|528105513|FG003|Overall Study|Physician Decision|0|||
146436856|NCT02089685|528105514|FG004|Overall Study|Physician Decision|0|||
146436857|NCT02089685|528105515|FG005|Overall Study|Physician Decision|4|||
146436858|NCT02089685|528105510|FG000|Overall Study|Screen failure|1|||
146436859|NCT02089685|528105511|FG001|Overall Study|Screen failure|0|||
146436860|NCT02089685|528105512|FG002|Overall Study|Screen failure|0|||
146436861|NCT02089685|528105513|FG003|Overall Study|Screen failure|0|||
146436862|NCT02089685|528105514|FG004|Overall Study|Screen failure|0|||
146436863|NCT02089685|528105515|FG005|Overall Study|Screen failure|0|||
146208438|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
146208439|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
146436864|NCT00505622|528105521|FG000|Overall Study|Adverse Event|5|||
146436865|NCT00505622|528105522|FG001|Overall Study|Adverse Event|6|||
146436866|NCT00505622|528105523|FG002|Overall Study|Adverse Event|4|||
146436867|NCT00505622|528105521|FG000|Overall Study|Protocol Violation|1|||
146436868|NCT00505622|528105522|FG001|Overall Study|Protocol Violation|1|||
146208440|NCT01600014|527280226|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
146436869|NCT00505622|528105523|FG002|Overall Study|Protocol Violation|0|||
146436870|NCT00505622|528105521|FG000|Overall Study|Withdrawal by Subject|0|||
146436871|NCT00505622|528105522|FG001|Overall Study|Withdrawal by Subject|3|||
146436872|NCT00505622|528105523|FG002|Overall Study|Withdrawal by Subject|2|||
146436873|NCT00505622|528105521|FG000|Overall Study|Study termination by sponsor|115|||
146436874|NCT00505622|528105522|FG001|Overall Study|Study termination by sponsor|98|||
146436875|NCT00505622|528105523|FG002|Overall Study|Study termination by sponsor|90|||
146436876|NCT03084471|528105526|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
146436877|NCT03084471|528105526|FG000|Overall Study|Condition under investigation worsened|84|||
146436878|NCT03084471|528105526|FG000|Overall Study|Lack of therapeutic response|2|||
146436879|NCT03084471|528105526|FG000|Overall Study|Protocol Violation|1|||
146436880|NCT03084471|528105526|FG000|Overall Study|Adverse Event|73|||
146208441|NCT01600014|527280227|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
146208442|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
146208443|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
146208444|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
146208445|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
146208446|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
146208447|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
146208448|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
146208449|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
146208450|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
146208451|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
146208452|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
146208453|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
146208454|NCT01600014|527280226|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
146208455|NCT01600014|527280227|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
146208456|NCT01600014|527280226|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
146208457|NCT01600014|527280227|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
146436881|NCT03084471|528105526|FG000|Overall Study|Withdrawal by Subject|12|||
146436882|NCT03084471|528105526|FG000|Overall Study|Disease relapse|181|||
146436883|NCT03084471|528105526|FG000|Overall Study|Subjective disease progression|359|||
146436884|NCT03084471|528105526|FG000|Overall Study|Other (as recorded)|33|||
146436885|NCT03084471|528105526|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
146436886|NCT00835692|528105527|FG000|First Intervention|Withdrawal by Subject|1|||
146436887|NCT00835692|528105528|FG001|First Intervention|Withdrawal by Subject|0|||
146436888|NCT04078022|528105531|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
146436889|NCT04078022|528105532|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
146436890|NCT00191815|528105533|FG000|Overall Study|Adverse Event|2|||
146436891|NCT00191815|528105533|FG000|Overall Study|Disease progression or relapse|24|||
146436892|NCT00191815|528105533|FG000|Overall Study|Death|2|||
146436893|NCT00191815|528105533|FG000|Overall Study|Protocol Violation|3|||
146436894|NCT00191815|528105533|FG000|Overall Study|Physician Decision|2|||
146436895|NCT00191815|528105533|FG000|Overall Study|Withdrawal by Subject|7|||
146436896|NCT03808376|528105534|FG000|Overall Study|Withdrawal by Subject|10|||
146436897|NCT03644550|528105535|FG000|Overall Study|Withdrawal by Subject|3|||
146436898|NCT03644550|528105535|FG000|Overall Study|Progressive disease|15|||
146436899|NCT03804983|528105536|FG000|Overall Study|Adverse Event|0|||
146208458|NCT01600014|527280226|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
146208459|NCT01600014|527280227|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
146208460|NCT01600014|527280226|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
146208461|NCT01600014|527280227|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
146285410|NCT01605916|527557858|FG001|Overall Study|Lack of Efficacy|3|||
146285411|NCT01605916|527557859|FG002|Overall Study|Lack of Efficacy|3|||
146285412|NCT01605916|527557860|FG003|Overall Study|Lack of Efficacy|5|||
146285413|NCT01605916|527557861|FG004|Overall Study|Lack of Efficacy|4|||
146436900|NCT03804983|528105537|FG001|Overall Study|Adverse Event|1|||
146436901|NCT03804983|528105536|FG000|Overall Study|Family Obligation|1|||
146436902|NCT03804983|528105537|FG001|Overall Study|Family Obligation|0|||
146436903|NCT02152163|528105538|FG000|Overall Study|Physician Decision|12|||
146436904|NCT02152163|528105539|FG001|Overall Study|Physician Decision|13|||
146436905|NCT03114891|528105553|FG000|First Treatment Round|Lost to Follow-up|0|||
146436906|NCT03114891|528105554|FG001|First Treatment Round|Lost to Follow-up|1|||
146436907|NCT03114891|528105555|FG002|First Treatment Round|Lost to Follow-up|1|||
146436908|NCT03114891|528105556|FG003|First Treatment Round|Lost to Follow-up|0|||
146208462|NCT04278586|527280230|FG000|Overall Study|Withdrawal by Subject|13|||
146208463|NCT04278586|527280231|FG001|Overall Study|Withdrawal by Subject|6|||
146208464|NCT04278586|527280230|FG000|Overall Study|Lost to Follow-up|37|||
146208465|NCT04278586|527280231|FG001|Overall Study|Lost to Follow-up|24|||
146208466|NCT02791230|527280232|FG000|Overall Study|Adverse Event|10|||
146285414|NCT01605916|527557857|FG000|Overall Study|Withdrawal by Subject|1|||
146285415|NCT01605916|527557858|FG001|Overall Study|Withdrawal by Subject|1|||
146285416|NCT01605916|527557859|FG002|Overall Study|Withdrawal by Subject|0|||
146285417|NCT01605916|527557860|FG003|Overall Study|Withdrawal by Subject|0|||
146285418|NCT01605916|527557861|FG004|Overall Study|Withdrawal by Subject|2|||
146285419|NCT01465347|527557862|FG000|Overall Study|Withdrawal by Subject|1|||
146285420|NCT01465347|527557863|FG001|Overall Study|Withdrawal by Subject|1|||
146285421|NCT01465347|527557862|FG000|Overall Study|Physician Decision|0|||
146285422|NCT01465347|527557863|FG001|Overall Study|Physician Decision|1|||
146285423|NCT01465347|527557862|FG000|Overall Study|Admitted to hospice|0|||
146285424|NCT01465347|527557863|FG001|Overall Study|Admitted to hospice|1|||
146285425|NCT02891837|527557864|FG000|Overall Study|Lost to Follow-up|2|||
146208467|NCT02791230|527280233|FG001|Overall Study|Adverse Event|9|||
146208468|NCT02791230|527280234|FG002|Overall Study|Adverse Event|66|||
146436909|NCT03114891|528105553|FG000|First Treatment Round|Withdrawal by Subject|0|||
146208469|NCT02791230|527280232|FG000|Overall Study|Death|38|||
146208470|NCT02791230|527280233|FG001|Overall Study|Death|25|||
146208471|NCT02791230|527280234|FG002|Overall Study|Death|184|||
146208472|NCT02791230|527280232|FG000|Overall Study|Lack of Efficacy|1|||
146285426|NCT02891837|527557865|FG001|Overall Study|Lost to Follow-up|0|||
146208473|NCT02791230|527280233|FG001|Overall Study|Lack of Efficacy|0|||
146208474|NCT02791230|527280234|FG002|Overall Study|Lack of Efficacy|3|||
146208475|NCT02791230|527280232|FG000|Overall Study|Lost to Follow-up|0|||
146208476|NCT02791230|527280233|FG001|Overall Study|Lost to Follow-up|0|||
146208477|NCT02791230|527280234|FG002|Overall Study|Lost to Follow-up|10|||
145952425|NCT00524680|526337950|FG001|Overall Study|Withdrawal by Subject|0|||
145952426|NCT00524680|526337951|FG002|Overall Study|Withdrawal by Subject|1|||
145952427|NCT00524680|526337952|FG003|Overall Study|Withdrawal by Subject|1|||
145952428|NCT03337048|526337958|FG000|Overall Study|Withdrawal by Subject|2|||
145952429|NCT03337048|526337959|FG001|Overall Study|Withdrawal by Subject|0|||
145952430|NCT03337048|526337960|FG002|Overall Study|Withdrawal by Subject|0|||
145952431|NCT04399538|526337962|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
145952432|NCT04399538|526337963|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
145952433|NCT04399538|526337964|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
145952434|NCT04399538|526337965|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
145952435|NCT04399538|526337966|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
145952436|NCT04399538|526337962|FG000|Double-Blind Treatment|Adverse Event|0|||
145952437|NCT04399538|526337963|FG001|Double-Blind Treatment|Adverse Event|0|||
145952438|NCT04399538|526337964|FG002|Double-Blind Treatment|Adverse Event|0|||
145952439|NCT04399538|526337965|FG003|Double-Blind Treatment|Adverse Event|0|||
145952440|NCT04399538|526337966|FG004|Double-Blind Treatment|Adverse Event|1|||
145952441|NCT04399538|526337962|FG000|Follow-Up|Adverse Event|0|||
145952442|NCT04399538|526337963|FG001|Follow-Up|Adverse Event|0|||
145952443|NCT04399538|526337964|FG002|Follow-Up|Adverse Event|0|||
145952444|NCT04399538|526337965|FG003|Follow-Up|Adverse Event|0|||
146208478|NCT02791230|527280232|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
146208479|NCT02791230|527280233|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
146208480|NCT02791230|527280234|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
145952445|NCT04399538|526337966|FG004|Follow-Up|Adverse Event|1|||
145952446|NCT04399538|526337962|FG000|Follow-Up|Withdrawal by Subject|0|||
145952447|NCT04399538|526337963|FG001|Follow-Up|Withdrawal by Subject|0|||
145952448|NCT04399538|526337964|FG002|Follow-Up|Withdrawal by Subject|0|||
145952449|NCT04399538|526337965|FG003|Follow-Up|Withdrawal by Subject|2|||
145952450|NCT04399538|526337966|FG004|Follow-Up|Withdrawal by Subject|0|||
145952451|NCT02756364|526337968|FG000|Overall Study|Site Terminated by Sponsor|24|||
145952452|NCT02756364|526337969|FG001|Overall Study|Site Terminated by Sponsor|30|||
145952453|NCT02756364|526337970|FG002|Overall Study|Site Terminated by Sponsor|21|||
145952454|NCT02756364|526337968|FG000|Overall Study|Death|20|||
145952455|NCT02756364|526337969|FG001|Overall Study|Death|15|||
145952456|NCT02756364|526337970|FG002|Overall Study|Death|18|||
145952457|NCT02756364|526337968|FG000|Overall Study|Withdrawal by Patient|2|||
145952458|NCT02756364|526337969|FG001|Overall Study|Withdrawal by Patient|1|||
145952459|NCT02756364|526337970|FG002|Overall Study|Withdrawal by Patient|8|||
145952460|NCT02756364|526337968|FG000|Overall Study|Lost to Follow-up|0|||
145952461|NCT02756364|526337969|FG001|Overall Study|Lost to Follow-up|1|||
145952462|NCT02756364|526337970|FG002|Overall Study|Lost to Follow-up|1|||
145952463|NCT02223364|526337971|FG000|Overall Study|Protocol Violation|3|||
145952464|NCT02223364|526337972|FG001|Overall Study|Protocol Violation|0|||
145952465|NCT02223364|526337973|FG002|Overall Study|Protocol Violation|3|||
145952466|NCT02223364|526337971|FG000|Overall Study|subject expired before surgery|1|||
145952467|NCT02223364|526337972|FG001|Overall Study|subject expired before surgery|0|||
145952468|NCT02223364|526337973|FG002|Overall Study|subject expired before surgery|0|||
145952469|NCT02223364|526337971|FG000|Overall Study|Physician Decision|1|||
145952470|NCT02223364|526337972|FG001|Overall Study|Physician Decision|0|||
145952471|NCT02223364|526337973|FG002|Overall Study|Physician Decision|0|||
145952472|NCT01416155|526337974|FG000|Overall Study|Adverse Event|8|||
145952473|NCT01416155|526337974|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
146208481|NCT02791230|527280232|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
146208482|NCT02791230|527280233|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
146208483|NCT02791230|527280234|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
146208484|NCT02791230|527280232|FG000|Overall Study|Study sites terminated by sponsor|1|||
146208485|NCT02791230|527280233|FG001|Overall Study|Study sites terminated by sponsor|0|||
146208486|NCT02791230|527280234|FG002|Overall Study|Study sites terminated by sponsor|5|||
146208487|NCT02791230|527280232|FG000|Overall Study|Other|9|||
145952474|NCT01416155|526337974|FG000|Overall Study|Withdrawal by Subject|33|||
145952475|NCT01416155|526337974|FG000|Overall Study|Investigator decision|8|||
145952476|NCT01416155|526337974|FG000|Overall Study|Other|7|||
145952477|NCT04811664|526337977|FG000|Overall Study|Lost to Follow-up|78|||
145952478|NCT04811664|526337978|FG001|Overall Study|Lost to Follow-up|125|||
145952479|NCT04811664|526337979|FG002|Overall Study|Lost to Follow-up|46|||
145952480|NCT04811664|526337977|FG000|Overall Study|Withdrawal by Subject|39|||
145952481|NCT04811664|526337978|FG001|Overall Study|Withdrawal by Subject|76|||
145952482|NCT04811664|526337979|FG002|Overall Study|Withdrawal by Subject|12|||
145952483|NCT04811664|526337977|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
146208488|NCT02791230|527280233|FG001|Overall Study|Other|1|||
145952484|NCT04811664|526337978|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
145952485|NCT04811664|526337979|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
145952486|NCT04811664|526337977|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
145952487|NCT04811664|526337978|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
145952488|NCT04811664|526337979|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
145952489|NCT04811664|526337977|FG000|Overall Study|Protocol Violation|0|||
145952490|NCT04811664|526337978|FG001|Overall Study|Protocol Violation|5|||
145952491|NCT04811664|526337979|FG002|Overall Study|Protocol Violation|11|||
145952492|NCT04811664|526337977|FG000|Overall Study|Study Terminated by Sponsor|4|||
145952493|NCT04811664|526337978|FG001|Overall Study|Study Terminated by Sponsor|3|||
145952494|NCT04811664|526337979|FG002|Overall Study|Study Terminated by Sponsor|34|||
145952495|NCT04811664|526337977|FG000|Overall Study|Early Study Closure|3|||
145952496|NCT04811664|526337978|FG001|Overall Study|Early Study Closure|7|||
145952497|NCT04811664|526337979|FG002|Overall Study|Early Study Closure|79|||
145952498|NCT04811664|526337977|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
145952499|NCT04811664|526337978|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
145952500|NCT04811664|526337979|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
145952501|NCT02717442|526337980|FG000|Overall Study|Study Terminated by Sponsor|31|||
145952502|NCT02717442|526337981|FG001|Overall Study|Study Terminated by Sponsor|29|||
145952503|NCT02717442|526337980|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
145952504|NCT02717442|526337981|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
145952505|NCT02717442|526337980|FG000|Overall Study|Other - Not Specified|2|||
145952506|NCT02717442|526337981|FG001|Overall Study|Other - Not Specified|0|||
145952507|NCT00382109|526337982|FG000|Overall Study|Adverse Event|3|||
145952508|NCT00382109|526337983|FG001|Overall Study|Adverse Event|0|||
145952509|NCT00382109|526337982|FG000|Overall Study|Physician Decision|6|||
145952510|NCT00382109|526337983|FG001|Overall Study|Physician Decision|1|||
145952511|NCT00382109|526337982|FG000|Overall Study|Withdrawal by Subject|1|||
145952512|NCT00382109|526337983|FG001|Overall Study|Withdrawal by Subject|0|||
145952513|NCT00382109|526337982|FG000|Overall Study|ineligible|2|||
145952514|NCT00382109|526337983|FG001|Overall Study|ineligible|0|||
145952515|NCT00382109|526337982|FG000|Overall Study|Other|0|||
145952516|NCT00382109|526337983|FG001|Overall Study|Other|2|||
145952517|NCT00382109|526337982|FG000|Overall Study|consent withdrawal|0|||
145952518|NCT00382109|526337983|FG001|Overall Study|consent withdrawal|1|||
145952519|NCT05052697|526337984|FG000|Substudy A|Lost to Follow-up|0|||
145952520|NCT05052697|526337985|FG001|Substudy A|Lost to Follow-up|0|||
145952521|NCT05052697|526337986|FG002|Substudy A|Lost to Follow-up|0|||
145952522|NCT05052697|526337987|FG003|Substudy A|Lost to Follow-up|0|||
145952523|NCT05052697|526337988|FG004|Substudy A|Lost to Follow-up|0|||
145952524|NCT05052697|526337989|FG005|Substudy A|Lost to Follow-up|1|||
145952525|NCT05052697|526337990|FG006|Substudy A|Lost to Follow-up|0|||
145952526|NCT05052697|526337991|FG007|Substudy A|Lost to Follow-up|0|||
145952527|NCT05052697|526337992|FG008|Substudy A|Lost to Follow-up|0|||
145952528|NCT05052697|526337993|FG009|Substudy A|Lost to Follow-up|0|||
145952529|NCT05052697|526337994|FG010|Substudy A|Lost to Follow-up|0|||
145952530|NCT05052697|526337995|FG011|Substudy A|Lost to Follow-up|0|||
145952531|NCT05052697|526337996|FG012|Substudy A|Lost to Follow-up|0|||
145952532|NCT05052697|526337997|FG013|Substudy A|Lost to Follow-up|0|||
145952533|NCT05052697|526337998|FG014|Substudy A|Lost to Follow-up|0|||
145952534|NCT05052697|526337999|FG015|Substudy A|Lost to Follow-up|2|||
145952535|NCT05052697|526338000|FG016|Substudy A|Lost to Follow-up|0|||
145952536|NCT05052697|526338001|FG017|Substudy A|Lost to Follow-up|0|||
145952537|NCT05052697|526338002|FG018|Substudy A|Lost to Follow-up|0|||
145952538|NCT05052697|526338003|FG019|Substudy A|Lost to Follow-up|0|||
145952539|NCT05052697|526338004|FG020|Substudy A|Lost to Follow-up|0|||
145952540|NCT05052697|526338005|FG021|Substudy A|Lost to Follow-up|0|||
145952541|NCT05052697|526338006|FG022|Substudy A|Lost to Follow-up|0|||
145952542|NCT05052697|526338007|FG023|Substudy A|Lost to Follow-up|0|||
145952543|NCT05052697|526338008|FG024|Substudy A|Lost to Follow-up|0|||
145952544|NCT05052697|526338009|FG025|Substudy A|Lost to Follow-up|0|||
145952545|NCT05052697|526338010|FG026|Substudy A|Lost to Follow-up|0|||
145952546|NCT05052697|526338011|FG027|Substudy A|Lost to Follow-up|0|||
146208489|NCT02791230|527280234|FG002|Overall Study|Other|28|||
146208490|NCT02791230|527280232|FG000|Overall Study|Protocol Violation|0|||
146208491|NCT02791230|527280233|FG001|Overall Study|Protocol Violation|0|||
146208492|NCT02791230|527280234|FG002|Overall Study|Protocol Violation|4|||
145952547|NCT05052697|526338012|FG028|Substudy A|Lost to Follow-up|0|||
145952548|NCT05052697|526338013|FG029|Substudy A|Lost to Follow-up|0|||
145952549|NCT05052697|526338014|FG030|Substudy A|Lost to Follow-up|0|||
145952550|NCT05052697|526338015|FG031|Substudy A|Lost to Follow-up|0|||
145952551|NCT05052697|526338016|FG032|Substudy A|Lost to Follow-up|0|||
145952552|NCT05052697|526338017|FG033|Substudy A|Lost to Follow-up|0|||
145952553|NCT05052697|526337984|FG000|Substudy A|No longer met eligibility criteria|0|||
145952554|NCT05052697|526337985|FG001|Substudy A|No longer met eligibility criteria|0|||
146208493|NCT02791230|527280232|FG000|Overall Study|Withdrawal by Subject|24|||
146208494|NCT02791230|527280233|FG001|Overall Study|Withdrawal by Subject|13|||
146208495|NCT02791230|527280234|FG002|Overall Study|Withdrawal by Subject|172|||
146436910|NCT03114891|528105554|FG001|First Treatment Round|Withdrawal by Subject|2|||
146436911|NCT03114891|528105555|FG002|First Treatment Round|Withdrawal by Subject|0|||
146436912|NCT03114891|528105556|FG003|First Treatment Round|Withdrawal by Subject|1|||
146436913|NCT03114891|528105553|FG000|3 Week Break|Lost to Follow-up|1|||
146436914|NCT03114891|528105554|FG001|3 Week Break|Lost to Follow-up|0|||
146436915|NCT03114891|528105555|FG002|3 Week Break|Lost to Follow-up|0|||
146436916|NCT03114891|528105556|FG003|3 Week Break|Lost to Follow-up|1|||
146436917|NCT03114891|528105553|FG000|3 Week Break|Withdrawal by Subject|0|||
146436918|NCT03114891|528105554|FG001|3 Week Break|Withdrawal by Subject|1|||
146436919|NCT03114891|528105555|FG002|3 Week Break|Withdrawal by Subject|0|||
146436920|NCT03114891|528105556|FG003|3 Week Break|Withdrawal by Subject|0|||
146436921|NCT03114891|528105553|FG000|Second Treatment Round|Lost to Follow-up|1|||
146436922|NCT03114891|528105554|FG001|Second Treatment Round|Lost to Follow-up|0|||
146436923|NCT03114891|528105555|FG002|Second Treatment Round|Lost to Follow-up|0|||
146436924|NCT03114891|528105556|FG003|Second Treatment Round|Lost to Follow-up|0|||
146436925|NCT03114891|528105553|FG000|Second Treatment Round|Physician Decision|1|||
146436926|NCT03114891|528105554|FG001|Second Treatment Round|Physician Decision|0|||
145952555|NCT05052697|526337986|FG002|Substudy A|No longer met eligibility criteria|0|||
146436927|NCT03114891|528105555|FG002|Second Treatment Round|Physician Decision|0|||
146436928|NCT03114891|528105556|FG003|Second Treatment Round|Physician Decision|0|||
146436929|NCT05511935|528107446|FG000|Overall Study|Lost to Follow-up|9|||
146436930|NCT05511935|528107447|FG001|Overall Study|Lost to Follow-up|27|||
146436931|NCT00373256|528107448|FG000|Overall Study|Adverse Event (AE)|1|||
146436932|NCT00373256|528107449|FG001|Overall Study|Adverse Event (AE)|5|||
146436933|NCT00373256|528107448|FG000|Overall Study|Lost to Follow-up|2|||
146436934|NCT00373256|528107449|FG001|Overall Study|Lost to Follow-up|1|||
146436935|NCT00373256|528107448|FG000|Overall Study|Death|9|||
146436936|NCT00373256|528107449|FG001|Overall Study|Death|8|||
146436937|NCT00373256|528107448|FG000|Overall Study|Objective Progression or Relapse|111|||
145952556|NCT05052697|526337987|FG003|Substudy A|No longer met eligibility criteria|0|||
145952557|NCT05052697|526337988|FG004|Substudy A|No longer met eligibility criteria|0|||
146436938|NCT00373256|528107449|FG001|Overall Study|Objective Progression or Relapse|104|||
146436939|NCT00373256|528107448|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
146436940|NCT00373256|528107449|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
146436941|NCT00373256|528107448|FG000|Overall Study|Other|73|||
146436942|NCT00373256|528107449|FG001|Overall Study|Other|107|||
146436943|NCT00373256|528107448|FG000|Overall Study|Protocol Violation|0|||
146436944|NCT00373256|528107449|FG001|Overall Study|Protocol Violation|2|||
146436945|NCT00373256|528107448|FG000|Overall Study|Study Terminated by Sponsor|41|||
146436946|NCT00373256|528107449|FG001|Overall Study|Study Terminated by Sponsor|13|||
146436947|NCT00334815|528107450|FG000|Overall Study|Adverse Event|3|||
146436948|NCT00334815|528107451|FG001|Overall Study|Adverse Event|2|||
146436949|NCT00334815|528107450|FG000|Overall Study|Death|0|||
146436950|NCT00334815|528107451|FG001|Overall Study|Death|2|||
146436951|NCT00334815|528107450|FG000|Overall Study|Progression|1|||
146436952|NCT00334815|528107451|FG001|Overall Study|Progression|0|||
146436953|NCT00334815|528107450|FG000|Overall Study|ineligible|1|||
146436954|NCT00334815|528107451|FG001|Overall Study|ineligible|1|||
146436955|NCT00334815|528107450|FG000|Overall Study|patient refused treatment|0|||
146436956|NCT00334815|528107451|FG001|Overall Study|patient refused treatment|1|||
146436957|NCT00334815|528107450|FG000|Overall Study|Physician Decision|2|||
146436958|NCT00334815|528107451|FG001|Overall Study|Physician Decision|4|||
146436959|NCT03121586|528107452|FG000|Overall Study|Study terminated by sponsor|0|||
146436960|NCT03121586|528107453|FG001|Overall Study|Study terminated by sponsor|0|||
146436961|NCT03121586|528107454|FG002|Overall Study|Study terminated by sponsor|99|||
146436962|NCT03121586|528107452|FG000|Overall Study|Withdrawal by Subject|37|||
146436963|NCT03121586|528107453|FG001|Overall Study|Withdrawal by Subject|14|||
146436964|NCT03121586|528107454|FG002|Overall Study|Withdrawal by Subject|9|||
146436965|NCT03121586|528107452|FG000|Overall Study|Not further specified|6|||
146436966|NCT03121586|528107453|FG001|Overall Study|Not further specified|11|||
146436967|NCT03121586|528107454|FG002|Overall Study|Not further specified|10|||
146436968|NCT03121586|528107452|FG000|Overall Study|Adverse Event|16|||
146436969|NCT03121586|528107453|FG001|Overall Study|Adverse Event|5|||
146436970|NCT03121586|528107454|FG002|Overall Study|Adverse Event|6|||
146436971|NCT03121586|528107452|FG000|Overall Study|Protocol Violation|0|||
146436972|NCT03121586|528107453|FG001|Overall Study|Protocol Violation|5|||
146436973|NCT03121586|528107454|FG002|Overall Study|Protocol Violation|0|||
146436974|NCT03121586|528107452|FG000|Overall Study|Lack of Efficacy|3|||
145952558|NCT05052697|526337989|FG005|Substudy A|No longer met eligibility criteria|0|||
145952559|NCT05052697|526337990|FG006|Substudy A|No longer met eligibility criteria|0|||
146436975|NCT03121586|528107453|FG001|Overall Study|Lack of Efficacy|3|||
146436976|NCT03121586|528107454|FG002|Overall Study|Lack of Efficacy|1|||
146436977|NCT03121586|528107452|FG000|Overall Study|Physician Decision|2|||
146436978|NCT03121586|528107453|FG001|Overall Study|Physician Decision|2|||
146436979|NCT03121586|528107454|FG002|Overall Study|Physician Decision|0|||
146436980|NCT03121586|528107452|FG000|Overall Study|Noncompliance with study drug|5|||
146436981|NCT03121586|528107453|FG001|Overall Study|Noncompliance with study drug|3|||
146436982|NCT03121586|528107454|FG002|Overall Study|Noncompliance with study drug|5|||
146436983|NCT03121586|528107452|FG000|Overall Study|Lost to Follow-up|4|||
146436984|NCT03121586|528107453|FG001|Overall Study|Lost to Follow-up|2|||
146436985|NCT03121586|528107454|FG002|Overall Study|Lost to Follow-up|0|||
145952560|NCT05052697|526337991|FG007|Substudy A|No longer met eligibility criteria|0|||
145952561|NCT05052697|526337992|FG008|Substudy A|No longer met eligibility criteria|0|||
146436986|NCT03121586|528107452|FG000|Overall Study|Death|2|||
146436987|NCT03121586|528107453|FG001|Overall Study|Death|0|||
146436988|NCT03121586|528107454|FG002|Overall Study|Death|0|||
146436989|NCT06381102|528107455|FG000|Washout 5 Days|Withdrawal by Subject|0|||
146436990|NCT06381102|528107456|FG001|Washout 5 Days|Withdrawal by Subject|2|||
146436991|NCT00446966|528107459|FG000|Overall Study|Lost to Follow-up|10|||
146436992|NCT00446966|528107460|FG001|Overall Study|Lost to Follow-up|7|||
146436993|NCT01440803|528107461|FG000|Overall Study|Met study stopping rule|2|||
146436994|NCT01440803|528107462|FG001|Overall Study|Met study stopping rule|1|||
146436995|NCT01440803|528107461|FG000|Overall Study|Lost to Follow-up|0|||
146436996|NCT01440803|528107462|FG001|Overall Study|Lost to Follow-up|2|||
146436997|NCT01440803|528107461|FG000|Overall Study|Withdrawal by Subject|0|||
146436998|NCT01440803|528107462|FG001|Overall Study|Withdrawal by Subject|1|||
146436999|NCT00443651|528107463|FG000|Overall Study|Death|1|||
146437000|NCT00443651|528107464|FG001|Overall Study|Death|5|||
146437001|NCT00443651|528107463|FG000|Overall Study|Adverse Event|5|||
146437002|NCT00443651|528107464|FG001|Overall Study|Adverse Event|6|||
146437003|NCT00443651|528107463|FG000|Overall Study|Lost to Follow-up|18|||
146437004|NCT00443651|528107464|FG001|Overall Study|Lost to Follow-up|12|||
146437005|NCT00443651|528107463|FG000|Overall Study|Patient's/Guardian's Decision|58|||
146437006|NCT00443651|528107464|FG001|Overall Study|Patient's/Guardian's Decision|30|||
146437007|NCT00443651|528107463|FG000|Overall Study|Physician Decision|13|||
146437008|NCT00443651|528107464|FG001|Overall Study|Physician Decision|4|||
146437009|NCT00443651|528107463|FG000|Overall Study|Pregnancy|0|||
146437010|NCT00443651|528107464|FG001|Overall Study|Pregnancy|1|||
146437011|NCT01564394|528107465|FG000|Overall Study|Withdrawal by Subject|6|||
146437012|NCT01564394|528107466|FG001|Overall Study|Withdrawal by Subject|10|||
146437013|NCT00859521|528107467|FG000|Washout|Withdrawal by Subject|0|||
146437014|NCT00859521|528107468|FG001|Washout|Withdrawal by Subject|1|||
146437015|NCT01609257|528107469|FG000|Overall Study|Lost to Follow-up|2|||
146437016|NCT01609257|528107470|FG001|Overall Study|Lost to Follow-up|1|||
146437017|NCT01609257|528107469|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
146437018|NCT01609257|528107470|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
146437019|NCT01609257|528107469|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
146437020|NCT01609257|528107470|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
146437021|NCT02125461|528107471|FG000|Overall Study|Withdrawal by Subject|30|||
146437022|NCT02125461|528107472|FG001|Overall Study|Withdrawal by Subject|16|||
146437023|NCT02125461|528107471|FG000|Overall Study|Lost to Follow-up|8|||
146437024|NCT02125461|528107472|FG001|Overall Study|Lost to Follow-up|3|||
146437025|NCT02125461|528107471|FG000|Overall Study|Death|260|||
146437026|NCT02125461|528107472|FG001|Overall Study|Death|149|||
146437027|NCT02125461|528107471|FG000|Overall Study|Missing Termination Reason|0|||
146437028|NCT02125461|528107472|FG001|Overall Study|Missing Termination Reason|1|||
146437029|NCT02888756|528107474|FG000|Analytical Treatment Interruption|Physician Decision|10|||
146437030|NCT02888756|528107475|FG001|Analytical Treatment Interruption|Physician Decision|6|||
145952562|NCT05052697|526337993|FG009|Substudy A|No longer met eligibility criteria|0|||
146437031|NCT02888756|528107476|FG002|Analytical Treatment Interruption|Physician Decision|5|||
146437032|NCT01547286|528107485|FG000|Overall Study|Did not meet all eligibility criteria|1|||
146437033|NCT01547286|528107485|FG000|Overall Study|Physician Decision|1|||
146208496|NCT02791230|527280232|FG000|Overall Study|Enrolled but not treated|0|||
146208497|NCT02791230|527280233|FG001|Overall Study|Enrolled but not treated|0|||
146208498|NCT02791230|527280234|FG002|Overall Study|Enrolled but not treated|5|||
146208499|NCT02723955|527280245|FG000|Escalation Phase|Death|1|||
146208500|NCT02723955|527280246|FG001|Escalation Phase|Death|1|||
146208501|NCT02723955|527280247|FG002|Escalation Phase|Death|2|||
146208502|NCT02723955|527280248|FG003|Escalation Phase|Death|7|||
146437034|NCT03415308|528107489|FG000|Overall Study|Lost to Follow-up|0|||
146208503|NCT02723955|527280249|FG004|Escalation Phase|Death|18|||
145952563|NCT05052697|526337994|FG010|Substudy A|No longer met eligibility criteria|0|||
145952564|NCT05052697|526337995|FG011|Substudy A|No longer met eligibility criteria|0|||
145952565|NCT05052697|526337996|FG012|Substudy A|No longer met eligibility criteria|0|||
145952566|NCT05052697|526337997|FG013|Substudy A|No longer met eligibility criteria|1|||
145952567|NCT05052697|526337998|FG014|Substudy A|No longer met eligibility criteria|0|||
145952568|NCT05052697|526337999|FG015|Substudy A|No longer met eligibility criteria|0|||
145952569|NCT05052697|526338000|FG016|Substudy A|No longer met eligibility criteria|0|||
145952570|NCT05052697|526338001|FG017|Substudy A|No longer met eligibility criteria|0|||
145952571|NCT05052697|526338002|FG018|Substudy A|No longer met eligibility criteria|0|||
145952572|NCT05052697|526338003|FG019|Substudy A|No longer met eligibility criteria|0|||
145952573|NCT05052697|526338004|FG020|Substudy A|No longer met eligibility criteria|0|||
145952574|NCT05052697|526338005|FG021|Substudy A|No longer met eligibility criteria|0|||
145952575|NCT05052697|526338006|FG022|Substudy A|No longer met eligibility criteria|0|||
145952576|NCT05052697|526338007|FG023|Substudy A|No longer met eligibility criteria|0|||
145952577|NCT05052697|526338008|FG024|Substudy A|No longer met eligibility criteria|0|||
145952578|NCT05052697|526338009|FG025|Substudy A|No longer met eligibility criteria|0|||
145952579|NCT05052697|526338010|FG026|Substudy A|No longer met eligibility criteria|0|||
145952580|NCT05052697|526338011|FG027|Substudy A|No longer met eligibility criteria|0|||
145952581|NCT05052697|526338012|FG028|Substudy A|No longer met eligibility criteria|0|||
145952582|NCT05052697|526338013|FG029|Substudy A|No longer met eligibility criteria|0|||
145952583|NCT05052697|526338014|FG030|Substudy A|No longer met eligibility criteria|0|||
145952584|NCT05052697|526338015|FG031|Substudy A|No longer met eligibility criteria|0|||
145952585|NCT05052697|526338016|FG032|Substudy A|No longer met eligibility criteria|0|||
145952586|NCT05052697|526338017|FG033|Substudy A|No longer met eligibility criteria|0|||
145952587|NCT05052697|526337984|FG000|Substudy A|Not vaccinated|0|||
145952588|NCT05052697|526337985|FG001|Substudy A|Not vaccinated|0|||
145952589|NCT05052697|526337986|FG002|Substudy A|Not vaccinated|0|||
145952590|NCT05052697|526337987|FG003|Substudy A|Not vaccinated|1|||
145952591|NCT05052697|526337988|FG004|Substudy A|Not vaccinated|0|||
145952592|NCT05052697|526337989|FG005|Substudy A|Not vaccinated|0|||
145952593|NCT05052697|526337990|FG006|Substudy A|Not vaccinated|0|||
145952594|NCT05052697|526337991|FG007|Substudy A|Not vaccinated|0|||
145952595|NCT05052697|526337992|FG008|Substudy A|Not vaccinated|1|||
145952596|NCT05052697|526337993|FG009|Substudy A|Not vaccinated|0|||
145952597|NCT05052697|526337994|FG010|Substudy A|Not vaccinated|0|||
145952598|NCT05052697|526337995|FG011|Substudy A|Not vaccinated|0|||
145952599|NCT05052697|526337996|FG012|Substudy A|Not vaccinated|0|||
145952600|NCT05052697|526337997|FG013|Substudy A|Not vaccinated|0|||
145952601|NCT05052697|526337998|FG014|Substudy A|Not vaccinated|0|||
145952602|NCT05052697|526337999|FG015|Substudy A|Not vaccinated|0|||
145952603|NCT05052697|526338000|FG016|Substudy A|Not vaccinated|0|||
145952604|NCT05052697|526338001|FG017|Substudy A|Not vaccinated|0|||
145952605|NCT05052697|526338002|FG018|Substudy A|Not vaccinated|0|||
145952606|NCT05052697|526338003|FG019|Substudy A|Not vaccinated|0|||
145952607|NCT05052697|526338004|FG020|Substudy A|Not vaccinated|0|||
145952608|NCT05052697|526338005|FG021|Substudy A|Not vaccinated|0|||
145952609|NCT05052697|526338006|FG022|Substudy A|Not vaccinated|0|||
145952610|NCT05052697|526338007|FG023|Substudy A|Not vaccinated|0|||
145952611|NCT05052697|526338008|FG024|Substudy A|Not vaccinated|0|||
145952612|NCT05052697|526338009|FG025|Substudy A|Not vaccinated|0|||
145952613|NCT05052697|526338010|FG026|Substudy A|Not vaccinated|0|||
145952614|NCT05052697|526338011|FG027|Substudy A|Not vaccinated|0|||
145952615|NCT05052697|526338012|FG028|Substudy A|Not vaccinated|0|||
145952616|NCT05052697|526338013|FG029|Substudy A|Not vaccinated|0|||
145952617|NCT05052697|526338014|FG030|Substudy A|Not vaccinated|0|||
145952618|NCT05052697|526338015|FG031|Substudy A|Not vaccinated|0|||
145952619|NCT05052697|526338016|FG032|Substudy A|Not vaccinated|0|||
145952620|NCT05052697|526338017|FG033|Substudy A|Not vaccinated|0|||
145952621|NCT05052697|526337984|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952622|NCT05052697|526337985|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952623|NCT05052697|526337986|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952624|NCT05052697|526337987|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952625|NCT05052697|526337988|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952626|NCT05052697|526337989|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952627|NCT05052697|526337990|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952628|NCT05052697|526337991|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952629|NCT05052697|526337992|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952630|NCT05052697|526337993|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952631|NCT05052697|526337994|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952632|NCT05052697|526337995|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952633|NCT05052697|526337996|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952634|NCT05052697|526337997|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952635|NCT05052697|526337998|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952636|NCT05052697|526337999|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952637|NCT05052697|526338000|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952638|NCT05052697|526338001|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146437035|NCT03415308|528107490|FG001|Overall Study|Lost to Follow-up|0|||
146437036|NCT03415308|528107491|FG002|Overall Study|Lost to Follow-up|1|||
146437037|NCT03415308|528107489|FG000|Overall Study|Scheduling Conflicts|0|||
146437038|NCT03415308|528107490|FG001|Overall Study|Scheduling Conflicts|0|||
146437039|NCT03415308|528107491|FG002|Overall Study|Scheduling Conflicts|7|||
146437040|NCT01471353|528107492|FG000|Overall Study|remain on study|3|||
146437041|NCT00836472|528107493|FG000|Washout|Adverse Event|1|||
146437042|NCT00836472|528107494|FG001|Washout|Adverse Event|2|||
146437043|NCT00836472|528107493|FG000|Washout|Withdrawal by Subject|1|||
145952639|NCT05052697|526338002|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
146437044|NCT00836472|528107494|FG001|Washout|Withdrawal by Subject|1|||
146437045|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
146437046|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
146437047|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
146437048|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
146437049|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437050|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437051|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437052|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437053|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437054|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437055|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437056|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437057|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437058|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
146437059|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
146437060|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
146437061|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
146437062|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
146437063|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437064|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437065|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437066|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437067|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437068|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437069|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437070|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437071|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437072|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146437073|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
146437074|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437075|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
146437076|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437077|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437078|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437079|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437080|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437081|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437082|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437083|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437084|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437085|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437086|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146437087|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
146437088|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
146437089|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
146437090|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437091|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437092|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437093|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437094|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437095|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437096|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437097|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437098|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437099|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437100|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146437101|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
146437102|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437103|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
146437104|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437105|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437106|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437107|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437108|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437109|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437110|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437111|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437112|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437113|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437114|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
146437115|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146437116|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437117|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146437118|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437119|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437120|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437121|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437122|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437123|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437124|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437125|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437126|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437127|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437128|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
146437129|NCT01695239|528107495|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
146437130|NCT01695239|528107496|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437131|NCT01695239|528107497|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437132|NCT01695239|528107498|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437133|NCT01695239|528107499|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437134|NCT01695239|528107500|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437135|NCT01695239|528107501|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146285427|NCT02891837|527557864|FG000|Overall Study|Withdrawal by Subject|1|||
146437136|NCT01695239|528107502|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437137|NCT01695239|528107503|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437138|NCT01695239|528107504|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437139|NCT01695239|528107505|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437140|NCT01695239|528107506|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437141|NCT01695239|528107507|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437142|NCT01695239|528107508|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146437143|NCT01695239|528107495|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437144|NCT01695239|528107496|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437145|NCT01695239|528107497|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437146|NCT01695239|528107498|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437147|NCT01695239|528107499|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437148|NCT01695239|528107500|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437149|NCT01695239|528107501|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437150|NCT01695239|528107502|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
146437151|NCT01695239|528107503|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437152|NCT01695239|528107504|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437153|NCT01695239|528107505|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437154|NCT01695239|528107506|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437155|NCT01695239|528107507|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437156|NCT01695239|528107508|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
146437157|NCT01695239|528107495|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437158|NCT01695239|528107496|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437159|NCT01695239|528107497|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437160|NCT01695239|528107498|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437161|NCT01695239|528107499|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437162|NCT01695239|528107500|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437163|NCT01695239|528107501|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146285428|NCT02891837|527557865|FG001|Overall Study|Withdrawal by Subject|0|||
146437164|NCT01695239|528107502|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
146437165|NCT01695239|528107503|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437166|NCT01695239|528107504|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437167|NCT01695239|528107505|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437168|NCT01695239|528107506|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437169|NCT01695239|528107507|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437170|NCT01695239|528107508|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
146437171|NCT01695239|528107495|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437172|NCT01695239|528107496|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437173|NCT01695239|528107497|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437174|NCT01695239|528107498|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437175|NCT01695239|528107499|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437176|NCT01695239|528107500|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437177|NCT01695239|528107501|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437178|NCT01695239|528107502|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
146437179|NCT01695239|528107503|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437180|NCT01695239|528107504|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437181|NCT01695239|528107505|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437182|NCT01695239|528107506|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437183|NCT01695239|528107507|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437184|NCT01695239|528107508|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
146437185|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437186|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146208504|NCT02723955|527280250|FG005|Escalation Phase|Death|17|||
146208505|NCT02723955|527280251|FG006|Escalation Phase|Death|11|||
146208506|NCT02723955|527280252|FG007|Escalation Phase|Death|21|||
146208507|NCT02723955|527280253|FG008|Escalation Phase|Death|3|||
146208508|NCT02723955|527280254|FG009|Escalation Phase|Death|0|||
146208509|NCT02723955|527280255|FG010|Escalation Phase|Death|0|||
146208510|NCT02723955|527280256|FG011|Escalation Phase|Death|0|||
146208511|NCT02723955|527280257|FG012|Escalation Phase|Death|2|||
146208512|NCT02723955|527280258|FG013|Escalation Phase|Death|4|||
146208513|NCT02723955|527280259|FG014|Escalation Phase|Death|5|||
146208514|NCT02723955|527280260|FG015|Escalation Phase|Death|6|||
146208515|NCT02723955|527280261|FG016|Escalation Phase|Death|6|||
146208516|NCT02723955|527280262|FG017|Escalation Phase|Death|7|||
146208517|NCT02723955|527280263|FG018|Escalation Phase|Death|1|||
146208518|NCT02723955|527280264|FG019|Escalation Phase|Death|3|||
146208519|NCT02723955|527280265|FG020|Escalation Phase|Death|13|||
146208520|NCT02723955|527280266|FG021|Escalation Phase|Death|3|||
146208521|NCT02723955|527280267|FG022|Escalation Phase|Death|2|||
146208522|NCT02723955|527280268|FG023|Escalation Phase|Death|4|||
146208523|NCT02723955|527280269|FG024|Escalation Phase|Death|31|||
146208524|NCT02723955|527280270|FG025|Escalation Phase|Death|7|||
146208525|NCT02723955|527280271|FG026|Escalation Phase|Death|13|||
146208526|NCT02723955|527280272|FG027|Escalation Phase|Death|0|||
146208527|NCT02723955|527280273|FG028|Escalation Phase|Death|1|||
146208528|NCT02723955|527280274|FG029|Escalation Phase|Death|0|||
146208529|NCT02723955|527280275|FG030|Escalation Phase|Death|0|||
146208530|NCT02723955|527280276|FG031|Escalation Phase|Death|0|||
146208531|NCT02723955|527280277|FG032|Escalation Phase|Death|0|||
146208532|NCT02723955|527280278|FG033|Escalation Phase|Death|0|||
146208533|NCT02723955|527280279|FG034|Escalation Phase|Death|0|||
146208534|NCT02723955|527280280|FG035|Escalation Phase|Death|0|||
146208535|NCT02723955|527280281|FG036|Escalation Phase|Death|0|||
146208536|NCT02723955|527280282|FG037|Escalation Phase|Death|0|||
146208537|NCT02723955|527280283|FG038|Escalation Phase|Death|0|||
146208538|NCT02723955|527280284|FG039|Escalation Phase|Death|0|||
146208539|NCT02723955|527280285|FG040|Escalation Phase|Death|0|||
146208540|NCT02723955|527280286|FG041|Escalation Phase|Death|0|||
146208541|NCT02723955|527280287|FG042|Escalation Phase|Death|0|||
146208542|NCT02723955|527280245|FG000|Escalation Phase|Lost to Follow-up|0|||
146208543|NCT02723955|527280246|FG001|Escalation Phase|Lost to Follow-up|0|||
146208544|NCT02723955|527280247|FG002|Escalation Phase|Lost to Follow-up|0|||
146437187|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437188|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437189|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437190|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146208545|NCT02723955|527280248|FG003|Escalation Phase|Lost to Follow-up|0|||
146208546|NCT02723955|527280249|FG004|Escalation Phase|Lost to Follow-up|0|||
146208547|NCT02723955|527280250|FG005|Escalation Phase|Lost to Follow-up|2|||
146208548|NCT02723955|527280251|FG006|Escalation Phase|Lost to Follow-up|1|||
146208549|NCT02723955|527280252|FG007|Escalation Phase|Lost to Follow-up|1|||
146208550|NCT02723955|527280253|FG008|Escalation Phase|Lost to Follow-up|1|||
146208551|NCT02723955|527280254|FG009|Escalation Phase|Lost to Follow-up|0|||
146208552|NCT02723955|527280255|FG010|Escalation Phase|Lost to Follow-up|0|||
146208553|NCT02723955|527280256|FG011|Escalation Phase|Lost to Follow-up|0|||
146208554|NCT02723955|527280257|FG012|Escalation Phase|Lost to Follow-up|1|||
146208555|NCT02723955|527280258|FG013|Escalation Phase|Lost to Follow-up|0|||
146208556|NCT02723955|527280259|FG014|Escalation Phase|Lost to Follow-up|0|||
146208557|NCT02723955|527280260|FG015|Escalation Phase|Lost to Follow-up|0|||
146208558|NCT02723955|527280261|FG016|Escalation Phase|Lost to Follow-up|1|||
146208559|NCT02723955|527280262|FG017|Escalation Phase|Lost to Follow-up|2|||
146208560|NCT02723955|527280263|FG018|Escalation Phase|Lost to Follow-up|0|||
146208561|NCT02723955|527280264|FG019|Escalation Phase|Lost to Follow-up|1|||
146437191|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437192|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437193|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
146437194|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
146437195|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437196|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437197|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437198|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
146437199|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
146437200|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
146437201|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
146437202|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
146437203|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
146437204|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
146437205|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
146437206|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
146437207|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
146437208|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
146437209|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
146437210|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
146437211|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
146437212|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
146437213|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437214|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437215|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437216|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437217|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437218|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437219|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437220|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437221|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
146437222|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
146437223|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437224|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437225|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437226|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
146437227|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
146437228|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
146437229|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
146437230|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
146437231|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
146437232|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
146437233|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
146437234|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
146437235|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
146437236|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
146437237|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
146437238|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
146437239|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
146437240|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
146437241|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437242|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437243|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437244|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437245|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437246|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437247|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437248|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437249|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
146437250|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
146437251|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437252|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437253|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437254|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
146437255|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437256|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437257|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437258|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437259|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437260|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437261|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437262|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437263|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
146437264|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
146437265|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437266|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437267|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437268|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
146437269|NCT01695239|528107495|FG000|Extension Long-Term Extension Periods|Death|0|||
146437270|NCT01695239|528107496|FG001|Extension Long-Term Extension Periods|Death|0|||
146437271|NCT01695239|528107497|FG002|Extension Long-Term Extension Periods|Death|0|||
146437272|NCT01695239|528107498|FG003|Extension Long-Term Extension Periods|Death|0|||
146437273|NCT01695239|528107499|FG004|Extension Long-Term Extension Periods|Death|0|||
146437274|NCT01695239|528107500|FG005|Extension Long-Term Extension Periods|Death|0|||
146437275|NCT01695239|528107501|FG006|Extension Long-Term Extension Periods|Death|0|||
146437276|NCT01695239|528107502|FG007|Extension Long-Term Extension Periods|Death|0|||
146437277|NCT01695239|528107503|FG008|Extension Long-Term Extension Periods|Death|1|||
146437278|NCT01695239|528107504|FG009|Extension Long-Term Extension Periods|Death|0|||
146437279|NCT01695239|528107505|FG010|Extension Long-Term Extension Periods|Death|0|||
146437280|NCT01695239|528107506|FG011|Extension Long-Term Extension Periods|Death|0|||
146437281|NCT01695239|528107507|FG012|Extension Long-Term Extension Periods|Death|0|||
146437282|NCT01695239|528107508|FG013|Extension Long-Term Extension Periods|Death|0|||
146437283|NCT01695239|528107495|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437284|NCT01695239|528107496|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437285|NCT01695239|528107497|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437286|NCT01695239|528107498|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437287|NCT01695239|528107499|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437288|NCT01695239|528107500|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437289|NCT01695239|528107501|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437290|NCT01695239|528107502|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437291|NCT01695239|528107503|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437292|NCT01695239|528107504|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437293|NCT01695239|528107505|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146437294|NCT01695239|528107506|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
146437295|NCT01695239|528107507|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
146437296|NCT01695239|528107508|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
146437297|NCT01695239|528107495|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437298|NCT01695239|528107496|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437299|NCT01695239|528107497|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437300|NCT01695239|528107498|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437301|NCT01695239|528107499|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437302|NCT01695239|528107500|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437303|NCT01695239|528107501|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437304|NCT01695239|528107502|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437305|NCT01695239|528107503|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437306|NCT01695239|528107504|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437307|NCT01695239|528107505|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146285429|NCT01103362|527557868|FG000|Overall Study|study terminated|596|||
146437308|NCT01695239|528107506|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146437309|NCT01695239|528107507|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146437310|NCT01695239|528107508|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146437311|NCT01695239|528107495|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437312|NCT01695239|528107496|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437313|NCT01695239|528107497|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437314|NCT01695239|528107498|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437315|NCT01695239|528107499|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437316|NCT01695239|528107500|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437317|NCT01695239|528107501|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437318|NCT01695239|528107502|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437319|NCT01695239|528107503|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437320|NCT01695239|528107504|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437321|NCT01695239|528107505|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437322|NCT01695239|528107506|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437323|NCT01695239|528107507|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
146437324|NCT01695239|528107508|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
146437325|NCT01695239|528107495|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437326|NCT01695239|528107496|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437327|NCT01695239|528107497|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437328|NCT01695239|528107498|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437329|NCT01695239|528107499|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437330|NCT01695239|528107500|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437331|NCT01695239|528107501|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437332|NCT01695239|528107502|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437333|NCT01695239|528107503|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437334|NCT01695239|528107504|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437335|NCT01695239|528107505|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437336|NCT01695239|528107506|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437337|NCT01695239|528107507|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146437338|NCT01695239|528107508|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
146437339|NCT03913377|528107511|FG000|Period 1|Test Article no longer available|0|||
146437340|NCT03913377|528107512|FG001|Period 1|Test Article no longer available|1|||
146437341|NCT03913377|528107513|FG002|Period 1|Test Article no longer available|0|||
146437342|NCT03913377|528107511|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
146437343|NCT03913377|528107512|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
146437344|NCT03913377|528107513|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
146437345|NCT05239195|528107514|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
146437346|NCT05239195|528107515|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
146437347|NCT03552484|528107518|FG000|Overall Study|Death|6|||
146437348|NCT03552484|528107519|FG001|Overall Study|Death|4|||
146437349|NCT03552484|528107518|FG000|Overall Study|Lost to Follow-up|0|||
146437350|NCT03552484|528107519|FG001|Overall Study|Lost to Follow-up|16|||
146437351|NCT02241551|528107520|FG000|Overall Study|Adverse Event|1|||
146437352|NCT02241551|528107521|FG001|Overall Study|Adverse Event|0|||
146437353|NCT03499353|528107522|FG000|Treatment|Adverse Event|3|||
146437354|NCT03499353|528107522|FG000|Treatment|Progressive Disease|10|||
146437355|NCT03499353|528107522|FG000|Treatment|Other|1|||
146437356|NCT03499353|528107522|FG000|Treatment|Withdrawal by Subject|2|||
146437357|NCT03499353|528107522|FG000|Long-Term Follow-up|Death|2|||
146437358|NCT03499353|528107522|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
146437359|NCT03499353|528107522|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
146437360|NCT01015287|528107525|FG000|Overall Study|Death|21|||
146437361|NCT01015287|528107526|FG001|Overall Study|Death|16|||
146437362|NCT01015287|528107525|FG000|Overall Study|Adverse Event|1|||
146437363|NCT01015287|528107526|FG001|Overall Study|Adverse Event|0|||
146437364|NCT01015287|528107525|FG000|Overall Study|Sponsor Decision|3|||
146437365|NCT01015287|528107526|FG001|Overall Study|Sponsor Decision|7|||
146437366|NCT01015287|528107525|FG000|Overall Study|Physician Decision|19|||
146437367|NCT01015287|528107526|FG001|Overall Study|Physician Decision|21|||
146083064|NCT02353143|526824733|FG008|Overall Study|patient receiving other treatment for AML|0|||
146083065|NCT02353143|526824725|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
146437368|NCT01015287|528107525|FG000|Overall Study|Withdrawal by Subject|14|||
146437369|NCT01015287|528107526|FG001|Overall Study|Withdrawal by Subject|19|||
146437370|NCT01015287|528107525|FG000|Overall Study|Entry Criteria not Met|11|||
146437371|NCT01015287|528107526|FG001|Overall Study|Entry Criteria not Met|14|||
146437372|NCT01015287|528107525|FG000|Overall Study|Lost to Follow-up|2|||
146437373|NCT01015287|528107526|FG001|Overall Study|Lost to Follow-up|1|||
146437374|NCT01015287|528107525|FG000|Overall Study|Protocol Violation|1|||
146437375|NCT01015287|528107526|FG001|Overall Study|Protocol Violation|1|||
146437376|NCT01592240|528107527|FG000|Overall Study|Adverse Event|1|||
146437377|NCT01592240|528107528|FG001|Overall Study|Adverse Event|0|||
146437378|NCT01592240|528107529|FG002|Overall Study|Adverse Event|0|||
146437379|NCT01592240|528107530|FG003|Overall Study|Adverse Event|1|||
146437380|NCT01592240|528107531|FG004|Overall Study|Adverse Event|1|||
146437381|NCT01592240|528107532|FG005|Overall Study|Adverse Event|0|||
146437382|NCT01592240|528107533|FG006|Overall Study|Adverse Event|0|||
146437383|NCT01592240|528107527|FG000|Overall Study|Death|0|||
146437384|NCT01592240|528107528|FG001|Overall Study|Death|1|||
146437385|NCT01592240|528107529|FG002|Overall Study|Death|0|||
146437386|NCT01592240|528107530|FG003|Overall Study|Death|0|||
146437387|NCT01592240|528107531|FG004|Overall Study|Death|0|||
146437388|NCT01592240|528107532|FG005|Overall Study|Death|0|||
146437389|NCT01592240|528107533|FG006|Overall Study|Death|0|||
146437390|NCT01592240|528107527|FG000|Overall Study|Lost to Follow-up|1|||
146437391|NCT01592240|528107528|FG001|Overall Study|Lost to Follow-up|3|||
146437392|NCT01592240|528107529|FG002|Overall Study|Lost to Follow-up|1|||
146437393|NCT01592240|528107530|FG003|Overall Study|Lost to Follow-up|0|||
146437394|NCT01592240|528107531|FG004|Overall Study|Lost to Follow-up|3|||
146437395|NCT01592240|528107532|FG005|Overall Study|Lost to Follow-up|2|||
146437396|NCT01592240|528107533|FG006|Overall Study|Lost to Follow-up|0|||
146437397|NCT01592240|528107527|FG000|Overall Study|Protocol Violation|0|||
146437398|NCT01592240|528107528|FG001|Overall Study|Protocol Violation|0|||
146437399|NCT01592240|528107529|FG002|Overall Study|Protocol Violation|0|||
146437400|NCT01592240|528107530|FG003|Overall Study|Protocol Violation|0|||
146437401|NCT01592240|528107531|FG004|Overall Study|Protocol Violation|0|||
146437402|NCT01592240|528107532|FG005|Overall Study|Protocol Violation|1|||
146437403|NCT01592240|528107533|FG006|Overall Study|Protocol Violation|0|||
146437404|NCT01592240|528107527|FG000|Overall Study|Withdrawal by Subject|0|||
146437405|NCT01592240|528107528|FG001|Overall Study|Withdrawal by Subject|4|||
146437406|NCT01592240|528107529|FG002|Overall Study|Withdrawal by Subject|4|||
146437407|NCT01592240|528107530|FG003|Overall Study|Withdrawal by Subject|1|||
146437408|NCT01592240|528107531|FG004|Overall Study|Withdrawal by Subject|3|||
146437409|NCT01592240|528107532|FG005|Overall Study|Withdrawal by Subject|0|||
146437410|NCT01592240|528107533|FG006|Overall Study|Withdrawal by Subject|2|||
146437411|NCT01592240|528107527|FG000|Overall Study|Other|0|||
146437412|NCT01592240|528107528|FG001|Overall Study|Other|3|||
146437413|NCT01592240|528107529|FG002|Overall Study|Other|1|||
146437414|NCT01592240|528107530|FG003|Overall Study|Other|1|||
146437415|NCT01592240|528107531|FG004|Overall Study|Other|0|||
146437416|NCT01592240|528107532|FG005|Overall Study|Other|0|||
146437417|NCT01592240|528107533|FG006|Overall Study|Other|1|||
146437418|NCT01592240|528107527|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146437419|NCT01592240|528107528|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
146437420|NCT01592240|528107529|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
146437421|NCT01592240|528107530|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
146437422|NCT01592240|528107531|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
146437423|NCT01592240|528107532|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
146437424|NCT01592240|528107533|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
146437425|NCT01117623|528107534|FG000|Overall Study|Adverse Event|0|||
146437426|NCT01117623|528107535|FG001|Overall Study|Adverse Event|2|||
146437427|NCT01117623|528107536|FG002|Overall Study|Adverse Event|4|||
146437428|NCT01117623|528107537|FG003|Overall Study|Adverse Event|0|||
146437429|NCT01117623|528107538|FG004|Overall Study|Adverse Event|2|||
146437430|NCT01117623|528107539|FG005|Overall Study|Adverse Event|0|||
146437431|NCT01117623|528107540|FG006|Overall Study|Adverse Event|0|||
146437432|NCT01117623|528107541|FG007|Overall Study|Adverse Event|2|||
146437433|NCT01117623|528107534|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
146437434|NCT01117623|528107535|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
146437435|NCT01117623|528107536|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
146437436|NCT01117623|528107537|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
146437437|NCT01117623|528107538|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
146437438|NCT01117623|528107539|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
146437439|NCT01117623|528107540|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
146437440|NCT01117623|528107541|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
146437441|NCT01117623|528107534|FG000|Overall Study|Withdrawal by Subject|0|||
146437442|NCT01117623|528107535|FG001|Overall Study|Withdrawal by Subject|0|||
146437443|NCT01117623|528107536|FG002|Overall Study|Withdrawal by Subject|2|||
146437444|NCT01117623|528107537|FG003|Overall Study|Withdrawal by Subject|0|||
146437445|NCT01117623|528107538|FG004|Overall Study|Withdrawal by Subject|0|||
146437446|NCT01117623|528107539|FG005|Overall Study|Withdrawal by Subject|1|||
146437447|NCT01117623|528107540|FG006|Overall Study|Withdrawal by Subject|1|||
146437448|NCT01117623|528107541|FG007|Overall Study|Withdrawal by Subject|1|||
146437449|NCT01117623|528107534|FG000|Overall Study|Non-compliance with study medication|0|||
146437450|NCT01117623|528107535|FG001|Overall Study|Non-compliance with study medication|0|||
146437451|NCT01117623|528107536|FG002|Overall Study|Non-compliance with study medication|0|||
146437452|NCT01117623|528107537|FG003|Overall Study|Non-compliance with study medication|0|||
146437453|NCT01117623|528107538|FG004|Overall Study|Non-compliance with study medication|0|||
146437454|NCT01117623|528107539|FG005|Overall Study|Non-compliance with study medication|0|||
146437455|NCT01117623|528107540|FG006|Overall Study|Non-compliance with study medication|0|||
146437456|NCT01117623|528107541|FG007|Overall Study|Non-compliance with study medication|1|||
146437457|NCT01117623|528107534|FG000|Overall Study|Invest. text: completed all planned txs|0|||
146437458|NCT01117623|528107535|FG001|Overall Study|Invest. text: completed all planned txs|0|||
146437459|NCT01117623|528107536|FG002|Overall Study|Invest. text: completed all planned txs|0|||
146437460|NCT01117623|528107537|FG003|Overall Study|Invest. text: completed all planned txs|0|||
146437461|NCT01117623|528107538|FG004|Overall Study|Invest. text: completed all planned txs|0|||
146437462|NCT01117623|528107539|FG005|Overall Study|Invest. text: completed all planned txs|1|||
146437463|NCT01117623|528107540|FG006|Overall Study|Invest. text: completed all planned txs|0|||
146437464|NCT01117623|528107541|FG007|Overall Study|Invest. text: completed all planned txs|0|||
146437465|NCT00469898|528107549|FG000|Overall Study|Adverse Event|7|||
146437466|NCT00469898|528107549|FG000|Overall Study|Withdrawal by Subject|4|||
146437467|NCT00469898|528107549|FG000|Overall Study|Death|4|||
146437468|NCT00469898|528107549|FG000|Overall Study|Disease progression|9|||
146437469|NCT00469898|528107549|FG000|Overall Study|Decreased performance status|1|||
146437470|NCT01205035|528107554|FG000|Overall Study|Withdrawal by Subject|1|||
146437471|NCT01205035|528107555|FG001|Overall Study|Withdrawal by Subject|0|||
146437472|NCT01205035|528107554|FG000|Overall Study|Physician Decision|1|||
146437473|NCT01205035|528107555|FG001|Overall Study|Physician Decision|0|||
146437474|NCT02751424|528107556|FG000|Part 2|Adverse Event|0|||
146437475|NCT02751424|528107557|FG001|Part 2|Adverse Event|0|||
146437476|NCT02751424|528107558|FG002|Part 2|Adverse Event|0|||
146437477|NCT02751424|528107559|FG003|Part 2|Adverse Event|0|||
146437478|NCT02751424|528107560|FG004|Part 2|Adverse Event|0|||
146437479|NCT02751424|528107561|FG005|Part 2|Adverse Event|0|||
146437480|NCT02751424|528107562|FG006|Part 2|Adverse Event|0|||
146437481|NCT02751424|528107563|FG007|Part 2|Adverse Event|5|||
146437482|NCT02751424|528107564|FG008|Part 2|Adverse Event|0|||
146437483|NCT01204294|528107565|FG000|Overall Study|Adverse Event|2|||
146437484|NCT01204294|528107566|FG001|Overall Study|Adverse Event|6|||
146437485|NCT01204294|528107567|FG002|Overall Study|Adverse Event|0|||
146437486|NCT01204294|528107568|FG003|Overall Study|Adverse Event|7|||
146437487|NCT01204294|528107569|FG004|Overall Study|Adverse Event|1|||
146437488|NCT01204294|528107570|FG005|Overall Study|Adverse Event|4|||
146437489|NCT01204294|528107571|FG006|Overall Study|Adverse Event|0|||
146437490|NCT01204294|528107565|FG000|Overall Study|Protocol Violation|1|||
146437491|NCT01204294|528107566|FG001|Overall Study|Protocol Violation|0|||
146437492|NCT01204294|528107567|FG002|Overall Study|Protocol Violation|2|||
146437493|NCT01204294|528107568|FG003|Overall Study|Protocol Violation|1|||
146437494|NCT01204294|528107569|FG004|Overall Study|Protocol Violation|0|||
146437495|NCT01204294|528107570|FG005|Overall Study|Protocol Violation|0|||
146437496|NCT01204294|528107571|FG006|Overall Study|Protocol Violation|0|||
146437497|NCT01204294|528107565|FG000|Overall Study|Withdrawal by Subject|0|||
146437498|NCT01204294|528107566|FG001|Overall Study|Withdrawal by Subject|2|||
146437499|NCT01204294|528107567|FG002|Overall Study|Withdrawal by Subject|2|||
146437500|NCT01204294|528107568|FG003|Overall Study|Withdrawal by Subject|1|||
146437501|NCT01204294|528107569|FG004|Overall Study|Withdrawal by Subject|1|||
146437502|NCT01204294|528107570|FG005|Overall Study|Withdrawal by Subject|1|||
146437503|NCT01204294|528107571|FG006|Overall Study|Withdrawal by Subject|2|||
146437504|NCT01204294|528107565|FG000|Overall Study|Lack of Efficacy|0|||
146437505|NCT01204294|528107566|FG001|Overall Study|Lack of Efficacy|0|||
146437506|NCT01204294|528107567|FG002|Overall Study|Lack of Efficacy|0|||
146437507|NCT01204294|528107568|FG003|Overall Study|Lack of Efficacy|2|||
146437508|NCT01204294|528107569|FG004|Overall Study|Lack of Efficacy|0|||
146437509|NCT01204294|528107570|FG005|Overall Study|Lack of Efficacy|0|||
146437510|NCT01204294|528107571|FG006|Overall Study|Lack of Efficacy|0|||
146437511|NCT01204294|528107565|FG000|Overall Study|Other (house moving)|0|||
146437512|NCT01204294|528107566|FG001|Overall Study|Other (house moving)|0|||
146437513|NCT01204294|528107567|FG002|Overall Study|Other (house moving)|1|||
146437514|NCT01204294|528107568|FG003|Overall Study|Other (house moving)|0|||
146437515|NCT01204294|528107569|FG004|Overall Study|Other (house moving)|0|||
146437516|NCT01204294|528107570|FG005|Overall Study|Other (house moving)|0|||
146437517|NCT01204294|528107571|FG006|Overall Study|Other (house moving)|0|||
146437518|NCT00245063|528107572|FG000|Overall Study|Adverse Event|6|||
146437519|NCT00245063|528107573|FG001|Overall Study|Adverse Event|5|||
146437520|NCT00245063|528107572|FG000|Overall Study|Death|1|||
146437521|NCT00245063|528107573|FG001|Overall Study|Death|0|||
146437522|NCT01839279|528107574|FG000|Overall Study|Adverse Event|4|||
146437523|NCT01839279|528107575|FG001|Overall Study|Adverse Event|1|||
146437524|NCT01839279|528107576|FG002|Overall Study|Adverse Event|1|||
146437525|NCT01839279|528107574|FG000|Overall Study|Withdrawal by Subject|4|||
146285430|NCT03538301|527557871|FG000|Overall Study|Adverse Event|1|||
146437526|NCT01839279|528107575|FG001|Overall Study|Withdrawal by Subject|1|||
146437527|NCT01839279|528107576|FG002|Overall Study|Withdrawal by Subject|1|||
146437528|NCT01839279|528107574|FG000|Overall Study|Classified as 'Other'|5|||
146437529|NCT01839279|528107575|FG001|Overall Study|Classified as 'Other'|0|||
146437530|NCT01839279|528107576|FG002|Overall Study|Classified as 'Other'|0|||
146437531|NCT00840216|528107580|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
146437532|NCT00840216|528107581|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
146437533|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Adverse Event|8|||
146437534|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Adverse Event|15|||
146437535|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Adverse Event|25|||
146437536|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
146437537|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
146437538|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
146437539|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
146437540|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
146437541|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
146437542|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
146437543|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
146437544|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
146437545|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146437546|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
146437547|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
146437548|NCT01058668|528107582|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
146437549|NCT01058668|528107583|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
146437550|NCT01058668|528107584|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
146437551|NCT00316277|528107585|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
146437552|NCT00316277|528107586|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
146437553|NCT00316277|528107585|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
146437554|NCT00316277|528107586|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
146437555|NCT00316277|528107585|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
146437556|NCT00316277|528107586|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
146437557|NCT00316277|528107585|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
146437558|NCT00316277|528107586|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
146437559|NCT00316277|528107585|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
146437560|NCT00316277|528107586|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
146437561|NCT00848536|528107589|FG000|Overall Study|Adverse Event|2|||
146437562|NCT00848536|528107590|FG001|Overall Study|Adverse Event|2|||
146437563|NCT00848536|528107589|FG000|Overall Study|Withdrawal by Subject|0|||
146437564|NCT00848536|528107590|FG001|Overall Study|Withdrawal by Subject|1|||
146437565|NCT00848536|528107589|FG000|Overall Study|Protocol Violation|0|||
146437566|NCT00848536|528107590|FG001|Overall Study|Protocol Violation|1|||
146437567|NCT00848536|528107589|FG000|Overall Study|Noncompliance|1|||
146437568|NCT00848536|528107590|FG001|Overall Study|Noncompliance|0|||
146437569|NCT00848536|528107589|FG000|Overall Study|Inadequate Control of IOP|1|||
146437570|NCT00848536|528107590|FG001|Overall Study|Inadequate Control of IOP|1|||
146437571|NCT00848536|528107589|FG000|Overall Study|Patient Moved|0|||
146437572|NCT00848536|528107590|FG001|Overall Study|Patient Moved|2|||
146437573|NCT01370733|528107591|FG000|Overall Study|Withdrawal by Subject|8|||
146437574|NCT01370733|528107592|FG001|Overall Study|Withdrawal by Subject|8|||
146437575|NCT01370733|528107591|FG000|Overall Study|Lost to Follow-up|3|||
146437576|NCT01370733|528107592|FG001|Overall Study|Lost to Follow-up|0|||
146437577|NCT01370733|528107591|FG000|Overall Study|Adverse Event|2|||
146437578|NCT01370733|528107592|FG001|Overall Study|Adverse Event|4|||
146437579|NCT01370733|528107591|FG000|Overall Study|Lack of Efficacy|3|||
146437580|NCT01370733|528107592|FG001|Overall Study|Lack of Efficacy|5|||
146437581|NCT01370733|528107591|FG000|Overall Study|Physician Decision|0|||
146437582|NCT01370733|528107592|FG001|Overall Study|Physician Decision|2|||
146437583|NCT01370733|528107591|FG000|Overall Study|Protocol Violation|1|||
145952640|NCT05052697|526338003|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
145952641|NCT05052697|526338004|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952642|NCT05052697|526338005|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
145952643|NCT05052697|526338006|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
146285431|NCT03538301|527557872|FG001|Overall Study|Adverse Event|4|||
146285432|NCT03538301|527557873|FG002|Overall Study|Adverse Event|4|||
146437584|NCT01370733|528107592|FG001|Overall Study|Protocol Violation|3|||
146437585|NCT06539676|528107593|FG000|Overall Study|Early study termination|1|||
146437586|NCT06539676|528107594|FG001|Overall Study|Early study termination|0|||
146437587|NCT06539676|528107595|FG002|Overall Study|Early study termination|6|||
146437588|NCT03214588|528107596|FG000|Overall Study|Adverse Event|1|||
146437589|NCT03214588|528107597|FG001|Overall Study|Adverse Event|0|||
146437590|NCT03214588|528107598|FG002|Overall Study|Adverse Event|2|||
146437591|NCT03214588|528107596|FG000|Overall Study|Reason Not Specified|0|||
146437592|NCT03214588|528107597|FG001|Overall Study|Reason Not Specified|1|||
146437593|NCT03214588|528107598|FG002|Overall Study|Reason Not Specified|0|||
146437594|NCT00700739|528107601|FG000|Overall Study|Lost to Follow-up|4|||
146437595|NCT00700739|528107602|FG001|Overall Study|Lost to Follow-up|4|||
146437596|NCT00185458|528107604|FG000|Contraception Phase|Adverse Event|37|||
146437597|NCT00185458|528107604|FG000|Contraception Phase|Lost to Follow-up|10|||
146083066|NCT02353143|526824726|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
146437598|NCT00185458|528107604|FG000|Contraception Phase|Protocol Violation|2|||
146437599|NCT00185458|528107604|FG000|Contraception Phase|Physician Decision|2|||
146437600|NCT00185458|528107604|FG000|Contraception Phase|Withdrawal by Subject|7|||
146437601|NCT00185458|528107604|FG000|HRT Phase|Adverse Event|18|||
146437602|NCT00185458|528107604|FG000|HRT Phase|Lost to Follow-up|4|||
146437603|NCT00185458|528107604|FG000|HRT Phase|Protocol Violation|2|||
146437604|NCT00185458|528107604|FG000|HRT Phase|Withdrawal by Subject|3|||
146437605|NCT03503318|528107606|FG000|Overall Study|Death|1|||
146437606|NCT03503318|528107607|FG001|Overall Study|Death|0|||
146437607|NCT03503318|528107608|FG002|Overall Study|Death|4|||
146437608|NCT03503318|528107606|FG000|Overall Study|Adverse Event|3|||
146437609|NCT03503318|528107607|FG001|Overall Study|Adverse Event|4|||
146437610|NCT03503318|528107608|FG002|Overall Study|Adverse Event|2|||
146437611|NCT03503318|528107606|FG000|Overall Study|Withdrawal by Subject|12|||
146437612|NCT03503318|528107607|FG001|Overall Study|Withdrawal by Subject|17|||
146437613|NCT03503318|528107608|FG002|Overall Study|Withdrawal by Subject|16|||
146437614|NCT03503318|528107606|FG000|Overall Study|Protocol Violation|5|||
146437615|NCT03503318|528107607|FG001|Overall Study|Protocol Violation|0|||
146437616|NCT03503318|528107608|FG002|Overall Study|Protocol Violation|3|||
146437617|NCT03503318|528107606|FG000|Overall Study|Lost to Follow-up|17|||
146437618|NCT03503318|528107607|FG001|Overall Study|Lost to Follow-up|15|||
146437619|NCT03503318|528107608|FG002|Overall Study|Lost to Follow-up|12|||
146437620|NCT03503318|528107606|FG000|Overall Study|Other than specified|1|||
146437621|NCT03503318|528107607|FG001|Overall Study|Other than specified|3|||
146437622|NCT03503318|528107608|FG002|Overall Study|Other than specified|3|||
146437623|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
146437624|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
146437625|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
146437626|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
146437627|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
146437628|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
146437629|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
146437630|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
146437631|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
146437632|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
146437633|NCT00424047|528107612|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
146437634|NCT00424047|528107613|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
146437635|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Adverse Event|22|||
146437636|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Adverse Event|12|||
146437637|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Progression of disease|92|||
146437638|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Progression of disease|128|||
146437639|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
146437640|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
146437641|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
146437642|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
146437643|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Death|11|||
146437644|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Death|11|||
146437645|NCT00424047|528107612|FG000|On Study at Time of Unblinding|Other|5|||
146437646|NCT00424047|528107613|FG001|On Study at Time of Unblinding|Other|4|||
146437647|NCT00424047|528107612|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
146437648|NCT00424047|528107613|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
146437649|NCT00424047|528107612|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
146437650|NCT00424047|528107613|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
146437651|NCT00424047|528107612|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
146437652|NCT00424047|528107613|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
146437653|NCT00424047|528107612|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
146437654|NCT00424047|528107613|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
146437655|NCT00424047|528107612|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
146437656|NCT00424047|528107613|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
146437657|NCT01010503|528107615|FG000|Overall Study|Adverse Event|1|||
146437658|NCT01010503|528107615|FG000|Overall Study|Death|1|||
146437659|NCT01154231|528107616|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
146437660|NCT01154231|528107616|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
146208562|NCT02723955|527280265|FG020|Escalation Phase|Lost to Follow-up|2|||
146208563|NCT02723955|527280266|FG021|Escalation Phase|Lost to Follow-up|1|||
146437661|NCT01097577|528107617|FG000|Overall Study|Adverse Event|0|||
146437662|NCT01097577|528107618|FG001|Overall Study|Adverse Event|1|||
146208564|NCT02723955|527280267|FG022|Escalation Phase|Lost to Follow-up|0|||
146208565|NCT02723955|527280268|FG023|Escalation Phase|Lost to Follow-up|0|||
146437663|NCT01952691|528109113|FG000|Overall Study|Lost to Follow-up|2|||
146437664|NCT00199901|528109114|FG000|Overall Study|Protocol Violation|2|||
146437665|NCT00199901|528109115|FG001|Overall Study|Protocol Violation|0|||
146437666|NCT00199901|528109114|FG000|Overall Study|Withdrawal by Subject|1|||
146437667|NCT00199901|528109115|FG001|Overall Study|Withdrawal by Subject|0|||
146437668|NCT00199901|528109114|FG000|Overall Study|Progressive Disease|24|||
146437669|NCT00199901|528109115|FG001|Overall Study|Progressive Disease|24|||
146437670|NCT01958294|528109125|FG000|Overall Study|Clinical Circumstances|2|||
146437671|NCT02566850|528109126|FG000|Overall Study|Protocol Violation|1|||
146437672|NCT03599193|528109127|FG000|Overall Study|Adverse Event|0|||
146437673|NCT03599193|528109128|FG001|Overall Study|Adverse Event|2|||
146437674|NCT03599193|528109127|FG000|Overall Study|Withdrawal by Subject|1|||
146437675|NCT03599193|528109128|FG001|Overall Study|Withdrawal by Subject|0|||
146437676|NCT03599193|528109127|FG000|Overall Study|Protocol Violation|1|||
146437677|NCT03599193|528109128|FG001|Overall Study|Protocol Violation|0|||
146437678|NCT03599193|528109127|FG000|Overall Study|Lost to Follow-up|0|||
146437679|NCT03599193|528109128|FG001|Overall Study|Lost to Follow-up|1|||
146437680|NCT04372238|528109131|FG000|Overall Study|Duplicate|3|||
146437681|NCT04372238|528109132|FG001|Overall Study|Duplicate|3|||
146437682|NCT04372238|528109131|FG000|Overall Study|Did not consent for data linkage|6|||
146437683|NCT04372238|528109132|FG001|Overall Study|Did not consent for data linkage|10|||
146437684|NCT04241458|528109133|FG000|Overall Study|Withdrawal by Subject|0|||
146437685|NCT04241458|528109134|FG001|Overall Study|Withdrawal by Subject|0|||
146437686|NCT04241458|528109135|FG002|Overall Study|Withdrawal by Subject|0|||
146437687|NCT04241458|528109136|FG003|Overall Study|Withdrawal by Subject|0|||
146437688|NCT04241458|528109137|FG004|Overall Study|Withdrawal by Subject|1|||
146437689|NCT06144424|528109138|FG000|Overall Study|Withdrawal by Subject|2|||
146437690|NCT06144424|528109139|FG001|Overall Study|Withdrawal by Subject|0|||
146437691|NCT06144424|528109138|FG000|Overall Study|Incarceration|1|||
146437692|NCT06144424|528109139|FG001|Overall Study|Incarceration|0|||
146437693|NCT02832063|528109140|FG000|Overall Study|Adverse Event|2|||
146437694|NCT02832063|528109141|FG001|Overall Study|Adverse Event|1|||
146437695|NCT02832063|528109140|FG000|Overall Study|Physician Decision|5|||
146437696|NCT02832063|528109141|FG001|Overall Study|Physician Decision|7|||
146437697|NCT02832063|528109140|FG000|Overall Study|Lost to Follow-up|15|||
146437698|NCT02832063|528109141|FG001|Overall Study|Lost to Follow-up|8|||
146437699|NCT02832063|528109140|FG000|Overall Study|Withdrawal by Subject|10|||
146437700|NCT02832063|528109141|FG001|Overall Study|Withdrawal by Subject|21|||
146437701|NCT02832063|528109140|FG000|Overall Study|Other|2|||
146437702|NCT02832063|528109141|FG001|Overall Study|Other|1|||
146437703|NCT03733730|528109142|FG000|Overall Study|Lost to Follow-up|1|||
146437704|NCT03733730|528109143|FG001|Overall Study|Lost to Follow-up|32|||
146437705|NCT03733730|528109142|FG000|Overall Study|Other|1|||
146437706|NCT03733730|528109143|FG001|Overall Study|Other|0|||
146437707|NCT03733730|528109142|FG000|Overall Study|Adverse Event|0|||
146437708|NCT03733730|528109143|FG001|Overall Study|Adverse Event|4|||
146437709|NCT03733730|528109142|FG000|Overall Study|Death|0|||
146437710|NCT03733730|528109143|FG001|Overall Study|Death|5|||
145952644|NCT05052697|526338007|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952645|NCT05052697|526338008|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146437711|NCT03733730|528109142|FG000|Overall Study|Withdrawal by Subject|0|||
146285433|NCT03538301|527557871|FG000|Overall Study|Death|1|||
146437712|NCT03733730|528109143|FG001|Overall Study|Withdrawal by Subject|8|||
146437713|NCT00772603|528109144|FG000|Overall Study|Withdrawal by Subject|11|||
146437714|NCT00772603|528109145|FG001|Overall Study|Withdrawal by Subject|10|||
146437715|NCT00772603|528109146|FG002|Overall Study|Withdrawal by Subject|6|||
146437716|NCT00772603|528109144|FG000|Overall Study|Adverse Event|37|||
146437717|NCT00772603|528109145|FG001|Overall Study|Adverse Event|18|||
146437718|NCT00772603|528109146|FG002|Overall Study|Adverse Event|10|||
146437719|NCT00772603|528109144|FG000|Overall Study|Subject Non-compliance|1|||
146437720|NCT00772603|528109145|FG001|Overall Study|Subject Non-compliance|6|||
146208566|NCT02723955|527280269|FG024|Escalation Phase|Lost to Follow-up|1|||
146208567|NCT02723955|527280270|FG025|Escalation Phase|Lost to Follow-up|1|||
146208568|NCT02723955|527280271|FG026|Escalation Phase|Lost to Follow-up|3|||
146208569|NCT02723955|527280272|FG027|Escalation Phase|Lost to Follow-up|0|||
146208570|NCT02723955|527280273|FG028|Escalation Phase|Lost to Follow-up|1|||
146208571|NCT02723955|527280274|FG029|Escalation Phase|Lost to Follow-up|0|||
146437721|NCT00772603|528109146|FG002|Overall Study|Subject Non-compliance|4|||
146437722|NCT00772603|528109144|FG000|Overall Study|Protocol Violation|0|||
146437723|NCT00772603|528109145|FG001|Overall Study|Protocol Violation|1|||
146437724|NCT00772603|528109146|FG002|Overall Study|Protocol Violation|1|||
146437725|NCT00772603|528109144|FG000|Overall Study|Lost to Follow-up|1|||
146437726|NCT00772603|528109145|FG001|Overall Study|Lost to Follow-up|5|||
146437727|NCT00772603|528109146|FG002|Overall Study|Lost to Follow-up|2|||
146437728|NCT00772603|528109144|FG000|Overall Study|Physician Decision|0|||
146437729|NCT00772603|528109145|FG001|Overall Study|Physician Decision|0|||
146437730|NCT00772603|528109146|FG002|Overall Study|Physician Decision|1|||
146437731|NCT00772603|528109144|FG000|Overall Study|Other|2|||
146437732|NCT00772603|528109145|FG001|Overall Study|Other|0|||
146437733|NCT00772603|528109146|FG002|Overall Study|Other|2|||
146437734|NCT00081653|528109150|FG000|Overall Study|Adverse Event|23|||
146437735|NCT00081653|528109151|FG001|Overall Study|Adverse Event|17|||
146437736|NCT00081653|528109150|FG000|Overall Study|Lost to Follow-up|2|||
146208572|NCT02723955|527280275|FG030|Escalation Phase|Lost to Follow-up|0|||
146208573|NCT02723955|527280276|FG031|Escalation Phase|Lost to Follow-up|0|||
146208574|NCT02723955|527280277|FG032|Escalation Phase|Lost to Follow-up|0|||
146208575|NCT02723955|527280278|FG033|Escalation Phase|Lost to Follow-up|0|||
146437737|NCT00081653|528109151|FG001|Overall Study|Lost to Follow-up|4|||
146437738|NCT00081653|528109150|FG000|Overall Study|Refused Treatment|18|||
146208576|NCT02723955|527280279|FG034|Escalation Phase|Lost to Follow-up|0|||
146208577|NCT02723955|527280280|FG035|Escalation Phase|Lost to Follow-up|0|||
146208578|NCT02723955|527280281|FG036|Escalation Phase|Lost to Follow-up|0|||
146437739|NCT00081653|528109151|FG001|Overall Study|Refused Treatment|14|||
146437740|NCT00081653|528109150|FG000|Overall Study|Low bone mineral density|1|||
146437741|NCT00081653|528109151|FG001|Overall Study|Low bone mineral density|0|||
146437742|NCT00081653|528109150|FG000|Overall Study|Bone loss|2|||
146437743|NCT00081653|528109151|FG001|Overall Study|Bone loss|0|||
146437744|NCT00081653|528109150|FG000|Overall Study|Participant leaving country|1|||
146437745|NCT00081653|528109151|FG001|Overall Study|Participant leaving country|0|||
146437746|NCT00081653|528109150|FG000|Overall Study|Loss of bone mass|0|||
146437747|NCT00081653|528109151|FG001|Overall Study|Loss of bone mass|2|||
146437748|NCT02663349|528109153|FG000|Overall Study|Withdrawal by Subject|6|||
146437749|NCT00928057|528109154|FG000|Overall Study|Adverse Event|1|||
146437750|NCT00928057|528109155|FG001|Overall Study|Adverse Event|2|||
146437751|NCT00928057|528109154|FG000|Overall Study|Withdrawal by Subject|1|||
146437752|NCT00928057|528109155|FG001|Overall Study|Withdrawal by Subject|0|||
146437753|NCT00928057|528109154|FG000|Overall Study|Lost to Follow-up|0|||
146437754|NCT00928057|528109155|FG001|Overall Study|Lost to Follow-up|1|||
146437755|NCT00928057|528109154|FG000|Overall Study|Protocol Violation|0|||
146208579|NCT02723955|527280282|FG037|Escalation Phase|Lost to Follow-up|0|||
146208580|NCT02723955|527280283|FG038|Escalation Phase|Lost to Follow-up|0|||
146208581|NCT02723955|527280284|FG039|Escalation Phase|Lost to Follow-up|0|||
146208582|NCT02723955|527280285|FG040|Escalation Phase|Lost to Follow-up|0|||
146208583|NCT02723955|527280286|FG041|Escalation Phase|Lost to Follow-up|0|||
146208584|NCT02723955|527280287|FG042|Escalation Phase|Lost to Follow-up|0|||
146208585|NCT02723955|527280245|FG000|Escalation Phase|Physician Decision|0|||
146208586|NCT02723955|527280246|FG001|Escalation Phase|Physician Decision|0|||
146208587|NCT02723955|527280247|FG002|Escalation Phase|Physician Decision|0|||
146208588|NCT02723955|527280248|FG003|Escalation Phase|Physician Decision|0|||
146208589|NCT02723955|527280249|FG004|Escalation Phase|Physician Decision|0|||
146208590|NCT02723955|527280250|FG005|Escalation Phase|Physician Decision|2|||
146208591|NCT02723955|527280251|FG006|Escalation Phase|Physician Decision|0|||
146208592|NCT02723955|527280252|FG007|Escalation Phase|Physician Decision|0|||
146208593|NCT02723955|527280253|FG008|Escalation Phase|Physician Decision|0|||
146208594|NCT02723955|527280254|FG009|Escalation Phase|Physician Decision|0|||
146208595|NCT02723955|527280255|FG010|Escalation Phase|Physician Decision|0|||
146208596|NCT02723955|527280256|FG011|Escalation Phase|Physician Decision|0|||
146208597|NCT02723955|527280257|FG012|Escalation Phase|Physician Decision|0|||
146208598|NCT02723955|527280258|FG013|Escalation Phase|Physician Decision|0|||
146208599|NCT02723955|527280259|FG014|Escalation Phase|Physician Decision|0|||
146208600|NCT02723955|527280260|FG015|Escalation Phase|Physician Decision|0|||
146208601|NCT02723955|527280261|FG016|Escalation Phase|Physician Decision|0|||
146208602|NCT02723955|527280262|FG017|Escalation Phase|Physician Decision|0|||
146208603|NCT02723955|527280263|FG018|Escalation Phase|Physician Decision|0|||
146208604|NCT02723955|527280264|FG019|Escalation Phase|Physician Decision|0|||
146208605|NCT02723955|527280265|FG020|Escalation Phase|Physician Decision|0|||
146208606|NCT02723955|527280266|FG021|Escalation Phase|Physician Decision|0|||
146208607|NCT02723955|527280267|FG022|Escalation Phase|Physician Decision|0|||
146208608|NCT02723955|527280268|FG023|Escalation Phase|Physician Decision|0|||
146208609|NCT02723955|527280269|FG024|Escalation Phase|Physician Decision|0|||
146208610|NCT02723955|527280270|FG025|Escalation Phase|Physician Decision|0|||
146208611|NCT02723955|527280271|FG026|Escalation Phase|Physician Decision|2|||
146208612|NCT02723955|527280272|FG027|Escalation Phase|Physician Decision|0|||
146208613|NCT02723955|527280273|FG028|Escalation Phase|Physician Decision|0|||
146208614|NCT02723955|527280274|FG029|Escalation Phase|Physician Decision|0|||
146208615|NCT02723955|527280275|FG030|Escalation Phase|Physician Decision|0|||
146208616|NCT02723955|527280276|FG031|Escalation Phase|Physician Decision|0|||
146208617|NCT02723955|527280277|FG032|Escalation Phase|Physician Decision|0|||
146208618|NCT02723955|527280278|FG033|Escalation Phase|Physician Decision|0|||
146208619|NCT02723955|527280279|FG034|Escalation Phase|Physician Decision|0|||
146208620|NCT02723955|527280280|FG035|Escalation Phase|Physician Decision|0|||
146208621|NCT02723955|527280281|FG036|Escalation Phase|Physician Decision|0|||
146208622|NCT02723955|527280282|FG037|Escalation Phase|Physician Decision|0|||
146208623|NCT02723955|527280283|FG038|Escalation Phase|Physician Decision|0|||
146208624|NCT02723955|527280284|FG039|Escalation Phase|Physician Decision|0|||
146208625|NCT02723955|527280285|FG040|Escalation Phase|Physician Decision|0|||
146208626|NCT02723955|527280286|FG041|Escalation Phase|Physician Decision|0|||
146208627|NCT02723955|527280287|FG042|Escalation Phase|Physician Decision|0|||
146208628|NCT02723955|527280245|FG000|Escalation Phase|Withdrawal by Subject|0|||
146208629|NCT02723955|527280246|FG001|Escalation Phase|Withdrawal by Subject|0|||
146208630|NCT02723955|527280247|FG002|Escalation Phase|Withdrawal by Subject|0|||
146208631|NCT02723955|527280248|FG003|Escalation Phase|Withdrawal by Subject|0|||
146208632|NCT02723955|527280249|FG004|Escalation Phase|Withdrawal by Subject|1|||
146437756|NCT00928057|528109155|FG001|Overall Study|Protocol Violation|1|||
146437757|NCT02451696|528109156|FG000|Overall Study|Surgery postponed|1|||
146437758|NCT02451696|528109157|FG001|Overall Study|Surgery postponed|0|||
146437759|NCT01557751|528109158|FG000|Overall Study|Physician Decision|3|||
146437760|NCT03674892|528109160|FG000|Overall Study|Lack of Efficacy|5|||
146437761|NCT03674892|528109160|FG000|Overall Study|Lost to Follow-up|3|||
146437762|NCT03674892|528109160|FG000|Overall Study|Migraine|2|||
146437763|NCT03674892|528109160|FG000|Overall Study|Excessive Tearing|1|||
146437764|NCT03674892|528109160|FG000|Overall Study|Increased Eye Pain|1|||
146437765|NCT03674892|528109160|FG000|Overall Study|Increased Facial Pain|1|||
146437766|NCT03674892|528109160|FG000|Overall Study|Sinus Irritation|1|||
146437767|NCT03674892|528109160|FG000|Overall Study|Sinus Infection|1|||
146437768|NCT05099380|528109161|FG000|Overall Study|Subject enrolled in error|1|||
146437769|NCT05099380|528109162|FG001|Overall Study|Subject enrolled in error|0|||
146437770|NCT05099380|528109161|FG000|Overall Study|Study Procedure|1|||
146208633|NCT02723955|527280250|FG005|Escalation Phase|Withdrawal by Subject|1|||
146437771|NCT05099380|528109162|FG001|Overall Study|Study Procedure|0|||
146437772|NCT05099380|528109161|FG000|Overall Study|Protocol Violation|1|||
146437773|NCT05099380|528109162|FG001|Overall Study|Protocol Violation|0|||
146437774|NCT05099380|528109161|FG000|Overall Study|Adverse Event|1|||
146437775|NCT05099380|528109162|FG001|Overall Study|Adverse Event|1|||
146437776|NCT05099380|528109161|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
146437777|NCT05099380|528109162|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
146437778|NCT02842853|528109163|FG000|Overall Study|Non-compliance with the protocol|3|||
146437779|NCT02842853|528109164|FG001|Overall Study|Non-compliance with the protocol|7|||
146437780|NCT02842853|528109165|FG002|Overall Study|Non-compliance with the protocol|2|||
146437781|NCT02842853|528109166|FG003|Overall Study|Non-compliance with the protocol|5|||
146437782|NCT02842853|528109163|FG000|Overall Study|Subject met exclusion criteria|0|||
146437783|NCT02842853|528109164|FG001|Overall Study|Subject met exclusion criteria|1|||
146437784|NCT02842853|528109165|FG002|Overall Study|Subject met exclusion criteria|0|||
146437785|NCT02842853|528109166|FG003|Overall Study|Subject met exclusion criteria|0|||
146437786|NCT02842853|528109163|FG000|Overall Study|Withdrawal by Subject|11|||
146437787|NCT02842853|528109164|FG001|Overall Study|Withdrawal by Subject|13|||
146437788|NCT02842853|528109165|FG002|Overall Study|Withdrawal by Subject|9|||
146437789|NCT02842853|528109166|FG003|Overall Study|Withdrawal by Subject|8|||
146437790|NCT02842853|528109163|FG000|Overall Study|Lost to Follow-up|9|||
146437791|NCT02842853|528109164|FG001|Overall Study|Lost to Follow-up|13|||
146437792|NCT02842853|528109165|FG002|Overall Study|Lost to Follow-up|10|||
146437793|NCT02842853|528109166|FG003|Overall Study|Lost to Follow-up|11|||
146437794|NCT04089553|528109167|FG000|Overall Study|Death|1|||
146437795|NCT04089553|528109168|FG001|Overall Study|Death|1|||
146437796|NCT04089553|528109167|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
146437797|NCT04089553|528109168|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
146437798|NCT04089553|528109167|FG000|Overall Study|Withdrawal by Subject|3|||
146437799|NCT04089553|528109168|FG001|Overall Study|Withdrawal by Subject|3|||
146437800|NCT04089553|528109167|FG000|Overall Study|Physician Decision|1|||
146437801|NCT04089553|528109168|FG001|Overall Study|Physician Decision|0|||
146437802|NCT04089553|528109167|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
146437803|NCT04089553|528109168|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
146437804|NCT04089553|528109167|FG000|Overall Study|Other|1|||
146437805|NCT04089553|528109168|FG001|Overall Study|Other|0|||
146437806|NCT04089553|528109167|FG000|Overall Study|Adverse Event|1|||
146437807|NCT04089553|528109168|FG001|Overall Study|Adverse Event|1|||
146437808|NCT01175135|528109176|FG000|Overall Study|Adverse Event|2|||
146437809|NCT01175135|528109177|FG001|Overall Study|Adverse Event|5|||
146437810|NCT01175135|528109178|FG002|Overall Study|Adverse Event|3|||
146437811|NCT01175135|528109179|FG003|Overall Study|Adverse Event|4|||
146208634|NCT02723955|527280251|FG006|Escalation Phase|Withdrawal by Subject|1|||
146437812|NCT01175135|528109176|FG000|Overall Study|Death|1|||
146437813|NCT01175135|528109177|FG001|Overall Study|Death|0|||
146437814|NCT01175135|528109178|FG002|Overall Study|Death|0|||
146437815|NCT01175135|528109179|FG003|Overall Study|Death|0|||
146437816|NCT01175135|528109176|FG000|Overall Study|Lack of Efficacy|4|||
146437817|NCT01175135|528109177|FG001|Overall Study|Lack of Efficacy|5|||
146437818|NCT01175135|528109178|FG002|Overall Study|Lack of Efficacy|0|||
146437819|NCT01175135|528109179|FG003|Overall Study|Lack of Efficacy|5|||
146437820|NCT01175135|528109176|FG000|Overall Study|Lost to Follow-up|1|||
146437821|NCT01175135|528109177|FG001|Overall Study|Lost to Follow-up|2|||
146437822|NCT01175135|528109178|FG002|Overall Study|Lost to Follow-up|0|||
146437823|NCT01175135|528109179|FG003|Overall Study|Lost to Follow-up|0|||
146437824|NCT01175135|528109176|FG000|Overall Study|Protocol Violation|1|||
146437825|NCT01175135|528109177|FG001|Overall Study|Protocol Violation|1|||
146437826|NCT01175135|528109178|FG002|Overall Study|Protocol Violation|0|||
146437827|NCT01175135|528109179|FG003|Overall Study|Protocol Violation|0|||
146437828|NCT01175135|528109176|FG000|Overall Study|Withdrawal by Subject|4|||
146437829|NCT01175135|528109177|FG001|Overall Study|Withdrawal by Subject|8|||
146437830|NCT01175135|528109178|FG002|Overall Study|Withdrawal by Subject|5|||
146437831|NCT01175135|528109179|FG003|Overall Study|Withdrawal by Subject|5|||
146437832|NCT01175135|528109176|FG000|Overall Study|Other|3|||
146437833|NCT01175135|528109177|FG001|Overall Study|Other|1|||
146437834|NCT01175135|528109178|FG002|Overall Study|Other|3|||
146437835|NCT01175135|528109179|FG003|Overall Study|Other|0|||
146437836|NCT01175135|528109176|FG000|Overall Study|Randomized But Not Treated|0|||
146437837|NCT01175135|528109177|FG001|Overall Study|Randomized But Not Treated|0|||
146437838|NCT01175135|528109178|FG002|Overall Study|Randomized But Not Treated|1|||
146437839|NCT01175135|528109179|FG003|Overall Study|Randomized But Not Treated|0|||
146437840|NCT01572662|528109180|FG000|Overall Study|Withdrawal by Subject|1|||
146437841|NCT01572662|528109181|FG001|Overall Study|Withdrawal by Subject|0|||
146437842|NCT01572662|528109180|FG000|Overall Study|Physician Decision|0|||
146437843|NCT01572662|528109181|FG001|Overall Study|Physician Decision|1|||
146208635|NCT02723955|527280252|FG007|Escalation Phase|Withdrawal by Subject|1|||
146208636|NCT02723955|527280253|FG008|Escalation Phase|Withdrawal by Subject|0|||
146437844|NCT03364192|528109182|FG000|Overall Study|Ineligible|10|||
146437845|NCT03364192|528109182|FG000|Overall Study|Withdrawal by Subject|5|||
146437846|NCT03364192|528109182|FG000|Overall Study|Lost to Follow-up|1|||
146437847|NCT04547192|528109185|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
146437848|NCT04547192|528109186|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
146437849|NCT04547192|528109187|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
146437850|NCT04547192|528109188|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
146437851|NCT04547192|528109185|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
146437852|NCT04547192|528109186|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
146437853|NCT04547192|528109187|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
146437854|NCT04547192|528109188|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
146437855|NCT04547192|528109185|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
146437856|NCT04547192|528109186|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
146437857|NCT04547192|528109187|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
146437858|NCT04547192|528109188|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
146437859|NCT04547192|528109185|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
146437860|NCT04547192|528109186|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
146437861|NCT04547192|528109187|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
146437862|NCT04547192|528109188|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
146437863|NCT04547192|528109185|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
146437864|NCT04547192|528109186|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
146437865|NCT04547192|528109187|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
146437866|NCT04547192|528109188|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
146437867|NCT00935012|528109191|FG000|Overall Study|Death|19|||
146437868|NCT00935012|528109191|FG000|Overall Study|Withdrawal by Subject|3|||
146437869|NCT00935012|528109191|FG000|Overall Study|Other|5|||
146437870|NCT00935012|528109191|FG000|Overall Study|Adverse Event|2|||
146437871|NCT01442155|528109192|FG000|Overall Study|Complete remission|35|||
146437872|NCT01442155|528109192|FG000|Overall Study|Recurrence|26|||
146437873|NCT01442155|528109192|FG000|Overall Study|Adverse Event|2|||
146437874|NCT01442155|528109192|FG000|Overall Study|Lost to Follow-up|2|||
146437875|NCT01590563|528109199|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
146437876|NCT02699463|528109204|FG000|Overall Study|Lost to Follow-up|11|||
146437877|NCT02699463|528109205|FG001|Overall Study|Lost to Follow-up|8|||
146437878|NCT02699463|528109204|FG000|Overall Study|Withdrawal by Subject|4|||
146437879|NCT02699463|528109205|FG001|Overall Study|Withdrawal by Subject|1|||
146437880|NCT02294981|528109206|FG000|Overall Study|Lost to Follow-up|1|||
146437881|NCT00909038|528109209|FG000|Overall Study|Protocol Violation|187|||
146437882|NCT00909038|528109209|FG000|Overall Study|Non-evaluable Subjects|230|||
146437883|NCT00909753|528109212|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
146437884|NCT00909753|528109213|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
146437885|NCT00909753|528109212|FG000|Period: Second Intervention|Protocol Violation|1|||
146437886|NCT00909753|528109213|FG001|Period: Second Intervention|Protocol Violation|0|||
146437887|NCT01895335|528109214|FG000|Overall Study|Adverse Event|106|||
145952646|NCT05052697|526338009|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146208637|NCT02723955|527280254|FG009|Escalation Phase|Withdrawal by Subject|0|||
146208638|NCT02723955|527280255|FG010|Escalation Phase|Withdrawal by Subject|0|||
146208639|NCT02723955|527280256|FG011|Escalation Phase|Withdrawal by Subject|0|||
146208640|NCT02723955|527280257|FG012|Escalation Phase|Withdrawal by Subject|1|||
146437888|NCT01895335|528109214|FG000|Overall Study|Lack of Efficacy|53|||
146437889|NCT01895335|528109214|FG000|Overall Study|Poor Compliance to Protocol|11|||
146437890|NCT01895335|528109214|FG000|Overall Study|Included But Not treated|1|||
146437891|NCT01895335|528109214|FG000|Overall Study|Other than Specified Above|44|||
146437892|NCT01647828|528109215|FG000|Overall Study|Death|3|||
146437893|NCT01647828|528109216|FG001|Overall Study|Death|4|||
146437894|NCT01647828|528109217|FG002|Overall Study|Death|4|||
146437895|NCT01647828|528109218|FG003|Overall Study|Death|5|||
146437896|NCT01647828|528109219|FG004|Overall Study|Death|6|||
146437897|NCT01647828|528109220|FG005|Overall Study|Death|3|||
146437898|NCT01647828|528109221|FG006|Overall Study|Death|10|||
145952647|NCT05052697|526338010|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146437899|NCT01647828|528109222|FG007|Overall Study|Death|60|||
146437900|NCT01647828|528109223|FG008|Overall Study|Death|71|||
146437901|NCT01647828|528109215|FG000|Overall Study|Withdrawal by Subject|2|||
146437902|NCT01647828|528109216|FG001|Overall Study|Withdrawal by Subject|0|||
146437903|NCT01647828|528109217|FG002|Overall Study|Withdrawal by Subject|0|||
146437904|NCT01647828|528109218|FG003|Overall Study|Withdrawal by Subject|1|||
146437905|NCT01647828|528109219|FG004|Overall Study|Withdrawal by Subject|0|||
146437906|NCT01647828|528109220|FG005|Overall Study|Withdrawal by Subject|0|||
146437907|NCT01647828|528109221|FG006|Overall Study|Withdrawal by Subject|1|||
146437908|NCT01647828|528109222|FG007|Overall Study|Withdrawal by Subject|0|||
146437909|NCT01647828|528109223|FG008|Overall Study|Withdrawal by Subject|2|||
146437910|NCT01647828|528109215|FG000|Overall Study|Study terminated by Sponsor|0|||
146437911|NCT01647828|528109216|FG001|Overall Study|Study terminated by Sponsor|0|||
146437912|NCT01647828|528109217|FG002|Overall Study|Study terminated by Sponsor|0|||
146437913|NCT01647828|528109218|FG003|Overall Study|Study terminated by Sponsor|0|||
146437914|NCT01647828|528109219|FG004|Overall Study|Study terminated by Sponsor|0|||
146437915|NCT01647828|528109220|FG005|Overall Study|Study terminated by Sponsor|0|||
146437916|NCT01647828|528109221|FG006|Overall Study|Study terminated by Sponsor|1|||
146437917|NCT01647828|528109222|FG007|Overall Study|Study terminated by Sponsor|26|||
146437918|NCT01647828|528109223|FG008|Overall Study|Study terminated by Sponsor|16|||
146437919|NCT01647828|528109215|FG000|Overall Study|Lost to Follow-up|0|||
146437920|NCT01647828|528109216|FG001|Overall Study|Lost to Follow-up|0|||
146437921|NCT01647828|528109217|FG002|Overall Study|Lost to Follow-up|0|||
146437922|NCT01647828|528109218|FG003|Overall Study|Lost to Follow-up|0|||
146437923|NCT01647828|528109219|FG004|Overall Study|Lost to Follow-up|0|||
146437924|NCT01647828|528109220|FG005|Overall Study|Lost to Follow-up|0|||
146437925|NCT01647828|528109221|FG006|Overall Study|Lost to Follow-up|0|||
146437926|NCT01647828|528109222|FG007|Overall Study|Lost to Follow-up|2|||
146437927|NCT01647828|528109223|FG008|Overall Study|Lost to Follow-up|0|||
146437928|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
146437929|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
146437930|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
146437931|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
146437932|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
146437933|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
146437934|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Death|9|||
146437935|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Death|7|||
146437936|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Death|14|||
146437937|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Death|7|||
146437938|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Death|0|||
146437939|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Death|0|||
146437940|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
146437941|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
146437942|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
146437943|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
146437944|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
146437945|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
146437946|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Other Event|49|||
146437947|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Other Event|52|||
146437948|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Other Event|41|||
146437949|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Other Event|58|||
146437950|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Other Event|0|||
146437951|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Other Event|0|||
146437952|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
146437953|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
146437954|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
146437955|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
146437956|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
146437957|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
146437958|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
146437959|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
146437960|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
146437961|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
145952648|NCT05052697|526338011|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952649|NCT05052697|526338012|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
146437962|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
146437963|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
146437964|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
146437965|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
146437966|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
146437967|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
146437968|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
146437969|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
146437970|NCT00205777|528109226|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
146437971|NCT00205777|528109227|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
146437972|NCT00205777|528109228|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
146437973|NCT00205777|528109229|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
146437974|NCT00205777|528109230|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
146437975|NCT00205777|528109231|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
146437976|NCT00205777|528109226|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
146437977|NCT00205777|528109227|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
146437978|NCT00205777|528109228|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
146437979|NCT00205777|528109229|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
146437980|NCT00205777|528109230|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
146437981|NCT00205777|528109231|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
146437982|NCT00205777|528109226|FG000|Completed Core Study, Entered SE I|Other Event|52|||
146437983|NCT00205777|528109227|FG001|Completed Core Study, Entered SE I|Other Event|46|||
146437984|NCT00205777|528109228|FG002|Completed Core Study, Entered SE I|Other Event|47|||
146437985|NCT00205777|528109229|FG003|Completed Core Study, Entered SE I|Other Event|50|||
146437986|NCT00205777|528109230|FG004|Completed Core Study, Entered SE I|Other Event|0|||
146437987|NCT00205777|528109231|FG005|Completed Core Study, Entered SE I|Other Event|0|||
146437988|NCT00205777|528109226|FG000|Study Extension I|Adverse Event|57|||
146437989|NCT00205777|528109227|FG001|Study Extension I|Adverse Event|0|||
146437990|NCT00205777|528109228|FG002|Study Extension I|Adverse Event|0|||
146437991|NCT00205777|528109229|FG003|Study Extension I|Adverse Event|61|||
146437992|NCT00205777|528109230|FG004|Study Extension I|Adverse Event|58|||
146437993|NCT00205777|528109231|FG005|Study Extension I|Adverse Event|0|||
146437994|NCT00205777|528109226|FG000|Study Extension I|Death|5|||
146437995|NCT00205777|528109227|FG001|Study Extension I|Death|0|||
146437996|NCT00205777|528109228|FG002|Study Extension I|Death|0|||
146437997|NCT00205777|528109229|FG003|Study Extension I|Death|1|||
146437998|NCT00205777|528109230|FG004|Study Extension I|Death|2|||
146437999|NCT00205777|528109231|FG005|Study Extension I|Death|0|||
146438000|NCT00205777|528109226|FG000|Study Extension I|Withdrawal by Subject|99|||
146438001|NCT00205777|528109227|FG001|Study Extension I|Withdrawal by Subject|0|||
146438002|NCT00205777|528109228|FG002|Study Extension I|Withdrawal by Subject|0|||
146438003|NCT00205777|528109229|FG003|Study Extension I|Withdrawal by Subject|106|||
146438004|NCT00205777|528109230|FG004|Study Extension I|Withdrawal by Subject|89|||
146438005|NCT00205777|528109231|FG005|Study Extension I|Withdrawal by Subject|0|||
146438006|NCT00205777|528109226|FG000|Study Extension I|Protocol Violation|4|||
146438007|NCT00205777|528109227|FG001|Study Extension I|Protocol Violation|0|||
146438008|NCT00205777|528109228|FG002|Study Extension I|Protocol Violation|0|||
146438009|NCT00205777|528109229|FG003|Study Extension I|Protocol Violation|8|||
146438010|NCT00205777|528109230|FG004|Study Extension I|Protocol Violation|8|||
146438011|NCT00205777|528109231|FG005|Study Extension I|Protocol Violation|0|||
146438012|NCT00205777|528109226|FG000|Study Extension I|Lack of Efficacy|0|||
146438013|NCT00205777|528109227|FG001|Study Extension I|Lack of Efficacy|0|||
146438014|NCT00205777|528109228|FG002|Study Extension I|Lack of Efficacy|0|||
146438015|NCT00205777|528109229|FG003|Study Extension I|Lack of Efficacy|1|||
146438016|NCT00205777|528109230|FG004|Study Extension I|Lack of Efficacy|2|||
146438017|NCT00205777|528109231|FG005|Study Extension I|Lack of Efficacy|0|||
146438018|NCT00205777|528109226|FG000|Study Extension I|Failed to return|15|||
146438019|NCT00205777|528109227|FG001|Study Extension I|Failed to return|0|||
146438020|NCT00205777|528109228|FG002|Study Extension I|Failed to return|0|||
146438021|NCT00205777|528109229|FG003|Study Extension I|Failed to return|17|||
146438022|NCT00205777|528109230|FG004|Study Extension I|Failed to return|13|||
146438023|NCT00205777|528109231|FG005|Study Extension I|Failed to return|0|||
146438024|NCT00205777|528109226|FG000|Study Extension I|Other Event|34|||
146438025|NCT00205777|528109227|FG001|Study Extension I|Other Event|0|||
146438026|NCT00205777|528109228|FG002|Study Extension I|Other Event|0|||
146438027|NCT00205777|528109229|FG003|Study Extension I|Other Event|34|||
146438028|NCT00205777|528109230|FG004|Study Extension I|Other Event|29|||
146438029|NCT00205777|528109231|FG005|Study Extension I|Other Event|0|||
146438030|NCT00205777|528109226|FG000|Study Extension I|Withdrawn as per protocol|0|||
146438031|NCT00205777|528109227|FG001|Study Extension I|Withdrawn as per protocol|0|||
146438032|NCT00205777|528109228|FG002|Study Extension I|Withdrawn as per protocol|1070|||
146438033|NCT00205777|528109229|FG003|Study Extension I|Withdrawn as per protocol|0|||
146438034|NCT00205777|528109230|FG004|Study Extension I|Withdrawn as per protocol|0|||
146438035|NCT00205777|528109231|FG005|Study Extension I|Withdrawn as per protocol|0|||
146438036|NCT00205777|528109226|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
146438037|NCT00205777|528109227|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
146438038|NCT00205777|528109228|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
145952650|NCT05052697|526338013|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952651|NCT05052697|526338014|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952652|NCT05052697|526338015|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952653|NCT05052697|526338016|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952654|NCT05052697|526338017|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145952655|NCT05052697|526337984|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952656|NCT05052697|526337985|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952657|NCT05052697|526337986|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952658|NCT05052697|526337987|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952659|NCT05052697|526337988|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952660|NCT05052697|526337989|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952661|NCT05052697|526337990|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952662|NCT05052697|526337991|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
146438039|NCT00205777|528109229|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
146438040|NCT00205777|528109230|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
146438041|NCT00205777|528109231|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
145952663|NCT05052697|526337992|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
146083067|NCT02353143|526824727|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
146438042|NCT00205777|528109226|FG000|Study Extension II|Adverse Event|0|||
146438043|NCT00205777|528109227|FG001|Study Extension II|Adverse Event|0|||
146438044|NCT00205777|528109228|FG002|Study Extension II|Adverse Event|0|||
146438045|NCT00205777|528109229|FG003|Study Extension II|Adverse Event|14|||
146438046|NCT00205777|528109230|FG004|Study Extension II|Adverse Event|0|||
146438047|NCT00205777|528109231|FG005|Study Extension II|Adverse Event|30|||
146438048|NCT00205777|528109226|FG000|Study Extension II|Death|0|||
146438049|NCT00205777|528109227|FG001|Study Extension II|Death|0|||
146438050|NCT00205777|528109228|FG002|Study Extension II|Death|0|||
146438051|NCT00205777|528109229|FG003|Study Extension II|Death|2|||
146438052|NCT00205777|528109230|FG004|Study Extension II|Death|0|||
146438053|NCT00205777|528109231|FG005|Study Extension II|Death|5|||
146438054|NCT00205777|528109226|FG000|Study Extension II|Withdrawal by Subject|0|||
146438055|NCT00205777|528109227|FG001|Study Extension II|Withdrawal by Subject|0|||
146438056|NCT00205777|528109228|FG002|Study Extension II|Withdrawal by Subject|0|||
146438057|NCT00205777|528109229|FG003|Study Extension II|Withdrawal by Subject|35|||
146438058|NCT00205777|528109230|FG004|Study Extension II|Withdrawal by Subject|0|||
146438059|NCT00205777|528109231|FG005|Study Extension II|Withdrawal by Subject|59|||
146438060|NCT00205777|528109226|FG000|Study Extension II|Protocol Violation|0|||
146438061|NCT00205777|528109227|FG001|Study Extension II|Protocol Violation|0|||
146438062|NCT00205777|528109228|FG002|Study Extension II|Protocol Violation|0|||
146438063|NCT00205777|528109229|FG003|Study Extension II|Protocol Violation|1|||
146438064|NCT00205777|528109230|FG004|Study Extension II|Protocol Violation|0|||
146438065|NCT00205777|528109231|FG005|Study Extension II|Protocol Violation|10|||
146438066|NCT00205777|528109226|FG000|Study Extension II|Lack of Efficacy|0|||
146438067|NCT00205777|528109227|FG001|Study Extension II|Lack of Efficacy|0|||
146438068|NCT00205777|528109228|FG002|Study Extension II|Lack of Efficacy|0|||
146438069|NCT00205777|528109229|FG003|Study Extension II|Lack of Efficacy|0|||
146438070|NCT00205777|528109230|FG004|Study Extension II|Lack of Efficacy|0|||
146438071|NCT00205777|528109231|FG005|Study Extension II|Lack of Efficacy|1|||
146438072|NCT00205777|528109226|FG000|Study Extension II|Failed to return|0|||
146438073|NCT00205777|528109227|FG001|Study Extension II|Failed to return|0|||
146438074|NCT00205777|528109228|FG002|Study Extension II|Failed to return|0|||
146438075|NCT00205777|528109229|FG003|Study Extension II|Failed to return|14|||
146438076|NCT00205777|528109230|FG004|Study Extension II|Failed to return|0|||
146438077|NCT00205777|528109231|FG005|Study Extension II|Failed to return|26|||
146438078|NCT00205777|528109226|FG000|Study Extension II|Other Event|0|||
146438079|NCT00205777|528109227|FG001|Study Extension II|Other Event|0|||
146438080|NCT00205777|528109228|FG002|Study Extension II|Other Event|0|||
146438081|NCT00205777|528109229|FG003|Study Extension II|Other Event|12|||
146438082|NCT00205777|528109230|FG004|Study Extension II|Other Event|0|||
146438083|NCT00205777|528109231|FG005|Study Extension II|Other Event|20|||
146438084|NCT00205777|528109226|FG000|Study Extension II|Enrolled but not treated|0|||
146438085|NCT00205777|528109227|FG001|Study Extension II|Enrolled but not treated|0|||
146438086|NCT00205777|528109228|FG002|Study Extension II|Enrolled but not treated|0|||
146438087|NCT00205777|528109229|FG003|Study Extension II|Enrolled but not treated|71|||
146438088|NCT00205777|528109230|FG004|Study Extension II|Enrolled but not treated|0|||
146438089|NCT00205777|528109231|FG005|Study Extension II|Enrolled but not treated|131|||
146438090|NCT01794845|528109234|FG000|Overall Study|Withdrawal by Subject|1|||
146438091|NCT02139826|528109235|FG000|Overall Study|Adverse Event|1|||
146438092|NCT00436163|528109236|FG000|Overall Study|Lost to Follow-up|2|||
146438093|NCT00436163|528109236|FG000|Overall Study|Adverse Event|1|||
146438094|NCT03719040|528109237|FG000|Overall Study|Withdrawal by Subject|177|||
146438095|NCT03719040|528109237|FG000|Overall Study|Lost to Follow-up|26|||
146438096|NCT06647173|528109238|FG000|Overall Study|Lost to Follow-up|24|||
146438097|NCT01841554|528109239|FG000|Overall Study|Death|7|||
146438098|NCT01841554|528109239|FG000|Overall Study|No Implantation|1|||
146438099|NCT01841554|528109239|FG000|Overall Study|Discontinued Follow Up|5|||
146438100|NCT01841554|528109239|FG000|Overall Study|Study exit due to secondary intervention|6|||
146438101|NCT00312897|528109242|FG000|Overall Study|Adverse Event|1|||
146438102|NCT00312897|528109243|FG001|Overall Study|Adverse Event|0|||
146438103|NCT00312897|528109242|FG000|Overall Study|Lost to Follow-up|2|||
146438104|NCT00312897|528109243|FG001|Overall Study|Lost to Follow-up|0|||
146438105|NCT00312897|528109242|FG000|Overall Study|Physician Decision|1|||
146438106|NCT00312897|528109243|FG001|Overall Study|Physician Decision|0|||
146438107|NCT00312897|528109242|FG000|Overall Study|Withdrawal by Subject|1|||
145952664|NCT05052697|526337993|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
146438108|NCT00312897|528109243|FG001|Overall Study|Withdrawal by Subject|3|||
146438109|NCT00312897|528109242|FG000|Overall Study|Pregnancy|1|||
146438110|NCT00312897|528109243|FG001|Overall Study|Pregnancy|0|||
146438111|NCT00312897|528109242|FG000|Overall Study|discontinued prior to getting treatment|0|||
146438112|NCT00312897|528109243|FG001|Overall Study|discontinued prior to getting treatment|3|||
146438113|NCT01473953|528109244|FG000|Overall Study|Other|1|||
146438114|NCT01473953|528109245|FG001|Overall Study|Other|0|||
146438115|NCT01473953|528109246|FG002|Overall Study|Other|0|||
146438116|NCT01473953|528109247|FG003|Overall Study|Other|0|||
146438117|NCT01473953|528109248|FG004|Overall Study|Other|0|||
146438118|NCT03100344|528109251|FG000|Overall Study|Adverse Event|0|||
146438119|NCT03100344|528109252|FG001|Overall Study|Adverse Event|3|||
146438120|NCT03100344|528109253|FG002|Overall Study|Adverse Event|2|||
146438121|NCT03100344|528109254|FG003|Overall Study|Adverse Event|3|||
146438122|NCT03100344|528109251|FG000|Overall Study|Lack of Efficacy|2|||
146438123|NCT03100344|528109252|FG001|Overall Study|Lack of Efficacy|0|||
146438124|NCT03100344|528109253|FG002|Overall Study|Lack of Efficacy|0|||
146438125|NCT03100344|528109254|FG003|Overall Study|Lack of Efficacy|0|||
146438126|NCT03100344|528109251|FG000|Overall Study|Protocol Violation|1|||
146438127|NCT03100344|528109252|FG001|Overall Study|Protocol Violation|0|||
146438128|NCT03100344|528109253|FG002|Overall Study|Protocol Violation|0|||
146438129|NCT03100344|528109254|FG003|Overall Study|Protocol Violation|0|||
146438130|NCT03100344|528109251|FG000|Overall Study|Withdrawal by Subject|10|||
146438131|NCT03100344|528109252|FG001|Overall Study|Withdrawal by Subject|7|||
146438132|NCT03100344|528109253|FG002|Overall Study|Withdrawal by Subject|4|||
146438133|NCT03100344|528109254|FG003|Overall Study|Withdrawal by Subject|8|||
146438134|NCT03100344|528109251|FG000|Overall Study|Lost to Follow-up|1|||
146438135|NCT03100344|528109252|FG001|Overall Study|Lost to Follow-up|1|||
146438136|NCT03100344|528109253|FG002|Overall Study|Lost to Follow-up|1|||
146438137|NCT03100344|528109254|FG003|Overall Study|Lost to Follow-up|1|||
146438138|NCT04633564|528109255|FG000|Period 1|Adverse Event|28|||
146438139|NCT04633564|528109256|FG001|Period 1|Adverse Event|19|||
146438140|NCT04633564|528109255|FG000|Period 1|Death|8|||
146438141|NCT04633564|528109256|FG001|Period 1|Death|7|||
146438142|NCT04633564|528109255|FG000|Period 1|Lost to Follow-up|3|||
146438143|NCT04633564|528109256|FG001|Period 1|Lost to Follow-up|5|||
146438144|NCT04633564|528109255|FG000|Period 1|Physician Decision|4|||
146438145|NCT04633564|528109256|FG001|Period 1|Physician Decision|12|||
146438146|NCT04633564|528109255|FG000|Period 1|Protocol Violation|0|||
146438147|NCT04633564|528109256|FG001|Period 1|Protocol Violation|1|||
146438148|NCT04633564|528109255|FG000|Period 1|Withdrawal by Subject|10|||
146438149|NCT04633564|528109256|FG001|Period 1|Withdrawal by Subject|8|||
146438150|NCT04633564|528109255|FG000|Period 1|Progressive disease|47|||
146438151|NCT04633564|528109256|FG001|Period 1|Progressive disease|51|||
146438152|NCT04633564|528109255|FG000|Period 1|Terminated by Sponsor|8|||
146438153|NCT04633564|528109256|FG001|Period 1|Terminated by Sponsor|6|||
146438154|NCT04633564|528109255|FG000|Period 2|Adverse Event|3|||
146438155|NCT04633564|528109256|FG001|Period 2|Adverse Event|4|||
146438156|NCT04633564|528109255|FG000|Period 2|Death|0|||
146438157|NCT04633564|528109256|FG001|Period 2|Death|2|||
146438158|NCT04633564|528109255|FG000|Period 2|Lost to Follow-up|0|||
146438159|NCT04633564|528109256|FG001|Period 2|Lost to Follow-up|1|||
146438160|NCT04633564|528109255|FG000|Period 2|Physician Decision|2|||
146438161|NCT04633564|528109256|FG001|Period 2|Physician Decision|4|||
146438162|NCT04633564|528109255|FG000|Period 2|Withdrawal by Subject|5|||
146438163|NCT04633564|528109256|FG001|Period 2|Withdrawal by Subject|1|||
146438164|NCT04633564|528109255|FG000|Period 2|Progressive Disease|74|||
146438165|NCT04633564|528109256|FG001|Period 2|Progressive Disease|82|||
146438166|NCT04633564|528109255|FG000|Period 2|Terminated by Sponsor|9|||
146438167|NCT04633564|528109256|FG001|Period 2|Terminated by Sponsor|3|||
146438168|NCT02011945|528109257|FG000|Overall Study|Participant requested to Discontinue|0|||
146438169|NCT02011945|528109258|FG001|Overall Study|Participant requested to Discontinue|1|||
146438170|NCT02011945|528109259|FG002|Overall Study|Participant requested to Discontinue|1|||
146438171|NCT02011945|528109257|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
146438172|NCT02011945|528109258|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
146438173|NCT02011945|528109259|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
146083068|NCT02353143|526824728|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
146208641|NCT02723955|527280258|FG013|Escalation Phase|Withdrawal by Subject|0|||
146208642|NCT02723955|527280259|FG014|Escalation Phase|Withdrawal by Subject|0|||
146208643|NCT02723955|527280260|FG015|Escalation Phase|Withdrawal by Subject|0|||
146208644|NCT02723955|527280261|FG016|Escalation Phase|Withdrawal by Subject|1|||
146438174|NCT02011945|528109257|FG000|Overall Study|Study Drug Toxicity|0|||
146438175|NCT02011945|528109258|FG001|Overall Study|Study Drug Toxicity|0|||
146438176|NCT02011945|528109259|FG002|Overall Study|Study Drug Toxicity|1|||
146438177|NCT02011945|528109257|FG000|Overall Study|Treatment Failure|0|||
146438178|NCT02011945|528109258|FG001|Overall Study|Treatment Failure|7|||
146438179|NCT02011945|528109259|FG002|Overall Study|Treatment Failure|6|||
146438180|NCT02011945|528109257|FG000|Overall Study|No Longer Meets Study Criteria|1|||
146438181|NCT02011945|528109258|FG001|Overall Study|No Longer Meets Study Criteria|0|||
146438182|NCT02011945|528109259|FG002|Overall Study|No Longer Meets Study Criteria|0|||
146438183|NCT02011945|528109257|FG000|Overall Study|Proceeded to stem cell transplant|0|||
146438184|NCT02011945|528109258|FG001|Overall Study|Proceeded to stem cell transplant|0|||
146438185|NCT02011945|528109259|FG002|Overall Study|Proceeded to stem cell transplant|1|||
146438186|NCT02011945|528109257|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
146438187|NCT02011945|528109258|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
146438188|NCT02011945|528109259|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
146438189|NCT00902538|528109260|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
146438190|NCT00902538|528109261|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
146438191|NCT00902538|528109262|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
146438192|NCT00902538|528109263|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
146438193|NCT00902538|528109264|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
146438194|NCT00902538|528109265|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
146438195|NCT00902538|528109260|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
146438196|NCT00902538|528109261|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
146438197|NCT00902538|528109262|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
146438198|NCT00902538|528109263|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
146438199|NCT00902538|528109264|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
146438200|NCT00902538|528109265|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
146438201|NCT00902538|528109260|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
146438202|NCT00902538|528109261|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
146438203|NCT00902538|528109262|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
146438204|NCT00902538|528109263|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
146438205|NCT00902538|528109264|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
146438206|NCT00902538|528109265|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
146438207|NCT00902538|528109260|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
146438208|NCT00902538|528109261|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
146438209|NCT00902538|528109262|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
146438210|NCT00902538|528109263|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
146438211|NCT00902538|528109264|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
146438212|NCT00902538|528109265|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
146438213|NCT00902538|528109260|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
146438214|NCT00902538|528109261|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
146438215|NCT00902538|528109262|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
146438216|NCT00902538|528109263|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
146438217|NCT00902538|528109264|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
146438218|NCT00902538|528109265|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
146438219|NCT00902538|528109260|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
146438220|NCT00902538|528109261|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
146438221|NCT00902538|528109262|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
146438222|NCT00902538|528109263|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
146438223|NCT00902538|528109264|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
146438224|NCT00902538|528109265|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
146438225|NCT00902538|528109260|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
146438226|NCT00902538|528109261|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
146438227|NCT00902538|528109262|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
146438228|NCT00902538|528109263|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
146438229|NCT00902538|528109264|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
146438230|NCT00902538|528109265|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
146438231|NCT00902538|528109260|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
146438232|NCT00902538|528109261|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
146438233|NCT00902538|528109262|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
146438234|NCT00902538|528109263|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
146438235|NCT00902538|528109264|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
146438236|NCT00902538|528109265|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
146438237|NCT00902538|528109260|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
146438238|NCT00902538|528109261|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
146438239|NCT00902538|528109262|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
146438240|NCT00902538|528109263|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
146438241|NCT00902538|528109264|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
146438242|NCT00902538|528109265|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
146438243|NCT00902538|528109260|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
146438244|NCT00902538|528109261|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
146438245|NCT00902538|528109262|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
146438246|NCT00902538|528109263|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
146438247|NCT00902538|528109264|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
146438248|NCT00902538|528109265|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
146285434|NCT03538301|527557872|FG001|Overall Study|Death|1|||
146438249|NCT00902538|528109260|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
146438250|NCT00902538|528109261|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
146438251|NCT00902538|528109262|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
146438252|NCT00902538|528109263|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
146438253|NCT00902538|528109264|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
146438254|NCT00902538|528109265|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
146438255|NCT00902538|528109260|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
146438256|NCT00902538|528109261|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
146438257|NCT00902538|528109262|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
146438258|NCT00902538|528109263|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
146438259|NCT00902538|528109264|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
146438260|NCT00902538|528109265|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
146438261|NCT00902538|528109260|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
146438262|NCT00902538|528109261|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
146438263|NCT00902538|528109262|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
146438264|NCT00902538|528109263|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
146438265|NCT00902538|528109264|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
146438266|NCT00902538|528109265|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
146438267|NCT00902538|528109260|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
146438268|NCT00902538|528109261|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
146438269|NCT00902538|528109262|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
146438270|NCT00902538|528109263|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
146438271|NCT00902538|528109264|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
146438272|NCT00902538|528109265|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
146438273|NCT00902538|528109260|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
146438274|NCT00902538|528109261|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
146438275|NCT00902538|528109262|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
146438276|NCT00902538|528109263|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
146438277|NCT00902538|528109264|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
146438278|NCT00902538|528109265|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
146438279|NCT00902538|528109260|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
146438280|NCT00902538|528109261|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
146438281|NCT00902538|528109262|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
146438282|NCT00902538|528109263|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
146438283|NCT00902538|528109264|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
146438284|NCT00902538|528109265|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
146438285|NCT00902538|528109260|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
146438286|NCT00902538|528109261|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
146438287|NCT00902538|528109262|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
146438288|NCT00902538|528109263|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
146438289|NCT00902538|528109264|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
146438290|NCT00902538|528109265|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
146438291|NCT00830258|528110717|FG000|First Intervention|Adverse Event|1|||
146438292|NCT00830258|528110718|FG001|First Intervention|Adverse Event|0|||
146438293|NCT00830258|528110717|FG000|Washout: 7 Days|Protocol Violation|1|||
146438294|NCT00830258|528110718|FG001|Washout: 7 Days|Protocol Violation|0|||
146438295|NCT00798603|528110719|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
146438296|NCT00798603|528110719|FG000|Overall Study|Withdrawal by Subject|10|||
146438297|NCT00798603|528110719|FG000|Overall Study|Adverse Event|22|||
146438298|NCT00798603|528110719|FG000|Overall Study|Physician Decision|1|||
146438299|NCT00798603|528110719|FG000|Overall Study|Lack of insurance coverage|1|||
146438300|NCT03206749|528110722|FG000|Overall Study|Withdrawal of consent|5|||
146438301|NCT03206749|528110723|FG001|Overall Study|Withdrawal of consent|3|||
146208645|NCT02723955|527280262|FG017|Escalation Phase|Withdrawal by Subject|0|||
146208646|NCT02723955|527280263|FG018|Escalation Phase|Withdrawal by Subject|0|||
146208647|NCT02723955|527280264|FG019|Escalation Phase|Withdrawal by Subject|0|||
146208648|NCT02723955|527280265|FG020|Escalation Phase|Withdrawal by Subject|0|||
146208649|NCT02723955|527280266|FG021|Escalation Phase|Withdrawal by Subject|0|||
146208650|NCT02723955|527280267|FG022|Escalation Phase|Withdrawal by Subject|0|||
146208651|NCT02723955|527280268|FG023|Escalation Phase|Withdrawal by Subject|2|||
146208652|NCT02723955|527280269|FG024|Escalation Phase|Withdrawal by Subject|0|||
146438302|NCT03206749|528110724|FG002|Overall Study|Withdrawal of consent|6|||
146438303|NCT03206749|528110722|FG000|Overall Study|Lost to Follow-up|0|||
146438304|NCT03206749|528110723|FG001|Overall Study|Lost to Follow-up|0|||
146438305|NCT03206749|528110724|FG002|Overall Study|Lost to Follow-up|1|||
146208653|NCT02723955|527280270|FG025|Escalation Phase|Withdrawal by Subject|1|||
146208654|NCT02723955|527280271|FG026|Escalation Phase|Withdrawal by Subject|0|||
146208655|NCT02723955|527280272|FG027|Escalation Phase|Withdrawal by Subject|0|||
146208656|NCT02723955|527280273|FG028|Escalation Phase|Withdrawal by Subject|1|||
146438306|NCT02752074|528110725|FG000|Overall Study|Lost to Follow-up|1|||
146438307|NCT02752074|528110726|FG001|Overall Study|Lost to Follow-up|4|||
146438308|NCT02752074|528110725|FG000|Overall Study|Death|146|||
146438309|NCT02752074|528110726|FG001|Overall Study|Death|129|||
146438310|NCT02752074|528110725|FG000|Overall Study|Withdrawal by Subject|9|||
146438311|NCT02752074|528110726|FG001|Overall Study|Withdrawal by Subject|10|||
146438312|NCT00488774|528110727|FG000|Overall Study|Withdrawal of consent|2|||
146438313|NCT00488774|528110728|FG001|Overall Study|Withdrawal of consent|2|||
146438314|NCT00488774|528110729|FG002|Overall Study|Withdrawal of consent|2|||
146438315|NCT00488774|528110730|FG003|Overall Study|Withdrawal of consent|0|||
146438316|NCT00488774|528110727|FG000|Overall Study|Other|6|||
146438317|NCT00488774|528110728|FG001|Overall Study|Other|3|||
146438318|NCT00488774|528110729|FG002|Overall Study|Other|2|||
146438319|NCT00488774|528110730|FG003|Overall Study|Other|2|||
146438320|NCT00488774|528110727|FG000|Overall Study|Lost to Follow-up|0|||
146438321|NCT00488774|528110728|FG001|Overall Study|Lost to Follow-up|0|||
146438322|NCT00488774|528110729|FG002|Overall Study|Lost to Follow-up|1|||
146438323|NCT00488774|528110730|FG003|Overall Study|Lost to Follow-up|1|||
146438324|NCT05523895|528110731|FG000|Overall Study|Adverse Event|2|||
146438325|NCT05523895|528110732|FG001|Overall Study|Adverse Event|1|||
146438326|NCT05523895|528110733|FG002|Overall Study|Adverse Event|1|||
146438327|NCT05523895|528110731|FG000|Overall Study|Lost to Follow-up|0|||
146438328|NCT05523895|528110732|FG001|Overall Study|Lost to Follow-up|1|||
146438329|NCT05523895|528110733|FG002|Overall Study|Lost to Follow-up|2|||
146438330|NCT05523895|528110731|FG000|Overall Study|Noncompliance with study drug|1|||
146438331|NCT05523895|528110732|FG001|Overall Study|Noncompliance with study drug|1|||
146438332|NCT05523895|528110733|FG002|Overall Study|Noncompliance with study drug|1|||
146438333|NCT05523895|528110731|FG000|Overall Study|Protocol Violation|0|||
146438334|NCT05523895|528110732|FG001|Overall Study|Protocol Violation|2|||
146438335|NCT05523895|528110733|FG002|Overall Study|Protocol Violation|0|||
146438336|NCT05523895|528110731|FG000|Overall Study|Withdrawal by Subject|1|||
146438337|NCT05523895|528110732|FG001|Overall Study|Withdrawal by Subject|3|||
146438338|NCT05523895|528110733|FG002|Overall Study|Withdrawal by Subject|1|||
146438339|NCT05523895|528110731|FG000|Overall Study|Not further specified|0|||
146438340|NCT05523895|528110732|FG001|Overall Study|Not further specified|3|||
146438341|NCT05523895|528110733|FG002|Overall Study|Not further specified|1|||
146438342|NCT01959672|528110736|FG000|Overall Study|Death|1|||
146438343|NCT05041361|528110737|FG000|Overall Study|Lost to Follow-up|1|||
146438344|NCT05041361|528110738|FG001|Overall Study|Lost to Follow-up|3|||
145952665|NCT05052697|526337994|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952666|NCT05052697|526337995|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952667|NCT05052697|526337996|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952668|NCT05052697|526337997|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952669|NCT05052697|526337998|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952670|NCT05052697|526337999|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952671|NCT05052697|526338000|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952672|NCT05052697|526338001|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
145952673|NCT05052697|526338002|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
146438345|NCT01919112|528110739|FG000|Secondary Analysis-day 30|Death|1|||
146438346|NCT01919112|528110740|FG001|Secondary Analysis-day 30|Death|1|||
146438347|NCT01919112|528110741|FG002|Secondary Analysis-day 30|Death|1|||
146438348|NCT01919112|528110739|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
146438349|NCT01919112|528110740|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
146438350|NCT01919112|528110741|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
146438351|NCT04692155|528110744|FG000|Overall Study|Death|1|||
146438352|NCT02554877|528110745|FG000|Overall Study|Adverse Event|2|||
146438353|NCT02554877|528110746|FG001|Overall Study|Adverse Event|0|||
146438354|NCT02554877|528110747|FG002|Overall Study|Adverse Event|0|||
145952674|NCT05052697|526338003|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952675|NCT05052697|526338004|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952676|NCT05052697|526338005|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
146208657|NCT02723955|527280274|FG029|Escalation Phase|Withdrawal by Subject|0|||
146208658|NCT02723955|527280275|FG030|Escalation Phase|Withdrawal by Subject|0|||
146438355|NCT02554877|528110748|FG003|Overall Study|Adverse Event|1|||
146438356|NCT02554877|528110745|FG000|Overall Study|Lost to Follow-up|1|||
146438357|NCT02554877|528110746|FG001|Overall Study|Lost to Follow-up|1|||
146438358|NCT02554877|528110747|FG002|Overall Study|Lost to Follow-up|1|||
146438359|NCT02554877|528110748|FG003|Overall Study|Lost to Follow-up|2|||
146438360|NCT02554877|528110745|FG000|Overall Study|Did not meet entrance criteria|0|||
146438361|NCT02554877|528110746|FG001|Overall Study|Did not meet entrance criteria|0|||
146438362|NCT02554877|528110747|FG002|Overall Study|Did not meet entrance criteria|1|||
146438363|NCT02554877|528110748|FG003|Overall Study|Did not meet entrance criteria|0|||
146438364|NCT02554877|528110745|FG000|Overall Study|No longer met eligibility criteria|1|||
146438365|NCT02554877|528110746|FG001|Overall Study|No longer met eligibility criteria|0|||
146438366|NCT02554877|528110747|FG002|Overall Study|No longer met eligibility criteria|1|||
146438367|NCT02554877|528110748|FG003|Overall Study|No longer met eligibility criteria|1|||
146438368|NCT02554877|528110745|FG000|Overall Study|Protocol Violation|3|||
146438369|NCT02554877|528110746|FG001|Overall Study|Protocol Violation|1|||
146438370|NCT02554877|528110747|FG002|Overall Study|Protocol Violation|1|||
146438371|NCT02554877|528110748|FG003|Overall Study|Protocol Violation|0|||
146438372|NCT02554877|528110745|FG000|Overall Study|Other|1|||
146438373|NCT02554877|528110746|FG001|Overall Study|Other|3|||
146438374|NCT02554877|528110747|FG002|Overall Study|Other|0|||
146438375|NCT02554877|528110748|FG003|Overall Study|Other|3|||
146438376|NCT02554877|528110745|FG000|Overall Study|Insufficient clinical response|4|||
146438377|NCT02554877|528110746|FG001|Overall Study|Insufficient clinical response|0|||
146438378|NCT02554877|528110747|FG002|Overall Study|Insufficient clinical response|0|||
146438379|NCT02554877|528110748|FG003|Overall Study|Insufficient clinical response|0|||
146438380|NCT02554877|528110745|FG000|Overall Study|No longer willing to participate|0|||
146438381|NCT02554877|528110746|FG001|Overall Study|No longer willing to participate|2|||
146438382|NCT02554877|528110747|FG002|Overall Study|No longer willing to participate|2|||
146438383|NCT02554877|528110748|FG003|Overall Study|No longer willing to participate|0|||
146438384|NCT00274651|528110749|FG000|Overall Study|Adverse Event|6|||
146438385|NCT00274651|528110750|FG001|Overall Study|Adverse Event|3|||
146438386|NCT00274651|528110749|FG000|Overall Study|Lack of Efficacy|13|||
146438387|NCT00274651|528110750|FG001|Overall Study|Lack of Efficacy|6|||
146438388|NCT00274651|528110749|FG000|Overall Study|Death|1|||
146438389|NCT00274651|528110750|FG001|Overall Study|Death|3|||
146438390|NCT00274651|528110749|FG000|Overall Study|Withdrawal by Subject|0|||
146438391|NCT00274651|528110750|FG001|Overall Study|Withdrawal by Subject|1|||
146438392|NCT00274651|528110749|FG000|Overall Study|Physician Decision|8|||
146438393|NCT00274651|528110750|FG001|Overall Study|Physician Decision|7|||
146438394|NCT03446768|528110751|FG000|Overall Study|Withdrawal by Subject|0|||
146438395|NCT03446768|528110752|FG001|Overall Study|Withdrawal by Subject|1|||
146438396|NCT02488239|528110755|FG000|Overall Study|Death|3|||
146438397|NCT02488239|528110755|FG000|Overall Study|Withdrawal by Subject|3|||
146438398|NCT02488239|528110755|FG000|Overall Study|Physician Decision|2|||
146438399|NCT02488239|528110755|FG000|Overall Study|Consent ineligible|1|||
146438400|NCT02488239|528110755|FG000|Overall Study|Did not undergo implant procedure|1|||
146438401|NCT04345653|528110759|FG000|Overall Study|Withdrawal by Subject|2|||
146438402|NCT03480763|528110764|FG000|Overall Study|Withdrawal by Subject|18|||
146438403|NCT03480763|528110765|FG001|Overall Study|Withdrawal by Subject|10|||
146438404|NCT03480763|528110764|FG000|Overall Study|Lost to Follow-up|4|||
146438405|NCT03480763|528110765|FG001|Overall Study|Lost to Follow-up|7|||
146438406|NCT03480763|528110764|FG000|Overall Study|non-study pneumococcal vaccine|1|||
146438407|NCT03480763|528110765|FG001|Overall Study|non-study pneumococcal vaccine|0|||
146438408|NCT03480763|528110764|FG000|Overall Study|oncological treatment|0|||
146438409|NCT03480763|528110765|FG001|Overall Study|oncological treatment|2|||
146438410|NCT03480763|528110764|FG000|Overall Study|pain with vaccination|1|||
146438411|NCT03480763|528110765|FG001|Overall Study|pain with vaccination|0|||
146438412|NCT00418938|528110766|FG000|Overall Study|Reimbursement|1|||
146438413|NCT00418938|528110767|FG001|Overall Study|Reimbursement|0|||
146438414|NCT00418938|528110766|FG000|Overall Study|Administrative decision|3|||
146438415|NCT00418938|528110767|FG001|Overall Study|Administrative decision|3|||
146438416|NCT00418938|528110766|FG000|Overall Study|Withdrawal by Subject|16|||
146438417|NCT00418938|528110767|FG001|Overall Study|Withdrawal by Subject|15|||
146438418|NCT00418938|528110766|FG000|Overall Study|Lost to Follow-up|1|||
146208659|NCT02723955|527280276|FG031|Escalation Phase|Withdrawal by Subject|0|||
146208660|NCT02723955|527280277|FG032|Escalation Phase|Withdrawal by Subject|0|||
146208661|NCT02723955|527280278|FG033|Escalation Phase|Withdrawal by Subject|0|||
146208662|NCT02723955|527280279|FG034|Escalation Phase|Withdrawal by Subject|0|||
146208663|NCT02723955|527280280|FG035|Escalation Phase|Withdrawal by Subject|0|||
146438419|NCT00418938|528110767|FG001|Overall Study|Lost to Follow-up|3|||
146438420|NCT00418938|528110766|FG000|Overall Study|Adverse Event|1|||
146438421|NCT00418938|528110767|FG001|Overall Study|Adverse Event|1|||
146438422|NCT00418938|528110766|FG000|Overall Study|On-going|1|||
146438423|NCT00418938|528110767|FG001|Overall Study|On-going|1|||
146438424|NCT00418938|528110766|FG000|Overall Study|Ineligibility Determined|1|||
146208664|NCT02723955|527280281|FG036|Escalation Phase|Withdrawal by Subject|0|||
146438425|NCT00418938|528110767|FG001|Overall Study|Ineligibility Determined|0|||
146438426|NCT00115063|528110770|FG000|Overall Study|Lost to Follow-up|98|||
146438427|NCT00115063|528110771|FG001|Overall Study|Lost to Follow-up|104|||
146438428|NCT00115063|528110770|FG000|Overall Study|Death|1|||
146438429|NCT00115063|528110771|FG001|Overall Study|Death|0|||
146438430|NCT01316055|528110772|FG000|Overall Study|Lost to Follow-up|1|||
146438431|NCT01316055|528110773|FG001|Overall Study|Lost to Follow-up|0|||
146438432|NCT01316055|528110774|FG002|Overall Study|Lost to Follow-up|0|||
146438433|NCT00003470|528110775|FG000|Overall Study|Not evaluable|6|||
146438434|NCT00748566|528110779|FG000|Overall Study|Adverse Event|49|||
146438435|NCT00748566|528110779|FG000|Overall Study|Death|1|||
146438436|NCT00748566|528110779|FG000|Overall Study|Lack of Efficacy|12|||
146438437|NCT00748566|528110779|FG000|Overall Study|Lost to Follow-up|1|||
146438438|NCT00748566|528110779|FG000|Overall Study|Protocol Violation|13|||
146438439|NCT00748566|528110779|FG000|Overall Study|Withdrawal by Subject|22|||
146438440|NCT00748566|528110779|FG000|Overall Study|Study terminated by sponsor|5|||
146438441|NCT00748566|528110779|FG000|Overall Study|Other|9|||
146438442|NCT01442376|528110782|FG000|Overall Study|Adverse Event|0|||
146438443|NCT01442376|528110783|FG001|Overall Study|Adverse Event|3|||
146438444|NCT01442376|528110784|FG002|Overall Study|Adverse Event|2|||
146438445|NCT01442376|528110782|FG000|Overall Study|Death|0|||
146438446|NCT01442376|528110783|FG001|Overall Study|Death|1|||
146438447|NCT01442376|528110784|FG002|Overall Study|Death|1|||
146438448|NCT01442376|528110782|FG000|Overall Study|Withdrawal of consent|0|||
146438449|NCT01442376|528110783|FG001|Overall Study|Withdrawal of consent|0|||
146438450|NCT01442376|528110784|FG002|Overall Study|Withdrawal of consent|1|||
146438451|NCT01442376|528110782|FG000|Overall Study|Patients not treated|2|||
146438452|NCT01442376|528110783|FG001|Overall Study|Patients not treated|3|||
146438453|NCT01442376|528110784|FG002|Overall Study|Patients not treated|1|||
146438454|NCT01442376|528110782|FG000|Overall Study|Not eligible for subsequent cycles|1|||
146438455|NCT01442376|528110783|FG001|Overall Study|Not eligible for subsequent cycles|2|||
146438456|NCT01442376|528110784|FG002|Overall Study|Not eligible for subsequent cycles|0|||
146438457|NCT00863330|528110785|FG000|Overall Study|study terminated early due to administra|6|||
146438458|NCT04404725|528110786|FG000|First Intervention|Withdrawal by Subject|0|||
146438459|NCT04404725|528110787|FG001|First Intervention|Withdrawal by Subject|2|||
146438460|NCT04404725|528110786|FG000|Second Intervention|Adverse Event|1|||
146438461|NCT04404725|528110787|FG001|Second Intervention|Adverse Event|1|||
146438462|NCT04404725|528110786|FG000|Second Intervention|Withdrawal by Subject|0|||
146438463|NCT04404725|528110787|FG001|Second Intervention|Withdrawal by Subject|1|||
146208665|NCT02723955|527280282|FG037|Escalation Phase|Withdrawal by Subject|0|||
146438464|NCT01075516|528110788|FG000|Overall Study|Death|5|||
146438465|NCT01075516|528110789|FG001|Overall Study|Death|9|||
146438466|NCT01075516|528110788|FG000|Overall Study|Lost to Follow-up|10|||
146438467|NCT01075516|528110789|FG001|Overall Study|Lost to Follow-up|2|||
146438468|NCT01075516|528110788|FG000|Overall Study|Withdrawal by Subject|3|||
146438469|NCT01075516|528110789|FG001|Overall Study|Withdrawal by Subject|5|||
146438470|NCT02252016|528110790|FG000|Overall Study|Lost to Follow-up|2|||
146438471|NCT02252016|528110791|FG001|Overall Study|Lost to Follow-up|1|||
146438472|NCT02252016|528110790|FG000|Overall Study|Physician Decision|1|||
146438473|NCT02252016|528110791|FG001|Overall Study|Physician Decision|0|||
146438474|NCT02252016|528110790|FG000|Overall Study|Withdrawal by Subject|0|||
146438475|NCT02252016|528110791|FG001|Overall Study|Withdrawal by Subject|2|||
146438476|NCT01825798|528110793|FG000|Overall Study|Adverse Event|1|||
146438477|NCT01825798|528110794|FG001|Overall Study|Adverse Event|5|||
146438478|NCT01825798|528110793|FG000|Overall Study|Lost to Follow-up|1|||
146438479|NCT01825798|528110794|FG001|Overall Study|Lost to Follow-up|0|||
146208666|NCT02723955|527280283|FG038|Escalation Phase|Withdrawal by Subject|0|||
146208667|NCT02723955|527280284|FG039|Escalation Phase|Withdrawal by Subject|0|||
146208668|NCT02723955|527280285|FG040|Escalation Phase|Withdrawal by Subject|0|||
146438480|NCT00834873|528110800|FG000|First Intervention|Adverse Event|0|||
146438481|NCT00834873|528110801|FG001|First Intervention|Adverse Event|1|||
146208669|NCT02723955|527280286|FG041|Escalation Phase|Withdrawal by Subject|0|||
146208670|NCT02723955|527280287|FG042|Escalation Phase|Withdrawal by Subject|0|||
146438482|NCT02055547|528110803|FG000|Overall Study|Protocol Violation|0|||
146438483|NCT02055547|528110804|FG001|Overall Study|Protocol Violation|0|||
146438484|NCT02055547|528110805|FG002|Overall Study|Protocol Violation|1|||
146438485|NCT02055547|528110806|FG003|Overall Study|Protocol Violation|0|||
146438486|NCT02055547|528110807|FG004|Overall Study|Protocol Violation|0|||
146438487|NCT02055547|528110808|FG005|Overall Study|Protocol Violation|0|||
146438488|NCT02055547|528110809|FG006|Overall Study|Protocol Violation|1|||
146438489|NCT02055547|528110810|FG007|Overall Study|Protocol Violation|0|||
146438490|NCT02055547|528110811|FG008|Overall Study|Protocol Violation|0|||
146438491|NCT02055547|528110812|FG009|Overall Study|Protocol Violation|0|||
146438492|NCT02055547|528110813|FG010|Overall Study|Protocol Violation|0|||
146438493|NCT02055547|528110814|FG011|Overall Study|Protocol Violation|0|||
146438494|NCT02055547|528110815|FG012|Overall Study|Protocol Violation|0|||
146438495|NCT02055547|528110816|FG013|Overall Study|Protocol Violation|0|||
146438496|NCT02055547|528110817|FG014|Overall Study|Protocol Violation|0|||
146438497|NCT02055547|528110818|FG015|Overall Study|Protocol Violation|0|||
146438498|NCT02055547|528110819|FG016|Overall Study|Protocol Violation|0|||
146438499|NCT02055547|528110820|FG017|Overall Study|Protocol Violation|0|||
146438500|NCT02055547|528110821|FG018|Overall Study|Protocol Violation|0|||
146438501|NCT02055547|528110803|FG000|Overall Study|Physician Decision|0|||
146438502|NCT02055547|528110804|FG001|Overall Study|Physician Decision|1|||
146438503|NCT02055547|528110805|FG002|Overall Study|Physician Decision|1|||
146438504|NCT02055547|528110806|FG003|Overall Study|Physician Decision|0|||
146438505|NCT02055547|528110807|FG004|Overall Study|Physician Decision|1|||
146438506|NCT02055547|528110808|FG005|Overall Study|Physician Decision|0|||
146438507|NCT02055547|528110809|FG006|Overall Study|Physician Decision|0|||
146438508|NCT02055547|528110810|FG007|Overall Study|Physician Decision|0|||
146438509|NCT02055547|528110811|FG008|Overall Study|Physician Decision|0|||
146438510|NCT02055547|528110812|FG009|Overall Study|Physician Decision|1|||
146438511|NCT02055547|528110813|FG010|Overall Study|Physician Decision|1|||
146438512|NCT02055547|528110814|FG011|Overall Study|Physician Decision|0|||
145952677|NCT05052697|526338006|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
146438513|NCT02055547|528110815|FG012|Overall Study|Physician Decision|0|||
146438514|NCT02055547|528110816|FG013|Overall Study|Physician Decision|0|||
146438515|NCT02055547|528110817|FG014|Overall Study|Physician Decision|0|||
146438516|NCT02055547|528110818|FG015|Overall Study|Physician Decision|0|||
145952678|NCT05052697|526338007|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952679|NCT05052697|526338008|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952680|NCT05052697|526338009|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952681|NCT05052697|526338010|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952682|NCT05052697|526338011|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952683|NCT05052697|526338012|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952684|NCT05052697|526338013|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952685|NCT05052697|526338014|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
146208671|NCT02723955|527280245|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146438517|NCT02055547|528110819|FG016|Overall Study|Physician Decision|0|||
146438518|NCT02055547|528110820|FG017|Overall Study|Physician Decision|0|||
146438519|NCT02055547|528110821|FG018|Overall Study|Physician Decision|0|||
146438520|NCT02055547|528110803|FG000|Overall Study|Adverse Event|0|||
146438521|NCT02055547|528110804|FG001|Overall Study|Adverse Event|0|||
146438522|NCT02055547|528110805|FG002|Overall Study|Adverse Event|0|||
146438523|NCT02055547|528110806|FG003|Overall Study|Adverse Event|0|||
146438524|NCT02055547|528110807|FG004|Overall Study|Adverse Event|0|||
146438525|NCT02055547|528110808|FG005|Overall Study|Adverse Event|0|||
146438526|NCT02055547|528110809|FG006|Overall Study|Adverse Event|1|||
146438527|NCT02055547|528110810|FG007|Overall Study|Adverse Event|0|||
146438528|NCT02055547|528110811|FG008|Overall Study|Adverse Event|1|||
146438529|NCT02055547|528110812|FG009|Overall Study|Adverse Event|0|||
146438530|NCT02055547|528110813|FG010|Overall Study|Adverse Event|0|||
146438531|NCT02055547|528110814|FG011|Overall Study|Adverse Event|0|||
146438532|NCT02055547|528110815|FG012|Overall Study|Adverse Event|0|||
146438533|NCT02055547|528110816|FG013|Overall Study|Adverse Event|0|||
146438534|NCT02055547|528110817|FG014|Overall Study|Adverse Event|0|||
146438535|NCT02055547|528110818|FG015|Overall Study|Adverse Event|0|||
146438536|NCT02055547|528110819|FG016|Overall Study|Adverse Event|0|||
146438537|NCT02055547|528110820|FG017|Overall Study|Adverse Event|0|||
146438538|NCT02055547|528110821|FG018|Overall Study|Adverse Event|0|||
146438539|NCT02055547|528110803|FG000|Overall Study|Withdrawal by Subject|0|||
146438540|NCT02055547|528110804|FG001|Overall Study|Withdrawal by Subject|0|||
146438541|NCT02055547|528110805|FG002|Overall Study|Withdrawal by Subject|0|||
146438542|NCT02055547|528110806|FG003|Overall Study|Withdrawal by Subject|0|||
146438543|NCT02055547|528110807|FG004|Overall Study|Withdrawal by Subject|0|||
146438544|NCT02055547|528110808|FG005|Overall Study|Withdrawal by Subject|1|||
146438545|NCT02055547|528110809|FG006|Overall Study|Withdrawal by Subject|0|||
146438546|NCT02055547|528110810|FG007|Overall Study|Withdrawal by Subject|0|||
145952686|NCT05052697|526338015|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
145952687|NCT05052697|526338016|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
146208672|NCT02723955|527280246|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208673|NCT02723955|527280247|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208674|NCT02723955|527280248|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208675|NCT02723955|527280249|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
146438547|NCT02055547|528110811|FG008|Overall Study|Withdrawal by Subject|1|||
146438548|NCT02055547|528110812|FG009|Overall Study|Withdrawal by Subject|0|||
146438549|NCT02055547|528110813|FG010|Overall Study|Withdrawal by Subject|0|||
145952688|NCT05052697|526338017|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
146438550|NCT02055547|528110814|FG011|Overall Study|Withdrawal by Subject|0|||
146438551|NCT02055547|528110815|FG012|Overall Study|Withdrawal by Subject|0|||
146438552|NCT02055547|528110816|FG013|Overall Study|Withdrawal by Subject|1|||
146438553|NCT02055547|528110817|FG014|Overall Study|Withdrawal by Subject|0|||
146438554|NCT02055547|528110818|FG015|Overall Study|Withdrawal by Subject|1|||
146438555|NCT02055547|528110819|FG016|Overall Study|Withdrawal by Subject|0|||
146438556|NCT02055547|528110820|FG017|Overall Study|Withdrawal by Subject|0|||
146438557|NCT02055547|528110821|FG018|Overall Study|Withdrawal by Subject|0|||
146438558|NCT02055547|528110803|FG000|Overall Study|Lost to Follow-up|0|||
146438559|NCT02055547|528110804|FG001|Overall Study|Lost to Follow-up|0|||
146438560|NCT02055547|528110805|FG002|Overall Study|Lost to Follow-up|1|||
146438561|NCT02055547|528110806|FG003|Overall Study|Lost to Follow-up|0|||
146438562|NCT02055547|528110807|FG004|Overall Study|Lost to Follow-up|0|||
146438563|NCT02055547|528110808|FG005|Overall Study|Lost to Follow-up|0|||
146438564|NCT02055547|528110809|FG006|Overall Study|Lost to Follow-up|0|||
146438565|NCT02055547|528110810|FG007|Overall Study|Lost to Follow-up|0|||
146438566|NCT02055547|528110811|FG008|Overall Study|Lost to Follow-up|0|||
146438567|NCT02055547|528110812|FG009|Overall Study|Lost to Follow-up|0|||
146438568|NCT02055547|528110813|FG010|Overall Study|Lost to Follow-up|0|||
146438569|NCT02055547|528110814|FG011|Overall Study|Lost to Follow-up|0|||
146438570|NCT02055547|528110815|FG012|Overall Study|Lost to Follow-up|0|||
146438571|NCT02055547|528110816|FG013|Overall Study|Lost to Follow-up|0|||
146438572|NCT02055547|528110817|FG014|Overall Study|Lost to Follow-up|0|||
146438573|NCT02055547|528110818|FG015|Overall Study|Lost to Follow-up|0|||
146438574|NCT02055547|528110819|FG016|Overall Study|Lost to Follow-up|0|||
146438575|NCT02055547|528110820|FG017|Overall Study|Lost to Follow-up|0|||
146438576|NCT02055547|528110821|FG018|Overall Study|Lost to Follow-up|0|||
146438577|NCT02911025|528110824|FG000|Overall Study|Lost to Follow-up|3|||
146438578|NCT02923349|528110828|FG000|Overall Study|Other|1|||
146438579|NCT02923349|528110829|FG001|Overall Study|Other|2|||
146438580|NCT02923349|528110830|FG002|Overall Study|Other|4|||
146438581|NCT02923349|528110831|FG003|Overall Study|Other|1|||
146438582|NCT02923349|528110832|FG004|Overall Study|Other|3|||
146438583|NCT02923349|528110833|FG005|Overall Study|Other|0|||
146438584|NCT02923349|528110834|FG006|Overall Study|Other|1|||
146438585|NCT02923349|528110828|FG000|Overall Study|Withdrawal by Subject|2|||
146438586|NCT02923349|528110829|FG001|Overall Study|Withdrawal by Subject|2|||
146438587|NCT02923349|528110830|FG002|Overall Study|Withdrawal by Subject|8|||
146438588|NCT02923349|528110831|FG003|Overall Study|Withdrawal by Subject|10|||
146438589|NCT02923349|528110832|FG004|Overall Study|Withdrawal by Subject|12|||
146438590|NCT02923349|528110833|FG005|Overall Study|Withdrawal by Subject|3|||
146438591|NCT02923349|528110834|FG006|Overall Study|Withdrawal by Subject|0|||
146438592|NCT02923349|528110828|FG000|Overall Study|Physician Decision|0|||
146438593|NCT02923349|528110829|FG001|Overall Study|Physician Decision|0|||
146438594|NCT02923349|528110830|FG002|Overall Study|Physician Decision|0|||
146438595|NCT02923349|528110831|FG003|Overall Study|Physician Decision|1|||
146438596|NCT02923349|528110832|FG004|Overall Study|Physician Decision|1|||
146438597|NCT02923349|528110833|FG005|Overall Study|Physician Decision|0|||
146438598|NCT02923349|528110834|FG006|Overall Study|Physician Decision|2|||
146438599|NCT02923349|528110828|FG000|Overall Study|Lost to Follow-up|0|||
146438600|NCT02923349|528110829|FG001|Overall Study|Lost to Follow-up|0|||
146438601|NCT02923349|528110830|FG002|Overall Study|Lost to Follow-up|3|||
146438602|NCT02923349|528110831|FG003|Overall Study|Lost to Follow-up|0|||
146438603|NCT02923349|528110832|FG004|Overall Study|Lost to Follow-up|1|||
146438604|NCT02923349|528110833|FG005|Overall Study|Lost to Follow-up|1|||
146438605|NCT02923349|528110834|FG006|Overall Study|Lost to Follow-up|0|||
146438606|NCT02923349|528110828|FG000|Overall Study|Death|1|||
146438607|NCT02923349|528110829|FG001|Overall Study|Death|0|||
146438608|NCT02923349|528110830|FG002|Overall Study|Death|2|||
146438609|NCT02923349|528110831|FG003|Overall Study|Death|4|||
146438610|NCT02923349|528110832|FG004|Overall Study|Death|2|||
146438611|NCT02923349|528110833|FG005|Overall Study|Death|3|||
146438612|NCT02923349|528110834|FG006|Overall Study|Death|0|||
146438613|NCT01120028|528110837|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
146438614|NCT01120028|528110838|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
146438615|NCT01120028|528110839|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
146438616|NCT01120028|528110840|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
146438617|NCT01120028|528110837|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
146438618|NCT01120028|528110838|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
146438619|NCT01120028|528110839|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
146438620|NCT01120028|528110840|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
146438621|NCT03250117|528110841|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
146438622|NCT03250117|528110842|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
146438623|NCT03250117|528110843|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
146438624|NCT03250117|528110844|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
146438625|NCT04063878|528110845|FG000|Overall Study|Withdrawal by Subject|2|||
146438626|NCT04063878|528110845|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
146438627|NCT02751827|528110846|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
146438628|NCT02751827|528110847|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
146438629|NCT02751827|528110848|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
146438630|NCT01248728|528110849|FG000|Overall Study|Adverse Event|1|||
146438631|NCT01248728|528110850|FG001|Overall Study|Adverse Event|1|||
146438632|NCT01248728|528110849|FG000|Overall Study|Withdrawal by Subject|2|||
146438633|NCT01248728|528110850|FG001|Overall Study|Withdrawal by Subject|1|||
146438634|NCT01248728|528110849|FG000|Overall Study|Lack of Efficacy|1|||
146438635|NCT01248728|528110850|FG001|Overall Study|Lack of Efficacy|0|||
146438636|NCT01838681|528110851|FG000|Period A|Adverse Event|39|||
146438637|NCT01838681|528110852|FG001|Period A|Adverse Event|0|||
146438638|NCT01838681|528110853|FG002|Period A|Adverse Event|0|||
146438639|NCT01838681|528110854|FG003|Period A|Adverse Event|0|||
146438640|NCT01838681|528110851|FG000|Period A|Lack of Efficacy|21|||
146438641|NCT01838681|528110852|FG001|Period A|Lack of Efficacy|0|||
146438642|NCT01838681|528110853|FG002|Period A|Lack of Efficacy|0|||
146438643|NCT01838681|528110854|FG003|Period A|Lack of Efficacy|0|||
146438644|NCT01838681|528110851|FG000|Period A|Early response|148|||
146438645|NCT01838681|528110852|FG001|Period A|Early response|0|||
146438646|NCT01838681|528110853|FG002|Period A|Early response|0|||
146438647|NCT01838681|528110854|FG003|Period A|Early response|0|||
146438648|NCT01838681|528110851|FG000|Period A|Withdrawal by Subject|70|||
146438649|NCT01838681|528110852|FG001|Period A|Withdrawal by Subject|0|||
146438650|NCT01838681|528110853|FG002|Period A|Withdrawal by Subject|0|||
146438651|NCT01838681|528110854|FG003|Period A|Withdrawal by Subject|0|||
146438652|NCT01838681|528110851|FG000|Period A|Protocol Violation|16|||
146438653|NCT01838681|528110852|FG001|Period A|Protocol Violation|0|||
146438654|NCT01838681|528110853|FG002|Period A|Protocol Violation|0|||
146438655|NCT01838681|528110854|FG003|Period A|Protocol Violation|0|||
146438656|NCT01838681|528110851|FG000|Period A|Non-compliance with IMP|6|||
146438657|NCT01838681|528110852|FG001|Period A|Non-compliance with IMP|0|||
146438658|NCT01838681|528110853|FG002|Period A|Non-compliance with IMP|0|||
146438659|NCT01838681|528110854|FG003|Period A|Non-compliance with IMP|0|||
146438660|NCT01838681|528110851|FG000|Period A|Lost to Follow-up|4|||
146438661|NCT01838681|528110852|FG001|Period A|Lost to Follow-up|0|||
146438662|NCT01838681|528110853|FG002|Period A|Lost to Follow-up|0|||
146438663|NCT01838681|528110854|FG003|Period A|Lost to Follow-up|0|||
146438664|NCT01838681|528110851|FG000|Period A|Withdrawal before treatment|4|||
146438665|NCT01838681|528110852|FG001|Period A|Withdrawal before treatment|0|||
146438666|NCT01838681|528110853|FG002|Period A|Withdrawal before treatment|0|||
146438667|NCT01838681|528110854|FG003|Period A|Withdrawal before treatment|0|||
146438668|NCT01838681|528110851|FG000|Period A|Administrative or other reasons|17|||
146438669|NCT01838681|528110852|FG001|Period A|Administrative or other reasons|0|||
146438670|NCT01838681|528110853|FG002|Period A|Administrative or other reasons|0|||
146438671|NCT01838681|528110854|FG003|Period A|Administrative or other reasons|0|||
146438672|NCT01838681|528110851|FG000|Period B/A+|Adverse Event|0|||
146438673|NCT01838681|528110852|FG001|Period B/A+|Adverse Event|13|||
146438674|NCT01838681|528110853|FG002|Period B/A+|Adverse Event|27|||
146438675|NCT01838681|528110854|FG003|Period B/A+|Adverse Event|16|||
146438676|NCT01838681|528110851|FG000|Period B/A+|Lack of Efficacy|0|||
146438677|NCT01838681|528110852|FG001|Period B/A+|Lack of Efficacy|9|||
146438678|NCT01838681|528110853|FG002|Period B/A+|Lack of Efficacy|11|||
146438679|NCT01838681|528110854|FG003|Period B/A+|Lack of Efficacy|6|||
146438680|NCT01838681|528110851|FG000|Period B/A+|Withdrawal by Subject|0|||
146438681|NCT01838681|528110852|FG001|Period B/A+|Withdrawal by Subject|28|||
146438682|NCT01838681|528110853|FG002|Period B/A+|Withdrawal by Subject|35|||
146438683|NCT01838681|528110854|FG003|Period B/A+|Withdrawal by Subject|47|||
146438684|NCT01838681|528110851|FG000|Period B/A+|Protocol Violation|0|||
146438685|NCT01838681|528110852|FG001|Period B/A+|Protocol Violation|1|||
146438686|NCT01838681|528110853|FG002|Period B/A+|Protocol Violation|4|||
146438687|NCT01838681|528110854|FG003|Period B/A+|Protocol Violation|6|||
146438688|NCT01838681|528110851|FG000|Period B/A+|Non-compliance with IMP|0|||
146438689|NCT01838681|528110852|FG001|Period B/A+|Non-compliance with IMP|2|||
146438690|NCT01838681|528110853|FG002|Period B/A+|Non-compliance with IMP|3|||
146438691|NCT01838681|528110854|FG003|Period B/A+|Non-compliance with IMP|3|||
146438692|NCT01838681|528110851|FG000|Period B/A+|Lost to Follow-up|0|||
146438693|NCT01838681|528110852|FG001|Period B/A+|Lost to Follow-up|2|||
146438694|NCT01838681|528110853|FG002|Period B/A+|Lost to Follow-up|5|||
146438695|NCT01838681|528110854|FG003|Period B/A+|Lost to Follow-up|11|||
146438696|NCT01838681|528110851|FG000|Period B/A+|Withdrawal before treatment|0|||
146438697|NCT01838681|528110852|FG001|Period B/A+|Withdrawal before treatment|1|||
146438698|NCT01838681|528110853|FG002|Period B/A+|Withdrawal before treatment|0|||
146438699|NCT01838681|528110854|FG003|Period B/A+|Withdrawal before treatment|0|||
146438700|NCT01838681|528110851|FG000|Period B/A+|Administrative or other reasons|0|||
146438701|NCT01838681|528110852|FG001|Period B/A+|Administrative or other reasons|6|||
146438702|NCT01838681|528110853|FG002|Period B/A+|Administrative or other reasons|10|||
146438703|NCT01838681|528110854|FG003|Period B/A+|Administrative or other reasons|28|||
146438704|NCT00796562|528110855|FG000|Overall Study|Death|49|||
146438705|NCT04198363|528110857|FG000|Overall Study|Adverse Event|1|||
146438706|NCT04198363|528110858|FG001|Overall Study|Adverse Event|1|||
146438707|NCT04198363|528110857|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
146438708|NCT04198363|528110858|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
146438709|NCT04198363|528110857|FG000|Overall Study|Reason not Specified|1|||
146438710|NCT04198363|528110858|FG001|Overall Study|Reason not Specified|0|||
146438711|NCT03067987|528110860|FG000|Overall Study|Lost to Follow-up|7|||
146438712|NCT03067987|528110861|FG001|Overall Study|Lost to Follow-up|10|||
146438713|NCT03067987|528110860|FG000|Overall Study|Protocol Violation|1|||
146438714|NCT03067987|528110861|FG001|Overall Study|Protocol Violation|2|||
146438715|NCT03067987|528110860|FG000|Overall Study|Withdrawal by Subject|2|||
146438716|NCT03067987|528110861|FG001|Overall Study|Withdrawal by Subject|1|||
146438717|NCT04827394|528110862|FG000|Overall Study|Physician Decision|0|||
146438718|NCT04827394|528110863|FG001|Overall Study|Physician Decision|2|||
146438719|NCT01404988|528110864|FG000|Overall Study|Death|2|||
146438720|NCT01404988|528110865|FG001|Overall Study|Death|0|||
146438721|NCT01404988|528110866|FG002|Overall Study|Death|2|||
146438722|NCT01404988|528110864|FG000|Overall Study|Adverse Event|1|||
146438723|NCT01404988|528110865|FG001|Overall Study|Adverse Event|0|||
146438724|NCT01404988|528110866|FG002|Overall Study|Adverse Event|0|||
146438725|NCT01404988|528110864|FG000|Overall Study|Withdrawal by Subject|2|||
146438726|NCT01404988|528110865|FG001|Overall Study|Withdrawal by Subject|2|||
146438727|NCT01404988|528110866|FG002|Overall Study|Withdrawal by Subject|0|||
146438728|NCT01404988|528110864|FG000|Overall Study|Lost to Follow-up|1|||
146438729|NCT01404988|528110865|FG001|Overall Study|Lost to Follow-up|2|||
146208676|NCT02723955|527280250|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
146208677|NCT02723955|527280251|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
146208678|NCT02723955|527280252|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
146208679|NCT02723955|527280253|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
146208680|NCT02723955|527280254|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208681|NCT02723955|527280255|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208682|NCT02723955|527280256|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208683|NCT02723955|527280257|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208684|NCT02723955|527280258|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146438730|NCT01404988|528110866|FG002|Overall Study|Lost to Follow-up|1|||
146438731|NCT00829764|528110867|FG000|First Intervention|Adverse Event|1|||
146438732|NCT00829764|528110868|FG001|First Intervention|Adverse Event|0|||
146438733|NCT00829764|528110867|FG000|First Intervention|Withdrawal by Subject|1|||
146438734|NCT00829764|528110868|FG001|First Intervention|Withdrawal by Subject|1|||
146438735|NCT04594252|528110869|FG000|Overall Study|Adverse Event|0|||
146438736|NCT04594252|528110870|FG001|Overall Study|Adverse Event|2|||
146438737|NCT00477594|528110871|FG000|Year 1 and Year 2|Adverse Event|4|||
146438738|NCT00477594|528110872|FG001|Year 1 and Year 2|Adverse Event|2|||
146438739|NCT00477594|528110871|FG000|Year 1 and Year 2|Physician Decision|2|||
146438740|NCT00477594|528110872|FG001|Year 1 and Year 2|Physician Decision|1|||
146438741|NCT00477594|528110871|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
146438742|NCT00477594|528110872|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
146438743|NCT00477594|528110871|FG000|Year 1 and Year 2|Other|1|||
146438744|NCT00477594|528110872|FG001|Year 1 and Year 2|Other|0|||
146438745|NCT00477594|528110871|FG000|Year 3|Adverse Event|1|||
146438746|NCT00477594|528110872|FG001|Year 3|Adverse Event|0|||
146438747|NCT00477594|528110871|FG000|Year 3|Withdrawal by Subject|1|||
146438748|NCT00477594|528110872|FG001|Year 3|Withdrawal by Subject|0|||
146438749|NCT00477594|528110871|FG000|Follow-up Period|Withdrawal by Subject|2|||
146438750|NCT00477594|528110872|FG001|Follow-up Period|Withdrawal by Subject|1|||
146438751|NCT00477594|528110871|FG000|Follow-up Period|Other|1|||
146438752|NCT00477594|528110872|FG001|Follow-up Period|Other|0|||
146438753|NCT00640341|528112869|FG000|Overall Study|Adverse Event|0|||
146438754|NCT00640341|528112870|FG001|Overall Study|Adverse Event|0|||
146438755|NCT00640341|528112871|FG002|Overall Study|Adverse Event|1|||
146438756|NCT00640341|528112869|FG000|Overall Study|Positive Slit Lamp Findings|0|||
146438757|NCT00640341|528112870|FG001|Overall Study|Positive Slit Lamp Findings|0|||
146438758|NCT00640341|528112871|FG002|Overall Study|Positive Slit Lamp Findings|1|||
146438759|NCT00640341|528112869|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
146438760|NCT00640341|528112870|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
146438761|NCT00640341|528112871|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
146438762|NCT00640341|528112869|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
146438763|NCT00640341|528112870|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
146438764|NCT00640341|528112871|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
146438765|NCT00640341|528112869|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
146438766|NCT00640341|528112870|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
146438767|NCT00640341|528112871|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
146438768|NCT00640341|528112869|FG000|Overall Study|Lost to Follow-up|2|||
146438769|NCT00640341|528112870|FG001|Overall Study|Lost to Follow-up|0|||
146438770|NCT00640341|528112871|FG002|Overall Study|Lost to Follow-up|0|||
146438771|NCT00640341|528112869|FG000|Overall Study|Withdrawal by Subject|4|||
146438772|NCT00640341|528112870|FG001|Overall Study|Withdrawal by Subject|0|||
146438773|NCT00640341|528112871|FG002|Overall Study|Withdrawal by Subject|1|||
146438774|NCT00640341|528112869|FG000|Overall Study|Unacceptable Lens Movement|1|||
146438775|NCT00640341|528112870|FG001|Overall Study|Unacceptable Lens Movement|0|||
146438776|NCT00640341|528112871|FG002|Overall Study|Unacceptable Lens Movement|0|||
146438777|NCT00640341|528112869|FG000|Overall Study|Poor fit/Uncomfortable|4|||
146438778|NCT00640341|528112870|FG001|Overall Study|Poor fit/Uncomfortable|0|||
146438779|NCT00640341|528112871|FG002|Overall Study|Poor fit/Uncomfortable|0|||
146438780|NCT00640341|528112869|FG000|Overall Study|Ineligable at Baseline|5|||
146438781|NCT00640341|528112870|FG001|Overall Study|Ineligable at Baseline|3|||
146438782|NCT00640341|528112871|FG002|Overall Study|Ineligable at Baseline|2|||
146438783|NCT00640341|528112869|FG000|Overall Study|Adverse event and positive slit lamp|1|||
146438784|NCT00640341|528112870|FG001|Overall Study|Adverse event and positive slit lamp|0|||
146438785|NCT00640341|528112871|FG002|Overall Study|Adverse event and positive slit lamp|0|||
146438786|NCT03578809|528112872|FG000|Overall Study|Death|0|||
146438787|NCT03578809|528112873|FG001|Overall Study|Death|2|||
146438788|NCT03578809|528112874|FG002|Overall Study|Death|0|||
146438789|NCT03578809|528112875|FG003|Overall Study|Death|1|||
146438790|NCT03578809|528112872|FG000|Overall Study|Lost to Follow-up|0|||
146438791|NCT03578809|528112873|FG001|Overall Study|Lost to Follow-up|1|||
146438792|NCT03578809|528112874|FG002|Overall Study|Lost to Follow-up|0|||
146438793|NCT03578809|528112875|FG003|Overall Study|Lost to Follow-up|0|||
146208685|NCT02723955|527280259|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146083069|NCT02353143|526824729|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
146208686|NCT02723955|527280260|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146438794|NCT03578809|528112872|FG000|Overall Study|Withdrawal by Subject|3|||
146438795|NCT03578809|528112873|FG001|Overall Study|Withdrawal by Subject|5|||
146438796|NCT03578809|528112874|FG002|Overall Study|Withdrawal by Subject|2|||
146438797|NCT03578809|528112875|FG003|Overall Study|Withdrawal by Subject|0|||
146438798|NCT03578809|528112872|FG000|Overall Study|Other|3|||
146438799|NCT03578809|528112873|FG001|Overall Study|Other|6|||
146438800|NCT03578809|528112874|FG002|Overall Study|Other|2|||
146438801|NCT03578809|528112875|FG003|Overall Study|Other|8|||
146438802|NCT02488109|528112876|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
146438803|NCT02488109|528112877|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
146438804|NCT02488109|528112876|FG000|12-month Follow-Up|Lost to Follow-up|4|||
146438805|NCT02488109|528112877|FG001|12-month Follow-Up|Lost to Follow-up|7|||
146438806|NCT02302716|528112878|FG000|Overall Study|Adverse Event|1|||
146438807|NCT02302716|528112879|FG001|Overall Study|Adverse Event|1|||
146438808|NCT02302716|528112878|FG000|Overall Study|Death|0|||
146438809|NCT02302716|528112879|FG001|Overall Study|Death|1|||
146438810|NCT02302716|528112878|FG000|Overall Study|Lack of Efficacy|0|||
146438811|NCT02302716|528112879|FG001|Overall Study|Lack of Efficacy|1|||
146438812|NCT02302716|528112878|FG000|Overall Study|Lost to Follow-up|2|||
146438813|NCT02302716|528112879|FG001|Overall Study|Lost to Follow-up|4|||
146438814|NCT02302716|528112878|FG000|Overall Study|Physician Decision|3|||
146438815|NCT02302716|528112879|FG001|Overall Study|Physician Decision|4|||
146438816|NCT02302716|528112878|FG000|Overall Study|Withdrawal by Subject|13|||
146438817|NCT02302716|528112879|FG001|Overall Study|Withdrawal by Subject|7|||
146438818|NCT02302716|528112878|FG000|Overall Study|Protocol Violation|0|||
146438819|NCT02302716|528112879|FG001|Overall Study|Protocol Violation|1|||
146438820|NCT00557245|528112883|FG000|Overall Study|Lost to Follow-up|7|||
146438821|NCT00557245|528112884|FG001|Overall Study|Lost to Follow-up|8|||
146438822|NCT00557245|528112885|FG002|Overall Study|Lost to Follow-up|10|||
146438823|NCT00557245|528112883|FG000|Overall Study|Ineligible|5|||
146438824|NCT00557245|528112884|FG001|Overall Study|Ineligible|4|||
146438825|NCT00557245|528112885|FG002|Overall Study|Ineligible|2|||
146438826|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Subject request|8|||
146438827|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Subject request|11|||
146438828|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
146438829|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
146438830|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
146438831|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
146438832|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
146438833|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
146438834|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
146438835|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
146438836|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
146438837|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
146438838|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Death|1|||
146438839|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Death|0|||
146438840|NCT00521586|528112886|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
146438841|NCT00521586|528112887|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
146438842|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
146438843|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
146438844|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
146438845|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
146438846|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
146438847|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
146285435|NCT03538301|527557873|FG002|Overall Study|Death|0|||
146285436|NCT03538301|527557871|FG000|Overall Study|Physician Decision|0|||
146285437|NCT03538301|527557872|FG001|Overall Study|Physician Decision|1|||
146438848|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
146438849|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
146438850|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
146438851|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
146438852|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
146438853|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
146438854|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
146438855|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
146438856|NCT00521586|528112886|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
146438857|NCT00521586|528112887|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
145952689|NCT05052697|526337984|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952690|NCT05052697|526337985|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952691|NCT05052697|526337986|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952692|NCT05052697|526337987|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952693|NCT05052697|526337988|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952694|NCT05052697|526337989|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952695|NCT05052697|526337990|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952696|NCT05052697|526337991|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952697|NCT05052697|526337992|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952698|NCT05052697|526337993|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952699|NCT05052697|526337994|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952700|NCT05052697|526337995|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952701|NCT05052697|526337996|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952702|NCT05052697|526337997|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952703|NCT05052697|526337998|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952704|NCT05052697|526337999|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952705|NCT05052697|526338000|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952706|NCT05052697|526338001|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952707|NCT05052697|526338002|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952708|NCT05052697|526338003|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
145952709|NCT05052697|526338004|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952710|NCT05052697|526338005|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952711|NCT05052697|526338006|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952712|NCT05052697|526338007|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952713|NCT05052697|526338008|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952714|NCT05052697|526338009|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952715|NCT05052697|526338010|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952716|NCT05052697|526338011|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952717|NCT05052697|526338012|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952718|NCT05052697|526338013|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952719|NCT05052697|526338014|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952720|NCT05052697|526338015|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952721|NCT05052697|526338016|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952722|NCT05052697|526338017|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145952723|NCT05052697|526337984|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952724|NCT05052697|526337985|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952725|NCT05052697|526337986|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952726|NCT05052697|526337987|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952727|NCT05052697|526337988|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146438858|NCT00521586|528112886|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
145952728|NCT05052697|526337989|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952729|NCT05052697|526337990|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952730|NCT05052697|526337991|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952731|NCT05052697|526337992|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
146208687|NCT02723955|527280261|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146438859|NCT00521586|528112887|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
146438860|NCT00521586|528112886|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
146438861|NCT00521586|528112887|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
146438862|NCT00521586|528112886|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
146438863|NCT00521586|528112887|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
146438864|NCT02392195|528112897|FG000|Overall Study|Lost to Follow-up|4|||
146438865|NCT02392195|528112897|FG000|Overall Study|Withdrawal by Subject|4|||
146438866|NCT00545792|528112900|FG000|Overall Study|Withdrawal by Subject|1|||
146438867|NCT01642277|528112901|FG000|Overall Study|Adverse Event|10|||
146438868|NCT01642277|528112902|FG001|Overall Study|Adverse Event|0|||
146438869|NCT01642277|528112901|FG000|Overall Study|Physician Decision|2|||
146438870|NCT01642277|528112902|FG001|Overall Study|Physician Decision|0|||
146438871|NCT01642277|528112901|FG000|Overall Study|Protocol Violation|1|||
146438872|NCT01642277|528112902|FG001|Overall Study|Protocol Violation|0|||
146438873|NCT01642277|528112901|FG000|Overall Study|Withdrawal by Subject|11|||
146438874|NCT01642277|528112902|FG001|Overall Study|Withdrawal by Subject|0|||
146438875|NCT03679598|528112903|FG000|Overall Study|Adverse Event|2|||
146438876|NCT03679598|528112904|FG001|Overall Study|Adverse Event|0|||
146438877|NCT03605342|528112905|FG000|Overall Study|Withdrawal by Subject|9|||
146438878|NCT03605342|528112906|FG001|Overall Study|Withdrawal by Subject|7|||
146438879|NCT03605342|528112905|FG000|Overall Study|Lost to Follow-up|1|||
146438880|NCT03605342|528112906|FG001|Overall Study|Lost to Follow-up|1|||
146438881|NCT01403194|528112909|FG000|Overall Study|Screen Failure|2|||
146438882|NCT01403194|528112909|FG000|Overall Study|Lost to Follow-up|8|||
146438883|NCT03428750|528112912|FG000|Overall Study|Withdrawal by Subject|11|||
146438884|NCT03428750|528112913|FG001|Overall Study|Withdrawal by Subject|10|||
146438885|NCT03428750|528112912|FG000|Overall Study|Lost to Follow-up|3|||
146438886|NCT03428750|528112913|FG001|Overall Study|Lost to Follow-up|9|||
146438887|NCT03428750|528112912|FG000|Overall Study|Adverse Event|9|||
146438888|NCT03428750|528112913|FG001|Overall Study|Adverse Event|1|||
146438889|NCT03428750|528112912|FG000|Overall Study|Protocol Violation|1|||
146438890|NCT03428750|528112913|FG001|Overall Study|Protocol Violation|0|||
146438891|NCT03428750|528112912|FG000|Overall Study|Administrative|0|||
146438892|NCT03428750|528112913|FG001|Overall Study|Administrative|1|||
146438893|NCT04474405|528112914|FG000|Overall Study|Withdrawal by Subject|0|||
146438894|NCT04474405|528112915|FG001|Overall Study|Withdrawal by Subject|0|||
146438895|NCT04474405|528112916|FG002|Overall Study|Withdrawal by Subject|1|||
146438896|NCT04474405|528112917|FG003|Overall Study|Withdrawal by Subject|0|||
146438897|NCT04474405|528112918|FG004|Overall Study|Withdrawal by Subject|1|||
146438898|NCT04474405|528112919|FG005|Overall Study|Withdrawal by Subject|0|||
146438899|NCT04474405|528112914|FG000|Overall Study|Other|0|||
146438900|NCT04474405|528112915|FG001|Overall Study|Other|0|||
146438901|NCT04474405|528112916|FG002|Overall Study|Other|0|||
146438902|NCT04474405|528112917|FG003|Overall Study|Other|0|||
146438903|NCT04474405|528112918|FG004|Overall Study|Other|3|||
146438904|NCT04474405|528112919|FG005|Overall Study|Other|0|||
146438905|NCT00918645|528112920|FG000|Overall Study|Withdrawal by Subject|1|||
146438906|NCT05133180|528112921|FG000|Overall Study|Withdrawal of consent|1|||
146438907|NCT05133180|528112922|FG001|Overall Study|Withdrawal of consent|1|||
146438908|NCT05133180|528112921|FG000|Overall Study|Lost to Follow-up|1|||
146438909|NCT05133180|528112922|FG001|Overall Study|Lost to Follow-up|1|||
146438910|NCT05133180|528112921|FG000|Overall Study|Documented disease progression|0|||
146438911|NCT05133180|528112922|FG001|Overall Study|Documented disease progression|1|||
146438912|NCT01604941|528112923|FG000|Overall Study|Adverse Event|1|||
146438913|NCT01604941|528112924|FG001|Overall Study|Adverse Event|2|||
146438914|NCT01604941|528112925|FG002|Overall Study|Adverse Event|0|||
146438915|NCT01604941|528112926|FG003|Overall Study|Adverse Event|0|||
146438916|NCT01604941|528112927|FG004|Overall Study|Adverse Event|1|||
146438917|NCT01604941|528112928|FG005|Overall Study|Adverse Event|5|||
146438918|NCT01604941|528112923|FG000|Overall Study|Non-compliance|1|||
146438919|NCT01604941|528112924|FG001|Overall Study|Non-compliance|0|||
146438920|NCT01604941|528112925|FG002|Overall Study|Non-compliance|0|||
146438921|NCT01604941|528112926|FG003|Overall Study|Non-compliance|0|||
146438922|NCT01604941|528112927|FG004|Overall Study|Non-compliance|0|||
146438923|NCT01604941|528112928|FG005|Overall Study|Non-compliance|0|||
146438924|NCT01604941|528112923|FG000|Overall Study|Participant Decision|0|||
146438925|NCT01604941|528112924|FG001|Overall Study|Participant Decision|0|||
146438926|NCT01604941|528112925|FG002|Overall Study|Participant Decision|0|||
146438927|NCT01604941|528112926|FG003|Overall Study|Participant Decision|0|||
146438928|NCT01604941|528112927|FG004|Overall Study|Participant Decision|0|||
146438929|NCT01604941|528112928|FG005|Overall Study|Participant Decision|2|||
146438930|NCT01604941|528112923|FG000|Overall Study|Early Study Termination|9|||
146438931|NCT01604941|528112924|FG001|Overall Study|Early Study Termination|2|||
146438932|NCT01604941|528112925|FG002|Overall Study|Early Study Termination|3|||
146438933|NCT01604941|528112926|FG003|Overall Study|Early Study Termination|3|||
146438934|NCT01604941|528112927|FG004|Overall Study|Early Study Termination|0|||
146438935|NCT01604941|528112928|FG005|Overall Study|Early Study Termination|0|||
146438936|NCT03366792|528112929|FG000|Overall Study|Withdrawal by Subject|7|||
146438937|NCT03366792|528112929|FG000|Overall Study|Lost to Follow-up|2|||
146438938|NCT03366792|528112929|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
146438939|NCT03366792|528112929|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
146438940|NCT03325881|528112933|FG000|Overall Study|Protocol Violation|0|||
146438941|NCT03325881|528112934|FG001|Overall Study|Protocol Violation|1|||
146438942|NCT03325881|528112933|FG000|Overall Study|Withdrawal by Subject|0|||
146438943|NCT03325881|528112934|FG001|Overall Study|Withdrawal by Subject|2|||
146438944|NCT03325881|528112933|FG000|Overall Study|Lack of Efficacy|2|||
146438945|NCT03325881|528112934|FG001|Overall Study|Lack of Efficacy|0|||
146438946|NCT03325881|528112933|FG000|Overall Study|Not treated|1|||
146438947|NCT03325881|528112934|FG001|Overall Study|Not treated|0|||
146438948|NCT03676634|528112936|FG000|Overall Study|Red blood cell loss|1|||
146438949|NCT03676634|528112936|FG000|Overall Study|Out-of-limit pulse|2|||
146438950|NCT01188681|528112937|FG000|Overall Study|bladder cancer|0|||
146438951|NCT01188681|528112938|FG001|Overall Study|bladder cancer|0|||
146438952|NCT01188681|528112939|FG002|Overall Study|bladder cancer|1|||
146438953|NCT01188681|528112940|FG003|Overall Study|bladder cancer|0|||
146438954|NCT01188681|528112937|FG000|Overall Study|Withdrawal by Subject|0|||
146438955|NCT01188681|528112938|FG001|Overall Study|Withdrawal by Subject|0|||
146438956|NCT01188681|528112939|FG002|Overall Study|Withdrawal by Subject|0|||
146438957|NCT01188681|528112940|FG003|Overall Study|Withdrawal by Subject|1|||
146438958|NCT00216736|528112944|FG000|Overall Study|Lost to Follow-up|1|||
146438959|NCT00216736|528112945|FG001|Overall Study|Lost to Follow-up|1|||
146438960|NCT02622386|528112946|FG000|First Assignment|Withdrawal by Subject|3|||
146438961|NCT02622386|528112947|FG001|First Assignment|Withdrawal by Subject|2|||
146438962|NCT02622386|528112946|FG000|Washout|Withdrawal by Subject|4|||
146438963|NCT02622386|528112947|FG001|Washout|Withdrawal by Subject|4|||
146285438|NCT03538301|527557873|FG002|Overall Study|Physician Decision|0|||
146285439|NCT03538301|527557871|FG000|Overall Study|Protocol Violation|0|||
146438964|NCT02622386|528112946|FG000|Second Assignment|Withdrawal by Subject|0|||
146438965|NCT02622386|528112947|FG001|Second Assignment|Withdrawal by Subject|2|||
146438966|NCT02890992|528112948|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146438967|NCT02890992|528112949|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
146438968|NCT02890992|528112950|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146438969|NCT02890992|528112951|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146438970|NCT02890992|528112952|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146083070|NCT02353143|526824730|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
146438971|NCT02890992|528112953|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146285440|NCT03538301|527557872|FG001|Overall Study|Protocol Violation|0|||
146438972|NCT02890992|528112954|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146438973|NCT02890992|528112955|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
146438974|NCT02890992|528112948|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438975|NCT02890992|528112949|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438976|NCT02890992|528112950|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438977|NCT02890992|528112951|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438978|NCT02890992|528112952|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438979|NCT02890992|528112953|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
146438980|NCT02890992|528112954|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
146438981|NCT02890992|528112955|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
146438982|NCT02890992|528112948|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438983|NCT02890992|528112949|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
146438984|NCT02890992|528112950|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438985|NCT02890992|528112951|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438986|NCT02890992|528112952|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438987|NCT02890992|528112953|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438988|NCT02890992|528112954|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438989|NCT02890992|528112955|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
146438990|NCT03236311|528112956|FG000|Overall Study|Study terminated by sponsor|0|||
146438991|NCT03236311|528112957|FG001|Overall Study|Study terminated by sponsor|2|||
146438992|NCT03236311|528112956|FG000|Overall Study|Adverse Event|0|||
146438993|NCT03236311|528112957|FG001|Overall Study|Adverse Event|1|||
146438994|NCT00918684|528112959|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
146438995|NCT00918684|528112959|FG000|Treatment Phase|Lack of Efficacy|6|||
146438996|NCT00918684|528112959|FG000|Treatment Phase|Lost to Follow-up|2|||
146438997|NCT00918684|528112959|FG000|Treatment Phase|Physician Decision|8|||
146438998|NCT00918684|528112959|FG000|Treatment Phase|Protocol Violation|1|||
146438999|NCT00918684|528112959|FG000|Treatment Phase|Withdrawal by Subject|8|||
146439000|NCT01051349|528112960|FG000|Overall Study|Adverse Event|88|||
146439001|NCT01051349|528112960|FG000|Overall Study|Consent Withdrawn|54|||
146439002|NCT01051349|528112960|FG000|Overall Study|Investigator Decision|6|||
146439003|NCT01051349|528112960|FG000|Overall Study|Lost to Follow-up|6|||
146439004|NCT01051349|528112960|FG000|Overall Study|Subject non-compliance|7|||
146439005|NCT01051349|528112960|FG000|Overall Study|Reason not Specified|12|||
146439006|NCT00402103|528112961|FG000|Overall Study|Adverse Event|60|||
146439007|NCT00402103|528112962|FG001|Overall Study|Adverse Event|7|||
146439008|NCT00402103|528112961|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146439009|NCT00402103|528112962|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146439010|NCT00402103|528112961|FG000|Overall Study|Condition no longer requires study drug|2|||
146439011|NCT00402103|528112962|FG001|Overall Study|Condition no longer requires study drug|0|||
146439012|NCT00402103|528112961|FG000|Overall Study|Protocol Deviation|8|||
146439013|NCT00402103|528112962|FG001|Overall Study|Protocol Deviation|0|||
146439014|NCT00402103|528112961|FG000|Overall Study|Patient withdrew consent|12|||
146439015|NCT00402103|528112962|FG001|Overall Study|Patient withdrew consent|1|||
146439016|NCT00402103|528112961|FG000|Overall Study|Lost to Follow-up|6|||
146439017|NCT00402103|528112962|FG001|Overall Study|Lost to Follow-up|3|||
146439018|NCT00402103|528112961|FG000|Overall Study|Administrative problems|2|||
146439019|NCT00402103|528112962|FG001|Overall Study|Administrative problems|0|||
146439020|NCT00484679|528112963|FG000|Overall Study|Withdrawal by Subject|3|||
146439021|NCT00841542|528112964|FG000|Period 1|Adverse Event|1|||
146439022|NCT00841542|528112965|FG001|Period 1|Adverse Event|0|||
146439023|NCT00418145|528112966|FG000|Overall Study|study terminated|6|||
146439024|NCT02462837|528112967|FG000|Overall Study|pt developed hives|1|||
146439025|NCT02462837|528112968|FG001|Overall Study|pt developed hives|0|||
146439026|NCT02462837|528112967|FG000|Overall Study|Withdrawal by Subject|1|||
146208688|NCT02723955|527280262|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208689|NCT02723955|527280263|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208690|NCT02723955|527280264|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208691|NCT02723955|527280265|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208692|NCT02723955|527280266|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146439027|NCT02462837|528112968|FG001|Overall Study|Withdrawal by Subject|0|||
146439028|NCT01075282|528112972|FG000|Overall Study|Withdrawal by Subject|11|||
146439029|NCT01075282|528112973|FG001|Overall Study|Withdrawal by Subject|7|||
146439030|NCT01075282|528112974|FG002|Overall Study|Withdrawal by Subject|11|||
146439031|NCT01075282|528112972|FG000|Overall Study|Adverse Event|9|||
146439032|NCT01075282|528112973|FG001|Overall Study|Adverse Event|8|||
146439033|NCT01075282|528112974|FG002|Overall Study|Adverse Event|5|||
146439034|NCT01075282|528112972|FG000|Overall Study|Entry Criteria Not Met|3|||
146439035|NCT01075282|528112973|FG001|Overall Study|Entry Criteria Not Met|2|||
146439036|NCT01075282|528112974|FG002|Overall Study|Entry Criteria Not Met|0|||
146439037|NCT01075282|528112972|FG000|Overall Study|Lost to Follow-up|3|||
146439038|NCT01075282|528112973|FG001|Overall Study|Lost to Follow-up|3|||
146439039|NCT01075282|528112974|FG002|Overall Study|Lost to Follow-up|3|||
146208693|NCT02723955|527280267|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208694|NCT02723955|527280268|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208695|NCT02723955|527280269|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208696|NCT02723955|527280270|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208697|NCT02723955|527280271|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208698|NCT02723955|527280272|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208699|NCT02723955|527280273|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208700|NCT02723955|527280274|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208701|NCT02723955|527280275|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208702|NCT02723955|527280276|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208703|NCT02723955|527280277|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208704|NCT02723955|527280278|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208705|NCT02723955|527280279|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208706|NCT02723955|527280280|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208707|NCT02723955|527280281|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146439040|NCT01075282|528112972|FG000|Overall Study|Physician Decision|3|||
146439041|NCT01075282|528112973|FG001|Overall Study|Physician Decision|3|||
146439042|NCT01075282|528112974|FG002|Overall Study|Physician Decision|3|||
146439043|NCT01075282|528112972|FG000|Overall Study|Lack of Efficacy|1|||
146439044|NCT01075282|528112973|FG001|Overall Study|Lack of Efficacy|1|||
146439045|NCT01075282|528112974|FG002|Overall Study|Lack of Efficacy|0|||
146439046|NCT01075282|528112972|FG000|Overall Study|Treatment Non-compliance|1|||
146439047|NCT01075282|528112973|FG001|Overall Study|Treatment Non-compliance|2|||
146439048|NCT01075282|528112974|FG002|Overall Study|Treatment Non-compliance|2|||
146439049|NCT01075282|528112972|FG000|Overall Study|Protocol Violation|0|||
146439050|NCT01075282|528112973|FG001|Overall Study|Protocol Violation|2|||
146439051|NCT01075282|528112974|FG002|Overall Study|Protocol Violation|1|||
146439052|NCT01075282|528112972|FG000|Overall Study|Death|0|||
146439053|NCT01075282|528112973|FG001|Overall Study|Death|1|||
146439054|NCT01075282|528112974|FG002|Overall Study|Death|2|||
146439055|NCT02679729|528112975|FG000|Overall Study|Lost to Follow-up|0|||
146439056|NCT02679729|528112976|FG001|Overall Study|Lost to Follow-up|1|||
146439057|NCT02679729|528112977|FG002|Overall Study|Lost to Follow-up|0|||
146439058|NCT02679729|528112978|FG003|Overall Study|Lost to Follow-up|0|||
146439059|NCT02679729|528112979|FG004|Overall Study|Lost to Follow-up|1|||
146439060|NCT02679729|528112980|FG005|Overall Study|Lost to Follow-up|0|||
146208708|NCT02723955|527280282|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208709|NCT02723955|527280283|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208710|NCT02723955|527280284|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208711|NCT02723955|527280285|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146439061|NCT02679729|528112981|FG006|Overall Study|Lost to Follow-up|0|||
146439062|NCT02679729|528112982|FG007|Overall Study|Lost to Follow-up|0|||
146439063|NCT02679729|528112983|FG008|Overall Study|Lost to Follow-up|0|||
146439064|NCT02679729|528112975|FG000|Overall Study|Participant decision|0|||
146439065|NCT02679729|528112976|FG001|Overall Study|Participant decision|1|||
146439066|NCT02679729|528112977|FG002|Overall Study|Participant decision|0|||
146439067|NCT02679729|528112978|FG003|Overall Study|Participant decision|0|||
146083071|NCT02353143|526824731|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
146439068|NCT02679729|528112979|FG004|Overall Study|Participant decision|0|||
146439069|NCT02679729|528112980|FG005|Overall Study|Participant decision|0|||
146439070|NCT02679729|528112981|FG006|Overall Study|Participant decision|1|||
146439071|NCT02679729|528112982|FG007|Overall Study|Participant decision|0|||
146439072|NCT02679729|528112983|FG008|Overall Study|Participant decision|0|||
146439073|NCT00906399|528113001|FG000|Year 1|Randomized But Not Treated|0|||
146439074|NCT00906399|528113002|FG001|Year 1|Randomized But Not Treated|1|||
146439075|NCT00906399|528113003|FG002|Year 1|Randomized But Not Treated|3|||
146439076|NCT00906399|528113004|FG003|Year 1|Randomized But Not Treated|0|||
146439077|NCT00906399|528113005|FG004|Year 1|Randomized But Not Treated|0|||
146439078|NCT00906399|528113006|FG005|Year 1|Randomized But Not Treated|0|||
146439079|NCT00906399|528113007|FG006|Year 1|Randomized But Not Treated|0|||
146439080|NCT00906399|528113001|FG000|Year 1|Adverse Event|4|||
146439081|NCT00906399|528113002|FG001|Year 1|Adverse Event|22|||
146439082|NCT00906399|528113003|FG002|Year 1|Adverse Event|24|||
146439083|NCT00906399|528113004|FG003|Year 1|Adverse Event|0|||
146439084|NCT00906399|528113005|FG004|Year 1|Adverse Event|0|||
146439085|NCT00906399|528113006|FG005|Year 1|Adverse Event|0|||
146439086|NCT00906399|528113007|FG006|Year 1|Adverse Event|0|||
146439087|NCT00906399|528113001|FG000|Year 1|Lost to Follow-up|4|||
146439088|NCT00906399|528113002|FG001|Year 1|Lost to Follow-up|4|||
146439089|NCT00906399|528113003|FG002|Year 1|Lost to Follow-up|2|||
146439090|NCT00906399|528113004|FG003|Year 1|Lost to Follow-up|0|||
146439091|NCT00906399|528113005|FG004|Year 1|Lost to Follow-up|0|||
146439092|NCT00906399|528113006|FG005|Year 1|Lost to Follow-up|0|||
146439093|NCT00906399|528113007|FG006|Year 1|Lost to Follow-up|0|||
146439094|NCT00906399|528113001|FG000|Year 1|Withdrawal by Subject|30|||
146439095|NCT00906399|528113002|FG001|Year 1|Withdrawal by Subject|32|||
146439096|NCT00906399|528113003|FG002|Year 1|Withdrawal by Subject|36|||
146439097|NCT00906399|528113004|FG003|Year 1|Withdrawal by Subject|0|||
146439098|NCT00906399|528113005|FG004|Year 1|Withdrawal by Subject|0|||
146439099|NCT00906399|528113006|FG005|Year 1|Withdrawal by Subject|0|||
146439100|NCT00906399|528113007|FG006|Year 1|Withdrawal by Subject|0|||
146439101|NCT00906399|528113001|FG000|Year 1|Physician Decision|0|||
146439102|NCT00906399|528113002|FG001|Year 1|Physician Decision|1|||
146439103|NCT00906399|528113003|FG002|Year 1|Physician Decision|3|||
146439104|NCT00906399|528113004|FG003|Year 1|Physician Decision|0|||
146439105|NCT00906399|528113005|FG004|Year 1|Physician Decision|0|||
146439106|NCT00906399|528113006|FG005|Year 1|Physician Decision|0|||
146439107|NCT00906399|528113007|FG006|Year 1|Physician Decision|0|||
146439108|NCT00906399|528113001|FG000|Year 1|Death|2|||
146439109|NCT00906399|528113002|FG001|Year 1|Death|1|||
146439110|NCT00906399|528113003|FG002|Year 1|Death|1|||
146439111|NCT00906399|528113004|FG003|Year 1|Death|0|||
146439112|NCT00906399|528113005|FG004|Year 1|Death|0|||
146439113|NCT00906399|528113006|FG005|Year 1|Death|0|||
146439114|NCT00906399|528113007|FG006|Year 1|Death|0|||
146439115|NCT00906399|528113001|FG000|Year 1|Other|4|||
146439116|NCT00906399|528113002|FG001|Year 1|Other|2|||
146439117|NCT00906399|528113003|FG002|Year 1|Other|7|||
146439118|NCT00906399|528113004|FG003|Year 1|Other|0|||
146439119|NCT00906399|528113005|FG004|Year 1|Other|0|||
146439120|NCT00906399|528113006|FG005|Year 1|Other|0|||
146439121|NCT00906399|528113007|FG006|Year 1|Other|0|||
146439122|NCT00906399|528113001|FG000|Year 2|Adverse Event|0|||
146439123|NCT00906399|528113002|FG001|Year 2|Adverse Event|0|||
146439124|NCT00906399|528113003|FG002|Year 2|Adverse Event|0|||
146439125|NCT00906399|528113004|FG003|Year 2|Adverse Event|9|||
146439126|NCT00906399|528113005|FG004|Year 2|Adverse Event|8|||
146439127|NCT00906399|528113006|FG005|Year 2|Adverse Event|11|||
146439128|NCT00906399|528113007|FG006|Year 2|Adverse Event|6|||
146439129|NCT00906399|528113001|FG000|Year 2|Lost to Follow-up|0|||
145952732|NCT05052697|526337993|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952733|NCT05052697|526337994|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952734|NCT05052697|526337995|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952735|NCT05052697|526337996|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952736|NCT05052697|526337997|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952737|NCT05052697|526337998|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952738|NCT05052697|526337999|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952739|NCT05052697|526338000|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952740|NCT05052697|526338001|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145952741|NCT05052697|526338002|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952742|NCT05052697|526338003|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952743|NCT05052697|526338004|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952744|NCT05052697|526338005|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952745|NCT05052697|526338006|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952746|NCT05052697|526338007|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952747|NCT05052697|526338008|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952748|NCT05052697|526338009|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145952749|NCT05052697|526338010|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952750|NCT05052697|526338011|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145952751|NCT05052697|526338012|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952752|NCT05052697|526338013|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952753|NCT05052697|526338014|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952754|NCT05052697|526338015|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952755|NCT05052697|526338016|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952756|NCT05052697|526338017|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145952757|NCT05052697|526337984|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952758|NCT05052697|526337985|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952759|NCT05052697|526337986|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146285441|NCT03538301|527557873|FG002|Overall Study|Protocol Violation|1|||
146285442|NCT03538301|527557871|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
146285443|NCT03538301|527557872|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
146285444|NCT03538301|527557873|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
146285445|NCT03616977|527557874|FG000|Period 1|Physician Decision|0|||
146285446|NCT03616977|527557875|FG001|Period 1|Physician Decision|1|||
146285447|NCT03616977|527557874|FG000|Period 3|Adverse Event|1|||
145952760|NCT05052697|526337987|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952761|NCT05052697|526337988|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952762|NCT05052697|526337989|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952763|NCT05052697|526337990|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952764|NCT05052697|526337991|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952765|NCT05052697|526337992|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952766|NCT05052697|526337993|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952767|NCT05052697|526337994|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952768|NCT05052697|526337995|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952769|NCT05052697|526337996|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952770|NCT05052697|526337997|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952771|NCT05052697|526337998|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952772|NCT05052697|526337999|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952773|NCT05052697|526338000|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952774|NCT05052697|526338001|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952775|NCT05052697|526338002|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146083072|NCT02353143|526824732|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
146285448|NCT03616977|527557875|FG001|Period 3|Adverse Event|1|||
146285449|NCT02665338|527557876|FG000|Overall Study|Withdrawal by Subject|0|||
146285450|NCT02665338|527557877|FG001|Overall Study|Withdrawal by Subject|1|||
146439130|NCT00906399|528113002|FG001|Year 2|Lost to Follow-up|0|||
146439131|NCT00906399|528113003|FG002|Year 2|Lost to Follow-up|0|||
146439132|NCT00906399|528113004|FG003|Year 2|Lost to Follow-up|1|||
146439133|NCT00906399|528113005|FG004|Year 2|Lost to Follow-up|4|||
146439134|NCT00906399|528113006|FG005|Year 2|Lost to Follow-up|2|||
146439135|NCT00906399|528113007|FG006|Year 2|Lost to Follow-up|4|||
146439136|NCT00906399|528113001|FG000|Year 2|Withdrawal by Subject|0|||
146439137|NCT00906399|528113002|FG001|Year 2|Withdrawal by Subject|0|||
146439138|NCT00906399|528113003|FG002|Year 2|Withdrawal by Subject|0|||
146208712|NCT02723955|527280286|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208713|NCT02723955|527280287|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
146208714|NCT02723955|527280245|FG000|Escalation Phase|Site Closed|0|||
146208715|NCT02723955|527280246|FG001|Escalation Phase|Site Closed|0|||
146208716|NCT02723955|527280247|FG002|Escalation Phase|Site Closed|0|||
146208717|NCT02723955|527280248|FG003|Escalation Phase|Site Closed|0|||
146208718|NCT02723955|527280249|FG004|Escalation Phase|Site Closed|0|||
146208719|NCT02723955|527280250|FG005|Escalation Phase|Site Closed|0|||
146208720|NCT02723955|527280251|FG006|Escalation Phase|Site Closed|0|||
146208721|NCT02723955|527280252|FG007|Escalation Phase|Site Closed|0|||
146208722|NCT02723955|527280253|FG008|Escalation Phase|Site Closed|0|||
146208723|NCT02723955|527280254|FG009|Escalation Phase|Site Closed|0|||
146208724|NCT02723955|527280255|FG010|Escalation Phase|Site Closed|0|||
146208725|NCT02723955|527280256|FG011|Escalation Phase|Site Closed|0|||
146208726|NCT02723955|527280257|FG012|Escalation Phase|Site Closed|0|||
146208727|NCT02723955|527280258|FG013|Escalation Phase|Site Closed|0|||
146208728|NCT02723955|527280259|FG014|Escalation Phase|Site Closed|0|||
146208729|NCT02723955|527280260|FG015|Escalation Phase|Site Closed|1|||
146439139|NCT00906399|528113004|FG003|Year 2|Withdrawal by Subject|17|||
146439140|NCT00906399|528113005|FG004|Year 2|Withdrawal by Subject|18|||
145952776|NCT05052697|526338003|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
146285451|NCT05326815|527557879|FG000|Overall Study|Withdrawal by Subject|3|||
146285452|NCT05326815|527557879|FG000|Overall Study|Did not complete required labs|6|||
146285453|NCT05326815|527557879|FG000|Overall Study|Screen fail- abnormal labs|5|||
146285454|NCT04617275|527557880|FG000|Treatment Period|Adverse Event|1|||
146285455|NCT04617275|527557881|FG001|Treatment Period|Adverse Event|6|||
146285456|NCT04617275|527557882|FG002|Treatment Period|Adverse Event|4|||
146285457|NCT04617275|527557883|FG003|Treatment Period|Adverse Event|6|||
146285458|NCT04617275|527557884|FG004|Treatment Period|Adverse Event|7|||
146285459|NCT04617275|527557885|FG005|Treatment Period|Adverse Event|8|||
146285460|NCT04617275|527557886|FG006|Treatment Period|Adverse Event|0|||
146285461|NCT04617275|527557887|FG007|Treatment Period|Adverse Event|12|||
146285462|NCT04617275|527557880|FG000|Treatment Period|Lost to Follow-up|0|||
146285463|NCT04617275|527557881|FG001|Treatment Period|Lost to Follow-up|0|||
146285464|NCT04617275|527557882|FG002|Treatment Period|Lost to Follow-up|2|||
146285465|NCT04617275|527557883|FG003|Treatment Period|Lost to Follow-up|0|||
146285466|NCT04617275|527557884|FG004|Treatment Period|Lost to Follow-up|0|||
146285467|NCT04617275|527557885|FG005|Treatment Period|Lost to Follow-up|3|||
146285468|NCT04617275|527557886|FG006|Treatment Period|Lost to Follow-up|0|||
146285469|NCT04617275|527557887|FG007|Treatment Period|Lost to Follow-up|2|||
146285470|NCT04617275|527557880|FG000|Treatment Period|No longer meets eligibility criteria|0|||
146285471|NCT04617275|527557881|FG001|Treatment Period|No longer meets eligibility criteria|0|||
146285472|NCT04617275|527557882|FG002|Treatment Period|No longer meets eligibility criteria|0|||
146285473|NCT04617275|527557883|FG003|Treatment Period|No longer meets eligibility criteria|1|||
146285474|NCT04617275|527557884|FG004|Treatment Period|No longer meets eligibility criteria|0|||
146285475|NCT04617275|527557885|FG005|Treatment Period|No longer meets eligibility criteria|0|||
146285476|NCT04617275|527557886|FG006|Treatment Period|No longer meets eligibility criteria|0|||
146285477|NCT04617275|527557887|FG007|Treatment Period|No longer meets eligibility criteria|0|||
146285478|NCT04617275|527557880|FG000|Treatment Period|Other|0|||
146285479|NCT04617275|527557881|FG001|Treatment Period|Other|1|||
146285480|NCT04617275|527557882|FG002|Treatment Period|Other|0|||
146285481|NCT04617275|527557883|FG003|Treatment Period|Other|0|||
146285482|NCT04617275|527557884|FG004|Treatment Period|Other|0|||
146285483|NCT04617275|527557885|FG005|Treatment Period|Other|0|||
146285484|NCT04617275|527557886|FG006|Treatment Period|Other|0|||
146285485|NCT04617275|527557887|FG007|Treatment Period|Other|0|||
146285486|NCT04617275|527557880|FG000|Treatment Period|Withdrawal by Subject|2|||
146285487|NCT04617275|527557881|FG001|Treatment Period|Withdrawal by Subject|0|||
146285488|NCT04617275|527557882|FG002|Treatment Period|Withdrawal by Subject|0|||
146285489|NCT04617275|527557883|FG003|Treatment Period|Withdrawal by Subject|2|||
146285490|NCT04617275|527557884|FG004|Treatment Period|Withdrawal by Subject|2|||
146285491|NCT04617275|527557885|FG005|Treatment Period|Withdrawal by Subject|0|||
146208730|NCT02723955|527280261|FG016|Escalation Phase|Site Closed|0|||
146208731|NCT02723955|527280262|FG017|Escalation Phase|Site Closed|2|||
146208732|NCT02723955|527280263|FG018|Escalation Phase|Site Closed|0|||
146208733|NCT02723955|527280264|FG019|Escalation Phase|Site Closed|0|||
146208734|NCT02723955|527280265|FG020|Escalation Phase|Site Closed|1|||
146208735|NCT02723955|527280266|FG021|Escalation Phase|Site Closed|0|||
146208736|NCT02723955|527280267|FG022|Escalation Phase|Site Closed|0|||
146208737|NCT02723955|527280268|FG023|Escalation Phase|Site Closed|0|||
146208738|NCT02723955|527280269|FG024|Escalation Phase|Site Closed|3|||
146208739|NCT02723955|527280270|FG025|Escalation Phase|Site Closed|1|||
146208740|NCT02723955|527280271|FG026|Escalation Phase|Site Closed|3|||
146208741|NCT02723955|527280272|FG027|Escalation Phase|Site Closed|1|||
146208742|NCT02723955|527280273|FG028|Escalation Phase|Site Closed|1|||
146208743|NCT02723955|527280274|FG029|Escalation Phase|Site Closed|0|||
146208744|NCT02723955|527280275|FG030|Escalation Phase|Site Closed|0|||
146208745|NCT02723955|527280276|FG031|Escalation Phase|Site Closed|0|||
146208746|NCT02723955|527280277|FG032|Escalation Phase|Site Closed|0|||
146208747|NCT02723955|527280278|FG033|Escalation Phase|Site Closed|0|||
146208748|NCT02723955|527280279|FG034|Escalation Phase|Site Closed|0|||
146208749|NCT02723955|527280280|FG035|Escalation Phase|Site Closed|0|||
146208750|NCT02723955|527280281|FG036|Escalation Phase|Site Closed|0|||
146208751|NCT02723955|527280282|FG037|Escalation Phase|Site Closed|0|||
146208752|NCT02723955|527280283|FG038|Escalation Phase|Site Closed|0|||
146208753|NCT02723955|527280284|FG039|Escalation Phase|Site Closed|0|||
146208754|NCT02723955|527280285|FG040|Escalation Phase|Site Closed|0|||
146208755|NCT02723955|527280286|FG041|Escalation Phase|Site Closed|0|||
146208756|NCT02723955|527280287|FG042|Escalation Phase|Site Closed|0|||
146208757|NCT02723955|527280245|FG000|Expansion Phase|Death|0|||
146208758|NCT02723955|527280246|FG001|Expansion Phase|Death|0|||
146208759|NCT02723955|527280247|FG002|Expansion Phase|Death|0|||
146208760|NCT02723955|527280248|FG003|Expansion Phase|Death|0|||
146208761|NCT02723955|527280249|FG004|Expansion Phase|Death|0|||
146208762|NCT02723955|527280250|FG005|Expansion Phase|Death|0|||
146208763|NCT02723955|527280251|FG006|Expansion Phase|Death|0|||
146208764|NCT02723955|527280252|FG007|Expansion Phase|Death|0|||
146208765|NCT02723955|527280253|FG008|Expansion Phase|Death|0|||
146208766|NCT02723955|527280254|FG009|Expansion Phase|Death|25|||
146208767|NCT02723955|527280255|FG010|Expansion Phase|Death|69|||
146208768|NCT02723955|527280256|FG011|Expansion Phase|Death|48|||
146208769|NCT02723955|527280257|FG012|Expansion Phase|Death|0|||
146208770|NCT02723955|527280258|FG013|Expansion Phase|Death|0|||
146208771|NCT02723955|527280259|FG014|Expansion Phase|Death|0|||
146208772|NCT02723955|527280260|FG015|Expansion Phase|Death|0|||
146208773|NCT02723955|527280261|FG016|Expansion Phase|Death|0|||
146208774|NCT02723955|527280262|FG017|Expansion Phase|Death|0|||
146208775|NCT02723955|527280263|FG018|Expansion Phase|Death|0|||
146208776|NCT02723955|527280264|FG019|Expansion Phase|Death|0|||
146208777|NCT02723955|527280265|FG020|Expansion Phase|Death|0|||
146208778|NCT02723955|527280266|FG021|Expansion Phase|Death|0|||
146208779|NCT02723955|527280267|FG022|Expansion Phase|Death|0|||
146208780|NCT02723955|527280268|FG023|Expansion Phase|Death|0|||
146208781|NCT02723955|527280269|FG024|Expansion Phase|Death|0|||
146208782|NCT02723955|527280270|FG025|Expansion Phase|Death|0|||
146208783|NCT02723955|527280271|FG026|Expansion Phase|Death|0|||
146208784|NCT02723955|527280272|FG027|Expansion Phase|Death|0|||
146208785|NCT02723955|527280273|FG028|Expansion Phase|Death|0|||
146208786|NCT02723955|527280274|FG029|Expansion Phase|Death|12|||
146208787|NCT02723955|527280275|FG030|Expansion Phase|Death|202|||
146208788|NCT02723955|527280276|FG031|Expansion Phase|Death|31|||
146083073|NCT02353143|526824733|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
146208789|NCT02723955|527280277|FG032|Expansion Phase|Death|17|||
146208790|NCT02723955|527280278|FG033|Expansion Phase|Death|2|||
146208791|NCT02723955|527280279|FG034|Expansion Phase|Death|3|||
146083074|NCT01029405|526824734|FG000|Overall Study|Withdrawal by Subject|0|||
146083075|NCT01029405|526824735|FG001|Overall Study|Withdrawal by Subject|1|||
146083076|NCT01029405|526824736|FG002|Overall Study|Withdrawal by Subject|2|||
146083077|NCT01029405|526824737|FG003|Overall Study|Withdrawal by Subject|0|||
146208792|NCT02723955|527280280|FG035|Expansion Phase|Death|3|||
146208793|NCT02723955|527280281|FG036|Expansion Phase|Death|1|||
146083078|NCT01029405|526824734|FG000|Overall Study|Protocol Violation|0|||
146083079|NCT01029405|526824735|FG001|Overall Study|Protocol Violation|0|||
146285492|NCT04617275|527557886|FG006|Treatment Period|Withdrawal by Subject|1|||
146208794|NCT02723955|527280282|FG037|Expansion Phase|Death|0|||
146208795|NCT02723955|527280283|FG038|Expansion Phase|Death|0|||
146208796|NCT02723955|527280284|FG039|Expansion Phase|Death|0|||
146208797|NCT02723955|527280285|FG040|Expansion Phase|Death|0|||
145952777|NCT05052697|526338004|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952778|NCT05052697|526338005|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952779|NCT05052697|526338006|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952780|NCT05052697|526338007|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952781|NCT05052697|526338008|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952782|NCT05052697|526338009|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952783|NCT05052697|526338010|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952784|NCT05052697|526338011|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952785|NCT05052697|526338012|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
145952786|NCT05052697|526338013|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952787|NCT05052697|526338014|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145952788|NCT05052697|526338015|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145952789|NCT05052697|526338016|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145952790|NCT05052697|526338017|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145952791|NCT05052697|526337984|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952792|NCT05052697|526337985|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952793|NCT05052697|526337986|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952794|NCT05052697|526337987|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952795|NCT05052697|526337988|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952796|NCT05052697|526337989|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952797|NCT05052697|526337990|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952798|NCT05052697|526337991|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952799|NCT05052697|526337992|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952800|NCT05052697|526337993|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952801|NCT05052697|526337994|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952802|NCT05052697|526337995|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952803|NCT05052697|526337996|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952804|NCT05052697|526337997|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952805|NCT05052697|526337998|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952806|NCT05052697|526337999|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952807|NCT05052697|526338000|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952808|NCT05052697|526338001|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952809|NCT05052697|526338002|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952810|NCT05052697|526338003|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952811|NCT05052697|526338004|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952812|NCT05052697|526338005|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952813|NCT05052697|526338006|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952814|NCT05052697|526338007|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952815|NCT05052697|526338008|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952816|NCT05052697|526338009|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952817|NCT05052697|526338010|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952818|NCT05052697|526338011|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952819|NCT05052697|526338012|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
145952820|NCT05052697|526338013|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
145952821|NCT05052697|526338014|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
145952822|NCT05052697|526338015|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
145952823|NCT05052697|526338016|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
145952824|NCT05052697|526338017|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145952825|NCT05052697|526337984|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952826|NCT05052697|526337985|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952827|NCT05052697|526337986|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952828|NCT05052697|526337987|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952829|NCT05052697|526337988|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952830|NCT05052697|526337989|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952831|NCT05052697|526337990|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952832|NCT05052697|526337991|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952833|NCT05052697|526337992|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952834|NCT05052697|526337993|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952835|NCT05052697|526337994|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952836|NCT05052697|526337995|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146208798|NCT02723955|527280286|FG041|Expansion Phase|Death|0|||
146208799|NCT02723955|527280287|FG042|Expansion Phase|Death|0|||
146208800|NCT02723955|527280245|FG000|Expansion Phase|Lost to Follow-up|0|||
146208801|NCT02723955|527280246|FG001|Expansion Phase|Lost to Follow-up|0|||
146208802|NCT02723955|527280247|FG002|Expansion Phase|Lost to Follow-up|0|||
145952837|NCT05052697|526337996|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952838|NCT05052697|526337997|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146208803|NCT02723955|527280248|FG003|Expansion Phase|Lost to Follow-up|0|||
146208804|NCT02723955|527280249|FG004|Expansion Phase|Lost to Follow-up|0|||
146439141|NCT00906399|528113006|FG005|Year 2|Withdrawal by Subject|27|||
146439142|NCT00906399|528113007|FG006|Year 2|Withdrawal by Subject|13|||
146439143|NCT00906399|528113001|FG000|Year 2|Physician Decision|0|||
146439144|NCT00906399|528113002|FG001|Year 2|Physician Decision|0|||
146439145|NCT00906399|528113003|FG002|Year 2|Physician Decision|0|||
146439146|NCT00906399|528113004|FG003|Year 2|Physician Decision|0|||
146439147|NCT00906399|528113005|FG004|Year 2|Physician Decision|2|||
146439148|NCT00906399|528113006|FG005|Year 2|Physician Decision|6|||
146439149|NCT00906399|528113007|FG006|Year 2|Physician Decision|3|||
146285493|NCT04617275|527557887|FG007|Treatment Period|Withdrawal by Subject|2|||
146285494|NCT04617275|527557880|FG000|Follow-up Period|Adverse Event|1|||
146285495|NCT04617275|527557881|FG001|Follow-up Period|Adverse Event|1|||
146083080|NCT01029405|526824736|FG002|Overall Study|Protocol Violation|0|||
146285496|NCT04617275|527557882|FG002|Follow-up Period|Adverse Event|2|||
146285497|NCT04617275|527557883|FG003|Follow-up Period|Adverse Event|3|||
146285498|NCT04617275|527557884|FG004|Follow-up Period|Adverse Event|4|||
146285499|NCT04617275|527557885|FG005|Follow-up Period|Adverse Event|3|||
146285500|NCT04617275|527557886|FG006|Follow-up Period|Adverse Event|0|||
146439150|NCT00906399|528113001|FG000|Year 2|Death|0|||
146439151|NCT00906399|528113002|FG001|Year 2|Death|0|||
146439152|NCT00906399|528113003|FG002|Year 2|Death|0|||
146439153|NCT00906399|528113004|FG003|Year 2|Death|1|||
146439154|NCT00906399|528113005|FG004|Year 2|Death|0|||
146439155|NCT00906399|528113006|FG005|Year 2|Death|0|||
146439156|NCT00906399|528113007|FG006|Year 2|Death|3|||
146439157|NCT00906399|528113001|FG000|Year 2|Other|0|||
146439158|NCT00906399|528113002|FG001|Year 2|Other|0|||
146439159|NCT00906399|528113003|FG002|Year 2|Other|0|||
146439160|NCT00906399|528113004|FG003|Year 2|Other|2|||
146439161|NCT00906399|528113005|FG004|Year 2|Other|3|||
146439162|NCT00906399|528113006|FG005|Year 2|Other|1|||
146439163|NCT00906399|528113007|FG006|Year 2|Other|0|||
146439164|NCT00624286|528113008|FG000|Overall Study|Protocol Deviation|7|||
146439165|NCT00624286|528113009|FG001|Overall Study|Protocol Deviation|9|||
146439166|NCT00624286|528113008|FG000|Overall Study|Adverse Event|6|||
146439167|NCT00624286|528113009|FG001|Overall Study|Adverse Event|3|||
146439168|NCT00624286|528113008|FG000|Overall Study|Withdrawal by Subject|5|||
146439169|NCT00624286|528113009|FG001|Overall Study|Withdrawal by Subject|4|||
146439170|NCT00624286|528113008|FG000|Overall Study|Lost to Follow-up|3|||
146439171|NCT00624286|528113009|FG001|Overall Study|Lost to Follow-up|2|||
146439172|NCT00624286|528113008|FG000|Overall Study|Administrative problems|3|||
146439173|NCT00624286|528113009|FG001|Overall Study|Administrative problems|0|||
146439174|NCT00624286|528113008|FG000|Overall Study|Lack of Efficacy|1|||
146439175|NCT00624286|528113009|FG001|Overall Study|Lack of Efficacy|6|||
146439176|NCT00624286|528113008|FG000|Overall Study|Not stated|0|||
146439177|NCT00624286|528113009|FG001|Overall Study|Not stated|1|||
146439178|NCT00624286|528113008|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146439179|NCT00624286|528113009|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146439180|NCT00624286|528113008|FG000|Overall Study|Death|0|||
146439181|NCT00624286|528113009|FG001|Overall Study|Death|1|||
146439182|NCT03488108|528113013|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
146439183|NCT03488108|528113014|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146439184|NCT03488108|528113013|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
146439185|NCT03488108|528113014|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
146439186|NCT00674128|528113021|FG000|Overall Study|Withdrawal by Subject|25|||
146439187|NCT00674128|528113022|FG001|Overall Study|Withdrawal by Subject|23|||
146439188|NCT04631562|528113023|FG000|Overall Study|Withdrawal by Subject|0|||
146439189|NCT04631562|528113024|FG001|Overall Study|Withdrawal by Subject|0|||
146439190|NCT04631562|528113025|FG002|Overall Study|Withdrawal by Subject|0|||
146439191|NCT04631562|528113026|FG003|Overall Study|Withdrawal by Subject|0|||
146439192|NCT04631562|528113027|FG004|Overall Study|Withdrawal by Subject|0|||
146439193|NCT04631562|528113028|FG005|Overall Study|Withdrawal by Subject|0|||
146439194|NCT04631562|528113029|FG006|Overall Study|Withdrawal by Subject|0|||
146439195|NCT04631562|528113030|FG007|Overall Study|Withdrawal by Subject|1|||
146439196|NCT04631562|528113031|FG008|Overall Study|Withdrawal by Subject|0|||
146439197|NCT04631562|528113023|FG000|Overall Study|Other|0|||
146439198|NCT04631562|528113024|FG001|Overall Study|Other|0|||
146439199|NCT04631562|528113025|FG002|Overall Study|Other|0|||
146439200|NCT04631562|528113026|FG003|Overall Study|Other|0|||
146439201|NCT04631562|528113027|FG004|Overall Study|Other|0|||
146439202|NCT04631562|528113028|FG005|Overall Study|Other|0|||
146439203|NCT04631562|528113029|FG006|Overall Study|Other|0|||
146439204|NCT04631562|528113030|FG007|Overall Study|Other|0|||
146439205|NCT04631562|528113031|FG008|Overall Study|Other|1|||
146439206|NCT04631562|528113023|FG000|Overall Study|Lost to Follow-up|0|||
146439207|NCT04631562|528113024|FG001|Overall Study|Lost to Follow-up|0|||
146439208|NCT04631562|528113025|FG002|Overall Study|Lost to Follow-up|0|||
146439209|NCT04631562|528113026|FG003|Overall Study|Lost to Follow-up|1|||
146439210|NCT04631562|528113027|FG004|Overall Study|Lost to Follow-up|0|||
146439211|NCT04631562|528113028|FG005|Overall Study|Lost to Follow-up|0|||
146439212|NCT04631562|528113029|FG006|Overall Study|Lost to Follow-up|0|||
146439213|NCT04631562|528113030|FG007|Overall Study|Lost to Follow-up|0|||
146439214|NCT04631562|528113031|FG008|Overall Study|Lost to Follow-up|0|||
146439215|NCT04631562|528113023|FG000|Overall Study|Adverse Event|0|||
146439216|NCT04631562|528113024|FG001|Overall Study|Adverse Event|0|||
146439217|NCT04631562|528113025|FG002|Overall Study|Adverse Event|0|||
146439218|NCT04631562|528113026|FG003|Overall Study|Adverse Event|0|||
146439219|NCT04631562|528113027|FG004|Overall Study|Adverse Event|0|||
146439220|NCT04631562|528113028|FG005|Overall Study|Adverse Event|0|||
146439221|NCT04631562|528113029|FG006|Overall Study|Adverse Event|1|||
146439222|NCT04631562|528113030|FG007|Overall Study|Adverse Event|0|||
146083081|NCT01029405|526824737|FG003|Overall Study|Protocol Violation|1|||
146083082|NCT01029405|526824734|FG000|Overall Study|Adverse Event|0|||
146083083|NCT01029405|526824735|FG001|Overall Study|Adverse Event|0|||
146083084|NCT01029405|526824736|FG002|Overall Study|Adverse Event|1|||
145952839|NCT05052697|526337998|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952840|NCT05052697|526337999|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952841|NCT05052697|526338000|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952842|NCT05052697|526338001|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952843|NCT05052697|526338002|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952844|NCT05052697|526338003|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952845|NCT05052697|526338004|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952846|NCT05052697|526338005|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952847|NCT05052697|526338006|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
146208805|NCT02723955|527280250|FG005|Expansion Phase|Lost to Follow-up|0|||
146208806|NCT02723955|527280251|FG006|Expansion Phase|Lost to Follow-up|0|||
146208807|NCT02723955|527280252|FG007|Expansion Phase|Lost to Follow-up|0|||
146208808|NCT02723955|527280253|FG008|Expansion Phase|Lost to Follow-up|0|||
145952848|NCT05052697|526338007|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952849|NCT05052697|526338008|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952850|NCT05052697|526338009|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952851|NCT05052697|526338010|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952852|NCT05052697|526338011|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952853|NCT05052697|526338012|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952854|NCT05052697|526338013|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952855|NCT05052697|526338014|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952856|NCT05052697|526338015|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952857|NCT05052697|526338016|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
145952858|NCT05052697|526338017|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145952859|NCT05052697|526337984|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952860|NCT05052697|526337985|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952861|NCT05052697|526337986|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952862|NCT05052697|526337987|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952863|NCT05052697|526337988|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952864|NCT05052697|526337989|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952865|NCT05052697|526337990|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952866|NCT05052697|526337991|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952867|NCT05052697|526337992|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952868|NCT05052697|526337993|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952869|NCT05052697|526337994|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952870|NCT05052697|526337995|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952871|NCT05052697|526337996|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952872|NCT05052697|526337997|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952873|NCT05052697|526337998|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952874|NCT05052697|526337999|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952875|NCT05052697|526338000|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952876|NCT05052697|526338001|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952877|NCT05052697|526338002|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952878|NCT05052697|526338003|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952879|NCT05052697|526338004|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952880|NCT05052697|526338005|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952881|NCT05052697|526338006|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952882|NCT05052697|526338007|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952883|NCT05052697|526338008|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952884|NCT05052697|526338009|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952885|NCT05052697|526338010|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952886|NCT05052697|526338011|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952887|NCT05052697|526338012|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
145952888|NCT05052697|526338013|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
145952889|NCT05052697|526338014|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
145952890|NCT05052697|526338015|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952891|NCT05052697|526338016|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
146208809|NCT02723955|527280254|FG009|Expansion Phase|Lost to Follow-up|0|||
146208810|NCT02723955|527280255|FG010|Expansion Phase|Lost to Follow-up|4|||
146208811|NCT02723955|527280256|FG011|Expansion Phase|Lost to Follow-up|1|||
146208812|NCT02723955|527280257|FG012|Expansion Phase|Lost to Follow-up|0|||
146208813|NCT02723955|527280258|FG013|Expansion Phase|Lost to Follow-up|0|||
146208814|NCT02723955|527280259|FG014|Expansion Phase|Lost to Follow-up|0|||
145952892|NCT05052697|526338017|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145952893|NCT00248833|526338020|FG000|Overall Study|Adverse Event|2|||
145952894|NCT00248833|526338021|FG001|Overall Study|Adverse Event|0|||
145952895|NCT00248833|526338022|FG002|Overall Study|Adverse Event|0|||
146208815|NCT02723955|527280260|FG015|Expansion Phase|Lost to Follow-up|0|||
146439223|NCT04631562|528113031|FG008|Overall Study|Adverse Event|0|||
145952896|NCT00248833|526338020|FG000|Overall Study|Withdrawal by Subject|0|||
146208816|NCT02723955|527280261|FG016|Expansion Phase|Lost to Follow-up|0|||
146208817|NCT02723955|527280262|FG017|Expansion Phase|Lost to Follow-up|0|||
146208818|NCT02723955|527280263|FG018|Expansion Phase|Lost to Follow-up|0|||
146208819|NCT02723955|527280264|FG019|Expansion Phase|Lost to Follow-up|0|||
146208820|NCT02723955|527280265|FG020|Expansion Phase|Lost to Follow-up|0|||
146208821|NCT02723955|527280266|FG021|Expansion Phase|Lost to Follow-up|0|||
146208822|NCT02723955|527280267|FG022|Expansion Phase|Lost to Follow-up|0|||
146208823|NCT02723955|527280268|FG023|Expansion Phase|Lost to Follow-up|0|||
146208824|NCT02723955|527280269|FG024|Expansion Phase|Lost to Follow-up|0|||
146208825|NCT02723955|527280270|FG025|Expansion Phase|Lost to Follow-up|0|||
146208826|NCT02723955|527280271|FG026|Expansion Phase|Lost to Follow-up|0|||
146208827|NCT02723955|527280272|FG027|Expansion Phase|Lost to Follow-up|0|||
146285501|NCT04617275|527557887|FG007|Follow-up Period|Adverse Event|3|||
145952897|NCT00248833|526338021|FG001|Overall Study|Withdrawal by Subject|1|||
145952898|NCT00248833|526338022|FG002|Overall Study|Withdrawal by Subject|1|||
145952899|NCT00248833|526338020|FG000|Overall Study|Lost to Follow-up|1|||
145952900|NCT00248833|526338021|FG001|Overall Study|Lost to Follow-up|1|||
145952901|NCT00248833|526338022|FG002|Overall Study|Lost to Follow-up|1|||
146439224|NCT02615249|528113038|FG000|Overall Study|Withdrawal by Subject|1|||
146439225|NCT00849797|528113044|FG000|First Intervention|bad veins|1|||
146439226|NCT00849797|528113045|FG001|First Intervention|bad veins|0|||
146439227|NCT00849797|528113044|FG000|First Intervention|Adverse Event|0|||
146439228|NCT00849797|528113045|FG001|First Intervention|Adverse Event|1|||
146439229|NCT00849797|528113044|FG000|Washout: One Week|Withdrawal by Subject|0|||
146439230|NCT00849797|528113045|FG001|Washout: One Week|Withdrawal by Subject|2|||
146439231|NCT00679081|528113046|FG000|Overall Study|Lost to Follow-up|1|||
146439232|NCT00725322|528113047|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
146439233|NCT00725322|528113048|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
146439234|NCT00725322|528113047|FG000|Washout (28 Days)|Protocol Violation|0|||
146439235|NCT00725322|528113048|FG001|Washout (28 Days)|Protocol Violation|1|||
146439236|NCT01279486|528113051|FG000|Overall Study|Lost to Follow-up|1|||
146439237|NCT03500094|528113055|FG000|Overall Study|Withdrawal by Subject|1|||
146439238|NCT03500094|528113055|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
146439239|NCT03500094|528113055|FG000|Overall Study|Lost to Follow-up|1|||
146439240|NCT02727192|528114932|FG000|Overall Study|Lost to Follow-up|1|||
146439241|NCT02727192|528114933|FG001|Overall Study|Lost to Follow-up|0|||
146439242|NCT02727192|528114934|FG002|Overall Study|Lost to Follow-up|0|||
146439243|NCT01380782|528114936|FG000|Overall Study|Adverse Event|0|||
146439244|NCT01380782|528114937|FG001|Overall Study|Adverse Event|1|||
146439245|NCT01380782|528114938|FG002|Overall Study|Adverse Event|0|||
146439246|NCT01380782|528114939|FG003|Overall Study|Adverse Event|0|||
146439247|NCT01380782|528114936|FG000|Overall Study|Death|1|||
146439248|NCT01380782|528114937|FG001|Overall Study|Death|0|||
146439249|NCT01380782|528114938|FG002|Overall Study|Death|0|||
146439250|NCT01380782|528114939|FG003|Overall Study|Death|0|||
146439251|NCT01380782|528114936|FG000|Overall Study|Lack of Efficacy|10|||
146439252|NCT01380782|528114937|FG001|Overall Study|Lack of Efficacy|9|||
146439253|NCT01380782|528114938|FG002|Overall Study|Lack of Efficacy|10|||
146439254|NCT01380782|528114939|FG003|Overall Study|Lack of Efficacy|3|||
146439255|NCT01380782|528114936|FG000|Overall Study|Physician Decision|1|||
146439256|NCT01380782|528114937|FG001|Overall Study|Physician Decision|0|||
146439257|NCT01380782|528114938|FG002|Overall Study|Physician Decision|0|||
146439258|NCT01380782|528114939|FG003|Overall Study|Physician Decision|0|||
146439259|NCT01380782|528114936|FG000|Overall Study|Withdrawal by Subject|0|||
146439260|NCT01380782|528114937|FG001|Overall Study|Withdrawal by Subject|0|||
146439261|NCT01380782|528114938|FG002|Overall Study|Withdrawal by Subject|1|||
146439262|NCT01380782|528114939|FG003|Overall Study|Withdrawal by Subject|1|||
146439263|NCT01701063|528114940|FG000|Overall Study|Lost to Follow-up|0|||
146439264|NCT01701063|528114941|FG001|Overall Study|Lost to Follow-up|1|||
146439265|NCT01701063|528114942|FG002|Overall Study|Lost to Follow-up|0|||
146439266|NCT01701063|528114940|FG000|Overall Study|Withdrawal by Subject|0|||
146439267|NCT01701063|528114941|FG001|Overall Study|Withdrawal by Subject|0|||
146439268|NCT01701063|528114942|FG002|Overall Study|Withdrawal by Subject|1|||
146439269|NCT01701063|528114940|FG000|Overall Study|Other|0|||
146439270|NCT01701063|528114941|FG001|Overall Study|Other|0|||
145952902|NCT00248833|526338020|FG000|Overall Study|Other|0|||
145952903|NCT00248833|526338021|FG001|Overall Study|Other|1|||
145952904|NCT00248833|526338022|FG002|Overall Study|Other|0|||
146285502|NCT04617275|527557880|FG000|Follow-up Period|Lost to Follow-up|0|||
146285503|NCT04617275|527557881|FG001|Follow-up Period|Lost to Follow-up|1|||
146285504|NCT04617275|527557882|FG002|Follow-up Period|Lost to Follow-up|2|||
146285505|NCT04617275|527557883|FG003|Follow-up Period|Lost to Follow-up|0|||
146439271|NCT01701063|528114942|FG002|Overall Study|Other|1|||
145952905|NCT01900899|526338023|FG000|Overall Study|Withdrawal by Subject|7|||
146439272|NCT02043132|528114943|FG000|Overall Study|Lost to Follow-up|1|||
146439273|NCT02043132|528114944|FG001|Overall Study|Lost to Follow-up|1|||
146439274|NCT02043132|528114943|FG000|Overall Study|screen failures|4|||
146439275|NCT02043132|528114944|FG001|Overall Study|screen failures|8|||
146439276|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
146439277|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
146439278|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
145952906|NCT01900899|526338024|FG001|Overall Study|Withdrawal by Subject|1|||
146439279|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
146439280|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
146439281|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
146439282|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
146439283|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
146439284|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
146439285|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
146439286|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
146439287|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
146439288|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
146439289|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
146439290|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
146439291|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
146439292|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
146439293|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
146439294|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
146439295|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
146439296|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
146439297|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
146439298|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
146439299|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
146439300|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
146439301|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
146439302|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
146439303|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
146439304|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
146439305|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
146439306|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
146439307|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
146439308|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
146439309|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
146439310|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
146439311|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
146439312|NCT04194801|528114945|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
146439313|NCT04194801|528114946|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
146439314|NCT04194801|528114947|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
146439315|NCT04194801|528114945|FG000|Part Ib/II End of Study|Death|2|||
146439316|NCT04194801|528114946|FG001|Part Ib/II End of Study|Death|3|||
146439317|NCT04194801|528114947|FG002|Part Ib/II End of Study|Death|3|||
146439318|NCT04194801|528114945|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
146208828|NCT02723955|527280273|FG028|Expansion Phase|Lost to Follow-up|0|||
146439319|NCT04194801|528114946|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
146439320|NCT04194801|528114947|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
146439321|NCT04194801|528114945|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
146439322|NCT04194801|528114946|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
146439323|NCT04194801|528114947|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
146439324|NCT04194801|528114945|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
146439325|NCT04194801|528114946|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
146439326|NCT04194801|528114947|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
146439327|NCT04194801|528114945|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
146439328|NCT04194801|528114946|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
146439329|NCT04194801|528114947|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
146439330|NCT00506831|528114948|FG000|Overall Study|Death|1|||
146439331|NCT00506831|528114948|FG000|Overall Study|Withdrawal by Subject|1|||
146439332|NCT01410227|528114952|FG000|Overall Study|Adverse Event|1|||
146439333|NCT01410227|528114953|FG001|Overall Study|Adverse Event|0|||
146439334|NCT01410227|528114954|FG002|Overall Study|Adverse Event|0|||
146439335|NCT01410227|528114955|FG003|Overall Study|Adverse Event|0|||
146439336|NCT01410227|528114952|FG000|Overall Study|Withdrawal by Subject|3|||
146439337|NCT01410227|528114953|FG001|Overall Study|Withdrawal by Subject|0|||
146439338|NCT01410227|528114954|FG002|Overall Study|Withdrawal by Subject|1|||
146439339|NCT01410227|528114955|FG003|Overall Study|Withdrawal by Subject|0|||
146439340|NCT01410227|528114952|FG000|Overall Study|Pregnancy|0|||
146439341|NCT01410227|528114953|FG001|Overall Study|Pregnancy|0|||
146439342|NCT01410227|528114954|FG002|Overall Study|Pregnancy|0|||
146439343|NCT01410227|528114955|FG003|Overall Study|Pregnancy|1|||
146439344|NCT01410227|528114952|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
146439345|NCT01410227|528114953|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
146439346|NCT01410227|528114954|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
146439347|NCT01410227|528114955|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
146208829|NCT02723955|527280274|FG029|Expansion Phase|Lost to Follow-up|1|||
146439348|NCT01808651|528114956|FG000|Study Period 1|Lost to Follow-up|1|||
146439349|NCT01808651|528114957|FG001|Study Period 1|Lost to Follow-up|3|||
146439350|NCT01808651|528114958|FG002|Study Period 1|Lost to Follow-up|0|||
146439351|NCT01808651|528114956|FG000|Study Period 1|Protocol Violation|1|||
146439352|NCT01808651|528114957|FG001|Study Period 1|Protocol Violation|0|||
146439353|NCT01808651|528114958|FG002|Study Period 1|Protocol Violation|1|||
146439354|NCT01808651|528114956|FG000|Study Period 1|Physician Decision|3|||
146439355|NCT01808651|528114957|FG001|Study Period 1|Physician Decision|2|||
146439356|NCT01808651|528114958|FG002|Study Period 1|Physician Decision|0|||
146439357|NCT01808651|528114956|FG000|Study Period 1|Lack of Efficacy|2|||
146439358|NCT01808651|528114957|FG001|Study Period 1|Lack of Efficacy|1|||
146439359|NCT01808651|528114958|FG002|Study Period 1|Lack of Efficacy|0|||
146439360|NCT01808651|528114956|FG000|Study Period 1|Adverse Event|10|||
146439361|NCT01808651|528114957|FG001|Study Period 1|Adverse Event|4|||
146439362|NCT01808651|528114958|FG002|Study Period 1|Adverse Event|1|||
146439363|NCT01808651|528114956|FG000|Study Period 1|Participant Decision|9|||
146439364|NCT01808651|528114957|FG001|Study Period 1|Participant Decision|7|||
146208830|NCT02723955|527280275|FG030|Expansion Phase|Lost to Follow-up|19|||
146208831|NCT02723955|527280276|FG031|Expansion Phase|Lost to Follow-up|2|||
146439365|NCT01808651|528114958|FG002|Study Period 1|Participant Decision|3|||
146439366|NCT00585286|528114961|FG000|Overall Study|Lost to Follow-up|1|||
146439367|NCT00608322|528114963|FG000|Overall Study|Death|2|||
146439368|NCT00608322|528114964|FG001|Overall Study|Death|1|||
146439369|NCT03497130|528114965|FG000|Overall Study|Lost to Follow-up|1|||
146439370|NCT03497130|528114966|FG001|Overall Study|Lost to Follow-up|1|||
146439371|NCT04002648|528114967|FG000|Overall Study|Lost to Follow-up|2|||
146439372|NCT04002648|528114968|FG001|Overall Study|Lost to Follow-up|0|||
146439373|NCT00829712|528114974|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
146439374|NCT00829712|528114975|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146439375|NCT00606281|528114976|FG000|Overall Study|Adverse Event|11|||
146439376|NCT00606281|528114977|FG001|Overall Study|Adverse Event|12|||
146439377|NCT00606281|528114976|FG000|Overall Study|Death|1|||
146439378|NCT00606281|528114977|FG001|Overall Study|Death|0|||
146439379|NCT00606281|528114976|FG000|Overall Study|Lack of Efficacy|28|||
146439380|NCT00606281|528114977|FG001|Overall Study|Lack of Efficacy|35|||
146439381|NCT00606281|528114976|FG000|Overall Study|Physician Decision|0|||
146439382|NCT00606281|528114977|FG001|Overall Study|Physician Decision|1|||
146439383|NCT00606281|528114976|FG000|Overall Study|Protocol Violation|3|||
146439384|NCT00606281|528114977|FG001|Overall Study|Protocol Violation|3|||
146439385|NCT00606281|528114976|FG000|Overall Study|Withdrawal by Subject|11|||
146439386|NCT00606281|528114977|FG001|Overall Study|Withdrawal by Subject|13|||
146439387|NCT00606281|528114976|FG000|Overall Study|Progression to depressive phase|1|||
146439388|NCT00606281|528114977|FG001|Overall Study|Progression to depressive phase|1|||
146439389|NCT00606281|528114976|FG000|Overall Study|Change of residence or other commitments|1|||
146439390|NCT00606281|528114977|FG001|Overall Study|Change of residence or other commitments|1|||
146439391|NCT03131895|528114979|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
146439392|NCT03131895|528114980|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
146439393|NCT03131895|528114981|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
146439394|NCT03131895|528114982|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
146439395|NCT03131895|528114979|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146439396|NCT03131895|528114980|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
146439397|NCT03131895|528114981|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
146439398|NCT03131895|528114982|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
146439399|NCT03131895|528114979|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146439400|NCT03131895|528114980|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
146439401|NCT03131895|528114981|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146439402|NCT03131895|528114982|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
146439403|NCT03131895|528114979|FG000|Washout Period (at Least 5 Days)|Other|0|||
146439404|NCT03131895|528114980|FG001|Washout Period (at Least 5 Days)|Other|0|||
146439405|NCT03131895|528114981|FG002|Washout Period (at Least 5 Days)|Other|2|||
146439406|NCT03131895|528114982|FG003|Washout Period (at Least 5 Days)|Other|0|||
146439407|NCT03131895|528114979|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
146439408|NCT03131895|528114980|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
146439409|NCT03131895|528114981|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
146439410|NCT03131895|528114982|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
146439411|NCT03131895|528114979|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
146439412|NCT03131895|528114980|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
146439413|NCT03131895|528114981|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
146439414|NCT03131895|528114982|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
146439415|NCT02213263|528114987|FG000|Overall Study|Insufficient clinical response|4|||
146439416|NCT02213263|528114988|FG001|Overall Study|Insufficient clinical response|3|||
146439417|NCT02213263|528114987|FG000|Overall Study|Lost to Follow-up|0|||
146439418|NCT02213263|528114988|FG001|Overall Study|Lost to Follow-up|1|||
146439419|NCT02213263|528114987|FG000|Overall Study|No longer willing to participate|3|||
146439420|NCT02213263|528114988|FG001|Overall Study|No longer willing to participate|4|||
145952907|NCT01900899|526338023|FG000|Overall Study|Migrated from study area|2|||
145952908|NCT01900899|526338024|FG001|Overall Study|Migrated from study area|0|||
145952909|NCT02772809|526338027|FG000|Overall Study|not completed some tasks|6|||
145952910|NCT00534105|526338028|FG000|Overall Study|Lost to Follow-up|23|||
145952911|NCT00534105|526338029|FG001|Overall Study|Lost to Follow-up|39|||
145952912|NCT00978341|526338030|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
145952913|NCT00978341|526338031|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
145952914|NCT03035916|526338032|FG000|Overall Study|Puncture failed|0|||
145952915|NCT03035916|526338033|FG001|Overall Study|Puncture failed|2|||
145952916|NCT03035916|526338034|FG002|Overall Study|Puncture failed|0|||
145952917|NCT01451554|526338035|FG000|Overall Study|Withdrawal by Subject|14|||
145952918|NCT01451554|526338036|FG001|Overall Study|Withdrawal by Subject|9|||
145952919|NCT01402986|526338037|FG000|Overall Study|Withdrawal by Subject|7|||
145952920|NCT01402986|526338038|FG001|Overall Study|Withdrawal by Subject|10|||
145952921|NCT01402986|526338039|FG002|Overall Study|Withdrawal by Subject|7|||
145952922|NCT01402986|526338040|FG003|Overall Study|Withdrawal by Subject|13|||
145952923|NCT01402986|526338037|FG000|Overall Study|Death|0|||
145952924|NCT01402986|526338038|FG001|Overall Study|Death|0|||
145952925|NCT01402986|526338039|FG002|Overall Study|Death|0|||
145952926|NCT01402986|526338040|FG003|Overall Study|Death|2|||
145952927|NCT01402986|526338037|FG000|Overall Study|Lost to Follow-up|0|||
145952928|NCT01402986|526338038|FG001|Overall Study|Lost to Follow-up|0|||
145952929|NCT01402986|526338039|FG002|Overall Study|Lost to Follow-up|0|||
145952930|NCT01402986|526338040|FG003|Overall Study|Lost to Follow-up|1|||
145952931|NCT01402986|526338037|FG000|Overall Study|Other|2|||
145952932|NCT01402986|526338038|FG001|Overall Study|Other|5|||
145952933|NCT01402986|526338039|FG002|Overall Study|Other|1|||
145952934|NCT01402986|526338040|FG003|Overall Study|Other|6|||
145952935|NCT02427802|526338041|FG000|Overall Study|Adverse Event|11|||
145952936|NCT02427802|526338042|FG001|Overall Study|Adverse Event|3|||
145952937|NCT02427802|526338043|FG002|Overall Study|Adverse Event|7|||
145952938|NCT02427802|526338041|FG000|Overall Study|Death|0|||
145952939|NCT02427802|526338042|FG001|Overall Study|Death|4|||
145952940|NCT02427802|526338043|FG002|Overall Study|Death|1|||
145952941|NCT02427802|526338041|FG000|Overall Study|Lost to Follow-up|13|||
145952942|NCT02427802|526338042|FG001|Overall Study|Lost to Follow-up|8|||
145952943|NCT02427802|526338043|FG002|Overall Study|Lost to Follow-up|8|||
145952944|NCT02427802|526338041|FG000|Overall Study|Physician Decision|4|||
145952945|NCT02427802|526338042|FG001|Overall Study|Physician Decision|2|||
146439421|NCT02213263|528114987|FG000|Overall Study|Progressive disease|20|||
146439422|NCT02213263|528114988|FG001|Overall Study|Progressive disease|14|||
146439423|NCT02213263|528114987|FG000|Overall Study|Protocol Violation|0|||
146439424|NCT02213263|528114988|FG001|Overall Study|Protocol Violation|1|||
146439425|NCT02213263|528114987|FG000|Overall Study|Adverse Event|1|||
145952946|NCT02427802|526338043|FG002|Overall Study|Physician Decision|4|||
145952947|NCT02427802|526338041|FG000|Overall Study|Withdrawal by Subject|10|||
145952948|NCT02427802|526338042|FG001|Overall Study|Withdrawal by Subject|5|||
145952949|NCT02427802|526338043|FG002|Overall Study|Withdrawal by Subject|11|||
146285506|NCT04617275|527557884|FG004|Follow-up Period|Lost to Follow-up|0|||
146439426|NCT02213263|528114988|FG001|Overall Study|Adverse Event|3|||
145952950|NCT02427802|526338041|FG000|Overall Study|Protocol Violation|3|||
145952951|NCT02427802|526338042|FG001|Overall Study|Protocol Violation|1|||
145952952|NCT02427802|526338043|FG002|Overall Study|Protocol Violation|1|||
145952953|NCT02427802|526338041|FG000|Overall Study|protocol specific treatment unrelated|18|||
145952954|NCT02427802|526338042|FG001|Overall Study|protocol specific treatment unrelated|11|||
145952955|NCT02427802|526338043|FG002|Overall Study|protocol specific treatment unrelated|11|||
146439427|NCT05752721|528114989|FG000|Overall Study|Lost to Follow-up|22|||
145952956|NCT02634983|526338044|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
145952957|NCT02634983|526338045|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
145952958|NCT03178851|526338046|FG000|Overall Study|Death|48|||
145952959|NCT03178851|526338047|FG001|Overall Study|Death|2|||
145952960|NCT03178851|526338048|FG002|Overall Study|Death|25|||
145952961|NCT03178851|526338046|FG000|Overall Study|Withdrawal by Subject|8|||
146439428|NCT05752721|528114990|FG001|Overall Study|Lost to Follow-up|20|||
146439429|NCT05752721|528114989|FG000|Overall Study|Withdrawal by Subject|15|||
146439430|NCT05752721|528114990|FG001|Overall Study|Withdrawal by Subject|12|||
146439431|NCT03158727|528114999|FG000|Overall Study|Withdrawal by Subject|2|||
146439432|NCT03158727|528115000|FG001|Overall Study|Withdrawal by Subject|6|||
146439433|NCT03158727|528114999|FG000|Overall Study|Death|11|||
146439434|NCT03158727|528115000|FG001|Overall Study|Death|12|||
146439435|NCT03158727|528114999|FG000|Overall Study|Lost to Follow-up|1|||
146439436|NCT03158727|528115000|FG001|Overall Study|Lost to Follow-up|0|||
146439437|NCT03158727|528114999|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
146439438|NCT03158727|528115000|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
146439439|NCT03158727|528114999|FG000|Overall Study|Visit 11 not done by mistake|0|||
146439440|NCT03158727|528115000|FG001|Overall Study|Visit 11 not done by mistake|1|||
146439441|NCT03158727|528114999|FG000|Overall Study|Enrolled, not treated|1|||
146439442|NCT03158727|528115000|FG001|Overall Study|Enrolled, not treated|0|||
146439443|NCT00669162|528115001|FG000|Overall Study|Withdrawal by Subject|1|||
146439444|NCT00807495|528115002|FG000|Overall Study|Adverse Event|6|||
146439445|NCT00807495|528115003|FG001|Overall Study|Adverse Event|3|||
146439446|NCT00807495|528115004|FG002|Overall Study|Adverse Event|1|||
146439447|NCT00807495|528115005|FG003|Overall Study|Adverse Event|1|||
146439448|NCT00807495|528115006|FG004|Overall Study|Adverse Event|2|||
146439449|NCT00807495|528115002|FG000|Overall Study|Withdrawal by Patient|2|||
146439450|NCT00807495|528115003|FG001|Overall Study|Withdrawal by Patient|0|||
146439451|NCT00807495|528115004|FG002|Overall Study|Withdrawal by Patient|1|||
146439452|NCT00807495|528115005|FG003|Overall Study|Withdrawal by Patient|0|||
146439453|NCT00807495|528115006|FG004|Overall Study|Withdrawal by Patient|0|||
146439454|NCT00807495|528115002|FG000|Overall Study|Reason Not Specified|0|||
146439455|NCT00807495|528115003|FG001|Overall Study|Reason Not Specified|3|||
146439456|NCT00807495|528115004|FG002|Overall Study|Reason Not Specified|2|||
146439457|NCT00807495|528115005|FG003|Overall Study|Reason Not Specified|0|||
146439458|NCT00807495|528115006|FG004|Overall Study|Reason Not Specified|3|||
146439459|NCT00985439|528115007|FG000|Overall Study|Adverse Event|0|||
146439460|NCT00985439|528115008|FG001|Overall Study|Adverse Event|0|||
146439461|NCT00985439|528115009|FG002|Overall Study|Adverse Event|1|||
146439462|NCT00985439|528115010|FG003|Overall Study|Adverse Event|0|||
146439463|NCT00463684|528115015|FG000|Overall Study|Withdrawal by Subject|1|||
146439464|NCT00463684|528115015|FG000|Overall Study|Lost to Follow-up|3|||
146439465|NCT01906372|528115016|FG000|Overall Study|Withdrawal by Subject|2|||
146439466|NCT00924638|528115018|FG000|Overall Study|Death|3|||
146439467|NCT00924638|528115019|FG001|Overall Study|Death|2|||
146439468|NCT00924638|528115018|FG000|Overall Study|Lost to Follow-up|1|||
146439469|NCT00924638|528115019|FG001|Overall Study|Lost to Follow-up|1|||
146439470|NCT00924638|528115018|FG000|Overall Study|Withdrawal by Subject|5|||
146439471|NCT00924638|528115019|FG001|Overall Study|Withdrawal by Subject|7|||
146439472|NCT00924638|528115018|FG000|Overall Study|Physician Decision|3|||
146439473|NCT00924638|528115019|FG001|Overall Study|Physician Decision|3|||
146439474|NCT00367133|528115020|FG000|2 Years|Death|20|||
146439475|NCT00367133|528115021|FG001|2 Years|Death|12|||
146439476|NCT00367133|528115022|FG002|2 Years|Death|12|||
146439477|NCT00367133|528115020|FG000|2 Years|Dropped|34|||
146439478|NCT00367133|528115021|FG001|2 Years|Dropped|19|||
146439479|NCT00367133|528115022|FG002|2 Years|Dropped|33|||
146439480|NCT00367133|528115020|FG000|2 Years|Missed visit|4|||
146208832|NCT02723955|527280277|FG032|Expansion Phase|Lost to Follow-up|1|||
146208833|NCT02723955|527280278|FG033|Expansion Phase|Lost to Follow-up|0|||
146439481|NCT00367133|528115021|FG001|2 Years|Missed visit|5|||
146439482|NCT00367133|528115022|FG002|2 Years|Missed visit|4|||
146439483|NCT00847535|528115028|FG000|Overall Study|Withdrawal by Subject|2|||
146439484|NCT00847535|528115029|FG001|Overall Study|Withdrawal by Subject|1|||
146439485|NCT00847535|528115030|FG002|Overall Study|Withdrawal by Subject|1|||
146439486|NCT00847535|528115028|FG000|Overall Study|Lost to Follow-up|0|||
146439487|NCT00847535|528115029|FG001|Overall Study|Lost to Follow-up|1|||
146439488|NCT00847535|528115030|FG002|Overall Study|Lost to Follow-up|0|||
146439489|NCT01252953|528115031|FG000|Overall Study|Withdrawal by Subject|16|||
146439490|NCT01252953|528115032|FG001|Overall Study|Withdrawal by Subject|17|||
146439491|NCT01252953|528115031|FG000|Overall Study|Lost to Follow-up|22|||
146208834|NCT02723955|527280279|FG034|Expansion Phase|Lost to Follow-up|0|||
146439492|NCT01252953|528115032|FG001|Overall Study|Lost to Follow-up|21|||
146439493|NCT02336074|528115033|FG000|Overall Study|Adverse Event|0|||
146439494|NCT02336074|528115034|FG001|Overall Study|Adverse Event|2|||
146439495|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Refused|1|||
146439496|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Refused|3|||
146208835|NCT02723955|527280280|FG035|Expansion Phase|Lost to Follow-up|0|||
146208836|NCT02723955|527280281|FG036|Expansion Phase|Lost to Follow-up|0|||
146439497|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Medical|0|||
146439498|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Medical|1|||
146439499|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
146439500|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
146439501|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
146439502|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
146439503|NCT02054715|528115037|FG000|Baseline/Follow-up 1|No Reason|0|||
146439504|NCT02054715|528115038|FG001|Baseline/Follow-up 1|No Reason|1|||
146208837|NCT02723955|527280282|FG037|Expansion Phase|Lost to Follow-up|0|||
146208838|NCT02723955|527280283|FG038|Expansion Phase|Lost to Follow-up|0|||
146208839|NCT02723955|527280284|FG039|Expansion Phase|Lost to Follow-up|0|||
146208840|NCT02723955|527280285|FG040|Expansion Phase|Lost to Follow-up|0|||
146208841|NCT02723955|527280286|FG041|Expansion Phase|Lost to Follow-up|0|||
146208842|NCT02723955|527280287|FG042|Expansion Phase|Lost to Follow-up|0|||
146208843|NCT02723955|527280245|FG000|Expansion Phase|Physician Decision|0|||
146208844|NCT02723955|527280246|FG001|Expansion Phase|Physician Decision|0|||
146208845|NCT02723955|527280247|FG002|Expansion Phase|Physician Decision|0|||
146208846|NCT02723955|527280248|FG003|Expansion Phase|Physician Decision|0|||
146208847|NCT02723955|527280249|FG004|Expansion Phase|Physician Decision|0|||
146439505|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
146439506|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
146439507|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Ineligible|3|||
146439508|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Ineligible|0|||
146439509|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Hospitalization|1|||
146439510|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Hospitalization|0|||
146439511|NCT02054715|528115037|FG000|Baseline/Follow-up 1|Changed Mind|1|||
146439512|NCT02054715|528115038|FG001|Baseline/Follow-up 1|Changed Mind|0|||
146439513|NCT02054715|528115037|FG000|Follow-up 2|Lost to Followup|3|||
146439514|NCT02054715|528115038|FG001|Follow-up 2|Lost to Followup|1|||
146439515|NCT02054715|528115037|FG000|Follow-up 2|Refused|3|||
146439516|NCT02054715|528115038|FG001|Follow-up 2|Refused|2|||
146439517|NCT02054715|528115037|FG000|Follow-up 2|Followup Not Completed|3|||
146439518|NCT02054715|528115038|FG001|Follow-up 2|Followup Not Completed|4|||
146439519|NCT02054715|528115037|FG000|Follow-up 2|Ineligible|4|||
146439520|NCT02054715|528115038|FG001|Follow-up 2|Ineligible|5|||
146439521|NCT02054715|528115037|FG000|Follow-up 2|Death|3|||
146439522|NCT02054715|528115038|FG001|Follow-up 2|Death|3|||
146439523|NCT02054715|528115037|FG000|Follow-up 2|Hospitalization|0|||
146439524|NCT02054715|528115038|FG001|Follow-up 2|Hospitalization|2|||
146439525|NCT02054715|528115037|FG000|Follow-up 2|Changed MD/Facility|0|||
146439526|NCT02054715|528115038|FG001|Follow-up 2|Changed MD/Facility|1|||
146439527|NCT02054715|528115037|FG000|Follow-up 2|Changed Mind|0|||
146439528|NCT02054715|528115038|FG001|Follow-up 2|Changed Mind|1|||
146439529|NCT02054715|528115037|FG000|Follow-up 2|No Reason|2|||
146439530|NCT02054715|528115038|FG001|Follow-up 2|No Reason|0|||
146439531|NCT02054715|528115037|FG000|Follow-up 2|Treatment Change or Delay|1|||
146439532|NCT02054715|528115038|FG001|Follow-up 2|Treatment Change or Delay|0|||
146439533|NCT00858780|528115039|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
146439534|NCT00858780|528115040|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
146439535|NCT00858780|528115041|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
146439536|NCT00858780|528115042|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
146439537|NCT00858780|528115043|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
146439538|NCT00858780|528115039|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
146439539|NCT00858780|528115040|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
146439540|NCT00858780|528115041|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
146439541|NCT00858780|528115042|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
146439542|NCT00858780|528115043|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
146439543|NCT00858780|528115039|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
146439544|NCT00858780|528115040|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
146439545|NCT00858780|528115041|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
146439546|NCT00858780|528115042|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
146439547|NCT00858780|528115043|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
146439548|NCT00858780|528115039|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
146439549|NCT00858780|528115040|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
146439550|NCT00858780|528115041|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
146439551|NCT00858780|528115042|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
146439552|NCT00858780|528115043|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
146439553|NCT00858780|528115039|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
146439554|NCT00858780|528115040|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
146439555|NCT00858780|528115041|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
146439556|NCT00858780|528115042|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
146439557|NCT00858780|528115043|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
146439558|NCT00858780|528115039|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
146439559|NCT00858780|528115040|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
146439560|NCT00858780|528115041|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
146439561|NCT00858780|528115042|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
146439562|NCT00858780|528115043|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
146439563|NCT05098743|528115047|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
146439564|NCT05098743|528115048|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
146439565|NCT05098743|528115047|FG000|Overall Study|Lost to Follow-up|1|||
146439566|NCT05098743|528115048|FG001|Overall Study|Lost to Follow-up|2|||
146439567|NCT01456221|528115049|FG000|Overall Study|Withdrawal by Subject|56|||
146439568|NCT01456221|528115050|FG001|Overall Study|Withdrawal by Subject|49|||
146439569|NCT01456221|528115049|FG000|Overall Study|Lost to Follow-up|1|||
146439570|NCT01456221|528115050|FG001|Overall Study|Lost to Follow-up|4|||
146439571|NCT01456221|528115049|FG000|Overall Study|Received medication|3|||
146439572|NCT01456221|528115050|FG001|Overall Study|Received medication|2|||
146439573|NCT01456221|528115049|FG000|Overall Study|Incomplete data|4|||
146439574|NCT01456221|528115050|FG001|Overall Study|Incomplete data|2|||
146439575|NCT04025021|528115051|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
146439576|NCT04025021|528115052|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
146439577|NCT03498560|528115053|FG000|Overall Study|Found Ineligible|2|||
146439578|NCT03498560|528115053|FG000|Overall Study|Withdrawal by Subject|14|||
146439579|NCT03498560|528115053|FG000|Overall Study|Lost to Follow-up|4|||
146439580|NCT03498560|528115053|FG000|Overall Study|Death|1|||
146439581|NCT00867360|528115058|FG000|Overall Study|Withdrawal by Subject|1|||
146439582|NCT00867360|528115059|FG001|Overall Study|Withdrawal by Subject|0|||
146439583|NCT00867360|528115058|FG000|Overall Study|Physician Decision|0|||
146439584|NCT00867360|528115059|FG001|Overall Study|Physician Decision|1|||
146439585|NCT01004510|528115060|FG000|Overall Study|Adverse Event|1|||
146439586|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
146439587|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
146439588|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
146439589|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
146439590|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
146439591|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439592|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439593|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439594|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439595|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439596|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439597|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439598|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439599|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439600|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439601|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439602|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439603|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439604|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439605|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439606|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439607|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439608|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439609|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439610|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439611|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
146439612|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439613|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
146439614|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439615|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439616|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439617|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439618|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439619|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439620|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439621|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439622|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439623|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439624|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439625|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439626|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439627|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146208848|NCT02723955|527280250|FG005|Expansion Phase|Physician Decision|0|||
146208849|NCT02723955|527280251|FG006|Expansion Phase|Physician Decision|0|||
146208850|NCT02723955|527280252|FG007|Expansion Phase|Physician Decision|0|||
146208851|NCT02723955|527280253|FG008|Expansion Phase|Physician Decision|0|||
146208852|NCT02723955|527280254|FG009|Expansion Phase|Physician Decision|0|||
146439628|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439629|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439630|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439631|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439632|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439633|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439634|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439635|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439636|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439637|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
146439638|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439639|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
146439640|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439641|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439642|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439643|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439644|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439645|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439646|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439647|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439648|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439649|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439650|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439651|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439652|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439653|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439654|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439655|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439656|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439657|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439658|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439659|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439660|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439661|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439662|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439663|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
146439664|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
146439665|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439666|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
146439667|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
146439668|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
146439669|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439670|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439671|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439672|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439673|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439674|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439675|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439676|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439677|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439678|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439679|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439680|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146083085|NCT01029405|526824737|FG003|Overall Study|Adverse Event|1|||
146439681|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439682|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439683|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439684|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439685|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439686|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439687|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439688|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439689|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
146439690|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
146439691|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
146439692|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
146439693|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
146439694|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
146439695|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439696|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439697|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439698|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439699|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439700|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439701|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439702|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439703|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439704|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439705|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439706|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439707|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439708|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439709|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439710|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439711|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439712|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439713|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439714|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439715|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
146439716|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|moved|0|||
146439717|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|moved|1|||
146439718|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|moved|1|||
146439719|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|moved|0|||
146439720|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|moved|0|||
146439721|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|moved|0|||
146439722|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|moved|0|||
145952962|NCT03178851|526338047|FG001|Overall Study|Withdrawal by Subject|0|||
145952963|NCT03178851|526338048|FG002|Overall Study|Withdrawal by Subject|0|||
145952964|NCT03178851|526338046|FG000|Overall Study|Lost to Follow-up|5|||
145952965|NCT03178851|526338047|FG001|Overall Study|Lost to Follow-up|2|||
145952966|NCT03178851|526338048|FG002|Overall Study|Lost to Follow-up|0|||
145952967|NCT03178851|526338046|FG000|Overall Study|Adverse Event|0|||
145952968|NCT03178851|526338047|FG001|Overall Study|Adverse Event|0|||
145952969|NCT03178851|526338048|FG002|Overall Study|Adverse Event|1|||
146208853|NCT02723955|527280255|FG010|Expansion Phase|Physician Decision|0|||
146208854|NCT02723955|527280256|FG011|Expansion Phase|Physician Decision|0|||
146208855|NCT02723955|527280257|FG012|Expansion Phase|Physician Decision|0|||
146208856|NCT02723955|527280258|FG013|Expansion Phase|Physician Decision|0|||
146208857|NCT02723955|527280259|FG014|Expansion Phase|Physician Decision|0|||
146208858|NCT02723955|527280260|FG015|Expansion Phase|Physician Decision|0|||
146208859|NCT02723955|527280261|FG016|Expansion Phase|Physician Decision|0|||
146208860|NCT02723955|527280262|FG017|Expansion Phase|Physician Decision|0|||
146208861|NCT02723955|527280263|FG018|Expansion Phase|Physician Decision|0|||
145952970|NCT03178851|526338046|FG000|Overall Study|Study Termination by Sponsor|31|||
145952971|NCT03178851|526338047|FG001|Overall Study|Study Termination by Sponsor|7|||
145952972|NCT03178851|526338048|FG002|Overall Study|Study Termination by Sponsor|26|||
145952973|NCT02226120|526338049|FG000|Overall Study|Adverse Event|60|||
145952974|NCT02226120|526338049|FG000|Overall Study|Death|172|||
145952975|NCT02226120|526338049|FG000|Overall Study|Study terminated by sponsor|1|||
145952976|NCT02226120|526338049|FG000|Overall Study|Technical problems|4|||
145952977|NCT02226120|526338049|FG000|Overall Study|Lost to Follow-up|13|||
145952978|NCT02226120|526338049|FG000|Overall Study|Physician Decision|21|||
145952979|NCT02226120|526338049|FG000|Overall Study|Withdrawal by parent/guardian|36|||
145952980|NCT02226120|526338049|FG000|Overall Study|Non-compliance with study drug|10|||
145952981|NCT02226120|526338049|FG000|Overall Study|Protocol deviation|1|||
145952982|NCT02226120|526338049|FG000|Overall Study|missing treatment disposition pages|2|||
146208862|NCT02723955|527280264|FG019|Expansion Phase|Physician Decision|0|||
146208863|NCT02723955|527280265|FG020|Expansion Phase|Physician Decision|0|||
146208864|NCT02723955|527280266|FG021|Expansion Phase|Physician Decision|0|||
146208865|NCT02723955|527280267|FG022|Expansion Phase|Physician Decision|0|||
146208866|NCT02723955|527280268|FG023|Expansion Phase|Physician Decision|0|||
146208867|NCT02723955|527280269|FG024|Expansion Phase|Physician Decision|0|||
146208868|NCT02723955|527280270|FG025|Expansion Phase|Physician Decision|0|||
145952983|NCT05188729|526338053|FG000|Overall Study|Withdrawal by Subject|0|||
145952984|NCT05188729|526338054|FG001|Overall Study|Withdrawal by Subject|0|||
145952985|NCT05188729|526338055|FG002|Overall Study|Withdrawal by Subject|0|||
146083086|NCT01029405|526824734|FG000|Overall Study|Lost to Follow-up|2|||
146208869|NCT02723955|527280271|FG026|Expansion Phase|Physician Decision|0|||
146285507|NCT04617275|527557885|FG005|Follow-up Period|Lost to Follow-up|4|||
146439723|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|moved|0|||
146439724|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|moved|0|||
146439725|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|moved|0|||
146439726|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|moved|0|||
146439727|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|moved|0|||
146439728|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|moved|0|||
146439729|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|moved|0|||
146439730|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|moved|0|||
146439731|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|moved|0|||
146439732|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|moved|0|||
146439733|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|moved|0|||
145952986|NCT05188729|526338056|FG003|Overall Study|Withdrawal by Subject|0|||
145952987|NCT05188729|526338057|FG004|Overall Study|Withdrawal by Subject|0|||
145952988|NCT05188729|526338058|FG005|Overall Study|Withdrawal by Subject|0|||
145952989|NCT05188729|526338059|FG006|Overall Study|Withdrawal by Subject|0|||
145952990|NCT05188729|526338060|FG007|Overall Study|Withdrawal by Subject|0|||
145952991|NCT05188729|526338061|FG008|Overall Study|Withdrawal by Subject|0|||
145952992|NCT05188729|526338062|FG009|Overall Study|Withdrawal by Subject|1|||
145952993|NCT05188729|526338063|FG010|Overall Study|Withdrawal by Subject|0|||
145952994|NCT05188729|526338064|FG011|Overall Study|Withdrawal by Subject|0|||
145952995|NCT05188729|526338065|FG012|Overall Study|Withdrawal by Subject|0|||
145952996|NCT05188729|526338053|FG000|Overall Study|Lost to Follow-up|0|||
145952997|NCT05188729|526338054|FG001|Overall Study|Lost to Follow-up|0|||
145952998|NCT05188729|526338055|FG002|Overall Study|Lost to Follow-up|0|||
145952999|NCT05188729|526338056|FG003|Overall Study|Lost to Follow-up|0|||
146208870|NCT02723955|527280272|FG027|Expansion Phase|Physician Decision|0|||
146208871|NCT02723955|527280273|FG028|Expansion Phase|Physician Decision|0|||
146208872|NCT02723955|527280274|FG029|Expansion Phase|Physician Decision|0|||
146208873|NCT02723955|527280275|FG030|Expansion Phase|Physician Decision|1|||
146208874|NCT02723955|527280276|FG031|Expansion Phase|Physician Decision|1|||
146208875|NCT02723955|527280277|FG032|Expansion Phase|Physician Decision|0|||
146208876|NCT02723955|527280278|FG033|Expansion Phase|Physician Decision|0|||
146208877|NCT02723955|527280279|FG034|Expansion Phase|Physician Decision|0|||
146208878|NCT02723955|527280280|FG035|Expansion Phase|Physician Decision|0|||
146208879|NCT02723955|527280281|FG036|Expansion Phase|Physician Decision|0|||
146208880|NCT02723955|527280282|FG037|Expansion Phase|Physician Decision|0|||
146208881|NCT02723955|527280283|FG038|Expansion Phase|Physician Decision|0|||
146208882|NCT02723955|527280284|FG039|Expansion Phase|Physician Decision|0|||
146208883|NCT02723955|527280285|FG040|Expansion Phase|Physician Decision|0|||
146208884|NCT02723955|527280286|FG041|Expansion Phase|Physician Decision|0|||
146208885|NCT02723955|527280287|FG042|Expansion Phase|Physician Decision|0|||
146208886|NCT02723955|527280245|FG000|Expansion Phase|Withdrawal by Subject|0|||
146208887|NCT02723955|527280246|FG001|Expansion Phase|Withdrawal by Subject|0|||
146208888|NCT02723955|527280247|FG002|Expansion Phase|Withdrawal by Subject|0|||
146208889|NCT02723955|527280248|FG003|Expansion Phase|Withdrawal by Subject|0|||
146208890|NCT02723955|527280249|FG004|Expansion Phase|Withdrawal by Subject|0|||
146208891|NCT02723955|527280250|FG005|Expansion Phase|Withdrawal by Subject|0|||
145953000|NCT05188729|526338057|FG004|Overall Study|Lost to Follow-up|0|||
146208892|NCT02723955|527280251|FG006|Expansion Phase|Withdrawal by Subject|0|||
146208893|NCT02723955|527280252|FG007|Expansion Phase|Withdrawal by Subject|0|||
146208894|NCT02723955|527280253|FG008|Expansion Phase|Withdrawal by Subject|0|||
146208895|NCT02723955|527280254|FG009|Expansion Phase|Withdrawal by Subject|2|||
146208896|NCT02723955|527280255|FG010|Expansion Phase|Withdrawal by Subject|1|||
146208897|NCT02723955|527280256|FG011|Expansion Phase|Withdrawal by Subject|0|||
146208898|NCT02723955|527280257|FG012|Expansion Phase|Withdrawal by Subject|0|||
146208899|NCT02723955|527280258|FG013|Expansion Phase|Withdrawal by Subject|0|||
146439734|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|moved|0|||
145953001|NCT05188729|526338058|FG005|Overall Study|Lost to Follow-up|0|||
145953002|NCT05188729|526338059|FG006|Overall Study|Lost to Follow-up|0|||
145953003|NCT05188729|526338060|FG007|Overall Study|Lost to Follow-up|0|||
145953004|NCT05188729|526338061|FG008|Overall Study|Lost to Follow-up|0|||
146208900|NCT02723955|527280259|FG014|Expansion Phase|Withdrawal by Subject|0|||
146208901|NCT02723955|527280260|FG015|Expansion Phase|Withdrawal by Subject|0|||
146208902|NCT02723955|527280261|FG016|Expansion Phase|Withdrawal by Subject|0|||
146208903|NCT02723955|527280262|FG017|Expansion Phase|Withdrawal by Subject|0|||
146208904|NCT02723955|527280263|FG018|Expansion Phase|Withdrawal by Subject|0|||
146208905|NCT02723955|527280264|FG019|Expansion Phase|Withdrawal by Subject|0|||
146208906|NCT02723955|527280265|FG020|Expansion Phase|Withdrawal by Subject|0|||
146208907|NCT02723955|527280266|FG021|Expansion Phase|Withdrawal by Subject|0|||
146208908|NCT02723955|527280267|FG022|Expansion Phase|Withdrawal by Subject|0|||
146208909|NCT02723955|527280268|FG023|Expansion Phase|Withdrawal by Subject|0|||
146208910|NCT02723955|527280269|FG024|Expansion Phase|Withdrawal by Subject|0|||
146208911|NCT02723955|527280270|FG025|Expansion Phase|Withdrawal by Subject|0|||
146208912|NCT02723955|527280271|FG026|Expansion Phase|Withdrawal by Subject|0|||
146208913|NCT02723955|527280272|FG027|Expansion Phase|Withdrawal by Subject|0|||
146208914|NCT02723955|527280273|FG028|Expansion Phase|Withdrawal by Subject|0|||
146208915|NCT02723955|527280274|FG029|Expansion Phase|Withdrawal by Subject|0|||
146208916|NCT02723955|527280275|FG030|Expansion Phase|Withdrawal by Subject|8|||
146208917|NCT02723955|527280276|FG031|Expansion Phase|Withdrawal by Subject|4|||
146208918|NCT02723955|527280277|FG032|Expansion Phase|Withdrawal by Subject|0|||
146208919|NCT02723955|527280278|FG033|Expansion Phase|Withdrawal by Subject|0|||
146208920|NCT02723955|527280279|FG034|Expansion Phase|Withdrawal by Subject|0|||
146208921|NCT02723955|527280280|FG035|Expansion Phase|Withdrawal by Subject|1|||
146208922|NCT02723955|527280281|FG036|Expansion Phase|Withdrawal by Subject|0|||
146208923|NCT02723955|527280282|FG037|Expansion Phase|Withdrawal by Subject|0|||
146208924|NCT02723955|527280283|FG038|Expansion Phase|Withdrawal by Subject|0|||
146208925|NCT02723955|527280284|FG039|Expansion Phase|Withdrawal by Subject|0|||
146208926|NCT02723955|527280285|FG040|Expansion Phase|Withdrawal by Subject|0|||
146208927|NCT02723955|527280286|FG041|Expansion Phase|Withdrawal by Subject|0|||
146208928|NCT02723955|527280287|FG042|Expansion Phase|Withdrawal by Subject|0|||
146208929|NCT02723955|527280245|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208930|NCT02723955|527280246|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208931|NCT02723955|527280247|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208932|NCT02723955|527280248|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208933|NCT02723955|527280249|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208934|NCT02723955|527280250|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208935|NCT02723955|527280251|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208936|NCT02723955|527280252|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208937|NCT02723955|527280253|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146439735|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|moved|0|||
146439736|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|moved|0|||
146439737|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|moved|0|||
146439738|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|moved|0|||
146439739|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|moved|0|||
146439740|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|moved|0|||
145953005|NCT05188729|526338062|FG009|Overall Study|Lost to Follow-up|0|||
146208938|NCT02723955|527280254|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
146208939|NCT02723955|527280255|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
146208940|NCT02723955|527280256|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
146208941|NCT02723955|527280257|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208942|NCT02723955|527280258|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208943|NCT02723955|527280259|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146439741|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|moved|0|||
146439742|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439743|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439744|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439745|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
146439746|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439747|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439748|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439749|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439750|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439751|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439752|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439753|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439754|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145953006|NCT05188729|526338063|FG010|Overall Study|Lost to Follow-up|1|||
146439755|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439756|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439757|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439758|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439759|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439760|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439761|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439762|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439763|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439764|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439765|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439766|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439767|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
146439768|NCT00112437|528115063|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439769|NCT00112437|528115064|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439770|NCT00112437|528115065|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439771|NCT00112437|528115066|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439772|NCT00112437|528115067|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
146439773|NCT00112437|528115068|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439774|NCT00112437|528115069|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439775|NCT00112437|528115070|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439776|NCT00112437|528115071|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439777|NCT00112437|528115072|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439778|NCT00112437|528115073|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439779|NCT00112437|528115074|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439780|NCT00112437|528115075|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439781|NCT00112437|528115076|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439782|NCT00112437|528115077|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145953007|NCT05188729|526338064|FG011|Overall Study|Lost to Follow-up|1|||
145953008|NCT05188729|526338065|FG012|Overall Study|Lost to Follow-up|0|||
145953009|NCT00520767|526338069|FG000|Overall Study|Death|2|||
145953010|NCT03396822|526340395|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
145953011|NCT03396822|526340395|FG000|Overall Study|Physician Decision|1|||
146208944|NCT02723955|527280260|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208945|NCT02723955|527280261|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208946|NCT02723955|527280262|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208947|NCT02723955|527280263|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208948|NCT02723955|527280264|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208949|NCT02723955|527280265|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208950|NCT02723955|527280266|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208951|NCT02723955|527280267|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208952|NCT02723955|527280268|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145953012|NCT02849704|526340398|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
145953013|NCT02849704|526340399|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
146208953|NCT02723955|527280269|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208954|NCT02723955|527280270|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208955|NCT02723955|527280271|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208956|NCT02723955|527280272|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145953014|NCT02849704|526340398|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
145953015|NCT02849704|526340399|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
145953016|NCT02849704|526340398|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
145953017|NCT02849704|526340399|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
145953018|NCT03251482|526340400|FG000|Overall Study|Withdrawal by Subject|0|||
146208957|NCT02723955|527280273|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208958|NCT02723955|527280274|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208959|NCT02723955|527280275|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
146208960|NCT02723955|527280276|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208961|NCT02723955|527280277|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146439783|NCT00112437|528115078|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146083087|NCT01029405|526824735|FG001|Overall Study|Lost to Follow-up|1|||
146208962|NCT02723955|527280278|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208963|NCT02723955|527280279|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208964|NCT02723955|527280280|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208965|NCT02723955|527280281|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146083088|NCT01029405|526824736|FG002|Overall Study|Lost to Follow-up|1|||
146208966|NCT02723955|527280282|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208967|NCT02723955|527280283|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208968|NCT02723955|527280284|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208969|NCT02723955|527280285|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208970|NCT02723955|527280286|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208971|NCT02723955|527280287|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
146208972|NCT02723955|527280245|FG000|Expansion Phase|Site Closed|0|||
146208973|NCT02723955|527280246|FG001|Expansion Phase|Site Closed|0|||
146208974|NCT02723955|527280247|FG002|Expansion Phase|Site Closed|0|||
146208975|NCT02723955|527280248|FG003|Expansion Phase|Site Closed|0|||
146208976|NCT02723955|527280249|FG004|Expansion Phase|Site Closed|0|||
146208977|NCT02723955|527280250|FG005|Expansion Phase|Site Closed|0|||
146208978|NCT02723955|527280251|FG006|Expansion Phase|Site Closed|0|||
146208979|NCT02723955|527280252|FG007|Expansion Phase|Site Closed|0|||
146208980|NCT02723955|527280253|FG008|Expansion Phase|Site Closed|0|||
146208981|NCT02723955|527280254|FG009|Expansion Phase|Site Closed|1|||
146208982|NCT02723955|527280255|FG010|Expansion Phase|Site Closed|2|||
146208983|NCT02723955|527280256|FG011|Expansion Phase|Site Closed|6|||
146208984|NCT02723955|527280257|FG012|Expansion Phase|Site Closed|0|||
146208985|NCT02723955|527280258|FG013|Expansion Phase|Site Closed|0|||
146208986|NCT02723955|527280259|FG014|Expansion Phase|Site Closed|0|||
146208987|NCT02723955|527280260|FG015|Expansion Phase|Site Closed|0|||
146208988|NCT02723955|527280261|FG016|Expansion Phase|Site Closed|0|||
146208989|NCT02723955|527280262|FG017|Expansion Phase|Site Closed|0|||
146208990|NCT02723955|527280263|FG018|Expansion Phase|Site Closed|0|||
146208991|NCT02723955|527280264|FG019|Expansion Phase|Site Closed|0|||
146208992|NCT02723955|527280265|FG020|Expansion Phase|Site Closed|0|||
146208993|NCT02723955|527280266|FG021|Expansion Phase|Site Closed|0|||
146208994|NCT02723955|527280267|FG022|Expansion Phase|Site Closed|0|||
146208995|NCT02723955|527280268|FG023|Expansion Phase|Site Closed|0|||
146208996|NCT02723955|527280269|FG024|Expansion Phase|Site Closed|0|||
146208997|NCT02723955|527280270|FG025|Expansion Phase|Site Closed|0|||
146208998|NCT02723955|527280271|FG026|Expansion Phase|Site Closed|0|||
146208999|NCT02723955|527280272|FG027|Expansion Phase|Site Closed|0|||
146209000|NCT02723955|527280273|FG028|Expansion Phase|Site Closed|0|||
146209001|NCT02723955|527280274|FG029|Expansion Phase|Site Closed|0|||
146209002|NCT02723955|527280275|FG030|Expansion Phase|Site Closed|8|||
146209003|NCT02723955|527280276|FG031|Expansion Phase|Site Closed|4|||
146209004|NCT02723955|527280277|FG032|Expansion Phase|Site Closed|2|||
146209005|NCT02723955|527280278|FG033|Expansion Phase|Site Closed|2|||
146209006|NCT02723955|527280279|FG034|Expansion Phase|Site Closed|0|||
146209007|NCT02723955|527280280|FG035|Expansion Phase|Site Closed|0|||
146209008|NCT02723955|527280281|FG036|Expansion Phase|Site Closed|0|||
146209009|NCT02723955|527280282|FG037|Expansion Phase|Site Closed|0|||
146209010|NCT02723955|527280283|FG038|Expansion Phase|Site Closed|0|||
146209011|NCT02723955|527280284|FG039|Expansion Phase|Site Closed|0|||
146209012|NCT02723955|527280285|FG040|Expansion Phase|Site Closed|0|||
146209013|NCT02723955|527280286|FG041|Expansion Phase|Site Closed|0|||
146209014|NCT02723955|527280287|FG042|Expansion Phase|Site Closed|0|||
146209015|NCT02723955|527280245|FG000|Crossover/ Re-treatment Phase|Death|0|||
146209016|NCT02723955|527280246|FG001|Crossover/ Re-treatment Phase|Death|0|||
146209017|NCT02723955|527280247|FG002|Crossover/ Re-treatment Phase|Death|0|||
146209018|NCT02723955|527280248|FG003|Crossover/ Re-treatment Phase|Death|0|||
146083089|NCT01029405|526824737|FG003|Overall Study|Lost to Follow-up|2|||
146209019|NCT02723955|527280249|FG004|Crossover/ Re-treatment Phase|Death|0|||
146209020|NCT02723955|527280250|FG005|Crossover/ Re-treatment Phase|Death|0|||
146209021|NCT02723955|527280251|FG006|Crossover/ Re-treatment Phase|Death|0|||
146209022|NCT02723955|527280252|FG007|Crossover/ Re-treatment Phase|Death|0|||
146209023|NCT02723955|527280253|FG008|Crossover/ Re-treatment Phase|Death|0|||
146209024|NCT02723955|527280254|FG009|Crossover/ Re-treatment Phase|Death|0|||
146209025|NCT02723955|527280255|FG010|Crossover/ Re-treatment Phase|Death|0|||
146209026|NCT02723955|527280256|FG011|Crossover/ Re-treatment Phase|Death|0|||
146209027|NCT02723955|527280257|FG012|Crossover/ Re-treatment Phase|Death|0|||
146209028|NCT02723955|527280258|FG013|Crossover/ Re-treatment Phase|Death|0|||
146209029|NCT02723955|527280259|FG014|Crossover/ Re-treatment Phase|Death|0|||
146439784|NCT00112437|528115079|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439785|NCT00112437|528115080|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146209030|NCT02723955|527280260|FG015|Crossover/ Re-treatment Phase|Death|0|||
146209031|NCT02723955|527280261|FG016|Crossover/ Re-treatment Phase|Death|0|||
146209032|NCT02723955|527280262|FG017|Crossover/ Re-treatment Phase|Death|0|||
146209033|NCT02723955|527280263|FG018|Crossover/ Re-treatment Phase|Death|0|||
146209034|NCT02723955|527280264|FG019|Crossover/ Re-treatment Phase|Death|0|||
146209035|NCT02723955|527280265|FG020|Crossover/ Re-treatment Phase|Death|0|||
146209036|NCT02723955|527280266|FG021|Crossover/ Re-treatment Phase|Death|0|||
146209037|NCT02723955|527280267|FG022|Crossover/ Re-treatment Phase|Death|0|||
146209038|NCT02723955|527280268|FG023|Crossover/ Re-treatment Phase|Death|0|||
146209039|NCT02723955|527280269|FG024|Crossover/ Re-treatment Phase|Death|0|||
146209040|NCT02723955|527280270|FG025|Crossover/ Re-treatment Phase|Death|0|||
146209041|NCT02723955|527280271|FG026|Crossover/ Re-treatment Phase|Death|0|||
146209042|NCT02723955|527280272|FG027|Crossover/ Re-treatment Phase|Death|0|||
146209043|NCT02723955|527280273|FG028|Crossover/ Re-treatment Phase|Death|0|||
146209044|NCT02723955|527280274|FG029|Crossover/ Re-treatment Phase|Death|0|||
146209045|NCT02723955|527280275|FG030|Crossover/ Re-treatment Phase|Death|0|||
146209046|NCT02723955|527280276|FG031|Crossover/ Re-treatment Phase|Death|0|||
146209047|NCT02723955|527280277|FG032|Crossover/ Re-treatment Phase|Death|0|||
146209048|NCT02723955|527280278|FG033|Crossover/ Re-treatment Phase|Death|0|||
146209049|NCT02723955|527280279|FG034|Crossover/ Re-treatment Phase|Death|0|||
146209050|NCT02723955|527280280|FG035|Crossover/ Re-treatment Phase|Death|0|||
146209051|NCT02723955|527280281|FG036|Crossover/ Re-treatment Phase|Death|0|||
146209052|NCT02723955|527280282|FG037|Crossover/ Re-treatment Phase|Death|1|||
146209053|NCT02723955|527280283|FG038|Crossover/ Re-treatment Phase|Death|14|||
146209054|NCT02723955|527280284|FG039|Crossover/ Re-treatment Phase|Death|32|||
146209055|NCT02723955|527280285|FG040|Crossover/ Re-treatment Phase|Death|2|||
146209056|NCT02723955|527280286|FG041|Crossover/ Re-treatment Phase|Death|1|||
146209057|NCT02723955|527280287|FG042|Crossover/ Re-treatment Phase|Death|0|||
146209058|NCT02723955|527280245|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209059|NCT02723955|527280246|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209060|NCT02723955|527280247|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209061|NCT02723955|527280248|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209062|NCT02723955|527280249|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209063|NCT02723955|527280250|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209064|NCT02723955|527280251|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209065|NCT02723955|527280252|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209066|NCT02723955|527280253|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209067|NCT02723955|527280254|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209068|NCT02723955|527280255|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209069|NCT02723955|527280256|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209070|NCT02723955|527280257|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209071|NCT02723955|527280258|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209072|NCT02723955|527280259|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209073|NCT02723955|527280260|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209074|NCT02723955|527280261|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209075|NCT02723955|527280262|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209076|NCT02723955|527280263|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209077|NCT02723955|527280264|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209078|NCT02723955|527280265|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209079|NCT02723955|527280266|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209080|NCT02723955|527280267|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209081|NCT02723955|527280268|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209082|NCT02723955|527280269|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209083|NCT02723955|527280270|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209084|NCT02723955|527280271|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146439786|NCT00112437|528115081|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439787|NCT00112437|528115082|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145953019|NCT03251482|526340401|FG001|Overall Study|Withdrawal by Subject|1|||
145953020|NCT03251482|526340402|FG002|Overall Study|Withdrawal by Subject|0|||
145953021|NCT03251482|526340403|FG003|Overall Study|Withdrawal by Subject|0|||
145953022|NCT03251482|526340404|FG004|Overall Study|Withdrawal by Subject|0|||
145953023|NCT02447328|526340407|FG000|Overall Study|Withdrawal by Subject|1|||
145953024|NCT04336475|526340414|FG000|Overall Study|pain|1|||
145953025|NCT04336475|526340415|FG001|Overall Study|pain|0|||
145953026|NCT04336475|526340414|FG000|Overall Study|upper respiratory infection|1|||
145953027|NCT04336475|526340415|FG001|Overall Study|upper respiratory infection|0|||
145953028|NCT04336475|526340414|FG000|Overall Study|Lost to Follow-up|0|||
145953029|NCT04336475|526340415|FG001|Overall Study|Lost to Follow-up|2|||
145953030|NCT01990573|526340418|FG000|Overall Study|Physician Decision|0|||
145953031|NCT01990573|526340419|FG001|Overall Study|Physician Decision|0|||
145953032|NCT01990573|526340420|FG002|Overall Study|Physician Decision|1|||
145953033|NCT01763827|526340425|FG000|Overall Study|Withdrawal by Subject|1|||
145953034|NCT01763827|526340426|FG001|Overall Study|Withdrawal by Subject|0|||
145953035|NCT01763827|526340427|FG002|Overall Study|Withdrawal by Subject|0|||
145953036|NCT01763827|526340428|FG003|Overall Study|Withdrawal by Subject|0|||
145953037|NCT01763827|526340429|FG004|Overall Study|Withdrawal by Subject|2|||
145953038|NCT01763827|526340430|FG005|Overall Study|Withdrawal by Subject|0|||
145953039|NCT01763827|526340425|FG000|Overall Study|Decision by sponsor|2|||
145953040|NCT01763827|526340426|FG001|Overall Study|Decision by sponsor|0|||
145953041|NCT01763827|526340427|FG002|Overall Study|Decision by sponsor|3|||
145953042|NCT01763827|526340428|FG003|Overall Study|Decision by sponsor|0|||
145953043|NCT01763827|526340429|FG004|Overall Study|Decision by sponsor|2|||
145953044|NCT01763827|526340430|FG005|Overall Study|Decision by sponsor|1|||
145953045|NCT01763827|526340425|FG000|Overall Study|Lost to Follow-up|0|||
145953046|NCT01763827|526340426|FG001|Overall Study|Lost to Follow-up|1|||
145953047|NCT01763827|526340427|FG002|Overall Study|Lost to Follow-up|1|||
145953048|NCT01763827|526340428|FG003|Overall Study|Lost to Follow-up|1|||
145953049|NCT01763827|526340429|FG004|Overall Study|Lost to Follow-up|2|||
145953050|NCT01763827|526340430|FG005|Overall Study|Lost to Follow-up|1|||
145953051|NCT02030119|526340431|FG000|Overall Study|Withdrawal by Subject|3|||
145953052|NCT02030119|526340432|FG001|Overall Study|Withdrawal by Subject|1|||
145953053|NCT02030119|526340433|FG002|Overall Study|Withdrawal by Subject|5|||
145953054|NCT02030119|526340434|FG003|Overall Study|Withdrawal by Subject|3|||
145953055|NCT02030119|526340431|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
145953056|NCT02030119|526340432|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
145953057|NCT02030119|526340433|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
145953058|NCT02030119|526340434|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
145953059|NCT00412932|526340437|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
145953060|NCT00412932|526340437|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
145953061|NCT00412932|526340437|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
145953062|NCT00412932|526340437|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
145953063|NCT00412932|526340437|FG000|Olmesartan (Olm) 20 mg|Other|1|||
145953064|NCT00412932|526340437|FG000|Olmesartan 40 mg|Adverse Event|4|||
145953065|NCT00412932|526340437|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
145953066|NCT00412932|526340437|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
145953067|NCT00412932|526340437|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
145953068|NCT00412932|526340437|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
145953069|NCT00412932|526340437|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
146439788|NCT00112437|528115083|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145953070|NCT00412932|526340437|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
145953071|NCT02259400|526340444|FG000|Overall Study|Death|0|||
145953072|NCT02259400|526340445|FG001|Overall Study|Death|2|||
145953073|NCT03498313|526340447|FG000|Experimental Period 1|Adverse Event|1|||
145953074|NCT03498313|526340448|FG001|Experimental Period 1|Adverse Event|0|||
145953075|NCT03498313|526340449|FG002|Experimental Period 1|Adverse Event|0|||
145953076|NCT03498313|526340450|FG003|Experimental Period 1|Adverse Event|1|||
145953077|NCT03498313|526340451|FG004|Experimental Period 1|Adverse Event|0|||
145953078|NCT03498313|526340452|FG005|Experimental Period 1|Adverse Event|0|||
145953079|NCT03498313|526340447|FG000|Experimental Period 1|Withdrawal by Subject|0|||
145953080|NCT03498313|526340448|FG001|Experimental Period 1|Withdrawal by Subject|1|||
145953081|NCT03498313|526340449|FG002|Experimental Period 1|Withdrawal by Subject|0|||
146209085|NCT02723955|527280272|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209086|NCT02723955|527280273|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209087|NCT02723955|527280274|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145953082|NCT03498313|526340450|FG003|Experimental Period 1|Withdrawal by Subject|0|||
145953083|NCT03498313|526340451|FG004|Experimental Period 1|Withdrawal by Subject|0|||
145953084|NCT03498313|526340452|FG005|Experimental Period 1|Withdrawal by Subject|0|||
146209088|NCT02723955|527280275|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209089|NCT02723955|527280276|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209090|NCT02723955|527280277|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209091|NCT02723955|527280278|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209092|NCT02723955|527280279|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209093|NCT02723955|527280280|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209094|NCT02723955|527280281|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209095|NCT02723955|527280282|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209096|NCT02723955|527280283|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209097|NCT02723955|527280284|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
146209098|NCT02723955|527280285|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209099|NCT02723955|527280286|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209100|NCT02723955|527280287|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
146209101|NCT02723955|527280245|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209102|NCT02723955|527280246|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209103|NCT02723955|527280247|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209104|NCT02723955|527280248|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439789|NCT00112437|528115084|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439790|NCT00112437|528115085|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439791|NCT00112437|528115086|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439792|NCT00112437|528115087|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439793|NCT00112437|528115088|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
146439794|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
146439795|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
146439796|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
146439797|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
146439798|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
146439799|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
146439800|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
146439801|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
146439802|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
146439803|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
146439804|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
146439805|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
146439806|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
146439807|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
146439808|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
146439809|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
146439810|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
146439811|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
146439812|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
146439813|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
146439814|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
146439815|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
146439816|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
146439817|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
146439818|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
146439819|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
146439820|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439821|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439822|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439823|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439824|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439825|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
146439826|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
146439827|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439828|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439829|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
146439830|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439831|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439832|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439833|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439834|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439835|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145953085|NCT03498313|526340447|FG000|Washout Period 1|Anovulation|1|||
145953086|NCT03498313|526340448|FG001|Washout Period 1|Anovulation|0|||
146209105|NCT02723955|527280249|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209106|NCT02723955|527280250|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209107|NCT02723955|527280251|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439836|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439837|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146209108|NCT02723955|527280252|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209109|NCT02723955|527280253|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209110|NCT02723955|527280254|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209111|NCT02723955|527280255|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209112|NCT02723955|527280256|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209113|NCT02723955|527280257|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209114|NCT02723955|527280258|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209115|NCT02723955|527280259|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209116|NCT02723955|527280260|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209117|NCT02723955|527280261|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209118|NCT02723955|527280262|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209119|NCT02723955|527280263|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209120|NCT02723955|527280264|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209121|NCT02723955|527280265|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209122|NCT02723955|527280266|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209123|NCT02723955|527280267|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209124|NCT02723955|527280268|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209125|NCT02723955|527280269|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209126|NCT02723955|527280270|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439838|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145953087|NCT03498313|526340449|FG002|Washout Period 1|Anovulation|0|||
145953088|NCT03498313|526340450|FG003|Washout Period 1|Anovulation|0|||
145953089|NCT03498313|526340451|FG004|Washout Period 1|Anovulation|0|||
145953090|NCT03498313|526340452|FG005|Washout Period 1|Anovulation|0|||
145953091|NCT03498313|526340447|FG000|Washout Period 1|Withdrawal by Subject|0|||
145953092|NCT03498313|526340448|FG001|Washout Period 1|Withdrawal by Subject|3|||
145953093|NCT03498313|526340449|FG002|Washout Period 1|Withdrawal by Subject|0|||
145953094|NCT03498313|526340450|FG003|Washout Period 1|Withdrawal by Subject|1|||
145953095|NCT03498313|526340451|FG004|Washout Period 1|Withdrawal by Subject|0|||
145953096|NCT03498313|526340452|FG005|Washout Period 1|Withdrawal by Subject|1|||
145953097|NCT03498313|526340447|FG000|Experimental Period 2|Adverse Event|0|||
145953098|NCT03498313|526340448|FG001|Experimental Period 2|Adverse Event|0|||
145953099|NCT03498313|526340449|FG002|Experimental Period 2|Adverse Event|0|||
145953100|NCT03498313|526340450|FG003|Experimental Period 2|Adverse Event|0|||
145953101|NCT03498313|526340451|FG004|Experimental Period 2|Adverse Event|1|||
145953102|NCT03498313|526340452|FG005|Experimental Period 2|Adverse Event|2|||
145953103|NCT03498313|526340447|FG000|Washout Period 2|Physician Decision|1|||
145953104|NCT03498313|526340448|FG001|Washout Period 2|Physician Decision|0|||
145953105|NCT03498313|526340449|FG002|Washout Period 2|Physician Decision|0|||
145953106|NCT03498313|526340450|FG003|Washout Period 2|Physician Decision|1|||
145953107|NCT03498313|526340451|FG004|Washout Period 2|Physician Decision|0|||
145953108|NCT03498313|526340452|FG005|Washout Period 2|Physician Decision|1|||
145953109|NCT03498313|526340447|FG000|Washout Period 2|Withdrawal by Subject|3|||
145953110|NCT03498313|526340448|FG001|Washout Period 2|Withdrawal by Subject|2|||
145953111|NCT03498313|526340449|FG002|Washout Period 2|Withdrawal by Subject|0|||
145953112|NCT03498313|526340450|FG003|Washout Period 2|Withdrawal by Subject|0|||
145953113|NCT03498313|526340451|FG004|Washout Period 2|Withdrawal by Subject|2|||
145953114|NCT03498313|526340452|FG005|Washout Period 2|Withdrawal by Subject|0|||
145953115|NCT03498313|526340447|FG000|Washout Period 2|Anovulation|0|||
145953116|NCT03498313|526340448|FG001|Washout Period 2|Anovulation|0|||
145953117|NCT03498313|526340449|FG002|Washout Period 2|Anovulation|0|||
145953118|NCT03498313|526340450|FG003|Washout Period 2|Anovulation|0|||
145953119|NCT03498313|526340451|FG004|Washout Period 2|Anovulation|0|||
145953120|NCT03498313|526340452|FG005|Washout Period 2|Anovulation|1|||
145953121|NCT02239640|526340453|FG000|Overall Study|Withdrawal by Subject|3|||
145953122|NCT02239640|526340453|FG000|Overall Study|Lost to Follow-up|72|||
145953123|NCT02239640|526340453|FG000|Overall Study|Death|142|||
145953124|NCT02630563|526340456|FG000|Overall Study|Administrative|1|||
146209127|NCT02723955|527280271|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209128|NCT02723955|527280272|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209129|NCT02723955|527280273|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439839|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439840|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145953125|NCT00929994|526340457|FG000|Overall Study|Withdrawal by Subject|1|||
145953126|NCT00929994|526340457|FG000|Overall Study|medical issue unrelated to intervention|4|||
145953127|NCT00929994|526340457|FG000|Overall Study|employment|1|||
145953128|NCT02061813|526340460|FG000|Overall Study|Withdrawal by Subject|1|||
145953129|NCT02061813|526340460|FG000|Overall Study|Protocol Violation|2|||
145953130|NCT00206427|526340461|FG000|Overall Study|Adverse Event|2|||
145953131|NCT03130959|526340465|FG000|Overall Study|Disease progression|19|||
145953132|NCT03130959|526340466|FG001|Overall Study|Disease progression|7|||
146209130|NCT02723955|527280274|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439841|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145953133|NCT03130959|526340467|FG002|Overall Study|Disease progression|12|||
146209131|NCT02723955|527280275|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209132|NCT02723955|527280276|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209133|NCT02723955|527280277|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209134|NCT02723955|527280278|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209135|NCT02723955|527280279|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209136|NCT02723955|527280280|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209137|NCT02723955|527280281|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
146439842|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439843|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439844|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439845|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
146439846|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439847|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439848|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439849|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146209138|NCT02723955|527280282|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209139|NCT02723955|527280283|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
146209140|NCT02723955|527280284|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
146209141|NCT02723955|527280285|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209142|NCT02723955|527280286|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
146209143|NCT02723955|527280287|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
146209144|NCT02723955|527280245|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
146209145|NCT02723955|527280246|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
146209146|NCT02723955|527280247|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
146209147|NCT02723955|527280248|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
146209148|NCT02723955|527280249|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
146209149|NCT02723955|527280250|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
146209150|NCT02723955|527280251|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
146209151|NCT02723955|527280252|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
146209152|NCT02723955|527280253|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
146209153|NCT02723955|527280254|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
146439850|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439851|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439852|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439853|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439854|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
146439855|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439856|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439857|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439858|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439859|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439860|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439861|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439862|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439863|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439864|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439865|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439866|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439867|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439868|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439869|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146209154|NCT02723955|527280255|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
146209155|NCT02723955|527280256|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
146209156|NCT02723955|527280257|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
146209157|NCT02723955|527280258|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
146209158|NCT02723955|527280259|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
146209159|NCT02723955|527280260|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
146439870|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439871|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
146439872|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439873|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439874|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
146209160|NCT02723955|527280261|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
146209161|NCT02723955|527280262|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
146209162|NCT02723955|527280263|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
146209163|NCT02723955|527280264|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
146209164|NCT02723955|527280265|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
146209165|NCT02723955|527280266|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
146209166|NCT02723955|527280267|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
146209167|NCT02723955|527280268|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
146209168|NCT02723955|527280269|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
146209169|NCT02723955|527280270|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
146439875|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
146083090|NCT01029405|526824734|FG000|Overall Study|Other|0|||
146209170|NCT02723955|527280271|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
146439876|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439877|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439878|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439879|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439880|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
146439881|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439882|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
146209171|NCT02723955|527280272|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
146209172|NCT02723955|527280273|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
146209173|NCT02723955|527280274|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
146209174|NCT02723955|527280275|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
146209175|NCT02723955|527280276|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
146209176|NCT02723955|527280277|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
146285508|NCT04617275|527557886|FG006|Follow-up Period|Lost to Follow-up|0|||
146285509|NCT04617275|527557887|FG007|Follow-up Period|Lost to Follow-up|3|||
146285510|NCT04617275|527557880|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
146285511|NCT04617275|527557881|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
146285512|NCT04617275|527557882|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
146285513|NCT04617275|527557883|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
146285514|NCT04617275|527557884|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
146285515|NCT04617275|527557885|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
146285516|NCT04617275|527557886|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
146285517|NCT04617275|527557887|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
146285518|NCT04617275|527557880|FG000|Follow-up Period|Other|0|||
146285519|NCT04617275|527557881|FG001|Follow-up Period|Other|1|||
146285520|NCT04617275|527557882|FG002|Follow-up Period|Other|0|||
146285521|NCT04617275|527557883|FG003|Follow-up Period|Other|0|||
146285522|NCT04617275|527557884|FG004|Follow-up Period|Other|0|||
146439883|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439884|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
146209177|NCT02723955|527280278|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
146209178|NCT02723955|527280279|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
146209179|NCT02723955|527280280|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
146285523|NCT04617275|527557885|FG005|Follow-up Period|Other|0|||
146285524|NCT04617275|527557886|FG006|Follow-up Period|Other|0|||
146439885|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
146209180|NCT02723955|527280281|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
146209181|NCT02723955|527280282|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
146209182|NCT02723955|527280283|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
146209183|NCT02723955|527280284|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
146285525|NCT04617275|527557887|FG007|Follow-up Period|Other|0|||
146439886|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439887|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439888|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439889|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439890|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439891|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439892|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439893|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439894|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439895|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439896|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
146439897|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
146285526|NCT04617275|527557880|FG000|Follow-up Period|Withdrawal by Subject|2|||
146285527|NCT04617275|527557881|FG001|Follow-up Period|Withdrawal by Subject|0|||
146439898|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439899|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439900|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146285528|NCT04617275|527557882|FG002|Follow-up Period|Withdrawal by Subject|0|||
146439901|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439902|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146209184|NCT02723955|527280285|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
146209185|NCT02723955|527280286|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
146209186|NCT02723955|527280287|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
146209187|NCT04999085|527280288|FG000|Overall Study|Death|1|||
146209188|NCT05056246|527280291|FG000|Overall Study|Adverse Event|0|||
146209189|NCT05056246|527280292|FG001|Overall Study|Adverse Event|0|||
146209190|NCT05056246|527280293|FG002|Overall Study|Adverse Event|0|||
146209191|NCT05056246|527280294|FG003|Overall Study|Adverse Event|0|||
146209192|NCT05056246|527280295|FG004|Overall Study|Adverse Event|1|||
146209193|NCT05056246|527280291|FG000|Overall Study|Lost to Follow-up|0|||
146209194|NCT05056246|527280292|FG001|Overall Study|Lost to Follow-up|0|||
146209195|NCT05056246|527280293|FG002|Overall Study|Lost to Follow-up|0|||
146209196|NCT05056246|527280294|FG003|Overall Study|Lost to Follow-up|2|||
146439903|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
146209197|NCT05056246|527280295|FG004|Overall Study|Lost to Follow-up|0|||
146209198|NCT05056246|527280291|FG000|Overall Study|Withdrawal by Subject|0|||
146209199|NCT05056246|527280292|FG001|Overall Study|Withdrawal by Subject|1|||
146209200|NCT05056246|527280293|FG002|Overall Study|Withdrawal by Subject|0|||
146209201|NCT05056246|527280294|FG003|Overall Study|Withdrawal by Subject|0|||
146209202|NCT05056246|527280295|FG004|Overall Study|Withdrawal by Subject|0|||
146209203|NCT05096819|527280300|FG000|Overall Study|Withdrawal by Subject|3|||
146209204|NCT05096819|527280301|FG001|Overall Study|Withdrawal by Subject|0|||
146209205|NCT03324984|527280302|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
146285529|NCT04617275|527557883|FG003|Follow-up Period|Withdrawal by Subject|2|||
146209206|NCT03324984|527280303|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
146209207|NCT02152137|527280305|FG000|Overall Study|Withdrawal by Subject|1|||
146209208|NCT02152137|527280305|FG000|Overall Study|Originally assigned to Arm B|3|||
146209209|NCT04878354|527280306|FG000|Overall Study|Adverse Event|4|||
146209210|NCT04878354|527280307|FG001|Overall Study|Adverse Event|13|||
146209211|NCT04878354|527280306|FG000|Overall Study|Withdrawal by Subject|14|||
146209212|NCT04878354|527280307|FG001|Overall Study|Withdrawal by Subject|12|||
146209213|NCT04878354|527280306|FG000|Overall Study|Lost to Follow-up|4|||
146209214|NCT04878354|527280307|FG001|Overall Study|Lost to Follow-up|1|||
146209215|NCT04878354|527280306|FG000|Overall Study|Lack of Efficacy|1|||
146209216|NCT04878354|527280307|FG001|Overall Study|Lack of Efficacy|0|||
146209217|NCT04878354|527280306|FG000|Overall Study|Protocol Violation|0|||
145953134|NCT03130959|526340468|FG003|Overall Study|Disease progression|7|||
145953135|NCT03130959|526340469|FG004|Overall Study|Disease progression|12|||
145953136|NCT03130959|526340470|FG005|Overall Study|Disease progression|3|||
145953137|NCT03130959|526340471|FG006|Overall Study|Disease progression|6|||
145953138|NCT03130959|526340472|FG007|Overall Study|Disease progression|3|||
145953139|NCT03130959|526340473|FG008|Overall Study|Disease progression|15|||
145953140|NCT03130959|526340474|FG009|Overall Study|Disease progression|8|||
145953141|NCT03130959|526340465|FG000|Overall Study|Study drug toxicity|2|||
145953142|NCT03130959|526340466|FG001|Overall Study|Study drug toxicity|2|||
145953143|NCT03130959|526340467|FG002|Overall Study|Study drug toxicity|1|||
145953144|NCT03130959|526340468|FG003|Overall Study|Study drug toxicity|2|||
145953145|NCT03130959|526340469|FG004|Overall Study|Study drug toxicity|1|||
145953146|NCT03130959|526340470|FG005|Overall Study|Study drug toxicity|1|||
145953147|NCT03130959|526340471|FG006|Overall Study|Study drug toxicity|3|||
145953148|NCT03130959|526340472|FG007|Overall Study|Study drug toxicity|0|||
145953149|NCT03130959|526340473|FG008|Overall Study|Study drug toxicity|3|||
145953150|NCT03130959|526340474|FG009|Overall Study|Study drug toxicity|3|||
145953151|NCT03130959|526340465|FG000|Overall Study|Other reasons|0|||
145953152|NCT03130959|526340466|FG001|Overall Study|Other reasons|0|||
145953153|NCT03130959|526340467|FG002|Overall Study|Other reasons|0|||
145953154|NCT03130959|526340468|FG003|Overall Study|Other reasons|0|||
145953155|NCT03130959|526340469|FG004|Overall Study|Other reasons|0|||
145953156|NCT03130959|526340470|FG005|Overall Study|Other reasons|1|||
145953157|NCT03130959|526340471|FG006|Overall Study|Other reasons|1|||
145953158|NCT03130959|526340472|FG007|Overall Study|Other reasons|0|||
145953159|NCT03130959|526340473|FG008|Overall Study|Other reasons|0|||
145953160|NCT03130959|526340474|FG009|Overall Study|Other reasons|0|||
145953161|NCT03130959|526340465|FG000|Overall Study|Subject request to discontinue therapy|0|||
145953162|NCT03130959|526340466|FG001|Overall Study|Subject request to discontinue therapy|0|||
145953163|NCT03130959|526340467|FG002|Overall Study|Subject request to discontinue therapy|1|||
145953164|NCT03130959|526340468|FG003|Overall Study|Subject request to discontinue therapy|1|||
145953165|NCT03130959|526340469|FG004|Overall Study|Subject request to discontinue therapy|0|||
145953166|NCT03130959|526340470|FG005|Overall Study|Subject request to discontinue therapy|0|||
145953167|NCT03130959|526340471|FG006|Overall Study|Subject request to discontinue therapy|1|||
145953168|NCT03130959|526340472|FG007|Overall Study|Subject request to discontinue therapy|1|||
145953169|NCT03130959|526340473|FG008|Overall Study|Subject request to discontinue therapy|0|||
145953170|NCT03130959|526340474|FG009|Overall Study|Subject request to discontinue therapy|0|||
145953171|NCT03130959|526340465|FG000|Overall Study|Not reported|0|||
145953172|NCT03130959|526340466|FG001|Overall Study|Not reported|0|||
145953173|NCT03130959|526340467|FG002|Overall Study|Not reported|0|||
145953174|NCT03130959|526340468|FG003|Overall Study|Not reported|1|||
145953175|NCT03130959|526340469|FG004|Overall Study|Not reported|0|||
145953176|NCT03130959|526340470|FG005|Overall Study|Not reported|1|||
145953177|NCT03130959|526340471|FG006|Overall Study|Not reported|0|||
146209218|NCT04878354|527280307|FG001|Overall Study|Protocol Violation|1|||
146209219|NCT04878354|527280306|FG000|Overall Study|"Reason stated as other in CRF"|2|||
145953178|NCT03130959|526340472|FG007|Overall Study|Not reported|0|||
145953179|NCT03130959|526340473|FG008|Overall Study|Not reported|0|||
145953180|NCT03130959|526340474|FG009|Overall Study|Not reported|1|||
145953181|NCT03130959|526340465|FG000|Overall Study|Adverse Event unrelated to drug|0|||
145953182|NCT03130959|526340466|FG001|Overall Study|Adverse Event unrelated to drug|0|||
145953183|NCT03130959|526340467|FG002|Overall Study|Adverse Event unrelated to drug|1|||
146209220|NCT04878354|527280307|FG001|Overall Study|"Reason stated as other in CRF"|3|||
146209221|NCT03358875|527280308|FG000|Overall Study|Death|409|||
146209222|NCT03358875|527280309|FG001|Overall Study|Death|223|||
146209223|NCT03358875|527280308|FG000|Overall Study|Study Closed by Sponsor|66|||
145953184|NCT03130959|526340468|FG003|Overall Study|Adverse Event unrelated to drug|1|||
146209224|NCT03358875|527280309|FG001|Overall Study|Study Closed by Sponsor|29|||
146209225|NCT03358875|527280308|FG000|Overall Study|Withdrawal by Subject|13|||
146209226|NCT03358875|527280309|FG001|Overall Study|Withdrawal by Subject|16|||
146209227|NCT03358875|527280308|FG000|Overall Study|Lost to Follow-up|13|||
145953185|NCT03130959|526340469|FG004|Overall Study|Adverse Event unrelated to drug|1|||
145953186|NCT03130959|526340470|FG005|Overall Study|Adverse Event unrelated to drug|0|||
145953187|NCT03130959|526340471|FG006|Overall Study|Adverse Event unrelated to drug|1|||
146209228|NCT03358875|527280309|FG001|Overall Study|Lost to Follow-up|2|||
146209229|NCT03358875|527280308|FG000|Overall Study|Miscellaneous|33|||
146209230|NCT03358875|527280309|FG001|Overall Study|Miscellaneous|0|||
146209231|NCT03358875|527280308|FG000|Overall Study|Remained on Study|1|||
146209232|NCT03358875|527280309|FG001|Overall Study|Remained on Study|0|||
146209233|NCT06194214|527280324|FG000|Overall Study|Adverse Event|1|||
146209234|NCT04847999|527280325|FG000|Overall Study|Lost to Follow-up|0|||
146209235|NCT04847999|527280326|FG001|Overall Study|Lost to Follow-up|1|||
146439904|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
146439905|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
146439906|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
146439907|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
146209236|NCT02879448|527280327|FG000|Overall Study|Death|251|||
146209237|NCT02879448|527280328|FG001|Overall Study|Death|263|||
146209238|NCT02879448|527280327|FG000|Overall Study|Lost to Follow-up|23|||
146209239|NCT02879448|527280328|FG001|Overall Study|Lost to Follow-up|28|||
146209240|NCT02879448|527280327|FG000|Overall Study|Withdrawal by Subject|42|||
146209241|NCT02879448|527280328|FG001|Overall Study|Withdrawal by Subject|79|||
146285530|NCT04617275|527557884|FG004|Follow-up Period|Withdrawal by Subject|2|||
146285531|NCT04617275|527557885|FG005|Follow-up Period|Withdrawal by Subject|0|||
146285532|NCT04617275|527557886|FG006|Follow-up Period|Withdrawal by Subject|1|||
146285533|NCT04617275|527557887|FG007|Follow-up Period|Withdrawal by Subject|2|||
146285534|NCT04927884|527557888|FG000|Overall Study|Progressive Disease|2|||
146285535|NCT05917470|527557889|FG000|Overall Study|Progressive Disease|1|||
146285536|NCT05917470|527557890|FG001|Overall Study|Progressive Disease|1|||
146285537|NCT05917470|527557891|FG002|Overall Study|Progressive Disease|2|||
146285538|NCT05917470|527557892|FG003|Overall Study|Progressive Disease|3|||
146285539|NCT05917470|527557893|FG004|Overall Study|Progressive Disease|1|||
146285540|NCT05917470|527557894|FG005|Overall Study|Progressive Disease|1|||
146083091|NCT01029405|526824735|FG001|Overall Study|Other|1|||
146285541|NCT05917470|527557895|FG006|Overall Study|Progressive Disease|0|||
146285542|NCT05917470|527557896|FG007|Overall Study|Progressive Disease|0|||
146209242|NCT02879448|527280327|FG000|Overall Study|Other Reasons|8|||
146209243|NCT02879448|527280328|FG001|Overall Study|Other Reasons|12|||
146209244|NCT03990649|527280340|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
146209245|NCT03990649|527280341|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
146209246|NCT03990649|527280342|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
146209247|NCT03990649|527280340|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
146209248|NCT03990649|527280341|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
146209249|NCT03990649|527280342|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
146209250|NCT03990649|527280340|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
146209251|NCT03990649|527280341|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
146209252|NCT03990649|527280342|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
146209253|NCT03990649|527280340|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
146209254|NCT03990649|527280341|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
146209255|NCT03990649|527280342|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
146209256|NCT03990649|527280340|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
146209257|NCT03990649|527280341|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
146209258|NCT03990649|527280342|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
146209259|NCT03990649|527280340|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
146209260|NCT03990649|527280341|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
146209261|NCT03990649|527280342|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
146209262|NCT03990649|527280340|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
146209263|NCT03990649|527280341|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
146209264|NCT03990649|527280342|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
146209265|NCT05773313|527280343|FG000|Overall Study|Lost to Follow-up|3|||
146209266|NCT03050814|527280344|FG000|Overall Study|Screen failures|0|||
146209267|NCT03050814|527280345|FG001|Overall Study|Screen failures|0|||
146209268|NCT03050814|527280346|FG002|Overall Study|Screen failures|4|||
146209269|NCT01443845|527280347|FG000|Overall Study|Protocol Violation|43|||
146209270|NCT01443845|527280348|FG001|Overall Study|Protocol Violation|45|||
146209271|NCT01443845|527280347|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
146209272|NCT01443845|527280348|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
146209273|NCT01443845|527280347|FG000|Overall Study|Deterioration in pulmonary function|1|||
146209274|NCT01443845|527280348|FG001|Overall Study|Deterioration in pulmonary function|4|||
146209275|NCT01443845|527280347|FG000|Overall Study|Lack of Efficacy|10|||
146209276|NCT01443845|527280348|FG001|Overall Study|Lack of Efficacy|5|||
146209277|NCT01443845|527280347|FG000|Overall Study|Adverse Event|64|||
146209278|NCT01443845|527280348|FG001|Overall Study|Adverse Event|138|||
146209279|NCT01443845|527280347|FG000|Overall Study|Withdrawal by Subject|63|||
146209280|NCT01443845|527280348|FG001|Overall Study|Withdrawal by Subject|67|||
146209281|NCT01443845|527280347|FG000|Overall Study|Military Conflict - Site Terminated|20|||
146209282|NCT01443845|527280348|FG001|Overall Study|Military Conflict - Site Terminated|21|||
146209283|NCT01443845|527280347|FG000|Overall Study|Lost to Follow-up|9|||
146209284|NCT01443845|527280348|FG001|Overall Study|Lost to Follow-up|13|||
146209285|NCT01471691|527280352|FG000|Overall Study|Lack of Efficacy|0|||
146209286|NCT01471691|527280353|FG001|Overall Study|Lack of Efficacy|1|||
146209287|NCT01854385|527280354|FG000|Pre-Treatment|Withdrawal by Subject|4|||
146209288|NCT01854385|527280354|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
146439908|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146209289|NCT01854385|527280354|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
146209290|NCT01854385|527280354|FG000|Pre-Treatment|Unable to come for study visits|1|||
146209291|NCT01854385|527280354|FG000|Treatment|Lost to Follow-up|1|||
146209292|NCT01610297|527280355|FG000|Overall Study|Lost to Follow-up|1|||
146209293|NCT01121991|527280356|FG000|Overall Study|Lack of Ovarian Response|2|||
146209294|NCT01121991|527280356|FG000|Overall Study|No Oocytes Retrieved|3|||
146209295|NCT01121991|527280356|FG000|Overall Study|No Fertilization|1|||
146209296|NCT02590432|527280357|FG000|Open-label Treatment Period|Adverse Event|97|||
146209297|NCT02590432|527280358|FG001|Open-label Treatment Period|Adverse Event|79|||
146209298|NCT02590432|527280359|FG002|Open-label Treatment Period|Adverse Event|0|||
146209299|NCT02590432|527280360|FG003|Open-label Treatment Period|Adverse Event|0|||
146209300|NCT02590432|527280361|FG004|Open-label Treatment Period|Adverse Event|0|||
146209301|NCT02590432|527280362|FG005|Open-label Treatment Period|Adverse Event|0|||
146209302|NCT02590432|527280363|FG006|Open-label Treatment Period|Adverse Event|0|||
146209303|NCT02590432|527280364|FG007|Open-label Treatment Period|Adverse Event|0|||
146209304|NCT02590432|527280365|FG008|Open-label Treatment Period|Adverse Event|0|||
146209305|NCT02590432|527280357|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
146209306|NCT02590432|527280358|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
146209307|NCT02590432|527280359|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
146209308|NCT02590432|527280360|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
146209309|NCT02590432|527280361|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
146209310|NCT02590432|527280362|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
146209311|NCT02590432|527280363|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
146209312|NCT02590432|527280364|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
146209313|NCT02590432|527280365|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
146209314|NCT02590432|527280357|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
146209315|NCT02590432|527280358|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
146209316|NCT02590432|527280359|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
146209317|NCT02590432|527280360|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
146209318|NCT02590432|527280361|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
146209319|NCT02590432|527280362|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
146209320|NCT02590432|527280363|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
146209321|NCT02590432|527280364|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
146209322|NCT02590432|527280365|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
146209323|NCT02590432|527280357|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
146209324|NCT02590432|527280358|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
146209325|NCT02590432|527280359|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146209326|NCT02590432|527280360|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
146209327|NCT02590432|527280361|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
146209328|NCT02590432|527280362|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
146439909|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439910|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439911|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439912|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439913|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439914|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439915|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439916|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439917|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439918|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439919|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439920|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439921|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439922|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439923|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
146439924|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439925|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439926|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439927|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439928|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439929|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439930|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439931|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439932|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439933|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
146439934|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439935|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439936|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439937|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439938|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439939|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439940|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439941|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146083092|NCT01029405|526824736|FG002|Overall Study|Other|0|||
146209329|NCT02590432|527280363|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
146209330|NCT02590432|527280364|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
146209331|NCT02590432|527280365|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
146209332|NCT02590432|527280357|FG000|Open-label Treatment Period|Protocol Violation|10|||
146439942|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439943|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439944|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439945|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439946|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439947|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439948|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439949|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
146439950|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439951|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439952|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439953|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439954|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439955|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439956|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439957|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439958|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439959|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
146439960|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439961|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439962|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439963|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439964|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439965|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439966|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439967|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439968|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439969|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439970|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439971|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439972|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439973|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439974|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439975|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
146439976|NCT00112437|528115063|FG000|Year 2 (12-Month Extension)|Moved|0|||
146439977|NCT00112437|528115064|FG001|Year 2 (12-Month Extension)|Moved|0|||
146439978|NCT00112437|528115065|FG002|Year 2 (12-Month Extension)|Moved|0|||
146439979|NCT00112437|528115066|FG003|Year 2 (12-Month Extension)|Moved|0|||
146439980|NCT00112437|528115067|FG004|Year 2 (12-Month Extension)|Moved|0|||
146439981|NCT00112437|528115068|FG005|Year 2 (12-Month Extension)|Moved|0|||
146439982|NCT00112437|528115069|FG006|Year 2 (12-Month Extension)|Moved|0|||
146439983|NCT00112437|528115070|FG007|Year 2 (12-Month Extension)|Moved|0|||
146439984|NCT00112437|528115071|FG008|Year 2 (12-Month Extension)|Moved|0|||
146439985|NCT00112437|528115072|FG009|Year 2 (12-Month Extension)|Moved|1|||
146439986|NCT00112437|528115073|FG010|Year 2 (12-Month Extension)|Moved|0|||
146439987|NCT00112437|528115074|FG011|Year 2 (12-Month Extension)|Moved|0|||
146439988|NCT00112437|528115075|FG012|Year 2 (12-Month Extension)|Moved|0|||
146439989|NCT00112437|528115076|FG013|Year 2 (12-Month Extension)|Moved|0|||
146439990|NCT00112437|528115077|FG014|Year 2 (12-Month Extension)|Moved|0|||
146439991|NCT00112437|528115078|FG015|Year 2 (12-Month Extension)|Moved|0|||
146439992|NCT00112437|528115079|FG016|Year 2 (12-Month Extension)|Moved|0|||
146439993|NCT00112437|528115080|FG017|Year 2 (12-Month Extension)|Moved|0|||
146439994|NCT00112437|528115081|FG018|Year 2 (12-Month Extension)|Moved|0|||
146439995|NCT00112437|528115082|FG019|Year 2 (12-Month Extension)|Moved|0|||
146439996|NCT00112437|528115083|FG020|Year 2 (12-Month Extension)|Moved|0|||
146439997|NCT00112437|528115084|FG021|Year 2 (12-Month Extension)|Moved|0|||
146439998|NCT00112437|528115085|FG022|Year 2 (12-Month Extension)|Moved|0|||
146439999|NCT00112437|528115086|FG023|Year 2 (12-Month Extension)|Moved|0|||
146440000|NCT00112437|528115087|FG024|Year 2 (12-Month Extension)|Moved|0|||
146440001|NCT00112437|528115088|FG025|Year 2 (12-Month Extension)|Moved|0|||
146440002|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
146440003|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
146440004|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
146440005|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
146440006|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
146440007|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
146440008|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
146440009|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
146440010|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
146440011|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
146440012|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
146440013|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
146440014|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
146440015|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
146440016|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
146440017|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
146440018|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
146440019|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
146440020|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
146440021|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
146440022|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
146440023|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
146440024|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
146440025|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
146440026|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
146209333|NCT02590432|527280358|FG001|Open-label Treatment Period|Protocol Violation|4|||
146209334|NCT02590432|527280359|FG002|Open-label Treatment Period|Protocol Violation|0|||
146440027|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
146440028|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440029|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440030|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440031|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440032|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440033|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440034|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440035|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440036|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440037|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440038|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440039|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
146440040|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440041|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
146440042|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146209335|NCT02590432|527280360|FG003|Open-label Treatment Period|Protocol Violation|0|||
146209336|NCT02590432|527280361|FG004|Open-label Treatment Period|Protocol Violation|0|||
146209337|NCT02590432|527280362|FG005|Open-label Treatment Period|Protocol Violation|0|||
146209338|NCT02590432|527280363|FG006|Open-label Treatment Period|Protocol Violation|0|||
146209339|NCT02590432|527280364|FG007|Open-label Treatment Period|Protocol Violation|0|||
146209340|NCT02590432|527280365|FG008|Open-label Treatment Period|Protocol Violation|0|||
146209341|NCT02590432|527280357|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
146209342|NCT02590432|527280358|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
146209343|NCT02590432|527280359|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209344|NCT02590432|527280360|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209345|NCT02590432|527280361|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209346|NCT02590432|527280362|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209347|NCT02590432|527280363|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209348|NCT02590432|527280364|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209349|NCT02590432|527280365|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
146209350|NCT02590432|527280357|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
146440043|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
146440044|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440045|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440046|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
146440047|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145953188|NCT03130959|526340472|FG007|Overall Study|Adverse Event unrelated to drug|0|||
145953189|NCT03130959|526340473|FG008|Overall Study|Adverse Event unrelated to drug|1|||
145953190|NCT03130959|526340474|FG009|Overall Study|Adverse Event unrelated to drug|1|||
146209351|NCT02590432|527280358|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
146209352|NCT02590432|527280359|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209353|NCT02590432|527280360|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209354|NCT02590432|527280361|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209355|NCT02590432|527280362|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209356|NCT02590432|527280363|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209357|NCT02590432|527280364|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209358|NCT02590432|527280365|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
146209359|NCT02590432|527280357|FG000|Double-blind Treatment Period|Adverse Event|0|||
146209360|NCT02590432|527280358|FG001|Double-blind Treatment Period|Adverse Event|0|||
146209361|NCT02590432|527280359|FG002|Double-blind Treatment Period|Adverse Event|14|||
146209362|NCT02590432|527280360|FG003|Double-blind Treatment Period|Adverse Event|12|||
146209363|NCT02590432|527280361|FG004|Double-blind Treatment Period|Adverse Event|6|||
146209364|NCT02590432|527280362|FG005|Double-blind Treatment Period|Adverse Event|22|||
146209365|NCT02590432|527280363|FG006|Double-blind Treatment Period|Adverse Event|20|||
146209366|NCT02590432|527280364|FG007|Double-blind Treatment Period|Adverse Event|0|||
146209367|NCT02590432|527280365|FG008|Double-blind Treatment Period|Adverse Event|0|||
146209368|NCT02590432|527280357|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146209369|NCT02590432|527280358|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146209370|NCT02590432|527280359|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
146209371|NCT02590432|527280360|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146209372|NCT02590432|527280361|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
146440048|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440049|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145953191|NCT03130959|526340465|FG000|Overall Study|Participant withdrew consent|0|||
145953192|NCT03130959|526340466|FG001|Overall Study|Participant withdrew consent|1|||
146440050|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145953193|NCT03130959|526340467|FG002|Overall Study|Participant withdrew consent|0|||
146209373|NCT02590432|527280362|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
146209374|NCT02590432|527280363|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
146440051|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145953194|NCT03130959|526340468|FG003|Overall Study|Participant withdrew consent|2|||
145953195|NCT03130959|526340469|FG004|Overall Study|Participant withdrew consent|1|||
146209375|NCT02590432|527280364|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
146209376|NCT02590432|527280365|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
146209377|NCT02590432|527280357|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
146209378|NCT02590432|527280358|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
146209379|NCT02590432|527280359|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
146209380|NCT02590432|527280360|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
146209381|NCT02590432|527280361|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
146209382|NCT02590432|527280362|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
146209383|NCT02590432|527280363|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
146209384|NCT02590432|527280364|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
146209385|NCT02590432|527280365|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
146209386|NCT02590432|527280357|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146209387|NCT02590432|527280358|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146209388|NCT02590432|527280359|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146440052|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440053|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
146440054|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146209389|NCT02590432|527280360|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146209390|NCT02590432|527280361|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
146209391|NCT02590432|527280362|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
146209392|NCT02590432|527280363|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
146209393|NCT02590432|527280364|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
146209394|NCT02590432|527280365|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
146209395|NCT02590432|527280357|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209396|NCT02590432|527280358|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209397|NCT02590432|527280359|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209398|NCT02590432|527280360|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209399|NCT02590432|527280361|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209400|NCT02590432|527280362|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
146209401|NCT02590432|527280363|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209402|NCT02590432|527280364|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209403|NCT02590432|527280365|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
146209404|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209405|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209406|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209407|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209408|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209409|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209410|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
146209411|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
146209412|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
146209413|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146440055|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440056|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440057|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145953196|NCT03130959|526340470|FG005|Overall Study|Participant withdrew consent|0|||
146083093|NCT01029405|526824737|FG003|Overall Study|Other|1|||
146440058|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146209414|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209415|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209416|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209417|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209418|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209419|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209420|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
146209421|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
146209422|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209423|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209424|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209425|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209426|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209427|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209428|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
146209429|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
146209430|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
146209431|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209432|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209433|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209434|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209435|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209436|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209437|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209438|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
146209439|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
146209440|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209441|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209442|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209443|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209444|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209445|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209446|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209447|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
146209448|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
146209449|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209450|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209451|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209452|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209453|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209454|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146440059|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440060|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146209455|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209456|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
146209457|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
146209458|NCT02590432|527280357|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209459|NCT02590432|527280358|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209460|NCT02590432|527280359|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209461|NCT02590432|527280360|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209462|NCT02590432|527280361|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209463|NCT02590432|527280362|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209464|NCT02590432|527280363|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209465|NCT02590432|527280364|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
146209466|NCT02590432|527280365|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
146209467|NCT04583423|527280369|FG000|Overall Study|Lost to Follow-up|0|||
146209468|NCT04583423|527280370|FG001|Overall Study|Lost to Follow-up|1|||
146209469|NCT04583423|527280371|FG002|Overall Study|Lost to Follow-up|0|||
146209470|NCT04583423|527280372|FG003|Overall Study|Lost to Follow-up|2|||
146209471|NCT04583423|527280369|FG000|Overall Study|Study Terminated by Sponsor|32|||
146209472|NCT04583423|527280370|FG001|Overall Study|Study Terminated by Sponsor|35|||
146209473|NCT04583423|527280371|FG002|Overall Study|Study Terminated by Sponsor|36|||
146209474|NCT04583423|527280372|FG003|Overall Study|Study Terminated by Sponsor|33|||
146209475|NCT04583423|527280369|FG000|Overall Study|Withdrawal by Subject|3|||
146209476|NCT04583423|527280370|FG001|Overall Study|Withdrawal by Subject|1|||
146209477|NCT04583423|527280371|FG002|Overall Study|Withdrawal by Subject|2|||
146209478|NCT04583423|527280372|FG003|Overall Study|Withdrawal by Subject|1|||
146209479|NCT02238483|527280373|FG000|Overall Study|Withdrawal by Subject|2|||
146209480|NCT02238483|527280374|FG001|Overall Study|Withdrawal by Subject|7|||
145953197|NCT03130959|526340471|FG006|Overall Study|Participant withdrew consent|0|||
146209481|NCT02238483|527280373|FG000|Overall Study|Lost to Follow-up|1|||
146209482|NCT02238483|527280374|FG001|Overall Study|Lost to Follow-up|1|||
146209483|NCT02238483|527280373|FG000|Overall Study|Protocol Violation|1|||
146209484|NCT02238483|527280374|FG001|Overall Study|Protocol Violation|2|||
146209485|NCT02238483|527280373|FG000|Overall Study|Death|1|||
146209486|NCT02238483|527280374|FG001|Overall Study|Death|0|||
146209487|NCT02238483|527280373|FG000|Overall Study|Adverse Event|7|||
146209488|NCT02238483|527280374|FG001|Overall Study|Adverse Event|3|||
146209489|NCT02238483|527280373|FG000|Overall Study|Withdrawn due to physician decision|1|||
146285543|NCT05917470|527557889|FG000|Overall Study|Withdrawal by Subject|0|||
146440061|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146209490|NCT02238483|527280374|FG001|Overall Study|Withdrawn due to physician decision|0|||
146209491|NCT02238483|527280373|FG000|Overall Study|Completion status not recorded|1|||
146209492|NCT02238483|527280374|FG001|Overall Study|Completion status not recorded|1|||
146209493|NCT02238483|527280373|FG000|Overall Study|Illness in family member|1|||
146209494|NCT02238483|527280374|FG001|Overall Study|Illness in family member|0|||
146209495|NCT00567489|527280375|FG000|Overall Study|Adverse Event|6|||
146209496|NCT00567489|527280376|FG001|Overall Study|Adverse Event|14|||
146209497|NCT00567489|527280375|FG000|Overall Study|Physician Decision|0|||
146209498|NCT00567489|527280376|FG001|Overall Study|Physician Decision|4|||
146209499|NCT00567489|527280375|FG000|Overall Study|Withdrawal by Subject|0|||
146209500|NCT00567489|527280376|FG001|Overall Study|Withdrawal by Subject|2|||
146209501|NCT00567489|527280375|FG000|Overall Study|Renal Transplantation|0|||
146209502|NCT00567489|527280376|FG001|Overall Study|Renal Transplantation|3|||
146209503|NCT00567489|527280375|FG000|Overall Study|Other|1|||
146209504|NCT00567489|527280376|FG001|Overall Study|Other|0|||
146209505|NCT04732338|527280384|FG000|Overall Study|Lost to Follow-up|3|||
146209506|NCT04732338|527280385|FG001|Overall Study|Lost to Follow-up|3|||
146209507|NCT02372253|527280386|FG000|Overall Study|Non Compliance|2|||
146440062|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440063|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440064|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440065|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145953198|NCT03130959|526340472|FG007|Overall Study|Participant withdrew consent|0|||
145953199|NCT03130959|526340473|FG008|Overall Study|Participant withdrew consent|0|||
145953200|NCT03130959|526340474|FG009|Overall Study|Participant withdrew consent|2|||
145953201|NCT03130959|526340465|FG000|Overall Study|Administrative reason by sponsor|1|||
145953202|NCT03130959|526340466|FG001|Overall Study|Administrative reason by sponsor|0|||
145953203|NCT03130959|526340467|FG002|Overall Study|Administrative reason by sponsor|1|||
145953204|NCT03130959|526340468|FG003|Overall Study|Administrative reason by sponsor|0|||
145953205|NCT03130959|526340469|FG004|Overall Study|Administrative reason by sponsor|0|||
145953206|NCT03130959|526340470|FG005|Overall Study|Administrative reason by sponsor|0|||
145953207|NCT03130959|526340471|FG006|Overall Study|Administrative reason by sponsor|0|||
145953208|NCT03130959|526340472|FG007|Overall Study|Administrative reason by sponsor|0|||
145953209|NCT03130959|526340473|FG008|Overall Study|Administrative reason by sponsor|0|||
145953210|NCT03130959|526340474|FG009|Overall Study|Administrative reason by sponsor|0|||
145953211|NCT03130959|526340465|FG000|Overall Study|Lost to Follow-up|1|||
145953212|NCT03130959|526340466|FG001|Overall Study|Lost to Follow-up|0|||
145953213|NCT03130959|526340467|FG002|Overall Study|Lost to Follow-up|0|||
145953214|NCT03130959|526340468|FG003|Overall Study|Lost to Follow-up|0|||
145953215|NCT03130959|526340469|FG004|Overall Study|Lost to Follow-up|0|||
145953216|NCT03130959|526340470|FG005|Overall Study|Lost to Follow-up|0|||
145953217|NCT03130959|526340471|FG006|Overall Study|Lost to Follow-up|0|||
145953218|NCT03130959|526340472|FG007|Overall Study|Lost to Follow-up|0|||
146440066|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440067|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440068|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440069|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
146440070|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440071|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145953219|NCT03130959|526340473|FG008|Overall Study|Lost to Follow-up|0|||
145953220|NCT03130959|526340474|FG009|Overall Study|Lost to Follow-up|0|||
145953221|NCT00572455|526340475|FG000|Stage I (14 Days)|Adverse Event|0|||
145953222|NCT00572455|526340476|FG001|Stage I (14 Days)|Adverse Event|0|||
145953223|NCT00572455|526340477|FG002|Stage I (14 Days)|Adverse Event|0|||
145953224|NCT00572455|526340478|FG003|Stage I (14 Days)|Adverse Event|0|||
145953225|NCT00572455|526340479|FG004|Stage I (14 Days)|Adverse Event|0|||
145953226|NCT00572455|526340480|FG005|Stage I (14 Days)|Adverse Event|3|||
145953227|NCT00572455|526340481|FG006|Stage I (14 Days)|Adverse Event|0|||
145953228|NCT00572455|526340482|FG007|Stage I (14 Days)|Adverse Event|0|||
145953229|NCT00572455|526340483|FG008|Stage I (14 Days)|Adverse Event|0|||
145953230|NCT00572455|526340484|FG009|Stage I (14 Days)|Adverse Event|0|||
145953231|NCT00572455|526340485|FG010|Stage I (14 Days)|Adverse Event|0|||
145953232|NCT00572455|526340486|FG011|Stage I (14 Days)|Adverse Event|0|||
145953233|NCT00572455|526340487|FG012|Stage I (14 Days)|Adverse Event|0|||
145953234|NCT00572455|526340488|FG013|Stage I (14 Days)|Adverse Event|0|||
145953235|NCT00572455|526340475|FG000|Stage I (14 Days)|Other|0|||
145953236|NCT00572455|526340476|FG001|Stage I (14 Days)|Other|0|||
145953237|NCT00572455|526340477|FG002|Stage I (14 Days)|Other|0|||
146209508|NCT02372253|527280387|FG001|Overall Study|Non Compliance|0|||
146440072|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145953238|NCT00572455|526340478|FG003|Stage I (14 Days)|Other|0|||
145953239|NCT00572455|526340479|FG004|Stage I (14 Days)|Other|1|||
145953240|NCT00572455|526340480|FG005|Stage I (14 Days)|Other|0|||
145953241|NCT00572455|526340481|FG006|Stage I (14 Days)|Other|0|||
145953242|NCT00572455|526340482|FG007|Stage I (14 Days)|Other|0|||
145953243|NCT00572455|526340483|FG008|Stage I (14 Days)|Other|0|||
145953244|NCT00572455|526340484|FG009|Stage I (14 Days)|Other|0|||
145953245|NCT00572455|526340485|FG010|Stage I (14 Days)|Other|0|||
146440073|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440074|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440075|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440076|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440077|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440078|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440079|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
146440080|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440081|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440082|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440083|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440084|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440085|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440086|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
145953246|NCT00572455|526340486|FG011|Stage I (14 Days)|Other|0|||
145953247|NCT00572455|526340487|FG012|Stage I (14 Days)|Other|0|||
145953248|NCT00572455|526340488|FG013|Stage I (14 Days)|Other|0|||
145953249|NCT00572455|526340475|FG000|Stage II (28 Days)|Adverse Event|0|||
145953250|NCT00572455|526340476|FG001|Stage II (28 Days)|Adverse Event|0|||
146440087|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440088|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440089|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440090|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440091|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440092|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440093|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440094|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440095|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
146440096|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440097|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440098|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440099|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440100|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440101|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440102|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440103|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440104|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440105|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
146440106|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440107|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440108|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440109|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440110|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953251|NCT00572455|526340477|FG002|Stage II (28 Days)|Adverse Event|0|||
145953252|NCT00572455|526340478|FG003|Stage II (28 Days)|Adverse Event|0|||
145953253|NCT00572455|526340479|FG004|Stage II (28 Days)|Adverse Event|0|||
145953254|NCT00572455|526340480|FG005|Stage II (28 Days)|Adverse Event|0|||
145953255|NCT00572455|526340481|FG006|Stage II (28 Days)|Adverse Event|0|||
145953256|NCT00572455|526340482|FG007|Stage II (28 Days)|Adverse Event|0|||
145953257|NCT00572455|526340483|FG008|Stage II (28 Days)|Adverse Event|1|||
145953258|NCT00572455|526340484|FG009|Stage II (28 Days)|Adverse Event|3|||
145953259|NCT00572455|526340485|FG010|Stage II (28 Days)|Adverse Event|3|||
145953260|NCT00572455|526340486|FG011|Stage II (28 Days)|Adverse Event|4|||
145953261|NCT00572455|526340487|FG012|Stage II (28 Days)|Adverse Event|5|||
145953262|NCT00572455|526340488|FG013|Stage II (28 Days)|Adverse Event|1|||
145953263|NCT00572455|526340475|FG000|Stage II (28 Days)|Death|0|||
145953264|NCT00572455|526340476|FG001|Stage II (28 Days)|Death|0|||
145953265|NCT00572455|526340477|FG002|Stage II (28 Days)|Death|0|||
145953266|NCT00572455|526340478|FG003|Stage II (28 Days)|Death|0|||
145953267|NCT00572455|526340479|FG004|Stage II (28 Days)|Death|0|||
145953268|NCT00572455|526340480|FG005|Stage II (28 Days)|Death|0|||
146440111|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440112|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440113|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440114|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440115|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440116|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440117|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
146440118|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440119|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440120|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
146440121|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953269|NCT00572455|526340481|FG006|Stage II (28 Days)|Death|0|||
146083094|NCT01534182|526824738|FG000|Overall Study|Administrative problems|1|||
145953270|NCT00572455|526340482|FG007|Stage II (28 Days)|Death|0|||
145953271|NCT00572455|526340483|FG008|Stage II (28 Days)|Death|1|||
145953272|NCT00572455|526340484|FG009|Stage II (28 Days)|Death|0|||
145953273|NCT00572455|526340485|FG010|Stage II (28 Days)|Death|0|||
146440122|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440123|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440124|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440125|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953274|NCT00572455|526340486|FG011|Stage II (28 Days)|Death|0|||
145953275|NCT00572455|526340487|FG012|Stage II (28 Days)|Death|0|||
145953276|NCT00572455|526340488|FG013|Stage II (28 Days)|Death|0|||
145953277|NCT00572455|526340475|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
145953278|NCT00572455|526340476|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
145953279|NCT00572455|526340477|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
145953280|NCT00572455|526340478|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
146083095|NCT01534182|526824739|FG001|Overall Study|Administrative problems|0|||
145953281|NCT00572455|526340479|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
145953282|NCT00572455|526340480|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
145953283|NCT00572455|526340481|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
145953284|NCT00572455|526340482|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
145953285|NCT00572455|526340483|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
145953286|NCT00572455|526340484|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
145953287|NCT00572455|526340485|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
145953288|NCT00572455|526340486|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
145953289|NCT00572455|526340487|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
145953290|NCT00572455|526340488|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
145953291|NCT00572455|526340475|FG000|Stage II (28 Days)|Other|0|||
145953292|NCT00572455|526340476|FG001|Stage II (28 Days)|Other|0|||
145953293|NCT00572455|526340477|FG002|Stage II (28 Days)|Other|0|||
145953294|NCT00572455|526340478|FG003|Stage II (28 Days)|Other|0|||
145953295|NCT00572455|526340479|FG004|Stage II (28 Days)|Other|0|||
145953296|NCT00572455|526340480|FG005|Stage II (28 Days)|Other|0|||
145953297|NCT00572455|526340481|FG006|Stage II (28 Days)|Other|0|||
145953298|NCT00572455|526340482|FG007|Stage II (28 Days)|Other|0|||
145953299|NCT00572455|526340483|FG008|Stage II (28 Days)|Other|1|||
145953300|NCT00572455|526340484|FG009|Stage II (28 Days)|Other|0|||
145953301|NCT00572455|526340485|FG010|Stage II (28 Days)|Other|0|||
145953302|NCT00572455|526340486|FG011|Stage II (28 Days)|Other|0|||
145953303|NCT00572455|526340487|FG012|Stage II (28 Days)|Other|0|||
145953304|NCT00572455|526340488|FG013|Stage II (28 Days)|Other|0|||
145953305|NCT00572455|526340475|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
145953306|NCT00572455|526340476|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
145953307|NCT00572455|526340477|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
145953308|NCT00572455|526340478|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
145953309|NCT00572455|526340479|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
145953310|NCT00572455|526340480|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
145953311|NCT00572455|526340481|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
145953312|NCT00572455|526340482|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
145953313|NCT00572455|526340483|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
145953314|NCT00572455|526340484|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
145953315|NCT00572455|526340485|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
145953316|NCT00572455|526340486|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
145953317|NCT00572455|526340487|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
145953318|NCT00572455|526340488|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
145953319|NCT02384538|526340489|FG000|Overall Study|Adverse Event|1|||
145953320|NCT02384538|526340490|FG001|Overall Study|Adverse Event|4|||
145953321|NCT02384538|526340489|FG000|Overall Study|Lack of Efficacy|4|||
145953322|NCT02384538|526340490|FG001|Overall Study|Lack of Efficacy|4|||
145953323|NCT02384538|526340489|FG000|Overall Study|Withdrew Consent|0|||
145953324|NCT02384538|526340490|FG001|Overall Study|Withdrew Consent|4|||
145953325|NCT02384538|526340489|FG000|Overall Study|Other|1|||
145953326|NCT02384538|526340490|FG001|Overall Study|Other|3|||
145953327|NCT02187029|526340493|FG000|Overall Study|Adverse Event|0|||
145953328|NCT02187029|526340494|FG001|Overall Study|Adverse Event|1|||
145953329|NCT02187029|526340495|FG002|Overall Study|Adverse Event|1|||
145953330|NCT02187029|526340496|FG003|Overall Study|Adverse Event|0|||
145953331|NCT02187029|526340493|FG000|Overall Study|Study Terminated by Sponsor|0|||
145953332|NCT02187029|526340494|FG001|Overall Study|Study Terminated by Sponsor|0|||
145953333|NCT02187029|526340495|FG002|Overall Study|Study Terminated by Sponsor|10|||
145953334|NCT02187029|526340496|FG003|Overall Study|Study Terminated by Sponsor|3|||
145953335|NCT02187029|526340493|FG000|Overall Study|Withdrawal by Subject|1|||
145953336|NCT02187029|526340494|FG001|Overall Study|Withdrawal by Subject|0|||
145953337|NCT02187029|526340495|FG002|Overall Study|Withdrawal by Subject|0|||
145953338|NCT02187029|526340496|FG003|Overall Study|Withdrawal by Subject|0|||
145953339|NCT03042910|526340497|FG000|Overall Study|Adverse Event|1|||
145953340|NCT03042910|526340497|FG000|Overall Study|Disease Progression|2|||
145953341|NCT03042910|526340497|FG000|Overall Study|Withdrawal by Subject|3|||
145953342|NCT03042910|526340497|FG000|Overall Study|Enrolled but not treated|1|||
145953343|NCT01909973|526340499|FG000|Overall Study|Lost to Follow-up|1|||
145953344|NCT01909973|526340500|FG001|Overall Study|Lost to Follow-up|0|||
145953345|NCT00809094|526340501|FG000|Overall Study|Lost to Follow-up|0|||
146440126|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440127|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440128|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
146440129|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953346|NCT00809094|526340502|FG001|Overall Study|Lost to Follow-up|1|||
145953347|NCT01690299|526340504|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
145953348|NCT01690299|526340505|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
145953349|NCT01690299|526340506|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
145953350|NCT01690299|526340507|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145953351|NCT01690299|526340508|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145953352|NCT01690299|526340509|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145953353|NCT01690299|526340504|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
145953354|NCT01690299|526340505|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145953355|NCT01690299|526340506|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145953356|NCT01690299|526340507|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145953357|NCT01690299|526340508|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145953358|NCT01690299|526340509|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145953359|NCT01690299|526340504|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
145953360|NCT01690299|526340505|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
145953361|NCT01690299|526340506|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145953362|NCT01690299|526340507|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145953363|NCT01690299|526340508|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145953364|NCT01690299|526340509|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145953365|NCT01690299|526340504|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
145953366|NCT01690299|526340505|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
145953367|NCT01690299|526340506|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
145953368|NCT01690299|526340507|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145953369|NCT01690299|526340508|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145953370|NCT01690299|526340509|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145953371|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145953372|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145953373|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145953374|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
145953375|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
145953376|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
145953377|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145953378|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145953379|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145953380|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
145953381|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
145953382|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
145953383|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145953384|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145953385|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145953386|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145953387|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
145953388|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
145953389|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145953390|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145953391|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145953392|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
145953393|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
145953394|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
145953395|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145953396|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145953397|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145953398|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
145953399|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
145953400|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
145953401|NCT01690299|526340504|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145953402|NCT01690299|526340505|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145953403|NCT01690299|526340506|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145953404|NCT01690299|526340507|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145953405|NCT01690299|526340508|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145953406|NCT01690299|526340509|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
145953407|NCT04676724|526340512|FG000|Overall Study|Adverse Event|2|||
145953408|NCT04676724|526340513|FG001|Overall Study|Adverse Event|0|||
145953409|NCT04676724|526340512|FG000|Overall Study|Lost to Follow-up|1|||
145953410|NCT04676724|526340513|FG001|Overall Study|Lost to Follow-up|0|||
146440130|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953411|NCT04676724|526340512|FG000|Overall Study|Physician Decision|0|||
146440131|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145953412|NCT04676724|526340513|FG001|Overall Study|Physician Decision|1|||
145953413|NCT04676724|526340512|FG000|Overall Study|Withdrawal by Subject|3|||
145953414|NCT04676724|526340513|FG001|Overall Study|Withdrawal by Subject|2|||
145953415|NCT00398047|526340517|FG000|Overall Study|all patient progressed before completion|3|||
145953416|NCT02521792|526340518|FG000|Overall Study|Study Terminated|6|||
145953417|NCT01151345|526340523|FG000|First Intervention Period|Protocol Violation|0|||
145953418|NCT01151345|526340524|FG001|First Intervention Period|Protocol Violation|1|||
145953419|NCT02588092|526340525|FG000|Overall Study|Death|4|||
145953420|NCT02588092|526340526|FG001|Overall Study|Death|3|||
145953421|NCT02588092|526340527|FG002|Overall Study|Death|3|||
145953422|NCT02588092|526340528|FG003|Overall Study|Death|3|||
145953423|NCT02588092|526340529|FG004|Overall Study|Death|2|||
145953424|NCT02588092|526340530|FG005|Overall Study|Death|2|||
145953425|NCT02588092|526340531|FG006|Overall Study|Death|2|||
145953426|NCT02588092|526340532|FG007|Overall Study|Death|1|||
145953427|NCT02588092|526340533|FG008|Overall Study|Death|5|||
145953428|NCT02588092|526340534|FG009|Overall Study|Death|2|||
145953429|NCT02588092|526340525|FG000|Overall Study|Withdrawal by Subject|0|||
145953430|NCT02588092|526340526|FG001|Overall Study|Withdrawal by Subject|0|||
145953431|NCT02588092|526340527|FG002|Overall Study|Withdrawal by Subject|0|||
145953432|NCT02588092|526340528|FG003|Overall Study|Withdrawal by Subject|0|||
145953433|NCT02588092|526340529|FG004|Overall Study|Withdrawal by Subject|0|||
145953434|NCT02588092|526340530|FG005|Overall Study|Withdrawal by Subject|1|||
145953435|NCT02588092|526340531|FG006|Overall Study|Withdrawal by Subject|1|||
145953436|NCT02588092|526340532|FG007|Overall Study|Withdrawal by Subject|2|||
145953437|NCT02588092|526340533|FG008|Overall Study|Withdrawal by Subject|0|||
145953438|NCT02588092|526340534|FG009|Overall Study|Withdrawal by Subject|0|||
145953439|NCT02588092|526340525|FG000|Overall Study|Started Another Treatment|0|||
145953440|NCT02588092|526340526|FG001|Overall Study|Started Another Treatment|0|||
145953441|NCT02588092|526340527|FG002|Overall Study|Started Another Treatment|0|||
145953442|NCT02588092|526340528|FG003|Overall Study|Started Another Treatment|0|||
145953443|NCT02588092|526340529|FG004|Overall Study|Started Another Treatment|1|||
145953444|NCT02588092|526340530|FG005|Overall Study|Started Another Treatment|0|||
145953445|NCT02588092|526340531|FG006|Overall Study|Started Another Treatment|0|||
145953446|NCT02588092|526340532|FG007|Overall Study|Started Another Treatment|1|||
145953447|NCT02588092|526340533|FG008|Overall Study|Started Another Treatment|0|||
145953448|NCT02588092|526340534|FG009|Overall Study|Started Another Treatment|0|||
145953449|NCT02588092|526340525|FG000|Overall Study|Sponsor Decision|0|||
145953450|NCT02588092|526340526|FG001|Overall Study|Sponsor Decision|0|||
146440132|NCT00112437|528115063|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440133|NCT00112437|528115064|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953451|NCT02588092|526340527|FG002|Overall Study|Sponsor Decision|0|||
145953452|NCT02588092|526340528|FG003|Overall Study|Sponsor Decision|0|||
145953453|NCT02588092|526340529|FG004|Overall Study|Sponsor Decision|0|||
145953454|NCT02588092|526340530|FG005|Overall Study|Sponsor Decision|0|||
145953455|NCT02588092|526340531|FG006|Overall Study|Sponsor Decision|0|||
145953456|NCT02588092|526340532|FG007|Overall Study|Sponsor Decision|0|||
145953457|NCT02588092|526340533|FG008|Overall Study|Sponsor Decision|1|||
145953458|NCT02588092|526340534|FG009|Overall Study|Sponsor Decision|1|||
145953459|NCT01348100|526340535|FG000|Overall Study|Subject Withdrew Consent|0|||
145953460|NCT01348100|526340536|FG001|Overall Study|Subject Withdrew Consent|0|||
145953461|NCT01348100|526340537|FG002|Overall Study|Subject Withdrew Consent|2|||
145953462|NCT01348100|526340538|FG003|Overall Study|Subject Withdrew Consent|0|||
145953463|NCT01348100|526340539|FG004|Overall Study|Subject Withdrew Consent|1|||
145953464|NCT01348100|526340540|FG005|Overall Study|Subject Withdrew Consent|0|||
145953465|NCT01348100|526340541|FG006|Overall Study|Subject Withdrew Consent|1|||
145953466|NCT01348100|526340535|FG000|Overall Study|Protocol Deviation|0|||
145953467|NCT01348100|526340536|FG001|Overall Study|Protocol Deviation|0|||
145953468|NCT01348100|526340537|FG002|Overall Study|Protocol Deviation|0|||
145953469|NCT01348100|526340538|FG003|Overall Study|Protocol Deviation|1|||
145953470|NCT01348100|526340539|FG004|Overall Study|Protocol Deviation|0|||
145953471|NCT01348100|526340540|FG005|Overall Study|Protocol Deviation|0|||
145953472|NCT01348100|526340541|FG006|Overall Study|Protocol Deviation|0|||
145953473|NCT01348100|526340535|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953474|NCT01348100|526340536|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953475|NCT01348100|526340537|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953476|NCT01348100|526340538|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953477|NCT01348100|526340539|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953478|NCT01348100|526340540|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145953479|NCT01348100|526340541|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145953480|NCT01348100|526340535|FG000|Overall Study|Lost to Follow-up|0|||
145953481|NCT01348100|526340536|FG001|Overall Study|Lost to Follow-up|0|||
145953482|NCT01348100|526340537|FG002|Overall Study|Lost to Follow-up|0|||
145953483|NCT01348100|526340538|FG003|Overall Study|Lost to Follow-up|0|||
145953484|NCT01348100|526340539|FG004|Overall Study|Lost to Follow-up|0|||
145953485|NCT01348100|526340540|FG005|Overall Study|Lost to Follow-up|0|||
145953486|NCT01348100|526340541|FG006|Overall Study|Lost to Follow-up|1|||
145953487|NCT01348100|526340535|FG000|Overall Study|Administrative Problems|0|||
145953488|NCT01348100|526340536|FG001|Overall Study|Administrative Problems|0|||
145953489|NCT01348100|526340537|FG002|Overall Study|Administrative Problems|0|||
146440134|NCT00112437|528115065|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440135|NCT00112437|528115066|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440136|NCT00112437|528115067|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440137|NCT00112437|528115068|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440138|NCT00112437|528115069|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440139|NCT00112437|528115070|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440140|NCT00112437|528115071|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440141|NCT00112437|528115072|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953490|NCT01348100|526340538|FG003|Overall Study|Administrative Problems|0|||
145953491|NCT01348100|526340539|FG004|Overall Study|Administrative Problems|0|||
145953492|NCT01348100|526340540|FG005|Overall Study|Administrative Problems|1|||
145953493|NCT01348100|526340541|FG006|Overall Study|Administrative Problems|1|||
145953494|NCT03883477|526340542|FG000|Overall Study|Death|1|||
145953495|NCT03883477|526340543|FG001|Overall Study|Death|0|||
145953496|NCT03883477|526340542|FG000|Overall Study|Protocol Violation|0|||
145953497|NCT03883477|526340543|FG001|Overall Study|Protocol Violation|1|||
145953498|NCT03762681|526340554|FG000|Part 1|Withdrawal by Subject|0|||
145953499|NCT03762681|526340555|FG001|Part 1|Withdrawal by Subject|0|||
145953500|NCT03762681|526340556|FG002|Part 1|Withdrawal by Subject|0|||
145953501|NCT03762681|526340557|FG003|Part 1|Withdrawal by Subject|1|||
145953502|NCT03762681|526340558|FG004|Part 1|Withdrawal by Subject|0|||
145953503|NCT03762681|526340559|FG005|Part 1|Withdrawal by Subject|0|||
145953504|NCT03762681|526340560|FG006|Part 1|Withdrawal by Subject|0|||
145953505|NCT03762681|526340561|FG007|Part 1|Withdrawal by Subject|0|||
145953506|NCT03762681|526340554|FG000|Part 2a|Pandemic Travel Restrictions|0|||
145953507|NCT03762681|526340555|FG001|Part 2a|Pandemic Travel Restrictions|0|||
145953508|NCT03762681|526340556|FG002|Part 2a|Pandemic Travel Restrictions|0|||
145953509|NCT03762681|526340557|FG003|Part 2a|Pandemic Travel Restrictions|0|||
145953510|NCT03762681|526340558|FG004|Part 2a|Pandemic Travel Restrictions|0|||
145953511|NCT03762681|526340559|FG005|Part 2a|Pandemic Travel Restrictions|0|||
145953512|NCT03762681|526340560|FG006|Part 2a|Pandemic Travel Restrictions|0|||
145953513|NCT03762681|526340561|FG007|Part 2a|Pandemic Travel Restrictions|1|||
145953514|NCT03148067|526340562|FG000|Overall Study|Lost to Follow-up|3|||
145953515|NCT03148067|526340562|FG000|Overall Study|Death|1|||
145953516|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
145953517|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
145953518|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
145953519|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
145953520|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
146440142|NCT00112437|528115073|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
146440143|NCT00112437|528115074|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
145953521|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
145953522|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
145953523|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
145953524|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
146083096|NCT01534182|526824738|FG000|Overall Study|Withdrawal by Subject|4|||
145953525|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
145953526|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145953527|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145953528|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
146083097|NCT01534182|526824739|FG001|Overall Study|Withdrawal by Subject|7|||
145953529|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
145953530|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145953531|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145953532|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
145953533|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145953534|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145953535|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145953536|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953537|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953538|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
145953539|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953540|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953541|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953542|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953543|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953544|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953545|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145953546|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953547|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953548|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953549|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953550|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953551|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
145953552|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953553|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
145953554|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953555|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145953556|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145953557|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145953558|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145953559|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145953560|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
145953561|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145953562|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145953563|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145953564|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145953565|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145953566|NCT04074330|526340570|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953567|NCT04074330|526340571|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145953568|NCT04074330|526340572|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145953569|NCT04074330|526340573|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145953570|NCT04074330|526340574|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953571|NCT04074330|526340575|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145953572|NCT04074330|526340576|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953573|NCT04074330|526340577|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953574|NCT04074330|526340578|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953575|NCT04074330|526340579|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145953576|NCT04074330|526340570|FG000|Dose Expansion (up to 42 Months)|Death|0|||
145953577|NCT04074330|526340571|FG001|Dose Expansion (up to 42 Months)|Death|0|||
145953578|NCT04074330|526340572|FG002|Dose Expansion (up to 42 Months)|Death|0|||
145953579|NCT04074330|526340573|FG003|Dose Expansion (up to 42 Months)|Death|0|||
145953580|NCT04074330|526340574|FG004|Dose Expansion (up to 42 Months)|Death|0|||
145953581|NCT04074330|526340575|FG005|Dose Expansion (up to 42 Months)|Death|0|||
145953582|NCT04074330|526340576|FG006|Dose Expansion (up to 42 Months)|Death|0|||
145953583|NCT04074330|526340577|FG007|Dose Expansion (up to 42 Months)|Death|0|||
145953584|NCT04074330|526340578|FG008|Dose Expansion (up to 42 Months)|Death|1|||
145953585|NCT04074330|526340579|FG009|Dose Expansion (up to 42 Months)|Death|0|||
145953586|NCT04074330|526340570|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953587|NCT04074330|526340571|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953588|NCT04074330|526340572|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953589|NCT04074330|526340573|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953590|NCT04074330|526340574|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953591|NCT04074330|526340575|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953592|NCT04074330|526340576|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953593|NCT04074330|526340577|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145953594|NCT04074330|526340578|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
145953595|NCT04074330|526340579|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
145953596|NCT03124537|526340580|FG000|Overall Study|Lost to Follow-up|3|||
145953597|NCT03124537|526340581|FG001|Overall Study|Lost to Follow-up|5|||
145953598|NCT03124537|526340580|FG000|Overall Study|App Crash, Incomplete Data|7|||
145953599|NCT03124537|526340581|FG001|Overall Study|App Crash, Incomplete Data|8|||
145953600|NCT03301831|526340582|FG000|Overall Study|Lost to Follow-up|5|||
145953601|NCT03301831|526340583|FG001|Overall Study|Lost to Follow-up|3|||
145953602|NCT03301831|526340582|FG000|Overall Study|Protocol Violation|4|||
145953603|NCT03301831|526340583|FG001|Overall Study|Protocol Violation|0|||
145953604|NCT03301831|526340582|FG000|Overall Study|Withdrawal by Subject|11|||
145953605|NCT03301831|526340583|FG001|Overall Study|Withdrawal by Subject|0|||
145953606|NCT00913770|526340585|FG000|Overall Study|Unable to contact|24|||
145953607|NCT00913770|526340586|FG001|Overall Study|Unable to contact|19|||
145953608|NCT00913770|526340587|FG002|Overall Study|Unable to contact|13|||
145953609|NCT00913770|526340585|FG000|Overall Study|Refused|11|||
145953610|NCT00913770|526340586|FG001|Overall Study|Refused|10|||
145953611|NCT00913770|526340587|FG002|Overall Study|Refused|8|||
145953612|NCT02348008|526340588|FG000|Overall Study|Adverse Event|2|||
146083098|NCT01534182|526824738|FG000|Overall Study|Adverse Event|7|||
146083099|NCT01534182|526824739|FG001|Overall Study|Adverse Event|3|||
146083100|NCT01525901|526824742|FG000|Period 2: 12 Weeks|Adverse Event|0|||
145953613|NCT02348008|526340589|FG001|Overall Study|Adverse Event|3|||
145953614|NCT02348008|526340590|FG002|Overall Study|Adverse Event|3|||
145953615|NCT02348008|526340588|FG000|Overall Study|Disease Progression|1|||
145953616|NCT02348008|526340589|FG001|Overall Study|Disease Progression|5|||
145953617|NCT02348008|526340590|FG002|Overall Study|Disease Progression|16|||
145953618|NCT02348008|526340588|FG000|Overall Study|Withdrawal by Subject|0|||
145953619|NCT02348008|526340589|FG001|Overall Study|Withdrawal by Subject|1|||
145953620|NCT02348008|526340590|FG002|Overall Study|Withdrawal by Subject|0|||
145953621|NCT02348008|526340588|FG000|Overall Study|Symptomatic Deterioration|0|||
145953622|NCT02348008|526340589|FG001|Overall Study|Symptomatic Deterioration|1|||
145953623|NCT02348008|526340590|FG002|Overall Study|Symptomatic Deterioration|0|||
145953624|NCT00893971|526340595|FG000|Overall Study|Physician Decision|3|||
145953625|NCT03268005|526340596|FG000|Overall Study|Death|2|||
145953626|NCT03268005|526340597|FG001|Overall Study|Death|1|||
145953627|NCT03268005|526340596|FG000|Overall Study|Lost to Follow-up|2|||
145953628|NCT03268005|526340597|FG001|Overall Study|Lost to Follow-up|2|||
145953629|NCT03268005|526340596|FG000|Overall Study|Withdrawal by Subject|11|||
145953630|NCT03268005|526340597|FG001|Overall Study|Withdrawal by Subject|11|||
145953631|NCT00492232|526340598|FG000|Placebo Run-in|Adverse Event|0|||
145953632|NCT00492232|526340599|FG001|Placebo Run-in|Adverse Event|2|||
145953633|NCT00492232|526340598|FG000|Placebo Run-in|Protocol Violation|0|||
145953634|NCT00492232|526340599|FG001|Placebo Run-in|Protocol Violation|3|||
145953635|NCT00492232|526340598|FG000|Placebo Run-in|Lost to Follow-up|0|||
145953636|NCT00492232|526340599|FG001|Placebo Run-in|Lost to Follow-up|3|||
145953637|NCT00492232|526340598|FG000|Placebo Run-in|Withdrawal by Subject|0|||
145953638|NCT00492232|526340599|FG001|Placebo Run-in|Withdrawal by Subject|8|||
145953639|NCT00492232|526340598|FG000|Placebo Run-in|Pregnancy|0|||
145953640|NCT00492232|526340599|FG001|Placebo Run-in|Pregnancy|1|||
145953641|NCT00492232|526340598|FG000|Placebo Run-in|Entrance criteria not met|0|||
145953642|NCT00492232|526340599|FG001|Placebo Run-in|Entrance criteria not met|45|||
145953643|NCT00492232|526340598|FG000|Placebo Run-in|Other|0|||
145953644|NCT00492232|526340599|FG001|Placebo Run-in|Other|6|||
145953645|NCT00492232|526340598|FG000|Placebo Run-in|Missing|0|||
145953646|NCT00492232|526340599|FG001|Placebo Run-in|Missing|2|||
145953647|NCT00492232|526340598|FG000|Double-Blind Treatment|Adverse Event|1|||
145953648|NCT00492232|526340599|FG001|Double-Blind Treatment|Adverse Event|2|||
145953649|NCT00492232|526340598|FG000|Double-Blind Treatment|Protocol Violation|3|||
145953650|NCT00492232|526340599|FG001|Double-Blind Treatment|Protocol Violation|7|||
145953651|NCT00492232|526340598|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
145953652|NCT00492232|526340599|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
145953653|NCT00492232|526340598|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
145953654|NCT00492232|526340599|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
145953655|NCT00492232|526340598|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
145953656|NCT00492232|526340599|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
145953657|NCT00492232|526340598|FG000|Double-Blind Treatment|Other|6|||
145953658|NCT00492232|526340599|FG001|Double-Blind Treatment|Other|5|||
145953659|NCT00492232|526340598|FG000|Double-Blind Treatment|Randomized not treated|1|||
145953660|NCT00492232|526340599|FG001|Double-Blind Treatment|Randomized not treated|0|||
145953661|NCT00492232|526340598|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
145953662|NCT00492232|526340599|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
145953663|NCT03597139|526340603|FG000|Overall Study|Adverse Event|3|||
145953664|NCT03597139|526340604|FG001|Overall Study|Adverse Event|0|||
145953665|NCT03597139|526340603|FG000|Overall Study|Protocol Non-compliance|1|||
145953666|NCT03597139|526340604|FG001|Overall Study|Protocol Non-compliance|0|||
145953667|NCT00398216|526343231|FG000|Overall Study|Adverse Event|4|||
145953668|NCT00398216|526343232|FG001|Overall Study|Adverse Event|2|||
145953669|NCT00398216|526343233|FG002|Overall Study|Adverse Event|5|||
145953670|NCT00398216|526343234|FG003|Overall Study|Adverse Event|7|||
145953671|NCT00398216|526343235|FG004|Overall Study|Adverse Event|2|||
146440144|NCT00112437|528115075|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953672|NCT00398216|526343231|FG000|Overall Study|Protocol Violation|2|||
145953673|NCT00398216|526343232|FG001|Overall Study|Protocol Violation|4|||
145953674|NCT00398216|526343233|FG002|Overall Study|Protocol Violation|5|||
145953675|NCT00398216|526343234|FG003|Overall Study|Protocol Violation|7|||
145953676|NCT00398216|526343235|FG004|Overall Study|Protocol Violation|5|||
145953677|NCT00398216|526343231|FG000|Overall Study|Lost to Follow-up|1|||
145953678|NCT00398216|526343232|FG001|Overall Study|Lost to Follow-up|6|||
145953679|NCT00398216|526343233|FG002|Overall Study|Lost to Follow-up|4|||
145953680|NCT00398216|526343234|FG003|Overall Study|Lost to Follow-up|4|||
145953681|NCT00398216|526343235|FG004|Overall Study|Lost to Follow-up|1|||
145953682|NCT00398216|526343231|FG000|Overall Study|Death|0|||
145953683|NCT00398216|526343232|FG001|Overall Study|Death|3|||
145953684|NCT00398216|526343233|FG002|Overall Study|Death|0|||
145953685|NCT00398216|526343234|FG003|Overall Study|Death|0|||
145953686|NCT00398216|526343235|FG004|Overall Study|Death|0|||
145953687|NCT00398216|526343231|FG000|Overall Study|Withdrawal by Subject|1|||
145953688|NCT00398216|526343232|FG001|Overall Study|Withdrawal by Subject|0|||
145953689|NCT00398216|526343233|FG002|Overall Study|Withdrawal by Subject|3|||
145953690|NCT00398216|526343234|FG003|Overall Study|Withdrawal by Subject|1|||
145953691|NCT00398216|526343235|FG004|Overall Study|Withdrawal by Subject|2|||
145953692|NCT00398216|526343231|FG000|Overall Study|administrative reasons|3|||
145953693|NCT00398216|526343232|FG001|Overall Study|administrative reasons|4|||
145953694|NCT00398216|526343233|FG002|Overall Study|administrative reasons|4|||
145953695|NCT00398216|526343234|FG003|Overall Study|administrative reasons|3|||
145953696|NCT00398216|526343235|FG004|Overall Study|administrative reasons|3|||
145953697|NCT00398216|526343231|FG000|Overall Study|entrance criteria|0|||
145953698|NCT00398216|526343232|FG001|Overall Study|entrance criteria|0|||
145953699|NCT00398216|526343233|FG002|Overall Study|entrance criteria|0|||
145953700|NCT00398216|526343234|FG003|Overall Study|entrance criteria|0|||
145953701|NCT00398216|526343235|FG004|Overall Study|entrance criteria|2|||
145953702|NCT00802672|526343236|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
145953703|NCT00802672|526343237|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
145953704|NCT00802672|526343238|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
145953705|NCT00802672|526343236|FG000|Overall Study|Adverse Event|1|||
145953706|NCT00802672|526343237|FG001|Overall Study|Adverse Event|1|||
145953707|NCT00802672|526343238|FG002|Overall Study|Adverse Event|1|||
145953708|NCT00802672|526343236|FG000|Overall Study|Protocol Violation|2|||
145953709|NCT00802672|526343237|FG001|Overall Study|Protocol Violation|1|||
145953710|NCT00802672|526343238|FG002|Overall Study|Protocol Violation|1|||
145953711|NCT00802672|526343236|FG000|Overall Study|Lost to Follow-up|5|||
145953712|NCT00802672|526343237|FG001|Overall Study|Lost to Follow-up|5|||
145953713|NCT00802672|526343238|FG002|Overall Study|Lost to Follow-up|3|||
145953714|NCT00802672|526343236|FG000|Overall Study|Withdrawal by Subject|1|||
145953715|NCT00802672|526343237|FG001|Overall Study|Withdrawal by Subject|1|||
145953716|NCT00802672|526343238|FG002|Overall Study|Withdrawal by Subject|2|||
145953717|NCT00802672|526343236|FG000|Overall Study|other|3|||
145953718|NCT00802672|526343237|FG001|Overall Study|other|1|||
145953719|NCT00802672|526343238|FG002|Overall Study|other|2|||
145953720|NCT02579382|526343239|FG000|Main Study Phase|Lost to Follow-up|0|||
145953721|NCT02579382|526343240|FG001|Main Study Phase|Lost to Follow-up|0|||
145953722|NCT02579382|526343241|FG002|Main Study Phase|Lost to Follow-up|2|||
145953723|NCT02579382|526343242|FG003|Main Study Phase|Lost to Follow-up|0|||
145953724|NCT02579382|526343239|FG000|Main Study Phase|Withdrew Consent|0|||
145953725|NCT02579382|526343240|FG001|Main Study Phase|Withdrew Consent|0|||
145953726|NCT02579382|526343241|FG002|Main Study Phase|Withdrew Consent|0|||
145953727|NCT02579382|526343242|FG003|Main Study Phase|Withdrew Consent|2|||
145953728|NCT02579382|526343239|FG000|Main Study Phase|Lack of Efficacy|0|||
145953729|NCT02579382|526343240|FG001|Main Study Phase|Lack of Efficacy|0|||
145953730|NCT02579382|526343241|FG002|Main Study Phase|Lack of Efficacy|0|||
145953731|NCT02579382|526343242|FG003|Main Study Phase|Lack of Efficacy|1|||
145953732|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
145953733|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
145953734|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
145953735|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
145953736|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
145953737|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
145953738|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
145953739|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
145953740|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
145953741|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145953742|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145953743|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145953744|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145953745|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
145953746|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145953747|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145953748|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145953749|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
145953750|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145953751|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145953752|NCT02579382|526343239|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145953753|NCT02579382|526343240|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
145953754|NCT02579382|526343241|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145953755|NCT02579382|526343242|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145953756|NCT00667992|526343243|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
145953757|NCT00667992|526343244|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
145953758|NCT00667992|526343243|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
145953759|NCT00667992|526343244|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
145953760|NCT00667992|526343243|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145953761|NCT00667992|526343244|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145953762|NCT00667992|526343243|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
145953763|NCT00667992|526343244|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
145953764|NCT00667992|526343243|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145953765|NCT00667992|526343244|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145953766|NCT00667992|526343243|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
145953767|NCT00667992|526343244|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
145953768|NCT00667992|526343243|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
145953769|NCT00667992|526343244|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
145953770|NCT00667992|526343243|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
145953771|NCT00667992|526343244|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
145953772|NCT00667992|526343243|FG000|Wash-out|Not within one doubling dilution|4|||
145953773|NCT00667992|526343244|FG001|Wash-out|Not within one doubling dilution|3|||
145953774|NCT00667992|526343243|FG000|Wash-out|Failure to wash-out|2|||
145953775|NCT00667992|526343244|FG001|Wash-out|Failure to wash-out|2|||
145953776|NCT00667992|526343243|FG000|Wash-out|Withdrawal by Subject|1|||
145953777|NCT00667992|526343244|FG001|Wash-out|Withdrawal by Subject|0|||
145953778|NCT00667992|526343243|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
145953779|NCT00667992|526343244|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
145953780|NCT00667992|526343243|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145953781|NCT00667992|526343244|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145953782|NCT02906579|526343251|FG000|Overall Study|Adverse Event|1|||
145953783|NCT02906579|526343251|FG000|Overall Study|Physician Decision|1|||
145953784|NCT00759655|526343252|FG000|Overall Study|Termination of the study by sponsor|1|||
145953785|NCT02213380|526343253|FG000|Underwent Randomization|Withdrawal by Subject|2|||
145953786|NCT02213380|526343254|FG001|Underwent Randomization|Withdrawal by Subject|0|||
145953787|NCT02213380|526343253|FG000|Underwent Randomization|Not treated|3|||
145953788|NCT02213380|526343254|FG001|Underwent Randomization|Not treated|3|||
145953789|NCT02213380|526343253|FG000|Per-protocol Analysis|Protocol Violation|32|||
145953790|NCT02213380|526343254|FG001|Per-protocol Analysis|Protocol Violation|36|||
145953791|NCT01310127|526343258|FG000|Overall Study|Protocol Violation|1|||
145953792|NCT01310127|526343259|FG001|Overall Study|Protocol Violation|1|||
145953793|NCT01310127|526343258|FG000|Overall Study|advanced psc cataract outlier|1|||
145953794|NCT01310127|526343259|FG001|Overall Study|advanced psc cataract outlier|0|||
145953795|NCT01490840|526343260|FG000|Phase 1|Lost to Follow-up|1|||
145953796|NCT01490840|526343261|FG001|Phase 1|Lost to Follow-up|0|||
145953797|NCT01490840|526343260|FG000|Phase 1|Adverse Event|2|||
145953798|NCT01490840|526343261|FG001|Phase 1|Adverse Event|1|||
145953799|NCT01490840|526343260|FG000|Phase 1|Withdrawal by Subject|6|||
145953800|NCT01490840|526343261|FG001|Phase 1|Withdrawal by Subject|5|||
145953801|NCT01490840|526343260|FG000|Phase 1|Visit 6a omitted|1|||
145953802|NCT01490840|526343261|FG001|Phase 1|Visit 6a omitted|0|||
145953803|NCT01490840|526343260|FG000|Phase 2|Withdrawal by Subject|4|||
145953804|NCT01490840|526343261|FG001|Phase 2|Withdrawal by Subject|3|||
145953805|NCT01490840|526343260|FG000|Phase 2|Permanent interruption of fingolimod|0|||
145953806|NCT01490840|526343261|FG001|Phase 2|Permanent interruption of fingolimod|1|||
145953807|NCT01490840|526343260|FG000|Phase 2|Lost to Follow-up|1|||
146440145|NCT00112437|528115076|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953808|NCT01490840|526343261|FG001|Phase 2|Lost to Follow-up|1|||
145953809|NCT01490840|526343260|FG000|Phase 2|Adverse Event|1|||
145953810|NCT01490840|526343261|FG001|Phase 2|Adverse Event|1|||
145953811|NCT01025284|526343265|FG000|Overall Study|Investigator Decision|0|||
145953812|NCT01025284|526343266|FG001|Overall Study|Investigator Decision|1|||
145953813|NCT01025284|526343267|FG002|Overall Study|Investigator Decision|0|||
145953814|NCT01025284|526343265|FG000|Overall Study|Withdrawal by Subject|0|||
145953815|NCT01025284|526343266|FG001|Overall Study|Withdrawal by Subject|1|||
145953816|NCT01025284|526343267|FG002|Overall Study|Withdrawal by Subject|0|||
145953817|NCT00905567|526343268|FG000|Washout|Withdrawal by Subject|0|||
145953818|NCT00905567|526343269|FG001|Washout|Withdrawal by Subject|1|||
145953819|NCT02542397|526343270|FG000|Overall Study|Death|2|||
145953820|NCT02542397|526343270|FG000|Overall Study|Physician Decision|6|||
145953821|NCT02542397|526343270|FG000|Overall Study|Withdrawal by Subject|6|||
145953822|NCT02542397|526343270|FG000|Overall Study|Lost to Follow-up|2|||
145953823|NCT01473940|526343276|FG000|Induction Therapy|Death|0|||
145953824|NCT01473940|526343277|FG001|Induction Therapy|Death|0|||
145953825|NCT01473940|526343278|FG002|Induction Therapy|Death|1|||
145953826|NCT01473940|526343279|FG003|Induction Therapy|Death|1|||
145953827|NCT01473940|526343276|FG000|Induction Therapy|Progressive Disease|0|||
145953828|NCT01473940|526343277|FG001|Induction Therapy|Progressive Disease|1|||
145953829|NCT01473940|526343278|FG002|Induction Therapy|Progressive Disease|1|||
145953830|NCT01473940|526343279|FG003|Induction Therapy|Progressive Disease|0|||
145953831|NCT01473940|526343276|FG000|Maintenance Therapy|Progressive Disease|1|||
145953832|NCT01473940|526343277|FG001|Maintenance Therapy|Progressive Disease|2|||
145953833|NCT01473940|526343278|FG002|Maintenance Therapy|Progressive Disease|1|||
145953834|NCT01473940|526343279|FG003|Maintenance Therapy|Progressive Disease|4|||
145953835|NCT00547248|526343280|FG000|Overall Study|Protocol Violation|0|||
145953836|NCT00547248|526343281|FG001|Overall Study|Protocol Violation|0|||
145953837|NCT00547248|526343282|FG002|Overall Study|Protocol Violation|1|||
145953838|NCT00547248|526343283|FG003|Overall Study|Protocol Violation|1|||
145953839|NCT00547248|526343280|FG000|Overall Study|Migrated/moved from study area|0|||
145953840|NCT00547248|526343281|FG001|Overall Study|Migrated/moved from study area|0|||
145953841|NCT00547248|526343282|FG002|Overall Study|Migrated/moved from study area|2|||
145953842|NCT00547248|526343283|FG003|Overall Study|Migrated/moved from study area|0|||
145953843|NCT00547248|526343280|FG000|Overall Study|Withdrawal by Subject|0|||
145953844|NCT00547248|526343281|FG001|Overall Study|Withdrawal by Subject|0|||
145953845|NCT00547248|526343282|FG002|Overall Study|Withdrawal by Subject|7|||
145953846|NCT00547248|526343283|FG003|Overall Study|Withdrawal by Subject|1|||
145953847|NCT00534248|526343284|FG000|Overall Study|Adverse Event|19|||
145953848|NCT00534248|526343285|FG001|Overall Study|Adverse Event|29|||
145953849|NCT00534248|526343284|FG000|Overall Study|Lost to Follow-up|353|||
145953850|NCT00534248|526343285|FG001|Overall Study|Lost to Follow-up|375|||
145953851|NCT00534248|526343284|FG000|Overall Study|Other protocol specified criteria|13|||
145953852|NCT00534248|526343285|FG001|Overall Study|Other protocol specified criteria|3|||
145953853|NCT00534248|526343284|FG000|Overall Study|Physician Decision|10|||
145953854|NCT00534248|526343285|FG001|Overall Study|Physician Decision|7|||
145953855|NCT00534248|526343284|FG000|Overall Study|Protocol Violation|3|||
145953856|NCT00534248|526343285|FG001|Overall Study|Protocol Violation|4|||
146285544|NCT05917470|527557890|FG001|Overall Study|Withdrawal by Subject|0|||
146285545|NCT05917470|527557891|FG002|Overall Study|Withdrawal by Subject|1|||
146285546|NCT05917470|527557892|FG003|Overall Study|Withdrawal by Subject|0|||
146285547|NCT05917470|527557893|FG004|Overall Study|Withdrawal by Subject|0|||
146285548|NCT05917470|527557894|FG005|Overall Study|Withdrawal by Subject|0|||
146285549|NCT05917470|527557895|FG006|Overall Study|Withdrawal by Subject|0|||
146285550|NCT05917470|527557896|FG007|Overall Study|Withdrawal by Subject|0|||
146285551|NCT05917470|527557889|FG000|Overall Study|Sponsor Decision|0|||
146285552|NCT05917470|527557890|FG001|Overall Study|Sponsor Decision|0|||
146285553|NCT05917470|527557891|FG002|Overall Study|Sponsor Decision|1|||
146285554|NCT05917470|527557892|FG003|Overall Study|Sponsor Decision|0|||
146285555|NCT05917470|527557893|FG004|Overall Study|Sponsor Decision|2|||
146285556|NCT05917470|527557894|FG005|Overall Study|Sponsor Decision|1|||
146285557|NCT05917470|527557895|FG006|Overall Study|Sponsor Decision|3|||
146285558|NCT05917470|527557896|FG007|Overall Study|Sponsor Decision|3|||
146285559|NCT05917470|527557889|FG000|Overall Study|Adverse Event|0|||
146285560|NCT05917470|527557890|FG001|Overall Study|Adverse Event|0|||
146285561|NCT05917470|527557891|FG002|Overall Study|Adverse Event|0|||
146285562|NCT05917470|527557892|FG003|Overall Study|Adverse Event|0|||
146285563|NCT05917470|527557893|FG004|Overall Study|Adverse Event|0|||
146285564|NCT05917470|527557894|FG005|Overall Study|Adverse Event|1|||
145953857|NCT00534248|526343284|FG000|Overall Study|Withdrawal by Subject|263|||
145953858|NCT00534248|526343285|FG001|Overall Study|Withdrawal by Subject|255|||
146285565|NCT05917470|527557895|FG006|Overall Study|Adverse Event|0|||
146285566|NCT05917470|527557896|FG007|Overall Study|Adverse Event|0|||
146285567|NCT01290029|527561055|FG000|Overall Study|Other|2|||
146285568|NCT00189488|527561056|FG000|Overall Study|Ineligibility determined|1|||
146285569|NCT00189488|527561057|FG001|Overall Study|Ineligibility determined|0|||
146285570|NCT00189488|527561056|FG000|Overall Study|Protocol deviation|2|||
146285571|NCT00189488|527561057|FG001|Overall Study|Protocol deviation|1|||
145953859|NCT00697593|526343290|FG000|Overall Study|Adverse Event|3|||
145953860|NCT00697593|526343290|FG000|Overall Study|Protocol Violation|1|||
145953861|NCT00697593|526343290|FG000|Overall Study|Lack of Efficacy|3|||
145953862|NCT00697593|526343290|FG000|Overall Study|Suspension of the study by sponsor|12|||
145953863|NCT02075008|526343299|FG000|Overall Study|Technical problems|1|||
145953864|NCT02075008|526343299|FG000|Overall Study|Pregnancy|1|||
145953865|NCT02075008|526343299|FG000|Overall Study|Physician Decision|1|||
145953866|NCT02075008|526343299|FG000|Overall Study|Lost to Follow-up|1|||
145953867|NCT02075008|526343299|FG000|Overall Study|Lack of Efficacy|1|||
145953868|NCT02075008|526343299|FG000|Overall Study|Death|1|||
146083101|NCT01525901|526824743|FG001|Period 2: 12 Weeks|Adverse Event|1|||
146083102|NCT01525901|526824744|FG002|Period 2: 12 Weeks|Adverse Event|0|||
145953869|NCT02075008|526343299|FG000|Overall Study|Adverse Event|5|||
145953870|NCT02075008|526343299|FG000|Overall Study|Withdrawal by Subject|6|||
145953871|NCT02075008|526343299|FG000|Overall Study|Study terminated by Sponsor|159|||
145953872|NCT04446429|526343300|FG000|Overall Study|Lost to Follow-up|6|||
145953873|NCT04446429|526343301|FG001|Overall Study|Lost to Follow-up|0|||
145953874|NCT05205005|526343302|FG000|Overall Study|Withdrawal by Subject|1|||
145953875|NCT05205005|526343303|FG001|Overall Study|Withdrawal by Subject|0|||
145953876|NCT05205005|526343302|FG000|Overall Study|Adverse Event|1|||
145953877|NCT05205005|526343303|FG001|Overall Study|Adverse Event|0|||
145953878|NCT00694356|526343307|FG000|Overall Study|Adverse Event|1|||
145953879|NCT00694356|526343308|FG001|Overall Study|Adverse Event|0|||
145953880|NCT00694356|526343309|FG002|Overall Study|Adverse Event|0|||
145953881|NCT00694356|526343307|FG000|Overall Study|Progressive Disease|2|||
145953882|NCT00694356|526343308|FG001|Overall Study|Progressive Disease|6|||
145953883|NCT00694356|526343309|FG002|Overall Study|Progressive Disease|6|||
145953884|NCT01763203|526343316|FG000|Overall Study|Death|4|||
145953885|NCT01763203|526343317|FG001|Overall Study|Death|7|||
145953886|NCT01763203|526343316|FG000|Overall Study|Lost to Follow-up|12|||
145953887|NCT01763203|526343317|FG001|Overall Study|Lost to Follow-up|12|||
145953888|NCT01763203|526343316|FG000|Overall Study|Withdrawal by Subject|8|||
145953889|NCT01763203|526343317|FG001|Overall Study|Withdrawal by Subject|12|||
145953890|NCT01763203|526343316|FG000|Overall Study|Moved out of study region|7|||
145953891|NCT01763203|526343317|FG001|Overall Study|Moved out of study region|10|||
145953892|NCT01763203|526343316|FG000|Overall Study|Physician Decision|2|||
145953893|NCT01763203|526343317|FG001|Overall Study|Physician Decision|1|||
145953894|NCT02756819|526343321|FG000|Overall Study|Lost for observation|23|||
146285572|NCT00189488|527561056|FG000|Overall Study|Adverse Event|2|||
146440146|NCT00112437|528115077|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953895|NCT02756819|526343321|FG000|Overall Study|Patient's unwillingness|16|||
145953896|NCT02756819|526343321|FG000|Overall Study|Insufficient efficacy|2|||
145953897|NCT02756819|526343321|FG000|Overall Study|Adverse Event|2|||
145953898|NCT02756819|526343321|FG000|Overall Study|Reason not Specified|9|||
145953899|NCT01491841|526343323|FG000|Overall Study|Screen Failure|10|||
145953900|NCT01491841|526343323|FG000|Overall Study|Withdrawal by Subject|1|||
145953901|NCT02933528|526343324|FG000|Overall Study|Lost to Follow-up|2|||
145953902|NCT00741598|526343325|FG000|Overall Study|Lost to Follow-up|3|||
145953903|NCT00741598|526343326|FG001|Overall Study|Lost to Follow-up|4|||
145953904|NCT00741598|526343325|FG000|Overall Study|Lack of Efficacy|1|||
145953905|NCT00741598|526343326|FG001|Overall Study|Lack of Efficacy|2|||
145953906|NCT00741598|526343325|FG000|Overall Study|Physician Decision|1|||
145953907|NCT00741598|526343326|FG001|Overall Study|Physician Decision|1|||
145953908|NCT00741598|526343325|FG000|Overall Study|Pregnancy|1|||
145953909|NCT00741598|526343326|FG001|Overall Study|Pregnancy|0|||
145953910|NCT00741598|526343325|FG000|Overall Study|Withdrawal by Subject|3|||
145953911|NCT00741598|526343326|FG001|Overall Study|Withdrawal by Subject|2|||
145953912|NCT04105842|526343329|FG000|Overall Study|Withdrawal by Subject|2|||
145953913|NCT01301079|526343330|FG000|Overall Study|Lost to Follow-up|2|||
145953914|NCT01301079|526343331|FG001|Overall Study|Lost to Follow-up|2|||
145953915|NCT00313586|526343332|FG000|Overall Study|Disease progression|14|||
145953916|NCT00313586|526343333|FG001|Overall Study|Disease progression|19|||
145953917|NCT00313586|526343334|FG002|Overall Study|Disease progression|10|||
145953918|NCT00313586|526343335|FG003|Overall Study|Disease progression|3|||
145953919|NCT00313586|526343332|FG000|Overall Study|Adverse Event|12|||
145953920|NCT00313586|526343333|FG001|Overall Study|Adverse Event|18|||
145953921|NCT00313586|526343334|FG002|Overall Study|Adverse Event|3|||
145953922|NCT00313586|526343335|FG003|Overall Study|Adverse Event|10|||
145953923|NCT00313586|526343332|FG000|Overall Study|Death|11|||
145953924|NCT00313586|526343333|FG001|Overall Study|Death|8|||
145953925|NCT00313586|526343334|FG002|Overall Study|Death|1|||
145953926|NCT00313586|526343335|FG003|Overall Study|Death|7|||
145953927|NCT00313586|526343332|FG000|Overall Study|Withdrawal by Subject|13|||
145953928|NCT00313586|526343333|FG001|Overall Study|Withdrawal by Subject|6|||
145953929|NCT00313586|526343334|FG002|Overall Study|Withdrawal by Subject|6|||
145953930|NCT00313586|526343335|FG003|Overall Study|Withdrawal by Subject|2|||
145953931|NCT00313586|526343332|FG000|Overall Study|Alternative therapy|3|||
145953932|NCT00313586|526343333|FG001|Overall Study|Alternative therapy|6|||
145953933|NCT00313586|526343334|FG002|Overall Study|Alternative therapy|2|||
145953934|NCT00313586|526343335|FG003|Overall Study|Alternative therapy|0|||
145953935|NCT00313586|526343332|FG000|Overall Study|Other complicating disease|2|||
145953936|NCT00313586|526343333|FG001|Overall Study|Other complicating disease|2|||
145953937|NCT00313586|526343334|FG002|Overall Study|Other complicating disease|0|||
145953938|NCT00313586|526343335|FG003|Overall Study|Other complicating disease|0|||
145953939|NCT00313586|526343332|FG000|Overall Study|Did not achieve HI-major/better response|10|||
145953940|NCT00313586|526343333|FG001|Overall Study|Did not achieve HI-major/better response|7|||
145953941|NCT00313586|526343334|FG002|Overall Study|Did not achieve HI-major/better response|2|||
145953942|NCT00313586|526343335|FG003|Overall Study|Did not achieve HI-major/better response|1|||
145953943|NCT00313586|526343332|FG000|Overall Study|Physician Decision|2|||
145953944|NCT00313586|526343333|FG001|Overall Study|Physician Decision|1|||
145953945|NCT00313586|526343334|FG002|Overall Study|Physician Decision|0|||
145953946|NCT00313586|526343335|FG003|Overall Study|Physician Decision|0|||
145953947|NCT00313586|526343332|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
145953948|NCT00313586|526343333|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
145953949|NCT00313586|526343334|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
145953950|NCT00313586|526343335|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
145953951|NCT00313586|526343332|FG000|Overall Study|Lost insurance|0|||
145953952|NCT00313586|526343333|FG001|Overall Study|Lost insurance|1|||
145953953|NCT00313586|526343334|FG002|Overall Study|Lost insurance|0|||
145953954|NCT00313586|526343335|FG003|Overall Study|Lost insurance|0|||
146440147|NCT00112437|528115078|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440148|NCT00112437|528115079|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440149|NCT00112437|528115080|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440150|NCT00112437|528115081|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440151|NCT00112437|528115082|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440152|NCT00112437|528115083|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440153|NCT00112437|528115084|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440154|NCT00112437|528115085|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440155|NCT00112437|528115086|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145953955|NCT00313586|526343332|FG000|Overall Study|Moved|0|||
145953956|NCT00313586|526343333|FG001|Overall Study|Moved|1|||
145953957|NCT00313586|526343334|FG002|Overall Study|Moved|0|||
145953958|NCT00313586|526343335|FG003|Overall Study|Moved|0|||
145953959|NCT00313586|526343332|FG000|Overall Study|Death before starting treatment|1|||
145953960|NCT00313586|526343333|FG001|Overall Study|Death before starting treatment|0|||
145953961|NCT00313586|526343334|FG002|Overall Study|Death before starting treatment|0|||
145953962|NCT00313586|526343335|FG003|Overall Study|Death before starting treatment|0|||
145953963|NCT02087670|526343336|FG000|Overall Study|Withdrawal by Subject|3|||
145953964|NCT02087670|526343337|FG001|Overall Study|Withdrawal by Subject|2|||
145953965|NCT03519919|526343339|FG000|Overall Study|Withdrawal by Subject|1|||
145953966|NCT03519919|526343339|FG000|Overall Study|Lack of Efficacy|1|||
145953967|NCT03519919|526343339|FG000|Overall Study|Screen Failure|1|||
145953968|NCT03076996|526343340|FG000|Overall Study|Withdrawal by Subject|2|||
145953969|NCT03076996|526343340|FG000|Overall Study|Lost to Follow-up|3|||
145953970|NCT03076996|526343340|FG000|Overall Study|Literacy precluded participation|1|||
145953971|NCT02144077|526343344|FG000|Overall Study|Withdrawal by Subject|3|||
146440156|NCT00112437|528115087|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440157|NCT00112437|528115088|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
146440158|NCT00112437|528115063|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146083103|NCT01525901|526824745|FG003|Period 2: 12 Weeks|Adverse Event|0|||
145953972|NCT02144077|526343345|FG001|Overall Study|Withdrawal by Subject|3|||
145953973|NCT02144077|526343344|FG000|Overall Study|Adverse Event|2|||
145953974|NCT02144077|526343345|FG001|Overall Study|Adverse Event|3|||
145953975|NCT02144077|526343344|FG000|Overall Study|Lost to Follow-up|2|||
145953976|NCT02144077|526343345|FG001|Overall Study|Lost to Follow-up|2|||
145953977|NCT02144077|526343344|FG000|Overall Study|Protocol Violation|1|||
145953978|NCT02144077|526343345|FG001|Overall Study|Protocol Violation|2|||
145953979|NCT02144077|526343344|FG000|Overall Study|Death|0|||
145953980|NCT02144077|526343345|FG001|Overall Study|Death|1|||
145953981|NCT02144077|526343344|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
145953982|NCT02144077|526343345|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
145953983|NCT00169104|526343346|FG000|Overall Study|Withdrawal by Subject|2|||
145953984|NCT00169104|526343347|FG001|Overall Study|Withdrawal by Subject|0|||
145953985|NCT00169104|526343346|FG000|Overall Study|Protocol Violation|0|||
145953986|NCT00169104|526343347|FG001|Overall Study|Protocol Violation|1|||
145953987|NCT00169104|526343346|FG000|Overall Study|Physician Decision|0|||
145953988|NCT00169104|526343347|FG001|Overall Study|Physician Decision|1|||
145953989|NCT00715299|526343353|FG000|Overall Study|Withdrawal by Subject|1|||
145953990|NCT00715299|526343353|FG000|Overall Study|Adverse Event|3|||
146083104|NCT05027971|526824748|FG000|Overall Study|Physician Decision|7|||
146083105|NCT05027971|526824749|FG001|Overall Study|Physician Decision|3|||
145953991|NCT00715299|526343353|FG000|Overall Study|failed the pre-screen exercise test|2|||
145953992|NCT02020889|526343354|FG000|Overall Study|Adverse Event|0|||
145953993|NCT02020889|526343355|FG001|Overall Study|Adverse Event|1|||
145953994|NCT02020889|526343354|FG000|Overall Study|Lack of Efficacy|1|||
145953995|NCT02020889|526343355|FG001|Overall Study|Lack of Efficacy|0|||
145953996|NCT02020889|526343354|FG000|Overall Study|Lost to Follow-up|1|||
146440159|NCT00112437|528115064|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440160|NCT00112437|528115065|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440161|NCT00112437|528115066|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440162|NCT00112437|528115067|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440163|NCT00112437|528115068|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440164|NCT00112437|528115069|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440165|NCT00112437|528115070|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440166|NCT00112437|528115071|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440167|NCT00112437|528115072|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440168|NCT00112437|528115073|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440169|NCT00112437|528115074|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146285573|NCT00189488|527561057|FG001|Overall Study|Adverse Event|1|||
146285574|NCT00189488|527561056|FG000|Overall Study|Withdrawal by Subject|2|||
146285575|NCT00189488|527561057|FG001|Overall Study|Withdrawal by Subject|6|||
146440170|NCT00112437|528115075|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145953997|NCT02020889|526343355|FG001|Overall Study|Lost to Follow-up|0|||
145953998|NCT02020889|526343354|FG000|Overall Study|Physician Decision|2|||
145953999|NCT02020889|526343355|FG001|Overall Study|Physician Decision|0|||
145954000|NCT02020889|526343354|FG000|Overall Study|Withdrawal by Subject|3|||
145954001|NCT02020889|526343355|FG001|Overall Study|Withdrawal by Subject|2|||
145954002|NCT01540981|526343356|FG000|Overall Study|Withdrawal by Subject|1|||
145954003|NCT01540981|526343357|FG001|Overall Study|Withdrawal by Subject|0|||
145954004|NCT01535443|526343359|FG000|Overall Study|Physician Decision|3|||
145954005|NCT00232557|526343360|FG000|Overall Study|Lost to Follow-up|3|||
145954006|NCT00232557|526343361|FG001|Overall Study|Lost to Follow-up|5|||
145954007|NCT02260817|526343362|FG000|Overall Study|Lost to Follow-up|0|||
145954008|NCT02260817|526343363|FG001|Overall Study|Lost to Follow-up|14|||
145954009|NCT02260817|526343362|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
145954010|NCT02260817|526343363|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
145954011|NCT02260817|526343362|FG000|Overall Study|Observation, no biopsy|0|||
145954012|NCT02260817|526343363|FG001|Overall Study|Observation, no biopsy|1|||
145954013|NCT02260817|526343362|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
145954014|NCT02260817|526343363|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
145954015|NCT02260817|526343362|FG000|Overall Study|Protocol Violation|0|||
145954016|NCT02260817|526343363|FG001|Overall Study|Protocol Violation|14|||
145954017|NCT04435808|526343366|FG000|Overall Study|Study stopped by DSMB|0|||
145954018|NCT04435808|526343367|FG001|Overall Study|Study stopped by DSMB|1|||
145954019|NCT03299101|526343368|FG000|Overall Study|Lost to Follow-up|1|||
145954020|NCT03299101|526343368|FG000|Overall Study|Withdrawal by Subject|5|||
145954021|NCT03299101|526343368|FG000|Overall Study|Surgery was changed|3|||
145954022|NCT03299101|526343368|FG000|Overall Study|Not enough time to complete prehab|1|||
145954023|NCT01882803|526343369|FG000|Overall Study|Disease Progression|1|||
145954024|NCT01882803|526343369|FG000|Overall Study|Withdrawal by Subject|9|||
145954025|NCT01882803|526343369|FG000|Overall Study|Death|68|||
145954026|NCT01882803|526343369|FG000|Overall Study|Physician Decision|3|||
145954027|NCT01882803|526343369|FG000|Overall Study|Lost to Follow-up|3|||
145954028|NCT01882803|526343369|FG000|Overall Study|Follow-up Completed|39|||
145954029|NCT01882803|526343369|FG000|Overall Study|Study Terminated by the Sponsor|6|||
145954030|NCT01563913|526343370|FG000|Overall Study|Physician Decision|1|||
145954031|NCT01563913|526343371|FG001|Overall Study|Physician Decision|0|||
145954032|NCT01563913|526343370|FG000|Overall Study|Spouse Passed Away|1|||
145954033|NCT01563913|526343371|FG001|Overall Study|Spouse Passed Away|0|||
145954034|NCT00551525|526343372|FG000|Overall Study|Protocol Violation|5|||
145954035|NCT00237692|526343375|FG000|Overall Study|Lost to Follow-up|9|||
145954036|NCT00237692|526343376|FG001|Overall Study|Lost to Follow-up|3|||
145954037|NCT00237692|526343377|FG002|Overall Study|Lost to Follow-up|5|||
145954038|NCT00237692|526343378|FG003|Overall Study|Lost to Follow-up|3|||
145954039|NCT00237692|526343375|FG000|Overall Study|Death|1|||
145954040|NCT00237692|526343376|FG001|Overall Study|Death|2|||
145954041|NCT00237692|526343377|FG002|Overall Study|Death|2|||
145954042|NCT00237692|526343378|FG003|Overall Study|Death|3|||
145954043|NCT00237692|526343375|FG000|Overall Study|Excluded - did not meet criteria|4|||
145954044|NCT00237692|526343376|FG001|Overall Study|Excluded - did not meet criteria|3|||
145954045|NCT00237692|526343377|FG002|Overall Study|Excluded - did not meet criteria|5|||
145954046|NCT00237692|526343378|FG003|Overall Study|Excluded - did not meet criteria|9|||
145954047|NCT00237692|526343375|FG000|Overall Study|Withdrawal by Subject|4|||
145954048|NCT00237692|526343376|FG001|Overall Study|Withdrawal by Subject|6|||
145954049|NCT00237692|526343377|FG002|Overall Study|Withdrawal by Subject|10|||
145954050|NCT00237692|526343378|FG003|Overall Study|Withdrawal by Subject|4|||
145954051|NCT00902746|526343379|FG000|Overall Study|Protocol Violation|7|||
145954052|NCT00902746|526343379|FG000|Overall Study|Withdrawal by Subject|16|||
145954053|NCT00902746|526343379|FG000|Overall Study|Adverse Event|8|||
145954054|NCT00902746|526343379|FG000|Overall Study|Lost to Follow-up|3|||
145954055|NCT00902746|526343379|FG000|Overall Study|Physician Decision|2|||
146083106|NCT05027971|526824748|FG000|Overall Study|Lost to Follow-up|1|||
146083107|NCT05027971|526824749|FG001|Overall Study|Lost to Follow-up|1|||
146083108|NCT05027971|526824748|FG000|Overall Study|Withdrawal by Subject|0|||
145954056|NCT02081001|526343381|FG000|Overall Study|Adverse Event|0|||
145954057|NCT02081001|526343382|FG001|Overall Study|Adverse Event|0|||
145954058|NCT02081001|526343383|FG002|Overall Study|Adverse Event|0|||
145954059|NCT02081001|526343384|FG003|Overall Study|Adverse Event|0|||
145954060|NCT02081001|526343385|FG004|Overall Study|Adverse Event|1|||
145954061|NCT02081001|526343386|FG005|Overall Study|Adverse Event|0|||
145954062|NCT02081001|526343387|FG006|Overall Study|Adverse Event|0|||
145954063|NCT02081001|526343388|FG007|Overall Study|Adverse Event|0|||
145954064|NCT02081001|526343389|FG008|Overall Study|Adverse Event|0|||
145954065|NCT02081001|526343390|FG009|Overall Study|Adverse Event|0|||
145954066|NCT02081001|526343391|FG010|Overall Study|Adverse Event|0|||
145954067|NCT02081001|526343392|FG011|Overall Study|Adverse Event|0|||
145954068|NCT01765569|526343393|FG000|Period B|Withdrawal by Subject|1|||
145954069|NCT01765569|526343393|FG000|Period C|Death|1|||
145954070|NCT00531947|526343394|FG000|Overall Study|Adverse Event|5|||
146285576|NCT00189488|527561056|FG000|Overall Study|Disease progression|2|||
145954071|NCT00531947|526343395|FG001|Overall Study|Adverse Event|10|||
145954072|NCT00531947|526343394|FG000|Overall Study|Lost to Follow-up|12|||
145954073|NCT00531947|526343395|FG001|Overall Study|Lost to Follow-up|9|||
145954074|NCT00531947|526343394|FG000|Overall Study|Withdrawal by Subject|14|||
145954075|NCT00531947|526343395|FG001|Overall Study|Withdrawal by Subject|19|||
145954076|NCT00531947|526343394|FG000|Overall Study|Protocol Violation|2|||
145954077|NCT00531947|526343395|FG001|Overall Study|Protocol Violation|1|||
145954078|NCT00531947|526343394|FG000|Overall Study|Non-Compliance|4|||
145954079|NCT00531947|526343395|FG001|Overall Study|Non-Compliance|7|||
145954080|NCT00531947|526343394|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
145954081|NCT00531947|526343395|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
145954082|NCT02383355|526343400|FG000|Overall Study|Adverse Event|2|||
145954083|NCT02383355|526343401|FG001|Overall Study|Adverse Event|0|||
145954084|NCT03681184|526343404|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
145954085|NCT03681184|526343405|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
145954086|NCT02787083|526343406|FG000|Overall Study|Adverse Event|1|||
145954087|NCT02787083|526343407|FG001|Overall Study|Adverse Event|0|||
145954088|NCT02787083|526343406|FG000|Overall Study|Withdrawal by Subject|2|||
145954089|NCT02787083|526343407|FG001|Overall Study|Withdrawal by Subject|2|||
145954090|NCT03162328|526343408|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
145954091|NCT03162328|526343409|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
145954092|NCT03162328|526343410|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
145954093|NCT03162328|526343408|FG000|Screening Period|Withdrawal by Subject|1|||
145954094|NCT03162328|526343409|FG001|Screening Period|Withdrawal by Subject|0|||
145954095|NCT03162328|526343410|FG002|Screening Period|Withdrawal by Subject|0|||
145954096|NCT03162328|526343408|FG000|Study Period|Withdrawal by Subject|0|||
145954097|NCT03162328|526343409|FG001|Study Period|Withdrawal by Subject|0|||
145954098|NCT03162328|526343410|FG002|Study Period|Withdrawal by Subject|1|||
145954099|NCT03275389|526343412|FG000|Overall Study|Lost to Follow-up|10|||
145954100|NCT03275389|526343413|FG001|Overall Study|Lost to Follow-up|10|||
145954101|NCT03275389|526343414|FG002|Overall Study|Lost to Follow-up|19|||
145954102|NCT03275389|526343415|FG003|Overall Study|Lost to Follow-up|12|||
145954103|NCT03275389|526343416|FG004|Overall Study|Lost to Follow-up|11|||
145954104|NCT03275389|526343417|FG005|Overall Study|Lost to Follow-up|12|||
145954105|NCT03275389|526343418|FG006|Overall Study|Lost to Follow-up|21|||
145954106|NCT03275389|526343419|FG007|Overall Study|Lost to Follow-up|15|||
145954107|NCT03275389|526343420|FG008|Overall Study|Lost to Follow-up|12|||
145954108|NCT03275389|526343421|FG009|Overall Study|Lost to Follow-up|14|||
145954109|NCT03275389|526343412|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954110|NCT03275389|526343413|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954111|NCT03275389|526343414|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954112|NCT03275389|526343415|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954113|NCT03275389|526343416|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954114|NCT03275389|526343417|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
145954115|NCT03275389|526343418|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954116|NCT03275389|526343419|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954117|NCT03275389|526343420|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145954118|NCT03275389|526343421|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
145954119|NCT03275389|526343412|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145954120|NCT03275389|526343413|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145954121|NCT03275389|526343414|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145954122|NCT03275389|526343415|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
145954123|NCT03275389|526343416|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145954124|NCT03275389|526343417|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145954125|NCT03275389|526343418|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145954126|NCT03275389|526343419|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145954127|NCT03275389|526343420|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145954128|NCT03275389|526343421|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145954129|NCT03275389|526343412|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954130|NCT03275389|526343413|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145954131|NCT03275389|526343414|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954132|NCT03275389|526343415|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
145954133|NCT03275389|526343416|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954134|NCT03275389|526343417|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954135|NCT03275389|526343418|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145954136|NCT03275389|526343419|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954137|NCT03275389|526343420|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954138|NCT03275389|526343421|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145954139|NCT03275389|526343412|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954140|NCT03275389|526343413|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954141|NCT03275389|526343414|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145954142|NCT03275389|526343415|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954143|NCT03275389|526343416|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954144|NCT03275389|526343417|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954145|NCT03275389|526343418|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954146|NCT03275389|526343419|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954147|NCT03275389|526343420|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145954148|NCT03275389|526343421|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145954149|NCT03275389|526343412|FG000|Overall Study|Other|0|||
145954150|NCT03275389|526343413|FG001|Overall Study|Other|4|||
145954151|NCT03275389|526343414|FG002|Overall Study|Other|3|||
145954152|NCT03275389|526343415|FG003|Overall Study|Other|2|||
145954153|NCT03275389|526343416|FG004|Overall Study|Other|2|||
145954154|NCT03275389|526343417|FG005|Overall Study|Other|2|||
145954155|NCT03275389|526343418|FG006|Overall Study|Other|0|||
145954156|NCT03275389|526343419|FG007|Overall Study|Other|0|||
145954157|NCT03275389|526343420|FG008|Overall Study|Other|1|||
145954158|NCT03275389|526343421|FG009|Overall Study|Other|0|||
145954159|NCT01790516|526343422|FG000|Overall Study|Physician Decision|1|||
145954160|NCT01790516|526343423|FG001|Overall Study|Physician Decision|0|||
145954161|NCT03749109|526343424|FG000|Overall Study|Adverse Event|2|||
145954162|NCT03749109|526343425|FG001|Overall Study|Adverse Event|0|||
145954163|NCT03034135|526343426|FG000|Overall Study|Withdrawal by Subject|2|||
145954164|NCT00401193|526345612|FG000|Overall Study|Adverse Event|1|||
145954165|NCT00401193|526345613|FG001|Overall Study|Adverse Event|3|||
145954166|NCT00401193|526345614|FG002|Overall Study|Adverse Event|1|||
145954167|NCT00401193|526345612|FG000|Overall Study|Protocol Violation|3|||
145954168|NCT00401193|526345613|FG001|Overall Study|Protocol Violation|1|||
145954169|NCT00401193|526345614|FG002|Overall Study|Protocol Violation|1|||
145954170|NCT00401193|526345612|FG000|Overall Study|Lost to Follow-up|6|||
145954171|NCT00401193|526345613|FG001|Overall Study|Lost to Follow-up|5|||
145954172|NCT00401193|526345614|FG002|Overall Study|Lost to Follow-up|1|||
145954173|NCT00401193|526345612|FG000|Overall Study|Withdrawal by Subject|2|||
145954174|NCT00401193|526345613|FG001|Overall Study|Withdrawal by Subject|0|||
145954175|NCT00401193|526345614|FG002|Overall Study|Withdrawal by Subject|1|||
145954176|NCT00401193|526345612|FG000|Overall Study|Other Event|3|||
145954177|NCT00401193|526345613|FG001|Overall Study|Other Event|2|||
145954178|NCT00401193|526345614|FG002|Overall Study|Other Event|2|||
145954179|NCT02526160|526345615|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
145954180|NCT02526160|526345616|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
145954181|NCT02526160|526345615|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
145954182|NCT02526160|526345616|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
145954183|NCT02526160|526345615|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
145954184|NCT02526160|526345616|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
145954185|NCT02526160|526345615|FG000|Open-Label Treatment Extension Period I|Death|0|||
145954186|NCT02526160|526345616|FG001|Open-Label Treatment Extension Period I|Death|1|||
145954187|NCT02526160|526345615|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
145954188|NCT02526160|526345616|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
145954189|NCT02526160|526345615|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
145954190|NCT02526160|526345616|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
145954191|NCT02526160|526345615|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
145954192|NCT02526160|526345616|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
145954193|NCT02526160|526345615|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
146285577|NCT00189488|527561057|FG001|Overall Study|Disease progression|4|||
145954194|NCT02526160|526345616|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
145954195|NCT01962948|526345619|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
145954196|NCT01962948|526345620|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
146285578|NCT00189488|527561056|FG000|Overall Study|Administrative Decision|0|||
145954197|NCT01962948|526345621|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
145954198|NCT01962948|526345622|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
145954199|NCT02576977|526345624|FG000|Overall Study|Adverse Event|13|||
145954200|NCT02576977|526345625|FG001|Overall Study|Adverse Event|2|||
145954201|NCT02576977|526345624|FG000|Overall Study|Death|73|||
145954202|NCT02576977|526345625|FG001|Overall Study|Death|60|||
145954203|NCT02576977|526345624|FG000|Overall Study|Screen failure|1|||
145954204|NCT02576977|526345625|FG001|Overall Study|Screen failure|0|||
145954205|NCT02576977|526345624|FG000|Overall Study|Study Terminated at Selected Sites|27|||
145954206|NCT02576977|526345625|FG001|Overall Study|Study Terminated at Selected Sites|50|||
145954207|NCT02576977|526345624|FG000|Overall Study|Withdrawal by Subject|11|||
145954208|NCT02576977|526345625|FG001|Overall Study|Withdrawal by Subject|11|||
145954209|NCT02576977|526345624|FG000|Overall Study|Final Disposition Unknown|0|||
145954210|NCT02576977|526345625|FG001|Overall Study|Final Disposition Unknown|1|||
145954211|NCT02576977|526345624|FG000|Overall Study|Lost to Follow-up|1|||
145954212|NCT02576977|526345625|FG001|Overall Study|Lost to Follow-up|0|||
145954213|NCT02576977|526345624|FG000|Overall Study|Progressive Disease|0|||
145954214|NCT02576977|526345625|FG001|Overall Study|Progressive Disease|1|||
145954215|NCT02823470|526345632|FG000|Overall Study|Adverse Event|1|||
145954216|NCT02823470|526345633|FG001|Overall Study|Adverse Event|0|||
145954217|NCT02823470|526345632|FG000|Overall Study|Study terminated by sponsor|8|||
145954218|NCT02823470|526345633|FG001|Overall Study|Study terminated by sponsor|15|||
145954219|NCT01073163|526345635|FG000|Overall Study|Adverse Event|1|||
145954220|NCT01073163|526345635|FG000|Overall Study|Disease Progression|1|||
145954221|NCT01073163|526345635|FG000|Overall Study|Early termination|1|||
145954222|NCT00703677|526345636|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
145954223|NCT04441788|526345637|FG000|Overall Study|Voluntary Withdrawl|0|||
145954224|NCT04441788|526345638|FG001|Overall Study|Voluntary Withdrawl|1|||
145954225|NCT04441788|526345639|FG002|Overall Study|Voluntary Withdrawl|0|||
145954226|NCT04441788|526345637|FG000|Overall Study|Ineligibility|1|||
145954227|NCT04441788|526345638|FG001|Overall Study|Ineligibility|0|||
145954228|NCT04441788|526345639|FG002|Overall Study|Ineligibility|0|||
145954229|NCT04441788|526345637|FG000|Overall Study|Adverse Event|0|||
145954230|NCT04441788|526345638|FG001|Overall Study|Adverse Event|0|||
145954231|NCT04441788|526345639|FG002|Overall Study|Adverse Event|4|||
145954232|NCT04441788|526345637|FG000|Overall Study|Study Terminated by Sponsor|16|||
145954233|NCT04441788|526345638|FG001|Overall Study|Study Terminated by Sponsor|16|||
145954234|NCT04441788|526345639|FG002|Overall Study|Study Terminated by Sponsor|12|||
145954235|NCT03859648|526345642|FG000|Overall Study|Lost to Follow-up|1|||
145954236|NCT03859648|526345642|FG000|Overall Study|Adverse Event|1|||
145954237|NCT02315664|526345643|FG000|Overall Study|Lost to Follow-up|1|||
145954238|NCT02315664|526345644|FG001|Overall Study|Lost to Follow-up|1|||
145954239|NCT02315664|526345643|FG000|Overall Study|Withdrawal by Subject|0|||
145954240|NCT02315664|526345644|FG001|Overall Study|Withdrawal by Subject|3|||
145954241|NCT01677182|526345645|FG000|Overall Study|Adverse Event|2|||
145954242|NCT01677182|526345646|FG001|Overall Study|Adverse Event|1|||
145954243|NCT01677182|526345647|FG002|Overall Study|Adverse Event|8|||
145954244|NCT01677182|526345645|FG000|Overall Study|Protocol Violation|5|||
145954245|NCT01677182|526345646|FG001|Overall Study|Protocol Violation|1|||
145954246|NCT01677182|526345647|FG002|Overall Study|Protocol Violation|4|||
145954247|NCT01677182|526345645|FG000|Overall Study|Lost to Follow-up|4|||
145954248|NCT01677182|526345646|FG001|Overall Study|Lost to Follow-up|0|||
145954249|NCT01677182|526345647|FG002|Overall Study|Lost to Follow-up|3|||
145954250|NCT01677182|526345645|FG000|Overall Study|Withdrawal by Subject|7|||
145954251|NCT01677182|526345646|FG001|Overall Study|Withdrawal by Subject|12|||
145954252|NCT01677182|526345647|FG002|Overall Study|Withdrawal by Subject|10|||
145954253|NCT01677182|526345645|FG000|Overall Study|Study termination|12|||
145954254|NCT01677182|526345646|FG001|Overall Study|Study termination|9|||
145954255|NCT01677182|526345647|FG002|Overall Study|Study termination|11|||
145954256|NCT01677182|526345645|FG000|Overall Study|Lack of Efficacy|3|||
145954257|NCT01677182|526345646|FG001|Overall Study|Lack of Efficacy|0|||
145954258|NCT01677182|526345647|FG002|Overall Study|Lack of Efficacy|1|||
145954259|NCT01677182|526345645|FG000|Overall Study|Other reasons|1|||
145954260|NCT01677182|526345646|FG001|Overall Study|Other reasons|5|||
145954261|NCT01677182|526345647|FG002|Overall Study|Other reasons|2|||
145954262|NCT02501161|526345648|FG000|Overall Study|Adverse Event|2|||
145954263|NCT02501161|526345649|FG001|Overall Study|Adverse Event|6|||
145954264|NCT02501161|526345648|FG000|Overall Study|Lost to Follow-up|7|||
145954265|NCT02501161|526345649|FG001|Overall Study|Lost to Follow-up|4|||
145954266|NCT02501161|526345648|FG000|Overall Study|Withdrawal by Subject|10|||
145954267|NCT02501161|526345649|FG001|Overall Study|Withdrawal by Subject|15|||
145954268|NCT02501161|526345648|FG000|Overall Study|Other|3|||
145954269|NCT02501161|526345649|FG001|Overall Study|Other|0|||
145954270|NCT02793947|526345651|FG000|Overall Study|Death|1|||
145954271|NCT02793947|526345652|FG001|Overall Study|Death|0|||
145954272|NCT02793947|526345651|FG000|Overall Study|Physician Decision|1|||
145954273|NCT02793947|526345652|FG001|Overall Study|Physician Decision|5|||
145954274|NCT01465230|526345655|FG000|Overall Study|Withdrawal by Subject|2|||
145954275|NCT01738919|526345657|FG000|Overall Study|Lost to Follow-up|1|||
145954276|NCT01738919|526345658|FG001|Overall Study|Lost to Follow-up|0|||
145954277|NCT01738919|526345657|FG000|Overall Study|Immigrated|0|||
145954278|NCT01738919|526345658|FG001|Overall Study|Immigrated|1|||
145954279|NCT01738919|526345657|FG000|Overall Study|Withdrawal by Subject|0|||
145954280|NCT01738919|526345658|FG001|Overall Study|Withdrawal by Subject|1|||
145954281|NCT01738919|526345657|FG000|Overall Study|Not treated in accordance to guidelines|0|||
145954282|NCT01738919|526345658|FG001|Overall Study|Not treated in accordance to guidelines|1|||
145954283|NCT02532257|526345662|FG000|Overall Study|Adverse Event|2|||
145954284|NCT02532257|526345662|FG000|Overall Study|Physician Decision|4|||
145954285|NCT02532257|526345662|FG000|Overall Study|Withdrawal by Subject|3|||
145954286|NCT02532257|526345662|FG000|Overall Study|Progressive Disease|10|||
145954287|NCT01255904|526345665|FG000|Overall Study|Physician Decision|1|||
145954288|NCT01255904|526345666|FG001|Overall Study|Physician Decision|4|||
145954289|NCT00184002|526345668|FG000|Overall Study|Adverse Event|9|||
145954290|NCT00184002|526345668|FG000|Overall Study|Death|3|||
145954291|NCT00184002|526345668|FG000|Overall Study|Physician Decision|1|||
145954292|NCT00184002|526345668|FG000|Overall Study|Withdrawal by Subject|4|||
145954293|NCT01724177|526345673|FG000|Overall Study|Adverse Event|8|||
145954294|NCT01724177|526345673|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
145954295|NCT01724177|526345673|FG000|Overall Study|Nervous participant|1|||
145954296|NCT01724177|526345673|FG000|Overall Study|Serious Adverse Event Related|1|||
145954297|NCT01705080|526345674|FG000|Overall Study|Missed visit|10|||
145954298|NCT01705080|526345675|FG001|Overall Study|Missed visit|4|||
145954299|NCT01705080|526345676|FG002|Overall Study|Missed visit|1|||
145954300|NCT01705080|526345674|FG000|Overall Study|Death|4|||
145954301|NCT01705080|526345675|FG001|Overall Study|Death|4|||
145954302|NCT01705080|526345676|FG002|Overall Study|Death|6|||
145954303|NCT01705080|526345674|FG000|Overall Study|Withdrawal by Subject|61|||
145954304|NCT01705080|526345675|FG001|Overall Study|Withdrawal by Subject|44|||
145954305|NCT01705080|526345676|FG002|Overall Study|Withdrawal by Subject|9|||
145954306|NCT00281697|526345681|FG000|Overall Study|> 60 days since last dose of study drug|4|||
145954307|NCT00281697|526345682|FG001|Overall Study|> 60 days since last dose of study drug|4|||
145954308|NCT00281697|526345681|FG000|Overall Study|Adverse Event|54|||
145954309|NCT00281697|526345682|FG001|Overall Study|Adverse Event|15|||
145954310|NCT00281697|526345681|FG000|Overall Study|Death|8|||
145954311|NCT00281697|526345682|FG001|Overall Study|Death|3|||
145954312|NCT00281697|526345681|FG000|Overall Study|Disease progression|279|||
145954313|NCT00281697|526345682|FG001|Overall Study|Disease progression|149|||
145954314|NCT00281697|526345681|FG000|Overall Study|Other|5|||
145954315|NCT00281697|526345682|FG001|Overall Study|Other|6|||
145954316|NCT00281697|526345681|FG000|Overall Study|Physician's decision to withdraw|15|||
145954317|NCT00281697|526345682|FG001|Overall Study|Physician's decision to withdraw|12|||
145954318|NCT00281697|526345681|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
145954319|NCT00281697|526345682|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
145954320|NCT00281697|526345681|FG000|Overall Study|Did not receive study drug|3|||
145954321|NCT00281697|526345682|FG001|Overall Study|Did not receive study drug|2|||
145954322|NCT00632125|526345683|FG000|Overall Study|Death|82|||
145954323|NCT00632125|526345683|FG000|Overall Study|Withdrawal by Subject|44|||
145954324|NCT00632125|526345683|FG000|Overall Study|Adverse Event|36|||
145954325|NCT00632125|526345683|FG000|Overall Study|Renal transplantation|17|||
145954326|NCT00632125|526345683|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
145954327|NCT00632125|526345683|FG000|Overall Study|Non-compliance|8|||
145954328|NCT00632125|526345683|FG000|Overall Study|Development of uncontrolled hypertension|5|||
145954329|NCT00632125|526345683|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
145954330|NCT02187861|526345690|FG000|Overall Study|Adverse Event|2|||
145954331|NCT02187861|526345691|FG001|Overall Study|Adverse Event|1|||
145954332|NCT02187861|526345692|FG002|Overall Study|Adverse Event|2|||
145954333|NCT02187861|526345693|FG003|Overall Study|Adverse Event|1|||
145954334|NCT02187861|526345690|FG000|Overall Study|Death|0|||
145954335|NCT02187861|526345691|FG001|Overall Study|Death|3|||
145954336|NCT02187861|526345692|FG002|Overall Study|Death|1|||
145954337|NCT02187861|526345693|FG003|Overall Study|Death|2|||
145954338|NCT02187861|526345690|FG000|Overall Study|Physician Decision|0|||
145954339|NCT02187861|526345691|FG001|Overall Study|Physician Decision|1|||
145954340|NCT02187861|526345692|FG002|Overall Study|Physician Decision|0|||
145954341|NCT02187861|526345693|FG003|Overall Study|Physician Decision|3|||
145954342|NCT02187861|526345690|FG000|Overall Study|Progressive Disease|4|||
145954343|NCT02187861|526345691|FG001|Overall Study|Progressive Disease|42|||
145954344|NCT02187861|526345692|FG002|Overall Study|Progressive Disease|19|||
145954345|NCT02187861|526345693|FG003|Overall Study|Progressive Disease|22|||
145954346|NCT02187861|526345690|FG000|Overall Study|Withdrawal by Subject|0|||
145954347|NCT02187861|526345691|FG001|Overall Study|Withdrawal by Subject|0|||
145954348|NCT02187861|526345692|FG002|Overall Study|Withdrawal by Subject|3|||
145954349|NCT02187861|526345693|FG003|Overall Study|Withdrawal by Subject|3|||
145954350|NCT02187861|526345690|FG000|Overall Study|Other|0|||
145954351|NCT02187861|526345691|FG001|Overall Study|Other|1|||
145954352|NCT02187861|526345692|FG002|Overall Study|Other|7|||
145954353|NCT02187861|526345693|FG003|Overall Study|Other|1|||
145954354|NCT01639703|526345694|FG000|Overall Study|Withdrawal by Subject|5|||
145954355|NCT01639703|526345694|FG000|Overall Study|Other reason|7|||
145954356|NCT01308463|526345695|FG000|Overall Study|Study Discontinued|23|||
145954357|NCT01308463|526345695|FG000|Overall Study|Death|4|||
145954358|NCT01308463|526345695|FG000|Overall Study|Revision|2|||
145954359|NCT01042392|526345696|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
146285579|NCT00189488|527561057|FG001|Overall Study|Administrative Decision|2|||
146285580|NCT00189488|527561056|FG000|Overall Study|Death|5|||
146285581|NCT00189488|527561057|FG001|Overall Study|Death|8|||
146285582|NCT00189488|527561056|FG000|Overall Study|Other|1|||
146285583|NCT00189488|527561057|FG001|Overall Study|Other|0|||
146285584|NCT02349425|527561058|FG000|Period 1|Adverse Event|1|||
146285585|NCT02349425|527561059|FG001|Period 1|Adverse Event|1|||
146285586|NCT02349425|527561060|FG002|Period 1|Adverse Event|0|||
146285587|NCT02349425|527561061|FG003|Period 1|Adverse Event|0|||
146285588|NCT02349425|527561058|FG000|Period 2|Adverse Event|0|||
146285589|NCT02349425|527561059|FG001|Period 2|Adverse Event|1|||
146440171|NCT00112437|528115076|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440172|NCT00112437|528115077|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145954360|NCT01042392|526345697|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
145954361|NCT01042392|526345698|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
145954362|NCT01042392|526345699|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
145954363|NCT01042392|526345696|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
145954364|NCT01042392|526345697|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
145954365|NCT01042392|526345698|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
145954366|NCT01042392|526345699|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
146285590|NCT02349425|527561060|FG002|Period 2|Adverse Event|1|||
146285591|NCT02349425|527561061|FG003|Period 2|Adverse Event|0|||
146285592|NCT01773291|527561064|FG000|Overall Study|Protocol Violation|1|||
146285593|NCT01773291|527561065|FG001|Overall Study|Protocol Violation|0|||
146285594|NCT01773291|527561066|FG002|Overall Study|Protocol Violation|0|||
145954367|NCT01042392|526345696|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
145954368|NCT01042392|526345697|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
145954369|NCT01042392|526345698|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
145954370|NCT01042392|526345699|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
145954371|NCT01042392|526345696|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145954372|NCT01042392|526345697|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145954373|NCT01042392|526345698|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
145954374|NCT01042392|526345699|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145954375|NCT01042392|526345696|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
145954376|NCT01042392|526345697|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145954377|NCT01042392|526345698|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145954378|NCT01042392|526345699|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145954379|NCT01042392|526345696|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145954380|NCT01042392|526345697|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145954381|NCT01042392|526345698|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
145954382|NCT01042392|526345699|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145954383|NCT01042392|526345696|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
145954384|NCT01042392|526345697|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145954385|NCT01042392|526345698|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145954386|NCT01042392|526345699|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145954387|NCT01042392|526345696|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145954388|NCT01042392|526345697|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145954389|NCT01042392|526345698|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
145954390|NCT01042392|526345699|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145954391|NCT01042392|526345696|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
145954392|NCT01042392|526345697|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145954393|NCT01042392|526345698|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145954394|NCT01042392|526345699|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145954395|NCT03117361|526345700|FG000|Overall Study|Progressive disease|5|||
145954396|NCT03117361|526345700|FG000|Overall Study|Death|1|||
145954397|NCT03117361|526345700|FG000|Overall Study|Physician Decision|2|||
145954398|NCT03117361|526345700|FG000|Overall Study|On study treatment at the end of study|1|||
145954399|NCT03117361|526345700|FG000|Overall Study|Treatment-related adverse event|1|||
145954400|NCT00587795|526345701|FG000|Overall Study|Withdrawal by Subject|1|||
146440173|NCT00112437|528115078|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440174|NCT00112437|528115079|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440175|NCT00112437|528115080|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440176|NCT00112437|528115081|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440177|NCT00112437|528115082|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440178|NCT00112437|528115083|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
146440179|NCT00112437|528115084|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
146440180|NCT00112437|528115085|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440181|NCT00112437|528115086|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440182|NCT00112437|528115087|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440183|NCT00112437|528115088|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
146440184|NCT00112437|528115063|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440185|NCT00112437|528115064|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440186|NCT00112437|528115065|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440187|NCT00112437|528115066|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440188|NCT00112437|528115067|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440189|NCT00112437|528115068|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440190|NCT00112437|528115069|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440191|NCT00112437|528115070|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440192|NCT00112437|528115071|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440193|NCT00112437|528115072|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440194|NCT00112437|528115073|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440195|NCT00112437|528115074|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440196|NCT00112437|528115075|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440197|NCT00112437|528115076|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145954401|NCT00587795|526345702|FG001|Overall Study|Withdrawal by Subject|0|||
145954402|NCT00943592|526345703|FG000|Overall Study|Death|3|||
145954403|NCT02072941|526345704|FG000|Overall Study|Withdrawal by Subject|29|||
145954404|NCT02072941|526345705|FG001|Overall Study|Withdrawal by Subject|21|||
145954405|NCT02072941|526345704|FG000|Overall Study|Lost to Follow-up|4|||
145954406|NCT02072941|526345705|FG001|Overall Study|Lost to Follow-up|4|||
145954407|NCT02072941|526345704|FG000|Overall Study|Death|3|||
145954408|NCT02072941|526345705|FG001|Overall Study|Death|2|||
145954409|NCT02072941|526345704|FG000|Overall Study|Removed by Study Staff|2|||
145954410|NCT02072941|526345705|FG001|Overall Study|Removed by Study Staff|2|||
145954411|NCT01247350|526345706|FG000|Overall Study|Adverse Event|0|||
145954412|NCT01247350|526345707|FG001|Overall Study|Adverse Event|0|||
145954413|NCT01247350|526345708|FG002|Overall Study|Adverse Event|1|||
145954414|NCT01247350|526345709|FG003|Overall Study|Adverse Event|0|||
145954415|NCT01247350|526345710|FG004|Overall Study|Adverse Event|0|||
145954416|NCT01247350|526345706|FG000|Overall Study|Withdrawal by Subject|0|||
145954417|NCT01247350|526345707|FG001|Overall Study|Withdrawal by Subject|0|||
145954418|NCT01247350|526345708|FG002|Overall Study|Withdrawal by Subject|0|||
145954419|NCT01247350|526345709|FG003|Overall Study|Withdrawal by Subject|1|||
145954420|NCT01247350|526345710|FG004|Overall Study|Withdrawal by Subject|0|||
145954421|NCT01247350|526345706|FG000|Overall Study|Entry criteria not met|0|||
145954422|NCT01247350|526345707|FG001|Overall Study|Entry criteria not met|0|||
145954423|NCT01247350|526345708|FG002|Overall Study|Entry criteria not met|0|||
145954424|NCT01247350|526345709|FG003|Overall Study|Entry criteria not met|0|||
145954425|NCT01247350|526345710|FG004|Overall Study|Entry criteria not met|1|||
145954426|NCT02438280|526345713|FG000|Overall Study|Physician Decision|1|||
145954427|NCT02438280|526345714|FG001|Overall Study|Physician Decision|0|||
145954428|NCT02982863|526345715|FG000|Overall Study|Not eligible patients|809|||
145954429|NCT02982863|526345716|FG001|Overall Study|Not eligible patients|4261|||
145954430|NCT02982863|526345717|FG002|Overall Study|Not eligible patients|1852|||
145954431|NCT02982863|526345718|FG003|Overall Study|Not eligible patients|1400|||
145954432|NCT02982863|526345719|FG004|Overall Study|Not eligible patients|492|||
145954433|NCT02457195|526345720|FG000|Overall Study|Adverse Event|3|||
145954434|NCT02457195|526345720|FG000|Overall Study|Protocol Violation|2|||
145954435|NCT02457195|526345720|FG000|Overall Study|Withdrawal by Subject|4|||
145954436|NCT05359952|526345721|FG000|Overall Study|Lost to Follow-up|1|||
145954437|NCT05359952|526345722|FG001|Overall Study|Lost to Follow-up|0|||
145954438|NCT05980013|526345723|FG000|Overall Study|Withdrawal by Subject|0|||
145954439|NCT05980013|526345724|FG001|Overall Study|Withdrawal by Subject|1|||
145954440|NCT05980013|526345723|FG000|Overall Study|Device Error|0|||
145954441|NCT05980013|526345724|FG001|Overall Study|Device Error|1|||
145954442|NCT03066778|526345725|FG000|Overall Study|Death|195|||
145954443|NCT03066778|526345726|FG001|Overall Study|Death|205|||
145954444|NCT03066778|526345725|FG000|Overall Study|Withdrawal by Subject|5|||
145954445|NCT03066778|526345726|FG001|Overall Study|Withdrawal by Subject|7|||
145954446|NCT02091414|526345727|FG000|Overall Study|Withdrawal by Subject|2|||
145954447|NCT02091414|526345727|FG000|Overall Study|Death|2|||
145954448|NCT00435461|526345728|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
145954449|NCT00435461|526345729|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
145954450|NCT00435461|526345730|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
145954451|NCT00435461|526345728|FG000|Overall Study|Protocol Violation|6|||
145954452|NCT00435461|526345729|FG001|Overall Study|Protocol Violation|9|||
145954453|NCT00435461|526345730|FG002|Overall Study|Protocol Violation|10|||
145954454|NCT00435461|526345728|FG000|Overall Study|Participant randomized(inadequate score)|1|||
145954455|NCT00435461|526345729|FG001|Overall Study|Participant randomized(inadequate score)|0|||
145954456|NCT00435461|526345730|FG002|Overall Study|Participant randomized(inadequate score)|0|||
145954457|NCT00435461|526345728|FG000|Overall Study|Compliance less than 80 percent|1|||
145954458|NCT00435461|526345729|FG001|Overall Study|Compliance less than 80 percent|0|||
145954459|NCT00435461|526345730|FG002|Overall Study|Compliance less than 80 percent|0|||
145954460|NCT00435461|526345728|FG000|Overall Study|In error, two study medications switched|1|||
145954461|NCT00435461|526345729|FG001|Overall Study|In error, two study medications switched|0|||
145954462|NCT00435461|526345730|FG002|Overall Study|In error, two study medications switched|0|||
145954463|NCT00435461|526345728|FG000|Overall Study|Lack of Efficacy|2|||
145954464|NCT00435461|526345729|FG001|Overall Study|Lack of Efficacy|1|||
145954465|NCT00435461|526345730|FG002|Overall Study|Lack of Efficacy|0|||
145954466|NCT00435461|526345728|FG000|Overall Study|Withdrawal by Subject|1|||
145954467|NCT00435461|526345729|FG001|Overall Study|Withdrawal by Subject|0|||
145954468|NCT00435461|526345730|FG002|Overall Study|Withdrawal by Subject|2|||
145954469|NCT00435461|526345728|FG000|Overall Study|Randomized in error|1|||
145954470|NCT00435461|526345729|FG001|Overall Study|Randomized in error|0|||
145954471|NCT00435461|526345730|FG002|Overall Study|Randomized in error|0|||
145954472|NCT00435461|526345728|FG000|Overall Study|Participant could not tolerate symptoms|0|||
145954473|NCT00435461|526345729|FG001|Overall Study|Participant could not tolerate symptoms|0|||
145954474|NCT00435461|526345730|FG002|Overall Study|Participant could not tolerate symptoms|1|||
145954475|NCT00435461|526345728|FG000|Overall Study|Participant could not swallow capsule|0|||
145954476|NCT00435461|526345729|FG001|Overall Study|Participant could not swallow capsule|0|||
145954477|NCT00435461|526345730|FG002|Overall Study|Participant could not swallow capsule|1|||
145954478|NCT00435461|526345728|FG000|Overall Study|Pregnancy|2|||
145954479|NCT00435461|526345729|FG001|Overall Study|Pregnancy|0|||
145954480|NCT00435461|526345730|FG002|Overall Study|Pregnancy|0|||
145954481|NCT00435461|526345728|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
145954482|NCT00435461|526345729|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
145954483|NCT00435461|526345730|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
145954484|NCT00435461|526345728|FG000|Overall Study|Participant ended study one day early|1|||
145954485|NCT00435461|526345729|FG001|Overall Study|Participant ended study one day early|0|||
145954486|NCT00435461|526345730|FG002|Overall Study|Participant ended study one day early|0|||
145954487|NCT00435461|526345728|FG000|Overall Study|Noncompliance with study requirements|1|||
145954488|NCT00435461|526345729|FG001|Overall Study|Noncompliance with study requirements|1|||
145954489|NCT00435461|526345730|FG002|Overall Study|Noncompliance with study requirements|1|||
145954490|NCT00435461|526345728|FG000|Overall Study|Adverse Event|1|||
145954491|NCT00435461|526345729|FG001|Overall Study|Adverse Event|2|||
145954492|NCT00435461|526345730|FG002|Overall Study|Adverse Event|6|||
145954493|NCT00435461|526345728|FG000|Overall Study|Non-Compliance of diary|2|||
145954494|NCT00435461|526345729|FG001|Overall Study|Non-Compliance of diary|0|||
145954495|NCT00435461|526345730|FG002|Overall Study|Non-Compliance of diary|1|||
145954496|NCT00435461|526345728|FG000|Overall Study|Lost to Follow-up|1|||
145954497|NCT00435461|526345729|FG001|Overall Study|Lost to Follow-up|1|||
145954498|NCT00435461|526345730|FG002|Overall Study|Lost to Follow-up|2|||
145954499|NCT01768559|526345731|FG000|Overall Study|Randomized but not treated|0|||
145954500|NCT01768559|526345732|FG001|Overall Study|Randomized but not treated|0|||
145954501|NCT01768559|526345733|FG002|Overall Study|Randomized but not treated|1|||
145954502|NCT01768559|526345731|FG000|Overall Study|Adverse Event|15|||
145954503|NCT01768559|526345732|FG001|Overall Study|Adverse Event|2|||
145954504|NCT01768559|526345733|FG002|Overall Study|Adverse Event|5|||
145954505|NCT01768559|526345731|FG000|Overall Study|Lack of Efficacy|6|||
145954506|NCT01768559|526345732|FG001|Overall Study|Lack of Efficacy|4|||
145954507|NCT01768559|526345733|FG002|Overall Study|Lack of Efficacy|0|||
145954508|NCT01768559|526345731|FG000|Overall Study|Poor compliance to protocol|0|||
145954509|NCT01768559|526345732|FG001|Overall Study|Poor compliance to protocol|3|||
145954510|NCT01768559|526345733|FG002|Overall Study|Poor compliance to protocol|2|||
145954511|NCT01768559|526345731|FG000|Overall Study|Other than specified|9|||
145954512|NCT01768559|526345732|FG001|Overall Study|Other than specified|8|||
145954513|NCT01768559|526345733|FG002|Overall Study|Other than specified|5|||
145954514|NCT03146741|526345734|FG000|Overall Study|Txp with non-HCV+ heart|4|||
145954515|NCT03146741|526345734|FG000|Overall Study|Listeted for MOT|2|||
145954516|NCT03146741|526345734|FG000|Overall Study|Physician Decision|2|||
145954517|NCT03146741|526345734|FG000|Overall Study|Awaiting txp|2|||
145954518|NCT00685360|526345738|FG000|Overall Study|Lost to Follow-up|0|||
145954519|NCT00685360|526345739|FG001|Overall Study|Lost to Follow-up|1|||
145954520|NCT00685360|526345740|FG002|Overall Study|Lost to Follow-up|2|||
145954521|NCT00685360|526345738|FG000|Overall Study|Adverse Event|4|||
145954522|NCT00685360|526345739|FG001|Overall Study|Adverse Event|6|||
145954523|NCT00685360|526345740|FG002|Overall Study|Adverse Event|4|||
145954524|NCT00685360|526345738|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
145954525|NCT00685360|526345739|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
145954526|NCT00685360|526345740|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
145954527|NCT00685360|526345738|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
145954528|NCT00685360|526345739|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
145954529|NCT00685360|526345740|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
145954530|NCT00685360|526345738|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
145954531|NCT00685360|526345739|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
145954532|NCT00685360|526345740|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
145954533|NCT00685360|526345738|FG000|Overall Study|Protocol Deviation|0|||
145954534|NCT00685360|526345739|FG001|Overall Study|Protocol Deviation|1|||
145954535|NCT00685360|526345740|FG002|Overall Study|Protocol Deviation|1|||
145954536|NCT01030718|526345747|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
145954537|NCT01030718|526345748|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
145954538|NCT01030718|526345749|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
145954539|NCT01030718|526345747|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
145954540|NCT01030718|526345748|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
145954541|NCT01030718|526345749|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
145954542|NCT01030718|526345747|FG000|Studies CA180-031 and -036 Combined|Death|0|||
145954543|NCT01030718|526345748|FG001|Studies CA180-031 and -036 Combined|Death|1|||
145954544|NCT01030718|526345749|FG002|Studies CA180-031 and -036 Combined|Death|0|||
145954545|NCT01030718|526345747|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
145954546|NCT01030718|526345748|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
145954547|NCT01030718|526345749|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
145954548|NCT01030718|526345747|FG000|Study CA180-036 Only|insufficient effect|1|||
145954549|NCT01030718|526345748|FG001|Study CA180-036 Only|insufficient effect|1|||
145954550|NCT01030718|526345749|FG002|Study CA180-036 Only|insufficient effect|5|||
145954551|NCT01030718|526345747|FG000|Study CA180-036 Only|Adverse Event|2|||
145954552|NCT01030718|526345748|FG001|Study CA180-036 Only|Adverse Event|3|||
145954553|NCT01030718|526345749|FG002|Study CA180-036 Only|Adverse Event|0|||
145954554|NCT01030718|526345747|FG000|Study CA180-036 Only|Death|0|||
145954555|NCT01030718|526345748|FG001|Study CA180-036 Only|Death|1|||
145954556|NCT01030718|526345749|FG002|Study CA180-036 Only|Death|0|||
145954557|NCT01030718|526345747|FG000|Study CA180-036 Only|Other Reasons|0|||
145954558|NCT01030718|526345748|FG001|Study CA180-036 Only|Other Reasons|2|||
145954559|NCT01030718|526345749|FG002|Study CA180-036 Only|Other Reasons|0|||
145954560|NCT00423813|526345750|FG000|Overall Study|Adverse Event|11|||
145954561|NCT00423813|526345751|FG001|Overall Study|Adverse Event|30|||
145954562|NCT00423813|526345752|FG002|Overall Study|Adverse Event|40|||
145954563|NCT00423813|526345750|FG000|Overall Study|Withdrawal by Subject|6|||
145954564|NCT00423813|526345751|FG001|Overall Study|Withdrawal by Subject|8|||
145954565|NCT00423813|526345752|FG002|Overall Study|Withdrawal by Subject|5|||
145954566|NCT00423813|526345750|FG000|Overall Study|Lost to Follow-up|5|||
145954567|NCT00423813|526345751|FG001|Overall Study|Lost to Follow-up|4|||
145954568|NCT00423813|526345752|FG002|Overall Study|Lost to Follow-up|4|||
145954569|NCT00423813|526345750|FG000|Overall Study|Lack of Efficacy|23|||
145954570|NCT00423813|526345751|FG001|Overall Study|Lack of Efficacy|18|||
145954571|NCT00423813|526345752|FG002|Overall Study|Lack of Efficacy|19|||
145954572|NCT00423813|526345750|FG000|Overall Study|Physician Decision|2|||
145954573|NCT00423813|526345751|FG001|Overall Study|Physician Decision|0|||
145954574|NCT00423813|526345752|FG002|Overall Study|Physician Decision|0|||
145954575|NCT00423813|526345750|FG000|Overall Study|Sponsor Decision|0|||
145954576|NCT00423813|526345751|FG001|Overall Study|Sponsor Decision|1|||
145954577|NCT00423813|526345752|FG002|Overall Study|Sponsor Decision|0|||
145954578|NCT00423813|526345750|FG000|Overall Study|Protocol Violation|9|||
145954579|NCT00423813|526345751|FG001|Overall Study|Protocol Violation|4|||
145954580|NCT00423813|526345752|FG002|Overall Study|Protocol Violation|4|||
145954581|NCT00423813|526345750|FG000|Overall Study|Pregnancy|0|||
145954582|NCT00423813|526345751|FG001|Overall Study|Pregnancy|0|||
146083109|NCT05027971|526824749|FG001|Overall Study|Withdrawal by Subject|2|||
146083110|NCT05027971|526824748|FG000|Overall Study|Non-study fiber used.|0|||
145954583|NCT00423813|526345752|FG002|Overall Study|Pregnancy|1|||
145954584|NCT00423813|526345750|FG000|Overall Study|Subject started night shift work|1|||
145954585|NCT00423813|526345751|FG001|Overall Study|Subject started night shift work|0|||
146440198|NCT00112437|528115077|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440199|NCT00112437|528115078|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440200|NCT00112437|528115079|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440201|NCT00112437|528115080|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440202|NCT00112437|528115081|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440203|NCT00112437|528115082|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440204|NCT00112437|528115083|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
146440205|NCT00112437|528115084|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440206|NCT00112437|528115085|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440207|NCT00112437|528115086|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146285595|NCT01773291|527561064|FG000|Overall Study|Withdrawal by Subject|0|||
146285596|NCT01773291|527561065|FG001|Overall Study|Withdrawal by Subject|0|||
145954586|NCT00423813|526345752|FG002|Overall Study|Subject started night shift work|0|||
146285597|NCT01773291|527561066|FG002|Overall Study|Withdrawal by Subject|1|||
146285598|NCT01491672|527561067|FG000|Overall Study|Lost to Follow-up|0|||
146285599|NCT01491672|527561068|FG001|Overall Study|Lost to Follow-up|4|||
146285600|NCT01491672|527561069|FG002|Overall Study|Lost to Follow-up|1|||
146285601|NCT01491672|527561067|FG000|Overall Study|Withdrawal by Subject|6|||
146285602|NCT01491672|527561068|FG001|Overall Study|Withdrawal by Subject|7|||
146285603|NCT01491672|527561069|FG002|Overall Study|Withdrawal by Subject|0|||
146285604|NCT01491672|527561067|FG000|Overall Study|Adverse Event|8|||
146285605|NCT01491672|527561068|FG001|Overall Study|Adverse Event|10|||
146285606|NCT01491672|527561069|FG002|Overall Study|Adverse Event|4|||
146285607|NCT01491672|527561067|FG000|Overall Study|Disease progression|42|||
146285608|NCT01491672|527561068|FG001|Overall Study|Disease progression|34|||
146285609|NCT01491672|527561069|FG002|Overall Study|Disease progression|6|||
146285610|NCT01491672|527561067|FG000|Overall Study|Protocol deviation|0|||
146285611|NCT01491672|527561068|FG001|Overall Study|Protocol deviation|1|||
146285612|NCT01491672|527561069|FG002|Overall Study|Protocol deviation|0|||
146285613|NCT01491672|527561067|FG000|Overall Study|Death|0|||
146285614|NCT01491672|527561068|FG001|Overall Study|Death|4|||
146285615|NCT01491672|527561069|FG002|Overall Study|Death|0|||
146285616|NCT02090959|527561070|FG000|Overall Study|Withdrawal by Subject|10|||
146285617|NCT02090959|527561070|FG000|Overall Study|Adverse Event|1|||
146285618|NCT02090959|527561070|FG000|Overall Study|Investigator decision|2|||
146285619|NCT02090959|527561070|FG000|Overall Study|Study termination|6|||
146285620|NCT02090959|527561070|FG000|Overall Study|Enrolled but not treated|1|||
146285621|NCT02090959|527561070|FG000|Overall Study|Transfer for compassionate use medicine|4|||
146285622|NCT02090959|527561070|FG000|Overall Study|Move to medical need program|3|||
146285623|NCT02090959|527561070|FG000|Overall Study|Entered in to other study|34|||
146285624|NCT02090959|527561070|FG000|Overall Study|Switched to commercial supply|88|||
146285625|NCT02090959|527561070|FG000|Overall Study|Other than specified|2|||
146285626|NCT02808143|527561071|FG000|Maintenance Phase|Disease recurrence|1|||
146285627|NCT02808143|527561072|FG001|Maintenance Phase|Disease recurrence|3|||
146285628|NCT02808143|527561071|FG000|Maintenance Phase|Disease progression|1|||
146285629|NCT02808143|527561072|FG001|Maintenance Phase|Disease progression|2|||
146285630|NCT02808143|527561071|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
146285631|NCT02808143|527561072|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
146285632|NCT02808143|527561071|FG000|Survival Follow-Up|Disease recurrence|0|||
146285633|NCT02808143|527561072|FG001|Survival Follow-Up|Disease recurrence|2|||
146285634|NCT02808143|527561071|FG000|Survival Follow-Up|Adverse Event|0|||
146285635|NCT02808143|527561072|FG001|Survival Follow-Up|Adverse Event|1|||
146285636|NCT02808143|527561071|FG000|Survival Follow-Up|Death|1|||
146285637|NCT02808143|527561072|FG001|Survival Follow-Up|Death|0|||
146285638|NCT00522873|527561075|FG000|Overall Study|Adverse Event|41|||
146285639|NCT00522873|527561076|FG001|Overall Study|Adverse Event|26|||
146285640|NCT00522873|527561075|FG000|Overall Study|Withdrawal by Subject|20|||
146285641|NCT00522873|527561076|FG001|Overall Study|Withdrawal by Subject|9|||
146285642|NCT00522873|527561075|FG000|Overall Study|Protocol Violation|14|||
146285643|NCT00522873|527561076|FG001|Overall Study|Protocol Violation|4|||
145954587|NCT00423813|526345750|FG000|Overall Study|Will start exclusionary medications|0|||
145954588|NCT00423813|526345751|FG001|Overall Study|Will start exclusionary medications|1|||
145954589|NCT00423813|526345752|FG002|Overall Study|Will start exclusionary medications|0|||
145954590|NCT00423813|526345750|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
145954591|NCT00423813|526345751|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
145954592|NCT00423813|526345752|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
145954593|NCT01386944|526345753|FG000|Overall Study|Adverse Event|26|||
145954594|NCT01386944|526345753|FG000|Overall Study|Lack of Efficacy|14|||
145954595|NCT01386944|526345753|FG000|Overall Study|Lost to Follow-up|8|||
145954596|NCT01386944|526345753|FG000|Overall Study|Unspecified reason|8|||
145954597|NCT04186221|526345755|FG000|Overall Study|Death|1|||
146285644|NCT00522873|527561075|FG000|Overall Study|Lost to Follow-up|11|||
146285645|NCT00522873|527561076|FG001|Overall Study|Lost to Follow-up|3|||
146285646|NCT00522873|527561075|FG000|Overall Study|Personal Reasons|8|||
146285647|NCT00522873|527561076|FG001|Overall Study|Personal Reasons|1|||
146285648|NCT00522873|527561075|FG000|Overall Study|Medication Errors|1|||
146285649|NCT00522873|527561076|FG001|Overall Study|Medication Errors|1|||
146285650|NCT00522873|527561075|FG000|Overall Study|Never Received Medication|1|||
145954598|NCT01904032|526345756|FG000|Overall Study|Adverse Event|3|||
146285651|NCT00522873|527561076|FG001|Overall Study|Never Received Medication|0|||
145954599|NCT01904032|526345757|FG001|Overall Study|Adverse Event|1|||
145954600|NCT01904032|526345756|FG000|Overall Study|Lost to Follow-up|4|||
146285652|NCT01874431|527561078|FG000|Overall Study|Physician Decision|0|||
146285653|NCT01874431|527561079|FG001|Overall Study|Physician Decision|0|||
146285654|NCT01874431|527561080|FG002|Overall Study|Physician Decision|1|||
146285655|NCT01874431|527561081|FG003|Overall Study|Physician Decision|0|||
146285656|NCT01874431|527561082|FG004|Overall Study|Physician Decision|0|||
146285657|NCT01874431|527561083|FG005|Overall Study|Physician Decision|0|||
146440208|NCT00112437|528115087|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440209|NCT00112437|528115088|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
146440210|NCT00112437|528115063|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440211|NCT00112437|528115064|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440212|NCT00112437|528115065|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440213|NCT00112437|528115066|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440214|NCT00112437|528115067|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440215|NCT00112437|528115068|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440216|NCT00112437|528115069|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440217|NCT00112437|528115070|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440218|NCT00112437|528115071|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440219|NCT00112437|528115072|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440220|NCT00112437|528115073|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440221|NCT00112437|528115074|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440222|NCT00112437|528115075|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440223|NCT00112437|528115076|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440224|NCT00112437|528115077|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440225|NCT00112437|528115078|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440226|NCT00112437|528115079|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440227|NCT00112437|528115080|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440228|NCT00112437|528115081|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440229|NCT00112437|528115082|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440230|NCT00112437|528115083|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440231|NCT00112437|528115084|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
146440232|NCT00112437|528115085|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440233|NCT00112437|528115086|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440234|NCT00112437|528115087|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440235|NCT00112437|528115088|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
146440236|NCT00112437|528115063|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440237|NCT00112437|528115064|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440238|NCT00112437|528115065|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440239|NCT00112437|528115066|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440240|NCT00112437|528115067|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440241|NCT00112437|528115068|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440242|NCT00112437|528115069|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440243|NCT00112437|528115070|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440244|NCT00112437|528115071|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440245|NCT00112437|528115072|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440246|NCT00112437|528115073|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440247|NCT00112437|528115074|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440248|NCT00112437|528115075|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440249|NCT00112437|528115076|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440250|NCT00112437|528115077|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440251|NCT00112437|528115078|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440252|NCT00112437|528115079|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440253|NCT00112437|528115080|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440254|NCT00112437|528115081|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440255|NCT00112437|528115082|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440256|NCT00112437|528115083|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440257|NCT00112437|528115084|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
146440258|NCT00112437|528115085|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440259|NCT00112437|528115086|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440260|NCT00112437|528115087|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440261|NCT00112437|528115088|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
146440262|NCT00112437|528115063|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440263|NCT00112437|528115064|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440264|NCT00112437|528115065|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440265|NCT00112437|528115066|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440266|NCT00112437|528115067|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440267|NCT00112437|528115068|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440268|NCT00112437|528115069|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440269|NCT00112437|528115070|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440270|NCT00112437|528115071|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440271|NCT00112437|528115072|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440272|NCT00112437|528115073|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440273|NCT00112437|528115074|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440274|NCT00112437|528115075|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440275|NCT00112437|528115076|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440276|NCT00112437|528115077|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440277|NCT00112437|528115078|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440278|NCT00112437|528115079|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440279|NCT00112437|528115080|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440280|NCT00112437|528115081|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440281|NCT00112437|528115082|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440282|NCT00112437|528115083|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
146440283|NCT00112437|528115084|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
146440284|NCT00112437|528115085|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440285|NCT00112437|528115086|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440286|NCT00112437|528115087|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440287|NCT00112437|528115088|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
146440288|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440289|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440290|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440291|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440292|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440293|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440294|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440295|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440296|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440297|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440298|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440299|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440300|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440301|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440302|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440303|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440304|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440305|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440306|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440307|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440308|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440309|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440310|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
146440311|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
145954601|NCT01904032|526345757|FG001|Overall Study|Lost to Follow-up|2|||
146440312|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
146440313|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
145954602|NCT00972283|526345767|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
145954603|NCT00972283|526345768|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
145954604|NCT00972283|526345767|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
145954605|NCT00972283|526345768|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
145954606|NCT00972283|526345767|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
145954607|NCT00972283|526345768|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
145954608|NCT00972283|526345767|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
145954609|NCT00972283|526345768|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
145954610|NCT00972283|526345767|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
145954611|NCT00972283|526345768|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
145954612|NCT00972283|526345767|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
145954613|NCT00972283|526345768|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
145954614|NCT00972283|526345767|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
145954615|NCT00972283|526345768|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
145954616|NCT00972283|526345767|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
145954617|NCT00972283|526345768|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
145954618|NCT00972283|526345767|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
145954619|NCT00972283|526345768|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
145954620|NCT00972283|526345767|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
145954621|NCT00972283|526345768|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
145954622|NCT00845676|526345776|FG000|Overall Study|Virologic breakthrough at week 20|1|||
145954623|NCT00845676|526345776|FG000|Overall Study|Adverse Event|1|||
145954624|NCT03373461|526345777|FG000|Part 2|Adverse Event|0|||
145954625|NCT03373461|526345778|FG001|Part 2|Adverse Event|1|||
145954626|NCT03373461|526345779|FG002|Part 2|Adverse Event|0|||
145954627|NCT03373461|526345780|FG003|Part 2|Adverse Event|0|||
145954628|NCT03373461|526345781|FG004|Part 2|Adverse Event|1|||
145954629|NCT04530838|526346974|FG000|Overall Study|Other|2|||
145954630|NCT04530838|526346975|FG001|Overall Study|Other|1|||
145954631|NCT04530838|526346976|FG002|Overall Study|Other|0|||
145954632|NCT04530838|526346974|FG000|Overall Study|Physician Decision|0|||
145954633|NCT04530838|526346975|FG001|Overall Study|Physician Decision|0|||
145954634|NCT04530838|526346976|FG002|Overall Study|Physician Decision|1|||
145954635|NCT04530838|526346974|FG000|Overall Study|Death|0|||
145954636|NCT04530838|526346975|FG001|Overall Study|Death|0|||
145954637|NCT04530838|526346976|FG002|Overall Study|Death|1|||
145954638|NCT04530838|526346974|FG000|Overall Study|Adverse Event|0|||
145954639|NCT04530838|526346975|FG001|Overall Study|Adverse Event|1|||
145954640|NCT04530838|526346976|FG002|Overall Study|Adverse Event|0|||
145954641|NCT04530838|526346974|FG000|Overall Study|No longer meets eligibility criteria|1|||
145954642|NCT04530838|526346975|FG001|Overall Study|No longer meets eligibility criteria|0|||
145954643|NCT04530838|526346976|FG002|Overall Study|No longer meets eligibility criteria|2|||
145954644|NCT04530838|526346974|FG000|Overall Study|Withdrawal by parent/guardian|5|||
145954645|NCT04530838|526346975|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145954646|NCT04530838|526346976|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145954647|NCT00762762|526346985|FG000|Overall Study|Did not return for appointments|6|||
145954648|NCT00762762|526346986|FG001|Overall Study|Did not return for appointments|8|||
145954649|NCT02489448|526346987|FG000|Overall Study|Death|3|||
145954650|NCT02489448|526346987|FG000|Overall Study|Withdrawal by Subject|2|||
145954651|NCT02849171|526346996|FG000|Overall Study|Withdrawal by Subject|1|||
145954652|NCT02849171|526346996|FG000|Overall Study|Not treated|1|||
145954653|NCT02090283|526346997|FG000|Overall Study|Withdrawal by Subject|6|||
145954654|NCT02090283|526346998|FG001|Overall Study|Withdrawal by Subject|6|||
145954655|NCT02090283|526346999|FG002|Overall Study|Withdrawal by Subject|6|||
145954656|NCT02090283|526346997|FG000|Overall Study|Sponsor Terminated Study|6|||
145954657|NCT02090283|526346998|FG001|Overall Study|Sponsor Terminated Study|6|||
145954658|NCT02090283|526346999|FG002|Overall Study|Sponsor Terminated Study|1|||
145954659|NCT02090283|526346997|FG000|Overall Study|Lost to Follow-up|2|||
145954660|NCT02090283|526346998|FG001|Overall Study|Lost to Follow-up|2|||
145954661|NCT02090283|526346999|FG002|Overall Study|Lost to Follow-up|3|||
145954662|NCT02090283|526346997|FG000|Overall Study|Adverse Event|1|||
145954663|NCT02090283|526346998|FG001|Overall Study|Adverse Event|1|||
145954664|NCT02090283|526346999|FG002|Overall Study|Adverse Event|0|||
145954665|NCT02090283|526346997|FG000|Overall Study|Protocol Violation|2|||
145954666|NCT02090283|526346998|FG001|Overall Study|Protocol Violation|0|||
145954667|NCT02090283|526346999|FG002|Overall Study|Protocol Violation|0|||
145954668|NCT02964338|526347000|FG000|Overall Study|Sponsor terminated study for futility|12|||
145954669|NCT02964338|526347001|FG001|Overall Study|Sponsor terminated study for futility|15|||
145954670|NCT02964338|526347002|FG002|Overall Study|Sponsor terminated study for futility|14|||
145954671|NCT02964338|526347000|FG000|Overall Study|Lack of Efficacy|0|||
145954672|NCT02964338|526347001|FG001|Overall Study|Lack of Efficacy|3|||
145954673|NCT02964338|526347002|FG002|Overall Study|Lack of Efficacy|0|||
145954674|NCT02964338|526347000|FG000|Overall Study|Lost to Follow-up|1|||
145954675|NCT02964338|526347001|FG001|Overall Study|Lost to Follow-up|0|||
145954676|NCT02964338|526347002|FG002|Overall Study|Lost to Follow-up|3|||
146440314|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Death|0|||
146440315|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Death|0|||
146440316|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Death|0|||
146440317|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Death|0|||
146440318|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Death|0|||
146440319|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Death|0|||
146440320|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Death|0|||
146440321|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Death|0|||
146440322|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Death|0|||
146440323|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Death|0|||
146440324|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Death|0|||
146440325|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Death|0|||
146440326|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Death|0|||
146440327|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Death|0|||
146440328|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Death|0|||
146440329|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Death|0|||
146440330|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Death|0|||
146440331|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Death|0|||
146440332|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Death|0|||
146440333|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Death|0|||
146440334|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Death|0|||
146440335|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Death|0|||
146440336|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Death|0|||
146440337|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Death|2|||
146440338|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Death|0|||
146440339|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Death|0|||
146440340|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440341|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440342|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440343|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440344|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440345|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440346|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440347|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440348|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440349|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440350|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440351|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440352|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440353|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440354|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440355|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440356|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440357|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440358|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440359|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440360|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440361|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440362|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440363|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440364|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
146440365|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
146440366|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Other|0|||
146440367|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Other|0|||
146440368|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Other|0|||
146440369|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Other|0|||
146440370|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Other|0|||
146440371|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Other|0|||
146440372|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Other|0|||
146440373|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Other|0|||
146440374|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Other|0|||
146440375|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Other|0|||
146440376|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Other|0|||
146440377|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Other|0|||
146440378|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Other|0|||
146440379|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Other|0|||
146440380|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Other|0|||
146440381|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Other|0|||
146209509|NCT02178098|527280390|FG000|Overall Study|Withdrawal by Subject|0|||
146440382|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Other|0|||
146440383|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Other|0|||
146440384|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Other|0|||
146440385|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Other|0|||
146440386|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Other|0|||
146440387|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Other|0|||
146440388|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Other|0|||
146440389|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Other|0|||
146440390|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Other|1|||
146440391|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Other|0|||
146440392|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440393|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440394|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440395|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440396|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440397|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440398|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440399|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440400|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440401|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440402|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440403|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440404|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440405|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440406|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440407|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440408|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440409|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440410|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440411|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440412|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440413|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440414|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440415|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
146440416|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440417|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
146440418|NCT00112437|528115063|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440419|NCT00112437|528115064|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440420|NCT00112437|528115065|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440421|NCT00112437|528115066|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440422|NCT00112437|528115067|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440423|NCT00112437|528115068|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440424|NCT00112437|528115069|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440425|NCT00112437|528115070|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440426|NCT00112437|528115071|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440427|NCT00112437|528115072|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440428|NCT00112437|528115073|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440429|NCT00112437|528115074|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440430|NCT00112437|528115075|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440431|NCT00112437|528115076|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440432|NCT00112437|528115077|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440433|NCT00112437|528115078|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440434|NCT00112437|528115079|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440435|NCT00112437|528115080|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440436|NCT00112437|528115081|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440437|NCT00112437|528115082|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440438|NCT00112437|528115083|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145954677|NCT02964338|526347000|FG000|Overall Study|Protocol Violation|0|||
146440439|NCT00112437|528115084|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440440|NCT00112437|528115085|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
146440441|NCT00112437|528115086|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
146440442|NCT00112437|528115087|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
146440443|NCT00112437|528115088|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
146440444|NCT01824576|528115090|FG000|Overall Study|Device deficiency|2|||
146440445|NCT03218787|528115091|FG000|Overall Study|Lost to Follow-up|12|||
146440446|NCT03218787|528115091|FG000|Overall Study|Withdrawal by Subject|72|||
146440447|NCT03218787|528115091|FG000|Overall Study|Physician Decision|11|||
146440448|NCT03218787|528115091|FG000|Overall Study|Death|111|||
146285658|NCT01874431|527561084|FG006|Overall Study|Physician Decision|0|||
146440449|NCT03531827|528115092|FG000|Overall Study|Adverse Event|2|||
146440450|NCT03531827|528115093|FG001|Overall Study|Adverse Event|0|||
146440451|NCT03531827|528115092|FG000|Overall Study|Progressive disease|1|||
146440452|NCT03531827|528115093|FG001|Overall Study|Progressive disease|0|||
146440453|NCT01494532|528115096|FG000|Overall Study|Adverse Event|4|||
146440454|NCT01494532|528115097|FG001|Overall Study|Adverse Event|1|||
146440455|NCT01494532|528115098|FG002|Overall Study|Adverse Event|8|||
146440456|NCT01494532|528115099|FG003|Overall Study|Adverse Event|6|||
146440457|NCT01494532|528115100|FG004|Overall Study|Adverse Event|5|||
146440458|NCT01494532|528115101|FG005|Overall Study|Adverse Event|0|||
146440459|NCT01494532|528115096|FG000|Overall Study|Lack of Efficacy|0|||
146440460|NCT01494532|528115097|FG001|Overall Study|Lack of Efficacy|0|||
146440461|NCT01494532|528115098|FG002|Overall Study|Lack of Efficacy|0|||
146440462|NCT01494532|528115099|FG003|Overall Study|Lack of Efficacy|0|||
146440463|NCT01494532|528115100|FG004|Overall Study|Lack of Efficacy|2|||
146440464|NCT01494532|528115101|FG005|Overall Study|Lack of Efficacy|0|||
146440465|NCT01494532|528115096|FG000|Overall Study|Protocol deviation|2|||
146440466|NCT01494532|528115097|FG001|Overall Study|Protocol deviation|1|||
146440467|NCT01494532|528115098|FG002|Overall Study|Protocol deviation|3|||
146440468|NCT01494532|528115099|FG003|Overall Study|Protocol deviation|2|||
146440469|NCT01494532|528115100|FG004|Overall Study|Protocol deviation|3|||
146440470|NCT01494532|528115101|FG005|Overall Study|Protocol deviation|0|||
146440471|NCT01494532|528115096|FG000|Overall Study|Protocol-defined stopping criteria|0|||
146440472|NCT01494532|528115097|FG001|Overall Study|Protocol-defined stopping criteria|0|||
146440473|NCT01494532|528115098|FG002|Overall Study|Protocol-defined stopping criteria|1|||
146440474|NCT01494532|528115099|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146440475|NCT01494532|528115100|FG004|Overall Study|Protocol-defined stopping criteria|0|||
146440476|NCT01494532|528115101|FG005|Overall Study|Protocol-defined stopping criteria|0|||
146440477|NCT01494532|528115096|FG000|Overall Study|Lost to Follow-up|1|||
146440478|NCT01494532|528115097|FG001|Overall Study|Lost to Follow-up|0|||
146440479|NCT01494532|528115098|FG002|Overall Study|Lost to Follow-up|0|||
146440480|NCT01494532|528115099|FG003|Overall Study|Lost to Follow-up|2|||
146440481|NCT01494532|528115100|FG004|Overall Study|Lost to Follow-up|0|||
146440482|NCT01494532|528115101|FG005|Overall Study|Lost to Follow-up|0|||
146440483|NCT01494532|528115096|FG000|Overall Study|Physician Decision|0|||
146440484|NCT01494532|528115097|FG001|Overall Study|Physician Decision|1|||
146440485|NCT01494532|528115098|FG002|Overall Study|Physician Decision|1|||
146440486|NCT01494532|528115099|FG003|Overall Study|Physician Decision|2|||
146440487|NCT01494532|528115100|FG004|Overall Study|Physician Decision|0|||
146440488|NCT01494532|528115101|FG005|Overall Study|Physician Decision|0|||
146440489|NCT01494532|528115096|FG000|Overall Study|Withdrawal by Subject|3|||
146440490|NCT01494532|528115097|FG001|Overall Study|Withdrawal by Subject|1|||
146440491|NCT01494532|528115098|FG002|Overall Study|Withdrawal by Subject|4|||
146440492|NCT01494532|528115099|FG003|Overall Study|Withdrawal by Subject|3|||
146440493|NCT01494532|528115100|FG004|Overall Study|Withdrawal by Subject|2|||
146440494|NCT01494532|528115101|FG005|Overall Study|Withdrawal by Subject|0|||
146440495|NCT03247686|528117034|FG000|Overall Study|Withdrawal by Subject|1|||
146285659|NCT01874431|527561085|FG007|Overall Study|Physician Decision|0|||
146285660|NCT01874431|527561078|FG000|Overall Study|Adverse Event|5|||
146440496|NCT03247686|528117035|FG001|Overall Study|Withdrawal by Subject|2|||
146440497|NCT01541215|528117038|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
146440498|NCT01541215|528117039|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
146440499|NCT01541215|528117038|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
146440500|NCT01541215|528117039|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
146440501|NCT01541215|528117038|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
146440502|NCT01541215|528117039|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
146440503|NCT01541215|528117038|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
146440504|NCT01541215|528117039|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
146440505|NCT01541215|528117038|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
146440506|NCT01541215|528117039|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
146440507|NCT01541215|528117038|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
146285661|NCT01874431|527561079|FG001|Overall Study|Adverse Event|4|||
146440508|NCT01541215|528117039|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
146440509|NCT02316223|528117050|FG000|Overall Study|Lack of Efficacy|0|||
146440510|NCT02316223|528117051|FG001|Overall Study|Lack of Efficacy|1|||
146440511|NCT02316223|528117052|FG002|Overall Study|Lack of Efficacy|1|||
146440512|NCT02316223|528117050|FG000|Overall Study|Lost to Follow-up|27|||
146440513|NCT02316223|528117051|FG001|Overall Study|Lost to Follow-up|34|||
146440514|NCT02316223|528117052|FG002|Overall Study|Lost to Follow-up|36|||
146440515|NCT02316223|528117050|FG000|Overall Study|COPD Diagnosis|3|||
146440516|NCT02316223|528117051|FG001|Overall Study|COPD Diagnosis|2|||
146440517|NCT02316223|528117052|FG002|Overall Study|COPD Diagnosis|3|||
146440518|NCT02316223|528117050|FG000|Overall Study|Reside outside study area|1|||
146440519|NCT02316223|528117051|FG001|Overall Study|Reside outside study area|1|||
146440520|NCT02316223|528117052|FG002|Overall Study|Reside outside study area|1|||
146440521|NCT02316223|528117050|FG000|Overall Study|No asthma|2|||
146440522|NCT02316223|528117051|FG001|Overall Study|No asthma|0|||
146440523|NCT02316223|528117052|FG002|Overall Study|No asthma|0|||
146440524|NCT02316223|528117050|FG000|Overall Study|Discontinued by PI|11|||
146440525|NCT02316223|528117051|FG001|Overall Study|Discontinued by PI|19|||
146440526|NCT02316223|528117052|FG002|Overall Study|Discontinued by PI|3|||
146440527|NCT00529763|528117054|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146440528|NCT00529763|528117055|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
146440529|NCT00529763|528117056|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146440530|NCT00529763|528117054|FG000|Overall Study|Death|1|||
146440531|NCT00529763|528117055|FG001|Overall Study|Death|1|||
146440532|NCT00529763|528117056|FG002|Overall Study|Death|1|||
146440533|NCT00529763|528117054|FG000|Overall Study|Disease Progression|10|||
146440534|NCT00529763|528117055|FG001|Overall Study|Disease Progression|16|||
146440535|NCT00529763|528117056|FG002|Overall Study|Disease Progression|11|||
146440536|NCT00529763|528117054|FG000|Overall Study|Lost to Follow-up|1|||
146440537|NCT00529763|528117055|FG001|Overall Study|Lost to Follow-up|2|||
146440538|NCT00529763|528117056|FG002|Overall Study|Lost to Follow-up|3|||
146440539|NCT00529763|528117054|FG000|Overall Study|Stem Cell Transplant|0|||
145954678|NCT02964338|526347001|FG001|Overall Study|Protocol Violation|1|||
145954679|NCT02964338|526347002|FG002|Overall Study|Protocol Violation|0|||
146440540|NCT00529763|528117055|FG001|Overall Study|Stem Cell Transplant|3|||
146440541|NCT00529763|528117056|FG002|Overall Study|Stem Cell Transplant|1|||
146440542|NCT00529763|528117054|FG000|Overall Study|Study Drug Toxicity|3|||
146440543|NCT00529763|528117055|FG001|Overall Study|Study Drug Toxicity|6|||
146440544|NCT00529763|528117056|FG002|Overall Study|Study Drug Toxicity|4|||
145954680|NCT02964338|526347000|FG000|Overall Study|Withdrawal by Subject|1|||
145954681|NCT02964338|526347001|FG001|Overall Study|Withdrawal by Subject|3|||
145954682|NCT02964338|526347002|FG002|Overall Study|Withdrawal by Subject|1|||
146440545|NCT00529763|528117054|FG000|Overall Study|Participant Withdrew Consent|2|||
146440546|NCT00529763|528117055|FG001|Overall Study|Participant Withdrew Consent|3|||
146440547|NCT00529763|528117056|FG002|Overall Study|Participant Withdrew Consent|4|||
146440548|NCT00529763|528117054|FG000|Overall Study|Other reasons|2|||
146440549|NCT00529763|528117055|FG001|Overall Study|Other reasons|0|||
145954683|NCT02964338|526347000|FG000|Overall Study|Adverse Event|2|||
146440550|NCT00529763|528117056|FG002|Overall Study|Other reasons|2|||
146440551|NCT00529763|528117054|FG000|Overall Study|Participant request to discontinue treatment|1|||
146440552|NCT00529763|528117055|FG001|Overall Study|Participant request to discontinue treatment|1|||
146440553|NCT00529763|528117056|FG002|Overall Study|Participant request to discontinue treatment|3|||
146440554|NCT03669250|528117057|FG000|Overall Study|Adverse Event|0|||
146440555|NCT03669250|528117058|FG001|Overall Study|Adverse Event|0|||
146440556|NCT03669250|528117059|FG002|Overall Study|Adverse Event|0|||
146440557|NCT03669250|528117060|FG003|Overall Study|Adverse Event|0|||
146440558|NCT03669250|528117061|FG004|Overall Study|Adverse Event|1|||
146440559|NCT03669250|528117062|FG005|Overall Study|Adverse Event|0|||
146440560|NCT03669250|528117057|FG000|Overall Study|Withdrawal by Subject|0|||
146440561|NCT03669250|528117058|FG001|Overall Study|Withdrawal by Subject|1|||
146440562|NCT03669250|528117059|FG002|Overall Study|Withdrawal by Subject|0|||
146440563|NCT03669250|528117060|FG003|Overall Study|Withdrawal by Subject|1|||
146440564|NCT03669250|528117061|FG004|Overall Study|Withdrawal by Subject|0|||
146440565|NCT03669250|528117062|FG005|Overall Study|Withdrawal by Subject|0|||
146440566|NCT00828321|528117063|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
146440567|NCT00828321|528117064|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
146440568|NCT00828321|528117063|FG000|Second Intervention|Protocol Violation|0|||
146440569|NCT00828321|528117064|FG001|Second Intervention|Protocol Violation|1|||
146440570|NCT02997176|528117065|FG000|Overall Study|Adverse Event|0|||
146440571|NCT02997176|528117066|FG001|Overall Study|Adverse Event|0|||
146440572|NCT02997176|528117067|FG002|Overall Study|Adverse Event|0|||
146440573|NCT02997176|528117068|FG003|Overall Study|Adverse Event|8|||
146440574|NCT02997176|528117065|FG000|Overall Study|Progressive Disease|1|||
146440575|NCT02997176|528117066|FG001|Overall Study|Progressive Disease|0|||
146440576|NCT02997176|528117067|FG002|Overall Study|Progressive Disease|1|||
146440577|NCT02997176|528117068|FG003|Overall Study|Progressive Disease|1|||
146440578|NCT02997176|528117065|FG000|Overall Study|Death|0|||
146440579|NCT02997176|528117066|FG001|Overall Study|Death|0|||
146440580|NCT02997176|528117067|FG002|Overall Study|Death|1|||
146440581|NCT02997176|528117068|FG003|Overall Study|Death|1|||
146440582|NCT02997176|528117065|FG000|Overall Study|Withdrawal by Subject|0|||
146440583|NCT02997176|528117066|FG001|Overall Study|Withdrawal by Subject|2|||
146440584|NCT02997176|528117067|FG002|Overall Study|Withdrawal by Subject|0|||
146440585|NCT02997176|528117068|FG003|Overall Study|Withdrawal by Subject|1|||
146440586|NCT01630616|528117073|FG000|Overall Study|Adverse Event|0|||
146440587|NCT01630616|528117074|FG001|Overall Study|Adverse Event|0|||
146440588|NCT01630616|528117075|FG002|Overall Study|Adverse Event|0|||
146440589|NCT01630616|528117076|FG003|Overall Study|Adverse Event|1|||
146440590|NCT01630616|528117077|FG004|Overall Study|Adverse Event|0|||
146440591|NCT01630616|528117078|FG005|Overall Study|Adverse Event|0|||
146440592|NCT01630616|528117073|FG000|Overall Study|Withdrawal by Subject|0|||
146440593|NCT01630616|528117074|FG001|Overall Study|Withdrawal by Subject|0|||
146440594|NCT01630616|528117075|FG002|Overall Study|Withdrawal by Subject|0|||
146440595|NCT01630616|528117076|FG003|Overall Study|Withdrawal by Subject|2|||
146440596|NCT01630616|528117077|FG004|Overall Study|Withdrawal by Subject|0|||
146440597|NCT01630616|528117078|FG005|Overall Study|Withdrawal by Subject|0|||
146440598|NCT00691704|528117079|FG000|Induction Therapy|Disease Progression|1|||
146440599|NCT00691704|528117079|FG000|Induction Therapy|Active Hepatitis|1|||
146440600|NCT00691704|528117079|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
146440601|NCT00691704|528117079|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
146440602|NCT00691704|528117079|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
146440603|NCT04406194|528117081|FG000|Period 1|Withdrawal by Subject|0|||
146440604|NCT04406194|528117082|FG001|Period 1|Withdrawal by Subject|1|||
146285662|NCT01874431|527561080|FG002|Overall Study|Adverse Event|6|||
146285663|NCT01874431|527561081|FG003|Overall Study|Adverse Event|5|||
146440605|NCT04102345|528117084|FG000|Overall Study|Withdrawal by Subject|1|||
146440606|NCT04102345|528117085|FG001|Overall Study|Withdrawal by Subject|0|||
146440607|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
146440608|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
146440609|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
146440610|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
146440611|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
146440612|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
146440613|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
146440614|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
146440615|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
146440616|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
146285664|NCT01874431|527561082|FG004|Overall Study|Adverse Event|2|||
146285665|NCT01874431|527561083|FG005|Overall Study|Adverse Event|8|||
146440617|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
146440618|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
146440619|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
146440620|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
145954684|NCT02964338|526347001|FG001|Overall Study|Adverse Event|1|||
145954685|NCT02964338|526347002|FG002|Overall Study|Adverse Event|1|||
145954686|NCT02964338|526347000|FG000|Overall Study|Non-compliant with e-diary|0|||
145954687|NCT02964338|526347001|FG001|Overall Study|Non-compliant with e-diary|1|||
145954688|NCT02964338|526347002|FG002|Overall Study|Non-compliant with e-diary|0|||
145954689|NCT02964338|526347000|FG000|Overall Study|Did not meet criteria|1|||
145954690|NCT02964338|526347001|FG001|Overall Study|Did not meet criteria|0|||
145954691|NCT02964338|526347002|FG002|Overall Study|Did not meet criteria|0|||
145954692|NCT00621257|526347003|FG000|Overall Study|Lost to Follow-up|4|||
145954693|NCT00621257|526347004|FG001|Overall Study|Lost to Follow-up|0|||
145954694|NCT00621257|526347005|FG002|Overall Study|Lost to Follow-up|2|||
145954695|NCT00621257|526347006|FG003|Overall Study|Lost to Follow-up|4|||
145954696|NCT00621257|526347007|FG004|Overall Study|Lost to Follow-up|7|||
145954697|NCT00621257|526347003|FG000|Overall Study|Adverse Event|0|||
145954698|NCT00621257|526347004|FG001|Overall Study|Adverse Event|1|||
145954699|NCT00621257|526347005|FG002|Overall Study|Adverse Event|1|||
145954700|NCT00621257|526347006|FG003|Overall Study|Adverse Event|0|||
145954701|NCT00621257|526347007|FG004|Overall Study|Adverse Event|0|||
145954702|NCT00621257|526347003|FG000|Overall Study|Physician Decision|0|||
145954703|NCT00621257|526347004|FG001|Overall Study|Physician Decision|2|||
145954704|NCT00621257|526347005|FG002|Overall Study|Physician Decision|0|||
145954705|NCT00621257|526347006|FG003|Overall Study|Physician Decision|1|||
145954706|NCT00621257|526347007|FG004|Overall Study|Physician Decision|1|||
145954707|NCT00621257|526347003|FG000|Overall Study|Withdrawal by Subject|0|||
145954708|NCT00621257|526347004|FG001|Overall Study|Withdrawal by Subject|0|||
145954709|NCT00621257|526347005|FG002|Overall Study|Withdrawal by Subject|0|||
145954710|NCT00621257|526347006|FG003|Overall Study|Withdrawal by Subject|1|||
145954711|NCT00621257|526347007|FG004|Overall Study|Withdrawal by Subject|1|||
145954712|NCT02171429|526347011|FG000|Overall Study|Other|0|||
145954713|NCT02171429|526347012|FG001|Overall Study|Other|1|||
145954714|NCT02171429|526347013|FG002|Overall Study|Other|1|||
145954715|NCT02171429|526347011|FG000|Overall Study|Non-Compliance|0|||
145954716|NCT02171429|526347012|FG001|Overall Study|Non-Compliance|0|||
145954717|NCT02171429|526347013|FG002|Overall Study|Non-Compliance|1|||
145954718|NCT02171429|526347011|FG000|Overall Study|Physician Decision|0|||
145954719|NCT02171429|526347012|FG001|Overall Study|Physician Decision|0|||
145954720|NCT02171429|526347013|FG002|Overall Study|Physician Decision|1|||
145954721|NCT02171429|526347011|FG000|Overall Study|Withdrawal by Subject|1|||
145954722|NCT02171429|526347012|FG001|Overall Study|Withdrawal by Subject|1|||
145954723|NCT02171429|526347013|FG002|Overall Study|Withdrawal by Subject|1|||
145954724|NCT02171429|526347011|FG000|Overall Study|Lost to Follow-up|0|||
145954725|NCT02171429|526347012|FG001|Overall Study|Lost to Follow-up|1|||
145954726|NCT02171429|526347013|FG002|Overall Study|Lost to Follow-up|0|||
145954727|NCT02171429|526347011|FG000|Overall Study|Death|0|||
145954728|NCT02171429|526347012|FG001|Overall Study|Death|0|||
145954729|NCT02171429|526347013|FG002|Overall Study|Death|1|||
145954730|NCT02821416|526347014|FG000|Overall Study|Adverse Event|0|||
145954731|NCT02821416|526347015|FG001|Overall Study|Adverse Event|1|||
145954732|NCT02821416|526347014|FG000|Overall Study|Withdrawal by Subject|2|||
145954733|NCT02821416|526347015|FG001|Overall Study|Withdrawal by Subject|0|||
145954734|NCT02821416|526347014|FG000|Overall Study|Lost to Follow-up|1|||
145954735|NCT02821416|526347015|FG001|Overall Study|Lost to Follow-up|0|||
145954736|NCT02256917|526347016|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
145954737|NCT02256917|526347016|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
145954738|NCT02256917|526347016|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
145954739|NCT02256917|526347016|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
145954740|NCT02256917|526347016|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
145954741|NCT04152083|526347017|FG000|Overall Study|Lost to Follow-up|2|||
145954742|NCT04152083|526347018|FG001|Overall Study|Lost to Follow-up|1|||
145954743|NCT04152083|526347017|FG000|Overall Study|Adverse Event|1|||
145954744|NCT04152083|526347018|FG001|Overall Study|Adverse Event|0|||
145954745|NCT04152083|526347017|FG000|Overall Study|Randomized but not treated|3|||
145954746|NCT04152083|526347018|FG001|Overall Study|Randomized but not treated|2|||
145954747|NCT02609386|526347019|FG000|Overall Study|Withdrawal by Subject|6|||
145954748|NCT02609386|526347020|FG001|Overall Study|Withdrawal by Subject|1|||
145954749|NCT02609386|526347019|FG000|Overall Study|Lost to Follow-up|3|||
145954750|NCT02609386|526347020|FG001|Overall Study|Lost to Follow-up|5|||
145954751|NCT02609386|526347019|FG000|Overall Study|Death|19|||
145954752|NCT02609386|526347020|FG001|Overall Study|Death|9|||
146083111|NCT05027971|526824749|FG001|Overall Study|Non-study fiber used.|1|||
145954753|NCT02609386|526347019|FG000|Overall Study|Physician Decision|0|||
145954754|NCT02609386|526347020|FG001|Overall Study|Physician Decision|2|||
145954755|NCT00540644|526347021|FG000|Overall Study|Adverse Event|3|||
145954756|NCT00540644|526347022|FG001|Overall Study|Adverse Event|1|||
145954757|NCT00540644|526347021|FG000|Overall Study|Disease Progression|3|||
145954758|NCT00540644|526347022|FG001|Overall Study|Disease Progression|1|||
145954759|NCT00540644|526347021|FG000|Overall Study|Physician Decision|0|||
145954760|NCT00540644|526347022|FG001|Overall Study|Physician Decision|5|||
145954761|NCT00540644|526347021|FG000|Overall Study|Withdrawal by Subject|2|||
146440621|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
146440622|NCT00385736|528117090|FG000|Efficacy Analysis Set - Induction|Other|0|||
146440623|NCT00385736|528117091|FG001|Efficacy Analysis Set - Induction|Other|0|||
146440624|NCT00385736|528117092|FG002|Efficacy Analysis Set - Induction|Other|1|||
146440625|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
146440626|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
146440627|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
146440628|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
146440629|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
146440630|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
146440631|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
146440632|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
146440633|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
146440634|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
146440635|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
146440636|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
146440637|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
146440638|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
146440639|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
146440640|NCT00385736|528117090|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
146440641|NCT00385736|528117091|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
146440642|NCT00385736|528117092|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
146440643|NCT00385736|528117090|FG000|Safety Analysis Set|Adverse Event|23|||
146440644|NCT00385736|528117091|FG001|Safety Analysis Set|Adverse Event|15|||
146440645|NCT00385736|528117092|FG002|Safety Analysis Set|Adverse Event|23|||
146440646|NCT00385736|528117090|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
146440647|NCT00385736|528117091|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
146440648|NCT00385736|528117092|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
146440649|NCT00385736|528117090|FG000|Safety Analysis Set|Lost to Follow-up|0|||
146440650|NCT00385736|528117091|FG001|Safety Analysis Set|Lost to Follow-up|2|||
146440651|NCT00385736|528117092|FG002|Safety Analysis Set|Lost to Follow-up|2|||
146440652|NCT00385736|528117090|FG000|Safety Analysis Set|Lack of Efficacy|38|||
146440653|NCT00385736|528117091|FG001|Safety Analysis Set|Lack of Efficacy|16|||
146440654|NCT00385736|528117092|FG002|Safety Analysis Set|Lack of Efficacy|31|||
146440655|NCT00385736|528117090|FG000|Safety Analysis Set|Protocol Violation|2|||
146440656|NCT00385736|528117091|FG001|Safety Analysis Set|Protocol Violation|1|||
146440657|NCT00385736|528117092|FG002|Safety Analysis Set|Protocol Violation|6|||
146440658|NCT00385736|528117090|FG000|Safety Analysis Set|Other|1|||
146440659|NCT00385736|528117091|FG001|Safety Analysis Set|Other|4|||
146440660|NCT00385736|528117092|FG002|Safety Analysis Set|Other|4|||
146440661|NCT05497557|528117093|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
146440662|NCT05497557|528117094|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
146440663|NCT05497557|528117095|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
146440664|NCT03827395|528117096|FG000|Overall Study|Lost to Follow-up|1|||
146440665|NCT03827395|528117097|FG001|Overall Study|Lost to Follow-up|0|||
146440666|NCT03827395|528117096|FG000|Overall Study|Protocol Violation|1|||
146440667|NCT03827395|528117097|FG001|Overall Study|Protocol Violation|0|||
146440668|NCT03827395|528117096|FG000|Overall Study|Became ineligible after enrollment|1|||
146440669|NCT03827395|528117097|FG001|Overall Study|Became ineligible after enrollment|2|||
146440670|NCT01923740|528117098|FG000|Overall Study|Lost to Follow-up|4|||
146440671|NCT01923740|528117099|FG001|Overall Study|Lost to Follow-up|9|||
146440672|NCT01923740|528117098|FG000|Overall Study|Withdrawal by Subject|2|||
146440673|NCT01923740|528117099|FG001|Overall Study|Withdrawal by Subject|0|||
146440674|NCT01537887|528117100|FG000|Period 1|Physician Decision|0|||
146440675|NCT01537887|528117101|FG001|Period 1|Physician Decision|0|||
146440676|NCT01537887|528117102|FG002|Period 1|Physician Decision|0|||
146440677|NCT01537887|528117103|FG003|Period 1|Physician Decision|0|||
146440678|NCT01537887|528117104|FG004|Period 1|Physician Decision|1|||
146440679|NCT01537887|528117105|FG005|Period 1|Physician Decision|1|||
146440680|NCT01537887|528117100|FG000|Period 1|Did not receive treatment|0|||
146440681|NCT01537887|528117101|FG001|Period 1|Did not receive treatment|0|||
146440682|NCT01537887|528117102|FG002|Period 1|Did not receive treatment|1|||
146440683|NCT01537887|528117103|FG003|Period 1|Did not receive treatment|0|||
146440684|NCT01537887|528117104|FG004|Period 1|Did not receive treatment|0|||
146440685|NCT01537887|528117105|FG005|Period 1|Did not receive treatment|0|||
146440686|NCT01537887|528117100|FG000|Period 2|Withdrawal by Subject|0|||
146440687|NCT01537887|528117101|FG001|Period 2|Withdrawal by Subject|1|||
146440688|NCT01537887|528117102|FG002|Period 2|Withdrawal by Subject|0|||
146440689|NCT01537887|528117103|FG003|Period 2|Withdrawal by Subject|0|||
146440690|NCT01537887|528117104|FG004|Period 2|Withdrawal by Subject|0|||
146440691|NCT01537887|528117105|FG005|Period 2|Withdrawal by Subject|0|||
146440692|NCT01537887|528117100|FG000|Period 3|Adverse Event|0|||
146440693|NCT01537887|528117101|FG001|Period 3|Adverse Event|0|||
146440694|NCT01537887|528117102|FG002|Period 3|Adverse Event|1|||
146440695|NCT01537887|528117103|FG003|Period 3|Adverse Event|0|||
146440696|NCT01537887|528117104|FG004|Period 3|Adverse Event|0|||
146440697|NCT01537887|528117105|FG005|Period 3|Adverse Event|0|||
145954762|NCT00540644|526347022|FG001|Overall Study|Withdrawal by Subject|2|||
145954763|NCT00540644|526347021|FG000|Overall Study|Noncomplilance|1|||
145954764|NCT00540644|526347022|FG001|Overall Study|Noncomplilance|0|||
145954765|NCT03280056|526347023|FG000|Overall Study|Withdrawal by Subject|12|||
145954766|NCT03280056|526347024|FG001|Overall Study|Withdrawal by Subject|14|||
145954767|NCT03280056|526347023|FG000|Overall Study|Death|9|||
145954768|NCT03280056|526347024|FG001|Overall Study|Death|2|||
145954769|NCT03280056|526347023|FG000|Overall Study|Adverse Event|1|||
145954770|NCT03280056|526347024|FG001|Overall Study|Adverse Event|3|||
145954771|NCT03280056|526347023|FG000|Overall Study|Lost to Follow-up|1|||
145954772|NCT03280056|526347024|FG001|Overall Study|Lost to Follow-up|1|||
145954773|NCT03280056|526347023|FG000|Overall Study|Physician Decision|0|||
145954774|NCT03280056|526347024|FG001|Overall Study|Physician Decision|1|||
145954775|NCT03280056|526347023|FG000|Overall Study|Early Discontinuation|1|||
145954776|NCT03280056|526347024|FG001|Overall Study|Early Discontinuation|0|||
145954777|NCT01869777|526347025|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
145954778|NCT01135524|526347032|FG000|Overall Study|Withdrawal by Subject|14|||
146285666|NCT01874431|527561084|FG006|Overall Study|Adverse Event|2|||
145954779|NCT01135524|526347032|FG000|Overall Study|Adverse Event|20|||
145954780|NCT01135524|526347032|FG000|Overall Study|Lost to Follow-up|3|||
146440698|NCT01537887|528117100|FG000|Period 3|Withdrawal by Subject|0|||
146440699|NCT01537887|528117101|FG001|Period 3|Withdrawal by Subject|1|||
146440700|NCT01537887|528117102|FG002|Period 3|Withdrawal by Subject|0|||
146440701|NCT01537887|528117103|FG003|Period 3|Withdrawal by Subject|0|||
146440702|NCT01537887|528117104|FG004|Period 3|Withdrawal by Subject|0|||
146440703|NCT01537887|528117105|FG005|Period 3|Withdrawal by Subject|0|||
146440704|NCT04723693|528117106|FG000|Overall Study|Withdrawal by Subject|2|||
146440705|NCT00294047|528117107|FG000|Month 48|Adverse Event|28|||
146440706|NCT00294047|528117108|FG001|Month 48|Adverse Event|13|||
146440707|NCT00294047|528117107|FG000|Month 48|Protocol Violation|4|||
146440708|NCT00294047|528117108|FG001|Month 48|Protocol Violation|4|||
145954781|NCT01135524|526347032|FG000|Overall Study|Administrative|151|||
145954782|NCT01135524|526347032|FG000|Overall Study|Lack of Efficacy|8|||
146440709|NCT00294047|528117107|FG000|Month 48|Withdrawal by Subject|111|||
146440710|NCT00294047|528117108|FG001|Month 48|Withdrawal by Subject|115|||
145954783|NCT03318003|526347033|FG000|Overall Study|Withdrawal by Subject|1|||
145954784|NCT03318003|526347034|FG001|Overall Study|Withdrawal by Subject|1|||
145954785|NCT03318003|526347033|FG000|Overall Study|fetal loss|0|||
145954786|NCT03318003|526347034|FG001|Overall Study|fetal loss|1|||
145954787|NCT02620787|526347039|FG000|Overall Study|Adverse Event|1|||
145954788|NCT02620787|526347040|FG001|Overall Study|Adverse Event|0|||
145954789|NCT02620787|526347039|FG000|Overall Study|Eligibility Criteria Not Met|1|||
145954790|NCT02620787|526347040|FG001|Overall Study|Eligibility Criteria Not Met|0|||
145954791|NCT00807612|526347042|FG000|Overall Study|Death|8|||
145954792|NCT00807612|526347042|FG000|Overall Study|Study early termination|5|||
145954793|NCT00807612|526347042|FG000|Overall Study|Withdrawal by Subject|1|||
145954794|NCT04819438|526347043|FG000|Overall Study|Withdrawal by Subject|1|||
145954795|NCT04819438|526347044|FG001|Overall Study|Withdrawal by Subject|0|||
145954796|NCT04819438|526347043|FG000|Overall Study|Adverse Event|0|||
145954797|NCT04819438|526347044|FG001|Overall Study|Adverse Event|1|||
145954798|NCT04819438|526347043|FG000|Overall Study|Protocol Violation|0|||
145954799|NCT04819438|526347044|FG001|Overall Study|Protocol Violation|1|||
145954800|NCT04607135|526347045|FG000|Overall Study|Physician Decision|1|||
146440711|NCT00294047|528117107|FG000|Month 48|Lost to Follow-up|272|||
146440712|NCT00294047|528117108|FG001|Month 48|Lost to Follow-up|287|||
146440713|NCT00294047|528117107|FG000|Month 48|Other|10|||
146440714|NCT00294047|528117108|FG001|Month 48|Other|14|||
146440715|NCT00294047|528117107|FG000|Month 84|Adverse Event|4|||
146440716|NCT00294047|528117108|FG001|Month 84|Adverse Event|2|||
146440717|NCT00294047|528117107|FG000|Month 84|Protocol Violation|1|||
145954801|NCT04607135|526347045|FG000|Overall Study|Withdrawal by Subject|1|||
145954802|NCT04607135|526347045|FG000|Overall Study|Equipment not working|3|||
145954803|NCT02869893|526347046|FG000|Overall Study|participant aversion to IV|5|||
145954804|NCT02869893|526347046|FG000|Overall Study|participant fear of MRI scanner|2|||
145954805|NCT02328937|526347047|FG000|Period 1|Lost to Follow-up|0|||
145954806|NCT02328937|526347048|FG001|Period 1|Lost to Follow-up|0|||
145954807|NCT02328937|526347049|FG002|Period 1|Lost to Follow-up|0|||
145954808|NCT02328937|526347050|FG003|Period 1|Lost to Follow-up|1|||
145954809|NCT02328937|526347051|FG004|Period 1|Lost to Follow-up|0|||
145954810|NCT02328937|526347052|FG005|Period 1|Lost to Follow-up|0|||
145954811|NCT02328937|526347047|FG000|Period 2|Adverse Event|0|||
145954812|NCT02328937|526347048|FG001|Period 2|Adverse Event|0|||
145954813|NCT02328937|526347049|FG002|Period 2|Adverse Event|1|||
145954814|NCT02328937|526347050|FG003|Period 2|Adverse Event|0|||
145954815|NCT02328937|526347051|FG004|Period 2|Adverse Event|0|||
145954816|NCT02328937|526347052|FG005|Period 2|Adverse Event|0|||
145954817|NCT03665077|526347055|FG000|Overall Study|Lost to Follow-up|2|||
145954818|NCT03665077|526347055|FG000|Overall Study|Physician Decision|2|||
145954819|NCT00837967|526347058|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
145954820|NCT00837967|526347059|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
145954821|NCT02504320|526347064|FG000|Treatment Period 1|Positive Drug Screen|0|||
145954822|NCT02504320|526347065|FG001|Treatment Period 1|Positive Drug Screen|0|||
145954823|NCT02504320|526347066|FG002|Treatment Period 1|Positive Drug Screen|1|||
145954824|NCT02504320|526347067|FG003|Treatment Period 1|Positive Drug Screen|0|||
145954825|NCT02504320|526347064|FG000|Treatment Period 2|Positive Drug Screen|0|||
145954826|NCT02504320|526347065|FG001|Treatment Period 2|Positive Drug Screen|1|||
145954827|NCT02504320|526347066|FG002|Treatment Period 2|Positive Drug Screen|0|||
145954828|NCT02504320|526347067|FG003|Treatment Period 2|Positive Drug Screen|0|||
145954829|NCT02504320|526347064|FG000|Treatment Period 3|Positive Drug Screen|0|||
145954830|NCT02504320|526347065|FG001|Treatment Period 3|Positive Drug Screen|0|||
145954831|NCT02504320|526347066|FG002|Treatment Period 3|Positive Drug Screen|0|||
145954832|NCT02504320|526347067|FG003|Treatment Period 3|Positive Drug Screen|1|||
145954833|NCT02504320|526347064|FG000|Treatment Period 3|Adverse Event|0|||
145954834|NCT02504320|526347065|FG001|Treatment Period 3|Adverse Event|0|||
145954835|NCT02504320|526347066|FG002|Treatment Period 3|Adverse Event|1|||
145954836|NCT02504320|526347067|FG003|Treatment Period 3|Adverse Event|0|||
145954837|NCT01210222|526347068|FG000|Overall Study|Ineligible|2|||
145954838|NCT01210222|526347068|FG000|Overall Study|Never treated|1|||
145954839|NCT01737879|526347069|FG000|Overall Study|Death|1|||
146440718|NCT00294047|528117108|FG001|Month 84|Protocol Violation|1|||
145954840|NCT01737879|526347069|FG000|Overall Study|Sponsor decision|40|||
145954841|NCT03293394|526347070|FG000|Follow-up (6 Months)|Adverse Event|4|||
145954842|NCT03293394|526347071|FG001|Follow-up (6 Months)|Adverse Event|2|||
145954843|NCT02497404|526347072|FG000|Overall Study|Adverse Event|1|||
145954844|NCT04865419|526347075|FG000|Overall Study|Other|1|||
146440719|NCT00294047|528117107|FG000|Month 84|Withdrawal by Subject|33|||
146440720|NCT00294047|528117108|FG001|Month 84|Withdrawal by Subject|31|||
145954845|NCT04865419|526347076|FG001|Overall Study|Other|2|||
145954846|NCT04865419|526347077|FG002|Overall Study|Other|2|||
145954847|NCT04865419|526347078|FG003|Overall Study|Other|1|||
145954848|NCT04865419|526347079|FG004|Overall Study|Other|3|||
145954849|NCT04865419|526347080|FG005|Overall Study|Other|0|||
145954850|NCT04865419|526347081|FG006|Overall Study|Other|0|||
145954851|NCT04865419|526347082|FG007|Overall Study|Other|1|||
146440721|NCT00294047|528117107|FG000|Month 84|Lost to Follow-up|187|||
146440722|NCT00294047|528117108|FG001|Month 84|Lost to Follow-up|190|||
146440723|NCT00294047|528117107|FG000|Month 84|Absent Cervix|2|||
146440724|NCT00294047|528117108|FG001|Month 84|Absent Cervix|0|||
146440725|NCT00294047|528117107|FG000|Month 84|Work related reasons|4|||
146440726|NCT00294047|528117108|FG001|Month 84|Work related reasons|2|||
146440727|NCT00294047|528117107|FG000|Month 84|Center closed, subject did not transfer|1|||
146440728|NCT00294047|528117108|FG001|Month 84|Center closed, subject did not transfer|0|||
146440729|NCT00294047|528117107|FG000|Month 84|Family problems|2|||
146440730|NCT00294047|528117108|FG001|Month 84|Family problems|2|||
146440731|NCT00294047|528117107|FG000|Month 84|Lack of time|3|||
146440732|NCT00294047|528117108|FG001|Month 84|Lack of time|1|||
146440733|NCT00294047|528117107|FG000|Month 84|Personal reason|2|||
146440734|NCT00294047|528117108|FG001|Month 84|Personal reason|4|||
146440735|NCT00294047|528117107|FG000|Month 84|Subject does not want male physician|1|||
146440736|NCT00294047|528117108|FG001|Month 84|Subject does not want male physician|0|||
146440737|NCT00294047|528117107|FG000|Month 84|Transport reimbursement delayed|0|||
146440738|NCT00294047|528117108|FG001|Month 84|Transport reimbursement delayed|1|||
146440739|NCT00294047|528117107|FG000|Month 84|Unable to reach study site|1|||
146440740|NCT00294047|528117108|FG001|Month 84|Unable to reach study site|0|||
146440741|NCT00294047|528117107|FG000|Month 84|Under investigation locally|1|||
146440742|NCT00294047|528117108|FG001|Month 84|Under investigation locally|0|||
146440743|NCT00294047|528117107|FG000|Month 84|Visit missed|0|||
146440744|NCT00294047|528117108|FG001|Month 84|Visit missed|1|||
146440745|NCT00294047|528117107|FG000|Month 84|No consent for Month 84 Follow-up|731|||
146440746|NCT00294047|528117108|FG001|Month 84|No consent for Month 84 Follow-up|754|||
146440747|NCT02157974|528117109|FG000|Overall Study|Withdrawal by Subject|0|||
146440748|NCT02157974|528117110|FG001|Overall Study|Withdrawal by Subject|1|||
146440749|NCT02157974|528117111|FG002|Overall Study|Withdrawal by Subject|0|||
146440750|NCT02157974|528117112|FG003|Overall Study|Withdrawal by Subject|0|||
146440751|NCT02157974|528117113|FG004|Overall Study|Withdrawal by Subject|0|||
146440752|NCT02157974|528117109|FG000|Overall Study|Screen Failure|0|||
146440753|NCT02157974|528117110|FG001|Overall Study|Screen Failure|1|||
146440754|NCT02157974|528117111|FG002|Overall Study|Screen Failure|0|||
146440755|NCT02157974|528117112|FG003|Overall Study|Screen Failure|0|||
146440756|NCT02157974|528117113|FG004|Overall Study|Screen Failure|0|||
146440757|NCT02157974|528117109|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
146440758|NCT02157974|528117110|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
146440759|NCT02157974|528117111|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
146440760|NCT02157974|528117112|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145954852|NCT04865419|526347083|FG008|Overall Study|Other|0|||
145954853|NCT04865419|526347084|FG009|Overall Study|Other|0|||
145954854|NCT04865419|526347085|FG010|Overall Study|Other|0|||
145954855|NCT04865419|526347075|FG000|Overall Study|Withdrawal by Subject|0|||
145954856|NCT04865419|526347076|FG001|Overall Study|Withdrawal by Subject|1|||
145954857|NCT04865419|526347077|FG002|Overall Study|Withdrawal by Subject|1|||
145954858|NCT04865419|526347078|FG003|Overall Study|Withdrawal by Subject|0|||
145954859|NCT04865419|526347079|FG004|Overall Study|Withdrawal by Subject|0|||
145954860|NCT04865419|526347080|FG005|Overall Study|Withdrawal by Subject|0|||
145954861|NCT04865419|526347081|FG006|Overall Study|Withdrawal by Subject|0|||
145954862|NCT04865419|526347082|FG007|Overall Study|Withdrawal by Subject|1|||
145954863|NCT04865419|526347083|FG008|Overall Study|Withdrawal by Subject|2|||
145954864|NCT04865419|526347084|FG009|Overall Study|Withdrawal by Subject|1|||
145954865|NCT04865419|526347085|FG010|Overall Study|Withdrawal by Subject|0|||
145954866|NCT04865419|526347075|FG000|Overall Study|Study terminated by Sponsor|0|||
145954867|NCT04865419|526347076|FG001|Overall Study|Study terminated by Sponsor|0|||
145954868|NCT04865419|526347077|FG002|Overall Study|Study terminated by Sponsor|0|||
145954869|NCT04865419|526347078|FG003|Overall Study|Study terminated by Sponsor|2|||
145954870|NCT04865419|526347079|FG004|Overall Study|Study terminated by Sponsor|2|||
145954871|NCT04865419|526347080|FG005|Overall Study|Study terminated by Sponsor|0|||
145954872|NCT04865419|526347081|FG006|Overall Study|Study terminated by Sponsor|0|||
145954873|NCT04865419|526347082|FG007|Overall Study|Study terminated by Sponsor|0|||
145954874|NCT04865419|526347083|FG008|Overall Study|Study terminated by Sponsor|0|||
145954875|NCT04865419|526347084|FG009|Overall Study|Study terminated by Sponsor|0|||
145954876|NCT04865419|526347085|FG010|Overall Study|Study terminated by Sponsor|1|||
145954877|NCT04865419|526347075|FG000|Overall Study|Death|3|||
145954878|NCT04865419|526347076|FG001|Overall Study|Death|1|||
145954879|NCT04865419|526347077|FG002|Overall Study|Death|4|||
145954880|NCT04865419|526347078|FG003|Overall Study|Death|2|||
145954881|NCT04865419|526347079|FG004|Overall Study|Death|5|||
146440761|NCT02157974|528117113|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145954882|NCT04865419|526347080|FG005|Overall Study|Death|2|||
145954883|NCT04865419|526347081|FG006|Overall Study|Death|1|||
145954884|NCT04865419|526347082|FG007|Overall Study|Death|1|||
145954885|NCT04865419|526347083|FG008|Overall Study|Death|2|||
146440762|NCT00540423|528117116|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146440763|NCT00540423|528117117|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146440764|NCT00540423|528117118|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146440765|NCT00540423|528117116|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
146440766|NCT00540423|528117117|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146440767|NCT00540423|528117118|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
146440768|NCT02280863|528117122|FG000|Integrated Platform|Met stopping criteria|0|||
146440769|NCT02280863|528117123|FG001|Integrated Platform|Met stopping criteria|1|||
146440770|NCT00263588|528117124|FG000|Overall Study|Death|54|||
146440771|NCT00263588|528117125|FG001|Overall Study|Death|90|||
146440772|NCT00263588|528117124|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
146440773|NCT00263588|528117125|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
146440774|NCT00263588|528117124|FG000|Overall Study|Lost to Follow-up|7|||
146440775|NCT00263588|528117125|FG001|Overall Study|Lost to Follow-up|10|||
146440776|NCT00263588|528117124|FG000|Overall Study|Withdrawal by Subject|3|||
146440777|NCT00263588|528117125|FG001|Overall Study|Withdrawal by Subject|4|||
146440778|NCT00263588|528117124|FG000|Overall Study|Protocol Violation|0|||
146440779|NCT00263588|528117125|FG001|Overall Study|Protocol Violation|1|||
146440780|NCT00263588|528117124|FG000|Overall Study|Investigator decision|7|||
146440781|NCT00263588|528117125|FG001|Overall Study|Investigator decision|15|||
146440782|NCT00263588|528117124|FG000|Overall Study|Sponsor terminated study|0|||
146440783|NCT00263588|528117125|FG001|Overall Study|Sponsor terminated study|1|||
146440784|NCT02412852|528117126|FG000|Overall Study|Withdrawal by Subject|0|||
146440785|NCT02412852|528117127|FG001|Overall Study|Withdrawal by Subject|1|||
146440786|NCT02412852|528117128|FG002|Overall Study|Withdrawal by Subject|0|||
146440787|NCT02412852|528117129|FG003|Overall Study|Withdrawal by Subject|0|||
146440788|NCT02412852|528117126|FG000|Overall Study|Physician Decision|0|||
146440789|NCT02412852|528117127|FG001|Overall Study|Physician Decision|0|||
146440790|NCT02412852|528117128|FG002|Overall Study|Physician Decision|0|||
146440791|NCT02412852|528117129|FG003|Overall Study|Physician Decision|1|||
146440792|NCT01174186|528117130|FG000|Overall Study|Lost to Follow-up|0|||
146440793|NCT01174186|528117131|FG001|Overall Study|Lost to Follow-up|1|||
146440794|NCT01174186|528117130|FG000|Overall Study|Withdrawal by Subject|0|||
146440795|NCT01174186|528117131|FG001|Overall Study|Withdrawal by Subject|2|||
146440796|NCT05274763|528117132|FG000|Overall Study|Lost to Follow-up|1|||
146440797|NCT03629054|528117133|FG000|Period 2 (4 Days)|Not treated|0|||
146440798|NCT03629054|528117134|FG001|Period 2 (4 Days)|Not treated|1|||
146440799|NCT02121184|528117135|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
146440800|NCT02121184|528117136|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
146440801|NCT02121184|528117135|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
146440802|NCT02121184|528117136|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
146440803|NCT02121184|528117135|FG000|Overall Study|Emergency cesarean section required|0|||
146440804|NCT02121184|528117136|FG001|Overall Study|Emergency cesarean section required|2|||
146440805|NCT02121184|528117135|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
146440806|NCT02121184|528117136|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
146440807|NCT00101439|528117141|FG000|Period 2|Withdrawal by Subject|0|||
146440808|NCT00101439|528117142|FG001|Period 2|Withdrawal by Subject|2|||
146440809|NCT01867658|528117143|FG000|Overall Study|Withdrawal by Subject|6|||
146440810|NCT01867658|528117143|FG000|Overall Study|Death|2|||
146440811|NCT01867658|528117143|FG000|Overall Study|Subject could not be contacted|1|||
145954886|NCT04865419|526347084|FG009|Overall Study|Death|2|||
145954887|NCT04865419|526347085|FG010|Overall Study|Death|1|||
145954888|NCT04865419|526347075|FG000|Overall Study|Lost to Follow-up|0|||
145954889|NCT04865419|526347076|FG001|Overall Study|Lost to Follow-up|0|||
145954890|NCT04865419|526347077|FG002|Overall Study|Lost to Follow-up|0|||
145954891|NCT04865419|526347078|FG003|Overall Study|Lost to Follow-up|0|||
145954892|NCT04865419|526347079|FG004|Overall Study|Lost to Follow-up|0|||
145954893|NCT04865419|526347080|FG005|Overall Study|Lost to Follow-up|0|||
145954894|NCT04865419|526347081|FG006|Overall Study|Lost to Follow-up|0|||
146440812|NCT02845336|528117144|FG000|Overall Study|Lost to Follow-up|3|||
146440813|NCT02845336|528117145|FG001|Overall Study|Lost to Follow-up|1|||
146440814|NCT02845336|528117144|FG000|Overall Study|Inability to get medication|2|||
146440815|NCT02845336|528117145|FG001|Overall Study|Inability to get medication|0|||
146440816|NCT01496118|528117146|FG000|Overall Study|Disease progression|3|||
146440817|NCT01496118|528117147|FG001|Overall Study|Disease progression|2|||
146440818|NCT01496118|528117148|FG002|Overall Study|Disease progression|3|||
146440819|NCT01496118|528117149|FG003|Overall Study|Disease progression|1|||
145954895|NCT04865419|526347082|FG007|Overall Study|Lost to Follow-up|0|||
146440820|NCT01496118|528117150|FG004|Overall Study|Disease progression|2|||
146440821|NCT01496118|528117151|FG005|Overall Study|Disease progression|2|||
146440822|NCT01496118|528117152|FG006|Overall Study|Disease progression|14|||
146440823|NCT01496118|528117153|FG007|Overall Study|Disease progression|10|||
146440824|NCT01496118|528117146|FG000|Overall Study|Physician Decision|0|||
146440825|NCT01496118|528117147|FG001|Overall Study|Physician Decision|0|||
146440826|NCT01496118|528117148|FG002|Overall Study|Physician Decision|0|||
146440827|NCT01496118|528117149|FG003|Overall Study|Physician Decision|0|||
146440828|NCT01496118|528117150|FG004|Overall Study|Physician Decision|1|||
146440829|NCT01496118|528117151|FG005|Overall Study|Physician Decision|0|||
146440830|NCT01496118|528117152|FG006|Overall Study|Physician Decision|3|||
146440831|NCT01496118|528117153|FG007|Overall Study|Physician Decision|6|||
146440832|NCT01496118|528117146|FG000|Overall Study|Adverse Event|1|||
146440833|NCT01496118|528117147|FG001|Overall Study|Adverse Event|1|||
146440834|NCT01496118|528117148|FG002|Overall Study|Adverse Event|0|||
146440835|NCT01496118|528117149|FG003|Overall Study|Adverse Event|0|||
146440836|NCT01496118|528117150|FG004|Overall Study|Adverse Event|0|||
146440837|NCT01496118|528117151|FG005|Overall Study|Adverse Event|0|||
146440838|NCT01496118|528117152|FG006|Overall Study|Adverse Event|6|||
146440839|NCT01496118|528117153|FG007|Overall Study|Adverse Event|10|||
146440840|NCT01496118|528117146|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
146440841|NCT01496118|528117147|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
146440842|NCT01496118|528117148|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145954896|NCT04865419|526347083|FG008|Overall Study|Lost to Follow-up|0|||
145954897|NCT04865419|526347084|FG009|Overall Study|Lost to Follow-up|1|||
145954898|NCT04865419|526347085|FG010|Overall Study|Lost to Follow-up|0|||
145954899|NCT00334295|526347086|FG000|Overall Study|Patients received fewer than 3 injection|5|||
145954900|NCT00792116|526347089|FG000|Overall Study|Lost to Follow-up|0|||
145954901|NCT00792116|526347090|FG001|Overall Study|Lost to Follow-up|1|||
145954902|NCT00792116|526347089|FG000|Overall Study|Discontnued intervention|1|||
145954903|NCT00792116|526347090|FG001|Overall Study|Discontnued intervention|0|||
145954904|NCT02453256|526347091|FG000|Double Blind Period|Death|1|||
145954905|NCT02453256|526347092|FG001|Double Blind Period|Death|1|||
145954906|NCT02453256|526347091|FG000|Double Blind Period|Adverse Event|3|||
145954907|NCT02453256|526347092|FG001|Double Blind Period|Adverse Event|2|||
145954908|NCT02453256|526347091|FG000|Double Blind Period|Withdrawal by Subject|9|||
145954909|NCT02453256|526347092|FG001|Double Blind Period|Withdrawal by Subject|5|||
145954910|NCT02453256|526347091|FG000|Double Blind Period|Other|0|||
145954911|NCT02453256|526347092|FG001|Double Blind Period|Other|1|||
145954912|NCT02453256|526347091|FG000|Open Label Period|Adverse Event|1|||
145954913|NCT02453256|526347092|FG001|Open Label Period|Adverse Event|3|||
145954914|NCT02453256|526347091|FG000|Open Label Period|Death|0|||
145954915|NCT02453256|526347092|FG001|Open Label Period|Death|1|||
145954916|NCT02453256|526347091|FG000|Open Label Period|Lost to Follow-up|1|||
145954917|NCT02453256|526347092|FG001|Open Label Period|Lost to Follow-up|0|||
145954918|NCT02453256|526347091|FG000|Open Label Period|Other|0|||
145954919|NCT02453256|526347092|FG001|Open Label Period|Other|2|||
145954920|NCT02453256|526347091|FG000|Open Label Period|Withdrawal by Subject|5|||
145954921|NCT02453256|526347092|FG001|Open Label Period|Withdrawal by Subject|1|||
145954922|NCT00980655|526347093|FG000|Overall Study|Adverse Event|13|||
145954923|NCT00980655|526347094|FG001|Overall Study|Adverse Event|31|||
145954924|NCT00980655|526347093|FG000|Overall Study|Death|0|||
145954925|NCT00980655|526347094|FG001|Overall Study|Death|7|||
145954926|NCT00980655|526347093|FG000|Overall Study|Protocol Violation|2|||
145954927|NCT00980655|526347094|FG001|Overall Study|Protocol Violation|7|||
145954928|NCT00980655|526347093|FG000|Overall Study|Withdrawal by Subject|0|||
145954929|NCT00980655|526347094|FG001|Overall Study|Withdrawal by Subject|4|||
145954930|NCT00980655|526347093|FG000|Overall Study|Lost to Follow-up|0|||
145954931|NCT00980655|526347094|FG001|Overall Study|Lost to Follow-up|1|||
145954932|NCT00980655|526347093|FG000|Overall Study|Parent/legal guardian request|1|||
145954933|NCT00980655|526347094|FG001|Overall Study|Parent/legal guardian request|0|||
145954934|NCT00980655|526347093|FG000|Overall Study|Other|0|||
145954935|NCT00980655|526347094|FG001|Overall Study|Other|1|||
145954936|NCT01972464|526347097|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
145954937|NCT01972464|526347098|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
145954938|NCT01972464|526347097|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
146440843|NCT01496118|528117149|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
146440844|NCT01496118|528117150|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
146440845|NCT01496118|528117151|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145954939|NCT01972464|526347098|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
146440846|NCT01496118|528117152|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
145954940|NCT01972464|526347097|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
145954941|NCT01972464|526347098|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
145954942|NCT01972464|526347097|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
145954943|NCT01972464|526347098|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
145954944|NCT00803712|526348851|FG000|Overall Study|Noncompliance|3|||
146083112|NCT05027971|526824748|FG000|Overall Study|Protocol Violation|0|||
145954945|NCT00803712|526348852|FG001|Overall Study|Noncompliance|0|||
145954946|NCT00803712|526348851|FG000|Overall Study|Adverse Event|5|||
145954947|NCT00803712|526348852|FG001|Overall Study|Adverse Event|0|||
146083113|NCT05027971|526824749|FG001|Overall Study|Protocol Violation|2|||
145954948|NCT00803712|526348851|FG000|Overall Study|Death|8|||
145954949|NCT00803712|526348852|FG001|Overall Study|Death|7|||
145954950|NCT00803712|526348851|FG000|Overall Study|Lost to Follow-up|3|||
146083114|NCT02112045|526824750|FG000|Overall Study|Withdrawal by Subject|1|||
146440847|NCT01496118|528117153|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145954951|NCT00803712|526348852|FG001|Overall Study|Lost to Follow-up|1|||
145954952|NCT00803712|526348851|FG000|Overall Study|Withdrawal by Subject|2|||
145954953|NCT00803712|526348852|FG001|Overall Study|Withdrawal by Subject|4|||
145954954|NCT00803712|526348851|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
145954955|NCT00803712|526348852|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
145954956|NCT00803712|526348851|FG000|Overall Study|Protocol criteria (other)|0|||
145954957|NCT00803712|526348852|FG001|Overall Study|Protocol criteria (other)|2|||
145954958|NCT00803712|526348851|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
145954959|NCT00803712|526348852|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
145954960|NCT00803712|526348851|FG000|Overall Study|Administrative decision|2|||
145954961|NCT00803712|526348852|FG001|Overall Study|Administrative decision|3|||
145954962|NCT00803712|526348851|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
145954963|NCT00803712|526348852|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
145954964|NCT02748057|526348853|FG000|Overall Study|Adverse Event|1|||
145954965|NCT02748057|526348854|FG001|Overall Study|Adverse Event|0|||
145954966|NCT02748057|526348853|FG000|Overall Study|Physician Decision|0|||
145954967|NCT02748057|526348854|FG001|Overall Study|Physician Decision|1|||
145954968|NCT02748057|526348853|FG000|Overall Study|Protocol Violation|2|||
145954969|NCT02748057|526348854|FG001|Overall Study|Protocol Violation|1|||
145954970|NCT02748057|526348853|FG000|Overall Study|Participant Moved|1|||
145954971|NCT02748057|526348854|FG001|Overall Study|Participant Moved|0|||
145954972|NCT02748057|526348853|FG000|Overall Study|Withdrawal by Subject|1|||
145954973|NCT02748057|526348854|FG001|Overall Study|Withdrawal by Subject|0|||
145954974|NCT03465709|526348856|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
145954975|NCT03465709|526348856|FG000|Overall Study|Withdrawal by Subject|3|||
145954976|NCT04892446|526348857|FG000|Overall Study|Death|4|||
145954977|NCT04892446|526348858|FG001|Overall Study|Death|4|||
145954978|NCT04892446|526348859|FG002|Overall Study|Death|0|||
145954979|NCT04892446|526348857|FG000|Overall Study|Withdrew consent|3|||
145954980|NCT04892446|526348858|FG001|Overall Study|Withdrew consent|0|||
145954981|NCT04892446|526348859|FG002|Overall Study|Withdrew consent|1|||
145954982|NCT04892446|526348857|FG000|Overall Study|Investigator's discretion|1|||
145954983|NCT04892446|526348858|FG001|Overall Study|Investigator's discretion|1|||
145954984|NCT04892446|526348859|FG002|Overall Study|Investigator's discretion|0|||
145954985|NCT04892446|526348857|FG000|Overall Study|Study terminated by sponsor|0|||
145954986|NCT04892446|526348858|FG001|Overall Study|Study terminated by sponsor|0|||
145954987|NCT04892446|526348859|FG002|Overall Study|Study terminated by sponsor|2|||
145954988|NCT03193047|526348861|FG000|Overall Study|Physician Decision|1|||
145954989|NCT03193047|526348862|FG001|Overall Study|Physician Decision|0|||
145954990|NCT03193047|526348861|FG000|Overall Study|Participant Left State|1|||
145954991|NCT03193047|526348862|FG001|Overall Study|Participant Left State|0|||
145954992|NCT00705341|526348863|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
145954993|NCT00705341|526348864|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
145954994|NCT00705341|526348865|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
145954995|NCT00705341|526348866|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
145954996|NCT00705341|526348863|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145954997|NCT00705341|526348864|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145954998|NCT00705341|526348865|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
145954999|NCT00705341|526348866|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145955000|NCT02585713|526348870|FG000|Overall Study|Withdrew prior to treatment|2|||
145955001|NCT02585713|526348871|FG001|Overall Study|Withdrew prior to treatment|7|||
145955002|NCT02585713|526348870|FG000|Overall Study|Other|3|||
145955003|NCT02585713|526348871|FG001|Overall Study|Other|1|||
145955004|NCT03173456|526348874|FG000|Baseline|Medication dispensing system malfunction'|0|||
145955005|NCT03173456|526348875|FG001|Baseline|Medication dispensing system malfunction'|1|||
145955006|NCT03173456|526348876|FG002|Baseline|Medication dispensing system malfunction'|0|||
145955007|NCT03173456|526348877|FG003|Baseline|Medication dispensing system malfunction'|0|||
145955008|NCT03173456|526348878|FG004|Baseline|Medication dispensing system malfunction'|2|||
146440848|NCT01496118|528117146|FG000|Overall Study|Death|0|||
146440849|NCT01496118|528117147|FG001|Overall Study|Death|0|||
146440850|NCT01496118|528117148|FG002|Overall Study|Death|0|||
146440851|NCT01496118|528117149|FG003|Overall Study|Death|0|||
145955009|NCT03173456|526348874|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
145955010|NCT03173456|526348875|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
145955011|NCT03173456|526348876|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
145955012|NCT03173456|526348877|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
145955013|NCT03173456|526348878|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
145955014|NCT01733121|526348879|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
145955015|NCT01733121|526348880|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
145955016|NCT01733121|526348879|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
145955017|NCT01733121|526348880|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
145955018|NCT01733121|526348879|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
145955019|NCT01733121|526348880|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
146440852|NCT01496118|528117150|FG004|Overall Study|Death|0|||
146440853|NCT01496118|528117151|FG005|Overall Study|Death|0|||
146440854|NCT01496118|528117152|FG006|Overall Study|Death|1|||
146440855|NCT01496118|528117153|FG007|Overall Study|Death|1|||
146440856|NCT01496118|528117146|FG000|Overall Study|Withdrawal by Subject|0|||
146440857|NCT01496118|528117147|FG001|Overall Study|Withdrawal by Subject|0|||
146440858|NCT01496118|528117148|FG002|Overall Study|Withdrawal by Subject|0|||
146440859|NCT01496118|528117149|FG003|Overall Study|Withdrawal by Subject|2|||
146440860|NCT01496118|528117150|FG004|Overall Study|Withdrawal by Subject|0|||
146440861|NCT01496118|528117151|FG005|Overall Study|Withdrawal by Subject|1|||
146440862|NCT01496118|528117152|FG006|Overall Study|Withdrawal by Subject|6|||
146440863|NCT01496118|528117153|FG007|Overall Study|Withdrawal by Subject|3|||
146440864|NCT00562718|528117162|FG000|Overall Study|Death|1|||
146440865|NCT00562718|528117162|FG000|Overall Study|Withdrawal by Subject|3|||
146285667|NCT01874431|527561085|FG007|Overall Study|Adverse Event|3|||
146440866|NCT00562718|528117162|FG000|Overall Study|Adverse Event|4|||
145955020|NCT01733121|526348879|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
146440867|NCT00562718|528117162|FG000|Overall Study|Lack of Efficacy|2|||
146440868|NCT00562718|528117162|FG000|Overall Study|not stated|1|||
146440869|NCT01151618|528117163|FG000|Overall Study|Adverse Event|2|||
146440870|NCT01151618|528117163|FG000|Overall Study|Withdrawal by Subject|7|||
146440871|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
146440872|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
146440873|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
146440874|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
146440875|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
146440876|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
146440877|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
146440878|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
146440879|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
146440880|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
146440881|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
146440882|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
146440883|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
146440884|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
146440885|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
146440886|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
146440887|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
146440888|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
146440889|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
146440890|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
146440891|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
146440892|NCT02227238|528117164|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
146440893|NCT02227238|528117165|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
146440894|NCT02227238|528117166|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
146440895|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
146440896|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
146440897|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
146440898|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
146083115|NCT02112045|526824751|FG001|Overall Study|Withdrawal by Subject|0|||
146440899|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
146440900|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
146440901|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
146440902|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
146440903|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
145955021|NCT01733121|526348880|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
146440904|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
146440905|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
146440906|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
146440907|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
146440908|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
146440909|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
146440910|NCT02227238|528117164|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
146440911|NCT02227238|528117165|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
146440912|NCT02227238|528117166|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
146440913|NCT01507662|528117167|FG000|Overall Study|Death|26|||
146440914|NCT01507662|528117168|FG001|Overall Study|Death|18|||
146440915|NCT01507662|528117167|FG000|Overall Study|Withdrawal by Subject|290|||
146440916|NCT01507662|528117168|FG001|Overall Study|Withdrawal by Subject|287|||
146440917|NCT01507662|528117167|FG000|Overall Study|Lost to Follow-up|498|||
146440918|NCT01507662|528117168|FG001|Overall Study|Lost to Follow-up|523|||
146440919|NCT01507662|528117167|FG000|Overall Study|Proxy interview done|2|||
146440920|NCT01507662|528117168|FG001|Overall Study|Proxy interview done|3|||
146440921|NCT02896296|528117172|FG000|Overall Study|Adverse Event|1|||
146440922|NCT02896296|528117172|FG000|Overall Study|Lost to Follow-up|19|||
146440923|NCT02896296|528117172|FG000|Overall Study|Pregnancy|1|||
146440924|NCT02896296|528117172|FG000|Overall Study|Physician Decision|2|||
146440925|NCT02896296|528117172|FG000|Overall Study|Withdrawal by Subject|10|||
146440926|NCT02896296|528117172|FG000|Overall Study|Site closing|7|||
146440927|NCT02896296|528117172|FG000|Overall Study|Incarceration|1|||
146440928|NCT02896296|528117172|FG000|Overall Study|Relocation|1|||
146440929|NCT02264977|528117173|FG000|Overall Study|Death|3|||
146440930|NCT02264977|528117173|FG000|Overall Study|Physician Decision|1|||
146440931|NCT02264977|528117173|FG000|Overall Study|Refuse to return|1|||
146440932|NCT03961204|528117178|FG000|Overall Study|Withdrawal by Subject|2|||
146440933|NCT03961204|528117178|FG000|Overall Study|Lost to Follow-up|3|||
146440934|NCT03961204|528117178|FG000|Overall Study|Other|1|||
146440935|NCT03961204|528117178|FG000|Overall Study|Missing|1|||
146440936|NCT00147498|528117181|FG000|Overall Study|Adverse Event|1|||
146440937|NCT00147498|528117182|FG001|Overall Study|Adverse Event|6|||
146440938|NCT00147498|528117183|FG002|Overall Study|Adverse Event|7|||
146440939|NCT00147498|528117184|FG003|Overall Study|Adverse Event|3|||
145955022|NCT03061188|526348883|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
146285668|NCT01874431|527561078|FG000|Overall Study|Protocol Violation|1|||
145955023|NCT03061188|526348884|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
145955024|NCT03061188|526348885|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
146440940|NCT00147498|528117181|FG000|Overall Study|Lack of Efficacy|1|||
146440941|NCT00147498|528117182|FG001|Overall Study|Lack of Efficacy|1|||
146440942|NCT00147498|528117183|FG002|Overall Study|Lack of Efficacy|1|||
146083116|NCT00627445|526824752|FG000|Overall Study|Adverse Event|3|||
146440943|NCT00147498|528117184|FG003|Overall Study|Lack of Efficacy|8|||
146440944|NCT00147498|528117181|FG000|Overall Study|Laboratory abnormality|0|||
146440945|NCT00147498|528117182|FG001|Overall Study|Laboratory abnormality|0|||
146440946|NCT00147498|528117183|FG002|Overall Study|Laboratory abnormality|2|||
146440947|NCT00147498|528117184|FG003|Overall Study|Laboratory abnormality|0|||
146440948|NCT00147498|528117181|FG000|Overall Study|Participant defaulted|0|||
146440949|NCT00147498|528117182|FG001|Overall Study|Participant defaulted|1|||
146440950|NCT00147498|528117183|FG002|Overall Study|Participant defaulted|4|||
146440951|NCT00147498|528117184|FG003|Overall Study|Participant defaulted|3|||
145955025|NCT03061188|526348886|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
145955026|NCT03061188|526348883|FG000|On Follow-up for 3 Years|Death|0|||
145955027|NCT03061188|526348884|FG001|On Follow-up for 3 Years|Death|3|||
145955028|NCT03061188|526348885|FG002|On Follow-up for 3 Years|Death|5|||
145955029|NCT03061188|526348886|FG003|On Follow-up for 3 Years|Death|4|||
145955030|NCT03061188|526348883|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
145955031|NCT03061188|526348884|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
146440952|NCT00147498|528117181|FG000|Overall Study|Other|1|||
146440953|NCT00147498|528117182|FG001|Overall Study|Other|1|||
146440954|NCT00147498|528117183|FG002|Overall Study|Other|3|||
146440955|NCT00147498|528117184|FG003|Overall Study|Other|3|||
146440956|NCT02452463|528117185|FG000|Overall Study|Death|1|||
146440957|NCT02452463|528117186|FG001|Overall Study|Death|0|||
146440958|NCT02452463|528117187|FG002|Overall Study|Death|0|||
146440959|NCT02452463|528117185|FG000|Overall Study|Study Suspended|1|||
146440960|NCT02452463|528117186|FG001|Overall Study|Study Suspended|0|||
146440961|NCT02452463|528117187|FG002|Overall Study|Study Suspended|0|||
146440962|NCT02452463|528117185|FG000|Overall Study|Recommended by DSMB|0|||
146440963|NCT02452463|528117186|FG001|Overall Study|Recommended by DSMB|1|||
146440964|NCT02452463|528117187|FG002|Overall Study|Recommended by DSMB|0|||
146440965|NCT02452463|528117185|FG000|Overall Study|Withdrawal by Subject|0|||
145955032|NCT03061188|526348885|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
145955033|NCT03061188|526348886|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
146083117|NCT00627445|526824753|FG001|Overall Study|Adverse Event|3|||
145955034|NCT02609984|526348888|FG000|Overall Study|Death|29|||
145955035|NCT02609984|526348889|FG001|Overall Study|Death|26|||
146440966|NCT02452463|528117186|FG001|Overall Study|Withdrawal by Subject|1|||
146440967|NCT02452463|528117187|FG002|Overall Study|Withdrawal by Subject|0|||
146440968|NCT01229150|528117188|FG000|Overall Study|Toxicity|2|||
146083118|NCT00627445|526824752|FG000|Overall Study|Lack of Efficacy|0|||
146440969|NCT01229150|528117189|FG001|Overall Study|Toxicity|2|||
146440970|NCT01229150|528117190|FG002|Overall Study|Toxicity|0|||
146440971|NCT01229150|528117191|FG003|Overall Study|Toxicity|0|||
146440972|NCT03506633|528118403|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
146440973|NCT03506633|528118404|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
146440974|NCT00258856|528118408|FG000|Overall Study|Lost to Follow-up|1|||
146083119|NCT00627445|526824753|FG001|Overall Study|Lack of Efficacy|1|||
146440975|NCT00258856|528118409|FG001|Overall Study|Lost to Follow-up|0|||
146083120|NCT00627445|526824752|FG000|Overall Study|Other|6|||
145955036|NCT02609984|526348888|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
145955037|NCT02609984|526348889|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
145955038|NCT02609984|526348888|FG000|Overall Study|Lost to Follow-up|1|||
145955039|NCT02609984|526348889|FG001|Overall Study|Lost to Follow-up|2|||
145955040|NCT02609984|526348888|FG000|Overall Study|Withdrawal by Subject|0|||
145955041|NCT02609984|526348889|FG001|Overall Study|Withdrawal by Subject|1|||
145955042|NCT02609984|526348888|FG000|Overall Study|Disease Progression|2|||
145955043|NCT02609984|526348889|FG001|Overall Study|Disease Progression|0|||
145955044|NCT02306850|526348895|FG000|Overall Study|Lack of Efficacy|2|||
145955045|NCT02420262|526348896|FG000|Overall Study|Adverse Event|1|||
145955046|NCT02420262|526348897|FG001|Overall Study|Adverse Event|0|||
145955047|NCT02420262|526348896|FG000|Overall Study|Withdrawal by Subject|1|||
145955048|NCT02420262|526348897|FG001|Overall Study|Withdrawal by Subject|4|||
145955049|NCT02420262|526348896|FG000|Overall Study|Unclassified|0|||
145955050|NCT02420262|526348897|FG001|Overall Study|Unclassified|1|||
145955051|NCT00941304|526348898|FG000|Overall Study|Lost to Follow-up|1|||
145955052|NCT00941304|526348899|FG001|Overall Study|Lost to Follow-up|0|||
145955053|NCT00941304|526348900|FG002|Overall Study|Lost to Follow-up|0|||
145955054|NCT00941304|526348901|FG003|Overall Study|Lost to Follow-up|0|||
145955055|NCT00941304|526348902|FG004|Overall Study|Lost to Follow-up|0|||
145955056|NCT00784719|526348905|FG000|Overall Study|Adverse Event|0|||
145955057|NCT00784719|526348906|FG001|Overall Study|Adverse Event|2|||
145955058|NCT00784719|526348907|FG002|Overall Study|Adverse Event|0|||
145955059|NCT00784719|526348908|FG003|Overall Study|Adverse Event|0|||
145955060|NCT00784719|526348909|FG004|Overall Study|Adverse Event|1|||
145955061|NCT00784719|526348910|FG005|Overall Study|Adverse Event|1|||
145955062|NCT00784719|526348911|FG006|Overall Study|Adverse Event|1|||
145955063|NCT00784719|526348905|FG000|Overall Study|Lost to Follow-up|0|||
145955064|NCT00784719|526348906|FG001|Overall Study|Lost to Follow-up|0|||
145955065|NCT00784719|526348907|FG002|Overall Study|Lost to Follow-up|0|||
145955066|NCT00784719|526348908|FG003|Overall Study|Lost to Follow-up|0|||
145955067|NCT00784719|526348909|FG004|Overall Study|Lost to Follow-up|1|||
145955068|NCT00784719|526348910|FG005|Overall Study|Lost to Follow-up|1|||
145955069|NCT00784719|526348911|FG006|Overall Study|Lost to Follow-up|0|||
145955070|NCT00784719|526348905|FG000|Overall Study|Other|2|||
145955071|NCT00784719|526348906|FG001|Overall Study|Other|1|||
145955072|NCT00784719|526348907|FG002|Overall Study|Other|1|||
145955073|NCT00784719|526348908|FG003|Overall Study|Other|0|||
145955074|NCT00784719|526348909|FG004|Overall Study|Other|2|||
145955075|NCT00784719|526348910|FG005|Overall Study|Other|1|||
145955076|NCT00784719|526348911|FG006|Overall Study|Other|3|||
145955077|NCT00784719|526348905|FG000|Overall Study|Withdrawal by Subject|1|||
145955078|NCT00784719|526348906|FG001|Overall Study|Withdrawal by Subject|0|||
145955079|NCT00784719|526348907|FG002|Overall Study|Withdrawal by Subject|0|||
145955080|NCT00784719|526348908|FG003|Overall Study|Withdrawal by Subject|0|||
145955081|NCT00784719|526348909|FG004|Overall Study|Withdrawal by Subject|2|||
145955082|NCT00784719|526348910|FG005|Overall Study|Withdrawal by Subject|0|||
145955083|NCT00784719|526348911|FG006|Overall Study|Withdrawal by Subject|1|||
145955084|NCT01408901|526348912|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
145955085|NCT01408901|526348913|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
145955086|NCT01408901|526348914|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
145955087|NCT01408901|526348915|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
145955088|NCT01408901|526348912|FG000|6-Week Follow-Up|Death|1|||
145955089|NCT01408901|526348913|FG001|6-Week Follow-Up|Death|0|||
145955090|NCT01408901|526348914|FG002|6-Week Follow-Up|Death|0|||
145955091|NCT01408901|526348915|FG003|6-Week Follow-Up|Death|0|||
145955092|NCT01408901|526348912|FG000|6-Week Follow-Up|Cancelled visit|0|||
145955093|NCT01408901|526348913|FG001|6-Week Follow-Up|Cancelled visit|1|||
145955094|NCT01408901|526348914|FG002|6-Week Follow-Up|Cancelled visit|0|||
145955095|NCT01408901|526348915|FG003|6-Week Follow-Up|Cancelled visit|2|||
145955096|NCT01408901|526348912|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145955097|NCT01408901|526348913|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145955098|NCT01408901|526348914|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145955099|NCT01408901|526348915|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
145955100|NCT01408901|526348912|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
145955101|NCT01408901|526348913|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145955102|NCT01408901|526348914|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145955103|NCT01408901|526348915|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145955104|NCT01408901|526348912|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
145955105|NCT01408901|526348913|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
145955106|NCT01408901|526348914|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
145955107|NCT01408901|526348915|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
145955108|NCT01408901|526348912|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
145955109|NCT01408901|526348913|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
145955110|NCT01408901|526348914|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
145955111|NCT01408901|526348915|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
145955112|NCT01408901|526348912|FG000|26-Week Follow-Up|Death|0|||
145955113|NCT01408901|526348913|FG001|26-Week Follow-Up|Death|1|||
145955114|NCT01408901|526348914|FG002|26-Week Follow-Up|Death|0|||
145955115|NCT01408901|526348915|FG003|26-Week Follow-Up|Death|0|||
145955116|NCT04978337|526348916|FG000|Overall Study|Withdrawal by Subject|0|||
145955117|NCT04978337|526348917|FG001|Overall Study|Withdrawal by Subject|1|||
145955118|NCT01436227|526348923|FG000|Overall Study|Adverse Event|7|||
145955119|NCT01436227|526348923|FG000|Overall Study|Death|1|||
145955120|NCT01436227|526348923|FG000|Overall Study|Lack of Efficacy|1|||
145955121|NCT01436227|526348923|FG000|Overall Study|Lost to Follow-up|3|||
145955122|NCT01436227|526348923|FG000|Overall Study|Physician Decision|1|||
145955123|NCT01436227|526348923|FG000|Overall Study|Withdrawal by Subject|7|||
145955124|NCT01436227|526348923|FG000|Overall Study|Disease progression, relapse|6|||
145955125|NCT05446142|526348926|FG000|Period 2|Adverse Event|1|||
145955126|NCT05446142|526348927|FG001|Period 2|Adverse Event|0|||
145955127|NCT05446142|526348928|FG002|Period 2|Adverse Event|0|||
145955128|NCT05446142|526348929|FG003|Period 2|Adverse Event|0|||
145955129|NCT05446142|526348930|FG004|Period 2|Adverse Event|0|||
145955130|NCT05446142|526348931|FG005|Period 2|Adverse Event|0|||
145955131|NCT02098395|526348936|FG000|Overall Study|Protocol Violation|2|||
145955132|NCT02098395|526348937|FG001|Overall Study|Protocol Violation|2|||
145955133|NCT02098395|526348938|FG002|Overall Study|Protocol Violation|0|||
145955134|NCT02098395|526348939|FG003|Overall Study|Protocol Violation|7|||
145955135|NCT02098395|526348936|FG000|Overall Study|Withdrawal by Subject|10|||
145955136|NCT02098395|526348937|FG001|Overall Study|Withdrawal by Subject|10|||
145955137|NCT02098395|526348938|FG002|Overall Study|Withdrawal by Subject|5|||
145955138|NCT02098395|526348939|FG003|Overall Study|Withdrawal by Subject|13|||
145955139|NCT02098395|526348936|FG000|Overall Study|Adverse Event|12|||
145955140|NCT02098395|526348937|FG001|Overall Study|Adverse Event|19|||
145955141|NCT02098395|526348938|FG002|Overall Study|Adverse Event|34|||
145955142|NCT02098395|526348939|FG003|Overall Study|Adverse Event|2|||
145955143|NCT02098395|526348936|FG000|Overall Study|Lost to Follow-up|2|||
145955144|NCT02098395|526348937|FG001|Overall Study|Lost to Follow-up|1|||
145955145|NCT02098395|526348938|FG002|Overall Study|Lost to Follow-up|0|||
145955146|NCT02098395|526348939|FG003|Overall Study|Lost to Follow-up|3|||
145955147|NCT02098395|526348936|FG000|Overall Study|Unclassified|0|||
145955148|NCT02098395|526348937|FG001|Overall Study|Unclassified|0|||
145955149|NCT02098395|526348938|FG002|Overall Study|Unclassified|3|||
145955150|NCT02098395|526348939|FG003|Overall Study|Unclassified|2|||
145955151|NCT00547157|526348942|FG000|Overall Study|Other|1|||
145955152|NCT00547157|526348943|FG001|Overall Study|Other|0|||
145955153|NCT00547157|526348942|FG000|Overall Study|Death|38|||
145955154|NCT00547157|526348943|FG001|Overall Study|Death|18|||
145955155|NCT00547157|526348942|FG000|Overall Study|Withdrawal by Subject|3|||
145955156|NCT00547157|526348943|FG001|Overall Study|Withdrawal by Subject|1|||
145955157|NCT00547157|526348942|FG000|Overall Study|Administrative decision|3|||
145955158|NCT00547157|526348943|FG001|Overall Study|Administrative decision|2|||
145955159|NCT00547157|526348942|FG000|Overall Study|Lost to Follow-up|4|||
145955160|NCT00547157|526348943|FG001|Overall Study|Lost to Follow-up|2|||
145955161|NCT04633226|526348950|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145955162|NCT04633226|526348950|FG000|Overall Study|Randomized by mistake without study treatment|1|||
145955163|NCT05415462|526348953|FG000|Overall Study|Death|18|||
145955164|NCT05415462|526348954|FG001|Overall Study|Death|10|||
145955165|NCT05415462|526348953|FG000|Overall Study|Lost to Follow-up|72|||
145955166|NCT05415462|526348954|FG001|Overall Study|Lost to Follow-up|64|||
145955167|NCT05415462|526348953|FG000|Overall Study|Physician Decision|5|||
145955168|NCT05415462|526348954|FG001|Overall Study|Physician Decision|5|||
145955169|NCT05415462|526348953|FG000|Overall Study|Protocol Deviation|1|||
145955170|NCT05415462|526348954|FG001|Overall Study|Protocol Deviation|0|||
145955171|NCT05415462|526348953|FG000|Overall Study|Withdrawal by Subject|129|||
145955172|NCT05415462|526348954|FG001|Overall Study|Withdrawal by Subject|101|||
145955173|NCT05415462|526348953|FG000|Overall Study|Other Than Specified|8|||
145955174|NCT05415462|526348954|FG001|Overall Study|Other Than Specified|8|||
145955175|NCT01087203|526348959|FG000|Overall Study|Lost to Follow-up|2|||
145955176|NCT01087203|526348960|FG001|Overall Study|Lost to Follow-up|0|||
145955177|NCT01087203|526348959|FG000|Overall Study|Withdrawal by Subject|2|||
145955178|NCT01087203|526348960|FG001|Overall Study|Withdrawal by Subject|6|||
145955179|NCT01087203|526348959|FG000|Overall Study|Lack of Efficacy|1|||
145955180|NCT01087203|526348960|FG001|Overall Study|Lack of Efficacy|2|||
145955181|NCT01087203|526348959|FG000|Overall Study|Study terminated by sponsor|27|||
145955182|NCT01087203|526348960|FG001|Overall Study|Study terminated by sponsor|27|||
145955183|NCT02559570|526348962|FG000|Overall Study|Adverse Event|0|||
145955184|NCT02559570|526348963|FG001|Overall Study|Adverse Event|2|||
145955185|NCT02559570|526348964|FG002|Overall Study|Adverse Event|0|||
145955186|NCT02559570|526348965|FG003|Overall Study|Adverse Event|1|||
145955187|NCT02559570|526348966|FG004|Overall Study|Adverse Event|0|||
145955188|NCT02559570|526348962|FG000|Overall Study|Withdrawal of Consent|0|||
145955189|NCT02559570|526348963|FG001|Overall Study|Withdrawal of Consent|0|||
145955190|NCT02559570|526348964|FG002|Overall Study|Withdrawal of Consent|1|||
145955191|NCT02559570|526348965|FG003|Overall Study|Withdrawal of Consent|2|||
145955192|NCT02559570|526348966|FG004|Overall Study|Withdrawal of Consent|1|||
145955193|NCT02559570|526348962|FG000|Overall Study|Lost to Follow-up|1|||
145955194|NCT02559570|526348963|FG001|Overall Study|Lost to Follow-up|0|||
145955195|NCT02559570|526348964|FG002|Overall Study|Lost to Follow-up|0|||
145955196|NCT02559570|526348965|FG003|Overall Study|Lost to Follow-up|0|||
145955197|NCT02559570|526348966|FG004|Overall Study|Lost to Follow-up|0|||
146440976|NCT00258856|528118410|FG002|Overall Study|Lost to Follow-up|2|||
146440977|NCT00258856|528118411|FG003|Overall Study|Lost to Follow-up|0|||
146440978|NCT00258856|528118408|FG000|Overall Study|Non-compliance|2|||
146440979|NCT00258856|528118409|FG001|Overall Study|Non-compliance|0|||
146440980|NCT00258856|528118410|FG002|Overall Study|Non-compliance|0|||
146440981|NCT00258856|528118411|FG003|Overall Study|Non-compliance|1|||
145955198|NCT02559570|526348962|FG000|Overall Study|Protocol Violation|1|||
145955199|NCT02559570|526348963|FG001|Overall Study|Protocol Violation|0|||
146440982|NCT01109849|528118412|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
146440983|NCT01109849|528118413|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
146440984|NCT01109849|528118414|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
146440985|NCT01109849|528118415|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
146440986|NCT01109849|528118416|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
146440987|NCT01109849|528118412|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
146440988|NCT01109849|528118413|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
145955200|NCT02559570|526348964|FG002|Overall Study|Protocol Violation|0|||
145955201|NCT02559570|526348965|FG003|Overall Study|Protocol Violation|0|||
145955202|NCT02559570|526348966|FG004|Overall Study|Protocol Violation|1|||
145955203|NCT02559570|526348962|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145955204|NCT02559570|526348963|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145955205|NCT02559570|526348964|FG002|Overall Study|Other Miscellaneous Reasons|1|||
145955206|NCT02559570|526348965|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145955207|NCT02559570|526348966|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145955208|NCT05095311|526348973|FG000|Overall Study|Lost to Follow-up|7|||
145955209|NCT05095311|526348974|FG001|Overall Study|Lost to Follow-up|0|||
145955210|NCT05095311|526348975|FG002|Overall Study|Lost to Follow-up|0|||
145955211|NCT02588664|526348980|FG000|Overall Study|Death|56|||
145955212|NCT02588664|526348981|FG001|Overall Study|Death|55|||
145955213|NCT02588664|526348980|FG000|Overall Study|Lost to Follow-up|1305|||
145955214|NCT02588664|526348981|FG001|Overall Study|Lost to Follow-up|990|||
145955215|NCT02500719|526348986|FG000|Overall Study|Lost to Follow-up|2|||
145955216|NCT02500719|526348987|FG001|Overall Study|Lost to Follow-up|3|||
146440989|NCT01109849|528118414|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
146440990|NCT01109849|528118415|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
146440991|NCT01109849|528118416|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
146440992|NCT01109849|528118412|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
146440993|NCT01109849|528118413|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
146440994|NCT01109849|528118414|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
146440995|NCT01109849|528118415|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
145955217|NCT02500719|526348986|FG000|Overall Study|Trauma history|1|||
145955218|NCT02500719|526348987|FG001|Overall Study|Trauma history|0|||
145955219|NCT02500719|526348986|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
145955220|NCT02500719|526348987|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
145955221|NCT02500719|526348986|FG000|Overall Study|Did not meet criteria for PTSD|0|||
145955222|NCT02500719|526348987|FG001|Overall Study|Did not meet criteria for PTSD|1|||
145955223|NCT02500719|526348986|FG000|Overall Study|Claustrophobia|0|||
145955224|NCT02500719|526348987|FG001|Overall Study|Claustrophobia|1|||
145955225|NCT02500719|526348986|FG000|Overall Study|History of head trauma|0|||
145955226|NCT02500719|526348987|FG001|Overall Study|History of head trauma|1|||
145955227|NCT02710084|526348990|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
145955228|NCT02710084|526348991|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
145955229|NCT00181883|526348992|FG000|Overall Study|Lack of Efficacy|2|||
145955230|NCT00181883|526348992|FG000|Overall Study|Treatment Limiting AEs|3|||
146440996|NCT01109849|528118416|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
145955231|NCT00181883|526348992|FG000|Overall Study|Withdrawal by Subject|4|||
145955232|NCT00181883|526348992|FG000|Overall Study|Lost to Follow-up|1|||
145955233|NCT05305989|526348993|FG000|Overall Study|Other|3|||
145955234|NCT05305989|526348994|FG001|Overall Study|Other|2|||
145955235|NCT05305989|526348995|FG002|Overall Study|Other|0|||
145955236|NCT05305989|526348993|FG000|Overall Study|Sponsor decision|2|||
145955237|NCT05305989|526348994|FG001|Overall Study|Sponsor decision|1|||
145955238|NCT05305989|526348995|FG002|Overall Study|Sponsor decision|0|||
145955239|NCT05305989|526348993|FG000|Overall Study|Protocol Violation|0|||
146440997|NCT01109849|528118412|FG000|Initial Randomization: ADHD Treatment|move away|2|||
146440998|NCT01109849|528118413|FG001|Initial Randomization: ADHD Treatment|move away|7|||
145955240|NCT05305989|526348994|FG001|Overall Study|Protocol Violation|1|||
145955241|NCT05305989|526348995|FG002|Overall Study|Protocol Violation|0|||
145955242|NCT05305989|526348993|FG000|Overall Study|Investigator decision|1|||
146083121|NCT00627445|526824753|FG001|Overall Study|Other|8|||
145955243|NCT05305989|526348994|FG001|Overall Study|Investigator decision|2|||
145955244|NCT05305989|526348995|FG002|Overall Study|Investigator decision|0|||
146440999|NCT01109849|528118414|FG002|Initial Randomization: ADHD Treatment|move away|0|||
146441000|NCT01109849|528118415|FG003|Initial Randomization: ADHD Treatment|move away|0|||
146441001|NCT01109849|528118416|FG004|Initial Randomization: ADHD Treatment|move away|0|||
146441002|NCT01109849|528118412|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
146441003|NCT01109849|528118413|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
146441004|NCT01109849|528118414|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
146441005|NCT01109849|528118415|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
146441006|NCT01109849|528118416|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
146441007|NCT01109849|528118412|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
146441008|NCT01109849|528118413|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
146441009|NCT01109849|528118414|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
146441010|NCT01109849|528118415|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
146441011|NCT01109849|528118416|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
146441012|NCT03969641|528118424|FG000|Overall Study|Lost to Follow-up|5|||
146441013|NCT03969641|528118425|FG001|Overall Study|Lost to Follow-up|3|||
146441014|NCT03969641|528118424|FG000|Overall Study|Withdrawal by Subject|1|||
146441015|NCT03969641|528118425|FG001|Overall Study|Withdrawal by Subject|2|||
146441016|NCT03969641|528118424|FG000|Overall Study|Found to be ineligible|1|||
146441017|NCT03969641|528118425|FG001|Overall Study|Found to be ineligible|1|||
146441018|NCT03969641|528118424|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
146441019|NCT03969641|528118425|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
146441020|NCT03969641|528118424|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
146441021|NCT03969641|528118425|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
146441022|NCT03969641|528118424|FG000|Overall Study|Elective termination|0|||
146441023|NCT03969641|528118425|FG001|Overall Study|Elective termination|1|||
146441024|NCT00754052|528118429|FG000|Overall Study|Study terminated by Sponsor|5|||
146441025|NCT00754052|528118430|FG001|Overall Study|Study terminated by Sponsor|3|||
146441026|NCT02658019|528118432|FG000|Overall Study|Adverse Event|1|||
146441027|NCT03234907|528118433|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
146441028|NCT03234907|528118434|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
146441029|NCT03234907|528118435|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
146441030|NCT03234907|528118436|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
146441031|NCT03234907|528118437|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
146441032|NCT03234907|528118438|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
146441033|NCT03234907|528118433|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
146441034|NCT03234907|528118434|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
146441035|NCT03234907|528118435|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
146441036|NCT03234907|528118436|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
146441037|NCT03234907|528118437|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
146441038|NCT03234907|528118438|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
146441039|NCT03234907|528118433|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
146441040|NCT03234907|528118434|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
146441041|NCT03234907|528118435|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
146441042|NCT03234907|528118436|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
146441043|NCT03234907|528118437|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
146441044|NCT03234907|528118438|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
146441045|NCT03234907|528118433|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
146441046|NCT03234907|528118434|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
146441047|NCT03234907|528118435|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
146441048|NCT03234907|528118436|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
146441049|NCT03234907|528118437|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
146441050|NCT03234907|528118438|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
146441051|NCT03234907|528118433|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
146441052|NCT03234907|528118434|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
146441053|NCT03234907|528118435|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
146441054|NCT03234907|528118436|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
146441055|NCT03234907|528118437|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
146441056|NCT03234907|528118438|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
146441057|NCT03234907|528118433|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
146441058|NCT03234907|528118434|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
146441059|NCT03234907|528118435|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
146441060|NCT03234907|528118436|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
146441061|NCT03234907|528118437|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
146441062|NCT03234907|528118438|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
146441063|NCT03234907|528118433|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
146441064|NCT03234907|528118434|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
146441065|NCT03234907|528118435|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
145955245|NCT05305989|526348993|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
145955246|NCT05305989|526348994|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
145955247|NCT05305989|526348995|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
145955248|NCT05305989|526348993|FG000|Overall Study|Adverse Event|1|||
145955249|NCT05305989|526348994|FG001|Overall Study|Adverse Event|1|||
145955250|NCT05305989|526348995|FG002|Overall Study|Adverse Event|0|||
145955251|NCT05305989|526348993|FG000|Overall Study|Enrolled but never dosed|3|||
145955252|NCT05305989|526348994|FG001|Overall Study|Enrolled but never dosed|2|||
145955253|NCT05305989|526348995|FG002|Overall Study|Enrolled but never dosed|1|||
145955254|NCT00282152|526348996|FG000|Overall Study|Withdrawal by Subject|1|||
145955255|NCT00282152|526348997|FG001|Overall Study|Withdrawal by Subject|0|||
145955256|NCT00585325|526348998|FG000|Overall Study|Withdrawal by Subject|1|||
145955257|NCT00585325|526348999|FG001|Overall Study|Withdrawal by Subject|1|||
145955258|NCT03092791|526349000|FG000|Overall Study|Lost to Follow-up|0|||
145955259|NCT03092791|526349001|FG001|Overall Study|Lost to Follow-up|0|||
145955260|NCT03092791|526349002|FG002|Overall Study|Lost to Follow-up|0|||
146441066|NCT03234907|528118436|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
146441067|NCT03234907|528118437|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
146441068|NCT03234907|528118438|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
146441069|NCT02986139|528118439|FG000|Overall Study|Sponsor Decision|1|||
146441070|NCT02986139|528118440|FG001|Overall Study|Sponsor Decision|2|||
146441071|NCT02986139|528118439|FG000|Overall Study|Withdrawal by Subject|0|||
146441072|NCT02986139|528118440|FG001|Overall Study|Withdrawal by Subject|1|||
146441073|NCT02986139|528118439|FG000|Overall Study|Lost to Follow-up|0|||
146441074|NCT02986139|528118440|FG001|Overall Study|Lost to Follow-up|1|||
146441075|NCT00414726|528118441|FG000|Overall Study|Withdrawal by Subject|0|||
146441076|NCT00414726|528118442|FG001|Overall Study|Withdrawal by Subject|1|||
146441077|NCT02107196|528118443|FG000|12-week Treatment Period|Adverse Event|6|||
146441078|NCT02107196|528118444|FG001|12-week Treatment Period|Adverse Event|3|||
146441079|NCT02107196|528118443|FG000|12-week Treatment Period|Lack of Efficacy|2|||
146441080|NCT02107196|528118444|FG001|12-week Treatment Period|Lack of Efficacy|1|||
146441081|NCT02107196|528118443|FG000|12-week Treatment Period|Lost to Follow-up|3|||
146441082|NCT02107196|528118444|FG001|12-week Treatment Period|Lost to Follow-up|6|||
146441083|NCT02107196|528118443|FG000|12-week Treatment Period|Physician Decision|0|||
146441084|NCT02107196|528118444|FG001|12-week Treatment Period|Physician Decision|1|||
146441085|NCT02107196|528118443|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
146441086|NCT02107196|528118444|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
146441087|NCT02107196|528118443|FG000|12-week Treatment Period|Protocol Violation|7|||
146441088|NCT02107196|528118444|FG001|12-week Treatment Period|Protocol Violation|8|||
146441089|NCT02107196|528118443|FG000|12-week Treatment Period|Reason Missing|11|||
146441090|NCT02107196|528118444|FG001|12-week Treatment Period|Reason Missing|8|||
146441091|NCT02107196|528118443|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
146441092|NCT02107196|528118444|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
146441093|NCT02107196|528118443|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
146441094|NCT02107196|528118444|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146441095|NCT02107196|528118443|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
146441096|NCT02107196|528118444|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
146441097|NCT02107196|528118443|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
145955261|NCT03092791|526349003|FG003|Overall Study|Lost to Follow-up|0|||
145955262|NCT03092791|526349004|FG004|Overall Study|Lost to Follow-up|0|||
145955263|NCT03092791|526349005|FG005|Overall Study|Lost to Follow-up|0|||
145955264|NCT03092791|526349006|FG006|Overall Study|Lost to Follow-up|1|||
145955265|NCT03092791|526349007|FG007|Overall Study|Lost to Follow-up|0|||
145955266|NCT03092791|526349000|FG000|Overall Study|Withdrawal of Consent|0|||
146441098|NCT02107196|528118444|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
146441099|NCT01993186|528118445|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
146441100|NCT01993186|528118446|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
146441101|NCT01993186|528118445|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
146441102|NCT01993186|528118446|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
146441103|NCT01993186|528118445|FG000|Open-Label Extension Period|Other, Not Specified|0|||
146441104|NCT01993186|528118446|FG001|Open-Label Extension Period|Other, Not Specified|1|||
146441105|NCT01993186|528118445|FG000|Open-Label Extension Period|Adverse Event|1|||
146441106|NCT01993186|528118446|FG001|Open-Label Extension Period|Adverse Event|0|||
146441107|NCT01993186|528118445|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
146441108|NCT01993186|528118446|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
146441109|NCT01993186|528118445|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
146441110|NCT01993186|528118446|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
146441111|NCT01993186|528118445|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
146441112|NCT01993186|528118446|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
145955267|NCT03092791|526349001|FG001|Overall Study|Withdrawal of Consent|0|||
146441113|NCT04158687|528118447|FG000|Overall Study|Adverse Event|2|||
146441114|NCT04158687|528118448|FG001|Overall Study|Adverse Event|3|||
146441115|NCT04158687|528118449|FG002|Overall Study|Adverse Event|0|||
146441116|NCT04158687|528118450|FG003|Overall Study|Adverse Event|3|||
146441117|NCT04158687|528118447|FG000|Overall Study|Lost to Follow-up|5|||
146441118|NCT04158687|528118448|FG001|Overall Study|Lost to Follow-up|12|||
146441119|NCT04158687|528118449|FG002|Overall Study|Lost to Follow-up|4|||
146441120|NCT04158687|528118450|FG003|Overall Study|Lost to Follow-up|5|||
146441121|NCT04158687|528118447|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
146441122|NCT04158687|528118448|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
146441123|NCT04158687|528118449|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
146441124|NCT04158687|528118450|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
146441125|NCT04158687|528118447|FG000|Overall Study|Non-Compliance with Study Medication|2|||
146441126|NCT04158687|528118448|FG001|Overall Study|Non-Compliance with Study Medication|2|||
146441127|NCT04158687|528118449|FG002|Overall Study|Non-Compliance with Study Medication|3|||
146441128|NCT04158687|528118450|FG003|Overall Study|Non-Compliance with Study Medication|0|||
146441129|NCT04158687|528118447|FG000|Overall Study|Investigator Decision|0|||
146441130|NCT04158687|528118448|FG001|Overall Study|Investigator Decision|0|||
146441131|NCT04158687|528118449|FG002|Overall Study|Investigator Decision|2|||
146441132|NCT04158687|528118450|FG003|Overall Study|Investigator Decision|0|||
146441133|NCT04158687|528118447|FG000|Overall Study|Protocol Violation|0|||
146441134|NCT04158687|528118448|FG001|Overall Study|Protocol Violation|2|||
146441135|NCT04158687|528118449|FG002|Overall Study|Protocol Violation|1|||
146441136|NCT04158687|528118450|FG003|Overall Study|Protocol Violation|0|||
146441137|NCT04158687|528118447|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
146441138|NCT04158687|528118448|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
146441139|NCT04158687|528118449|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
146441140|NCT04158687|528118450|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
146441141|NCT04158687|528118447|FG000|Overall Study|Reason not Specified|3|||
146441142|NCT04158687|528118448|FG001|Overall Study|Reason not Specified|2|||
146441143|NCT04158687|528118449|FG002|Overall Study|Reason not Specified|4|||
146441144|NCT04158687|528118450|FG003|Overall Study|Reason not Specified|4|||
146441145|NCT04523480|528118451|FG000|Overall Study|Lost to Follow-up|30|||
146441146|NCT04523480|528118452|FG001|Overall Study|Lost to Follow-up|35|||
146441147|NCT04523480|528118453|FG002|Overall Study|Lost to Follow-up|0|||
146441148|NCT00640393|528118454|FG000|Part 1|Lost to Follow-up|2|||
146441149|NCT00640393|528118455|FG001|Part 1|Lost to Follow-up|0|||
146441150|NCT00640393|528118456|FG002|Part 1|Lost to Follow-up|0|||
146441151|NCT00640393|528118454|FG000|Part 1|Withdrawal by Subject|3|||
146441152|NCT00640393|528118455|FG001|Part 1|Withdrawal by Subject|0|||
146441153|NCT00640393|528118456|FG002|Part 1|Withdrawal by Subject|0|||
146441154|NCT00640393|528118454|FG000|Randomization|Withdrawn per protocol|17|||
146441155|NCT00640393|528118455|FG001|Randomization|Withdrawn per protocol|0|||
146441156|NCT00640393|528118456|FG002|Randomization|Withdrawn per protocol|0|||
146441157|NCT00640393|528118454|FG000|Randomization|Never randomized by site|2|||
146441158|NCT00640393|528118455|FG001|Randomization|Never randomized by site|0|||
146441159|NCT00640393|528118456|FG002|Randomization|Never randomized by site|0|||
146441160|NCT00640393|528118454|FG000|Part 2|Lost to Follow-up|0|||
146441161|NCT00640393|528118455|FG001|Part 2|Lost to Follow-up|2|||
146441162|NCT00640393|528118456|FG002|Part 2|Lost to Follow-up|2|||
146441163|NCT00640393|528118454|FG000|Part 2|Withdrawal by Subject|0|||
146441164|NCT00640393|528118455|FG001|Part 2|Withdrawal by Subject|6|||
146441165|NCT00640393|528118456|FG002|Part 2|Withdrawal by Subject|1|||
146441166|NCT00640393|528118454|FG000|Part 2|Non-adherence|0|||
146441167|NCT00640393|528118455|FG001|Part 2|Non-adherence|1|||
146441168|NCT00640393|528118456|FG002|Part 2|Non-adherence|0|||
146441169|NCT00640393|528118454|FG000|Part 2|Adverse Event|0|||
145955268|NCT03092791|526349002|FG002|Overall Study|Withdrawal of Consent|0|||
145955269|NCT03092791|526349003|FG003|Overall Study|Withdrawal of Consent|0|||
145955270|NCT03092791|526349004|FG004|Overall Study|Withdrawal of Consent|4|||
145955271|NCT03092791|526349005|FG005|Overall Study|Withdrawal of Consent|12|||
146441170|NCT00640393|528118455|FG001|Part 2|Adverse Event|1|||
146441171|NCT00640393|528118456|FG002|Part 2|Adverse Event|0|||
146441172|NCT03540160|528118461|FG000|Overall Study|Protocol Violation|1|||
146441173|NCT03540160|528118461|FG000|Overall Study|Physician Decision|8|||
146441174|NCT03540160|528118461|FG000|Overall Study|Lack of Efficacy|60|||
146441175|NCT03540160|528118461|FG000|Overall Study|Pregnancy|1|||
146441176|NCT03540160|528118461|FG000|Overall Study|Adverse Event|20|||
146441177|NCT03540160|528118461|FG000|Overall Study|Withdrawal by Subject|68|||
146441178|NCT03540160|528118461|FG000|Overall Study|COVID-19|2|||
146441179|NCT03540160|528118461|FG000|Overall Study|Study Closure|10|||
146441180|NCT03540160|528118461|FG000|Overall Study|Lost to Follow-up|18|||
146441181|NCT03540160|528118461|FG000|Overall Study|Sponsor decision|191|||
145955272|NCT03092791|526349006|FG006|Overall Study|Withdrawal of Consent|6|||
146441182|NCT00198133|528118462|FG000|Overall Study|Disease progression|2|||
146441183|NCT00198133|528118463|FG001|Overall Study|Disease progression|5|||
146441184|NCT00198133|528118462|FG000|Overall Study|Adverse Event|1|||
146441185|NCT00198133|528118463|FG001|Overall Study|Adverse Event|3|||
146441186|NCT00198133|528118462|FG000|Overall Study|Withdrawal by Subject|1|||
146441187|NCT00198133|528118463|FG001|Overall Study|Withdrawal by Subject|0|||
146441188|NCT00198133|528118462|FG000|Overall Study|Physician Decision|1|||
146441189|NCT00198133|528118463|FG001|Overall Study|Physician Decision|0|||
146441190|NCT00835666|528118466|FG000|Washout|Protocol Violation|1|||
146441191|NCT00835666|528118467|FG001|Washout|Protocol Violation|0|||
146441192|NCT00835666|528118466|FG000|Washout|Withdrawal by Subject|1|||
146441193|NCT00835666|528118467|FG001|Washout|Withdrawal by Subject|0|||
146441194|NCT00635648|528118468|FG000|Overall Study|Adverse Event|12|||
146441195|NCT00635648|528118468|FG000|Overall Study|Withdrawal by Subject|9|||
146441196|NCT00635648|528118468|FG000|Overall Study|Physician Decision|4|||
146441197|NCT00635648|528118468|FG000|Overall Study|Rapid progression of baseline disease|4|||
146441198|NCT00635648|528118468|FG000|Overall Study|Use of other antifungal agent needed|1|||
146441199|NCT00635648|528118468|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
146441200|NCT00635648|528118468|FG000|Overall Study|Noncompliance with protocol|1|||
146441201|NCT00635648|528118468|FG000|Overall Study|Other reason|2|||
146441202|NCT02450539|528118472|FG000|Overall Study|Withdrawal by Subject|12|||
146441203|NCT02450539|528118473|FG001|Overall Study|Withdrawal by Subject|6|||
146441204|NCT02450539|528118472|FG000|Overall Study|Lost to Follow-up|4|||
146441205|NCT02450539|528118473|FG001|Overall Study|Lost to Follow-up|1|||
146441206|NCT01484912|528118476|FG000|Overall Study|Withdrawal by Subject|1|||
146441207|NCT01484912|528118477|FG001|Overall Study|Withdrawal by Subject|0|||
146441208|NCT01484912|528118476|FG000|Overall Study|Physician Decision|0|||
146441209|NCT01484912|528118477|FG001|Overall Study|Physician Decision|1|||
146441210|NCT00472212|528118480|FG000|Overall Study|Lost to Follow-up|6|||
146441211|NCT00472212|528118481|FG001|Overall Study|Lost to Follow-up|4|||
146441212|NCT00958724|528118490|FG000|Overall Study|Disease Progression|6|||
146441213|NCT05604014|528118491|FG000|Overall Study|Lost to Follow-up|13|||
146441214|NCT00840203|528118492|FG000|First Intervention|Protocol Violation|1|||
146441215|NCT00840203|528118493|FG001|First Intervention|Protocol Violation|1|||
146441216|NCT00840203|528118492|FG000|Washout|Protocol Violation|1|||
146441217|NCT00840203|528118493|FG001|Washout|Protocol Violation|0|||
146441218|NCT00989950|528118505|FG000|Randomized Phase|Protocol Violation|1|||
146441219|NCT00989950|528118506|FG001|Randomized Phase|Protocol Violation|0|||
146441220|NCT00989950|528118507|FG002|Randomized Phase|Protocol Violation|0|||
146441221|NCT00989950|528118508|FG003|Randomized Phase|Protocol Violation|0|||
146441222|NCT00989950|528118505|FG000|Randomized Phase|Adverse Event|0|||
146441223|NCT00989950|528118506|FG001|Randomized Phase|Adverse Event|1|||
146441224|NCT00989950|528118507|FG002|Randomized Phase|Adverse Event|0|||
146441225|NCT00989950|528118508|FG003|Randomized Phase|Adverse Event|0|||
146441226|NCT03101358|528118512|FG000|Overall Study|Non-compliance with study schedule|1|||
146441227|NCT03101358|528118513|FG001|Overall Study|Non-compliance with study schedule|0|||
146441228|NCT03101358|528118514|FG002|Overall Study|Non-compliance with study schedule|0|||
146441229|NCT03101358|528118515|FG003|Overall Study|Non-compliance with study schedule|1|||
146441230|NCT03101358|528118512|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
146441231|NCT03101358|528118513|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
146441232|NCT03101358|528118514|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
146441233|NCT03101358|528118515|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
146441234|NCT03101358|528118512|FG000|Overall Study|Physician Decision|1|||
146441235|NCT03101358|528118513|FG001|Overall Study|Physician Decision|0|||
146441236|NCT03101358|528118514|FG002|Overall Study|Physician Decision|0|||
146441237|NCT03101358|528118515|FG003|Overall Study|Physician Decision|3|||
146441238|NCT03101358|528118512|FG000|Overall Study|Adverse Event|0|||
146441239|NCT03101358|528118513|FG001|Overall Study|Adverse Event|0|||
146441240|NCT03101358|528118514|FG002|Overall Study|Adverse Event|1|||
146441241|NCT03101358|528118515|FG003|Overall Study|Adverse Event|0|||
146441242|NCT03101358|528118512|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
146441243|NCT03101358|528118513|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
146441244|NCT03101358|528118514|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
146441245|NCT03101358|528118515|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
146441246|NCT03101358|528118512|FG000|Overall Study|Lost to Follow-up|1|||
146441247|NCT03101358|528118513|FG001|Overall Study|Lost to Follow-up|0|||
146441248|NCT03101358|528118514|FG002|Overall Study|Lost to Follow-up|0|||
146441249|NCT03101358|528118515|FG003|Overall Study|Lost to Follow-up|1|||
146441250|NCT02426918|528118516|FG000|Overall Study|Adverse Event|2|||
146441251|NCT02426918|528118517|FG001|Overall Study|Adverse Event|2|||
146441252|NCT02426918|528118518|FG002|Overall Study|Adverse Event|0|||
146441253|NCT02426918|528118516|FG000|Overall Study|Physician Decision|1|||
146441254|NCT02426918|528118517|FG001|Overall Study|Physician Decision|1|||
146441255|NCT02426918|528118518|FG002|Overall Study|Physician Decision|1|||
146441256|NCT02426918|528118516|FG000|Overall Study|Withdrawal by Subject|5|||
146441257|NCT02426918|528118517|FG001|Overall Study|Withdrawal by Subject|5|||
146441258|NCT02426918|528118518|FG002|Overall Study|Withdrawal by Subject|4|||
146441259|NCT02426918|528118516|FG000|Overall Study|Other|9|||
146441260|NCT02426918|528118517|FG001|Overall Study|Other|11|||
146441261|NCT02426918|528118518|FG002|Overall Study|Other|9|||
146441262|NCT01190865|528118524|FG000|Overall Study|Withdrawal by Subject|1|||
146441263|NCT01190865|528118524|FG000|Overall Study|Non-compliance|2|||
146441264|NCT00829452|528118525|FG000|First Intervention|Withdrawal by Subject|0|||
146441265|NCT00829452|528118526|FG001|First Intervention|Withdrawal by Subject|1|||
146441266|NCT00829452|528118525|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
146441267|NCT00829452|528118526|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
146441268|NCT00829452|528118525|FG000|Second Intervention|Physician Decision|0|||
146441269|NCT00829452|528118526|FG001|Second Intervention|Physician Decision|1|||
146441270|NCT00574847|528118529|FG000|Overall Study|Adverse Event|2|||
146441271|NCT00574847|528118530|FG001|Overall Study|Adverse Event|0|||
146441272|NCT00574847|528118529|FG000|Overall Study|Death|1|||
146441273|NCT00574847|528118530|FG001|Overall Study|Death|0|||
146441274|NCT00574847|528118529|FG000|Overall Study|Withdrawal by Subject|2|||
146441275|NCT00574847|528118530|FG001|Overall Study|Withdrawal by Subject|2|||
146441276|NCT00574847|528118529|FG000|Overall Study|Physician Decision|1|||
146441277|NCT00574847|528118530|FG001|Overall Study|Physician Decision|0|||
146441278|NCT00574847|528118529|FG000|Overall Study|Did not receive medication (declined)|2|||
146441279|NCT00574847|528118530|FG001|Overall Study|Did not receive medication (declined)|5|||
146441280|NCT02471807|528118535|FG000|Overall Study|Death|14|||
146441281|NCT02471807|528118535|FG000|Overall Study|Withdrawal by Subject|2|||
146441282|NCT02471807|528118535|FG000|Overall Study|Explant|5|||
146441283|NCT02471807|528118535|FG000|Overall Study|Lost to Follow-up|1|||
146441284|NCT01559363|528118538|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
146441285|NCT01559363|528118539|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
146441286|NCT01559363|528118540|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
146441287|NCT01559363|528118541|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
146441288|NCT01559363|528118542|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
146441289|NCT01559363|528118543|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
146441290|NCT01559363|528118538|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
146441291|NCT01559363|528118539|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
146441292|NCT01559363|528118540|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
146441293|NCT01559363|528118541|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
146441294|NCT01559363|528118542|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
146441295|NCT01559363|528118543|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
146441296|NCT01559363|528118538|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
146441297|NCT01559363|528118539|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
146441298|NCT01559363|528118540|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
146441299|NCT01559363|528118541|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
146441300|NCT01559363|528118542|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
146441301|NCT01559363|528118543|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
146441302|NCT01559363|528118538|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
146441303|NCT01559363|528118539|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
146441304|NCT01559363|528118540|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
146441305|NCT01559363|528118541|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
146441306|NCT01559363|528118542|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
146441307|NCT01559363|528118543|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
146441308|NCT01559363|528118538|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
146441309|NCT01559363|528118539|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
146441310|NCT01559363|528118540|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
146441311|NCT01559363|528118541|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
146441312|NCT01559363|528118542|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
146441313|NCT01559363|528118543|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
146441314|NCT01559363|528118538|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
146441315|NCT01559363|528118539|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
146441316|NCT01559363|528118540|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
146441317|NCT01559363|528118541|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
146441318|NCT01559363|528118542|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
146441319|NCT01559363|528118543|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
146441320|NCT01559363|528118538|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
146441321|NCT01559363|528118539|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
146441322|NCT01559363|528118540|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
146441323|NCT01559363|528118541|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
146441324|NCT01559363|528118542|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
146441325|NCT01559363|528118543|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
146441326|NCT00957021|528118544|FG000|Overall Study|Death|5|||
146441327|NCT00957021|528118544|FG000|Overall Study|Lost to Follow-up|8|||
146441328|NCT00957021|528118544|FG000|Overall Study|Withdrawal by Subject|34|||
146441329|NCT00957021|528118544|FG000|Overall Study|No 2 yr ROM data|35|||
146441330|NCT00957021|528118544|FG000|Overall Study|Revised study component by 2 yr visit|8|||
146441331|NCT00957021|528118544|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
146441332|NCT00957021|528118544|FG000|Overall Study|Surgery Cancelled|9|||
146441333|NCT00957021|528118544|FG000|Overall Study|Termination due to language issue|2|||
146441334|NCT00487435|528118551|FG000|Overall Study|Adverse Event|146|||
146441335|NCT00487435|528118551|FG000|Overall Study|Death|2|||
146441336|NCT00487435|528118551|FG000|Overall Study|Lack of Efficacy|33|||
146441337|NCT00487435|528118551|FG000|Overall Study|Lost to Follow-up|54|||
146441338|NCT00487435|528118551|FG000|Overall Study|Pregnancy|2|||
146441339|NCT00487435|528118551|FG000|Overall Study|Withdrawal by Subject|132|||
146441340|NCT00487435|528118551|FG000|Overall Study|Resolution Of Pain|1|||
146441341|NCT00487435|528118551|FG000|Overall Study|Study Medication Non-Compliant|32|||
146441342|NCT00487435|528118551|FG000|Overall Study|Other|83|||
146441343|NCT00868998|528118559|FG000|Overall Study|Screen Failure|1|||
146441344|NCT00868998|528118559|FG000|Overall Study|Withdrawal by Subject|1|||
146441345|NCT00868998|528118559|FG000|Overall Study|Progression of disease|2|||
146441346|NCT00868998|528118559|FG000|Overall Study|Death|1|||
146441347|NCT01483820|528118561|FG000|Overall Study|Lack of Efficacy|6|||
146441348|NCT01483820|528118561|FG000|Overall Study|Adverse Event|1|||
146441349|NCT01483820|528118561|FG000|Overall Study|Death|1|||
146441350|NCT01395017|528118564|FG000|Overall Study|Lost to Follow-up|1|||
146441351|NCT01395017|528118565|FG001|Overall Study|Lost to Follow-up|0|||
146441352|NCT01395017|528118564|FG000|Overall Study|Adverse Event|26|||
146441353|NCT01395017|528118565|FG001|Overall Study|Adverse Event|12|||
146441354|NCT01395017|528118564|FG000|Overall Study|Physician Decision|11|||
146441355|NCT01395017|528118565|FG001|Overall Study|Physician Decision|15|||
146441356|NCT01395017|528118564|FG000|Overall Study|Withdrawal by Subject|14|||
146441357|NCT01395017|528118565|FG001|Overall Study|Withdrawal by Subject|8|||
146441358|NCT01395017|528118564|FG000|Overall Study|Protocol deviation|1|||
146441359|NCT01395017|528118565|FG001|Overall Study|Protocol deviation|2|||
146441360|NCT01395017|528118564|FG000|Overall Study|Death|4|||
146441361|NCT01395017|528118565|FG001|Overall Study|Death|3|||
146441362|NCT01395017|528118564|FG000|Overall Study|Disease progression|42|||
146441363|NCT01395017|528118565|FG001|Overall Study|Disease progression|58|||
146441364|NCT01395017|528118564|FG000|Overall Study|Sponsor discontinued study|1|||
146441365|NCT01395017|528118565|FG001|Overall Study|Sponsor discontinued study|4|||
146441366|NCT00858403|528118567|FG000|Overall Study|Withdrawal by Subject|1|||
146441367|NCT00858403|528118567|FG000|Overall Study|Death|3|||
146441368|NCT00858403|528118567|FG000|Overall Study|Disease Progression|1|||
146441369|NCT00243347|528118568|FG000|Overall Study|Lack of Efficacy|4|||
146441370|NCT00243347|528118568|FG000|Overall Study|Adverse Event|2|||
146441371|NCT00243347|528118568|FG000|Overall Study|Death|1|||
146441372|NCT00243347|528118568|FG000|Overall Study|Withdrawal by Subject|5|||
146441373|NCT00243347|528118568|FG000|Overall Study|Condition worsened|7|||
146441374|NCT01018862|528118575|FG000|Overall Study|Adverse Event|2|||
146441375|NCT01018862|528118576|FG001|Overall Study|Adverse Event|0|||
146441376|NCT01018862|528118577|FG002|Overall Study|Adverse Event|6|||
146441377|NCT01018862|528118575|FG000|Overall Study|Lack of Efficacy|1|||
146441378|NCT01018862|528118576|FG001|Overall Study|Lack of Efficacy|0|||
146441379|NCT01018862|528118577|FG002|Overall Study|Lack of Efficacy|2|||
146441380|NCT01018862|528118575|FG000|Overall Study|Lost to Follow-up|3|||
146441381|NCT01018862|528118576|FG001|Overall Study|Lost to Follow-up|1|||
146441382|NCT01018862|528118577|FG002|Overall Study|Lost to Follow-up|0|||
146441383|NCT01018862|528118575|FG000|Overall Study|Protocol Violation|1|||
146441384|NCT01018862|528118576|FG001|Overall Study|Protocol Violation|3|||
146441385|NCT01018862|528118577|FG002|Overall Study|Protocol Violation|3|||
146441386|NCT01018862|528118575|FG000|Overall Study|Withdrawal by Subject|1|||
146441387|NCT01018862|528118576|FG001|Overall Study|Withdrawal by Subject|2|||
146441388|NCT01018862|528118577|FG002|Overall Study|Withdrawal by Subject|1|||
146441389|NCT01018862|528118575|FG000|Overall Study|administrative problems|5|||
146441390|NCT01018862|528118576|FG001|Overall Study|administrative problems|4|||
146285669|NCT01874431|527561079|FG001|Overall Study|Protocol Violation|1|||
146285670|NCT01874431|527561080|FG002|Overall Study|Protocol Violation|1|||
146441391|NCT01018862|528118577|FG002|Overall Study|administrative problems|4|||
146441392|NCT01968031|528118581|FG000|Overall Study|Adverse Event|13|||
146441393|NCT01968031|528118582|FG001|Overall Study|Adverse Event|10|||
146441394|NCT01968031|528118583|FG002|Overall Study|Adverse Event|22|||
146441395|NCT01968031|528118581|FG000|Overall Study|Withdrawal by Subject|3|||
146441396|NCT01968031|528118582|FG001|Overall Study|Withdrawal by Subject|7|||
146441397|NCT01968031|528118583|FG002|Overall Study|Withdrawal by Subject|3|||
146441398|NCT01968031|528118581|FG000|Overall Study|Did not meet entry criteria|1|||
146441399|NCT01968031|528118582|FG001|Overall Study|Did not meet entry criteria|1|||
146441400|NCT01968031|528118583|FG002|Overall Study|Did not meet entry criteria|1|||
146441401|NCT01968031|528118581|FG000|Overall Study|Noncompliance|0|||
146441402|NCT01968031|528118582|FG001|Overall Study|Noncompliance|0|||
146441403|NCT01968031|528118583|FG002|Overall Study|Noncompliance|2|||
146441404|NCT01968031|528118581|FG000|Overall Study|Failed inclusion criteria|0|||
146441405|NCT01968031|528118582|FG001|Overall Study|Failed inclusion criteria|2|||
146441406|NCT01968031|528118583|FG002|Overall Study|Failed inclusion criteria|0|||
146441407|NCT01968031|528118581|FG000|Overall Study|Death|0|||
146441408|NCT01968031|528118582|FG001|Overall Study|Death|0|||
146441409|NCT01968031|528118583|FG002|Overall Study|Death|1|||
146441410|NCT01968031|528118581|FG000|Overall Study|Prohibited concomitant medication|1|||
146441411|NCT01968031|528118582|FG001|Overall Study|Prohibited concomitant medication|0|||
146441412|NCT01968031|528118583|FG002|Overall Study|Prohibited concomitant medication|0|||
146441413|NCT00834444|528120394|FG000|First Intervention|Adverse Event|1|||
146441414|NCT00834444|528120395|FG001|First Intervention|Adverse Event|0|||
146441415|NCT00834444|528120394|FG000|First Intervention|Intolerance to Venopuncture|0|||
146441416|NCT00834444|528120395|FG001|First Intervention|Intolerance to Venopuncture|1|||
146285671|NCT01874431|527561081|FG003|Overall Study|Protocol Violation|0|||
146441417|NCT00834444|528120394|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
146441418|NCT00834444|528120395|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
146441419|NCT00834444|528120394|FG000|Second Intervention|Adverse Event|1|||
146441420|NCT00834444|528120395|FG001|Second Intervention|Adverse Event|0|||
146441421|NCT00731939|528120399|FG000|Overall Study|Adverse Event|6|||
146441422|NCT00731939|528120399|FG000|Overall Study|Lost to Follow-up|15|||
146441423|NCT00731939|528120399|FG000|Overall Study|Not implanted with study device|9|||
146441424|NCT00731939|528120399|FG000|Overall Study|Withdrawal by Subject|2|||
146441425|NCT00731939|528120399|FG000|Overall Study|Did not meet enrollment criteria|2|||
146441426|NCT02704091|528120400|FG000|Overall Study|Adverse Event|4|||
146441427|NCT02704091|528120401|FG001|Overall Study|Adverse Event|3|||
146441428|NCT02704091|528120400|FG000|Overall Study|Protocol Violation|5|||
146441429|NCT02704091|528120401|FG001|Overall Study|Protocol Violation|3|||
146441430|NCT02704091|528120400|FG000|Overall Study|Consent withdrawn|4|||
146441431|NCT02704091|528120401|FG001|Overall Study|Consent withdrawn|4|||
146441432|NCT02704091|528120400|FG000|Overall Study|Lost to Follow-up|13|||
146441433|NCT02704091|528120401|FG001|Overall Study|Lost to Follow-up|5|||
146441434|NCT02704091|528120400|FG000|Overall Study|Other|2|||
146441435|NCT02704091|528120401|FG001|Overall Study|Other|8|||
146441436|NCT01634139|528120402|FG000|Overall Study|Non compliant with protocol|1|||
146441437|NCT01634139|528120403|FG001|Overall Study|Non compliant with protocol|0|||
146441438|NCT01634139|528120404|FG002|Overall Study|Non compliant with protocol|0|||
146441439|NCT01634139|528120402|FG000|Overall Study|Consent withdrawn not due to AE|4|||
146441440|NCT01634139|528120403|FG001|Overall Study|Consent withdrawn not due to AE|3|||
146441441|NCT01634139|528120404|FG002|Overall Study|Consent withdrawn not due to AE|2|||
146441442|NCT01634139|528120402|FG000|Overall Study|Other|4|||
146441443|NCT01634139|528120403|FG001|Overall Study|Other|0|||
146441444|NCT01634139|528120404|FG002|Overall Study|Other|3|||
146441445|NCT01634139|528120402|FG000|Overall Study|Lost to Follow-up|0|||
146441446|NCT01634139|528120403|FG001|Overall Study|Lost to Follow-up|2|||
146441447|NCT01634139|528120404|FG002|Overall Study|Lost to Follow-up|0|||
146441448|NCT01634139|528120402|FG000|Overall Study|Not treated|1|||
146441449|NCT01634139|528120403|FG001|Overall Study|Not treated|1|||
146441450|NCT01634139|528120404|FG002|Overall Study|Not treated|0|||
146441451|NCT00425308|528120405|FG000|Overall Study|Adverse Event|2|||
146441452|NCT00425308|528120406|FG001|Overall Study|Adverse Event|1|||
146441453|NCT00425308|528120405|FG000|Overall Study|Withdrawal by Subject|1|||
146441454|NCT00425308|528120406|FG001|Overall Study|Withdrawal by Subject|0|||
146441455|NCT00425308|528120405|FG000|Overall Study|Death|1|||
146441456|NCT00425308|528120406|FG001|Overall Study|Death|0|||
146441457|NCT04411680|528120407|FG000|Treatment Period|Adverse Event|3|||
146441458|NCT04411680|528120408|FG001|Treatment Period|Adverse Event|0|||
146441459|NCT04411680|528120407|FG000|Treatment Period|Discharged from hospital|18|||
146441460|NCT04411680|528120408|FG001|Treatment Period|Discharged from hospital|7|||
146441461|NCT04411680|528120407|FG000|Treatment Period|Missed 1 or more doses|8|||
146441462|NCT04411680|528120408|FG001|Treatment Period|Missed 1 or more doses|0|||
146441463|NCT04411680|528120407|FG000|Treatment Period|Transferred to another hospital|0|||
146441464|NCT04411680|528120408|FG001|Treatment Period|Transferred to another hospital|1|||
146441465|NCT04411680|528120407|FG000|Follow up Period|Withdrawal by Subject|2|||
146441466|NCT04411680|528120408|FG001|Follow up Period|Withdrawal by Subject|0|||
146441467|NCT04411680|528120407|FG000|Follow up Period|Lost to Follow-up|5|||
146441468|NCT04411680|528120408|FG001|Follow up Period|Lost to Follow-up|6|||
146441469|NCT04411680|528120407|FG000|Follow up Period|Death|11|||
146441470|NCT04411680|528120408|FG001|Follow up Period|Death|8|||
146441471|NCT00841659|528120409|FG000|Washout: 2 Weeks|Protocol Violation|1|||
146441472|NCT00841659|528120410|FG001|Washout: 2 Weeks|Protocol Violation|0|||
146441473|NCT02420353|528120411|FG000|Overall Study|Withdrawal by Subject|0|||
146441474|NCT02420353|528120412|FG001|Overall Study|Withdrawal by Subject|1|||
146441475|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
146441476|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
146441477|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
146441478|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
146441479|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
146441480|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
146441481|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
146441482|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
146441483|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
146441484|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
146441485|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
146441486|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
146441487|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
146441488|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
146441489|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
146441490|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
146441491|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
146441492|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
146441493|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
146441494|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
146441495|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
146441496|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
146441497|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
146441498|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
146441499|NCT00073307|528120418|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
146441500|NCT00073307|528120419|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
146441501|NCT00073307|528120420|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
146441502|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
146441503|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
146441504|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
146441505|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
146441506|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
146441507|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
146441508|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
146441509|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
146083122|NCT01238588|526824759|FG000|Overall Study|Withdrawal by Subject|1|||
146083123|NCT01238588|526824759|FG000|Overall Study|Physician Decision|2|||
146441510|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
146441511|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
146441512|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
146441513|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
146441514|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
146441515|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
146441516|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
146441517|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
146441518|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
146441519|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
146441520|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
146441521|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
146441522|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
146441523|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
146441524|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
146441525|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
146441526|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
146441527|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
146441528|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
146441529|NCT00073307|528120418|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
146441530|NCT00073307|528120419|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
146441531|NCT00073307|528120420|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
146441532|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
146441533|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
146441534|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
146441535|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
146441536|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
146441537|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
146441538|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
146441539|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
146441540|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
146441541|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
146441542|NCT01438060|528120421|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
146441543|NCT01438060|528120422|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
146441544|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
146441545|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
146441546|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
146441547|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
146441548|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
146441549|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
146441550|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
146441551|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
146441552|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
146441553|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
146441554|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
146441555|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
146441556|NCT01438060|528120421|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
146441557|NCT01438060|528120422|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
146441558|NCT01438060|528120421|FG000|On Study Beyond Week 140|Adverse Event|0|||
146441559|NCT01438060|528120422|FG001|On Study Beyond Week 140|Adverse Event|2|||
146441560|NCT01438060|528120421|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
146441561|NCT01438060|528120422|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
146441562|NCT01438060|528120421|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
146441563|NCT01438060|528120422|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
146441564|NCT01438060|528120421|FG000|On Study Beyond Week 140|Death|0|||
146441565|NCT01438060|528120422|FG001|On Study Beyond Week 140|Death|1|||
146441566|NCT01438060|528120421|FG000|On Study Beyond Week 140|Other Reason|0|||
146441567|NCT01438060|528120422|FG001|On Study Beyond Week 140|Other Reason|3|||
146441568|NCT04608448|528120423|FG000|Overall Study|Withdrawal by Subject|1|||
146441569|NCT04608448|528120423|FG000|Overall Study|Adverse Event|1|||
146441570|NCT01149057|528120424|FG000|Overall Study|Lack of Efficacy|16|||
146441571|NCT01149057|528120424|FG000|Overall Study|Adverse Event|13|||
146441572|NCT01149057|528120424|FG000|Overall Study|Withdrawal by Subject|9|||
146441573|NCT01149057|528120424|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
146441574|NCT01149057|528120424|FG000|Overall Study|B Cell Depletion|4|||
146441575|NCT01149057|528120424|FG000|Overall Study|Participant Non-Compliance|2|||
146441576|NCT01149057|528120424|FG000|Overall Study|Lost to Follow-up|1|||
146441577|NCT01149057|528120424|FG000|Overall Study|High Parathyroid Hormone Value|1|||
146441578|NCT01149057|528120424|FG000|Overall Study|Other|6|||
146441579|NCT01964950|528120425|FG000|Overall Study|Protocol Violation|25|||
146441580|NCT03499873|528120426|FG000|Overall Study|Withdrawal by Subject|4|||
146441581|NCT03499873|528120427|FG001|Overall Study|Withdrawal by Subject|6|||
146441582|NCT03499873|528120428|FG002|Overall Study|Withdrawal by Subject|1|||
146441583|NCT03499873|528120426|FG000|Overall Study|Subjects condition worsened|0|||
146441584|NCT03499873|528120427|FG001|Overall Study|Subjects condition worsened|3|||
146441585|NCT03499873|528120428|FG002|Overall Study|Subjects condition worsened|11|||
146441586|NCT03499873|528120426|FG000|Overall Study|Adverse Event|8|||
146441587|NCT03499873|528120427|FG001|Overall Study|Adverse Event|3|||
146441588|NCT03499873|528120428|FG002|Overall Study|Adverse Event|6|||
146441589|NCT03499873|528120426|FG000|Overall Study|Physician Decision|1|||
146441590|NCT03499873|528120427|FG001|Overall Study|Physician Decision|0|||
146441591|NCT03499873|528120428|FG002|Overall Study|Physician Decision|0|||
146441592|NCT03499873|528120426|FG000|Overall Study|Administrative reasons|0|||
146441593|NCT03499873|528120427|FG001|Overall Study|Administrative reasons|1|||
146441594|NCT03499873|528120428|FG002|Overall Study|Administrative reasons|0|||
146441595|NCT03499873|528120426|FG000|Overall Study|Concomitant therapy|5|||
146441596|NCT03499873|528120427|FG001|Overall Study|Concomitant therapy|4|||
146441597|NCT03499873|528120428|FG002|Overall Study|Concomitant therapy|7|||
146441598|NCT03499873|528120426|FG000|Overall Study|Miscellaneous|1|||
146441599|NCT03499873|528120427|FG001|Overall Study|Miscellaneous|2|||
146441600|NCT03499873|528120428|FG002|Overall Study|Miscellaneous|2|||
146441601|NCT03499873|528120426|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
146441602|NCT03499873|528120427|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
146441603|NCT03499873|528120428|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
146441604|NCT03602339|528120429|FG000|Overall Study|Withdrawal by Subject|9|||
146441605|NCT03602339|528120429|FG000|Overall Study|Physician Decision|2|||
146441606|NCT03602339|528120429|FG000|Overall Study|Other reason|4|||
146441607|NCT01297504|528120430|FG000|Overall Study|Invalid Consent|1|||
146441608|NCT01297504|528120430|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
146441609|NCT01297504|528120430|FG000|Overall Study|No Study Visits|4|||
146441610|NCT01297504|528120430|FG000|Overall Study|Death|3|||
146441611|NCT01297504|528120430|FG000|Overall Study|Lost to Follow-up|43|||
146441612|NCT01297504|528120430|FG000|Overall Study|Withdrawal by Subject|9|||
146441613|NCT01297504|528120430|FG000|Overall Study|Site Closure|3|||
146441614|NCT01297504|528120430|FG000|Overall Study|Protocol Violation|3|||
146441615|NCT00654186|528120431|FG000|Overall Study|Withdrawal by Subject|5|||
146441616|NCT01024855|528120436|FG000|Overall Study|Inclusion/exclusion criteria|1|||
146441617|NCT03306277|528120438|FG000|Overall Study|Death|1|||
146441618|NCT03306277|528120438|FG000|Overall Study|Adverse Event|1|||
146441619|NCT03306277|528120438|FG000|Overall Study|Withdrawal by Subject|1|||
146441620|NCT01968551|528120440|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
146441621|NCT01968551|528120441|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
146441622|NCT01968551|528120442|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
146441623|NCT01968551|528120440|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
146441624|NCT01968551|528120441|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
146441625|NCT01968551|528120442|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
146441626|NCT01968551|528120440|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
146441627|NCT01968551|528120441|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
146441628|NCT01968551|528120442|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
146441629|NCT01968551|528120440|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
146441630|NCT01968551|528120441|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
146441631|NCT01968551|528120442|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
146441632|NCT01968551|528120440|FG000|Extension Phase|Adverse Event|0|||
146441633|NCT01968551|528120441|FG001|Extension Phase|Adverse Event|0|||
146441634|NCT01968551|528120442|FG002|Extension Phase|Adverse Event|2|||
146441635|NCT01968551|528120440|FG000|Extension Phase|Death|0|||
146441636|NCT01968551|528120441|FG001|Extension Phase|Death|1|||
146441637|NCT01968551|528120442|FG002|Extension Phase|Death|0|||
146441638|NCT01968551|528120440|FG000|Extension Phase|Withdrew Consent|0|||
146441639|NCT01968551|528120441|FG001|Extension Phase|Withdrew Consent|0|||
146441640|NCT01968551|528120442|FG002|Extension Phase|Withdrew Consent|1|||
146441641|NCT01968551|528120440|FG000|Extension Phase|Lost to Follow-up|1|||
146441642|NCT01968551|528120441|FG001|Extension Phase|Lost to Follow-up|0|||
146441643|NCT01968551|528120442|FG002|Extension Phase|Lost to Follow-up|1|||
146441644|NCT04060251|528120443|FG000|Overall Study|Study terminated due to low enrollment.|7|||
146441645|NCT04060251|528120444|FG001|Overall Study|Study terminated due to low enrollment.|5|||
146441646|NCT04060251|528120445|FG002|Overall Study|Study terminated due to low enrollment.|7|||
146441647|NCT04060251|528120443|FG000|Overall Study|Adverse Event|1|||
146441648|NCT04060251|528120444|FG001|Overall Study|Adverse Event|1|||
146441649|NCT04060251|528120445|FG002|Overall Study|Adverse Event|0|||
146441650|NCT01155531|528120446|FG000|Overall Study|Adverse Event|0|||
146441651|NCT01155531|528120447|FG001|Overall Study|Adverse Event|0|||
146441652|NCT01155531|528120448|FG002|Overall Study|Adverse Event|1|||
146441653|NCT01155531|528120449|FG003|Overall Study|Adverse Event|0|||
146441654|NCT01155531|528120446|FG000|Overall Study|Lost to Follow-up|0|||
146441655|NCT01155531|528120447|FG001|Overall Study|Lost to Follow-up|0|||
146441656|NCT01155531|528120448|FG002|Overall Study|Lost to Follow-up|0|||
146441657|NCT01155531|528120449|FG003|Overall Study|Lost to Follow-up|1|||
146441658|NCT01155531|528120446|FG000|Overall Study|Withdrawal by Subject|1|||
146441659|NCT01155531|528120447|FG001|Overall Study|Withdrawal by Subject|0|||
146441660|NCT01155531|528120448|FG002|Overall Study|Withdrawal by Subject|1|||
146441661|NCT01155531|528120449|FG003|Overall Study|Withdrawal by Subject|0|||
146441662|NCT01087502|528120450|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
146441663|NCT01087502|528120451|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
146441664|NCT01087502|528120450|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
146441665|NCT01087502|528120451|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
146441666|NCT01087502|528120450|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
146441667|NCT01087502|528120451|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
146441668|NCT01087502|528120450|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
146441669|NCT01087502|528120451|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
146441670|NCT01087502|528120450|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
146441671|NCT01087502|528120451|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
145955273|NCT03092791|526349007|FG007|Overall Study|Withdrawal of Consent|4|||
145955274|NCT03092791|526349000|FG000|Overall Study|Study Termination|0|||
145955275|NCT03092791|526349001|FG001|Overall Study|Study Termination|0|||
145955276|NCT03092791|526349002|FG002|Overall Study|Study Termination|0|||
145955277|NCT03092791|526349003|FG003|Overall Study|Study Termination|0|||
145955278|NCT03092791|526349004|FG004|Overall Study|Study Termination|55|||
145955279|NCT03092791|526349005|FG005|Overall Study|Study Termination|46|||
145955280|NCT03092791|526349006|FG006|Overall Study|Study Termination|53|||
145955281|NCT03092791|526349007|FG007|Overall Study|Study Termination|55|||
145955282|NCT03092791|526349000|FG000|Overall Study|Death|0|||
146441672|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
146441673|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
145955283|NCT03092791|526349001|FG001|Overall Study|Death|0|||
145955284|NCT03092791|526349002|FG002|Overall Study|Death|0|||
145955285|NCT03092791|526349003|FG003|Overall Study|Death|0|||
145955286|NCT03092791|526349004|FG004|Overall Study|Death|0|||
145955287|NCT03092791|526349005|FG005|Overall Study|Death|1|||
145955288|NCT03092791|526349006|FG006|Overall Study|Death|0|||
145955289|NCT03092791|526349007|FG007|Overall Study|Death|1|||
146441674|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
146441675|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
146441676|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
146441677|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
146441678|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
146441679|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
146441680|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
146441681|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
146441682|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
146441683|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
146441684|NCT01087502|528120450|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
145955290|NCT03092791|526349000|FG000|Overall Study|Reason Not Specified|0|||
146441685|NCT01087502|528120451|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
146441686|NCT01653704|528120452|FG000|Overall Study|Technical failure during recording|1|||
146441687|NCT01653704|528120453|FG001|Overall Study|Technical failure during recording|1|||
146441688|NCT01653704|528120452|FG000|Overall Study|Performance not reflective of training|1|||
146441689|NCT01653704|528120453|FG001|Overall Study|Performance not reflective of training|0|||
146441690|NCT02705716|528120454|FG000|Overall Study|Adverse Event|0|||
145955291|NCT03092791|526349001|FG001|Overall Study|Reason Not Specified|0|||
145955292|NCT03092791|526349002|FG002|Overall Study|Reason Not Specified|0|||
146441691|NCT02705716|528120455|FG001|Overall Study|Adverse Event|1|||
146441692|NCT02705716|528120454|FG000|Overall Study|Protocol Violation|3|||
146441693|NCT02705716|528120455|FG001|Overall Study|Protocol Violation|0|||
146441694|NCT02705716|528120454|FG000|Overall Study|Withdrawal of Consent|1|||
146441695|NCT02705716|528120455|FG001|Overall Study|Withdrawal of Consent|1|||
146441696|NCT01986647|528120456|FG000|Overall Study|Lost to Follow-up|4|||
146441697|NCT01986647|528120457|FG001|Overall Study|Lost to Follow-up|1|||
146441698|NCT01986647|528120458|FG002|Overall Study|Lost to Follow-up|4|||
146441699|NCT01986647|528120459|FG003|Overall Study|Lost to Follow-up|4|||
146441700|NCT01986647|528120456|FG000|Overall Study|Withdrawal by Subject|1|||
145955293|NCT03092791|526349003|FG003|Overall Study|Reason Not Specified|0|||
145955294|NCT03092791|526349004|FG004|Overall Study|Reason Not Specified|1|||
145955295|NCT03092791|526349005|FG005|Overall Study|Reason Not Specified|1|||
145955296|NCT03092791|526349006|FG006|Overall Study|Reason Not Specified|0|||
145955297|NCT03092791|526349007|FG007|Overall Study|Reason Not Specified|0|||
145955298|NCT02182830|526349008|FG000|Overall Study|Not Treated|1|||
145955299|NCT02182830|526349009|FG001|Overall Study|Not Treated|1|||
145955300|NCT02182830|526349008|FG000|Overall Study|Trial stopped, reason missing|3|||
145955301|NCT02182830|526349009|FG001|Overall Study|Trial stopped, reason missing|3|||
145955302|NCT02182830|526349008|FG000|Overall Study|Consent withdrawn|8|||
145955303|NCT02182830|526349009|FG001|Overall Study|Consent withdrawn|8|||
145955304|NCT02182830|526349008|FG000|Overall Study|Lost to Follow-up|3|||
145955305|NCT02182830|526349009|FG001|Overall Study|Lost to Follow-up|3|||
145955306|NCT01990768|526349010|FG000|Intervention Started|Found to be ineligible|14|||
145955307|NCT01990768|526349011|FG001|Intervention Started|Found to be ineligible|13|||
145955308|NCT01990768|526349012|FG002|Intervention Started|Found to be ineligible|11|||
145955309|NCT01990768|526349010|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
145955310|NCT01990768|526349011|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
145955311|NCT01990768|526349012|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
145955312|NCT01990768|526349010|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
145955313|NCT01990768|526349011|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
145955314|NCT01990768|526349012|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
145955315|NCT01990768|526349010|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
145955316|NCT01990768|526349011|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
145955317|NCT01990768|526349012|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
145955318|NCT01990768|526349010|FG000|Intervention Started|Patient care priority|1|||
145955319|NCT01990768|526349011|FG001|Intervention Started|Patient care priority|2|||
145955320|NCT01990768|526349012|FG002|Intervention Started|Patient care priority|3|||
145955321|NCT01990768|526349010|FG000|Intervention Started|IV lost|2|||
145955322|NCT01990768|526349011|FG001|Intervention Started|IV lost|2|||
145955323|NCT01990768|526349012|FG002|Intervention Started|IV lost|2|||
145955324|NCT01990768|526349010|FG000|Intervention Started|Required CPR|1|||
145955325|NCT01990768|526349011|FG001|Intervention Started|Required CPR|1|||
145955326|NCT01990768|526349012|FG002|Intervention Started|Required CPR|0|||
145955327|NCT01990768|526349010|FG000|Intervention Started|Seizure or hx of seizure|0|||
145955328|NCT01990768|526349011|FG001|Intervention Started|Seizure or hx of seizure|0|||
145955329|NCT01990768|526349012|FG002|Intervention Started|Seizure or hx of seizure|2|||
145955330|NCT01990768|526349010|FG000|Intervention Started|Discovered to be pregnant|0|||
145955331|NCT01990768|526349011|FG001|Intervention Started|Discovered to be pregnant|1|||
145955332|NCT01990768|526349012|FG002|Intervention Started|Discovered to be pregnant|0|||
145955333|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
145955334|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
145955335|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
145955336|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
145955337|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
145955338|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
145955339|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
145955340|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
145955341|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
145955342|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
145955343|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
145955344|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
145955345|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Death|3|||
145955346|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Death|1|||
145955347|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Death|1|||
145955348|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Discharged|2|||
145955349|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Discharged|1|||
145955350|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Discharged|0|||
146285672|NCT01874431|527561082|FG004|Overall Study|Protocol Violation|3|||
146441701|NCT01986647|528120457|FG001|Overall Study|Withdrawal by Subject|3|||
146441702|NCT01986647|528120458|FG002|Overall Study|Withdrawal by Subject|2|||
146441703|NCT01986647|528120459|FG003|Overall Study|Withdrawal by Subject|3|||
146441704|NCT01986647|528120456|FG000|Overall Study|Health|5|||
146441705|NCT01986647|528120457|FG001|Overall Study|Health|3|||
146441706|NCT01986647|528120458|FG002|Overall Study|Health|6|||
146441707|NCT01986647|528120459|FG003|Overall Study|Health|4|||
146441708|NCT01663896|528120462|FG000|Overall Study|Various reasons|43|||
146441709|NCT00999687|528120463|FG000|First Intervention|Withdrawal by Subject|1|||
146441710|NCT00999687|528120463|FG000|Second Intervention|Withdrawal by Subject|2|||
146441711|NCT00999687|528120463|FG000|Second Intervention|Lack of Efficacy|1|||
146441712|NCT03541252|528120466|FG000|Overall Study|Withdrawal by Subject|1|||
146441713|NCT01960296|528120473|FG000|Overall Study|Postponed surgery|1|||
146441714|NCT01960296|528120474|FG001|Overall Study|Postponed surgery|0|||
146441715|NCT01960296|528120473|FG000|Overall Study|Received different procedure|1|||
146441716|NCT01960296|528120474|FG001|Overall Study|Received different procedure|3|||
146441717|NCT02003391|528120475|FG000|Overall Study|Withdrawal by Subject|2|||
146441718|NCT02003391|528120476|FG001|Overall Study|Withdrawal by Subject|1|||
146441719|NCT02003391|528120475|FG000|Overall Study|Protocol Violation|0|||
146441720|NCT02003391|528120476|FG001|Overall Study|Protocol Violation|1|||
146441721|NCT02003391|528120475|FG000|Overall Study|Adverse Event|1|||
146441722|NCT02003391|528120476|FG001|Overall Study|Adverse Event|0|||
146441723|NCT02272803|528120477|FG000|Overall Study|Disease progression|16|||
146441724|NCT02272803|528120478|FG001|Overall Study|Disease progression|8|||
146441725|NCT02272803|528120477|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
146441726|NCT02272803|528120478|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
146441727|NCT02272803|528120477|FG000|Overall Study|Study drug toxicity|4|||
146441728|NCT02272803|528120478|FG001|Overall Study|Study drug toxicity|9|||
146441729|NCT02272803|528120477|FG000|Overall Study|Participant request to discontinue study treatment|3|||
146441730|NCT02272803|528120478|FG001|Overall Study|Participant request to discontinue study treatment|7|||
146441731|NCT02272803|528120477|FG000|Overall Study|Maximum clinical benefit|4|||
146441732|NCT02272803|528120478|FG001|Overall Study|Maximum clinical benefit|2|||
146441733|NCT02272803|528120477|FG000|Overall Study|Poor/non-compliance|2|||
146441734|NCT02272803|528120478|FG001|Overall Study|Poor/non-compliance|2|||
146441735|NCT02272803|528120477|FG000|Overall Study|Withdrawal by Subject|2|||
146441736|NCT02272803|528120478|FG001|Overall Study|Withdrawal by Subject|1|||
146441737|NCT02272803|528120477|FG000|Overall Study|Death|0|||
146441738|NCT02272803|528120478|FG001|Overall Study|Death|1|||
146441739|NCT02272803|528120477|FG000|Overall Study|Other reasons|1|||
146441740|NCT02272803|528120478|FG001|Overall Study|Other reasons|3|||
146441741|NCT02272803|528120477|FG000|Overall Study|Administrative reason by sponsor|5|||
146441742|NCT02272803|528120478|FG001|Overall Study|Administrative reason by sponsor|4|||
146441743|NCT02611323|528120479|FG000|Overall Study|Death|3|||
146441744|NCT02611323|528120480|FG001|Overall Study|Death|1|||
146441745|NCT02611323|528120481|FG002|Overall Study|Death|0|||
146441746|NCT02611323|528120482|FG003|Overall Study|Death|0|||
146441747|NCT02611323|528120483|FG004|Overall Study|Death|1|||
146441748|NCT02611323|528120484|FG005|Overall Study|Death|1|||
146441749|NCT02611323|528120485|FG006|Overall Study|Death|8|||
146441750|NCT02611323|528120486|FG007|Overall Study|Death|0|||
146441751|NCT02611323|528120487|FG008|Overall Study|Death|4|||
146441752|NCT02611323|528120488|FG009|Overall Study|Death|6|||
146441753|NCT02611323|528120489|FG010|Overall Study|Death|26|||
146441754|NCT02611323|528120479|FG000|Overall Study|Lost to Follow-up|1|||
146441755|NCT02611323|528120480|FG001|Overall Study|Lost to Follow-up|0|||
146441756|NCT02611323|528120481|FG002|Overall Study|Lost to Follow-up|0|||
146441757|NCT02611323|528120482|FG003|Overall Study|Lost to Follow-up|0|||
146441758|NCT02611323|528120483|FG004|Overall Study|Lost to Follow-up|0|||
146441759|NCT02611323|528120484|FG005|Overall Study|Lost to Follow-up|0|||
146441760|NCT02611323|528120485|FG006|Overall Study|Lost to Follow-up|3|||
146441761|NCT02611323|528120486|FG007|Overall Study|Lost to Follow-up|0|||
146441762|NCT02611323|528120487|FG008|Overall Study|Lost to Follow-up|0|||
146441763|NCT02611323|528120488|FG009|Overall Study|Lost to Follow-up|0|||
146441764|NCT02611323|528120489|FG010|Overall Study|Lost to Follow-up|2|||
146441765|NCT02611323|528120479|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441766|NCT02611323|528120480|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441767|NCT02611323|528120481|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441768|NCT02611323|528120482|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441769|NCT02611323|528120483|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441770|NCT02611323|528120484|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441771|NCT02611323|528120485|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441772|NCT02611323|528120486|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441773|NCT02611323|528120487|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
145955351|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
145955352|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
145955353|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
145955354|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
145955355|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
146441774|NCT02611323|528120488|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
146441775|NCT02611323|528120489|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
146441776|NCT02611323|528120479|FG000|Overall Study|Progressive Disease|0|||
146441777|NCT02611323|528120480|FG001|Overall Study|Progressive Disease|0|||
146441778|NCT02611323|528120481|FG002|Overall Study|Progressive Disease|0|||
146441779|NCT02611323|528120482|FG003|Overall Study|Progressive Disease|0|||
146441780|NCT02611323|528120483|FG004|Overall Study|Progressive Disease|0|||
146441781|NCT02611323|528120484|FG005|Overall Study|Progressive Disease|0|||
146441782|NCT02611323|528120485|FG006|Overall Study|Progressive Disease|0|||
146441783|NCT02611323|528120486|FG007|Overall Study|Progressive Disease|0|||
146441784|NCT02611323|528120487|FG008|Overall Study|Progressive Disease|0|||
146441785|NCT02611323|528120488|FG009|Overall Study|Progressive Disease|0|||
146441786|NCT02611323|528120489|FG010|Overall Study|Progressive Disease|1|||
146441787|NCT02611323|528120479|FG000|Overall Study|Withdrawal by Subject|1|||
146441788|NCT02611323|528120480|FG001|Overall Study|Withdrawal by Subject|0|||
146441789|NCT02611323|528120481|FG002|Overall Study|Withdrawal by Subject|0|||
146441790|NCT02611323|528120482|FG003|Overall Study|Withdrawal by Subject|0|||
146441791|NCT02611323|528120483|FG004|Overall Study|Withdrawal by Subject|0|||
146441792|NCT02611323|528120484|FG005|Overall Study|Withdrawal by Subject|0|||
146441793|NCT02611323|528120485|FG006|Overall Study|Withdrawal by Subject|0|||
146441794|NCT02611323|528120486|FG007|Overall Study|Withdrawal by Subject|1|||
146441795|NCT02611323|528120487|FG008|Overall Study|Withdrawal by Subject|0|||
146441796|NCT02611323|528120488|FG009|Overall Study|Withdrawal by Subject|1|||
146441797|NCT02611323|528120489|FG010|Overall Study|Withdrawal by Subject|0|||
146441798|NCT02597049|528120490|FG000|Overall Study|Lost to Follow-up|0|||
145955356|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
145955357|NCT01990768|526349010|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
146285673|NCT01874431|527561083|FG005|Overall Study|Protocol Violation|2|||
146285674|NCT01874431|527561084|FG006|Overall Study|Protocol Violation|1|||
146441799|NCT02597049|528120491|FG001|Overall Study|Lost to Follow-up|3|||
146441800|NCT02597049|528120492|FG002|Overall Study|Lost to Follow-up|2|||
146441801|NCT02597049|528120490|FG000|Overall Study|Withdrawal by Subject|2|||
146441802|NCT02597049|528120491|FG001|Overall Study|Withdrawal by Subject|2|||
146441803|NCT02597049|528120492|FG002|Overall Study|Withdrawal by Subject|1|||
146441804|NCT02597049|528120490|FG000|Overall Study|Adverse Event|2|||
146441805|NCT02597049|528120491|FG001|Overall Study|Adverse Event|0|||
146441806|NCT02597049|528120492|FG002|Overall Study|Adverse Event|0|||
146441807|NCT02597049|528120490|FG000|Overall Study|Death|2|||
146441808|NCT02597049|528120491|FG001|Overall Study|Death|0|||
146441809|NCT02597049|528120492|FG002|Overall Study|Death|0|||
146441810|NCT02597049|528120490|FG000|Overall Study|Noncompliant with Study Visits|1|||
146441811|NCT02597049|528120491|FG001|Overall Study|Noncompliant with Study Visits|0|||
146441812|NCT02597049|528120492|FG002|Overall Study|Noncompliant with Study Visits|0|||
146441813|NCT03573544|528120495|FG000|Overall Study|Adverse Event|0|||
146441814|NCT03573544|528120496|FG001|Overall Study|Adverse Event|0|||
146441815|NCT03573544|528120497|FG002|Overall Study|Adverse Event|0|||
146441816|NCT03573544|528120498|FG003|Overall Study|Adverse Event|3|||
146441817|NCT03573544|528120499|FG004|Overall Study|Adverse Event|1|||
146441818|NCT03573544|528120500|FG005|Overall Study|Adverse Event|0|||
146441819|NCT03573544|528120501|FG006|Overall Study|Adverse Event|2|||
146441820|NCT03573544|528120502|FG007|Overall Study|Adverse Event|0|||
146441821|NCT03573544|528120495|FG000|Overall Study|Physician Decision|0|||
146441822|NCT03573544|528120496|FG001|Overall Study|Physician Decision|0|||
146441823|NCT03573544|528120497|FG002|Overall Study|Physician Decision|0|||
146441824|NCT03573544|528120498|FG003|Overall Study|Physician Decision|0|||
145955358|NCT01990768|526349011|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
145955359|NCT01990768|526349012|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
146285675|NCT01874431|527561085|FG007|Overall Study|Protocol Violation|1|||
146285676|NCT01874431|527561078|FG000|Overall Study|Non-compliance|0|||
146441825|NCT03573544|528120499|FG004|Overall Study|Physician Decision|0|||
146441826|NCT03573544|528120500|FG005|Overall Study|Physician Decision|0|||
146441827|NCT03573544|528120501|FG006|Overall Study|Physician Decision|1|||
146441828|NCT03573544|528120502|FG007|Overall Study|Physician Decision|0|||
146441829|NCT03573544|528120495|FG000|Overall Study|Withdrawal by Subject|2|||
145955360|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
146441830|NCT03573544|528120496|FG001|Overall Study|Withdrawal by Subject|0|||
146441831|NCT03573544|528120497|FG002|Overall Study|Withdrawal by Subject|0|||
146441832|NCT03573544|528120498|FG003|Overall Study|Withdrawal by Subject|1|||
146441833|NCT03573544|528120499|FG004|Overall Study|Withdrawal by Subject|1|||
146441834|NCT03573544|528120500|FG005|Overall Study|Withdrawal by Subject|1|||
146441835|NCT03573544|528120501|FG006|Overall Study|Withdrawal by Subject|0|||
146441836|NCT03573544|528120502|FG007|Overall Study|Withdrawal by Subject|1|||
146441837|NCT03573544|528120495|FG000|Overall Study|Disease progression|3|||
146441838|NCT03573544|528120496|FG001|Overall Study|Disease progression|3|||
146441839|NCT03573544|528120497|FG002|Overall Study|Disease progression|6|||
146441840|NCT03573544|528120498|FG003|Overall Study|Disease progression|4|||
146441841|NCT03573544|528120499|FG004|Overall Study|Disease progression|5|||
146441842|NCT03573544|528120500|FG005|Overall Study|Disease progression|7|||
145955361|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
145955362|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
145955363|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
145955364|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
146441843|NCT03573544|528120501|FG006|Overall Study|Disease progression|6|||
146441844|NCT03573544|528120502|FG007|Overall Study|Disease progression|7|||
146441845|NCT01899053|528120503|FG000|Overall Study|Progressive Disease|4|||
146441846|NCT01899053|528120504|FG001|Overall Study|Progressive Disease|0|||
146441847|NCT01899053|528120505|FG002|Overall Study|Progressive Disease|3|||
146441848|NCT01899053|528120506|FG003|Overall Study|Progressive Disease|0|||
146441849|NCT01899053|528120507|FG004|Overall Study|Progressive Disease|3|||
146441850|NCT01899053|528120508|FG005|Overall Study|Progressive Disease|1|||
146441851|NCT01899053|528120509|FG006|Overall Study|Progressive Disease|1|||
146441852|NCT01899053|528120510|FG007|Overall Study|Progressive Disease|1|||
146441853|NCT01899053|528120511|FG008|Overall Study|Progressive Disease|4|||
146441854|NCT01899053|528120512|FG009|Overall Study|Progressive Disease|3|||
146441855|NCT01899053|528120513|FG010|Overall Study|Progressive Disease|12|||
145955365|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
145955366|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
145955367|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
145955368|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
145955369|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
145955370|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
145955371|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
146441856|NCT01899053|528120514|FG011|Overall Study|Progressive Disease|5|||
146441857|NCT01899053|528120515|FG012|Overall Study|Progressive Disease|8|||
146441858|NCT01899053|528120516|FG013|Overall Study|Progressive Disease|17|||
146441859|NCT01899053|528120503|FG000|Overall Study|Adverse Event|1|||
146441860|NCT01899053|528120504|FG001|Overall Study|Adverse Event|1|||
145955372|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
145955373|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
145955374|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
145955375|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
145955376|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
145955377|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
145955378|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
145955379|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
145955380|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
145955381|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
145955382|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
145955383|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
146441861|NCT01899053|528120505|FG002|Overall Study|Adverse Event|1|||
146441862|NCT01899053|528120506|FG003|Overall Study|Adverse Event|3|||
146441863|NCT01899053|528120507|FG004|Overall Study|Adverse Event|1|||
146441864|NCT01899053|528120508|FG005|Overall Study|Adverse Event|1|||
146441865|NCT01899053|528120509|FG006|Overall Study|Adverse Event|1|||
146441866|NCT01899053|528120510|FG007|Overall Study|Adverse Event|0|||
146441867|NCT01899053|528120511|FG008|Overall Study|Adverse Event|2|||
146441868|NCT01899053|528120512|FG009|Overall Study|Adverse Event|0|||
146441869|NCT01899053|528120513|FG010|Overall Study|Adverse Event|3|||
146441870|NCT01899053|528120514|FG011|Overall Study|Adverse Event|1|||
146441871|NCT01899053|528120515|FG012|Overall Study|Adverse Event|2|||
146441872|NCT01899053|528120516|FG013|Overall Study|Adverse Event|2|||
146441873|NCT01899053|528120503|FG000|Overall Study|Reason Not Specified|0|||
146441874|NCT01899053|528120504|FG001|Overall Study|Reason Not Specified|0|||
146441875|NCT01899053|528120505|FG002|Overall Study|Reason Not Specified|0|||
146441876|NCT01899053|528120506|FG003|Overall Study|Reason Not Specified|0|||
146441877|NCT01899053|528120507|FG004|Overall Study|Reason Not Specified|0|||
146441878|NCT01899053|528120508|FG005|Overall Study|Reason Not Specified|0|||
146441879|NCT01899053|528120509|FG006|Overall Study|Reason Not Specified|1|||
146441880|NCT01899053|528120510|FG007|Overall Study|Reason Not Specified|0|||
146441881|NCT01899053|528120511|FG008|Overall Study|Reason Not Specified|0|||
146441882|NCT01899053|528120512|FG009|Overall Study|Reason Not Specified|0|||
146441883|NCT01899053|528120513|FG010|Overall Study|Reason Not Specified|0|||
146441884|NCT01899053|528120514|FG011|Overall Study|Reason Not Specified|0|||
145955384|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
146441885|NCT01899053|528120515|FG012|Overall Study|Reason Not Specified|1|||
146441886|NCT01899053|528120516|FG013|Overall Study|Reason Not Specified|0|||
146441887|NCT01899053|528120503|FG000|Overall Study|Withdrawal by Subject|1|||
146441888|NCT01899053|528120504|FG001|Overall Study|Withdrawal by Subject|1|||
146441889|NCT01899053|528120505|FG002|Overall Study|Withdrawal by Subject|2|||
146441890|NCT01899053|528120506|FG003|Overall Study|Withdrawal by Subject|0|||
145955385|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
146441891|NCT01899053|528120507|FG004|Overall Study|Withdrawal by Subject|2|||
146441892|NCT01899053|528120508|FG005|Overall Study|Withdrawal by Subject|0|||
146441893|NCT01899053|528120509|FG006|Overall Study|Withdrawal by Subject|0|||
146441894|NCT01899053|528120510|FG007|Overall Study|Withdrawal by Subject|1|||
146441895|NCT01899053|528120511|FG008|Overall Study|Withdrawal by Subject|0|||
146441896|NCT01899053|528120512|FG009|Overall Study|Withdrawal by Subject|0|||
146441897|NCT01899053|528120513|FG010|Overall Study|Withdrawal by Subject|0|||
146441898|NCT01899053|528120514|FG011|Overall Study|Withdrawal by Subject|0|||
146441899|NCT01899053|528120515|FG012|Overall Study|Withdrawal by Subject|1|||
146441900|NCT01899053|528120516|FG013|Overall Study|Withdrawal by Subject|1|||
146441901|NCT01899053|528120503|FG000|Overall Study|Protocol Violation|0|||
146441902|NCT01899053|528120504|FG001|Overall Study|Protocol Violation|0|||
146441903|NCT01899053|528120505|FG002|Overall Study|Protocol Violation|1|||
146441904|NCT01899053|528120506|FG003|Overall Study|Protocol Violation|0|||
146441905|NCT01899053|528120507|FG004|Overall Study|Protocol Violation|0|||
146441906|NCT01899053|528120508|FG005|Overall Study|Protocol Violation|0|||
146441907|NCT01899053|528120509|FG006|Overall Study|Protocol Violation|0|||
146441908|NCT01899053|528120510|FG007|Overall Study|Protocol Violation|0|||
146441909|NCT01899053|528120511|FG008|Overall Study|Protocol Violation|0|||
146441910|NCT01899053|528120512|FG009|Overall Study|Protocol Violation|0|||
146441911|NCT01899053|528120513|FG010|Overall Study|Protocol Violation|0|||
146441912|NCT01899053|528120514|FG011|Overall Study|Protocol Violation|0|||
145955386|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
145955387|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
145955388|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
145955389|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
145955390|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145955391|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145955392|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145955393|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
145955394|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
145955395|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
146441913|NCT01899053|528120515|FG012|Overall Study|Protocol Violation|0|||
146441914|NCT01899053|528120516|FG013|Overall Study|Protocol Violation|0|||
146441915|NCT01899053|528120503|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
146441916|NCT01899053|528120504|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
146441917|NCT01899053|528120505|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441918|NCT01899053|528120506|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
145955396|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
146441919|NCT01899053|528120507|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441920|NCT01899053|528120508|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441921|NCT01899053|528120509|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441922|NCT01899053|528120510|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441923|NCT01899053|528120511|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441924|NCT01899053|528120512|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441925|NCT01899053|528120513|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
146441926|NCT01899053|528120514|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441927|NCT01899053|528120515|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441928|NCT01899053|528120516|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
146441929|NCT01899053|528120503|FG000|Overall Study|Symptomatic Deterioration|0|||
146441930|NCT01899053|528120504|FG001|Overall Study|Symptomatic Deterioration|0|||
146441931|NCT01899053|528120505|FG002|Overall Study|Symptomatic Deterioration|0|||
146441932|NCT01899053|528120506|FG003|Overall Study|Symptomatic Deterioration|0|||
146441933|NCT01899053|528120507|FG004|Overall Study|Symptomatic Deterioration|0|||
146441934|NCT01899053|528120508|FG005|Overall Study|Symptomatic Deterioration|1|||
146441935|NCT01899053|528120509|FG006|Overall Study|Symptomatic Deterioration|0|||
146441936|NCT01899053|528120510|FG007|Overall Study|Symptomatic Deterioration|1|||
146441937|NCT01899053|528120511|FG008|Overall Study|Symptomatic Deterioration|0|||
146441938|NCT01899053|528120512|FG009|Overall Study|Symptomatic Deterioration|0|||
146441939|NCT01899053|528120513|FG010|Overall Study|Symptomatic Deterioration|0|||
146441940|NCT01899053|528120514|FG011|Overall Study|Symptomatic Deterioration|1|||
146441941|NCT01899053|528120515|FG012|Overall Study|Symptomatic Deterioration|2|||
146441942|NCT01899053|528120516|FG013|Overall Study|Symptomatic Deterioration|0|||
146441943|NCT03105297|528120517|FG000|Baseline Phase (Day 1)|Other|21|||
146441944|NCT03105297|528120517|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
146441945|NCT03105297|528120517|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
146441946|NCT00227370|528120519|FG000|Overall Study|Withdrawal by Subject|1|||
146441947|NCT00227370|528120520|FG001|Overall Study|Withdrawal by Subject|2|||
146441948|NCT00227370|528120519|FG000|Overall Study|Death|3|||
146441949|NCT00227370|528120520|FG001|Overall Study|Death|4|||
146441950|NCT00227370|528120519|FG000|Overall Study|Adverse Event|6|||
146441951|NCT00227370|528120520|FG001|Overall Study|Adverse Event|11|||
146441952|NCT00227370|528120519|FG000|Overall Study|Physician Decision|9|||
146441953|NCT00227370|528120520|FG001|Overall Study|Physician Decision|6|||
146441954|NCT00227370|528120519|FG000|Overall Study|Other reasons|2|||
146441955|NCT00227370|528120520|FG001|Overall Study|Other reasons|1|||
146441956|NCT03846193|528120521|FG000|Overall Study|Physician Decision|0|||
146441957|NCT03846193|528120522|FG001|Overall Study|Physician Decision|0|||
146441958|NCT03846193|528120523|FG002|Overall Study|Physician Decision|1|||
146441959|NCT03846193|528120524|FG003|Overall Study|Physician Decision|0|||
146441960|NCT03846193|528120525|FG004|Overall Study|Physician Decision|0|||
146441961|NCT03846193|528120521|FG000|Overall Study|Lost to Follow-up|0|||
146441962|NCT03846193|528120522|FG001|Overall Study|Lost to Follow-up|0|||
146441963|NCT03846193|528120523|FG002|Overall Study|Lost to Follow-up|0|||
146441964|NCT03846193|528120524|FG003|Overall Study|Lost to Follow-up|0|||
146441965|NCT03846193|528120525|FG004|Overall Study|Lost to Follow-up|1|||
146441966|NCT03846193|528120521|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
146441967|NCT03846193|528120522|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
146441968|NCT03846193|528120523|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
146441969|NCT03846193|528120524|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
146441970|NCT03846193|528120525|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
146441971|NCT01401062|528120527|FG000|Overall Study|Death|9|||
146441972|NCT01401062|528120528|FG001|Overall Study|Death|7|||
146441973|NCT01401062|528120527|FG000|Overall Study|Physician Decision|1|||
146441974|NCT01401062|528120528|FG001|Overall Study|Physician Decision|0|||
146441975|NCT01401062|528120527|FG000|Overall Study|Withdrawal by Subject|1|||
146441976|NCT01401062|528120528|FG001|Overall Study|Withdrawal by Subject|1|||
146441977|NCT01131260|528120531|FG000|Overall Study|Randomization error|5|||
146441978|NCT01131260|528120532|FG001|Overall Study|Randomization error|1|||
146441979|NCT01131260|528120531|FG000|Overall Study|Declined to continue participation|8|||
146441980|NCT01131260|528120532|FG001|Overall Study|Declined to continue participation|13|||
146441981|NCT01131260|528120531|FG000|Overall Study|Physician Decision|22|||
146441982|NCT01131260|528120532|FG001|Overall Study|Physician Decision|24|||
146441983|NCT01131260|528120531|FG000|Overall Study|Technical problems|7|||
146441984|NCT01131260|528120532|FG001|Overall Study|Technical problems|6|||
146441985|NCT01131260|528120531|FG000|Overall Study|Staff error|2|||
146441986|NCT01131260|528120532|FG001|Overall Study|Staff error|1|||
146441987|NCT01131260|528120531|FG000|Overall Study|Ineligible|0|||
146441988|NCT01131260|528120532|FG001|Overall Study|Ineligible|2|||
146441989|NCT03684928|528120536|FG000|First Intervention|Lost to Follow-up|0|||
146441990|NCT03684928|528120537|FG001|First Intervention|Lost to Follow-up|1|||
146441991|NCT03684928|528120536|FG000|First Intervention|Withdrawal by Subject|0|||
146441992|NCT03684928|528120537|FG001|First Intervention|Withdrawal by Subject|2|||
146441993|NCT03684928|528120536|FG000|Second Intervention|Soft Tissue Injury|1|||
146441994|NCT03684928|528120537|FG001|Second Intervention|Soft Tissue Injury|0|||
146441995|NCT01891357|528120538|FG000|Overall Study|Protocol Violation|3|||
146441996|NCT00840879|528120539|FG000|Second Intervention|Withdrawal by Subject|1|||
146441997|NCT00840879|528120540|FG001|Second Intervention|Withdrawal by Subject|0|||
146441998|NCT00874276|528120541|FG000|Overall Study|Withdrawal by Subject|1|||
146441999|NCT00874276|528120542|FG001|Overall Study|Withdrawal by Subject|1|||
146442000|NCT03733145|528120543|FG000|Overall Study|screenfail|3|||
146442001|NCT03733145|528120544|FG001|Overall Study|screenfail|3|||
146442002|NCT03733145|528120545|FG002|Overall Study|screenfail|2|||
146442003|NCT02485158|528122089|FG000|Overall Study|Withdrawal by Subject|3|||
146442004|NCT02485158|528122089|FG000|Overall Study|expected drug side effect|1|||
146442005|NCT01098851|528122090|FG000|Overall Study|Equipment failure|1|||
146442006|NCT01098851|528122091|FG001|Overall Study|Equipment failure|0|||
146442007|NCT03087786|528122092|FG000|Overall Study|Withdrawal by Subject|2|||
146442008|NCT03087786|528122093|FG001|Overall Study|Withdrawal by Subject|0|||
146442009|NCT00516295|528122097|FG000|Overall Study|Lack of Efficacy|2|||
146442010|NCT00516295|528122098|FG001|Overall Study|Lack of Efficacy|0|||
146442011|NCT00516295|528122099|FG002|Overall Study|Lack of Efficacy|0|||
146442012|NCT00516295|528122097|FG000|Overall Study|Ineligible|1|||
146442013|NCT00516295|528122098|FG001|Overall Study|Ineligible|0|||
146442014|NCT00516295|528122099|FG002|Overall Study|Ineligible|0|||
146442015|NCT02034513|528122102|FG000|Overall Study|Adverse Event|11|||
146442016|NCT02034513|528122103|FG001|Overall Study|Adverse Event|10|||
146442017|NCT02034513|528122102|FG000|Overall Study|Lack of Efficacy|0|||
146442018|NCT02034513|528122103|FG001|Overall Study|Lack of Efficacy|1|||
146442019|NCT02034513|528122102|FG000|Overall Study|Lost to Follow-up|6|||
146442020|NCT02034513|528122103|FG001|Overall Study|Lost to Follow-up|7|||
146442021|NCT02034513|528122102|FG000|Overall Study|Pregnancy|0|||
146442022|NCT02034513|528122103|FG001|Overall Study|Pregnancy|3|||
146442023|NCT02034513|528122102|FG000|Overall Study|Protocol Violation|7|||
146442024|NCT02034513|528122103|FG001|Overall Study|Protocol Violation|10|||
146442025|NCT02034513|528122102|FG000|Overall Study|Withdrawal by Subject|25|||
146442026|NCT02034513|528122103|FG001|Overall Study|Withdrawal by Subject|25|||
146442027|NCT02034513|528122102|FG000|Overall Study|Unclassified|0|||
146442028|NCT02034513|528122103|FG001|Overall Study|Unclassified|1|||
146442029|NCT04661202|528122104|FG000|Overall Study|Withdrawal by Subject|1|||
146442030|NCT04661202|528122105|FG001|Overall Study|Withdrawal by Subject|1|||
146442031|NCT04661202|528122104|FG000|Overall Study|Lack of Efficacy|2|||
146442032|NCT04661202|528122105|FG001|Overall Study|Lack of Efficacy|0|||
146442033|NCT02578641|528122106|FG000|Overall Study|Adverse Event|5|||
146442034|NCT02578641|528122107|FG001|Overall Study|Adverse Event|15|||
146442035|NCT02578641|528122106|FG000|Overall Study|Death|16|||
146442036|NCT02578641|528122107|FG001|Overall Study|Death|8|||
146442037|NCT02578641|528122106|FG000|Overall Study|Lost to Follow-up|0|||
146442038|NCT02578641|528122107|FG001|Overall Study|Lost to Follow-up|1|||
146442039|NCT02578641|528122106|FG000|Overall Study|Withdrawal by Subject|14|||
146442040|NCT02578641|528122107|FG001|Overall Study|Withdrawal by Subject|7|||
146442041|NCT02578641|528122106|FG000|Overall Study|Progressive Disease|69|||
146442042|NCT02578641|528122107|FG001|Overall Study|Progressive Disease|21|||
146442043|NCT02578641|528122106|FG000|Overall Study|No Study Drug|2|||
146442044|NCT02578641|528122107|FG001|Overall Study|No Study Drug|0|||
146442045|NCT02578641|528122106|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
146442046|NCT02578641|528122107|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
146442047|NCT02578641|528122106|FG000|Overall Study|Non-compliance with Study Schedule|1|||
146442048|NCT02578641|528122107|FG001|Overall Study|Non-compliance with Study Schedule|0|||
146442049|NCT02578641|528122106|FG000|Overall Study|Other|1|||
146442050|NCT02578641|528122107|FG001|Overall Study|Other|10|||
146442051|NCT02578641|528122106|FG000|Overall Study|Not treated|1|||
146442052|NCT02578641|528122107|FG001|Overall Study|Not treated|4|||
146442053|NCT02313558|528122109|FG000|Overall Study|Withdrawal by Subject|2|||
146442054|NCT02313558|528122110|FG001|Overall Study|Withdrawal by Subject|0|||
146442055|NCT02313558|528122109|FG000|Overall Study|Lost to Follow-up|4|||
146442056|NCT02313558|528122110|FG001|Overall Study|Lost to Follow-up|4|||
146442057|NCT02694536|528122118|FG000|Overall Study|Progressive Disease|40|||
146442058|NCT02694536|528122118|FG000|Overall Study|Lost to Follow-up|1|||
146442059|NCT02694536|528122118|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
146442060|NCT02694536|528122118|FG000|Overall Study|Withdrawal by Subject|8|||
146442061|NCT02694536|528122118|FG000|Overall Study|Death|8|||
146442062|NCT02694536|528122118|FG000|Overall Study|Other|22|||
146442063|NCT01911429|528122119|FG000|Overall Study|Adverse Event|5|||
146442064|NCT01911429|528122120|FG001|Overall Study|Adverse Event|3|||
146442065|NCT01911429|528122121|FG002|Overall Study|Adverse Event|9|||
146442066|NCT01911429|528122119|FG000|Overall Study|Lack of Efficacy|1|||
146442067|NCT01911429|528122120|FG001|Overall Study|Lack of Efficacy|2|||
146442068|NCT01911429|528122121|FG002|Overall Study|Lack of Efficacy|4|||
146442069|NCT01911429|528122119|FG000|Overall Study|Lost to Follow-up|0|||
146442070|NCT01911429|528122120|FG001|Overall Study|Lost to Follow-up|0|||
146442071|NCT01911429|528122121|FG002|Overall Study|Lost to Follow-up|1|||
146442072|NCT01911429|528122119|FG000|Overall Study|Protocol Violation|0|||
146442073|NCT01911429|528122120|FG001|Overall Study|Protocol Violation|0|||
146442074|NCT01911429|528122121|FG002|Overall Study|Protocol Violation|1|||
146442075|NCT01911429|528122119|FG000|Overall Study|Withdrawal by Subject|5|||
146442076|NCT01911429|528122120|FG001|Overall Study|Withdrawal by Subject|5|||
146442077|NCT01911429|528122121|FG002|Overall Study|Withdrawal by Subject|4|||
146442078|NCT01911429|528122119|FG000|Overall Study|Accidental randomization|0|||
146442079|NCT01911429|528122120|FG001|Overall Study|Accidental randomization|0|||
146442080|NCT01911429|528122121|FG002|Overall Study|Accidental randomization|1|||
146442081|NCT01911429|528122119|FG000|Overall Study|subject left study|1|||
146442082|NCT01911429|528122120|FG001|Overall Study|subject left study|0|||
146442083|NCT01911429|528122121|FG002|Overall Study|subject left study|0|||
146442084|NCT03707587|528122124|FG000|Overall Study|Death|0|||
146442085|NCT03707587|528122125|FG001|Overall Study|Death|1|||
146442086|NCT01266902|528122129|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
146442087|NCT01266902|528122130|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
146442088|NCT01266902|528122131|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
146442089|NCT01266902|528122129|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
146442090|NCT01266902|528122130|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
146442091|NCT01266902|528122131|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
146442092|NCT01266902|528122129|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
146442093|NCT01266902|528122130|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
146442094|NCT01266902|528122131|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
146442095|NCT01266902|528122129|FG000|Period 1 (Main Study)|Adverse Event|3|||
146442096|NCT01266902|528122130|FG001|Period 1 (Main Study)|Adverse Event|11|||
146442097|NCT01266902|528122131|FG002|Period 1 (Main Study)|Adverse Event|0|||
146442098|NCT01266902|528122129|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
146442099|NCT01266902|528122130|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
146442100|NCT01266902|528122131|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
146442101|NCT01266902|528122129|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
146442102|NCT01266902|528122130|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
146442103|NCT01266902|528122131|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
146442104|NCT01266902|528122129|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
146442105|NCT01266902|528122130|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
146442106|NCT01266902|528122131|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
146442107|NCT01266902|528122129|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
146442108|NCT01266902|528122130|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
146442109|NCT01266902|528122131|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
146442110|NCT01266902|528122129|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
146442111|NCT01266902|528122130|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
146442112|NCT01266902|528122131|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
146442113|NCT01266902|528122129|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
146442114|NCT01266902|528122130|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
146442115|NCT01266902|528122131|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
146442116|NCT05562011|528122132|FG000|Overall Study|Withdrawal by Subject|3|||
146442117|NCT05562011|528122132|FG000|Overall Study|Lost to Follow-up|1|||
146442118|NCT05562011|528122132|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
146442119|NCT05562011|528122132|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
146442120|NCT05562011|528122132|FG000|Overall Study|Device malfunction|13|||
146442121|NCT04567329|528122135|FG000|Overall Study|Withdrawal by Subject|5|||
146442122|NCT04567329|528122136|FG001|Overall Study|Withdrawal by Subject|6|||
146442123|NCT04567329|528122135|FG000|Overall Study|Protocol Violation|2|||
146442124|NCT04567329|528122136|FG001|Overall Study|Protocol Violation|3|||
146442125|NCT04567329|528122135|FG000|Overall Study|Discontinued|2|||
146442126|NCT04567329|528122136|FG001|Overall Study|Discontinued|2|||
146442127|NCT04567329|528122135|FG000|Overall Study|Lost to Follow-up|0|||
146442128|NCT04567329|528122136|FG001|Overall Study|Lost to Follow-up|1|||
146442129|NCT04567329|528122135|FG000|Overall Study|Lack of Efficacy|0|||
146442130|NCT04567329|528122136|FG001|Overall Study|Lack of Efficacy|1|||
146442131|NCT00881751|528122164|FG000|Overall Study|Physician Decision|0|||
146442132|NCT00881751|528122165|FG001|Overall Study|Physician Decision|1|||
146442133|NCT00881751|528122164|FG000|Overall Study|Adverse Event|0|||
146442134|NCT00881751|528122165|FG001|Overall Study|Adverse Event|2|||
146442135|NCT00881751|528122164|FG000|Overall Study|Withdrawal by Subject|0|||
146442136|NCT00881751|528122165|FG001|Overall Study|Withdrawal by Subject|2|||
146442137|NCT02436200|528122166|FG000|Overall Study|Significant outlier|1|||
146442138|NCT00672984|528122167|FG000|First Intervention|Adverse Event|5|||
146442139|NCT00672984|528122168|FG001|First Intervention|Adverse Event|0|||
146442140|NCT00672984|528122169|FG002|First Intervention|Adverse Event|0|||
146442141|NCT00672984|528122167|FG000|First Intervention|Withdrawal by Subject|1|||
146442142|NCT00672984|528122168|FG001|First Intervention|Withdrawal by Subject|2|||
146442143|NCT00672984|528122169|FG002|First Intervention|Withdrawal by Subject|2|||
146442144|NCT00672984|528122167|FG000|First Intervention|Sponsor decision|3|||
146442145|NCT00672984|528122168|FG001|First Intervention|Sponsor decision|0|||
146442146|NCT00672984|528122169|FG002|First Intervention|Sponsor decision|0|||
146442147|NCT00672984|528122167|FG000|Second Intervention|Non-compliance with facility policies|0|||
146442148|NCT00672984|528122168|FG001|Second Intervention|Non-compliance with facility policies|2|||
146442149|NCT00672984|528122169|FG002|Second Intervention|Non-compliance with facility policies|0|||
146442150|NCT00672984|528122167|FG000|Second Intervention|Withdrawal by Subject|0|||
146442151|NCT00672984|528122168|FG001|Second Intervention|Withdrawal by Subject|3|||
146442152|NCT00672984|528122169|FG002|Second Intervention|Withdrawal by Subject|0|||
146442153|NCT00672984|528122167|FG000|Second Intervention|Protocol Violation|0|||
146442154|NCT00672984|528122168|FG001|Second Intervention|Protocol Violation|1|||
146442155|NCT00672984|528122169|FG002|Second Intervention|Protocol Violation|1|||
146442156|NCT00672984|528122167|FG000|Third Intervention|Adverse Event|1|||
146442157|NCT00672984|528122168|FG001|Third Intervention|Adverse Event|0|||
146442158|NCT00672984|528122169|FG002|Third Intervention|Adverse Event|1|||
146442159|NCT00009945|528122170|FG000|Overall Study|no follow up data|7|||
146442160|NCT00009945|528122171|FG001|Overall Study|no follow up data|5|||
146442161|NCT00819169|528122174|FG000|Overall Study|Withdrawal by Subject|2|||
146442162|NCT00819169|528122175|FG001|Overall Study|Withdrawal by Subject|0|||
146442163|NCT00819169|528122176|FG002|Overall Study|Withdrawal by Subject|0|||
146442164|NCT00819169|528122177|FG003|Overall Study|Withdrawal by Subject|1|||
146442165|NCT00819169|528122178|FG004|Overall Study|Withdrawal by Subject|1|||
146442166|NCT00819169|528122179|FG005|Overall Study|Withdrawal by Subject|1|||
146442167|NCT00819169|528122180|FG006|Overall Study|Withdrawal by Subject|5|||
146442168|NCT00819169|528122181|FG007|Overall Study|Withdrawal by Subject|1|||
146442169|NCT00819169|528122182|FG008|Overall Study|Withdrawal by Subject|4|||
145955397|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
145955398|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
145955399|NCT01990768|526349010|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
145955400|NCT01990768|526349011|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
145955401|NCT01990768|526349012|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
145955402|NCT01990768|526349010|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
145955403|NCT01990768|526349011|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
145955404|NCT01990768|526349012|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
145955405|NCT01990768|526349010|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
145955406|NCT01990768|526349011|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
145955407|NCT01990768|526349012|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
145955408|NCT01990768|526349010|FG000|6-Month Follow-up|No contact information|5|||
145955409|NCT01990768|526349011|FG001|6-Month Follow-up|No contact information|6|||
145955410|NCT01990768|526349012|FG002|6-Month Follow-up|No contact information|5|||
145955411|NCT01990768|526349010|FG000|6-Month Follow-up|Homeless|4|||
145955412|NCT01990768|526349011|FG001|6-Month Follow-up|Homeless|3|||
145955413|NCT01990768|526349012|FG002|6-Month Follow-up|Homeless|6|||
145955414|NCT01990768|526349010|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
145955415|NCT01990768|526349011|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
145955416|NCT01990768|526349012|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
145955417|NCT01990768|526349010|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
146442170|NCT00819169|528122174|FG000|Overall Study|Lost to Follow-up|0|||
146442171|NCT00819169|528122175|FG001|Overall Study|Lost to Follow-up|2|||
146442172|NCT00819169|528122176|FG002|Overall Study|Lost to Follow-up|0|||
146442173|NCT00819169|528122177|FG003|Overall Study|Lost to Follow-up|1|||
146442174|NCT00819169|528122178|FG004|Overall Study|Lost to Follow-up|0|||
146442175|NCT00819169|528122179|FG005|Overall Study|Lost to Follow-up|6|||
146442176|NCT00819169|528122180|FG006|Overall Study|Lost to Follow-up|2|||
146442177|NCT00819169|528122181|FG007|Overall Study|Lost to Follow-up|2|||
146442178|NCT00819169|528122182|FG008|Overall Study|Lost to Follow-up|1|||
146442179|NCT00819169|528122174|FG000|Overall Study|Death|1|||
146442180|NCT00819169|528122175|FG001|Overall Study|Death|1|||
146442181|NCT00819169|528122176|FG002|Overall Study|Death|3|||
146442182|NCT00819169|528122177|FG003|Overall Study|Death|8|||
146442183|NCT00819169|528122178|FG004|Overall Study|Death|5|||
146442184|NCT00819169|528122179|FG005|Overall Study|Death|7|||
146442185|NCT00819169|528122180|FG006|Overall Study|Death|9|||
146442186|NCT00819169|528122181|FG007|Overall Study|Death|4|||
146442187|NCT00819169|528122182|FG008|Overall Study|Death|7|||
146442188|NCT00819169|528122174|FG000|Overall Study|Ineligibility determined|0|||
146442189|NCT00819169|528122175|FG001|Overall Study|Ineligibility determined|0|||
146442190|NCT00819169|528122176|FG002|Overall Study|Ineligibility determined|0|||
146442191|NCT00819169|528122177|FG003|Overall Study|Ineligibility determined|2|||
146442192|NCT00819169|528122178|FG004|Overall Study|Ineligibility determined|0|||
146442193|NCT00819169|528122179|FG005|Overall Study|Ineligibility determined|0|||
146442194|NCT00819169|528122180|FG006|Overall Study|Ineligibility determined|0|||
146442195|NCT00819169|528122181|FG007|Overall Study|Ineligibility determined|0|||
146442196|NCT00819169|528122182|FG008|Overall Study|Ineligibility determined|1|||
146442197|NCT00819169|528122174|FG000|Overall Study|Adverse Event|0|||
146442198|NCT00819169|528122175|FG001|Overall Study|Adverse Event|0|||
146442199|NCT00819169|528122176|FG002|Overall Study|Adverse Event|0|||
146442200|NCT00819169|528122177|FG003|Overall Study|Adverse Event|0|||
146442201|NCT00819169|528122178|FG004|Overall Study|Adverse Event|1|||
146442202|NCT00819169|528122179|FG005|Overall Study|Adverse Event|0|||
146442203|NCT00819169|528122180|FG006|Overall Study|Adverse Event|0|||
146442204|NCT00819169|528122181|FG007|Overall Study|Adverse Event|0|||
146442205|NCT00819169|528122182|FG008|Overall Study|Adverse Event|0|||
146442206|NCT00819169|528122174|FG000|Overall Study|Administrative Decision|0|||
146442207|NCT00819169|528122175|FG001|Overall Study|Administrative Decision|0|||
146442208|NCT00819169|528122176|FG002|Overall Study|Administrative Decision|0|||
146442209|NCT00819169|528122177|FG003|Overall Study|Administrative Decision|0|||
146442210|NCT00819169|528122178|FG004|Overall Study|Administrative Decision|1|||
146442211|NCT00819169|528122179|FG005|Overall Study|Administrative Decision|2|||
146442212|NCT00819169|528122180|FG006|Overall Study|Administrative Decision|0|||
146442213|NCT00819169|528122181|FG007|Overall Study|Administrative Decision|2|||
146442214|NCT00819169|528122182|FG008|Overall Study|Administrative Decision|0|||
146442215|NCT00406393|528122183|FG000|Overall Study|Did not undergo transplantation|2|||
146442216|NCT00406393|528122184|FG001|Overall Study|Did not undergo transplantation|1|||
146442217|NCT01632306|528122185|FG000|Overall Study|Protocol Violation|1|||
146442218|NCT01632306|528122186|FG001|Overall Study|Protocol Violation|0|||
146442219|NCT01632306|528122187|FG002|Overall Study|Protocol Violation|0|||
146442220|NCT03966911|528122190|FG000|Overall Study|Adverse Event|1|||
146442221|NCT03966911|528122191|FG001|Overall Study|Adverse Event|1|||
146442222|NCT03966911|528122190|FG000|Overall Study|Withdrawal by Subject|8|||
146442223|NCT03966911|528122191|FG001|Overall Study|Withdrawal by Subject|2|||
146442224|NCT03966911|528122190|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
146442225|NCT03966911|528122191|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
146442226|NCT00985751|528122192|FG000|Overall Study|Adverse Event|0|||
146442227|NCT00985751|528122193|FG001|Overall Study|Adverse Event|0|||
146442228|NCT00985751|528122194|FG002|Overall Study|Adverse Event|0|||
146442229|NCT00985751|528122195|FG003|Overall Study|Adverse Event|0|||
146442230|NCT00985751|528122196|FG004|Overall Study|Adverse Event|1|||
146442231|NCT00380588|528122197|FG000|Overall Study|Unequivocal Disease Progression|25|||
146442232|NCT00380588|528122198|FG001|Overall Study|Unequivocal Disease Progression|34|||
146442233|NCT00380588|528122197|FG000|Overall Study|Next Cycle Not Started|4|||
146442234|NCT00380588|528122198|FG001|Overall Study|Next Cycle Not Started|0|||
146442235|NCT00380588|528122197|FG000|Overall Study|Adverse Event|7|||
146442236|NCT00380588|528122198|FG001|Overall Study|Adverse Event|3|||
146442237|NCT00380588|528122197|FG000|Overall Study|Withdrawal by Subject|1|||
146442238|NCT00380588|528122198|FG001|Overall Study|Withdrawal by Subject|3|||
146442239|NCT00380588|528122197|FG000|Overall Study|Physician Decision|2|||
146442240|NCT00380588|528122198|FG001|Overall Study|Physician Decision|0|||
146442241|NCT02905435|528122199|FG000|Overall Study|Death|2|||
146442242|NCT02905435|528122199|FG000|Overall Study|Physician Decision|1|||
146442243|NCT02905435|528122199|FG000|Overall Study|Lost to Follow-up|4|||
146442244|NCT01046084|528122207|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
146442245|NCT01046084|528122208|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
146442246|NCT00474188|528122209|FG000|Overall Study|Withdrawal by Subject|1|||
146442247|NCT00474188|528122209|FG000|Overall Study|Study discontinued by sponsor|5|||
146442248|NCT03614728|528122210|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
146442249|NCT03614728|528122211|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
146442250|NCT03614728|528122212|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
145955418|NCT01990768|526349011|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
145955419|NCT01990768|526349012|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
146442251|NCT03614728|528122213|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
146442252|NCT03614728|528122210|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
146442253|NCT03614728|528122211|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
145955420|NCT01990768|526349010|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
145955421|NCT01990768|526349011|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
145955422|NCT01990768|526349012|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
145955423|NCT00154375|526349013|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
145955424|NCT00154375|526349014|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
145955425|NCT00154375|526349013|FG000|Overall Study|Adverse Event|18|||
145955426|NCT00154375|526349014|FG001|Overall Study|Adverse Event|20|||
145955427|NCT00154375|526349013|FG000|Overall Study|Withdrawal by Subject|14|||
145955428|NCT00154375|526349014|FG001|Overall Study|Withdrawal by Subject|10|||
145955429|NCT00154375|526349013|FG000|Overall Study|Death|5|||
145955430|NCT00154375|526349014|FG001|Overall Study|Death|13|||
145955431|NCT00154375|526349013|FG000|Overall Study|Study drug no longer required|5|||
146442254|NCT03614728|528122212|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
146442255|NCT03614728|528122213|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
146442256|NCT00842309|528122218|FG000|Overall Study|Withdrawal by Subject|3|||
146442257|NCT00842309|528122219|FG001|Overall Study|Withdrawal by Subject|1|||
146442258|NCT04476277|528122220|FG000|Overall Study|Withdrawal by Subject|0|||
146442259|NCT04476277|528122221|FG001|Overall Study|Withdrawal by Subject|0|||
146442260|NCT04476277|528122222|FG002|Overall Study|Withdrawal by Subject|1|||
146442261|NCT04476277|528122223|FG003|Overall Study|Withdrawal by Subject|0|||
146442262|NCT01962298|528122224|FG000|Overall Study|Protocol Violation|1|||
146442263|NCT01962298|528122225|FG001|Overall Study|Protocol Violation|0|||
146442264|NCT01962298|528122226|FG002|Overall Study|Protocol Violation|1|||
146442265|NCT01962298|528122227|FG003|Overall Study|Protocol Violation|1|||
146442266|NCT01962298|528122228|FG004|Overall Study|Protocol Violation|0|||
146442267|NCT01962298|528122224|FG000|Overall Study|Data quality insufficient|2|||
146442268|NCT01962298|528122225|FG001|Overall Study|Data quality insufficient|0|||
145955432|NCT00154375|526349014|FG001|Overall Study|Study drug no longer required|3|||
145955433|NCT00154375|526349013|FG000|Overall Study|Lost to Follow-up|2|||
145955434|NCT00154375|526349014|FG001|Overall Study|Lost to Follow-up|1|||
145955435|NCT00154375|526349013|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145955436|NCT00154375|526349014|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145955437|NCT00154375|526349013|FG000|Overall Study|Protocol Violation|0|||
145955438|NCT00154375|526349014|FG001|Overall Study|Protocol Violation|1|||
145955439|NCT00154375|526349013|FG000|Overall Study|Suspected progression of disease|44|||
145955440|NCT00154375|526349014|FG001|Overall Study|Suspected progression of disease|30|||
145955441|NCT01588405|526349017|FG000|Overall Study|Adverse Event|1|||
146442269|NCT01962298|528122226|FG002|Overall Study|Data quality insufficient|3|||
146442270|NCT01962298|528122227|FG003|Overall Study|Data quality insufficient|1|||
146442271|NCT01962298|528122228|FG004|Overall Study|Data quality insufficient|4|||
146442272|NCT01962298|528122224|FG000|Overall Study|Insufficient data|0|||
146442273|NCT01962298|528122225|FG001|Overall Study|Insufficient data|2|||
146442274|NCT01962298|528122226|FG002|Overall Study|Insufficient data|1|||
146442275|NCT01962298|528122227|FG003|Overall Study|Insufficient data|0|||
146442276|NCT01962298|528122228|FG004|Overall Study|Insufficient data|1|||
146442277|NCT01962298|528122224|FG000|Overall Study|Incorrect data recorded|0|||
146442278|NCT01962298|528122225|FG001|Overall Study|Incorrect data recorded|1|||
146442279|NCT01962298|528122226|FG002|Overall Study|Incorrect data recorded|0|||
146442280|NCT01962298|528122227|FG003|Overall Study|Incorrect data recorded|0|||
146442281|NCT01962298|528122228|FG004|Overall Study|Incorrect data recorded|0|||
146442282|NCT01962298|528122224|FG000|Overall Study|Physician Decision|0|||
146442283|NCT01962298|528122225|FG001|Overall Study|Physician Decision|1|||
146442284|NCT01962298|528122226|FG002|Overall Study|Physician Decision|0|||
146442285|NCT01962298|528122227|FG003|Overall Study|Physician Decision|0|||
145955442|NCT01588405|526349017|FG000|Overall Study|Clinical Worsening|1|||
145955443|NCT00481767|526349018|FG000|Overall Study|Withdrawal by Subject|16|||
145955444|NCT00481767|526349019|FG001|Overall Study|Withdrawal by Subject|11|||
145955445|NCT00481767|526349018|FG000|Overall Study|Lost to Follow-up|16|||
145955446|NCT00481767|526349019|FG001|Overall Study|Lost to Follow-up|10|||
145955447|NCT01554163|526349022|FG000|Overall Study|Adverse Event|3|||
145955448|NCT01554163|526349023|FG001|Overall Study|Adverse Event|0|||
145955449|NCT01554163|526349022|FG000|Overall Study|Lack of Efficacy|1|||
145955450|NCT01554163|526349023|FG001|Overall Study|Lack of Efficacy|0|||
146442286|NCT01962298|528122228|FG004|Overall Study|Physician Decision|1|||
146442287|NCT01576705|528122229|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
146442288|NCT01576705|528122230|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
146442289|NCT01576705|528122231|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
146442290|NCT01576705|528122232|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
146442291|NCT01576705|528122229|FG000|Overall Study|invalid ICF|0|||
146442292|NCT01576705|528122230|FG001|Overall Study|invalid ICF|1|||
146442293|NCT01576705|528122231|FG002|Overall Study|invalid ICF|0|||
146442294|NCT01576705|528122232|FG003|Overall Study|invalid ICF|0|||
146442295|NCT03727139|528122233|FG000|Overall Study|Protocol Violation|60|||
146442296|NCT00566722|528122234|FG000|Overall Study|Adverse Event|0|||
146442297|NCT00566722|528122235|FG001|Overall Study|Adverse Event|1|||
146442298|NCT00566722|528122236|FG002|Overall Study|Adverse Event|0|||
146442299|NCT00566722|528122234|FG000|Overall Study|Withdrawal by Subject|0|||
146442300|NCT00566722|528122235|FG001|Overall Study|Withdrawal by Subject|0|||
146442301|NCT00566722|528122236|FG002|Overall Study|Withdrawal by Subject|1|||
146442302|NCT00566722|528122234|FG000|Overall Study|Lost to Follow-up|1|||
146442303|NCT00566722|528122235|FG001|Overall Study|Lost to Follow-up|1|||
146442304|NCT00566722|528122236|FG002|Overall Study|Lost to Follow-up|1|||
146442305|NCT00566722|528122234|FG000|Overall Study|Lack of Efficacy|1|||
146442306|NCT00566722|528122235|FG001|Overall Study|Lack of Efficacy|2|||
146442307|NCT00566722|528122236|FG002|Overall Study|Lack of Efficacy|4|||
146442308|NCT00566722|528122234|FG000|Overall Study|Did not meet exclusion criteria|0|||
146442309|NCT00566722|528122235|FG001|Overall Study|Did not meet exclusion criteria|0|||
146442310|NCT00566722|528122236|FG002|Overall Study|Did not meet exclusion criteria|2|||
146442311|NCT00566722|528122234|FG000|Overall Study|Serious adverse event|0|||
146442312|NCT00566722|528122235|FG001|Overall Study|Serious adverse event|1|||
146442313|NCT00566722|528122236|FG002|Overall Study|Serious adverse event|0|||
146442314|NCT00566722|528122234|FG000|Overall Study|Noncompliant with drug administration|0|||
146442315|NCT00566722|528122235|FG001|Overall Study|Noncompliant with drug administration|0|||
146442316|NCT00566722|528122236|FG002|Overall Study|Noncompliant with drug administration|1|||
146442317|NCT01390948|528122237|FG000|Overall Study|End of Study|1|||
146442318|NCT01390948|528122238|FG001|Overall Study|End of Study|0|||
146442319|NCT01390948|528122239|FG002|Overall Study|End of Study|0|||
146442320|NCT01390948|528122237|FG000|Overall Study|Withdrew consent|2|||
146442321|NCT01390948|528122238|FG001|Overall Study|Withdrew consent|2|||
146442322|NCT01390948|528122239|FG002|Overall Study|Withdrew consent|0|||
146442323|NCT01390948|528122237|FG000|Overall Study|Progressive Disease|2|||
146442324|NCT01390948|528122238|FG001|Overall Study|Progressive Disease|5|||
146442325|NCT01390948|528122239|FG002|Overall Study|Progressive Disease|0|||
146442326|NCT01390948|528122237|FG000|Overall Study|Death during follow-up|10|||
146442327|NCT01390948|528122238|FG001|Overall Study|Death during follow-up|11|||
146442328|NCT01390948|528122239|FG002|Overall Study|Death during follow-up|1|||
146442329|NCT02218216|528122242|FG000|Overall Study|Study terminated before completed|6|||
146442330|NCT02218216|528122243|FG001|Overall Study|Study terminated before completed|0|||
146442331|NCT02218216|528122244|FG002|Overall Study|Study terminated before completed|0|||
146442332|NCT05740098|528122249|FG000|Overall Study|Lost to Follow-up|26|||
146442333|NCT05740098|528122250|FG001|Overall Study|Lost to Follow-up|17|||
146442334|NCT05740098|528122251|FG002|Overall Study|Lost to Follow-up|21|||
146442335|NCT03867760|528122252|FG000|Overall Study|Lost to Follow-up|2|||
146442336|NCT03867760|528122253|FG001|Overall Study|Lost to Follow-up|3|||
146442337|NCT03867760|528122252|FG000|Overall Study|Withdrawal by Subject|1|||
146442338|NCT03867760|528122253|FG001|Overall Study|Withdrawal by Subject|2|||
146442339|NCT03867760|528122252|FG000|Overall Study|subject could not meet study logistics|3|||
146442340|NCT03867760|528122253|FG001|Overall Study|subject could not meet study logistics|3|||
146442341|NCT01073631|528122254|FG000|Overall Study|Death|82|||
146442342|NCT01073631|528122254|FG000|Overall Study|Adverse Event|24|||
146442343|NCT01073631|528122254|FG000|Overall Study|Other|63|||
146442344|NCT04573309|528123588|FG000|Overall Study|Protocol Violation|1|||
146442345|NCT04573309|528123589|FG001|Overall Study|Protocol Violation|0|||
146442346|NCT01691430|528123592|FG000|Overall Study|Death|17|||
146442347|NCT01691430|528123593|FG001|Overall Study|Death|16|||
146442348|NCT01691430|528123592|FG000|Overall Study|Withdrawal by Subject|5|||
146442349|NCT01691430|528123593|FG001|Overall Study|Withdrawal by Subject|1|||
146442350|NCT01691430|528123592|FG000|Overall Study|Lost to Follow-up|0|||
146442351|NCT01691430|528123593|FG001|Overall Study|Lost to Follow-up|3|||
146442352|NCT01894230|528123594|FG000|Overall Study|Lost to Follow-up|2|||
146442353|NCT01894230|528123595|FG001|Overall Study|Lost to Follow-up|2|||
146442354|NCT01894230|528123594|FG000|Overall Study|Withdrawal by Subject|4|||
146442355|NCT01894230|528123595|FG001|Overall Study|Withdrawal by Subject|4|||
146442356|NCT01894230|528123594|FG000|Overall Study|Non-adherent|0|||
146442357|NCT01894230|528123595|FG001|Overall Study|Non-adherent|1|||
146442358|NCT01894230|528123594|FG000|Overall Study|Death|1|||
146442359|NCT01894230|528123595|FG001|Overall Study|Death|0|||
146442360|NCT02219009|528123598|FG000|Overall Study|Withdrawal by Subject|5|||
146442361|NCT02219009|528123599|FG001|Overall Study|Withdrawal by Subject|1|||
146442362|NCT02219009|528123598|FG000|Overall Study|Adverse Event|2|||
146442363|NCT02219009|528123599|FG001|Overall Study|Adverse Event|4|||
146442364|NCT02219009|528123598|FG000|Overall Study|Lost to Follow-up|2|||
146442365|NCT02219009|528123599|FG001|Overall Study|Lost to Follow-up|2|||
146442366|NCT02219009|528123598|FG000|Overall Study|Protocol deviation|1|||
146442367|NCT02219009|528123599|FG001|Overall Study|Protocol deviation|0|||
146442368|NCT02219009|528123598|FG000|Overall Study|Physician Decision|0|||
146442369|NCT02219009|528123599|FG001|Overall Study|Physician Decision|1|||
146442370|NCT00660387|528123600|FG000|Overall Study|Adverse Event|1|||
146442371|NCT00660387|528123601|FG001|Overall Study|Adverse Event|2|||
146442372|NCT00660387|528123600|FG000|Overall Study|Lack of Efficacy|0|||
146442373|NCT00660387|528123601|FG001|Overall Study|Lack of Efficacy|1|||
146442374|NCT00660387|528123600|FG000|Overall Study|Protocol Violation|1|||
146442375|NCT00660387|528123601|FG001|Overall Study|Protocol Violation|0|||
146442376|NCT02966340|528123602|FG000|Overall Study|Adverse Event|0|||
146442377|NCT02966340|528123603|FG001|Overall Study|Adverse Event|1|||
146442378|NCT02966340|528123602|FG000|Overall Study|Lost to Follow-up|0|||
146442379|NCT02966340|528123603|FG001|Overall Study|Lost to Follow-up|1|||
146442380|NCT02966340|528123602|FG000|Overall Study|Withdrawal by Subject|1|||
146442381|NCT02966340|528123603|FG001|Overall Study|Withdrawal by Subject|0|||
146442382|NCT02966340|528123602|FG000|Overall Study|data acquisition error|1|||
146442383|NCT02966340|528123603|FG001|Overall Study|data acquisition error|0|||
146442384|NCT02966340|528123602|FG000|Overall Study|startle non-responder|1|||
146442385|NCT02966340|528123603|FG001|Overall Study|startle non-responder|1|||
146442386|NCT00202839|528123604|FG000|Overall Study|Adverse Event|1|||
146442387|NCT00202839|528123605|FG001|Overall Study|Adverse Event|5|||
146442388|NCT00202839|528123604|FG000|Overall Study|Physician Decision|12|||
146442389|NCT00202839|528123605|FG001|Overall Study|Physician Decision|0|||
146442390|NCT00202839|528123604|FG000|Overall Study|Withdrawal by Subject|6|||
146442391|NCT00202839|528123605|FG001|Overall Study|Withdrawal by Subject|2|||
146442392|NCT00202839|528123604|FG000|Overall Study|Protocol Violation|2|||
146442393|NCT00202839|528123605|FG001|Overall Study|Protocol Violation|1|||
146442394|NCT00202839|528123604|FG000|Overall Study|Lost to Follow-up|3|||
146442395|NCT00202839|528123605|FG001|Overall Study|Lost to Follow-up|2|||
146442396|NCT00642993|528123608|FG000|Overall Study|Adverse Event|85|||
146442397|NCT00642993|528123609|FG001|Overall Study|Adverse Event|4|||
146442398|NCT00642993|528123608|FG000|Overall Study|Lost to Follow-up|8|||
146442399|NCT00642993|528123609|FG001|Overall Study|Lost to Follow-up|4|||
146442400|NCT00642993|528123608|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
146442401|NCT00642993|528123609|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
146442402|NCT00642993|528123608|FG000|Overall Study|Protocol Violation|1|||
146442403|NCT00642993|528123609|FG001|Overall Study|Protocol Violation|4|||
146442404|NCT00642993|528123608|FG000|Overall Study|Did not meet protocol eligibility|0|||
146442405|NCT00642993|528123609|FG001|Overall Study|Did not meet protocol eligibility|1|||
146442406|NCT00642993|528123608|FG000|Overall Study|Administrative|1|||
146442407|NCT00642993|528123609|FG001|Overall Study|Administrative|0|||
146442408|NCT02583048|528123610|FG000|Overall Study|Withdrawal by Subject|0|||
145955451|NCT01554163|526349022|FG000|Overall Study|Lost to Follow-up|1|||
145955452|NCT01554163|526349023|FG001|Overall Study|Lost to Follow-up|0|||
146442409|NCT02583048|528123611|FG001|Overall Study|Withdrawal by Subject|1|||
145955453|NCT01554163|526349022|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146442410|NCT02583048|528123612|FG002|Overall Study|Withdrawal by Subject|0|||
146442411|NCT02583048|528123610|FG000|Overall Study|Failed to meet eligibility criterion|0|||
146442412|NCT02583048|528123611|FG001|Overall Study|Failed to meet eligibility criterion|0|||
146442413|NCT02583048|528123612|FG002|Overall Study|Failed to meet eligibility criterion|1|||
146442414|NCT00960154|528123613|FG000|Overall Study|Study termination|25|||
146442415|NCT00960154|528123614|FG001|Overall Study|Study termination|25|||
146442416|NCT03119662|528123615|FG000|Overall Study|Withdrawal by Subject|0|||
146442417|NCT03119662|528123616|FG001|Overall Study|Withdrawal by Subject|1|||
146442418|NCT02817828|528123617|FG000|Overall Study|Lost to Follow-up|41|||
146442419|NCT02817828|528123617|FG000|Overall Study|Adverse event not related to bleeding|104|||
146442420|NCT02817828|528123617|FG000|Overall Study|Adverse event related to bleeding|53|||
146442421|NCT02817828|528123617|FG000|Overall Study|Protocol Violation|11|||
146442422|NCT02817828|528123617|FG000|Overall Study|Pregnancy|7|||
146442423|NCT02817828|528123617|FG000|Overall Study|Pregnancy wish|15|||
146442424|NCT02817828|528123617|FG000|Overall Study|Withdrawal by Subject|78|||
146442425|NCT02817828|528123617|FG000|Overall Study|Other|26|||
146442426|NCT00757705|528123618|FG000|Overall Study|Adverse Event|19|||
146442427|NCT00757705|528123618|FG000|Overall Study|Lost to Follow-up|16|||
146442428|NCT00757705|528123618|FG000|Overall Study|Withdrawal by Subject|25|||
146442429|NCT00757705|528123618|FG000|Overall Study|Insufficient Response|26|||
146442430|NCT00757705|528123618|FG000|Overall Study|Ineligible to continue|8|||
146442431|NCT00757705|528123618|FG000|Overall Study|Non-compliant|9|||
146442432|NCT00757705|528123618|FG000|Overall Study|Other|18|||
146442433|NCT00659815|528123625|FG000|Overall Study|Study related symptoms and complaints|2|||
146442434|NCT00659815|528123626|FG001|Overall Study|Study related symptoms and complaints|1|||
146442435|NCT00659815|528123625|FG000|Overall Study|Inability to maintain wearing schedule|1|||
146442436|NCT00659815|528123626|FG001|Overall Study|Inability to maintain wearing schedule|2|||
146442437|NCT00659815|528123625|FG000|Overall Study|Withdrawal by Subject|1|||
146442438|NCT00659815|528123626|FG001|Overall Study|Withdrawal by Subject|1|||
146442439|NCT02651987|528123627|FG000|Overall Study|Adverse Event|2|||
146442440|NCT02651987|528123628|FG001|Overall Study|Adverse Event|2|||
146442441|NCT02651987|528123627|FG000|Overall Study|Consent Withdrawn|2|||
146442442|NCT02651987|528123628|FG001|Overall Study|Consent Withdrawn|0|||
146442443|NCT02651987|528123627|FG000|Overall Study|Local PD|0|||
146442444|NCT02651987|528123628|FG001|Overall Study|Local PD|2|||
146442445|NCT02651987|528123627|FG000|Overall Study|Investigator Decision|1|||
146442446|NCT02651987|528123628|FG001|Overall Study|Investigator Decision|1|||
146442447|NCT04408924|528123629|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
146442448|NCT04408924|528123629|FG000|Overall Study|Lost to Follow-up|3|||
146442449|NCT04408924|528123629|FG000|Overall Study|Withdrawal by Subject|5|||
146442450|NCT04408924|528123629|FG000|Overall Study|Sponsor Decision|2|||
146442451|NCT02998541|528123631|FG000|Overall Study|Adverse Event|4|||
146442452|NCT02998541|528123632|FG001|Overall Study|Adverse Event|5|||
146442453|NCT02998541|528123633|FG002|Overall Study|Adverse Event|1|||
146442454|NCT02998541|528123631|FG000|Overall Study|Protocol Violation|1|||
146442455|NCT02998541|528123632|FG001|Overall Study|Protocol Violation|0|||
146442456|NCT02998541|528123633|FG002|Overall Study|Protocol Violation|0|||
146442457|NCT02998541|528123631|FG000|Overall Study|Withdrawal by Subject|3|||
146442458|NCT02998541|528123632|FG001|Overall Study|Withdrawal by Subject|1|||
146442459|NCT02998541|528123633|FG002|Overall Study|Withdrawal by Subject|0|||
146442460|NCT02998541|528123631|FG000|Overall Study|Lost to Follow-up|0|||
146442461|NCT02998541|528123632|FG001|Overall Study|Lost to Follow-up|3|||
146442462|NCT02998541|528123633|FG002|Overall Study|Lost to Follow-up|1|||
146442463|NCT02998541|528123631|FG000|Overall Study|Physician Decision|0|||
146442464|NCT02998541|528123632|FG001|Overall Study|Physician Decision|0|||
146442465|NCT02998541|528123633|FG002|Overall Study|Physician Decision|3|||
146442466|NCT02998541|528123631|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146442467|NCT02998541|528123632|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146442468|NCT02998541|528123633|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
146442469|NCT01513239|528123639|FG000|Period 1: Main Phase|Adverse Event|1|||
146442470|NCT01513239|528123640|FG001|Period 1: Main Phase|Adverse Event|1|||
146442471|NCT01513239|528123641|FG002|Period 1: Main Phase|Adverse Event|2|||
146442472|NCT01513239|528123642|FG003|Period 1: Main Phase|Adverse Event|0|||
146442473|NCT01513239|528123643|FG004|Period 1: Main Phase|Adverse Event|0|||
146442474|NCT01513239|528123644|FG005|Period 1: Main Phase|Adverse Event|0|||
146442475|NCT01513239|528123639|FG000|Period 1: Main Phase|Death|29|||
146442476|NCT01513239|528123640|FG001|Period 1: Main Phase|Death|22|||
146442477|NCT01513239|528123641|FG002|Period 1: Main Phase|Death|32|||
146442478|NCT01513239|528123642|FG003|Period 1: Main Phase|Death|0|||
146442479|NCT01513239|528123643|FG004|Period 1: Main Phase|Death|0|||
146442480|NCT01513239|528123644|FG005|Period 1: Main Phase|Death|0|||
146442481|NCT01513239|528123639|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
146442482|NCT01513239|528123640|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
146442483|NCT01513239|528123641|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
146442484|NCT01513239|528123642|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
146442485|NCT01513239|528123643|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
146442486|NCT01513239|528123644|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
146442487|NCT01513239|528123639|FG000|Period 1: Main Phase|Physician Decision|4|||
146442488|NCT01513239|528123640|FG001|Period 1: Main Phase|Physician Decision|4|||
146442489|NCT01513239|528123641|FG002|Period 1: Main Phase|Physician Decision|4|||
146442490|NCT01513239|528123642|FG003|Period 1: Main Phase|Physician Decision|0|||
146442491|NCT01513239|528123643|FG004|Period 1: Main Phase|Physician Decision|0|||
146442492|NCT01513239|528123644|FG005|Period 1: Main Phase|Physician Decision|0|||
146442493|NCT01513239|528123639|FG000|Period 1: Main Phase|Protocol Violation|2|||
146442494|NCT01513239|528123640|FG001|Period 1: Main Phase|Protocol Violation|2|||
146442495|NCT01513239|528123641|FG002|Period 1: Main Phase|Protocol Violation|2|||
146442496|NCT01513239|528123642|FG003|Period 1: Main Phase|Protocol Violation|0|||
146442497|NCT01513239|528123643|FG004|Period 1: Main Phase|Protocol Violation|0|||
146442498|NCT01513239|528123644|FG005|Period 1: Main Phase|Protocol Violation|0|||
146442499|NCT01513239|528123639|FG000|Period 1: Main Phase|Technical Problems|1|||
146442500|NCT01513239|528123640|FG001|Period 1: Main Phase|Technical Problems|2|||
146442501|NCT01513239|528123641|FG002|Period 1: Main Phase|Technical Problems|0|||
146442502|NCT01513239|528123642|FG003|Period 1: Main Phase|Technical Problems|0|||
146442503|NCT01513239|528123643|FG004|Period 1: Main Phase|Technical Problems|0|||
146442504|NCT01513239|528123644|FG005|Period 1: Main Phase|Technical Problems|0|||
146442505|NCT01513239|528123639|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
146442506|NCT01513239|528123640|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
146442507|NCT01513239|528123641|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
146442508|NCT01513239|528123642|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
146442509|NCT01513239|528123643|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
146442510|NCT01513239|528123644|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
146442511|NCT01513239|528123639|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
146442512|NCT01513239|528123640|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
146442513|NCT01513239|528123641|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
146442514|NCT01513239|528123642|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
146442515|NCT01513239|528123643|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
146442516|NCT01513239|528123644|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
146442517|NCT01513239|528123639|FG000|Period 2: 9 Month Extension Phase|Death|0|||
146442518|NCT01513239|528123640|FG001|Period 2: 9 Month Extension Phase|Death|0|||
146442519|NCT01513239|528123641|FG002|Period 2: 9 Month Extension Phase|Death|0|||
146442520|NCT01513239|528123642|FG003|Period 2: 9 Month Extension Phase|Death|2|||
146442521|NCT01513239|528123643|FG004|Period 2: 9 Month Extension Phase|Death|5|||
146442522|NCT01513239|528123644|FG005|Period 2: 9 Month Extension Phase|Death|2|||
146442523|NCT01513239|528123639|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
146442524|NCT01513239|528123640|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
146442525|NCT01513239|528123641|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
146442526|NCT01513239|528123642|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
146442527|NCT01513239|528123643|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
146442528|NCT01513239|528123644|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
146442529|NCT01513239|528123639|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145955454|NCT01554163|526349023|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145955455|NCT01554163|526349022|FG000|Overall Study|Protocol Violation|0|||
145955456|NCT01554163|526349023|FG001|Overall Study|Protocol Violation|4|||
145955457|NCT01554163|526349022|FG000|Overall Study|Withdrawal by Subject|1|||
145955458|NCT01554163|526349023|FG001|Overall Study|Withdrawal by Subject|5|||
145955459|NCT01554163|526349022|FG000|Overall Study|Not Treated|1|||
145955460|NCT01554163|526349023|FG001|Overall Study|Not Treated|0|||
146442530|NCT01513239|528123640|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
146442531|NCT01513239|528123641|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
146442532|NCT01513239|528123642|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
146442533|NCT01513239|528123643|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
146442534|NCT01513239|528123644|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
146442535|NCT01513239|528123639|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
146442536|NCT01513239|528123640|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
146442537|NCT01513239|528123641|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
146442538|NCT01513239|528123642|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
146442539|NCT01513239|528123643|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
146442540|NCT01513239|528123644|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
146442541|NCT00396162|528123645|FG000|Overall Study|Withdrawal by Subject|2|||
146442542|NCT00396162|528123646|FG001|Overall Study|Withdrawal by Subject|3|||
146442543|NCT01741545|528123647|FG000|Treatment Period|Lack of Efficacy|0|||
146442544|NCT01741545|528123648|FG001|Treatment Period|Lack of Efficacy|1|||
146442545|NCT01741545|528123647|FG000|Treatment Period|Adverse event, non-fatal|1|||
146442546|NCT01741545|528123648|FG001|Treatment Period|Adverse event, non-fatal|3|||
146442547|NCT01741545|528123647|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
146442548|NCT01741545|528123648|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
146442549|NCT01741545|528123647|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
146442550|NCT01741545|528123648|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
146442551|NCT01456962|528123649|FG000|Overall Study|Lost to Follow-up|2|||
146442552|NCT01456962|528123650|FG001|Overall Study|Lost to Follow-up|1|||
146442553|NCT03358147|528123653|FG000|Overall Study|Withdrawal by Subject|13|||
146442554|NCT03358147|528123654|FG001|Overall Study|Withdrawal by Subject|19|||
146442555|NCT03358147|528123655|FG002|Overall Study|Withdrawal by Subject|16|||
146442556|NCT03358147|528123656|FG003|Overall Study|Withdrawal by Subject|10|||
146442557|NCT03358147|528123657|FG004|Overall Study|Withdrawal by Subject|5|||
146442558|NCT03358147|528123653|FG000|Overall Study|Adverse Event|3|||
146442559|NCT03358147|528123654|FG001|Overall Study|Adverse Event|9|||
146442560|NCT03358147|528123655|FG002|Overall Study|Adverse Event|7|||
146442561|NCT03358147|528123656|FG003|Overall Study|Adverse Event|5|||
146442562|NCT03358147|528123657|FG004|Overall Study|Adverse Event|2|||
146442563|NCT03358147|528123653|FG000|Overall Study|Lost to Follow-up|4|||
146442564|NCT03358147|528123654|FG001|Overall Study|Lost to Follow-up|3|||
146442565|NCT03358147|528123655|FG002|Overall Study|Lost to Follow-up|7|||
146442566|NCT03358147|528123656|FG003|Overall Study|Lost to Follow-up|6|||
146442567|NCT03358147|528123657|FG004|Overall Study|Lost to Follow-up|4|||
146442568|NCT03358147|528123653|FG000|Overall Study|Major Protocol Deviation|11|||
146442569|NCT03358147|528123654|FG001|Overall Study|Major Protocol Deviation|3|||
146442570|NCT03358147|528123655|FG002|Overall Study|Major Protocol Deviation|2|||
146442571|NCT03358147|528123656|FG003|Overall Study|Major Protocol Deviation|3|||
146442572|NCT03358147|528123657|FG004|Overall Study|Major Protocol Deviation|1|||
146442573|NCT03358147|528123653|FG000|Overall Study|Protocol specified criteria|2|||
146442574|NCT03358147|528123654|FG001|Overall Study|Protocol specified criteria|3|||
146442575|NCT03358147|528123655|FG002|Overall Study|Protocol specified criteria|0|||
146442576|NCT03358147|528123656|FG003|Overall Study|Protocol specified criteria|3|||
146442577|NCT03358147|528123657|FG004|Overall Study|Protocol specified criteria|1|||
146442578|NCT03358147|528123653|FG000|Overall Study|Physician Decision|1|||
146442579|NCT03358147|528123654|FG001|Overall Study|Physician Decision|0|||
146442580|NCT03358147|528123655|FG002|Overall Study|Physician Decision|1|||
146442581|NCT03358147|528123656|FG003|Overall Study|Physician Decision|6|||
146442582|NCT03358147|528123657|FG004|Overall Study|Physician Decision|1|||
146442583|NCT03358147|528123653|FG000|Overall Study|Administrative reasons|0|||
146442584|NCT03358147|528123654|FG001|Overall Study|Administrative reasons|1|||
146442585|NCT03358147|528123655|FG002|Overall Study|Administrative reasons|0|||
146442586|NCT03358147|528123656|FG003|Overall Study|Administrative reasons|3|||
146442587|NCT03358147|528123657|FG004|Overall Study|Administrative reasons|0|||
146442588|NCT03358147|528123653|FG000|Overall Study|Lack of Efficacy|0|||
146442589|NCT03358147|528123654|FG001|Overall Study|Lack of Efficacy|1|||
146442590|NCT03358147|528123655|FG002|Overall Study|Lack of Efficacy|1|||
146442591|NCT03358147|528123656|FG003|Overall Study|Lack of Efficacy|0|||
146442592|NCT03358147|528123657|FG004|Overall Study|Lack of Efficacy|0|||
146442593|NCT01945580|528123658|FG000|Overall Study|Withdrawal by Subject|13|||
146442594|NCT01945580|528123659|FG001|Overall Study|Withdrawal by Subject|35|||
146442595|NCT01945580|528123658|FG000|Overall Study|Physician Decision|3|||
146442596|NCT01945580|528123659|FG001|Overall Study|Physician Decision|2|||
146442597|NCT01945580|528123658|FG000|Overall Study|Lost to Follow-up|26|||
146442598|NCT01945580|528123659|FG001|Overall Study|Lost to Follow-up|39|||
146442599|NCT01945580|528123658|FG000|Overall Study|Death|7|||
146442600|NCT01945580|528123659|FG001|Overall Study|Death|2|||
146442601|NCT01945580|528123658|FG000|Overall Study|Patient moved out of state|0|||
146442602|NCT01945580|528123659|FG001|Overall Study|Patient moved out of state|1|||
146442603|NCT01945580|528123658|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
146442604|NCT01945580|528123659|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
146442605|NCT01945580|528123658|FG000|Overall Study|Family illness - unable to return|0|||
146442606|NCT01945580|528123659|FG001|Overall Study|Family illness - unable to return|1|||
146442607|NCT01945580|528123658|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
146442608|NCT01945580|528123659|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
146442609|NCT01945580|528123658|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
146442610|NCT01945580|528123659|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
146442611|NCT01945580|528123658|FG000|Overall Study|Noncompliance with 36 month visit|1|||
146442612|NCT01945580|528123659|FG001|Overall Study|Noncompliance with 36 month visit|0|||
146442613|NCT01945580|528123658|FG000|Overall Study|The patient moved.|1|||
146442614|NCT01945580|528123659|FG001|Overall Study|The patient moved.|0|||
146442615|NCT01945580|528123658|FG000|Overall Study|No data available|0|||
146442616|NCT01945580|528123659|FG001|Overall Study|No data available|2|||
146442617|NCT02933060|528123660|FG000|Overall Study|Withdrawal by Subject|0|||
146442618|NCT02933060|528123661|FG001|Overall Study|Withdrawal by Subject|1|||
146442619|NCT05034874|528123664|FG000|Overall Study|Withdrawal by Subject|6|||
146442620|NCT05034874|528123665|FG001|Overall Study|Withdrawal by Subject|6|||
146442621|NCT05034874|528123664|FG000|Overall Study|Lost to Follow-up|18|||
146442622|NCT05034874|528123665|FG001|Overall Study|Lost to Follow-up|8|||
146442623|NCT05034874|528123664|FG000|Overall Study|Physician Decision|0|||
146442624|NCT05034874|528123665|FG001|Overall Study|Physician Decision|1|||
146442625|NCT05034874|528123664|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
146442626|NCT05034874|528123665|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
146442627|NCT00474058|528123666|FG000|Overall Study|Adverse Event|11|||
146442628|NCT00474058|528123667|FG001|Overall Study|Adverse Event|6|||
146442629|NCT00474058|528123666|FG000|Overall Study|Lack of Efficacy|0|||
146442630|NCT00474058|528123667|FG001|Overall Study|Lack of Efficacy|4|||
146442631|NCT00474058|528123666|FG000|Overall Study|Withdrawal by Subject|11|||
146442632|NCT00474058|528123667|FG001|Overall Study|Withdrawal by Subject|7|||
146442633|NCT00474058|528123666|FG000|Overall Study|Other|2|||
146442634|NCT00474058|528123667|FG001|Overall Study|Other|0|||
146442635|NCT02640235|528123668|FG000|Overall Study|Withdrawal by Subject|7|||
146442636|NCT02640235|528123669|FG001|Overall Study|Withdrawal by Subject|6|||
146442637|NCT02640235|528123668|FG000|Overall Study|Lost to Follow-up|4|||
146442638|NCT02640235|528123669|FG001|Overall Study|Lost to Follow-up|3|||
146442639|NCT02640235|528123668|FG000|Overall Study|Death|2|||
146442640|NCT02640235|528123669|FG001|Overall Study|Death|3|||
146442641|NCT02640235|528123668|FG000|Overall Study|Other|1|||
146442642|NCT02640235|528123669|FG001|Overall Study|Other|2|||
146442643|NCT00503867|528123672|FG000|Overall Study|Lost to Follow-up|1|||
146442644|NCT00503867|528123672|FG000|Overall Study|Adverse Event|1|||
146442645|NCT05616728|528123673|FG000|Overall Study|Lost to Follow-up|0|||
146442646|NCT05616728|528123674|FG001|Overall Study|Lost to Follow-up|0|||
146442647|NCT05616728|528123675|FG002|Overall Study|Lost to Follow-up|1|||
146442648|NCT05616728|528123673|FG000|Overall Study|Withdrawal by Subject|1|||
146442649|NCT05616728|528123674|FG001|Overall Study|Withdrawal by Subject|1|||
146442650|NCT05616728|528123675|FG002|Overall Study|Withdrawal by Subject|0|||
146442651|NCT05616728|528123673|FG000|Overall Study|Physician Decision|1|||
146442652|NCT05616728|528123674|FG001|Overall Study|Physician Decision|1|||
146442653|NCT05616728|528123675|FG002|Overall Study|Physician Decision|1|||
146442654|NCT05616728|528123673|FG000|Overall Study|Other|0|||
146442655|NCT05616728|528123674|FG001|Overall Study|Other|2|||
146442656|NCT05616728|528123675|FG002|Overall Study|Other|0|||
146442657|NCT00577655|528123676|FG000|Overall Study|Patient Request|0|||
146442658|NCT00577655|528123677|FG001|Overall Study|Patient Request|2|||
146442659|NCT00577655|528123676|FG000|Overall Study|Protocol Violation|0|||
146442660|NCT00577655|528123677|FG001|Overall Study|Protocol Violation|1|||
146442661|NCT00577655|528123676|FG000|Overall Study|Lost to Follow-up|1|||
146442662|NCT00577655|528123677|FG001|Overall Study|Lost to Follow-up|1|||
146442663|NCT00875524|528123679|FG000|Overall Study|Serious adverse event|0|||
146442664|NCT00875524|528123680|FG001|Overall Study|Serious adverse event|1|||
146442665|NCT00875524|528123679|FG000|Overall Study|Protocol Violation|4|||
146442666|NCT00875524|528123680|FG001|Overall Study|Protocol Violation|0|||
146442667|NCT00875524|528123679|FG000|Overall Study|Lost to Follow-up|1|||
146442668|NCT00875524|528123680|FG001|Overall Study|Lost to Follow-up|0|||
146442669|NCT00875524|528123679|FG000|Overall Study|Withdrawal by Subject|3|||
146442670|NCT00875524|528123680|FG001|Overall Study|Withdrawal by Subject|5|||
146442671|NCT01370863|528123684|FG000|Overall Study|Adverse Event|1|||
146442672|NCT01370863|528123685|FG001|Overall Study|Adverse Event|1|||
146442673|NCT01370863|528123684|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
146442674|NCT01370863|528123685|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
146442675|NCT01370863|528123684|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146442676|NCT01370863|528123685|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146442677|NCT02096705|528123688|FG000|Treatment|Adverse Event|6|||
146442678|NCT02096705|528123689|FG001|Treatment|Adverse Event|3|||
146442679|NCT02096705|528123688|FG000|Treatment|Subject request to discontinue treatment|1|||
146442680|NCT02096705|528123689|FG001|Treatment|Subject request to discontinue treatment|1|||
146442681|NCT02096705|528123688|FG000|Treatment|Withdrawal by Subject|1|||
146442682|NCT02096705|528123689|FG001|Treatment|Withdrawal by Subject|0|||
146442683|NCT02096705|528123688|FG000|Treatment|Other|1|||
146442684|NCT02096705|528123689|FG001|Treatment|Other|1|||
146442685|NCT02096705|528123688|FG000|Follow-up|Withdrawal by Subject|1|||
146442686|NCT02096705|528123689|FG001|Follow-up|Withdrawal by Subject|0|||
146442687|NCT02096705|528123688|FG000|Follow-up|Adverse Event|2|||
146442688|NCT02096705|528123689|FG001|Follow-up|Adverse Event|2|||
146442689|NCT02096705|528123688|FG000|Follow-up|Subjects not reporting status|1|||
146442690|NCT02096705|528123689|FG001|Follow-up|Subjects not reporting status|2|||
146442691|NCT02377349|528123690|FG000|Overall Study|Serious Adverse Event|1|||
146442692|NCT02377349|528123691|FG001|Overall Study|Serious Adverse Event|0|||
146442693|NCT02377349|528123690|FG000|Overall Study|Protocol Violation|3|||
146442694|NCT02377349|528123691|FG001|Overall Study|Protocol Violation|2|||
146442695|NCT02377349|528123690|FG000|Overall Study|Withdrawal by Subject|5|||
146442696|NCT02377349|528123691|FG001|Overall Study|Withdrawal by Subject|3|||
146442697|NCT02377349|528123690|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
146442698|NCT02377349|528123691|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
146442699|NCT02377349|528123690|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
146442700|NCT02377349|528123691|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
146442701|NCT02377349|528123690|FG000|Overall Study|Other|0|||
146442702|NCT02377349|528123691|FG001|Overall Study|Other|1|||
146442703|NCT03277248|528123694|FG000|Overall Study|Adverse Event|3|||
146442704|NCT03277248|528123695|FG001|Overall Study|Adverse Event|1|||
146442705|NCT03277248|528123694|FG000|Overall Study|Subject Withdrawal of Consent|6|||
146442706|NCT03277248|528123695|FG001|Overall Study|Subject Withdrawal of Consent|23|||
146442707|NCT03277248|528123694|FG000|Overall Study|Investigator/Sponsor Decision|2|||
146442708|NCT03277248|528123695|FG001|Overall Study|Investigator/Sponsor Decision|2|||
146442709|NCT03277248|528123694|FG000|Overall Study|Pregnancy|4|||
146442710|NCT03277248|528123695|FG001|Overall Study|Pregnancy|1|||
146442711|NCT03277248|528123694|FG000|Overall Study|Lost to Follow-up|0|||
146442712|NCT03277248|528123695|FG001|Overall Study|Lost to Follow-up|2|||
146442713|NCT03277248|528123694|FG000|Overall Study|Lack of Efficacy|0|||
146442714|NCT03277248|528123695|FG001|Overall Study|Lack of Efficacy|2|||
146442715|NCT03277248|528123694|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
146442716|NCT03277248|528123695|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
146442717|NCT01971645|528123702|FG000|Overall Study|Adverse Event|1|||
146442718|NCT01971645|528123703|FG001|Overall Study|Adverse Event|0|||
146442719|NCT01971645|528123704|FG002|Overall Study|Adverse Event|0|||
146442720|NCT01971645|528123702|FG000|Overall Study|Lost to Follow-up|1|||
146442721|NCT01971645|528123703|FG001|Overall Study|Lost to Follow-up|0|||
146442722|NCT01971645|528123704|FG002|Overall Study|Lost to Follow-up|1|||
146442723|NCT01971645|528123702|FG000|Overall Study|Protocol Violation|0|||
146442724|NCT01971645|528123703|FG001|Overall Study|Protocol Violation|0|||
146442725|NCT01971645|528123704|FG002|Overall Study|Protocol Violation|1|||
146442726|NCT02119936|528123705|FG000|Overall Study|Lost to Follow-up|10|||
146442727|NCT01566435|528123708|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
146442728|NCT04236596|528123709|FG000|Overall Study|Withdrawal by Subject|1|||
146442729|NCT04236596|528123709|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
145955461|NCT02557516|526349025|FG000|Overall Study|Adverse Event|1|||
145955462|NCT02557516|526349026|FG001|Overall Study|Adverse Event|0|||
145955463|NCT02557516|526349027|FG002|Overall Study|Adverse Event|2|||
145955464|NCT02557516|526349028|FG003|Overall Study|Adverse Event|1|||
145955465|NCT02557516|526349025|FG000|Overall Study|Disease progression|0|||
145955466|NCT02557516|526349026|FG001|Overall Study|Disease progression|2|||
145955467|NCT02557516|526349027|FG002|Overall Study|Disease progression|0|||
145955468|NCT02557516|526349028|FG003|Overall Study|Disease progression|0|||
145955469|NCT02557516|526349025|FG000|Overall Study|Physician Decision|0|||
145955470|NCT02557516|526349026|FG001|Overall Study|Physician Decision|2|||
145955471|NCT02557516|526349027|FG002|Overall Study|Physician Decision|0|||
145955472|NCT02557516|526349028|FG003|Overall Study|Physician Decision|0|||
145955473|NCT02557516|526349025|FG000|Overall Study|Sponsor decision|0|||
145955474|NCT02557516|526349026|FG001|Overall Study|Sponsor decision|1|||
145955475|NCT02557516|526349027|FG002|Overall Study|Sponsor decision|2|||
145955476|NCT02557516|526349028|FG003|Overall Study|Sponsor decision|8|||
145955477|NCT03335813|526350848|FG000|Overall Study|Withdrawal by Subject|1|||
145955478|NCT02861664|526350849|FG000|Overall Study|Withdrawal of Consent|0|||
145955479|NCT02861664|526350850|FG001|Overall Study|Withdrawal of Consent|1|||
145955480|NCT00905632|526350851|FG000|Overall Study|Adverse Event|0|||
145955481|NCT00905632|526350852|FG001|Overall Study|Adverse Event|0|||
145955482|NCT00905632|526350853|FG002|Overall Study|Adverse Event|0|||
145955483|NCT00905632|526350854|FG003|Overall Study|Adverse Event|0|||
145955484|NCT00905632|526350855|FG004|Overall Study|Adverse Event|0|||
145955485|NCT00905632|526350856|FG005|Overall Study|Adverse Event|1|||
145955486|NCT00905632|526350857|FG006|Overall Study|Adverse Event|4|||
145955487|NCT00577772|526350858|FG000|Overall Study|Lost to Follow-up|0|||
145955488|NCT00577772|526350859|FG001|Overall Study|Lost to Follow-up|1|||
145955489|NCT00856999|526350860|FG000|Overall Study|Withdrawal by Subject|5|||
145955490|NCT00610168|526350862|FG000|Overall Study|Withdrawal by Subject|2|||
145955491|NCT00610168|526350863|FG001|Overall Study|Withdrawal by Subject|0|||
145955492|NCT00878800|526350870|FG000|Overall Study|Adverse Event|0|||
145955493|NCT00878800|526350871|FG001|Overall Study|Adverse Event|0|||
145955494|NCT00878800|526350872|FG002|Overall Study|Adverse Event|2|||
145955495|NCT00878800|526350873|FG003|Overall Study|Adverse Event|0|||
145955496|NCT00878800|526350874|FG004|Overall Study|Adverse Event|1|||
145955497|NCT00878800|526350870|FG000|Overall Study|Progressive disease|1|||
145955498|NCT00878800|526350871|FG001|Overall Study|Progressive disease|5|||
145955499|NCT00878800|526350872|FG002|Overall Study|Progressive disease|6|||
145955500|NCT00878800|526350873|FG003|Overall Study|Progressive disease|5|||
145955501|NCT00878800|526350874|FG004|Overall Study|Progressive disease|13|||
145955502|NCT00878800|526350870|FG000|Overall Study|Withdrew consent|1|||
145955503|NCT00878800|526350871|FG001|Overall Study|Withdrew consent|1|||
145955504|NCT00878800|526350872|FG002|Overall Study|Withdrew consent|0|||
145955505|NCT00878800|526350873|FG003|Overall Study|Withdrew consent|1|||
145955506|NCT00878800|526350874|FG004|Overall Study|Withdrew consent|1|||
145955507|NCT00878800|526350870|FG000|Overall Study|Death|0|||
145955508|NCT00878800|526350871|FG001|Overall Study|Death|0|||
145955509|NCT00878800|526350872|FG002|Overall Study|Death|1|||
145955510|NCT00878800|526350873|FG003|Overall Study|Death|0|||
145955511|NCT00878800|526350874|FG004|Overall Study|Death|0|||
145955512|NCT00878800|526350870|FG000|Overall Study|Other|1|||
145955513|NCT00878800|526350871|FG001|Overall Study|Other|1|||
145955514|NCT00878800|526350872|FG002|Overall Study|Other|0|||
145955515|NCT00878800|526350873|FG003|Overall Study|Other|0|||
145955516|NCT00878800|526350874|FG004|Overall Study|Other|1|||
145955517|NCT00613821|526350875|FG000|Overall Study|Withdrawal by Subject|1|||
145955518|NCT00613821|526350876|FG001|Overall Study|Withdrawal by Subject|0|||
145955519|NCT00613821|526350875|FG000|Overall Study|Physician Decision|1|||
145955520|NCT00613821|526350876|FG001|Overall Study|Physician Decision|1|||
145955521|NCT01266824|526350878|FG000|Overall Study|Study terminated prior to completion|2|||
145955522|NCT01266824|526350879|FG001|Overall Study|Study terminated prior to completion|3|||
145955523|NCT02302846|526350880|FG000|Overall Study|Withdrawal by Subject|1|||
145955524|NCT00397189|526350881|FG000|3 Weeks Period|Lost to Follow-up|5|||
145955525|NCT00397189|526350882|FG001|3 Weeks Period|Lost to Follow-up|4|||
145955526|NCT00397189|526350881|FG000|3 Weeks Period|Adverse Event|3|||
145955527|NCT00397189|526350882|FG001|3 Weeks Period|Adverse Event|2|||
145955528|NCT00397189|526350881|FG000|3 Weeks Period|Withdrawal by Subject|13|||
145955529|NCT00397189|526350882|FG001|3 Weeks Period|Withdrawal by Subject|9|||
145955530|NCT00397189|526350881|FG000|3 Weeks Period|Physician Decision|0|||
145955531|NCT00397189|526350882|FG001|3 Weeks Period|Physician Decision|2|||
145955532|NCT00397189|526350881|FG000|3 Weeks Period|Protocol Violation|0|||
145955533|NCT00397189|526350882|FG001|3 Weeks Period|Protocol Violation|3|||
145955534|NCT00397189|526350881|FG000|3 Weeks Period|Other|0|||
145955535|NCT00397189|526350882|FG001|3 Weeks Period|Other|2|||
145955536|NCT03410992|526350883|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955537|NCT03410992|526350884|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
145955538|NCT03410992|526350885|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955539|NCT03410992|526350886|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955540|NCT03410992|526350887|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146442730|NCT04236596|528123709|FG000|Overall Study|Participants did not receive implant at all|4|||
146442731|NCT02957331|528123710|FG000|Overall Study|Protocol Violation|1|||
146442732|NCT02957331|528123711|FG001|Overall Study|Protocol Violation|0|||
146442733|NCT02588339|528123712|FG000|Overall Study|Withdrawal by Subject|1|||
146442734|NCT02588339|528123712|FG000|Overall Study|GVHD Progression prior to treatment|2|||
146442735|NCT01622660|528125211|FG000|Overall Study|Adverse Event|1|||
146442736|NCT02259348|528125212|FG000|Overall Study|Donors|6|||
146442737|NCT02259348|528125212|FG000|Overall Study|Death|4|||
146442738|NCT04211766|528125213|FG000|Overall Study|Withdrawal by Subject|5|||
146442739|NCT04211766|528125214|FG001|Overall Study|Withdrawal by Subject|1|||
146442740|NCT01120899|528125215|FG000|Overall Study|Withdrawal by Subject|3|||
146442741|NCT02664415|528125216|FG000|Overall Study|Adverse Event|1|||
146442742|NCT02664415|528125217|FG001|Overall Study|Adverse Event|0|||
146442743|NCT01151280|528125218|FG000|Overall Study|Adverse Event|1|||
146442744|NCT01151280|528125218|FG000|Overall Study|Lack of Efficacy|3|||
146442745|NCT00660660|528125219|FG000|Overall Study|Adverse Event|1|||
146442746|NCT00660660|528125220|FG001|Overall Study|Adverse Event|0|||
146442747|NCT00660660|528125219|FG000|Overall Study|Lost to Follow-up|0|||
146442748|NCT00660660|528125220|FG001|Overall Study|Lost to Follow-up|6|||
146442749|NCT00660660|528125219|FG000|Overall Study|Lack of Efficacy|0|||
146442750|NCT00660660|528125220|FG001|Overall Study|Lack of Efficacy|2|||
146442751|NCT00660660|528125219|FG000|Overall Study|Withdrawal by Subject|3|||
146442752|NCT00660660|528125220|FG001|Overall Study|Withdrawal by Subject|0|||
146442753|NCT00660660|528125219|FG000|Overall Study|Incorrect enrollment and other|0|||
146442754|NCT00660660|528125220|FG001|Overall Study|Incorrect enrollment and other|1|||
146442755|NCT00660660|528125219|FG000|Overall Study|New medication after randomization|1|||
146442756|NCT00660660|528125220|FG001|Overall Study|New medication after randomization|0|||
146442757|NCT02308241|528125221|FG000|Overall Study|Withdrawal by Subject|3|||
146442758|NCT00486434|528125222|FG000|Overall Study|Withdrawal by Subject|34|||
146442759|NCT00486434|528125223|FG001|Overall Study|Withdrawal by Subject|39|||
146442760|NCT00486434|528125222|FG000|Overall Study|Adverse Event|118|||
146442761|NCT00486434|528125223|FG001|Overall Study|Adverse Event|44|||
146442762|NCT00486434|528125222|FG000|Overall Study|Protocol Violation|22|||
146442763|NCT00486434|528125223|FG001|Overall Study|Protocol Violation|21|||
146442764|NCT00486434|528125222|FG000|Overall Study|Lack of Efficacy|12|||
146442765|NCT00486434|528125223|FG001|Overall Study|Lack of Efficacy|19|||
146442766|NCT00486434|528125222|FG000|Overall Study|Lost to Follow-up|2|||
146442767|NCT00486434|528125223|FG001|Overall Study|Lost to Follow-up|3|||
146442768|NCT00486434|528125222|FG000|Overall Study|Death|1|||
146442769|NCT00486434|528125223|FG001|Overall Study|Death|2|||
146442770|NCT00486434|528125222|FG000|Overall Study|Personal reasons|5|||
146442771|NCT00486434|528125223|FG001|Overall Study|Personal reasons|6|||
146442772|NCT02218541|528125224|FG000|Overall Study|Lost to Follow-up|2|||
146442773|NCT02218541|528125225|FG001|Overall Study|Lost to Follow-up|1|||
146442774|NCT02218541|528125224|FG000|Overall Study|Implant Failure|4|||
146442775|NCT02218541|528125225|FG001|Overall Study|Implant Failure|1|||
146442776|NCT00856349|528125226|FG000|Overall Study|Death|418|||
146442777|NCT00856349|528125226|FG000|Overall Study|Withdrawal by Subject|116|||
146442778|NCT00856349|528125226|FG000|Overall Study|Lost to Follow-up|91|||
146442779|NCT00856349|528125226|FG000|Overall Study|Protocol Violation|38|||
146442780|NCT00856349|528125226|FG000|Overall Study|Physician Decision|13|||
146442781|NCT00856349|528125226|FG000|Overall Study|Subject relocation|104|||
145955541|NCT03410992|526350888|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146442782|NCT00856349|528125226|FG000|Overall Study|Device explant|33|||
146442783|NCT00856349|528125226|FG000|Overall Study|Site closure|78|||
146442784|NCT00856349|528125226|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
146442785|NCT02725515|528125227|FG000|Overall Study|Refused infusion (no study treatment)|1|||
145955542|NCT03410992|526350889|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
146442786|NCT02725515|528125228|FG001|Overall Study|Refused infusion (no study treatment)|0|||
146442787|NCT02725515|528125227|FG000|Overall Study|Loss of Improvement per Protocol|14|||
146442788|NCT02725515|528125228|FG001|Overall Study|Loss of Improvement per Protocol|25|||
146442789|NCT02725515|528125227|FG000|Overall Study|Withdrawal by Subject|2|||
146442790|NCT02725515|528125228|FG001|Overall Study|Withdrawal by Subject|1|||
146442791|NCT02725515|528125227|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146442792|NCT02725515|528125228|FG001|Overall Study|Non-Compliance With Study Drug|3|||
146442793|NCT02725515|528125227|FG000|Overall Study|Lost to Follow-up|1|||
146442794|NCT02725515|528125228|FG001|Overall Study|Lost to Follow-up|1|||
146442795|NCT02725515|528125227|FG000|Overall Study|Adverse Event|7|||
146442796|NCT02725515|528125228|FG001|Overall Study|Adverse Event|2|||
146442797|NCT02725515|528125227|FG000|Overall Study|No Documented Disease Improvement|0|||
146442798|NCT02725515|528125228|FG001|Overall Study|No Documented Disease Improvement|1|||
146442799|NCT02725515|528125227|FG000|Overall Study|Completed Study Under Original Protocol|0|||
146442800|NCT02725515|528125228|FG001|Overall Study|Completed Study Under Original Protocol|1|||
146442801|NCT02725515|528125227|FG000|Overall Study|Lack of Response|0|||
146442802|NCT02725515|528125228|FG001|Overall Study|Lack of Response|1|||
146442803|NCT00183196|528125238|FG000|Overall Study|Withdrawal by Subject|18|||
146442804|NCT00183196|528125239|FG001|Overall Study|Withdrawal by Subject|11|||
146442805|NCT00183196|528125240|FG002|Overall Study|Withdrawal by Subject|13|||
146442806|NCT00183196|528125238|FG000|Overall Study|Adverse Event|1|||
146442807|NCT00183196|528125239|FG001|Overall Study|Adverse Event|2|||
146442808|NCT00183196|528125240|FG002|Overall Study|Adverse Event|2|||
146442809|NCT00183196|528125238|FG000|Overall Study|Legal event|1|||
146442810|NCT00183196|528125239|FG001|Overall Study|Legal event|1|||
146442811|NCT00183196|528125240|FG002|Overall Study|Legal event|1|||
146442812|NCT00183196|528125238|FG000|Overall Study|Required more intensive care|0|||
146442813|NCT00183196|528125239|FG001|Overall Study|Required more intensive care|1|||
146442814|NCT00183196|528125240|FG002|Overall Study|Required more intensive care|2|||
146442815|NCT03387462|528125241|FG000|Overall Study|Lost to Follow-up|1|||
146442816|NCT01460628|528125242|FG000|Overall Study|Adverse Event|3|||
146442817|NCT01460628|528125242|FG000|Overall Study|Withdrawal by Subject|2|||
146442818|NCT01664039|528125246|FG000|Overall Study|Adverse Event|3|||
146442819|NCT01664039|528125247|FG001|Overall Study|Adverse Event|4|||
146442820|NCT01664039|528125246|FG000|Overall Study|Lost to Follow-up|1|||
146442821|NCT01664039|528125247|FG001|Overall Study|Lost to Follow-up|1|||
146442822|NCT01664039|528125246|FG000|Overall Study|Withdrawal by Subject|1|||
146442823|NCT01664039|528125247|FG001|Overall Study|Withdrawal by Subject|3|||
146442824|NCT01664039|528125246|FG000|Overall Study|Noncompliance|1|||
146442825|NCT01664039|528125247|FG001|Overall Study|Noncompliance|1|||
146442826|NCT01853176|528125250|FG000|Overall Study|Study terminated|4|||
146442827|NCT01853176|528125251|FG001|Overall Study|Study terminated|0|||
146442828|NCT01944722|528125252|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
146442829|NCT01944722|528125252|FG000|Overall Study|Specimen Shipping Issues|34|||
146442830|NCT01944722|528125252|FG000|Overall Study|Improper Storage/Transport|5|||
146442831|NCT01944722|528125252|FG000|Overall Study|Insufficient Volume for Test|1|||
146442832|NCT01944722|528125252|FG000|Overall Study|Missing Specimens|3|||
146442833|NCT01944722|528125252|FG000|Overall Study|Specimens Mislabeled|2|||
146442834|NCT01944722|528125252|FG000|Overall Study|Withdrawal by Subject|8|||
146442835|NCT01944722|528125252|FG000|Overall Study|NILM Subjects <30 years old|8106|||
146442836|NCT01944722|528125252|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
146442837|NCT01944722|528125252|FG000|Overall Study|>ASCUS Cytology|1122|||
146442838|NCT02906917|528125256|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
146442839|NCT02906917|528125257|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
146442840|NCT02906917|528125256|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
146442841|NCT02906917|528125257|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
146442842|NCT02906917|528125256|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
146442843|NCT02906917|528125257|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
146442844|NCT02906917|528125256|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
146442845|NCT02906917|528125257|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
146442846|NCT02906917|528125256|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
146442847|NCT02906917|528125257|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
146442848|NCT02906917|528125256|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
146442849|NCT02906917|528125257|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
146442850|NCT02906917|528125256|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
146442851|NCT02906917|528125257|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
146442852|NCT02906917|528125256|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
146442853|NCT02906917|528125257|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
146442854|NCT00687739|528125259|FG000|Overall Study|Lost to Follow-up|2|||
146442855|NCT00687739|528125260|FG001|Overall Study|Lost to Follow-up|2|||
146442856|NCT00687739|528125261|FG002|Overall Study|Lost to Follow-up|1|||
146442857|NCT00687739|528125262|FG003|Overall Study|Lost to Follow-up|2|||
146442858|NCT00687739|528125259|FG000|Overall Study|Adverse Event|0|||
145955543|NCT03410992|526350890|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955544|NCT03410992|526350891|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955545|NCT03410992|526350892|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955546|NCT03410992|526350893|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145955547|NCT03410992|526350883|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
145955548|NCT03410992|526350884|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
145955549|NCT03410992|526350885|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955550|NCT03410992|526350886|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955551|NCT03410992|526350887|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955552|NCT03410992|526350888|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955553|NCT03410992|526350889|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955554|NCT03410992|526350890|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955555|NCT03410992|526350891|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955556|NCT03410992|526350892|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955557|NCT03410992|526350893|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145955558|NCT03410992|526350883|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
145955559|NCT03410992|526350884|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
145955560|NCT03410992|526350885|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955561|NCT03410992|526350886|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955562|NCT03410992|526350887|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955563|NCT03410992|526350888|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955564|NCT03410992|526350889|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955565|NCT03410992|526350890|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955566|NCT03410992|526350891|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955567|NCT03410992|526350892|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955568|NCT03410992|526350893|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145955569|NCT03410992|526350883|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
145955570|NCT03410992|526350884|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955571|NCT03410992|526350885|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955572|NCT03410992|526350886|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955573|NCT03410992|526350887|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955574|NCT03410992|526350888|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955575|NCT03410992|526350889|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
146442859|NCT00687739|528125260|FG001|Overall Study|Adverse Event|1|||
146442860|NCT00687739|528125261|FG002|Overall Study|Adverse Event|1|||
146442861|NCT00687739|528125262|FG003|Overall Study|Adverse Event|0|||
146442862|NCT05387408|528125267|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
146442863|NCT03599362|528125271|FG000|Overall Study|Screen Failure|3|||
146442864|NCT01370083|528125273|FG000|Overall Study|Lost to Follow-up|2|||
146442865|NCT01370083|528125274|FG001|Overall Study|Lost to Follow-up|0|||
146442866|NCT01370083|528125273|FG000|Overall Study|Adverse Event|0|||
146442867|NCT01370083|528125274|FG001|Overall Study|Adverse Event|1|||
146442868|NCT02072096|528125276|FG000|Overall Study|Lack of Efficacy|18|||
146442869|NCT02072096|528125277|FG001|Overall Study|Lack of Efficacy|29|||
146442870|NCT02072096|528125276|FG000|Overall Study|Protocol Violation|7|||
146442871|NCT02072096|528125277|FG001|Overall Study|Protocol Violation|7|||
146442872|NCT02072096|528125276|FG000|Overall Study|Withdrawal by Subject|5|||
145955576|NCT03410992|526350890|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955577|NCT03410992|526350891|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955578|NCT03410992|526350892|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955579|NCT03410992|526350893|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145955580|NCT03410992|526350883|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
145955581|NCT03410992|526350884|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
145955582|NCT03410992|526350885|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955583|NCT03410992|526350886|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955584|NCT03410992|526350887|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955585|NCT03410992|526350888|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955586|NCT03410992|526350889|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955587|NCT03410992|526350890|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955588|NCT03410992|526350891|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146209510|NCT02178098|527280391|FG001|Overall Study|Withdrawal by Subject|6|||
145955589|NCT03410992|526350892|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
146083124|NCT00247611|526824760|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
146442873|NCT02072096|528125277|FG001|Overall Study|Withdrawal by Subject|7|||
146442874|NCT02072096|528125276|FG000|Overall Study|Adverse Event|5|||
146442875|NCT02072096|528125277|FG001|Overall Study|Adverse Event|2|||
146442876|NCT02072096|528125276|FG000|Overall Study|No Reason Provided|4|||
146442877|NCT02072096|528125277|FG001|Overall Study|No Reason Provided|2|||
146442878|NCT02072096|528125276|FG000|Overall Study|Death|2|||
146442879|NCT02072096|528125277|FG001|Overall Study|Death|0|||
146442880|NCT02072096|528125276|FG000|Overall Study|Physician Decision|0|||
146442881|NCT02072096|528125277|FG001|Overall Study|Physician Decision|1|||
146442882|NCT02072096|528125276|FG000|Overall Study|Study Terminated by Sponsor|43|||
146442883|NCT02072096|528125277|FG001|Overall Study|Study Terminated by Sponsor|30|||
146442884|NCT02072096|528125276|FG000|Overall Study|Lost to Follow-up|1|||
145955590|NCT03410992|526350893|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145955591|NCT03410992|526350883|FG000|Week 16 Assessment|Incorrect escapers|0|||
145955592|NCT03410992|526350884|FG001|Week 16 Assessment|Incorrect escapers|6|||
145955593|NCT03410992|526350885|FG002|Week 16 Assessment|Incorrect escapers|0|||
145955594|NCT03410992|526350886|FG003|Week 16 Assessment|Incorrect escapers|0|||
145955595|NCT03410992|526350887|FG004|Week 16 Assessment|Incorrect escapers|0|||
146442885|NCT02072096|528125277|FG001|Overall Study|Lost to Follow-up|0|||
146442886|NCT01168856|528125287|FG000|Overall Study|Lost to Follow-up|4|||
146442887|NCT01168856|528125288|FG001|Overall Study|Lost to Follow-up|34|||
146442888|NCT01168856|528125287|FG000|Overall Study|Withdrawal by Subject|6|||
146442889|NCT01168856|528125288|FG001|Overall Study|Withdrawal by Subject|8|||
146442890|NCT01168856|528125287|FG000|Overall Study|Physician Decision|2|||
146442891|NCT01168856|528125288|FG001|Overall Study|Physician Decision|1|||
146442892|NCT01168856|528125287|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
146442893|NCT01168856|528125288|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
146442894|NCT01168856|528125287|FG000|Overall Study|Participant received anti-HCV treatment|1|||
146442895|NCT01168856|528125288|FG001|Overall Study|Participant received anti-HCV treatment|0|||
146442896|NCT01168856|528125287|FG000|Overall Study|Death|0|||
146442897|NCT01168856|528125288|FG001|Overall Study|Death|2|||
146442898|NCT01168856|528125287|FG000|Overall Study|Other|1|||
146442899|NCT01168856|528125288|FG001|Overall Study|Other|291|||
146442900|NCT01168856|528125287|FG000|Overall Study|Protocol Violation|4|||
146442901|NCT01168856|528125288|FG001|Overall Study|Protocol Violation|6|||
146442902|NCT04442503|528125289|FG000|Overall Study|Adverse Event|1|||
146442903|NCT04442503|528125290|FG001|Overall Study|Adverse Event|1|||
146442904|NCT04442503|528125289|FG000|Overall Study|Lost to Follow-up|8|||
146442905|NCT04442503|528125290|FG001|Overall Study|Lost to Follow-up|6|||
146442906|NCT04442503|528125289|FG000|Overall Study|Physician Decision|0|||
146442907|NCT04442503|528125290|FG001|Overall Study|Physician Decision|2|||
146442908|NCT04442503|528125289|FG000|Overall Study|Withdrawal by Subject|3|||
146442909|NCT04442503|528125290|FG001|Overall Study|Withdrawal by Subject|4|||
146442910|NCT04442503|528125289|FG000|Overall Study|Reason not Specified|0|||
146442911|NCT04442503|528125290|FG001|Overall Study|Reason not Specified|1|||
146442912|NCT04442503|528125289|FG000|Overall Study|Randomized but not Treated|3|||
146442913|NCT04442503|528125290|FG001|Overall Study|Randomized but not Treated|1|||
146442914|NCT00387153|528125291|FG000|Overall Study|Adverse Event|1|||
146442915|NCT00387153|528125291|FG000|Overall Study|Disease Progression|3|||
146442916|NCT00387153|528125291|FG000|Overall Study|Lack of Response|4|||
145955596|NCT03410992|526350888|FG005|Week 16 Assessment|Incorrect escapers|0|||
145955597|NCT03410992|526350889|FG006|Week 16 Assessment|Incorrect escapers|0|||
145955598|NCT03410992|526350890|FG007|Week 16 Assessment|Incorrect escapers|0|||
146442917|NCT00301964|528125296|FG000|Overall Study|Second primary|2|||
146442918|NCT00301964|528125296|FG000|Overall Study|Wrong primary|1|||
146442919|NCT00301964|528125296|FG000|Overall Study|Inadequate pathology|1|||
146442920|NCT02385708|528125298|FG000|Overall Study|Withdrawal by Subject|0|||
146442921|NCT02385708|528125299|FG001|Overall Study|Withdrawal by Subject|2|||
146442922|NCT02385708|528125298|FG000|Overall Study|Withdrawn - surgery canceled|2|||
146442923|NCT02385708|528125299|FG001|Overall Study|Withdrawn - surgery canceled|5|||
146442924|NCT02385708|528125298|FG000|Overall Study|Investigator decision|5|||
146442925|NCT02385708|528125299|FG001|Overall Study|Investigator decision|7|||
146442926|NCT02385708|528125298|FG000|Overall Study|Protocol Violation|1|||
146442927|NCT02385708|528125299|FG001|Overall Study|Protocol Violation|1|||
146442928|NCT03504085|528125300|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
146442929|NCT03504085|528125301|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
146442930|NCT03504085|528125300|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
146442931|NCT03504085|528125301|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
146442932|NCT01143337|528125302|FG000|Overall Study|Adverse Event|3|||
146442933|NCT01143337|528125303|FG001|Overall Study|Adverse Event|9|||
146442934|NCT01143337|528125304|FG002|Overall Study|Adverse Event|5|||
146442935|NCT01143337|528125302|FG000|Overall Study|Lack of Efficacy|6|||
146442936|NCT01143337|528125303|FG001|Overall Study|Lack of Efficacy|2|||
146442937|NCT01143337|528125304|FG002|Overall Study|Lack of Efficacy|1|||
146442938|NCT01143337|528125302|FG000|Overall Study|Protocol Violation|1|||
146442939|NCT01143337|528125303|FG001|Overall Study|Protocol Violation|0|||
146442940|NCT01143337|528125304|FG002|Overall Study|Protocol Violation|0|||
146442941|NCT01143337|528125302|FG000|Overall Study|Withdrawal by Subject|0|||
146442942|NCT01143337|528125303|FG001|Overall Study|Withdrawal by Subject|0|||
146442943|NCT01143337|528125304|FG002|Overall Study|Withdrawal by Subject|1|||
146442944|NCT01143337|528125302|FG000|Overall Study|Other reason|0|||
146442945|NCT01143337|528125303|FG001|Overall Study|Other reason|0|||
146442946|NCT01143337|528125304|FG002|Overall Study|Other reason|5|||
146442947|NCT02761915|528125305|FG000|Overall Study|Death|3|||
146442948|NCT02761915|528125306|FG001|Overall Study|Death|1|||
146442949|NCT02761915|528125307|FG002|Overall Study|Death|1|||
146442950|NCT02761915|528125308|FG003|Overall Study|Death|1|||
146442951|NCT02761915|528125309|FG004|Overall Study|Death|0|||
146442952|NCT02761915|528125310|FG005|Overall Study|Death|1|||
146442953|NCT02761915|528125305|FG000|Overall Study|Withdrawal by Subject|1|||
146442954|NCT02761915|528125306|FG001|Overall Study|Withdrawal by Subject|0|||
146442955|NCT02761915|528125307|FG002|Overall Study|Withdrawal by Subject|0|||
146442956|NCT02761915|528125308|FG003|Overall Study|Withdrawal by Subject|0|||
146442957|NCT02761915|528125309|FG004|Overall Study|Withdrawal by Subject|1|||
146442958|NCT02761915|528125310|FG005|Overall Study|Withdrawal by Subject|2|||
146442959|NCT02761915|528125305|FG000|Overall Study|Disease Progression|0|||
146442960|NCT02761915|528125306|FG001|Overall Study|Disease Progression|0|||
146442961|NCT02761915|528125307|FG002|Overall Study|Disease Progression|0|||
146442962|NCT02761915|528125308|FG003|Overall Study|Disease Progression|2|||
146442963|NCT02761915|528125309|FG004|Overall Study|Disease Progression|2|||
146442964|NCT02761915|528125310|FG005|Overall Study|Disease Progression|2|||
146442965|NCT01926119|528125321|FG000|Overall Study|Withdrawal by Subject|1|||
146442966|NCT02654145|528125325|FG000|Overall Study|Lack of Efficacy|1|||
146442967|NCT02654145|528125325|FG000|Overall Study|Protocol Violation|1|||
146442968|NCT02654145|528125325|FG000|Overall Study|Withdrawal by Subject|5|||
146442969|NCT00354835|528125326|FG000|Overall Study|Death|1|||
146442970|NCT00354835|528125327|FG001|Overall Study|Death|1|||
146442971|NCT00354835|528125326|FG000|Overall Study|Physician Decision|8|||
146442972|NCT00354835|528125327|FG001|Overall Study|Physician Decision|13|||
146442973|NCT00354835|528125326|FG000|Overall Study|Withdrawal by Subject|2|||
146442974|NCT00354835|528125327|FG001|Overall Study|Withdrawal by Subject|1|||
146442975|NCT00354835|528125326|FG000|Overall Study|Ineligible|17|||
146442976|NCT00354835|528125327|FG001|Overall Study|Ineligible|16|||
146442977|NCT00354835|528125326|FG000|Overall Study|Disease progression or relapse|15|||
146442978|NCT00354835|528125327|FG001|Overall Study|Disease progression or relapse|22|||
146442979|NCT00354835|528125326|FG000|Overall Study|Adverse Event|6|||
146442980|NCT00354835|528125327|FG001|Overall Study|Adverse Event|0|||
146442981|NCT00354835|528125326|FG000|Overall Study|Refusal of further therapy|3|||
146442982|NCT00354835|528125327|FG001|Overall Study|Refusal of further therapy|8|||
146442983|NCT00645853|528125328|FG000|Overall Study|Adverse Event|18|||
146442984|NCT00645853|528125329|FG001|Overall Study|Adverse Event|7|||
146442985|NCT00645853|528125328|FG000|Overall Study|AZ study closure in Hungary|60|||
146442986|NCT00645853|528125329|FG001|Overall Study|AZ study closure in Hungary|40|||
146442987|NCT00645853|528125328|FG000|Overall Study|Withdrawal by Subject|5|||
146442988|NCT00645853|528125329|FG001|Overall Study|Withdrawal by Subject|2|||
146442989|NCT00645853|528125328|FG000|Overall Study|Protocol Violation|0|||
146442990|NCT00645853|528125329|FG001|Overall Study|Protocol Violation|2|||
146442991|NCT00645853|528125328|FG000|Overall Study|Discontinuation criteria|2|||
146442992|NCT00645853|528125329|FG001|Overall Study|Discontinuation criteria|2|||
146442993|NCT00645853|528125328|FG000|Overall Study|recall of ICF, planned operation, death|7|||
146442994|NCT00645853|528125329|FG001|Overall Study|recall of ICF, planned operation, death|4|||
146442995|NCT02637141|528125332|FG000|Overall Study|Adverse Event|1|||
146442996|NCT02637141|528125333|FG001|Overall Study|Adverse Event|1|||
146442997|NCT02637141|528125334|FG002|Overall Study|Adverse Event|0|||
146442998|NCT02637141|528125332|FG000|Overall Study|Withdrawal by Subject|1|||
146442999|NCT02637141|528125333|FG001|Overall Study|Withdrawal by Subject|1|||
146443000|NCT02637141|528125334|FG002|Overall Study|Withdrawal by Subject|1|||
146443001|NCT01597791|528125335|FG000|Overall Study|Physician Decision|2|||
146443002|NCT01597791|528125336|FG001|Overall Study|Physician Decision|1|||
146443003|NCT01597791|528125335|FG000|Overall Study|Cesarean Section|6|||
146443004|NCT01597791|528125336|FG001|Overall Study|Cesarean Section|7|||
146443005|NCT01597791|528125335|FG000|Overall Study|Subject withdrawal|0|||
146443006|NCT01597791|528125336|FG001|Overall Study|Subject withdrawal|1|||
146443007|NCT01597791|528125335|FG000|Overall Study|Protocol Violation|0|||
146443008|NCT01597791|528125336|FG001|Overall Study|Protocol Violation|1|||
146443009|NCT01728116|528125337|FG000|Overall Study|Sponsor Terminated Study|106|||
146443010|NCT01728116|528125338|FG001|Overall Study|Sponsor Terminated Study|35|||
146443011|NCT01728116|528125337|FG000|Overall Study|Withdrawal by Subject|16|||
146443012|NCT01728116|528125338|FG001|Overall Study|Withdrawal by Subject|9|||
146443013|NCT01728116|528125337|FG000|Overall Study|Adverse Event|13|||
146443014|NCT01728116|528125338|FG001|Overall Study|Adverse Event|0|||
146443015|NCT01728116|528125337|FG000|Overall Study|Procedure/device failure|7|||
146443016|NCT01728116|528125338|FG001|Overall Study|Procedure/device failure|0|||
146443017|NCT01728116|528125337|FG000|Overall Study|Lost to Follow-up|9|||
146443018|NCT01728116|528125338|FG001|Overall Study|Lost to Follow-up|2|||
146443019|NCT01728116|528125337|FG000|Overall Study|Physician Decision|2|||
146443020|NCT01728116|528125338|FG001|Overall Study|Physician Decision|0|||
146443021|NCT01728116|528125337|FG000|Overall Study|Subject Non-Compliance|2|||
146443022|NCT01728116|528125338|FG001|Overall Study|Subject Non-Compliance|0|||
146443023|NCT01728116|528125337|FG000|Overall Study|Inter-current finding at procedure|1|||
146443024|NCT01728116|528125338|FG001|Overall Study|Inter-current finding at procedure|0|||
146443025|NCT01728116|528125337|FG000|Overall Study|Incorrectly enrolled in Study|0|||
146443026|NCT01728116|528125338|FG001|Overall Study|Incorrectly enrolled in Study|1|||
146443027|NCT01728116|528125337|FG000|Overall Study|various not noted previously|5|||
146443028|NCT01728116|528125338|FG001|Overall Study|various not noted previously|0|||
146443029|NCT01868243|528125339|FG000|Overall Study|Death|0|||
146443030|NCT01868243|528125340|FG001|Overall Study|Death|1|||
146443031|NCT00467597|528125341|FG000|Overall Study|Withdrawal by Subject|2|||
146443032|NCT00467597|528125342|FG001|Overall Study|Withdrawal by Subject|0|||
146443033|NCT00379353|528125345|FG000|Overall Study|Hospitalization|3|||
146443034|NCT00379353|528125346|FG001|Overall Study|Hospitalization|3|||
146443035|NCT00379353|528125345|FG000|Overall Study|Withdrawal by Subject|5|||
146443036|NCT00379353|528125346|FG001|Overall Study|Withdrawal by Subject|2|||
146443037|NCT00379353|528125345|FG000|Overall Study|Death|1|||
146443038|NCT00379353|528125346|FG001|Overall Study|Death|0|||
146443039|NCT00379353|528125345|FG000|Overall Study|Cardiac Tamponade|1|||
146443040|NCT00379353|528125346|FG001|Overall Study|Cardiac Tamponade|0|||
146443041|NCT00379353|528125345|FG000|Overall Study|Non-compliance|1|||
146443042|NCT00379353|528125346|FG001|Overall Study|Non-compliance|0|||
146443043|NCT00379353|528125345|FG000|Overall Study|Conflicting drug treatment|0|||
146443044|NCT00379353|528125346|FG001|Overall Study|Conflicting drug treatment|1|||
146443045|NCT05412121|528125349|FG000|Overall Study|Withdrawal by Subject|4|||
146443046|NCT05412121|528125349|FG000|Overall Study|Physician Decision|1|||
146443047|NCT05412121|528125349|FG000|Overall Study|Lost to Follow-up|5|||
146443048|NCT02670551|528125350|FG000|Overall Study|Adverse Event|4|||
146443049|NCT02670551|528125351|FG001|Overall Study|Adverse Event|7|||
146443050|NCT02670551|528125352|FG002|Overall Study|Adverse Event|9|||
146443051|NCT02670551|528125350|FG000|Overall Study|Lack of Efficacy|2|||
146443052|NCT02670551|528125351|FG001|Overall Study|Lack of Efficacy|0|||
146443053|NCT02670551|528125352|FG002|Overall Study|Lack of Efficacy|3|||
146443054|NCT02670551|528125350|FG000|Overall Study|Withdrawal of Consent|6|||
146443055|NCT02670551|528125351|FG001|Overall Study|Withdrawal of Consent|3|||
146443056|NCT02670551|528125352|FG002|Overall Study|Withdrawal of Consent|8|||
146443057|NCT02670551|528125350|FG000|Overall Study|Lost to Follow-up|5|||
146443058|NCT02670551|528125351|FG001|Overall Study|Lost to Follow-up|7|||
146443059|NCT02670551|528125352|FG002|Overall Study|Lost to Follow-up|6|||
146443060|NCT02670551|528125350|FG000|Overall Study|Protocol Violation|1|||
146443061|NCT02670551|528125351|FG001|Overall Study|Protocol Violation|0|||
146443062|NCT02670551|528125352|FG002|Overall Study|Protocol Violation|0|||
146443063|NCT02670551|528125350|FG000|Overall Study|Noncompliance with study drug|3|||
146443064|NCT02670551|528125351|FG001|Overall Study|Noncompliance with study drug|3|||
146443065|NCT02670551|528125352|FG002|Overall Study|Noncompliance with study drug|2|||
146443066|NCT02670551|528125350|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146443067|NCT02670551|528125351|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146443068|NCT02670551|528125352|FG002|Overall Study|Other Miscellaneous Reasons|3|||
146443069|NCT02670551|528125350|FG000|Overall Study|Did Not Receive Treatment|5|||
146443070|NCT02670551|528125351|FG001|Overall Study|Did Not Receive Treatment|3|||
146443071|NCT02670551|528125352|FG002|Overall Study|Did Not Receive Treatment|0|||
146443072|NCT05315713|528125353|FG000|Overall Study|Death|5|||
146443073|NCT05315713|528125353|FG000|Overall Study|Progressive disease|1|||
146443074|NCT05315713|528125353|FG000|Overall Study|Withdrawal by Subject|1|||
146443075|NCT05315713|528125353|FG000|Overall Study|Study terminated by sponsor|1|||
146443076|NCT02535923|528125354|FG000|Overall Study|Lost to Follow-up|5|||
146443077|NCT02535923|528125355|FG001|Overall Study|Lost to Follow-up|5|||
146443078|NCT02535923|528125354|FG000|Overall Study|Withdrawal by Subject|4|||
146443079|NCT02535923|528125355|FG001|Overall Study|Withdrawal by Subject|3|||
146443080|NCT00685334|528125361|FG000|Overall Study|Withdrawal by Subject|5|||
146443081|NCT00685334|528125362|FG001|Overall Study|Withdrawal by Subject|6|||
146443082|NCT00685334|528125361|FG000|Overall Study|Lost to Follow-up|4|||
146443083|NCT00685334|528125362|FG001|Overall Study|Lost to Follow-up|0|||
146443084|NCT00685334|528125361|FG000|Overall Study|Chose to enter hospital|1|||
146443085|NCT00685334|528125362|FG001|Overall Study|Chose to enter hospital|1|||
146443086|NCT03694197|528125363|FG000|Overall Study|Adverse Event|9|||
146443087|NCT03694197|528125363|FG000|Overall Study|Protocol became inconvenient to participate|1|||
146443088|NCT03694197|528125363|FG000|Overall Study|Physician Decision|4|||
146443089|NCT03694197|528125363|FG000|Overall Study|Study terminated by sponsor|1350|||
146443090|NCT03694197|528125363|FG000|Overall Study|Participant moved|5|||
146443091|NCT03694197|528125363|FG000|Overall Study|Participant withdrew consent|10|||
146209511|NCT02178098|527280390|FG000|Overall Study|Adverse Event|1|||
146443092|NCT03694197|528125363|FG000|Overall Study|Related to IMP administration|1|||
146443093|NCT03694197|528125363|FG000|Overall Study|Not disclosed|5|||
146209512|NCT02178098|527280391|FG001|Overall Study|Adverse Event|2|||
146443094|NCT02300987|528126644|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
146443095|NCT02300987|528126645|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
146443096|NCT02300987|528126644|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
146443097|NCT02300987|528126645|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
146443098|NCT02300987|528126644|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
146443099|NCT02300987|528126645|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
146443100|NCT02300987|528126644|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
146443101|NCT02300987|528126645|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
146443102|NCT02300987|528126644|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
146285677|NCT01874431|527561079|FG001|Overall Study|Non-compliance|0|||
146285678|NCT01874431|527561080|FG002|Overall Study|Non-compliance|0|||
146285679|NCT01874431|527561081|FG003|Overall Study|Non-compliance|0|||
146285680|NCT01874431|527561082|FG004|Overall Study|Non-compliance|1|||
146285681|NCT01874431|527561083|FG005|Overall Study|Non-compliance|0|||
146285682|NCT01874431|527561084|FG006|Overall Study|Non-compliance|1|||
146285683|NCT01874431|527561085|FG007|Overall Study|Non-compliance|0|||
146285684|NCT01874431|527561078|FG000|Overall Study|Logistical difficulties|0|||
146285685|NCT01874431|527561079|FG001|Overall Study|Logistical difficulties|0|||
146285686|NCT01874431|527561080|FG002|Overall Study|Logistical difficulties|0|||
146285687|NCT01874431|527561081|FG003|Overall Study|Logistical difficulties|0|||
146285688|NCT01874431|527561082|FG004|Overall Study|Logistical difficulties|0|||
146285689|NCT01874431|527561083|FG005|Overall Study|Logistical difficulties|0|||
146285690|NCT01874431|527561084|FG006|Overall Study|Logistical difficulties|1|||
146285691|NCT01874431|527561085|FG007|Overall Study|Logistical difficulties|0|||
146285692|NCT01874431|527561078|FG000|Overall Study|Withdrawal by Subject|0|||
146285693|NCT01874431|527561079|FG001|Overall Study|Withdrawal by Subject|0|||
146285694|NCT01874431|527561080|FG002|Overall Study|Withdrawal by Subject|1|||
146285695|NCT01874431|527561081|FG003|Overall Study|Withdrawal by Subject|2|||
146285696|NCT01874431|527561082|FG004|Overall Study|Withdrawal by Subject|1|||
146285697|NCT01874431|527561083|FG005|Overall Study|Withdrawal by Subject|1|||
146285698|NCT01874431|527561084|FG006|Overall Study|Withdrawal by Subject|3|||
146285699|NCT01874431|527561085|FG007|Overall Study|Withdrawal by Subject|0|||
146285700|NCT01874431|527561078|FG000|Overall Study|Sponsor decision|0|||
146285701|NCT01874431|527561079|FG001|Overall Study|Sponsor decision|0|||
146285702|NCT01874431|527561080|FG002|Overall Study|Sponsor decision|0|||
146285703|NCT01874431|527561081|FG003|Overall Study|Sponsor decision|0|||
146285704|NCT01874431|527561082|FG004|Overall Study|Sponsor decision|1|||
146285705|NCT01874431|527561083|FG005|Overall Study|Sponsor decision|0|||
146443103|NCT02300987|528126645|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
146443104|NCT03086135|528126646|FG000|Overall Study|Adverse Event|1|||
146443105|NCT03086135|528126646|FG000|Overall Study|Lost to Follow-up|2|||
146285706|NCT01874431|527561084|FG006|Overall Study|Sponsor decision|0|||
146285707|NCT01874431|527561085|FG007|Overall Study|Sponsor decision|0|||
146285708|NCT01874431|527561078|FG000|Overall Study|Lost to Follow-up|0|||
146285709|NCT01874431|527561079|FG001|Overall Study|Lost to Follow-up|0|||
146285710|NCT01874431|527561080|FG002|Overall Study|Lost to Follow-up|1|||
146285711|NCT01874431|527561081|FG003|Overall Study|Lost to Follow-up|0|||
146443106|NCT01023061|528126647|FG000|Overall Study|Withdrawal prior to treatment|2|||
146443107|NCT00820599|528126651|FG000|Overall Study|Death|129|||
146443108|NCT00820599|528126651|FG000|Overall Study|Withdrawal by Subject|2|||
146443109|NCT03686215|528126652|FG000|Overall Study|Adverse Event|0|||
146443110|NCT03686215|528126653|FG001|Overall Study|Adverse Event|0|||
146443111|NCT03686215|528126654|FG002|Overall Study|Adverse Event|7|||
146443112|NCT03686215|528126652|FG000|Overall Study|Physician Decision|0|||
146443113|NCT03686215|528126653|FG001|Overall Study|Physician Decision|0|||
146443114|NCT03686215|528126654|FG002|Overall Study|Physician Decision|1|||
146443115|NCT03686215|528126652|FG000|Overall Study|Protocol Violation|0|||
146443116|NCT03686215|528126653|FG001|Overall Study|Protocol Violation|0|||
146443117|NCT03686215|528126654|FG002|Overall Study|Protocol Violation|4|||
146443118|NCT03686215|528126652|FG000|Overall Study|Device issue|1|||
146443119|NCT03686215|528126653|FG001|Overall Study|Device issue|0|||
146443120|NCT03686215|528126654|FG002|Overall Study|Device issue|2|||
146443121|NCT00522041|528126655|FG000|Overall Study|Adverse Event|9|||
146443122|NCT00522041|528126656|FG001|Overall Study|Adverse Event|3|||
146443123|NCT00522041|528126655|FG000|Overall Study|Protocol Violation|2|||
146443124|NCT00522041|528126656|FG001|Overall Study|Protocol Violation|0|||
146443125|NCT00522041|528126655|FG000|Overall Study|Lost to Follow-up|1|||
146443126|NCT00522041|528126656|FG001|Overall Study|Lost to Follow-up|4|||
146443127|NCT00522041|528126655|FG000|Overall Study|Voluntary withdrawal|5|||
146443128|NCT00522041|528126656|FG001|Overall Study|Voluntary withdrawal|4|||
146443129|NCT00522041|528126655|FG000|Overall Study|Did not receive treatment|0|||
146443130|NCT00522041|528126656|FG001|Overall Study|Did not receive treatment|1|||
146443131|NCT00874549|528126657|FG000|Overall Study|Adverse Event|0|||
146443132|NCT00874549|528126658|FG001|Overall Study|Adverse Event|0|||
146443133|NCT00874549|528126659|FG002|Overall Study|Adverse Event|1|||
146443134|NCT00874549|528126660|FG003|Overall Study|Adverse Event|0|||
146443135|NCT00874549|528126657|FG000|Overall Study|Protocol Violation|1|||
146443136|NCT00874549|528126658|FG001|Overall Study|Protocol Violation|0|||
146443137|NCT00874549|528126659|FG002|Overall Study|Protocol Violation|2|||
146443138|NCT00874549|528126660|FG003|Overall Study|Protocol Violation|1|||
146443139|NCT00874549|528126657|FG000|Overall Study|Lost to Follow-up|0|||
146443140|NCT00874549|528126658|FG001|Overall Study|Lost to Follow-up|0|||
146443141|NCT00874549|528126659|FG002|Overall Study|Lost to Follow-up|1|||
146443142|NCT00874549|528126660|FG003|Overall Study|Lost to Follow-up|0|||
146443143|NCT00874549|528126657|FG000|Overall Study|Withdrawal by Subject|0|||
146443144|NCT00874549|528126658|FG001|Overall Study|Withdrawal by Subject|1|||
146443145|NCT00874549|528126659|FG002|Overall Study|Withdrawal by Subject|0|||
146443146|NCT00874549|528126660|FG003|Overall Study|Withdrawal by Subject|1|||
146443147|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
146443148|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
146443149|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
146443150|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
146443151|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
146443152|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
146443153|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
146443154|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
146443155|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
146443156|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
146443157|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
146443158|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
146443159|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
146443160|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
146443161|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
146443162|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
146443163|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
146443164|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
146443165|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
146443166|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
146443167|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
146443168|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
146443169|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
146443170|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
146443171|NCT01710358|528126661|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
146443172|NCT01710358|528126662|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
146443173|NCT01710358|528126663|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
146443174|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
146443175|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
146443176|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
146443177|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
146443178|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
146443179|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
146443180|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
146443181|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
146443182|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
146443183|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
146443184|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
146443185|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
146209513|NCT02178098|527280390|FG000|Overall Study|Protocol Violation|1|||
146443186|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
146443187|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
146443188|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
146443189|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
146443190|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
146443191|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
146443192|NCT01710358|528126661|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
146443193|NCT01710358|528126662|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
146443194|NCT01710358|528126663|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
146443195|NCT01710358|528126661|FG000|Rescue Period|Adverse Event|0|||
146443196|NCT01710358|528126662|FG001|Rescue Period|Adverse Event|15|||
146443197|NCT01710358|528126663|FG002|Rescue Period|Adverse Event|0|||
146443198|NCT01710358|528126661|FG000|Rescue Period|Death|0|||
146443199|NCT01710358|528126662|FG001|Rescue Period|Death|1|||
146443200|NCT01710358|528126663|FG002|Rescue Period|Death|0|||
146443201|NCT01710358|528126661|FG000|Rescue Period|Lack of Efficacy|0|||
146443202|NCT01710358|528126662|FG001|Rescue Period|Lack of Efficacy|7|||
146443203|NCT01710358|528126663|FG002|Rescue Period|Lack of Efficacy|0|||
146443204|NCT01710358|528126661|FG000|Rescue Period|Withdrawal by Subject|0|||
146443205|NCT01710358|528126662|FG001|Rescue Period|Withdrawal by Subject|8|||
146443206|NCT01710358|528126663|FG002|Rescue Period|Withdrawal by Subject|0|||
146443207|NCT00084864|528126664|FG000|Overall Study|Adverse Event|1|||
146443208|NCT00084864|528126665|FG001|Overall Study|Adverse Event|0|||
146443209|NCT00084864|528126666|FG002|Overall Study|Adverse Event|0|||
146443210|NCT00084864|528126667|FG003|Overall Study|Adverse Event|0|||
146443211|NCT01721772|528126672|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
146443212|NCT01721772|528126673|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
146443213|NCT01721772|528126672|FG000|Pre-Treatment|Poor/non-compliance|0|||
146443214|NCT01721772|528126673|FG001|Pre-Treatment|Poor/non-compliance|1|||
146443215|NCT01721772|528126672|FG000|Pre-Treatment|Participant withdrew consent|0|||
146443216|NCT01721772|528126673|FG001|Pre-Treatment|Participant withdrew consent|1|||
146443217|NCT01721772|528126672|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
146443218|NCT01721772|528126673|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
146443219|NCT01721772|528126672|FG000|Treatment|Disease progression|119|||
146443220|NCT01721772|528126673|FG001|Treatment|Disease progression|168|||
146443221|NCT01721772|528126672|FG000|Treatment|Study drug toxicity|19|||
146443222|NCT01721772|528126673|FG001|Treatment|Study drug toxicity|10|||
146443223|NCT01721772|528126672|FG000|Treatment|Adverse event unrelated to study drug|7|||
146443224|NCT01721772|528126673|FG001|Treatment|Adverse event unrelated to study drug|7|||
146443225|NCT01721772|528126672|FG000|Treatment|Maximum clinical benefit|16|||
146443226|NCT01721772|528126673|FG001|Treatment|Maximum clinical benefit|4|||
146443227|NCT01721772|528126672|FG000|Treatment|Other|19|||
146443228|NCT01721772|528126673|FG001|Treatment|Other|2|||
146443229|NCT01721772|528126672|FG000|Treatment|Participant withdrew consent|2|||
146443230|NCT01721772|528126673|FG001|Treatment|Participant withdrew consent|5|||
146443231|NCT01721772|528126672|FG000|Treatment|Participant request to discontinue study treatment|21|||
146443232|NCT01721772|528126673|FG001|Treatment|Participant request to discontinue study treatment|8|||
146443233|NCT01721772|528126672|FG000|Treatment|Death|1|||
146443234|NCT01721772|528126673|FG001|Treatment|Death|0|||
146443235|NCT01721772|528126672|FG000|Treatment|Not reported|1|||
146443236|NCT01721772|528126673|FG001|Treatment|Not reported|0|||
146443237|NCT01721772|528126672|FG000|Treatment|Poor/non-compliance|1|||
146443238|NCT01721772|528126673|FG001|Treatment|Poor/non-compliance|0|||
146443239|NCT01721772|528126672|FG000|Treatment|Lost to Follow-up|0|||
146443240|NCT01721772|528126673|FG001|Treatment|Lost to Follow-up|1|||
146443241|NCT04542694|528126674|FG000|Overall Study|The need for prohibited therapy|2|||
146443242|NCT04542694|528126675|FG001|Overall Study|The need for prohibited therapy|0|||
146443243|NCT04542694|528126674|FG000|Overall Study|Adverse Event|1|||
146443244|NCT04542694|528126675|FG001|Overall Study|Adverse Event|0|||
146443245|NCT04542694|528126674|FG000|Overall Study|Protocol Violation|1|||
146443246|NCT04542694|528126675|FG001|Overall Study|Protocol Violation|0|||
146443247|NCT00969124|528126676|FG000|Overall Study|Protocol Violation|2|||
146443248|NCT00969124|528126676|FG000|Overall Study|Inadequate bowel preparation|15|||
146443249|NCT00969124|528126676|FG000|Overall Study|Inability to reach cecum|9|||
146443250|NCT00969124|528126676|FG000|Overall Study|Previously unrecognized disease|3|||
146443251|NCT00969124|528126676|FG000|Overall Study|Technical error|1|||
146443252|NCT00874822|528126677|FG000|Overall Study|excluded by criteria|8|||
146443253|NCT02854800|528126678|FG000|Overall Study|Protocol Violation|16|||
146443254|NCT02854800|528126679|FG001|Overall Study|Protocol Violation|11|||
146443255|NCT02854800|528126680|FG002|Overall Study|Protocol Violation|3|||
146443256|NCT02854800|528126678|FG000|Overall Study|Withdrawal by Subject|4|||
146443257|NCT02854800|528126679|FG001|Overall Study|Withdrawal by Subject|2|||
146443258|NCT02854800|528126680|FG002|Overall Study|Withdrawal by Subject|3|||
146443259|NCT05278858|528126682|FG000|Overall Study|Withdrawal by Subject|1|||
146443260|NCT00840658|528126683|FG000|Overall Study|Death|2|||
146443261|NCT00840658|528126684|FG001|Overall Study|Death|2|||
146443262|NCT00840658|528126685|FG002|Overall Study|Death|3|||
146443263|NCT00840658|528126686|FG003|Overall Study|Death|3|||
146443264|NCT00840658|528126683|FG000|Overall Study|Lost to Follow-up|3|||
146443265|NCT00840658|528126684|FG001|Overall Study|Lost to Follow-up|1|||
146443266|NCT00840658|528126685|FG002|Overall Study|Lost to Follow-up|2|||
146443267|NCT00840658|528126686|FG003|Overall Study|Lost to Follow-up|1|||
146443268|NCT01859598|528126688|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
146443269|NCT00573313|528126689|FG000|Overall Study|Protocol Violation|5|||
146443270|NCT00573313|528126690|FG001|Overall Study|Protocol Violation|0|||
146443271|NCT00573313|528126691|FG002|Overall Study|Protocol Violation|6|||
146443272|NCT00573313|528126692|FG003|Overall Study|Protocol Violation|0|||
146443273|NCT00295490|528126695|FG000|Overall Study|Protocol Violation|0|||
146443274|NCT00295490|528126696|FG001|Overall Study|Protocol Violation|0|||
146443275|NCT00295490|528126697|FG002|Overall Study|Protocol Violation|3|||
146443276|NCT00295490|528126698|FG003|Overall Study|Protocol Violation|3|||
146443277|NCT00295490|528126695|FG000|Overall Study|Withdrawal by Subject|0|||
145955599|NCT03410992|526350891|FG008|Week 16 Assessment|Incorrect escapers|0|||
145955600|NCT03410992|526350892|FG009|Week 16 Assessment|Incorrect escapers|0|||
145955601|NCT03410992|526350893|FG010|Week 16 Assessment|Incorrect escapers|0|||
145955602|NCT03410992|526350883|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955603|NCT03410992|526350884|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955604|NCT03410992|526350885|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955605|NCT03410992|526350886|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
145955606|NCT03410992|526350887|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
145955607|NCT03410992|526350888|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955608|NCT03410992|526350889|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955609|NCT03410992|526350890|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955610|NCT03410992|526350891|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955611|NCT03410992|526350892|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955612|NCT03410992|526350893|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145955613|NCT03410992|526350883|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955614|NCT03410992|526350884|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
146285712|NCT01874431|527561082|FG004|Overall Study|Lost to Follow-up|0|||
146443278|NCT00295490|528126696|FG001|Overall Study|Withdrawal by Subject|2|||
146443279|NCT00295490|528126697|FG002|Overall Study|Withdrawal by Subject|0|||
146285713|NCT01874431|527561083|FG005|Overall Study|Lost to Follow-up|0|||
146285714|NCT01874431|527561084|FG006|Overall Study|Lost to Follow-up|0|||
146285715|NCT01874431|527561085|FG007|Overall Study|Lost to Follow-up|0|||
146285716|NCT00523640|527561092|FG000|Overall Study|Death|1|||
146285717|NCT02399254|527561093|FG000|Overall Study|Physician Decision|2|||
146285718|NCT02334423|527561094|FG000|Overall Study|Protocol Violation|10|||
146285719|NCT02334423|527561095|FG001|Overall Study|Protocol Violation|3|||
146285720|NCT02930226|527561096|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
146285721|NCT02930226|527561097|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
146285722|NCT02930226|527561098|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
146285723|NCT02930226|527561099|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
146285724|NCT02930226|527561100|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
146285725|NCT02930226|527561101|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
146285726|NCT00652327|527561102|FG000|Overall Study|Adverse Event|0|||
146285727|NCT00652327|527561103|FG001|Overall Study|Adverse Event|2|||
146285728|NCT00652327|527561102|FG000|Overall Study|Lost to Follow-up|0|||
146285729|NCT00652327|527561103|FG001|Overall Study|Lost to Follow-up|3|||
146285730|NCT01076647|527561104|FG000|Overall Study|Adverse Event|4|||
146285731|NCT01076647|527561105|FG001|Overall Study|Adverse Event|1|||
146285732|NCT01076647|527561104|FG000|Overall Study|Lack of Efficacy|0|||
146443280|NCT00295490|528126698|FG003|Overall Study|Withdrawal by Subject|1|||
146443281|NCT00295490|528126695|FG000|Overall Study|Lost to Follow-up|0|||
146443282|NCT00295490|528126696|FG001|Overall Study|Lost to Follow-up|0|||
146443283|NCT00295490|528126697|FG002|Overall Study|Lost to Follow-up|1|||
145955615|NCT03410992|526350885|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955616|NCT03410992|526350886|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
145955617|NCT03410992|526350887|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
145955618|NCT03410992|526350888|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
145955619|NCT03410992|526350889|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955620|NCT03410992|526350890|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955621|NCT03410992|526350891|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955622|NCT03410992|526350892|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955623|NCT03410992|526350893|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145955624|NCT03410992|526350883|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955625|NCT03410992|526350884|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955626|NCT03410992|526350885|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955627|NCT03410992|526350886|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955628|NCT03410992|526350887|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146443284|NCT00295490|528126698|FG003|Overall Study|Lost to Follow-up|0|||
146285733|NCT01076647|527561105|FG001|Overall Study|Lack of Efficacy|1|||
146285734|NCT01076647|527561104|FG000|Overall Study|Protocol Violation|7|||
146285735|NCT01076647|527561105|FG001|Overall Study|Protocol Violation|9|||
146285736|NCT01076647|527561104|FG000|Overall Study|Withdrawal criteria|2|||
146285737|NCT01076647|527561105|FG001|Overall Study|Withdrawal criteria|2|||
146443285|NCT00295490|528126695|FG000|Overall Study|Adverse Event|1|||
145955629|NCT03410992|526350888|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
146443286|NCT00295490|528126696|FG001|Overall Study|Adverse Event|0|||
146443287|NCT00295490|528126697|FG002|Overall Study|Adverse Event|0|||
146443288|NCT00295490|528126698|FG003|Overall Study|Adverse Event|0|||
146443289|NCT00295490|528126695|FG000|Overall Study|Other|0|||
146443290|NCT00295490|528126696|FG001|Overall Study|Other|2|||
146443291|NCT00295490|528126697|FG002|Overall Study|Other|0|||
146443292|NCT00295490|528126698|FG003|Overall Study|Other|1|||
146443293|NCT03885934|528126699|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
146443294|NCT03885934|528126700|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
146443295|NCT03885934|528126701|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
146443296|NCT03885934|528126702|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
146443297|NCT03885934|528126703|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
146443298|NCT03885934|528126704|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
146443299|NCT03255980|528126705|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
146443300|NCT03255980|528126706|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
146443301|NCT03255980|528126707|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
146443302|NCT03255980|528126708|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
146443303|NCT03255980|528126705|FG000|Overall Study|Adverse Event|1|||
146443304|NCT03255980|528126706|FG001|Overall Study|Adverse Event|1|||
146443305|NCT03255980|528126707|FG002|Overall Study|Adverse Event|0|||
146443306|NCT03255980|528126708|FG003|Overall Study|Adverse Event|1|||
146443307|NCT03255980|528126705|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
146443308|NCT03255980|528126706|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
146443309|NCT03255980|528126707|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
146443310|NCT03255980|528126708|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
146443311|NCT03255980|528126705|FG000|Overall Study|Lost to Follow-up|1|||
146443312|NCT03255980|528126706|FG001|Overall Study|Lost to Follow-up|1|||
146443313|NCT03255980|528126707|FG002|Overall Study|Lost to Follow-up|0|||
146443314|NCT03255980|528126708|FG003|Overall Study|Lost to Follow-up|3|||
145955630|NCT03410992|526350889|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955631|NCT03410992|526350890|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955632|NCT03410992|526350891|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955633|NCT03410992|526350892|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145955634|NCT03410992|526350893|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
146209514|NCT02178098|527280391|FG001|Overall Study|Protocol Violation|1|||
146443315|NCT03255980|528126705|FG000|Overall Study|Withdrawal by Subject|0|||
146443316|NCT03255980|528126706|FG001|Overall Study|Withdrawal by Subject|1|||
146443317|NCT03255980|528126707|FG002|Overall Study|Withdrawal by Subject|0|||
146443318|NCT03255980|528126708|FG003|Overall Study|Withdrawal by Subject|3|||
146443319|NCT04473326|528126709|FG000|Overall Study|Death|0|||
146443320|NCT04473326|528126710|FG001|Overall Study|Death|1|||
146443321|NCT04473326|528126709|FG000|Overall Study|Withdrawal by Subject|1|||
146443322|NCT04473326|528126710|FG001|Overall Study|Withdrawal by Subject|2|||
146209515|NCT02178098|527280390|FG000|Overall Study|Lost to Follow-up|0|||
146443323|NCT01451541|528126713|FG000|Overall Study|Adverse Event|4|||
146443324|NCT01451541|528126714|FG001|Overall Study|Adverse Event|3|||
146443325|NCT01451541|528126715|FG002|Overall Study|Adverse Event|6|||
146443326|NCT01451541|528126713|FG000|Overall Study|Lack of Efficacy|2|||
146443327|NCT01451541|528126714|FG001|Overall Study|Lack of Efficacy|0|||
146443328|NCT01451541|528126715|FG002|Overall Study|Lack of Efficacy|0|||
146443329|NCT01451541|528126713|FG000|Overall Study|Lost to Follow-up|4|||
146443330|NCT01451541|528126714|FG001|Overall Study|Lost to Follow-up|4|||
146443331|NCT01451541|528126715|FG002|Overall Study|Lost to Follow-up|7|||
146443332|NCT01451541|528126713|FG000|Overall Study|Withdrawal by Subject|15|||
146443333|NCT01451541|528126714|FG001|Overall Study|Withdrawal by Subject|8|||
146443334|NCT01451541|528126715|FG002|Overall Study|Withdrawal by Subject|6|||
146443335|NCT01451541|528126713|FG000|Overall Study|randomization error, noncompliance|11|||
146443336|NCT01451541|528126714|FG001|Overall Study|randomization error, noncompliance|10|||
146443337|NCT01451541|528126715|FG002|Overall Study|randomization error, noncompliance|8|||
146443338|NCT04164758|528126716|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
146443339|NCT04164758|528126717|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
146443340|NCT04164758|528126718|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
146443341|NCT04164758|528126716|FG000|Overall Study|Adverse Event|0|||
146443342|NCT04164758|528126717|FG001|Overall Study|Adverse Event|1|||
146443343|NCT04164758|528126718|FG002|Overall Study|Adverse Event|0|||
146443344|NCT03366428|528126723|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
146443345|NCT03366428|528126723|FG000|Overall Study|Adverse Event|12|||
146443346|NCT03366428|528126723|FG000|Overall Study|Clinical progression|2|||
146443347|NCT03366428|528126723|FG000|Overall Study|Withdrawal by Subject|4|||
146443348|NCT02166606|528126724|FG000|Overall Study|Adverse Event|3|||
146443349|NCT02166606|528126724|FG000|Overall Study|Death|31|||
146285738|NCT01076647|527561104|FG000|Overall Study|Unclassified|12|||
146285739|NCT01076647|527561105|FG001|Overall Study|Unclassified|12|||
146285740|NCT02224690|527561113|FG000|Overall Study|Adverse Event|8|||
146285741|NCT02224690|527561114|FG001|Overall Study|Adverse Event|1|||
146285742|NCT02224690|527561113|FG000|Overall Study|Met Withdrawal Criteria|4|||
146285743|NCT02224690|527561114|FG001|Overall Study|Met Withdrawal Criteria|0|||
146285744|NCT02224690|527561113|FG000|Overall Study|Use of G-tube|1|||
146285745|NCT02224690|527561114|FG001|Overall Study|Use of G-tube|0|||
146285746|NCT02224690|527561113|FG000|Overall Study|Did not meet eligibility criteria|1|||
146285747|NCT02224690|527561114|FG001|Overall Study|Did not meet eligibility criteria|0|||
146285748|NCT01577745|527561115|FG000|Overall Study|Withdrawal by Subject|0|||
146285749|NCT01577745|527561116|FG001|Overall Study|Withdrawal by Subject|1|||
146285750|NCT01577745|527561117|FG002|Overall Study|Withdrawal by Subject|0|||
146285751|NCT01577745|527561118|FG003|Overall Study|Withdrawal by Subject|3|||
146285752|NCT01577745|527561119|FG004|Overall Study|Withdrawal by Subject|2|||
146285753|NCT01577745|527561120|FG005|Overall Study|Withdrawal by Subject|0|||
146285754|NCT01577745|527561115|FG000|Overall Study|Death|3|||
146285755|NCT01577745|527561116|FG001|Overall Study|Death|2|||
146285756|NCT01577745|527561117|FG002|Overall Study|Death|2|||
146443350|NCT02166606|528126724|FG000|Overall Study|Protocol Violation|7|||
146443351|NCT02166606|528126724|FG000|Overall Study|Lost to Follow-up|30|||
146443352|NCT02166606|528126724|FG000|Overall Study|Withdrawal by Subject|1|||
146443353|NCT02166606|528126724|FG000|Overall Study|Physician Decision|1|||
146443354|NCT02166606|528126724|FG000|Overall Study|Device upgrade|1|||
146443355|NCT02166606|528126724|FG000|Overall Study|Enrolled after End of Enrollment|4|||
146443356|NCT01958476|528126729|FG000|Overall Study|Parent requested exclusion from analysis|1|||
146443357|NCT01958476|528126730|FG001|Overall Study|Parent requested exclusion from analysis|0|||
146443358|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
146443359|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
146443360|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
146443361|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
146443362|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|Death|3|||
146443363|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|Death|1|||
146285757|NCT01577745|527561118|FG003|Overall Study|Death|1|||
146285758|NCT01577745|527561119|FG004|Overall Study|Death|1|||
146285759|NCT01577745|527561120|FG005|Overall Study|Death|3|||
146285760|NCT01577745|527561115|FG000|Overall Study|Physician Decision|0|||
146285761|NCT01577745|527561116|FG001|Overall Study|Physician Decision|0|||
146285762|NCT01577745|527561117|FG002|Overall Study|Physician Decision|0|||
146443364|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
146443365|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
146443366|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
146443367|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
146443368|NCT00537095|528126732|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
146443369|NCT00537095|528126733|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
146443370|NCT00537095|528126732|FG000|Open-label Period (590 Days)|Adverse Event|2|||
146443371|NCT00537095|528126733|FG001|Open-label Period (590 Days)|Adverse Event|11|||
146443372|NCT00537095|528126732|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
146443373|NCT00537095|528126733|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
146443374|NCT00537095|528126732|FG000|Open-label Period (590 Days)|Death|2|||
146443375|NCT00537095|528126733|FG001|Open-label Period (590 Days)|Death|2|||
146443376|NCT00537095|528126732|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
146443377|NCT00537095|528126733|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
146443378|NCT00537095|528126732|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
146443379|NCT00537095|528126733|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
146443380|NCT00533507|528126734|FG000|Overall Study|Withdrawal by Subject|1|||
146443381|NCT02943096|528126735|FG000|Overall Study|Lack of Efficacy|0|||
146443382|NCT02943096|528126736|FG001|Overall Study|Lack of Efficacy|1|||
146443383|NCT05065619|528126737|FG000|Up to Day 42|Lost to Follow-up|1|||
146443384|NCT05065619|528126738|FG001|Up to Day 42|Lost to Follow-up|0|||
146443385|NCT05065619|528126737|FG000|Up to Day 42|Withdrawal by Subject|1|||
146443386|NCT05065619|528126738|FG001|Up to Day 42|Withdrawal by Subject|0|||
146443387|NCT05065619|528126737|FG000|After Day 43|Lost to Follow-up|1|||
146443388|NCT05065619|528126738|FG001|After Day 43|Lost to Follow-up|0|||
146443389|NCT05065619|528126737|FG000|After Day 43|Physician Decision|3|||
146443390|NCT05065619|528126738|FG001|After Day 43|Physician Decision|0|||
146443391|NCT05065619|528126737|FG000|After Day 43|Withdrawal by Subject|1|||
146443392|NCT05065619|528126738|FG001|After Day 43|Withdrawal by Subject|2|||
146443393|NCT05065619|528126737|FG000|After Day 43|Public vaccination|6|||
146443394|NCT05065619|528126738|FG001|After Day 43|Public vaccination|8|||
146443395|NCT05065619|528126737|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
146443396|NCT05065619|528126738|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
146443397|NCT05065619|528126737|FG000|After Day 43|Study Terminated by Sponsor|88|||
146443398|NCT05065619|528126738|FG001|After Day 43|Study Terminated by Sponsor|16|||
146443399|NCT00714051|528126740|FG000|Overall Study|Withdrawal by Subject|1|||
146443400|NCT00714051|528126741|FG001|Overall Study|Withdrawal by Subject|0|||
146443401|NCT00714051|528126740|FG000|Overall Study|Death|0|||
146443402|NCT00714051|528126741|FG001|Overall Study|Death|1|||
146443403|NCT00570128|528126750|FG000|Overall Study|Adverse Event|1|||
146443404|NCT00570128|528126751|FG001|Overall Study|Adverse Event|0|||
146443405|NCT00570128|528126750|FG000|Overall Study|Lost to Follow-up|1|||
146443406|NCT00570128|528126751|FG001|Overall Study|Lost to Follow-up|0|||
146443407|NCT00570128|528126750|FG000|Overall Study|Withdrawal by Subject|2|||
146443408|NCT00570128|528126751|FG001|Overall Study|Withdrawal by Subject|0|||
146443409|NCT03868631|528126752|FG000|Baseline to Week 6|Adverse Event|0|||
146443410|NCT03868631|528126753|FG001|Baseline to Week 6|Adverse Event|3|||
146443411|NCT03868631|528126752|FG000|Baseline to Week 6|Protocol Violation|1|||
146443412|NCT03868631|528126753|FG001|Baseline to Week 6|Protocol Violation|1|||
146443413|NCT03868631|528126752|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
146443414|NCT03868631|528126753|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
146209516|NCT02178098|527280391|FG001|Overall Study|Lost to Follow-up|1|||
146443415|NCT03868631|528126752|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
146443416|NCT03868631|528126753|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
146443417|NCT03868631|528126752|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
146443418|NCT03868631|528126753|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
146443419|NCT03868631|528126752|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
146443420|NCT03868631|528126753|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
146443421|NCT01929681|528126754|FG000|Overall Study|Withdrawal by Subject|1|||
146443422|NCT01929681|528126755|FG001|Overall Study|Withdrawal by Subject|0|||
146443423|NCT01929681|528126754|FG000|Overall Study|Physician Decision|1|||
146443424|NCT01929681|528126755|FG001|Overall Study|Physician Decision|1|||
146443425|NCT01971554|528126756|FG000|Overall Study|Lost to Follow-up|1|||
146443426|NCT01971554|528126757|FG001|Overall Study|Lost to Follow-up|0|||
146443427|NCT01971554|528126758|FG002|Overall Study|Lost to Follow-up|0|||
146443428|NCT01971554|528126759|FG003|Overall Study|Lost to Follow-up|0|||
146443429|NCT01426854|528126760|FG000|Overall Study|Adverse Event|1|||
146443430|NCT01426854|528126761|FG001|Overall Study|Adverse Event|5|||
146443431|NCT01426854|528126760|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
146443432|NCT01426854|528126761|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
146443433|NCT01426854|528126760|FG000|Overall Study|Lost to Follow-up|3|||
146443434|NCT01426854|528126761|FG001|Overall Study|Lost to Follow-up|0|||
146443435|NCT01426854|528126760|FG000|Overall Study|Noncompliance|0|||
146443436|NCT01426854|528126761|FG001|Overall Study|Noncompliance|1|||
146443437|NCT01426854|528126760|FG000|Overall Study|Treatment Failure|0|||
146443438|NCT01426854|528126761|FG001|Overall Study|Treatment Failure|16|||
146443439|NCT01426854|528126760|FG000|Overall Study|Protocol Deviation|0|||
146443440|NCT01426854|528126761|FG001|Overall Study|Protocol Deviation|1|||
146443441|NCT01426854|528126760|FG000|Overall Study|Other|3|||
146443442|NCT01426854|528126761|FG001|Overall Study|Other|2|||
146443443|NCT03555695|528126762|FG000|Overall Study|Withdrawal by Subject|1|||
146443444|NCT03555695|528126762|FG000|Overall Study|Lost to Follow-up|1|||
146443445|NCT03555695|528126762|FG000|Overall Study|appendicitis (unrelated)|1|||
146443446|NCT03555695|528126762|FG000|Overall Study|pre-existing sciatica|1|||
146443447|NCT01942135|528126766|FG000|Overall Study|Adverse Event|21|||
146443448|NCT01942135|528126767|FG001|Overall Study|Adverse Event|7|||
146443449|NCT01942135|528126766|FG000|Overall Study|Global Deterioration of Health Status|9|||
146443450|NCT01942135|528126767|FG001|Overall Study|Global Deterioration of Health Status|6|||
146443451|NCT01942135|528126766|FG000|Overall Study|Randomized Not Treated|2|||
146443452|NCT01942135|528126767|FG001|Overall Study|Randomized Not Treated|2|||
146443453|NCT01942135|528126766|FG000|Overall Study|Death|2|||
146443454|NCT01942135|528126767|FG001|Overall Study|Death|1|||
146443455|NCT01942135|528126766|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
146443456|NCT01942135|528126767|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
146443457|NCT01942135|528126766|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
146443458|NCT01942135|528126767|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
146443459|NCT01942135|528126766|FG000|Overall Study|Withdrawal by Subject|4|||
146443460|NCT01942135|528126767|FG001|Overall Study|Withdrawal by Subject|3|||
146443461|NCT01942135|528126766|FG000|Overall Study|Protocol Violation|1|||
146443462|NCT01942135|528126767|FG001|Overall Study|Protocol Violation|0|||
146443463|NCT01942135|528126766|FG000|Overall Study|Other|19|||
146443464|NCT01942135|528126767|FG001|Overall Study|Other|4|||
145955635|NCT03410992|526350883|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955636|NCT03410992|526350884|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955637|NCT03410992|526350885|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955638|NCT03410992|526350886|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
146443465|NCT01717040|528126768|FG000|Overall Study|Lost to Follow-up|2|||
146443466|NCT01717040|528126769|FG001|Overall Study|Lost to Follow-up|3|||
146443467|NCT01717040|528126768|FG000|Overall Study|Lack of Efficacy|1|||
146443468|NCT01717040|528126769|FG001|Overall Study|Lack of Efficacy|1|||
146443469|NCT01717040|528126768|FG000|Overall Study|Adverse Event|1|||
146443470|NCT01717040|528126769|FG001|Overall Study|Adverse Event|0|||
146443471|NCT01717040|528126768|FG000|Overall Study|Required Medication Change|0|||
146443472|NCT01717040|528126769|FG001|Overall Study|Required Medication Change|1|||
146443473|NCT01717040|528126768|FG000|Overall Study|New Substance Use Disorder|1|||
146443474|NCT01717040|528126769|FG001|Overall Study|New Substance Use Disorder|0|||
146443475|NCT03196284|528126770|FG000|Main Part|Withdrawal by Subject|0|||
146443476|NCT03196284|528126771|FG001|Main Part|Withdrawal by Subject|1|||
145955639|NCT03410992|526350887|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
145955640|NCT03410992|526350888|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
145955641|NCT03410992|526350889|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
146443477|NCT03196284|528126772|FG002|Main Part|Withdrawal by Subject|0|||
146443478|NCT03196284|528126770|FG000|Extension Part|Lack of Efficacy|0|||
146443479|NCT03196284|528126771|FG001|Extension Part|Lack of Efficacy|0|||
146443480|NCT03196284|528126772|FG002|Extension Part|Lack of Efficacy|1|||
146443481|NCT03196284|528126770|FG000|Extension Part|Withdrawal by Subject|0|||
146443482|NCT03196284|528126771|FG001|Extension Part|Withdrawal by Subject|0|||
146443483|NCT03196284|528126772|FG002|Extension Part|Withdrawal by Subject|1|||
146443484|NCT03196284|528126770|FG000|Extension Part|Physician Decision|0|||
146443485|NCT03196284|528126771|FG001|Extension Part|Physician Decision|0|||
146443486|NCT03196284|528126772|FG002|Extension Part|Physician Decision|1|||
146443487|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
146443488|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
146443489|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
146443490|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
146443491|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
146443492|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
146443493|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
146443494|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
146443495|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
146443496|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
145955642|NCT03410992|526350890|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955643|NCT03410992|526350891|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955644|NCT03410992|526350892|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955645|NCT03410992|526350893|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145955646|NCT03410992|526350883|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955647|NCT03410992|526350884|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955648|NCT03410992|526350885|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955649|NCT03410992|526350886|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955650|NCT03410992|526350887|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955651|NCT03410992|526350888|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955652|NCT03410992|526350889|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955653|NCT03410992|526350890|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
145955654|NCT03410992|526350891|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955655|NCT03410992|526350892|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955656|NCT03410992|526350893|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
145955657|NCT03410992|526350883|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955658|NCT03410992|526350884|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955659|NCT03410992|526350885|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955660|NCT03410992|526350886|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955661|NCT03410992|526350887|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955662|NCT03410992|526350888|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955663|NCT03410992|526350889|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955664|NCT03410992|526350890|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955665|NCT03410992|526350891|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
145955666|NCT03410992|526350892|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955667|NCT03410992|526350893|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145955668|NCT01896193|526350895|FG000|Overall Study|Lack of Efficacy|20|||
145955669|NCT01896193|526350896|FG001|Overall Study|Lack of Efficacy|11|||
145955670|NCT01896193|526350895|FG000|Overall Study|Protocol Violation|0|||
145955671|NCT01896193|526350896|FG001|Overall Study|Protocol Violation|1|||
145955672|NCT01896193|526350895|FG000|Overall Study|Withdrew Consent|1|||
145955673|NCT01896193|526350896|FG001|Overall Study|Withdrew Consent|0|||
145955674|NCT02959918|526350899|FG000|Overall Study|Adverse Event|1|||
145955675|NCT02959918|526350900|FG001|Overall Study|Adverse Event|1|||
145955676|NCT02959918|526350901|FG002|Overall Study|Adverse Event|2|||
145955677|NCT02959918|526350902|FG003|Overall Study|Adverse Event|0|||
145955678|NCT02959918|526350903|FG004|Overall Study|Adverse Event|0|||
145955679|NCT02959918|526350904|FG005|Overall Study|Adverse Event|2|||
145955680|NCT02959918|526350905|FG006|Overall Study|Adverse Event|2|||
145955681|NCT02959918|526350906|FG007|Overall Study|Adverse Event|1|||
146083125|NCT00247611|526824761|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
146443497|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
146443498|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
145955682|NCT02959918|526350907|FG008|Overall Study|Adverse Event|2|||
145955683|NCT02959918|526350908|FG009|Overall Study|Adverse Event|1|||
145955684|NCT02959918|526350909|FG010|Overall Study|Adverse Event|1|||
145955685|NCT02959918|526350910|FG011|Overall Study|Adverse Event|3|||
145955686|NCT02959918|526350911|FG012|Overall Study|Adverse Event|2|||
145955687|NCT02959918|526350912|FG013|Overall Study|Adverse Event|4|||
145955688|NCT02959918|526350899|FG000|Overall Study|Lost to Follow-up|0|||
146443499|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
146443500|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
146443501|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
146443502|NCT01139762|528126773|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
146443503|NCT01139762|528126774|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
146443504|NCT01139762|528126775|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
146443505|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
146443506|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
146443507|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
146443508|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Death|0|||
146443509|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Death|1|||
146443510|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Death|1|||
146443511|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
146443512|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
146443513|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
146443514|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
146443515|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
146443516|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
146443517|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
146443518|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
146443519|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
146443520|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
146443521|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
146443522|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
146443523|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
146443524|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
146443525|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
146443526|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
146443527|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
146443528|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
146443529|NCT01139762|528126773|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
146443530|NCT01139762|528126774|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
146443531|NCT01139762|528126775|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
146443532|NCT01675596|528126776|FG000|Overall Study|Death|6|||
146443533|NCT01675596|528126776|FG000|Overall Study|Exit with other reason|1|||
146443534|NCT01675596|528126776|FG000|Overall Study|Missed Visit|1|||
146443535|NCT00087529|528126778|FG000|Overall Study|Death|1|||
146443536|NCT00087529|528126779|FG001|Overall Study|Death|0|||
146443537|NCT00087529|528126778|FG000|Overall Study|Adverse Event|0|||
146443538|NCT00087529|528126779|FG001|Overall Study|Adverse Event|8|||
146443539|NCT00087529|528126778|FG000|Overall Study|Pregnancy|0|||
146443540|NCT00087529|528126779|FG001|Overall Study|Pregnancy|1|||
146443541|NCT00087529|528126778|FG000|Overall Study|Lost to Follow-up|2|||
146443542|NCT00087529|528126779|FG001|Overall Study|Lost to Follow-up|3|||
146443543|NCT00087529|528126778|FG000|Overall Study|Participant Decision|14|||
146443544|NCT00087529|528126779|FG001|Overall Study|Participant Decision|37|||
146443545|NCT00087529|528126778|FG000|Overall Study|Physician Decision|4|||
145955689|NCT02959918|526350900|FG001|Overall Study|Lost to Follow-up|0|||
146443546|NCT00087529|528126779|FG001|Overall Study|Physician Decision|8|||
145955690|NCT02959918|526350901|FG002|Overall Study|Lost to Follow-up|0|||
146443547|NCT00087529|528126778|FG000|Overall Study|Initiation of Excluded Therapy|0|||
146443548|NCT00087529|528126779|FG001|Overall Study|Initiation of Excluded Therapy|1|||
146443549|NCT00087529|528126778|FG000|Overall Study|Participant Noncompliance|0|||
146443550|NCT00087529|528126779|FG001|Overall Study|Participant Noncompliance|1|||
146443551|NCT00087529|528126778|FG000|Overall Study|Disease Progression|5|||
146443552|NCT00087529|528126779|FG001|Overall Study|Disease Progression|4|||
146443553|NCT00087529|528126778|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
146443554|NCT00087529|528126779|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
146443555|NCT04590781|528128489|FG000|Overall Study|Death|0|||
146443556|NCT04590781|528128490|FG001|Overall Study|Death|2|||
146443557|NCT04590781|528128489|FG000|Overall Study|Withdrawal by Subject|2|||
146443558|NCT04590781|528128490|FG001|Overall Study|Withdrawal by Subject|0|||
146443559|NCT01662024|528128497|FG000|Overall Study|Pregnancy|2|||
146443560|NCT01662024|528128497|FG000|Overall Study|Withdrawal by Subject|3|||
146443561|NCT00927251|528128498|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
146443562|NCT01813435|528128499|FG000|Overall Study|did not finish experimental regimen|1902|||
146443563|NCT01813435|528128500|FG001|Overall Study|did not finish experimental regimen|770|||
146443564|NCT01813435|528128499|FG000|Overall Study|Lost to Follow-up|268|||
146443565|NCT01813435|528128500|FG001|Overall Study|Lost to Follow-up|237|||
146443566|NCT01490190|528128501|FG000|Overall Study|Withdrawal by Subject|9|||
146443567|NCT01490190|528128501|FG000|Overall Study|Adverse Event|17|||
146443568|NCT01490190|528128501|FG000|Overall Study|Protocol Violation|5|||
146443569|NCT01490190|528128501|FG000|Overall Study|Lost to Follow-up|13|||
146443570|NCT01490190|528128501|FG000|Overall Study|Relocation|1|||
146443571|NCT01490190|528128501|FG000|Overall Study|Inconvenience|1|||
146443572|NCT01490190|528128501|FG000|Overall Study|Ring expulsion|2|||
146443573|NCT02435433|528128504|FG000|Overall Study|Withdrawal by Subject|2|||
146443574|NCT02435433|528128505|FG001|Overall Study|Withdrawal by Subject|3|||
146443575|NCT02435433|528128506|FG002|Overall Study|Withdrawal by Subject|1|||
146443576|NCT02435433|528128507|FG003|Overall Study|Withdrawal by Subject|0|||
146443577|NCT02435433|528128508|FG004|Overall Study|Withdrawal by Subject|0|||
146443578|NCT02435433|528128504|FG000|Overall Study|Lost to Follow-up|2|||
146443579|NCT02435433|528128505|FG001|Overall Study|Lost to Follow-up|2|||
146443580|NCT02435433|528128506|FG002|Overall Study|Lost to Follow-up|4|||
146443581|NCT02435433|528128507|FG003|Overall Study|Lost to Follow-up|1|||
146443582|NCT02435433|528128508|FG004|Overall Study|Lost to Follow-up|0|||
146443583|NCT01243151|528128509|FG000|Overall Study|Adverse Event|0|||
146443584|NCT01243151|528128510|FG001|Overall Study|Adverse Event|1|||
146443585|NCT01243151|528128511|FG002|Overall Study|Adverse Event|0|||
146443586|NCT01243151|528128512|FG003|Overall Study|Adverse Event|0|||
146443587|NCT01243151|528128513|FG004|Overall Study|Adverse Event|0|||
146443588|NCT01243151|528128509|FG000|Overall Study|Protocol Violation|0|||
146443589|NCT01243151|528128510|FG001|Overall Study|Protocol Violation|0|||
146443590|NCT01243151|528128511|FG002|Overall Study|Protocol Violation|1|||
146443591|NCT01243151|528128512|FG003|Overall Study|Protocol Violation|0|||
146443592|NCT01243151|528128513|FG004|Overall Study|Protocol Violation|0|||
146443593|NCT01243151|528128509|FG000|Overall Study|Other|0|||
146443594|NCT01243151|528128510|FG001|Overall Study|Other|0|||
146443595|NCT01243151|528128511|FG002|Overall Study|Other|0|||
146443596|NCT01243151|528128512|FG003|Overall Study|Other|1|||
146443597|NCT01243151|528128513|FG004|Overall Study|Other|0|||
146443598|NCT01243151|528128509|FG000|Overall Study|Randomized but not treated|0|||
146443599|NCT01243151|528128510|FG001|Overall Study|Randomized but not treated|0|||
146443600|NCT01243151|528128511|FG002|Overall Study|Randomized but not treated|0|||
146443601|NCT01243151|528128512|FG003|Overall Study|Randomized but not treated|1|||
146443602|NCT01243151|528128513|FG004|Overall Study|Randomized but not treated|0|||
146443603|NCT00210639|528128519|FG000|Overall Study|Lost to Follow-up|37|||
146443604|NCT00210639|528128520|FG001|Overall Study|Lost to Follow-up|29|||
146443605|NCT00210639|528128519|FG000|Overall Study|Withdrawal by Subject|8|||
146443606|NCT00210639|528128520|FG001|Overall Study|Withdrawal by Subject|1|||
146443607|NCT00210639|528128519|FG000|Overall Study|Other|18|||
146443608|NCT00210639|528128520|FG001|Overall Study|Other|12|||
146443609|NCT02786953|528128528|FG000|Overall Study|Withdrawal by Subject|3|||
146443610|NCT02786953|528128529|FG001|Overall Study|Withdrawal by Subject|0|||
146443611|NCT02786953|528128528|FG000|Overall Study|Physician Decision|0|||
146443612|NCT02786953|528128529|FG001|Overall Study|Physician Decision|1|||
146443613|NCT04697173|528128535|FG000|Overall Study|Withdrawal by Subject|34|||
146443614|NCT04697173|528128536|FG001|Overall Study|Withdrawal by Subject|38|||
146443615|NCT05004649|528128537|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
145955691|NCT02959918|526350902|FG003|Overall Study|Lost to Follow-up|0|||
146443616|NCT05004649|528128537|FG000|Overall Study|Lost to Follow-up|1|||
146443617|NCT05004649|528128537|FG000|Overall Study|Withdrawal by Subject|2|||
146443618|NCT05004649|528128537|FG000|Overall Study|COVID-19|1|||
146443619|NCT04133311|528128539|FG000|Period 1 Double Masked Treatment Period|Death|1|||
146443620|NCT04133311|528128540|FG001|Period 1 Double Masked Treatment Period|Death|0|||
145955692|NCT02959918|526350903|FG004|Overall Study|Lost to Follow-up|0|||
145955693|NCT02959918|526350904|FG005|Overall Study|Lost to Follow-up|0|||
145955694|NCT02959918|526350905|FG006|Overall Study|Lost to Follow-up|0|||
145955695|NCT02959918|526350906|FG007|Overall Study|Lost to Follow-up|0|||
145955696|NCT02959918|526350907|FG008|Overall Study|Lost to Follow-up|0|||
145955697|NCT02959918|526350908|FG009|Overall Study|Lost to Follow-up|1|||
145955698|NCT02959918|526350909|FG010|Overall Study|Lost to Follow-up|0|||
145955699|NCT02959918|526350910|FG011|Overall Study|Lost to Follow-up|0|||
145955700|NCT02959918|526350911|FG012|Overall Study|Lost to Follow-up|1|||
145955701|NCT02959918|526350912|FG013|Overall Study|Lost to Follow-up|0|||
145955702|NCT02959918|526350899|FG000|Overall Study|Withdrawal by Subject|0|||
145955703|NCT02959918|526350900|FG001|Overall Study|Withdrawal by Subject|0|||
145955704|NCT02959918|526350901|FG002|Overall Study|Withdrawal by Subject|1|||
145955705|NCT02959918|526350902|FG003|Overall Study|Withdrawal by Subject|2|||
145955706|NCT02959918|526350903|FG004|Overall Study|Withdrawal by Subject|0|||
145955707|NCT02959918|526350904|FG005|Overall Study|Withdrawal by Subject|0|||
145955708|NCT02959918|526350905|FG006|Overall Study|Withdrawal by Subject|1|||
145955709|NCT02959918|526350906|FG007|Overall Study|Withdrawal by Subject|0|||
145955710|NCT02959918|526350907|FG008|Overall Study|Withdrawal by Subject|1|||
145955711|NCT02959918|526350908|FG009|Overall Study|Withdrawal by Subject|1|||
145955712|NCT02959918|526350909|FG010|Overall Study|Withdrawal by Subject|2|||
145955713|NCT02959918|526350910|FG011|Overall Study|Withdrawal by Subject|3|||
145955714|NCT02959918|526350911|FG012|Overall Study|Withdrawal by Subject|1|||
145955715|NCT02959918|526350912|FG013|Overall Study|Withdrawal by Subject|1|||
145955716|NCT02959918|526350899|FG000|Overall Study|Protocol Violation|0|||
145955717|NCT02959918|526350900|FG001|Overall Study|Protocol Violation|0|||
145955718|NCT02959918|526350901|FG002|Overall Study|Protocol Violation|1|||
145955719|NCT02959918|526350902|FG003|Overall Study|Protocol Violation|0|||
145955720|NCT02959918|526350903|FG004|Overall Study|Protocol Violation|0|||
145955721|NCT02959918|526350904|FG005|Overall Study|Protocol Violation|1|||
145955722|NCT02959918|526350905|FG006|Overall Study|Protocol Violation|0|||
145955723|NCT02959918|526350906|FG007|Overall Study|Protocol Violation|0|||
145955724|NCT02959918|526350907|FG008|Overall Study|Protocol Violation|2|||
145955725|NCT02959918|526350908|FG009|Overall Study|Protocol Violation|1|||
145955726|NCT02959918|526350909|FG010|Overall Study|Protocol Violation|0|||
145955727|NCT02959918|526350910|FG011|Overall Study|Protocol Violation|1|||
145955728|NCT02959918|526350911|FG012|Overall Study|Protocol Violation|1|||
145955729|NCT02959918|526350912|FG013|Overall Study|Protocol Violation|0|||
145955730|NCT02959918|526350899|FG000|Overall Study|Stopping Rule Met|1|||
145955731|NCT02959918|526350900|FG001|Overall Study|Stopping Rule Met|0|||
145955732|NCT02959918|526350901|FG002|Overall Study|Stopping Rule Met|3|||
145955733|NCT02959918|526350902|FG003|Overall Study|Stopping Rule Met|4|||
145955734|NCT02959918|526350903|FG004|Overall Study|Stopping Rule Met|5|||
145955735|NCT02959918|526350904|FG005|Overall Study|Stopping Rule Met|3|||
145955736|NCT02959918|526350905|FG006|Overall Study|Stopping Rule Met|2|||
145955737|NCT02959918|526350906|FG007|Overall Study|Stopping Rule Met|4|||
145955738|NCT02959918|526350907|FG008|Overall Study|Stopping Rule Met|1|||
145955739|NCT02959918|526350908|FG009|Overall Study|Stopping Rule Met|1|||
145955740|NCT02959918|526350909|FG010|Overall Study|Stopping Rule Met|3|||
145955741|NCT02959918|526350910|FG011|Overall Study|Stopping Rule Met|5|||
145955742|NCT02959918|526350911|FG012|Overall Study|Stopping Rule Met|2|||
145955743|NCT02959918|526350912|FG013|Overall Study|Stopping Rule Met|1|||
145955744|NCT02959918|526350899|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
145955745|NCT02959918|526350900|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
145955746|NCT02959918|526350901|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
145955747|NCT02959918|526350902|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
145955748|NCT02959918|526350903|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955749|NCT02959918|526350904|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955750|NCT02959918|526350905|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955751|NCT02959918|526350906|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955752|NCT02959918|526350907|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955753|NCT02959918|526350908|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955754|NCT02959918|526350909|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955755|NCT02959918|526350910|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955756|NCT02959918|526350911|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955757|NCT02959918|526350912|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145955758|NCT02959918|526350899|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955759|NCT02959918|526350900|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955760|NCT02959918|526350901|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955761|NCT02959918|526350902|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955762|NCT02959918|526350903|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955763|NCT02959918|526350904|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955764|NCT02959918|526350905|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955765|NCT02959918|526350906|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
146443621|NCT04133311|528128541|FG002|Period 1 Double Masked Treatment Period|Death|0|||
146443622|NCT04133311|528128542|FG003|Period 1 Double Masked Treatment Period|Death|0|||
146443623|NCT04133311|528128539|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
146443624|NCT04133311|528128540|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
146443625|NCT04133311|528128541|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
146443626|NCT04133311|528128542|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
145955766|NCT02959918|526350907|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
146443627|NCT04133311|528128539|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
146443628|NCT04133311|528128540|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
146443629|NCT04133311|528128541|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
146443630|NCT04133311|528128542|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
146443631|NCT04133311|528128539|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
146443632|NCT04133311|528128540|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
146443633|NCT04133311|528128541|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
146443634|NCT04133311|528128542|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
146443635|NCT04133311|528128539|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
146443636|NCT04133311|528128540|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
146443637|NCT04133311|528128541|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
146443638|NCT04133311|528128542|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
146443639|NCT04133311|528128539|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
145955767|NCT02959918|526350908|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955768|NCT02959918|526350909|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955769|NCT02959918|526350910|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955770|NCT02959918|526350911|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955771|NCT02959918|526350912|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145955772|NCT02959918|526350899|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955773|NCT02959918|526350900|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955774|NCT02959918|526350901|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955775|NCT02959918|526350902|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955776|NCT02959918|526350903|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955777|NCT02959918|526350904|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955778|NCT02959918|526350905|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955779|NCT02959918|526350906|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955780|NCT02959918|526350907|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
145955781|NCT02959918|526350908|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955782|NCT02959918|526350909|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955783|NCT02959918|526350910|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955784|NCT02959918|526350911|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955785|NCT02959918|526350912|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145955786|NCT02959918|526350899|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955787|NCT02959918|526350900|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955788|NCT02959918|526350901|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955789|NCT02959918|526350902|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955790|NCT02959918|526350903|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955791|NCT02959918|526350904|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955792|NCT02959918|526350905|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955793|NCT02959918|526350906|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955794|NCT02959918|526350907|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955795|NCT02959918|526350908|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
145955796|NCT02959918|526350909|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
146083126|NCT00247611|526824760|FG000|Baselined|Completed baseline only|9|||
146083127|NCT00247611|526824761|FG001|Baselined|Completed baseline only|8|||
146443640|NCT04133311|528128540|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
146443641|NCT04133311|528128541|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
146443642|NCT04133311|528128542|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
146443643|NCT04133311|528128539|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
146443644|NCT04133311|528128540|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
146443645|NCT04133311|528128541|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
146443646|NCT04133311|528128542|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
146443647|NCT04133311|528128539|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
146443648|NCT04133311|528128540|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
146443649|NCT04133311|528128541|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
146443650|NCT04133311|528128542|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
146443651|NCT00728754|528128545|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
146443652|NCT00728754|528128546|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
146443653|NCT00728754|528128545|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
146443654|NCT00728754|528128546|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
146443655|NCT00728754|528128545|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
146443656|NCT00728754|528128546|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
146443657|NCT01532908|528128556|FG000|Overall Study|Not Transplanted|1|||
146443658|NCT01532908|528128557|FG001|Overall Study|Not Transplanted|0|||
146443659|NCT01993940|528128558|FG000|Overall Study|Adverse Event|16|||
146443660|NCT01993940|528128559|FG001|Overall Study|Adverse Event|11|||
146443661|NCT01993940|528128558|FG000|Overall Study|Withdrawal by Subject|15|||
146443662|NCT01993940|528128559|FG001|Overall Study|Withdrawal by Subject|19|||
146443663|NCT01993940|528128558|FG000|Overall Study|Lost to Follow-up|2|||
146443664|NCT01993940|528128559|FG001|Overall Study|Lost to Follow-up|5|||
146443665|NCT01993940|528128558|FG000|Overall Study|Protocol Violation|5|||
146443666|NCT01993940|528128559|FG001|Overall Study|Protocol Violation|8|||
146443667|NCT01993940|528128558|FG000|Overall Study|Death|1|||
146443668|NCT01993940|528128559|FG001|Overall Study|Death|0|||
146443669|NCT01993940|528128558|FG000|Overall Study|Other - Miscellaneous|1|||
146443670|NCT01993940|528128559|FG001|Overall Study|Other - Miscellaneous|1|||
146443671|NCT01824498|528128560|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
146443672|NCT01824498|528128561|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
146443673|NCT01824498|528128562|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
146443674|NCT01824498|528128563|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
146443675|NCT01824498|528128564|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
146443676|NCT01824498|528128565|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
146443677|NCT01567527|528128566|FG000|Conversion Phase.|Protocol deviation|3|||
146443678|NCT01567527|528128567|FG001|Conversion Phase.|Protocol deviation|0|||
146443679|NCT01567527|528128568|FG002|Conversion Phase.|Protocol deviation|0|||
146443680|NCT01567527|528128569|FG003|Conversion Phase.|Protocol deviation|0|||
146443681|NCT01567527|528128570|FG004|Conversion Phase.|Protocol deviation|0|||
146443682|NCT01567527|528128566|FG000|Conversion Phase.|Met withdrawal criteria|10|||
146443683|NCT01567527|528128567|FG001|Conversion Phase.|Met withdrawal criteria|0|||
146443684|NCT01567527|528128568|FG002|Conversion Phase.|Met withdrawal criteria|0|||
146443685|NCT01567527|528128569|FG003|Conversion Phase.|Met withdrawal criteria|0|||
146443686|NCT01567527|528128570|FG004|Conversion Phase.|Met withdrawal criteria|0|||
146443687|NCT01567527|528128566|FG000|Conversion Phase.|Withdrawal by Subject|32|||
146443688|NCT01567527|528128567|FG001|Conversion Phase.|Withdrawal by Subject|0|||
146443689|NCT01567527|528128568|FG002|Conversion Phase.|Withdrawal by Subject|0|||
146443690|NCT01567527|528128569|FG003|Conversion Phase.|Withdrawal by Subject|0|||
146443691|NCT01567527|528128570|FG004|Conversion Phase.|Withdrawal by Subject|0|||
146443692|NCT01567527|528128566|FG000|Conversion Phase.|Lost to Follow-up|16|||
146443693|NCT01567527|528128567|FG001|Conversion Phase.|Lost to Follow-up|0|||
146443694|NCT01567527|528128568|FG002|Conversion Phase.|Lost to Follow-up|0|||
146443695|NCT01567527|528128569|FG003|Conversion Phase.|Lost to Follow-up|0|||
146443696|NCT01567527|528128570|FG004|Conversion Phase.|Lost to Follow-up|0|||
146443697|NCT01567527|528128566|FG000|Conversion Phase.|Lack of Efficacy|2|||
146443698|NCT01567527|528128567|FG001|Conversion Phase.|Lack of Efficacy|0|||
146443699|NCT01567527|528128568|FG002|Conversion Phase.|Lack of Efficacy|0|||
146443700|NCT01567527|528128569|FG003|Conversion Phase.|Lack of Efficacy|0|||
146443701|NCT01567527|528128570|FG004|Conversion Phase.|Lack of Efficacy|0|||
146443702|NCT01567527|528128566|FG000|Conversion Phase.|Adverse Event|33|||
146443703|NCT01567527|528128567|FG001|Conversion Phase.|Adverse Event|0|||
146443704|NCT01567527|528128568|FG002|Conversion Phase.|Adverse Event|0|||
146443705|NCT01567527|528128569|FG003|Conversion Phase.|Adverse Event|0|||
146443706|NCT01567527|528128570|FG004|Conversion Phase.|Adverse Event|0|||
146443707|NCT01567527|528128566|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
146443708|NCT01567527|528128567|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
146443709|NCT01567527|528128568|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
146443710|NCT01567527|528128569|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
146443711|NCT01567527|528128570|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
146443712|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
146443713|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
146443714|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
146443715|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
146443716|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
146443717|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
146443718|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
146443719|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
146443720|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
146443721|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
146443722|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
146443723|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
146443724|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
146443725|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
146443726|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
146443727|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
146443728|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
146443729|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
146443730|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
146443731|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
146443732|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
146443733|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
146443734|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
146443735|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
146443736|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
146443737|NCT01567527|528128566|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
146443738|NCT01567527|528128567|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
146443739|NCT01567527|528128568|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
146443740|NCT01567527|528128569|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
146443741|NCT01567527|528128570|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
146443742|NCT01567527|528128566|FG000|IM Depot Stabilization.|Protocol deviation|0|||
146443743|NCT01567527|528128567|FG001|IM Depot Stabilization.|Protocol deviation|0|||
146443744|NCT01567527|528128568|FG002|IM Depot Stabilization.|Protocol deviation|5|||
146443745|NCT01567527|528128569|FG003|IM Depot Stabilization.|Protocol deviation|0|||
146443746|NCT01567527|528128570|FG004|IM Depot Stabilization.|Protocol deviation|0|||
146443747|NCT01567527|528128566|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
146443748|NCT01567527|528128567|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
146443749|NCT01567527|528128568|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
146443750|NCT01567527|528128569|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
146443751|NCT01567527|528128570|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
146443752|NCT01567527|528128566|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
146443753|NCT01567527|528128567|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
146443754|NCT01567527|528128568|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
146443755|NCT01567527|528128569|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
146443756|NCT01567527|528128570|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
146443757|NCT01567527|528128566|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
146443758|NCT01567527|528128567|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
146443759|NCT01567527|528128568|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
146443760|NCT01567527|528128569|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
146443761|NCT01567527|528128570|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
146443762|NCT01567527|528128566|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
146443763|NCT01567527|528128567|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
146443764|NCT01567527|528128568|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
146443765|NCT01567527|528128569|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
146443766|NCT01567527|528128570|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
146443767|NCT01567527|528128566|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
146443768|NCT01567527|528128567|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
146443769|NCT01567527|528128568|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
146443770|NCT01567527|528128569|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
146443771|NCT01567527|528128570|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
146443772|NCT01567527|528128566|FG000|IM Depot Stabilization.|Adverse Event|0|||
146443773|NCT01567527|528128567|FG001|IM Depot Stabilization.|Adverse Event|0|||
146443774|NCT01567527|528128568|FG002|IM Depot Stabilization.|Adverse Event|37|||
146443775|NCT01567527|528128569|FG003|IM Depot Stabilization.|Adverse Event|0|||
146443776|NCT01567527|528128570|FG004|IM Depot Stabilization.|Adverse Event|0|||
146443777|NCT01567527|528128566|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
146443778|NCT01567527|528128567|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
146209517|NCT02178098|527280390|FG000|Overall Study|Sponsor Request|1|||
145955797|NCT02959918|526350910|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955798|NCT02959918|526350911|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955799|NCT02959918|526350912|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145955800|NCT00436826|526350914|FG000|Double Blind Period (DBP)|Adverse Event|2|||
145955801|NCT00436826|526350915|FG001|Double Blind Period (DBP)|Adverse Event|0|||
145955802|NCT00436826|526350916|FG002|Double Blind Period (DBP)|Adverse Event|0|||
145955803|NCT00436826|526350917|FG003|Double Blind Period (DBP)|Adverse Event|0|||
145955804|NCT00436826|526350918|FG004|Double Blind Period (DBP)|Adverse Event|0|||
145955805|NCT00436826|526350919|FG005|Double Blind Period (DBP)|Adverse Event|0|||
145955806|NCT00436826|526350914|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
145955807|NCT00436826|526350915|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
145955808|NCT00436826|526350916|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
145955809|NCT00436826|526350917|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
145955810|NCT00436826|526350918|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
145955811|NCT00436826|526350919|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
145955812|NCT00436826|526350914|FG000|Double Blind Period (DBP)|Other|10|||
145955813|NCT00436826|526350915|FG001|Double Blind Period (DBP)|Other|11|||
145955814|NCT00436826|526350916|FG002|Double Blind Period (DBP)|Other|0|||
145955815|NCT00436826|526350917|FG003|Double Blind Period (DBP)|Other|0|||
145955816|NCT00436826|526350918|FG004|Double Blind Period (DBP)|Other|0|||
145955817|NCT00436826|526350919|FG005|Double Blind Period (DBP)|Other|0|||
145955818|NCT00436826|526350914|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145955819|NCT00436826|526350915|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145955820|NCT00436826|526350916|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145955821|NCT00436826|526350917|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
145955822|NCT00436826|526350918|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145955823|NCT00436826|526350919|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145955824|NCT00436826|526350914|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145955825|NCT00436826|526350915|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145955826|NCT00436826|526350916|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
145955827|NCT00436826|526350917|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
145955828|NCT00436826|526350918|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145955829|NCT00436826|526350919|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145955830|NCT00436826|526350914|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145955831|NCT00436826|526350915|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145955832|NCT00436826|526350916|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145955833|NCT00436826|526350917|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145955834|NCT00436826|526350918|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
145955835|NCT00436826|526350919|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
145955836|NCT00110357|526350925|FG000|Overall Study|Deterioration without progression|2|||
145955837|NCT00110357|526350926|FG001|Overall Study|Deterioration without progression|0|||
145955838|NCT00110357|526350925|FG000|Overall Study|Disease progression/relapse|20|||
145955839|NCT00110357|526350926|FG001|Overall Study|Disease progression/relapse|15|||
145955840|NCT00110357|526350925|FG000|Overall Study|Study Closure|1|||
145955841|NCT00110357|526350926|FG001|Overall Study|Study Closure|0|||
145955842|NCT00110357|526350925|FG000|Overall Study|Study Drug Toxicity|1|||
145955843|NCT00110357|526350926|FG001|Overall Study|Study Drug Toxicity|3|||
145955844|NCT00110357|526350925|FG000|Overall Study|Withdrawal by Subject|3|||
145955845|NCT00110357|526350926|FG001|Overall Study|Withdrawal by Subject|1|||
145955846|NCT04004260|526350927|FG000|Overall Study|Withdrawal by Subject|7|||
145955847|NCT04004260|526350928|FG001|Overall Study|Withdrawal by Subject|3|||
145955848|NCT04004260|526350927|FG000|Overall Study|Lost to Follow-up|22|||
145955849|NCT04004260|526350928|FG001|Overall Study|Lost to Follow-up|12|||
145955850|NCT04004260|526350927|FG000|Overall Study|Did not engage in intervention|13|||
145955851|NCT04004260|526350928|FG001|Overall Study|Did not engage in intervention|17|||
145955852|NCT03382418|526350929|FG000|Overall Study|Withdrawal by Subject|1|||
145955853|NCT03382418|526350930|FG001|Overall Study|Withdrawal by Subject|0|||
145955854|NCT03382418|526350931|FG002|Overall Study|Withdrawal by Subject|0|||
145955855|NCT03382418|526350929|FG000|Overall Study|Lost to Follow-up|2|||
145955856|NCT03382418|526350930|FG001|Overall Study|Lost to Follow-up|3|||
145955857|NCT03382418|526350931|FG002|Overall Study|Lost to Follow-up|0|||
145955858|NCT05464420|526350932|FG000|Overall Study|Death|0|||
145955859|NCT05464420|526350933|FG001|Overall Study|Death|0|||
145955860|NCT05464420|526350934|FG002|Overall Study|Death|0|||
145955861|NCT05464420|526350935|FG003|Overall Study|Death|1|||
145955862|NCT05464420|526350932|FG000|Overall Study|Lost to Follow-up|16|||
145955863|NCT05464420|526350933|FG001|Overall Study|Lost to Follow-up|11|||
145955864|NCT05464420|526350934|FG002|Overall Study|Lost to Follow-up|11|||
145955865|NCT05464420|526350935|FG003|Overall Study|Lost to Follow-up|11|||
145955866|NCT05464420|526350932|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
145955867|NCT05464420|526350933|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
146443779|NCT01567527|528128568|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
146443780|NCT01567527|528128569|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
146443781|NCT01567527|528128570|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
145955868|NCT05464420|526350934|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
145955869|NCT05464420|526350935|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
146443782|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
145955870|NCT05464420|526350932|FG000|Overall Study|Withdrawal by Subject|4|||
146443783|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
146443784|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
146443785|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
146443786|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
146443787|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
146443788|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
145955871|NCT05464420|526350933|FG001|Overall Study|Withdrawal by Subject|8|||
145955872|NCT05464420|526350934|FG002|Overall Study|Withdrawal by Subject|3|||
145955873|NCT05464420|526350935|FG003|Overall Study|Withdrawal by Subject|1|||
145955874|NCT05464420|526350932|FG000|Overall Study|Protocol Violation|0|||
145955875|NCT05464420|526350933|FG001|Overall Study|Protocol Violation|0|||
145955876|NCT05464420|526350934|FG002|Overall Study|Protocol Violation|1|||
145955877|NCT05464420|526350935|FG003|Overall Study|Protocol Violation|1|||
145955878|NCT05464420|526350932|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
145955879|NCT05464420|526350933|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
145955880|NCT05464420|526350934|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
145955881|NCT05464420|526350935|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
145955882|NCT02360280|526350936|FG000|Overall Study|Withdrawal by Subject|2|||
145955883|NCT02360280|526350937|FG001|Overall Study|Withdrawal by Subject|0|||
145955884|NCT02360280|526350936|FG000|Overall Study|Adverse Event|0|||
145955885|NCT02360280|526350937|FG001|Overall Study|Adverse Event|1|||
145955886|NCT02360280|526350936|FG000|Overall Study|Lost to Follow-up|1|||
145955887|NCT02360280|526350937|FG001|Overall Study|Lost to Follow-up|0|||
145955888|NCT01383018|526350938|FG000|Overall Study|Adverse Event|14|||
145955889|NCT01383018|526350938|FG000|Overall Study|Death|10|||
145955890|NCT01383018|526350938|FG000|Overall Study|Lost to Follow-up|5|||
145955891|NCT01383018|526350938|FG000|Overall Study|Physician Decision|5|||
146443789|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
146443790|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
146443791|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
146443792|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
146443793|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
146443794|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
146443795|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
146443796|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
146443797|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
146443798|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
146443799|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
146443800|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
146443801|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
146443802|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146443803|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146443804|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146443805|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
146443806|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
146443807|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
146443808|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
145955892|NCT01383018|526350938|FG000|Overall Study|Withdrawal by Subject|9|||
145955893|NCT01383018|526350938|FG000|Overall Study|Subject not implanted|76|||
145955894|NCT01383018|526350938|FG000|Overall Study|Missed Visit|247|||
145955895|NCT01383018|526350938|FG000|Overall Study|Site closed early-not compliance related|7|||
145955896|NCT01383018|526350938|FG000|Overall Study|Patient moved away from site|1|||
145955897|NCT01383018|526350938|FG000|Overall Study|Subject Incarcerated|1|||
145955898|NCT00320788|526350939|FG000|Overall Study|Adverse Event|0|||
145955899|NCT00320788|526350940|FG001|Overall Study|Adverse Event|0|||
145955900|NCT00320788|526350941|FG002|Overall Study|Adverse Event|0|||
145955901|NCT00320788|526350942|FG003|Overall Study|Adverse Event|1|||
145955902|NCT00320788|526350943|FG004|Overall Study|Adverse Event|0|||
145955903|NCT00320788|526350939|FG000|Overall Study|Death|0|||
145955904|NCT00320788|526350940|FG001|Overall Study|Death|0|||
145955905|NCT00320788|526350941|FG002|Overall Study|Death|1|||
145955906|NCT00320788|526350942|FG003|Overall Study|Death|0|||
145955907|NCT00320788|526350943|FG004|Overall Study|Death|1|||
145955908|NCT00320788|526350939|FG000|Overall Study|Lost to Follow-up|0|||
145955909|NCT00320788|526350940|FG001|Overall Study|Lost to Follow-up|2|||
145955910|NCT00320788|526350941|FG002|Overall Study|Lost to Follow-up|1|||
145955911|NCT00320788|526350942|FG003|Overall Study|Lost to Follow-up|0|||
145955912|NCT00320788|526350943|FG004|Overall Study|Lost to Follow-up|0|||
145955913|NCT00320788|526350939|FG000|Overall Study|Decision by the Sponsor|1|||
145955914|NCT00320788|526350940|FG001|Overall Study|Decision by the Sponsor|1|||
145955915|NCT00320788|526350941|FG002|Overall Study|Decision by the Sponsor|0|||
145955916|NCT00320788|526350942|FG003|Overall Study|Decision by the Sponsor|0|||
145955917|NCT00320788|526350943|FG004|Overall Study|Decision by the Sponsor|1|||
146209518|NCT02178098|527280391|FG001|Overall Study|Sponsor Request|0|||
145955918|NCT00320788|526350939|FG000|Overall Study|Other|1|||
145955919|NCT00320788|526350940|FG001|Overall Study|Other|2|||
145955920|NCT00320788|526350941|FG002|Overall Study|Other|1|||
145955921|NCT00320788|526350942|FG003|Overall Study|Other|1|||
145955922|NCT00320788|526350943|FG004|Overall Study|Other|1|||
145955923|NCT00320788|526350939|FG000|Overall Study|Physician Decision|1|||
145955924|NCT00320788|526350940|FG001|Overall Study|Physician Decision|1|||
146443809|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
146443810|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
146443811|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
146443812|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
146443813|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
146443814|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
146443815|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
146443816|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
146443817|NCT01567527|528128566|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146443818|NCT01567527|528128567|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146443819|NCT01567527|528128568|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146443820|NCT01567527|528128569|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
146443821|NCT01567527|528128570|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
146443822|NCT02311894|528128572|FG000|Overall Study|Discontinued in error|1|||
146443823|NCT02311894|528128572|FG000|Overall Study|Lost to Follow-up|1|||
146443824|NCT02311894|528128572|FG000|Overall Study|Adverse Event|1|||
146443825|NCT02311894|528128572|FG000|Overall Study|Withdrawal by Subject|1|||
146443826|NCT01050764|528128575|FG000|Overall Study|Death, before HSCT|1|||
146443827|NCT01050764|528128575|FG000|Overall Study|Donor mobilization failure, death|1|||
146443828|NCT01050764|528128575|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
146443829|NCT01528735|528128585|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
146443830|NCT01528735|528128586|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
146443831|NCT01528735|528128585|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
146443832|NCT01528735|528128586|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
146443833|NCT00556673|528128587|FG000|Overall Study|Protocol deviation|3|||
146443834|NCT00556673|528128588|FG001|Overall Study|Protocol deviation|2|||
146443835|NCT00757172|528128589|FG000|Overall Study|Withdrawal by Subject|4|||
146443836|NCT00757172|528128589|FG000|Overall Study|Physician Decision|3|||
146443837|NCT00757172|528128589|FG000|Overall Study|Progression|4|||
146443838|NCT00494013|528128590|FG000|Overall Study|Adverse Event|0|||
146443839|NCT00494013|528128591|FG001|Overall Study|Adverse Event|1|||
146443840|NCT00494013|528128590|FG000|Overall Study|Entry Criteria Not Met|1|||
146443841|NCT00494013|528128591|FG001|Overall Study|Entry Criteria Not Met|4|||
146443842|NCT00494013|528128590|FG000|Overall Study|Lost to Follow-up|5|||
146443843|NCT00494013|528128591|FG001|Overall Study|Lost to Follow-up|6|||
146443844|NCT00494013|528128590|FG000|Overall Study|Physician Decision|3|||
146443845|NCT00494013|528128591|FG001|Overall Study|Physician Decision|5|||
146443846|NCT00494013|528128590|FG000|Overall Study|Protocol Violation|8|||
146443847|NCT00494013|528128591|FG001|Overall Study|Protocol Violation|5|||
146443848|NCT00494013|528128590|FG000|Overall Study|Withdrawal by Subject|13|||
146443849|NCT00494013|528128591|FG001|Overall Study|Withdrawal by Subject|14|||
146443850|NCT00494013|528128590|FG000|Overall Study|Sponsor Decision|0|||
146443851|NCT00494013|528128591|FG001|Overall Study|Sponsor Decision|1|||
146443852|NCT04194151|528128592|FG000|Overall Study|Physician Decision|1|||
146443853|NCT04194151|528128593|FG001|Overall Study|Physician Decision|1|||
146443854|NCT04194151|528128594|FG002|Overall Study|Physician Decision|1|||
146443855|NCT04194151|528128595|FG003|Overall Study|Physician Decision|1|||
146443856|NCT04194151|528128596|FG004|Overall Study|Physician Decision|0|||
146443857|NCT04194151|528128597|FG005|Overall Study|Physician Decision|1|||
146443858|NCT04194151|528128592|FG000|Overall Study|Monitorization problem|0|||
146443859|NCT04194151|528128593|FG001|Overall Study|Monitorization problem|1|||
146443860|NCT04194151|528128594|FG002|Overall Study|Monitorization problem|0|||
146443861|NCT04194151|528128595|FG003|Overall Study|Monitorization problem|0|||
146443862|NCT04194151|528128596|FG004|Overall Study|Monitorization problem|0|||
145955925|NCT00320788|526350941|FG002|Overall Study|Physician Decision|0|||
145955926|NCT00320788|526350942|FG003|Overall Study|Physician Decision|0|||
146443863|NCT04194151|528128597|FG005|Overall Study|Monitorization problem|0|||
146443864|NCT04203823|528128598|FG000|Overall Study|Withdrawal by Subject|2|||
146443865|NCT04203823|528128599|FG001|Overall Study|Withdrawal by Subject|2|||
146443866|NCT04203823|528128598|FG000|Overall Study|Adverse Event|1|||
146443867|NCT04203823|528128599|FG001|Overall Study|Adverse Event|1|||
146443868|NCT04203823|528128598|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146443869|NCT04203823|528128599|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
146443870|NCT01499043|528128600|FG000|Overall Study|Progressive disease (radiographic)|2|||
146443871|NCT01499043|528128600|FG000|Overall Study|Progressive disease (clinical)|1|||
146443872|NCT01499043|528128600|FG000|Overall Study|Withdrawal by Subject|2|||
146443873|NCT01499043|528128600|FG000|Overall Study|Adverse Event|1|||
146443874|NCT03193021|528128601|FG000|Overall Study|Lost to Follow-up|1|||
146443875|NCT03193021|528128602|FG001|Overall Study|Lost to Follow-up|1|||
146443876|NCT02286466|528128603|FG000|Overall Study|Death|1|||
146443877|NCT02286466|528128604|FG001|Overall Study|Death|3|||
146443878|NCT02286466|528128603|FG000|Overall Study|Withdrawal by Subject|5|||
146443879|NCT02286466|528128604|FG001|Overall Study|Withdrawal by Subject|2|||
146443880|NCT02286466|528128603|FG000|Overall Study|Lost to Follow-up|1|||
146443881|NCT02286466|528128604|FG001|Overall Study|Lost to Follow-up|4|||
146443882|NCT02286466|528128603|FG000|Overall Study|Declined Clinician Assessment|0|||
146443883|NCT02286466|528128604|FG001|Overall Study|Declined Clinician Assessment|1|||
146443884|NCT00835081|528128605|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146443885|NCT00835081|528128606|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146443886|NCT00421304|528128607|FG000|Overall Study|Lost to Follow-up|5|||
146443887|NCT00421304|528128608|FG001|Overall Study|Lost to Follow-up|2|||
146443888|NCT00421304|528128609|FG002|Overall Study|Lost to Follow-up|5|||
146443889|NCT00421304|528128607|FG000|Overall Study|Withdrawal by Subject|2|||
146443890|NCT00421304|528128608|FG001|Overall Study|Withdrawal by Subject|2|||
146443891|NCT00421304|528128609|FG002|Overall Study|Withdrawal by Subject|2|||
146443892|NCT00421304|528128607|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
146443893|NCT00421304|528128608|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
146443894|NCT00421304|528128609|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
146443895|NCT00421304|528128607|FG000|Overall Study|Did not attend Day 360 visit|0|||
146443896|NCT00421304|528128608|FG001|Overall Study|Did not attend Day 360 visit|0|||
146443897|NCT00421304|528128609|FG002|Overall Study|Did not attend Day 360 visit|1|||
146443898|NCT01912807|528128610|FG000|Overall Study|Did not meet elegibility criteria|6|||
146443899|NCT01912807|528128611|FG001|Overall Study|Did not meet elegibility criteria|4|||
146443900|NCT01912807|528128610|FG000|Overall Study|Lost to Follow-up|36|||
146443901|NCT01912807|528128611|FG001|Overall Study|Lost to Follow-up|37|||
146443902|NCT04750239|528128612|FG000|Overall Study|Withdrawal by Subject|2|||
146443903|NCT04750239|528128612|FG000|Overall Study|Trial terminated by sponsor|1|||
146443904|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Adverse Event|8|||
146443905|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Adverse Event|5|||
146443906|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Adverse Event|9|||
146443907|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Adverse Event|0|||
146443908|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Adverse Event|0|||
146443909|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Adverse Event|0|||
146443910|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
146443911|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
146443912|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
146443913|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
146443914|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
146443915|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
146443916|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
146443917|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
146443918|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
146443919|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
146443920|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
146443921|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
146443922|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Physician Decision|4|||
146443923|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Physician Decision|0|||
146443924|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Physician Decision|2|||
146443925|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Physician Decision|0|||
146443926|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Physician Decision|0|||
146443927|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Physician Decision|0|||
146443928|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Pregnancy|1|||
146443929|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Pregnancy|2|||
146443930|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Pregnancy|0|||
145955927|NCT00320788|526350943|FG004|Overall Study|Physician Decision|0|||
146443931|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Pregnancy|0|||
146443932|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Pregnancy|0|||
145955928|NCT00320788|526350939|FG000|Overall Study|Protocol Violation|0|||
145955929|NCT00320788|526350940|FG001|Overall Study|Protocol Violation|0|||
146443933|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Pregnancy|0|||
146443934|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
145955930|NCT00320788|526350941|FG002|Overall Study|Protocol Violation|0|||
146443935|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
146443936|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
146443937|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
146443938|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
146443939|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
146443940|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
146443941|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
146443942|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
146443943|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
146443944|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
146443945|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
146443946|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
146443947|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
146443948|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
146443949|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
146443950|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146443951|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146443952|NCT02614196|528128613|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
146443953|NCT02614196|528128614|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
146443954|NCT02614196|528128615|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
146443955|NCT02614196|528128616|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
146443956|NCT02614196|528128617|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
146443957|NCT02614196|528128618|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
146443958|NCT02614196|528128613|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
146443959|NCT02614196|528128614|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
146443960|NCT02614196|528128615|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
146443961|NCT02614196|528128616|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
146443962|NCT02614196|528128617|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
146443963|NCT02614196|528128618|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
146443964|NCT02614196|528128613|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
146443965|NCT02614196|528128614|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
146443966|NCT02614196|528128615|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
146443967|NCT02614196|528128616|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
146443968|NCT02614196|528128617|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
146443969|NCT02614196|528128618|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
146443970|NCT02614196|528128613|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
146443971|NCT02614196|528128614|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
146443972|NCT02614196|528128615|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
146443973|NCT02614196|528128616|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
146443974|NCT02614196|528128617|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
146443975|NCT02614196|528128618|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
146443976|NCT02614196|528128613|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
146443977|NCT02614196|528128614|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
146443978|NCT02614196|528128615|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
146443979|NCT02614196|528128616|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
146443980|NCT02614196|528128617|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
146443981|NCT02614196|528128618|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
146443982|NCT00919711|528128619|FG000|Overall Study|Withdrawal by Subject|15|||
146443983|NCT00919711|528128620|FG001|Overall Study|Withdrawal by Subject|7|||
146443984|NCT00919711|528128619|FG000|Overall Study|Adverse Event|13|||
146443985|NCT00919711|528128620|FG001|Overall Study|Adverse Event|3|||
146443986|NCT00919711|528128619|FG000|Overall Study|Other|1|||
146443987|NCT00919711|528128620|FG001|Overall Study|Other|2|||
146443988|NCT00919711|528128619|FG000|Overall Study|Administrative Decision|0|||
146443989|NCT00919711|528128620|FG001|Overall Study|Administrative Decision|1|||
146443990|NCT00919711|528128619|FG000|Overall Study|Lost to Follow-up|2|||
146443991|NCT00919711|528128620|FG001|Overall Study|Lost to Follow-up|0|||
146443992|NCT00919711|528128619|FG000|Overall Study|Death|1|||
146443993|NCT00919711|528128620|FG001|Overall Study|Death|0|||
146443994|NCT00919711|528128619|FG000|Overall Study|Noncompliance|1|||
146443995|NCT00919711|528128620|FG001|Overall Study|Noncompliance|0|||
146443996|NCT00903877|528128621|FG000|Overall Study|Did not meet study criteria|33|||
146443997|NCT00903877|528128621|FG000|Overall Study|Withdrawal by Subject|3|||
146443998|NCT00903877|528128621|FG000|Overall Study|Adverse Event|2|||
146443999|NCT00903877|528128621|FG000|Overall Study|Lost to Follow-up|1|||
146444000|NCT00903877|528128621|FG000|Overall Study|Participation put on hold|4|||
146444001|NCT01562613|528128622|FG000|Overall Study|Lost to Follow-up|2|||
146444002|NCT01562613|528128622|FG000|Overall Study|Withdrawal by Subject|2|||
146444003|NCT04388787|528128623|FG000|Blinded Period|Patient could not follow instructions|1|||
146444004|NCT04388787|528128623|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
146444005|NCT00663234|528128624|FG000|Overall Study|Not willing to adhere to requirements|1|||
146444006|NCT01253564|528128627|FG000|Overall Study|Disease Progression|22|||
146444007|NCT01253564|528128627|FG000|Overall Study|Withdrawal by Subject|1|||
146444008|NCT01253564|528128627|FG000|Overall Study|Serious Adverse Event|1|||
146444009|NCT01751087|528128630|FG000|Overall Study|Withdrawal by Subject|1|||
146444010|NCT01751087|528128631|FG001|Overall Study|Withdrawal by Subject|0|||
146444011|NCT01751087|528128632|FG002|Overall Study|Withdrawal by Subject|0|||
146444012|NCT01751087|528128630|FG000|Overall Study|Physician Decision|0|||
146444013|NCT01751087|528128631|FG001|Overall Study|Physician Decision|0|||
146444014|NCT01751087|528128632|FG002|Overall Study|Physician Decision|1|||
146444015|NCT01520987|528130325|FG000|Overall Study|Withdrawal by Subject|1|||
146444016|NCT01520987|528130326|FG001|Overall Study|Withdrawal by Subject|0|||
146444017|NCT01520987|528130327|FG002|Overall Study|Withdrawal by Subject|0|||
146444018|NCT01520987|528130328|FG003|Overall Study|Withdrawal by Subject|0|||
146444019|NCT01520987|528130329|FG004|Overall Study|Withdrawal by Subject|0|||
146285763|NCT01577745|527561118|FG003|Overall Study|Physician Decision|1|||
145955931|NCT00320788|526350942|FG003|Overall Study|Protocol Violation|0|||
145955932|NCT00320788|526350943|FG004|Overall Study|Protocol Violation|1|||
145955933|NCT00320788|526350939|FG000|Overall Study|Withdrawal by Subject|3|||
146444020|NCT01520987|528130330|FG005|Overall Study|Withdrawal by Subject|1|||
146444021|NCT01520987|528130331|FG006|Overall Study|Withdrawal by Subject|0|||
146444022|NCT01520987|528130332|FG007|Overall Study|Withdrawal by Subject|0|||
146444023|NCT02005562|528130333|FG000|Overall Study|Death|2|||
146444024|NCT02005562|528130334|FG001|Overall Study|Death|2|||
146444025|NCT02005562|528130333|FG000|Overall Study|Graft loss|7|||
146444026|NCT02005562|528130334|FG001|Overall Study|Graft loss|6|||
146444027|NCT02005562|528130333|FG000|Overall Study|Withdrawal by Subject|2|||
146444028|NCT02005562|528130334|FG001|Overall Study|Withdrawal by Subject|2|||
146444029|NCT02005562|528130333|FG000|Overall Study|No transplant|1|||
146444030|NCT02005562|528130334|FG001|Overall Study|No transplant|4|||
146444031|NCT02005562|528130333|FG000|Overall Study|Physician Decision|0|||
146444032|NCT02005562|528130334|FG001|Overall Study|Physician Decision|1|||
146444033|NCT04729101|528130335|FG000|Overall Study|Adverse Event|1|||
146444034|NCT04729101|528130336|FG001|Overall Study|Adverse Event|0|||
146444035|NCT04729101|528130335|FG000|Overall Study|Physician Decision|1|||
146444036|NCT04729101|528130336|FG001|Overall Study|Physician Decision|0|||
146444037|NCT04729101|528130335|FG000|Overall Study|Withdrawal by Subject|1|||
146444038|NCT04729101|528130336|FG001|Overall Study|Withdrawal by Subject|0|||
146444039|NCT02940522|528130337|FG000|Overall Study|Lost to Follow-up|1|||
146444040|NCT02940522|528130338|FG001|Overall Study|Lost to Follow-up|2|||
146444041|NCT02940522|528130337|FG000|Overall Study|Withdrawal by Subject|1|||
146444042|NCT02940522|528130338|FG001|Overall Study|Withdrawal by Subject|0|||
146444043|NCT00274625|528130339|FG000|Overall Study|Lost to Follow-up|46|||
146444044|NCT00274625|528130340|FG001|Overall Study|Lost to Follow-up|54|||
146444045|NCT00274625|528130339|FG000|Overall Study|Excluded from analysis|14|||
145955934|NCT00320788|526350940|FG001|Overall Study|Withdrawal by Subject|0|||
145955935|NCT00320788|526350941|FG002|Overall Study|Withdrawal by Subject|0|||
145955936|NCT00320788|526350942|FG003|Overall Study|Withdrawal by Subject|3|||
145955937|NCT00320788|526350943|FG004|Overall Study|Withdrawal by Subject|1|||
145955938|NCT03414229|526350945|FG000|Overall Study|Adverse Event|1|||
145955939|NCT03414229|526350946|FG001|Overall Study|Adverse Event|0|||
145955940|NCT03414229|526350947|FG002|Overall Study|Adverse Event|2|||
145955941|NCT03414229|526350948|FG003|Overall Study|Adverse Event|1|||
145955942|NCT03414229|526350945|FG000|Overall Study|Lack of Efficacy|7|||
145955943|NCT03414229|526350946|FG001|Overall Study|Lack of Efficacy|4|||
145955944|NCT03414229|526350947|FG002|Overall Study|Lack of Efficacy|1|||
145955945|NCT03414229|526350948|FG003|Overall Study|Lack of Efficacy|9|||
145955946|NCT03414229|526350945|FG000|Overall Study|Change in therapy|1|||
145955947|NCT03414229|526350946|FG001|Overall Study|Change in therapy|0|||
145955948|NCT03414229|526350947|FG002|Overall Study|Change in therapy|0|||
145955949|NCT03414229|526350948|FG003|Overall Study|Change in therapy|0|||
145955950|NCT03414229|526350945|FG000|Overall Study|Pregnancy|0|||
145955951|NCT03414229|526350946|FG001|Overall Study|Pregnancy|0|||
145955952|NCT03414229|526350947|FG002|Overall Study|Pregnancy|1|||
145955953|NCT03414229|526350948|FG003|Overall Study|Pregnancy|0|||
145955954|NCT03414229|526350945|FG000|Overall Study|Withdrawal by Subject|0|||
145955955|NCT03414229|526350946|FG001|Overall Study|Withdrawal by Subject|1|||
145955956|NCT03414229|526350947|FG002|Overall Study|Withdrawal by Subject|1|||
145955957|NCT03414229|526350948|FG003|Overall Study|Withdrawal by Subject|0|||
145955958|NCT05568797|526350955|FG000|Overall Study|Adverse Event|0|||
146444046|NCT00274625|528130340|FG001|Overall Study|Excluded from analysis|8|||
145955959|NCT05568797|526350956|FG001|Overall Study|Adverse Event|8|||
145955960|NCT05568797|526350955|FG000|Overall Study|Lost to Follow-up|2|||
146285764|NCT01577745|527561119|FG004|Overall Study|Physician Decision|1|||
146444047|NCT00762411|528130343|FG000|Initial Treatment|Death|7|||
145955961|NCT05568797|526350956|FG001|Overall Study|Lost to Follow-up|3|||
145955962|NCT05568797|526350955|FG000|Overall Study|Withdrawal by Subject|1|||
146444048|NCT00762411|528130344|FG001|Initial Treatment|Death|6|||
145955963|NCT05568797|526350956|FG001|Overall Study|Withdrawal by Subject|10|||
146444049|NCT00762411|528130343|FG000|Initial Treatment|Adverse Event|132|||
145955964|NCT05568797|526350955|FG000|Overall Study|Other|2|||
145955965|NCT05568797|526350956|FG001|Overall Study|Other|2|||
145955966|NCT00099632|526350959|FG000|Overall Study|Lost to Follow-up|1|||
146209519|NCT02178098|527280390|FG000|Overall Study|Other|2|||
146444050|NCT00762411|528130344|FG001|Initial Treatment|Adverse Event|40|||
146444051|NCT00762411|528130343|FG000|Initial Treatment|Protocol Violation|4|||
146444052|NCT00762411|528130344|FG001|Initial Treatment|Protocol Violation|1|||
146444053|NCT00762411|528130343|FG000|Initial Treatment|Withdrawal by Subject|65|||
146444054|NCT00762411|528130344|FG001|Initial Treatment|Withdrawal by Subject|52|||
146444055|NCT00762411|528130343|FG000|Initial Treatment|Physician Decision|1|||
146444056|NCT00762411|528130344|FG001|Initial Treatment|Physician Decision|0|||
146444057|NCT00762411|528130343|FG000|Initial Treatment|Sponsor Decision|293|||
146444058|NCT00762411|528130344|FG001|Initial Treatment|Sponsor Decision|401|||
146444059|NCT00762411|528130343|FG000|Initial Treatment|Lost to Follow-up|5|||
146444060|NCT00762411|528130344|FG001|Initial Treatment|Lost to Follow-up|0|||
146444061|NCT00762411|528130343|FG000|Initial Treatment|Caregiver Decision|21|||
146444062|NCT00762411|528130344|FG001|Initial Treatment|Caregiver Decision|16|||
146444063|NCT00762411|528130343|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
146444064|NCT00762411|528130344|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
146444065|NCT00762411|528130343|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
146444066|NCT00762411|528130344|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
146444067|NCT00762411|528130343|FG000|Delayed Start|Adverse Event|0|||
146444068|NCT00762411|528130344|FG001|Delayed Start|Adverse Event|4|||
146444069|NCT00762411|528130343|FG000|Delayed Start|Protocol Violation|0|||
146444070|NCT00762411|528130344|FG001|Delayed Start|Protocol Violation|1|||
146444071|NCT00762411|528130343|FG000|Delayed Start|Sponsor Decision|16|||
146444072|NCT00762411|528130344|FG001|Delayed Start|Sponsor Decision|20|||
146444073|NCT00762411|528130343|FG000|Delayed Start|Caregiver Decision|1|||
146444074|NCT00762411|528130344|FG001|Delayed Start|Caregiver Decision|1|||
146444075|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
146444076|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
146444077|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
146444078|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
146444079|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
146444080|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
146444081|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
146444082|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
146444083|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
146444084|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
146444085|NCT00762411|528130343|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
146444086|NCT00762411|528130344|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
146444087|NCT02710214|528130348|FG000|Overall Study|Lost to Follow-up|1|||
146444088|NCT02710214|528130349|FG001|Overall Study|Lost to Follow-up|0|||
146444089|NCT02710214|528130348|FG000|Overall Study|Lack of Efficacy|0|||
146444090|NCT02710214|528130349|FG001|Overall Study|Lack of Efficacy|1|||
146444091|NCT02710214|528130348|FG000|Overall Study|Death|0|||
146444092|NCT02710214|528130349|FG001|Overall Study|Death|1|||
146444093|NCT02832167|528130350|FG000|Treatment Period 1|Disease progression|90|||
146444094|NCT02832167|528130350|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
146444095|NCT02832167|528130350|FG000|Treatment Period 1|Death|2|||
146444096|NCT02832167|528130350|FG000|Treatment Period 1|Study Drug Toxicity|6|||
146444097|NCT02832167|528130350|FG000|Treatment Period 1|Participant request to discontinue|9|||
146444098|NCT02832167|528130350|FG000|Treatment Period 1|No longer meet study criteria|1|||
146444099|NCT02832167|528130350|FG000|Treatment Period 1|Participant withdrew consent|3|||
146444100|NCT02832167|528130350|FG000|Treatment Period 1|Other reasons|6|||
146444101|NCT02832167|528130350|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
146444102|NCT02832167|528130350|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
146444103|NCT02832167|528130350|FG000|Transition From Period 1 to Period 2|Death|2|||
146444104|NCT02832167|528130350|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
146444105|NCT02832167|528130350|FG000|Treatment Period 2|Disease progression|69|||
146444106|NCT02832167|528130350|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
145955967|NCT00099632|526350960|FG001|Overall Study|Lost to Follow-up|0|||
146444107|NCT02832167|528130350|FG000|Treatment Period 2|Maximum clinical benefit|1|||
146444108|NCT02832167|528130350|FG000|Treatment Period 2|Study Drug Toxicity|5|||
146444109|NCT02832167|528130350|FG000|Treatment Period 2|Participant request to discontinue|2|||
146444110|NCT02832167|528130350|FG000|Treatment Period 2|Participant withdrew consent|3|||
145955968|NCT00099632|526350961|FG002|Overall Study|Lost to Follow-up|3|||
145955969|NCT00099632|526350962|FG003|Overall Study|Lost to Follow-up|1|||
145955970|NCT00099632|526350963|FG004|Overall Study|Lost to Follow-up|1|||
146444111|NCT02832167|528130350|FG000|Treatment Period 2|Other reasons|3|||
146444112|NCT01754376|528130351|FG000|Overall Study|Adverse Event|1|||
146444113|NCT01754376|528130351|FG000|Overall Study|Lack of Efficacy|2|||
146444114|NCT04556734|528130352|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
146444115|NCT04556734|528130353|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146444116|NCT04556734|528130354|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146444117|NCT04556734|528130355|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146444118|NCT04556734|528130356|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146444119|NCT04556734|528130357|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146444120|NCT04556734|528130358|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146444121|NCT04556734|528130359|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146444122|NCT04556734|528130352|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
146444123|NCT04556734|528130353|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146209520|NCT02178098|527280391|FG001|Overall Study|Other|2|||
146209521|NCT03101371|527280400|FG000|Overall Study|Physician Decision|0|||
146444124|NCT04556734|528130354|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146209522|NCT03101371|527280401|FG001|Overall Study|Physician Decision|1|||
146444125|NCT04556734|528130355|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146444126|NCT04556734|528130356|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146444127|NCT04556734|528130357|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146444128|NCT04556734|528130358|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146444129|NCT04556734|528130359|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146444130|NCT04556734|528130352|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146444131|NCT04556734|528130353|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444132|NCT04556734|528130354|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146444133|NCT04556734|528130355|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444134|NCT04556734|528130356|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444135|NCT04556734|528130357|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444136|NCT04556734|528130358|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444137|NCT04556734|528130359|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146444138|NCT04556734|528130352|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
146444139|NCT04556734|528130353|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444140|NCT04556734|528130354|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444141|NCT04556734|528130355|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444142|NCT04556734|528130356|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444143|NCT04556734|528130357|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444144|NCT04556734|528130358|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444145|NCT04556734|528130359|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146444146|NCT04556734|528130352|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444147|NCT04556734|528130353|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444148|NCT04556734|528130354|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
146444149|NCT04556734|528130355|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444150|NCT04556734|528130356|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444151|NCT04556734|528130357|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444152|NCT04556734|528130358|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444153|NCT04556734|528130359|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
146444154|NCT04556734|528130352|FG000|OLE Period (28 Weeks)|Not reported|0|||
146444155|NCT04556734|528130353|FG001|OLE Period (28 Weeks)|Not reported|0|||
146444156|NCT04556734|528130354|FG002|OLE Period (28 Weeks)|Not reported|0|||
146444157|NCT04556734|528130355|FG003|OLE Period (28 Weeks)|Not reported|0|||
146444158|NCT04556734|528130356|FG004|OLE Period (28 Weeks)|Not reported|0|||
146444159|NCT04556734|528130357|FG005|OLE Period (28 Weeks)|Not reported|1|||
146444160|NCT04556734|528130358|FG006|OLE Period (28 Weeks)|Not reported|0|||
146444161|NCT04556734|528130359|FG007|OLE Period (28 Weeks)|Not reported|0|||
146444162|NCT04556734|528130352|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444163|NCT04556734|528130353|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444164|NCT04556734|528130354|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444165|NCT04556734|528130355|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444166|NCT04556734|528130356|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444167|NCT04556734|528130357|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444168|NCT04556734|528130358|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
146444169|NCT04556734|528130359|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
146444170|NCT04556734|528130352|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
146444171|NCT04556734|528130353|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
146444172|NCT04556734|528130354|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
146444173|NCT04556734|528130355|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
146444174|NCT04556734|528130356|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
146444175|NCT04556734|528130357|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
146444176|NCT04556734|528130358|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
146444177|NCT04556734|528130359|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
146444178|NCT04556734|528130352|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146444179|NCT04556734|528130353|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146444180|NCT04556734|528130354|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146444181|NCT04556734|528130355|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
146444182|NCT04556734|528130356|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
146444183|NCT04556734|528130357|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
146444184|NCT04556734|528130358|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
146444185|NCT04556734|528130359|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
146444186|NCT04264819|528130365|FG000|Overall Study|Physician Decision|19|||
146444187|NCT04264819|528130365|FG000|Overall Study|Adverse Event|12|||
146444188|NCT04264819|528130365|FG000|Overall Study|Withdrawal by Subject|11|||
146444189|NCT04264819|528130365|FG000|Overall Study|Lost to Follow-up|2|||
146444190|NCT04264819|528130365|FG000|Overall Study|Death|2|||
146444191|NCT01680016|528130366|FG000|Overall Study|Adverse Event|0|||
146444192|NCT01680016|528130367|FG001|Overall Study|Adverse Event|0|||
146444193|NCT01680016|528130368|FG002|Overall Study|Adverse Event|1|||
146444194|NCT01680016|528130369|FG003|Overall Study|Adverse Event|4|||
146444195|NCT01680016|528130366|FG000|Overall Study|The Subject went out of The Trial|1|||
146444196|NCT01680016|528130367|FG001|Overall Study|The Subject went out of The Trial|0|||
146083128|NCT05395091|526824762|FG000|Baseline to Month 12|Adverse Event|7|||
146083129|NCT05395091|526824763|FG001|Baseline to Month 12|Adverse Event|2|||
146444197|NCT01680016|528130368|FG002|Overall Study|The Subject went out of The Trial|3|||
146444198|NCT01680016|528130369|FG003|Overall Study|The Subject went out of The Trial|0|||
146444199|NCT01680016|528130366|FG000|Overall Study|Protocol Violation|0|||
146444200|NCT01680016|528130367|FG001|Overall Study|Protocol Violation|1|||
146444201|NCT01680016|528130368|FG002|Overall Study|Protocol Violation|0|||
146444202|NCT01680016|528130369|FG003|Overall Study|Protocol Violation|0|||
146444203|NCT01680016|528130366|FG000|Overall Study|Withdrawal by Subject|5|||
146444204|NCT01680016|528130367|FG001|Overall Study|Withdrawal by Subject|7|||
146444205|NCT01680016|528130368|FG002|Overall Study|Withdrawal by Subject|1|||
146444206|NCT01680016|528130369|FG003|Overall Study|Withdrawal by Subject|1|||
146444207|NCT02846883|528130375|FG000|Overall Study|Death|0|||
146444208|NCT02846883|528130376|FG001|Overall Study|Death|1|||
146444209|NCT02846883|528130377|FG002|Overall Study|Death|1|||
146444210|NCT02846883|528130375|FG000|Overall Study|Lost to Follow-up|0|||
146444211|NCT02846883|528130376|FG001|Overall Study|Lost to Follow-up|0|||
146444212|NCT02846883|528130377|FG002|Overall Study|Lost to Follow-up|1|||
146444213|NCT02846883|528130375|FG000|Overall Study|Withdrawal by Subject|1|||
146444214|NCT02846883|528130376|FG001|Overall Study|Withdrawal by Subject|0|||
146444215|NCT02846883|528130377|FG002|Overall Study|Withdrawal by Subject|0|||
146444216|NCT02846883|528130375|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
146444217|NCT02846883|528130376|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
146444218|NCT02846883|528130377|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
146444219|NCT02846883|528130375|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
146444220|NCT02846883|528130376|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
146444221|NCT02846883|528130377|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
146444222|NCT04768296|528130381|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
146444223|NCT04768296|528130382|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
146444224|NCT02655224|528130389|FG000|Overall Study|Adverse Event|1|||
146444225|NCT02655224|528130390|FG001|Overall Study|Adverse Event|1|||
146444226|NCT01119625|528130391|FG000|Overall Study|Lost to Follow-up|1|||
146444227|NCT01119625|528130392|FG001|Overall Study|Lost to Follow-up|2|||
146444228|NCT01119625|528130391|FG000|Overall Study|Withdrawal by Subject|2|||
146444229|NCT01119625|528130392|FG001|Overall Study|Withdrawal by Subject|1|||
146444230|NCT01119625|528130391|FG000|Overall Study|Other|0|||
146444231|NCT01119625|528130392|FG001|Overall Study|Other|1|||
146444232|NCT00397254|528130395|FG000|Overall Study|Lost to Follow-up|2|||
146444233|NCT00397254|528130396|FG001|Overall Study|Lost to Follow-up|2|||
146444234|NCT02627963|528130397|FG000|Overall Study|Randomized but not treated|2|||
146444235|NCT02627963|528130398|FG001|Overall Study|Randomized but not treated|6|||
146444236|NCT03073798|528130402|FG000|Overall Study|Adverse Event|1|||
146444237|NCT03073798|528130402|FG000|Overall Study|Withdrawal by Subject|1|||
146444238|NCT02372006|528130407|FG000|Overall Study|Progressive disease|8|||
146444239|NCT02372006|528130408|FG001|Overall Study|Progressive disease|7|||
146444240|NCT02372006|528130409|FG002|Overall Study|Progressive disease|34|||
146444241|NCT02372006|528130407|FG000|Overall Study|Dose limiting toxicity|0|||
146444242|NCT02372006|528130408|FG001|Overall Study|Dose limiting toxicity|1|||
146444243|NCT02372006|528130409|FG002|Overall Study|Dose limiting toxicity|0|||
146444244|NCT02372006|528130407|FG000|Overall Study|Adverse Event|0|||
146444245|NCT02372006|528130408|FG001|Overall Study|Adverse Event|0|||
146444246|NCT02372006|528130409|FG002|Overall Study|Adverse Event|3|||
146444247|NCT02372006|528130407|FG000|Overall Study|Withdrawal by Subject|0|||
146444248|NCT02372006|528130408|FG001|Overall Study|Withdrawal by Subject|1|||
146444249|NCT02372006|528130409|FG002|Overall Study|Withdrawal by Subject|1|||
146444250|NCT02372006|528130407|FG000|Overall Study|Other reason for not completing|0|||
146444251|NCT02372006|528130408|FG001|Overall Study|Other reason for not completing|0|||
146444252|NCT02372006|528130409|FG002|Overall Study|Other reason for not completing|1|||
146444253|NCT02611362|528130414|FG000|Overall Study|Withdrawal by Subject|7|||
146444254|NCT02611362|528130415|FG001|Overall Study|Withdrawal by Subject|2|||
146444255|NCT02611362|528130414|FG000|Overall Study|Lost to Follow-up|2|||
146444256|NCT02611362|528130415|FG001|Overall Study|Lost to Follow-up|4|||
146444257|NCT00354159|528130416|FG000|Randomized Study Period|Withdrawal by Subject|5|||
146444258|NCT00354159|528130417|FG001|Randomized Study Period|Withdrawal by Subject|3|||
146444259|NCT00354159|528130416|FG000|Randomized Study Period|Physician Decision|6|||
146444260|NCT00354159|528130417|FG001|Randomized Study Period|Physician Decision|10|||
146444261|NCT00354159|528130416|FG000|Randomized Study Period|Lost to Follow-up|4|||
146444262|NCT00354159|528130417|FG001|Randomized Study Period|Lost to Follow-up|0|||
146444263|NCT00354159|528130416|FG000|Randomized Study Period|Death|7|||
146444264|NCT00354159|528130417|FG001|Randomized Study Period|Death|9|||
146444265|NCT00354159|528130416|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
146444266|NCT00354159|528130417|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
146444267|NCT00354159|528130416|FG000|Long-term Follow-up|Physician Decision|127|||
146444268|NCT00354159|528130417|FG001|Long-term Follow-up|Physician Decision|122|||
146444269|NCT00354159|528130416|FG000|Long-term Follow-up|Lost to Follow-up|1|||
146444270|NCT00354159|528130417|FG001|Long-term Follow-up|Lost to Follow-up|0|||
146444271|NCT00354159|528130416|FG000|Long-term Follow-up|Death|14|||
146444272|NCT00354159|528130417|FG001|Long-term Follow-up|Death|11|||
146444273|NCT00354159|528130416|FG000|Long-term Follow-up|Study Closed|29|||
146444274|NCT00354159|528130417|FG001|Long-term Follow-up|Study Closed|34|||
146444275|NCT02229084|528130419|FG000|Overall Study|Adverse Event|1|||
146444276|NCT02229084|528130420|FG001|Overall Study|Adverse Event|0|||
146444277|NCT02229084|528130421|FG002|Overall Study|Adverse Event|0|||
146444278|NCT02229084|528130422|FG003|Overall Study|Adverse Event|0|||
146444279|NCT02229084|528130423|FG004|Overall Study|Adverse Event|0|||
146444280|NCT02229084|528130424|FG005|Overall Study|Adverse Event|0|||
146444281|NCT02229084|528130425|FG006|Overall Study|Adverse Event|0|||
146444282|NCT02229084|528130419|FG000|Overall Study|Lost to Follow-up|0|||
146444283|NCT02229084|528130420|FG001|Overall Study|Lost to Follow-up|0|||
146444284|NCT02229084|528130421|FG002|Overall Study|Lost to Follow-up|1|||
146444285|NCT02229084|528130422|FG003|Overall Study|Lost to Follow-up|1|||
146444286|NCT02229084|528130423|FG004|Overall Study|Lost to Follow-up|0|||
146444287|NCT02229084|528130424|FG005|Overall Study|Lost to Follow-up|0|||
146444288|NCT02229084|528130425|FG006|Overall Study|Lost to Follow-up|1|||
146444289|NCT02229084|528130419|FG000|Overall Study|Physician Decision|0|||
146444290|NCT02229084|528130420|FG001|Overall Study|Physician Decision|0|||
146444291|NCT02229084|528130421|FG002|Overall Study|Physician Decision|0|||
146444292|NCT02229084|528130422|FG003|Overall Study|Physician Decision|1|||
146444293|NCT02229084|528130423|FG004|Overall Study|Physician Decision|3|||
146444294|NCT02229084|528130424|FG005|Overall Study|Physician Decision|0|||
146444295|NCT02229084|528130425|FG006|Overall Study|Physician Decision|1|||
146444296|NCT02229084|528130419|FG000|Overall Study|Withdrawal by Subject|0|||
146444297|NCT02229084|528130420|FG001|Overall Study|Withdrawal by Subject|0|||
146444298|NCT02229084|528130421|FG002|Overall Study|Withdrawal by Subject|1|||
146444299|NCT02229084|528130422|FG003|Overall Study|Withdrawal by Subject|0|||
146444300|NCT02229084|528130423|FG004|Overall Study|Withdrawal by Subject|1|||
146444301|NCT02229084|528130424|FG005|Overall Study|Withdrawal by Subject|1|||
146444302|NCT02229084|528130425|FG006|Overall Study|Withdrawal by Subject|1|||
146444303|NCT02229084|528130419|FG000|Overall Study|Death|0|||
146444304|NCT02229084|528130420|FG001|Overall Study|Death|0|||
146444305|NCT02229084|528130421|FG002|Overall Study|Death|0|||
146444306|NCT02229084|528130422|FG003|Overall Study|Death|0|||
146285765|NCT01577745|527561120|FG005|Overall Study|Physician Decision|0|||
146285766|NCT01577745|527561115|FG000|Overall Study|Lost to Follow-up|0|||
145955971|NCT00099632|526350964|FG005|Overall Study|Lost to Follow-up|0|||
145955972|NCT00099632|526350959|FG000|Overall Study|Withdrawal by Subject|0|||
145955973|NCT00099632|526350960|FG001|Overall Study|Withdrawal by Subject|1|||
145955974|NCT00099632|526350961|FG002|Overall Study|Withdrawal by Subject|0|||
146444307|NCT02229084|528130423|FG004|Overall Study|Death|0|||
146444308|NCT02229084|528130424|FG005|Overall Study|Death|0|||
146444309|NCT02229084|528130425|FG006|Overall Study|Death|1|||
146444310|NCT01559116|528130435|FG000|Overall Study|Adverse Event|10|||
145955975|NCT00099632|526350962|FG003|Overall Study|Withdrawal by Subject|0|||
145955976|NCT00099632|526350963|FG004|Overall Study|Withdrawal by Subject|0|||
146285767|NCT01577745|527561116|FG001|Overall Study|Lost to Follow-up|0|||
146444311|NCT01559116|528130435|FG000|Overall Study|Lack of Efficacy|1|||
146444312|NCT01559116|528130435|FG000|Overall Study|Lost to Follow-up|1|||
146444313|NCT01559116|528130435|FG000|Overall Study|Protocol Violation|1|||
146444314|NCT01559116|528130435|FG000|Overall Study|Withdrawal by Subject|4|||
146444315|NCT01559116|528130435|FG000|Overall Study|other than stated above|9|||
146444316|NCT04610580|528130436|FG000|Two-way Crossover Period|Adverse Event|1|||
146444317|NCT04610580|528130437|FG001|Two-way Crossover Period|Adverse Event|0|||
146444318|NCT04610580|528130438|FG002|Two-way Crossover Period|Adverse Event|0|||
146444319|NCT04610580|528130439|FG003|Two-way Crossover Period|Adverse Event|0|||
146444320|NCT04610580|528130440|FG004|Two-way Crossover Period|Adverse Event|0|||
146444321|NCT04610580|528130441|FG005|Two-way Crossover Period|Adverse Event|0|||
146444322|NCT04610580|528130436|FG000|Two-way Crossover Period|Physician Decision|1|||
146444323|NCT04610580|528130437|FG001|Two-way Crossover Period|Physician Decision|0|||
146444324|NCT04610580|528130438|FG002|Two-way Crossover Period|Physician Decision|0|||
146444325|NCT04610580|528130439|FG003|Two-way Crossover Period|Physician Decision|0|||
146444326|NCT04610580|528130440|FG004|Two-way Crossover Period|Physician Decision|0|||
146444327|NCT04610580|528130441|FG005|Two-way Crossover Period|Physician Decision|0|||
146444328|NCT04610580|528130436|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
146444329|NCT04610580|528130437|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
146444330|NCT04610580|528130438|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
146444331|NCT04610580|528130439|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
146444332|NCT04610580|528130440|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
146444333|NCT04610580|528130441|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
146444334|NCT04610580|528130436|FG000|Two-way Crossover Period|Other than specified|0|||
146444335|NCT04610580|528130437|FG001|Two-way Crossover Period|Other than specified|1|||
146444336|NCT04610580|528130438|FG002|Two-way Crossover Period|Other than specified|0|||
146444337|NCT04610580|528130439|FG003|Two-way Crossover Period|Other than specified|0|||
146444338|NCT04610580|528130440|FG004|Two-way Crossover Period|Other than specified|0|||
146444339|NCT04610580|528130441|FG005|Two-way Crossover Period|Other than specified|0|||
146444340|NCT04610580|528130436|FG000|Washout Before Extension Period|Other than specified|0|||
146444341|NCT04610580|528130437|FG001|Washout Before Extension Period|Other than specified|1|||
146444342|NCT04610580|528130438|FG002|Washout Before Extension Period|Other than specified|0|||
146444343|NCT04610580|528130439|FG003|Washout Before Extension Period|Other than specified|0|||
146444344|NCT04610580|528130440|FG004|Washout Before Extension Period|Other than specified|0|||
146444345|NCT04610580|528130441|FG005|Washout Before Extension Period|Other than specified|0|||
146444346|NCT04610580|528130436|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
146444347|NCT04610580|528130437|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
146444348|NCT04610580|528130438|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
146444349|NCT04610580|528130439|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
146444350|NCT04610580|528130440|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
146444351|NCT04610580|528130441|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
146444352|NCT04610580|528130436|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
146444353|NCT04610580|528130437|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
146444354|NCT04610580|528130438|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
146444355|NCT04610580|528130439|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
146444356|NCT04610580|528130440|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
146444357|NCT04610580|528130441|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
146444358|NCT02179190|528130442|FG000|Enrollment|Exit Prior to Device Attempt|11|||
146444359|NCT02179190|528130442|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
146444360|NCT02179190|528130442|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
146444361|NCT02179190|528130442|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
146444362|NCT02179190|528130442|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
146444363|NCT02179190|528130442|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
146444364|NCT03480022|528130445|FG000|Overall Study|Pregnancy|2|||
146444365|NCT03480022|528130446|FG001|Overall Study|Pregnancy|0|||
146444366|NCT03480022|528130445|FG000|Overall Study|Adverse Event|6|||
146444367|NCT03480022|528130446|FG001|Overall Study|Adverse Event|0|||
146444368|NCT03480022|528130445|FG000|Overall Study|Lack of Efficacy|0|||
146444369|NCT03480022|528130446|FG001|Overall Study|Lack of Efficacy|2|||
146444370|NCT03480022|528130445|FG000|Overall Study|Physician Decision|0|||
146444371|NCT03480022|528130446|FG001|Overall Study|Physician Decision|1|||
146444372|NCT03480022|528130445|FG000|Overall Study|Withdrawal by Subject|2|||
146444373|NCT03480022|528130446|FG001|Overall Study|Withdrawal by Subject|0|||
146444374|NCT03480022|528130445|FG000|Overall Study|Medication concerns|1|||
146444375|NCT03480022|528130446|FG001|Overall Study|Medication concerns|0|||
145955977|NCT00099632|526350964|FG005|Overall Study|Withdrawal by Subject|1|||
145955978|NCT00099632|526350959|FG000|Overall Study|Protocol Violation|0|||
145955979|NCT00099632|526350960|FG001|Overall Study|Protocol Violation|0|||
145955980|NCT00099632|526350961|FG002|Overall Study|Protocol Violation|0|||
145955981|NCT00099632|526350962|FG003|Overall Study|Protocol Violation|0|||
145955982|NCT00099632|526350963|FG004|Overall Study|Protocol Violation|0|||
146444376|NCT03480022|528130445|FG000|Overall Study|Family member COVID exposure|0|||
146444377|NCT03480022|528130446|FG001|Overall Study|Family member COVID exposure|1|||
145955983|NCT00099632|526350964|FG005|Overall Study|Protocol Violation|1|||
145955984|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
145955985|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
145955986|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
146444378|NCT00881569|528130447|FG000|Overall Study|Disease progression|1|||
146444379|NCT00881569|528130448|FG001|Overall Study|Disease progression|1|||
146444380|NCT01670097|528130453|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
146444381|NCT01670097|528130454|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
146444382|NCT01670097|528130453|FG000|Overall Study|Study burden|1|||
146444383|NCT01670097|528130454|FG001|Overall Study|Study burden|0|||
146444384|NCT01670097|528130453|FG000|Overall Study|COPD exacerbation|0|||
146444385|NCT01670097|528130454|FG001|Overall Study|COPD exacerbation|1|||
146444386|NCT01670097|528130453|FG000|Overall Study|Neutropenia|0|||
146444387|NCT01670097|528130454|FG001|Overall Study|Neutropenia|1|||
146444388|NCT01670097|528130453|FG000|Overall Study|Clinical deterioration|0|||
146444389|NCT01670097|528130454|FG001|Overall Study|Clinical deterioration|1|||
146444390|NCT01670097|528130453|FG000|Overall Study|Disease progression|0|||
146444391|NCT01670097|528130454|FG001|Overall Study|Disease progression|1|||
146444392|NCT03259165|528130455|FG000|Overall Study|COVID 19 pandemic|1|||
146444393|NCT03259165|528130456|FG001|Overall Study|COVID 19 pandemic|1|||
146444394|NCT01949532|528130457|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
146444395|NCT01949532|528130458|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
146444396|NCT05665387|528130459|FG000|Overall Study|Withdrawal by Subject|1|||
146444397|NCT05665387|528130460|FG001|Overall Study|Withdrawal by Subject|0|||
146444398|NCT05665387|528130461|FG002|Overall Study|Withdrawal by Subject|1|||
146444399|NCT00884390|528130462|FG000|Overall Study|Adverse Event|0|||
146444400|NCT00884390|528130463|FG001|Overall Study|Adverse Event|1|||
146444401|NCT00884390|528130462|FG000|Overall Study|Lost to Follow-up|0|||
146444402|NCT00884390|528130463|FG001|Overall Study|Lost to Follow-up|1|||
146444403|NCT00884390|528130462|FG000|Overall Study|Physician Decision|2|||
146444404|NCT00884390|528130463|FG001|Overall Study|Physician Decision|1|||
146444405|NCT00884390|528130462|FG000|Overall Study|Protocol Violation|4|||
146444406|NCT00884390|528130463|FG001|Overall Study|Protocol Violation|1|||
146444407|NCT00884390|528130462|FG000|Overall Study|Withdrawal by Subject|4|||
146444408|NCT00884390|528130463|FG001|Overall Study|Withdrawal by Subject|1|||
146444409|NCT00884390|528130462|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
146444410|NCT00884390|528130463|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
146444411|NCT00884390|528130462|FG000|Overall Study|Other|11|||
146444412|NCT00884390|528130463|FG001|Overall Study|Other|1|||
146444413|NCT03980522|528130467|FG000|Treatment Period|Adverse Event|1|||
146444414|NCT03980522|528130468|FG001|Treatment Period|Adverse Event|0|||
146444415|NCT03980522|528130469|FG002|Treatment Period|Adverse Event|0|||
146444416|NCT03980522|528130470|FG003|Treatment Period|Adverse Event|0|||
146444417|NCT03980522|528130471|FG004|Treatment Period|Adverse Event|0|||
146444418|NCT01874535|528130472|FG000|Overall Study|Lost to Follow-up|10|||
146444419|NCT01874535|528130473|FG001|Overall Study|Lost to Follow-up|9|||
146444420|NCT01874535|528130472|FG000|Overall Study|incomplete symptom resolution|45|||
146444421|NCT01874535|528130473|FG001|Overall Study|incomplete symptom resolution|35|||
146444422|NCT01215721|528130474|FG000|Overall Study|Adverse Event|2|||
146444423|NCT00045162|528130475|FG000|Overall Study|Ineligible|12|||
146444424|NCT00045162|528130476|FG001|Overall Study|Ineligible|8|||
146444425|NCT00045162|528130475|FG000|Overall Study|Not treated|7|||
146444426|NCT00045162|528130476|FG001|Overall Study|Not treated|2|||
146444427|NCT00045162|528130475|FG000|Overall Study|Adverse Event|55|||
146444428|NCT00045162|528130476|FG001|Overall Study|Adverse Event|50|||
146444429|NCT00045162|528130475|FG000|Overall Study|Lack of Efficacy|32|||
146444430|NCT00045162|528130476|FG001|Overall Study|Lack of Efficacy|29|||
146444431|NCT00045162|528130475|FG000|Overall Study|Death|10|||
146444432|NCT00045162|528130476|FG001|Overall Study|Death|10|||
146444433|NCT00045162|528130475|FG000|Overall Study|Withdrawal by Subject|5|||
146444434|NCT00045162|528130476|FG001|Overall Study|Withdrawal by Subject|3|||
146444435|NCT00045162|528130475|FG000|Overall Study|Other|21|||
146444436|NCT00045162|528130476|FG001|Overall Study|Other|16|||
146444437|NCT01044433|528130477|FG000|Overall Study|Lost to Follow-up|3|||
146444438|NCT01044433|528130477|FG000|Overall Study|Withdrawal by Subject|3|||
146444439|NCT02616380|528130478|FG000|Overall Study|Lost to Follow-up|1|||
146444440|NCT02616380|528130478|FG000|Overall Study|Other|2|||
146444441|NCT00939523|528130483|FG000|Overall Study|Lack of Efficacy|1|||
146444442|NCT00939523|528130483|FG000|Overall Study|Physician Decision|2|||
146444443|NCT00024258|528130484|FG000|Overall Study|Withdrawal by Subject|1|||
146444444|NCT00024258|528130484|FG000|Overall Study|Disease Progression|8|||
146444445|NCT00442351|528131812|FG000|Overall Study|Administrative|6|||
146444446|NCT00442351|528131813|FG001|Overall Study|Administrative|5|||
146444447|NCT00442351|528131812|FG000|Overall Study|Did not meet protocol eligibility|1|||
146444448|NCT00442351|528131813|FG001|Overall Study|Did not meet protocol eligibility|0|||
146444449|NCT00442351|528131812|FG000|Overall Study|Other|0|||
146444450|NCT00442351|528131813|FG001|Overall Study|Other|1|||
146444451|NCT00108628|528131820|FG000|Overall Study|Withdrawal by Subject|17|||
146444452|NCT00108628|528131821|FG001|Overall Study|Withdrawal by Subject|9|||
146444453|NCT00108628|528131820|FG000|Overall Study|Lack of Efficacy|2|||
146444454|NCT00108628|528131821|FG001|Overall Study|Lack of Efficacy|1|||
146444455|NCT00108628|528131820|FG000|Overall Study|Death|1|||
146444456|NCT00108628|528131821|FG001|Overall Study|Death|0|||
146444457|NCT01453153|528131822|FG000|Overall Study|Physician Decision|0|||
146444458|NCT01453153|528131823|FG001|Overall Study|Physician Decision|0|||
146444459|NCT01453153|528131824|FG002|Overall Study|Physician Decision|1|||
146444460|NCT01453153|528131822|FG000|Overall Study|Progressive Disease|3|||
146444461|NCT01453153|528131823|FG001|Overall Study|Progressive Disease|2|||
146444462|NCT01453153|528131824|FG002|Overall Study|Progressive Disease|16|||
146444463|NCT01453153|528131822|FG000|Overall Study|Withdrawal by Subject|0|||
146444464|NCT01453153|528131823|FG001|Overall Study|Withdrawal by Subject|1|||
146444465|NCT01453153|528131824|FG002|Overall Study|Withdrawal by Subject|2|||
146444466|NCT01453153|528131822|FG000|Overall Study|Adverse Event|1|||
146444467|NCT01453153|528131823|FG001|Overall Study|Adverse Event|1|||
146444468|NCT01453153|528131824|FG002|Overall Study|Adverse Event|1|||
146444469|NCT03547635|528131825|FG000|Overall Study|Adverse Event|5|||
146444470|NCT03547635|528131826|FG001|Overall Study|Adverse Event|2|||
146444471|NCT03547635|528131827|FG002|Overall Study|Adverse Event|3|||
146444472|NCT03547635|528131825|FG000|Overall Study|Lost to Follow-up|1|||
146444473|NCT03547635|528131826|FG001|Overall Study|Lost to Follow-up|3|||
146444474|NCT03547635|528131827|FG002|Overall Study|Lost to Follow-up|4|||
146444475|NCT03547635|528131825|FG000|Overall Study|Withdrawal by Subject|1|||
146444476|NCT03547635|528131826|FG001|Overall Study|Withdrawal by Subject|0|||
146444477|NCT03547635|528131827|FG002|Overall Study|Withdrawal by Subject|0|||
146444478|NCT03547635|528131825|FG000|Overall Study|Withdrawal By PI|0|||
146444479|NCT03547635|528131826|FG001|Overall Study|Withdrawal By PI|1|||
146444480|NCT03547635|528131827|FG002|Overall Study|Withdrawal By PI|0|||
146444481|NCT03547635|528131825|FG000|Overall Study|Withdrawal by Sponsor|0|||
146444482|NCT03547635|528131826|FG001|Overall Study|Withdrawal by Sponsor|0|||
146444483|NCT03547635|528131827|FG002|Overall Study|Withdrawal by Sponsor|1|||
146444484|NCT03547635|528131825|FG000|Overall Study|Errant Randomization before Treatment|0|||
146444485|NCT03547635|528131826|FG001|Overall Study|Errant Randomization before Treatment|1|||
146444486|NCT03547635|528131827|FG002|Overall Study|Errant Randomization before Treatment|0|||
146444487|NCT03547635|528131825|FG000|Overall Study|Withdrawal by Subject|1|||
146444488|NCT03547635|528131826|FG001|Overall Study|Withdrawal by Subject|0|||
146444489|NCT03547635|528131827|FG002|Overall Study|Withdrawal by Subject|0|||
146444490|NCT02415387|528131832|FG000|Overall Study|Withdrawal by Subject|6|||
146444491|NCT02415387|528131833|FG001|Overall Study|Withdrawal by Subject|1|||
146444492|NCT02415387|528131832|FG000|Overall Study|blood draw problem|0|||
146444493|NCT02415387|528131833|FG001|Overall Study|blood draw problem|1|||
146444494|NCT02415387|528131832|FG000|Overall Study|Protocol Violation|1|||
146444495|NCT02415387|528131833|FG001|Overall Study|Protocol Violation|0|||
146444496|NCT03035890|528131834|FG000|Overall Study|Death|1|||
146444497|NCT03243396|528131835|FG000|Overall Study|Lost to Follow-up|2|||
146444498|NCT03243396|528131836|FG001|Overall Study|Lost to Follow-up|3|||
146444499|NCT03243396|528131837|FG002|Overall Study|Lost to Follow-up|15|||
146444500|NCT03243396|528131838|FG003|Overall Study|Lost to Follow-up|8|||
146444501|NCT03243396|528131839|FG004|Overall Study|Lost to Follow-up|1|||
146444502|NCT03243396|528131840|FG005|Overall Study|Lost to Follow-up|4|||
146444503|NCT03243396|528131841|FG006|Overall Study|Lost to Follow-up|9|||
146444504|NCT00452348|528131844|FG000|Overall Study|Adverse Event|6|||
146444505|NCT00452348|528131845|FG001|Overall Study|Adverse Event|9|||
146444506|NCT00452348|528131844|FG000|Overall Study|Lack of Efficacy|10|||
146444507|NCT00452348|528131845|FG001|Overall Study|Lack of Efficacy|9|||
146444508|NCT00452348|528131844|FG000|Overall Study|Lost to Follow-up|14|||
146444509|NCT00452348|528131845|FG001|Overall Study|Lost to Follow-up|8|||
146444510|NCT00452348|528131844|FG000|Overall Study|Protocol Violation|22|||
146444511|NCT00452348|528131845|FG001|Overall Study|Protocol Violation|28|||
146444512|NCT00452348|528131844|FG000|Overall Study|Withdrawal by Subject|18|||
146444513|NCT00452348|528131845|FG001|Overall Study|Withdrawal by Subject|21|||
146444514|NCT00452348|528131844|FG000|Overall Study|Other|9|||
146444515|NCT00452348|528131845|FG001|Overall Study|Other|9|||
146444516|NCT00544167|528131849|FG000|Overall Study|Adverse Event|21|||
146444517|NCT00544167|528131849|FG000|Overall Study|Physician Decision|8|||
146444518|NCT03343639|528131852|FG000|Overall Study|Withdrawal by Subject|10|||
146444519|NCT03343639|528131853|FG001|Overall Study|Withdrawal by Subject|6|||
146444520|NCT03343639|528131852|FG000|Overall Study|Lost to Follow-up|4|||
146444521|NCT03343639|528131853|FG001|Overall Study|Lost to Follow-up|5|||
146444522|NCT03343639|528131852|FG000|Overall Study|Protocol Violation|0|||
146444523|NCT03343639|528131853|FG001|Overall Study|Protocol Violation|1|||
146444524|NCT00735696|528131860|FG000|Overall Study|Withdrawal by Subject|1|||
145955987|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
146444525|NCT00735696|528131860|FG000|Overall Study|Enrolled but never Treated|1|||
146444526|NCT02274558|528131862|FG000|Overall Study|Adverse Event|2|||
146444527|NCT02274558|528131863|FG001|Overall Study|Adverse Event|4|||
146444528|NCT02274558|528131864|FG002|Overall Study|Adverse Event|2|||
146444529|NCT02274558|528131862|FG000|Overall Study|Non-compliance|2|||
146444530|NCT02274558|528131863|FG001|Overall Study|Non-compliance|1|||
146444531|NCT02274558|528131864|FG002|Overall Study|Non-compliance|0|||
146444532|NCT02274558|528131862|FG000|Overall Study|Withdrawal by Subject|1|||
146444533|NCT02274558|528131863|FG001|Overall Study|Withdrawal by Subject|5|||
146444534|NCT02274558|528131864|FG002|Overall Study|Withdrawal by Subject|4|||
146444535|NCT02274558|528131862|FG000|Overall Study|Death|0|||
146444536|NCT02274558|528131863|FG001|Overall Study|Death|0|||
146444537|NCT02274558|528131864|FG002|Overall Study|Death|1|||
146444538|NCT02274558|528131862|FG000|Overall Study|Lost to Follow-up|2|||
146444539|NCT02274558|528131863|FG001|Overall Study|Lost to Follow-up|1|||
146444540|NCT02274558|528131864|FG002|Overall Study|Lost to Follow-up|1|||
146444541|NCT02274558|528131862|FG000|Overall Study|Physician Decision|0|||
146444542|NCT02274558|528131863|FG001|Overall Study|Physician Decision|2|||
146444543|NCT02274558|528131864|FG002|Overall Study|Physician Decision|1|||
146444544|NCT02460835|528131865|FG000|Overall Study|Disease progression prior to treatment|3|||
146444545|NCT02460835|528131865|FG000|Overall Study|Unable to complete planning scans|2|||
146444546|NCT02460835|528131865|FG000|Overall Study|Decrease in performance status|1|||
146444547|NCT02460835|528131865|FG000|Overall Study|Withdrawal by Subject|3|||
146444548|NCT02460835|528131865|FG000|Overall Study|Underwent fractionated RT|10|||
146444549|NCT02460835|528131865|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
146444550|NCT02733627|528131872|FG000|Overall Study|Adverse Event|0|||
146444551|NCT02733627|528131873|FG001|Overall Study|Adverse Event|1|||
146444552|NCT02733627|528131874|FG002|Overall Study|Adverse Event|1|||
146444553|NCT02733627|528131875|FG003|Overall Study|Adverse Event|0|||
146444554|NCT02733627|528131872|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
146444555|NCT02733627|528131873|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
146444556|NCT02733627|528131874|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
146444557|NCT02733627|528131875|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
146444558|NCT00059332|528131876|FG000|Overall Study|Withdrawal by Subject|2|||
146444559|NCT00059332|528131877|FG001|Overall Study|Withdrawal by Subject|1|||
146444560|NCT00059332|528131876|FG000|Overall Study|Lost to Follow-up|1|||
146444561|NCT00059332|528131877|FG001|Overall Study|Lost to Follow-up|1|||
146444562|NCT02587143|528131878|FG000|Overall Study|Adverse Event|1|||
146444563|NCT02587143|528131879|FG001|Overall Study|Adverse Event|0|||
146444564|NCT02754492|528131880|FG000|Overall Study|Protocol Violation|2|||
146444565|NCT02754492|528131881|FG001|Overall Study|Protocol Violation|2|||
146444566|NCT02754492|528131882|FG002|Overall Study|Protocol Violation|0|||
146444567|NCT02754492|528131883|FG003|Overall Study|Protocol Violation|1|||
146444568|NCT02754492|528131880|FG000|Overall Study|Withdrawal by Subject|2|||
146444569|NCT02754492|528131881|FG001|Overall Study|Withdrawal by Subject|0|||
146444570|NCT02754492|528131882|FG002|Overall Study|Withdrawal by Subject|0|||
146444571|NCT02754492|528131883|FG003|Overall Study|Withdrawal by Subject|0|||
146444572|NCT02754492|528131880|FG000|Overall Study|Equipment malfuntion|0|||
146444573|NCT02754492|528131881|FG001|Overall Study|Equipment malfuntion|0|||
146444574|NCT02754492|528131882|FG002|Overall Study|Equipment malfuntion|2|||
146444575|NCT02754492|528131883|FG003|Overall Study|Equipment malfuntion|5|||
146444576|NCT02754492|528131880|FG000|Overall Study|Adverse Event|0|||
146444577|NCT02754492|528131881|FG001|Overall Study|Adverse Event|0|||
146444578|NCT02754492|528131882|FG002|Overall Study|Adverse Event|0|||
146444579|NCT02754492|528131883|FG003|Overall Study|Adverse Event|13|||
146444580|NCT02754492|528131880|FG000|Overall Study|Venous access issues not resulting in AE|0|||
146444581|NCT02754492|528131881|FG001|Overall Study|Venous access issues not resulting in AE|0|||
146444582|NCT02754492|528131882|FG002|Overall Study|Venous access issues not resulting in AE|0|||
146444583|NCT02754492|528131883|FG003|Overall Study|Venous access issues not resulting in AE|4|||
146444584|NCT00487695|528131884|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
146444585|NCT00487695|528131885|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
146444586|NCT00487695|528131884|FG000|First Procedure|active wheezing (did not have procedure)|1|||
146444587|NCT00487695|528131885|FG001|First Procedure|active wheezing (did not have procedure)|0|||
146444588|NCT00487695|528131884|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
146444589|NCT00487695|528131885|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
146444590|NCT00487695|528131884|FG000|Second Procedure|active wheezing|0|||
146444591|NCT00487695|528131885|FG001|Second Procedure|active wheezing|1|||
146444592|NCT00487695|528131884|FG000|Second Procedure|Withdrawal by Subject|1|||
146444593|NCT00487695|528131885|FG001|Second Procedure|Withdrawal by Subject|2|||
146444594|NCT01186458|528131888|FG000|Overall Study|Adverse Event|1|||
146444595|NCT04281472|528131889|FG000|Stage A|Lack of Efficacy|8|||
146444596|NCT04281472|528131890|FG001|Stage A|Lack of Efficacy|0|||
146444597|NCT04281472|528131891|FG002|Stage A|Lack of Efficacy|0|||
146444598|NCT04281472|528131889|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
146444599|NCT04281472|528131890|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
146444600|NCT04281472|528131891|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
146444601|NCT04281472|528131889|FG000|Stage A|Adverse Event|20|||
146444602|NCT04281472|528131890|FG001|Stage A|Adverse Event|0|||
146444603|NCT04281472|528131891|FG002|Stage A|Adverse Event|0|||
145955988|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
145955989|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
146444604|NCT04281472|528131889|FG000|Stage A|Death|1|||
146444605|NCT04281472|528131890|FG001|Stage A|Death|0|||
146444606|NCT04281472|528131891|FG002|Stage A|Death|0|||
146444607|NCT04281472|528131889|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
146444608|NCT04281472|528131890|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
146444609|NCT04281472|528131891|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
146444610|NCT04281472|528131889|FG000|Stage A|Lost to Follow-up|2|||
146444611|NCT04281472|528131890|FG001|Stage A|Lost to Follow-up|0|||
146444612|NCT04281472|528131891|FG002|Stage A|Lost to Follow-up|0|||
146444613|NCT04281472|528131889|FG000|Stage A|Non-compliance with study drug|1|||
146444614|NCT04281472|528131890|FG001|Stage A|Non-compliance with study drug|0|||
146444615|NCT04281472|528131891|FG002|Stage A|Non-compliance with study drug|0|||
146444616|NCT04281472|528131889|FG000|Stage A|Physician Decision|1|||
146444617|NCT04281472|528131890|FG001|Stage A|Physician Decision|0|||
146444618|NCT04281472|528131891|FG002|Stage A|Physician Decision|0|||
146444619|NCT04281472|528131889|FG000|Stage A|Prohibited medications|2|||
146444620|NCT04281472|528131890|FG001|Stage A|Prohibited medications|0|||
146444621|NCT04281472|528131891|FG002|Stage A|Prohibited medications|0|||
146444622|NCT04281472|528131889|FG000|Stage A|Withdrawal by Subject|11|||
146444623|NCT04281472|528131890|FG001|Stage A|Withdrawal by Subject|0|||
146444624|NCT04281472|528131891|FG002|Stage A|Withdrawal by Subject|0|||
145955990|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
145955991|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
146444625|NCT04281472|528131889|FG000|Stage A|Other|5|||
146444626|NCT04281472|528131890|FG001|Stage A|Other|0|||
146444627|NCT04281472|528131891|FG002|Stage A|Other|0|||
146444628|NCT04281472|528131889|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
146444629|NCT04281472|528131890|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
146444630|NCT04281472|528131891|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
146444631|NCT04281472|528131889|FG000|Stage B|Adverse Event|0|||
146444632|NCT04281472|528131890|FG001|Stage B|Adverse Event|3|||
146444633|NCT04281472|528131891|FG002|Stage B|Adverse Event|0|||
146444634|NCT04281472|528131889|FG000|Stage B|Death|0|||
146444635|NCT04281472|528131890|FG001|Stage B|Death|0|||
145955992|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
145955993|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
146444636|NCT04281472|528131891|FG002|Stage B|Death|1|||
146444637|NCT04281472|528131889|FG000|Stage B|Lack of Efficacy|0|||
146444638|NCT04281472|528131890|FG001|Stage B|Lack of Efficacy|0|||
146444639|NCT04281472|528131891|FG002|Stage B|Lack of Efficacy|1|||
146444640|NCT04281472|528131889|FG000|Stage B|Lost to Follow-up|0|||
146444641|NCT04281472|528131890|FG001|Stage B|Lost to Follow-up|0|||
146444642|NCT04281472|528131891|FG002|Stage B|Lost to Follow-up|2|||
146444643|NCT04281472|528131889|FG000|Stage B|Prohibited medications|0|||
146444644|NCT04281472|528131890|FG001|Stage B|Prohibited medications|2|||
146444645|NCT04281472|528131891|FG002|Stage B|Prohibited medications|1|||
146444646|NCT04281472|528131889|FG000|Stage B|Protocol Violation|0|||
146444647|NCT04281472|528131890|FG001|Stage B|Protocol Violation|1|||
146444648|NCT04281472|528131891|FG002|Stage B|Protocol Violation|1|||
146444649|NCT04281472|528131889|FG000|Stage B|Sponsor decision|0|||
146444650|NCT04281472|528131890|FG001|Stage B|Sponsor decision|0|||
146444651|NCT04281472|528131891|FG002|Stage B|Sponsor decision|1|||
145955994|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
145955995|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
145955996|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
145955997|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
146209523|NCT03101371|527280400|FG000|Overall Study|Lost to Follow-up|1|||
146209524|NCT03101371|527280401|FG001|Overall Study|Lost to Follow-up|4|||
146209525|NCT03101371|527280400|FG000|Overall Study|Did not meet eligibility criteria|2|||
146444652|NCT04281472|528131889|FG000|Stage B|Withdrawal by Subject|0|||
146444653|NCT04281472|528131890|FG001|Stage B|Withdrawal by Subject|3|||
146444654|NCT04281472|528131891|FG002|Stage B|Withdrawal by Subject|3|||
146444655|NCT04281472|528131889|FG000|Stage B|Other|0|||
146444656|NCT04281472|528131890|FG001|Stage B|Other|3|||
146444657|NCT04281472|528131891|FG002|Stage B|Other|0|||
146444658|NCT00152451|528131892|FG000|Overall Study|Adverse Event|4|||
146444659|NCT00323258|528131894|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
146444660|NCT00323258|528131895|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
146444661|NCT00323258|528131894|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
146444662|NCT00323258|528131895|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
146444663|NCT00323258|528131894|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
146444664|NCT00323258|528131895|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
146444665|NCT00323258|528131894|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
146444666|NCT00323258|528131895|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
146444667|NCT00323258|528131894|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
146444668|NCT00323258|528131895|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
146444669|NCT00323258|528131894|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
146444670|NCT00323258|528131895|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
146444671|NCT00323258|528131894|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
146444672|NCT00323258|528131895|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
146444673|NCT01055834|528131896|FG000|Treatment Period I|Adverse Event|1|||
146444674|NCT01055834|528131897|FG001|Treatment Period I|Adverse Event|0|||
146444675|NCT01717313|528131898|FG000|Phase A (Weeks 0 to 24)|Death|0|||
146444676|NCT01717313|528131899|FG001|Phase A (Weeks 0 to 24)|Death|1|||
146444677|NCT01717313|528131898|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
146444678|NCT01717313|528131899|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
146444679|NCT01717313|528131898|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
145955998|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
145955999|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
145956000|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
145956001|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145956002|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145956003|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145956004|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
145956005|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145956006|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145956007|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145956008|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145956009|NCT02137226|526350987|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
145956010|NCT02137226|526350988|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
145956011|NCT02137226|526350989|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
145956012|NCT02137226|526350990|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
145956013|NCT02137226|526350991|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
145956014|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
145956015|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
145956016|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
145956017|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
145956018|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
145956019|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
145956020|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
145956021|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
146209526|NCT03101371|527280401|FG001|Overall Study|Did not meet eligibility criteria|1|||
145956022|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
146209527|NCT01094184|527280402|FG000|Overall Study|Death|35|||
146209528|NCT01094184|527280403|FG001|Overall Study|Death|11|||
146209529|NCT04766034|527280404|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146209530|NCT04766034|527280405|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146209531|NCT04766034|527280406|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146209532|NCT04766034|527280407|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
146209533|NCT04766034|527280408|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
146209534|NCT04766034|527280404|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146209535|NCT04766034|527280405|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146209536|NCT04766034|527280406|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146209537|NCT04766034|527280407|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
146444680|NCT01717313|528131899|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
146444681|NCT01717313|528131898|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
145956023|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
145956024|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
145956025|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
145956026|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
145956027|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
145956028|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
145956029|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145956030|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145956031|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
145956032|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145956033|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
146444682|NCT01717313|528131899|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
146444683|NCT01717313|528131898|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
146444684|NCT01717313|528131899|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
146444685|NCT01717313|528131898|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
146444686|NCT01717313|528131899|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
146444687|NCT01717313|528131898|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
146444688|NCT01717313|528131899|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
146444689|NCT01717313|528131898|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
146444690|NCT01717313|528131899|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
146444691|NCT01717313|528131898|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
146444692|NCT01717313|528131899|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
146444693|NCT00743145|528131901|FG000|Overall Study|Withdrawal by Subject|1|||
146444694|NCT00743145|528131901|FG000|Overall Study|Adverse Event|2|||
146444695|NCT00743145|528131901|FG000|Overall Study|Pregnancy|1|||
146444696|NCT01745094|528131902|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
146444697|NCT01745094|528131903|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
146444698|NCT01745094|528131904|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
146444699|NCT01745094|528131905|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
146444700|NCT01745094|528131902|FG000|Overall Study|Adverse Event|0|||
146444701|NCT01745094|528131903|FG001|Overall Study|Adverse Event|0|||
146444702|NCT01745094|528131904|FG002|Overall Study|Adverse Event|3|||
146444703|NCT01745094|528131905|FG003|Overall Study|Adverse Event|0|||
146444704|NCT01745094|528131902|FG000|Overall Study|Withdrawal by Subject|2|||
146444705|NCT01745094|528131903|FG001|Overall Study|Withdrawal by Subject|0|||
146444706|NCT01745094|528131904|FG002|Overall Study|Withdrawal by Subject|1|||
146444707|NCT01745094|528131905|FG003|Overall Study|Withdrawal by Subject|2|||
146444708|NCT01745094|528131902|FG000|Overall Study|Protocol Violation|1|||
146444709|NCT01745094|528131903|FG001|Overall Study|Protocol Violation|0|||
146444710|NCT01745094|528131904|FG002|Overall Study|Protocol Violation|3|||
146444711|NCT01745094|528131905|FG003|Overall Study|Protocol Violation|1|||
146444712|NCT01745094|528131902|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
146444713|NCT01745094|528131903|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
146444714|NCT01745094|528131904|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
146444715|NCT01745094|528131905|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
146444716|NCT01745094|528131902|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
146444717|NCT01745094|528131903|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
146444718|NCT01745094|528131904|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
146444719|NCT01745094|528131905|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
146444720|NCT01745094|528131902|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
146444721|NCT01745094|528131903|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
146444722|NCT01745094|528131904|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
146444723|NCT01745094|528131905|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
146444724|NCT01097694|528131906|FG000|Overall Study|Adverse Event|5|||
146444725|NCT01097694|528131907|FG001|Overall Study|Adverse Event|0|||
146444726|NCT01097694|528131906|FG000|Overall Study|Lost to Follow-up|0|||
146444727|NCT01097694|528131907|FG001|Overall Study|Lost to Follow-up|3|||
146444728|NCT01097694|528131906|FG000|Overall Study|Withdrawal by Subject|3|||
146444729|NCT01097694|528131907|FG001|Overall Study|Withdrawal by Subject|1|||
145956034|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145956035|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145956036|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
145956037|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145956038|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145956039|NCT02137226|526350987|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
145956040|NCT02137226|526350988|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
145956041|NCT02137226|526350989|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
145956042|NCT02137226|526350990|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
145956043|NCT02137226|526350991|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
145956044|NCT02998996|526350992|FG000|Overall Study|Lost to Follow-up|0|||
145956045|NCT02998996|526350993|FG001|Overall Study|Lost to Follow-up|0|||
145956046|NCT02998996|526350994|FG002|Overall Study|Lost to Follow-up|1|||
145956047|NCT02998996|526350995|FG003|Overall Study|Lost to Follow-up|0|||
145956048|NCT02998996|526350996|FG004|Overall Study|Lost to Follow-up|0|||
145956049|NCT02998996|526350997|FG005|Overall Study|Lost to Follow-up|0|||
145956050|NCT02998996|526350992|FG000|Overall Study|Pregnancy|0|||
145956051|NCT02998996|526350993|FG001|Overall Study|Pregnancy|1|||
145956052|NCT02998996|526350994|FG002|Overall Study|Pregnancy|0|||
146444730|NCT03922750|528131908|FG000|Overall Study|Unclassified|0|||
146444731|NCT03922750|528131909|FG001|Overall Study|Unclassified|0|||
146444732|NCT03922750|528131910|FG002|Overall Study|Unclassified|1|||
146444733|NCT03922750|528131908|FG000|Overall Study|Adverse Event|0|||
146444734|NCT03922750|528131909|FG001|Overall Study|Adverse Event|1|||
146444735|NCT03922750|528131910|FG002|Overall Study|Adverse Event|0|||
146444736|NCT00668395|528131911|FG000|Overall Study|Withdrawal by Subject|4|||
146444737|NCT00668395|528131912|FG001|Overall Study|Withdrawal by Subject|4|||
146444738|NCT00668395|528131913|FG002|Overall Study|Withdrawal by Subject|1|||
146444739|NCT00668395|528131911|FG000|Overall Study|Adverse Event|1|||
146444740|NCT00668395|528131912|FG001|Overall Study|Adverse Event|1|||
146444741|NCT00668395|528131913|FG002|Overall Study|Adverse Event|0|||
146444742|NCT00668395|528131911|FG000|Overall Study|Physician Decision|1|||
146444743|NCT00668395|528131912|FG001|Overall Study|Physician Decision|1|||
146444744|NCT00668395|528131913|FG002|Overall Study|Physician Decision|0|||
146444745|NCT00697827|528131914|FG000|Overall Study|enrolled but not treated|2|||
146444746|NCT00697827|528131915|FG001|Overall Study|enrolled but not treated|1|||
146444747|NCT03732833|528131916|FG000|Overall Study|Adverse Event|0|||
146444748|NCT03732833|528131917|FG001|Overall Study|Adverse Event|3|||
146444749|NCT03732833|528131918|FG002|Overall Study|Adverse Event|1|||
146444750|NCT03732833|528131916|FG000|Overall Study|Withdrawal by Subject|11|||
146444751|NCT03732833|528131917|FG001|Overall Study|Withdrawal by Subject|13|||
146444752|NCT03732833|528131918|FG002|Overall Study|Withdrawal by Subject|8|||
146444753|NCT03732833|528131916|FG000|Overall Study|Lost to Follow-up|3|||
146444754|NCT03732833|528131917|FG001|Overall Study|Lost to Follow-up|5|||
146444755|NCT03732833|528131918|FG002|Overall Study|Lost to Follow-up|4|||
146444756|NCT03732833|528131916|FG000|Overall Study|Pregnancy|0|||
146444757|NCT03732833|528131917|FG001|Overall Study|Pregnancy|2|||
146444758|NCT03732833|528131918|FG002|Overall Study|Pregnancy|0|||
145956053|NCT02998996|526350995|FG003|Overall Study|Pregnancy|0|||
146444759|NCT03732833|528131916|FG000|Overall Study|Physician Decision|2|||
146444760|NCT03732833|528131917|FG001|Overall Study|Physician Decision|3|||
146444761|NCT03732833|528131918|FG002|Overall Study|Physician Decision|1|||
146444762|NCT03732833|528131916|FG000|Overall Study|Covid-19 related and other reasons|2|||
146444763|NCT03732833|528131917|FG001|Overall Study|Covid-19 related and other reasons|7|||
146444764|NCT03732833|528131918|FG002|Overall Study|Covid-19 related and other reasons|3|||
146444765|NCT01691612|528131921|FG000|Overall Study|deemed ineligible after 1st visit|6|||
146444766|NCT01691612|528131921|FG000|Overall Study|Adverse Event|1|||
146444767|NCT02623218|528131922|FG000|Overall Study|Lost to Follow-up|0|||
146444768|NCT02623218|528131923|FG001|Overall Study|Lost to Follow-up|1|||
146444769|NCT02623218|528131924|FG002|Overall Study|Lost to Follow-up|0|||
146444770|NCT02623218|528131925|FG003|Overall Study|Lost to Follow-up|0|||
146444771|NCT02623218|528131926|FG004|Overall Study|Lost to Follow-up|0|||
146444772|NCT01726803|528131927|FG000|Overall Study|Lost to Follow-up|6|||
146444773|NCT01726803|528131928|FG001|Overall Study|Lost to Follow-up|1|||
146444774|NCT01726803|528131927|FG000|Overall Study|Withdrawal by Subject|1|||
146444775|NCT01726803|528131928|FG001|Overall Study|Withdrawal by Subject|0|||
146444776|NCT02005276|528131930|FG000|Overall Study|No longer interested|5|||
146444777|NCT02005276|528131931|FG001|Overall Study|No longer interested|2|||
146444778|NCT02005276|528131932|FG002|Overall Study|No longer interested|3|||
146444779|NCT02005276|528131933|FG003|Overall Study|No longer interested|3|||
146444780|NCT01970592|528131934|FG000|Overall Study|Withdrawal by Subject|4|||
146444781|NCT01970592|528131934|FG000|Overall Study|Physician Decision|1|||
146444782|NCT01970592|528131934|FG000|Overall Study|Adverse Event|1|||
146444783|NCT01091363|528131937|FG000|Overall Study|Withdrawal by Subject|11|||
146444784|NCT01091363|528131938|FG001|Overall Study|Withdrawal by Subject|15|||
146444785|NCT01091363|528131937|FG000|Overall Study|Lost to Follow-up|2|||
146444786|NCT01091363|528131938|FG001|Overall Study|Lost to Follow-up|2|||
146444787|NCT00021541|528131939|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
146444788|NCT00021541|528131940|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
146444789|NCT00021541|528131939|FG000|Period 1-First Treatment|Adverse Event|2|||
146444790|NCT00021541|528131940|FG001|Period 1-First Treatment|Adverse Event|1|||
146444791|NCT00021541|528131939|FG000|Period 1-First Treatment|non-adherence|3|||
146444792|NCT00021541|528131940|FG001|Period 1-First Treatment|non-adherence|0|||
146444793|NCT00021541|528131939|FG000|Period 1-First Treatment|Death|1|||
146444794|NCT00021541|528131940|FG001|Period 1-First Treatment|Death|0|||
146444795|NCT00021541|528131939|FG000|Period 1-First Treatment|Pts that did not progress|2|||
146444796|NCT00021541|528131940|FG001|Period 1-First Treatment|Pts that did not progress|2|||
145956054|NCT02998996|526350996|FG004|Overall Study|Pregnancy|0|||
145956055|NCT02998996|526350997|FG005|Overall Study|Pregnancy|0|||
145956056|NCT02998996|526350992|FG000|Overall Study|Family reasons|0|||
145956057|NCT02998996|526350993|FG001|Overall Study|Family reasons|0|||
145956058|NCT02998996|526350994|FG002|Overall Study|Family reasons|0|||
145956059|NCT02998996|526350995|FG003|Overall Study|Family reasons|0|||
146444797|NCT00021541|528131939|FG000|Period 1-First Treatment|Ineligible|0|||
146444798|NCT00021541|528131940|FG001|Period 1-First Treatment|Ineligible|2|||
146444799|NCT00021541|528131939|FG000|Period 2-crossover|refused phase B|2|||
146444800|NCT00021541|528131940|FG001|Period 2-crossover|refused phase B|2|||
146444801|NCT00021541|528131939|FG000|Period 2-crossover|Withdrawal by Subject|3|||
146444802|NCT00021541|528131940|FG001|Period 2-crossover|Withdrawal by Subject|4|||
146444803|NCT00021541|528131939|FG000|Period 2-crossover|Adverse Event|2|||
146444804|NCT00021541|528131940|FG001|Period 2-crossover|Adverse Event|2|||
146444805|NCT00021541|528131939|FG000|Period 2-crossover|non-adherence|1|||
146444806|NCT00021541|528131940|FG001|Period 2-crossover|non-adherence|0|||
146444807|NCT00021541|528131939|FG000|Period 2-crossover|Pts that did not progress|2|||
146444808|NCT00021541|528131940|FG001|Period 2-crossover|Pts that did not progress|3|||
146444809|NCT05263505|528131944|FG000|Overall Study|Adverse Event|0|||
145956060|NCT02998996|526350996|FG004|Overall Study|Family reasons|1|||
145956061|NCT02998996|526350997|FG005|Overall Study|Family reasons|0|||
145956062|NCT01398358|526351000|FG000|Overall Study|Lost to Follow-up|11|||
145956063|NCT01398358|526351001|FG001|Overall Study|Lost to Follow-up|21|||
145956064|NCT01398358|526351002|FG002|Overall Study|Lost to Follow-up|18|||
145956065|NCT01398358|526351000|FG000|Overall Study|Withdrawal by Subject|3|||
145956066|NCT01398358|526351001|FG001|Overall Study|Withdrawal by Subject|2|||
146444810|NCT05263505|528131945|FG001|Overall Study|Adverse Event|1|||
146444811|NCT00826241|528131946|FG000|Overall Study|Withdrawal from Follow-up|1|||
146444812|NCT00826241|528131946|FG000|Overall Study|Withdrew consent|2|||
146444813|NCT00826241|528131946|FG000|Overall Study|Death|4|||
146444814|NCT00826241|528131946|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
146444815|NCT00826241|528131946|FG000|Overall Study|Non-compliance|1|||
146444816|NCT00826241|528131946|FG000|Overall Study|Progression of disease|1|||
146444817|NCT00826241|528131946|FG000|Overall Study|Patient refused follow-up|3|||
146444818|NCT00826241|528131946|FG000|Overall Study|Lost to Follow-up|9|||
146444819|NCT00826241|528131946|FG000|Overall Study|Could not obtain records|1|||
146444820|NCT00826241|528131946|FG000|Overall Study|Screen failure|2|||
146444821|NCT00826241|528131946|FG000|Overall Study|Pt unable to proceed to registration|1|||
146444822|NCT00826241|528131946|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
146444823|NCT01898598|528131947|FG000|Overall Study|Adverse Event|1|||
146444824|NCT01898598|528131948|FG001|Overall Study|Adverse Event|0|||
146444825|NCT01898598|528131947|FG000|Overall Study|Withdrawal by Subject|3|||
146444826|NCT01898598|528131948|FG001|Overall Study|Withdrawal by Subject|0|||
146444827|NCT01898598|528131947|FG000|Overall Study|Lost to Follow-up|0|||
146444828|NCT01898598|528131948|FG001|Overall Study|Lost to Follow-up|1|||
146444829|NCT01898598|528131947|FG000|Overall Study|Other|0|||
146444830|NCT01898598|528131948|FG001|Overall Study|Other|1|||
146444831|NCT03833427|528131949|FG000|Overall Study|Death|4|||
146444832|NCT03833427|528131950|FG001|Overall Study|Death|2|||
146444833|NCT03833427|528131951|FG002|Overall Study|Death|9|||
146444834|NCT03833427|528131952|FG003|Overall Study|Death|11|||
146444835|NCT03833427|528131953|FG004|Overall Study|Death|0|||
146444836|NCT03833427|528131954|FG005|Overall Study|Death|0|||
146444837|NCT03833427|528131955|FG006|Overall Study|Death|0|||
146444838|NCT03833427|528131949|FG000|Overall Study|Withdrawal by Subject|0|||
146444839|NCT03833427|528131950|FG001|Overall Study|Withdrawal by Subject|1|||
146444840|NCT03833427|528131951|FG002|Overall Study|Withdrawal by Subject|1|||
145956067|NCT01398358|526351002|FG002|Overall Study|Withdrawal by Subject|2|||
145956068|NCT01398358|526351000|FG000|Overall Study|no longer eligible|1|||
145956069|NCT01398358|526351001|FG001|Overall Study|no longer eligible|0|||
145956070|NCT01398358|526351002|FG002|Overall Study|no longer eligible|1|||
145956071|NCT00003896|526351005|FG000|Overall Study|Adverse Event|16|||
145956072|NCT00003896|526351005|FG000|Overall Study|Withdrawal by Subject|1|||
145956073|NCT00003896|526351005|FG000|Overall Study|Lack of Efficacy|1|||
145956074|NCT00003896|526351005|FG000|Overall Study|Death|3|||
145956075|NCT00003896|526351005|FG000|Overall Study|not protocol specified|3|||
145956076|NCT00003896|526351005|FG000|Overall Study|ineligible|5|||
145956077|NCT00985686|526351006|FG000|Overall Study|Lost to Follow-up|1|||
145956078|NCT00985686|526351007|FG001|Overall Study|Lost to Follow-up|1|||
145956079|NCT00985686|526351008|FG002|Overall Study|Lost to Follow-up|0|||
145956080|NCT00985686|526351009|FG003|Overall Study|Lost to Follow-up|2|||
145956081|NCT01670045|526351010|FG000|Overall Study|Withdrawal by Subject|3|||
145956082|NCT01670045|526351010|FG000|Overall Study|Adverse Event|1|||
145956083|NCT01670045|526351010|FG000|Overall Study|Death|1|||
145956084|NCT01670045|526351010|FG000|Overall Study|Lost to Follow-up|11|||
145956085|NCT03134911|526351011|FG000|Overall Study|Screen failure|31|||
145956086|NCT03134911|526351011|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
145956087|NCT00184093|526351014|FG000|Overall Study|Adverse Event|3|||
145956088|NCT00184093|526351014|FG000|Overall Study|Lost to Follow-up|3|||
145956089|NCT00184093|526351014|FG000|Overall Study|Physician Decision|1|||
145956090|NCT00184093|526351014|FG000|Overall Study|Withdrawal by Subject|2|||
146444841|NCT03833427|528131952|FG003|Overall Study|Withdrawal by Subject|0|||
146444842|NCT03833427|528131953|FG004|Overall Study|Withdrawal by Subject|0|||
146444843|NCT03833427|528131954|FG005|Overall Study|Withdrawal by Subject|0|||
146444844|NCT03833427|528131955|FG006|Overall Study|Withdrawal by Subject|0|||
146444845|NCT03833427|528131949|FG000|Overall Study|Sponsor Decision|0|||
146444846|NCT03833427|528131950|FG001|Overall Study|Sponsor Decision|0|||
145956091|NCT00396383|526351017|FG000|Overall Study|Death|2|||
145956092|NCT00396383|526351017|FG000|Overall Study|Lost to Follow-up|1|||
145956093|NCT00534638|526351018|FG000|Overall Study|Withdrawal by Subject|3|||
145956094|NCT00534638|526351019|FG001|Overall Study|Withdrawal by Subject|4|||
145956095|NCT00534638|526351018|FG000|Overall Study|Migrated/moved from study area|13|||
145956096|NCT00534638|526351019|FG001|Overall Study|Migrated/moved from study area|11|||
145956097|NCT00534638|526351018|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
146444847|NCT03833427|528131951|FG002|Overall Study|Sponsor Decision|1|||
146444848|NCT03833427|528131952|FG003|Overall Study|Sponsor Decision|3|||
146444849|NCT03833427|528131953|FG004|Overall Study|Sponsor Decision|0|||
146444850|NCT03833427|528131954|FG005|Overall Study|Sponsor Decision|0|||
146083130|NCT05395091|526824764|FG002|Baseline to Month 12|Adverse Event|0|||
146444851|NCT03833427|528131955|FG006|Overall Study|Sponsor Decision|0|||
146444852|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
146444853|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
146444854|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
146444855|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
146444856|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
146444857|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
146444858|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
146444859|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
146444860|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
146444861|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
146444862|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
146444863|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
146444864|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
146444865|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
146444866|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
146444867|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
146444868|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
146444869|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
146444870|NCT00950300|528131962|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
146083131|NCT05395091|526824762|FG000|Baseline to Month 12|Death|3|||
146083132|NCT05395091|526824763|FG001|Baseline to Month 12|Death|1|||
146083133|NCT05395091|526824764|FG002|Baseline to Month 12|Death|0|||
146083134|NCT05395091|526824762|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
146083135|NCT05395091|526824763|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
146083136|NCT05395091|526824764|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
146083137|NCT05395091|526824762|FG000|Baseline to Month 12|Protocol Violation|2|||
146083138|NCT05395091|526824763|FG001|Baseline to Month 12|Protocol Violation|3|||
146083139|NCT05395091|526824764|FG002|Baseline to Month 12|Protocol Violation|0|||
146083140|NCT05395091|526824762|FG000|Baseline to Month 12|Physician Decision|1|||
146083141|NCT05395091|526824763|FG001|Baseline to Month 12|Physician Decision|0|||
146083142|NCT05395091|526824764|FG002|Baseline to Month 12|Physician Decision|0|||
146083143|NCT05395091|526824762|FG000|Month 12 to Month 18|Death|1|||
146083144|NCT05395091|526824763|FG001|Month 12 to Month 18|Death|0|||
146083145|NCT05395091|526824764|FG002|Month 12 to Month 18|Death|0|||
146083146|NCT05395091|526824762|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
146083147|NCT05395091|526824763|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
146083148|NCT05395091|526824764|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
146444871|NCT00950300|528131963|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
146083149|NCT05395091|526824762|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
146083150|NCT05395091|526824763|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
146083151|NCT05395091|526824764|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
146209538|NCT04766034|527280408|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
146209539|NCT04766034|527280404|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
146209540|NCT04766034|527280405|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
146209541|NCT04766034|527280406|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
146209542|NCT04766034|527280407|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
146209543|NCT04766034|527280408|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
146209544|NCT04766034|527280404|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
146209545|NCT04766034|527280405|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
146209546|NCT04766034|527280406|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
146209547|NCT04766034|527280407|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
146209548|NCT04766034|527280408|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
146209549|NCT04992390|527280414|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
146209550|NCT04992390|527280415|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
146209551|NCT04992390|527280416|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
146209552|NCT04992390|527280414|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
146209553|NCT04992390|527280415|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
146209554|NCT04992390|527280416|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
146209555|NCT04992390|527280414|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
146209556|NCT04992390|527280415|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
146209557|NCT04992390|527280416|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
146285768|NCT01577745|527561117|FG002|Overall Study|Lost to Follow-up|0|||
146444872|NCT00950300|528131962|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
146444873|NCT00950300|528131963|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
146444874|NCT00950300|528131962|FG000|TFFU Period|Death|4|||
146444875|NCT00950300|528131963|FG001|TFFU Period|Death|1|||
146444876|NCT00950300|528131962|FG000|TFFU Period|Refused Treatment|10|||
146444877|NCT00950300|528131963|FG001|TFFU Period|Refused Treatment|11|||
146444878|NCT00950300|528131962|FG000|TFFU Period|Failure to Return|16|||
146444879|NCT00950300|528131963|FG001|TFFU Period|Failure to Return|16|||
146444880|NCT00950300|528131962|FG000|TFFU Period|Recurrence of Disease|63|||
146444881|NCT00950300|528131963|FG001|TFFU Period|Recurrence of Disease|72|||
146444882|NCT00950300|528131962|FG000|TFFU Period|Other|4|||
146444883|NCT00950300|528131963|FG001|TFFU Period|Other|3|||
146444884|NCT00950300|528131962|FG000|SFU Period|Death|44|||
146444885|NCT00950300|528131963|FG001|SFU Period|Death|42|||
146444886|NCT00950300|528131962|FG000|SFU Period|Lost to Follow-up|30|||
146444887|NCT00950300|528131963|FG001|SFU Period|Lost to Follow-up|28|||
146444888|NCT00950300|528131962|FG000|SFU Period|Withdrawal by Subject|4|||
146444889|NCT00950300|528131963|FG001|SFU Period|Withdrawal by Subject|8|||
146444890|NCT01596127|528131964|FG000|Overall Study|Patient Ineligible|1|||
146444891|NCT00438633|528131965|FG000|Overall Study|Withdrawal by Subject|1|||
146444892|NCT00438633|528131966|FG001|Overall Study|Withdrawal by Subject|0|||
146444893|NCT00438633|528131965|FG000|Overall Study|Lost to Follow-up|15|||
146444894|NCT00438633|528131966|FG001|Overall Study|Lost to Follow-up|17|||
146444895|NCT01539239|528131967|FG000|Overall Study|Death|5|||
146444896|NCT01539239|528131968|FG001|Overall Study|Death|5|||
146444897|NCT01539239|528131967|FG000|Overall Study|Lost to Follow-up|7|||
146444898|NCT01539239|528131968|FG001|Overall Study|Lost to Follow-up|12|||
146444899|NCT01350934|528133747|FG000|Base Study|Adverse Event|6|||
146444900|NCT01350934|528133748|FG001|Base Study|Adverse Event|0|||
146444901|NCT01350934|528133747|FG000|Base Study|Lost to Follow-up|1|||
146444902|NCT01350934|528133748|FG001|Base Study|Lost to Follow-up|0|||
146444903|NCT01350934|528133747|FG000|Base Study|Protocol Violation|1|||
146444904|NCT01350934|528133748|FG001|Base Study|Protocol Violation|1|||
146444905|NCT01350934|528133747|FG000|Base Study|Withdrawal by Subject|1|||
146444906|NCT01350934|528133748|FG001|Base Study|Withdrawal by Subject|2|||
146444907|NCT01350934|528133747|FG000|Base Study|Non-Compliance With Study Drug|2|||
146444908|NCT01350934|528133748|FG001|Base Study|Non-Compliance With Study Drug|0|||
146444909|NCT01350934|528133747|FG000|Extension Study|Adverse Event|2|||
146444910|NCT01350934|528133748|FG001|Extension Study|Adverse Event|1|||
146444911|NCT01350934|528133747|FG000|Extension Study|Lost to Follow-up|2|||
146444912|NCT01350934|528133748|FG001|Extension Study|Lost to Follow-up|0|||
145956098|NCT00534638|526351019|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
145956099|NCT00534638|526351018|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
145956100|NCT00534638|526351019|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
145956101|NCT00534638|526351018|FG000|Overall Study|Other|1685|||
145956102|NCT00534638|526351019|FG001|Overall Study|Other|902|||
145956103|NCT02903420|526351020|FG000|Overall Study|Death|3|||
146285769|NCT01577745|527561118|FG003|Overall Study|Lost to Follow-up|0|||
146444913|NCT01350934|528133747|FG000|Extension Study|Protocol Violation|1|||
146444914|NCT01350934|528133748|FG001|Extension Study|Protocol Violation|1|||
146444915|NCT01350934|528133747|FG000|Extension Study|Lack of Efficacy|0|||
146444916|NCT01350934|528133748|FG001|Extension Study|Lack of Efficacy|1|||
146444917|NCT01350934|528133747|FG000|Extension Study|Withdrawal by Subject|0|||
146444918|NCT01350934|528133748|FG001|Extension Study|Withdrawal by Subject|1|||
146444919|NCT01011335|528133751|FG000|Overall Study|Lost to Follow-up|0|||
146444920|NCT01011335|528133752|FG001|Overall Study|Lost to Follow-up|0|||
146444921|NCT01011335|528133753|FG002|Overall Study|Lost to Follow-up|1|||
146444922|NCT01011335|528133754|FG003|Overall Study|Lost to Follow-up|1|||
146444923|NCT01011335|528133755|FG004|Overall Study|Lost to Follow-up|1|||
146444924|NCT01011335|528133756|FG005|Overall Study|Lost to Follow-up|1|||
146444925|NCT01011335|528133757|FG006|Overall Study|Lost to Follow-up|2|||
146444926|NCT01011335|528133758|FG007|Overall Study|Lost to Follow-up|2|||
146444927|NCT01011335|528133759|FG008|Overall Study|Lost to Follow-up|1|||
146444928|NCT01011335|528133760|FG009|Overall Study|Lost to Follow-up|0|||
146444929|NCT01011335|528133761|FG010|Overall Study|Lost to Follow-up|0|||
146444930|NCT01011335|528133762|FG011|Overall Study|Lost to Follow-up|1|||
146444931|NCT01011335|528133763|FG012|Overall Study|Lost to Follow-up|2|||
146444932|NCT01011335|528133751|FG000|Overall Study|Protocol Violation|0|||
146444933|NCT01011335|528133752|FG001|Overall Study|Protocol Violation|1|||
146444934|NCT01011335|528133753|FG002|Overall Study|Protocol Violation|0|||
146444935|NCT01011335|528133754|FG003|Overall Study|Protocol Violation|0|||
146444936|NCT01011335|528133755|FG004|Overall Study|Protocol Violation|0|||
145956104|NCT01216332|526351023|FG000|Overall Study|Withdrawal by Subject|4|||
145956105|NCT01216332|526351024|FG001|Overall Study|Withdrawal by Subject|0|||
145956106|NCT01066871|526351026|FG000|Overall Study|Lost to Follow-up|0|||
145956107|NCT01066871|526351027|FG001|Overall Study|Lost to Follow-up|2|||
146285770|NCT01577745|527561119|FG004|Overall Study|Lost to Follow-up|0|||
146285771|NCT01577745|527561120|FG005|Overall Study|Lost to Follow-up|1|||
146444937|NCT01011335|528133756|FG005|Overall Study|Protocol Violation|0|||
146444938|NCT01011335|528133757|FG006|Overall Study|Protocol Violation|0|||
146444939|NCT01011335|528133758|FG007|Overall Study|Protocol Violation|0|||
146444940|NCT01011335|528133759|FG008|Overall Study|Protocol Violation|0|||
145956108|NCT01066871|526351028|FG002|Overall Study|Lost to Follow-up|2|||
145956109|NCT01066871|526351029|FG003|Overall Study|Lost to Follow-up|0|||
145956110|NCT01066871|526351026|FG000|Overall Study|Protocol Violation|1|||
145956111|NCT01066871|526351027|FG001|Overall Study|Protocol Violation|0|||
145956112|NCT01066871|526351028|FG002|Overall Study|Protocol Violation|3|||
145956113|NCT01066871|526351029|FG003|Overall Study|Protocol Violation|2|||
145956114|NCT01066871|526351026|FG000|Overall Study|Lack of Efficacy|0|||
145956115|NCT01066871|526351027|FG001|Overall Study|Lack of Efficacy|0|||
145956116|NCT01066871|526351028|FG002|Overall Study|Lack of Efficacy|0|||
145956117|NCT01066871|526351029|FG003|Overall Study|Lack of Efficacy|1|||
145956118|NCT01066871|526351026|FG000|Overall Study|Withdrawal by Subject|3|||
145956119|NCT01066871|526351027|FG001|Overall Study|Withdrawal by Subject|1|||
145956120|NCT01066871|526351028|FG002|Overall Study|Withdrawal by Subject|0|||
145956121|NCT01066871|526351029|FG003|Overall Study|Withdrawal by Subject|0|||
145956122|NCT01066871|526351026|FG000|Overall Study|Other|0|||
145956123|NCT01066871|526351027|FG001|Overall Study|Other|2|||
145956124|NCT01066871|526351028|FG002|Overall Study|Other|1|||
145956125|NCT01066871|526351029|FG003|Overall Study|Other|2|||
145956126|NCT04162795|526351032|FG000|Overall Study|Other|16|||
145956127|NCT04162795|526351032|FG000|Overall Study|Screen failures|10|||
145956128|NCT02029274|526351035|FG000|Overall Study|Adverse Event|1|||
145956129|NCT02029274|526351036|FG001|Overall Study|Adverse Event|0|||
146285772|NCT01577745|527561115|FG000|Overall Study|Alternative Therapy|0|||
146285773|NCT01577745|527561116|FG001|Overall Study|Alternative Therapy|0|||
146285774|NCT01577745|527561117|FG002|Overall Study|Alternative Therapy|0|||
145956130|NCT02029274|526351037|FG002|Overall Study|Adverse Event|2|||
145956131|NCT02029274|526351038|FG003|Overall Study|Adverse Event|2|||
145956132|NCT01124292|526351039|FG000|Overall Study|Lost to Follow-up|2|||
146285775|NCT01577745|527561118|FG003|Overall Study|Alternative Therapy|1|||
146285776|NCT01577745|527561119|FG004|Overall Study|Alternative Therapy|1|||
146444941|NCT01011335|528133760|FG009|Overall Study|Protocol Violation|0|||
146444942|NCT01011335|528133761|FG010|Overall Study|Protocol Violation|0|||
146444943|NCT01011335|528133762|FG011|Overall Study|Protocol Violation|0|||
146444944|NCT01011335|528133763|FG012|Overall Study|Protocol Violation|0|||
146444945|NCT01011335|528133751|FG000|Overall Study|Moved/deployed or no booster|1|||
146444946|NCT01011335|528133752|FG001|Overall Study|Moved/deployed or no booster|0|||
146444947|NCT01011335|528133753|FG002|Overall Study|Moved/deployed or no booster|0|||
146444948|NCT01011335|528133754|FG003|Overall Study|Moved/deployed or no booster|1|||
146444949|NCT01011335|528133755|FG004|Overall Study|Moved/deployed or no booster|0|||
146444950|NCT01011335|528133756|FG005|Overall Study|Moved/deployed or no booster|0|||
146444951|NCT01011335|528133757|FG006|Overall Study|Moved/deployed or no booster|1|||
146444952|NCT01011335|528133758|FG007|Overall Study|Moved/deployed or no booster|0|||
146444953|NCT01011335|528133759|FG008|Overall Study|Moved/deployed or no booster|1|||
146444954|NCT01011335|528133760|FG009|Overall Study|Moved/deployed or no booster|0|||
146444955|NCT01011335|528133761|FG010|Overall Study|Moved/deployed or no booster|2|||
146444956|NCT01011335|528133762|FG011|Overall Study|Moved/deployed or no booster|0|||
146444957|NCT01011335|528133763|FG012|Overall Study|Moved/deployed or no booster|0|||
146444958|NCT01011335|528133751|FG000|Overall Study|Adverse Event|0|||
146444959|NCT01011335|528133752|FG001|Overall Study|Adverse Event|0|||
146444960|NCT01011335|528133753|FG002|Overall Study|Adverse Event|0|||
146444961|NCT01011335|528133754|FG003|Overall Study|Adverse Event|0|||
146444962|NCT01011335|528133755|FG004|Overall Study|Adverse Event|0|||
146444963|NCT01011335|528133756|FG005|Overall Study|Adverse Event|0|||
146444964|NCT01011335|528133757|FG006|Overall Study|Adverse Event|0|||
146444965|NCT01011335|528133758|FG007|Overall Study|Adverse Event|0|||
146444966|NCT01011335|528133759|FG008|Overall Study|Adverse Event|0|||
146444967|NCT01011335|528133760|FG009|Overall Study|Adverse Event|0|||
146444968|NCT01011335|528133761|FG010|Overall Study|Adverse Event|4|||
146444969|NCT01011335|528133762|FG011|Overall Study|Adverse Event|0|||
146444970|NCT01011335|528133763|FG012|Overall Study|Adverse Event|1|||
146444971|NCT01765751|528133771|FG000|Overall Study|Lost to Follow-up|0|||
146444972|NCT01765751|528133772|FG001|Overall Study|Lost to Follow-up|2|||
146444973|NCT01765751|528133773|FG002|Overall Study|Lost to Follow-up|1|||
146444974|NCT01257581|528133777|FG000|Overall Study|Early Termination|3|||
146444975|NCT01257581|528133778|FG001|Overall Study|Early Termination|1|||
146444976|NCT01257581|528133779|FG002|Overall Study|Early Termination|2|||
146444977|NCT01257581|528133777|FG000|Overall Study|Death|2|||
146444978|NCT01257581|528133778|FG001|Overall Study|Death|2|||
146444979|NCT01257581|528133779|FG002|Overall Study|Death|4|||
146444980|NCT00517192|528133786|FG000|Overall Study|Adverse Event|1|||
146444981|NCT00517192|528133787|FG001|Overall Study|Adverse Event|1|||
146444982|NCT00517192|528133786|FG000|Overall Study|Lost to Follow-up|1|||
146444983|NCT00517192|528133787|FG001|Overall Study|Lost to Follow-up|1|||
146444984|NCT00517192|528133786|FG000|Overall Study|Withdrawal by Subject|1|||
146444985|NCT00517192|528133787|FG001|Overall Study|Withdrawal by Subject|0|||
146444986|NCT00517192|528133786|FG000|Overall Study|Early termination of the trial|16|||
146444987|NCT00517192|528133787|FG001|Overall Study|Early termination of the trial|18|||
146444988|NCT03167606|528133796|FG000|Overall Study|Lost to Follow-up|73|||
146444989|NCT03167606|528133797|FG001|Overall Study|Lost to Follow-up|64|||
146444990|NCT03167606|528133796|FG000|Overall Study|Withdrawal by Subject|6|||
146444991|NCT03167606|528133797|FG001|Overall Study|Withdrawal by Subject|5|||
146444992|NCT03167606|528133796|FG000|Overall Study|Withdrawal by Investigator|0|||
146444993|NCT03167606|528133797|FG001|Overall Study|Withdrawal by Investigator|2|||
146444994|NCT02483416|528133798|FG000|Overall Study|Other reason|0|||
146444995|NCT02483416|528133799|FG001|Overall Study|Other reason|1|||
146444996|NCT02483416|528133798|FG000|Overall Study|Treatment stop|3|||
146444997|NCT02483416|528133799|FG001|Overall Study|Treatment stop|0|||
146444998|NCT04633642|528133803|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
146444999|NCT04633642|528133804|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
146445000|NCT00611884|528133805|FG000|Overall Study|Adverse Event|1|||
146445001|NCT00611884|528133806|FG001|Overall Study|Adverse Event|0|||
146445002|NCT00611884|528133807|FG002|Overall Study|Adverse Event|0|||
146445003|NCT00611884|528133808|FG003|Overall Study|Adverse Event|1|||
146445004|NCT00611884|528133805|FG000|Overall Study|Non-Compliance|1|||
146445005|NCT00611884|528133806|FG001|Overall Study|Non-Compliance|4|||
146445006|NCT00611884|528133807|FG002|Overall Study|Non-Compliance|2|||
146445007|NCT00611884|528133808|FG003|Overall Study|Non-Compliance|2|||
146445008|NCT00611884|528133805|FG000|Overall Study|Lack of Efficacy|0|||
146445009|NCT00611884|528133806|FG001|Overall Study|Lack of Efficacy|1|||
146445010|NCT00611884|528133807|FG002|Overall Study|Lack of Efficacy|0|||
146445011|NCT00611884|528133808|FG003|Overall Study|Lack of Efficacy|0|||
146445012|NCT00611884|528133805|FG000|Overall Study|Unclassified|7|||
146445013|NCT00611884|528133806|FG001|Overall Study|Unclassified|4|||
146445014|NCT00611884|528133807|FG002|Overall Study|Unclassified|2|||
146445015|NCT00611884|528133808|FG003|Overall Study|Unclassified|3|||
146445016|NCT00981799|528133809|FG000|Overall Study|Adverse Event|1|||
146445017|NCT00981799|528133810|FG001|Overall Study|Adverse Event|1|||
146445018|NCT00981799|528133811|FG002|Overall Study|Adverse Event|0|||
146445019|NCT00981799|528133812|FG003|Overall Study|Adverse Event|0|||
146445020|NCT02167594|528133813|FG000|Overall Study|Withdrawal by Subject|2|||
146445021|NCT02167594|528133814|FG001|Overall Study|Withdrawal by Subject|0|||
146445022|NCT02167594|528133815|FG002|Overall Study|Withdrawal by Subject|0|||
146445023|NCT02167594|528133813|FG000|Overall Study|Death|0|||
146445024|NCT02167594|528133814|FG001|Overall Study|Death|1|||
146445025|NCT02167594|528133815|FG002|Overall Study|Death|0|||
146445026|NCT03433703|528133816|FG000|Overall Study|Study terminated by Sponsor|2|||
146445027|NCT01943435|528133831|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
146445028|NCT01943435|528133832|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
146445029|NCT01943435|528133833|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
146445030|NCT01943435|528133831|FG000|Intervention Period|Withdrawal by Subject|3|||
146445031|NCT01943435|528133832|FG001|Intervention Period|Withdrawal by Subject|3|||
146445032|NCT01943435|528133833|FG002|Intervention Period|Withdrawal by Subject|4|||
146445033|NCT01943435|528133831|FG000|2 Month Follow up|Lost to Follow-up|2|||
146445034|NCT01943435|528133832|FG001|2 Month Follow up|Lost to Follow-up|3|||
146445035|NCT01943435|528133833|FG002|2 Month Follow up|Lost to Follow-up|0|||
145956133|NCT01124292|526351040|FG001|Overall Study|Lost to Follow-up|4|||
145956134|NCT01124292|526351041|FG002|Overall Study|Lost to Follow-up|3|||
145956135|NCT01124292|526351039|FG000|Overall Study|Physician Decision|0|||
145956136|NCT01124292|526351040|FG001|Overall Study|Physician Decision|3|||
145956137|NCT01124292|526351041|FG002|Overall Study|Physician Decision|2|||
145956138|NCT01124292|526351039|FG000|Overall Study|Withdrawal by Subject|0|||
145956139|NCT01124292|526351040|FG001|Overall Study|Withdrawal by Subject|6|||
145956140|NCT01124292|526351041|FG002|Overall Study|Withdrawal by Subject|2|||
145956141|NCT01124292|526351039|FG000|Overall Study|medical issue unrelated to the study|0|||
145956142|NCT01124292|526351040|FG001|Overall Study|medical issue unrelated to the study|0|||
145956143|NCT01124292|526351041|FG002|Overall Study|medical issue unrelated to the study|2|||
145956144|NCT01124292|526351039|FG000|Overall Study|piercing track closed|0|||
145956145|NCT01124292|526351040|FG001|Overall Study|piercing track closed|2|||
145956146|NCT01124292|526351041|FG002|Overall Study|piercing track closed|1|||
145956147|NCT00636636|526351043|FG000|Overall Study|Other reason|4|||
145956148|NCT00636636|526351044|FG001|Overall Study|Other reason|6|||
145956149|NCT00636636|526351043|FG000|Overall Study|Adverse Event|19|||
145956150|NCT00636636|526351044|FG001|Overall Study|Adverse Event|8|||
145956151|NCT00636636|526351043|FG000|Overall Study|Lack of Efficacy|7|||
145956152|NCT00636636|526351044|FG001|Overall Study|Lack of Efficacy|12|||
145956153|NCT00636636|526351043|FG000|Overall Study|Protocol Violation|2|||
145956154|NCT00636636|526351044|FG001|Overall Study|Protocol Violation|2|||
145956155|NCT00636636|526351043|FG000|Overall Study|Lost to Follow-up|0|||
146209558|NCT04992390|527280414|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
145956156|NCT00636636|526351044|FG001|Overall Study|Lost to Follow-up|1|||
145956157|NCT00636636|526351043|FG000|Overall Study|Death|0|||
145956158|NCT00636636|526351044|FG001|Overall Study|Death|1|||
145956159|NCT00636636|526351043|FG000|Overall Study|Withdrawal by Subject|4|||
145956160|NCT00636636|526351044|FG001|Overall Study|Withdrawal by Subject|9|||
145956161|NCT01366638|526351045|FG000|Overall Study|Withdrawal by Subject|0|||
145956162|NCT01366638|526351046|FG001|Overall Study|Withdrawal by Subject|0|||
145956163|NCT01366638|526351047|FG002|Overall Study|Withdrawal by Subject|6|||
146209559|NCT04992390|527280415|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
146285777|NCT01577745|527561120|FG005|Overall Study|Alternative Therapy|0|||
146445036|NCT01943435|528133831|FG000|6 Month Follow up|Lost to Follow-up|12|||
146445037|NCT01943435|528133832|FG001|6 Month Follow up|Lost to Follow-up|7|||
146445038|NCT01943435|528133833|FG002|6 Month Follow up|Lost to Follow-up|15|||
146445039|NCT01617096|528133840|FG000|Overall Study|Withdrawal by Subject|96|||
146445040|NCT01617096|528133841|FG001|Overall Study|Withdrawal by Subject|81|||
146445041|NCT01617096|528133840|FG000|Overall Study|Lost to Follow-up|37|||
146445042|NCT01617096|528133841|FG001|Overall Study|Lost to Follow-up|32|||
146445043|NCT01617096|528133840|FG000|Overall Study|Physician Decision|10|||
146445044|NCT01617096|528133841|FG001|Overall Study|Physician Decision|18|||
146445045|NCT01617096|528133840|FG000|Overall Study|Death|4|||
146445046|NCT01617096|528133841|FG001|Overall Study|Death|3|||
146445047|NCT01617096|528133840|FG000|Overall Study|Other|1|||
146445048|NCT01617096|528133841|FG001|Overall Study|Other|3|||
146445049|NCT02046122|528133846|FG000|Overall Study|Physician Decision|8|||
146445050|NCT02046122|528133846|FG000|Overall Study|Withdrawal by Subject|1|||
146445051|NCT04535986|528133849|FG000|Overall Study|Death|4|||
146445052|NCT04535986|528133850|FG001|Overall Study|Death|5|||
146445053|NCT04535986|528133849|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
146445054|NCT04535986|528133850|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
146445055|NCT04535986|528133849|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
146445056|NCT04535986|528133850|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
146445057|NCT04535986|528133849|FG000|Overall Study|Adverse Event|10|||
146445058|NCT04535986|528133850|FG001|Overall Study|Adverse Event|1|||
146445059|NCT04535986|528133849|FG000|Overall Study|Lack of Efficacy|3|||
146445060|NCT04535986|528133850|FG001|Overall Study|Lack of Efficacy|2|||
146445061|NCT04535986|528133849|FG000|Overall Study|Investigator discretion|3|||
146445062|NCT04535986|528133850|FG001|Overall Study|Investigator discretion|0|||
146445063|NCT04535986|528133849|FG000|Overall Study|Withdrawal by Subject|32|||
146445064|NCT04535986|528133850|FG001|Overall Study|Withdrawal by Subject|14|||
146445065|NCT04535986|528133849|FG000|Overall Study|Lost to Follow-up|5|||
146445066|NCT04535986|528133850|FG001|Overall Study|Lost to Follow-up|3|||
146445067|NCT04535986|528133849|FG000|Overall Study|Other|7|||
146445068|NCT04535986|528133850|FG001|Overall Study|Other|3|||
146445069|NCT01196390|528133851|FG000|Overall Study|Protocol Violation|4|||
146445070|NCT01196390|528133852|FG001|Overall Study|Protocol Violation|5|||
146445071|NCT03141151|528133861|FG000|Overall Study|Lost to Follow-up|3|||
146445072|NCT03141151|528133862|FG001|Overall Study|Lost to Follow-up|2|||
146445073|NCT03141151|528133861|FG000|Overall Study|Withdrawal by Subject|3|||
146445074|NCT03141151|528133862|FG001|Overall Study|Withdrawal by Subject|2|||
146445075|NCT04561115|528133863|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
146445076|NCT04561115|528133864|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
146445077|NCT04561115|528133863|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
146445078|NCT04561115|528133864|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
146445079|NCT04561115|528133863|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
146445080|NCT04561115|528133864|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
146445081|NCT02985398|528133865|FG000|Overall Study|Adverse Event|1|||
146445082|NCT02985398|528133865|FG000|Overall Study|Lost to Follow-up|4|||
146445083|NCT02985398|528133865|FG000|Overall Study|Withdrawal by Subject|8|||
146445084|NCT02985398|528133865|FG000|Overall Study|Study Burden|9|||
146445085|NCT00283842|528133870|FG000|Overall Study|Adverse Event|8|||
146445086|NCT00283842|528133871|FG001|Overall Study|Adverse Event|7|||
146445087|NCT00283842|528133872|FG002|Overall Study|Adverse Event|21|||
146445088|NCT00283842|528133873|FG003|Overall Study|Adverse Event|21|||
146445089|NCT00283842|528133874|FG004|Overall Study|Adverse Event|5|||
146445090|NCT00283842|528133870|FG000|Overall Study|Protocol Violation|1|||
146445091|NCT00283842|528133871|FG001|Overall Study|Protocol Violation|5|||
146445092|NCT00283842|528133872|FG002|Overall Study|Protocol Violation|4|||
146445093|NCT00283842|528133873|FG003|Overall Study|Protocol Violation|0|||
146445094|NCT00283842|528133874|FG004|Overall Study|Protocol Violation|0|||
146445095|NCT00283842|528133870|FG000|Overall Study|Protocol deviation|0|||
146445096|NCT00283842|528133871|FG001|Overall Study|Protocol deviation|0|||
146445097|NCT00283842|528133872|FG002|Overall Study|Protocol deviation|0|||
146445098|NCT00283842|528133873|FG003|Overall Study|Protocol deviation|0|||
146445099|NCT00283842|528133874|FG004|Overall Study|Protocol deviation|2|||
146445100|NCT00283842|528133870|FG000|Overall Study|Withdrawal by Subject|2|||
146445101|NCT00283842|528133871|FG001|Overall Study|Withdrawal by Subject|1|||
146083152|NCT05395091|526824762|FG000|Month 12 to Month 18|Other reasons|0|||
146083153|NCT05395091|526824763|FG001|Month 12 to Month 18|Other reasons|0|||
146083154|NCT05395091|526824764|FG002|Month 12 to Month 18|Other reasons|1|||
146083155|NCT01509053|526824766|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
146083156|NCT01509053|526824766|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
146083157|NCT01509053|526824766|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
146083158|NCT01509053|526824766|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
146083159|NCT01509053|526824766|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
146083160|NCT01509053|526824766|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
146083161|NCT01915303|526824769|FG000|Core Phase|Adverse Event|7|||
146083162|NCT01915303|526824769|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
146083163|NCT01915303|526824769|FG000|Core Phase|Death|2|||
146083164|NCT01915303|526824769|FG000|Core Phase|Protocol Violation|2|||
146083165|NCT01915303|526824769|FG000|Core Phase|Abnormal lab value|1|||
146083166|NCT01915303|526824769|FG000|Core Phase|Withdrawal by Subject|1|||
146083167|NCT01915303|526824769|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
146083168|NCT01915303|526824769|FG000|Extension Phase|Withdrawal by Subject|4|||
146083169|NCT01915303|526824769|FG000|Extension Phase|Adverse Event|3|||
146083170|NCT01915303|526824769|FG000|Extension Phase|Death|1|||
146083171|NCT01915303|526824769|FG000|Extension Phase|Protocol Violation|1|||
146083172|NCT00834080|526824771|FG000|Overall Study|Adverse Event|7|||
146083173|NCT00834080|526824771|FG000|Overall Study|Lost to Follow-up|7|||
146083174|NCT00834080|526824771|FG000|Overall Study|Withdrawal by Subject|5|||
146083175|NCT00834080|526824771|FG000|Overall Study|Other - Pregnancy|1|||
146083176|NCT00834080|526824771|FG000|Overall Study|Other - False positive tests of the UDS|1|||
146083177|NCT00834080|526824771|FG000|Overall Study|Physician Decision|1|||
146083178|NCT00834080|526824771|FG000|Overall Study|Subject Relocated|1|||
146083179|NCT00796523|526824775|FG000|Overall Study|Lost to Follow-up|9|||
146083180|NCT00796523|526824776|FG001|Overall Study|Lost to Follow-up|7|||
146083181|NCT00321646|526824778|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
146083182|NCT00321646|526824778|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
146083183|NCT00321646|526824778|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
146083184|NCT01284491|526824780|FG000|Overall Study|Study termination|13|||
146083185|NCT02694757|526824781|FG000|Overall Study|Lack of Efficacy|3|||
146083186|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
146083187|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
146083188|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
146083189|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
146083190|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
146083191|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
146083192|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
146083193|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
146083194|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
146083195|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
146083196|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
146083197|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
146083198|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
146083199|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
146083200|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
146083201|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
146083202|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
146083203|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146083204|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146083205|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
146083206|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
146083207|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146083208|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
146083209|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146083210|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
146083211|NCT00095147|526824782|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
146083212|NCT00095147|526824783|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
146083213|NCT00095147|526824784|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146083214|NCT00095147|526824785|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146083215|NCT00095147|526824786|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
146083216|NCT00095147|526824782|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
146083217|NCT00095147|526824783|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
146083218|NCT00095147|526824784|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
146083219|NCT00095147|526824785|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
146083220|NCT00095147|526824786|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
146083221|NCT00095147|526824782|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
146083222|NCT00095147|526824783|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
146083223|NCT00095147|526824784|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146083224|NCT00095147|526824785|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146083225|NCT00095147|526824786|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
146083226|NCT00095147|526824782|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
146083227|NCT00095147|526824783|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
146083228|NCT00095147|526824784|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
146083229|NCT00095147|526824785|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
146083230|NCT00095147|526824786|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
146083231|NCT00095147|526824782|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
146083232|NCT00095147|526824783|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
146083233|NCT00095147|526824784|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146083234|NCT00095147|526824785|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146083235|NCT00095147|526824786|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
146083236|NCT00095147|526824782|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
146083237|NCT00095147|526824783|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146083238|NCT00095147|526824784|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146083239|NCT00095147|526824785|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
146083240|NCT00095147|526824786|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
146083241|NCT00095147|526824782|FG000|Long-term Extension Period|Death|0|||
146083242|NCT00095147|526824783|FG001|Long-term Extension Period|Death|0|||
146083243|NCT00095147|526824784|FG002|Long-term Extension Period|Death|0|||
146083244|NCT00095147|526824785|FG003|Long-term Extension Period|Death|0|||
146083245|NCT00095147|526824786|FG004|Long-term Extension Period|Death|3|||
146083246|NCT00095147|526824782|FG000|Long-term Extension Period|Adverse Event|0|||
146083247|NCT00095147|526824783|FG001|Long-term Extension Period|Adverse Event|0|||
146083248|NCT00095147|526824784|FG002|Long-term Extension Period|Adverse Event|0|||
146083249|NCT00095147|526824785|FG003|Long-term Extension Period|Adverse Event|0|||
146445102|NCT00283842|528133872|FG002|Overall Study|Withdrawal by Subject|1|||
146445103|NCT00283842|528133873|FG003|Overall Study|Withdrawal by Subject|5|||
146445104|NCT00283842|528133874|FG004|Overall Study|Withdrawal by Subject|4|||
146445105|NCT00283842|528133870|FG000|Overall Study|Lack of Efficacy|1|||
146445106|NCT00283842|528133871|FG001|Overall Study|Lack of Efficacy|3|||
146445107|NCT00283842|528133872|FG002|Overall Study|Lack of Efficacy|1|||
146445108|NCT00283842|528133873|FG003|Overall Study|Lack of Efficacy|0|||
146445109|NCT00283842|528133874|FG004|Overall Study|Lack of Efficacy|3|||
146445110|NCT00283842|528133870|FG000|Overall Study|Lost to Follow-up|0|||
146445111|NCT00283842|528133871|FG001|Overall Study|Lost to Follow-up|2|||
146445112|NCT00283842|528133872|FG002|Overall Study|Lost to Follow-up|4|||
145956164|NCT01366638|526351045|FG000|Overall Study|Other|1|||
145956165|NCT01366638|526351046|FG001|Overall Study|Other|0|||
145956166|NCT01366638|526351047|FG002|Overall Study|Other|0|||
145956167|NCT01237327|526351048|FG000|Overall Study|Protocol Violation: Core Study|1|||
145956168|NCT01237327|526351049|FG001|Overall Study|Protocol Violation: Core Study|0|||
145956169|NCT01237327|526351048|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
145956170|NCT01237327|526351049|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
145956171|NCT01237327|526351048|FG000|Overall Study|Progression of Disease: Core Study|18|||
146083250|NCT00095147|526824786|FG004|Long-term Extension Period|Adverse Event|11|||
146083251|NCT00095147|526824782|FG000|Long-term Extension Period|Lack of Efficacy|0|||
146445113|NCT00283842|528133873|FG003|Overall Study|Lost to Follow-up|1|||
146445114|NCT00283842|528133874|FG004|Overall Study|Lost to Follow-up|1|||
146445115|NCT02004691|528133875|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
146445116|NCT02004691|528133876|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
146445117|NCT02004691|528133875|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
146445118|NCT02004691|528133876|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
146445119|NCT02004691|528133875|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
146445120|NCT02004691|528133876|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
146445121|NCT02004691|528133875|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
146083252|NCT00095147|526824783|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146083253|NCT00095147|526824784|FG002|Long-term Extension Period|Lack of Efficacy|0|||
146083254|NCT00095147|526824785|FG003|Long-term Extension Period|Lack of Efficacy|0|||
146083255|NCT00095147|526824786|FG004|Long-term Extension Period|Lack of Efficacy|9|||
146445122|NCT02004691|528133876|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
146445123|NCT02004691|528133875|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
146445124|NCT02004691|528133876|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
146445125|NCT02004691|528133875|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
146083256|NCT00095147|526824782|FG000|Long-term Extension Period|Lost to Follow-up|0|||
146083257|NCT00095147|526824783|FG001|Long-term Extension Period|Lost to Follow-up|0|||
146445126|NCT02004691|528133876|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
146445127|NCT02472639|528133877|FG000|Overall Study|Physician Decision|4|||
146445128|NCT02472639|528133878|FG001|Overall Study|Physician Decision|3|||
146445129|NCT00751023|528133879|FG000|Overall Study|Lost to Follow-up|11|||
145956172|NCT01237327|526351049|FG001|Overall Study|Progression of Disease: Core Study|22|||
145956173|NCT01237327|526351048|FG000|Overall Study|Progression of Disease: Extension Study|15|||
145956174|NCT01237327|526351049|FG001|Overall Study|Progression of Disease: Extension Study|13|||
145956175|NCT01237327|526351048|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
145956176|NCT01237327|526351049|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
145956177|NCT01237327|526351048|FG000|Overall Study|Withdrawal by Subject|1|||
145956178|NCT01237327|526351049|FG001|Overall Study|Withdrawal by Subject|3|||
145956179|NCT01237327|526351048|FG000|Overall Study|Lost to Follow-up|3|||
145956180|NCT01237327|526351049|FG001|Overall Study|Lost to Follow-up|0|||
145956181|NCT00524173|526351050|FG000|Overall Study|Lost to Follow-up|0|||
145956182|NCT00524173|526351051|FG001|Overall Study|Lost to Follow-up|1|||
145956183|NCT00524173|526351050|FG000|Overall Study|Death|1|||
145956184|NCT00524173|526351051|FG001|Overall Study|Death|0|||
145956185|NCT00524173|526351050|FG000|Overall Study|Had not reached endpoint at study close|4|||
145956186|NCT00524173|526351051|FG001|Overall Study|Had not reached endpoint at study close|1|||
145956187|NCT03300180|526351052|FG000|Baseline|Withdrawal by Subject|4|||
145956188|NCT03300180|526351053|FG001|Baseline|Withdrawal by Subject|6|||
145956189|NCT03300180|526351054|FG002|Baseline|Withdrawal by Subject|4|||
145956190|NCT03300180|526351052|FG000|6 Month Outcome|Withdrawal by Subject|12|||
145956191|NCT03300180|526351053|FG001|6 Month Outcome|Withdrawal by Subject|12|||
145956192|NCT03300180|526351054|FG002|6 Month Outcome|Withdrawal by Subject|19|||
145956193|NCT03300180|526351052|FG000|6 Month Outcome|Death|2|||
145956194|NCT03300180|526351053|FG001|6 Month Outcome|Death|4|||
145956195|NCT03300180|526351054|FG002|6 Month Outcome|Death|3|||
145956196|NCT03300180|526351052|FG000|6 Month Outcome|Missed Assessment|43|||
145956197|NCT03300180|526351053|FG001|6 Month Outcome|Missed Assessment|52|||
145956198|NCT03300180|526351054|FG002|6 Month Outcome|Missed Assessment|46|||
145956199|NCT03300180|526351052|FG000|12 Month Outcome|Withdrawal by Subject|3|||
145956200|NCT03300180|526351053|FG001|12 Month Outcome|Withdrawal by Subject|6|||
145956201|NCT03300180|526351054|FG002|12 Month Outcome|Withdrawal by Subject|6|||
145956202|NCT03300180|526351052|FG000|12 Month Outcome|Death|9|||
145956203|NCT03300180|526351053|FG001|12 Month Outcome|Death|6|||
145956204|NCT03300180|526351054|FG002|12 Month Outcome|Death|6|||
145956205|NCT03300180|526351052|FG000|12 Month Outcome|Missed Assessment|62|||
145956206|NCT03300180|526351053|FG001|12 Month Outcome|Missed Assessment|59|||
145956207|NCT03300180|526351054|FG002|12 Month Outcome|Missed Assessment|58|||
145956208|NCT03300180|526351052|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
145956209|NCT03300180|526351053|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
145956210|NCT03300180|526351054|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
145956211|NCT03300180|526351052|FG000|18 Month Outcome Assessment|Death|8|||
145956212|NCT03300180|526351053|FG001|18 Month Outcome Assessment|Death|5|||
145956213|NCT03300180|526351054|FG002|18 Month Outcome Assessment|Death|5|||
145956214|NCT03300180|526351052|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
145956215|NCT03300180|526351053|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
145956216|NCT03300180|526351054|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
145956217|NCT03300180|526351052|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
145956218|NCT03300180|526351053|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
145956219|NCT03300180|526351054|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
146445130|NCT00751023|528133880|FG001|Overall Study|Lost to Follow-up|7|||
146445131|NCT01211262|528133884|FG000|Overall Study|Progressive Disease|18|||
146445132|NCT01211262|528133885|FG001|Overall Study|Progressive Disease|9|||
146445133|NCT01211262|528133884|FG000|Overall Study|Adverse Event|4|||
146445134|NCT01211262|528133885|FG001|Overall Study|Adverse Event|0|||
146445135|NCT01211262|528133884|FG000|Overall Study|Withdrawal of Consent|1|||
146445136|NCT01211262|528133885|FG001|Overall Study|Withdrawal of Consent|0|||
146445137|NCT01211262|528133884|FG000|Overall Study|Other|0|||
146445138|NCT01211262|528133885|FG001|Overall Study|Other|1|||
146445139|NCT01277510|528133886|FG000|Double-blind Phase|Non-compliance|0|||
146445140|NCT01277510|528133887|FG001|Double-blind Phase|Non-compliance|1|||
145956220|NCT03300180|526351052|FG000|24 Month Outcome Assessment|Death|13|||
145956221|NCT03300180|526351053|FG001|24 Month Outcome Assessment|Death|13|||
146083258|NCT00095147|526824784|FG002|Long-term Extension Period|Lost to Follow-up|0|||
146083259|NCT00095147|526824785|FG003|Long-term Extension Period|Lost to Follow-up|0|||
146083260|NCT00095147|526824786|FG004|Long-term Extension Period|Lost to Follow-up|6|||
146285778|NCT00122460|527561121|FG000|Overall Study|investigational study phase ongoing|7|||
146445141|NCT01277510|528133886|FG000|Double-blind Phase|Adverse Event|1|||
146445142|NCT01277510|528133887|FG001|Double-blind Phase|Adverse Event|0|||
145956222|NCT03300180|526351054|FG002|24 Month Outcome Assessment|Death|3|||
145956223|NCT03300180|526351052|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
145956224|NCT03300180|526351053|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
145956225|NCT03300180|526351054|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
145956226|NCT01941537|526351057|FG000|Overall Study|Lack of Efficacy|1|||
145956227|NCT01941537|526351058|FG001|Overall Study|Lack of Efficacy|2|||
145956228|NCT01941537|526351057|FG000|Overall Study|Lost to Follow-up|1|||
146445143|NCT01277510|528133886|FG000|Double-blind Phase|Withdrawal by Subject|2|||
146445144|NCT01277510|528133887|FG001|Double-blind Phase|Withdrawal by Subject|0|||
146445145|NCT01277510|528133886|FG000|Double-blind Phase|Administrative decision|7|||
146445146|NCT01277510|528133887|FG001|Double-blind Phase|Administrative decision|9|||
146445147|NCT01277510|528133886|FG000|Double-blind Phase|Death|0|||
146445148|NCT01277510|528133887|FG001|Double-blind Phase|Death|1|||
146445149|NCT01277510|528133886|FG000|Double-blind Phase|Protocol-specified criteria|2|||
146445150|NCT01277510|528133887|FG001|Double-blind Phase|Protocol-specified criteria|6|||
146445151|NCT01277510|528133886|FG000|Double-blind Phase|Other|1|||
146445152|NCT01277510|528133887|FG001|Double-blind Phase|Other|1|||
146445153|NCT01277510|528133886|FG000|Open-label Phase|Administrative decision|4|||
146445154|NCT01277510|528133887|FG001|Open-label Phase|Administrative decision|3|||
146445155|NCT01277510|528133886|FG000|Open-label Phase|Protocol-specified criteria|1|||
146445156|NCT01277510|528133887|FG001|Open-label Phase|Protocol-specified criteria|0|||
146445157|NCT01277510|528133886|FG000|Open-label Phase|Never received investigational product|2|||
146445158|NCT01277510|528133887|FG001|Open-label Phase|Never received investigational product|0|||
146445159|NCT01685008|528133888|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
146445160|NCT01685008|528133889|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
146445161|NCT01685008|528133890|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
146445162|NCT01685008|528133891|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
146445163|NCT01685008|528133888|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
146445164|NCT01685008|528133889|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
145956229|NCT01941537|526351058|FG001|Overall Study|Lost to Follow-up|0|||
146445165|NCT01685008|528133890|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
146445166|NCT01685008|528133891|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
146445167|NCT01685008|528133888|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
146445168|NCT01685008|528133889|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
146445169|NCT01685008|528133890|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
146445170|NCT01685008|528133891|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
146445171|NCT01685008|528133888|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
146445172|NCT01685008|528133889|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
146445173|NCT01685008|528133890|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
146445174|NCT01685008|528133891|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
146445175|NCT01685008|528133888|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
146445176|NCT01685008|528133889|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
146445177|NCT01685008|528133890|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
146445178|NCT01685008|528133891|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
146445179|NCT04049097|528133892|FG000|Overall Study|Adverse Event|18|||
146445180|NCT04049097|528133892|FG000|Overall Study|Death|2|||
146445181|NCT04049097|528133892|FG000|Overall Study|Lost to Follow-up|1|||
146445182|NCT04049097|528133892|FG000|Overall Study|Physician Decision|2|||
146445183|NCT04049097|528133892|FG000|Overall Study|Withdrawal by Subject|9|||
146445184|NCT04049097|528133892|FG000|Overall Study|Protocol Violation|2|||
146445185|NCT04049097|528133892|FG000|Overall Study|Other|1|||
146445186|NCT04049097|528133892|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
146445187|NCT01320722|528133893|FG000|Overall Study|Did not Receive Intervention|3|||
146445188|NCT01320722|528133894|FG001|Overall Study|Did not Receive Intervention|2|||
146445189|NCT01320722|528133895|FG002|Overall Study|Did not Receive Intervention|1|||
145956230|NCT01941537|526351057|FG000|Overall Study|Pregnancy|1|||
145956231|NCT01941537|526351058|FG001|Overall Study|Pregnancy|0|||
145956232|NCT01941537|526351057|FG000|Overall Study|Adverse Event|1|||
146285779|NCT00122460|527561122|FG001|Overall Study|investigational study phase ongoing|1|||
146445190|NCT01320722|528133896|FG003|Overall Study|Did not Receive Intervention|1|||
146445191|NCT01320722|528133897|FG004|Overall Study|Did not Receive Intervention|2|||
146445192|NCT01320722|528133893|FG000|Overall Study|Lost to Follow-up|0|||
146445193|NCT01320722|528133894|FG001|Overall Study|Lost to Follow-up|1|||
146445194|NCT01320722|528133895|FG002|Overall Study|Lost to Follow-up|0|||
146445195|NCT01320722|528133896|FG003|Overall Study|Lost to Follow-up|1|||
146445196|NCT01320722|528133897|FG004|Overall Study|Lost to Follow-up|3|||
146445197|NCT01320722|528133893|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
145956233|NCT01941537|526351058|FG001|Overall Study|Adverse Event|0|||
146445198|NCT01320722|528133894|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
146445199|NCT01320722|528133895|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
146445200|NCT01320722|528133896|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
146445201|NCT01320722|528133897|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
146445202|NCT01320722|528133893|FG000|Overall Study|Participant Developed a Rash|0|||
146445203|NCT01320722|528133894|FG001|Overall Study|Participant Developed a Rash|0|||
146445204|NCT01320722|528133895|FG002|Overall Study|Participant Developed a Rash|2|||
146445205|NCT01320722|528133896|FG003|Overall Study|Participant Developed a Rash|1|||
146445206|NCT01320722|528133897|FG004|Overall Study|Participant Developed a Rash|1|||
146445207|NCT01320722|528133893|FG000|Overall Study|Non-compliant with Medication|0|||
146445208|NCT01320722|528133894|FG001|Overall Study|Non-compliant with Medication|0|||
146445209|NCT01320722|528133895|FG002|Overall Study|Non-compliant with Medication|1|||
146445210|NCT01320722|528133896|FG003|Overall Study|Non-compliant with Medication|0|||
146445211|NCT01320722|528133897|FG004|Overall Study|Non-compliant with Medication|0|||
146445212|NCT01320722|528133893|FG000|Overall Study|Adverse Event|0|||
146445213|NCT01320722|528133894|FG001|Overall Study|Adverse Event|0|||
146445214|NCT01320722|528133895|FG002|Overall Study|Adverse Event|3|||
146445215|NCT01320722|528133896|FG003|Overall Study|Adverse Event|6|||
146445216|NCT01320722|528133897|FG004|Overall Study|Adverse Event|0|||
146445217|NCT01320722|528133893|FG000|Overall Study|Not Compliant with Study Procedures|0|||
146445218|NCT01320722|528133894|FG001|Overall Study|Not Compliant with Study Procedures|0|||
146445219|NCT01320722|528133895|FG002|Overall Study|Not Compliant with Study Procedures|0|||
146445220|NCT01320722|528133896|FG003|Overall Study|Not Compliant with Study Procedures|4|||
146445221|NCT01320722|528133897|FG004|Overall Study|Not Compliant with Study Procedures|0|||
146445222|NCT01320722|528133893|FG000|Overall Study|Pregnancy|0|||
146445223|NCT01320722|528133894|FG001|Overall Study|Pregnancy|0|||
146445224|NCT01320722|528133895|FG002|Overall Study|Pregnancy|0|||
146445225|NCT01320722|528133896|FG003|Overall Study|Pregnancy|1|||
146445226|NCT01320722|528133897|FG004|Overall Study|Pregnancy|0|||
146445227|NCT01320722|528133893|FG000|Overall Study|Started an Exclusionary Medication|0|||
146445228|NCT01320722|528133894|FG001|Overall Study|Started an Exclusionary Medication|0|||
146445229|NCT01320722|528133895|FG002|Overall Study|Started an Exclusionary Medication|0|||
146445230|NCT01320722|528133896|FG003|Overall Study|Started an Exclusionary Medication|0|||
146445231|NCT01320722|528133897|FG004|Overall Study|Started an Exclusionary Medication|1|||
146445232|NCT01320722|528133893|FG000|Overall Study|Withdrew due to Health Condition|0|||
146445233|NCT01320722|528133894|FG001|Overall Study|Withdrew due to Health Condition|0|||
146445234|NCT01320722|528133895|FG002|Overall Study|Withdrew due to Health Condition|0|||
146445235|NCT01320722|528133896|FG003|Overall Study|Withdrew due to Health Condition|0|||
146445236|NCT01320722|528133897|FG004|Overall Study|Withdrew due to Health Condition|1|||
146445237|NCT01341405|528133902|FG000|Overall Study|Adverse Event|0|||
146445238|NCT01341405|528133903|FG001|Overall Study|Adverse Event|1|||
146445239|NCT01341405|528133904|FG002|Overall Study|Adverse Event|1|||
146445240|NCT01341405|528133902|FG000|Overall Study|Withdrawal by Subject|3|||
146445241|NCT01341405|528133903|FG001|Overall Study|Withdrawal by Subject|2|||
145956234|NCT01941537|526351057|FG000|Overall Study|Withdrawal by Subject|0|||
145956235|NCT01941537|526351058|FG001|Overall Study|Withdrawal by Subject|1|||
145956236|NCT00669318|526352416|FG000|Overall Study|Withdrawal by Subject|2|||
145956237|NCT00524771|526352417|FG000|Overall Study|Protocol Violation|220|||
145956238|NCT00524771|526352418|FG001|Overall Study|Protocol Violation|585|||
145956239|NCT01223404|526352419|FG000|First Intervention (1 Day)|Adverse Event|0|||
145956240|NCT01223404|526352420|FG001|First Intervention (1 Day)|Adverse Event|0|||
145956241|NCT01223404|526352421|FG002|First Intervention (1 Day)|Adverse Event|0|||
145956242|NCT01223404|526352422|FG003|First Intervention (1 Day)|Adverse Event|1|||
145956243|NCT01223404|526352423|FG004|First Intervention (1 Day)|Adverse Event|0|||
145956244|NCT01223404|526352424|FG005|First Intervention (1 Day)|Adverse Event|0|||
145956245|NCT01223404|526352419|FG000|Second Intervention (1 Day)|Adverse Event|1|||
145956246|NCT01223404|526352420|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145956247|NCT01223404|526352421|FG002|Second Intervention (1 Day)|Adverse Event|0|||
145956248|NCT01223404|526352422|FG003|Second Intervention (1 Day)|Adverse Event|0|||
145956249|NCT01223404|526352423|FG004|Second Intervention (1 Day)|Adverse Event|0|||
145956250|NCT01223404|526352424|FG005|Second Intervention (1 Day)|Adverse Event|0|||
146209560|NCT04992390|527280416|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
146445242|NCT01341405|528133904|FG002|Overall Study|Withdrawal by Subject|1|||
146445243|NCT03407729|528133905|FG000|Overall Study|Lost to Follow-up|2|||
146445244|NCT03407729|528133906|FG001|Overall Study|Lost to Follow-up|0|||
146445245|NCT03407729|528133905|FG000|Overall Study|Unable to schedule|0|||
146445246|NCT03407729|528133906|FG001|Overall Study|Unable to schedule|3|||
146445247|NCT03950674|528133907|FG000|Overall Study|Death|16|||
145956251|NCT01223404|526352419|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145956252|NCT01223404|526352420|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145956253|NCT01223404|526352421|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145956254|NCT01223404|526352422|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
145956255|NCT01223404|526352423|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
146445248|NCT03950674|528133908|FG001|Overall Study|Death|15|||
146445249|NCT03950674|528133907|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
146445250|NCT03950674|528133908|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
146445251|NCT03428945|528133910|FG000|Overall Study|Lost to Follow-up|5|||
146445252|NCT03428945|528133911|FG001|Overall Study|Lost to Follow-up|3|||
146445253|NCT03428945|528133910|FG000|Overall Study|Withdrawal by Subject|10|||
146445254|NCT03428945|528133911|FG001|Overall Study|Withdrawal by Subject|10|||
146445255|NCT00982228|528133912|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
146445256|NCT00982228|528133913|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
146445257|NCT00982228|528133912|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
146209561|NCT04992390|527280414|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
146209562|NCT04992390|527280415|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
146209563|NCT04992390|527280416|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
146445258|NCT00982228|528133913|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
146445259|NCT00982228|528133912|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
146445260|NCT00982228|528133913|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
146445261|NCT00982228|528133912|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
146445262|NCT00982228|528133913|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
146445263|NCT00982228|528133912|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
146445264|NCT00982228|528133913|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
146209564|NCT04992390|527280414|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
146209565|NCT04992390|527280415|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
146445265|NCT00982228|528133912|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
146445266|NCT00982228|528133913|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
146445267|NCT00982228|528133912|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
146445268|NCT00982228|528133913|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
146445269|NCT00982228|528133912|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
146445270|NCT00982228|528133913|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
146445271|NCT00982228|528133912|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
146445272|NCT00982228|528133913|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
146445273|NCT00982228|528133912|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
146445274|NCT00982228|528133913|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
146445275|NCT00360490|528133917|FG000|Overall Study|Adverse Event|4|||
146445276|NCT00360490|528133918|FG001|Overall Study|Adverse Event|2|||
146445277|NCT00360490|528133917|FG000|Overall Study|Lost to Follow-up|2|||
146445278|NCT00360490|528133918|FG001|Overall Study|Lost to Follow-up|1|||
146445279|NCT00360490|528133917|FG000|Overall Study|Physician Decision|2|||
146445280|NCT00360490|528133918|FG001|Overall Study|Physician Decision|1|||
146445281|NCT00360490|528133917|FG000|Overall Study|Protocol Violation|0|||
146445282|NCT00360490|528133918|FG001|Overall Study|Protocol Violation|4|||
146445283|NCT00360490|528133917|FG000|Overall Study|Withdrawal by Subject|1|||
146445284|NCT00360490|528133918|FG001|Overall Study|Withdrawal by Subject|3|||
146445285|NCT00633022|528133920|FG000|Overall Study|Adverse Event|1|||
146445286|NCT00633022|528133921|FG001|Overall Study|Adverse Event|0|||
146445287|NCT00633022|528133922|FG002|Overall Study|Adverse Event|5|||
146445288|NCT00633022|528133920|FG000|Overall Study|Physician Decision|0|||
146445289|NCT00633022|528133921|FG001|Overall Study|Physician Decision|1|||
146445290|NCT00633022|528133922|FG002|Overall Study|Physician Decision|0|||
146445291|NCT05135273|528135316|FG000|Overall Study|Recruited into the army|0|||
146445292|NCT05135273|528135317|FG001|Overall Study|Recruited into the army|0|||
146445293|NCT05135273|528135318|FG002|Overall Study|Recruited into the army|0|||
146445294|NCT05135273|528135319|FG003|Overall Study|Recruited into the army|0|||
146445295|NCT05135273|528135320|FG004|Overall Study|Recruited into the army|1|||
146445296|NCT05135273|528135321|FG005|Overall Study|Recruited into the army|0|||
146445297|NCT05135273|528135322|FG006|Overall Study|Recruited into the army|0|||
146445298|NCT05135273|528135323|FG007|Overall Study|Recruited into the army|0|||
146445299|NCT05135273|528135316|FG000|Overall Study|Moved away from study site|0|||
146445300|NCT05135273|528135317|FG001|Overall Study|Moved away from study site|0|||
146445301|NCT05135273|528135318|FG002|Overall Study|Moved away from study site|0|||
146445302|NCT05135273|528135319|FG003|Overall Study|Moved away from study site|0|||
146445303|NCT05135273|528135320|FG004|Overall Study|Moved away from study site|0|||
145890971|NCT01207440|526107573|FG003|Overall Study|Withdrawal by Subject|3|||
146445304|NCT05135273|528135321|FG005|Overall Study|Moved away from study site|1|||
146445305|NCT05135273|528135322|FG006|Overall Study|Moved away from study site|1|||
146445306|NCT05135273|528135323|FG007|Overall Study|Moved away from study site|0|||
146445307|NCT05135273|528135316|FG000|Overall Study|Travel|0|||
146445308|NCT05135273|528135317|FG001|Overall Study|Travel|0|||
146445309|NCT05135273|528135318|FG002|Overall Study|Travel|0|||
146445310|NCT05135273|528135319|FG003|Overall Study|Travel|0|||
146445311|NCT05135273|528135320|FG004|Overall Study|Travel|0|||
146445312|NCT05135273|528135321|FG005|Overall Study|Travel|0|||
146445313|NCT05135273|528135322|FG006|Overall Study|Travel|0|||
146445314|NCT05135273|528135323|FG007|Overall Study|Travel|1|||
146445315|NCT01958060|528135326|FG000|Overall Study|Not treated|2|||
146445316|NCT01958060|528135327|FG001|Overall Study|Not treated|0|||
146445317|NCT01958060|528135328|FG002|Overall Study|Not treated|0|||
146445318|NCT01958060|528135329|FG003|Overall Study|Not treated|0|||
146445319|NCT01958060|528135330|FG004|Overall Study|Not treated|1|||
146445320|NCT01958060|528135331|FG005|Overall Study|Not treated|0|||
146445321|NCT01705717|528135332|FG000|Overall Study|Adverse Event|2|||
146445322|NCT01705717|528135333|FG001|Overall Study|Adverse Event|2|||
146445323|NCT01705717|528135332|FG000|Overall Study|Lack of Efficacy|0|||
146445324|NCT01705717|528135333|FG001|Overall Study|Lack of Efficacy|1|||
146445325|NCT01705717|528135332|FG000|Overall Study|Other|0|||
146445326|NCT01705717|528135333|FG001|Overall Study|Other|2|||
146445327|NCT00500318|528135338|FG000|Overall Study|Adverse Event|3|||
146445328|NCT00500318|528135339|FG001|Overall Study|Adverse Event|8|||
146445329|NCT00500318|528135338|FG000|Overall Study|Protocol Violation|1|||
146445330|NCT00500318|528135339|FG001|Overall Study|Protocol Violation|3|||
146445331|NCT00500318|528135338|FG000|Overall Study|Withdrawal by Subject|1|||
146445332|NCT00500318|528135339|FG001|Overall Study|Withdrawal by Subject|2|||
146445333|NCT00500318|528135338|FG000|Overall Study|Lack of Efficacy|0|||
146445334|NCT00500318|528135339|FG001|Overall Study|Lack of Efficacy|3|||
146445335|NCT00500318|528135338|FG000|Overall Study|Other Reason|0|||
146445336|NCT00500318|528135339|FG001|Overall Study|Other Reason|1|||
146445337|NCT00799708|528135340|FG000|Overall Study|non-compliance|1|||
146445338|NCT00799708|528135341|FG001|Overall Study|non-compliance|0|||
146445339|NCT00799708|528135342|FG002|Overall Study|non-compliance|0|||
146445340|NCT00880334|528135343|FG000|Randomized Phase|Physician Decision|1|||
146445341|NCT00880334|528135344|FG001|Randomized Phase|Physician Decision|0|||
146445342|NCT00880334|528135343|FG000|Randomized Phase|Withdrawal by Subject|2|||
146445343|NCT00880334|528135344|FG001|Randomized Phase|Withdrawal by Subject|1|||
146445344|NCT00880334|528135343|FG000|Randomized Phase|Inadequate Labs|1|||
146445345|NCT00880334|528135344|FG001|Randomized Phase|Inadequate Labs|1|||
146445346|NCT00880334|528135343|FG000|Randomized Phase|Brain Metastasis|0|||
146445347|NCT00880334|528135344|FG001|Randomized Phase|Brain Metastasis|1|||
146445348|NCT00880334|528135343|FG000|Randomized Phase|Crossover Participants|0|||
146445349|NCT00880334|528135344|FG001|Randomized Phase|Crossover Participants|37|||
146445350|NCT02473393|528135345|FG000|Overall Study|Adverse Event|0|||
146445351|NCT02473393|528135346|FG001|Overall Study|Adverse Event|0|||
146445352|NCT02473393|528135347|FG002|Overall Study|Adverse Event|1|||
146445353|NCT02473393|528135348|FG003|Overall Study|Adverse Event|0|||
146445354|NCT02473393|528135345|FG000|Overall Study|Withdrawal by Subject|0|||
146445355|NCT02473393|528135346|FG001|Overall Study|Withdrawal by Subject|0|||
146445356|NCT02473393|528135347|FG002|Overall Study|Withdrawal by Subject|1|||
146445357|NCT02473393|528135348|FG003|Overall Study|Withdrawal by Subject|1|||
146445358|NCT01157234|528135351|FG000|Overall Study|Withdrawal by Subject|1|||
146445359|NCT01157234|528135352|FG001|Overall Study|Withdrawal by Subject|0|||
146445360|NCT00063258|528135358|FG000|Overall Study|Physician Decision|2|||
146445361|NCT00063258|528135359|FG001|Overall Study|Physician Decision|0|||
146445362|NCT00063258|528135358|FG000|Overall Study|Lack of Efficacy|2|||
146445363|NCT00063258|528135359|FG001|Overall Study|Lack of Efficacy|0|||
146445364|NCT02246764|528135360|FG000|Overall Study|Adverse Event|15|||
146445365|NCT02246764|528135361|FG001|Overall Study|Adverse Event|29|||
146445366|NCT02246764|528135362|FG002|Overall Study|Adverse Event|1|||
146445367|NCT02246764|528135360|FG000|Overall Study|Withdrawal by Subject|0|||
146445368|NCT02246764|528135361|FG001|Overall Study|Withdrawal by Subject|0|||
146445369|NCT02246764|528135362|FG002|Overall Study|Withdrawal by Subject|1|||
146445370|NCT02246764|528135360|FG000|Overall Study|Disallowed Concomitant Medication|1|||
146445371|NCT02246764|528135361|FG001|Overall Study|Disallowed Concomitant Medication|0|||
146445372|NCT02246764|528135362|FG002|Overall Study|Disallowed Concomitant Medication|0|||
146445373|NCT02246764|528135360|FG000|Overall Study|Physician Decision|0|||
146445374|NCT02246764|528135361|FG001|Overall Study|Physician Decision|2|||
146445375|NCT02246764|528135362|FG002|Overall Study|Physician Decision|1|||
146445376|NCT02246764|528135360|FG000|Overall Study|Protocol Violation|2|||
146445377|NCT02246764|528135361|FG001|Overall Study|Protocol Violation|1|||
146445378|NCT02246764|528135362|FG002|Overall Study|Protocol Violation|1|||
146445379|NCT05393271|528135363|FG000|Overall Study|Physician Decision|0|||
146445380|NCT05393271|528135364|FG001|Overall Study|Physician Decision|0|||
146445381|NCT05393271|528135365|FG002|Overall Study|Physician Decision|0|||
146445382|NCT05393271|528135366|FG003|Overall Study|Physician Decision|0|||
146445383|NCT05393271|528135367|FG004|Overall Study|Physician Decision|0|||
146445384|NCT05393271|528135368|FG005|Overall Study|Physician Decision|0|||
146445385|NCT05393271|528135369|FG006|Overall Study|Physician Decision|1|||
146445386|NCT05393271|528135370|FG007|Overall Study|Physician Decision|0|||
146445387|NCT05393271|528135371|FG008|Overall Study|Physician Decision|0|||
146445388|NCT05393271|528135372|FG009|Overall Study|Physician Decision|0|||
146445389|NCT05393271|528135373|FG010|Overall Study|Physician Decision|0|||
146445390|NCT00413049|528135378|FG000|Overall Study|Adverse Event|10|||
146445391|NCT00413049|528135379|FG001|Overall Study|Adverse Event|8|||
146445392|NCT00413049|528135378|FG000|Overall Study|Withdrawal by Subject|7|||
146445393|NCT00413049|528135379|FG001|Overall Study|Withdrawal by Subject|5|||
146445394|NCT00413049|528135378|FG000|Overall Study|Lost to Follow-up|2|||
146445395|NCT00413049|528135379|FG001|Overall Study|Lost to Follow-up|3|||
146445396|NCT00413049|528135378|FG000|Overall Study|Protocol Violation|3|||
146445397|NCT00413049|528135379|FG001|Overall Study|Protocol Violation|1|||
146445398|NCT00413049|528135378|FG000|Overall Study|Subject no longer requires study drug|0|||
146445399|NCT00413049|528135379|FG001|Overall Study|Subject no longer requires study drug|1|||
146445400|NCT00413049|528135378|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146445401|NCT00413049|528135379|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146445402|NCT00413049|528135378|FG000|Overall Study|Lack of Efficacy|1|||
146445403|NCT00413049|528135379|FG001|Overall Study|Lack of Efficacy|0|||
146445404|NCT03314857|528135382|FG000|Overall Study|Death|4|||
146445405|NCT03314857|528135382|FG000|Overall Study|Physician Decision|1|||
146445406|NCT01408888|528135385|FG000|First Intervention|Adverse Event|0|||
146445407|NCT01408888|528135386|FG001|First Intervention|Adverse Event|1|||
146445408|NCT01408888|528135385|FG000|First Intervention|Withdrawal by Subject|0|||
146445409|NCT01408888|528135386|FG001|First Intervention|Withdrawal by Subject|2|||
146445410|NCT01408888|528135385|FG000|Second Intervention|Withdrawal by Subject|1|||
146445411|NCT01408888|528135386|FG001|Second Intervention|Withdrawal by Subject|0|||
146445412|NCT01408888|528135385|FG000|Second Intervention|Adverse Event|1|||
146445413|NCT01408888|528135386|FG001|Second Intervention|Adverse Event|0|||
146445414|NCT00695110|528135391|FG000|Treatment Period 1|Adverse Event|1|||
146445415|NCT00695110|528135391|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146445416|NCT00695110|528135391|FG000|Treatment Period 3|Withdrawal by Subject|1|||
146445417|NCT00695110|528135391|FG000|Treatment Period 4|Adverse Event|1|||
146445418|NCT02104817|528135392|FG000|Overall Study|Death|363|||
146445419|NCT02104817|528135393|FG001|Overall Study|Death|330|||
146445420|NCT02104817|528135392|FG000|Overall Study|Lost to Follow-up|3|||
146445421|NCT02104817|528135393|FG001|Overall Study|Lost to Follow-up|2|||
146445422|NCT02104817|528135392|FG000|Overall Study|Protocol Violation|0|||
146445423|NCT02104817|528135393|FG001|Overall Study|Protocol Violation|1|||
146445424|NCT02104817|528135392|FG000|Overall Study|Study terminated by sponsor|5854|||
146445425|NCT02104817|528135393|FG001|Overall Study|Study terminated by sponsor|5901|||
146445426|NCT02104817|528135392|FG000|Overall Study|Withdrawal by Subject|111|||
146445427|NCT02104817|528135393|FG001|Overall Study|Withdrawal by Subject|78|||
146445428|NCT02104817|528135392|FG000|Overall Study|Other reasons|128|||
146445429|NCT02104817|528135393|FG001|Overall Study|Other reasons|135|||
146445430|NCT02575339|528135397|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
146445431|NCT02575339|528135398|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146445432|NCT02575339|528135399|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146445433|NCT02575339|528135397|FG000|Study Treatment|Disease Progression|5|||
146445434|NCT02575339|528135398|FG001|Study Treatment|Disease Progression|2|||
146445435|NCT02575339|528135399|FG002|Study Treatment|Disease Progression|0|||
146445436|NCT02575339|528135397|FG000|Study Treatment|Adverse Event|1|||
146445437|NCT02575339|528135398|FG001|Study Treatment|Adverse Event|2|||
146445438|NCT02575339|528135399|FG002|Study Treatment|Adverse Event|0|||
146445439|NCT02575339|528135397|FG000|Follow up|Death|6|||
146445440|NCT02575339|528135398|FG001|Follow up|Death|2|||
146445441|NCT02575339|528135399|FG002|Follow up|Death|0|||
146445442|NCT02575339|528135397|FG000|Follow up|Study Terminated|0|||
146445443|NCT02575339|528135398|FG001|Follow up|Study Terminated|2|||
146445444|NCT02575339|528135399|FG002|Follow up|Study Terminated|0|||
146445445|NCT02575339|528135397|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
146445446|NCT02575339|528135398|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
146445447|NCT02575339|528135399|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
146445448|NCT04768114|528135404|FG000|Overall Study|Lost to Follow-up|5|||
146445449|NCT04768114|528135405|FG001|Overall Study|Lost to Follow-up|10|||
146445450|NCT04768114|528135404|FG000|Overall Study|Withdrawal by Subject|0|||
146445451|NCT04768114|528135405|FG001|Overall Study|Withdrawal by Subject|1|||
146445452|NCT01963260|528135410|FG000|Overall Study|Withdrawal by Subject|2|||
146445453|NCT01963260|528135411|FG001|Overall Study|Withdrawal by Subject|0|||
146445454|NCT01963260|528135412|FG002|Overall Study|Withdrawal by Subject|0|||
146445455|NCT01963260|528135413|FG003|Overall Study|Withdrawal by Subject|1|||
146445456|NCT01963260|528135414|FG004|Overall Study|Withdrawal by Subject|2|||
146445457|NCT01963260|528135415|FG005|Overall Study|Withdrawal by Subject|0|||
146445458|NCT01963260|528135416|FG006|Overall Study|Withdrawal by Subject|0|||
146445459|NCT01963260|528135417|FG007|Overall Study|Withdrawal by Subject|0|||
146445460|NCT01963260|528135418|FG008|Overall Study|Withdrawal by Subject|0|||
146445461|NCT01963260|528135419|FG009|Overall Study|Withdrawal by Subject|0|||
146445462|NCT00160524|528135420|FG000|Overall Study|Adverse Event|119|||
146445463|NCT00160524|528135420|FG000|Overall Study|Adverse Event and Other|94|||
146445464|NCT00160524|528135420|FG000|Overall Study|Protocol Violation|16|||
146445465|NCT00160524|528135420|FG000|Overall Study|Protocol Violation and Other|2|||
146445466|NCT00160524|528135420|FG000|Overall Study|Withdrawal by Subject|141|||
146445467|NCT00160524|528135420|FG000|Overall Study|Withdrawal by Subject and Other|17|||
146445468|NCT00160524|528135420|FG000|Overall Study|Physician Decision|27|||
146445469|NCT00160524|528135420|FG000|Overall Study|Physician Decision and Other|6|||
146445470|NCT00160524|528135420|FG000|Overall Study|Lost to Follow-up|13|||
146445471|NCT00160524|528135420|FG000|Overall Study|Lost to Follow-up and Other|1|||
146445472|NCT00160524|528135420|FG000|Overall Study|Lack of Efficacy|21|||
146445473|NCT00160524|528135420|FG000|Overall Study|Lack of Efficacy and Other|1|||
146445474|NCT00160524|528135420|FG000|Overall Study|Other|20|||
146445475|NCT04892147|528135421|FG000|Overall Study|Withdrawal by Subject|2|||
146445476|NCT04892147|528135422|FG001|Overall Study|Withdrawal by Subject|0|||
146445477|NCT03828539|528135426|FG000|Overall Study|Adverse Event|3|||
146445478|NCT03828539|528135427|FG001|Overall Study|Adverse Event|12|||
146445479|NCT03828539|528135426|FG000|Overall Study|Patient's/guardian's decision|3|||
146445480|NCT03828539|528135427|FG001|Overall Study|Patient's/guardian's decision|5|||
146445481|NCT03828539|528135426|FG000|Overall Study|Lost to Follow-up|4|||
146445482|NCT03828539|528135427|FG001|Overall Study|Lost to Follow-up|2|||
146445483|NCT03828539|528135426|FG000|Overall Study|Protocol Violation|3|||
146445484|NCT03828539|528135427|FG001|Overall Study|Protocol Violation|2|||
146445485|NCT03828539|528135426|FG000|Overall Study|Withdrawal of informed consent|2|||
146445486|NCT03828539|528135427|FG001|Overall Study|Withdrawal of informed consent|1|||
146445487|NCT03828539|528135426|FG000|Overall Study|New therapy for study indication|1|||
146445488|NCT03828539|528135427|FG001|Overall Study|New therapy for study indication|0|||
146445489|NCT02760433|528135428|FG000|Overall Study|Lost to Follow-up|1|||
146445490|NCT02760433|528135429|FG001|Overall Study|Lost to Follow-up|0|||
146445491|NCT02760433|528135430|FG002|Overall Study|Lost to Follow-up|1|||
146445492|NCT02760433|528135431|FG003|Overall Study|Lost to Follow-up|0|||
146445493|NCT02760433|528135432|FG004|Overall Study|Lost to Follow-up|0|||
146445494|NCT02760433|528135428|FG000|Overall Study|Withdrawal by Subject|23|||
146445495|NCT02760433|528135429|FG001|Overall Study|Withdrawal by Subject|9|||
146445496|NCT02760433|528135430|FG002|Overall Study|Withdrawal by Subject|0|||
146445497|NCT02760433|528135431|FG003|Overall Study|Withdrawal by Subject|2|||
146445498|NCT02760433|528135432|FG004|Overall Study|Withdrawal by Subject|9|||
146445499|NCT02760433|528135428|FG000|Overall Study|Lack of Response At Week 14|0|||
146445500|NCT02760433|528135429|FG001|Overall Study|Lack of Response At Week 14|0|||
146445501|NCT02760433|528135430|FG002|Overall Study|Lack of Response At Week 14|0|||
146445502|NCT02760433|528135431|FG003|Overall Study|Lack of Response At Week 14|0|||
146445503|NCT02760433|528135432|FG004|Overall Study|Lack of Response At Week 14|1|||
146285780|NCT00825916|527561123|FG000|Overall Study|Lost to Follow-up|4|||
146285781|NCT00825916|527561124|FG001|Overall Study|Lost to Follow-up|2|||
146285782|NCT00825916|527561125|FG002|Overall Study|Lost to Follow-up|1|||
146285783|NCT02962960|527561126|FG000|Overall Study|Withdrawal by Subject|1|||
146445504|NCT02760433|528135428|FG000|Overall Study|Subject refused to continue the study|1|||
146285784|NCT02962960|527561127|FG001|Overall Study|Withdrawal by Subject|1|||
146285785|NCT02962960|527561128|FG002|Overall Study|Withdrawal by Subject|0|||
146285786|NCT02962960|527561126|FG000|Overall Study|Adverse Event|1|||
146285787|NCT02962960|527561127|FG001|Overall Study|Adverse Event|1|||
146445505|NCT02760433|528135429|FG001|Overall Study|Subject refused to continue the study|0|||
146445506|NCT02760433|528135430|FG002|Overall Study|Subject refused to continue the study|0|||
146445507|NCT02760433|528135431|FG003|Overall Study|Subject refused to continue the study|0|||
146445508|NCT02760433|528135432|FG004|Overall Study|Subject refused to continue the study|0|||
146445509|NCT02760433|528135428|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
146445510|NCT02760433|528135429|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
146445511|NCT02760433|528135430|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
146445512|NCT02760433|528135431|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
146445513|NCT02760433|528135432|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
146445514|NCT02760433|528135428|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
146445515|NCT02760433|528135429|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
146445516|NCT02760433|528135430|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
146445517|NCT02760433|528135431|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
146445518|NCT02760433|528135432|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
146445519|NCT00057941|528135433|FG000|Overall Study|Death|1|||
145956256|NCT01223404|526352424|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145956257|NCT02492165|526352425|FG000|Overall Study|Withdrawal by Subject|0|||
145956258|NCT02492165|526352426|FG001|Overall Study|Withdrawal by Subject|1|||
145956259|NCT02492165|526352427|FG002|Overall Study|Withdrawal by Subject|0|||
145956260|NCT02492165|526352428|FG003|Overall Study|Withdrawal by Subject|0|||
145956261|NCT00707057|526352429|FG000|Overall Study|Withdrawal by Subject|8|||
145956262|NCT00707057|526352430|FG001|Overall Study|Withdrawal by Subject|3|||
145956263|NCT00707057|526352429|FG000|Overall Study|Dosed incorrectly|0|||
145956264|NCT00707057|526352430|FG001|Overall Study|Dosed incorrectly|1|||
145956265|NCT01639144|526352433|FG000|Overall Study|Withdrawal by Subject|4|||
145956266|NCT01639144|526352434|FG001|Overall Study|Withdrawal by Subject|2|||
145956267|NCT01639144|526352433|FG000|Overall Study|Physician Decision|2|||
145956268|NCT01639144|526352434|FG001|Overall Study|Physician Decision|0|||
145956269|NCT01639144|526352433|FG000|Overall Study|Met postoperative exclusion criteria|4|||
145956270|NCT01639144|526352434|FG001|Overall Study|Met postoperative exclusion criteria|3|||
145956271|NCT00305227|526352439|FG000|Overall Study|Lost to Follow-up|7|||
146285788|NCT02962960|527561128|FG002|Overall Study|Adverse Event|0|||
146285789|NCT02962960|527561126|FG000|Overall Study|Protocol Violation|1|||
145956272|NCT00305227|526352440|FG001|Overall Study|Lost to Follow-up|6|||
145956273|NCT00411450|526352443|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
145956274|NCT01059773|526352444|FG000|Overall Study|Adverse Event|2|||
145956275|NCT01059773|526352445|FG001|Overall Study|Adverse Event|2|||
145956276|NCT01059773|526352444|FG000|Overall Study|Withdrawal by Subject|1|||
145956277|NCT01059773|526352445|FG001|Overall Study|Withdrawal by Subject|5|||
145956278|NCT01059773|526352444|FG000|Overall Study|Lost to Follow-up|1|||
145956279|NCT01059773|526352445|FG001|Overall Study|Lost to Follow-up|1|||
145956280|NCT01059773|526352444|FG000|Overall Study|Pregnancy|1|||
145956281|NCT01059773|526352445|FG001|Overall Study|Pregnancy|1|||
145956282|NCT01059773|526352444|FG000|Overall Study|Protocol Violation|6|||
145956283|NCT01059773|526352445|FG001|Overall Study|Protocol Violation|2|||
145956284|NCT01059773|526352444|FG000|Overall Study|Physician Decision|5|||
146445520|NCT00057941|528135434|FG001|Overall Study|Death|2|||
145956285|NCT01059773|526352445|FG001|Overall Study|Physician Decision|4|||
145956286|NCT01059773|526352444|FG000|Overall Study|Lack of Efficacy|3|||
145956287|NCT01059773|526352445|FG001|Overall Study|Lack of Efficacy|3|||
146445521|NCT00057941|528135433|FG000|Overall Study|Adverse Event|7|||
146445522|NCT00057941|528135434|FG001|Overall Study|Adverse Event|9|||
146445523|NCT00057941|528135433|FG000|Overall Study|Lack of Efficacy|54|||
146445524|NCT00057941|528135434|FG001|Overall Study|Lack of Efficacy|53|||
146445525|NCT00057941|528135433|FG000|Overall Study|Withdrawal by Subject|6|||
146445526|NCT00057941|528135434|FG001|Overall Study|Withdrawal by Subject|1|||
146445527|NCT00057941|528135433|FG000|Overall Study|still on treatment|3|||
146445528|NCT00057941|528135434|FG001|Overall Study|still on treatment|1|||
146445529|NCT00057941|528135433|FG000|Overall Study|insurance, symptomatic deterioration|1|||
146445530|NCT00057941|528135434|FG001|Overall Study|insurance, symptomatic deterioration|3|||
146445531|NCT00057941|528135433|FG000|Overall Study|Ineligible|2|||
146445532|NCT00057941|528135434|FG001|Overall Study|Ineligible|5|||
146445533|NCT00766493|528135435|FG000|30 Days Post-Procedure|Discontinued|7|||
146445534|NCT00766493|528135435|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
146445535|NCT00766493|528135435|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
146445536|NCT01849458|528135437|FG000|Overall Study|Lost to Follow-up|4|||
146445537|NCT03439085|528135438|FG000|Overall Study|Death|2|||
146445538|NCT03439085|528135438|FG000|Overall Study|Screen Failure|20|||
146445539|NCT01863433|528135439|FG000|Overall Study|Protocol Violation|1|||
146445540|NCT02224053|528135440|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
146445541|NCT02224053|528135440|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
146445542|NCT02224053|528135440|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
146445543|NCT02224053|528135440|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
146445544|NCT02224053|528135440|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
146445545|NCT03448692|528135441|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
146445546|NCT03448692|528135442|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
146445547|NCT03448692|528135441|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
146445548|NCT03448692|528135442|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
146445549|NCT03448692|528135441|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
146445550|NCT03448692|528135442|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
146445551|NCT03448692|528135441|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
146445552|NCT03448692|528135442|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
146445553|NCT03448692|528135441|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
146445554|NCT03448692|528135442|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
146445555|NCT02786927|528135443|FG000|Overall Study|Adverse Event|1|||
146445556|NCT02786927|528135443|FG000|Overall Study|Protocol Violation|4|||
146445557|NCT01801917|528135444|FG000|Period 1 - Randomized|Adverse Event|1|||
146445558|NCT01801917|528135445|FG001|Period 1 - Randomized|Adverse Event|0|||
146445559|NCT01801917|528135446|FG002|Period 1 - Randomized|Adverse Event|1|||
146445560|NCT01801917|528135447|FG003|Period 1 - Randomized|Adverse Event|0|||
146445561|NCT03919695|528135448|FG000|3-month Follow-up|Death|1|||
146445562|NCT03919695|528135449|FG001|3-month Follow-up|Death|1|||
146445563|NCT03919695|528135448|FG000|3-month Follow-up|unable to contact|0|||
146445564|NCT03919695|528135449|FG001|3-month Follow-up|unable to contact|3|||
146445565|NCT03919695|528135448|FG000|3-month Follow-up|in prison|0|||
146445566|NCT03919695|528135449|FG001|3-month Follow-up|in prison|1|||
146445567|NCT03919695|528135448|FG000|6-month Follow-up|Death|0|||
146445568|NCT03919695|528135449|FG001|6-month Follow-up|Death|1|||
146445569|NCT03919695|528135448|FG000|6-month Follow-up|Lost to Follow-up|1|||
146445570|NCT03919695|528135449|FG001|6-month Follow-up|Lost to Follow-up|2|||
146445571|NCT03919695|528135448|FG000|6-month Follow-up|in prison|0|||
146445572|NCT03919695|528135449|FG001|6-month Follow-up|in prison|2|||
146445573|NCT03919695|528135448|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
146445574|NCT03919695|528135449|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
146445575|NCT03919695|528135448|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
146083261|NCT00095147|526824782|FG000|Long-term Extension Period|Withdrawal of consent|0|||
146083262|NCT00095147|526824783|FG001|Long-term Extension Period|Withdrawal of consent|0|||
146083263|NCT00095147|526824784|FG002|Long-term Extension Period|Withdrawal of consent|0|||
146083264|NCT00095147|526824785|FG003|Long-term Extension Period|Withdrawal of consent|0|||
146083265|NCT00095147|526824786|FG004|Long-term Extension Period|Withdrawal of consent|12|||
146083266|NCT00095147|526824782|FG000|Long-term Extension Period|Pregnancy|0|||
146445576|NCT03919695|528135449|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
146445577|NCT02416934|528135451|FG000|Overall Study|given steroids|1|||
146445578|NCT02416934|528135452|FG001|Overall Study|given steroids|2|||
146445579|NCT02416934|528135451|FG000|Overall Study|Lost to Follow-up|0|||
146445580|NCT02416934|528135452|FG001|Overall Study|Lost to Follow-up|2|||
146445581|NCT02416934|528135451|FG000|Overall Study|Withdrawal by Subject|1|||
146445582|NCT02416934|528135452|FG001|Overall Study|Withdrawal by Subject|0|||
146445583|NCT02416934|528135451|FG000|Overall Study|recruited during continuing renewal proc|0|||
146445584|NCT02416934|528135452|FG001|Overall Study|recruited during continuing renewal proc|1|||
146445585|NCT02416934|528135451|FG000|Overall Study|Protocol Violation|0|||
146445586|NCT02416934|528135452|FG001|Overall Study|Protocol Violation|1|||
146445587|NCT02416934|528135451|FG000|Overall Study|surgery started late|0|||
146445588|NCT02416934|528135452|FG001|Overall Study|surgery started late|1|||
146445589|NCT02416934|528135451|FG000|Overall Study|re-operation|1|||
146445590|NCT02416934|528135452|FG001|Overall Study|re-operation|0|||
146445591|NCT01337596|528135464|FG000|Overall Study|Withdrawal by Subject|0|||
146445592|NCT01337596|528135465|FG001|Overall Study|Withdrawal by Subject|0|||
146445593|NCT01337596|528135466|FG002|Overall Study|Withdrawal by Subject|0|||
146445594|NCT01337596|528135467|FG003|Overall Study|Withdrawal by Subject|0|||
146445595|NCT01337596|528135468|FG004|Overall Study|Withdrawal by Subject|2|||
146445596|NCT01337596|528135469|FG005|Overall Study|Withdrawal by Subject|0|||
146445597|NCT01337596|528135470|FG006|Overall Study|Withdrawal by Subject|0|||
146445598|NCT01337596|528135471|FG007|Overall Study|Withdrawal by Subject|0|||
146445599|NCT01337596|528135472|FG008|Overall Study|Withdrawal by Subject|0|||
146445600|NCT03201003|528135476|FG000|Overall Study|Adverse Event|14|||
146445601|NCT03201003|528135477|FG001|Overall Study|Adverse Event|1|||
146445602|NCT03201003|528135476|FG000|Overall Study|Other reasons|5|||
146445603|NCT03201003|528135477|FG001|Overall Study|Other reasons|1|||
146445604|NCT03201003|528135476|FG000|Overall Study|Withdrawal by Subject|4|||
146445605|NCT03201003|528135477|FG001|Overall Study|Withdrawal by Subject|1|||
146445606|NCT03201003|528135476|FG000|Overall Study|Lost to Follow-up|2|||
146445607|NCT03201003|528135477|FG001|Overall Study|Lost to Follow-up|0|||
146445608|NCT03201003|528135476|FG000|Overall Study|Protocol Violation|1|||
146445609|NCT03201003|528135477|FG001|Overall Study|Protocol Violation|0|||
146445610|NCT00834613|528135478|FG000|First Intervention|Protocol Violation|1|||
146445611|NCT00834613|528135479|FG001|First Intervention|Protocol Violation|0|||
146445612|NCT00697619|528135485|FG000|Overall Study|Lack of Efficacy|2|||
146445613|NCT00697619|528135486|FG001|Overall Study|Lack of Efficacy|2|||
146445614|NCT00697619|528135485|FG000|Overall Study|Adverse Event|4|||
146445615|NCT00697619|528135486|FG001|Overall Study|Adverse Event|6|||
146445616|NCT01188226|528137183|FG000|Overall Study|Withdrawal by Subject|4|||
146445617|NCT04980456|528137184|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
146445618|NCT04980456|528137185|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
146445619|NCT04980456|528137184|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
146445620|NCT04980456|528137185|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
146445621|NCT04980456|528137184|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
146445622|NCT04980456|528137185|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
146445623|NCT04980456|528137184|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
146445624|NCT04980456|528137185|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
146445625|NCT04832971|528137186|FG000|Overall Study|Death|1|||
146445626|NCT04832971|528137187|FG001|Overall Study|Death|0|||
146445627|NCT04832971|528137188|FG002|Overall Study|Death|0|||
146445628|NCT04832971|528137189|FG003|Overall Study|Death|0|||
146445629|NCT04832971|528137186|FG000|Overall Study|Lost to Follow-up|1|||
146445630|NCT04832971|528137187|FG001|Overall Study|Lost to Follow-up|1|||
146445631|NCT04832971|528137188|FG002|Overall Study|Lost to Follow-up|1|||
146445632|NCT04832971|528137189|FG003|Overall Study|Lost to Follow-up|0|||
146445633|NCT04832971|528137186|FG000|Overall Study|Withdrawal by Subject|1|||
146445634|NCT04832971|528137187|FG001|Overall Study|Withdrawal by Subject|3|||
146445635|NCT04832971|528137188|FG002|Overall Study|Withdrawal by Subject|2|||
146445636|NCT04832971|528137189|FG003|Overall Study|Withdrawal by Subject|2|||
146445637|NCT04832971|528137186|FG000|Overall Study|Other, Not Specified|0|||
146445638|NCT04832971|528137187|FG001|Overall Study|Other, Not Specified|0|||
146445639|NCT04832971|528137188|FG002|Overall Study|Other, Not Specified|1|||
146445640|NCT04832971|528137189|FG003|Overall Study|Other, Not Specified|0|||
146445641|NCT02293460|528137190|FG000|Overall Study|Protocol Violation|1|||
146445642|NCT02293460|528137190|FG000|Overall Study|Lack of Efficacy|2|||
146445643|NCT02293460|528137190|FG000|Overall Study|Adverse Event|2|||
146445644|NCT02293460|528137190|FG000|Overall Study|Withdrawal by Subject|1|||
146445645|NCT00224484|528137191|FG000|Overall Study|Serious Adverse Event|1|||
146445646|NCT00224484|528137192|FG001|Overall Study|Serious Adverse Event|1|||
146445647|NCT00224484|528137193|FG002|Overall Study|Serious Adverse Event|0|||
146445648|NCT00224484|528137191|FG000|Overall Study|Non-Serious Adverse Event|5|||
146445649|NCT00224484|528137192|FG001|Overall Study|Non-Serious Adverse Event|7|||
146083267|NCT00095147|526824783|FG001|Long-term Extension Period|Pregnancy|0|||
146445650|NCT00224484|528137193|FG002|Overall Study|Non-Serious Adverse Event|3|||
146445651|NCT00224484|528137191|FG000|Overall Study|Protocol Violation|2|||
146445652|NCT00224484|528137192|FG001|Overall Study|Protocol Violation|2|||
146445653|NCT00224484|528137193|FG002|Overall Study|Protocol Violation|0|||
146445654|NCT00224484|528137191|FG000|Overall Study|Withdrawal by Subject|49|||
146445655|NCT00224484|528137192|FG001|Overall Study|Withdrawal by Subject|18|||
146445656|NCT00224484|528137193|FG002|Overall Study|Withdrawal by Subject|16|||
146445657|NCT00224484|528137191|FG000|Overall Study|Migrated/moved from study area|18|||
146445658|NCT00224484|528137192|FG001|Overall Study|Migrated/moved from study area|5|||
146445659|NCT00224484|528137193|FG002|Overall Study|Migrated/moved from study area|5|||
145956288|NCT01059773|526352444|FG000|Overall Study|Death|0|||
145956289|NCT01059773|526352445|FG001|Overall Study|Death|1|||
145956290|NCT01059773|526352444|FG000|Overall Study|Malignancy including squamous cell skin|0|||
145956291|NCT01059773|526352445|FG001|Overall Study|Malignancy including squamous cell skin|1|||
146445660|NCT00224484|528137191|FG000|Overall Study|Lost to Follow-up|66|||
146445661|NCT00224484|528137192|FG001|Overall Study|Lost to Follow-up|28|||
146445662|NCT00224484|528137193|FG002|Overall Study|Lost to Follow-up|36|||
146445663|NCT00224484|528137191|FG000|Overall Study|Reason not specified|5|||
146445664|NCT00224484|528137192|FG001|Overall Study|Reason not specified|4|||
146445665|NCT00224484|528137193|FG002|Overall Study|Reason not specified|2|||
146445666|NCT01074008|528137196|FG000|Overall Study|Adverse Event|0|||
146445667|NCT01074008|528137197|FG001|Overall Study|Adverse Event|1|||
146445668|NCT01074008|528137198|FG002|Overall Study|Adverse Event|0|||
146445669|NCT01074008|528137199|FG003|Overall Study|Adverse Event|0|||
146445670|NCT01074008|528137200|FG004|Overall Study|Adverse Event|0|||
146445671|NCT01074008|528137201|FG005|Overall Study|Adverse Event|0|||
146445672|NCT01074008|528137202|FG006|Overall Study|Adverse Event|0|||
146445673|NCT01074008|528137203|FG007|Overall Study|Adverse Event|0|||
146445674|NCT01074008|528137204|FG008|Overall Study|Adverse Event|0|||
146445675|NCT01074008|528137196|FG000|Overall Study|Withdrawal by Subject|1|||
146445676|NCT01074008|528137197|FG001|Overall Study|Withdrawal by Subject|1|||
146445677|NCT01074008|528137198|FG002|Overall Study|Withdrawal by Subject|1|||
146445678|NCT01074008|528137199|FG003|Overall Study|Withdrawal by Subject|0|||
146445679|NCT01074008|528137200|FG004|Overall Study|Withdrawal by Subject|1|||
146445680|NCT01074008|528137201|FG005|Overall Study|Withdrawal by Subject|0|||
146445681|NCT01074008|528137202|FG006|Overall Study|Withdrawal by Subject|0|||
146445682|NCT01074008|528137203|FG007|Overall Study|Withdrawal by Subject|0|||
146445683|NCT01074008|528137204|FG008|Overall Study|Withdrawal by Subject|0|||
146445684|NCT01074008|528137196|FG000|Overall Study|Lost to Follow-up|0|||
146445685|NCT01074008|528137197|FG001|Overall Study|Lost to Follow-up|1|||
146445686|NCT01074008|528137198|FG002|Overall Study|Lost to Follow-up|1|||
146445687|NCT01074008|528137199|FG003|Overall Study|Lost to Follow-up|1|||
146445688|NCT01074008|528137200|FG004|Overall Study|Lost to Follow-up|1|||
146445689|NCT01074008|528137201|FG005|Overall Study|Lost to Follow-up|0|||
146445690|NCT01074008|528137202|FG006|Overall Study|Lost to Follow-up|1|||
146445691|NCT01074008|528137203|FG007|Overall Study|Lost to Follow-up|0|||
146445692|NCT01074008|528137204|FG008|Overall Study|Lost to Follow-up|4|||
146445693|NCT02805309|528137205|FG000|Overall Study|Lost to Follow-up|2|||
146445694|NCT02805309|528137206|FG001|Overall Study|Lost to Follow-up|2|||
146445695|NCT02805309|528137207|FG002|Overall Study|Lost to Follow-up|2|||
146445696|NCT02805309|528137205|FG000|Overall Study|Post-Randomization Exclusion|0|||
146445697|NCT02805309|528137206|FG001|Overall Study|Post-Randomization Exclusion|2|||
146083268|NCT00095147|526824784|FG002|Long-term Extension Period|Pregnancy|0|||
146445698|NCT02805309|528137207|FG002|Overall Study|Post-Randomization Exclusion|1|||
146445699|NCT01636934|528137208|FG000|Overall Study|Withdrawal by Subject|3|||
146445700|NCT01636934|528137209|FG001|Overall Study|Withdrawal by Subject|2|||
146445701|NCT01636934|528137208|FG000|Overall Study|Chemo cancel|1|||
146445702|NCT01636934|528137209|FG001|Overall Study|Chemo cancel|0|||
146445703|NCT01636934|528137208|FG000|Overall Study|Too ill to continue|1|||
146445704|NCT01636934|528137209|FG001|Overall Study|Too ill to continue|0|||
146285790|NCT02962960|527561127|FG001|Overall Study|Protocol Violation|0|||
146445705|NCT01636934|528137208|FG000|Overall Study|Never started study medication|1|||
146445706|NCT01636934|528137209|FG001|Overall Study|Never started study medication|1|||
146445707|NCT03687242|528137214|FG000|Overall Study|Adverse Event|1|||
146445708|NCT00377156|528137217|FG000|Overall Study|Death|23|||
146445709|NCT00377156|528137218|FG001|Overall Study|Death|19|||
146445710|NCT00377156|528137217|FG000|Overall Study|Withdrawal by Subject|16|||
146445711|NCT00377156|528137218|FG001|Overall Study|Withdrawal by Subject|24|||
146445712|NCT00377156|528137217|FG000|Overall Study|Had follow-up <90 d|3|||
146445713|NCT00377156|528137218|FG001|Overall Study|Had follow-up <90 d|6|||
146445714|NCT00377156|528137217|FG000|Overall Study|Cancellation|1|||
146445715|NCT00377156|528137218|FG001|Overall Study|Cancellation|0|||
146445716|NCT00377156|528137217|FG000|Overall Study|Refused testing|0|||
146445717|NCT00377156|528137218|FG001|Overall Study|Refused testing|1|||
146445718|NCT00377156|528137217|FG000|Overall Study|Ineligible|0|||
146445719|NCT00377156|528137218|FG001|Overall Study|Ineligible|1|||
146445720|NCT00377156|528137217|FG000|Overall Study|Disability or language problem|0|||
146445721|NCT00377156|528137218|FG001|Overall Study|Disability or language problem|1|||
146445722|NCT00377156|528137217|FG000|Overall Study|Other|5|||
146445723|NCT00377156|528137218|FG001|Overall Study|Other|2|||
146445724|NCT00288704|528137219|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
146445725|NCT00288704|528137220|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
146445726|NCT00288704|528137221|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
146445727|NCT00288704|528137219|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
146445728|NCT00288704|528137220|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
146445729|NCT00288704|528137221|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
146445730|NCT00288704|528137219|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
146445731|NCT00288704|528137220|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
146445732|NCT00288704|528137221|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
146445733|NCT00288704|528137219|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
146445734|NCT00288704|528137220|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
146445735|NCT00288704|528137221|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
146445736|NCT00288704|528137219|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
146445737|NCT00288704|528137220|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
146083269|NCT00095147|526824785|FG003|Long-term Extension Period|Pregnancy|0|||
146083270|NCT00095147|526824786|FG004|Long-term Extension Period|Pregnancy|1|||
146083271|NCT00095147|526824782|FG000|Long-term Extension Period|No longer meets study criteria|0|||
146083272|NCT00095147|526824783|FG001|Long-term Extension Period|No longer meets study criteria|0|||
146445738|NCT00288704|528137221|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
146445739|NCT00288704|528137219|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
146445740|NCT00288704|528137220|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
146445741|NCT00288704|528137221|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
146445742|NCT00288704|528137219|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
146445743|NCT00288704|528137220|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
146083273|NCT00095147|526824784|FG002|Long-term Extension Period|No longer meets study criteria|0|||
146083274|NCT00095147|526824785|FG003|Long-term Extension Period|No longer meets study criteria|0|||
146083275|NCT00095147|526824786|FG004|Long-term Extension Period|No longer meets study criteria|1|||
146083276|NCT00095147|526824782|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
146083277|NCT00095147|526824783|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
146083278|NCT00095147|526824784|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
146083279|NCT00095147|526824785|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
146083280|NCT00095147|526824786|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
146083281|NCT00095147|526824782|FG000|Long-term Extension Period|Leaving country|0|||
146083282|NCT00095147|526824783|FG001|Long-term Extension Period|Leaving country|0|||
146083283|NCT00095147|526824784|FG002|Long-term Extension Period|Leaving country|0|||
146083284|NCT00095147|526824785|FG003|Long-term Extension Period|Leaving country|0|||
146083285|NCT00095147|526824786|FG004|Long-term Extension Period|Leaving country|1|||
146083286|NCT02650921|526824787|FG000|Overall Study|Withdrawal by Subject|4|||
146083287|NCT02650921|526824787|FG000|Overall Study|Lost to Follow-up|2|||
146083288|NCT02650921|526824787|FG000|Overall Study|Adverse Event|1|||
146083289|NCT02650921|526824787|FG000|Overall Study|Due to Medical Condition|1|||
146083290|NCT02395302|526824788|FG000|Overall Study|Screen Failure|3|||
146083291|NCT02395302|526824788|FG000|Overall Study|Run In Failure|7|||
146083292|NCT02395302|526824788|FG000|Overall Study|Withdrawal by Subject|2|||
146083293|NCT02395302|526824788|FG000|Overall Study|Physician Decision|2|||
146083294|NCT00783302|526824789|FG000|Overall Study|Lost to Follow-up|17|||
146083295|NCT00783302|526824789|FG000|Overall Study|Technical Problems|11|||
146083296|NCT00783302|526824789|FG000|Overall Study|Protocol Violation|3|||
146083297|NCT00783302|526824789|FG000|Overall Study|Physician Decision|1|||
146083298|NCT00783302|526824789|FG000|Overall Study|Withdrawal by Subject|3|||
146083299|NCT00160667|526824790|FG000|Overall Study|Adverse Event|3|||
146083300|NCT00160667|526824791|FG001|Overall Study|Adverse Event|1|||
146083301|NCT00160667|526824792|FG002|Overall Study|Adverse Event|4|||
146083302|NCT00160667|526824790|FG000|Overall Study|Withdrawal by Subject|2|||
146083303|NCT00160667|526824791|FG001|Overall Study|Withdrawal by Subject|0|||
146083304|NCT00160667|526824792|FG002|Overall Study|Withdrawal by Subject|1|||
146083305|NCT00160667|526824790|FG000|Overall Study|Lack of Efficacy|0|||
146083306|NCT00160667|526824791|FG001|Overall Study|Lack of Efficacy|1|||
146083307|NCT00160667|526824792|FG002|Overall Study|Lack of Efficacy|0|||
146083308|NCT00160667|526824790|FG000|Overall Study|Protocol Violation|0|||
146083309|NCT00160667|526824791|FG001|Overall Study|Protocol Violation|1|||
146083310|NCT00160667|526824792|FG002|Overall Study|Protocol Violation|0|||
146083311|NCT00160667|526824790|FG000|Overall Study|Patient decision|0|||
146083312|NCT00160667|526824791|FG001|Overall Study|Patient decision|0|||
146445744|NCT00288704|528137221|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
146445745|NCT01579006|528137222|FG000|Overall Study|Lack of Efficacy|10|||
146445746|NCT01579006|528137222|FG000|Overall Study|Adverse Event|13|||
146445747|NCT01579006|528137222|FG000|Overall Study|Withdrawal by Subject|5|||
146445748|NCT01579006|528137222|FG000|Overall Study|Non-compliance|3|||
146445749|NCT01579006|528137222|FG000|Overall Study|Due to participant's health fund|1|||
146445750|NCT01579006|528137222|FG000|Overall Study|Scheduled surgery|1|||
146445751|NCT01802216|528137225|FG000|4 Month Visit|Participant did not show to visit|3|||
146445752|NCT01802216|528137226|FG001|4 Month Visit|Participant did not show to visit|4|||
146083313|NCT00160667|526824792|FG002|Overall Study|Patient decision|1|||
146083314|NCT01917656|526824796|FG000|Overall Study|Adverse Event|11|||
146083315|NCT01917656|526824797|FG001|Overall Study|Adverse Event|0|||
146083316|NCT01917656|526824796|FG000|Overall Study|Withdrawal criteria|8|||
146083317|NCT01917656|526824797|FG001|Overall Study|Withdrawal criteria|14|||
146083318|NCT01917656|526824796|FG000|Overall Study|Unclassified|0|||
146209566|NCT04992390|527280416|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
146209567|NCT04992390|527280414|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
146209568|NCT04992390|527280415|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
146209569|NCT04992390|527280416|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
146445753|NCT01802216|528137225|FG000|8 Month Visit|Participant did not show to visit|3|||
146083319|NCT01917656|526824797|FG001|Overall Study|Unclassified|3|||
146209570|NCT04992390|527280414|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
146445754|NCT01802216|528137226|FG001|8 Month Visit|Participant did not show to visit|5|||
146445755|NCT01802216|528137225|FG000|12 Month Visit|Participant did not show to visit|3|||
146445756|NCT01802216|528137226|FG001|12 Month Visit|Participant did not show to visit|4|||
146445757|NCT04675775|528137227|FG000|Overall Study|Withdrawal by Subject|7|||
146445758|NCT02340780|528137229|FG000|Overall Study|Ineligible|1|||
146445759|NCT01957150|528137230|FG000|Overall Study|Adverse Event|23|||
146445760|NCT01957150|528137231|FG001|Overall Study|Adverse Event|20|||
146445761|NCT01957150|528137230|FG000|Overall Study|Withdrawal by Subject|13|||
146445762|NCT01957150|528137231|FG001|Overall Study|Withdrawal by Subject|17|||
146445763|NCT01957150|528137230|FG000|Overall Study|Physician Decision|3|||
146445764|NCT01957150|528137231|FG001|Overall Study|Physician Decision|6|||
146445765|NCT01957150|528137230|FG000|Overall Study|Lost to Follow-up|4|||
146445766|NCT01957150|528137231|FG001|Overall Study|Lost to Follow-up|4|||
146445767|NCT01957150|528137230|FG000|Overall Study|Protocol Violation|1|||
146445768|NCT01957150|528137231|FG001|Overall Study|Protocol Violation|0|||
146445769|NCT01957150|528137230|FG000|Overall Study|Lack of Efficacy|11|||
146445770|NCT01957150|528137231|FG001|Overall Study|Lack of Efficacy|11|||
146445771|NCT03223909|528137232|FG000|Overall Study|Protocol Violation|48|||
146445772|NCT03223909|528137233|FG001|Overall Study|Protocol Violation|45|||
146445773|NCT03223909|528137234|FG002|Overall Study|Protocol Violation|16|||
146445774|NCT01698554|528137237|FG000|Overall Study|Adverse Event|2|||
146445775|NCT01698554|528137238|FG001|Overall Study|Adverse Event|5|||
146445776|NCT01698554|528137239|FG002|Overall Study|Adverse Event|0|||
146445777|NCT01698554|528137240|FG003|Overall Study|Adverse Event|1|||
146445778|NCT01698554|528137237|FG000|Overall Study|Lost to Follow-up|1|||
146445779|NCT01698554|528137238|FG001|Overall Study|Lost to Follow-up|0|||
146445780|NCT01698554|528137239|FG002|Overall Study|Lost to Follow-up|0|||
146445781|NCT01698554|528137240|FG003|Overall Study|Lost to Follow-up|0|||
146445782|NCT01698554|528137237|FG000|Overall Study|Personal Reasons|0|||
146445783|NCT01698554|528137238|FG001|Overall Study|Personal Reasons|5|||
146445784|NCT01698554|528137239|FG002|Overall Study|Personal Reasons|1|||
146445785|NCT01698554|528137240|FG003|Overall Study|Personal Reasons|1|||
146445786|NCT01698554|528137237|FG000|Overall Study|Protocol Violation|2|||
146445787|NCT01698554|528137238|FG001|Overall Study|Protocol Violation|0|||
146445788|NCT01698554|528137239|FG002|Overall Study|Protocol Violation|1|||
146445789|NCT01698554|528137240|FG003|Overall Study|Protocol Violation|0|||
146445790|NCT01698554|528137237|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146445791|NCT01698554|528137238|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146445792|NCT01698554|528137239|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146445793|NCT01698554|528137240|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146445794|NCT00252564|528137241|FG000|Overall Study|Adverse Event|17|||
146445795|NCT00252564|528137242|FG001|Overall Study|Adverse Event|13|||
146445796|NCT00252564|528137241|FG000|Overall Study|Unrelated Complication|2|||
146445797|NCT00252564|528137242|FG001|Overall Study|Unrelated Complication|1|||
146445798|NCT00252564|528137241|FG000|Overall Study|Disease Progression|14|||
146445799|NCT00252564|528137242|FG001|Overall Study|Disease Progression|20|||
146445800|NCT00252564|528137241|FG000|Overall Study|Death|0|||
146445801|NCT00252564|528137242|FG001|Overall Study|Death|3|||
146445802|NCT00252564|528137241|FG000|Overall Study|Physician Decision|1|||
146445803|NCT00252564|528137242|FG001|Overall Study|Physician Decision|0|||
146445804|NCT00252564|528137241|FG000|Overall Study|Lost to Follow-up|1|||
146445805|NCT00252564|528137242|FG001|Overall Study|Lost to Follow-up|0|||
146445806|NCT00252564|528137241|FG000|Overall Study|Patient Request|4|||
146445807|NCT00252564|528137242|FG001|Overall Study|Patient Request|5|||
146445808|NCT00252564|528137241|FG000|Overall Study|Withdrawal by Subject|0|||
146445809|NCT00252564|528137242|FG001|Overall Study|Withdrawal by Subject|2|||
146445810|NCT01583530|528137243|FG000|Overall Study|Adverse Event|0|||
146445811|NCT01583530|528137244|FG001|Overall Study|Adverse Event|0|||
146445812|NCT01583530|528137245|FG002|Overall Study|Adverse Event|0|||
146445813|NCT01583530|528137246|FG003|Overall Study|Adverse Event|0|||
146445814|NCT01583530|528137247|FG004|Overall Study|Adverse Event|0|||
146445815|NCT01583530|528137248|FG005|Overall Study|Adverse Event|1|||
146445816|NCT01583530|528137243|FG000|Overall Study|Withdrawal by Subject|0|||
146445817|NCT01583530|528137244|FG001|Overall Study|Withdrawal by Subject|3|||
146445818|NCT01583530|528137245|FG002|Overall Study|Withdrawal by Subject|0|||
146445819|NCT01583530|528137246|FG003|Overall Study|Withdrawal by Subject|1|||
146445820|NCT01583530|528137247|FG004|Overall Study|Withdrawal by Subject|1|||
145956292|NCT01059773|526352444|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
146445821|NCT01583530|528137248|FG005|Overall Study|Withdrawal by Subject|2|||
146445822|NCT01583530|528137243|FG000|Overall Study|Lost to Follow-up|0|||
146445823|NCT01583530|528137244|FG001|Overall Study|Lost to Follow-up|0|||
146445824|NCT01583530|528137245|FG002|Overall Study|Lost to Follow-up|0|||
146445825|NCT01583530|528137246|FG003|Overall Study|Lost to Follow-up|0|||
146445826|NCT01583530|528137247|FG004|Overall Study|Lost to Follow-up|3|||
146445827|NCT01583530|528137248|FG005|Overall Study|Lost to Follow-up|0|||
146445828|NCT01583530|528137243|FG000|Overall Study|Lack of compliance|0|||
146445829|NCT01583530|528137244|FG001|Overall Study|Lack of compliance|0|||
146445830|NCT01583530|528137245|FG002|Overall Study|Lack of compliance|0|||
146445831|NCT01583530|528137246|FG003|Overall Study|Lack of compliance|0|||
146445832|NCT01583530|528137247|FG004|Overall Study|Lack of compliance|1|||
146445833|NCT01583530|528137248|FG005|Overall Study|Lack of compliance|0|||
146445834|NCT02416180|528137249|FG000|Overall Study|Withdrawal by Subject|1|||
146445835|NCT00640926|528137250|FG000|Overall Study|Adverse Event|2|||
146445836|NCT00640926|528137251|FG001|Overall Study|Adverse Event|3|||
146445837|NCT00640926|528137252|FG002|Overall Study|Adverse Event|2|||
146445838|NCT00640926|528137250|FG000|Overall Study|Lack of Efficacy|0|||
146445839|NCT00640926|528137251|FG001|Overall Study|Lack of Efficacy|2|||
146445840|NCT00640926|528137252|FG002|Overall Study|Lack of Efficacy|1|||
146445841|NCT00640926|528137250|FG000|Overall Study|Protocol Violation|2|||
146445842|NCT00640926|528137251|FG001|Overall Study|Protocol Violation|0|||
146445843|NCT00640926|528137252|FG002|Overall Study|Protocol Violation|2|||
146445844|NCT00640926|528137250|FG000|Overall Study|Lost to Follow-up|3|||
146445845|NCT00640926|528137251|FG001|Overall Study|Lost to Follow-up|1|||
146445846|NCT00640926|528137252|FG002|Overall Study|Lost to Follow-up|2|||
146445847|NCT00640926|528137250|FG000|Overall Study|Withdrawal by Subject|1|||
146445848|NCT00640926|528137251|FG001|Overall Study|Withdrawal by Subject|0|||
146445849|NCT00640926|528137252|FG002|Overall Study|Withdrawal by Subject|1|||
146445850|NCT01841073|528137255|FG000|Overall Study|Adverse Event|1|||
146445851|NCT01841073|528137256|FG001|Overall Study|Adverse Event|1|||
146445852|NCT01841073|528137255|FG000|Overall Study|Physician Decision|1|||
146445853|NCT01841073|528137256|FG001|Overall Study|Physician Decision|0|||
146445854|NCT01841073|528137255|FG000|Overall Study|Lost to Follow-up|0|||
146445855|NCT01841073|528137256|FG001|Overall Study|Lost to Follow-up|2|||
146445856|NCT02858037|528137257|FG000|Overall Study|Death|1|||
146445857|NCT02858037|528137257|FG000|Overall Study|Withdrawal by Subject|18|||
146445858|NCT02858037|528137257|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
146445859|NCT02858037|528137257|FG000|Overall Study|Lost to Follow-up|3|||
146445860|NCT02858037|528137257|FG000|Overall Study|Other|4|||
146445861|NCT00550147|528137260|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
146445862|NCT00550147|528137260|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
146445863|NCT00550147|528137260|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
146445864|NCT00550147|528137260|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
146445865|NCT00550147|528137260|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
146445866|NCT04320745|528137261|FG000|Overall Study|Adverse Event|26|||
146445867|NCT04320745|528137261|FG000|Overall Study|Withdrawal by Subject|4|||
146445868|NCT04320745|528137261|FG000|Overall Study|Lost to Follow-up|12|||
146445869|NCT04320745|528137261|FG000|Overall Study|Protocol Deviation|2|||
146445870|NCT04320745|528137261|FG000|Overall Study|Non-compliance With Study Drug|2|||
146445871|NCT04320745|528137261|FG000|Overall Study|Reason Not Specified|1|||
146445872|NCT00046839|528137262|FG000|Overall Study|Ineligible / No protocol treatment|0|||
146445873|NCT00046839|528137263|FG001|Overall Study|Ineligible / No protocol treatment|2|||
146445874|NCT00046839|528137262|FG000|Overall Study|Withdrawal of consent|1|||
146445875|NCT00046839|528137263|FG001|Overall Study|Withdrawal of consent|0|||
146445876|NCT02050321|528137266|FG000|Overall Study|Withdrawal by Subject|1|||
146445877|NCT02050321|528137266|FG000|Overall Study|Adverse Event|1|||
146445878|NCT00715676|528137271|FG000|Overall Study|Adverse Event|3|||
146083320|NCT01917656|526824796|FG000|Overall Study|Withdrawal by Subject|4|||
146083321|NCT01917656|526824797|FG001|Overall Study|Withdrawal by Subject|3|||
146083322|NCT01917656|526824796|FG000|Overall Study|Lost to Follow-up|3|||
146445879|NCT00715676|528137272|FG001|Overall Study|Adverse Event|5|||
146445880|NCT00715676|528137273|FG002|Overall Study|Adverse Event|21|||
146445881|NCT00715676|528137271|FG000|Overall Study|Withdrawal by Subject|1|||
146445882|NCT00715676|528137272|FG001|Overall Study|Withdrawal by Subject|3|||
146445883|NCT00715676|528137273|FG002|Overall Study|Withdrawal by Subject|8|||
146445884|NCT00715676|528137271|FG000|Overall Study|Lost to Follow-up|1|||
146445885|NCT00715676|528137272|FG001|Overall Study|Lost to Follow-up|2|||
146445886|NCT00715676|528137273|FG002|Overall Study|Lost to Follow-up|1|||
146445887|NCT00715676|528137271|FG000|Overall Study|Terminated by Sponsor|1|||
146445888|NCT00715676|528137272|FG001|Overall Study|Terminated by Sponsor|0|||
146445889|NCT00715676|528137273|FG002|Overall Study|Terminated by Sponsor|0|||
146445890|NCT00715676|528137271|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
146445891|NCT00715676|528137272|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
146445892|NCT00715676|528137273|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
146445893|NCT00715676|528137271|FG000|Overall Study|Use of Exclusionary Medication|0|||
146445894|NCT00715676|528137272|FG001|Overall Study|Use of Exclusionary Medication|0|||
146445895|NCT00715676|528137273|FG002|Overall Study|Use of Exclusionary Medication|1|||
146445896|NCT00715676|528137271|FG000|Overall Study|Elevated Blood Glucose|0|||
146445897|NCT00715676|528137272|FG001|Overall Study|Elevated Blood Glucose|1|||
146445898|NCT00715676|528137273|FG002|Overall Study|Elevated Blood Glucose|0|||
146445899|NCT04994431|528137274|FG000|Overall Study|Adverse Event|1|||
146445900|NCT04994431|528137275|FG001|Overall Study|Adverse Event|0|||
146445901|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
146445902|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
146445903|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
146445904|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
146445905|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
146445906|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
146445907|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
146445908|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
146445909|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
146445910|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
146445911|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
146445912|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
146445913|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
146445914|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
146445915|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
146445916|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
146445917|NCT01067521|528137277|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
146445918|NCT01067521|528137278|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
146445919|NCT01067521|528137277|FG000|Open-Label Period|Death|3|||
146445920|NCT01067521|528137278|FG001|Open-Label Period|Death|1|||
146445921|NCT01067521|528137277|FG000|Open-Label Period|Adverse Event|30|||
146445922|NCT01067521|528137278|FG001|Open-Label Period|Adverse Event|28|||
146445923|NCT01067521|528137277|FG000|Open-Label Period|Withdrawal by Subject|160|||
146445924|NCT01067521|528137278|FG001|Open-Label Period|Withdrawal by Subject|88|||
146445925|NCT01067521|528137277|FG000|Open-Label Period|Physician Decision|13|||
146445926|NCT01067521|528137278|FG001|Open-Label Period|Physician Decision|11|||
146445927|NCT01067521|528137277|FG000|Open-Label Period|Non-compliance with study drug|5|||
146445928|NCT01067521|528137278|FG001|Open-Label Period|Non-compliance with study drug|0|||
146445929|NCT01067521|528137277|FG000|Open-Label Period|Protocol Violation|3|||
146445930|NCT01067521|528137278|FG001|Open-Label Period|Protocol Violation|0|||
146445931|NCT01067521|528137277|FG000|Open-Label Period|Pregnancy|14|||
146445932|NCT01067521|528137278|FG001|Open-Label Period|Pregnancy|8|||
146445933|NCT01067521|528137277|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
146445934|NCT01067521|528137278|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
146445935|NCT01067521|528137277|FG000|Open-Label Period|Lost to Follow-up|21|||
146445936|NCT01067521|528137278|FG001|Open-Label Period|Lost to Follow-up|20|||
146445937|NCT01547728|528137279|FG000|Overall Study|Change in procedure and equipment|1|||
146445938|NCT01547728|528137279|FG000|Overall Study|Drug not ready for subject|1|||
146445939|NCT01547728|528137279|FG000|Overall Study|Screen failure|39|||
146445940|NCT02151149|528137280|FG000|Treatment Period|Death|2|||
146445941|NCT02151149|528137281|FG001|Treatment Period|Death|3|||
146445942|NCT02151149|528137280|FG000|Treatment Period|Adverse Event|17|||
146445943|NCT02151149|528137281|FG001|Treatment Period|Adverse Event|14|||
146445944|NCT02151149|528137280|FG000|Treatment Period|Progressive Disease|25|||
146445945|NCT02151149|528137281|FG001|Treatment Period|Progressive Disease|24|||
146445946|NCT02151149|528137280|FG000|Treatment Period|Symptomatic Deterioration|2|||
146445947|NCT02151149|528137281|FG001|Treatment Period|Symptomatic Deterioration|10|||
146445948|NCT02151149|528137280|FG000|Treatment Period|Withdrawal by Subject|13|||
146445949|NCT02151149|528137281|FG001|Treatment Period|Withdrawal by Subject|11|||
146445950|NCT02151149|528137280|FG000|Treatment Period|Miscellaneous|8|||
146445951|NCT02151149|528137281|FG001|Treatment Period|Miscellaneous|7|||
146445952|NCT02151149|528137280|FG000|Treatment Period|Participants randomized but not treated|3|||
146445953|NCT02151149|528137281|FG001|Treatment Period|Participants randomized but not treated|2|||
146445954|NCT02151149|528137280|FG000|Follow-Up Period|Lost to Follow-up|2|||
146445955|NCT02151149|528137281|FG001|Follow-Up Period|Lost to Follow-up|3|||
146445956|NCT02151149|528137280|FG000|Follow-Up Period|Death|37|||
146445957|NCT02151149|528137281|FG001|Follow-Up Period|Death|34|||
146445958|NCT03419962|528137284|FG000|Overall Study|Change to other medication|1|||
146445959|NCT03419962|528137284|FG000|Overall Study|Refusal of continuing with trial drug|1|||
146445960|NCT03419962|528137284|FG000|Overall Study|Lost to Follow-up|3|||
146445961|NCT03419962|528137284|FG000|Overall Study|Difficulty in inhaling the doses|1|||
146445962|NCT03419962|528137284|FG000|Overall Study|Missing completion data|31|||
146445963|NCT04142658|528137285|FG000|Overall Study|Death|2|||
146445964|NCT04142658|528137286|FG001|Overall Study|Death|1|||
146445965|NCT04142658|528137285|FG000|Overall Study|Lost to Follow-up|4|||
146445966|NCT04142658|528137286|FG001|Overall Study|Lost to Follow-up|13|||
146445967|NCT04142658|528137285|FG000|Overall Study|Withdrawal by Subject|9|||
146445968|NCT04142658|528137286|FG001|Overall Study|Withdrawal by Subject|16|||
146445969|NCT01781234|528137287|FG000|Overall Study|Adverse Event|2|||
146445970|NCT01781234|528137288|FG001|Overall Study|Adverse Event|0|||
146445971|NCT01781234|528137287|FG000|Overall Study|Protocol Violation|3|||
146445972|NCT01781234|528137288|FG001|Overall Study|Protocol Violation|0|||
146445973|NCT01781234|528137287|FG000|Overall Study|Withdrawal by Subject|4|||
146445974|NCT01781234|528137288|FG001|Overall Study|Withdrawal by Subject|3|||
146445975|NCT00830167|528137291|FG000|Overall Study|Lack of Efficacy|26|||
146445976|NCT00830167|528137292|FG001|Overall Study|Lack of Efficacy|10|||
146445977|NCT00830167|528137291|FG000|Overall Study|Adverse Event|8|||
146445978|NCT00830167|528137292|FG001|Overall Study|Adverse Event|24|||
146445979|NCT00830167|528137291|FG000|Overall Study|Not meeting entrance criteria|2|||
146445980|NCT00830167|528137292|FG001|Overall Study|Not meeting entrance criteria|5|||
146445981|NCT00830167|528137291|FG000|Overall Study|Withdrawal by Subject|2|||
146445982|NCT00830167|528137292|FG001|Overall Study|Withdrawal by Subject|0|||
146445983|NCT00830167|528137291|FG000|Overall Study|Lost to Follow-up|0|||
146445984|NCT00830167|528137292|FG001|Overall Study|Lost to Follow-up|1|||
146445985|NCT00830167|528137291|FG000|Overall Study|Protocol Violation|0|||
146445986|NCT00830167|528137292|FG001|Overall Study|Protocol Violation|1|||
146445987|NCT00830167|528137291|FG000|Overall Study|Other|2|||
146445988|NCT00830167|528137292|FG001|Overall Study|Other|2|||
146445989|NCT01499160|528137296|FG000|Overall Study|Adverse Event|1|||
146445990|NCT01499160|528137296|FG000|Overall Study|Withdrawal by Subject|1|||
146285791|NCT02962960|527561128|FG002|Overall Study|Protocol Violation|0|||
146445991|NCT01438476|528137297|FG000|Overall Study|Protocol Violation|1|||
146445992|NCT01438476|528137298|FG001|Overall Study|Protocol Violation|0|||
146445993|NCT01438476|528137297|FG000|Overall Study|Withdrawal by Subject|1|||
146445994|NCT01438476|528137298|FG001|Overall Study|Withdrawal by Subject|0|||
146445995|NCT01438476|528137297|FG000|Overall Study|No Surgery- Disease|8|||
146445996|NCT01438476|528137298|FG001|Overall Study|No Surgery- Disease|10|||
146445997|NCT01438476|528137297|FG000|Overall Study|Communication barrier|0|||
146445998|NCT01438476|528137298|FG001|Overall Study|Communication barrier|1|||
146445999|NCT02289820|528137299|FG000|Overall Study|Withdrawal by Subject|2|||
146446000|NCT02289820|528137300|FG001|Overall Study|Withdrawal by Subject|1|||
146446001|NCT02289820|528137301|FG002|Overall Study|Withdrawal by Subject|2|||
146446002|NCT02289820|528137302|FG003|Overall Study|Withdrawal by Subject|1|||
146446003|NCT02289820|528137303|FG004|Overall Study|Withdrawal by Subject|0|||
146446004|NCT02289820|528137304|FG005|Overall Study|Withdrawal by Subject|0|||
146446005|NCT02289820|528137305|FG006|Overall Study|Withdrawal by Subject|1|||
146446006|NCT02289820|528137299|FG000|Overall Study|Death|0|||
146446007|NCT02289820|528137300|FG001|Overall Study|Death|0|||
146446008|NCT02289820|528137301|FG002|Overall Study|Death|1|||
146446009|NCT02289820|528137302|FG003|Overall Study|Death|0|||
146446010|NCT02289820|528137303|FG004|Overall Study|Death|0|||
146446011|NCT02289820|528137304|FG005|Overall Study|Death|0|||
146446012|NCT02289820|528137305|FG006|Overall Study|Death|0|||
146446013|NCT02289820|528137299|FG000|Overall Study|Lost to Follow-up|0|||
146446014|NCT02289820|528137300|FG001|Overall Study|Lost to Follow-up|0|||
146446015|NCT02289820|528137301|FG002|Overall Study|Lost to Follow-up|3|||
146446016|NCT02289820|528137302|FG003|Overall Study|Lost to Follow-up|1|||
146446017|NCT02289820|528137303|FG004|Overall Study|Lost to Follow-up|0|||
146446018|NCT02289820|528137304|FG005|Overall Study|Lost to Follow-up|1|||
146446019|NCT02289820|528137305|FG006|Overall Study|Lost to Follow-up|1|||
146446020|NCT02289820|528137299|FG000|Overall Study|withdrawal of consent|0|||
146446021|NCT02289820|528137300|FG001|Overall Study|withdrawal of consent|1|||
146446022|NCT02289820|528137301|FG002|Overall Study|withdrawal of consent|0|||
146446023|NCT02289820|528137302|FG003|Overall Study|withdrawal of consent|0|||
146446024|NCT02289820|528137303|FG004|Overall Study|withdrawal of consent|0|||
146446025|NCT02289820|528137304|FG005|Overall Study|withdrawal of consent|0|||
146446026|NCT02289820|528137305|FG006|Overall Study|withdrawal of consent|0|||
146446027|NCT01924364|528137312|FG000|Overall Study|Physician Decision|3|||
146446028|NCT00265785|528137313|FG000|Overall Study|Adverse Event|4|||
146446029|NCT00265785|528137313|FG000|Overall Study|Withdrawal by Subject|3|||
146446030|NCT00265785|528137313|FG000|Overall Study|Progression/Relapse|15|||
146446031|NCT00265785|528137313|FG000|Overall Study|Not protocol specified|2|||
146446032|NCT00265785|528137313|FG000|Overall Study|Ineligible|1|||
146446033|NCT00265785|528137313|FG000|Overall Study|Did not receive protocol treatment|2|||
146446034|NCT00603512|528137314|FG000|Overall Study|Adverse Event|0|||
146446035|NCT00603512|528137315|FG001|Overall Study|Adverse Event|2|||
146446036|NCT00603512|528137316|FG002|Overall Study|Adverse Event|4|||
146446037|NCT00603512|528137317|FG003|Overall Study|Adverse Event|4|||
146446038|NCT00603512|528137318|FG004|Overall Study|Adverse Event|2|||
146446039|NCT00603512|528137314|FG000|Overall Study|Lack of Efficacy|0|||
146446040|NCT00603512|528137315|FG001|Overall Study|Lack of Efficacy|1|||
146446041|NCT00603512|528137316|FG002|Overall Study|Lack of Efficacy|0|||
146446042|NCT00603512|528137317|FG003|Overall Study|Lack of Efficacy|0|||
146446043|NCT00603512|528137318|FG004|Overall Study|Lack of Efficacy|1|||
146446044|NCT00603512|528137314|FG000|Overall Study|Other|2|||
146446045|NCT00603512|528137315|FG001|Overall Study|Other|1|||
146446046|NCT00603512|528137316|FG002|Overall Study|Other|0|||
146446047|NCT00603512|528137317|FG003|Overall Study|Other|1|||
146446048|NCT00603512|528137318|FG004|Overall Study|Other|1|||
146446049|NCT00603512|528137314|FG000|Overall Study|Withdrawal by Subject|0|||
146446050|NCT00603512|528137315|FG001|Overall Study|Withdrawal by Subject|0|||
146446051|NCT00603512|528137316|FG002|Overall Study|Withdrawal by Subject|0|||
146446052|NCT00603512|528137317|FG003|Overall Study|Withdrawal by Subject|0|||
146446053|NCT00603512|528137318|FG004|Overall Study|Withdrawal by Subject|1|||
146446054|NCT00603512|528137314|FG000|Overall Study|Randomized but not treated|0|||
146446055|NCT00603512|528137315|FG001|Overall Study|Randomized but not treated|1|||
146446056|NCT00603512|528137316|FG002|Overall Study|Randomized but not treated|1|||
146446057|NCT00603512|528137317|FG003|Overall Study|Randomized but not treated|2|||
146446058|NCT00603512|528137318|FG004|Overall Study|Randomized but not treated|0|||
146446059|NCT04979858|528137319|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
146446060|NCT04979858|528137320|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
146446061|NCT04253236|528137321|FG000|Overall Study|Adverse Event|1|||
146446062|NCT04253236|528137322|FG001|Overall Study|Adverse Event|0|||
146446063|NCT04253236|528137321|FG000|Overall Study|Safety Concerns|1|||
146446064|NCT04253236|528137322|FG001|Overall Study|Safety Concerns|0|||
146446065|NCT04253236|528137321|FG000|Overall Study|Study Terminated by Sponsor|1|||
146446066|NCT04253236|528137322|FG001|Overall Study|Study Terminated by Sponsor|0|||
146446067|NCT01688882|528137323|FG000|Overall Study|Adverse Event|1|||
146446068|NCT01688882|528137324|FG001|Overall Study|Adverse Event|0|||
146446069|NCT01688882|528137323|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145956293|NCT01059773|526352445|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
145956294|NCT01059773|526352444|FG000|Overall Study|Other|1|||
145956295|NCT01059773|526352445|FG001|Overall Study|Other|3|||
145956296|NCT00141518|526352448|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
145956297|NCT00141518|526352449|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
146446070|NCT01688882|528137324|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145956298|NCT00141518|526352450|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
145956299|NCT00141518|526352448|FG000|Overall Study|Adverse Event|7|||
146446071|NCT01688882|528137323|FG000|Overall Study|Administrative problems|1|||
146446072|NCT01688882|528137324|FG001|Overall Study|Administrative problems|0|||
146446073|NCT00860262|528137328|FG000|Overall Study|Adverse Event|9|||
146446074|NCT00860262|528137329|FG001|Overall Study|Adverse Event|6|||
146446075|NCT00860262|528137330|FG002|Overall Study|Adverse Event|7|||
146446076|NCT00860262|528137328|FG000|Overall Study|Protocol Violation|0|||
146446077|NCT00860262|528137329|FG001|Overall Study|Protocol Violation|1|||
146446078|NCT00860262|528137330|FG002|Overall Study|Protocol Violation|0|||
146446079|NCT00860262|528137328|FG000|Overall Study|Lost to Follow-up|2|||
146446080|NCT00860262|528137329|FG001|Overall Study|Lost to Follow-up|0|||
146446081|NCT00860262|528137330|FG002|Overall Study|Lost to Follow-up|1|||
146446082|NCT00860262|528137328|FG000|Overall Study|Withdrawal by Subject|4|||
146446083|NCT00860262|528137329|FG001|Overall Study|Withdrawal by Subject|8|||
146446084|NCT00860262|528137330|FG002|Overall Study|Withdrawal by Subject|6|||
146083323|NCT01917656|526824797|FG001|Overall Study|Lost to Follow-up|4|||
146083324|NCT02285062|526824798|FG000|Pre-Treatment Period|Protocol Violation|0|||
146083325|NCT02285062|526824799|FG001|Pre-Treatment Period|Protocol Violation|2|||
146083326|NCT02285062|526824798|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146083327|NCT02285062|526824799|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146083328|NCT02015221|526824800|FG000|Overall Study|Withdrawal by Subject|8|||
146083329|NCT02015221|526824801|FG001|Overall Study|Withdrawal by Subject|6|||
146083330|NCT02015221|526824800|FG000|Overall Study|Lost to Follow-up|1|||
146083331|NCT02015221|526824801|FG001|Overall Study|Lost to Follow-up|0|||
146083332|NCT01306929|526824802|FG000|Overall Study|Withdrawal by Subject|23|||
146083333|NCT01306929|526824802|FG000|Overall Study|Adverse Event|21|||
146083334|NCT01306929|526824802|FG000|Overall Study|Physician Decision|13|||
145956300|NCT00141518|526352449|FG001|Overall Study|Adverse Event|5|||
145956301|NCT00141518|526352450|FG002|Overall Study|Adverse Event|2|||
146083335|NCT01306929|526824802|FG000|Overall Study|Death|8|||
145956302|NCT00141518|526352448|FG000|Overall Study|Withdrawal by Subject|2|||
145956303|NCT00141518|526352449|FG001|Overall Study|Withdrawal by Subject|0|||
145956304|NCT00141518|526352450|FG002|Overall Study|Withdrawal by Subject|2|||
146083336|NCT01306929|526824802|FG000|Overall Study|Withdrawal by parent/guardian|5|||
146083337|NCT01306929|526824802|FG000|Overall Study|Protocol Violation|3|||
146083338|NCT01306929|526824802|FG000|Overall Study|Non-compliance with study drug|2|||
146083339|NCT01306929|526824802|FG000|Overall Study|Lost to Follow-up|2|||
146083340|NCT01306929|526824802|FG000|Overall Study|Various|17|||
146083341|NCT03709576|526824808|FG000|Overall Study|progression prior to enrollment|1|||
146083342|NCT03041129|526824812|FG000|Overall Study|Withdrawal by Subject|2|||
146083343|NCT03041129|526824813|FG001|Overall Study|Withdrawal by Subject|0|||
146083344|NCT03041129|526824814|FG002|Overall Study|Withdrawal by Subject|0|||
145956305|NCT00141518|526352448|FG000|Overall Study|Protocol Violation|1|||
145956306|NCT00141518|526352449|FG001|Overall Study|Protocol Violation|1|||
145956307|NCT00141518|526352450|FG002|Overall Study|Protocol Violation|2|||
145956308|NCT00141518|526352448|FG000|Overall Study|Lack of Efficacy|5|||
145956309|NCT00141518|526352449|FG001|Overall Study|Lack of Efficacy|0|||
145956310|NCT00141518|526352450|FG002|Overall Study|Lack of Efficacy|0|||
145956311|NCT01806168|526352452|FG000|Overall Study|Adverse Event|1|||
145956312|NCT01806168|526352453|FG001|Overall Study|Adverse Event|0|||
145956313|NCT01806168|526352454|FG002|Overall Study|Adverse Event|0|||
145956314|NCT01806168|526352452|FG000|Overall Study|Withdrawal by Subject|0|||
145956315|NCT01806168|526352453|FG001|Overall Study|Withdrawal by Subject|1|||
145956316|NCT01806168|526352454|FG002|Overall Study|Withdrawal by Subject|2|||
145956317|NCT01806168|526352452|FG000|Overall Study|Protocol Violation|0|||
145956318|NCT01806168|526352453|FG001|Overall Study|Protocol Violation|0|||
145956319|NCT01806168|526352454|FG002|Overall Study|Protocol Violation|1|||
145956320|NCT01029262|526352457|FG000|Overall Study|Adverse Event|9|||
145956321|NCT01029262|526352458|FG001|Overall Study|Adverse Event|52|||
145956322|NCT01029262|526352457|FG000|Overall Study|Lack of therapeutic effect|57|||
145956323|NCT01029262|526352458|FG001|Overall Study|Lack of therapeutic effect|76|||
146083345|NCT03041129|526824815|FG003|Overall Study|Withdrawal by Subject|0|||
146083346|NCT00510653|526824818|FG000|Overall Study|Withdrawal by Subject|8|||
146209571|NCT04992390|527280415|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
146209572|NCT04992390|527280416|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
145956324|NCT01029262|526352457|FG000|Overall Study|Withdrawal by Subject|10|||
146083347|NCT00510653|526824818|FG000|Overall Study|Monetary|3|||
146083348|NCT00890045|526824819|FG000|Overall Study|Death|0|||
145956325|NCT01029262|526352458|FG001|Overall Study|Withdrawal by Subject|17|||
145956326|NCT01029262|526352457|FG000|Overall Study|Protocol Violation|2|||
145956327|NCT01029262|526352458|FG001|Overall Study|Protocol Violation|3|||
145956328|NCT01029262|526352457|FG000|Overall Study|Miscellaneous|1|||
146083349|NCT00890045|526824820|FG001|Overall Study|Death|1|||
146083350|NCT00890045|526824819|FG000|Overall Study|Did not receive HeRO Graft|0|||
146083351|NCT00890045|526824820|FG001|Overall Study|Did not receive HeRO Graft|2|||
145956329|NCT01029262|526352458|FG001|Overall Study|Miscellaneous|9|||
145956330|NCT01029262|526352457|FG000|Overall Study|Death|0|||
145956331|NCT01029262|526352458|FG001|Overall Study|Death|3|||
145956332|NCT01001910|526352459|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
145956333|NCT00614874|526352460|FG000|Overall Study|Protocol Violation|1|||
145956334|NCT00614874|526352460|FG000|Overall Study|Withdrawal by Subject|1|||
146209573|NCT04992390|527280414|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
145956335|NCT03904420|526352461|FG000|Overall Study|Study terminated|2|||
146209574|NCT04992390|527280415|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
146209575|NCT04992390|527280416|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
146446085|NCT00860262|528137328|FG000|Overall Study|Lack of Efficacy|0|||
146446086|NCT00860262|528137329|FG001|Overall Study|Lack of Efficacy|4|||
146446087|NCT00860262|528137330|FG002|Overall Study|Lack of Efficacy|3|||
146446088|NCT00860262|528137328|FG000|Overall Study|Other|5|||
146446089|NCT00860262|528137329|FG001|Overall Study|Other|3|||
146446090|NCT00860262|528137330|FG002|Overall Study|Other|1|||
146446091|NCT00124618|528137331|FG000|Overall Study|Ineligible|1|||
146446092|NCT04640194|528137337|FG000|Overall Study|Adverse Event|3|||
146446093|NCT04640194|528137338|FG001|Overall Study|Adverse Event|7|||
146446094|NCT04640194|528137339|FG002|Overall Study|Adverse Event|0|||
146446095|NCT04640194|528137340|FG003|Overall Study|Adverse Event|5|||
146446096|NCT04640194|528137341|FG004|Overall Study|Adverse Event|0|||
146446097|NCT04640194|528137342|FG005|Overall Study|Adverse Event|4|||
146446098|NCT04640194|528137343|FG006|Overall Study|Adverse Event|0|||
146446099|NCT04640194|528137337|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
146446100|NCT04640194|528137338|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
146446101|NCT04640194|528137339|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
146446102|NCT04640194|528137340|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
146446103|NCT04640194|528137341|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
146446104|NCT04640194|528137342|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
146446105|NCT04640194|528137343|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
146446106|NCT04640194|528137337|FG000|Overall Study|fibrinogen level too low|0|||
146446107|NCT04640194|528137338|FG001|Overall Study|fibrinogen level too low|0|||
146446108|NCT04640194|528137339|FG002|Overall Study|fibrinogen level too low|0|||
146446109|NCT04640194|528137340|FG003|Overall Study|fibrinogen level too low|1|||
146446110|NCT04640194|528137341|FG004|Overall Study|fibrinogen level too low|0|||
146446111|NCT04640194|528137342|FG005|Overall Study|fibrinogen level too low|0|||
146446112|NCT04640194|528137343|FG006|Overall Study|fibrinogen level too low|0|||
146446113|NCT04640194|528137337|FG000|Overall Study|mild bleeding|0|||
146446114|NCT04640194|528137338|FG001|Overall Study|mild bleeding|0|||
146446115|NCT04640194|528137339|FG002|Overall Study|mild bleeding|0|||
146446116|NCT04640194|528137340|FG003|Overall Study|mild bleeding|1|||
146446117|NCT04640194|528137341|FG004|Overall Study|mild bleeding|0|||
146446118|NCT04640194|528137342|FG005|Overall Study|mild bleeding|0|||
146446119|NCT04640194|528137343|FG006|Overall Study|mild bleeding|0|||
146446120|NCT04640194|528137337|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446121|NCT04640194|528137338|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
146446122|NCT04640194|528137339|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446123|NCT04640194|528137340|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446124|NCT04640194|528137341|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446125|NCT04640194|528137342|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446126|NCT04640194|528137343|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
146446127|NCT01709903|528137344|FG000|Overall Study|administrative problems|2|||
146446128|NCT01709903|528137345|FG001|Overall Study|administrative problems|6|||
146446129|NCT01709903|528137344|FG000|Overall Study|Abnormal test procedure results|1|||
146446130|NCT01709903|528137345|FG001|Overall Study|Abnormal test procedure results|0|||
146446131|NCT01709903|528137344|FG000|Overall Study|In ability to use device|1|||
146446132|NCT01709903|528137345|FG001|Overall Study|In ability to use device|1|||
146446133|NCT01709903|528137344|FG000|Overall Study|no longer needed study drug|0|||
146446134|NCT01709903|528137345|FG001|Overall Study|no longer needed study drug|1|||
146446135|NCT01709903|528137344|FG000|Overall Study|Lost to Follow-up|0|||
146446136|NCT01709903|528137345|FG001|Overall Study|Lost to Follow-up|2|||
145956336|NCT03904420|526352462|FG001|Overall Study|Study terminated|2|||
145956337|NCT01468454|526352463|FG000|Overall Study|Did not have surgery after PET|9|||
145956338|NCT01462630|526352465|FG000|Overall Study|Did not initiate therapy|3|||
145956339|NCT01462630|526352465|FG000|Overall Study|Death|1|||
145956340|NCT01462630|526352465|FG000|Overall Study|Protocol Violation|2|||
145956341|NCT01462630|526352465|FG000|Overall Study|Adverse Event|1|||
145956342|NCT01048541|526352468|FG000|Overall Study|Withdrawal by Subject|1|||
145956343|NCT01048541|526352469|FG001|Overall Study|Withdrawal by Subject|0|||
145956344|NCT00996034|526352474|FG000|Overall Study|Lost to Follow-up|2|||
146446137|NCT01709903|528137344|FG000|Overall Study|Death|2|||
146446138|NCT01709903|528137345|FG001|Overall Study|Death|0|||
146446139|NCT01709903|528137344|FG000|Overall Study|Protocol Violation|3|||
146446140|NCT01709903|528137345|FG001|Overall Study|Protocol Violation|2|||
146446141|NCT01709903|528137344|FG000|Overall Study|Lack of Efficacy|3|||
146446142|NCT01709903|528137345|FG001|Overall Study|Lack of Efficacy|3|||
146446143|NCT01709903|528137344|FG000|Overall Study|Withdrawal by Subject|6|||
146446144|NCT01709903|528137345|FG001|Overall Study|Withdrawal by Subject|6|||
146209576|NCT04992390|527280414|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
145956345|NCT00996034|526352474|FG000|Overall Study|withdrawn by PI|1|||
146446145|NCT01709903|528137344|FG000|Overall Study|Adverse Event|11|||
146446146|NCT01709903|528137345|FG001|Overall Study|Adverse Event|18|||
146446147|NCT02061280|528137346|FG000|Overall Study|Protocol Violation|12|||
146446148|NCT02061280|528137347|FG001|Overall Study|Protocol Violation|8|||
146446149|NCT02061280|528137346|FG000|Overall Study|moved out of state|0|||
145956346|NCT01720524|526352475|FG000|Part A|Insufficient Clinical Response|2|||
145956347|NCT01720524|526352476|FG001|Part A|Insufficient Clinical Response|4|||
145956348|NCT01720524|526352475|FG000|Part A|Adverse Event|2|||
145956349|NCT01720524|526352476|FG001|Part A|Adverse Event|2|||
145956350|NCT01720524|526352475|FG000|Part A|Death|2|||
145956351|NCT01720524|526352476|FG001|Part A|Death|1|||
145956352|NCT01720524|526352475|FG000|Part A|Lost to Follow-up|0|||
145956353|NCT01720524|526352476|FG001|Part A|Lost to Follow-up|1|||
145956354|NCT01720524|526352475|FG000|Part A|Missed 28 day follow-up visit|1|||
145956355|NCT01720524|526352476|FG001|Part A|Missed 28 day follow-up visit|1|||
145956356|NCT01720524|526352475|FG000|Part A|Withdrawal by Subject|0|||
145956357|NCT01720524|526352476|FG001|Part A|Withdrawal by Subject|1|||
145956358|NCT01720524|526352475|FG000|Part A|Other|0|||
145956359|NCT01720524|526352476|FG001|Part A|Other|1|||
145956360|NCT01720524|526352475|FG000|Part A|Lost to Follow-up|0|||
145956361|NCT01720524|526352476|FG001|Part A|Lost to Follow-up|1|||
145956362|NCT01720524|526352475|FG000|Part B|No longer willing to participate in study|1|||
145956363|NCT01720524|526352476|FG001|Part B|No longer willing to participate in study|4|||
146285792|NCT02344004|527561136|FG000|Overall Study|Adverse Event|11|||
145956364|NCT01720524|526352475|FG000|Part B|Other|2|||
145956365|NCT01720524|526352476|FG001|Part B|Other|0|||
145956366|NCT01720524|526352475|FG000|Part B|Lost to Follow-up|2|||
145956367|NCT01720524|526352476|FG001|Part B|Lost to Follow-up|3|||
145956368|NCT01720524|526352475|FG000|Part B|Death|0|||
145956369|NCT01720524|526352476|FG001|Part B|Death|2|||
145956370|NCT00158262|526352480|FG000|Overall Study|Lost to Follow-up|1|||
145956371|NCT00158262|526352481|FG001|Overall Study|Lost to Follow-up|1|||
145956372|NCT02105285|526352484|FG000|Overall Study|Adverse Event|1|||
146446150|NCT02061280|528137347|FG001|Overall Study|moved out of state|1|||
146446151|NCT02061280|528137346|FG000|Overall Study|Withdrawal by Subject|1|||
146446152|NCT02061280|528137347|FG001|Overall Study|Withdrawal by Subject|2|||
146446153|NCT02061280|528137346|FG000|Overall Study|Lost to Follow-up|5|||
146446154|NCT02061280|528137347|FG001|Overall Study|Lost to Follow-up|1|||
146446155|NCT03759379|528138888|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
146446156|NCT03759379|528138889|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
146446157|NCT03759379|528138888|FG000|Treatment Period|Death|2|||
146446158|NCT03759379|528138889|FG001|Treatment Period|Death|3|||
146446159|NCT03759379|528138888|FG000|Treatment Period|Lost to Follow-up|1|||
146446160|NCT03759379|528138889|FG001|Treatment Period|Lost to Follow-up|0|||
146446161|NCT03759379|528138888|FG000|Treatment Period|Physician Decision|0|||
146446162|NCT03759379|528138889|FG001|Treatment Period|Physician Decision|1|||
146446163|NCT02325414|528138890|FG000|Overall Study|Withdrawal by Subject|3|||
146446164|NCT02325414|528138891|FG001|Overall Study|Withdrawal by Subject|1|||
146446165|NCT02325414|528138890|FG000|Overall Study|Lost to Follow-up|5|||
146446166|NCT02325414|528138891|FG001|Overall Study|Lost to Follow-up|5|||
146446167|NCT05722522|528138892|FG000|Overall Study|Adverse Event|0|||
146446168|NCT05722522|528138893|FG001|Overall Study|Adverse Event|1|||
146446169|NCT03834961|528138896|FG000|Overall Study|Lack of Efficacy|1|||
146446170|NCT03834961|528138897|FG001|Overall Study|Lack of Efficacy|1|||
146446171|NCT03834961|528138898|FG002|Overall Study|Lack of Efficacy|0|||
146446172|NCT03834961|528138896|FG000|Overall Study|Physician Decision|0|||
146446173|NCT03834961|528138897|FG001|Overall Study|Physician Decision|1|||
146446174|NCT03834961|528138898|FG002|Overall Study|Physician Decision|0|||
146446175|NCT04736199|528138901|FG000|Overall Study|Adverse Event|28|||
146446176|NCT04736199|528138902|FG001|Overall Study|Adverse Event|22|||
146446177|NCT04736199|528138901|FG000|Overall Study|Death|9|||
146446178|NCT04736199|528138902|FG001|Overall Study|Death|3|||
146446179|NCT04736199|528138901|FG000|Overall Study|Lost to Follow-up|4|||
146446180|NCT04736199|528138902|FG001|Overall Study|Lost to Follow-up|1|||
146446181|NCT04736199|528138901|FG000|Overall Study|Physician Decision|5|||
146446182|NCT04736199|528138902|FG001|Overall Study|Physician Decision|9|||
146446183|NCT04736199|528138901|FG000|Overall Study|Withdrawal by Subject|21|||
146446184|NCT04736199|528138902|FG001|Overall Study|Withdrawal by Subject|9|||
146446185|NCT04736199|528138901|FG000|Overall Study|Progressive disease|120|||
146446186|NCT04736199|528138902|FG001|Overall Study|Progressive disease|101|||
146446187|NCT04736199|528138901|FG000|Overall Study|Subject decision|13|||
146446188|NCT04736199|528138902|FG001|Overall Study|Subject decision|13|||
146446189|NCT04736199|528138901|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
146446190|NCT04736199|528138902|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
146446191|NCT04736199|528138901|FG000|Overall Study|Additional primary malignancy|1|||
146446192|NCT04736199|528138902|FG001|Overall Study|Additional primary malignancy|0|||
146446193|NCT04736199|528138901|FG000|Overall Study|Non-compliance with study drug|0|||
146446194|NCT04736199|528138902|FG001|Overall Study|Non-compliance with study drug|1|||
146446195|NCT04736199|528138901|FG000|Overall Study|Other reason|0|||
146446196|NCT04736199|528138902|FG001|Overall Study|Other reason|1|||
146446197|NCT04736199|528138901|FG000|Overall Study|Ongoing with study drug|240|||
146446198|NCT04736199|528138902|FG001|Overall Study|Ongoing with study drug|63|||
146446199|NCT04736199|528138901|FG000|Overall Study|Study drug never administered|3|||
146446200|NCT04736199|528138902|FG001|Overall Study|Study drug never administered|0|||
146446201|NCT02775851|528138903|FG000|Overall Study|Adverse Event|1|||
146446202|NCT02775851|528138904|FG001|Overall Study|Adverse Event|10|||
146446203|NCT02775851|528138903|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
146446204|NCT02775851|528138904|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
146446205|NCT02775851|528138903|FG000|Overall Study|Progression/Relapse|0|||
146446206|NCT02775851|528138904|FG001|Overall Study|Progression/Relapse|4|||
146446207|NCT02775851|528138903|FG000|Overall Study|Other - Not Protocol Specified|0|||
146446208|NCT02775851|528138904|FG001|Overall Study|Other - Not Protocol Specified|7|||
146446209|NCT02775851|528138903|FG000|Overall Study|Withdrawal by Subject|1|||
146446210|NCT02775851|528138904|FG001|Overall Study|Withdrawal by Subject|0|||
146446211|NCT04732871|528138905|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
146446212|NCT04732871|528138906|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
146446213|NCT04732871|528138907|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
146446214|NCT04732871|528138905|FG000|Overall Study|Lost to Follow-up|7|||
146446215|NCT04732871|528138906|FG001|Overall Study|Lost to Follow-up|4|||
146446216|NCT04732871|528138907|FG002|Overall Study|Lost to Follow-up|3|||
146446217|NCT04732871|528138905|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
146446218|NCT04732871|528138906|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
146446219|NCT04732871|528138907|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
146446220|NCT04732871|528138905|FG000|Overall Study|Migrated / moved from the study area|5|||
146446221|NCT04732871|528138906|FG001|Overall Study|Migrated / moved from the study area|0|||
146446222|NCT04732871|528138907|FG002|Overall Study|Migrated / moved from the study area|0|||
146446223|NCT04732871|528138905|FG000|Overall Study|Other|1|||
146446224|NCT04732871|528138906|FG001|Overall Study|Other|0|||
146446225|NCT04732871|528138907|FG002|Overall Study|Other|1|||
146446226|NCT04732871|528138905|FG000|Overall Study|Ongoing|6|||
146446227|NCT04732871|528138906|FG001|Overall Study|Ongoing|0|||
146446228|NCT04732871|528138907|FG002|Overall Study|Ongoing|1|||
146446229|NCT04732871|528138905|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
146446230|NCT04732871|528138906|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
146446231|NCT04732871|528138907|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
146446232|NCT05918055|528138909|FG000|Phase I - Dose Level 1|Ineligible|0|||
146446233|NCT05918055|528138910|FG001|Phase I - Dose Level 1|Ineligible|0|||
146446234|NCT05918055|528138911|FG002|Phase I - Dose Level 1|Ineligible|1|||
146446235|NCT05918055|528138909|FG000|Phase I - Dose Level -1|Physician Decision|1|||
146446236|NCT05918055|528138910|FG001|Phase I - Dose Level -1|Physician Decision|0|||
146446237|NCT05918055|528138911|FG002|Phase I - Dose Level -1|Physician Decision|0|||
146446238|NCT05610605|528138914|FG000|6-month Assessment|Death|1|||
146446239|NCT05610605|528138915|FG001|6-month Assessment|Death|1|||
146446240|NCT05610605|528138914|FG000|6-month Assessment|Lost to Follow-up|20|||
146446241|NCT05610605|528138915|FG001|6-month Assessment|Lost to Follow-up|0|||
146446242|NCT05610605|528138914|FG000|6-month Assessment|Institutionalized|1|||
146446243|NCT05610605|528138915|FG001|6-month Assessment|Institutionalized|2|||
146446244|NCT05610605|528138914|FG000|12-month Assessment|Death|2|||
146446245|NCT05610605|528138915|FG001|12-month Assessment|Death|1|||
146446246|NCT05610605|528138914|FG000|12-month Assessment|Lost to Follow-up|1|||
146446247|NCT05610605|528138915|FG001|12-month Assessment|Lost to Follow-up|4|||
146446248|NCT05610605|528138914|FG000|12-month Assessment|Institutionalized|2|||
146446249|NCT05610605|528138915|FG001|12-month Assessment|Institutionalized|1|||
146446250|NCT00042289|528138917|FG000|Overall Study|Lost to Follow-up|3|||
146446251|NCT00042289|528138918|FG001|Overall Study|Lost to Follow-up|0|||
146446252|NCT00042289|528138919|FG002|Overall Study|Lost to Follow-up|0|||
146446253|NCT00042289|528138920|FG003|Overall Study|Lost to Follow-up|1|||
146446254|NCT00042289|528138921|FG004|Overall Study|Lost to Follow-up|3|||
146446255|NCT00042289|528138922|FG005|Overall Study|Lost to Follow-up|3|||
146446256|NCT00042289|528138923|FG006|Overall Study|Lost to Follow-up|6|||
146446257|NCT00042289|528138924|FG007|Overall Study|Lost to Follow-up|1|||
146446258|NCT00042289|528138925|FG008|Overall Study|Lost to Follow-up|1|||
146446259|NCT00042289|528138926|FG009|Overall Study|Lost to Follow-up|0|||
146446260|NCT00042289|528138927|FG010|Overall Study|Lost to Follow-up|0|||
146446261|NCT00042289|528138928|FG011|Overall Study|Lost to Follow-up|0|||
146446262|NCT00042289|528138929|FG012|Overall Study|Lost to Follow-up|0|||
146446263|NCT00042289|528138930|FG013|Overall Study|Lost to Follow-up|0|||
146446264|NCT00042289|528138931|FG014|Overall Study|Lost to Follow-up|0|||
146083352|NCT00890045|526824819|FG000|Overall Study|Lost to Follow-up|5|||
146083353|NCT00890045|526824820|FG001|Overall Study|Lost to Follow-up|7|||
146209577|NCT04992390|527280415|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
146209578|NCT04992390|527280416|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
146446265|NCT00042289|528138932|FG015|Overall Study|Lost to Follow-up|1|||
146446266|NCT00042289|528138933|FG016|Overall Study|Lost to Follow-up|1|||
146446267|NCT00042289|528138934|FG017|Overall Study|Lost to Follow-up|0|||
146446268|NCT00042289|528138935|FG018|Overall Study|Lost to Follow-up|3|||
146446269|NCT00042289|528138936|FG019|Overall Study|Lost to Follow-up|2|||
146446270|NCT00042289|528138937|FG020|Overall Study|Lost to Follow-up|0|||
146446271|NCT00042289|528138938|FG021|Overall Study|Lost to Follow-up|0|||
146446272|NCT00042289|528138939|FG022|Overall Study|Lost to Follow-up|0|||
146083354|NCT00483756|526824823|FG000|Overall Study|Death|2|||
146446273|NCT00042289|528138940|FG023|Overall Study|Lost to Follow-up|0|||
146446274|NCT00042289|528138941|FG024|Overall Study|Lost to Follow-up|0|||
146446275|NCT00042289|528138942|FG025|Overall Study|Lost to Follow-up|0|||
146446276|NCT00042289|528138943|FG026|Overall Study|Lost to Follow-up|2|||
146446277|NCT00042289|528138944|FG027|Overall Study|Lost to Follow-up|2|||
146446278|NCT00042289|528138945|FG028|Overall Study|Lost to Follow-up|2|||
146446279|NCT00042289|528138946|FG029|Overall Study|Lost to Follow-up|0|||
146446280|NCT00042289|528138947|FG030|Overall Study|Lost to Follow-up|0|||
146446281|NCT00042289|528138948|FG031|Overall Study|Lost to Follow-up|2|||
146446282|NCT00042289|528138949|FG032|Overall Study|Lost to Follow-up|1|||
146446283|NCT00042289|528138950|FG033|Overall Study|Lost to Follow-up|1|||
146446284|NCT00042289|528138951|FG034|Overall Study|Lost to Follow-up|1|||
146446285|NCT00042289|528138952|FG035|Overall Study|Lost to Follow-up|2|||
145956373|NCT02105285|526352485|FG001|Overall Study|Adverse Event|1|||
146446286|NCT00042289|528138953|FG036|Overall Study|Lost to Follow-up|1|||
146446287|NCT00042289|528138954|FG037|Overall Study|Lost to Follow-up|1|||
146446288|NCT00042289|528138955|FG038|Overall Study|Lost to Follow-up|0|||
146446289|NCT00042289|528138956|FG039|Overall Study|Lost to Follow-up|5|||
146446290|NCT00042289|528138957|FG040|Overall Study|Lost to Follow-up|0|||
146446291|NCT00042289|528138958|FG041|Overall Study|Lost to Follow-up|2|||
146446292|NCT00042289|528138959|FG042|Overall Study|Lost to Follow-up|2|||
146446293|NCT00042289|528138960|FG043|Overall Study|Lost to Follow-up|0|||
146446294|NCT00042289|528138961|FG044|Overall Study|Lost to Follow-up|0|||
146446295|NCT00042289|528138962|FG045|Overall Study|Lost to Follow-up|1|||
146446296|NCT00042289|528138963|FG046|Overall Study|Lost to Follow-up|0|||
146446297|NCT00042289|528138917|FG000|Overall Study|Other reason|0|||
146446298|NCT00042289|528138918|FG001|Overall Study|Other reason|0|||
146446299|NCT00042289|528138919|FG002|Overall Study|Other reason|0|||
146446300|NCT00042289|528138920|FG003|Overall Study|Other reason|2|||
146446301|NCT00042289|528138921|FG004|Overall Study|Other reason|0|||
146446302|NCT00042289|528138922|FG005|Overall Study|Other reason|0|||
146446303|NCT00042289|528138923|FG006|Overall Study|Other reason|0|||
146446304|NCT00042289|528138924|FG007|Overall Study|Other reason|0|||
146446305|NCT00042289|528138925|FG008|Overall Study|Other reason|0|||
146446306|NCT00042289|528138926|FG009|Overall Study|Other reason|0|||
146446307|NCT00042289|528138927|FG010|Overall Study|Other reason|0|||
146446308|NCT00042289|528138928|FG011|Overall Study|Other reason|0|||
146446309|NCT00042289|528138929|FG012|Overall Study|Other reason|0|||
146446310|NCT00042289|528138930|FG013|Overall Study|Other reason|0|||
146446311|NCT00042289|528138931|FG014|Overall Study|Other reason|0|||
146446312|NCT00042289|528138932|FG015|Overall Study|Other reason|0|||
146446313|NCT00042289|528138933|FG016|Overall Study|Other reason|0|||
146446314|NCT00042289|528138934|FG017|Overall Study|Other reason|0|||
146446315|NCT00042289|528138935|FG018|Overall Study|Other reason|1|||
146446316|NCT00042289|528138936|FG019|Overall Study|Other reason|0|||
146446317|NCT00042289|528138937|FG020|Overall Study|Other reason|0|||
146446318|NCT00042289|528138938|FG021|Overall Study|Other reason|0|||
146083355|NCT00483756|526824824|FG001|Overall Study|Death|0|||
146083356|NCT00483756|526824825|FG002|Overall Study|Death|1|||
145956374|NCT02105285|526352486|FG002|Overall Study|Adverse Event|0|||
145956375|NCT02105285|526352484|FG000|Overall Study|Protocol Violation|0|||
146083357|NCT00483756|526824823|FG000|Overall Study|Adverse Event|19|||
146446319|NCT00042289|528138939|FG022|Overall Study|Other reason|0|||
146446320|NCT00042289|528138940|FG023|Overall Study|Other reason|1|||
146446321|NCT00042289|528138941|FG024|Overall Study|Other reason|0|||
146446322|NCT00042289|528138942|FG025|Overall Study|Other reason|0|||
146446323|NCT00042289|528138943|FG026|Overall Study|Other reason|1|||
146446324|NCT00042289|528138944|FG027|Overall Study|Other reason|0|||
146446325|NCT00042289|528138945|FG028|Overall Study|Other reason|3|||
146446326|NCT00042289|528138946|FG029|Overall Study|Other reason|0|||
146446327|NCT00042289|528138947|FG030|Overall Study|Other reason|0|||
146446328|NCT00042289|528138948|FG031|Overall Study|Other reason|1|||
146446329|NCT00042289|528138949|FG032|Overall Study|Other reason|0|||
146446330|NCT00042289|528138950|FG033|Overall Study|Other reason|1|||
146446331|NCT00042289|528138951|FG034|Overall Study|Other reason|0|||
146446332|NCT00042289|528138952|FG035|Overall Study|Other reason|2|||
146446333|NCT00042289|528138953|FG036|Overall Study|Other reason|0|||
146446334|NCT00042289|528138954|FG037|Overall Study|Other reason|0|||
146446335|NCT00042289|528138955|FG038|Overall Study|Other reason|0|||
146446336|NCT00042289|528138956|FG039|Overall Study|Other reason|0|||
146446337|NCT00042289|528138957|FG040|Overall Study|Other reason|0|||
146446338|NCT00042289|528138958|FG041|Overall Study|Other reason|0|||
146446339|NCT00042289|528138959|FG042|Overall Study|Other reason|0|||
146446340|NCT00042289|528138960|FG043|Overall Study|Other reason|1|||
146446341|NCT00042289|528138961|FG044|Overall Study|Other reason|0|||
146446342|NCT00042289|528138962|FG045|Overall Study|Other reason|0|||
146446343|NCT00042289|528138963|FG046|Overall Study|Other reason|0|||
145956376|NCT02105285|526352485|FG001|Overall Study|Protocol Violation|1|||
145956377|NCT02105285|526352486|FG002|Overall Study|Protocol Violation|0|||
145956378|NCT02105285|526352484|FG000|Overall Study|Withdrawal by Subject|1|||
145956379|NCT02105285|526352485|FG001|Overall Study|Withdrawal by Subject|0|||
145956380|NCT02105285|526352486|FG002|Overall Study|Withdrawal by Subject|0|||
145956381|NCT01421641|526352487|FG000|Overall Study|Protocol Violation|2|||
145956382|NCT01421641|526352488|FG001|Overall Study|Protocol Violation|2|||
145956383|NCT02420119|526352490|FG000|Overall Study|insufficient laboratory data|5|||
145956384|NCT02364388|526352491|FG000|Overall Study|Protocol Violation|1|||
145956385|NCT02364388|526352491|FG000|Overall Study|Technical Failure|3|||
145956386|NCT02364388|526352491|FG000|Overall Study|No OA/US data|2|||
145956387|NCT02364388|526352491|FG000|Overall Study|No Biopsy|2|||
145956388|NCT03231306|526352492|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
145956389|NCT03231306|526352492|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
145956390|NCT03231306|526352492|FG000|Overall Study|Treatment delay > 21 days|2|||
145956391|NCT03231306|526352492|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
145956392|NCT03231306|526352492|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
145956393|NCT03231306|526352492|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
145956394|NCT03231306|526352492|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
145956395|NCT03231306|526352492|FG000|Overall Study|More than 1 Reason|2|||
145956396|NCT04501952|526352493|FG000|Overall Study|Adverse Event|0|||
145956397|NCT04501952|526352494|FG001|Overall Study|Adverse Event|3|||
145956398|NCT04501952|526352493|FG000|Overall Study|Investigator's Discretion|0|||
145956399|NCT04501952|526352494|FG001|Overall Study|Investigator's Discretion|1|||
146446344|NCT00042289|528138917|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146446345|NCT00042289|528138918|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146446346|NCT00042289|528138919|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146446347|NCT00042289|528138920|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146446348|NCT00042289|528138921|FG004|Overall Study|Severe debilitation, unable to continue|0|||
146446349|NCT00042289|528138922|FG005|Overall Study|Severe debilitation, unable to continue|0|||
146446350|NCT00042289|528138923|FG006|Overall Study|Severe debilitation, unable to continue|0|||
146446351|NCT00042289|528138924|FG007|Overall Study|Severe debilitation, unable to continue|0|||
145956400|NCT04501952|526352493|FG000|Overall Study|Protocol Violation|1|||
146285793|NCT02344004|527561137|FG001|Overall Study|Adverse Event|1|||
146285794|NCT02344004|527561136|FG000|Overall Study|Death|9|||
146446352|NCT00042289|528138925|FG008|Overall Study|Severe debilitation, unable to continue|0|||
146446353|NCT00042289|528138926|FG009|Overall Study|Severe debilitation, unable to continue|0|||
146446354|NCT00042289|528138927|FG010|Overall Study|Severe debilitation, unable to continue|0|||
146446355|NCT00042289|528138928|FG011|Overall Study|Severe debilitation, unable to continue|0|||
146446356|NCT00042289|528138929|FG012|Overall Study|Severe debilitation, unable to continue|0|||
146446357|NCT00042289|528138930|FG013|Overall Study|Severe debilitation, unable to continue|0|||
146446358|NCT00042289|528138931|FG014|Overall Study|Severe debilitation, unable to continue|0|||
146446359|NCT00042289|528138932|FG015|Overall Study|Severe debilitation, unable to continue|0|||
146446360|NCT00042289|528138933|FG016|Overall Study|Severe debilitation, unable to continue|0|||
146446361|NCT00042289|528138934|FG017|Overall Study|Severe debilitation, unable to continue|0|||
146446362|NCT00042289|528138935|FG018|Overall Study|Severe debilitation, unable to continue|0|||
146446363|NCT00042289|528138936|FG019|Overall Study|Severe debilitation, unable to continue|0|||
146446364|NCT00042289|528138937|FG020|Overall Study|Severe debilitation, unable to continue|0|||
146446365|NCT00042289|528138938|FG021|Overall Study|Severe debilitation, unable to continue|1|||
146446366|NCT00042289|528138939|FG022|Overall Study|Severe debilitation, unable to continue|0|||
146446367|NCT00042289|528138940|FG023|Overall Study|Severe debilitation, unable to continue|1|||
146446368|NCT00042289|528138941|FG024|Overall Study|Severe debilitation, unable to continue|0|||
146446369|NCT00042289|528138942|FG025|Overall Study|Severe debilitation, unable to continue|0|||
146446370|NCT00042289|528138943|FG026|Overall Study|Severe debilitation, unable to continue|0|||
146446371|NCT00042289|528138944|FG027|Overall Study|Severe debilitation, unable to continue|1|||
146446372|NCT00042289|528138945|FG028|Overall Study|Severe debilitation, unable to continue|0|||
146446373|NCT00042289|528138946|FG029|Overall Study|Severe debilitation, unable to continue|0|||
146446374|NCT00042289|528138947|FG030|Overall Study|Severe debilitation, unable to continue|0|||
146446375|NCT00042289|528138948|FG031|Overall Study|Severe debilitation, unable to continue|1|||
146446376|NCT00042289|528138949|FG032|Overall Study|Severe debilitation, unable to continue|1|||
146446377|NCT00042289|528138950|FG033|Overall Study|Severe debilitation, unable to continue|0|||
146446378|NCT00042289|528138951|FG034|Overall Study|Severe debilitation, unable to continue|0|||
146446379|NCT00042289|528138952|FG035|Overall Study|Severe debilitation, unable to continue|0|||
146446380|NCT00042289|528138953|FG036|Overall Study|Severe debilitation, unable to continue|0|||
146446381|NCT00042289|528138954|FG037|Overall Study|Severe debilitation, unable to continue|0|||
146446382|NCT00042289|528138955|FG038|Overall Study|Severe debilitation, unable to continue|0|||
146446383|NCT00042289|528138956|FG039|Overall Study|Severe debilitation, unable to continue|0|||
146446384|NCT00042289|528138957|FG040|Overall Study|Severe debilitation, unable to continue|0|||
146446385|NCT00042289|528138958|FG041|Overall Study|Severe debilitation, unable to continue|0|||
146446386|NCT00042289|528138959|FG042|Overall Study|Severe debilitation, unable to continue|0|||
146446387|NCT00042289|528138960|FG043|Overall Study|Severe debilitation, unable to continue|0|||
146446388|NCT00042289|528138961|FG044|Overall Study|Severe debilitation, unable to continue|0|||
146446389|NCT00042289|528138962|FG045|Overall Study|Severe debilitation, unable to continue|0|||
146446390|NCT00042289|528138963|FG046|Overall Study|Severe debilitation, unable to continue|0|||
146446391|NCT00042289|528138917|FG000|Overall Study|Site closed|0|||
146446392|NCT00042289|528138918|FG001|Overall Study|Site closed|0|||
146446393|NCT00042289|528138919|FG002|Overall Study|Site closed|0|||
146446394|NCT00042289|528138920|FG003|Overall Study|Site closed|0|||
146446395|NCT00042289|528138921|FG004|Overall Study|Site closed|0|||
146446396|NCT00042289|528138922|FG005|Overall Study|Site closed|0|||
146446397|NCT00042289|528138923|FG006|Overall Study|Site closed|0|||
146446398|NCT00042289|528138924|FG007|Overall Study|Site closed|0|||
146446399|NCT00042289|528138925|FG008|Overall Study|Site closed|0|||
146446400|NCT00042289|528138926|FG009|Overall Study|Site closed|0|||
146446401|NCT00042289|528138927|FG010|Overall Study|Site closed|0|||
146446402|NCT00042289|528138928|FG011|Overall Study|Site closed|0|||
146446403|NCT00042289|528138929|FG012|Overall Study|Site closed|0|||
146446404|NCT00042289|528138930|FG013|Overall Study|Site closed|0|||
146446405|NCT00042289|528138931|FG014|Overall Study|Site closed|0|||
146446406|NCT00042289|528138932|FG015|Overall Study|Site closed|0|||
146446407|NCT00042289|528138933|FG016|Overall Study|Site closed|0|||
146446408|NCT00042289|528138934|FG017|Overall Study|Site closed|0|||
146446409|NCT00042289|528138935|FG018|Overall Study|Site closed|0|||
146446410|NCT00042289|528138936|FG019|Overall Study|Site closed|0|||
145956401|NCT04501952|526352494|FG001|Overall Study|Protocol Violation|1|||
145956402|NCT04501952|526352493|FG000|Overall Study|Withdrew Consent|5|||
145956403|NCT04501952|526352494|FG001|Overall Study|Withdrew Consent|4|||
145956404|NCT04501952|526352493|FG000|Overall Study|Lost to Follow-up|7|||
145956405|NCT04501952|526352494|FG001|Overall Study|Lost to Follow-up|2|||
145956406|NCT04501952|526352493|FG000|Overall Study|Randomized and Never Treated|13|||
145956407|NCT04501952|526352494|FG001|Overall Study|Randomized and Never Treated|9|||
145956408|NCT02472886|526352499|FG000|Overall Study|Lack of Efficacy|0|||
145956409|NCT02472886|526352500|FG001|Overall Study|Lack of Efficacy|2|||
145956410|NCT02472886|526352501|FG002|Overall Study|Lack of Efficacy|1|||
145956411|NCT04533438|526352502|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
145956412|NCT04533438|526352503|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
145956413|NCT02797678|526352504|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
146446411|NCT00042289|528138937|FG020|Overall Study|Site closed|0|||
146446412|NCT00042289|528138938|FG021|Overall Study|Site closed|0|||
146446413|NCT00042289|528138939|FG022|Overall Study|Site closed|0|||
146446414|NCT00042289|528138940|FG023|Overall Study|Site closed|0|||
146446415|NCT00042289|528138941|FG024|Overall Study|Site closed|0|||
146446416|NCT00042289|528138942|FG025|Overall Study|Site closed|0|||
146446417|NCT00042289|528138943|FG026|Overall Study|Site closed|0|||
146446418|NCT00042289|528138944|FG027|Overall Study|Site closed|0|||
146446419|NCT00042289|528138945|FG028|Overall Study|Site closed|0|||
146446420|NCT00042289|528138946|FG029|Overall Study|Site closed|0|||
146446421|NCT00042289|528138947|FG030|Overall Study|Site closed|0|||
146446422|NCT00042289|528138948|FG031|Overall Study|Site closed|3|||
146446423|NCT00042289|528138949|FG032|Overall Study|Site closed|0|||
146446424|NCT00042289|528138950|FG033|Overall Study|Site closed|0|||
146446425|NCT00042289|528138951|FG034|Overall Study|Site closed|0|||
146446426|NCT00042289|528138952|FG035|Overall Study|Site closed|0|||
146446427|NCT00042289|528138953|FG036|Overall Study|Site closed|1|||
146446428|NCT00042289|528138954|FG037|Overall Study|Site closed|0|||
146446429|NCT00042289|528138955|FG038|Overall Study|Site closed|0|||
146446430|NCT00042289|528138956|FG039|Overall Study|Site closed|0|||
146446431|NCT00042289|528138957|FG040|Overall Study|Site closed|0|||
146446432|NCT00042289|528138958|FG041|Overall Study|Site closed|0|||
146446433|NCT00042289|528138959|FG042|Overall Study|Site closed|1|||
146446434|NCT00042289|528138960|FG043|Overall Study|Site closed|0|||
146446435|NCT00042289|528138961|FG044|Overall Study|Site closed|0|||
146446436|NCT00042289|528138962|FG045|Overall Study|Site closed|0|||
146446437|NCT00042289|528138963|FG046|Overall Study|Site closed|0|||
146446438|NCT00042289|528138917|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
146446439|NCT00042289|528138918|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
146446440|NCT00042289|528138919|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
146446441|NCT00042289|528138920|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
146446442|NCT00042289|528138921|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
146446443|NCT00042289|528138922|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
146446444|NCT00042289|528138923|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
146446445|NCT00042289|528138924|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
146446446|NCT00042289|528138925|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
146446447|NCT00042289|528138926|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
146446448|NCT00042289|528138927|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
146446449|NCT00042289|528138928|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
146446450|NCT00042289|528138929|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
146446451|NCT00042289|528138930|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
146446452|NCT00042289|528138931|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
146446453|NCT00042289|528138932|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
146446454|NCT00042289|528138933|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
146446455|NCT00042289|528138934|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
146446456|NCT00042289|528138935|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
146446457|NCT00042289|528138936|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
146446458|NCT00042289|528138937|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
146446459|NCT00042289|528138938|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
146446460|NCT00042289|528138939|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
146446461|NCT00042289|528138940|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
146446462|NCT00042289|528138941|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
146446463|NCT00042289|528138942|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
146446464|NCT00042289|528138943|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
146446465|NCT00042289|528138944|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
146446466|NCT00042289|528138945|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
146446467|NCT00042289|528138946|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
146446468|NCT00042289|528138947|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
146446469|NCT00042289|528138948|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
146446470|NCT00042289|528138949|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
146446471|NCT00042289|528138950|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
146446472|NCT00042289|528138951|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
146446473|NCT00042289|528138952|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
146446474|NCT00042289|528138953|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
146446475|NCT00042289|528138954|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
146446476|NCT00042289|528138955|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
146285795|NCT02344004|527561137|FG001|Overall Study|Death|7|||
146446477|NCT00042289|528138956|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
146446478|NCT00042289|528138957|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
146446479|NCT00042289|528138958|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
146285796|NCT02344004|527561136|FG000|Overall Study|Physician Decision|4|||
146446480|NCT00042289|528138959|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
146446481|NCT00042289|528138960|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
146446482|NCT00042289|528138961|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
146446483|NCT00042289|528138962|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
146446484|NCT00042289|528138963|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
146446485|NCT00042289|528138917|FG000|Overall Study|Protocol Violation|0|||
146446486|NCT00042289|528138918|FG001|Overall Study|Protocol Violation|0|||
146446487|NCT00042289|528138919|FG002|Overall Study|Protocol Violation|0|||
146446488|NCT00042289|528138920|FG003|Overall Study|Protocol Violation|0|||
146446489|NCT00042289|528138921|FG004|Overall Study|Protocol Violation|0|||
146446490|NCT00042289|528138922|FG005|Overall Study|Protocol Violation|1|||
146446491|NCT00042289|528138923|FG006|Overall Study|Protocol Violation|0|||
146446492|NCT00042289|528138924|FG007|Overall Study|Protocol Violation|1|||
146446493|NCT00042289|528138925|FG008|Overall Study|Protocol Violation|0|||
146446494|NCT00042289|528138926|FG009|Overall Study|Protocol Violation|0|||
146446495|NCT00042289|528138927|FG010|Overall Study|Protocol Violation|0|||
146446496|NCT00042289|528138928|FG011|Overall Study|Protocol Violation|0|||
146446497|NCT00042289|528138929|FG012|Overall Study|Protocol Violation|0|||
146446498|NCT00042289|528138930|FG013|Overall Study|Protocol Violation|0|||
146446499|NCT00042289|528138931|FG014|Overall Study|Protocol Violation|0|||
146446500|NCT00042289|528138932|FG015|Overall Study|Protocol Violation|0|||
146446501|NCT00042289|528138933|FG016|Overall Study|Protocol Violation|0|||
146446502|NCT00042289|528138934|FG017|Overall Study|Protocol Violation|0|||
146446503|NCT00042289|528138935|FG018|Overall Study|Protocol Violation|0|||
146446504|NCT00042289|528138936|FG019|Overall Study|Protocol Violation|0|||
146446505|NCT00042289|528138937|FG020|Overall Study|Protocol Violation|0|||
146446506|NCT00042289|528138938|FG021|Overall Study|Protocol Violation|0|||
146446507|NCT00042289|528138939|FG022|Overall Study|Protocol Violation|0|||
146446508|NCT00042289|528138940|FG023|Overall Study|Protocol Violation|1|||
146446509|NCT00042289|528138941|FG024|Overall Study|Protocol Violation|1|||
146446510|NCT00042289|528138942|FG025|Overall Study|Protocol Violation|0|||
146446511|NCT00042289|528138943|FG026|Overall Study|Protocol Violation|2|||
146446512|NCT00042289|528138944|FG027|Overall Study|Protocol Violation|0|||
146446513|NCT00042289|528138945|FG028|Overall Study|Protocol Violation|0|||
146446514|NCT00042289|528138946|FG029|Overall Study|Protocol Violation|0|||
146446515|NCT00042289|528138947|FG030|Overall Study|Protocol Violation|1|||
146446516|NCT00042289|528138948|FG031|Overall Study|Protocol Violation|0|||
146446517|NCT00042289|528138949|FG032|Overall Study|Protocol Violation|0|||
146446518|NCT00042289|528138950|FG033|Overall Study|Protocol Violation|0|||
146446519|NCT00042289|528138951|FG034|Overall Study|Protocol Violation|0|||
146446520|NCT00042289|528138952|FG035|Overall Study|Protocol Violation|0|||
146446521|NCT00042289|528138953|FG036|Overall Study|Protocol Violation|0|||
146446522|NCT00042289|528138954|FG037|Overall Study|Protocol Violation|0|||
146446523|NCT00042289|528138955|FG038|Overall Study|Protocol Violation|0|||
146446524|NCT00042289|528138956|FG039|Overall Study|Protocol Violation|0|||
146446525|NCT00042289|528138957|FG040|Overall Study|Protocol Violation|0|||
146446526|NCT00042289|528138958|FG041|Overall Study|Protocol Violation|1|||
146446527|NCT00042289|528138959|FG042|Overall Study|Protocol Violation|1|||
146446528|NCT00042289|528138960|FG043|Overall Study|Protocol Violation|1|||
146446529|NCT00042289|528138961|FG044|Overall Study|Protocol Violation|0|||
146446530|NCT00042289|528138962|FG045|Overall Study|Protocol Violation|0|||
146446531|NCT00042289|528138963|FG046|Overall Study|Protocol Violation|0|||
146446532|NCT00042289|528138917|FG000|Overall Study|Withdrawal by Subject|4|||
146446533|NCT00042289|528138918|FG001|Overall Study|Withdrawal by Subject|1|||
146446534|NCT00042289|528138919|FG002|Overall Study|Withdrawal by Subject|0|||
146446535|NCT00042289|528138920|FG003|Overall Study|Withdrawal by Subject|2|||
146446536|NCT00042289|528138921|FG004|Overall Study|Withdrawal by Subject|0|||
146446537|NCT00042289|528138922|FG005|Overall Study|Withdrawal by Subject|2|||
146446538|NCT00042289|528138923|FG006|Overall Study|Withdrawal by Subject|0|||
146446539|NCT00042289|528138924|FG007|Overall Study|Withdrawal by Subject|0|||
146446540|NCT00042289|528138925|FG008|Overall Study|Withdrawal by Subject|0|||
146285797|NCT02344004|527561137|FG001|Overall Study|Physician Decision|1|||
146285798|NCT02344004|527561136|FG000|Overall Study|Withdrawal by Subject|22|||
146446541|NCT00042289|528138926|FG009|Overall Study|Withdrawal by Subject|1|||
146446542|NCT00042289|528138927|FG010|Overall Study|Withdrawal by Subject|0|||
146446543|NCT00042289|528138928|FG011|Overall Study|Withdrawal by Subject|0|||
146446544|NCT00042289|528138929|FG012|Overall Study|Withdrawal by Subject|2|||
146446545|NCT00042289|528138930|FG013|Overall Study|Withdrawal by Subject|0|||
146446546|NCT00042289|528138931|FG014|Overall Study|Withdrawal by Subject|0|||
146446547|NCT00042289|528138932|FG015|Overall Study|Withdrawal by Subject|0|||
146446548|NCT00042289|528138933|FG016|Overall Study|Withdrawal by Subject|0|||
146446549|NCT00042289|528138934|FG017|Overall Study|Withdrawal by Subject|0|||
146446550|NCT00042289|528138935|FG018|Overall Study|Withdrawal by Subject|0|||
146446551|NCT00042289|528138936|FG019|Overall Study|Withdrawal by Subject|0|||
146446552|NCT00042289|528138937|FG020|Overall Study|Withdrawal by Subject|0|||
146285799|NCT02344004|527561137|FG001|Overall Study|Withdrawal by Subject|5|||
146285800|NCT02344004|527561136|FG000|Overall Study|Rescue Medication|2|||
146285801|NCT02344004|527561137|FG001|Overall Study|Rescue Medication|0|||
146285802|NCT02344004|527561136|FG000|Overall Study|Other Not Specified|12|||
146285803|NCT02344004|527561137|FG001|Overall Study|Other Not Specified|0|||
146285804|NCT02344004|527561136|FG000|Overall Study|Protocol Violation|1|||
146285805|NCT02344004|527561137|FG001|Overall Study|Protocol Violation|0|||
146285806|NCT01502631|527561138|FG000|Overall Study|Adverse Event|5|||
146446553|NCT00042289|528138938|FG021|Overall Study|Withdrawal by Subject|1|||
146446554|NCT00042289|528138939|FG022|Overall Study|Withdrawal by Subject|1|||
146446555|NCT00042289|528138940|FG023|Overall Study|Withdrawal by Subject|1|||
146446556|NCT00042289|528138941|FG024|Overall Study|Withdrawal by Subject|0|||
146446557|NCT00042289|528138942|FG025|Overall Study|Withdrawal by Subject|0|||
146446558|NCT00042289|528138943|FG026|Overall Study|Withdrawal by Subject|1|||
146446559|NCT00042289|528138944|FG027|Overall Study|Withdrawal by Subject|0|||
146446560|NCT00042289|528138945|FG028|Overall Study|Withdrawal by Subject|2|||
146446561|NCT00042289|528138946|FG029|Overall Study|Withdrawal by Subject|0|||
146446562|NCT00042289|528138947|FG030|Overall Study|Withdrawal by Subject|0|||
146446563|NCT00042289|528138948|FG031|Overall Study|Withdrawal by Subject|1|||
146446564|NCT00042289|528138949|FG032|Overall Study|Withdrawal by Subject|2|||
146446565|NCT00042289|528138950|FG033|Overall Study|Withdrawal by Subject|1|||
146285807|NCT01502631|527561139|FG001|Overall Study|Adverse Event|8|||
146285808|NCT01502631|527561138|FG000|Overall Study|Lost to Follow-up|2|||
146446566|NCT00042289|528138951|FG034|Overall Study|Withdrawal by Subject|0|||
146446567|NCT00042289|528138952|FG035|Overall Study|Withdrawal by Subject|0|||
146446568|NCT00042289|528138953|FG036|Overall Study|Withdrawal by Subject|0|||
146446569|NCT00042289|528138954|FG037|Overall Study|Withdrawal by Subject|1|||
146446570|NCT00042289|528138955|FG038|Overall Study|Withdrawal by Subject|0|||
146446571|NCT00042289|528138956|FG039|Overall Study|Withdrawal by Subject|0|||
146285809|NCT01502631|527561139|FG001|Overall Study|Lost to Follow-up|2|||
146285810|NCT01502631|527561138|FG000|Overall Study|Participant withdrew consent|2|||
146285811|NCT01502631|527561139|FG001|Overall Study|Participant withdrew consent|4|||
146446572|NCT00042289|528138957|FG040|Overall Study|Withdrawal by Subject|0|||
146285812|NCT01502631|527561138|FG000|Overall Study|Participant non-compliant|1|||
146285813|NCT01502631|527561139|FG001|Overall Study|Participant non-compliant|0|||
146285814|NCT01502631|527561138|FG000|Overall Study|Investigator's decision|0|||
146285815|NCT01502631|527561139|FG001|Overall Study|Investigator's decision|1|||
146446573|NCT00042289|528138958|FG041|Overall Study|Withdrawal by Subject|0|||
146446574|NCT00042289|528138959|FG042|Overall Study|Withdrawal by Subject|1|||
146446575|NCT00042289|528138960|FG043|Overall Study|Withdrawal by Subject|0|||
146446576|NCT00042289|528138961|FG044|Overall Study|Withdrawal by Subject|0|||
146446577|NCT00042289|528138962|FG045|Overall Study|Withdrawal by Subject|0|||
146446578|NCT00042289|528138963|FG046|Overall Study|Withdrawal by Subject|0|||
146285816|NCT01502631|527561138|FG000|Overall Study|Other|10|||
146285817|NCT01502631|527561139|FG001|Overall Study|Other|5|||
146285818|NCT00395460|527561141|FG000|Overall Study|Withdrawal by Subject|1|||
146285819|NCT00395460|527561142|FG001|Overall Study|Withdrawal by Subject|0|||
146285820|NCT04223830|527561146|FG000|Overall Study|Lost to Follow-up|9|||
146285821|NCT04223830|527561146|FG000|Overall Study|Adverse Event|1|||
146285822|NCT00862719|527561147|FG000|Overall Study|Disease Progression|5|||
146285823|NCT00862719|527561148|FG001|Overall Study|Disease Progression|0|||
146285824|NCT00862719|527561149|FG002|Overall Study|Disease Progression|1|||
146285825|NCT00862719|527561150|FG003|Overall Study|Disease Progression|0|||
146285826|NCT00862719|527561147|FG000|Overall Study|Death|5|||
146285827|NCT00862719|527561148|FG001|Overall Study|Death|6|||
146285828|NCT00862719|527561149|FG002|Overall Study|Death|1|||
146285829|NCT00862719|527561150|FG003|Overall Study|Death|1|||
146285830|NCT00862719|527561147|FG000|Overall Study|Engraftment failure|0|||
146285831|NCT00862719|527561148|FG001|Overall Study|Engraftment failure|0|||
146285832|NCT00862719|527561149|FG002|Overall Study|Engraftment failure|1|||
146285833|NCT00862719|527561150|FG003|Overall Study|Engraftment failure|0|||
146285834|NCT00862719|527561147|FG000|Overall Study|Veno-Occlusive Disease|0|||
146285835|NCT00862719|527561148|FG001|Overall Study|Veno-Occlusive Disease|0|||
146285836|NCT00862719|527561149|FG002|Overall Study|Veno-Occlusive Disease|1|||
146446579|NCT03973996|528138964|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146446580|NCT03973996|528138965|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146285837|NCT00862719|527561150|FG003|Overall Study|Veno-Occlusive Disease|0|||
146285838|NCT01806623|527561151|FG000|Overall Study|Withdrawal by Subject|1|||
146285839|NCT01806623|527561151|FG000|Overall Study|Adverse Event|1|||
146446581|NCT03973996|528138966|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146446582|NCT03973996|528138967|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
146446583|NCT04662710|528138968|FG000|Overall Study|Death|14|||
146446584|NCT04662710|528138969|FG001|Overall Study|Death|331|||
146446585|NCT04662710|528138970|FG002|Overall Study|Death|367|||
146446586|NCT04662710|528138968|FG000|Overall Study|Ongoing|1|||
146446587|NCT04662710|528138969|FG001|Overall Study|Ongoing|109|||
146446588|NCT04662710|528138970|FG002|Overall Study|Ongoing|56|||
146446589|NCT04662710|528138968|FG000|Overall Study|Withdrawal by Subject|0|||
146446590|NCT04662710|528138969|FG001|Overall Study|Withdrawal by Subject|3|||
146446591|NCT04662710|528138970|FG002|Overall Study|Withdrawal by Subject|14|||
146446592|NCT04974047|528138979|FG000|Overall Study|Sponsor Ended Study|20|||
146446593|NCT04974047|528138980|FG001|Overall Study|Sponsor Ended Study|22|||
146446594|NCT04974047|528138979|FG000|Overall Study|Death|8|||
146446595|NCT04974047|528138980|FG001|Overall Study|Death|17|||
146446596|NCT04974047|528138979|FG000|Overall Study|Lost to Follow-up|2|||
146446597|NCT04974047|528138980|FG001|Overall Study|Lost to Follow-up|0|||
146446598|NCT04974047|528138979|FG000|Overall Study|Withdrawal by Subject|0|||
146446599|NCT04974047|528138980|FG001|Overall Study|Withdrawal by Subject|1|||
146446600|NCT03391466|528138981|FG000|Overall Study|Death|84|||
146446601|NCT03391466|528138982|FG001|Overall Study|Death|91|||
146446602|NCT03391466|528138981|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
146446603|NCT03391466|528138982|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
146446604|NCT03391466|528138981|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
146446605|NCT03391466|528138982|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
146446606|NCT03391466|528138981|FG000|Overall Study|Lost to Follow-up|9|||
146446607|NCT03391466|528138982|FG001|Overall Study|Lost to Follow-up|5|||
146446608|NCT03391466|528138981|FG000|Overall Study|Reason Not Specified|2|||
146446609|NCT03391466|528138982|FG001|Overall Study|Reason Not Specified|2|||
146446610|NCT03391466|528138981|FG000|Overall Study|Investigator Decision|0|||
146209579|NCT04992390|527280414|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
146209580|NCT04992390|527280415|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
146209581|NCT04992390|527280416|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
146209582|NCT04992390|527280414|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
146446611|NCT03391466|528138982|FG001|Overall Study|Investigator Decision|1|||
146446612|NCT03055013|528138985|FG000|Overall Study|Adverse Event|78|||
146446613|NCT03055013|528138986|FG001|Overall Study|Adverse Event|0|||
146446614|NCT03055013|528138985|FG000|Overall Study|Death|6|||
146446615|NCT03055013|528138986|FG001|Overall Study|Death|0|||
146446616|NCT03055013|528138985|FG000|Overall Study|Disease relapse|33|||
146446617|NCT03055013|528138986|FG001|Overall Study|Disease relapse|0|||
146446618|NCT03055013|528138985|FG000|Overall Study|Withdrawal by Subject|28|||
146446619|NCT03055013|528138986|FG001|Overall Study|Withdrawal by Subject|0|||
146446620|NCT03055013|528138985|FG000|Overall Study|Other complicating disease|5|||
146446621|NCT03055013|528138986|FG001|Overall Study|Other complicating disease|0|||
146446622|NCT03055013|528138985|FG000|Overall Study|Physician Decision|1|||
146446623|NCT03055013|528138986|FG001|Overall Study|Physician Decision|0|||
146446624|NCT03055013|528138985|FG000|Overall Study|Benign mass/non-RCC|4|||
146446625|NCT03055013|528138986|FG001|Overall Study|Benign mass/non-RCC|0|||
146446626|NCT03055013|528138985|FG000|Overall Study|Enrolled in another trial|1|||
146446627|NCT03055013|528138986|FG001|Overall Study|Enrolled in another trial|0|||
146446628|NCT03055013|528138985|FG000|Overall Study|Non-protocol therapy|1|||
146446629|NCT03055013|528138986|FG001|Overall Study|Non-protocol therapy|0|||
146446630|NCT03055013|528138985|FG000|Overall Study|Incompliance|1|||
146446631|NCT03055013|528138986|FG001|Overall Study|Incompliance|0|||
146446632|NCT03055013|528138985|FG000|Overall Study|Insurance issues|1|||
146446633|NCT03055013|528138986|FG001|Overall Study|Insurance issues|0|||
146446634|NCT03055013|528138985|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
146446635|NCT03055013|528138986|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
146446636|NCT03055013|528138985|FG000|Overall Study|Did not receive nivolumab|10|||
146446637|NCT03055013|528138986|FG001|Overall Study|Did not receive nivolumab|0|||
146446638|NCT03055013|528138985|FG000|Overall Study|Did not receive surgery|0|||
146446639|NCT03055013|528138986|FG001|Overall Study|Did not receive surgery|28|||
146446640|NCT02502266|528138987|FG000|Overall Study|Adverse Event|0|||
146446641|NCT02502266|528138988|FG001|Overall Study|Adverse Event|0|||
146446642|NCT02502266|528138989|FG002|Overall Study|Adverse Event|0|||
146446643|NCT02502266|528138990|FG003|Overall Study|Adverse Event|0|||
146446644|NCT02502266|528138991|FG004|Overall Study|Adverse Event|1|||
146446645|NCT02502266|528138992|FG005|Overall Study|Adverse Event|1|||
146446646|NCT02502266|528138993|FG006|Overall Study|Adverse Event|1|||
146446647|NCT02502266|528138987|FG000|Overall Study|Withdrawal by Subject|30|||
146446648|NCT02502266|528138988|FG001|Overall Study|Withdrawal by Subject|15|||
146446649|NCT02502266|528138989|FG002|Overall Study|Withdrawal by Subject|16|||
146446650|NCT02502266|528138990|FG003|Overall Study|Withdrawal by Subject|0|||
146446651|NCT02502266|528138991|FG004|Overall Study|Withdrawal by Subject|0|||
146446652|NCT02502266|528138992|FG005|Overall Study|Withdrawal by Subject|0|||
146446653|NCT02502266|528138993|FG006|Overall Study|Withdrawal by Subject|0|||
146446654|NCT02502266|528138987|FG000|Overall Study|Still on Treatment|0|||
146446655|NCT02502266|528138988|FG001|Overall Study|Still on Treatment|0|||
146446656|NCT02502266|528138989|FG002|Overall Study|Still on Treatment|1|||
146446657|NCT02502266|528138990|FG003|Overall Study|Still on Treatment|0|||
146446658|NCT02502266|528138991|FG004|Overall Study|Still on Treatment|0|||
146446659|NCT02502266|528138992|FG005|Overall Study|Still on Treatment|0|||
146446660|NCT02502266|528138993|FG006|Overall Study|Still on Treatment|0|||
146446661|NCT02502266|528138987|FG000|Overall Study|Other Reasons|19|||
146446662|NCT02502266|528138988|FG001|Overall Study|Other Reasons|6|||
146446663|NCT02502266|528138989|FG002|Overall Study|Other Reasons|14|||
146446664|NCT02502266|528138990|FG003|Overall Study|Other Reasons|0|||
146446665|NCT02502266|528138991|FG004|Overall Study|Other Reasons|1|||
146446666|NCT02502266|528138992|FG005|Overall Study|Other Reasons|1|||
146446667|NCT02502266|528138993|FG006|Overall Study|Other Reasons|0|||
146446668|NCT02502266|528138987|FG000|Overall Study|Arm 4 Discontinued|0|||
146446669|NCT02502266|528138988|FG001|Overall Study|Arm 4 Discontinued|0|||
146446670|NCT02502266|528138989|FG002|Overall Study|Arm 4 Discontinued|0|||
146446671|NCT02502266|528138990|FG003|Overall Study|Arm 4 Discontinued|52|||
146446672|NCT02502266|528138991|FG004|Overall Study|Arm 4 Discontinued|0|||
146446673|NCT02502266|528138992|FG005|Overall Study|Arm 4 Discontinued|0|||
146446674|NCT02502266|528138993|FG006|Overall Study|Arm 4 Discontinued|0|||
146446675|NCT02502266|528138987|FG000|Overall Study|Never treated|0|||
146446676|NCT02502266|528138988|FG001|Overall Study|Never treated|0|||
146446677|NCT02502266|528138989|FG002|Overall Study|Never treated|0|||
146446678|NCT02502266|528138990|FG003|Overall Study|Never treated|0|||
146446679|NCT02502266|528138991|FG004|Overall Study|Never treated|0|||
146446680|NCT02502266|528138992|FG005|Overall Study|Never treated|1|||
146446681|NCT02502266|528138993|FG006|Overall Study|Never treated|0|||
146446682|NCT05595369|528138994|FG000|Overall Study|Adverse Event|2|||
146446683|NCT05595369|528138995|FG001|Overall Study|Adverse Event|0|||
146446684|NCT05595369|528138996|FG002|Overall Study|Adverse Event|0|||
146446685|NCT05595369|528138994|FG000|Overall Study|Lost to Follow-up|11|||
146446686|NCT05595369|528138995|FG001|Overall Study|Lost to Follow-up|10|||
146446687|NCT05595369|528138996|FG002|Overall Study|Lost to Follow-up|10|||
146446688|NCT05595369|528138994|FG000|Overall Study|Physician Decision|1|||
146446689|NCT05595369|528138995|FG001|Overall Study|Physician Decision|0|||
146446690|NCT05595369|528138996|FG002|Overall Study|Physician Decision|0|||
146446691|NCT05595369|528138994|FG000|Overall Study|Withdrawal by Subject|5|||
146446692|NCT05595369|528138995|FG001|Overall Study|Withdrawal by Subject|7|||
146446693|NCT05595369|528138996|FG002|Overall Study|Withdrawal by Subject|6|||
146446694|NCT05595369|528138994|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146446695|NCT05595369|528138995|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
146446696|NCT05595369|528138996|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
146446697|NCT05595369|528138994|FG000|Overall Study|Study Drug Non-compliance|0|||
146446698|NCT05595369|528138995|FG001|Overall Study|Study Drug Non-compliance|1|||
146446699|NCT05595369|528138996|FG002|Overall Study|Study Drug Non-compliance|0|||
146446700|NCT05595369|528138994|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
146446701|NCT05595369|528138995|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
146446702|NCT05595369|528138996|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
146446703|NCT05480800|528138999|FG000|Overall Study|Withdrawal by Subject|0|||
146446704|NCT05480800|528139000|FG001|Overall Study|Withdrawal by Subject|0|||
146446705|NCT05480800|528139001|FG002|Overall Study|Withdrawal by Subject|2|||
146446706|NCT05480800|528139002|FG003|Overall Study|Withdrawal by Subject|1|||
146446707|NCT05480800|528139003|FG004|Overall Study|Withdrawal by Subject|0|||
146446708|NCT05480800|528139004|FG005|Overall Study|Withdrawal by Subject|0|||
146446709|NCT05480800|528139005|FG006|Overall Study|Withdrawal by Subject|1|||
146446710|NCT05480800|528139006|FG007|Overall Study|Withdrawal by Subject|0|||
146446711|NCT05480800|528138999|FG000|Overall Study|Other|0|||
146446712|NCT05480800|528139000|FG001|Overall Study|Other|0|||
146446713|NCT05480800|528139001|FG002|Overall Study|Other|0|||
146446714|NCT05480800|528139002|FG003|Overall Study|Other|0|||
146446715|NCT05480800|528139003|FG004|Overall Study|Other|0|||
146446716|NCT05480800|528139004|FG005|Overall Study|Other|0|||
146446717|NCT05480800|528139005|FG006|Overall Study|Other|1|||
146446718|NCT05480800|528139006|FG007|Overall Study|Other|0|||
146446719|NCT03466346|528139007|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
146446720|NCT03466346|528139008|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
146446721|NCT03466346|528139009|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
146446722|NCT03466346|528139010|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
146446723|NCT03466346|528139011|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
146446724|NCT03466346|528139007|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
146446725|NCT03466346|528139008|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
146446726|NCT03466346|528139009|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
146446727|NCT03466346|528139010|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
146446728|NCT03466346|528139011|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
146446729|NCT03466346|528139007|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
146446730|NCT03466346|528139008|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
146446731|NCT03466346|528139009|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
146446732|NCT03466346|528139010|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
146446733|NCT03466346|528139011|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
146446734|NCT03466346|528139007|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
146446735|NCT03466346|528139008|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
146446736|NCT03466346|528139009|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
146446737|NCT03466346|528139010|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
146446738|NCT03466346|528139011|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
146446739|NCT03466346|528139007|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
146446740|NCT03466346|528139008|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
146446741|NCT03466346|528139009|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
146083358|NCT00483756|526824824|FG001|Overall Study|Adverse Event|38|||
146209583|NCT04992390|527280415|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
146209584|NCT04992390|527280416|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
146446742|NCT03466346|528139010|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
146446743|NCT03466346|528139011|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
146446744|NCT03466346|528139007|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
146446745|NCT03466346|528139008|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
146446746|NCT03466346|528139009|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
146446747|NCT03466346|528139010|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
146446748|NCT03466346|528139011|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
146446749|NCT03466346|528139007|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
146446750|NCT03466346|528139008|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
146446751|NCT03466346|528139009|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
146446752|NCT03466346|528139010|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
146446753|NCT03466346|528139011|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
146446754|NCT05282823|528139012|FG000|Overall Study|Withdrawal by Subject|9|||
146446755|NCT05282823|528139012|FG000|Overall Study|Adverse Event|1|||
146446756|NCT05282823|528139012|FG000|Overall Study|did not meet protocol criteria|2|||
146446757|NCT05282823|528139012|FG000|Overall Study|Withdrawal by Subject|7|||
146446758|NCT05569174|528139015|FG000|Overall Study|Adverse Event|0|||
146446759|NCT05569174|528139016|FG001|Overall Study|Adverse Event|1|||
146446760|NCT05569174|528139015|FG000|Overall Study|Lack of compliance|0|||
146446761|NCT05569174|528139016|FG001|Overall Study|Lack of compliance|1|||
146446762|NCT05569174|528139015|FG000|Overall Study|Withdrawal of consent|0|||
146446763|NCT05569174|528139016|FG001|Overall Study|Withdrawal of consent|1|||
146446764|NCT05569174|528139015|FG000|Overall Study|Participant wish|0|||
146446765|NCT05569174|528139016|FG001|Overall Study|Participant wish|1|||
146446766|NCT05569174|528139015|FG000|Overall Study|Lost to Follow-up|0|||
146446767|NCT05569174|528139016|FG001|Overall Study|Lost to Follow-up|1|||
146446768|NCT05693805|528139020|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
146446769|NCT05693805|528139021|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
146446770|NCT03895086|528139023|FG000|Overall Study|Early termination study|1|||
146446771|NCT03895086|528139024|FG001|Overall Study|Early termination study|0|||
146446772|NCT01976936|528139025|FG000|Overall Study|Did not receive at least 9 doses|9|||
146446773|NCT01976936|528139026|FG001|Overall Study|Did not receive at least 9 doses|4|||
146446774|NCT06408870|528139027|FG000|Washout period|Withdrawal by Subject|1|||
146446775|NCT06408870|528139028|FG001|Washout period|Withdrawal by Subject|0|||
146446776|NCT06408870|528139027|FG000|Washout period|Adverse Event|2|||
146446777|NCT06408870|528139028|FG001|Washout period|Adverse Event|0|||
146446778|NCT06129149|528139031|FG000|Overall Study|Death|1|||
146446779|NCT04649359|528139032|FG000|Overall Study|Withdrawal by Subject|7|||
146446780|NCT04649359|528139033|FG001|Overall Study|Withdrawal by Subject|7|||
146446781|NCT04649359|528139032|FG000|Overall Study|Death|41|||
146446782|NCT04649359|528139033|FG001|Overall Study|Death|26|||
146446783|NCT04649359|528139032|FG000|Overall Study|Ongoing in the study|75|||
146446784|NCT04649359|528139033|FG001|Overall Study|Ongoing in the study|31|||
146446785|NCT04656652|528139036|FG000|Overall Study|Lost to Follow-up|2|||
146446786|NCT04656652|528139037|FG001|Overall Study|Lost to Follow-up|2|||
146446787|NCT04656652|528139036|FG000|Overall Study|Death|213|||
146446788|NCT04656652|528139037|FG001|Overall Study|Death|212|||
146446789|NCT04656652|528139036|FG000|Overall Study|Other|1|||
146446790|NCT04656652|528139037|FG001|Overall Study|Other|0|||
146446791|NCT04656652|528139036|FG000|Overall Study|Withdrawal by Subject|15|||
146446792|NCT04656652|528139037|FG001|Overall Study|Withdrawal by Subject|29|||
146446793|NCT02152982|528139040|FG000|Overall Study|Withdrawal by Subject|17|||
146446794|NCT02152982|528139041|FG001|Overall Study|Withdrawal by Subject|16|||
146446795|NCT02152982|528139040|FG000|Overall Study|Did not start treatment|11|||
146446796|NCT02152982|528139041|FG001|Overall Study|Did not start treatment|5|||
146446797|NCT02152982|528139040|FG000|Overall Study|Disease progression|41|||
146446798|NCT02152982|528139041|FG001|Overall Study|Disease progression|52|||
146446799|NCT02152982|528139040|FG000|Overall Study|Adverse Event|7|||
146446800|NCT02152982|528139041|FG001|Overall Study|Adverse Event|12|||
146446801|NCT02152982|528139040|FG000|Overall Study|Complicating disease|1|||
146285840|NCT01806623|527561151|FG000|Overall Study|Did not meet the inclusion criteria|56|||
146285841|NCT01737827|527561152|FG000|Overall Study|Adverse Event|3|||
146446802|NCT02152982|528139041|FG001|Overall Study|Complicating disease|1|||
146446803|NCT02152982|528139040|FG000|Overall Study|Death|0|||
146446804|NCT02152982|528139041|FG001|Overall Study|Death|3|||
146446805|NCT02152982|528139040|FG000|Overall Study|Physician Decision|3|||
146083359|NCT00483756|526824825|FG002|Overall Study|Adverse Event|40|||
146446806|NCT02152982|528139041|FG001|Overall Study|Physician Decision|0|||
146446807|NCT02306161|528139045|FG000|Overall Study|Death|1|||
146446808|NCT02306161|528139046|FG001|Overall Study|Death|3|||
146446809|NCT02306161|528139045|FG000|Overall Study|Lack of Efficacy|20|||
146446810|NCT02306161|528139046|FG001|Overall Study|Lack of Efficacy|43|||
146446811|NCT02306161|528139045|FG000|Overall Study|Physician Decision|30|||
146446812|NCT02306161|528139046|FG001|Overall Study|Physician Decision|18|||
146446813|NCT02306161|528139045|FG000|Overall Study|Withdrawal by Subject|4|||
146446814|NCT02306161|528139046|FG001|Overall Study|Withdrawal by Subject|0|||
146446815|NCT02306161|528139045|FG000|Overall Study|Ineligible|9|||
146446816|NCT02306161|528139046|FG001|Overall Study|Ineligible|5|||
146446817|NCT05911841|528140913|FG000|Induction Period|Study Terminated by Sponsor|2|||
146446818|NCT05911841|528140914|FG001|Induction Period|Study Terminated by Sponsor|0|||
146446819|NCT05911841|528140915|FG002|Induction Period|Study Terminated by Sponsor|14|||
146446820|NCT05911841|528140916|FG003|Induction Period|Study Terminated by Sponsor|6|||
146446821|NCT05911841|528140917|FG004|Induction Period|Study Terminated by Sponsor|0|||
146446822|NCT05911841|528140918|FG005|Induction Period|Study Terminated by Sponsor|0|||
146446823|NCT05911841|528140919|FG006|Induction Period|Study Terminated by Sponsor|0|||
146446824|NCT05911841|528140920|FG007|Induction Period|Study Terminated by Sponsor|0|||
146446825|NCT05911841|528140921|FG008|Induction Period|Study Terminated by Sponsor|0|||
146446826|NCT05911841|528140922|FG009|Induction Period|Study Terminated by Sponsor|0|||
146446827|NCT05911841|528140913|FG000|Induction Period|Withdrawal by Subject|4|||
146446828|NCT05911841|528140914|FG001|Induction Period|Withdrawal by Subject|3|||
146446829|NCT05911841|528140915|FG002|Induction Period|Withdrawal by Subject|4|||
145956414|NCT02797678|526352505|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145956415|NCT02797678|526352506|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145956416|NCT02797678|526352507|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145956417|NCT02797678|526352504|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
145956418|NCT02797678|526352505|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
146446830|NCT05911841|528140916|FG003|Induction Period|Withdrawal by Subject|6|||
146446831|NCT05911841|528140917|FG004|Induction Period|Withdrawal by Subject|0|||
146446832|NCT05911841|528140918|FG005|Induction Period|Withdrawal by Subject|0|||
146446833|NCT05911841|528140919|FG006|Induction Period|Withdrawal by Subject|0|||
146446834|NCT05911841|528140920|FG007|Induction Period|Withdrawal by Subject|0|||
146446835|NCT05911841|528140921|FG008|Induction Period|Withdrawal by Subject|0|||
146446836|NCT05911841|528140922|FG009|Induction Period|Withdrawal by Subject|0|||
146446837|NCT05911841|528140913|FG000|Induction Period|Lack of Efficacy|3|||
146446838|NCT05911841|528140914|FG001|Induction Period|Lack of Efficacy|0|||
146446839|NCT05911841|528140915|FG002|Induction Period|Lack of Efficacy|3|||
146446840|NCT05911841|528140916|FG003|Induction Period|Lack of Efficacy|3|||
146446841|NCT05911841|528140917|FG004|Induction Period|Lack of Efficacy|0|||
146446842|NCT05911841|528140918|FG005|Induction Period|Lack of Efficacy|0|||
146446843|NCT05911841|528140919|FG006|Induction Period|Lack of Efficacy|0|||
146446844|NCT05911841|528140920|FG007|Induction Period|Lack of Efficacy|0|||
146446845|NCT05911841|528140921|FG008|Induction Period|Lack of Efficacy|0|||
146446846|NCT05911841|528140922|FG009|Induction Period|Lack of Efficacy|0|||
146446847|NCT05911841|528140913|FG000|Induction Period|Adverse Event|3|||
146446848|NCT05911841|528140914|FG001|Induction Period|Adverse Event|1|||
146446849|NCT05911841|528140915|FG002|Induction Period|Adverse Event|2|||
146446850|NCT05911841|528140916|FG003|Induction Period|Adverse Event|0|||
146446851|NCT05911841|528140917|FG004|Induction Period|Adverse Event|0|||
146446852|NCT05911841|528140918|FG005|Induction Period|Adverse Event|0|||
146446853|NCT05911841|528140919|FG006|Induction Period|Adverse Event|0|||
145956419|NCT02797678|526352506|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
145956420|NCT02797678|526352507|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
145956421|NCT02797678|526352504|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
146446854|NCT05911841|528140920|FG007|Induction Period|Adverse Event|0|||
146446855|NCT05911841|528140921|FG008|Induction Period|Adverse Event|0|||
146446856|NCT05911841|528140922|FG009|Induction Period|Adverse Event|0|||
146446857|NCT05911841|528140913|FG000|Induction Period|Assigned Treatment by Mistake|0|||
146446858|NCT05911841|528140914|FG001|Induction Period|Assigned Treatment by Mistake|1|||
146446859|NCT05911841|528140915|FG002|Induction Period|Assigned Treatment by Mistake|0|||
146446860|NCT05911841|528140916|FG003|Induction Period|Assigned Treatment by Mistake|1|||
146446861|NCT05911841|528140917|FG004|Induction Period|Assigned Treatment by Mistake|0|||
146446862|NCT05911841|528140918|FG005|Induction Period|Assigned Treatment by Mistake|0|||
146446863|NCT05911841|528140919|FG006|Induction Period|Assigned Treatment by Mistake|0|||
146446864|NCT05911841|528140920|FG007|Induction Period|Assigned Treatment by Mistake|0|||
146446865|NCT05911841|528140921|FG008|Induction Period|Assigned Treatment by Mistake|0|||
146446866|NCT05911841|528140922|FG009|Induction Period|Assigned Treatment by Mistake|0|||
146446867|NCT05911841|528140913|FG000|Induction Period|Lost to Follow-up|0|||
146446868|NCT05911841|528140914|FG001|Induction Period|Lost to Follow-up|0|||
146446869|NCT05911841|528140915|FG002|Induction Period|Lost to Follow-up|1|||
146446870|NCT05911841|528140916|FG003|Induction Period|Lost to Follow-up|1|||
146446871|NCT05911841|528140917|FG004|Induction Period|Lost to Follow-up|0|||
146446872|NCT05911841|528140918|FG005|Induction Period|Lost to Follow-up|0|||
146446873|NCT05911841|528140919|FG006|Induction Period|Lost to Follow-up|0|||
146446874|NCT05911841|528140920|FG007|Induction Period|Lost to Follow-up|0|||
146446875|NCT05911841|528140921|FG008|Induction Period|Lost to Follow-up|0|||
146446876|NCT05911841|528140922|FG009|Induction Period|Lost to Follow-up|0|||
146446877|NCT05911841|528140913|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
146446878|NCT05911841|528140914|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
146446879|NCT05911841|528140915|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
146446880|NCT05911841|528140916|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
146446881|NCT05911841|528140917|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
146446882|NCT05911841|528140918|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
146446883|NCT05911841|528140919|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
146446884|NCT05911841|528140920|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
146446885|NCT05911841|528140921|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
146446886|NCT05911841|528140922|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
146446887|NCT05911841|528140913|FG000|Maintenance Period|Lack of Efficacy|0|||
146446888|NCT05911841|528140914|FG001|Maintenance Period|Lack of Efficacy|0|||
146446889|NCT05911841|528140915|FG002|Maintenance Period|Lack of Efficacy|0|||
146446890|NCT05911841|528140916|FG003|Maintenance Period|Lack of Efficacy|0|||
146446891|NCT05911841|528140917|FG004|Maintenance Period|Lack of Efficacy|1|||
146446892|NCT05911841|528140918|FG005|Maintenance Period|Lack of Efficacy|0|||
146446893|NCT05911841|528140919|FG006|Maintenance Period|Lack of Efficacy|1|||
146446894|NCT05911841|528140920|FG007|Maintenance Period|Lack of Efficacy|0|||
146446895|NCT05911841|528140921|FG008|Maintenance Period|Lack of Efficacy|0|||
146446896|NCT05911841|528140922|FG009|Maintenance Period|Lack of Efficacy|0|||
146446897|NCT05911841|528140913|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
146446898|NCT05911841|528140914|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
146446899|NCT05911841|528140915|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
146446900|NCT05911841|528140916|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
146446901|NCT05911841|528140917|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
146446902|NCT05911841|528140918|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
146446903|NCT05911841|528140919|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
146446904|NCT05911841|528140920|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
146446905|NCT05911841|528140921|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
146446906|NCT05911841|528140922|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
146446907|NCT05911841|528140913|FG000|Maintenance Period|Withdrawal by Subject|0|||
146446908|NCT05911841|528140914|FG001|Maintenance Period|Withdrawal by Subject|0|||
146446909|NCT05911841|528140915|FG002|Maintenance Period|Withdrawal by Subject|0|||
146446910|NCT05911841|528140916|FG003|Maintenance Period|Withdrawal by Subject|0|||
146446911|NCT05911841|528140917|FG004|Maintenance Period|Withdrawal by Subject|0|||
146446912|NCT05911841|528140918|FG005|Maintenance Period|Withdrawal by Subject|1|||
146446913|NCT05911841|528140919|FG006|Maintenance Period|Withdrawal by Subject|0|||
146446914|NCT05911841|528140920|FG007|Maintenance Period|Withdrawal by Subject|1|||
146446915|NCT05911841|528140921|FG008|Maintenance Period|Withdrawal by Subject|0|||
146446916|NCT05911841|528140922|FG009|Maintenance Period|Withdrawal by Subject|0|||
146446917|NCT05911841|528140913|FG000|Maintenance Period|Adverse Event|0|||
146446918|NCT05911841|528140914|FG001|Maintenance Period|Adverse Event|0|||
146446919|NCT05911841|528140915|FG002|Maintenance Period|Adverse Event|0|||
146446920|NCT05911841|528140916|FG003|Maintenance Period|Adverse Event|0|||
146446921|NCT05911841|528140917|FG004|Maintenance Period|Adverse Event|0|||
146446922|NCT05911841|528140918|FG005|Maintenance Period|Adverse Event|0|||
146446923|NCT05911841|528140919|FG006|Maintenance Period|Adverse Event|0|||
146446924|NCT05911841|528140920|FG007|Maintenance Period|Adverse Event|1|||
146446925|NCT05911841|528140921|FG008|Maintenance Period|Adverse Event|0|||
146446926|NCT05911841|528140922|FG009|Maintenance Period|Adverse Event|0|||
146446927|NCT05911841|528140913|FG000|Escape Period|Adverse Event|0|||
146446928|NCT05911841|528140914|FG001|Escape Period|Adverse Event|0|||
146446929|NCT05911841|528140915|FG002|Escape Period|Adverse Event|0|||
146446930|NCT05911841|528140916|FG003|Escape Period|Adverse Event|0|||
146446931|NCT05911841|528140917|FG004|Escape Period|Adverse Event|0|||
146446932|NCT05911841|528140918|FG005|Escape Period|Adverse Event|0|||
146446933|NCT05911841|528140919|FG006|Escape Period|Adverse Event|0|||
146446934|NCT05911841|528140920|FG007|Escape Period|Adverse Event|0|||
146446935|NCT05911841|528140921|FG008|Escape Period|Adverse Event|0|||
146446936|NCT05911841|528140922|FG009|Escape Period|Adverse Event|1|||
146446937|NCT05911841|528140913|FG000|Escape Period|Lack of Efficacy|0|||
146446938|NCT05911841|528140914|FG001|Escape Period|Lack of Efficacy|0|||
146446939|NCT05911841|528140915|FG002|Escape Period|Lack of Efficacy|0|||
146446940|NCT05911841|528140916|FG003|Escape Period|Lack of Efficacy|0|||
146446941|NCT05911841|528140917|FG004|Escape Period|Lack of Efficacy|0|||
146446942|NCT05911841|528140918|FG005|Escape Period|Lack of Efficacy|0|||
146446943|NCT05911841|528140919|FG006|Escape Period|Lack of Efficacy|0|||
146446944|NCT05911841|528140920|FG007|Escape Period|Lack of Efficacy|0|||
146446945|NCT05911841|528140921|FG008|Escape Period|Lack of Efficacy|0|||
146446946|NCT05911841|528140922|FG009|Escape Period|Lack of Efficacy|31|||
146446947|NCT05911841|528140913|FG000|Escape Period|Lost to Follow-up|0|||
146446948|NCT05911841|528140914|FG001|Escape Period|Lost to Follow-up|0|||
146446949|NCT05911841|528140915|FG002|Escape Period|Lost to Follow-up|0|||
146446950|NCT05911841|528140916|FG003|Escape Period|Lost to Follow-up|0|||
146446951|NCT05911841|528140917|FG004|Escape Period|Lost to Follow-up|0|||
146446952|NCT05911841|528140918|FG005|Escape Period|Lost to Follow-up|0|||
146446953|NCT05911841|528140919|FG006|Escape Period|Lost to Follow-up|0|||
146446954|NCT05911841|528140920|FG007|Escape Period|Lost to Follow-up|0|||
146446955|NCT05911841|528140921|FG008|Escape Period|Lost to Follow-up|0|||
146446956|NCT05911841|528140922|FG009|Escape Period|Lost to Follow-up|1|||
146446957|NCT05911841|528140913|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446958|NCT05911841|528140914|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446959|NCT05911841|528140915|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446960|NCT05911841|528140916|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446961|NCT05911841|528140917|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446962|NCT05911841|528140918|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446963|NCT05911841|528140919|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446964|NCT05911841|528140920|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446965|NCT05911841|528140921|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
146446966|NCT05911841|528140922|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
146446967|NCT05911841|528140913|FG000|Escape Period|Site Terminated by Sponsor|0|||
146446968|NCT05911841|528140914|FG001|Escape Period|Site Terminated by Sponsor|0|||
146446969|NCT05911841|528140915|FG002|Escape Period|Site Terminated by Sponsor|0|||
146446970|NCT05911841|528140916|FG003|Escape Period|Site Terminated by Sponsor|0|||
146446971|NCT05911841|528140917|FG004|Escape Period|Site Terminated by Sponsor|0|||
146446972|NCT05911841|528140918|FG005|Escape Period|Site Terminated by Sponsor|0|||
146446973|NCT05911841|528140919|FG006|Escape Period|Site Terminated by Sponsor|0|||
146446974|NCT05911841|528140920|FG007|Escape Period|Site Terminated by Sponsor|0|||
146446975|NCT05911841|528140921|FG008|Escape Period|Site Terminated by Sponsor|0|||
146446976|NCT05911841|528140922|FG009|Escape Period|Site Terminated by Sponsor|1|||
146446977|NCT05911841|528140913|FG000|Escape Period|Study Terminated by Sponsor|0|||
146446978|NCT05911841|528140914|FG001|Escape Period|Study Terminated by Sponsor|0|||
146446979|NCT05911841|528140915|FG002|Escape Period|Study Terminated by Sponsor|0|||
146446980|NCT05911841|528140916|FG003|Escape Period|Study Terminated by Sponsor|0|||
146446981|NCT05911841|528140917|FG004|Escape Period|Study Terminated by Sponsor|0|||
146446982|NCT05911841|528140918|FG005|Escape Period|Study Terminated by Sponsor|0|||
146446983|NCT05911841|528140919|FG006|Escape Period|Study Terminated by Sponsor|0|||
146446984|NCT05911841|528140920|FG007|Escape Period|Study Terminated by Sponsor|0|||
146446985|NCT05911841|528140921|FG008|Escape Period|Study Terminated by Sponsor|0|||
146446986|NCT05911841|528140922|FG009|Escape Period|Study Terminated by Sponsor|34|||
146446987|NCT05911841|528140913|FG000|Escape Period|Withdrawal by Subject|0|||
146446988|NCT05911841|528140914|FG001|Escape Period|Withdrawal by Subject|0|||
146446989|NCT05911841|528140915|FG002|Escape Period|Withdrawal by Subject|0|||
146446990|NCT05911841|528140916|FG003|Escape Period|Withdrawal by Subject|0|||
146446991|NCT05911841|528140917|FG004|Escape Period|Withdrawal by Subject|0|||
145956422|NCT02797678|526352505|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
145956423|NCT02797678|526352506|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
145956424|NCT02797678|526352507|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
145956425|NCT03046953|526352519|FG000|Overall Study|Relapse/progressive disease|21|||
145956426|NCT03046953|526352519|FG000|Overall Study|Death|2|||
145956427|NCT03046953|526352519|FG000|Overall Study|Withdrawal by Subject|3|||
145956428|NCT00420628|526352522|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
146446992|NCT05911841|528140918|FG005|Escape Period|Withdrawal by Subject|0|||
146446993|NCT05911841|528140919|FG006|Escape Period|Withdrawal by Subject|0|||
146446994|NCT05911841|528140920|FG007|Escape Period|Withdrawal by Subject|0|||
146446995|NCT05911841|528140921|FG008|Escape Period|Withdrawal by Subject|0|||
146446996|NCT05911841|528140922|FG009|Escape Period|Withdrawal by Subject|10|||
146446997|NCT03230487|528140925|FG000|Overall Study|Adverse Event|0|||
145956429|NCT00420628|526352523|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
146446998|NCT03230487|528140926|FG001|Overall Study|Adverse Event|0|||
146446999|NCT03230487|528140927|FG002|Overall Study|Adverse Event|0|||
146447000|NCT03230487|528140928|FG003|Overall Study|Adverse Event|1|||
146447001|NCT03230487|528140929|FG004|Overall Study|Adverse Event|0|||
146447002|NCT03230487|528140930|FG005|Overall Study|Adverse Event|0|||
146447003|NCT05212948|528140931|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
146447004|NCT05212948|528140932|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
146447005|NCT05212948|528140931|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
146447006|NCT05212948|528140932|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
146447007|NCT05212948|528140931|FG000|Initial Vaccination Period|Pregnancy|20|||
146447008|NCT05212948|528140932|FG001|Initial Vaccination Period|Pregnancy|14|||
146447009|NCT05212948|528140931|FG000|Initial Vaccination Period|Physician Decision|686|||
146447010|NCT05212948|528140932|FG001|Initial Vaccination Period|Physician Decision|401|||
146447011|NCT05212948|528140931|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
146447012|NCT05212948|528140932|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
146447013|NCT05212948|528140931|FG000|Initial Vaccination Period|Death|23|||
146447014|NCT05212948|528140932|FG001|Initial Vaccination Period|Death|18|||
146447015|NCT05212948|528140931|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
146447016|NCT05212948|528140932|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
146447017|NCT05212948|528140931|FG000|Initial Vaccination Period|Adverse Event|36|||
146447018|NCT05212948|528140932|FG001|Initial Vaccination Period|Adverse Event|23|||
146447019|NCT05212948|528140931|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
146447020|NCT05212948|528140932|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
146447021|NCT05212948|528140931|FG000|Crossover Vaccination Period|Pregnancy|6|||
146447022|NCT05212948|528140932|FG001|Crossover Vaccination Period|Pregnancy|1|||
146447023|NCT05212948|528140931|FG000|Crossover Vaccination Period|Physician Decision|49|||
146447024|NCT05212948|528140932|FG001|Crossover Vaccination Period|Physician Decision|24|||
146447025|NCT05212948|528140931|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
146447026|NCT05212948|528140932|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
146447027|NCT05212948|528140931|FG000|Crossover Vaccination Period|Death|10|||
146447028|NCT05212948|528140932|FG001|Crossover Vaccination Period|Death|5|||
146447029|NCT05212948|528140931|FG000|Crossover Vaccination Period|Adverse Event|9|||
146447030|NCT05212948|528140932|FG001|Crossover Vaccination Period|Adverse Event|4|||
146447031|NCT04530552|528140936|FG000|Overall Study|Physician Decision|0|||
146447032|NCT04530552|528140937|FG001|Overall Study|Physician Decision|1|||
146447033|NCT04530552|528140936|FG000|Overall Study|Withdrawal by Subject|0|||
146447034|NCT04530552|528140937|FG001|Overall Study|Withdrawal by Subject|1|||
146447035|NCT04530552|528140936|FG000|Overall Study|Adverse Event|0|||
146447036|NCT04530552|528140937|FG001|Overall Study|Adverse Event|1|||
146447037|NCT04530552|528140936|FG000|Overall Study|No surgery|0|||
146447038|NCT04530552|528140937|FG001|Overall Study|No surgery|1|||
146447039|NCT05162586|528140938|FG000|Overall Study|Other|0|||
146447040|NCT05162586|528140939|FG001|Overall Study|Other|0|||
146447041|NCT05162586|528140940|FG002|Overall Study|Other|0|||
146447042|NCT05162586|528140941|FG003|Overall Study|Other|0|||
146447043|NCT05162586|528140942|FG004|Overall Study|Other|1|||
146447044|NCT05162586|528140943|FG005|Overall Study|Other|0|||
146447045|NCT05162586|528140944|FG006|Overall Study|Other|2|||
146447046|NCT05162586|528140945|FG007|Overall Study|Other|2|||
146447047|NCT05162586|528140938|FG000|Overall Study|Lack of Efficacy|0|||
146447048|NCT05162586|528140939|FG001|Overall Study|Lack of Efficacy|0|||
146447049|NCT05162586|528140940|FG002|Overall Study|Lack of Efficacy|0|||
146447050|NCT05162586|528140941|FG003|Overall Study|Lack of Efficacy|0|||
146447051|NCT05162586|528140942|FG004|Overall Study|Lack of Efficacy|1|||
146447052|NCT05162586|528140943|FG005|Overall Study|Lack of Efficacy|0|||
146447053|NCT05162586|528140944|FG006|Overall Study|Lack of Efficacy|0|||
146447054|NCT05162586|528140945|FG007|Overall Study|Lack of Efficacy|1|||
146447055|NCT05162586|528140938|FG000|Overall Study|Lost to Follow-up|0|||
146447056|NCT05162586|528140939|FG001|Overall Study|Lost to Follow-up|0|||
146447057|NCT05162586|528140940|FG002|Overall Study|Lost to Follow-up|0|||
146447058|NCT05162586|528140941|FG003|Overall Study|Lost to Follow-up|0|||
146447059|NCT05162586|528140942|FG004|Overall Study|Lost to Follow-up|2|||
146447060|NCT05162586|528140943|FG005|Overall Study|Lost to Follow-up|0|||
146447061|NCT05162586|528140944|FG006|Overall Study|Lost to Follow-up|0|||
146447062|NCT05162586|528140945|FG007|Overall Study|Lost to Follow-up|2|||
145956430|NCT00420628|526352522|FG000|Overall Study|Lost to Follow-up|3|||
146447063|NCT05162586|528140938|FG000|Overall Study|Non-Compliance|0|||
146447064|NCT05162586|528140939|FG001|Overall Study|Non-Compliance|1|||
146447065|NCT05162586|528140940|FG002|Overall Study|Non-Compliance|0|||
146447066|NCT05162586|528140941|FG003|Overall Study|Non-Compliance|0|||
146447067|NCT05162586|528140942|FG004|Overall Study|Non-Compliance|1|||
145956431|NCT00420628|526352523|FG001|Overall Study|Lost to Follow-up|2|||
145956432|NCT00420628|526352522|FG000|Overall Study|Adverse Event|1|||
145956433|NCT00420628|526352523|FG001|Overall Study|Adverse Event|0|||
145956434|NCT02716584|526352524|FG000|Overall Study|Lost to Follow-up|8|||
145956435|NCT02716584|526352525|FG001|Overall Study|Lost to Follow-up|5|||
146447068|NCT05162586|528140943|FG005|Overall Study|Non-Compliance|0|||
146447069|NCT05162586|528140944|FG006|Overall Study|Non-Compliance|0|||
146447070|NCT05162586|528140945|FG007|Overall Study|Non-Compliance|1|||
146447071|NCT05162586|528140938|FG000|Overall Study|Withdrawal by Subject|2|||
146447072|NCT05162586|528140939|FG001|Overall Study|Withdrawal by Subject|0|||
146447073|NCT05162586|528140940|FG002|Overall Study|Withdrawal by Subject|0|||
145956436|NCT00805129|526352536|FG000|Overall Study|Not treated|1|||
146447074|NCT05162586|528140941|FG003|Overall Study|Withdrawal by Subject|0|||
146447075|NCT05162586|528140942|FG004|Overall Study|Withdrawal by Subject|7|||
146447076|NCT05162586|528140943|FG005|Overall Study|Withdrawal by Subject|6|||
146447077|NCT05162586|528140944|FG006|Overall Study|Withdrawal by Subject|2|||
146447078|NCT05162586|528140945|FG007|Overall Study|Withdrawal by Subject|2|||
146447079|NCT05162586|528140938|FG000|Overall Study|Adverse Event|2|||
146447080|NCT05162586|528140939|FG001|Overall Study|Adverse Event|0|||
146447081|NCT05162586|528140940|FG002|Overall Study|Adverse Event|1|||
146447082|NCT05162586|528140941|FG003|Overall Study|Adverse Event|2|||
146447083|NCT05162586|528140942|FG004|Overall Study|Adverse Event|4|||
146447084|NCT05162586|528140943|FG005|Overall Study|Adverse Event|1|||
146447085|NCT05162586|528140944|FG006|Overall Study|Adverse Event|5|||
146447086|NCT05162586|528140945|FG007|Overall Study|Adverse Event|2|||
146447087|NCT05347693|528140946|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
146447088|NCT05347693|528140947|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
146447089|NCT05347693|528140948|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
146447090|NCT05347693|528140946|FG000|Inpatient Period|Withdrawal of consent|10|||
146447091|NCT05347693|528140947|FG001|Inpatient Period|Withdrawal of consent|0|||
146447092|NCT05347693|528140948|FG002|Inpatient Period|Withdrawal of consent|0|||
146447093|NCT05347693|528140946|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
146447094|NCT05347693|528140947|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
146447095|NCT05347693|528140948|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
146447096|NCT05347693|528140946|FG000|Inpatient Period|Screening Failure|8|||
146447097|NCT05347693|528140947|FG001|Inpatient Period|Screening Failure|0|||
146447098|NCT05347693|528140948|FG002|Inpatient Period|Screening Failure|0|||
146447099|NCT05347693|528140946|FG000|Inpatient Period|Death|2|||
146447100|NCT05347693|528140947|FG001|Inpatient Period|Death|0|||
146447101|NCT05347693|528140948|FG002|Inpatient Period|Death|0|||
146447102|NCT05347693|528140946|FG000|Inpatient Period|Physician Decision|5|||
145956437|NCT00571662|526352537|FG000|Overall Study|Withdrawal by Subject|2|||
145956438|NCT00571662|526352537|FG000|Overall Study|psychiatric instability|1|||
145956439|NCT00571662|526352537|FG000|Overall Study|Adverse Event|5|||
145956440|NCT01868165|526352538|FG000|Overall Study|Withdrawal by Subject|36|||
145956441|NCT01868165|526352538|FG000|Overall Study|Physician Decision|2|||
145956442|NCT01868165|526352538|FG000|Overall Study|Lost to Follow-up|3|||
145956443|NCT01868165|526352538|FG000|Overall Study|Death|4|||
145956444|NCT01429298|526352539|FG000|Overall Study|Protocol Violation|4|||
145956445|NCT01429298|526352540|FG001|Overall Study|Protocol Violation|6|||
145956446|NCT01839916|526352541|FG000|Overall Study|Death|9|||
145956447|NCT01839916|526352541|FG000|Overall Study|Physician Decision|17|||
145956448|NCT01839916|526352541|FG000|Overall Study|Relapse|12|||
145956449|NCT01839916|526352541|FG000|Overall Study|GVHD|2|||
145956450|NCT01839916|526352541|FG000|Overall Study|Graft Failure|1|||
145956451|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
146447103|NCT05347693|528140947|FG001|Inpatient Period|Physician Decision|0|||
146447104|NCT05347693|528140948|FG002|Inpatient Period|Physician Decision|0|||
145956452|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145956453|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145956454|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145956455|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
146083360|NCT00483756|526824823|FG000|Overall Study|Lack of Efficacy|1|||
145956456|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145956457|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145956458|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145956459|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
145956460|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
145956461|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
146209585|NCT04992390|527280414|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
146209586|NCT04992390|527280415|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
146209587|NCT04992390|527280416|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
146209588|NCT04992390|527280414|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
146209589|NCT04992390|527280415|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
146209590|NCT04992390|527280416|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
146209591|NCT04992390|527280414|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
146209592|NCT04992390|527280415|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
146209593|NCT04992390|527280416|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
146209594|NCT04992390|527280414|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
146209595|NCT04992390|527280415|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
146209596|NCT04992390|527280416|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
146209597|NCT05028582|527280417|FG000|Overall Study|Lost to Follow-up|11|||
146209598|NCT05028582|527280418|FG001|Overall Study|Lost to Follow-up|9|||
146209599|NCT05028582|527280417|FG000|Overall Study|Withdrawal by Subject|9|||
146209600|NCT05028582|527280418|FG001|Overall Study|Withdrawal by Subject|10|||
146209601|NCT05028582|527280417|FG000|Overall Study|Adverse Event|5|||
146209602|NCT05028582|527280418|FG001|Overall Study|Adverse Event|2|||
146209603|NCT05028582|527280417|FG000|Overall Study|Miscellaneous|3|||
146209604|NCT05028582|527280418|FG001|Overall Study|Miscellaneous|2|||
146209605|NCT05028582|527280417|FG000|Overall Study|Lack of Efficacy|3|||
146209606|NCT05028582|527280418|FG001|Overall Study|Lack of Efficacy|1|||
146209607|NCT05028582|527280417|FG000|Overall Study|Physician Decision|0|||
146209608|NCT05028582|527280418|FG001|Overall Study|Physician Decision|1|||
146209609|NCT04939246|527280419|FG000|After Treatment|Death|4|||
146209610|NCT04939246|527280419|FG000|After Treatment|Lost to Follow-up|1|||
146209611|NCT04939246|527280419|FG000|After Treatment|Discharged to hospice|2|||
146209612|NCT02576509|527282120|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
146209613|NCT02576509|527282121|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
146209614|NCT02576509|527282120|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
146209615|NCT02576509|527282121|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
146209616|NCT02576509|527282120|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
146209617|NCT02576509|527282121|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
146209618|NCT02576509|527282120|FG000|Treatment Period|Disease progression|263|||
146209619|NCT02576509|527282121|FG001|Treatment Period|Disease progression|244|||
146209620|NCT02576509|527282120|FG000|Treatment Period|Study drug toxicity|37|||
146209621|NCT02576509|527282121|FG001|Treatment Period|Study drug toxicity|41|||
146209622|NCT02576509|527282120|FG000|Treatment Period|Death|1|||
146209623|NCT02576509|527282121|FG001|Treatment Period|Death|1|||
146209624|NCT02576509|527282120|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
146209625|NCT02576509|527282121|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
146209626|NCT02576509|527282120|FG000|Treatment Period|Participant request to stop treatment|8|||
146209627|NCT02576509|527282121|FG001|Treatment Period|Participant request to stop treatment|18|||
146209628|NCT02576509|527282120|FG000|Treatment Period|Participant withdrew consent|3|||
146209629|NCT02576509|527282121|FG001|Treatment Period|Participant withdrew consent|7|||
146209630|NCT02576509|527282120|FG000|Treatment Period|Lost to Follow-up|0|||
146209631|NCT02576509|527282121|FG001|Treatment Period|Lost to Follow-up|1|||
146209632|NCT02576509|527282120|FG000|Treatment Period|Maximum clinical benefit|1|||
145956462|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
145956463|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
146209633|NCT02576509|527282121|FG001|Treatment Period|Maximum clinical benefit|0|||
146209634|NCT02576509|527282120|FG000|Treatment Period|Poor/non-compliance|1|||
146209635|NCT02576509|527282121|FG001|Treatment Period|Poor/non-compliance|1|||
146209636|NCT02576509|527282120|FG000|Treatment Period|Participant no longer meets criteria|1|||
146209637|NCT02576509|527282121|FG001|Treatment Period|Participant no longer meets criteria|0|||
146209638|NCT02576509|527282120|FG000|Treatment Period|Other reason|12|||
146209639|NCT02576509|527282121|FG001|Treatment Period|Other reason|8|||
146209640|NCT02576509|527282120|FG000|Treatment Period|NOT REPORTED|1|||
146209641|NCT02576509|527282121|FG001|Treatment Period|NOT REPORTED|0|||
146209642|NCT02576509|527282120|FG000|Treatment Period|Administrative reason by sponsor|0|||
146209643|NCT02576509|527282121|FG001|Treatment Period|Administrative reason by sponsor|1|||
146209644|NCT01216176|527282125|FG000|Overall Study|Adverse Event|0|||
146209645|NCT01216176|527282126|FG001|Overall Study|Adverse Event|8|||
146209646|NCT01216176|527282127|FG002|Overall Study|Adverse Event|0|||
146209647|NCT01216176|527282125|FG000|Overall Study|Physician Decision|0|||
146447105|NCT05347693|528140946|FG000|Inpatient Period|Adverse Event|3|||
146447106|NCT05347693|528140947|FG001|Inpatient Period|Adverse Event|0|||
146447107|NCT05347693|528140948|FG002|Inpatient Period|Adverse Event|0|||
146447108|NCT05347693|528140946|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
146447109|NCT05347693|528140947|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
146447110|NCT05347693|528140948|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
146447111|NCT05347693|528140946|FG000|Outpatient Period|Adverse Event|0|||
146447112|NCT05347693|528140947|FG001|Outpatient Period|Adverse Event|9|||
146447113|NCT05347693|528140948|FG002|Outpatient Period|Adverse Event|0|||
146447114|NCT05347693|528140946|FG000|Outpatient Period|Death|0|||
146447115|NCT05347693|528140947|FG001|Outpatient Period|Death|6|||
146447116|NCT05347693|528140948|FG002|Outpatient Period|Death|2|||
146447117|NCT05347693|528140946|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
146447118|NCT05347693|528140947|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
146447119|NCT05347693|528140948|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
146447120|NCT05347693|528140946|FG000|Outpatient Period|Lost to Follow-up|0|||
146447121|NCT05347693|528140947|FG001|Outpatient Period|Lost to Follow-up|0|||
146447122|NCT05347693|528140948|FG002|Outpatient Period|Lost to Follow-up|1|||
146447123|NCT05347693|528140946|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
146447124|NCT05347693|528140947|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
146447125|NCT05347693|528140948|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
146447126|NCT05347693|528140946|FG000|Outpatient Period|Scheduled hemodialysis|0|||
146447127|NCT05347693|528140947|FG001|Outpatient Period|Scheduled hemodialysis|1|||
146447128|NCT05347693|528140948|FG002|Outpatient Period|Scheduled hemodialysis|0|||
146447129|NCT05347693|528140946|FG000|Outpatient Period|Severe HK|0|||
146447130|NCT05347693|528140947|FG001|Outpatient Period|Severe HK|0|||
146447131|NCT05347693|528140948|FG002|Outpatient Period|Severe HK|1|||
146447132|NCT05347693|528140946|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
146447133|NCT05347693|528140947|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
146447134|NCT05347693|528140948|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
146447135|NCT05347693|528140946|FG000|Outpatient Period|Start of dialysis|0|||
146447136|NCT05347693|528140947|FG001|Outpatient Period|Start of dialysis|0|||
146447137|NCT05347693|528140948|FG002|Outpatient Period|Start of dialysis|1|||
146447138|NCT05347693|528140946|FG000|Outpatient Period|The participant entered hemodialysis|0|||
146447139|NCT05347693|528140947|FG001|Outpatient Period|The participant entered hemodialysis|0|||
146447140|NCT05347693|528140948|FG002|Outpatient Period|The participant entered hemodialysis|1|||
146447141|NCT05347693|528140946|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
146447142|NCT05347693|528140947|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
146447143|NCT05347693|528140948|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
146447144|NCT05347693|528140946|FG000|Outpatient Period|Withdrawal by Subject|0|||
146447145|NCT05347693|528140947|FG001|Outpatient Period|Withdrawal by Subject|8|||
146447146|NCT05347693|528140948|FG002|Outpatient Period|Withdrawal by Subject|5|||
146447147|NCT02048813|528140949|FG000|Overall Study|Still on treatment|279|||
146447148|NCT02048813|528140950|FG001|Overall Study|Still on treatment|0|||
146447149|NCT02048813|528140949|FG000|Overall Study|Adverse Event|40|||
146447150|NCT02048813|528140950|FG001|Overall Study|Adverse Event|38|||
146447151|NCT02048813|528140949|FG000|Overall Study|Disease progression|13|||
146447152|NCT02048813|528140950|FG001|Overall Study|Disease progression|3|||
146447153|NCT02048813|528140949|FG000|Overall Study|Withdrawal by Subject|7|||
146447154|NCT02048813|528140950|FG001|Overall Study|Withdrawal by Subject|8|||
146447155|NCT02048813|528140949|FG000|Overall Study|Death|2|||
146447156|NCT02048813|528140950|FG001|Overall Study|Death|1|||
146447157|NCT02048813|528140949|FG000|Overall Study|Complication|2|||
146447158|NCT02048813|528140950|FG001|Overall Study|Complication|2|||
146447159|NCT02048813|528140949|FG000|Overall Study|Non-protocol therapy|0|||
146447160|NCT02048813|528140950|FG001|Overall Study|Non-protocol therapy|1|||
146447161|NCT02048813|528140949|FG000|Overall Study|Second primary cancer|2|||
146447162|NCT02048813|528140950|FG001|Overall Study|Second primary cancer|0|||
146447163|NCT02048813|528140949|FG000|Overall Study|Insurance|2|||
146447164|NCT02048813|528140950|FG001|Overall Study|Insurance|0|||
146447165|NCT02048813|528140949|FG000|Overall Study|Wound infection/healing|2|||
146447166|NCT02048813|528140950|FG001|Overall Study|Wound infection/healing|0|||
146447167|NCT02048813|528140949|FG000|Overall Study|Missed appointment|3|||
146447168|NCT02048813|528140950|FG001|Overall Study|Missed appointment|0|||
146447169|NCT02048813|528140949|FG000|Overall Study|Never started treatment|2|||
145956464|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146447170|NCT02048813|528140950|FG001|Overall Study|Never started treatment|17|||
146447171|NCT01708954|528140951|FG000|Step 1|Disease progression|26|||
146447172|NCT01708954|528140952|FG001|Step 1|Disease progression|17|||
146447173|NCT01708954|528140953|FG002|Step 1|Disease progression|14|||
146447174|NCT01708954|528140951|FG000|Step 1|Adverse Event|3|||
146447175|NCT01708954|528140952|FG001|Step 1|Adverse Event|11|||
146447176|NCT01708954|528140953|FG002|Step 1|Adverse Event|13|||
146447177|NCT01708954|528140951|FG000|Step 1|Death|3|||
146447178|NCT01708954|528140952|FG001|Step 1|Death|2|||
146447179|NCT01708954|528140953|FG002|Step 1|Death|3|||
146447180|NCT01708954|528140951|FG000|Step 1|Withdrawal by Subject|2|||
146447181|NCT01708954|528140952|FG001|Step 1|Withdrawal by Subject|5|||
146447182|NCT01708954|528140953|FG002|Step 1|Withdrawal by Subject|3|||
146447183|NCT01708954|528140951|FG000|Step 1|Other complicating disease|0|||
146447184|NCT01708954|528140952|FG001|Step 1|Other complicating disease|2|||
146447185|NCT01708954|528140953|FG002|Step 1|Other complicating disease|0|||
146447186|NCT01708954|528140951|FG000|Step 1|Crossed over to Step 2|2|||
146447187|NCT01708954|528140952|FG001|Step 1|Crossed over to Step 2|0|||
146447188|NCT01708954|528140953|FG002|Step 1|Crossed over to Step 2|0|||
146447189|NCT01708954|528140951|FG000|Step 1|Symptomatic deterioration|1|||
146447190|NCT01708954|528140952|FG001|Step 1|Symptomatic deterioration|0|||
146447191|NCT01708954|528140953|FG002|Step 1|Symptomatic deterioration|1|||
146447192|NCT01708954|528140951|FG000|Step 1|Off-treatment reason not submitted|1|||
146447193|NCT01708954|528140952|FG001|Step 1|Off-treatment reason not submitted|1|||
146447194|NCT01708954|528140953|FG002|Step 1|Off-treatment reason not submitted|1|||
146447195|NCT01708954|528140951|FG000|Step 1|Ineligible or never received treatment|4|||
146447196|NCT01708954|528140952|FG001|Step 1|Ineligible or never received treatment|2|||
146447197|NCT01708954|528140953|FG002|Step 1|Ineligible or never received treatment|8|||
146447198|NCT01708954|528140951|FG000|Step 2|Disease progression|9|||
146447199|NCT01708954|528140952|FG001|Step 2|Disease progression|4|||
146447200|NCT01708954|528140953|FG002|Step 2|Disease progression|0|||
146447201|NCT01708954|528140951|FG000|Step 2|Adverse Event|3|||
146447202|NCT01708954|528140952|FG001|Step 2|Adverse Event|2|||
146447203|NCT01708954|528140953|FG002|Step 2|Adverse Event|0|||
146447204|NCT01708954|528140951|FG000|Step 2|Withdrawal by Subject|1|||
146447205|NCT01708954|528140952|FG001|Step 2|Withdrawal by Subject|1|||
146447206|NCT01708954|528140953|FG002|Step 2|Withdrawal by Subject|0|||
146447207|NCT01192776|528140954|FG000|Overall Study|Death|8|||
146447208|NCT01192776|528140955|FG001|Overall Study|Death|15|||
146447209|NCT01192776|528140956|FG002|Overall Study|Death|18|||
146447210|NCT01192776|528140957|FG003|Overall Study|Death|15|||
146447211|NCT01192776|528140954|FG000|Overall Study|Lost to Follow-up|3|||
146447212|NCT01192776|528140955|FG001|Overall Study|Lost to Follow-up|6|||
146447213|NCT01192776|528140956|FG002|Overall Study|Lost to Follow-up|3|||
146447214|NCT01192776|528140957|FG003|Overall Study|Lost to Follow-up|5|||
146447215|NCT01358877|528140972|FG000|Overall Study|Withdrawal by Subject|475|||
146447216|NCT01358877|528140973|FG001|Overall Study|Withdrawal by Subject|466|||
146447217|NCT01358877|528140972|FG000|Overall Study|Recurrence of disease|181|||
146447218|NCT01358877|528140973|FG001|Overall Study|Recurrence of disease|269|||
146447219|NCT01358877|528140972|FG000|Overall Study|Lost to Follow-up|181|||
146447220|NCT01358877|528140973|FG001|Overall Study|Lost to Follow-up|176|||
146447221|NCT01358877|528140972|FG000|Overall Study|Death|41|||
146447222|NCT01358877|528140973|FG001|Overall Study|Death|46|||
146447223|NCT01358877|528140972|FG000|Overall Study|Adverse Event|39|||
146447224|NCT01358877|528140973|FG001|Overall Study|Adverse Event|42|||
146209648|NCT01216176|527282126|FG001|Overall Study|Physician Decision|0|||
146447225|NCT01358877|528140972|FG000|Overall Study|Physician Decision|43|||
146447226|NCT01358877|528140973|FG001|Overall Study|Physician Decision|32|||
146447227|NCT01358877|528140972|FG000|Overall Study|Contralateral breast cancer|42|||
146447228|NCT01358877|528140973|FG001|Overall Study|Contralateral breast cancer|28|||
146447229|NCT01358877|528140972|FG000|Overall Study|Reason not specified|37|||
146447230|NCT01358877|528140973|FG001|Overall Study|Reason not specified|29|||
146447231|NCT02567435|528140974|FG000|Overall Study|Death|1|||
146447232|NCT02567435|528140975|FG001|Overall Study|Death|1|||
146447233|NCT02567435|528140976|FG002|Overall Study|Death|0|||
146447234|NCT02567435|528140977|FG003|Overall Study|Death|0|||
146447235|NCT02567435|528140974|FG000|Overall Study|Ineligible|1|||
146447236|NCT02567435|528140975|FG001|Overall Study|Ineligible|3|||
146447237|NCT02567435|528140976|FG002|Overall Study|Ineligible|0|||
146447238|NCT02567435|528140977|FG003|Overall Study|Ineligible|0|||
146447239|NCT02567435|528140974|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
146447240|NCT02567435|528140975|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
146447241|NCT02567435|528140976|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
146447242|NCT02567435|528140977|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
146447243|NCT02166463|528140978|FG000|Overall Study|Lost to Follow-up|0|||
146447244|NCT02166463|528140979|FG001|Overall Study|Lost to Follow-up|1|||
146447245|NCT02166463|528140978|FG000|Overall Study|Physician Decision|10|||
146447246|NCT02166463|528140979|FG001|Overall Study|Physician Decision|10|||
146447247|NCT02166463|528140978|FG000|Overall Study|Ineligible|11|||
146447248|NCT02166463|528140979|FG001|Overall Study|Ineligible|2|||
146447249|NCT02166463|528140978|FG000|Overall Study|Progressive Disease|9|||
146447250|NCT02166463|528140979|FG001|Overall Study|Progressive Disease|6|||
146447251|NCT02166463|528140978|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
146447252|NCT02166463|528140979|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
146447253|NCT02166463|528140978|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
146447254|NCT02166463|528140979|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
146447255|NCT02166463|528140978|FG000|Overall Study|Refusal of further protocol therapy|5|||
146447256|NCT02166463|528140979|FG001|Overall Study|Refusal of further protocol therapy|6|||
146447257|NCT05552261|528140983|FG000|Overall Study|Withdrawal by Subject|1|||
146447258|NCT05552261|528140983|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
146447259|NCT02003222|528140984|FG000|Induction|Never started treatment|0|||
146447260|NCT02003222|528140985|FG001|Induction|Never started treatment|0|||
146447261|NCT02003222|528140986|FG002|Induction|Never started treatment|0|||
146447262|NCT02003222|528140987|FG003|Induction|Never started treatment|0|||
146447263|NCT02003222|528140988|FG004|Induction|Never started treatment|8|||
146447264|NCT02003222|528140984|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
146447265|NCT02003222|528140985|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
146447266|NCT02003222|528140986|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
146447267|NCT02003222|528140987|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
146447268|NCT02003222|528140988|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
146447269|NCT02003222|528140984|FG000|Induction|Adverse Event|0|||
146447270|NCT02003222|528140985|FG001|Induction|Adverse Event|0|||
146447271|NCT02003222|528140986|FG002|Induction|Adverse Event|0|||
146447272|NCT02003222|528140987|FG003|Induction|Adverse Event|0|||
146447273|NCT02003222|528140988|FG004|Induction|Adverse Event|13|||
146447274|NCT02003222|528140984|FG000|Induction|Alternative therapy|0|||
146447275|NCT02003222|528140985|FG001|Induction|Alternative therapy|0|||
146447276|NCT02003222|528140986|FG002|Induction|Alternative therapy|0|||
146447277|NCT02003222|528140987|FG003|Induction|Alternative therapy|0|||
146447278|NCT02003222|528140988|FG004|Induction|Alternative therapy|12|||
146447279|NCT02003222|528140984|FG000|Induction|Disease progression|0|||
146447280|NCT02003222|528140985|FG001|Induction|Disease progression|0|||
146447281|NCT02003222|528140986|FG002|Induction|Disease progression|0|||
146447282|NCT02003222|528140987|FG003|Induction|Disease progression|0|||
146447283|NCT02003222|528140988|FG004|Induction|Disease progression|22|||
146447284|NCT02003222|528140984|FG000|Induction|Death|0|||
146447285|NCT02003222|528140985|FG001|Induction|Death|0|||
146447286|NCT02003222|528140986|FG002|Induction|Death|0|||
146447287|NCT02003222|528140987|FG003|Induction|Death|0|||
146447288|NCT02003222|528140988|FG004|Induction|Death|3|||
146447289|NCT02003222|528140984|FG000|Induction|Withdrawal by Subject|0|||
146447290|NCT02003222|528140985|FG001|Induction|Withdrawal by Subject|0|||
146447291|NCT02003222|528140986|FG002|Induction|Withdrawal by Subject|0|||
146447292|NCT02003222|528140987|FG003|Induction|Withdrawal by Subject|0|||
146447293|NCT02003222|528140988|FG004|Induction|Withdrawal by Subject|8|||
146447294|NCT02003222|528140984|FG000|Induction|Other reasons|0|||
146447295|NCT02003222|528140985|FG001|Induction|Other reasons|0|||
146447296|NCT02003222|528140986|FG002|Induction|Other reasons|0|||
146447297|NCT02003222|528140987|FG003|Induction|Other reasons|0|||
146447298|NCT02003222|528140988|FG004|Induction|Other reasons|22|||
146447299|NCT02003222|528140984|FG000|Intensification|Never started treatment|0|||
146447300|NCT02003222|528140985|FG001|Intensification|Never started treatment|0|||
146447301|NCT02003222|528140986|FG002|Intensification|Never started treatment|0|||
146447302|NCT02003222|528140987|FG003|Intensification|Never started treatment|0|||
146447303|NCT02003222|528140988|FG004|Intensification|Never started treatment|2|||
146447304|NCT02003222|528140984|FG000|Intensification|Adverse Event|0|||
146447305|NCT02003222|528140985|FG001|Intensification|Adverse Event|0|||
146447306|NCT02003222|528140986|FG002|Intensification|Adverse Event|0|||
146447307|NCT02003222|528140987|FG003|Intensification|Adverse Event|0|||
146447308|NCT02003222|528140988|FG004|Intensification|Adverse Event|6|||
146447309|NCT02003222|528140984|FG000|Intensification|Alternative therapy|0|||
146447310|NCT02003222|528140985|FG001|Intensification|Alternative therapy|0|||
146447311|NCT02003222|528140986|FG002|Intensification|Alternative therapy|0|||
146447312|NCT02003222|528140987|FG003|Intensification|Alternative therapy|0|||
146447313|NCT02003222|528140988|FG004|Intensification|Alternative therapy|8|||
146447314|NCT02003222|528140984|FG000|Intensification|Disease progression|0|||
146447315|NCT02003222|528140985|FG001|Intensification|Disease progression|0|||
146447316|NCT02003222|528140986|FG002|Intensification|Disease progression|0|||
146447317|NCT02003222|528140987|FG003|Intensification|Disease progression|0|||
146447318|NCT02003222|528140988|FG004|Intensification|Disease progression|18|||
146447319|NCT02003222|528140984|FG000|Intensification|Withdrawal by Subject|0|||
146447320|NCT02003222|528140985|FG001|Intensification|Withdrawal by Subject|0|||
146447321|NCT02003222|528140986|FG002|Intensification|Withdrawal by Subject|0|||
146447322|NCT02003222|528140987|FG003|Intensification|Withdrawal by Subject|0|||
146447323|NCT02003222|528140988|FG004|Intensification|Withdrawal by Subject|5|||
146447324|NCT02003222|528140984|FG000|Intensification|Other reasons|0|||
146447325|NCT02003222|528140985|FG001|Intensification|Other reasons|0|||
146447326|NCT02003222|528140986|FG002|Intensification|Other reasons|0|||
146447327|NCT02003222|528140987|FG003|Intensification|Other reasons|0|||
146447328|NCT02003222|528140988|FG004|Intensification|Other reasons|8|||
146447329|NCT03025035|528140993|FG000|Overall Study|Death|2|||
146447330|NCT03025035|528140993|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
146447331|NCT04941768|528140994|FG000|Overall Study|Lost to Follow-up|10|||
146447332|NCT04941768|528140994|FG000|Overall Study|Death|24|||
146447333|NCT04941768|528140994|FG000|Overall Study|Progressive Disease|4|||
146447334|NCT04941768|528140994|FG000|Overall Study|Withdrawal by Subject|4|||
146447335|NCT04941768|528140994|FG000|Overall Study|Other|3|||
146447336|NCT04941768|528140994|FG000|Overall Study|Treatment ongoing|21|||
146447337|NCT04941768|528140994|FG000|Overall Study|Off treatment and in follow-up|21|||
146447338|NCT03302078|528140996|FG000|Washout Period|Adverse Event|0|||
146447339|NCT03302078|528140997|FG001|Washout Period|Adverse Event|1|||
146447340|NCT05030584|528141000|FG000|Overall Study|Adverse Event|17|||
146447341|NCT05030584|528141001|FG001|Overall Study|Adverse Event|2|||
146447342|NCT05030584|528141000|FG000|Overall Study|Lack of Efficacy|0|||
146447343|NCT05030584|528141001|FG001|Overall Study|Lack of Efficacy|6|||
146447344|NCT05030584|528141000|FG000|Overall Study|Lost to Follow-up|5|||
146447345|NCT05030584|528141001|FG001|Overall Study|Lost to Follow-up|2|||
146447346|NCT05030584|528141000|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146447347|NCT05030584|528141001|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146447348|NCT05030584|528141000|FG000|Overall Study|Other reason|4|||
146447349|NCT05030584|528141001|FG001|Overall Study|Other reason|3|||
146447350|NCT05030584|528141000|FG000|Overall Study|Physician Decision|1|||
146447351|NCT05030584|528141001|FG001|Overall Study|Physician Decision|4|||
146447352|NCT05030584|528141000|FG000|Overall Study|Protocol Violation|0|||
146447353|NCT05030584|528141001|FG001|Overall Study|Protocol Violation|2|||
146447354|NCT05030584|528141000|FG000|Overall Study|Randomized by Mistake|0|||
146209649|NCT01216176|527282127|FG002|Overall Study|Physician Decision|1|||
146447355|NCT05030584|528141001|FG001|Overall Study|Randomized by Mistake|2|||
146447356|NCT05030584|528141000|FG000|Overall Study|Withdrawal by Subject|21|||
146447357|NCT05030584|528141001|FG001|Overall Study|Withdrawal by Subject|28|||
146447358|NCT05030584|528141000|FG000|Overall Study|Technical Problems|0|||
146447359|NCT05030584|528141001|FG001|Overall Study|Technical Problems|1|||
146209650|NCT03398148|527282130|FG000|Substudy 1 Period 1|Adverse Event|5|||
146447360|NCT05030584|528141000|FG000|Overall Study|Completed post-treatment/FU visits|41|||
146447361|NCT05030584|528141001|FG001|Overall Study|Completed post-treatment/FU visits|31|||
146447362|NCT01886872|528141002|FG000|Overall Study|Ineligible|7|||
146447363|NCT01886872|528141003|FG001|Overall Study|Ineligible|4|||
146447364|NCT01886872|528141004|FG002|Overall Study|Ineligible|12|||
146447365|NCT05063448|528141009|FG000|Overall Study|Withdrawal by Subject|1|||
146447366|NCT05148299|528141011|FG000|Treatment Period|Adverse Event|1|||
146447367|NCT05148299|528141011|FG000|Treatment Period|Physician Decision|1|||
146447368|NCT05148299|528141011|FG000|Treatment Period|Death|1|||
146447369|NCT05148299|528141011|FG000|Follow-up Period|Death|3|||
146447370|NCT01856192|528141015|FG000|Overall Study|Adverse Event|12|||
146447371|NCT01856192|528141016|FG001|Overall Study|Adverse Event|4|||
146447372|NCT01856192|528141015|FG000|Overall Study|Alternative therapy|0|||
146447373|NCT01856192|528141016|FG001|Overall Study|Alternative therapy|3|||
146447374|NCT01856192|528141015|FG000|Overall Study|Death|3|||
146447375|NCT01856192|528141016|FG001|Overall Study|Death|5|||
146447376|NCT01856192|528141015|FG000|Overall Study|Lack of Efficacy|0|||
146447377|NCT01856192|528141016|FG001|Overall Study|Lack of Efficacy|5|||
146447378|NCT01856192|528141015|FG000|Overall Study|Withdrawal by Subject|1|||
146447379|NCT01856192|528141016|FG001|Overall Study|Withdrawal by Subject|1|||
146447380|NCT01856192|528141015|FG000|Overall Study|Other diseases|1|||
146447381|NCT01856192|528141016|FG001|Overall Study|Other diseases|0|||
146447382|NCT01856192|528141015|FG000|Overall Study|Never started treatment|7|||
146447383|NCT01856192|528141016|FG001|Overall Study|Never started treatment|5|||
146447384|NCT01856192|528141015|FG000|Overall Study|Path ineligible|20|||
146447385|NCT01856192|528141016|FG001|Overall Study|Path ineligible|34|||
146447386|NCT01856192|528141015|FG000|Overall Study|Non-path ineligible|2|||
146447387|NCT01856192|528141016|FG001|Overall Study|Non-path ineligible|2|||
146447388|NCT01856192|528141015|FG000|Overall Study|Physician Decision|1|||
146447389|NCT01856192|528141016|FG001|Overall Study|Physician Decision|1|||
146447390|NCT01856192|528141015|FG000|Overall Study|Suspicion of progressive disease|1|||
146447391|NCT01856192|528141016|FG001|Overall Study|Suspicion of progressive disease|0|||
146447392|NCT01856192|528141015|FG000|Overall Study|Non-compliance|1|||
146447393|NCT01856192|528141016|FG001|Overall Study|Non-compliance|0|||
146447394|NCT04777331|528141017|FG000|DBT Period|Death|2|||
146447395|NCT04777331|528141018|FG001|DBT Period|Death|1|||
146447396|NCT04777331|528141019|FG002|DBT Period|Death|0|||
146447397|NCT04777331|528141017|FG000|DBT Period|Reason not Specified|1|||
146447398|NCT04777331|528141018|FG001|DBT Period|Reason not Specified|1|||
146447399|NCT04777331|528141019|FG002|DBT Period|Reason not Specified|0|||
146447400|NCT04777331|528141017|FG000|DBT Period|Physician Decision|4|||
146447401|NCT04777331|528141018|FG001|DBT Period|Physician Decision|0|||
146447402|NCT04777331|528141019|FG002|DBT Period|Physician Decision|0|||
146447403|NCT04777331|528141017|FG000|DBT Period|Withdrawal by Subject|12|||
146447404|NCT04777331|528141018|FG001|DBT Period|Withdrawal by Subject|11|||
146447405|NCT04777331|528141019|FG002|DBT Period|Withdrawal by Subject|0|||
146447406|NCT04777331|528141017|FG000|DBT Period|Randomized but not Treated|1|||
146447407|NCT04777331|528141018|FG001|DBT Period|Randomized but not Treated|3|||
146447408|NCT04777331|528141019|FG002|DBT Period|Randomized but not Treated|0|||
146447409|NCT04777331|528141017|FG000|OLE Period|Ongoing in OLE|0|||
146447410|NCT04777331|528141018|FG001|OLE Period|Ongoing in OLE|0|||
146447411|NCT04777331|528141019|FG002|OLE Period|Ongoing in OLE|534|||
146447412|NCT02642042|528141020|FG000|Overall Study|Adverse Event|22|||
146447413|NCT02642042|528141020|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146447414|NCT02642042|528141020|FG000|Overall Study|Progression/Relapse|28|||
146447415|NCT02642042|528141020|FG000|Overall Study|Death|1|||
146447416|NCT02642042|528141020|FG000|Overall Study|Not Protocol Specified|2|||
146447417|NCT04108468|528141021|FG000|Overall Study|Physician Decision|0|||
146447418|NCT04108468|528141022|FG001|Overall Study|Physician Decision|1|||
146447419|NCT04108468|528141021|FG000|Overall Study|Lost to Follow-up|0|||
146447420|NCT04108468|528141022|FG001|Overall Study|Lost to Follow-up|1|||
146447421|NCT04108468|528141021|FG000|Overall Study|Non-compliance|1|||
146447422|NCT04108468|528141022|FG001|Overall Study|Non-compliance|1|||
146447423|NCT04108468|528141021|FG000|Overall Study|Unable to attend final visit|2|||
146447424|NCT04108468|528141022|FG001|Overall Study|Unable to attend final visit|0|||
146447425|NCT04108468|528141021|FG000|Overall Study|Missed study medication|0|||
146447426|NCT04108468|528141022|FG001|Overall Study|Missed study medication|1|||
146447427|NCT03047213|528141023|FG000|Overall Study|Withdrawal by Subject|2|||
146447428|NCT03047213|528141024|FG001|Overall Study|Withdrawal by Subject|0|||
146447429|NCT03047213|528141023|FG000|Overall Study|Adverse Event|2|||
146447430|NCT03047213|528141024|FG001|Overall Study|Adverse Event|0|||
146447431|NCT03260023|528141025|FG000|Overall Study|Adverse Event|0|||
146447432|NCT03260023|528141026|FG001|Overall Study|Adverse Event|0|||
146447433|NCT03260023|528141027|FG002|Overall Study|Adverse Event|4|||
146447434|NCT03260023|528141028|FG003|Overall Study|Adverse Event|4|||
146447435|NCT03260023|528141029|FG004|Overall Study|Adverse Event|4|||
146447436|NCT03260023|528141030|FG005|Overall Study|Adverse Event|1|||
146447437|NCT03260023|528141031|FG006|Overall Study|Adverse Event|2|||
146447438|NCT03260023|528141025|FG000|Overall Study|Clinical Progression|0|||
146447439|NCT03260023|528141026|FG001|Overall Study|Clinical Progression|1|||
146447440|NCT03260023|528141027|FG002|Overall Study|Clinical Progression|3|||
146447441|NCT03260023|528141028|FG003|Overall Study|Clinical Progression|1|||
146447442|NCT03260023|528141029|FG004|Overall Study|Clinical Progression|0|||
146447443|NCT03260023|528141030|FG005|Overall Study|Clinical Progression|0|||
146447444|NCT03260023|528141031|FG006|Overall Study|Clinical Progression|0|||
146447445|NCT03260023|528141025|FG000|Overall Study|Physician Decision|0|||
146447446|NCT03260023|528141026|FG001|Overall Study|Physician Decision|0|||
146447447|NCT03260023|528141027|FG002|Overall Study|Physician Decision|0|||
146447448|NCT03260023|528141028|FG003|Overall Study|Physician Decision|1|||
146447449|NCT03260023|528141029|FG004|Overall Study|Physician Decision|1|||
146447450|NCT03260023|528141030|FG005|Overall Study|Physician Decision|0|||
146447451|NCT03260023|528141031|FG006|Overall Study|Physician Decision|0|||
146447452|NCT03260023|528141025|FG000|Overall Study|Withdrawal by Subject|0|||
146447453|NCT03260023|528141026|FG001|Overall Study|Withdrawal by Subject|0|||
146447454|NCT03260023|528141027|FG002|Overall Study|Withdrawal by Subject|0|||
146447455|NCT03260023|528141028|FG003|Overall Study|Withdrawal by Subject|0|||
146447456|NCT03260023|528141029|FG004|Overall Study|Withdrawal by Subject|3|||
146447457|NCT03260023|528141030|FG005|Overall Study|Withdrawal by Subject|0|||
146447458|NCT03260023|528141031|FG006|Overall Study|Withdrawal by Subject|0|||
146447459|NCT03260023|528141025|FG000|Overall Study|Under trial intervention|0|||
146447460|NCT03260023|528141026|FG001|Overall Study|Under trial intervention|0|||
146447461|NCT03260023|528141027|FG002|Overall Study|Under trial intervention|2|||
146447462|NCT03260023|528141028|FG003|Overall Study|Under trial intervention|5|||
146447463|NCT03260023|528141029|FG004|Overall Study|Under trial intervention|3|||
146447464|NCT03260023|528141030|FG005|Overall Study|Under trial intervention|0|||
146447465|NCT03260023|528141031|FG006|Overall Study|Under trial intervention|0|||
146447466|NCT05035407|528141032|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
146447467|NCT05035407|528141033|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
146447468|NCT05035407|528141034|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
146447469|NCT05035407|528141035|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
146447470|NCT05035407|528141036|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
146447471|NCT05035407|528141037|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
146447472|NCT04220021|528141038|FG000|Overall Study|Withdrawal by Subject|11|||
146447473|NCT04220021|528141038|FG000|Overall Study|Physician Decision|2|||
146447474|NCT04220021|528141038|FG000|Overall Study|Non-study related illness|5|||
146447475|NCT00098475|528141039|FG000|Step 1|Progressive disease|33|||
146447476|NCT00098475|528141040|FG001|Step 1|Progressive disease|35|||
146447477|NCT00098475|528141041|FG002|Step 1|Progressive disease|2|||
146447478|NCT00098475|528141042|FG003|Step 1|Progressive disease|1|||
146447479|NCT00098475|528141039|FG000|Step 1|Adverse Event|56|||
146447480|NCT00098475|528141040|FG001|Step 1|Adverse Event|37|||
146447481|NCT00098475|528141041|FG002|Step 1|Adverse Event|0|||
146447482|NCT00098475|528141042|FG003|Step 1|Adverse Event|1|||
146447483|NCT00098475|528141039|FG000|Step 1|Death|8|||
146447484|NCT00098475|528141040|FG001|Step 1|Death|5|||
146447485|NCT00098475|528141041|FG002|Step 1|Death|0|||
146447486|NCT00098475|528141042|FG003|Step 1|Death|1|||
146447487|NCT00098475|528141039|FG000|Step 1|Withdrawal by Subject|14|||
146447488|NCT00098475|528141040|FG001|Step 1|Withdrawal by Subject|11|||
146447489|NCT00098475|528141041|FG002|Step 1|Withdrawal by Subject|0|||
146447490|NCT00098475|528141042|FG003|Step 1|Withdrawal by Subject|0|||
146447491|NCT00098475|528141039|FG000|Step 1|Physician Decision|5|||
146447492|NCT00098475|528141040|FG001|Step 1|Physician Decision|2|||
146447493|NCT00098475|528141041|FG002|Step 1|Physician Decision|0|||
146447494|NCT00098475|528141042|FG003|Step 1|Physician Decision|0|||
146447495|NCT00098475|528141039|FG000|Step 1|Alternative therapy|31|||
146447496|NCT00098475|528141040|FG001|Step 1|Alternative therapy|43|||
146447497|NCT00098475|528141041|FG002|Step 1|Alternative therapy|1|||
146447498|NCT00098475|528141042|FG003|Step 1|Alternative therapy|0|||
146447499|NCT00098475|528141039|FG000|Step 1|Other disease|2|||
146447500|NCT00098475|528141040|FG001|Step 1|Other disease|1|||
146447501|NCT00098475|528141041|FG002|Step 1|Other disease|1|||
146447502|NCT00098475|528141042|FG003|Step 1|Other disease|0|||
146447503|NCT00098475|528141039|FG000|Step 1|Never started treatment|0|||
146447504|NCT00098475|528141040|FG001|Step 1|Never started treatment|2|||
146447505|NCT00098475|528141041|FG002|Step 1|Never started treatment|0|||
146447506|NCT00098475|528141042|FG003|Step 1|Never started treatment|0|||
146447507|NCT00098475|528141039|FG000|Step 1|Still on treatment as of this analysis|14|||
146447508|NCT00098475|528141040|FG001|Step 1|Still on treatment as of this analysis|27|||
145956465|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146285842|NCT01737827|527561153|FG001|Overall Study|Adverse Event|6|||
146285843|NCT01737827|527561154|FG002|Overall Study|Adverse Event|0|||
146285844|NCT01737827|527561152|FG000|Overall Study|Lost to Follow-up|0|||
146447509|NCT00098475|528141041|FG002|Step 1|Still on treatment as of this analysis|0|||
146447510|NCT00098475|528141042|FG003|Step 1|Still on treatment as of this analysis|0|||
146447511|NCT00098475|528141039|FG000|Step 1|Knee surgery|1|||
146447512|NCT00098475|528141040|FG001|Step 1|Knee surgery|0|||
146447513|NCT00098475|528141041|FG002|Step 1|Knee surgery|0|||
146447514|NCT00098475|528141042|FG003|Step 1|Knee surgery|0|||
145956466|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
146285845|NCT01737827|527561153|FG001|Overall Study|Lost to Follow-up|1|||
146447515|NCT00098475|528141039|FG000|Step 1|Complications|1|||
146447516|NCT00098475|528141040|FG001|Step 1|Complications|0|||
146447517|NCT00098475|528141041|FG002|Step 1|Complications|0|||
146447518|NCT00098475|528141042|FG003|Step 1|Complications|0|||
146447519|NCT00098475|528141039|FG000|Step 1|Cannot comply due to other tx|0|||
146447520|NCT00098475|528141040|FG001|Step 1|Cannot comply due to other tx|1|||
146447521|NCT00098475|528141041|FG002|Step 1|Cannot comply due to other tx|0|||
146447522|NCT00098475|528141042|FG003|Step 1|Cannot comply due to other tx|0|||
146447523|NCT00098475|528141039|FG000|Step 1|Both patient and physician's decision|2|||
146447524|NCT00098475|528141040|FG001|Step 1|Both patient and physician's decision|1|||
146447525|NCT00098475|528141041|FG002|Step 1|Both patient and physician's decision|0|||
146447526|NCT00098475|528141042|FG003|Step 1|Both patient and physician's decision|0|||
146447527|NCT00098475|528141039|FG000|Step 1|Incorrect disease assessment|2|||
146447528|NCT00098475|528141040|FG001|Step 1|Incorrect disease assessment|0|||
146447529|NCT00098475|528141041|FG002|Step 1|Incorrect disease assessment|0|||
146447530|NCT00098475|528141042|FG003|Step 1|Incorrect disease assessment|0|||
146447531|NCT00098475|528141039|FG000|Step 1|Off treatment for > specified timeframe|1|||
146447532|NCT00098475|528141040|FG001|Step 1|Off treatment for > specified timeframe|1|||
146447533|NCT00098475|528141041|FG002|Step 1|Off treatment for > specified timeframe|0|||
146447534|NCT00098475|528141042|FG003|Step 1|Off treatment for > specified timeframe|0|||
146447535|NCT00098475|528141039|FG000|Step 1|Declining performance status|0|||
146447536|NCT00098475|528141040|FG001|Step 1|Declining performance status|1|||
146447537|NCT00098475|528141041|FG002|Step 1|Declining performance status|0|||
146447538|NCT00098475|528141042|FG003|Step 1|Declining performance status|0|||
146447539|NCT00098475|528141039|FG000|Step 1|Insurance issue|0|||
146447540|NCT00098475|528141040|FG001|Step 1|Insurance issue|1|||
146447541|NCT00098475|528141041|FG002|Step 1|Insurance issue|0|||
146447542|NCT00098475|528141042|FG003|Step 1|Insurance issue|0|||
146447543|NCT00098475|528141039|FG000|Step 1|Rising paraprotein|0|||
146447544|NCT00098475|528141040|FG001|Step 1|Rising paraprotein|1|||
146447545|NCT00098475|528141041|FG002|Step 1|Rising paraprotein|0|||
146447546|NCT00098475|528141042|FG003|Step 1|Rising paraprotein|0|||
146447547|NCT00098475|528141039|FG000|Step 1|Referred to other physicians|0|||
146447548|NCT00098475|528141040|FG001|Step 1|Referred to other physicians|1|||
146447549|NCT00098475|528141041|FG002|Step 1|Referred to other physicians|0|||
146447550|NCT00098475|528141042|FG003|Step 1|Referred to other physicians|0|||
146447551|NCT00098475|528141039|FG000|Step 1|Criteria to continue treatment not met|0|||
146447552|NCT00098475|528141040|FG001|Step 1|Criteria to continue treatment not met|1|||
146447553|NCT00098475|528141041|FG002|Step 1|Criteria to continue treatment not met|0|||
146447554|NCT00098475|528141042|FG003|Step 1|Criteria to continue treatment not met|0|||
146447555|NCT00098475|528141039|FG000|Step 1|Misinterpretation of lab data|0|||
146447556|NCT00098475|528141040|FG001|Step 1|Misinterpretation of lab data|1|||
146447557|NCT00098475|528141041|FG002|Step 1|Misinterpretation of lab data|0|||
146447558|NCT00098475|528141042|FG003|Step 1|Misinterpretation of lab data|0|||
146447559|NCT00098475|528141039|FG000|Step 1|Patient fell with fracture|1|||
146447560|NCT00098475|528141040|FG001|Step 1|Patient fell with fracture|0|||
146447561|NCT00098475|528141041|FG002|Step 1|Patient fell with fracture|0|||
146447562|NCT00098475|528141042|FG003|Step 1|Patient fell with fracture|0|||
146447563|NCT00098475|528141039|FG000|Step 1|Not documented|0|||
146447564|NCT00098475|528141040|FG001|Step 1|Not documented|1|||
146447565|NCT00098475|528141041|FG002|Step 1|Not documented|0|||
146447566|NCT00098475|528141042|FG003|Step 1|Not documented|0|||
146447567|NCT00098475|528141039|FG000|Step 2|Disease progression|1|||
146447568|NCT00098475|528141040|FG001|Step 2|Disease progression|4|||
146447569|NCT00098475|528141041|FG002|Step 2|Disease progression|0|||
146447570|NCT00098475|528141042|FG003|Step 2|Disease progression|0|||
146447571|NCT00098475|528141039|FG000|Step 2|Adverse Event|2|||
146447572|NCT00098475|528141040|FG001|Step 2|Adverse Event|0|||
146447573|NCT00098475|528141041|FG002|Step 2|Adverse Event|0|||
146447574|NCT00098475|528141042|FG003|Step 2|Adverse Event|0|||
146447575|NCT00098475|528141039|FG000|Step 2|Withdrawal by Subject|0|||
146447576|NCT00098475|528141040|FG001|Step 2|Withdrawal by Subject|2|||
146447577|NCT00098475|528141041|FG002|Step 2|Withdrawal by Subject|0|||
146447578|NCT00098475|528141042|FG003|Step 2|Withdrawal by Subject|0|||
146447579|NCT00098475|528141039|FG000|Step 2|Physician Decision|0|||
146447580|NCT00098475|528141040|FG001|Step 2|Physician Decision|1|||
146447581|NCT00098475|528141041|FG002|Step 2|Physician Decision|0|||
146447582|NCT00098475|528141042|FG003|Step 2|Physician Decision|0|||
146447583|NCT00098475|528141039|FG000|Step 2|Alternative therapy|1|||
146447584|NCT00098475|528141040|FG001|Step 2|Alternative therapy|2|||
146447585|NCT00098475|528141041|FG002|Step 2|Alternative therapy|0|||
146447586|NCT00098475|528141042|FG003|Step 2|Alternative therapy|0|||
146447587|NCT00098475|528141039|FG000|Step 2|Never started treatment|1|||
146447588|NCT00098475|528141040|FG001|Step 2|Never started treatment|1|||
146447589|NCT00098475|528141041|FG002|Step 2|Never started treatment|0|||
146447590|NCT00098475|528141042|FG003|Step 2|Never started treatment|0|||
146447591|NCT03892746|528141045|FG000|Overall Study|Withdrawal by Subject|2|||
146447592|NCT03892746|528141046|FG001|Overall Study|Withdrawal by Subject|1|||
146447593|NCT03892746|528141045|FG000|Overall Study|Lost to Follow-up|2|||
146447594|NCT03892746|528141046|FG001|Overall Study|Lost to Follow-up|0|||
146447595|NCT04004000|528141051|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
146447596|NCT06121609|528141052|FG000|Overall Study|Lack of Efficacy|0|||
146447597|NCT06121609|528141053|FG001|Overall Study|Lack of Efficacy|0|||
146447598|NCT06121609|528141054|FG002|Overall Study|Lack of Efficacy|45|||
146447599|NCT02115282|528141055|FG000|Overall Study|Disease progression during treatment|216|||
146447600|NCT02115282|528141056|FG001|Overall Study|Disease progression during treatment|229|||
146447601|NCT02115282|528141055|FG000|Overall Study|Adverse Event|49|||
146447602|NCT02115282|528141056|FG001|Overall Study|Adverse Event|23|||
146447603|NCT02115282|528141055|FG000|Overall Study|Death|1|||
146447604|NCT02115282|528141056|FG001|Overall Study|Death|3|||
146447605|NCT02115282|528141055|FG000|Overall Study|Alternative therapy|1|||
146447606|NCT02115282|528141056|FG001|Overall Study|Alternative therapy|1|||
146447607|NCT02115282|528141055|FG000|Overall Study|Complicating disease|0|||
146447608|NCT02115282|528141056|FG001|Overall Study|Complicating disease|3|||
146447609|NCT02115282|528141055|FG000|Overall Study|Withdrawal by Subject|12|||
146447610|NCT02115282|528141056|FG001|Overall Study|Withdrawal by Subject|10|||
146447611|NCT02115282|528141055|FG000|Overall Study|Symptomatic progression/deterioration|7|||
146447612|NCT02115282|528141056|FG001|Overall Study|Symptomatic progression/deterioration|18|||
146447613|NCT02115282|528141055|FG000|Overall Study|Non-compliance|5|||
146447614|NCT02115282|528141056|FG001|Overall Study|Non-compliance|1|||
146447615|NCT02115282|528141055|FG000|Overall Study|Protocol Violation|2|||
146447616|NCT02115282|528141056|FG001|Overall Study|Protocol Violation|2|||
146447617|NCT02115282|528141055|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
146447618|NCT02115282|528141056|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
146447619|NCT02115282|528141055|FG000|Overall Study|Not start protocol therapy|9|||
146447620|NCT02115282|528141056|FG001|Overall Study|Not start protocol therapy|10|||
146447621|NCT06494761|528141057|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
146447622|NCT06494761|528141057|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
146447623|NCT03422068|528141058|FG000|Overall Study|Adverse Event|0|||
145956467|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
145956468|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145956469|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145956470|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145956471|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
145956472|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145956473|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145956474|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145956475|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
145956476|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145956477|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145956478|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145956479|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
145956480|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145956481|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145956482|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145956483|NCT03538691|526352544|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
145956484|NCT03538691|526352545|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
145956485|NCT03538691|526352546|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
146285846|NCT01737827|527561154|FG002|Overall Study|Lost to Follow-up|0|||
146447624|NCT03422068|528141059|FG001|Overall Study|Adverse Event|1|||
146447625|NCT03422068|528141058|FG000|Overall Study|Inconvenience to frequent study visits|0|||
146447626|NCT03422068|528141059|FG001|Overall Study|Inconvenience to frequent study visits|1|||
146447627|NCT06393127|528141061|FG000|Washout period|Withdrawal by Subject|1|||
146447628|NCT06393127|528141062|FG001|Washout period|Withdrawal by Subject|0|||
146447629|NCT06393127|528141061|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
146285847|NCT01737827|527561152|FG000|Overall Study|Physician Decision|0|||
146447630|NCT06393127|528141062|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
146447631|NCT02446600|528141063|FG000|Overall Study|Never treated|20|||
146447632|NCT02446600|528141064|FG001|Overall Study|Never treated|2|||
146447633|NCT02446600|528141065|FG002|Overall Study|Never treated|6|||
146447634|NCT02446600|528141066|FG003|Overall Study|Never treated|0|||
146447635|NCT02446600|528141063|FG000|Overall Study|Withdrawal by Subject|19|||
146447636|NCT02446600|528141064|FG001|Overall Study|Withdrawal by Subject|5|||
146447637|NCT02446600|528141065|FG002|Overall Study|Withdrawal by Subject|17|||
146447638|NCT02446600|528141066|FG003|Overall Study|Withdrawal by Subject|0|||
146447639|NCT02446600|528141063|FG000|Overall Study|Ineligible|1|||
146447640|NCT02446600|528141064|FG001|Overall Study|Ineligible|4|||
146447641|NCT02446600|528141065|FG002|Overall Study|Ineligible|4|||
146447642|NCT02446600|528141066|FG003|Overall Study|Ineligible|1|||
146447643|NCT02446600|528141063|FG000|Overall Study|Duplicate Enrollment|0|||
146447644|NCT02446600|528141064|FG001|Overall Study|Duplicate Enrollment|1|||
146447645|NCT02446600|528141065|FG002|Overall Study|Duplicate Enrollment|0|||
146447646|NCT02446600|528141066|FG003|Overall Study|Duplicate Enrollment|0|||
146447647|NCT04865289|528141067|FG000|Overall Study|Death|34|||
146447648|NCT04865289|528141068|FG001|Overall Study|Death|25|||
146447649|NCT04865289|528141067|FG000|Overall Study|Physician Decision|27|||
146447650|NCT04865289|528141068|FG001|Overall Study|Physician Decision|27|||
145956486|NCT03538691|526352547|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
145956487|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145956488|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
145956489|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145956490|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145956491|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145956492|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
145956493|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145956494|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145956495|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145956496|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
145956497|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145956498|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145956499|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
146447651|NCT04865289|528141067|FG000|Overall Study|Sponsor Decision|11|||
146447652|NCT04865289|528141068|FG001|Overall Study|Sponsor Decision|1|||
146447653|NCT04865289|528141067|FG000|Overall Study|Withdrawal by Subject|2|||
146447654|NCT04865289|528141068|FG001|Overall Study|Withdrawal by Subject|3|||
146447655|NCT02466971|528141069|FG000|Overall Study|eligible and never treated|14|||
146447656|NCT02466971|528141070|FG001|Overall Study|eligible and never treated|20|||
146447657|NCT02466971|528141069|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
146447658|NCT02466971|528141070|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
146447659|NCT02466971|528141069|FG000|Overall Study|ineligible and treated|1|||
146447660|NCT02466971|528141070|FG001|Overall Study|ineligible and treated|0|||
146447661|NCT02466971|528141069|FG000|Overall Study|ineligible and never treated|0|||
146447662|NCT02466971|528141070|FG001|Overall Study|ineligible and never treated|1|||
146447663|NCT06128525|528141078|FG000|Overall Study|Patient withdrew consent|1|||
146447664|NCT03210714|528141079|FG000|Overall Study|Adverse Event|6|||
146447665|NCT03210714|528141079|FG000|Overall Study|Physician Decision|1|||
146447666|NCT03210714|528141079|FG000|Overall Study|Progressive disease|11|||
146447667|NCT03210714|528141079|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
146447668|NCT02867592|528141080|FG000|Overall Study|Adverse Event|3|||
146447669|NCT02867592|528141081|FG001|Overall Study|Adverse Event|0|||
146447670|NCT02867592|528141082|FG002|Overall Study|Adverse Event|2|||
146447671|NCT02867592|528141083|FG003|Overall Study|Adverse Event|1|||
146447672|NCT02867592|528141084|FG004|Overall Study|Adverse Event|1|||
146447673|NCT02867592|528141085|FG005|Overall Study|Adverse Event|5|||
146447674|NCT02867592|528141080|FG000|Overall Study|Death|0|||
146447675|NCT02867592|528141081|FG001|Overall Study|Death|0|||
146447676|NCT02867592|528141082|FG002|Overall Study|Death|0|||
146447677|NCT02867592|528141083|FG003|Overall Study|Death|1|||
145956500|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
146209651|NCT03398148|527282131|FG001|Substudy 1 Period 1|Adverse Event|2|||
146447678|NCT02867592|528141084|FG004|Overall Study|Death|0|||
146447679|NCT02867592|528141085|FG005|Overall Study|Death|1|||
146447680|NCT02867592|528141080|FG000|Overall Study|Lack of Efficacy|8|||
146447681|NCT02867592|528141081|FG001|Overall Study|Lack of Efficacy|10|||
146209652|NCT03398148|527282132|FG002|Substudy 1 Period 1|Adverse Event|2|||
146447682|NCT02867592|528141082|FG002|Overall Study|Lack of Efficacy|8|||
146447683|NCT02867592|528141083|FG003|Overall Study|Lack of Efficacy|8|||
146447684|NCT02867592|528141084|FG004|Overall Study|Lack of Efficacy|12|||
146447685|NCT02867592|528141085|FG005|Overall Study|Lack of Efficacy|17|||
146447686|NCT02867592|528141080|FG000|Overall Study|Physician Decision|1|||
146447687|NCT02867592|528141081|FG001|Overall Study|Physician Decision|2|||
146447688|NCT02867592|528141082|FG002|Overall Study|Physician Decision|2|||
145956501|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
145956502|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
146447689|NCT02867592|528141083|FG003|Overall Study|Physician Decision|0|||
146447690|NCT02867592|528141084|FG004|Overall Study|Physician Decision|5|||
146447691|NCT02867592|528141085|FG005|Overall Study|Physician Decision|1|||
146447692|NCT02867592|528141080|FG000|Overall Study|Protocol Violation|0|||
146447693|NCT02867592|528141081|FG001|Overall Study|Protocol Violation|0|||
146447694|NCT02867592|528141082|FG002|Overall Study|Protocol Violation|0|||
146447695|NCT02867592|528141083|FG003|Overall Study|Protocol Violation|0|||
146447696|NCT02867592|528141084|FG004|Overall Study|Protocol Violation|1|||
146447697|NCT02867592|528141085|FG005|Overall Study|Protocol Violation|1|||
146447698|NCT02867592|528141080|FG000|Overall Study|Withdrawal by Subject|0|||
146447699|NCT02867592|528141081|FG001|Overall Study|Withdrawal by Subject|1|||
146447700|NCT02867592|528141082|FG002|Overall Study|Withdrawal by Subject|0|||
146447701|NCT02867592|528141083|FG003|Overall Study|Withdrawal by Subject|1|||
146447702|NCT02867592|528141084|FG004|Overall Study|Withdrawal by Subject|3|||
146447703|NCT02867592|528141085|FG005|Overall Study|Withdrawal by Subject|3|||
146447704|NCT02867592|528141080|FG000|Overall Study|Ineligible|1|||
146447705|NCT02867592|528141081|FG001|Overall Study|Ineligible|1|||
146447706|NCT02867592|528141082|FG002|Overall Study|Ineligible|0|||
146447707|NCT02867592|528141083|FG003|Overall Study|Ineligible|0|||
146447708|NCT02867592|528141084|FG004|Overall Study|Ineligible|2|||
146447709|NCT02867592|528141085|FG005|Overall Study|Ineligible|0|||
146447710|NCT02867592|528141080|FG000|Overall Study|No Treatment|1|||
146447711|NCT02867592|528141081|FG001|Overall Study|No Treatment|0|||
146447712|NCT02867592|528141082|FG002|Overall Study|No Treatment|0|||
146447713|NCT02867592|528141083|FG003|Overall Study|No Treatment|0|||
146447714|NCT02867592|528141084|FG004|Overall Study|No Treatment|0|||
146447715|NCT02867592|528141085|FG005|Overall Study|No Treatment|0|||
146447716|NCT02867592|528141080|FG000|Overall Study|Still on Therapy|0|||
146447717|NCT02867592|528141081|FG001|Overall Study|Still on Therapy|0|||
146447718|NCT02867592|528141082|FG002|Overall Study|Still on Therapy|0|||
146447719|NCT02867592|528141083|FG003|Overall Study|Still on Therapy|0|||
146447720|NCT02867592|528141084|FG004|Overall Study|Still on Therapy|1|||
146447721|NCT02867592|528141085|FG005|Overall Study|Still on Therapy|0|||
146447722|NCT02867592|528141080|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
146447723|NCT02867592|528141081|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
146447724|NCT02867592|528141082|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
146447725|NCT02867592|528141083|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
146447726|NCT02867592|528141084|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
146447727|NCT02867592|528141085|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
146447728|NCT02867592|528141080|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
146447729|NCT02867592|528141081|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
146447730|NCT02867592|528141082|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
146447731|NCT02867592|528141083|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
146447732|NCT02867592|528141084|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
146447733|NCT02867592|528141085|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
146447734|NCT00803179|528141086|FG000|Overall Study|Lost to Follow-up|3|||
146447735|NCT04158648|528141087|FG000|Overall Study|Ongoing in the Study|69|||
146447736|NCT04158648|528141087|FG000|Overall Study|Withdrawal by Subject|4|||
146447737|NCT04589650|528141088|FG000|Overall Study|Subject decision|6|||
146447738|NCT04589650|528141089|FG001|Overall Study|Subject decision|2|||
146447739|NCT04589650|528141090|FG002|Overall Study|Subject decision|2|||
145956503|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
145956504|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
145956505|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
146209653|NCT03398148|527282133|FG003|Substudy 1 Period 1|Adverse Event|0|||
146209654|NCT03398148|527282134|FG004|Substudy 1 Period 1|Adverse Event|8|||
146447740|NCT04589650|528141091|FG003|Overall Study|Subject decision|0|||
146447741|NCT04589650|528141092|FG004|Overall Study|Subject decision|0|||
146447742|NCT04589650|528141093|FG005|Overall Study|Subject decision|0|||
146447743|NCT04589650|528141088|FG000|Overall Study|Adverse Event|3|||
146447744|NCT04589650|528141089|FG001|Overall Study|Adverse Event|1|||
146447745|NCT04589650|528141090|FG002|Overall Study|Adverse Event|1|||
146447746|NCT04589650|528141091|FG003|Overall Study|Adverse Event|1|||
146447747|NCT04589650|528141092|FG004|Overall Study|Adverse Event|0|||
146447748|NCT04589650|528141093|FG005|Overall Study|Adverse Event|1|||
146447749|NCT04589650|528141088|FG000|Overall Study|Physician Decision|1|||
146447750|NCT04589650|528141089|FG001|Overall Study|Physician Decision|1|||
146209655|NCT03398148|527282135|FG005|Substudy 1 Period 1|Adverse Event|0|||
146209656|NCT03398148|527282136|FG006|Substudy 1 Period 1|Adverse Event|0|||
146447751|NCT04589650|528141090|FG002|Overall Study|Physician Decision|0|||
146447752|NCT04589650|528141091|FG003|Overall Study|Physician Decision|0|||
146447753|NCT04589650|528141092|FG004|Overall Study|Physician Decision|0|||
146447754|NCT04589650|528141093|FG005|Overall Study|Physician Decision|0|||
146447755|NCT04589650|528141088|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146447756|NCT04589650|528141089|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146447757|NCT04589650|528141090|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146447758|NCT04589650|528141091|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146447759|NCT04589650|528141092|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
146447760|NCT04589650|528141093|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
146447761|NCT04589650|528141088|FG000|Overall Study|Death|0|||
146447762|NCT04589650|528141089|FG001|Overall Study|Death|0|||
146447763|NCT04589650|528141090|FG002|Overall Study|Death|0|||
146447764|NCT04589650|528141091|FG003|Overall Study|Death|1|||
146447765|NCT04589650|528141092|FG004|Overall Study|Death|0|||
146447766|NCT04589650|528141093|FG005|Overall Study|Death|0|||
146447767|NCT04589650|528141088|FG000|Overall Study|Guardian Decision|0|||
146447768|NCT04589650|528141089|FG001|Overall Study|Guardian Decision|0|||
146447769|NCT04589650|528141090|FG002|Overall Study|Guardian Decision|0|||
146447770|NCT04589650|528141091|FG003|Overall Study|Guardian Decision|1|||
146447771|NCT04589650|528141092|FG004|Overall Study|Guardian Decision|0|||
146447772|NCT04589650|528141093|FG005|Overall Study|Guardian Decision|0|||
146447773|NCT04935879|528141097|FG000|Overall Study|Adverse Event|2|||
146447774|NCT04935879|528141098|FG001|Overall Study|Adverse Event|1|||
146447775|NCT04935879|528141097|FG000|Overall Study|Lost to Follow-up|1|||
146447776|NCT04935879|528141098|FG001|Overall Study|Lost to Follow-up|1|||
146447777|NCT04935879|528141097|FG000|Overall Study|Pregnancy|2|||
146447778|NCT04935879|528141098|FG001|Overall Study|Pregnancy|3|||
146447779|NCT04935879|528141097|FG000|Overall Study|Withdrawal by Subject|8|||
146447780|NCT04935879|528141098|FG001|Overall Study|Withdrawal by Subject|6|||
146447781|NCT04935879|528141097|FG000|Overall Study|Other|3|||
146447782|NCT04935879|528141098|FG001|Overall Study|Other|3|||
146447783|NCT03566238|528141099|FG000|Overall Study|Adverse Event|0|||
146447784|NCT03566238|528141100|FG001|Overall Study|Adverse Event|0|||
146447785|NCT03566238|528141101|FG002|Overall Study|Adverse Event|1|||
146447786|NCT03566238|528141099|FG000|Overall Study|Lack of Efficacy|5|||
146447787|NCT03566238|528141100|FG001|Overall Study|Lack of Efficacy|4|||
146447788|NCT03566238|528141101|FG002|Overall Study|Lack of Efficacy|2|||
146447789|NCT03566238|528141099|FG000|Overall Study|Other|0|||
146447790|NCT03566238|528141100|FG001|Overall Study|Other|1|||
146447791|NCT03566238|528141101|FG002|Overall Study|Other|0|||
146447792|NCT02101853|528141102|FG000|Block 1 Induction|Adverse Event|11|||
146447793|NCT02101853|528141103|FG001|Block 1 Induction|Adverse Event|0|||
146447794|NCT02101853|528141104|FG002|Block 1 Induction|Adverse Event|0|||
146447795|NCT02101853|528141105|FG003|Block 1 Induction|Adverse Event|0|||
146447796|NCT02101853|528141106|FG004|Block 1 Induction|Adverse Event|0|||
146447797|NCT02101853|528141107|FG005|Block 1 Induction|Adverse Event|0|||
146447798|NCT02101853|528141102|FG000|Block 1 Induction|Death|20|||
146447799|NCT02101853|528141103|FG001|Block 1 Induction|Death|0|||
146447800|NCT02101853|528141104|FG002|Block 1 Induction|Death|0|||
146447801|NCT02101853|528141105|FG003|Block 1 Induction|Death|0|||
146447802|NCT02101853|528141106|FG004|Block 1 Induction|Death|0|||
146447803|NCT02101853|528141107|FG005|Block 1 Induction|Death|0|||
146447804|NCT02101853|528141102|FG000|Block 1 Induction|Lack of Efficacy|6|||
146447805|NCT02101853|528141103|FG001|Block 1 Induction|Lack of Efficacy|0|||
146447806|NCT02101853|528141104|FG002|Block 1 Induction|Lack of Efficacy|0|||
146447807|NCT02101853|528141105|FG003|Block 1 Induction|Lack of Efficacy|0|||
146447808|NCT02101853|528141106|FG004|Block 1 Induction|Lack of Efficacy|0|||
146447809|NCT02101853|528141107|FG005|Block 1 Induction|Lack of Efficacy|0|||
146447810|NCT02101853|528141102|FG000|Block 1 Induction|Physician Decision|61|||
146447811|NCT02101853|528141103|FG001|Block 1 Induction|Physician Decision|0|||
146447812|NCT02101853|528141104|FG002|Block 1 Induction|Physician Decision|0|||
146447813|NCT02101853|528141105|FG003|Block 1 Induction|Physician Decision|0|||
146447814|NCT02101853|528141106|FG004|Block 1 Induction|Physician Decision|0|||
146447815|NCT02101853|528141107|FG005|Block 1 Induction|Physician Decision|0|||
146447816|NCT02101853|528141102|FG000|Block 1 Induction|Protocol Violation|2|||
146447817|NCT02101853|528141103|FG001|Block 1 Induction|Protocol Violation|0|||
146447818|NCT02101853|528141104|FG002|Block 1 Induction|Protocol Violation|0|||
146447819|NCT02101853|528141105|FG003|Block 1 Induction|Protocol Violation|0|||
146447820|NCT02101853|528141106|FG004|Block 1 Induction|Protocol Violation|0|||
146447821|NCT02101853|528141107|FG005|Block 1 Induction|Protocol Violation|0|||
146447822|NCT02101853|528141102|FG000|Block 1 Induction|Withdrawal by Subject|65|||
146447823|NCT02101853|528141103|FG001|Block 1 Induction|Withdrawal by Subject|0|||
146447824|NCT02101853|528141104|FG002|Block 1 Induction|Withdrawal by Subject|0|||
146447825|NCT02101853|528141105|FG003|Block 1 Induction|Withdrawal by Subject|0|||
146447826|NCT02101853|528141106|FG004|Block 1 Induction|Withdrawal by Subject|0|||
146447827|NCT02101853|528141107|FG005|Block 1 Induction|Withdrawal by Subject|0|||
146447828|NCT02101853|528141102|FG000|Block 1 Induction|Ineligible|8|||
146447829|NCT02101853|528141103|FG001|Block 1 Induction|Ineligible|0|||
146447830|NCT02101853|528141104|FG002|Block 1 Induction|Ineligible|0|||
146447831|NCT02101853|528141105|FG003|Block 1 Induction|Ineligible|0|||
146447832|NCT02101853|528141106|FG004|Block 1 Induction|Ineligible|0|||
146447833|NCT02101853|528141107|FG005|Block 1 Induction|Ineligible|0|||
146447834|NCT02101853|528141102|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
146447835|NCT02101853|528141103|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
146447836|NCT02101853|528141104|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
146447837|NCT02101853|528141105|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
146447838|NCT02101853|528141106|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
146447839|NCT02101853|528141107|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
146447840|NCT02101853|528141102|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
146447841|NCT02101853|528141103|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447842|NCT02101853|528141104|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447843|NCT02101853|528141105|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447844|NCT02101853|528141106|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447845|NCT02101853|528141107|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447846|NCT02101853|528141102|FG000|Post Induction Randomization|Adverse Event|0|||
146447847|NCT02101853|528141103|FG001|Post Induction Randomization|Adverse Event|3|||
146447848|NCT02101853|528141104|FG002|Post Induction Randomization|Adverse Event|8|||
146447849|NCT02101853|528141105|FG003|Post Induction Randomization|Adverse Event|4|||
146447850|NCT02101853|528141106|FG004|Post Induction Randomization|Adverse Event|4|||
146447851|NCT02101853|528141107|FG005|Post Induction Randomization|Adverse Event|0|||
146447852|NCT02101853|528141102|FG000|Post Induction Randomization|Death|0|||
146447853|NCT02101853|528141103|FG001|Post Induction Randomization|Death|9|||
146447854|NCT02101853|528141104|FG002|Post Induction Randomization|Death|2|||
146447855|NCT02101853|528141105|FG003|Post Induction Randomization|Death|2|||
146447856|NCT02101853|528141106|FG004|Post Induction Randomization|Death|0|||
146447857|NCT02101853|528141107|FG005|Post Induction Randomization|Death|0|||
146447858|NCT02101853|528141102|FG000|Post Induction Randomization|Lack of Efficacy|0|||
146447859|NCT02101853|528141103|FG001|Post Induction Randomization|Lack of Efficacy|14|||
146447860|NCT02101853|528141104|FG002|Post Induction Randomization|Lack of Efficacy|23|||
146447861|NCT02101853|528141105|FG003|Post Induction Randomization|Lack of Efficacy|18|||
146447862|NCT02101853|528141106|FG004|Post Induction Randomization|Lack of Efficacy|21|||
146447863|NCT02101853|528141107|FG005|Post Induction Randomization|Lack of Efficacy|0|||
146447864|NCT02101853|528141102|FG000|Post Induction Randomization|Physician Decision|0|||
146447865|NCT02101853|528141103|FG001|Post Induction Randomization|Physician Decision|43|||
146447866|NCT02101853|528141104|FG002|Post Induction Randomization|Physician Decision|23|||
146447867|NCT02101853|528141105|FG003|Post Induction Randomization|Physician Decision|14|||
146447868|NCT02101853|528141106|FG004|Post Induction Randomization|Physician Decision|14|||
146447869|NCT02101853|528141107|FG005|Post Induction Randomization|Physician Decision|0|||
146447870|NCT02101853|528141102|FG000|Post Induction Randomization|Protocol Violation|0|||
146447871|NCT02101853|528141103|FG001|Post Induction Randomization|Protocol Violation|3|||
146447872|NCT02101853|528141104|FG002|Post Induction Randomization|Protocol Violation|0|||
146447873|NCT02101853|528141105|FG003|Post Induction Randomization|Protocol Violation|0|||
146447874|NCT02101853|528141106|FG004|Post Induction Randomization|Protocol Violation|0|||
146447875|NCT02101853|528141107|FG005|Post Induction Randomization|Protocol Violation|0|||
146447876|NCT02101853|528141102|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
146447877|NCT02101853|528141103|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
146447878|NCT02101853|528141104|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
146447879|NCT02101853|528141105|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
146447880|NCT02101853|528141106|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
146447881|NCT02101853|528141107|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
146447882|NCT02101853|528141102|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146209657|NCT03398148|527282137|FG007|Substudy 1 Period 1|Adverse Event|0|||
146447883|NCT02101853|528141103|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447884|NCT02101853|528141104|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447885|NCT02101853|528141105|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
146447886|NCT02101853|528141106|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447887|NCT02101853|528141107|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
146447888|NCT02101853|528141102|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
146447889|NCT02101853|528141103|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
146447890|NCT02101853|528141104|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
146447891|NCT02101853|528141105|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
146447892|NCT02101853|528141106|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
146447893|NCT02101853|528141107|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
146447894|NCT02101853|528141102|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
146447895|NCT02101853|528141103|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
146447896|NCT02101853|528141104|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
146447897|NCT02101853|528141105|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
146447898|NCT02101853|528141106|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
146447899|NCT02101853|528141107|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
146447900|NCT02101853|528141102|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
146447901|NCT02101853|528141103|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
146447902|NCT02101853|528141104|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
146447903|NCT02101853|528141105|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
146447904|NCT02101853|528141106|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
146447905|NCT02101853|528141107|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
146447906|NCT02101853|528141102|FG000|Blinatumomab Salvage Therapy|Death|0|||
146447907|NCT02101853|528141103|FG001|Blinatumomab Salvage Therapy|Death|0|||
146447908|NCT02101853|528141104|FG002|Blinatumomab Salvage Therapy|Death|0|||
146447909|NCT02101853|528141105|FG003|Blinatumomab Salvage Therapy|Death|0|||
146447910|NCT02101853|528141106|FG004|Blinatumomab Salvage Therapy|Death|0|||
146447911|NCT02101853|528141107|FG005|Blinatumomab Salvage Therapy|Death|2|||
146447912|NCT02101853|528141102|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
146447913|NCT02101853|528141103|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
146447914|NCT02101853|528141104|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
146447915|NCT02101853|528141105|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
146447916|NCT02101853|528141106|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
146447917|NCT02101853|528141107|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
146447918|NCT02101853|528141102|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
146447919|NCT02101853|528141103|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
146447920|NCT02101853|528141104|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
146447921|NCT02101853|528141105|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
146447922|NCT02101853|528141106|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
146447923|NCT02101853|528141107|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
146447924|NCT02101853|528141102|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
146447925|NCT02101853|528141103|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
146447926|NCT02101853|528141104|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
146447927|NCT02101853|528141105|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
146447928|NCT02101853|528141106|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
146447929|NCT02101853|528141107|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
146447930|NCT02112916|528141108|FG000|Overall Study|Adverse Event|6|||
146447931|NCT02112916|528141109|FG001|Overall Study|Adverse Event|9|||
146447932|NCT02112916|528141110|FG002|Overall Study|Adverse Event|3|||
145956506|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
145956507|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
146209658|NCT03398148|527282138|FG008|Substudy 1 Period 1|Adverse Event|0|||
145956508|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
145956509|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
145956510|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
145956511|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145956512|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
145956513|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145956514|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145956515|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145956516|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
145956517|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145956518|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145956519|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145956520|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
145956521|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145956522|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145956523|NCT03538691|526352544|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145956524|NCT03538691|526352545|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
145956525|NCT03538691|526352546|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145956526|NCT03538691|526352547|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145956527|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
145956528|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
145956529|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
145956530|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
145956531|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
145956532|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
145956533|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
145956534|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
145956535|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
145956536|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
145956537|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
145956538|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
145956539|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
145956540|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
145956541|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
145956542|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
145956543|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
145956544|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
145956545|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
145956546|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
145956547|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145956548|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145956549|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
145956550|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145956551|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
145956552|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
145956553|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
145956554|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
145956555|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
145956556|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
145956557|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
146209659|NCT03398148|527282139|FG009|Substudy 1 Period 1|Adverse Event|0|||
146209660|NCT03398148|527282140|FG010|Substudy 1 Period 1|Adverse Event|0|||
146209661|NCT03398148|527282141|FG011|Substudy 1 Period 1|Adverse Event|0|||
146447933|NCT02112916|528141111|FG003|Overall Study|Adverse Event|2|||
146447934|NCT02112916|528141108|FG000|Overall Study|Death|9|||
146447935|NCT02112916|528141109|FG001|Overall Study|Death|9|||
146447936|NCT02112916|528141110|FG002|Overall Study|Death|3|||
146447937|NCT02112916|528141111|FG003|Overall Study|Death|4|||
146447938|NCT02112916|528141108|FG000|Overall Study|Lost to Follow-up|1|||
146447939|NCT02112916|528141109|FG001|Overall Study|Lost to Follow-up|0|||
146447940|NCT02112916|528141110|FG002|Overall Study|Lost to Follow-up|0|||
146209662|NCT03398148|527282142|FG012|Substudy 1 Period 1|Adverse Event|0|||
146447941|NCT02112916|528141111|FG003|Overall Study|Lost to Follow-up|0|||
146447942|NCT02112916|528141108|FG000|Overall Study|Physician Decision|94|||
146447943|NCT02112916|528141109|FG001|Overall Study|Physician Decision|72|||
146447944|NCT02112916|528141110|FG002|Overall Study|Physician Decision|24|||
146447945|NCT02112916|528141111|FG003|Overall Study|Physician Decision|15|||
146447946|NCT02112916|528141108|FG000|Overall Study|Withdrawal by Subject|5|||
146447947|NCT02112916|528141109|FG001|Overall Study|Withdrawal by Subject|3|||
146447948|NCT02112916|528141110|FG002|Overall Study|Withdrawal by Subject|1|||
145956558|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
146083361|NCT00483756|526824824|FG001|Overall Study|Lack of Efficacy|0|||
146447949|NCT02112916|528141111|FG003|Overall Study|Withdrawal by Subject|1|||
146447950|NCT02112916|528141108|FG000|Overall Study|Ineligible|4|||
146447951|NCT02112916|528141109|FG001|Overall Study|Ineligible|8|||
146447952|NCT02112916|528141110|FG002|Overall Study|Ineligible|3|||
146447953|NCT02112916|528141111|FG003|Overall Study|Ineligible|8|||
146447954|NCT02112916|528141108|FG000|Overall Study|Inevaluable|6|||
146447955|NCT02112916|528141109|FG001|Overall Study|Inevaluable|4|||
146447956|NCT02112916|528141110|FG002|Overall Study|Inevaluable|5|||
146447957|NCT02112916|528141111|FG003|Overall Study|Inevaluable|5|||
146447958|NCT02112916|528141108|FG000|Overall Study|Refusal of further protocol therapy|19|||
146447959|NCT02112916|528141109|FG001|Overall Study|Refusal of further protocol therapy|16|||
146447960|NCT02112916|528141110|FG002|Overall Study|Refusal of further protocol therapy|1|||
146447961|NCT02112916|528141111|FG003|Overall Study|Refusal of further protocol therapy|7|||
146447962|NCT02112916|528141108|FG000|Overall Study|Development of SMN|1|||
146447963|NCT02112916|528141109|FG001|Overall Study|Development of SMN|0|||
146447964|NCT02112916|528141110|FG002|Overall Study|Development of SMN|0|||
146447965|NCT02112916|528141111|FG003|Overall Study|Development of SMN|1|||
146447966|NCT02112916|528141108|FG000|Overall Study|Relapse/Progression|10|||
146447967|NCT02112916|528141109|FG001|Overall Study|Relapse/Progression|18|||
146447968|NCT02112916|528141110|FG002|Overall Study|Relapse/Progression|15|||
146447969|NCT02112916|528141111|FG003|Overall Study|Relapse/Progression|2|||
146447970|NCT02112916|528141108|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
146447971|NCT02112916|528141109|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
146447972|NCT02112916|528141110|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
146447973|NCT02112916|528141111|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
146447974|NCT02112916|528141108|FG000|Overall Study|Still on Therapy|44|||
146447975|NCT02112916|528141109|FG001|Overall Study|Still on Therapy|47|||
146447976|NCT02112916|528141110|FG002|Overall Study|Still on Therapy|3|||
146447977|NCT02112916|528141111|FG003|Overall Study|Still on Therapy|2|||
146447978|NCT02112916|528141108|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
146447979|NCT02112916|528141109|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
146447980|NCT02112916|528141110|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
146447981|NCT02112916|528141111|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
146447982|NCT02112916|528141108|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
146447983|NCT02112916|528141109|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
146447984|NCT02112916|528141110|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
146447985|NCT02112916|528141111|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
146447986|NCT05467540|528141112|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
146447987|NCT05467540|528141112|FG000|3-Month Follow-up|Lost to Follow-up|4|||
146447988|NCT05467540|528141112|FG000|3-Month Follow-up|Death|5|||
146447989|NCT05467540|528141112|FG000|12-Month Follow-up|Lost to Follow-up|6|||
146447990|NCT05467540|528141112|FG000|12-Month Follow-up|Death|8|||
146447991|NCT05467540|528141112|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
146447992|NCT06070610|528141115|FG000|Washout period|Adverse Event|1|||
146447993|NCT06070610|528141115|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
146447994|NCT02485860|528141691|FG000|Overall Study|Lost to Follow-up|4|||
146447995|NCT02485860|528141692|FG001|Overall Study|Lost to Follow-up|1|||
146447996|NCT02485860|528141691|FG000|Overall Study|Physician Decision|1|||
146447997|NCT02485860|528141692|FG001|Overall Study|Physician Decision|2|||
146447998|NCT02485860|528141691|FG000|Overall Study|Health context (COVID-19)|1|||
146447999|NCT02485860|528141692|FG001|Overall Study|Health context (COVID-19)|0|||
146448000|NCT04490057|528141697|FG000|Stage 1|Death|1|||
146448001|NCT04490057|528141698|FG001|Stage 1|Death|2|||
146448002|NCT04490057|528141699|FG002|Stage 1|Death|0|||
146448003|NCT04490057|528141700|FG003|Stage 1|Death|0|||
146448004|NCT04490057|528141701|FG004|Stage 1|Death|0|||
146448005|NCT04490057|528141702|FG005|Stage 1|Death|0|||
146448006|NCT04490057|528141703|FG006|Stage 1|Death|0|||
146448007|NCT04490057|528141704|FG007|Stage 1|Death|0|||
146448008|NCT04490057|528141697|FG000|Stage 1|Withdrawal by Subject|2|||
146448009|NCT04490057|528141698|FG001|Stage 1|Withdrawal by Subject|0|||
146448010|NCT04490057|528141699|FG002|Stage 1|Withdrawal by Subject|0|||
146448011|NCT04490057|528141700|FG003|Stage 1|Withdrawal by Subject|0|||
146448012|NCT04490057|528141701|FG004|Stage 1|Withdrawal by Subject|0|||
146448013|NCT04490057|528141702|FG005|Stage 1|Withdrawal by Subject|0|||
146448014|NCT04490057|528141703|FG006|Stage 1|Withdrawal by Subject|0|||
146448015|NCT04490057|528141704|FG007|Stage 1|Withdrawal by Subject|0|||
146448016|NCT04490057|528141697|FG000|Stage 2|Death|0|||
146448017|NCT04490057|528141698|FG001|Stage 2|Death|0|||
146448018|NCT04490057|528141699|FG002|Stage 2|Death|0|||
146448019|NCT04490057|528141700|FG003|Stage 2|Death|0|||
146448020|NCT04490057|528141701|FG004|Stage 2|Death|1|||
146448021|NCT04490057|528141702|FG005|Stage 2|Death|0|||
146448022|NCT04490057|528141703|FG006|Stage 2|Death|0|||
146448023|NCT04490057|528141704|FG007|Stage 2|Death|0|||
146448024|NCT04490057|528141697|FG000|Stage 2|Lost to Follow-up|0|||
146448025|NCT04490057|528141698|FG001|Stage 2|Lost to Follow-up|0|||
146448026|NCT04490057|528141699|FG002|Stage 2|Lost to Follow-up|0|||
146448027|NCT04490057|528141700|FG003|Stage 2|Lost to Follow-up|11|||
146448028|NCT04490057|528141701|FG004|Stage 2|Lost to Follow-up|17|||
146448029|NCT04490057|528141702|FG005|Stage 2|Lost to Follow-up|4|||
146448030|NCT04490057|528141703|FG006|Stage 2|Lost to Follow-up|21|||
146448031|NCT04490057|528141704|FG007|Stage 2|Lost to Follow-up|14|||
146448032|NCT02839707|528141708|FG000|Phase I|Not eligible for analysis|9|||
146448033|NCT02839707|528141709|FG001|Phase I|Not eligible for analysis|0|||
146448034|NCT02839707|528141710|FG002|Phase I|Not eligible for analysis|0|||
146448035|NCT02839707|528141708|FG000|Phase II|Not treated according to protocol|4|||
146448036|NCT02839707|528141709|FG001|Phase II|Not treated according to protocol|0|||
146448037|NCT02839707|528141710|FG002|Phase II|Not treated according to protocol|2|||
146448038|NCT02839707|528141708|FG000|Phase III|Not treated according to protocol|0|||
146448039|NCT02839707|528141709|FG001|Phase III|Not treated according to protocol|0|||
146448040|NCT02839707|528141710|FG002|Phase III|Not treated according to protocol|4|||
146448041|NCT02890355|528141711|FG000|Overall Study|Adverse Event|5|||
146448042|NCT02890355|528141712|FG001|Overall Study|Adverse Event|5|||
146448043|NCT02890355|528141711|FG000|Overall Study|Refusal unrelated to adverse event|5|||
146448044|NCT02890355|528141712|FG001|Overall Study|Refusal unrelated to adverse event|10|||
146448045|NCT02890355|528141711|FG000|Overall Study|Progression/relapse|46|||
146448046|NCT02890355|528141712|FG001|Overall Study|Progression/relapse|39|||
146448047|NCT02890355|528141711|FG000|Overall Study|Not protocol specified|3|||
146448048|NCT02890355|528141712|FG001|Overall Study|Not protocol specified|4|||
146448049|NCT04584983|528141713|FG000|Overall Study|Parental request for withdraw|2|||
146448050|NCT04584983|528141714|FG001|Overall Study|Parental request for withdraw|0|||
146448051|NCT05377489|528141715|FG000|Overall Study|Withdrawal by Subject|122|||
146448052|NCT05377489|528141715|FG000|Overall Study|Lost to Follow-up|21|||
146448053|NCT05377489|528141715|FG000|Overall Study|Lack of Efficacy|10|||
145956559|NCT03538691|526352544|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145956560|NCT03538691|526352545|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145956561|NCT03538691|526352546|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
145956562|NCT03538691|526352547|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
145956563|NCT01243177|526352550|FG000|Overall Study|Lack of Efficacy|47|||
145956564|NCT01243177|526352551|FG001|Overall Study|Lack of Efficacy|31|||
145956565|NCT01243177|526352550|FG000|Overall Study|Protocol Violation|11|||
145956566|NCT01243177|526352551|FG001|Overall Study|Protocol Violation|10|||
145956567|NCT01243177|526352550|FG000|Overall Study|Lost to Follow-up|15|||
145956568|NCT01243177|526352551|FG001|Overall Study|Lost to Follow-up|18|||
145956569|NCT01243177|526352550|FG000|Overall Study|Withdrawal by Subject|46|||
145956570|NCT01243177|526352551|FG001|Overall Study|Withdrawal by Subject|38|||
145956571|NCT01243177|526352550|FG000|Overall Study|AE, serious fatal|0|||
145956572|NCT01243177|526352551|FG001|Overall Study|AE, serious fatal|1|||
146448054|NCT05377489|528141715|FG000|Overall Study|Adverse Event|5|||
146448055|NCT05377489|528141715|FG000|Overall Study|Death|4|||
145956573|NCT01243177|526352550|FG000|Overall Study|SAE, non-fatal|7|||
146448056|NCT05377489|528141715|FG000|Overall Study|Physician Decision|3|||
146448057|NCT05377489|528141715|FG000|Overall Study|Protocol Violation|1|||
146448058|NCT05377489|528141715|FG000|Overall Study|Other|9|||
146448059|NCT03586479|528141716|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
146448060|NCT03586479|528141717|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
146448061|NCT03586479|528141718|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
146448062|NCT03586479|528141716|FG000|Overall Study|Protocol Violation|2|||
146448063|NCT03586479|528141717|FG001|Overall Study|Protocol Violation|0|||
146448064|NCT03586479|528141718|FG002|Overall Study|Protocol Violation|0|||
146448065|NCT03586479|528141716|FG000|Overall Study|Lost to Follow-up|1|||
146448066|NCT03586479|528141717|FG001|Overall Study|Lost to Follow-up|1|||
146448067|NCT03586479|528141718|FG002|Overall Study|Lost to Follow-up|2|||
146448068|NCT03586479|528141716|FG000|Overall Study|Behavioral Issues|1|||
146448069|NCT03586479|528141717|FG001|Overall Study|Behavioral Issues|0|||
146448070|NCT03586479|528141718|FG002|Overall Study|Behavioral Issues|0|||
146448071|NCT05938920|528141719|FG000|Overall Study|Adverse Event|1|||
146448072|NCT05938920|528141720|FG001|Overall Study|Adverse Event|3|||
146448073|NCT05938920|528141721|FG002|Overall Study|Adverse Event|2|||
146448074|NCT05938920|528141722|FG003|Overall Study|Adverse Event|1|||
146448075|NCT05938920|528141719|FG000|Overall Study|Death|0|||
146448076|NCT05938920|528141720|FG001|Overall Study|Death|1|||
146448077|NCT05938920|528141721|FG002|Overall Study|Death|0|||
146448078|NCT05938920|528141722|FG003|Overall Study|Death|0|||
146448079|NCT05938920|528141719|FG000|Overall Study|Lost to Follow-up|0|||
146448080|NCT05938920|528141720|FG001|Overall Study|Lost to Follow-up|0|||
146448081|NCT05938920|528141721|FG002|Overall Study|Lost to Follow-up|1|||
146448082|NCT05938920|528141722|FG003|Overall Study|Lost to Follow-up|0|||
146448083|NCT05938920|528141719|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
146448084|NCT05938920|528141720|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
146448085|NCT05938920|528141721|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
146448086|NCT05938920|528141722|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
146448087|NCT05938920|528141719|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
146448088|NCT05938920|528141720|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
146448089|NCT05938920|528141721|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
146448090|NCT05938920|528141722|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
146448091|NCT05938920|528141719|FG000|Overall Study|Participant Refused to Come In|0|||
146448092|NCT05938920|528141720|FG001|Overall Study|Participant Refused to Come In|0|||
146448093|NCT05938920|528141721|FG002|Overall Study|Participant Refused to Come In|1|||
146448094|NCT05938920|528141722|FG003|Overall Study|Participant Refused to Come In|0|||
146448095|NCT02634710|528141723|FG000|Overall Study|Death|4|||
146448096|NCT02180867|528141724|FG000|Overall Study|Adverse Event|3|||
146448097|NCT02180867|528141725|FG001|Overall Study|Adverse Event|4|||
146448098|NCT02180867|528141726|FG002|Overall Study|Adverse Event|1|||
146448099|NCT02180867|528141727|FG003|Overall Study|Adverse Event|5|||
146448100|NCT02180867|528141728|FG004|Overall Study|Adverse Event|0|||
146448101|NCT02180867|528141729|FG005|Overall Study|Adverse Event|0|||
146448102|NCT02180867|528141730|FG006|Overall Study|Adverse Event|0|||
146209663|NCT03398148|527282143|FG013|Substudy 1 Period 1|Adverse Event|0|||
146209664|NCT03398148|527282144|FG014|Substudy 1 Period 1|Adverse Event|0|||
146209665|NCT03398148|527282130|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
146448103|NCT02180867|528141724|FG000|Overall Study|Death|0|||
146448104|NCT02180867|528141725|FG001|Overall Study|Death|0|||
146448105|NCT02180867|528141726|FG002|Overall Study|Death|0|||
146448106|NCT02180867|528141727|FG003|Overall Study|Death|0|||
146448107|NCT02180867|528141728|FG004|Overall Study|Death|1|||
146448108|NCT02180867|528141729|FG005|Overall Study|Death|0|||
146448109|NCT02180867|528141730|FG006|Overall Study|Death|0|||
146448110|NCT02180867|528141724|FG000|Overall Study|Lack of Efficacy|0|||
146448111|NCT02180867|528141725|FG001|Overall Study|Lack of Efficacy|2|||
146209666|NCT03398148|527282131|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
146209667|NCT03398148|527282132|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209668|NCT03398148|527282133|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
146448112|NCT02180867|528141726|FG002|Overall Study|Lack of Efficacy|0|||
146448113|NCT02180867|528141727|FG003|Overall Study|Lack of Efficacy|1|||
146448114|NCT02180867|528141728|FG004|Overall Study|Lack of Efficacy|6|||
146448115|NCT02180867|528141729|FG005|Overall Study|Lack of Efficacy|0|||
146448116|NCT02180867|528141730|FG006|Overall Study|Lack of Efficacy|1|||
146448117|NCT02180867|528141724|FG000|Overall Study|Physician Decision|1|||
146448118|NCT02180867|528141725|FG001|Overall Study|Physician Decision|3|||
146448119|NCT02180867|528141726|FG002|Overall Study|Physician Decision|1|||
146448120|NCT02180867|528141727|FG003|Overall Study|Physician Decision|10|||
146448121|NCT02180867|528141728|FG004|Overall Study|Physician Decision|9|||
146448122|NCT02180867|528141729|FG005|Overall Study|Physician Decision|3|||
146448123|NCT02180867|528141730|FG006|Overall Study|Physician Decision|4|||
146448124|NCT02180867|528141724|FG000|Overall Study|Withdrawal by Subject|0|||
146448125|NCT02180867|528141725|FG001|Overall Study|Withdrawal by Subject|0|||
146448126|NCT02180867|528141726|FG002|Overall Study|Withdrawal by Subject|0|||
146448127|NCT02180867|528141727|FG003|Overall Study|Withdrawal by Subject|1|||
146448128|NCT02180867|528141728|FG004|Overall Study|Withdrawal by Subject|1|||
146448129|NCT02180867|528141729|FG005|Overall Study|Withdrawal by Subject|0|||
146448130|NCT02180867|528141730|FG006|Overall Study|Withdrawal by Subject|0|||
146448131|NCT02180867|528141724|FG000|Overall Study|Ineligible|1|||
146448132|NCT02180867|528141725|FG001|Overall Study|Ineligible|2|||
146448133|NCT02180867|528141726|FG002|Overall Study|Ineligible|0|||
146448134|NCT02180867|528141727|FG003|Overall Study|Ineligible|3|||
146448135|NCT02180867|528141728|FG004|Overall Study|Ineligible|5|||
146448136|NCT02180867|528141729|FG005|Overall Study|Ineligible|0|||
146448137|NCT02180867|528141730|FG006|Overall Study|Ineligible|0|||
146448138|NCT02180867|528141724|FG000|Overall Study|Repeat Eligibility Studies|0|||
146448139|NCT02180867|528141725|FG001|Overall Study|Repeat Eligibility Studies|0|||
146448140|NCT02180867|528141726|FG002|Overall Study|Repeat Eligibility Studies|0|||
146448141|NCT02180867|528141727|FG003|Overall Study|Repeat Eligibility Studies|0|||
146448142|NCT02180867|528141728|FG004|Overall Study|Repeat Eligibility Studies|1|||
146448143|NCT02180867|528141729|FG005|Overall Study|Repeat Eligibility Studies|0|||
146448144|NCT02180867|528141730|FG006|Overall Study|Repeat Eligibility Studies|0|||
146448145|NCT02180867|528141724|FG000|Overall Study|Refusal of further protocol therapy|1|||
146448146|NCT02180867|528141725|FG001|Overall Study|Refusal of further protocol therapy|0|||
146448147|NCT02180867|528141726|FG002|Overall Study|Refusal of further protocol therapy|2|||
146448148|NCT02180867|528141727|FG003|Overall Study|Refusal of further protocol therapy|6|||
146448149|NCT02180867|528141728|FG004|Overall Study|Refusal of further protocol therapy|4|||
146448150|NCT02180867|528141729|FG005|Overall Study|Refusal of further protocol therapy|0|||
146448151|NCT02180867|528141730|FG006|Overall Study|Refusal of further protocol therapy|0|||
146448152|NCT04129450|528141734|FG000|Overall Study|Lost to Follow-up|20|||
146448153|NCT04129450|528141735|FG001|Overall Study|Lost to Follow-up|10|||
146448154|NCT04129450|528141734|FG000|Overall Study|Withdrawal by Subject|9|||
146448155|NCT04129450|528141735|FG001|Overall Study|Withdrawal by Subject|5|||
146448156|NCT04129450|528141734|FG000|Overall Study|Work Family Obligations|2|||
146448157|NCT04129450|528141735|FG001|Overall Study|Work Family Obligations|0|||
146448158|NCT04129450|528141734|FG000|Overall Study|Other|3|||
146448159|NCT04129450|528141735|FG001|Overall Study|Other|0|||
146209669|NCT03398148|527282134|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
146209670|NCT03398148|527282135|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209671|NCT03398148|527282136|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209672|NCT03398148|527282137|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209673|NCT03398148|527282138|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209674|NCT03398148|527282139|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209675|NCT03398148|527282140|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209676|NCT03398148|527282141|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209677|NCT03398148|527282142|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209678|NCT03398148|527282143|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209679|NCT03398148|527282144|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
146209680|NCT03398148|527282130|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
146209681|NCT03398148|527282131|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
146209682|NCT03398148|527282132|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
146209683|NCT03398148|527282133|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
146209684|NCT03398148|527282134|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
146209685|NCT03398148|527282135|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
146209686|NCT03398148|527282136|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
146209687|NCT03398148|527282137|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
146209688|NCT03398148|527282138|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
146209689|NCT03398148|527282139|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
146209690|NCT03398148|527282140|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
146209691|NCT03398148|527282141|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
146209692|NCT03398148|527282142|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
146209693|NCT03398148|527282143|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
146209694|NCT03398148|527282144|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
146209695|NCT03398148|527282130|FG000|Substudy 1 Period 1|Other|0|||
146209696|NCT03398148|527282131|FG001|Substudy 1 Period 1|Other|1|||
146209697|NCT03398148|527282132|FG002|Substudy 1 Period 1|Other|0|||
146209698|NCT03398148|527282133|FG003|Substudy 1 Period 1|Other|0|||
146209699|NCT03398148|527282134|FG004|Substudy 1 Period 1|Other|3|||
146209700|NCT03398148|527282135|FG005|Substudy 1 Period 1|Other|0|||
146209701|NCT03398148|527282136|FG006|Substudy 1 Period 1|Other|0|||
146209702|NCT03398148|527282137|FG007|Substudy 1 Period 1|Other|0|||
146209703|NCT03398148|527282138|FG008|Substudy 1 Period 1|Other|0|||
146209704|NCT03398148|527282139|FG009|Substudy 1 Period 1|Other|0|||
146209705|NCT03398148|527282140|FG010|Substudy 1 Period 1|Other|0|||
146209706|NCT03398148|527282141|FG011|Substudy 1 Period 1|Other|0|||
146209707|NCT03398148|527282142|FG012|Substudy 1 Period 1|Other|0|||
146209708|NCT03398148|527282143|FG013|Substudy 1 Period 1|Other|0|||
146209709|NCT03398148|527282144|FG014|Substudy 1 Period 1|Other|0|||
146209710|NCT03398148|527282130|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209711|NCT03398148|527282131|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209712|NCT03398148|527282132|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
146285848|NCT01737827|527561153|FG001|Overall Study|Physician Decision|2|||
146285849|NCT01737827|527561154|FG002|Overall Study|Physician Decision|0|||
146209713|NCT03398148|527282133|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209714|NCT03398148|527282134|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
146209715|NCT03398148|527282135|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209716|NCT03398148|527282136|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209717|NCT03398148|527282137|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209718|NCT03398148|527282138|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209719|NCT03398148|527282139|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209720|NCT03398148|527282140|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209721|NCT03398148|527282141|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209722|NCT03398148|527282142|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209723|NCT03398148|527282143|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209724|NCT03398148|527282144|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
146209725|NCT03398148|527282130|FG000|Substudy 1 Period 2|Adverse Event|0|||
146209726|NCT03398148|527282131|FG001|Substudy 1 Period 2|Adverse Event|0|||
146209727|NCT03398148|527282132|FG002|Substudy 1 Period 2|Adverse Event|0|||
146209728|NCT03398148|527282133|FG003|Substudy 1 Period 2|Adverse Event|0|||
146209729|NCT03398148|527282134|FG004|Substudy 1 Period 2|Adverse Event|0|||
146209730|NCT03398148|527282135|FG005|Substudy 1 Period 2|Adverse Event|2|||
146209731|NCT03398148|527282136|FG006|Substudy 1 Period 2|Adverse Event|4|||
146209732|NCT03398148|527282137|FG007|Substudy 1 Period 2|Adverse Event|0|||
146209733|NCT03398148|527282138|FG008|Substudy 1 Period 2|Adverse Event|0|||
146209734|NCT03398148|527282139|FG009|Substudy 1 Period 2|Adverse Event|0|||
146209735|NCT03398148|527282140|FG010|Substudy 1 Period 2|Adverse Event|0|||
146209736|NCT03398148|527282141|FG011|Substudy 1 Period 2|Adverse Event|0|||
146209737|NCT03398148|527282142|FG012|Substudy 1 Period 2|Adverse Event|0|||
146209738|NCT03398148|527282143|FG013|Substudy 1 Period 2|Adverse Event|0|||
146209739|NCT03398148|527282144|FG014|Substudy 1 Period 2|Adverse Event|0|||
146209740|NCT03398148|527282130|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209741|NCT03398148|527282131|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209742|NCT03398148|527282132|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209743|NCT03398148|527282133|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209744|NCT03398148|527282134|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209745|NCT03398148|527282135|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209746|NCT03398148|527282136|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
146209747|NCT03398148|527282137|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
146209748|NCT03398148|527282138|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209749|NCT03398148|527282139|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209750|NCT03398148|527282140|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209751|NCT03398148|527282141|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209752|NCT03398148|527282142|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209753|NCT03398148|527282143|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209754|NCT03398148|527282144|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
146209755|NCT03398148|527282130|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
146209756|NCT03398148|527282131|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
146209757|NCT03398148|527282132|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
146209758|NCT03398148|527282133|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
146209759|NCT03398148|527282134|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
146209760|NCT03398148|527282135|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
146209761|NCT03398148|527282136|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
146209762|NCT03398148|527282137|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
146209763|NCT03398148|527282138|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
146209764|NCT03398148|527282139|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
146209765|NCT03398148|527282140|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
146209766|NCT03398148|527282141|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
146209767|NCT03398148|527282142|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
146209768|NCT03398148|527282143|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
146209769|NCT03398148|527282144|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
146209770|NCT03398148|527282130|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209771|NCT03398148|527282131|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209772|NCT03398148|527282132|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209773|NCT03398148|527282133|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209774|NCT03398148|527282134|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209775|NCT03398148|527282135|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146285850|NCT01737827|527561152|FG000|Overall Study|Progressive Disease|5|||
146285851|NCT01737827|527561153|FG001|Overall Study|Progressive Disease|16|||
145956574|NCT01243177|526352551|FG001|Overall Study|SAE, non-fatal|9|||
146209776|NCT03398148|527282136|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
146209777|NCT03398148|527282137|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209778|NCT03398148|527282138|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209779|NCT03398148|527282139|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209780|NCT03398148|527282140|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209781|NCT03398148|527282141|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209782|NCT03398148|527282142|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209783|NCT03398148|527282143|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209784|NCT03398148|527282144|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209785|NCT03398148|527282130|FG000|Substudy 1 Period 2|Other|0|||
146209786|NCT03398148|527282131|FG001|Substudy 1 Period 2|Other|0|||
146209787|NCT03398148|527282132|FG002|Substudy 1 Period 2|Other|0|||
146209788|NCT03398148|527282133|FG003|Substudy 1 Period 2|Other|0|||
146209789|NCT03398148|527282134|FG004|Substudy 1 Period 2|Other|0|||
146209790|NCT03398148|527282135|FG005|Substudy 1 Period 2|Other|0|||
146209791|NCT03398148|527282136|FG006|Substudy 1 Period 2|Other|1|||
146209792|NCT03398148|527282137|FG007|Substudy 1 Period 2|Other|0|||
146209793|NCT03398148|527282138|FG008|Substudy 1 Period 2|Other|0|||
146209794|NCT03398148|527282139|FG009|Substudy 1 Period 2|Other|0|||
146209795|NCT03398148|527282140|FG010|Substudy 1 Period 2|Other|0|||
146209796|NCT03398148|527282141|FG011|Substudy 1 Period 2|Other|0|||
146209797|NCT03398148|527282142|FG012|Substudy 1 Period 2|Other|0|||
146209798|NCT03398148|527282143|FG013|Substudy 1 Period 2|Other|0|||
146209799|NCT03398148|527282144|FG014|Substudy 1 Period 2|Other|0|||
146209800|NCT03398148|527282130|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209801|NCT03398148|527282131|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209802|NCT03398148|527282132|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209803|NCT03398148|527282133|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209804|NCT03398148|527282134|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209805|NCT03398148|527282135|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209806|NCT03398148|527282136|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
146209807|NCT03398148|527282137|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209808|NCT03398148|527282138|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209809|NCT03398148|527282139|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209810|NCT03398148|527282140|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209811|NCT03398148|527282141|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209812|NCT03398148|527282142|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209813|NCT03398148|527282143|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209814|NCT03398148|527282144|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
146209815|NCT03398148|527282130|FG000|Substudy 2 Period 1|Adverse Event|0|||
146209816|NCT03398148|527282131|FG001|Substudy 2 Period 1|Adverse Event|0|||
146209817|NCT03398148|527282132|FG002|Substudy 2 Period 1|Adverse Event|0|||
146209818|NCT03398148|527282133|FG003|Substudy 2 Period 1|Adverse Event|0|||
146209819|NCT03398148|527282134|FG004|Substudy 2 Period 1|Adverse Event|0|||
146209820|NCT03398148|527282135|FG005|Substudy 2 Period 1|Adverse Event|0|||
146209821|NCT03398148|527282136|FG006|Substudy 2 Period 1|Adverse Event|0|||
146209822|NCT03398148|527282137|FG007|Substudy 2 Period 1|Adverse Event|0|||
146209823|NCT03398148|527282138|FG008|Substudy 2 Period 1|Adverse Event|0|||
146209824|NCT03398148|527282139|FG009|Substudy 2 Period 1|Adverse Event|12|||
146209825|NCT03398148|527282140|FG010|Substudy 2 Period 1|Adverse Event|2|||
146209826|NCT03398148|527282141|FG011|Substudy 2 Period 1|Adverse Event|0|||
146209827|NCT03398148|527282142|FG012|Substudy 2 Period 1|Adverse Event|0|||
146209828|NCT03398148|527282143|FG013|Substudy 2 Period 1|Adverse Event|0|||
145956575|NCT01243177|526352550|FG000|Overall Study|AE, non-serious non-fatal|40|||
145956576|NCT01243177|526352551|FG001|Overall Study|AE, non-serious non-fatal|58|||
146209829|NCT03398148|527282144|FG014|Substudy 2 Period 1|Adverse Event|0|||
146209830|NCT03398148|527282130|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145956577|NCT01243177|526352550|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
145956578|NCT01243177|526352551|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
145956579|NCT01243177|526352550|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145956580|NCT01243177|526352551|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
145956581|NCT01243177|526352550|FG000|Overall Study|Other Reason|11|||
145956582|NCT01243177|526352551|FG001|Overall Study|Other Reason|12|||
145956583|NCT05259163|526353996|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
145956584|NCT05259163|526353997|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
145956585|NCT01971567|526354010|FG000|Overall Study|Withdrawal by Subject|3|||
145956586|NCT01971567|526354011|FG001|Overall Study|Withdrawal by Subject|2|||
145956587|NCT01971567|526354010|FG000|Overall Study|Lost to Follow-up|1|||
146209831|NCT03398148|527282131|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209832|NCT03398148|527282132|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209833|NCT03398148|527282133|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209834|NCT03398148|527282134|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145956588|NCT01971567|526354011|FG001|Overall Study|Lost to Follow-up|0|||
145956589|NCT01239394|526354014|FG000|Overall Study|Adverse Event|1|||
145956590|NCT03492437|526354017|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145956591|NCT03492437|526354018|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145956592|NCT02915159|526354019|FG000|Overall Study|Participant no longer meets criteria|2|||
145956593|NCT02915159|526354020|FG001|Overall Study|Participant no longer meets criteria|0|||
145956594|NCT02915159|526354019|FG000|Overall Study|poor/non-compliance|1|||
145956595|NCT02915159|526354020|FG001|Overall Study|poor/non-compliance|0|||
145956596|NCT02915159|526354019|FG000|Overall Study|Participant withdrew consent|5|||
145956597|NCT02915159|526354020|FG001|Overall Study|Participant withdrew consent|1|||
145956598|NCT02915159|526354019|FG000|Overall Study|Request to discontinue treatment|1|||
145956599|NCT02915159|526354020|FG001|Overall Study|Request to discontinue treatment|2|||
146083362|NCT00483756|526824825|FG002|Overall Study|Lack of Efficacy|0|||
146083363|NCT00483756|526824823|FG000|Overall Study|Lost to Follow-up|3|||
146209835|NCT03398148|527282135|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209836|NCT03398148|527282136|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209837|NCT03398148|527282137|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209838|NCT03398148|527282138|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145956600|NCT02915159|526354019|FG000|Overall Study|Adverse Event|2|||
145956601|NCT02915159|526354020|FG001|Overall Study|Adverse Event|2|||
146209839|NCT03398148|527282139|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
145956602|NCT02915159|526354019|FG000|Overall Study|Lack of Efficacy|0|||
146209840|NCT03398148|527282140|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
146209841|NCT03398148|527282141|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209842|NCT03398148|527282142|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209843|NCT03398148|527282143|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209844|NCT03398148|527282144|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
146209845|NCT03398148|527282130|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
146209846|NCT03398148|527282131|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
145956603|NCT02915159|526354020|FG001|Overall Study|Lack of Efficacy|3|||
145956604|NCT04534517|526354021|FG000|Overall Study|Adverse Event|1|||
145956605|NCT04534517|526354021|FG000|Overall Study|Withdrawal by Subject|1|||
145956606|NCT04534517|526354021|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145956607|NCT04534517|526354021|FG000|Overall Study|COVID-19 Related|1|||
146209847|NCT03398148|527282132|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
146209848|NCT03398148|527282133|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
145956608|NCT03872843|526354022|FG000|Overall Study|Lost to Follow-up|5|||
145956609|NCT03872843|526354023|FG001|Overall Study|Lost to Follow-up|7|||
145956610|NCT05133323|526354024|FG000|Overall Study|Lack of Efficacy|0|||
145956611|NCT05133323|526354025|FG001|Overall Study|Lack of Efficacy|0|||
145956612|NCT05133323|526354026|FG002|Overall Study|Lack of Efficacy|1|||
145956613|NCT05133323|526354024|FG000|Overall Study|Withdrawal by Subject|2|||
145956614|NCT05133323|526354025|FG001|Overall Study|Withdrawal by Subject|1|||
145956615|NCT05133323|526354026|FG002|Overall Study|Withdrawal by Subject|0|||
145956616|NCT01714544|526354027|FG000|Overall Study|Lost to Follow-up|1|||
145956617|NCT01714544|526354027|FG000|Overall Study|Physician Decision|1|||
145956618|NCT01714544|526354027|FG000|Overall Study|Withdrawal by Subject|1|||
145956619|NCT02465437|526354037|FG000|Overall Study|Physician Decision|0|||
145956620|NCT02465437|526354038|FG001|Overall Study|Physician Decision|0|||
145956621|NCT02465437|526354039|FG002|Overall Study|Physician Decision|1|||
145956622|NCT02465437|526354040|FG003|Overall Study|Physician Decision|0|||
145956623|NCT02465437|526354037|FG000|Overall Study|Withdrawal by Subject|1|||
145956624|NCT02465437|526354038|FG001|Overall Study|Withdrawal by Subject|0|||
145956625|NCT02465437|526354039|FG002|Overall Study|Withdrawal by Subject|0|||
146209849|NCT03398148|527282134|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
145956626|NCT02465437|526354040|FG003|Overall Study|Withdrawal by Subject|1|||
145956627|NCT02465437|526354037|FG000|Overall Study|Adverse Event|0|||
145956628|NCT02465437|526354038|FG001|Overall Study|Adverse Event|1|||
145956629|NCT02465437|526354039|FG002|Overall Study|Adverse Event|0|||
145956630|NCT02465437|526354040|FG003|Overall Study|Adverse Event|0|||
145956631|NCT00003483|526354041|FG000|Overall Study|Not evaluable|1|||
146285852|NCT01737827|527561154|FG002|Overall Study|Progressive Disease|2|||
145956632|NCT00103662|526354042|FG000|Overall Study|Entered Rescue Procedure|0|||
146083364|NCT00483756|526824824|FG001|Overall Study|Lost to Follow-up|1|||
145956633|NCT00103662|526354043|FG001|Overall Study|Entered Rescue Procedure|7|||
145956634|NCT00103662|526354042|FG000|Overall Study|Death|7|||
145956635|NCT00103662|526354043|FG001|Overall Study|Death|7|||
145956636|NCT00103662|526354042|FG000|Overall Study|Elective Withdrawal|5|||
145956637|NCT00103662|526354043|FG001|Overall Study|Elective Withdrawal|5|||
145956638|NCT00103662|526354042|FG000|Overall Study|Lost to Follow-up|0|||
145956639|NCT00103662|526354043|FG001|Overall Study|Lost to Follow-up|1|||
145956640|NCT00103662|526354042|FG000|Overall Study|Other|6|||
145956641|NCT00103662|526354043|FG001|Overall Study|Other|9|||
145956642|NCT00103662|526354042|FG000|Overall Study|Failed mobilization|0|||
145956643|NCT00103662|526354043|FG001|Overall Study|Failed mobilization|4|||
145956644|NCT00103662|526354042|FG000|Overall Study|Intercurrent illness|1|||
145956645|NCT00103662|526354043|FG001|Overall Study|Intercurrent illness|0|||
145956646|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
146209850|NCT03398148|527282135|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
146209851|NCT03398148|527282136|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
146209852|NCT03398148|527282137|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
146209853|NCT03398148|527282138|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
145956647|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
146209854|NCT03398148|527282139|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
146209855|NCT03398148|527282140|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
146209856|NCT03398148|527282141|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
146209857|NCT03398148|527282142|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
146209858|NCT03398148|527282143|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
146209859|NCT03398148|527282144|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
146209860|NCT03398148|527282130|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209861|NCT03398148|527282131|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145890972|NCT01207440|526107574|FG004|Overall Study|Withdrawal by Subject|2|||
146209862|NCT03398148|527282132|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209863|NCT03398148|527282133|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209864|NCT03398148|527282134|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209865|NCT03398148|527282135|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209866|NCT03398148|527282136|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209867|NCT03398148|527282137|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209868|NCT03398148|527282138|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209869|NCT03398148|527282139|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209870|NCT03398148|527282140|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
146209871|NCT03398148|527282141|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209872|NCT03398148|527282142|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209873|NCT03398148|527282143|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209874|NCT03398148|527282144|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
146209875|NCT03398148|527282130|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209876|NCT03398148|527282131|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209877|NCT03398148|527282132|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209878|NCT03398148|527282133|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209879|NCT03398148|527282134|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209880|NCT03398148|527282135|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146285853|NCT01737827|527561152|FG000|Overall Study|Study Terminated by Sponsor|0|||
146083365|NCT00483756|526824825|FG002|Overall Study|Lost to Follow-up|0|||
146083366|NCT00483756|526824823|FG000|Overall Study|Withdrawal by Subject|5|||
146083367|NCT00483756|526824824|FG001|Overall Study|Withdrawal by Subject|3|||
146083368|NCT00483756|526824825|FG002|Overall Study|Withdrawal by Subject|4|||
146083369|NCT00483756|526824823|FG000|Overall Study|Other|2|||
146083370|NCT00483756|526824824|FG001|Overall Study|Other|4|||
146083371|NCT00483756|526824825|FG002|Overall Study|Other|3|||
146083372|NCT00483756|526824823|FG000|Overall Study|Randomized, Not Treated|1|||
146083373|NCT00483756|526824824|FG001|Overall Study|Randomized, Not Treated|4|||
146083374|NCT00483756|526824825|FG002|Overall Study|Randomized, Not Treated|4|||
146083375|NCT01947855|526824826|FG000|Overall Study|Withdrawal by Subject|1|||
146083376|NCT01947855|526824827|FG001|Overall Study|Withdrawal by Subject|0|||
146083377|NCT01947855|526824828|FG002|Overall Study|Withdrawal by Subject|0|||
146083378|NCT00436501|526824829|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
146083379|NCT00436501|526824830|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
146083380|NCT00436501|526824829|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
146083381|NCT00436501|526824830|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
146083382|NCT00495040|526824831|FG000|Overall Study|Withdrawal by Subject|3|||
146083383|NCT00621621|526824834|FG000|Overall Study|Subjects were exited at EP study|30|||
146083384|NCT00621621|526824835|FG001|Overall Study|Subjects were exited at EP study|0|||
146083385|NCT03011892|526824840|FG000|Double Blind (DB) Period|Adverse Event|0|||
146083386|NCT03011892|526824841|FG001|Double Blind (DB) Period|Adverse Event|1|||
146083387|NCT03011892|526824842|FG002|Double Blind (DB) Period|Adverse Event|1|||
146083388|NCT03011892|526824843|FG003|Double Blind (DB) Period|Adverse Event|0|||
146083389|NCT03011892|526824844|FG004|Double Blind (DB) Period|Adverse Event|0|||
146083390|NCT03011892|526824845|FG005|Double Blind (DB) Period|Adverse Event|0|||
146083391|NCT03011892|526824846|FG006|Double Blind (DB) Period|Adverse Event|0|||
146083392|NCT03011892|526824847|FG007|Double Blind (DB) Period|Adverse Event|0|||
146083393|NCT03011892|526824848|FG008|Double Blind (DB) Period|Adverse Event|0|||
146083394|NCT03011892|526824849|FG009|Double Blind (DB) Period|Adverse Event|0|||
146083395|NCT03011892|526824850|FG010|Double Blind (DB) Period|Adverse Event|0|||
146083396|NCT03011892|526824851|FG011|Double Blind (DB) Period|Adverse Event|0|||
146083397|NCT03011892|526824840|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
146083398|NCT03011892|526824841|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
146083399|NCT03011892|526824842|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
146083400|NCT03011892|526824843|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
146083401|NCT03011892|526824844|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
146083402|NCT03011892|526824845|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
146083403|NCT03011892|526824846|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
146083404|NCT03011892|526824847|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
146083405|NCT03011892|526824848|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
146083406|NCT03011892|526824849|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
146083407|NCT03011892|526824850|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
146083408|NCT03011892|526824851|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
146083409|NCT03011892|526824840|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
146083410|NCT03011892|526824841|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
146083411|NCT03011892|526824842|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
146083412|NCT03011892|526824843|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
146083413|NCT03011892|526824844|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
146083414|NCT03011892|526824845|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
146083415|NCT03011892|526824846|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
146083416|NCT03011892|526824847|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
145956648|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
145956649|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
145956650|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
145956651|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
145956652|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
145956653|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
145956654|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
145956655|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
145956656|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
145956657|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
145956658|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
145956659|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
145956660|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Death|1|||
145956661|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Death|0|||
146083417|NCT03011892|526824848|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
146083418|NCT03011892|526824849|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
146083419|NCT03011892|526824850|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
146209881|NCT03398148|527282136|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209882|NCT03398148|527282137|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146083420|NCT03011892|526824851|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
146083421|NCT03011892|526824840|FG000|Double Blind (DB) Period|Other|1|||
146083422|NCT03011892|526824841|FG001|Double Blind (DB) Period|Other|1|||
146083423|NCT03011892|526824842|FG002|Double Blind (DB) Period|Other|1|||
146083424|NCT03011892|526824843|FG003|Double Blind (DB) Period|Other|0|||
146083425|NCT03011892|526824844|FG004|Double Blind (DB) Period|Other|1|||
146083426|NCT03011892|526824845|FG005|Double Blind (DB) Period|Other|0|||
146083427|NCT03011892|526824846|FG006|Double Blind (DB) Period|Other|0|||
146083428|NCT03011892|526824847|FG007|Double Blind (DB) Period|Other|0|||
146083429|NCT03011892|526824848|FG008|Double Blind (DB) Period|Other|0|||
146083430|NCT03011892|526824849|FG009|Double Blind (DB) Period|Other|0|||
146083431|NCT03011892|526824850|FG010|Double Blind (DB) Period|Other|0|||
146083432|NCT03011892|526824851|FG011|Double Blind (DB) Period|Other|0|||
146083433|NCT03011892|526824840|FG000|Double Blind (DB) Period|Physician Decision|1|||
146083434|NCT03011892|526824841|FG001|Double Blind (DB) Period|Physician Decision|0|||
146083435|NCT03011892|526824842|FG002|Double Blind (DB) Period|Physician Decision|1|||
146083436|NCT03011892|526824843|FG003|Double Blind (DB) Period|Physician Decision|0|||
146083437|NCT03011892|526824844|FG004|Double Blind (DB) Period|Physician Decision|0|||
146083438|NCT03011892|526824845|FG005|Double Blind (DB) Period|Physician Decision|0|||
146083439|NCT03011892|526824846|FG006|Double Blind (DB) Period|Physician Decision|0|||
146083440|NCT03011892|526824847|FG007|Double Blind (DB) Period|Physician Decision|0|||
146083441|NCT03011892|526824848|FG008|Double Blind (DB) Period|Physician Decision|0|||
146083442|NCT03011892|526824849|FG009|Double Blind (DB) Period|Physician Decision|0|||
146083443|NCT03011892|526824850|FG010|Double Blind (DB) Period|Physician Decision|0|||
146083444|NCT03011892|526824851|FG011|Double Blind (DB) Period|Physician Decision|0|||
146083445|NCT03011892|526824840|FG000|Double Blind (DB) Period|Pregnancy|0|||
146083446|NCT03011892|526824841|FG001|Double Blind (DB) Period|Pregnancy|0|||
146083447|NCT03011892|526824842|FG002|Double Blind (DB) Period|Pregnancy|0|||
146083448|NCT03011892|526824843|FG003|Double Blind (DB) Period|Pregnancy|0|||
146083449|NCT03011892|526824844|FG004|Double Blind (DB) Period|Pregnancy|1|||
146083450|NCT03011892|526824845|FG005|Double Blind (DB) Period|Pregnancy|0|||
146083451|NCT03011892|526824846|FG006|Double Blind (DB) Period|Pregnancy|0|||
146083452|NCT03011892|526824847|FG007|Double Blind (DB) Period|Pregnancy|0|||
146083453|NCT03011892|526824848|FG008|Double Blind (DB) Period|Pregnancy|0|||
146083454|NCT03011892|526824849|FG009|Double Blind (DB) Period|Pregnancy|0|||
146083455|NCT03011892|526824850|FG010|Double Blind (DB) Period|Pregnancy|0|||
146083456|NCT03011892|526824851|FG011|Double Blind (DB) Period|Pregnancy|0|||
146083457|NCT03011892|526824840|FG000|Double Blind (DB) Period|Protocol Violation|1|||
146083458|NCT03011892|526824841|FG001|Double Blind (DB) Period|Protocol Violation|0|||
146083459|NCT03011892|526824842|FG002|Double Blind (DB) Period|Protocol Violation|0|||
146083460|NCT03011892|526824843|FG003|Double Blind (DB) Period|Protocol Violation|0|||
146083461|NCT03011892|526824844|FG004|Double Blind (DB) Period|Protocol Violation|0|||
146083462|NCT03011892|526824845|FG005|Double Blind (DB) Period|Protocol Violation|0|||
146209883|NCT03398148|527282138|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209884|NCT03398148|527282139|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209885|NCT03398148|527282140|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
146209886|NCT03398148|527282141|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209887|NCT03398148|527282142|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209888|NCT03398148|527282143|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146209889|NCT03398148|527282144|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
146083463|NCT03011892|526824846|FG006|Double Blind (DB) Period|Protocol Violation|0|||
146083464|NCT03011892|526824847|FG007|Double Blind (DB) Period|Protocol Violation|0|||
146083465|NCT03011892|526824848|FG008|Double Blind (DB) Period|Protocol Violation|0|||
146083466|NCT03011892|526824849|FG009|Double Blind (DB) Period|Protocol Violation|0|||
146083467|NCT03011892|526824850|FG010|Double Blind (DB) Period|Protocol Violation|0|||
146209890|NCT03398148|527282130|FG000|Substudy 2 Period 1|Other|0|||
146209891|NCT03398148|527282131|FG001|Substudy 2 Period 1|Other|0|||
146209892|NCT03398148|527282132|FG002|Substudy 2 Period 1|Other|0|||
146083468|NCT03011892|526824851|FG011|Double Blind (DB) Period|Protocol Violation|0|||
146209893|NCT03398148|527282133|FG003|Substudy 2 Period 1|Other|0|||
146209894|NCT03398148|527282134|FG004|Substudy 2 Period 1|Other|0|||
146209895|NCT03398148|527282135|FG005|Substudy 2 Period 1|Other|0|||
146209896|NCT03398148|527282136|FG006|Substudy 2 Period 1|Other|0|||
146209897|NCT03398148|527282137|FG007|Substudy 2 Period 1|Other|0|||
146209898|NCT03398148|527282138|FG008|Substudy 2 Period 1|Other|0|||
146209899|NCT03398148|527282139|FG009|Substudy 2 Period 1|Other|4|||
146209900|NCT03398148|527282140|FG010|Substudy 2 Period 1|Other|4|||
146209901|NCT03398148|527282141|FG011|Substudy 2 Period 1|Other|0|||
145956662|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
146209902|NCT03398148|527282142|FG012|Substudy 2 Period 1|Other|0|||
146209903|NCT03398148|527282143|FG013|Substudy 2 Period 1|Other|0|||
146209904|NCT03398148|527282144|FG014|Substudy 2 Period 1|Other|0|||
146209905|NCT03398148|527282130|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209906|NCT03398148|527282131|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
146083469|NCT03011892|526824840|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
146083470|NCT03011892|526824841|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
146083471|NCT03011892|526824842|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
146083472|NCT03011892|526824843|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
146083473|NCT03011892|526824844|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
146083474|NCT03011892|526824845|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
146083475|NCT03011892|526824846|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083476|NCT03011892|526824847|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083477|NCT03011892|526824848|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083478|NCT03011892|526824849|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083479|NCT03011892|526824850|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083480|NCT03011892|526824851|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
146083481|NCT03011892|526824840|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
146083482|NCT03011892|526824841|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
146083483|NCT03011892|526824842|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
146083484|NCT03011892|526824843|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
146083485|NCT03011892|526824844|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
146083486|NCT03011892|526824845|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
146083487|NCT03011892|526824846|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
146083488|NCT03011892|526824847|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
146083489|NCT03011892|526824848|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
146083490|NCT03011892|526824849|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
146083491|NCT03011892|526824850|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
146209907|NCT03398148|527282132|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209908|NCT03398148|527282133|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209909|NCT03398148|527282134|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209910|NCT03398148|527282135|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209911|NCT03398148|527282136|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209912|NCT03398148|527282137|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209913|NCT03398148|527282138|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209914|NCT03398148|527282139|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209915|NCT03398148|527282140|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
146209916|NCT03398148|527282141|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209917|NCT03398148|527282142|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209918|NCT03398148|527282143|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209919|NCT03398148|527282144|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
146209920|NCT03398148|527282130|FG000|Substudy 2 Period 2|Adverse Event|0|||
146209921|NCT03398148|527282131|FG001|Substudy 2 Period 2|Adverse Event|0|||
146209922|NCT03398148|527282132|FG002|Substudy 2 Period 2|Adverse Event|0|||
146209923|NCT03398148|527282133|FG003|Substudy 2 Period 2|Adverse Event|0|||
146209924|NCT03398148|527282134|FG004|Substudy 2 Period 2|Adverse Event|0|||
146209925|NCT03398148|527282135|FG005|Substudy 2 Period 2|Adverse Event|0|||
146209926|NCT03398148|527282136|FG006|Substudy 2 Period 2|Adverse Event|0|||
146209927|NCT03398148|527282137|FG007|Substudy 2 Period 2|Adverse Event|0|||
146209928|NCT03398148|527282138|FG008|Substudy 2 Period 2|Adverse Event|0|||
146209929|NCT03398148|527282139|FG009|Substudy 2 Period 2|Adverse Event|0|||
146209930|NCT03398148|527282140|FG010|Substudy 2 Period 2|Adverse Event|0|||
146209931|NCT03398148|527282141|FG011|Substudy 2 Period 2|Adverse Event|0|||
146209932|NCT03398148|527282142|FG012|Substudy 2 Period 2|Adverse Event|0|||
146209933|NCT03398148|527282143|FG013|Substudy 2 Period 2|Adverse Event|1|||
146209934|NCT03398148|527282144|FG014|Substudy 2 Period 2|Adverse Event|3|||
146209935|NCT03398148|527282130|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
146209936|NCT03398148|527282131|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
146209937|NCT03398148|527282132|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
146209938|NCT03398148|527282133|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
146209939|NCT03398148|527282134|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
146209940|NCT03398148|527282135|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
146209941|NCT03398148|527282136|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
146209942|NCT03398148|527282137|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
146209943|NCT03398148|527282138|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
146209944|NCT03398148|527282139|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
146209945|NCT03398148|527282140|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
146209946|NCT03398148|527282141|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
146209947|NCT03398148|527282142|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
146209948|NCT03398148|527282143|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
146209949|NCT03398148|527282144|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
146209950|NCT03398148|527282130|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209951|NCT03398148|527282131|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209952|NCT03398148|527282132|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209953|NCT03398148|527282133|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209954|NCT03398148|527282134|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209955|NCT03398148|527282135|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209956|NCT03398148|527282136|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209957|NCT03398148|527282137|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209958|NCT03398148|527282138|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209959|NCT03398148|527282139|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209960|NCT03398148|527282140|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209961|NCT03398148|527282141|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
146209962|NCT03398148|527282142|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
146209963|NCT03398148|527282143|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
146209964|NCT03398148|527282144|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
146209965|NCT03398148|527282130|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
146209966|NCT03398148|527282131|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
146209967|NCT03398148|527282132|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
146209968|NCT03398148|527282133|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
146209969|NCT03398148|527282134|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
146209970|NCT03398148|527282135|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
146209971|NCT03398148|527282136|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
146209972|NCT03398148|527282137|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
146209973|NCT03398148|527282138|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
146209974|NCT03398148|527282139|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
146209975|NCT03398148|527282140|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
146209976|NCT03398148|527282141|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
146285854|NCT01737827|527561153|FG001|Overall Study|Study Terminated by Sponsor|1|||
146285855|NCT01737827|527561154|FG002|Overall Study|Study Terminated by Sponsor|0|||
146209977|NCT03398148|527282142|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
146209978|NCT03398148|527282143|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
146209979|NCT03398148|527282144|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
146209980|NCT03398148|527282130|FG000|Substudy 2 Period 2|Other|0|||
146209981|NCT03398148|527282131|FG001|Substudy 2 Period 2|Other|0|||
146209982|NCT03398148|527282132|FG002|Substudy 2 Period 2|Other|0|||
146209983|NCT03398148|527282133|FG003|Substudy 2 Period 2|Other|0|||
145956663|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
146285856|NCT01737827|527561152|FG000|Overall Study|Subject/Guardian Decision|0|||
146209984|NCT03398148|527282134|FG004|Substudy 2 Period 2|Other|0|||
146209985|NCT03398148|527282135|FG005|Substudy 2 Period 2|Other|0|||
146209986|NCT03398148|527282136|FG006|Substudy 2 Period 2|Other|0|||
146209987|NCT03398148|527282137|FG007|Substudy 2 Period 2|Other|0|||
145956664|NCT00105989|526354044|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
145956665|NCT00105989|526354045|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
145956666|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
145956667|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
145956668|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
145956669|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
145956670|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
145956671|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
145956672|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
145956673|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
145956674|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
145956675|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
145956676|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
145956677|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
145956678|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
145956679|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
145956680|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Death|0|||
145956681|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Death|0|||
145956682|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
145956683|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
145956684|NCT00105989|526354044|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
145956685|NCT00105989|526354045|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
145956686|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
145956687|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
145956688|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
145956689|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
145956690|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
145956691|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
145956692|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
145956693|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
145956694|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
145956695|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
145956696|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
145956697|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
145956698|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
145956699|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
145956700|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
145956701|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
145956702|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
145956703|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
145956704|NCT00105989|526354044|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
145956705|NCT00105989|526354045|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
145956706|NCT01968811|526354046|FG000|Overall Study|Protocol Violation|4|||
145956707|NCT01968811|526354046|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
145956708|NCT01716663|526354048|FG000|Overall Study|Withdrawn prior to procedure|4|||
145956709|NCT01716663|526354048|FG000|Overall Study|Treated with non-study catheter|2|||
145956710|NCT00872521|526354049|FG000|Completed PAD Induction|Patient choice|0|||
145956711|NCT00872521|526354050|FG001|Completed PAD Induction|Patient choice|1|||
145956712|NCT00872521|526354051|FG002|Completed PAD Induction|Patient choice|0|||
145956713|NCT00872521|526354049|FG000|Completed PAD Induction|Disease progression|0|||
145956714|NCT00872521|526354050|FG001|Completed PAD Induction|Disease progression|2|||
145956715|NCT00872521|526354051|FG002|Completed PAD Induction|Disease progression|0|||
145956716|NCT00872521|526354049|FG000|Completed PAD Induction|Adverse Event|4|||
145956717|NCT00872521|526354050|FG001|Completed PAD Induction|Adverse Event|0|||
145956718|NCT00872521|526354051|FG002|Completed PAD Induction|Adverse Event|0|||
145956719|NCT00872521|526354049|FG000|Completed PAD Induction|Death|1|||
145956720|NCT00872521|526354050|FG001|Completed PAD Induction|Death|1|||
145956721|NCT00872521|526354051|FG002|Completed PAD Induction|Death|0|||
145956722|NCT00872521|526354049|FG000|Primary Endpoint Analysis|Other|1|||
145956723|NCT00872521|526354050|FG001|Primary Endpoint Analysis|Other|2|||
145956724|NCT00872521|526354051|FG002|Primary Endpoint Analysis|Other|0|||
145956725|NCT00872521|526354049|FG000|Primary Endpoint Analysis|Patient choice|0|||
145956726|NCT00872521|526354050|FG001|Primary Endpoint Analysis|Patient choice|1|||
145956727|NCT00872521|526354051|FG002|Primary Endpoint Analysis|Patient choice|0|||
145956728|NCT00872521|526354049|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
145956729|NCT00872521|526354050|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
145956730|NCT00872521|526354051|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
146209988|NCT03398148|527282138|FG008|Substudy 2 Period 2|Other|0|||
146209989|NCT03398148|527282139|FG009|Substudy 2 Period 2|Other|0|||
146209990|NCT03398148|527282140|FG010|Substudy 2 Period 2|Other|0|||
146209991|NCT03398148|527282141|FG011|Substudy 2 Period 2|Other|0|||
146209992|NCT03398148|527282142|FG012|Substudy 2 Period 2|Other|0|||
146209993|NCT03398148|527282143|FG013|Substudy 2 Period 2|Other|1|||
146209994|NCT03398148|527282144|FG014|Substudy 2 Period 2|Other|1|||
146209995|NCT03398148|527282130|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
146209996|NCT03398148|527282131|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
146209997|NCT03398148|527282132|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
146209998|NCT03398148|527282133|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
146285857|NCT01737827|527561153|FG001|Overall Study|Subject/Guardian Decision|2|||
146285858|NCT01737827|527561154|FG002|Overall Study|Subject/Guardian Decision|0|||
146285859|NCT01451827|527561155|FG000|Overall Study|Adverse Event|2|||
146285860|NCT01451827|527561156|FG001|Overall Study|Adverse Event|0|||
146285861|NCT01451827|527561157|FG002|Overall Study|Adverse Event|1|||
146285862|NCT01451827|527561158|FG003|Overall Study|Adverse Event|1|||
146285863|NCT01451827|527561155|FG000|Overall Study|Protocol deviation|1|||
146285864|NCT01451827|527561156|FG001|Overall Study|Protocol deviation|0|||
145956731|NCT00872521|526354049|FG000|Primary Endpoint Analysis|Patient response missing|0|||
145956732|NCT00872521|526354050|FG001|Primary Endpoint Analysis|Patient response missing|0|||
145956733|NCT00872521|526354051|FG002|Primary Endpoint Analysis|Patient response missing|1|||
146285865|NCT01451827|527561157|FG002|Overall Study|Protocol deviation|0|||
146285866|NCT01451827|527561158|FG003|Overall Study|Protocol deviation|0|||
146209999|NCT03398148|527282134|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210000|NCT03398148|527282135|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
145956734|NCT00872521|526354049|FG000|Completed 3-month Follow up|Other|0|||
145956735|NCT00872521|526354050|FG001|Completed 3-month Follow up|Other|2|||
145956736|NCT00872521|526354051|FG002|Completed 3-month Follow up|Other|0|||
145956737|NCT00872521|526354049|FG000|Completed 3-month Follow up|Physician Decision|0|||
145956738|NCT00872521|526354050|FG001|Completed 3-month Follow up|Physician Decision|1|||
145956739|NCT00872521|526354051|FG002|Completed 3-month Follow up|Physician Decision|0|||
145956740|NCT00872521|526354049|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
145956741|NCT00872521|526354050|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
145956742|NCT00872521|526354051|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
145956743|NCT03006562|526354052|FG000|Overall Study|Lost to Follow-up|0|||
145956744|NCT03006562|526354053|FG001|Overall Study|Lost to Follow-up|1|||
145956745|NCT01089127|526354058|FG000|Overall Study|Adverse Event|5|||
145956746|NCT01089127|526354059|FG001|Overall Study|Adverse Event|1|||
145956747|NCT01089127|526354060|FG002|Overall Study|Adverse Event|1|||
145956748|NCT01089127|526354061|FG003|Overall Study|Adverse Event|0|||
145956749|NCT01089127|526354062|FG004|Overall Study|Adverse Event|0|||
145956750|NCT01089127|526354063|FG005|Overall Study|Adverse Event|1|||
146083492|NCT03011892|526824851|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
146083493|NCT03011892|526824840|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
146083494|NCT03011892|526824841|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
146083495|NCT03011892|526824842|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
146083496|NCT03011892|526824843|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
146210001|NCT03398148|527282136|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210002|NCT03398148|527282137|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210003|NCT03398148|527282138|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210004|NCT03398148|527282139|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
145956751|NCT01089127|526354058|FG000|Overall Study|Subject withdrew consent|0|||
145956752|NCT01089127|526354059|FG001|Overall Study|Subject withdrew consent|1|||
145956753|NCT01089127|526354060|FG002|Overall Study|Subject withdrew consent|1|||
145956754|NCT01089127|526354061|FG003|Overall Study|Subject withdrew consent|1|||
145956755|NCT01089127|526354062|FG004|Overall Study|Subject withdrew consent|0|||
145956756|NCT01089127|526354063|FG005|Overall Study|Subject withdrew consent|2|||
145956757|NCT01089127|526354058|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145956758|NCT01089127|526354059|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145956759|NCT01089127|526354060|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145956760|NCT01089127|526354061|FG003|Overall Study|Abnormal test procedure result(s)|0|||
145956761|NCT01089127|526354062|FG004|Overall Study|Abnormal test procedure result(s)|0|||
145956762|NCT01089127|526354063|FG005|Overall Study|Abnormal test procedure result(s)|0|||
145956763|NCT01089127|526354058|FG000|Overall Study|Lost to Follow-up|1|||
145956764|NCT01089127|526354059|FG001|Overall Study|Lost to Follow-up|1|||
145956765|NCT01089127|526354060|FG002|Overall Study|Lost to Follow-up|0|||
145956766|NCT01089127|526354061|FG003|Overall Study|Lost to Follow-up|0|||
145956767|NCT01089127|526354062|FG004|Overall Study|Lost to Follow-up|1|||
145956768|NCT01089127|526354063|FG005|Overall Study|Lost to Follow-up|0|||
145956769|NCT01089127|526354058|FG000|Overall Study|Protocol deviation|0|||
145956770|NCT01089127|526354059|FG001|Overall Study|Protocol deviation|1|||
145956771|NCT01089127|526354060|FG002|Overall Study|Protocol deviation|0|||
145956772|NCT01089127|526354061|FG003|Overall Study|Protocol deviation|0|||
145956773|NCT01089127|526354062|FG004|Overall Study|Protocol deviation|1|||
145956774|NCT01089127|526354063|FG005|Overall Study|Protocol deviation|0|||
145956775|NCT00511810|526354067|FG000|Overall Study|Lost to Follow-up|1|||
145956776|NCT00511810|526354068|FG001|Overall Study|Lost to Follow-up|2|||
145956777|NCT00511810|526354067|FG000|Overall Study|Lack of Efficacy|0|||
145956778|NCT00511810|526354068|FG001|Overall Study|Lack of Efficacy|2|||
145956779|NCT00511810|526354067|FG000|Overall Study|Refused second scn|0|||
145956780|NCT00511810|526354068|FG001|Overall Study|Refused second scn|1|||
145956781|NCT02427841|526354069|FG000|Overall Study|Lack of Efficacy|5|||
146210005|NCT03398148|527282140|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210006|NCT03398148|527282141|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210007|NCT03398148|527282142|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
146210008|NCT03398148|527282143|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
146210009|NCT03398148|527282144|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
146210010|NCT04201834|527282145|FG000|Overall Study|Screen fail|1|||
146210011|NCT00212355|527282146|FG000|Overall Study|Adverse Event|1|||
146210012|NCT00212355|527282146|FG000|Overall Study|Withdrawal by Subject|1|||
146210013|NCT00212355|527282146|FG000|Overall Study|A change of address|1|||
146210014|NCT04104321|527282152|FG000|Overall Study|didn't take the study drug|3|||
146210015|NCT03012841|527282153|FG000|Overall Study|Protocol Violation|0|||
145956782|NCT02427841|526354069|FG000|Overall Study|Physician Decision|2|||
146210016|NCT03012841|527282154|FG001|Overall Study|Protocol Violation|10|||
146285867|NCT01451827|527561155|FG000|Overall Study|Lost to Follow-up|0|||
146285868|NCT01451827|527561156|FG001|Overall Study|Lost to Follow-up|3|||
145956783|NCT02427841|526354069|FG000|Overall Study|Withdrawal by Subject|1|||
146285869|NCT01451827|527561157|FG002|Overall Study|Lost to Follow-up|0|||
146285870|NCT01451827|527561158|FG003|Overall Study|Lost to Follow-up|2|||
146285871|NCT01451827|527561155|FG000|Overall Study|Participant met withdrawal criteria|0|||
146285872|NCT01451827|527561156|FG001|Overall Study|Participant met withdrawal criteria|2|||
146210017|NCT03012841|527282153|FG000|Overall Study|Lost to Follow-up|6|||
145956784|NCT02592447|526354072|FG000|Overall Study|Lost to Follow-up|1|||
146210018|NCT03012841|527282154|FG001|Overall Study|Lost to Follow-up|1|||
146210019|NCT03012841|527282153|FG000|Overall Study|Withdrawal by Subject|6|||
146210020|NCT03012841|527282154|FG001|Overall Study|Withdrawal by Subject|0|||
146210021|NCT03012841|527282153|FG000|Overall Study|Unable to complete 12 month visit|6|||
146210022|NCT03012841|527282154|FG001|Overall Study|Unable to complete 12 month visit|0|||
146210023|NCT03012841|527282153|FG000|Overall Study|Subject relocation|1|||
146210024|NCT03012841|527282154|FG001|Overall Study|Subject relocation|0|||
146210025|NCT03012841|527282153|FG000|Overall Study|Seasonal winter travel|1|||
146210026|NCT03012841|527282154|FG001|Overall Study|Seasonal winter travel|0|||
146210027|NCT03012841|527282153|FG000|Overall Study|Physician Decision|0|||
146210028|NCT03012841|527282154|FG001|Overall Study|Physician Decision|2|||
145956785|NCT02592447|526354073|FG001|Overall Study|Lost to Follow-up|0|||
146083497|NCT03011892|526824844|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
146083498|NCT03011892|526824845|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
146083499|NCT03011892|526824846|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
146083500|NCT03011892|526824847|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
146210029|NCT03012841|527282153|FG000|Overall Study|No ablation performed|0|||
146083501|NCT03011892|526824848|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
146083502|NCT03011892|526824849|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
146083503|NCT03011892|526824850|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
146083504|NCT03011892|526824851|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
146083505|NCT03011892|526824840|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
146083506|NCT03011892|526824841|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
146083507|NCT03011892|526824842|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
146083508|NCT03011892|526824843|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
146210030|NCT03012841|527282154|FG001|Overall Study|No ablation performed|2|||
146210031|NCT03012841|527282153|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
146210032|NCT03012841|527282154|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
146083509|NCT03011892|526824844|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
146210033|NCT03012841|527282153|FG000|Overall Study|Insurance change|0|||
146210034|NCT03012841|527282154|FG001|Overall Study|Insurance change|1|||
146210035|NCT03954184|527282155|FG000|Overall Study|Lost to Follow-up|500|||
146210036|NCT03954184|527282156|FG001|Overall Study|Lost to Follow-up|0|||
146210037|NCT04038957|527282157|FG000|Overall Study|Withdrawal by Subject|1|||
146210038|NCT04038957|527282157|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
146210039|NCT04065048|527282158|FG000|Overall Study|Withdrawal by Subject|1|||
146083510|NCT03011892|526824845|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
146210040|NCT04065048|527282159|FG001|Overall Study|Withdrawal by Subject|2|||
146210041|NCT04065048|527282160|FG002|Overall Study|Withdrawal by Subject|1|||
146210042|NCT04065048|527282161|FG003|Overall Study|Withdrawal by Subject|1|||
146210043|NCT04065048|527282158|FG000|Overall Study|Adverse Event|1|||
146210044|NCT04065048|527282159|FG001|Overall Study|Adverse Event|0|||
146210045|NCT04065048|527282160|FG002|Overall Study|Adverse Event|1|||
146210046|NCT04065048|527282161|FG003|Overall Study|Adverse Event|0|||
146210047|NCT03397108|527282162|FG000|Overall Study|Lost to Follow-up|15|||
146210048|NCT03397108|527282163|FG001|Overall Study|Lost to Follow-up|0|||
146210049|NCT03397108|527282162|FG000|Overall Study|Insufficient milk production|3|||
146210050|NCT03397108|527282163|FG001|Overall Study|Insufficient milk production|2|||
146210051|NCT03397108|527282162|FG000|Overall Study|Withdrawal by Subject|2|||
146210052|NCT03397108|527282163|FG001|Overall Study|Withdrawal by Subject|0|||
146210053|NCT03554265|527282164|FG000|Overall Study|Withdrawal by Subject|2|||
146210054|NCT03554265|527282165|FG001|Overall Study|Withdrawal by Subject|2|||
146210055|NCT03554265|527282166|FG002|Overall Study|Withdrawal by Subject|3|||
146210056|NCT03554265|527282164|FG000|Overall Study|Physician Decision|0|||
146210057|NCT03554265|527282165|FG001|Overall Study|Physician Decision|0|||
146210058|NCT03554265|527282166|FG002|Overall Study|Physician Decision|1|||
146210059|NCT02652260|527282167|FG000|Base Study|Pregnancy|0|||
146210060|NCT02652260|527282168|FG001|Base Study|Pregnancy|1|||
146210061|NCT02652260|527282167|FG000|Base Study|Withdrawal by Subject|0|||
146210062|NCT02652260|527282168|FG001|Base Study|Withdrawal by Subject|1|||
146210063|NCT02652260|527282167|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
146210064|NCT02652260|527282168|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
146210065|NCT02652260|527282167|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
146210066|NCT02652260|527282168|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
146210067|NCT02652260|527282167|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
146210068|NCT02652260|527282168|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
146210069|NCT02652260|527282167|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
146210070|NCT02652260|527282168|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
146210071|NCT02652260|527282167|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
146210072|NCT02652260|527282168|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
146210073|NCT02652260|527282167|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
146210074|NCT02652260|527282168|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
146210075|NCT02652260|527282167|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
146210076|NCT02652260|527282168|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
146210077|NCT02652260|527282167|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
146210078|NCT02652260|527282168|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
146210079|NCT02652260|527282167|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
146210080|NCT02652260|527282168|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
146210081|NCT02652260|527282167|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
146210082|NCT02652260|527282168|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
146210083|NCT02652260|527282167|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
146210084|NCT02652260|527282168|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
146210085|NCT02652260|527282167|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
146210086|NCT02652260|527282168|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
146210087|NCT05104697|527282169|FG000|Overall Study|Withdrawal by Subject|0|||
146210088|NCT05104697|527282170|FG001|Overall Study|Withdrawal by Subject|1|||
146210089|NCT04468776|527282171|FG000|Overall Study|Lost to Follow-up|4|||
146210090|NCT04468776|527282172|FG001|Overall Study|Lost to Follow-up|3|||
146210091|NCT04468776|527282173|FG002|Overall Study|Lost to Follow-up|4|||
146210092|NCT04468776|527282171|FG000|Overall Study|Withdrawal by Subject|1|||
146210093|NCT04468776|527282172|FG001|Overall Study|Withdrawal by Subject|10|||
146210094|NCT04468776|527282173|FG002|Overall Study|Withdrawal by Subject|4|||
146210095|NCT04468776|527282171|FG000|Overall Study|Physician Decision|0|||
146210096|NCT04468776|527282172|FG001|Overall Study|Physician Decision|1|||
146210097|NCT04468776|527282173|FG002|Overall Study|Physician Decision|1|||
146210098|NCT05687903|527282174|FG000|Overall Study|Protocol Deviation|1|||
146210099|NCT05687903|527282175|FG001|Overall Study|Protocol Deviation|1|||
146210100|NCT05687903|527282176|FG002|Overall Study|Protocol Deviation|0|||
146210101|NCT05687903|527282177|FG003|Overall Study|Protocol Deviation|1|||
146210102|NCT05687903|527282178|FG004|Overall Study|Protocol Deviation|0|||
146210103|NCT05613205|527282179|FG000|Overall Study|Lost to Follow-up|0|||
146210104|NCT05613205|527282180|FG001|Overall Study|Lost to Follow-up|0|||
146083511|NCT03011892|526824846|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
146285873|NCT01451827|527561157|FG002|Overall Study|Participant met withdrawal criteria|0|||
146285874|NCT01451827|527561158|FG003|Overall Study|Participant met withdrawal criteria|0|||
146285875|NCT01451827|527561155|FG000|Overall Study|Withdrawal by Subject|0|||
146285876|NCT01451827|527561156|FG001|Overall Study|Withdrawal by Subject|0|||
146285877|NCT01451827|527561157|FG002|Overall Study|Withdrawal by Subject|1|||
146285878|NCT01451827|527561158|FG003|Overall Study|Withdrawal by Subject|1|||
146285879|NCT01964924|527561159|FG000|Trametinib Monotherapy|Progression|19|||
146285880|NCT01964924|527561160|FG001|Trametinib Monotherapy|Progression|0|||
146285881|NCT01528345|527561161|FG000|Overall Study|Adverse Event|10|||
146285882|NCT01528345|527561162|FG001|Overall Study|Adverse Event|1|||
146285883|NCT01528345|527561161|FG000|Overall Study|Death|1|||
146285884|NCT01528345|527561162|FG001|Overall Study|Death|1|||
146285885|NCT01528345|527561161|FG000|Overall Study|Non-compliance with study treatment|1|||
146285886|NCT01528345|527561162|FG001|Overall Study|Non-compliance with study treatment|0|||
146285887|NCT01528345|527561161|FG000|Overall Study|Progressive Disease|26|||
146285888|NCT01528345|527561162|FG001|Overall Study|Progressive Disease|40|||
146285889|NCT01528345|527561161|FG000|Overall Study|Study Terminated by Sponsor|4|||
146285890|NCT01528345|527561162|FG001|Overall Study|Study Terminated by Sponsor|8|||
146285891|NCT01528345|527561161|FG000|Overall Study|Subject/Guardian Decision|5|||
146285892|NCT01528345|527561162|FG001|Overall Study|Subject/Guardian Decision|0|||
146285893|NCT02424734|527561163|FG000|Overall Study|Treatment stopped to be discharged home|2|||
146285894|NCT02424734|527561164|FG001|Overall Study|Treatment stopped to be discharged home|2|||
146285895|NCT02424734|527561165|FG002|Overall Study|Treatment stopped to be discharged home|0|||
146285896|NCT02150343|527561170|FG000|Overall Study|Adverse Event|2|||
146285897|NCT02150343|527561171|FG001|Overall Study|Adverse Event|0|||
146285898|NCT02150343|527561172|FG002|Overall Study|Adverse Event|1|||
146285899|NCT02150343|527561173|FG003|Overall Study|Adverse Event|1|||
146285900|NCT02150343|527561170|FG000|Overall Study|Withdrawal by Subject|13|||
146285901|NCT02150343|527561171|FG001|Overall Study|Withdrawal by Subject|10|||
146285902|NCT02150343|527561172|FG002|Overall Study|Withdrawal by Subject|9|||
146285903|NCT02150343|527561173|FG003|Overall Study|Withdrawal by Subject|4|||
146285904|NCT02150343|527561170|FG000|Overall Study|Lost to Follow-up|4|||
146285905|NCT02150343|527561171|FG001|Overall Study|Lost to Follow-up|4|||
146285906|NCT02150343|527561172|FG002|Overall Study|Lost to Follow-up|2|||
146285907|NCT02150343|527561173|FG003|Overall Study|Lost to Follow-up|3|||
146285908|NCT02150343|527561170|FG000|Overall Study|Other|2|||
146285909|NCT02150343|527561171|FG001|Overall Study|Other|6|||
146285910|NCT02150343|527561172|FG002|Overall Study|Other|0|||
146285911|NCT02150343|527561173|FG003|Overall Study|Other|2|||
145956786|NCT02592447|526354072|FG000|Overall Study|Ineligible after randomization|1|||
145956787|NCT02592447|526354073|FG001|Overall Study|Ineligible after randomization|0|||
145956788|NCT02592447|526354072|FG000|Overall Study|Withdrawal by Subject|0|||
145956789|NCT02592447|526354073|FG001|Overall Study|Withdrawal by Subject|1|||
145956790|NCT01096160|526354078|FG000|Overall Study|Adverse Event|0|||
145956791|NCT01096160|526354079|FG001|Overall Study|Adverse Event|0|||
145956792|NCT01096160|526354080|FG002|Overall Study|Adverse Event|1|||
145956793|NCT01096160|526354081|FG003|Overall Study|Adverse Event|0|||
145956794|NCT01096160|526354082|FG004|Overall Study|Adverse Event|0|||
145956795|NCT01096160|526354083|FG005|Overall Study|Adverse Event|0|||
145956796|NCT01096160|526354084|FG006|Overall Study|Adverse Event|0|||
145956797|NCT01096160|526354085|FG007|Overall Study|Adverse Event|0|||
145956798|NCT01096160|526354086|FG008|Overall Study|Adverse Event|0|||
145956799|NCT01096160|526354087|FG009|Overall Study|Adverse Event|1|||
145956800|NCT01096160|526354078|FG000|Overall Study|Met stopping criteria per protocol|0|||
145956801|NCT01096160|526354079|FG001|Overall Study|Met stopping criteria per protocol|0|||
145956802|NCT01096160|526354080|FG002|Overall Study|Met stopping criteria per protocol|0|||
145956803|NCT01096160|526354081|FG003|Overall Study|Met stopping criteria per protocol|0|||
145956804|NCT01096160|526354082|FG004|Overall Study|Met stopping criteria per protocol|1|||
145956805|NCT01096160|526354083|FG005|Overall Study|Met stopping criteria per protocol|0|||
145956806|NCT01096160|526354084|FG006|Overall Study|Met stopping criteria per protocol|2|||
145956807|NCT01096160|526354085|FG007|Overall Study|Met stopping criteria per protocol|0|||
145956808|NCT01096160|526354086|FG008|Overall Study|Met stopping criteria per protocol|2|||
145956809|NCT01096160|526354087|FG009|Overall Study|Met stopping criteria per protocol|0|||
145956810|NCT00627497|526354089|FG000|Overall Study|Lost to Follow-up|1|||
145956811|NCT00627497|526354090|FG001|Overall Study|Lost to Follow-up|1|||
145956812|NCT00627497|526354091|FG002|Overall Study|Lost to Follow-up|0|||
145956813|NCT00627497|526354092|FG003|Overall Study|Lost to Follow-up|0|||
145956814|NCT06060496|526354093|FG000|Overall Study|Withdrawal by Subject|2|||
145956815|NCT06060496|526354093|FG000|Overall Study|Lost to Follow-up|2|||
145956816|NCT02028507|526354094|FG000|Overall Study|Progressive Disease|122|||
145956817|NCT02028507|526354095|FG001|Overall Study|Progressive Disease|90|||
145956818|NCT02028507|526354096|FG002|Overall Study|Progressive Disease|102|||
145956819|NCT02028507|526354097|FG003|Overall Study|Progressive Disease|89|||
145956820|NCT02028507|526354094|FG000|Overall Study|Adverse Event|8|||
145956821|NCT02028507|526354095|FG001|Overall Study|Adverse Event|25|||
145956822|NCT02028507|526354096|FG002|Overall Study|Adverse Event|3|||
145956823|NCT02028507|526354097|FG003|Overall Study|Adverse Event|16|||
145956824|NCT02028507|526354094|FG000|Overall Study|Withdrawal by Subject|6|||
145956825|NCT02028507|526354095|FG001|Overall Study|Withdrawal by Subject|8|||
145956826|NCT02028507|526354096|FG002|Overall Study|Withdrawal by Subject|5|||
145956827|NCT02028507|526354097|FG003|Overall Study|Withdrawal by Subject|9|||
145956828|NCT02028507|526354094|FG000|Overall Study|Protocol Violation|2|||
145956829|NCT02028507|526354095|FG001|Overall Study|Protocol Violation|4|||
145956830|NCT02028507|526354096|FG002|Overall Study|Protocol Violation|1|||
145956831|NCT02028507|526354097|FG003|Overall Study|Protocol Violation|3|||
145956832|NCT02028507|526354094|FG000|Overall Study|Physician Decision|0|||
145956833|NCT02028507|526354095|FG001|Overall Study|Physician Decision|4|||
145956834|NCT02028507|526354096|FG002|Overall Study|Physician Decision|0|||
145956835|NCT02028507|526354097|FG003|Overall Study|Physician Decision|0|||
145956836|NCT02028507|526354094|FG000|Overall Study|Death|1|||
145956837|NCT02028507|526354095|FG001|Overall Study|Death|0|||
145956838|NCT02028507|526354096|FG002|Overall Study|Death|1|||
145956839|NCT02028507|526354097|FG003|Overall Study|Death|3|||
145956840|NCT02028507|526354094|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
145956841|NCT02028507|526354095|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
145956842|NCT02028507|526354096|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
145956843|NCT02028507|526354097|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
145956844|NCT02028507|526354094|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
145956845|NCT02028507|526354095|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
145956846|NCT02028507|526354096|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
145956847|NCT02028507|526354097|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
145956848|NCT02028507|526354094|FG000|Overall Study|Randomized But Not Treated|3|||
145956849|NCT02028507|526354095|FG001|Overall Study|Randomized But Not Treated|6|||
145956850|NCT02028507|526354096|FG002|Overall Study|Randomized But Not Treated|0|||
145956851|NCT02028507|526354097|FG003|Overall Study|Randomized But Not Treated|4|||
145956852|NCT02028507|526354094|FG000|Overall Study|Enzyme defect|0|||
145956853|NCT02028507|526354095|FG001|Overall Study|Enzyme defect|0|||
145956854|NCT02028507|526354096|FG002|Overall Study|Enzyme defect|0|||
146083512|NCT03011892|526824847|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
146285912|NCT02729753|527561174|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
146285913|NCT02729753|527561175|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
146285914|NCT01090427|527561176|FG000|After Controlled Period|Death|0|||
145956855|NCT02028507|526354097|FG003|Overall Study|Enzyme defect|1|||
145956856|NCT02028507|526354094|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145956857|NCT02028507|526354095|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145956858|NCT02028507|526354096|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145956859|NCT02028507|526354097|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
145956860|NCT02028507|526354094|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
145956861|NCT02028507|526354095|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
145956862|NCT02028507|526354096|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
145956863|NCT02028507|526354097|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
145956864|NCT02258659|526354098|FG000|Overall Study|Withdrawal by Subject|1|||
145956865|NCT03990051|526354099|FG000|Masked Period|Lost to Follow-up|1|||
145956866|NCT03990051|526354100|FG001|Masked Period|Lost to Follow-up|0|||
145956867|NCT03990051|526354099|FG000|Long Term Period|Death|1|||
145956868|NCT03990051|526354100|FG001|Long Term Period|Death|1|||
145956869|NCT03990051|526354099|FG000|Long Term Period|Lost to Follow-up|7|||
145956870|NCT03990051|526354100|FG001|Long Term Period|Lost to Follow-up|2|||
145956871|NCT00272844|526354101|FG000|Overall Study|Withdrawal by Subject|5|||
145956872|NCT03060291|526354102|FG000|3-month Follow-up|Declined to respond|8|||
145956873|NCT03060291|526354103|FG001|3-month Follow-up|Declined to respond|10|||
145956874|NCT03060291|526354104|FG002|3-month Follow-up|Declined to respond|2|||
145956875|NCT03060291|526354102|FG000|6-month Follow-up|Declined to respond|7|||
145956876|NCT03060291|526354103|FG001|6-month Follow-up|Declined to respond|13|||
145956877|NCT03060291|526354104|FG002|6-month Follow-up|Declined to respond|4|||
145956878|NCT03060291|526354102|FG000|12-month Follow-up|Declined to respond|7|||
145956879|NCT03060291|526354103|FG001|12-month Follow-up|Declined to respond|16|||
145956880|NCT03060291|526354104|FG002|12-month Follow-up|Declined to respond|6|||
146285915|NCT01090427|527561177|FG001|After Controlled Period|Death|0|||
146285916|NCT01090427|527561178|FG002|After Controlled Period|Death|0|||
145956881|NCT00618826|526354105|FG000|Overall Study|Adverse Event|1|||
145956882|NCT01509664|526354107|FG000|Overall Study|Lost to Follow-up|15|||
145956883|NCT01509664|526354108|FG001|Overall Study|Lost to Follow-up|21|||
145956884|NCT01556932|526354111|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
145956885|NCT01556932|526354112|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
145956886|NCT03743025|526354113|FG000|Overall Study|Surgery was cancelled|2|||
145956887|NCT03743025|526354114|FG001|Overall Study|Surgery was cancelled|1|||
145956888|NCT00791700|526354115|FG000|Overall Study|Insufficient clinical response|1|||
145956889|NCT00791700|526354116|FG001|Overall Study|Insufficient clinical response|4|||
146285917|NCT01090427|527561179|FG003|After Controlled Period|Death|0|||
146285918|NCT01090427|527561180|FG004|After Controlled Period|Death|0|||
146285919|NCT01090427|527561181|FG005|After Controlled Period|Death|1|||
146285920|NCT01090427|527561182|FG006|After Controlled Period|Death|0|||
146285921|NCT01090427|527561176|FG000|After Controlled Period|Lack of Efficacy|0|||
146285922|NCT01090427|527561177|FG001|After Controlled Period|Lack of Efficacy|0|||
146285923|NCT01090427|527561178|FG002|After Controlled Period|Lack of Efficacy|0|||
146285924|NCT01090427|527561179|FG003|After Controlled Period|Lack of Efficacy|0|||
146285925|NCT01090427|527561180|FG004|After Controlled Period|Lack of Efficacy|0|||
146285926|NCT01090427|527561181|FG005|After Controlled Period|Lack of Efficacy|3|||
146285927|NCT01090427|527561182|FG006|After Controlled Period|Lack of Efficacy|2|||
146285928|NCT01090427|527561176|FG000|After Controlled Period|Adverse Event|0|||
146285929|NCT01090427|527561177|FG001|After Controlled Period|Adverse Event|0|||
146285930|NCT01090427|527561178|FG002|After Controlled Period|Adverse Event|0|||
146285931|NCT01090427|527561179|FG003|After Controlled Period|Adverse Event|2|||
146285932|NCT01090427|527561180|FG004|After Controlled Period|Adverse Event|0|||
146285933|NCT01090427|527561181|FG005|After Controlled Period|Adverse Event|1|||
146285934|NCT01090427|527561182|FG006|After Controlled Period|Adverse Event|0|||
146285935|NCT01154010|527561183|FG000|Overall Study|Lost to Follow-up|0|||
146285936|NCT01154010|527561184|FG001|Overall Study|Lost to Follow-up|1|||
146285937|NCT00439231|527561185|FG000|Overall Study|Lack of Efficacy|28|||
146285938|NCT02413333|527561191|FG000|Period 1|Adverse Event|1|||
146285939|NCT02413333|527561192|FG001|Period 1|Adverse Event|0|||
146285940|NCT02413333|527561191|FG000|Period 1|Reason Not Specified|0|||
146285941|NCT02413333|527561192|FG001|Period 1|Reason Not Specified|1|||
146285942|NCT02413333|527561191|FG000|Period 2|Protocol Deviation|1|||
146285943|NCT02413333|527561192|FG001|Period 2|Protocol Deviation|0|||
146285944|NCT00709852|527561193|FG000|Period 1|Adverse Event|2|||
146285945|NCT00709852|527561194|FG001|Period 1|Adverse Event|0|||
145956890|NCT00791700|526354117|FG002|Overall Study|Insufficient clinical response|1|||
145956891|NCT00791700|526354118|FG003|Overall Study|Insufficient clinical response|8|||
145956892|NCT00791700|526354115|FG000|Overall Study|No longer willing to participate|1|||
146285946|NCT00709852|527561193|FG000|Period 1|Withdrawal by Subject|4|||
146285947|NCT00709852|527561194|FG001|Period 1|Withdrawal by Subject|2|||
146285948|NCT00709852|527561193|FG000|Period 1|Protocol Violation|1|||
146210105|NCT05613205|527282181|FG002|Overall Study|Lost to Follow-up|1|||
146210106|NCT05613205|527282182|FG003|Overall Study|Lost to Follow-up|1|||
146210107|NCT05613205|527282183|FG004|Overall Study|Lost to Follow-up|0|||
146210108|NCT05613205|527282179|FG000|Overall Study|Withdrawal by Subject|0|||
146210109|NCT05613205|527282180|FG001|Overall Study|Withdrawal by Subject|0|||
146210110|NCT05613205|527282181|FG002|Overall Study|Withdrawal by Subject|1|||
146210111|NCT05613205|527282182|FG003|Overall Study|Withdrawal by Subject|1|||
146210112|NCT05613205|527282183|FG004|Overall Study|Withdrawal by Subject|0|||
146210113|NCT04300231|527282186|FG000|Overall Study|Protocol Violation|4|||
146210114|NCT04300231|527282187|FG001|Overall Study|Protocol Violation|3|||
146210115|NCT04300231|527282188|FG002|Overall Study|Protocol Violation|0|||
146210116|NCT04300231|527282189|FG003|Overall Study|Protocol Violation|2|||
146210117|NCT02015520|527282191|FG000|Overall Study|Lack of Efficacy|1|||
146210118|NCT02015520|527282192|FG001|Overall Study|Lack of Efficacy|0|||
146210119|NCT02015520|527282193|FG002|Overall Study|Lack of Efficacy|3|||
146210120|NCT02015520|527282194|FG003|Overall Study|Lack of Efficacy|2|||
146210121|NCT02015520|527282191|FG000|Overall Study|Adverse Event|0|||
146210122|NCT02015520|527282192|FG001|Overall Study|Adverse Event|0|||
146210123|NCT02015520|527282193|FG002|Overall Study|Adverse Event|0|||
146210124|NCT02015520|527282194|FG003|Overall Study|Adverse Event|1|||
146210125|NCT02015520|527282191|FG000|Overall Study|Withdrawal by Subject|2|||
145956893|NCT00791700|526354116|FG001|Overall Study|No longer willing to participate|1|||
145956894|NCT00791700|526354117|FG002|Overall Study|No longer willing to participate|0|||
145956895|NCT00791700|526354118|FG003|Overall Study|No longer willing to participate|8|||
145956896|NCT00791700|526354115|FG000|Overall Study|Non-compliance with study treatment|0|||
145956897|NCT00791700|526354116|FG001|Overall Study|Non-compliance with study treatment|2|||
145956898|NCT00791700|526354117|FG002|Overall Study|Non-compliance with study treatment|0|||
145956899|NCT00791700|526354118|FG003|Overall Study|Non-compliance with study treatment|4|||
145956900|NCT00791700|526354115|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146083513|NCT03011892|526824848|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
145956901|NCT00791700|526354116|FG001|Overall Study|Withdrawn due to pregnancy|0|||
145956902|NCT00791700|526354117|FG002|Overall Study|Withdrawn due to pregnancy|0|||
145956903|NCT00791700|526354118|FG003|Overall Study|Withdrawn due to pregnancy|1|||
145956904|NCT00791700|526354115|FG000|Overall Study|Other|0|||
145956905|NCT00791700|526354116|FG001|Overall Study|Other|1|||
145956906|NCT00791700|526354117|FG002|Overall Study|Other|0|||
145956907|NCT00791700|526354118|FG003|Overall Study|Other|1|||
145956908|NCT00791700|526354115|FG000|Overall Study|Death|0|||
145956909|NCT00791700|526354116|FG001|Overall Study|Death|0|||
145956910|NCT00791700|526354117|FG002|Overall Study|Death|0|||
145956911|NCT00791700|526354118|FG003|Overall Study|Death|1|||
146210126|NCT02015520|527282192|FG001|Overall Study|Withdrawal by Subject|2|||
146210127|NCT02015520|527282193|FG002|Overall Study|Withdrawal by Subject|1|||
146210128|NCT02015520|527282194|FG003|Overall Study|Withdrawal by Subject|0|||
146210129|NCT02015520|527282191|FG000|Overall Study|Death|1|||
145956912|NCT00791700|526354115|FG000|Overall Study|Lost to Follow-up|4|||
145956913|NCT00791700|526354116|FG001|Overall Study|Lost to Follow-up|3|||
145956914|NCT00791700|526354117|FG002|Overall Study|Lost to Follow-up|4|||
145956915|NCT00791700|526354118|FG003|Overall Study|Lost to Follow-up|6|||
145956916|NCT00791700|526354115|FG000|Overall Study|Adverse Event|0|||
145956917|NCT00791700|526354116|FG001|Overall Study|Adverse Event|0|||
145956918|NCT00791700|526354117|FG002|Overall Study|Adverse Event|1|||
145956919|NCT00791700|526354118|FG003|Overall Study|Adverse Event|1|||
145956920|NCT00991289|526354121|FG000|Overall Study|Adverse Event|1|||
145956921|NCT00991289|526354121|FG000|Overall Study|Physician Decision|2|||
145956922|NCT00991289|526354121|FG000|Overall Study|Withdrawal by Subject|3|||
145956923|NCT00991289|526354121|FG000|Overall Study|Lost to Follow-up|4|||
145956924|NCT00991289|526354121|FG000|Overall Study|Protocol Violation|2|||
145956925|NCT03131687|526354122|FG000|Overall Study|Adverse Event|0|||
145956926|NCT03131687|526354123|FG001|Overall Study|Adverse Event|1|||
145956927|NCT03131687|526354124|FG002|Overall Study|Adverse Event|0|||
146210130|NCT02015520|527282192|FG001|Overall Study|Death|0|||
146210131|NCT02015520|527282193|FG002|Overall Study|Death|0|||
146285949|NCT00709852|527561194|FG001|Period 1|Protocol Violation|0|||
145956928|NCT03131687|526354125|FG003|Overall Study|Adverse Event|1|||
146210132|NCT02015520|527282194|FG003|Overall Study|Death|0|||
146210133|NCT02015520|527282191|FG000|Overall Study|Lost to Follow-up|0|||
145956929|NCT03131687|526354126|FG004|Overall Study|Adverse Event|2|||
145956930|NCT03131687|526354127|FG005|Overall Study|Adverse Event|2|||
145956931|NCT03131687|526354122|FG000|Overall Study|Death|1|||
146210134|NCT02015520|527282192|FG001|Overall Study|Lost to Follow-up|0|||
146210135|NCT02015520|527282193|FG002|Overall Study|Lost to Follow-up|1|||
146210136|NCT02015520|527282194|FG003|Overall Study|Lost to Follow-up|0|||
145956932|NCT03131687|526354123|FG001|Overall Study|Death|0|||
145956933|NCT03131687|526354124|FG002|Overall Study|Death|0|||
146210137|NCT02015520|527282191|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146210138|NCT02015520|527282192|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146210139|NCT02015520|527282193|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
145956934|NCT03131687|526354125|FG003|Overall Study|Death|0|||
145956935|NCT03131687|526354126|FG004|Overall Study|Death|0|||
146210140|NCT02015520|527282194|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
146210141|NCT02015520|527282191|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
146210142|NCT02015520|527282192|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
146210143|NCT02015520|527282193|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
146210144|NCT02015520|527282194|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
146210145|NCT02386553|527282195|FG000|Overall Study|Reason Not Specified|1|||
146210146|NCT02386553|527282196|FG001|Overall Study|Reason Not Specified|1|||
146210147|NCT02386553|527282195|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
146210148|NCT02386553|527282196|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
146210149|NCT02006758|527282201|FG000|Overall Study|Protocol Violation|1|||
146210150|NCT02006758|527282201|FG000|Overall Study|Death|1|||
146210151|NCT02006758|527282201|FG000|Overall Study|Lost to Follow-up|4|||
146210152|NCT02006758|527282201|FG000|Overall Study|Withdrawal by Subject|4|||
146210153|NCT02006758|527282201|FG000|Overall Study|Procedurally excluded|1|||
146210154|NCT02006758|527282201|FG000|Overall Study|Other|2|||
146210155|NCT01619410|527282202|FG000|Overall Study|Lost to Follow-up|7|||
146210156|NCT01619410|527282203|FG001|Overall Study|Lost to Follow-up|4|||
146210157|NCT02740231|527282208|FG000|Overall Study|Withdrawal by Subject|1|||
145956936|NCT03131687|526354127|FG005|Overall Study|Death|0|||
145956937|NCT03131687|526354122|FG000|Overall Study|Withdrawal by Subject|3|||
146210158|NCT02740231|527282209|FG001|Overall Study|Withdrawal by Subject|1|||
146210159|NCT02740231|527282210|FG002|Overall Study|Withdrawal by Subject|1|||
145956938|NCT03131687|526354123|FG001|Overall Study|Withdrawal by Subject|3|||
145956939|NCT03131687|526354124|FG002|Overall Study|Withdrawal by Subject|3|||
145956940|NCT03131687|526354125|FG003|Overall Study|Withdrawal by Subject|1|||
145956941|NCT03131687|526354126|FG004|Overall Study|Withdrawal by Subject|2|||
146285950|NCT00709852|527561193|FG000|Period 1|Defective scanner|0|||
146285951|NCT00709852|527561194|FG001|Period 1|Defective scanner|1|||
146083514|NCT03011892|526824849|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
145956942|NCT03131687|526354127|FG005|Overall Study|Withdrawal by Subject|1|||
145956943|NCT03131687|526354122|FG000|Overall Study|Lost to Follow-up|1|||
145956944|NCT03131687|526354123|FG001|Overall Study|Lost to Follow-up|4|||
145956945|NCT03131687|526354124|FG002|Overall Study|Lost to Follow-up|0|||
145956946|NCT03131687|526354125|FG003|Overall Study|Lost to Follow-up|1|||
145956947|NCT03131687|526354126|FG004|Overall Study|Lost to Follow-up|4|||
145956948|NCT03131687|526354127|FG005|Overall Study|Lost to Follow-up|2|||
145956949|NCT03131687|526354122|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
145956950|NCT03131687|526354123|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
145956951|NCT03131687|526354124|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
145956952|NCT03131687|526354125|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
145956953|NCT03131687|526354126|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
145956954|NCT03131687|526354127|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
145956955|NCT03131687|526354122|FG000|Overall Study|Principle Investigator Decision|0|||
145956956|NCT03131687|526354123|FG001|Overall Study|Principle Investigator Decision|1|||
145956957|NCT03131687|526354124|FG002|Overall Study|Principle Investigator Decision|0|||
145956958|NCT03131687|526354125|FG003|Overall Study|Principle Investigator Decision|0|||
145956959|NCT03131687|526354126|FG004|Overall Study|Principle Investigator Decision|0|||
145956960|NCT03131687|526354127|FG005|Overall Study|Principle Investigator Decision|0|||
145956961|NCT03131687|526354122|FG000|Overall Study|Inadvertent Enrollment|0|||
145956962|NCT03131687|526354123|FG001|Overall Study|Inadvertent Enrollment|0|||
145956963|NCT03131687|526354124|FG002|Overall Study|Inadvertent Enrollment|0|||
145956964|NCT03131687|526354125|FG003|Overall Study|Inadvertent Enrollment|1|||
145956965|NCT03131687|526354126|FG004|Overall Study|Inadvertent Enrollment|0|||
145956966|NCT03131687|526354127|FG005|Overall Study|Inadvertent Enrollment|0|||
146083515|NCT03011892|526824850|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
146083516|NCT03011892|526824851|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
146083517|NCT03011892|526824840|FG000|Open Label (OL) Period|Reason not specified|0|||
146083518|NCT03011892|526824841|FG001|Open Label (OL) Period|Reason not specified|0|||
146083519|NCT03011892|526824842|FG002|Open Label (OL) Period|Reason not specified|0|||
146083520|NCT03011892|526824843|FG003|Open Label (OL) Period|Reason not specified|0|||
146083521|NCT03011892|526824844|FG004|Open Label (OL) Period|Reason not specified|0|||
146083522|NCT03011892|526824845|FG005|Open Label (OL) Period|Reason not specified|0|||
146083523|NCT03011892|526824846|FG006|Open Label (OL) Period|Reason not specified|0|||
146083524|NCT03011892|526824847|FG007|Open Label (OL) Period|Reason not specified|1|||
146083525|NCT03011892|526824848|FG008|Open Label (OL) Period|Reason not specified|0|||
146083526|NCT03011892|526824849|FG009|Open Label (OL) Period|Reason not specified|0|||
146083527|NCT03011892|526824850|FG010|Open Label (OL) Period|Reason not specified|0|||
146083528|NCT03011892|526824851|FG011|Open Label (OL) Period|Reason not specified|0|||
146083529|NCT02282293|526824852|FG000|Overall Study|Lost to Follow-up|2|||
146083530|NCT02282293|526824853|FG001|Overall Study|Lost to Follow-up|2|||
146083531|NCT02282293|526824852|FG000|Overall Study|Unable to comply with study procedures|1|||
146083532|NCT02282293|526824853|FG001|Overall Study|Unable to comply with study procedures|0|||
146083533|NCT02282293|526824852|FG000|Overall Study|Moved out of study area|0|||
146083534|NCT02282293|526824853|FG001|Overall Study|Moved out of study area|1|||
146083535|NCT00906971|526824866|FG000|Overall Study|Withdrawal by Subject|8|||
146083536|NCT00906971|526824867|FG001|Overall Study|Withdrawal by Subject|2|||
146083537|NCT00906971|526824866|FG000|Overall Study|Lost to Follow-up|0|||
146210160|NCT02740231|527282211|FG003|Overall Study|Withdrawal by Subject|0|||
146210161|NCT02740231|527282208|FG000|Overall Study|Lack of Efficacy|0|||
146210162|NCT02740231|527282209|FG001|Overall Study|Lack of Efficacy|1|||
146210163|NCT02740231|527282210|FG002|Overall Study|Lack of Efficacy|0|||
146210164|NCT02740231|527282211|FG003|Overall Study|Lack of Efficacy|4|||
146083538|NCT00906971|526824867|FG001|Overall Study|Lost to Follow-up|1|||
146083539|NCT01551420|526824868|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
146083540|NCT01551420|526824869|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
146083541|NCT01551420|526824868|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
146083542|NCT01551420|526824869|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
146083543|NCT01551420|526824868|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
146083544|NCT01551420|526824869|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
146083545|NCT01551420|526824868|FG000|Screened for Part B Eligibility|Declined participation|8|||
146083546|NCT01551420|526824869|FG001|Screened for Part B Eligibility|Declined participation|1|||
146083547|NCT01551420|526824868|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
146083548|NCT01551420|526824869|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
146083549|NCT01551420|526824868|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
146083550|NCT01551420|526824869|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
146083551|NCT01551420|526824868|FG000|Home Use (Part B)|Withdrawal by staff|0|||
146210165|NCT02740231|527282208|FG000|Overall Study|Lost to Follow-up|1|||
146210166|NCT02740231|527282209|FG001|Overall Study|Lost to Follow-up|3|||
146083552|NCT01551420|526824869|FG001|Home Use (Part B)|Withdrawal by staff|1|||
146210167|NCT02740231|527282210|FG002|Overall Study|Lost to Follow-up|0|||
146210168|NCT02740231|527282211|FG003|Overall Study|Lost to Follow-up|3|||
146210169|NCT02740231|527282208|FG000|Overall Study|Adverse Event|0|||
146210170|NCT02740231|527282209|FG001|Overall Study|Adverse Event|1|||
146210171|NCT02740231|527282210|FG002|Overall Study|Adverse Event|0|||
146210172|NCT02740231|527282211|FG003|Overall Study|Adverse Event|1|||
146210173|NCT04328727|527282213|FG000|Overall Study|Guardian Decision|1|||
146210174|NCT04328727|527282213|FG000|Overall Study|Participant decision|4|||
146210175|NCT04328727|527282213|FG000|Overall Study|Death|3|||
146210176|NCT04149002|527282214|FG000|Overall Study|Lost to Follow-up|1|||
146210177|NCT04149002|527282215|FG001|Overall Study|Lost to Follow-up|0|||
146210178|NCT04149002|527282214|FG000|Overall Study|Withdrawal by Subject|1|||
146210179|NCT04149002|527282215|FG001|Overall Study|Withdrawal by Subject|0|||
146210180|NCT04704284|527282216|FG000|Overall Study|Withdrawal by Subject|1|||
146210181|NCT03930420|527282221|FG000|Overall Study|Withdrawal by Subject|7|||
146210182|NCT03930420|527282222|FG001|Overall Study|Withdrawal by Subject|9|||
146210183|NCT02538341|527282227|FG000|Overall Study|Lost to Follow-up|51|||
146210184|NCT02538341|527282228|FG001|Overall Study|Lost to Follow-up|46|||
146210185|NCT02538341|527282227|FG000|Overall Study|Withdrawal by Subject|3|||
146285952|NCT00709852|527561193|FG000|Period 1|Lost to Follow-up|1|||
146285953|NCT00709852|527561194|FG001|Period 1|Lost to Follow-up|0|||
146285954|NCT00709852|527561193|FG000|Period 2|Protocol Violation|4|||
146285955|NCT00709852|527561194|FG001|Period 2|Protocol Violation|1|||
146285956|NCT00709852|527561193|FG000|Period 2|Adverse Event|1|||
146285957|NCT00709852|527561194|FG001|Period 2|Adverse Event|1|||
146285958|NCT00709852|527561193|FG000|Period 2|Lost to Follow-up|1|||
146285959|NCT00709852|527561194|FG001|Period 2|Lost to Follow-up|0|||
146285960|NCT00709852|527561193|FG000|Period 2|No 72-hour follow-up|3|||
146285961|NCT00709852|527561194|FG001|Period 2|No 72-hour follow-up|0|||
146285962|NCT01048671|527561201|FG000|Overall Study|Protocol Violation|0|||
146285963|NCT01048671|527561202|FG001|Overall Study|Protocol Violation|1|||
146285964|NCT01048671|527561203|FG002|Overall Study|Protocol Violation|1|||
146285965|NCT00296400|527561204|FG000|Overall Study|Adverse Event|7|||
146285966|NCT00296400|527561205|FG001|Overall Study|Adverse Event|7|||
146285967|NCT00296400|527561206|FG002|Overall Study|Adverse Event|7|||
146285968|NCT00296400|527561204|FG000|Overall Study|Withdrawal by Subject|5|||
146285969|NCT00296400|527561205|FG001|Overall Study|Withdrawal by Subject|6|||
146285970|NCT00296400|527561206|FG002|Overall Study|Withdrawal by Subject|2|||
146285971|NCT00296400|527561204|FG000|Overall Study|Incorrect enrollment|2|||
146285972|NCT00296400|527561205|FG001|Overall Study|Incorrect enrollment|0|||
146285973|NCT00296400|527561206|FG002|Overall Study|Incorrect enrollment|0|||
146285974|NCT00296400|527561204|FG000|Overall Study|Protocol Violation|1|||
146285975|NCT00296400|527561205|FG001|Overall Study|Protocol Violation|1|||
146285976|NCT00296400|527561206|FG002|Overall Study|Protocol Violation|1|||
146285977|NCT00296400|527561204|FG000|Overall Study|Lost to Follow-up|1|||
146285978|NCT00296400|527561205|FG001|Overall Study|Lost to Follow-up|1|||
146285979|NCT00296400|527561206|FG002|Overall Study|Lost to Follow-up|2|||
146285980|NCT00296400|527561204|FG000|Overall Study|Study specific discontinuation criteria|0|||
146285981|NCT00296400|527561205|FG001|Overall Study|Study specific discontinuation criteria|0|||
146285982|NCT00296400|527561206|FG002|Overall Study|Study specific discontinuation criteria|1|||
146285983|NCT00296400|527561204|FG000|Overall Study|Visit 10 was performed earlier|0|||
146285984|NCT00296400|527561205|FG001|Overall Study|Visit 10 was performed earlier|1|||
146285985|NCT00296400|527561206|FG002|Overall Study|Visit 10 was performed earlier|0|||
146285986|NCT00296400|527561204|FG000|Overall Study|Pregnancy|1|||
146285987|NCT00296400|527561205|FG001|Overall Study|Pregnancy|2|||
146285988|NCT00296400|527561206|FG002|Overall Study|Pregnancy|0|||
146285989|NCT01014533|527561207|FG000|Overall Study|Protocol Violation|3|||
146285990|NCT01014533|527561208|FG001|Overall Study|Protocol Violation|2|||
146285991|NCT01014533|527561207|FG000|Overall Study|Withdrawal by Subject|2|||
146285992|NCT01014533|527561208|FG001|Overall Study|Withdrawal by Subject|0|||
146285993|NCT01014533|527561207|FG000|Overall Study|unable to come to appointment|0|||
146285994|NCT01014533|527561208|FG001|Overall Study|unable to come to appointment|3|||
146285995|NCT00412061|527561213|FG000|Double Blind Phase|Disease Progression|101|||
146285996|NCT00412061|527561214|FG001|Double Blind Phase|Disease Progression|154|||
146285997|NCT00412061|527561213|FG000|Double Blind Phase|Adverse Event|61|||
146285998|NCT00412061|527561214|FG001|Double Blind Phase|Adverse Event|16|||
146285999|NCT00412061|527561213|FG000|Double Blind Phase|Final Primary Analysis|26|||
146286000|NCT00412061|527561214|FG001|Double Blind Phase|Final Primary Analysis|14|||
146286001|NCT00412061|527561213|FG000|Double Blind Phase|Withdrawal by Subject|18|||
146286002|NCT00412061|527561214|FG001|Double Blind Phase|Withdrawal by Subject|20|||
146286003|NCT00412061|527561213|FG000|Double Blind Phase|Death|6|||
146286004|NCT00412061|527561214|FG001|Double Blind Phase|Death|3|||
146286005|NCT00412061|527561213|FG000|Double Blind Phase|Protocol Violation|3|||
146286006|NCT00412061|527561214|FG001|Double Blind Phase|Protocol Violation|4|||
145956967|NCT04039204|526354128|FG000|Overall Study|Withdrawal by Subject|0|||
145956968|NCT04039204|526354129|FG001|Overall Study|Withdrawal by Subject|2|||
145956969|NCT01903993|526354130|FG000|Overall Study|Death|118|||
145956970|NCT01903993|526354131|FG001|Overall Study|Death|121|||
145956971|NCT01903993|526354130|FG000|Overall Study|Withdrawal by Subject|15|||
145956972|NCT01903993|526354131|FG001|Overall Study|Withdrawal by Subject|4|||
145956973|NCT01903993|526354130|FG000|Overall Study|Lost to Follow-up|2|||
145956974|NCT01903993|526354131|FG001|Overall Study|Lost to Follow-up|3|||
145956975|NCT01903993|526354130|FG000|Overall Study|Study Terminated by Sponsor|8|||
145956976|NCT01903993|526354131|FG001|Overall Study|Study Terminated by Sponsor|14|||
146083553|NCT00169442|526824870|FG000|Overall Study|Withdrawal by Subject|0|||
146083554|NCT00169442|526824871|FG001|Overall Study|Withdrawal by Subject|0|||
146083555|NCT00169442|526824872|FG002|Overall Study|Withdrawal by Subject|1|||
146083556|NCT00169442|526824873|FG003|Overall Study|Withdrawal by Subject|0|||
146083557|NCT00169442|526824874|FG004|Overall Study|Withdrawal by Subject|0|||
146083558|NCT00169442|526824875|FG005|Overall Study|Withdrawal by Subject|0|||
146083559|NCT00169442|526824870|FG000|Overall Study|Migrated/moved from study area|0|||
146083560|NCT00169442|526824871|FG001|Overall Study|Migrated/moved from study area|0|||
146083561|NCT00169442|526824872|FG002|Overall Study|Migrated/moved from study area|0|||
146083562|NCT00169442|526824873|FG003|Overall Study|Migrated/moved from study area|0|||
146083563|NCT00169442|526824874|FG004|Overall Study|Migrated/moved from study area|0|||
146083564|NCT00169442|526824875|FG005|Overall Study|Migrated/moved from study area|2|||
146083565|NCT00169442|526824870|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146083566|NCT00169442|526824871|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146083567|NCT00169442|526824872|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146083568|NCT00169442|526824873|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146083569|NCT00169442|526824874|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
146083570|NCT00169442|526824875|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
146083571|NCT00169442|526824870|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146083572|NCT00169442|526824871|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
146083573|NCT00169442|526824872|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146083574|NCT00169442|526824873|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146083575|NCT00169442|526824874|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146083576|NCT00169442|526824875|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
146083577|NCT04463069|526824878|FG000|Overall Study|Withdrawal by Subject|2|||
146083578|NCT04463069|526824879|FG001|Overall Study|Withdrawal by Subject|10|||
146083579|NCT04463069|526824878|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
146083580|NCT04463069|526824879|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
146083581|NCT02055365|526826498|FG000|Overall Study|Prematurely Withdrawn|1|||
146083582|NCT01258998|526826501|FG000|Overall Study|Ineligible|1|||
146083583|NCT01143389|526826502|FG000|Overall Study|Lost to Follow-up|26|||
146083584|NCT01143389|526826503|FG001|Overall Study|Lost to Follow-up|25|||
146083585|NCT04966910|526826504|FG000|Baseline|Participant did not complete measure|0|||
146083586|NCT04966910|526826505|FG001|Baseline|Participant did not complete measure|0|||
146083587|NCT04966910|526826506|FG002|Baseline|Participant did not complete measure|1|||
146083588|NCT04966910|526826507|FG003|Baseline|Participant did not complete measure|0|||
146083589|NCT04966910|526826504|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
146083590|NCT04966910|526826505|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
146083591|NCT04966910|526826506|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
146083592|NCT04966910|526826507|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
146083593|NCT04966910|526826504|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
146083594|NCT04966910|526826505|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
146083595|NCT04966910|526826506|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
146083596|NCT04966910|526826507|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
146286007|NCT00412061|527561213|FG000|Double Blind Phase|New Cander Therapy|1|||
145956977|NCT01903993|526354130|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
145956978|NCT01903993|526354131|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
145956979|NCT02385110|526354132|FG000|Overall Study|Early Death|1|||
145956980|NCT02385110|526354133|FG001|Overall Study|Early Death|0|||
145956981|NCT05251233|526356156|FG000|Overall Study|Disease progression - did not start treatment|0|||
145956982|NCT05251233|526356157|FG001|Overall Study|Disease progression - did not start treatment|0|||
145956983|NCT05251233|526356158|FG002|Overall Study|Disease progression - did not start treatment|5|||
145956984|NCT05251233|526356156|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
145956985|NCT05251233|526356157|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
145956986|NCT05251233|526356158|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
145956987|NCT05251233|526356156|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
145956988|NCT05251233|526356157|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
145956989|NCT05251233|526356158|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
145956990|NCT05251233|526356156|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
145956991|NCT05251233|526356157|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
145956992|NCT05251233|526356158|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
145956993|NCT05251233|526356156|FG000|Overall Study|Death - did not start treatment|3|||
145956994|NCT05251233|526356157|FG001|Overall Study|Death - did not start treatment|0|||
145956995|NCT05251233|526356158|FG002|Overall Study|Death - did not start treatment|0|||
145956996|NCT05251233|526356156|FG000|Overall Study|Withdrawal by Subject|2|||
145956997|NCT05251233|526356157|FG001|Overall Study|Withdrawal by Subject|2|||
145956998|NCT05251233|526356158|FG002|Overall Study|Withdrawal by Subject|0|||
145956999|NCT05251233|526356156|FG000|Overall Study|Other complicating disease|2|||
145957000|NCT05251233|526356157|FG001|Overall Study|Other complicating disease|1|||
145957001|NCT05251233|526356158|FG002|Overall Study|Other complicating disease|0|||
145957002|NCT05251233|526356156|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
146210186|NCT02538341|527282228|FG001|Overall Study|Withdrawal by Subject|1|||
146210187|NCT02538341|527282227|FG000|Overall Study|Death|2|||
145957003|NCT05251233|526356157|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
145957004|NCT05251233|526356158|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
145957005|NCT05251233|526356156|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
145957006|NCT05251233|526356157|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
145957007|NCT05251233|526356158|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
145957008|NCT00103285|526356159|FG000|Induction|Adverse Event|14|||
145957009|NCT00103285|526356160|FG001|Induction|Adverse Event|0|||
145957010|NCT00103285|526356161|FG002|Induction|Adverse Event|0|||
145957011|NCT00103285|526356162|FG003|Induction|Adverse Event|0|||
146210188|NCT02538341|527282228|FG001|Overall Study|Death|0|||
146210189|NCT00331136|527282229|FG000|Overall Study|Adverse Event|3|||
146210190|NCT00331136|527282230|FG001|Overall Study|Adverse Event|5|||
146083597|NCT04966910|526826504|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
146083598|NCT04966910|526826505|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
146083599|NCT04966910|526826506|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
146083600|NCT04966910|526826507|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
146083601|NCT00002931|526826511|FG000|Overall Study|rapidly progressing disease during|2|||
146083602|NCT02276027|526826512|FG000|Overall Study|Death|1|||
146083603|NCT02276027|526826513|FG001|Overall Study|Death|0|||
146083604|NCT02276027|526826514|FG002|Overall Study|Death|0|||
146083605|NCT02276027|526826515|FG003|Overall Study|Death|2|||
146083606|NCT02276027|526826512|FG000|Overall Study|Physician Decision|0|||
146210191|NCT00331136|527282231|FG002|Overall Study|Adverse Event|0|||
146210192|NCT00331136|527282232|FG003|Overall Study|Adverse Event|1|||
146210193|NCT00331136|527282229|FG000|Overall Study|Withdrawal by Subject|0|||
146210194|NCT00331136|527282230|FG001|Overall Study|Withdrawal by Subject|1|||
146083607|NCT02276027|526826513|FG001|Overall Study|Physician Decision|0|||
146083608|NCT02276027|526826514|FG002|Overall Study|Physician Decision|0|||
146210195|NCT00331136|527282231|FG002|Overall Study|Withdrawal by Subject|0|||
146210196|NCT00331136|527282232|FG003|Overall Study|Withdrawal by Subject|0|||
146210197|NCT00331136|527282229|FG000|Overall Study|Lost to Follow-up|0|||
146210198|NCT00331136|527282230|FG001|Overall Study|Lost to Follow-up|1|||
146210199|NCT00331136|527282231|FG002|Overall Study|Lost to Follow-up|0|||
146210200|NCT00331136|527282232|FG003|Overall Study|Lost to Follow-up|0|||
146210201|NCT00331136|527282229|FG000|Overall Study|Protocol Violation|1|||
146210202|NCT00331136|527282230|FG001|Overall Study|Protocol Violation|0|||
146210203|NCT00331136|527282231|FG002|Overall Study|Protocol Violation|0|||
146210204|NCT00331136|527282232|FG003|Overall Study|Protocol Violation|0|||
146210205|NCT00331136|527282229|FG000|Overall Study|Not treated|1|||
146210206|NCT00331136|527282230|FG001|Overall Study|Not treated|0|||
146210207|NCT00331136|527282231|FG002|Overall Study|Not treated|0|||
146210208|NCT00331136|527282232|FG003|Overall Study|Not treated|0|||
145957012|NCT00103285|526356163|FG004|Induction|Adverse Event|0|||
146210209|NCT02321514|527282233|FG000|Overall Study|Death|15|||
146210210|NCT02321514|527282233|FG000|Overall Study|Missed Visit|7|||
146210211|NCT02321514|527282233|FG000|Overall Study|Study Exit|3|||
146210212|NCT00393484|527282239|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
146210213|NCT00393484|527282240|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
146210214|NCT00393484|527282239|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
146210215|NCT00393484|527282240|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
146210216|NCT00393484|527282239|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
146210217|NCT00393484|527282240|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
146210218|NCT00393484|527282239|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
146210219|NCT00393484|527282240|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
146210220|NCT00393484|527282239|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
146210221|NCT00393484|527282240|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
145957013|NCT00103285|526356164|FG005|Induction|Adverse Event|0|||
145957014|NCT00103285|526356165|FG006|Induction|Adverse Event|0|||
145957015|NCT00103285|526356166|FG007|Induction|Adverse Event|0|||
145957016|NCT00103285|526356159|FG000|Induction|Death|24|||
145957017|NCT00103285|526356160|FG001|Induction|Death|0|||
145957018|NCT00103285|526356161|FG002|Induction|Death|0|||
145957019|NCT00103285|526356162|FG003|Induction|Death|0|||
145957020|NCT00103285|526356163|FG004|Induction|Death|0|||
145957021|NCT00103285|526356164|FG005|Induction|Death|0|||
145957022|NCT00103285|526356165|FG006|Induction|Death|0|||
145957023|NCT00103285|526356166|FG007|Induction|Death|0|||
145957024|NCT00103285|526356159|FG000|Induction|Physician Decision|103|||
145957025|NCT00103285|526356160|FG001|Induction|Physician Decision|0|||
145957026|NCT00103285|526356161|FG002|Induction|Physician Decision|0|||
145957027|NCT00103285|526356162|FG003|Induction|Physician Decision|0|||
145957028|NCT00103285|526356163|FG004|Induction|Physician Decision|0|||
145957029|NCT00103285|526356164|FG005|Induction|Physician Decision|0|||
145957030|NCT00103285|526356165|FG006|Induction|Physician Decision|0|||
145957031|NCT00103285|526356166|FG007|Induction|Physician Decision|0|||
145957032|NCT00103285|526356159|FG000|Induction|Withdrawal by Subject|1|||
145957033|NCT00103285|526356160|FG001|Induction|Withdrawal by Subject|0|||
145957034|NCT00103285|526356161|FG002|Induction|Withdrawal by Subject|0|||
145957035|NCT00103285|526356162|FG003|Induction|Withdrawal by Subject|0|||
145957036|NCT00103285|526356163|FG004|Induction|Withdrawal by Subject|0|||
145957037|NCT00103285|526356164|FG005|Induction|Withdrawal by Subject|0|||
145957038|NCT00103285|526356165|FG006|Induction|Withdrawal by Subject|0|||
145957039|NCT00103285|526356166|FG007|Induction|Withdrawal by Subject|0|||
145957040|NCT00103285|526356159|FG000|Induction|Ineligible|43|||
145957041|NCT00103285|526356160|FG001|Induction|Ineligible|0|||
145957042|NCT00103285|526356161|FG002|Induction|Ineligible|0|||
145957043|NCT00103285|526356162|FG003|Induction|Ineligible|0|||
145957044|NCT00103285|526356163|FG004|Induction|Ineligible|0|||
145957045|NCT00103285|526356164|FG005|Induction|Ineligible|0|||
145957046|NCT00103285|526356165|FG006|Induction|Ineligible|0|||
145957047|NCT00103285|526356166|FG007|Induction|Ineligible|0|||
145957048|NCT00103285|526356159|FG000|Induction|Refusal|906|||
146210222|NCT00393484|527282239|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
146210223|NCT00393484|527282240|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
146210224|NCT00393484|527282239|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
146210225|NCT00393484|527282240|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
146210226|NCT00393484|527282239|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
146210227|NCT00393484|527282240|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
146210228|NCT00393484|527282239|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
146210229|NCT00393484|527282240|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
146210230|NCT00393484|527282239|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
146210231|NCT00393484|527282240|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
146210232|NCT00088413|527282247|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146210233|NCT00088413|527282248|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146210234|NCT00088413|527282249|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
146210235|NCT00088413|527282250|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
146210236|NCT00088413|527282247|FG000|Overall Study|Adverse Events/Side Effects|0|||
146210237|NCT00088413|527282248|FG001|Overall Study|Adverse Events/Side Effects|1|||
146210238|NCT00088413|527282249|FG002|Overall Study|Adverse Events/Side Effects|1|||
146210239|NCT00088413|527282250|FG003|Overall Study|Adverse Events/Side Effects|0|||
146210240|NCT00088413|527282247|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
146210241|NCT00088413|527282248|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
146210242|NCT00088413|527282249|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
146210243|NCT00088413|527282250|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
146210244|NCT00088413|527282247|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
146210245|NCT00088413|527282248|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
146210246|NCT00088413|527282249|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
146210247|NCT00088413|527282250|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
146210248|NCT00088413|527282247|FG000|Overall Study|Death|0|||
146210249|NCT00088413|527282248|FG001|Overall Study|Death|1|||
146210250|NCT00088413|527282249|FG002|Overall Study|Death|0|||
146210251|NCT00088413|527282250|FG003|Overall Study|Death|0|||
146210252|NCT00088413|527282247|FG000|Overall Study|Progressive disease|9|||
146210253|NCT00088413|527282248|FG001|Overall Study|Progressive disease|11|||
146210254|NCT00088413|527282249|FG002|Overall Study|Progressive disease|8|||
146210255|NCT00088413|527282250|FG003|Overall Study|Progressive disease|14|||
146210256|NCT00088413|527282247|FG000|Overall Study|Other|0|||
146210257|NCT00088413|527282248|FG001|Overall Study|Other|1|||
146210258|NCT00088413|527282249|FG002|Overall Study|Other|0|||
146286008|NCT00412061|527561214|FG001|Double Blind Phase|New Cander Therapy|1|||
146286009|NCT00412061|527561213|FG000|Double Blind Phase|Lost to Follow-up|0|||
146210259|NCT00088413|527282250|FG003|Overall Study|Other|0|||
146210260|NCT00088413|527282247|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
146210261|NCT00088413|527282248|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
146210262|NCT00088413|527282249|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
146210263|NCT00088413|527282250|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
146210264|NCT00031694|527282253|FG000|Overall Study|Adverse Event|12|||
146210265|NCT00031694|527282253|FG000|Overall Study|Death|2|||
146210266|NCT00031694|527282253|FG000|Overall Study|Withdrawal by Subject|5|||
146210267|NCT01976312|527282254|FG000|Overall Study|Pregnancy|0|||
146210268|NCT01976312|527282255|FG001|Overall Study|Pregnancy|1|||
146210269|NCT01976312|527282254|FG000|Overall Study|Lost to Follow-up|2|||
146210270|NCT01976312|527282255|FG001|Overall Study|Lost to Follow-up|0|||
146210271|NCT01976312|527282254|FG000|Overall Study|Withdrawal by Subject|7|||
146210272|NCT01976312|527282255|FG001|Overall Study|Withdrawal by Subject|2|||
146210273|NCT01976312|527282254|FG000|Overall Study|Adverse Event|6|||
145957049|NCT00103285|526356160|FG001|Induction|Refusal|0|||
145957050|NCT00103285|526356161|FG002|Induction|Refusal|0|||
145957051|NCT00103285|526356162|FG003|Induction|Refusal|0|||
145957052|NCT00103285|526356163|FG004|Induction|Refusal|0|||
145957053|NCT00103285|526356164|FG005|Induction|Refusal|0|||
145957054|NCT00103285|526356165|FG006|Induction|Refusal|0|||
145957055|NCT00103285|526356166|FG007|Induction|Refusal|0|||
145957056|NCT00103285|526356159|FG000|Induction|Other|258|||
145957057|NCT00103285|526356160|FG001|Induction|Other|0|||
145957058|NCT00103285|526356161|FG002|Induction|Other|0|||
145957059|NCT00103285|526356162|FG003|Induction|Other|0|||
146083609|NCT02276027|526826515|FG003|Overall Study|Physician Decision|1|||
146083610|NCT02276027|526826512|FG000|Overall Study|Progressive disease|1|||
146083611|NCT02276027|526826513|FG001|Overall Study|Progressive disease|13|||
145957060|NCT00103285|526356163|FG004|Induction|Other|0|||
145957061|NCT00103285|526356164|FG005|Induction|Other|0|||
145957062|NCT00103285|526356165|FG006|Induction|Other|0|||
146210274|NCT01976312|527282255|FG001|Overall Study|Adverse Event|6|||
146210275|NCT01976312|527282254|FG000|Overall Study|Protocol Violation|2|||
146210276|NCT01976312|527282255|FG001|Overall Study|Protocol Violation|0|||
146210277|NCT01538719|527282256|FG000|Overall Study|Lost to Follow-up|2|||
146210278|NCT01538719|527282257|FG001|Overall Study|Lost to Follow-up|0|||
146210279|NCT00774852|527282264|FG000|Overall Study|Adverse Event|9|||
146210280|NCT00774852|527282265|FG001|Overall Study|Adverse Event|6|||
146210281|NCT00774852|527282264|FG000|Overall Study|Death|2|||
146210282|NCT00774852|527282265|FG001|Overall Study|Death|1|||
146210283|NCT00774852|527282264|FG000|Overall Study|Lack of Efficacy|3|||
146210284|NCT00774852|527282265|FG001|Overall Study|Lack of Efficacy|7|||
146210285|NCT00774852|527282264|FG000|Overall Study|Lost to Follow-up|9|||
146210286|NCT00774852|527282265|FG001|Overall Study|Lost to Follow-up|5|||
146210287|NCT00774852|527282264|FG000|Overall Study|Physician Decision|2|||
146210288|NCT00774852|527282265|FG001|Overall Study|Physician Decision|6|||
146210289|NCT00774852|527282264|FG000|Overall Study|Pregnancy|1|||
146210290|NCT00774852|527282265|FG001|Overall Study|Pregnancy|2|||
146210291|NCT00774852|527282264|FG000|Overall Study|Withdrawal by Subject|2|||
146210292|NCT00774852|527282265|FG001|Overall Study|Withdrawal by Subject|2|||
146210293|NCT00774852|527282264|FG000|Overall Study|Non-responder|15|||
146210294|NCT00774852|527282265|FG001|Overall Study|Non-responder|11|||
146286010|NCT00412061|527561214|FG001|Double Blind Phase|Lost to Follow-up|1|||
145957063|NCT00103285|526356166|FG007|Induction|Other|0|||
146083612|NCT02276027|526826514|FG002|Overall Study|Progressive disease|12|||
146210295|NCT00774852|527282264|FG000|Overall Study|Subject non-compliance|0|||
146210296|NCT00774852|527282265|FG001|Overall Study|Subject non-compliance|1|||
146210297|NCT00774852|527282264|FG000|Overall Study|Protocol Violation|1|||
146286011|NCT00412061|527561213|FG000|Open Label Phase|Disease Progression|0|||
145957064|NCT00103285|526356159|FG000|Response Assignment|Adverse Event|0|||
145957065|NCT00103285|526356160|FG001|Response Assignment|Adverse Event|8|||
145957066|NCT00103285|526356161|FG002|Response Assignment|Adverse Event|3|||
145957067|NCT00103285|526356162|FG003|Response Assignment|Adverse Event|2|||
145957068|NCT00103285|526356163|FG004|Response Assignment|Adverse Event|3|||
146083613|NCT02276027|526826515|FG003|Overall Study|Progressive disease|14|||
146210298|NCT00774852|527282265|FG001|Overall Study|Protocol Violation|0|||
146210299|NCT00774852|527282264|FG000|Overall Study|Subject received prohibited medication|1|||
146210300|NCT00774852|527282265|FG001|Overall Study|Subject received prohibited medication|0|||
146210301|NCT02807779|527282266|FG000|Overall Study|Lost to Follow-up|1|||
146210302|NCT02807779|527282267|FG001|Overall Study|Lost to Follow-up|0|||
146210303|NCT02807779|527282268|FG002|Overall Study|Lost to Follow-up|0|||
146210304|NCT02807779|527282266|FG000|Overall Study|Physician Decision|2|||
146210305|NCT02807779|527282267|FG001|Overall Study|Physician Decision|0|||
146286012|NCT00412061|527561214|FG001|Open Label Phase|Disease Progression|86|||
146210306|NCT02807779|527282268|FG002|Overall Study|Physician Decision|1|||
146210307|NCT02807779|527282266|FG000|Overall Study|Death|1|||
146210308|NCT02807779|527282267|FG001|Overall Study|Death|1|||
146210309|NCT02807779|527282268|FG002|Overall Study|Death|0|||
146210310|NCT06024174|527282269|FG000|Overall Study|Other Reasons|1|||
146210311|NCT06024174|527282269|FG000|Overall Study|Study terminated by Sponsor|4|||
146210312|NCT04310735|527283989|FG000|Overall Study|Withdrawal by Subject|1|||
146210313|NCT04310735|527283990|FG001|Overall Study|Withdrawal by Subject|3|||
146210314|NCT04310735|527283991|FG002|Overall Study|Withdrawal by Subject|8|||
146210315|NCT04310735|527283989|FG000|Overall Study|Equipment malfunction|0|||
146210316|NCT04310735|527283990|FG001|Overall Study|Equipment malfunction|1|||
146210317|NCT04310735|527283991|FG002|Overall Study|Equipment malfunction|0|||
146210318|NCT03398200|527283992|FG000|Overall Study|Withdrawal by Subject|0|||
146210319|NCT03398200|527283993|FG001|Overall Study|Withdrawal by Subject|1|||
146210320|NCT04842500|527283996|FG000|Overall Study|Withdrawal by Subject|4|||
146210321|NCT04842500|527283997|FG001|Overall Study|Withdrawal by Subject|1|||
146210322|NCT04842500|527283998|FG002|Overall Study|Withdrawal by Subject|2|||
146210323|NCT04842500|527283999|FG003|Overall Study|Withdrawal by Subject|3|||
146210324|NCT04842500|527283996|FG000|Overall Study|Protocol Violation|1|||
146210325|NCT04842500|527283997|FG001|Overall Study|Protocol Violation|0|||
146210326|NCT04842500|527283998|FG002|Overall Study|Protocol Violation|0|||
146210327|NCT04842500|527283999|FG003|Overall Study|Protocol Violation|1|||
146210328|NCT03845465|527284002|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
146210329|NCT03845465|527284003|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
146210330|NCT03845465|527284002|FG000|6-month Data Collection|Withdrawal by Subject|0|||
146210331|NCT03845465|527284003|FG001|6-month Data Collection|Withdrawal by Subject|2|||
146210332|NCT03845465|527284002|FG000|12-month Data Collection|Withdrawal by Subject|0|||
146210333|NCT03845465|527284003|FG001|12-month Data Collection|Withdrawal by Subject|2|||
146210334|NCT05656911|527284004|FG000|Treatment Phase|Physician Decision|2|||
146210335|NCT05656911|527284005|FG001|Treatment Phase|Physician Decision|0|||
146210336|NCT05656911|527284004|FG000|Treatment Phase|Lack of Efficacy|6|||
146210337|NCT05656911|527284005|FG001|Treatment Phase|Lack of Efficacy|3|||
146210338|NCT05656911|527284004|FG000|Treatment Phase|Subject Decision|4|||
146210339|NCT05656911|527284005|FG001|Treatment Phase|Subject Decision|2|||
146210340|NCT05656911|527284004|FG000|Treatment Phase|Other Reasons|1|||
146210341|NCT05656911|527284005|FG001|Treatment Phase|Other Reasons|0|||
146210342|NCT05656911|527284004|FG000|Treatment Phase|Adverse Event|3|||
146210343|NCT05656911|527284005|FG001|Treatment Phase|Adverse Event|1|||
146210344|NCT05656911|527284004|FG000|Follow-up Phase|Subject Decision|0|||
146210345|NCT05656911|527284005|FG001|Follow-up Phase|Subject Decision|1|||
146210346|NCT05656911|527284004|FG000|Follow-up Phase|Missing|1|||
146210347|NCT05656911|527284005|FG001|Follow-up Phase|Missing|0|||
146210348|NCT03547908|527284006|FG000|Blinded Phase|Lost to Follow-up|3|||
146210349|NCT03547908|527284007|FG001|Blinded Phase|Lost to Follow-up|3|||
146210350|NCT03547908|527284008|FG002|Blinded Phase|Lost to Follow-up|0|||
146210351|NCT03547908|527284009|FG003|Blinded Phase|Lost to Follow-up|0|||
146210352|NCT03547908|527284006|FG000|Blinded Phase|Withdrew Consent|2|||
146210353|NCT03547908|527284007|FG001|Blinded Phase|Withdrew Consent|3|||
146210354|NCT03547908|527284008|FG002|Blinded Phase|Withdrew Consent|0|||
146210355|NCT03547908|527284009|FG003|Blinded Phase|Withdrew Consent|0|||
146210356|NCT03547908|527284006|FG000|Blinded Phase|Investigator's Discretion|2|||
146210357|NCT03547908|527284007|FG001|Blinded Phase|Investigator's Discretion|1|||
146210358|NCT03547908|527284008|FG002|Blinded Phase|Investigator's Discretion|0|||
146210359|NCT03547908|527284009|FG003|Blinded Phase|Investigator's Discretion|0|||
146210360|NCT03547908|527284006|FG000|Blinded Phase|Death|2|||
146210361|NCT03547908|527284007|FG001|Blinded Phase|Death|0|||
146210362|NCT03547908|527284008|FG002|Blinded Phase|Death|0|||
146210363|NCT03547908|527284009|FG003|Blinded Phase|Death|0|||
146210364|NCT03547908|527284006|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
146210365|NCT03547908|527284007|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
146210366|NCT03547908|527284008|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
146210367|NCT03547908|527284009|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
146210368|NCT03547908|527284006|FG000|Blinded Phase|Adverse Event|1|||
146210369|NCT03547908|527284007|FG001|Blinded Phase|Adverse Event|0|||
146210370|NCT03547908|527284008|FG002|Blinded Phase|Adverse Event|0|||
146210371|NCT03547908|527284009|FG003|Blinded Phase|Adverse Event|0|||
146210372|NCT03547908|527284006|FG000|Blinded Phase|Randomized But Never Treated|1|||
146210373|NCT03547908|527284007|FG001|Blinded Phase|Randomized But Never Treated|0|||
146210374|NCT03547908|527284008|FG002|Blinded Phase|Randomized But Never Treated|0|||
146210375|NCT03547908|527284009|FG003|Blinded Phase|Randomized But Never Treated|0|||
146210376|NCT03547908|527284006|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
146210377|NCT03547908|527284007|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
146210378|NCT03547908|527284008|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
146210379|NCT03547908|527284009|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
146210380|NCT03547908|527284006|FG000|Open-label Extension Phase|Death|0|||
146210381|NCT03547908|527284007|FG001|Open-label Extension Phase|Death|0|||
146210382|NCT03547908|527284008|FG002|Open-label Extension Phase|Death|1|||
146286013|NCT00412061|527561213|FG000|Open Label Phase|Adverse Event|0|||
146286014|NCT00412061|527561214|FG001|Open Label Phase|Adverse Event|46|||
146286015|NCT00412061|527561213|FG000|Open Label Phase|Withdrawal by Subject|0|||
146286016|NCT00412061|527561214|FG001|Open Label Phase|Withdrawal by Subject|15|||
146286017|NCT00412061|527561213|FG000|Open Label Phase|Administrative Problems|0|||
146286018|NCT00412061|527561214|FG001|Open Label Phase|Administrative Problems|13|||
146286019|NCT00412061|527561213|FG000|Open Label Phase|Death|0|||
146286020|NCT00412061|527561214|FG001|Open Label Phase|Death|7|||
146286021|NCT00412061|527561213|FG000|Open Label Phase|Lost to Follow-up|0|||
146286022|NCT00412061|527561214|FG001|Open Label Phase|Lost to Follow-up|2|||
146286023|NCT00412061|527561213|FG000|Open Label Phase|New Cancer Therapy|0|||
146286024|NCT00412061|527561214|FG001|Open Label Phase|New Cancer Therapy|1|||
146286025|NCT02689518|527561216|FG000|Overall Study|Withdrawal by Subject|3|||
146286026|NCT02433340|527561220|FG000|Overall Study|Adverse Event|0|||
146286027|NCT02433340|527561221|FG001|Overall Study|Adverse Event|0|||
146286028|NCT02433340|527561222|FG002|Overall Study|Adverse Event|1|||
146286029|NCT02433340|527561223|FG003|Overall Study|Adverse Event|0|||
146286030|NCT02433340|527561220|FG000|Overall Study|Withdrawal by Subject|1|||
146286031|NCT02433340|527561221|FG001|Overall Study|Withdrawal by Subject|0|||
146286032|NCT02433340|527561222|FG002|Overall Study|Withdrawal by Subject|1|||
146286033|NCT02433340|527561223|FG003|Overall Study|Withdrawal by Subject|2|||
146286034|NCT02433340|527561220|FG000|Overall Study|Lost to Follow-up|0|||
146286035|NCT02433340|527561221|FG001|Overall Study|Lost to Follow-up|1|||
146286036|NCT02433340|527561222|FG002|Overall Study|Lost to Follow-up|0|||
146286037|NCT02433340|527561223|FG003|Overall Study|Lost to Follow-up|0|||
146286038|NCT02433340|527561220|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
146286039|NCT02433340|527561221|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
146286040|NCT02433340|527561222|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
146286041|NCT02433340|527561223|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
146286042|NCT02433340|527561220|FG000|Overall Study|Other|0|||
146286043|NCT02433340|527561221|FG001|Overall Study|Other|1|||
146286044|NCT02433340|527561222|FG002|Overall Study|Other|0|||
146286045|NCT02433340|527561223|FG003|Overall Study|Other|0|||
146286046|NCT01178385|527561224|FG000|Overall Study|Withdrawal by Subject|2|||
146286047|NCT01178385|527561225|FG001|Overall Study|Withdrawal by Subject|0|||
146286048|NCT02679508|527561229|FG000|Healing Phase|Protocol Violation|1|||
146286049|NCT02679508|527561230|FG001|Healing Phase|Protocol Violation|1|||
146286050|NCT02679508|527561229|FG000|Healing Phase|Lost to Follow-up|1|||
146286051|NCT02679508|527561230|FG001|Healing Phase|Lost to Follow-up|0|||
146286052|NCT02679508|527561229|FG000|Maintenance Phase|Adverse Event|12|||
146286053|NCT02679508|527561230|FG001|Maintenance Phase|Adverse Event|2|||
146286054|NCT02679508|527561229|FG000|Maintenance Phase|Lost to Follow-up|0|||
146286055|NCT02679508|527561230|FG001|Maintenance Phase|Lost to Follow-up|1|||
146286056|NCT02679508|527561229|FG000|Maintenance Phase|Withdrawal by Subject|15|||
146286057|NCT02679508|527561230|FG001|Maintenance Phase|Withdrawal by Subject|8|||
146286058|NCT02679508|527561229|FG000|Maintenance Phase|Other|5|||
146286059|NCT02679508|527561230|FG001|Maintenance Phase|Other|4|||
146286060|NCT03143166|527561231|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
146286061|NCT00589121|527561234|FG000|Overall Study|Protocol Violation|2|||
146286062|NCT00589121|527561235|FG001|Overall Study|Protocol Violation|6|||
146286063|NCT00589121|527561234|FG000|Overall Study|No protocol treatment received|0|||
146286064|NCT00589121|527561235|FG001|Overall Study|No protocol treatment received|1|||
146286065|NCT00847808|527561236|FG000|Overall Study|Adverse Event|7|||
146286066|NCT00847808|527561236|FG000|Overall Study|Protocol Violation|1|||
146286067|NCT00847808|527561236|FG000|Overall Study|Lost to Follow-up|1|||
146286068|NCT00847808|527561236|FG000|Overall Study|Withdrawal by Subject|4|||
146286069|NCT00847808|527561236|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
146286070|NCT00847808|527561236|FG000|Overall Study|Participant Took Excluded Medication|1|||
146286071|NCT00925132|527561237|FG000|Overall Study|Withdrawal by Subject|2|||
146286072|NCT00925132|527561238|FG001|Overall Study|Withdrawal by Subject|0|||
146286073|NCT00925132|527561239|FG002|Overall Study|Withdrawal by Subject|0|||
146286074|NCT00925132|527561240|FG003|Overall Study|Withdrawal by Subject|0|||
146286075|NCT00925132|527561241|FG004|Overall Study|Withdrawal by Subject|1|||
146286076|NCT00925132|527561237|FG000|Overall Study|Removed due to disease progression|0|||
146210383|NCT03547908|527284009|FG003|Open-label Extension Phase|Death|0|||
146210384|NCT04607044|527284016|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
146210385|NCT04607044|527284016|FG000|Overall Study|Adverse Event|1|||
146210386|NCT04607044|527284016|FG000|Overall Study|Did not receive study device|3|||
146210387|NCT04607044|527284016|FG000|Overall Study|Death|1|||
146210388|NCT05403801|527284017|FG000|Overall Study|Withdrawal by Subject|2|||
146210389|NCT05075408|527284018|FG000|Overall Study|Withdrawal by Subject|5|||
146210390|NCT05075408|527284019|FG001|Overall Study|Withdrawal by Subject|3|||
146210391|NCT05075408|527284020|FG002|Overall Study|Withdrawal by Subject|4|||
146210392|NCT05075408|527284018|FG000|Overall Study|Adverse Event|5|||
146210393|NCT05075408|527284019|FG001|Overall Study|Adverse Event|7|||
146210394|NCT05075408|527284020|FG002|Overall Study|Adverse Event|8|||
146210395|NCT05075408|527284018|FG000|Overall Study|Protocol Violation|0|||
146210396|NCT05075408|527284019|FG001|Overall Study|Protocol Violation|1|||
146210397|NCT05075408|527284020|FG002|Overall Study|Protocol Violation|0|||
146210398|NCT05075408|527284018|FG000|Overall Study|Lost to Follow-up|2|||
146210399|NCT05075408|527284019|FG001|Overall Study|Lost to Follow-up|1|||
146210400|NCT05075408|527284020|FG002|Overall Study|Lost to Follow-up|1|||
146210401|NCT05075408|527284018|FG000|Overall Study|Physician Decision|1|||
146210402|NCT05075408|527284019|FG001|Overall Study|Physician Decision|0|||
146210403|NCT05075408|527284020|FG002|Overall Study|Physician Decision|0|||
146210404|NCT05075408|527284018|FG000|Overall Study|Other-unspecified|3|||
146210405|NCT05075408|527284019|FG001|Overall Study|Other-unspecified|2|||
146210406|NCT05075408|527284020|FG002|Overall Study|Other-unspecified|0|||
146210407|NCT03103321|527284021|FG000|Overall Study|Protocol Violation|1|||
146210408|NCT03103321|527284022|FG001|Overall Study|Protocol Violation|1|||
146210409|NCT03103321|527284023|FG002|Overall Study|Protocol Violation|1|||
146210410|NCT03103321|527284024|FG003|Overall Study|Protocol Violation|0|||
146210411|NCT06629454|527284028|FG000|Overall Study|Withdraw by Clinician Decision|1|||
146210412|NCT01704079|527284029|FG000|Overall Study|Withdrawal by Subject|5|||
146210413|NCT01704079|527284030|FG001|Overall Study|Withdrawal by Subject|7|||
146210414|NCT01704079|527284029|FG000|Overall Study|Lost to Follow-up|2|||
146210415|NCT01704079|527284030|FG001|Overall Study|Lost to Follow-up|5|||
146210416|NCT01704079|527284029|FG000|Overall Study|Adverse Event|4|||
146210417|NCT01704079|527284030|FG001|Overall Study|Adverse Event|7|||
146210418|NCT01704079|527284029|FG000|Overall Study|Protocol Violation|1|||
146210419|NCT01704079|527284030|FG001|Overall Study|Protocol Violation|0|||
146210420|NCT01704079|527284029|FG000|Overall Study|Subject noncompliance|2|||
146210421|NCT01704079|527284030|FG001|Overall Study|Subject noncompliance|3|||
146210422|NCT01704079|527284029|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
146210423|NCT01704079|527284030|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
146210424|NCT05846646|527284036|FG000|Overall Study|Physician Decision|1|||
146210425|NCT05846646|527284037|FG001|Overall Study|Physician Decision|0|||
146210426|NCT05846646|527284038|FG002|Overall Study|Physician Decision|0|||
146210427|NCT05846646|527284036|FG000|Overall Study|Lack of Efficacy|1|||
146210428|NCT05846646|527284037|FG001|Overall Study|Lack of Efficacy|1|||
146210429|NCT05846646|527284038|FG002|Overall Study|Lack of Efficacy|0|||
146210430|NCT05846646|527284036|FG000|Overall Study|Early Study Termination|1|||
146210431|NCT05846646|527284037|FG001|Overall Study|Early Study Termination|2|||
146210432|NCT05846646|527284038|FG002|Overall Study|Early Study Termination|0|||
146210433|NCT00505934|527284039|FG000|Overall Study|Adverse Event|1|||
146210434|NCT00505934|527284039|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
146210435|NCT00505934|527284039|FG000|Overall Study|Other: IV dose needed to be changed|1|||
146210436|NCT02461628|527284044|FG000|Overall Study|Refused to complete survey|4|||
146286077|NCT00925132|527561238|FG001|Overall Study|Removed due to disease progression|0|||
146286078|NCT00925132|527561239|FG002|Overall Study|Removed due to disease progression|0|||
146286079|NCT00925132|527561240|FG003|Overall Study|Removed due to disease progression|0|||
146286080|NCT00925132|527561241|FG004|Overall Study|Removed due to disease progression|4|||
146286081|NCT02545933|527561242|FG000|Overall Study|Adverse Event|3|||
146210437|NCT02461628|527284045|FG001|Overall Study|Refused to complete survey|7|||
146210438|NCT00998881|527284048|FG000|Overall Study|Adverse Event|2|||
146210439|NCT00998881|527284049|FG001|Overall Study|Adverse Event|2|||
146210440|NCT00998881|527284048|FG000|Overall Study|Lack of Efficacy|1|||
146210441|NCT00998881|527284049|FG001|Overall Study|Lack of Efficacy|0|||
146210442|NCT00998881|527284048|FG000|Overall Study|Physician Decision|3|||
146210443|NCT00998881|527284049|FG001|Overall Study|Physician Decision|0|||
146210444|NCT00998881|527284048|FG000|Overall Study|Withdrawal by Subject|1|||
146210445|NCT00998881|527284049|FG001|Overall Study|Withdrawal by Subject|0|||
146286082|NCT02545933|527561243|FG001|Overall Study|Adverse Event|0|||
146210446|NCT00998881|527284048|FG000|Overall Study|Personal matter|1|||
146210447|NCT00998881|527284049|FG001|Overall Study|Personal matter|0|||
146210448|NCT02462759|527284050|FG000|Part 1: Double Blind|Death|1|||
145957069|NCT00103285|526356164|FG005|Response Assignment|Adverse Event|1|||
145957070|NCT00103285|526356165|FG006|Response Assignment|Adverse Event|1|||
145957071|NCT00103285|526356166|FG007|Response Assignment|Adverse Event|2|||
145957072|NCT00103285|526356159|FG000|Response Assignment|Death|0|||
145957073|NCT00103285|526356160|FG001|Response Assignment|Death|5|||
145957074|NCT00103285|526356161|FG002|Response Assignment|Death|2|||
145957075|NCT00103285|526356162|FG003|Response Assignment|Death|2|||
145957076|NCT00103285|526356163|FG004|Response Assignment|Death|3|||
145957077|NCT00103285|526356164|FG005|Response Assignment|Death|1|||
145957078|NCT00103285|526356165|FG006|Response Assignment|Death|0|||
145957079|NCT00103285|526356166|FG007|Response Assignment|Death|8|||
145957080|NCT00103285|526356159|FG000|Response Assignment|Lost to Follow-up|0|||
145957081|NCT00103285|526356160|FG001|Response Assignment|Lost to Follow-up|9|||
145957082|NCT00103285|526356161|FG002|Response Assignment|Lost to Follow-up|5|||
145957083|NCT00103285|526356162|FG003|Response Assignment|Lost to Follow-up|5|||
145957084|NCT00103285|526356163|FG004|Response Assignment|Lost to Follow-up|1|||
145957085|NCT00103285|526356164|FG005|Response Assignment|Lost to Follow-up|2|||
145957086|NCT00103285|526356165|FG006|Response Assignment|Lost to Follow-up|2|||
145957087|NCT00103285|526356166|FG007|Response Assignment|Lost to Follow-up|5|||
145957088|NCT00103285|526356159|FG000|Response Assignment|Physician Decision|0|||
145957089|NCT00103285|526356160|FG001|Response Assignment|Physician Decision|13|||
145957090|NCT00103285|526356161|FG002|Response Assignment|Physician Decision|14|||
145957091|NCT00103285|526356162|FG003|Response Assignment|Physician Decision|9|||
145957092|NCT00103285|526356163|FG004|Response Assignment|Physician Decision|13|||
145957093|NCT00103285|526356164|FG005|Response Assignment|Physician Decision|7|||
145957094|NCT00103285|526356165|FG006|Response Assignment|Physician Decision|4|||
145957095|NCT00103285|526356166|FG007|Response Assignment|Physician Decision|35|||
145957096|NCT00103285|526356159|FG000|Response Assignment|Protocol Violation|0|||
145957097|NCT00103285|526356160|FG001|Response Assignment|Protocol Violation|2|||
145957098|NCT00103285|526356161|FG002|Response Assignment|Protocol Violation|0|||
145957099|NCT00103285|526356162|FG003|Response Assignment|Protocol Violation|0|||
145957100|NCT00103285|526356163|FG004|Response Assignment|Protocol Violation|0|||
145957101|NCT00103285|526356164|FG005|Response Assignment|Protocol Violation|0|||
145957102|NCT00103285|526356165|FG006|Response Assignment|Protocol Violation|0|||
145957103|NCT00103285|526356166|FG007|Response Assignment|Protocol Violation|0|||
145957104|NCT00103285|526356159|FG000|Response Assignment|Withdrawal by Subject|0|||
145957105|NCT00103285|526356160|FG001|Response Assignment|Withdrawal by Subject|4|||
145957106|NCT00103285|526356161|FG002|Response Assignment|Withdrawal by Subject|1|||
145957107|NCT00103285|526356162|FG003|Response Assignment|Withdrawal by Subject|1|||
145957108|NCT00103285|526356163|FG004|Response Assignment|Withdrawal by Subject|2|||
145957109|NCT00103285|526356164|FG005|Response Assignment|Withdrawal by Subject|2|||
145957110|NCT00103285|526356165|FG006|Response Assignment|Withdrawal by Subject|0|||
145957111|NCT00103285|526356166|FG007|Response Assignment|Withdrawal by Subject|2|||
145957112|NCT00103285|526356159|FG000|Response Assignment|Ineligible|0|||
145957113|NCT00103285|526356160|FG001|Response Assignment|Ineligible|8|||
145957114|NCT00103285|526356161|FG002|Response Assignment|Ineligible|6|||
145957115|NCT00103285|526356162|FG003|Response Assignment|Ineligible|2|||
145957116|NCT00103285|526356163|FG004|Response Assignment|Ineligible|0|||
145957117|NCT00103285|526356164|FG005|Response Assignment|Ineligible|3|||
145957118|NCT00103285|526356165|FG006|Response Assignment|Ineligible|1|||
145957119|NCT00103285|526356166|FG007|Response Assignment|Ineligible|5|||
145957120|NCT00103285|526356159|FG000|Response Assignment|Refusal|0|||
145957121|NCT00103285|526356160|FG001|Response Assignment|Refusal|53|||
146210449|NCT02462759|527284051|FG001|Part 1: Double Blind|Death|0|||
146210450|NCT02462759|527284052|FG002|Part 1: Double Blind|Death|0|||
146210451|NCT04110054|527284053|FG000|Overall Study|COVID-19 reason other than AE|0|||
145957122|NCT00103285|526356161|FG002|Response Assignment|Refusal|5|||
145957123|NCT00103285|526356162|FG003|Response Assignment|Refusal|3|||
145957124|NCT00103285|526356163|FG004|Response Assignment|Refusal|25|||
145957125|NCT00103285|526356164|FG005|Response Assignment|Refusal|15|||
145957126|NCT00103285|526356165|FG006|Response Assignment|Refusal|30|||
145957127|NCT00103285|526356166|FG007|Response Assignment|Refusal|10|||
145957128|NCT00103285|526356159|FG000|Response Assignment|Other|0|||
145957129|NCT00103285|526356160|FG001|Response Assignment|Other|30|||
145957130|NCT00103285|526356161|FG002|Response Assignment|Other|48|||
146286083|NCT02545933|527561244|FG002|Overall Study|Adverse Event|0|||
146286084|NCT02545933|527561242|FG000|Overall Study|Withdrawal by Subject|2|||
146210452|NCT04110054|527284054|FG001|Overall Study|COVID-19 reason other than AE|0|||
146210453|NCT04110054|527284055|FG002|Overall Study|COVID-19 reason other than AE|2|||
146210454|NCT04110054|527284056|FG003|Overall Study|COVID-19 reason other than AE|0|||
146210455|NCT04110054|527284053|FG000|Overall Study|Withdrawal by Subject|0|||
146210456|NCT04110054|527284054|FG001|Overall Study|Withdrawal by Subject|3|||
146210457|NCT04110054|527284055|FG002|Overall Study|Withdrawal by Subject|2|||
146210458|NCT04110054|527284056|FG003|Overall Study|Withdrawal by Subject|0|||
146210459|NCT04110054|527284053|FG000|Overall Study|Adverse Event|1|||
146210460|NCT04110054|527284054|FG001|Overall Study|Adverse Event|1|||
146210461|NCT04110054|527284055|FG002|Overall Study|Adverse Event|4|||
146210462|NCT04110054|527284056|FG003|Overall Study|Adverse Event|3|||
146210463|NCT01000480|527284058|FG000|Induction Phase|Adverse Event|2|||
146210464|NCT01000480|527284058|FG000|Induction Phase|Lost to Follow-up|1|||
145957131|NCT00103285|526356162|FG003|Response Assignment|Other|38|||
145957132|NCT00103285|526356163|FG004|Response Assignment|Other|37|||
145957133|NCT00103285|526356164|FG005|Response Assignment|Other|17|||
146210465|NCT01000480|527284058|FG000|Induction Phase|Physician Decision|1|||
145957134|NCT00103285|526356165|FG006|Response Assignment|Other|11|||
145957135|NCT00103285|526356166|FG007|Response Assignment|Other|53|||
146210466|NCT01000480|527284058|FG000|Induction Phase|Entry Criteria Not Met|3|||
146210467|NCT01000480|527284058|FG000|Concurrent Therapy Phase|Adverse Event|4|||
146083614|NCT02276027|526826512|FG000|Overall Study|Subject/guardian decision|0|||
146083615|NCT02276027|526826513|FG001|Overall Study|Subject/guardian decision|1|||
146083616|NCT02276027|526826514|FG002|Overall Study|Subject/guardian decision|0|||
146083617|NCT02276027|526826515|FG003|Overall Study|Subject/guardian decision|3|||
146083618|NCT02276027|526826512|FG000|Overall Study|Adverse Event|0|||
146083619|NCT02276027|526826513|FG001|Overall Study|Adverse Event|2|||
146083620|NCT02276027|526826514|FG002|Overall Study|Adverse Event|8|||
146083621|NCT02276027|526826515|FG003|Overall Study|Adverse Event|2|||
146083622|NCT03224598|526826516|FG000|Overall Study|Lost to Follow-up|0|||
146083623|NCT03224598|526826517|FG001|Overall Study|Lost to Follow-up|2|||
146083624|NCT03224598|526826518|FG002|Overall Study|Lost to Follow-up|0|||
146083625|NCT03224598|526826516|FG000|Overall Study|Other|0|||
146083626|NCT03224598|526826517|FG001|Overall Study|Other|1|||
146083627|NCT03224598|526826518|FG002|Overall Study|Other|0|||
145957136|NCT02624947|526356167|FG000|Maternal Participants|Adverse Event|5|||
145957137|NCT02624947|526356168|FG001|Maternal Participants|Adverse Event|0|||
145957138|NCT02624947|526356167|FG000|Maternal Participants|Investigator Decision|5|||
145957139|NCT02624947|526356168|FG001|Maternal Participants|Investigator Decision|3|||
145957140|NCT02624947|526356167|FG000|Maternal Participants|Lost to Follow-up|54|||
145957141|NCT02624947|526356168|FG001|Maternal Participants|Lost to Follow-up|24|||
145957142|NCT02624947|526356167|FG000|Maternal Participants|Non Compliance|8|||
145957143|NCT02624947|526356168|FG001|Maternal Participants|Non Compliance|5|||
145957144|NCT02624947|526356167|FG000|Maternal Participants|Sponsor Request|1|||
145957145|NCT02624947|526356168|FG001|Maternal Participants|Sponsor Request|1|||
145957146|NCT02624947|526356167|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
145957147|NCT02624947|526356168|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
145957148|NCT02624947|526356167|FG000|Maternal Participants|Miscellaneous|23|||
145957149|NCT02624947|526356168|FG001|Maternal Participants|Miscellaneous|15|||
145957150|NCT02624947|526356167|FG000|Infant Participants|Adverse Event|18|||
145957151|NCT02624947|526356168|FG001|Infant Participants|Adverse Event|11|||
145957152|NCT02624947|526356167|FG000|Infant Participants|Investigator Decision|5|||
145957153|NCT02624947|526356168|FG001|Infant Participants|Investigator Decision|4|||
145957154|NCT02624947|526356167|FG000|Infant Participants|Lost to Follow-up|93|||
145957155|NCT02624947|526356168|FG001|Infant Participants|Lost to Follow-up|58|||
145957156|NCT02624947|526356167|FG000|Infant Participants|Non Compliance|17|||
145957157|NCT02624947|526356168|FG001|Infant Participants|Non Compliance|7|||
145957158|NCT02624947|526356167|FG000|Infant Participants|Sponsor Request|0|||
145957159|NCT02624947|526356168|FG001|Infant Participants|Sponsor Request|1|||
145957160|NCT02624947|526356167|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
145957161|NCT02624947|526356168|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
145957162|NCT02624947|526356167|FG000|Infant Participants|Miscellaneous|50|||
145957163|NCT02624947|526356168|FG001|Infant Participants|Miscellaneous|26|||
145957164|NCT03654729|526356169|FG000|Overall Study|Death|9|||
145957165|NCT03654729|526356170|FG001|Overall Study|Death|9|||
146286085|NCT02545933|527561243|FG001|Overall Study|Withdrawal by Subject|3|||
146286086|NCT02545933|527561244|FG002|Overall Study|Withdrawal by Subject|3|||
145957166|NCT03654729|526356171|FG002|Overall Study|Death|16|||
145957167|NCT03654729|526356169|FG000|Overall Study|Withdrawal by Subject|8|||
145957168|NCT03654729|526356170|FG001|Overall Study|Withdrawal by Subject|6|||
145957169|NCT03654729|526356171|FG002|Overall Study|Withdrawal by Subject|4|||
145957170|NCT03654729|526356169|FG000|Overall Study|Study terminated by Sponsor|3|||
145957171|NCT03654729|526356170|FG001|Overall Study|Study terminated by Sponsor|5|||
145957172|NCT03654729|526356171|FG002|Overall Study|Study terminated by Sponsor|4|||
146083628|NCT02446171|526826528|FG000|Overall Study|Withdrawal by Subject|0|||
146083629|NCT02446171|526826529|FG001|Overall Study|Withdrawal by Subject|0|||
146083630|NCT02446171|526826530|FG002|Overall Study|Withdrawal by Subject|2|||
146083631|NCT02446171|526826531|FG003|Overall Study|Withdrawal by Subject|0|||
146083632|NCT01142089|526826532|FG000|Overall Study|Physician Decision|1|||
145957173|NCT03654729|526356169|FG000|Overall Study|Not reported|2|||
145957174|NCT03654729|526356170|FG001|Overall Study|Not reported|4|||
145957175|NCT03654729|526356171|FG002|Overall Study|Not reported|5|||
145957176|NCT03654729|526356169|FG000|Overall Study|Progressive disease|3|||
145957177|NCT03654729|526356170|FG001|Overall Study|Progressive disease|0|||
145957178|NCT03654729|526356171|FG002|Overall Study|Progressive disease|0|||
145957179|NCT03654729|526356169|FG000|Overall Study|Lost to Follow-up|2|||
145957180|NCT03654729|526356170|FG001|Overall Study|Lost to Follow-up|0|||
145957181|NCT03654729|526356171|FG002|Overall Study|Lost to Follow-up|0|||
145957182|NCT03654729|526356169|FG000|Overall Study|Physician Decision|2|||
145957183|NCT03654729|526356170|FG001|Overall Study|Physician Decision|0|||
145957184|NCT03654729|526356171|FG002|Overall Study|Physician Decision|0|||
145957185|NCT03654729|526356169|FG000|Overall Study|Protocol Violation|1|||
145957186|NCT03654729|526356170|FG001|Overall Study|Protocol Violation|1|||
145957187|NCT03654729|526356171|FG002|Overall Study|Protocol Violation|0|||
145957188|NCT03654729|526356169|FG000|Overall Study|Non-compliance with study drug|0|||
145957189|NCT03654729|526356170|FG001|Overall Study|Non-compliance with study drug|1|||
145957190|NCT03654729|526356171|FG002|Overall Study|Non-compliance with study drug|0|||
145957191|NCT03654729|526356169|FG000|Overall Study|Site terminated by Sponsor|1|||
145957192|NCT03654729|526356170|FG001|Overall Study|Site terminated by Sponsor|0|||
145957193|NCT03654729|526356171|FG002|Overall Study|Site terminated by Sponsor|0|||
145957194|NCT01919164|526356176|FG000|Overall Study|Adverse Event|6|||
145957195|NCT01919164|526356177|FG001|Overall Study|Adverse Event|4|||
145957196|NCT01919164|526356178|FG002|Overall Study|Adverse Event|9|||
145957197|NCT01919164|526356179|FG003|Overall Study|Adverse Event|3|||
145957198|NCT01919164|526356180|FG004|Overall Study|Adverse Event|2|||
145957199|NCT01919164|526356176|FG000|Overall Study|Lost to Follow-up|2|||
145957200|NCT01919164|526356177|FG001|Overall Study|Lost to Follow-up|2|||
145957201|NCT01919164|526356178|FG002|Overall Study|Lost to Follow-up|2|||
145957202|NCT01919164|526356179|FG003|Overall Study|Lost to Follow-up|0|||
145957203|NCT01919164|526356180|FG004|Overall Study|Lost to Follow-up|4|||
145957204|NCT01919164|526356176|FG000|Overall Study|Death|1|||
145957205|NCT01919164|526356177|FG001|Overall Study|Death|0|||
145957206|NCT01919164|526356178|FG002|Overall Study|Death|0|||
145957207|NCT01919164|526356179|FG003|Overall Study|Death|0|||
145957208|NCT01919164|526356180|FG004|Overall Study|Death|0|||
145957209|NCT01919164|526356176|FG000|Overall Study|Protocol Violation|6|||
145957210|NCT01919164|526356177|FG001|Overall Study|Protocol Violation|0|||
145957211|NCT01919164|526356178|FG002|Overall Study|Protocol Violation|3|||
145957212|NCT01919164|526356179|FG003|Overall Study|Protocol Violation|2|||
145957213|NCT01919164|526356180|FG004|Overall Study|Protocol Violation|2|||
145957214|NCT01919164|526356176|FG000|Overall Study|Disease progression|2|||
145957215|NCT01919164|526356177|FG001|Overall Study|Disease progression|2|||
145957216|NCT01919164|526356178|FG002|Overall Study|Disease progression|1|||
145957217|NCT01919164|526356179|FG003|Overall Study|Disease progression|2|||
145957218|NCT01919164|526356180|FG004|Overall Study|Disease progression|1|||
146286087|NCT02545933|527561242|FG000|Overall Study|Protocol Violation|1|||
145957219|NCT01919164|526356176|FG000|Overall Study|Withdrew consent|13|||
145957220|NCT01919164|526356177|FG001|Overall Study|Withdrew consent|13|||
145957221|NCT01919164|526356178|FG002|Overall Study|Withdrew consent|14|||
145957222|NCT01919164|526356179|FG003|Overall Study|Withdrew consent|14|||
145957223|NCT01919164|526356180|FG004|Overall Study|Withdrew consent|9|||
145957224|NCT01919164|526356176|FG000|Overall Study|Other Un-specified|13|||
145957225|NCT01919164|526356177|FG001|Overall Study|Other Un-specified|9|||
145957226|NCT01919164|526356178|FG002|Overall Study|Other Un-specified|8|||
145957227|NCT01919164|526356179|FG003|Overall Study|Other Un-specified|7|||
145957228|NCT01919164|526356180|FG004|Overall Study|Other Un-specified|15|||
145957229|NCT00588146|526356181|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
145957230|NCT00588146|526356182|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
145957231|NCT02100839|526356183|FG000|Multiple Ascending Dose|Adverse Event|2|||
145957232|NCT02100839|526356184|FG001|Multiple Ascending Dose|Adverse Event|0|||
145957233|NCT02100839|526356183|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
145957234|NCT02100839|526356184|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
145957235|NCT00463801|526356186|FG000|Overall Study|Protocol Violation|1|||
145957236|NCT00463801|526356186|FG000|Overall Study|Lack of Efficacy|2|||
145957237|NCT00463801|526356186|FG000|Overall Study|Adverse Event|4|||
145957238|NCT00463801|526356186|FG000|Overall Study|Lost to Follow-up|5|||
145957239|NCT00463801|526356186|FG000|Overall Study|No longer require therapy|1|||
145957240|NCT03272347|526356187|FG000|Overall Study|Death|0|||
145957241|NCT03272347|526356188|FG001|Overall Study|Death|0|||
145957242|NCT03272347|526356189|FG002|Overall Study|Death|0|||
145957243|NCT03272347|526356190|FG003|Overall Study|Death|1|||
145957244|NCT03272347|526356187|FG000|Overall Study|Lost to Follow-up|1|||
145957245|NCT03272347|526356188|FG001|Overall Study|Lost to Follow-up|3|||
145957246|NCT03272347|526356189|FG002|Overall Study|Lost to Follow-up|5|||
145957247|NCT03272347|526356190|FG003|Overall Study|Lost to Follow-up|1|||
145957248|NCT03272347|526356187|FG000|Overall Study|Physician Decision|4|||
145957249|NCT03272347|526356188|FG001|Overall Study|Physician Decision|2|||
145957250|NCT03272347|526356189|FG002|Overall Study|Physician Decision|5|||
145957251|NCT03272347|526356190|FG003|Overall Study|Physician Decision|4|||
145957252|NCT03272347|526356187|FG000|Overall Study|Screen Failure|1|||
145957253|NCT03272347|526356188|FG001|Overall Study|Screen Failure|0|||
145957254|NCT03272347|526356189|FG002|Overall Study|Screen Failure|0|||
145957255|NCT03272347|526356190|FG003|Overall Study|Screen Failure|0|||
145957256|NCT03272347|526356187|FG000|Overall Study|Withdrawal by Subject|5|||
145957257|NCT03272347|526356188|FG001|Overall Study|Withdrawal by Subject|1|||
145957258|NCT03272347|526356189|FG002|Overall Study|Withdrawal by Subject|2|||
145957259|NCT03272347|526356190|FG003|Overall Study|Withdrawal by Subject|1|||
145957260|NCT00940888|526356191|FG000|Overall Study|Unsuccessful Implant|4|||
145957261|NCT00940888|526356191|FG000|Overall Study|Death|461|||
145957262|NCT00940888|526356191|FG000|Overall Study|Withdrawn - Non-Death|364|||
145957263|NCT00940888|526356191|FG000|Overall Study|Lost to Follow-up|6|||
145957264|NCT01409915|526356195|FG000|Overall Study|Adverse Event|0|||
145957265|NCT01409915|526356196|FG001|Overall Study|Adverse Event|2|||
145957266|NCT01409915|526356195|FG000|Overall Study|Withdrawal by Subject|0|||
145957267|NCT01409915|526356196|FG001|Overall Study|Withdrawal by Subject|1|||
145957268|NCT01409915|526356195|FG000|Overall Study|Protocol Violation|1|||
145957269|NCT01409915|526356196|FG001|Overall Study|Protocol Violation|0|||
145957270|NCT00391872|526356197|FG000|Overall Study|Protocol Violation|7|||
145957271|NCT00391872|526356198|FG001|Overall Study|Protocol Violation|2|||
145957272|NCT00391872|526356197|FG000|Overall Study|Withdrawal by Subject|296|||
146210468|NCT01000480|527284058|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
146210469|NCT01000480|527284058|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
146210470|NCT01000480|527284058|FG000|Concurrent Therapy Phase|Physician Decision|1|||
146210471|NCT02374307|527284062|FG000|3-months Follow-up|Lost to Follow-up|1|||
146210472|NCT02374307|527284063|FG001|3-months Follow-up|Lost to Follow-up|2|||
146210473|NCT02374307|527284062|FG000|3-months Follow-up|Withdrawal by Subject|1|||
145957273|NCT00391872|526356198|FG001|Overall Study|Withdrawal by Subject|249|||
145957274|NCT00391872|526356197|FG000|Overall Study|Reason unknown|2|||
145957275|NCT00391872|526356198|FG001|Overall Study|Reason unknown|4|||
145957276|NCT00391872|526356197|FG000|Overall Study|Lost to Follow-up|2|||
145957277|NCT00391872|526356198|FG001|Overall Study|Lost to Follow-up|0|||
145957278|NCT00215644|526356199|FG000|Overall Study|Disease Progression|28|||
145957279|NCT00215644|526356200|FG001|Overall Study|Disease Progression|10|||
145957280|NCT00215644|526356199|FG000|Overall Study|Adverse Event|2|||
145957281|NCT00215644|526356200|FG001|Overall Study|Adverse Event|9|||
145957282|NCT00215644|526356199|FG000|Overall Study|Death|1|||
146210474|NCT02374307|527284063|FG001|3-months Follow-up|Withdrawal by Subject|4|||
145957283|NCT00215644|526356200|FG001|Overall Study|Death|2|||
146210475|NCT02374307|527284062|FG000|3-months Follow-up|Death|1|||
146210476|NCT02374307|527284063|FG001|3-months Follow-up|Death|2|||
146210477|NCT02374307|527284062|FG000|3-months Follow-up|Missed first follow-up|5|||
146210478|NCT02374307|527284063|FG001|3-months Follow-up|Missed first follow-up|1|||
146210479|NCT02374307|527284062|FG000|6-months Follow-up|Lost to Follow-up|1|||
146210480|NCT02374307|527284063|FG001|6-months Follow-up|Lost to Follow-up|2|||
146286088|NCT02545933|527561243|FG001|Overall Study|Protocol Violation|0|||
146286089|NCT02545933|527561244|FG002|Overall Study|Protocol Violation|1|||
146210481|NCT02374307|527284062|FG000|6-months Follow-up|Death|2|||
146210482|NCT02374307|527284063|FG001|6-months Follow-up|Death|1|||
146210483|NCT02374307|527284062|FG000|6-months Follow-up|Withdrawal by Subject|0|||
146210484|NCT02374307|527284063|FG001|6-months Follow-up|Withdrawal by Subject|3|||
146210485|NCT00632203|527284064|FG000|Overall Study|Did not start study treatment|1|||
146210486|NCT00632203|527284065|FG001|Overall Study|Did not start study treatment|0|||
146210487|NCT04452318|527284068|FG000|Overall Study|Physician Decision|1|||
146210488|NCT04452318|527284069|FG001|Overall Study|Physician Decision|2|||
146210489|NCT04452318|527284070|FG002|Overall Study|Physician Decision|0|||
146083633|NCT01142089|526826533|FG001|Overall Study|Physician Decision|0|||
146210490|NCT04452318|527284071|FG003|Overall Study|Physician Decision|2|||
146286090|NCT01370590|527561245|FG000|Period 1|Adverse Event|8|||
145957284|NCT00215644|526356199|FG000|Overall Study|Withdrawal by Subject|1|||
145957285|NCT00215644|526356200|FG001|Overall Study|Withdrawal by Subject|0|||
145957286|NCT00215644|526356199|FG000|Overall Study|Other|3|||
146083634|NCT01142089|526826532|FG000|Overall Study|Withdrawal by Subject|1|||
146083635|NCT01142089|526826533|FG001|Overall Study|Withdrawal by Subject|2|||
146083636|NCT01142089|526826532|FG000|Overall Study|Use of prohibited medications|0|||
146083637|NCT01142089|526826533|FG001|Overall Study|Use of prohibited medications|1|||
146083638|NCT01142089|526826532|FG000|Overall Study|Noncompliance with study procedures|2|||
146083639|NCT01142089|526826533|FG001|Overall Study|Noncompliance with study procedures|1|||
146083640|NCT01142089|526826532|FG000|Overall Study|Patient required rescue medication|8|||
146083641|NCT01142089|526826533|FG001|Overall Study|Patient required rescue medication|17|||
146083642|NCT02907892|526826538|FG000|Overall Study|Lost to Follow-up|27|||
146083643|NCT02907892|526826539|FG001|Overall Study|Lost to Follow-up|40|||
146083644|NCT01974765|526826540|FG000|Overall Study|Withdrawal by Subject|1|||
146083645|NCT01974765|526826540|FG000|Overall Study|Death|1|||
146083646|NCT01974765|526826540|FG000|Overall Study|Adverse Event|2|||
146083647|NCT03328182|526826543|FG000|Overall Study|Withdrawal by Subject|1|||
146083648|NCT03328182|526826543|FG000|Overall Study|Protocol Violation|2|||
146083649|NCT03328182|526826543|FG000|Overall Study|No Product Evaluated|1|||
146083650|NCT04531462|526826544|FG000|Overall Study|Withdrawal by Subject|3|||
146083651|NCT04531462|526826545|FG001|Overall Study|Withdrawal by Subject|1|||
146083652|NCT04531462|526826544|FG000|Overall Study|Adverse Event|3|||
146083653|NCT04531462|526826545|FG001|Overall Study|Adverse Event|3|||
146083654|NCT00504582|526826546|FG000|Overall Study|Lost to Follow-up|1|||
146083655|NCT00504582|526826547|FG001|Overall Study|Lost to Follow-up|0|||
146083656|NCT00504582|526826548|FG002|Overall Study|Lost to Follow-up|0|||
146083657|NCT00348933|526826551|FG000|Overall Study|Withdrawal by Subject|10|||
146210491|NCT04452318|527284072|FG004|Overall Study|Physician Decision|0|||
145957287|NCT00215644|526356200|FG001|Overall Study|Other|15|||
145957288|NCT00215644|526356199|FG000|Overall Study|Randomized but Not Treated|1|||
145957289|NCT00215644|526356200|FG001|Overall Study|Randomized but Not Treated|0|||
145957290|NCT02250300|526356201|FG000|Expansion Phase|Death|6|||
145957291|NCT02250300|526356202|FG001|Expansion Phase|Death|7|||
145957292|NCT02250300|526356203|FG002|Expansion Phase|Death|0|||
145957293|NCT02250300|526356204|FG003|Expansion Phase|Death|0|||
145957294|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
145957295|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
145957296|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
145957297|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
145957298|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
145957299|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
145957300|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
145957301|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
145957302|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
145957303|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
145957304|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
145957305|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
145957306|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
145957307|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
145957308|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
145957309|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
145957310|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
145957311|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
145957312|NCT03569098|526356206|FG000|Double-Blind Treatment Cycle 1|Other|1|||
145957313|NCT03569098|526356207|FG001|Double-Blind Treatment Cycle 1|Other|0|||
145957314|NCT03569098|526356208|FG002|Double-Blind Treatment Cycle 1|Other|1|||
145957315|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
145957316|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
145957317|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
145957318|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
145957319|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
145957320|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
146210492|NCT04452318|527284073|FG005|Overall Study|Physician Decision|2|||
146210493|NCT04452318|527284074|FG006|Overall Study|Physician Decision|5|||
146210494|NCT04452318|527284068|FG000|Overall Study|Death|2|||
146210495|NCT04452318|527284069|FG001|Overall Study|Death|3|||
145957321|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
145957322|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
145957323|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
146083658|NCT00348933|526826551|FG000|Overall Study|Lost to Follow-up|6|||
146083659|NCT00348933|526826551|FG000|Overall Study|Protocol Violation|2|||
146083660|NCT00348933|526826551|FG000|Overall Study|Adverse Event|7|||
146083661|NCT01264081|526826552|FG000|Participants Screened|Screening failures|30|||
146083662|NCT01264081|526826552|FG000|Started Treatment|Withdrawal by Subject|1|||
146210496|NCT04452318|527284070|FG002|Overall Study|Death|0|||
146210497|NCT04452318|527284071|FG003|Overall Study|Death|0|||
146210498|NCT04452318|527284072|FG004|Overall Study|Death|0|||
146210499|NCT04452318|527284073|FG005|Overall Study|Death|0|||
146210500|NCT04452318|527284074|FG006|Overall Study|Death|0|||
146210501|NCT04452318|527284068|FG000|Overall Study|Lost to Follow-up|38|||
146210502|NCT04452318|527284069|FG001|Overall Study|Lost to Follow-up|28|||
146210503|NCT04452318|527284070|FG002|Overall Study|Lost to Follow-up|0|||
146210504|NCT04452318|527284071|FG003|Overall Study|Lost to Follow-up|3|||
146210505|NCT04452318|527284072|FG004|Overall Study|Lost to Follow-up|3|||
146210506|NCT04452318|527284073|FG005|Overall Study|Lost to Follow-up|2|||
146210507|NCT04452318|527284074|FG006|Overall Study|Lost to Follow-up|1|||
146210508|NCT04452318|527284068|FG000|Overall Study|Withdrawal by Subject|46|||
146210509|NCT04452318|527284069|FG001|Overall Study|Withdrawal by Subject|40|||
146210510|NCT04452318|527284070|FG002|Overall Study|Withdrawal by Subject|0|||
146210511|NCT04452318|527284071|FG003|Overall Study|Withdrawal by Subject|18|||
146210512|NCT04452318|527284072|FG004|Overall Study|Withdrawal by Subject|6|||
146210513|NCT04452318|527284073|FG005|Overall Study|Withdrawal by Subject|8|||
146210514|NCT04452318|527284074|FG006|Overall Study|Withdrawal by Subject|6|||
146210515|NCT02554786|527284075|FG000|Overall Study|Subject/guardian decision|29|||
146210516|NCT02554786|527284076|FG001|Overall Study|Subject/guardian decision|17|||
146210517|NCT02554786|527284077|FG002|Overall Study|Subject/guardian decision|18|||
146210518|NCT02554786|527284078|FG003|Overall Study|Subject/guardian decision|30|||
146210519|NCT02554786|527284079|FG004|Overall Study|Subject/guardian decision|20|||
146210520|NCT02554786|527284075|FG000|Overall Study|Lost to Follow-up|4|||
146210521|NCT02554786|527284076|FG001|Overall Study|Lost to Follow-up|3|||
146210522|NCT02554786|527284077|FG002|Overall Study|Lost to Follow-up|4|||
146210523|NCT02554786|527284078|FG003|Overall Study|Lost to Follow-up|2|||
146210524|NCT02554786|527284079|FG004|Overall Study|Lost to Follow-up|2|||
146210525|NCT02554786|527284075|FG000|Overall Study|Protocol deviation|1|||
146210526|NCT02554786|527284076|FG001|Overall Study|Protocol deviation|3|||
146210527|NCT02554786|527284077|FG002|Overall Study|Protocol deviation|3|||
146210528|NCT02554786|527284078|FG003|Overall Study|Protocol deviation|4|||
146210529|NCT02554786|527284079|FG004|Overall Study|Protocol deviation|2|||
146210530|NCT02554786|527284075|FG000|Overall Study|Technical problems|1|||
146210531|NCT02554786|527284076|FG001|Overall Study|Technical problems|1|||
146210532|NCT02554786|527284077|FG002|Overall Study|Technical problems|0|||
146210533|NCT02554786|527284078|FG003|Overall Study|Technical problems|2|||
146210534|NCT02554786|527284079|FG004|Overall Study|Technical problems|1|||
146210535|NCT02554786|527284075|FG000|Overall Study|Adverse Event|0|||
146210536|NCT02554786|527284076|FG001|Overall Study|Adverse Event|0|||
146210537|NCT02554786|527284077|FG002|Overall Study|Adverse Event|0|||
146210538|NCT02554786|527284078|FG003|Overall Study|Adverse Event|0|||
146210539|NCT02554786|527284079|FG004|Overall Study|Adverse Event|2|||
146210540|NCT02554786|527284075|FG000|Overall Study|Death|0|||
146210541|NCT02554786|527284076|FG001|Overall Study|Death|0|||
146210542|NCT02554786|527284077|FG002|Overall Study|Death|0|||
146210543|NCT02554786|527284078|FG003|Overall Study|Death|1|||
146210544|NCT02554786|527284079|FG004|Overall Study|Death|0|||
146210545|NCT02554786|527284075|FG000|Overall Study|Non-compliance with study treatment|0|||
146210546|NCT02554786|527284076|FG001|Overall Study|Non-compliance with study treatment|1|||
146210547|NCT02554786|527284077|FG002|Overall Study|Non-compliance with study treatment|1|||
146210548|NCT02554786|527284078|FG003|Overall Study|Non-compliance with study treatment|0|||
146210549|NCT02554786|527284079|FG004|Overall Study|Non-compliance with study treatment|1|||
146210550|NCT02554786|527284075|FG000|Overall Study|Physician Decision|0|||
146210551|NCT02554786|527284076|FG001|Overall Study|Physician Decision|1|||
146210552|NCT02554786|527284077|FG002|Overall Study|Physician Decision|4|||
146210553|NCT02554786|527284078|FG003|Overall Study|Physician Decision|1|||
146210554|NCT02554786|527284079|FG004|Overall Study|Physician Decision|1|||
146210555|NCT02554786|527284075|FG000|Overall Study|Pregnancy|0|||
146210556|NCT02554786|527284076|FG001|Overall Study|Pregnancy|0|||
146210557|NCT02554786|527284077|FG002|Overall Study|Pregnancy|0|||
146210558|NCT02554786|527284078|FG003|Overall Study|Pregnancy|1|||
146210559|NCT02554786|527284079|FG004|Overall Study|Pregnancy|1|||
146210560|NCT00604669|527284080|FG000|Overall Study|lack of information in chart|7|||
146210561|NCT01695954|527284081|FG000|Overall Study|Withdrawal by Subject|4|||
146210562|NCT01695954|527284082|FG001|Overall Study|Withdrawal by Subject|0|||
146210563|NCT01695954|527284081|FG000|Overall Study|Adverse Event|0|||
146210564|NCT01695954|527284082|FG001|Overall Study|Adverse Event|2|||
146210565|NCT03330795|527284097|FG000|Overall Study|Death|3|||
145957324|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
145957325|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
145957326|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
145957327|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
145957328|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
145957329|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
145957330|NCT03569098|526356206|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
145957331|NCT03569098|526356207|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
145957332|NCT03569098|526356208|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
145957333|NCT01516736|526356215|FG000|Overall Study|Withdrawal by Subject|10|||
145957334|NCT01516736|526356216|FG001|Overall Study|Withdrawal by Subject|4|||
145957335|NCT01516736|526356215|FG000|Overall Study|Adverse Event|4|||
145957336|NCT01516736|526356216|FG001|Overall Study|Adverse Event|5|||
145957337|NCT01516736|526356215|FG000|Overall Study|Death|3|||
145957338|NCT01516736|526356216|FG001|Overall Study|Death|1|||
145957339|NCT01516736|526356215|FG000|Overall Study|Physician Decision|2|||
145957340|NCT01516736|526356216|FG001|Overall Study|Physician Decision|1|||
145957341|NCT01516736|526356215|FG000|Overall Study|Lack of Efficacy|1|||
145957342|NCT01516736|526356216|FG001|Overall Study|Lack of Efficacy|0|||
145957343|NCT01516736|526356215|FG000|Overall Study|Protocol Violation|0|||
145957344|NCT01516736|526356216|FG001|Overall Study|Protocol Violation|1|||
145957345|NCT01516736|526356215|FG000|Overall Study|Other (not specified)|0|||
146210566|NCT03330795|527284097|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
146210567|NCT00539734|527284099|FG000|Overall Study|Protocol Violation|1|||
146210568|NCT01070069|527284100|FG000|Overall Study|Death|1|||
146210569|NCT01070069|527284101|FG001|Overall Study|Death|0|||
146210570|NCT01070069|527284102|FG002|Overall Study|Death|2|||
146210571|NCT01070069|527284103|FG003|Overall Study|Death|0|||
146210572|NCT01070069|527284104|FG004|Overall Study|Death|1|||
146210573|NCT01070069|527284100|FG000|Overall Study|Withdrawal by Subject|1|||
146210574|NCT01070069|527284101|FG001|Overall Study|Withdrawal by Subject|1|||
145957346|NCT01516736|526356216|FG001|Overall Study|Other (not specified)|1|||
145957347|NCT02781818|526356217|FG000|Overall Study|Lost to Follow-up|4|||
145957348|NCT02781818|526356218|FG001|Overall Study|Lost to Follow-up|2|||
145957349|NCT02781818|526356219|FG002|Overall Study|Lost to Follow-up|1|||
145957350|NCT01877668|526356220|FG000|Overall Study|Death|0|||
145957351|NCT01877668|526356221|FG001|Overall Study|Death|0|||
145957352|NCT01877668|526356222|FG002|Overall Study|Death|0|||
145957353|NCT01877668|526356223|FG003|Overall Study|Death|1|||
145957354|NCT01877668|526356224|FG004|Overall Study|Death|0|||
145957355|NCT01877668|526356220|FG000|Overall Study|No longer met study criteria|1|||
145957356|NCT01877668|526356221|FG001|Overall Study|No longer met study criteria|0|||
145957357|NCT01877668|526356222|FG002|Overall Study|No longer met study criteria|1|||
145957358|NCT01877668|526356223|FG003|Overall Study|No longer met study criteria|0|||
145957359|NCT01877668|526356224|FG004|Overall Study|No longer met study criteria|0|||
146210575|NCT01070069|527284102|FG002|Overall Study|Withdrawal by Subject|4|||
145957360|NCT01877668|526356220|FG000|Overall Study|Insufficient clinical response|0|||
145957361|NCT01877668|526356221|FG001|Overall Study|Insufficient clinical response|1|||
145957362|NCT01877668|526356222|FG002|Overall Study|Insufficient clinical response|2|||
145957363|NCT01877668|526356223|FG003|Overall Study|Insufficient clinical response|2|||
145957364|NCT01877668|526356224|FG004|Overall Study|Insufficient clinical response|0|||
145957365|NCT01877668|526356220|FG000|Overall Study|Lost to Follow-up|0|||
145957366|NCT01877668|526356221|FG001|Overall Study|Lost to Follow-up|2|||
145957367|NCT01877668|526356222|FG002|Overall Study|Lost to Follow-up|1|||
145957368|NCT01877668|526356223|FG003|Overall Study|Lost to Follow-up|0|||
145957369|NCT01877668|526356224|FG004|Overall Study|Lost to Follow-up|0|||
145957370|NCT01877668|526356220|FG000|Overall Study|Withdrawal by Subject|2|||
145957371|NCT01877668|526356221|FG001|Overall Study|Withdrawal by Subject|0|||
145957372|NCT01877668|526356222|FG002|Overall Study|Withdrawal by Subject|3|||
145957373|NCT01877668|526356223|FG003|Overall Study|Withdrawal by Subject|2|||
145957374|NCT01877668|526356224|FG004|Overall Study|Withdrawal by Subject|2|||
145957375|NCT01877668|526356220|FG000|Overall Study|Other|1|||
145957376|NCT01877668|526356221|FG001|Overall Study|Other|1|||
145957377|NCT01877668|526356222|FG002|Overall Study|Other|1|||
145957378|NCT01877668|526356223|FG003|Overall Study|Other|1|||
145957379|NCT01877668|526356224|FG004|Overall Study|Other|3|||
145957380|NCT01877668|526356220|FG000|Overall Study|Protocol Violation|1|||
145957381|NCT01877668|526356221|FG001|Overall Study|Protocol Violation|1|||
145957382|NCT01877668|526356222|FG002|Overall Study|Protocol Violation|0|||
145957383|NCT01877668|526356223|FG003|Overall Study|Protocol Violation|0|||
145957384|NCT01877668|526356224|FG004|Overall Study|Protocol Violation|3|||
145957385|NCT01877668|526356220|FG000|Overall Study|Adverse event related to study drug|2|||
145957386|NCT01877668|526356221|FG001|Overall Study|Adverse event related to study drug|2|||
145957387|NCT01877668|526356222|FG002|Overall Study|Adverse event related to study drug|2|||
145957388|NCT01877668|526356223|FG003|Overall Study|Adverse event related to study drug|2|||
145957389|NCT01877668|526356224|FG004|Overall Study|Adverse event related to study drug|1|||
145957390|NCT01877668|526356220|FG000|Overall Study|Adverse event unrelated to study drug|4|||
145957391|NCT01877668|526356221|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145957392|NCT01877668|526356222|FG002|Overall Study|Adverse event unrelated to study drug|2|||
145957393|NCT01877668|526356223|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145957394|NCT01877668|526356224|FG004|Overall Study|Adverse event unrelated to study drug|1|||
145957395|NCT01302418|526356225|FG000|Overall Study|Protocol Violation|9|||
145957396|NCT01302418|526356225|FG000|Overall Study|Non-evaluable|9|||
145957397|NCT01697800|526356226|FG000|Overall Study|Death|0|||
146286091|NCT01370590|527561246|FG001|Period 1|Adverse Event|4|||
146286092|NCT01370590|527561245|FG000|Period 1|Lost to Follow-up|2|||
146286093|NCT01370590|527561246|FG001|Period 1|Lost to Follow-up|2|||
146286094|NCT01370590|527561245|FG000|Period 1|Protocol Violation|2|||
146286095|NCT01370590|527561246|FG001|Period 1|Protocol Violation|2|||
146286096|NCT01370590|527561245|FG000|Period 1|Withdrawal by Subject|4|||
146286097|NCT01370590|527561246|FG001|Period 1|Withdrawal by Subject|2|||
146286098|NCT01370590|527561245|FG000|Period 1|Could not access randomization system|0|||
146286099|NCT01370590|527561246|FG001|Period 1|Could not access randomization system|1|||
146286100|NCT01370590|527561245|FG000|Crossover Washout Period|Adverse Event|1|||
146286101|NCT01370590|527561246|FG001|Crossover Washout Period|Adverse Event|4|||
146286102|NCT01370590|527561245|FG000|Crossover Washout Period|Lost to Follow-up|2|||
146286103|NCT01370590|527561246|FG001|Crossover Washout Period|Lost to Follow-up|0|||
146286104|NCT01370590|527561245|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
146286105|NCT01370590|527561246|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
146286106|NCT01370590|527561245|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
146286107|NCT01370590|527561246|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
146286108|NCT01370590|527561245|FG000|Period 2|Adverse Event|0|||
146286109|NCT01370590|527561246|FG001|Period 2|Adverse Event|1|||
146286110|NCT01370590|527561245|FG000|Period 2|Withdrawal by Subject|1|||
146286111|NCT01370590|527561246|FG001|Period 2|Withdrawal by Subject|1|||
146286112|NCT05172050|527561247|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
146286113|NCT05172050|527561248|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
146286114|NCT05172050|527561249|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
146286115|NCT05172050|527561247|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
146286116|NCT05172050|527561248|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
146286117|NCT05172050|527561249|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
146286118|NCT05172050|527561247|FG000|Overall Study|Other|2|||
146286119|NCT05172050|527561248|FG001|Overall Study|Other|2|||
146286120|NCT05172050|527561249|FG002|Overall Study|Other|1|||
146286121|NCT05180500|527561250|FG000|Overall Study|Adverse Event|1|||
146286122|NCT05180500|527561251|FG001|Overall Study|Adverse Event|0|||
146083663|NCT01264081|526826552|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
146083664|NCT01489111|526826553|FG000|Overall Study|Withdrawal criterion|1|||
146286123|NCT05180500|527561250|FG000|Overall Study|Withdrawal by Subject|2|||
146286124|NCT05180500|527561251|FG001|Overall Study|Withdrawal by Subject|0|||
146286125|NCT03992846|527561252|FG000|Overall Study|Adverse Event|8|||
145957398|NCT01697800|526356227|FG001|Overall Study|Death|1|||
146286126|NCT03992846|527561253|FG001|Overall Study|Adverse Event|6|||
146210576|NCT01070069|527284103|FG003|Overall Study|Withdrawal by Subject|0|||
146210577|NCT01070069|527284104|FG004|Overall Study|Withdrawal by Subject|0|||
146210578|NCT01070069|527284100|FG000|Overall Study|Lost to Follow-up|4|||
146210579|NCT01070069|527284101|FG001|Overall Study|Lost to Follow-up|1|||
146210580|NCT01070069|527284102|FG002|Overall Study|Lost to Follow-up|0|||
146210581|NCT01070069|527284103|FG003|Overall Study|Lost to Follow-up|0|||
146210582|NCT01070069|527284104|FG004|Overall Study|Lost to Follow-up|3|||
146210583|NCT01771731|527284105|FG000|Overall Study|Physician Decision|1|||
146210584|NCT01771731|527284106|FG001|Overall Study|Physician Decision|0|||
146210585|NCT01771731|527284105|FG000|Overall Study|Protocol Violation|0|||
146210586|NCT01771731|527284106|FG001|Overall Study|Protocol Violation|1|||
146210587|NCT01771731|527284105|FG000|Overall Study|Adverse event: Pain Crisis|1|||
146210588|NCT01771731|527284106|FG001|Overall Study|Adverse event: Pain Crisis|1|||
146210589|NCT03201562|527284107|FG000|Overall Study|Physician Decision|0|||
146210590|NCT03201562|527284108|FG001|Overall Study|Physician Decision|0|||
146210591|NCT03201562|527284109|FG002|Overall Study|Physician Decision|1|||
146210592|NCT03201562|527284107|FG000|Overall Study|Adverse Event|0|||
146210593|NCT03201562|527284108|FG001|Overall Study|Adverse Event|0|||
146210594|NCT03201562|527284109|FG002|Overall Study|Adverse Event|1|||
146210595|NCT03201562|527284107|FG000|Overall Study|Lost to Follow-up|0|||
146210596|NCT03201562|527284108|FG001|Overall Study|Lost to Follow-up|1|||
146210597|NCT03201562|527284109|FG002|Overall Study|Lost to Follow-up|2|||
146210598|NCT00065260|527284110|FG000|Overall Study|Death|0|||
146210599|NCT00065260|527284111|FG001|Overall Study|Death|1|||
146210600|NCT00001277|527284112|FG000|Overall Study|Adverse Event|0|||
146210601|NCT00001277|527284113|FG001|Overall Study|Adverse Event|0|||
146210602|NCT00001277|527284114|FG002|Overall Study|Adverse Event|1|||
146083665|NCT02716896|526826554|FG000|Overall Study|Physician Decision|0|||
146286127|NCT03992846|527561254|FG002|Overall Study|Adverse Event|3|||
146286128|NCT03992846|527561252|FG000|Overall Study|Lost to Follow-up|0|||
146286129|NCT03992846|527561253|FG001|Overall Study|Lost to Follow-up|1|||
146286130|NCT03992846|527561254|FG002|Overall Study|Lost to Follow-up|1|||
146286131|NCT03992846|527561252|FG000|Overall Study|Pregnancy|2|||
146286132|NCT03992846|527561253|FG001|Overall Study|Pregnancy|0|||
146286133|NCT03992846|527561254|FG002|Overall Study|Pregnancy|1|||
146286134|NCT03992846|527561252|FG000|Overall Study|Protocol Violation|1|||
146286135|NCT03992846|527561253|FG001|Overall Study|Protocol Violation|2|||
146286136|NCT03992846|527561254|FG002|Overall Study|Protocol Violation|0|||
146083666|NCT02716896|526826555|FG001|Overall Study|Physician Decision|1|||
146083667|NCT01727700|526826556|FG000|Overall Study|Adverse Event|0|||
146083668|NCT01727700|526826557|FG001|Overall Study|Adverse Event|7|||
146083669|NCT01727700|526826558|FG002|Overall Study|Adverse Event|1|||
146083670|NCT01727700|526826556|FG000|Overall Study|Particpant withdrew consent|0|||
146083671|NCT01727700|526826557|FG001|Overall Study|Particpant withdrew consent|3|||
146083672|NCT01727700|526826558|FG002|Overall Study|Particpant withdrew consent|1|||
146083673|NCT01727700|526826556|FG000|Overall Study|Protocol Violation|2|||
146083674|NCT01727700|526826557|FG001|Overall Study|Protocol Violation|0|||
146083675|NCT01727700|526826558|FG002|Overall Study|Protocol Violation|0|||
146083676|NCT01757691|526826563|FG000|Overall Study|Administrative problems|2|||
146083677|NCT01757691|526826564|FG001|Overall Study|Administrative problems|0|||
146083678|NCT00464490|526826569|FG000|Overall Study|Physician Decision|11|||
146083679|NCT00464490|526826570|FG001|Overall Study|Physician Decision|11|||
146083680|NCT03188042|526826571|FG000|Overall Study|Withdrawal by Subject|1|||
146083681|NCT03188042|526826572|FG001|Overall Study|Withdrawal by Subject|1|||
146083682|NCT03860935|526826573|FG000|Overall Study|Withdrawal of Consent|15|||
146286137|NCT03992846|527561252|FG000|Overall Study|Withdrawal by Subject|8|||
146286138|NCT03992846|527561253|FG001|Overall Study|Withdrawal by Subject|10|||
146286139|NCT03992846|527561254|FG002|Overall Study|Withdrawal by Subject|20|||
146286140|NCT03992846|527561252|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
146286141|NCT03992846|527561253|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
146286142|NCT03992846|527561254|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
146286143|NCT04101318|527562610|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
146286144|NCT04101318|527562611|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
146286145|NCT04101318|527562610|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
146286146|NCT04101318|527562611|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
146083683|NCT03860935|526826574|FG001|Overall Study|Withdrawal of Consent|6|||
146286147|NCT04101318|527562610|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
146083684|NCT03860935|526826573|FG000|Overall Study|Death|75|||
146083685|NCT03860935|526826574|FG001|Overall Study|Death|51|||
146286148|NCT04101318|527562611|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
146286149|NCT02966301|527562612|FG000|Overall Study|Death|2|||
146083686|NCT04575597|526826575|FG000|Overall Study|Death|0|||
146083687|NCT04575597|526826576|FG001|Overall Study|Death|0|||
146083688|NCT04575597|526826577|FG002|Overall Study|Death|0|||
146083689|NCT04575597|526826578|FG003|Overall Study|Death|1|||
146083690|NCT04575597|526826579|FG004|Overall Study|Death|3|||
146083691|NCT04575597|526826580|FG005|Overall Study|Death|14|||
145957399|NCT01957579|526356233|FG000|Overall Study|Withdrawal of concent|0|||
145957400|NCT01957579|526356234|FG001|Overall Study|Withdrawal of concent|1|||
145957401|NCT01957579|526356235|FG002|Overall Study|Withdrawal of concent|0|||
145957402|NCT01957579|526356236|FG003|Overall Study|Withdrawal of concent|0|||
145957403|NCT01957579|526356233|FG000|Overall Study|Death|0|||
145957404|NCT01957579|526356234|FG001|Overall Study|Death|0|||
145957405|NCT01957579|526356235|FG002|Overall Study|Death|2|||
145957406|NCT01957579|526356236|FG003|Overall Study|Death|0|||
145957407|NCT01000974|526356238|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
145957408|NCT01000974|526356239|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
146083692|NCT04575597|526826575|FG000|Overall Study|Lost to Follow-up|2|||
146286150|NCT02966301|527562612|FG000|Overall Study|Withdrawal by Subject|1|||
146210603|NCT00001277|527284112|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
146210604|NCT00001277|527284113|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
146210605|NCT00001277|527284114|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
146210606|NCT04484935|527284115|FG000|Overall Study|Other|0|||
146210607|NCT04484935|527284116|FG001|Overall Study|Other|1|||
146210608|NCT04484935|527284115|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146210609|NCT04484935|527284116|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146286151|NCT01375114|527562615|FG000|Overall Study|Lost to Follow-up|1|||
146286152|NCT01375114|527562616|FG001|Overall Study|Lost to Follow-up|0|||
146286153|NCT01375114|527562617|FG002|Overall Study|Lost to Follow-up|1|||
146083693|NCT04575597|526826576|FG001|Overall Study|Lost to Follow-up|1|||
146083694|NCT04575597|526826577|FG002|Overall Study|Lost to Follow-up|1|||
146083695|NCT04575597|526826578|FG003|Overall Study|Lost to Follow-up|2|||
146083696|NCT04575597|526826579|FG004|Overall Study|Lost to Follow-up|10|||
146083697|NCT04575597|526826580|FG005|Overall Study|Lost to Follow-up|8|||
146210610|NCT04484935|527284115|FG000|Overall Study|Lost to Follow-up|1|||
146210611|NCT04484935|527284116|FG001|Overall Study|Lost to Follow-up|0|||
146286154|NCT01375114|527562615|FG000|Overall Study|Disease Progression|3|||
146210612|NCT04484935|527284115|FG000|Overall Study|Death|2|||
146083698|NCT04575597|526826575|FG000|Overall Study|Withdrawal by Subject|2|||
146083699|NCT04575597|526826576|FG001|Overall Study|Withdrawal by Subject|2|||
146083700|NCT04575597|526826577|FG002|Overall Study|Withdrawal by Subject|4|||
146083701|NCT04575597|526826578|FG003|Overall Study|Withdrawal by Subject|2|||
146083702|NCT04575597|526826579|FG004|Overall Study|Withdrawal by Subject|25|||
146083703|NCT04575597|526826580|FG005|Overall Study|Withdrawal by Subject|28|||
146083704|NCT04575597|526826575|FG000|Overall Study|Not Recorded|0|||
146083705|NCT04575597|526826576|FG001|Overall Study|Not Recorded|0|||
146083706|NCT04575597|526826577|FG002|Overall Study|Not Recorded|0|||
146210613|NCT04484935|527284116|FG001|Overall Study|Death|1|||
146083707|NCT04575597|526826578|FG003|Overall Study|Not Recorded|0|||
146210614|NCT01044303|527284125|FG000|Overall Study|Lost to Follow-up|2|||
146210615|NCT02539225|527284128|FG000|Part A|Adverse Event|13|||
146210616|NCT02539225|527284129|FG001|Part A|Adverse Event|4|||
146210617|NCT02539225|527284128|FG000|Part A|Withdrawal by Subject|2|||
146210618|NCT02539225|527284129|FG001|Part A|Withdrawal by Subject|4|||
146210619|NCT02539225|527284128|FG000|Part A|Physician Decision|4|||
146210620|NCT02539225|527284129|FG001|Part A|Physician Decision|7|||
146210621|NCT02539225|527284128|FG000|Part A|Did Not Receive study Drug|1|||
146210622|NCT02539225|527284129|FG001|Part A|Did Not Receive study Drug|1|||
146210623|NCT02539225|527284128|FG000|Pre Treatment for Part B|Progressive disease|1|||
146286155|NCT01375114|527562616|FG001|Overall Study|Disease Progression|2|||
145957409|NCT01000974|526356240|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
146210624|NCT02539225|527284129|FG001|Pre Treatment for Part B|Progressive disease|1|||
146083708|NCT04575597|526826579|FG004|Overall Study|Not Recorded|0|||
146083709|NCT04575597|526826580|FG005|Overall Study|Not Recorded|2|||
146083710|NCT04575597|526826575|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146083711|NCT04575597|526826576|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146083712|NCT04575597|526826577|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146083713|NCT04575597|526826578|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146083714|NCT04575597|526826579|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
146083715|NCT04575597|526826580|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146083716|NCT01268579|526826581|FG000|Overall Study|Adverse Event|1|||
146083717|NCT01268579|526826581|FG000|Overall Study|Withdrawal by Subject|2|||
146083718|NCT01209832|526826582|FG000|Period 1|Sponsor Decision and was not dosed|1|||
146083719|NCT01209832|526826582|FG000|Period 2|Sponsor Decision|1|||
146083720|NCT02692651|526826583|FG000|Study Treatment|Death|7|||
146083721|NCT02692651|526826584|FG001|Study Treatment|Death|3|||
146083722|NCT02692651|526826583|FG000|Study Treatment|comfort care|1|||
146083723|NCT02692651|526826584|FG001|Study Treatment|comfort care|1|||
146083724|NCT02692651|526826583|FG000|Study Treatment|Protocol violation per treating team preference|8|||
146083725|NCT02692651|526826584|FG001|Study Treatment|Protocol violation per treating team preference|6|||
146083726|NCT02692651|526826583|FG000|Post Study Treatment Follow-up|Death|4|||
146083727|NCT02692651|526826584|FG001|Post Study Treatment Follow-up|Death|4|||
146083728|NCT02480712|526826585|FG000|Overall Study|Enrolled but Never Treated|1|||
146210625|NCT02539225|527284128|FG000|Pre Treatment for Part B|Adverse Event|1|||
146210626|NCT02539225|527284129|FG001|Pre Treatment for Part B|Adverse Event|1|||
146210627|NCT02539225|527284128|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
146210628|NCT02539225|527284129|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
146210629|NCT02539225|527284128|FG000|Pre Treatment for Part B|Physician Decision|2|||
146210630|NCT02539225|527284129|FG001|Pre Treatment for Part B|Physician Decision|0|||
146210631|NCT02539225|527284128|FG000|Part B|Adverse Event|4|||
146210632|NCT02539225|527284129|FG001|Part B|Adverse Event|4|||
146210633|NCT02539225|527284128|FG000|Part B|Withdrawal by Subject|0|||
146210634|NCT02539225|527284129|FG001|Part B|Withdrawal by Subject|3|||
146210635|NCT02539225|527284128|FG000|Part B|Physician Decision|0|||
146210636|NCT02539225|527284129|FG001|Part B|Physician Decision|9|||
146210637|NCT01109524|527284130|FG000|Overall Study|Disease Progression|29|||
146210638|NCT01109524|527284130|FG000|Overall Study|Study Drug toxicity|6|||
146210639|NCT01109524|527284130|FG000|Overall Study|Adverse Event|4|||
146210640|NCT01109524|527284130|FG000|Overall Study|Withdrawal by Subject|2|||
146210641|NCT01109524|527284130|FG000|Overall Study|Maximum clinical benefit|3|||
146210642|NCT01109524|527284130|FG000|Overall Study|Death|2|||
146210643|NCT01109524|527284130|FG000|Overall Study|No longer meets criteria|2|||
146210644|NCT01109524|527284130|FG000|Overall Study|Participant requested to end treatment|4|||
146210645|NCT01109524|527284130|FG000|Overall Study|Other|5|||
146210646|NCT02318134|527284136|FG000|Overall Study|Withdrawal by Subject|2|||
146210647|NCT02318134|527284137|FG001|Overall Study|Withdrawal by Subject|1|||
146210648|NCT02556138|527284142|FG000|Overall Study|Withdrawal by Subject|1|||
146210649|NCT01037985|527284145|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
146210650|NCT01037985|527284146|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
146210651|NCT01037985|527284145|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
146210652|NCT01037985|527284146|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
146210653|NCT01037985|527284145|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
146210654|NCT01037985|527284146|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
146210655|NCT01037985|527284145|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
146210656|NCT01037985|527284146|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
146210657|NCT01609218|527284148|FG000|Period 1|Adverse Event|3|||
146210658|NCT01609218|527284149|FG001|Period 1|Adverse Event|5|||
146210659|NCT01609218|527284148|FG000|Period 1|Sponsor Decision|0|||
146210660|NCT01609218|527284149|FG001|Period 1|Sponsor Decision|1|||
146210661|NCT01609218|527284148|FG000|Period 2|Adverse Event|1|||
146210662|NCT01609218|527284149|FG001|Period 2|Adverse Event|0|||
146210663|NCT04428112|527284150|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
146083729|NCT02480712|526826585|FG000|Overall Study|Lost to Follow-up|5|||
146210664|NCT04428112|527284151|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
146210665|NCT04428112|527284150|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
146210666|NCT04428112|527284151|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
146210667|NCT04428112|527284150|FG000|Overall Study|Withdrawal by Subject|9|||
146210668|NCT04428112|527284151|FG001|Overall Study|Withdrawal by Subject|4|||
146210669|NCT04428112|527284150|FG000|Overall Study|Lost to Follow-up|27|||
146210670|NCT04428112|527284151|FG001|Overall Study|Lost to Follow-up|7|||
146210671|NCT05134337|527285917|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
146210672|NCT05134337|527285918|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
146210673|NCT03725722|527285919|FG000|Overall Study|Lack of Efficacy|2|||
146210674|NCT03725722|527285920|FG001|Overall Study|Lack of Efficacy|1|||
146210675|NCT03725722|527285921|FG002|Overall Study|Lack of Efficacy|2|||
146210676|NCT03725722|527285922|FG003|Overall Study|Lack of Efficacy|0|||
146210677|NCT03725722|527285923|FG004|Overall Study|Lack of Efficacy|2|||
146210678|NCT03725722|527285919|FG000|Overall Study|Adverse Event|2|||
146210679|NCT03725722|527285920|FG001|Overall Study|Adverse Event|2|||
146210680|NCT03725722|527285921|FG002|Overall Study|Adverse Event|1|||
146210681|NCT03725722|527285922|FG003|Overall Study|Adverse Event|0|||
146210682|NCT03725722|527285923|FG004|Overall Study|Adverse Event|6|||
146210683|NCT03725722|527285919|FG000|Overall Study|Withdrawal by Subject|4|||
146210684|NCT03725722|527285920|FG001|Overall Study|Withdrawal by Subject|1|||
146210685|NCT03725722|527285921|FG002|Overall Study|Withdrawal by Subject|0|||
146210686|NCT03725722|527285922|FG003|Overall Study|Withdrawal by Subject|4|||
146210687|NCT03725722|527285923|FG004|Overall Study|Withdrawal by Subject|4|||
146210688|NCT03725722|527285919|FG000|Overall Study|Lost to Follow-up|3|||
146210689|NCT03725722|527285920|FG001|Overall Study|Lost to Follow-up|1|||
146210690|NCT03725722|527285921|FG002|Overall Study|Lost to Follow-up|2|||
146210691|NCT03725722|527285922|FG003|Overall Study|Lost to Follow-up|2|||
146210692|NCT03725722|527285923|FG004|Overall Study|Lost to Follow-up|1|||
146210693|NCT03725722|527285919|FG000|Overall Study|Personal reasons|0|||
146210694|NCT03725722|527285920|FG001|Overall Study|Personal reasons|0|||
146210695|NCT03725722|527285921|FG002|Overall Study|Personal reasons|1|||
146210696|NCT03725722|527285922|FG003|Overall Study|Personal reasons|0|||
146210697|NCT03725722|527285923|FG004|Overall Study|Personal reasons|1|||
146210698|NCT03725722|527285919|FG000|Overall Study|COVID-19 situation|0|||
146210699|NCT03725722|527285920|FG001|Overall Study|COVID-19 situation|1|||
146210700|NCT03725722|527285921|FG002|Overall Study|COVID-19 situation|0|||
146210701|NCT03725722|527285922|FG003|Overall Study|COVID-19 situation|0|||
146210702|NCT03725722|527285923|FG004|Overall Study|COVID-19 situation|0|||
146210703|NCT03481660|527285927|FG000|Overall Study|Adverse Event|5|||
146210704|NCT03481660|527285928|FG001|Overall Study|Adverse Event|4|||
146210705|NCT03481660|527285927|FG000|Overall Study|Death|13|||
146210706|NCT03481660|527285928|FG001|Overall Study|Death|9|||
146210707|NCT03481660|527285927|FG000|Overall Study|Lost to Follow-up|2|||
146210708|NCT03481660|527285928|FG001|Overall Study|Lost to Follow-up|2|||
146210709|NCT03481660|527285927|FG000|Overall Study|Physician Decision|2|||
146210710|NCT03481660|527285928|FG001|Overall Study|Physician Decision|3|||
146210711|NCT03481660|527285927|FG000|Overall Study|Withdrawal by Subject|14|||
146210712|NCT03481660|527285928|FG001|Overall Study|Withdrawal by Subject|7|||
146210713|NCT01259401|527285929|FG000|4-month Follow-up|Death|0|||
146210714|NCT01259401|527285930|FG001|4-month Follow-up|Death|1|||
146210715|NCT01259401|527285929|FG000|4-month Follow-up|Lost to Follow-up|0|||
146210716|NCT01259401|527285930|FG001|4-month Follow-up|Lost to Follow-up|1|||
146210717|NCT00186992|527285931|FG000|Overall Study|Withdrawal by Subject|5|||
146210718|NCT00186992|527285931|FG000|Overall Study|Physician's discretion|13|||
146210719|NCT00186992|527285931|FG000|Overall Study|PI Discretion|4|||
146210720|NCT00186992|527285931|FG000|Overall Study|Ineligible|2|||
146210721|NCT00186992|527285931|FG000|Overall Study|Lost to Follow-up|2|||
146286156|NCT01375114|527562617|FG002|Overall Study|Disease Progression|2|||
146286157|NCT01375114|527562615|FG000|Overall Study|Patient Changed Mind|0|||
145957410|NCT01000974|526356238|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
146210722|NCT00186992|527285931|FG000|Overall Study|Still on Study|9|||
146210723|NCT03683069|527285932|FG000|Overall Study|see limitations|12|||
146286158|NCT01375114|527562616|FG001|Overall Study|Patient Changed Mind|0|||
145957411|NCT01000974|526356239|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
146210724|NCT03683069|527285933|FG001|Overall Study|see limitations|13|||
146210725|NCT05696080|527285934|FG000|Overall Study|Lost to Follow-up|2|||
146210726|NCT05696080|527285935|FG001|Overall Study|Lost to Follow-up|1|||
146210727|NCT05696080|527285934|FG000|Overall Study|Physician Decision|1|||
146210728|NCT05696080|527285935|FG001|Overall Study|Physician Decision|0|||
146286159|NCT01375114|527562617|FG002|Overall Study|Patient Changed Mind|2|||
146210729|NCT05696080|527285934|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146210730|NCT05696080|527285935|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146210731|NCT05696080|527285934|FG000|Overall Study|Withdrawal by Subject|12|||
146083730|NCT02480712|526826585|FG000|Overall Study|Withdrew Consent|3|||
146083731|NCT02480712|526826585|FG000|Overall Study|Death|1|||
146083732|NCT02480712|526826585|FG000|Overall Study|Lack of Efficacy|1|||
146083733|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
146083734|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
146083735|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
146083736|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
146083737|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
146210732|NCT05696080|527285935|FG001|Overall Study|Withdrawal by Subject|0|||
146210733|NCT05478525|527285938|FG000|Overall Study|Withdrawal by Subject|0|||
146210734|NCT05478525|527285939|FG001|Overall Study|Withdrawal by Subject|1|||
146210735|NCT05478525|527285940|FG002|Overall Study|Withdrawal by Subject|2|||
146210736|NCT05478525|527285941|FG003|Overall Study|Withdrawal by Subject|0|||
146210737|NCT05478525|527285938|FG000|Overall Study|COVID-19 Infection|2|||
146210738|NCT05478525|527285939|FG001|Overall Study|COVID-19 Infection|0|||
146210739|NCT05478525|527285940|FG002|Overall Study|COVID-19 Infection|1|||
146210740|NCT05478525|527285941|FG003|Overall Study|COVID-19 Infection|1|||
146210741|NCT01649271|527285942|FG000|Overall Study|Progressive disease|4|||
146210742|NCT01649271|527285943|FG001|Overall Study|Progressive disease|5|||
146083738|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
146286160|NCT01375114|527562615|FG000|Overall Study|Pruritus|0|||
146083739|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
146083740|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
146286161|NCT01375114|527562616|FG001|Overall Study|Pruritus|0|||
146083741|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
146210743|NCT01649271|527285942|FG000|Overall Study|Other Adverse Event|0|||
146286162|NCT01375114|527562617|FG002|Overall Study|Pruritus|1|||
146210744|NCT01649271|527285943|FG001|Overall Study|Other Adverse Event|2|||
146210745|NCT01649271|527285942|FG000|Overall Study|Withdrawal by Subject|1|||
146210746|NCT01649271|527285943|FG001|Overall Study|Withdrawal by Subject|0|||
146210747|NCT01649271|527285942|FG000|Overall Study|Other than stated above|1|||
146210748|NCT01649271|527285943|FG001|Overall Study|Other than stated above|0|||
146210749|NCT05644002|527285944|FG000|Overall Study|Lost to Follow-up|1|||
146210750|NCT05644002|527285945|FG001|Overall Study|Lost to Follow-up|2|||
146210751|NCT05644002|527285944|FG000|Overall Study|Withdrawal by Subject|0|||
146210752|NCT05644002|527285945|FG001|Overall Study|Withdrawal by Subject|1|||
146210753|NCT05756075|527285948|FG000|Overall Study|Withdrawal by Subject|16|||
146210754|NCT05756075|527285949|FG001|Overall Study|Withdrawal by Subject|9|||
146210755|NCT01991977|527285950|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
146210756|NCT01991977|527285950|FG000|Overall Study|Withdrew after start of treatment|5|||
146210757|NCT02605837|527285953|FG000|Overall Study|Adverse Event|3|||
146210758|NCT02605837|527285954|FG001|Overall Study|Adverse Event|1|||
146210759|NCT02605837|527285953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146210760|NCT02605837|527285954|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146210761|NCT02605837|527285953|FG000|Overall Study|Withdrawal by Subject|8|||
146210762|NCT02605837|527285954|FG001|Overall Study|Withdrawal by Subject|8|||
146210763|NCT02605837|527285953|FG000|Overall Study|Physician Decision|0|||
146210764|NCT02605837|527285954|FG001|Overall Study|Physician Decision|1|||
146210765|NCT03416023|527285955|FG000|Overall Study|Exclusion criteria failure|1|||
146210766|NCT03416023|527285955|FG000|Overall Study|Withdrawal by Subject|6|||
146210767|NCT03416023|527285955|FG000|Overall Study|Explanted|7|||
146210768|NCT03416023|527285955|FG000|Overall Study|Physician Decision|1|||
146210769|NCT03416023|527285955|FG000|Overall Study|Lost to Follow-up|1|||
146210770|NCT03416023|527285955|FG000|Overall Study|Death|1|||
146210771|NCT03651895|527285956|FG000|First Drug Assignment|Adverse Event|4|||
146210772|NCT03651895|527285957|FG001|First Drug Assignment|Adverse Event|5|||
146210773|NCT03651895|527285956|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
146210774|NCT03651895|527285957|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
146210775|NCT02837510|527285958|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
146210776|NCT02837510|527285959|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
146210777|NCT02837510|527285958|FG000|Washout (2 Weeks)|Adverse Event|0|||
146210778|NCT02837510|527285959|FG001|Washout (2 Weeks)|Adverse Event|1|||
146210779|NCT02837510|527285958|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146210780|NCT02837510|527285959|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146210781|NCT02837510|527285958|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
146210782|NCT02837510|527285959|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
146210783|NCT02837510|527285958|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
146210784|NCT02837510|527285959|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
146210785|NCT02837510|527285958|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
146210786|NCT02837510|527285959|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
146210787|NCT05419505|527285961|FG000|Overall Study|Adverse Event|0|||
146210788|NCT05419505|527285962|FG001|Overall Study|Adverse Event|0|||
146210789|NCT05419505|527285963|FG002|Overall Study|Adverse Event|0|||
146210790|NCT05419505|527285964|FG003|Overall Study|Adverse Event|1|||
146210791|NCT05419505|527285965|FG004|Overall Study|Adverse Event|0|||
146210792|NCT05419505|527285966|FG005|Overall Study|Adverse Event|0|||
146210793|NCT05419505|527285967|FG006|Overall Study|Adverse Event|0|||
146210794|NCT05419505|527285968|FG007|Overall Study|Adverse Event|0|||
146210795|NCT05419505|527285961|FG000|Overall Study|Withdrawal by Subject|1|||
146210796|NCT05419505|527285962|FG001|Overall Study|Withdrawal by Subject|2|||
146210797|NCT05419505|527285963|FG002|Overall Study|Withdrawal by Subject|0|||
146210798|NCT05419505|527285964|FG003|Overall Study|Withdrawal by Subject|0|||
146210799|NCT05419505|527285965|FG004|Overall Study|Withdrawal by Subject|0|||
146210800|NCT05419505|527285966|FG005|Overall Study|Withdrawal by Subject|0|||
146210801|NCT05419505|527285967|FG006|Overall Study|Withdrawal by Subject|1|||
146210802|NCT05419505|527285968|FG007|Overall Study|Withdrawal by Subject|0|||
146210803|NCT05419505|527285961|FG000|Overall Study|Lost to Follow-up|2|||
146210804|NCT05419505|527285962|FG001|Overall Study|Lost to Follow-up|1|||
146210805|NCT05419505|527285963|FG002|Overall Study|Lost to Follow-up|0|||
146210806|NCT05419505|527285964|FG003|Overall Study|Lost to Follow-up|0|||
146210807|NCT05419505|527285965|FG004|Overall Study|Lost to Follow-up|1|||
146210808|NCT05419505|527285966|FG005|Overall Study|Lost to Follow-up|2|||
146210809|NCT05419505|527285967|FG006|Overall Study|Lost to Follow-up|0|||
146210810|NCT05419505|527285968|FG007|Overall Study|Lost to Follow-up|1|||
146210811|NCT02780388|527285971|FG000|Overall Study|Lost to Follow-up|0|||
146210812|NCT02780388|527285972|FG001|Overall Study|Lost to Follow-up|1|||
146210813|NCT02780388|527285973|FG002|Overall Study|Lost to Follow-up|0|||
146210814|NCT02780388|527285974|FG003|Overall Study|Lost to Follow-up|0|||
146210815|NCT02780388|527285975|FG004|Overall Study|Lost to Follow-up|0|||
146210816|NCT02780388|527285971|FG000|Overall Study|Withdrawal by Subject|1|||
146210817|NCT02780388|527285972|FG001|Overall Study|Withdrawal by Subject|1|||
146210818|NCT02780388|527285973|FG002|Overall Study|Withdrawal by Subject|0|||
146210819|NCT02780388|527285974|FG003|Overall Study|Withdrawal by Subject|0|||
146210820|NCT02780388|527285975|FG004|Overall Study|Withdrawal by Subject|0|||
146210821|NCT04527146|527285976|FG000|Overall Study|Withdrawal by Subject|12|||
146210822|NCT04527146|527285977|FG001|Overall Study|Withdrawal by Subject|15|||
146210823|NCT04527146|527285978|FG002|Overall Study|Withdrawal by Subject|7|||
146210824|NCT04527146|527285979|FG003|Overall Study|Withdrawal by Subject|16|||
146210825|NCT04527146|527285976|FG000|Overall Study|Lost to Follow-up|13|||
146210826|NCT04527146|527285977|FG001|Overall Study|Lost to Follow-up|9|||
146210827|NCT04527146|527285978|FG002|Overall Study|Lost to Follow-up|16|||
146210828|NCT04527146|527285979|FG003|Overall Study|Lost to Follow-up|13|||
146210829|NCT04527146|527285976|FG000|Overall Study|Death|0|||
146210830|NCT04527146|527285977|FG001|Overall Study|Death|1|||
146210831|NCT04527146|527285978|FG002|Overall Study|Death|1|||
146210832|NCT04527146|527285979|FG003|Overall Study|Death|0|||
146210833|NCT04527146|527285976|FG000|Overall Study|Adverse Event|0|||
146210834|NCT04527146|527285977|FG001|Overall Study|Adverse Event|0|||
146210835|NCT04527146|527285978|FG002|Overall Study|Adverse Event|1|||
146210836|NCT04527146|527285979|FG003|Overall Study|Adverse Event|0|||
146210837|NCT04527146|527285976|FG000|Overall Study|Ineligible after randomization|2|||
146210838|NCT04527146|527285977|FG001|Overall Study|Ineligible after randomization|0|||
146210839|NCT04527146|527285978|FG002|Overall Study|Ineligible after randomization|2|||
146210840|NCT04527146|527285979|FG003|Overall Study|Ineligible after randomization|2|||
146210841|NCT04527146|527285976|FG000|Overall Study|Moved to a different group|6|||
146210842|NCT04527146|527285977|FG001|Overall Study|Moved to a different group|3|||
146286163|NCT01375114|527562615|FG000|Overall Study|Restlessness|0|||
146210843|NCT04527146|527285978|FG002|Overall Study|Moved to a different group|0|||
146210844|NCT04527146|527285979|FG003|Overall Study|Moved to a different group|2|||
146210845|NCT05107401|527285980|FG000|Overall Study|Lost to Follow-up|13|||
146210846|NCT05107401|527285981|FG001|Overall Study|Lost to Follow-up|12|||
146210847|NCT04337372|527285983|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
146210848|NCT04337372|527285984|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
146210849|NCT04337372|527285985|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
146210850|NCT04337372|527285986|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
146210851|NCT04337372|527285983|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
146210852|NCT04337372|527285984|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
146210853|NCT04337372|527285985|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
146210854|NCT04337372|527285986|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
146210855|NCT04337372|527285983|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
146210856|NCT04337372|527285984|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
146210857|NCT04337372|527285985|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
146210858|NCT04337372|527285986|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
146210859|NCT04337372|527285983|FG000|Day 2: EEG Measures|Protocol Violation|6|||
146210860|NCT04337372|527285984|FG001|Day 2: EEG Measures|Protocol Violation|6|||
146210861|NCT04337372|527285985|FG002|Day 2: EEG Measures|Protocol Violation|5|||
146210862|NCT04337372|527285986|FG003|Day 2: EEG Measures|Protocol Violation|17|||
146210863|NCT05307783|527285987|FG000|Overall Study|Death|7|||
146210864|NCT05307783|527285987|FG000|Overall Study|Lost to Follow-up|4|||
146210865|NCT04883645|527285988|FG000|Overall Study|Death|1|||
146210866|NCT03460236|527285992|FG000|Overall Study|failed radiographic screening|16|||
146210867|NCT03460236|527285992|FG000|Overall Study|Withdrawal by Subject|11|||
146210868|NCT04869982|527286002|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
146210869|NCT04869982|527286003|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
146210870|NCT04869982|527286002|FG000|Overall Study|Migrated / moved from the study area|1|||
146210871|NCT04869982|527286003|FG001|Overall Study|Migrated / moved from the study area|1|||
146210872|NCT04869982|527286002|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
146210873|NCT04869982|527286003|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
146210874|NCT04869982|527286002|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
146210875|NCT04869982|527286003|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
146210876|NCT04869982|527286002|FG000|Overall Study|Solicited adverse event|2|||
146210877|NCT04869982|527286003|FG001|Overall Study|Solicited adverse event|1|||
146210878|NCT04608045|527286004|FG000|Overall Study|Physician Decision|1|||
146210879|NCT03857620|527286006|FG000|Overall Study|Death|4|||
146210880|NCT03857620|527286007|FG001|Overall Study|Death|5|||
146210881|NCT03857620|527286008|FG002|Overall Study|Death|7|||
146210882|NCT03857620|527286006|FG000|Overall Study|Lost to Follow-up|2|||
146210883|NCT03857620|527286007|FG001|Overall Study|Lost to Follow-up|5|||
146210884|NCT03857620|527286008|FG002|Overall Study|Lost to Follow-up|3|||
146210885|NCT03857620|527286006|FG000|Overall Study|Disease progression or relapse after study registration|1|||
146210886|NCT03857620|527286007|FG001|Overall Study|Disease progression or relapse after study registration|5|||
146210887|NCT03857620|527286008|FG002|Overall Study|Disease progression or relapse after study registration|1|||
146210888|NCT03857620|527286006|FG000|Overall Study|Ineligible|5|||
146210889|NCT03857620|527286007|FG001|Overall Study|Ineligible|0|||
146210890|NCT03857620|527286008|FG002|Overall Study|Ineligible|2|||
146210891|NCT03857620|527286006|FG000|Overall Study|No malignancy|1|||
146210892|NCT03857620|527286007|FG001|Overall Study|No malignancy|0|||
146210893|NCT03857620|527286008|FG002|Overall Study|No malignancy|1|||
146210894|NCT03857620|527286006|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
146210895|NCT03857620|527286007|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
146210896|NCT03857620|527286008|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
146210897|NCT03857620|527286006|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
146210898|NCT03857620|527286007|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
146210899|NCT03857620|527286008|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
146210900|NCT03857620|527286006|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
146210901|NCT03857620|527286007|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
146210902|NCT03857620|527286008|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
146210903|NCT03857620|527286006|FG000|Overall Study|Surgery not performed, patient decision|0|||
146210904|NCT03857620|527286007|FG001|Overall Study|Surgery not performed, patient decision|3|||
146210905|NCT03857620|527286008|FG002|Overall Study|Surgery not performed, patient decision|1|||
146210906|NCT03857620|527286006|FG000|Overall Study|Surgery not performed, other reason|3|||
146210907|NCT03857620|527286007|FG001|Overall Study|Surgery not performed, other reason|1|||
146210908|NCT03857620|527286008|FG002|Overall Study|Surgery not performed, other reason|4|||
146210909|NCT03857620|527286006|FG000|Overall Study|Worsening performance status after surgery performed|0|||
146210910|NCT03857620|527286007|FG001|Overall Study|Worsening performance status after surgery performed|1|||
146210911|NCT03857620|527286008|FG002|Overall Study|Worsening performance status after surgery performed|1|||
146210912|NCT02473250|527286009|FG000|Overall Study|Lost to Follow-up|10|||
146210913|NCT02473250|527286009|FG000|Overall Study|Physician Decision|5|||
146210914|NCT02473250|527286009|FG000|Overall Study|Did not tolerate medication washout|3|||
146210915|NCT02473250|527286009|FG000|Overall Study|Antidepressant effect of divalproex|2|||
146210916|NCT03271151|527286010|FG000|Overall Study|Lost to Follow-up|1|||
146210917|NCT03271151|527286011|FG001|Overall Study|Lost to Follow-up|3|||
146210918|NCT03271151|527286010|FG000|Overall Study|Withdrawal by Subject|1|||
146210919|NCT03271151|527286011|FG001|Overall Study|Withdrawal by Subject|0|||
146210920|NCT04118452|527286012|FG000|Overall Study|Lost to Follow-up|5|||
146210921|NCT04118452|527286013|FG001|Overall Study|Lost to Follow-up|5|||
146210922|NCT04118452|527286012|FG000|Overall Study|Withdrawal by Subject|17|||
146210923|NCT04118452|527286013|FG001|Overall Study|Withdrawal by Subject|17|||
146210924|NCT03215030|527286014|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
146210925|NCT03215030|527286015|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
146210926|NCT03215030|527286016|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210927|NCT03215030|527286017|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
146210928|NCT03215030|527286018|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210929|NCT03215030|527286019|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210930|NCT03215030|527286020|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210931|NCT03215030|527286021|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146286164|NCT01375114|527562616|FG001|Overall Study|Restlessness|0|||
146286165|NCT01375114|527562617|FG002|Overall Study|Restlessness|1|||
146210932|NCT03215030|527286022|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210933|NCT03215030|527286023|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
146286166|NCT01375114|527562615|FG000|Overall Study|Diarrhea|0|||
146210934|NCT03215030|527286024|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210935|NCT03215030|527286025|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
146210936|NCT03215030|527286014|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146210937|NCT03215030|527286015|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210938|NCT03215030|527286016|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210939|NCT03215030|527286017|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146210940|NCT03215030|527286018|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210941|NCT03215030|527286019|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210942|NCT03215030|527286020|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210943|NCT03215030|527286021|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210944|NCT03215030|527286022|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210945|NCT03215030|527286023|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210946|NCT03215030|527286024|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210947|NCT03215030|527286025|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146210948|NCT03215030|527286014|FG000|Part 1: Dose Escalation|Death|15|||
146210949|NCT03215030|527286015|FG001|Part 1: Dose Escalation|Death|6|||
146210950|NCT03215030|527286016|FG002|Part 1: Dose Escalation|Death|6|||
146210951|NCT03215030|527286017|FG003|Part 1: Dose Escalation|Death|8|||
146210952|NCT03215030|527286018|FG004|Part 1: Dose Escalation|Death|0|||
146210953|NCT03215030|527286019|FG005|Part 1: Dose Escalation|Death|0|||
146210954|NCT03215030|527286020|FG006|Part 1: Dose Escalation|Death|0|||
146210955|NCT03215030|527286021|FG007|Part 1: Dose Escalation|Death|0|||
146210956|NCT03215030|527286022|FG008|Part 1: Dose Escalation|Death|0|||
146210957|NCT03215030|527286023|FG009|Part 1: Dose Escalation|Death|0|||
146210958|NCT03215030|527286024|FG010|Part 1: Dose Escalation|Death|0|||
146210959|NCT03215030|527286025|FG011|Part 1: Dose Escalation|Death|0|||
146210960|NCT03215030|527286014|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
146210961|NCT03215030|527286015|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
146210962|NCT03215030|527286016|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
146210963|NCT03215030|527286017|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
146210964|NCT03215030|527286018|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
146210965|NCT03215030|527286019|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
146210966|NCT03215030|527286020|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
146210967|NCT03215030|527286021|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
146210968|NCT03215030|527286022|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
146210969|NCT03215030|527286023|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
146210970|NCT03215030|527286024|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
146210971|NCT03215030|527286025|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
146210972|NCT03215030|527286014|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210973|NCT03215030|527286015|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210974|NCT03215030|527286016|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210975|NCT03215030|527286017|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210976|NCT03215030|527286018|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210977|NCT03215030|527286019|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210978|NCT03215030|527286020|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210979|NCT03215030|527286021|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
146210980|NCT03215030|527286022|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210981|NCT03215030|527286023|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210982|NCT03215030|527286024|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210983|NCT03215030|527286025|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
146210984|NCT03215030|527286014|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210985|NCT03215030|527286015|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210986|NCT03215030|527286016|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210987|NCT03215030|527286017|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210988|NCT03215030|527286018|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146210989|NCT03215030|527286019|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146210990|NCT03215030|527286020|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
146210991|NCT03215030|527286021|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
146210992|NCT03215030|527286022|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210993|NCT03215030|527286023|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210994|NCT03215030|527286024|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210995|NCT03215030|527286025|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146210996|NCT03215030|527286014|FG000|Part 2: Dose Expansion|Death|0|||
146210997|NCT03215030|527286015|FG001|Part 2: Dose Expansion|Death|0|||
146210998|NCT03215030|527286016|FG002|Part 2: Dose Expansion|Death|0|||
146210999|NCT03215030|527286017|FG003|Part 2: Dose Expansion|Death|0|||
146211000|NCT03215030|527286018|FG004|Part 2: Dose Expansion|Death|3|||
146211001|NCT03215030|527286019|FG005|Part 2: Dose Expansion|Death|1|||
146211002|NCT03215030|527286020|FG006|Part 2: Dose Expansion|Death|5|||
146211003|NCT03215030|527286021|FG007|Part 2: Dose Expansion|Death|4|||
146211004|NCT03215030|527286022|FG008|Part 2: Dose Expansion|Death|0|||
146211005|NCT03215030|527286023|FG009|Part 2: Dose Expansion|Death|0|||
146211006|NCT03215030|527286024|FG010|Part 2: Dose Expansion|Death|0|||
146211007|NCT03215030|527286025|FG011|Part 2: Dose Expansion|Death|0|||
146211008|NCT03215030|527286014|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
146211009|NCT03215030|527286015|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
146211010|NCT03215030|527286016|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
146211011|NCT03215030|527286017|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
146211012|NCT03215030|527286018|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
146211013|NCT03215030|527286019|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
146211014|NCT03215030|527286020|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
146211015|NCT03215030|527286021|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
146286167|NCT01375114|527562616|FG001|Overall Study|Diarrhea|0|||
145957412|NCT01000974|526356240|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
146211016|NCT03215030|527286022|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
146211017|NCT03215030|527286023|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
146211018|NCT03215030|527286024|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
146211019|NCT03215030|527286025|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
146211020|NCT03215030|527286014|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
146211021|NCT03215030|527286015|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
146211022|NCT03215030|527286016|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
146211023|NCT03215030|527286017|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
146211024|NCT03215030|527286018|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
146211025|NCT03215030|527286019|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
146211026|NCT03215030|527286020|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
146211027|NCT03215030|527286021|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
146211028|NCT03215030|527286022|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
146211029|NCT03215030|527286023|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
146211030|NCT03215030|527286024|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
146211031|NCT03215030|527286025|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
146211032|NCT03215030|527286014|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211033|NCT03215030|527286015|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211034|NCT03215030|527286016|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211035|NCT03215030|527286017|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211036|NCT03215030|527286018|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211037|NCT03215030|527286019|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211038|NCT03215030|527286020|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146286168|NCT01375114|527562617|FG002|Overall Study|Diarrhea|1|||
146286169|NCT01375114|527562615|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
146286170|NCT01375114|527562616|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
146286171|NCT01375114|527562617|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
146286172|NCT01375114|527562615|FG000|Overall Study|Nausea|0|||
145957413|NCT01000974|526356238|FG000|Primary Vaccination Phase|Protocol Violation|40|||
145957414|NCT01000974|526356239|FG001|Primary Vaccination Phase|Protocol Violation|3|||
145957415|NCT01000974|526356240|FG002|Primary Vaccination Phase|Protocol Violation|2|||
145957416|NCT01000974|526356238|FG000|Primary Vaccination Phase|Adverse Event|14|||
145957417|NCT01000974|526356239|FG001|Primary Vaccination Phase|Adverse Event|2|||
145957418|NCT01000974|526356240|FG002|Primary Vaccination Phase|Adverse Event|2|||
145957419|NCT01000974|526356238|FG000|Primary Vaccination Phase|Other|4|||
145957420|NCT01000974|526356239|FG001|Primary Vaccination Phase|Other|9|||
145957421|NCT01000974|526356240|FG002|Primary Vaccination Phase|Other|12|||
145957422|NCT01000974|526356238|FG000|Booster Vaccination Phase|Protocol Violation|0|||
145957423|NCT01000974|526356239|FG001|Booster Vaccination Phase|Protocol Violation|0|||
146211039|NCT03215030|527286021|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211040|NCT03215030|527286022|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
145957424|NCT01000974|526356240|FG002|Booster Vaccination Phase|Protocol Violation|2|||
146211041|NCT03215030|527286023|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
146211042|NCT03215030|527286024|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211043|NCT03215030|527286025|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
146211044|NCT03215030|527286014|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211045|NCT03215030|527286015|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211046|NCT03215030|527286016|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211047|NCT03215030|527286017|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211048|NCT03215030|527286018|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211049|NCT03215030|527286019|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211050|NCT03215030|527286020|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211051|NCT03215030|527286021|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211052|NCT03215030|527286022|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
146211053|NCT03215030|527286023|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
146211054|NCT03215030|527286024|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211055|NCT03215030|527286025|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
146211056|NCT03215030|527286014|FG000|Part 3: Dose Extension|Death|0|||
146211057|NCT03215030|527286015|FG001|Part 3: Dose Extension|Death|0|||
146211058|NCT03215030|527286016|FG002|Part 3: Dose Extension|Death|0|||
146211059|NCT03215030|527286017|FG003|Part 3: Dose Extension|Death|0|||
146211060|NCT03215030|527286018|FG004|Part 3: Dose Extension|Death|0|||
146211061|NCT03215030|527286019|FG005|Part 3: Dose Extension|Death|0|||
146211062|NCT03215030|527286020|FG006|Part 3: Dose Extension|Death|0|||
146211063|NCT03215030|527286021|FG007|Part 3: Dose Extension|Death|0|||
146211064|NCT03215030|527286022|FG008|Part 3: Dose Extension|Death|19|||
146211065|NCT03215030|527286023|FG009|Part 3: Dose Extension|Death|20|||
146211066|NCT03215030|527286024|FG010|Part 3: Dose Extension|Death|0|||
146211067|NCT03215030|527286025|FG011|Part 3: Dose Extension|Death|0|||
146211068|NCT03215030|527286014|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
146211069|NCT03215030|527286015|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
146211070|NCT03215030|527286016|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
146211071|NCT03215030|527286017|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
146211072|NCT03215030|527286018|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
146211073|NCT03215030|527286019|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
146211074|NCT03215030|527286020|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
146211075|NCT03215030|527286021|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
146211076|NCT03215030|527286022|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
146211077|NCT03215030|527286023|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
146211078|NCT03215030|527286024|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
146211079|NCT03215030|527286025|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
146286173|NCT01375114|527562616|FG001|Overall Study|Nausea|1|||
146286174|NCT01375114|527562617|FG002|Overall Study|Nausea|0|||
146286175|NCT01375114|527562615|FG000|Overall Study|Increased AST/ALT|0|||
146211080|NCT03215030|527286014|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211081|NCT03215030|527286015|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211082|NCT03215030|527286016|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146083742|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
146211083|NCT03215030|527286017|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146286176|NCT01375114|527562616|FG001|Overall Study|Increased AST/ALT|1|||
146211084|NCT03215030|527286018|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211085|NCT03215030|527286019|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211086|NCT03215030|527286020|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211087|NCT03215030|527286021|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211088|NCT03215030|527286022|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211089|NCT03215030|527286023|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
146211090|NCT03215030|527286024|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
146211091|NCT03215030|527286025|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
146083743|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
146211092|NCT05215847|527286026|FG000|Overall Study|Lost to Follow-up|1|||
146211093|NCT03433339|527286027|FG000|Overall Study|Lost to Follow-up|2|||
146211094|NCT03433339|527286028|FG001|Overall Study|Lost to Follow-up|0|||
146211095|NCT03433339|527286027|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
146211096|NCT03433339|527286028|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
146211097|NCT03433339|527286027|FG000|Overall Study|Withdrawal by Subject|0|||
146211098|NCT03433339|527286028|FG001|Overall Study|Withdrawal by Subject|2|||
146211099|NCT05952076|527286029|FG000|Overall Study|Death|1|||
146211100|NCT05952076|527286030|FG001|Overall Study|Death|1|||
146211101|NCT05952076|527286029|FG000|Overall Study|Lost to Follow-up|0|||
146211102|NCT05952076|527286030|FG001|Overall Study|Lost to Follow-up|1|||
146211103|NCT06023082|527286036|FG000|Overall Study|Withdrawal by Subject|2|||
146211104|NCT06023082|527286036|FG000|Overall Study|Lost to Follow-up|15|||
146211105|NCT06023082|527286036|FG000|Overall Study|Side effects|5|||
146211106|NCT05136404|527286037|FG000|Period 1|Adverse Event|0|||
146211107|NCT05136404|527286038|FG001|Period 1|Adverse Event|1|||
146211108|NCT05136404|527286039|FG002|Period 1|Adverse Event|1|||
146211109|NCT05136404|527286037|FG000|Period 2|Inappropriate Behavior|0|||
146211110|NCT05136404|527286038|FG001|Period 2|Inappropriate Behavior|0|||
146211111|NCT05136404|527286039|FG002|Period 2|Inappropriate Behavior|1|||
146211112|NCT05136404|527286037|FG000|Period 3|Adverse Event|0|||
146211113|NCT05136404|527286038|FG001|Period 3|Adverse Event|0|||
146211114|NCT05136404|527286039|FG002|Period 3|Adverse Event|1|||
146211115|NCT03584516|527286040|FG000|Part 1|Death|2|||
146211116|NCT03584516|527286041|FG001|Part 1|Death|3|||
146211117|NCT03584516|527286042|FG002|Part 1|Death|0|||
146211118|NCT03584516|527286043|FG003|Part 1|Death|0|||
146211119|NCT03584516|527286044|FG004|Part 1|Death|0|||
146211120|NCT03584516|527286045|FG005|Part 1|Death|0|||
146211121|NCT03584516|527286040|FG000|Part 1|Withdrawal by Subject|2|||
146211122|NCT03584516|527286041|FG001|Part 1|Withdrawal by Subject|0|||
146211123|NCT03584516|527286042|FG002|Part 1|Withdrawal by Subject|0|||
146211124|NCT03584516|527286043|FG003|Part 1|Withdrawal by Subject|0|||
146211125|NCT03584516|527286044|FG004|Part 1|Withdrawal by Subject|0|||
146083744|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
146083745|NCT01087788|526826592|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
146211126|NCT03584516|527286045|FG005|Part 1|Withdrawal by Subject|0|||
146211127|NCT03584516|527286040|FG000|Part 1|Lost to Follow-up|1|||
146211128|NCT03584516|527286041|FG001|Part 1|Lost to Follow-up|0|||
146211129|NCT03584516|527286042|FG002|Part 1|Lost to Follow-up|0|||
146083746|NCT01087788|526826593|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
146211130|NCT03584516|527286043|FG003|Part 1|Lost to Follow-up|0|||
146211131|NCT03584516|527286044|FG004|Part 1|Lost to Follow-up|0|||
146211132|NCT03584516|527286045|FG005|Part 1|Lost to Follow-up|0|||
146211133|NCT03584516|527286040|FG000|Part 1|Study Terminated by Sponsor|0|||
146211134|NCT03584516|527286041|FG001|Part 1|Study Terminated by Sponsor|2|||
146211135|NCT03584516|527286042|FG002|Part 1|Study Terminated by Sponsor|0|||
146211136|NCT03584516|527286043|FG003|Part 1|Study Terminated by Sponsor|0|||
146211137|NCT03584516|527286044|FG004|Part 1|Study Terminated by Sponsor|0|||
146211138|NCT03584516|527286045|FG005|Part 1|Study Terminated by Sponsor|0|||
146211139|NCT03584516|527286040|FG000|Part 1 Expansion|Death|0|||
146211140|NCT03584516|527286041|FG001|Part 1 Expansion|Death|0|||
146211141|NCT03584516|527286042|FG002|Part 1 Expansion|Death|9|||
146211142|NCT03584516|527286043|FG003|Part 1 Expansion|Death|8|||
146211143|NCT03584516|527286044|FG004|Part 1 Expansion|Death|4|||
146211144|NCT03584516|527286045|FG005|Part 1 Expansion|Death|5|||
146211145|NCT03584516|527286040|FG000|Part 1 Expansion|Lost to Follow-up|0|||
146211146|NCT03584516|527286041|FG001|Part 1 Expansion|Lost to Follow-up|0|||
146211147|NCT03584516|527286042|FG002|Part 1 Expansion|Lost to Follow-up|0|||
146211148|NCT03584516|527286043|FG003|Part 1 Expansion|Lost to Follow-up|1|||
146211149|NCT03584516|527286044|FG004|Part 1 Expansion|Lost to Follow-up|0|||
146211150|NCT03584516|527286045|FG005|Part 1 Expansion|Lost to Follow-up|0|||
146211151|NCT03584516|527286040|FG000|Part 1 Expansion|Physician Decision|0|||
146211152|NCT03584516|527286041|FG001|Part 1 Expansion|Physician Decision|0|||
146211153|NCT03584516|527286042|FG002|Part 1 Expansion|Physician Decision|4|||
146211154|NCT03584516|527286043|FG003|Part 1 Expansion|Physician Decision|3|||
146211155|NCT03584516|527286044|FG004|Part 1 Expansion|Physician Decision|2|||
146211156|NCT03584516|527286045|FG005|Part 1 Expansion|Physician Decision|3|||
146211157|NCT03584516|527286040|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
146211158|NCT03584516|527286041|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
146211159|NCT03584516|527286042|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
146211160|NCT03584516|527286043|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
146211161|NCT03584516|527286044|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
146211162|NCT03584516|527286045|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
146211163|NCT03584516|527286040|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
146211164|NCT03584516|527286041|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
146211165|NCT03584516|527286042|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
146211166|NCT03584516|527286043|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
146211167|NCT03584516|527286044|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
146211168|NCT03584516|527286045|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
146211169|NCT03584516|527286040|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146211170|NCT03584516|527286041|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146211171|NCT03584516|527286042|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146211172|NCT03584516|527286043|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
146211173|NCT03584516|527286044|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146211174|NCT03584516|527286045|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
146211175|NCT03584516|527286040|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146286177|NCT01375114|527562617|FG002|Overall Study|Increased AST/ALT|0|||
146211176|NCT03584516|527286041|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146083747|NCT01087788|526826594|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
146083748|NCT01087788|526826592|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
146083749|NCT01087788|526826593|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
146083750|NCT01087788|526826594|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
146083751|NCT01087788|526826592|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
146083752|NCT01087788|526826593|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
146083753|NCT01087788|526826594|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
146083754|NCT01087788|526826592|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
146083755|NCT01087788|526826593|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
146083756|NCT01087788|526826594|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
146083757|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
146083758|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
146083759|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
146083760|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
146083761|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
146083762|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
146083763|NCT01087788|526826592|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
146083764|NCT01087788|526826593|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
146083765|NCT01087788|526826594|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
146083766|NCT01087788|526826592|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
146083767|NCT01087788|526826593|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
146083768|NCT01087788|526826594|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
146083769|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
146083770|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
146083771|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
146083772|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
146083773|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
146083774|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
146083775|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
146083776|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
146083777|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
146083778|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
146083779|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
146083780|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
146083781|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
146083782|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
146083783|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
146083784|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
146083785|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
146083786|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
146083787|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
146083788|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
146083789|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
146083790|NCT01087788|526826592|FG000|24-weeks Dose-blind Period|Patient moved|0|||
146083791|NCT01087788|526826593|FG001|24-weeks Dose-blind Period|Patient moved|0|||
146083792|NCT01087788|526826594|FG002|24-weeks Dose-blind Period|Patient moved|1|||
146083793|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
146083794|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
146083795|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
146083796|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
146083797|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
146083798|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
146083799|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
146083800|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
146211177|NCT03584516|527286042|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146211178|NCT03584516|527286043|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146211179|NCT03584516|527286044|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
146211180|NCT03584516|527286045|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
146211181|NCT05986565|527286046|FG000|Overall Study|Lost to Follow-up|8|||
146211182|NCT05986565|527286047|FG001|Overall Study|Lost to Follow-up|3|||
146211183|NCT05986565|527286046|FG000|Overall Study|Withdrawal by Subject|0|||
146211184|NCT05986565|527286047|FG001|Overall Study|Withdrawal by Subject|1|||
146211185|NCT00670046|527286050|FG000|Overall Study|Lost to Follow-up|1|||
146211186|NCT00670046|527286051|FG001|Overall Study|Lost to Follow-up|1|||
146211187|NCT00670046|527286050|FG000|Overall Study|Withdrawal by Subject|0|||
146211188|NCT00670046|527286051|FG001|Overall Study|Withdrawal by Subject|1|||
146211189|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
146211190|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
146211191|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
146211192|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
146211193|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
146211194|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146211195|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146211196|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
146211197|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146211198|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
146211199|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
146211200|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
146211201|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
146083801|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
146083802|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
146083803|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
146083804|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
146083805|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
146083806|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
146083807|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
146083808|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
146083809|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
146083810|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
146083811|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
146083812|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
146083813|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
146083814|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
146083815|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
146083816|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
146083817|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
146083818|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
146083819|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
146083820|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
146083821|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
146083822|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
146083823|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
146083824|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
146083825|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
146083826|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
146083827|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
146083828|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
146083829|NCT01087788|526826592|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
146211202|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
146211203|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
146083830|NCT01087788|526826593|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
146083831|NCT01087788|526826594|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
146211204|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146083832|NCT04604132|526826595|FG000|Overall Study|Adverse Event|2|||
146083833|NCT04604132|526826596|FG001|Overall Study|Adverse Event|0|||
146083834|NCT04604132|526826597|FG002|Overall Study|Adverse Event|0|||
145957425|NCT01000974|526356238|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
146211205|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
146286178|NCT01375114|527562615|FG000|Overall Study|Vaginal Hemorrhage|0|||
146083835|NCT04604132|526826598|FG003|Overall Study|Adverse Event|1|||
146083836|NCT04604132|526826599|FG004|Overall Study|Adverse Event|2|||
146211206|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
146211207|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146211208|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
146211209|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
146211210|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
146211211|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
146211212|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
146211213|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
146211214|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146211215|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146211216|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
146211217|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146211218|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
146211219|NCT04759833|527286060|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146211220|NCT04759833|527286061|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
146211221|NCT04759833|527286062|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146211222|NCT04759833|527286063|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146211223|NCT04759833|527286064|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
146211224|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146211225|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146211226|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
146211227|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
146211228|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
146211229|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146211230|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146211231|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146211232|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
146211233|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
146211234|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146211235|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146211236|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
146211237|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
146211238|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
146211239|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146211240|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146211241|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
146211242|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
146211243|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
146211244|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146211245|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146211246|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
146211247|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
146211248|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
146211249|NCT04759833|527286060|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146211250|NCT04759833|527286061|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146211251|NCT04759833|527286062|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
146211252|NCT04759833|527286063|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
146211253|NCT04759833|527286064|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
146211254|NCT03446157|527286065|FG000|Overall Study|Death|11|||
146211255|NCT03446157|527286066|FG001|Overall Study|Death|9|||
146211256|NCT03446157|527286065|FG000|Overall Study|Lost to Follow-up|0|||
146211257|NCT03446157|527286066|FG001|Overall Study|Lost to Follow-up|1|||
146211258|NCT03446157|527286065|FG000|Overall Study|Withdrawal by Subject|2|||
146211259|NCT03446157|527286066|FG001|Overall Study|Withdrawal by Subject|1|||
146211260|NCT04402294|527286071|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
146211261|NCT04402294|527286072|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
146211262|NCT04402294|527286071|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
146286179|NCT01375114|527562616|FG001|Overall Study|Vaginal Hemorrhage|1|||
146211263|NCT04402294|527286072|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
146211264|NCT05307978|527288132|FG000|Overall Study|Lost to Follow-up|0|||
146211265|NCT05307978|527288133|FG001|Overall Study|Lost to Follow-up|1|||
146211266|NCT05307978|527288134|FG002|Overall Study|Lost to Follow-up|0|||
146211267|NCT05307978|527288135|FG003|Overall Study|Lost to Follow-up|4|||
146083837|NCT04604132|526826595|FG000|Overall Study|Study terminated by sponsor|0|||
146083838|NCT04604132|526826596|FG001|Overall Study|Study terminated by sponsor|0|||
146083839|NCT04604132|526826597|FG002|Overall Study|Study terminated by sponsor|0|||
146211268|NCT05307978|527288136|FG004|Overall Study|Lost to Follow-up|0|||
146211269|NCT05307978|527288137|FG005|Overall Study|Lost to Follow-up|0|||
146211270|NCT05307978|527288138|FG006|Overall Study|Lost to Follow-up|1|||
146211271|NCT03424811|527288139|FG000|Overall Study|Lost to Follow-up|9|||
146083840|NCT04604132|526826598|FG003|Overall Study|Study terminated by sponsor|0|||
146211272|NCT03424811|527288140|FG001|Overall Study|Lost to Follow-up|0|||
146211273|NCT00567398|527288141|FG000|Overall Study|Adverse Event|6|||
146211274|NCT00567398|527288142|FG001|Overall Study|Adverse Event|14|||
146211275|NCT00567398|527288141|FG000|Overall Study|Physician Decision|0|||
146211276|NCT00567398|527288142|FG001|Overall Study|Physician Decision|4|||
146211277|NCT00567398|527288141|FG000|Overall Study|Withdrawal by Subject|0|||
146211278|NCT00567398|527288142|FG001|Overall Study|Withdrawal by Subject|2|||
146211279|NCT00567398|527288141|FG000|Overall Study|Renal Transplantation|0|||
146211280|NCT00567398|527288142|FG001|Overall Study|Renal Transplantation|3|||
146211281|NCT00567398|527288141|FG000|Overall Study|Other|1|||
146211282|NCT00567398|527288142|FG001|Overall Study|Other|0|||
146211283|NCT03517553|527288143|FG000|Overall Study|Withdrawal by Subject|2|||
146211284|NCT04247542|527288148|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
146211285|NCT04247542|527288149|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
146211286|NCT04247542|527288150|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
146211287|NCT04247542|527288148|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
146211288|NCT04247542|527288149|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
146211289|NCT04247542|527288150|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
146211290|NCT02201108|527288151|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
146211291|NCT02201108|527288152|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
146211292|NCT02201108|527288153|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
146211293|NCT02201108|527288151|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
146211294|NCT02201108|527288152|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
146286180|NCT01375114|527562617|FG002|Overall Study|Vaginal Hemorrhage|0|||
146083841|NCT04604132|526826599|FG004|Overall Study|Study terminated by sponsor|1|||
146083842|NCT04604132|526826595|FG000|Overall Study|Progressive disease: Clinical progression|0|||
146211295|NCT02201108|527288153|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
146211296|NCT02201108|527288151|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
146211297|NCT02201108|527288152|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
146211298|NCT02201108|527288153|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
146211299|NCT02201108|527288151|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
146211300|NCT02201108|527288152|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
146211301|NCT02201108|527288153|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
146211302|NCT02201108|527288151|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
146211303|NCT02201108|527288152|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
146211304|NCT02201108|527288153|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
146211305|NCT02201108|527288151|FG000|Open Label Period (up to Week 192)|Other reason|4|||
146211306|NCT02201108|527288152|FG001|Open Label Period (up to Week 192)|Other reason|7|||
146211307|NCT02201108|527288153|FG002|Open Label Period (up to Week 192)|Other reason|0|||
146211308|NCT02201108|527288151|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
146211309|NCT02201108|527288152|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
146211310|NCT02201108|527288153|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
146211311|NCT02201108|527288151|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
146211312|NCT02201108|527288152|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
146211313|NCT02201108|527288153|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
146211314|NCT02201108|527288151|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
146211315|NCT02201108|527288152|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
146211316|NCT02201108|527288153|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
146211317|NCT03438188|527288154|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146211318|NCT03438188|527288155|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146211319|NCT03438188|527288156|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
146211320|NCT03438188|527288154|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
146211321|NCT03438188|527288155|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
146211322|NCT03438188|527288156|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
146211323|NCT03438188|527288154|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
146211324|NCT03438188|527288155|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
146211325|NCT03438188|527288156|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
146211326|NCT03438188|527288154|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
146211327|NCT03438188|527288155|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
146211328|NCT03438188|527288156|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
146211329|NCT03438188|527288154|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
146211330|NCT03438188|527288155|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
146211331|NCT03438188|527288156|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
146211332|NCT04143061|527288158|FG000|Overall Study|Protocol Deviation|0|||
146211333|NCT04143061|527288159|FG001|Overall Study|Protocol Deviation|0|||
146211334|NCT04143061|527288160|FG002|Overall Study|Protocol Deviation|0|||
146211335|NCT04143061|527288161|FG003|Overall Study|Protocol Deviation|0|||
146211336|NCT04143061|527288162|FG004|Overall Study|Protocol Deviation|0|||
146211337|NCT04143061|527288163|FG005|Overall Study|Protocol Deviation|0|||
146211338|NCT04143061|527288164|FG006|Overall Study|Protocol Deviation|5|||
146211339|NCT04143061|527288165|FG007|Overall Study|Protocol Deviation|5|||
146211340|NCT04143061|527288158|FG000|Overall Study|Withdrawal by Subject|2|||
146211341|NCT04143061|527288159|FG001|Overall Study|Withdrawal by Subject|0|||
146211342|NCT04143061|527288160|FG002|Overall Study|Withdrawal by Subject|0|||
146211343|NCT04143061|527288161|FG003|Overall Study|Withdrawal by Subject|0|||
146211344|NCT04143061|527288162|FG004|Overall Study|Withdrawal by Subject|0|||
146211345|NCT04143061|527288163|FG005|Overall Study|Withdrawal by Subject|1|||
146211346|NCT04143061|527288164|FG006|Overall Study|Withdrawal by Subject|0|||
146211347|NCT04143061|527288165|FG007|Overall Study|Withdrawal by Subject|0|||
146211348|NCT04143061|527288158|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146211349|NCT04143061|527288159|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146211350|NCT04143061|527288160|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146211351|NCT04143061|527288161|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146211352|NCT04143061|527288162|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
146211353|NCT04143061|527288163|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
146211354|NCT04143061|527288164|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
146286181|NCT01375114|527562615|FG000|Overall Study|Family problem|0|||
146211355|NCT04143061|527288165|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
146211356|NCT03602014|527288172|FG000|Overall Study|Lost to Follow-up|2|||
146211357|NCT03602014|527288173|FG001|Overall Study|Lost to Follow-up|0|||
146211358|NCT03602014|527288174|FG002|Overall Study|Lost to Follow-up|0|||
146211359|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146211360|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146211361|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
146286182|NCT01375114|527562616|FG001|Overall Study|Family problem|1|||
146211362|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
145890973|NCT01207440|526107575|FG005|Overall Study|Withdrawal by Subject|2|||
146211363|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
146211364|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146211365|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146211366|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146211367|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
146211368|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
146211369|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146211370|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146211371|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146211372|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
146211373|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
146211374|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146211375|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146211376|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
145957426|NCT01000974|526356239|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
146083843|NCT04604132|526826596|FG001|Overall Study|Progressive disease: Clinical progression|0|||
146211377|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
146211378|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
146211379|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146211380|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146211381|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146211382|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
146211383|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
146211384|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146211385|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146211386|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146211387|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
146211388|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
146211389|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146211390|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146211391|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146211392|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
146083844|NCT04604132|526826597|FG002|Overall Study|Progressive disease: Clinical progression|1|||
146083845|NCT04604132|526826598|FG003|Overall Study|Progressive disease: Clinical progression|0|||
146083846|NCT04604132|526826599|FG004|Overall Study|Progressive disease: Clinical progression|0|||
146211393|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
146083847|NCT04604132|526826595|FG000|Overall Study|Progressive disease: Radiological progression|8|||
146083848|NCT04604132|526826596|FG001|Overall Study|Progressive disease: Radiological progression|7|||
146211394|NCT01898494|527288178|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146211395|NCT01898494|527288179|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146211396|NCT01898494|527288180|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146211397|NCT01898494|527288181|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
146286183|NCT01375114|527562617|FG002|Overall Study|Family problem|0|||
146286184|NCT01375114|527562615|FG000|Overall Study|Protocol Violation|2|||
146286185|NCT01375114|527562616|FG001|Overall Study|Protocol Violation|0|||
146286186|NCT01375114|527562617|FG002|Overall Study|Protocol Violation|0|||
146286187|NCT01888900|527562618|FG000|Overall Study|failed treatment|0|||
146286188|NCT01888900|527562619|FG001|Overall Study|failed treatment|2|||
146286189|NCT01065844|527562622|FG000|Overall Study|Adverse Event|5|||
146286190|NCT01415531|527562623|FG000|Overall Study|Adverse Event|7|||
146286191|NCT01415531|527562624|FG001|Overall Study|Adverse Event|10|||
146286192|NCT01415531|527562623|FG000|Overall Study|Lack of Efficacy|3|||
146286193|NCT01415531|527562624|FG001|Overall Study|Lack of Efficacy|2|||
146286194|NCT01415531|527562623|FG000|Overall Study|Protocol Violation|0|||
146286195|NCT01415531|527562624|FG001|Overall Study|Protocol Violation|1|||
146286196|NCT01415531|527562623|FG000|Overall Study|Withdrawal by Subject|5|||
146211398|NCT01898494|527288182|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
146211399|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146211400|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146211401|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
146211402|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
146211403|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
146211404|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146211405|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146211406|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
146211407|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
146211408|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
146211409|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
146211410|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
146211411|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
146211412|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
146211413|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
146211414|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146211415|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
146211416|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146211417|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146211418|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
146286197|NCT01415531|527562624|FG001|Overall Study|Withdrawal by Subject|4|||
146286198|NCT01415531|527562623|FG000|Overall Study|Lost to Follow-up|6|||
146286199|NCT01415531|527562624|FG001|Overall Study|Lost to Follow-up|14|||
146286200|NCT01415531|527562623|FG000|Overall Study|Lack of Compliance|1|||
146211419|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146211420|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146211421|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
146211422|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146286201|NCT01415531|527562624|FG001|Overall Study|Lack of Compliance|4|||
146286202|NCT01415531|527562623|FG000|Overall Study|Other Reasons|3|||
146286203|NCT01415531|527562624|FG001|Overall Study|Other Reasons|2|||
146286204|NCT02319525|527562625|FG000|Overall Study|Withdrawal by Subject|2|||
146286205|NCT02319525|527562626|FG001|Overall Study|Withdrawal by Subject|1|||
146286206|NCT01200589|527562627|FG000|Overall Study|Withdrawal by Subject|13|||
146286207|NCT01200589|527562628|FG001|Overall Study|Withdrawal by Subject|11|||
146286208|NCT01200589|527562627|FG000|Overall Study|Physician Decision|2|||
146286209|NCT01200589|527562628|FG001|Overall Study|Physician Decision|2|||
146286210|NCT01200589|527562627|FG000|Overall Study|Lost to Follow-up|5|||
146286211|NCT01200589|527562628|FG001|Overall Study|Lost to Follow-up|4|||
146286212|NCT01200589|527562627|FG000|Overall Study|Study terminated|170|||
146286213|NCT01200589|527562628|FG001|Overall Study|Study terminated|172|||
146286214|NCT00185965|527562629|FG000|Overall Study|Adverse Event|0|||
146286215|NCT00185965|527562630|FG001|Overall Study|Adverse Event|1|||
146286216|NCT03814187|527562631|FG000|Overall Study|Sponsor's Administrative Decision|0|||
146286217|NCT03814187|527562632|FG001|Overall Study|Sponsor's Administrative Decision|0|||
146286218|NCT03814187|527562633|FG002|Overall Study|Sponsor's Administrative Decision|272|||
146286219|NCT03814187|527562631|FG000|Overall Study|Death|80|||
146286220|NCT03814187|527562632|FG001|Overall Study|Death|81|||
146286221|NCT03814187|527562633|FG002|Overall Study|Death|4|||
146286222|NCT03814187|527562631|FG000|Overall Study|Withdrew Consent|77|||
146286223|NCT03814187|527562632|FG001|Overall Study|Withdrew Consent|78|||
146286224|NCT03814187|527562633|FG002|Overall Study|Withdrew Consent|2|||
146286225|NCT03814187|527562631|FG000|Overall Study|Lost to Follow-up|47|||
146286226|NCT03814187|527562632|FG001|Overall Study|Lost to Follow-up|52|||
146286227|NCT03814187|527562633|FG002|Overall Study|Lost to Follow-up|1|||
146286228|NCT03814187|527562631|FG000|Overall Study|Adverse Event|22|||
146286229|NCT03814187|527562632|FG001|Overall Study|Adverse Event|23|||
146286230|NCT03814187|527562633|FG002|Overall Study|Adverse Event|0|||
146286231|NCT03814187|527562631|FG000|Overall Study|Physician Decision|7|||
146286232|NCT03814187|527562632|FG001|Overall Study|Physician Decision|4|||
146286233|NCT03814187|527562633|FG002|Overall Study|Physician Decision|2|||
146286234|NCT03814187|527562631|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
146286235|NCT03814187|527562632|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
146286236|NCT03814187|527562633|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
146286237|NCT03814187|527562631|FG000|Overall Study|Other reasons|34|||
146286238|NCT03814187|527562632|FG001|Overall Study|Other reasons|40|||
146286239|NCT03814187|527562633|FG002|Overall Study|Other reasons|2|||
146286240|NCT02009761|527562635|FG000|Overall Study|Adverse Event|4|||
146286241|NCT00825825|527562636|FG000|First Medication Period (14 Days)|Adverse Event|1|||
146286242|NCT00825825|527562637|FG001|First Medication Period (14 Days)|Adverse Event|0|||
146286243|NCT00825825|527562638|FG002|First Medication Period (14 Days)|Adverse Event|0|||
146286244|NCT00825825|527562639|FG003|First Medication Period (14 Days)|Adverse Event|0|||
146286245|NCT00825825|527562640|FG004|First Medication Period (14 Days)|Adverse Event|0|||
146286246|NCT00825825|527562641|FG005|First Medication Period (14 Days)|Adverse Event|1|||
146286247|NCT00825825|527562636|FG000|First Medication Period (14 Days)|Physician Decision|2|||
146286248|NCT00825825|527562637|FG001|First Medication Period (14 Days)|Physician Decision|0|||
146286249|NCT00825825|527562638|FG002|First Medication Period (14 Days)|Physician Decision|1|||
146286250|NCT00825825|527562639|FG003|First Medication Period (14 Days)|Physician Decision|0|||
146286251|NCT00825825|527562640|FG004|First Medication Period (14 Days)|Physician Decision|0|||
146286252|NCT00825825|527562641|FG005|First Medication Period (14 Days)|Physician Decision|1|||
146286253|NCT00825825|527562636|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
146286254|NCT00825825|527562637|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
146286255|NCT00825825|527562638|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
146286256|NCT00825825|527562639|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
146286257|NCT00825825|527562640|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
146286258|NCT00825825|527562641|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
146286259|NCT00825825|527562636|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
146286260|NCT00825825|527562637|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
146286261|NCT00825825|527562638|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
146286262|NCT00825825|527562639|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
146286263|NCT00825825|527562640|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
146286264|NCT00825825|527562641|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
146286265|NCT00825825|527562636|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
146286266|NCT00825825|527562637|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
146286267|NCT00825825|527562638|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
146286268|NCT00825825|527562639|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
146286269|NCT00825825|527562640|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
146083849|NCT04604132|526826597|FG002|Overall Study|Progressive disease: Radiological progression|10|||
146286270|NCT00825825|527562641|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
146286271|NCT00825825|527562636|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
146286272|NCT00825825|527562637|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
146286273|NCT00825825|527562638|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
146286274|NCT00825825|527562639|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
146286275|NCT00825825|527562640|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
146286276|NCT00825825|527562641|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
146286277|NCT00825825|527562636|FG000|Third Medication Period (14 Days)|poor data quality|0|||
146286278|NCT00825825|527562637|FG001|Third Medication Period (14 Days)|poor data quality|1|||
146286279|NCT00825825|527562638|FG002|Third Medication Period (14 Days)|poor data quality|0|||
146286280|NCT00825825|527562639|FG003|Third Medication Period (14 Days)|poor data quality|0|||
146286281|NCT00825825|527562640|FG004|Third Medication Period (14 Days)|poor data quality|0|||
146286282|NCT00825825|527562641|FG005|Third Medication Period (14 Days)|poor data quality|0|||
146286283|NCT01047293|527562646|FG000|Overall Study|DLT criteria not fulfilled|1|||
146286284|NCT01047293|527562647|FG001|Overall Study|DLT criteria not fulfilled|1|||
146286285|NCT01047293|527562648|FG002|Overall Study|DLT criteria not fulfilled|0|||
146286286|NCT01047293|527562649|FG003|Overall Study|DLT criteria not fulfilled|0|||
146286287|NCT00757783|527562650|FG000|Overall Study|Adverse Event|0|||
146286288|NCT00757783|527562651|FG001|Overall Study|Adverse Event|2|||
146286289|NCT00757783|527562650|FG000|Overall Study|Lost to Follow-up|1|||
146286290|NCT00757783|527562651|FG001|Overall Study|Lost to Follow-up|1|||
146286291|NCT00757783|527562650|FG000|Overall Study|Protocol Violation|1|||
146286292|NCT00757783|527562651|FG001|Overall Study|Protocol Violation|0|||
146286293|NCT00757783|527562650|FG000|Overall Study|Withdrawal by Subject|2|||
146286294|NCT00757783|527562651|FG001|Overall Study|Withdrawal by Subject|1|||
146286295|NCT00757783|527562650|FG000|Overall Study|Other|1|||
146286296|NCT00757783|527562651|FG001|Overall Study|Other|2|||
146286297|NCT02372136|527562656|FG000|Overall Study|Death|3|||
146286298|NCT02372136|527562657|FG001|Overall Study|Death|1|||
146286299|NCT00985946|527562658|FG000|Overall Study|Lost to Follow-up|6|||
146286300|NCT00985946|527562658|FG000|Overall Study|Withdrawal by Subject|1|||
146286301|NCT03265938|527562662|FG000|Overall Study|Withdrawal by Subject|1|||
146286302|NCT03265938|527562662|FG000|Overall Study|Physician Decision|1|||
146286303|NCT03265938|527562662|FG000|Overall Study|friable mass|6|||
146286304|NCT02673515|527562663|FG000|Overall Study|Lack of motivation|2|||
146286305|NCT02673515|527562664|FG001|Overall Study|Lack of motivation|1|||
146286306|NCT03683823|527562665|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
146286307|NCT03683823|527562666|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
146286308|NCT03683823|527562665|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
146286309|NCT03683823|527562666|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
146286310|NCT03683823|527562665|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
146286311|NCT03683823|527562666|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
146286312|NCT03965351|527562668|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146286313|NCT03965351|527562669|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
146286314|NCT03965351|527562668|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
146286315|NCT03965351|527562669|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
146286316|NCT01323972|527562671|FG000|Overall Study|Withdrawal by Subject|1|||
146286317|NCT01323972|527562672|FG001|Overall Study|Withdrawal by Subject|0|||
146286318|NCT01323972|527562673|FG002|Overall Study|Withdrawal by Subject|1|||
146286319|NCT01323972|527562674|FG003|Overall Study|Withdrawal by Subject|0|||
146286320|NCT01323972|527562671|FG000|Overall Study|Migrated/moved from study area|1|||
146286321|NCT01323972|527562672|FG001|Overall Study|Migrated/moved from study area|2|||
146286322|NCT01323972|527562673|FG002|Overall Study|Migrated/moved from study area|0|||
146286323|NCT01323972|527562674|FG003|Overall Study|Migrated/moved from study area|0|||
146286324|NCT01323972|527562671|FG000|Overall Study|Lost to Follow-up|0|||
146286325|NCT01323972|527562672|FG001|Overall Study|Lost to Follow-up|1|||
146286326|NCT01323972|527562673|FG002|Overall Study|Lost to Follow-up|1|||
146286327|NCT01323972|527562674|FG003|Overall Study|Lost to Follow-up|1|||
146286328|NCT00994682|527562675|FG000|Double Bilnd|Withdrawal by Subject|5|||
146286329|NCT00994682|527562676|FG001|Double Bilnd|Withdrawal by Subject|6|||
146286330|NCT00994682|527562675|FG000|Double Bilnd|Lost to Follow-up|3|||
146286331|NCT00994682|527562676|FG001|Double Bilnd|Lost to Follow-up|3|||
146286332|NCT00994682|527562675|FG000|Double Bilnd|Adverse Event|1|||
146286333|NCT00994682|527562676|FG001|Double Bilnd|Adverse Event|0|||
146083850|NCT04604132|526826598|FG003|Overall Study|Progressive disease: Radiological progression|4|||
146286334|NCT00994682|527562675|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
146286335|NCT00994682|527562676|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
146286336|NCT00994682|527562675|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
146286337|NCT00994682|527562676|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
146286338|NCT00994682|527562675|FG000|Pioglitazone Open Label|Physician Decision|6|||
146286339|NCT00994682|527562676|FG001|Pioglitazone Open Label|Physician Decision|1|||
146286340|NCT00928018|527562677|FG000|Overall Study|Withdrawal by Subject|1|||
146286341|NCT00928018|527562678|FG001|Overall Study|Withdrawal by Subject|0|||
146286342|NCT00943111|527562681|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
146286343|NCT00943111|527562682|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
146211423|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
146211424|NCT01898494|527288178|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
146211425|NCT01898494|527288179|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
146211426|NCT01898494|527288180|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
146211427|NCT01898494|527288181|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
146211428|NCT01898494|527288182|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
146211429|NCT03289039|527288185|FG000|Overall Study|Withdrawal by Subject|0|||
146211430|NCT03289039|527288186|FG001|Overall Study|Withdrawal by Subject|1|||
146211431|NCT03289039|527288185|FG000|Overall Study|Became ineligible prior to treatment start|0|||
146211432|NCT03289039|527288186|FG001|Overall Study|Became ineligible prior to treatment start|1|||
146211433|NCT03289039|527288185|FG000|Overall Study|progressed before treatment start|1|||
146211434|NCT03289039|527288186|FG001|Overall Study|progressed before treatment start|0|||
146211435|NCT02819843|527288187|FG000|Overall Study|Disease progression before RT|0|||
146211436|NCT02819843|527288188|FG001|Overall Study|Disease progression before RT|1|||
146211437|NCT04732494|527288189|FG000|Overall Study|Death|39|||
146211438|NCT04732494|527288190|FG001|Overall Study|Death|36|||
146211439|NCT04732494|527288189|FG000|Overall Study|Study Closed by Sponsor|20|||
146211440|NCT04732494|527288190|FG001|Overall Study|Study Closed by Sponsor|15|||
146211441|NCT04732494|527288189|FG000|Overall Study|Withdrawal by Subject|2|||
146211442|NCT04732494|527288190|FG001|Overall Study|Withdrawal by Subject|7|||
146211443|NCT04732494|527288189|FG000|Overall Study|Lost to Follow-up|1|||
146211444|NCT04732494|527288190|FG001|Overall Study|Lost to Follow-up|5|||
146211445|NCT03055858|527288191|FG000|Overall Study|Death|9|||
146211446|NCT03055858|527288191|FG000|Overall Study|Withdrawal by Subject|11|||
146211447|NCT03055858|527288191|FG000|Overall Study|Lost to Follow-up|6|||
146211448|NCT03055858|527288191|FG000|Overall Study|Missed Follow-Up Visits|18|||
146211449|NCT04586920|527288192|FG000|Overall Study|Lost to Follow-up|0|||
146211450|NCT04586920|527288193|FG001|Overall Study|Lost to Follow-up|0|||
146211451|NCT04586920|527288194|FG002|Overall Study|Lost to Follow-up|0|||
146211452|NCT04586920|527288195|FG003|Overall Study|Lost to Follow-up|0|||
146211453|NCT04586920|527288196|FG004|Overall Study|Lost to Follow-up|0|||
146211454|NCT04586920|527288197|FG005|Overall Study|Lost to Follow-up|0|||
146211455|NCT04586920|527288198|FG006|Overall Study|Lost to Follow-up|1|||
146211456|NCT04586920|527288199|FG007|Overall Study|Lost to Follow-up|1|||
146211457|NCT04586920|527288200|FG008|Overall Study|Lost to Follow-up|0|||
146211458|NCT04586920|527288201|FG009|Overall Study|Lost to Follow-up|1|||
146211459|NCT04586920|527288202|FG010|Overall Study|Lost to Follow-up|0|||
146211460|NCT04586920|527288203|FG011|Overall Study|Lost to Follow-up|0|||
146211461|NCT04586920|527288204|FG012|Overall Study|Lost to Follow-up|0|||
146211462|NCT04586920|527288205|FG013|Overall Study|Lost to Follow-up|1|||
146211463|NCT04586920|527288206|FG014|Overall Study|Lost to Follow-up|0|||
146211464|NCT04586920|527288207|FG015|Overall Study|Lost to Follow-up|0|||
146211465|NCT04586920|527288208|FG016|Overall Study|Lost to Follow-up|0|||
146211466|NCT04586920|527288209|FG017|Overall Study|Lost to Follow-up|0|||
146211467|NCT04586920|527288192|FG000|Overall Study|Withdrawal by Subject|0|||
146211468|NCT04586920|527288193|FG001|Overall Study|Withdrawal by Subject|0|||
146211469|NCT04586920|527288194|FG002|Overall Study|Withdrawal by Subject|0|||
146211470|NCT04586920|527288195|FG003|Overall Study|Withdrawal by Subject|0|||
146211471|NCT04586920|527288196|FG004|Overall Study|Withdrawal by Subject|0|||
146211472|NCT04586920|527288197|FG005|Overall Study|Withdrawal by Subject|0|||
146211473|NCT04586920|527288198|FG006|Overall Study|Withdrawal by Subject|0|||
146211474|NCT04586920|527288199|FG007|Overall Study|Withdrawal by Subject|1|||
146211475|NCT04586920|527288200|FG008|Overall Study|Withdrawal by Subject|0|||
146211476|NCT04586920|527288201|FG009|Overall Study|Withdrawal by Subject|1|||
146211477|NCT04586920|527288202|FG010|Overall Study|Withdrawal by Subject|0|||
146211478|NCT04586920|527288203|FG011|Overall Study|Withdrawal by Subject|1|||
146211479|NCT04586920|527288204|FG012|Overall Study|Withdrawal by Subject|0|||
146211480|NCT04586920|527288205|FG013|Overall Study|Withdrawal by Subject|0|||
146211481|NCT04586920|527288206|FG014|Overall Study|Withdrawal by Subject|0|||
146211482|NCT04586920|527288207|FG015|Overall Study|Withdrawal by Subject|0|||
146211483|NCT04586920|527288208|FG016|Overall Study|Withdrawal by Subject|0|||
146211484|NCT04586920|527288209|FG017|Overall Study|Withdrawal by Subject|0|||
146211485|NCT01718743|527288210|FG000|Overall Study|Physician Decision|7|||
146211486|NCT01718743|527288210|FG000|Overall Study|Withdrawal by Subject|14|||
146211487|NCT01718743|527288210|FG000|Overall Study|Progressive Disease|22|||
146211488|NCT01718743|527288210|FG000|Overall Study|Toxicity|1|||
146211489|NCT01718743|527288210|FG000|Overall Study|Malignancy|1|||
146211490|NCT02728557|527288211|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
146211491|NCT02728557|527288212|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
146211492|NCT02728557|527288211|FG000|Overall Study|Dissatisfaction with research tasks|0|||
146211493|NCT02728557|527288212|FG001|Overall Study|Dissatisfaction with research tasks|1|||
146211494|NCT02728557|527288211|FG000|Overall Study|Scheduling or change in availability|1|||
146211495|NCT02728557|527288212|FG001|Overall Study|Scheduling or change in availability|1|||
146211496|NCT03416010|527288213|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
146211497|NCT03416010|527288214|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
146211498|NCT03416010|527288213|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
146211499|NCT03416010|527288214|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
146211500|NCT03416010|527288213|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
146211501|NCT03416010|527288214|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
146211502|NCT03416010|527288213|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
146211503|NCT03416010|527288214|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
146211504|NCT03416010|527288213|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
146211505|NCT03416010|527288214|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
146211506|NCT03416010|527288213|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
146211507|NCT03416010|527288214|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
146211508|NCT03416010|527288213|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
146211509|NCT03416010|527288214|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
146211510|NCT03948763|527288215|FG000|Overall Study|Sponsor's decision|0|||
146211511|NCT03948763|527288216|FG001|Overall Study|Sponsor's decision|2|||
146211512|NCT03948763|527288217|FG002|Overall Study|Sponsor's decision|6|||
146211513|NCT03948763|527288218|FG003|Overall Study|Sponsor's decision|4|||
146211514|NCT03948763|527288219|FG004|Overall Study|Sponsor's decision|0|||
146211515|NCT03948763|527288215|FG000|Overall Study|Physician Decision|0|||
146211516|NCT03948763|527288216|FG001|Overall Study|Physician Decision|0|||
146211517|NCT03948763|527288217|FG002|Overall Study|Physician Decision|1|||
146211518|NCT03948763|527288218|FG003|Overall Study|Physician Decision|0|||
146211519|NCT03948763|527288219|FG004|Overall Study|Physician Decision|0|||
146211520|NCT03948763|527288215|FG000|Overall Study|Lost to Follow-up|0|||
146211521|NCT03948763|527288216|FG001|Overall Study|Lost to Follow-up|0|||
146211522|NCT03948763|527288217|FG002|Overall Study|Lost to Follow-up|0|||
146211523|NCT03948763|527288218|FG003|Overall Study|Lost to Follow-up|0|||
146211524|NCT03948763|527288219|FG004|Overall Study|Lost to Follow-up|1|||
146211525|NCT03948763|527288215|FG000|Overall Study|Death|2|||
146211526|NCT03948763|527288216|FG001|Overall Study|Death|12|||
146211527|NCT03948763|527288217|FG002|Overall Study|Death|13|||
146211528|NCT03948763|527288218|FG003|Overall Study|Death|10|||
146211529|NCT03948763|527288219|FG004|Overall Study|Death|11|||
146211530|NCT03948763|527288215|FG000|Overall Study|Withdrawal by Subject|1|||
146211531|NCT03948763|527288216|FG001|Overall Study|Withdrawal by Subject|1|||
146211532|NCT03948763|527288217|FG002|Overall Study|Withdrawal by Subject|0|||
146211533|NCT03948763|527288218|FG003|Overall Study|Withdrawal by Subject|2|||
146211534|NCT03948763|527288219|FG004|Overall Study|Withdrawal by Subject|4|||
146211535|NCT04600752|527288224|FG000|Overall Study|Physician Decision|0|||
146211536|NCT04600752|527288225|FG001|Overall Study|Physician Decision|0|||
146211537|NCT04600752|527288226|FG002|Overall Study|Physician Decision|1|||
146211538|NCT04600752|527288224|FG000|Overall Study|Adverse Event|0|||
146211539|NCT04600752|527288225|FG001|Overall Study|Adverse Event|1|||
146211540|NCT04600752|527288226|FG002|Overall Study|Adverse Event|0|||
146211541|NCT04600752|527288224|FG000|Overall Study|Withdrawal by Subject|2|||
146211542|NCT04600752|527288225|FG001|Overall Study|Withdrawal by Subject|1|||
146211543|NCT04600752|527288226|FG002|Overall Study|Withdrawal by Subject|0|||
146211544|NCT04600752|527288224|FG000|Overall Study|Lack of Efficacy|1|||
146211545|NCT04600752|527288225|FG001|Overall Study|Lack of Efficacy|0|||
146211546|NCT04600752|527288226|FG002|Overall Study|Lack of Efficacy|0|||
146211547|NCT03732820|527288227|FG000|Overall Study|Death|168|||
146286344|NCT00943111|527562683|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
146286345|NCT00943111|527562681|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
146286346|NCT00943111|527562682|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
146286347|NCT00943111|527562683|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
146211548|NCT03732820|527288228|FG001|Overall Study|Death|203|||
146211549|NCT03732820|527288227|FG000|Overall Study|Other|2|||
146211550|NCT03732820|527288228|FG001|Overall Study|Other|2|||
146211551|NCT03732820|527288227|FG000|Overall Study|Failure to meet randomisation criteria|1|||
146211552|NCT03732820|527288228|FG001|Overall Study|Failure to meet randomisation criteria|1|||
146211553|NCT03732820|527288227|FG000|Overall Study|Patient decision|14|||
146211554|NCT03732820|527288228|FG001|Overall Study|Patient decision|10|||
146211555|NCT03732820|527288227|FG000|Overall Study|Screen failure|0|||
146211556|NCT03732820|527288228|FG001|Overall Study|Screen failure|1|||
146211557|NCT03732820|527288227|FG000|Overall Study|Patients ongoing study at data cut off|210|||
146211558|NCT03732820|527288228|FG001|Overall Study|Patients ongoing study at data cut off|178|||
146211559|NCT03732820|527288227|FG000|Overall Study|Lost to Follow-up|4|||
146211560|NCT03732820|527288228|FG001|Overall Study|Lost to Follow-up|2|||
146211561|NCT04238247|527288229|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
146211562|NCT04238247|527288230|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
146211563|NCT04238247|527288231|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
146211564|NCT04238247|527288232|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
146211565|NCT04238247|527288229|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
146211566|NCT04238247|527288230|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
146211567|NCT04238247|527288231|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
146211568|NCT04238247|527288232|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
146211569|NCT04238247|527288229|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
145957427|NCT01000974|526356240|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
145957428|NCT01000974|526356238|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
146083851|NCT04604132|526826599|FG004|Overall Study|Progressive disease: Radiological progression|3|||
146083852|NCT04604132|526826595|FG000|Overall Study|Death|3|||
146083853|NCT04604132|526826596|FG001|Overall Study|Death|1|||
146083854|NCT04604132|526826597|FG002|Overall Study|Death|2|||
146083855|NCT04604132|526826598|FG003|Overall Study|Death|1|||
146211570|NCT04238247|527288230|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
146211571|NCT04238247|527288231|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
146211572|NCT04238247|527288232|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
146211573|NCT04238247|527288229|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
146211574|NCT04238247|527288230|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
146211575|NCT04238247|527288231|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
146211576|NCT04238247|527288232|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
146211577|NCT06061081|527288233|FG000|Overall Study|Withdrawal by Subject|1|||
146211578|NCT06061081|527288234|FG001|Overall Study|Withdrawal by Subject|0|||
146211579|NCT06061081|527288235|FG002|Overall Study|Withdrawal by Subject|0|||
146211580|NCT06061081|527288236|FG003|Overall Study|Withdrawal by Subject|0|||
146211581|NCT06061081|527288237|FG004|Overall Study|Withdrawal by Subject|0|||
146211582|NCT02252172|527288238|FG000|Overall Study|Lost to Follow-up|9|||
146211583|NCT02252172|527288239|FG001|Overall Study|Lost to Follow-up|6|||
146211584|NCT02252172|527288238|FG000|Overall Study|Death|218|||
146211585|NCT02252172|527288239|FG001|Overall Study|Death|175|||
146211586|NCT02252172|527288238|FG000|Overall Study|Withdrawal by Subject|20|||
146211587|NCT02252172|527288239|FG001|Overall Study|Withdrawal by Subject|15|||
146211588|NCT02252172|527288238|FG000|Overall Study|Physician Decision|0|||
146211589|NCT02252172|527288239|FG001|Overall Study|Physician Decision|1|||
146211590|NCT02252172|527288238|FG000|Overall Study|End of data collection|122|||
146211591|NCT02252172|527288239|FG001|Overall Study|End of data collection|170|||
146211592|NCT02252172|527288238|FG000|Overall Study|Site closure|0|||
146211593|NCT02252172|527288239|FG001|Overall Study|Site closure|1|||
146211594|NCT05575076|527288240|FG000|Overall Study|Adverse Event|24|||
146211595|NCT05575076|527288240|FG000|Overall Study|Death|7|||
146211596|NCT05575076|527288240|FG000|Overall Study|Lost to Follow-up|16|||
146211597|NCT05575076|527288240|FG000|Overall Study|Non-Compliance|3|||
146211598|NCT05575076|527288240|FG000|Overall Study|Physician Decision|6|||
146211599|NCT05575076|527288240|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
146211600|NCT05575076|527288240|FG000|Overall Study|Withdrawal by Subject|71|||
146211601|NCT05575076|527288240|FG000|Overall Study|Study Terminated by Sponsor|630|||
146211602|NCT05575076|527288240|FG000|Overall Study|Other|17|||
146211603|NCT03380390|527288241|FG000|Overall Study|Adverse Event|3|||
146211604|NCT02886286|527288242|FG000|Overall Study|pump motor stall|0|||
146211605|NCT02886286|527288243|FG001|Overall Study|pump motor stall|1|||
146211606|NCT01127373|527288244|FG000|Overall Study|Not Treated|3|||
146211607|NCT01127373|527288244|FG000|Overall Study|Lost to Follow-up|7|||
146211608|NCT01127373|527288244|FG000|Overall Study|Withdrawal by Subject|1|||
146211609|NCT01127373|527288244|FG000|Overall Study|Disease progression|1|||
146211610|NCT00522951|527288249|FG000|Period 1|body motion|0|||
146211611|NCT00522951|527288250|FG001|Period 1|body motion|1|||
146211612|NCT00522951|527288249|FG000|Washout Period|Adverse Event|0|||
146211613|NCT00522951|527288250|FG001|Washout Period|Adverse Event|1|||
146211614|NCT00522951|527288249|FG000|Washout Period|Death|0|||
146083856|NCT04604132|526826599|FG004|Overall Study|Death|0|||
146083857|NCT00952380|526826600|FG000|Overall Study|Other|0|||
146211615|NCT00522951|527288250|FG001|Washout Period|Death|1|||
146211616|NCT00522951|527288249|FG000|Period 2|Withdrawal by Subject|1|||
146211617|NCT00522951|527288250|FG001|Period 2|Withdrawal by Subject|0|||
146211618|NCT00522951|527288249|FG000|Period 2|residual contrast medium|1|||
146211619|NCT00522951|527288250|FG001|Period 2|residual contrast medium|1|||
146211620|NCT01426412|527288255|FG000|Overall Study|Withdrawal by Subject|1|||
146211621|NCT01426412|527288256|FG001|Overall Study|Withdrawal by Subject|0|||
146211622|NCT01426412|527288257|FG002|Overall Study|Withdrawal by Subject|0|||
146211623|NCT01426412|527288258|FG003|Overall Study|Withdrawal by Subject|0|||
146211624|NCT01426412|527288259|FG004|Overall Study|Withdrawal by Subject|1|||
146211625|NCT01426412|527288260|FG005|Overall Study|Withdrawal by Subject|0|||
146211626|NCT01426412|527288261|FG006|Overall Study|Withdrawal by Subject|0|||
146211627|NCT01426412|527288262|FG007|Overall Study|Withdrawal by Subject|3|||
146211628|NCT01426412|527288263|FG008|Overall Study|Withdrawal by Subject|1|||
146211629|NCT02376790|527288265|FG000|Overall Study|Withdrawal by Subject|43|||
146211630|NCT02376790|527288266|FG001|Overall Study|Withdrawal by Subject|36|||
146211631|NCT02376790|527288267|FG002|Overall Study|Withdrawal by Subject|37|||
146083858|NCT00952380|526826601|FG001|Overall Study|Other|0|||
146211632|NCT02376790|527288265|FG000|Overall Study|Decision by Sponsor|2|||
146211633|NCT02376790|527288266|FG001|Overall Study|Decision by Sponsor|1|||
145957429|NCT01000974|526356239|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
145957430|NCT01000974|526356240|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
146211634|NCT02376790|527288267|FG002|Overall Study|Decision by Sponsor|4|||
146211635|NCT02376790|527288265|FG000|Overall Study|Lost to Follow-up|15|||
146211636|NCT02376790|527288266|FG001|Overall Study|Lost to Follow-up|10|||
146211637|NCT02376790|527288267|FG002|Overall Study|Lost to Follow-up|12|||
146211638|NCT03014453|527288268|FG000|Overall Study|Lost to Follow-up|12|||
146211639|NCT03014453|527288268|FG000|Overall Study|Discontinued GER|3|||
146211640|NCT03014453|527288268|FG000|Overall Study|Excluded|19|||
146211641|NCT03014453|527288268|FG000|Overall Study|Refused to take part in|37|||
146211642|NCT05450458|527288269|FG000|Overall Study|Lost to Follow-up|4|||
146211643|NCT02141074|527288274|FG000|Pre-prophylaxis|Adverse Event|3|||
146211644|NCT02141074|527288275|FG001|Pre-prophylaxis|Adverse Event|0|||
146083859|NCT00952380|526826602|FG002|Overall Study|Other|0|||
146211645|NCT02141074|527288274|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
146211646|NCT02141074|527288275|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
146211647|NCT02141074|527288274|FG000|Prophylaxis|Adverse Event|0|||
146211648|NCT02141074|527288275|FG001|Prophylaxis|Adverse Event|4|||
146211649|NCT02141074|527288274|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
146211650|NCT02141074|527288275|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
146211651|NCT02141074|527288274|FG000|Prophylaxis|Withdrawal by Subject|0|||
146211652|NCT02141074|527288275|FG001|Prophylaxis|Withdrawal by Subject|1|||
146211653|NCT00262301|527288278|FG000|Double-blind Phase|Lost to Follow-up|1|||
146211654|NCT00262301|527288279|FG001|Double-blind Phase|Lost to Follow-up|0|||
146211655|NCT00262301|527288280|FG002|Double-blind Phase|Lost to Follow-up|0|||
146286348|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
146286349|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
146286350|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
146286351|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
146286352|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
146083860|NCT00952380|526826603|FG003|Overall Study|Other|0|||
146286353|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
146286354|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
146211656|NCT00262301|527288278|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
146211657|NCT00262301|527288279|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
146211658|NCT00262301|527288280|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
146211659|NCT03101930|527288281|FG000|Overall Study|Withdrawal by Subject|2|||
146211660|NCT03101930|527288282|FG001|Overall Study|Withdrawal by Subject|1|||
146211661|NCT03101930|527288283|FG002|Overall Study|Withdrawal by Subject|2|||
146211662|NCT01017146|527288284|FG000|Overall Study|Adverse Event|11|||
146211663|NCT01017146|527288285|FG001|Overall Study|Adverse Event|1|||
146211664|NCT01017146|527288284|FG000|Overall Study|Lost to Follow-up|14|||
146211665|NCT01017146|527288285|FG001|Overall Study|Lost to Follow-up|14|||
146211666|NCT01017146|527288284|FG000|Overall Study|Noncompliance with Study Product|1|||
146211667|NCT01017146|527288285|FG001|Overall Study|Noncompliance with Study Product|1|||
146211668|NCT01017146|527288284|FG000|Overall Study|Withdrawal by Subject|32|||
146211669|NCT01017146|527288285|FG001|Overall Study|Withdrawal by Subject|16|||
145957431|NCT01000974|526356238|FG000|Booster Vaccination Phase|Other|24|||
145957432|NCT01000974|526356239|FG001|Booster Vaccination Phase|Other|6|||
145957433|NCT01000974|526356240|FG002|Booster Vaccination Phase|Other|4|||
145957434|NCT03365934|526356241|FG000|Overall Study|Adverse Event|1|||
145957435|NCT03365934|526356241|FG000|Overall Study|Withdrawal by Subject|1|||
145957436|NCT01307891|526356242|FG000|Overall Study|Progressive Disease|3|||
145957437|NCT01307891|526356243|FG001|Overall Study|Progressive Disease|1|||
145957438|NCT02750332|526356244|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145957439|NCT02750332|526356245|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145957440|NCT02937740|526356246|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
145957441|NCT02937740|526356247|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
145957442|NCT02937740|526356246|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
145957443|NCT02937740|526356247|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
145957444|NCT02937740|526356246|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
145957445|NCT02937740|526356247|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
145957446|NCT02937740|526356246|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
145957447|NCT02937740|526356247|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
145957448|NCT02937740|526356246|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
145957449|NCT02937740|526356247|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
145957450|NCT02937740|526356246|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
145957451|NCT02937740|526356247|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
145957452|NCT02485483|526356253|FG000|Overall Study|Depression at baseline|15|||
145957453|NCT02485483|526356254|FG001|Overall Study|Depression at baseline|0|||
145957454|NCT02485483|526356253|FG000|Overall Study|Discontinued after baseline|39|||
145957455|NCT02485483|526356254|FG001|Overall Study|Discontinued after baseline|0|||
145957456|NCT00823264|526356260|FG000|Overall Study|Protocol Violation|2|||
145957457|NCT00823264|526356261|FG001|Overall Study|Protocol Violation|0|||
145957458|NCT03373760|526356267|FG000|Overall Study|Adverse Event|8|||
145957459|NCT03373760|526356267|FG000|Overall Study|Disease Progression|46|||
145957460|NCT03373760|526356267|FG000|Overall Study|Death|4|||
145957461|NCT01093586|526356268|FG000|Overall Study|Failed to engraft|3|||
145957462|NCT01300247|526356271|FG000|Overall Study|Death|1|||
145957463|NCT01300247|526356272|FG001|Overall Study|Death|1|||
145957464|NCT01300247|526356271|FG000|Overall Study|Lost to Follow-up|2|||
145957465|NCT01300247|526356272|FG001|Overall Study|Lost to Follow-up|0|||
145957466|NCT01300247|526356271|FG000|Overall Study|Withdrawal by Subject|1|||
145957467|NCT01300247|526356272|FG001|Overall Study|Withdrawal by Subject|0|||
145957468|NCT01300247|526356271|FG000|Overall Study|Non-Compliance|0|||
145957469|NCT01300247|526356272|FG001|Overall Study|Non-Compliance|1|||
145957470|NCT00922116|526356273|FG000|Overall Study|Adverse Event|4|||
145957471|NCT00922116|526356273|FG000|Overall Study|Death|1|||
145957472|NCT00922116|526356273|FG000|Overall Study|Lost to Follow-up|1|||
145957473|NCT00922116|526356273|FG000|Overall Study|Withdrawal by Subject|4|||
146286355|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
146286356|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
146286357|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
145957474|NCT00922116|526356273|FG000|Overall Study|Other|5|||
145957475|NCT00527826|526356274|FG000|Overall Study|Adverse Event|10|||
145957476|NCT00527826|526356275|FG001|Overall Study|Adverse Event|10|||
146286358|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
146286359|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
145957477|NCT00527826|526356274|FG000|Overall Study|Lost to Follow-up|3|||
145957478|NCT00527826|526356275|FG001|Overall Study|Lost to Follow-up|2|||
145957479|NCT00527826|526356274|FG000|Overall Study|Withdrawal by Subject|5|||
145957480|NCT00527826|526356275|FG001|Overall Study|Withdrawal by Subject|8|||
145957481|NCT00527826|526356274|FG000|Overall Study|Inclusion Criteria Not Met|3|||
145957482|NCT00527826|526356275|FG001|Overall Study|Inclusion Criteria Not Met|3|||
145957483|NCT00527826|526356274|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
146211670|NCT01017146|527288284|FG000|Overall Study|Relocation|0|||
146211671|NCT01017146|527288285|FG001|Overall Study|Relocation|4|||
146211672|NCT01017146|527288284|FG000|Overall Study|Pregnancy|2|||
146211673|NCT01017146|527288285|FG001|Overall Study|Pregnancy|1|||
145957484|NCT00527826|526356275|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
145957485|NCT00527826|526356274|FG000|Overall Study|Additional Intake of Viani forte|0|||
145957486|NCT00527826|526356275|FG001|Overall Study|Additional Intake of Viani forte|1|||
145957487|NCT00527826|526356274|FG000|Overall Study|Participant moved away|0|||
145957488|NCT00527826|526356275|FG001|Overall Study|Participant moved away|1|||
145957489|NCT01808261|526356276|FG000|Overall Study|Physician Decision|0|||
145957490|NCT01808261|526356277|FG001|Overall Study|Physician Decision|2|||
145957491|NCT01808261|526356276|FG000|Overall Study|Study Closed/Terminated|25|||
145957492|NCT01808261|526356277|FG001|Overall Study|Study Closed/Terminated|23|||
146211674|NCT01017146|527288284|FG000|Overall Study|Protocol Violation|2|||
146211675|NCT01017146|527288285|FG001|Overall Study|Protocol Violation|0|||
145957493|NCT01808261|526356276|FG000|Overall Study|Adverse event, non-fatal|2|||
145957494|NCT01808261|526356277|FG001|Overall Study|Adverse event, non-fatal|0|||
145957495|NCT01808261|526356276|FG000|Overall Study|Consent withdrawn by subject|6|||
145957496|NCT01808261|526356277|FG001|Overall Study|Consent withdrawn by subject|7|||
145957497|NCT01808261|526356276|FG000|Overall Study|Lost to Follow-up|3|||
145957498|NCT01808261|526356277|FG001|Overall Study|Lost to Follow-up|1|||
145957499|NCT02080364|526356282|FG000|Baseline Period|Protocol Violation|2|||
145957500|NCT02080364|526356283|FG001|Baseline Period|Protocol Violation|1|||
145957501|NCT02080364|526356284|FG002|Baseline Period|Protocol Violation|0|||
145957502|NCT02080364|526356285|FG003|Baseline Period|Protocol Violation|0|||
145957503|NCT02080364|526356282|FG000|Baseline Period|Other|0|||
145957504|NCT02080364|526356283|FG001|Baseline Period|Other|1|||
145957505|NCT02080364|526356284|FG002|Baseline Period|Other|1|||
145957506|NCT02080364|526356285|FG003|Baseline Period|Other|0|||
145957507|NCT02080364|526356282|FG000|Treatment Period|Adverse Event|10|||
145957508|NCT02080364|526356283|FG001|Treatment Period|Adverse Event|15|||
145957509|NCT02080364|526356284|FG002|Treatment Period|Adverse Event|11|||
145957510|NCT02080364|526356285|FG003|Treatment Period|Adverse Event|14|||
145957511|NCT02080364|526356282|FG000|Treatment Period|Lost to Follow-up|2|||
145957512|NCT02080364|526356283|FG001|Treatment Period|Lost to Follow-up|3|||
145957513|NCT02080364|526356284|FG002|Treatment Period|Lost to Follow-up|5|||
145957514|NCT02080364|526356285|FG003|Treatment Period|Lost to Follow-up|0|||
145957515|NCT02080364|526356282|FG000|Treatment Period|Protocol Violation|5|||
145957516|NCT02080364|526356283|FG001|Treatment Period|Protocol Violation|3|||
145957517|NCT02080364|526356284|FG002|Treatment Period|Protocol Violation|5|||
145957518|NCT02080364|526356285|FG003|Treatment Period|Protocol Violation|1|||
145957519|NCT02080364|526356282|FG000|Treatment Period|Withdrawal by Subject|16|||
145957520|NCT02080364|526356283|FG001|Treatment Period|Withdrawal by Subject|16|||
145957521|NCT02080364|526356284|FG002|Treatment Period|Withdrawal by Subject|15|||
145957522|NCT02080364|526356285|FG003|Treatment Period|Withdrawal by Subject|10|||
145957523|NCT02080364|526356282|FG000|Treatment Period|Study Terminated by Sponsor|0|||
145957524|NCT02080364|526356283|FG001|Treatment Period|Study Terminated by Sponsor|0|||
145957525|NCT02080364|526356284|FG002|Treatment Period|Study Terminated by Sponsor|180|||
145957526|NCT02080364|526356285|FG003|Treatment Period|Study Terminated by Sponsor|183|||
145957527|NCT02080364|526356282|FG000|Treatment Period|Other|14|||
145957528|NCT02080364|526356283|FG001|Treatment Period|Other|12|||
145957529|NCT02080364|526356284|FG002|Treatment Period|Other|21|||
145957530|NCT02080364|526356285|FG003|Treatment Period|Other|16|||
145957531|NCT02256839|526356286|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
145957532|NCT02256839|526356287|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
145957533|NCT01843803|526356288|FG000|Overall Study|not a Veteran, did not see provider|1|||
146211676|NCT01017146|527288284|FG000|Overall Study|Took Excluded Medication|2|||
146211677|NCT01017146|527288285|FG001|Overall Study|Took Excluded Medication|0|||
146211678|NCT01017146|527288284|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146211679|NCT01017146|527288285|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
146211680|NCT01017146|527288284|FG000|Overall Study|Change in Work Situation|1|||
145957534|NCT01843803|526356289|FG001|Overall Study|not a Veteran, did not see provider|3|||
145957535|NCT05285787|526356291|FG000|Overall Study|Withdrawal by Subject|1|||
145957536|NCT01051817|526356299|FG000|Overall Study|Adverse Event|0|||
145957537|NCT01051817|526356300|FG001|Overall Study|Adverse Event|2|||
146211681|NCT01017146|527288285|FG001|Overall Study|Change in Work Situation|0|||
146211682|NCT01747486|527288286|FG000|Stage 1|Physician Decision|3|||
146211683|NCT01747486|527288287|FG001|Stage 1|Physician Decision|0|||
145957538|NCT01051817|526356299|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
145957539|NCT01051817|526356300|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
145957540|NCT01051817|526356299|FG000|Overall Study|Withdrawal by Subject|3|||
146211684|NCT01747486|527288286|FG000|Stage 1|Withdrawal by Subject|4|||
145957541|NCT01051817|526356300|FG001|Overall Study|Withdrawal by Subject|5|||
145957542|NCT01051817|526356299|FG000|Overall Study|Protocol Violation|0|||
145957543|NCT01051817|526356300|FG001|Overall Study|Protocol Violation|1|||
145957544|NCT04346199|526356301|FG000|Overall Study|Death|8|||
145957545|NCT04346199|526356302|FG001|Overall Study|Death|9|||
146211685|NCT01747486|527288287|FG001|Stage 1|Withdrawal by Subject|3|||
146211686|NCT01747486|527288286|FG000|Stage 1|Disease progression|4|||
146211687|NCT01747486|527288287|FG001|Stage 1|Disease progression|9|||
145957546|NCT04346199|526356301|FG000|Overall Study|Lost to Follow-up|0|||
145957547|NCT04346199|526356302|FG001|Overall Study|Lost to Follow-up|1|||
145957548|NCT04346199|526356301|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
145957549|NCT04346199|526356302|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
145957550|NCT04346199|526356301|FG000|Overall Study|Withdrawal by Subject|5|||
145957551|NCT04346199|526356302|FG001|Overall Study|Withdrawal by Subject|1|||
145957552|NCT00627926|526356303|FG000|Overall Study|Adverse Event|26|||
145957553|NCT00627926|526356304|FG001|Overall Study|Adverse Event|37|||
145957554|NCT00627926|526356305|FG002|Overall Study|Adverse Event|36|||
145957555|NCT00627926|526356303|FG000|Overall Study|Death|1|||
145957556|NCT00627926|526356304|FG001|Overall Study|Death|0|||
145957557|NCT00627926|526356305|FG002|Overall Study|Death|0|||
145957558|NCT00627926|526356303|FG000|Overall Study|Lost to Follow-up|4|||
145957559|NCT00627926|526356304|FG001|Overall Study|Lost to Follow-up|3|||
145957560|NCT00627926|526356305|FG002|Overall Study|Lost to Follow-up|4|||
145957561|NCT00627926|526356303|FG000|Overall Study|Withdrawal by Subject|2|||
145957562|NCT00627926|526356304|FG001|Overall Study|Withdrawal by Subject|1|||
145957563|NCT00627926|526356305|FG002|Overall Study|Withdrawal by Subject|0|||
145957564|NCT00627926|526356303|FG000|Overall Study|Lack of Efficacy|118|||
145957565|NCT00627926|526356304|FG001|Overall Study|Lack of Efficacy|40|||
145957566|NCT00627926|526356305|FG002|Overall Study|Lack of Efficacy|38|||
145957567|NCT00627926|526356303|FG000|Overall Study|Noncompliance/unspecified|8|||
145957568|NCT00627926|526356304|FG001|Overall Study|Noncompliance/unspecified|23|||
145957569|NCT00627926|526356305|FG002|Overall Study|Noncompliance/unspecified|17|||
145957570|NCT02401035|526356306|FG000|Overall Study|Withdrawal by Subject|1|||
145957571|NCT02401035|526356307|FG001|Overall Study|Withdrawal by Subject|0|||
145957572|NCT00869128|526356308|FG000|Overall Study|lack of Compliance|6|||
145957573|NCT00869128|526356309|FG001|Overall Study|lack of Compliance|6|||
145957574|NCT01118663|526356311|FG000|Overall Study|Adverse Event|2|||
145957575|NCT01118663|526356312|FG001|Overall Study|Adverse Event|1|||
145957576|NCT01118663|526356311|FG000|Overall Study|Withdrawal by Subject|0|||
145957577|NCT01118663|526356312|FG001|Overall Study|Withdrawal by Subject|1|||
145957578|NCT01189461|526356313|FG000|Overall Study|Lack of Efficacy|13|||
145957579|NCT01189461|526356313|FG000|Overall Study|Lost to Follow-up|1|||
145957580|NCT01189461|526356313|FG000|Overall Study|Withdrawal by Subject|6|||
145957581|NCT01189461|526356313|FG000|Overall Study|Protocol Violation|1|||
145957582|NCT01189461|526356313|FG000|Overall Study|Adverse Event|2|||
146211688|NCT01747486|527288286|FG000|Stage 1|Death|1|||
145957583|NCT01189461|526356313|FG000|Overall Study|Did not meet entrance criteria|3|||
145957584|NCT01189461|526356313|FG000|Overall Study|Other|8|||
145957585|NCT00656175|526356314|FG000|Overall Study|Adverse Event|1|||
145957586|NCT00656175|526356315|FG001|Overall Study|Adverse Event|0|||
146211689|NCT01747486|527288287|FG001|Stage 1|Death|1|||
146211690|NCT01747486|527288286|FG000|Stage 2|Physician Decision|2|||
145957587|NCT00656175|526356314|FG000|Overall Study|Transportation issues|0|||
145957588|NCT00656175|526356315|FG001|Overall Study|Transportation issues|1|||
145957589|NCT03283930|526356318|FG000|Overall Study|Scheduling conflict|8|||
145957590|NCT03283930|526356319|FG001|Overall Study|Scheduling conflict|10|||
145957591|NCT03283930|526356318|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
145957592|NCT03283930|526356319|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
145957593|NCT03283930|526356318|FG000|Overall Study|Technical software issue|2|||
145957594|NCT03283930|526356319|FG001|Overall Study|Technical software issue|2|||
145957595|NCT02282163|526356322|FG000|Overall Study|Protocol Violation|1|||
145957596|NCT03472521|526356323|FG000|Overall Study|Lost to Follow-up|3|||
145957597|NCT03472521|526356324|FG001|Overall Study|Lost to Follow-up|2|||
145957598|NCT03472521|526356323|FG000|Overall Study|Discontinued intervention|3|||
145957599|NCT03472521|526356324|FG001|Overall Study|Discontinued intervention|1|||
146211691|NCT01747486|527288287|FG001|Stage 2|Physician Decision|0|||
146211692|NCT01747486|527288286|FG000|Stage 2|Withdrawal by Subject|1|||
145957600|NCT00452439|526358100|FG000|Overall Study|Lost to Follow-up|1|||
145957601|NCT00452439|526358101|FG001|Overall Study|Lost to Follow-up|1|||
145957602|NCT00452439|526358100|FG000|Overall Study|Refused Treatment|4|||
145957603|NCT00452439|526358101|FG001|Overall Study|Refused Treatment|3|||
145957604|NCT00452439|526358100|FG000|Overall Study|Death|3|||
146211693|NCT01747486|527288287|FG001|Stage 2|Withdrawal by Subject|0|||
146211694|NCT01747486|527288286|FG000|Stage 2|New Cancer Therapy|3|||
145957605|NCT00452439|526358101|FG001|Overall Study|Death|1|||
145957606|NCT00452439|526358100|FG000|Overall Study|Bone Marrow Transplant|0|||
145957607|NCT00452439|526358101|FG001|Overall Study|Bone Marrow Transplant|1|||
145957608|NCT00452439|526358100|FG000|Overall Study|Too Ill to Continue|0|||
145957609|NCT00452439|526358101|FG001|Overall Study|Too Ill to Continue|1|||
145957610|NCT00452439|526358100|FG000|Overall Study|Failed to achieve complete response|2|||
145957611|NCT00452439|526358101|FG001|Overall Study|Failed to achieve complete response|0|||
145957612|NCT00452439|526358100|FG000|Overall Study|Relapse|3|||
145957613|NCT00452439|526358101|FG001|Overall Study|Relapse|0|||
145957614|NCT00452439|526358100|FG000|Overall Study|Fracture|1|||
146211695|NCT01747486|527288287|FG001|Stage 2|New Cancer Therapy|0|||
146211696|NCT01747486|527288286|FG000|Stage 2|Disease Progression|3|||
146211697|NCT01747486|527288287|FG001|Stage 2|Disease Progression|0|||
146211698|NCT01084707|527288291|FG000|Overall Study|Withdrawal by Subject|6|||
146211699|NCT00087139|527288292|FG000|Overall Study|Adverse Event|18|||
146211700|NCT00087139|527288293|FG001|Overall Study|Adverse Event|17|||
146211701|NCT00087139|527288294|FG002|Overall Study|Adverse Event|13|||
146211702|NCT00087139|527288292|FG000|Overall Study|Death|2|||
146211703|NCT00087139|527288293|FG001|Overall Study|Death|1|||
146211704|NCT00087139|527288294|FG002|Overall Study|Death|0|||
146211705|NCT00087139|527288292|FG000|Overall Study|Withdrawal by Subject|3|||
146211706|NCT00087139|527288293|FG001|Overall Study|Withdrawal by Subject|2|||
146211707|NCT00087139|527288294|FG002|Overall Study|Withdrawal by Subject|2|||
146211708|NCT00087139|527288292|FG000|Overall Study|Physician Decision|1|||
146083861|NCT00952380|526826604|FG004|Overall Study|Other|1|||
145957615|NCT00452439|526358101|FG001|Overall Study|Fracture|0|||
146211709|NCT00087139|527288293|FG001|Overall Study|Physician Decision|1|||
146211710|NCT00087139|527288294|FG002|Overall Study|Physician Decision|1|||
146211711|NCT00087139|527288292|FG000|Overall Study|Disease progression|9|||
146211712|NCT00087139|527288293|FG001|Overall Study|Disease progression|19|||
145957616|NCT01381926|526358102|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
146211713|NCT00087139|527288294|FG002|Overall Study|Disease progression|12|||
146211714|NCT00087139|527288292|FG000|Overall Study|Ineligible|4|||
146211715|NCT00087139|527288293|FG001|Overall Study|Ineligible|7|||
145957617|NCT01381926|526358103|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
145957618|NCT01381926|526358102|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
145957619|NCT01381926|526358103|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
145957620|NCT04826484|526358121|FG000|Overall Study|Lost to Follow-up|2|||
145957621|NCT04826484|526358122|FG001|Overall Study|Lost to Follow-up|0|||
146211716|NCT00087139|527288294|FG002|Overall Study|Ineligible|4|||
146211717|NCT00087139|527288292|FG000|Overall Study|Symptomatic deterioration|1|||
146211718|NCT00087139|527288293|FG001|Overall Study|Symptomatic deterioration|1|||
145957622|NCT03512353|526358125|FG000|Overall Study|Sponsor Decision|3|||
145957623|NCT03512353|526358125|FG000|Overall Study|Death|1|||
146211719|NCT00087139|527288294|FG002|Overall Study|Symptomatic deterioration|3|||
146211720|NCT00087139|527288292|FG000|Overall Study|Use of coumadin|1|||
146211721|NCT00087139|527288293|FG001|Overall Study|Use of coumadin|0|||
146211722|NCT00087139|527288294|FG002|Overall Study|Use of coumadin|0|||
146211723|NCT00087139|527288292|FG000|Overall Study|Response achieved|0|||
146211724|NCT00087139|527288293|FG001|Overall Study|Response achieved|1|||
146211725|NCT00087139|527288294|FG002|Overall Study|Response achieved|0|||
146211726|NCT00087139|527288292|FG000|Overall Study|Extradural disease|0|||
146211727|NCT00087139|527288293|FG001|Overall Study|Extradural disease|0|||
146211728|NCT00087139|527288294|FG002|Overall Study|Extradural disease|1|||
146211729|NCT00976495|527288295|FG000|Overall Study|Withdrawal by Subject|0|||
146211730|NCT00976495|527288296|FG001|Overall Study|Withdrawal by Subject|1|||
146211731|NCT00976495|527288297|FG002|Overall Study|Withdrawal by Subject|0|||
146211732|NCT02272816|527288298|FG000|Overall Study|Adverse Event|1|||
146211733|NCT05171777|527288299|FG000|Treatment Crossover Period|Adverse Event|9|||
146211734|NCT05171777|527288300|FG001|Treatment Crossover Period|Adverse Event|6|||
146211735|NCT05171777|527288301|FG002|Treatment Crossover Period|Adverse Event|0|||
146211736|NCT05171777|527288302|FG003|Treatment Crossover Period|Adverse Event|0|||
146211737|NCT05171777|527288299|FG000|Treatment Crossover Period|Death|5|||
146211738|NCT05171777|527288300|FG001|Treatment Crossover Period|Death|5|||
146211739|NCT05171777|527288301|FG002|Treatment Crossover Period|Death|0|||
146211740|NCT05171777|527288302|FG003|Treatment Crossover Period|Death|0|||
146211741|NCT05171777|527288299|FG000|Treatment Crossover Period|Disease Relapse|0|||
146211742|NCT05171777|527288300|FG001|Treatment Crossover Period|Disease Relapse|1|||
146211743|NCT05171777|527288301|FG002|Treatment Crossover Period|Disease Relapse|0|||
146211744|NCT05171777|527288302|FG003|Treatment Crossover Period|Disease Relapse|0|||
146211745|NCT05171777|527288299|FG000|Treatment Crossover Period|Reason not Specified|2|||
146211746|NCT05171777|527288300|FG001|Treatment Crossover Period|Reason not Specified|1|||
146211747|NCT05171777|527288301|FG002|Treatment Crossover Period|Reason not Specified|0|||
146211748|NCT05171777|527288302|FG003|Treatment Crossover Period|Reason not Specified|0|||
146211749|NCT05171777|527288299|FG000|Treatment Crossover Period|Physician Decision|0|||
146211750|NCT05171777|527288300|FG001|Treatment Crossover Period|Physician Decision|1|||
146211751|NCT05171777|527288301|FG002|Treatment Crossover Period|Physician Decision|0|||
146211752|NCT05171777|527288302|FG003|Treatment Crossover Period|Physician Decision|0|||
146211753|NCT05171777|527288299|FG000|Treatment Crossover Period|Progressive Disease|13|||
146211754|NCT05171777|527288300|FG001|Treatment Crossover Period|Progressive Disease|9|||
146211755|NCT05171777|527288301|FG002|Treatment Crossover Period|Progressive Disease|0|||
146211756|NCT05171777|527288302|FG003|Treatment Crossover Period|Progressive Disease|0|||
146211757|NCT05171777|527288299|FG000|Treatment Crossover Period|Protocol Violation|0|||
146211758|NCT05171777|527288300|FG001|Treatment Crossover Period|Protocol Violation|2|||
146211759|NCT05171777|527288301|FG002|Treatment Crossover Period|Protocol Violation|0|||
146211760|NCT05171777|527288302|FG003|Treatment Crossover Period|Protocol Violation|0|||
146211761|NCT05171777|527288299|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
146211762|NCT05171777|527288300|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
146211763|NCT05171777|527288301|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
146211764|NCT05171777|527288302|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
146211765|NCT05171777|527288299|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
146211766|NCT05171777|527288300|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
146211767|NCT05171777|527288301|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
146211768|NCT05171777|527288302|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
146211769|NCT05171777|527288299|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
146211770|NCT05171777|527288300|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
146286360|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
145957624|NCT00758498|526358126|FG000|Overall Study|Adverse Event|2|||
146211771|NCT05171777|527288301|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
146211772|NCT05171777|527288302|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
146211773|NCT05171777|527288299|FG000|Treatment Continuation Period|Death|0|||
146211774|NCT05171777|527288300|FG001|Treatment Continuation Period|Death|0|||
146211775|NCT05171777|527288301|FG002|Treatment Continuation Period|Death|1|||
146211776|NCT05171777|527288302|FG003|Treatment Continuation Period|Death|6|||
146211777|NCT05171777|527288299|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
146211778|NCT05171777|527288300|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
146211779|NCT05171777|527288301|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
146211780|NCT05171777|527288302|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
146211781|NCT04154384|527288303|FG000|Overall Study|Lost to Follow-up|24|||
146211782|NCT04154384|527288304|FG001|Overall Study|Lost to Follow-up|33|||
146211783|NCT04154384|527288305|FG002|Overall Study|Lost to Follow-up|0|||
146211784|NCT04154384|527288303|FG000|Overall Study|Withdrawal by Subject|7|||
146211785|NCT04154384|527288304|FG001|Overall Study|Withdrawal by Subject|18|||
146211786|NCT04154384|527288305|FG002|Overall Study|Withdrawal by Subject|0|||
146211787|NCT04154384|527288303|FG000|Overall Study|Missing outcome data|1|||
146211788|NCT04154384|527288304|FG001|Overall Study|Missing outcome data|0|||
146211789|NCT04154384|527288305|FG002|Overall Study|Missing outcome data|0|||
146211790|NCT01136876|527288306|FG000|Overall Study|Lost to Follow-up|0|||
146211791|NCT01136876|527288307|FG001|Overall Study|Lost to Follow-up|1|||
146286361|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
146286362|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
146286363|NCT00943111|527562681|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
145957625|NCT00758498|526358127|FG001|Overall Study|Adverse Event|2|||
146211792|NCT01136876|527288306|FG000|Overall Study|Physician Decision|3|||
146211793|NCT01136876|527288307|FG001|Overall Study|Physician Decision|5|||
146211794|NCT01136876|527288306|FG000|Overall Study|Missing NGAL measurement|2|||
146211795|NCT01136876|527288307|FG001|Overall Study|Missing NGAL measurement|5|||
146211796|NCT05321069|527288308|FG000|Overall Study|Adverse Event|52|||
146211797|NCT05321069|527288309|FG001|Overall Study|Adverse Event|52|||
146211798|NCT05321069|527288310|FG002|Overall Study|Adverse Event|64|||
146211799|NCT05321069|527288308|FG000|Overall Study|Protocol Violation|1|||
146211800|NCT05321069|527288309|FG001|Overall Study|Protocol Violation|1|||
146211801|NCT05321069|527288310|FG002|Overall Study|Protocol Violation|0|||
146211802|NCT05321069|527288308|FG000|Overall Study|Withdrawal by Subject|23|||
146211803|NCT05321069|527288309|FG001|Overall Study|Withdrawal by Subject|18|||
146211804|NCT05321069|527288310|FG002|Overall Study|Withdrawal by Subject|12|||
146211805|NCT05321069|527288308|FG000|Overall Study|Lost to Follow-up|1|||
146211806|NCT05321069|527288309|FG001|Overall Study|Lost to Follow-up|0|||
146211807|NCT05321069|527288310|FG002|Overall Study|Lost to Follow-up|1|||
146211808|NCT05321069|527288308|FG000|Overall Study|No reason stated by the participants|23|||
146211809|NCT05321069|527288309|FG001|Overall Study|No reason stated by the participants|22|||
146211810|NCT05321069|527288310|FG002|Overall Study|No reason stated by the participants|16|||
146211811|NCT05321069|527288308|FG000|Overall Study|Lack of Efficacy|1|||
146211812|NCT05321069|527288309|FG001|Overall Study|Lack of Efficacy|1|||
146211813|NCT05321069|527288310|FG002|Overall Study|Lack of Efficacy|0|||
146211814|NCT02412748|527288313|FG000|Overall Study|Lost to Follow-up|38|||
146211815|NCT02412748|527288314|FG001|Overall Study|Lost to Follow-up|39|||
146211816|NCT04128319|527288315|FG000|Overall Study|Death|3|||
146211817|NCT04048382|527288323|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
146211818|NCT04048382|527288324|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
146211819|NCT04048382|527288323|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
146211820|NCT04048382|527288324|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
146211821|NCT04048382|527288323|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
146211822|NCT04048382|527288324|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
146211823|NCT01227265|527288325|FG000|Overall Study|Did Not Receive Treatment|1|||
146211824|NCT01227265|527288326|FG001|Overall Study|Did Not Receive Treatment|2|||
146211825|NCT01227265|527288327|FG002|Overall Study|Did Not Receive Treatment|0|||
146211826|NCT01227265|527288325|FG000|Overall Study|Administrative|1|||
146211827|NCT01227265|527288326|FG001|Overall Study|Administrative|0|||
146211828|NCT01227265|527288327|FG002|Overall Study|Administrative|2|||
146211829|NCT01227265|527288325|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146211830|NCT01227265|527288326|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
146211831|NCT01227265|527288327|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
146211832|NCT01227265|527288325|FG000|Overall Study|Protocol Violation|2|||
146211833|NCT01227265|527288326|FG001|Overall Study|Protocol Violation|1|||
146211834|NCT01227265|527288327|FG002|Overall Study|Protocol Violation|0|||
146211835|NCT01227265|527288325|FG000|Overall Study|Withdrawal by Subject|7|||
146211836|NCT01227265|527288326|FG001|Overall Study|Withdrawal by Subject|7|||
146211837|NCT01227265|527288327|FG002|Overall Study|Withdrawal by Subject|3|||
146211838|NCT01227265|527288325|FG000|Overall Study|Lost to Follow-up|2|||
146211839|NCT01227265|527288326|FG001|Overall Study|Lost to Follow-up|0|||
146211840|NCT01227265|527288327|FG002|Overall Study|Lost to Follow-up|3|||
146211841|NCT01227265|527288325|FG000|Overall Study|Adverse Event|6|||
146211842|NCT01227265|527288326|FG001|Overall Study|Adverse Event|10|||
146211843|NCT01227265|527288327|FG002|Overall Study|Adverse Event|5|||
146211844|NCT03481816|527288329|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
146211845|NCT03481816|527288330|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
146211846|NCT03481816|527288329|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
146211847|NCT03481816|527288330|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
146211848|NCT03481816|527288329|FG000|Dose Expansion|Withdrawal by Subject|0|||
146211849|NCT03481816|527288330|FG001|Dose Expansion|Withdrawal by Subject|2|||
146211850|NCT03481816|527288329|FG000|Dose Expansion|Physician Decision|0|||
146211851|NCT03481816|527288330|FG001|Dose Expansion|Physician Decision|5|||
146211852|NCT02269475|527288331|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
146211853|NCT02269475|527288332|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
146211854|NCT02269475|527288331|FG000|Overall Study|Withdrawal by Subject|0|||
146211855|NCT02269475|527288332|FG001|Overall Study|Withdrawal by Subject|1|||
146211856|NCT05368558|527288337|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
146211857|NCT05368558|527288338|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
146211858|NCT05368558|527288339|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
146211859|NCT05368558|527288340|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211860|NCT05368558|527288341|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211861|NCT05368558|527288342|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211862|NCT05368558|527288343|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211863|NCT05368558|527288344|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211864|NCT05368558|527288345|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211865|NCT05368558|527288346|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146286364|NCT00943111|527562682|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
146286365|NCT00943111|527562683|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
146211866|NCT05368558|527288347|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211867|NCT05368558|527288348|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
146211868|NCT05368558|527288337|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211869|NCT05368558|527288338|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211870|NCT05368558|527288339|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211871|NCT05368558|527288340|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
146211872|NCT05368558|527288341|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211873|NCT05368558|527288342|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
146211874|NCT05368558|527288343|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211875|NCT05368558|527288344|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146083862|NCT00952380|526826600|FG000|Overall Study|Withdrawal by Subject|0|||
146083863|NCT00952380|526826601|FG001|Overall Study|Withdrawal by Subject|0|||
146211876|NCT05368558|527288345|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211877|NCT05368558|527288346|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146083864|NCT00952380|526826602|FG002|Overall Study|Withdrawal by Subject|1|||
146083865|NCT00952380|526826603|FG003|Overall Study|Withdrawal by Subject|0|||
146211878|NCT05368558|527288347|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211879|NCT05368558|527288348|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
146211880|NCT05368558|527288337|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211881|NCT05368558|527288338|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211882|NCT05368558|527288339|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211883|NCT05368558|527288340|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
146211884|NCT05368558|527288341|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211885|NCT05368558|527288342|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211886|NCT05368558|527288343|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211887|NCT05368558|527288344|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211888|NCT05368558|527288345|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211889|NCT05368558|527288346|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211890|NCT05368558|527288347|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211891|NCT05368558|527288348|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
146211892|NCT05368558|527288337|FG000|Blinded Extension Period (BEP)|other|0|||
146211893|NCT05368558|527288338|FG001|Blinded Extension Period (BEP)|other|0|||
146211894|NCT05368558|527288339|FG002|Blinded Extension Period (BEP)|other|0|||
146211895|NCT05368558|527288340|FG003|Blinded Extension Period (BEP)|other|0|||
146211896|NCT05368558|527288341|FG004|Blinded Extension Period (BEP)|other|0|||
146211897|NCT05368558|527288342|FG005|Blinded Extension Period (BEP)|other|1|||
146211898|NCT05368558|527288343|FG006|Blinded Extension Period (BEP)|other|0|||
146211899|NCT05368558|527288344|FG007|Blinded Extension Period (BEP)|other|0|||
146211900|NCT05368558|527288345|FG008|Blinded Extension Period (BEP)|other|0|||
146211901|NCT05368558|527288346|FG009|Blinded Extension Period (BEP)|other|0|||
146211902|NCT05368558|527288347|FG010|Blinded Extension Period (BEP)|other|0|||
146211903|NCT05368558|527288348|FG011|Blinded Extension Period (BEP)|other|0|||
146211904|NCT04994509|527288349|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
146211905|NCT04994509|527288350|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
146211906|NCT04994509|527288351|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
146211907|NCT04994509|527288349|FG000|Overall Study|Withdrew Consent|73|||
146211908|NCT04994509|527288350|FG001|Overall Study|Withdrew Consent|72|||
146211909|NCT04994509|527288351|FG002|Overall Study|Withdrew Consent|46|||
146211910|NCT04994509|527288349|FG000|Overall Study|Lost to Follow-up|39|||
146211911|NCT04994509|527288350|FG001|Overall Study|Lost to Follow-up|36|||
146211912|NCT04994509|527288351|FG002|Overall Study|Lost to Follow-up|26|||
146211913|NCT04994509|527288349|FG000|Overall Study|HIV-1 Infection|4|||
146211914|NCT04994509|527288350|FG001|Overall Study|HIV-1 Infection|20|||
146211915|NCT04994509|527288351|FG002|Overall Study|HIV-1 Infection|12|||
146211916|NCT04994509|527288349|FG000|Overall Study|Investigator's Discretion|9|||
146211917|NCT04994509|527288350|FG001|Overall Study|Investigator's Discretion|8|||
146211918|NCT04994509|527288351|FG002|Overall Study|Investigator's Discretion|11|||
146211919|NCT04994509|527288349|FG000|Overall Study|Randomized but Never Treated|10|||
146211920|NCT04994509|527288350|FG001|Overall Study|Randomized but Never Treated|10|||
146211921|NCT04994509|527288351|FG002|Overall Study|Randomized but Never Treated|3|||
146211922|NCT04994509|527288349|FG000|Overall Study|Pregnancy|5|||
146211923|NCT04994509|527288350|FG001|Overall Study|Pregnancy|5|||
146211924|NCT04994509|527288351|FG002|Overall Study|Pregnancy|0|||
146211925|NCT04994509|527288349|FG000|Overall Study|Death|0|||
146211926|NCT04994509|527288350|FG001|Overall Study|Death|5|||
146211927|NCT04994509|527288351|FG002|Overall Study|Death|0|||
146211928|NCT04994509|527288349|FG000|Overall Study|Adverse Event|2|||
146211929|NCT04994509|527288350|FG001|Overall Study|Adverse Event|1|||
146211930|NCT04994509|527288351|FG002|Overall Study|Adverse Event|0|||
146211931|NCT04994509|527288349|FG000|Overall Study|Non-compliance With Study Drug|1|||
146211932|NCT04994509|527288350|FG001|Overall Study|Non-compliance With Study Drug|1|||
146211933|NCT04994509|527288351|FG002|Overall Study|Non-compliance With Study Drug|1|||
146211934|NCT04994509|527288349|FG000|Overall Study|Withdrew Assent|3|||
146211935|NCT04994509|527288350|FG001|Overall Study|Withdrew Assent|0|||
146211936|NCT04994509|527288351|FG002|Overall Study|Withdrew Assent|0|||
146211937|NCT04994509|527288349|FG000|Overall Study|Protocol Violation|1|||
146211938|NCT04994509|527288350|FG001|Overall Study|Protocol Violation|0|||
146211939|NCT04994509|527288351|FG002|Overall Study|Protocol Violation|0|||
146211940|NCT04459416|527290176|FG000|Overall Study|Lost to Follow-up|2|||
146211941|NCT04459416|527290177|FG001|Overall Study|Lost to Follow-up|0|||
146211942|NCT04459416|527290176|FG000|Overall Study|Withdrawal by Subject|8|||
146211943|NCT04459416|527290177|FG001|Overall Study|Withdrawal by Subject|10|||
146211944|NCT04459416|527290176|FG000|Overall Study|Disease progression|0|||
146211945|NCT04459416|527290177|FG001|Overall Study|Disease progression|3|||
146211946|NCT03744312|527290178|FG000|Overall Study|Withdrawal by Subject|0|||
146211947|NCT03744312|527290179|FG001|Overall Study|Withdrawal by Subject|1|||
146211948|NCT03744312|527290178|FG000|Overall Study|Screen fail|0|||
146211949|NCT03744312|527290179|FG001|Overall Study|Screen fail|1|||
146211950|NCT04579380|527290180|FG000|Overall Study|Death|9|||
146211951|NCT04579380|527290181|FG001|Overall Study|Death|22|||
146211952|NCT04579380|527290182|FG002|Overall Study|Death|22|||
146211953|NCT04579380|527290183|FG003|Overall Study|Death|17|||
146211954|NCT04579380|527290184|FG004|Overall Study|Death|6|||
146211955|NCT04579380|527290185|FG005|Overall Study|Death|21|||
146211956|NCT04579380|527290186|FG006|Overall Study|Death|10|||
146211957|NCT04579380|527290187|FG007|Overall Study|Death|11|||
146211958|NCT04579380|527290188|FG008|Overall Study|Death|25|||
146211959|NCT04579380|527290180|FG000|Overall Study|Withdrawal by Subject|0|||
146211960|NCT04579380|527290181|FG001|Overall Study|Withdrawal by Subject|3|||
146211961|NCT04579380|527290182|FG002|Overall Study|Withdrawal by Subject|4|||
146211962|NCT04579380|527290183|FG003|Overall Study|Withdrawal by Subject|0|||
146211963|NCT04579380|527290184|FG004|Overall Study|Withdrawal by Subject|1|||
146211964|NCT04579380|527290185|FG005|Overall Study|Withdrawal by Subject|2|||
146211965|NCT04579380|527290186|FG006|Overall Study|Withdrawal by Subject|0|||
146211966|NCT04579380|527290187|FG007|Overall Study|Withdrawal by Subject|1|||
146211967|NCT04579380|527290188|FG008|Overall Study|Withdrawal by Subject|2|||
146211968|NCT04579380|527290180|FG000|Overall Study|Ongoing|2|||
146211969|NCT04579380|527290181|FG001|Overall Study|Ongoing|6|||
146211970|NCT04579380|527290182|FG002|Overall Study|Ongoing|4|||
146211971|NCT04579380|527290183|FG003|Overall Study|Ongoing|8|||
146211972|NCT04579380|527290184|FG004|Overall Study|Ongoing|5|||
146211973|NCT04579380|527290185|FG005|Overall Study|Ongoing|8|||
146211974|NCT04579380|527290186|FG006|Overall Study|Ongoing|3|||
146211975|NCT04579380|527290187|FG007|Overall Study|Ongoing|19|||
146211976|NCT04579380|527290188|FG008|Overall Study|Ongoing|6|||
146211977|NCT03821844|527290189|FG000|Overall Study|Death|37|||
146083866|NCT00952380|526826604|FG004|Overall Study|Withdrawal by Subject|2|||
146083867|NCT00952380|526826600|FG000|Overall Study|Adverse Event|0|||
146083868|NCT00952380|526826601|FG001|Overall Study|Adverse Event|1|||
146083869|NCT00952380|526826602|FG002|Overall Study|Adverse Event|0|||
146083870|NCT00952380|526826603|FG003|Overall Study|Adverse Event|0|||
146083871|NCT00952380|526826604|FG004|Overall Study|Adverse Event|3|||
146083872|NCT00952380|526826600|FG000|Overall Study|Physician Decision|0|||
146211978|NCT03821844|527290190|FG001|Overall Study|Death|31|||
146211979|NCT03821844|527290189|FG000|Overall Study|Discharged|10|||
146211980|NCT03821844|527290190|FG001|Overall Study|Discharged|14|||
146211981|NCT03821844|527290189|FG000|Overall Study|Not present in facility at followup|2|||
146211982|NCT03821844|527290190|FG001|Overall Study|Not present in facility at followup|3|||
146211983|NCT03913195|527290191|FG000|Overall Study|Adverse Event|0|||
146211984|NCT03913195|527290192|FG001|Overall Study|Adverse Event|0|||
146211985|NCT03913195|527290193|FG002|Overall Study|Adverse Event|1|||
146211986|NCT03913195|527290194|FG003|Overall Study|Adverse Event|1|||
146211987|NCT03913195|527290195|FG004|Overall Study|Adverse Event|0|||
146211988|NCT03913195|527290191|FG000|Overall Study|Withdrawal by Subject|0|||
146211989|NCT03913195|527290192|FG001|Overall Study|Withdrawal by Subject|0|||
146211990|NCT03913195|527290193|FG002|Overall Study|Withdrawal by Subject|1|||
146211991|NCT03913195|527290194|FG003|Overall Study|Withdrawal by Subject|0|||
146211992|NCT03913195|527290195|FG004|Overall Study|Withdrawal by Subject|1|||
146211993|NCT03913195|527290191|FG000|Overall Study|non adherence to study|0|||
145957626|NCT00758498|526358128|FG002|Overall Study|Adverse Event|3|||
146211994|NCT03913195|527290192|FG001|Overall Study|non adherence to study|0|||
146083873|NCT00952380|526826601|FG001|Overall Study|Physician Decision|0|||
146083874|NCT00952380|526826602|FG002|Overall Study|Physician Decision|1|||
146211995|NCT03913195|527290193|FG002|Overall Study|non adherence to study|1|||
146211996|NCT03913195|527290194|FG003|Overall Study|non adherence to study|0|||
146211997|NCT03913195|527290195|FG004|Overall Study|non adherence to study|0|||
146211998|NCT02525692|527290196|FG000|Overall Study|Withdrawal by Subject|1|||
146211999|NCT02525692|527290197|FG001|Overall Study|Withdrawal by Subject|1|||
145957627|NCT00758498|526358126|FG000|Overall Study|Subject legally detained out of state|1|||
145957628|NCT00758498|526358127|FG001|Overall Study|Subject legally detained out of state|0|||
146212000|NCT02525692|527290198|FG002|Overall Study|Withdrawal by Subject|0|||
146212001|NCT02525692|527290199|FG003|Overall Study|Withdrawal by Subject|5|||
146212002|NCT02525692|527290200|FG004|Overall Study|Withdrawal by Subject|0|||
146212003|NCT02525692|527290201|FG005|Overall Study|Withdrawal by Subject|1|||
146212004|NCT02525692|527290196|FG000|Overall Study|Death|16|||
146212005|NCT02525692|527290197|FG001|Overall Study|Death|18|||
146212006|NCT02525692|527290198|FG002|Overall Study|Death|7|||
146212007|NCT02525692|527290199|FG003|Overall Study|Death|20|||
146212008|NCT02525692|527290200|FG004|Overall Study|Death|3|||
146212009|NCT02525692|527290201|FG005|Overall Study|Death|6|||
146212010|NCT02525692|527290196|FG000|Overall Study|Lost to Follow-up|0|||
146286366|NCT02859324|527562684|FG000|Overall Study|Death|4|||
146286367|NCT02859324|527562685|FG001|Overall Study|Death|6|||
146286368|NCT02859324|527562686|FG002|Overall Study|Death|5|||
146286369|NCT02859324|527562684|FG000|Overall Study|Other reasons|3|||
146286370|NCT02859324|527562685|FG001|Overall Study|Other reasons|3|||
146286371|NCT02859324|527562686|FG002|Overall Study|Other reasons|0|||
146286372|NCT02008877|527562687|FG000|Overall Study|Inevaluable|0|||
146286373|NCT02008877|527562688|FG001|Overall Study|Inevaluable|1|||
146286374|NCT02008877|527562689|FG002|Overall Study|Inevaluable|0|||
146286375|NCT01049217|527562690|FG000|Overall Study|Adverse Event|2|||
146286376|NCT01049217|527562691|FG001|Overall Study|Adverse Event|1|||
146286377|NCT01049217|527562690|FG000|Overall Study|Lack of Efficacy|1|||
146286378|NCT01049217|527562691|FG001|Overall Study|Lack of Efficacy|1|||
146286379|NCT01049217|527562690|FG000|Overall Study|Lost to Follow-up|3|||
146286380|NCT01049217|527562691|FG001|Overall Study|Lost to Follow-up|8|||
146286381|NCT01049217|527562690|FG000|Overall Study|Withdrawal by Subject|4|||
146286382|NCT01049217|527562691|FG001|Overall Study|Withdrawal by Subject|3|||
146286383|NCT01049217|527562690|FG000|Overall Study|Protocol Violation|1|||
146286384|NCT01049217|527562691|FG001|Overall Study|Protocol Violation|3|||
146286385|NCT01049217|527562690|FG000|Overall Study|Pregnancy|1|||
146286386|NCT01049217|527562691|FG001|Overall Study|Pregnancy|0|||
146286387|NCT01049217|527562690|FG000|Overall Study|Study Terminated by Sponsor|43|||
146286388|NCT01049217|527562691|FG001|Overall Study|Study Terminated by Sponsor|43|||
146286389|NCT01049217|527562690|FG000|Overall Study|Other|1|||
146212011|NCT02525692|527290197|FG001|Overall Study|Lost to Follow-up|0|||
146212012|NCT02525692|527290198|FG002|Overall Study|Lost to Follow-up|1|||
146212013|NCT02525692|527290199|FG003|Overall Study|Lost to Follow-up|5|||
146212014|NCT02525692|527290200|FG004|Overall Study|Lost to Follow-up|0|||
146212015|NCT02525692|527290201|FG005|Overall Study|Lost to Follow-up|0|||
146212016|NCT05510232|527290202|FG000|Overall Study|Withdrawal by Subject|2|||
146212017|NCT05510232|527290203|FG001|Overall Study|Withdrawal by Subject|7|||
146212018|NCT05510232|527290204|FG002|Overall Study|Withdrawal by Subject|6|||
146212019|NCT00979576|527290214|FG000|Combination Treatment Phase|Progressive disease|3|||
146286390|NCT01049217|527562691|FG001|Overall Study|Other|2|||
146286391|NCT01049217|527562690|FG000|Overall Study|Randomized but not Treated|0|||
146286392|NCT01049217|527562691|FG001|Overall Study|Randomized but not Treated|2|||
146286393|NCT01946438|527562692|FG000|Overall Study|Adverse Event|0|||
146286394|NCT01946438|527562693|FG001|Overall Study|Adverse Event|0|||
146286395|NCT01946438|527562694|FG002|Overall Study|Adverse Event|0|||
146212020|NCT00979576|527290215|FG001|Combination Treatment Phase|Progressive disease|1|||
146212021|NCT00979576|527290216|FG002|Combination Treatment Phase|Progressive disease|5|||
146212022|NCT00979576|527290214|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
146212023|NCT00979576|527290215|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
146212024|NCT00979576|527290216|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
146212025|NCT00979576|527290214|FG000|Combination Treatment Phase|Adverse Event|0|||
146212026|NCT00979576|527290215|FG001|Combination Treatment Phase|Adverse Event|2|||
146212027|NCT00979576|527290216|FG002|Combination Treatment Phase|Adverse Event|2|||
146212028|NCT00979576|527290214|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
146212029|NCT00979576|527290215|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
146212030|NCT00979576|527290216|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
146212031|NCT04855760|527290219|FG000|Overall Study|Adverse Event|21|||
146212032|NCT04855760|527290219|FG000|Overall Study|Withdrawal by Subject|116|||
146212033|NCT04855760|527290219|FG000|Overall Study|Lack of Efficacy|21|||
146212034|NCT04855760|527290219|FG000|Overall Study|Lost to Follow-up|49|||
146212035|NCT04855760|527290219|FG000|Overall Study|Protocol Violation|2|||
146083875|NCT00952380|526826603|FG003|Overall Study|Physician Decision|2|||
146212036|NCT04855760|527290219|FG000|Overall Study|Physician Decision|5|||
146212037|NCT04855760|527290219|FG000|Overall Study|Pregnancy|1|||
146212038|NCT04855760|527290219|FG000|Overall Study|Non-Compliance with Study Drug|11|||
146212039|NCT04855760|527290219|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
146212040|NCT04855760|527290219|FG000|Overall Study|Study Completed by Sponsor|202|||
146212041|NCT04855760|527290219|FG000|Overall Study|Other|13|||
146212042|NCT04840199|527290220|FG000|Overall Study|Study Terminated by Sponsor|8|||
146212043|NCT04840199|527290221|FG001|Overall Study|Study Terminated by Sponsor|9|||
146212044|NCT04840199|527290220|FG000|Overall Study|Lost to Follow-up|0|||
146212045|NCT04840199|527290221|FG001|Overall Study|Lost to Follow-up|2|||
146212046|NCT04840199|527290220|FG000|Overall Study|Withdrawal by Subject|2|||
146212047|NCT04840199|527290221|FG001|Overall Study|Withdrawal by Subject|0|||
146212048|NCT04840199|527290220|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
146212049|NCT04840199|527290221|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
146212050|NCT02553642|527290229|FG000|Overall Study|Withdrawal by Subject|0|||
146212051|NCT02553642|527290230|FG001|Overall Study|Withdrawal by Subject|3|||
146212052|NCT02553642|527290229|FG000|Overall Study|Physician Decision|0|||
146212053|NCT02553642|527290230|FG001|Overall Study|Physician Decision|1|||
146212054|NCT02553642|527290229|FG000|Overall Study|Additional cancer dx|0|||
146212055|NCT02553642|527290230|FG001|Overall Study|Additional cancer dx|1|||
146212056|NCT02553642|527290229|FG000|Overall Study|Never started treatment|0|||
146212057|NCT02553642|527290230|FG001|Overall Study|Never started treatment|1|||
146212058|NCT05444192|527290231|FG000|Overall Study|Lost to Follow-up|1|||
146212059|NCT05444192|527290232|FG001|Overall Study|Lost to Follow-up|0|||
146212060|NCT04424927|527290233|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
146212061|NCT04424927|527290234|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
146212062|NCT04424927|527290235|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
146212063|NCT04424927|527290236|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
146212064|NCT04424927|527290237|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
146212065|NCT04424927|527290233|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
146212066|NCT04424927|527290234|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
146212067|NCT04424927|527290235|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
146212068|NCT04424927|527290236|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
146212069|NCT04424927|527290237|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
146212070|NCT04424927|527290233|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
146212071|NCT04424927|527290234|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146212072|NCT04424927|527290235|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146212073|NCT04424927|527290236|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146212074|NCT04424927|527290237|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
146212075|NCT04424927|527290233|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
146212076|NCT04424927|527290234|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146212077|NCT04424927|527290235|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146212078|NCT04424927|527290236|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146212079|NCT04424927|527290237|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
146212080|NCT04424927|527290233|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146212081|NCT04424927|527290234|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
146212082|NCT04424927|527290235|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
146212083|NCT04424927|527290236|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146212084|NCT04424927|527290237|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
146212085|NCT04424927|527290233|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
146212086|NCT04424927|527290234|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
146212087|NCT04424927|527290235|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
146212088|NCT04424927|527290236|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
146212089|NCT04424927|527290237|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
146212090|NCT04424927|527290233|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146212091|NCT04424927|527290234|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
146212092|NCT04424927|527290235|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146212093|NCT04424927|527290236|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
146212094|NCT04424927|527290237|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
146212095|NCT04424927|527290233|FG000|Double-blind Period (24 Weeks)|Other|0|||
146212096|NCT04424927|527290234|FG001|Double-blind Period (24 Weeks)|Other|1|||
146212097|NCT04424927|527290235|FG002|Double-blind Period (24 Weeks)|Other|3|||
146212098|NCT04424927|527290236|FG003|Double-blind Period (24 Weeks)|Other|1|||
146212099|NCT04424927|527290237|FG004|Double-blind Period (24 Weeks)|Other|0|||
146212100|NCT04791709|527290241|FG000|Overall Study|Withdrawal by Subject|3|||
146212101|NCT02724956|527290242|FG000|Overall Study|Physician Decision|1|||
146083876|NCT00952380|526826604|FG004|Overall Study|Physician Decision|0|||
146083877|NCT00952380|526826600|FG000|Overall Study|Non-compliant to protocol|0|||
146083878|NCT00952380|526826601|FG001|Overall Study|Non-compliant to protocol|0|||
146212102|NCT02724956|527290243|FG001|Overall Study|Physician Decision|0|||
146212103|NCT02724956|527290242|FG000|Overall Study|Lack of Efficacy|0|||
146286396|NCT01946438|527562695|FG003|Overall Study|Adverse Event|1|||
146286397|NCT01946438|527562692|FG000|Overall Study|Serious Adverse event|1|||
146286398|NCT01946438|527562693|FG001|Overall Study|Serious Adverse event|0|||
146286399|NCT01946438|527562694|FG002|Overall Study|Serious Adverse event|0|||
146286400|NCT01946438|527562695|FG003|Overall Study|Serious Adverse event|0|||
146286401|NCT01946438|527562692|FG000|Overall Study|Protocol Violation|0|||
146286402|NCT01946438|527562693|FG001|Overall Study|Protocol Violation|0|||
146286403|NCT01946438|527562694|FG002|Overall Study|Protocol Violation|1|||
146286404|NCT01946438|527562695|FG003|Overall Study|Protocol Violation|0|||
146286405|NCT01946438|527562692|FG000|Overall Study|Withdrawal by Subject|1|||
146286406|NCT01946438|527562693|FG001|Overall Study|Withdrawal by Subject|0|||
146286407|NCT01946438|527562694|FG002|Overall Study|Withdrawal by Subject|0|||
146286408|NCT01946438|527562695|FG003|Overall Study|Withdrawal by Subject|0|||
146286409|NCT02412371|527562696|FG000|Overall Study|Withdrawal by Subject|0|||
146286410|NCT02412371|527562697|FG001|Overall Study|Withdrawal by Subject|2|||
146286411|NCT02412371|527562698|FG002|Overall Study|Withdrawal by Subject|0|||
146286412|NCT02412371|527562699|FG003|Overall Study|Withdrawal by Subject|1|||
146286413|NCT02412371|527562700|FG004|Overall Study|Withdrawal by Subject|1|||
146286414|NCT02412371|527562701|FG005|Overall Study|Withdrawal by Subject|0|||
146286415|NCT02412371|527562696|FG000|Overall Study|Sponsor Discontinued Study|1|||
146286416|NCT02412371|527562697|FG001|Overall Study|Sponsor Discontinued Study|4|||
146286417|NCT02412371|527562698|FG002|Overall Study|Sponsor Discontinued Study|6|||
146286418|NCT02412371|527562699|FG003|Overall Study|Sponsor Discontinued Study|4|||
146286419|NCT02412371|527562700|FG004|Overall Study|Sponsor Discontinued Study|5|||
146286420|NCT02412371|527562701|FG005|Overall Study|Sponsor Discontinued Study|0|||
146286421|NCT02412371|527562696|FG000|Overall Study|Death|4|||
146286422|NCT02412371|527562697|FG001|Overall Study|Death|2|||
146286423|NCT02412371|527562698|FG002|Overall Study|Death|1|||
146286424|NCT02412371|527562699|FG003|Overall Study|Death|3|||
146286425|NCT02412371|527562700|FG004|Overall Study|Death|5|||
146286426|NCT02412371|527562701|FG005|Overall Study|Death|2|||
146286427|NCT02412371|527562696|FG000|Overall Study|Other|2|||
146286428|NCT02412371|527562697|FG001|Overall Study|Other|1|||
146286429|NCT02412371|527562698|FG002|Overall Study|Other|0|||
146286430|NCT02412371|527562699|FG003|Overall Study|Other|0|||
146286431|NCT02412371|527562700|FG004|Overall Study|Other|1|||
146286432|NCT02412371|527562701|FG005|Overall Study|Other|3|||
146286433|NCT00998335|527562702|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
146286434|NCT00998335|527562703|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
146286435|NCT05000931|527562712|FG000|Overall Study|Lost to Follow-up|1|||
146286436|NCT03149549|527562713|FG000|Study Discontinuation--Treatment Period|Death|0|||
146286437|NCT03149549|527562714|FG001|Study Discontinuation--Treatment Period|Death|0|||
146286438|NCT03149549|527562715|FG002|Study Discontinuation--Treatment Period|Death|0|||
146286439|NCT03149549|527562716|FG003|Study Discontinuation--Treatment Period|Death|1|||
146286440|NCT03149549|527562717|FG004|Study Discontinuation--Treatment Period|Death|2|||
146286441|NCT03149549|527562718|FG005|Study Discontinuation--Treatment Period|Death|1|||
146286442|NCT03149549|527562719|FG006|Study Discontinuation--Treatment Period|Death|1|||
146286443|NCT03149549|527562720|FG007|Study Discontinuation--Treatment Period|Death|2|||
146286444|NCT03149549|527562721|FG008|Study Discontinuation--Treatment Period|Death|4|||
146286445|NCT03149549|527562722|FG009|Study Discontinuation--Treatment Period|Death|1|||
146286446|NCT03149549|527562723|FG010|Study Discontinuation--Treatment Period|Death|0|||
146286447|NCT03149549|527562724|FG011|Study Discontinuation--Treatment Period|Death|0|||
146286448|NCT03149549|527562725|FG012|Study Discontinuation--Treatment Period|Death|1|||
146286449|NCT03149549|527562713|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286450|NCT03149549|527562714|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286451|NCT03149549|527562715|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286452|NCT03149549|527562716|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286453|NCT03149549|527562717|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286454|NCT03149549|527562718|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286455|NCT03149549|527562719|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286456|NCT03149549|527562720|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
146286457|NCT03149549|527562721|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286458|NCT03149549|527562722|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286459|NCT03149549|527562723|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286460|NCT03149549|527562724|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
146286461|NCT03149549|527562725|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
146286462|NCT03149549|527562713|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286463|NCT03149549|527562714|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286464|NCT03149549|527562715|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286465|NCT03149549|527562716|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
146286466|NCT03149549|527562717|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146286467|NCT03149549|527562718|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
146286468|NCT03149549|527562719|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146286469|NCT03149549|527562720|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286470|NCT03149549|527562721|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
146286471|NCT03149549|527562722|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286472|NCT03149549|527562723|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286473|NCT03149549|527562724|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286474|NCT03149549|527562725|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
146286475|NCT03149549|527562713|FG000|Study Discontinuation--Treatment Period|Other|0|||
146286476|NCT03149549|527562714|FG001|Study Discontinuation--Treatment Period|Other|0|||
146286477|NCT03149549|527562715|FG002|Study Discontinuation--Treatment Period|Other|0|||
146286478|NCT03149549|527562716|FG003|Study Discontinuation--Treatment Period|Other|0|||
146286479|NCT03149549|527562717|FG004|Study Discontinuation--Treatment Period|Other|0|||
146286480|NCT03149549|527562718|FG005|Study Discontinuation--Treatment Period|Other|0|||
146286481|NCT03149549|527562719|FG006|Study Discontinuation--Treatment Period|Other|0|||
146286482|NCT03149549|527562720|FG007|Study Discontinuation--Treatment Period|Other|1|||
146286483|NCT03149549|527562721|FG008|Study Discontinuation--Treatment Period|Other|0|||
146286484|NCT03149549|527562722|FG009|Study Discontinuation--Treatment Period|Other|1|||
146286485|NCT03149549|527562723|FG010|Study Discontinuation--Treatment Period|Other|0|||
146286486|NCT03149549|527562724|FG011|Study Discontinuation--Treatment Period|Other|0|||
146286487|NCT03149549|527562725|FG012|Study Discontinuation--Treatment Period|Other|0|||
146286488|NCT03149549|527562713|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286489|NCT03149549|527562714|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286490|NCT03149549|527562715|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286491|NCT03149549|527562716|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146212104|NCT02724956|527290243|FG001|Overall Study|Lack of Efficacy|1|||
146212105|NCT02724956|527290242|FG000|Overall Study|Withdrawal by Subject|0|||
146212106|NCT02724956|527290243|FG001|Overall Study|Withdrawal by Subject|1|||
146212107|NCT01532388|527290244|FG000|3-month Follow-up|Lost to Follow-up|68|||
146212108|NCT01532388|527290245|FG001|3-month Follow-up|Lost to Follow-up|68|||
146212109|NCT01532388|527290244|FG000|6-month Follow-up|Lost to Follow-up|74|||
146212110|NCT01532388|527290245|FG001|6-month Follow-up|Lost to Follow-up|66|||
146212111|NCT01532388|527290244|FG000|12-month Follow-up|Lost to Follow-up|69|||
146212112|NCT01532388|527290245|FG001|12-month Follow-up|Lost to Follow-up|67|||
146212113|NCT00792636|527290246|FG000|Overall Study|Protocol Violation|17|||
146212114|NCT00792636|527290247|FG001|Overall Study|Protocol Violation|23|||
146212115|NCT00792636|527290248|FG002|Overall Study|Protocol Violation|20|||
146212116|NCT00792636|527290246|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
146212117|NCT00792636|527290247|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
146212118|NCT00792636|527290248|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
146212119|NCT00792636|527290246|FG000|Overall Study|Lost to Follow-up|13|||
146212120|NCT00792636|527290247|FG001|Overall Study|Lost to Follow-up|19|||
146212121|NCT00792636|527290248|FG002|Overall Study|Lost to Follow-up|14|||
146212122|NCT00792636|527290246|FG000|Overall Study|Withdrew Consent|10|||
146212123|NCT00792636|527290247|FG001|Overall Study|Withdrew Consent|13|||
146212124|NCT00792636|527290248|FG002|Overall Study|Withdrew Consent|9|||
146212125|NCT00792636|527290246|FG000|Overall Study|Lack of Efficacy|3|||
146212126|NCT00792636|527290247|FG001|Overall Study|Lack of Efficacy|4|||
146212127|NCT00792636|527290248|FG002|Overall Study|Lack of Efficacy|13|||
146212128|NCT00792636|527290246|FG000|Overall Study|Adverse Event|4|||
146212129|NCT00792636|527290247|FG001|Overall Study|Adverse Event|2|||
146212130|NCT00792636|527290248|FG002|Overall Study|Adverse Event|3|||
146212131|NCT00792636|527290246|FG000|Overall Study|Investigator Discretion|2|||
146212132|NCT00792636|527290247|FG001|Overall Study|Investigator Discretion|0|||
146212133|NCT00792636|527290248|FG002|Overall Study|Investigator Discretion|2|||
146212134|NCT01046136|527290249|FG000|Overall Study|Withdrawal by Subject|0|||
146212135|NCT01046136|527290250|FG001|Overall Study|Withdrawal by Subject|4|||
146212136|NCT01046136|527290249|FG000|Overall Study|Physician Decision|1|||
146083879|NCT00952380|526826602|FG002|Overall Study|Non-compliant to protocol|0|||
146083880|NCT00952380|526826603|FG003|Overall Study|Non-compliant to protocol|1|||
146212137|NCT01046136|527290250|FG001|Overall Study|Physician Decision|1|||
146212138|NCT01046136|527290249|FG000|Overall Study|Lost to Follow-up|3|||
146212139|NCT01046136|527290250|FG001|Overall Study|Lost to Follow-up|3|||
146212140|NCT04579250|527290251|FG000|Overall Study|Withdrawal by Subject|1|||
146212141|NCT04579250|527290252|FG001|Overall Study|Withdrawal by Subject|1|||
146212142|NCT04579250|527290253|FG002|Overall Study|Withdrawal by Subject|0|||
146212143|NCT04579250|527290251|FG000|Overall Study|Lost to Follow-up|1|||
146212144|NCT04579250|527290252|FG001|Overall Study|Lost to Follow-up|1|||
146212145|NCT04579250|527290253|FG002|Overall Study|Lost to Follow-up|0|||
146212146|NCT04579250|527290251|FG000|Overall Study|Moved from area|0|||
146212147|NCT04579250|527290252|FG001|Overall Study|Moved from area|1|||
146212148|NCT04579250|527290253|FG002|Overall Study|Moved from area|2|||
146212149|NCT02058108|527290254|FG000|Overall Study|Abnormal Laboratory Values|0|||
146212150|NCT02058108|527290255|FG001|Overall Study|Abnormal Laboratory Values|1|||
146212151|NCT02058108|527290254|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
146212152|NCT02058108|527290255|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146212153|NCT02058108|527290254|FG000|Overall Study|No longer requires study drug|0|||
146212154|NCT02058108|527290255|FG001|Overall Study|No longer requires study drug|1|||
146212155|NCT02058108|527290254|FG000|Overall Study|Withdrawal by Subject|1|||
146212156|NCT02058108|527290255|FG001|Overall Study|Withdrawal by Subject|0|||
146212157|NCT02058108|527290254|FG000|Overall Study|Administrative problems|3|||
146212158|NCT02058108|527290255|FG001|Overall Study|Administrative problems|3|||
146212159|NCT02058108|527290254|FG000|Overall Study|Protocol Violation|0|||
146212160|NCT02058108|527290255|FG001|Overall Study|Protocol Violation|1|||
146212161|NCT01376700|527290259|FG000|Overall Study|Sponsor terminated study early|8|||
146212162|NCT01376700|527290259|FG000|Overall Study|Low or high titer inhibitor|8|||
146212163|NCT00727909|527290260|FG000|Overall Study|Withdrawal by Subject|5|||
146212164|NCT00727909|527290261|FG001|Overall Study|Withdrawal by Subject|11|||
146212165|NCT00727909|527290262|FG002|Overall Study|Withdrawal by Subject|8|||
146212166|NCT00727909|527290263|FG003|Overall Study|Withdrawal by Subject|5|||
146212167|NCT00727909|527290260|FG000|Overall Study|Death|0|||
146212168|NCT00727909|527290261|FG001|Overall Study|Death|0|||
146212169|NCT00727909|527290262|FG002|Overall Study|Death|1|||
146212170|NCT00727909|527290263|FG003|Overall Study|Death|0|||
146212171|NCT01696773|527290264|FG000|Days 15-27, Washout|Adverse Event|1|||
146212172|NCT01696773|527290265|FG001|Days 15-27, Washout|Adverse Event|0|||
146212173|NCT05623345|527290274|FG000|Overall Study|Withdrawal by Subject|14|||
146212174|NCT05623345|527290275|FG001|Overall Study|Withdrawal by Subject|0|||
146212175|NCT05623345|527290276|FG002|Overall Study|Withdrawal by Subject|9|||
146212176|NCT05623345|527290277|FG003|Overall Study|Withdrawal by Subject|20|||
146212177|NCT05623345|527290274|FG000|Overall Study|Lost to Follow-up|3|||
146212178|NCT05623345|527290275|FG001|Overall Study|Lost to Follow-up|0|||
146212179|NCT05623345|527290276|FG002|Overall Study|Lost to Follow-up|7|||
146286492|NCT03149549|527562717|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146212180|NCT05623345|527290277|FG003|Overall Study|Lost to Follow-up|2|||
146212181|NCT05623345|527290274|FG000|Overall Study|Termination of Study By Sponsor|37|||
146212182|NCT05623345|527290275|FG001|Overall Study|Termination of Study By Sponsor|4|||
146083881|NCT00952380|526826604|FG004|Overall Study|Non-compliant to protocol|0|||
146083882|NCT00534313|526826608|FG000|Short-term Period|Adverse Event|1|||
146083883|NCT00534313|526826609|FG001|Short-term Period|Adverse Event|2|||
146083884|NCT00534313|526826610|FG002|Short-term Period|Adverse Event|1|||
146083885|NCT00534313|526826611|FG003|Short-term Period|Adverse Event|3|||
146083886|NCT00534313|526826608|FG000|Short-term Period|Lack of Efficacy|3|||
146083887|NCT00534313|526826609|FG001|Short-term Period|Lack of Efficacy|4|||
146212183|NCT05623345|527290276|FG002|Overall Study|Termination of Study By Sponsor|40|||
146212184|NCT05623345|527290277|FG003|Overall Study|Termination of Study By Sponsor|38|||
146212185|NCT05384730|527290278|FG000|Overall Study|Adverse Event|1|||
146212186|NCT05384730|527290279|FG001|Overall Study|Adverse Event|0|||
146212187|NCT05384730|527290278|FG000|Overall Study|Lack of social support|2|||
146212188|NCT05384730|527290279|FG001|Overall Study|Lack of social support|0|||
146212189|NCT05384730|527290278|FG000|Overall Study|Hospital readmission|2|||
146212190|NCT05384730|527290279|FG001|Overall Study|Hospital readmission|0|||
146212191|NCT05384730|527290278|FG000|Overall Study|Disease progression|5|||
146212192|NCT05384730|527290279|FG001|Overall Study|Disease progression|0|||
146212193|NCT05384730|527290278|FG000|Overall Study|Overwhelmed with College commitments|0|||
146212194|NCT05384730|527290279|FG001|Overall Study|Overwhelmed with College commitments|2|||
146212195|NCT04287985|527290287|FG000|Overall Study|Adverse Event|1|||
146212196|NCT04287985|527290288|FG001|Overall Study|Adverse Event|0|||
146212197|NCT04287985|527290289|FG002|Overall Study|Adverse Event|0|||
146212198|NCT04287985|527290290|FG003|Overall Study|Adverse Event|0|||
146212199|NCT04287985|527290287|FG000|Overall Study|Protocol Violation|0|||
146083888|NCT00534313|526826610|FG002|Short-term Period|Lack of Efficacy|0|||
146083889|NCT00534313|526826611|FG003|Short-term Period|Lack of Efficacy|3|||
146212200|NCT04287985|527290288|FG001|Overall Study|Protocol Violation|1|||
146212201|NCT04287985|527290289|FG002|Overall Study|Protocol Violation|0|||
146212202|NCT04287985|527290290|FG003|Overall Study|Protocol Violation|0|||
146212203|NCT04287985|527290287|FG000|Overall Study|Physician Decision|0|||
146212204|NCT04287985|527290288|FG001|Overall Study|Physician Decision|0|||
146212205|NCT04287985|527290289|FG002|Overall Study|Physician Decision|0|||
146212206|NCT04287985|527290290|FG003|Overall Study|Physician Decision|1|||
146212207|NCT04287985|527290287|FG000|Overall Study|Withdrawal by Subject|2|||
145957629|NCT00758498|526358128|FG002|Overall Study|Subject legally detained out of state|0|||
146286493|NCT03149549|527562718|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
146286494|NCT03149549|527562719|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
146286495|NCT03149549|527562720|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286496|NCT03149549|527562721|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
146286497|NCT03149549|527562722|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286498|NCT03149549|527562723|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286499|NCT03149549|527562724|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286500|NCT03149549|527562725|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
146286501|NCT03149549|527562713|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286502|NCT03149549|527562714|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286503|NCT03149549|527562715|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286504|NCT03149549|527562716|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286505|NCT03149549|527562717|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
146286506|NCT03149549|527562718|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286507|NCT03149549|527562719|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286508|NCT03149549|527562720|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
146286509|NCT03149549|527562721|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
146286510|NCT03149549|527562722|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286511|NCT03149549|527562723|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
146286512|NCT03149549|527562724|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
146286513|NCT03149549|527562725|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
146286514|NCT03149549|527562713|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286515|NCT03149549|527562714|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286516|NCT03149549|527562715|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286517|NCT03149549|527562716|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286518|NCT03149549|527562717|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146286519|NCT03149549|527562718|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286520|NCT03149549|527562719|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286521|NCT03149549|527562720|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
146286522|NCT03149549|527562721|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146286523|NCT03149549|527562722|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146286524|NCT03149549|527562723|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
146286525|NCT03149549|527562724|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
146286526|NCT03149549|527562725|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
146286527|NCT03149549|527562713|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
146286528|NCT03149549|527562714|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
146286529|NCT03149549|527562715|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
146286530|NCT03149549|527562716|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
146286531|NCT03149549|527562717|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
146286532|NCT03149549|527562718|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
146286533|NCT03149549|527562719|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
146286534|NCT03149549|527562720|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
146286535|NCT03149549|527562721|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
146286536|NCT03149549|527562722|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
146286537|NCT03149549|527562723|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
146286538|NCT03149549|527562724|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
146286539|NCT03149549|527562725|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
146286540|NCT03149549|527562713|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
146286541|NCT03149549|527562714|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
146286542|NCT03149549|527562715|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
146286543|NCT03149549|527562716|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
146286544|NCT03149549|527562717|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
146286545|NCT03149549|527562718|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
146286546|NCT03149549|527562719|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
146286547|NCT03149549|527562720|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
145957630|NCT00758498|526358126|FG000|Overall Study|Withdrawal by Subject|0|||
146212208|NCT04287985|527290288|FG001|Overall Study|Withdrawal by Subject|1|||
146212209|NCT04287985|527290289|FG002|Overall Study|Withdrawal by Subject|1|||
146212210|NCT04287985|527290290|FG003|Overall Study|Withdrawal by Subject|2|||
146212211|NCT01340066|527290291|FG000|Placebo Run in Period|Screen Failures|27|||
146212212|NCT01340066|527290292|FG001|Placebo Run in Period|Screen Failures|0|||
146212213|NCT01340066|527290293|FG002|Placebo Run in Period|Screen Failures|0|||
146212214|NCT01340066|527290291|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
146212215|NCT01340066|527290292|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
146212216|NCT01340066|527290293|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
146212217|NCT01340066|527290291|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
146212218|NCT01340066|527290292|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
146212219|NCT01340066|527290293|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
146212220|NCT01340066|527290291|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
146212221|NCT01340066|527290292|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
146212222|NCT01340066|527290293|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
146212223|NCT02789020|527290294|FG000|Overall Study|Withdrawal by Subject|6|||
146212224|NCT02789020|527290295|FG001|Overall Study|Withdrawal by Subject|5|||
146212225|NCT03771352|527290306|FG000|Overall Study|Screen failure|2|||
146212226|NCT03771352|527290306|FG000|Overall Study|Withdrawal by Subject|2|||
146212227|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146212228|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146212229|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
146212230|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
146212231|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
146212232|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
146212233|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
146212234|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
146212235|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146212236|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146212237|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
146212238|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
146212239|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146212240|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146212241|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
146212242|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
146212243|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
146212244|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
146212245|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
146212246|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
146212247|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
146212248|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
146212249|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
146212250|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
146212251|NCT03338816|527290307|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146212252|NCT03338816|527290308|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146212253|NCT03338816|527290309|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
146212254|NCT03338816|527290310|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
146212255|NCT04315181|527290320|FG000|Overall Study|Non-responsive to drug conditions.|1|||
146212256|NCT03833167|527290321|FG000|Overall Study|Withdrawal by Subject|4|||
146212257|NCT03833167|527290322|FG001|Overall Study|Withdrawal by Subject|6|||
146212258|NCT03833167|527290321|FG000|Overall Study|Ongoing|186|||
146212259|NCT03833167|527290322|FG001|Overall Study|Ongoing|194|||
146212260|NCT03833167|527290321|FG000|Overall Study|Lost to Follow-up|1|||
146212261|NCT03833167|527290322|FG001|Overall Study|Lost to Follow-up|1|||
146212262|NCT03833167|527290321|FG000|Overall Study|Physician Decision|0|||
146212263|NCT03833167|527290322|FG001|Overall Study|Physician Decision|2|||
146212264|NCT03833167|527290321|FG000|Overall Study|Death|34|||
146212265|NCT03833167|527290322|FG001|Overall Study|Death|22|||
146212266|NCT01948661|527290324|FG000|Overall Study|Withdrawal by Subject|2|||
146212267|NCT01948661|527290325|FG001|Overall Study|Withdrawal by Subject|4|||
146212268|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Adverse Event|4|||
146212269|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Adverse Event|1|||
146212270|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
146212271|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
146212272|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
146212273|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
146212274|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
146212275|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
146212276|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
146212277|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
146212278|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Other|6|||
146212279|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Other|1|||
146212280|NCT03271489|527290326|FG000|Double-Blind (DB) Period|Missing|1|||
146212281|NCT03271489|527290327|FG001|Double-Blind (DB) Period|Missing|0|||
146212282|NCT03271489|527290326|FG000|Open-Label (OL) Period|Adverse Event|2|||
146212283|NCT03271489|527290327|FG001|Open-Label (OL) Period|Adverse Event|0|||
146212284|NCT03271489|527290326|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
146212285|NCT03271489|527290327|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
146212286|NCT03271489|527290326|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
146212287|NCT03271489|527290327|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
146212288|NCT03271489|527290326|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
146212289|NCT03271489|527290327|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
146212290|NCT03271489|527290326|FG000|Open-Label (OL) Period|No Specified|2|||
146212291|NCT03271489|527290327|FG001|Open-Label (OL) Period|No Specified|2|||
146212292|NCT03271489|527290326|FG000|Open-Label (OL) Period|Missing|2|||
146212293|NCT03271489|527290327|FG001|Open-Label (OL) Period|Missing|0|||
146212294|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
146212295|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
146212296|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
146212297|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
146212298|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
146212299|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
146212300|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
146212301|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
145957631|NCT00758498|526358127|FG001|Overall Study|Withdrawal by Subject|0|||
146212302|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
146212303|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
146212304|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
146212305|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
146212306|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
146212307|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
146212308|NCT03271489|527290326|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
146212309|NCT03271489|527290327|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
146212310|NCT05494788|527290333|FG000|Initial Treatment Period|Adverse Event|2|||
146212311|NCT05494788|527290333|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
146212312|NCT05494788|527290333|FG000|Extension Period|Adverse Event|1|||
146212313|NCT05494788|527290333|FG000|Extension Period|Withdrawal by Subject|1|||
146212314|NCT05480943|527290334|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
146212315|NCT05480943|527290334|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
146212316|NCT05480943|527290334|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
146212317|NCT05480943|527290334|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
146212318|NCT00976937|527290335|FG000|Overall Study|Adverse Event|4|||
146212319|NCT00976937|527290336|FG001|Overall Study|Adverse Event|5|||
146212320|NCT00976937|527290335|FG000|Overall Study|Lost to Follow-up|2|||
146212321|NCT00976937|527290336|FG001|Overall Study|Lost to Follow-up|1|||
146212322|NCT00976937|527290335|FG000|Overall Study|Withdrawal by Subject|5|||
146212323|NCT00976937|527290336|FG001|Overall Study|Withdrawal by Subject|3|||
146212324|NCT00976937|527290335|FG000|Overall Study|Poor compliance to protocol|3|||
146212325|NCT00976937|527290336|FG001|Overall Study|Poor compliance to protocol|0|||
146212326|NCT00976937|527290335|FG000|Overall Study|Personal and Familial Reason|2|||
146212327|NCT00976937|527290336|FG001|Overall Study|Personal and Familial Reason|2|||
146212328|NCT03069313|527290337|FG000|Overall Study|Adverse Event|5|||
146212329|NCT04218266|527290338|FG000|Overall Study|Death|1|||
146212330|NCT04218266|527290339|FG001|Overall Study|Death|2|||
146212331|NCT04218266|527290340|FG002|Overall Study|Death|3|||
146212332|NCT04218266|527290338|FG000|Overall Study|Adverse Event|13|||
146212333|NCT04218266|527290339|FG001|Overall Study|Adverse Event|14|||
146212334|NCT04218266|527290340|FG002|Overall Study|Adverse Event|11|||
146212335|NCT04218266|527290338|FG000|Overall Study|Other|7|||
146212336|NCT04218266|527290339|FG001|Overall Study|Other|5|||
146212337|NCT04218266|527290340|FG002|Overall Study|Other|14|||
146212338|NCT04218266|527290338|FG000|Overall Study|Physician Decision|1|||
146212339|NCT04218266|527290339|FG001|Overall Study|Physician Decision|3|||
146212340|NCT04218266|527290340|FG002|Overall Study|Physician Decision|2|||
146212341|NCT04218266|527290338|FG000|Overall Study|Non-compliance with study drug|0|||
146212342|NCT04218266|527290339|FG001|Overall Study|Non-compliance with study drug|0|||
146212343|NCT04218266|527290340|FG002|Overall Study|Non-compliance with study drug|1|||
146212344|NCT04218266|527290338|FG000|Overall Study|Withdrawal by Subject|1|||
146212345|NCT04218266|527290339|FG001|Overall Study|Withdrawal by Subject|3|||
146212346|NCT04218266|527290340|FG002|Overall Study|Withdrawal by Subject|1|||
146212347|NCT04218266|527290338|FG000|Overall Study|Study drug never administered|2|||
146212348|NCT04218266|527290339|FG001|Overall Study|Study drug never administered|0|||
146212349|NCT04218266|527290340|FG002|Overall Study|Study drug never administered|0|||
146212350|NCT01011946|527290342|FG000|Overall Study|Transferred to another hospital|2|||
146212351|NCT01011946|527290342|FG000|Overall Study|No pathological lab value|1|||
146212352|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
146212353|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
146212354|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
146083890|NCT00534313|526826608|FG000|Short-term Period|Participant not meeting study criteria|0|||
146212355|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
146212356|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
146212357|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
146212358|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
146212359|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
146212360|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
145957632|NCT00758498|526358128|FG002|Overall Study|Withdrawal by Subject|1|||
145957633|NCT00758498|526358126|FG000|Overall Study|Noncompliance to study procedures|0|||
145957634|NCT00758498|526358127|FG001|Overall Study|Noncompliance to study procedures|0|||
145957635|NCT00758498|526358128|FG002|Overall Study|Noncompliance to study procedures|1|||
146212361|NCT03939312|527290343|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
146212362|NCT03939312|527290343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
146212363|NCT03939312|527290343|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
146212364|NCT02119650|527290344|FG000|Overall Study|Adverse Event|3|||
146212365|NCT02119650|527290345|FG001|Overall Study|Adverse Event|4|||
146212366|NCT02119650|527290344|FG000|Overall Study|Subject decision|2|||
146212367|NCT02119650|527290345|FG001|Overall Study|Subject decision|3|||
146212368|NCT02119650|527290344|FG000|Overall Study|Disease progression|11|||
146212369|NCT02119650|527290345|FG001|Overall Study|Disease progression|14|||
146212370|NCT02119650|527290344|FG000|Overall Study|Death|5|||
146212371|NCT02119650|527290345|FG001|Overall Study|Death|1|||
146212372|NCT02119650|527290344|FG000|Overall Study|Noncompliance with study treatment|1|||
146212373|NCT02119650|527290345|FG001|Overall Study|Noncompliance with study treatment|1|||
146212374|NCT02119650|527290344|FG000|Overall Study|Study terminated by the sponsor|1|||
146212375|NCT02119650|527290345|FG001|Overall Study|Study terminated by the sponsor|0|||
146212376|NCT02119650|527290344|FG000|Overall Study|Physician Decision|0|||
146212377|NCT02119650|527290345|FG001|Overall Study|Physician Decision|2|||
146212378|NCT02119650|527290344|FG000|Overall Study|Multiple reasons for termination|2|||
146212379|NCT02119650|527290345|FG001|Overall Study|Multiple reasons for termination|1|||
146212380|NCT02730871|527290346|FG000|Overall Study|Adverse Event|6|||
146212381|NCT02730871|527290347|FG001|Overall Study|Adverse Event|0|||
146212382|NCT04623775|527290348|FG000|Randomization|No Longer Meets Study Criteria|2|||
146212383|NCT04623775|527290349|FG001|Randomization|No Longer Meets Study Criteria|1|||
146212384|NCT04623775|527290350|FG002|Randomization|No Longer Meets Study Criteria|0|||
146212385|NCT04623775|527290351|FG003|Randomization|No Longer Meets Study Criteria|0|||
146212386|NCT04623775|527290348|FG000|Randomization|Withdrew Consent|0|||
145957636|NCT02581488|526358132|FG000|Overall Study|Adverse Event|6|||
145957637|NCT02581488|526358133|FG001|Overall Study|Adverse Event|7|||
145957638|NCT02581488|526358132|FG000|Overall Study|Lost to Follow-up|1|||
145957639|NCT02581488|526358133|FG001|Overall Study|Lost to Follow-up|0|||
145957640|NCT02581488|526358132|FG000|Overall Study|Withdrawal by Subject|1|||
145957641|NCT02581488|526358133|FG001|Overall Study|Withdrawal by Subject|0|||
145957642|NCT02581488|526358132|FG000|Overall Study|Non-Compliance|1|||
145957643|NCT02581488|526358133|FG001|Overall Study|Non-Compliance|0|||
145957644|NCT02581488|526358132|FG000|Overall Study|Protocol Violation|0|||
145957645|NCT02581488|526358133|FG001|Overall Study|Protocol Violation|4|||
145957646|NCT00954122|526358134|FG000|Overall Study|Withdrawal by Subject|5|||
145957647|NCT00954122|526358134|FG000|Overall Study|Adverse Event|1|||
145957648|NCT00954122|526358134|FG000|Overall Study|Safety Reason|1|||
145957649|NCT04194489|526358135|FG000|Overall Study|Withdrawal by Subject|5|||
145957650|NCT04194489|526358135|FG000|Overall Study|Lost to Follow-up|48|||
145957651|NCT02291029|526358138|FG000|Overall Study|Withdrawal by Subject|0|||
145957652|NCT02291029|526358139|FG001|Overall Study|Withdrawal by Subject|0|||
145957653|NCT02291029|526358140|FG002|Overall Study|Withdrawal by Subject|1|||
145957654|NCT02291029|526358141|FG003|Overall Study|Withdrawal by Subject|0|||
145957655|NCT02291029|526358142|FG004|Overall Study|Withdrawal by Subject|0|||
145957656|NCT02291029|526358143|FG005|Overall Study|Withdrawal by Subject|0|||
145957657|NCT02291029|526358138|FG000|Overall Study|Adverse Event|0|||
145957658|NCT02291029|526358139|FG001|Overall Study|Adverse Event|1|||
145957659|NCT02291029|526358140|FG002|Overall Study|Adverse Event|0|||
145957660|NCT02291029|526358141|FG003|Overall Study|Adverse Event|0|||
145957661|NCT02291029|526358142|FG004|Overall Study|Adverse Event|0|||
145957662|NCT02291029|526358143|FG005|Overall Study|Adverse Event|0|||
145957663|NCT00377637|526358144|FG000|Induction Phase|Adverse Event|12|||
146212387|NCT04623775|527290349|FG001|Randomization|Withdrew Consent|0|||
146212388|NCT04623775|527290350|FG002|Randomization|Withdrew Consent|0|||
146212389|NCT04623775|527290351|FG003|Randomization|Withdrew Consent|1|||
146212390|NCT04623775|527290348|FG000|Randomization|Other Reasons|0|||
146212391|NCT04623775|527290349|FG001|Randomization|Other Reasons|0|||
146212392|NCT04623775|527290350|FG002|Randomization|Other Reasons|0|||
146212393|NCT04623775|527290351|FG003|Randomization|Other Reasons|1|||
146212394|NCT04623775|527290348|FG000|Treatment Period|participant withdrew consent|4|||
146212395|NCT04623775|527290349|FG001|Treatment Period|participant withdrew consent|0|||
146212396|NCT04623775|527290350|FG002|Treatment Period|participant withdrew consent|1|||
146212397|NCT04623775|527290351|FG003|Treatment Period|participant withdrew consent|2|||
146212398|NCT04623775|527290348|FG000|Treatment Period|Death|3|||
146083891|NCT00534313|526826609|FG001|Short-term Period|Participant not meeting study criteria|0|||
146083892|NCT00534313|526826610|FG002|Short-term Period|Participant not meeting study criteria|0|||
146083893|NCT00534313|526826611|FG003|Short-term Period|Participant not meeting study criteria|1|||
146083894|NCT00534313|526826608|FG000|Short-term Period|Participant withdrew consent|2|||
146083895|NCT00534313|526826609|FG001|Short-term Period|Participant withdrew consent|0|||
146083896|NCT00534313|526826610|FG002|Short-term Period|Participant withdrew consent|0|||
146083897|NCT00534313|526826611|FG003|Short-term Period|Participant withdrew consent|2|||
146083898|NCT00534313|526826608|FG000|Short-term Period|Pregnancy|0|||
146083899|NCT00534313|526826609|FG001|Short-term Period|Pregnancy|0|||
146083900|NCT00534313|526826610|FG002|Short-term Period|Pregnancy|1|||
146083901|NCT00534313|526826611|FG003|Short-term Period|Pregnancy|0|||
146083902|NCT00534313|526826608|FG000|Long-term Period|Adverse Event|2|||
146083903|NCT00534313|526826609|FG001|Long-term Period|Adverse Event|1|||
146083904|NCT00534313|526826610|FG002|Long-term Period|Adverse Event|0|||
146083905|NCT00534313|526826611|FG003|Long-term Period|Adverse Event|1|||
146083906|NCT00534313|526826608|FG000|Long-term Period|Lack of Efficacy|14|||
146083907|NCT00534313|526826609|FG001|Long-term Period|Lack of Efficacy|10|||
146083908|NCT00534313|526826610|FG002|Long-term Period|Lack of Efficacy|14|||
146083909|NCT00534313|526826611|FG003|Long-term Period|Lack of Efficacy|12|||
146083910|NCT00534313|526826608|FG000|Long-term Period|Lost to Follow-up|1|||
146212399|NCT04623775|527290349|FG001|Treatment Period|Death|1|||
146212400|NCT04623775|527290350|FG002|Treatment Period|Death|4|||
146212401|NCT04623775|527290351|FG003|Treatment Period|Death|2|||
146212402|NCT04623775|527290348|FG000|Treatment Period|Lost to Follow-up|0|||
146212403|NCT04623775|527290349|FG001|Treatment Period|Lost to Follow-up|2|||
146212404|NCT04623775|527290350|FG002|Treatment Period|Lost to Follow-up|0|||
145957664|NCT00377637|526358145|FG001|Induction Phase|Adverse Event|21|||
146083911|NCT00534313|526826609|FG001|Long-term Period|Lost to Follow-up|2|||
146083912|NCT00534313|526826610|FG002|Long-term Period|Lost to Follow-up|0|||
146083913|NCT00534313|526826611|FG003|Long-term Period|Lost to Follow-up|0|||
146083914|NCT00534313|526826608|FG000|Long-term Period|Withdrawal by Subject|2|||
146083915|NCT00534313|526826609|FG001|Long-term Period|Withdrawal by Subject|2|||
146212405|NCT04623775|527290351|FG003|Treatment Period|Lost to Follow-up|0|||
146212406|NCT04623775|527290348|FG000|Treatment Period|poor/non compliance|0|||
146212407|NCT04623775|527290349|FG001|Treatment Period|poor/non compliance|0|||
146212408|NCT04623775|527290350|FG002|Treatment Period|poor/non compliance|1|||
146212409|NCT04623775|527290351|FG003|Treatment Period|poor/non compliance|0|||
146212410|NCT04623775|527290348|FG000|Treatment Period|participant no longer meets study criteria|0|||
146212411|NCT04623775|527290349|FG001|Treatment Period|participant no longer meets study criteria|1|||
146212412|NCT04623775|527290350|FG002|Treatment Period|participant no longer meets study criteria|0|||
146212413|NCT04623775|527290351|FG003|Treatment Period|participant no longer meets study criteria|0|||
146212414|NCT04623775|527290348|FG000|Treatment Period|administrative reasons by sponsor|3|||
146212415|NCT04623775|527290349|FG001|Treatment Period|administrative reasons by sponsor|2|||
146212416|NCT04623775|527290350|FG002|Treatment Period|administrative reasons by sponsor|0|||
146212417|NCT04623775|527290351|FG003|Treatment Period|administrative reasons by sponsor|0|||
146212418|NCT04623775|527290348|FG000|Treatment Period|other reasons|2|||
146212419|NCT04623775|527290349|FG001|Treatment Period|other reasons|0|||
146212420|NCT04623775|527290350|FG002|Treatment Period|other reasons|1|||
146212421|NCT04623775|527290351|FG003|Treatment Period|other reasons|1|||
146212422|NCT04623775|527290348|FG000|Treatment Period|disease progression|40|||
146212423|NCT04623775|527290349|FG001|Treatment Period|disease progression|35|||
146212424|NCT04623775|527290350|FG002|Treatment Period|disease progression|63|||
146212425|NCT04623775|527290351|FG003|Treatment Period|disease progression|63|||
146212426|NCT04623775|527290348|FG000|Treatment Period|study drug toxicity|12|||
146212427|NCT04623775|527290349|FG001|Treatment Period|study drug toxicity|15|||
146212428|NCT04623775|527290350|FG002|Treatment Period|study drug toxicity|13|||
146212429|NCT04623775|527290351|FG003|Treatment Period|study drug toxicity|12|||
146212430|NCT04623775|527290348|FG000|Treatment Period|AE unrelated to study drug|4|||
146212431|NCT04623775|527290349|FG001|Treatment Period|AE unrelated to study drug|9|||
146212432|NCT04623775|527290350|FG002|Treatment Period|AE unrelated to study drug|12|||
146212433|NCT04623775|527290351|FG003|Treatment Period|AE unrelated to study drug|9|||
146212434|NCT04623775|527290348|FG000|Treatment Period|participant request to discontinue treatment|0|||
146212435|NCT04623775|527290349|FG001|Treatment Period|participant request to discontinue treatment|2|||
146212436|NCT04623775|527290350|FG002|Treatment Period|participant request to discontinue treatment|2|||
146212437|NCT04623775|527290351|FG003|Treatment Period|participant request to discontinue treatment|0|||
146212438|NCT03582722|527290355|FG000|Overall Study|Lost to Follow-up|1|||
146212439|NCT03582722|527290356|FG001|Overall Study|Lost to Follow-up|4|||
146212440|NCT03582722|527290355|FG000|Overall Study|Withdrawal by Subject|3|||
146212441|NCT03582722|527290356|FG001|Overall Study|Withdrawal by Subject|3|||
146212442|NCT01959698|527290357|FG000|Overall Study|Adverse Event|0|||
146212443|NCT01959698|527290358|FG001|Overall Study|Adverse Event|0|||
146212444|NCT01959698|527290359|FG002|Overall Study|Adverse Event|0|||
146212445|NCT01959698|527290360|FG003|Overall Study|Adverse Event|0|||
145957665|NCT00377637|526358146|FG002|Induction Phase|Adverse Event|0|||
145957666|NCT00377637|526358147|FG003|Induction Phase|Adverse Event|0|||
145957667|NCT00377637|526358144|FG000|Induction Phase|Deterioration/serum creatinine|2|||
146212446|NCT01959698|527290361|FG004|Overall Study|Adverse Event|0|||
146212447|NCT01959698|527290362|FG005|Overall Study|Adverse Event|0|||
145957668|NCT00377637|526358145|FG001|Induction Phase|Deterioration/serum creatinine|0|||
145957669|NCT00377637|526358146|FG002|Induction Phase|Deterioration/serum creatinine|0|||
145957670|NCT00377637|526358147|FG003|Induction Phase|Deterioration/serum creatinine|0|||
145957671|NCT00377637|526358144|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145957672|NCT00377637|526358145|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
145957673|NCT00377637|526358146|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145957674|NCT00377637|526358147|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145957675|NCT00377637|526358144|FG000|Induction Phase|Lost to Follow-up|2|||
145957676|NCT00377637|526358145|FG001|Induction Phase|Lost to Follow-up|1|||
145957677|NCT00377637|526358146|FG002|Induction Phase|Lost to Follow-up|0|||
145957678|NCT00377637|526358147|FG003|Induction Phase|Lost to Follow-up|0|||
145957679|NCT00377637|526358144|FG000|Induction Phase|Death|1|||
145957680|NCT00377637|526358145|FG001|Induction Phase|Death|3|||
145957681|NCT00377637|526358146|FG002|Induction Phase|Death|0|||
145957682|NCT00377637|526358147|FG003|Induction Phase|Death|0|||
145957683|NCT00377637|526358144|FG000|Induction Phase|Withdrawal by Subject|5|||
145957684|NCT00377637|526358145|FG001|Induction Phase|Withdrawal by Subject|6|||
145957685|NCT00377637|526358146|FG002|Induction Phase|Withdrawal by Subject|0|||
145957686|NCT00377637|526358147|FG003|Induction Phase|Withdrawal by Subject|0|||
145957687|NCT00377637|526358144|FG000|Induction Phase|Physician Decision|3|||
145957688|NCT00377637|526358145|FG001|Induction Phase|Physician Decision|1|||
145957689|NCT00377637|526358146|FG002|Induction Phase|Physician Decision|0|||
145957690|NCT00377637|526358147|FG003|Induction Phase|Physician Decision|0|||
146083916|NCT00534313|526826610|FG002|Long-term Period|Withdrawal by Subject|0|||
146083917|NCT00534313|526826611|FG003|Long-term Period|Withdrawal by Subject|0|||
146212448|NCT01959698|527290363|FG006|Overall Study|Adverse Event|1|||
146212449|NCT01959698|527290357|FG000|Overall Study|Physician Decision|1|||
146212450|NCT01959698|527290358|FG001|Overall Study|Physician Decision|0|||
146212451|NCT01959698|527290359|FG002|Overall Study|Physician Decision|1|||
146212452|NCT01959698|527290360|FG003|Overall Study|Physician Decision|2|||
146212453|NCT01959698|527290361|FG004|Overall Study|Physician Decision|0|||
146212454|NCT01959698|527290362|FG005|Overall Study|Physician Decision|3|||
146212455|NCT01959698|527290363|FG006|Overall Study|Physician Decision|3|||
146212456|NCT04112316|527292859|FG000|First Period (8 Weeks)|Protocol Violation|1|||
146212457|NCT04112316|527292860|FG001|First Period (8 Weeks)|Protocol Violation|0|||
146212458|NCT04112316|527292859|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
146212459|NCT04112316|527292860|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
146212460|NCT03055377|527292870|FG000|Treatment Phase|Lost to Follow-up|28|||
146212461|NCT03055377|527292871|FG001|Treatment Phase|Lost to Follow-up|24|||
146212462|NCT03055377|527292870|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
146212463|NCT03055377|527292871|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
146212464|NCT04905407|527292881|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
146212465|NCT04905407|527292882|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
146212466|NCT04905407|527292883|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
146212467|NCT04905407|527292884|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
146212468|NCT04905407|527292881|FG000|Part 1 and Part 2|Death|7|||
146212469|NCT04905407|527292882|FG001|Part 1 and Part 2|Death|7|||
146212470|NCT04905407|527292883|FG002|Part 1 and Part 2|Death|7|||
146212471|NCT04905407|527292884|FG003|Part 1 and Part 2|Death|0|||
146212472|NCT04905407|527292881|FG000|Part 1 and Part 2|Other than specified|0|||
146212473|NCT04905407|527292882|FG001|Part 1 and Part 2|Other than specified|0|||
146212474|NCT04905407|527292883|FG002|Part 1 and Part 2|Other than specified|1|||
146212475|NCT04905407|527292884|FG003|Part 1 and Part 2|Other than specified|0|||
146212476|NCT04905407|527292881|FG000|Part 3|Death|0|||
146212477|NCT04905407|527292882|FG001|Part 3|Death|0|||
146212478|NCT04905407|527292883|FG002|Part 3|Death|0|||
146212479|NCT04905407|527292884|FG003|Part 3|Death|2|||
146212480|NCT00411151|527292893|FG000|Overall Study|Death|38|||
146212481|NCT00411151|527292893|FG000|Overall Study|Withdrawal by Subject|2|||
146212482|NCT00411151|527292893|FG000|Overall Study|Lost to Follow-up|2|||
146212483|NCT00411151|527292893|FG000|Overall Study|Protocol Violation|1|||
145957691|NCT00377637|526358144|FG000|Induction Phase|Sponsor decision|1|||
146212484|NCT00411151|527292893|FG000|Overall Study|Trial prematurely closed|4|||
146212485|NCT01989455|527292900|FG000|Overall Study|Adverse Event|0|||
146212486|NCT01989455|527292901|FG001|Overall Study|Adverse Event|1|||
146212487|NCT01989455|527292902|FG002|Overall Study|Adverse Event|0|||
146212488|NCT01989455|527292903|FG003|Overall Study|Adverse Event|0|||
146212489|NCT01989455|527292904|FG004|Overall Study|Adverse Event|0|||
146212490|NCT01989455|527292900|FG000|Overall Study|Withdrawal by Subject|0|||
146212491|NCT01989455|527292901|FG001|Overall Study|Withdrawal by Subject|1|||
146212492|NCT01989455|527292902|FG002|Overall Study|Withdrawal by Subject|0|||
146212493|NCT01989455|527292903|FG003|Overall Study|Withdrawal by Subject|0|||
146212494|NCT01989455|527292904|FG004|Overall Study|Withdrawal by Subject|0|||
146212495|NCT01989455|527292900|FG000|Overall Study|Technical problems with infusion|0|||
146212496|NCT01989455|527292901|FG001|Overall Study|Technical problems with infusion|0|||
146212497|NCT01989455|527292902|FG002|Overall Study|Technical problems with infusion|1|||
146212498|NCT01989455|527292903|FG003|Overall Study|Technical problems with infusion|0|||
146212499|NCT01989455|527292904|FG004|Overall Study|Technical problems with infusion|1|||
146212500|NCT00999167|527292905|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
146212501|NCT00999167|527292906|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
146212502|NCT00999167|527292907|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
146212503|NCT00999167|527292905|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
146212504|NCT00999167|527292906|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
146212505|NCT00999167|527292907|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
146212506|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
146212507|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
146212508|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
146212509|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
146212510|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
146212511|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
146212512|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
146286548|NCT03149549|527562721|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
146286549|NCT03149549|527562722|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
146286550|NCT03149549|527562723|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
146286551|NCT03149549|527562724|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
146286552|NCT03149549|527562725|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
146286553|NCT01892540|527562728|FG000|Overall Study|Did not complete PET/MRI|0|||
146286554|NCT01892540|527562729|FG001|Overall Study|Did not complete PET/MRI|0|||
146286555|NCT01892540|527562730|FG002|Overall Study|Did not complete PET/MRI|2|||
146286556|NCT01892540|527562728|FG000|Overall Study|Did not fit in scanner|0|||
146286557|NCT01892540|527562729|FG001|Overall Study|Did not fit in scanner|0|||
146286558|NCT01892540|527562730|FG002|Overall Study|Did not fit in scanner|1|||
146286559|NCT03141905|527562733|FG000|Overall Study|Death|3|||
146286560|NCT03141905|527562734|FG001|Overall Study|Death|2|||
146286561|NCT03141905|527562733|FG000|Overall Study|Withdrawal by Subject|1|||
146286562|NCT03141905|527562734|FG001|Overall Study|Withdrawal by Subject|0|||
146286563|NCT03141905|527562733|FG000|Overall Study|Lost to Follow-up|3|||
146286564|NCT03141905|527562734|FG001|Overall Study|Lost to Follow-up|7|||
146286565|NCT03141905|527562733|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
146286566|NCT03141905|527562734|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
146286567|NCT04227704|527562740|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
146286568|NCT04227704|527562741|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
146286569|NCT04227704|527562742|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
146286570|NCT04227704|527562740|FG000|Overall Study|due to C/S being cancelled|1|||
146286571|NCT04227704|527562741|FG001|Overall Study|due to C/S being cancelled|0|||
146286572|NCT04227704|527562742|FG002|Overall Study|due to C/S being cancelled|0|||
146286573|NCT01775124|527562746|FG000|Core Period|Disease Progression|0|||
146286574|NCT01775124|527562747|FG001|Core Period|Disease Progression|1|||
146286575|NCT01775124|527562746|FG000|Core Period|Physician Decision|1|||
146286576|NCT01775124|527562747|FG001|Core Period|Physician Decision|1|||
146286577|NCT01775124|527562746|FG000|Core Period|Death|0|||
146286578|NCT01775124|527562747|FG001|Core Period|Death|1|||
146286579|NCT01775124|527562746|FG000|Core Period|Administrative problems|1|||
146286580|NCT01775124|527562747|FG001|Core Period|Administrative problems|0|||
146212513|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
146212514|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
146212515|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
146212516|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
146212517|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
146212518|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
146212519|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
146212520|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
146212521|NCT00999167|527292905|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
146212522|NCT00999167|527292906|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
146212523|NCT00999167|527292907|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
146212524|NCT00448669|527292908|FG000|Overall Study|Lost to Follow-up|52|||
146212525|NCT00448669|527292909|FG001|Overall Study|Lost to Follow-up|63|||
146212526|NCT00448669|527292908|FG000|Overall Study|Withdrawal by Subject|90|||
146286581|NCT01775124|527562746|FG000|Core Period|Withdrawal by Subject|4|||
146286582|NCT01775124|527562747|FG001|Core Period|Withdrawal by Subject|2|||
146286583|NCT01775124|527562746|FG000|Core Period|Adverse Event|5|||
146286584|NCT01775124|527562747|FG001|Core Period|Adverse Event|5|||
146286585|NCT01775124|527562746|FG000|Extension Period|Adverse Event|3|||
146286586|NCT01775124|527562747|FG001|Extension Period|Adverse Event|2|||
146286587|NCT01775124|527562746|FG000|Extension Period|Physician Decision|0|||
146286588|NCT01775124|527562747|FG001|Extension Period|Physician Decision|2|||
146286589|NCT01775124|527562746|FG000|Extension Period|Administrative problems|0|||
146286590|NCT01775124|527562747|FG001|Extension Period|Administrative problems|1|||
146286591|NCT01775124|527562746|FG000|Extension Period|Lost to Follow-up|0|||
146286592|NCT01775124|527562747|FG001|Extension Period|Lost to Follow-up|1|||
146286593|NCT01775124|527562746|FG000|Extension Period|Withdrawal by Subject|9|||
145957692|NCT00377637|526358145|FG001|Induction Phase|Sponsor decision|2|||
146286594|NCT01775124|527562747|FG001|Extension Period|Withdrawal by Subject|12|||
146212527|NCT00448669|527292909|FG001|Overall Study|Withdrawal by Subject|74|||
146212528|NCT00448669|527292908|FG000|Overall Study|Relocated|49|||
146212529|NCT00448669|527292909|FG001|Overall Study|Relocated|36|||
146212530|NCT00448669|527292908|FG000|Overall Study|Were withdrawn by investigator|10|||
146212531|NCT00448669|527292909|FG001|Overall Study|Were withdrawn by investigator|6|||
146212532|NCT00448669|527292908|FG000|Overall Study|Death|2|||
146212533|NCT00448669|527292909|FG001|Overall Study|Death|4|||
146212534|NCT00448669|527292908|FG000|Overall Study|Had other reasons|5|||
146212535|NCT00448669|527292909|FG001|Overall Study|Had other reasons|6|||
146212536|NCT00448669|527292908|FG000|Overall Study|HIV-infected at enrollment|1|||
146212537|NCT00448669|527292909|FG001|Overall Study|HIV-infected at enrollment|2|||
146212538|NCT00448669|527292908|FG000|Overall Study|Never started drug|9|||
146212539|NCT00448669|527292909|FG001|Overall Study|Never started drug|7|||
146212540|NCT02638337|527292914|FG000|Overall Study|Adverse Event|6|||
146212541|NCT02638337|527292915|FG001|Overall Study|Adverse Event|10|||
146212542|NCT02638337|527292914|FG000|Overall Study|Protocol Violation|3|||
146212543|NCT02638337|527292915|FG001|Overall Study|Protocol Violation|0|||
146212544|NCT02638337|527292914|FG000|Overall Study|Withdrawal by Subject|13|||
146212545|NCT02638337|527292915|FG001|Overall Study|Withdrawal by Subject|16|||
146212546|NCT02638337|527292914|FG000|Overall Study|Lost to Follow-up|7|||
146212547|NCT02638337|527292915|FG001|Overall Study|Lost to Follow-up|7|||
146212548|NCT02638337|527292914|FG000|Overall Study|Other - Miscellaneous|4|||
146212549|NCT02638337|527292915|FG001|Overall Study|Other - Miscellaneous|3|||
146212550|NCT00274469|527292916|FG000|Overall Study|Death|63|||
146212551|NCT00274469|527292917|FG001|Overall Study|Death|74|||
146212552|NCT00274469|527292916|FG000|Overall Study|Did not consent to OS follow-up|16|||
146212553|NCT00274469|527292917|FG001|Overall Study|Did not consent to OS follow-up|19|||
146212554|NCT05512962|527292918|FG000|Overall Study|Withdrawal by Subject|1|||
146212555|NCT05512962|527292919|FG001|Overall Study|Withdrawal by Subject|0|||
146212556|NCT04950127|527292920|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
146212557|NCT04950127|527292921|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
146212558|NCT04950127|527292922|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
146212559|NCT04950127|527292923|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
146212560|NCT04950127|527292924|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
146212561|NCT04950127|527292925|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
146212562|NCT04950127|527292920|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
146212563|NCT04950127|527292921|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
146212564|NCT04950127|527292922|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
146212565|NCT04950127|527292923|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
146212566|NCT04950127|527292924|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
146212567|NCT04950127|527292925|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
146212568|NCT04950127|527292920|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
146212569|NCT04950127|527292921|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
146212570|NCT04950127|527292922|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146212571|NCT04950127|527292923|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146212572|NCT04950127|527292924|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146212573|NCT04950127|527292925|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
146212574|NCT04950127|527292920|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146212575|NCT04950127|527292921|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146212576|NCT04950127|527292922|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146212577|NCT04950127|527292923|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146212578|NCT04950127|527292924|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
146212579|NCT04950127|527292925|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
146212580|NCT04950127|527292920|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
146083918|NCT00534313|526826608|FG000|Long-term Period|No longer meets study criteria|0|||
146083919|NCT00534313|526826609|FG001|Long-term Period|No longer meets study criteria|1|||
146212581|NCT04950127|527292921|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
146212582|NCT04950127|527292922|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
146212583|NCT04950127|527292923|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
146212584|NCT04950127|527292924|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
146212585|NCT04950127|527292925|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
146083920|NCT00534313|526826610|FG002|Long-term Period|No longer meets study criteria|0|||
146212586|NCT01711632|527292926|FG000|Overall Study|Adverse Event|4|||
146212587|NCT01711632|527292926|FG000|Overall Study|Death|3|||
146212588|NCT01711632|527292926|FG000|Overall Study|Lost to Follow-up|3|||
146212589|NCT01711632|527292926|FG000|Overall Study|Withdrawal by Subject|4|||
146212590|NCT01711632|527292926|FG000|Overall Study|Progressive disease|2|||
146212591|NCT01711632|527292926|FG000|Overall Study|No follow up required in re-treatment|3|||
146212592|NCT01711632|527292926|FG000|Overall Study|No follow up required in re-treatment|3|||
146212593|NCT02860130|527292927|FG000|Overall Study|Adverse Event|2|||
146212594|NCT02860130|527292928|FG001|Overall Study|Adverse Event|3|||
146212595|NCT02860130|527292927|FG000|Overall Study|Protocol Violation|1|||
146212596|NCT02860130|527292928|FG001|Overall Study|Protocol Violation|1|||
146212597|NCT02860130|527292927|FG000|Overall Study|Withdrawal by Subject|0|||
146212598|NCT02860130|527292928|FG001|Overall Study|Withdrawal by Subject|2|||
146212599|NCT02860130|527292927|FG000|Overall Study|Physician Decision|2|||
146286595|NCT02317432|527562748|FG000|Overall Study|Death|4|||
146286596|NCT02317432|527562749|FG001|Overall Study|Death|1|||
146286597|NCT02317432|527562748|FG000|Overall Study|Lost to Follow-up|0|||
146286598|NCT02317432|527562749|FG001|Overall Study|Lost to Follow-up|5|||
146286599|NCT02317432|527562748|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
146286600|NCT02317432|527562749|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
146286601|NCT00727311|527562754|FG000|Overall Study|Did not receive drug|316|||
146286602|NCT00727311|527562754|FG000|Overall Study|Missing end of therapy data|205|||
146286603|NCT00727311|527562754|FG000|Overall Study|Adverse Event|58|||
146286604|NCT00727311|527562754|FG000|Overall Study|Lack of Efficacy|242|||
146286605|NCT00727311|527562754|FG000|Overall Study|Lost to Follow-up|73|||
146286606|NCT00727311|527562754|FG000|Overall Study|Withdrawal by Subject|77|||
146286607|NCT00727311|527562754|FG000|Overall Study|Other|97|||
146286608|NCT00727311|527562754|FG000|Overall Study|Multiple reasons|39|||
146286609|NCT02359877|527564236|FG000|Overall Study|Withdrawal by Subject|1|||
146286610|NCT02359877|527564237|FG001|Overall Study|Withdrawal by Subject|0|||
146286611|NCT02359877|527564238|FG002|Overall Study|Withdrawal by Subject|0|||
146286612|NCT02359877|527564239|FG003|Overall Study|Withdrawal by Subject|2|||
146286613|NCT02359877|527564236|FG000|Overall Study|Adverse Event|0|||
146286614|NCT02359877|527564237|FG001|Overall Study|Adverse Event|0|||
146286615|NCT02359877|527564238|FG002|Overall Study|Adverse Event|0|||
146286616|NCT02359877|527564239|FG003|Overall Study|Adverse Event|1|||
145957693|NCT00377637|526358146|FG002|Induction Phase|Sponsor decision|0|||
146286617|NCT02186223|527564241|FG000|Overall Study|Not eligible for device placement|6|||
146286618|NCT02186223|527564241|FG000|Overall Study|Unable to obtain femoral access|3|||
146212600|NCT02860130|527292928|FG001|Overall Study|Physician Decision|2|||
146212601|NCT02860130|527292927|FG000|Overall Study|Other|2|||
146212602|NCT02860130|527292928|FG001|Overall Study|Other|1|||
146212603|NCT01467427|527292929|FG000|Overall Study|Withdrawal by Subject|1|||
146212604|NCT01467427|527292930|FG001|Overall Study|Withdrawal by Subject|0|||
146212605|NCT01467427|527292929|FG000|Overall Study|Not continuing in extension phase|0|||
146212606|NCT01467427|527292930|FG001|Overall Study|Not continuing in extension phase|2|||
146212607|NCT01467427|527292929|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
146212608|NCT01467427|527292930|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
146212609|NCT01467427|527292929|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
146212610|NCT01467427|527292930|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
146212611|NCT01467427|527292929|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
146212612|NCT01467427|527292930|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
146212613|NCT01467427|527292929|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
146212614|NCT01467427|527292930|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
146212615|NCT04838613|527292931|FG000|Overall Study|Withdrawal by Subject|3|||
146212616|NCT04838613|527292932|FG001|Overall Study|Withdrawal by Subject|6|||
146212617|NCT04838613|527292931|FG000|Overall Study|Protocol Deviation|3|||
146212618|NCT04838613|527292932|FG001|Overall Study|Protocol Deviation|2|||
146212619|NCT04838613|527292931|FG000|Overall Study|Technical Problems|0|||
146212620|NCT04838613|527292932|FG001|Overall Study|Technical Problems|5|||
146212621|NCT04838613|527292931|FG000|Overall Study|Physician Decision|2|||
146212622|NCT04838613|527292932|FG001|Overall Study|Physician Decision|0|||
146212623|NCT04970654|527292933|FG000|Overall Study|Withdrawal by parents/guardian|1|||
146212624|NCT04970654|527292934|FG001|Overall Study|Withdrawal by parents/guardian|2|||
146212625|NCT04970654|527292933|FG000|Overall Study|Unclassified|2|||
146212626|NCT04970654|527292934|FG001|Overall Study|Unclassified|1|||
146212627|NCT04970654|527292933|FG000|Overall Study|Lost to Follow-up|1|||
146212628|NCT04970654|527292934|FG001|Overall Study|Lost to Follow-up|0|||
146212629|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
146212630|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
146212631|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
146212632|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
146212633|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
146212634|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
146212635|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
146212636|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
146212637|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
146212638|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
146212639|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
146212640|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
146212641|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
146212642|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
146212643|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
146212644|NCT02137850|527292935|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
146212645|NCT02137850|527292936|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
146212646|NCT02137850|527292937|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
146212647|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146212648|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
146212649|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146212650|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
146212651|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
145957694|NCT00377637|526358147|FG003|Induction Phase|Sponsor decision|0|||
145957695|NCT00377637|526358144|FG000|Induction Phase|Non-Compliance|1|||
146212652|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
146212653|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
146212654|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
146212655|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
146212656|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
146212657|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
146212658|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
146212659|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Other|0|||
146286619|NCT02186223|527564241|FG000|Overall Study|Death|3|||
145957696|NCT00377637|526358145|FG001|Induction Phase|Non-Compliance|0|||
146212660|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Other|1|||
146212661|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Other|0|||
146212662|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
146286620|NCT02186223|527564241|FG000|Overall Study|Device in place less than 48 hours|9|||
146286621|NCT00252733|527564242|FG000|Overall Study|Withdrawal by Subject|73|||
146212663|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
146212664|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
146212665|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Early site closure|0|||
146212666|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Early site closure|2|||
146212667|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Early site closure|0|||
146212668|NCT02137850|527292935|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
146212669|NCT02137850|527292936|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
146212670|NCT02137850|527292937|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
146212671|NCT02137850|527292935|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
146212672|NCT02137850|527292936|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
146212673|NCT02137850|527292937|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
146212674|NCT02137850|527292935|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
146212675|NCT02137850|527292936|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
146212676|NCT02137850|527292937|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
146212677|NCT02137850|527292935|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
146212678|NCT02137850|527292936|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
146212679|NCT02137850|527292937|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
146212680|NCT02137850|527292935|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
146212681|NCT02137850|527292936|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
146212682|NCT02137850|527292937|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
146212683|NCT02137850|527292935|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
146212684|NCT02137850|527292936|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
146212685|NCT02137850|527292937|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
146212686|NCT02137850|527292935|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146212687|NCT02137850|527292936|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
146212688|NCT02137850|527292937|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
146212689|NCT02137850|527292935|FG000|Extension Phase: Prophylaxis|Other|0|||
146212690|NCT02137850|527292936|FG001|Extension Phase: Prophylaxis|Other|1|||
146212691|NCT02137850|527292937|FG002|Extension Phase: Prophylaxis|Other|0|||
146212692|NCT02137850|527292935|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
146212693|NCT02137850|527292936|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
146212694|NCT02137850|527292937|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
146212695|NCT00136435|527292938|FG000|Overall Study|Ineligible|8|||
146212696|NCT00136435|527292938|FG000|Overall Study|Induction Death|1|||
146212697|NCT00136435|527292938|FG000|Overall Study|Induction Failure|10|||
146212698|NCT00136435|527292938|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
146212699|NCT00136435|527292938|FG000|Overall Study|Withdrawal by Subject|3|||
146212700|NCT00136435|527292938|FG000|Overall Study|Adverse Event|19|||
146212701|NCT00136435|527292938|FG000|Overall Study|Relapse|4|||
146212702|NCT00136435|527292938|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
146212703|NCT02794480|527292939|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146212704|NCT02794480|527292940|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146212705|NCT02794480|527292941|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
146212706|NCT02794480|527292942|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
146212707|NCT02794480|527292939|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146212708|NCT02794480|527292940|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146212709|NCT02794480|527292941|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
146212710|NCT02794480|527292942|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
146212711|NCT02794480|527292939|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146212712|NCT02794480|527292940|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146286622|NCT00252733|527564243|FG001|Overall Study|Withdrawal by Subject|67|||
146286623|NCT00252733|527564242|FG000|Overall Study|Death|7|||
146286624|NCT00252733|527564243|FG001|Overall Study|Death|5|||
146286625|NCT00252733|527564242|FG000|Overall Study|Lost to Follow-up|12|||
146286626|NCT00252733|527564243|FG001|Overall Study|Lost to Follow-up|6|||
146212713|NCT02794480|527292941|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146212714|NCT02794480|527292942|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
146212715|NCT02794480|527292939|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146212716|NCT02794480|527292940|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
146212717|NCT02794480|527292941|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146212718|NCT02794480|527292942|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146212719|NCT02794480|527292939|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146212720|NCT02794480|527292940|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146212721|NCT02794480|527292941|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146212722|NCT02794480|527292942|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146212723|NCT00901901|527292943|FG000|Treatment Period|Adverse Event|120|||
146212724|NCT00901901|527292944|FG001|Treatment Period|Adverse Event|128|||
146212725|NCT00901901|527292943|FG000|Treatment Period|Withdrawal by Subject|26|||
146212726|NCT00901901|527292944|FG001|Treatment Period|Withdrawal by Subject|24|||
146212727|NCT00901901|527292943|FG000|Treatment Period|Physician Decision|2|||
146212728|NCT00901901|527292944|FG001|Treatment Period|Physician Decision|2|||
146212729|NCT00901901|527292943|FG000|Treatment Period|Lost to Follow-up|3|||
146212730|NCT00901901|527292944|FG001|Treatment Period|Lost to Follow-up|5|||
146212731|NCT00901901|527292943|FG000|Treatment Period|Noncompliance with study medication|4|||
146212732|NCT00901901|527292944|FG001|Treatment Period|Noncompliance with study medication|1|||
146212733|NCT00901901|527292943|FG000|Treatment Period|Missing|1|||
146212734|NCT00901901|527292944|FG001|Treatment Period|Missing|0|||
146212735|NCT00901901|527292943|FG000|Treatment Period|Never treated|0|||
146212736|NCT00901901|527292944|FG001|Treatment Period|Never treated|3|||
145957697|NCT00377637|526358146|FG002|Induction Phase|Non-Compliance|0|||
146286627|NCT00252733|527564242|FG000|Overall Study|Multiple Reasons|14|||
146286628|NCT00252733|527564243|FG001|Overall Study|Multiple Reasons|14|||
146286629|NCT00876928|527564244|FG000|Overall Study|Lost to Follow-up|2|||
146286630|NCT00876928|527564245|FG001|Overall Study|Lost to Follow-up|5|||
146286631|NCT00876928|527564244|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
146286632|NCT00876928|527564245|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
146286633|NCT01111474|527564246|FG000|Overall Study|Lost to Follow-up|12|||
146286634|NCT00558259|527564247|FG000|Overall Study|Adverse Event|50|||
146286635|NCT00558259|527564248|FG001|Overall Study|Adverse Event|81|||
146286636|NCT00558259|527564247|FG000|Overall Study|Protocol Violation|9|||
146286637|NCT00558259|527564248|FG001|Overall Study|Protocol Violation|5|||
145957698|NCT00377637|526358147|FG003|Induction Phase|Non-Compliance|0|||
146286638|NCT00558259|527564247|FG000|Overall Study|Withdrawal by Subject|12|||
146286639|NCT00558259|527564248|FG001|Overall Study|Withdrawal by Subject|13|||
146286640|NCT02874924|527564249|FG000|Overall Study|Adverse Event|2|||
146212737|NCT00901901|527292943|FG000|Treatment Period|Protocol driven decision point|0|||
146286641|NCT02874924|527564250|FG001|Overall Study|Adverse Event|0|||
146286642|NCT02874924|527564251|FG002|Overall Study|Adverse Event|0|||
146286643|NCT02874924|527564249|FG000|Overall Study|Withdrawal by Subject|1|||
146286644|NCT02874924|527564250|FG001|Overall Study|Withdrawal by Subject|0|||
146286645|NCT02874924|527564251|FG002|Overall Study|Withdrawal by Subject|0|||
146286646|NCT02029846|527564254|FG000|Overall Study|n=1 each arm|1|||
146286647|NCT02029846|527564255|FG001|Overall Study|n=1 each arm|1|||
146286648|NCT03718533|527564260|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
146286649|NCT03718533|527564260|FG000|Overall Study|Protocol deviation|1|||
146286650|NCT03718533|527564260|FG000|Overall Study|Disease progression|1|||
146286651|NCT03718533|527564260|FG000|Overall Study|Relapse|1|||
146286652|NCT03718533|527564260|FG000|Overall Study|Physician Decision|2|||
146286653|NCT03718533|527564260|FG000|Overall Study|Physician Decision and Adverse Event|1|||
146286654|NCT01248065|527564268|FG000|Overall Study|Lost to Follow-up|3|||
146286655|NCT01248065|527564269|FG001|Overall Study|Lost to Follow-up|5|||
146286656|NCT01248065|527564268|FG000|Overall Study|Withdrawal by Subject|14|||
146286657|NCT01248065|527564269|FG001|Overall Study|Withdrawal by Subject|11|||
146286658|NCT01248065|527564268|FG000|Overall Study|Adverse Event|3|||
146286659|NCT01248065|527564269|FG001|Overall Study|Adverse Event|0|||
146286660|NCT01248065|527564268|FG000|Overall Study|Third treatment failure event|3|||
146286661|NCT01248065|527564269|FG001|Overall Study|Third treatment failure event|1|||
146286662|NCT01248065|527564268|FG000|Overall Study|Other|3|||
146286663|NCT01248065|527564269|FG001|Overall Study|Other|5|||
146286664|NCT02518490|527564276|FG000|Overall Study|Withdrawal by Subject|1|||
146286665|NCT02518490|527564277|FG001|Overall Study|Withdrawal by Subject|1|||
146286666|NCT04256629|527564278|FG000|Overall Study|Adverse Event|0|||
146286667|NCT04256629|527564279|FG001|Overall Study|Adverse Event|0|||
146286668|NCT04256629|527564280|FG002|Overall Study|Adverse Event|0|||
146286669|NCT04256629|527564281|FG003|Overall Study|Adverse Event|0|||
146286670|NCT04256629|527564282|FG004|Overall Study|Adverse Event|0|||
146286671|NCT04256629|527564283|FG005|Overall Study|Adverse Event|1|||
146286672|NCT04256629|527564278|FG000|Overall Study|Protocol Violation|0|||
146286673|NCT04256629|527564279|FG001|Overall Study|Protocol Violation|1|||
146286674|NCT04256629|527564280|FG002|Overall Study|Protocol Violation|0|||
146286675|NCT04256629|527564281|FG003|Overall Study|Protocol Violation|0|||
146286676|NCT04256629|527564282|FG004|Overall Study|Protocol Violation|0|||
145957699|NCT00377637|526358144|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
145957700|NCT00377637|526358145|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
145957701|NCT00377637|526358146|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
145957702|NCT00377637|526358147|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
146286677|NCT04256629|527564283|FG005|Overall Study|Protocol Violation|0|||
146286678|NCT00346632|527564284|FG000|Overall Study|Progressive Disease|2|||
146286679|NCT00346632|527564285|FG001|Overall Study|Progressive Disease|2|||
146286680|NCT00346632|527564286|FG002|Overall Study|Progressive Disease|4|||
146286681|NCT00346632|527564287|FG003|Overall Study|Progressive Disease|3|||
145957703|NCT00377637|526358144|FG000|Maintenance Phase|Adverse Event|0|||
146286682|NCT00346632|527564288|FG004|Overall Study|Progressive Disease|3|||
146286683|NCT00346632|527564289|FG005|Overall Study|Progressive Disease|1|||
146286684|NCT00346632|527564290|FG006|Overall Study|Progressive Disease|2|||
146286685|NCT00346632|527564291|FG007|Overall Study|Progressive Disease|2|||
146212738|NCT00901901|527292944|FG001|Treatment Period|Protocol driven decision point|2|||
146212739|NCT00901901|527292943|FG000|Treatment Period|Study terminated by sponsor|2|||
146212740|NCT00901901|527292944|FG001|Treatment Period|Study terminated by sponsor|0|||
146212741|NCT00901901|527292943|FG000|Treatment Period|Protocol Violation|5|||
146212742|NCT00901901|527292944|FG001|Treatment Period|Protocol Violation|9|||
146212743|NCT00901901|527292943|FG000|Treatment Period|Switch to commercial drug|1|||
146286686|NCT00346632|527564292|FG008|Overall Study|Progressive Disease|2|||
146286687|NCT00346632|527564293|FG009|Overall Study|Progressive Disease|2|||
146286688|NCT00346632|527564284|FG000|Overall Study|Adverse Event|0|||
146286689|NCT00346632|527564285|FG001|Overall Study|Adverse Event|0|||
146286690|NCT00346632|527564286|FG002|Overall Study|Adverse Event|0|||
146286691|NCT00346632|527564287|FG003|Overall Study|Adverse Event|0|||
146286692|NCT00346632|527564288|FG004|Overall Study|Adverse Event|1|||
146286693|NCT00346632|527564289|FG005|Overall Study|Adverse Event|1|||
146286694|NCT00346632|527564290|FG006|Overall Study|Adverse Event|1|||
146286695|NCT00346632|527564291|FG007|Overall Study|Adverse Event|0|||
146286696|NCT00346632|527564292|FG008|Overall Study|Adverse Event|0|||
146286697|NCT00346632|527564293|FG009|Overall Study|Adverse Event|0|||
146286698|NCT00346632|527564284|FG000|Overall Study|Death|0|||
146286699|NCT00346632|527564285|FG001|Overall Study|Death|0|||
146286700|NCT00346632|527564286|FG002|Overall Study|Death|1|||
146286701|NCT00346632|527564287|FG003|Overall Study|Death|0|||
146286702|NCT00346632|527564288|FG004|Overall Study|Death|0|||
146286703|NCT00346632|527564289|FG005|Overall Study|Death|0|||
146286704|NCT00346632|527564290|FG006|Overall Study|Death|0|||
146286705|NCT00346632|527564291|FG007|Overall Study|Death|0|||
146286706|NCT00346632|527564292|FG008|Overall Study|Death|0|||
146212744|NCT00901901|527292944|FG001|Treatment Period|Switch to commercial drug|1|||
146212745|NCT00901901|527292943|FG000|Treatment Period|Transfer to treatment continuation study|5|||
146212746|NCT00901901|527292944|FG001|Treatment Period|Transfer to treatment continuation study|2|||
146212747|NCT00901901|527292943|FG000|Follow-up Period|Death|181|||
146212748|NCT00901901|527292944|FG001|Follow-up Period|Death|208|||
146212749|NCT00901901|527292943|FG000|Follow-up Period|Protocol driven decision point|47|||
146212750|NCT00901901|527292944|FG001|Follow-up Period|Protocol driven decision point|36|||
146212751|NCT00901901|527292943|FG000|Follow-up Period|Withdrawal by Subject|6|||
146212752|NCT00901901|527292944|FG001|Follow-up Period|Withdrawal by Subject|9|||
146212753|NCT00901901|527292943|FG000|Follow-up Period|Lost to Follow-up|12|||
146212754|NCT00901901|527292944|FG001|Follow-up Period|Lost to Follow-up|8|||
146212755|NCT00901901|527292943|FG000|Follow-up Period|Missing|94|||
146212756|NCT00901901|527292944|FG001|Follow-up Period|Missing|80|||
146212757|NCT00632749|527292947|FG000|Overall Study|Progressive disease|3|||
146212758|NCT00632749|527292948|FG001|Overall Study|Progressive disease|2|||
146212759|NCT00632749|527292949|FG002|Overall Study|Progressive disease|2|||
146212760|NCT00632749|527292950|FG003|Overall Study|Progressive disease|2|||
146212761|NCT00632749|527292951|FG004|Overall Study|Progressive disease|4|||
146212762|NCT00632749|527292952|FG005|Overall Study|Progressive disease|4|||
146212763|NCT00632749|527292953|FG006|Overall Study|Progressive disease|3|||
146212764|NCT00632749|527292954|FG007|Overall Study|Progressive disease|2|||
146212765|NCT00632749|527292955|FG008|Overall Study|Progressive disease|3|||
146212766|NCT00632749|527292956|FG009|Overall Study|Progressive disease|2|||
146212767|NCT00632749|527292957|FG010|Overall Study|Progressive disease|4|||
146286707|NCT00346632|527564293|FG009|Overall Study|Death|0|||
146286708|NCT00346632|527564284|FG000|Overall Study|Protocol Violation|0|||
146286709|NCT00346632|527564285|FG001|Overall Study|Protocol Violation|0|||
146286710|NCT00346632|527564286|FG002|Overall Study|Protocol Violation|0|||
146286711|NCT00346632|527564287|FG003|Overall Study|Protocol Violation|0|||
146286712|NCT00346632|527564288|FG004|Overall Study|Protocol Violation|0|||
146212768|NCT00632749|527292958|FG011|Overall Study|Progressive disease|3|||
146212769|NCT00632749|527292959|FG012|Overall Study|Progressive disease|2|||
146212770|NCT00632749|527292960|FG013|Overall Study|Progressive disease|4|||
146212771|NCT00632749|527292947|FG000|Overall Study|Other Adverse event|1|||
146212772|NCT00632749|527292948|FG001|Overall Study|Other Adverse event|1|||
146286713|NCT00346632|527564289|FG005|Overall Study|Protocol Violation|0|||
145957704|NCT00377637|526358145|FG001|Maintenance Phase|Adverse Event|0|||
146212773|NCT00632749|527292949|FG002|Overall Study|Other Adverse event|1|||
146286714|NCT00346632|527564290|FG006|Overall Study|Protocol Violation|1|||
146212774|NCT00632749|527292950|FG003|Overall Study|Other Adverse event|1|||
146212775|NCT00632749|527292951|FG004|Overall Study|Other Adverse event|2|||
146212776|NCT00632749|527292952|FG005|Overall Study|Other Adverse event|4|||
146212777|NCT00632749|527292953|FG006|Overall Study|Other Adverse event|1|||
146212778|NCT00632749|527292954|FG007|Overall Study|Other Adverse event|2|||
146212779|NCT00632749|527292955|FG008|Overall Study|Other Adverse event|2|||
146286715|NCT00346632|527564291|FG007|Overall Study|Protocol Violation|0|||
146286716|NCT00346632|527564292|FG008|Overall Study|Protocol Violation|0|||
146286717|NCT00346632|527564293|FG009|Overall Study|Protocol Violation|0|||
146286718|NCT00346632|527564284|FG000|Overall Study|Withdrawal by Subject|0|||
146286719|NCT00346632|527564285|FG001|Overall Study|Withdrawal by Subject|0|||
146286720|NCT00346632|527564286|FG002|Overall Study|Withdrawal by Subject|0|||
146286721|NCT00346632|527564287|FG003|Overall Study|Withdrawal by Subject|0|||
146286722|NCT00346632|527564288|FG004|Overall Study|Withdrawal by Subject|0|||
146286723|NCT00346632|527564289|FG005|Overall Study|Withdrawal by Subject|0|||
146286724|NCT00346632|527564290|FG006|Overall Study|Withdrawal by Subject|1|||
146286725|NCT00346632|527564291|FG007|Overall Study|Withdrawal by Subject|0|||
146286726|NCT00346632|527564292|FG008|Overall Study|Withdrawal by Subject|0|||
146286727|NCT00346632|527564293|FG009|Overall Study|Withdrawal by Subject|0|||
146286728|NCT00346632|527564284|FG000|Overall Study|Switched to alternative treatment|0|||
146286729|NCT00346632|527564285|FG001|Overall Study|Switched to alternative treatment|0|||
146286730|NCT00346632|527564286|FG002|Overall Study|Switched to alternative treatment|1|||
146286731|NCT00346632|527564287|FG003|Overall Study|Switched to alternative treatment|0|||
146286732|NCT00346632|527564288|FG004|Overall Study|Switched to alternative treatment|0|||
146286733|NCT00346632|527564289|FG005|Overall Study|Switched to alternative treatment|0|||
146286734|NCT00346632|527564290|FG006|Overall Study|Switched to alternative treatment|0|||
146286735|NCT00346632|527564291|FG007|Overall Study|Switched to alternative treatment|0|||
146286736|NCT00346632|527564292|FG008|Overall Study|Switched to alternative treatment|0|||
146286737|NCT00346632|527564293|FG009|Overall Study|Switched to alternative treatment|0|||
146286738|NCT00346632|527564284|FG000|Overall Study|Not Stated|1|||
146286739|NCT00346632|527564285|FG001|Overall Study|Not Stated|1|||
146286740|NCT00346632|527564286|FG002|Overall Study|Not Stated|0|||
146286741|NCT00346632|527564287|FG003|Overall Study|Not Stated|0|||
146286742|NCT00346632|527564288|FG004|Overall Study|Not Stated|0|||
146286743|NCT00346632|527564289|FG005|Overall Study|Not Stated|0|||
146286744|NCT00346632|527564290|FG006|Overall Study|Not Stated|0|||
146286745|NCT00346632|527564291|FG007|Overall Study|Not Stated|2|||
146286746|NCT00346632|527564292|FG008|Overall Study|Not Stated|2|||
146286747|NCT00346632|527564293|FG009|Overall Study|Not Stated|1|||
146286748|NCT00477334|527564294|FG000|Overall Study|Discontinued prior to taking study drug|106|||
146286749|NCT00477334|527564295|FG001|Overall Study|Discontinued prior to taking study drug|53|||
146286750|NCT00477334|527564294|FG000|Overall Study|Adverse Event|1|||
146286751|NCT00477334|527564295|FG001|Overall Study|Adverse Event|2|||
146286752|NCT00477334|527564294|FG000|Overall Study|Withdrawal by Subject|2|||
146286753|NCT00477334|527564295|FG001|Overall Study|Withdrawal by Subject|1|||
146286754|NCT00477334|527564294|FG000|Overall Study|Lost to Follow-up|15|||
146286755|NCT00477334|527564295|FG001|Overall Study|Lost to Follow-up|4|||
146286756|NCT00477334|527564294|FG000|Overall Study|Administrative Problems|39|||
146286757|NCT00477334|527564295|FG001|Overall Study|Administrative Problems|15|||
146286758|NCT00477334|527564294|FG000|Overall Study|Protocol Violation|7|||
146286759|NCT00477334|527564295|FG001|Overall Study|Protocol Violation|1|||
146286760|NCT00297232|527564296|FG000|Overall Study|Lack of Efficacy|7|||
146286761|NCT00297232|527564296|FG000|Overall Study|Lost to Follow-up|10|||
146286762|NCT00297232|527564296|FG000|Overall Study|Adverse Event|63|||
146286763|NCT00297232|527564296|FG000|Overall Study|Voluntary Withdrawal|120|||
146286764|NCT00297232|527564296|FG000|Overall Study|Subject was Noncompliant|9|||
146286765|NCT00297232|527564296|FG000|Overall Study|Death|9|||
146286766|NCT00297232|527564296|FG000|Overall Study|Anti-natalizumab Positive|8|||
146286767|NCT00297232|527564296|FG000|Overall Study|Switched to Commercial Tysabri|22|||
146286768|NCT00297232|527564296|FG000|Overall Study|Disease Progression|8|||
146286769|NCT00297232|527564296|FG000|Overall Study|Fear of PML|10|||
146286770|NCT00297232|527564296|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
146286771|NCT00297232|527564296|FG000|Overall Study|Miscellaneous|5|||
146286772|NCT00297232|527564296|FG000|Overall Study|Sponsor Decision|34|||
146286773|NCT00297232|527564296|FG000|Overall Study|Subject Relocated|7|||
146286774|NCT00297232|527564296|FG000|Overall Study|Subject Withdrew Consent|37|||
146286775|NCT00297232|527564296|FG000|Overall Study|Persistently Positive Antibodies|11|||
146286776|NCT00297232|527564296|FG000|Overall Study|Investigator Withdrew From Program|19|||
146286777|NCT00297232|527564296|FG000|Overall Study|Did Not Enroll to Week 264|34|||
146286778|NCT00297232|527564296|FG000|Overall Study|Did Not Enroll to Week 480|17|||
146286779|NCT00297232|527564296|FG000|Overall Study|No data available after Week 264|161|||
146286780|NCT00297232|527564296|FG000|Overall Study|Other|1|||
146286781|NCT03625895|527564297|FG000|Overall Study|Protocol Violation|585|||
146286782|NCT00552240|527564300|FG000|Overall Study|Adverse Event|9|||
146286783|NCT00552240|527564301|FG001|Overall Study|Adverse Event|9|||
146286784|NCT00552240|527564300|FG000|Overall Study|Protocol Violation|1|||
146286785|NCT00552240|527564301|FG001|Overall Study|Protocol Violation|1|||
146286786|NCT00552240|527564300|FG000|Overall Study|Lost to Follow-up|5|||
146212780|NCT00632749|527292956|FG009|Overall Study|Other Adverse event|0|||
146212781|NCT00632749|527292957|FG010|Overall Study|Other Adverse event|1|||
146212782|NCT00632749|527292958|FG011|Overall Study|Other Adverse event|0|||
146212783|NCT00632749|527292959|FG012|Overall Study|Other Adverse event|1|||
146212784|NCT00632749|527292960|FG013|Overall Study|Other Adverse event|0|||
146212785|NCT00632749|527292947|FG000|Overall Study|Refuse to continue medication|0|||
146212786|NCT00632749|527292948|FG001|Overall Study|Refuse to continue medication|0|||
146212787|NCT00632749|527292949|FG002|Overall Study|Refuse to continue medication|0|||
146212788|NCT00632749|527292950|FG003|Overall Study|Refuse to continue medication|1|||
146212789|NCT00632749|527292951|FG004|Overall Study|Refuse to continue medication|0|||
146212790|NCT00632749|527292952|FG005|Overall Study|Refuse to continue medication|0|||
146212791|NCT00632749|527292953|FG006|Overall Study|Refuse to continue medication|0|||
146212792|NCT00632749|527292954|FG007|Overall Study|Refuse to continue medication|0|||
146286787|NCT00552240|527564301|FG001|Overall Study|Lost to Follow-up|6|||
146286788|NCT00552240|527564300|FG000|Overall Study|Withdrawal by Subject|2|||
146212793|NCT00632749|527292955|FG008|Overall Study|Refuse to continue medication|0|||
146286789|NCT00552240|527564301|FG001|Overall Study|Withdrawal by Subject|2|||
146286790|NCT00552240|527564300|FG000|Overall Study|Lack of Efficacy|6|||
146286791|NCT00552240|527564301|FG001|Overall Study|Lack of Efficacy|0|||
146212794|NCT00632749|527292956|FG009|Overall Study|Refuse to continue medication|1|||
146212795|NCT00632749|527292957|FG010|Overall Study|Refuse to continue medication|0|||
146212796|NCT00632749|527292958|FG011|Overall Study|Refuse to continue medication|0|||
146212797|NCT00632749|527292959|FG012|Overall Study|Refuse to continue medication|0|||
146212798|NCT00632749|527292960|FG013|Overall Study|Refuse to continue medication|0|||
146212799|NCT00632749|527292947|FG000|Overall Study|Reason other than those specified above|0|||
146212800|NCT00632749|527292948|FG001|Overall Study|Reason other than those specified above|2|||
146212801|NCT00632749|527292949|FG002|Overall Study|Reason other than those specified above|0|||
146212802|NCT00632749|527292950|FG003|Overall Study|Reason other than those specified above|0|||
146212803|NCT00632749|527292951|FG004|Overall Study|Reason other than those specified above|1|||
146212804|NCT00632749|527292952|FG005|Overall Study|Reason other than those specified above|0|||
146286792|NCT00552240|527564300|FG000|Overall Study|Other|1|||
146212805|NCT00632749|527292953|FG006|Overall Study|Reason other than those specified above|1|||
146212806|NCT00632749|527292954|FG007|Overall Study|Reason other than those specified above|0|||
146212807|NCT00632749|527292955|FG008|Overall Study|Reason other than those specified above|0|||
146212808|NCT00632749|527292956|FG009|Overall Study|Reason other than those specified above|0|||
146212809|NCT00632749|527292957|FG010|Overall Study|Reason other than those specified above|2|||
146212810|NCT00632749|527292958|FG011|Overall Study|Reason other than those specified above|1|||
146212811|NCT00632749|527292959|FG012|Overall Study|Reason other than those specified above|0|||
146212812|NCT00632749|527292960|FG013|Overall Study|Reason other than those specified above|2|||
146212817|NCT04999592|527292962|FG000|Overall Study|Withdrawal by Subject|1|||
146212818|NCT04999592|527292963|FG001|Overall Study|Withdrawal by Subject|0|||
146212819|NCT00879333|527292964|FG000|Overall Study|Adverse Event|94|||
146212820|NCT00879333|527292965|FG001|Overall Study|Adverse Event|34|||
146212821|NCT00879333|527292964|FG000|Overall Study|Abnormal Laboratory Value|1|||
146212822|NCT00879333|527292965|FG001|Overall Study|Abnormal Laboratory Value|0|||
146212823|NCT00879333|527292964|FG000|Overall Study|Withdrawal by Subject|20|||
146212824|NCT00879333|527292965|FG001|Overall Study|Withdrawal by Subject|7|||
146212825|NCT00879333|527292964|FG000|Overall Study|Lost to Follow-up|2|||
146212826|NCT00879333|527292965|FG001|Overall Study|Lost to Follow-up|1|||
146212827|NCT00879333|527292964|FG000|Overall Study|Administrative Problems|2|||
146212828|NCT00879333|527292965|FG001|Overall Study|Administrative Problems|0|||
146212829|NCT00879333|527292964|FG000|Overall Study|Death|16|||
146212830|NCT00879333|527292965|FG001|Overall Study|Death|5|||
146212831|NCT00879333|527292964|FG000|Overall Study|Disease Progression|292|||
146212832|NCT00879333|527292965|FG001|Overall Study|Disease Progression|169|||
146212833|NCT00879333|527292964|FG000|Overall Study|Protocol Violation|1|||
146212834|NCT00879333|527292965|FG001|Overall Study|Protocol Violation|1|||
146212835|NCT02671435|527292973|FG000|Overall Study|Death|1|||
146212836|NCT02671435|527292974|FG001|Overall Study|Death|3|||
146212837|NCT02671435|527292975|FG002|Overall Study|Death|0|||
146212838|NCT02671435|527292976|FG003|Overall Study|Death|16|||
146212839|NCT02671435|527292977|FG004|Overall Study|Death|14|||
146212840|NCT02671435|527292978|FG005|Overall Study|Death|29|||
146212841|NCT02671435|527292979|FG006|Overall Study|Death|34|||
146212842|NCT02671435|527292980|FG007|Overall Study|Death|28|||
146212843|NCT02671435|527292981|FG008|Overall Study|Death|19|||
146286793|NCT00552240|527564301|FG001|Overall Study|Other|0|||
146286794|NCT02679573|527564302|FG000|Overall Study|Adverse Event|13|||
145957705|NCT00377637|526358146|FG002|Maintenance Phase|Adverse Event|29|||
145957706|NCT00377637|526358147|FG003|Maintenance Phase|Adverse Event|43|||
145957707|NCT00377637|526358144|FG000|Maintenance Phase|Physician Decision|0|||
146212844|NCT02671435|527292982|FG009|Overall Study|Death|10|||
146212845|NCT02671435|527292983|FG010|Overall Study|Death|8|||
146212846|NCT02671435|527292984|FG011|Overall Study|Death|29|||
146212847|NCT02671435|527292985|FG012|Overall Study|Death|29|||
146212848|NCT02671435|527292986|FG013|Overall Study|Death|29|||
146286795|NCT02679573|527564303|FG001|Overall Study|Adverse Event|6|||
145957708|NCT00377637|526358145|FG001|Maintenance Phase|Physician Decision|0|||
145957709|NCT00377637|526358146|FG002|Maintenance Phase|Physician Decision|5|||
146212849|NCT02671435|527292987|FG014|Overall Study|Death|27|||
146212850|NCT02671435|527292973|FG000|Overall Study|Lost to Follow-up|0|||
146212851|NCT02671435|527292974|FG001|Overall Study|Lost to Follow-up|0|||
146212852|NCT02671435|527292975|FG002|Overall Study|Lost to Follow-up|1|||
146212853|NCT02671435|527292976|FG003|Overall Study|Lost to Follow-up|0|||
146212854|NCT02671435|527292977|FG004|Overall Study|Lost to Follow-up|1|||
146212855|NCT02671435|527292978|FG005|Overall Study|Lost to Follow-up|1|||
146212856|NCT02671435|527292979|FG006|Overall Study|Lost to Follow-up|2|||
146212857|NCT02671435|527292980|FG007|Overall Study|Lost to Follow-up|2|||
146212858|NCT02671435|527292981|FG008|Overall Study|Lost to Follow-up|0|||
146212859|NCT02671435|527292982|FG009|Overall Study|Lost to Follow-up|2|||
146212860|NCT02671435|527292983|FG010|Overall Study|Lost to Follow-up|0|||
146083921|NCT00534313|526826611|FG003|Long-term Period|No longer meets study criteria|0|||
146083922|NCT00534313|526826608|FG000|Long-term Period|Poor compliance/noncompliance|0|||
146083923|NCT00534313|526826609|FG001|Long-term Period|Poor compliance/noncompliance|1|||
146083924|NCT00534313|526826610|FG002|Long-term Period|Poor compliance/noncompliance|1|||
146212861|NCT02671435|527292984|FG011|Overall Study|Lost to Follow-up|3|||
146212862|NCT02671435|527292985|FG012|Overall Study|Lost to Follow-up|3|||
146212863|NCT02671435|527292986|FG013|Overall Study|Lost to Follow-up|2|||
146212864|NCT02671435|527292987|FG014|Overall Study|Lost to Follow-up|0|||
146212865|NCT02671435|527292973|FG000|Overall Study|Withdrawal by Subject|2|||
146212866|NCT02671435|527292974|FG001|Overall Study|Withdrawal by Subject|0|||
146212867|NCT02671435|527292975|FG002|Overall Study|Withdrawal by Subject|2|||
146212868|NCT02671435|527292976|FG003|Overall Study|Withdrawal by Subject|2|||
146212869|NCT02671435|527292977|FG004|Overall Study|Withdrawal by Subject|2|||
146212870|NCT02671435|527292978|FG005|Overall Study|Withdrawal by Subject|7|||
146212871|NCT02671435|527292979|FG006|Overall Study|Withdrawal by Subject|2|||
146212872|NCT02671435|527292980|FG007|Overall Study|Withdrawal by Subject|7|||
146212873|NCT02671435|527292981|FG008|Overall Study|Withdrawal by Subject|1|||
146212874|NCT02671435|527292982|FG009|Overall Study|Withdrawal by Subject|1|||
146212875|NCT02671435|527292983|FG010|Overall Study|Withdrawal by Subject|2|||
146212876|NCT02671435|527292984|FG011|Overall Study|Withdrawal by Subject|4|||
146212877|NCT02671435|527292985|FG012|Overall Study|Withdrawal by Subject|4|||
146212878|NCT02671435|527292986|FG013|Overall Study|Withdrawal by Subject|4|||
146212879|NCT02671435|527292987|FG014|Overall Study|Withdrawal by Subject|2|||
146212880|NCT02671435|527292973|FG000|Overall Study|Un-specified|0|||
146212881|NCT02671435|527292974|FG001|Overall Study|Un-specified|0|||
146212882|NCT02671435|527292975|FG002|Overall Study|Un-specified|0|||
146212883|NCT02671435|527292976|FG003|Overall Study|Un-specified|0|||
146212884|NCT02671435|527292977|FG004|Overall Study|Un-specified|1|||
145957710|NCT00377637|526358147|FG003|Maintenance Phase|Physician Decision|4|||
145957711|NCT00377637|526358144|FG000|Maintenance Phase|Lost to Follow-up|0|||
145957712|NCT00377637|526358145|FG001|Maintenance Phase|Lost to Follow-up|0|||
146212885|NCT02671435|527292978|FG005|Overall Study|Un-specified|3|||
146212886|NCT02671435|527292979|FG006|Overall Study|Un-specified|2|||
146212887|NCT02671435|527292980|FG007|Overall Study|Un-specified|3|||
146212888|NCT02671435|527292981|FG008|Overall Study|Un-specified|0|||
146212889|NCT02671435|527292982|FG009|Overall Study|Un-specified|5|||
146212890|NCT02671435|527292983|FG010|Overall Study|Un-specified|8|||
146212891|NCT02671435|527292984|FG011|Overall Study|Un-specified|4|||
146212892|NCT02671435|527292985|FG012|Overall Study|Un-specified|5|||
146212893|NCT02671435|527292986|FG013|Overall Study|Un-specified|9|||
146212894|NCT02671435|527292987|FG014|Overall Study|Un-specified|8|||
146212895|NCT04095104|527292988|FG000|Overall Study|Withdrawal by Subject|0|||
146212896|NCT04095104|527292989|FG001|Overall Study|Withdrawal by Subject|1|||
146212897|NCT03432858|527292991|FG000|Overall Study|Protocol Violation|2|||
146212898|NCT03432858|527292992|FG001|Overall Study|Protocol Violation|1|||
146212899|NCT03432858|527292993|FG002|Overall Study|Protocol Violation|9|||
146212900|NCT03432858|527292991|FG000|Overall Study|Withdrawal by Subject|0|||
146212901|NCT03432858|527292992|FG001|Overall Study|Withdrawal by Subject|1|||
146212902|NCT03432858|527292993|FG002|Overall Study|Withdrawal by Subject|1|||
146212903|NCT03432858|527292991|FG000|Overall Study|Procedure canceled/rescheduled|0|||
146212904|NCT03432858|527292992|FG001|Overall Study|Procedure canceled/rescheduled|9|||
146212905|NCT03432858|527292993|FG002|Overall Study|Procedure canceled/rescheduled|6|||
146212906|NCT03432858|527292991|FG000|Overall Study|Required postop mobilization with splinting|0|||
146212907|NCT03432858|527292992|FG001|Overall Study|Required postop mobilization with splinting|0|||
146212908|NCT03432858|527292993|FG002|Overall Study|Required postop mobilization with splinting|1|||
146212909|NCT04820686|527292994|FG000|Overall Study|Withdrawal by Subject|5|||
146212910|NCT04820686|527292995|FG001|Overall Study|Withdrawal by Subject|2|||
146212911|NCT04820686|527292996|FG002|Overall Study|Withdrawal by Subject|3|||
146212912|NCT04820686|527292994|FG000|Overall Study|Study Termination|25|||
146212913|NCT04820686|527292995|FG001|Overall Study|Study Termination|13|||
146212914|NCT04820686|527292996|FG002|Overall Study|Study Termination|14|||
146286796|NCT02679573|527564302|FG000|Overall Study|Lack of Efficacy|12|||
146212915|NCT04820686|527292994|FG000|Overall Study|Adverse Event|0|||
146212916|NCT04820686|527292995|FG001|Overall Study|Adverse Event|1|||
146212917|NCT04820686|527292996|FG002|Overall Study|Adverse Event|0|||
146286797|NCT02679573|527564303|FG001|Overall Study|Lack of Efficacy|15|||
146286798|NCT02679573|527564302|FG000|Overall Study|Could not complete required study visits|6|||
146286799|NCT02679573|527564303|FG001|Overall Study|Could not complete required study visits|2|||
146286800|NCT02679573|527564302|FG000|Overall Study|Withdrawal by Subject|2|||
146286801|NCT02679573|527564303|FG001|Overall Study|Withdrawal by Subject|9|||
146286802|NCT02679573|527564302|FG000|Overall Study|Death|2|||
146286803|NCT02679573|527564303|FG001|Overall Study|Death|0|||
146286804|NCT02679573|527564302|FG000|Overall Study|Physician Decision|2|||
146286805|NCT02679573|527564303|FG001|Overall Study|Physician Decision|4|||
146286806|NCT02679573|527564302|FG000|Overall Study|Lost to Follow-up|0|||
146286807|NCT02679573|527564303|FG001|Overall Study|Lost to Follow-up|3|||
146286808|NCT03545503|527564304|FG000|Overall Study|Protocol Violation|14|||
146286809|NCT03545503|527564305|FG001|Overall Study|Protocol Violation|16|||
146286810|NCT05753670|527564306|FG000|Overall Study|Withdrawal by Subject|6|||
146286811|NCT05753670|527564307|FG001|Overall Study|Withdrawal by Subject|8|||
146286812|NCT05753670|527564306|FG000|Overall Study|Protocol Violation|3|||
146286813|NCT05753670|527564307|FG001|Overall Study|Protocol Violation|1|||
146286814|NCT02483585|527564308|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
146286815|NCT02483585|527564309|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
146286816|NCT02483585|527564308|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146286817|NCT02483585|527564309|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146212918|NCT01424670|527292997|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
146212919|NCT01424670|527292998|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
146212920|NCT01424670|527292997|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
146212921|NCT01424670|527292998|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
146212922|NCT01424670|527292997|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
146212923|NCT01424670|527292998|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
146212924|NCT01424670|527292997|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
146212925|NCT01424670|527292998|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
146212926|NCT01424670|527292997|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
146212927|NCT01424670|527292998|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
146212928|NCT01424670|527292997|FG000|Continuation Period|Adverse Event|13|||
146212929|NCT01424670|527292998|FG001|Continuation Period|Adverse Event|5|||
146212930|NCT01424670|527292997|FG000|Continuation Period|Lost to Follow-up|2|||
146212931|NCT01424670|527292998|FG001|Continuation Period|Lost to Follow-up|0|||
146212932|NCT01424670|527292997|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
146212933|NCT01424670|527292998|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
146212934|NCT01424670|527292997|FG000|Continuation Period|Physician Decision|5|||
146212935|NCT01424670|527292998|FG001|Continuation Period|Physician Decision|4|||
146212936|NCT01424670|527292997|FG000|Continuation Period|Withdrawal by Subject|13|||
146212937|NCT01424670|527292998|FG001|Continuation Period|Withdrawal by Subject|4|||
146212938|NCT00761189|527292999|FG000|Overall Study|Adverse Event|42|||
146212939|NCT00761189|527292999|FG000|Overall Study|Lack of Efficacy|45|||
146212940|NCT00761189|527292999|FG000|Overall Study|Lost to Follow-up|36|||
146212941|NCT00761189|527292999|FG000|Overall Study|Withdrawal by Subject|49|||
146212942|NCT00761189|527292999|FG000|Overall Study|Other|13|||
146212943|NCT01494922|527293000|FG000|Overall Study|Adverse Event|1|||
146212944|NCT04377308|527293001|FG000|Overall Study|Withdrawal by Subject|0|||
146212945|NCT04377308|527293002|FG001|Overall Study|Withdrawal by Subject|1|||
146212946|NCT02759016|527293003|FG000|Overall Study|Not treated with BI 836826|1|||
146212947|NCT02759016|527293004|FG001|Overall Study|Not treated with BI 836826|0|||
146212948|NCT02759016|527293003|FG000|Overall Study|Progressive disease|1|||
146212949|NCT02759016|527293004|FG001|Overall Study|Progressive disease|0|||
146212950|NCT02759016|527293003|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
146212951|NCT02759016|527293004|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
146212952|NCT02759016|527293003|FG000|Overall Study|Other not defined above|2|||
146212953|NCT02759016|527293004|FG001|Overall Study|Other not defined above|1|||
146286818|NCT02483585|527564308|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
146286819|NCT02483585|527564309|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
146212954|NCT03988842|527293005|FG000|Overall Study|Death|1|||
146212955|NCT02891915|527293006|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
146212956|NCT02891915|527293007|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
146212957|NCT02891915|527293006|FG000|Overall Study|Withdrawal by Subject|3|||
146212958|NCT02891915|527293007|FG001|Overall Study|Withdrawal by Subject|3|||
146286820|NCT02483585|527564308|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
146212959|NCT02891915|527293006|FG000|Overall Study|Became Ineligible After Enrollment|2|||
146212960|NCT02891915|527293007|FG001|Overall Study|Became Ineligible After Enrollment|1|||
146286821|NCT02483585|527564309|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
146212961|NCT02891915|527293006|FG000|Overall Study|Lost to Follow-up|1|||
146212962|NCT02891915|527293007|FG001|Overall Study|Lost to Follow-up|4|||
146212963|NCT02891915|527293006|FG000|Overall Study|Physician Decision|1|||
146212964|NCT02891915|527293007|FG001|Overall Study|Physician Decision|0|||
146212965|NCT00709098|527293011|FG000|Double-blind Period|Withdrawal of consent|3|||
146212966|NCT00709098|527293012|FG001|Double-blind Period|Withdrawal of consent|3|||
146212967|NCT00709098|527293013|FG002|Double-blind Period|Withdrawal of consent|0|||
146212968|NCT00709098|527293011|FG000|Double-blind Period|Administrative reason|1|||
146212969|NCT00709098|527293012|FG001|Double-blind Period|Administrative reason|3|||
146212970|NCT00709098|527293013|FG002|Double-blind Period|Administrative reason|0|||
146212971|NCT00709098|527293011|FG000|Double-blind Period|Death|1|||
146212972|NCT00709098|527293012|FG001|Double-blind Period|Death|1|||
146212973|NCT00709098|527293013|FG002|Double-blind Period|Death|0|||
146212974|NCT00709098|527293011|FG000|Double-blind Period|Lost to Follow-up|1|||
146212975|NCT00709098|527293012|FG001|Double-blind Period|Lost to Follow-up|1|||
146212976|NCT00709098|527293013|FG002|Double-blind Period|Lost to Follow-up|0|||
146212977|NCT00709098|527293011|FG000|Open-label Period|Withdrawal of consent|0|||
146212978|NCT00709098|527293012|FG001|Open-label Period|Withdrawal of consent|0|||
146212979|NCT00709098|527293013|FG002|Open-label Period|Withdrawal of consent|7|||
146212980|NCT00709098|527293011|FG000|Open-label Period|Administrative reason|0|||
146212981|NCT00709098|527293012|FG001|Open-label Period|Administrative reason|0|||
146212982|NCT00709098|527293013|FG002|Open-label Period|Administrative reason|5|||
146212983|NCT00709098|527293011|FG000|Open-label Period|Death|0|||
146212984|NCT00709098|527293012|FG001|Open-label Period|Death|0|||
146212985|NCT00709098|527293013|FG002|Open-label Period|Death|1|||
146212986|NCT00709098|527293011|FG000|Open-label Period|Lost to Follow-up|0|||
146212987|NCT00709098|527293012|FG001|Open-label Period|Lost to Follow-up|0|||
146212988|NCT00709098|527293013|FG002|Open-label Period|Lost to Follow-up|1|||
146212989|NCT01303445|527293016|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
146212990|NCT01303445|527293017|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
146212991|NCT01303445|527293016|FG000|Second Intervention (7 Days)|Adverse Event|0|||
146212992|NCT01303445|527293017|FG001|Second Intervention (7 Days)|Adverse Event|2|||
146212993|NCT01303445|527293016|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
146212994|NCT01303445|527293017|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
146212995|NCT01303445|527293016|FG000|Washout (14 Days)|Protocol Violation|1|||
146212996|NCT01303445|527293017|FG001|Washout (14 Days)|Protocol Violation|0|||
146212997|NCT01303445|527293016|FG000|Washout (14 Days)|Lost to Follow-up|0|||
146212998|NCT01303445|527293017|FG001|Washout (14 Days)|Lost to Follow-up|2|||
146212999|NCT01303445|527293016|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
146213000|NCT01303445|527293017|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
146213001|NCT01303445|527293016|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
146213002|NCT01303445|527293017|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
146213003|NCT03690206|527293018|FG000|Overall Study|Withdrawal by Subject|2|||
146213004|NCT03690206|527293019|FG001|Overall Study|Withdrawal by Subject|0|||
146213005|NCT03690206|527293020|FG002|Overall Study|Withdrawal by Subject|0|||
146213006|NCT03690206|527293018|FG000|Overall Study|ICF withdrawal|2|||
146213007|NCT03690206|527293019|FG001|Overall Study|ICF withdrawal|0|||
146286822|NCT02483585|527564308|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
146213008|NCT03690206|527293020|FG002|Overall Study|ICF withdrawal|0|||
146213009|NCT03978637|527293023|FG000|Overall Study|Death|0|||
146213010|NCT03978637|527293024|FG001|Overall Study|Death|2|||
146213011|NCT03978637|527293025|FG002|Overall Study|Death|2|||
146213012|NCT03978637|527293026|FG003|Overall Study|Death|0|||
146213013|NCT03978637|527293023|FG000|Overall Study|Withdrawal by Subject|0|||
146213014|NCT03978637|527293024|FG001|Overall Study|Withdrawal by Subject|0|||
146213015|NCT03978637|527293025|FG002|Overall Study|Withdrawal by Subject|1|||
146213016|NCT03978637|527293026|FG003|Overall Study|Withdrawal by Subject|0|||
146213017|NCT03978637|527293023|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
146213018|NCT03978637|527293024|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
146213019|NCT03978637|527293025|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
146213020|NCT03978637|527293026|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
146213021|NCT04924062|527294382|FG000|Overall Study|Death|49|||
146213022|NCT04924062|527294383|FG001|Overall Study|Death|63|||
146213023|NCT04924062|527294382|FG000|Overall Study|Participant On-going|26|||
146213024|NCT04924062|527294383|FG001|Overall Study|Participant On-going|20|||
146213025|NCT03899961|527294384|FG000|Overall Study|-delivery prior to|2|||
146213026|NCT03899961|527294385|FG001|Overall Study|-delivery prior to|7|||
146213027|NCT03899961|527294384|FG000|Overall Study|req general anesth|1|||
146213028|NCT03899961|527294385|FG001|Overall Study|req general anesth|2|||
146213029|NCT03899961|527294384|FG000|Overall Study|capacity|5|||
146213030|NCT03899961|527294385|FG001|Overall Study|capacity|6|||
146213031|NCT03899961|527294384|FG000|Overall Study|Withdrawal by Subject|1|||
146213032|NCT03899961|527294385|FG001|Overall Study|Withdrawal by Subject|1|||
146213033|NCT04059354|527294392|FG000|Overall Study|COVID-19 pandemic|3|||
146213034|NCT02396199|527294394|FG000|Overall Study|Lost to Follow-up|1|||
146083925|NCT00534313|526826611|FG003|Long-term Period|Poor compliance/noncompliance|0|||
146083926|NCT00534313|526826608|FG000|Long-term Period|Administrative reason by sponsor|17|||
146213035|NCT02396199|527294394|FG000|Overall Study|Death|4|||
146213036|NCT04093362|527294395|FG000|Overall Study|Study Termination|1|||
146213037|NCT04093362|527294396|FG001|Overall Study|Study Termination|1|||
146213038|NCT04093362|527294395|FG000|Overall Study|Withdrawal of Consent|1|||
146213039|NCT04093362|527294396|FG001|Overall Study|Withdrawal of Consent|0|||
146213040|NCT04093362|527294395|FG000|Overall Study|Death|1|||
146213041|NCT04093362|527294396|FG001|Overall Study|Death|3|||
146213042|NCT04093362|527294395|FG000|Overall Study|Reason not Specified|1|||
146213043|NCT04093362|527294396|FG001|Overall Study|Reason not Specified|2|||
146213044|NCT01938547|527294397|FG000|Overall Study|Physician Decision|1|||
146213045|NCT04823611|527294400|FG000|Overall Study|Adverse Event|2|||
146213046|NCT04823611|527294401|FG001|Overall Study|Adverse Event|0|||
146213047|NCT04823611|527294402|FG002|Overall Study|Adverse Event|1|||
146213048|NCT04823611|527294403|FG003|Overall Study|Adverse Event|0|||
146213049|NCT04823611|527294404|FG004|Overall Study|Adverse Event|0|||
146213050|NCT04823611|527294405|FG005|Overall Study|Adverse Event|0|||
146213051|NCT04823611|527294406|FG006|Overall Study|Adverse Event|0|||
146213052|NCT03739996|527294412|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
146213053|NCT03739996|527294412|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
146213054|NCT03739996|527294412|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
145957713|NCT00377637|526358146|FG002|Maintenance Phase|Lost to Follow-up|3|||
145957714|NCT00377637|526358147|FG003|Maintenance Phase|Lost to Follow-up|1|||
145957715|NCT00377637|526358144|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145957716|NCT00377637|526358145|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145957717|NCT00377637|526358146|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145957718|NCT00377637|526358147|FG003|Maintenance Phase|Withdrawal by Subject|3|||
145957719|NCT00377637|526358144|FG000|Maintenance Phase|Sponsor decision|0|||
145957720|NCT00377637|526358145|FG001|Maintenance Phase|Sponsor decision|0|||
145957721|NCT00377637|526358146|FG002|Maintenance Phase|Sponsor decision|2|||
145957722|NCT00377637|526358147|FG003|Maintenance Phase|Sponsor decision|3|||
145957723|NCT00377637|526358144|FG000|Maintenance Phase|Non-compliance|0|||
145957724|NCT00377637|526358145|FG001|Maintenance Phase|Non-compliance|0|||
145957725|NCT00377637|526358146|FG002|Maintenance Phase|Non-compliance|1|||
145957726|NCT00377637|526358147|FG003|Maintenance Phase|Non-compliance|1|||
145957727|NCT00377637|526358144|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
146213055|NCT03739996|527294412|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
145957728|NCT00377637|526358145|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
145957729|NCT00377637|526358146|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
146213056|NCT03739996|527294412|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
145957730|NCT00377637|526358147|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
145957731|NCT00377637|526358144|FG000|Maintenance Phase|Death|0|||
146213057|NCT03739996|527294412|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
145957732|NCT00377637|526358145|FG001|Maintenance Phase|Death|0|||
146213058|NCT03739996|527294412|FG000|Step 3 (SOC ART)|Death|1|||
146213059|NCT03739996|527294412|FG000|Step 3 (SOC ART)|Participant moved|1|||
146213060|NCT04716634|527294413|FG000|Overall Study|Death|24|||
146213061|NCT04716634|527294414|FG001|Overall Study|Death|24|||
146213062|NCT04716634|527294415|FG002|Overall Study|Death|8|||
146213063|NCT04716634|527294413|FG000|Overall Study|Closed by Sponsor|4|||
146213064|NCT04716634|527294414|FG001|Overall Study|Closed by Sponsor|4|||
146213065|NCT04716634|527294415|FG002|Overall Study|Closed by Sponsor|5|||
146213066|NCT04716634|527294413|FG000|Overall Study|Lost to Follow-up|1|||
146213067|NCT04716634|527294414|FG001|Overall Study|Lost to Follow-up|0|||
146213068|NCT04716634|527294415|FG002|Overall Study|Lost to Follow-up|1|||
146213069|NCT04716634|527294413|FG000|Overall Study|Withdrawal by Subject|0|||
146213070|NCT04716634|527294414|FG001|Overall Study|Withdrawal by Subject|0|||
146213071|NCT04716634|527294415|FG002|Overall Study|Withdrawal by Subject|1|||
146213072|NCT01673984|527294419|FG000|Overall Study|Adverse Event|1|||
146213073|NCT01673984|527294420|FG001|Overall Study|Adverse Event|0|||
146213074|NCT01673984|527294419|FG000|Overall Study|Study termination|9|||
146213075|NCT01673984|527294420|FG001|Overall Study|Study termination|6|||
146213076|NCT00150813|527294423|FG000|Overall Study|Adverse Event|1|||
146213077|NCT00150813|527294423|FG000|Overall Study|Lack of Efficacy|1|||
146213078|NCT00150813|527294423|FG000|Overall Study|Lost to Follow-up|5|||
146213079|NCT00150813|527294423|FG000|Overall Study|Withdrawal by Subject|5|||
146213080|NCT00150813|527294423|FG000|Overall Study|Remission|3|||
146213081|NCT00150813|527294423|FG000|Overall Study|Planned pregancy|1|||
146213082|NCT00150813|527294423|FG000|Overall Study|Switch to commercially available LEV|2|||
146213083|NCT01820260|527294425|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213084|NCT01820260|527294426|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213085|NCT01820260|527294427|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213086|NCT01820260|527294428|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213087|NCT01820260|527294429|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213088|NCT01820260|527294430|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213089|NCT01820260|527294431|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
146213090|NCT01820260|527294432|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213091|NCT01820260|527294433|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213092|NCT01820260|527294434|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213093|NCT01820260|527294435|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213094|NCT01820260|527294436|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213095|NCT01820260|527294437|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213096|NCT01820260|527294438|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
146213097|NCT01820260|527294425|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213098|NCT01820260|527294426|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213099|NCT01820260|527294427|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213100|NCT01820260|527294428|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145957733|NCT00377637|526358146|FG002|Maintenance Phase|Death|0|||
146213101|NCT01820260|527294429|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213102|NCT01820260|527294430|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213103|NCT01820260|527294431|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213104|NCT01820260|527294432|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213105|NCT01820260|527294433|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213106|NCT01820260|527294434|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
146213107|NCT01820260|527294435|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213108|NCT01820260|527294436|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213109|NCT01820260|527294437|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146213110|NCT01820260|527294438|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
146083927|NCT00534313|526826609|FG001|Long-term Period|Administrative reason by sponsor|15|||
146213111|NCT05415410|527294439|FG000|Overall Study|Death|3|||
146213112|NCT05415410|527294440|FG001|Overall Study|Death|6|||
146213113|NCT05415410|527294441|FG002|Overall Study|Death|1|||
146213114|NCT05415410|527294439|FG000|Overall Study|Trial Terminated by Sponsor|1|||
146213115|NCT05415410|527294440|FG001|Overall Study|Trial Terminated by Sponsor|5|||
146213116|NCT05415410|527294441|FG002|Overall Study|Trial Terminated by Sponsor|0|||
146213117|NCT05415410|527294439|FG000|Overall Study|Adverse Event|2|||
146213118|NCT05415410|527294440|FG001|Overall Study|Adverse Event|1|||
146213119|NCT05415410|527294441|FG002|Overall Study|Adverse Event|0|||
146213120|NCT05415410|527294439|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
146213121|NCT05415410|527294440|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
146213122|NCT05415410|527294441|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
146213123|NCT05415410|527294439|FG000|Overall Study|Withdrawal by Subject|1|||
146213124|NCT05415410|527294440|FG001|Overall Study|Withdrawal by Subject|0|||
146213125|NCT05415410|527294441|FG002|Overall Study|Withdrawal by Subject|0|||
146213126|NCT05415410|527294439|FG000|Overall Study|Pregnancy|5|||
146213127|NCT05415410|527294440|FG001|Overall Study|Pregnancy|2|||
146213128|NCT05415410|527294441|FG002|Overall Study|Pregnancy|0|||
146213129|NCT02365766|527294445|FG000|Overall Study|Withdrawal by Subject|0|||
146213130|NCT02365766|527294446|FG001|Overall Study|Withdrawal by Subject|0|||
146213131|NCT02365766|527294447|FG002|Overall Study|Withdrawal by Subject|1|||
146213132|NCT02365766|527294445|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146213133|NCT02365766|527294446|FG001|Overall Study|Eligibility Criteria Not Met|0|||
146213134|NCT02365766|527294447|FG002|Overall Study|Eligibility Criteria Not Met|1|||
146213135|NCT00650104|527294454|FG000|Overall Study|Adverse Event|17|||
146213136|NCT00650104|527294454|FG000|Overall Study|Death|2|||
146213137|NCT00650104|527294454|FG000|Overall Study|Withdrawal by Subject|11|||
146213138|NCT00650104|527294454|FG000|Overall Study|Physician Decision|7|||
146213139|NCT00650104|527294454|FG000|Overall Study|Lost to Follow-up|1|||
146213140|NCT00650104|527294454|FG000|Overall Study|Non-compliance|2|||
146213141|NCT00650104|527294454|FG000|Overall Study|Sponsor Terminated Dosing|1|||
146213142|NCT00894543|527294455|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
146213143|NCT00894543|527294456|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
146213144|NCT00894543|527294455|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
146213145|NCT00894543|527294456|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
146213146|NCT04048681|527294457|FG000|Overall Study|family emergency|0|||
146213147|NCT04048681|527294458|FG001|Overall Study|family emergency|0|||
146213148|NCT04048681|527294459|FG002|Overall Study|family emergency|0|||
146213149|NCT04048681|527294460|FG003|Overall Study|family emergency|1|||
146213150|NCT04048681|527294461|FG004|Overall Study|family emergency|0|||
146213151|NCT03385629|527294467|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
146213152|NCT03385629|527294468|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
146213153|NCT03385629|527294467|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
146213154|NCT03385629|527294468|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
146213155|NCT03385629|527294467|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
146213156|NCT03385629|527294468|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
146213157|NCT02919449|527294469|FG000|Overall Study|Withdrawal by Subject|1|||
146213158|NCT02919449|527294469|FG000|Overall Study|Investigator decision|1|||
146213159|NCT04711135|527294470|FG000|Overall Study|Physician Decision|0|||
146213160|NCT04711135|527294471|FG001|Overall Study|Physician Decision|1|||
145957734|NCT00377637|526358147|FG003|Maintenance Phase|Death|1|||
145957735|NCT00493012|526358148|FG000|Overall Study|Lost to Follow-up|18|||
145957736|NCT00493012|526358149|FG001|Overall Study|Lost to Follow-up|17|||
145957737|NCT04147247|526358150|FG000|Overall Study|Progressive disease|3|||
145957738|NCT04147247|526358151|FG001|Overall Study|Progressive disease|3|||
145957739|NCT04147247|526358152|FG002|Overall Study|Progressive disease|4|||
145957740|NCT04147247|526358153|FG003|Overall Study|Progressive disease|4|||
145957741|NCT04147247|526358154|FG004|Overall Study|Progressive disease|3|||
145957742|NCT04147247|526358150|FG000|Overall Study|Physician Decision|0|||
145957743|NCT04147247|526358151|FG001|Overall Study|Physician Decision|1|||
145957744|NCT04147247|526358152|FG002|Overall Study|Physician Decision|0|||
146286823|NCT02483585|527564309|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
145957745|NCT04147247|526358153|FG003|Overall Study|Physician Decision|0|||
145957746|NCT04147247|526358154|FG004|Overall Study|Physician Decision|0|||
146213161|NCT04711135|527294470|FG000|Overall Study|Ongoing treatment|0|||
146213162|NCT04711135|527294471|FG001|Overall Study|Ongoing treatment|1|||
146213163|NCT03578536|527294475|FG000|Overall Study|Lost to Follow-up|1|||
146213164|NCT02874534|527294477|FG000|Overall Study|Withdrawal by Subject|5|||
146213165|NCT02874534|527294478|FG001|Overall Study|Withdrawal by Subject|8|||
146213166|NCT02874534|527294477|FG000|Overall Study|Lost to Follow-up|2|||
146213167|NCT02874534|527294478|FG001|Overall Study|Lost to Follow-up|2|||
146213168|NCT02874534|527294477|FG000|Overall Study|Ongoing in study|1|||
146213169|NCT02874534|527294478|FG001|Overall Study|Ongoing in study|1|||
146213170|NCT04431726|527294479|FG000|Overall Study|Ongoing in the Study|55|||
146213171|NCT05198310|527294480|FG000|Overall Study|Lost to Follow-up|0|||
146213172|NCT05198310|527294481|FG001|Overall Study|Lost to Follow-up|1|||
146213173|NCT05198310|527294482|FG002|Overall Study|Lost to Follow-up|0|||
146213174|NCT05198310|527294483|FG003|Overall Study|Lost to Follow-up|0|||
146213175|NCT05198310|527294484|FG004|Overall Study|Lost to Follow-up|0|||
146213176|NCT05198310|527294485|FG005|Overall Study|Lost to Follow-up|0|||
146213177|NCT05198310|527294486|FG006|Overall Study|Lost to Follow-up|0|||
146213178|NCT05198310|527294487|FG007|Overall Study|Lost to Follow-up|0|||
146213179|NCT05198310|527294480|FG000|Overall Study|Withdrawal by Subject|0|||
146213180|NCT05198310|527294481|FG001|Overall Study|Withdrawal by Subject|0|||
146213181|NCT05198310|527294482|FG002|Overall Study|Withdrawal by Subject|0|||
146213182|NCT05198310|527294483|FG003|Overall Study|Withdrawal by Subject|2|||
146213183|NCT05198310|527294484|FG004|Overall Study|Withdrawal by Subject|0|||
146213184|NCT05198310|527294485|FG005|Overall Study|Withdrawal by Subject|2|||
146213185|NCT05198310|527294486|FG006|Overall Study|Withdrawal by Subject|1|||
146213186|NCT05198310|527294487|FG007|Overall Study|Withdrawal by Subject|3|||
146213187|NCT04281485|527294488|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
146213188|NCT04281485|527294489|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
146213189|NCT04281485|527294488|FG000|Overall Study|Ongoing (Safety data collection)|10|||
146213190|NCT04281485|527294489|FG001|Overall Study|Ongoing (Safety data collection)|5|||
146213191|NCT04436107|527294490|FG000|Overall Study|Sponsor Ended Study|2|||
146213192|NCT04436107|527294491|FG001|Overall Study|Sponsor Ended Study|4|||
146213193|NCT04436107|527294492|FG002|Overall Study|Sponsor Ended Study|8|||
146213194|NCT04436107|527294493|FG003|Overall Study|Sponsor Ended Study|20|||
146213195|NCT04436107|527294490|FG000|Overall Study|Death|3|||
146213196|NCT04436107|527294491|FG001|Overall Study|Death|5|||
146213197|NCT04436107|527294492|FG002|Overall Study|Death|3|||
146213198|NCT04436107|527294493|FG003|Overall Study|Death|18|||
146213199|NCT04436107|527294490|FG000|Overall Study|Withdrawal by Subject|1|||
146213200|NCT04436107|527294491|FG001|Overall Study|Withdrawal by Subject|1|||
146213201|NCT04436107|527294492|FG002|Overall Study|Withdrawal by Subject|0|||
146213202|NCT04436107|527294493|FG003|Overall Study|Withdrawal by Subject|1|||
146213203|NCT01095796|527294494|FG000|Overall Study|Randomized but Not Treated|5|||
146213204|NCT01095796|527294495|FG001|Overall Study|Randomized but Not Treated|2|||
146286824|NCT02483585|527564308|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
146286825|NCT02483585|527564309|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
146286826|NCT02483585|527564308|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
146286827|NCT02483585|527564309|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
146286828|NCT01236339|527564315|FG000|Overall Study|Termination of study by sponsor|11|||
145957747|NCT04147247|526358150|FG000|Overall Study|Clinical Disease Progression|0|||
146213205|NCT01095796|527294494|FG000|Overall Study|Adverse Event|9|||
146213206|NCT01095796|527294495|FG001|Overall Study|Adverse Event|19|||
146213207|NCT01095796|527294494|FG000|Overall Study|Death|3|||
146213208|NCT01095796|527294495|FG001|Overall Study|Death|2|||
146213209|NCT01095796|527294494|FG000|Overall Study|Pregnancy|2|||
146286829|NCT01236339|527564316|FG001|Overall Study|Termination of study by sponsor|13|||
146286830|NCT01098097|527564317|FG000|Overall Study|Adverse Event|17|||
146213210|NCT01095796|527294495|FG001|Overall Study|Pregnancy|0|||
146213211|NCT01095796|527294494|FG000|Overall Study|Lack of Efficacy|5|||
146213212|NCT01095796|527294495|FG001|Overall Study|Lack of Efficacy|3|||
146213213|NCT01095796|527294494|FG000|Overall Study|Investigator's Discretion|7|||
146213214|NCT01095796|527294495|FG001|Overall Study|Investigator's Discretion|2|||
146213215|NCT01095796|527294494|FG000|Overall Study|Withdrew Consent|16|||
146213216|NCT01095796|527294495|FG001|Overall Study|Withdrew Consent|22|||
146213217|NCT01095796|527294494|FG000|Overall Study|Lost to Follow-up|27|||
146213218|NCT01095796|527294495|FG001|Overall Study|Lost to Follow-up|29|||
146213219|NCT01095796|527294494|FG000|Overall Study|Participant Noncompliance|5|||
146213220|NCT01095796|527294495|FG001|Overall Study|Participant Noncompliance|10|||
146213221|NCT01095796|527294494|FG000|Overall Study|Protocol Violation|1|||
146213222|NCT01095796|527294495|FG001|Overall Study|Protocol Violation|0|||
146213223|NCT01095796|527294494|FG000|Overall Study|Participant Transferred to Another Study|215|||
146083928|NCT00534313|526826610|FG002|Long-term Period|Administrative reason by sponsor|26|||
146083929|NCT00534313|526826611|FG003|Long-term Period|Administrative reason by sponsor|18|||
146213224|NCT01095796|527294495|FG001|Overall Study|Participant Transferred to Another Study|200|||
146213225|NCT04116736|527294500|FG000|Overall Study|Withdrew consent during study|3|||
146213226|NCT04116736|527294501|FG001|Overall Study|Withdrew consent during study|1|||
146213227|NCT04116736|527294500|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
146213228|NCT04116736|527294501|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
146213229|NCT04116736|527294500|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
146213230|NCT04116736|527294501|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
146213231|NCT04116736|527294500|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
146213232|NCT04116736|527294501|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
146213233|NCT04116736|527294500|FG000|Overall Study|Subject was enrolled in error|2|||
146213234|NCT04116736|527294501|FG001|Overall Study|Subject was enrolled in error|0|||
146213235|NCT04116736|527294500|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
146213236|NCT04116736|527294501|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
146213237|NCT04116736|527294500|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
146213238|NCT04116736|527294501|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
146213239|NCT04116736|527294500|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
146213240|NCT04116736|527294501|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
146213241|NCT03517969|527294502|FG000|Overall Study|Never started protocol treatment|3|||
146213242|NCT03517969|527294503|FG001|Overall Study|Never started protocol treatment|5|||
146213243|NCT03517969|527294502|FG000|Overall Study|Disease progression|11|||
146213244|NCT03517969|527294503|FG001|Overall Study|Disease progression|16|||
146213245|NCT03517969|527294502|FG000|Overall Study|PSA progression|8|||
146083930|NCT00534313|526826608|FG000|Long-term Period|Other|1|||
146213246|NCT03517969|527294503|FG001|Overall Study|PSA progression|1|||
145957748|NCT04147247|526358151|FG001|Overall Study|Clinical Disease Progression|0|||
146213247|NCT03517969|527294502|FG000|Overall Study|Clinical progression|4|||
146213248|NCT03517969|527294503|FG001|Overall Study|Clinical progression|2|||
146213249|NCT03517969|527294502|FG000|Overall Study|Adverse Event|5|||
146213250|NCT03517969|527294503|FG001|Overall Study|Adverse Event|4|||
146213251|NCT03517969|527294502|FG000|Overall Study|Intercurrent illness|1|||
146213252|NCT03517969|527294503|FG001|Overall Study|Intercurrent illness|2|||
146213253|NCT03517969|527294502|FG000|Overall Study|Death|1|||
146213254|NCT03517969|527294503|FG001|Overall Study|Death|1|||
146213255|NCT03517969|527294502|FG000|Overall Study|Withdrawal by Subject|1|||
146213256|NCT03517969|527294503|FG001|Overall Study|Withdrawal by Subject|2|||
146213257|NCT03517969|527294502|FG000|Overall Study|Physician Decision|1|||
146213258|NCT03517969|527294503|FG001|Overall Study|Physician Decision|1|||
146213259|NCT03517969|527294502|FG000|Overall Study|No clinical benefit|1|||
146213260|NCT03517969|527294503|FG001|Overall Study|No clinical benefit|0|||
146213261|NCT03517969|527294502|FG000|Overall Study|Delayed treatment for dental treatment|1|||
146213262|NCT03517969|527294503|FG001|Overall Study|Delayed treatment for dental treatment|0|||
146213263|NCT03517969|527294502|FG000|Overall Study|Difficult to maintain appointment|0|||
146213264|NCT03517969|527294503|FG001|Overall Study|Difficult to maintain appointment|1|||
146213265|NCT03517969|527294502|FG000|Overall Study|Protocol Violation|0|||
146213266|NCT03517969|527294503|FG001|Overall Study|Protocol Violation|1|||
146213267|NCT04854096|527294504|FG000|Overall Study|Adverse Event|1|||
146083931|NCT00534313|526826609|FG001|Long-term Period|Other|2|||
146083932|NCT00534313|526826610|FG002|Long-term Period|Other|2|||
146213268|NCT04854096|527294505|FG001|Overall Study|Adverse Event|0|||
146213269|NCT04854096|527294504|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
146213270|NCT04854096|527294505|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
146213271|NCT04854096|527294504|FG000|Overall Study|Withdrawal by Subject|1|||
146213272|NCT04854096|527294505|FG001|Overall Study|Withdrawal by Subject|0|||
146213273|NCT04854096|527294504|FG000|Overall Study|Other reasons|1|||
146213274|NCT04854096|527294505|FG001|Overall Study|Other reasons|0|||
146213275|NCT01721291|527294509|FG000|Overall Study|Withdrawal by Subject|1|||
146213276|NCT01721291|527294510|FG001|Overall Study|Withdrawal by Subject|0|||
146213277|NCT01721291|527294509|FG000|Overall Study|did not like the treatment|1|||
145957749|NCT04147247|526358152|FG002|Overall Study|Clinical Disease Progression|0|||
145957750|NCT04147247|526358153|FG003|Overall Study|Clinical Disease Progression|0|||
145957751|NCT04147247|526358154|FG004|Overall Study|Clinical Disease Progression|1|||
145957752|NCT04147247|526358150|FG000|Overall Study|Adverse Event|0|||
145957753|NCT04147247|526358151|FG001|Overall Study|Adverse Event|0|||
146213278|NCT01721291|527294510|FG001|Overall Study|did not like the treatment|0|||
145957754|NCT04147247|526358152|FG002|Overall Study|Adverse Event|1|||
146213279|NCT01091168|527294511|FG000|Overall Study|Progressive disease|250|||
146213280|NCT01091168|527294512|FG001|Overall Study|Progressive disease|234|||
146213281|NCT01091168|527294511|FG000|Overall Study|Adverse Event|21|||
146213282|NCT01091168|527294512|FG001|Overall Study|Adverse Event|24|||
146213283|NCT01091168|527294511|FG000|Overall Study|Lost to Follow-up|0|||
146213284|NCT01091168|527294512|FG001|Overall Study|Lost to Follow-up|1|||
146213285|NCT01091168|527294511|FG000|Overall Study|Physician, patient's decision, other|27|||
146213286|NCT01091168|527294512|FG001|Overall Study|Physician, patient's decision, other|37|||
146213287|NCT03767517|527294513|FG000|Overall Study|Lost to Follow-up|16|||
146213288|NCT03767517|527294514|FG001|Overall Study|Lost to Follow-up|10|||
146213289|NCT03767517|527294513|FG000|Overall Study|Death|2|||
146213290|NCT03767517|527294514|FG001|Overall Study|Death|3|||
146213291|NCT04533022|527295568|FG000|Overall Study|Withdrawal by Subject|15|||
145957755|NCT04147247|526358153|FG003|Overall Study|Adverse Event|0|||
146213292|NCT04533022|527295568|FG000|Overall Study|Adverse Event|6|||
146213293|NCT04533022|527295568|FG000|Overall Study|Death|1|||
146213294|NCT04533022|527295568|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
146213295|NCT04533022|527295568|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
146213296|NCT02163447|527295569|FG000|Overall Study|Withdrawal by Subject|2|||
146213297|NCT02163447|527295570|FG001|Overall Study|Withdrawal by Subject|0|||
146213298|NCT02163447|527295571|FG002|Overall Study|Withdrawal by Subject|1|||
146213299|NCT02163447|527295569|FG000|Overall Study|Lost to Follow-up|1|||
146213300|NCT02163447|527295570|FG001|Overall Study|Lost to Follow-up|3|||
146213301|NCT02163447|527295571|FG002|Overall Study|Lost to Follow-up|0|||
146213302|NCT02163447|527295569|FG000|Overall Study|Moved out of study area|2|||
146213303|NCT02163447|527295570|FG001|Overall Study|Moved out of study area|3|||
146213304|NCT02163447|527295571|FG002|Overall Study|Moved out of study area|2|||
146213305|NCT02163447|527295569|FG000|Overall Study|Became HIV infected at time of delivery|1|||
146083933|NCT00534313|526826611|FG003|Long-term Period|Other|2|||
146083934|NCT03007888|526826612|FG000|First Intervention (14 Days)|Adverse Event|1|||
146083935|NCT03007888|526826613|FG001|First Intervention (14 Days)|Adverse Event|0|||
145957756|NCT04147247|526358154|FG004|Overall Study|Adverse Event|1|||
145957757|NCT00327340|526358155|FG000|Overall Study|Withdrawal by Subject|1|||
145957758|NCT00327340|526358156|FG001|Overall Study|Withdrawal by Subject|5|||
146286831|NCT01098097|527564317|FG000|Overall Study|Lost to Follow-up|18|||
145957759|NCT00327340|526358155|FG000|Overall Study|Physician Decision|1|||
146286832|NCT01098097|527564317|FG000|Overall Study|Status unknown|16|||
146083936|NCT00927940|526826614|FG000|Overall Study|Death|1|||
146083937|NCT00827931|526826616|FG000|Overall Study|Death|3|||
146083938|NCT00827931|526826617|FG001|Overall Study|Death|5|||
146213306|NCT02163447|527295570|FG001|Overall Study|Became HIV infected at time of delivery|0|||
146213307|NCT02163447|527295571|FG002|Overall Study|Became HIV infected at time of delivery|0|||
146083939|NCT00827931|526826616|FG000|Overall Study|Adverse Event|1|||
146286833|NCT01098097|527564317|FG000|Overall Study|No reason reported|31|||
146286834|NCT00394082|527564318|FG000|Overall Study|Unacceptable toxicity|15|||
145957760|NCT00327340|526358156|FG001|Overall Study|Physician Decision|1|||
145957761|NCT00327340|526358155|FG000|Overall Study|Disease Progression|10|||
145957762|NCT00327340|526358156|FG001|Overall Study|Disease Progression|19|||
146286835|NCT00394082|527564318|FG000|Overall Study|Adverse Event|4|||
146286836|NCT00394082|527564318|FG000|Overall Study|Physician Decision|4|||
146286837|NCT00394082|527564318|FG000|Overall Study|Withdrawal by Subject|2|||
146286838|NCT00394082|527564318|FG000|Overall Study|Other|1|||
146286839|NCT01945060|527564319|FG000|Overall Study|Lost to follow up|1|||
146286840|NCT01945060|527564320|FG001|Overall Study|Lost to follow up|0|||
146286841|NCT01945060|527564319|FG000|Overall Study|Distress related to IV access|0|||
146286842|NCT01945060|527564320|FG001|Overall Study|Distress related to IV access|1|||
146286843|NCT00577577|527564328|FG000|Overall Study|Adverse Event|3|||
146286844|NCT00577577|527564329|FG001|Overall Study|Adverse Event|2|||
146286845|NCT00577577|527564328|FG000|Overall Study|Lost to Follow-up|1|||
146286846|NCT00577577|527564329|FG001|Overall Study|Lost to Follow-up|0|||
146286847|NCT00577577|527564328|FG000|Overall Study|Protocol Violation|0|||
146286848|NCT00577577|527564329|FG001|Overall Study|Protocol Violation|3|||
146286849|NCT00577577|527564328|FG000|Overall Study|Transportation|1|||
146286850|NCT00577577|527564329|FG001|Overall Study|Transportation|0|||
146286851|NCT00232544|527564330|FG000|Overall Study|Lost to Follow-up|20|||
146286852|NCT00232544|527564331|FG001|Overall Study|Lost to Follow-up|15|||
146286853|NCT00116753|527564332|FG000|Overall Study|Adverse Event|16|||
146286854|NCT00116753|527564333|FG001|Overall Study|Adverse Event|10|||
146286855|NCT00116753|527564334|FG002|Overall Study|Adverse Event|7|||
146286856|NCT00116753|527564332|FG000|Overall Study|Withdrawal by Subject|11|||
146286857|NCT00116753|527564333|FG001|Overall Study|Withdrawal by Subject|12|||
146286858|NCT00116753|527564334|FG002|Overall Study|Withdrawal by Subject|8|||
146286859|NCT00116753|527564332|FG000|Overall Study|Lost to Follow-up|0|||
146286860|NCT00116753|527564333|FG001|Overall Study|Lost to Follow-up|2|||
146286861|NCT00116753|527564334|FG002|Overall Study|Lost to Follow-up|1|||
146286862|NCT00116753|527564332|FG000|Overall Study|Protocol Violation|0|||
146286863|NCT00116753|527564333|FG001|Overall Study|Protocol Violation|0|||
146286864|NCT00116753|527564334|FG002|Overall Study|Protocol Violation|1|||
146286865|NCT00116753|527564332|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
146286866|NCT00116753|527564333|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
146286867|NCT00116753|527564334|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
146286868|NCT00116753|527564332|FG000|Overall Study|Disease Progression|3|||
146286869|NCT00116753|527564333|FG001|Overall Study|Disease Progression|4|||
146286870|NCT00116753|527564334|FG002|Overall Study|Disease Progression|3|||
146286871|NCT00116753|527564332|FG000|Overall Study|Abnormal Echocardiogram|0|||
146286872|NCT00116753|527564333|FG001|Overall Study|Abnormal Echocardiogram|0|||
146286873|NCT00116753|527564334|FG002|Overall Study|Abnormal Echocardiogram|1|||
146286874|NCT00116753|527564332|FG000|Overall Study|Progressive Parkinson's Disease|1|||
146286875|NCT00116753|527564333|FG001|Overall Study|Progressive Parkinson's Disease|0|||
146286876|NCT00116753|527564334|FG002|Overall Study|Progressive Parkinson's Disease|0|||
146286877|NCT00116753|527564332|FG000|Overall Study|Dosing Error|0|||
146286878|NCT00116753|527564333|FG001|Overall Study|Dosing Error|1|||
146286879|NCT00116753|527564334|FG002|Overall Study|Dosing Error|0|||
146286880|NCT01590082|527564335|FG000|Overall Study|Withdrawal by Subject|1|||
146286881|NCT01590082|527564336|FG001|Overall Study|Withdrawal by Subject|0|||
146286882|NCT01590082|527564335|FG000|Overall Study|Ineligible|1|||
146286883|NCT01590082|527564336|FG001|Overall Study|Ineligible|0|||
146286884|NCT01210664|527564337|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146286885|NCT01210664|527564338|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146286886|NCT01210664|527564339|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
146286887|NCT01210664|527564340|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
146286888|NCT01210664|527564337|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
146286889|NCT01210664|527564338|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
145957763|NCT00327340|526358155|FG000|Overall Study|Symptomatic Disease|0|||
145957764|NCT00327340|526358156|FG001|Overall Study|Symptomatic Disease|2|||
145957765|NCT00327340|526358155|FG000|Overall Study|Adverse Event|3|||
145957766|NCT00327340|526358156|FG001|Overall Study|Adverse Event|3|||
145957767|NCT00522548|526358157|FG000|Overall Study|Adverse Event|2|||
145957768|NCT00522548|526358158|FG001|Overall Study|Adverse Event|2|||
145957769|NCT00522548|526358157|FG000|Overall Study|Withdrawal by Subject|0|||
145957770|NCT00522548|526358158|FG001|Overall Study|Withdrawal by Subject|2|||
145957771|NCT04155463|526358159|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
145957772|NCT04155463|526358160|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
145957773|NCT00113295|526358161|FG000|Overall Study|Adverse Event|4|||
145957774|NCT00113295|526358162|FG001|Overall Study|Adverse Event|1|||
146213308|NCT05415436|527295572|FG000|Overall Study|Surgeon cancelled procedure|1|||
146213309|NCT05415436|527295573|FG001|Overall Study|Surgeon cancelled procedure|0|||
146286890|NCT01210664|527564339|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
146286891|NCT01210664|527564340|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
146286892|NCT01210664|527564337|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146286893|NCT01210664|527564338|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146286894|NCT01210664|527564339|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
146286895|NCT01210664|527564340|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
146286896|NCT01853644|527564341|FG000|Registration and Treatment Start|Did not start treatment|1|||
146286897|NCT01853644|527564341|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
146286898|NCT01853644|527564341|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
146286899|NCT01853644|527564341|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
146286900|NCT01853644|527564341|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
146286901|NCT01853644|527564341|FG000|Continued Treatment After First Response|Adverse Event|2|||
146286902|NCT01853644|527564341|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
146286903|NCT02891408|527564342|FG000|Overall Study|Lost to Follow-up|0|||
146286904|NCT02891408|527564343|FG001|Overall Study|Lost to Follow-up|0|||
146286905|NCT02891408|527564344|FG002|Overall Study|Lost to Follow-up|1|||
146083940|NCT00827931|526826617|FG001|Overall Study|Adverse Event|0|||
146083941|NCT00827931|526826616|FG000|Overall Study|Lost to Follow-up|1|||
146083942|NCT00827931|526826617|FG001|Overall Study|Lost to Follow-up|0|||
146083943|NCT00827931|526826616|FG000|Overall Study|Withdrawal by Subject|0|||
146286906|NCT02891408|527564345|FG003|Overall Study|Lost to Follow-up|0|||
146286907|NCT02891408|527564346|FG004|Overall Study|Lost to Follow-up|0|||
146286908|NCT02891408|527564347|FG005|Overall Study|Lost to Follow-up|0|||
146286909|NCT02891408|527564348|FG006|Overall Study|Lost to Follow-up|0|||
146286910|NCT01054170|527564349|FG000|Overall Study|Protocol Violation|1|||
146083944|NCT00827931|526826617|FG001|Overall Study|Withdrawal by Subject|1|||
146083945|NCT00827931|526826616|FG000|Overall Study|Other|1|||
146083946|NCT00827931|526826617|FG001|Overall Study|Other|0|||
146286911|NCT01054170|527564350|FG001|Overall Study|Protocol Violation|0|||
146083947|NCT01870076|526826618|FG000|Overall Study|Withdrawal by Subject|1|||
146083948|NCT01870076|526826619|FG001|Overall Study|Withdrawal by Subject|0|||
146083949|NCT01870076|526826620|FG002|Overall Study|Withdrawal by Subject|1|||
146213310|NCT05415436|527295572|FG000|Overall Study|Death|1|||
146213311|NCT05415436|527295573|FG001|Overall Study|Death|0|||
146213312|NCT03819686|527295575|FG000|Overall Study|Lost to Follow-up|2|||
146213313|NCT03819686|527295576|FG001|Overall Study|Lost to Follow-up|3|||
146213314|NCT03157167|527295579|FG000|Overall Study|Withdrawal by Subject|1|||
146213315|NCT03157167|527295580|FG001|Overall Study|Withdrawal by Subject|0|||
146213316|NCT03157167|527295581|FG002|Overall Study|Withdrawal by Subject|0|||
146213317|NCT02597946|527295582|FG000|Overall Study|Withdrawal by Subject|1|||
146213318|NCT02597946|527295582|FG000|Overall Study|Progressive disease|16|||
146213319|NCT02597946|527295582|FG000|Overall Study|Other than above|1|||
146213320|NCT04868110|527295591|FG000|Overall Study|Withdrawal by Subject|3|||
146213321|NCT04868110|527295592|FG001|Overall Study|Withdrawal by Subject|4|||
146213322|NCT03263026|527295593|FG000|Overall Study|Withdrawal by Subject|1|||
146213323|NCT03263026|527295594|FG001|Overall Study|Withdrawal by Subject|0|||
146213324|NCT03263026|527295593|FG000|Overall Study|Death|1|||
146213325|NCT03263026|527295594|FG001|Overall Study|Death|0|||
146213326|NCT03263026|527295593|FG000|Overall Study|Other/ Various|41|||
146213327|NCT03263026|527295594|FG001|Overall Study|Other/ Various|29|||
146213328|NCT05320432|527295602|FG000|Overall Study|Withdrawal by Subject|0|||
146213329|NCT05320432|527295603|FG001|Overall Study|Withdrawal by Subject|2|||
146213330|NCT05038566|527295604|FG000|Overall Study|Technical Difficulties with the Device|0|||
146213331|NCT05038566|527295605|FG001|Overall Study|Technical Difficulties with the Device|1|||
146213338|NCT00601900|527295614|FG000|Overall Study|Withdrawal by Subject|0|||
146213339|NCT00601900|527295615|FG001|Overall Study|Withdrawal by Subject|3|||
146213340|NCT02697136|527295617|FG000|Overall Study|Adverse Event|3|||
146213341|NCT02697136|527295618|FG001|Overall Study|Adverse Event|0|||
146213342|NCT02500758|527295622|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
146213343|NCT02500758|527295623|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
146286912|NCT01054170|527564349|FG000|Overall Study|Withdrawal by Subject|3|||
146286913|NCT01054170|527564350|FG001|Overall Study|Withdrawal by Subject|2|||
146083950|NCT01870076|526826621|FG003|Overall Study|Withdrawal by Subject|0|||
146286914|NCT01054170|527564349|FG000|Overall Study|Adverse Event|0|||
146286915|NCT01054170|527564350|FG001|Overall Study|Adverse Event|4|||
146286916|NCT02951767|527564351|FG000|Overall Study|Study Terminated By Sponsor|9|||
146286917|NCT02951767|527564351|FG000|Overall Study|Withdrawal by Subject|11|||
146286918|NCT02951767|527564351|FG000|Overall Study|Death|96|||
146286919|NCT02951767|527564351|FG000|Overall Study|Lost to Follow-up|2|||
146286920|NCT02951767|527564351|FG000|Overall Study|Physician Decision|1|||
146286921|NCT02549196|527564352|FG000|Overall Study|Protocol Violation|0|||
146286922|NCT02549196|527564353|FG001|Overall Study|Protocol Violation|0|||
146286923|NCT02549196|527564354|FG002|Overall Study|Protocol Violation|0|||
146286924|NCT02549196|527564355|FG003|Overall Study|Protocol Violation|1|||
146286925|NCT02549196|527564352|FG000|Overall Study|Withdrawal by Subject|1|||
146286926|NCT02549196|527564353|FG001|Overall Study|Withdrawal by Subject|0|||
146286927|NCT02549196|527564354|FG002|Overall Study|Withdrawal by Subject|1|||
146286928|NCT02549196|527564355|FG003|Overall Study|Withdrawal by Subject|0|||
146286929|NCT01442779|527564356|FG000|Overall Study|Withdrawal by Subject|3|||
146286930|NCT01442779|527564356|FG000|Overall Study|Death|3|||
146286931|NCT01442779|527564356|FG000|Overall Study|Non-compliance|1|||
146286932|NCT00609765|527564359|FG000|Overall Study|Study ended prior to 12 months|1|||
146286933|NCT00950950|527564360|FG000|Overall Study|Adverse Event|1|||
146286934|NCT00950950|527564361|FG001|Overall Study|Adverse Event|0|||
146083951|NCT00492063|526826622|FG000|Overall Study|Death|0|||
146286935|NCT00950950|527564360|FG000|Overall Study|Withdrawal by Subject|0|||
146286936|NCT00950950|527564361|FG001|Overall Study|Withdrawal by Subject|1|||
146286937|NCT01920854|527564364|FG000|Overall Study|Withdrawal by Subject|1|||
146286938|NCT01920854|527564365|FG001|Overall Study|Withdrawal by Subject|0|||
146213344|NCT02500758|527295622|FG000|Washout (1 Week)|Lost to Follow-up|2|||
146213345|NCT02500758|527295623|FG001|Washout (1 Week)|Lost to Follow-up|2|||
146213346|NCT02500758|527295622|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
146213347|NCT02500758|527295623|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
146213348|NCT02500758|527295622|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
146213349|NCT02500758|527295623|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
146213350|NCT02500758|527295622|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
146213351|NCT02500758|527295623|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
146213352|NCT02538900|527295624|FG000|Overall Study|Death|2|||
146213353|NCT02538900|527295625|FG001|Overall Study|Death|2|||
146213354|NCT02538900|527295626|FG002|Overall Study|Death|2|||
146213355|NCT02538900|527295624|FG000|Overall Study|Withdrawal by Subject|18|||
146213356|NCT02538900|527295625|FG001|Overall Study|Withdrawal by Subject|16|||
146213357|NCT02538900|527295626|FG002|Overall Study|Withdrawal by Subject|15|||
146213358|NCT02923180|527295627|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
146213359|NCT02923180|527295627|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
146213360|NCT02140645|527295631|FG000|Overall Study|Not linked|5489|||
146213361|NCT02140645|527295632|FG001|Overall Study|Not linked|61654|||
146213362|NCT02140645|527295633|FG002|Overall Study|Not linked|4236|||
146213363|NCT02140645|527295634|FG003|Overall Study|Not linked|13833|||
146213364|NCT02140645|527295635|FG004|Overall Study|Not linked|3286|||
146213365|NCT02140645|527295636|FG005|Overall Study|Not linked|70896|||
146213366|NCT01101451|527295637|FG000|Overall Study|Eligible and never treated|0|||
146213367|NCT01101451|527295638|FG001|Overall Study|Eligible and never treated|5|||
146213368|NCT01101451|527295637|FG000|Overall Study|Ineligible and treated|12|||
146213369|NCT01101451|527295638|FG001|Overall Study|Ineligible and treated|8|||
146213370|NCT01101451|527295637|FG000|Overall Study|Ineligible and never treated|2|||
146213371|NCT01101451|527295638|FG001|Overall Study|Ineligible and never treated|2|||
146213372|NCT02965846|527295643|FG000|Overall Study|Lost to Follow-up|1|||
146213373|NCT02965846|527295644|FG001|Overall Study|Lost to Follow-up|0|||
146213374|NCT02965846|527295645|FG002|Overall Study|Lost to Follow-up|0|||
146213375|NCT02965846|527295643|FG000|Overall Study|Withdrawal by Subject|0|||
146213376|NCT02965846|527295644|FG001|Overall Study|Withdrawal by Subject|1|||
146213377|NCT02965846|527295645|FG002|Overall Study|Withdrawal by Subject|0|||
146213378|NCT02965846|527295643|FG000|Overall Study|Study Terminated By Sponsor|4|||
146213379|NCT02965846|527295644|FG001|Overall Study|Study Terminated By Sponsor|4|||
146213380|NCT02965846|527295645|FG002|Overall Study|Study Terminated By Sponsor|0|||
146213381|NCT02965846|527295643|FG000|Overall Study|Participants not randomized|0|||
146213382|NCT02965846|527295644|FG001|Overall Study|Participants not randomized|0|||
146213383|NCT02965846|527295645|FG002|Overall Study|Participants not randomized|33|||
146213384|NCT02814838|527295646|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
146213385|NCT02814838|527295647|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
146213386|NCT02814838|527295646|FG000|Overall Study|Consent withdrawal|1|||
146213387|NCT02814838|527295647|FG001|Overall Study|Consent withdrawal|1|||
146213388|NCT00593489|527295648|FG000|Allocation|did not attend workshop; allocation not|2|||
146213389|NCT00593489|527295649|FG001|Allocation|did not attend workshop; allocation not|1|||
146213390|NCT00073749|527295650|FG000|Overall Study|Disease Progression|2|||
146213391|NCT00073749|527295651|FG001|Overall Study|Disease Progression|0|||
146213392|NCT00073749|527295652|FG002|Overall Study|Disease Progression|3|||
146213393|NCT00073749|527295653|FG003|Overall Study|Disease Progression|2|||
146213394|NCT00073749|527295654|FG004|Overall Study|Disease Progression|3|||
146213395|NCT00073749|527295655|FG005|Overall Study|Disease Progression|1|||
146213396|NCT00073749|527295656|FG006|Overall Study|Disease Progression|3|||
146213397|NCT00073749|527295650|FG000|Overall Study|Death|0|||
146213398|NCT00073749|527295651|FG001|Overall Study|Death|1|||
146213399|NCT00073749|527295652|FG002|Overall Study|Death|1|||
146213400|NCT00073749|527295653|FG003|Overall Study|Death|0|||
146213401|NCT00073749|527295654|FG004|Overall Study|Death|0|||
146213402|NCT00073749|527295655|FG005|Overall Study|Death|0|||
146213403|NCT00073749|527295656|FG006|Overall Study|Death|29|||
146213404|NCT00073749|527295650|FG000|Overall Study|Adverse Event|0|||
146213405|NCT00073749|527295651|FG001|Overall Study|Adverse Event|3|||
146213406|NCT00073749|527295652|FG002|Overall Study|Adverse Event|6|||
146213407|NCT00073749|527295653|FG003|Overall Study|Adverse Event|4|||
146213408|NCT00073749|527295654|FG004|Overall Study|Adverse Event|2|||
146213409|NCT00073749|527295655|FG005|Overall Study|Adverse Event|1|||
146213410|NCT00073749|527295656|FG006|Overall Study|Adverse Event|0|||
146213411|NCT00073749|527295650|FG000|Overall Study|Physician Decision|0|||
146213412|NCT00073749|527295651|FG001|Overall Study|Physician Decision|0|||
146213413|NCT00073749|527295652|FG002|Overall Study|Physician Decision|1|||
146213414|NCT00073749|527295653|FG003|Overall Study|Physician Decision|0|||
146213415|NCT00073749|527295654|FG004|Overall Study|Physician Decision|0|||
146213416|NCT00073749|527295655|FG005|Overall Study|Physician Decision|2|||
146213417|NCT00073749|527295656|FG006|Overall Study|Physician Decision|0|||
146213418|NCT00073749|527295650|FG000|Overall Study|Withdrawal by Subject|0|||
146213419|NCT00073749|527295651|FG001|Overall Study|Withdrawal by Subject|1|||
146213420|NCT00073749|527295652|FG002|Overall Study|Withdrawal by Subject|0|||
146213421|NCT00073749|527295653|FG003|Overall Study|Withdrawal by Subject|0|||
146213422|NCT00073749|527295654|FG004|Overall Study|Withdrawal by Subject|1|||
146213423|NCT00073749|527295655|FG005|Overall Study|Withdrawal by Subject|0|||
146213424|NCT00073749|527295656|FG006|Overall Study|Withdrawal by Subject|2|||
146213425|NCT00073749|527295650|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
146213426|NCT00073749|527295651|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146213427|NCT00073749|527295652|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
146213428|NCT00073749|527295653|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
146213429|NCT00073749|527295654|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
146213430|NCT00073749|527295655|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
146213431|NCT00073749|527295656|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
146213432|NCT00073749|527295650|FG000|Overall Study|Lost to Follow-up|0|||
146213433|NCT00073749|527295651|FG001|Overall Study|Lost to Follow-up|0|||
146213434|NCT00073749|527295652|FG002|Overall Study|Lost to Follow-up|0|||
146213435|NCT00073749|527295653|FG003|Overall Study|Lost to Follow-up|0|||
146213436|NCT00073749|527295654|FG004|Overall Study|Lost to Follow-up|0|||
146213437|NCT00073749|527295655|FG005|Overall Study|Lost to Follow-up|0|||
146213438|NCT00073749|527295656|FG006|Overall Study|Lost to Follow-up|2|||
146213439|NCT00073749|527295650|FG000|Overall Study|Other|0|||
146213440|NCT00073749|527295651|FG001|Overall Study|Other|0|||
146213441|NCT00073749|527295652|FG002|Overall Study|Other|0|||
146213442|NCT00073749|527295653|FG003|Overall Study|Other|0|||
146213443|NCT00073749|527295654|FG004|Overall Study|Other|0|||
146213444|NCT00073749|527295655|FG005|Overall Study|Other|2|||
146213445|NCT00073749|527295656|FG006|Overall Study|Other|0|||
146213446|NCT00611559|527295657|FG000|Overall Study|Lost to Follow-up|0|||
146213447|NCT00611559|527295658|FG001|Overall Study|Lost to Follow-up|1|||
146213448|NCT00611559|527295659|FG002|Overall Study|Lost to Follow-up|0|||
146213449|NCT00611559|527295657|FG000|Overall Study|Protocol Violation|1|||
146213450|NCT00611559|527295658|FG001|Overall Study|Protocol Violation|0|||
146213451|NCT00611559|527295659|FG002|Overall Study|Protocol Violation|1|||
146213452|NCT05048186|527295662|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
146213453|NCT05048186|527295663|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
146213454|NCT05048186|527295662|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
146286939|NCT01920854|527564366|FG002|Overall Study|Withdrawal by Subject|0|||
146213455|NCT05048186|527295663|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
146213456|NCT00951379|527295664|FG000|Overall Study|Adverse Event|4|||
146213457|NCT00951379|527295665|FG001|Overall Study|Adverse Event|1|||
146213458|NCT00951379|527295664|FG000|Overall Study|Withdrawal by Subject|1|||
146213459|NCT00951379|527295665|FG001|Overall Study|Withdrawal by Subject|0|||
146213460|NCT00951379|527295664|FG000|Overall Study|Noncompliance|1|||
146213461|NCT00951379|527295665|FG001|Overall Study|Noncompliance|0|||
146213462|NCT00951379|527295664|FG000|Overall Study|Disease Progression|0|||
146213463|NCT00951379|527295665|FG001|Overall Study|Disease Progression|1|||
146213464|NCT02742519|527295669|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
146213465|NCT02742519|527295670|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
146213466|NCT02742519|527295671|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
146213467|NCT02742519|527295669|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
146213468|NCT02742519|527295670|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
146213469|NCT02742519|527295671|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
146213470|NCT02742519|527295669|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
146213471|NCT02742519|527295670|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
146213472|NCT02742519|527295671|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
146213473|NCT01872078|527295672|FG000|Overall Study|Adverse Event|0|||
146213474|NCT01872078|527295673|FG001|Overall Study|Adverse Event|0|||
146213475|NCT01872078|527295674|FG002|Overall Study|Adverse Event|1|||
146213476|NCT01872078|527295675|FG003|Overall Study|Adverse Event|0|||
146213477|NCT01872078|527295672|FG000|Overall Study|Dose administration non-compliance|0|||
146213478|NCT01872078|527295673|FG001|Overall Study|Dose administration non-compliance|0|||
146213479|NCT01872078|527295674|FG002|Overall Study|Dose administration non-compliance|0|||
146213480|NCT01872078|527295675|FG003|Overall Study|Dose administration non-compliance|1|||
146213481|NCT01872078|527295672|FG000|Overall Study|Protocol Violation|0|||
146213482|NCT01872078|527295673|FG001|Overall Study|Protocol Violation|0|||
146213483|NCT01872078|527295674|FG002|Overall Study|Protocol Violation|1|||
146213484|NCT01872078|527295675|FG003|Overall Study|Protocol Violation|0|||
146213485|NCT01872078|527295672|FG000|Overall Study|Withdrawal by Subject|0|||
146213486|NCT01872078|527295673|FG001|Overall Study|Withdrawal by Subject|0|||
146213487|NCT01872078|527295674|FG002|Overall Study|Withdrawal by Subject|1|||
146213488|NCT01872078|527295675|FG003|Overall Study|Withdrawal by Subject|0|||
146213489|NCT01872078|527295672|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
146213490|NCT01872078|527295673|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
146213491|NCT01872078|527295674|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
146213492|NCT01872078|527295675|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
146213493|NCT03580369|527295676|FG000|Overall Study|No treatment due to mis-randomization|1|||
146213494|NCT03580369|527295677|FG001|Overall Study|No treatment due to mis-randomization|0|||
146213495|NCT03580369|527295678|FG002|Overall Study|No treatment due to mis-randomization|0|||
146213496|NCT03580369|527295679|FG003|Overall Study|No treatment due to mis-randomization|0|||
146213497|NCT03580369|527295680|FG004|Overall Study|No treatment due to mis-randomization|3|||
146213498|NCT03580369|527295681|FG005|Overall Study|No treatment due to mis-randomization|0|||
146213499|NCT03580369|527295682|FG006|Overall Study|No treatment due to mis-randomization|0|||
146213500|NCT03580369|527295683|FG007|Overall Study|No treatment due to mis-randomization|0|||
146213501|NCT03580369|527295676|FG000|Overall Study|Reason unknown|0|||
146213502|NCT03580369|527295677|FG001|Overall Study|Reason unknown|0|||
146213503|NCT03580369|527295678|FG002|Overall Study|Reason unknown|1|||
146213504|NCT03580369|527295679|FG003|Overall Study|Reason unknown|0|||
146213505|NCT03580369|527295680|FG004|Overall Study|Reason unknown|0|||
146213506|NCT03580369|527295681|FG005|Overall Study|Reason unknown|0|||
146213507|NCT03580369|527295682|FG006|Overall Study|Reason unknown|0|||
146213508|NCT03580369|527295683|FG007|Overall Study|Reason unknown|0|||
145890974|NCT01207440|526107576|FG006|Overall Study|Withdrawal by Subject|0|||
146213509|NCT03580369|527295676|FG000|Overall Study|Technical problems|0|||
146213510|NCT03580369|527295677|FG001|Overall Study|Technical problems|0|||
146213511|NCT03580369|527295678|FG002|Overall Study|Technical problems|0|||
146213512|NCT03580369|527295679|FG003|Overall Study|Technical problems|0|||
146213513|NCT03580369|527295680|FG004|Overall Study|Technical problems|1|||
146213514|NCT03580369|527295681|FG005|Overall Study|Technical problems|0|||
146213515|NCT03580369|527295682|FG006|Overall Study|Technical problems|2|||
146213516|NCT03580369|527295683|FG007|Overall Study|Technical problems|0|||
146213517|NCT03580369|527295676|FG000|Overall Study|Pregnancy|2|||
146213518|NCT03580369|527295677|FG001|Overall Study|Pregnancy|0|||
146213519|NCT03580369|527295678|FG002|Overall Study|Pregnancy|3|||
146213520|NCT03580369|527295679|FG003|Overall Study|Pregnancy|0|||
146213521|NCT03580369|527295680|FG004|Overall Study|Pregnancy|2|||
146213522|NCT03580369|527295681|FG005|Overall Study|Pregnancy|0|||
146213523|NCT03580369|527295682|FG006|Overall Study|Pregnancy|0|||
146213524|NCT03580369|527295683|FG007|Overall Study|Pregnancy|0|||
146213525|NCT03580369|527295676|FG000|Overall Study|Lost to Follow-up|2|||
146213526|NCT03580369|527295677|FG001|Overall Study|Lost to Follow-up|0|||
146213527|NCT03580369|527295678|FG002|Overall Study|Lost to Follow-up|2|||
146213528|NCT03580369|527295679|FG003|Overall Study|Lost to Follow-up|0|||
146213529|NCT03580369|527295680|FG004|Overall Study|Lost to Follow-up|3|||
146286940|NCT01920854|527564367|FG003|Overall Study|Withdrawal by Subject|0|||
146286941|NCT01920854|527564368|FG004|Overall Study|Withdrawal by Subject|1|||
146286942|NCT01920854|527564369|FG005|Overall Study|Withdrawal by Subject|0|||
146286943|NCT01920854|527564370|FG006|Overall Study|Withdrawal by Subject|1|||
146286944|NCT00729378|527567260|FG000|Baseline|Did not complete study measurements|72|||
146286945|NCT00729378|527567261|FG001|Baseline|Did not complete study measurements|33|||
146286946|NCT00729378|527567260|FG000|Baseline|Withdrawal by Subject|66|||
146286947|NCT00729378|527567261|FG001|Baseline|Withdrawal by Subject|59|||
146286948|NCT00729378|527567260|FG000|12-months|Lost to Follow-up|100|||
146286949|NCT00729378|527567261|FG001|12-months|Lost to Follow-up|65|||
146286950|NCT00729378|527567260|FG000|24-months|Lost to Follow-up|72|||
146286951|NCT00729378|527567261|FG001|24-months|Lost to Follow-up|51|||
146083952|NCT00492063|526826623|FG001|Overall Study|Death|0|||
146083953|NCT00492063|526826624|FG002|Overall Study|Death|1|||
146213530|NCT03580369|527295681|FG005|Overall Study|Lost to Follow-up|0|||
146213531|NCT03580369|527295682|FG006|Overall Study|Lost to Follow-up|1|||
146083954|NCT00492063|526826625|FG003|Overall Study|Death|2|||
146213532|NCT03580369|527295683|FG007|Overall Study|Lost to Follow-up|0|||
146213533|NCT03580369|527295676|FG000|Overall Study|Physician Decision|4|||
146213534|NCT03580369|527295677|FG001|Overall Study|Physician Decision|0|||
146213535|NCT03580369|527295678|FG002|Overall Study|Physician Decision|4|||
146213536|NCT03580369|527295679|FG003|Overall Study|Physician Decision|1|||
146213537|NCT03580369|527295680|FG004|Overall Study|Physician Decision|1|||
146213538|NCT03580369|527295681|FG005|Overall Study|Physician Decision|0|||
146213539|NCT03580369|527295682|FG006|Overall Study|Physician Decision|0|||
146213540|NCT03580369|527295683|FG007|Overall Study|Physician Decision|0|||
146213541|NCT03580369|527295676|FG000|Overall Study|Lack of Efficacy|3|||
146213542|NCT03580369|527295677|FG001|Overall Study|Lack of Efficacy|0|||
146213543|NCT03580369|527295678|FG002|Overall Study|Lack of Efficacy|7|||
146213544|NCT03580369|527295679|FG003|Overall Study|Lack of Efficacy|0|||
146213545|NCT03580369|527295680|FG004|Overall Study|Lack of Efficacy|2|||
146213546|NCT03580369|527295681|FG005|Overall Study|Lack of Efficacy|0|||
146213547|NCT03580369|527295682|FG006|Overall Study|Lack of Efficacy|3|||
146083955|NCT00492063|526826622|FG000|Overall Study|Withdrawal by Subject|4|||
146083956|NCT00492063|526826623|FG001|Overall Study|Withdrawal by Subject|3|||
146286952|NCT00729378|527567260|FG000|36-months|Lost to Follow-up|15|||
146286953|NCT00729378|527567261|FG001|36-months|Lost to Follow-up|6|||
146083957|NCT00492063|526826624|FG002|Overall Study|Withdrawal by Subject|5|||
146213548|NCT03580369|527295683|FG007|Overall Study|Lack of Efficacy|0|||
146213549|NCT03580369|527295676|FG000|Overall Study|Protocol Violation|6|||
146213550|NCT03580369|527295677|FG001|Overall Study|Protocol Violation|0|||
146213551|NCT03580369|527295678|FG002|Overall Study|Protocol Violation|6|||
146213552|NCT03580369|527295679|FG003|Overall Study|Protocol Violation|1|||
146213553|NCT03580369|527295680|FG004|Overall Study|Protocol Violation|8|||
146213554|NCT03580369|527295681|FG005|Overall Study|Protocol Violation|2|||
146213555|NCT03580369|527295682|FG006|Overall Study|Protocol Violation|1|||
146213556|NCT03580369|527295683|FG007|Overall Study|Protocol Violation|0|||
146213557|NCT03580369|527295676|FG000|Overall Study|Adverse Event|7|||
146213558|NCT03580369|527295677|FG001|Overall Study|Adverse Event|0|||
146213559|NCT03580369|527295678|FG002|Overall Study|Adverse Event|14|||
146213560|NCT03580369|527295679|FG003|Overall Study|Adverse Event|1|||
146213561|NCT03580369|527295680|FG004|Overall Study|Adverse Event|6|||
146213562|NCT03580369|527295681|FG005|Overall Study|Adverse Event|0|||
146213563|NCT03580369|527295682|FG006|Overall Study|Adverse Event|1|||
146083958|NCT00492063|526826625|FG003|Overall Study|Withdrawal by Subject|4|||
146213564|NCT03580369|527295683|FG007|Overall Study|Adverse Event|0|||
146213565|NCT03580369|527295676|FG000|Overall Study|Withdrawal by Subject|19|||
146213566|NCT03580369|527295677|FG001|Overall Study|Withdrawal by Subject|0|||
146213567|NCT03580369|527295678|FG002|Overall Study|Withdrawal by Subject|17|||
146213568|NCT03580369|527295679|FG003|Overall Study|Withdrawal by Subject|0|||
146213569|NCT03580369|527295680|FG004|Overall Study|Withdrawal by Subject|16|||
146213570|NCT03580369|527295681|FG005|Overall Study|Withdrawal by Subject|1|||
146213571|NCT03580369|527295682|FG006|Overall Study|Withdrawal by Subject|7|||
146213572|NCT03580369|527295683|FG007|Overall Study|Withdrawal by Subject|0|||
146083959|NCT00492063|526826622|FG000|Overall Study|Lost to Follow-up|6|||
146083960|NCT00492063|526826623|FG001|Overall Study|Lost to Follow-up|11|||
146213573|NCT03912831|527295684|FG000|Overall Study|Death|1|||
146213574|NCT03912831|527295685|FG001|Overall Study|Death|1|||
146213575|NCT03912831|527295686|FG002|Overall Study|Death|1|||
146213576|NCT03912831|527295687|FG003|Overall Study|Death|1|||
146213577|NCT03912831|527295688|FG004|Overall Study|Death|1|||
146213578|NCT03912831|527295689|FG005|Overall Study|Death|1|||
146213579|NCT03912831|527295684|FG000|Overall Study|Reason not Specified|0|||
146213580|NCT03912831|527295685|FG001|Overall Study|Reason not Specified|0|||
146213581|NCT03912831|527295686|FG002|Overall Study|Reason not Specified|0|||
146213582|NCT03912831|527295687|FG003|Overall Study|Reason not Specified|0|||
146083961|NCT00492063|526826624|FG002|Overall Study|Lost to Follow-up|5|||
146083962|NCT00492063|526826625|FG003|Overall Study|Lost to Follow-up|3|||
146083963|NCT00492063|526826622|FG000|Overall Study|Protocol Violation|0|||
146213583|NCT03912831|527295688|FG004|Overall Study|Reason not Specified|1|||
146213584|NCT03912831|527295689|FG005|Overall Study|Reason not Specified|0|||
146286954|NCT01586910|527567262|FG000|Overall Study|Death|4|||
146213585|NCT03912831|527295684|FG000|Overall Study|Withdrawal by Participant|0|||
146213586|NCT03912831|527295685|FG001|Overall Study|Withdrawal by Participant|0|||
146213587|NCT03912831|527295686|FG002|Overall Study|Withdrawal by Participant|0|||
146213588|NCT03912831|527295687|FG003|Overall Study|Withdrawal by Participant|0|||
146213589|NCT03912831|527295688|FG004|Overall Study|Withdrawal by Participant|1|||
146213590|NCT03912831|527295689|FG005|Overall Study|Withdrawal by Participant|0|||
146213591|NCT05239039|527295695|FG000|Overall Study|Withdrawal by Subject|0|||
146213592|NCT05239039|527295696|FG001|Overall Study|Withdrawal by Subject|1|||
146213593|NCT03152786|527297039|FG000|Overall Study|Withdrawal by Subject|2|||
146213594|NCT03152786|527297040|FG001|Overall Study|Withdrawal by Subject|1|||
146213595|NCT02349412|527297045|FG000|Overall Study|Withdrawal by Subject|7|||
146213596|NCT02349412|527297046|FG001|Overall Study|Withdrawal by Subject|7|||
146213597|NCT06066541|527297047|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
146213598|NCT06066541|527297048|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
146213599|NCT06066541|527297049|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
146213600|NCT06066541|527297050|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
146213601|NCT06066541|527297051|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
146213602|NCT06066541|527297052|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
146213603|NCT06066541|527297053|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
146213604|NCT06066541|527297047|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
146213605|NCT06066541|527297048|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
146213606|NCT06066541|527297049|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
146213607|NCT06066541|527297050|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
146213608|NCT06066541|527297051|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
146213609|NCT06066541|527297052|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
146213610|NCT06066541|527297053|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
146213611|NCT03897686|527297055|FG000|Overall Study|Protocol Violation|1|||
146213612|NCT03897686|527297056|FG001|Overall Study|Protocol Violation|1|||
146213613|NCT03897686|527297055|FG000|Overall Study|Withdrawal by Subject|1|||
146213614|NCT03897686|527297056|FG001|Overall Study|Withdrawal by Subject|1|||
146213615|NCT04842643|527297060|FG000|Overall Study|Physician Decision|1|||
146213616|NCT04842643|527297060|FG000|Overall Study|Other|1|||
146213617|NCT00739648|527297066|FG000|Overall Study|Adverse Event|3|||
146286955|NCT01586910|527567263|FG001|Overall Study|Death|4|||
146213618|NCT00739648|527297067|FG001|Overall Study|Adverse Event|15|||
146213619|NCT00739648|527297066|FG000|Overall Study|Withdrawal by Subject|13|||
146213620|NCT00739648|527297067|FG001|Overall Study|Withdrawal by Subject|25|||
146213621|NCT00739648|527297066|FG000|Overall Study|Lost to Follow-up|4|||
146213622|NCT00739648|527297067|FG001|Overall Study|Lost to Follow-up|7|||
146213623|NCT00739648|527297066|FG000|Overall Study|Death|2|||
146213624|NCT00739648|527297067|FG001|Overall Study|Death|0|||
146213625|NCT00739648|527297066|FG000|Overall Study|Do not know|4|||
146213626|NCT00739648|527297067|FG001|Overall Study|Do not know|6|||
146213627|NCT02840474|527297070|FG000|Overall Study|Lost to Follow-up|1|||
146213628|NCT02840474|527297071|FG001|Overall Study|Lost to Follow-up|0|||
146213629|NCT03192891|527297072|FG000|Overall Study|Lost to Follow-up|55|||
146213630|NCT04850807|527297073|FG000|Overall Study|Death|50|||
146213631|NCT04850807|527297074|FG001|Overall Study|Death|55|||
146213632|NCT04850807|527297073|FG000|Overall Study|Discharged|17|||
146213633|NCT04850807|527297074|FG001|Overall Study|Discharged|13|||
146213634|NCT04850807|527297073|FG000|Overall Study|Incomplete baseline data|3|||
146213635|NCT04850807|527297074|FG001|Overall Study|Incomplete baseline data|2|||
146213636|NCT05387447|527297078|FG000|Overall Study|Participants changed their minds about study participation.|3|||
146213637|NCT05387447|527297079|FG001|Overall Study|Participants changed their minds about study participation.|5|||
146213638|NCT04178733|527297080|FG000|Overall Study|Investigator Decision|0|||
146213639|NCT04178733|527297081|FG001|Overall Study|Investigator Decision|0|||
146213640|NCT04178733|527297082|FG002|Overall Study|Investigator Decision|0|||
146213641|NCT04178733|527297083|FG003|Overall Study|Investigator Decision|1|||
146213642|NCT04178733|527297084|FG004|Overall Study|Investigator Decision|2|||
146213643|NCT03655132|527297087|FG000|Overall Study|Lost to Follow-up|2|||
146213644|NCT03655132|527297088|FG001|Overall Study|Lost to Follow-up|1|||
146213645|NCT03655132|527297087|FG000|Overall Study|Withdrawal by Subject|0|||
146213646|NCT03655132|527297088|FG001|Overall Study|Withdrawal by Subject|1|||
146213647|NCT03655132|527297087|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
146213648|NCT03655132|527297088|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
146213649|NCT02651324|527297090|FG000|Overall Study|drug not administered, due dispensing issue|1|||
146213650|NCT02651324|527297091|FG001|Overall Study|drug not administered, due dispensing issue|0|||
146213651|NCT05919082|527297094|FG000|Overall Study|Adverse Event|3|||
146213652|NCT05919082|527297095|FG001|Overall Study|Adverse Event|0|||
146213653|NCT05919082|527297094|FG000|Overall Study|Lost to Follow-up|0|||
146213654|NCT05919082|527297095|FG001|Overall Study|Lost to Follow-up|1|||
146213655|NCT05919082|527297094|FG000|Overall Study|Withdrawal by Subject|8|||
146213656|NCT05919082|527297095|FG001|Overall Study|Withdrawal by Subject|9|||
146213657|NCT05919082|527297094|FG000|Overall Study|Lack of Efficacy|0|||
145957775|NCT00113295|526358161|FG000|Overall Study|Unrelated Medical Illness|1|||
145957776|NCT00113295|526358162|FG001|Overall Study|Unrelated Medical Illness|0|||
145957777|NCT03334188|526358167|FG000|Overall Study|Withdrawal by Subject|0|||
145957778|NCT03334188|526358168|FG001|Overall Study|Withdrawal by Subject|1|||
145957779|NCT03334188|526358167|FG000|Overall Study|Death|1|||
145957780|NCT03334188|526358168|FG001|Overall Study|Death|0|||
145957781|NCT03334188|526358167|FG000|Overall Study|Never had qualifying clinic visit|7|||
145957782|NCT03334188|526358168|FG001|Overall Study|Never had qualifying clinic visit|7|||
145957783|NCT03442088|526358175|FG000|Overall Study|Adverse Event|1|||
145957784|NCT03442088|526358175|FG000|Overall Study|Lack of Efficacy|2|||
145957785|NCT03442088|526358175|FG000|Overall Study|Lost to Follow-up|2|||
145957786|NCT01001520|526358176|FG000|Medication Period 1|Withdrawal by Subject|2|||
145957787|NCT01001520|526358177|FG001|Medication Period 1|Withdrawal by Subject|2|||
145957788|NCT01001520|526358176|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
145957789|NCT01001520|526358177|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
145957790|NCT01001520|526358176|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
145957791|NCT01001520|526358177|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
145957792|NCT01001520|526358176|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
145957793|NCT01001520|526358177|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
145957794|NCT01001520|526358176|FG000|Washout Period|Withdrawal by Subject|2|||
145957795|NCT01001520|526358177|FG001|Washout Period|Withdrawal by Subject|1|||
145957796|NCT01001520|526358176|FG000|Medication Period 2|Withdrawal by Subject|0|||
145957797|NCT01001520|526358177|FG001|Medication Period 2|Withdrawal by Subject|3|||
145957798|NCT00357877|526358178|FG000|Overall Study|Death|2|||
145957799|NCT00357877|526358179|FG001|Overall Study|Death|1|||
145957800|NCT00357877|526358178|FG000|Overall Study|Lost to Follow-up|20|||
145957801|NCT00357877|526358179|FG001|Overall Study|Lost to Follow-up|23|||
145957802|NCT00357877|526358178|FG000|Overall Study|Withdrawal by Subject|3|||
145957803|NCT00357877|526358179|FG001|Overall Study|Withdrawal by Subject|3|||
145957804|NCT00357877|526358178|FG000|Overall Study|Administrative withdrawal|1|||
145957805|NCT00357877|526358179|FG001|Overall Study|Administrative withdrawal|1|||
145957806|NCT00357877|526358178|FG000|Overall Study|Other|0|||
146213658|NCT05919082|527297095|FG001|Overall Study|Lack of Efficacy|1|||
146213659|NCT05919082|527297094|FG000|Overall Study|Investigator Decision|1|||
146213660|NCT05919082|527297095|FG001|Overall Study|Investigator Decision|0|||
146083964|NCT00492063|526826623|FG001|Overall Study|Protocol Violation|0|||
145957807|NCT00357877|526358179|FG001|Overall Study|Other|2|||
146213661|NCT04538417|527297097|FG000|Overall Study|Withdrawal by Subject|2|||
146213662|NCT02249949|527297099|FG000|Overall Study|Cancelled prior to treatment|2|||
146213663|NCT02097420|527297102|FG000|Overall Study|Death|6|||
146213664|NCT02097420|527297102|FG000|Overall Study|Valve explanted|13|||
146213665|NCT02097420|527297102|FG000|Overall Study|Other Reason|1|||
146213666|NCT01707030|527297119|FG000|Overall Study|Death|1|||
146213667|NCT01707030|527297120|FG001|Overall Study|Death|1|||
146213668|NCT01707030|527297119|FG000|Overall Study|Withdrawal by Subject|2|||
146213669|NCT01707030|527297120|FG001|Overall Study|Withdrawal by Subject|3|||
146213670|NCT01707030|527297119|FG000|Overall Study|Lost to Follow-up|8|||
146213671|NCT01707030|527297120|FG001|Overall Study|Lost to Follow-up|13|||
146213672|NCT04820855|527297122|FG000|Overall Study|Lost to Follow-up|6|||
146213673|NCT04820855|527297123|FG001|Overall Study|Lost to Follow-up|9|||
146213674|NCT04838262|527297124|FG000|Overall Study|Withdrawal by Subject|9|||
146213675|NCT04838262|527297125|FG001|Overall Study|Withdrawal by Subject|4|||
146213676|NCT04437433|527297126|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
146213677|NCT04437433|527297127|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
146213678|NCT04437433|527297126|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
146213679|NCT04437433|527297127|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
146213680|NCT04437433|527297126|FG000|Overall Study|Adverse Event|9|||
146213681|NCT04437433|527297127|FG001|Overall Study|Adverse Event|0|||
146213682|NCT04437433|527297126|FG000|Overall Study|Lack of Efficacy|4|||
146213683|NCT04437433|527297127|FG001|Overall Study|Lack of Efficacy|0|||
146213684|NCT04437433|527297126|FG000|Overall Study|Withdrawal by Subject|4|||
146213685|NCT04437433|527297127|FG001|Overall Study|Withdrawal by Subject|1|||
146213686|NCT04437433|527297126|FG000|Overall Study|Protocol Deviation|0|||
146213687|NCT04437433|527297127|FG001|Overall Study|Protocol Deviation|1|||
146213688|NCT04437433|527297126|FG000|Overall Study|Other, not specified|0|||
146213689|NCT04437433|527297127|FG001|Overall Study|Other, not specified|1|||
146213690|NCT04245501|527297128|FG000|Overall Study|Adverse Event|2|||
146213691|NCT04245501|527297129|FG001|Overall Study|Adverse Event|0|||
146213692|NCT04245501|527297128|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
146213693|NCT04245501|527297129|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
146213694|NCT00446225|527297140|FG000|Overall Study|Protocol Violation|1|||
146213695|NCT00446225|527297141|FG001|Overall Study|Protocol Violation|0|||
146213696|NCT04450342|527297142|FG000|Overall Study|Adverse Event|1|||
146213697|NCT04450342|527297143|FG001|Overall Study|Adverse Event|1|||
146213698|NCT04450342|527297144|FG002|Overall Study|Adverse Event|0|||
146213699|NCT04450342|527297142|FG000|Overall Study|Device not used|1|||
146213700|NCT04450342|527297143|FG001|Overall Study|Device not used|0|||
146213701|NCT04450342|527297144|FG002|Overall Study|Device not used|0|||
146213702|NCT04450342|527297142|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
146213703|NCT04450342|527297143|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
146213704|NCT04450342|527297144|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
146213705|NCT04450342|527297142|FG000|Overall Study|Physician Decision|1|||
146213706|NCT04450342|527297143|FG001|Overall Study|Physician Decision|0|||
146213707|NCT04450342|527297144|FG002|Overall Study|Physician Decision|1|||
145957808|NCT04668209|526358182|FG000|Overall Study|Withdrawal by Subject|2|||
146213708|NCT04450342|527297142|FG000|Overall Study|Protocol Deviation|0|||
146213709|NCT04450342|527297143|FG001|Overall Study|Protocol Deviation|1|||
146213710|NCT04450342|527297144|FG002|Overall Study|Protocol Deviation|0|||
146213711|NCT04450342|527297142|FG000|Overall Study|Reoperation|1|||
146213712|NCT04450342|527297143|FG001|Overall Study|Reoperation|1|||
146213713|NCT04450342|527297144|FG002|Overall Study|Reoperation|0|||
145957809|NCT04668209|526358183|FG001|Overall Study|Withdrawal by Subject|2|||
145957810|NCT04668209|526358182|FG000|Overall Study|Lost to Follow-up|3|||
146213714|NCT04450342|527297142|FG000|Overall Study|Screen Failures|0|||
146213715|NCT04450342|527297143|FG001|Overall Study|Screen Failures|0|||
146083965|NCT00492063|526826624|FG002|Overall Study|Protocol Violation|0|||
146213716|NCT04450342|527297144|FG002|Overall Study|Screen Failures|2|||
146213717|NCT04450342|527297142|FG000|Overall Study|Site Terminated by Sponsor|1|||
146213718|NCT04450342|527297143|FG001|Overall Study|Site Terminated by Sponsor|1|||
146213719|NCT04450342|527297144|FG002|Overall Study|Site Terminated by Sponsor|1|||
146213720|NCT04450342|527297142|FG000|Overall Study|Study Terminated by Sponsor|31|||
146213721|NCT04450342|527297143|FG001|Overall Study|Study Terminated by Sponsor|29|||
146213722|NCT04450342|527297144|FG002|Overall Study|Study Terminated by Sponsor|6|||
146213723|NCT04450342|527297142|FG000|Overall Study|Withdrawal by Subject|0|||
146213724|NCT04450342|527297143|FG001|Overall Study|Withdrawal by Subject|1|||
146213725|NCT04450342|527297144|FG002|Overall Study|Withdrawal by Subject|2|||
145957811|NCT04668209|526358183|FG001|Overall Study|Lost to Follow-up|4|||
145957812|NCT04668209|526358182|FG000|Overall Study|Subject Expired|2|||
145957813|NCT04668209|526358183|FG001|Overall Study|Subject Expired|0|||
145957814|NCT04668209|526358182|FG000|Overall Study|Withdrawn from study|0|||
145957815|NCT04668209|526358183|FG001|Overall Study|Withdrawn from study|1|||
145957816|NCT04668209|526358182|FG000|Overall Study|Adverse Event|0|||
145957817|NCT04668209|526358183|FG001|Overall Study|Adverse Event|1|||
145957818|NCT00613366|526358193|FG000|Overall Study|Withdrawal by Subject|3|||
145957819|NCT00613366|526358194|FG001|Overall Study|Withdrawal by Subject|2|||
145957820|NCT02907463|526358195|FG000|Overall Study|Lost to Follow-up|17|||
145957821|NCT02907463|526358195|FG000|Overall Study|Death|10|||
145957822|NCT02907463|526358195|FG000|Overall Study|Withdrawal by Subject|4|||
145957823|NCT02907463|526358195|FG000|Overall Study|MIS Approach was not used|2|||
145957824|NCT02907463|526358195|FG000|Overall Study|Not Implanted with Study Device|2|||
145957825|NCT02907463|526358195|FG000|Overall Study|Device Explanted|1|||
145957826|NCT02907463|526358195|FG000|Overall Study|Missing Exit Form|1|||
145957827|NCT04878055|526358196|FG000|Overall Study|Patient transferred in another department|0|||
145957828|NCT04878055|526358197|FG001|Overall Study|Patient transferred in another department|2|||
145957829|NCT04878055|526358196|FG000|Overall Study|Physician Decision|1|||
145957830|NCT04878055|526358197|FG001|Overall Study|Physician Decision|1|||
145957831|NCT04878055|526358196|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
145957832|NCT04878055|526358197|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
145957833|NCT04878055|526358196|FG000|Overall Study|Adverse Event|12|||
145957834|NCT04878055|526358197|FG001|Overall Study|Adverse Event|7|||
145957835|NCT04878055|526358196|FG000|Overall Study|Other|5|||
145957836|NCT04878055|526358197|FG001|Overall Study|Other|0|||
145957837|NCT04878055|526358196|FG000|Overall Study|Withdrawal by Subject|7|||
145957838|NCT04878055|526358197|FG001|Overall Study|Withdrawal by Subject|3|||
145957839|NCT04878055|526358196|FG000|Overall Study|Lost to Follow-up|10|||
145957840|NCT04878055|526358197|FG001|Overall Study|Lost to Follow-up|1|||
145957841|NCT05225558|526358203|FG000|Overall Study|Withdrawal by Subject|4|||
145957842|NCT05225558|526358204|FG001|Overall Study|Withdrawal by Subject|3|||
145957843|NCT05225558|526358203|FG000|Overall Study|Adverse Event|1|||
145957844|NCT05225558|526358204|FG001|Overall Study|Adverse Event|0|||
145957845|NCT05225558|526358203|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
145957846|NCT05225558|526358204|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
145957847|NCT05225558|526358203|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
145957848|NCT05225558|526358204|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
145957849|NCT00970489|526358205|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
145957850|NCT00970489|526358206|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
145957851|NCT02659943|526358207|FG000|Overall Study|Switched to alternative treatment|1|||
145957852|NCT02659943|526358208|FG001|Overall Study|Switched to alternative treatment|1|||
145957853|NCT02659943|526358209|FG002|Overall Study|Switched to alternative treatment|0|||
145957854|NCT02659943|526358210|FG003|Overall Study|Switched to alternative treatment|2|||
146213726|NCT05633407|527297145|FG000|Overall Study|Physician Decision|2|||
146213727|NCT05633407|527297146|FG001|Overall Study|Physician Decision|0|||
146213728|NCT05633407|527297145|FG000|Overall Study|Adverse Event|1|||
146213729|NCT05633407|527297146|FG001|Overall Study|Adverse Event|0|||
146213730|NCT05633407|527297145|FG000|Overall Study|Withdrawal by Subject|1|||
146213731|NCT05633407|527297146|FG001|Overall Study|Withdrawal by Subject|0|||
146213732|NCT05633407|527297145|FG000|Overall Study|Other|1|||
146213733|NCT05633407|527297146|FG001|Overall Study|Other|1|||
146213734|NCT05268302|527297151|FG000|Overall Study|Death|0|||
146213735|NCT05268302|527297152|FG001|Overall Study|Death|1|||
145957855|NCT02659943|526358211|FG004|Overall Study|Switched to alternative treatment|1|||
145957856|NCT02659943|526358212|FG005|Overall Study|Switched to alternative treatment|0|||
145957857|NCT02659943|526358213|FG006|Overall Study|Switched to alternative treatment|1|||
145957858|NCT02659943|526358207|FG000|Overall Study|Disease progression on study|0|||
145957859|NCT02659943|526358208|FG001|Overall Study|Disease progression on study|1|||
146213736|NCT04093752|527297156|FG000|Overall Study|Adverse Event|7|||
146213737|NCT04093752|527297157|FG001|Overall Study|Adverse Event|19|||
146213738|NCT04093752|527297158|FG002|Overall Study|Adverse Event|18|||
146213739|NCT04093752|527297159|FG003|Overall Study|Adverse Event|4|||
146213740|NCT04093752|527297156|FG000|Overall Study|Withdrawal by Subject|6|||
146213741|NCT04093752|527297157|FG001|Overall Study|Withdrawal by Subject|6|||
146213742|NCT04093752|527297158|FG002|Overall Study|Withdrawal by Subject|8|||
146286956|NCT01586910|527567262|FG000|Overall Study|Withdrawal by Subject|6|||
146286957|NCT01586910|527567263|FG001|Overall Study|Withdrawal by Subject|43|||
146286958|NCT01586910|527567262|FG000|Overall Study|Physician withdrew Subject|5|||
146286959|NCT01586910|527567263|FG001|Overall Study|Physician withdrew Subject|24|||
146286960|NCT00346268|527567264|FG000|Overall Study|Adverse Event|1|||
146286961|NCT00346268|527567265|FG001|Overall Study|Adverse Event|0|||
146286962|NCT00346268|527567264|FG000|Overall Study|Protocol Violation|1|||
146286963|NCT00346268|527567265|FG001|Overall Study|Protocol Violation|0|||
146286964|NCT00346268|527567264|FG000|Overall Study|Participant refused|0|||
146286965|NCT00346268|527567265|FG001|Overall Study|Participant refused|3|||
146286966|NCT00031551|527567266|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
146286967|NCT00031551|527567267|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
146286968|NCT02164383|527567268|FG000|Overall Study|Lost to Follow-up|1|||
146286969|NCT02164383|527567269|FG001|Overall Study|Lost to Follow-up|0|||
146286970|NCT00743275|527567270|FG000|Overall Study|Protocol Violation|0|||
146286971|NCT00743275|527567271|FG001|Overall Study|Protocol Violation|1|||
146286972|NCT01672723|527567272|FG000|First Intervention|Adverse Event|3|||
146286973|NCT01672723|527567273|FG001|First Intervention|Adverse Event|0|||
146286974|NCT00484289|527567284|FG000|Long Term Phase|Adverse Event|1|||
146286975|NCT00484289|527567285|FG001|Long Term Phase|Adverse Event|17|||
146286976|NCT00484289|527567286|FG002|Long Term Phase|Adverse Event|5|||
146286977|NCT00484289|527567284|FG000|Long Term Phase|Withdrawal by Subject|0|||
146286978|NCT00484289|527567285|FG001|Long Term Phase|Withdrawal by Subject|7|||
146286979|NCT00484289|527567286|FG002|Long Term Phase|Withdrawal by Subject|6|||
146286980|NCT00484289|527567284|FG000|Long Term Phase|Inadequate response|2|||
145957860|NCT02659943|526358209|FG002|Overall Study|Disease progression on study|1|||
145957861|NCT02659943|526358210|FG003|Overall Study|Disease progression on study|1|||
145957862|NCT02659943|526358211|FG004|Overall Study|Disease progression on study|1|||
145957863|NCT02659943|526358212|FG005|Overall Study|Disease progression on study|4|||
145957864|NCT02659943|526358213|FG006|Overall Study|Disease progression on study|0|||
145957865|NCT02659943|526358207|FG000|Overall Study|Patient's condition per principal investigator|0|||
145957866|NCT02659943|526358208|FG001|Overall Study|Patient's condition per principal investigator|0|||
145957867|NCT02659943|526358209|FG002|Overall Study|Patient's condition per principal investigator|0|||
145957868|NCT02659943|526358210|FG003|Overall Study|Patient's condition per principal investigator|0|||
145957869|NCT02659943|526358211|FG004|Overall Study|Patient's condition per principal investigator|0|||
145957870|NCT02659943|526358212|FG005|Overall Study|Patient's condition per principal investigator|1|||
145957871|NCT02659943|526358213|FG006|Overall Study|Patient's condition per principal investigator|0|||
146083966|NCT00492063|526826625|FG003|Overall Study|Protocol Violation|1|||
146083967|NCT00608569|526826628|FG000|Overall Study|Death|4|||
146213743|NCT04093752|527297159|FG003|Overall Study|Withdrawal by Subject|20|||
146213744|NCT04093752|527297156|FG000|Overall Study|Lost to Follow-up|2|||
146213745|NCT04093752|527297157|FG001|Overall Study|Lost to Follow-up|1|||
146213746|NCT04093752|527297158|FG002|Overall Study|Lost to Follow-up|1|||
146213747|NCT04093752|527297159|FG003|Overall Study|Lost to Follow-up|1|||
146213748|NCT04093752|527297156|FG000|Overall Study|Death|0|||
146213749|NCT04093752|527297157|FG001|Overall Study|Death|0|||
145957872|NCT02659943|526358207|FG000|Overall Study|Ineligible|0|||
145957873|NCT02659943|526358208|FG001|Overall Study|Ineligible|0|||
145957874|NCT02659943|526358209|FG002|Overall Study|Ineligible|0|||
146213750|NCT04093752|527297158|FG002|Overall Study|Death|1|||
146213751|NCT04093752|527297159|FG003|Overall Study|Death|2|||
146213752|NCT04093752|527297156|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
146213753|NCT04093752|527297157|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
145957875|NCT02659943|526358210|FG003|Overall Study|Ineligible|0|||
145957876|NCT02659943|526358211|FG004|Overall Study|Ineligible|0|||
145957877|NCT02659943|526358212|FG005|Overall Study|Ineligible|0|||
145957878|NCT02659943|526358213|FG006|Overall Study|Ineligible|1|||
146083968|NCT00608569|526826629|FG001|Overall Study|Death|3|||
146213754|NCT04093752|527297158|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
146213755|NCT04093752|527297159|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
146286981|NCT00484289|527567285|FG001|Long Term Phase|Inadequate response|7|||
146286982|NCT00484289|527567286|FG002|Long Term Phase|Inadequate response|4|||
146286983|NCT00484289|527567284|FG000|Long Term Phase|Other Reason|0|||
146286984|NCT00484289|527567285|FG001|Long Term Phase|Other Reason|5|||
146286985|NCT00484289|527567286|FG002|Long Term Phase|Other Reason|1|||
145957879|NCT02659943|526358207|FG000|Overall Study|No longer meets eligibility|0|||
145957880|NCT02659943|526358208|FG001|Overall Study|No longer meets eligibility|0|||
145957881|NCT02659943|526358209|FG002|Overall Study|No longer meets eligibility|0|||
145957882|NCT02659943|526358210|FG003|Overall Study|No longer meets eligibility|0|||
145957883|NCT02659943|526358211|FG004|Overall Study|No longer meets eligibility|0|||
145957884|NCT02659943|526358212|FG005|Overall Study|No longer meets eligibility|0|||
145957885|NCT02659943|526358213|FG006|Overall Study|No longer meets eligibility|1|||
145957886|NCT02659943|526358207|FG000|Overall Study|No treatment, per protocol|0|||
145957887|NCT02659943|526358208|FG001|Overall Study|No treatment, per protocol|0|||
145957888|NCT02659943|526358209|FG002|Overall Study|No treatment, per protocol|0|||
145957889|NCT02659943|526358210|FG003|Overall Study|No treatment, per protocol|0|||
145957890|NCT02659943|526358211|FG004|Overall Study|No treatment, per protocol|0|||
145957891|NCT02659943|526358212|FG005|Overall Study|No treatment, per protocol|0|||
145957892|NCT02659943|526358213|FG006|Overall Study|No treatment, per protocol|3|||
145957893|NCT01723072|526358214|FG000|Overall Study|Withdrawal by Subject|7|||
146213756|NCT04093752|527297156|FG000|Overall Study|Covid 19|0|||
146213757|NCT04093752|527297157|FG001|Overall Study|Covid 19|0|||
146213758|NCT04093752|527297158|FG002|Overall Study|Covid 19|0|||
145957894|NCT01723072|526358215|FG001|Overall Study|Withdrawal by Subject|13|||
145957895|NCT01723072|526358214|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
145957896|NCT01723072|526358215|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
145957897|NCT01723072|526358214|FG000|Overall Study|Other|4|||
145957898|NCT01723072|526358215|FG001|Overall Study|Other|3|||
145957899|NCT03428100|526358216|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
145957900|NCT03428100|526358217|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
146213759|NCT04093752|527297159|FG003|Overall Study|Covid 19|1|||
146286986|NCT00484289|527567284|FG000|Post Marketing Phase|Adverse Event|0|||
146286987|NCT00484289|527567285|FG001|Post Marketing Phase|Adverse Event|1|||
146286988|NCT00484289|527567286|FG002|Post Marketing Phase|Adverse Event|0|||
146286989|NCT02831387|527567287|FG000|Overall Study|Withdrawal by Subject|1|||
146286990|NCT02831387|527567288|FG001|Overall Study|Withdrawal by Subject|1|||
146286991|NCT02831387|527567287|FG000|Overall Study|Discontinued due to stock recovery|0|||
146286992|NCT02831387|527567288|FG001|Overall Study|Discontinued due to stock recovery|1|||
146286993|NCT00192647|527567289|FG000|Overall Study|Death|1|||
146286994|NCT00192647|527567290|FG001|Overall Study|Death|1|||
145957901|NCT03428100|526358218|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
145957902|NCT03428100|526358219|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
145957903|NCT03428100|526358220|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957904|NCT03428100|526358221|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957905|NCT03428100|526358222|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957906|NCT03428100|526358223|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957907|NCT03428100|526358224|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957908|NCT03428100|526358225|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957909|NCT03428100|526358226|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957910|NCT03428100|526358227|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957911|NCT03428100|526358228|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957912|NCT03428100|526358229|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957913|NCT03428100|526358230|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957914|NCT03428100|526358231|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957915|NCT03428100|526358232|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957916|NCT03428100|526358233|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957917|NCT03428100|526358234|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145957918|NCT03428100|526358216|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
145957919|NCT03428100|526358217|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
145957920|NCT03428100|526358218|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
145957921|NCT03428100|526358219|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
145957922|NCT03428100|526358220|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957923|NCT03428100|526358221|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957924|NCT03428100|526358222|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957925|NCT03428100|526358223|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957926|NCT03428100|526358224|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957927|NCT03428100|526358225|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957928|NCT03428100|526358226|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957929|NCT03428100|526358227|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957930|NCT03428100|526358228|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957931|NCT03428100|526358229|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957932|NCT03428100|526358230|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957933|NCT03428100|526358231|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957934|NCT03428100|526358232|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957935|NCT03428100|526358233|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957936|NCT03428100|526358234|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145957937|NCT03428100|526358216|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957938|NCT03428100|526358217|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
145957939|NCT03428100|526358218|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
145957940|NCT03428100|526358219|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957941|NCT03428100|526358220|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957942|NCT03428100|526358221|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957943|NCT03428100|526358222|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957944|NCT03428100|526358223|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957945|NCT03428100|526358224|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957946|NCT03428100|526358225|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
146286995|NCT00192647|527567289|FG000|Overall Study|Adverse Event|35|||
146286996|NCT00192647|527567290|FG001|Overall Study|Adverse Event|29|||
146286997|NCT00192647|527567289|FG000|Overall Study|Laboratory Test Abnormality|4|||
146286998|NCT00192647|527567290|FG001|Overall Study|Laboratory Test Abnormality|2|||
146083969|NCT00608569|526826628|FG000|Overall Study|Lost to Follow-up|4|||
146083970|NCT00608569|526826629|FG001|Overall Study|Lost to Follow-up|5|||
146083971|NCT00608569|526826628|FG000|Overall Study|Withdrawal by Subject|1|||
146083972|NCT00608569|526826629|FG001|Overall Study|Withdrawal by Subject|0|||
146083973|NCT00608569|526826628|FG000|Overall Study|Adverse Event|1|||
146083974|NCT00608569|526826629|FG001|Overall Study|Adverse Event|0|||
146083975|NCT00608569|526826628|FG000|Overall Study|Unable to adhere with study requirements|0|||
146083976|NCT00608569|526826629|FG001|Overall Study|Unable to adhere with study requirements|1|||
146083977|NCT02312687|526826632|FG000|Overall Study|Other, Not Specified|1|||
146083978|NCT00384111|526826633|FG000|Overall Study|Disease Progression|3|||
146083979|NCT00384111|526826633|FG000|Overall Study|Adverse Event|1|||
146083980|NCT00384111|526826633|FG000|Overall Study|Investigator Decision|3|||
146083981|NCT00384111|526826633|FG000|Overall Study|Study Terminated by the Sponsor|19|||
146083982|NCT03645434|526826642|FG000|Period 1|Adverse Event|0|||
146083983|NCT03645434|526826643|FG001|Period 1|Adverse Event|0|||
146083984|NCT03645434|526826644|FG002|Period 1|Adverse Event|0|||
146083985|NCT03645434|526826645|FG003|Period 1|Adverse Event|1|||
146083986|NCT03645434|526826646|FG004|Period 1|Adverse Event|0|||
146083987|NCT03645434|526826647|FG005|Period 1|Adverse Event|0|||
146083988|NCT03645434|526826642|FG000|Period 1|COPD exacerbation|0|||
146083989|NCT03645434|526826643|FG001|Period 1|COPD exacerbation|0|||
146083990|NCT03645434|526826644|FG002|Period 1|COPD exacerbation|0|||
146083991|NCT03645434|526826645|FG003|Period 1|COPD exacerbation|0|||
146083992|NCT03645434|526826646|FG004|Period 1|COPD exacerbation|1|||
146083993|NCT03645434|526826647|FG005|Period 1|COPD exacerbation|0|||
146083994|NCT00167778|526826648|FG000|Overall Study|Withdrawal by Subject|1|||
146083995|NCT02654717|526826649|FG000|Overall Study|Adverse Event|2|||
146083996|NCT02654717|526826650|FG001|Overall Study|Adverse Event|2|||
146083997|NCT02654717|526826649|FG000|Overall Study|Protocol Violation|1|||
146083998|NCT02654717|526826650|FG001|Overall Study|Protocol Violation|2|||
146083999|NCT02654717|526826649|FG000|Overall Study|Withdrawal by Subject|0|||
146084000|NCT02654717|526826650|FG001|Overall Study|Withdrawal by Subject|1|||
146084001|NCT02654717|526826649|FG000|Overall Study|Non-permitted medication|3|||
146084002|NCT02654717|526826650|FG001|Overall Study|Non-permitted medication|0|||
146084003|NCT00336583|526827876|FG000|Overall Study|Lost to Follow-up|1|||
146084004|NCT00336583|526827876|FG000|Overall Study|Death|1|||
146084005|NCT02054481|526827877|FG000|Overall Study|Adverse Event|1|||
146084006|NCT02054481|526827878|FG001|Overall Study|Adverse Event|1|||
146084007|NCT02054481|526827879|FG002|Overall Study|Adverse Event|0|||
146084008|NCT02054481|526827880|FG003|Overall Study|Adverse Event|1|||
146084009|NCT02054481|526827877|FG000|Overall Study|Lost to Follow-up|1|||
146084010|NCT02054481|526827878|FG001|Overall Study|Lost to Follow-up|0|||
146084011|NCT02054481|526827879|FG002|Overall Study|Lost to Follow-up|0|||
146084012|NCT02054481|526827880|FG003|Overall Study|Lost to Follow-up|0|||
146084013|NCT02054481|526827877|FG000|Overall Study|Other reason|2|||
146084014|NCT02054481|526827878|FG001|Overall Study|Other reason|1|||
146084015|NCT02054481|526827879|FG002|Overall Study|Other reason|2|||
146084016|NCT02054481|526827880|FG003|Overall Study|Other reason|0|||
146084017|NCT02320903|526827881|FG000|Overall Study|Withdrawal by Subject|0|||
146084018|NCT02320903|526827882|FG001|Overall Study|Withdrawal by Subject|9|||
146084019|NCT02320903|526827883|FG002|Overall Study|Withdrawal by Subject|9|||
146084020|NCT02320903|526827881|FG000|Overall Study|Exited therapy; no longer eligible|8|||
146213760|NCT04093752|527297156|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146213761|NCT04093752|527297157|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146213762|NCT04093752|527297158|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
146213763|NCT04093752|527297159|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
146213764|NCT04093752|527297156|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
146213765|NCT04093752|527297157|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
146213766|NCT04093752|527297158|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
146213767|NCT04093752|527297159|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
146213768|NCT04093752|527297156|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
146084021|NCT02320903|526827882|FG001|Overall Study|Exited therapy; no longer eligible|2|||
146084022|NCT02320903|526827883|FG002|Overall Study|Exited therapy; no longer eligible|2|||
146213769|NCT04093752|527297157|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
146213770|NCT04093752|527297158|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
146213771|NCT04093752|527297159|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
146213772|NCT03527160|527297164|FG000|Overall Study|No urine collected|13|||
145957947|NCT03428100|526358226|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957948|NCT03428100|526358227|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957949|NCT03428100|526358228|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957950|NCT03428100|526358229|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957951|NCT03428100|526358230|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957952|NCT03428100|526358231|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957953|NCT03428100|526358232|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957954|NCT03428100|526358233|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957955|NCT03428100|526358234|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145957956|NCT03428100|526358216|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
145957957|NCT03428100|526358217|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957958|NCT03428100|526358218|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957959|NCT03428100|526358219|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957960|NCT03428100|526358220|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957961|NCT03428100|526358221|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957962|NCT03428100|526358222|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957963|NCT03428100|526358223|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957964|NCT03428100|526358224|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957965|NCT03428100|526358225|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957966|NCT03428100|526358226|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957967|NCT03428100|526358227|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957968|NCT03428100|526358228|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957969|NCT03428100|526358229|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957970|NCT03428100|526358230|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957971|NCT03428100|526358231|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957972|NCT03428100|526358232|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957973|NCT03428100|526358233|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957974|NCT03428100|526358234|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145957975|NCT03428100|526358216|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957976|NCT03428100|526358217|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
145957977|NCT03428100|526358218|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957978|NCT03428100|526358219|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957979|NCT03428100|526358220|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957980|NCT03428100|526358221|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957981|NCT03428100|526358222|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957982|NCT03428100|526358223|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957983|NCT03428100|526358224|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957984|NCT03428100|526358225|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957985|NCT03428100|526358226|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957986|NCT03428100|526358227|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957987|NCT03428100|526358228|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957988|NCT03428100|526358229|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957989|NCT03428100|526358230|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957990|NCT03428100|526358231|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957991|NCT03428100|526358232|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957992|NCT03428100|526358233|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957993|NCT03428100|526358234|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145957994|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145957995|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145957996|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145957997|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145957998|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145957999|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
145958000|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958001|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
145958002|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958003|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145958004|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958005|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145958006|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
146213773|NCT03527160|527297164|FG000|Overall Study|No clinical serum creatinine collected|6|||
146213774|NCT03527160|527297164|FG000|Overall Study|Did not meet inclusion|2|||
145958007|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958008|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958009|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145958010|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
145958011|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
146084023|NCT02320903|526827881|FG000|Overall Study|Lost to Follow-up|0|||
146084024|NCT02320903|526827882|FG001|Overall Study|Lost to Follow-up|5|||
146084025|NCT02320903|526827883|FG002|Overall Study|Lost to Follow-up|5|||
146084026|NCT00883688|526827884|FG000|Overall Study|Ineligible|2|||
146084027|NCT03086967|526827891|FG000|Overall Study|Screen Failure|2|||
146084028|NCT03086967|526827892|FG001|Overall Study|Screen Failure|2|||
146084029|NCT01475071|526827899|FG000|Overall Study|Physician Decision|1|||
146084030|NCT01475071|526827899|FG000|Overall Study|Withdrawal by Subject|6|||
146084031|NCT01475071|526827899|FG000|Overall Study|Lost to Follow-up|1|||
146084032|NCT01752036|526827901|FG000|Overall Study|Death|2|||
146084033|NCT02230527|526827902|FG000|Overall Study|Withdrawal by Subject|1|||
146084034|NCT02230527|526827903|FG001|Overall Study|Withdrawal by Subject|1|||
146084035|NCT02230527|526827902|FG000|Overall Study|Death|1|||
146084036|NCT02230527|526827903|FG001|Overall Study|Death|0|||
146084037|NCT02230527|526827902|FG000|Overall Study|Lost to Follow-up|2|||
146084038|NCT02230527|526827903|FG001|Overall Study|Lost to Follow-up|1|||
146084039|NCT02230527|526827902|FG000|Overall Study|Other|1|||
146084040|NCT02230527|526827903|FG001|Overall Study|Other|0|||
146084041|NCT01011478|526827904|FG000|Overall Study|No follow up data|12|||
146084042|NCT01011478|526827905|FG001|Overall Study|No follow up data|7|||
146084043|NCT04461600|526827906|FG000|Overall Study|Death|6|||
146084044|NCT04461600|526827907|FG001|Overall Study|Death|5|||
146084045|NCT04461600|526827906|FG000|Overall Study|Withdrawal by Subject|0|||
146084046|NCT04461600|526827907|FG001|Overall Study|Withdrawal by Subject|1|||
146084047|NCT02278471|526827911|FG000|Overall Study|Lost to Follow-up|6|||
146084048|NCT02278471|526827912|FG001|Overall Study|Lost to Follow-up|15|||
146084049|NCT02278471|526827911|FG000|Overall Study|Death|2|||
146084050|NCT02278471|526827912|FG001|Overall Study|Death|2|||
146084051|NCT02278471|526827911|FG000|Overall Study|Withdrawal by Subject|0|||
146084052|NCT02278471|526827912|FG001|Overall Study|Withdrawal by Subject|3|||
146084053|NCT00640835|526827913|FG000|Overall Study|Adverse Event|5|||
146084054|NCT00640835|526827914|FG001|Overall Study|Adverse Event|3|||
146084055|NCT00640835|526827913|FG000|Overall Study|Withdrawal by Subject|12|||
146084056|NCT00640835|526827914|FG001|Overall Study|Withdrawal by Subject|14|||
145958012|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145958013|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
145958014|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
145958015|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
145958016|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
145958017|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
145958018|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
145958019|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
145958020|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
145958021|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
145958022|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
145958023|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
145958024|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
145958025|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
145958026|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
146084057|NCT00640835|526827913|FG000|Overall Study|Physician Decision|10|||
146084058|NCT00640835|526827914|FG001|Overall Study|Physician Decision|14|||
146084059|NCT00640835|526827913|FG000|Overall Study|Sponsor's Decision|11|||
146084060|NCT00640835|526827914|FG001|Overall Study|Sponsor's Decision|7|||
146084061|NCT00640835|526827913|FG000|Overall Study|Protocol Violation|2|||
146084062|NCT00640835|526827914|FG001|Overall Study|Protocol Violation|2|||
146084063|NCT00640835|526827913|FG000|Overall Study|Lost to Follow-up|17|||
146084064|NCT00640835|526827914|FG001|Overall Study|Lost to Follow-up|13|||
146084065|NCT00640835|526827913|FG000|Overall Study|Other Reason|19|||
145958027|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
145958028|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
146084066|NCT00640835|526827914|FG001|Overall Study|Other Reason|4|||
146084067|NCT01437995|526827915|FG000|Overall Study|Lost to Follow-up|11|||
146084068|NCT01437995|526827916|FG001|Overall Study|Lost to Follow-up|18|||
146084069|NCT01437995|526827917|FG002|Overall Study|Lost to Follow-up|20|||
146213775|NCT02910713|527297165|FG000|Overall Study|Protocol Violation|2|||
146213776|NCT02910713|527297165|FG000|Overall Study|Subject Choice|4|||
146213777|NCT02910713|527297165|FG000|Overall Study|Received One Application|10|||
146213778|NCT02910713|527297165|FG000|Overall Study|Received Neither Application|18|||
146213779|NCT02910713|527297165|FG000|Overall Study|Enrollment cap|7|||
146213780|NCT02910713|527297165|FG000|Overall Study|Investigator Discretion|1|||
146213781|NCT04442126|527297174|FG000|Overall Study|Withdrawal by Subject|0|||
146213782|NCT04442126|527297175|FG001|Overall Study|Withdrawal by Subject|0|||
146213783|NCT04442126|527297176|FG002|Overall Study|Withdrawal by Subject|0|||
145958029|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
145958030|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
145958031|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
145958032|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958033|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958034|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958035|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958036|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
145958037|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
145958038|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
145958039|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145958040|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958041|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145958042|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145958043|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145958044|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
145958045|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
145958046|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
145958047|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
145958048|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145958049|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145958050|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
145958051|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958052|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958053|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958054|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958055|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958056|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958057|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958058|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145958059|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958060|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958061|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958062|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
145958063|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145958064|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958065|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
146213784|NCT04442126|527297177|FG003|Overall Study|Withdrawal by Subject|2|||
146213785|NCT04442126|527297178|FG004|Overall Study|Withdrawal by Subject|1|||
146213786|NCT04442126|527297179|FG005|Overall Study|Withdrawal by Subject|0|||
146213787|NCT04442126|527297180|FG006|Overall Study|Withdrawal by Subject|1|||
146213788|NCT04442126|527297181|FG007|Overall Study|Withdrawal by Subject|1|||
146213789|NCT04442126|527297182|FG008|Overall Study|Withdrawal by Subject|3|||
146213790|NCT04442126|527297174|FG000|Overall Study|Death|1|||
146213791|NCT04442126|527297175|FG001|Overall Study|Death|0|||
146213792|NCT04442126|527297176|FG002|Overall Study|Death|0|||
146213793|NCT04442126|527297177|FG003|Overall Study|Death|1|||
146213794|NCT04442126|527297178|FG004|Overall Study|Death|2|||
146213795|NCT04442126|527297179|FG005|Overall Study|Death|2|||
146213796|NCT04442126|527297180|FG006|Overall Study|Death|4|||
146213797|NCT04442126|527297181|FG007|Overall Study|Death|1|||
146213798|NCT04442126|527297182|FG008|Overall Study|Death|5|||
146213799|NCT04442126|527297174|FG000|Overall Study|Study Terminated by Sponsor|0|||
146213800|NCT04442126|527297175|FG001|Overall Study|Study Terminated by Sponsor|0|||
146213801|NCT04442126|527297176|FG002|Overall Study|Study Terminated by Sponsor|0|||
146213802|NCT04442126|527297177|FG003|Overall Study|Study Terminated by Sponsor|0|||
146213803|NCT04442126|527297178|FG004|Overall Study|Study Terminated by Sponsor|0|||
146213804|NCT04442126|527297179|FG005|Overall Study|Study Terminated by Sponsor|1|||
146213805|NCT04442126|527297180|FG006|Overall Study|Study Terminated by Sponsor|4|||
146213806|NCT04442126|527297181|FG007|Overall Study|Study Terminated by Sponsor|2|||
146213807|NCT04442126|527297182|FG008|Overall Study|Study Terminated by Sponsor|10|||
146213808|NCT04442126|527297174|FG000|Overall Study|Lost to Follow-up|0|||
146213809|NCT04442126|527297175|FG001|Overall Study|Lost to Follow-up|0|||
146213810|NCT04442126|527297176|FG002|Overall Study|Lost to Follow-up|0|||
146213811|NCT04442126|527297177|FG003|Overall Study|Lost to Follow-up|0|||
146213812|NCT04442126|527297178|FG004|Overall Study|Lost to Follow-up|0|||
146213813|NCT04442126|527297179|FG005|Overall Study|Lost to Follow-up|0|||
146213814|NCT04442126|527297180|FG006|Overall Study|Lost to Follow-up|0|||
146213815|NCT04442126|527297181|FG007|Overall Study|Lost to Follow-up|1|||
146213816|NCT04442126|527297182|FG008|Overall Study|Lost to Follow-up|2|||
146213817|NCT04442126|527297174|FG000|Overall Study|Progressive Disease|0|||
146213818|NCT04442126|527297175|FG001|Overall Study|Progressive Disease|1|||
146213819|NCT04442126|527297176|FG002|Overall Study|Progressive Disease|3|||
146213820|NCT04442126|527297177|FG003|Overall Study|Progressive Disease|0|||
146213821|NCT04442126|527297178|FG004|Overall Study|Progressive Disease|3|||
146213822|NCT04442126|527297179|FG005|Overall Study|Progressive Disease|0|||
146286999|NCT00192647|527567289|FG000|Overall Study|Insufficient Therapeutic Response|53|||
146213823|NCT04442126|527297180|FG006|Overall Study|Progressive Disease|0|||
146213824|NCT04442126|527297181|FG007|Overall Study|Progressive Disease|0|||
146213825|NCT04442126|527297182|FG008|Overall Study|Progressive Disease|0|||
146213826|NCT04442126|527297174|FG000|Overall Study|Other|0|||
146213827|NCT04442126|527297175|FG001|Overall Study|Other|0|||
146213828|NCT04442126|527297176|FG002|Overall Study|Other|0|||
146213829|NCT04442126|527297177|FG003|Overall Study|Other|0|||
145958066|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958067|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958068|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145958069|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145958070|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
145958071|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
145958072|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
145958073|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
145958074|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
145958075|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
145958076|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
145958077|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
145958078|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
145958079|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
145958080|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
145958081|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
145958082|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
145958083|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
145958084|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
145958085|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
145958086|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
145958087|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
145958088|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
145958089|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958090|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958091|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958092|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958093|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958094|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958095|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
145958096|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958097|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958098|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958099|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958100|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958101|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958102|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958103|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958104|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958105|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958106|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145958107|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
145958108|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145958109|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145958110|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145958111|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145958112|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
145958113|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
145958114|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145958115|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145958116|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
145958117|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
145958118|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
145958119|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
145958120|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145958121|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
145958122|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
146213830|NCT04442126|527297178|FG004|Overall Study|Other|0|||
146213831|NCT04442126|527297179|FG005|Overall Study|Other|0|||
146213832|NCT04442126|527297180|FG006|Overall Study|Other|0|||
146213833|NCT04442126|527297181|FG007|Overall Study|Other|0|||
146213834|NCT04442126|527297182|FG008|Overall Study|Other|1|||
146213835|NCT06450405|527297183|FG000|Overall Study|Study funding terminated.|0|||
146213836|NCT06450405|527297184|FG001|Overall Study|Study funding terminated.|2|||
146213837|NCT04923347|527298400|FG000|Overall Study|Withdrawal by Subject|14|||
146213838|NCT04052516|527298401|FG000|Overall Study|Withdrawal by Subject|4|||
146213839|NCT04052516|527298402|FG001|Overall Study|Withdrawal by Subject|5|||
146213840|NCT04052516|527298403|FG002|Overall Study|Withdrawal by Subject|6|||
146213841|NCT04052516|527298401|FG000|Overall Study|Adverse Event|3|||
146213842|NCT04052516|527298402|FG001|Overall Study|Adverse Event|2|||
146213843|NCT04052516|527298403|FG002|Overall Study|Adverse Event|8|||
146213844|NCT04052516|527298401|FG000|Overall Study|Lost to Follow-up|2|||
146213845|NCT04052516|527298402|FG001|Overall Study|Lost to Follow-up|5|||
146213846|NCT04052516|527298403|FG002|Overall Study|Lost to Follow-up|3|||
146213847|NCT04052516|527298401|FG000|Overall Study|Protocol Violation|1|||
146213848|NCT04052516|527298402|FG001|Overall Study|Protocol Violation|1|||
146213849|NCT04052516|527298403|FG002|Overall Study|Protocol Violation|0|||
146213850|NCT04052516|527298401|FG000|Overall Study|Death|1|||
146213851|NCT04052516|527298402|FG001|Overall Study|Death|0|||
146213852|NCT04052516|527298403|FG002|Overall Study|Death|0|||
146213853|NCT04052516|527298401|FG000|Overall Study|Physician Decision|0|||
146213854|NCT04052516|527298402|FG001|Overall Study|Physician Decision|1|||
146213855|NCT04052516|527298403|FG002|Overall Study|Physician Decision|0|||
146213856|NCT04052516|527298401|FG000|Overall Study|Pregnancy|1|||
146213857|NCT04052516|527298402|FG001|Overall Study|Pregnancy|0|||
146213858|NCT04052516|527298403|FG002|Overall Study|Pregnancy|0|||
146213859|NCT04052516|527298401|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
146213860|NCT04052516|527298402|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
146213861|NCT04052516|527298403|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
146213862|NCT04052516|527298401|FG000|Overall Study|Reason not recorded|0|||
146213863|NCT04052516|527298402|FG001|Overall Study|Reason not recorded|1|||
146213864|NCT04052516|527298403|FG002|Overall Study|Reason not recorded|0|||
146213865|NCT05113966|527298404|FG000|Overall Study|Death|21|||
146213866|NCT05113966|527298404|FG000|Overall Study|Study Terminated by Sponsor|9|||
146213867|NCT05386355|527298405|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146213868|NCT05386355|527298406|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146213869|NCT05386355|527298407|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146213870|NCT05386355|527298408|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
146213871|NCT04521478|527298413|FG000|Overall Study|Protocol Violation|2|||
146213872|NCT04521478|527298414|FG001|Overall Study|Protocol Violation|0|||
146213873|NCT04521478|527298415|FG002|Overall Study|Protocol Violation|1|||
146213874|NCT04521478|527298416|FG003|Overall Study|Protocol Violation|0|||
146213875|NCT04521478|527298417|FG004|Overall Study|Protocol Violation|0|||
146213876|NCT04521478|527298418|FG005|Overall Study|Protocol Violation|0|||
146213877|NCT04521478|527298413|FG000|Overall Study|Technical Problems|0|||
146213878|NCT04521478|527298414|FG001|Overall Study|Technical Problems|0|||
146213879|NCT04521478|527298415|FG002|Overall Study|Technical Problems|0|||
146213880|NCT04521478|527298416|FG003|Overall Study|Technical Problems|1|||
146213881|NCT04521478|527298417|FG004|Overall Study|Technical Problems|0|||
146213882|NCT04521478|527298418|FG005|Overall Study|Technical Problems|0|||
146213883|NCT04521478|527298413|FG000|Overall Study|Burden of Study Procedures|1|||
146213884|NCT04521478|527298414|FG001|Overall Study|Burden of Study Procedures|0|||
146213885|NCT04521478|527298415|FG002|Overall Study|Burden of Study Procedures|0|||
146213886|NCT04521478|527298416|FG003|Overall Study|Burden of Study Procedures|1|||
146213887|NCT04521478|527298417|FG004|Overall Study|Burden of Study Procedures|0|||
146213888|NCT04521478|527298418|FG005|Overall Study|Burden of Study Procedures|1|||
146213889|NCT04521478|527298413|FG000|Overall Study|Lack of Efficacy|0|||
146213890|NCT04521478|527298414|FG001|Overall Study|Lack of Efficacy|0|||
146213891|NCT04521478|527298415|FG002|Overall Study|Lack of Efficacy|0|||
146213892|NCT04521478|527298416|FG003|Overall Study|Lack of Efficacy|0|||
146213893|NCT04521478|527298417|FG004|Overall Study|Lack of Efficacy|1|||
146213894|NCT04521478|527298418|FG005|Overall Study|Lack of Efficacy|1|||
146213895|NCT04521478|527298413|FG000|Overall Study|Adverse Event|7|||
146213896|NCT04521478|527298414|FG001|Overall Study|Adverse Event|0|||
146213897|NCT04521478|527298415|FG002|Overall Study|Adverse Event|2|||
146213898|NCT04521478|527298416|FG003|Overall Study|Adverse Event|1|||
146213899|NCT04521478|527298417|FG004|Overall Study|Adverse Event|2|||
146213900|NCT04521478|527298418|FG005|Overall Study|Adverse Event|7|||
146213901|NCT04521478|527298413|FG000|Overall Study|No Reason Available|0|||
146213902|NCT04521478|527298414|FG001|Overall Study|No Reason Available|2|||
146213903|NCT04521478|527298415|FG002|Overall Study|No Reason Available|0|||
146213904|NCT04521478|527298416|FG003|Overall Study|No Reason Available|0|||
146213905|NCT04521478|527298417|FG004|Overall Study|No Reason Available|1|||
146213906|NCT04521478|527298418|FG005|Overall Study|No Reason Available|0|||
146213907|NCT04521478|527298413|FG000|Overall Study|Other than listed|3|||
146213908|NCT04521478|527298414|FG001|Overall Study|Other than listed|3|||
146213909|NCT04521478|527298415|FG002|Overall Study|Other than listed|3|||
146213910|NCT04521478|527298416|FG003|Overall Study|Other than listed|2|||
146213911|NCT04521478|527298417|FG004|Overall Study|Other than listed|3|||
146213912|NCT04521478|527298418|FG005|Overall Study|Other than listed|3|||
146213913|NCT04521478|527298413|FG000|Overall Study|Not treated|0|||
146213914|NCT04521478|527298414|FG001|Overall Study|Not treated|0|||
146213915|NCT04521478|527298415|FG002|Overall Study|Not treated|0|||
146213916|NCT04521478|527298416|FG003|Overall Study|Not treated|0|||
146213917|NCT04521478|527298417|FG004|Overall Study|Not treated|0|||
146213918|NCT04521478|527298418|FG005|Overall Study|Not treated|1|||
146213919|NCT03625882|527298419|FG000|Overall Study|Protocol Violation|3|||
146213920|NCT05058391|527298422|FG000|Overall Study|Adverse Event|1|||
146213921|NCT03833245|527298424|FG000|Overall Study|Death|0|||
146213922|NCT03833245|527298425|FG001|Overall Study|Death|1|||
146213923|NCT03775109|527298426|FG000|Overall Study|Adverse Event|1|||
146213924|NCT03775109|527298427|FG001|Overall Study|Adverse Event|0|||
146213925|NCT03775109|527298426|FG000|Overall Study|COVID-19 outbreak|2|||
146213926|NCT03775109|527298427|FG001|Overall Study|COVID-19 outbreak|0|||
146213927|NCT03775109|527298426|FG000|Overall Study|Lost to Follow-up|0|||
146213928|NCT03775109|527298427|FG001|Overall Study|Lost to Follow-up|2|||
146213929|NCT03775109|527298426|FG000|Overall Study|Withdrawal by Subject|1|||
146213930|NCT03775109|527298427|FG001|Overall Study|Withdrawal by Subject|1|||
146213931|NCT03775109|527298426|FG000|Overall Study|Death|0|||
146213932|NCT03775109|527298427|FG001|Overall Study|Death|1|||
146213933|NCT03775109|527298426|FG000|Overall Study|Lack of Efficacy|1|||
146213934|NCT03775109|527298427|FG001|Overall Study|Lack of Efficacy|0|||
146213935|NCT03347383|527298428|FG000|Overall Study|Death|39|||
146213936|NCT03347383|527298428|FG000|Overall Study|Withdrawal by Subject|3|||
146213937|NCT03347383|527298428|FG000|Overall Study|Lost to Follow-up|9|||
146213938|NCT03484702|527298429|FG000|Treatment Period|Death|3|||
146213939|NCT03484702|527298430|FG001|Treatment Period|Death|1|||
146213940|NCT03484702|527298431|FG002|Treatment Period|Death|0|||
146213941|NCT03484702|527298432|FG003|Treatment Period|Death|0|||
146213942|NCT03484702|527298433|FG004|Treatment Period|Death|0|||
146213943|NCT03484702|527298434|FG005|Treatment Period|Death|0|||
146213944|NCT03484702|527298429|FG000|Treatment Period|Adverse Event|1|||
146213945|NCT03484702|527298430|FG001|Treatment Period|Adverse Event|0|||
146213946|NCT03484702|527298431|FG002|Treatment Period|Adverse Event|0|||
146213947|NCT03484702|527298432|FG003|Treatment Period|Adverse Event|0|||
146213948|NCT03484702|527298433|FG004|Treatment Period|Adverse Event|0|||
146213949|NCT03484702|527298434|FG005|Treatment Period|Adverse Event|0|||
146213950|NCT03484702|527298429|FG000|Treatment Period|Participant Withdrew from Study|0|||
146213951|NCT03484702|527298430|FG001|Treatment Period|Participant Withdrew from Study|1|||
146213952|NCT03484702|527298431|FG002|Treatment Period|Participant Withdrew from Study|0|||
146213953|NCT03484702|527298432|FG003|Treatment Period|Participant Withdrew from Study|0|||
146213954|NCT03484702|527298433|FG004|Treatment Period|Participant Withdrew from Study|0|||
146287000|NCT00192647|527567290|FG001|Overall Study|Insufficient Therapeutic Response|83|||
146084070|NCT04618770|526827918|FG000|Overall Study|Censored from Analysis|12|||
146213955|NCT03484702|527298434|FG005|Treatment Period|Participant Withdrew from Study|0|||
146213956|NCT03484702|527298429|FG000|Treatment Period|Physician Decision|0|||
146213957|NCT03484702|527298430|FG001|Treatment Period|Physician Decision|1|||
146213958|NCT03484702|527298431|FG002|Treatment Period|Physician Decision|0|||
146213959|NCT03484702|527298432|FG003|Treatment Period|Physician Decision|0|||
146213960|NCT03484702|527298433|FG004|Treatment Period|Physician Decision|0|||
146287001|NCT00192647|527567289|FG000|Overall Study|Entry Criteria Violation|6|||
146213961|NCT03484702|527298434|FG005|Treatment Period|Physician Decision|1|||
146213962|NCT01894061|527298437|FG000|Overall Study|Screen failure|1|||
146213963|NCT01894061|527298437|FG000|Overall Study|Withdrawal by Subject|1|||
146213964|NCT05110495|527298438|FG000|Overall Study|Lost to Follow-up|1|||
146213965|NCT05110495|527298438|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
146213966|NCT05141903|527298440|FG000|Overall Study|Withdrawal by Subject|0|||
146213967|NCT05141903|527298441|FG001|Overall Study|Withdrawal by Subject|1|||
146213968|NCT05141903|527298442|FG002|Overall Study|Withdrawal by Subject|1|||
146213969|NCT05141903|527298443|FG003|Overall Study|Withdrawal by Subject|0|||
145958123|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
145958124|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
145958125|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
145958126|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
145958127|NCT03428100|526358216|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958128|NCT03428100|526358217|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958129|NCT03428100|526358218|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958130|NCT03428100|526358219|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958131|NCT03428100|526358220|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145958132|NCT03428100|526358221|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958133|NCT03428100|526358222|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145958134|NCT03428100|526358223|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145958135|NCT03428100|526358224|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958136|NCT03428100|526358225|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
145958137|NCT03428100|526358226|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
145958138|NCT03428100|526358227|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145958139|NCT03428100|526358228|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145958140|NCT03428100|526358229|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145958141|NCT03428100|526358230|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
145958142|NCT03428100|526358231|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958143|NCT03428100|526358232|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
145958144|NCT03428100|526358233|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145958145|NCT03428100|526358234|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145958146|NCT02106351|526358238|FG000|Treatment Cycle 1|Adverse Event|2|||
145958147|NCT02106351|526358239|FG001|Treatment Cycle 1|Adverse Event|0|||
145958148|NCT02106351|526358240|FG002|Treatment Cycle 1|Adverse Event|0|||
145958149|NCT02106351|526358238|FG000|Treatment Cycle 1|Consent withdrawn|1|||
145958150|NCT02106351|526358239|FG001|Treatment Cycle 1|Consent withdrawn|0|||
145958151|NCT02106351|526358240|FG002|Treatment Cycle 1|Consent withdrawn|2|||
145958152|NCT02106351|526358238|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
145958153|NCT02106351|526358239|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
145958154|NCT02106351|526358240|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
145958155|NCT02106351|526358238|FG000|Treatment Cycle 1|Other|0|||
145958156|NCT02106351|526358239|FG001|Treatment Cycle 1|Other|3|||
145958157|NCT02106351|526358240|FG002|Treatment Cycle 1|Other|1|||
145958158|NCT02106351|526358238|FG000|Treatment Cycle 1|Randomised but not treated|1|||
145958159|NCT02106351|526358239|FG001|Treatment Cycle 1|Randomised but not treated|0|||
145958160|NCT02106351|526358240|FG002|Treatment Cycle 1|Randomised but not treated|1|||
145958161|NCT02106351|526358238|FG000|Treatment Cycle 2|Adverse Event|0|||
145958162|NCT02106351|526358239|FG001|Treatment Cycle 2|Adverse Event|2|||
145958163|NCT02106351|526358240|FG002|Treatment Cycle 2|Adverse Event|0|||
145958164|NCT02106351|526358238|FG000|Treatment Cycle 2|Consent withdrawn|0|||
145958165|NCT02106351|526358239|FG001|Treatment Cycle 2|Consent withdrawn|1|||
145958166|NCT02106351|526358240|FG002|Treatment Cycle 2|Consent withdrawn|1|||
145958167|NCT02106351|526358238|FG000|Treatment Cycle 2|Other|0|||
145958168|NCT02106351|526358239|FG001|Treatment Cycle 2|Other|2|||
145958169|NCT02106351|526358240|FG002|Treatment Cycle 2|Other|2|||
145958170|NCT02106351|526358238|FG000|Treatment Cycle 3|Adverse Event|0|||
145958171|NCT02106351|526358239|FG001|Treatment Cycle 3|Adverse Event|1|||
145958172|NCT02106351|526358240|FG002|Treatment Cycle 3|Adverse Event|0|||
145958173|NCT02106351|526358238|FG000|Treatment Cycle 3|Consent withdrawn|0|||
145958174|NCT02106351|526358239|FG001|Treatment Cycle 3|Consent withdrawn|0|||
145958175|NCT02106351|526358240|FG002|Treatment Cycle 3|Consent withdrawn|2|||
145958176|NCT02106351|526358238|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
145958177|NCT02106351|526358239|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
145958178|NCT02106351|526358240|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
145958179|NCT02106351|526358238|FG000|Treatment Cycle 3|Other|0|||
145958180|NCT02106351|526358239|FG001|Treatment Cycle 3|Other|2|||
145958181|NCT02106351|526358240|FG002|Treatment Cycle 3|Other|3|||
145958182|NCT02106351|526358238|FG000|Treatment Cycle 4|Consent withdrawn|0|||
145958183|NCT02106351|526358239|FG001|Treatment Cycle 4|Consent withdrawn|0|||
145958184|NCT02106351|526358240|FG002|Treatment Cycle 4|Consent withdrawn|2|||
145958185|NCT02106351|526358238|FG000|Treatment Cycle 4|Other|0|||
145958186|NCT02106351|526358239|FG001|Treatment Cycle 4|Other|1|||
145958187|NCT02106351|526358240|FG002|Treatment Cycle 4|Other|0|||
146084071|NCT04618770|526827918|FG000|Overall Study|Early Termination|25|||
145958188|NCT00069823|526358246|FG000|Overall Study|Did not have follow-up diary cards|6|||
145958189|NCT00069823|526358247|FG001|Overall Study|Did not have follow-up diary cards|3|||
145958190|NCT03560869|526358248|FG000|Overall Study|Withdrawal by Subject|3|||
145958191|NCT03560869|526358249|FG001|Overall Study|Withdrawal by Subject|4|||
145958192|NCT03560869|526358248|FG000|Overall Study|Screening failure|4|||
145958193|NCT03560869|526358249|FG001|Overall Study|Screening failure|4|||
146213970|NCT05141903|527298444|FG004|Overall Study|Withdrawal by Subject|0|||
146213971|NCT05141903|527298440|FG000|Overall Study|Other|1|||
146213972|NCT05141903|527298441|FG001|Overall Study|Other|1|||
145958194|NCT03560869|526358248|FG000|Overall Study|Withdrawal by PI|0|||
146084072|NCT04456673|526827919|FG000|Overall Study|Adverse Event|7|||
146084073|NCT04456673|526827920|FG001|Overall Study|Adverse Event|14|||
146213973|NCT05141903|527298442|FG002|Overall Study|Other|0|||
146213974|NCT05141903|527298443|FG003|Overall Study|Other|0|||
146213975|NCT05141903|527298444|FG004|Overall Study|Other|0|||
146213976|NCT02630823|527298447|FG000|Overall Study|Withdrawal by Subject|1|||
146213977|NCT02630823|527298447|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
146213978|NCT02287311|527298455|FG000|Cohort 1: Dose Level 1|Death|2|||
146213979|NCT02287311|527298456|FG001|Cohort 1: Dose Level 1|Death|0|||
146213980|NCT02287311|527298457|FG002|Cohort 1: Dose Level 1|Death|0|||
146213981|NCT02287311|527298458|FG003|Cohort 1: Dose Level 1|Death|3|||
146213982|NCT02287311|527298459|FG004|Cohort 1: Dose Level 1|Death|0|||
146213983|NCT02287311|527298460|FG005|Cohort 1: Dose Level 1|Death|0|||
146213984|NCT02287311|527298461|FG006|Cohort 1: Dose Level 1|Death|1|||
146213985|NCT02287311|527298462|FG007|Cohort 1: Dose Level 1|Death|0|||
146213986|NCT02287311|527298463|FG008|Cohort 1: Dose Level 1|Death|0|||
146213987|NCT02287311|527298455|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213988|NCT02287311|527298456|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213989|NCT02287311|527298457|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213990|NCT02287311|527298458|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
146213991|NCT02287311|527298459|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213992|NCT02287311|527298460|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213993|NCT02287311|527298461|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
146213994|NCT02287311|527298462|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213995|NCT02287311|527298463|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
146213996|NCT02287311|527298455|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
146213997|NCT02287311|527298456|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
146213998|NCT02287311|527298457|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
146213999|NCT02287311|527298458|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
146214000|NCT02287311|527298459|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
146214001|NCT02287311|527298460|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
146214002|NCT02287311|527298461|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
146214003|NCT02287311|527298462|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
146214004|NCT02287311|527298463|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
146214005|NCT02287311|527298455|FG000|Cohort 2: Dose Level 2|Death|0|||
146214006|NCT02287311|527298456|FG001|Cohort 2: Dose Level 2|Death|2|||
146214007|NCT02287311|527298457|FG002|Cohort 2: Dose Level 2|Death|0|||
146214008|NCT02287311|527298458|FG003|Cohort 2: Dose Level 2|Death|0|||
146214009|NCT02287311|527298459|FG004|Cohort 2: Dose Level 2|Death|2|||
146214010|NCT02287311|527298460|FG005|Cohort 2: Dose Level 2|Death|0|||
146214011|NCT02287311|527298461|FG006|Cohort 2: Dose Level 2|Death|0|||
146214012|NCT02287311|527298462|FG007|Cohort 2: Dose Level 2|Death|2|||
146214013|NCT02287311|527298463|FG008|Cohort 2: Dose Level 2|Death|0|||
146214014|NCT02287311|527298455|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214015|NCT02287311|527298456|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214016|NCT02287311|527298457|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214017|NCT02287311|527298458|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214018|NCT02287311|527298459|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
146214019|NCT02287311|527298460|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214020|NCT02287311|527298461|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214021|NCT02287311|527298462|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214022|NCT02287311|527298463|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
146214023|NCT02287311|527298455|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214024|NCT02287311|527298456|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
146214025|NCT02287311|527298457|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214026|NCT02287311|527298458|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214027|NCT02287311|527298459|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
146287002|NCT00192647|527567290|FG001|Overall Study|Entry Criteria Violation|6|||
146287003|NCT00192647|527567289|FG000|Overall Study|Protocol Violation|3|||
146214028|NCT02287311|527298460|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214029|NCT02287311|527298461|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214030|NCT02287311|527298462|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214031|NCT02287311|527298463|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
146214032|NCT02287311|527298455|FG000|Cohort 3: Dose Level 3|Death|0|||
146214033|NCT02287311|527298456|FG001|Cohort 3: Dose Level 3|Death|0|||
146214034|NCT02287311|527298457|FG002|Cohort 3: Dose Level 3|Death|4|||
146214035|NCT02287311|527298458|FG003|Cohort 3: Dose Level 3|Death|0|||
146214036|NCT02287311|527298459|FG004|Cohort 3: Dose Level 3|Death|0|||
146214037|NCT02287311|527298460|FG005|Cohort 3: Dose Level 3|Death|4|||
146214038|NCT02287311|527298461|FG006|Cohort 3: Dose Level 3|Death|0|||
146214039|NCT02287311|527298462|FG007|Cohort 3: Dose Level 3|Death|0|||
146214040|NCT02287311|527298463|FG008|Cohort 3: Dose Level 3|Death|2|||
146214041|NCT02287311|527298455|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146214042|NCT02287311|527298456|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146287004|NCT00192647|527567290|FG001|Overall Study|Protocol Violation|1|||
145958195|NCT03560869|526358249|FG001|Overall Study|Withdrawal by PI|1|||
145958196|NCT01801111|526358250|FG000|Overall Study|Adverse Event|12|||
145958197|NCT01801111|526358250|FG000|Overall Study|Death|8|||
145958198|NCT01801111|526358250|FG000|Overall Study|Physician Decision|5|||
145958199|NCT01801111|526358250|FG000|Overall Study|Other|1|||
145958200|NCT01801111|526358250|FG000|Overall Study|Withdrawal by Subject|4|||
145958201|NCT01801111|526358250|FG000|Overall Study|Study Terminated by Sponsor|27|||
145958202|NCT01801111|526358250|FG000|Overall Study|Progressive Disease|81|||
145958203|NCT01210482|526358251|FG000|Overall Study|Protocol Violation|1|||
145958204|NCT01210482|526358251|FG000|Overall Study|Case Report Forms were not collected|18|||
145958205|NCT01210482|526358251|FG000|Overall Study|Duplicated|2|||
145958206|NCT01210482|526358251|FG000|Overall Study|No Drug Administration|28|||
145958207|NCT01223937|526358252|FG000|Overall Study|Withdrawal by Subject|3|||
145958208|NCT01223937|526358253|FG001|Overall Study|Withdrawal by Subject|2|||
145958209|NCT01223937|526358252|FG000|Overall Study|Lost to Follow-up|1|||
145958210|NCT01223937|526358253|FG001|Overall Study|Lost to Follow-up|4|||
145958211|NCT01223937|526358252|FG000|Overall Study|Adverse Event|1|||
145958212|NCT01223937|526358253|FG001|Overall Study|Adverse Event|4|||
145958213|NCT01223937|526358252|FG000|Overall Study|Protocol Violation|8|||
145958214|NCT01223937|526358253|FG001|Overall Study|Protocol Violation|7|||
146214043|NCT02287311|527298457|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
145958215|NCT01223937|526358252|FG000|Overall Study|Other|4|||
145958216|NCT01223937|526358253|FG001|Overall Study|Other|1|||
145958217|NCT00765817|526358254|FG000|Overall Study|Adverse Event|13|||
145958218|NCT00765817|526358255|FG001|Overall Study|Adverse Event|1|||
145958219|NCT00765817|526358254|FG000|Overall Study|Death|0|||
146214044|NCT02287311|527298458|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146214045|NCT02287311|527298459|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146084074|NCT04456673|526827919|FG000|Overall Study|Poor compliance to protocol|1|||
146084075|NCT04456673|526827920|FG001|Overall Study|Poor compliance to protocol|0|||
146084076|NCT04456673|526827919|FG000|Overall Study|Withdrawal by Subject|31|||
146084077|NCT04456673|526827920|FG001|Overall Study|Withdrawal by Subject|23|||
146084078|NCT04456673|526827919|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
146084079|NCT04456673|526827920|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
146084080|NCT04391049|526827921|FG000|Overall Study|Protocol Violation|1|||
146084081|NCT03874429|526827922|FG000|Overall Study|Adverse Event|2|||
146084082|NCT03874429|526827923|FG001|Overall Study|Adverse Event|2|||
146084083|NCT03874429|526827922|FG000|Overall Study|Lack of Efficacy|0|||
146084084|NCT03874429|526827923|FG001|Overall Study|Lack of Efficacy|1|||
146084085|NCT03874429|526827922|FG000|Overall Study|Covid-19 pandemic|4|||
146084086|NCT03874429|526827923|FG001|Overall Study|Covid-19 pandemic|2|||
146084087|NCT00704522|526827924|FG000|Overall Study|Lack of Efficacy|65|||
146084088|NCT00704522|526827925|FG001|Overall Study|Lack of Efficacy|17|||
146084089|NCT00704522|526827924|FG000|Overall Study|Failure to appear again at hospital|56|||
146084090|NCT00704522|526827925|FG001|Overall Study|Failure to appear again at hospital|10|||
146084091|NCT00704522|526827924|FG000|Overall Study|Withdrawal by Subject|17|||
146084092|NCT00704522|526827925|FG001|Overall Study|Withdrawal by Subject|8|||
146084093|NCT00704522|526827924|FG000|Overall Study|Adverse Event|9|||
146084094|NCT00704522|526827925|FG001|Overall Study|Adverse Event|1|||
146084095|NCT00704522|526827924|FG000|Overall Study|Undefined causes|9|||
146084096|NCT00704522|526827925|FG001|Overall Study|Undefined causes|7|||
146084097|NCT00704522|526827924|FG000|Overall Study|No information on therapy end|27|||
146084098|NCT00704522|526827925|FG001|Overall Study|No information on therapy end|2|||
146214046|NCT02287311|527298460|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
146214047|NCT02287311|527298461|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146214048|NCT02287311|527298462|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
146084099|NCT00775203|526827926|FG000|Overall Study|Adverse Event|25|||
146084100|NCT00775203|526827927|FG001|Overall Study|Adverse Event|6|||
146084101|NCT00775203|526827926|FG000|Overall Study|Lack of Efficacy|8|||
146084102|NCT00775203|526827927|FG001|Overall Study|Lack of Efficacy|9|||
146084103|NCT00775203|526827926|FG000|Overall Study|Withdrawal by Subject|11|||
146214049|NCT02287311|527298463|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145958220|NCT00765817|526358255|FG001|Overall Study|Death|1|||
145958221|NCT00765817|526358254|FG000|Overall Study|Entry criteria not met|2|||
146214050|NCT02287311|527298455|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145958222|NCT00765817|526358255|FG001|Overall Study|Entry criteria not met|2|||
146214051|NCT02287311|527298456|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214052|NCT02287311|527298457|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214053|NCT02287311|527298458|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214054|NCT02287311|527298459|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214055|NCT02287311|527298460|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
146214056|NCT02287311|527298461|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214057|NCT02287311|527298462|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
146214058|NCT02287311|527298463|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
146214059|NCT05461131|527298464|FG000|Overall Study|Lost to Follow-up|0|||
146214060|NCT05461131|527298465|FG001|Overall Study|Lost to Follow-up|2|||
146214061|NCT04549168|527298467|FG000|Randomization Phase|Adverse Event|0|||
146214062|NCT04549168|527298468|FG001|Randomization Phase|Adverse Event|0|||
146214063|NCT04549168|527298469|FG002|Randomization Phase|Adverse Event|1|||
146214064|NCT04549168|527298467|FG000|Randomization Phase|Other|0|||
146214065|NCT04549168|527298468|FG001|Randomization Phase|Other|2|||
146214066|NCT04549168|527298469|FG002|Randomization Phase|Other|0|||
146214067|NCT04549168|527298467|FG000|Randomization Phase|Withdrawal by Subject|0|||
146214068|NCT04549168|527298468|FG001|Randomization Phase|Withdrawal by Subject|2|||
146214069|NCT04549168|527298469|FG002|Randomization Phase|Withdrawal by Subject|1|||
146214070|NCT05374837|527298473|FG000|Overall Study|Lost to Follow-up|17|||
146214071|NCT05374837|527298474|FG001|Overall Study|Lost to Follow-up|18|||
146214072|NCT00676715|527298475|FG000|Treatment Period (TP)|Adverse Event|0|||
146214073|NCT00676715|527298476|FG001|Treatment Period (TP)|Adverse Event|3|||
146214074|NCT00676715|527298477|FG002|Treatment Period (TP)|Adverse Event|2|||
146214075|NCT00676715|527298478|FG003|Treatment Period (TP)|Adverse Event|2|||
146214076|NCT00676715|527298475|FG000|Treatment Period (TP)|Death|0|||
146214077|NCT00676715|527298476|FG001|Treatment Period (TP)|Death|0|||
146214078|NCT00676715|527298477|FG002|Treatment Period (TP)|Death|1|||
146214079|NCT00676715|527298478|FG003|Treatment Period (TP)|Death|0|||
146214080|NCT00676715|527298475|FG000|Treatment Period (TP)|Failure to return|1|||
146214081|NCT00676715|527298476|FG001|Treatment Period (TP)|Failure to return|0|||
146214082|NCT00676715|527298477|FG002|Treatment Period (TP)|Failure to return|0|||
146214083|NCT00676715|527298478|FG003|Treatment Period (TP)|Failure to return|0|||
146214084|NCT00676715|527298475|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146214085|NCT00676715|527298476|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146214086|NCT00676715|527298477|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
146214087|NCT00676715|527298478|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
146214088|NCT00676715|527298475|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
146214089|NCT00676715|527298476|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
146214090|NCT00676715|527298477|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
146214091|NCT00676715|527298478|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
145958223|NCT00765817|526358254|FG000|Overall Study|Loss of glucose control|0|||
145958224|NCT00765817|526358255|FG001|Overall Study|Loss of glucose control|2|||
145958225|NCT00765817|526358254|FG000|Overall Study|Lost to Follow-up|1|||
145958226|NCT00765817|526358255|FG001|Overall Study|Lost to Follow-up|3|||
145958227|NCT00765817|526358254|FG000|Overall Study|Physician Decision|2|||
145958228|NCT00765817|526358255|FG001|Overall Study|Physician Decision|1|||
145958229|NCT00765817|526358254|FG000|Overall Study|Protocol Violation|1|||
145958230|NCT00765817|526358255|FG001|Overall Study|Protocol Violation|1|||
146214092|NCT00676715|527298475|FG000|Treatment Period (TP)|Withdrew consent|3|||
146214093|NCT00676715|527298476|FG001|Treatment Period (TP)|Withdrew consent|3|||
145958231|NCT00765817|526358254|FG000|Overall Study|Subject decision|7|||
145958232|NCT00765817|526358255|FG001|Overall Study|Subject decision|11|||
146214094|NCT00676715|527298477|FG002|Treatment Period (TP)|Withdrew consent|3|||
145958233|NCT06597084|526358256|FG000|Overall Study|Withdrawal by Subject|4|||
145958234|NCT06597084|526358257|FG001|Overall Study|Withdrawal by Subject|9|||
145958235|NCT06597084|526358256|FG000|Overall Study|Consent was not given by the patient until V2|0|||
145958236|NCT06597084|526358257|FG001|Overall Study|Consent was not given by the patient until V2|3|||
145958237|NCT06597084|526358256|FG000|Overall Study|Physician Decision|1|||
145958238|NCT06597084|526358257|FG001|Overall Study|Physician Decision|0|||
145958239|NCT06597084|526358256|FG000|Overall Study|Adverse Event|3|||
145958240|NCT06597084|526358257|FG001|Overall Study|Adverse Event|2|||
145958241|NCT06597084|526358256|FG000|Overall Study|Death|4|||
145958242|NCT06597084|526358257|FG001|Overall Study|Death|0|||
145958243|NCT06597084|526358256|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
145958244|NCT06597084|526358257|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
145958245|NCT06597084|526358256|FG000|Overall Study|Lost to Follow-up|4|||
145958246|NCT06597084|526358257|FG001|Overall Study|Lost to Follow-up|2|||
145958247|NCT06597084|526358256|FG000|Overall Study|Other. Not specified|1|||
145958248|NCT06597084|526358257|FG001|Overall Study|Other. Not specified|0|||
145958249|NCT00255164|526358262|FG000|Overall Study|Adverse Event|10|||
145958250|NCT00255164|526358263|FG001|Overall Study|Adverse Event|6|||
145958251|NCT00255164|526358264|FG002|Overall Study|Adverse Event|9|||
145958252|NCT00255164|526358262|FG000|Overall Study|Lost to Follow-up|4|||
145958253|NCT00255164|526358263|FG001|Overall Study|Lost to Follow-up|3|||
145958254|NCT00255164|526358264|FG002|Overall Study|Lost to Follow-up|4|||
145958255|NCT00255164|526358262|FG000|Overall Study|Withdrawal by Subject|18|||
145958256|NCT00255164|526358263|FG001|Overall Study|Withdrawal by Subject|17|||
145958257|NCT00255164|526358264|FG002|Overall Study|Withdrawal by Subject|8|||
145958258|NCT00255164|526358262|FG000|Overall Study|Noncompliance|0|||
145958259|NCT00255164|526358263|FG001|Overall Study|Noncompliance|1|||
145958260|NCT00255164|526358264|FG002|Overall Study|Noncompliance|2|||
145958261|NCT00255164|526358262|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
145958262|NCT00255164|526358263|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
145958263|NCT00255164|526358264|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
145958264|NCT00255164|526358262|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
145958265|NCT00255164|526358263|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
145958266|NCT00255164|526358264|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
145958267|NCT00255164|526358262|FG000|Overall Study|Possible Barrett's Esophagus|1|||
145958268|NCT00255164|526358263|FG001|Overall Study|Possible Barrett's Esophagus|3|||
145958269|NCT00255164|526358264|FG002|Overall Study|Possible Barrett's Esophagus|8|||
145958270|NCT00255164|526358262|FG000|Overall Study|Esophageal Stricture|0|||
145958271|NCT00255164|526358263|FG001|Overall Study|Esophageal Stricture|0|||
145958272|NCT00255164|526358264|FG002|Overall Study|Esophageal Stricture|1|||
145958273|NCT00255164|526358262|FG000|Overall Study|Therapeutic Failure|11|||
145958274|NCT00255164|526358263|FG001|Overall Study|Therapeutic Failure|2|||
145958275|NCT00255164|526358264|FG002|Overall Study|Therapeutic Failure|3|||
145958276|NCT03677869|526358265|FG000|Overall Study|Withdrawal by Subject|1|||
145958277|NCT01845597|526360275|FG000|Overall Study|Death|8|||
145958278|NCT01845597|526360275|FG000|Overall Study|Lost to Follow-up|22|||
145958279|NCT04085601|526360282|FG000|Overall Study|Lost to Follow-up|1|||
145958280|NCT04085601|526360283|FG001|Overall Study|Lost to Follow-up|0|||
145958281|NCT04085601|526360282|FG000|Overall Study|Death|1|||
145958282|NCT04085601|526360283|FG001|Overall Study|Death|1|||
145958283|NCT00956839|526360284|FG000|Overall Study|Lost to Follow-up|3|||
145958284|NCT00956839|526360285|FG001|Overall Study|Lost to Follow-up|0|||
145958285|NCT00956839|526360286|FG002|Overall Study|Lost to Follow-up|3|||
145958286|NCT02121795|526360287|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
145958287|NCT02121795|526360288|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
145958288|NCT02121795|526360287|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
145958289|NCT02121795|526360288|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
145958290|NCT02121795|526360287|FG000|Double-Blind Phase|Lost to Follow-up|7|||
145958291|NCT02121795|526360288|FG001|Double-Blind Phase|Lost to Follow-up|4|||
145958292|NCT02121795|526360287|FG000|Double-Blind Phase|Physician Decision|2|||
145958293|NCT02121795|526360288|FG001|Double-Blind Phase|Physician Decision|5|||
145958294|NCT02121795|526360287|FG000|Double-Blind Phase|Adverse Event|5|||
145958295|NCT02121795|526360288|FG001|Double-Blind Phase|Adverse Event|0|||
145958296|NCT02121795|526360287|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
145958297|NCT02121795|526360288|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
145958298|NCT02121795|526360287|FG000|Double-Blind Phase|Protocol Violation|0|||
145958299|NCT02121795|526360288|FG001|Double-Blind Phase|Protocol Violation|3|||
145958300|NCT02121795|526360287|FG000|Double-Blind Phase|Death|1|||
145958301|NCT02121795|526360288|FG001|Double-Blind Phase|Death|1|||
145958302|NCT02121795|526360287|FG000|Open-Label Phase|Physician Decision|8|||
145958303|NCT02121795|526360288|FG001|Open-Label Phase|Physician Decision|8|||
145958304|NCT02121795|526360287|FG000|Open-Label Phase|Withdrawal by Subject|3|||
145958305|NCT02121795|526360288|FG001|Open-Label Phase|Withdrawal by Subject|2|||
145958306|NCT02121795|526360287|FG000|Open-Label Phase|Lost to Follow-up|1|||
145958307|NCT02121795|526360288|FG001|Open-Label Phase|Lost to Follow-up|0|||
146214095|NCT00676715|527298478|FG003|Treatment Period (TP)|Withdrew consent|3|||
146214096|NCT00676715|527298475|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
146214097|NCT00676715|527298476|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
146214098|NCT00676715|527298477|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
146214099|NCT00676715|527298478|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
146214100|NCT00676715|527298475|FG000|Treatment Period (TP)|Administrative|0|||
146214101|NCT00676715|527298476|FG001|Treatment Period (TP)|Administrative|0|||
145958308|NCT00994110|526360289|FG000|Overall Study|Withdrawal by Subject|9|||
146214102|NCT00676715|527298477|FG002|Treatment Period (TP)|Administrative|0|||
146214103|NCT00676715|527298478|FG003|Treatment Period (TP)|Administrative|1|||
146214104|NCT00676715|527298475|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
146214105|NCT00676715|527298476|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
146214106|NCT00676715|527298477|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
145958309|NCT00994110|526360290|FG001|Overall Study|Withdrawal by Subject|9|||
145958310|NCT00994110|526360289|FG000|Overall Study|Not Treated|4|||
145958311|NCT00994110|526360290|FG001|Overall Study|Not Treated|8|||
145958312|NCT00994110|526360289|FG000|Overall Study|Adverse Event|1|||
145958313|NCT00994110|526360290|FG001|Overall Study|Adverse Event|0|||
145958314|NCT00994110|526360289|FG000|Overall Study|Patient not resected|41|||
145958315|NCT00994110|526360290|FG001|Overall Study|Patient not resected|52|||
145958316|NCT00994110|526360289|FG000|Overall Study|Pt not eligible|10|||
145958317|NCT00994110|526360290|FG001|Overall Study|Pt not eligible|5|||
145958318|NCT01914393|526360291|FG000|Overall Study|Protocol Violation|11|||
145958319|NCT01914393|526360292|FG001|Overall Study|Protocol Violation|3|||
145958320|NCT01914393|526360293|FG002|Overall Study|Protocol Violation|19|||
145958321|NCT01914393|526360291|FG000|Overall Study|Lack of Efficacy|11|||
145958322|NCT01914393|526360292|FG001|Overall Study|Lack of Efficacy|16|||
145958323|NCT01914393|526360293|FG002|Overall Study|Lack of Efficacy|5|||
145958324|NCT01914393|526360291|FG000|Overall Study|no reason given|14|||
145958325|NCT01914393|526360292|FG001|Overall Study|no reason given|8|||
145958326|NCT01914393|526360293|FG002|Overall Study|no reason given|16|||
145958327|NCT01914393|526360291|FG000|Overall Study|Adverse Event|29|||
145958328|NCT01914393|526360292|FG001|Overall Study|Adverse Event|18|||
145958329|NCT01914393|526360293|FG002|Overall Study|Adverse Event|31|||
145958330|NCT01914393|526360291|FG000|Overall Study|Withdrawal by Subject|38|||
145958331|NCT01914393|526360292|FG001|Overall Study|Withdrawal by Subject|20|||
145958332|NCT01914393|526360293|FG002|Overall Study|Withdrawal by Subject|47|||
145958333|NCT01914393|526360291|FG000|Overall Study|Lost to Follow-up|12|||
145958334|NCT01914393|526360292|FG001|Overall Study|Lost to Follow-up|6|||
145958335|NCT01914393|526360293|FG002|Overall Study|Lost to Follow-up|19|||
145958336|NCT01914393|526360291|FG000|Overall Study|subject never dosed|0|||
145958337|NCT01914393|526360292|FG001|Overall Study|subject never dosed|0|||
145958338|NCT01914393|526360293|FG002|Overall Study|subject never dosed|1|||
145958339|NCT00666211|526360294|FG000|Overall Study|Withdrawal by Subject|10|||
145958340|NCT00666211|526360295|FG001|Overall Study|Withdrawal by Subject|13|||
145958341|NCT00666211|526360294|FG000|Overall Study|went off medication, no more pain|1|||
145958342|NCT00666211|526360295|FG001|Overall Study|went off medication, no more pain|0|||
145958343|NCT00666211|526360294|FG000|Overall Study|patient non-compliant|6|||
145958344|NCT00666211|526360295|FG001|Overall Study|patient non-compliant|6|||
145958345|NCT00666211|526360294|FG000|Overall Study|disease progression|1|||
145958346|NCT00666211|526360295|FG001|Overall Study|disease progression|8|||
145958347|NCT00666211|526360294|FG000|Overall Study|Lost to Follow-up|2|||
145958348|NCT00666211|526360295|FG001|Overall Study|Lost to Follow-up|0|||
145958349|NCT00666211|526360294|FG000|Overall Study|toxicity|0|||
145958350|NCT00666211|526360295|FG001|Overall Study|toxicity|2|||
145958351|NCT00666211|526360294|FG000|Overall Study|hospital admission|0|||
145958352|NCT00666211|526360295|FG001|Overall Study|hospital admission|5|||
145958353|NCT00666211|526360294|FG000|Overall Study|Death|0|||
145958354|NCT00666211|526360295|FG001|Overall Study|Death|2|||
145958355|NCT00666211|526360294|FG000|Overall Study|off tx for other complicating disease|0|||
145958356|NCT00666211|526360295|FG001|Overall Study|off tx for other complicating disease|1|||
145958357|NCT00666211|526360294|FG000|Overall Study|Physician Decision|0|||
145958358|NCT00666211|526360295|FG001|Overall Study|Physician Decision|1|||
145958359|NCT02999789|526360298|FG000|Overall Study|Withdrawal by Subject|0|||
145958360|NCT02999789|526360299|FG001|Overall Study|Withdrawal by Subject|1|||
145958361|NCT02999789|526360298|FG000|Overall Study|Became ineligible|1|||
145958362|NCT02999789|526360299|FG001|Overall Study|Became ineligible|2|||
145958363|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
145958364|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145958365|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
146214107|NCT00676715|527298478|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
146214108|NCT00676715|527298475|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
146214109|NCT00676715|527298476|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
146214110|NCT00676715|527298477|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
146214111|NCT00676715|527298478|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
146214112|NCT00676715|527298475|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146214113|NCT00676715|527298476|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146214114|NCT00676715|527298477|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
145958366|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145958367|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145958368|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
145958369|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145958370|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145958371|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
146084104|NCT00775203|526827927|FG001|Overall Study|Withdrawal by Subject|9|||
145958372|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145958373|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
145958374|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145958375|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145958376|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145958377|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145958378|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
145958379|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145958380|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145958381|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145958382|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145958383|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
145958384|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145958385|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145958386|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145958387|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145958388|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
145958389|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145958390|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145958391|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145958392|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145958393|NCT01111565|526360300|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
145958394|NCT01111565|526360301|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145958395|NCT01111565|526360302|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145958396|NCT01111565|526360303|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145958397|NCT01111565|526360304|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145958398|NCT01111565|526360300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145958399|NCT01111565|526360301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145958400|NCT01111565|526360302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145958401|NCT01111565|526360303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
145958402|NCT01111565|526360304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145958403|NCT01111565|526360300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145958404|NCT01111565|526360301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145958405|NCT01111565|526360302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
145958406|NCT01111565|526360303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145958407|NCT01111565|526360304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145958408|NCT01111565|526360300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
146214115|NCT00676715|527298478|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
146214116|NCT00676715|527298475|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
146214117|NCT00676715|527298476|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
146214118|NCT00676715|527298477|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
146214119|NCT00676715|527298478|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
146214120|NCT00676715|527298475|FG000|Treatment-free Period (TFP)|Death|1|||
146214121|NCT00676715|527298476|FG001|Treatment-free Period (TFP)|Death|1|||
146214122|NCT00676715|527298477|FG002|Treatment-free Period (TFP)|Death|1|||
146214123|NCT00676715|527298478|FG003|Treatment-free Period (TFP)|Death|0|||
146214124|NCT00676715|527298475|FG000|Open Label Extension (OLE)|Reason not provided|3|||
146214125|NCT00676715|527298476|FG001|Open Label Extension (OLE)|Reason not provided|4|||
146214126|NCT00676715|527298477|FG002|Open Label Extension (OLE)|Reason not provided|1|||
146214127|NCT00676715|527298478|FG003|Open Label Extension (OLE)|Reason not provided|4|||
146214128|NCT00676715|527298475|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
146214129|NCT00676715|527298476|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
146214130|NCT00676715|527298477|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
146214131|NCT00676715|527298478|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
146214132|NCT00676715|527298475|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
146214133|NCT00676715|527298476|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
146214134|NCT00676715|527298477|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
146214135|NCT00676715|527298478|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
146214136|NCT00676715|527298475|FG000|Open Label Extension (OLE)|Adverse Event|0|||
146214137|NCT00676715|527298476|FG001|Open Label Extension (OLE)|Adverse Event|3|||
146214138|NCT00676715|527298477|FG002|Open Label Extension (OLE)|Adverse Event|1|||
146214139|NCT00676715|527298478|FG003|Open Label Extension (OLE)|Adverse Event|0|||
146214140|NCT00676715|527298475|FG000|Open Label Extension (OLE)|Death|2|||
146214141|NCT00676715|527298476|FG001|Open Label Extension (OLE)|Death|0|||
146214142|NCT00676715|527298477|FG002|Open Label Extension (OLE)|Death|2|||
146214143|NCT00676715|527298478|FG003|Open Label Extension (OLE)|Death|2|||
146214144|NCT05249439|527298479|FG000|Overall Study|Withdrawal by Subject|2|||
146214145|NCT05249439|527298480|FG001|Overall Study|Withdrawal by Subject|5|||
146214146|NCT05249439|527298479|FG000|Overall Study|Physician Decision|3|||
146214147|NCT05249439|527298480|FG001|Overall Study|Physician Decision|1|||
146214148|NCT02549339|527298487|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
146287005|NCT00192647|527567289|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
146287006|NCT00192647|527567290|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
146287007|NCT00192647|527567289|FG000|Overall Study|Failure to Return|11|||
146287008|NCT00192647|527567290|FG001|Overall Study|Failure to Return|13|||
146287009|NCT00192647|527567289|FG000|Overall Study|Other/Administrative|5|||
146287010|NCT00192647|527567290|FG001|Overall Study|Other/Administrative|3|||
146287011|NCT01828073|527567291|FG000|Overall Study|Lost to Follow-up|1|||
146287012|NCT01828073|527567292|FG001|Overall Study|Lost to Follow-up|2|||
146287013|NCT00690443|527567297|FG000|Overall Study|Adverse Event|1|||
146287014|NCT00690443|527567298|FG001|Overall Study|Adverse Event|2|||
146287015|NCT03057977|527567299|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
146287016|NCT03057977|527567300|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
146287017|NCT03057977|527567299|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
146287018|NCT03057977|527567300|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
146287019|NCT03057977|527567299|FG000|Discontinuation From Treatment|Protocol Violation|6|||
146287020|NCT03057977|527567300|FG001|Discontinuation From Treatment|Protocol Violation|5|||
146287021|NCT03057977|527567299|FG000|Discontinuation From Treatment|Not treated|4|||
146287022|NCT03057977|527567300|FG001|Discontinuation From Treatment|Not treated|0|||
146287023|NCT03057977|527567299|FG000|Discontinuation From Treatment|Adverse Event|343|||
146287024|NCT03057977|527567300|FG001|Discontinuation From Treatment|Adverse Event|337|||
146287025|NCT03057977|527567299|FG000|Discontinuation From Treatment|Reason Unknown|0|||
146287026|NCT03057977|527567300|FG001|Discontinuation From Treatment|Reason Unknown|1|||
146287027|NCT03057977|527567299|FG000|Discontinuation From Treatment|Personal Reasons|1|||
146287028|NCT03057977|527567300|FG001|Discontinuation From Treatment|Personal Reasons|1|||
146287029|NCT03057977|527567299|FG000|Discontinuation From Treatment|Unblinded medication|1|||
146287030|NCT03057977|527567300|FG001|Discontinuation From Treatment|Unblinded medication|0|||
146287031|NCT03057977|527567299|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
146287032|NCT03057977|527567300|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
146287033|NCT03057977|527567299|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
146287034|NCT03057977|527567300|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
146287035|NCT03057977|527567299|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
146287036|NCT03057977|527567300|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
146287037|NCT03057977|527567299|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
146287038|NCT03057977|527567300|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
146287039|NCT03057977|527567299|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
146287040|NCT03057977|527567300|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
146287041|NCT03057977|527567299|FG000|Discontinuation From Treatment|Not attending study visit|3|||
146287042|NCT03057977|527567300|FG001|Discontinuation From Treatment|Not attending study visit|10|||
146287043|NCT03057977|527567299|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
146287044|NCT03057977|527567300|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
146287045|NCT03057977|527567299|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
146287046|NCT03057977|527567300|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
146287047|NCT03057977|527567299|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
146287048|NCT03057977|527567300|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
146287049|NCT03057977|527567299|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
146287050|NCT03057977|527567300|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
146287051|NCT03057977|527567299|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
146287052|NCT03057977|527567300|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
146287053|NCT00953407|527567301|FG000|Overall Study|Failed inclusion criteria|1|||
146287054|NCT00953407|527567302|FG001|Overall Study|Failed inclusion criteria|1|||
146287055|NCT00953407|527567303|FG002|Overall Study|Failed inclusion criteria|1|||
146287056|NCT00953407|527567304|FG003|Overall Study|Failed inclusion criteria|1|||
146287057|NCT00953407|527567305|FG004|Overall Study|Failed inclusion criteria|1|||
146287058|NCT00953407|527567301|FG000|Overall Study|Lost to Follow-up|0|||
146287059|NCT00953407|527567302|FG001|Overall Study|Lost to Follow-up|0|||
146287060|NCT00953407|527567303|FG002|Overall Study|Lost to Follow-up|0|||
146287061|NCT00953407|527567304|FG003|Overall Study|Lost to Follow-up|1|||
146287062|NCT00953407|527567305|FG004|Overall Study|Lost to Follow-up|0|||
146287063|NCT02502097|527567306|FG000|Period 1|Adverse Event|0|||
146287064|NCT02502097|527567307|FG001|Period 1|Adverse Event|0|||
145958409|NCT01111565|526360301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
145958410|NCT01111565|526360302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
146214149|NCT02549339|527298488|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
146214150|NCT02549339|527298487|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
146214151|NCT02549339|527298488|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
146214152|NCT02549339|527298487|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
146214153|NCT02549339|527298488|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
146214154|NCT02549339|527298487|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
146214155|NCT02549339|527298488|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
146214156|NCT02549339|527298487|FG000|12-month Follow-up|Lack of Efficacy|0|||
146214157|NCT02549339|527298488|FG001|12-month Follow-up|Lack of Efficacy|2|||
146214158|NCT02549339|527298487|FG000|12-month Follow-up|Withdrawal by Subject|8|||
146214159|NCT02549339|527298488|FG001|12-month Follow-up|Withdrawal by Subject|3|||
146214160|NCT02549339|527298487|FG000|12-month Follow-up|Lost to Follow-up|1|||
146214161|NCT02549339|527298488|FG001|12-month Follow-up|Lost to Follow-up|3|||
146214162|NCT02549339|527298487|FG000|12-month Follow-up|Other|0|||
146214163|NCT02549339|527298488|FG001|12-month Follow-up|Other|3|||
146214164|NCT02728076|527298489|FG000|Overall Study|Physician Decision|4|||
146214165|NCT05054374|527298490|FG000|Overall Study|Withdrawal by Subject|1|||
146214166|NCT05054374|527298491|FG001|Overall Study|Withdrawal by Subject|0|||
146214167|NCT05054374|527298492|FG002|Overall Study|Withdrawal by Subject|0|||
146214168|NCT05054374|527298493|FG003|Overall Study|Withdrawal by Subject|0|||
146214169|NCT05054374|527298490|FG000|Overall Study|Progressive Disease|5|||
146214170|NCT05054374|527298491|FG001|Overall Study|Progressive Disease|0|||
146214171|NCT05054374|527298492|FG002|Overall Study|Progressive Disease|0|||
146214172|NCT05054374|527298493|FG003|Overall Study|Progressive Disease|0|||
146214173|NCT05691309|527298494|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
146214174|NCT05691309|527298494|FG000|Overall Study|vancomycin levels not evaluable|2|||
146214175|NCT03526861|527298498|FG000|Initial Treatment Period|Not dosed|1|||
146214176|NCT03526861|527298499|FG001|Initial Treatment Period|Not dosed|1|||
146214177|NCT03526861|527298500|FG002|Initial Treatment Period|Not dosed|1|||
146214178|NCT03526861|527298501|FG003|Initial Treatment Period|Not dosed|0|||
146214179|NCT03526861|527298502|FG004|Initial Treatment Period|Not dosed|0|||
146214180|NCT03526861|527298503|FG005|Initial Treatment Period|Not dosed|0|||
146214181|NCT03526861|527298504|FG006|Initial Treatment Period|Not dosed|0|||
146214182|NCT03526861|527298505|FG007|Initial Treatment Period|Not dosed|0|||
146214183|NCT03526861|527298506|FG008|Initial Treatment Period|Not dosed|0|||
146214184|NCT03526861|527298498|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
146214185|NCT03526861|527298499|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
146214186|NCT03526861|527298500|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
146214187|NCT03526861|527298501|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214188|NCT03526861|527298502|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214189|NCT03526861|527298503|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214190|NCT03526861|527298504|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214191|NCT03526861|527298505|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214192|NCT03526861|527298506|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214193|NCT03526861|527298498|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
146214194|NCT03526861|527298499|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
146214195|NCT03526861|527298500|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
146214196|NCT03526861|527298501|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146214197|NCT03526861|527298502|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146214198|NCT03526861|527298503|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146214199|NCT03526861|527298504|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146214200|NCT03526861|527298505|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146287065|NCT02502097|527567308|FG002|Period 1|Adverse Event|1|||
146287066|NCT02502097|527567309|FG003|Period 1|Adverse Event|0|||
146287067|NCT02502097|527567306|FG000|Wash Out Period|Adverse Event|0|||
146287068|NCT02502097|527567307|FG001|Wash Out Period|Adverse Event|1|||
146287069|NCT02502097|527567308|FG002|Wash Out Period|Adverse Event|1|||
146287070|NCT02502097|527567309|FG003|Wash Out Period|Adverse Event|1|||
146287071|NCT02502097|527567306|FG000|Period 2|Adverse Event|0|||
146287072|NCT02502097|527567307|FG001|Period 2|Adverse Event|0|||
146287073|NCT02502097|527567308|FG002|Period 2|Adverse Event|1|||
146287074|NCT02502097|527567309|FG003|Period 2|Adverse Event|0|||
146287075|NCT01350336|527567310|FG000|Overall Study|Lost to Follow-up|31|||
145958411|NCT01111565|526360303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
145958412|NCT01111565|526360304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
145958413|NCT01111565|526360300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145958414|NCT01111565|526360301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145958415|NCT01111565|526360302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145958416|NCT01111565|526360303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
145958417|NCT01111565|526360304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145958418|NCT01111565|526360300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145958419|NCT01111565|526360301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145958420|NCT01111565|526360302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145958421|NCT01111565|526360303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145958422|NCT01111565|526360304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
146287076|NCT01350336|527567310|FG000|Overall Study|Withdrawal by Subject|14|||
146287077|NCT01350336|527567310|FG000|Overall Study|Physician Decision|8|||
146287078|NCT01350336|527567310|FG000|Overall Study|Death|4|||
146287079|NCT01016977|527567318|FG000|Overall Study|Lost to Follow-up|1|||
146287080|NCT01016977|527567319|FG001|Overall Study|Lost to Follow-up|0|||
146287081|NCT01016977|527567318|FG000|Overall Study|Withdrawal by Subject|2|||
146287082|NCT01016977|527567319|FG001|Overall Study|Withdrawal by Subject|2|||
146287083|NCT05081388|527567322|FG000|Overall Study|Adverse Event|1|||
146287084|NCT05081388|527567323|FG001|Overall Study|Adverse Event|0|||
146287085|NCT05081388|527567324|FG002|Overall Study|Adverse Event|0|||
146287086|NCT05081388|527567325|FG003|Overall Study|Adverse Event|0|||
146287087|NCT05081388|527567326|FG004|Overall Study|Adverse Event|0|||
146287088|NCT05081388|527567322|FG000|Overall Study|Lost to Follow-up|0|||
146287089|NCT05081388|527567323|FG001|Overall Study|Lost to Follow-up|1|||
146287090|NCT05081388|527567324|FG002|Overall Study|Lost to Follow-up|0|||
146287091|NCT05081388|527567325|FG003|Overall Study|Lost to Follow-up|0|||
146287092|NCT05081388|527567326|FG004|Overall Study|Lost to Follow-up|0|||
146287093|NCT05081388|527567322|FG000|Overall Study|Subject decision|0|||
146287094|NCT05081388|527567323|FG001|Overall Study|Subject decision|0|||
146287095|NCT05081388|527567324|FG002|Overall Study|Subject decision|0|||
146287096|NCT05081388|527567325|FG003|Overall Study|Subject decision|1|||
146287097|NCT05081388|527567326|FG004|Overall Study|Subject decision|0|||
146287098|NCT01776541|527567327|FG000|Overall Study|Administrative Reason|6|||
146287099|NCT01776541|527567328|FG001|Overall Study|Administrative Reason|2|||
146287100|NCT01776541|527567327|FG000|Overall Study|Death|4|||
146287101|NCT01776541|527567328|FG001|Overall Study|Death|0|||
146287102|NCT01776541|527567327|FG000|Overall Study|Lost to Follow-up|27|||
146287103|NCT01776541|527567328|FG001|Overall Study|Lost to Follow-up|48|||
146287104|NCT01776541|527567327|FG000|Overall Study|Unclassified|5|||
146287105|NCT01776541|527567328|FG001|Overall Study|Unclassified|4|||
146287106|NCT01776541|527567327|FG000|Overall Study|Protocol Violation|2|||
146287107|NCT01776541|527567328|FG001|Overall Study|Protocol Violation|1|||
146287108|NCT01776541|527567327|FG000|Overall Study|Withdrawal by Subject|12|||
146287109|NCT01776541|527567328|FG001|Overall Study|Withdrawal by Subject|20|||
146287110|NCT04279392|527567329|FG000|Overall Study|Physician Decision|1|||
146287111|NCT04279392|527567330|FG001|Overall Study|Physician Decision|0|||
146287112|NCT01171807|527567331|FG000|Overall Study|Treatment failure|2|||
146287113|NCT01171807|527567332|FG001|Overall Study|Treatment failure|4|||
146287114|NCT01171807|527567331|FG000|Overall Study|Non compliance|1|||
146287115|NCT01171807|527567332|FG001|Overall Study|Non compliance|0|||
146214201|NCT03526861|527298506|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
146214202|NCT03526861|527298498|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146287116|NCT01171807|527567331|FG000|Overall Study|Lost to Follow-up|3|||
146287117|NCT01171807|527567332|FG001|Overall Study|Lost to Follow-up|0|||
146287118|NCT01901341|527567333|FG000|Overall Study|Adverse Event|4|||
146287119|NCT01901341|527567334|FG001|Overall Study|Adverse Event|2|||
146287120|NCT01901341|527567333|FG000|Overall Study|Lack of Efficacy|0|||
146287121|NCT01901341|527567334|FG001|Overall Study|Lack of Efficacy|2|||
146287122|NCT01901341|527567333|FG000|Overall Study|Lost to Follow-up|0|||
146287123|NCT01901341|527567334|FG001|Overall Study|Lost to Follow-up|1|||
146287124|NCT01901341|527567333|FG000|Overall Study|Protocol Violation|2|||
146287125|NCT01901341|527567334|FG001|Overall Study|Protocol Violation|0|||
146214203|NCT03526861|527298499|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214204|NCT03526861|527298500|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214205|NCT03526861|527298501|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146214206|NCT03526861|527298502|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146214207|NCT03526861|527298503|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214208|NCT03526861|527298504|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
146214209|NCT03526861|527298505|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214210|NCT03526861|527298506|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214211|NCT03526861|527298498|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146214212|NCT03526861|527298499|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146214213|NCT03526861|527298500|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146214214|NCT03526861|527298501|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
146214215|NCT03526861|527298502|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
146214216|NCT03526861|527298503|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
146214217|NCT03526861|527298504|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
146214218|NCT03526861|527298505|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
146214219|NCT03526861|527298506|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
146214220|NCT03526861|527298498|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214221|NCT03526861|527298499|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214222|NCT03526861|527298500|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214223|NCT03526861|527298501|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
146214224|NCT03526861|527298502|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146287126|NCT01901341|527567333|FG000|Overall Study|Study Terminated by Sponsor|13|||
146287127|NCT01901341|527567334|FG001|Overall Study|Study Terminated by Sponsor|15|||
146287128|NCT01901341|527567333|FG000|Overall Study|Withdrawal by Subject|1|||
146214225|NCT03526861|527298503|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214226|NCT03526861|527298504|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214227|NCT03526861|527298505|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214228|NCT03526861|527298506|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214229|NCT03526861|527298498|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214230|NCT03526861|527298499|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214231|NCT03526861|527298500|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214232|NCT03526861|527298501|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214233|NCT03526861|527298502|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214234|NCT03526861|527298503|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214235|NCT03526861|527298504|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214236|NCT03526861|527298505|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
146214237|NCT03526861|527298506|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
146287129|NCT01901341|527567334|FG001|Overall Study|Withdrawal by Subject|1|||
146287130|NCT00156819|527567335|FG000|Overall Study|Lost to Follow-up|1|||
146287131|NCT00156819|527567336|FG001|Overall Study|Lost to Follow-up|1|||
146287132|NCT00156819|527567337|FG002|Overall Study|Lost to Follow-up|3|||
146287133|NCT01689337|527567338|FG000|Overall Study|Study Discontinuation|1|||
146287134|NCT01981473|527567339|FG000|Overall Study|Incorrect diagnosis of RA|0|||
146287135|NCT01981473|527567340|FG001|Overall Study|Incorrect diagnosis of RA|0|||
146287136|NCT01981473|527567341|FG002|Overall Study|Incorrect diagnosis of RA|1|||
146287137|NCT01981473|527567339|FG000|Overall Study|Received treatment for < 6 months|0|||
146214238|NCT03526861|527298498|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214239|NCT03526861|527298499|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214240|NCT03526861|527298500|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214241|NCT03526861|527298501|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214242|NCT03526861|527298502|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214243|NCT03526861|527298503|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214244|NCT03526861|527298504|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146287138|NCT01981473|527567340|FG001|Overall Study|Received treatment for < 6 months|0|||
146287139|NCT01981473|527567341|FG002|Overall Study|Received treatment for < 6 months|1|||
146287140|NCT01981473|527567339|FG000|Overall Study|Received treatment for >24 months|2|||
146287141|NCT01981473|527567340|FG001|Overall Study|Received treatment for >24 months|0|||
146287142|NCT01981473|527567341|FG002|Overall Study|Received treatment for >24 months|6|||
146287143|NCT00738582|527567342|FG000|Combination Therapy|Completed Combination Therapy|1|||
146287144|NCT00738582|527567343|FG001|Combination Therapy|Completed Combination Therapy|0|||
146287145|NCT00738582|527567342|FG000|Combination Therapy|Physician Decision|1|||
146287146|NCT00738582|527567343|FG001|Combination Therapy|Physician Decision|0|||
146287147|NCT00738582|527567342|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
146287148|NCT00738582|527567343|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
146287149|NCT00738582|527567342|FG000|Combination Therapy|Other|5|||
146287150|NCT00738582|527567343|FG001|Combination Therapy|Other|0|||
146287151|NCT00738582|527567342|FG000|Combination Therapy|Adverse Event|16|||
146214245|NCT03526861|527298505|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
146214246|NCT03526861|527298506|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
146214247|NCT03526861|527298498|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214248|NCT03526861|527298499|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214249|NCT03526861|527298500|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214250|NCT03526861|527298501|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214251|NCT03526861|527298502|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214252|NCT03526861|527298503|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214253|NCT03526861|527298504|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214254|NCT03526861|527298505|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
146214255|NCT03526861|527298506|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
146214256|NCT04391894|527298511|FG000|Overall Study|Adverse Event|1|||
146214257|NCT04391894|527298512|FG001|Overall Study|Adverse Event|1|||
146214258|NCT04391894|527298513|FG002|Overall Study|Adverse Event|1|||
146214259|NCT04391894|527298514|FG003|Overall Study|Adverse Event|1|||
146214260|NCT04391894|527298515|FG004|Overall Study|Adverse Event|1|||
146214261|NCT04391894|527298511|FG000|Overall Study|Lost to Follow-up|1|||
146214262|NCT04391894|527298512|FG001|Overall Study|Lost to Follow-up|0|||
146214263|NCT04391894|527298513|FG002|Overall Study|Lost to Follow-up|0|||
146214264|NCT04391894|527298514|FG003|Overall Study|Lost to Follow-up|0|||
146214265|NCT04391894|527298515|FG004|Overall Study|Lost to Follow-up|0|||
146214266|NCT04391894|527298511|FG000|Overall Study|Protocol Violation|0|||
146214267|NCT04391894|527298512|FG001|Overall Study|Protocol Violation|0|||
146214268|NCT04391894|527298513|FG002|Overall Study|Protocol Violation|0|||
146214269|NCT04391894|527298514|FG003|Overall Study|Protocol Violation|1|||
146214270|NCT04391894|527298515|FG004|Overall Study|Protocol Violation|0|||
146214271|NCT04391894|527298511|FG000|Overall Study|Withdrawal by Subject|2|||
146214272|NCT04391894|527298512|FG001|Overall Study|Withdrawal by Subject|0|||
146214273|NCT04391894|527298513|FG002|Overall Study|Withdrawal by Subject|3|||
146214274|NCT04391894|527298514|FG003|Overall Study|Withdrawal by Subject|0|||
146214275|NCT04391894|527298515|FG004|Overall Study|Withdrawal by Subject|1|||
146214276|NCT04391894|527298511|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
146214277|NCT04391894|527298512|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
146214278|NCT04391894|527298513|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
146214279|NCT04391894|527298514|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
146214280|NCT04391894|527298515|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
146214281|NCT02323321|527298519|FG000|Overall Study|Re-Transplant|1|||
146214282|NCT02323321|527298519|FG000|Overall Study|Death|12|||
146214283|NCT00220740|527298520|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
146214284|NCT00220740|527298521|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
146214285|NCT00220740|527298520|FG000|Efficacy Period|Adverse Event|1|||
146287152|NCT00738582|527567343|FG001|Combination Therapy|Adverse Event|0|||
146287153|NCT00738582|527567342|FG000|Combination Therapy|Progressive Disease|9|||
146287154|NCT00738582|527567343|FG001|Combination Therapy|Progressive Disease|0|||
146287155|NCT00738582|527567342|FG000|Maintenance Therapy|Other|0|||
146214286|NCT00220740|527298521|FG001|Efficacy Period|Adverse Event|1|||
146214287|NCT00220740|527298520|FG000|Efficacy Period|Withdrawal by Subject|1|||
146214288|NCT00220740|527298521|FG001|Efficacy Period|Withdrawal by Subject|0|||
146214289|NCT00220740|527298520|FG000|Efficacy Period|Protocol Violation|1|||
146214290|NCT00220740|527298521|FG001|Efficacy Period|Protocol Violation|0|||
146214291|NCT00220740|527298520|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
146214292|NCT00220740|527298521|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
146214293|NCT01057433|527298522|FG000|Overall Study|Adverse Event|1|||
146214294|NCT04774237|527298524|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
146214295|NCT04774237|527298525|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
146214296|NCT04774237|527298526|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
146214297|NCT04774237|527298527|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
146214298|NCT04774237|527298528|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
146214299|NCT04774237|527298529|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
146214300|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
146214301|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146214302|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146214303|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146214304|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
146214305|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
146214306|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
146214307|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146214308|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146214309|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
146214310|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
146214311|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
146214312|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146214313|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146214314|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
146214315|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
146214316|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146214317|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146214318|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146214319|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
146214320|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
146214321|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
146214322|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146214323|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146214324|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
146214325|NCT05338086|527299967|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
146214326|NCT05338086|527299968|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
146214327|NCT05338086|527299969|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
146214328|NCT05338086|527299970|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
146214329|NCT05338086|527299971|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
146214330|NCT05338086|527299967|FG000|Transition Period (M12 to M18)|Death|0|||
146214331|NCT05338086|527299968|FG001|Transition Period (M12 to M18)|Death|0|||
146214332|NCT05338086|527299969|FG002|Transition Period (M12 to M18)|Death|1|||
146214333|NCT05338086|527299970|FG003|Transition Period (M12 to M18)|Death|0|||
146214334|NCT05338086|527299971|FG004|Transition Period (M12 to M18)|Death|0|||
146214335|NCT05338086|527299967|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
146214336|NCT05338086|527299968|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
146214337|NCT05338086|527299969|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
146214338|NCT05338086|527299970|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
146214339|NCT05338086|527299971|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
146214340|NCT05338086|527299967|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
146214341|NCT05338086|527299968|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
146214342|NCT05338086|527299969|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
146214343|NCT05338086|527299970|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
146214344|NCT05338086|527299971|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
146214345|NCT05338086|527299967|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
146214346|NCT05338086|527299968|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
146214347|NCT05338086|527299969|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
146287156|NCT00738582|527567343|FG001|Maintenance Therapy|Other|2|||
146287157|NCT00738582|527567342|FG000|Maintenance Therapy|Adverse Event|0|||
146214348|NCT05338086|527299970|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
146214349|NCT05338086|527299971|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
146214350|NCT03940703|527299972|FG000|Overall Study|Still under treatment|31|||
146214351|NCT03940703|527299973|FG001|Overall Study|Still under treatment|0|||
146214352|NCT00753090|527299985|FG000|Overall Study|Withdrawal by Subject|10|||
146214353|NCT00753090|527299986|FG001|Overall Study|Withdrawal by Subject|10|||
146214354|NCT00753090|527299985|FG000|Overall Study|Death|17|||
146287158|NCT00738582|527567343|FG001|Maintenance Therapy|Adverse Event|6|||
146287159|NCT00738582|527567342|FG000|Maintenance Therapy|Progressive Disease|0|||
146287160|NCT00738582|527567343|FG001|Maintenance Therapy|Progressive Disease|47|||
146287161|NCT00738582|527567342|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
146287162|NCT00738582|527567343|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
146287163|NCT00642772|527567344|FG000|Overall Study|Lost to Follow-up|3|||
146287164|NCT00642772|527567344|FG000|Overall Study|Withdrawal by Subject|7|||
146287165|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
146214355|NCT00753090|527299986|FG001|Overall Study|Death|6|||
146287166|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
146214356|NCT00753090|527299985|FG000|Overall Study|Study Prosthesis Removed|12|||
146214357|NCT00753090|527299986|FG001|Overall Study|Study Prosthesis Removed|3|||
146214358|NCT00753090|527299985|FG000|Overall Study|Lost to Follow-up|2|||
146214359|NCT00753090|527299986|FG001|Overall Study|Lost to Follow-up|2|||
146287167|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
146287168|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
145958423|NCT02824224|526360305|FG000|Overall Study|Discontinued, IUS expulsion|0|||
145958424|NCT02824224|526360306|FG001|Overall Study|Discontinued, IUS expulsion|1|||
145958425|NCT02824224|526360305|FG000|Overall Study|Did not show up for allocation visit|2|||
145958426|NCT02824224|526360306|FG001|Overall Study|Did not show up for allocation visit|0|||
145958427|NCT02683239|526360307|FG000|Overall Study|Protocol Violation|35|||
145958428|NCT02683239|526360308|FG001|Overall Study|Protocol Violation|23|||
145958429|NCT02683239|526360309|FG002|Overall Study|Protocol Violation|26|||
145958430|NCT02683239|526360310|FG003|Overall Study|Protocol Violation|4|||
145958431|NCT02683239|526360311|FG004|Overall Study|Protocol Violation|35|||
145958432|NCT02683239|526360312|FG005|Overall Study|Protocol Violation|4|||
145958433|NCT02683239|526360313|FG006|Overall Study|Protocol Violation|5|||
145958434|NCT02683239|526360307|FG000|Overall Study|Adverse Event|64|||
145958435|NCT02683239|526360308|FG001|Overall Study|Adverse Event|39|||
145958436|NCT02683239|526360309|FG002|Overall Study|Adverse Event|42|||
145958437|NCT02683239|526360310|FG003|Overall Study|Adverse Event|16|||
145958438|NCT02683239|526360311|FG004|Overall Study|Adverse Event|189|||
145958439|NCT02683239|526360312|FG005|Overall Study|Adverse Event|9|||
145958440|NCT02683239|526360313|FG006|Overall Study|Adverse Event|9|||
145958441|NCT02683239|526360307|FG000|Overall Study|Physician Decision|38|||
145958442|NCT02683239|526360308|FG001|Overall Study|Physician Decision|19|||
145958443|NCT02683239|526360309|FG002|Overall Study|Physician Decision|14|||
145958444|NCT02683239|526360310|FG003|Overall Study|Physician Decision|73|||
145958445|NCT02683239|526360311|FG004|Overall Study|Physician Decision|143|||
145958446|NCT02683239|526360312|FG005|Overall Study|Physician Decision|14|||
145958447|NCT02683239|526360313|FG006|Overall Study|Physician Decision|15|||
145958448|NCT02683239|526360307|FG000|Overall Study|Withdrawal by Subject|187|||
145958449|NCT02683239|526360308|FG001|Overall Study|Withdrawal by Subject|99|||
145958450|NCT02683239|526360309|FG002|Overall Study|Withdrawal by Subject|91|||
145958451|NCT02683239|526360310|FG003|Overall Study|Withdrawal by Subject|18|||
145958452|NCT02683239|526360311|FG004|Overall Study|Withdrawal by Subject|248|||
145958453|NCT02683239|526360312|FG005|Overall Study|Withdrawal by Subject|22|||
145958454|NCT02683239|526360313|FG006|Overall Study|Withdrawal by Subject|28|||
145958455|NCT02683239|526360307|FG000|Overall Study|Lost to Follow-up|77|||
145958456|NCT02683239|526360308|FG001|Overall Study|Lost to Follow-up|24|||
145958457|NCT02683239|526360309|FG002|Overall Study|Lost to Follow-up|25|||
145958458|NCT02683239|526360310|FG003|Overall Study|Lost to Follow-up|7|||
145958459|NCT02683239|526360311|FG004|Overall Study|Lost to Follow-up|88|||
145958460|NCT02683239|526360312|FG005|Overall Study|Lost to Follow-up|8|||
145958461|NCT02683239|526360313|FG006|Overall Study|Lost to Follow-up|11|||
145958462|NCT02683239|526360307|FG000|Overall Study|Death|9|||
145958463|NCT02683239|526360308|FG001|Overall Study|Death|5|||
145958464|NCT02683239|526360309|FG002|Overall Study|Death|8|||
145958465|NCT02683239|526360310|FG003|Overall Study|Death|0|||
145958466|NCT02683239|526360311|FG004|Overall Study|Death|12|||
145958467|NCT02683239|526360312|FG005|Overall Study|Death|1|||
145958468|NCT02683239|526360313|FG006|Overall Study|Death|0|||
145958469|NCT02683239|526360307|FG000|Overall Study|Lack of Efficacy|50|||
145958470|NCT02683239|526360308|FG001|Overall Study|Lack of Efficacy|23|||
145958471|NCT02683239|526360309|FG002|Overall Study|Lack of Efficacy|12|||
145958472|NCT02683239|526360310|FG003|Overall Study|Lack of Efficacy|2|||
145958473|NCT02683239|526360311|FG004|Overall Study|Lack of Efficacy|29|||
146214360|NCT00753090|527299985|FG000|Overall Study|Other|127|||
146214361|NCT00753090|527299986|FG001|Overall Study|Other|75|||
146214362|NCT04173663|527299993|FG000|Overall Study|Withdrawal by Subject|1|||
145958474|NCT02683239|526360312|FG005|Overall Study|Lack of Efficacy|2|||
145958475|NCT02683239|526360313|FG006|Overall Study|Lack of Efficacy|3|||
145958476|NCT02683239|526360307|FG000|Overall Study|Missing data|0|||
145958477|NCT02683239|526360308|FG001|Overall Study|Missing data|1|||
145958478|NCT02683239|526360309|FG002|Overall Study|Missing data|1|||
145958479|NCT02683239|526360310|FG003|Overall Study|Missing data|0|||
146084105|NCT00775203|526827926|FG000|Overall Study|Lost to Follow-up|11|||
145958480|NCT02683239|526360311|FG004|Overall Study|Missing data|1|||
146214363|NCT04173663|527299994|FG001|Overall Study|Withdrawal by Subject|6|||
146214364|NCT04173663|527299993|FG000|Overall Study|Lost to Follow-up|17|||
146214365|NCT04173663|527299994|FG001|Overall Study|Lost to Follow-up|24|||
145958481|NCT02683239|526360312|FG005|Overall Study|Missing data|0|||
145958482|NCT02683239|526360313|FG006|Overall Study|Missing data|0|||
145958483|NCT00368108|526360316|FG000|Overall Study|Adverse Event|38|||
145958484|NCT00368108|526360317|FG001|Overall Study|Adverse Event|26|||
145958485|NCT00368108|526360318|FG002|Overall Study|Adverse Event|44|||
145958486|NCT00368108|526360316|FG000|Overall Study|Abnormal Laboratory Value|0|||
145958487|NCT00368108|526360317|FG001|Overall Study|Abnormal Laboratory Value|0|||
145958488|NCT00368108|526360318|FG002|Overall Study|Abnormal Laboratory Value|3|||
145958489|NCT00368108|526360316|FG000|Overall Study|Protocol Violation|5|||
145958490|NCT00368108|526360317|FG001|Overall Study|Protocol Violation|9|||
145958491|NCT00368108|526360318|FG002|Overall Study|Protocol Violation|9|||
145958492|NCT00368108|526360316|FG000|Overall Study|Withdrawal by Subject|9|||
145958493|NCT00368108|526360317|FG001|Overall Study|Withdrawal by Subject|3|||
145958494|NCT00368108|526360318|FG002|Overall Study|Withdrawal by Subject|5|||
145958495|NCT00368108|526360316|FG000|Overall Study|Lack of Efficacy|7|||
145958496|NCT00368108|526360317|FG001|Overall Study|Lack of Efficacy|8|||
145958497|NCT00368108|526360318|FG002|Overall Study|Lack of Efficacy|5|||
145958498|NCT00368108|526360316|FG000|Overall Study|Physician Decision|2|||
145958499|NCT00368108|526360317|FG001|Overall Study|Physician Decision|0|||
146084106|NCT00775203|526827927|FG001|Overall Study|Lost to Follow-up|15|||
146084107|NCT00775203|526827926|FG000|Overall Study|Administrative reason|2|||
146084108|NCT00775203|526827927|FG001|Overall Study|Administrative reason|0|||
146084109|NCT00775203|526827926|FG000|Overall Study|Noncompliance|4|||
146084110|NCT00775203|526827927|FG001|Overall Study|Noncompliance|2|||
146084111|NCT00775203|526827926|FG000|Overall Study|Protocol Violation|0|||
146084112|NCT00775203|526827927|FG001|Overall Study|Protocol Violation|1|||
146084113|NCT00775203|526827926|FG000|Overall Study|Entered other study|1|||
146084114|NCT00775203|526827927|FG001|Overall Study|Entered other study|0|||
146084115|NCT00775203|526827926|FG000|Overall Study|Physician Decision|0|||
146084116|NCT00775203|526827927|FG001|Overall Study|Physician Decision|1|||
146084117|NCT04896229|526827929|FG000|Overall Study|Lost to Follow-up|113|||
146084118|NCT04896229|526827930|FG001|Overall Study|Lost to Follow-up|113|||
146084119|NCT04395001|526827931|FG000|Overall Study|Lost to Follow-up|8|||
146084120|NCT04395001|526827932|FG001|Overall Study|Lost to Follow-up|9|||
146084121|NCT04395001|526827933|FG002|Overall Study|Lost to Follow-up|5|||
146214366|NCT04402489|527299996|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146214367|NCT04402489|527299997|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
146214368|NCT04402489|527299998|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146214369|NCT04402489|527299999|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146214370|NCT04402489|527300000|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
146214371|NCT04402489|527299996|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
146214372|NCT04402489|527299997|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146214373|NCT04402489|527299998|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146214374|NCT04402489|527299999|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146214375|NCT04402489|527300000|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
146214376|NCT04402489|527299996|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
146214377|NCT04402489|527299997|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
146214378|NCT04402489|527299998|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
146214379|NCT04402489|527299999|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
146214380|NCT04402489|527300000|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
146214381|NCT04402489|527299996|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146214382|NCT04402489|527299997|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146214383|NCT04402489|527299998|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
146214384|NCT04402489|527299999|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146214385|NCT04402489|527300000|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
146214386|NCT04402489|527299996|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146214387|NCT04402489|527299997|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146214388|NCT04402489|527299998|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146214389|NCT04402489|527299999|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
146214390|NCT04402489|527300000|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
146214391|NCT04402489|527299996|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146214392|NCT04402489|527299997|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
146214393|NCT04402489|527299998|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
146214394|NCT04402489|527299999|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146214395|NCT04402489|527300000|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
146214396|NCT03089398|527300009|FG000|Overall Study|Death|4|||
146214397|NCT03089398|527300010|FG001|Overall Study|Death|9|||
146214398|NCT03089398|527300009|FG000|Overall Study|Lost to Follow-up|21|||
146214399|NCT03089398|527300010|FG001|Overall Study|Lost to Follow-up|30|||
146214400|NCT03089398|527300009|FG000|Overall Study|Withdrawal by Subject|2|||
146214401|NCT03089398|527300010|FG001|Overall Study|Withdrawal by Subject|2|||
146214402|NCT05439603|527300011|FG000|Overall Study|met withdrawal criteria|2|||
146214403|NCT03896516|527300012|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
146214404|NCT03896516|527300013|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
146214405|NCT03896516|527300012|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
146214406|NCT03896516|527300013|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
145958500|NCT00368108|526360318|FG002|Overall Study|Physician Decision|1|||
146084122|NCT04395001|526827931|FG000|Overall Study|Withdrawal by Subject|3|||
146084123|NCT04395001|526827932|FG001|Overall Study|Withdrawal by Subject|1|||
146214407|NCT03896516|527300012|FG000|Washout Period|Physician Decision|3|||
146214408|NCT03896516|527300013|FG001|Washout Period|Physician Decision|1|||
146214409|NCT03896516|527300012|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
146214410|NCT03896516|527300013|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
146214411|NCT02682316|527300018|FG000|Overall Study|Benign Final Pathology|27|||
146214412|NCT02682316|527300019|FG001|Overall Study|Benign Final Pathology|26|||
146214413|NCT02682316|527300018|FG000|Overall Study|Reoperation before 30 days|7|||
146214414|NCT02682316|527300019|FG001|Overall Study|Reoperation before 30 days|6|||
146214415|NCT02682316|527300018|FG000|Overall Study|Ineligible|1|||
146214416|NCT02682316|527300019|FG001|Overall Study|Ineligible|0|||
146214417|NCT02682316|527300018|FG000|Overall Study|Death|1|||
146287169|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
146287170|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
146287171|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
146287172|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
146287173|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
146287174|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
146287175|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
146287176|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
146287177|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
146287178|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
146287179|NCT00757588|527567345|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
146287180|NCT00757588|527567346|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
146287181|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
146287182|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
146287183|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
146287184|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
146287185|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
146287186|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
146287187|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
146287188|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
146287189|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
146287190|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
146287191|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
146287192|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
146287193|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
146287194|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
146287195|NCT00757588|527567345|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
146287196|NCT00757588|527567346|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
146287197|NCT00799513|527567354|FG000|Overall Study|Physician Decision|1|||
146287198|NCT00799513|527567354|FG000|Overall Study|Adverse Event|1|||
146287199|NCT05398237|527567355|FG000|Overall Study|Withdrawal by Subject|1|||
146287200|NCT01312857|527567357|FG000|Overall Study|Adverse Event|1|||
146287201|NCT01312857|527567358|FG001|Overall Study|Adverse Event|1|||
146287202|NCT01312857|527567357|FG000|Overall Study|Lost to Follow-up|2|||
146287203|NCT01312857|527567358|FG001|Overall Study|Lost to Follow-up|0|||
146287204|NCT01312857|527567357|FG000|Overall Study|Physician Decision|3|||
146287205|NCT01312857|527567358|FG001|Overall Study|Physician Decision|0|||
146287206|NCT01312857|527567357|FG000|Overall Study|Withdrawal by Subject|2|||
145958501|NCT00368108|526360316|FG000|Overall Study|Other|3|||
145958502|NCT00368108|526360317|FG001|Overall Study|Other|7|||
145958503|NCT00368108|526360318|FG002|Overall Study|Other|1|||
145958504|NCT04131712|526360321|FG000|Overall Study|COVID related|0|||
145958505|NCT04131712|526360322|FG001|Overall Study|COVID related|0|||
145958506|NCT04131712|526360323|FG002|Overall Study|COVID related|2|||
145958507|NCT04131712|526360324|FG003|Overall Study|COVID related|0|||
145958508|NCT04131712|526360321|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145958509|NCT04131712|526360322|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145958510|NCT04131712|526360323|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
145958511|NCT04131712|526360324|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145958512|NCT01719380|526360331|FG000|Overall Study|Adverse Event|0|||
145958513|NCT01719380|526360332|FG001|Overall Study|Adverse Event|0|||
145958514|NCT01719380|526360333|FG002|Overall Study|Adverse Event|1|||
145958515|NCT01719380|526360334|FG003|Overall Study|Adverse Event|2|||
145958516|NCT01719380|526360335|FG004|Overall Study|Adverse Event|0|||
145958517|NCT01719380|526360336|FG005|Overall Study|Adverse Event|1|||
145958518|NCT01719380|526360337|FG006|Overall Study|Adverse Event|0|||
145958519|NCT01719380|526360338|FG007|Overall Study|Adverse Event|1|||
145958520|NCT01719380|526360339|FG008|Overall Study|Adverse Event|4|||
145958521|NCT01719380|526360340|FG009|Overall Study|Adverse Event|3|||
145958522|NCT01719380|526360331|FG000|Overall Study|Death|0|||
145958523|NCT01719380|526360332|FG001|Overall Study|Death|1|||
145958524|NCT01719380|526360333|FG002|Overall Study|Death|0|||
145958525|NCT01719380|526360334|FG003|Overall Study|Death|0|||
145958526|NCT01719380|526360335|FG004|Overall Study|Death|0|||
145958527|NCT01719380|526360336|FG005|Overall Study|Death|0|||
145958528|NCT01719380|526360337|FG006|Overall Study|Death|0|||
145958529|NCT01719380|526360338|FG007|Overall Study|Death|0|||
145958530|NCT01719380|526360339|FG008|Overall Study|Death|3|||
145958531|NCT01719380|526360340|FG009|Overall Study|Death|3|||
145958532|NCT01719380|526360331|FG000|Overall Study|Participant/Guardian Decision|0|||
145958533|NCT01719380|526360332|FG001|Overall Study|Participant/Guardian Decision|0|||
145958534|NCT01719380|526360333|FG002|Overall Study|Participant/Guardian Decision|1|||
145958535|NCT01719380|526360334|FG003|Overall Study|Participant/Guardian Decision|0|||
145958536|NCT01719380|526360335|FG004|Overall Study|Participant/Guardian Decision|0|||
145958537|NCT01719380|526360336|FG005|Overall Study|Participant/Guardian Decision|0|||
145958538|NCT01719380|526360337|FG006|Overall Study|Participant/Guardian Decision|0|||
145958539|NCT01719380|526360338|FG007|Overall Study|Participant/Guardian Decision|0|||
145958540|NCT01719380|526360339|FG008|Overall Study|Participant/Guardian Decision|2|||
145958541|NCT01719380|526360340|FG009|Overall Study|Participant/Guardian Decision|2|||
145958542|NCT01719380|526360331|FG000|Overall Study|Physician Decision|0|||
145958543|NCT01719380|526360332|FG001|Overall Study|Physician Decision|0|||
145958544|NCT01719380|526360333|FG002|Overall Study|Physician Decision|2|||
145958545|NCT01719380|526360334|FG003|Overall Study|Physician Decision|0|||
145958546|NCT01719380|526360335|FG004|Overall Study|Physician Decision|0|||
145958547|NCT01719380|526360336|FG005|Overall Study|Physician Decision|0|||
145958548|NCT01719380|526360337|FG006|Overall Study|Physician Decision|0|||
145958549|NCT01719380|526360338|FG007|Overall Study|Physician Decision|0|||
145958550|NCT01719380|526360339|FG008|Overall Study|Physician Decision|1|||
145958551|NCT01719380|526360340|FG009|Overall Study|Physician Decision|1|||
145958552|NCT01719380|526360331|FG000|Overall Study|Lack of Efficacy|2|||
145958553|NCT01719380|526360332|FG001|Overall Study|Lack of Efficacy|6|||
145958554|NCT01719380|526360333|FG002|Overall Study|Lack of Efficacy|5|||
145958555|NCT01719380|526360334|FG003|Overall Study|Lack of Efficacy|6|||
145958556|NCT01719380|526360335|FG004|Overall Study|Lack of Efficacy|3|||
145958557|NCT01719380|526360336|FG005|Overall Study|Lack of Efficacy|7|||
145958558|NCT01719380|526360337|FG006|Overall Study|Lack of Efficacy|10|||
145958559|NCT01719380|526360338|FG007|Overall Study|Lack of Efficacy|6|||
146214418|NCT02682316|527300019|FG001|Overall Study|Death|0|||
146214419|NCT02682316|527300018|FG000|Overall Study|Lost to Follow-up|7|||
146214420|NCT02682316|527300019|FG001|Overall Study|Lost to Follow-up|3|||
146214421|NCT02662062|527300023|FG000|Overall Study|Withdrawal by Subject|1|||
146214422|NCT05406921|527300024|FG000|Overall Study|Withdrawal by Subject|25|||
146214423|NCT05406921|527300025|FG001|Overall Study|Withdrawal by Subject|0|||
146214424|NCT05406921|527300026|FG002|Overall Study|Withdrawal by Subject|25|||
145958560|NCT01719380|526360339|FG008|Overall Study|Lack of Efficacy|39|||
145958561|NCT01719380|526360340|FG009|Overall Study|Lack of Efficacy|42|||
145958562|NCT01719380|526360331|FG000|Overall Study|Progressive Disease|0|||
145958563|NCT01719380|526360332|FG001|Overall Study|Progressive Disease|0|||
145958564|NCT01719380|526360333|FG002|Overall Study|Progressive Disease|0|||
145958565|NCT01719380|526360334|FG003|Overall Study|Progressive Disease|0|||
145958566|NCT01719380|526360335|FG004|Overall Study|Progressive Disease|0|||
145958567|NCT01719380|526360336|FG005|Overall Study|Progressive Disease|0|||
145958568|NCT01719380|526360337|FG006|Overall Study|Progressive Disease|0|||
145958569|NCT01719380|526360338|FG007|Overall Study|Progressive Disease|0|||
145958570|NCT01719380|526360339|FG008|Overall Study|Progressive Disease|1|||
145958571|NCT01719380|526360340|FG009|Overall Study|Progressive Disease|0|||
145958572|NCT03200548|526360341|FG000|Overall Study|Withdrawal by Subject|5|||
146214425|NCT05406921|527300024|FG000|Overall Study|Protocol Violation|0|||
146214426|NCT05406921|527300025|FG001|Overall Study|Protocol Violation|12|||
146287207|NCT01312857|527567358|FG001|Overall Study|Withdrawal by Subject|0|||
146287208|NCT02781844|527567363|FG000|Treatment Period 1|Adverse Event|0|||
146287209|NCT02781844|527567364|FG001|Treatment Period 1|Adverse Event|0|||
146214427|NCT05406921|527300026|FG002|Overall Study|Protocol Violation|0|||
146214428|NCT04831281|527300029|FG000|Overall Study|Adverse Event|1|||
146214429|NCT04831281|527300030|FG001|Overall Study|Adverse Event|0|||
146214430|NCT04831281|527300031|FG002|Overall Study|Adverse Event|3|||
146214431|NCT04831281|527300029|FG000|Overall Study|Withdrawal by Subject|0|||
146214432|NCT04831281|527300030|FG001|Overall Study|Withdrawal by Subject|1|||
146214433|NCT04831281|527300031|FG002|Overall Study|Withdrawal by Subject|2|||
146214434|NCT04831281|527300029|FG000|Overall Study|Undetermined|1|||
146214435|NCT04831281|527300030|FG001|Overall Study|Undetermined|1|||
146214436|NCT04831281|527300031|FG002|Overall Study|Undetermined|0|||
146214437|NCT05059262|527300032|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
146214438|NCT05059262|527300033|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
146214439|NCT05059262|527300032|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
146214440|NCT05059262|527300033|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
146214441|NCT05059262|527300032|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
146214442|NCT05059262|527300033|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
146214443|NCT05059262|527300032|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
146214444|NCT05059262|527300033|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
146214445|NCT05059262|527300032|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
146214446|NCT05059262|527300033|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
146214447|NCT05059262|527300032|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
146214448|NCT05059262|527300033|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
146214449|NCT05059262|527300032|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
146214450|NCT05059262|527300033|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
146214451|NCT05059262|527300032|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
146287210|NCT02781844|527567365|FG002|Treatment Period 1|Adverse Event|0|||
146287211|NCT02781844|527567366|FG003|Treatment Period 1|Adverse Event|0|||
146287212|NCT02781844|527567367|FG004|Treatment Period 1|Adverse Event|0|||
146287213|NCT02781844|527567368|FG005|Treatment Period 1|Adverse Event|1|||
146214452|NCT05059262|527300033|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
146214453|NCT05059262|527300032|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
146214454|NCT05059262|527300033|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
146287214|NCT02781844|527567369|FG006|Treatment Period 1|Adverse Event|0|||
146287215|NCT02781844|527567370|FG007|Treatment Period 1|Adverse Event|0|||
146214455|NCT05021640|527300037|FG000|Overall Study|Lost to Follow-up|0|||
146214456|NCT05021640|527300038|FG001|Overall Study|Lost to Follow-up|0|||
146214457|NCT05021640|527300039|FG002|Overall Study|Lost to Follow-up|0|||
146214458|NCT05021640|527300040|FG003|Overall Study|Lost to Follow-up|0|||
146214459|NCT05021640|527300041|FG004|Overall Study|Lost to Follow-up|1|||
146287216|NCT00321373|527567375|FG000|Overall Study|Adverse Event|0|||
146214460|NCT04737772|527300042|FG000|Phase 2 Study|Lost to Follow-up|15|||
146214461|NCT04737772|527300043|FG001|Phase 2 Study|Lost to Follow-up|15|||
146214462|NCT04737772|527300042|FG000|Phase 2 Study|Withdrawal by Subject|0|||
146214463|NCT04737772|527300043|FG001|Phase 2 Study|Withdrawal by Subject|1|||
146214464|NCT04737772|527300042|FG000|Phase 2 Study|Did not take any coaching calls|4|||
146214465|NCT04737772|527300043|FG001|Phase 2 Study|Did not take any coaching calls|0|||
146214466|NCT04737772|527300042|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
146214467|NCT04737772|527300043|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
146214468|NCT04737772|527300042|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
146214469|NCT04737772|527300043|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
146214470|NCT04089371|527300047|FG000|Overall Study|Withdrawal by Subject|0|||
146214471|NCT04089371|527300048|FG001|Overall Study|Withdrawal by Subject|1|||
146214472|NCT04089371|527300047|FG000|Overall Study|Study terminated early|0|||
146214473|NCT04089371|527300048|FG001|Overall Study|Study terminated early|9|||
146214474|NCT04382898|527300049|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
146214475|NCT04382898|527300050|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
146214476|NCT04382898|527300051|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
146214477|NCT04382898|527300052|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
146214478|NCT04382898|527300053|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
146214479|NCT04382898|527300049|FG000|Part 1: Dose Titration|Death|6|||
146214480|NCT04382898|527300050|FG001|Part 1: Dose Titration|Death|0|||
146214481|NCT04382898|527300051|FG002|Part 1: Dose Titration|Death|0|||
146214482|NCT04382898|527300052|FG003|Part 1: Dose Titration|Death|0|||
146214483|NCT04382898|527300053|FG004|Part 1: Dose Titration|Death|0|||
146214484|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146214485|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146214486|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146214487|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146214488|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146214489|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
146214490|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
146214491|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
146214492|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
146214493|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
146214494|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Death|0|||
146214495|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Death|17|||
146214496|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Death|13|||
146214497|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Death|1|||
146214498|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Death|0|||
146214499|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
146214500|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
146214501|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
146214502|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
146214503|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
146214504|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
146214505|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146214506|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146214507|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
146214508|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
146214509|NCT04382898|527300049|FG000|Part 2: Dose Expansion|Other|0|||
146214510|NCT04382898|527300050|FG001|Part 2: Dose Expansion|Other|0|||
146214511|NCT04382898|527300051|FG002|Part 2: Dose Expansion|Other|1|||
146214512|NCT04382898|527300052|FG003|Part 2: Dose Expansion|Other|0|||
146214513|NCT04382898|527300053|FG004|Part 2: Dose Expansion|Other|0|||
146214514|NCT05229120|527300054|FG000|Overall Study|Withdrawal by Subject|8|||
146214515|NCT03932682|527300055|FG000|Overall Study|Death|1|||
146214516|NCT03932682|527300056|FG001|Overall Study|Death|2|||
146214517|NCT03932682|527300055|FG000|Overall Study|Withdrawal by Subject|37|||
146214518|NCT03932682|527300056|FG001|Overall Study|Withdrawal by Subject|45|||
146214519|NCT03932682|527300055|FG000|Overall Study|Lost to Follow-up|19|||
146214520|NCT03932682|527300056|FG001|Overall Study|Lost to Follow-up|25|||
146214521|NCT03932682|527300055|FG000|Overall Study|Protocol Violation|0|||
146214522|NCT03932682|527300056|FG001|Overall Study|Protocol Violation|2|||
146214523|NCT03932682|527300055|FG000|Overall Study|Other|9|||
146214524|NCT03932682|527300056|FG001|Overall Study|Other|23|||
146214525|NCT02900924|527300057|FG000|Overall Study|Death|52|||
146214526|NCT02900924|527300057|FG000|Overall Study|Lost to Follow-up|4|||
146084124|NCT04395001|526827933|FG002|Overall Study|Withdrawal by Subject|3|||
146084125|NCT04395001|526827931|FG000|Overall Study|missed appointment|7|||
146214527|NCT02900924|527300057|FG000|Overall Study|Withdrawal by Subject|20|||
146214528|NCT02900924|527300057|FG000|Overall Study|Missed Visit|33|||
146214529|NCT05956002|527300058|FG000|Treatment Period 3|Adverse Event|0|||
145958573|NCT03200548|526360342|FG001|Overall Study|Withdrawal by Subject|11|||
146214530|NCT05956002|527300059|FG001|Treatment Period 3|Adverse Event|0|||
145958574|NCT03200548|526360343|FG002|Overall Study|Withdrawal by Subject|7|||
145958575|NCT03200548|526360344|FG003|Overall Study|Withdrawal by Subject|6|||
145958576|NCT00447772|526360345|FG000|Overall Study|Lack of Efficacy|3|||
145958577|NCT00447772|526360345|FG000|Overall Study|Insufficient compliance|6|||
145958578|NCT00447772|526360345|FG000|Overall Study|Discontinuation of drug therapy|1|||
145958579|NCT00447772|526360345|FG000|Overall Study|Lost to Follow-up|9|||
145958580|NCT00447772|526360345|FG000|Overall Study|Withdrawal by Subject|1|||
145958581|NCT00447772|526360345|FG000|Overall Study|Unable to attend all study visits|2|||
145958582|NCT00447772|526360345|FG000|Overall Study|Adverse Event|1|||
145958583|NCT00447772|526360345|FG000|Overall Study|Patient relocated|1|||
145958584|NCT00447772|526360345|FG000|Overall Study|Incomplete documentation at visit 1|1|||
146214531|NCT05956002|527300060|FG002|Treatment Period 3|Adverse Event|1|||
146214532|NCT05956002|527300061|FG003|Treatment Period 3|Adverse Event|0|||
146214533|NCT02307565|527300062|FG000|Overall Study|Adverse Event|3|||
146214534|NCT02307565|527300063|FG001|Overall Study|Adverse Event|2|||
146214535|NCT02307565|527300062|FG000|Overall Study|Withdrawal by Subject|2|||
146214536|NCT02307565|527300063|FG001|Overall Study|Withdrawal by Subject|2|||
146214537|NCT04936035|527300064|FG000|Overall Study|Adverse Event|0|||
145958585|NCT00447772|526360345|FG000|Overall Study|Chemotherapy for lung cancer|1|||
145958586|NCT00447772|526360345|FG000|Overall Study|Premature re-injection required|1|||
145958587|NCT00716456|526360346|FG000|Overall Study|Adverse Event|0|||
145958588|NCT00716456|526360347|FG001|Overall Study|Adverse Event|2|||
145958589|NCT00716456|526360348|FG002|Overall Study|Adverse Event|0|||
145958590|NCT00875563|526360353|FG000|Overall Study|Death|4|||
145958591|NCT00875563|526360353|FG000|Overall Study|Withdrawal by Subject|7|||
145958592|NCT00875563|526360353|FG000|Overall Study|No long-term (3-5 year) consent|6|||
145958593|NCT00875563|526360353|FG000|Overall Study|Still be eligible for follow-up|7|||
146214538|NCT04936035|527300065|FG001|Overall Study|Adverse Event|1|||
146214539|NCT04936035|527300066|FG002|Overall Study|Adverse Event|0|||
146214540|NCT04936035|527300067|FG003|Overall Study|Adverse Event|0|||
146214541|NCT04936035|527300068|FG004|Overall Study|Adverse Event|0|||
146214542|NCT04936035|527300064|FG000|Overall Study|Death|0|||
146214543|NCT04936035|527300065|FG001|Overall Study|Death|0|||
146287217|NCT00321373|527567376|FG001|Overall Study|Adverse Event|0|||
145958594|NCT02896569|526360354|FG000|Overall Study|Lost to Follow-up|2|||
145958595|NCT02896569|526360355|FG001|Overall Study|Lost to Follow-up|1|||
145958596|NCT02896569|526360354|FG000|Overall Study|Physician Decision|1|||
145958597|NCT02896569|526360355|FG001|Overall Study|Physician Decision|3|||
145958598|NCT02896569|526360354|FG000|Overall Study|Adverse Event|0|||
145958599|NCT02896569|526360355|FG001|Overall Study|Adverse Event|1|||
146214544|NCT04936035|527300066|FG002|Overall Study|Death|0|||
146214545|NCT04936035|527300067|FG003|Overall Study|Death|1|||
146214546|NCT04936035|527300068|FG004|Overall Study|Death|0|||
146214547|NCT04936035|527300064|FG000|Overall Study|Lost to Follow-up|0|||
146214548|NCT04936035|527300065|FG001|Overall Study|Lost to Follow-up|1|||
146214549|NCT04936035|527300066|FG002|Overall Study|Lost to Follow-up|1|||
146214550|NCT04936035|527300067|FG003|Overall Study|Lost to Follow-up|2|||
146214551|NCT04936035|527300068|FG004|Overall Study|Lost to Follow-up|1|||
146214552|NCT04936035|527300064|FG000|Overall Study|Physician Decision|0|||
146214553|NCT04936035|527300065|FG001|Overall Study|Physician Decision|1|||
146214554|NCT04936035|527300066|FG002|Overall Study|Physician Decision|0|||
146214555|NCT04936035|527300067|FG003|Overall Study|Physician Decision|0|||
146214556|NCT04936035|527300068|FG004|Overall Study|Physician Decision|0|||
146214557|NCT04936035|527300064|FG000|Overall Study|Protocol Deviation|0|||
146214558|NCT04936035|527300065|FG001|Overall Study|Protocol Deviation|0|||
146214559|NCT04936035|527300066|FG002|Overall Study|Protocol Deviation|1|||
146214560|NCT04936035|527300067|FG003|Overall Study|Protocol Deviation|0|||
146214561|NCT04936035|527300068|FG004|Overall Study|Protocol Deviation|0|||
146214562|NCT04936035|527300064|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
146214563|NCT04936035|527300065|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
146214564|NCT04936035|527300066|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
146214565|NCT04936035|527300067|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
146214566|NCT04936035|527300068|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
146214567|NCT04936035|527300064|FG000|Overall Study|Reason Unknown|0|||
146214568|NCT04936035|527300065|FG001|Overall Study|Reason Unknown|0|||
146214569|NCT04936035|527300066|FG002|Overall Study|Reason Unknown|0|||
146214570|NCT04936035|527300067|FG003|Overall Study|Reason Unknown|0|||
146214571|NCT04936035|527300068|FG004|Overall Study|Reason Unknown|1|||
146214572|NCT04936035|527300064|FG000|Overall Study|Withdrawal by Subject|1|||
146214573|NCT04936035|527300065|FG001|Overall Study|Withdrawal by Subject|0|||
146214574|NCT04936035|527300066|FG002|Overall Study|Withdrawal by Subject|0|||
145958600|NCT02896569|526360354|FG000|Overall Study|Withdrawal by Subject|1|||
145958601|NCT02896569|526360355|FG001|Overall Study|Withdrawal by Subject|0|||
145958602|NCT00313846|526360356|FG000|Overall Study|Withdrawal by Subject|2|||
145958603|NCT00313846|526360357|FG001|Overall Study|Withdrawal by Subject|0|||
145958604|NCT00313846|526360356|FG000|Overall Study|Adverse Event|1|||
145958605|NCT00313846|526360357|FG001|Overall Study|Adverse Event|8|||
145958606|NCT00313846|526360356|FG000|Overall Study|Administrative|2|||
145958607|NCT00313846|526360357|FG001|Overall Study|Administrative|3|||
145958608|NCT03257436|526360358|FG000|Overall Study|Withdrawal by Subject|76|||
145958609|NCT03257436|526360358|FG000|Overall Study|Death|19|||
145958610|NCT01841970|526360363|FG000|Overall Study|Withdrawal by Subject|1|||
145958611|NCT01841970|526360363|FG000|Overall Study|Physician Decision|2|||
145958612|NCT01841970|526360363|FG000|Overall Study|Lost to Follow-up|8|||
145958613|NCT03478371|526360364|FG000|Overall Study|non-compliance|1|||
145958614|NCT03478371|526360364|FG000|Overall Study|Lost to Follow-up|4|||
145958615|NCT02849743|526360366|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
145958616|NCT02849743|526360367|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
145958617|NCT02849743|526360366|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
145958618|NCT02849743|526360367|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145958619|NCT03874013|526360374|FG000|Overall Study|Adverse Event|0|||
145958620|NCT03874013|526360375|FG001|Overall Study|Adverse Event|1|||
145958621|NCT01411852|526360376|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
145958622|NCT01411852|526360377|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
146214575|NCT04936035|527300067|FG003|Overall Study|Withdrawal by Subject|0|||
145958623|NCT01411852|526360376|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
145958624|NCT01411852|526360377|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
145958625|NCT01411852|526360376|FG000|Prehospital Intervention Phase|Found to be under age|0|||
145958626|NCT01411852|526360377|FG001|Prehospital Intervention Phase|Found to be under age|1|||
145958627|NCT01411852|526360376|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
145958628|NCT01411852|526360377|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
145958629|NCT01411852|526360376|FG000|Hospital Intervention Phase|Severe head injury|5|||
145958630|NCT01411852|526360377|FG001|Hospital Intervention Phase|Severe head injury|4|||
145958631|NCT01411852|526360376|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
145958632|NCT01411852|526360377|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
145958633|NCT01411852|526360376|FG000|Hospital Intervention Phase|Miscommunication error|1|||
145958634|NCT01411852|526360377|FG001|Hospital Intervention Phase|Miscommunication error|2|||
145958635|NCT01411852|526360376|FG000|Hospital Intervention Phase|CPR administered|3|||
145958636|NCT01411852|526360377|FG001|Hospital Intervention Phase|CPR administered|1|||
145958637|NCT01411852|526360376|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
145958638|NCT01411852|526360377|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
145958639|NCT01411852|526360376|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
145958640|NCT01411852|526360377|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
145958641|NCT01411852|526360376|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
145958642|NCT01411852|526360377|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
145958643|NCT01411852|526360376|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
145958644|NCT01411852|526360377|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
145958645|NCT01411852|526360376|FG000|Hospital Intervention Phase|Other ineligible|2|||
145958646|NCT01411852|526360377|FG001|Hospital Intervention Phase|Other ineligible|2|||
145958647|NCT01411852|526360376|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
145958648|NCT01411852|526360377|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
145958649|NCT01411852|526360376|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
145958650|NCT01411852|526360377|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
145958651|NCT01411852|526360376|FG000|Hospital Intervention Phase|Vascular access failed|1|||
145958652|NCT01411852|526360377|FG001|Hospital Intervention Phase|Vascular access failed|0|||
145958653|NCT03489343|526360384|FG000|Overall Study|Documented progressive disease|1|||
145958654|NCT03489343|526360385|FG001|Overall Study|Documented progressive disease|0|||
145958655|NCT03489343|526360386|FG002|Overall Study|Documented progressive disease|3|||
145958656|NCT03489343|526360387|FG003|Overall Study|Documented progressive disease|1|||
145958657|NCT03489343|526360388|FG004|Overall Study|Documented progressive disease|3|||
145958658|NCT03489343|526360389|FG005|Overall Study|Documented progressive disease|5|||
145958659|NCT03489343|526360390|FG006|Overall Study|Documented progressive disease|4|||
145958660|NCT03489343|526360384|FG000|Overall Study|Adverse Event|0|||
145958661|NCT03489343|526360385|FG001|Overall Study|Adverse Event|1|||
145958662|NCT03489343|526360386|FG002|Overall Study|Adverse Event|0|||
145958663|NCT03489343|526360387|FG003|Overall Study|Adverse Event|0|||
145958664|NCT03489343|526360388|FG004|Overall Study|Adverse Event|0|||
145958665|NCT03489343|526360389|FG005|Overall Study|Adverse Event|1|||
145958666|NCT03489343|526360390|FG006|Overall Study|Adverse Event|0|||
145958667|NCT03489343|526360384|FG000|Overall Study|Withdrawal by Subject|0|||
145958668|NCT03489343|526360385|FG001|Overall Study|Withdrawal by Subject|0|||
145958669|NCT03489343|526360386|FG002|Overall Study|Withdrawal by Subject|0|||
145958670|NCT03489343|526360387|FG003|Overall Study|Withdrawal by Subject|1|||
145958671|NCT03489343|526360388|FG004|Overall Study|Withdrawal by Subject|0|||
145958672|NCT03489343|526360389|FG005|Overall Study|Withdrawal by Subject|1|||
145958673|NCT03489343|526360390|FG006|Overall Study|Withdrawal by Subject|1|||
145958674|NCT03489343|526360384|FG000|Overall Study|Clinical progression|0|||
145958675|NCT03489343|526360385|FG001|Overall Study|Clinical progression|0|||
145958676|NCT03489343|526360386|FG002|Overall Study|Clinical progression|0|||
145958677|NCT03489343|526360387|FG003|Overall Study|Clinical progression|1|||
145958678|NCT03489343|526360388|FG004|Overall Study|Clinical progression|0|||
145958679|NCT03489343|526360389|FG005|Overall Study|Clinical progression|0|||
145958680|NCT03489343|526360390|FG006|Overall Study|Clinical progression|1|||
145958681|NCT00327717|526360391|FG000|Overall Study|Adverse Event|6|||
145958682|NCT00327717|526360392|FG001|Overall Study|Adverse Event|6|||
145958683|NCT00327717|526360391|FG000|Overall Study|Lack of Efficacy|0|||
145958684|NCT00327717|526360392|FG001|Overall Study|Lack of Efficacy|1|||
145958685|NCT00327717|526360391|FG000|Overall Study|Withdrawal by Subject|3|||
145958686|NCT00327717|526360392|FG001|Overall Study|Withdrawal by Subject|7|||
145958687|NCT01630135|526360394|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
145958688|NCT01630135|526360395|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
145958689|NCT01502033|526360396|FG000|Overall Study|1 participant had scalp discomfort|1|||
145958690|NCT01502033|526360396|FG000|Overall Study|1 participant had worsening depression|1|||
145958691|NCT01502033|526360396|FG000|Overall Study|1 participant went back to school|1|||
145958692|NCT03804268|526360407|FG000|Overall Study|Adverse Event|2|||
145958693|NCT03804268|526360408|FG001|Overall Study|Adverse Event|2|||
145958694|NCT03804268|526360407|FG000|Overall Study|Withdrawal by Subject|2|||
145958695|NCT03804268|526360408|FG001|Overall Study|Withdrawal by Subject|0|||
145958696|NCT03804268|526360407|FG000|Overall Study|Lost to Follow-up|1|||
145958697|NCT03804268|526360408|FG001|Overall Study|Lost to Follow-up|0|||
145958698|NCT03804268|526360407|FG000|Overall Study|Physician Decision|2|||
145958699|NCT03804268|526360408|FG001|Overall Study|Physician Decision|0|||
145958700|NCT03311841|526360413|FG000|14-day Wash-out|Adverse Event|0|||
145958701|NCT03311841|526360414|FG001|14-day Wash-out|Adverse Event|1|||
145958702|NCT03311841|526360415|FG002|14-day Wash-out|Adverse Event|0|||
145958703|NCT03311841|526360416|FG003|14-day Wash-out|Adverse Event|0|||
145958704|NCT03311841|526360417|FG004|14-day Wash-out|Adverse Event|0|||
146084126|NCT04395001|526827932|FG001|Overall Study|missed appointment|4|||
146287218|NCT00321373|527567377|FG002|Overall Study|Adverse Event|1|||
146287219|NCT00321373|527567375|FG000|Overall Study|Lost to Follow-up|1|||
146287220|NCT00321373|527567376|FG001|Overall Study|Lost to Follow-up|0|||
146287221|NCT00321373|527567377|FG002|Overall Study|Lost to Follow-up|1|||
146287222|NCT00321373|527567375|FG000|Overall Study|Withdrawal by Subject|1|||
146287223|NCT00321373|527567376|FG001|Overall Study|Withdrawal by Subject|0|||
146287224|NCT00321373|527567377|FG002|Overall Study|Withdrawal by Subject|0|||
146287225|NCT00321373|527567375|FG000|Overall Study|Other|0|||
146287226|NCT00321373|527567376|FG001|Overall Study|Other|0|||
146287227|NCT00321373|527567377|FG002|Overall Study|Other|1|||
146287228|NCT01774487|527567378|FG000|Overall Study|Did not tolerate taste|4|||
146287229|NCT01774487|527567379|FG001|Overall Study|Did not tolerate taste|4|||
146287230|NCT04275089|527567380|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
146287231|NCT02354508|527567383|FG000|Period 1: Core Phase|Adverse Event|1|||
146287232|NCT02354508|527567384|FG001|Period 1: Core Phase|Adverse Event|1|||
146287233|NCT02354508|527567385|FG002|Period 1: Core Phase|Adverse Event|2|||
146287234|NCT02354508|527567383|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
146287235|NCT02354508|527567384|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
146287236|NCT02354508|527567385|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
146287237|NCT02354508|527567383|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
146287238|NCT02354508|527567384|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
146287239|NCT02354508|527567385|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
146287240|NCT02354508|527567383|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
146287241|NCT02354508|527567384|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
145958705|NCT03311841|526360413|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
145958706|NCT03311841|526360414|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
145958707|NCT03311841|526360415|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
145958708|NCT03311841|526360416|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
145958709|NCT03311841|526360417|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
145958710|NCT01026948|526360423|FG000|Overall Study|Physician Decision|8|||
145958711|NCT02989402|526360425|FG000|Overall Study|Adverse event, or serious adverse event|4|||
145958712|NCT02989402|526360425|FG000|Overall Study|Death|2|||
145958713|NCT02989402|526360425|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
145958714|NCT02989402|526360425|FG000|Overall Study|Lost to Follow-up|8|||
145958715|NCT02989402|526360425|FG000|Overall Study|Patient no longer on monotherapy|1|||
145958716|NCT02989402|526360425|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
145958717|NCT02989402|526360425|FG000|Overall Study|Withdrawal by Subject|7|||
145958718|NCT02989402|526360425|FG000|Overall Study|Other|2|||
145958719|NCT02824627|526360440|FG000|Overall Study|Adverse Event|1|||
145958720|NCT02824627|526360441|FG001|Overall Study|Adverse Event|2|||
145958721|NCT02824627|526360440|FG000|Overall Study|Lost to Follow-up|2|||
145958722|NCT02824627|526360441|FG001|Overall Study|Lost to Follow-up|1|||
145958723|NCT00672633|526360442|FG000|Overall Study|Withdrawal by Subject|0|||
145958724|NCT00672633|526360443|FG001|Overall Study|Withdrawal by Subject|1|||
145958725|NCT01938846|526360444|FG000|Overall Study|Progressive disease|26|||
145958726|NCT01938846|526360445|FG001|Overall Study|Progressive disease|18|||
145958727|NCT01938846|526360446|FG002|Overall Study|Progressive disease|16|||
145958728|NCT01938846|526360444|FG000|Overall Study|Adverse Event|8|||
145958729|NCT01938846|526360445|FG001|Overall Study|Adverse Event|4|||
145958730|NCT01938846|526360446|FG002|Overall Study|Adverse Event|3|||
145958731|NCT01938846|526360444|FG000|Overall Study|Withdrawal by Subject|2|||
145958732|NCT01938846|526360445|FG001|Overall Study|Withdrawal by Subject|2|||
145958733|NCT01938846|526360446|FG002|Overall Study|Withdrawal by Subject|1|||
145958734|NCT01938846|526360444|FG000|Overall Study|Other than listed|5|||
145958735|NCT01938846|526360445|FG001|Overall Study|Other than listed|1|||
145958736|NCT01938846|526360446|FG002|Overall Study|Other than listed|4|||
145958737|NCT02499120|526360447|FG000|Overall Study|Death|52|||
145958738|NCT02499120|526360448|FG001|Overall Study|Death|43|||
146287242|NCT02354508|527567385|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
146287243|NCT02354508|527567383|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
146287244|NCT02354508|527567384|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
146287245|NCT02354508|527567385|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
146287246|NCT02354508|527567383|FG000|Period 2: Extension Phase|Physician Decision|5|||
146287247|NCT02354508|527567384|FG001|Period 2: Extension Phase|Physician Decision|0|||
146287248|NCT02354508|527567385|FG002|Period 2: Extension Phase|Physician Decision|1|||
146287249|NCT02354508|527567383|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
145958739|NCT02499120|526360447|FG000|Overall Study|Lost to Follow-up|1|||
145958740|NCT02499120|526360448|FG001|Overall Study|Lost to Follow-up|2|||
145958741|NCT02499120|526360447|FG000|Overall Study|Participant refused further follow-up|1|||
145958742|NCT02499120|526360448|FG001|Overall Study|Participant refused further follow-up|0|||
145958743|NCT02499120|526360447|FG000|Overall Study|Withdrawal by Subject|2|||
145958744|NCT02499120|526360448|FG001|Overall Study|Withdrawal by Subject|5|||
145958745|NCT02499120|526360447|FG000|Overall Study|Other|9|||
146287250|NCT02354508|527567384|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
146287251|NCT02354508|527567385|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
146287252|NCT02354508|527567383|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
146287253|NCT02354508|527567384|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
146287254|NCT02354508|527567385|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
146287255|NCT02354508|527567383|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
146287256|NCT02354508|527567384|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
146287257|NCT02354508|527567385|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
146287258|NCT02585232|527567389|FG000|Overall Study|Lost to Follow-up|8|||
146287259|NCT02585232|527567390|FG001|Overall Study|Lost to Follow-up|8|||
146287260|NCT02585232|527567389|FG000|Overall Study|Withdrawal by Subject|4|||
146287261|NCT02585232|527567390|FG001|Overall Study|Withdrawal by Subject|8|||
146287262|NCT00461032|527567391|FG000|Overall Study|Adverse Event|5|||
146287263|NCT00461032|527567392|FG001|Overall Study|Adverse Event|6|||
146287264|NCT00461032|527567391|FG000|Overall Study|Lack of Efficacy|5|||
146287265|NCT00461032|527567392|FG001|Overall Study|Lack of Efficacy|1|||
146287266|NCT00461032|527567391|FG000|Overall Study|Lost to Follow-up|7|||
146287267|NCT00461032|527567392|FG001|Overall Study|Lost to Follow-up|12|||
146287268|NCT00461032|527567391|FG000|Overall Study|Protocol Violation|4|||
146287269|NCT00461032|527567392|FG001|Overall Study|Protocol Violation|4|||
146287270|NCT00461032|527567391|FG000|Overall Study|Withdrawal by Subject|7|||
146287271|NCT00461032|527567392|FG001|Overall Study|Withdrawal by Subject|15|||
146287272|NCT00461032|527567391|FG000|Overall Study|Patient Moved or Relocated|2|||
146287273|NCT00461032|527567392|FG001|Overall Study|Patient Moved or Relocated|1|||
146287274|NCT00461032|527567391|FG000|Overall Study|Other|7|||
146287275|NCT00461032|527567392|FG001|Overall Study|Other|5|||
146287276|NCT04447846|527567393|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
146287277|NCT02257567|527567395|FG000|Overall Study|Adverse Event|0|||
146287278|NCT02257567|527567396|FG001|Overall Study|Adverse Event|0|||
146287279|NCT02257567|527567397|FG002|Overall Study|Adverse Event|0|||
146287280|NCT02257567|527567398|FG003|Overall Study|Adverse Event|1|||
146287281|NCT02257567|527567399|FG004|Overall Study|Adverse Event|1|||
146287282|NCT02257567|527567400|FG005|Overall Study|Adverse Event|0|||
146287283|NCT02257567|527567401|FG006|Overall Study|Adverse Event|0|||
146287284|NCT02257567|527567402|FG007|Overall Study|Adverse Event|0|||
146287285|NCT02257567|527567403|FG008|Overall Study|Adverse Event|1|||
146287286|NCT02257567|527567404|FG009|Overall Study|Adverse Event|0|||
146287287|NCT02257567|527567405|FG010|Overall Study|Adverse Event|0|||
146287288|NCT02257567|527567395|FG000|Overall Study|Death|2|||
146287289|NCT02257567|527567396|FG001|Overall Study|Death|2|||
146287290|NCT02257567|527567397|FG002|Overall Study|Death|2|||
146287291|NCT02257567|527567398|FG003|Overall Study|Death|4|||
146287292|NCT02257567|527567399|FG004|Overall Study|Death|15|||
146287293|NCT02257567|527567400|FG005|Overall Study|Death|11|||
146287294|NCT02257567|527567401|FG006|Overall Study|Death|26|||
146287295|NCT02257567|527567402|FG007|Overall Study|Death|30|||
146287296|NCT02257567|527567403|FG008|Overall Study|Death|2|||
146287297|NCT02257567|527567404|FG009|Overall Study|Death|18|||
146287298|NCT02257567|527567405|FG010|Overall Study|Death|65|||
146287299|NCT02257567|527567395|FG000|Overall Study|Lost to Follow-up|0|||
146287300|NCT02257567|527567396|FG001|Overall Study|Lost to Follow-up|0|||
146287301|NCT02257567|527567397|FG002|Overall Study|Lost to Follow-up|0|||
146287302|NCT02257567|527567398|FG003|Overall Study|Lost to Follow-up|0|||
146287303|NCT02257567|527567399|FG004|Overall Study|Lost to Follow-up|2|||
146287304|NCT02257567|527567400|FG005|Overall Study|Lost to Follow-up|2|||
146287305|NCT02257567|527567401|FG006|Overall Study|Lost to Follow-up|0|||
146287306|NCT02257567|527567402|FG007|Overall Study|Lost to Follow-up|0|||
146287307|NCT02257567|527567403|FG008|Overall Study|Lost to Follow-up|0|||
146287308|NCT02257567|527567404|FG009|Overall Study|Lost to Follow-up|1|||
146287309|NCT02257567|527567405|FG010|Overall Study|Lost to Follow-up|1|||
146287310|NCT02257567|527567395|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287311|NCT02257567|527567396|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287312|NCT02257567|527567397|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287313|NCT02257567|527567398|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287314|NCT02257567|527567399|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
146287315|NCT02257567|527567400|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287316|NCT02257567|527567401|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
146287317|NCT02257567|527567402|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146294420|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Adverse Event|7|||
146287318|NCT02257567|527567403|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287319|NCT02257567|527567404|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287320|NCT02257567|527567405|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
146287321|NCT02257567|527567395|FG000|Overall Study|Physician Decision|0|||
146287322|NCT02257567|527567396|FG001|Overall Study|Physician Decision|0|||
146287323|NCT02257567|527567397|FG002|Overall Study|Physician Decision|0|||
146287324|NCT02257567|527567398|FG003|Overall Study|Physician Decision|0|||
146287325|NCT02257567|527567399|FG004|Overall Study|Physician Decision|0|||
146287326|NCT02257567|527567400|FG005|Overall Study|Physician Decision|0|||
146287327|NCT02257567|527567401|FG006|Overall Study|Physician Decision|0|||
146287328|NCT02257567|527567402|FG007|Overall Study|Physician Decision|2|||
146287329|NCT02257567|527567403|FG008|Overall Study|Physician Decision|0|||
146287330|NCT02257567|527567404|FG009|Overall Study|Physician Decision|1|||
146287331|NCT02257567|527567405|FG010|Overall Study|Physician Decision|0|||
146287332|NCT02257567|527567395|FG000|Overall Study|Withdrawal by Subject|0|||
146287333|NCT02257567|527567396|FG001|Overall Study|Withdrawal by Subject|0|||
146287334|NCT02257567|527567397|FG002|Overall Study|Withdrawal by Subject|2|||
146287335|NCT02257567|527567398|FG003|Overall Study|Withdrawal by Subject|0|||
146287336|NCT02257567|527567399|FG004|Overall Study|Withdrawal by Subject|0|||
146287337|NCT02257567|527567400|FG005|Overall Study|Withdrawal by Subject|6|||
146287338|NCT02257567|527567401|FG006|Overall Study|Withdrawal by Subject|6|||
146287339|NCT02257567|527567402|FG007|Overall Study|Withdrawal by Subject|6|||
146287340|NCT02257567|527567403|FG008|Overall Study|Withdrawal by Subject|1|||
146287341|NCT02257567|527567404|FG009|Overall Study|Withdrawal by Subject|1|||
145958746|NCT02499120|526360448|FG001|Overall Study|Other|10|||
145958747|NCT00964028|526360453|FG000|Overall Study|Withdrawal by Subject|0|||
145958748|NCT00964028|526360454|FG001|Overall Study|Withdrawal by Subject|1|||
145958749|NCT01603407|526360455|FG000|Overall Study|Adverse Event|1|||
145958750|NCT01603407|526360456|FG001|Overall Study|Adverse Event|1|||
146287342|NCT02257567|527567405|FG010|Overall Study|Withdrawal by Subject|10|||
146287343|NCT00871780|527567408|FG000|Overall Study|Enrolled But Not Treated|6|||
146287344|NCT00871780|527567408|FG000|Overall Study|Withdrawal by Subject|9|||
146287345|NCT00871780|527567408|FG000|Overall Study|Adverse Event|6|||
146287346|NCT00871780|527567408|FG000|Overall Study|Voluntary Discontinuation|4|||
145958751|NCT01603407|526360457|FG002|Overall Study|Adverse Event|1|||
146287347|NCT00871780|527567408|FG000|Overall Study|Death|1|||
146287348|NCT00871780|527567408|FG000|Overall Study|Physician Decision|1|||
146287349|NCT05767021|527567409|FG000|Overall Study|Adverse Event|2|||
146287350|NCT05767021|527567409|FG000|Overall Study|Protocol Deviation|1|||
145958752|NCT01603407|526360455|FG000|Overall Study|Protocol Violation|2|||
145958753|NCT01603407|526360456|FG001|Overall Study|Protocol Violation|2|||
145958754|NCT01603407|526360457|FG002|Overall Study|Protocol Violation|0|||
145958755|NCT01603407|526360455|FG000|Overall Study|Withdrawal by Subject|8|||
145958756|NCT01603407|526360456|FG001|Overall Study|Withdrawal by Subject|5|||
145958757|NCT01603407|526360457|FG002|Overall Study|Withdrawal by Subject|7|||
145958758|NCT01603407|526360455|FG000|Overall Study|Lost to Follow-up|0|||
145958759|NCT01603407|526360456|FG001|Overall Study|Lost to Follow-up|3|||
145958760|NCT01603407|526360457|FG002|Overall Study|Lost to Follow-up|2|||
145958761|NCT03999749|526360460|FG000|Overall Study|Toxicity|16|||
145958762|NCT03999749|526360460|FG000|Overall Study|Withdrawal by Subject|3|||
145958763|NCT03999749|526360460|FG000|Overall Study|Disease progression|26|||
145958764|NCT03999749|526360460|FG000|Overall Study|Physician Decision|4|||
145958765|NCT03999749|526360460|FG000|Overall Study|Death|5|||
145958766|NCT03999749|526360460|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
145958767|NCT04587336|526360463|FG000|Overall Study|Lost to Follow-up|1|||
145958768|NCT04587336|526360464|FG001|Overall Study|Lost to Follow-up|0|||
145958769|NCT02299388|526361863|FG000|Overall Study|Withdrawal by Subject|0|||
145958770|NCT02299388|526361864|FG001|Overall Study|Withdrawal by Subject|1|||
145958771|NCT00003537|526361865|FG000|Overall Study|Not evalauable|1|||
145958772|NCT01051557|526361866|FG000|Overall Study|Physician Decision|1|||
145958773|NCT01051557|526361867|FG001|Overall Study|Physician Decision|0|||
145958774|NCT01051557|526361868|FG002|Overall Study|Physician Decision|0|||
145958775|NCT01051557|526361869|FG003|Overall Study|Physician Decision|0|||
145958776|NCT01051557|526361870|FG004|Overall Study|Physician Decision|0|||
145958777|NCT01051557|526361871|FG005|Overall Study|Physician Decision|0|||
145958778|NCT01051557|526361872|FG006|Overall Study|Physician Decision|0|||
145958779|NCT01051557|526361866|FG000|Overall Study|disease progression|3|||
145958780|NCT01051557|526361867|FG001|Overall Study|disease progression|3|||
145958781|NCT01051557|526361868|FG002|Overall Study|disease progression|5|||
145958782|NCT01051557|526361869|FG003|Overall Study|disease progression|2|||
145958783|NCT01051557|526361870|FG004|Overall Study|disease progression|4|||
145958784|NCT01051557|526361871|FG005|Overall Study|disease progression|3|||
145958785|NCT01051557|526361872|FG006|Overall Study|disease progression|1|||
145958786|NCT01051557|526361866|FG000|Overall Study|Withdrawal by Subject|0|||
145958787|NCT01051557|526361867|FG001|Overall Study|Withdrawal by Subject|0|||
145958788|NCT01051557|526361868|FG002|Overall Study|Withdrawal by Subject|1|||
145958789|NCT01051557|526361869|FG003|Overall Study|Withdrawal by Subject|0|||
145958790|NCT01051557|526361870|FG004|Overall Study|Withdrawal by Subject|2|||
145958791|NCT01051557|526361871|FG005|Overall Study|Withdrawal by Subject|0|||
145958792|NCT01051557|526361872|FG006|Overall Study|Withdrawal by Subject|1|||
145958793|NCT01051557|526361866|FG000|Overall Study|Adverse Event|0|||
145958794|NCT01051557|526361867|FG001|Overall Study|Adverse Event|0|||
145958795|NCT01051557|526361868|FG002|Overall Study|Adverse Event|0|||
145958796|NCT01051557|526361869|FG003|Overall Study|Adverse Event|1|||
145958797|NCT01051557|526361870|FG004|Overall Study|Adverse Event|1|||
145958798|NCT01051557|526361871|FG005|Overall Study|Adverse Event|3|||
145958799|NCT01051557|526361872|FG006|Overall Study|Adverse Event|4|||
145958800|NCT00130689|526361874|FG000|Overall Study|Progressive Disease|29|||
145958801|NCT00130689|526361874|FG000|Overall Study|Death|1|||
145958802|NCT00130689|526361874|FG000|Overall Study|Clinical Deterioration|4|||
145958803|NCT00130689|526361874|FG000|Overall Study|Withdrawal by Subject|3|||
145958804|NCT00130689|526361874|FG000|Overall Study|Ineligible|6|||
145958805|NCT00766597|526361875|FG000|Overall Study|Unexpected closure of study|4|||
145958806|NCT00766597|526361875|FG000|Overall Study|Without CCR5-tropic virus|5|||
145958807|NCT00943397|526361876|FG000|Overall Study|Adverse Event|0|||
145958808|NCT00943397|526361877|FG001|Overall Study|Adverse Event|6|||
145958809|NCT00943397|526361876|FG000|Overall Study|Lost to Follow-up|0|||
145958810|NCT00943397|526361877|FG001|Overall Study|Lost to Follow-up|4|||
145958811|NCT00943397|526361876|FG000|Overall Study|Protocol Violation|2|||
145958812|NCT00943397|526361877|FG001|Overall Study|Protocol Violation|5|||
145958813|NCT00943397|526361876|FG000|Overall Study|Withdrawal by Subject|1|||
145958814|NCT00943397|526361877|FG001|Overall Study|Withdrawal by Subject|1|||
145958815|NCT00943397|526361876|FG000|Overall Study|Site terminated and other|12|||
145958816|NCT00943397|526361877|FG001|Overall Study|Site terminated and other|56|||
145958817|NCT01254656|526361878|FG000|Overall Study|Discontinued due to termination of study|40|||
145958818|NCT01254656|526361879|FG001|Overall Study|Discontinued due to termination of study|39|||
145958819|NCT01254656|526361880|FG002|Overall Study|Discontinued due to termination of study|13|||
145958820|NCT01254656|526361878|FG000|Overall Study|Lack of Efficacy|3|||
145958821|NCT01254656|526361879|FG001|Overall Study|Lack of Efficacy|0|||
145958822|NCT01254656|526361880|FG002|Overall Study|Lack of Efficacy|0|||
145958823|NCT01254656|526361878|FG000|Overall Study|Lost to Follow-up|1|||
145958824|NCT01254656|526361879|FG001|Overall Study|Lost to Follow-up|0|||
145958825|NCT01254656|526361880|FG002|Overall Study|Lost to Follow-up|2|||
145958826|NCT01254656|526361878|FG000|Overall Study|Withdrawal by Subject|2|||
145958827|NCT01254656|526361879|FG001|Overall Study|Withdrawal by Subject|2|||
145958828|NCT01254656|526361880|FG002|Overall Study|Withdrawal by Subject|1|||
145958829|NCT01254656|526361878|FG000|Overall Study|Pregnancy|0|||
145958830|NCT01254656|526361879|FG001|Overall Study|Pregnancy|0|||
145958831|NCT01254656|526361880|FG002|Overall Study|Pregnancy|2|||
145958832|NCT01254656|526361878|FG000|Overall Study|Adverse Event|1|||
145958833|NCT01254656|526361879|FG001|Overall Study|Adverse Event|1|||
145958834|NCT01254656|526361880|FG002|Overall Study|Adverse Event|0|||
145958835|NCT01254656|526361878|FG000|Overall Study|Death|0|||
145958836|NCT01254656|526361879|FG001|Overall Study|Death|1|||
145958837|NCT01254656|526361880|FG002|Overall Study|Death|0|||
145958838|NCT02948829|526361881|FG000|Overall Study|Lost to Follow-up|2|||
145958839|NCT02948829|526361881|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
145958840|NCT02948829|526361881|FG000|Overall Study|Pregnancy|1|||
145958841|NCT02948829|526361881|FG000|Overall Study|Other: Reason not Specified|8|||
145958842|NCT01004978|526361882|FG000|Overall Study|Disease progression|31|||
145958843|NCT01004978|526361883|FG001|Overall Study|Disease progression|48|||
145958844|NCT01004978|526361882|FG000|Overall Study|Adverse Event|42|||
145958845|NCT01004978|526361883|FG001|Overall Study|Adverse Event|22|||
145958846|NCT01004978|526361882|FG000|Overall Study|Death|3|||
145958847|NCT01004978|526361883|FG001|Overall Study|Death|2|||
145958848|NCT01004978|526361882|FG000|Overall Study|Withdrawal by Subject|16|||
145958849|NCT01004978|526361883|FG001|Overall Study|Withdrawal by Subject|16|||
145958850|NCT01004978|526361882|FG000|Overall Study|Alternative therapy|4|||
145958851|NCT01004978|526361883|FG001|Overall Study|Alternative therapy|8|||
145958852|NCT01004978|526361882|FG000|Overall Study|Physician Decision|6|||
145958853|NCT01004978|526361883|FG001|Overall Study|Physician Decision|3|||
145958854|NCT01004978|526361882|FG000|Overall Study|Other complicating disease|2|||
145958855|NCT01004978|526361883|FG001|Overall Study|Other complicating disease|2|||
145958856|NCT01004978|526361882|FG000|Overall Study|Protocol Violation|2|||
145958857|NCT01004978|526361883|FG001|Overall Study|Protocol Violation|3|||
145958858|NCT01004978|526361882|FG000|Overall Study|Non-compliance|3|||
145958859|NCT01004978|526361883|FG001|Overall Study|Non-compliance|2|||
145958860|NCT01004978|526361882|FG000|Overall Study|Ineligible|1|||
145958861|NCT01004978|526361883|FG001|Overall Study|Ineligible|0|||
145958862|NCT01004978|526361882|FG000|Overall Study|Unblinded|0|||
145958863|NCT01004978|526361883|FG001|Overall Study|Unblinded|1|||
145958864|NCT01004978|526361882|FG000|Overall Study|Performance status worsening|0|||
145958865|NCT01004978|526361883|FG001|Overall Study|Performance status worsening|1|||
145958866|NCT01004978|526361882|FG000|Overall Study|Never started treatment|8|||
145958867|NCT01004978|526361883|FG001|Overall Study|Never started treatment|9|||
146214576|NCT04936035|527300068|FG004|Overall Study|Withdrawal by Subject|0|||
146214577|NCT04936035|527300064|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146214578|NCT04936035|527300065|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146214579|NCT04936035|527300066|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146214580|NCT04936035|527300067|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
146214581|NCT04936035|527300068|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
146214582|NCT04936035|527300064|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146214583|NCT04936035|527300065|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146214584|NCT04936035|527300066|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146214585|NCT04936035|527300067|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
146214586|NCT04936035|527300068|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
146214587|NCT04936035|527300064|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146214588|NCT04936035|527300065|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146214589|NCT04936035|527300066|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146214590|NCT04936035|527300067|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
146214591|NCT04936035|527300068|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
146214592|NCT04401800|527300069|FG000|Overall Study|Death|17|||
146214593|NCT04401800|527300069|FG000|Overall Study|Lost to Follow-up|5|||
146287351|NCT05767021|527567409|FG000|Overall Study|Withdrawal by Subject|1|||
145958868|NCT00369915|526361884|FG000|Overall Study|expected side effects|2|||
145958869|NCT00369915|526361885|FG001|Overall Study|expected side effects|1|||
145958870|NCT00369915|526361884|FG000|Overall Study|Withdrawal by Subject|4|||
146287352|NCT05767021|527567409|FG000|Overall Study|Physician Decision|1|||
146287353|NCT05767021|527567409|FG000|Overall Study|Lack of Efficacy|11|||
146287354|NCT05767021|527567409|FG000|Overall Study|Assigned Treatment by Mistake|1|||
146287355|NCT06377488|527567410|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
146287356|NCT06377488|527567410|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
146287357|NCT06377488|527567410|FG000|Overall Study|Protocol Violation|1|||
146287358|NCT06377488|527567410|FG000|Overall Study|Lost to Follow-up|1|||
146287359|NCT06377488|527567410|FG000|Overall Study|Incorrect Lens Dispensed|2|||
146287360|NCT00906945|527567411|FG000|Overall Study|Found to be not eligible|0|||
146287361|NCT00906945|527567412|FG001|Overall Study|Found to be not eligible|0|||
146287362|NCT00906945|527567413|FG002|Overall Study|Found to be not eligible|0|||
146287363|NCT00906945|527567414|FG003|Overall Study|Found to be not eligible|1|||
146287364|NCT00906945|527567415|FG004|Overall Study|Found to be not eligible|1|||
146287365|NCT00906945|527567416|FG005|Overall Study|Found to be not eligible|1|||
146287366|NCT00906945|527567411|FG000|Overall Study|Physician Decision|0|||
146287367|NCT00906945|527567412|FG001|Overall Study|Physician Decision|0|||
146287368|NCT00906945|527567413|FG002|Overall Study|Physician Decision|0|||
146287369|NCT00906945|527567414|FG003|Overall Study|Physician Decision|0|||
146287370|NCT00906945|527567415|FG004|Overall Study|Physician Decision|0|||
146287371|NCT00906945|527567416|FG005|Overall Study|Physician Decision|1|||
146287372|NCT02751320|527567418|FG000|Overall Study|Adverse Event|2|||
146287373|NCT02751320|527567418|FG000|Overall Study|Withdrawal by Subject|1|||
146287374|NCT05249829|527567419|FG000|Overall Study|Participant Relocation|0|||
146287375|NCT05249829|527567420|FG001|Overall Study|Participant Relocation|1|||
146287376|NCT05249829|527567421|FG002|Overall Study|Participant Relocation|2|||
146287377|NCT05249829|527567422|FG003|Overall Study|Participant Relocation|2|||
146287378|NCT05249829|527567419|FG000|Overall Study|Withdrawal by Subject|9|||
146287379|NCT05249829|527567420|FG001|Overall Study|Withdrawal by Subject|17|||
146287380|NCT05249829|527567421|FG002|Overall Study|Withdrawal by Subject|40|||
146287381|NCT05249829|527567422|FG003|Overall Study|Withdrawal by Subject|35|||
146287382|NCT05249829|527567419|FG000|Overall Study|Physician Decision|1|||
146287383|NCT05249829|527567420|FG001|Overall Study|Physician Decision|0|||
146287384|NCT05249829|527567421|FG002|Overall Study|Physician Decision|0|||
146287385|NCT05249829|527567422|FG003|Overall Study|Physician Decision|0|||
146287386|NCT05249829|527567419|FG000|Overall Study|Lost to Follow-up|16|||
146287387|NCT05249829|527567420|FG001|Overall Study|Lost to Follow-up|16|||
146287388|NCT05249829|527567421|FG002|Overall Study|Lost to Follow-up|57|||
146287389|NCT05249829|527567422|FG003|Overall Study|Lost to Follow-up|60|||
146287390|NCT05249829|527567419|FG000|Overall Study|Adverse Event|2|||
146287391|NCT05249829|527567420|FG001|Overall Study|Adverse Event|2|||
146287392|NCT05249829|527567421|FG002|Overall Study|Adverse Event|2|||
146287393|NCT05249829|527567422|FG003|Overall Study|Adverse Event|2|||
146287394|NCT05249829|527567419|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
146287395|NCT05249829|527567420|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
146287396|NCT05249829|527567421|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
146287397|NCT05249829|527567422|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
146084127|NCT04395001|526827933|FG002|Overall Study|missed appointment|1|||
146287398|NCT05249829|527567419|FG000|Overall Study|Protocol Violation|2|||
146287399|NCT05249829|527567420|FG001|Overall Study|Protocol Violation|0|||
146287400|NCT05249829|527567421|FG002|Overall Study|Protocol Violation|5|||
146287401|NCT05249829|527567422|FG003|Overall Study|Protocol Violation|3|||
146214594|NCT04401800|527300069|FG000|Overall Study|Withdrawal by Subject|4|||
146214595|NCT01772472|527300074|FG000|Overall Study|Death|126|||
146214596|NCT01772472|527300075|FG001|Overall Study|Death|94|||
146214597|NCT01772472|527300074|FG000|Overall Study|Lost to Follow-up|51|||
146214598|NCT01772472|527300075|FG001|Overall Study|Lost to Follow-up|50|||
146214599|NCT01772472|527300074|FG000|Overall Study|Other|9|||
146214600|NCT01772472|527300075|FG001|Overall Study|Other|7|||
146214601|NCT01772472|527300074|FG000|Overall Study|Physician Decision|1|||
146214602|NCT01772472|527300075|FG001|Overall Study|Physician Decision|7|||
146214603|NCT01772472|527300074|FG000|Overall Study|Withdrawal by Subject|115|||
146214604|NCT01772472|527300075|FG001|Overall Study|Withdrawal by Subject|90|||
146214605|NCT01772472|527300074|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
146214606|NCT01772472|527300075|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
146214607|NCT04757610|527300077|FG000|Overall Study|Adverse Event|13|||
146214608|NCT04757610|527300078|FG001|Overall Study|Adverse Event|10|||
146214609|NCT04757610|527300079|FG002|Overall Study|Adverse Event|5|||
146214610|NCT04757610|527300077|FG000|Overall Study|Death|5|||
146214611|NCT04757610|527300078|FG001|Overall Study|Death|13|||
146214612|NCT04757610|527300079|FG002|Overall Study|Death|8|||
146214613|NCT04757610|527300077|FG000|Overall Study|Lack of Efficacy|1|||
146214614|NCT04757610|527300078|FG001|Overall Study|Lack of Efficacy|2|||
146214615|NCT04757610|527300079|FG002|Overall Study|Lack of Efficacy|3|||
146214616|NCT04757610|527300077|FG000|Overall Study|Lost to Follow-up|7|||
146214617|NCT04757610|527300078|FG001|Overall Study|Lost to Follow-up|2|||
146214618|NCT04757610|527300079|FG002|Overall Study|Lost to Follow-up|7|||
146214619|NCT04757610|527300077|FG000|Overall Study|Physician Decision|4|||
146214620|NCT04757610|527300078|FG001|Overall Study|Physician Decision|1|||
146214621|NCT04757610|527300079|FG002|Overall Study|Physician Decision|2|||
146214622|NCT04757610|527300077|FG000|Overall Study|Withdrawal by Subject|26|||
146214623|NCT04757610|527300078|FG001|Overall Study|Withdrawal by Subject|25|||
146214624|NCT04757610|527300079|FG002|Overall Study|Withdrawal by Subject|25|||
146214625|NCT04757610|527300077|FG000|Overall Study|Study Terminated by Sponsor|105|||
146214626|NCT04757610|527300078|FG001|Overall Study|Study Terminated by Sponsor|105|||
146214627|NCT04757610|527300079|FG002|Overall Study|Study Terminated by Sponsor|110|||
146214628|NCT04757610|527300077|FG000|Overall Study|Randomized in Error|1|||
146214629|NCT04757610|527300078|FG001|Overall Study|Randomized in Error|0|||
146214630|NCT04757610|527300079|FG002|Overall Study|Randomized in Error|0|||
146214631|NCT06143670|527301530|FG000|Overall Study|Lost to Follow-up|0|||
146214632|NCT06143670|527301531|FG001|Overall Study|Lost to Follow-up|1|||
146214633|NCT06143670|527301530|FG000|Overall Study|Withdrawal by Subject|3|||
146214634|NCT06143670|527301531|FG001|Overall Study|Withdrawal by Subject|0|||
146214635|NCT03747484|527301532|FG000|Overall Study|Lack of Efficacy|0|||
146214636|NCT03747484|527301533|FG001|Overall Study|Lack of Efficacy|1|||
146214637|NCT03747484|527301534|FG002|Overall Study|Lack of Efficacy|1|||
146214638|NCT03747484|527301535|FG003|Overall Study|Lack of Efficacy|2|||
146214639|NCT03747484|527301536|FG004|Overall Study|Lack of Efficacy|2|||
146214640|NCT05816551|527301552|FG000|Overall Study|Withdrawal by Subject|0|||
146214641|NCT05816551|527301553|FG001|Overall Study|Withdrawal by Subject|1|||
146214642|NCT05816551|527301552|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
146214643|NCT05816551|527301553|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
146214644|NCT05062265|527301561|FG000|Overall Study|Withdrawal by Subject|1|||
146214645|NCT05062265|527301562|FG001|Overall Study|Withdrawal by Subject|0|||
146214646|NCT03101904|527301567|FG000|Wash Out (10 Days)|Adverse Event|1|||
146214647|NCT03101904|527301568|FG001|Wash Out (10 Days)|Adverse Event|0|||
146214648|NCT03101904|527301567|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
146214649|NCT03101904|527301568|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
146214650|NCT04630262|527301569|FG000|Overall Study|Intraoperative Screen Failure|5|||
146214651|NCT04630262|527301569|FG000|Overall Study|Study terminated prematurely|71|||
146214652|NCT04630262|527301569|FG000|Overall Study|Withdrawal by Subject|2|||
146214653|NCT04630262|527301569|FG000|Overall Study|Physician Decision|2|||
146214654|NCT01195831|527301571|FG000|Overall Study|Lost to Follow-up|2|||
146214655|NCT01195831|527301572|FG001|Overall Study|Lost to Follow-up|4|||
146214656|NCT01195831|527301571|FG000|Overall Study|Withdrawal by Subject|2|||
146214657|NCT01195831|527301572|FG001|Overall Study|Withdrawal by Subject|2|||
146214658|NCT01195831|527301571|FG000|Overall Study|Adverse Event|4|||
146214659|NCT01195831|527301572|FG001|Overall Study|Adverse Event|2|||
146214660|NCT01195831|527301571|FG000|Overall Study|Protocol Violation|0|||
146214661|NCT01195831|527301572|FG001|Overall Study|Protocol Violation|2|||
146214662|NCT04703322|527301573|FG000|Overall Study|Ongoing|8|||
146214663|NCT04703322|527301573|FG000|Overall Study|Withdrawal by Subject|1|||
146214664|NCT04638998|527301574|FG000|Overall Study|Withdrawal by Subject|1|||
146214665|NCT04638998|527301575|FG001|Overall Study|Withdrawal by Subject|3|||
146214666|NCT01180634|527301578|FG000|Overall Study|Adverse Event|4|||
145958871|NCT00369915|526361885|FG001|Overall Study|Withdrawal by Subject|1|||
145958872|NCT00369915|526361884|FG000|Overall Study|W/drawl by investigators|0|||
145958873|NCT00369915|526361885|FG001|Overall Study|W/drawl by investigators|1|||
145958874|NCT01447407|526361904|FG000|Overall Study|Withdrawal by Subject|2|||
145958875|NCT01447407|526361905|FG001|Overall Study|Withdrawal by Subject|0|||
145958876|NCT01447407|526361906|FG002|Overall Study|Withdrawal by Subject|0|||
145958877|NCT01447407|526361907|FG003|Overall Study|Withdrawal by Subject|1|||
145958878|NCT01447407|526361904|FG000|Overall Study|Physician Decision|0|||
145958879|NCT01447407|526361905|FG001|Overall Study|Physician Decision|0|||
145958880|NCT01447407|526361906|FG002|Overall Study|Physician Decision|1|||
145958881|NCT01447407|526361907|FG003|Overall Study|Physician Decision|1|||
145958882|NCT00268983|526361910|FG000|Overall Study|Death|3|||
145958883|NCT00268983|526361911|FG001|Overall Study|Death|0|||
145958884|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
145958885|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
145958886|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
145958887|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Death|0|||
145958888|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Death|1|||
145958889|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Death|0|||
146214667|NCT01180634|527301579|FG001|Overall Study|Adverse Event|1|||
146214668|NCT01180634|527301578|FG000|Overall Study|Miscellaneous|2|||
146214669|NCT01180634|527301579|FG001|Overall Study|Miscellaneous|0|||
146214670|NCT01180634|527301578|FG000|Overall Study|Withdrawal by Subject|4|||
146214671|NCT01180634|527301579|FG001|Overall Study|Withdrawal by Subject|0|||
146214672|NCT03692611|527301580|FG000|Overall Study|Found to be ineligible postrandomization|3|||
146214673|NCT03692611|527301581|FG001|Overall Study|Found to be ineligible postrandomization|0|||
146214674|NCT04419168|527301582|FG000|Overall Study|Protocol Violation|1|||
146214675|NCT04419168|527301583|FG001|Overall Study|Protocol Violation|1|||
146214676|NCT04419168|527301582|FG000|Overall Study|Lost to Follow-up|7|||
145958890|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
145958891|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
145958892|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
145958893|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
145958894|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
145958895|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
145958896|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145958897|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145958898|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145958899|NCT01064414|526361912|FG000|Core Period: Baseline to Week 26|Other|4|||
145958900|NCT01064414|526361913|FG001|Core Period: Baseline to Week 26|Other|7|||
145958901|NCT01064414|526361914|FG002|Core Period: Baseline to Week 26|Other|2|||
145958902|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145958903|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145958904|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145958905|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Death|0|||
145958906|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Death|1|||
145958907|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145958908|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
145958909|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145958910|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145958911|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
145958912|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145958913|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145958914|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145958915|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145958916|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145958917|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
145958918|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145958919|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145958920|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145958921|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145958922|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145958923|NCT01064414|526361912|FG000|Extension Period: Week 26 to Week 52|Other|5|||
145958924|NCT01064414|526361913|FG001|Extension Period: Week 26 to Week 52|Other|2|||
145958925|NCT01064414|526361914|FG002|Extension Period: Week 26 to Week 52|Other|1|||
145958926|NCT02532374|526361922|FG000|Overall Study|Withdrawal by Subject|1|||
145958927|NCT02532374|526361922|FG000|Overall Study|Physician Decision|1|||
145958928|NCT02762084|526361923|FG000|Overall Study|Withdrawal by Subject|1|||
145958929|NCT02762084|526361924|FG001|Overall Study|Withdrawal by Subject|0|||
145958930|NCT02762084|526361925|FG002|Overall Study|Withdrawal by Subject|0|||
145958931|NCT02762084|526361923|FG000|Overall Study|Adverse Event|0|||
145958932|NCT02762084|526361924|FG001|Overall Study|Adverse Event|0|||
145958933|NCT02762084|526361925|FG002|Overall Study|Adverse Event|1|||
145958934|NCT01348139|526361928|FG000|Period 1|Adverse Event|1|||
145958935|NCT01348139|526361929|FG001|Period 1|Adverse Event|0|||
145958936|NCT01348139|526361930|FG002|Period 1|Adverse Event|0|||
145958937|NCT01348139|526361931|FG003|Period 1|Adverse Event|0|||
145958938|NCT01348139|526361932|FG004|Period 1|Adverse Event|0|||
145958939|NCT01348139|526361933|FG005|Period 1|Adverse Event|0|||
145958940|NCT02254772|526361934|FG000|Overall Study|Ineligible|1|||
145958941|NCT02254772|526361934|FG000|Overall Study|Withdrawal by Subject|1|||
145958942|NCT01765296|526361935|FG000|Overall Study|Protocol Violation|0|||
145958943|NCT01765296|526361936|FG001|Overall Study|Protocol Violation|5|||
145958944|NCT01765296|526361937|FG002|Overall Study|Protocol Violation|4|||
145958945|NCT01765296|526361935|FG000|Overall Study|Withdrawal by Subject|4|||
145958946|NCT01765296|526361936|FG001|Overall Study|Withdrawal by Subject|2|||
145958947|NCT01765296|526361937|FG002|Overall Study|Withdrawal by Subject|2|||
145958948|NCT01765296|526361935|FG000|Overall Study|Adverse Event|1|||
145958949|NCT01765296|526361936|FG001|Overall Study|Adverse Event|13|||
145958950|NCT01765296|526361937|FG002|Overall Study|Adverse Event|5|||
145958951|NCT01765296|526361935|FG000|Overall Study|Lack of Efficacy|0|||
145958952|NCT01765296|526361936|FG001|Overall Study|Lack of Efficacy|0|||
145958953|NCT01765296|526361937|FG002|Overall Study|Lack of Efficacy|2|||
145958954|NCT01619852|526361938|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
145958955|NCT01619852|526361939|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
145958956|NCT01619852|526361938|FG000|3 Month Follow up|Lost to Follow-up|31|||
145958957|NCT01619852|526361939|FG001|3 Month Follow up|Lost to Follow-up|34|||
146084128|NCT04418661|526827934|FG000|Overall Study|Adverse Event|0|||
145958958|NCT04556760|526361940|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145958959|NCT04556760|526361941|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
146084129|NCT04418661|526827935|FG001|Overall Study|Adverse Event|1|||
145958960|NCT04556760|526361942|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145958961|NCT04556760|526361943|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145958962|NCT04556760|526361944|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145958963|NCT04556760|526361945|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145958964|NCT04556760|526361940|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145958965|NCT04556760|526361941|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145958966|NCT04556760|526361942|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145958967|NCT04556760|526361943|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
146214677|NCT04419168|527301583|FG001|Overall Study|Lost to Follow-up|7|||
146214678|NCT04419168|527301582|FG000|Overall Study|Missed 6-month Visit|48|||
146214679|NCT04419168|527301583|FG001|Overall Study|Missed 6-month Visit|45|||
146214680|NCT03713086|527301585|FG000|Overall Study|Withdrawal by Subject|0|||
145958968|NCT04556760|526361944|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145958969|NCT04556760|526361945|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145958970|NCT01610037|526361949|FG000|All Patients|Adverse Event|27|||
145958971|NCT01610037|526361950|FG001|All Patients|Adverse Event|22|||
145958972|NCT01610037|526361951|FG002|All Patients|Adverse Event|26|||
145958973|NCT01610037|526361949|FG000|All Patients|Withdrawal by Subject|12|||
145958974|NCT01610037|526361950|FG001|All Patients|Withdrawal by Subject|10|||
145958975|NCT01610037|526361951|FG002|All Patients|Withdrawal by Subject|20|||
145958976|NCT01610037|526361949|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
145958977|NCT01610037|526361950|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
145958978|NCT01610037|526361951|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
145958979|NCT01610037|526361949|FG000|All Patients|Death|4|||
145958980|NCT01610037|526361950|FG001|All Patients|Death|2|||
145958981|NCT01610037|526361951|FG002|All Patients|Death|1|||
145958982|NCT01610037|526361949|FG000|All Patients|Protocol deviation|4|||
145958983|NCT01610037|526361950|FG001|All Patients|Protocol deviation|3|||
145958984|NCT01610037|526361951|FG002|All Patients|Protocol deviation|3|||
145958985|NCT01610037|526361949|FG000|All Patients|Abnormal laboratory value|1|||
145958986|NCT01610037|526361950|FG001|All Patients|Abnormal laboratory value|1|||
145958987|NCT01610037|526361951|FG002|All Patients|Abnormal laboratory value|0|||
145958988|NCT01610037|526361949|FG000|All Patients|Administrative problems|1|||
145958989|NCT01610037|526361950|FG001|All Patients|Administrative problems|4|||
145958990|NCT01610037|526361951|FG002|All Patients|Administrative problems|4|||
145958991|NCT01610037|526361949|FG000|All Patients|Lost to Follow-up|1|||
145958992|NCT01610037|526361950|FG001|All Patients|Lost to Follow-up|0|||
145958993|NCT01610037|526361951|FG002|All Patients|Lost to Follow-up|0|||
145958994|NCT01610037|526361949|FG000|All Patients|Abnormal test procedure result(s)|0|||
145958995|NCT01610037|526361950|FG001|All Patients|Abnormal test procedure result(s)|1|||
145958996|NCT01610037|526361951|FG002|All Patients|Abnormal test procedure result(s)|3|||
145958997|NCT01610037|526361949|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
145958998|NCT01610037|526361950|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
145958999|NCT01610037|526361951|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
145959000|NCT01610037|526361949|FG000|Treatment and Follow up Period|Death|10|||
145959001|NCT01610037|526361950|FG001|Treatment and Follow up Period|Death|5|||
145959002|NCT01610037|526361951|FG002|Treatment and Follow up Period|Death|4|||
145959003|NCT01610037|526361949|FG000|Treatment and Follow up Period|Administrative problems|1|||
145959004|NCT01610037|526361950|FG001|Treatment and Follow up Period|Administrative problems|3|||
145959005|NCT01610037|526361951|FG002|Treatment and Follow up Period|Administrative problems|2|||
145959006|NCT01610037|526361949|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
146214681|NCT03713086|527301586|FG001|Overall Study|Withdrawal by Subject|2|||
145959007|NCT01610037|526361950|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
145959008|NCT01610037|526361951|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
145959009|NCT00321906|526361953|FG000|Overall Study|Adverse Event|36|||
145959010|NCT00321906|526361954|FG001|Overall Study|Adverse Event|44|||
145959011|NCT00321906|526361953|FG000|Overall Study|Death|9|||
145959012|NCT00321906|526361954|FG001|Overall Study|Death|6|||
145959013|NCT00321906|526361953|FG000|Overall Study|Lost to Follow-up|1|||
145959014|NCT00321906|526361954|FG001|Overall Study|Lost to Follow-up|2|||
145959015|NCT00321906|526361953|FG000|Overall Study|Withdrawal by Subject|0|||
145959016|NCT00321906|526361954|FG001|Overall Study|Withdrawal by Subject|4|||
145959017|NCT04767373|526361959|FG000|Overall Study|Death|6|||
145959018|NCT04767373|526361960|FG001|Overall Study|Death|3|||
145959019|NCT04767373|526361959|FG000|Overall Study|Lost to Follow-up|67|||
145959020|NCT04767373|526361960|FG001|Overall Study|Lost to Follow-up|35|||
145959021|NCT04767373|526361959|FG000|Overall Study|Physician Decision|15|||
146214682|NCT03713086|527301587|FG002|Overall Study|Withdrawal by Subject|1|||
146214683|NCT03713086|527301588|FG003|Overall Study|Withdrawal by Subject|0|||
146214684|NCT03713086|527301585|FG000|Overall Study|Lost to Follow-up|0|||
146214685|NCT03713086|527301586|FG001|Overall Study|Lost to Follow-up|1|||
146214686|NCT03713086|527301587|FG002|Overall Study|Lost to Follow-up|0|||
146214687|NCT03713086|527301588|FG003|Overall Study|Lost to Follow-up|1|||
145959022|NCT04767373|526361960|FG001|Overall Study|Physician Decision|4|||
145959023|NCT04767373|526361959|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145959024|NCT04767373|526361960|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145959025|NCT04767373|526361959|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
145959026|NCT04767373|526361960|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
145959027|NCT04767373|526361959|FG000|Overall Study|Other|1|||
145959028|NCT04767373|526361960|FG001|Overall Study|Other|2|||
145959029|NCT02658669|526361961|FG000|Overall Study|Lost to Follow-up|7|||
145959030|NCT02658669|526361962|FG001|Overall Study|Lost to Follow-up|5|||
145959031|NCT00186485|526361963|FG000|Overall Study|Lost to Follow-up|3|||
145959032|NCT00838097|526361964|FG000|Overall Study|Ineligibility determined|6|||
145959033|NCT00838097|526361964|FG000|Overall Study|Adverse Event|2|||
145959034|NCT00838097|526361964|FG000|Overall Study|Withdrawal by Subject|3|||
145959035|NCT00838097|526361964|FG000|Overall Study|Requirement for alternative therapy|2|||
145959036|NCT00838097|526361964|FG000|Overall Study|Physician Decision|4|||
145959037|NCT00838097|526361964|FG000|Overall Study|Lost to Follow-up|11|||
145959038|NCT00838097|526361964|FG000|Overall Study|Death|6|||
145959039|NCT00838097|526361964|FG000|Overall Study|Protocol-specified criteria|142|||
145959040|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
145959041|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
145959042|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Adverse Event|57|||
145959043|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Adverse Event|49|||
145959044|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
145959045|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
146214688|NCT05009251|527301589|FG000|Overall Study|Protocol Violation|100|||
146214689|NCT05009251|527301590|FG001|Overall Study|Protocol Violation|105|||
146214690|NCT05009251|527301591|FG002|Overall Study|Protocol Violation|119|||
146214691|NCT05009251|527301592|FG003|Overall Study|Protocol Violation|120|||
145959046|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Site closure|3|||
145959047|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Site closure|2|||
145959048|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
145959049|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
145959050|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Physician Decision|48|||
145959051|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Physician Decision|38|||
145959052|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
145959053|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
145959054|NCT01705977|526361979|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
145959055|NCT01705977|526361980|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
145959056|NCT01705977|526361979|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
145959057|NCT01705977|526361980|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
146084130|NCT04418661|526827936|FG002|Overall Study|Adverse Event|5|||
146214692|NCT05009251|527301593|FG004|Overall Study|Protocol Violation|119|||
145959058|NCT01705977|526361979|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
145959059|NCT01705977|526361980|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
145959060|NCT01705977|526361979|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
145959061|NCT01705977|526361980|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
145959062|NCT01705977|526361979|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
145959063|NCT01705977|526361980|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
145959064|NCT01462110|526361987|FG000|Overall Study|Adverse Event|1|||
145959065|NCT01462110|526361988|FG001|Overall Study|Adverse Event|0|||
145959066|NCT00753675|526361989|FG000|Overall Study|other reason|11|||
145959067|NCT00753675|526361990|FG001|Overall Study|other reason|12|||
145959068|NCT00753675|526361991|FG002|Overall Study|other reason|13|||
145959069|NCT00753675|526361989|FG000|Overall Study|Death|1|||
145959070|NCT00753675|526361990|FG001|Overall Study|Death|2|||
145959071|NCT00753675|526361991|FG002|Overall Study|Death|4|||
145959072|NCT00753675|526361989|FG000|Overall Study|Adverse Event|11|||
146214693|NCT05009251|527301589|FG000|Overall Study|Death|25|||
145959073|NCT00753675|526361990|FG001|Overall Study|Adverse Event|9|||
145959074|NCT00753675|526361991|FG002|Overall Study|Adverse Event|4|||
145959075|NCT00753675|526361989|FG000|Overall Study|Objective progression of disease|35|||
145959076|NCT00753675|526361990|FG001|Overall Study|Objective progression of disease|35|||
145959077|NCT00753675|526361991|FG002|Overall Study|Objective progression of disease|35|||
145959078|NCT00753675|526361989|FG000|Overall Study|Withdrawal by Subject|0|||
146214694|NCT05009251|527301590|FG001|Overall Study|Death|22|||
146214695|NCT05009251|527301591|FG002|Overall Study|Death|24|||
146214696|NCT05009251|527301592|FG003|Overall Study|Death|19|||
146214697|NCT05009251|527301593|FG004|Overall Study|Death|15|||
146214698|NCT06311084|527301598|FG000|Overall Study|Lost to Follow-up|14|||
146214699|NCT03988634|527301599|FG000|Double-Blind|Adverse Event|4|||
146214700|NCT03988634|527301600|FG001|Double-Blind|Adverse Event|0|||
146214701|NCT03988634|527301601|FG002|Double-Blind|Adverse Event|0|||
146214702|NCT03988634|527301599|FG000|Double-Blind|Death|18|||
146214703|NCT03988634|527301600|FG001|Double-Blind|Death|26|||
146214704|NCT03988634|527301601|FG002|Double-Blind|Death|0|||
146214705|NCT03988634|527301599|FG000|Double-Blind|Lost to Follow-up|6|||
146214706|NCT03988634|527301600|FG001|Double-Blind|Lost to Follow-up|7|||
146214707|NCT03988634|527301601|FG002|Double-Blind|Lost to Follow-up|0|||
146214708|NCT03988634|527301599|FG000|Double-Blind|Physician Decision|9|||
146214709|NCT03988634|527301600|FG001|Double-Blind|Physician Decision|5|||
146214710|NCT03988634|527301601|FG002|Double-Blind|Physician Decision|0|||
146214711|NCT03988634|527301599|FG000|Double-Blind|Subject decision|24|||
146214712|NCT03988634|527301600|FG001|Double-Blind|Subject decision|13|||
146214713|NCT03988634|527301601|FG002|Double-Blind|Subject decision|0|||
146214714|NCT03988634|527301599|FG000|Open-Label|Adverse Event|0|||
146214715|NCT03988634|527301600|FG001|Open-Label|Adverse Event|0|||
146214716|NCT03988634|527301601|FG002|Open-Label|Adverse Event|7|||
146214717|NCT03988634|527301599|FG000|Open-Label|Physician Decision|0|||
146214718|NCT03988634|527301600|FG001|Open-Label|Physician Decision|0|||
146214719|NCT03988634|527301601|FG002|Open-Label|Physician Decision|1|||
146214720|NCT03988634|527301599|FG000|Open-Label|Technical problems|0|||
146214721|NCT03988634|527301600|FG001|Open-Label|Technical problems|0|||
146214722|NCT03988634|527301601|FG002|Open-Label|Technical problems|1|||
146214723|NCT03161379|527301616|FG000|Overall Study|Withdrawal by Subject|4|||
146214724|NCT03161379|527301616|FG000|Overall Study|disease progression during chemotherapy|5|||
146214725|NCT03161379|527301616|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
146214726|NCT03161379|527301616|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
146214727|NCT03393975|527301618|FG000|Urgent Treatment Period|Physician Decision|0|||
146214728|NCT03393975|527301619|FG001|Urgent Treatment Period|Physician Decision|0|||
146214729|NCT03393975|527301620|FG002|Urgent Treatment Period|Physician Decision|0|||
146214730|NCT03393975|527301621|FG003|Urgent Treatment Period|Physician Decision|1|||
146214731|NCT03393975|527301618|FG000|Prophylaxis Period 1|Reason not Specified|0|||
145959079|NCT00753675|526361990|FG001|Overall Study|Withdrawal by Subject|1|||
145959080|NCT00753675|526361991|FG002|Overall Study|Withdrawal by Subject|0|||
145959081|NCT00753675|526361989|FG000|Overall Study|Lost to Follow-up|1|||
146214732|NCT03393975|527301619|FG001|Prophylaxis Period 1|Reason not Specified|1|||
145959082|NCT00753675|526361990|FG001|Overall Study|Lost to Follow-up|0|||
145959083|NCT00753675|526361991|FG002|Overall Study|Lost to Follow-up|0|||
145959084|NCT05279131|526361993|FG000|Overall Study|Lost to Follow-up|1|||
145959085|NCT05279131|526361993|FG000|Overall Study|Death|1|||
145959086|NCT05279131|526361993|FG000|Overall Study|Physician Decision|1|||
146214733|NCT03393975|527301620|FG002|Prophylaxis Period 1|Reason not Specified|0|||
146214734|NCT03393975|527301621|FG003|Prophylaxis Period 1|Reason not Specified|0|||
146214735|NCT03393975|527301618|FG000|Prophylaxis Period 2|Reason not Specified|0|||
146214736|NCT03393975|527301619|FG001|Prophylaxis Period 2|Reason not Specified|1|||
146214737|NCT03393975|527301620|FG002|Prophylaxis Period 2|Reason not Specified|0|||
146214738|NCT03393975|527301621|FG003|Prophylaxis Period 2|Reason not Specified|0|||
145959087|NCT02149264|526361999|FG000|Overall Study|Withdrawal by Subject|9|||
145959088|NCT02149264|526361999|FG000|Overall Study|Adverse Event|7|||
145959089|NCT02149264|526361999|FG000|Overall Study|Physician Decision|3|||
145959090|NCT02149264|526361999|FG000|Overall Study|Protocol Violation|1|||
145959091|NCT00520039|526362006|FG000|Overall Study|Exclusion criteria met at first visit|7|||
145959092|NCT00520039|526362007|FG001|Overall Study|Exclusion criteria met at first visit|5|||
145959093|NCT05176717|526362008|FG000|Overall Study|Sponsor Decision|1|||
145959094|NCT05176717|526362009|FG001|Overall Study|Sponsor Decision|2|||
145959095|NCT05176717|526362010|FG002|Overall Study|Sponsor Decision|2|||
146214739|NCT03315754|527301622|FG000|Overall Study|COVID-19 complications leading to death|1|||
145959096|NCT03284853|526362011|FG000|Overall Study|Adverse Event|40|||
145959097|NCT03284853|526362012|FG001|Overall Study|Adverse Event|4|||
145959098|NCT03284853|526362011|FG000|Overall Study|Withdrawal by Subject|5|||
145959099|NCT03284853|526362012|FG001|Overall Study|Withdrawal by Subject|1|||
145959100|NCT03284853|526362011|FG000|Overall Study|Lost to Follow-up|1|||
145959101|NCT03284853|526362012|FG001|Overall Study|Lost to Follow-up|0|||
145959102|NCT03284853|526362011|FG000|Overall Study|Lack of Efficacy|1|||
145959103|NCT03284853|526362012|FG001|Overall Study|Lack of Efficacy|0|||
145959104|NCT03284853|526362011|FG000|Overall Study|Disallowed Concurrent Medication|1|||
146214740|NCT03315754|527301622|FG000|Overall Study|insurance coverage issue|1|||
146214741|NCT04024813|527301623|FG000|Overall Study|Study terminated by Sponsor|1|||
146214742|NCT05536440|527301625|FG000|Overall Study|Adverse Event|0|||
146214743|NCT05536440|527301626|FG001|Overall Study|Adverse Event|0|||
146214744|NCT05536440|527301627|FG002|Overall Study|Adverse Event|0|||
146214745|NCT05536440|527301628|FG003|Overall Study|Adverse Event|0|||
146214746|NCT05536440|527301629|FG004|Overall Study|Adverse Event|0|||
146214747|NCT05536440|527301630|FG005|Overall Study|Adverse Event|0|||
146214748|NCT05536440|527301631|FG006|Overall Study|Adverse Event|0|||
146214749|NCT05536440|527301632|FG007|Overall Study|Adverse Event|0|||
146214750|NCT05536440|527301633|FG008|Overall Study|Adverse Event|1|||
146214751|NCT00931710|527301636|FG000|Overall Study|Adverse Event|16|||
146214752|NCT00931710|527301637|FG001|Overall Study|Adverse Event|10|||
146214753|NCT00931710|527301636|FG000|Overall Study|Abnormal test procedure results|2|||
146214754|NCT00931710|527301637|FG001|Overall Study|Abnormal test procedure results|0|||
146214755|NCT00931710|527301636|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
145959105|NCT03284853|526362012|FG001|Overall Study|Disallowed Concurrent Medication|1|||
146214756|NCT00931710|527301637|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
146214757|NCT00931710|527301636|FG000|Overall Study|Patient withdrew consent|4|||
146214758|NCT00931710|527301637|FG001|Overall Study|Patient withdrew consent|9|||
145959106|NCT03284853|526362011|FG000|Overall Study|Protocol Violation|3|||
145959107|NCT03284853|526362012|FG001|Overall Study|Protocol Violation|3|||
145959108|NCT03284853|526362011|FG000|Overall Study|Death|0|||
145959109|NCT03284853|526362012|FG001|Overall Study|Death|1|||
145959110|NCT03284853|526362011|FG000|Overall Study|Other - Reason not reported in CSR|4|||
146214759|NCT00931710|527301636|FG000|Overall Study|Lost to Follow-up|6|||
146214760|NCT00931710|527301637|FG001|Overall Study|Lost to Follow-up|5|||
146214761|NCT00931710|527301636|FG000|Overall Study|Protocol deviation|1|||
146214762|NCT00931710|527301637|FG001|Overall Study|Protocol deviation|2|||
146214763|NCT03338790|527301641|FG000|Overall Study|Disease Progression|65|||
146214764|NCT03338790|527301642|FG001|Overall Study|Disease Progression|43|||
145959111|NCT03284853|526362012|FG001|Overall Study|Other - Reason not reported in CSR|3|||
145959112|NCT02308228|526362014|FG000|Overall Study|Adverse Event|3|||
145959113|NCT02308228|526362015|FG001|Overall Study|Adverse Event|4|||
146214765|NCT03338790|527301643|FG002|Overall Study|Disease Progression|50|||
145959114|NCT02308228|526362014|FG000|Overall Study|Withdrawal by Subject|5|||
145959115|NCT02308228|526362015|FG001|Overall Study|Withdrawal by Subject|3|||
145959116|NCT02143024|526362016|FG000|Overall Study|Lost to Follow-up|1|||
145959117|NCT02143024|526362017|FG001|Overall Study|Lost to Follow-up|1|||
145959118|NCT02143024|526362016|FG000|Overall Study|Withdrawal by Subject|1|||
145959119|NCT02143024|526362017|FG001|Overall Study|Withdrawal by Subject|0|||
145959120|NCT05219968|526362020|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
145959121|NCT05219968|526362021|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145959122|NCT05219968|526362022|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145959123|NCT05219968|526362023|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145959124|NCT05219968|526362024|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145959125|NCT05219968|526362020|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
145959126|NCT05219968|526362021|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
145959127|NCT05219968|526362022|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
145959128|NCT05219968|526362023|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
145959129|NCT05219968|526362024|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
145959130|NCT05219968|526362020|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
145959131|NCT05219968|526362021|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
145959132|NCT05219968|526362022|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
145959133|NCT05219968|526362023|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
145959134|NCT05219968|526362024|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
145959135|NCT05219968|526362020|FG000|Week 24 Treatment Period|Adverse Event|3|||
145959136|NCT05219968|526362021|FG001|Week 24 Treatment Period|Adverse Event|0|||
145959137|NCT05219968|526362022|FG002|Week 24 Treatment Period|Adverse Event|0|||
145959138|NCT05219968|526362023|FG003|Week 24 Treatment Period|Adverse Event|0|||
145959139|NCT05219968|526362024|FG004|Week 24 Treatment Period|Adverse Event|0|||
145959140|NCT05219968|526362020|FG000|Week 24 Treatment Period|Physician Decision|0|||
145959141|NCT05219968|526362021|FG001|Week 24 Treatment Period|Physician Decision|1|||
145959142|NCT05219968|526362022|FG002|Week 24 Treatment Period|Physician Decision|0|||
145959143|NCT05219968|526362023|FG003|Week 24 Treatment Period|Physician Decision|0|||
145959144|NCT05219968|526362024|FG004|Week 24 Treatment Period|Physician Decision|0|||
145959145|NCT05219968|526362020|FG000|Week 24 Treatment Period|Other, not specified|3|||
145959146|NCT05219968|526362021|FG001|Week 24 Treatment Period|Other, not specified|0|||
145959147|NCT05219968|526362022|FG002|Week 24 Treatment Period|Other, not specified|0|||
145959148|NCT05219968|526362023|FG003|Week 24 Treatment Period|Other, not specified|0|||
145959149|NCT05219968|526362024|FG004|Week 24 Treatment Period|Other, not specified|0|||
145959150|NCT05219968|526362020|FG000|Safety Extension Period|Treatment administration failure|0|||
145959151|NCT05219968|526362021|FG001|Safety Extension Period|Treatment administration failure|0|||
145959152|NCT05219968|526362022|FG002|Safety Extension Period|Treatment administration failure|0|||
145959153|NCT05219968|526362023|FG003|Safety Extension Period|Treatment administration failure|1|||
145959154|NCT05219968|526362024|FG004|Safety Extension Period|Treatment administration failure|4|||
145959155|NCT05219968|526362020|FG000|Safety Extension Period|Bilateral dislodgement|0|||
145959156|NCT05219968|526362021|FG001|Safety Extension Period|Bilateral dislodgement|0|||
145959157|NCT05219968|526362022|FG002|Safety Extension Period|Bilateral dislodgement|4|||
145959158|NCT05219968|526362023|FG003|Safety Extension Period|Bilateral dislodgement|0|||
145959159|NCT05219968|526362024|FG004|Safety Extension Period|Bilateral dislodgement|1|||
145959160|NCT05219968|526362020|FG000|Safety Extension Period|Withdrawal by Subject|0|||
145959161|NCT05219968|526362021|FG001|Safety Extension Period|Withdrawal by Subject|0|||
145959162|NCT05219968|526362022|FG002|Safety Extension Period|Withdrawal by Subject|2|||
145959163|NCT05219968|526362023|FG003|Safety Extension Period|Withdrawal by Subject|0|||
145959164|NCT05219968|526362024|FG004|Safety Extension Period|Withdrawal by Subject|4|||
145959165|NCT05219968|526362020|FG000|Safety Extension Period|Adverse Event|0|||
145959166|NCT05219968|526362021|FG001|Safety Extension Period|Adverse Event|0|||
145959167|NCT05219968|526362022|FG002|Safety Extension Period|Adverse Event|2|||
145959168|NCT05219968|526362023|FG003|Safety Extension Period|Adverse Event|1|||
145959169|NCT05219968|526362024|FG004|Safety Extension Period|Adverse Event|1|||
145959170|NCT05219968|526362020|FG000|Safety Extension Period|Lost to Follow-up|0|||
145959171|NCT05219968|526362021|FG001|Safety Extension Period|Lost to Follow-up|0|||
145959172|NCT05219968|526362022|FG002|Safety Extension Period|Lost to Follow-up|0|||
145959173|NCT05219968|526362023|FG003|Safety Extension Period|Lost to Follow-up|1|||
145959174|NCT05219968|526362024|FG004|Safety Extension Period|Lost to Follow-up|0|||
145959175|NCT02358031|526363679|FG000|Overall Study|Death|253|||
145959176|NCT02358031|526363680|FG001|Overall Study|Death|237|||
145959177|NCT02358031|526363681|FG002|Overall Study|Death|266|||
145959178|NCT02358031|526363679|FG000|Overall Study|Lost to Follow-up|1|||
145959179|NCT02358031|526363680|FG001|Overall Study|Lost to Follow-up|1|||
145959180|NCT02358031|526363681|FG002|Overall Study|Lost to Follow-up|0|||
146084131|NCT04418661|526827937|FG003|Overall Study|Adverse Event|3|||
145959181|NCT02358031|526363679|FG000|Overall Study|Withdrawal by Subject|19|||
145959182|NCT02358031|526363680|FG001|Overall Study|Withdrawal by Subject|14|||
145959183|NCT02358031|526363681|FG002|Overall Study|Withdrawal by Subject|18|||
145959184|NCT02358031|526363679|FG000|Overall Study|Sponsor Decision|26|||
145959185|NCT02358031|526363680|FG001|Overall Study|Sponsor Decision|28|||
146084132|NCT04418661|526827938|FG004|Overall Study|Adverse Event|0|||
146084133|NCT04418661|526827939|FG005|Overall Study|Adverse Event|2|||
145959186|NCT02358031|526363681|FG002|Overall Study|Sponsor Decision|16|||
145959187|NCT01212094|526363682|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
145959188|NCT01212094|526363683|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
145959189|NCT01212094|526363684|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
146287402|NCT05249829|527567419|FG000|Overall Study|Death|0|||
146287403|NCT05249829|527567420|FG001|Overall Study|Death|1|||
146287404|NCT05249829|527567421|FG002|Overall Study|Death|2|||
146287405|NCT05249829|527567422|FG003|Overall Study|Death|4|||
146287406|NCT00513604|527567423|FG000|Overall Study|Not treated|2|||
146287407|NCT00513604|527567424|FG001|Overall Study|Not treated|0|||
146287408|NCT00513604|527567425|FG002|Overall Study|Not treated|1|||
146287409|NCT00513604|527567426|FG003|Overall Study|Not treated|0|||
146287410|NCT00513604|527567427|FG004|Overall Study|Not treated|0|||
146287411|NCT00513604|527567423|FG000|Overall Study|Death during treatment|0|||
146287412|NCT00513604|527567424|FG001|Overall Study|Death during treatment|3|||
146287413|NCT00513604|527567425|FG002|Overall Study|Death during treatment|2|||
146287414|NCT00513604|527567426|FG003|Overall Study|Death during treatment|0|||
146287415|NCT00513604|527567427|FG004|Overall Study|Death during treatment|0|||
145959190|NCT01212094|526363682|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
145959191|NCT01212094|526363683|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
145959192|NCT01212094|526363684|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
145959193|NCT01212094|526363682|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
145959194|NCT01212094|526363683|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
145959195|NCT01212094|526363684|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
145959196|NCT01212094|526363682|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
145959197|NCT01212094|526363683|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
145959198|NCT01212094|526363684|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
145959199|NCT01212094|526363682|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
145959200|NCT01212094|526363683|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
145959201|NCT01212094|526363684|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
145959202|NCT01212094|526363682|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
145959203|NCT01212094|526363683|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
145959204|NCT01212094|526363684|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
145959205|NCT05664581|526363686|FG000|Overall Study|Withdrawal by Subject|2|||
145959206|NCT03101150|526363687|FG000|Overall Study|Lost to Follow-up|2|||
145959207|NCT03101150|526363688|FG001|Overall Study|Lost to Follow-up|4|||
145959208|NCT03101150|526363687|FG000|Overall Study|Miscarriage|3|||
145959209|NCT03101150|526363688|FG001|Overall Study|Miscarriage|6|||
145959210|NCT01317641|526363690|FG000|Overall Study|Not treated|0|||
145959211|NCT01317641|526363691|FG001|Overall Study|Not treated|0|||
145959212|NCT01317641|526363692|FG002|Overall Study|Not treated|0|||
145959213|NCT01317641|526363693|FG003|Overall Study|Not treated|0|||
145959214|NCT01317641|526363694|FG004|Overall Study|Not treated|0|||
145959215|NCT01317641|526363695|FG005|Overall Study|Not treated|0|||
145959216|NCT01317641|526363696|FG006|Overall Study|Not treated|0|||
145959217|NCT01317641|526363697|FG007|Overall Study|Not treated|1|||
145959218|NCT01317641|526363698|FG008|Overall Study|Not treated|1|||
145959219|NCT01317641|526363690|FG000|Overall Study|Adverse Event|0|||
145959220|NCT01317641|526363691|FG001|Overall Study|Adverse Event|1|||
146084134|NCT04418661|526827934|FG000|Overall Study|Progressive disease|4|||
146084135|NCT04418661|526827935|FG001|Overall Study|Progressive disease|11|||
146084136|NCT04418661|526827936|FG002|Overall Study|Progressive disease|6|||
146214766|NCT03338790|527301644|FG003|Overall Study|Disease Progression|37|||
146214767|NCT03338790|527301641|FG000|Overall Study|Study Drug Toxicity|9|||
146214768|NCT03338790|527301642|FG001|Overall Study|Study Drug Toxicity|8|||
146214769|NCT03338790|527301643|FG002|Overall Study|Study Drug Toxicity|15|||
146214770|NCT03338790|527301644|FG003|Overall Study|Study Drug Toxicity|0|||
146214771|NCT03338790|527301641|FG000|Overall Study|Death|1|||
146214772|NCT03338790|527301642|FG001|Overall Study|Death|1|||
146214773|NCT03338790|527301643|FG002|Overall Study|Death|1|||
146214774|NCT03338790|527301644|FG003|Overall Study|Death|0|||
146214775|NCT03338790|527301641|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
146214776|NCT03338790|527301642|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
146214777|NCT03338790|527301643|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
146214778|NCT03338790|527301644|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
146214779|NCT03338790|527301641|FG000|Overall Study|Participant request to discontinue study treatment|3|||
146214780|NCT03338790|527301642|FG001|Overall Study|Participant request to discontinue study treatment|3|||
146214781|NCT03338790|527301643|FG002|Overall Study|Participant request to discontinue study treatment|2|||
146214782|NCT03338790|527301644|FG003|Overall Study|Participant request to discontinue study treatment|1|||
146214783|NCT03338790|527301641|FG000|Overall Study|Poor/non-compliance|0|||
145959221|NCT01317641|526363692|FG002|Overall Study|Adverse Event|0|||
145959222|NCT01317641|526363693|FG003|Overall Study|Adverse Event|1|||
145959223|NCT01317641|526363694|FG004|Overall Study|Adverse Event|0|||
145959224|NCT01317641|526363695|FG005|Overall Study|Adverse Event|0|||
145959225|NCT01317641|526363696|FG006|Overall Study|Adverse Event|2|||
145959226|NCT01317641|526363697|FG007|Overall Study|Adverse Event|1|||
145959227|NCT01317641|526363698|FG008|Overall Study|Adverse Event|0|||
145959228|NCT01317641|526363690|FG000|Overall Study|Protocol Violation|1|||
145959229|NCT01317641|526363691|FG001|Overall Study|Protocol Violation|0|||
145959230|NCT01317641|526363692|FG002|Overall Study|Protocol Violation|0|||
145959231|NCT01317641|526363693|FG003|Overall Study|Protocol Violation|0|||
145959232|NCT01317641|526363694|FG004|Overall Study|Protocol Violation|0|||
145959233|NCT01317641|526363695|FG005|Overall Study|Protocol Violation|0|||
145959234|NCT01317641|526363696|FG006|Overall Study|Protocol Violation|0|||
145959235|NCT01317641|526363697|FG007|Overall Study|Protocol Violation|0|||
145959236|NCT01317641|526363698|FG008|Overall Study|Protocol Violation|0|||
145959237|NCT01317641|526363690|FG000|Overall Study|Disease progression|0|||
145959238|NCT01317641|526363691|FG001|Overall Study|Disease progression|0|||
145959239|NCT01317641|526363692|FG002|Overall Study|Disease progression|0|||
145959240|NCT01317641|526363693|FG003|Overall Study|Disease progression|0|||
145959241|NCT01317641|526363694|FG004|Overall Study|Disease progression|0|||
145959242|NCT01317641|526363695|FG005|Overall Study|Disease progression|0|||
145959243|NCT01317641|526363696|FG006|Overall Study|Disease progression|0|||
145959244|NCT01317641|526363697|FG007|Overall Study|Disease progression|3|||
145959245|NCT01317641|526363698|FG008|Overall Study|Disease progression|4|||
145959246|NCT01317641|526363690|FG000|Overall Study|Withdrawal by Subject|0|||
145959247|NCT01317641|526363691|FG001|Overall Study|Withdrawal by Subject|0|||
145959248|NCT01317641|526363692|FG002|Overall Study|Withdrawal by Subject|0|||
145959249|NCT01317641|526363693|FG003|Overall Study|Withdrawal by Subject|0|||
145959250|NCT01317641|526363694|FG004|Overall Study|Withdrawal by Subject|0|||
145959251|NCT01317641|526363695|FG005|Overall Study|Withdrawal by Subject|0|||
145959252|NCT01317641|526363696|FG006|Overall Study|Withdrawal by Subject|1|||
145959253|NCT01317641|526363697|FG007|Overall Study|Withdrawal by Subject|0|||
145959254|NCT01317641|526363698|FG008|Overall Study|Withdrawal by Subject|0|||
145959255|NCT00715559|526363699|FG000|Overall Study|medication not tolerated - nausea|1|||
145959256|NCT02019550|526363700|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145959257|NCT02019550|526363701|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
145959258|NCT02787304|526363704|FG000|Overall Study|Adverse Event|9|||
145959259|NCT02787304|526363705|FG001|Overall Study|Adverse Event|3|||
145959260|NCT02787304|526363706|FG002|Overall Study|Adverse Event|8|||
145959261|NCT02787304|526363707|FG003|Overall Study|Adverse Event|1|||
145959262|NCT02787304|526363704|FG000|Overall Study|Withdrawal by Subject|1|||
145959263|NCT02787304|526363705|FG001|Overall Study|Withdrawal by Subject|4|||
145959264|NCT02787304|526363706|FG002|Overall Study|Withdrawal by Subject|0|||
145959265|NCT02787304|526363707|FG003|Overall Study|Withdrawal by Subject|0|||
145959266|NCT02787304|526363704|FG000|Overall Study|Lost to Follow-up|1|||
145959267|NCT02787304|526363705|FG001|Overall Study|Lost to Follow-up|0|||
145959268|NCT02787304|526363706|FG002|Overall Study|Lost to Follow-up|0|||
145959269|NCT02787304|526363707|FG003|Overall Study|Lost to Follow-up|1|||
145959270|NCT02787304|526363704|FG000|Overall Study|Noncompliance with study drug|0|||
145959271|NCT02787304|526363705|FG001|Overall Study|Noncompliance with study drug|0|||
145959272|NCT02787304|526363706|FG002|Overall Study|Noncompliance with study drug|1|||
145959273|NCT02787304|526363707|FG003|Overall Study|Noncompliance with study drug|0|||
145959274|NCT02787304|526363704|FG000|Overall Study|Physician Decision|0|||
145959275|NCT02787304|526363705|FG001|Overall Study|Physician Decision|0|||
145959276|NCT02787304|526363706|FG002|Overall Study|Physician Decision|1|||
145959277|NCT02787304|526363707|FG003|Overall Study|Physician Decision|0|||
145959278|NCT02787304|526363704|FG000|Overall Study|Study terminated by sponsor|25|||
145959279|NCT02787304|526363705|FG001|Overall Study|Study terminated by sponsor|31|||
145959280|NCT02787304|526363706|FG002|Overall Study|Study terminated by sponsor|31|||
145959281|NCT02787304|526363707|FG003|Overall Study|Study terminated by sponsor|32|||
145959282|NCT04771013|526363709|FG000|Overall Study|Withdrawal by Subject|2|||
145959283|NCT04771013|526363710|FG001|Overall Study|Withdrawal by Subject|0|||
145959284|NCT04771013|526363709|FG000|Overall Study|Death|0|||
145959285|NCT04771013|526363710|FG001|Overall Study|Death|5|||
145959286|NCT04771013|526363709|FG000|Overall Study|Referred to another hospital before day 20|0|||
145959287|NCT04771013|526363710|FG001|Overall Study|Referred to another hospital before day 20|1|||
145959288|NCT00823134|526363711|FG000|Overall Study|Invalid measurement|1|||
145959289|NCT00419757|526363715|FG000|Overall Study|Adverse Event|1|||
145959290|NCT00419757|526363716|FG001|Overall Study|Adverse Event|4|||
145959291|NCT00419757|526363715|FG000|Overall Study|Lost to Follow-up|1|||
145959292|NCT00419757|526363716|FG001|Overall Study|Lost to Follow-up|4|||
145959293|NCT00419757|526363715|FG000|Overall Study|Withdrawal by Subject|7|||
145959294|NCT00419757|526363716|FG001|Overall Study|Withdrawal by Subject|1|||
145959295|NCT00419757|526363715|FG000|Overall Study|Protocol Violation|2|||
145959296|NCT00419757|526363716|FG001|Overall Study|Protocol Violation|3|||
145959297|NCT00419757|526363715|FG000|Overall Study|Study specific discontinuation criteria|4|||
145959298|NCT00419757|526363716|FG001|Overall Study|Study specific discontinuation criteria|8|||
145959299|NCT00419757|526363715|FG000|Overall Study|Multiple reasons|3|||
145959300|NCT00419757|526363716|FG001|Overall Study|Multiple reasons|1|||
145959301|NCT00379834|526363721|FG000|Overall Study|Time constraints|2|||
145959302|NCT01519817|526363722|FG000|Overall Study|Withdrawal by Subject|1|||
145959303|NCT01519817|526363723|FG001|Overall Study|Withdrawal by Subject|0|||
145959304|NCT01519817|526363724|FG002|Overall Study|Withdrawal by Subject|0|||
145959305|NCT01519817|526363725|FG003|Overall Study|Withdrawal by Subject|0|||
145959306|NCT01519817|526363722|FG000|Overall Study|Off study due to infection|0|||
145959307|NCT01519817|526363723|FG001|Overall Study|Off study due to infection|0|||
145959308|NCT01519817|526363724|FG002|Overall Study|Off study due to infection|0|||
145959309|NCT01519817|526363725|FG003|Overall Study|Off study due to infection|1|||
145959310|NCT02922153|526363726|FG000|Overall Study|Death|8|||
145959311|NCT02922153|526363727|FG001|Overall Study|Death|1|||
145959312|NCT02922153|526363726|FG000|Overall Study|Lost to Follow-up|1|||
145959313|NCT02922153|526363727|FG001|Overall Study|Lost to Follow-up|0|||
145959314|NCT02922153|526363726|FG000|Overall Study|Physician Decision|1|||
145959315|NCT02922153|526363727|FG001|Overall Study|Physician Decision|1|||
145959316|NCT01325350|526363730|FG000|Overall Study|Adverse Event|3|||
145959317|NCT01325350|526363731|FG001|Overall Study|Adverse Event|3|||
145959318|NCT01325350|526363732|FG002|Overall Study|Adverse Event|3|||
145959319|NCT01325350|526363733|FG003|Overall Study|Adverse Event|1|||
145959320|NCT01325350|526363734|FG004|Overall Study|Adverse Event|2|||
145959321|NCT01325350|526363730|FG000|Overall Study|Pregnancy|0|||
145959322|NCT01325350|526363731|FG001|Overall Study|Pregnancy|0|||
145959323|NCT01325350|526363732|FG002|Overall Study|Pregnancy|1|||
145959324|NCT01325350|526363733|FG003|Overall Study|Pregnancy|0|||
145959325|NCT01325350|526363734|FG004|Overall Study|Pregnancy|1|||
145959326|NCT01325350|526363730|FG000|Overall Study|Lost to Follow-up|1|||
145959327|NCT01325350|526363731|FG001|Overall Study|Lost to Follow-up|0|||
145959328|NCT01325350|526363732|FG002|Overall Study|Lost to Follow-up|5|||
145959329|NCT01325350|526363733|FG003|Overall Study|Lost to Follow-up|1|||
145959330|NCT01325350|526363734|FG004|Overall Study|Lost to Follow-up|5|||
145959331|NCT01325350|526363730|FG000|Overall Study|Personal Reasons|2|||
145959332|NCT01325350|526363731|FG001|Overall Study|Personal Reasons|1|||
145959333|NCT01325350|526363732|FG002|Overall Study|Personal Reasons|6|||
145959334|NCT01325350|526363733|FG003|Overall Study|Personal Reasons|5|||
145959335|NCT01325350|526363734|FG004|Overall Study|Personal Reasons|3|||
145959336|NCT01325350|526363730|FG000|Overall Study|Protocol Violation|0|||
145959337|NCT01325350|526363731|FG001|Overall Study|Protocol Violation|0|||
145959338|NCT01325350|526363732|FG002|Overall Study|Protocol Violation|0|||
145959339|NCT01325350|526363733|FG003|Overall Study|Protocol Violation|1|||
145959340|NCT01325350|526363734|FG004|Overall Study|Protocol Violation|0|||
145959341|NCT01325350|526363730|FG000|Overall Study|Withdrawal by Subject|0|||
145959342|NCT01325350|526363731|FG001|Overall Study|Withdrawal by Subject|0|||
145959343|NCT01325350|526363732|FG002|Overall Study|Withdrawal by Subject|1|||
145959344|NCT01325350|526363733|FG003|Overall Study|Withdrawal by Subject|1|||
145959345|NCT01325350|526363734|FG004|Overall Study|Withdrawal by Subject|0|||
145959346|NCT01325350|526363730|FG000|Overall Study|Did Not Receive Treatment|0|||
145959347|NCT01325350|526363731|FG001|Overall Study|Did Not Receive Treatment|1|||
145959348|NCT01325350|526363732|FG002|Overall Study|Did Not Receive Treatment|1|||
145959349|NCT01325350|526363733|FG003|Overall Study|Did Not Receive Treatment|0|||
145959350|NCT01325350|526363734|FG004|Overall Study|Did Not Receive Treatment|1|||
145959351|NCT01128296|526363737|FG000|Overall Study|Physician Decision|0|||
145959352|NCT01128296|526363738|FG001|Overall Study|Physician Decision|0|||
145959353|NCT01128296|526363739|FG002|Overall Study|Physician Decision|0|||
145959354|NCT01128296|526363740|FG003|Overall Study|Physician Decision|0|||
145959355|NCT01128296|526363741|FG004|Overall Study|Physician Decision|0|||
145959356|NCT01128296|526363742|FG005|Overall Study|Physician Decision|3|||
145959357|NCT01128296|526363737|FG000|Overall Study|Withdrawal by Subject|0|||
145959358|NCT01128296|526363738|FG001|Overall Study|Withdrawal by Subject|0|||
145959359|NCT01128296|526363739|FG002|Overall Study|Withdrawal by Subject|0|||
145959360|NCT01128296|526363740|FG003|Overall Study|Withdrawal by Subject|0|||
145959361|NCT01128296|526363741|FG004|Overall Study|Withdrawal by Subject|0|||
145959362|NCT01128296|526363742|FG005|Overall Study|Withdrawal by Subject|2|||
145959363|NCT03316586|526363747|FG000|Overall Study|Adverse Event|2|||
145959364|NCT03316586|526363747|FG000|Overall Study|Physician Decision|3|||
145959365|NCT03316586|526363747|FG000|Overall Study|Lack of Efficacy|10|||
145959366|NCT03316586|526363747|FG000|Overall Study|still on treatment|1|||
145959367|NCT03316586|526363747|FG000|Overall Study|Patient needed radiation therapy|1|||
145959368|NCT03316586|526363747|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
145959369|NCT04547140|526363751|FG000|Overall Study|Adverse Event|0|||
145959370|NCT04547140|526363752|FG001|Overall Study|Adverse Event|1|||
145959371|NCT04547140|526363751|FG000|Overall Study|Withdrawal by Subject|0|||
145959372|NCT04547140|526363752|FG001|Overall Study|Withdrawal by Subject|1|||
145959373|NCT04547140|526363751|FG000|Overall Study|Lost to Follow-up|3|||
145959374|NCT04547140|526363752|FG001|Overall Study|Lost to Follow-up|1|||
145959375|NCT04547140|526363751|FG000|Overall Study|Death|2|||
145959376|NCT04547140|526363752|FG001|Overall Study|Death|1|||
145959377|NCT04547140|526363751|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
145959378|NCT04547140|526363752|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
145959379|NCT04547140|526363751|FG000|Overall Study|Pregnancy|1|||
145959380|NCT04547140|526363752|FG001|Overall Study|Pregnancy|0|||
145959381|NCT04547140|526363751|FG000|Overall Study|Reason Not Specified|4|||
145959382|NCT04547140|526363752|FG001|Overall Study|Reason Not Specified|1|||
145959383|NCT00873730|526363753|FG000|Overall Study|Protocol Deviation|5|||
145959384|NCT00873730|526363754|FG001|Overall Study|Protocol Deviation|2|||
145959385|NCT00873730|526363753|FG000|Overall Study|Adverse Event|0|||
145959386|NCT00873730|526363754|FG001|Overall Study|Adverse Event|2|||
145959387|NCT00873730|526363753|FG000|Overall Study|Withdrawal by Subject|0|||
146214784|NCT03338790|527301642|FG001|Overall Study|Poor/non-compliance|1|||
145959388|NCT00873730|526363754|FG001|Overall Study|Withdrawal by Subject|1|||
145959389|NCT00873730|526363753|FG000|Overall Study|Sponsor decision|1|||
145959390|NCT00873730|526363754|FG001|Overall Study|Sponsor decision|0|||
145959391|NCT04613739|526363755|FG000|Overall Study|Lost to Follow-up|6|||
145959392|NCT04613739|526363756|FG001|Overall Study|Lost to Follow-up|9|||
145959393|NCT04613739|526363755|FG000|Overall Study|potentially duplicative/fraudulent|1|||
145959394|NCT04613739|526363756|FG001|Overall Study|potentially duplicative/fraudulent|3|||
145959395|NCT01178125|526363757|FG000|Overall Study|Lost to Follow-up|397|||
146287416|NCT00196976|527567428|FG000|Primary Study|Migrated from study area|0|||
146287417|NCT00196976|527567429|FG001|Primary Study|Migrated from study area|0|||
145959396|NCT01178125|526363757|FG000|Overall Study|Adverse Event|244|||
145959397|NCT01178125|526363757|FG000|Overall Study|Withdrawal by Subject|209|||
145959398|NCT01178125|526363757|FG000|Overall Study|Noncompliance|184|||
145959399|NCT01178125|526363757|FG000|Overall Study|Pregnancy|55|||
145959400|NCT01178125|526363757|FG000|Overall Study|Other Reason|39|||
145959401|NCT01178125|526363757|FG000|Overall Study|Sponsor Decision|28|||
145959402|NCT01178125|526363757|FG000|Overall Study|Protocol Violation|17|||
145959403|NCT01178125|526363757|FG000|Overall Study|Investigator Decision|5|||
145959404|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959405|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
145959406|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
145959407|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959408|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959409|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959410|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959411|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959412|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959413|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959414|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959415|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959416|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959417|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959418|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145959419|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
145959420|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
145959421|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959422|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959423|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959424|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959425|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959426|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959427|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959428|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959429|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959430|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959431|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959432|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959433|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145959434|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
145959435|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
145959436|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
145959437|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959438|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959439|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959440|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959441|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959442|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959443|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959444|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959445|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146084137|NCT04418661|526827937|FG003|Overall Study|Progressive disease|11|||
146084138|NCT04418661|526827938|FG004|Overall Study|Progressive disease|1|||
146084139|NCT04418661|526827939|FG005|Overall Study|Progressive disease|12|||
146084140|NCT04418661|526827934|FG000|Overall Study|Withdrawal by Subject|0|||
146084141|NCT04418661|526827935|FG001|Overall Study|Withdrawal by Subject|1|||
146084142|NCT04418661|526827936|FG002|Overall Study|Withdrawal by Subject|0|||
146084143|NCT04418661|526827937|FG003|Overall Study|Withdrawal by Subject|1|||
146214785|NCT03338790|527301643|FG002|Overall Study|Poor/non-compliance|0|||
146214786|NCT03338790|527301644|FG003|Overall Study|Poor/non-compliance|0|||
146214787|NCT03338790|527301641|FG000|Overall Study|Participant withdrew consent|1|||
146214788|NCT03338790|527301642|FG001|Overall Study|Participant withdrew consent|0|||
145959446|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959447|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959448|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145959449|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959450|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959451|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
145959452|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959453|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959454|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959455|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959456|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959457|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959458|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959459|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959460|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959461|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959462|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959463|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145959464|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959465|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959466|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
145959467|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959468|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959469|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959470|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959471|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
146084144|NCT04418661|526827938|FG004|Overall Study|Withdrawal by Subject|0|||
146084145|NCT04418661|526827939|FG005|Overall Study|Withdrawal by Subject|0|||
145959472|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959473|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959474|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959475|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959476|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959477|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959478|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145959479|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959480|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959481|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
145959482|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959483|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959484|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959485|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959486|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959487|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959488|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959489|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
146214789|NCT03338790|527301643|FG002|Overall Study|Participant withdrew consent|1|||
146214790|NCT03338790|527301644|FG003|Overall Study|Participant withdrew consent|1|||
146214791|NCT03338790|527301641|FG000|Overall Study|Other reasons|0|||
146214792|NCT03338790|527301642|FG001|Overall Study|Other reasons|5|||
146214793|NCT03338790|527301643|FG002|Overall Study|Other reasons|0|||
146214794|NCT03338790|527301644|FG003|Overall Study|Other reasons|2|||
145959490|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959491|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959492|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959493|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145959494|NCT02326272|526363758|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959495|NCT02326272|526363759|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959496|NCT02326272|526363760|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
145959497|NCT02326272|526363761|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959498|NCT02326272|526363762|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959499|NCT02326272|526363763|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959500|NCT02326272|526363764|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959501|NCT02326272|526363765|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959502|NCT02326272|526363766|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959503|NCT02326272|526363767|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959504|NCT02326272|526363768|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959505|NCT02326272|526363769|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959506|NCT02326272|526363770|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959507|NCT02326272|526363771|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959508|NCT02326272|526363772|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145959509|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959510|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959511|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146084146|NCT04418661|526827934|FG000|Overall Study|Other|0|||
146214795|NCT03338790|527301641|FG000|Overall Study|Not reported|0|||
145959512|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959513|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145959514|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
145959515|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
145959516|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145959517|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145959518|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959519|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959520|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959521|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959522|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959523|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145959524|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146214796|NCT03338790|527301642|FG001|Overall Study|Not reported|0|||
146214797|NCT03338790|527301643|FG002|Overall Study|Not reported|1|||
146214798|NCT03338790|527301644|FG003|Overall Study|Not reported|0|||
146214799|NCT03338790|527301641|FG000|Overall Study|Completed treatment period|1|||
146214800|NCT03338790|527301642|FG001|Overall Study|Completed treatment period|2|||
146214801|NCT03338790|527301643|FG002|Overall Study|Completed treatment period|0|||
146214802|NCT03338790|527301644|FG003|Overall Study|Completed treatment period|0|||
146214803|NCT05319860|527301649|FG000|Overall Study|Death|1|||
146214804|NCT05319860|527301650|FG001|Overall Study|Death|1|||
146214805|NCT05319860|527301649|FG000|Overall Study|Lost to Follow-up|3|||
146214806|NCT05319860|527301650|FG001|Overall Study|Lost to Follow-up|1|||
146214807|NCT05319860|527301649|FG000|Overall Study|Withdrawal by Subject|1|||
146214808|NCT05319860|527301650|FG001|Overall Study|Withdrawal by Subject|7|||
146214809|NCT04314895|527301651|FG000|Overall Study|Lost to Follow-up|1|||
146214810|NCT04314895|527301651|FG000|Overall Study|Death|10|||
146214811|NCT04314895|527301651|FG000|Overall Study|Physician Decision|2|||
146214812|NCT03941860|527301652|FG000|Overall Study|Withdrawal by Subject|0|||
146214813|NCT03941860|527301653|FG001|Overall Study|Withdrawal by Subject|1|||
146214814|NCT03361748|527301657|FG000|Overall Study|Death|77|||
146214815|NCT03361748|527301657|FG000|Overall Study|Lost to Follow-up|4|||
145959525|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959526|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146214816|NCT03361748|527301657|FG000|Overall Study|Withdrawal by Subject|20|||
146214817|NCT02596126|527301658|FG000|Overall Study|Lost to Follow-up|12|||
146214818|NCT02596126|527301659|FG001|Overall Study|Lost to Follow-up|21|||
146214819|NCT02596126|527301658|FG000|Overall Study|Protocol Violation|7|||
146214820|NCT02596126|527301659|FG001|Overall Study|Protocol Violation|9|||
146214821|NCT05792423|527301665|FG000|Overall Study|Withdrawal by Subject|2|||
146214822|NCT05691452|527302895|FG000|Overall Study|Withdrawal by Subject|1|||
146214823|NCT05691452|527302896|FG001|Overall Study|Withdrawal by Subject|1|||
146214824|NCT05691452|527302897|FG002|Overall Study|Withdrawal by Subject|0|||
146214825|NCT05691452|527302895|FG000|Overall Study|Physician Decision|1|||
145959527|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146214826|NCT05691452|527302896|FG001|Overall Study|Physician Decision|0|||
146214827|NCT05691452|527302897|FG002|Overall Study|Physician Decision|0|||
146214828|NCT05691452|527302895|FG000|Overall Study|Lost to Follow-up|0|||
146214829|NCT05691452|527302896|FG001|Overall Study|Lost to Follow-up|0|||
146214830|NCT05691452|527302897|FG002|Overall Study|Lost to Follow-up|1|||
146214831|NCT05691452|527302895|FG000|Overall Study|Adverse Event|0|||
146214832|NCT05691452|527302896|FG001|Overall Study|Adverse Event|0|||
145959528|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959529|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
145959530|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145959531|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959532|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145959533|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145959534|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959535|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959536|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959537|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959538|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145959539|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959540|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959541|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959542|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959543|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959544|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145959545|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959546|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145959547|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959548|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959549|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959550|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959551|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959552|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959553|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145959554|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959555|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959556|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959557|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145959558|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959559|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
145959560|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145959561|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145959562|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959563|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145959564|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959565|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959566|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959567|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959568|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145959569|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959570|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959571|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959572|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959573|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959574|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959575|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
146214833|NCT05691452|527302897|FG002|Overall Study|Adverse Event|1|||
146214834|NCT03648840|527302903|FG000|First IV Infusion Session|Adverse Event|0|||
145959576|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
145959577|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959578|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959579|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959580|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959581|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959582|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959583|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145959584|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959585|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959586|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146214835|NCT03648840|527302904|FG001|First IV Infusion Session|Adverse Event|2|||
146214836|NCT03648840|527302903|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
146214837|NCT03648840|527302904|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
146214838|NCT03648840|527302903|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
146214839|NCT03648840|527302904|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
146214840|NCT03648840|527302903|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
146214841|NCT03648840|527302904|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
146214842|NCT05418296|527302907|FG000|Overall Study|Withdrawal by Subject|4|||
145959587|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959588|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959589|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959590|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
146214843|NCT05418296|527302908|FG001|Overall Study|Withdrawal by Subject|1|||
146214844|NCT05382936|527302909|FG000|Overall Study|Progressive Disease|3|||
146214845|NCT05382936|527302910|FG001|Overall Study|Progressive Disease|5|||
146214846|NCT05382936|527302911|FG002|Overall Study|Progressive Disease|2|||
145959591|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959592|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959593|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959594|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959595|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959596|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
146084147|NCT04418661|526827935|FG001|Overall Study|Other|0|||
146084148|NCT04418661|526827936|FG002|Overall Study|Other|1|||
146084149|NCT04418661|526827937|FG003|Overall Study|Other|3|||
146084150|NCT04418661|526827938|FG004|Overall Study|Other|0|||
145959597|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959598|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145959599|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
146084151|NCT04418661|526827939|FG005|Overall Study|Other|1|||
146084152|NCT00329901|526827943|FG000|Overall Study|Withdrawal by Subject|4|||
146287418|NCT00196976|527567430|FG002|Primary Study|Migrated from study area|0|||
145959600|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959601|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959602|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959603|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959604|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959605|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959606|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959607|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
145959608|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959609|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959610|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959611|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959612|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959613|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145959614|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959615|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959616|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959617|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959618|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959619|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
145959620|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
145959621|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
145959622|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
145959623|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959624|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959625|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959626|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959627|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959628|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145959629|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959630|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959631|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959632|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959633|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959634|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
145959635|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959636|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959637|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959638|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959639|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959640|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959641|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959642|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959643|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145959644|NCT02326272|526363758|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
146084153|NCT00329901|526827944|FG001|Overall Study|Withdrawal by Subject|3|||
146084154|NCT00329901|526827945|FG002|Overall Study|Withdrawal by Subject|2|||
146084155|NCT00329901|526827943|FG000|Overall Study|Lost to Follow-up|2|||
146084156|NCT00329901|526827944|FG001|Overall Study|Lost to Follow-up|0|||
145959645|NCT02326272|526363759|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959646|NCT02326272|526363760|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959647|NCT02326272|526363761|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959648|NCT02326272|526363762|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959649|NCT02326272|526363763|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959650|NCT02326272|526363764|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
145959651|NCT02326272|526363765|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959652|NCT02326272|526363766|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959653|NCT02326272|526363767|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959654|NCT02326272|526363768|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959655|NCT02326272|526363769|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959656|NCT02326272|526363770|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959657|NCT02326272|526363771|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959658|NCT02326272|526363772|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145959659|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
145959660|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
145959661|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
145959662|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
145959663|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
145959664|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
145959665|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
145959666|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
145959667|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
145959668|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
145959669|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
145959670|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
145959671|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
145959672|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
145959673|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
145959674|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959675|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959676|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959677|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959678|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959679|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959680|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959681|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959682|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959683|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959684|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
145959685|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
145959686|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
146084157|NCT00329901|526827945|FG002|Overall Study|Lost to Follow-up|1|||
146084158|NCT00329901|526827943|FG000|Overall Study|Protocol Violation|1|||
146084159|NCT00329901|526827944|FG001|Overall Study|Protocol Violation|0|||
146084160|NCT00329901|526827945|FG002|Overall Study|Protocol Violation|1|||
146084161|NCT00329901|526827943|FG000|Overall Study|Unable to classify|2|||
145959687|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145959688|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
145959689|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146084162|NCT00329901|526827944|FG001|Overall Study|Unable to classify|2|||
146084163|NCT00329901|526827945|FG002|Overall Study|Unable to classify|0|||
146084164|NCT00992589|526827946|FG000|Open-Label Phase|Adverse Event|4|||
146084165|NCT00992589|526827947|FG001|Open-Label Phase|Adverse Event|0|||
146084166|NCT00992589|526827948|FG002|Open-Label Phase|Adverse Event|0|||
146084167|NCT00992589|526827949|FG003|Open-Label Phase|Adverse Event|0|||
146084168|NCT00992589|526827946|FG000|Open-Label Phase|Withdrawal by Subject|20|||
145959690|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959691|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959692|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145881321|NCT02722616|526072606|FG000|Overall Study|Sponsor closed study after one month|2|||
145881322|NCT02722616|526072607|FG001|Overall Study|Sponsor closed study after one month|0|||
145881323|NCT02722616|526072608|FG002|Overall Study|Sponsor closed study after one month|0|||
145881324|NCT02031237|526072609|FG000|Overall Study|Death|1|||
145881325|NCT02031237|526072610|FG001|Overall Study|Death|5|||
145881326|NCT02031237|526072611|FG002|Overall Study|Death|0|||
145881327|NCT02031237|526072609|FG000|Overall Study|Physician Decision|0|||
145881328|NCT02031237|526072610|FG001|Overall Study|Physician Decision|1|||
145881329|NCT02031237|526072611|FG002|Overall Study|Physician Decision|0|||
145881330|NCT02031237|526072609|FG000|Overall Study|Withdrawal by Subject|2|||
145881331|NCT02031237|526072610|FG001|Overall Study|Withdrawal by Subject|2|||
145881332|NCT02031237|526072611|FG002|Overall Study|Withdrawal by Subject|0|||
145881333|NCT02031237|526072609|FG000|Overall Study|Protocol Violation|2|||
145881334|NCT02031237|526072610|FG001|Overall Study|Protocol Violation|6|||
145881335|NCT02031237|526072611|FG002|Overall Study|Protocol Violation|0|||
145881336|NCT02031237|526072609|FG000|Overall Study|Alternate Treatment Given|0|||
145881337|NCT02031237|526072610|FG001|Overall Study|Alternate Treatment Given|0|||
145881338|NCT02031237|526072611|FG002|Overall Study|Alternate Treatment Given|3|||
145881339|NCT00676650|526072614|FG000|Overall Study|Death|45|||
145881340|NCT00676650|526072615|FG001|Overall Study|Death|14|||
145881341|NCT00676650|526072614|FG000|Overall Study|Adverse Event|159|||
145959693|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959694|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146084169|NCT00992589|526827947|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146084170|NCT00992589|526827948|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145881342|NCT00676650|526072615|FG001|Overall Study|Adverse Event|21|||
145881343|NCT00676650|526072614|FG000|Overall Study|Global deterioration of health status|66|||
145881344|NCT00676650|526072615|FG001|Overall Study|Global deterioration of health status|31|||
145881345|NCT00676650|526072614|FG000|Overall Study|Lost to Follow-up|0|||
145881346|NCT00676650|526072615|FG001|Overall Study|Lost to Follow-up|1|||
145881347|NCT00676650|526072614|FG000|Overall Study|Objective progression or relapse|189|||
145881348|NCT00676650|526072615|FG001|Overall Study|Objective progression or relapse|140|||
145881349|NCT00676650|526072614|FG000|Overall Study|Other|14|||
145881350|NCT00676650|526072615|FG001|Overall Study|Other|10|||
145881351|NCT00676650|526072614|FG000|Overall Study|Protocol Violation|3|||
145881352|NCT00676650|526072615|FG001|Overall Study|Protocol Violation|1|||
145881353|NCT00676650|526072614|FG000|Overall Study|Study terminated by sponsor|57|||
145881354|NCT00676650|526072615|FG001|Overall Study|Study terminated by sponsor|43|||
145959695|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959696|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959697|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959698|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959699|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145959700|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959701|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145959702|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959703|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145959704|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959705|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959706|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959707|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959708|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959709|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959710|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959711|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959712|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959713|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959714|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959715|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
145959716|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959717|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959718|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145959719|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959720|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959721|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959722|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959723|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959724|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959725|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959726|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959727|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146214847|NCT05382936|527302912|FG003|Overall Study|Progressive Disease|5|||
146214848|NCT05382936|527302909|FG000|Overall Study|Adverse Event|0|||
146214849|NCT05382936|527302910|FG001|Overall Study|Adverse Event|1|||
146214850|NCT05382936|527302911|FG002|Overall Study|Adverse Event|1|||
146214851|NCT05382936|527302912|FG003|Overall Study|Adverse Event|0|||
146214852|NCT05382936|527302909|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146214853|NCT05382936|527302910|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
145959728|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959729|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
145959730|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959731|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
145959732|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145959733|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
145959734|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959735|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959736|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959737|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959738|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959739|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959740|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959741|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959742|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959743|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959744|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959745|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
145959746|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146214854|NCT05382936|527302911|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146084171|NCT00992589|526827949|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146084172|NCT00992589|526827946|FG000|Open-Label Phase|Lost to Follow-up|1|||
145959747|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145959748|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
145959749|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959750|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959751|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959752|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959753|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959754|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959755|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959756|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959757|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959758|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146214855|NCT05382936|527302912|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
146214856|NCT05382936|527302909|FG000|Overall Study|Withdrawal by Subject|0|||
146214857|NCT05382936|527302910|FG001|Overall Study|Withdrawal by Subject|0|||
146214858|NCT05382936|527302911|FG002|Overall Study|Withdrawal by Subject|1|||
146214859|NCT05382936|527302912|FG003|Overall Study|Withdrawal by Subject|1|||
146214860|NCT05063994|527302915|FG000|Cortef Run-In|Withdrawal of Consent|1|||
146214861|NCT05063994|527302916|FG001|Cortef Run-In|Withdrawal of Consent|0|||
146214862|NCT05063994|527302917|FG002|Cortef Run-In|Withdrawal of Consent|0|||
146214863|NCT05063994|527302915|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
146214864|NCT05063994|527302916|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
145959759|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145959760|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
145959761|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145959762|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146214865|NCT05063994|527302917|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
146214866|NCT05063994|527302915|FG000|Treatment|Physician Decision|0|||
146214867|NCT05063994|527302916|FG001|Treatment|Physician Decision|0|||
146287419|NCT00196976|527567431|FG003|Primary Study|Migrated from study area|0|||
146287420|NCT00196976|527567432|FG004|Primary Study|Migrated from study area|0|||
146084173|NCT00992589|526827947|FG001|Open-Label Phase|Lost to Follow-up|0|||
146084174|NCT00992589|526827948|FG002|Open-Label Phase|Lost to Follow-up|0|||
146084175|NCT00992589|526827949|FG003|Open-Label Phase|Lost to Follow-up|0|||
146084176|NCT00992589|526827946|FG000|Open-Label Phase|Protocol Violation|3|||
146084177|NCT00992589|526827947|FG001|Open-Label Phase|Protocol Violation|0|||
146084178|NCT00992589|526827948|FG002|Open-Label Phase|Protocol Violation|0|||
146084179|NCT00992589|526827949|FG003|Open-Label Phase|Protocol Violation|0|||
146084180|NCT00992589|526827946|FG000|Open-Label Phase|Physician Decision|4|||
146084181|NCT00992589|526827947|FG001|Open-Label Phase|Physician Decision|0|||
146084182|NCT00992589|526827948|FG002|Open-Label Phase|Physician Decision|0|||
146084183|NCT00992589|526827949|FG003|Open-Label Phase|Physician Decision|0|||
146084184|NCT00992589|526827946|FG000|Open-Label Phase|Other|45|||
146084185|NCT00992589|526827947|FG001|Open-Label Phase|Other|0|||
146084186|NCT00992589|526827948|FG002|Open-Label Phase|Other|0|||
146084187|NCT00992589|526827949|FG003|Open-Label Phase|Other|0|||
146084188|NCT00992589|526827946|FG000|Double-Blind Phase|Adverse Event|0|||
146084189|NCT00992589|526827947|FG001|Double-Blind Phase|Adverse Event|6|||
146084190|NCT00992589|526827948|FG002|Double-Blind Phase|Adverse Event|2|||
146084191|NCT00992589|526827949|FG003|Double-Blind Phase|Adverse Event|3|||
146084192|NCT00992589|526827946|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146084193|NCT00992589|526827947|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146084194|NCT00992589|526827948|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
146084195|NCT00992589|526827949|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
146214868|NCT05063994|527302917|FG002|Treatment|Physician Decision|1|||
146214869|NCT05063994|527302915|FG000|Treatment|Withdrawal by Subject|0|||
146214870|NCT05063994|527302916|FG001|Treatment|Withdrawal by Subject|0|||
146214871|NCT05063994|527302917|FG002|Treatment|Withdrawal by Subject|1|||
146214872|NCT05063994|527302915|FG000|Treatment|Withdrawal of Consent|0|||
145959763|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145959764|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959765|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959766|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959767|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959768|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959769|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959770|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959771|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959772|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959773|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959774|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959775|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
145959776|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959777|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959778|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145959779|NCT02326272|526363758|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959780|NCT02326272|526363759|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959781|NCT02326272|526363760|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959782|NCT02326272|526363761|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959783|NCT02326272|526363762|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959784|NCT02326272|526363763|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959785|NCT02326272|526363764|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959786|NCT02326272|526363765|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959787|NCT02326272|526363766|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959788|NCT02326272|526363767|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959789|NCT02326272|526363768|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146084196|NCT00992589|526827946|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146084197|NCT00992589|526827947|FG001|Double-Blind Phase|Lost to Follow-up|0|||
146084198|NCT00992589|526827948|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146084199|NCT00992589|526827949|FG003|Double-Blind Phase|Lost to Follow-up|2|||
146084200|NCT00992589|526827946|FG000|Double-Blind Phase|Other|0|||
146084201|NCT00992589|526827947|FG001|Double-Blind Phase|Other|1|||
146084202|NCT00992589|526827948|FG002|Double-Blind Phase|Other|6|||
146084203|NCT00992589|526827949|FG003|Double-Blind Phase|Other|3|||
146084204|NCT00045942|526827950|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
146084205|NCT00045942|526827951|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084206|NCT00045942|526827952|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084207|NCT00045942|526827953|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084208|NCT00045942|526827954|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084209|NCT00045942|526827955|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084210|NCT00045942|526827956|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145959790|NCT02326272|526363769|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
146084211|NCT00045942|526827957|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146084212|NCT00045942|526827958|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
146214873|NCT05063994|527302916|FG001|Treatment|Withdrawal of Consent|0|||
146287421|NCT00196976|527567433|FG005|Primary Study|Migrated from study area|0|||
146287422|NCT00196976|527567434|FG006|Primary Study|Migrated from study area|0|||
146287423|NCT00196976|527567435|FG007|Primary Study|Migrated from study area|1|||
146287424|NCT00196976|527567436|FG008|Primary Study|Migrated from study area|0|||
146287425|NCT00196976|527567437|FG009|Primary Study|Migrated from study area|0|||
146287426|NCT00196976|527567438|FG010|Primary Study|Migrated from study area|0|||
146084213|NCT00045942|526827950|FG000|PKC412A2104 (Core)|Adverse Event|5|||
146084214|NCT00045942|526827951|FG001|PKC412A2104 (Core)|Adverse Event|0|||
146084215|NCT00045942|526827952|FG002|PKC412A2104 (Core)|Adverse Event|0|||
146287427|NCT00196976|527567439|FG011|Primary Study|Migrated from study area|0|||
146287428|NCT00196976|527567440|FG012|Primary Study|Migrated from study area|0|||
146287429|NCT00196976|527567441|FG013|Primary Study|Migrated from study area|0|||
146287430|NCT00196976|527567428|FG000|Primary Study|Protocol Violation|0|||
146287431|NCT00196976|527567429|FG001|Primary Study|Protocol Violation|1|||
145881355|NCT00676650|526072614|FG000|Overall Study|Withdrawal by Subject|48|||
145881356|NCT00676650|526072615|FG001|Overall Study|Withdrawal by Subject|24|||
145881357|NCT00676650|526072614|FG000|Overall Study|Randomized but not treated|3|||
145881358|NCT00676650|526072615|FG001|Overall Study|Randomized but not treated|4|||
145881359|NCT02297841|526072619|FG000|Overall Study|Withdrawal by Subject|1|||
145881360|NCT02297841|526072619|FG000|Overall Study|Protocol Violation|7|||
145881361|NCT05061992|526072620|FG000|Overall Study|Excess bowel movements|1|||
145881362|NCT05061992|526072621|FG001|Overall Study|Excess bowel movements|0|||
146084216|NCT00045942|526827953|FG003|PKC412A2104 (Core)|Adverse Event|0|||
146084217|NCT00045942|526827954|FG004|PKC412A2104 (Core)|Adverse Event|0|||
145881363|NCT05061992|526072620|FG000|Overall Study|Complications of Medical Care|1|||
145881364|NCT05061992|526072621|FG001|Overall Study|Complications of Medical Care|0|||
145881365|NCT05061992|526072620|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
145959791|NCT02326272|526363770|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
145959792|NCT02326272|526363771|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959793|NCT02326272|526363772|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145959794|NCT00735943|526363778|FG000|Overall Study|Lost to Follow-up|1|||
145959795|NCT00735943|526363778|FG000|Overall Study|Adverse Event|1|||
145959796|NCT01265394|526363779|FG000|Overall Study|Subjects withdrawn|37|||
145959797|NCT02185417|526363780|FG000|Overall Study|Death|448|||
145959798|NCT02185417|526363781|FG001|Overall Study|Death|446|||
145959799|NCT02185417|526363782|FG002|Overall Study|Death|0|||
145959800|NCT02185417|526363780|FG000|Overall Study|Withdrawal by Subject|7|||
145959801|NCT02185417|526363781|FG001|Overall Study|Withdrawal by Subject|12|||
145959802|NCT02185417|526363782|FG002|Overall Study|Withdrawal by Subject|0|||
145959803|NCT03131167|526363785|FG000|Overall Study|Other (Unspecified)|0|||
145959804|NCT03131167|526363786|FG001|Overall Study|Other (Unspecified)|0|||
145959805|NCT03131167|526363787|FG002|Overall Study|Other (Unspecified)|0|||
145959806|NCT03131167|526363788|FG003|Overall Study|Other (Unspecified)|0|||
145959807|NCT03131167|526363789|FG004|Overall Study|Other (Unspecified)|0|||
145959808|NCT03131167|526363790|FG005|Overall Study|Other (Unspecified)|1|||
145959809|NCT03131167|526363791|FG006|Overall Study|Other (Unspecified)|0|||
145959810|NCT03131167|526363792|FG007|Overall Study|Other (Unspecified)|0|||
145959811|NCT03131167|526363793|FG008|Overall Study|Other (Unspecified)|0|||
145959812|NCT03131167|526363794|FG009|Overall Study|Other (Unspecified)|0|||
145959813|NCT03131167|526363795|FG010|Overall Study|Other (Unspecified)|0|||
145959814|NCT03131167|526363796|FG011|Overall Study|Other (Unspecified)|0|||
145959815|NCT03131167|526363797|FG012|Overall Study|Other (Unspecified)|0|||
145959816|NCT01781962|526363798|FG000|Overall Study|Other Miscellaneous Reasons|5|||
145959817|NCT03933449|526363799|FG000|Overall Study|Adverse Event|6|||
145959818|NCT03933449|526363800|FG001|Overall Study|Adverse Event|4|||
145959819|NCT03933449|526363799|FG000|Overall Study|Death|55|||
145959820|NCT03933449|526363800|FG001|Overall Study|Death|57|||
145959821|NCT03933449|526363799|FG000|Overall Study|Sponsor Decision|1|||
145959822|NCT03933449|526363800|FG001|Overall Study|Sponsor Decision|0|||
145959823|NCT03075267|526363804|FG000|Overall Study|Protocol Violation|1|||
145959824|NCT03075267|526363805|FG001|Overall Study|Protocol Violation|0|||
145959825|NCT03075267|526363806|FG002|Overall Study|Protocol Violation|0|||
145959826|NCT02168491|526363807|FG000|Overall Study|Withdrawal by Subject|1|||
145959827|NCT00809445|526363808|FG000|1 Month Follow-up|Lost contact|1|||
145959828|NCT00809445|526363809|FG001|1 Month Follow-up|Lost contact|2|||
145959829|NCT00809445|526363810|FG002|1 Month Follow-up|Lost contact|1|||
145959830|NCT00809445|526363808|FG000|1 Month Follow-up|Withdrew consent|1|||
145959831|NCT00809445|526363809|FG001|1 Month Follow-up|Withdrew consent|1|||
145959832|NCT00809445|526363810|FG002|1 Month Follow-up|Withdrew consent|1|||
145959833|NCT00809445|526363808|FG000|1 Month Follow-up|Death|0|||
145959834|NCT00809445|526363809|FG001|1 Month Follow-up|Death|1|||
145959835|NCT00809445|526363810|FG002|1 Month Follow-up|Death|1|||
145959836|NCT00809445|526363808|FG000|1 Month Follow-up|Incarcerated|0|||
145959837|NCT00809445|526363809|FG001|1 Month Follow-up|Incarcerated|0|||
145959838|NCT00809445|526363810|FG002|1 Month Follow-up|Incarcerated|1|||
145959839|NCT00809445|526363808|FG000|6 Month Follow-up|Lost contact|16|||
145959840|NCT00809445|526363809|FG001|6 Month Follow-up|Lost contact|14|||
145959841|NCT00809445|526363810|FG002|6 Month Follow-up|Lost contact|14|||
145959842|NCT00809445|526363808|FG000|6 Month Follow-up|Death|2|||
145959843|NCT00809445|526363809|FG001|6 Month Follow-up|Death|1|||
145959844|NCT00809445|526363810|FG002|6 Month Follow-up|Death|1|||
145959845|NCT00809445|526363808|FG000|6 Month Follow-up|Incarcerated|6|||
145959846|NCT00809445|526363809|FG001|6 Month Follow-up|Incarcerated|8|||
145959847|NCT00809445|526363810|FG002|6 Month Follow-up|Incarcerated|8|||
145959848|NCT00809445|526363808|FG000|6 Month Follow-up|Withdrew consent|0|||
145959849|NCT00809445|526363809|FG001|6 Month Follow-up|Withdrew consent|0|||
145959850|NCT00809445|526363810|FG002|6 Month Follow-up|Withdrew consent|1|||
145959851|NCT01566604|526363812|FG000|Overall Study|Patient's inability to use the device|1|||
145959852|NCT01566604|526363813|FG001|Overall Study|Patient's inability to use the device|0|||
145959853|NCT01566604|526363812|FG000|Overall Study|Administrative problems|1|||
145959854|NCT01566604|526363813|FG001|Overall Study|Administrative problems|0|||
145959855|NCT01566604|526363812|FG000|Overall Study|Lack of Efficacy|1|||
145959856|NCT01566604|526363813|FG001|Overall Study|Lack of Efficacy|2|||
145959857|NCT01566604|526363812|FG000|Overall Study|Protocol deviation|2|||
145959858|NCT01566604|526363813|FG001|Overall Study|Protocol deviation|0|||
145959859|NCT01566604|526363812|FG000|Overall Study|Abnormal laboratory value|2|||
145959860|NCT01566604|526363813|FG001|Overall Study|Abnormal laboratory value|0|||
145959861|NCT01566604|526363812|FG000|Overall Study|Death|4|||
145959862|NCT01566604|526363813|FG001|Overall Study|Death|1|||
145959863|NCT01566604|526363812|FG000|Overall Study|Adverse Event|4|||
145959864|NCT01566604|526363813|FG001|Overall Study|Adverse Event|2|||
145959865|NCT01566604|526363812|FG000|Overall Study|Withdrawal by Subject|9|||
145959866|NCT01566604|526363813|FG001|Overall Study|Withdrawal by Subject|6|||
145959867|NCT00705757|526363814|FG000|Overall Study|Lack of Efficacy|5|||
145959868|NCT00705757|526363815|FG001|Overall Study|Lack of Efficacy|1|||
145959869|NCT00705757|526363816|FG002|Overall Study|Lack of Efficacy|3|||
145959870|NCT00705757|526363814|FG000|Overall Study|Lost to Follow-up|7|||
145959871|NCT00705757|526363815|FG001|Overall Study|Lost to Follow-up|6|||
145959872|NCT00705757|526363816|FG002|Overall Study|Lost to Follow-up|6|||
145959873|NCT00705757|526363814|FG000|Overall Study|Withdrawal by Subject|1|||
145959874|NCT00705757|526363815|FG001|Overall Study|Withdrawal by Subject|1|||
145959875|NCT00705757|526363816|FG002|Overall Study|Withdrawal by Subject|2|||
145959876|NCT00661089|526363817|FG000|Overall Study|1 subject withdrawal|0|||
145959877|NCT00661089|526363818|FG001|Overall Study|1 subject withdrawal|1|||
145959878|NCT00661089|526363817|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
145959879|NCT00661089|526363818|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
145959880|NCT01443858|526363825|FG000|Overall Study|Withdrawal by Subject|9|||
145959881|NCT01443858|526363826|FG001|Overall Study|Withdrawal by Subject|8|||
145959882|NCT01443858|526363827|FG002|Overall Study|Withdrawal by Subject|5|||
145959883|NCT01443858|526363825|FG000|Overall Study|Lack of Efficacy|1|||
145959884|NCT01443858|526363826|FG001|Overall Study|Lack of Efficacy|0|||
145959885|NCT01443858|526363827|FG002|Overall Study|Lack of Efficacy|0|||
145959886|NCT01443858|526363825|FG000|Overall Study|Lost to Follow-up|5|||
145959887|NCT01443858|526363826|FG001|Overall Study|Lost to Follow-up|5|||
145959888|NCT01443858|526363827|FG002|Overall Study|Lost to Follow-up|2|||
145959889|NCT03361306|526363831|FG000|Overall Study|Death|6|||
145959890|NCT01272908|526363833|FG000|Initial Treatment Period|Adverse Event|1|||
145959891|NCT01272908|526363833|FG000|Initial Treatment Period|Lack of Efficacy|5|||
145959892|NCT01272908|526363833|FG000|Initial Treatment Period|Protocol Violation|1|||
145959893|NCT01272908|526363833|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
145959894|NCT01272908|526363833|FG000|Re-Treatment Period|Adverse Event|2|||
145959895|NCT01272908|526363833|FG000|Re-Treatment Period|Lack of Efficacy|3|||
145959896|NCT01272908|526363833|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
145959897|NCT02221648|526363834|FG000|Overall Study|Withdrawal by Subject|3|||
145959898|NCT02221648|526363835|FG001|Overall Study|Withdrawal by Subject|3|||
145959899|NCT00149396|526363836|FG000|Overall Study|Death|15|||
145959900|NCT00149396|526363836|FG000|Overall Study|Withdrawal by Subject|1|||
145959901|NCT00149396|526363836|FG000|Overall Study|Subject noncompliance|2|||
145959902|NCT00149396|526363836|FG000|Overall Study|other treatment|5|||
145959903|NCT00807885|526363837|FG000|Overall Study|Lost to Follow-up|0|||
145959904|NCT00807885|526363838|FG001|Overall Study|Lost to Follow-up|0|||
145959905|NCT00807885|526363839|FG002|Overall Study|Lost to Follow-up|0|||
145959906|NCT00807885|526363840|FG003|Overall Study|Lost to Follow-up|0|||
145959907|NCT00807885|526363841|FG004|Overall Study|Lost to Follow-up|0|||
145959908|NCT00807885|526363842|FG005|Overall Study|Lost to Follow-up|1|||
145959909|NCT00807885|526363843|FG006|Overall Study|Lost to Follow-up|0|||
145959910|NCT00807885|526363844|FG007|Overall Study|Lost to Follow-up|0|||
145959911|NCT00807885|526363845|FG008|Overall Study|Lost to Follow-up|0|||
145959912|NCT00810069|526363846|FG000|Lead-in Period I|Adverse Event|43|||
145959913|NCT00810069|526363847|FG001|Lead-in Period I|Adverse Event|0|||
145959914|NCT00810069|526363848|FG002|Lead-in Period I|Adverse Event|0|||
145959915|NCT00810069|526363846|FG000|Lead-in Period I|Lack of Efficacy|1|||
145959916|NCT00810069|526363847|FG001|Lead-in Period I|Lack of Efficacy|0|||
145959917|NCT00810069|526363848|FG002|Lead-in Period I|Lack of Efficacy|0|||
145959918|NCT00810069|526363846|FG000|Lead-in Period I|Lost to Follow-up|19|||
145959919|NCT00810069|526363847|FG001|Lead-in Period I|Lost to Follow-up|0|||
145959920|NCT00810069|526363848|FG002|Lead-in Period I|Lost to Follow-up|0|||
145959921|NCT00810069|526363846|FG000|Lead-in Period I|Physician Decision|1|||
145959922|NCT00810069|526363847|FG001|Lead-in Period I|Physician Decision|0|||
145959923|NCT00810069|526363848|FG002|Lead-in Period I|Physician Decision|0|||
145959924|NCT00810069|526363846|FG000|Lead-in Period I|Protocol Violation|1|||
145959925|NCT00810069|526363847|FG001|Lead-in Period I|Protocol Violation|0|||
145959926|NCT00810069|526363848|FG002|Lead-in Period I|Protocol Violation|0|||
145959927|NCT00810069|526363846|FG000|Lead-in Period I|Withdrawal by Subject|46|||
145959928|NCT00810069|526363847|FG001|Lead-in Period I|Withdrawal by Subject|0|||
145959929|NCT00810069|526363848|FG002|Lead-in Period I|Withdrawal by Subject|0|||
145959930|NCT00810069|526363846|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
145959931|NCT00810069|526363847|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
145959932|NCT00810069|526363848|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
145959933|NCT00810069|526363846|FG000|Lead-in Period I|Randomization criteria not met|158|||
145959934|NCT00810069|526363847|FG001|Lead-in Period I|Randomization criteria not met|0|||
145959935|NCT00810069|526363848|FG002|Lead-in Period I|Randomization criteria not met|0|||
145959936|NCT00810069|526363846|FG000|Double-Blind Period II|Adverse Event|0|||
145959937|NCT00810069|526363847|FG001|Double-Blind Period II|Adverse Event|9|||
145959938|NCT00810069|526363848|FG002|Double-Blind Period II|Adverse Event|8|||
145959939|NCT00810069|526363846|FG000|Double-Blind Period II|Lack of Efficacy|0|||
145959940|NCT00810069|526363847|FG001|Double-Blind Period II|Lack of Efficacy|7|||
145959941|NCT00810069|526363848|FG002|Double-Blind Period II|Lack of Efficacy|12|||
145959942|NCT00810069|526363846|FG000|Double-Blind Period II|Lost to Follow-up|0|||
145959943|NCT00810069|526363847|FG001|Double-Blind Period II|Lost to Follow-up|9|||
145959944|NCT00810069|526363848|FG002|Double-Blind Period II|Lost to Follow-up|9|||
145959945|NCT00810069|526363846|FG000|Double-Blind Period II|Physician Decision|0|||
145959946|NCT00810069|526363847|FG001|Double-Blind Period II|Physician Decision|0|||
145959947|NCT00810069|526363848|FG002|Double-Blind Period II|Physician Decision|1|||
145959948|NCT00810069|526363846|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
145959949|NCT00810069|526363847|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
145959950|NCT00810069|526363848|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
145959951|NCT00810069|526363846|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
145959952|NCT00810069|526363847|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
145959953|NCT00810069|526363848|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
145959954|NCT00810069|526363846|FG000|Double-Blind Period II|Clinical relapse|0|||
145959955|NCT00810069|526363847|FG001|Double-Blind Period II|Clinical relapse|3|||
145959956|NCT00810069|526363848|FG002|Double-Blind Period II|Clinical relapse|0|||
145959957|NCT00810069|526363846|FG000|Double-Blind Period II|Protocol Violation|0|||
145959958|NCT00810069|526363847|FG001|Double-Blind Period II|Protocol Violation|7|||
145959959|NCT00810069|526363848|FG002|Double-Blind Period II|Protocol Violation|6|||
145959960|NCT01951417|526363849|FG000|Overall Study|Withdrawal by Subject|1|||
145959961|NCT01951417|526363849|FG000|Overall Study|Protocol Violation|2|||
145959962|NCT01951417|526363849|FG000|Overall Study|Lost to Follow-up|6|||
145959963|NCT00977613|526363850|FG000|Overall Study|Lost to Follow-up|16|||
145959964|NCT01598610|526363853|FG000|Overall Study|Adverse Event|1|||
145959965|NCT02039778|526363856|FG000|Overall Study|Death|2|||
145959966|NCT02039778|526363856|FG000|Overall Study|Withdrawal by Subject|1|||
145959967|NCT02039778|526363856|FG000|Overall Study|Never started the protocol treatment|1|||
145959968|NCT00325819|526363859|FG000|Overall Study|Study product lost in mail|2|||
145959969|NCT00325819|526363860|FG001|Overall Study|Study product lost in mail|1|||
145959970|NCT00325819|526363859|FG000|Overall Study|Did not take a dose of study product|4|||
145959971|NCT00325819|526363860|FG001|Overall Study|Did not take a dose of study product|9|||
145959972|NCT00325819|526363859|FG000|Overall Study|Lost to Follow-up|3|||
145959973|NCT00325819|526363860|FG001|Overall Study|Lost to Follow-up|3|||
145959974|NCT01716806|526365322|FG000|Overall Study|Patient withdrawal of consent|4|||
145959975|NCT01716806|526365323|FG001|Overall Study|Patient withdrawal of consent|2|||
145959976|NCT01716806|526365324|FG002|Overall Study|Patient withdrawal of consent|4|||
145959977|NCT01716806|526365325|FG003|Overall Study|Patient withdrawal of consent|3|||
145959978|NCT01716806|526365326|FG004|Overall Study|Patient withdrawal of consent|2|||
145959979|NCT01716806|526365327|FG005|Overall Study|Patient withdrawal of consent|0|||
145959980|NCT01716806|526365322|FG000|Overall Study|Lost to Follow-up|3|||
145959981|NCT01716806|526365323|FG001|Overall Study|Lost to Follow-up|3|||
145959982|NCT01716806|526365324|FG002|Overall Study|Lost to Follow-up|0|||
145959983|NCT01716806|526365325|FG003|Overall Study|Lost to Follow-up|2|||
145959984|NCT01716806|526365326|FG004|Overall Study|Lost to Follow-up|1|||
145959985|NCT01716806|526365327|FG005|Overall Study|Lost to Follow-up|0|||
146084218|NCT00045942|526827955|FG005|PKC412A2104 (Core)|Adverse Event|0|||
145959986|NCT01716806|526365322|FG000|Overall Study|Death|13|||
145959987|NCT01716806|526365323|FG001|Overall Study|Death|9|||
145959988|NCT01716806|526365324|FG002|Overall Study|Death|12|||
145959989|NCT01716806|526365325|FG003|Overall Study|Death|4|||
145959990|NCT01716806|526365326|FG004|Overall Study|Death|10|||
145959991|NCT01716806|526365327|FG005|Overall Study|Death|5|||
145959992|NCT01716806|526365322|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145959993|NCT01716806|526365323|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145959994|NCT01716806|526365324|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145959995|NCT01716806|526365325|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145959996|NCT01716806|526365326|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
145959997|NCT01716806|526365327|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
146084219|NCT00045942|526827956|FG006|PKC412A2104 (Core)|Adverse Event|0|||
146084220|NCT00045942|526827957|FG007|PKC412A2104 (Core)|Adverse Event|0|||
146084221|NCT00045942|526827958|FG008|PKC412A2104 (Core)|Adverse Event|0|||
146084222|NCT00045942|526827950|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
146084223|NCT00045942|526827951|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084224|NCT00045942|526827952|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084225|NCT00045942|526827953|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084226|NCT00045942|526827954|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084227|NCT00045942|526827955|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
145959998|NCT01716806|526365322|FG000|Overall Study|PI decision|0|||
145959999|NCT01716806|526365323|FG001|Overall Study|PI decision|0|||
146084228|NCT00045942|526827956|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084229|NCT00045942|526827957|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
145960000|NCT01716806|526365324|FG002|Overall Study|PI decision|0|||
145960001|NCT01716806|526365325|FG003|Overall Study|PI decision|0|||
145960002|NCT01716806|526365326|FG004|Overall Study|PI decision|1|||
145960003|NCT01716806|526365327|FG005|Overall Study|PI decision|0|||
145960004|NCT01716806|526365322|FG000|Overall Study|Change in performance status|1|||
145960005|NCT01716806|526365323|FG001|Overall Study|Change in performance status|0|||
145960006|NCT01716806|526365324|FG002|Overall Study|Change in performance status|0|||
145960007|NCT01716806|526365325|FG003|Overall Study|Change in performance status|0|||
145960008|NCT01716806|526365326|FG004|Overall Study|Change in performance status|0|||
145960009|NCT01716806|526365327|FG005|Overall Study|Change in performance status|0|||
145960010|NCT01716806|526365322|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
145960011|NCT01716806|526365323|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
145960012|NCT01716806|526365324|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
145960013|NCT01716806|526365325|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
145960014|NCT01716806|526365326|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
145960015|NCT01716806|526365327|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
145960016|NCT01716806|526365322|FG000|Overall Study|Sponsor direction|7|||
145960017|NCT01716806|526365323|FG001|Overall Study|Sponsor direction|8|||
145960018|NCT01716806|526365324|FG002|Overall Study|Sponsor direction|5|||
145960019|NCT01716806|526365325|FG003|Overall Study|Sponsor direction|12|||
145960020|NCT01716806|526365326|FG004|Overall Study|Sponsor direction|16|||
145960021|NCT01716806|526365327|FG005|Overall Study|Sponsor direction|1|||
145960022|NCT02692586|526365328|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
145960023|NCT02692586|526365328|FG000|Overall Study|Received adjunctive thrombolytics|2|||
145960024|NCT03506438|526365332|FG000|Overall Study|Lost to Follow-up|8|||
145960025|NCT03506438|526365333|FG001|Overall Study|Lost to Follow-up|7|||
145960026|NCT03506438|526365334|FG002|Overall Study|Lost to Follow-up|8|||
145960027|NCT03506438|526365335|FG003|Overall Study|Lost to Follow-up|7|||
145960028|NCT03506438|526365336|FG004|Overall Study|Lost to Follow-up|0|||
145960029|NCT03506438|526365337|FG005|Overall Study|Lost to Follow-up|0|||
145960030|NCT03934216|526365342|FG000|Overall Study|Other Reasons|5|||
145960031|NCT03934216|526365343|FG001|Overall Study|Other Reasons|5|||
145960032|NCT03934216|526365342|FG000|Overall Study|Adverse Event|22|||
145960033|NCT03934216|526365343|FG001|Overall Study|Adverse Event|11|||
145960034|NCT03934216|526365342|FG000|Overall Study|Lack of Efficacy|8|||
145960035|NCT03934216|526365343|FG001|Overall Study|Lack of Efficacy|7|||
145960036|NCT03934216|526365342|FG000|Overall Study|Lost to Follow-up|2|||
145960037|NCT03934216|526365343|FG001|Overall Study|Lost to Follow-up|0|||
145960038|NCT03934216|526365342|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145960039|NCT03934216|526365343|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145960040|NCT03934216|526365342|FG000|Overall Study|Pregnancy|1|||
145960041|NCT03934216|526365343|FG001|Overall Study|Pregnancy|0|||
145960042|NCT03934216|526365342|FG000|Overall Study|Withdrawal by Subject|18|||
145960043|NCT03934216|526365343|FG001|Overall Study|Withdrawal by Subject|6|||
145960044|NCT03934216|526365342|FG000|Overall Study|Randomized but not treated|1|||
145960045|NCT03934216|526365343|FG001|Overall Study|Randomized but not treated|1|||
145960046|NCT01053741|526365344|FG000|2nd Study Intervention|Physician Decision|0|||
145960047|NCT01053741|526365345|FG001|2nd Study Intervention|Physician Decision|1|||
145960048|NCT00619827|526365346|FG000|Overall Study|Adverse Event|1|||
145960049|NCT00619827|526365347|FG001|Overall Study|Adverse Event|2|||
145960050|NCT00619827|526365346|FG000|Overall Study|Withdrawal by Subject|2|||
145960051|NCT00619827|526365347|FG001|Overall Study|Withdrawal by Subject|2|||
145960052|NCT01396083|526365348|FG000|Overall Study|Adverse Event|2|||
145960053|NCT01396083|526365349|FG001|Overall Study|Adverse Event|28|||
145960054|NCT01396083|526365348|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146214874|NCT05063994|527302917|FG002|Treatment|Withdrawal of Consent|1|||
145960055|NCT01396083|526365349|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145960056|NCT01396083|526365348|FG000|Overall Study|Consent withdrawn|4|||
145960057|NCT01396083|526365349|FG001|Overall Study|Consent withdrawn|5|||
145960058|NCT01396083|526365348|FG000|Overall Study|Protocol deviation(s)|0|||
145960059|NCT01396083|526365349|FG001|Overall Study|Protocol deviation(s)|1|||
145960060|NCT01396083|526365348|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145960061|NCT01396083|526365349|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145960062|NCT01396083|526365348|FG000|Overall Study|Administrative problems|1|||
145960063|NCT01396083|526365349|FG001|Overall Study|Administrative problems|0|||
145960064|NCT01396083|526365348|FG000|Overall Study|Lost to Follow-up|1|||
145960065|NCT01396083|526365349|FG001|Overall Study|Lost to Follow-up|0|||
145960066|NCT02806713|526365350|FG000|Overall Study|Urethral injury during procedure|1|||
145960067|NCT02806713|526365351|FG001|Overall Study|Urethral injury during procedure|0|||
145960068|NCT02806713|526365350|FG000|Overall Study|cancelled surgery|1|||
145960069|NCT02806713|526365351|FG001|Overall Study|cancelled surgery|2|||
145960070|NCT00735709|526365352|FG000|Overall Study|Adverse Event|2|||
145960071|NCT00735709|526365353|FG001|Overall Study|Adverse Event|3|||
145960072|NCT00735709|526365354|FG002|Overall Study|Adverse Event|1|||
145960073|NCT00735709|526365355|FG003|Overall Study|Adverse Event|5|||
145960074|NCT00735709|526365352|FG000|Overall Study|Lack of Efficacy|8|||
145960075|NCT00735709|526365353|FG001|Overall Study|Lack of Efficacy|4|||
145960076|NCT00735709|526365354|FG002|Overall Study|Lack of Efficacy|2|||
145960077|NCT00735709|526365355|FG003|Overall Study|Lack of Efficacy|3|||
145960078|NCT00735709|526365352|FG000|Overall Study|Noncompliance|0|||
145960079|NCT00735709|526365353|FG001|Overall Study|Noncompliance|0|||
145960080|NCT00735709|526365354|FG002|Overall Study|Noncompliance|1|||
145960081|NCT00735709|526365355|FG003|Overall Study|Noncompliance|0|||
145960082|NCT00735709|526365352|FG000|Overall Study|Protocol deviations|1|||
145960083|NCT00735709|526365353|FG001|Overall Study|Protocol deviations|2|||
145960084|NCT00735709|526365354|FG002|Overall Study|Protocol deviations|1|||
145960085|NCT00735709|526365355|FG003|Overall Study|Protocol deviations|1|||
145960086|NCT00735709|526365352|FG000|Overall Study|Voluntary Withdrawal|1|||
145960087|NCT00735709|526365353|FG001|Overall Study|Voluntary Withdrawal|3|||
145960088|NCT00735709|526365354|FG002|Overall Study|Voluntary Withdrawal|5|||
145960089|NCT00735709|526365355|FG003|Overall Study|Voluntary Withdrawal|7|||
145960090|NCT00735709|526365352|FG000|Overall Study|Lost to Follow-up|0|||
145960091|NCT00735709|526365353|FG001|Overall Study|Lost to Follow-up|1|||
145960092|NCT00735709|526365354|FG002|Overall Study|Lost to Follow-up|1|||
145960093|NCT00735709|526365355|FG003|Overall Study|Lost to Follow-up|1|||
145960094|NCT00735709|526365352|FG000|Overall Study|Excluded medication|1|||
145960095|NCT00735709|526365353|FG001|Overall Study|Excluded medication|0|||
145960096|NCT00735709|526365354|FG002|Overall Study|Excluded medication|0|||
145960097|NCT00735709|526365355|FG003|Overall Study|Excluded medication|1|||
145960098|NCT00521365|526365375|FG000|Overall Study|Adverse Event|3|||
145960099|NCT00521365|526365375|FG000|Overall Study|Lost to Follow-up|6|||
145960100|NCT00521365|526365375|FG000|Overall Study|Protocol deviation|2|||
145960101|NCT00521365|526365375|FG000|Overall Study|Drug compliance|3|||
145960102|NCT00521365|526365375|FG000|Overall Study|Usage of not allowed drugs|6|||
145960103|NCT03150082|526365376|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
145960104|NCT03150082|526365377|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
145960105|NCT02119299|526365378|FG000|Overall Study|Withdrawal by Subject|7|||
145960106|NCT02119299|526365378|FG000|Overall Study|Lack of Efficacy|1|||
145960107|NCT02119299|526365378|FG000|Overall Study|Pregnancy|1|||
145960108|NCT00115778|526365380|FG000|Overall Study|Withdrawal by Subject|0|||
145960109|NCT00115778|526365381|FG001|Overall Study|Withdrawal by Subject|1|||
145960110|NCT00249873|526365384|FG000|Overall Study|Not treated|7|||
145960111|NCT00249873|526365385|FG001|Overall Study|Not treated|8|||
145960112|NCT00249873|526365384|FG000|Overall Study|Significant thrombocytopenia|9|||
145960113|NCT00249873|526365385|FG001|Overall Study|Significant thrombocytopenia|8|||
145960114|NCT00249873|526365384|FG000|Overall Study|Severe allergic reaction|8|||
145960115|NCT00249873|526365385|FG001|Overall Study|Severe allergic reaction|1|||
145960116|NCT00249873|526365384|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
145960117|NCT00249873|526365385|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
145960118|NCT00249873|526365384|FG000|Overall Study|Other Serious Adverse Event|86|||
145960119|NCT00249873|526365385|FG001|Overall Study|Other Serious Adverse Event|97|||
145960120|NCT00249873|526365384|FG000|Overall Study|Qualifying condition not present|20|||
145960121|NCT00249873|526365385|FG001|Overall Study|Qualifying condition not present|23|||
146287432|NCT00196976|527567430|FG002|Primary Study|Protocol Violation|1|||
146287433|NCT00196976|527567431|FG003|Primary Study|Protocol Violation|0|||
146287434|NCT00196976|527567432|FG004|Primary Study|Protocol Violation|0|||
146287435|NCT00196976|527567433|FG005|Primary Study|Protocol Violation|0|||
146287436|NCT00196976|527567434|FG006|Primary Study|Protocol Violation|0|||
146287437|NCT00196976|527567435|FG007|Primary Study|Protocol Violation|0|||
146287438|NCT00196976|527567436|FG008|Primary Study|Protocol Violation|0|||
146287439|NCT00196976|527567437|FG009|Primary Study|Protocol Violation|0|||
146287440|NCT00196976|527567438|FG010|Primary Study|Protocol Violation|0|||
146287441|NCT00196976|527567439|FG011|Primary Study|Protocol Violation|0|||
146287442|NCT00196976|527567440|FG012|Primary Study|Protocol Violation|0|||
146287443|NCT00196976|527567441|FG013|Primary Study|Protocol Violation|0|||
145960122|NCT00249873|526365384|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
145960123|NCT00249873|526365385|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
145960124|NCT00249873|526365384|FG000|Overall Study|Withdrawal by Subject|504|||
146287444|NCT00196976|527567428|FG000|Primary Study|Withdrawal by Subject|1|||
146287445|NCT00196976|527567429|FG001|Primary Study|Withdrawal by Subject|0|||
146287446|NCT00196976|527567430|FG002|Primary Study|Withdrawal by Subject|1|||
146287447|NCT00196976|527567431|FG003|Primary Study|Withdrawal by Subject|1|||
146287448|NCT00196976|527567432|FG004|Primary Study|Withdrawal by Subject|2|||
146287449|NCT00196976|527567433|FG005|Primary Study|Withdrawal by Subject|1|||
146287450|NCT00196976|527567434|FG006|Primary Study|Withdrawal by Subject|0|||
145960125|NCT00249873|526365385|FG001|Overall Study|Withdrawal by Subject|466|||
145960126|NCT00249873|526365384|FG000|Overall Study|Lost to Follow-up|4|||
145960127|NCT00249873|526365385|FG001|Overall Study|Lost to Follow-up|7|||
145960128|NCT00249873|526365384|FG000|Overall Study|Minor bleeding|99|||
145960129|NCT00249873|526365385|FG001|Overall Study|Minor bleeding|37|||
145960130|NCT00249873|526365384|FG000|Overall Study|Non-compliance|41|||
145960131|NCT00249873|526365385|FG001|Overall Study|Non-compliance|46|||
145960132|NCT00249873|526365384|FG000|Overall Study|Other non serious Adverse Event|112|||
146214875|NCT03692676|527302920|FG000|Overall Study|exclude patients with prior use|4424|||
146214876|NCT03692676|527302921|FG001|Overall Study|exclude patients with prior use|24726|||
146214877|NCT03692676|527302922|FG002|Overall Study|exclude patients with prior use|0|||
146214878|NCT03692676|527302923|FG003|Overall Study|exclude patients with prior use|0|||
146214879|NCT03692676|527302920|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
146214880|NCT03692676|527302921|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
146214881|NCT03692676|527302922|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
146214882|NCT03692676|527302923|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
146214883|NCT03692676|527302920|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
146214884|NCT03692676|527302921|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
146214885|NCT03692676|527302922|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
146214886|NCT03692676|527302923|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
146214887|NCT03692676|527302920|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
146214888|NCT03692676|527302921|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
146214889|NCT03692676|527302922|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
146214890|NCT03692676|527302923|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
146214891|NCT03692676|527302920|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
146214892|NCT03692676|527302921|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
146214893|NCT03692676|527302922|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
146214894|NCT03692676|527302923|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
146214895|NCT03692676|527302920|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
146214896|NCT03692676|527302921|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
145960133|NCT00249873|526365385|FG001|Overall Study|Other non serious Adverse Event|108|||
146287451|NCT00196976|527567435|FG007|Primary Study|Withdrawal by Subject|0|||
146287452|NCT00196976|527567436|FG008|Primary Study|Withdrawal by Subject|0|||
146287453|NCT00196976|527567437|FG009|Primary Study|Withdrawal by Subject|1|||
146287454|NCT00196976|527567438|FG010|Primary Study|Withdrawal by Subject|0|||
146287455|NCT00196976|527567439|FG011|Primary Study|Withdrawal by Subject|0|||
145960134|NCT00249873|526365384|FG000|Overall Study|Other contraindicated medication|1|||
146214897|NCT03692676|527302922|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
146214898|NCT03692676|527302923|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
146214899|NCT03692676|527302920|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
146214900|NCT03692676|527302921|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
146214901|NCT03692676|527302922|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
146214902|NCT03692676|527302923|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
146214903|NCT03692676|527302920|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
146214904|NCT03692676|527302921|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
146214905|NCT03692676|527302922|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
146214906|NCT03692676|527302923|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
146214907|NCT03692676|527302920|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
146214908|NCT03692676|527302921|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
146214909|NCT03692676|527302922|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
146214910|NCT03692676|527302923|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
146214911|NCT03692676|527302920|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
146214912|NCT03692676|527302921|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
146214913|NCT03692676|527302922|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
146214914|NCT03692676|527302923|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
146214915|NCT03692676|527302920|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
146214916|NCT03692676|527302921|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
146214917|NCT03692676|527302922|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
145960135|NCT00249873|526365385|FG001|Overall Study|Other contraindicated medication|0|||
145960136|NCT00249873|526365384|FG000|Overall Study|Patient not wish to continue after May08|3|||
146214918|NCT03692676|527302923|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
146214919|NCT03692676|527302920|FG000|Overall Study|Other|0|||
146214920|NCT03692676|527302921|FG001|Overall Study|Other|805|||
146214921|NCT03692676|527302922|FG002|Overall Study|Other|758|||
146214922|NCT03692676|527302923|FG003|Overall Study|Other|277|||
146214923|NCT03692676|527302920|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
146214924|NCT03692676|527302921|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
145960137|NCT00249873|526365385|FG001|Overall Study|Patient not wish to continue after May08|4|||
145960138|NCT00249873|526365384|FG000|Overall Study|Physician withdrew consent|59|||
145960139|NCT00249873|526365385|FG001|Overall Study|Physician withdrew consent|60|||
145960140|NCT00249873|526365384|FG000|Overall Study|Open label clopidogrel required|31|||
145960141|NCT00249873|526365385|FG001|Overall Study|Open label clopidogrel required|42|||
145960142|NCT00249873|526365384|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
145960143|NCT00249873|526365385|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
145960144|NCT00249873|526365384|FG000|Overall Study|Oral anticoagulant required|159|||
145960145|NCT00249873|526365385|FG001|Overall Study|Oral anticoagulant required|157|||
145960146|NCT00249873|526365384|FG000|Overall Study|Study drug intolerance|5|||
145960147|NCT00249873|526365385|FG001|Overall Study|Study drug intolerance|0|||
145960148|NCT00249873|526365384|FG000|Overall Study|Surgery/ procedure|9|||
145960149|NCT00249873|526365385|FG001|Overall Study|Surgery/ procedure|9|||
145960150|NCT00249873|526365384|FG000|Overall Study|Event related to cardiac condition|12|||
145960151|NCT00249873|526365385|FG001|Overall Study|Event related to cardiac condition|21|||
145960152|NCT00249873|526365384|FG000|Overall Study|Thromboembolic/outcome event|82|||
145960153|NCT00249873|526365385|FG001|Overall Study|Thromboembolic/outcome event|122|||
145960154|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Death|20|||
145960155|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Death|26|||
145960156|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
145960157|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
145960158|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
145960159|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
145960160|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
145960161|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
145960162|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
145960163|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
145960164|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
146214925|NCT03692676|527302922|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
146214926|NCT03692676|527302923|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
146214927|NCT00616967|527302924|FG000|Overall Study|Withdrawal by Subject|0|||
146214928|NCT00616967|527302925|FG001|Overall Study|Withdrawal by Subject|0|||
145881366|NCT05061992|526072621|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
145881367|NCT05061992|526072620|FG000|Overall Study|Withdrawal by Subject|0|||
145881368|NCT05061992|526072621|FG001|Overall Study|Withdrawal by Subject|1|||
145881369|NCT02459418|526072622|FG000|Overall Study|Exclusion Criteria|4|||
145881370|NCT02459418|526072623|FG001|Overall Study|Exclusion Criteria|0|||
145881371|NCT02459418|526072622|FG000|Overall Study|Protocol Violation|0|||
145881372|NCT02459418|526072623|FG001|Overall Study|Protocol Violation|2|||
145881373|NCT02459418|526072622|FG000|Overall Study|Physician Decision|0|||
145881374|NCT02459418|526072623|FG001|Overall Study|Physician Decision|2|||
145881375|NCT02459418|526072622|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
145881376|NCT02459418|526072623|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
145881377|NCT02459418|526072622|FG000|Overall Study|Adverse Event|0|||
145881378|NCT02459418|526072623|FG001|Overall Study|Adverse Event|1|||
145881379|NCT02459418|526072622|FG000|Overall Study|Withdrawal by Subject|1|||
145881380|NCT02459418|526072623|FG001|Overall Study|Withdrawal by Subject|1|||
145881381|NCT02459418|526072622|FG000|Overall Study|Elevated Creatine Kinase|1|||
145881382|NCT02459418|526072623|FG001|Overall Study|Elevated Creatine Kinase|0|||
145881383|NCT02459418|526072622|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
145881384|NCT02459418|526072623|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
145881385|NCT00653159|526072624|FG000|Overall Study|Adverse Event|4|||
145881386|NCT00653159|526072625|FG001|Overall Study|Adverse Event|1|||
145881387|NCT00653159|526072624|FG000|Overall Study|Lost to Follow-up|1|||
145881388|NCT00653159|526072625|FG001|Overall Study|Lost to Follow-up|2|||
145881389|NCT01872715|526072626|FG000|Overall Study|Adverse Event|1|||
146214929|NCT00616967|527302926|FG002|Overall Study|Withdrawal by Subject|1|||
146214930|NCT02910583|527302927|FG000|Overall Study|Death|7|||
146214931|NCT02910583|527302928|FG001|Overall Study|Death|3|||
145881390|NCT01872715|526072626|FG000|Overall Study|Protocol Violation|1|||
145881391|NCT01872715|526072626|FG000|Overall Study|Withdrawal by Subject|2|||
145881392|NCT00683592|526072627|FG000|Overall Study|Adverse Event|12|||
145881393|NCT00683592|526072628|FG001|Overall Study|Adverse Event|4|||
145881394|NCT00683592|526072627|FG000|Overall Study|Withdrawal by Subject|11|||
146287456|NCT00196976|527567440|FG012|Primary Study|Withdrawal by Subject|0|||
146287457|NCT00196976|527567441|FG013|Primary Study|Withdrawal by Subject|0|||
146287458|NCT00196976|527567428|FG000|Primary Study|Lost to Follow-up|0|||
146287459|NCT00196976|527567429|FG001|Primary Study|Lost to Follow-up|0|||
146287460|NCT00196976|527567430|FG002|Primary Study|Lost to Follow-up|0|||
146287461|NCT00196976|527567431|FG003|Primary Study|Lost to Follow-up|0|||
146287462|NCT00196976|527567432|FG004|Primary Study|Lost to Follow-up|1|||
146287463|NCT00196976|527567433|FG005|Primary Study|Lost to Follow-up|1|||
146287464|NCT00196976|527567434|FG006|Primary Study|Lost to Follow-up|0|||
146287465|NCT00196976|527567435|FG007|Primary Study|Lost to Follow-up|2|||
146287466|NCT00196976|527567436|FG008|Primary Study|Lost to Follow-up|0|||
146287467|NCT00196976|527567437|FG009|Primary Study|Lost to Follow-up|0|||
145960165|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
146214932|NCT02910583|527302927|FG000|Overall Study|Lost to Follow-up|1|||
146214933|NCT02910583|527302928|FG001|Overall Study|Lost to Follow-up|0|||
146214934|NCT02910583|527302927|FG000|Overall Study|Withdrawal by Subject|12|||
146214935|NCT02910583|527302928|FG001|Overall Study|Withdrawal by Subject|8|||
146214936|NCT02910583|527302927|FG000|Overall Study|Other, Not Specified|6|||
146214937|NCT02910583|527302928|FG001|Overall Study|Other, Not Specified|3|||
146214938|NCT04263311|527302929|FG000|Overall Study|Lost to Follow-up|1|||
146214939|NCT04263311|527302930|FG001|Overall Study|Lost to Follow-up|2|||
146214940|NCT04263311|527302931|FG002|Overall Study|Lost to Follow-up|0|||
146214941|NCT04263311|527302929|FG000|Overall Study|Health Issues|1|||
146214942|NCT04263311|527302930|FG001|Overall Study|Health Issues|0|||
146214943|NCT04263311|527302931|FG002|Overall Study|Health Issues|0|||
146214944|NCT04263311|527302929|FG000|Overall Study|Left the country|1|||
146214945|NCT04263311|527302930|FG001|Overall Study|Left the country|0|||
145960166|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
146214946|NCT04263311|527302931|FG002|Overall Study|Left the country|0|||
146214947|NCT04263311|527302929|FG000|Overall Study|Unable to maintain time commitment|1|||
146287468|NCT00196976|527567438|FG010|Primary Study|Lost to Follow-up|0|||
146287469|NCT00196976|527567439|FG011|Primary Study|Lost to Follow-up|0|||
146287470|NCT00196976|527567440|FG012|Primary Study|Lost to Follow-up|0|||
146287471|NCT00196976|527567441|FG013|Primary Study|Lost to Follow-up|0|||
146287472|NCT00196976|527567428|FG000|Primary Study|Other|0|||
146287473|NCT00196976|527567429|FG001|Primary Study|Other|0|||
145960167|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
145960168|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
145960169|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
145960170|NCT00643201|526365388|FG000|Randomized, Completed 6 Months of Study|Other|107|||
145960171|NCT00643201|526365389|FG001|Randomized, Completed 6 Months of Study|Other|107|||
145960172|NCT00643201|526365388|FG000|Completed Study Follow Up|Death|28|||
145960173|NCT00643201|526365389|FG001|Completed Study Follow Up|Death|34|||
145960174|NCT00643201|526365388|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
145960175|NCT00643201|526365389|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
145960176|NCT00643201|526365388|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
145960177|NCT00643201|526365389|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
145960178|NCT00643201|526365388|FG000|Completed Study Follow Up|non-specified|1|||
145960179|NCT00643201|526365389|FG001|Completed Study Follow Up|non-specified|0|||
145960180|NCT00274742|526365396|FG000|Overall Study|Adverse Event|0|||
145960181|NCT00274742|526365397|FG001|Overall Study|Adverse Event|4|||
145960182|NCT00274742|526365398|FG002|Overall Study|Adverse Event|1|||
145960183|NCT00274742|526365399|FG003|Overall Study|Adverse Event|4|||
145960184|NCT00274742|526365400|FG004|Overall Study|Adverse Event|12|||
145960185|NCT00274742|526365401|FG005|Overall Study|Adverse Event|3|||
145960186|NCT00274742|526365396|FG000|Overall Study|Lost to Follow-up|0|||
145960187|NCT00274742|526365397|FG001|Overall Study|Lost to Follow-up|0|||
145960188|NCT00274742|526365398|FG002|Overall Study|Lost to Follow-up|0|||
145960189|NCT00274742|526365399|FG003|Overall Study|Lost to Follow-up|0|||
145960190|NCT00274742|526365400|FG004|Overall Study|Lost to Follow-up|1|||
145960191|NCT00274742|526365401|FG005|Overall Study|Lost to Follow-up|0|||
145960192|NCT00274742|526365396|FG000|Overall Study|End of Study|0|||
145960193|NCT00274742|526365397|FG001|Overall Study|End of Study|0|||
146287474|NCT00196976|527567430|FG002|Primary Study|Other|2|||
146287475|NCT00196976|527567431|FG003|Primary Study|Other|0|||
146287476|NCT00196976|527567432|FG004|Primary Study|Other|0|||
145960194|NCT00274742|526365398|FG002|Overall Study|End of Study|0|||
145960195|NCT00274742|526365399|FG003|Overall Study|End of Study|1|||
145960196|NCT00274742|526365400|FG004|Overall Study|End of Study|0|||
146287477|NCT00196976|527567433|FG005|Primary Study|Other|0|||
146084230|NCT00045942|526827958|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
146084231|NCT00045942|526827950|FG000|PKC412A2104 (Core)|Death|1|||
146084232|NCT00045942|526827951|FG001|PKC412A2104 (Core)|Death|0|||
146287478|NCT00196976|527567434|FG006|Primary Study|Other|0|||
146084233|NCT00045942|526827952|FG002|PKC412A2104 (Core)|Death|0|||
146214948|NCT04263311|527302930|FG001|Overall Study|Unable to maintain time commitment|0|||
146214949|NCT04263311|527302931|FG002|Overall Study|Unable to maintain time commitment|0|||
146214950|NCT04263311|527302929|FG000|Overall Study|No longer interested|1|||
146214951|NCT04263311|527302930|FG001|Overall Study|No longer interested|0|||
146214952|NCT04263311|527302931|FG002|Overall Study|No longer interested|0|||
146214953|NCT04263311|527302929|FG000|Overall Study|Ineligible post consent|0|||
146214954|NCT04263311|527302930|FG001|Overall Study|Ineligible post consent|0|||
146214955|NCT04263311|527302931|FG002|Overall Study|Ineligible post consent|5|||
146214956|NCT03958955|527302932|FG000|Overall Study|Adverse Event|1|||
146214957|NCT04673929|527302933|FG000|Overall Study|Death|73|||
146214958|NCT04673929|527302933|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
146214959|NCT05082909|527302935|FG000|Overall Study|Protocol Violation|0|||
146214960|NCT05082909|527302936|FG001|Overall Study|Protocol Violation|0|||
146214961|NCT05082909|527302937|FG002|Overall Study|Protocol Violation|1|||
146214962|NCT05082909|527302938|FG003|Overall Study|Protocol Violation|0|||
146214963|NCT05082909|527302939|FG004|Overall Study|Protocol Violation|0|||
146214964|NCT05082909|527302940|FG005|Overall Study|Protocol Violation|0|||
146214965|NCT04088630|527302941|FG000|Overall Study|Lost to Follow-up|3|||
146214966|NCT04088630|527302942|FG001|Overall Study|Lost to Follow-up|2|||
146214967|NCT04088630|527302943|FG002|Overall Study|Lost to Follow-up|6|||
146214968|NCT04088630|527302941|FG000|Overall Study|Death|3|||
146214969|NCT04088630|527302942|FG001|Overall Study|Death|1|||
146214970|NCT04088630|527302943|FG002|Overall Study|Death|1|||
146214971|NCT04088630|527302941|FG000|Overall Study|Physician Decision|0|||
146214972|NCT04088630|527302942|FG001|Overall Study|Physician Decision|1|||
146214973|NCT04088630|527302943|FG002|Overall Study|Physician Decision|1|||
146214974|NCT02954341|527302944|FG000|Overall Study|Attempted Implant unsuccessful|5|||
146214975|NCT02954341|527302944|FG000|Overall Study|Death|90|||
146214976|NCT02954341|527302944|FG000|Overall Study|Withdrawal by Subject|4|||
146214977|NCT02954341|527302944|FG000|Overall Study|Physician Decision|13|||
146214978|NCT02954341|527302944|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
146214979|NCT02954341|527302944|FG000|Overall Study|Not implanted due to physician's decision|1|||
146214980|NCT02954341|527302944|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
146214981|NCT04321031|527302951|FG000|Overall Study|Adverse Event|0|||
146214982|NCT04321031|527302952|FG001|Overall Study|Adverse Event|2|||
146214983|NCT04321031|527302953|FG002|Overall Study|Adverse Event|2|||
146214984|NCT04321031|527302954|FG003|Overall Study|Adverse Event|2|||
146214985|NCT04321031|527302955|FG004|Overall Study|Adverse Event|2|||
146214986|NCT04321031|527302956|FG005|Overall Study|Adverse Event|2|||
145881395|NCT00683592|526072628|FG001|Overall Study|Withdrawal by Subject|11|||
145881396|NCT00683592|526072627|FG000|Overall Study|Lost to Follow-up|17|||
145881397|NCT00683592|526072628|FG001|Overall Study|Lost to Follow-up|17|||
145881398|NCT00683592|526072627|FG000|Overall Study|Lack of Efficacy|3|||
146214987|NCT04321031|527302957|FG006|Overall Study|Adverse Event|0|||
146214988|NCT04321031|527302951|FG000|Overall Study|Lost to Follow-up|0|||
146214989|NCT04321031|527302952|FG001|Overall Study|Lost to Follow-up|0|||
146214990|NCT04321031|527302953|FG002|Overall Study|Lost to Follow-up|0|||
146214991|NCT04321031|527302954|FG003|Overall Study|Lost to Follow-up|1|||
146214992|NCT04321031|527302955|FG004|Overall Study|Lost to Follow-up|0|||
146214993|NCT04321031|527302956|FG005|Overall Study|Lost to Follow-up|2|||
146214994|NCT04321031|527302957|FG006|Overall Study|Lost to Follow-up|1|||
146214995|NCT04321031|527302951|FG000|Overall Study|Withdrawal by Subject|2|||
146214996|NCT04321031|527302952|FG001|Overall Study|Withdrawal by Subject|2|||
146214997|NCT04321031|527302953|FG002|Overall Study|Withdrawal by Subject|1|||
146214998|NCT04321031|527302954|FG003|Overall Study|Withdrawal by Subject|3|||
146214999|NCT04321031|527302955|FG004|Overall Study|Withdrawal by Subject|1|||
146215000|NCT04321031|527302956|FG005|Overall Study|Withdrawal by Subject|0|||
146215001|NCT04321031|527302957|FG006|Overall Study|Withdrawal by Subject|1|||
146215002|NCT04321031|527302951|FG000|Overall Study|Non-compliance with study drug|0|||
146215003|NCT04321031|527302952|FG001|Overall Study|Non-compliance with study drug|0|||
146215004|NCT04321031|527302953|FG002|Overall Study|Non-compliance with study drug|0|||
146215005|NCT04321031|527302954|FG003|Overall Study|Non-compliance with study drug|0|||
146215006|NCT04321031|527302955|FG004|Overall Study|Non-compliance with study drug|0|||
146215007|NCT04321031|527302956|FG005|Overall Study|Non-compliance with study drug|1|||
146215008|NCT04321031|527302957|FG006|Overall Study|Non-compliance with study drug|0|||
146215009|NCT04321031|527302951|FG000|Overall Study|Other|0|||
146215010|NCT04321031|527302952|FG001|Overall Study|Other|0|||
146215011|NCT04321031|527302953|FG002|Overall Study|Other|0|||
146215012|NCT04321031|527302954|FG003|Overall Study|Other|1|||
146215013|NCT04321031|527302955|FG004|Overall Study|Other|0|||
146215014|NCT04321031|527302956|FG005|Overall Study|Other|0|||
146215015|NCT04321031|527302957|FG006|Overall Study|Other|0|||
146215016|NCT04237298|527302960|FG000|Overall Study|Lost to Follow-up|4|||
146215017|NCT04237298|527302961|FG001|Overall Study|Lost to Follow-up|5|||
146215018|NCT04812535|527302965|FG000|Overall Study|Withdrawal by Subject|0|||
146215019|NCT04812535|527302966|FG001|Overall Study|Withdrawal by Subject|0|||
146215020|NCT04812535|527302967|FG002|Overall Study|Withdrawal by Subject|0|||
146215021|NCT04812535|527302968|FG003|Overall Study|Withdrawal by Subject|1|||
146215022|NCT04812535|527302965|FG000|Overall Study|Death|7|||
146215023|NCT04812535|527302966|FG001|Overall Study|Death|2|||
146215024|NCT04812535|527302967|FG002|Overall Study|Death|4|||
146215025|NCT04812535|527302968|FG003|Overall Study|Death|1|||
146215026|NCT04812535|527302965|FG000|Overall Study|Due to premature study termination by sponsor|2|||
146215027|NCT04812535|527302966|FG001|Overall Study|Due to premature study termination by sponsor|0|||
146215028|NCT04812535|527302967|FG002|Overall Study|Due to premature study termination by sponsor|1|||
146215029|NCT04812535|527302968|FG003|Overall Study|Due to premature study termination by sponsor|3|||
146215030|NCT03846505|527302971|FG000|Treatment Phase|Withdrawal by Subject|9|||
146215031|NCT03846505|527302972|FG001|Treatment Phase|Withdrawal by Subject|11|||
146215032|NCT03846505|527302971|FG000|Treatment Phase|Lost to Follow-up|6|||
146215033|NCT03846505|527302972|FG001|Treatment Phase|Lost to Follow-up|2|||
146215034|NCT03846505|527302971|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
146215035|NCT03846505|527302972|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
146215036|NCT03846505|527302971|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
146215037|NCT03846505|527302972|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
146215038|NCT05569252|527302973|FG000|Overall Study|Adverse event (central vision loss)|1|||
146215039|NCT05569252|527302974|FG001|Overall Study|Adverse event (central vision loss)|0|||
146215040|NCT05569252|527302975|FG002|Overall Study|Adverse event (central vision loss)|0|||
146215041|NCT05569252|527302976|FG003|Overall Study|Adverse event (central vision loss)|0|||
146215042|NCT03665597|527302977|FG000|Period 1|Adverse Event|1|||
146215043|NCT03665597|527302978|FG001|Period 1|Adverse Event|0|||
146215044|NCT03665597|527302979|FG002|Period 1|Adverse Event|0|||
146215045|NCT03665597|527302980|FG003|Period 1|Adverse Event|1|||
146215046|NCT03665597|527302981|FG004|Period 1|Adverse Event|0|||
145881399|NCT00683592|526072628|FG001|Overall Study|Lack of Efficacy|7|||
146215047|NCT03665597|527302982|FG005|Period 1|Adverse Event|0|||
146215048|NCT03665597|527302983|FG006|Period 1|Adverse Event|0|||
146215049|NCT03665597|527302977|FG000|Period 1|Screen Failure|0|||
146215050|NCT03665597|527302978|FG001|Period 1|Screen Failure|0|||
146215051|NCT03665597|527302979|FG002|Period 1|Screen Failure|0|||
146215052|NCT03665597|527302980|FG003|Period 1|Screen Failure|1|||
146215053|NCT03665597|527302981|FG004|Period 1|Screen Failure|0|||
146215054|NCT03665597|527302982|FG005|Period 1|Screen Failure|0|||
146215055|NCT03665597|527302983|FG006|Period 1|Screen Failure|0|||
146215056|NCT03665597|527302977|FG000|Period 1|Death|0|||
146215057|NCT03665597|527302978|FG001|Period 1|Death|0|||
146215058|NCT03665597|527302979|FG002|Period 1|Death|0|||
146215059|NCT03665597|527302980|FG003|Period 1|Death|0|||
146215060|NCT03665597|527302981|FG004|Period 1|Death|0|||
146215061|NCT03665597|527302982|FG005|Period 1|Death|0|||
146215062|NCT03665597|527302983|FG006|Period 1|Death|45|||
146215063|NCT03665597|527302977|FG000|Period 1|Withdrawal by Subject|0|||
146215064|NCT03665597|527302978|FG001|Period 1|Withdrawal by Subject|0|||
146215065|NCT03665597|527302979|FG002|Period 1|Withdrawal by Subject|0|||
146215066|NCT03665597|527302980|FG003|Period 1|Withdrawal by Subject|0|||
146084234|NCT00045942|526827953|FG003|PKC412A2104 (Core)|Death|0|||
146215067|NCT03665597|527302981|FG004|Period 1|Withdrawal by Subject|0|||
146215068|NCT03665597|527302982|FG005|Period 1|Withdrawal by Subject|0|||
145881400|NCT00683592|526072627|FG000|Overall Study|Physician Decision|0|||
145881401|NCT00683592|526072628|FG001|Overall Study|Physician Decision|1|||
145881402|NCT00683592|526072627|FG000|Overall Study|Non-compliance|3|||
145881403|NCT00683592|526072628|FG001|Overall Study|Non-compliance|5|||
145881404|NCT00683592|526072627|FG000|Overall Study|Other|1|||
145881405|NCT00683592|526072628|FG001|Overall Study|Other|1|||
145881406|NCT02697617|526072629|FG000|Overall Study|Withdrawal by Subject|0|||
145881407|NCT02697617|526072630|FG001|Overall Study|Withdrawal by Subject|2|||
145881408|NCT02697617|526072629|FG000|Overall Study|Pregnancy|1|||
145881409|NCT02697617|526072630|FG001|Overall Study|Pregnancy|0|||
145881410|NCT04167618|526072632|FG000|Overall Study|Trial terminated by sponsor|1|||
146084235|NCT00045942|526827954|FG004|PKC412A2104 (Core)|Death|0|||
146084236|NCT00045942|526827955|FG005|PKC412A2104 (Core)|Death|0|||
146084237|NCT00045942|526827956|FG006|PKC412A2104 (Core)|Death|0|||
145881411|NCT04167618|526072633|FG001|Overall Study|Trial terminated by sponsor|1|||
145881412|NCT02943993|526072636|FG000|Overall Study|Withdrawal by Subject|52|||
145960197|NCT00274742|526365401|FG005|Overall Study|End of Study|0|||
146287479|NCT00196976|527567435|FG007|Primary Study|Other|0|||
146287480|NCT00196976|527567436|FG008|Primary Study|Other|0|||
146287481|NCT00196976|527567437|FG009|Primary Study|Other|0|||
146287482|NCT00196976|527567438|FG010|Primary Study|Other|0|||
146287483|NCT00196976|527567439|FG011|Primary Study|Other|0|||
146287484|NCT00196976|527567440|FG012|Primary Study|Other|0|||
146287485|NCT00196976|527567441|FG013|Primary Study|Other|0|||
146287486|NCT00196976|527567428|FG000|Booster Study|Withdrawal by Subject|0|||
146287487|NCT00196976|527567429|FG001|Booster Study|Withdrawal by Subject|0|||
146287488|NCT00196976|527567430|FG002|Booster Study|Withdrawal by Subject|0|||
146287489|NCT00196976|527567431|FG003|Booster Study|Withdrawal by Subject|0|||
146287490|NCT00196976|527567432|FG004|Booster Study|Withdrawal by Subject|0|||
146287491|NCT00196976|527567433|FG005|Booster Study|Withdrawal by Subject|0|||
146287492|NCT00196976|527567434|FG006|Booster Study|Withdrawal by Subject|0|||
146287493|NCT00196976|527567435|FG007|Booster Study|Withdrawal by Subject|0|||
146287494|NCT00196976|527567436|FG008|Booster Study|Withdrawal by Subject|0|||
146287495|NCT00196976|527567437|FG009|Booster Study|Withdrawal by Subject|0|||
146287496|NCT00196976|527567438|FG010|Booster Study|Withdrawal by Subject|1|||
146287497|NCT00196976|527567439|FG011|Booster Study|Withdrawal by Subject|0|||
145881413|NCT02943993|526072636|FG000|Overall Study|Transfer to another institution|6|||
145881414|NCT02943993|526072636|FG000|Overall Study|Lost to Follow-up|135|||
145881415|NCT02943993|526072636|FG000|Overall Study|Death|98|||
145881416|NCT02943993|526072636|FG000|Overall Study|Other reason for premature termination|32|||
145881417|NCT02943993|526072636|FG000|Overall Study|Missing reason for termination|7|||
145881418|NCT05996198|526072640|FG000|Overall Study|Withdrawal by Subject|1|||
145881419|NCT05996198|526072641|FG001|Overall Study|Withdrawal by Subject|0|||
145881420|NCT00876265|526072642|FG000|Overall Study|Miscellaneous reasons|4|||
145881421|NCT00876265|526072642|FG000|Overall Study|Lost to Follow-up|6|||
146287498|NCT00196976|527567440|FG012|Booster Study|Withdrawal by Subject|0|||
145881422|NCT00876265|526072642|FG000|Overall Study|Withdrawal by Subject|2|||
146287499|NCT00196976|527567441|FG013|Booster Study|Withdrawal by Subject|0|||
145881423|NCT01755975|526072643|FG000|Overall Study|Adverse Event|0|||
145881424|NCT01755975|526072644|FG001|Overall Study|Adverse Event|0|||
145881425|NCT01755975|526072645|FG002|Overall Study|Adverse Event|1|||
146287500|NCT00196976|527567428|FG000|Booster Study|Lost to Follow-up|0|||
146287501|NCT00196976|527567429|FG001|Booster Study|Lost to Follow-up|0|||
146287502|NCT00196976|527567430|FG002|Booster Study|Lost to Follow-up|0|||
146287503|NCT00196976|527567431|FG003|Booster Study|Lost to Follow-up|0|||
146215069|NCT03665597|527302983|FG006|Period 1|Withdrawal by Subject|5|||
146215070|NCT03665597|527302977|FG000|Period 2|Adverse Event|0|||
146215071|NCT03665597|527302978|FG001|Period 2|Adverse Event|0|||
146215072|NCT03665597|527302979|FG002|Period 2|Adverse Event|0|||
146215073|NCT03665597|527302980|FG003|Period 2|Adverse Event|0|||
146215074|NCT03665597|527302981|FG004|Period 2|Adverse Event|0|||
146215075|NCT03665597|527302982|FG005|Period 2|Adverse Event|1|||
146215076|NCT03665597|527302983|FG006|Period 2|Adverse Event|0|||
146215077|NCT03665597|527302977|FG000|Period 3|Adverse Event|0|||
146215078|NCT03665597|527302978|FG001|Period 3|Adverse Event|1|||
146215079|NCT03665597|527302979|FG002|Period 3|Adverse Event|0|||
146215080|NCT03665597|527302980|FG003|Period 3|Adverse Event|0|||
146215081|NCT03665597|527302981|FG004|Period 3|Adverse Event|0|||
146215082|NCT03665597|527302982|FG005|Period 3|Adverse Event|0|||
146215083|NCT03665597|527302983|FG006|Period 3|Adverse Event|0|||
146215084|NCT03665597|527302977|FG000|Period 3|Death|0|||
146215085|NCT03665597|527302978|FG001|Period 3|Death|0|||
146215086|NCT03665597|527302979|FG002|Period 3|Death|0|||
146215087|NCT03665597|527302980|FG003|Period 3|Death|0|||
146215088|NCT03665597|527302981|FG004|Period 3|Death|1|||
146215089|NCT03665597|527302982|FG005|Period 3|Death|0|||
146215090|NCT03665597|527302983|FG006|Period 3|Death|0|||
146215091|NCT03665597|527302977|FG000|Period 4|Adverse Event|2|||
146215092|NCT03665597|527302978|FG001|Period 4|Adverse Event|2|||
146215093|NCT03665597|527302979|FG002|Period 4|Adverse Event|2|||
146215094|NCT03665597|527302980|FG003|Period 4|Adverse Event|2|||
146215095|NCT03665597|527302981|FG004|Period 4|Adverse Event|1|||
146215096|NCT03665597|527302982|FG005|Period 4|Adverse Event|0|||
146215097|NCT03665597|527302983|FG006|Period 4|Adverse Event|0|||
146215098|NCT03665597|527302977|FG000|Period 4|Death|0|||
146215099|NCT03665597|527302978|FG001|Period 4|Death|0|||
146215100|NCT03665597|527302979|FG002|Period 4|Death|2|||
146215101|NCT03665597|527302980|FG003|Period 4|Death|0|||
146215102|NCT03665597|527302981|FG004|Period 4|Death|0|||
146215103|NCT03665597|527302982|FG005|Period 4|Death|0|||
146215104|NCT03665597|527302983|FG006|Period 4|Death|0|||
146215105|NCT03665597|527302977|FG000|Period 4|Physician Decision|1|||
146215106|NCT03665597|527302978|FG001|Period 4|Physician Decision|2|||
146215107|NCT03665597|527302979|FG002|Period 4|Physician Decision|0|||
146215108|NCT03665597|527302980|FG003|Period 4|Physician Decision|0|||
146215109|NCT03665597|527302981|FG004|Period 4|Physician Decision|0|||
146215110|NCT03665597|527302982|FG005|Period 4|Physician Decision|0|||
146215111|NCT03665597|527302983|FG006|Period 4|Physician Decision|0|||
146215112|NCT04831216|527302984|FG000|Overall Study|Lost to Follow-up|32|||
146215113|NCT04410042|527302987|FG000|Overall Study|Not Eligible|1|||
146215114|NCT04410042|527302988|FG001|Overall Study|Not Eligible|1|||
146215115|NCT01494662|527302989|FG000|Overall Study|Withdrawal by Subject|0|||
146215116|NCT01494662|527302990|FG001|Overall Study|Withdrawal by Subject|0|||
146215117|NCT01494662|527302991|FG002|Overall Study|Withdrawal by Subject|1|||
146215118|NCT01494662|527302992|FG003|Overall Study|Withdrawal by Subject|0|||
146215119|NCT01494662|527302993|FG004|Overall Study|Withdrawal by Subject|0|||
146215120|NCT01494662|527302994|FG005|Overall Study|Withdrawal by Subject|0|||
146215121|NCT01494662|527302995|FG006|Overall Study|Withdrawal by Subject|0|||
146215122|NCT01494662|527302989|FG000|Overall Study|Physician Decision|0|||
146215123|NCT01494662|527302990|FG001|Overall Study|Physician Decision|0|||
146215124|NCT01494662|527302991|FG002|Overall Study|Physician Decision|1|||
146215125|NCT01494662|527302992|FG003|Overall Study|Physician Decision|0|||
146215126|NCT01494662|527302993|FG004|Overall Study|Physician Decision|0|||
146215127|NCT01494662|527302994|FG005|Overall Study|Physician Decision|0|||
146215128|NCT01494662|527302995|FG006|Overall Study|Physician Decision|0|||
146215129|NCT04072822|527302996|FG000|Treatment|Adverse Event|9|||
146215130|NCT04072822|527302997|FG001|Treatment|Adverse Event|5|||
145881426|NCT01755975|526072646|FG003|Overall Study|Adverse Event|0|||
146215131|NCT04072822|527302996|FG000|Treatment|Met Stopping Criteria|13|||
146287504|NCT00196976|527567432|FG004|Booster Study|Lost to Follow-up|0|||
146287505|NCT00196976|527567433|FG005|Booster Study|Lost to Follow-up|0|||
145881427|NCT01755975|526072647|FG004|Overall Study|Adverse Event|2|||
145881428|NCT00965757|526072656|FG000|Double-blind Phase|Progression of concomitant disease|1|||
146215132|NCT04072822|527302997|FG001|Treatment|Met Stopping Criteria|24|||
146215133|NCT04072822|527302996|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
146215134|NCT04072822|527302997|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
146215135|NCT04072822|527302996|FG000|Treatment|Withdrawal by Subject|0|||
146287506|NCT00196976|527567434|FG006|Booster Study|Lost to Follow-up|0|||
146215136|NCT04072822|527302997|FG001|Treatment|Withdrawal by Subject|2|||
146215137|NCT04072822|527302996|FG000|Treatment|Death|0|||
146215138|NCT04072822|527302997|FG001|Treatment|Death|2|||
146287507|NCT00196976|527567435|FG007|Booster Study|Lost to Follow-up|0|||
146215139|NCT04072822|527302996|FG000|Treatment|Lost to Follow-up|11|||
146215140|NCT04072822|527302997|FG001|Treatment|Lost to Follow-up|3|||
146215141|NCT04072822|527302996|FG000|Treatment|Physician Decision|1|||
146215142|NCT04072822|527302997|FG001|Treatment|Physician Decision|0|||
146215143|NCT04072822|527302996|FG000|Treatment|Other|7|||
146215144|NCT04072822|527302997|FG001|Treatment|Other|9|||
146215145|NCT04072822|527302996|FG000|Follow-up|Withdrawal by Subject|1|||
146287508|NCT00196976|527567436|FG008|Booster Study|Lost to Follow-up|0|||
146215146|NCT04072822|527302997|FG001|Follow-up|Withdrawal by Subject|0|||
146215147|NCT04072822|527302996|FG000|Follow-up|Lost to Follow-up|5|||
146215148|NCT04072822|527302997|FG001|Follow-up|Lost to Follow-up|4|||
146215149|NCT05481320|527302998|FG000|Overall Study|Withdrawal by Subject|1|||
146215150|NCT05481320|527302999|FG001|Overall Study|Withdrawal by Subject|1|||
146215151|NCT05481320|527302998|FG000|Overall Study|Care recipent passed away|0|||
146215152|NCT05481320|527302999|FG001|Overall Study|Care recipent passed away|1|||
146215153|NCT05481320|527302998|FG000|Overall Study|Out-of-window assessment|0|||
146215154|NCT05481320|527302999|FG001|Overall Study|Out-of-window assessment|1|||
146215155|NCT05481320|527302998|FG000|Overall Study|No longer a primary caregiver|3|||
146215156|NCT05481320|527302999|FG001|Overall Study|No longer a primary caregiver|0|||
146215157|NCT05481320|527302998|FG000|Overall Study|Unable to contact|1|||
146215158|NCT05481320|527302999|FG001|Overall Study|Unable to contact|0|||
146215159|NCT02811679|527303000|FG000|Overall Study|Adverse Event|1|||
146215160|NCT02811679|527303000|FG000|Overall Study|Lack of Efficacy|6|||
146215161|NCT02811679|527303000|FG000|Overall Study|Early study closure due to slow accrual|3|||
146215162|NCT01361711|527303003|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
146215163|NCT01361711|527303003|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
146215164|NCT01361711|527303003|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
146215165|NCT01361711|527303003|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
146215166|NCT01361711|527303003|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
146215167|NCT01361711|527303003|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
146215168|NCT01361711|527303003|FG000|Completed Week 18 of Treatment|Other|9|||
146215169|NCT01361711|527303003|FG000|10 Year Follow-up|Still in follow-up|22|||
146215170|NCT01361711|527303003|FG000|10 Year Follow-up|Death|7|||
146215171|NCT01361711|527303003|FG000|10 Year Follow-up|Developed new cancer|1|||
146215172|NCT01361711|527303003|FG000|10 Year Follow-up|Lost to Follow-up|2|||
146215173|NCT01361711|527303003|FG000|10 Year Follow-up|New treatment started|6|||
146215174|NCT01361711|527303003|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
146215175|NCT01361711|527303003|FG000|10 Year Follow-up|Progressive Disease|1|||
146215176|NCT03930342|527303004|FG000|Overall Study|Lost to Follow-up|70|||
146215177|NCT03930342|527303005|FG001|Overall Study|Lost to Follow-up|77|||
146215178|NCT02471638|527303014|FG000|Overall Study|Early Term Withdrawal|10|||
146215179|NCT02187003|527305104|FG000|Overall Study|Adverse Event|2|||
146215180|NCT02187003|527305105|FG001|Overall Study|Adverse Event|0|||
146215181|NCT02187003|527305104|FG000|Overall Study|Lost to Follow-up|14|||
146215182|NCT02187003|527305105|FG001|Overall Study|Lost to Follow-up|10|||
146215183|NCT02187003|527305104|FG000|Overall Study|Withdrawal by Subject|3|||
146215184|NCT02187003|527305105|FG001|Overall Study|Withdrawal by Subject|7|||
146215185|NCT02187003|527305104|FG000|Overall Study|Protocol Violation|2|||
146215186|NCT02187003|527305105|FG001|Overall Study|Protocol Violation|4|||
146215187|NCT02187003|527305104|FG000|Overall Study|Other|5|||
146215188|NCT02187003|527305105|FG001|Overall Study|Other|5|||
146215189|NCT02187003|527305104|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146215190|NCT02187003|527305105|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
146215191|NCT04593472|527305106|FG000|Overall Study|Death|31|||
146215192|NCT04593472|527305107|FG001|Overall Study|Death|27|||
146215193|NCT04593472|527305106|FG000|Overall Study|Withdrawal by Subject|12|||
146215194|NCT04593472|527305107|FG001|Overall Study|Withdrawal by Subject|12|||
146215195|NCT04593472|527305106|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
146215196|NCT04593472|527305107|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
146215197|NCT04593472|527305106|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
146215198|NCT04593472|527305107|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
146215199|NCT04593472|527305106|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
146215200|NCT04593472|527305107|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
146215201|NCT04593472|527305106|FG000|Overall Study|Lost to Follow-up|0|||
146215202|NCT04593472|527305107|FG001|Overall Study|Lost to Follow-up|2|||
146215203|NCT04593472|527305106|FG000|Overall Study|Still collecting 24-month assessment|17|||
146215204|NCT04593472|527305107|FG001|Overall Study|Still collecting 24-month assessment|10|||
146215205|NCT04833777|527305111|FG000|Overall Study|Lost to Follow-up|1|||
146215206|NCT04833777|527305112|FG001|Overall Study|Lost to Follow-up|0|||
146215207|NCT04490915|527305119|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146215208|NCT04490915|527305120|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146215209|NCT04490915|527305119|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146215210|NCT04490915|527305120|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146215211|NCT04490915|527305119|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146215212|NCT04490915|527305120|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
146215213|NCT04490915|527305119|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
146215214|NCT04490915|527305120|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
146084238|NCT00045942|526827957|FG007|PKC412A2104 (Core)|Death|0|||
145881429|NCT00965757|526072657|FG001|Double-blind Phase|Progression of concomitant disease|2|||
146215215|NCT04490915|527305119|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
145960198|NCT00274742|526365396|FG000|Overall Study|Disease Progression|0|||
145960199|NCT00274742|526365397|FG001|Overall Study|Disease Progression|1|||
146215216|NCT04490915|527305120|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
146215217|NCT04490915|527305119|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
145960200|NCT00274742|526365398|FG002|Overall Study|Disease Progression|1|||
145881430|NCT00965757|526072658|FG002|Double-blind Phase|Progression of concomitant disease|0|||
145881431|NCT00965757|526072659|FG003|Double-blind Phase|Progression of concomitant disease|0|||
145881432|NCT00965757|526072656|FG000|Double-blind Phase|Adverse drug reaction|2|||
145881433|NCT00965757|526072657|FG001|Double-blind Phase|Adverse drug reaction|1|||
146215218|NCT04490915|527305120|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
146215219|NCT04490915|527305119|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
146215220|NCT04490915|527305120|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
146215221|NCT04725240|527305121|FG000|Overall Study|Adverse Event|2|||
146215222|NCT04083235|527305147|FG000|Overall Study|Death|252|||
146215223|NCT04083235|527305148|FG001|Overall Study|Death|277|||
146215224|NCT04083235|527305147|FG000|Overall Study|Withdrawal by Subject|13|||
146215225|NCT04083235|527305148|FG001|Overall Study|Withdrawal by Subject|17|||
146215226|NCT04083235|527305147|FG000|Overall Study|Lost to Follow-up|1|||
146215227|NCT04083235|527305148|FG001|Overall Study|Lost to Follow-up|1|||
146215228|NCT04083235|527305147|FG000|Overall Study|Does not meet entry criteria|1|||
146215229|NCT04083235|527305148|FG001|Overall Study|Does not meet entry criteria|0|||
146215230|NCT04083235|527305147|FG000|Overall Study|Did not receive treatment|13|||
146215231|NCT04083235|527305148|FG001|Overall Study|Did not receive treatment|8|||
146215232|NCT04083235|527305147|FG000|Overall Study|Ongoing at the time of DCO|44|||
146215233|NCT04083235|527305148|FG001|Overall Study|Ongoing at the time of DCO|7|||
146215234|NCT02312960|527305149|FG000|Overall Study|Death|24|||
146215235|NCT02312960|527305150|FG001|Overall Study|Death|32|||
146215236|NCT02312960|527305151|FG002|Overall Study|Death|25|||
146215237|NCT02312960|527305152|FG003|Overall Study|Death|11|||
146215238|NCT02312960|527305153|FG004|Overall Study|Death|5|||
146215239|NCT02312960|527305154|FG005|Overall Study|Death|5|||
146215240|NCT02312960|527305155|FG006|Overall Study|Death|8|||
146215241|NCT02312960|527305156|FG007|Overall Study|Death|5|||
146215242|NCT02312960|527305157|FG008|Overall Study|Death|7|||
146215243|NCT02312960|527305158|FG009|Overall Study|Death|3|||
146215244|NCT02312960|527305159|FG010|Overall Study|Death|3|||
146215245|NCT02312960|527305160|FG011|Overall Study|Death|1|||
146215246|NCT02312960|527305161|FG012|Overall Study|Death|25|||
146215247|NCT02312960|527305162|FG013|Overall Study|Death|19|||
146215248|NCT02312960|527305149|FG000|Overall Study|Missing|0|||
146215249|NCT02312960|527305150|FG001|Overall Study|Missing|0|||
146215250|NCT02312960|527305151|FG002|Overall Study|Missing|2|||
146215251|NCT02312960|527305152|FG003|Overall Study|Missing|0|||
146215252|NCT02312960|527305153|FG004|Overall Study|Missing|0|||
146215253|NCT02312960|527305154|FG005|Overall Study|Missing|0|||
146215254|NCT02312960|527305155|FG006|Overall Study|Missing|0|||
146215255|NCT02312960|527305156|FG007|Overall Study|Missing|0|||
146215256|NCT02312960|527305157|FG008|Overall Study|Missing|0|||
146215257|NCT02312960|527305158|FG009|Overall Study|Missing|0|||
146215258|NCT02312960|527305159|FG010|Overall Study|Missing|0|||
146215259|NCT02312960|527305160|FG011|Overall Study|Missing|0|||
146215260|NCT02312960|527305161|FG012|Overall Study|Missing|0|||
146215261|NCT02312960|527305162|FG013|Overall Study|Missing|0|||
146215262|NCT02312960|527305149|FG000|Overall Study|Lost to Follow-up|0|||
146215263|NCT02312960|527305150|FG001|Overall Study|Lost to Follow-up|0|||
146215264|NCT02312960|527305151|FG002|Overall Study|Lost to Follow-up|1|||
146215265|NCT02312960|527305152|FG003|Overall Study|Lost to Follow-up|0|||
146215266|NCT02312960|527305153|FG004|Overall Study|Lost to Follow-up|0|||
146215267|NCT02312960|527305154|FG005|Overall Study|Lost to Follow-up|0|||
146215268|NCT02312960|527305155|FG006|Overall Study|Lost to Follow-up|1|||
146215269|NCT02312960|527305156|FG007|Overall Study|Lost to Follow-up|1|||
146215270|NCT02312960|527305157|FG008|Overall Study|Lost to Follow-up|0|||
146215271|NCT02312960|527305158|FG009|Overall Study|Lost to Follow-up|1|||
146215272|NCT02312960|527305159|FG010|Overall Study|Lost to Follow-up|0|||
146215273|NCT02312960|527305160|FG011|Overall Study|Lost to Follow-up|0|||
146215274|NCT02312960|527305161|FG012|Overall Study|Lost to Follow-up|1|||
146215275|NCT02312960|527305162|FG013|Overall Study|Lost to Follow-up|0|||
146215276|NCT02312960|527305149|FG000|Overall Study|Withdrawal by Subject|1|||
146215277|NCT02312960|527305150|FG001|Overall Study|Withdrawal by Subject|2|||
146215278|NCT02312960|527305151|FG002|Overall Study|Withdrawal by Subject|0|||
146215279|NCT02312960|527305152|FG003|Overall Study|Withdrawal by Subject|0|||
146215280|NCT02312960|527305153|FG004|Overall Study|Withdrawal by Subject|1|||
146215281|NCT02312960|527305154|FG005|Overall Study|Withdrawal by Subject|0|||
146215282|NCT02312960|527305155|FG006|Overall Study|Withdrawal by Subject|1|||
146215283|NCT02312960|527305156|FG007|Overall Study|Withdrawal by Subject|2|||
146215284|NCT02312960|527305157|FG008|Overall Study|Withdrawal by Subject|2|||
146215285|NCT02312960|527305158|FG009|Overall Study|Withdrawal by Subject|3|||
146215286|NCT02312960|527305159|FG010|Overall Study|Withdrawal by Subject|0|||
146215287|NCT02312960|527305160|FG011|Overall Study|Withdrawal by Subject|0|||
146215288|NCT02312960|527305161|FG012|Overall Study|Withdrawal by Subject|2|||
146215289|NCT02312960|527305162|FG013|Overall Study|Withdrawal by Subject|0|||
146215290|NCT04060355|527305164|FG000|Overall Study|Lost to Follow-up|41|||
146215291|NCT01140880|527305165|FG000|Overall Study|Death|0|||
146215292|NCT01140880|527305166|FG001|Overall Study|Death|1|||
146215293|NCT01140880|527305165|FG000|Overall Study|Withdrawal by Subject|6|||
146215294|NCT01140880|527305166|FG001|Overall Study|Withdrawal by Subject|3|||
146287509|NCT00196976|527567437|FG009|Booster Study|Lost to Follow-up|0|||
146287510|NCT00196976|527567438|FG010|Booster Study|Lost to Follow-up|1|||
146287511|NCT00196976|527567439|FG011|Booster Study|Lost to Follow-up|2|||
146287512|NCT00196976|527567440|FG012|Booster Study|Lost to Follow-up|0|||
146287513|NCT00196976|527567441|FG013|Booster Study|Lost to Follow-up|0|||
146287514|NCT01535560|527567442|FG000|Overall Study|Adverse Event|12|||
146287515|NCT01535560|527567443|FG001|Overall Study|Adverse Event|7|||
146287516|NCT01535560|527567442|FG000|Overall Study|Lost to Follow-up|1|||
146287517|NCT01535560|527567443|FG001|Overall Study|Lost to Follow-up|3|||
146287518|NCT01535560|527567442|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
146287519|NCT01535560|527567443|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
146287520|NCT01535560|527567442|FG000|Overall Study|Treatment Failure|21|||
145960201|NCT00274742|526365399|FG003|Overall Study|Disease Progression|0|||
145960202|NCT00274742|526365400|FG004|Overall Study|Disease Progression|1|||
146215295|NCT01140880|527305165|FG000|Overall Study|Lost to Follow-up|8|||
146215296|NCT01140880|527305166|FG001|Overall Study|Lost to Follow-up|10|||
146215297|NCT01140880|527305165|FG000|Overall Study|Protocol Violation|0|||
146215298|NCT01140880|527305166|FG001|Overall Study|Protocol Violation|30|||
146215299|NCT02724878|527305167|FG000|Overall Study|Still on Active Therapy|15|||
146215300|NCT02724878|527305167|FG000|Overall Study|Disease Progression|31|||
146215301|NCT02724878|527305167|FG000|Overall Study|Toxicity|5|||
146215302|NCT02724878|527305167|FG000|Overall Study|Death|1|||
146215303|NCT02724878|527305167|FG000|Overall Study|Withdrawal by Subject|4|||
146215304|NCT02724878|527305167|FG000|Overall Study|Lost to Follow-up|2|||
146215305|NCT02724878|527305167|FG000|Overall Study|Protocol Violation|1|||
146215306|NCT02724878|527305167|FG000|Overall Study|Ineligible for Study Drug|5|||
146215307|NCT02724878|527305167|FG000|Overall Study|not started|1|||
146215308|NCT03779204|527305171|FG000|Overall Study|Lost to Follow-up|2|||
146215309|NCT03779204|527305172|FG001|Overall Study|Lost to Follow-up|0|||
145960203|NCT00274742|526365401|FG005|Overall Study|Disease Progression|0|||
146215310|NCT04421378|527305173|FG000|Overall Study|Adverse Event|2|||
146215311|NCT04421378|527305174|FG001|Overall Study|Adverse Event|7|||
146215312|NCT04421378|527305175|FG002|Overall Study|Adverse Event|0|||
146215313|NCT04421378|527305176|FG003|Overall Study|Adverse Event|1|||
146287521|NCT01535560|527567443|FG001|Overall Study|Treatment Failure|83|||
146215314|NCT04421378|527305177|FG004|Overall Study|Adverse Event|0|||
146215315|NCT04421378|527305173|FG000|Overall Study|Physician Decision|1|||
146287522|NCT01535560|527567442|FG000|Overall Study|Other|0|||
145881434|NCT00965757|526072658|FG002|Double-blind Phase|Adverse drug reaction|0|||
145881435|NCT00965757|526072659|FG003|Double-blind Phase|Adverse drug reaction|0|||
145881436|NCT00965757|526072656|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
145881437|NCT00965757|526072657|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
145881438|NCT00965757|526072658|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
145881439|NCT00965757|526072659|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
146215316|NCT04421378|527305174|FG001|Overall Study|Physician Decision|2|||
146215317|NCT04421378|527305175|FG002|Overall Study|Physician Decision|0|||
146215318|NCT04421378|527305176|FG003|Overall Study|Physician Decision|0|||
146215319|NCT04421378|527305177|FG004|Overall Study|Physician Decision|0|||
146215320|NCT04421378|527305173|FG000|Overall Study|Progressive Disease|16|||
146215321|NCT04421378|527305174|FG001|Overall Study|Progressive Disease|4|||
146215322|NCT04421378|527305175|FG002|Overall Study|Progressive Disease|18|||
146215323|NCT04421378|527305176|FG003|Overall Study|Progressive Disease|11|||
146215324|NCT04421378|527305177|FG004|Overall Study|Progressive Disease|3|||
146215325|NCT04421378|527305173|FG000|Overall Study|Study Terminated by Sponsor|0|||
146215326|NCT04421378|527305174|FG001|Overall Study|Study Terminated by Sponsor|1|||
146215327|NCT04421378|527305175|FG002|Overall Study|Study Terminated by Sponsor|1|||
146215328|NCT04421378|527305176|FG003|Overall Study|Study Terminated by Sponsor|0|||
146215329|NCT04421378|527305177|FG004|Overall Study|Study Terminated by Sponsor|0|||
146215330|NCT04421378|527305173|FG000|Overall Study|Withdrawal by Subject|3|||
146215331|NCT04421378|527305174|FG001|Overall Study|Withdrawal by Subject|1|||
146215332|NCT04421378|527305175|FG002|Overall Study|Withdrawal by Subject|0|||
146215333|NCT04421378|527305176|FG003|Overall Study|Withdrawal by Subject|2|||
146215334|NCT04421378|527305177|FG004|Overall Study|Withdrawal by Subject|0|||
146215335|NCT04421378|527305173|FG000|Overall Study|Other|1|||
146215336|NCT04421378|527305174|FG001|Overall Study|Other|0|||
146215337|NCT04421378|527305175|FG002|Overall Study|Other|0|||
146215338|NCT04421378|527305176|FG003|Overall Study|Other|0|||
146215339|NCT04421378|527305177|FG004|Overall Study|Other|0|||
146215340|NCT04258709|527305178|FG000|Overall Study|Lost to Follow-up|10|||
146215341|NCT04258709|527305179|FG001|Overall Study|Lost to Follow-up|4|||
146215342|NCT04258709|527305178|FG000|Overall Study|Withdrawal by Subject|1|||
146215343|NCT04258709|527305179|FG001|Overall Study|Withdrawal by Subject|0|||
146215344|NCT04258709|527305178|FG000|Overall Study|Fetal demise|0|||
146215345|NCT04258709|527305179|FG001|Overall Study|Fetal demise|1|||
146215346|NCT04258709|527305178|FG000|Overall Study|Protocol Violation|1|||
145881440|NCT00965757|526072656|FG000|Double-blind Phase|Lack of Efficacy|7|||
145881441|NCT00965757|526072657|FG001|Double-blind Phase|Lack of Efficacy|11|||
145881442|NCT00965757|526072658|FG002|Double-blind Phase|Lack of Efficacy|0|||
145881443|NCT00965757|526072659|FG003|Double-blind Phase|Lack of Efficacy|0|||
145881444|NCT00965757|526072656|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
145881445|NCT00965757|526072657|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145881446|NCT00965757|526072658|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145881447|NCT00965757|526072659|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145881448|NCT00965757|526072656|FG000|Double-blind Phase|Lost to Follow-up|0|||
145881449|NCT00965757|526072657|FG001|Double-blind Phase|Lost to Follow-up|1|||
146215347|NCT04258709|527305179|FG001|Overall Study|Protocol Violation|1|||
145881450|NCT00965757|526072658|FG002|Double-blind Phase|Lost to Follow-up|0|||
146215348|NCT02592330|527305180|FG000|Overall Study|Withdrawal by Subject|1|||
146215349|NCT02592330|527305181|FG001|Overall Study|Withdrawal by Subject|0|||
146215350|NCT02592330|527305180|FG000|Overall Study|Failed Biopsy|1|||
146287523|NCT01535560|527567443|FG001|Overall Study|Other|1|||
146287524|NCT01535560|527567442|FG000|Overall Study|Randomized in Error|0|||
146287525|NCT01535560|527567443|FG001|Overall Study|Randomized in Error|1|||
146287526|NCT02842827|527567446|FG000|Overall Study|Adverse Event|0|||
146287527|NCT02842827|527567447|FG001|Overall Study|Adverse Event|1|||
146287528|NCT02842827|527567448|FG002|Overall Study|Adverse Event|0|||
146287529|NCT02842827|527567449|FG003|Overall Study|Adverse Event|1|||
146287530|NCT02842827|527567450|FG004|Overall Study|Adverse Event|0|||
146287531|NCT02842827|527567451|FG005|Overall Study|Adverse Event|1|||
146287532|NCT02842827|527567452|FG006|Overall Study|Adverse Event|0|||
146287533|NCT02842827|527567453|FG007|Overall Study|Adverse Event|0|||
146287534|NCT02842827|527567446|FG000|Overall Study|Death|1|||
146287535|NCT02842827|527567447|FG001|Overall Study|Death|0|||
146287536|NCT02842827|527567448|FG002|Overall Study|Death|2|||
146287537|NCT02842827|527567449|FG003|Overall Study|Death|3|||
146287538|NCT02842827|527567450|FG004|Overall Study|Death|2|||
146287539|NCT02842827|527567451|FG005|Overall Study|Death|1|||
146287540|NCT02842827|527567452|FG006|Overall Study|Death|0|||
146287541|NCT02842827|527567453|FG007|Overall Study|Death|4|||
146287542|NCT02842827|527567446|FG000|Overall Study|Physician Decision|1|||
146287543|NCT02842827|527567447|FG001|Overall Study|Physician Decision|3|||
146287544|NCT02842827|527567448|FG002|Overall Study|Physician Decision|0|||
146287545|NCT02842827|527567449|FG003|Overall Study|Physician Decision|0|||
146287546|NCT02842827|527567450|FG004|Overall Study|Physician Decision|1|||
146287547|NCT02842827|527567451|FG005|Overall Study|Physician Decision|4|||
146287548|NCT02842827|527567452|FG006|Overall Study|Physician Decision|2|||
146287549|NCT02842827|527567453|FG007|Overall Study|Physician Decision|1|||
146287550|NCT02842827|527567446|FG000|Overall Study|Protocol Defined Disease Progression|0|||
146287551|NCT02842827|527567447|FG001|Overall Study|Protocol Defined Disease Progression|0|||
146287552|NCT02842827|527567448|FG002|Overall Study|Protocol Defined Disease Progression|0|||
146287553|NCT02842827|527567449|FG003|Overall Study|Protocol Defined Disease Progression|0|||
146287554|NCT02842827|527567450|FG004|Overall Study|Protocol Defined Disease Progression|0|||
146287555|NCT02842827|527567451|FG005|Overall Study|Protocol Defined Disease Progression|1|||
146287556|NCT02842827|527567452|FG006|Overall Study|Protocol Defined Disease Progression|0|||
146287557|NCT02842827|527567453|FG007|Overall Study|Protocol Defined Disease Progression|0|||
146287558|NCT02842827|527567446|FG000|Overall Study|Participant Withdrawal of Consent|1|||
146287559|NCT02842827|527567447|FG001|Overall Study|Participant Withdrawal of Consent|2|||
146287560|NCT02842827|527567448|FG002|Overall Study|Participant Withdrawal of Consent|2|||
146287561|NCT02842827|527567449|FG003|Overall Study|Participant Withdrawal of Consent|2|||
146287562|NCT02842827|527567450|FG004|Overall Study|Participant Withdrawal of Consent|2|||
146287563|NCT02842827|527567451|FG005|Overall Study|Participant Withdrawal of Consent|1|||
146287564|NCT02842827|527567452|FG006|Overall Study|Participant Withdrawal of Consent|2|||
146287565|NCT02842827|527567453|FG007|Overall Study|Participant Withdrawal of Consent|1|||
146287566|NCT02649946|527567459|FG000|Overall Study|Withdrawal by Subject|1|||
146287567|NCT02649946|527567460|FG001|Overall Study|Withdrawal by Subject|1|||
146287568|NCT02649946|527567459|FG000|Overall Study|Death|7|||
146287569|NCT02649946|527567460|FG001|Overall Study|Death|9|||
146287570|NCT02649946|527567459|FG000|Overall Study|Physician Decision|1|||
146287571|NCT02649946|527567460|FG001|Overall Study|Physician Decision|0|||
146287572|NCT02649946|527567459|FG000|Overall Study|Lost to Follow-up|2|||
146215351|NCT02592330|527305181|FG001|Overall Study|Failed Biopsy|0|||
146215352|NCT03090152|527305182|FG000|Overall Study|Withdrawal by Subject|0|||
146215353|NCT03090152|527305183|FG001|Overall Study|Withdrawal by Subject|2|||
146215354|NCT03090152|527305184|FG002|Overall Study|Withdrawal by Subject|1|||
146215355|NCT03090152|527305182|FG000|Overall Study|Surgery Canceled|1|||
146215356|NCT03090152|527305183|FG001|Overall Study|Surgery Canceled|0|||
146215357|NCT03090152|527305184|FG002|Overall Study|Surgery Canceled|0|||
145881451|NCT00965757|526072659|FG003|Double-blind Phase|Lost to Follow-up|0|||
146215358|NCT03090152|527305182|FG000|Overall Study|Epidural catheter could not be placed|0|||
146215359|NCT03090152|527305183|FG001|Overall Study|Epidural catheter could not be placed|2|||
146215360|NCT03090152|527305184|FG002|Overall Study|Epidural catheter could not be placed|0|||
146215361|NCT02927769|527305185|FG000|Induction Phase|Study drug toxicity|1|||
146215362|NCT02927769|527305186|FG001|Induction Phase|Study drug toxicity|1|||
146215363|NCT02927769|527305185|FG000|Induction Phase|Disease progression|0|||
146215364|NCT02927769|527305186|FG001|Induction Phase|Disease progression|1|||
146215365|NCT02927769|527305185|FG000|Intensification Phase|Study drug toxicity|1|||
146215366|NCT02927769|527305186|FG001|Intensification Phase|Study drug toxicity|0|||
146215367|NCT02807636|527305189|FG000|Overall Study|Lost to Follow-up|10|||
146215368|NCT02807636|527305190|FG001|Overall Study|Lost to Follow-up|13|||
146215369|NCT02807636|527305191|FG002|Overall Study|Lost to Follow-up|6|||
146215370|NCT02807636|527305189|FG000|Overall Study|Protocol Deviation|1|||
146215371|NCT02807636|527305190|FG001|Overall Study|Protocol Deviation|0|||
146215372|NCT02807636|527305191|FG002|Overall Study|Protocol Deviation|0|||
146215373|NCT02807636|527305189|FG000|Overall Study|Symptomatic Deterioration|0|||
146215374|NCT02807636|527305190|FG001|Overall Study|Symptomatic Deterioration|1|||
146215375|NCT02807636|527305191|FG002|Overall Study|Symptomatic Deterioration|0|||
146215376|NCT02807636|527305189|FG000|Overall Study|Withdrawal by Subject|39|||
146215377|NCT02807636|527305190|FG001|Overall Study|Withdrawal by Subject|28|||
146215378|NCT02807636|527305191|FG002|Overall Study|Withdrawal by Subject|24|||
146215379|NCT02807636|527305189|FG000|Overall Study|Death|303|||
146215380|NCT02807636|527305190|FG001|Overall Study|Death|332|||
146215381|NCT02807636|527305191|FG002|Overall Study|Death|272|||
146215382|NCT02807636|527305189|FG000|Overall Study|Study Terminated By Sponsor|47|||
146215383|NCT02807636|527305190|FG001|Overall Study|Study Terminated By Sponsor|76|||
146215384|NCT02807636|527305191|FG002|Overall Study|Study Terminated By Sponsor|60|||
146215385|NCT02807636|527305189|FG000|Overall Study|Physician Decision|0|||
146215386|NCT02807636|527305190|FG001|Overall Study|Physician Decision|1|||
146215387|NCT02807636|527305191|FG002|Overall Study|Physician Decision|0|||
146215388|NCT03175029|527305192|FG000|Overall Study|Withdrawal by Subject|2|||
146215389|NCT03175029|527305193|FG001|Overall Study|Withdrawal by Subject|1|||
146215390|NCT03175029|527305192|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
146215391|NCT03175029|527305193|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
146215392|NCT05227209|527305196|FG000|Overall Study|Adverse Event|11|||
146215393|NCT05227209|527305196|FG000|Overall Study|Lost to Follow-up|1|||
146215394|NCT05227209|527305196|FG000|Overall Study|Withdrawal by Subject|7|||
146215395|NCT05227209|527305196|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
146215396|NCT05633953|527305197|FG000|Overall Study|Adverse Event|7|||
146215397|NCT05633953|527305197|FG000|Overall Study|Death|30|||
146215398|NCT05633953|527305197|FG000|Overall Study|Lost to Follow-up|1|||
146215399|NCT05633953|527305197|FG000|Overall Study|Osilodrostat discontinued|4|||
146215400|NCT05633953|527305197|FG000|Overall Study|Physician Decision|1|||
146215401|NCT05633953|527305197|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
146215402|NCT05633953|527305197|FG000|Overall Study|Progressive disease|2|||
146215403|NCT00512070|527305203|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
146215404|NCT00512070|527305204|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
146215405|NCT00512070|527305205|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
146215406|NCT00512070|527305203|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
146215407|NCT00512070|527305204|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
146215408|NCT00512070|527305205|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
146215409|NCT00961571|527305206|FG000|Overall Study|Physician Decision|39|||
146215410|NCT05524233|527305207|FG000|Overall Study|Lost to Follow-up|2|||
146215411|NCT05524233|527305207|FG000|Overall Study|Adverse Event|2|||
146215412|NCT05524233|527305207|FG000|Overall Study|Withdrawal by Subject|1|||
146215413|NCT05337748|527305209|FG000|Overall Study|Withdrawal by Subject|1|||
146215414|NCT05337748|527305210|FG001|Overall Study|Withdrawal by Subject|0|||
146215415|NCT05337748|527305209|FG000|Overall Study|Death|1|||
146215416|NCT05337748|527305210|FG001|Overall Study|Death|0|||
145881452|NCT00965757|526072656|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
145881453|NCT00965757|526072657|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
145881454|NCT00965757|526072658|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
145881455|NCT00965757|526072659|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
146215417|NCT02506959|527305211|FG000|Overall Study|Physician Decision|2|||
146215418|NCT02506959|527305212|FG001|Overall Study|Physician Decision|1|||
145881456|NCT00965757|526072656|FG000|Double-blind Phase|Other|1|||
146215419|NCT03453619|527305216|FG000|Core Study (Part A)|Physician Decision|0|||
146215420|NCT03453619|527305217|FG001|Core Study (Part A)|Physician Decision|0|||
146215421|NCT03453619|527305218|FG002|Core Study (Part A)|Physician Decision|2|||
146215422|NCT03453619|527305219|FG003|Core Study (Part A)|Physician Decision|0|||
146215423|NCT03453619|527305216|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
145881457|NCT00965757|526072657|FG001|Double-blind Phase|Other|0|||
145881458|NCT00965757|526072658|FG002|Double-blind Phase|Other|0|||
145881459|NCT00965757|526072659|FG003|Double-blind Phase|Other|0|||
145881460|NCT00965757|526072656|FG000|Extension Phase|Progression of concomitant disease|0|||
145881461|NCT00965757|526072657|FG001|Extension Phase|Progression of concomitant disease|0|||
145881462|NCT00965757|526072658|FG002|Extension Phase|Progression of concomitant disease|4|||
145881463|NCT00965757|526072659|FG003|Extension Phase|Progression of concomitant disease|2|||
145881464|NCT00965757|526072656|FG000|Extension Phase|Adverse drug reaction|0|||
145881465|NCT00965757|526072657|FG001|Extension Phase|Adverse drug reaction|0|||
146215424|NCT03453619|527305217|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
146215425|NCT03453619|527305218|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
146215426|NCT03453619|527305219|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
146215427|NCT03453619|527305216|FG000|Core Study (Part A)|Other|0|||
145881466|NCT00965757|526072658|FG002|Extension Phase|Adverse drug reaction|6|||
145881467|NCT00965757|526072659|FG003|Extension Phase|Adverse drug reaction|3|||
145881468|NCT00965757|526072656|FG000|Extension Phase|Abnormal Laboratory Value|0|||
145960204|NCT00274742|526365396|FG000|Overall Study|Other|0|||
145960205|NCT00274742|526365397|FG001|Overall Study|Other|3|||
146215428|NCT03453619|527305217|FG001|Core Study (Part A)|Other|1|||
145881469|NCT00965757|526072657|FG001|Extension Phase|Abnormal Laboratory Value|0|||
145960206|NCT00274742|526365398|FG002|Overall Study|Other|0|||
146215429|NCT03453619|527305218|FG002|Core Study (Part A)|Other|0|||
146215430|NCT03453619|527305219|FG003|Core Study (Part A)|Other|0|||
146215431|NCT03453619|527305216|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
146215432|NCT03453619|527305217|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
146287573|NCT02649946|527567460|FG001|Overall Study|Lost to Follow-up|1|||
145960207|NCT00274742|526365399|FG003|Overall Study|Other|0|||
145960208|NCT00274742|526365400|FG004|Overall Study|Other|2|||
145960209|NCT00274742|526365401|FG005|Overall Study|Other|0|||
145960210|NCT04742673|526365404|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
145960211|NCT04742673|526365405|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
145960212|NCT01158261|526365408|FG000|Overall Study|Lost to Follow-up|9|||
145960213|NCT01158261|526365408|FG000|Overall Study|Death|7|||
146215433|NCT03453619|527305218|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
146215434|NCT03453619|527305219|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
145881470|NCT00965757|526072658|FG002|Extension Phase|Abnormal Laboratory Value|6|||
146215435|NCT03453619|527305216|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
146215436|NCT03453619|527305217|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
145881471|NCT00965757|526072659|FG003|Extension Phase|Abnormal Laboratory Value|1|||
145881472|NCT00965757|526072656|FG000|Extension Phase|Lack of Efficacy|0|||
145881473|NCT00965757|526072657|FG001|Extension Phase|Lack of Efficacy|0|||
145881474|NCT00965757|526072658|FG002|Extension Phase|Lack of Efficacy|8|||
145881475|NCT00965757|526072659|FG003|Extension Phase|Lack of Efficacy|12|||
145881476|NCT00965757|526072656|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145881477|NCT00965757|526072657|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145881478|NCT00965757|526072658|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
145881479|NCT00965757|526072659|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145881480|NCT00965757|526072656|FG000|Extension Phase|Lost to Follow-up|0|||
145881481|NCT00965757|526072657|FG001|Extension Phase|Lost to Follow-up|0|||
145881482|NCT00965757|526072658|FG002|Extension Phase|Lost to Follow-up|0|||
145881483|NCT00965757|526072659|FG003|Extension Phase|Lost to Follow-up|1|||
145881484|NCT00965757|526072656|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
145881485|NCT00965757|526072657|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
145881486|NCT00965757|526072658|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
145881487|NCT00965757|526072659|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
145881488|NCT00965757|526072656|FG000|Extension Phase|Protocol Violation|0|||
145881489|NCT00965757|526072657|FG001|Extension Phase|Protocol Violation|0|||
145881490|NCT00965757|526072658|FG002|Extension Phase|Protocol Violation|0|||
145881491|NCT00965757|526072659|FG003|Extension Phase|Protocol Violation|1|||
145881492|NCT00965757|526072656|FG000|Extension Phase|Other|0|||
145881493|NCT00965757|526072657|FG001|Extension Phase|Other|0|||
145881494|NCT00965757|526072658|FG002|Extension Phase|Other|2|||
145881495|NCT00965757|526072659|FG003|Extension Phase|Other|1|||
145881496|NCT03807440|526072660|FG000|Overall Study|No documentation of index date 2|320|||
145881497|NCT03807440|526072660|FG000|Overall Study|No informed consent for index date 2|117|||
145881498|NCT02451358|526072661|FG000|Overall Study|Withdrawal by Subject|1|||
145881499|NCT02451358|526072662|FG001|Overall Study|Withdrawal by Subject|1|||
145960214|NCT01158261|526365408|FG000|Overall Study|Withdrawal by Subject|1|||
145960215|NCT02899065|526365411|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
145960216|NCT02899065|526365412|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
146084239|NCT00045942|526827958|FG008|PKC412A2104 (Core)|Death|0|||
146215437|NCT03453619|527305218|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
146215438|NCT03453619|527305219|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
146215439|NCT03453619|527305216|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146215440|NCT03453619|527305217|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146215441|NCT03453619|527305218|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
146215442|NCT03453619|527305219|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
146215443|NCT03453619|527305216|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
146215444|NCT03453619|527305217|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
146215445|NCT03453619|527305218|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
146215446|NCT03453619|527305219|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
146215447|NCT05862870|527305222|FG000|Overall Study|Lost to Follow-up|3|||
146215448|NCT03143153|527305223|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
146215449|NCT03143153|527305224|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
146215450|NCT03143153|527305225|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
146215451|NCT03143153|527305223|FG000|Pre-Treatment|Participant withdrew consent|0|||
146215452|NCT03143153|527305224|FG001|Pre-Treatment|Participant withdrew consent|1|||
146215453|NCT03143153|527305225|FG002|Pre-Treatment|Participant withdrew consent|12|||
146215454|NCT03143153|527305223|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
146215455|NCT03143153|527305224|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
146215456|NCT03143153|527305225|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
146215457|NCT03143153|527305223|FG000|Pre-Treatment|Other Reasons|1|||
146215458|NCT03143153|527305224|FG001|Pre-Treatment|Other Reasons|2|||
146215459|NCT03143153|527305225|FG002|Pre-Treatment|Other Reasons|1|||
146215460|NCT03143153|527305223|FG000|Pre-Treatment|Disease Progression|1|||
146215461|NCT03143153|527305224|FG001|Pre-Treatment|Disease Progression|1|||
146215462|NCT03143153|527305225|FG002|Pre-Treatment|Disease Progression|2|||
146215463|NCT03143153|527305223|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
146215464|NCT03143153|527305224|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
146215465|NCT03143153|527305225|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
146215466|NCT03143153|527305223|FG000|Treatment|Disease progression|174|||
146215467|NCT03143153|527305224|FG001|Treatment|Disease progression|184|||
146215468|NCT03143153|527305225|FG002|Treatment|Disease progression|193|||
145960217|NCT02899065|526365411|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
145960218|NCT02899065|526365412|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
145960219|NCT02899065|526365411|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
145960220|NCT02899065|526365412|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
145960221|NCT00971867|526365413|FG000|Overall Study|Adverse Event|4|||
145960222|NCT00971867|526365413|FG000|Overall Study|Participant Withdrew Consent|1|||
145960223|NCT00971867|526365413|FG000|Overall Study|Disease Progression|6|||
145960224|NCT02983045|526365415|FG000|Overall Study|Withdrawal by Subject|0|||
145960225|NCT02983045|526365416|FG001|Overall Study|Withdrawal by Subject|1|||
145960226|NCT02983045|526365417|FG002|Overall Study|Withdrawal by Subject|0|||
145960227|NCT02983045|526365418|FG003|Overall Study|Withdrawal by Subject|5|||
145960228|NCT02983045|526365419|FG004|Overall Study|Withdrawal by Subject|0|||
145960229|NCT02983045|526365420|FG005|Overall Study|Withdrawal by Subject|72|||
145960230|NCT02983045|526365421|FG006|Overall Study|Withdrawal by Subject|0|||
145960231|NCT02983045|526365422|FG007|Overall Study|Withdrawal by Subject|0|||
145960232|NCT02983045|526365423|FG008|Overall Study|Withdrawal by Subject|0|||
145960233|NCT02983045|526365424|FG009|Overall Study|Withdrawal by Subject|2|||
145960234|NCT02983045|526365415|FG000|Overall Study|Lost to Follow-up|0|||
145960235|NCT02983045|526365416|FG001|Overall Study|Lost to Follow-up|0|||
145960236|NCT02983045|526365417|FG002|Overall Study|Lost to Follow-up|0|||
145960237|NCT02983045|526365418|FG003|Overall Study|Lost to Follow-up|0|||
145960238|NCT02983045|526365419|FG004|Overall Study|Lost to Follow-up|0|||
146215469|NCT03143153|527305223|FG000|Treatment|Study drug toxicity|59|||
146215470|NCT03143153|527305224|FG001|Treatment|Study drug toxicity|33|||
146215471|NCT03143153|527305225|FG002|Treatment|Study drug toxicity|40|||
146215472|NCT03143153|527305223|FG000|Treatment|Death|5|||
146215473|NCT03143153|527305224|FG001|Treatment|Death|3|||
146215474|NCT03143153|527305225|FG002|Treatment|Death|4|||
146215475|NCT03143153|527305223|FG000|Treatment|Adverse event unrelated to study drug|19|||
146215476|NCT03143153|527305224|FG001|Treatment|Adverse event unrelated to study drug|28|||
146215477|NCT03143153|527305225|FG002|Treatment|Adverse event unrelated to study drug|12|||
146215478|NCT03143153|527305223|FG000|Treatment|Participant request to discontinue study treatment|13|||
146215479|NCT03143153|527305224|FG001|Treatment|Participant request to discontinue study treatment|15|||
146215480|NCT03143153|527305225|FG002|Treatment|Participant request to discontinue study treatment|20|||
146215481|NCT03143153|527305223|FG000|Treatment|Participant withdrew consent|3|||
146215482|NCT03143153|527305224|FG001|Treatment|Participant withdrew consent|4|||
146215483|NCT03143153|527305225|FG002|Treatment|Participant withdrew consent|12|||
146215484|NCT03143153|527305223|FG000|Treatment|Pregnancy|1|||
146215485|NCT03143153|527305224|FG001|Treatment|Pregnancy|0|||
146215486|NCT03143153|527305225|FG002|Treatment|Pregnancy|0|||
146215487|NCT03143153|527305223|FG000|Treatment|Maximum clinical benefit|1|||
146215488|NCT03143153|527305224|FG001|Treatment|Maximum clinical benefit|3|||
146215489|NCT03143153|527305225|FG002|Treatment|Maximum clinical benefit|4|||
146215490|NCT03143153|527305223|FG000|Treatment|Completed treatment as per Protocol|13|||
146215491|NCT03143153|527305224|FG001|Treatment|Completed treatment as per Protocol|8|||
146215492|NCT03143153|527305225|FG002|Treatment|Completed treatment as per Protocol|0|||
146215493|NCT03143153|527305223|FG000|Treatment|Other reasons|12|||
146215494|NCT03143153|527305224|FG001|Treatment|Other reasons|7|||
146215495|NCT03143153|527305225|FG002|Treatment|Other reasons|15|||
146215496|NCT03143153|527305223|FG000|Treatment|Not reported|1|||
146215497|NCT03143153|527305224|FG001|Treatment|Not reported|0|||
146215498|NCT03143153|527305225|FG002|Treatment|Not reported|0|||
146215499|NCT02530671|527305226|FG000|Overall Study|Lost to Follow-up|2|||
146215500|NCT02530671|527305227|FG001|Overall Study|Lost to Follow-up|0|||
146215501|NCT02530671|527305226|FG000|Overall Study|Withdrawal by Subject|1|||
146215502|NCT02530671|527305227|FG001|Overall Study|Withdrawal by Subject|0|||
146215503|NCT03126019|527305234|FG000|Overall Study|Death|5|||
146215504|NCT03126019|527305235|FG001|Overall Study|Death|27|||
146215505|NCT03126019|527305234|FG000|Overall Study|Lost to Follow-up|2|||
146215506|NCT03126019|527305235|FG001|Overall Study|Lost to Follow-up|4|||
146215507|NCT03126019|527305234|FG000|Overall Study|Withdrawal by Subject|1|||
146215508|NCT03126019|527305235|FG001|Overall Study|Withdrawal by Subject|9|||
146215509|NCT03126019|527305234|FG000|Overall Study|Physician Decision|1|||
146215510|NCT03126019|527305235|FG001|Overall Study|Physician Decision|0|||
146215511|NCT03126019|527305234|FG000|Overall Study|Transitioned to Rollover Study|0|||
146215512|NCT03126019|527305235|FG001|Overall Study|Transitioned to Rollover Study|11|||
146215513|NCT03126019|527305234|FG000|Overall Study|Did Not Return to Site for Care|0|||
146215514|NCT03126019|527305235|FG001|Overall Study|Did Not Return to Site for Care|1|||
146215515|NCT03126019|527305234|FG000|Overall Study|Site Closed|0|||
146215516|NCT03126019|527305235|FG001|Overall Study|Site Closed|1|||
146215517|NCT00170573|527305237|FG000|Overall Study|Violation of inclusion criteria|13|||
146215518|NCT04556656|527305238|FG000|Overall Study|Withdrawal by Subject|14|||
146215519|NCT04556656|527305239|FG001|Overall Study|Withdrawal by Subject|12|||
146215520|NCT04556656|527305238|FG000|Overall Study|Physician Decision|1|||
146215521|NCT04556656|527305239|FG001|Overall Study|Physician Decision|0|||
146215522|NCT04556656|527305238|FG000|Overall Study|Adverse Event|4|||
146215523|NCT04556656|527305239|FG001|Overall Study|Adverse Event|7|||
146215524|NCT04556656|527305238|FG000|Overall Study|Death|4|||
146215525|NCT04556656|527305239|FG001|Overall Study|Death|0|||
146215526|NCT04556656|527305238|FG000|Overall Study|Lost to Follow-up|3|||
146215527|NCT04556656|527305239|FG001|Overall Study|Lost to Follow-up|2|||
146215528|NCT04556656|527305238|FG000|Overall Study|Not further specified|2|||
146215529|NCT04556656|527305239|FG001|Overall Study|Not further specified|1|||
146215530|NCT04541706|527305243|FG000|Overall Study|Withdrawal by Subject|3|||
146215531|NCT04541706|527305243|FG000|Overall Study|Progressive disease|33|||
146215532|NCT04541706|527305243|FG000|Overall Study|Physician Decision|1|||
146215533|NCT04541706|527305243|FG000|Overall Study|Lost to Follow-up|2|||
146215534|NCT04541706|527305243|FG000|Overall Study|Death|5|||
146215535|NCT04541706|527305243|FG000|Overall Study|Adverse Event|1|||
146215536|NCT05563246|527305251|FG000|Overall Study|Withdrawal by Subject|1|||
146215537|NCT05563246|527305252|FG001|Overall Study|Withdrawal by Subject|2|||
146215538|NCT05563246|527305253|FG002|Overall Study|Withdrawal by Subject|0|||
146215539|NCT05563246|527305254|FG003|Overall Study|Withdrawal by Subject|0|||
146215540|NCT05563246|527305251|FG000|Overall Study|Protocol Deviation|0|||
146215541|NCT05563246|527305252|FG001|Overall Study|Protocol Deviation|1|||
146215542|NCT05563246|527305253|FG002|Overall Study|Protocol Deviation|0|||
146215543|NCT05563246|527305254|FG003|Overall Study|Protocol Deviation|0|||
146215544|NCT05563246|527305251|FG000|Overall Study|Physician Decision|0|||
145881500|NCT02451358|526072663|FG002|Overall Study|Withdrawal by Subject|0|||
145881501|NCT02451358|526072664|FG003|Overall Study|Withdrawal by Subject|0|||
145881502|NCT02451358|526072661|FG000|Overall Study|Protocol Violation|0|||
145881503|NCT02451358|526072662|FG001|Overall Study|Protocol Violation|1|||
145881504|NCT02451358|526072663|FG002|Overall Study|Protocol Violation|1|||
145881505|NCT02451358|526072664|FG003|Overall Study|Protocol Violation|0|||
145881506|NCT01398787|526072667|FG000|Overall Study|Adverse Event|1|||
145881507|NCT03414034|526072668|FG000|Overall Study|Adverse Event|6|||
145881508|NCT03414034|526072669|FG001|Overall Study|Adverse Event|1|||
145881509|NCT03414034|526072670|FG002|Overall Study|Adverse Event|1|||
145881510|NCT03414034|526072668|FG000|Overall Study|Death|0|||
145881511|NCT03414034|526072669|FG001|Overall Study|Death|0|||
145881512|NCT03414034|526072670|FG002|Overall Study|Death|1|||
145881513|NCT03414034|526072668|FG000|Overall Study|Non-compliance With Study Drug|0|||
145881514|NCT03414034|526072669|FG001|Overall Study|Non-compliance With Study Drug|0|||
145881515|NCT03414034|526072670|FG002|Overall Study|Non-compliance With Study Drug|1|||
145881516|NCT03414034|526072668|FG000|Overall Study|Physician Decision|1|||
145881517|NCT03414034|526072669|FG001|Overall Study|Physician Decision|3|||
145881518|NCT03414034|526072670|FG002|Overall Study|Physician Decision|2|||
145881519|NCT03414034|526072668|FG000|Overall Study|Withdrawal of Informed Consent|2|||
145881520|NCT03414034|526072669|FG001|Overall Study|Withdrawal of Informed Consent|1|||
145881521|NCT03414034|526072670|FG002|Overall Study|Withdrawal of Informed Consent|4|||
145881522|NCT03414034|526072668|FG000|Overall Study|Progressive Disease|15|||
145881523|NCT03414034|526072669|FG001|Overall Study|Progressive Disease|15|||
145960239|NCT02983045|526365420|FG005|Overall Study|Lost to Follow-up|10|||
145960240|NCT02983045|526365421|FG006|Overall Study|Lost to Follow-up|0|||
145960241|NCT02983045|526365422|FG007|Overall Study|Lost to Follow-up|0|||
145960242|NCT02983045|526365423|FG008|Overall Study|Lost to Follow-up|0|||
145960243|NCT02983045|526365424|FG009|Overall Study|Lost to Follow-up|0|||
145960244|NCT00905424|526365425|FG000|Overall Study|Lost to Follow-up|3|||
145960245|NCT00905424|526365426|FG001|Overall Study|Lost to Follow-up|3|||
145960246|NCT00905424|526365425|FG000|Overall Study|Withdrawal by Subject|1|||
145960247|NCT00905424|526365426|FG001|Overall Study|Withdrawal by Subject|2|||
146215545|NCT05563246|527305252|FG001|Overall Study|Physician Decision|1|||
146215546|NCT05563246|527305253|FG002|Overall Study|Physician Decision|0|||
146215547|NCT05563246|527305254|FG003|Overall Study|Physician Decision|0|||
146084240|NCT00045942|526827950|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
146084241|NCT00045942|526827951|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
146287574|NCT02649946|527567459|FG000|Overall Study|Erroneously enrolled|1|||
146287575|NCT02649946|527567460|FG001|Overall Study|Erroneously enrolled|0|||
146287576|NCT02649946|527567459|FG000|Overall Study|Missed 6-month follow-up visit|0|||
146287577|NCT02649946|527567460|FG001|Overall Study|Missed 6-month follow-up visit|4|||
146287578|NCT02054520|527567461|FG000|Overall Study|Adverse Event|1|||
146287579|NCT02054520|527567462|FG001|Overall Study|Adverse Event|4|||
146287580|NCT02054520|527567463|FG002|Overall Study|Adverse Event|2|||
146287581|NCT02054520|527567464|FG003|Overall Study|Adverse Event|1|||
146287582|NCT02054520|527567465|FG004|Overall Study|Adverse Event|1|||
146287583|NCT02054520|527567466|FG005|Overall Study|Adverse Event|0|||
146287584|NCT02054520|527567461|FG000|Overall Study|Lack of Efficacy|7|||
146287585|NCT02054520|527567462|FG001|Overall Study|Lack of Efficacy|0|||
146287586|NCT02054520|527567463|FG002|Overall Study|Lack of Efficacy|2|||
146287587|NCT02054520|527567464|FG003|Overall Study|Lack of Efficacy|1|||
146287588|NCT02054520|527567465|FG004|Overall Study|Lack of Efficacy|3|||
146287589|NCT02054520|527567466|FG005|Overall Study|Lack of Efficacy|2|||
146287590|NCT02054520|527567461|FG000|Overall Study|Withdrawal by Subject|1|||
146287591|NCT02054520|527567462|FG001|Overall Study|Withdrawal by Subject|0|||
146287592|NCT02054520|527567463|FG002|Overall Study|Withdrawal by Subject|0|||
146287593|NCT02054520|527567464|FG003|Overall Study|Withdrawal by Subject|2|||
146287594|NCT02054520|527567465|FG004|Overall Study|Withdrawal by Subject|1|||
146287595|NCT02054520|527567466|FG005|Overall Study|Withdrawal by Subject|0|||
146287596|NCT02054520|527567461|FG000|Overall Study|Physician Decision|0|||
146287597|NCT02054520|527567462|FG001|Overall Study|Physician Decision|1|||
146287598|NCT02054520|527567463|FG002|Overall Study|Physician Decision|0|||
146287599|NCT02054520|527567464|FG003|Overall Study|Physician Decision|1|||
145960248|NCT00905424|526365425|FG000|Overall Study|Adverse Event|4|||
145960249|NCT00905424|526365426|FG001|Overall Study|Adverse Event|2|||
146287600|NCT02054520|527567465|FG004|Overall Study|Physician Decision|0|||
146287601|NCT02054520|527567466|FG005|Overall Study|Physician Decision|1|||
146287602|NCT02054520|527567461|FG000|Overall Study|Study terminated by Sponsor|0|||
145960250|NCT00905424|526365425|FG000|Overall Study|Non-compliance with study medication|2|||
145960251|NCT00905424|526365426|FG001|Overall Study|Non-compliance with study medication|0|||
145960252|NCT00905424|526365425|FG000|Overall Study|Sponsor decision|1|||
145960253|NCT00905424|526365426|FG001|Overall Study|Sponsor decision|0|||
145960254|NCT00905424|526365425|FG000|Overall Study|Positive urine drug screen|0|||
145960255|NCT00905424|526365426|FG001|Overall Study|Positive urine drug screen|1|||
145960256|NCT00905424|526365425|FG000|Overall Study|Non-adherence to visit schedule|0|||
145960257|NCT00905424|526365426|FG001|Overall Study|Non-adherence to visit schedule|1|||
145960258|NCT00379899|526365429|FG000|Overall Study|Adverse Event|7|||
145960259|NCT00379899|526365430|FG001|Overall Study|Adverse Event|3|||
146084242|NCT00045942|526827952|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
146084243|NCT00045942|526827953|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
146084244|NCT00045942|526827954|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
146084245|NCT00045942|526827955|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
146084246|NCT00045942|526827956|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
146287603|NCT02054520|527567462|FG001|Overall Study|Study terminated by Sponsor|0|||
146287604|NCT02054520|527567463|FG002|Overall Study|Study terminated by Sponsor|2|||
146287605|NCT02054520|527567464|FG003|Overall Study|Study terminated by Sponsor|1|||
146287606|NCT02054520|527567465|FG004|Overall Study|Study terminated by Sponsor|0|||
146287607|NCT02054520|527567466|FG005|Overall Study|Study terminated by Sponsor|0|||
146287608|NCT01272804|527567467|FG000|Overall Study|Adverse Event|1|||
146287609|NCT01272804|527567468|FG001|Overall Study|Adverse Event|0|||
146287610|NCT01272804|527567469|FG002|Overall Study|Adverse Event|0|||
146287611|NCT01272804|527567470|FG003|Overall Study|Adverse Event|0|||
146287612|NCT01272804|527567471|FG004|Overall Study|Adverse Event|2|||
146287613|NCT01272804|527567472|FG005|Overall Study|Adverse Event|1|||
146215548|NCT05563246|527305251|FG000|Overall Study|Adverse Event|0|||
146215549|NCT05563246|527305252|FG001|Overall Study|Adverse Event|0|||
146215550|NCT05563246|527305253|FG002|Overall Study|Adverse Event|2|||
146215551|NCT05563246|527305254|FG003|Overall Study|Adverse Event|0|||
146215552|NCT05563246|527305251|FG000|Overall Study|Lost to Follow-up|0|||
146215553|NCT05563246|527305252|FG001|Overall Study|Lost to Follow-up|0|||
145960260|NCT00379899|526365429|FG000|Overall Study|Death|10|||
146215554|NCT05563246|527305253|FG002|Overall Study|Lost to Follow-up|1|||
146215555|NCT05563246|527305254|FG003|Overall Study|Lost to Follow-up|0|||
146215556|NCT01566695|527305255|FG000|Overall Study|Lack of Efficacy|1|||
146215557|NCT01566695|527305256|FG001|Overall Study|Lack of Efficacy|0|||
146215558|NCT01566695|527305255|FG000|Overall Study|Adverse Event|3|||
146215559|NCT01566695|527305256|FG001|Overall Study|Adverse Event|0|||
146215560|NCT01566695|527305255|FG000|Overall Study|Death|79|||
146287614|NCT03801915|527567473|FG000|Overall Study|Screen failure|0|||
146287615|NCT03801915|527567474|FG001|Overall Study|Screen failure|0|||
145960261|NCT00379899|526365430|FG001|Overall Study|Death|10|||
146215561|NCT01566695|527305256|FG001|Overall Study|Death|86|||
146215562|NCT01566695|527305255|FG000|Overall Study|Withdrawal by Subject|13|||
146215563|NCT01566695|527305256|FG001|Overall Study|Withdrawal by Subject|12|||
146215564|NCT01566695|527305255|FG000|Overall Study|Lost to Follow-up|0|||
146215565|NCT01566695|527305256|FG001|Overall Study|Lost to Follow-up|3|||
146215566|NCT01566695|527305255|FG000|Overall Study|Other reasons|11|||
146215567|NCT01566695|527305256|FG001|Overall Study|Other reasons|8|||
146215568|NCT03763708|527305257|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
146215569|NCT03763708|527305258|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215570|NCT03763708|527305259|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215571|NCT03763708|527305260|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215572|NCT03763708|527305261|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215573|NCT03763708|527305262|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215574|NCT03763708|527305263|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215575|NCT03763708|527305264|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215576|NCT03763708|527305265|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
146215577|NCT03763708|527305257|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215578|NCT03763708|527305258|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215579|NCT03763708|527305259|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
146215580|NCT03763708|527305260|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215581|NCT03763708|527305261|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215582|NCT03763708|527305262|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215583|NCT03763708|527305263|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215584|NCT03763708|527305264|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215585|NCT03763708|527305265|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
146215586|NCT03763708|527305257|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215587|NCT03763708|527305258|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215588|NCT03763708|527305259|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215589|NCT03763708|527305260|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
146215590|NCT03763708|527305261|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215591|NCT03763708|527305262|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215592|NCT03763708|527305263|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215593|NCT03763708|527305264|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215594|NCT03763708|527305265|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
146215595|NCT03763708|527305257|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215596|NCT03763708|527305258|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215597|NCT03763708|527305259|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215598|NCT03763708|527305260|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215599|NCT03763708|527305261|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
146215600|NCT03763708|527305262|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215601|NCT03763708|527305263|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215602|NCT03763708|527305264|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215603|NCT03763708|527305265|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
146215604|NCT03763708|527305257|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215605|NCT03763708|527305258|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215606|NCT03763708|527305259|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146287616|NCT03801915|527567475|FG002|Overall Study|Screen failure|1|||
146287617|NCT03801915|527567473|FG000|Overall Study|Ineligible|1|||
146287618|NCT03801915|527567474|FG001|Overall Study|Ineligible|0|||
146287619|NCT03801915|527567475|FG002|Overall Study|Ineligible|0|||
146287620|NCT03801915|527567473|FG000|Overall Study|Physician Decision|2|||
146287621|NCT03801915|527567474|FG001|Overall Study|Physician Decision|1|||
146287622|NCT03801915|527567475|FG002|Overall Study|Physician Decision|0|||
146287623|NCT01328717|527569276|FG000|Overall Study|Adverse Event|1|||
145881524|NCT03414034|526072670|FG002|Overall Study|Progressive Disease|17|||
145881525|NCT03414034|526072668|FG000|Overall Study|Miscellaneous|0|||
145881526|NCT03414034|526072669|FG001|Overall Study|Miscellaneous|0|||
145881527|NCT03414034|526072670|FG002|Overall Study|Miscellaneous|2|||
145881528|NCT01332968|526072672|FG000|Induction Period|Adverse Event|23|||
146287624|NCT01201317|527569277|FG000|Overall Study|Withdrawal by Subject|5|||
146215607|NCT03763708|527305260|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215608|NCT03763708|527305261|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215609|NCT03763708|527305262|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
146215610|NCT03763708|527305263|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215611|NCT03763708|527305264|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215612|NCT03763708|527305265|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
146215613|NCT03763708|527305257|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215614|NCT03763708|527305258|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215615|NCT03763708|527305259|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215616|NCT03763708|527305260|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215617|NCT03763708|527305261|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215618|NCT03763708|527305262|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215619|NCT03763708|527305263|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
146215620|NCT03763708|527305264|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215621|NCT03763708|527305265|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
146215622|NCT03763708|527305257|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
146215623|NCT03763708|527305258|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
146215624|NCT03763708|527305259|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
146215625|NCT03763708|527305260|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
146215626|NCT03763708|527305261|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
146215627|NCT03763708|527305262|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
146215628|NCT03763708|527305263|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
146215629|NCT03763708|527305264|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
146215630|NCT03763708|527305265|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
146215631|NCT03763708|527305257|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
146215632|NCT03763708|527305258|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
146215633|NCT03763708|527305259|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
146215634|NCT03763708|527305260|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
146215635|NCT03763708|527305261|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
146215636|NCT03763708|527305262|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
146215637|NCT03763708|527305263|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
146215638|NCT03763708|527305264|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
146215639|NCT03763708|527305265|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
145881529|NCT01332968|526072673|FG001|Induction Period|Adverse Event|26|||
145881530|NCT01332968|526072674|FG002|Induction Period|Adverse Event|0|||
145881531|NCT01332968|526072675|FG003|Induction Period|Adverse Event|0|||
145881532|NCT01332968|526072676|FG004|Induction Period|Adverse Event|0|||
145881533|NCT01332968|526072677|FG005|Induction Period|Adverse Event|0|||
145881534|NCT01332968|526072678|FG006|Induction Period|Adverse Event|0|||
145881535|NCT01332968|526072679|FG007|Induction Period|Adverse Event|0|||
145881536|NCT01332968|526072672|FG000|Induction Period|Death|1|||
145881537|NCT01332968|526072673|FG001|Induction Period|Death|4|||
145881538|NCT01332968|526072674|FG002|Induction Period|Death|0|||
145881539|NCT01332968|526072675|FG003|Induction Period|Death|0|||
145881540|NCT01332968|526072676|FG004|Induction Period|Death|0|||
145881541|NCT01332968|526072677|FG005|Induction Period|Death|0|||
145881542|NCT01332968|526072678|FG006|Induction Period|Death|0|||
145881543|NCT01332968|526072679|FG007|Induction Period|Death|0|||
145881544|NCT01332968|526072672|FG000|Induction Period|Non-compliance|1|||
145881545|NCT01332968|526072673|FG001|Induction Period|Non-compliance|0|||
145881546|NCT01332968|526072674|FG002|Induction Period|Non-compliance|0|||
145881547|NCT01332968|526072675|FG003|Induction Period|Non-compliance|0|||
145881548|NCT01332968|526072676|FG004|Induction Period|Non-compliance|0|||
145881549|NCT01332968|526072677|FG005|Induction Period|Non-compliance|0|||
145881550|NCT01332968|526072678|FG006|Induction Period|Non-compliance|0|||
145881551|NCT01332968|526072679|FG007|Induction Period|Non-compliance|0|||
145881552|NCT01332968|526072672|FG000|Induction Period|Other|2|||
145881553|NCT01332968|526072673|FG001|Induction Period|Other|2|||
145881554|NCT01332968|526072674|FG002|Induction Period|Other|0|||
145881555|NCT01332968|526072675|FG003|Induction Period|Other|0|||
145960262|NCT00379899|526365429|FG000|Overall Study|Lost to Follow-up|2|||
146215640|NCT03763708|527305257|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
146215641|NCT03763708|527305258|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
146215642|NCT03763708|527305259|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
146215643|NCT03763708|527305260|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
146215644|NCT03763708|527305261|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
146215645|NCT03763708|527305262|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
146215646|NCT03763708|527305263|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
146215647|NCT03763708|527305264|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
145881556|NCT01332968|526072676|FG004|Induction Period|Other|0|||
145881557|NCT01332968|526072677|FG005|Induction Period|Other|0|||
145881558|NCT01332968|526072678|FG006|Induction Period|Other|0|||
145881559|NCT01332968|526072679|FG007|Induction Period|Other|0|||
145881560|NCT01332968|526072672|FG000|Induction Period|Physician Decision|6|||
145881561|NCT01332968|526072673|FG001|Induction Period|Physician Decision|1|||
145881562|NCT01332968|526072674|FG002|Induction Period|Physician Decision|0|||
145881563|NCT01332968|526072675|FG003|Induction Period|Physician Decision|0|||
145881564|NCT01332968|526072676|FG004|Induction Period|Physician Decision|0|||
146084247|NCT00045942|526827957|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
146084248|NCT00045942|526827958|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
146084249|NCT00045942|526827950|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
146084250|NCT00045942|526827951|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
146084251|NCT00045942|526827952|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
146084252|NCT00045942|526827953|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
146084253|NCT00045942|526827954|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
146084254|NCT00045942|526827955|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
146084255|NCT00045942|526827956|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
146084256|NCT00045942|526827957|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
146084257|NCT00045942|526827958|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
146084258|NCT00045942|526827950|FG000|PKC412A2104E1|Lack of Efficacy|0|||
146084259|NCT00045942|526827951|FG001|PKC412A2104E1|Lack of Efficacy|11|||
146084260|NCT00045942|526827952|FG002|PKC412A2104E1|Lack of Efficacy|11|||
146084261|NCT00045942|526827953|FG003|PKC412A2104E1|Lack of Efficacy|23|||
146084262|NCT00045942|526827954|FG004|PKC412A2104E1|Lack of Efficacy|17|||
146084263|NCT00045942|526827955|FG005|PKC412A2104E1|Lack of Efficacy|0|||
146084264|NCT00045942|526827956|FG006|PKC412A2104E1|Lack of Efficacy|0|||
146084265|NCT00045942|526827957|FG007|PKC412A2104E1|Lack of Efficacy|0|||
146084266|NCT00045942|526827958|FG008|PKC412A2104E1|Lack of Efficacy|0|||
146084267|NCT00045942|526827950|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
146084268|NCT00045942|526827951|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
146084269|NCT00045942|526827952|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
146084270|NCT00045942|526827953|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
146084271|NCT00045942|526827954|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
146084272|NCT00045942|526827955|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
146084273|NCT00045942|526827956|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
146084274|NCT00045942|526827957|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
146084275|NCT00045942|526827958|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
146084276|NCT00045942|526827950|FG000|PKC412A2104E1|Adverse Event|0|||
146084277|NCT00045942|526827951|FG001|PKC412A2104E1|Adverse Event|1|||
146084278|NCT00045942|526827952|FG002|PKC412A2104E1|Adverse Event|1|||
146084279|NCT00045942|526827953|FG003|PKC412A2104E1|Adverse Event|3|||
146084280|NCT00045942|526827954|FG004|PKC412A2104E1|Adverse Event|6|||
146084281|NCT00045942|526827955|FG005|PKC412A2104E1|Adverse Event|0|||
146215648|NCT03763708|527305265|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
146215649|NCT05470400|527305266|FG000|Overall Study|Lost to Follow-up|0|||
146084282|NCT00045942|526827956|FG006|PKC412A2104E1|Adverse Event|0|||
146084283|NCT00045942|526827957|FG007|PKC412A2104E1|Adverse Event|0|||
146084284|NCT00045942|526827958|FG008|PKC412A2104E1|Adverse Event|0|||
146084285|NCT00045942|526827950|FG000|PKC412A2104E1|Death|0|||
146084286|NCT00045942|526827951|FG001|PKC412A2104E1|Death|4|||
146084287|NCT00045942|526827952|FG002|PKC412A2104E1|Death|1|||
146215650|NCT05470400|527305267|FG001|Overall Study|Lost to Follow-up|0|||
146215651|NCT05470400|527305268|FG002|Overall Study|Lost to Follow-up|0|||
146215652|NCT05470400|527305269|FG003|Overall Study|Lost to Follow-up|0|||
146215653|NCT05470400|527305270|FG004|Overall Study|Lost to Follow-up|0|||
146215654|NCT05470400|527305271|FG005|Overall Study|Lost to Follow-up|0|||
146215655|NCT05470400|527305272|FG006|Overall Study|Lost to Follow-up|0|||
146084288|NCT00045942|526827953|FG003|PKC412A2104E1|Death|1|||
146084289|NCT00045942|526827954|FG004|PKC412A2104E1|Death|1|||
146215656|NCT05470400|527305273|FG007|Overall Study|Lost to Follow-up|1|||
146084290|NCT00045942|526827955|FG005|PKC412A2104E1|Death|0|||
146084291|NCT00045942|526827956|FG006|PKC412A2104E1|Death|0|||
146084292|NCT00045942|526827957|FG007|PKC412A2104E1|Death|0|||
146084293|NCT00045942|526827958|FG008|PKC412A2104E1|Death|0|||
146215657|NCT05470400|527305266|FG000|Overall Study|Withdrawal by Subject|1|||
146215658|NCT05470400|527305267|FG001|Overall Study|Withdrawal by Subject|0|||
146215659|NCT05470400|527305268|FG002|Overall Study|Withdrawal by Subject|0|||
146215660|NCT05470400|527305269|FG003|Overall Study|Withdrawal by Subject|0|||
145881565|NCT01332968|526072677|FG005|Induction Period|Physician Decision|0|||
145881566|NCT01332968|526072678|FG006|Induction Period|Physician Decision|0|||
145881567|NCT01332968|526072679|FG007|Induction Period|Physician Decision|0|||
145881568|NCT01332968|526072672|FG000|Induction Period|Progressive Disease|15|||
145881569|NCT01332968|526072673|FG001|Induction Period|Progressive Disease|7|||
145881570|NCT01332968|526072674|FG002|Induction Period|Progressive Disease|0|||
145881571|NCT01332968|526072675|FG003|Induction Period|Progressive Disease|0|||
145881572|NCT01332968|526072676|FG004|Induction Period|Progressive Disease|0|||
145881573|NCT01332968|526072677|FG005|Induction Period|Progressive Disease|0|||
145881574|NCT01332968|526072678|FG006|Induction Period|Progressive Disease|0|||
145881575|NCT01332968|526072679|FG007|Induction Period|Progressive Disease|0|||
145881576|NCT01332968|526072672|FG000|Induction Period|Protocol Violation|3|||
146215661|NCT05470400|527305270|FG004|Overall Study|Withdrawal by Subject|0|||
146215662|NCT05470400|527305271|FG005|Overall Study|Withdrawal by Subject|1|||
146215663|NCT05470400|527305272|FG006|Overall Study|Withdrawal by Subject|0|||
145881577|NCT01332968|526072673|FG001|Induction Period|Protocol Violation|4|||
145881578|NCT01332968|526072674|FG002|Induction Period|Protocol Violation|0|||
145881579|NCT01332968|526072675|FG003|Induction Period|Protocol Violation|0|||
145881580|NCT01332968|526072676|FG004|Induction Period|Protocol Violation|0|||
146215664|NCT05470400|527305273|FG007|Overall Study|Withdrawal by Subject|2|||
146215665|NCT03436745|527305282|FG000|Overall Study|Ineligible|0|||
146215666|NCT03436745|527305283|FG001|Overall Study|Ineligible|0|||
146215667|NCT03436745|527305284|FG002|Overall Study|Ineligible|1|||
146215668|NCT04588298|527305285|FG000|Overall Study|Adverse Event|0|||
146215669|NCT04588298|527305286|FG001|Overall Study|Adverse Event|0|||
146215670|NCT04588298|527305287|FG002|Overall Study|Adverse Event|1|||
146215671|NCT04588298|527305288|FG003|Overall Study|Adverse Event|0|||
146215672|NCT04588298|527305289|FG004|Overall Study|Adverse Event|2|||
146215673|NCT04588298|527305285|FG000|Overall Study|Withdrawal by Subject|1|||
146215674|NCT04588298|527305286|FG001|Overall Study|Withdrawal by Subject|0|||
146215675|NCT04588298|527305287|FG002|Overall Study|Withdrawal by Subject|0|||
146215676|NCT04588298|527305288|FG003|Overall Study|Withdrawal by Subject|1|||
146215677|NCT04588298|527305289|FG004|Overall Study|Withdrawal by Subject|0|||
146215678|NCT05592418|527305290|FG000|Overall Study|Adverse Event|1|||
146215679|NCT05592418|527305291|FG001|Overall Study|Adverse Event|0|||
146215680|NCT05592418|527305290|FG000|Overall Study|Lost to Follow-up|1|||
146215681|NCT05592418|527305291|FG001|Overall Study|Lost to Follow-up|3|||
146215682|NCT05592418|527305290|FG000|Overall Study|Withdrawal by Subject|2|||
146215683|NCT05592418|527305291|FG001|Overall Study|Withdrawal by Subject|7|||
146215684|NCT05371652|527305292|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
146215685|NCT05371652|527305292|FG000|Overall Study|Withdrawal by Subject|12|||
146215686|NCT05371652|527305292|FG000|Overall Study|Adverse Event|1|||
146215687|NCT05371652|527305292|FG000|Overall Study|Other|11|||
146215688|NCT03978871|527305293|FG000|Overall Study|Lost to Follow-up|11|||
146215689|NCT03978871|527305294|FG001|Overall Study|Lost to Follow-up|12|||
146215690|NCT01331005|527307111|FG000|Overall Study|Lost to Follow-up|2|||
146215691|NCT01331005|527307112|FG001|Overall Study|Lost to Follow-up|1|||
146215692|NCT01331005|527307111|FG000|Overall Study|Withdrawal by Subject|2|||
146215693|NCT01331005|527307112|FG001|Overall Study|Withdrawal by Subject|3|||
146215694|NCT03016169|527307113|FG000|Overall Study|Lost to Follow-up|4|||
146215695|NCT03016169|527307113|FG000|Overall Study|Death|54|||
146215696|NCT03016169|527307113|FG000|Overall Study|Device Explant|11|||
146215697|NCT03016169|527307113|FG000|Overall Study|Withdrawal by Subject|19|||
146215698|NCT03016169|527307113|FG000|Overall Study|Other Reasons|1|||
146215699|NCT03131648|527307115|FG000|Initial Treatment Period|Not dosed|2|||
146215700|NCT03131648|527307116|FG001|Initial Treatment Period|Not dosed|2|||
146215701|NCT03131648|527307117|FG002|Initial Treatment Period|Not dosed|0|||
146215702|NCT03131648|527307118|FG003|Initial Treatment Period|Not dosed|0|||
146215703|NCT03131648|527307119|FG004|Initial Treatment Period|Not dosed|0|||
146215704|NCT03131648|527307120|FG005|Initial Treatment Period|Not dosed|0|||
146215705|NCT03131648|527307121|FG006|Initial Treatment Period|Not dosed|0|||
145881581|NCT01332968|526072677|FG005|Induction Period|Protocol Violation|0|||
145881582|NCT01332968|526072678|FG006|Induction Period|Protocol Violation|0|||
145881583|NCT01332968|526072679|FG007|Induction Period|Protocol Violation|0|||
145881584|NCT01332968|526072672|FG000|Induction Period|Withdrawal by Subject|3|||
145881585|NCT01332968|526072673|FG001|Induction Period|Withdrawal by Subject|5|||
145881586|NCT01332968|526072674|FG002|Induction Period|Withdrawal by Subject|0|||
145881587|NCT01332968|526072675|FG003|Induction Period|Withdrawal by Subject|0|||
145881588|NCT01332968|526072676|FG004|Induction Period|Withdrawal by Subject|0|||
145881589|NCT01332968|526072677|FG005|Induction Period|Withdrawal by Subject|0|||
146215706|NCT03131648|527307122|FG007|Initial Treatment Period|Not dosed|0|||
146215707|NCT03131648|527307115|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
146215708|NCT03131648|527307116|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
146215709|NCT03131648|527307117|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215710|NCT03131648|527307118|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215711|NCT03131648|527307119|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215712|NCT03131648|527307120|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215713|NCT03131648|527307121|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215714|NCT03131648|527307122|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146215715|NCT03131648|527307115|FG000|Open-label Treatment|Discontinued IMP|0|||
146215716|NCT03131648|527307116|FG001|Open-label Treatment|Discontinued IMP|0|||
146215717|NCT03131648|527307117|FG002|Open-label Treatment|Discontinued IMP|0|||
146215718|NCT03131648|527307118|FG003|Open-label Treatment|Discontinued IMP|0|||
146215719|NCT03131648|527307119|FG004|Open-label Treatment|Discontinued IMP|0|||
146215720|NCT03131648|527307120|FG005|Open-label Treatment|Discontinued IMP|0|||
146215721|NCT03131648|527307121|FG006|Open-label Treatment|Discontinued IMP|112|||
146215722|NCT03131648|527307122|FG007|Open-label Treatment|Discontinued IMP|0|||
146215723|NCT03131648|527307115|FG000|Open-label Treatment|Completed Week 50|0|||
146287625|NCT01201317|527569278|FG001|Overall Study|Withdrawal by Subject|0|||
146215724|NCT03131648|527307116|FG001|Open-label Treatment|Completed Week 50|0|||
146215725|NCT03131648|527307117|FG002|Open-label Treatment|Completed Week 50|0|||
146215726|NCT03131648|527307118|FG003|Open-label Treatment|Completed Week 50|0|||
146215727|NCT03131648|527307119|FG004|Open-label Treatment|Completed Week 50|0|||
146215728|NCT03131648|527307120|FG005|Open-label Treatment|Completed Week 50|0|||
146215729|NCT03131648|527307121|FG006|Open-label Treatment|Completed Week 50|6|||
146215730|NCT03131648|527307122|FG007|Open-label Treatment|Completed Week 50|0|||
146215731|NCT03131648|527307115|FG000|Maintenance Treatment Period|Not dosed|0|||
146215732|NCT03131648|527307116|FG001|Maintenance Treatment Period|Not dosed|0|||
146215733|NCT03131648|527307117|FG002|Maintenance Treatment Period|Not dosed|3|||
146215734|NCT03131648|527307118|FG003|Maintenance Treatment Period|Not dosed|2|||
146215735|NCT03131648|527307119|FG004|Maintenance Treatment Period|Not dosed|1|||
146215736|NCT03131648|527307120|FG005|Maintenance Treatment Period|Not dosed|0|||
146215737|NCT03131648|527307121|FG006|Maintenance Treatment Period|Not dosed|0|||
146215738|NCT03131648|527307122|FG007|Maintenance Treatment Period|Not dosed|0|||
146215739|NCT03131648|527307115|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
146215740|NCT03131648|527307116|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
146215741|NCT03131648|527307117|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
146215742|NCT03131648|527307118|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
145881590|NCT01332968|526072678|FG006|Induction Period|Withdrawal by Subject|0|||
145881591|NCT01332968|526072679|FG007|Induction Period|Withdrawal by Subject|0|||
145881592|NCT01332968|526072672|FG000|Induction Period|Randomised but not treated|4|||
145881593|NCT01332968|526072673|FG001|Induction Period|Randomised but not treated|7|||
145881594|NCT01332968|526072674|FG002|Induction Period|Randomised but not treated|0|||
145881595|NCT01332968|526072675|FG003|Induction Period|Randomised but not treated|0|||
145881596|NCT01332968|526072676|FG004|Induction Period|Randomised but not treated|0|||
145881597|NCT01332968|526072677|FG005|Induction Period|Randomised but not treated|0|||
145881598|NCT01332968|526072678|FG006|Induction Period|Randomised but not treated|0|||
145881599|NCT01332968|526072679|FG007|Induction Period|Randomised but not treated|0|||
145881600|NCT01332968|526072672|FG000|Maintenance/Observation Period|Adverse Event|0|||
145881601|NCT01332968|526072673|FG001|Maintenance/Observation Period|Adverse Event|0|||
145881602|NCT01332968|526072674|FG002|Maintenance/Observation Period|Adverse Event|53|||
145881603|NCT01332968|526072675|FG003|Maintenance/Observation Period|Adverse Event|66|||
145881604|NCT01332968|526072676|FG004|Maintenance/Observation Period|Adverse Event|0|||
145881605|NCT01332968|526072677|FG005|Maintenance/Observation Period|Adverse Event|0|||
145881606|NCT01332968|526072678|FG006|Maintenance/Observation Period|Adverse Event|0|||
145881607|NCT01332968|526072679|FG007|Maintenance/Observation Period|Adverse Event|0|||
145881608|NCT01332968|526072672|FG000|Maintenance/Observation Period|Death|0|||
145881609|NCT01332968|526072673|FG001|Maintenance/Observation Period|Death|0|||
145881610|NCT01332968|526072674|FG002|Maintenance/Observation Period|Death|5|||
146215743|NCT03131648|527307119|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
146215744|NCT03131648|527307120|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
146287626|NCT01201317|527569279|FG002|Overall Study|Withdrawal by Subject|3|||
146287627|NCT01201317|527569277|FG000|Overall Study|Adverse Event|2|||
146287628|NCT01201317|527569278|FG001|Overall Study|Adverse Event|2|||
146287629|NCT01201317|527569279|FG002|Overall Study|Adverse Event|2|||
146287630|NCT01201317|527569277|FG000|Overall Study|Screen failure|1|||
146287631|NCT01201317|527569278|FG001|Overall Study|Screen failure|1|||
146287632|NCT01201317|527569279|FG002|Overall Study|Screen failure|0|||
146287633|NCT01201317|527569277|FG000|Overall Study|Protocol Violation|0|||
146215745|NCT03131648|527307121|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
146215746|NCT03131648|527307122|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
146215747|NCT03131648|527307115|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146215748|NCT03131648|527307116|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146215749|NCT03131648|527307117|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
146215750|NCT03131648|527307118|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
146287634|NCT01201317|527569278|FG001|Overall Study|Protocol Violation|1|||
146287635|NCT01201317|527569279|FG002|Overall Study|Protocol Violation|1|||
146287636|NCT01201317|527569277|FG000|Overall Study|Death|0|||
146287637|NCT01201317|527569278|FG001|Overall Study|Death|1|||
146287638|NCT01201317|527569279|FG002|Overall Study|Death|0|||
146287639|NCT01201317|527569277|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146287640|NCT01201317|527569278|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146287641|NCT01201317|527569279|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146287642|NCT01201317|527569277|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
146287643|NCT01201317|527569278|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
146287644|NCT01201317|527569279|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
146287645|NCT01201317|527569277|FG000|Overall Study|Decrease in renal function|0|||
146287646|NCT01201317|527569278|FG001|Overall Study|Decrease in renal function|1|||
146287647|NCT01201317|527569279|FG002|Overall Study|Decrease in renal function|0|||
146287648|NCT01201317|527569277|FG000|Overall Study|Lack of Efficacy|1|||
146287649|NCT01201317|527569278|FG001|Overall Study|Lack of Efficacy|0|||
146287650|NCT01201317|527569279|FG002|Overall Study|Lack of Efficacy|0|||
146287651|NCT01201317|527569277|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
146287652|NCT01201317|527569278|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
146287653|NCT01201317|527569279|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
145960263|NCT00379899|526365430|FG001|Overall Study|Lost to Follow-up|4|||
145960264|NCT00379899|526365429|FG000|Overall Study|Physician Decision|3|||
145960265|NCT00379899|526365430|FG001|Overall Study|Physician Decision|4|||
145960266|NCT00379899|526365429|FG000|Overall Study|Withdrawal by Subject|5|||
146215751|NCT03131648|527307119|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
146215752|NCT03131648|527307120|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
146215753|NCT03131648|527307121|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146215754|NCT03131648|527307122|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146215755|NCT03131648|527307115|FG000|Maintenance Treatment Period|Completed Week 50|0|||
146215756|NCT03131648|527307116|FG001|Maintenance Treatment Period|Completed Week 50|0|||
146215757|NCT03131648|527307117|FG002|Maintenance Treatment Period|Completed Week 50|0|||
146215758|NCT03131648|527307118|FG003|Maintenance Treatment Period|Completed Week 50|0|||
146215759|NCT03131648|527307119|FG004|Maintenance Treatment Period|Completed Week 50|1|||
146215760|NCT03131648|527307120|FG005|Maintenance Treatment Period|Completed Week 50|0|||
146215761|NCT03131648|527307121|FG006|Maintenance Treatment Period|Completed Week 50|0|||
146215762|NCT03131648|527307122|FG007|Maintenance Treatment Period|Completed Week 50|0|||
146215763|NCT03131648|527307115|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
146215764|NCT03131648|527307116|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
146215765|NCT03131648|527307117|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
146215766|NCT03131648|527307118|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
146287654|NCT02079610|527569280|FG000|Overall Study|Withdrawal by Subject|1|||
145960267|NCT00379899|526365430|FG001|Overall Study|Withdrawal by Subject|5|||
145960268|NCT00379899|526365429|FG000|Overall Study|Ineligibility determined|0|||
145960269|NCT00379899|526365430|FG001|Overall Study|Ineligibility determined|1|||
145960270|NCT00379899|526365429|FG000|Overall Study|Noncompliance|1|||
145960271|NCT00379899|526365430|FG001|Overall Study|Noncompliance|1|||
145960272|NCT00379899|526365429|FG000|Overall Study|Parathyroidectomy|0|||
145960273|NCT00379899|526365430|FG001|Overall Study|Parathyroidectomy|2|||
146287655|NCT02079610|527569281|FG001|Overall Study|Withdrawal by Subject|1|||
146287656|NCT04964388|527569282|FG000|Overall Study|Lost to Follow-up|3|||
145960274|NCT00379899|526365429|FG000|Overall Study|Renal transplantation|5|||
145960275|NCT00379899|526365430|FG001|Overall Study|Renal transplantation|4|||
145960276|NCT00379899|526365429|FG000|Overall Study|Coronary artery bypass graft|1|||
146287657|NCT04964388|527569283|FG001|Overall Study|Lost to Follow-up|2|||
146287658|NCT01052103|527569284|FG000|Overall Study|Adverse Event|10|||
145960277|NCT00379899|526365430|FG001|Overall Study|Coronary artery bypass graft|1|||
146215767|NCT03131648|527307119|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
146287659|NCT01052103|527569285|FG001|Overall Study|Adverse Event|6|||
145881611|NCT01332968|526072675|FG003|Maintenance/Observation Period|Death|6|||
145881612|NCT01332968|526072676|FG004|Maintenance/Observation Period|Death|0|||
145881613|NCT01332968|526072677|FG005|Maintenance/Observation Period|Death|0|||
145881614|NCT01332968|526072678|FG006|Maintenance/Observation Period|Death|0|||
145881615|NCT01332968|526072679|FG007|Maintenance/Observation Period|Death|0|||
145881616|NCT01332968|526072672|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
145881617|NCT01332968|526072673|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
145881618|NCT01332968|526072674|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
145881619|NCT01332968|526072675|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
146215768|NCT03131648|527307120|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
146215769|NCT03131648|527307121|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
146215770|NCT03131648|527307122|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
146215771|NCT04150718|527307130|FG000|Overall Study|Withdrawal by Subject|2|||
146215772|NCT04150718|527307131|FG001|Overall Study|Withdrawal by Subject|7|||
146215773|NCT04150718|527307132|FG002|Overall Study|Withdrawal by Subject|1|||
146215774|NCT04150718|527307130|FG000|Overall Study|Lost to Follow-up|1|||
146215775|NCT04150718|527307131|FG001|Overall Study|Lost to Follow-up|2|||
146215776|NCT04150718|527307132|FG002|Overall Study|Lost to Follow-up|0|||
146215777|NCT04150718|527307130|FG000|Overall Study|Ineligible|1|||
146215778|NCT04150718|527307131|FG001|Overall Study|Ineligible|0|||
146215779|NCT04150718|527307132|FG002|Overall Study|Ineligible|10|||
146215780|NCT02729311|527307134|FG000|Overall Study|Withdrawal by Subject|8|||
146215781|NCT02729311|527307135|FG001|Overall Study|Withdrawal by Subject|2|||
146215782|NCT05324124|527307136|FG000|Period 1|Withdrawal by Subject|1|||
146215783|NCT05324124|527307137|FG001|Period 1|Withdrawal by Subject|0|||
146215784|NCT05324124|527307136|FG000|Period 1|Physician Decision|0|||
146215785|NCT05324124|527307137|FG001|Period 1|Physician Decision|1|||
146215786|NCT04034251|527307138|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
146215787|NCT04034251|527307139|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
146215788|NCT04034251|527307140|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
146215789|NCT05034952|527307141|FG000|Overall Study|Adverse Event|1|||
146215790|NCT05034952|527307142|FG001|Overall Study|Adverse Event|0|||
146215791|NCT05034952|527307143|FG002|Overall Study|Adverse Event|0|||
146215792|NCT05034952|527307144|FG003|Overall Study|Adverse Event|0|||
146215793|NCT05034952|527307141|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146215794|NCT05034952|527307142|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146215795|NCT05034952|527307143|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
146215796|NCT05034952|527307144|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
146215797|NCT05034952|527307141|FG000|Overall Study|Lost to Follow-up|1|||
145960278|NCT00379899|526365429|FG000|Overall Study|Other protocol-specified criteria|3|||
145960279|NCT00379899|526365430|FG001|Overall Study|Other protocol-specified criteria|4|||
145960280|NCT00379899|526365429|FG000|Overall Study|Other|3|||
145960281|NCT00379899|526365430|FG001|Overall Study|Other|1|||
145960282|NCT01922258|526365431|FG000|Overall Study|Lost to Follow-up|1|||
145960283|NCT01922258|526365432|FG001|Overall Study|Lost to Follow-up|1|||
145960284|NCT01922258|526365431|FG000|Overall Study|Adverse Event|9|||
145960285|NCT01922258|526365432|FG001|Overall Study|Adverse Event|2|||
145960286|NCT01922258|526365431|FG000|Overall Study|Met Withdrawal Criteria|0|||
145960287|NCT01922258|526365432|FG001|Overall Study|Met Withdrawal Criteria|4|||
145960288|NCT01922258|526365431|FG000|Overall Study|Withdrawn by the Investigator|1|||
145960289|NCT01922258|526365432|FG001|Overall Study|Withdrawn by the Investigator|4|||
145960290|NCT01922258|526365431|FG000|Overall Study|Withdrawal by participant|5|||
145960291|NCT01922258|526365432|FG001|Overall Study|Withdrawal by participant|5|||
145960292|NCT05225389|526365433|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
145960293|NCT01585246|526365434|FG000|Overall Study|Lost to Follow-up|0|||
145960294|NCT01585246|526365435|FG001|Overall Study|Lost to Follow-up|0|||
145960295|NCT01585246|526365436|FG002|Overall Study|Lost to Follow-up|2|||
145960296|NCT01585246|526365437|FG003|Overall Study|Lost to Follow-up|1|||
145960297|NCT01585246|526365438|FG004|Overall Study|Lost to Follow-up|0|||
145960298|NCT01585246|526365434|FG000|Overall Study|Protocol Violation|0|||
145960299|NCT01585246|526365435|FG001|Overall Study|Protocol Violation|0|||
145960300|NCT01585246|526365436|FG002|Overall Study|Protocol Violation|0|||
145960301|NCT01585246|526365437|FG003|Overall Study|Protocol Violation|0|||
145960302|NCT01585246|526365438|FG004|Overall Study|Protocol Violation|1|||
145960303|NCT01585246|526365434|FG000|Overall Study|Withdrawal by Subject|0|||
145960304|NCT01585246|526365435|FG001|Overall Study|Withdrawal by Subject|0|||
145960305|NCT01585246|526365436|FG002|Overall Study|Withdrawal by Subject|1|||
145960306|NCT01585246|526365437|FG003|Overall Study|Withdrawal by Subject|2|||
145960307|NCT01585246|526365438|FG004|Overall Study|Withdrawal by Subject|1|||
145960308|NCT01585246|526365434|FG000|Overall Study|Other|0|||
145960309|NCT01585246|526365435|FG001|Overall Study|Other|1|||
146215798|NCT05034952|527307142|FG001|Overall Study|Lost to Follow-up|4|||
146215799|NCT05034952|527307143|FG002|Overall Study|Lost to Follow-up|3|||
146215800|NCT05034952|527307144|FG003|Overall Study|Lost to Follow-up|3|||
146215801|NCT05034952|527307141|FG000|Overall Study|Other|0|||
146215802|NCT05034952|527307142|FG001|Overall Study|Other|0|||
146215803|NCT05034952|527307143|FG002|Overall Study|Other|0|||
146215804|NCT05034952|527307144|FG003|Overall Study|Other|1|||
146215805|NCT02287610|527307145|FG000|Overall Study|Lost to Follow-up|3|||
146215806|NCT02287610|527307145|FG000|Overall Study|Withdrawal by Subject|8|||
146215807|NCT02287610|527307145|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
146215808|NCT04950660|527307150|FG000|Overall Study|Protocol Violation|4|||
146215809|NCT04950660|527307151|FG001|Overall Study|Protocol Violation|2|||
146215810|NCT04950660|527307150|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
146215811|NCT04950660|527307151|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
146215812|NCT04950660|527307150|FG000|Overall Study|Withdrawal by Subject|0|||
146215813|NCT04950660|527307151|FG001|Overall Study|Withdrawal by Subject|1|||
146215814|NCT04950660|527307150|FG000|Overall Study|Hypotension|1|||
146215815|NCT04950660|527307151|FG001|Overall Study|Hypotension|0|||
146215816|NCT04783935|527307166|FG000|Overall Study|Withdrawal by Subject|6|||
146215817|NCT04783935|527307166|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
146215818|NCT04783935|527307166|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
145881620|NCT01332968|526072676|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
145881621|NCT01332968|526072677|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
145881622|NCT01332968|526072678|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
145881623|NCT01332968|526072679|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
145881624|NCT01332968|526072672|FG000|Maintenance/Observation Period|Non-compliance|0|||
145881625|NCT01332968|526072673|FG001|Maintenance/Observation Period|Non-compliance|0|||
145881626|NCT01332968|526072674|FG002|Maintenance/Observation Period|Non-compliance|4|||
146215819|NCT04783935|527307166|FG000|Overall Study|Lost to Follow-up|3|||
146215820|NCT04783935|527307166|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
146215821|NCT02437318|527307168|FG000|Overall Study|Progressive disease|207|||
145881627|NCT01332968|526072675|FG003|Maintenance/Observation Period|Non-compliance|3|||
145881628|NCT01332968|526072676|FG004|Maintenance/Observation Period|Non-compliance|0|||
146215822|NCT02437318|527307169|FG001|Overall Study|Progressive disease|240|||
146084294|NCT00045942|526827950|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146215823|NCT02437318|527307168|FG000|Overall Study|Subject/guardian decision|24|||
146215824|NCT02437318|527307169|FG001|Overall Study|Subject/guardian decision|11|||
146215825|NCT02437318|527307168|FG000|Overall Study|Physician Decision|29|||
146215826|NCT02437318|527307169|FG001|Overall Study|Physician Decision|22|||
146215827|NCT02437318|527307168|FG000|Overall Study|Adverse Event|14|||
146215828|NCT02437318|527307169|FG001|Overall Study|Adverse Event|4|||
146215829|NCT02437318|527307168|FG000|Overall Study|Death|4|||
146215830|NCT02437318|527307169|FG001|Overall Study|Death|4|||
145881629|NCT01332968|526072677|FG005|Maintenance/Observation Period|Non-compliance|0|||
145881630|NCT01332968|526072678|FG006|Maintenance/Observation Period|Non-compliance|0|||
145881631|NCT01332968|526072679|FG007|Maintenance/Observation Period|Non-compliance|0|||
145881632|NCT01332968|526072672|FG000|Maintenance/Observation Period|Other|0|||
145881633|NCT01332968|526072673|FG001|Maintenance/Observation Period|Other|0|||
145881634|NCT01332968|526072674|FG002|Maintenance/Observation Period|Other|4|||
145881635|NCT01332968|526072675|FG003|Maintenance/Observation Period|Other|7|||
145881636|NCT01332968|526072676|FG004|Maintenance/Observation Period|Other|0|||
145881637|NCT01332968|526072677|FG005|Maintenance/Observation Period|Other|0|||
145881638|NCT01332968|526072678|FG006|Maintenance/Observation Period|Other|0|||
145881639|NCT01332968|526072679|FG007|Maintenance/Observation Period|Other|0|||
145881640|NCT01332968|526072672|FG000|Maintenance/Observation Period|Physician Decision|0|||
146084295|NCT00045942|526827951|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146287660|NCT01052103|527569284|FG000|Overall Study|Entry Criteria Not Met|3|||
146287661|NCT01052103|527569285|FG001|Overall Study|Entry Criteria Not Met|1|||
146287662|NCT01052103|527569284|FG000|Overall Study|Lost to Follow-up|3|||
145881641|NCT01332968|526072673|FG001|Maintenance/Observation Period|Physician Decision|0|||
145881642|NCT01332968|526072674|FG002|Maintenance/Observation Period|Physician Decision|14|||
145881643|NCT01332968|526072675|FG003|Maintenance/Observation Period|Physician Decision|19|||
146215831|NCT02437318|527307168|FG000|Overall Study|Protocol deviation|5|||
146215832|NCT02437318|527307169|FG001|Overall Study|Protocol deviation|7|||
146215833|NCT02437318|527307168|FG000|Overall Study|Sponsor decision|1|||
145960310|NCT01585246|526365436|FG002|Overall Study|Other|1|||
145960311|NCT01585246|526365437|FG003|Overall Study|Other|1|||
145960312|NCT01585246|526365438|FG004|Overall Study|Other|0|||
145960313|NCT04552132|526365439|FG000|Overall Study|Lost to Follow-up|4|||
145960314|NCT04552132|526365440|FG001|Overall Study|Lost to Follow-up|3|||
145960315|NCT04552132|526365439|FG000|Overall Study|Protocol Violation|1|||
145960316|NCT04552132|526365440|FG001|Overall Study|Protocol Violation|0|||
145960317|NCT01657162|526365441|FG000|Overall Study|Adverse Event|26|||
145960318|NCT01657162|526365442|FG001|Overall Study|Adverse Event|36|||
145960319|NCT01657162|526365441|FG000|Overall Study|Withdrawal by Subject|13|||
145960320|NCT01657162|526365442|FG001|Overall Study|Withdrawal by Subject|13|||
145960321|NCT01657162|526365441|FG000|Overall Study|Continuing Significant Deterioration|9|||
145960322|NCT01657162|526365442|FG001|Overall Study|Continuing Significant Deterioration|3|||
146215834|NCT02437318|527307169|FG001|Overall Study|Sponsor decision|0|||
146215835|NCT00920621|527307175|FG000|Overall Study|Lost to Follow-up|16|||
145881644|NCT01332968|526072676|FG004|Maintenance/Observation Period|Physician Decision|0|||
145881645|NCT01332968|526072677|FG005|Maintenance/Observation Period|Physician Decision|1|||
145881646|NCT01332968|526072678|FG006|Maintenance/Observation Period|Physician Decision|0|||
146084296|NCT00045942|526827952|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
146084297|NCT00045942|526827953|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
145881647|NCT01332968|526072679|FG007|Maintenance/Observation Period|Physician Decision|0|||
146084298|NCT00045942|526827954|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146215836|NCT00920621|527307176|FG001|Overall Study|Lost to Follow-up|17|||
145881648|NCT01332968|526072672|FG000|Maintenance/Observation Period|Progressive Disease|0|||
145881649|NCT01332968|526072673|FG001|Maintenance/Observation Period|Progressive Disease|0|||
146215837|NCT00920621|527307177|FG002|Overall Study|Lost to Follow-up|19|||
146215838|NCT00920621|527307178|FG003|Overall Study|Lost to Follow-up|21|||
146215839|NCT00920621|527307175|FG000|Overall Study|Fetal/neonatal deaths|16|||
146215840|NCT00920621|527307176|FG001|Overall Study|Fetal/neonatal deaths|14|||
146215841|NCT00920621|527307177|FG002|Overall Study|Fetal/neonatal deaths|16|||
146215842|NCT00920621|527307178|FG003|Overall Study|Fetal/neonatal deaths|14|||
146215843|NCT00920621|527307175|FG000|Overall Study|Blood sample not collected|22|||
146215844|NCT00920621|527307176|FG001|Overall Study|Blood sample not collected|14|||
146215845|NCT00920621|527307177|FG002|Overall Study|Blood sample not collected|0|||
146215846|NCT00920621|527307178|FG003|Overall Study|Blood sample not collected|0|||
146215847|NCT06074523|527307179|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
146215848|NCT06074523|527307179|FG000|Overall Study|Withdrawal by Subject|1|||
146215849|NCT01426425|527307180|FG000|Overall Study|Exited prior to EP study|22|||
146215850|NCT01426425|527307180|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
146215851|NCT01426425|527307180|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
146215852|NCT03281291|527307181|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
146215853|NCT03281291|527307182|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
146215854|NCT03281291|527307183|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
146215855|NCT03281291|527307184|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
146215856|NCT03281291|527307185|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
146215857|NCT03281291|527307181|FG000|Overall Study|Protocol Deviation|2|||
146215858|NCT03281291|527307182|FG001|Overall Study|Protocol Deviation|0|||
146215859|NCT03281291|527307183|FG002|Overall Study|Protocol Deviation|1|||
146215860|NCT03281291|527307184|FG003|Overall Study|Protocol Deviation|2|||
146215861|NCT03281291|527307185|FG004|Overall Study|Protocol Deviation|1|||
146215862|NCT03281291|527307181|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
146215863|NCT03281291|527307182|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146235067|NCT00622700|527378450|FG003|Extension Treatment Period|Adverse Event|5|||
145960323|NCT01657162|526365441|FG000|Overall Study|Refusal of Treatment|4|||
145960324|NCT01657162|526365442|FG001|Overall Study|Refusal of Treatment|6|||
145960325|NCT01657162|526365441|FG000|Overall Study|Lost to Follow-up|3|||
145960326|NCT01657162|526365442|FG001|Overall Study|Lost to Follow-up|4|||
145960327|NCT01657162|526365441|FG000|Overall Study|Death|2|||
145960328|NCT01657162|526365442|FG001|Overall Study|Death|3|||
145960329|NCT01657162|526365441|FG000|Overall Study|Inability to Complete Study Procedures|1|||
145960330|NCT01657162|526365442|FG001|Overall Study|Inability to Complete Study Procedures|7|||
145960331|NCT01657162|526365441|FG000|Overall Study|Protocol Violation|1|||
145960332|NCT01657162|526365442|FG001|Overall Study|Protocol Violation|0|||
145960333|NCT01657162|526365441|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
145960334|NCT01657162|526365442|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
145960335|NCT01657162|526365441|FG000|Overall Study|Other than Specified|0|||
145960336|NCT01657162|526365442|FG001|Overall Study|Other than Specified|2|||
145960337|NCT03360019|526365445|FG000|Overall Study|Withdrawal by Subject|2|||
145960338|NCT03360019|526365446|FG001|Overall Study|Withdrawal by Subject|0|||
145960339|NCT03360019|526365447|FG002|Overall Study|Withdrawal by Subject|0|||
145960340|NCT03360019|526365445|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
145960341|NCT03360019|526365446|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
145960342|NCT03360019|526365447|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
145960343|NCT00096538|526365450|FG000|Overall Study|Withdrawal by Subject|1|||
146215864|NCT03281291|527307183|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
146215865|NCT03281291|527307184|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
146215866|NCT03281291|527307185|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
145960344|NCT01691378|526365452|FG000|Overall Study|Withdrawal by Subject|2|||
145960345|NCT01691378|526365453|FG001|Overall Study|Withdrawal by Subject|0|||
145960346|NCT01691378|526365452|FG000|Overall Study|Lost to Follow-up|5|||
145960347|NCT01691378|526365453|FG001|Overall Study|Lost to Follow-up|2|||
145960348|NCT02329327|526365458|FG000|Overall Study|Death|78|||
145960349|NCT02329327|526365459|FG001|Overall Study|Death|0|||
145960350|NCT02329327|526365458|FG000|Overall Study|Withdrawal by Subject|3|||
145960351|NCT02329327|526365459|FG001|Overall Study|Withdrawal by Subject|0|||
145960352|NCT02329327|526365458|FG000|Overall Study|Lost to Follow-up|4|||
145960353|NCT02329327|526365459|FG001|Overall Study|Lost to Follow-up|0|||
145960354|NCT04888494|526365463|FG000|Overall Study|Lost to Follow-up|2|||
145960355|NCT04888494|526365464|FG001|Overall Study|Lost to Follow-up|3|||
145960356|NCT04888494|526365463|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
145960357|NCT04888494|526365464|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
145960358|NCT03430856|526365465|FG000|Overall Study|Adverse Event|0|||
145960359|NCT03430856|526365466|FG001|Overall Study|Adverse Event|1|||
145960360|NCT03430856|526365467|FG002|Overall Study|Adverse Event|0|||
145960361|NCT03430856|526365465|FG000|Overall Study|Rescue criteria|1|||
145960362|NCT03430856|526365466|FG001|Overall Study|Rescue criteria|1|||
145960363|NCT03430856|526365467|FG002|Overall Study|Rescue criteria|0|||
145960364|NCT03430856|526365465|FG000|Overall Study|Voluntary withdrawal of consent|1|||
145960365|NCT03430856|526365466|FG001|Overall Study|Voluntary withdrawal of consent|1|||
145960366|NCT03430856|526365467|FG002|Overall Study|Voluntary withdrawal of consent|1|||
145960367|NCT00565604|526365471|FG000|Overall Study|Failure to treat|2|||
145960368|NCT00565604|526365471|FG000|Overall Study|Lost to Follow-up|2|||
145960369|NCT04754542|526365472|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
145960370|NCT04754542|526365473|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
145960371|NCT01718483|526367559|FG000|Overall Study|Withdrawal by Subject|14|||
145960372|NCT01718483|526367560|FG001|Overall Study|Withdrawal by Subject|12|||
146215867|NCT03281291|527307181|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
146215868|NCT03281291|527307182|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
146215869|NCT03281291|527307183|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
146215870|NCT03281291|527307184|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
146215871|NCT03281291|527307185|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
146215872|NCT03281291|527307181|FG000|Overall Study|Lost to Follow-up|10|||
146215873|NCT03281291|527307182|FG001|Overall Study|Lost to Follow-up|10|||
146215874|NCT03281291|527307183|FG002|Overall Study|Lost to Follow-up|4|||
146215875|NCT03281291|527307184|FG003|Overall Study|Lost to Follow-up|6|||
146215876|NCT03281291|527307185|FG004|Overall Study|Lost to Follow-up|10|||
146215877|NCT03281291|527307181|FG000|Overall Study|Other|0|||
146215878|NCT03281291|527307182|FG001|Overall Study|Other|2|||
146215879|NCT03281291|527307183|FG002|Overall Study|Other|0|||
146215880|NCT03281291|527307184|FG003|Overall Study|Other|2|||
145960373|NCT01718483|526367559|FG000|Overall Study|Adverse Event|5|||
145960374|NCT01718483|526367560|FG001|Overall Study|Adverse Event|12|||
145960375|NCT01718483|526367559|FG000|Overall Study|Lost to Follow-up|8|||
145960376|NCT01718483|526367560|FG001|Overall Study|Lost to Follow-up|3|||
146215881|NCT03281291|527307185|FG004|Overall Study|Other|1|||
146215882|NCT04956861|527307186|FG000|Overall Study|Withdrawal by Subject|4|||
146215883|NCT04956861|527307187|FG001|Overall Study|Withdrawal by Subject|4|||
145960377|NCT01718483|526367559|FG000|Overall Study|Protocol Violation|4|||
145960378|NCT01718483|526367560|FG001|Overall Study|Protocol Violation|2|||
145960379|NCT01718483|526367559|FG000|Overall Study|Other|1|||
145960380|NCT01718483|526367560|FG001|Overall Study|Other|4|||
145960381|NCT01718483|526367559|FG000|Overall Study|Pregnancy|1|||
145960382|NCT01718483|526367560|FG001|Overall Study|Pregnancy|1|||
145960383|NCT01718483|526367559|FG000|Overall Study|Lack of Efficacy|1|||
146287663|NCT01052103|527569285|FG001|Overall Study|Lost to Follow-up|5|||
146287664|NCT01052103|527569284|FG000|Overall Study|Protocol Violation|10|||
146287665|NCT01052103|527569285|FG001|Overall Study|Protocol Violation|4|||
146287666|NCT01052103|527569284|FG000|Overall Study|Scheduling conflict|2|||
146287667|NCT01052103|527569285|FG001|Overall Study|Scheduling conflict|1|||
146287668|NCT01052103|527569284|FG000|Overall Study|Sponsor Decision|2|||
146287669|NCT01052103|527569285|FG001|Overall Study|Sponsor Decision|0|||
146287670|NCT01052103|527569284|FG000|Overall Study|Withdrawal by Subject|3|||
146287671|NCT01052103|527569285|FG001|Overall Study|Withdrawal by Subject|6|||
146287672|NCT01052103|527569284|FG000|Overall Study|Perceived Lack of Efficacy|1|||
146287673|NCT01052103|527569285|FG001|Overall Study|Perceived Lack of Efficacy|0|||
146287674|NCT04874415|527569288|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287675|NCT04874415|527569289|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287676|NCT04874415|527569290|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287677|NCT04874415|527569291|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287678|NCT04874415|527569292|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287679|NCT04874415|527569293|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287680|NCT04874415|527569294|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146287681|NCT04874415|527569295|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287682|NCT04874415|527569296|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
146287683|NCT04874415|527569297|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146287684|NCT04874415|527569298|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287685|NCT04874415|527569299|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146287686|NCT04874415|527569300|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146287687|NCT04874415|527569301|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
146287688|NCT04874415|527569302|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
146287689|NCT04874415|527569303|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
146287690|NCT04874415|527569288|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287691|NCT04874415|527569289|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287692|NCT04874415|527569290|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287693|NCT04874415|527569291|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287694|NCT04874415|527569292|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287695|NCT04874415|527569293|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287696|NCT04874415|527569294|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287697|NCT04874415|527569295|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287698|NCT04874415|527569296|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287699|NCT04874415|527569297|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
146287700|NCT04874415|527569298|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287701|NCT04874415|527569299|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287702|NCT04874415|527569300|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287703|NCT04874415|527569301|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287704|NCT04874415|527569302|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
146287705|NCT04874415|527569303|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
146287706|NCT04874415|527569288|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287707|NCT04874415|527569289|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287708|NCT04874415|527569290|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287709|NCT04874415|527569291|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287710|NCT04874415|527569292|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
146287711|NCT04874415|527569293|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287712|NCT04874415|527569294|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287713|NCT04874415|527569295|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287714|NCT04874415|527569296|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287715|NCT04874415|527569297|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145960384|NCT01718483|526367560|FG001|Overall Study|Lack of Efficacy|0|||
146084299|NCT00045942|526827955|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146084300|NCT00045942|526827956|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146287716|NCT04874415|527569298|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145960385|NCT04110314|526367561|FG000|Overall Study|Did not meet inclusion criteria|35255|||
145960386|NCT04110314|526367562|FG001|Overall Study|Did not meet inclusion criteria|35104|||
145960387|NCT04110314|526367563|FG002|Overall Study|Did not meet inclusion criteria|35636|||
146287717|NCT04874415|527569299|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287718|NCT04874415|527569300|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287719|NCT04874415|527569301|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287720|NCT04874415|527569302|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287721|NCT04874415|527569303|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
146287722|NCT05062759|527569304|FG000|Overall Study|Death|0|||
146287723|NCT05062759|527569305|FG001|Overall Study|Death|1|||
146287724|NCT05062759|527569304|FG000|Overall Study|Lost to Follow-up|1|||
146287725|NCT05062759|527569305|FG001|Overall Study|Lost to Follow-up|0|||
146287726|NCT00903006|527569306|FG000|Overall Study|Withdrawal by Subject|2|||
146287727|NCT00903006|527569307|FG001|Overall Study|Withdrawal by Subject|0|||
146287728|NCT00903006|527569308|FG002|Overall Study|Withdrawal by Subject|0|||
146287729|NCT00903006|527569309|FG003|Overall Study|Withdrawal by Subject|0|||
146287730|NCT00903006|527569306|FG000|Overall Study|Progressive Disease|0|||
146287731|NCT00903006|527569307|FG001|Overall Study|Progressive Disease|3|||
146287732|NCT00903006|527569308|FG002|Overall Study|Progressive Disease|1|||
146287733|NCT00903006|527569309|FG003|Overall Study|Progressive Disease|0|||
146287734|NCT03405792|527569310|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
146287735|NCT03405792|527569311|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
146287736|NCT03405792|527569310|FG000|Overall Study|o Did not receive pembrolizumab|1|||
146287737|NCT03405792|527569311|FG001|Overall Study|o Did not receive pembrolizumab|0|||
146287738|NCT01383499|527569312|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
146287739|NCT01383499|527569313|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146287740|NCT01383499|527569314|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146287741|NCT01383499|527569315|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
146287742|NCT02572882|527569316|FG000|Overall Study|Withdrawal by Subject|1|||
146287743|NCT02572882|527569316|FG000|Overall Study|Participant received kidney transplant|1|||
146287744|NCT01079663|527569320|FG000|Overall Study|Adverse Event|0|||
146287745|NCT01079663|527569321|FG001|Overall Study|Adverse Event|2|||
146287746|NCT01079663|527569320|FG000|Overall Study|Protocol Violation|0|||
146287747|NCT01079663|527569321|FG001|Overall Study|Protocol Violation|2|||
146287748|NCT03587974|527569322|FG000|Overall Study|caregiver demented, care recipient died|3|||
146287749|NCT03587974|527569323|FG001|Overall Study|caregiver demented, care recipient died|3|||
146287750|NCT03587974|527569322|FG000|Overall Study|Withdrawal by Subject|2|||
146287751|NCT03587974|527569323|FG001|Overall Study|Withdrawal by Subject|1|||
145881650|NCT01332968|526072674|FG002|Maintenance/Observation Period|Progressive Disease|72|||
145881651|NCT01332968|526072675|FG003|Maintenance/Observation Period|Progressive Disease|40|||
145881652|NCT01332968|526072676|FG004|Maintenance/Observation Period|Progressive Disease|0|||
145881653|NCT01332968|526072677|FG005|Maintenance/Observation Period|Progressive Disease|0|||
145881654|NCT01332968|526072678|FG006|Maintenance/Observation Period|Progressive Disease|0|||
145881655|NCT01332968|526072679|FG007|Maintenance/Observation Period|Progressive Disease|0|||
146215884|NCT04956861|527307188|FG002|Overall Study|Withdrawal by Subject|2|||
145881656|NCT01332968|526072672|FG000|Maintenance/Observation Period|Protocol Violation|0|||
145881657|NCT01332968|526072673|FG001|Maintenance/Observation Period|Protocol Violation|0|||
145881658|NCT01332968|526072674|FG002|Maintenance/Observation Period|Protocol Violation|1|||
145881659|NCT01332968|526072675|FG003|Maintenance/Observation Period|Protocol Violation|1|||
145881660|NCT01332968|526072676|FG004|Maintenance/Observation Period|Protocol Violation|0|||
145881661|NCT01332968|526072677|FG005|Maintenance/Observation Period|Protocol Violation|0|||
145881662|NCT01332968|526072678|FG006|Maintenance/Observation Period|Protocol Violation|0|||
146215885|NCT04956861|527307186|FG000|Overall Study|Physician Decision|4|||
146215886|NCT04956861|527307187|FG001|Overall Study|Physician Decision|5|||
146215887|NCT04956861|527307188|FG002|Overall Study|Physician Decision|1|||
145881663|NCT01332968|526072679|FG007|Maintenance/Observation Period|Protocol Violation|0|||
145881664|NCT01332968|526072672|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
145881665|NCT01332968|526072673|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
146287752|NCT00372229|527569326|FG000|Study Phase|Graft loss|0|||
145881666|NCT01332968|526072674|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
146287753|NCT00372229|527569327|FG001|Study Phase|Graft loss|3|||
145881667|NCT01332968|526072675|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
145881668|NCT01332968|526072676|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
145881669|NCT01332968|526072677|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
145881670|NCT01332968|526072678|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
145881671|NCT01332968|526072679|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
145881672|NCT01332968|526072672|FG000|Follow-Up Period|Adverse Event|0|||
145881673|NCT01332968|526072673|FG001|Follow-Up Period|Adverse Event|0|||
145881674|NCT01332968|526072674|FG002|Follow-Up Period|Adverse Event|0|||
145881675|NCT01332968|526072675|FG003|Follow-Up Period|Adverse Event|0|||
145881676|NCT01332968|526072676|FG004|Follow-Up Period|Adverse Event|0|||
145881677|NCT01332968|526072677|FG005|Follow-Up Period|Adverse Event|0|||
145881678|NCT01332968|526072678|FG006|Follow-Up Period|Adverse Event|0|||
145881679|NCT01332968|526072679|FG007|Follow-Up Period|Adverse Event|4|||
146215888|NCT04294225|527307196|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
146215889|NCT04294225|527307196|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
146215890|NCT04294225|527307196|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
146215891|NCT04294225|527307196|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
146215892|NCT04294225|527307196|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
146215893|NCT01809691|527307197|FG000|Overall Study|Currently on Treatment|192|||
146215894|NCT01809691|527307198|FG001|Overall Study|Currently on Treatment|100|||
145960388|NCT04110314|526367564|FG003|Overall Study|Did not meet inclusion criteria|35135|||
145960389|NCT04110314|526367565|FG004|Overall Study|Did not meet inclusion criteria|35247|||
145960390|NCT04110314|526367566|FG005|Overall Study|Did not meet inclusion criteria|35727|||
145960391|NCT00974311|526367569|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
145960392|NCT00974311|526367570|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
145960393|NCT00974311|526367569|FG000|DB Phase (up to 24 Months)|Death|561|||
145960394|NCT00974311|526367570|FG001|DB Phase (up to 24 Months)|Death|298|||
145960395|NCT00974311|526367569|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
146287754|NCT00372229|527569326|FG000|Study Phase|Protocol Violation|3|||
146287755|NCT00372229|527569327|FG001|Study Phase|Protocol Violation|4|||
145881680|NCT01332968|526072672|FG000|Follow-Up Period|Death|0|||
145881681|NCT01332968|526072673|FG001|Follow-Up Period|Death|0|||
145881682|NCT01332968|526072674|FG002|Follow-Up Period|Death|0|||
145881683|NCT01332968|526072675|FG003|Follow-Up Period|Death|0|||
145881684|NCT01332968|526072676|FG004|Follow-Up Period|Death|0|||
145881685|NCT01332968|526072677|FG005|Follow-Up Period|Death|0|||
145881686|NCT01332968|526072678|FG006|Follow-Up Period|Death|27|||
145881687|NCT01332968|526072679|FG007|Follow-Up Period|Death|30|||
145881688|NCT01332968|526072672|FG000|Follow-Up Period|Lost to Follow-up|0|||
146215895|NCT01809691|527307197|FG000|Overall Study|No Protocol Treatment|10|||
146215896|NCT01809691|527307198|FG001|Overall Study|No Protocol Treatment|11|||
146215897|NCT01809691|527307197|FG000|Overall Study|Adverse Event|80|||
146215898|NCT01809691|527307198|FG001|Overall Study|Adverse Event|21|||
146215899|NCT01809691|527307197|FG000|Overall Study|Disease Progression|226|||
146215900|NCT01809691|527307198|FG001|Overall Study|Disease Progression|372|||
146215901|NCT01809691|527307197|FG000|Overall Study|Death|26|||
146215902|NCT01809691|527307198|FG001|Overall Study|Death|13|||
146215903|NCT01809691|527307197|FG000|Overall Study|Participant Refusal|70|||
146215904|NCT01809691|527307198|FG001|Overall Study|Participant Refusal|72|||
146215905|NCT01809691|527307197|FG000|Overall Study|Other, Not Specified|34|||
146215906|NCT01809691|527307198|FG001|Overall Study|Other, Not Specified|52|||
146215907|NCT02281955|527307212|FG000|Overall Study|Death|1|||
146215908|NCT02783300|527307218|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215909|NCT02783300|527307219|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215910|NCT02783300|527307220|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215911|NCT02783300|527307221|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215912|NCT02783300|527307222|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215913|NCT02783300|527307223|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215914|NCT02783300|527307224|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
146215915|NCT02783300|527307225|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215916|NCT02783300|527307226|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215917|NCT02783300|527307227|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215918|NCT02783300|527307228|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215919|NCT02783300|527307229|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215920|NCT02783300|527307230|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215921|NCT02783300|527307231|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215922|NCT02783300|527307232|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215923|NCT02783300|527307233|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215924|NCT02783300|527307234|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215925|NCT02783300|527307235|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215926|NCT02783300|527307236|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215927|NCT02783300|527307237|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215928|NCT02783300|527307238|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215929|NCT02783300|527307239|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215930|NCT02783300|527307240|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215931|NCT02783300|527307241|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215932|NCT02783300|527307242|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215933|NCT02783300|527307243|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146287756|NCT00372229|527569326|FG000|Study Phase|Consent withdrawn|16|||
146215934|NCT02783300|527307244|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
146215935|NCT02783300|527307218|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215936|NCT02783300|527307219|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215937|NCT02783300|527307220|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215938|NCT02783300|527307221|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
146215939|NCT02783300|527307222|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215940|NCT02783300|527307223|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215941|NCT02783300|527307224|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215942|NCT02783300|527307225|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215943|NCT02783300|527307226|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215944|NCT02783300|527307227|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215945|NCT02783300|527307228|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215946|NCT02783300|527307229|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215947|NCT02783300|527307230|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215948|NCT02783300|527307231|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215949|NCT02783300|527307232|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215950|NCT02783300|527307233|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215951|NCT02783300|527307234|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215952|NCT02783300|527307235|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215953|NCT02783300|527307236|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215954|NCT02783300|527307237|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215955|NCT02783300|527307238|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215956|NCT02783300|527307239|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215957|NCT02783300|527307240|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215958|NCT02783300|527307241|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215959|NCT02783300|527307242|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215960|NCT02783300|527307243|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215961|NCT02783300|527307244|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
146215962|NCT02783300|527307218|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
146215963|NCT02783300|527307219|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
146215964|NCT02783300|527307220|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
146215965|NCT02783300|527307221|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
146215966|NCT02783300|527307222|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
146215967|NCT02783300|527307223|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
146215968|NCT02783300|527307224|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
146215969|NCT02783300|527307225|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
146215970|NCT02783300|527307226|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
146215971|NCT02783300|527307227|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
146215972|NCT02783300|527307228|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
146215973|NCT02783300|527307229|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
146215974|NCT02783300|527307230|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
146215975|NCT02783300|527307231|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
146215976|NCT02783300|527307232|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
146215977|NCT02783300|527307233|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
146215978|NCT02783300|527307234|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
146215979|NCT02783300|527307235|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
146215980|NCT02783300|527307236|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
146215981|NCT02783300|527307237|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
146215982|NCT02783300|527307238|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
146215983|NCT02783300|527307239|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
146215984|NCT02783300|527307240|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
146215985|NCT02783300|527307241|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
146215986|NCT02783300|527307242|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
146215987|NCT02783300|527307243|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
146215988|NCT02783300|527307244|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
146215989|NCT02783300|527307218|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215990|NCT02783300|527307219|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215991|NCT02783300|527307220|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215992|NCT02783300|527307221|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215993|NCT02783300|527307222|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215994|NCT02783300|527307223|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145960396|NCT00974311|526367570|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
146215995|NCT02783300|527307224|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
146215996|NCT02783300|527307225|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215997|NCT02783300|527307226|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146215998|NCT02783300|527307227|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145960397|NCT00974311|526367569|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
146215999|NCT02783300|527307228|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216000|NCT02783300|527307229|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216001|NCT02783300|527307230|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
146216002|NCT02783300|527307231|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216003|NCT02783300|527307232|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216004|NCT02783300|527307233|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216005|NCT02783300|527307234|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216006|NCT02783300|527307235|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216007|NCT02783300|527307236|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216008|NCT02783300|527307237|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216009|NCT02783300|527307238|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216010|NCT02783300|527307239|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216011|NCT02783300|527307240|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216012|NCT02783300|527307241|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216013|NCT02783300|527307242|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216014|NCT02783300|527307243|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216015|NCT02783300|527307244|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
146216016|NCT02783300|527307218|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216017|NCT02783300|527307219|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216018|NCT02783300|527307220|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216019|NCT02783300|527307221|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216020|NCT02783300|527307222|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146216021|NCT02783300|527307223|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216022|NCT02783300|527307224|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146216023|NCT02783300|527307225|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216024|NCT02783300|527307226|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216025|NCT02783300|527307227|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
146216026|NCT02783300|527307228|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216027|NCT02783300|527307229|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216028|NCT02783300|527307230|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
146216029|NCT02783300|527307231|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216030|NCT02783300|527307232|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216031|NCT02783300|527307233|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216032|NCT02783300|527307234|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216033|NCT02783300|527307235|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216034|NCT02783300|527307236|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216035|NCT02783300|527307237|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216036|NCT02783300|527307238|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216037|NCT02783300|527307239|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216038|NCT02783300|527307240|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216039|NCT02783300|527307241|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216040|NCT02783300|527307242|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216041|NCT02783300|527307243|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216042|NCT02783300|527307244|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
146216043|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216044|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216045|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216046|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216047|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216048|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216049|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216050|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216051|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216052|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216053|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216054|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216055|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216056|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216057|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216058|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146216059|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216060|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
146216061|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
146216062|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146216063|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216064|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216065|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216066|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216067|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
146216068|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216069|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
146216070|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216071|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216072|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216073|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216074|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216075|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216076|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216077|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216078|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216079|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216080|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216081|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216082|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216083|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216084|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216085|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216086|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
146216087|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216088|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
146216089|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
146216090|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216091|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216092|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216093|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216094|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216095|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146216096|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
146084301|NCT00045942|526827957|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146084302|NCT00045942|526827958|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
146084303|NCT00045942|526827950|FG000|PKC412A2104E2|Lost to Follow-up|0|||
146084304|NCT00045942|526827951|FG001|PKC412A2104E2|Lost to Follow-up|0|||
146084305|NCT00045942|526827952|FG002|PKC412A2104E2|Lost to Follow-up|0|||
146084306|NCT00045942|526827953|FG003|PKC412A2104E2|Lost to Follow-up|0|||
146084307|NCT00045942|526827954|FG004|PKC412A2104E2|Lost to Follow-up|0|||
146084308|NCT00045942|526827955|FG005|PKC412A2104E2|Lost to Follow-up|0|||
146084309|NCT00045942|526827956|FG006|PKC412A2104E2|Lost to Follow-up|0|||
146084310|NCT00045942|526827957|FG007|PKC412A2104E2|Lost to Follow-up|3|||
146084311|NCT00045942|526827958|FG008|PKC412A2104E2|Lost to Follow-up|0|||
146084312|NCT00045942|526827950|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
146084313|NCT00045942|526827951|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
146084314|NCT00045942|526827952|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
146084315|NCT00045942|526827953|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
146216097|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146084316|NCT00045942|526827954|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
146084317|NCT00045942|526827955|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
146084318|NCT00045942|526827956|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
146216098|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216099|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216100|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216101|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145960398|NCT00974311|526367570|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
145960399|NCT00974311|526367569|FG000|DB Phase (up to 24 Months)|Other|1|||
145960400|NCT00974311|526367570|FG001|DB Phase (up to 24 Months)|Other|0|||
145960401|NCT00974311|526367569|FG000|OLE Phase (up to 77 Months)|Death|14|||
145960402|NCT00974311|526367570|FG001|OLE Phase (up to 77 Months)|Death|21|||
145960403|NCT00974311|526367569|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
145960404|NCT00974311|526367570|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
145960405|NCT00974311|526367569|FG000|OLE Phase (up to 77 Months)|Other|15|||
145960406|NCT00974311|526367570|FG001|OLE Phase (up to 77 Months)|Other|2|||
145960407|NCT00974311|526367569|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
145960408|NCT00974311|526367570|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
145960409|NCT00165503|526367571|FG000|Overall Study|Death|1|||
145960410|NCT00165503|526367571|FG000|Overall Study|Lost to Follow-up|12|||
145960411|NCT00165503|526367571|FG000|Overall Study|Unresectable|3|||
145960412|NCT02346708|526367572|FG000|Overall Study|Adverse Event|2|||
145960413|NCT02346708|526367573|FG001|Overall Study|Adverse Event|0|||
145960414|NCT02346708|526367572|FG000|Overall Study|Protocol Violation|0|||
145960415|NCT02346708|526367573|FG001|Overall Study|Protocol Violation|1|||
145960416|NCT02976519|526367574|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960417|NCT02976519|526367575|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
145960418|NCT02976519|526367576|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960419|NCT02976519|526367577|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960420|NCT02976519|526367578|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960421|NCT02976519|526367579|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960422|NCT02976519|526367580|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145960423|NCT02976519|526367574|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960424|NCT02976519|526367575|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960425|NCT02976519|526367576|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960426|NCT02976519|526367577|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
145960427|NCT02976519|526367578|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960428|NCT02976519|526367579|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960429|NCT02976519|526367580|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145960430|NCT02976519|526367574|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960431|NCT02976519|526367575|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960432|NCT02976519|526367576|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960433|NCT02976519|526367577|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960434|NCT02976519|526367578|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960435|NCT02976519|526367579|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145960436|NCT02976519|526367580|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
145960437|NCT02976519|526367574|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960438|NCT02976519|526367575|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960439|NCT02976519|526367576|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960440|NCT02976519|526367577|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960441|NCT02976519|526367578|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960442|NCT02976519|526367579|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145960443|NCT02976519|526367580|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
145960444|NCT02976519|526367574|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145960445|NCT02976519|526367575|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145960446|NCT02976519|526367576|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146216102|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216103|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216104|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216105|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216106|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216107|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216108|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145960447|NCT02976519|526367577|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145960448|NCT02976519|526367578|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146216109|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145960449|NCT02976519|526367579|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
146216110|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216111|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216112|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216113|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146216114|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216115|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146216116|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
146216117|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
146216118|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216119|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216120|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216121|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216122|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216123|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
146216124|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216125|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216126|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216127|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216128|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216129|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216130|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216131|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216132|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216133|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216134|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216135|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216136|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216137|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216138|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216139|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
146216140|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216141|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145960450|NCT02976519|526367580|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
145960451|NCT00928434|526367583|FG000|Overall Study|Adverse Event|14|||
145960452|NCT00928434|526367584|FG001|Overall Study|Adverse Event|5|||
145960453|NCT00928434|526367585|FG002|Overall Study|Adverse Event|18|||
145960454|NCT00928434|526367583|FG000|Overall Study|Protocol Violation|5|||
145960455|NCT00928434|526367584|FG001|Overall Study|Protocol Violation|0|||
145960456|NCT00928434|526367585|FG002|Overall Study|Protocol Violation|8|||
146216142|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216143|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216144|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216145|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216146|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
146216147|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216148|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216149|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216150|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
146216151|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216152|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216153|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216154|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216155|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216156|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216157|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216158|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216159|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216160|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216161|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216162|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216163|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216164|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
146216165|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
145960457|NCT00928434|526367583|FG000|Overall Study|Physician Decision|2|||
146216166|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
146216167|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
146216168|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216169|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
146216170|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
146216171|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216172|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216173|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216174|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216175|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216176|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216177|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
146216178|NCT02783300|527307218|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216179|NCT02783300|527307219|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216180|NCT02783300|527307220|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216181|NCT02783300|527307221|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216182|NCT02783300|527307222|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216183|NCT02783300|527307223|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216184|NCT02783300|527307224|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146287757|NCT00372229|527569327|FG001|Study Phase|Consent withdrawn|14|||
146287758|NCT00372229|527569326|FG000|Study Phase|Refused treatment/did not cooperate|3|||
146287759|NCT00372229|527569327|FG001|Study Phase|Refused treatment/did not cooperate|1|||
146287760|NCT00372229|527569326|FG000|Study Phase|Death|3|||
146287761|NCT00372229|527569327|FG001|Study Phase|Death|2|||
146287762|NCT00372229|527569326|FG000|Study Phase|Reason not specified|3|||
146287763|NCT00372229|527569327|FG001|Study Phase|Reason not specified|2|||
146287764|NCT00372229|527569326|FG000|Study Phase|Lost to Follow-up|3|||
146287765|NCT00372229|527569327|FG001|Study Phase|Lost to Follow-up|3|||
146287766|NCT00372229|527569326|FG000|Follow-Up Phase|Graft loss|8|||
146287767|NCT00372229|527569327|FG001|Follow-Up Phase|Graft loss|7|||
146287768|NCT00372229|527569326|FG000|Follow-Up Phase|Consent withdrawn|13|||
146287769|NCT00372229|527569327|FG001|Follow-Up Phase|Consent withdrawn|19|||
146287770|NCT00372229|527569326|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
146287771|NCT00372229|527569327|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
146287772|NCT00372229|527569326|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
145960458|NCT00928434|526367584|FG001|Overall Study|Physician Decision|0|||
145960459|NCT00928434|526367585|FG002|Overall Study|Physician Decision|3|||
145960460|NCT00928434|526367583|FG000|Overall Study|Lost to Follow-up|1|||
145960461|NCT00928434|526367584|FG001|Overall Study|Lost to Follow-up|0|||
145960462|NCT00928434|526367585|FG002|Overall Study|Lost to Follow-up|3|||
145960463|NCT00928434|526367583|FG000|Overall Study|Withdrawal by Subject|5|||
145960464|NCT00928434|526367584|FG001|Overall Study|Withdrawal by Subject|3|||
145960465|NCT00928434|526367585|FG002|Overall Study|Withdrawal by Subject|2|||
145960466|NCT00928434|526367583|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
145960467|NCT00928434|526367584|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
145960468|NCT00928434|526367585|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
146216185|NCT02783300|527307225|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216186|NCT02783300|527307226|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216187|NCT02783300|527307227|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216188|NCT02783300|527307228|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216189|NCT02783300|527307229|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216190|NCT02783300|527307230|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216191|NCT02783300|527307231|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
146216192|NCT02783300|527307232|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146216193|NCT02783300|527307233|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146216194|NCT02783300|527307234|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146216195|NCT02783300|527307235|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146216196|NCT02783300|527307236|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146216197|NCT02783300|527307237|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
146216198|NCT02783300|527307238|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146216199|NCT02783300|527307239|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146216200|NCT02783300|527307240|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
146216201|NCT02783300|527307241|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
146216202|NCT02783300|527307242|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
146216203|NCT02783300|527307243|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
146216204|NCT02783300|527307244|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
146216205|NCT02783300|527307218|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216206|NCT02783300|527307219|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216207|NCT02783300|527307220|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216208|NCT02783300|527307221|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216209|NCT02783300|527307222|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216210|NCT02783300|527307223|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216211|NCT02783300|527307224|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216212|NCT02783300|527307225|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216213|NCT02783300|527307226|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216214|NCT02783300|527307227|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216215|NCT02783300|527307228|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216216|NCT02783300|527307229|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216217|NCT02783300|527307230|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216218|NCT02783300|527307231|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216219|NCT02783300|527307232|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216220|NCT02783300|527307233|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216221|NCT02783300|527307234|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216222|NCT02783300|527307235|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216223|NCT02783300|527307236|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216224|NCT02783300|527307237|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216225|NCT02783300|527307238|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216226|NCT02783300|527307239|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216227|NCT02783300|527307240|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216228|NCT02783300|527307241|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216229|NCT02783300|527307242|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216230|NCT02783300|527307243|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
146216231|NCT02783300|527307244|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
146287773|NCT00372229|527569327|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
145960469|NCT00928434|526367583|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
145960470|NCT00928434|526367584|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
145960471|NCT00928434|526367585|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
145960472|NCT00928434|526367583|FG000|Overall Study|Other (not meeting above criteria)|5|||
145960473|NCT00928434|526367584|FG001|Overall Study|Other (not meeting above criteria)|1|||
145960474|NCT00928434|526367585|FG002|Overall Study|Other (not meeting above criteria)|2|||
145960475|NCT01278342|526367588|FG000|Overall Study|Physician Decision|0|||
146216232|NCT02783300|527307218|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216233|NCT02783300|527307219|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216234|NCT02783300|527307220|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216235|NCT02783300|527307221|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216236|NCT02783300|527307222|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216237|NCT02783300|527307223|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216238|NCT02783300|527307224|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216239|NCT02783300|527307225|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216240|NCT02783300|527307226|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216241|NCT02783300|527307227|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216242|NCT02783300|527307228|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216243|NCT02783300|527307229|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216244|NCT02783300|527307230|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216245|NCT02783300|527307231|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216246|NCT02783300|527307232|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216247|NCT02783300|527307233|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216248|NCT02783300|527307234|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216249|NCT02783300|527307235|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216250|NCT02783300|527307236|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216251|NCT02783300|527307237|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216252|NCT02783300|527307238|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216253|NCT02783300|527307239|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216254|NCT02783300|527307240|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216255|NCT02783300|527307241|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216256|NCT02783300|527307242|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216257|NCT02783300|527307243|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
146216258|NCT02783300|527307244|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
146216259|NCT03535272|527307245|FG000|Overall Study|Lost to Follow-up|71|||
146216260|NCT03535272|527307246|FG001|Overall Study|Lost to Follow-up|73|||
146216261|NCT02913872|527307253|FG000|Overall Study|Withdrawal by Subject|1|||
146216262|NCT04739956|527307256|FG000|Overall Study|Withdrawal by Subject|1|||
146216263|NCT04739956|527307257|FG001|Overall Study|Withdrawal by Subject|1|||
146216264|NCT03519581|527307258|FG000|Overall Study|Lost to Follow-up|3|||
146216265|NCT03519581|527307259|FG001|Overall Study|Lost to Follow-up|2|||
146216266|NCT03519581|527307258|FG000|Overall Study|Adverse Event|5|||
146216267|NCT03519581|527307259|FG001|Overall Study|Adverse Event|2|||
146216268|NCT03519581|527307258|FG000|Overall Study|Withdrawal by Subject|2|||
146216269|NCT03519581|527307259|FG001|Overall Study|Withdrawal by Subject|0|||
146216270|NCT03519581|527307258|FG000|Overall Study|Change to insurance|2|||
146216271|NCT03519581|527307259|FG001|Overall Study|Change to insurance|1|||
146216272|NCT03519581|527307258|FG000|Overall Study|Other|2|||
146216273|NCT03519581|527307259|FG001|Overall Study|Other|4|||
146216274|NCT03110315|527307260|FG000|Overall Study|Withdrawal by Subject|1|||
146216275|NCT03110315|527307261|FG001|Overall Study|Withdrawal by Subject|0|||
146216276|NCT03468218|527307266|FG000|Overall Study|Adverse Event|5|||
146216277|NCT03468218|527307266|FG000|Overall Study|Progressive Disease|16|||
146216278|NCT03468218|527307266|FG000|Overall Study|Death|1|||
146216279|NCT03468218|527307266|FG000|Overall Study|Alternate therapy|1|||
146216280|NCT03468218|527307266|FG000|Overall Study|Withdrawal by Subject|2|||
146216281|NCT02312557|527308879|FG000|Overall Study|Survival follow-up|4|||
146216282|NCT02736409|527308880|FG000|Overall Study|Withdrawal by Subject|4|||
146216283|NCT02736409|527308881|FG001|Overall Study|Withdrawal by Subject|2|||
146216284|NCT02736409|527308882|FG002|Overall Study|Withdrawal by Subject|17|||
146216285|NCT02736409|527308883|FG003|Overall Study|Withdrawal by Subject|3|||
146216286|NCT02736409|527308880|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146216287|NCT02736409|527308881|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146216288|NCT02736409|527308882|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146216289|NCT02736409|527308883|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146216290|NCT02736409|527308880|FG000|Overall Study|Adverse Event|0|||
146216291|NCT02736409|527308881|FG001|Overall Study|Adverse Event|1|||
146216292|NCT02736409|527308882|FG002|Overall Study|Adverse Event|5|||
146216293|NCT02736409|527308883|FG003|Overall Study|Adverse Event|4|||
145881689|NCT01332968|526072673|FG001|Follow-Up Period|Lost to Follow-up|0|||
145881690|NCT01332968|526072674|FG002|Follow-Up Period|Lost to Follow-up|0|||
145881691|NCT01332968|526072675|FG003|Follow-Up Period|Lost to Follow-up|0|||
145881692|NCT01332968|526072676|FG004|Follow-Up Period|Lost to Follow-up|0|||
146216294|NCT02736409|527308880|FG000|Overall Study|Other|0|||
146216295|NCT02736409|527308881|FG001|Overall Study|Other|0|||
146216296|NCT02736409|527308882|FG002|Overall Study|Other|1|||
146216297|NCT02736409|527308883|FG003|Overall Study|Other|1|||
146216298|NCT02736409|527308880|FG000|Overall Study|Pregnancy|0|||
146216299|NCT02736409|527308881|FG001|Overall Study|Pregnancy|0|||
146216300|NCT02736409|527308882|FG002|Overall Study|Pregnancy|1|||
146216301|NCT02736409|527308883|FG003|Overall Study|Pregnancy|0|||
146216302|NCT02736409|527308880|FG000|Overall Study|Lost to Follow-up|0|||
146216303|NCT02736409|527308881|FG001|Overall Study|Lost to Follow-up|0|||
146216304|NCT02736409|527308882|FG002|Overall Study|Lost to Follow-up|2|||
146216305|NCT02736409|527308883|FG003|Overall Study|Lost to Follow-up|1|||
146216306|NCT02736409|527308880|FG000|Overall Study|Physician Decision|0|||
146216307|NCT02736409|527308881|FG001|Overall Study|Physician Decision|0|||
146216308|NCT02736409|527308882|FG002|Overall Study|Physician Decision|0|||
146216309|NCT02736409|527308883|FG003|Overall Study|Physician Decision|2|||
146216310|NCT04390048|527308884|FG000|Overall Study|Withdrawal by Subject|1|||
146216311|NCT04390048|527308885|FG001|Overall Study|Withdrawal by Subject|3|||
146216312|NCT01415154|527308886|FG000|Overall Study|Lack of Efficacy|4|||
146216313|NCT01415154|527308887|FG001|Overall Study|Lack of Efficacy|5|||
146216314|NCT01415154|527308886|FG000|Overall Study|Withdrawal by Subject|7|||
146216315|NCT01415154|527308887|FG001|Overall Study|Withdrawal by Subject|8|||
146216316|NCT01415154|527308886|FG000|Overall Study|Lost to Follow-up|1|||
146216317|NCT01415154|527308887|FG001|Overall Study|Lost to Follow-up|4|||
146216318|NCT01415154|527308886|FG000|Overall Study|Protocol Violation|0|||
146216319|NCT01415154|527308887|FG001|Overall Study|Protocol Violation|1|||
146216320|NCT01415154|527308886|FG000|Overall Study|Satisfactory Response|0|||
146216321|NCT01415154|527308887|FG001|Overall Study|Satisfactory Response|1|||
146216322|NCT01415154|527308886|FG000|Overall Study|Adverse Event|1|||
146216323|NCT01415154|527308887|FG001|Overall Study|Adverse Event|1|||
146216324|NCT06283173|527308918|FG000|Overall Study|Did not show for first visit|10|||
146216325|NCT06283173|527308918|FG000|Overall Study|Lost to Follow-up|12|||
146216326|NCT06283173|527308918|FG000|Overall Study|Physician Decision|7|||
146216327|NCT01416831|527308924|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
146216328|NCT01416831|527308925|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
146216329|NCT04784559|527308928|FG000|Overall Study|Withdrawal by Subject|3|||
146216330|NCT04784559|527308929|FG001|Overall Study|Withdrawal by Subject|2|||
146216331|NCT04784559|527308930|FG002|Overall Study|Withdrawal by Subject|1|||
146216332|NCT04784559|527308928|FG000|Overall Study|Death|2|||
146216333|NCT04784559|527308929|FG001|Overall Study|Death|1|||
146216334|NCT04784559|527308930|FG002|Overall Study|Death|2|||
146216335|NCT04784559|527308928|FG000|Overall Study|Lost to Follow-up|0|||
146216336|NCT04784559|527308929|FG001|Overall Study|Lost to Follow-up|0|||
146216337|NCT04784559|527308930|FG002|Overall Study|Lost to Follow-up|2|||
146216338|NCT04784559|527308928|FG000|Overall Study|Participant worsened, PI decision|1|||
146216339|NCT04784559|527308929|FG001|Overall Study|Participant worsened, PI decision|0|||
146216340|NCT04784559|527308930|FG002|Overall Study|Participant worsened, PI decision|0|||
146216341|NCT04784559|527308928|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
146216342|NCT04784559|527308929|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
146216343|NCT04784559|527308930|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
146216344|NCT04784559|527308928|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
146216345|NCT04784559|527308929|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
146216346|NCT04784559|527308930|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
146216347|NCT04784559|527308928|FG000|Overall Study|Did not meet all inclusion criteria|0|||
146216348|NCT04784559|527308929|FG001|Overall Study|Did not meet all inclusion criteria|1|||
146216349|NCT04784559|527308930|FG002|Overall Study|Did not meet all inclusion criteria|0|||
146216350|NCT04784559|527308928|FG000|Overall Study|The participant was transferred to IRCU|0|||
146216351|NCT04784559|527308929|FG001|Overall Study|The participant was transferred to IRCU|1|||
146216352|NCT04784559|527308930|FG002|Overall Study|The participant was transferred to IRCU|0|||
146216353|NCT04784559|527308928|FG000|Overall Study|SAE|0|||
146216354|NCT04784559|527308929|FG001|Overall Study|SAE|1|||
146216355|NCT04784559|527308930|FG002|Overall Study|SAE|0|||
146216356|NCT04784559|527308928|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
146216357|NCT04784559|527308929|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
146216358|NCT04784559|527308930|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
146216359|NCT03138512|527308932|FG000|Randomization|Participants withdrew consent|0|||
146216360|NCT03138512|527308933|FG001|Randomization|Participants withdrew consent|1|||
146216361|NCT03138512|527308934|FG002|Randomization|Participants withdrew consent|1|||
146216362|NCT03138512|527308935|FG003|Randomization|Participants withdrew consent|0|||
146216363|NCT03138512|527308936|FG004|Randomization|Participants withdrew consent|0|||
146216364|NCT03138512|527308932|FG000|Randomization|Participant no longer meets study criteria|0|||
146216365|NCT03138512|527308933|FG001|Randomization|Participant no longer meets study criteria|3|||
146287774|NCT00372229|527569326|FG000|Follow-Up Phase|Death|9|||
146287775|NCT00372229|527569327|FG001|Follow-Up Phase|Death|12|||
145881693|NCT01332968|526072677|FG005|Follow-Up Period|Lost to Follow-up|0|||
146216366|NCT03138512|527308934|FG002|Randomization|Participant no longer meets study criteria|1|||
145881694|NCT01332968|526072678|FG006|Follow-Up Period|Lost to Follow-up|11|||
145881695|NCT01332968|526072679|FG007|Follow-Up Period|Lost to Follow-up|15|||
145881696|NCT01332968|526072672|FG000|Follow-Up Period|Non-compliance|0|||
146216367|NCT03138512|527308935|FG003|Randomization|Participant no longer meets study criteria|1|||
146287776|NCT00372229|527569326|FG000|Follow-Up Phase|Administrative|1|||
146216368|NCT03138512|527308936|FG004|Randomization|Participant no longer meets study criteria|3|||
146216369|NCT03138512|527308932|FG000|Randomization|Other reasons|1|||
146216370|NCT03138512|527308933|FG001|Randomization|Other reasons|0|||
146216371|NCT03138512|527308934|FG002|Randomization|Other reasons|0|||
146216372|NCT03138512|527308935|FG003|Randomization|Other reasons|0|||
146216373|NCT03138512|527308936|FG004|Randomization|Other reasons|0|||
146216374|NCT03138512|527308932|FG000|Treatment Part A|Disease recurrence|10|||
146216375|NCT03138512|527308933|FG001|Treatment Part A|Disease recurrence|20|||
146216376|NCT03138512|527308934|FG002|Treatment Part A|Disease recurrence|0|||
146216377|NCT03138512|527308935|FG003|Treatment Part A|Disease recurrence|0|||
146216378|NCT03138512|527308936|FG004|Treatment Part A|Disease recurrence|0|||
146216379|NCT03138512|527308932|FG000|Treatment Part A|Study Drug Toxicity|132|||
146216380|NCT03138512|527308933|FG001|Treatment Part A|Study Drug Toxicity|5|||
146216381|NCT03138512|527308934|FG002|Treatment Part A|Study Drug Toxicity|0|||
146216382|NCT03138512|527308935|FG003|Treatment Part A|Study Drug Toxicity|0|||
146216383|NCT03138512|527308936|FG004|Treatment Part A|Study Drug Toxicity|0|||
146216384|NCT03138512|527308932|FG000|Treatment Part A|Death|1|||
146216385|NCT03138512|527308933|FG001|Treatment Part A|Death|0|||
146216386|NCT03138512|527308934|FG002|Treatment Part A|Death|0|||
146216387|NCT03138512|527308935|FG003|Treatment Part A|Death|0|||
146216388|NCT03138512|527308936|FG004|Treatment Part A|Death|0|||
146216389|NCT03138512|527308932|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
146216390|NCT03138512|527308933|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
146216391|NCT03138512|527308934|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
146216392|NCT03138512|527308935|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
146216393|NCT03138512|527308936|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
146216394|NCT03138512|527308932|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
146216395|NCT03138512|527308933|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
146216396|NCT03138512|527308934|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
146216397|NCT03138512|527308935|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
146216398|NCT03138512|527308936|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
146216399|NCT03138512|527308932|FG000|Treatment Part A|Participant withdrew consent|2|||
146216400|NCT03138512|527308933|FG001|Treatment Part A|Participant withdrew consent|4|||
146216401|NCT03138512|527308934|FG002|Treatment Part A|Participant withdrew consent|0|||
146216402|NCT03138512|527308935|FG003|Treatment Part A|Participant withdrew consent|0|||
146216403|NCT03138512|527308936|FG004|Treatment Part A|Participant withdrew consent|0|||
146216404|NCT03138512|527308932|FG000|Treatment Part A|Lost to Follow-up|0|||
146216405|NCT03138512|527308933|FG001|Treatment Part A|Lost to Follow-up|1|||
146216406|NCT03138512|527308934|FG002|Treatment Part A|Lost to Follow-up|0|||
146216407|NCT03138512|527308935|FG003|Treatment Part A|Lost to Follow-up|0|||
146216408|NCT03138512|527308936|FG004|Treatment Part A|Lost to Follow-up|0|||
146216409|NCT03138512|527308932|FG000|Treatment Part A|Poor/non-compliance|1|||
146216410|NCT03138512|527308933|FG001|Treatment Part A|Poor/non-compliance|0|||
146216411|NCT03138512|527308934|FG002|Treatment Part A|Poor/non-compliance|0|||
146216412|NCT03138512|527308935|FG003|Treatment Part A|Poor/non-compliance|0|||
146216413|NCT03138512|527308936|FG004|Treatment Part A|Poor/non-compliance|0|||
146216414|NCT03138512|527308932|FG000|Treatment Part A|Pregnancy|0|||
146216415|NCT03138512|527308933|FG001|Treatment Part A|Pregnancy|1|||
146216416|NCT03138512|527308934|FG002|Treatment Part A|Pregnancy|0|||
146216417|NCT03138512|527308935|FG003|Treatment Part A|Pregnancy|0|||
146216418|NCT03138512|527308936|FG004|Treatment Part A|Pregnancy|0|||
146216419|NCT03138512|527308932|FG000|Treatment Part A|Other reasons|11|||
146216420|NCT03138512|527308933|FG001|Treatment Part A|Other reasons|8|||
146216421|NCT03138512|527308934|FG002|Treatment Part A|Other reasons|0|||
146216422|NCT03138512|527308935|FG003|Treatment Part A|Other reasons|0|||
146216423|NCT03138512|527308936|FG004|Treatment Part A|Other reasons|0|||
146216424|NCT03138512|527308932|FG000|Treatment Part B|Disease recurrence|0|||
146216425|NCT03138512|527308933|FG001|Treatment Part B|Disease recurrence|0|||
146216426|NCT03138512|527308934|FG002|Treatment Part B|Disease recurrence|6|||
145881697|NCT01332968|526072673|FG001|Follow-Up Period|Non-compliance|0|||
145881698|NCT01332968|526072674|FG002|Follow-Up Period|Non-compliance|0|||
145881699|NCT01332968|526072675|FG003|Follow-Up Period|Non-compliance|0|||
145881700|NCT01332968|526072676|FG004|Follow-Up Period|Non-compliance|0|||
145881701|NCT01332968|526072677|FG005|Follow-Up Period|Non-compliance|0|||
145881702|NCT01332968|526072678|FG006|Follow-Up Period|Non-compliance|4|||
145881703|NCT01332968|526072679|FG007|Follow-Up Period|Non-compliance|9|||
146216427|NCT03138512|527308935|FG003|Treatment Part B|Disease recurrence|12|||
146216428|NCT03138512|527308936|FG004|Treatment Part B|Disease recurrence|10|||
146216429|NCT03138512|527308932|FG000|Treatment Part B|Study drug toxicity|0|||
146216430|NCT03138512|527308933|FG001|Treatment Part B|Study drug toxicity|0|||
146216431|NCT03138512|527308934|FG002|Treatment Part B|Study drug toxicity|63|||
146216432|NCT03138512|527308935|FG003|Treatment Part B|Study drug toxicity|3|||
146216433|NCT03138512|527308936|FG004|Treatment Part B|Study drug toxicity|45|||
146216434|NCT03138512|527308932|FG000|Treatment Part B|Death|0|||
146216435|NCT03138512|527308933|FG001|Treatment Part B|Death|0|||
146216436|NCT03138512|527308934|FG002|Treatment Part B|Death|1|||
146216437|NCT03138512|527308935|FG003|Treatment Part B|Death|0|||
146216438|NCT03138512|527308936|FG004|Treatment Part B|Death|0|||
146216439|NCT03138512|527308932|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
146216440|NCT03138512|527308933|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
146216441|NCT03138512|527308934|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
146216442|NCT03138512|527308935|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
146216443|NCT03138512|527308936|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
146216444|NCT03138512|527308932|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
146216445|NCT03138512|527308933|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
146216446|NCT03138512|527308934|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
145881704|NCT01332968|526072672|FG000|Follow-Up Period|Other|0|||
145881705|NCT01332968|526072673|FG001|Follow-Up Period|Other|0|||
145881706|NCT01332968|526072674|FG002|Follow-Up Period|Other|0|||
145881707|NCT01332968|526072675|FG003|Follow-Up Period|Other|0|||
145881708|NCT01332968|526072676|FG004|Follow-Up Period|Other|0|||
145881709|NCT01332968|526072677|FG005|Follow-Up Period|Other|0|||
145881710|NCT01332968|526072678|FG006|Follow-Up Period|Other|18|||
146216447|NCT03138512|527308935|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
146216448|NCT03138512|527308936|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
146216449|NCT03138512|527308932|FG000|Treatment Part B|Participant withdrew consent|0|||
146216450|NCT03138512|527308933|FG001|Treatment Part B|Participant withdrew consent|0|||
146216451|NCT03138512|527308934|FG002|Treatment Part B|Participant withdrew consent|1|||
146216452|NCT03138512|527308935|FG003|Treatment Part B|Participant withdrew consent|1|||
146216453|NCT03138512|527308936|FG004|Treatment Part B|Participant withdrew consent|2|||
146216454|NCT03138512|527308932|FG000|Treatment Part B|Lost to Follow-up|0|||
146216455|NCT03138512|527308933|FG001|Treatment Part B|Lost to Follow-up|0|||
146216456|NCT03138512|527308934|FG002|Treatment Part B|Lost to Follow-up|0|||
146216457|NCT03138512|527308935|FG003|Treatment Part B|Lost to Follow-up|1|||
146216458|NCT03138512|527308936|FG004|Treatment Part B|Lost to Follow-up|0|||
146216459|NCT03138512|527308932|FG000|Treatment Part B|Poor/non-compliance|0|||
146216460|NCT03138512|527308933|FG001|Treatment Part B|Poor/non-compliance|0|||
146216461|NCT03138512|527308934|FG002|Treatment Part B|Poor/non-compliance|1|||
146216462|NCT03138512|527308935|FG003|Treatment Part B|Poor/non-compliance|1|||
146216463|NCT03138512|527308936|FG004|Treatment Part B|Poor/non-compliance|1|||
146216464|NCT03138512|527308932|FG000|Treatment Part B|Other reasons|0|||
146216465|NCT03138512|527308933|FG001|Treatment Part B|Other reasons|0|||
146216466|NCT03138512|527308934|FG002|Treatment Part B|Other reasons|3|||
146216467|NCT03138512|527308935|FG003|Treatment Part B|Other reasons|1|||
146216468|NCT03138512|527308936|FG004|Treatment Part B|Other reasons|5|||
146216469|NCT05323084|527308938|FG000|Period 2 - Washout|Lost to Follow-up|0|||
146216470|NCT05323084|527308939|FG001|Period 2 - Washout|Lost to Follow-up|1|||
146216471|NCT04382404|527308940|FG000|Overall Study|Adverse Event|1|||
146216472|NCT04382404|527308940|FG000|Overall Study|Lost to Follow-up|2|||
146216473|NCT05687916|527308945|FG000|Overall Study|Adverse Event|1|||
146216474|NCT05687916|527308946|FG001|Overall Study|Adverse Event|2|||
146216475|NCT05687916|527308947|FG002|Overall Study|Adverse Event|0|||
146216476|NCT05687916|527308945|FG000|Overall Study|Withdrawal by Subject|1|||
146216477|NCT05687916|527308946|FG001|Overall Study|Withdrawal by Subject|0|||
146216478|NCT05687916|527308947|FG002|Overall Study|Withdrawal by Subject|1|||
146216479|NCT05687916|527308945|FG000|Overall Study|Protocol Violation|0|||
146216480|NCT05687916|527308946|FG001|Overall Study|Protocol Violation|2|||
146216481|NCT05687916|527308947|FG002|Overall Study|Protocol Violation|1|||
146216482|NCT05687916|527308945|FG000|Overall Study|Reason not Specified|1|||
146216483|NCT05687916|527308946|FG001|Overall Study|Reason not Specified|0|||
146216484|NCT05687916|527308947|FG002|Overall Study|Reason not Specified|0|||
146216485|NCT03332017|527308948|FG000|Overall Study|Lost to Follow-up|1|||
146216486|NCT03332017|527308949|FG001|Overall Study|Lost to Follow-up|2|||
146216487|NCT03332017|527308948|FG000|Overall Study|Death|17|||
146216488|NCT03332017|527308949|FG001|Overall Study|Death|16|||
146216489|NCT03332017|527308948|FG000|Overall Study|Withdrawal by Subject|6|||
146216490|NCT03332017|527308949|FG001|Overall Study|Withdrawal by Subject|14|||
145881711|NCT01332968|526072679|FG007|Follow-Up Period|Other|21|||
146216491|NCT03332017|527308948|FG000|Overall Study|Other|1|||
146216492|NCT03332017|527308949|FG001|Overall Study|Other|3|||
146216493|NCT03332017|527308948|FG000|Overall Study|Remained in Study (Ongoing)|47|||
146216494|NCT03332017|527308949|FG001|Overall Study|Remained in Study (Ongoing)|110|||
145881712|NCT01332968|526072672|FG000|Follow-Up Period|Physician Decision|0|||
145881713|NCT01332968|526072673|FG001|Follow-Up Period|Physician Decision|0|||
145881714|NCT01332968|526072674|FG002|Follow-Up Period|Physician Decision|0|||
146216495|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
146216496|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
146216497|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
146216498|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216499|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216500|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216501|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216502|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216503|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216504|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216505|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216506|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216507|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
146216508|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
146216509|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
146216510|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216511|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216512|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216513|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216514|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216515|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216516|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216517|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216518|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216519|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216520|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
146216521|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
146216522|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
146216523|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216524|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216525|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216526|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216527|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216528|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216529|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216530|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216531|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216532|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216533|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
146216534|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
146216535|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
146216536|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216537|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216538|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216539|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216540|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216541|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216542|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216543|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216544|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216545|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216546|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
146216547|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
146216548|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
146216549|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
146216550|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216551|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216552|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216553|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216554|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216555|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216556|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216557|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216558|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216559|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
146216560|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
146216561|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
145881715|NCT01332968|526072675|FG003|Follow-Up Period|Physician Decision|0|||
145881716|NCT01332968|526072676|FG004|Follow-Up Period|Physician Decision|0|||
146216562|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
146216563|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216564|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216565|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216566|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216567|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216568|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216569|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216570|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216571|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216572|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
146216573|NCT01261312|527308950|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
146216574|NCT01261312|527308951|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216575|NCT01261312|527308952|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
146216576|NCT01261312|527308953|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216577|NCT01261312|527308954|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216578|NCT01261312|527308955|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216579|NCT01261312|527308956|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216580|NCT01261312|527308957|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216581|NCT01261312|527308958|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216582|NCT01261312|527308959|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216583|NCT01261312|527308960|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216584|NCT01261312|527308961|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216585|NCT01261312|527308962|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
146216586|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216587|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216588|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216589|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
146216590|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
146216591|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
146216592|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216593|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216594|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216595|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216596|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216597|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216598|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
146216599|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216600|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216601|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216602|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216603|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
146216604|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
146216605|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216606|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216607|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216608|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216609|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216610|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216611|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
146216612|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216613|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216614|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216615|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216616|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
146216617|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
146216618|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216619|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216620|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216621|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216622|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216623|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216624|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
146216625|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216626|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216627|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216628|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
146216629|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
146216630|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
146216631|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216632|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216633|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216634|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216635|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
146084319|NCT00045942|526827957|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
146216636|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216637|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
146216638|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216639|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216640|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146084320|NCT00045942|526827958|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
146084321|NCT00045942|526827950|FG000|PKC412A2104E2|Lack of Efficacy|0|||
146084322|NCT00045942|526827951|FG001|PKC412A2104E2|Lack of Efficacy|0|||
146084323|NCT00045942|526827952|FG002|PKC412A2104E2|Lack of Efficacy|0|||
146084324|NCT00045942|526827953|FG003|PKC412A2104E2|Lack of Efficacy|0|||
146084325|NCT00045942|526827954|FG004|PKC412A2104E2|Lack of Efficacy|0|||
146084326|NCT00045942|526827955|FG005|PKC412A2104E2|Lack of Efficacy|3|||
146084327|NCT00045942|526827956|FG006|PKC412A2104E2|Lack of Efficacy|2|||
146084328|NCT00045942|526827957|FG007|PKC412A2104E2|Lack of Efficacy|2|||
146084329|NCT00045942|526827958|FG008|PKC412A2104E2|Lack of Efficacy|6|||
146084330|NCT00045942|526827950|FG000|PKC412A2104E2|Adverse Event|0|||
146084331|NCT00045942|526827951|FG001|PKC412A2104E2|Adverse Event|0|||
146084332|NCT00045942|526827952|FG002|PKC412A2104E2|Adverse Event|0|||
146084333|NCT00045942|526827953|FG003|PKC412A2104E2|Adverse Event|0|||
146084334|NCT00045942|526827954|FG004|PKC412A2104E2|Adverse Event|0|||
146084335|NCT00045942|526827955|FG005|PKC412A2104E2|Adverse Event|4|||
146084336|NCT00045942|526827956|FG006|PKC412A2104E2|Adverse Event|3|||
146084337|NCT00045942|526827957|FG007|PKC412A2104E2|Adverse Event|1|||
146084338|NCT00045942|526827958|FG008|PKC412A2104E2|Adverse Event|0|||
146084339|NCT00045942|526827950|FG000|PKC412A2104E2|Death|0|||
146084340|NCT00045942|526827951|FG001|PKC412A2104E2|Death|0|||
146084341|NCT00045942|526827952|FG002|PKC412A2104E2|Death|0|||
146084342|NCT00045942|526827953|FG003|PKC412A2104E2|Death|0|||
146084343|NCT00045942|526827954|FG004|PKC412A2104E2|Death|0|||
146084344|NCT00045942|526827955|FG005|PKC412A2104E2|Death|1|||
146084345|NCT00045942|526827956|FG006|PKC412A2104E2|Death|2|||
146084346|NCT00045942|526827957|FG007|PKC412A2104E2|Death|0|||
146084347|NCT00045942|526827958|FG008|PKC412A2104E2|Death|0|||
146084348|NCT01101308|526827959|FG000|Period 1|Adverse Event|2|||
146216641|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216642|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216643|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
146216644|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216645|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216646|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216647|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216648|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216649|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216650|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
146216651|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216652|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216653|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216654|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
146216655|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
146084349|NCT01101308|526827960|FG001|Period 1|Adverse Event|1|||
146084350|NCT01101308|526827959|FG000|Period 1|Positive for cotinine|1|||
146084351|NCT01101308|526827960|FG001|Period 1|Positive for cotinine|0|||
146084352|NCT02984943|526827961|FG000|Overall Study|Withdrawal by Subject|3|||
146084353|NCT02984943|526827961|FG000|Overall Study|Physician Decision|1|||
146216656|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
146216657|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216658|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146084354|NCT00711516|526827966|FG000|Overall Study|Adverse Event|1|||
146084355|NCT00711516|526827967|FG001|Overall Study|Adverse Event|1|||
146084356|NCT00711516|526827966|FG000|Overall Study|Withdrawal by Subject|0|||
146216659|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146084357|NCT00711516|526827967|FG001|Overall Study|Withdrawal by Subject|1|||
146084358|NCT00711516|526827966|FG000|Overall Study|Protocol Violation|0|||
146084359|NCT00711516|526827967|FG001|Overall Study|Protocol Violation|1|||
146084360|NCT01895361|526827971|FG000|Overall Study|Adverse Event|1|||
146084361|NCT01895361|526827972|FG001|Overall Study|Adverse Event|1|||
146216660|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216661|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216662|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216663|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
146216664|NCT01261312|527308950|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216665|NCT01261312|527308951|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216666|NCT01261312|527308952|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216667|NCT01261312|527308953|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
146216668|NCT01261312|527308954|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
146216669|NCT01261312|527308955|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
146216670|NCT01261312|527308956|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216671|NCT01261312|527308957|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216672|NCT01261312|527308958|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216673|NCT01261312|527308959|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216674|NCT01261312|527308960|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216675|NCT01261312|527308961|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216676|NCT01261312|527308962|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
146216677|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216678|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216679|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216680|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216681|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216682|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216683|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
146216684|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
146216685|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
146216686|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216687|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216688|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216689|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
146216690|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216691|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216692|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216693|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216694|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216695|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216696|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216697|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
146216698|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
146216699|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216700|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216701|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216702|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
146216703|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216704|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216705|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216706|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216707|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216708|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216709|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146216710|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146216711|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
146216712|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216713|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216714|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216715|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
146216716|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
146216717|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
146216718|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
146216719|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
146216720|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
146216721|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
146216722|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
146216723|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
146216724|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
146216725|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
146216726|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
146216727|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
146216728|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
146216729|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216730|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216731|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216732|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216733|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216734|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216735|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
146216736|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
146216737|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
146216738|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216739|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216740|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216741|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
146216742|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216743|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216744|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216745|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216746|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216747|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216748|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
146216749|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
146216750|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
146216751|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216752|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216753|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216754|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
146216755|NCT01261312|527308950|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216756|NCT01261312|527308951|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216757|NCT01261312|527308952|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216758|NCT01261312|527308953|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216759|NCT01261312|527308954|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216760|NCT01261312|527308955|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216761|NCT01261312|527308956|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
146216762|NCT01261312|527308957|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
146216763|NCT01261312|527308958|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
146216764|NCT01261312|527308959|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216765|NCT01261312|527308960|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216766|NCT01261312|527308961|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216767|NCT01261312|527308962|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
146216768|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216769|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216770|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216771|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216772|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216773|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216774|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216775|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216776|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
146216777|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
146216778|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
146216779|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
146216780|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
146216781|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216782|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216783|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216784|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216785|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216786|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216787|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216788|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216789|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
146216790|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
146216791|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145960476|NCT01278342|526367589|FG001|Overall Study|Physician Decision|1|||
146216792|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
146216793|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
146216794|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216795|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216796|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216797|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216798|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216799|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216800|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216801|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216802|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
146216803|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
146216804|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
146216805|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
146216806|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
146216807|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216808|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216809|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216810|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216811|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216812|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216813|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216814|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216815|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
146216816|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
146216817|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
146216818|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
146216819|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
146216820|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216821|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216822|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216823|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216824|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216825|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216826|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216827|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216828|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
146216829|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
146216830|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
146216831|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
146216832|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
146216833|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216834|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216835|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216836|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216837|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216838|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216839|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216840|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216841|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
146216842|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
146216843|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
146216844|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
146216845|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
146216846|NCT01261312|527308950|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216847|NCT01261312|527308951|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216848|NCT01261312|527308952|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216849|NCT01261312|527308953|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216850|NCT01261312|527308954|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216851|NCT01261312|527308955|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216852|NCT01261312|527308956|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216853|NCT01261312|527308957|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216854|NCT01261312|527308958|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
146216855|NCT01261312|527308959|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146216856|NCT01261312|527308960|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146216857|NCT01261312|527308961|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
146216858|NCT01261312|527308962|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
146216859|NCT01580488|527308970|FG000|Overall Study|Withdrawal by Subject|1|||
146216860|NCT03336333|527308971|FG000|Overall Study|Remained on study at time of data cut-off|202|||
146216861|NCT03336333|527308972|FG001|Overall Study|Remained on study at time of data cut-off|219|||
146216862|NCT03336333|527308973|FG002|Overall Study|Remained on study at time of data cut-off|102|||
146216863|NCT03336333|527308971|FG000|Overall Study|Death|14|||
146216864|NCT03336333|527308972|FG001|Overall Study|Death|16|||
146216865|NCT03336333|527308973|FG002|Overall Study|Death|8|||
146216866|NCT03336333|527308971|FG000|Overall Study|Withdrawal by Subject|16|||
146216867|NCT03336333|527308972|FG001|Overall Study|Withdrawal by Subject|5|||
146216868|NCT03336333|527308973|FG002|Overall Study|Withdrawal by Subject|1|||
146216869|NCT03336333|527308971|FG000|Overall Study|Physician Decision|5|||
146216870|NCT03336333|527308972|FG001|Overall Study|Physician Decision|1|||
146216871|NCT03336333|527308973|FG002|Overall Study|Physician Decision|0|||
146216872|NCT03336333|527308971|FG000|Overall Study|Lost to Follow-up|1|||
146216873|NCT03336333|527308972|FG001|Overall Study|Lost to Follow-up|0|||
146216874|NCT03336333|527308973|FG002|Overall Study|Lost to Follow-up|0|||
146216875|NCT04927065|527308974|FG000|First Booster|Adverse Event|1|||
146216876|NCT04927065|527308975|FG001|First Booster|Adverse Event|0|||
146216877|NCT04927065|527308976|FG002|First Booster|Adverse Event|0|||
146216878|NCT04927065|527308977|FG003|First Booster|Adverse Event|0|||
146216879|NCT04927065|527308978|FG004|First Booster|Adverse Event|0|||
146216880|NCT04927065|527308979|FG005|First Booster|Adverse Event|0|||
146216881|NCT04927065|527308980|FG006|First Booster|Adverse Event|0|||
146216882|NCT04927065|527308981|FG007|First Booster|Adverse Event|1|||
146216883|NCT04927065|527308982|FG008|First Booster|Adverse Event|0|||
146216884|NCT04927065|527308983|FG009|First Booster|Adverse Event|0|||
146216885|NCT04927065|527308984|FG010|First Booster|Adverse Event|0|||
146216886|NCT04927065|527308985|FG011|First Booster|Adverse Event|0|||
146216887|NCT04927065|527308986|FG012|First Booster|Adverse Event|0|||
146216888|NCT04927065|527308987|FG013|First Booster|Adverse Event|0|||
146216889|NCT04927065|527308988|FG014|First Booster|Adverse Event|0|||
146216890|NCT04927065|527308989|FG015|First Booster|Adverse Event|0|||
146216891|NCT04927065|527308974|FG000|First Booster|Death|1|||
146216892|NCT04927065|527308975|FG001|First Booster|Death|0|||
146216893|NCT04927065|527308976|FG002|First Booster|Death|0|||
146216894|NCT04927065|527308977|FG003|First Booster|Death|1|||
146216895|NCT04927065|527308978|FG004|First Booster|Death|0|||
146216896|NCT04927065|527308979|FG005|First Booster|Death|1|||
146216897|NCT04927065|527308980|FG006|First Booster|Death|0|||
146216898|NCT04927065|527308981|FG007|First Booster|Death|0|||
146216899|NCT04927065|527308982|FG008|First Booster|Death|0|||
146216900|NCT04927065|527308983|FG009|First Booster|Death|0|||
146216901|NCT04927065|527308984|FG010|First Booster|Death|0|||
146216902|NCT04927065|527308985|FG011|First Booster|Death|0|||
146216903|NCT04927065|527308986|FG012|First Booster|Death|0|||
146216904|NCT04927065|527308987|FG013|First Booster|Death|0|||
146216905|NCT04927065|527308988|FG014|First Booster|Death|0|||
146216906|NCT04927065|527308989|FG015|First Booster|Death|0|||
146216907|NCT04927065|527308974|FG000|First Booster|Lost to Follow-up|8|||
146216908|NCT04927065|527308975|FG001|First Booster|Lost to Follow-up|20|||
146216909|NCT04927065|527308976|FG002|First Booster|Lost to Follow-up|0|||
146216910|NCT04927065|527308977|FG003|First Booster|Lost to Follow-up|11|||
146216911|NCT04927065|527308978|FG004|First Booster|Lost to Follow-up|43|||
146216912|NCT04927065|527308979|FG005|First Booster|Lost to Follow-up|30|||
146216913|NCT04927065|527308980|FG006|First Booster|Lost to Follow-up|28|||
146216914|NCT04927065|527308981|FG007|First Booster|Lost to Follow-up|23|||
146216915|NCT04927065|527308982|FG008|First Booster|Lost to Follow-up|4|||
146216916|NCT04927065|527308983|FG009|First Booster|Lost to Follow-up|15|||
146216917|NCT04927065|527308984|FG010|First Booster|Lost to Follow-up|0|||
146216918|NCT04927065|527308985|FG011|First Booster|Lost to Follow-up|0|||
146216919|NCT04927065|527308986|FG012|First Booster|Lost to Follow-up|0|||
146216920|NCT04927065|527308987|FG013|First Booster|Lost to Follow-up|0|||
146216921|NCT04927065|527308988|FG014|First Booster|Lost to Follow-up|0|||
146216922|NCT04927065|527308989|FG015|First Booster|Lost to Follow-up|0|||
146216923|NCT04927065|527308974|FG000|First Booster|Physician Decision|1|||
146216924|NCT04927065|527308975|FG001|First Booster|Physician Decision|0|||
146216925|NCT04927065|527308976|FG002|First Booster|Physician Decision|0|||
146216926|NCT04927065|527308977|FG003|First Booster|Physician Decision|3|||
146216927|NCT04927065|527308978|FG004|First Booster|Physician Decision|1|||
146216928|NCT04927065|527308979|FG005|First Booster|Physician Decision|1|||
146216929|NCT04927065|527308980|FG006|First Booster|Physician Decision|0|||
146216930|NCT04927065|527308981|FG007|First Booster|Physician Decision|3|||
146216931|NCT04927065|527308982|FG008|First Booster|Physician Decision|0|||
146216932|NCT04927065|527308983|FG009|First Booster|Physician Decision|0|||
146216933|NCT04927065|527308984|FG010|First Booster|Physician Decision|0|||
146216934|NCT04927065|527308985|FG011|First Booster|Physician Decision|0|||
146216935|NCT04927065|527308986|FG012|First Booster|Physician Decision|0|||
146216936|NCT04927065|527308987|FG013|First Booster|Physician Decision|0|||
146216937|NCT04927065|527308988|FG014|First Booster|Physician Decision|0|||
146216938|NCT04927065|527308989|FG015|First Booster|Physician Decision|0|||
146216939|NCT04927065|527308974|FG000|First Booster|Protocol Violation|4|||
146216940|NCT04927065|527308975|FG001|First Booster|Protocol Violation|4|||
146216941|NCT04927065|527308976|FG002|First Booster|Protocol Violation|0|||
146216942|NCT04927065|527308977|FG003|First Booster|Protocol Violation|3|||
146216943|NCT04927065|527308978|FG004|First Booster|Protocol Violation|0|||
146216944|NCT04927065|527308979|FG005|First Booster|Protocol Violation|0|||
146216945|NCT04927065|527308980|FG006|First Booster|Protocol Violation|0|||
146216946|NCT04927065|527308981|FG007|First Booster|Protocol Violation|2|||
146216947|NCT04927065|527308982|FG008|First Booster|Protocol Violation|0|||
146216948|NCT04927065|527308983|FG009|First Booster|Protocol Violation|0|||
146216949|NCT04927065|527308984|FG010|First Booster|Protocol Violation|0|||
146216950|NCT04927065|527308985|FG011|First Booster|Protocol Violation|0|||
146216951|NCT04927065|527308986|FG012|First Booster|Protocol Violation|0|||
146216952|NCT04927065|527308987|FG013|First Booster|Protocol Violation|0|||
146216953|NCT04927065|527308988|FG014|First Booster|Protocol Violation|0|||
146216954|NCT04927065|527308989|FG015|First Booster|Protocol Violation|0|||
146216955|NCT04927065|527308974|FG000|First Booster|Withdrawal by Subject|8|||
146216956|NCT04927065|527308975|FG001|First Booster|Withdrawal by Subject|23|||
146216957|NCT04927065|527308976|FG002|First Booster|Withdrawal by Subject|0|||
146216958|NCT04927065|527308977|FG003|First Booster|Withdrawal by Subject|19|||
146216959|NCT04927065|527308978|FG004|First Booster|Withdrawal by Subject|20|||
146216960|NCT04927065|527308979|FG005|First Booster|Withdrawal by Subject|15|||
146216961|NCT04927065|527308980|FG006|First Booster|Withdrawal by Subject|6|||
146216962|NCT04927065|527308981|FG007|First Booster|Withdrawal by Subject|24|||
146216963|NCT04927065|527308982|FG008|First Booster|Withdrawal by Subject|0|||
146216964|NCT04927065|527308983|FG009|First Booster|Withdrawal by Subject|4|||
146216965|NCT04927065|527308984|FG010|First Booster|Withdrawal by Subject|0|||
146216966|NCT04927065|527308985|FG011|First Booster|Withdrawal by Subject|0|||
146216967|NCT04927065|527308986|FG012|First Booster|Withdrawal by Subject|0|||
146216968|NCT04927065|527308987|FG013|First Booster|Withdrawal by Subject|0|||
146216969|NCT04927065|527308988|FG014|First Booster|Withdrawal by Subject|0|||
146216970|NCT04927065|527308989|FG015|First Booster|Withdrawal by Subject|0|||
146216971|NCT04927065|527308974|FG000|First Booster|Other Than Specified|1|||
146216972|NCT04927065|527308975|FG001|First Booster|Other Than Specified|1|||
146216973|NCT04927065|527308976|FG002|First Booster|Other Than Specified|0|||
146216974|NCT04927065|527308977|FG003|First Booster|Other Than Specified|1|||
146216975|NCT04927065|527308978|FG004|First Booster|Other Than Specified|2|||
146216976|NCT04927065|527308979|FG005|First Booster|Other Than Specified|3|||
146216977|NCT04927065|527308980|FG006|First Booster|Other Than Specified|2|||
146216978|NCT04927065|527308981|FG007|First Booster|Other Than Specified|6|||
146216979|NCT04927065|527308982|FG008|First Booster|Other Than Specified|0|||
146216980|NCT04927065|527308983|FG009|First Booster|Other Than Specified|4|||
146216981|NCT04927065|527308984|FG010|First Booster|Other Than Specified|0|||
146216982|NCT04927065|527308985|FG011|First Booster|Other Than Specified|0|||
146216983|NCT04927065|527308986|FG012|First Booster|Other Than Specified|0|||
146216984|NCT04927065|527308987|FG013|First Booster|Other Than Specified|0|||
146216985|NCT04927065|527308988|FG014|First Booster|Other Than Specified|0|||
146216986|NCT04927065|527308989|FG015|First Booster|Other Than Specified|0|||
146216987|NCT04927065|527308974|FG000|Second Booster|Death|0|||
146216988|NCT04927065|527308975|FG001|Second Booster|Death|0|||
146216989|NCT04927065|527308976|FG002|Second Booster|Death|0|||
146216990|NCT04927065|527308977|FG003|Second Booster|Death|0|||
146216991|NCT04927065|527308978|FG004|Second Booster|Death|0|||
146216992|NCT04927065|527308979|FG005|Second Booster|Death|0|||
146216993|NCT04927065|527308980|FG006|Second Booster|Death|0|||
146216994|NCT04927065|527308981|FG007|Second Booster|Death|0|||
146216995|NCT04927065|527308982|FG008|Second Booster|Death|0|||
146216996|NCT04927065|527308983|FG009|Second Booster|Death|0|||
146216997|NCT04927065|527308984|FG010|Second Booster|Death|2|||
146216998|NCT04927065|527308985|FG011|Second Booster|Death|0|||
146216999|NCT04927065|527308986|FG012|Second Booster|Death|2|||
146217000|NCT04927065|527308987|FG013|Second Booster|Death|2|||
146217001|NCT04927065|527308988|FG014|Second Booster|Death|0|||
146217002|NCT04927065|527308989|FG015|Second Booster|Death|0|||
146217003|NCT04927065|527308974|FG000|Second Booster|Lost to Follow-up|0|||
146217004|NCT04927065|527308975|FG001|Second Booster|Lost to Follow-up|0|||
146217005|NCT04927065|527308976|FG002|Second Booster|Lost to Follow-up|3|||
146217006|NCT04927065|527308977|FG003|Second Booster|Lost to Follow-up|0|||
146217007|NCT04927065|527308978|FG004|Second Booster|Lost to Follow-up|0|||
146217008|NCT04927065|527308979|FG005|Second Booster|Lost to Follow-up|0|||
146217009|NCT04927065|527308980|FG006|Second Booster|Lost to Follow-up|0|||
146217010|NCT04927065|527308981|FG007|Second Booster|Lost to Follow-up|0|||
146217011|NCT04927065|527308982|FG008|Second Booster|Lost to Follow-up|0|||
146217012|NCT04927065|527308983|FG009|Second Booster|Lost to Follow-up|0|||
146217013|NCT04927065|527308984|FG010|Second Booster|Lost to Follow-up|14|||
146217014|NCT04927065|527308985|FG011|Second Booster|Lost to Follow-up|10|||
146217015|NCT04927065|527308986|FG012|Second Booster|Lost to Follow-up|13|||
146217016|NCT04927065|527308987|FG013|Second Booster|Lost to Follow-up|16|||
146217017|NCT04927065|527308988|FG014|Second Booster|Lost to Follow-up|0|||
146217018|NCT04927065|527308989|FG015|Second Booster|Lost to Follow-up|0|||
146217019|NCT04927065|527308974|FG000|Second Booster|Physician Decision|0|||
146217020|NCT04927065|527308975|FG001|Second Booster|Physician Decision|0|||
146217021|NCT04927065|527308976|FG002|Second Booster|Physician Decision|0|||
145960477|NCT01278342|526367590|FG002|Overall Study|Physician Decision|0|||
146217022|NCT04927065|527308977|FG003|Second Booster|Physician Decision|0|||
146217023|NCT04927065|527308978|FG004|Second Booster|Physician Decision|0|||
146217024|NCT04927065|527308979|FG005|Second Booster|Physician Decision|0|||
145960478|NCT01278342|526367588|FG000|Overall Study|Lost to Follow-up|1|||
146217025|NCT04927065|527308980|FG006|Second Booster|Physician Decision|0|||
146217026|NCT04927065|527308981|FG007|Second Booster|Physician Decision|0|||
146217027|NCT04927065|527308982|FG008|Second Booster|Physician Decision|0|||
146217028|NCT04927065|527308983|FG009|Second Booster|Physician Decision|0|||
146217029|NCT04927065|527308984|FG010|Second Booster|Physician Decision|0|||
146217030|NCT04927065|527308985|FG011|Second Booster|Physician Decision|3|||
146217031|NCT04927065|527308986|FG012|Second Booster|Physician Decision|0|||
146217032|NCT04927065|527308987|FG013|Second Booster|Physician Decision|1|||
146217033|NCT04927065|527308988|FG014|Second Booster|Physician Decision|0|||
146217034|NCT04927065|527308989|FG015|Second Booster|Physician Decision|0|||
146217035|NCT04927065|527308974|FG000|Second Booster|Withdrawal by Subject|0|||
146217036|NCT04927065|527308975|FG001|Second Booster|Withdrawal by Subject|0|||
146217037|NCT04927065|527308976|FG002|Second Booster|Withdrawal by Subject|4|||
146217038|NCT04927065|527308977|FG003|Second Booster|Withdrawal by Subject|0|||
146217039|NCT04927065|527308978|FG004|Second Booster|Withdrawal by Subject|0|||
146217040|NCT04927065|527308979|FG005|Second Booster|Withdrawal by Subject|0|||
146217041|NCT04927065|527308980|FG006|Second Booster|Withdrawal by Subject|0|||
146217042|NCT04927065|527308981|FG007|Second Booster|Withdrawal by Subject|0|||
146217043|NCT04927065|527308982|FG008|Second Booster|Withdrawal by Subject|0|||
146217044|NCT04927065|527308983|FG009|Second Booster|Withdrawal by Subject|0|||
146217045|NCT04927065|527308984|FG010|Second Booster|Withdrawal by Subject|3|||
146217046|NCT04927065|527308985|FG011|Second Booster|Withdrawal by Subject|16|||
146217047|NCT04927065|527308986|FG012|Second Booster|Withdrawal by Subject|13|||
146217048|NCT04927065|527308987|FG013|Second Booster|Withdrawal by Subject|9|||
146217049|NCT04927065|527308988|FG014|Second Booster|Withdrawal by Subject|0|||
146217050|NCT04927065|527308989|FG015|Second Booster|Withdrawal by Subject|0|||
146217051|NCT04927065|527308974|FG000|Second Booster|Other Than Specified|0|||
146217052|NCT04927065|527308975|FG001|Second Booster|Other Than Specified|0|||
146217053|NCT04927065|527308976|FG002|Second Booster|Other Than Specified|0|||
146217054|NCT04927065|527308977|FG003|Second Booster|Other Than Specified|0|||
146217055|NCT04927065|527308978|FG004|Second Booster|Other Than Specified|0|||
146217056|NCT04927065|527308979|FG005|Second Booster|Other Than Specified|0|||
146217057|NCT04927065|527308980|FG006|Second Booster|Other Than Specified|0|||
146217058|NCT04927065|527308981|FG007|Second Booster|Other Than Specified|0|||
146217059|NCT04927065|527308982|FG008|Second Booster|Other Than Specified|0|||
146217060|NCT04927065|527308983|FG009|Second Booster|Other Than Specified|0|||
146217061|NCT04927065|527308984|FG010|Second Booster|Other Than Specified|1|||
146217062|NCT04927065|527308985|FG011|Second Booster|Other Than Specified|1|||
146217063|NCT04927065|527308986|FG012|Second Booster|Other Than Specified|4|||
146217064|NCT04927065|527308987|FG013|Second Booster|Other Than Specified|0|||
146217065|NCT04927065|527308988|FG014|Second Booster|Other Than Specified|0|||
146217066|NCT04927065|527308989|FG015|Second Booster|Other Than Specified|0|||
146217067|NCT04927065|527308974|FG000|Third Booster|Lost to Follow-up|0|||
146217068|NCT04927065|527308975|FG001|Third Booster|Lost to Follow-up|0|||
146217069|NCT04927065|527308976|FG002|Third Booster|Lost to Follow-up|0|||
146217070|NCT04927065|527308977|FG003|Third Booster|Lost to Follow-up|0|||
146217071|NCT04927065|527308978|FG004|Third Booster|Lost to Follow-up|0|||
146217072|NCT04927065|527308979|FG005|Third Booster|Lost to Follow-up|0|||
146217073|NCT04927065|527308980|FG006|Third Booster|Lost to Follow-up|0|||
146217074|NCT04927065|527308981|FG007|Third Booster|Lost to Follow-up|0|||
146217075|NCT04927065|527308982|FG008|Third Booster|Lost to Follow-up|0|||
146217076|NCT04927065|527308983|FG009|Third Booster|Lost to Follow-up|0|||
146217077|NCT04927065|527308984|FG010|Third Booster|Lost to Follow-up|0|||
146217078|NCT04927065|527308985|FG011|Third Booster|Lost to Follow-up|0|||
146217079|NCT04927065|527308986|FG012|Third Booster|Lost to Follow-up|0|||
146217080|NCT04927065|527308987|FG013|Third Booster|Lost to Follow-up|0|||
146217081|NCT04927065|527308988|FG014|Third Booster|Lost to Follow-up|0|||
146217082|NCT04927065|527308989|FG015|Third Booster|Lost to Follow-up|1|||
146217083|NCT04927065|527308974|FG000|Third Booster|Withdrawal by Subject|0|||
146217084|NCT04927065|527308975|FG001|Third Booster|Withdrawal by Subject|0|||
146217085|NCT04927065|527308976|FG002|Third Booster|Withdrawal by Subject|0|||
146217086|NCT04927065|527308977|FG003|Third Booster|Withdrawal by Subject|0|||
146217087|NCT04927065|527308978|FG004|Third Booster|Withdrawal by Subject|0|||
146217088|NCT04927065|527308979|FG005|Third Booster|Withdrawal by Subject|0|||
146217089|NCT04927065|527308980|FG006|Third Booster|Withdrawal by Subject|0|||
146217090|NCT04927065|527308981|FG007|Third Booster|Withdrawal by Subject|0|||
146217091|NCT04927065|527308982|FG008|Third Booster|Withdrawal by Subject|0|||
146217092|NCT04927065|527308983|FG009|Third Booster|Withdrawal by Subject|0|||
146217093|NCT04927065|527308984|FG010|Third Booster|Withdrawal by Subject|0|||
146217094|NCT04927065|527308985|FG011|Third Booster|Withdrawal by Subject|0|||
146217095|NCT04927065|527308986|FG012|Third Booster|Withdrawal by Subject|0|||
146217096|NCT04927065|527308987|FG013|Third Booster|Withdrawal by Subject|0|||
146217097|NCT04927065|527308988|FG014|Third Booster|Withdrawal by Subject|0|||
146217098|NCT04927065|527308989|FG015|Third Booster|Withdrawal by Subject|1|||
146217099|NCT03892616|527308996|FG000|Washout Period 2|Met discontinuation criterion|0|||
146217100|NCT03892616|527308997|FG001|Washout Period 2|Met discontinuation criterion|0|||
146217101|NCT03892616|527308998|FG002|Washout Period 2|Met discontinuation criterion|0|||
146217102|NCT03892616|527308999|FG003|Washout Period 2|Met discontinuation criterion|0|||
146217103|NCT03892616|527309000|FG004|Washout Period 2|Met discontinuation criterion|0|||
146217104|NCT03892616|527309001|FG005|Washout Period 2|Met discontinuation criterion|0|||
146217105|NCT03892616|527309002|FG006|Washout Period 2|Met discontinuation criterion|0|||
146217106|NCT03892616|527309003|FG007|Washout Period 2|Met discontinuation criterion|0|||
146217107|NCT03892616|527309004|FG008|Washout Period 2|Met discontinuation criterion|1|||
146217108|NCT03892616|527309005|FG009|Washout Period 2|Met discontinuation criterion|0|||
146217109|NCT03892616|527309006|FG010|Washout Period 2|Met discontinuation criterion|0|||
146217110|NCT03892616|527309007|FG011|Washout Period 2|Met discontinuation criterion|0|||
146217111|NCT02243709|527309008|FG000|Phase 1|Lost to Follow-up|0|||
146217112|NCT02243709|527309009|FG001|Phase 1|Lost to Follow-up|1|||
146217113|NCT02243709|527309008|FG000|Phase 1|Withdrawal by Subject|1|||
146217114|NCT02243709|527309009|FG001|Phase 1|Withdrawal by Subject|0|||
146217115|NCT02243709|527309008|FG000|Phase 1|Protocol Violation|0|||
146217116|NCT02243709|527309009|FG001|Phase 1|Protocol Violation|1|||
146217117|NCT02243709|527309008|FG000|Phase 1|Adverse Event|0|||
146217118|NCT02243709|527309009|FG001|Phase 1|Adverse Event|1|||
146217119|NCT04347161|527309012|FG000|Overall Study|Death|0|||
146217120|NCT04347161|527309013|FG001|Overall Study|Death|2|||
146217121|NCT04347161|527309012|FG000|Overall Study|Withdrawal by Subject|1|||
146217122|NCT04347161|527309013|FG001|Overall Study|Withdrawal by Subject|0|||
146217123|NCT04347161|527309012|FG000|Overall Study|Lost to Follow-up|0|||
146217124|NCT04347161|527309013|FG001|Overall Study|Lost to Follow-up|1|||
146217125|NCT04347161|527309012|FG000|Overall Study|No longer on study medication|1|||
146217126|NCT04347161|527309013|FG001|Overall Study|No longer on study medication|1|||
146217127|NCT04169373|527309014|FG000|Week 1 to Week 14|Adverse Event|1|||
146217128|NCT04169373|527309015|FG001|Week 1 to Week 14|Adverse Event|0|||
146217129|NCT04169373|527309016|FG002|Week 1 to Week 14|Adverse Event|1|||
146217130|NCT04169373|527309017|FG003|Week 1 to Week 14|Adverse Event|2|||
146217131|NCT04169373|527309014|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
146217132|NCT04169373|527309015|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
146217133|NCT04169373|527309016|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
146217134|NCT04169373|527309017|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
146217135|NCT04169373|527309014|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
146217136|NCT04169373|527309015|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
146217137|NCT04169373|527309016|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
146217138|NCT04169373|527309017|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
146217139|NCT04169373|527309014|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146217140|NCT04169373|527309015|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
146217141|NCT04169373|527309016|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146217142|NCT04169373|527309017|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
146217143|NCT04169373|527309014|FG000|Week 1 to Week 14|Other|1|||
146217144|NCT04169373|527309015|FG001|Week 1 to Week 14|Other|3|||
146217145|NCT04169373|527309016|FG002|Week 1 to Week 14|Other|3|||
146217146|NCT04169373|527309017|FG003|Week 1 to Week 14|Other|5|||
146217147|NCT04169373|527309014|FG000|Week 14 to Week 52|Adverse Event|1|||
146217148|NCT04169373|527309015|FG001|Week 14 to Week 52|Adverse Event|0|||
146217149|NCT04169373|527309016|FG002|Week 14 to Week 52|Adverse Event|0|||
146217150|NCT04169373|527309017|FG003|Week 14 to Week 52|Adverse Event|1|||
146217151|NCT04169373|527309014|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
146217152|NCT04169373|527309015|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
146217153|NCT04169373|527309016|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
146217154|NCT04169373|527309017|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
146217155|NCT04169373|527309014|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
146217156|NCT04169373|527309015|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
146217157|NCT04169373|527309016|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
146217158|NCT04169373|527309017|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
146217159|NCT04169373|527309014|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
146217160|NCT04169373|527309015|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146217161|NCT04169373|527309016|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146084362|NCT01895361|526827973|FG002|Overall Study|Adverse Event|3|||
146217162|NCT04169373|527309017|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
146217163|NCT04169373|527309014|FG000|Week 14 to Week 52|Other|4|||
146217164|NCT04169373|527309015|FG001|Week 14 to Week 52|Other|5|||
146217165|NCT04169373|527309016|FG002|Week 14 to Week 52|Other|4|||
146217166|NCT04169373|527309017|FG003|Week 14 to Week 52|Other|5|||
146217167|NCT04169373|527309014|FG000|Week 14 to Week 52|Ongoing|0|||
146217168|NCT04169373|527309015|FG001|Week 14 to Week 52|Ongoing|1|||
146217169|NCT04169373|527309016|FG002|Week 14 to Week 52|Ongoing|0|||
146217170|NCT04169373|527309017|FG003|Week 14 to Week 52|Ongoing|0|||
146217171|NCT04533347|527309018|FG000|Overall Study|Adverse Event|1|||
146217172|NCT04533347|527309019|FG001|Overall Study|Adverse Event|2|||
146217173|NCT04533347|527309018|FG000|Overall Study|Lost to Follow-up|2|||
146217174|NCT04533347|527309019|FG001|Overall Study|Lost to Follow-up|0|||
146217175|NCT04533347|527309018|FG000|Overall Study|Withdrawal by Subject|1|||
146217176|NCT04533347|527309019|FG001|Overall Study|Withdrawal by Subject|0|||
146217177|NCT04610892|527309020|FG000|Overall Study|Adverse Event|1|||
146084363|NCT01895361|526827971|FG000|Overall Study|Death|2|||
146217178|NCT04610892|527309021|FG001|Overall Study|Adverse Event|0|||
146217179|NCT04610892|527309022|FG002|Overall Study|Adverse Event|0|||
146217180|NCT04610892|527309023|FG003|Overall Study|Adverse Event|1|||
146217181|NCT04610892|527309024|FG004|Overall Study|Adverse Event|3|||
146084364|NCT01895361|526827972|FG001|Overall Study|Death|1|||
146217182|NCT04610892|527309020|FG000|Overall Study|Death|0|||
146217183|NCT04610892|527309021|FG001|Overall Study|Death|1|||
146217184|NCT04610892|527309022|FG002|Overall Study|Death|0|||
146217185|NCT04610892|527309023|FG003|Overall Study|Death|1|||
146217186|NCT04610892|527309024|FG004|Overall Study|Death|0|||
146217187|NCT04610892|527309020|FG000|Overall Study|Withdrawal by Subject|3|||
146217188|NCT04610892|527309021|FG001|Overall Study|Withdrawal by Subject|2|||
146217189|NCT04610892|527309022|FG002|Overall Study|Withdrawal by Subject|0|||
146217190|NCT04610892|527309023|FG003|Overall Study|Withdrawal by Subject|6|||
146217191|NCT04610892|527309024|FG004|Overall Study|Withdrawal by Subject|6|||
146217192|NCT04610892|527309020|FG000|Overall Study|Subjects who did not receive treatment|1|||
146217193|NCT04610892|527309021|FG001|Overall Study|Subjects who did not receive treatment|0|||
146217194|NCT04610892|527309022|FG002|Overall Study|Subjects who did not receive treatment|0|||
146217195|NCT04610892|527309023|FG003|Overall Study|Subjects who did not receive treatment|0|||
146217196|NCT04610892|527309024|FG004|Overall Study|Subjects who did not receive treatment|2|||
146217197|NCT05520190|527309025|FG000|Overall Study|Lost to Follow-up|7|||
146217198|NCT05520190|527309025|FG000|Overall Study|Withdrawal by Subject|2|||
146217199|NCT01748448|527309028|FG000|Treatment Period|Consent withdrawn by subject|1|||
146217200|NCT01748448|527309029|FG001|Treatment Period|Consent withdrawn by subject|0|||
146217201|NCT01748448|527309028|FG000|Treatment Period|Adverse Event|1|||
146217202|NCT01748448|527309029|FG001|Treatment Period|Adverse Event|0|||
146217203|NCT01748448|527309028|FG000|Treatment Period|Personal|0|||
146217204|NCT01748448|527309029|FG001|Treatment Period|Personal|1|||
146217205|NCT03924986|527309031|FG000|Overall Study|Death|57|||
146217206|NCT03924986|527309032|FG001|Overall Study|Death|66|||
146217207|NCT03924986|527309031|FG000|Overall Study|Study Concluded by Sponsor|51|||
146217208|NCT03924986|527309032|FG001|Overall Study|Study Concluded by Sponsor|41|||
146217209|NCT03924986|527309031|FG000|Overall Study|Withdrawal by Subject|15|||
146217210|NCT03924986|527309032|FG001|Overall Study|Withdrawal by Subject|20|||
146217211|NCT03924986|527309031|FG000|Overall Study|Lost to Follow-up|7|||
146217212|NCT03924986|527309032|FG001|Overall Study|Lost to Follow-up|5|||
146217213|NCT03924986|527309031|FG000|Overall Study|Miscellaneous|1|||
146217214|NCT03924986|527309032|FG001|Overall Study|Miscellaneous|0|||
146217215|NCT03699709|527309038|FG000|Overall Study|Death|1|||
146217216|NCT03699709|527309039|FG001|Overall Study|Death|2|||
146217217|NCT03699709|527309038|FG000|Overall Study|Lost to Follow-up|10|||
146217218|NCT03699709|527309039|FG001|Overall Study|Lost to Follow-up|3|||
146217219|NCT03699709|527309038|FG000|Overall Study|Withdrawal by Subject|5|||
146217220|NCT03699709|527309039|FG001|Overall Study|Withdrawal by Subject|0|||
146217221|NCT03699709|527309038|FG000|Overall Study|incarcerated|1|||
146217222|NCT03699709|527309039|FG001|Overall Study|incarcerated|0|||
146217223|NCT03699709|527309038|FG000|Overall Study|scheduled, but no show|0|||
146217224|NCT03699709|527309039|FG001|Overall Study|scheduled, but no show|1|||
146217225|NCT02907099|527309040|FG000|Overall Study|Adverse Event|1|||
146217226|NCT02907099|527309040|FG000|Overall Study|Withdrawal by Subject|2|||
146217227|NCT02907099|527309040|FG000|Overall Study|Screen Fail|2|||
146217228|NCT05134233|527309045|FG000|Overall Study|Pregnancy|1|||
146217229|NCT05134233|527309045|FG000|Overall Study|MEP value too low|2|||
146217230|NCT05134233|527309045|FG000|Overall Study|Lost to Follow-up|1|||
146217231|NCT03652688|527309050|FG000|Baseline|Withdrawal by Subject|0|||
146217232|NCT03652688|527309051|FG001|Baseline|Withdrawal by Subject|3|||
146217233|NCT03652688|527309050|FG000|Follow-up|Lost to Follow-up|56|||
146217234|NCT03652688|527309051|FG001|Follow-up|Lost to Follow-up|54|||
146217235|NCT05089734|527309052|FG000|Overall Study|Still on study|122|||
146217236|NCT05089734|527309053|FG001|Overall Study|Still on study|101|||
146217237|NCT05089734|527309052|FG000|Overall Study|Death|161|||
146217238|NCT05089734|527309053|FG001|Overall Study|Death|179|||
146217239|NCT05089734|527309052|FG000|Overall Study|Withdrew consent|11|||
146217240|NCT05089734|527309053|FG001|Overall Study|Withdrew consent|24|||
146217241|NCT05089734|527309052|FG000|Overall Study|Lost to Follow-up|5|||
146217242|NCT05089734|527309053|FG001|Overall Study|Lost to Follow-up|0|||
146217243|NCT03406871|527310584|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
146217244|NCT03406871|527310585|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
146217245|NCT03406871|527310586|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
145960479|NCT01278342|526367589|FG001|Overall Study|Lost to Follow-up|0|||
145960480|NCT01278342|526367590|FG002|Overall Study|Lost to Follow-up|0|||
146217246|NCT03406871|527310584|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
146217247|NCT03406871|527310585|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
146217248|NCT03406871|527310586|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
146217249|NCT03406871|527310584|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
146217250|NCT03406871|527310585|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
146217251|NCT03406871|527310586|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
146217252|NCT03406871|527310584|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
146217253|NCT03406871|527310585|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
146217254|NCT03406871|527310586|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
146217255|NCT03406871|527310584|FG000|Expansion Cohort(Final Analysis)|Death|0|||
146217256|NCT03406871|527310585|FG001|Expansion Cohort(Final Analysis)|Death|1|||
146217257|NCT03406871|527310586|FG002|Expansion Cohort(Final Analysis)|Death|0|||
146217258|NCT03406871|527310584|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
146217259|NCT03406871|527310585|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
146217260|NCT03406871|527310586|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
146217261|NCT04005716|527310592|FG000|Overall Study|Death|175|||
146217262|NCT04005716|527310593|FG001|Overall Study|Death|196|||
146217263|NCT04005716|527310592|FG000|Overall Study|Withdrawal by Subject|1|||
146217264|NCT04005716|527310593|FG001|Overall Study|Withdrawal by Subject|6|||
146217265|NCT04005716|527310592|FG000|Overall Study|Lost to Follow-up|2|||
146217266|NCT04005716|527310593|FG001|Overall Study|Lost to Follow-up|2|||
146217267|NCT04021602|527310594|FG000|Overall Study|Lost to Follow-up|3|||
146217268|NCT04021602|527310595|FG001|Overall Study|Lost to Follow-up|3|||
146217269|NCT04021602|527310596|FG002|Overall Study|Lost to Follow-up|1|||
146217270|NCT04021602|527310594|FG000|Overall Study|Adverse Event|1|||
146217271|NCT04021602|527310595|FG001|Overall Study|Adverse Event|0|||
146217272|NCT04021602|527310596|FG002|Overall Study|Adverse Event|1|||
146217273|NCT05178316|527310603|FG000|Overall Study|Adverse Event|5|||
146217274|NCT05178316|527310604|FG001|Overall Study|Adverse Event|4|||
146217275|NCT05178316|527310605|FG002|Overall Study|Adverse Event|9|||
146217276|NCT05178316|527310603|FG000|Overall Study|Enrolled in Error|1|||
146217277|NCT05178316|527310604|FG001|Overall Study|Enrolled in Error|2|||
146217278|NCT05178316|527310605|FG002|Overall Study|Enrolled in Error|1|||
146217279|NCT05178316|527310603|FG000|Overall Study|Lost to Follow-up|3|||
146217280|NCT05178316|527310604|FG001|Overall Study|Lost to Follow-up|15|||
146217281|NCT05178316|527310605|FG002|Overall Study|Lost to Follow-up|11|||
146217282|NCT05178316|527310603|FG000|Overall Study|Noncompliance|1|||
146217283|NCT05178316|527310604|FG001|Overall Study|Noncompliance|3|||
146217284|NCT05178316|527310605|FG002|Overall Study|Noncompliance|1|||
146217285|NCT05178316|527310603|FG000|Overall Study|Other|0|||
146217286|NCT05178316|527310604|FG001|Overall Study|Other|1|||
146217287|NCT05178316|527310605|FG002|Overall Study|Other|0|||
146217288|NCT05178316|527310603|FG000|Overall Study|Physician Decision|0|||
146217289|NCT05178316|527310604|FG001|Overall Study|Physician Decision|3|||
146217290|NCT05178316|527310605|FG002|Overall Study|Physician Decision|2|||
146217291|NCT05178316|527310603|FG000|Overall Study|Protocol deviation|1|||
146217292|NCT05178316|527310604|FG001|Overall Study|Protocol deviation|0|||
146217293|NCT05178316|527310605|FG002|Overall Study|Protocol deviation|1|||
146217294|NCT05178316|527310603|FG000|Overall Study|Sponsor decision|1|||
146217295|NCT05178316|527310604|FG001|Overall Study|Sponsor decision|0|||
145960481|NCT01278342|526367588|FG000|Overall Study|Administrative problems|2|||
145960482|NCT01278342|526367589|FG001|Overall Study|Administrative problems|0|||
145960483|NCT01278342|526367590|FG002|Overall Study|Administrative problems|0|||
145960484|NCT01278342|526367588|FG000|Overall Study|Other|1|||
145960485|NCT01278342|526367589|FG001|Overall Study|Other|0|||
145960486|NCT01278342|526367590|FG002|Overall Study|Other|0|||
145960487|NCT05417412|526367602|FG000|Overall Study|Lost to Follow-up|2|||
145960488|NCT01576575|526367603|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
145960489|NCT01576575|526367603|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
146217296|NCT05178316|527310605|FG002|Overall Study|Sponsor decision|1|||
146217297|NCT05178316|527310603|FG000|Overall Study|Withdrawal by Subject|5|||
146217298|NCT05178316|527310604|FG001|Overall Study|Withdrawal by Subject|11|||
146217299|NCT05178316|527310605|FG002|Overall Study|Withdrawal by Subject|5|||
145960490|NCT01576575|526367603|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
145960491|NCT02157519|526367607|FG000|Overall Study|Death|3|||
145960492|NCT02157519|526367608|FG001|Overall Study|Death|1|||
145960493|NCT02157519|526367607|FG000|Overall Study|Withdrawal by Subject|7|||
146217300|NCT03907397|527310609|FG000|Overall Study|Lost to Follow-up|0|||
146217301|NCT03907397|527310610|FG001|Overall Study|Lost to Follow-up|1|||
146217302|NCT03907397|527310609|FG000|Overall Study|Physician Decision|2|||
146217303|NCT03907397|527310610|FG001|Overall Study|Physician Decision|1|||
146217304|NCT03907397|527310609|FG000|Overall Study|Withdrawal by Subject|5|||
146217305|NCT03907397|527310610|FG001|Overall Study|Withdrawal by Subject|4|||
146235068|NCT00622700|527378451|FG004|Extension Treatment Period|Adverse Event|9|||
145960494|NCT02157519|526367608|FG001|Overall Study|Withdrawal by Subject|0|||
146084365|NCT01895361|526827973|FG002|Overall Study|Death|2|||
146084366|NCT01895361|526827971|FG000|Overall Study|Lost to Follow-up|4|||
146084367|NCT01895361|526827972|FG001|Overall Study|Lost to Follow-up|4|||
146084368|NCT01895361|526827973|FG002|Overall Study|Lost to Follow-up|6|||
146084369|NCT01895361|526827971|FG000|Overall Study|Non-compliance with study|1|||
146084370|NCT01895361|526827972|FG001|Overall Study|Non-compliance with study|3|||
146084371|NCT01895361|526827973|FG002|Overall Study|Non-compliance with study|1|||
146084372|NCT01895361|526827971|FG000|Overall Study|Physician Decision|2|||
146084373|NCT01895361|526827972|FG001|Overall Study|Physician Decision|2|||
146084374|NCT01895361|526827973|FG002|Overall Study|Physician Decision|2|||
146084375|NCT01895361|526827971|FG000|Overall Study|Withdrawal by Subject|7|||
146084376|NCT01895361|526827972|FG001|Overall Study|Withdrawal by Subject|6|||
146084377|NCT01895361|526827973|FG002|Overall Study|Withdrawal by Subject|6|||
146084378|NCT01895361|526827971|FG000|Overall Study|Lack of Efficacy|0|||
146084379|NCT01895361|526827972|FG001|Overall Study|Lack of Efficacy|1|||
146084380|NCT01895361|526827973|FG002|Overall Study|Lack of Efficacy|0|||
146084381|NCT01895361|526827971|FG000|Overall Study|Reasons different from categories above|7|||
146084382|NCT01895361|526827972|FG001|Overall Study|Reasons different from categories above|3|||
146084383|NCT01895361|526827973|FG002|Overall Study|Reasons different from categories above|4|||
146084384|NCT01860846|526827983|FG000|Overall Study|Lost to Follow-up|33|||
146084385|NCT05463198|526827984|FG000|Overall Study|Withdrawal by Subject|19|||
146084386|NCT05463198|526827984|FG000|Overall Study|Procedure Notes Missing|18|||
146084387|NCT02239120|526827987|FG000|Overall Study|Death|56|||
146084388|NCT02239120|526827988|FG001|Overall Study|Death|58|||
146084389|NCT02239120|526827987|FG000|Overall Study|Lost to Follow-up|19|||
146084390|NCT02239120|526827988|FG001|Overall Study|Lost to Follow-up|14|||
146084391|NCT00466687|526827989|FG000|Overall Study|Adverse Event|1|||
146084392|NCT00466687|526827989|FG000|Overall Study|Other complicating illness|3|||
146084393|NCT00466687|526827989|FG000|Overall Study|Withdrawal by Subject|1|||
146084394|NCT00466687|526827989|FG000|Overall Study|Disease progression|29|||
146084395|NCT00046891|526827990|FG000|Overall Study|Cancels|5|||
146084396|NCT00046891|526827991|FG001|Overall Study|Cancels|9|||
146084397|NCT00046891|526827990|FG000|Overall Study|Ineligible|1|||
146084398|NCT00046891|526827991|FG001|Overall Study|Ineligible|1|||
146084399|NCT00046891|526827990|FG000|Overall Study|Withdrawal by Subject|18|||
146084400|NCT00046891|526827991|FG001|Overall Study|Withdrawal by Subject|15|||
146084401|NCT00046891|526827990|FG000|Overall Study|Adverse Event|5|||
146084402|NCT00046891|526827991|FG001|Overall Study|Adverse Event|5|||
146084403|NCT01514370|526827993|FG000|Overall Study|Protocol Violation|2|||
146084404|NCT01514370|526827994|FG001|Overall Study|Protocol Violation|3|||
146084405|NCT01514370|526827993|FG000|Overall Study|Lost to Follow-up|0|||
146084406|NCT01514370|526827994|FG001|Overall Study|Lost to Follow-up|2|||
146084407|NCT01514370|526827993|FG000|Overall Study|Withdrawal by Subject|2|||
146084408|NCT01514370|526827994|FG001|Overall Study|Withdrawal by Subject|1|||
146084409|NCT01514370|526827993|FG000|Overall Study|Adverse Event|1|||
146084410|NCT01514370|526827994|FG001|Overall Study|Adverse Event|3|||
146084411|NCT01514370|526827993|FG000|Overall Study|Other|6|||
146084412|NCT01514370|526827994|FG001|Overall Study|Other|7|||
146084413|NCT01159431|526827995|FG000|Overall Study|Adverse Event|1|||
146084414|NCT01159431|526827996|FG001|Overall Study|Adverse Event|2|||
146084415|NCT01159431|526827995|FG000|Overall Study|non-compliance|1|||
146084416|NCT01159431|526827996|FG001|Overall Study|non-compliance|1|||
146084417|NCT01159431|526827995|FG000|Overall Study|Lack of Efficacy|0|||
146084418|NCT01159431|526827996|FG001|Overall Study|Lack of Efficacy|3|||
146084419|NCT00604214|526827999|FG000|Baseline to Day 28|Death|223|||
146084420|NCT00604214|526828000|FG001|Baseline to Day 28|Death|202|||
146084421|NCT00604214|526827999|FG000|Baseline to Day 28|Lost to Follow-up|2|||
146084422|NCT00604214|526828000|FG001|Baseline to Day 28|Lost to Follow-up|4|||
146084423|NCT00604214|526827999|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
146084424|NCT00604214|526828000|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
146084425|NCT00604214|526827999|FG000|Day 29 to Day 90|Death|64|||
146084426|NCT00604214|526828000|FG001|Day 29 to Day 90|Death|67|||
146084427|NCT00604214|526827999|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
146084428|NCT00604214|526828000|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
146084429|NCT00604214|526827999|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
146084430|NCT00604214|526828000|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
146084431|NCT00604214|526827999|FG000|Day 91 to Day 180|Death|19|||
146084432|NCT00604214|526828000|FG001|Day 91 to Day 180|Death|23|||
146084433|NCT00604214|526827999|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
146084434|NCT00604214|526828000|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
146084435|NCT00604214|526827999|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
146084436|NCT00604214|526828000|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
146084437|NCT00534599|526828001|FG000|Overall Study|Adverse Event|25|||
146084438|NCT00534599|526828002|FG001|Overall Study|Adverse Event|4|||
146084439|NCT00534599|526828001|FG000|Overall Study|Incorrect enrollment|2|||
146084440|NCT00534599|526828002|FG001|Overall Study|Incorrect enrollment|1|||
146084441|NCT00534599|526828001|FG000|Overall Study|Mis-randomization|2|||
146084442|NCT00534599|526828002|FG001|Overall Study|Mis-randomization|2|||
146084443|NCT00534599|526828001|FG000|Overall Study|Developed study-specific d/c criteria|5|||
146217306|NCT03907397|527310609|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
146217307|NCT03907397|527310610|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
146217308|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
146217309|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
146217310|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
146217311|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
146217312|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
146217313|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
146217314|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
146217315|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
146217316|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
146217317|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
146217318|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
146217319|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
146217320|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
146217321|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
146217322|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
146217323|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
146217324|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
146217325|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
146217326|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
146217327|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
146217328|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
146217329|NCT05369403|527310611|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
146217330|NCT05369403|527310612|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
146217331|NCT05369403|527310613|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
146217332|NCT05369403|527310611|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
146217333|NCT05369403|527310612|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
146217334|NCT05369403|527310613|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
146217335|NCT05369403|527310611|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
146217336|NCT05369403|527310612|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
146217337|NCT05369403|527310613|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
146217338|NCT05369403|527310611|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
146217339|NCT05369403|527310612|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
146217340|NCT05369403|527310613|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
146217341|NCT02689284|527310614|FG000|Overall Study|Adverse Event|1|||
146217342|NCT02689284|527310615|FG001|Overall Study|Adverse Event|8|||
146217343|NCT02689284|527310614|FG000|Overall Study|Death|0|||
146217344|NCT02689284|527310615|FG001|Overall Study|Death|1|||
146217345|NCT02689284|527310614|FG000|Overall Study|Physician Decision|1|||
146217346|NCT02689284|527310615|FG001|Overall Study|Physician Decision|2|||
146217347|NCT02689284|527310614|FG000|Overall Study|Withdrawal by Subject|0|||
146217348|NCT02689284|527310615|FG001|Overall Study|Withdrawal by Subject|1|||
146217349|NCT02689284|527310614|FG000|Overall Study|progression of cancer|1|||
146217350|NCT02689284|527310615|FG001|Overall Study|progression of cancer|72|||
146217351|NCT02689284|527310614|FG000|Overall Study|decreased heart function|0|||
146217352|NCT02689284|527310615|FG001|Overall Study|decreased heart function|1|||
146217353|NCT02689284|527310614|FG000|Overall Study|concern for anemia|0|||
146217354|NCT02689284|527310615|FG001|Overall Study|concern for anemia|1|||
146217355|NCT02689284|527310614|FG000|Overall Study|no measurable cancer for evaluation|0|||
145960495|NCT02157519|526367607|FG000|Overall Study|Lost to Follow-up|1|||
145960496|NCT02157519|526367608|FG001|Overall Study|Lost to Follow-up|0|||
145960497|NCT01656395|526367609|FG000|Overall Study|Adverse Event|1|||
145960498|NCT01656395|526367610|FG001|Overall Study|Adverse Event|14|||
145960499|NCT01656395|526367611|FG002|Overall Study|Adverse Event|5|||
145960500|NCT01656395|526367612|FG003|Overall Study|Adverse Event|4|||
145960501|NCT01656395|526367613|FG004|Overall Study|Adverse Event|5|||
145960502|NCT01656395|526367614|FG005|Overall Study|Adverse Event|7|||
145960503|NCT01656395|526367615|FG006|Overall Study|Adverse Event|0|||
145960504|NCT01656395|526367616|FG007|Overall Study|Adverse Event|0|||
145960505|NCT01656395|526367609|FG000|Overall Study|Lack of Efficacy|1|||
145960506|NCT01656395|526367610|FG001|Overall Study|Lack of Efficacy|8|||
145960507|NCT01656395|526367611|FG002|Overall Study|Lack of Efficacy|6|||
146217356|NCT02689284|527310615|FG001|Overall Study|no measurable cancer for evaluation|1|||
146217357|NCT03232138|527310616|FG000|Overall Study|Physician Decision|1|||
145960508|NCT01656395|526367612|FG003|Overall Study|Lack of Efficacy|1|||
145960509|NCT01656395|526367613|FG004|Overall Study|Lack of Efficacy|1|||
145960510|NCT01656395|526367614|FG005|Overall Study|Lack of Efficacy|6|||
146217358|NCT03232138|527310617|FG001|Overall Study|Physician Decision|0|||
146217359|NCT03232138|527310616|FG000|Overall Study|Adverse Event|2|||
146217360|NCT03232138|527310617|FG001|Overall Study|Adverse Event|0|||
146217361|NCT03232138|527310616|FG000|Overall Study|Withdrawal by Subject|1|||
146217362|NCT03232138|527310617|FG001|Overall Study|Withdrawal by Subject|2|||
146217363|NCT03920111|527310621|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
146217364|NCT03920111|527310622|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
146217365|NCT03920111|527310623|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
146217366|NCT05268393|527310624|FG000|Overall Study|Withdrawal by Subject|2|||
146217367|NCT05268393|527310625|FG001|Overall Study|Withdrawal by Subject|1|||
146217368|NCT05516147|527310626|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
146217369|NCT03396926|527310628|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
146217370|NCT03396926|527310629|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
146217371|NCT02035787|527310630|FG000|Overall Study- 12 Months|Adverse Event|3|||
146217372|NCT02035787|527310631|FG001|Overall Study- 12 Months|Adverse Event|0|||
146217373|NCT02035787|527310630|FG000|Overall Study- 12 Months|Complete response|4|||
146217374|NCT02035787|527310631|FG001|Overall Study- 12 Months|Complete response|1|||
146217375|NCT02035787|527310630|FG000|Overall Study- 12 Months|Protocol Violation|1|||
146217376|NCT02035787|527310631|FG001|Overall Study- 12 Months|Protocol Violation|1|||
146217377|NCT06414213|527310632|FG000|Overall Study|Lost to Follow-up|1|||
146217378|NCT06414213|527310633|FG001|Overall Study|Lost to Follow-up|1|||
146217379|NCT06414213|527310634|FG002|Overall Study|Lost to Follow-up|3|||
146217380|NCT00450658|527310637|FG000|Overall Study|Adverse Event|24|||
146217381|NCT00450658|527310638|FG001|Overall Study|Adverse Event|15|||
146217382|NCT00450658|527310637|FG000|Overall Study|Withdrawal by Subject|43|||
146217383|NCT00450658|527310638|FG001|Overall Study|Withdrawal by Subject|26|||
146217384|NCT00450658|527310637|FG000|Overall Study|Lost to Follow-up|22|||
146217385|NCT00450658|527310638|FG001|Overall Study|Lost to Follow-up|5|||
146217386|NCT00450658|527310637|FG000|Overall Study|UGI ulcer|33|||
146217387|NCT00450658|527310638|FG001|Overall Study|UGI ulcer|34|||
146217388|NCT00450658|527310637|FG000|Overall Study|misc|21|||
146217389|NCT00450658|527310638|FG001|Overall Study|misc|10|||
146217390|NCT04727554|527310639|FG000|Overall Study|Lost to Follow-up|0|||
146217391|NCT04727554|527310640|FG001|Overall Study|Lost to Follow-up|1|||
146217392|NCT04727554|527310639|FG000|Overall Study|Death|2|||
146217393|NCT04727554|527310640|FG001|Overall Study|Death|6|||
146217394|NCT04727554|527310639|FG000|Overall Study|Withdrawal by Subject|1|||
146217395|NCT04727554|527310640|FG001|Overall Study|Withdrawal by Subject|0|||
146217396|NCT05763823|527310641|FG000|Overall Study|Death|6|||
146217397|NCT05763823|527310641|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146217398|NCT05763823|527310641|FG000|Overall Study|Withdrawal by Subject|6|||
146217399|NCT01997840|527310644|FG000|Overall Study|Lost to Follow-up|0|||
146217400|NCT01997840|527310645|FG001|Overall Study|Lost to Follow-up|0|||
146217401|NCT01997840|527310646|FG002|Overall Study|Lost to Follow-up|1|||
146217402|NCT01997840|527310647|FG003|Overall Study|Lost to Follow-up|0|||
146217403|NCT01997840|527310644|FG000|Overall Study|Withdrawal by participant|0|||
146217404|NCT01997840|527310645|FG001|Overall Study|Withdrawal by participant|0|||
146217405|NCT01997840|527310646|FG002|Overall Study|Withdrawal by participant|8|||
146217406|NCT01997840|527310647|FG003|Overall Study|Withdrawal by participant|1|||
146217407|NCT01997840|527310644|FG000|Overall Study|Physician Decision|0|||
146217408|NCT01997840|527310645|FG001|Overall Study|Physician Decision|0|||
146217409|NCT01997840|527310646|FG002|Overall Study|Physician Decision|3|||
146217410|NCT01997840|527310647|FG003|Overall Study|Physician Decision|0|||
146217411|NCT01997840|527310644|FG000|Overall Study|Progressive disease|3|||
146217412|NCT01997840|527310645|FG001|Overall Study|Progressive disease|4|||
146217413|NCT01997840|527310646|FG002|Overall Study|Progressive disease|57|||
146217414|NCT01997840|527310647|FG003|Overall Study|Progressive disease|8|||
146217415|NCT01997840|527310644|FG000|Overall Study|Other reasons|0|||
146217416|NCT01997840|527310645|FG001|Overall Study|Other reasons|0|||
146217417|NCT01997840|527310646|FG002|Overall Study|Other reasons|1|||
146217418|NCT01997840|527310647|FG003|Overall Study|Other reasons|0|||
146217419|NCT01997840|527310644|FG000|Overall Study|Adverse Event|0|||
146217420|NCT01997840|527310645|FG001|Overall Study|Adverse Event|0|||
146084444|NCT00534599|526828002|FG001|Overall Study|Developed study-specific d/c criteria|0|||
146084445|NCT00534599|526828001|FG000|Overall Study|Lack of Efficacy|0|||
146084446|NCT00534599|526828002|FG001|Overall Study|Lack of Efficacy|1|||
146084447|NCT00534599|526828001|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
146217421|NCT01997840|527310646|FG002|Overall Study|Adverse Event|15|||
146217422|NCT01997840|527310647|FG003|Overall Study|Adverse Event|2|||
146217423|NCT05256706|527310649|FG000|Overall Study|Lost to Follow-up|9|||
146217424|NCT05256706|527310650|FG001|Overall Study|Lost to Follow-up|3|||
146217425|NCT05256706|527310649|FG000|Overall Study|Withdrawal by Subject|7|||
146217426|NCT05256706|527310650|FG001|Overall Study|Withdrawal by Subject|11|||
146217427|NCT05256706|527310649|FG000|Overall Study|Screen Failures|3|||
146217428|NCT05256706|527310650|FG001|Overall Study|Screen Failures|0|||
146217429|NCT03850678|527310655|FG000|Overall Study|Withdrawal by Subject|3|||
146217430|NCT03850678|527310656|FG001|Overall Study|Withdrawal by Subject|0|||
146217431|NCT03850678|527310655|FG000|Overall Study|Experimenter Error|1|||
146217432|NCT03850678|527310656|FG001|Overall Study|Experimenter Error|1|||
146217433|NCT03850678|527310655|FG000|Overall Study|Did Not Condition To Experiment|7|||
146217434|NCT03850678|527310656|FG001|Overall Study|Did Not Condition To Experiment|2|||
146217435|NCT03720795|527310660|FG000|Phase 1|Lost to Follow-up|4|||
146217436|NCT03720795|527310660|FG000|Phase 1|Withdrawal by Subject|6|||
146217437|NCT03720795|527310660|FG000|Phase 1|Protocol Violation|1|||
146217438|NCT03720795|527310660|FG000|Phase 1|Other|1|||
146217439|NCT03720795|527310660|FG000|Phase 2|Lost to Follow-up|5|||
146217440|NCT03720795|527310660|FG000|Phase 2|Withdrawal by Subject|10|||
146217441|NCT03720795|527310660|FG000|Phase 2|Protocol Violation|2|||
146217442|NCT03720795|527310660|FG000|3 Month Follow Up|Lost to Follow-up|2|||
146217443|NCT05311384|527310661|FG000|Overall Study|Uncontrolled health conditions|2|||
146217444|NCT05311384|527310661|FG000|Overall Study|Withdrawal by Subject|1|||
146217445|NCT04322643|527310662|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
146217446|NCT03302494|527310663|FG000|Overall Study|Other|7|||
146217447|NCT03302494|527310664|FG001|Overall Study|Other|4|||
146217448|NCT03302494|527310665|FG002|Overall Study|Other|6|||
146217449|NCT03302494|527310663|FG000|Overall Study|Withdrawal by Subject|10|||
146217450|NCT03302494|527310664|FG001|Overall Study|Withdrawal by Subject|2|||
146217451|NCT03302494|527310665|FG002|Overall Study|Withdrawal by Subject|9|||
146217452|NCT03302494|527310663|FG000|Overall Study|Study Terminated by Sponsor|32|||
146217453|NCT03302494|527310664|FG001|Overall Study|Study Terminated by Sponsor|29|||
146217454|NCT03302494|527310665|FG002|Overall Study|Study Terminated by Sponsor|30|||
146217455|NCT03302494|527310663|FG000|Overall Study|Physician Decision|1|||
146217456|NCT03302494|527310664|FG001|Overall Study|Physician Decision|0|||
146217457|NCT03302494|527310665|FG002|Overall Study|Physician Decision|1|||
146217458|NCT03302494|527310663|FG000|Overall Study|Lost to Follow-up|1|||
146217459|NCT03302494|527310664|FG001|Overall Study|Lost to Follow-up|3|||
146217460|NCT03302494|527310665|FG002|Overall Study|Lost to Follow-up|3|||
146217461|NCT03302494|527310663|FG000|Overall Study|Death|13|||
146217462|NCT03302494|527310664|FG001|Overall Study|Death|11|||
146217463|NCT03302494|527310665|FG002|Overall Study|Death|4|||
146217464|NCT03302494|527310663|FG000|Overall Study|Adverse Event|1|||
146217465|NCT03302494|527310664|FG001|Overall Study|Adverse Event|2|||
146217466|NCT03302494|527310665|FG002|Overall Study|Adverse Event|0|||
146217467|NCT03302494|527310663|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
146217468|NCT03302494|527310664|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
146217469|NCT03302494|527310665|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
146217470|NCT01573442|527310666|FG000|Overall Study|Cancels|9|||
146217471|NCT01573442|527310667|FG001|Overall Study|Cancels|10|||
146217472|NCT05710107|527310671|FG000|Overall Study|Withdrawal by Subject|1|||
146217473|NCT05710107|527310672|FG001|Overall Study|Withdrawal by Subject|1|||
146217474|NCT05710107|527310671|FG000|Overall Study|Lost to Follow-up|8|||
146217475|NCT05710107|527310672|FG001|Overall Study|Lost to Follow-up|9|||
146217476|NCT05710107|527310671|FG000|Overall Study|Unable to place assigned block|2|||
146217477|NCT05710107|527310672|FG001|Overall Study|Unable to place assigned block|0|||
146217478|NCT05710107|527310671|FG000|Overall Study|Withdrawn by study team|0|||
146217479|NCT05710107|527310672|FG001|Overall Study|Withdrawn by study team|1|||
146217480|NCT04166773|527310673|FG000|Overall Study|Adverse Event|2|||
146217481|NCT04166773|527310674|FG001|Overall Study|Adverse Event|0|||
146217482|NCT04166773|527310675|FG002|Overall Study|Adverse Event|2|||
146217483|NCT04166773|527310676|FG003|Overall Study|Adverse Event|1|||
146217484|NCT04166773|527310673|FG000|Overall Study|Lost to Follow-up|4|||
146217485|NCT04166773|527310674|FG001|Overall Study|Lost to Follow-up|2|||
146217486|NCT04166773|527310675|FG002|Overall Study|Lost to Follow-up|1|||
146217487|NCT04166773|527310676|FG003|Overall Study|Lost to Follow-up|3|||
146217488|NCT04166773|527310673|FG000|Overall Study|Physician Decision|0|||
146217489|NCT04166773|527310674|FG001|Overall Study|Physician Decision|0|||
146217490|NCT04166773|527310675|FG002|Overall Study|Physician Decision|0|||
145960511|NCT01656395|526367615|FG006|Overall Study|Lack of Efficacy|0|||
145960512|NCT01656395|526367616|FG007|Overall Study|Lack of Efficacy|0|||
145960513|NCT01656395|526367609|FG000|Overall Study|Lost to Follow-up|1|||
145960514|NCT01656395|526367610|FG001|Overall Study|Lost to Follow-up|0|||
146217491|NCT04166773|527310676|FG003|Overall Study|Physician Decision|1|||
146217492|NCT04166773|527310673|FG000|Overall Study|Withdrawal by Subject|1|||
146217493|NCT04166773|527310674|FG001|Overall Study|Withdrawal by Subject|1|||
146217494|NCT04166773|527310675|FG002|Overall Study|Withdrawal by Subject|2|||
146217495|NCT04166773|527310676|FG003|Overall Study|Withdrawal by Subject|5|||
146217496|NCT04763265|527310677|FG000|Overall Study|Adverse Event|1|||
146217497|NCT04763265|527310678|FG001|Overall Study|Adverse Event|0|||
146217498|NCT04763265|527310677|FG000|Overall Study|Lost to Follow-up|2|||
146217499|NCT04763265|527310678|FG001|Overall Study|Lost to Follow-up|4|||
146217500|NCT04763265|527310677|FG000|Overall Study|Withdrawal by Subject|0|||
146217501|NCT04763265|527310678|FG001|Overall Study|Withdrawal by Subject|1|||
146217502|NCT04952909|527310683|FG000|Overall Study|Death|3|||
146217503|NCT02515773|527310687|FG000|Overall Study|Withdrawal by Subject|12|||
146217504|NCT02515773|527310688|FG001|Overall Study|Withdrawal by Subject|2|||
146217505|NCT02515773|527310687|FG000|Overall Study|Lost to Follow-up|119|||
146217506|NCT02515773|527310688|FG001|Overall Study|Lost to Follow-up|126|||
146217507|NCT02515773|527310687|FG000|Overall Study|Discharged from Clinic Services|53|||
146217508|NCT02515773|527310688|FG001|Overall Study|Discharged from Clinic Services|84|||
146217509|NCT02515773|527310687|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
146217510|NCT02515773|527310688|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
146217511|NCT02515773|527310687|FG000|Overall Study|Follow-up at non-study site|8|||
146217512|NCT02515773|527310688|FG001|Overall Study|Follow-up at non-study site|16|||
146217513|NCT02515773|527310687|FG000|Overall Study|Moved from area|9|||
146217514|NCT02515773|527310688|FG001|Overall Study|Moved from area|14|||
146217515|NCT05434078|527310690|FG000|Overall Study|Lost to Follow-up|2|||
146217516|NCT05434078|527310691|FG001|Overall Study|Lost to Follow-up|1|||
146217517|NCT05434078|527310690|FG000|Overall Study|Withdrawal by Subject|1|||
146217518|NCT05434078|527310691|FG001|Overall Study|Withdrawal by Subject|0|||
146217519|NCT04072380|527310692|FG000|Overall Study|Adverse Event|4|||
146217520|NCT04072380|527310693|FG001|Overall Study|Adverse Event|6|||
146217521|NCT04072380|527310694|FG002|Overall Study|Adverse Event|0|||
146217522|NCT04072380|527310692|FG000|Overall Study|Withdrawal by Subject|3|||
146217523|NCT04072380|527310693|FG001|Overall Study|Withdrawal by Subject|1|||
146217524|NCT04072380|527310694|FG002|Overall Study|Withdrawal by Subject|1|||
146217525|NCT04072380|527310692|FG000|Overall Study|Physician Decision|2|||
146217526|NCT04072380|527310693|FG001|Overall Study|Physician Decision|0|||
146217527|NCT04072380|527310694|FG002|Overall Study|Physician Decision|0|||
146217528|NCT04072380|527310692|FG000|Overall Study|Protocol Violation|0|||
146217529|NCT04072380|527310693|FG001|Overall Study|Protocol Violation|2|||
146217530|NCT04072380|527310694|FG002|Overall Study|Protocol Violation|3|||
146217531|NCT04072380|527310692|FG000|Overall Study|Intercurrent Illness and Others|3|||
146217532|NCT04072380|527310693|FG001|Overall Study|Intercurrent Illness and Others|5|||
146217533|NCT04072380|527310694|FG002|Overall Study|Intercurrent Illness and Others|6|||
146217534|NCT03033576|527310698|FG000|Overall Study|Ineligible|1|||
146217535|NCT03033576|527310699|FG001|Overall Study|Ineligible|1|||
146217536|NCT03033576|527310698|FG000|Overall Study|Adverse Event|4|||
146217537|NCT03033576|527310699|FG001|Overall Study|Adverse Event|20|||
146217538|NCT03033576|527310698|FG000|Overall Study|Progression/relapse|9|||
146217539|NCT03033576|527310699|FG001|Overall Study|Progression/relapse|36|||
146217540|NCT03033576|527310698|FG000|Overall Study|Death|1|||
146217541|NCT03033576|527310699|FG001|Overall Study|Death|1|||
146217542|NCT03033576|527310698|FG000|Overall Study|Patient refusal|1|||
146217543|NCT03033576|527310699|FG001|Overall Study|Patient refusal|6|||
146217544|NCT03033576|527310698|FG000|Overall Study|Other, unspecified reasons|0|||
146217545|NCT03033576|527310699|FG001|Overall Study|Other, unspecified reasons|4|||
146217546|NCT03033576|527310698|FG000|Overall Study|Currently on protocol therapy|0|||
146217547|NCT03033576|527310699|FG001|Overall Study|Currently on protocol therapy|2|||
146217548|NCT03557697|527310700|FG000|Overall Study|Withdrawal by Subject|2|||
146217549|NCT03557697|527310701|FG001|Overall Study|Withdrawal by Subject|4|||
146217550|NCT06491433|527310702|FG000|Overall Study|Protocol Violation|51|||
146217551|NCT06491433|527310702|FG000|Overall Study|consent withdrawal|2|||
146217552|NCT06491433|527310702|FG000|Overall Study|screen failure|1|||
146217553|NCT01214616|527310707|FG000|Overall Study|Progressive disease|2|||
146217554|NCT01214616|527310708|FG001|Overall Study|Progressive disease|2|||
146217555|NCT01214616|527310709|FG002|Overall Study|Progressive disease|2|||
146217556|NCT01214616|527310710|FG003|Overall Study|Progressive disease|4|||
146217557|NCT01214616|527310707|FG000|Overall Study|Dose limiting toxicity|0|||
146217558|NCT01214616|527310708|FG001|Overall Study|Dose limiting toxicity|2|||
146217559|NCT01214616|527310709|FG002|Overall Study|Dose limiting toxicity|0|||
146217560|NCT01214616|527310710|FG003|Overall Study|Dose limiting toxicity|0|||
146217561|NCT01214616|527310707|FG000|Overall Study|Other adverse events|0|||
146217562|NCT01214616|527310708|FG001|Overall Study|Other adverse events|1|||
146217563|NCT01214616|527310709|FG002|Overall Study|Other adverse events|1|||
146217564|NCT01214616|527310710|FG003|Overall Study|Other adverse events|1|||
146217565|NCT01214616|527310707|FG000|Overall Study|Withdrawal by Subject|1|||
146217566|NCT01214616|527310708|FG001|Overall Study|Withdrawal by Subject|0|||
146217567|NCT01214616|527310709|FG002|Overall Study|Withdrawal by Subject|0|||
146217568|NCT01214616|527310710|FG003|Overall Study|Withdrawal by Subject|1|||
146217569|NCT04015167|527310722|FG000|Overall Study|Lost to Follow-up|40|||
146217570|NCT04015167|527310722|FG000|Overall Study|Adverse Event|5|||
146217571|NCT04015167|527310722|FG000|Overall Study|Withdrawal by Subject|2|||
145960515|NCT01656395|526367611|FG002|Overall Study|Lost to Follow-up|0|||
146217572|NCT04015167|527310722|FG000|Overall Study|Subject went to jail|1|||
146217573|NCT03640312|527310723|FG000|Overall Study|Lost to Follow-up|3|||
146217574|NCT03640312|527310724|FG001|Overall Study|Lost to Follow-up|6|||
146217575|NCT02761057|527310730|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
146217576|NCT02761057|527310731|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
146217577|NCT02761057|527310732|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
146217578|NCT02761057|527310733|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
146217579|NCT02761057|527310730|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
146217580|NCT02761057|527310731|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
146217581|NCT02761057|527310732|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
146217582|NCT02761057|527310733|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
146217583|NCT02761057|527310730|FG000|Overall Study|Currently On Study Treatment|0|||
146217584|NCT02761057|527310731|FG001|Overall Study|Currently On Study Treatment|3|||
146217585|NCT02761057|527310732|FG002|Overall Study|Currently On Study Treatment|0|||
146217586|NCT02761057|527310733|FG003|Overall Study|Currently On Study Treatment|0|||
146217587|NCT02761057|527310730|FG000|Overall Study|Adverse Event|11|||
146217588|NCT02761057|527310731|FG001|Overall Study|Adverse Event|9|||
146217589|NCT02761057|527310732|FG002|Overall Study|Adverse Event|5|||
146217590|NCT02761057|527310733|FG003|Overall Study|Adverse Event|3|||
146217591|NCT02761057|527310730|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
146217592|NCT02761057|527310731|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
146217593|NCT02761057|527310732|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
146217594|NCT02761057|527310733|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
146217595|NCT02761057|527310730|FG000|Overall Study|Progression/Relapse|29|||
146217596|NCT02761057|527310731|FG001|Overall Study|Progression/Relapse|27|||
146217597|NCT02761057|527310732|FG002|Overall Study|Progression/Relapse|20|||
146217598|NCT02761057|527310733|FG003|Overall Study|Progression/Relapse|23|||
146217599|NCT02761057|527310730|FG000|Overall Study|Death|2|||
146217600|NCT02761057|527310731|FG001|Overall Study|Death|2|||
146217601|NCT02761057|527310732|FG002|Overall Study|Death|1|||
146217602|NCT02761057|527310733|FG003|Overall Study|Death|1|||
146217603|NCT02761057|527310730|FG000|Overall Study|Other - Not Protocol Specified|2|||
146217604|NCT02761057|527310731|FG001|Overall Study|Other - Not Protocol Specified|1|||
146217605|NCT02761057|527310732|FG002|Overall Study|Other - Not Protocol Specified|2|||
146217606|NCT02761057|527310733|FG003|Overall Study|Other - Not Protocol Specified|0|||
146217607|NCT06037369|527310734|FG000|Overall Study|Lost to Follow-up|0|||
146217608|NCT06037369|527310735|FG001|Overall Study|Lost to Follow-up|1|||
146217609|NCT05008835|527310737|FG000|Overall Study|Adverse Event|5|||
146217610|NCT05008835|527310738|FG001|Overall Study|Adverse Event|2|||
146217611|NCT05008835|527310739|FG002|Overall Study|Adverse Event|1|||
146217612|NCT05008835|527310737|FG000|Overall Study|Lack of Efficacy|0|||
146217613|NCT05008835|527310738|FG001|Overall Study|Lack of Efficacy|0|||
146217614|NCT05008835|527310739|FG002|Overall Study|Lack of Efficacy|1|||
146217615|NCT05008835|527310737|FG000|Overall Study|Study terminated by sponsor|0|||
146217616|NCT05008835|527310738|FG001|Overall Study|Study terminated by sponsor|0|||
146217617|NCT05008835|527310739|FG002|Overall Study|Study terminated by sponsor|1|||
146217618|NCT05008835|527310737|FG000|Overall Study|Not further specified|3|||
145960516|NCT01656395|526367612|FG003|Overall Study|Lost to Follow-up|0|||
145960517|NCT01656395|526367613|FG004|Overall Study|Lost to Follow-up|0|||
145960518|NCT01656395|526367614|FG005|Overall Study|Lost to Follow-up|0|||
145960519|NCT01656395|526367615|FG006|Overall Study|Lost to Follow-up|0|||
145960520|NCT01656395|526367616|FG007|Overall Study|Lost to Follow-up|0|||
145960521|NCT01656395|526367609|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145960522|NCT01656395|526367610|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145960523|NCT01656395|526367611|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145960524|NCT01656395|526367612|FG003|Overall Study|Non-Compliance with Study Drug|0|||
145960525|NCT01656395|526367613|FG004|Overall Study|Non-Compliance with Study Drug|1|||
145960526|NCT01656395|526367614|FG005|Overall Study|Non-Compliance with Study Drug|1|||
145960527|NCT01656395|526367615|FG006|Overall Study|Non-Compliance with Study Drug|0|||
145960528|NCT01656395|526367616|FG007|Overall Study|Non-Compliance with Study Drug|0|||
145960529|NCT01656395|526367609|FG000|Overall Study|Other|0|||
145960530|NCT01656395|526367610|FG001|Overall Study|Other|0|||
145960531|NCT01656395|526367611|FG002|Overall Study|Other|1|||
145960532|NCT01656395|526367612|FG003|Overall Study|Other|0|||
146217619|NCT05008835|527310738|FG001|Overall Study|Not further specified|2|||
146217620|NCT05008835|527310739|FG002|Overall Study|Not further specified|1|||
145960533|NCT01656395|526367613|FG004|Overall Study|Other|0|||
145960534|NCT01656395|526367614|FG005|Overall Study|Other|1|||
146217621|NCT04876118|527310744|FG000|Overall Study|Pregnancy|1|||
146217622|NCT04876118|527310744|FG000|Overall Study|Withdrawal by Subject|14|||
146217623|NCT03047928|527312526|FG000|Overall Study|Adverse Event|0|||
146217624|NCT03047928|527312527|FG001|Overall Study|Adverse Event|2|||
146217625|NCT03047928|527312528|FG002|Overall Study|Adverse Event|0|||
146217626|NCT03047928|527312526|FG000|Overall Study|Protocol Violation|0|||
146217627|NCT03047928|527312527|FG001|Overall Study|Protocol Violation|1|||
146217628|NCT03047928|527312528|FG002|Overall Study|Protocol Violation|0|||
145960535|NCT01656395|526367615|FG006|Overall Study|Other|0|||
146217629|NCT03047928|527312526|FG000|Overall Study|included in another protocol|0|||
146084448|NCT00534599|526828002|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
146084449|NCT00534599|526828001|FG000|Overall Study|Protocol Violation|1|||
146084450|NCT00534599|526828002|FG001|Overall Study|Protocol Violation|3|||
146084451|NCT00534599|526828001|FG000|Overall Study|Lost to Follow-up|11|||
146084452|NCT00534599|526828002|FG001|Overall Study|Lost to Follow-up|14|||
146084453|NCT00534599|526828001|FG000|Overall Study|Withdrawal by Subject|4|||
146084454|NCT00534599|526828002|FG001|Overall Study|Withdrawal by Subject|6|||
146084455|NCT00534599|526828001|FG000|Overall Study|Other|7|||
146084456|NCT00534599|526828002|FG001|Overall Study|Other|0|||
146084457|NCT00773383|526830158|FG000|Overall Study|Adverse Event|4|||
146217630|NCT03047928|527312527|FG001|Overall Study|included in another protocol|1|||
146217631|NCT03047928|527312528|FG002|Overall Study|included in another protocol|0|||
146217632|NCT03623321|527312529|FG000|Overall Study|Adverse Event|32|||
146217633|NCT03623321|527312529|FG000|Overall Study|Death|9|||
146217634|NCT03623321|527312529|FG000|Overall Study|Lack of Efficacy|9|||
146217635|NCT03623321|527312529|FG000|Overall Study|Lost to Follow-up|6|||
146217636|NCT03623321|527312529|FG000|Overall Study|Noncompliance with study drug|6|||
146217637|NCT03623321|527312529|FG000|Overall Study|Use of prohibited medication|3|||
146217638|NCT03623321|527312529|FG000|Overall Study|Physician Decision|5|||
146217639|NCT03623321|527312529|FG000|Overall Study|Protocol Violation|1|||
146217640|NCT03623321|527312529|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
146217641|NCT03623321|527312529|FG000|Overall Study|Not further specified|43|||
146217642|NCT04241068|527312533|FG000|Core Treatment Period|Adverse Event|91|||
146217643|NCT04241068|527312533|FG000|Core Treatment Period|Change of Treatment|4|||
146217644|NCT04241068|527312533|FG000|Core Treatment Period|Consent Withdrawn|143|||
146217645|NCT04241068|527312533|FG000|Core Treatment Period|Death|26|||
146217646|NCT04241068|527312533|FG000|Core Treatment Period|Disease Progression|67|||
146217647|NCT04241068|527312533|FG000|Core Treatment Period|Investigator Decision|40|||
146217648|NCT04241068|527312533|FG000|Core Treatment Period|Loss of Capacity|9|||
146217649|NCT04241068|527312533|FG000|Core Treatment Period|Lost to Follow-up|11|||
146217650|NCT04241068|527312533|FG000|Core Treatment Period|Relocation|4|||
146217651|NCT04241068|527312533|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
146217652|NCT04241068|527312533|FG000|Core Treatment Period|Study Visit Burden|40|||
146217653|NCT04241068|527312533|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
146217654|NCT04241068|527312533|FG000|Core Treatment Period|Missing|2|||
146217655|NCT04241068|527312533|FG000|Core Treatment Period|Reason Not Specified|41|||
146217656|NCT04241068|527312533|FG000|LTE Period|Adverse Event|19|||
146217657|NCT04241068|527312533|FG000|LTE Period|Change of Treatment|1|||
146217658|NCT04241068|527312533|FG000|LTE Period|Consent Withdrawn|71|||
146217659|NCT04241068|527312533|FG000|LTE Period|Death|8|||
146217660|NCT04241068|527312533|FG000|LTE Period|Disease Progression|11|||
146217661|NCT04241068|527312533|FG000|LTE Period|Investigator Decision|12|||
146217662|NCT04241068|527312533|FG000|LTE Period|Loss of Capacity|2|||
146217663|NCT04241068|527312533|FG000|LTE Period|Lost to Follow-up|7|||
146217664|NCT04241068|527312533|FG000|LTE Period|Relocation|6|||
146217665|NCT04241068|527312533|FG000|LTE Period|Site Terminated by Sponsor|26|||
146217666|NCT04241068|527312533|FG000|LTE Period|Study Terminated by Sponsor|276|||
146217667|NCT04241068|527312533|FG000|LTE Period|Study Visit Burden|10|||
146217668|NCT04241068|527312533|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
146217669|NCT04241068|527312533|FG000|LTE Period|Reason Not Specified|65|||
146217670|NCT03443323|527312535|FG000|Overall Study|Lost to Follow-up|2|||
146287777|NCT00372229|527569327|FG001|Follow-Up Phase|Administrative|0|||
146287778|NCT00372229|527569326|FG000|Follow-Up Phase|Reason not specified|2|||
146287779|NCT00372229|527569327|FG001|Follow-Up Phase|Reason not specified|3|||
146287780|NCT00372229|527569326|FG000|Follow-Up Phase|Lost to Follow-up|12|||
146287781|NCT00372229|527569327|FG001|Follow-Up Phase|Lost to Follow-up|10|||
145960536|NCT01656395|526367616|FG007|Overall Study|Other|0|||
145960537|NCT01656395|526367609|FG000|Overall Study|Physician Decision|2|||
145960538|NCT01656395|526367610|FG001|Overall Study|Physician Decision|3|||
145960539|NCT01656395|526367611|FG002|Overall Study|Physician Decision|3|||
145960540|NCT01656395|526367612|FG003|Overall Study|Physician Decision|2|||
145960541|NCT01656395|526367613|FG004|Overall Study|Physician Decision|3|||
145960542|NCT01656395|526367614|FG005|Overall Study|Physician Decision|3|||
145960543|NCT01656395|526367615|FG006|Overall Study|Physician Decision|0|||
146217671|NCT03443323|527312536|FG001|Overall Study|Lost to Follow-up|2|||
146217672|NCT03443323|527312535|FG000|Overall Study|PI withdrawal|1|||
146217673|NCT03443323|527312536|FG001|Overall Study|PI withdrawal|0|||
146217674|NCT00418886|527312537|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
146217675|NCT00418886|527312538|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
146217676|NCT00418886|527312537|FG000|Randomized Period|Death|122|||
146217677|NCT00418886|527312538|FG001|Randomized Period|Death|147|||
146217678|NCT00418886|527312537|FG000|Randomized Period|Withdrawal by Subject|9|||
146217679|NCT00418886|527312538|FG001|Randomized Period|Withdrawal by Subject|10|||
146217680|NCT00418886|527312537|FG000|Randomized Period|Lost to Follow-up|4|||
145960544|NCT01656395|526367616|FG007|Overall Study|Physician Decision|0|||
145960545|NCT01656395|526367609|FG000|Overall Study|Pregnancy|0|||
145960546|NCT01656395|526367610|FG001|Overall Study|Pregnancy|0|||
145960547|NCT01656395|526367611|FG002|Overall Study|Pregnancy|1|||
146217681|NCT00418886|527312538|FG001|Randomized Period|Lost to Follow-up|6|||
146217682|NCT00418886|527312537|FG000|Randomized Period|withdrawn due to other reason|1|||
146217683|NCT00418886|527312538|FG001|Randomized Period|withdrawn due to other reason|0|||
146217684|NCT00418886|527312537|FG000|Randomized Period|randomised but no treatment received|0|||
146217685|NCT00418886|527312538|FG001|Randomized Period|randomised but no treatment received|1|||
146217686|NCT04060654|527312539|FG000|Overall Study|Withdrawal by Subject|1|||
146217687|NCT04060654|527312539|FG000|Overall Study|Lost to Follow-up|5|||
146217688|NCT04887129|527312540|FG000|Overall Study|Lost to Follow-up|0|||
146217689|NCT04887129|527312541|FG001|Overall Study|Lost to Follow-up|24|||
146217690|NCT04887129|527312540|FG000|Overall Study|Withdrawal by Subject|9|||
146217691|NCT04887129|527312541|FG001|Overall Study|Withdrawal by Subject|57|||
146217692|NCT04887129|527312540|FG000|Overall Study|Other|2|||
146217693|NCT04887129|527312541|FG001|Overall Study|Other|9|||
146217694|NCT03683719|527312543|FG000|Overall Study|Lack of Efficacy|1|||
146217695|NCT03683719|527312544|FG001|Overall Study|Lack of Efficacy|3|||
146217696|NCT03683719|527312545|FG002|Overall Study|Lack of Efficacy|4|||
146217697|NCT03683719|527312546|FG003|Overall Study|Lack of Efficacy|0|||
146217698|NCT03683719|527312547|FG004|Overall Study|Lack of Efficacy|4|||
146217699|NCT03683719|527312543|FG000|Overall Study|Adverse Event|6|||
146217700|NCT03683719|527312544|FG001|Overall Study|Adverse Event|6|||
146217701|NCT03683719|527312545|FG002|Overall Study|Adverse Event|0|||
146217702|NCT03683719|527312546|FG003|Overall Study|Adverse Event|1|||
146217703|NCT03683719|527312547|FG004|Overall Study|Adverse Event|3|||
146217704|NCT03683719|527312543|FG000|Overall Study|Withdrawal by Subject|4|||
146217705|NCT03683719|527312544|FG001|Overall Study|Withdrawal by Subject|4|||
146217706|NCT03683719|527312545|FG002|Overall Study|Withdrawal by Subject|3|||
146217707|NCT03683719|527312546|FG003|Overall Study|Withdrawal by Subject|5|||
146217708|NCT03683719|527312547|FG004|Overall Study|Withdrawal by Subject|5|||
146217709|NCT03683719|527312543|FG000|Overall Study|Lost to Follow-up|1|||
146217710|NCT03683719|527312544|FG001|Overall Study|Lost to Follow-up|0|||
146217711|NCT03683719|527312545|FG002|Overall Study|Lost to Follow-up|0|||
146217712|NCT03683719|527312546|FG003|Overall Study|Lost to Follow-up|1|||
146217713|NCT03683719|527312547|FG004|Overall Study|Lost to Follow-up|1|||
146217714|NCT03683719|527312543|FG000|Overall Study|Other personal reasons|0|||
146217715|NCT03683719|527312544|FG001|Overall Study|Other personal reasons|0|||
146217716|NCT03683719|527312545|FG002|Overall Study|Other personal reasons|1|||
146217717|NCT03683719|527312546|FG003|Overall Study|Other personal reasons|0|||
146217718|NCT03683719|527312547|FG004|Overall Study|Other personal reasons|1|||
146217719|NCT03056040|527312551|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
146217720|NCT03056040|527312552|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
146217721|NCT03056040|527312551|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
146217722|NCT03056040|527312552|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
146217723|NCT03056040|527312551|FG000|Primary Evaluation Period|Pregnancy|0|||
146217724|NCT03056040|527312552|FG001|Primary Evaluation Period|Pregnancy|1|||
146217725|NCT03056040|527312551|FG000|Primary Evaluation Period|Randomized, not treated|1|||
146217726|NCT03056040|527312552|FG001|Primary Evaluation Period|Randomized, not treated|1|||
146217727|NCT03056040|527312551|FG000|Extension Period|Physician Decision|3|||
146217728|NCT03056040|527312552|FG001|Extension Period|Physician Decision|3|||
146217729|NCT03056040|527312551|FG000|Extension Period|Lost to Follow-up|0|||
146217730|NCT03056040|527312552|FG001|Extension Period|Lost to Follow-up|1|||
146217731|NCT03056040|527312551|FG000|Extension Period|Death|0|||
146217732|NCT03056040|527312552|FG001|Extension Period|Death|3|||
145881717|NCT01332968|526072677|FG005|Follow-Up Period|Physician Decision|0|||
145881718|NCT01332968|526072678|FG006|Follow-Up Period|Physician Decision|12|||
145881719|NCT01332968|526072679|FG007|Follow-Up Period|Physician Decision|15|||
145881720|NCT01332968|526072672|FG000|Follow-Up Period|Progressive Disease|0|||
146217733|NCT03056040|527312551|FG000|Extension Period|Withdrawal by Subject|1|||
146217734|NCT03056040|527312552|FG001|Extension Period|Withdrawal by Subject|0|||
146217735|NCT03445988|527312555|FG000|Overall Study|Lost to Follow-up|14|||
146217736|NCT03445988|527312556|FG001|Overall Study|Lost to Follow-up|26|||
146217737|NCT03445988|527312557|FG002|Overall Study|Lost to Follow-up|27|||
146217738|NCT03445988|527312558|FG003|Overall Study|Lost to Follow-up|66|||
146217739|NCT03445988|527312555|FG000|Overall Study|Withdrawal by Subject|7|||
146217740|NCT03445988|527312556|FG001|Overall Study|Withdrawal by Subject|4|||
146217741|NCT03445988|527312557|FG002|Overall Study|Withdrawal by Subject|3|||
146217742|NCT03445988|527312558|FG003|Overall Study|Withdrawal by Subject|5|||
146217743|NCT03445988|527312555|FG000|Overall Study|Death (unrelated to study)|5|||
146217744|NCT03445988|527312556|FG001|Overall Study|Death (unrelated to study)|1|||
146217745|NCT03445988|527312557|FG002|Overall Study|Death (unrelated to study)|2|||
146217746|NCT03445988|527312558|FG003|Overall Study|Death (unrelated to study)|4|||
146217747|NCT05784662|527312559|FG000|Overall Study|Lost to Follow-up|21|||
146217748|NCT05784662|527312560|FG001|Overall Study|Lost to Follow-up|17|||
146217749|NCT04274764|527312561|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
145881721|NCT01332968|526072673|FG001|Follow-Up Period|Progressive Disease|0|||
146217750|NCT04274764|527312562|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
146217751|NCT03611621|527312578|FG000|Overall Study|Graft loss|3|||
146084458|NCT00773383|526830158|FG000|Overall Study|Death|1|||
146084459|NCT00773383|526830158|FG000|Overall Study|Progression of Disease|23|||
146084460|NCT00773383|526830158|FG000|Overall Study|Other|2|||
146084461|NCT00773383|526830158|FG000|Overall Study|No study dose received|1|||
146084462|NCT03384693|526830159|FG000|Overall Study|Adverse Event|3|||
146084463|NCT03811093|526830177|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
146084464|NCT03811093|526830178|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
146084465|NCT03811093|526830177|FG000|Overall Study|Unable to measure body fat percentage|2|||
146084466|NCT03811093|526830178|FG001|Overall Study|Unable to measure body fat percentage|0|||
146084467|NCT01095094|526830180|FG000|Overall Study|Withdrawal by Subject|1|||
146084468|NCT01095094|526830180|FG000|Overall Study|Death|1|||
146084469|NCT01095094|526830180|FG000|Overall Study|Physician Decision|1|||
146084470|NCT03699475|526830182|FG000|Overall Study|Death|1|||
146084471|NCT00137839|526830183|FG000|Overall Study|Adverse Event|7|||
146084472|NCT00137839|526830183|FG000|Overall Study|Physician Decision|7|||
146084473|NCT00137839|526830183|FG000|Overall Study|Death|8|||
146084474|NCT00137839|526830183|FG000|Overall Study|Disease Progression|60|||
146084475|NCT00137839|526830183|FG000|Overall Study|Not Start Treatment|1|||
146084476|NCT00137839|526830183|FG000|Overall Study|Prolonged Treatment Delay|1|||
146084477|NCT00528970|526830184|FG000|Overall Study|Adverse Event|6|||
146084478|NCT00528970|526830185|FG001|Overall Study|Adverse Event|8|||
146084479|NCT00528970|526830186|FG002|Overall Study|Adverse Event|5|||
146084480|NCT00528970|526830184|FG000|Overall Study|Lost to Follow-up|0|||
146084481|NCT00528970|526830185|FG001|Overall Study|Lost to Follow-up|0|||
146084482|NCT00528970|526830186|FG002|Overall Study|Lost to Follow-up|1|||
146084483|NCT00528970|526830184|FG000|Overall Study|Other than specified|2|||
146084484|NCT00528970|526830185|FG001|Overall Study|Other than specified|3|||
146084485|NCT00528970|526830186|FG002|Overall Study|Other than specified|3|||
146084486|NCT00528970|526830184|FG000|Overall Study|Protocol Violation|2|||
146084487|NCT00528970|526830185|FG001|Overall Study|Protocol Violation|1|||
146084488|NCT00528970|526830186|FG002|Overall Study|Protocol Violation|4|||
146084489|NCT00528970|526830184|FG000|Overall Study|Lack of Efficacy|0|||
146084490|NCT00528970|526830185|FG001|Overall Study|Lack of Efficacy|0|||
146084491|NCT00528970|526830186|FG002|Overall Study|Lack of Efficacy|1|||
146084492|NCT00528970|526830184|FG000|Overall Study|Withdrawal by Subject|4|||
146084493|NCT00528970|526830185|FG001|Overall Study|Withdrawal by Subject|3|||
145960548|NCT01656395|526367612|FG003|Overall Study|Pregnancy|0|||
145960549|NCT01656395|526367613|FG004|Overall Study|Pregnancy|0|||
145960550|NCT01656395|526367614|FG005|Overall Study|Pregnancy|0|||
145960551|NCT01656395|526367615|FG006|Overall Study|Pregnancy|0|||
145960552|NCT01656395|526367616|FG007|Overall Study|Pregnancy|0|||
145960553|NCT01656395|526367609|FG000|Overall Study|Progressive Disease|0|||
145960554|NCT01656395|526367610|FG001|Overall Study|Progressive Disease|0|||
145960555|NCT01656395|526367611|FG002|Overall Study|Progressive Disease|0|||
145960556|NCT01656395|526367612|FG003|Overall Study|Progressive Disease|0|||
145960557|NCT01656395|526367613|FG004|Overall Study|Progressive Disease|0|||
145960558|NCT01656395|526367614|FG005|Overall Study|Progressive Disease|1|||
145960559|NCT01656395|526367615|FG006|Overall Study|Progressive Disease|0|||
145960560|NCT01656395|526367616|FG007|Overall Study|Progressive Disease|0|||
145960561|NCT01656395|526367609|FG000|Overall Study|Protocol Violation|6|||
145960562|NCT01656395|526367610|FG001|Overall Study|Protocol Violation|6|||
145960563|NCT01656395|526367611|FG002|Overall Study|Protocol Violation|9|||
145960564|NCT01656395|526367612|FG003|Overall Study|Protocol Violation|2|||
145960565|NCT01656395|526367613|FG004|Overall Study|Protocol Violation|4|||
145960566|NCT01656395|526367614|FG005|Overall Study|Protocol Violation|10|||
146084494|NCT00528970|526830186|FG002|Overall Study|Withdrawal by Subject|5|||
146217752|NCT03611621|527312578|FG000|Overall Study|Death|3|||
146217753|NCT03611621|527312578|FG000|Overall Study|Lost to Follow-up|1|||
146217754|NCT03853746|527312583|FG000|Overall Study|Withdrawal by Subject|1|||
146217755|NCT01084876|527312584|FG000|Main Study Treatment Period|Adverse Event|12|||
146217756|NCT01084876|527312585|FG001|Main Study Treatment Period|Adverse Event|7|||
146217757|NCT01084876|527312584|FG000|Main Study Treatment Period|Disease Progression|41|||
145960567|NCT01656395|526367615|FG006|Overall Study|Protocol Violation|0|||
145960568|NCT01656395|526367616|FG007|Overall Study|Protocol Violation|0|||
146084495|NCT00528970|526830184|FG000|Overall Study|Randomized but not treated|0|||
145960569|NCT01656395|526367609|FG000|Overall Study|Screen Failure|2|||
146217758|NCT01084876|527312585|FG001|Main Study Treatment Period|Disease Progression|24|||
146217759|NCT01084876|527312584|FG000|Main Study Treatment Period|Physician Decision|2|||
145960570|NCT01656395|526367610|FG001|Overall Study|Screen Failure|1|||
145960571|NCT01656395|526367611|FG002|Overall Study|Screen Failure|7|||
145960572|NCT01656395|526367612|FG003|Overall Study|Screen Failure|1|||
145960573|NCT01656395|526367613|FG004|Overall Study|Screen Failure|0|||
146084496|NCT00528970|526830185|FG001|Overall Study|Randomized but not treated|0|||
146084497|NCT00528970|526830186|FG002|Overall Study|Randomized but not treated|1|||
146084498|NCT03739242|526830194|FG000|Overall Study|Withdrawal by Subject|1|||
146084499|NCT03739242|526830195|FG001|Overall Study|Withdrawal by Subject|1|||
146084500|NCT03739242|526830194|FG000|Overall Study|Protocol Violation|0|||
146217760|NCT01084876|527312585|FG001|Main Study Treatment Period|Physician Decision|0|||
146217761|NCT01084876|527312584|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
146217762|NCT01084876|527312585|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
146217763|NCT01084876|527312584|FG000|Main Study Treatment Period|Other Reason|0|||
146217764|NCT01084876|527312585|FG001|Main Study Treatment Period|Other Reason|1|||
146217765|NCT01084876|527312584|FG000|Main Study Treatment Period|Other|0|||
146217766|NCT01084876|527312585|FG001|Main Study Treatment Period|Other|1|||
146217767|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
146217768|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
146217769|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
146217770|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
146217771|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
146217772|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
146217773|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
146217774|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
146217775|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
146217776|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
146217777|NCT01084876|527312584|FG000|Treatment Period Beyond Cycle 8|Other|6|||
146217778|NCT01084876|527312585|FG001|Treatment Period Beyond Cycle 8|Other|9|||
146217779|NCT02724631|527312588|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
146217780|NCT04971395|527312589|FG000|Overall Study|Withdrawal by Subject|0|||
146217781|NCT04971395|527312590|FG001|Overall Study|Withdrawal by Subject|1|||
146217782|NCT04971395|527312591|FG002|Overall Study|Withdrawal by Subject|0|||
146217783|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Other|0|||
146217784|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Other|0|||
146217785|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Other|0|||
146217786|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Other|0|||
146217787|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Other|0|||
146217788|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Other|0|||
146217789|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Other|0|||
146217790|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Other|0|||
146217791|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Other|0|||
146217792|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Other|0|||
146217793|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Other|1|||
146217794|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Other|1|||
146217795|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Other|1|||
146217796|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Other|0|||
146217797|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Other|3|||
146217798|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Other|1|||
146217799|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Other|1|||
146217800|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Other|0|||
146217801|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960574|NCT01656395|526367614|FG005|Overall Study|Screen Failure|8|||
145960575|NCT01656395|526367615|FG006|Overall Study|Screen Failure|0|||
145960576|NCT01656395|526367616|FG007|Overall Study|Screen Failure|0|||
145960577|NCT01656395|526367609|FG000|Overall Study|Withdrawal by Subject|3|||
145960578|NCT01656395|526367610|FG001|Overall Study|Withdrawal by Subject|1|||
145960579|NCT01656395|526367611|FG002|Overall Study|Withdrawal by Subject|4|||
145960580|NCT01656395|526367612|FG003|Overall Study|Withdrawal by Subject|2|||
145960581|NCT01656395|526367613|FG004|Overall Study|Withdrawal by Subject|0|||
145960582|NCT01656395|526367614|FG005|Overall Study|Withdrawal by Subject|3|||
145960583|NCT01656395|526367615|FG006|Overall Study|Withdrawal by Subject|0|||
145960584|NCT01656395|526367616|FG007|Overall Study|Withdrawal by Subject|0|||
145960585|NCT02048722|526367621|FG000|2 Cycles of Treatment|Adverse Event|2|||
145960586|NCT02048722|526367621|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
145960587|NCT02048722|526367621|FG000|2 Cycles of Treatment|Progressive Disease|2|||
145960588|NCT02048722|526367621|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
145960589|NCT02048722|526367621|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
145960590|NCT02048722|526367621|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
145960591|NCT04073303|526367625|FG000|Overall Study|Adverse Event|0|||
145960592|NCT04073303|526367626|FG001|Overall Study|Adverse Event|2|||
146217802|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960593|NCT04073303|526367625|FG000|Overall Study|Withdrawal by Subject|16|||
146217803|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960594|NCT04073303|526367626|FG001|Overall Study|Withdrawal by Subject|36|||
145960595|NCT04073303|526367625|FG000|Overall Study|Lost to Follow-up|6|||
145960596|NCT04073303|526367626|FG001|Overall Study|Lost to Follow-up|1|||
146217804|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217805|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960597|NCT04073303|526367625|FG000|Overall Study|Protocol Deviation|0|||
145960598|NCT04073303|526367626|FG001|Overall Study|Protocol Deviation|4|||
145960599|NCT04073303|526367625|FG000|Overall Study|Other|1|||
146217806|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217807|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
146217808|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217809|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
146217810|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960600|NCT04073303|526367626|FG001|Overall Study|Other|1|||
145960601|NCT03126786|526367634|FG000|Overall Study|Adverse Event|3|||
145960602|NCT03126786|526367635|FG001|Overall Study|Adverse Event|0|||
145960603|NCT03126786|526367634|FG000|Overall Study|Lost to Follow-up|0|||
145960604|NCT03126786|526367635|FG001|Overall Study|Lost to Follow-up|1|||
145960605|NCT03126786|526367634|FG000|Overall Study|Withdrawal by Subject|3|||
145960606|NCT03126786|526367635|FG001|Overall Study|Withdrawal by Subject|1|||
145960607|NCT03113968|526367636|FG000|Overall Study|Withdrawal by Subject|31|||
145960608|NCT03113968|526367637|FG001|Overall Study|Withdrawal by Subject|4|||
145960609|NCT04805671|526367638|FG000|Overall Study|Death|2|||
145960610|NCT04805671|526367639|FG001|Overall Study|Death|7|||
145960611|NCT04805671|526367638|FG000|Overall Study|Lost to Follow-up|1|||
145960612|NCT04805671|526367639|FG001|Overall Study|Lost to Follow-up|0|||
145960613|NCT04805671|526367638|FG000|Overall Study|Withdrawal by Subject|9|||
145960614|NCT04805671|526367639|FG001|Overall Study|Withdrawal by Subject|7|||
145960615|NCT04805671|526367638|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
145960616|NCT04805671|526367639|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
145960617|NCT01261390|526367640|FG000|Overall Study|Significant Concurrent Illness|1|||
145960618|NCT01261390|526367641|FG001|Overall Study|Significant Concurrent Illness|0|||
145960619|NCT01261390|526367642|FG002|Overall Study|Significant Concurrent Illness|1|||
145960620|NCT01261390|526367643|FG003|Overall Study|Significant Concurrent Illness|0|||
145960621|NCT01261390|526367640|FG000|Overall Study|Dissatisfaction with Treatment|2|||
145960622|NCT01261390|526367641|FG001|Overall Study|Dissatisfaction with Treatment|1|||
145960623|NCT01261390|526367642|FG002|Overall Study|Dissatisfaction with Treatment|1|||
145960624|NCT01261390|526367643|FG003|Overall Study|Dissatisfaction with Treatment|2|||
145960625|NCT01261390|526367640|FG000|Overall Study|Relocation|0|||
145960626|NCT01261390|526367641|FG001|Overall Study|Relocation|1|||
145960627|NCT01261390|526367642|FG002|Overall Study|Relocation|0|||
145960628|NCT01261390|526367643|FG003|Overall Study|Relocation|0|||
145960629|NCT01261390|526367640|FG000|Overall Study|Loss of Interest in the Study|3|||
145960630|NCT01261390|526367641|FG001|Overall Study|Loss of Interest in the Study|1|||
145960631|NCT01261390|526367642|FG002|Overall Study|Loss of Interest in the Study|0|||
145960632|NCT01261390|526367643|FG003|Overall Study|Loss of Interest in the Study|0|||
145960633|NCT01261390|526367640|FG000|Overall Study|Lost to Follow-up|1|||
145960634|NCT01261390|526367641|FG001|Overall Study|Lost to Follow-up|6|||
145960635|NCT01261390|526367642|FG002|Overall Study|Lost to Follow-up|5|||
145960636|NCT01261390|526367643|FG003|Overall Study|Lost to Follow-up|6|||
145960637|NCT03421379|526367644|FG000|Period 1|Withdrawal by Subject|0|||
145960638|NCT03421379|526367645|FG001|Period 1|Withdrawal by Subject|1|||
145960639|NCT03421379|526367644|FG000|Period 1|Physician Decision|1|||
145960640|NCT03421379|526367645|FG001|Period 1|Physician Decision|1|||
145960641|NCT03421379|526367644|FG000|Period 1|Did not receive treatment|1|||
145960642|NCT03421379|526367645|FG001|Period 1|Did not receive treatment|2|||
145960643|NCT01497067|526367647|FG000|Overall Study|Lost to Follow-up|56|||
145960644|NCT01497067|526367647|FG000|Overall Study|Adverse Event|3|||
145960645|NCT01497067|526367647|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
145960646|NCT01497067|526367647|FG000|Overall Study|Other|13|||
145960647|NCT03771963|526367648|FG000|Overall Study|Lost to Follow-up|22|||
145960648|NCT03771963|526367648|FG000|Overall Study|Withdrawal of Consent|10|||
145960649|NCT03066830|526367649|FG000|Overall Study|At the Participant's own Request|16|||
145960650|NCT03066830|526367650|FG001|Overall Study|At the Participant's own Request|17|||
145960651|NCT03066830|526367649|FG000|Overall Study|Other|3|||
145960652|NCT03066830|526367650|FG001|Overall Study|Other|0|||
145960653|NCT03066830|526367649|FG000|Overall Study|Poor Compliance to Protocol|1|||
145960654|NCT03066830|526367650|FG001|Overall Study|Poor Compliance to Protocol|0|||
145960655|NCT03066830|526367649|FG000|Overall Study|Adverse Event|2|||
145960656|NCT03066830|526367650|FG001|Overall Study|Adverse Event|2|||
145960657|NCT03066830|526367649|FG000|Overall Study|Lost to Follow-up|11|||
145960658|NCT03066830|526367650|FG001|Overall Study|Lost to Follow-up|3|||
145960659|NCT02686164|526367658|FG000|Overall Study|Adverse Event|1|||
146217811|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960660|NCT02686164|526367658|FG000|Overall Study|Withdrawal of consent|1|||
145960661|NCT02686164|526367658|FG000|Overall Study|Clinical progression|1|||
145960662|NCT02324361|526367659|FG000|Overall Study|Lost to Follow-up|5|||
145960663|NCT02324361|526367660|FG001|Overall Study|Lost to Follow-up|2|||
145960664|NCT00003471|526367663|FG000|Overall Study|Not evaluable|4|||
145960665|NCT00715403|526367664|FG000|Overall Study|Progressive disease|0|||
146217812|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960666|NCT00715403|526367665|FG001|Overall Study|Progressive disease|1|||
145960667|NCT00715403|526367666|FG002|Overall Study|Progressive disease|3|||
145960668|NCT00715403|526367667|FG003|Overall Study|Progressive disease|9|||
145960669|NCT00715403|526367668|FG004|Overall Study|Progressive disease|5|||
145960670|NCT00715403|526367669|FG005|Overall Study|Progressive disease|14|||
145960671|NCT00715403|526367670|FG006|Overall Study|Progressive disease|1|||
145960672|NCT00715403|526367664|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
145960673|NCT00715403|526367665|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
146217813|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
145960674|NCT00715403|526367666|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
145960675|NCT00715403|526367667|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
145960676|NCT00715403|526367668|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
145960677|NCT00715403|526367669|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
145960678|NCT00715403|526367670|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
145960679|NCT00715403|526367664|FG000|Overall Study|Other Adverse Event than DLT|1|||
145960680|NCT00715403|526367665|FG001|Overall Study|Other Adverse Event than DLT|0|||
145960681|NCT00715403|526367666|FG002|Overall Study|Other Adverse Event than DLT|0|||
145960682|NCT00715403|526367667|FG003|Overall Study|Other Adverse Event than DLT|0|||
145960683|NCT00715403|526367668|FG004|Overall Study|Other Adverse Event than DLT|0|||
145960684|NCT00715403|526367669|FG005|Overall Study|Other Adverse Event than DLT|2|||
145960685|NCT00715403|526367670|FG006|Overall Study|Other Adverse Event than DLT|0|||
145960686|NCT00715403|526367664|FG000|Overall Study|Protocol Violation|0|||
145960687|NCT00715403|526367665|FG001|Overall Study|Protocol Violation|0|||
145960688|NCT00715403|526367666|FG002|Overall Study|Protocol Violation|0|||
145960689|NCT00715403|526367667|FG003|Overall Study|Protocol Violation|0|||
145960690|NCT00715403|526367668|FG004|Overall Study|Protocol Violation|0|||
145960691|NCT00715403|526367669|FG005|Overall Study|Protocol Violation|1|||
145960692|NCT00715403|526367670|FG006|Overall Study|Protocol Violation|0|||
145960693|NCT00715403|526367664|FG000|Overall Study|Other reason not defined above|0|||
145960694|NCT00715403|526367665|FG001|Overall Study|Other reason not defined above|0|||
146217814|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217815|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960695|NCT00715403|526367666|FG002|Overall Study|Other reason not defined above|1|||
145960696|NCT00715403|526367667|FG003|Overall Study|Other reason not defined above|0|||
145960697|NCT00715403|526367668|FG004|Overall Study|Other reason not defined above|1|||
145960698|NCT00715403|526367669|FG005|Overall Study|Other reason not defined above|1|||
145960699|NCT00715403|526367670|FG006|Overall Study|Other reason not defined above|0|||
145960700|NCT04235504|526367674|FG000|Study Phase|Withdrawal by Subject|5|||
145960701|NCT04235504|526367675|FG001|Study Phase|Withdrawal by Subject|2|||
145960702|NCT04235504|526367676|FG002|Study Phase|Withdrawal by Subject|0|||
145960703|NCT04235504|526367677|FG003|Study Phase|Withdrawal by Subject|0|||
145960704|NCT04235504|526367674|FG000|Continuation Phase|Withdrawal by Subject|0|||
145960705|NCT04235504|526367675|FG001|Continuation Phase|Withdrawal by Subject|4|||
145960706|NCT04235504|526367676|FG002|Continuation Phase|Withdrawal by Subject|0|||
145960707|NCT04235504|526367677|FG003|Continuation Phase|Withdrawal by Subject|0|||
145960708|NCT04235504|526367674|FG000|Continuation Phase|Adverse Event|0|||
145960709|NCT04235504|526367675|FG001|Continuation Phase|Adverse Event|1|||
145960710|NCT04235504|526367676|FG002|Continuation Phase|Adverse Event|0|||
145960711|NCT04235504|526367677|FG003|Continuation Phase|Adverse Event|0|||
145960712|NCT04235504|526367674|FG000|Continuation Phase|Physician Decision|1|||
145960713|NCT04235504|526367675|FG001|Continuation Phase|Physician Decision|2|||
145960714|NCT04235504|526367676|FG002|Continuation Phase|Physician Decision|1|||
145960715|NCT04235504|526367677|FG003|Continuation Phase|Physician Decision|0|||
145960716|NCT00101868|526367684|FG000|Overall Study|Death|10|||
145960717|NCT00101868|526367685|FG001|Overall Study|Death|10|||
145960718|NCT00101868|526367684|FG000|Overall Study|Withdrawal by Subject|8|||
145960719|NCT00101868|526367685|FG001|Overall Study|Withdrawal by Subject|9|||
145960720|NCT00101868|526367684|FG000|Overall Study|Protocol Violation|3|||
145960721|NCT00101868|526367685|FG001|Overall Study|Protocol Violation|0|||
145960722|NCT00101868|526367684|FG000|Overall Study|Lost to Follow-up|8|||
145960723|NCT00101868|526367685|FG001|Overall Study|Lost to Follow-up|13|||
145960724|NCT03839394|526367686|FG000|Overall Study|Lost to Follow-up|6|||
145960725|NCT03839394|526367687|FG001|Overall Study|Lost to Follow-up|8|||
145960726|NCT03839394|526367686|FG000|Overall Study|Withdrawal by Subject|0|||
145960727|NCT03839394|526367687|FG001|Overall Study|Withdrawal by Subject|2|||
145960728|NCT04001803|526367688|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
146084501|NCT03739242|526830195|FG001|Overall Study|Protocol Violation|1|||
146217816|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217817|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
146217818|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
145960729|NCT04001803|526367688|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
145960730|NCT04001803|526367688|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
146084502|NCT01122394|526830196|FG000|Overall Study|Withdrawal by Subject|1|||
145960731|NCT04001803|526367688|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
145960732|NCT04001803|526367688|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
145960733|NCT04001803|526367688|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
145960734|NCT04001803|526367688|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
145960735|NCT04001803|526367688|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
145960736|NCT04001803|526367688|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
145960737|NCT04001803|526367688|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
145960738|NCT01931397|526367691|FG000|Overall Study|Physician Decision|2|||
146217819|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217820|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217821|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217822|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217823|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217824|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217825|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217826|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
146217827|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217828|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217829|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217830|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217831|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217832|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217833|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217834|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217835|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217836|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
146217837|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217838|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217839|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217840|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217841|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217842|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217843|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217844|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217845|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217846|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
146217847|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217848|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217849|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217850|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217851|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217852|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217853|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217854|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
146217855|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Death|0|||
146217856|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Death|0|||
146217857|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Death|0|||
146217858|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Death|0|||
146217859|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Death|0|||
146217860|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Death|0|||
146217861|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Death|0|||
146217862|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Death|0|||
146217863|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Death|0|||
146217864|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Death|1|||
146217865|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Death|0|||
146217866|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Death|1|||
146217867|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Death|0|||
146217868|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Death|1|||
146217869|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Death|0|||
146217870|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Death|0|||
146217871|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Death|2|||
146217872|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Death|0|||
146217873|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
146217874|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
146217875|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
146217876|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
146217877|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
146217878|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
146287782|NCT03536143|527569328|FG000|Overall Study|Early termination, Sponsor decision|1|||
146217879|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
146217880|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
146217881|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
146217882|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
146217883|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
146217884|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
146217885|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
146217886|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
146217887|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
146217888|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
146217889|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
146217890|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
146217891|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Adverse Event|0|||
146217892|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Adverse Event|0|||
146217893|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Adverse Event|0|||
146217894|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Adverse Event|0|||
146217895|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Adverse Event|0|||
146217896|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Adverse Event|0|||
146217897|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Adverse Event|2|||
146217898|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Adverse Event|0|||
146217899|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Adverse Event|0|||
146217900|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Adverse Event|0|||
146217901|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Adverse Event|1|||
146217902|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Adverse Event|2|||
146217903|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Adverse Event|0|||
146217904|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Adverse Event|1|||
146217905|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Adverse Event|0|||
146217906|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Adverse Event|0|||
146217907|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Adverse Event|1|||
146217908|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Adverse Event|0|||
146217909|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
146217910|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
146217911|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
146217912|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
146217913|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
146217914|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
146217915|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
146217916|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
146217917|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
146217918|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
146217919|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
146217920|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
146217921|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
146217922|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
146217923|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
146217924|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
146217925|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
146217926|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
146217927|NCT03269136|527312592|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217928|NCT03269136|527312593|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217929|NCT03269136|527312594|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217930|NCT03269136|527312595|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217931|NCT03269136|527312596|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217932|NCT03269136|527312597|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217933|NCT03269136|527312598|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217934|NCT03269136|527312599|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217935|NCT03269136|527312600|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217936|NCT03269136|527312601|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217937|NCT03269136|527312602|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217938|NCT03269136|527312603|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217939|NCT03269136|527312604|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146217940|NCT03269136|527312605|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146217941|NCT03269136|527312606|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146217942|NCT03269136|527312607|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217943|NCT03269136|527312608|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146217944|NCT03269136|527312609|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146217945|NCT03269136|527312592|FG000|Part 2A: Dose Expansion|Other|0|||
146287783|NCT01878214|527569329|FG000|Overall Study|Withdrawal by Subject|18|||
146217946|NCT03269136|527312593|FG001|Part 2A: Dose Expansion|Other|0|||
146217947|NCT03269136|527312594|FG002|Part 2A: Dose Expansion|Other|0|||
146217948|NCT03269136|527312595|FG003|Part 2A: Dose Expansion|Other|0|||
146217949|NCT03269136|527312596|FG004|Part 2A: Dose Expansion|Other|0|||
146217950|NCT03269136|527312597|FG005|Part 2A: Dose Expansion|Other|0|||
146217951|NCT03269136|527312598|FG006|Part 2A: Dose Expansion|Other|0|||
146084503|NCT01122394|526830197|FG001|Overall Study|Withdrawal by Subject|1|||
146084504|NCT01122394|526830196|FG000|Overall Study|Lost to Follow-up|2|||
146084505|NCT01122394|526830197|FG001|Overall Study|Lost to Follow-up|2|||
146084506|NCT01122394|526830196|FG000|Overall Study|Adverse Event|0|||
146084507|NCT01122394|526830197|FG001|Overall Study|Adverse Event|1|||
146084508|NCT02446743|526830198|FG000|Overall Study|Withdrawal by Subject|1|||
146084509|NCT02446743|526830199|FG001|Overall Study|Withdrawal by Subject|1|||
146084510|NCT02446743|526830198|FG000|Overall Study|Lost to Follow-up|1|||
146217952|NCT03269136|527312599|FG007|Part 2A: Dose Expansion|Other|0|||
146217953|NCT03269136|527312600|FG008|Part 2A: Dose Expansion|Other|0|||
146217954|NCT03269136|527312601|FG009|Part 2A: Dose Expansion|Other|0|||
146217955|NCT03269136|527312602|FG010|Part 2A: Dose Expansion|Other|0|||
146217956|NCT03269136|527312603|FG011|Part 2A: Dose Expansion|Other|0|||
146217957|NCT03269136|527312604|FG012|Part 2A: Dose Expansion|Other|0|||
146217958|NCT03269136|527312605|FG013|Part 2A: Dose Expansion|Other|0|||
146217959|NCT03269136|527312606|FG014|Part 2A: Dose Expansion|Other|0|||
146217960|NCT03269136|527312607|FG015|Part 2A: Dose Expansion|Other|0|||
146217961|NCT03269136|527312608|FG016|Part 2A: Dose Expansion|Other|0|||
146217962|NCT03269136|527312609|FG017|Part 2A: Dose Expansion|Other|1|||
146217963|NCT03269136|527312592|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217964|NCT03269136|527312593|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217965|NCT03269136|527312594|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217966|NCT03269136|527312595|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217967|NCT03269136|527312596|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217968|NCT03269136|527312597|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217969|NCT03269136|527312598|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217970|NCT03269136|527312599|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217971|NCT03269136|527312600|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217972|NCT03269136|527312601|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217973|NCT03269136|527312602|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217974|NCT03269136|527312603|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217975|NCT03269136|527312604|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217976|NCT03269136|527312605|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217977|NCT03269136|527312606|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217978|NCT03269136|527312607|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217979|NCT03269136|527312608|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
146217980|NCT03269136|527312609|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
146217981|NCT03269136|527312592|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
146217982|NCT03269136|527312593|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
146217983|NCT03269136|527312594|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
146217984|NCT03269136|527312595|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
146217985|NCT03269136|527312596|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
146217986|NCT03269136|527312597|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
146217987|NCT03269136|527312598|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
146217988|NCT03269136|527312599|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
146217989|NCT03269136|527312600|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
146217990|NCT03269136|527312601|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
146217991|NCT03269136|527312602|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
146217992|NCT03269136|527312603|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
146217993|NCT03269136|527312604|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
146217994|NCT03269136|527312605|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
146217995|NCT03269136|527312606|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
146217996|NCT03269136|527312607|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
146217997|NCT03269136|527312608|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
146217998|NCT03269136|527312609|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
146217999|NCT03269136|527312592|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
146218000|NCT03269136|527312593|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
146218001|NCT03269136|527312594|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
146218002|NCT03269136|527312595|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
146218003|NCT03269136|527312596|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
146218004|NCT03269136|527312597|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
146084511|NCT02446743|526830199|FG001|Overall Study|Lost to Follow-up|0|||
146084512|NCT02446743|526830198|FG000|Overall Study|Adverse Event|1|||
146084513|NCT02446743|526830199|FG001|Overall Study|Adverse Event|1|||
146218005|NCT03269136|527312598|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
146218006|NCT03269136|527312599|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
146218007|NCT03269136|527312600|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
146218008|NCT03269136|527312601|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
146218009|NCT03269136|527312602|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
146218010|NCT03269136|527312603|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
146218011|NCT03269136|527312604|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
146218012|NCT03269136|527312605|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
146084514|NCT02446743|526830198|FG000|Overall Study|Other|2|||
146084515|NCT02446743|526830199|FG001|Overall Study|Other|3|||
146084516|NCT00039871|526830200|FG000|Overall Study|Adverse Event|165|||
146084517|NCT00039871|526830200|FG000|Overall Study|Lost to Follow-up|18|||
146084518|NCT00039871|526830200|FG000|Overall Study|Protocol Violation|24|||
146084519|NCT00039871|526830200|FG000|Overall Study|Withdrawal by Subject|97|||
146084520|NCT00039871|526830200|FG000|Overall Study|Did not meet eligibility criteria|11|||
146084521|NCT00039871|526830200|FG000|Overall Study|Administrative|1|||
146084522|NCT00039871|526830200|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
146084523|NCT00039871|526830200|FG000|Overall Study|Never entered follow-up|7|||
146084524|NCT03361176|526830201|FG000|Overall Study|Lost to Follow-up|1|||
146084525|NCT03361176|526830202|FG001|Overall Study|Lost to Follow-up|2|||
146084526|NCT03361176|526830201|FG000|Overall Study|Adverse Event|0|||
146084527|NCT03361176|526830202|FG001|Overall Study|Adverse Event|2|||
146084528|NCT03361176|526830201|FG000|Overall Study|Withdrawal by Subject|0|||
146084529|NCT03361176|526830202|FG001|Overall Study|Withdrawal by Subject|1|||
146084530|NCT02478398|526830203|FG000|Overall Study|Adverse Event|20|||
146084531|NCT02478398|526830204|FG001|Overall Study|Adverse Event|5|||
146218013|NCT03269136|527312606|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
146218014|NCT03269136|527312607|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
146218015|NCT03269136|527312608|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
146218016|NCT03269136|527312609|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
146218017|NCT03269136|527312592|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
146218018|NCT03269136|527312593|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
146218019|NCT03269136|527312594|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
146218020|NCT03269136|527312595|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
146218021|NCT03269136|527312596|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
146218022|NCT03269136|527312597|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
146218023|NCT03269136|527312598|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
146218024|NCT03269136|527312599|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
146218025|NCT03269136|527312600|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
146218026|NCT03269136|527312601|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
146218027|NCT03269136|527312602|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
146218028|NCT03269136|527312603|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
146218029|NCT03269136|527312604|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
146218030|NCT03269136|527312605|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
146218031|NCT03269136|527312606|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
146218032|NCT03269136|527312607|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
146218033|NCT03269136|527312608|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
146218034|NCT03269136|527312609|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
146218035|NCT05071807|527312612|FG000|Overall Study|Withdrawal by Subject|4|||
146218036|NCT05071807|527312613|FG001|Overall Study|Withdrawal by Subject|0|||
146218037|NCT05071807|527312612|FG000|Overall Study|Unrelated medical issues|3|||
146218038|NCT05071807|527312613|FG001|Overall Study|Unrelated medical issues|0|||
146218039|NCT05071807|527312612|FG000|Overall Study|Relocated|0|||
146218040|NCT05071807|527312613|FG001|Overall Study|Relocated|1|||
146218041|NCT05308004|527312615|FG000|Overall Study|Not seen by Palliative Care NP|0|||
146218042|NCT05308004|527312616|FG001|Overall Study|Not seen by Palliative Care NP|1|||
146218043|NCT04552223|527312623|FG000|Overall Study|Withdrawal by Subject|1|||
146218044|NCT04856163|527312624|FG000|Overall Study|Lost to Follow-up|97|||
146218045|NCT04856163|527312625|FG001|Overall Study|Lost to Follow-up|100|||
146218046|NCT04359108|527312632|FG000|Overall Study|Withdrawal by Subject|1|||
146218047|NCT04359108|527312633|FG001|Overall Study|Withdrawal by Subject|0|||
146218048|NCT04359108|527312632|FG000|Overall Study|Unable or too feeble to walk independently|0|||
146218049|NCT04359108|527312633|FG001|Overall Study|Unable or too feeble to walk independently|2|||
146218050|NCT04359108|527312632|FG000|Overall Study|Argus II system stopped functioning|0|||
146218051|NCT04359108|527312633|FG001|Overall Study|Argus II system stopped functioning|1|||
146218052|NCT04359108|527312632|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
146218053|NCT04359108|527312633|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
146218054|NCT06393088|527312634|FG000|Overall Study|Withdrawal by Subject|0|||
146218055|NCT06393088|527312635|FG001|Overall Study|Withdrawal by Subject|2|||
146218056|NCT04176965|527312636|FG000|Overall Study|Death|1|||
146218057|NCT04176965|527312637|FG001|Overall Study|Death|2|||
146218058|NCT04176965|527312636|FG000|Overall Study|Lost to Follow-up|10|||
146218059|NCT04176965|527312637|FG001|Overall Study|Lost to Follow-up|2|||
146218060|NCT04176965|527312636|FG000|Overall Study|Withdrawal by Subject|6|||
146218061|NCT04176965|527312637|FG001|Overall Study|Withdrawal by Subject|1|||
146084532|NCT02478398|526830203|FG000|Overall Study|Lost to Follow-up|5|||
146084533|NCT02478398|526830204|FG001|Overall Study|Lost to Follow-up|4|||
146218062|NCT03903146|527312638|FG000|Overall Study|Lost to Follow-up|6|||
146084534|NCT02478398|526830203|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146218063|NCT03903146|527312639|FG001|Overall Study|Lost to Follow-up|4|||
146218064|NCT03903146|527312638|FG000|Overall Study|Withdrawal by Subject|0|||
146218065|NCT03903146|527312639|FG001|Overall Study|Withdrawal by Subject|1|||
146218066|NCT05551637|527312642|FG000|Overall Study|Lack of Efficacy|0|||
146218067|NCT05551637|527312643|FG001|Overall Study|Lack of Efficacy|6|||
146218068|NCT05551637|527312642|FG000|Overall Study|Lost to Follow-up|1|||
146218069|NCT05551637|527312643|FG001|Overall Study|Lost to Follow-up|1|||
146218070|NCT04924660|527312646|FG000|United States|Death|29|||
146218071|NCT04924660|527312647|FG001|United States|Death|32|||
146218072|NCT04924660|527312648|FG002|United States|Death|34|||
146218073|NCT04924660|527312649|FG003|United States|Death|25|||
146218074|NCT04924660|527312650|FG004|United States|Death|26|||
146218075|NCT04924660|527312651|FG005|United States|Death|23|||
146218076|NCT04924660|527312646|FG000|United States|Lost to Follow-up|15|||
146218077|NCT04924660|527312647|FG001|United States|Lost to Follow-up|10|||
146218078|NCT04924660|527312648|FG002|United States|Lost to Follow-up|13|||
146218079|NCT04924660|527312649|FG003|United States|Lost to Follow-up|5|||
146218080|NCT04924660|527312650|FG004|United States|Lost to Follow-up|19|||
146218081|NCT04924660|527312651|FG005|United States|Lost to Follow-up|20|||
146218082|NCT04924660|527312646|FG000|United States|Withdrawal by Subject|8|||
146218083|NCT04924660|527312647|FG001|United States|Withdrawal by Subject|3|||
146218084|NCT04924660|527312648|FG002|United States|Withdrawal by Subject|3|||
146218085|NCT04924660|527312649|FG003|United States|Withdrawal by Subject|3|||
146218086|NCT04924660|527312650|FG004|United States|Withdrawal by Subject|8|||
146218087|NCT04924660|527312651|FG005|United States|Withdrawal by Subject|4|||
146218088|NCT04924660|527312646|FG000|Spain|Death|0|||
146218089|NCT04924660|527312647|FG001|Spain|Death|0|||
146218090|NCT04924660|527312648|FG002|Spain|Death|0|||
146218091|NCT04924660|527312649|FG003|Spain|Death|0|||
145881722|NCT01332968|526072674|FG002|Follow-Up Period|Progressive Disease|0|||
145881723|NCT01332968|526072675|FG003|Follow-Up Period|Progressive Disease|0|||
145881724|NCT01332968|526072676|FG004|Follow-Up Period|Progressive Disease|0|||
145881725|NCT01332968|526072677|FG005|Follow-Up Period|Progressive Disease|0|||
145881726|NCT01332968|526072678|FG006|Follow-Up Period|Progressive Disease|126|||
145881727|NCT01332968|526072679|FG007|Follow-Up Period|Progressive Disease|106|||
146218092|NCT04924660|527312650|FG004|Spain|Death|0|||
146218093|NCT04924660|527312651|FG005|Spain|Death|2|||
146218094|NCT04924660|527312646|FG000|Spain|Lost to Follow-up|0|||
146218095|NCT04924660|527312647|FG001|Spain|Lost to Follow-up|0|||
146218096|NCT04924660|527312648|FG002|Spain|Lost to Follow-up|0|||
146218097|NCT04924660|527312649|FG003|Spain|Lost to Follow-up|0|||
146218098|NCT04924660|527312650|FG004|Spain|Lost to Follow-up|1|||
146218099|NCT04924660|527312651|FG005|Spain|Lost to Follow-up|0|||
146218100|NCT04924660|527312646|FG000|Brazil|Death|0|||
146218101|NCT04924660|527312647|FG001|Brazil|Death|0|||
146218102|NCT04924660|527312648|FG002|Brazil|Death|0|||
146218103|NCT04924660|527312649|FG003|Brazil|Death|0|||
145881728|NCT01332968|526072672|FG000|Follow-Up Period|Protocol Violation|0|||
146218104|NCT04924660|527312650|FG004|Brazil|Death|1|||
146218105|NCT04924660|527312651|FG005|Brazil|Death|0|||
146218106|NCT04924660|527312646|FG000|Italy|Lost to Follow-up|0|||
146218107|NCT04924660|527312647|FG001|Italy|Lost to Follow-up|0|||
146218108|NCT04924660|527312648|FG002|Italy|Lost to Follow-up|0|||
146218109|NCT04924660|527312649|FG003|Italy|Lost to Follow-up|0|||
146218110|NCT04924660|527312650|FG004|Italy|Lost to Follow-up|0|||
146218111|NCT04924660|527312651|FG005|Italy|Lost to Follow-up|1|||
145960739|NCT01931397|526367691|FG000|Overall Study|Withdrawal by Subject|8|||
145960740|NCT01931397|526367691|FG000|Overall Study|moved out of state|1|||
145960741|NCT02493517|526367695|FG000|Overall Study|Protocol Violation|1|||
145960742|NCT02493517|526367696|FG001|Overall Study|Protocol Violation|2|||
145960743|NCT02493517|526367695|FG000|Overall Study|Withdrawal by Subject|1|||
146218112|NCT04924660|527312646|FG000|South Africa|Death|0|||
146218113|NCT04924660|527312647|FG001|South Africa|Death|0|||
146218114|NCT04924660|527312648|FG002|South Africa|Death|0|||
146218115|NCT04924660|527312649|FG003|South Africa|Death|0|||
146218116|NCT04924660|527312650|FG004|South Africa|Death|0|||
146218117|NCT04924660|527312651|FG005|South Africa|Death|1|||
146218118|NCT04924660|527312646|FG000|South Africa|Lost to Follow-up|0|||
146218119|NCT04924660|527312647|FG001|South Africa|Lost to Follow-up|0|||
146218120|NCT04924660|527312648|FG002|South Africa|Lost to Follow-up|0|||
146218121|NCT04924660|527312649|FG003|South Africa|Lost to Follow-up|0|||
146218122|NCT04924660|527312650|FG004|South Africa|Lost to Follow-up|0|||
146218123|NCT04924660|527312651|FG005|South Africa|Lost to Follow-up|1|||
146218124|NCT05894577|527312654|FG000|Overall Study|No receipt of study drug|14|||
146218125|NCT05894577|527312655|FG001|Overall Study|No receipt of study drug|13|||
146218126|NCT05894577|527312654|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
146218127|NCT05894577|527312655|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
146218128|NCT05894577|527312654|FG000|Overall Study|Screen Fail|2|||
146218129|NCT05894577|527312655|FG001|Overall Study|Screen Fail|0|||
146218130|NCT05894577|527312654|FG000|Overall Study|Study drug recall|86|||
146218131|NCT05894577|527312655|FG001|Overall Study|Study drug recall|63|||
146218132|NCT03197662|527312657|FG000|Overall Study|Withdrawn by family|0|||
146218133|NCT03197662|527312658|FG001|Overall Study|Withdrawn by family|2|||
146218134|NCT02949362|527312662|FG000|Retrospective Period|Inform consent not signed by participant|4|||
146218135|NCT02949362|527312663|FG001|Retrospective Period|Inform consent not signed by participant|1|||
146218136|NCT02949362|527312664|FG002|Retrospective Period|Inform consent not signed by participant|0|||
146218137|NCT02949362|527312665|FG003|Retrospective Period|Inform consent not signed by participant|0|||
146218138|NCT02949362|527312662|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146218139|NCT02949362|527312663|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146218140|NCT02949362|527312664|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
146218141|NCT02949362|527312665|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
146218142|NCT02949362|527312662|FG000|Prospective Period|Other|0|||
146218143|NCT02949362|527312663|FG001|Prospective Period|Other|0|||
146218144|NCT02949362|527312664|FG002|Prospective Period|Other|0|||
146218145|NCT02949362|527312665|FG003|Prospective Period|Other|4|||
146218146|NCT03476460|527312666|FG000|Overall Study|Withdrawal by Subject|3|||
146218147|NCT03476460|527312667|FG001|Overall Study|Withdrawal by Subject|2|||
146218148|NCT03476460|527312666|FG000|Overall Study|Non-compliance with treatment|3|||
146218149|NCT03476460|527312667|FG001|Overall Study|Non-compliance with treatment|0|||
146218150|NCT03476460|527312666|FG000|Overall Study|Missing laboratory tests|5|||
146218151|NCT03476460|527312667|FG001|Overall Study|Missing laboratory tests|5|||
146218152|NCT03476460|527312666|FG000|Overall Study|Adverse Event|0|||
146218153|NCT03476460|527312667|FG001|Overall Study|Adverse Event|1|||
146218154|NCT05609760|527312675|FG000|Overall Study|Lost to Follow-up|0|||
146218155|NCT05609760|527312676|FG001|Overall Study|Lost to Follow-up|1|||
146218156|NCT05609760|527312675|FG000|Overall Study|Withdrawal by Subject|1|||
146218157|NCT05609760|527312676|FG001|Overall Study|Withdrawal by Subject|0|||
146218158|NCT03396588|527312677|FG000|Overall Study|Physician Decision|2|||
146218159|NCT03396588|527312678|FG001|Overall Study|Physician Decision|3|||
146218160|NCT05179395|527312679|FG000|Overall Study|Lack of Efficacy|1|||
146218161|NCT00812461|527312681|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
146218162|NCT00812461|527312682|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
146218163|NCT00812461|527312681|FG000|All Treated Patients|Adverse Event|8|||
146218164|NCT00812461|527312682|FG001|All Treated Patients|Adverse Event|15|||
146218165|NCT00812461|527312681|FG000|All Treated Patients|Lack of Efficacy|13|||
146218166|NCT00812461|527312682|FG001|All Treated Patients|Lack of Efficacy|7|||
146218167|NCT00812461|527312681|FG000|All Treated Patients|Non-compliance|6|||
146218168|NCT00812461|527312682|FG001|All Treated Patients|Non-compliance|9|||
146218169|NCT00812461|527312681|FG000|All Treated Patients|Protocol Violation|36|||
146218170|NCT00812461|527312682|FG001|All Treated Patients|Protocol Violation|27|||
146218171|NCT00812461|527312681|FG000|All Treated Patients|Withdrawal by Subject|45|||
146218172|NCT00812461|527312682|FG001|All Treated Patients|Withdrawal by Subject|54|||
146218173|NCT00812461|527312681|FG000|All Treated Patients|Lost to Follow-up|11|||
146218174|NCT00812461|527312682|FG001|All Treated Patients|Lost to Follow-up|14|||
146218175|NCT00812461|527312681|FG000|All Treated Patients|Other Reason|13|||
146218176|NCT00812461|527312682|FG001|All Treated Patients|Other Reason|21|||
146218177|NCT05351554|527312684|FG000|Overall Study|Study terminated by sponsor|1|||
146218178|NCT02671903|527314826|FG000|Period 0 (Run-In)|Death|0|||
146287784|NCT01878214|527569330|FG001|Overall Study|Withdrawal by Subject|7|||
146287785|NCT01878214|527569329|FG000|Overall Study|Death|0|||
146287786|NCT01878214|527569330|FG001|Overall Study|Death|1|||
146287787|NCT01878214|527569329|FG000|Overall Study|Lost to Follow-up|35|||
146287788|NCT01878214|527569330|FG001|Overall Study|Lost to Follow-up|36|||
146287789|NCT01174160|527569331|FG000|Overall Study|Adverse Event|1|||
146287790|NCT01174160|527569332|FG001|Overall Study|Adverse Event|0|||
146287791|NCT01174160|527569331|FG000|Overall Study|Lost to Follow-up|1|||
146287792|NCT01174160|527569332|FG001|Overall Study|Lost to Follow-up|0|||
146287793|NCT01174160|527569331|FG000|Overall Study|Physician Decision|1|||
146287794|NCT01174160|527569332|FG001|Overall Study|Physician Decision|0|||
146287795|NCT01174160|527569331|FG000|Overall Study|Protocol Violation|4|||
146287796|NCT01174160|527569332|FG001|Overall Study|Protocol Violation|6|||
145960744|NCT02493517|526367696|FG001|Overall Study|Withdrawal by Subject|2|||
145960745|NCT02493517|526367695|FG000|Overall Study|Adverse Event|0|||
145960746|NCT02493517|526367696|FG001|Overall Study|Adverse Event|2|||
146287797|NCT01174160|527569331|FG000|Overall Study|Withdrawal by Subject|1|||
145960747|NCT02493517|526367695|FG000|Overall Study|Missed study visit|0|||
146287798|NCT01174160|527569332|FG001|Overall Study|Withdrawal by Subject|0|||
146287799|NCT01590017|527569333|FG000|Overall Study|Adverse Event|1|||
146287800|NCT01590017|527569333|FG000|Overall Study|Withdrawal by Subject|1|||
146287801|NCT01590017|527569333|FG000|Overall Study|Lack of Efficacy|1|||
145881729|NCT01332968|526072673|FG001|Follow-Up Period|Protocol Violation|0|||
145881730|NCT01332968|526072674|FG002|Follow-Up Period|Protocol Violation|0|||
145881731|NCT01332968|526072675|FG003|Follow-Up Period|Protocol Violation|0|||
145881732|NCT01332968|526072676|FG004|Follow-Up Period|Protocol Violation|0|||
145881733|NCT01332968|526072677|FG005|Follow-Up Period|Protocol Violation|0|||
145881734|NCT01332968|526072678|FG006|Follow-Up Period|Protocol Violation|1|||
145881735|NCT01332968|526072679|FG007|Follow-Up Period|Protocol Violation|0|||
145881736|NCT01332968|526072672|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145881737|NCT01332968|526072673|FG001|Follow-Up Period|Withdrawal by Subject|0|||
145881738|NCT01332968|526072674|FG002|Follow-Up Period|Withdrawal by Subject|0|||
146287802|NCT01590017|527569333|FG000|Overall Study|Physician Decision|1|||
146287803|NCT02527343|527569334|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
146287804|NCT02527343|527569335|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146287805|NCT02527343|527569336|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146287806|NCT02527343|527569337|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146287807|NCT02527343|527569338|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146287808|NCT02527343|527569339|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
146287809|NCT02527343|527569334|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
146287810|NCT02527343|527569335|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146287811|NCT02527343|527569336|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146287812|NCT02527343|527569337|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146287813|NCT02527343|527569338|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146287814|NCT02527343|527569339|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
146287815|NCT02527343|527569334|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146287816|NCT02527343|527569335|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
146287817|NCT02527343|527569336|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146287818|NCT02527343|527569337|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146287819|NCT02527343|527569338|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146287820|NCT02527343|527569339|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146287821|NCT02527343|527569334|FG000|RT Period: Weeks 1 to 52|Other|4|||
146287822|NCT02527343|527569335|FG001|RT Period: Weeks 1 to 52|Other|3|||
146287823|NCT02527343|527569336|FG002|RT Period: Weeks 1 to 52|Other|0|||
146287824|NCT02527343|527569337|FG003|RT Period: Weeks 1 to 52|Other|0|||
146287825|NCT02527343|527569338|FG004|RT Period: Weeks 1 to 52|Other|0|||
146287826|NCT02527343|527569339|FG005|RT Period: Weeks 1 to 52|Other|0|||
146287827|NCT02527343|527569334|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146287828|NCT02527343|527569335|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146287829|NCT02527343|527569336|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
146287830|NCT02527343|527569337|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146287831|NCT02527343|527569338|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146287832|NCT02527343|527569339|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
146287833|NCT02527343|527569334|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146287834|NCT02527343|527569335|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146287835|NCT02527343|527569336|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145960748|NCT02493517|526367696|FG001|Overall Study|Missed study visit|1|||
146218179|NCT02671903|527314827|FG001|Period 0 (Run-In)|Death|0|||
145881739|NCT01332968|526072675|FG003|Follow-Up Period|Withdrawal by Subject|0|||
145881740|NCT01332968|526072676|FG004|Follow-Up Period|Withdrawal by Subject|0|||
145881741|NCT01332968|526072677|FG005|Follow-Up Period|Withdrawal by Subject|0|||
145881742|NCT01332968|526072678|FG006|Follow-Up Period|Withdrawal by Subject|29|||
145881743|NCT01332968|526072679|FG007|Follow-Up Period|Withdrawal by Subject|32|||
145881744|NCT01332968|526072672|FG000|Follow-Up Period|No reason provided|0|||
145881745|NCT01332968|526072673|FG001|Follow-Up Period|No reason provided|0|||
145881746|NCT01332968|526072674|FG002|Follow-Up Period|No reason provided|0|||
145881747|NCT01332968|526072675|FG003|Follow-Up Period|No reason provided|0|||
145881748|NCT01332968|526072676|FG004|Follow-Up Period|No reason provided|0|||
145881749|NCT01332968|526072677|FG005|Follow-Up Period|No reason provided|0|||
145881750|NCT01332968|526072678|FG006|Follow-Up Period|No reason provided|2|||
145881751|NCT01332968|526072679|FG007|Follow-Up Period|No reason provided|3|||
145881752|NCT04010227|526072680|FG000|Overall Study|Death|1|||
145881753|NCT04010227|526072681|FG001|Overall Study|Death|2|||
145881754|NCT04010227|526072680|FG000|Overall Study|Medical Reasons|4|||
145881755|NCT04010227|526072681|FG001|Overall Study|Medical Reasons|3|||
145881756|NCT04010227|526072680|FG000|Overall Study|Withdrawal by Subject|2|||
145881757|NCT04010227|526072681|FG001|Overall Study|Withdrawal by Subject|0|||
145881758|NCT04010227|526072680|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
145881759|NCT04010227|526072681|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
145881760|NCT00702507|526072682|FG000|Initial Treatment Phase|Adverse Event|2|||
145881761|NCT00702507|526072682|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
145881762|NCT00702507|526072682|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
145881763|NCT00702507|526072682|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
145881764|NCT00702507|526072682|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
146218180|NCT02671903|527314828|FG002|Period 0 (Run-In)|Death|3|||
145881765|NCT00702507|526072682|FG000|Follow-up Phase|Protocol Violation|2|||
145881766|NCT00702507|526072682|FG000|Follow-up Phase|Lost to Follow-up|23|||
145881767|NCT00702507|526072682|FG000|Follow-up Phase|Late Enrollment|1|||
145881768|NCT02308696|526072684|FG000|Overall Study|Lost to Follow-up|28|||
145881769|NCT02308696|526072685|FG001|Overall Study|Lost to Follow-up|21|||
145881770|NCT02308696|526072684|FG000|Overall Study|Death|8|||
145881771|NCT02308696|526072685|FG001|Overall Study|Death|4|||
145881772|NCT02308696|526072684|FG000|Overall Study|Moved to a Higher Level of Care|17|||
145881773|NCT02308696|526072685|FG001|Overall Study|Moved to a Higher Level of Care|6|||
145881774|NCT04194008|526072690|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
145881775|NCT04194008|526072690|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
145881776|NCT04194008|526072690|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
145881777|NCT04194008|526072690|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
145881778|NCT04194008|526072690|FG000|Treatment Phase With Nerivio|Missing data|4|||
145881779|NCT04194008|526072690|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
145881780|NCT02522780|526072694|FG000|Overall Study|Consent withdrawn by subject|5|||
145881781|NCT02522780|526072695|FG001|Overall Study|Consent withdrawn by subject|7|||
145881782|NCT02522780|526072694|FG000|Overall Study|Protocol deviation|1|||
145881783|NCT02522780|526072695|FG001|Overall Study|Protocol deviation|3|||
145881784|NCT02522780|526072694|FG000|Overall Study|Subject refused endoscopic procedure|0|||
145881785|NCT02522780|526072695|FG001|Overall Study|Subject refused endoscopic procedure|1|||
145881786|NCT02522780|526072694|FG000|Overall Study|Adverse event, non-fatal|11|||
145881787|NCT02522780|526072695|FG001|Overall Study|Adverse event, non-fatal|16|||
145881788|NCT02260635|526072696|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
145881789|NCT02260635|526072697|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
145881790|NCT02260635|526072696|FG000|Open-Label Extension|Study Termination|25|||
145881791|NCT02260635|526072697|FG001|Open-Label Extension|Study Termination|25|||
145881792|NCT02260635|526072696|FG000|Open-Label Extension|Withdrawal by Subject|1|||
145881793|NCT02260635|526072697|FG001|Open-Label Extension|Withdrawal by Subject|0|||
145881794|NCT00926367|526072698|FG000|Overall Study|Withdrawal by Subject|0|||
145881795|NCT00926367|526072699|FG001|Overall Study|Withdrawal by Subject|1|||
145881796|NCT00926367|526072698|FG000|Overall Study|Lost to Follow-up|1|||
145881797|NCT00926367|526072699|FG001|Overall Study|Lost to Follow-up|0|||
145881798|NCT00926367|526072698|FG000|Overall Study|Skin Irritation|1|||
145881799|NCT00926367|526072699|FG001|Overall Study|Skin Irritation|2|||
145881800|NCT01517867|526072700|FG000|Overall Study|never started treatment|29|||
145881801|NCT01517867|526072701|FG001|Overall Study|never started treatment|32|||
145881802|NCT01517867|526072700|FG000|Overall Study|Withdrawal by Subject|34|||
145881803|NCT01517867|526072701|FG001|Overall Study|Withdrawal by Subject|30|||
145881804|NCT01517867|526072700|FG000|Overall Study|Still in treatment at study end|0|||
146218181|NCT02671903|527314826|FG000|Period 0 (Run-In)|Physician Decision|0|||
146218182|NCT02671903|527314827|FG001|Period 0 (Run-In)|Physician Decision|0|||
146218183|NCT02671903|527314828|FG002|Period 0 (Run-In)|Physician Decision|4|||
146218184|NCT02671903|527314826|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
146218185|NCT02671903|527314827|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
145960749|NCT01367249|526367697|FG000|Overall Study|Withdrawal by Subject|6|||
146218186|NCT02671903|527314828|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
146218187|NCT02671903|527314826|FG000|Period 0 (Run-In)|Protocol Violation|0|||
145960750|NCT01367249|526367698|FG001|Overall Study|Withdrawal by Subject|6|||
145960751|NCT01367249|526367697|FG000|Overall Study|Other|3|||
145960752|NCT01367249|526367698|FG001|Overall Study|Other|10|||
145960753|NCT03718429|526367699|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
145960754|NCT03718429|526367700|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
145960755|NCT03718429|526367701|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
145960756|NCT03718429|526367702|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
145960757|NCT05404711|526367703|FG000|Completed Study Visit|Withdrawal by Subject|1|||
145960758|NCT05404711|526367703|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
145960759|NCT05404711|526367703|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
145960760|NCT05404711|526367703|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
145960761|NCT05404711|526367703|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
145960762|NCT05404711|526367703|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
145960763|NCT02058589|526367704|FG000|Overall Study|Serious Adverse Event|1|||
146218188|NCT02671903|527314827|FG001|Period 0 (Run-In)|Protocol Violation|0|||
146218189|NCT02671903|527314828|FG002|Period 0 (Run-In)|Protocol Violation|1|||
146218190|NCT02671903|527314826|FG000|Period 0 (Run-In)|Adverse Event|0|||
146218191|NCT02671903|527314827|FG001|Period 0 (Run-In)|Adverse Event|0|||
145960764|NCT02058589|526367705|FG001|Overall Study|Serious Adverse Event|1|||
145960765|NCT02058589|526367704|FG000|Overall Study|Non-Serious Adverse Event|1|||
145881805|NCT01517867|526072701|FG001|Overall Study|Still in treatment at study end|3|||
145881806|NCT03294317|526072703|FG000|Overall Study|Physician Decision|1|||
145881807|NCT03294317|526072703|FG000|Overall Study|Withdrawal by Subject|6|||
145881808|NCT03294317|526072703|FG000|Overall Study|Lost to Follow-up|1|||
145881809|NCT03294317|526072703|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
145881810|NCT03294317|526072703|FG000|Overall Study|Failed HB lead implant|8|||
145881811|NCT03294317|526072703|FG000|Overall Study|Received CRT instead|1|||
145881812|NCT03294317|526072703|FG000|Overall Study|Exited after lead revision|2|||
145881813|NCT04307849|526072704|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
145881814|NCT04307849|526072705|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
146218192|NCT02671903|527314828|FG002|Period 0 (Run-In)|Adverse Event|1|||
146218193|NCT02671903|527314826|FG000|Period 0 (Run-In)|Implantation Failure|0|||
146218194|NCT02671903|527314827|FG001|Period 0 (Run-In)|Implantation Failure|0|||
146218195|NCT02671903|527314828|FG002|Period 0 (Run-In)|Implantation Failure|2|||
146218196|NCT02671903|527314826|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
146218197|NCT02671903|527314827|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
146218198|NCT02671903|527314828|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
146218199|NCT03376321|527314829|FG000|Overall Study|Other|5|||
146218200|NCT03376321|527314830|FG001|Overall Study|Other|1|||
146218201|NCT03376321|527314829|FG000|Overall Study|Withdrawal by Subject|8|||
146218202|NCT03376321|527314830|FG001|Overall Study|Withdrawal by Subject|14|||
146218203|NCT03376321|527314829|FG000|Overall Study|Lost to Follow-up|1|||
146218204|NCT03376321|527314830|FG001|Overall Study|Lost to Follow-up|7|||
146218205|NCT03376321|527314829|FG000|Overall Study|Death|4|||
146218206|NCT03376321|527314830|FG001|Overall Study|Death|0|||
146218207|NCT03376321|527314829|FG000|Overall Study|Randomized, not treated|5|||
146218208|NCT03376321|527314830|FG001|Overall Study|Randomized, not treated|3|||
146218209|NCT02992925|527314831|FG000|Cohort 2|Physician Decision|0|||
145881815|NCT04307849|526072706|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
146218210|NCT02992925|527314832|FG001|Cohort 2|Physician Decision|0|||
146218211|NCT02992925|527314833|FG002|Cohort 2|Physician Decision|1|||
146218212|NCT02992925|527314834|FG003|Cohort 2|Physician Decision|0|||
146218213|NCT02992925|527314831|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
145881816|NCT04307849|526072707|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
145881817|NCT04307849|526072708|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
145881818|NCT04307849|526072709|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
145881819|NCT04307849|526072704|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145881820|NCT04307849|526072705|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145881821|NCT04307849|526072706|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
146287836|NCT02527343|527569337|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
146287837|NCT02527343|527569338|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146287838|NCT02527343|527569339|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
146287839|NCT02527343|527569334|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146287840|NCT02527343|527569335|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146287841|NCT02527343|527569336|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146287842|NCT02527343|527569337|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146287843|NCT02527343|527569338|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
146287844|NCT02527343|527569339|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
146287845|NCT02527343|527569334|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146287846|NCT02527343|527569335|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146287847|NCT02527343|527569336|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146287848|NCT02527343|527569337|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
146287849|NCT02527343|527569338|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
146287850|NCT02527343|527569339|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
146287851|NCT02527343|527569334|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146287852|NCT02527343|527569335|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146287853|NCT02527343|527569336|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146287854|NCT02527343|527569337|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
146287855|NCT02527343|527569338|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
146287856|NCT02527343|527569339|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
146287857|NCT02527343|527569334|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
146287858|NCT02527343|527569335|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
146287859|NCT02527343|527569336|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
146287860|NCT02527343|527569337|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
146287861|NCT02527343|527569338|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
146287862|NCT02527343|527569339|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
146287863|NCT02527343|527569334|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
146287864|NCT02527343|527569335|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
146287865|NCT02527343|527569336|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
146287866|NCT02527343|527569337|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
146287867|NCT02527343|527569338|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
146287868|NCT02527343|527569339|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
146287869|NCT02527343|527569334|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146287870|NCT02527343|527569335|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146287871|NCT02527343|527569336|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146287872|NCT02527343|527569337|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146287873|NCT02527343|527569338|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
146287874|NCT02527343|527569339|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
146287875|NCT02527343|527569334|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
146287876|NCT02527343|527569335|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
146287877|NCT02527343|527569336|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
146287878|NCT02527343|527569337|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
146287879|NCT02527343|527569338|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
146287880|NCT02527343|527569339|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
145881822|NCT04307849|526072707|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145881823|NCT04307849|526072708|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145881824|NCT04307849|526072709|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145881825|NCT04307849|526072704|FG000|Overall Study|Family member did not want them to continue|0|||
145881826|NCT04307849|526072705|FG001|Overall Study|Family member did not want them to continue|0|||
146287881|NCT05559099|527569344|FG000|Overall Study|Death|5|||
146287882|NCT05559099|527569345|FG001|Overall Study|Death|4|||
146287883|NCT05559099|527569344|FG000|Overall Study|Lost to Follow-up|0|||
146287884|NCT05559099|527569345|FG001|Overall Study|Lost to Follow-up|2|||
146287885|NCT05559099|527569344|FG000|Overall Study|Adverse Event|1|||
145881827|NCT04307849|526072706|FG002|Overall Study|Family member did not want them to continue|1|||
145881828|NCT04307849|526072707|FG003|Overall Study|Family member did not want them to continue|0|||
145881829|NCT04307849|526072708|FG004|Overall Study|Family member did not want them to continue|0|||
145881830|NCT04307849|526072709|FG005|Overall Study|Family member did not want them to continue|0|||
145881831|NCT04307849|526072704|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
145881832|NCT04307849|526072705|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
145881833|NCT04307849|526072706|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
145881834|NCT04307849|526072707|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
145881835|NCT04307849|526072708|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
145881836|NCT04307849|526072709|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
145881837|NCT01294449|526072710|FG000|Overall Study|Death|11|||
145881838|NCT01294449|526072711|FG001|Overall Study|Death|12|||
145881839|NCT01294449|526072710|FG000|Overall Study|Withdrawal by Subject|1|||
145881840|NCT01294449|526072711|FG001|Overall Study|Withdrawal by Subject|3|||
145881841|NCT02911935|526072712|FG000|Overall Study|Lost to Follow-up|5|||
145881842|NCT02911935|526072713|FG001|Overall Study|Lost to Follow-up|7|||
145881843|NCT01685216|526072714|FG000|Overall Study|Did not receive study drug|1|||
146218214|NCT02992925|527314832|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
146218215|NCT02992925|527314833|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
146218216|NCT02992925|527314834|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
146218217|NCT02995434|527314835|FG000|Overall Study|Adverse Event|1|||
146218218|NCT02995434|527314836|FG001|Overall Study|Adverse Event|0|||
146218219|NCT02995434|527314835|FG000|Overall Study|Withdrawal by Subject|6|||
146218220|NCT02995434|527314836|FG001|Overall Study|Withdrawal by Subject|3|||
146218221|NCT05273749|527314837|FG000|Overall Study|Adverse Event|14|||
146218222|NCT05273749|527314838|FG001|Overall Study|Adverse Event|8|||
146218223|NCT05273749|527314837|FG000|Overall Study|Lack of Efficacy|2|||
146218224|NCT05273749|527314838|FG001|Overall Study|Lack of Efficacy|8|||
146218225|NCT05273749|527314837|FG000|Overall Study|Physician Decision|0|||
146218226|NCT05273749|527314838|FG001|Overall Study|Physician Decision|2|||
146218227|NCT05273749|527314837|FG000|Overall Study|Withdrawal by Subject|14|||
146218228|NCT05273749|527314838|FG001|Overall Study|Withdrawal by Subject|16|||
146218229|NCT05273749|527314837|FG000|Overall Study|Lost to Follow-up|10|||
146218230|NCT05273749|527314838|FG001|Overall Study|Lost to Follow-up|10|||
146218231|NCT05273749|527314837|FG000|Overall Study|Pregnancy|1|||
146218232|NCT05273749|527314838|FG001|Overall Study|Pregnancy|0|||
146218233|NCT05273749|527314837|FG000|Overall Study|Non-Compliance|3|||
146218234|NCT05273749|527314838|FG001|Overall Study|Non-Compliance|2|||
146218235|NCT05273749|527314837|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
146218236|NCT05273749|527314838|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
146218237|NCT04806594|527314847|FG000|Overall Study|Withdrawal by Subject|2|||
146218238|NCT04806594|527314847|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
146218239|NCT02543281|527314848|FG000|Overall Study|Lost to Follow-up|0|||
146218240|NCT02543281|527314849|FG001|Overall Study|Lost to Follow-up|0|||
146218241|NCT02543281|527314850|FG002|Overall Study|Lost to Follow-up|1|||
146218242|NCT04318548|527314851|FG000|Overall Study|Adverse Event|0|||
146218243|NCT04318548|527314852|FG001|Overall Study|Adverse Event|0|||
146218244|NCT04318548|527314853|FG002|Overall Study|Adverse Event|1|||
146218245|NCT04318548|527314851|FG000|Overall Study|Lost to Follow-up|6|||
146218246|NCT04318548|527314852|FG001|Overall Study|Lost to Follow-up|13|||
146218247|NCT04318548|527314853|FG002|Overall Study|Lost to Follow-up|9|||
146218248|NCT04318548|527314851|FG000|Overall Study|Protocol Violation|1|||
146218249|NCT04318548|527314852|FG001|Overall Study|Protocol Violation|0|||
146218250|NCT04318548|527314853|FG002|Overall Study|Protocol Violation|2|||
146218251|NCT04318548|527314851|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
146218252|NCT04318548|527314852|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
145960766|NCT02058589|526367705|FG001|Overall Study|Non-Serious Adverse Event|0|||
146218253|NCT04318548|527314853|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
146218254|NCT04318548|527314851|FG000|Overall Study|Migrated / moved from the study area|0|||
146218255|NCT04318548|527314852|FG001|Overall Study|Migrated / moved from the study area|0|||
146218256|NCT04318548|527314853|FG002|Overall Study|Migrated / moved from the study area|1|||
146218257|NCT04318548|527314851|FG000|Overall Study|Other|1|||
146218258|NCT04318548|527314852|FG001|Overall Study|Other|2|||
146218259|NCT04318548|527314853|FG002|Overall Study|Other|3|||
146218260|NCT05247489|527314854|FG000|Overall Study|Lost to Follow-up|5|||
146218261|NCT05247489|527314855|FG001|Overall Study|Lost to Follow-up|1|||
146218262|NCT05247489|527314854|FG000|Overall Study|Withdrawal by Subject|6|||
146218263|NCT05247489|527314855|FG001|Overall Study|Withdrawal by Subject|7|||
146218264|NCT05247489|527314854|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
146218265|NCT05247489|527314855|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
146218266|NCT05247489|527314854|FG000|Overall Study|Left Country|1|||
146218267|NCT05247489|527314855|FG001|Overall Study|Left Country|0|||
146218268|NCT05247489|527314854|FG000|Overall Study|Noncompliance with Investigational Product|1|||
146218269|NCT05247489|527314855|FG001|Overall Study|Noncompliance with Investigational Product|0|||
146218270|NCT05247489|527314854|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
146218271|NCT05247489|527314855|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
146218272|NCT05215314|527314862|FG000|Overall Study|Lost to Follow-up|2|||
146218273|NCT05215314|527314863|FG001|Overall Study|Lost to Follow-up|2|||
146218274|NCT05215314|527314862|FG000|Overall Study|Withdrawal by Subject|2|||
146218275|NCT05215314|527314863|FG001|Overall Study|Withdrawal by Subject|0|||
146218276|NCT05215314|527314862|FG000|Overall Study|Physician Decision|1|||
146218277|NCT05215314|527314863|FG001|Overall Study|Physician Decision|0|||
146218278|NCT04179500|527314864|FG000|Treatment|Withdrawal by Subject|1|||
146218279|NCT04179500|527314864|FG000|Treatment|Adverse Event|2|||
146218280|NCT04179500|527314864|FG000|Treatment|pyrazinamide resistance|1|||
146218281|NCT03366649|527314870|FG000|Overall Study|Failed preoperative screening|4|||
146218282|NCT03366649|527314871|FG001|Overall Study|Failed preoperative screening|0|||
146218283|NCT03366649|527314872|FG002|Overall Study|Failed preoperative screening|0|||
146287886|NCT05559099|527569345|FG001|Overall Study|Adverse Event|1|||
146287887|NCT04018092|527569346|FG000|Overall Study|Withdrawal by Subject|1|||
146287888|NCT04018092|527569347|FG001|Overall Study|Withdrawal by Subject|1|||
146287889|NCT04018092|527569346|FG000|Overall Study|Withdrawal by Subject|1|||
146218284|NCT03366649|527314870|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
146218285|NCT03366649|527314871|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
146218286|NCT03366649|527314872|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
146287890|NCT04018092|527569347|FG001|Overall Study|Withdrawal by Subject|1|||
146218287|NCT03673111|527314873|FG000|Overall Study|Protocol Violation|0|||
146218288|NCT03673111|527314874|FG001|Overall Study|Protocol Violation|0|||
146218289|NCT03673111|527314875|FG002|Overall Study|Protocol Violation|0|||
146218290|NCT03673111|527314876|FG003|Overall Study|Protocol Violation|0|||
146218291|NCT03673111|527314877|FG004|Overall Study|Protocol Violation|0|||
146218292|NCT03673111|527314878|FG005|Overall Study|Protocol Violation|0|||
146218293|NCT03673111|527314879|FG006|Overall Study|Protocol Violation|0|||
146218294|NCT03673111|527314880|FG007|Overall Study|Protocol Violation|0|||
146218295|NCT03673111|527314881|FG008|Overall Study|Protocol Violation|0|||
146218296|NCT03673111|527314882|FG009|Overall Study|Protocol Violation|0|||
146218297|NCT03673111|527314883|FG010|Overall Study|Protocol Violation|1|||
146218298|NCT03673111|527314884|FG011|Overall Study|Protocol Violation|0|||
146287891|NCT04745026|527569350|FG000|Overall Study|Physician Decision|1|||
146287892|NCT04745026|527569351|FG001|Overall Study|Physician Decision|0|||
146218299|NCT03673111|527314885|FG012|Overall Study|Protocol Violation|0|||
146218300|NCT03673111|527314886|FG013|Overall Study|Protocol Violation|0|||
146218301|NCT03673111|527314873|FG000|Overall Study|Adverse Event|1|||
146218302|NCT03673111|527314874|FG001|Overall Study|Adverse Event|0|||
146218303|NCT03673111|527314875|FG002|Overall Study|Adverse Event|0|||
146218304|NCT03673111|527314876|FG003|Overall Study|Adverse Event|0|||
146218305|NCT03673111|527314877|FG004|Overall Study|Adverse Event|0|||
146218306|NCT03673111|527314878|FG005|Overall Study|Adverse Event|0|||
146218307|NCT03673111|527314879|FG006|Overall Study|Adverse Event|0|||
146218308|NCT03673111|527314880|FG007|Overall Study|Adverse Event|0|||
146218309|NCT03673111|527314881|FG008|Overall Study|Adverse Event|0|||
146218310|NCT03673111|527314882|FG009|Overall Study|Adverse Event|0|||
146218311|NCT03673111|527314883|FG010|Overall Study|Adverse Event|0|||
146218312|NCT03673111|527314884|FG011|Overall Study|Adverse Event|0|||
146218313|NCT03673111|527314885|FG012|Overall Study|Adverse Event|0|||
146218314|NCT03673111|527314886|FG013|Overall Study|Adverse Event|0|||
146218315|NCT03792555|527314887|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
146218316|NCT03792555|527314888|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
146218317|NCT03792555|527314889|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
146218318|NCT03792555|527314887|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
146218319|NCT03792555|527314888|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
146218320|NCT03792555|527314889|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
146218321|NCT03792555|527314887|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
146218322|NCT03792555|527314888|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
146218323|NCT03792555|527314889|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
146218324|NCT04485039|527314893|FG000|TPOXX Only|Adverse Event|2|||
146218325|NCT04485039|527314893|FG000|TPOXX Only|Physician Decision|1|||
146218326|NCT04485039|527314893|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
146218327|NCT04485039|527314893|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
146218328|NCT00378105|527314895|FG000|Overall Study|Adverse Event|3|||
146218329|NCT00378105|527314896|FG001|Overall Study|Adverse Event|1|||
146218330|NCT00378105|527314895|FG000|Overall Study|Withdrawal by Subject|3|||
146218331|NCT00378105|527314896|FG001|Overall Study|Withdrawal by Subject|3|||
146218332|NCT00378105|527314895|FG000|Overall Study|Death|1|||
146218333|NCT00378105|527314896|FG001|Overall Study|Death|0|||
146218334|NCT00378105|527314895|FG000|Overall Study|Going to transplant|7|||
146218335|NCT00378105|527314896|FG001|Overall Study|Going to transplant|8|||
146218336|NCT00378105|527314895|FG000|Overall Study|Progressive disease|3|||
146218337|NCT00378105|527314896|FG001|Overall Study|Progressive disease|3|||
146218338|NCT00378105|527314895|FG000|Overall Study|remain on study|3|||
146218339|NCT00378105|527314896|FG001|Overall Study|remain on study|11|||
146218340|NCT00378105|527314895|FG000|Overall Study|Physician Decision|0|||
146218341|NCT00378105|527314896|FG001|Overall Study|Physician Decision|2|||
146218342|NCT00378105|527314895|FG000|Overall Study|Going non-protocol therapy|0|||
146218343|NCT00378105|527314896|FG001|Overall Study|Going non-protocol therapy|1|||
146218344|NCT00378105|527314895|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
146218345|NCT00378105|527314896|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
146218346|NCT02120456|527314897|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218347|NCT02120456|527314898|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218348|NCT02120456|527314899|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146287893|NCT04745026|527569350|FG000|Overall Study|Adverse Event|2|||
146287894|NCT04745026|527569351|FG001|Overall Study|Adverse Event|2|||
146287895|NCT04745026|527569350|FG000|Overall Study|Protocol Violation|1|||
146287896|NCT04745026|527569351|FG001|Overall Study|Protocol Violation|3|||
146287897|NCT04745026|527569350|FG000|Overall Study|Lost to Follow-up|4|||
146287898|NCT04745026|527569351|FG001|Overall Study|Lost to Follow-up|3|||
146287899|NCT04745026|527569350|FG000|Overall Study|Withdrawal by Subject|5|||
146287900|NCT04745026|527569351|FG001|Overall Study|Withdrawal by Subject|5|||
146287901|NCT05478499|527569352|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
146287902|NCT05478499|527569353|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
145881884|NCT02387762|526072729|FG000|Overall Study|Withdrawal by Subject|1|||
145881885|NCT02387762|526072730|FG001|Overall Study|Withdrawal by Subject|0|||
145881886|NCT00593827|526072731|FG000|Overall Study|On Active Treatment/Pending|0|||
145881887|NCT00593827|526072732|FG001|Overall Study|On Active Treatment/Pending|2|||
145881888|NCT01160640|526072733|FG000|Overall Study|Physician Decision|3|||
145881889|NCT01160640|526072734|FG001|Overall Study|Physician Decision|3|||
145881890|NCT01160640|526072733|FG000|Overall Study|Incarceration|1|||
145881891|NCT01160640|526072734|FG001|Overall Study|Incarceration|0|||
145881892|NCT01160640|526072733|FG000|Overall Study|Withdrawal by Subject|0|||
145881893|NCT01160640|526072734|FG001|Overall Study|Withdrawal by Subject|3|||
145881894|NCT02169336|526072735|FG000|Overall Study|Lack of Efficacy|1|||
145881895|NCT02169336|526072736|FG001|Overall Study|Lack of Efficacy|1|||
145881896|NCT02169336|526072737|FG002|Overall Study|Lack of Efficacy|0|||
145881897|NCT02169336|526072735|FG000|Overall Study|Adverse Event|2|||
145881898|NCT02169336|526072736|FG001|Overall Study|Adverse Event|3|||
145881899|NCT02169336|526072737|FG002|Overall Study|Adverse Event|1|||
145881900|NCT02169336|526072735|FG000|Overall Study|Withdrawal by Subject|1|||
145881901|NCT02169336|526072736|FG001|Overall Study|Withdrawal by Subject|0|||
145881902|NCT02169336|526072737|FG002|Overall Study|Withdrawal by Subject|0|||
145881903|NCT02169336|526072735|FG000|Overall Study|Physician Decision|0|||
145881904|NCT02169336|526072736|FG001|Overall Study|Physician Decision|0|||
145881905|NCT02169336|526072737|FG002|Overall Study|Physician Decision|1|||
145881906|NCT02169336|526072735|FG000|Overall Study|Subject declined to continue dosing|0|||
145881907|NCT02169336|526072736|FG001|Overall Study|Subject declined to continue dosing|0|||
145881908|NCT02169336|526072737|FG002|Overall Study|Subject declined to continue dosing|1|||
145881909|NCT01598896|526072740|FG000|Overall Study|Withdrawal by Subject|0|||
145881910|NCT01598896|526072741|FG001|Overall Study|Withdrawal by Subject|1|||
145881911|NCT01598896|526072740|FG000|Overall Study|Lack of Efficacy|0|||
145881912|NCT01598896|526072741|FG001|Overall Study|Lack of Efficacy|1|||
146287903|NCT05478499|527569352|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
145881913|NCT03370510|526072743|FG000|Overall Study|COVID-19|2|||
145881914|NCT03370510|526072744|FG001|Overall Study|COVID-19|0|||
146287904|NCT05478499|527569353|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
146218349|NCT02120456|527314900|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218350|NCT02120456|527314901|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218351|NCT02120456|527314902|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218352|NCT02120456|527314903|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
146218353|NCT02120456|527314904|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218354|NCT02120456|527314905|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
146218355|NCT02120456|527314897|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218356|NCT02120456|527314898|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218357|NCT02120456|527314899|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218358|NCT02120456|527314900|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218359|NCT02120456|527314901|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218360|NCT02120456|527314902|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218361|NCT02120456|527314903|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
146218362|NCT02120456|527314904|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218363|NCT02120456|527314905|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
146218364|NCT02120456|527314897|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218365|NCT02120456|527314898|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218366|NCT02120456|527314899|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218367|NCT02120456|527314900|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218368|NCT02120456|527314901|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218369|NCT02120456|527314902|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218370|NCT02120456|527314903|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218371|NCT02120456|527314904|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
146218372|NCT02120456|527314905|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
146218373|NCT05192200|527314906|FG000|Treatment Period|Other|1|||
146218374|NCT05192200|527314906|FG000|Treatment Period|Lack of Efficacy|1|||
146218375|NCT05192200|527314906|FG000|Treatment Period|Withdrawal by Subject|1|||
146218376|NCT05192200|527314906|FG000|Follow-up|Withdrawal by Subject|1|||
146218377|NCT04492007|527314907|FG000|Overall Study|Lost to Follow-up|1|||
146218378|NCT04492007|527314908|FG001|Overall Study|Lost to Follow-up|1|||
146218379|NCT04492007|527314909|FG002|Overall Study|Lost to Follow-up|2|||
146218380|NCT04492007|527314910|FG003|Overall Study|Lost to Follow-up|2|||
146287905|NCT05478499|527569352|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
145960767|NCT02058589|526367704|FG000|Overall Study|Withdrawal by Subject|0|||
145960768|NCT02058589|526367705|FG001|Overall Study|Withdrawal by Subject|1|||
145960769|NCT02346877|526367706|FG000|Overall Study|Adverse Event|1|||
146218381|NCT04492007|527314907|FG000|Overall Study|Protocol Violation|1|||
146218382|NCT04492007|527314908|FG001|Overall Study|Protocol Violation|1|||
146287906|NCT05478499|527569353|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
145960770|NCT02346877|526367707|FG001|Overall Study|Adverse Event|0|||
146218383|NCT04492007|527314909|FG002|Overall Study|Protocol Violation|1|||
146218384|NCT04492007|527314910|FG003|Overall Study|Protocol Violation|1|||
146218385|NCT04492007|527314907|FG000|Overall Study|Withdrawal by Subject|0|||
146218386|NCT04492007|527314908|FG001|Overall Study|Withdrawal by Subject|0|||
146218387|NCT04492007|527314909|FG002|Overall Study|Withdrawal by Subject|1|||
146218388|NCT04492007|527314910|FG003|Overall Study|Withdrawal by Subject|1|||
146218389|NCT04177823|527314913|FG000|Overall Study|Physician Decision|1|||
146218390|NCT04177823|527314913|FG000|Overall Study|Withdrawal by Subject|1|||
146218391|NCT04229992|527314914|FG000|Overall Study|Withdrawal by Subject|0|||
146218392|NCT04229992|527314915|FG001|Overall Study|Withdrawal by Subject|2|||
146218393|NCT04229992|527314916|FG002|Overall Study|Withdrawal by Subject|1|||
146218394|NCT04229992|527314917|FG003|Overall Study|Withdrawal by Subject|1|||
146218395|NCT04229992|527314914|FG000|Overall Study|Adverse Event|1|||
146218396|NCT04229992|527314915|FG001|Overall Study|Adverse Event|1|||
146218397|NCT04229992|527314916|FG002|Overall Study|Adverse Event|3|||
146218398|NCT04229992|527314917|FG003|Overall Study|Adverse Event|1|||
146218399|NCT04229992|527314914|FG000|Overall Study|Lost to Follow-up|0|||
146218400|NCT04229992|527314915|FG001|Overall Study|Lost to Follow-up|0|||
146218401|NCT04229992|527314916|FG002|Overall Study|Lost to Follow-up|0|||
146218402|NCT04229992|527314917|FG003|Overall Study|Lost to Follow-up|1|||
146218403|NCT03770273|527314918|FG000|Overall Study|Adverse Event|2|||
146218404|NCT03770273|527314919|FG001|Overall Study|Adverse Event|0|||
146218405|NCT03770273|527314918|FG000|Overall Study|Lost to Follow-up|1|||
146218406|NCT03770273|527314919|FG001|Overall Study|Lost to Follow-up|1|||
146218407|NCT03707951|527314920|FG000|Overall Study|Lost to Follow-up|8|||
146218408|NCT03707951|527314921|FG001|Overall Study|Lost to Follow-up|17|||
146218409|NCT03707951|527314920|FG000|Overall Study|Withdrawal by Subject|6|||
146218410|NCT03707951|527314921|FG001|Overall Study|Withdrawal by Subject|6|||
146218411|NCT01999075|527314922|FG000|Overall Study|Lost to Follow-up|0|||
146218412|NCT01999075|527314923|FG001|Overall Study|Lost to Follow-up|2|||
146218413|NCT01999075|527314922|FG000|Overall Study|Withdrawal by Subject|2|||
146218414|NCT01999075|527314923|FG001|Overall Study|Withdrawal by Subject|7|||
146218415|NCT01999075|527314922|FG000|Overall Study|Enrolled in drug trial|3|||
146218416|NCT01999075|527314923|FG001|Overall Study|Enrolled in drug trial|1|||
146218417|NCT01999075|527314922|FG000|Overall Study|Became ineligible|0|||
146218418|NCT01999075|527314923|FG001|Overall Study|Became ineligible|2|||
146218419|NCT03792256|527314925|FG000|Overall Study|Death|0|||
146218420|NCT03792256|527314926|FG001|Overall Study|Death|1|||
146218421|NCT03792256|527314925|FG000|Overall Study|Lack of Efficacy|0|||
146218422|NCT03792256|527314926|FG001|Overall Study|Lack of Efficacy|1|||
146218423|NCT03792256|527314925|FG000|Overall Study|Withdrawal by Subject|0|||
146218424|NCT03792256|527314926|FG001|Overall Study|Withdrawal by Subject|1|||
146218425|NCT04760678|527314927|FG000|Overall Study|Death|13|||
146218426|NCT04760678|527314927|FG000|Overall Study|Lost to Follow-up|48|||
146218427|NCT04760678|527314927|FG000|Overall Study|Withdrawal by Subject|1|||
146218428|NCT04562649|527314928|FG000|Overall Study|Withdrawal by Subject|11|||
146218429|NCT04562649|527314929|FG001|Overall Study|Withdrawal by Subject|8|||
146218430|NCT04562649|527314928|FG000|Overall Study|Lost to Follow-up|26|||
146218431|NCT04562649|527314929|FG001|Overall Study|Lost to Follow-up|20|||
146218432|NCT05368103|527314930|FG000|Overall Study|Withdrawal by Subject|4|||
146218433|NCT05368103|527314930|FG000|Overall Study|Lost to Follow-up|1|||
146218434|NCT05368103|527314930|FG000|Overall Study|Lack of Efficacy|3|||
146218435|NCT03675282|527314933|FG000|Overall Study|Lost to Follow-up|4|||
146218436|NCT03675282|527314934|FG001|Overall Study|Lost to Follow-up|8|||
146218437|NCT03675282|527314935|FG002|Overall Study|Lost to Follow-up|1|||
146218438|NCT03675282|527314936|FG003|Overall Study|Lost to Follow-up|0|||
146218439|NCT03675282|527314937|FG004|Overall Study|Lost to Follow-up|2|||
146218440|NCT03675282|527314938|FG005|Overall Study|Lost to Follow-up|7|||
145960771|NCT02346877|526367706|FG000|Overall Study|Administrative Decision|1|||
145960772|NCT02346877|526367707|FG001|Overall Study|Administrative Decision|0|||
145960773|NCT02346877|526367706|FG000|Overall Study|Sponsor Decision|12|||
146218441|NCT03675282|527314933|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
146218442|NCT03675282|527314934|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
146218443|NCT03675282|527314935|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
146218444|NCT03675282|527314936|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
146218445|NCT03675282|527314937|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
145960774|NCT02346877|526367707|FG001|Overall Study|Sponsor Decision|0|||
146218446|NCT03675282|527314938|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
146218447|NCT03675282|527314933|FG000|Overall Study|Physician Decision|1|||
146218448|NCT03675282|527314934|FG001|Overall Study|Physician Decision|0|||
146218449|NCT03675282|527314935|FG002|Overall Study|Physician Decision|0|||
146218450|NCT03675282|527314936|FG003|Overall Study|Physician Decision|0|||
146218451|NCT03675282|527314937|FG004|Overall Study|Physician Decision|0|||
146218452|NCT03675282|527314938|FG005|Overall Study|Physician Decision|0|||
146084535|NCT02478398|526830204|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146084536|NCT02478398|526830203|FG000|Overall Study|Protocol Violation|3|||
146084537|NCT02478398|526830204|FG001|Overall Study|Protocol Violation|1|||
146084538|NCT02478398|526830203|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
146084539|NCT02478398|526830204|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146084540|NCT02478398|526830203|FG000|Overall Study|Withdrawal By Participant|10|||
146084541|NCT02478398|526830204|FG001|Overall Study|Withdrawal By Participant|4|||
146084542|NCT00635024|526830205|FG000|Overall Study|Adverse Event|1|||
146084543|NCT02142387|526830206|FG000|Overall Study|<19 years old|49|||
146084544|NCT02142387|526830207|FG001|Overall Study|<19 years old|326|||
146084545|NCT02142387|526830206|FG000|Overall Study|non-cardiac etiology|504|||
145881915|NCT02614898|526072745|FG000|Overall Study|Participated until study termination|10|||
146084546|NCT02142387|526830207|FG001|Overall Study|non-cardiac etiology|3431|||
146084547|NCT02142387|526830206|FG000|Overall Study|CPR not performed|74|||
146084548|NCT02142387|526830207|FG001|Overall Study|CPR not performed|473|||
145881916|NCT02614898|526072746|FG001|Overall Study|Participated until study termination|26|||
145881917|NCT02614898|526072745|FG000|Overall Study|Lost to Follow-up|0|||
145881918|NCT02614898|526072746|FG001|Overall Study|Lost to Follow-up|2|||
146084549|NCT02142387|526830206|FG000|Overall Study|witnessed by paramedic|139|||
146084550|NCT02142387|526830207|FG001|Overall Study|witnessed by paramedic|917|||
146084551|NCT02142387|526830206|FG000|Overall Study|incomplete data|1|||
146084552|NCT02142387|526830207|FG001|Overall Study|incomplete data|9|||
146084553|NCT02142387|526830206|FG000|Overall Study|occurred not at home|298|||
146218453|NCT05177848|527314942|FG000|Overall Study|Lost to Follow-up|1|||
146218454|NCT05177848|527314943|FG001|Overall Study|Lost to Follow-up|4|||
146218455|NCT05177848|527314942|FG000|Overall Study|Discontinued|2|||
146218456|NCT05177848|527314943|FG001|Overall Study|Discontinued|1|||
146218457|NCT05486078|527314953|FG000|Overall Study|4 drop out and one withdrawn|5|||
146218458|NCT05076708|527314954|FG000|Overall Study|Withdrawal by Subject|4|||
146218459|NCT05076708|527314954|FG000|Overall Study|Lost to study during switch phase|8|||
146218460|NCT02908477|527314955|FG000|Overall Study|Withdrawal by Subject|8|||
146218461|NCT02908477|527314956|FG001|Overall Study|Withdrawal by Subject|28|||
146218462|NCT02924272|527314960|FG000|Overall Study|Site Terminated by Sponsor|4|||
146218463|NCT02924272|527314961|FG001|Overall Study|Site Terminated by Sponsor|1|||
146218464|NCT02924272|527314960|FG000|Overall Study|Withdrawal by Subject|2|||
146218465|NCT02924272|527314961|FG001|Overall Study|Withdrawal by Subject|0|||
146218466|NCT02924272|527314960|FG000|Overall Study|Adverse Event|3|||
146218467|NCT02924272|527314961|FG001|Overall Study|Adverse Event|0|||
146218468|NCT02924272|527314960|FG000|Overall Study|Progressive Disease|11|||
146218469|NCT02924272|527314961|FG001|Overall Study|Progressive Disease|8|||
146218470|NCT02924272|527314960|FG000|Overall Study|Clinical Deterioration|1|||
146218471|NCT02924272|527314961|FG001|Overall Study|Clinical Deterioration|0|||
146218472|NCT02924272|527314960|FG000|Overall Study|Death|1|||
146218473|NCT02924272|527314961|FG001|Overall Study|Death|0|||
146218474|NCT02924272|527314960|FG000|Overall Study|Reason Not Specified|1|||
146218475|NCT02924272|527314961|FG001|Overall Study|Reason Not Specified|0|||
146218476|NCT03150810|527314964|FG000|Overall Study|Death|4|||
145881919|NCT02614898|526072745|FG000|Overall Study|Physician Decision|1|||
145881920|NCT02614898|526072746|FG001|Overall Study|Physician Decision|8|||
145881921|NCT02614898|526072745|FG000|Overall Study|Study Terminated by Sponsor|3|||
146084554|NCT02142387|526830207|FG001|Overall Study|occurred not at home|2474|||
146084555|NCT00420641|526830210|FG000|Overall Study|Adverse Event|3|||
146084556|NCT00420641|526830211|FG001|Overall Study|Adverse Event|25|||
146218477|NCT03150810|527314965|FG001|Overall Study|Death|8|||
146084557|NCT00420641|526830212|FG002|Overall Study|Adverse Event|10|||
146084558|NCT00420641|526830210|FG000|Overall Study|Lost to Follow-up|2|||
146218478|NCT03150810|527314966|FG002|Overall Study|Death|7|||
146218479|NCT03150810|527314967|FG003|Overall Study|Death|2|||
146218480|NCT03150810|527314968|FG004|Overall Study|Death|2|||
146218481|NCT03150810|527314969|FG005|Overall Study|Death|10|||
146218482|NCT03150810|527314970|FG006|Overall Study|Death|8|||
146084559|NCT00420641|526830211|FG001|Overall Study|Lost to Follow-up|4|||
146218483|NCT03150810|527314971|FG007|Overall Study|Death|6|||
145960775|NCT02346877|526367706|FG000|Overall Study|Missing|5|||
145960776|NCT02346877|526367707|FG001|Overall Study|Missing|0|||
145960777|NCT00490971|526367709|FG000|Acute/Continuation|Adverse Event|62|||
145960778|NCT00490971|526367710|FG001|Acute/Continuation|Adverse Event|13|||
145960779|NCT00490971|526367711|FG002|Acute/Continuation|Adverse Event|0|||
145960780|NCT00490971|526367712|FG003|Acute/Continuation|Adverse Event|0|||
145960781|NCT00490971|526367713|FG004|Acute/Continuation|Adverse Event|0|||
146218484|NCT03150810|527314972|FG008|Overall Study|Death|18|||
146218485|NCT03150810|527314973|FG009|Overall Study|Death|3|||
146218486|NCT03150810|527314974|FG010|Overall Study|Death|19|||
146218487|NCT03150810|527314975|FG011|Overall Study|Death|1|||
146218488|NCT03150810|527314976|FG012|Overall Study|Death|19|||
146218489|NCT03150810|527314964|FG000|Overall Study|Withdrawal by Subject|0|||
146218490|NCT03150810|527314965|FG001|Overall Study|Withdrawal by Subject|1|||
146218491|NCT03150810|527314966|FG002|Overall Study|Withdrawal by Subject|1|||
146218492|NCT03150810|527314967|FG003|Overall Study|Withdrawal by Subject|1|||
146218493|NCT03150810|527314968|FG004|Overall Study|Withdrawal by Subject|0|||
146218494|NCT03150810|527314969|FG005|Overall Study|Withdrawal by Subject|0|||
146218495|NCT03150810|527314970|FG006|Overall Study|Withdrawal by Subject|2|||
146218496|NCT03150810|527314971|FG007|Overall Study|Withdrawal by Subject|0|||
146218497|NCT03150810|527314972|FG008|Overall Study|Withdrawal by Subject|2|||
146218498|NCT03150810|527314973|FG009|Overall Study|Withdrawal by Subject|0|||
146218499|NCT03150810|527314974|FG010|Overall Study|Withdrawal by Subject|1|||
146218500|NCT03150810|527314975|FG011|Overall Study|Withdrawal by Subject|0|||
145960782|NCT00490971|526367709|FG000|Acute/Continuation|Death|2|||
146218501|NCT03150810|527314976|FG012|Overall Study|Withdrawal by Subject|1|||
146218502|NCT03150810|527314964|FG000|Overall Study|Sponsor Decision|0|||
146218503|NCT03150810|527314965|FG001|Overall Study|Sponsor Decision|2|||
146218504|NCT03150810|527314966|FG002|Overall Study|Sponsor Decision|0|||
146218505|NCT03150810|527314967|FG003|Overall Study|Sponsor Decision|0|||
145881922|NCT02614898|526072746|FG001|Overall Study|Study Terminated by Sponsor|0|||
145881923|NCT02614898|526072745|FG000|Overall Study|Withdrawal by Subject|0|||
145881924|NCT02614898|526072746|FG001|Overall Study|Withdrawal by Subject|2|||
145881925|NCT02614898|526072745|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145881926|NCT02614898|526072746|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145881927|NCT02614898|526072745|FG000|Overall Study|Other-Additional Information Unavailable|0|||
145881928|NCT02614898|526072746|FG001|Overall Study|Other-Additional Information Unavailable|11|||
145881929|NCT02614898|526072745|FG000|Overall Study|Missing|0|||
145881930|NCT02614898|526072746|FG001|Overall Study|Missing|1|||
145960783|NCT00490971|526367710|FG001|Acute/Continuation|Death|0|||
145960784|NCT00490971|526367711|FG002|Acute/Continuation|Death|0|||
145960785|NCT00490971|526367712|FG003|Acute/Continuation|Death|0|||
146287907|NCT05478499|527569352|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
146287908|NCT05478499|527569353|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
146287909|NCT05478499|527569352|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
146287910|NCT05478499|527569353|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
146287911|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
146287912|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
146287913|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
146287914|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
146287915|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
146287916|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
146287917|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
146287918|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
146287919|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
146287920|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
146287921|NCT05478499|527569352|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
146287922|NCT05478499|527569353|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
146287923|NCT04426851|527569354|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
146287924|NCT04426851|527569355|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
146287925|NCT04426851|527569354|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
146287926|NCT04426851|527569355|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
146287927|NCT03256851|527569359|FG000|Overall Study|Withdrawal by Subject|1|||
146287928|NCT03256851|527569360|FG001|Overall Study|Withdrawal by Subject|0|||
146287929|NCT00903630|527569364|FG000|Phase 2|Adverse Event|0|||
146287930|NCT00903630|527569365|FG001|Phase 2|Adverse Event|0|||
146287931|NCT00903630|527569366|FG002|Phase 2|Adverse Event|1|||
146287932|NCT01831856|527569369|FG000|Overall Study|Adverse Event|5|||
146287933|NCT01831856|527569370|FG001|Overall Study|Adverse Event|8|||
146287934|NCT01831856|527569369|FG000|Overall Study|Lack of Efficacy|13|||
146287935|NCT01831856|527569370|FG001|Overall Study|Lack of Efficacy|11|||
146287936|NCT01831856|527569369|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
146287937|NCT01831856|527569370|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
146287938|NCT05208866|527569371|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
146287939|NCT02581631|527569383|FG000|Overall Study|Disease progression|29|||
146287940|NCT02581631|527569384|FG001|Overall Study|Disease progression|19|||
146287941|NCT02581631|527569385|FG002|Overall Study|Disease progression|13|||
146287942|NCT02581631|527569386|FG003|Overall Study|Disease progression|5|||
146287943|NCT02581631|527569387|FG004|Overall Study|Disease progression|8|||
146287944|NCT02581631|527569383|FG000|Overall Study|Study drug toxicity|4|||
146287945|NCT02581631|527569384|FG001|Overall Study|Study drug toxicity|6|||
146287946|NCT02581631|527569385|FG002|Overall Study|Study drug toxicity|7|||
146287947|NCT02581631|527569386|FG003|Overall Study|Study drug toxicity|0|||
146287948|NCT02581631|527569387|FG004|Overall Study|Study drug toxicity|3|||
146287949|NCT02581631|527569383|FG000|Overall Study|AE unrelated to study drug|3|||
145960786|NCT00490971|526367713|FG004|Acute/Continuation|Death|0|||
145960787|NCT00490971|526367709|FG000|Acute/Continuation|Lack of Efficacy|106|||
145960788|NCT00490971|526367710|FG001|Acute/Continuation|Lack of Efficacy|12|||
145960789|NCT00490971|526367711|FG002|Acute/Continuation|Lack of Efficacy|0|||
146287950|NCT02581631|527569384|FG001|Overall Study|AE unrelated to study drug|1|||
145881931|NCT00239005|526072747|FG000|Overall Study|Adverse Event|6|||
145960790|NCT00490971|526367712|FG003|Acute/Continuation|Lack of Efficacy|0|||
145960791|NCT00490971|526367713|FG004|Acute/Continuation|Lack of Efficacy|0|||
145960792|NCT00490971|526367709|FG000|Acute/Continuation|Lost to Follow-up|23|||
145960793|NCT00490971|526367710|FG001|Acute/Continuation|Lost to Follow-up|7|||
145960794|NCT00490971|526367711|FG002|Acute/Continuation|Lost to Follow-up|0|||
146287951|NCT02581631|527569385|FG002|Overall Study|AE unrelated to study drug|1|||
146287952|NCT02581631|527569386|FG003|Overall Study|AE unrelated to study drug|0|||
146287953|NCT02581631|527569387|FG004|Overall Study|AE unrelated to study drug|2|||
146287954|NCT02581631|527569383|FG000|Overall Study|Request to discontinue|1|||
146287955|NCT02581631|527569384|FG001|Overall Study|Request to discontinue|0|||
146287956|NCT02581631|527569385|FG002|Overall Study|Request to discontinue|3|||
145881932|NCT00239005|526072748|FG001|Overall Study|Adverse Event|6|||
145960795|NCT00490971|526367712|FG003|Acute/Continuation|Lost to Follow-up|0|||
146287957|NCT02581631|527569386|FG003|Overall Study|Request to discontinue|0|||
145881933|NCT00239005|526072747|FG000|Overall Study|Withdrawal by Subject|3|||
145881934|NCT00239005|526072748|FG001|Overall Study|Withdrawal by Subject|4|||
145881935|NCT00239005|526072747|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
145881936|NCT00239005|526072748|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
145881937|NCT00239005|526072747|FG000|Overall Study|Protocol Violation|1|||
145881938|NCT00239005|526072748|FG001|Overall Study|Protocol Violation|0|||
145881939|NCT00239005|526072747|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
145881940|NCT00239005|526072748|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
145881941|NCT00239005|526072747|FG000|Overall Study|Lost to Follow-up|0|||
145881942|NCT00239005|526072748|FG001|Overall Study|Lost to Follow-up|1|||
145881943|NCT03382041|526072749|FG000|Overall Study|Consent Form Lost|2|||
145881944|NCT03382041|526072750|FG001|Overall Study|Consent Form Lost|1|||
145881945|NCT03382041|526072749|FG000|Overall Study|Withdrawal by Subject|1|||
145881946|NCT03382041|526072750|FG001|Overall Study|Withdrawal by Subject|4|||
145881947|NCT03382041|526072749|FG000|Overall Study|Lost to Follow-up|1|||
145881948|NCT03382041|526072750|FG001|Overall Study|Lost to Follow-up|4|||
145881949|NCT00688844|526072751|FG000|Overall Study|Lost to Follow-up|10|||
145881950|NCT01374451|526072752|FG000|Overall Study|Administrative problems|1|||
145881951|NCT01374451|526072753|FG001|Overall Study|Administrative problems|0|||
145881952|NCT03493919|526072754|FG000|Overall Study|Other|2|||
145881953|NCT03493919|526072755|FG001|Overall Study|Other|0|||
145881954|NCT03493919|526072756|FG002|Overall Study|Other|1|||
145881955|NCT03493919|526072757|FG003|Overall Study|Other|0|||
145881956|NCT03493919|526072754|FG000|Overall Study|Withdrawal by Subject|9|||
145881957|NCT03493919|526072755|FG001|Overall Study|Withdrawal by Subject|3|||
145881958|NCT03493919|526072756|FG002|Overall Study|Withdrawal by Subject|1|||
145881959|NCT03493919|526072757|FG003|Overall Study|Withdrawal by Subject|1|||
145960796|NCT00490971|526367713|FG004|Acute/Continuation|Lost to Follow-up|0|||
145960797|NCT00490971|526367709|FG000|Acute/Continuation|Protocol Violation|10|||
145960798|NCT00490971|526367710|FG001|Acute/Continuation|Protocol Violation|2|||
145960799|NCT00490971|526367711|FG002|Acute/Continuation|Protocol Violation|0|||
146218506|NCT03150810|527314968|FG004|Overall Study|Sponsor Decision|1|||
146218507|NCT03150810|527314969|FG005|Overall Study|Sponsor Decision|1|||
146218508|NCT03150810|527314970|FG006|Overall Study|Sponsor Decision|0|||
146218509|NCT03150810|527314971|FG007|Overall Study|Sponsor Decision|0|||
146218510|NCT03150810|527314972|FG008|Overall Study|Sponsor Decision|1|||
146218511|NCT03150810|527314973|FG009|Overall Study|Sponsor Decision|0|||
146218512|NCT03150810|527314974|FG010|Overall Study|Sponsor Decision|0|||
146218513|NCT03150810|527314975|FG011|Overall Study|Sponsor Decision|0|||
146218514|NCT03150810|527314976|FG012|Overall Study|Sponsor Decision|5|||
146218515|NCT03150810|527314964|FG000|Overall Study|Lost to Follow-up|0|||
146218516|NCT03150810|527314965|FG001|Overall Study|Lost to Follow-up|1|||
146218517|NCT03150810|527314966|FG002|Overall Study|Lost to Follow-up|1|||
146218518|NCT03150810|527314967|FG003|Overall Study|Lost to Follow-up|0|||
146218519|NCT03150810|527314968|FG004|Overall Study|Lost to Follow-up|0|||
146218520|NCT03150810|527314969|FG005|Overall Study|Lost to Follow-up|0|||
146218521|NCT03150810|527314970|FG006|Overall Study|Lost to Follow-up|1|||
146218522|NCT03150810|527314971|FG007|Overall Study|Lost to Follow-up|0|||
146218523|NCT03150810|527314972|FG008|Overall Study|Lost to Follow-up|0|||
146218524|NCT03150810|527314973|FG009|Overall Study|Lost to Follow-up|0|||
146218525|NCT03150810|527314974|FG010|Overall Study|Lost to Follow-up|1|||
146218526|NCT03150810|527314975|FG011|Overall Study|Lost to Follow-up|0|||
146218527|NCT03150810|527314976|FG012|Overall Study|Lost to Follow-up|0|||
146218528|NCT03150810|527314964|FG000|Overall Study|Physician Decision|0|||
146218529|NCT03150810|527314965|FG001|Overall Study|Physician Decision|0|||
146218530|NCT03150810|527314966|FG002|Overall Study|Physician Decision|0|||
146218531|NCT03150810|527314967|FG003|Overall Study|Physician Decision|0|||
146218532|NCT03150810|527314968|FG004|Overall Study|Physician Decision|0|||
146218533|NCT03150810|527314969|FG005|Overall Study|Physician Decision|1|||
146218534|NCT03150810|527314970|FG006|Overall Study|Physician Decision|1|||
146218535|NCT03150810|527314971|FG007|Overall Study|Physician Decision|0|||
146218536|NCT03150810|527314972|FG008|Overall Study|Physician Decision|0|||
146218537|NCT03150810|527314973|FG009|Overall Study|Physician Decision|0|||
146218538|NCT03150810|527314974|FG010|Overall Study|Physician Decision|0|||
146218539|NCT03150810|527314975|FG011|Overall Study|Physician Decision|0|||
146218540|NCT03150810|527314976|FG012|Overall Study|Physician Decision|0|||
146218541|NCT03150810|527314964|FG000|Overall Study|Site withdrawal from study|0|||
146218542|NCT03150810|527314965|FG001|Overall Study|Site withdrawal from study|1|||
146218543|NCT03150810|527314966|FG002|Overall Study|Site withdrawal from study|0|||
146218544|NCT03150810|527314967|FG003|Overall Study|Site withdrawal from study|0|||
146218545|NCT03150810|527314968|FG004|Overall Study|Site withdrawal from study|0|||
146218546|NCT03150810|527314969|FG005|Overall Study|Site withdrawal from study|0|||
146218547|NCT03150810|527314970|FG006|Overall Study|Site withdrawal from study|0|||
146218548|NCT03150810|527314971|FG007|Overall Study|Site withdrawal from study|0|||
146218549|NCT03150810|527314972|FG008|Overall Study|Site withdrawal from study|0|||
146218550|NCT03150810|527314973|FG009|Overall Study|Site withdrawal from study|1|||
146218551|NCT03150810|527314974|FG010|Overall Study|Site withdrawal from study|1|||
146218552|NCT03150810|527314975|FG011|Overall Study|Site withdrawal from study|0|||
146218553|NCT03150810|527314976|FG012|Overall Study|Site withdrawal from study|0|||
146218554|NCT03150810|527314964|FG000|Overall Study|Hospice|0|||
146218555|NCT03150810|527314965|FG001|Overall Study|Hospice|0|||
146218556|NCT03150810|527314966|FG002|Overall Study|Hospice|0|||
146218557|NCT03150810|527314967|FG003|Overall Study|Hospice|0|||
146218558|NCT03150810|527314968|FG004|Overall Study|Hospice|0|||
146218559|NCT03150810|527314969|FG005|Overall Study|Hospice|1|||
146218560|NCT03150810|527314970|FG006|Overall Study|Hospice|0|||
146218561|NCT03150810|527314971|FG007|Overall Study|Hospice|0|||
146218562|NCT03150810|527314972|FG008|Overall Study|Hospice|0|||
146218563|NCT03150810|527314973|FG009|Overall Study|Hospice|0|||
146218564|NCT03150810|527314974|FG010|Overall Study|Hospice|0|||
146218565|NCT03150810|527314975|FG011|Overall Study|Hospice|0|||
146218566|NCT03150810|527314976|FG012|Overall Study|Hospice|0|||
146218567|NCT03150810|527314964|FG000|Overall Study|Participant relocated abroad.|0|||
146218568|NCT03150810|527314965|FG001|Overall Study|Participant relocated abroad.|0|||
146218569|NCT03150810|527314966|FG002|Overall Study|Participant relocated abroad.|0|||
146218570|NCT03150810|527314967|FG003|Overall Study|Participant relocated abroad.|0|||
146218571|NCT03150810|527314968|FG004|Overall Study|Participant relocated abroad.|0|||
146218572|NCT03150810|527314969|FG005|Overall Study|Participant relocated abroad.|1|||
146218573|NCT03150810|527314970|FG006|Overall Study|Participant relocated abroad.|0|||
146218574|NCT03150810|527314971|FG007|Overall Study|Participant relocated abroad.|0|||
146218575|NCT03150810|527314972|FG008|Overall Study|Participant relocated abroad.|0|||
146218576|NCT03150810|527314973|FG009|Overall Study|Participant relocated abroad.|0|||
146218577|NCT03150810|527314974|FG010|Overall Study|Participant relocated abroad.|0|||
146218578|NCT03150810|527314975|FG011|Overall Study|Participant relocated abroad.|0|||
146218579|NCT03150810|527314976|FG012|Overall Study|Participant relocated abroad.|0|||
146218580|NCT03150810|527314964|FG000|Overall Study|Transferred care to oncologist|0|||
146218581|NCT03150810|527314965|FG001|Overall Study|Transferred care to oncologist|0|||
146218582|NCT03150810|527314966|FG002|Overall Study|Transferred care to oncologist|0|||
146218583|NCT03150810|527314967|FG003|Overall Study|Transferred care to oncologist|0|||
146218584|NCT03150810|527314968|FG004|Overall Study|Transferred care to oncologist|0|||
146218585|NCT03150810|527314969|FG005|Overall Study|Transferred care to oncologist|0|||
146218586|NCT03150810|527314970|FG006|Overall Study|Transferred care to oncologist|2|||
146218587|NCT03150810|527314971|FG007|Overall Study|Transferred care to oncologist|0|||
146218588|NCT03150810|527314972|FG008|Overall Study|Transferred care to oncologist|0|||
146218589|NCT03150810|527314973|FG009|Overall Study|Transferred care to oncologist|0|||
146218590|NCT03150810|527314974|FG010|Overall Study|Transferred care to oncologist|0|||
146218591|NCT03150810|527314975|FG011|Overall Study|Transferred care to oncologist|0|||
146218592|NCT03150810|527314976|FG012|Overall Study|Transferred care to oncologist|0|||
146218593|NCT02919683|527314977|FG000|Post-Surgery Follow-Up|Death|2|||
146218594|NCT02919683|527314978|FG001|Post-Surgery Follow-Up|Death|2|||
146218595|NCT02919683|527314977|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
146218596|NCT02919683|527314978|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
146218597|NCT03721952|527314990|FG000|Overall Study|Lost to Follow-up|0|||
146218598|NCT03721952|527314991|FG001|Overall Study|Lost to Follow-up|0|||
146218599|NCT03721952|527314992|FG002|Overall Study|Lost to Follow-up|2|||
146218600|NCT03721952|527314993|FG003|Overall Study|Lost to Follow-up|0|||
146218601|NCT03721952|527314994|FG004|Overall Study|Lost to Follow-up|0|||
146218602|NCT03721952|527314990|FG000|Overall Study|Protocol Violation|0|||
146218603|NCT03721952|527314991|FG001|Overall Study|Protocol Violation|1|||
146218604|NCT03721952|527314992|FG002|Overall Study|Protocol Violation|0|||
146218605|NCT03721952|527314993|FG003|Overall Study|Protocol Violation|0|||
146218606|NCT03721952|527314994|FG004|Overall Study|Protocol Violation|0|||
145881960|NCT03493919|526072754|FG000|Overall Study|Lost to Follow-up|5|||
145881961|NCT03493919|526072755|FG001|Overall Study|Lost to Follow-up|0|||
145881962|NCT03493919|526072756|FG002|Overall Study|Lost to Follow-up|0|||
145881963|NCT03493919|526072757|FG003|Overall Study|Lost to Follow-up|3|||
145881964|NCT03493919|526072754|FG000|Overall Study|Adverse Event|0|||
145881965|NCT03493919|526072755|FG001|Overall Study|Adverse Event|1|||
145881966|NCT03493919|526072756|FG002|Overall Study|Adverse Event|0|||
145881967|NCT03493919|526072757|FG003|Overall Study|Adverse Event|0|||
145881968|NCT01977456|526072759|FG000|Overall Study|Death|5|||
146218607|NCT03721952|527314990|FG000|Overall Study|Withdrawal by Subject|1|||
146218608|NCT03721952|527314991|FG001|Overall Study|Withdrawal by Subject|0|||
146218609|NCT03721952|527314992|FG002|Overall Study|Withdrawal by Subject|40|||
146218610|NCT03721952|527314993|FG003|Overall Study|Withdrawal by Subject|28|||
145881969|NCT00724958|526072762|FG000|Overall Study|Adverse Event|28|||
145881970|NCT00724958|526072762|FG000|Overall Study|Loss of Response|40|||
146218611|NCT03721952|527314994|FG004|Overall Study|Withdrawal by Subject|0|||
146218612|NCT05292365|527314995|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
146218613|NCT05292365|527314996|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
146218614|NCT05292365|527314997|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
145881971|NCT00724958|526072762|FG000|Overall Study|No Response|18|||
145881972|NCT00724958|526072762|FG000|Overall Study|Remission|7|||
145881973|NCT00724958|526072762|FG000|Overall Study|Other Reason|76|||
145881974|NCT00724958|526072762|FG000|Overall Study|No documentation for end of therapy|13|||
146218615|NCT05292365|527314998|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
146218616|NCT04495894|527315002|FG000|Overall Study|Withdrawal by Subject|2|||
146218617|NCT04495894|527315003|FG001|Overall Study|Withdrawal by Subject|0|||
146218618|NCT04495894|527315004|FG002|Overall Study|Withdrawal by Subject|2|||
146218619|NCT04495894|527315005|FG003|Overall Study|Withdrawal by Subject|3|||
146218620|NCT04495894|527315002|FG000|Overall Study|Early termination|0|||
146218621|NCT04495894|527315003|FG001|Overall Study|Early termination|0|||
146218622|NCT04495894|527315004|FG002|Overall Study|Early termination|3|||
146218623|NCT04495894|527315005|FG003|Overall Study|Early termination|0|||
146218624|NCT03364647|527315006|FG000|Overall Study|Withdrawal by Subject|3|||
146218625|NCT03364647|527315007|FG001|Overall Study|Withdrawal by Subject|1|||
146218626|NCT01000961|527315008|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146218627|NCT01000961|527315009|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146218628|NCT01000961|527315008|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
146218629|NCT01000961|527315009|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
146218630|NCT05746455|527315018|FG000|Overall Study|Discharged from Clinical Service|1|||
146218631|NCT05746455|527315018|FG000|Overall Study|Lost to Follow-up|1|||
146218632|NCT03896789|527315023|FG000|Baseline|Lost to Follow-up|1|||
146218633|NCT03896789|527315024|FG001|Baseline|Lost to Follow-up|2|||
146218634|NCT03896789|527315023|FG000|Baseline|Death|3|||
146218635|NCT03896789|527315024|FG001|Baseline|Death|6|||
146218636|NCT03896789|527315023|FG000|Post-Randomization|Lost to Follow-up|12|||
146218637|NCT03896789|527315024|FG001|Post-Randomization|Lost to Follow-up|11|||
146218638|NCT03896789|527315023|FG000|Post-Randomization|Death|12|||
146218639|NCT03896789|527315024|FG001|Post-Randomization|Death|13|||
146218640|NCT03447470|527315026|FG000|Overall Study|Death|0|||
146218641|NCT03447470|527315027|FG001|Overall Study|Death|1|||
146218642|NCT03447470|527315028|FG002|Overall Study|Death|3|||
146218643|NCT03447470|527315029|FG003|Overall Study|Death|0|||
146218644|NCT03447470|527315030|FG004|Overall Study|Death|1|||
146218645|NCT03447470|527315031|FG005|Overall Study|Death|0|||
146218646|NCT03447470|527315032|FG006|Overall Study|Death|3|||
146218647|NCT03447470|527315033|FG007|Overall Study|Death|3|||
146218648|NCT03447470|527315034|FG008|Overall Study|Death|1|||
146218649|NCT03447470|527315026|FG000|Overall Study|Withdrawal by Subject|1|||
146218650|NCT03447470|527315027|FG001|Overall Study|Withdrawal by Subject|0|||
146218651|NCT03447470|527315028|FG002|Overall Study|Withdrawal by Subject|0|||
146218652|NCT03447470|527315029|FG003|Overall Study|Withdrawal by Subject|0|||
146218653|NCT03447470|527315030|FG004|Overall Study|Withdrawal by Subject|1|||
146218654|NCT03447470|527315031|FG005|Overall Study|Withdrawal by Subject|0|||
146218655|NCT03447470|527315032|FG006|Overall Study|Withdrawal by Subject|1|||
146218656|NCT03447470|527315033|FG007|Overall Study|Withdrawal by Subject|1|||
146218657|NCT03447470|527315034|FG008|Overall Study|Withdrawal by Subject|3|||
146218658|NCT03447470|527315026|FG000|Overall Study|Treatment discontinued|3|||
146218659|NCT03447470|527315027|FG001|Overall Study|Treatment discontinued|2|||
146218660|NCT03447470|527315028|FG002|Overall Study|Treatment discontinued|4|||
146218661|NCT03447470|527315029|FG003|Overall Study|Treatment discontinued|6|||
146218662|NCT03447470|527315030|FG004|Overall Study|Treatment discontinued|2|||
146218663|NCT03447470|527315031|FG005|Overall Study|Treatment discontinued|1|||
146218664|NCT03447470|527315032|FG006|Overall Study|Treatment discontinued|2|||
146218665|NCT03447470|527315033|FG007|Overall Study|Treatment discontinued|4|||
146218666|NCT03447470|527315034|FG008|Overall Study|Treatment discontinued|3|||
146218667|NCT05184192|527315036|FG000|Overall Study|Lost to Follow-up|4|||
146218668|NCT05184192|527315037|FG001|Overall Study|Lost to Follow-up|7|||
146218669|NCT05184192|527315036|FG000|Overall Study|Adverse Event|1|||
146218670|NCT05184192|527315037|FG001|Overall Study|Adverse Event|4|||
146218671|NCT05184192|527315036|FG000|Overall Study|PI withdrawal|1|||
146218672|NCT05184192|527315037|FG001|Overall Study|PI withdrawal|2|||
146218673|NCT05184192|527315036|FG000|Overall Study|Withdrew due to adverse effect|1|||
146218674|NCT05184192|527315037|FG001|Overall Study|Withdrew due to adverse effect|0|||
146218675|NCT05184192|527315036|FG000|Overall Study|Medication schedule|1|||
146218676|NCT05184192|527315037|FG001|Overall Study|Medication schedule|0|||
146218677|NCT05184192|527315036|FG000|Overall Study|Concern for adverse effects|0|||
146218678|NCT05184192|527315037|FG001|Overall Study|Concern for adverse effects|4|||
146218679|NCT05603143|527315043|FG000|Overall Study|Withdrew consent|6|||
146218680|NCT05603143|527315044|FG001|Overall Study|Withdrew consent|2|||
146218681|NCT05603143|527315043|FG000|Overall Study|Randomized but never treated|0|||
146218682|NCT05603143|527315044|FG001|Overall Study|Randomized but never treated|3|||
145881975|NCT00965731|526072763|FG000|Overall Study|Death|0|||
145881976|NCT00965731|526072764|FG001|Overall Study|Death|4|||
146218683|NCT05603143|527315043|FG000|Overall Study|Adverse Event|2|||
146218684|NCT05603143|527315044|FG001|Overall Study|Adverse Event|0|||
146218685|NCT05603143|527315043|FG000|Overall Study|Death|0|||
146218686|NCT05603143|527315044|FG001|Overall Study|Death|1|||
146218687|NCT05603143|527315043|FG000|Overall Study|Investigator's discretion|1|||
146218688|NCT05603143|527315044|FG001|Overall Study|Investigator's discretion|0|||
146287958|NCT02581631|527569387|FG004|Overall Study|Request to discontinue|1|||
146287959|NCT02581631|527569383|FG000|Overall Study|participant withdrew consent|3|||
146287960|NCT02581631|527569384|FG001|Overall Study|participant withdrew consent|0|||
146287961|NCT02581631|527569385|FG002|Overall Study|participant withdrew consent|1|||
146287962|NCT02581631|527569386|FG003|Overall Study|participant withdrew consent|0|||
145960800|NCT00490971|526367712|FG003|Acute/Continuation|Protocol Violation|0|||
145960801|NCT00490971|526367713|FG004|Acute/Continuation|Protocol Violation|0|||
145960802|NCT00490971|526367709|FG000|Acute/Continuation|Withdrawal by Subject|92|||
146218689|NCT05603143|527315043|FG000|Overall Study|Lost to Follow-up|0|||
146218690|NCT05603143|527315044|FG001|Overall Study|Lost to Follow-up|1|||
146218691|NCT05603143|527315043|FG000|Overall Study|Protocol Violation|0|||
146218692|NCT05603143|527315044|FG001|Overall Study|Protocol Violation|1|||
146218693|NCT04505904|527315045|FG000|Overall Study|Withdrawal by Subject|1|||
146218694|NCT04505904|527315046|FG001|Overall Study|Withdrawal by Subject|2|||
146218695|NCT04505904|527315047|FG002|Overall Study|Withdrawal by Subject|0|||
146218696|NCT04505904|527315048|FG003|Overall Study|Withdrawal by Subject|0|||
145881977|NCT00965731|526072763|FG000|Overall Study|Withdrawal by Subject|0|||
146218697|NCT04505904|527315045|FG000|Overall Study|Physician Decision|1|||
146218698|NCT04505904|527315046|FG001|Overall Study|Physician Decision|0|||
146218699|NCT04505904|527315047|FG002|Overall Study|Physician Decision|0|||
146218700|NCT04505904|527315048|FG003|Overall Study|Physician Decision|0|||
146218701|NCT04505904|527315045|FG000|Overall Study|Adverse Event|0|||
146218702|NCT04505904|527315046|FG001|Overall Study|Adverse Event|1|||
146218703|NCT04505904|527315047|FG002|Overall Study|Adverse Event|0|||
146218704|NCT04505904|527315048|FG003|Overall Study|Adverse Event|0|||
146218705|NCT04277442|527315051|FG000|Overall Study|Death|1|||
146218706|NCT05084508|527315052|FG000|Overall Study|Lost to Follow-up|6|||
146218707|NCT05084508|527315053|FG001|Overall Study|Lost to Follow-up|3|||
146218708|NCT05084508|527315054|FG002|Overall Study|Lost to Follow-up|7|||
146218709|NCT05084508|527315055|FG003|Overall Study|Lost to Follow-up|3|||
146218710|NCT05084508|527315052|FG000|Overall Study|Withdrawal by Subject|0|||
146218711|NCT05084508|527315053|FG001|Overall Study|Withdrawal by Subject|2|||
146218712|NCT05084508|527315054|FG002|Overall Study|Withdrawal by Subject|3|||
146218713|NCT05084508|527315055|FG003|Overall Study|Withdrawal by Subject|1|||
146218714|NCT05084508|527315052|FG000|Overall Study|Other|0|||
146218715|NCT05084508|527315053|FG001|Overall Study|Other|0|||
146218716|NCT05084508|527315054|FG002|Overall Study|Other|0|||
145881978|NCT00965731|526072764|FG001|Overall Study|Withdrawal by Subject|1|||
145881979|NCT00965731|526072763|FG000|Overall Study|Other|7|||
145881980|NCT00965731|526072764|FG001|Overall Study|Other|15|||
145881981|NCT04773600|526072765|FG000|Overall Study|Withdrawal by Subject|15|||
145881982|NCT04773600|526072766|FG001|Overall Study|Withdrawal by Subject|9|||
145881983|NCT04773600|526072765|FG000|Overall Study|Lost to Follow-up|10|||
145881984|NCT04773600|526072766|FG001|Overall Study|Lost to Follow-up|6|||
145881985|NCT04773600|526072765|FG000|Overall Study|Adverse Event|8|||
145881986|NCT04773600|526072766|FG001|Overall Study|Adverse Event|2|||
145881987|NCT04773600|526072765|FG000|Overall Study|Lack of Efficacy|2|||
145881988|NCT04773600|526072766|FG001|Overall Study|Lack of Efficacy|3|||
145881989|NCT04773600|526072765|FG000|Overall Study|Noncompliance|2|||
145881990|NCT04773600|526072766|FG001|Overall Study|Noncompliance|0|||
145881991|NCT04773600|526072765|FG000|Overall Study|Protocol Violation|2|||
145881992|NCT04773600|526072766|FG001|Overall Study|Protocol Violation|0|||
145881993|NCT04773600|526072765|FG000|Overall Study|Physician Decision|0|||
145881994|NCT04773600|526072766|FG001|Overall Study|Physician Decision|1|||
145881995|NCT04773600|526072765|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
145881996|NCT04773600|526072766|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
145881997|NCT04773600|526072765|FG000|Overall Study|Emergency Travel Out of Country|1|||
145881998|NCT04773600|526072766|FG001|Overall Study|Emergency Travel Out of Country|0|||
145881999|NCT01841060|526074661|FG000|Overall Study|Protocol Violation|10|||
145882000|NCT03303417|526074672|FG000|Overall Study|Withdrawal by Subject|1|||
145882001|NCT03303417|526074673|FG001|Overall Study|Withdrawal by Subject|1|||
145882002|NCT01848210|526074676|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
145882003|NCT01848210|526074677|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
145882004|NCT01848210|526074676|FG000|Overall Study|Lost to Follow-up|24|||
145882005|NCT01848210|526074677|FG001|Overall Study|Lost to Follow-up|12|||
145882006|NCT01848210|526074676|FG000|Overall Study|Protocol Violation|3|||
145882007|NCT01848210|526074677|FG001|Overall Study|Protocol Violation|5|||
145882008|NCT01848210|526074676|FG000|Overall Study|Use of Forbidden Drugs|9|||
145882009|NCT01848210|526074677|FG001|Overall Study|Use of Forbidden Drugs|10|||
146218717|NCT05084508|527315055|FG003|Overall Study|Other|1|||
146287963|NCT02581631|527569387|FG004|Overall Study|participant withdrew consent|0|||
145882010|NCT01848210|526074676|FG000|Overall Study|Impedition Condition|5|||
145882011|NCT01848210|526074677|FG001|Overall Study|Impedition Condition|9|||
145882012|NCT01848210|526074676|FG000|Overall Study|Adverse Event|7|||
146218718|NCT05093829|527315056|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146218719|NCT05093829|527315057|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146218720|NCT05093829|527315058|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
146287964|NCT02581631|527569383|FG000|Overall Study|Maximum clinical benefit|1|||
146287965|NCT02581631|527569384|FG001|Overall Study|Maximum clinical benefit|7|||
146287966|NCT02581631|527569385|FG002|Overall Study|Maximum clinical benefit|1|||
145882013|NCT01848210|526074677|FG001|Overall Study|Adverse Event|9|||
145882014|NCT01848210|526074676|FG000|Overall Study|Discontinuation Criterion|5|||
145882015|NCT01848210|526074677|FG001|Overall Study|Discontinuation Criterion|7|||
145882016|NCT01848210|526074676|FG000|Overall Study|Hypesensitivity|1|||
145882017|NCT01848210|526074677|FG001|Overall Study|Hypesensitivity|0|||
146287967|NCT02581631|527569386|FG003|Overall Study|Maximum clinical benefit|3|||
146287968|NCT02581631|527569387|FG004|Overall Study|Maximum clinical benefit|13|||
146287969|NCT02581631|527569383|FG000|Overall Study|Other Reasons|1|||
146287970|NCT02581631|527569384|FG001|Overall Study|Other Reasons|0|||
146287971|NCT02581631|527569385|FG002|Overall Study|Other Reasons|2|||
146287972|NCT02581631|527569386|FG003|Overall Study|Other Reasons|2|||
146287973|NCT02581631|527569387|FG004|Overall Study|Other Reasons|3|||
146287974|NCT02581631|527569383|FG000|Overall Study|Poor/Non-Compliance|0|||
146287975|NCT02581631|527569384|FG001|Overall Study|Poor/Non-Compliance|0|||
146287976|NCT02581631|527569385|FG002|Overall Study|Poor/Non-Compliance|1|||
146287977|NCT02581631|527569386|FG003|Overall Study|Poor/Non-Compliance|0|||
146287978|NCT02581631|527569387|FG004|Overall Study|Poor/Non-Compliance|0|||
146287979|NCT00986973|527569388|FG000|Overall Study|Withdrawn by study team|1|||
146287980|NCT00598273|527569389|FG000|Overall Study|Adverse Event|4|||
146287981|NCT00598273|527569390|FG001|Overall Study|Adverse Event|5|||
146287982|NCT00598273|527569391|FG002|Overall Study|Adverse Event|2|||
146287983|NCT00598273|527569389|FG000|Overall Study|Death|6|||
146287984|NCT00598273|527569390|FG001|Overall Study|Death|12|||
146287985|NCT00598273|527569391|FG002|Overall Study|Death|8|||
146287986|NCT00598273|527569389|FG000|Overall Study|Lost to Follow-up|8|||
146287987|NCT00598273|527569390|FG001|Overall Study|Lost to Follow-up|3|||
146287988|NCT00598273|527569391|FG002|Overall Study|Lost to Follow-up|5|||
146287989|NCT00598273|527569389|FG000|Overall Study|Physician Decision|0|||
146287990|NCT00598273|527569390|FG001|Overall Study|Physician Decision|0|||
146287991|NCT00598273|527569391|FG002|Overall Study|Physician Decision|1|||
146287992|NCT00598273|527569389|FG000|Overall Study|Withdrawal by Subject|12|||
146287993|NCT00598273|527569390|FG001|Overall Study|Withdrawal by Subject|10|||
146287994|NCT00598273|527569391|FG002|Overall Study|Withdrawal by Subject|10|||
146287995|NCT00598273|527569389|FG000|Overall Study|Noncompliance|3|||
146287996|NCT00598273|527569390|FG001|Overall Study|Noncompliance|2|||
146287997|NCT00598273|527569391|FG002|Overall Study|Noncompliance|3|||
146287998|NCT00598273|527569389|FG000|Overall Study|Relocation|0|||
146287999|NCT00598273|527569390|FG001|Overall Study|Relocation|2|||
146288000|NCT00598273|527569391|FG002|Overall Study|Relocation|4|||
146288001|NCT00598273|527569389|FG000|Overall Study|Renal transplant|1|||
146288002|NCT00598273|527569390|FG001|Overall Study|Renal transplant|0|||
146288003|NCT00598273|527569391|FG002|Overall Study|Renal transplant|1|||
146288004|NCT00598273|527569389|FG000|Overall Study|Site elected to close|1|||
146288005|NCT00598273|527569390|FG001|Overall Study|Site elected to close|0|||
146288006|NCT00598273|527569391|FG002|Overall Study|Site elected to close|0|||
146288007|NCT00598273|527569389|FG000|Overall Study|Started dialysis|6|||
146288008|NCT00598273|527569390|FG001|Overall Study|Started dialysis|4|||
146288009|NCT00598273|527569391|FG002|Overall Study|Started dialysis|5|||
146288010|NCT03426605|527569392|FG000|Overall Study|AML relapse or progression|2|||
146288011|NCT03426605|527569393|FG001|Overall Study|AML relapse or progression|1|||
146288012|NCT03426605|527569394|FG002|Overall Study|AML relapse or progression|2|||
146288013|NCT03426605|527569395|FG003|Overall Study|AML relapse or progression|2|||
146288014|NCT03426605|527569392|FG000|Overall Study|Treatment failure|3|||
146288015|NCT03426605|527569393|FG001|Overall Study|Treatment failure|2|||
146288016|NCT03426605|527569394|FG002|Overall Study|Treatment failure|0|||
146288017|NCT03426605|527569395|FG003|Overall Study|Treatment failure|0|||
146288018|NCT03426605|527569392|FG000|Overall Study|Adverse Event|1|||
146288019|NCT03426605|527569393|FG001|Overall Study|Adverse Event|0|||
145960803|NCT00490971|526367710|FG001|Acute/Continuation|Withdrawal by Subject|24|||
145960804|NCT00490971|526367711|FG002|Acute/Continuation|Withdrawal by Subject|0|||
146288020|NCT03426605|527569394|FG002|Overall Study|Adverse Event|1|||
146288021|NCT03426605|527569395|FG003|Overall Study|Adverse Event|1|||
146288022|NCT03426605|527569392|FG000|Overall Study|Withdrawal by Subject|0|||
146288023|NCT03426605|527569393|FG001|Overall Study|Withdrawal by Subject|0|||
146288024|NCT03426605|527569394|FG002|Overall Study|Withdrawal by Subject|1|||
145960805|NCT00490971|526367712|FG003|Acute/Continuation|Withdrawal by Subject|0|||
146288025|NCT03426605|527569395|FG003|Overall Study|Withdrawal by Subject|1|||
146288026|NCT01815138|527569398|FG000|Overall Study|Withdrawal by Subject|0|||
146288027|NCT01815138|527569399|FG001|Overall Study|Withdrawal by Subject|1|||
146288028|NCT01815138|527569398|FG000|Overall Study|Physician Decision|8|||
146288029|NCT01815138|527569399|FG001|Overall Study|Physician Decision|5|||
146288030|NCT01211288|527569402|FG000|Overall Study|Lost to Follow-up|1|||
146218721|NCT05093829|527315059|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146218722|NCT05093829|527315060|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
146218723|NCT05302596|527315061|FG000|Overall Study|Withdrawal by Subject|1|||
146218724|NCT05302596|527315062|FG001|Overall Study|Withdrawal by Subject|1|||
146218725|NCT04353661|527317284|FG000|Overall Study|Protocol Violation|0|||
146218726|NCT04353661|527317285|FG001|Overall Study|Protocol Violation|0|||
146218727|NCT04353661|527317286|FG002|Overall Study|Protocol Violation|1|||
146218728|NCT04353661|527317284|FG000|Overall Study|Study termination by the Sponsor|1|||
146218729|NCT04353661|527317285|FG001|Overall Study|Study termination by the Sponsor|1|||
146218730|NCT04353661|527317286|FG002|Overall Study|Study termination by the Sponsor|1|||
146218731|NCT00667251|527317287|FG000|Overall Study|Disease progression|232|||
146218732|NCT00667251|527317288|FG001|Overall Study|Disease progression|203|||
146218733|NCT00667251|527317287|FG000|Overall Study|Toxicity|44|||
146218734|NCT00667251|527317288|FG001|Overall Study|Toxicity|23|||
146218735|NCT00667251|527317287|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
146218736|NCT00667251|527317288|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
146218737|NCT00667251|527317287|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
146218738|NCT00667251|527317288|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
146218739|NCT00667251|527317287|FG000|Overall Study|Symptomatic progression|8|||
146218740|NCT00667251|527317288|FG001|Overall Study|Symptomatic progression|4|||
146218741|NCT00667251|527317287|FG000|Overall Study|Death|6|||
146218742|NCT00667251|527317288|FG001|Overall Study|Death|11|||
146218743|NCT00667251|527317287|FG000|Overall Study|Intercurrent illness|5|||
146218744|NCT00667251|527317288|FG001|Overall Study|Intercurrent illness|6|||
146218745|NCT00667251|527317287|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
146218746|NCT00667251|527317288|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
146218747|NCT00667251|527317287|FG000|Overall Study|Randomized not Treated|4|||
146218748|NCT00667251|527317288|FG001|Overall Study|Randomized not Treated|1|||
146218749|NCT02727699|527317290|FG000|Overall Study|Adverse Event|2|||
146218750|NCT02727699|527317291|FG001|Overall Study|Adverse Event|0|||
146218751|NCT02727699|527317290|FG000|Overall Study|Withdrawal by Subject|5|||
146218752|NCT02727699|527317291|FG001|Overall Study|Withdrawal by Subject|3|||
146218753|NCT02727699|527317290|FG000|Overall Study|Protocol Violation|0|||
146218754|NCT02727699|527317291|FG001|Overall Study|Protocol Violation|1|||
146218755|NCT02727699|527317290|FG000|Overall Study|Physician Decision|0|||
146218756|NCT02727699|527317291|FG001|Overall Study|Physician Decision|1|||
146218757|NCT02727699|527317290|FG000|Overall Study|Lost to Follow-up|1|||
146218758|NCT02727699|527317291|FG001|Overall Study|Lost to Follow-up|0|||
146218759|NCT02727699|527317290|FG000|Overall Study|Sponsor Decision|1|||
146218760|NCT02727699|527317291|FG001|Overall Study|Sponsor Decision|0|||
146218761|NCT03457142|527317292|FG000|Overall Study|Death|1|||
146218762|NCT01413100|527317293|FG000|Overall Study|Withdrawal by Subject|1|||
146218763|NCT04896476|527317303|FG000|Overall Study|Withdrawal by Subject|1|||
146218764|NCT04896476|527317303|FG000|Overall Study|Lost to Follow-up|2|||
146218765|NCT03476187|527317304|FG000|Overall Study|Protocol Violation|7|||
146218766|NCT03476187|527317304|FG000|Overall Study|Physician Decision|5|||
146218767|NCT05948670|527317306|FG000|Overall Study|Protocol Violation|6|||
146218768|NCT05948670|527317307|FG001|Overall Study|Protocol Violation|8|||
146218769|NCT05948670|527317306|FG000|Overall Study|Withdrawal by Subject|0|||
146218770|NCT05948670|527317307|FG001|Overall Study|Withdrawal by Subject|1|||
146218771|NCT02921230|527317312|FG000|Overall Study|Withdrawal by Subject|20|||
146218772|NCT02921230|527317313|FG001|Overall Study|Withdrawal by Subject|8|||
146218773|NCT02921230|527317312|FG000|Overall Study|Death|12|||
146218774|NCT02921230|527317313|FG001|Overall Study|Death|3|||
146218775|NCT02921230|527317312|FG000|Overall Study|Protocol Violation|17|||
146218776|NCT02921230|527317313|FG001|Overall Study|Protocol Violation|6|||
146218777|NCT02921230|527317312|FG000|Overall Study|Early completion|5|||
146218778|NCT02921230|527317313|FG001|Overall Study|Early completion|1|||
146218779|NCT02921230|527317312|FG000|Overall Study|Pending data entry|1|||
146218780|NCT02921230|527317313|FG001|Overall Study|Pending data entry|0|||
146218781|NCT02677298|527317326|FG000|Double Blind Phase|Adverse Event|2|||
146218782|NCT02677298|527317327|FG001|Double Blind Phase|Adverse Event|1|||
146218783|NCT02677298|527317328|FG002|Double Blind Phase|Adverse Event|0|||
146218784|NCT02677298|527317326|FG000|Double Blind Phase|Physician Decision|5|||
146218785|NCT02677298|527317327|FG001|Double Blind Phase|Physician Decision|0|||
146218786|NCT02677298|527317328|FG002|Double Blind Phase|Physician Decision|0|||
146218787|NCT02677298|527317326|FG000|Double Blind Phase|Lost to Follow-up|11|||
146218788|NCT02677298|527317327|FG001|Double Blind Phase|Lost to Follow-up|7|||
146218789|NCT02677298|527317328|FG002|Double Blind Phase|Lost to Follow-up|0|||
146218790|NCT02677298|527317326|FG000|Double Blind Phase|Withdrawal by Subject|11|||
146218791|NCT02677298|527317327|FG001|Double Blind Phase|Withdrawal by Subject|8|||
146218792|NCT02677298|527317328|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146218793|NCT02677298|527317326|FG000|Double Blind Phase|No study drug available at site|0|||
146218794|NCT02677298|527317327|FG001|Double Blind Phase|No study drug available at site|1|||
145960806|NCT00490971|526367713|FG004|Acute/Continuation|Withdrawal by Subject|0|||
145960807|NCT00490971|526367709|FG000|Acute/Continuation|Other|11|||
146218795|NCT02677298|527317328|FG002|Double Blind Phase|No study drug available at site|0|||
146218796|NCT02677298|527317326|FG000|Open Label Phase|Adverse Event|0|||
146218797|NCT02677298|527317327|FG001|Open Label Phase|Adverse Event|0|||
146218798|NCT02677298|527317328|FG002|Open Label Phase|Adverse Event|4|||
146218799|NCT02677298|527317326|FG000|Open Label Phase|Physician Decision|0|||
146218800|NCT02677298|527317327|FG001|Open Label Phase|Physician Decision|0|||
146218801|NCT02677298|527317328|FG002|Open Label Phase|Physician Decision|1|||
146218802|NCT02677298|527317326|FG000|Open Label Phase|Lost to Follow-up|0|||
146218803|NCT02677298|527317327|FG001|Open Label Phase|Lost to Follow-up|0|||
146218804|NCT02677298|527317328|FG002|Open Label Phase|Lost to Follow-up|17|||
146218805|NCT02677298|527317326|FG000|Open Label Phase|Withdrawal by Subject|0|||
146218806|NCT02677298|527317327|FG001|Open Label Phase|Withdrawal by Subject|0|||
145882018|NCT01848210|526074676|FG000|Overall Study|Hepatic Function Alteration|4|||
145882019|NCT01848210|526074677|FG001|Overall Study|Hepatic Function Alteration|0|||
145882020|NCT01848210|526074676|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
145882021|NCT01848210|526074677|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
145882022|NCT01848210|526074676|FG000|Overall Study|Administrative|1|||
145882023|NCT01848210|526074677|FG001|Overall Study|Administrative|0|||
145882024|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
145882025|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
145882026|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
145882027|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
145882028|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
145882029|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
145882030|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
145882031|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
145882032|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
146218807|NCT02677298|527317328|FG002|Open Label Phase|Withdrawal by Subject|38|||
146218808|NCT03988608|527317329|FG000|Overall Study|Adverse Event|1|||
146218809|NCT03988608|527317329|FG000|Overall Study|Lost to Follow-up|1|||
146218810|NCT03988608|527317329|FG000|Overall Study|Withdrawal by Subject|3|||
146218811|NCT03988608|527317329|FG000|Overall Study|Death|1|||
146218812|NCT03338933|527317340|FG000|Screening Visit|Lost to Follow-up|1|||
146218813|NCT03338933|527317341|FG001|Screening Visit|Lost to Follow-up|3|||
146218814|NCT03338933|527317342|FG002|Screening Visit|Lost to Follow-up|1|||
146218815|NCT03338933|527317343|FG003|Screening Visit|Lost to Follow-up|4|||
146218816|NCT03338933|527317340|FG000|Screening Visit|Screen fail after consent|2|||
146218817|NCT03338933|527317341|FG001|Screening Visit|Screen fail after consent|7|||
146218818|NCT03338933|527317342|FG002|Screening Visit|Screen fail after consent|1|||
146218819|NCT03338933|527317343|FG003|Screening Visit|Screen fail after consent|4|||
146218820|NCT03338933|527317340|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
146218821|NCT03338933|527317341|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
146218822|NCT03338933|527317342|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
146218823|NCT03338933|527317343|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
146218824|NCT03338933|527317340|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
146218825|NCT03338933|527317341|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
146218826|NCT03338933|527317342|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
146218827|NCT03338933|527317343|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
146218828|NCT03338933|527317340|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
146218829|NCT03338933|527317341|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
146218830|NCT03338933|527317342|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
146218831|NCT03338933|527317343|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
146218832|NCT00999804|527317346|FG000|Overall Study|Lack of Efficacy|9|||
146218833|NCT00999804|527317347|FG001|Overall Study|Lack of Efficacy|2|||
146218834|NCT00999804|527317346|FG000|Overall Study|Adverse Event|4|||
146218835|NCT00999804|527317347|FG001|Overall Study|Adverse Event|3|||
146218836|NCT00999804|527317346|FG000|Overall Study|Withdrawal by Subject|4|||
146218837|NCT00999804|527317347|FG001|Overall Study|Withdrawal by Subject|0|||
146218838|NCT00999804|527317346|FG000|Overall Study|Death|1|||
146218839|NCT00999804|527317347|FG001|Overall Study|Death|0|||
146218840|NCT00999804|527317346|FG000|Overall Study|Ineligible|3|||
146218841|NCT00999804|527317347|FG001|Overall Study|Ineligible|0|||
146218842|NCT04526704|527317349|FG000|Overall Study|Adverse Event|1|||
146218843|NCT04526704|527317350|FG001|Overall Study|Adverse Event|0|||
146218844|NCT04526704|527317349|FG000|Overall Study|Physician Decision|1|||
146218845|NCT04526704|527317350|FG001|Overall Study|Physician Decision|0|||
146218846|NCT04526704|527317349|FG000|Overall Study|Withdrawal by Subject|2|||
146218847|NCT04526704|527317350|FG001|Overall Study|Withdrawal by Subject|0|||
146218848|NCT00881621|527317351|FG000|Overall Study|Physician Decision|34|||
145882033|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
145882034|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
145960808|NCT00490971|526367710|FG001|Acute/Continuation|Other|4|||
146218849|NCT05116787|527317352|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
146218850|NCT05116787|527317353|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
146218851|NCT05116787|527317352|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
146218852|NCT05116787|527317353|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
146218853|NCT05116787|527317352|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
146218854|NCT05116787|527317353|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
146218855|NCT05116787|527317352|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
145960809|NCT00490971|526367711|FG002|Acute/Continuation|Other|0|||
145960810|NCT00490971|526367712|FG003|Acute/Continuation|Other|0|||
145960811|NCT00490971|526367713|FG004|Acute/Continuation|Other|0|||
145960812|NCT00490971|526367709|FG000|Maintenance|Adverse Event|0|||
145960813|NCT00490971|526367710|FG001|Maintenance|Adverse Event|0|||
145960814|NCT00490971|526367711|FG002|Maintenance|Adverse Event|4|||
145960815|NCT00490971|526367712|FG003|Maintenance|Adverse Event|5|||
145960816|NCT00490971|526367713|FG004|Maintenance|Adverse Event|7|||
145960817|NCT00490971|526367709|FG000|Maintenance|Death|0|||
145960818|NCT00490971|526367710|FG001|Maintenance|Death|0|||
145960819|NCT00490971|526367711|FG002|Maintenance|Death|0|||
145960820|NCT00490971|526367712|FG003|Maintenance|Death|2|||
145960821|NCT00490971|526367713|FG004|Maintenance|Death|0|||
145960822|NCT00490971|526367709|FG000|Maintenance|Lost to Follow-up|0|||
145960823|NCT00490971|526367710|FG001|Maintenance|Lost to Follow-up|0|||
145960824|NCT00490971|526367711|FG002|Maintenance|Lost to Follow-up|5|||
146218856|NCT05116787|527317353|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
146218857|NCT02737436|527317354|FG000|Washout Period|Lost to Follow-up|5|||
146218858|NCT02737436|527317355|FG001|Washout Period|Lost to Follow-up|11|||
146218859|NCT02737436|527317354|FG000|Data Analysis|Scanning data problems|5|||
146218860|NCT02737436|527317355|FG001|Data Analysis|Scanning data problems|8|||
146218861|NCT05179837|527317357|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
146218862|NCT05179837|527317357|FG000|Overall Study|Device malfunctioned|1|||
146218863|NCT05179837|527317357|FG000|Overall Study|Image quality too low|2|||
146218864|NCT03158129|527317358|FG000|Overall Study|Adverse Event|0|||
146218865|NCT03158129|527317359|FG001|Overall Study|Adverse Event|1|||
146218866|NCT03158129|527317360|FG002|Overall Study|Adverse Event|0|||
146218867|NCT03158129|527317361|FG003|Overall Study|Adverse Event|0|||
146218868|NCT03158129|527317358|FG000|Overall Study|Death|0|||
146218869|NCT03158129|527317359|FG001|Overall Study|Death|0|||
146218870|NCT03158129|527317360|FG002|Overall Study|Death|0|||
146218871|NCT03158129|527317361|FG003|Overall Study|Death|1|||
146218872|NCT03158129|527317358|FG000|Overall Study|High surgical risk|1|||
146218873|NCT03158129|527317359|FG001|Overall Study|High surgical risk|1|||
146218874|NCT03158129|527317360|FG002|Overall Study|High surgical risk|0|||
146218875|NCT03158129|527317361|FG003|Overall Study|High surgical risk|0|||
146218876|NCT03158129|527317358|FG000|Overall Study|Progression|1|||
146218877|NCT03158129|527317359|FG001|Overall Study|Progression|1|||
146218878|NCT03158129|527317360|FG002|Overall Study|Progression|0|||
146218879|NCT03158129|527317361|FG003|Overall Study|Progression|0|||
146218880|NCT03158129|527317358|FG000|Overall Study|Lack of resectability|0|||
146218881|NCT03158129|527317359|FG001|Overall Study|Lack of resectability|1|||
146218882|NCT03158129|527317360|FG002|Overall Study|Lack of resectability|0|||
146218883|NCT03158129|527317361|FG003|Overall Study|Lack of resectability|0|||
146218884|NCT03158129|527317358|FG000|Overall Study|Declined surgery|0|||
146218885|NCT03158129|527317359|FG001|Overall Study|Declined surgery|1|||
146218886|NCT03158129|527317360|FG002|Overall Study|Declined surgery|0|||
146218887|NCT03158129|527317361|FG003|Overall Study|Declined surgery|0|||
146218888|NCT03158129|527317358|FG000|Overall Study|No longer surgical candidate|0|||
146218889|NCT03158129|527317359|FG001|Overall Study|No longer surgical candidate|0|||
146218890|NCT03158129|527317360|FG002|Overall Study|No longer surgical candidate|0|||
146218891|NCT03158129|527317361|FG003|Overall Study|No longer surgical candidate|1|||
146218892|NCT03719443|527317362|FG000|Overall Study|Lost to Follow-up|0|||
146218893|NCT03719443|527317363|FG001|Overall Study|Lost to Follow-up|0|||
145960825|NCT00490971|526367712|FG003|Maintenance|Lost to Follow-up|8|||
145960826|NCT00490971|526367713|FG004|Maintenance|Lost to Follow-up|10|||
145960827|NCT00490971|526367709|FG000|Maintenance|Pregnancy|0|||
146218894|NCT03719443|527317364|FG002|Overall Study|Lost to Follow-up|1|||
146218895|NCT03719443|527317365|FG003|Overall Study|Lost to Follow-up|0|||
146218896|NCT03719443|527317366|FG004|Overall Study|Lost to Follow-up|1|||
145960828|NCT00490971|526367710|FG001|Maintenance|Pregnancy|0|||
145960829|NCT00490971|526367711|FG002|Maintenance|Pregnancy|1|||
145960830|NCT00490971|526367712|FG003|Maintenance|Pregnancy|0|||
146218897|NCT03719443|527317367|FG005|Overall Study|Lost to Follow-up|0|||
146218898|NCT03719443|527317368|FG006|Overall Study|Lost to Follow-up|1|||
146218899|NCT03719443|527317362|FG000|Overall Study|Withdrawal by Subject|0|||
146218900|NCT03719443|527317363|FG001|Overall Study|Withdrawal by Subject|0|||
146218901|NCT03719443|527317364|FG002|Overall Study|Withdrawal by Subject|1|||
146218902|NCT03719443|527317365|FG003|Overall Study|Withdrawal by Subject|0|||
146218903|NCT03719443|527317366|FG004|Overall Study|Withdrawal by Subject|0|||
145960831|NCT00490971|526367713|FG004|Maintenance|Pregnancy|0|||
145960832|NCT00490971|526367709|FG000|Maintenance|Protocol Violation|0|||
146218904|NCT03719443|527317367|FG005|Overall Study|Withdrawal by Subject|0|||
146218905|NCT03719443|527317368|FG006|Overall Study|Withdrawal by Subject|0|||
146218906|NCT05051124|527317369|FG000|Overall Study|Lost to Follow-up|2|||
146218907|NCT05051124|527317369|FG000|Overall Study|Withdrawal by Subject|1|||
146218908|NCT05051124|527317369|FG000|Overall Study|Residential relocation|2|||
146218909|NCT05051124|527317369|FG000|Overall Study|Death|1|||
146218910|NCT04782973|527317370|FG000|Overall Study|Withdrawal by Subject|5|||
146218911|NCT04782973|527317370|FG000|Overall Study|Protocol Violation|6|||
146218912|NCT04782973|527317370|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
146218913|NCT00554788|527317371|FG000|Overall Study|Adverse Event|0|||
146218914|NCT00554788|527317372|FG001|Overall Study|Adverse Event|1|||
146218915|NCT00554788|527317373|FG002|Overall Study|Adverse Event|2|||
146218916|NCT00554788|527317371|FG000|Overall Study|Lost to Follow-up|4|||
146218917|NCT00554788|527317372|FG001|Overall Study|Lost to Follow-up|3|||
146218918|NCT00554788|527317373|FG002|Overall Study|Lost to Follow-up|3|||
146218919|NCT00554788|527317371|FG000|Overall Study|Physician Decision|1|||
146218920|NCT00554788|527317372|FG001|Overall Study|Physician Decision|1|||
146218921|NCT00554788|527317373|FG002|Overall Study|Physician Decision|3|||
146218922|NCT00554788|527317371|FG000|Overall Study|Withdrawal by Subject|0|||
146218923|NCT00554788|527317372|FG001|Overall Study|Withdrawal by Subject|0|||
146218924|NCT00554788|527317373|FG002|Overall Study|Withdrawal by Subject|1|||
146218925|NCT00554788|527317371|FG000|Overall Study|Refusal of further protocol therapy|0|||
146218926|NCT00554788|527317372|FG001|Overall Study|Refusal of further protocol therapy|1|||
146218927|NCT00554788|527317373|FG002|Overall Study|Refusal of further protocol therapy|1|||
146218928|NCT00554788|527317371|FG000|Overall Study|Progressive disease|0|||
146218929|NCT00554788|527317372|FG001|Overall Study|Progressive disease|0|||
146218930|NCT00554788|527317373|FG002|Overall Study|Progressive disease|3|||
146218931|NCT00554788|527317371|FG000|Overall Study|Ineligible|2|||
146218932|NCT00554788|527317372|FG001|Overall Study|Ineligible|0|||
146218933|NCT00554788|527317373|FG002|Overall Study|Ineligible|1|||
146218934|NCT06205407|527317374|FG000|Period 2|Withdrawal by Subject|0|||
146218935|NCT06205407|527317375|FG001|Period 2|Withdrawal by Subject|1|||
146218936|NCT06205407|527317374|FG000|Period 2|Adverse Event|2|||
146218937|NCT06205407|527317375|FG001|Period 2|Adverse Event|1|||
145882035|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
145882036|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
145882037|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
145882038|NCT04592419|526074678|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
145882039|NCT04592419|526074679|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
145882040|NCT04592419|526074678|FG000|Open-Label Extension Period|Adverse Event|1|||
145882041|NCT04592419|526074679|FG001|Open-Label Extension Period|Adverse Event|2|||
145882042|NCT04592419|526074678|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
145882043|NCT04592419|526074679|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
145882044|NCT04592419|526074678|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
145882045|NCT04592419|526074679|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
145882046|NCT04592419|526074678|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
145882047|NCT04592419|526074679|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
145882048|NCT04592419|526074678|FG000|Open-Label Extension Period|Sponsor Request|73|||
145882049|NCT04592419|526074679|FG001|Open-Label Extension Period|Sponsor Request|84|||
145882050|NCT00381849|526074680|FG000|Wash Out|Withdrawal by Subject|0|||
145882051|NCT00381849|526074681|FG001|Wash Out|Withdrawal by Subject|1|||
145882052|NCT01765270|526074685|FG000|Overall Study|Physician Decision|1|||
145882053|NCT01765270|526074686|FG001|Overall Study|Physician Decision|0|||
145882054|NCT01765270|526074685|FG000|Overall Study|Withdrawal by Subject|0|||
145882055|NCT01765270|526074686|FG001|Overall Study|Withdrawal by Subject|1|||
145882056|NCT00329160|526074687|FG000|Overall Study|Adverse Event|27|||
145882057|NCT00329160|526074687|FG000|Overall Study|Withdrawal by Subject|13|||
145882058|NCT00329160|526074687|FG000|Overall Study|Protocol Violation|2|||
145882059|NCT00329160|526074687|FG000|Overall Study|Did not Receive Study Drug|1|||
146218938|NCT02577835|527317377|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
146218939|NCT04749615|527317378|FG000|Overall Study|Lost to Follow-up|6|||
146218940|NCT04749615|527317379|FG001|Overall Study|Lost to Follow-up|10|||
146218941|NCT02274662|527317384|FG000|Overall Study|Death|1|||
146218942|NCT02274662|527317384|FG000|Overall Study|Lost to Follow-up|3|||
146218943|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
145882060|NCT00329160|526074687|FG000|Overall Study|Incomplete IVUS|45|||
145882061|NCT00493792|526074688|FG000|Overall Study|Death|55|||
145882062|NCT00493792|526074689|FG001|Overall Study|Death|50|||
145882063|NCT00493792|526074688|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
145882064|NCT00493792|526074689|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
146218944|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
146218945|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
146218946|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146218947|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146218948|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146218949|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
146218950|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218951|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
146218952|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218953|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218954|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218955|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218956|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
146218957|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146218958|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
146218959|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
146218960|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146218961|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146218962|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146218963|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
146218964|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
146218965|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218966|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218967|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218968|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218969|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218970|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
146218971|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218972|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
146218973|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218974|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218975|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218976|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218977|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
146218978|NCT02962895|527317385|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218979|NCT02962895|527317386|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218980|NCT02962895|527317387|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218981|NCT02962895|527317388|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
146218982|NCT02962895|527317389|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218983|NCT02962895|527317390|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218984|NCT02962895|527317391|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
146218985|NCT02962895|527317385|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145882065|NCT00685035|526074690|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
145882066|NCT00685035|526074691|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
145882067|NCT04968925|526074695|FG000|Phase I- Period 1|COVID-19 related|0|||
145882068|NCT04968925|526074696|FG001|Phase I- Period 1|COVID-19 related|1|||
145882069|NCT04968925|526074697|FG002|Phase I- Period 1|COVID-19 related|0|||
145882070|NCT04968925|526074698|FG003|Phase I- Period 1|COVID-19 related|0|||
145882071|NCT04968925|526074695|FG000|Phase I- Period 1|Subject enrolled in error|1|||
145960833|NCT00490971|526367710|FG001|Maintenance|Protocol Violation|0|||
145960834|NCT00490971|526367711|FG002|Maintenance|Protocol Violation|4|||
145960835|NCT00490971|526367712|FG003|Maintenance|Protocol Violation|1|||
145960836|NCT00490971|526367713|FG004|Maintenance|Protocol Violation|1|||
146218986|NCT02962895|527317386|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146218987|NCT02962895|527317387|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146218988|NCT02962895|527317388|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146218989|NCT02962895|527317389|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146218990|NCT02962895|527317390|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
146218991|NCT02962895|527317391|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
146218992|NCT02962895|527317385|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146218993|NCT02962895|527317386|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146218994|NCT02962895|527317387|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146218995|NCT02962895|527317388|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146218996|NCT02962895|527317389|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
146218997|NCT02962895|527317390|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
146218998|NCT02962895|527317391|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
146218999|NCT02962895|527317385|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219000|NCT02962895|527317386|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219001|NCT02962895|527317387|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219002|NCT02962895|527317388|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219003|NCT02962895|527317389|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219004|NCT02962895|527317390|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
146219005|NCT02962895|527317391|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
146219006|NCT02962895|527317385|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219007|NCT02962895|527317386|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
146219008|NCT02962895|527317387|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219009|NCT02962895|527317388|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219010|NCT02962895|527317389|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219011|NCT02962895|527317390|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219012|NCT02962895|527317391|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
146219013|NCT02962895|527317385|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219014|NCT02962895|527317386|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219015|NCT02962895|527317387|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219016|NCT02962895|527317388|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219017|NCT02962895|527317389|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
146219018|NCT02962895|527317390|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219019|NCT02962895|527317391|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
146219020|NCT02962895|527317385|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219021|NCT02962895|527317386|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219022|NCT02962895|527317387|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219023|NCT02962895|527317388|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219024|NCT02962895|527317389|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
146219025|NCT02962895|527317390|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219026|NCT02962895|527317391|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
146219027|NCT02962895|527317385|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146219028|NCT02962895|527317386|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
146219029|NCT02962895|527317387|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
146219030|NCT02962895|527317388|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
146219031|NCT02962895|527317389|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146219032|NCT02962895|527317390|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146219033|NCT02962895|527317391|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
146219034|NCT02962895|527317385|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
146288031|NCT01211288|527569403|FG001|Overall Study|Lost to Follow-up|1|||
145882072|NCT04968925|526074696|FG001|Phase I- Period 1|Subject enrolled in error|1|||
145882073|NCT04968925|526074697|FG002|Phase I- Period 1|Subject enrolled in error|0|||
145882074|NCT04968925|526074698|FG003|Phase I- Period 1|Subject enrolled in error|0|||
145882075|NCT04968925|526074695|FG000|Phase II- Period 1|COVID-19 Related|0|||
145960837|NCT00490971|526367709|FG000|Maintenance|Withdrawal by Subject|0|||
146219035|NCT02962895|527317386|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146219036|NCT02962895|527317387|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
146219037|NCT02962895|527317388|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
146219038|NCT02962895|527317389|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146219039|NCT02962895|527317390|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
146219040|NCT02962895|527317391|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
146219041|NCT01606215|527317400|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
146219042|NCT01606215|527317401|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
146219043|NCT04592549|527317402|FG000|Overall Study|Withdrawal by Subject|0|||
146219044|NCT04592549|527317403|FG001|Overall Study|Withdrawal by Subject|1|||
146219045|NCT04592549|527317404|FG002|Overall Study|Withdrawal by Subject|0|||
146219046|NCT04592549|527317405|FG003|Overall Study|Withdrawal by Subject|1|||
146219047|NCT04592549|527317406|FG004|Overall Study|Withdrawal by Subject|1|||
146219048|NCT04592549|527317407|FG005|Overall Study|Withdrawal by Subject|0|||
146219049|NCT04592549|527317402|FG000|Overall Study|Lost to Follow-up|2|||
146219050|NCT04592549|527317403|FG001|Overall Study|Lost to Follow-up|0|||
146219051|NCT04592549|527317404|FG002|Overall Study|Lost to Follow-up|0|||
146219052|NCT04592549|527317405|FG003|Overall Study|Lost to Follow-up|1|||
146219053|NCT04592549|527317406|FG004|Overall Study|Lost to Follow-up|1|||
146219054|NCT04592549|527317407|FG005|Overall Study|Lost to Follow-up|1|||
146219055|NCT04295798|527317408|FG000|Overall Study|Lost to Follow-up|1|||
146219056|NCT04624633|527317409|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
146219057|NCT04624633|527317410|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
146219058|NCT04624633|527317409|FG000|Overall Study|Death|1|||
146219059|NCT04624633|527317410|FG001|Overall Study|Death|0|||
146219060|NCT01902173|527317411|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
146219061|NCT01902173|527317412|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146219062|NCT01902173|527317413|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146219063|NCT01902173|527317414|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146219064|NCT01902173|527317415|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146219065|NCT01902173|527317416|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
146219066|NCT01902173|527317411|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
146219067|NCT01902173|527317412|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146219068|NCT01902173|527317413|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146219069|NCT01902173|527317414|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146219070|NCT01902173|527317415|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146219071|NCT01902173|527317416|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
146219072|NCT01902173|527317411|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146219073|NCT01902173|527317412|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
146219074|NCT01902173|527317413|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146219075|NCT01902173|527317414|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146219076|NCT01902173|527317415|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146219077|NCT01902173|527317416|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
146219078|NCT01902173|527317411|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146219079|NCT01902173|527317412|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
146219080|NCT01902173|527317413|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146219081|NCT01902173|527317414|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146219082|NCT01902173|527317415|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146219083|NCT01902173|527317416|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
146219084|NCT01902173|527317411|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146219085|NCT01902173|527317412|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
146219086|NCT01902173|527317413|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146219087|NCT01902173|527317414|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146219088|NCT01902173|527317415|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146219089|NCT01902173|527317416|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
146219090|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146219091|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146084560|NCT00420641|526830212|FG002|Overall Study|Lost to Follow-up|2|||
146219092|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
146219093|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146219094|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146219095|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
146219096|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146219097|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146219098|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
146219099|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146219100|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146219101|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
146219102|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146219103|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146219104|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146219105|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
146219106|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146219107|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
146219108|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146219109|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146219110|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146219111|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
146219112|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146219113|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
146219114|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146219115|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146219116|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146219117|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146219118|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
146219119|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
146219120|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146219121|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146219122|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146219123|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146219124|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
146219125|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
146219126|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146219127|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146219128|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146219129|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146219130|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
146219131|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
146219132|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146219133|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146219134|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146219135|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146219136|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
146219137|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
146219138|NCT01902173|527317411|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146219139|NCT01902173|527317412|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146219140|NCT01902173|527317413|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146219141|NCT01902173|527317414|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146219142|NCT01902173|527317415|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
146219143|NCT01902173|527317416|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
146219144|NCT04625283|527317418|FG000|Overall Study|post randomization exclusion|28|||
146219145|NCT04625283|527317419|FG001|Overall Study|post randomization exclusion|20|||
146219146|NCT05020249|527317420|FG000|Overall Study|Protocol Violation|1|||
146219147|NCT05020249|527317421|FG001|Overall Study|Protocol Violation|0|||
146288032|NCT01588496|527569404|FG000|Overall Study|Withdrawal by Subject|0|||
146288033|NCT01588496|527569405|FG001|Overall Study|Withdrawal by Subject|1|||
145882076|NCT04968925|526074696|FG001|Phase II- Period 1|COVID-19 Related|0|||
145882077|NCT04968925|526074697|FG002|Phase II- Period 1|COVID-19 Related|6|||
145882078|NCT04968925|526074698|FG003|Phase II- Period 1|COVID-19 Related|6|||
145882079|NCT04968925|526074695|FG000|Phase II- Period 1|Subject enrolled in error|0|||
145882080|NCT04968925|526074696|FG001|Phase II- Period 1|Subject enrolled in error|0|||
145882081|NCT04968925|526074697|FG002|Phase II- Period 1|Subject enrolled in error|1|||
145882082|NCT04968925|526074698|FG003|Phase II- Period 1|Subject enrolled in error|0|||
145882083|NCT04968925|526074695|FG000|Phase II -Period 2|COVID-19 related|0|||
145882084|NCT04968925|526074696|FG001|Phase II -Period 2|COVID-19 related|0|||
145882085|NCT04968925|526074697|FG002|Phase II -Period 2|COVID-19 related|4|||
145882086|NCT04968925|526074698|FG003|Phase II -Period 2|COVID-19 related|3|||
146219148|NCT05364671|527317422|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
146219149|NCT05364671|527317423|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
146219150|NCT05364671|527317422|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
146219151|NCT05364671|527317423|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
146219152|NCT05364671|527317422|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
146219153|NCT05364671|527317423|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
146219154|NCT05364671|527317422|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
146219155|NCT05364671|527317423|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
146219156|NCT05364671|527317422|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
146219157|NCT05364671|527317423|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
146219158|NCT03536754|527317426|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
146288034|NCT01588496|527569406|FG002|Overall Study|Withdrawal by Subject|0|||
146288035|NCT01551212|527569407|FG000|Overall Study|Graft loss/Retransplantation|0|||
146288036|NCT01551212|527569408|FG001|Overall Study|Graft loss/Retransplantation|1|||
146288037|NCT01551212|527569407|FG000|Overall Study|Administrative problems|1|||
146288038|NCT01551212|527569408|FG001|Overall Study|Administrative problems|2|||
146288039|NCT01551212|527569407|FG000|Overall Study|Lost to Follow-up|0|||
146288040|NCT01551212|527569408|FG001|Overall Study|Lost to Follow-up|1|||
146288041|NCT01551212|527569407|FG000|Overall Study|Protocol Violation|0|||
146288042|NCT01551212|527569408|FG001|Overall Study|Protocol Violation|1|||
146288043|NCT01551212|527569407|FG000|Overall Study|Withdrawal by Subject|0|||
145882087|NCT04968925|526074695|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
145882088|NCT04968925|526074696|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
145882089|NCT04968925|526074697|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
145882090|NCT04968925|526074698|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
145882091|NCT00996437|526074703|FG000|Overall Study|Death|1|||
145882092|NCT00996437|526074704|FG001|Overall Study|Death|0|||
145882093|NCT00996437|526074703|FG000|Overall Study|Dropped|2|||
145882094|NCT00996437|526074704|FG001|Overall Study|Dropped|2|||
145882095|NCT00996437|526074703|FG000|Overall Study|Missed|2|||
145882096|NCT00996437|526074704|FG001|Overall Study|Missed|5|||
145882097|NCT03653026|526074705|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
145882098|NCT03653026|526074706|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
145882099|NCT03653026|526074707|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
145882100|NCT03653026|526074708|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
145882101|NCT03653026|526074705|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
145882102|NCT03653026|526074706|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
145882103|NCT03653026|526074707|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145882104|NCT03653026|526074708|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145882105|NCT03653026|526074705|FG000|Part 1: Placebo-controlled Period|Other|0|||
145882106|NCT03653026|526074706|FG001|Part 1: Placebo-controlled Period|Other|3|||
145882107|NCT03653026|526074707|FG002|Part 1: Placebo-controlled Period|Other|0|||
146288044|NCT01551212|527569408|FG001|Overall Study|Withdrawal by Subject|7|||
146288045|NCT01551212|527569407|FG000|Overall Study|Death|2|||
146288046|NCT01551212|527569408|FG001|Overall Study|Death|4|||
146288047|NCT01551212|527569407|FG000|Overall Study|Never Received Study Treatment|2|||
146288048|NCT01551212|527569408|FG001|Overall Study|Never Received Study Treatment|4|||
146288049|NCT05924945|527569409|FG000|Overall Study|Withdrawal by Subject|3|||
146288050|NCT05924945|527569410|FG001|Overall Study|Withdrawal by Subject|4|||
146288051|NCT02471833|527569411|FG000|Overall Study|Lost to Follow-up|1|||
146288052|NCT02471833|527569412|FG001|Overall Study|Lost to Follow-up|0|||
146288053|NCT02471833|527569413|FG002|Overall Study|Lost to Follow-up|0|||
146288054|NCT02471833|527569411|FG000|Overall Study|Withdrawal by Subject|2|||
146288055|NCT02471833|527569412|FG001|Overall Study|Withdrawal by Subject|1|||
146288056|NCT02471833|527569413|FG002|Overall Study|Withdrawal by Subject|5|||
146288057|NCT04217590|527569414|FG000|Overall Study|Other|1|||
146288058|NCT04217590|527569415|FG001|Overall Study|Other|1|||
146288059|NCT04217590|527569414|FG000|Overall Study|Withdrawal by Subject|3|||
146288060|NCT04217590|527569415|FG001|Overall Study|Withdrawal by Subject|1|||
146288061|NCT04217590|527569414|FG000|Overall Study|Death|0|||
146288062|NCT04217590|527569415|FG001|Overall Study|Death|1|||
146288063|NCT02232243|527569418|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
146288064|NCT02232243|527569419|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
146288065|NCT02232243|527569420|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
146288066|NCT05026710|527569421|FG000|Overall Study|No longer met eligibility criteria|3|||
146288067|NCT05026710|527569422|FG001|Overall Study|No longer met eligibility criteria|1|||
146288068|NCT00490724|527569423|FG000|Period I|Physician Decision|0|||
146288069|NCT00490724|527569424|FG001|Period I|Physician Decision|0|||
146288070|NCT00490724|527569425|FG002|Period I|Physician Decision|1|||
146288071|NCT00490724|527569423|FG000|Period II|Treatment Discontinuation|3|||
146288072|NCT00490724|527569424|FG001|Period II|Treatment Discontinuation|1|||
146288073|NCT00490724|527569425|FG002|Period II|Treatment Discontinuation|3|||
146288074|NCT03218397|527569426|FG000|Overall Study|Prior positive blood culture|8|||
146288075|NCT03218397|527569427|FG001|Overall Study|Prior positive blood culture|13|||
146288076|NCT03218397|527569426|FG000|Overall Study|Comfort care|8|||
146288077|NCT03218397|527569427|FG001|Overall Study|Comfort care|5|||
146288078|NCT03218397|527569426|FG000|Overall Study|Comfort care and positive blood culture|1|||
146288079|NCT03218397|527569427|FG001|Overall Study|Comfort care and positive blood culture|0|||
146288080|NCT03218397|527569426|FG000|Overall Study|Comfort care and mixed culture|0|||
146288081|NCT03218397|527569427|FG001|Overall Study|Comfort care and mixed culture|1|||
145960838|NCT00490971|526367710|FG001|Maintenance|Withdrawal by Subject|0|||
146288082|NCT03218397|527569426|FG000|Overall Study|Mixed culture|2|||
145960839|NCT00490971|526367711|FG002|Maintenance|Withdrawal by Subject|26|||
145960840|NCT00490971|526367712|FG003|Maintenance|Withdrawal by Subject|28|||
145960841|NCT00490971|526367713|FG004|Maintenance|Withdrawal by Subject|18|||
145960842|NCT00490971|526367709|FG000|Maintenance|Other|0|||
145960843|NCT00490971|526367710|FG001|Maintenance|Other|0|||
145960844|NCT00490971|526367711|FG002|Maintenance|Other|11|||
145960845|NCT00490971|526367712|FG003|Maintenance|Other|9|||
145960846|NCT00490971|526367713|FG004|Maintenance|Other|3|||
145960847|NCT04980014|526369411|FG000|Overall Study|Participants who are Duplicated|1|||
145960848|NCT04980014|526369411|FG000|Overall Study|Follow-up Failure|13|||
145960849|NCT04980014|526369411|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
146288083|NCT03218397|527569427|FG001|Overall Study|Mixed culture|2|||
146288084|NCT03218397|527569426|FG000|Overall Study|Inaccessible hospital records|2|||
146288085|NCT03218397|527569427|FG001|Overall Study|Inaccessible hospital records|5|||
146288086|NCT03218397|527569426|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
146288087|NCT03218397|527569427|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
146288088|NCT03218397|527569426|FG000|Overall Study|Randomized during laboratory off hours|2|||
146288089|NCT03218397|527569427|FG001|Overall Study|Randomized during laboratory off hours|1|||
146288090|NCT01796548|527569428|FG000|Overall Study|Lost to Follow-up|1|||
146288091|NCT01796548|527569428|FG000|Overall Study|Other|2|||
145960850|NCT04980014|526369411|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
145960851|NCT04980014|526369411|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
145960852|NCT02317991|526369412|FG000|Overall Study|Adverse Event|12|||
145960853|NCT02317991|526369412|FG000|Overall Study|Death|4|||
145960854|NCT02317991|526369412|FG000|Overall Study|Withdrawal by Subject|8|||
145960855|NCT02317991|526369412|FG000|Overall Study|Progressive Disease|41|||
145960856|NCT01051921|526369414|FG000|Overall Study|Physician Decision|9|||
145960857|NCT01051921|526369414|FG000|Overall Study|Adverse Event|8|||
146288092|NCT00126503|527569429|FG000|Overall Study|disease progression|23|||
146288093|NCT00126503|527569430|FG001|Overall Study|disease progression|14|||
146288094|NCT00126503|527569429|FG000|Overall Study|Withdrawal by Subject|0|||
146288095|NCT00126503|527569430|FG001|Overall Study|Withdrawal by Subject|1|||
146288096|NCT00126503|527569429|FG000|Overall Study|alternative therapy|1|||
146288097|NCT00126503|527569430|FG001|Overall Study|alternative therapy|1|||
146288098|NCT00126503|527569429|FG000|Overall Study|other complicating disease|4|||
146288099|NCT00126503|527569430|FG001|Overall Study|other complicating disease|1|||
146219159|NCT03536754|527317427|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
146219160|NCT03536754|527317428|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
146219161|NCT03536754|527317429|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
146219162|NCT03536754|527317430|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
146219163|NCT03536754|527317426|FG000|Open Label Extension|Other|0|||
146219164|NCT03536754|527317427|FG001|Open Label Extension|Other|0|||
146219165|NCT03536754|527317428|FG002|Open Label Extension|Other|0|||
146219166|NCT03536754|527317429|FG003|Open Label Extension|Other|0|||
146219167|NCT03536754|527317430|FG004|Open Label Extension|Other|1|||
146219168|NCT03382652|527317433|FG000|Overall Study|Lost to Follow-up|6|||
146219169|NCT03382652|527317433|FG000|Overall Study|Death|4|||
146219170|NCT03382652|527317433|FG000|Overall Study|Revision|5|||
146219171|NCT03382652|527317433|FG000|Overall Study|Patient withdrew|3|||
146219172|NCT03382652|527317433|FG000|Overall Study|Other reasons|21|||
146219173|NCT04810650|527317435|FG000|Overall Study|Disenrolled in error|0|||
146219174|NCT04810650|527317436|FG001|Overall Study|Disenrolled in error|0|||
146219175|NCT04810650|527317437|FG002|Overall Study|Disenrolled in error|0|||
146219176|NCT04810650|527317438|FG003|Overall Study|Disenrolled in error|0|||
146219177|NCT04810650|527317439|FG004|Overall Study|Disenrolled in error|0|||
146219178|NCT04810650|527317440|FG005|Overall Study|Disenrolled in error|0|||
146219179|NCT04810650|527317441|FG006|Overall Study|Disenrolled in error|0|||
146219180|NCT04810650|527317442|FG007|Overall Study|Disenrolled in error|0|||
146219181|NCT04810650|527317443|FG008|Overall Study|Disenrolled in error|1|||
146219182|NCT04810650|527317444|FG009|Overall Study|Disenrolled in error|0|||
146219183|NCT04810650|527317445|FG010|Overall Study|Disenrolled in error|0|||
146219184|NCT04810650|527317446|FG011|Overall Study|Disenrolled in error|0|||
146219185|NCT04810650|527317447|FG012|Overall Study|Disenrolled in error|0|||
146219186|NCT04810650|527317448|FG013|Overall Study|Disenrolled in error|0|||
146219187|NCT04810650|527317435|FG000|Overall Study|Death|0|||
146219188|NCT04810650|527317436|FG001|Overall Study|Death|0|||
146219189|NCT04810650|527317437|FG002|Overall Study|Death|0|||
146219190|NCT04810650|527317438|FG003|Overall Study|Death|0|||
146219191|NCT04810650|527317439|FG004|Overall Study|Death|0|||
146219192|NCT04810650|527317440|FG005|Overall Study|Death|0|||
146219193|NCT04810650|527317441|FG006|Overall Study|Death|2|||
146219194|NCT04810650|527317442|FG007|Overall Study|Death|2|||
146219195|NCT04810650|527317443|FG008|Overall Study|Death|0|||
146219196|NCT04810650|527317444|FG009|Overall Study|Death|1|||
146219197|NCT04810650|527317445|FG010|Overall Study|Death|0|||
146219198|NCT04810650|527317446|FG011|Overall Study|Death|0|||
146219199|NCT04810650|527317447|FG012|Overall Study|Death|2|||
146219200|NCT04810650|527317448|FG013|Overall Study|Death|1|||
146219201|NCT04810650|527317435|FG000|Overall Study|Moved/transferred care|0|||
146219202|NCT04810650|527317436|FG001|Overall Study|Moved/transferred care|0|||
145960858|NCT01051921|526369414|FG000|Overall Study|Withdrawal by Subject|7|||
146219203|NCT04810650|527317437|FG002|Overall Study|Moved/transferred care|0|||
146219204|NCT04810650|527317438|FG003|Overall Study|Moved/transferred care|0|||
146219205|NCT04810650|527317439|FG004|Overall Study|Moved/transferred care|0|||
146219206|NCT04810650|527317440|FG005|Overall Study|Moved/transferred care|0|||
146219207|NCT04810650|527317441|FG006|Overall Study|Moved/transferred care|0|||
146219208|NCT04810650|527317442|FG007|Overall Study|Moved/transferred care|1|||
146219209|NCT04810650|527317443|FG008|Overall Study|Moved/transferred care|12|||
146219210|NCT04810650|527317444|FG009|Overall Study|Moved/transferred care|10|||
146219211|NCT04810650|527317445|FG010|Overall Study|Moved/transferred care|0|||
146219212|NCT04810650|527317446|FG011|Overall Study|Moved/transferred care|0|||
146219213|NCT04810650|527317447|FG012|Overall Study|Moved/transferred care|0|||
146219214|NCT04810650|527317448|FG013|Overall Study|Moved/transferred care|0|||
146219215|NCT04810650|527317435|FG000|Overall Study|Lost to Follow-up|15|||
146219216|NCT04810650|527317436|FG001|Overall Study|Lost to Follow-up|12|||
146219217|NCT04810650|527317437|FG002|Overall Study|Lost to Follow-up|7|||
146219218|NCT04810650|527317438|FG003|Overall Study|Lost to Follow-up|9|||
146219219|NCT04810650|527317439|FG004|Overall Study|Lost to Follow-up|10|||
146219220|NCT04810650|527317440|FG005|Overall Study|Lost to Follow-up|6|||
146219221|NCT04810650|527317441|FG006|Overall Study|Lost to Follow-up|0|||
146219222|NCT04810650|527317442|FG007|Overall Study|Lost to Follow-up|0|||
146219223|NCT04810650|527317443|FG008|Overall Study|Lost to Follow-up|0|||
146219224|NCT04810650|527317444|FG009|Overall Study|Lost to Follow-up|0|||
146219225|NCT04810650|527317445|FG010|Overall Study|Lost to Follow-up|1|||
146219226|NCT04810650|527317446|FG011|Overall Study|Lost to Follow-up|0|||
145960859|NCT01051921|526369414|FG000|Overall Study|Lost to Follow-up|4|||
146219227|NCT04810650|527317447|FG012|Overall Study|Lost to Follow-up|3|||
145960860|NCT01051921|526369414|FG000|Overall Study|virological failure|1|||
146219228|NCT04810650|527317448|FG013|Overall Study|Lost to Follow-up|9|||
146219229|NCT04810650|527317435|FG000|Overall Study|Participant declined|0|||
146219230|NCT04810650|527317436|FG001|Overall Study|Participant declined|0|||
146219231|NCT04810650|527317437|FG002|Overall Study|Participant declined|0|||
146219232|NCT04810650|527317438|FG003|Overall Study|Participant declined|0|||
146219233|NCT04810650|527317439|FG004|Overall Study|Participant declined|0|||
146219234|NCT04810650|527317440|FG005|Overall Study|Participant declined|0|||
146219235|NCT04810650|527317441|FG006|Overall Study|Participant declined|0|||
146219236|NCT04810650|527317442|FG007|Overall Study|Participant declined|0|||
146219237|NCT04810650|527317443|FG008|Overall Study|Participant declined|0|||
146219238|NCT04810650|527317444|FG009|Overall Study|Participant declined|0|||
146219239|NCT04810650|527317445|FG010|Overall Study|Participant declined|2|||
146219240|NCT04810650|527317446|FG011|Overall Study|Participant declined|0|||
146219241|NCT04810650|527317447|FG012|Overall Study|Participant declined|0|||
146219242|NCT04810650|527317448|FG013|Overall Study|Participant declined|0|||
146219243|NCT05794243|527317449|FG000|Overall Study|Withdrawal by Subject|1|||
146219244|NCT05794243|527317450|FG001|Overall Study|Withdrawal by Subject|0|||
146219245|NCT05794243|527317451|FG002|Overall Study|Withdrawal by Subject|1|||
146219246|NCT05794243|527317449|FG000|Overall Study|Physician Decision|0|||
146219247|NCT05794243|527317450|FG001|Overall Study|Physician Decision|3|||
146219248|NCT05794243|527317451|FG002|Overall Study|Physician Decision|1|||
146219249|NCT04652700|527317454|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
146219250|NCT04652700|527317455|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
146219251|NCT04652700|527317454|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
146219252|NCT04652700|527317455|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
146219253|NCT04652700|527317454|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
146219254|NCT04652700|527317455|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
146219255|NCT04652700|527317454|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
146219256|NCT04652700|527317455|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
146084561|NCT00420641|526830210|FG000|Overall Study|Protocol Violation|8|||
145960861|NCT01051921|526369414|FG000|Overall Study|patient moved|1|||
146219257|NCT04652700|527317454|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
146219258|NCT04652700|527317455|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
146219259|NCT04652700|527317454|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
146219260|NCT04652700|527317455|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
146219261|NCT04652700|527317454|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
146219262|NCT04652700|527317455|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
146219263|NCT04652700|527317454|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
146219264|NCT04652700|527317455|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
146219265|NCT04652700|527317454|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
146219266|NCT04652700|527317455|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
146219267|NCT04187833|527317456|FG000|Overall Study|Withdrawal by Subject|1|||
146219268|NCT04209465|527317459|FG000|Overall Study|Adverse Event|0|||
146219269|NCT04209465|527317460|FG001|Overall Study|Adverse Event|0|||
146219270|NCT04209465|527317461|FG002|Overall Study|Adverse Event|0|||
146219271|NCT04209465|527317462|FG003|Overall Study|Adverse Event|0|||
146219272|NCT04209465|527317463|FG004|Overall Study|Adverse Event|0|||
146219273|NCT04209465|527317464|FG005|Overall Study|Adverse Event|1|||
146219274|NCT04209465|527317465|FG006|Overall Study|Adverse Event|0|||
146219275|NCT04209465|527317466|FG007|Overall Study|Adverse Event|0|||
146219276|NCT04209465|527317467|FG008|Overall Study|Adverse Event|1|||
146219277|NCT04209465|527317468|FG009|Overall Study|Adverse Event|0|||
146219278|NCT04209465|527317469|FG010|Overall Study|Adverse Event|2|||
146219279|NCT04209465|527317470|FG011|Overall Study|Adverse Event|1|||
146219280|NCT04209465|527317471|FG012|Overall Study|Adverse Event|1|||
146219281|NCT04209465|527317459|FG000|Overall Study|Death|1|||
146219282|NCT04209465|527317460|FG001|Overall Study|Death|0|||
146219283|NCT04209465|527317461|FG002|Overall Study|Death|0|||
146219284|NCT04209465|527317462|FG003|Overall Study|Death|0|||
146219285|NCT04209465|527317463|FG004|Overall Study|Death|2|||
146219286|NCT04209465|527317464|FG005|Overall Study|Death|7|||
146219287|NCT04209465|527317465|FG006|Overall Study|Death|2|||
146219288|NCT04209465|527317466|FG007|Overall Study|Death|2|||
146219289|NCT04209465|527317467|FG008|Overall Study|Death|1|||
146219290|NCT04209465|527317468|FG009|Overall Study|Death|1|||
146219291|NCT04209465|527317469|FG010|Overall Study|Death|1|||
146219292|NCT04209465|527317470|FG011|Overall Study|Death|0|||
146219293|NCT04209465|527317471|FG012|Overall Study|Death|10|||
146219294|NCT04209465|527317459|FG000|Overall Study|Physician Decision|0|||
146219295|NCT04209465|527317460|FG001|Overall Study|Physician Decision|1|||
146219296|NCT04209465|527317461|FG002|Overall Study|Physician Decision|0|||
146219297|NCT04209465|527317462|FG003|Overall Study|Physician Decision|0|||
146288100|NCT00126503|527569429|FG000|Overall Study|Death|3|||
146219298|NCT04209465|527317463|FG004|Overall Study|Physician Decision|0|||
146219299|NCT04209465|527317464|FG005|Overall Study|Physician Decision|0|||
146219300|NCT04209465|527317465|FG006|Overall Study|Physician Decision|0|||
146219301|NCT04209465|527317466|FG007|Overall Study|Physician Decision|0|||
146219302|NCT04209465|527317467|FG008|Overall Study|Physician Decision|0|||
146219303|NCT04209465|527317468|FG009|Overall Study|Physician Decision|0|||
146219304|NCT04209465|527317469|FG010|Overall Study|Physician Decision|0|||
146219305|NCT04209465|527317470|FG011|Overall Study|Physician Decision|0|||
146219306|NCT04209465|527317471|FG012|Overall Study|Physician Decision|0|||
146219307|NCT04209465|527317459|FG000|Overall Study|Progressive Disease|0|||
146219308|NCT04209465|527317460|FG001|Overall Study|Progressive Disease|0|||
146219309|NCT04209465|527317461|FG002|Overall Study|Progressive Disease|1|||
146219310|NCT04209465|527317462|FG003|Overall Study|Progressive Disease|2|||
146219311|NCT04209465|527317463|FG004|Overall Study|Progressive Disease|8|||
146219312|NCT04209465|527317464|FG005|Overall Study|Progressive Disease|5|||
146219313|NCT04209465|527317465|FG006|Overall Study|Progressive Disease|3|||
146219314|NCT04209465|527317466|FG007|Overall Study|Progressive Disease|4|||
146219315|NCT04209465|527317467|FG008|Overall Study|Progressive Disease|1|||
146219316|NCT04209465|527317468|FG009|Overall Study|Progressive Disease|3|||
146219317|NCT04209465|527317469|FG010|Overall Study|Progressive Disease|2|||
146219318|NCT04209465|527317470|FG011|Overall Study|Progressive Disease|1|||
146219319|NCT04209465|527317471|FG012|Overall Study|Progressive Disease|0|||
146219320|NCT04209465|527317459|FG000|Overall Study|Withdrawal by Subject|0|||
146219321|NCT04209465|527317460|FG001|Overall Study|Withdrawal by Subject|0|||
146219322|NCT04209465|527317461|FG002|Overall Study|Withdrawal by Subject|0|||
146219323|NCT04209465|527317462|FG003|Overall Study|Withdrawal by Subject|0|||
146219324|NCT04209465|527317463|FG004|Overall Study|Withdrawal by Subject|0|||
146219325|NCT04209465|527317464|FG005|Overall Study|Withdrawal by Subject|1|||
146219326|NCT04209465|527317465|FG006|Overall Study|Withdrawal by Subject|2|||
145882108|NCT03653026|526074708|FG003|Part 1: Placebo-controlled Period|Other|0|||
145882109|NCT03653026|526074705|FG000|Part 2: Open-label Extension|Adverse Event|0|||
145882110|NCT03653026|526074706|FG001|Part 2: Open-label Extension|Adverse Event|0|||
145882111|NCT03653026|526074707|FG002|Part 2: Open-label Extension|Adverse Event|1|||
145882112|NCT03653026|526074708|FG003|Part 2: Open-label Extension|Adverse Event|1|||
145882113|NCT03653026|526074705|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145882114|NCT03653026|526074706|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145882115|NCT03653026|526074707|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
145882116|NCT03653026|526074708|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
145882117|NCT03653026|526074705|FG000|Part 2: Open-label Extension|Other|0|||
145882118|NCT03653026|526074706|FG001|Part 2: Open-label Extension|Other|0|||
145882119|NCT03653026|526074707|FG002|Part 2: Open-label Extension|Other|1|||
145882120|NCT03653026|526074708|FG003|Part 2: Open-label Extension|Other|2|||
145882121|NCT02457819|526074714|FG000|Overall Study|reason not given|8|||
145882122|NCT02457819|526074714|FG000|Overall Study|Withdrawal by Subject|24|||
146219327|NCT04209465|527317466|FG007|Overall Study|Withdrawal by Subject|0|||
146219328|NCT04209465|527317467|FG008|Overall Study|Withdrawal by Subject|1|||
146219329|NCT04209465|527317468|FG009|Overall Study|Withdrawal by Subject|0|||
146219330|NCT04209465|527317469|FG010|Overall Study|Withdrawal by Subject|0|||
146219331|NCT04209465|527317470|FG011|Overall Study|Withdrawal by Subject|2|||
146219332|NCT04209465|527317471|FG012|Overall Study|Withdrawal by Subject|2|||
146219333|NCT04209465|527317459|FG000|Overall Study|Lost to Follow-up|0|||
146219334|NCT04209465|527317460|FG001|Overall Study|Lost to Follow-up|0|||
146219335|NCT04209465|527317461|FG002|Overall Study|Lost to Follow-up|0|||
146219336|NCT04209465|527317462|FG003|Overall Study|Lost to Follow-up|0|||
146219337|NCT04209465|527317463|FG004|Overall Study|Lost to Follow-up|0|||
146219338|NCT04209465|527317464|FG005|Overall Study|Lost to Follow-up|1|||
146219339|NCT04209465|527317465|FG006|Overall Study|Lost to Follow-up|0|||
146219340|NCT04209465|527317466|FG007|Overall Study|Lost to Follow-up|0|||
146219341|NCT04209465|527317467|FG008|Overall Study|Lost to Follow-up|1|||
146219342|NCT04209465|527317468|FG009|Overall Study|Lost to Follow-up|0|||
146219343|NCT04209465|527317469|FG010|Overall Study|Lost to Follow-up|0|||
146219344|NCT04209465|527317470|FG011|Overall Study|Lost to Follow-up|1|||
146219345|NCT04209465|527317471|FG012|Overall Study|Lost to Follow-up|0|||
146219346|NCT04209465|527317459|FG000|Overall Study|Started new therapy|0|||
146219347|NCT04209465|527317460|FG001|Overall Study|Started new therapy|0|||
146219348|NCT04209465|527317461|FG002|Overall Study|Started new therapy|0|||
146219349|NCT04209465|527317462|FG003|Overall Study|Started new therapy|0|||
146219350|NCT04209465|527317463|FG004|Overall Study|Started new therapy|0|||
146219351|NCT04209465|527317464|FG005|Overall Study|Started new therapy|1|||
146219352|NCT04209465|527317465|FG006|Overall Study|Started new therapy|0|||
146219353|NCT04209465|527317466|FG007|Overall Study|Started new therapy|0|||
146219354|NCT04209465|527317467|FG008|Overall Study|Started new therapy|0|||
146219355|NCT04209465|527317468|FG009|Overall Study|Started new therapy|0|||
146219356|NCT04209465|527317469|FG010|Overall Study|Started new therapy|0|||
146219357|NCT04209465|527317470|FG011|Overall Study|Started new therapy|0|||
146219358|NCT04209465|527317471|FG012|Overall Study|Started new therapy|0|||
146219359|NCT04209465|527317459|FG000|Overall Study|Study terminated early by sponsor|0|||
146219360|NCT04209465|527317460|FG001|Overall Study|Study terminated early by sponsor|0|||
146219361|NCT04209465|527317461|FG002|Overall Study|Study terminated early by sponsor|0|||
145882123|NCT02457819|526074714|FG000|Overall Study|Protocol Violation|1|||
145882124|NCT02457819|526074714|FG000|Overall Study|non compliance with study drug|4|||
145960862|NCT01001429|526369415|FG000|Overall Study|surgery cancelled|0|||
146219362|NCT04209465|527317462|FG003|Overall Study|Study terminated early by sponsor|0|||
146219363|NCT04209465|527317463|FG004|Overall Study|Study terminated early by sponsor|0|||
146219364|NCT04209465|527317464|FG005|Overall Study|Study terminated early by sponsor|0|||
146219365|NCT04209465|527317465|FG006|Overall Study|Study terminated early by sponsor|3|||
146219366|NCT04209465|527317466|FG007|Overall Study|Study terminated early by sponsor|0|||
146219367|NCT04209465|527317467|FG008|Overall Study|Study terminated early by sponsor|0|||
146219368|NCT04209465|527317468|FG009|Overall Study|Study terminated early by sponsor|0|||
146219369|NCT04209465|527317469|FG010|Overall Study|Study terminated early by sponsor|0|||
146219370|NCT04209465|527317470|FG011|Overall Study|Study terminated early by sponsor|0|||
146219371|NCT04209465|527317471|FG012|Overall Study|Study terminated early by sponsor|3|||
146219372|NCT04209465|527317459|FG000|Overall Study|Other|0|||
146219373|NCT04209465|527317460|FG001|Overall Study|Other|0|||
146219374|NCT04209465|527317461|FG002|Overall Study|Other|0|||
146219375|NCT04209465|527317462|FG003|Overall Study|Other|0|||
146219376|NCT04209465|527317463|FG004|Overall Study|Other|0|||
146219377|NCT04209465|527317464|FG005|Overall Study|Other|0|||
146219378|NCT04209465|527317465|FG006|Overall Study|Other|0|||
146219379|NCT04209465|527317466|FG007|Overall Study|Other|0|||
146219380|NCT04209465|527317467|FG008|Overall Study|Other|1|||
146219381|NCT04209465|527317468|FG009|Overall Study|Other|0|||
146219382|NCT04209465|527317469|FG010|Overall Study|Other|0|||
146219383|NCT04209465|527317470|FG011|Overall Study|Other|0|||
146219384|NCT04209465|527317471|FG012|Overall Study|Other|0|||
146219385|NCT03097549|527317472|FG000|Overall Study|Withdrawal by Subject|1|||
146219386|NCT03097549|527317473|FG001|Overall Study|Withdrawal by Subject|0|||
146219387|NCT03097549|527317472|FG000|Overall Study|Lost to Follow-up|1|||
146219388|NCT03097549|527317473|FG001|Overall Study|Lost to Follow-up|0|||
146219389|NCT05783102|527317474|FG000|Overall Study|Lost to Follow-up|1|||
146219390|NCT05783102|527317474|FG000|Overall Study|Withdrawal by Subject|2|||
146219391|NCT01744782|527319038|FG000|Overall Study|Death|1|||
146219392|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Physician Decision|1|||
146219393|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Physician Decision|0|||
146219394|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
146219395|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
146219396|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
146219397|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
146219398|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Pregnancy|0|||
146219399|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Pregnancy|2|||
146219400|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
146219401|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
146219402|NCT01785719|527319039|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
146219403|NCT01785719|527319040|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
146219404|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
146219405|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
146219406|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
146219407|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
146219408|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
146219409|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
146219410|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
146219411|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
146219412|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
146219413|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
146219414|NCT01785719|527319039|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
146219415|NCT01785719|527319040|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
146219416|NCT01785719|527319039|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
146219417|NCT01785719|527319040|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
146219418|NCT01785719|527319039|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
146219419|NCT01785719|527319040|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
146219420|NCT01785719|527319039|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
146219421|NCT01785719|527319040|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
146219422|NCT04977947|527319043|FG000|Overall Study|Lost to Follow-up|1|||
146219423|NCT04977947|527319044|FG001|Overall Study|Lost to Follow-up|1|||
146219424|NCT05875142|527319045|FG000|Overall Study|Lost to Follow-up|0|||
146219425|NCT05875142|527319046|FG001|Overall Study|Lost to Follow-up|1|||
146219426|NCT05875142|527319047|FG002|Overall Study|Lost to Follow-up|1|||
146219427|NCT03436290|527319048|FG000|Overall Study|Post-randomization Exclusion|1|||
146219428|NCT03436290|527319049|FG001|Overall Study|Post-randomization Exclusion|0|||
146219429|NCT03436290|527319048|FG000|Overall Study|Death|6|||
146219430|NCT03436290|527319049|FG001|Overall Study|Death|0|||
146219431|NCT03436290|527319048|FG000|Overall Study|Withdrawal by Subject|4|||
146219432|NCT03436290|527319049|FG001|Overall Study|Withdrawal by Subject|0|||
146219433|NCT03436290|527319048|FG000|Overall Study|Protocol Violation|30|||
146219434|NCT03436290|527319049|FG001|Overall Study|Protocol Violation|0|||
146219435|NCT04142788|527319050|FG000|Overall Study|Trial terminated prematurely|2|||
146219436|NCT04142788|527319051|FG001|Overall Study|Trial terminated prematurely|2|||
146084562|NCT00420641|526830211|FG001|Overall Study|Protocol Violation|8|||
146219437|NCT03891667|527319059|FG000|Overall Study|Physician Decision|1|||
146219438|NCT03891667|527319060|FG001|Overall Study|Physician Decision|1|||
146219439|NCT03891667|527319059|FG000|Overall Study|COVID related pause|1|||
146219440|NCT03891667|527319060|FG001|Overall Study|COVID related pause|0|||
146219441|NCT03891667|527319059|FG000|Overall Study|Withdrawal by Subject|0|||
146219442|NCT03891667|527319060|FG001|Overall Study|Withdrawal by Subject|1|||
146219443|NCT03891667|527319059|FG000|Overall Study|Adverse Event|0|||
146219444|NCT03891667|527319060|FG001|Overall Study|Adverse Event|1|||
146288101|NCT00126503|527569430|FG001|Overall Study|Death|0|||
146288102|NCT00126503|527569429|FG000|Overall Study|Adverse Event|13|||
146288103|NCT00126503|527569430|FG001|Overall Study|Adverse Event|3|||
146288104|NCT00126503|527569429|FG000|Overall Study|non-compliant|1|||
146288105|NCT00126503|527569430|FG001|Overall Study|non-compliant|0|||
146288106|NCT00126503|527569429|FG000|Overall Study|Physician Decision|2|||
146288107|NCT00126503|527569430|FG001|Overall Study|Physician Decision|1|||
146288108|NCT02457559|527569431|FG000|Overall Study|Progressive Disease|1|||
146288109|NCT02457559|527569432|FG001|Overall Study|Progressive Disease|2|||
146288110|NCT02457559|527569433|FG002|Overall Study|Progressive Disease|3|||
146288111|NCT02457559|527569434|FG003|Overall Study|Progressive Disease|0|||
146288112|NCT02457559|527569435|FG004|Overall Study|Progressive Disease|0|||
146288113|NCT02457559|527569436|FG005|Overall Study|Progressive Disease|2|||
146288114|NCT02457559|527569437|FG006|Overall Study|Progressive Disease|1|||
146288115|NCT02457559|527569438|FG007|Overall Study|Progressive Disease|0|||
146288116|NCT02457559|527569439|FG008|Overall Study|Progressive Disease|1|||
146288117|NCT02457559|527569440|FG009|Overall Study|Progressive Disease|1|||
146288118|NCT02457559|527569441|FG010|Overall Study|Progressive Disease|1|||
146288119|NCT02457559|527569431|FG000|Overall Study|Investigator's Discretion|0|||
146288120|NCT02457559|527569432|FG001|Overall Study|Investigator's Discretion|0|||
146288121|NCT02457559|527569433|FG002|Overall Study|Investigator's Discretion|2|||
146288122|NCT02457559|527569434|FG003|Overall Study|Investigator's Discretion|0|||
146288123|NCT02457559|527569435|FG004|Overall Study|Investigator's Discretion|1|||
146288124|NCT02457559|527569436|FG005|Overall Study|Investigator's Discretion|0|||
146288125|NCT02457559|527569437|FG006|Overall Study|Investigator's Discretion|1|||
146288126|NCT02457559|527569438|FG007|Overall Study|Investigator's Discretion|0|||
146288127|NCT02457559|527569439|FG008|Overall Study|Investigator's Discretion|1|||
146288128|NCT02457559|527569440|FG009|Overall Study|Investigator's Discretion|0|||
146288129|NCT02457559|527569441|FG010|Overall Study|Investigator's Discretion|1|||
146288130|NCT02457559|527569431|FG000|Overall Study|Adverse Event|0|||
146288131|NCT02457559|527569432|FG001|Overall Study|Adverse Event|1|||
146288132|NCT02457559|527569433|FG002|Overall Study|Adverse Event|2|||
146288133|NCT02457559|527569434|FG003|Overall Study|Adverse Event|0|||
146288134|NCT02457559|527569435|FG004|Overall Study|Adverse Event|0|||
146288135|NCT02457559|527569436|FG005|Overall Study|Adverse Event|0|||
146288136|NCT02457559|527569437|FG006|Overall Study|Adverse Event|0|||
146288137|NCT02457559|527569438|FG007|Overall Study|Adverse Event|0|||
146288138|NCT02457559|527569439|FG008|Overall Study|Adverse Event|0|||
146288139|NCT02457559|527569440|FG009|Overall Study|Adverse Event|0|||
146288140|NCT02457559|527569441|FG010|Overall Study|Adverse Event|0|||
146288141|NCT02457559|527569431|FG000|Overall Study|Reason not Specified|1|||
146288142|NCT02457559|527569432|FG001|Overall Study|Reason not Specified|0|||
146288143|NCT02457559|527569433|FG002|Overall Study|Reason not Specified|0|||
146288144|NCT02457559|527569434|FG003|Overall Study|Reason not Specified|0|||
146288145|NCT02457559|527569435|FG004|Overall Study|Reason not Specified|0|||
146288146|NCT02457559|527569436|FG005|Overall Study|Reason not Specified|0|||
146288147|NCT02457559|527569437|FG006|Overall Study|Reason not Specified|0|||
146219445|NCT04256941|527319061|FG000|Overall Study|Withdrawal by Subject|0|||
146219446|NCT04256941|527319062|FG001|Overall Study|Withdrawal by Subject|1|||
146219447|NCT04256941|527319061|FG000|Overall Study|Death|1|||
146219448|NCT04256941|527319062|FG001|Overall Study|Death|0|||
146219449|NCT04256941|527319061|FG000|Overall Study|Disease Progession|0|||
146219450|NCT04256941|527319062|FG001|Overall Study|Disease Progession|2|||
146219451|NCT04717492|527319079|FG000|Overall Study|Withdrawal by Subject|2|||
146219452|NCT04717492|527319080|FG001|Overall Study|Withdrawal by Subject|13|||
146219453|NCT04717492|527319079|FG000|Overall Study|Lost to Follow-up|2|||
146219454|NCT04717492|527319080|FG001|Overall Study|Lost to Follow-up|9|||
146219455|NCT04456517|527319081|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
146219456|NCT04456517|527319082|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
146219457|NCT03766009|527319083|FG000|Usual Care|Death|0|||
146288148|NCT02457559|527569438|FG007|Overall Study|Reason not Specified|0|||
146288149|NCT02457559|527569439|FG008|Overall Study|Reason not Specified|0|||
146288150|NCT02457559|527569440|FG009|Overall Study|Reason not Specified|2|||
146288151|NCT02457559|527569441|FG010|Overall Study|Reason not Specified|0|||
146288152|NCT02457559|527569431|FG000|Overall Study|Death|0|||
146288153|NCT02457559|527569432|FG001|Overall Study|Death|0|||
146288154|NCT02457559|527569433|FG002|Overall Study|Death|0|||
146288155|NCT02457559|527569434|FG003|Overall Study|Death|0|||
146288156|NCT02457559|527569435|FG004|Overall Study|Death|0|||
146288157|NCT02457559|527569436|FG005|Overall Study|Death|0|||
146288158|NCT02457559|527569437|FG006|Overall Study|Death|0|||
146288159|NCT02457559|527569438|FG007|Overall Study|Death|0|||
146288160|NCT02457559|527569439|FG008|Overall Study|Death|1|||
146288161|NCT02457559|527569440|FG009|Overall Study|Death|1|||
146219458|NCT03766009|527319084|FG001|Usual Care|Death|0|||
146219459|NCT03766009|527319085|FG002|Usual Care|Death|0|||
146219460|NCT03766009|527319086|FG003|Usual Care|Death|1|||
146219461|NCT03766009|527319087|FG004|Usual Care|Death|0|||
146219462|NCT03766009|527319088|FG005|Usual Care|Death|0|||
146219463|NCT03766009|527319083|FG000|Usual Care|Lost to Follow-up|0|||
146219464|NCT03766009|527319084|FG001|Usual Care|Lost to Follow-up|0|||
146219465|NCT03766009|527319085|FG002|Usual Care|Lost to Follow-up|0|||
146219466|NCT03766009|527319086|FG003|Usual Care|Lost to Follow-up|1|||
146219467|NCT03766009|527319087|FG004|Usual Care|Lost to Follow-up|0|||
146219468|NCT03766009|527319088|FG005|Usual Care|Lost to Follow-up|0|||
146219469|NCT03766009|527319083|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
146219470|NCT03766009|527319084|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
146219471|NCT03766009|527319085|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
146219472|NCT03766009|527319086|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
146219473|NCT03766009|527319087|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
146219474|NCT03766009|527319088|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
146219475|NCT03766009|527319083|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146219476|NCT03766009|527319084|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
146219477|NCT03766009|527319085|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146219478|NCT03766009|527319086|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
146219479|NCT03766009|527319087|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146219480|NCT03766009|527319088|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
146219481|NCT03766009|527319083|FG000|Usual Care|No treatment or declined surgery|0|||
146219482|NCT03766009|527319084|FG001|Usual Care|No treatment or declined surgery|0|||
146219483|NCT03766009|527319085|FG002|Usual Care|No treatment or declined surgery|0|||
146219484|NCT03766009|527319086|FG003|Usual Care|No treatment or declined surgery|2|||
146219485|NCT03766009|527319087|FG004|Usual Care|No treatment or declined surgery|0|||
146219486|NCT03766009|527319088|FG005|Usual Care|No treatment or declined surgery|0|||
146219487|NCT03766009|527319083|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
146219488|NCT03766009|527319084|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
146219489|NCT03766009|527319085|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
146219490|NCT03766009|527319086|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
146219491|NCT03766009|527319087|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
146219492|NCT03766009|527319088|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
146219493|NCT03766009|527319083|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146219494|NCT03766009|527319084|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
146219495|NCT03766009|527319085|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146219496|NCT03766009|527319086|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146219497|NCT03766009|527319087|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146219498|NCT03766009|527319088|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
146219499|NCT03766009|527319083|FG000|Usual Care|Ineligible|0|||
146219500|NCT03766009|527319084|FG001|Usual Care|Ineligible|1|||
146219501|NCT03766009|527319085|FG002|Usual Care|Ineligible|0|||
146219502|NCT03766009|527319086|FG003|Usual Care|Ineligible|0|||
146219503|NCT03766009|527319087|FG004|Usual Care|Ineligible|0|||
146219504|NCT03766009|527319088|FG005|Usual Care|Ineligible|0|||
146219505|NCT03766009|527319083|FG000|Usual Care|Other: Staff turnover|0|||
146219506|NCT03766009|527319084|FG001|Usual Care|Other: Staff turnover|0|||
146219507|NCT03766009|527319085|FG002|Usual Care|Other: Staff turnover|0|||
146219508|NCT03766009|527319086|FG003|Usual Care|Other: Staff turnover|0|||
146219509|NCT03766009|527319087|FG004|Usual Care|Other: Staff turnover|0|||
146219510|NCT03766009|527319088|FG005|Usual Care|Other: Staff turnover|2|||
146219511|NCT03936322|527319093|FG000|Overall Study|Lost to Follow-up|1|||
145882125|NCT02457819|526074714|FG000|Overall Study|Lost to Follow-up|10|||
145882126|NCT02457819|526074714|FG000|Overall Study|Lack of Efficacy|19|||
145882127|NCT02457819|526074714|FG000|Overall Study|Adverse Event|33|||
145882128|NCT01933919|526074715|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
145882129|NCT01933919|526074716|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
145882130|NCT01933919|526074715|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
145882131|NCT01933919|526074716|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
145882132|NCT01933919|526074715|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
145882133|NCT01933919|526074716|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
145882134|NCT01933919|526074715|FG000|Open-label Long-term Phase|Adverse Event|2|||
145882135|NCT01933919|526074716|FG001|Open-label Long-term Phase|Adverse Event|0|||
145882136|NCT01933919|526074715|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
145882137|NCT01933919|526074716|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
145882138|NCT01933919|526074715|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
146219512|NCT03936322|527319093|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
146219513|NCT02734290|527319094|FG000|Overall Study|Adverse Event|1|||
145960863|NCT01001429|526369416|FG001|Overall Study|surgery cancelled|1|||
146219514|NCT02734290|527319095|FG001|Overall Study|Adverse Event|0|||
145960864|NCT01063855|526369417|FG000|Overall Study|Adverse Event|4|||
145960865|NCT01063855|526369418|FG001|Overall Study|Adverse Event|4|||
145960866|NCT01063855|526369417|FG000|Overall Study|Death|0|||
145960867|NCT01063855|526369418|FG001|Overall Study|Death|1|||
145960868|NCT01063855|526369417|FG000|Overall Study|Lost to Follow-up|8|||
145960869|NCT01063855|526369418|FG001|Overall Study|Lost to Follow-up|4|||
145960870|NCT01063855|526369417|FG000|Overall Study|Pregnancy|1|||
145960871|NCT01063855|526369418|FG001|Overall Study|Pregnancy|0|||
145960872|NCT01063855|526369417|FG000|Overall Study|Lack of Efficacy|0|||
145960873|NCT01063855|526369418|FG001|Overall Study|Lack of Efficacy|1|||
145960874|NCT01063855|526369417|FG000|Overall Study|Withdrawal by Subject|11|||
145960875|NCT01063855|526369418|FG001|Overall Study|Withdrawal by Subject|8|||
145960876|NCT01063855|526369417|FG000|Overall Study|Reason not specified|13|||
145960877|NCT01063855|526369418|FG001|Overall Study|Reason not specified|11|||
145960878|NCT01165307|526369419|FG000|Overall Study|Lost to Follow-up|11|||
145960879|NCT01165307|526369420|FG001|Overall Study|Lost to Follow-up|3|||
145960880|NCT01165307|526369419|FG000|Overall Study|Withdrawal by Subject|2|||
145960881|NCT01165307|526369420|FG001|Overall Study|Withdrawal by Subject|0|||
145960882|NCT01165307|526369419|FG000|Overall Study|Subject not available for contact|1|||
145960883|NCT01165307|526369420|FG001|Overall Study|Subject not available for contact|0|||
145960884|NCT03627832|526369425|FG000|Overall Study|Withdrawal by Subject|10|||
145960885|NCT03627832|526369426|FG001|Overall Study|Withdrawal by Subject|1|||
145960886|NCT00048035|526369432|FG000|Core Period|Early Withdrawals|4|||
145960887|NCT00048035|526369433|FG001|Core Period|Early Withdrawals|2|||
145960888|NCT00048035|526369434|FG002|Core Period|Early Withdrawals|1|||
146219515|NCT02734290|527319094|FG000|Overall Study|Death|1|||
146219516|NCT02734290|527319095|FG001|Overall Study|Death|0|||
146219517|NCT03829410|527319097|FG000|Overall Study|Adverse Event|1|||
146219518|NCT03829410|527319098|FG001|Overall Study|Adverse Event|0|||
146219519|NCT03829410|527319099|FG002|Overall Study|Adverse Event|1|||
146219520|NCT03829410|527319100|FG003|Overall Study|Adverse Event|4|||
146219521|NCT03829410|527319097|FG000|Overall Study|Physician Decision|0|||
146219522|NCT03829410|527319098|FG001|Overall Study|Physician Decision|0|||
146219523|NCT03829410|527319099|FG002|Overall Study|Physician Decision|0|||
146219524|NCT03829410|527319100|FG003|Overall Study|Physician Decision|2|||
146219525|NCT03829410|527319097|FG000|Overall Study|Disease Progressing|3|||
146219526|NCT03829410|527319098|FG001|Overall Study|Disease Progressing|4|||
146219527|NCT03829410|527319099|FG002|Overall Study|Disease Progressing|2|||
146219528|NCT03829410|527319100|FG003|Overall Study|Disease Progressing|31|||
146219529|NCT03829410|527319097|FG000|Overall Study|Miscellaneous|2|||
146219530|NCT03829410|527319098|FG001|Overall Study|Miscellaneous|4|||
146219531|NCT03829410|527319099|FG002|Overall Study|Miscellaneous|3|||
146219532|NCT03829410|527319100|FG003|Overall Study|Miscellaneous|10|||
146219533|NCT04676022|527319101|FG000|Overall Study|Screen Failure/|1|||
146219534|NCT04676022|527319102|FG001|Overall Study|Screen Failure/|1|||
146219535|NCT04676022|527319103|FG002|Overall Study|Screen Failure/|85|||
146219536|NCT04676022|527319101|FG000|Overall Study|Lost to Follow-up|1|||
146219537|NCT04676022|527319102|FG001|Overall Study|Lost to Follow-up|1|||
146219538|NCT04676022|527319103|FG002|Overall Study|Lost to Follow-up|0|||
146219539|NCT04676022|527319101|FG000|Overall Study|Adverse Event|2|||
146219540|NCT04676022|527319102|FG001|Overall Study|Adverse Event|0|||
146219541|NCT04676022|527319103|FG002|Overall Study|Adverse Event|1|||
146219542|NCT04676022|527319101|FG000|Overall Study|Physician Decision|2|||
145960889|NCT00048035|526369435|FG003|Core Period|Early Withdrawals|1|||
145960890|NCT00048035|526369436|FG004|Core Period|Early Withdrawals|1|||
145960891|NCT00048035|526369437|FG005|Core Period|Early Withdrawals|1|||
146219543|NCT04676022|527319102|FG001|Overall Study|Physician Decision|0|||
146219544|NCT04676022|527319103|FG002|Overall Study|Physician Decision|1|||
146219545|NCT04676022|527319101|FG000|Overall Study|Withdrawal by Subject|3|||
146219546|NCT04676022|527319102|FG001|Overall Study|Withdrawal by Subject|1|||
146219547|NCT04676022|527319103|FG002|Overall Study|Withdrawal by Subject|6|||
146219548|NCT04676022|527319101|FG000|Overall Study|Will not move forward with permanent implant|6|||
146219549|NCT04676022|527319102|FG001|Overall Study|Will not move forward with permanent implant|0|||
146219550|NCT04676022|527319103|FG002|Overall Study|Will not move forward with permanent implant|0|||
145960892|NCT00048035|526369438|FG006|Core Period|Early Withdrawals|0|||
145960893|NCT00048035|526369439|FG007|Core Period|Early Withdrawals|0|||
146219551|NCT04676022|527319101|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
146219552|NCT04676022|527319102|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
146219553|NCT04676022|527319103|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
146219554|NCT05409183|527319105|FG000|Complete Study|Adverse Event|1|||
146219555|NCT05409183|527319106|FG001|Complete Study|Adverse Event|2|||
146219556|NCT05409183|527319105|FG000|Complete Study|Withdrawal by Subject|3|||
146219557|NCT05409183|527319106|FG001|Complete Study|Withdrawal by Subject|0|||
146219558|NCT02936752|527319107|FG000|Overall Study|Death|2|||
146084563|NCT00420641|526830212|FG002|Overall Study|Protocol Violation|7|||
145960894|NCT00048035|526369432|FG000|Extension Year 1|Early Withdrawals|0|||
145960895|NCT00048035|526369433|FG001|Extension Year 1|Early Withdrawals|0|||
145960896|NCT00048035|526369434|FG002|Extension Year 1|Early Withdrawals|0|||
145960897|NCT00048035|526369435|FG003|Extension Year 1|Early Withdrawals|0|||
145960898|NCT00048035|526369436|FG004|Extension Year 1|Early Withdrawals|0|||
145960899|NCT00048035|526369437|FG005|Extension Year 1|Early Withdrawals|0|||
145960900|NCT00048035|526369438|FG006|Extension Year 1|Early Withdrawals|11|||
145960901|NCT00048035|526369439|FG007|Extension Year 1|Early Withdrawals|11|||
145960902|NCT00048035|526369432|FG000|Extension Year 2|Early Withdrawals|0|||
145960903|NCT00048035|526369433|FG001|Extension Year 2|Early Withdrawals|0|||
145960904|NCT00048035|526369434|FG002|Extension Year 2|Early Withdrawals|0|||
145960905|NCT00048035|526369435|FG003|Extension Year 2|Early Withdrawals|0|||
145960906|NCT00048035|526369436|FG004|Extension Year 2|Early Withdrawals|0|||
145960907|NCT00048035|526369437|FG005|Extension Year 2|Early Withdrawals|0|||
145960908|NCT00048035|526369438|FG006|Extension Year 2|Early Withdrawals|3|||
146219559|NCT02936752|527319108|FG001|Overall Study|Death|1|||
146219560|NCT02936752|527319107|FG000|Overall Study|Physician Decision|4|||
146219561|NCT02936752|527319108|FG001|Overall Study|Physician Decision|0|||
146219562|NCT02936752|527319107|FG000|Overall Study|Withdrawal by Subject|0|||
146219563|NCT02936752|527319108|FG001|Overall Study|Withdrawal by Subject|2|||
146219564|NCT05282173|527319119|FG000|Overall Study|Missed|3|||
146219565|NCT05282173|527319120|FG001|Overall Study|Missed|2|||
146219566|NCT05282173|527319121|FG002|Overall Study|Missed|4|||
146219567|NCT04719390|527319127|FG000|Overall Study|Withdrawal by Subject|1|||
146219568|NCT03307343|527319128|FG000|Overall Study|Withdrawal by Subject|1|||
146219569|NCT03307343|527319129|FG001|Overall Study|Withdrawal by Subject|2|||
146219570|NCT03307343|527319128|FG000|Overall Study|Pregnancy|0|||
146219571|NCT03307343|527319129|FG001|Overall Study|Pregnancy|2|||
146219572|NCT03307343|527319128|FG000|Overall Study|Physician Decision|1|||
146219573|NCT03307343|527319129|FG001|Overall Study|Physician Decision|0|||
146219574|NCT03307343|527319128|FG000|Overall Study|Lost to Follow-up|0|||
146219575|NCT03307343|527319129|FG001|Overall Study|Lost to Follow-up|2|||
146219576|NCT03016754|527319132|FG000|Overall Study|Death|5|||
146219577|NCT03016754|527319133|FG001|Overall Study|Death|4|||
146219578|NCT03016754|527319134|FG002|Overall Study|Death|5|||
146219579|NCT03016754|527319135|FG003|Overall Study|Death|1|||
146219580|NCT03016754|527319132|FG000|Overall Study|Lost to Follow-up|23|||
146219581|NCT03016754|527319133|FG001|Overall Study|Lost to Follow-up|17|||
146219582|NCT03016754|527319134|FG002|Overall Study|Lost to Follow-up|4|||
146219583|NCT03016754|527319135|FG003|Overall Study|Lost to Follow-up|2|||
146219584|NCT03016754|527319132|FG000|Overall Study|Withdrawal by Subject|6|||
146219585|NCT03016754|527319133|FG001|Overall Study|Withdrawal by Subject|6|||
146219586|NCT03016754|527319134|FG002|Overall Study|Withdrawal by Subject|2|||
146219587|NCT03016754|527319135|FG003|Overall Study|Withdrawal by Subject|2|||
146219588|NCT03016754|527319132|FG000|Overall Study|Other/Unknown|2|||
146219589|NCT03016754|527319133|FG001|Overall Study|Other/Unknown|4|||
146219590|NCT03016754|527319134|FG002|Overall Study|Other/Unknown|2|||
146219591|NCT03016754|527319135|FG003|Overall Study|Other/Unknown|1|||
146219592|NCT03016754|527319132|FG000|Overall Study|Protocol Violation|0|||
146219593|NCT03016754|527319133|FG001|Overall Study|Protocol Violation|0|||
146219594|NCT03016754|527319134|FG002|Overall Study|Protocol Violation|0|||
146219595|NCT03016754|527319135|FG003|Overall Study|Protocol Violation|4|||
146219596|NCT04185298|527319142|FG000|Overall Study|Lost to Follow-up|1|||
146219597|NCT04185298|527319143|FG001|Overall Study|Lost to Follow-up|3|||
146219598|NCT04185298|527319142|FG000|Overall Study|Withdrawal by Subject|0|||
146219599|NCT04185298|527319143|FG001|Overall Study|Withdrawal by Subject|3|||
146219600|NCT01798498|527319144|FG000|Overall Study|Lost to Follow-up|1|||
146219601|NCT04927364|527319148|FG000|Overall Study|Withdrawal by Subject|3|||
146219602|NCT04927364|527319148|FG000|Overall Study|Unable to complete preassessment MRI|1|||
146219603|NCT05087992|527319155|FG000|Overall Study|Adverse Event|0|||
146219604|NCT05087992|527319156|FG001|Overall Study|Adverse Event|1|||
146219605|NCT05087992|527319157|FG002|Overall Study|Adverse Event|0|||
146219606|NCT05087992|527319155|FG000|Overall Study|Withdrawal by Subject|2|||
146219607|NCT05087992|527319156|FG001|Overall Study|Withdrawal by Subject|0|||
146219608|NCT05087992|527319157|FG002|Overall Study|Withdrawal by Subject|0|||
146219609|NCT05087992|527319155|FG000|Overall Study|clinical disease progression|3|||
146219610|NCT05087992|527319156|FG001|Overall Study|clinical disease progression|1|||
146219611|NCT05087992|527319157|FG002|Overall Study|clinical disease progression|0|||
146219612|NCT05087992|527319155|FG000|Overall Study|objective disease progression|4|||
146219613|NCT05087992|527319156|FG001|Overall Study|objective disease progression|1|||
146219614|NCT05087992|527319157|FG002|Overall Study|objective disease progression|0|||
146219615|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
146219616|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
146219617|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
146219618|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
146219619|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
146219620|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
146219621|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146219622|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146219623|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
146219624|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146219625|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
146219626|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146219627|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
146219628|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
146219629|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
146219630|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146219631|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146219632|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
146219633|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219634|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
146219635|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
146219636|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219637|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219638|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
146219639|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219640|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219641|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
146219642|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
146219643|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146219644|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
146219645|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
146219646|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
146219647|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
146219648|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146219649|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146219650|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
146219651|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
146219652|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
146219653|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
146219654|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
146219655|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
146219656|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
146219657|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146219658|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146219659|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
146219660|NCT01369355|527319162|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
146219661|NCT01369355|527319163|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
146219662|NCT01369355|527319164|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
146219663|NCT01369355|527319165|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
146219664|NCT01369355|527319166|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
146219665|NCT01369355|527319167|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
146219666|NCT01369355|527319168|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
146219667|NCT01369355|527319169|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
146219668|NCT01369355|527319170|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
146219669|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219670|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219671|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219672|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219673|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219674|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
146219675|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
146219676|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
146219677|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
146219678|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Death|0|||
146219679|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Death|0|||
146219680|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Death|0|||
146219681|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Death|0|||
146219682|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Death|0|||
146219683|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Death|0|||
146219684|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Death|0|||
146219685|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Death|1|||
146219686|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Death|3|||
146219687|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219688|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219689|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219690|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219691|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219692|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
146219693|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
146219694|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
146219695|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
146219696|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219697|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219698|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219699|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219700|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219701|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219702|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
146219703|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
146219704|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
146219705|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219706|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219707|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219708|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219709|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219710|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
146219711|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
146219712|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
146219713|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
146219714|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219715|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219716|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219717|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219718|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219719|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
146219720|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
146219721|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
146219722|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
146219723|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219724|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219725|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219726|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219727|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219728|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
146219729|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
146219730|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
146219731|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
146219732|NCT01369355|527319162|FG000|Long-term Extension (Week 44-272)|Other|0|||
146219733|NCT01369355|527319163|FG001|Long-term Extension (Week 44-272)|Other|0|||
146219734|NCT01369355|527319164|FG002|Long-term Extension (Week 44-272)|Other|0|||
146219735|NCT01369355|527319165|FG003|Long-term Extension (Week 44-272)|Other|0|||
146219736|NCT01369355|527319166|FG004|Long-term Extension (Week 44-272)|Other|0|||
146219737|NCT01369355|527319167|FG005|Long-term Extension (Week 44-272)|Other|0|||
146219738|NCT01369355|527319168|FG006|Long-term Extension (Week 44-272)|Other|110|||
146219739|NCT01369355|527319169|FG007|Long-term Extension (Week 44-272)|Other|9|||
146219740|NCT01369355|527319170|FG008|Long-term Extension (Week 44-272)|Other|17|||
146219741|NCT02319759|527319173|FG000|Week 0 - 16|Lack of Efficacy|1|||
146219742|NCT02319759|527319174|FG001|Week 0 - 16|Lack of Efficacy|0|||
146219743|NCT02319759|527319175|FG002|Week 0 - 16|Lack of Efficacy|0|||
146219744|NCT02319759|527319176|FG003|Week 0 - 16|Lack of Efficacy|0|||
146219745|NCT02319759|527319177|FG004|Week 0 - 16|Lack of Efficacy|0|||
146219746|NCT02319759|527319173|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
146219747|NCT02319759|527319174|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
146219748|NCT02319759|527319175|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
146219749|NCT02319759|527319176|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
146219750|NCT02319759|527319177|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
146219751|NCT02319759|527319173|FG000|Week 16 - 24|Lack of Efficacy|1|||
146219752|NCT02319759|527319174|FG001|Week 16 - 24|Lack of Efficacy|0|||
146219753|NCT02319759|527319175|FG002|Week 16 - 24|Lack of Efficacy|1|||
146219754|NCT02319759|527319176|FG003|Week 16 - 24|Lack of Efficacy|0|||
146219755|NCT02319759|527319177|FG004|Week 16 - 24|Lack of Efficacy|0|||
146219756|NCT02319759|527319173|FG000|Week 16 - 24|Lost to Follow-up|1|||
146219757|NCT02319759|527319174|FG001|Week 16 - 24|Lost to Follow-up|0|||
146219758|NCT02319759|527319175|FG002|Week 16 - 24|Lost to Follow-up|0|||
146219759|NCT02319759|527319176|FG003|Week 16 - 24|Lost to Follow-up|0|||
146219760|NCT02319759|527319177|FG004|Week 16 - 24|Lost to Follow-up|0|||
146219761|NCT02319759|527319173|FG000|Week 16 - 24|Withdrawal by Subject|0|||
146219762|NCT02319759|527319174|FG001|Week 16 - 24|Withdrawal by Subject|0|||
146219763|NCT02319759|527319175|FG002|Week 16 - 24|Withdrawal by Subject|2|||
146219764|NCT02319759|527319176|FG003|Week 16 - 24|Withdrawal by Subject|0|||
146219765|NCT02319759|527319177|FG004|Week 16 - 24|Withdrawal by Subject|0|||
146219766|NCT02319759|527319173|FG000|Week 24 - 56|Adverse Event|0|||
146219767|NCT02319759|527319174|FG001|Week 24 - 56|Adverse Event|0|||
146219768|NCT02319759|527319175|FG002|Week 24 - 56|Adverse Event|2|||
146219769|NCT02319759|527319176|FG003|Week 24 - 56|Adverse Event|0|||
146219770|NCT02319759|527319177|FG004|Week 24 - 56|Adverse Event|0|||
146219771|NCT02319759|527319173|FG000|Week 24 - 56|Lack of Efficacy|0|||
146219772|NCT02319759|527319174|FG001|Week 24 - 56|Lack of Efficacy|0|||
146219773|NCT02319759|527319175|FG002|Week 24 - 56|Lack of Efficacy|0|||
145882139|NCT01933919|526074716|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
146219774|NCT02319759|527319176|FG003|Week 24 - 56|Lack of Efficacy|2|||
146219775|NCT02319759|527319177|FG004|Week 24 - 56|Lack of Efficacy|1|||
146219776|NCT02319759|527319173|FG000|Week 24 - 56|Withdrawal by Subject|0|||
146219777|NCT02319759|527319174|FG001|Week 24 - 56|Withdrawal by Subject|1|||
146219778|NCT02319759|527319175|FG002|Week 24 - 56|Withdrawal by Subject|0|||
146219779|NCT02319759|527319176|FG003|Week 24 - 56|Withdrawal by Subject|0|||
146219780|NCT02319759|527319177|FG004|Week 24 - 56|Withdrawal by Subject|0|||
146219781|NCT02319759|527319173|FG000|Week 24 - 56|Lost to Follow-up|0|||
146219782|NCT02319759|527319174|FG001|Week 24 - 56|Lost to Follow-up|0|||
146219783|NCT02319759|527319175|FG002|Week 24 - 56|Lost to Follow-up|0|||
146219784|NCT02319759|527319176|FG003|Week 24 - 56|Lost to Follow-up|0|||
146219785|NCT02319759|527319177|FG004|Week 24 - 56|Lost to Follow-up|1|||
146219786|NCT06424236|527319178|FG000|Overall Study|Adverse Event|0|||
146219787|NCT06424236|527319179|FG001|Overall Study|Adverse Event|1|||
146219788|NCT06424236|527319180|FG002|Overall Study|Adverse Event|0|||
146219789|NCT06424236|527319178|FG000|Overall Study|Withdrawal by Subject|3|||
146219790|NCT06424236|527319179|FG001|Overall Study|Withdrawal by Subject|1|||
145882140|NCT01933919|526074715|FG000|Open-label Long-term Phase|Other|1|||
145882141|NCT01933919|526074716|FG001|Open-label Long-term Phase|Other|2|||
145882142|NCT00852917|526074717|FG000|Overall Study|Adverse Event|13|||
145882143|NCT00852917|526074718|FG001|Overall Study|Adverse Event|20|||
145882144|NCT00852917|526074719|FG002|Overall Study|Adverse Event|35|||
145882145|NCT00852917|526074720|FG003|Overall Study|Adverse Event|17|||
145882146|NCT00852917|526074717|FG000|Overall Study|Lack of Efficacy|21|||
145882147|NCT00852917|526074718|FG001|Overall Study|Lack of Efficacy|11|||
145882148|NCT00852917|526074719|FG002|Overall Study|Lack of Efficacy|11|||
145882149|NCT00852917|526074720|FG003|Overall Study|Lack of Efficacy|47|||
145882150|NCT00852917|526074717|FG000|Overall Study|Withdrawal by Subject|4|||
145882151|NCT00852917|526074718|FG001|Overall Study|Withdrawal by Subject|8|||
145882152|NCT00852917|526074719|FG002|Overall Study|Withdrawal by Subject|10|||
145882153|NCT00852917|526074720|FG003|Overall Study|Withdrawal by Subject|9|||
145882154|NCT00852917|526074717|FG000|Overall Study|Physician Decision|6|||
145882155|NCT00852917|526074718|FG001|Overall Study|Physician Decision|7|||
145882156|NCT00852917|526074719|FG002|Overall Study|Physician Decision|2|||
145882157|NCT00852917|526074720|FG003|Overall Study|Physician Decision|19|||
145882158|NCT00852917|526074717|FG000|Overall Study|Death|0|||
145882159|NCT00852917|526074718|FG001|Overall Study|Death|0|||
145882160|NCT00852917|526074719|FG002|Overall Study|Death|0|||
145882161|NCT00852917|526074720|FG003|Overall Study|Death|1|||
145882162|NCT02161549|526074721|FG000|Overall Study|Physician Decision|6|||
145882163|NCT02161549|526074722|FG001|Overall Study|Physician Decision|2|||
145882164|NCT00979212|526074723|FG000|Overall Study|Protocol Violation|1|||
145882165|NCT00979212|526074724|FG001|Overall Study|Protocol Violation|8|||
145882166|NCT00979212|526074723|FG000|Overall Study|No protocol therapy received|1|||
145882167|NCT00979212|526074724|FG001|Overall Study|No protocol therapy received|0|||
145882168|NCT04886063|526074727|FG000|Overall Study|Adverse Event|50|||
145882169|NCT04886063|526074727|FG000|Overall Study|Lack of Efficacy|31|||
145882170|NCT04886063|526074727|FG000|Overall Study|Withdrawal by Subject|45|||
145882171|NCT04886063|526074727|FG000|Overall Study|Physician Decision|3|||
145882172|NCT04886063|526074727|FG000|Overall Study|Protocol Violation|3|||
145960909|NCT00048035|526369439|FG007|Extension Year 2|Early Withdrawals|3|||
145882173|NCT04886063|526074727|FG000|Overall Study|Site closure|4|||
145882174|NCT04886063|526074727|FG000|Overall Study|Nursing home replacement|3|||
145882175|NCT04886063|526074727|FG000|Overall Study|Lost to Follow-up|5|||
145882176|NCT04886063|526074727|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
145882177|NCT04886063|526074727|FG000|Overall Study|>1 reason|20|||
145882178|NCT00177164|526074730|FG000|Overall Study|Protocol Violation|0|||
145882179|NCT00177164|526074731|FG001|Overall Study|Protocol Violation|7|||
145960910|NCT05137717|526369440|FG000|Overall Study|Death|2|||
146219791|NCT06424236|527319180|FG002|Overall Study|Withdrawal by Subject|2|||
146219792|NCT06424236|527319178|FG000|Overall Study|Physician Decision|0|||
145882180|NCT00177164|526074730|FG000|Overall Study|Lost to Follow-up|4|||
145882181|NCT00177164|526074731|FG001|Overall Study|Lost to Follow-up|5|||
145882182|NCT00177164|526074730|FG000|Overall Study|increase in alcohol and drug use|1|||
146219793|NCT06424236|527319179|FG001|Overall Study|Physician Decision|1|||
146219794|NCT06424236|527319180|FG002|Overall Study|Physician Decision|0|||
146219795|NCT06424236|527319178|FG000|Overall Study|Study Terminated by Sponsor|11|||
146288162|NCT02457559|527569441|FG010|Overall Study|Death|0|||
146288163|NCT02374671|527569444|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
146288164|NCT02374671|527569445|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
146288165|NCT02374671|527569446|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
146288166|NCT02374671|527569444|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
146288167|NCT02374671|527569445|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
146288168|NCT02374671|527569446|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
146288169|NCT02374671|527569444|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
146288170|NCT02374671|527569445|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
146288171|NCT02374671|527569446|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
146288172|NCT02374671|527569444|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
146288173|NCT02374671|527569445|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
146288174|NCT02374671|527569446|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
146288175|NCT02374671|527569444|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
146288176|NCT02374671|527569445|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146288177|NCT02374671|527569446|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
146288178|NCT02495792|527569449|FG000|Overall Study|Lost to Follow-up|5|||
146288179|NCT02495792|527569450|FG001|Overall Study|Lost to Follow-up|9|||
146288180|NCT02495792|527569449|FG000|Overall Study|Protocol Violation|32|||
146288181|NCT02495792|527569450|FG001|Overall Study|Protocol Violation|31|||
146288182|NCT02523599|527569451|FG000|Overall Study|Adverse Event|1|||
146288183|NCT02523599|527569452|FG001|Overall Study|Adverse Event|0|||
146288184|NCT02523599|527569451|FG000|Overall Study|Physician Decision|1|||
146288185|NCT02523599|527569452|FG001|Overall Study|Physician Decision|0|||
146288186|NCT02523599|527569451|FG000|Overall Study|Lost to Follow-up|4|||
146288187|NCT02523599|527569452|FG001|Overall Study|Lost to Follow-up|1|||
146288188|NCT02523599|527569451|FG000|Overall Study|Did not return for Day 30 visit|2|||
146288189|NCT02523599|527569452|FG001|Overall Study|Did not return for Day 30 visit|0|||
146288190|NCT06729606|527569457|FG000|Overall Study|Adverse Event|0|||
146288191|NCT06729606|527569458|FG001|Overall Study|Adverse Event|2|||
146288192|NCT06729606|527569457|FG000|Overall Study|Death|1|||
146288193|NCT06729606|527569458|FG001|Overall Study|Death|0|||
146288194|NCT06729606|527569457|FG000|Overall Study|Physician Decision|0|||
146288195|NCT06729606|527569458|FG001|Overall Study|Physician Decision|1|||
146288196|NCT06729606|527569457|FG000|Overall Study|Withdrawal by Subject|2|||
146288197|NCT06729606|527569458|FG001|Overall Study|Withdrawal by Subject|4|||
146288198|NCT03570892|527569459|FG000|Overall Study|Death|51|||
146288199|NCT03570892|527569460|FG001|Overall Study|Death|45|||
146288200|NCT03570892|527569459|FG000|Overall Study|Subject decision|5|||
146288201|NCT03570892|527569460|FG001|Overall Study|Subject decision|3|||
146288202|NCT03570892|527569459|FG000|Overall Study|Protocol Violation|1|||
146288203|NCT03570892|527569460|FG001|Overall Study|Protocol Violation|4|||
146288204|NCT03570892|527569459|FG000|Overall Study|Physician Decision|0|||
146288205|NCT03570892|527569460|FG001|Overall Study|Physician Decision|2|||
146288206|NCT01177722|527571305|FG000|Overall Study|Serious Adverse Event|0|||
146288207|NCT01177722|527571306|FG001|Overall Study|Serious Adverse Event|0|||
146288208|NCT01177722|527571307|FG002|Overall Study|Serious Adverse Event|1|||
146288209|NCT01177722|527571308|FG003|Overall Study|Serious Adverse Event|0|||
146288210|NCT01177722|527571305|FG000|Overall Study|Protocol Violation|0|||
146219796|NCT06424236|527319179|FG001|Overall Study|Study Terminated by Sponsor|20|||
146219797|NCT06424236|527319180|FG002|Overall Study|Study Terminated by Sponsor|16|||
146219798|NCT06424236|527319178|FG000|Overall Study|Lost to Follow-up|0|||
146219799|NCT06424236|527319179|FG001|Overall Study|Lost to Follow-up|1|||
146219800|NCT06424236|527319180|FG002|Overall Study|Lost to Follow-up|0|||
146219801|NCT06424236|527319178|FG000|Overall Study|Disease Progression|0|||
146219802|NCT06424236|527319179|FG001|Overall Study|Disease Progression|1|||
146219803|NCT06424236|527319180|FG002|Overall Study|Disease Progression|2|||
146219804|NCT06424236|527319178|FG000|Overall Study|Other|0|||
146219805|NCT06424236|527319179|FG001|Overall Study|Other|0|||
146219806|NCT06424236|527319180|FG002|Overall Study|Other|1|||
146219807|NCT01959425|527319182|FG000|Overall Study|Withdrawal by Subject|5|||
146219808|NCT01959425|527319183|FG001|Overall Study|Withdrawal by Subject|4|||
146219809|NCT01959425|527319182|FG000|Overall Study|Lost to Follow-up|1|||
146219810|NCT01959425|527319183|FG001|Overall Study|Lost to Follow-up|0|||
146219811|NCT01959425|527319182|FG000|Overall Study|Discontinued Subjects|6|||
146219812|NCT01959425|527319183|FG001|Overall Study|Discontinued Subjects|4|||
146288211|NCT01177722|527571306|FG001|Overall Study|Protocol Violation|0|||
146288212|NCT01177722|527571307|FG002|Overall Study|Protocol Violation|1|||
146288213|NCT01177722|527571308|FG003|Overall Study|Protocol Violation|0|||
146288214|NCT01177722|527571305|FG000|Overall Study|Lost to Follow-up|3|||
146288215|NCT01177722|527571306|FG001|Overall Study|Lost to Follow-up|4|||
146288216|NCT01177722|527571307|FG002|Overall Study|Lost to Follow-up|3|||
146219813|NCT02262728|527319184|FG000|Follow-up Phase (3 Years)|Death|0|||
146219814|NCT02262728|527319185|FG001|Follow-up Phase (3 Years)|Death|1|||
146219815|NCT02262728|527319184|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
146219816|NCT02262728|527319185|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
146219817|NCT02262728|527319184|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
146219818|NCT02262728|527319185|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
146219819|NCT01824394|527319188|FG000|Overall Study|Early Termination|1|||
146219820|NCT01824394|527319189|FG001|Overall Study|Early Termination|1|||
146219821|NCT01824394|527319190|FG002|Overall Study|Early Termination|3|||
146084564|NCT00420641|526830210|FG000|Overall Study|Withdrawal by Subject|15|||
146084565|NCT00420641|526830211|FG001|Overall Study|Withdrawal by Subject|21|||
146219822|NCT01824394|527319188|FG000|Overall Study|Withdrawn due to Study Termination|91|||
146219823|NCT01824394|527319189|FG001|Overall Study|Withdrawn due to Study Termination|83|||
146219824|NCT01824394|527319190|FG002|Overall Study|Withdrawn due to Study Termination|41|||
146219825|NCT01824394|527319188|FG000|Overall Study|Lost to Follow-up|0|||
146219826|NCT01824394|527319189|FG001|Overall Study|Lost to Follow-up|9|||
146219827|NCT01824394|527319190|FG002|Overall Study|Lost to Follow-up|3|||
146219828|NCT01824394|527319188|FG000|Overall Study|Death|3|||
146219829|NCT01824394|527319189|FG001|Overall Study|Death|2|||
146219830|NCT01824394|527319190|FG002|Overall Study|Death|4|||
146219831|NCT01824394|527319188|FG000|Overall Study|Discontinued Subjects|1|||
146219832|NCT01824394|527319189|FG001|Overall Study|Discontinued Subjects|1|||
146219833|NCT01824394|527319190|FG002|Overall Study|Discontinued Subjects|2|||
146219834|NCT01824394|527319188|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
146219835|NCT01824394|527319189|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
146219836|NCT01824394|527319190|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
146084566|NCT00420641|526830212|FG002|Overall Study|Withdrawal by Subject|14|||
146084567|NCT00420641|526830210|FG000|Overall Study|Lack of Efficacy|6|||
146084568|NCT00420641|526830211|FG001|Overall Study|Lack of Efficacy|5|||
146084569|NCT00420641|526830212|FG002|Overall Study|Lack of Efficacy|4|||
146084570|NCT00420641|526830210|FG000|Overall Study|Non-compliance|7|||
146084571|NCT00420641|526830211|FG001|Overall Study|Non-compliance|5|||
146084572|NCT00420641|526830212|FG002|Overall Study|Non-compliance|4|||
146084573|NCT00420641|526830210|FG000|Overall Study|Other|4|||
146084574|NCT00420641|526830211|FG001|Overall Study|Other|4|||
146084575|NCT00420641|526830212|FG002|Overall Study|Other|3|||
146084576|NCT03459690|526830219|FG000|Overall Study|Lost to Follow-up|0|||
146084577|NCT03459690|526830220|FG001|Overall Study|Lost to Follow-up|1|||
146084578|NCT03459690|526830219|FG000|Overall Study|Withdrawal by Subject|1|||
146084579|NCT03459690|526830220|FG001|Overall Study|Withdrawal by Subject|1|||
146084580|NCT02586506|526830221|FG000|Overall Study|Protocol Violation|6|||
146084581|NCT02586506|526830221|FG000|Overall Study|Lost to Follow-up|1|||
146084582|NCT02586506|526830221|FG000|Overall Study|Other Reason|2|||
146084583|NCT02536404|526830229|FG000|Overall Study|Adverse Event|5|||
146084584|NCT02536404|526830230|FG001|Overall Study|Adverse Event|0|||
146084585|NCT02536404|526830229|FG000|Overall Study|Withdrawal by Subject|4|||
146084586|NCT02536404|526830230|FG001|Overall Study|Withdrawal by Subject|1|||
146084587|NCT02536404|526830229|FG000|Overall Study|Physician Decision|10|||
146084588|NCT02536404|526830230|FG001|Overall Study|Physician Decision|0|||
146084589|NCT02536404|526830229|FG000|Overall Study|Sponsor decision|1|||
146084590|NCT02536404|526830230|FG001|Overall Study|Sponsor decision|0|||
146084591|NCT02158364|526830231|FG000|Overall Study|Case report forms uncollected|10|||
146084592|NCT02158364|526830231|FG000|Overall Study|Protocol Deviation|50|||
146084593|NCT04381988|526830234|FG000|Overall Study|The study was terminated|4|||
146084594|NCT04381988|526830235|FG001|Overall Study|The study was terminated|0|||
146084595|NCT01944839|526830236|FG000|Overall Study|Physician Decision|2|||
146084596|NCT01944839|526830237|FG001|Overall Study|Physician Decision|2|||
146084597|NCT01944839|526830236|FG000|Overall Study|Protocol Violation|0|||
146084598|NCT01944839|526830237|FG001|Overall Study|Protocol Violation|1|||
146084599|NCT01944839|526830236|FG000|Overall Study|Adverse Event|10|||
146084600|NCT01944839|526830237|FG001|Overall Study|Adverse Event|5|||
146219837|NCT02619838|527319191|FG000|Overall Study|Lost to Follow-up|9|||
146219838|NCT02619838|527319191|FG000|Overall Study|Withdrawal by Subject|15|||
146219839|NCT00227344|527319192|FG000|Overall Study|study terminated early|12|||
146084601|NCT01944839|526830236|FG000|Overall Study|Withdrawal by Subject|9|||
146084602|NCT01944839|526830237|FG001|Overall Study|Withdrawal by Subject|17|||
146084603|NCT01944839|526830236|FG000|Overall Study|Lost to Follow-up|1|||
146084604|NCT01944839|526830237|FG001|Overall Study|Lost to Follow-up|0|||
146084605|NCT01944839|526830236|FG000|Overall Study|Subject non-compliance|0|||
146084606|NCT01944839|526830237|FG001|Overall Study|Subject non-compliance|3|||
146219840|NCT00227344|527319193|FG001|Overall Study|study terminated early|5|||
146219841|NCT01987895|527319194|FG000|Overall Study|Withdrawal by Subject|12|||
146219842|NCT01987895|527319195|FG001|Overall Study|Withdrawal by Subject|7|||
146219843|NCT01987895|527319194|FG000|Overall Study|Physician Decision|8|||
146219844|NCT01987895|527319195|FG001|Overall Study|Physician Decision|10|||
146219845|NCT01987895|527319194|FG000|Overall Study|Death|7|||
146219846|NCT01987895|527319195|FG001|Overall Study|Death|7|||
146084607|NCT00609362|526830238|FG000|Overall Study|Withdrawal by Subject|2|||
146084608|NCT00609362|526830239|FG001|Overall Study|Withdrawal by Subject|1|||
146084609|NCT00609362|526830238|FG000|Overall Study|Adverse Event|1|||
146084610|NCT00609362|526830239|FG001|Overall Study|Adverse Event|0|||
146219847|NCT01987895|527319194|FG000|Overall Study|Lost to Follow-up|3|||
145960911|NCT05137717|526369440|FG000|Overall Study|Withdrawal by Subject|6|||
145960912|NCT02619617|526369441|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
145960913|NCT02619617|526369442|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
145960914|NCT02619617|526369441|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
145960915|NCT02619617|526369442|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
145960916|NCT00509899|526369444|FG000|Overall Study|Progressive disease|1|||
145960917|NCT00509899|526369445|FG001|Overall Study|Progressive disease|3|||
145960918|NCT00509899|526369446|FG002|Overall Study|Progressive disease|5|||
145960919|NCT00509899|526369447|FG003|Overall Study|Progressive disease|1|||
145960920|NCT00509899|526369448|FG004|Overall Study|Progressive disease|0|||
145960921|NCT00509899|526369449|FG005|Overall Study|Progressive disease|1|||
145960922|NCT00509899|526369450|FG006|Overall Study|Progressive disease|0|||
146219848|NCT01987895|527319195|FG001|Overall Study|Lost to Follow-up|5|||
146219849|NCT01987895|527319194|FG000|Overall Study|randomized before giving IC|0|||
146219850|NCT01987895|527319195|FG001|Overall Study|randomized before giving IC|1|||
146219851|NCT05006872|527319199|FG000|Overall Study|Lost to Follow-up|37|||
146219852|NCT05006872|527319200|FG001|Overall Study|Lost to Follow-up|31|||
146219853|NCT04971681|527319203|FG000|Followup|Lost to Follow-up|1|||
146219854|NCT04971681|527319204|FG001|Followup|Lost to Follow-up|0|||
146219855|NCT00686335|527319205|FG000|Run-in Period|Adverse Event|1|||
146219856|NCT00686335|527319205|FG000|Run-in Period|asthma exacerbation|1|||
146219857|NCT00686335|527319205|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
146219858|NCT04788511|527319206|FG000|Overall Study|Withdrawal by Subject|2|||
146219859|NCT04788511|527319207|FG001|Overall Study|Withdrawal by Subject|1|||
146219860|NCT04788511|527319206|FG000|Overall Study|Lost to Follow-up|2|||
146219861|NCT04788511|527319207|FG001|Overall Study|Lost to Follow-up|7|||
146219862|NCT04788511|527319206|FG000|Overall Study|Death|3|||
146219863|NCT04788511|527319207|FG001|Overall Study|Death|4|||
146219864|NCT04492722|527319213|FG000|Overall Study|Adverse Event|7|||
146219865|NCT04492722|527319214|FG001|Overall Study|Adverse Event|2|||
146219866|NCT04492722|527319215|FG002|Overall Study|Adverse Event|3|||
146219867|NCT04492722|527319216|FG003|Overall Study|Adverse Event|0|||
146219868|NCT04492722|527319213|FG000|Overall Study|Death|0|||
146219869|NCT04492722|527319214|FG001|Overall Study|Death|0|||
146219870|NCT04492722|527319215|FG002|Overall Study|Death|0|||
146219871|NCT04492722|527319216|FG003|Overall Study|Death|1|||
146219872|NCT04492722|527319213|FG000|Overall Study|Lost to Follow-up|0|||
146219873|NCT04492722|527319214|FG001|Overall Study|Lost to Follow-up|1|||
146219874|NCT04492722|527319215|FG002|Overall Study|Lost to Follow-up|0|||
146219875|NCT04492722|527319216|FG003|Overall Study|Lost to Follow-up|1|||
146219876|NCT04492722|527319213|FG000|Overall Study|Physician Decision|0|||
146219877|NCT04492722|527319214|FG001|Overall Study|Physician Decision|3|||
146219878|NCT04492722|527319215|FG002|Overall Study|Physician Decision|1|||
146219879|NCT04492722|527319216|FG003|Overall Study|Physician Decision|1|||
146219880|NCT04492722|527319213|FG000|Overall Study|Withdrawal by Subject|6|||
146219881|NCT04492722|527319214|FG001|Overall Study|Withdrawal by Subject|6|||
146219882|NCT04492722|527319215|FG002|Overall Study|Withdrawal by Subject|0|||
145960923|NCT00509899|526369451|FG007|Overall Study|Progressive disease|0|||
145960924|NCT00509899|526369444|FG000|Overall Study|Unacceptable Toxicity|1|||
145960925|NCT00509899|526369445|FG001|Overall Study|Unacceptable Toxicity|0|||
145960926|NCT00509899|526369446|FG002|Overall Study|Unacceptable Toxicity|0|||
145960927|NCT00509899|526369447|FG003|Overall Study|Unacceptable Toxicity|2|||
145960928|NCT00509899|526369448|FG004|Overall Study|Unacceptable Toxicity|0|||
145960929|NCT00509899|526369449|FG005|Overall Study|Unacceptable Toxicity|0|||
145960930|NCT00509899|526369450|FG006|Overall Study|Unacceptable Toxicity|0|||
145960931|NCT00509899|526369451|FG007|Overall Study|Unacceptable Toxicity|0|||
145960932|NCT00509899|526369444|FG000|Overall Study|Withdrawal by Subject|6|||
145960933|NCT00509899|526369445|FG001|Overall Study|Withdrawal by Subject|2|||
145960934|NCT00509899|526369446|FG002|Overall Study|Withdrawal by Subject|3|||
145960935|NCT00509899|526369447|FG003|Overall Study|Withdrawal by Subject|0|||
145960936|NCT00509899|526369448|FG004|Overall Study|Withdrawal by Subject|3|||
146084611|NCT05093790|526830240|FG000|Overall Study|Failure to meet continuation criteria|0|||
146219883|NCT04492722|527319216|FG003|Overall Study|Withdrawal by Subject|3|||
146219884|NCT04492722|527319213|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
146219885|NCT04492722|527319214|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
146219886|NCT04492722|527319215|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
146219887|NCT04492722|527319216|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
146219888|NCT04492722|527319213|FG000|Overall Study|Due to Covid-19 pandemic|7|||
146219889|NCT04492722|527319214|FG001|Overall Study|Due to Covid-19 pandemic|3|||
145960937|NCT00509899|526369449|FG005|Overall Study|Withdrawal by Subject|2|||
145960938|NCT00509899|526369450|FG006|Overall Study|Withdrawal by Subject|0|||
145960939|NCT00509899|526369451|FG007|Overall Study|Withdrawal by Subject|0|||
145960940|NCT00509899|526369444|FG000|Overall Study|Physician Decision|4|||
146219890|NCT04492722|527319215|FG002|Overall Study|Due to Covid-19 pandemic|7|||
145960941|NCT00509899|526369445|FG001|Overall Study|Physician Decision|2|||
145960942|NCT00509899|526369446|FG002|Overall Study|Physician Decision|7|||
146219891|NCT04492722|527319216|FG003|Overall Study|Due to Covid-19 pandemic|6|||
146084612|NCT05093790|526830241|FG001|Overall Study|Failure to meet continuation criteria|0|||
146084613|NCT05093790|526830242|FG002|Overall Study|Failure to meet continuation criteria|1|||
146084614|NCT05093790|526830243|FG003|Overall Study|Failure to meet continuation criteria|0|||
146084615|NCT05093790|526830240|FG000|Overall Study|Adverse Event|1|||
146084616|NCT05093790|526830241|FG001|Overall Study|Adverse Event|0|||
146084617|NCT05093790|526830242|FG002|Overall Study|Adverse Event|0|||
146084618|NCT05093790|526830243|FG003|Overall Study|Adverse Event|0|||
146084619|NCT01587898|526830244|FG000|Overall Study|Adverse Event|1|||
146084620|NCT01587898|526830245|FG001|Overall Study|Adverse Event|1|||
146084621|NCT01587898|526830246|FG002|Overall Study|Adverse Event|0|||
146084622|NCT01587898|526830247|FG003|Overall Study|Adverse Event|0|||
146084623|NCT01587898|526830244|FG000|Overall Study|Protocol Violation|0|||
146084624|NCT01587898|526830245|FG001|Overall Study|Protocol Violation|2|||
146084625|NCT01587898|526830246|FG002|Overall Study|Protocol Violation|1|||
146084626|NCT01587898|526830247|FG003|Overall Study|Protocol Violation|1|||
146084627|NCT01587898|526830244|FG000|Overall Study|Lost to Follow-up|0|||
146084628|NCT01587898|526830245|FG001|Overall Study|Lost to Follow-up|0|||
146084629|NCT01587898|526830246|FG002|Overall Study|Lost to Follow-up|0|||
146084630|NCT01587898|526830247|FG003|Overall Study|Lost to Follow-up|1|||
146084631|NCT01587898|526830244|FG000|Overall Study|Withdrawal by Subject|2|||
146084632|NCT01587898|526830245|FG001|Overall Study|Withdrawal by Subject|1|||
146084633|NCT01587898|526830246|FG002|Overall Study|Withdrawal by Subject|0|||
146084634|NCT01587898|526830247|FG003|Overall Study|Withdrawal by Subject|0|||
146084635|NCT01587898|526830244|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
146084636|NCT01587898|526830245|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
146084637|NCT01587898|526830246|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
146084638|NCT01587898|526830247|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
146084639|NCT00502203|526830248|FG000|Overall Study|Inevaluable|1|||
146084640|NCT01903252|526830251|FG000|Double-Blind Induction|Adverse Event|20|||
146084641|NCT01903252|526830252|FG001|Double-Blind Induction|Adverse Event|18|||
146084642|NCT01903252|526830253|FG002|Double-Blind Induction|Adverse Event|0|||
146084643|NCT01903252|526830254|FG003|Double-Blind Induction|Adverse Event|0|||
146084644|NCT01903252|526830255|FG004|Double-Blind Induction|Adverse Event|0|||
146084645|NCT01903252|526830256|FG005|Double-Blind Induction|Adverse Event|0|||
146084646|NCT01903252|526830251|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
146084647|NCT01903252|526830252|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
146084648|NCT01903252|526830253|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
146084649|NCT01903252|526830254|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
146084650|NCT01903252|526830255|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
146084651|NCT01903252|526830256|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
146084652|NCT01903252|526830251|FG000|Double-Blind Induction|Physician Decision|2|||
146084653|NCT01903252|526830252|FG001|Double-Blind Induction|Physician Decision|3|||
146084654|NCT01903252|526830253|FG002|Double-Blind Induction|Physician Decision|0|||
146084655|NCT01903252|526830254|FG003|Double-Blind Induction|Physician Decision|0|||
146084656|NCT01903252|526830255|FG004|Double-Blind Induction|Physician Decision|0|||
146084657|NCT01903252|526830256|FG005|Double-Blind Induction|Physician Decision|0|||
146084658|NCT01903252|526830251|FG000|Double-Blind Induction|non-compliance,|7|||
146084659|NCT01903252|526830252|FG001|Double-Blind Induction|non-compliance,|7|||
146084660|NCT01903252|526830253|FG002|Double-Blind Induction|non-compliance,|0|||
146084661|NCT01903252|526830254|FG003|Double-Blind Induction|non-compliance,|0|||
146084662|NCT01903252|526830255|FG004|Double-Blind Induction|non-compliance,|0|||
146084663|NCT01903252|526830256|FG005|Double-Blind Induction|non-compliance,|0|||
146219892|NCT04492722|527319213|FG000|Overall Study|Failure to meet randomisation criteria|2|||
146219893|NCT04492722|527319214|FG001|Overall Study|Failure to meet randomisation criteria|3|||
146219894|NCT04492722|527319215|FG002|Overall Study|Failure to meet randomisation criteria|4|||
146219895|NCT04492722|527319216|FG003|Overall Study|Failure to meet randomisation criteria|2|||
146219896|NCT04492722|527319213|FG000|Overall Study|Early termination from the study|54|||
146219897|NCT04492722|527319214|FG001|Overall Study|Early termination from the study|51|||
146219898|NCT04492722|527319215|FG002|Overall Study|Early termination from the study|50|||
146219899|NCT04492722|527319216|FG003|Overall Study|Early termination from the study|50|||
146219900|NCT04492722|527319213|FG000|Overall Study|Missing|3|||
146219901|NCT04492722|527319214|FG001|Overall Study|Missing|0|||
146084664|NCT01903252|526830251|FG000|Extended Induction, Open-Label|Adverse Event|0|||
146084665|NCT01903252|526830252|FG001|Extended Induction, Open-Label|Adverse Event|0|||
146084666|NCT01903252|526830253|FG002|Extended Induction, Open-Label|Adverse Event|17|||
146084667|NCT01903252|526830254|FG003|Extended Induction, Open-Label|Adverse Event|0|||
146219902|NCT04492722|527319215|FG002|Overall Study|Missing|0|||
146084668|NCT01903252|526830255|FG004|Extended Induction, Open-Label|Adverse Event|0|||
146219903|NCT04492722|527319216|FG003|Overall Study|Missing|5|||
146219904|NCT04492722|527319213|FG000|Overall Study|Participants who did not receive treatment|0|||
146084669|NCT01903252|526830256|FG005|Extended Induction, Open-Label|Adverse Event|0|||
146084670|NCT01903252|526830251|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146219905|NCT04492722|527319214|FG001|Overall Study|Participants who did not receive treatment|1|||
146219906|NCT04492722|527319215|FG002|Overall Study|Participants who did not receive treatment|4|||
146084671|NCT01903252|526830252|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146219907|NCT04492722|527319216|FG003|Overall Study|Participants who did not receive treatment|0|||
146084672|NCT01903252|526830253|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
146219908|NCT04029688|527321181|FG000|Overall Study|Death|8|||
146219909|NCT04029688|527321182|FG001|Overall Study|Death|3|||
146219910|NCT04029688|527321183|FG002|Overall Study|Death|6|||
146219911|NCT04029688|527321184|FG003|Overall Study|Death|2|||
146219912|NCT04029688|527321185|FG004|Overall Study|Death|5|||
146219913|NCT04029688|527321186|FG005|Overall Study|Death|0|||
146219914|NCT04029688|527321187|FG006|Overall Study|Death|2|||
146219915|NCT04029688|527321188|FG007|Overall Study|Death|3|||
146219916|NCT04029688|527321181|FG000|Overall Study|Study Terminated by Sponsor|0|||
146219917|NCT04029688|527321182|FG001|Overall Study|Study Terminated by Sponsor|0|||
146219918|NCT04029688|527321183|FG002|Overall Study|Study Terminated by Sponsor|0|||
146219919|NCT04029688|527321184|FG003|Overall Study|Study Terminated by Sponsor|0|||
146219920|NCT04029688|527321185|FG004|Overall Study|Study Terminated by Sponsor|1|||
146219921|NCT04029688|527321186|FG005|Overall Study|Study Terminated by Sponsor|3|||
146219922|NCT04029688|527321187|FG006|Overall Study|Study Terminated by Sponsor|1|||
146219923|NCT04029688|527321188|FG007|Overall Study|Study Terminated by Sponsor|3|||
146219924|NCT04029688|527321181|FG000|Overall Study|Withdrawal by Subject|0|||
146219925|NCT04029688|527321182|FG001|Overall Study|Withdrawal by Subject|0|||
146219926|NCT04029688|527321183|FG002|Overall Study|Withdrawal by Subject|0|||
146219927|NCT04029688|527321184|FG003|Overall Study|Withdrawal by Subject|1|||
146219928|NCT04029688|527321185|FG004|Overall Study|Withdrawal by Subject|0|||
146219929|NCT04029688|527321186|FG005|Overall Study|Withdrawal by Subject|0|||
146219930|NCT04029688|527321187|FG006|Overall Study|Withdrawal by Subject|0|||
146219931|NCT04029688|527321188|FG007|Overall Study|Withdrawal by Subject|0|||
146219932|NCT01396278|527321190|FG000|Overall Study|Adverse Event|0|||
146219933|NCT01396278|527321191|FG001|Overall Study|Adverse Event|0|||
146219934|NCT01396278|527321192|FG002|Overall Study|Adverse Event|0|||
146219935|NCT01396278|527321193|FG003|Overall Study|Adverse Event|2|||
146219936|NCT01396278|527321194|FG004|Overall Study|Adverse Event|0|||
146219937|NCT01396278|527321190|FG000|Overall Study|Withdraw due to trial termination|2|||
146219938|NCT01396278|527321191|FG001|Overall Study|Withdraw due to trial termination|1|||
146219939|NCT01396278|527321192|FG002|Overall Study|Withdraw due to trial termination|1|||
146219940|NCT01396278|527321193|FG003|Overall Study|Withdraw due to trial termination|0|||
146219941|NCT01396278|527321194|FG004|Overall Study|Withdraw due to trial termination|2|||
146219942|NCT04764448|527321197|FG000|Overall Study|Study terminated by sponsor|2|||
146219943|NCT04764448|527321198|FG001|Overall Study|Study terminated by sponsor|2|||
146219944|NCT04764448|527321199|FG002|Overall Study|Study terminated by sponsor|5|||
146219945|NCT04764448|527321197|FG000|Overall Study|Withdrawal by Subject|3|||
146219946|NCT04764448|527321198|FG001|Overall Study|Withdrawal by Subject|3|||
146219947|NCT04764448|527321199|FG002|Overall Study|Withdrawal by Subject|1|||
146219948|NCT04515576|527321200|FG000|Overall Study|Withdrawal by Subject|0|||
146219949|NCT04515576|527321201|FG001|Overall Study|Withdrawal by Subject|0|||
146219950|NCT04515576|527321202|FG002|Overall Study|Withdrawal by Subject|0|||
146219951|NCT04515576|527321203|FG003|Overall Study|Withdrawal by Subject|0|||
146219952|NCT04515576|527321204|FG004|Overall Study|Withdrawal by Subject|0|||
146219953|NCT04515576|527321205|FG005|Overall Study|Withdrawal by Subject|1|||
146219954|NCT03812679|527321206|FG000|Overall Study|Adverse Event|2|||
146219955|NCT03812679|527321206|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
146219956|NCT03812679|527321206|FG000|Overall Study|Renal transplant|1|||
146219957|NCT03812679|527321206|FG000|Overall Study|Withdrawal by Subject|1|||
146219958|NCT03812679|527321206|FG000|Overall Study|Termination of study|2|||
146084673|NCT01903252|526830254|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146084674|NCT01903252|526830255|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146084675|NCT01903252|526830256|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
146084676|NCT01903252|526830251|FG000|Extended Induction, Open-Label|Physician Decision|0|||
146084677|NCT01903252|526830252|FG001|Extended Induction, Open-Label|Physician Decision|0|||
146084678|NCT01903252|526830253|FG002|Extended Induction, Open-Label|Physician Decision|1|||
146084679|NCT01903252|526830254|FG003|Extended Induction, Open-Label|Physician Decision|0|||
146219959|NCT03812679|527321206|FG000|Overall Study|Water device replacement|1|||
146219960|NCT05653427|527321207|FG000|Overall Study|Study Terminated by Sponsor|13|||
146219961|NCT05590403|527321208|FG000|Overall Study|Lost to Follow-up|13|||
146219962|NCT05590403|527321209|FG001|Overall Study|Lost to Follow-up|1|||
146219963|NCT05590403|527321210|FG002|Overall Study|Lost to Follow-up|7|||
146219964|NCT05590403|527321211|FG003|Overall Study|Lost to Follow-up|3|||
146084680|NCT01903252|526830255|FG004|Extended Induction, Open-Label|Physician Decision|0|||
146219965|NCT05590403|527321212|FG004|Overall Study|Lost to Follow-up|4|||
146219966|NCT05590403|527321208|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
146219967|NCT05590403|527321209|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
146219968|NCT05590403|527321210|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
146219969|NCT05590403|527321211|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
146219970|NCT05590403|527321212|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
146219971|NCT05590403|527321208|FG000|Overall Study|Other|2|||
146084681|NCT01903252|526830256|FG005|Extended Induction, Open-Label|Physician Decision|0|||
146084682|NCT01903252|526830251|FG000|Maintenance, Open-Label|Adverse Event|0|||
146084683|NCT01903252|526830252|FG001|Maintenance, Open-Label|Adverse Event|0|||
146084684|NCT01903252|526830253|FG002|Maintenance, Open-Label|Adverse Event|0|||
146084685|NCT01903252|526830254|FG003|Maintenance, Open-Label|Adverse Event|3|||
146084686|NCT01903252|526830255|FG004|Maintenance, Open-Label|Adverse Event|9|||
146084687|NCT01903252|526830256|FG005|Maintenance, Open-Label|Adverse Event|14|||
146084688|NCT01903252|526830251|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
146219972|NCT05590403|527321209|FG001|Overall Study|Other|0|||
146219973|NCT05590403|527321210|FG002|Overall Study|Other|2|||
146219974|NCT05590403|527321211|FG003|Overall Study|Other|2|||
146219975|NCT05590403|527321212|FG004|Overall Study|Other|0|||
146219976|NCT05590403|527321208|FG000|Overall Study|Migrated / moved from the study area|1|||
146219977|NCT05590403|527321209|FG001|Overall Study|Migrated / moved from the study area|1|||
146219978|NCT05590403|527321210|FG002|Overall Study|Migrated / moved from the study area|0|||
146219979|NCT05590403|527321211|FG003|Overall Study|Migrated / moved from the study area|3|||
146219980|NCT05590403|527321212|FG004|Overall Study|Migrated / moved from the study area|1|||
146219981|NCT05590403|527321208|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
146219982|NCT05590403|527321209|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
146219983|NCT05590403|527321210|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
146219984|NCT05590403|527321211|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
146219985|NCT05590403|527321212|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
146219986|NCT05659537|527321213|FG000|Overall Study|Adverse Event|5|||
146219987|NCT05659537|527321213|FG000|Overall Study|Lost to Follow-up|4|||
146219988|NCT05659537|527321213|FG000|Overall Study|Withdrawal by Subject|13|||
146219989|NCT05659537|527321213|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
146219990|NCT05659537|527321213|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
146219991|NCT05659537|527321213|FG000|Overall Study|Participant was suffering from anaemia|1|||
146219992|NCT03575897|527321217|FG000|Overall Study|Lost to Follow-up|12|||
146219993|NCT03575897|527321218|FG001|Overall Study|Lost to Follow-up|13|||
146219994|NCT01160211|527321220|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
146219995|NCT01160211|527321221|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
146219996|NCT01160211|527321222|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
146219997|NCT01160211|527321220|FG000|Overall Study|Lost to Follow-up|4|||
146219998|NCT01160211|527321221|FG001|Overall Study|Lost to Follow-up|8|||
146219999|NCT01160211|527321222|FG002|Overall Study|Lost to Follow-up|4|||
146220000|NCT01160211|527321220|FG000|Overall Study|Physician Decision|1|||
146220001|NCT01160211|527321221|FG001|Overall Study|Physician Decision|0|||
146220002|NCT01160211|527321222|FG002|Overall Study|Physician Decision|0|||
146220003|NCT01160211|527321220|FG000|Overall Study|Withdrawal by Subject|4|||
146220004|NCT01160211|527321221|FG001|Overall Study|Withdrawal by Subject|2|||
146220005|NCT01160211|527321222|FG002|Overall Study|Withdrawal by Subject|2|||
146220006|NCT01160211|527321220|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
146220007|NCT01160211|527321221|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
146220008|NCT01160211|527321222|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
146220009|NCT03611491|527321227|FG000|Overall Study|Lost to Follow-up|1|||
146220010|NCT03194217|527321228|FG000|Overall Study|Adverse Event|0|||
146220011|NCT03194217|527321229|FG001|Overall Study|Adverse Event|2|||
146220012|NCT03194217|527321230|FG002|Overall Study|Adverse Event|3|||
146220013|NCT03194217|527321231|FG003|Overall Study|Adverse Event|3|||
146220014|NCT03194217|527321228|FG000|Overall Study|Failure to meet randomisation criteria|0|||
146220015|NCT03194217|527321229|FG001|Overall Study|Failure to meet randomisation criteria|0|||
146220016|NCT03194217|527321230|FG002|Overall Study|Failure to meet randomisation criteria|0|||
146220017|NCT03194217|527321231|FG003|Overall Study|Failure to meet randomisation criteria|1|||
146220018|NCT03194217|527321228|FG000|Overall Study|Other|0|||
146220019|NCT03194217|527321229|FG001|Overall Study|Other|1|||
146220020|NCT03194217|527321230|FG002|Overall Study|Other|1|||
146220021|NCT03194217|527321231|FG003|Overall Study|Other|0|||
146220022|NCT04806451|527321232|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
146220023|NCT04806451|527321233|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
146220024|NCT04806451|527321232|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
146220025|NCT04806451|527321233|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
146220026|NCT04806451|527321232|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
146220027|NCT04806451|527321233|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
146220028|NCT05835336|527321234|FG000|Overall Study|Withdrawal by Subject|5|||
146220029|NCT05835336|527321234|FG000|Overall Study|Did not complete the personalization process|3|||
146220030|NCT04489771|527321235|FG000|Overall Study|Death|27|||
146220031|NCT04489771|527321236|FG001|Overall Study|Death|25|||
146084689|NCT01903252|526830252|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
146084690|NCT01903252|526830253|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
146220032|NCT04489771|527321235|FG000|Overall Study|Withdrawal by Subject|1|||
146220033|NCT04489771|527321236|FG001|Overall Study|Withdrawal by Subject|0|||
146288217|NCT01177722|527571308|FG003|Overall Study|Lost to Follow-up|1|||
146220034|NCT04489771|527321235|FG000|Overall Study|Participants Ongoing in Study|50|||
146084691|NCT01903252|526830254|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
146220035|NCT04489771|527321236|FG001|Overall Study|Participants Ongoing in Study|51|||
146220036|NCT03134196|527321248|FG000|Overall Study|Death|2|||
146220037|NCT03134196|527321249|FG001|Overall Study|Death|1|||
146220038|NCT03134196|527321248|FG000|Overall Study|Lost to Follow-up|13|||
146220039|NCT03134196|527321249|FG001|Overall Study|Lost to Follow-up|15|||
146220040|NCT03134196|527321248|FG000|Overall Study|Physician Decision|0|||
146220041|NCT03134196|527321249|FG001|Overall Study|Physician Decision|1|||
146220042|NCT03134196|527321248|FG000|Overall Study|Withdrawal by Subject|19|||
146220043|NCT03134196|527321249|FG001|Overall Study|Withdrawal by Subject|12|||
146220044|NCT03134196|527321248|FG000|Overall Study|Site Unable to Contact Participant|2|||
146220045|NCT03134196|527321249|FG001|Overall Study|Site Unable to Contact Participant|0|||
146220046|NCT03134196|527321248|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
146220047|NCT03134196|527321249|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
146220048|NCT03134196|527321248|FG000|Overall Study|Scheduling Conflict|1|||
146220049|NCT03134196|527321249|FG001|Overall Study|Scheduling Conflict|0|||
146084692|NCT01903252|526830255|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
146084693|NCT01903252|526830256|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
146084694|NCT01903252|526830251|FG000|Maintenance, Open-Label|Other|0|||
146084695|NCT01903252|526830252|FG001|Maintenance, Open-Label|Other|0|||
146084696|NCT01903252|526830253|FG002|Maintenance, Open-Label|Other|0|||
146084697|NCT01903252|526830254|FG003|Maintenance, Open-Label|Other|2|||
146084698|NCT01903252|526830255|FG004|Maintenance, Open-Label|Other|6|||
146084699|NCT01903252|526830256|FG005|Maintenance, Open-Label|Other|2|||
146084700|NCT01239732|526830257|FG000|Overall Study|Termination of study per protocol|667|||
146084701|NCT01239732|526830257|FG000|Overall Study|Death|226|||
146084702|NCT01239732|526830257|FG000|Overall Study|Withdrawal by Subject|87|||
146084703|NCT01239732|526830257|FG000|Overall Study|Adverse Event|6|||
146084704|NCT01239732|526830257|FG000|Overall Study|Protocol Violation|3|||
146084705|NCT01239732|526830257|FG000|Overall Study|Participant non compliance|5|||
146084706|NCT01239732|526830257|FG000|Overall Study|Study termination by sponsor|2|||
146084707|NCT01239732|526830257|FG000|Overall Study|Investigator's decision|4|||
146084708|NCT01239732|526830257|FG000|Overall Study|Treatment failure|2|||
146084709|NCT01239732|526830257|FG000|Overall Study|Other|19|||
146084710|NCT01381562|526830258|FG000|Overall Study|Adverse Event|0|||
146084711|NCT01381562|526830259|FG001|Overall Study|Adverse Event|1|||
146084712|NCT01381562|526830260|FG002|Overall Study|Adverse Event|0|||
146084713|NCT02660138|526830262|FG000|Overall Study|Adverse Event|0|||
146084714|NCT02660138|526830263|FG001|Overall Study|Adverse Event|3|||
146084715|NCT02660138|526830264|FG002|Overall Study|Adverse Event|2|||
146084716|NCT02660138|526830262|FG000|Overall Study|Lack of Efficacy|1|||
146084717|NCT02660138|526830263|FG001|Overall Study|Lack of Efficacy|2|||
146084718|NCT02660138|526830264|FG002|Overall Study|Lack of Efficacy|1|||
146084719|NCT02660138|526830262|FG000|Overall Study|Withdrawal by Subject|7|||
146084720|NCT02660138|526830263|FG001|Overall Study|Withdrawal by Subject|6|||
146084721|NCT02660138|526830264|FG002|Overall Study|Withdrawal by Subject|6|||
146084722|NCT02660138|526830262|FG000|Overall Study|Lost to Follow-up|4|||
146084723|NCT02660138|526830263|FG001|Overall Study|Lost to Follow-up|4|||
146084724|NCT02660138|526830264|FG002|Overall Study|Lost to Follow-up|1|||
146084725|NCT02660138|526830262|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
146084726|NCT02660138|526830263|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
146084727|NCT02660138|526830264|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
146084728|NCT02660138|526830262|FG000|Overall Study|Other|1|||
146084729|NCT02660138|526830263|FG001|Overall Study|Other|1|||
146084730|NCT02660138|526830264|FG002|Overall Study|Other|0|||
146084731|NCT02660138|526830262|FG000|Overall Study|Not treated|0|||
146084732|NCT02660138|526830263|FG001|Overall Study|Not treated|1|||
146084733|NCT02660138|526830264|FG002|Overall Study|Not treated|0|||
146084734|NCT00308581|526830268|FG000|Induction Phase|Adverse Event|0|||
146084735|NCT00308581|526830269|FG001|Induction Phase|Adverse Event|0|||
146084736|NCT00308581|526830270|FG002|Induction Phase|Adverse Event|37|||
146084737|NCT00308581|526830268|FG000|Induction Phase|Lack of Efficacy|0|||
146084738|NCT00308581|526830269|FG001|Induction Phase|Lack of Efficacy|0|||
146220050|NCT04059484|527321259|FG000|Overall Study|Adverse Event|2|||
146220051|NCT04059484|527321260|FG001|Overall Study|Adverse Event|5|||
146220052|NCT04059484|527321259|FG000|Overall Study|Withdrawal by Subject|5|||
146220053|NCT04059484|527321260|FG001|Overall Study|Withdrawal by Subject|3|||
146220054|NCT04059484|527321259|FG000|Overall Study|Progressive disease|112|||
146220055|NCT04059484|527321260|FG001|Overall Study|Progressive disease|112|||
146220056|NCT04059484|527321259|FG000|Overall Study|Other|8|||
146084739|NCT00308581|526830270|FG002|Induction Phase|Lack of Efficacy|121|||
146084740|NCT00308581|526830268|FG000|Induction Phase|Withdrawal by Subject|0|||
146084741|NCT00308581|526830269|FG001|Induction Phase|Withdrawal by Subject|0|||
146084742|NCT00308581|526830270|FG002|Induction Phase|Withdrawal by Subject|5|||
146084743|NCT00308581|526830268|FG000|Induction Phase|Unknown reason|0|||
146084744|NCT00308581|526830269|FG001|Induction Phase|Unknown reason|0|||
146084745|NCT00308581|526830270|FG002|Induction Phase|Unknown reason|3|||
146084746|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Adverse Event|10|||
146220057|NCT04059484|527321260|FG001|Overall Study|Other|3|||
146220058|NCT04059484|527321259|FG000|Overall Study|Ongoing|20|||
146220059|NCT04059484|527321260|FG001|Overall Study|Ongoing|20|||
146220060|NCT04292223|527321261|FG000|Overall Study|Adverse Event|1|||
146220061|NCT04292223|527321261|FG000|Overall Study|Lost to Follow-up|1|||
146220062|NCT04292223|527321261|FG000|Overall Study|Noncompliance with study drug|2|||
146220063|NCT04292223|527321261|FG000|Overall Study|Patient moved out of the state|1|||
146220064|NCT04683744|527321263|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
146220065|NCT04683744|527321264|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
146220066|NCT04683744|527321265|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
146220067|NCT04316871|527321267|FG000|Overall Study|Protocol Violation|2|||
146220068|NCT04316871|527321268|FG001|Overall Study|Protocol Violation|2|||
146220069|NCT04316871|527321269|FG002|Overall Study|Protocol Violation|2|||
146220070|NCT04316871|527321270|FG003|Overall Study|Protocol Violation|2|||
146220071|NCT04650269|527321271|FG000|Overall Study|Death|3|||
146220072|NCT04650269|527321271|FG000|Overall Study|Lost to Follow-up|6|||
146220073|NCT04091750|527321272|FG000|Overall Study|Adverse Event|4|||
146220074|NCT04091750|527321272|FG000|Overall Study|Withdrawal by Subject|1|||
146220075|NCT02919306|527321273|FG000|Overall Study|Withdrawal by Subject|1|||
146220076|NCT02919306|527321274|FG001|Overall Study|Withdrawal by Subject|0|||
146220077|NCT02919306|527321273|FG000|Overall Study|Protocol Violation|1|||
146220078|NCT02919306|527321274|FG001|Overall Study|Protocol Violation|0|||
146220079|NCT04473222|527321275|FG000|Overall Study|Lost to Follow-up|13|||
146220080|NCT04473222|527321276|FG001|Overall Study|Lost to Follow-up|13|||
146220081|NCT04473222|527321275|FG000|Overall Study|Withdrawal by Subject|0|||
146220082|NCT04473222|527321276|FG001|Overall Study|Withdrawal by Subject|1|||
146220083|NCT04473222|527321275|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
146220084|NCT04473222|527321276|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
146220085|NCT04293055|527321277|FG000|Overall Study|Lost to Follow-up|1|||
146220086|NCT04293055|527321278|FG001|Overall Study|Lost to Follow-up|1|||
146220087|NCT04293055|527321277|FG000|Overall Study|Did not trigger randomization|6|||
146220088|NCT04293055|527321278|FG001|Overall Study|Did not trigger randomization|5|||
146220089|NCT03560609|527321279|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
146220090|NCT03560609|527321280|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
146220091|NCT05780437|527321289|FG000|Overall Study|Withdrawal by Subject|22|||
146220092|NCT05780437|527321290|FG001|Overall Study|Withdrawal by Subject|16|||
146220093|NCT03452579|527321297|FG000|Overall Study|Death|0|||
146220094|NCT03452579|527321298|FG001|Overall Study|Death|1|||
146220095|NCT03452579|527321297|FG000|Overall Study|Withdrawal by Subject|2|||
146220096|NCT03452579|527321298|FG001|Overall Study|Withdrawal by Subject|0|||
146220097|NCT03452579|527321297|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
146220098|NCT03452579|527321298|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
146220099|NCT03452579|527321297|FG000|Overall Study|Physician Decision|1|||
146220100|NCT03452579|527321298|FG001|Overall Study|Physician Decision|1|||
146220101|NCT03452579|527321297|FG000|Overall Study|Adverse Event|1|||
146220102|NCT03452579|527321298|FG001|Overall Study|Adverse Event|4|||
146220103|NCT05647304|527321301|FG000|Overall Study|Withdrawal by Subject|1|||
146220104|NCT05647304|527321302|FG001|Overall Study|Withdrawal by Subject|0|||
146220105|NCT04171999|527321303|FG000|Overall Study|deemed ineligible after randomization|2|||
146220106|NCT04171999|527321304|FG001|Overall Study|deemed ineligible after randomization|1|||
146220107|NCT06181760|527321307|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
146220108|NCT06181760|527321308|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
146220109|NCT06181760|527321309|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
146220110|NCT06181760|527321310|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
146220111|NCT03524612|527321311|FG000|Overall Study|Lack of Efficacy|10|||
146220112|NCT03524612|527321311|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
146220113|NCT03524612|527321311|FG000|Overall Study|Adverse Event|10|||
146220114|NCT03524612|527321311|FG000|Overall Study|Withdrawal by Subject|7|||
146220115|NCT03524612|527321311|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
146220116|NCT03524612|527321311|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
146220117|NCT03524612|527321311|FG000|Overall Study|New therapy for study indication|6|||
146220118|NCT03524612|527321311|FG000|Overall Study|Death|3|||
146220119|NCT03524612|527321311|FG000|Overall Study|Lost to Follow-up|2|||
146220120|NCT03524612|527321311|FG000|Overall Study|Protocol Violation|1|||
146220121|NCT04623671|527321312|FG000|Overall Study|Adverse Event|0|||
146220122|NCT04623671|527321313|FG001|Overall Study|Adverse Event|1|||
146220123|NCT04623671|527321312|FG000|Overall Study|Lost to Follow-up|2|||
146220124|NCT04623671|527321313|FG001|Overall Study|Lost to Follow-up|1|||
146220125|NCT04623671|527321312|FG000|Overall Study|Death|5|||
146220126|NCT04623671|527321313|FG001|Overall Study|Death|5|||
146220127|NCT00613106|527321314|FG000|Overall Study|Adverse Event|3|||
146220128|NCT00613106|527321315|FG001|Overall Study|Adverse Event|1|||
146220129|NCT00613106|527321314|FG000|Overall Study|Withdrawal by Subject|6|||
146220130|NCT00613106|527321315|FG001|Overall Study|Withdrawal by Subject|3|||
146220131|NCT00613106|527321314|FG000|Overall Study|Lost to Follow-up|7|||
146220132|NCT00613106|527321315|FG001|Overall Study|Lost to Follow-up|2|||
146220133|NCT00613106|527321314|FG000|Overall Study|misc|4|||
146220134|NCT00613106|527321315|FG001|Overall Study|misc|3|||
146220135|NCT05296525|527321320|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146220136|NCT05296525|527321321|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146220137|NCT05296525|527321322|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
146220138|NCT05296525|527321323|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
146220139|NCT01420237|527321324|FG000|Overall Study|Death|13|||
146220140|NCT01420237|527321324|FG000|Overall Study|Withdrawal by Subject|41|||
146220141|NCT01420237|527321324|FG000|Overall Study|Lost to Follow-up|32|||
146220142|NCT01420237|527321324|FG000|Overall Study|Adverse Event|10|||
146220143|NCT01420237|527321324|FG000|Overall Study|Investigative Site Termination|43|||
146220144|NCT01420237|527321324|FG000|Overall Study|Censored because study device not implanted|21|||
146220145|NCT01420237|527321324|FG000|Overall Study|Censored because surgery not performed|2|||
146220146|NCT01420237|527321324|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
146220147|NCT01420237|527321324|FG000|Overall Study|Sponsor terminated study early|127|||
146220148|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
146220149|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
146220150|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
146220151|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
146220152|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
146220153|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
146220154|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
146220155|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
146220156|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
146220157|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
146220158|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
146220159|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
146220160|NCT04338061|527321325|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
146220161|NCT04338061|527321326|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
146220162|NCT04338061|527321325|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
146220163|NCT04338061|527321326|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
146220164|NCT04338061|527321325|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
146220165|NCT04338061|527321326|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
146220166|NCT04338061|527321325|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
146220167|NCT04338061|527321326|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
146220168|NCT04338061|527321325|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
146220169|NCT04338061|527321326|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
146220170|NCT04338061|527321325|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
146220171|NCT04338061|527321326|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
146220172|NCT04074759|527321327|FG000|Overall Study|Withdrawal by Subject|0|||
146220173|NCT04074759|527321328|FG001|Overall Study|Withdrawal by Subject|0|||
146220174|NCT04074759|527321329|FG002|Overall Study|Withdrawal by Subject|0|||
146220175|NCT04074759|527321330|FG003|Overall Study|Withdrawal by Subject|0|||
145882183|NCT00177164|526074731|FG001|Overall Study|increase in alcohol and drug use|2|||
145882184|NCT00177164|526074730|FG000|Overall Study|Adverse Event|1|||
145882185|NCT00177164|526074731|FG001|Overall Study|Adverse Event|0|||
146220176|NCT04074759|527321331|FG004|Overall Study|Withdrawal by Subject|0|||
146220177|NCT04074759|527321332|FG005|Overall Study|Withdrawal by Subject|2|||
146220178|NCT04074759|527321333|FG006|Overall Study|Withdrawal by Subject|0|||
146220179|NCT04074759|527321334|FG007|Overall Study|Withdrawal by Subject|2|||
146220180|NCT04074759|527321335|FG008|Overall Study|Withdrawal by Subject|1|||
146220181|NCT04074759|527321336|FG009|Overall Study|Withdrawal by Subject|2|||
146220182|NCT04074759|527321337|FG010|Overall Study|Withdrawal by Subject|9|||
146220183|NCT04074759|527321338|FG011|Overall Study|Withdrawal by Subject|2|||
146220184|NCT04074759|527321339|FG012|Overall Study|Withdrawal by Subject|1|||
146220185|NCT04074759|527321340|FG013|Overall Study|Withdrawal by Subject|3|||
146220186|NCT04074759|527321341|FG014|Overall Study|Withdrawal by Subject|2|||
146220187|NCT04074759|527321342|FG015|Overall Study|Withdrawal by Subject|0|||
146220188|NCT04074759|527321343|FG016|Overall Study|Withdrawal by Subject|0|||
146220189|NCT04074759|527321344|FG017|Overall Study|Withdrawal by Subject|3|||
146220190|NCT04074759|527321345|FG018|Overall Study|Withdrawal by Subject|1|||
146220191|NCT04074759|527321327|FG000|Overall Study|Death|1|||
146220192|NCT04074759|527321328|FG001|Overall Study|Death|0|||
146220193|NCT04074759|527321329|FG002|Overall Study|Death|1|||
145882186|NCT00177164|526074730|FG000|Overall Study|discharge from hospital|1|||
145882187|NCT00177164|526074731|FG001|Overall Study|discharge from hospital|0|||
145882188|NCT00177164|526074730|FG000|Overall Study|Lack of Efficacy|2|||
146288218|NCT01177722|527571305|FG000|Overall Study|Withdrawal by Subject|10|||
146288219|NCT01177722|527571306|FG001|Overall Study|Withdrawal by Subject|6|||
146288220|NCT01177722|527571307|FG002|Overall Study|Withdrawal by Subject|4|||
146288221|NCT01177722|527571308|FG003|Overall Study|Withdrawal by Subject|6|||
146288222|NCT02563522|527571312|FG000|Overall Study|Adverse Event|2|||
146288223|NCT02563522|527571313|FG001|Overall Study|Adverse Event|3|||
146288224|NCT02563522|527571312|FG000|Overall Study|Lost to Follow-up|1|||
146288225|NCT02563522|527571313|FG001|Overall Study|Lost to Follow-up|0|||
146288226|NCT02563522|527571312|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
146288227|NCT02563522|527571313|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
146288228|NCT00918580|527571314|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
146288229|NCT00918580|527571314|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
146288230|NCT00918580|527571314|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
146288231|NCT00918580|527571314|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
146288232|NCT00918580|527571314|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
146288233|NCT00918580|527571314|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
146288234|NCT00918580|527571314|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
146288235|NCT03486457|527571315|FG000|Up to Month 3|Adverse Event|2|||
146288236|NCT03486457|527571316|FG001|Up to Month 3|Adverse Event|5|||
146288237|NCT03486457|527571315|FG000|Up to Month 3|Lack of Efficacy|1|||
146084747|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Adverse Event|17|||
146084748|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Adverse Event|0|||
146084749|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
146288238|NCT03486457|527571316|FG001|Up to Month 3|Lack of Efficacy|0|||
146288239|NCT03486457|527571315|FG000|Up to Month 3|Withdrawal by Subject|1|||
146288240|NCT03486457|527571316|FG001|Up to Month 3|Withdrawal by Subject|0|||
146288241|NCT03486457|527571315|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
146288242|NCT03486457|527571316|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
146288243|NCT03486457|527571315|FG000|Up to Month 3|Other|1|||
146288244|NCT03486457|527571316|FG001|Up to Month 3|Other|0|||
146288245|NCT03486457|527571315|FG000|Month 3 to Month 6|Adverse Event|2|||
146288246|NCT03486457|527571316|FG001|Month 3 to Month 6|Adverse Event|0|||
146288247|NCT03486457|527571315|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
146288248|NCT03486457|527571316|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
146220194|NCT04074759|527321330|FG003|Overall Study|Death|1|||
146220195|NCT04074759|527321331|FG004|Overall Study|Death|2|||
146220196|NCT04074759|527321332|FG005|Overall Study|Death|0|||
146220197|NCT04074759|527321333|FG006|Overall Study|Death|1|||
146220198|NCT04074759|527321334|FG007|Overall Study|Death|0|||
146220199|NCT04074759|527321335|FG008|Overall Study|Death|3|||
146220200|NCT04074759|527321336|FG009|Overall Study|Death|2|||
146220201|NCT04074759|527321337|FG010|Overall Study|Death|4|||
146220202|NCT04074759|527321338|FG011|Overall Study|Death|1|||
146220203|NCT04074759|527321339|FG012|Overall Study|Death|0|||
146220204|NCT04074759|527321340|FG013|Overall Study|Death|2|||
146220205|NCT04074759|527321341|FG014|Overall Study|Death|1|||
146220206|NCT04074759|527321342|FG015|Overall Study|Death|0|||
146220207|NCT04074759|527321343|FG016|Overall Study|Death|1|||
146220208|NCT04074759|527321344|FG017|Overall Study|Death|0|||
146220209|NCT04074759|527321345|FG018|Overall Study|Death|1|||
146220210|NCT04074759|527321327|FG000|Overall Study|Lost to Follow-up|0|||
146220211|NCT04074759|527321328|FG001|Overall Study|Lost to Follow-up|0|||
146220212|NCT04074759|527321329|FG002|Overall Study|Lost to Follow-up|0|||
146220213|NCT04074759|527321330|FG003|Overall Study|Lost to Follow-up|0|||
146220214|NCT04074759|527321331|FG004|Overall Study|Lost to Follow-up|0|||
146220215|NCT04074759|527321332|FG005|Overall Study|Lost to Follow-up|0|||
146220216|NCT04074759|527321333|FG006|Overall Study|Lost to Follow-up|0|||
146220217|NCT04074759|527321334|FG007|Overall Study|Lost to Follow-up|0|||
146220218|NCT04074759|527321335|FG008|Overall Study|Lost to Follow-up|0|||
146220219|NCT04074759|527321336|FG009|Overall Study|Lost to Follow-up|0|||
146220220|NCT04074759|527321337|FG010|Overall Study|Lost to Follow-up|1|||
146220221|NCT04074759|527321338|FG011|Overall Study|Lost to Follow-up|0|||
146220222|NCT04074759|527321339|FG012|Overall Study|Lost to Follow-up|0|||
146220223|NCT04074759|527321340|FG013|Overall Study|Lost to Follow-up|0|||
146220224|NCT04074759|527321341|FG014|Overall Study|Lost to Follow-up|0|||
146084750|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
146084751|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
146288249|NCT03486457|527571315|FG000|Month 3 to Month 6|Pregnancy|0|||
146288250|NCT03486457|527571316|FG001|Month 3 to Month 6|Pregnancy|1|||
146288251|NCT03486457|527571315|FG000|Month 3 to Month 6|Other|1|||
146288252|NCT03486457|527571316|FG001|Month 3 to Month 6|Other|0|||
146220225|NCT04074759|527321342|FG015|Overall Study|Lost to Follow-up|0|||
146220226|NCT04074759|527321343|FG016|Overall Study|Lost to Follow-up|1|||
146220227|NCT04074759|527321344|FG017|Overall Study|Lost to Follow-up|0|||
146288253|NCT00946101|527571317|FG000|Overall Study|Lost to Follow-up|2|||
146220228|NCT04074759|527321345|FG018|Overall Study|Lost to Follow-up|1|||
146220229|NCT04074759|527321327|FG000|Overall Study|Other|0|||
146220230|NCT04074759|527321328|FG001|Overall Study|Other|1|||
146220231|NCT04074759|527321329|FG002|Overall Study|Other|1|||
146220232|NCT04074759|527321330|FG003|Overall Study|Other|0|||
146220233|NCT04074759|527321331|FG004|Overall Study|Other|2|||
146220234|NCT04074759|527321332|FG005|Overall Study|Other|1|||
146220235|NCT04074759|527321333|FG006|Overall Study|Other|2|||
146220236|NCT04074759|527321334|FG007|Overall Study|Other|1|||
146220237|NCT04074759|527321335|FG008|Overall Study|Other|1|||
146220238|NCT04074759|527321336|FG009|Overall Study|Other|4|||
146220239|NCT04074759|527321337|FG010|Overall Study|Other|4|||
146220240|NCT04074759|527321338|FG011|Overall Study|Other|2|||
146220241|NCT04074759|527321339|FG012|Overall Study|Other|0|||
146220242|NCT04074759|527321340|FG013|Overall Study|Other|0|||
146220243|NCT04074759|527321341|FG014|Overall Study|Other|0|||
146220244|NCT04074759|527321342|FG015|Overall Study|Other|1|||
146220245|NCT04074759|527321343|FG016|Overall Study|Other|0|||
146220246|NCT04074759|527321344|FG017|Overall Study|Other|0|||
146220247|NCT04074759|527321345|FG018|Overall Study|Other|0|||
146220248|NCT04074759|527321327|FG000|Overall Study|Missing end of study status|0|||
146220249|NCT04074759|527321328|FG001|Overall Study|Missing end of study status|0|||
146220250|NCT04074759|527321329|FG002|Overall Study|Missing end of study status|0|||
146220251|NCT04074759|527321330|FG003|Overall Study|Missing end of study status|0|||
146220252|NCT04074759|527321331|FG004|Overall Study|Missing end of study status|0|||
146220253|NCT04074759|527321332|FG005|Overall Study|Missing end of study status|0|||
146220254|NCT04074759|527321333|FG006|Overall Study|Missing end of study status|0|||
146220255|NCT04074759|527321334|FG007|Overall Study|Missing end of study status|0|||
146220256|NCT04074759|527321335|FG008|Overall Study|Missing end of study status|0|||
146220257|NCT04074759|527321336|FG009|Overall Study|Missing end of study status|0|||
146220258|NCT04074759|527321337|FG010|Overall Study|Missing end of study status|2|||
146220259|NCT04074759|527321338|FG011|Overall Study|Missing end of study status|0|||
146220260|NCT04074759|527321339|FG012|Overall Study|Missing end of study status|0|||
146220261|NCT04074759|527321340|FG013|Overall Study|Missing end of study status|0|||
146220262|NCT04074759|527321341|FG014|Overall Study|Missing end of study status|0|||
146220263|NCT04074759|527321342|FG015|Overall Study|Missing end of study status|0|||
146220264|NCT04074759|527321343|FG016|Overall Study|Missing end of study status|1|||
146220265|NCT04074759|527321344|FG017|Overall Study|Missing end of study status|0|||
146220266|NCT04074759|527321345|FG018|Overall Study|Missing end of study status|0|||
146220267|NCT03631784|527321346|FG000|Overall Study|Participants Ongoing|1|||
146220268|NCT03631784|527321347|FG001|Overall Study|Participants Ongoing|0|||
146220269|NCT03631784|527321346|FG000|Overall Study|Withdrawal by Subject|3|||
146220270|NCT03631784|527321347|FG001|Overall Study|Withdrawal by Subject|3|||
146220271|NCT03631784|527321346|FG000|Overall Study|Sponsor's Decision|36|||
146220272|NCT03631784|527321347|FG001|Overall Study|Sponsor's Decision|52|||
146220273|NCT03631784|527321346|FG000|Overall Study|Lost to Follow-up|1|||
146220274|NCT03631784|527321347|FG001|Overall Study|Lost to Follow-up|0|||
146220275|NCT03631784|527321346|FG000|Overall Study|Death|71|||
146220276|NCT03631784|527321347|FG001|Overall Study|Death|49|||
146220277|NCT05329220|527321348|FG000|Active Trial Period|Adverse Event|0|||
146220278|NCT05329220|527321349|FG001|Active Trial Period|Adverse Event|0|||
146220279|NCT05329220|527321350|FG002|Active Trial Period|Adverse Event|0|||
146220280|NCT05329220|527321351|FG003|Active Trial Period|Adverse Event|0|||
146220281|NCT05329220|527321352|FG004|Active Trial Period|Adverse Event|1|||
146220282|NCT05329220|527321353|FG005|Active Trial Period|Adverse Event|0|||
146220283|NCT05329220|527321348|FG000|Active Trial Period|Lost to Follow-up|0|||
146220284|NCT05329220|527321349|FG001|Active Trial Period|Lost to Follow-up|0|||
146220285|NCT05329220|527321350|FG002|Active Trial Period|Lost to Follow-up|0|||
146220286|NCT05329220|527321351|FG003|Active Trial Period|Lost to Follow-up|0|||
146220287|NCT05329220|527321352|FG004|Active Trial Period|Lost to Follow-up|32|||
146220288|NCT05329220|527321353|FG005|Active Trial Period|Lost to Follow-up|28|||
146220289|NCT05329220|527321348|FG000|Active Trial Period|Physician Decision|0|||
146220290|NCT05329220|527321349|FG001|Active Trial Period|Physician Decision|0|||
146220291|NCT05329220|527321350|FG002|Active Trial Period|Physician Decision|0|||
146220292|NCT05329220|527321351|FG003|Active Trial Period|Physician Decision|0|||
146220293|NCT05329220|527321352|FG004|Active Trial Period|Physician Decision|2|||
146220294|NCT05329220|527321353|FG005|Active Trial Period|Physician Decision|0|||
146220295|NCT05329220|527321348|FG000|Active Trial Period|Protocol Violation|0|||
146220296|NCT05329220|527321349|FG001|Active Trial Period|Protocol Violation|0|||
146220297|NCT05329220|527321350|FG002|Active Trial Period|Protocol Violation|0|||
146220298|NCT05329220|527321351|FG003|Active Trial Period|Protocol Violation|0|||
146220299|NCT05329220|527321352|FG004|Active Trial Period|Protocol Violation|1|||
146220300|NCT05329220|527321353|FG005|Active Trial Period|Protocol Violation|3|||
146220301|NCT05329220|527321348|FG000|Active Trial Period|Withdrawal by Subject|0|||
146220302|NCT05329220|527321349|FG001|Active Trial Period|Withdrawal by Subject|0|||
145882189|NCT00177164|526074731|FG001|Overall Study|Lack of Efficacy|1|||
146220303|NCT05329220|527321350|FG002|Active Trial Period|Withdrawal by Subject|0|||
146220304|NCT05329220|527321351|FG003|Active Trial Period|Withdrawal by Subject|1|||
146220305|NCT05329220|527321352|FG004|Active Trial Period|Withdrawal by Subject|12|||
146288254|NCT00946101|527571318|FG001|Overall Study|Lost to Follow-up|1|||
146220306|NCT05329220|527321353|FG005|Active Trial Period|Withdrawal by Subject|13|||
146220307|NCT05329220|527321348|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146220308|NCT05329220|527321349|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146220309|NCT05329220|527321350|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146220310|NCT05329220|527321351|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146220311|NCT05329220|527321352|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
146220312|NCT05329220|527321353|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
146220313|NCT05329220|527321348|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146220314|NCT05329220|527321349|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146220315|NCT05329220|527321350|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146220316|NCT05329220|527321351|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146220317|NCT05329220|527321352|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
146220318|NCT05329220|527321353|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
146220319|NCT05329220|527321348|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
146220320|NCT05329220|527321349|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
146220321|NCT05329220|527321350|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
146220322|NCT05329220|527321351|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
146220323|NCT05329220|527321352|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
146220324|NCT05329220|527321353|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
146220325|NCT05329220|527321348|FG000|Follow-up Period|Adverse Event|0|||
146220326|NCT05329220|527321349|FG001|Follow-up Period|Adverse Event|0|||
146220327|NCT05329220|527321350|FG002|Follow-up Period|Adverse Event|0|||
146220328|NCT05329220|527321351|FG003|Follow-up Period|Adverse Event|0|||
146220329|NCT05329220|527321352|FG004|Follow-up Period|Adverse Event|2|||
146220330|NCT05329220|527321353|FG005|Follow-up Period|Adverse Event|1|||
146220331|NCT05329220|527321348|FG000|Follow-up Period|Death|0|||
146220332|NCT05329220|527321349|FG001|Follow-up Period|Death|0|||
146220333|NCT05329220|527321350|FG002|Follow-up Period|Death|1|||
146220334|NCT05329220|527321351|FG003|Follow-up Period|Death|1|||
146220335|NCT05329220|527321352|FG004|Follow-up Period|Death|0|||
146220336|NCT05329220|527321353|FG005|Follow-up Period|Death|1|||
146220337|NCT05329220|527321348|FG000|Follow-up Period|Lost to Follow-up|0|||
146220338|NCT05329220|527321349|FG001|Follow-up Period|Lost to Follow-up|1|||
146220339|NCT05329220|527321350|FG002|Follow-up Period|Lost to Follow-up|2|||
146220340|NCT05329220|527321351|FG003|Follow-up Period|Lost to Follow-up|2|||
146220341|NCT05329220|527321352|FG004|Follow-up Period|Lost to Follow-up|113|||
146220342|NCT05329220|527321353|FG005|Follow-up Period|Lost to Follow-up|89|||
146220343|NCT05329220|527321348|FG000|Follow-up Period|Physician Decision|0|||
146288255|NCT00946101|527571317|FG000|Overall Study|Withdrawal of consent|2|||
145882190|NCT00177164|526074730|FG000|Overall Study|Pregnancy|0|||
145882191|NCT00177164|526074731|FG001|Overall Study|Pregnancy|1|||
145882192|NCT01344018|526074737|FG000|Overall Study|Death|22|||
145882193|NCT01344018|526074738|FG001|Overall Study|Death|25|||
145882194|NCT01344018|526074737|FG000|Overall Study|Lost to Follow-up|4|||
146288256|NCT00946101|527571318|FG001|Overall Study|Withdrawal of consent|0|||
146288257|NCT00946101|527571317|FG000|Overall Study|Physician Decision|0|||
146288258|NCT00946101|527571318|FG001|Overall Study|Physician Decision|1|||
146288259|NCT01347762|527571319|FG000|Overall Study|Lost to Follow-up|0|||
146288260|NCT01347762|527571320|FG001|Overall Study|Lost to Follow-up|1|||
146288261|NCT01347762|527571321|FG002|Overall Study|Lost to Follow-up|6|||
146288262|NCT01347762|527571322|FG003|Overall Study|Lost to Follow-up|5|||
146288263|NCT01347762|527571319|FG000|Overall Study|Withdrawal by Subject|4|||
146288264|NCT01347762|527571320|FG001|Overall Study|Withdrawal by Subject|1|||
146288265|NCT01347762|527571321|FG002|Overall Study|Withdrawal by Subject|3|||
146288266|NCT01347762|527571322|FG003|Overall Study|Withdrawal by Subject|3|||
146288267|NCT00093808|527571323|FG000|Overall Study|Cancel participation before receiving tx|1|||
146288268|NCT00093808|527571323|FG000|Overall Study|Protocol Violation|1|||
146288269|NCT00701220|527571324|FG000|Overall Study|Withdrawal by Subject|0|||
146288270|NCT00701220|527571325|FG001|Overall Study|Withdrawal by Subject|2|||
146288271|NCT00701220|527571324|FG000|Overall Study|Protocol Violation|2|||
145882195|NCT01344018|526074738|FG001|Overall Study|Lost to Follow-up|7|||
145882196|NCT05070754|526074739|FG000|Overall Study|Withdrawal by Subject|0|||
145882197|NCT05070754|526074740|FG001|Overall Study|Withdrawal by Subject|0|||
145960943|NCT00509899|526369447|FG003|Overall Study|Physician Decision|0|||
146288272|NCT00701220|527571325|FG001|Overall Study|Protocol Violation|0|||
146288273|NCT03235284|527571326|FG000|Overall Study|Adverse Event|1|||
146288274|NCT03235284|527571327|FG001|Overall Study|Adverse Event|2|||
145882198|NCT05070754|526074741|FG002|Overall Study|Withdrawal by Subject|0|||
145960944|NCT00509899|526369448|FG004|Overall Study|Physician Decision|1|||
146288275|NCT03235284|527571328|FG002|Overall Study|Adverse Event|1|||
145882199|NCT05070754|526074742|FG003|Overall Study|Withdrawal by Subject|1|||
145882200|NCT05070754|526074739|FG000|Overall Study|Protocol Violation|0|||
145960945|NCT00509899|526369449|FG005|Overall Study|Physician Decision|4|||
145882201|NCT05070754|526074740|FG001|Overall Study|Protocol Violation|0|||
145882202|NCT05070754|526074741|FG002|Overall Study|Protocol Violation|0|||
145882203|NCT05070754|526074742|FG003|Overall Study|Protocol Violation|1|||
145882204|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
145882205|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
146084752|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
146084753|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
146288276|NCT00310037|527571329|FG000|Overall Study|Adverse Event|7|||
146220344|NCT05329220|527321349|FG001|Follow-up Period|Physician Decision|0|||
146288277|NCT00310037|527571330|FG001|Overall Study|Adverse Event|14|||
146288278|NCT00310037|527571329|FG000|Overall Study|Withdrawal by Subject|4|||
146288279|NCT00310037|527571330|FG001|Overall Study|Withdrawal by Subject|3|||
146288280|NCT00310037|527571329|FG000|Overall Study|Progression|6|||
146288281|NCT00310037|527571330|FG001|Overall Study|Progression|0|||
146288282|NCT00310037|527571329|FG000|Overall Study|Non-protocol treatment|1|||
146288283|NCT00310037|527571330|FG001|Overall Study|Non-protocol treatment|0|||
146288284|NCT01382706|527571341|FG000|Overall Study|Adverse Event|1|||
146288285|NCT01382706|527571341|FG000|Overall Study|Withdrawal by Subject|1|||
146288286|NCT04055090|527571342|FG000|Overall Study|screen failure|1|||
146288287|NCT04055090|527571343|FG001|Overall Study|screen failure|0|||
146288288|NCT04055090|527571342|FG000|Overall Study|Withdrawal by Subject|1|||
146288289|NCT04055090|527571343|FG001|Overall Study|Withdrawal by Subject|0|||
146288290|NCT02476279|527571346|FG000|Overall Study|Lost to Follow-up|1|||
146288291|NCT02476279|527571347|FG001|Overall Study|Lost to Follow-up|1|||
146288292|NCT02208999|527571348|FG000|Overall Study|Lost to Follow-up|1|||
146288293|NCT00319839|527571349|FG000|Overall Study|Adverse Event|5|||
146220345|NCT05329220|527321350|FG002|Follow-up Period|Physician Decision|0|||
146220346|NCT05329220|527321351|FG003|Follow-up Period|Physician Decision|0|||
146220347|NCT05329220|527321352|FG004|Follow-up Period|Physician Decision|2|||
146220348|NCT05329220|527321353|FG005|Follow-up Period|Physician Decision|2|||
146220349|NCT05329220|527321348|FG000|Follow-up Period|Protocol Violation|0|||
146220350|NCT05329220|527321349|FG001|Follow-up Period|Protocol Violation|0|||
146220351|NCT05329220|527321350|FG002|Follow-up Period|Protocol Violation|0|||
146220352|NCT05329220|527321351|FG003|Follow-up Period|Protocol Violation|0|||
146220353|NCT05329220|527321352|FG004|Follow-up Period|Protocol Violation|0|||
146220354|NCT05329220|527321353|FG005|Follow-up Period|Protocol Violation|1|||
146220355|NCT05329220|527321348|FG000|Follow-up Period|Withdrawal by Subject|0|||
146220356|NCT05329220|527321349|FG001|Follow-up Period|Withdrawal by Subject|0|||
146220357|NCT05329220|527321350|FG002|Follow-up Period|Withdrawal by Subject|1|||
146220358|NCT05329220|527321351|FG003|Follow-up Period|Withdrawal by Subject|1|||
146220359|NCT05329220|527321352|FG004|Follow-up Period|Withdrawal by Subject|34|||
146288294|NCT00319839|527571349|FG000|Overall Study|Withdrawal by Subject|1|||
146288295|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
146288296|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
146288297|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
146288298|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
146288299|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
146288300|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
146288301|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
146288302|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146288303|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146288304|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146288305|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146288306|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
146288307|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146288308|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
146220360|NCT05329220|527321353|FG005|Follow-up Period|Withdrawal by Subject|35|||
146220361|NCT05329220|527321348|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146220362|NCT05329220|527321349|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145882206|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
145882207|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
146084754|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
146288309|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
146288310|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
146288311|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
146288312|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
146288313|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
145882208|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
145882209|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
146288314|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
146288315|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
145882210|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
146084755|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
146084756|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
146084757|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
146084758|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
146084759|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
146084760|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
146084761|NCT00308581|526830268|FG000|Randomized Maintenance Phase|Unknown reason|3|||
146220363|NCT05329220|527321350|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
146220364|NCT05329220|527321351|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146220365|NCT05329220|527321352|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146220366|NCT05329220|527321353|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
146220367|NCT05329220|527321348|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146220368|NCT05329220|527321349|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146220369|NCT05329220|527321350|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146220370|NCT05329220|527321351|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146220371|NCT05329220|527321352|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
146220372|NCT05329220|527321353|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
146220373|NCT05329220|527321348|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146220374|NCT05329220|527321349|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146220375|NCT05329220|527321350|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146220376|NCT05329220|527321351|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146220377|NCT05329220|527321352|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
146220378|NCT05329220|527321353|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
146220379|NCT05329220|527321348|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146220380|NCT05329220|527321349|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146220381|NCT05329220|527321350|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146084762|NCT00308581|526830269|FG001|Randomized Maintenance Phase|Unknown reason|0|||
146084763|NCT00308581|526830270|FG002|Randomized Maintenance Phase|Unknown reason|0|||
146084764|NCT00899353|526830271|FG000|Overall Study|Adverse Event|2|||
146084765|NCT00899353|526830271|FG000|Overall Study|Lost to Follow-up|1|||
146084766|NCT00899353|526830271|FG000|Overall Study|Withdrawal by Subject|2|||
146084767|NCT00592774|526830282|FG000|Overall Study|Adverse Event|5|||
146084768|NCT00592774|526830283|FG001|Overall Study|Adverse Event|19|||
146084769|NCT00592774|526830284|FG002|Overall Study|Adverse Event|2|||
146084770|NCT00592774|526830285|FG003|Overall Study|Adverse Event|14|||
146084771|NCT00592774|526830286|FG004|Overall Study|Adverse Event|8|||
146084772|NCT00592774|526830282|FG000|Overall Study|Protocol Violation|0|||
146084773|NCT00592774|526830283|FG001|Overall Study|Protocol Violation|1|||
146084774|NCT00592774|526830284|FG002|Overall Study|Protocol Violation|0|||
146084775|NCT00592774|526830285|FG003|Overall Study|Protocol Violation|0|||
146084776|NCT00592774|526830286|FG004|Overall Study|Protocol Violation|1|||
146084777|NCT00592774|526830282|FG000|Overall Study|Withdrawal by Subject|3|||
146084778|NCT00592774|526830283|FG001|Overall Study|Withdrawal by Subject|7|||
146084779|NCT00592774|526830284|FG002|Overall Study|Withdrawal by Subject|0|||
146084780|NCT00592774|526830285|FG003|Overall Study|Withdrawal by Subject|0|||
146220382|NCT05329220|527321351|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146220383|NCT05329220|527321352|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
146220384|NCT05329220|527321353|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
146220385|NCT05329220|527321348|FG000|Follow-up Period|EARLY TERMINATION|0|||
146220386|NCT05329220|527321349|FG001|Follow-up Period|EARLY TERMINATION|0|||
146220387|NCT05329220|527321350|FG002|Follow-up Period|EARLY TERMINATION|0|||
146220388|NCT05329220|527321351|FG003|Follow-up Period|EARLY TERMINATION|0|||
146220389|NCT05329220|527321352|FG004|Follow-up Period|EARLY TERMINATION|0|||
146220390|NCT05329220|527321353|FG005|Follow-up Period|EARLY TERMINATION|1|||
146220391|NCT05329220|527321348|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146220392|NCT05329220|527321349|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146220393|NCT05329220|527321350|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146220394|NCT05329220|527321351|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146220395|NCT05329220|527321352|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
146220396|NCT05329220|527321353|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
146220397|NCT05329220|527321348|FG000|Follow-up Period|DROPPED|0|||
146220398|NCT05329220|527321349|FG001|Follow-up Period|DROPPED|0|||
146220399|NCT05329220|527321350|FG002|Follow-up Period|DROPPED|0|||
146220400|NCT05329220|527321351|FG003|Follow-up Period|DROPPED|0|||
146220401|NCT05329220|527321352|FG004|Follow-up Period|DROPPED|0|||
146084781|NCT00592774|526830286|FG004|Overall Study|Withdrawal by Subject|0|||
146084782|NCT00592774|526830282|FG000|Overall Study|Lack of Efficacy|3|||
146084783|NCT00592774|526830283|FG001|Overall Study|Lack of Efficacy|3|||
146288316|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288317|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288318|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288319|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
146288320|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
146220402|NCT05329220|527321353|FG005|Follow-up Period|DROPPED|1|||
146220403|NCT05329220|527321348|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146220404|NCT05329220|527321349|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146220405|NCT05329220|527321350|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146220406|NCT05329220|527321351|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146220407|NCT05329220|527321352|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
146220408|NCT05329220|527321353|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
146220409|NCT02465268|527321355|FG000|Overall Study|Withdrawal by Subject|4|||
146220410|NCT02465268|527321356|FG001|Overall Study|Withdrawal by Subject|3|||
146220411|NCT02465268|527321357|FG002|Overall Study|Withdrawal by Subject|1|||
146220412|NCT02465268|527321355|FG000|Overall Study|Not evaluable per protocol criteria|3|||
146220413|NCT02465268|527321356|FG001|Overall Study|Not evaluable per protocol criteria|2|||
146220414|NCT02465268|527321357|FG002|Overall Study|Not evaluable per protocol criteria|1|||
146220415|NCT02465268|527321355|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
146220416|NCT02465268|527321356|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
146220417|NCT02465268|527321357|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
146220418|NCT02465268|527321355|FG000|Overall Study|Study drug did not pass QA/QC|1|||
146220419|NCT02465268|527321356|FG001|Overall Study|Study drug did not pass QA/QC|0|||
146220420|NCT02465268|527321357|FG002|Overall Study|Study drug did not pass QA/QC|0|||
146220421|NCT02465268|527321355|FG000|Overall Study|Adverse Event|0|||
146220422|NCT02465268|527321356|FG001|Overall Study|Adverse Event|1|||
146220423|NCT02465268|527321357|FG002|Overall Study|Adverse Event|0|||
146220424|NCT02465268|527321355|FG000|Overall Study|Physician Decision|0|||
146220425|NCT02465268|527321356|FG001|Overall Study|Physician Decision|1|||
146220426|NCT02465268|527321357|FG002|Overall Study|Physician Decision|0|||
146220427|NCT02547363|527321360|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146220428|NCT02547363|527321361|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146220429|NCT02547363|527321360|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
146220430|NCT02547363|527321361|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
146220431|NCT02547363|527321360|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146220432|NCT02547363|527321361|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146220433|NCT02547363|527321360|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
146220434|NCT02547363|527321361|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
146220435|NCT02547363|527321360|FG000|12-month Follow-up|Withdrawal by Subject|4|||
146220436|NCT02547363|527321361|FG001|12-month Follow-up|Withdrawal by Subject|3|||
146220437|NCT02547363|527321360|FG000|12-month Follow-up|Lost to Follow-up|4|||
146220438|NCT02547363|527321361|FG001|12-month Follow-up|Lost to Follow-up|1|||
146220439|NCT02547363|527321360|FG000|12-month Follow-up|Lack of Efficacy|1|||
146220440|NCT02547363|527321361|FG001|12-month Follow-up|Lack of Efficacy|1|||
146220441|NCT02547363|527321360|FG000|12-month Follow-up|Other|1|||
146220442|NCT02547363|527321361|FG001|12-month Follow-up|Other|0|||
146220443|NCT04130438|527323678|FG000|Overall Study|Lost to Follow-up|0|||
146220444|NCT04130438|527323679|FG001|Overall Study|Lost to Follow-up|0|||
146220445|NCT04130438|527323680|FG002|Overall Study|Lost to Follow-up|1|||
146220446|NCT03953508|527323681|FG000|Baseline|Lost to Follow-up|3|||
146220447|NCT03953508|527323682|FG001|Baseline|Lost to Follow-up|2|||
146220448|NCT03953508|527323681|FG000|6-month Follow-up|Lost to Follow-up|62|||
146220449|NCT03953508|527323682|FG001|6-month Follow-up|Lost to Follow-up|70|||
146220450|NCT03771417|527323683|FG000|Overall Study|Withdrawal by Subject|1|||
146220451|NCT03771417|527323684|FG001|Overall Study|Withdrawal by Subject|0|||
146220452|NCT03771417|527323685|FG002|Overall Study|Withdrawal by Subject|0|||
146220453|NCT03771417|527323683|FG000|Overall Study|Covid-19 Shutdown|0|||
146220454|NCT03771417|527323684|FG001|Overall Study|Covid-19 Shutdown|1|||
146220455|NCT03771417|527323685|FG002|Overall Study|Covid-19 Shutdown|0|||
146220456|NCT05119023|527323689|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
146288321|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288322|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146220457|NCT05119023|527323689|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
146288323|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146220458|NCT05119023|527323689|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
146220459|NCT04509674|527323695|FG000|Overall Study|Not treated|33|||
146220460|NCT04509674|527323696|FG001|Overall Study|Not treated|26|||
146220461|NCT04509674|527323695|FG000|Overall Study|Protocol Violation|9|||
146220462|NCT04509674|527323696|FG001|Overall Study|Protocol Violation|10|||
146220463|NCT04509674|527323695|FG000|Overall Study|Lost to Follow-up|31|||
146220464|NCT04509674|527323696|FG001|Overall Study|Lost to Follow-up|39|||
146220465|NCT04509674|527323695|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
146220466|NCT04509674|527323696|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
146220467|NCT04509674|527323695|FG000|Overall Study|Adverse event, serious fatal event|11|||
146220468|NCT04509674|527323696|FG001|Overall Study|Adverse event, serious fatal event|4|||
146084784|NCT00592774|526830284|FG002|Overall Study|Lack of Efficacy|0|||
146084785|NCT00592774|526830285|FG003|Overall Study|Lack of Efficacy|0|||
146084786|NCT00592774|526830286|FG004|Overall Study|Lack of Efficacy|2|||
146084787|NCT00592774|526830282|FG000|Overall Study|Physician Decision|0|||
146084788|NCT00592774|526830283|FG001|Overall Study|Physician Decision|1|||
146084789|NCT00592774|526830284|FG002|Overall Study|Physician Decision|1|||
146084790|NCT00592774|526830285|FG003|Overall Study|Physician Decision|0|||
146084791|NCT00592774|526830286|FG004|Overall Study|Physician Decision|1|||
146084792|NCT00592774|526830282|FG000|Overall Study|Other|0|||
146084793|NCT00592774|526830283|FG001|Overall Study|Other|1|||
146084794|NCT00592774|526830284|FG002|Overall Study|Other|1|||
146084795|NCT00592774|526830285|FG003|Overall Study|Other|0|||
146084796|NCT00592774|526830286|FG004|Overall Study|Other|2|||
146084797|NCT01892384|526830287|FG000|Overall Study|Withdrawal by Subject|1|||
146084798|NCT01892384|526830288|FG001|Overall Study|Withdrawal by Subject|1|||
146084799|NCT01892384|526830289|FG002|Overall Study|Withdrawal by Subject|0|||
146084800|NCT01892384|526830290|FG003|Overall Study|Withdrawal by Subject|0|||
146084801|NCT01924429|526830296|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
146084802|NCT01924429|526830297|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
146084803|NCT03985878|526830300|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
146084804|NCT03985878|526830300|FG000|Overall Study|Study Terminated by Sponsor|12|||
146084805|NCT03985878|526830300|FG000|Overall Study|Withdrawal by Subject|1|||
146084806|NCT01606878|526830301|FG000|Overall Study|Adverse Event|1|||
146084807|NCT01606878|526830302|FG001|Overall Study|Adverse Event|1|||
146084808|NCT01606878|526830303|FG002|Overall Study|Adverse Event|0|||
146084809|NCT01606878|526830304|FG003|Overall Study|Adverse Event|0|||
146084810|NCT01606878|526830305|FG004|Overall Study|Adverse Event|0|||
146084811|NCT01606878|526830306|FG005|Overall Study|Adverse Event|0|||
146084812|NCT01606878|526830307|FG006|Overall Study|Adverse Event|1|||
146084813|NCT01606878|526830308|FG007|Overall Study|Adverse Event|0|||
146084814|NCT01606878|526830309|FG008|Overall Study|Adverse Event|1|||
146084815|NCT01606878|526830310|FG009|Overall Study|Adverse Event|3|||
146084816|NCT01606878|526830311|FG010|Overall Study|Adverse Event|0|||
146084817|NCT01606878|526830301|FG000|Overall Study|Lack of Efficacy|1|||
146084818|NCT01606878|526830302|FG001|Overall Study|Lack of Efficacy|1|||
146084819|NCT01606878|526830303|FG002|Overall Study|Lack of Efficacy|1|||
146084820|NCT01606878|526830304|FG003|Overall Study|Lack of Efficacy|2|||
146084821|NCT01606878|526830305|FG004|Overall Study|Lack of Efficacy|1|||
146084822|NCT01606878|526830306|FG005|Overall Study|Lack of Efficacy|2|||
146084823|NCT01606878|526830307|FG006|Overall Study|Lack of Efficacy|1|||
146084824|NCT01606878|526830308|FG007|Overall Study|Lack of Efficacy|2|||
146084825|NCT01606878|526830309|FG008|Overall Study|Lack of Efficacy|2|||
146084826|NCT01606878|526830310|FG009|Overall Study|Lack of Efficacy|0|||
146084827|NCT01606878|526830311|FG010|Overall Study|Lack of Efficacy|1|||
146084828|NCT01606878|526830301|FG000|Overall Study|Physician Decision|1|||
146084829|NCT01606878|526830302|FG001|Overall Study|Physician Decision|0|||
146084830|NCT01606878|526830303|FG002|Overall Study|Physician Decision|2|||
146084831|NCT01606878|526830304|FG003|Overall Study|Physician Decision|1|||
146084832|NCT01606878|526830305|FG004|Overall Study|Physician Decision|1|||
146084833|NCT01606878|526830306|FG005|Overall Study|Physician Decision|1|||
146084834|NCT01606878|526830307|FG006|Overall Study|Physician Decision|2|||
146084835|NCT01606878|526830308|FG007|Overall Study|Physician Decision|0|||
146084836|NCT01606878|526830309|FG008|Overall Study|Physician Decision|1|||
146084837|NCT01606878|526830310|FG009|Overall Study|Physician Decision|0|||
146084838|NCT01606878|526830311|FG010|Overall Study|Physician Decision|0|||
146084839|NCT01606878|526830301|FG000|Overall Study|Withdrawal by Subject|3|||
146084840|NCT01606878|526830302|FG001|Overall Study|Withdrawal by Subject|2|||
146084841|NCT01606878|526830303|FG002|Overall Study|Withdrawal by Subject|2|||
146220469|NCT04509674|527323695|FG000|Overall Study|Adverse event, non-fatal event|107|||
146220470|NCT04509674|527323696|FG001|Overall Study|Adverse event, non-fatal event|118|||
146220471|NCT04509674|527323695|FG000|Overall Study|Other reason than listed|106|||
146084842|NCT01606878|526830304|FG003|Overall Study|Withdrawal by Subject|0|||
146084843|NCT01606878|526830305|FG004|Overall Study|Withdrawal by Subject|1|||
146084844|NCT01606878|526830306|FG005|Overall Study|Withdrawal by Subject|1|||
146084845|NCT01606878|526830307|FG006|Overall Study|Withdrawal by Subject|2|||
146084846|NCT01606878|526830308|FG007|Overall Study|Withdrawal by Subject|1|||
146084847|NCT01606878|526830309|FG008|Overall Study|Withdrawal by Subject|2|||
146084848|NCT01606878|526830310|FG009|Overall Study|Withdrawal by Subject|0|||
146084849|NCT01606878|526830311|FG010|Overall Study|Withdrawal by Subject|2|||
146084850|NCT00129311|526830314|FG000|Overall Study|Withdrawal by Subject|12|||
146084851|NCT00129311|526830315|FG001|Overall Study|Withdrawal by Subject|19|||
146084852|NCT00853970|526830325|FG000|Overall Study|Withdrawal by Subject|2|||
145882211|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
146288324|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146288325|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146288326|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146288327|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
146288328|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146288329|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
146288330|NCT04494256|527571350|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288331|NCT04494256|527571351|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288332|NCT04494256|527571352|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288333|NCT04494256|527571353|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288334|NCT04494256|527571354|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
146288335|NCT04494256|527571355|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288336|NCT04494256|527571356|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
146288337|NCT04494256|527571350|FG000|Part 2: Open Label Period|Death|0|||
146288338|NCT04494256|527571351|FG001|Part 2: Open Label Period|Death|0|||
146288339|NCT04494256|527571352|FG002|Part 2: Open Label Period|Death|0|||
146288340|NCT04494256|527571353|FG003|Part 2: Open Label Period|Death|0|||
146288341|NCT04494256|527571354|FG004|Part 2: Open Label Period|Death|0|||
146288342|NCT04494256|527571355|FG005|Part 2: Open Label Period|Death|4|||
146288343|NCT04494256|527571356|FG006|Part 2: Open Label Period|Death|2|||
146288344|NCT04494256|527571350|FG000|Part 2: Open Label Period|Adverse Event|0|||
146288345|NCT04494256|527571351|FG001|Part 2: Open Label Period|Adverse Event|0|||
146288346|NCT04494256|527571352|FG002|Part 2: Open Label Period|Adverse Event|0|||
146288347|NCT04494256|527571353|FG003|Part 2: Open Label Period|Adverse Event|0|||
146288348|NCT04494256|527571354|FG004|Part 2: Open Label Period|Adverse Event|0|||
146288349|NCT04494256|527571355|FG005|Part 2: Open Label Period|Adverse Event|0|||
146288350|NCT04494256|527571356|FG006|Part 2: Open Label Period|Adverse Event|2|||
146288351|NCT04494256|527571350|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146288352|NCT04494256|527571351|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146288353|NCT04494256|527571352|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146288354|NCT04494256|527571353|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146288355|NCT04494256|527571354|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
146288356|NCT04494256|527571355|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
146288357|NCT04494256|527571356|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
145882212|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
145882213|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Other|1|||
145882214|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Other|4|||
145882215|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Other|5|||
145882216|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
145882217|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
145882218|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
145882219|NCT02725411|526074747|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
146288358|NCT04494256|527571350|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288359|NCT04494256|527571351|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288360|NCT04494256|527571352|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288361|NCT04494256|527571353|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288362|NCT04494256|527571354|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288363|NCT04494256|527571355|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
146288364|NCT04494256|527571356|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
146288365|NCT04494256|527571350|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146288366|NCT04494256|527571351|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146288367|NCT04494256|527571352|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146288368|NCT04494256|527571353|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146288369|NCT04494256|527571354|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
146288370|NCT04494256|527571355|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
146288371|NCT04494256|527571356|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
146288372|NCT04494256|527571350|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288373|NCT04494256|527571351|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288374|NCT04494256|527571352|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288375|NCT04494256|527571353|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
146288376|NCT04494256|527571354|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145882220|NCT02725411|526074748|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
145882221|NCT02725411|526074749|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
145882222|NCT02725411|526074747|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
146220472|NCT04509674|527323696|FG001|Overall Study|Other reason than listed|95|||
146220473|NCT04064164|527323698|FG000|Overall Study|Withdrawal by Subject|8|||
146220474|NCT04064164|527323699|FG001|Overall Study|Withdrawal by Subject|8|||
146084853|NCT00853970|526830326|FG001|Overall Study|Withdrawal by Subject|1|||
146084854|NCT00853970|526830325|FG000|Overall Study|Cancelled surgery|4|||
146084855|NCT00853970|526830326|FG001|Overall Study|Cancelled surgery|2|||
146084856|NCT04085367|526831984|FG000|Overall Study|Adverse Event|1|||
146220475|NCT06190691|527323700|FG000|Overall Study|Adverse Event|2|||
146220476|NCT06190691|527323701|FG001|Overall Study|Adverse Event|0|||
146220477|NCT06190691|527323702|FG002|Overall Study|Adverse Event|0|||
146220478|NCT06190691|527323703|FG003|Overall Study|Adverse Event|0|||
146220479|NCT02023866|527323705|FG000|Overall Study|Non-compliance|2|||
146220480|NCT02023866|527323705|FG000|Overall Study|Adverse Event|3|||
146220481|NCT02023866|527323705|FG000|Overall Study|Withdrawal by Subject|1|||
146220482|NCT03839940|527323706|FG000|Overall Study|Withdrawal by Subject|3|||
146220483|NCT03839940|527323707|FG001|Overall Study|Withdrawal by Subject|0|||
146220484|NCT03839940|527323706|FG000|Overall Study|Protocol Violation|0|||
146220485|NCT03839940|527323707|FG001|Overall Study|Protocol Violation|1|||
146220486|NCT03839940|527323706|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
146220487|NCT03839940|527323707|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
146220488|NCT03241745|527323708|FG000|Overall Study|Adverse Event|7|||
146220489|NCT03241745|527323708|FG000|Overall Study|Death|1|||
146220490|NCT03241745|527323708|FG000|Overall Study|Withdrawal by Subject|5|||
146220491|NCT03241745|527323708|FG000|Overall Study|Treatment delay >28 days|2|||
146220492|NCT03241745|527323708|FG000|Overall Study|Lack of Efficacy|14|||
146220493|NCT04019873|527323709|FG000|Overall Study|Discontinued from the treatment|1|||
146220494|NCT04019873|527323710|FG001|Overall Study|Discontinued from the treatment|39|||
146220495|NCT04019873|527323711|FG002|Overall Study|Discontinued from the treatment|2|||
146220496|NCT03524118|527323713|FG000|Overall Study|Lost to Follow-up|0|||
146220497|NCT03524118|527323714|FG001|Overall Study|Lost to Follow-up|0|||
146220498|NCT03524118|527323715|FG002|Overall Study|Lost to Follow-up|0|||
146220499|NCT03524118|527323716|FG003|Overall Study|Lost to Follow-up|0|||
146220500|NCT03524118|527323717|FG004|Overall Study|Lost to Follow-up|1|||
146220501|NCT03524118|527323718|FG005|Overall Study|Lost to Follow-up|0|||
146220502|NCT03524118|527323713|FG000|Overall Study|Other|0|||
146220503|NCT03524118|527323714|FG001|Overall Study|Other|1|||
146220504|NCT03524118|527323715|FG002|Overall Study|Other|0|||
146220505|NCT03524118|527323716|FG003|Overall Study|Other|0|||
146220506|NCT03524118|527323717|FG004|Overall Study|Other|1|||
146220507|NCT03524118|527323718|FG005|Overall Study|Other|1|||
146220508|NCT03524118|527323713|FG000|Overall Study|Physician Decision|0|||
146220509|NCT03524118|527323714|FG001|Overall Study|Physician Decision|0|||
146220510|NCT03524118|527323715|FG002|Overall Study|Physician Decision|0|||
146220511|NCT03524118|527323716|FG003|Overall Study|Physician Decision|0|||
146220512|NCT03524118|527323717|FG004|Overall Study|Physician Decision|1|||
146220513|NCT03524118|527323718|FG005|Overall Study|Physician Decision|0|||
146220514|NCT03524118|527323713|FG000|Overall Study|Protocol Violation|0|||
146220515|NCT03524118|527323714|FG001|Overall Study|Protocol Violation|0|||
146220516|NCT03524118|527323715|FG002|Overall Study|Protocol Violation|1|||
146084857|NCT04085367|526831985|FG001|Overall Study|Adverse Event|1|||
146084858|NCT04085367|526831984|FG000|Overall Study|Withdrawal by Subject|13|||
146084859|NCT04085367|526831985|FG001|Overall Study|Withdrawal by Subject|4|||
146084860|NCT04085367|526831984|FG000|Overall Study|Lost to Follow-up|3|||
146084861|NCT04085367|526831985|FG001|Overall Study|Lost to Follow-up|1|||
146084862|NCT04085367|526831984|FG000|Overall Study|Other unspecified|2|||
146084863|NCT04085367|526831985|FG001|Overall Study|Other unspecified|1|||
146084864|NCT04085367|526831984|FG000|Overall Study|Status Unknown|1|||
146084865|NCT04085367|526831985|FG001|Overall Study|Status Unknown|1|||
146084866|NCT03603509|526831987|FG000|Overall Study|Lost to Follow-up|3|||
146084867|NCT03603509|526831988|FG001|Overall Study|Lost to Follow-up|4|||
146084868|NCT00130442|526831991|FG000|Overall Study|Withdrawal by Subject|0|||
146084869|NCT00130442|526831992|FG001|Overall Study|Withdrawal by Subject|1|||
146220517|NCT03524118|527323716|FG003|Overall Study|Protocol Violation|0|||
146220518|NCT03524118|527323717|FG004|Overall Study|Protocol Violation|1|||
146220519|NCT03524118|527323718|FG005|Overall Study|Protocol Violation|0|||
146220520|NCT03524118|527323713|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146220521|NCT03524118|527323714|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146084870|NCT00130442|526831991|FG000|Overall Study|did not meet criteria|1|||
146084871|NCT00130442|526831992|FG001|Overall Study|did not meet criteria|1|||
146084872|NCT00814333|526831994|FG000|Enrollment|Lost to Follow-up|1|||
146084873|NCT00814333|526831995|FG001|Enrollment|Lost to Follow-up|0|||
146084874|NCT01527357|526831996|FG000|Overall Study|Death|8|||
146220522|NCT03524118|527323715|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146220523|NCT03524118|527323716|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
146220524|NCT03524118|527323717|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
146220525|NCT03524118|527323718|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146220526|NCT01437709|527323719|FG000|Overall Study|Adverse Event|0|||
146220527|NCT01437709|527323720|FG001|Overall Study|Adverse Event|1|||
146084875|NCT01527357|526831997|FG001|Overall Study|Death|2|||
145882223|NCT02725411|526074748|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
146084876|NCT01527357|526831996|FG000|Overall Study|Lost to Follow-up|6|||
146220528|NCT01437709|527323721|FG002|Overall Study|Adverse Event|0|||
146220529|NCT01437709|527323719|FG000|Overall Study|Pt trasnferred care|0|||
146220530|NCT01437709|527323720|FG001|Overall Study|Pt trasnferred care|1|||
146220531|NCT01437709|527323721|FG002|Overall Study|Pt trasnferred care|0|||
146220532|NCT01842542|527323722|FG000|Overall Study|Withdrawal by Subject|2|||
146220533|NCT01842542|527323722|FG000|Overall Study|Lack of Efficacy|1|||
146220534|NCT01842542|527323722|FG000|Overall Study|Protocol Non-compliance|2|||
146220535|NCT01842542|527323722|FG000|Overall Study|Lost to Follow-up|1|||
146220536|NCT04908722|527323723|FG000|Overall Study|Protocol deviation|1|||
146220537|NCT04908722|527323724|FG001|Overall Study|Protocol deviation|0|||
146220538|NCT04908722|527323725|FG002|Overall Study|Protocol deviation|0|||
146220539|NCT04908722|527323726|FG003|Overall Study|Protocol deviation|0|||
146220540|NCT04908722|527323727|FG004|Overall Study|Protocol deviation|0|||
146220541|NCT04908722|527323728|FG005|Overall Study|Protocol deviation|1|||
146220542|NCT04908722|527323723|FG000|Overall Study|Lost to Follow-up|33|||
146220543|NCT04908722|527323724|FG001|Overall Study|Lost to Follow-up|33|||
146220544|NCT04908722|527323725|FG002|Overall Study|Lost to Follow-up|36|||
146220545|NCT04908722|527323726|FG003|Overall Study|Lost to Follow-up|30|||
146220546|NCT04908722|527323727|FG004|Overall Study|Lost to Follow-up|32|||
146220547|NCT04908722|527323728|FG005|Overall Study|Lost to Follow-up|34|||
146220548|NCT04908722|527323723|FG000|Overall Study|Physician Decision|1|||
146220549|NCT04908722|527323724|FG001|Overall Study|Physician Decision|1|||
146220550|NCT04908722|527323725|FG002|Overall Study|Physician Decision|1|||
146220551|NCT04908722|527323726|FG003|Overall Study|Physician Decision|2|||
146220552|NCT04908722|527323727|FG004|Overall Study|Physician Decision|0|||
146220553|NCT04908722|527323728|FG005|Overall Study|Physician Decision|0|||
146220554|NCT04908722|527323723|FG000|Overall Study|Death|1|||
146220555|NCT04908722|527323724|FG001|Overall Study|Death|0|||
146220556|NCT04908722|527323725|FG002|Overall Study|Death|0|||
146220557|NCT04908722|527323726|FG003|Overall Study|Death|0|||
146220558|NCT04908722|527323727|FG004|Overall Study|Death|0|||
146220559|NCT04908722|527323728|FG005|Overall Study|Death|1|||
146220560|NCT04908722|527323723|FG000|Overall Study|Withdrawal by Subject|12|||
146220561|NCT04908722|527323724|FG001|Overall Study|Withdrawal by Subject|8|||
146220562|NCT04908722|527323725|FG002|Overall Study|Withdrawal by Subject|7|||
146220563|NCT04908722|527323726|FG003|Overall Study|Withdrawal by Subject|6|||
146220564|NCT04908722|527323727|FG004|Overall Study|Withdrawal by Subject|12|||
146220565|NCT04908722|527323728|FG005|Overall Study|Withdrawal by Subject|14|||
146220566|NCT04908722|527323723|FG000|Overall Study|Other|3|||
146220567|NCT04908722|527323724|FG001|Overall Study|Other|1|||
146220568|NCT04908722|527323725|FG002|Overall Study|Other|3|||
146220569|NCT04908722|527323726|FG003|Overall Study|Other|2|||
146220570|NCT04908722|527323727|FG004|Overall Study|Other|4|||
146220571|NCT04908722|527323728|FG005|Overall Study|Other|1|||
146220572|NCT04908722|527323723|FG000|Overall Study|Initiated prohibited medication|0|||
146220573|NCT04908722|527323724|FG001|Overall Study|Initiated prohibited medication|0|||
146220574|NCT04908722|527323725|FG002|Overall Study|Initiated prohibited medication|0|||
146220575|NCT04908722|527323726|FG003|Overall Study|Initiated prohibited medication|1|||
146220576|NCT04908722|527323727|FG004|Overall Study|Initiated prohibited medication|0|||
146220577|NCT04908722|527323728|FG005|Overall Study|Initiated prohibited medication|1|||
146220578|NCT04908722|527323723|FG000|Overall Study|Randomized but not vaccinated|3|||
146220579|NCT04908722|527323724|FG001|Overall Study|Randomized but not vaccinated|1|||
146220580|NCT04908722|527323725|FG002|Overall Study|Randomized but not vaccinated|2|||
146220581|NCT04908722|527323726|FG003|Overall Study|Randomized but not vaccinated|2|||
146220582|NCT04908722|527323727|FG004|Overall Study|Randomized but not vaccinated|3|||
146220583|NCT04908722|527323728|FG005|Overall Study|Randomized but not vaccinated|4|||
146220584|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
146220585|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
146220586|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
146220587|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
146220588|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
146220589|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
146220590|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
146220591|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
146220592|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
146220593|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
146220594|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
146220595|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
146220596|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
146220597|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
146220598|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
146220599|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
145882224|NCT02725411|526074749|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
146220600|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
146220601|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
146220602|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
146220603|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
146220604|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
146220605|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
146084877|NCT01527357|526831997|FG001|Overall Study|Lost to Follow-up|4|||
146084878|NCT01527357|526831996|FG000|Overall Study|Withdrew Consent|1|||
146084879|NCT01527357|526831997|FG001|Overall Study|Withdrew Consent|1|||
146084880|NCT01527357|526831996|FG000|Overall Study|Non-compliance|0|||
146084881|NCT01527357|526831997|FG001|Overall Study|Non-compliance|1|||
146084882|NCT01527357|526831996|FG000|Overall Study|No Day 29 Visit|0|||
146084883|NCT01527357|526831997|FG001|Overall Study|No Day 29 Visit|1|||
146084884|NCT01527357|526831996|FG000|Overall Study|Did Not Receive Treatment|2|||
146084885|NCT01527357|526831997|FG001|Overall Study|Did Not Receive Treatment|0|||
146084886|NCT00910247|526831998|FG000|Overall Study|Adverse Event|15|||
146084887|NCT00910247|526831998|FG000|Overall Study|Death|2|||
146084888|NCT00910247|526831998|FG000|Overall Study|Lost to Follow-up|10|||
146084889|NCT00910247|526831998|FG000|Overall Study|Physician Decision|3|||
146084890|NCT00910247|526831998|FG000|Overall Study|Protocol Violation|10|||
146084891|NCT00910247|526831998|FG000|Overall Study|Withdrawal by Subject|25|||
146220606|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
146220607|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
146220608|NCT01715285|527323729|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
146084892|NCT00910247|526831998|FG000|Overall Study|Not collected|4|||
146084893|NCT02519855|526832000|FG000|Overall Study|Adverse Event|0|||
146084894|NCT02519855|526832001|FG001|Overall Study|Adverse Event|1|||
146084895|NCT02519855|526832000|FG000|Overall Study|Lost to Follow-up|3|||
146084896|NCT02519855|526832001|FG001|Overall Study|Lost to Follow-up|3|||
146084897|NCT00003830|526832002|FG000|Overall Study|No follow up data|3|||
146084898|NCT00003830|526832003|FG001|Overall Study|No follow up data|0|||
146084899|NCT00003830|526832002|FG000|Overall Study|Sentinel node positive patients|829|||
146084900|NCT00003830|526832003|FG001|Overall Study|Sentinel node positive patients|793|||
146084901|NCT05347147|526832004|FG000|Overall Study|Lost to Follow-up|0|||
146084902|NCT05347147|526832005|FG001|Overall Study|Lost to Follow-up|1|||
146084903|NCT05347147|526832004|FG000|Overall Study|Sponsor request|3|||
146084904|NCT05347147|526832005|FG001|Overall Study|Sponsor request|3|||
146084905|NCT05347147|526832004|FG000|Overall Study|Study termination|2|||
146084906|NCT05347147|526832005|FG001|Overall Study|Study termination|1|||
146084907|NCT03565367|526832006|FG000|Overall Study|No scan due to technical issues|4|||
146084908|NCT03565367|526832007|FG001|Overall Study|No scan due to technical issues|0|||
146084909|NCT00923364|526832010|FG000|Overall Study|Death|3|||
146084910|NCT00923364|526832011|FG001|Overall Study|Death|0|||
146084911|NCT00923364|526832010|FG000|Overall Study|Did not go to transplant|1|||
146084912|NCT00923364|526832011|FG001|Overall Study|Did not go to transplant|0|||
146084913|NCT01397825|526832015|FG000|Overall Study|Progressive Disease|10|||
146084914|NCT01397825|526832016|FG001|Overall Study|Progressive Disease|3|||
146084915|NCT01397825|526832017|FG002|Overall Study|Progressive Disease|11|||
146084916|NCT01397825|526832018|FG003|Overall Study|Progressive Disease|1|||
146084917|NCT01397825|526832019|FG004|Overall Study|Progressive Disease|0|||
146084918|NCT01397825|526832015|FG000|Overall Study|Symptomatic Deterioration|2|||
146084919|NCT01397825|526832016|FG001|Overall Study|Symptomatic Deterioration|0|||
146084920|NCT01397825|526832017|FG002|Overall Study|Symptomatic Deterioration|4|||
146084921|NCT01397825|526832018|FG003|Overall Study|Symptomatic Deterioration|0|||
146084922|NCT01397825|526832019|FG004|Overall Study|Symptomatic Deterioration|0|||
146084923|NCT01397825|526832015|FG000|Overall Study|Adverse Event|0|||
146084924|NCT01397825|526832016|FG001|Overall Study|Adverse Event|1|||
146084925|NCT01397825|526832017|FG002|Overall Study|Adverse Event|5|||
146084926|NCT01397825|526832018|FG003|Overall Study|Adverse Event|1|||
146084927|NCT01397825|526832019|FG004|Overall Study|Adverse Event|0|||
146084928|NCT01397825|526832015|FG000|Overall Study|Withdrawal by Subject|1|||
146084929|NCT01397825|526832016|FG001|Overall Study|Withdrawal by Subject|0|||
146084930|NCT01397825|526832017|FG002|Overall Study|Withdrawal by Subject|5|||
146084931|NCT01397825|526832018|FG003|Overall Study|Withdrawal by Subject|1|||
146084932|NCT01397825|526832019|FG004|Overall Study|Withdrawal by Subject|0|||
146084933|NCT01931670|526832020|FG000|Treatment Period|Exclusionary Medication Received|1|||
146084934|NCT01931670|526832021|FG001|Treatment Period|Exclusionary Medication Received|1|||
146084935|NCT01931670|526832022|FG002|Treatment Period|Exclusionary Medication Received|1|||
146084936|NCT01931670|526832020|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
146084937|NCT01931670|526832021|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
146220609|NCT01715285|527323730|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
146220610|NCT01715285|527323731|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
146084938|NCT01931670|526832022|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
146084939|NCT01931670|526832020|FG000|Treatment Period|Subject Noncompliant|4|||
146084940|NCT01931670|526832021|FG001|Treatment Period|Subject Noncompliant|9|||
146288377|NCT04494256|527571355|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
146288378|NCT04494256|527571356|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
146288379|NCT04494256|527571350|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146288380|NCT04494256|527571351|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146288381|NCT04494256|527571352|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146288382|NCT04494256|527571353|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146288383|NCT04494256|527571354|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
146288384|NCT04494256|527571355|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
146288385|NCT04494256|527571356|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
146288386|NCT02128542|527571357|FG000|Overall Study|Lost to Follow-up|3|||
146288387|NCT02128542|527571358|FG001|Overall Study|Lost to Follow-up|0|||
146288388|NCT02128542|527571357|FG000|Overall Study|Withdrew Consent|1|||
146288389|NCT02128542|527571358|FG001|Overall Study|Withdrew Consent|0|||
146288390|NCT01778023|527571359|FG000|Overall Study|Withdrawal by Subject|0|||
146288391|NCT01778023|527571360|FG001|Overall Study|Withdrawal by Subject|3|||
146288392|NCT04025580|527571361|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
146288393|NCT04025580|527571362|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
146288394|NCT04025580|527571363|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
146288395|NCT01249274|527571367|FG000|Overall Study|Lost to Follow-up|3|||
146288396|NCT01249274|527571368|FG001|Overall Study|Lost to Follow-up|4|||
146288397|NCT01249274|527571367|FG000|Overall Study|Received inpatient substance treatment|1|||
146288398|NCT01249274|527571368|FG001|Overall Study|Received inpatient substance treatment|2|||
146288399|NCT00138671|527571369|FG000|Overall Study|Death|0|||
146288400|NCT00138671|527571370|FG001|Overall Study|Death|3|||
146288401|NCT00138671|527571369|FG000|Overall Study|Adverse Event|6|||
146288402|NCT00138671|527571370|FG001|Overall Study|Adverse Event|3|||
146288403|NCT00138671|527571369|FG000|Overall Study|Lost to Follow-up|1|||
146288404|NCT00138671|527571370|FG001|Overall Study|Lost to Follow-up|2|||
146288405|NCT00138671|527571369|FG000|Overall Study|Withdrawal by Subject|3|||
146288406|NCT00138671|527571370|FG001|Overall Study|Withdrawal by Subject|5|||
146288407|NCT00138671|527571369|FG000|Overall Study|Other|3|||
146288408|NCT00138671|527571370|FG001|Overall Study|Other|3|||
146288409|NCT04634825|527571371|FG000|Overall Study|Death|10|||
146288410|NCT04634825|527571372|FG001|Overall Study|Death|3|||
146288411|NCT04634825|527571371|FG000|Overall Study|Lost to Follow-up|1|||
146288412|NCT04634825|527571372|FG001|Overall Study|Lost to Follow-up|0|||
146288413|NCT04634825|527571371|FG000|Overall Study|Study terminated by sponsor|35|||
146288414|NCT04634825|527571372|FG001|Overall Study|Study terminated by sponsor|11|||
146288415|NCT04634825|527571371|FG000|Overall Study|Withdrawal by Subject|2|||
146288416|NCT04634825|527571372|FG001|Overall Study|Withdrawal by Subject|0|||
146288417|NCT01100034|527571375|FG000|Overall Study|Lost to Follow-up|11|||
146288418|NCT01100034|527571375|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
146288419|NCT01100034|527571375|FG000|Overall Study|Withdrawal by Subject|4|||
146288420|NCT01100034|527571375|FG000|Overall Study|Sponsor decision|21|||
146288421|NCT01100034|527571375|FG000|Overall Study|Participated in another clinical trial|1|||
146288422|NCT01100034|527571375|FG000|Overall Study|Participants moved to another hospital|4|||
146288423|NCT01100034|527571375|FG000|Overall Study|Site closed due to non-responsiveness|1|||
146288424|NCT00402597|527571376|FG000|Overall Study|Death|15|||
146288425|NCT00402597|527571377|FG001|Overall Study|Death|7|||
146288426|NCT00402597|527571378|FG002|Overall Study|Death|6|||
146288427|NCT00402597|527571379|FG003|Overall Study|Death|4|||
146288428|NCT00402597|527571380|FG004|Overall Study|Death|6|||
146288429|NCT00402597|527571376|FG000|Overall Study|Adverse Event|81|||
146220611|NCT01715285|527323729|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
146220612|NCT01715285|527323730|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
146220613|NCT01715285|527323731|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
146220614|NCT01715285|527323729|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
146288430|NCT00402597|527571377|FG001|Overall Study|Adverse Event|18|||
146288431|NCT00402597|527571378|FG002|Overall Study|Adverse Event|106|||
146220615|NCT01715285|527323730|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
146220616|NCT01715285|527323731|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
146220617|NCT01715285|527323729|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
146220618|NCT01715285|527323730|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
146288432|NCT00402597|527571379|FG003|Overall Study|Adverse Event|39|||
146288433|NCT00402597|527571380|FG004|Overall Study|Adverse Event|71|||
146288434|NCT00402597|527571376|FG000|Overall Study|Lost to Follow-up|8|||
146288435|NCT00402597|527571377|FG001|Overall Study|Lost to Follow-up|1|||
146288436|NCT00402597|527571378|FG002|Overall Study|Lost to Follow-up|8|||
146288437|NCT00402597|527571379|FG003|Overall Study|Lost to Follow-up|2|||
146288438|NCT00402597|527571380|FG004|Overall Study|Lost to Follow-up|3|||
146288439|NCT00402597|527571376|FG000|Overall Study|Withdrawal by Subject|57|||
145882225|NCT02725411|526074747|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
145882226|NCT02725411|526074748|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
145882227|NCT02725411|526074749|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
146288440|NCT00402597|527571377|FG001|Overall Study|Withdrawal by Subject|16|||
146220619|NCT01715285|527323731|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
146220620|NCT01715285|527323729|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
146220621|NCT01715285|527323730|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
146220622|NCT01715285|527323731|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
146220623|NCT01715285|527323729|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
146220624|NCT01715285|527323730|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
146220625|NCT01715285|527323731|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
146220626|NCT03474679|527323732|FG000|Overall Study|Death|7|||
146220627|NCT03474679|527323732|FG000|Overall Study|Withdrawal by Subject|1|||
146220628|NCT02573493|527323736|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
146220629|NCT02573493|527323737|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
146220630|NCT02573493|527323738|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
146220631|NCT02573493|527323739|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
146220632|NCT02677805|527323743|FG000|Double Blind Phase|Lost to Follow-up|8|||
146220633|NCT02677805|527323744|FG001|Double Blind Phase|Lost to Follow-up|3|||
145882228|NCT02725411|526074747|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
145882229|NCT02725411|526074748|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
145882230|NCT02725411|526074749|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
145882231|NCT02725411|526074747|FG000|Follow-up Period (24 Weeks)|Other|1|||
145882232|NCT02725411|526074748|FG001|Follow-up Period (24 Weeks)|Other|4|||
145882233|NCT02725411|526074749|FG002|Follow-up Period (24 Weeks)|Other|2|||
145882234|NCT02725411|526074747|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
145882235|NCT02725411|526074748|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
145882236|NCT02725411|526074749|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
145882237|NCT03847974|526074750|FG000|Overall Study|relocated out of region|3|||
145882238|NCT03847974|526074750|FG000|Overall Study|Withdrawal by Subject|2|||
145882239|NCT03847974|526074750|FG000|Overall Study|Adverse Event|1|||
145882240|NCT00756717|526074753|FG000|Overall Study|Withdrawal by Subject|2|||
145882241|NCT02654015|526074754|FG000|Overall Study|Death|12|||
145882242|NCT02654015|526074754|FG000|Overall Study|Lost to Follow-up|3|||
145882243|NCT01896505|526074755|FG000|Overall Study|Adverse Event|1|||
145882244|NCT01896505|526074756|FG001|Overall Study|Adverse Event|0|||
145882245|NCT01896505|526074757|FG002|Overall Study|Adverse Event|2|||
145882246|NCT01896505|526074758|FG003|Overall Study|Adverse Event|1|||
145882247|NCT01896505|526074759|FG004|Overall Study|Adverse Event|1|||
145882248|NCT01896505|526074760|FG005|Overall Study|Adverse Event|0|||
145882249|NCT01896505|526074755|FG000|Overall Study|Physician Decision|1|||
145882250|NCT01896505|526074756|FG001|Overall Study|Physician Decision|3|||
145882251|NCT01896505|526074757|FG002|Overall Study|Physician Decision|2|||
145882252|NCT01896505|526074758|FG003|Overall Study|Physician Decision|0|||
145882253|NCT01896505|526074759|FG004|Overall Study|Physician Decision|0|||
145882254|NCT01896505|526074760|FG005|Overall Study|Physician Decision|1|||
145882255|NCT01896505|526074755|FG000|Overall Study|Withdrawal by Subject|1|||
145882256|NCT01896505|526074756|FG001|Overall Study|Withdrawal by Subject|0|||
145882257|NCT01896505|526074757|FG002|Overall Study|Withdrawal by Subject|3|||
145882258|NCT01896505|526074758|FG003|Overall Study|Withdrawal by Subject|1|||
145882259|NCT01896505|526074759|FG004|Overall Study|Withdrawal by Subject|0|||
145882260|NCT01896505|526074760|FG005|Overall Study|Withdrawal by Subject|0|||
145882261|NCT01896505|526074755|FG000|Overall Study|Disease Progression|7|||
145882262|NCT01896505|526074756|FG001|Overall Study|Disease Progression|5|||
145882263|NCT01896505|526074757|FG002|Overall Study|Disease Progression|8|||
145882264|NCT01896505|526074758|FG003|Overall Study|Disease Progression|4|||
145882265|NCT01896505|526074759|FG004|Overall Study|Disease Progression|4|||
145882266|NCT01896505|526074760|FG005|Overall Study|Disease Progression|4|||
145882267|NCT01896505|526074755|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
145882268|NCT01896505|526074756|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
145882269|NCT01896505|526074757|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
145882270|NCT01896505|526074758|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
145882271|NCT01896505|526074759|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
145882272|NCT01896505|526074760|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
145882273|NCT01896505|526074755|FG000|Overall Study|Intercurrent illness|0|||
145882274|NCT01896505|526074756|FG001|Overall Study|Intercurrent illness|1|||
145882275|NCT01896505|526074757|FG002|Overall Study|Intercurrent illness|0|||
145882276|NCT01896505|526074758|FG003|Overall Study|Intercurrent illness|0|||
145882277|NCT01896505|526074759|FG004|Overall Study|Intercurrent illness|0|||
145882278|NCT01896505|526074760|FG005|Overall Study|Intercurrent illness|0|||
145882279|NCT01896505|526074755|FG000|Overall Study|Death|0|||
145882280|NCT01896505|526074756|FG001|Overall Study|Death|0|||
145882281|NCT01896505|526074757|FG002|Overall Study|Death|1|||
145882282|NCT01896505|526074758|FG003|Overall Study|Death|1|||
145882283|NCT01896505|526074759|FG004|Overall Study|Death|0|||
145882284|NCT01896505|526074760|FG005|Overall Study|Death|1|||
145882285|NCT02466386|526074761|FG000|Overall Study|Adverse Event|5|||
145882286|NCT02466386|526074761|FG000|Overall Study|Protocol Violation|2|||
145960946|NCT00509899|526369450|FG006|Overall Study|Physician Decision|0|||
146220634|NCT02677805|527323745|FG002|Double Blind Phase|Lost to Follow-up|0|||
146220635|NCT02677805|527323743|FG000|Double Blind Phase|Withdrawal by Subject|5|||
146220636|NCT02677805|527323744|FG001|Double Blind Phase|Withdrawal by Subject|2|||
146220637|NCT02677805|527323745|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146220638|NCT02677805|527323743|FG000|Open Label Phase|Lost to Follow-up|0|||
146220639|NCT02677805|527323744|FG001|Open Label Phase|Lost to Follow-up|0|||
146220640|NCT02677805|527323745|FG002|Open Label Phase|Lost to Follow-up|10|||
146220641|NCT02677805|527323743|FG000|Open Label Phase|Withdrawal by Subject|0|||
146220642|NCT02677805|527323744|FG001|Open Label Phase|Withdrawal by Subject|0|||
146220643|NCT02677805|527323745|FG002|Open Label Phase|Withdrawal by Subject|6|||
146220644|NCT04111536|527323750|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146220645|NCT04111536|527323751|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146220646|NCT04111536|527323750|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
146220647|NCT04111536|527323751|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
146220648|NCT04111536|527323750|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
146220649|NCT04111536|527323751|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146220650|NCT04111536|527323750|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
146220651|NCT04111536|527323751|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
146220652|NCT04350463|527323752|FG000|Overall Study|Other reason|0|||
146220653|NCT04350463|527323753|FG001|Overall Study|Other reason|0|||
146220654|NCT04350463|527323754|FG002|Overall Study|Other reason|0|||
146220655|NCT04350463|527323755|FG003|Overall Study|Other reason|1|||
146220656|NCT04350463|527323752|FG000|Overall Study|Lost to Follow-up|0|||
146220657|NCT04350463|527323753|FG001|Overall Study|Lost to Follow-up|0|||
146220658|NCT04350463|527323754|FG002|Overall Study|Lost to Follow-up|0|||
146220659|NCT04350463|527323755|FG003|Overall Study|Lost to Follow-up|2|||
146220660|NCT04350463|527323752|FG000|Overall Study|Withdrawal by Subject|4|||
146220661|NCT04350463|527323753|FG001|Overall Study|Withdrawal by Subject|0|||
146220662|NCT04350463|527323754|FG002|Overall Study|Withdrawal by Subject|1|||
146220663|NCT04350463|527323755|FG003|Overall Study|Withdrawal by Subject|4|||
146220664|NCT04350463|527323752|FG000|Overall Study|Adverse Event|0|||
146220665|NCT04350463|527323753|FG001|Overall Study|Adverse Event|0|||
146084941|NCT01931670|526832022|FG002|Treatment Period|Subject Noncompliant|5|||
146084942|NCT01931670|526832020|FG000|Treatment Period|Adverse Event|19|||
146084943|NCT01931670|526832021|FG001|Treatment Period|Adverse Event|8|||
146084944|NCT01931670|526832022|FG002|Treatment Period|Adverse Event|21|||
146084945|NCT01931670|526832020|FG000|Treatment Period|Lack of Efficacy|11|||
146084946|NCT01931670|526832021|FG001|Treatment Period|Lack of Efficacy|2|||
146084947|NCT01931670|526832022|FG002|Treatment Period|Lack of Efficacy|2|||
146084948|NCT01931670|526832020|FG000|Treatment Period|Pregnancy|7|||
146084949|NCT01931670|526832021|FG001|Treatment Period|Pregnancy|2|||
146084950|NCT01931670|526832022|FG002|Treatment Period|Pregnancy|0|||
146084951|NCT01931670|526832020|FG000|Treatment Period|Other|8|||
146220666|NCT04350463|527323754|FG002|Overall Study|Adverse Event|0|||
146220667|NCT04350463|527323755|FG003|Overall Study|Adverse Event|2|||
146220668|NCT04350463|527323752|FG000|Overall Study|Death|27|||
146220669|NCT04350463|527323753|FG001|Overall Study|Death|2|||
146220670|NCT04350463|527323754|FG002|Overall Study|Death|13|||
146220671|NCT04350463|527323755|FG003|Overall Study|Death|26|||
146220672|NCT03544281|527323756|FG000|Main Study Phase|Death|3|||
146084952|NCT01931670|526832021|FG001|Treatment Period|Other|7|||
146084953|NCT01931670|526832022|FG002|Treatment Period|Other|2|||
146084954|NCT01931670|526832020|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
146084955|NCT01931670|526832021|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
146084956|NCT01931670|526832022|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
146084957|NCT01931670|526832020|FG000|Treatment Period|Lost to Follow-up|19|||
146084958|NCT01931670|526832021|FG001|Treatment Period|Lost to Follow-up|5|||
146220673|NCT03544281|527323757|FG001|Main Study Phase|Death|2|||
145882287|NCT02466386|526074761|FG000|Overall Study|Withdrawal by Subject|14|||
145882288|NCT02466386|526074761|FG000|Overall Study|Lost to Follow-up|5|||
145882289|NCT02466386|526074761|FG000|Overall Study|Lack of Efficacy|8|||
145882290|NCT02466386|526074761|FG000|Overall Study|Other|10|||
146220674|NCT03544281|527323758|FG002|Main Study Phase|Death|6|||
146084959|NCT01931670|526832022|FG002|Treatment Period|Lost to Follow-up|7|||
146084960|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
146220675|NCT03544281|527323759|FG003|Main Study Phase|Death|8|||
146220676|NCT03544281|527323760|FG004|Main Study Phase|Death|4|||
146220677|NCT03544281|527323761|FG005|Main Study Phase|Death|2|||
146084961|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
146084962|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
146084963|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
146220678|NCT03544281|527323762|FG006|Main Study Phase|Death|4|||
145882291|NCT05317195|526074762|FG000|Randomization|Withdrawal by Subject|1|||
146220679|NCT03544281|527323763|FG007|Main Study Phase|Death|5|||
146220680|NCT03544281|527323764|FG008|Main Study Phase|Death|5|||
146220681|NCT03544281|527323765|FG009|Main Study Phase|Death|8|||
146220682|NCT03544281|527323766|FG010|Main Study Phase|Death|6|||
146220683|NCT03544281|527323767|FG011|Main Study Phase|Death|4|||
146220684|NCT03544281|527323768|FG012|Main Study Phase|Death|0|||
146220685|NCT03544281|527323769|FG013|Main Study Phase|Death|0|||
146220686|NCT03544281|527323770|FG014|Main Study Phase|Death|0|||
146220687|NCT03544281|527323771|FG015|Main Study Phase|Death|0|||
146220688|NCT03544281|527323772|FG016|Main Study Phase|Death|0|||
146220689|NCT03544281|527323773|FG017|Main Study Phase|Death|0|||
146220690|NCT03544281|527323774|FG018|Main Study Phase|Death|0|||
146220691|NCT03544281|527323775|FG019|Main Study Phase|Death|0|||
146220692|NCT03544281|527323776|FG020|Main Study Phase|Death|0|||
146220693|NCT03544281|527323777|FG021|Main Study Phase|Death|0|||
146288441|NCT00402597|527571378|FG002|Overall Study|Withdrawal by Subject|65|||
146288442|NCT00402597|527571379|FG003|Overall Study|Withdrawal by Subject|15|||
146288443|NCT00402597|527571380|FG004|Overall Study|Withdrawal by Subject|24|||
146288444|NCT00402597|527571376|FG000|Overall Study|reason not specified|30|||
146288445|NCT00402597|527571377|FG001|Overall Study|reason not specified|4|||
146288446|NCT00402597|527571378|FG002|Overall Study|reason not specified|27|||
146288447|NCT00402597|527571379|FG003|Overall Study|reason not specified|14|||
146288448|NCT00402597|527571380|FG004|Overall Study|reason not specified|20|||
146288449|NCT00336895|527571381|FG000|Overall Study|diarrhea|1|||
146288450|NCT00336895|527571381|FG000|Overall Study|nausea and upset stomach|1|||
146288451|NCT00336895|527571381|FG000|Overall Study|Physician Decision|1|||
146288452|NCT00336895|527571381|FG000|Overall Study|screen failed|1|||
146288453|NCT02308020|527571382|FG000|Overall Study|Lost to Follow-up|1|||
146288454|NCT02308020|527571383|FG001|Overall Study|Lost to Follow-up|7|||
146288455|NCT02308020|527571384|FG002|Overall Study|Lost to Follow-up|0|||
146288456|NCT02308020|527571385|FG003|Overall Study|Lost to Follow-up|0|||
146288457|NCT02308020|527571386|FG004|Overall Study|Lost to Follow-up|1|||
146288458|NCT02308020|527571387|FG005|Overall Study|Lost to Follow-up|2|||
146288459|NCT02308020|527571382|FG000|Overall Study|Sponsor Decision|0|||
146288460|NCT02308020|527571383|FG001|Overall Study|Sponsor Decision|8|||
146288461|NCT02308020|527571384|FG002|Overall Study|Sponsor Decision|0|||
146288462|NCT02308020|527571385|FG003|Overall Study|Sponsor Decision|2|||
146288463|NCT02308020|527571386|FG004|Overall Study|Sponsor Decision|2|||
146288464|NCT02308020|527571387|FG005|Overall Study|Sponsor Decision|1|||
146288465|NCT02308020|527571382|FG000|Overall Study|Withdrawal by Subject|3|||
146288466|NCT02308020|527571383|FG001|Overall Study|Withdrawal by Subject|5|||
146288467|NCT02308020|527571384|FG002|Overall Study|Withdrawal by Subject|3|||
146288468|NCT02308020|527571385|FG003|Overall Study|Withdrawal by Subject|2|||
146288469|NCT02308020|527571386|FG004|Overall Study|Withdrawal by Subject|1|||
146288470|NCT02308020|527571387|FG005|Overall Study|Withdrawal by Subject|2|||
146288471|NCT01270971|527571388|FG000|Overall Study|Withdrawal by Subject|24|||
146288472|NCT01270971|527571389|FG001|Overall Study|Withdrawal by Subject|11|||
146288473|NCT01270971|527571388|FG000|Overall Study|Lost to Follow-up|18|||
146288474|NCT01270971|527571389|FG001|Overall Study|Lost to Follow-up|5|||
146220694|NCT03544281|527323756|FG000|Main Study Phase|Lost to Follow-up|0|||
146220695|NCT03544281|527323757|FG001|Main Study Phase|Lost to Follow-up|0|||
146220696|NCT03544281|527323758|FG002|Main Study Phase|Lost to Follow-up|0|||
146220697|NCT03544281|527323759|FG003|Main Study Phase|Lost to Follow-up|0|||
146220698|NCT03544281|527323760|FG004|Main Study Phase|Lost to Follow-up|0|||
146220699|NCT03544281|527323761|FG005|Main Study Phase|Lost to Follow-up|0|||
146220700|NCT03544281|527323762|FG006|Main Study Phase|Lost to Follow-up|0|||
146220701|NCT03544281|527323763|FG007|Main Study Phase|Lost to Follow-up|0|||
146288475|NCT01270971|527571388|FG000|Overall Study|Adverse Event|1|||
146288476|NCT01270971|527571389|FG001|Overall Study|Adverse Event|2|||
146288477|NCT01270971|527571388|FG000|Overall Study|Non compliance|2|||
146288478|NCT01270971|527571389|FG001|Overall Study|Non compliance|2|||
146288479|NCT01270971|527571388|FG000|Overall Study|Non-specific|7|||
146288480|NCT01270971|527571389|FG001|Overall Study|Non-specific|3|||
146288481|NCT02003573|527571393|FG000|Overall Study|Progressive disease|2|||
146288482|NCT02003573|527571394|FG001|Overall Study|Progressive disease|0|||
146084964|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
146220702|NCT03544281|527323764|FG008|Main Study Phase|Lost to Follow-up|0|||
146288483|NCT02003573|527571395|FG002|Overall Study|Progressive disease|1|||
146288484|NCT02003573|527571393|FG000|Overall Study|Other Adverse event|0|||
146288485|NCT02003573|527571394|FG001|Overall Study|Other Adverse event|1|||
146288486|NCT02003573|527571395|FG002|Overall Study|Other Adverse event|1|||
146288487|NCT02003573|527571393|FG000|Overall Study|Refuse to take trial medication|0|||
146288488|NCT02003573|527571394|FG001|Overall Study|Refuse to take trial medication|1|||
146288489|NCT02003573|527571395|FG002|Overall Study|Refuse to take trial medication|1|||
146288490|NCT02003573|527571393|FG000|Overall Study|Other than specified|1|||
146288491|NCT02003573|527571394|FG001|Overall Study|Other than specified|2|||
146288492|NCT02003573|527571395|FG002|Overall Study|Other than specified|3|||
146220703|NCT03544281|527323765|FG009|Main Study Phase|Lost to Follow-up|0|||
146220704|NCT03544281|527323766|FG010|Main Study Phase|Lost to Follow-up|1|||
146220705|NCT03544281|527323767|FG011|Main Study Phase|Lost to Follow-up|0|||
146220706|NCT03544281|527323768|FG012|Main Study Phase|Lost to Follow-up|0|||
146220707|NCT03544281|527323769|FG013|Main Study Phase|Lost to Follow-up|0|||
146288493|NCT00704405|527571402|FG000|Overall Study (NC Population)|Adverse Event|1|||
145882292|NCT05317195|526074762|FG000|Randomization|Discontinued|6|||
145882293|NCT05317195|526074762|FG000|Admission|Withdrawal by Subject|2|||
145882294|NCT02063217|526074763|FG000|Overall Study|Withdrawal by Subject|1|||
145882295|NCT02063217|526074764|FG001|Overall Study|Withdrawal by Subject|0|||
145882296|NCT02063217|526074765|FG002|Overall Study|Withdrawal by Subject|0|||
145882297|NCT00889252|526074766|FG000|Overall Study|Adverse Event|2|||
145882298|NCT00889252|526074767|FG001|Overall Study|Adverse Event|4|||
145882299|NCT00889252|526074766|FG000|Overall Study|Withdrawal by Subject|3|||
145882300|NCT00889252|526074767|FG001|Overall Study|Withdrawal by Subject|0|||
146220708|NCT03544281|527323770|FG014|Main Study Phase|Lost to Follow-up|0|||
146220709|NCT03544281|527323771|FG015|Main Study Phase|Lost to Follow-up|0|||
146220710|NCT03544281|527323772|FG016|Main Study Phase|Lost to Follow-up|0|||
146220711|NCT03544281|527323773|FG017|Main Study Phase|Lost to Follow-up|0|||
146220712|NCT03544281|527323774|FG018|Main Study Phase|Lost to Follow-up|0|||
146220713|NCT03544281|527323775|FG019|Main Study Phase|Lost to Follow-up|0|||
146220714|NCT03544281|527323776|FG020|Main Study Phase|Lost to Follow-up|0|||
146220715|NCT03544281|527323777|FG021|Main Study Phase|Lost to Follow-up|0|||
146220716|NCT03544281|527323756|FG000|Main Study Phase|Physician Decision|0|||
146220717|NCT03544281|527323757|FG001|Main Study Phase|Physician Decision|0|||
146220718|NCT03544281|527323758|FG002|Main Study Phase|Physician Decision|0|||
146220719|NCT03544281|527323759|FG003|Main Study Phase|Physician Decision|0|||
146220720|NCT03544281|527323760|FG004|Main Study Phase|Physician Decision|0|||
146220721|NCT03544281|527323761|FG005|Main Study Phase|Physician Decision|0|||
146220722|NCT03544281|527323762|FG006|Main Study Phase|Physician Decision|0|||
146220723|NCT03544281|527323763|FG007|Main Study Phase|Physician Decision|1|||
146220724|NCT03544281|527323764|FG008|Main Study Phase|Physician Decision|0|||
146220725|NCT03544281|527323765|FG009|Main Study Phase|Physician Decision|0|||
146220726|NCT03544281|527323766|FG010|Main Study Phase|Physician Decision|0|||
146220727|NCT03544281|527323767|FG011|Main Study Phase|Physician Decision|0|||
146220728|NCT03544281|527323768|FG012|Main Study Phase|Physician Decision|0|||
146220729|NCT03544281|527323769|FG013|Main Study Phase|Physician Decision|0|||
146220730|NCT03544281|527323770|FG014|Main Study Phase|Physician Decision|0|||
146220731|NCT03544281|527323771|FG015|Main Study Phase|Physician Decision|0|||
146220732|NCT03544281|527323772|FG016|Main Study Phase|Physician Decision|0|||
146220733|NCT03544281|527323773|FG017|Main Study Phase|Physician Decision|0|||
146220734|NCT03544281|527323774|FG018|Main Study Phase|Physician Decision|0|||
146220735|NCT03544281|527323775|FG019|Main Study Phase|Physician Decision|0|||
146220736|NCT03544281|527323776|FG020|Main Study Phase|Physician Decision|0|||
146220737|NCT03544281|527323777|FG021|Main Study Phase|Physician Decision|0|||
146220738|NCT03544281|527323756|FG000|Main Study Phase|Withdrawal by Subject|2|||
146220739|NCT03544281|527323757|FG001|Main Study Phase|Withdrawal by Subject|0|||
146220740|NCT03544281|527323758|FG002|Main Study Phase|Withdrawal by Subject|1|||
146220741|NCT03544281|527323759|FG003|Main Study Phase|Withdrawal by Subject|2|||
146220742|NCT03544281|527323760|FG004|Main Study Phase|Withdrawal by Subject|0|||
146220743|NCT03544281|527323761|FG005|Main Study Phase|Withdrawal by Subject|0|||
146220744|NCT03544281|527323762|FG006|Main Study Phase|Withdrawal by Subject|0|||
146220745|NCT03544281|527323763|FG007|Main Study Phase|Withdrawal by Subject|0|||
146220746|NCT03544281|527323764|FG008|Main Study Phase|Withdrawal by Subject|2|||
146220747|NCT03544281|527323765|FG009|Main Study Phase|Withdrawal by Subject|3|||
146220748|NCT03544281|527323766|FG010|Main Study Phase|Withdrawal by Subject|0|||
146220749|NCT03544281|527323767|FG011|Main Study Phase|Withdrawal by Subject|4|||
146220750|NCT03544281|527323768|FG012|Main Study Phase|Withdrawal by Subject|0|||
146220751|NCT03544281|527323769|FG013|Main Study Phase|Withdrawal by Subject|0|||
146220752|NCT03544281|527323770|FG014|Main Study Phase|Withdrawal by Subject|0|||
146220753|NCT03544281|527323771|FG015|Main Study Phase|Withdrawal by Subject|0|||
146220754|NCT03544281|527323772|FG016|Main Study Phase|Withdrawal by Subject|0|||
146220755|NCT03544281|527323773|FG017|Main Study Phase|Withdrawal by Subject|0|||
146220756|NCT03544281|527323774|FG018|Main Study Phase|Withdrawal by Subject|0|||
146220757|NCT03544281|527323775|FG019|Main Study Phase|Withdrawal by Subject|0|||
146220758|NCT03544281|527323776|FG020|Main Study Phase|Withdrawal by Subject|0|||
146220759|NCT03544281|527323777|FG021|Main Study Phase|Withdrawal by Subject|0|||
146220760|NCT03544281|527323756|FG000|Main Study Phase|Ongoing|3|||
146220761|NCT03544281|527323757|FG001|Main Study Phase|Ongoing|1|||
146220762|NCT03544281|527323758|FG002|Main Study Phase|Ongoing|2|||
146220763|NCT03544281|527323759|FG003|Main Study Phase|Ongoing|4|||
146220764|NCT03544281|527323760|FG004|Main Study Phase|Ongoing|2|||
146220765|NCT03544281|527323761|FG005|Main Study Phase|Ongoing|4|||
146220766|NCT03544281|527323762|FG006|Main Study Phase|Ongoing|4|||
146220767|NCT03544281|527323763|FG007|Main Study Phase|Ongoing|0|||
146220768|NCT03544281|527323764|FG008|Main Study Phase|Ongoing|2|||
146220769|NCT03544281|527323765|FG009|Main Study Phase|Ongoing|2|||
146220770|NCT03544281|527323766|FG010|Main Study Phase|Ongoing|1|||
146220771|NCT03544281|527323767|FG011|Main Study Phase|Ongoing|0|||
146220772|NCT03544281|527323768|FG012|Main Study Phase|Ongoing|0|||
146220773|NCT03544281|527323769|FG013|Main Study Phase|Ongoing|0|||
146220774|NCT03544281|527323770|FG014|Main Study Phase|Ongoing|0|||
146220775|NCT03544281|527323771|FG015|Main Study Phase|Ongoing|0|||
146220776|NCT03544281|527323772|FG016|Main Study Phase|Ongoing|0|||
146220777|NCT03544281|527323773|FG017|Main Study Phase|Ongoing|0|||
146220778|NCT03544281|527323774|FG018|Main Study Phase|Ongoing|0|||
146220779|NCT03544281|527323775|FG019|Main Study Phase|Ongoing|0|||
146220780|NCT03544281|527323776|FG020|Main Study Phase|Ongoing|0|||
146220781|NCT03544281|527323777|FG021|Main Study Phase|Ongoing|0|||
146220782|NCT03544281|527323756|FG000|Main Study Phase|Investigator Site Closed|0|||
146220783|NCT03544281|527323757|FG001|Main Study Phase|Investigator Site Closed|0|||
145882301|NCT00889252|526074766|FG000|Overall Study|Protocol Violation|2|||
145882302|NCT00889252|526074767|FG001|Overall Study|Protocol Violation|0|||
145882303|NCT04203667|526074774|FG000|Overall Study|Withdrawal by Subject|1|||
145882304|NCT04203667|526074774|FG000|Overall Study|Lost to Follow-up|1|||
145882305|NCT04203667|526074774|FG000|Overall Study|Death|1|||
145882306|NCT04203667|526074774|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
145882307|NCT01833169|526074775|FG000|Overall Study|Disease Progression|99|||
145882308|NCT01833169|526074775|FG000|Overall Study|Adverse Event|33|||
145882309|NCT01833169|526074775|FG000|Overall Study|Withdrawal by Subject|9|||
145882310|NCT01833169|526074775|FG000|Overall Study|Death|3|||
145882311|NCT01833169|526074775|FG000|Overall Study|Physician Decision|2|||
145882312|NCT01183884|526074779|FG000|Overall Study|Progressive Disease|26|||
145882313|NCT01183884|526074779|FG000|Overall Study|Adverse Event|3|||
145882314|NCT01183884|526074779|FG000|Overall Study|Withdrawal by Subject|1|||
145882315|NCT01183884|526074779|FG000|Overall Study|Other Complicating Disease|3|||
145882316|NCT01183884|526074779|FG000|Overall Study|Not Treated|1|||
145882317|NCT01183884|526074779|FG000|Overall Study|Other|4|||
145882318|NCT04718129|526074784|FG000|Overall Study|Lost to Follow-up|6|||
145882319|NCT04718129|526074785|FG001|Overall Study|Lost to Follow-up|7|||
145882320|NCT02212457|526074786|FG000|Overall Study|Adverse Event|1|||
145882321|NCT02212457|526074787|FG001|Overall Study|Adverse Event|2|||
145882322|NCT02212457|526074788|FG002|Overall Study|Adverse Event|2|||
145882323|NCT02212457|526074789|FG003|Overall Study|Adverse Event|2|||
145882324|NCT02212457|526074790|FG004|Overall Study|Adverse Event|0|||
145882325|NCT02212457|526074791|FG005|Overall Study|Adverse Event|1|||
145882326|NCT02212457|526074786|FG000|Overall Study|Withdrawal by Subject|8|||
145882327|NCT02212457|526074787|FG001|Overall Study|Withdrawal by Subject|10|||
145882328|NCT02212457|526074788|FG002|Overall Study|Withdrawal by Subject|8|||
145882329|NCT02212457|526074789|FG003|Overall Study|Withdrawal by Subject|6|||
145882330|NCT02212457|526074790|FG004|Overall Study|Withdrawal by Subject|5|||
145882331|NCT02212457|526074791|FG005|Overall Study|Withdrawal by Subject|4|||
145882332|NCT02212457|526074786|FG000|Overall Study|Lost to Follow-up|6|||
145882333|NCT02212457|526074787|FG001|Overall Study|Lost to Follow-up|7|||
145882334|NCT02212457|526074788|FG002|Overall Study|Lost to Follow-up|4|||
145882335|NCT02212457|526074789|FG003|Overall Study|Lost to Follow-up|1|||
145882336|NCT02212457|526074790|FG004|Overall Study|Lost to Follow-up|8|||
145882337|NCT02212457|526074791|FG005|Overall Study|Lost to Follow-up|4|||
145882338|NCT02212457|526074786|FG000|Overall Study|Protocol Violation|2|||
145882339|NCT02212457|526074787|FG001|Overall Study|Protocol Violation|1|||
145882340|NCT02212457|526074788|FG002|Overall Study|Protocol Violation|0|||
145882341|NCT02212457|526074789|FG003|Overall Study|Protocol Violation|1|||
145882342|NCT02212457|526074790|FG004|Overall Study|Protocol Violation|2|||
145882343|NCT02212457|526074791|FG005|Overall Study|Protocol Violation|3|||
146220784|NCT03544281|527323758|FG002|Main Study Phase|Investigator Site Closed|0|||
146220785|NCT03544281|527323759|FG003|Main Study Phase|Investigator Site Closed|0|||
146220786|NCT03544281|527323760|FG004|Main Study Phase|Investigator Site Closed|0|||
146220787|NCT03544281|527323761|FG005|Main Study Phase|Investigator Site Closed|0|||
146220788|NCT03544281|527323762|FG006|Main Study Phase|Investigator Site Closed|0|||
146220789|NCT03544281|527323763|FG007|Main Study Phase|Investigator Site Closed|0|||
146220790|NCT03544281|527323764|FG008|Main Study Phase|Investigator Site Closed|0|||
146220791|NCT03544281|527323765|FG009|Main Study Phase|Investigator Site Closed|1|||
146220792|NCT03544281|527323766|FG010|Main Study Phase|Investigator Site Closed|0|||
146220793|NCT03544281|527323767|FG011|Main Study Phase|Investigator Site Closed|0|||
146220794|NCT03544281|527323768|FG012|Main Study Phase|Investigator Site Closed|0|||
146220795|NCT03544281|527323769|FG013|Main Study Phase|Investigator Site Closed|0|||
146220796|NCT03544281|527323770|FG014|Main Study Phase|Investigator Site Closed|0|||
146220797|NCT03544281|527323771|FG015|Main Study Phase|Investigator Site Closed|0|||
145882344|NCT02212457|526074786|FG000|Overall Study|Other|2|||
145882345|NCT02212457|526074787|FG001|Overall Study|Other|1|||
145882346|NCT02212457|526074788|FG002|Overall Study|Other|2|||
145882347|NCT02212457|526074789|FG003|Overall Study|Other|1|||
145882348|NCT02212457|526074790|FG004|Overall Study|Other|0|||
145882349|NCT02212457|526074791|FG005|Overall Study|Other|1|||
145882350|NCT00420095|526074793|FG000|Overall Study|Adverse Event|1|||
145882351|NCT00420095|526074794|FG001|Overall Study|Adverse Event|0|||
146220798|NCT03544281|527323772|FG016|Main Study Phase|Investigator Site Closed|0|||
146220799|NCT03544281|527323773|FG017|Main Study Phase|Investigator Site Closed|0|||
146220800|NCT03544281|527323774|FG018|Main Study Phase|Investigator Site Closed|0|||
146220801|NCT03544281|527323775|FG019|Main Study Phase|Investigator Site Closed|0|||
145882352|NCT00420095|526074793|FG000|Overall Study|Protocol Violation|1|||
145882353|NCT00420095|526074794|FG001|Overall Study|Protocol Violation|1|||
145882354|NCT00420095|526074793|FG000|Overall Study|Lost to Follow-up|1|||
145882355|NCT00420095|526074794|FG001|Overall Study|Lost to Follow-up|0|||
146084965|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
146084966|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
146084967|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
146084968|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
146084969|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
146084970|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
146084971|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
146084972|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
146084973|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
146084974|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
146084975|NCT01931670|526832020|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
146084976|NCT01931670|526832021|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
146084977|NCT01931670|526832022|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
146084978|NCT00976508|526832024|FG000|Overall Study|Death|7|||
146084979|NCT00976508|526832025|FG001|Overall Study|Death|1|||
146084980|NCT00976508|526832024|FG000|Overall Study|Lost to Follow-up|1|||
146084981|NCT00976508|526832025|FG001|Overall Study|Lost to Follow-up|0|||
146084982|NCT00976508|526832024|FG000|Overall Study|Withdrawal by Subject|1|||
146084983|NCT00976508|526832025|FG001|Overall Study|Withdrawal by Subject|0|||
146084984|NCT00976508|526832024|FG000|Overall Study|Disease Progression|4|||
146084985|NCT00976508|526832025|FG001|Overall Study|Disease Progression|4|||
146084986|NCT00976508|526832024|FG000|Overall Study|Subject Enrolled in Hospice|1|||
146084987|NCT00976508|526832025|FG001|Overall Study|Subject Enrolled in Hospice|0|||
146084988|NCT00976508|526832024|FG000|Overall Study|Terminated by the Sponsor|0|||
146084989|NCT00976508|526832025|FG001|Overall Study|Terminated by the Sponsor|1|||
146084990|NCT04352127|526832026|FG000|Overall Study|Unable to obtain readings|4|||
146084991|NCT04352127|526832027|FG001|Overall Study|Unable to obtain readings|1|||
146084992|NCT01992159|526832028|FG000|Overall Study|Withdrawal by Subject|4|||
146084993|NCT01992159|526832029|FG001|Overall Study|Withdrawal by Subject|7|||
146084994|NCT01992159|526832030|FG002|Overall Study|Withdrawal by Subject|0|||
146084995|NCT01992159|526832031|FG003|Overall Study|Withdrawal by Subject|3|||
146084996|NCT01992159|526832028|FG000|Overall Study|Adverse Event|0|||
146084997|NCT01992159|526832029|FG001|Overall Study|Adverse Event|1|||
146084998|NCT01992159|526832030|FG002|Overall Study|Adverse Event|0|||
146084999|NCT01992159|526832031|FG003|Overall Study|Adverse Event|1|||
146085000|NCT01992159|526832028|FG000|Overall Study|Death|0|||
146085001|NCT01992159|526832029|FG001|Overall Study|Death|0|||
146085002|NCT01992159|526832030|FG002|Overall Study|Death|1|||
146085003|NCT01992159|526832031|FG003|Overall Study|Death|0|||
146085004|NCT03023046|526832035|FG000|Overall Study|Withdrawal by Subject|1|||
146085005|NCT01205581|526832036|FG000|Overall Study|Withdrawal by Subject|1|||
146085006|NCT01205581|526832037|FG001|Overall Study|Withdrawal by Subject|0|||
146085007|NCT01205581|526832038|FG002|Overall Study|Withdrawal by Subject|0|||
146085008|NCT01205581|526832039|FG003|Overall Study|Withdrawal by Subject|0|||
146085009|NCT01205581|526832040|FG004|Overall Study|Withdrawal by Subject|0|||
146085010|NCT01205581|526832041|FG005|Overall Study|Withdrawal by Subject|0|||
146085011|NCT01236118|526832042|FG000|Overall Study|Adverse Event|2|||
146085012|NCT01236118|526832043|FG001|Overall Study|Adverse Event|0|||
146085013|NCT01236118|526832044|FG002|Overall Study|Adverse Event|2|||
146085014|NCT01236118|526832042|FG000|Overall Study|Physician Decision|0|||
146085015|NCT01236118|526832043|FG001|Overall Study|Physician Decision|1|||
146085016|NCT01236118|526832044|FG002|Overall Study|Physician Decision|0|||
146085017|NCT01236118|526832042|FG000|Overall Study|Withdrawal by Subject|0|||
146085018|NCT01236118|526832043|FG001|Overall Study|Withdrawal by Subject|0|||
146085019|NCT01236118|526832044|FG002|Overall Study|Withdrawal by Subject|1|||
146085020|NCT04535167|526832045|FG000|Treatment|Adverse Event|0|||
146085021|NCT04535167|526832046|FG001|Treatment|Adverse Event|0|||
146085022|NCT04535167|526832047|FG002|Treatment|Adverse Event|0|||
146085023|NCT04535167|526832048|FG003|Treatment|Adverse Event|0|||
146085024|NCT04535167|526832049|FG004|Treatment|Adverse Event|0|||
146220802|NCT03544281|527323776|FG020|Main Study Phase|Investigator Site Closed|0|||
146220803|NCT03544281|527323777|FG021|Main Study Phase|Investigator Site Closed|0|||
146220804|NCT03544281|527323756|FG000|Main Study Phase|Did not receive study treatment|0|||
146220805|NCT03544281|527323757|FG001|Main Study Phase|Did not receive study treatment|0|||
146220806|NCT03544281|527323758|FG002|Main Study Phase|Did not receive study treatment|0|||
146085025|NCT04535167|526832050|FG005|Treatment|Adverse Event|0|||
146085026|NCT04535167|526832051|FG006|Treatment|Adverse Event|1|||
146085027|NCT04535167|526832045|FG000|Follow-Up|Death|0|||
146085028|NCT04535167|526832046|FG001|Follow-Up|Death|0|||
146085029|NCT04535167|526832047|FG002|Follow-Up|Death|0|||
146085030|NCT04535167|526832048|FG003|Follow-Up|Death|0|||
146085031|NCT04535167|526832049|FG004|Follow-Up|Death|0|||
146085032|NCT04535167|526832050|FG005|Follow-Up|Death|0|||
146085033|NCT04535167|526832051|FG006|Follow-Up|Death|1|||
146085034|NCT04535167|526832045|FG000|Follow-Up|Lost to Follow-up|0|||
146085035|NCT04535167|526832046|FG001|Follow-Up|Lost to Follow-up|0|||
146220807|NCT03544281|527323759|FG003|Main Study Phase|Did not receive study treatment|0|||
146220808|NCT03544281|527323760|FG004|Main Study Phase|Did not receive study treatment|0|||
146220809|NCT03544281|527323761|FG005|Main Study Phase|Did not receive study treatment|0|||
146220810|NCT03544281|527323762|FG006|Main Study Phase|Did not receive study treatment|1|||
146288494|NCT00704405|527571403|FG001|Overall Study (NC Population)|Adverse Event|0|||
146288495|NCT00704405|527571404|FG002|Overall Study (NC Population)|Adverse Event|0|||
146288496|NCT00704405|527571405|FG003|Overall Study (NC Population)|Adverse Event|0|||
146288497|NCT00704405|527571406|FG004|Overall Study (NC Population)|Adverse Event|0|||
146288498|NCT00704405|527571402|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
146288499|NCT00704405|527571403|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
146288500|NCT00704405|527571404|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
146288501|NCT00704405|527571405|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
146288502|NCT00704405|527571406|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
146288503|NCT00704405|527571402|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
146288504|NCT00704405|527571403|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
146288505|NCT00704405|527571404|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
146220811|NCT03544281|527323763|FG007|Main Study Phase|Did not receive study treatment|0|||
146220812|NCT03544281|527323764|FG008|Main Study Phase|Did not receive study treatment|0|||
146220813|NCT03544281|527323765|FG009|Main Study Phase|Did not receive study treatment|0|||
146220814|NCT03544281|527323766|FG010|Main Study Phase|Did not receive study treatment|0|||
146220815|NCT03544281|527323767|FG011|Main Study Phase|Did not receive study treatment|0|||
146288506|NCT00704405|527571405|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
146288507|NCT00704405|527571406|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
146288508|NCT00704405|527571402|FG000|Overall Study (NC Population)|Other|0|||
146288509|NCT00704405|527571403|FG001|Overall Study (NC Population)|Other|0|||
146288510|NCT00704405|527571404|FG002|Overall Study (NC Population)|Other|0|||
146288511|NCT00704405|527571405|FG003|Overall Study (NC Population)|Other|0|||
146288512|NCT00704405|527571406|FG004|Overall Study (NC Population)|Other|1|||
146288513|NCT00704405|527571402|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
146288514|NCT00704405|527571403|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
146288515|NCT00704405|527571404|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
146288516|NCT00704405|527571405|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
146288517|NCT00704405|527571406|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
146288518|NCT00704405|527571402|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
146288519|NCT00704405|527571403|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
146288520|NCT00704405|527571404|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
146288521|NCT00704405|527571405|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
146288522|NCT00704405|527571406|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
146288523|NCT01395888|527571407|FG000|2-week Run-in Period|Adverse Event|2|||
146288524|NCT01395888|527571408|FG001|2-week Run-in Period|Adverse Event|0|||
146288525|NCT01395888|527571409|FG002|2-week Run-in Period|Adverse Event|0|||
146288526|NCT01395888|527571407|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
146288527|NCT01395888|527571408|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146288528|NCT01395888|527571409|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146288529|NCT01395888|527571407|FG000|2-week Run-in Period|Lost to Follow-up|1|||
146288530|NCT01395888|527571408|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146288531|NCT01395888|527571409|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146288532|NCT01395888|527571407|FG000|2-week Run-in Period|Protocol Violation|2|||
146288533|NCT01395888|527571408|FG001|2-week Run-in Period|Protocol Violation|0|||
146220816|NCT03544281|527323768|FG012|Main Study Phase|Did not receive study treatment|0|||
146220817|NCT03544281|527323769|FG013|Main Study Phase|Did not receive study treatment|0|||
146220818|NCT03544281|527323770|FG014|Main Study Phase|Did not receive study treatment|0|||
146220819|NCT03544281|527323771|FG015|Main Study Phase|Did not receive study treatment|0|||
146220820|NCT03544281|527323772|FG016|Main Study Phase|Did not receive study treatment|0|||
146220821|NCT03544281|527323773|FG017|Main Study Phase|Did not receive study treatment|0|||
146220822|NCT03544281|527323774|FG018|Main Study Phase|Did not receive study treatment|0|||
146220823|NCT03544281|527323775|FG019|Main Study Phase|Did not receive study treatment|0|||
146220824|NCT03544281|527323776|FG020|Main Study Phase|Did not receive study treatment|0|||
146220825|NCT03544281|527323777|FG021|Main Study Phase|Did not receive study treatment|0|||
146220826|NCT03544281|527323756|FG000|PACT Phase|Adverse Event|0|||
146220827|NCT03544281|527323757|FG001|PACT Phase|Adverse Event|0|||
146220828|NCT03544281|527323758|FG002|PACT Phase|Adverse Event|0|||
146220829|NCT03544281|527323759|FG003|PACT Phase|Adverse Event|0|||
146220830|NCT03544281|527323760|FG004|PACT Phase|Adverse Event|0|||
146288534|NCT01395888|527571409|FG002|2-week Run-in Period|Protocol Violation|0|||
146288535|NCT01395888|527571407|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
146288536|NCT01395888|527571408|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146288537|NCT01395888|527571409|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146220831|NCT03544281|527323761|FG005|PACT Phase|Adverse Event|0|||
146220832|NCT03544281|527323762|FG006|PACT Phase|Adverse Event|0|||
146220833|NCT03544281|527323763|FG007|PACT Phase|Adverse Event|0|||
146220834|NCT03544281|527323764|FG008|PACT Phase|Adverse Event|0|||
146220835|NCT03544281|527323765|FG009|PACT Phase|Adverse Event|0|||
146220836|NCT03544281|527323766|FG010|PACT Phase|Adverse Event|0|||
146220837|NCT03544281|527323767|FG011|PACT Phase|Adverse Event|0|||
146220838|NCT03544281|527323768|FG012|PACT Phase|Adverse Event|1|||
146220839|NCT03544281|527323769|FG013|PACT Phase|Adverse Event|0|||
146220840|NCT03544281|527323770|FG014|PACT Phase|Adverse Event|0|||
146220841|NCT03544281|527323771|FG015|PACT Phase|Adverse Event|0|||
146220842|NCT03544281|527323772|FG016|PACT Phase|Adverse Event|0|||
146220843|NCT03544281|527323773|FG017|PACT Phase|Adverse Event|1|||
146220844|NCT03544281|527323774|FG018|PACT Phase|Adverse Event|1|||
146220845|NCT03544281|527323775|FG019|PACT Phase|Adverse Event|0|||
146220846|NCT03544281|527323776|FG020|PACT Phase|Adverse Event|0|||
146220847|NCT03544281|527323777|FG021|PACT Phase|Adverse Event|0|||
146220848|NCT02547987|527323778|FG000|Overall Study|Withdrawal by Subject|1|||
146220849|NCT02547987|527323778|FG000|Overall Study|Adverse Event|2|||
146220850|NCT04282148|527323779|FG000|Overall Study|Death|7|||
146220851|NCT04282148|527323779|FG000|Overall Study|Withdrawal by Subject|1|||
146220852|NCT04282148|527323779|FG000|Overall Study|Physician Decision|1|||
146220853|NCT04938492|527323781|FG000|Overall Study|Lost to Follow-up|17|||
146220854|NCT04938492|527323782|FG001|Overall Study|Lost to Follow-up|18|||
146220855|NCT03448107|527323784|FG000|Overall Study|Lost to Follow-up|229|||
146220856|NCT03448107|527323785|FG001|Overall Study|Lost to Follow-up|258|||
146220857|NCT04025554|527323786|FG000|Overall Study|Adverse Event|3|||
146220858|NCT03115476|527323787|FG000|LP0084-1369|Death|1|||
146220859|NCT03115476|527323788|FG001|LP0084-1369|Death|0|||
146220860|NCT03115476|527323789|FG002|LP0084-1369|Death|2|||
146220861|NCT03115476|527323787|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
146220862|NCT03115476|527323788|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
146220863|NCT03115476|527323789|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
146220864|NCT05257486|527323793|FG000|Overall Study|Protocol Violation|3|||
146220865|NCT03865498|527323794|FG000|Overall Study|Lack of Efficacy|12|||
146220866|NCT03865498|527323795|FG001|Overall Study|Lack of Efficacy|11|||
146220867|NCT03865498|527323794|FG000|Overall Study|Lost to Follow-up|125|||
146220868|NCT03865498|527323795|FG001|Overall Study|Lost to Follow-up|133|||
146220869|NCT03865498|527323794|FG000|Overall Study|Withdrawal by Subject|2|||
146220870|NCT03865498|527323795|FG001|Overall Study|Withdrawal by Subject|4|||
146220871|NCT01648023|527323796|FG000|Overall Study|Screen Fail Post Randomization|1|||
146220872|NCT01648023|527323797|FG001|Overall Study|Screen Fail Post Randomization|2|||
146220873|NCT04137289|527323806|FG000|Overall Study|Death|0|||
146220874|NCT04137289|527323807|FG001|Overall Study|Death|0|||
146220875|NCT04137289|527323808|FG002|Overall Study|Death|0|||
146220876|NCT04137289|527323809|FG003|Overall Study|Death|0|||
146220877|NCT04137289|527323810|FG004|Overall Study|Death|0|||
146220878|NCT04137289|527323811|FG005|Overall Study|Death|0|||
146220879|NCT04137289|527323812|FG006|Overall Study|Death|1|||
146220880|NCT04137289|527323813|FG007|Overall Study|Death|0|||
146220881|NCT04137289|527323814|FG008|Overall Study|Death|0|||
146220882|NCT04137289|527323806|FG000|Overall Study|Clinical disease progression|0|||
146220883|NCT04137289|527323807|FG001|Overall Study|Clinical disease progression|0|||
146220884|NCT04137289|527323808|FG002|Overall Study|Clinical disease progression|0|||
146220885|NCT04137289|527323809|FG003|Overall Study|Clinical disease progression|4|||
146220886|NCT04137289|527323810|FG004|Overall Study|Clinical disease progression|4|||
146220887|NCT04137289|527323811|FG005|Overall Study|Clinical disease progression|2|||
146220888|NCT04137289|527323812|FG006|Overall Study|Clinical disease progression|5|||
146220889|NCT04137289|527323813|FG007|Overall Study|Clinical disease progression|1|||
146220890|NCT04137289|527323814|FG008|Overall Study|Clinical disease progression|0|||
146220891|NCT04137289|527323806|FG000|Overall Study|Lost to Follow-up|0|||
146220892|NCT04137289|527323807|FG001|Overall Study|Lost to Follow-up|0|||
146220893|NCT04137289|527323808|FG002|Overall Study|Lost to Follow-up|0|||
146220894|NCT04137289|527323809|FG003|Overall Study|Lost to Follow-up|1|||
146220895|NCT04137289|527323810|FG004|Overall Study|Lost to Follow-up|0|||
146220896|NCT04137289|527323811|FG005|Overall Study|Lost to Follow-up|0|||
146220897|NCT04137289|527323812|FG006|Overall Study|Lost to Follow-up|0|||
146220898|NCT04137289|527323813|FG007|Overall Study|Lost to Follow-up|0|||
146220899|NCT04137289|527323814|FG008|Overall Study|Lost to Follow-up|0|||
146220900|NCT04137289|527323806|FG000|Overall Study|Adverse Event|0|||
146220901|NCT04137289|527323807|FG001|Overall Study|Adverse Event|0|||
146220902|NCT04137289|527323808|FG002|Overall Study|Adverse Event|1|||
146220903|NCT04137289|527323809|FG003|Overall Study|Adverse Event|0|||
146220904|NCT04137289|527323810|FG004|Overall Study|Adverse Event|0|||
146220905|NCT04137289|527323811|FG005|Overall Study|Adverse Event|1|||
146220906|NCT04137289|527323812|FG006|Overall Study|Adverse Event|0|||
146220907|NCT04137289|527323813|FG007|Overall Study|Adverse Event|0|||
146220908|NCT04137289|527323814|FG008|Overall Study|Adverse Event|0|||
146220909|NCT04137289|527323806|FG000|Overall Study|Lack of clinical benefit|0|||
146220910|NCT04137289|527323807|FG001|Overall Study|Lack of clinical benefit|0|||
146220911|NCT04137289|527323808|FG002|Overall Study|Lack of clinical benefit|0|||
146220912|NCT04137289|527323809|FG003|Overall Study|Lack of clinical benefit|0|||
146220913|NCT04137289|527323810|FG004|Overall Study|Lack of clinical benefit|0|||
146220914|NCT04137289|527323811|FG005|Overall Study|Lack of clinical benefit|0|||
146220915|NCT04137289|527323812|FG006|Overall Study|Lack of clinical benefit|0|||
145882356|NCT00393705|526074795|FG000|Overall Study|Adverse Event|0|||
145882357|NCT00393705|526074796|FG001|Overall Study|Adverse Event|2|||
145882358|NCT00393705|526074795|FG000|Overall Study|Death|0|||
145882359|NCT00393705|526074796|FG001|Overall Study|Death|1|||
145882360|NCT00393705|526074795|FG000|Overall Study|Lost to Follow-up|2|||
145882361|NCT00393705|526074796|FG001|Overall Study|Lost to Follow-up|2|||
145882362|NCT00393705|526074795|FG000|Overall Study|Entry Criteria Not Met|10|||
145882363|NCT00393705|526074796|FG001|Overall Study|Entry Criteria Not Met|10|||
145882364|NCT00393705|526074795|FG000|Overall Study|Protocol Violation|4|||
145882365|NCT00393705|526074796|FG001|Overall Study|Protocol Violation|3|||
145882366|NCT00393705|526074795|FG000|Overall Study|Withdrawal by Subject|5|||
145882367|NCT00393705|526074796|FG001|Overall Study|Withdrawal by Subject|3|||
145882368|NCT00393705|526074795|FG000|Overall Study|Physician Decision|2|||
146220916|NCT04137289|527323813|FG007|Overall Study|Lack of clinical benefit|0|||
146220917|NCT04137289|527323814|FG008|Overall Study|Lack of clinical benefit|1|||
145882369|NCT00393705|526074796|FG001|Overall Study|Physician Decision|2|||
145882370|NCT01120691|526074799|FG000|Overall Study|Adverse Event|59|||
146220918|NCT04137289|527323806|FG000|Overall Study|Objective disease progression|1|||
145882371|NCT01120691|526074800|FG001|Overall Study|Adverse Event|67|||
145882372|NCT01120691|526074801|FG002|Overall Study|Adverse Event|47|||
145882373|NCT01120691|526074799|FG000|Overall Study|Subject withdrew consent|33|||
145882374|NCT01120691|526074800|FG001|Overall Study|Subject withdrew consent|50|||
145882375|NCT01120691|526074801|FG002|Overall Study|Subject withdrew consent|44|||
145882376|NCT01120691|526074799|FG000|Overall Study|Death|21|||
145882377|NCT01120691|526074800|FG001|Overall Study|Death|22|||
145882378|NCT01120691|526074801|FG002|Overall Study|Death|24|||
145882379|NCT01120691|526074799|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
145882380|NCT01120691|526074800|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
145882381|NCT01120691|526074801|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
145882382|NCT01120691|526074799|FG000|Overall Study|Administrative problems|15|||
145882383|NCT01120691|526074800|FG001|Overall Study|Administrative problems|8|||
145882384|NCT01120691|526074801|FG002|Overall Study|Administrative problems|9|||
145882385|NCT01120691|526074799|FG000|Overall Study|Protocol deviation|13|||
145882386|NCT01120691|526074800|FG001|Overall Study|Protocol deviation|12|||
145882387|NCT01120691|526074801|FG002|Overall Study|Protocol deviation|12|||
145882388|NCT01120691|526074799|FG000|Overall Study|Lost to Follow-up|5|||
145882389|NCT01120691|526074800|FG001|Overall Study|Lost to Follow-up|6|||
145882390|NCT01120691|526074801|FG002|Overall Study|Lost to Follow-up|4|||
145882391|NCT01120691|526074799|FG000|Overall Study|Abnormal test procedure result(s)|3|||
145882392|NCT01120691|526074800|FG001|Overall Study|Abnormal test procedure result(s)|2|||
145882393|NCT01120691|526074801|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145882394|NCT01120691|526074799|FG000|Overall Study|Patient's inability to use the device|3|||
145882395|NCT01120691|526074800|FG001|Overall Study|Patient's inability to use the device|1|||
145882396|NCT01120691|526074801|FG002|Overall Study|Patient's inability to use the device|0|||
145882397|NCT01120691|526074799|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145882398|NCT01120691|526074800|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145882399|NCT01120691|526074801|FG002|Overall Study|Abnormal laboratory value(s)|4|||
145882400|NCT00642811|526074802|FG000|Overall Study|Adverse Event|2|||
145882401|NCT00642811|526074803|FG001|Overall Study|Adverse Event|3|||
145882402|NCT00642811|526074804|FG002|Overall Study|Adverse Event|0|||
145882403|NCT00642811|526074805|FG003|Overall Study|Adverse Event|0|||
145882404|NCT00642811|526074806|FG004|Overall Study|Adverse Event|0|||
145882405|NCT00642811|526074807|FG005|Overall Study|Adverse Event|1|||
145882406|NCT00642811|526074802|FG000|Overall Study|Developement of discontinuation criteria|0|||
145882407|NCT00642811|526074803|FG001|Overall Study|Developement of discontinuation criteria|0|||
145882408|NCT00642811|526074804|FG002|Overall Study|Developement of discontinuation criteria|0|||
146220919|NCT04137289|527323807|FG001|Overall Study|Objective disease progression|1|||
146220920|NCT04137289|527323808|FG002|Overall Study|Objective disease progression|6|||
146220921|NCT04137289|527323809|FG003|Overall Study|Objective disease progression|18|||
146220922|NCT04137289|527323810|FG004|Overall Study|Objective disease progression|12|||
146220923|NCT04137289|527323811|FG005|Overall Study|Objective disease progression|20|||
146220924|NCT04137289|527323812|FG006|Overall Study|Objective disease progression|18|||
146220925|NCT04137289|527323813|FG007|Overall Study|Objective disease progression|7|||
146220926|NCT04137289|527323814|FG008|Overall Study|Objective disease progression|6|||
146220927|NCT04307355|527323815|FG000|Overall Study|Non-Compliance|3|||
146220928|NCT04307355|527323816|FG001|Overall Study|Non-Compliance|3|||
146220929|NCT04307355|527323817|FG002|Overall Study|Non-Compliance|0|||
146220930|NCT05386030|527323820|FG000|Overall Study|Death|1|||
146220931|NCT05386030|527323821|FG001|Overall Study|Death|0|||
145882409|NCT00642811|526074805|FG003|Overall Study|Developement of discontinuation criteria|0|||
145882410|NCT00642811|526074806|FG004|Overall Study|Developement of discontinuation criteria|1|||
145882411|NCT00642811|526074807|FG005|Overall Study|Developement of discontinuation criteria|0|||
146220932|NCT05386030|527323820|FG000|Overall Study|Physician Decision|2|||
146220933|NCT05386030|527323821|FG001|Overall Study|Physician Decision|1|||
146220934|NCT05386030|527323820|FG000|Overall Study|Lost to Follow-up|19|||
146220935|NCT05386030|527323821|FG001|Overall Study|Lost to Follow-up|7|||
146288538|NCT01395888|527571407|FG000|Treatment Period (TP)|Adverse Event|0|||
146288539|NCT01395888|527571408|FG001|Treatment Period (TP)|Adverse Event|7|||
146288540|NCT01395888|527571409|FG002|Treatment Period (TP)|Adverse Event|6|||
146288541|NCT01395888|527571407|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
146288542|NCT01395888|527571408|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
146288543|NCT01395888|527571409|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
146288544|NCT01395888|527571407|FG000|Treatment Period (TP)|Protocol Violation|0|||
146288545|NCT01395888|527571408|FG001|Treatment Period (TP)|Protocol Violation|1|||
146288546|NCT01395888|527571409|FG002|Treatment Period (TP)|Protocol Violation|5|||
146288547|NCT01395888|527571407|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
146288548|NCT01395888|527571408|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
146288549|NCT01395888|527571409|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
146288550|NCT01395888|527571407|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
146288551|NCT01395888|527571408|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
146288552|NCT01395888|527571409|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
146288553|NCT00903682|527571410|FG000|Overall Study|Adverse Event|6|||
146288554|NCT00903682|527571411|FG001|Overall Study|Adverse Event|13|||
146288555|NCT00903682|527571410|FG000|Overall Study|Lost to Follow-up|1|||
146288556|NCT00903682|527571411|FG001|Overall Study|Lost to Follow-up|0|||
146288557|NCT00903682|527571410|FG000|Overall Study|Withdrawal by Subject|5|||
146288558|NCT00903682|527571411|FG001|Overall Study|Withdrawal by Subject|0|||
146288559|NCT00903682|527571410|FG000|Overall Study|Pregnancy|0|||
146288560|NCT00903682|527571411|FG001|Overall Study|Pregnancy|1|||
146288561|NCT00903682|527571410|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
146288562|NCT00903682|527571411|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
146288563|NCT00903682|527571410|FG000|Overall Study|Subject Non-Compliant|1|||
146288564|NCT00903682|527571411|FG001|Overall Study|Subject Non-Compliant|0|||
146288565|NCT00903682|527571410|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
146288566|NCT00903682|527571411|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
146288567|NCT00903682|527571410|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
146288568|NCT00903682|527571411|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
146288569|NCT03169101|527571412|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
146288570|NCT03169101|527571413|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
146288571|NCT03169101|527571414|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
146288572|NCT03169101|527571415|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
146288573|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
146288574|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
146288575|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
146288576|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
146288577|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
146288578|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
146288579|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
146288580|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
146288581|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
146288582|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
146288583|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
146288584|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
146288585|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
146288586|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
146288587|NCT00600886|527571416|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
146288588|NCT00600886|527571417|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
146288589|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
146288590|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
146288591|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
146288592|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
146288593|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
146288594|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
146288595|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
146288596|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
146288597|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
145882412|NCT00642811|526074802|FG000|Overall Study|Severe Non-compliance to protocol|1|||
145882413|NCT00642811|526074803|FG001|Overall Study|Severe Non-compliance to protocol|0|||
146288598|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
146288599|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
146288600|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
146288601|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Death|1|||
146288602|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Death|1|||
146288603|NCT00600886|527571416|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
146288604|NCT00600886|527571417|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
146288605|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
146288606|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
146288607|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
146288608|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
146288609|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
146288610|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
146288611|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
146288612|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
146288613|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
146288614|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
146288615|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
146288616|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
146288617|NCT00600886|527571416|FG000|Extension - After Crossover (CAS)|Death|1|||
146288618|NCT00600886|527571417|FG001|Extension - After Crossover (CAS)|Death|0|||
146288619|NCT02053792|527571418|FG000|Overall Study|Physician Decision|0|||
146288620|NCT02053792|527571419|FG001|Overall Study|Physician Decision|1|||
146288621|NCT02053792|527571418|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
146220936|NCT05386030|527323820|FG000|Overall Study|Withdrawal by Subject|20|||
146220937|NCT05386030|527323821|FG001|Overall Study|Withdrawal by Subject|10|||
146220938|NCT05386030|527323820|FG000|Overall Study|Eligibility criteria violation|1|||
146220939|NCT05386030|527323821|FG001|Overall Study|Eligibility criteria violation|1|||
146220940|NCT05386030|527323820|FG000|Overall Study|Personal Reasons|1|||
146220941|NCT05386030|527323821|FG001|Overall Study|Personal Reasons|0|||
145960947|NCT00509899|526369451|FG007|Overall Study|Physician Decision|0|||
145960948|NCT00509899|526369444|FG000|Overall Study|Intercurrent Illness|1|||
145960949|NCT00509899|526369445|FG001|Overall Study|Intercurrent Illness|0|||
145960950|NCT00509899|526369446|FG002|Overall Study|Intercurrent Illness|0|||
145960951|NCT00509899|526369447|FG003|Overall Study|Intercurrent Illness|1|||
145960952|NCT00509899|526369448|FG004|Overall Study|Intercurrent Illness|0|||
145960953|NCT00509899|526369449|FG005|Overall Study|Intercurrent Illness|1|||
145960954|NCT00509899|526369450|FG006|Overall Study|Intercurrent Illness|0|||
145960955|NCT00509899|526369451|FG007|Overall Study|Intercurrent Illness|0|||
145960956|NCT00509899|526369444|FG000|Overall Study|Death|2|||
146220942|NCT03213691|527323822|FG000|Overall Study|Adverse Event|2|||
146220943|NCT03213691|527323822|FG000|Overall Study|Death|3|||
146220944|NCT03213691|527323822|FG000|Overall Study|Physician Decision|1|||
146220945|NCT03213691|527323822|FG000|Overall Study|Progressive Disease|14|||
146220946|NCT03213691|527323822|FG000|Overall Study|Ineligible|1|||
146220947|NCT03161028|527323823|FG000|Overall Study|Withdrawal by Subject|6|||
146220948|NCT03161028|527323824|FG001|Overall Study|Withdrawal by Subject|4|||
146220949|NCT03161028|527323823|FG000|Overall Study|Adverse Event|5|||
146220950|NCT03161028|527323824|FG001|Overall Study|Adverse Event|1|||
145960957|NCT00509899|526369445|FG001|Overall Study|Death|2|||
146220951|NCT03161028|527323823|FG000|Overall Study|Study drug side effects|2|||
146220952|NCT03161028|527323824|FG001|Overall Study|Study drug side effects|2|||
146220953|NCT03161028|527323823|FG000|Overall Study|Administrative PD/UP|4|||
146220954|NCT03161028|527323824|FG001|Overall Study|Administrative PD/UP|2|||
145960958|NCT00509899|526369446|FG002|Overall Study|Death|3|||
145960959|NCT00509899|526369447|FG003|Overall Study|Death|0|||
145960960|NCT00509899|526369448|FG004|Overall Study|Death|1|||
145960961|NCT00509899|526369449|FG005|Overall Study|Death|1|||
145960962|NCT00509899|526369450|FG006|Overall Study|Death|1|||
145960963|NCT00509899|526369451|FG007|Overall Study|Death|1|||
145960964|NCT00509899|526369444|FG000|Overall Study|Lack of Efficacy|1|||
145960965|NCT00509899|526369445|FG001|Overall Study|Lack of Efficacy|0|||
145960966|NCT00509899|526369446|FG002|Overall Study|Lack of Efficacy|2|||
145960967|NCT00509899|526369447|FG003|Overall Study|Lack of Efficacy|0|||
145960968|NCT00509899|526369448|FG004|Overall Study|Lack of Efficacy|0|||
145960969|NCT00509899|526369449|FG005|Overall Study|Lack of Efficacy|1|||
145960970|NCT00509899|526369450|FG006|Overall Study|Lack of Efficacy|0|||
145960971|NCT00509899|526369451|FG007|Overall Study|Lack of Efficacy|0|||
145960972|NCT01711983|526369456|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
145960973|NCT01711983|526369456|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
145960974|NCT01711983|526369456|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
145960975|NCT01711983|526369456|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
145960976|NCT00737100|526369457|FG000|Overall Study|Adverse Event|6|||
145960977|NCT00737100|526369458|FG001|Overall Study|Adverse Event|5|||
146220955|NCT03161028|527323823|FG000|Overall Study|Lost to Follow-up|2|||
145960978|NCT00737100|526369459|FG002|Overall Study|Adverse Event|3|||
145960979|NCT00737100|526369457|FG000|Overall Study|Lost to Follow-up|0|||
145960980|NCT00737100|526369458|FG001|Overall Study|Lost to Follow-up|1|||
145960981|NCT00737100|526369459|FG002|Overall Study|Lost to Follow-up|0|||
145960982|NCT00737100|526369457|FG000|Overall Study|Withdrawal by Subject|0|||
145960983|NCT00737100|526369458|FG001|Overall Study|Withdrawal by Subject|0|||
145960984|NCT00737100|526369459|FG002|Overall Study|Withdrawal by Subject|3|||
146220956|NCT03161028|527323824|FG001|Overall Study|Lost to Follow-up|0|||
145960985|NCT00737100|526369457|FG000|Overall Study|Reason discontinued not explained above|1|||
146220957|NCT03161028|527323823|FG000|Overall Study|Unable to comply with procedures|1|||
146220958|NCT03161028|527323824|FG001|Overall Study|Unable to comply with procedures|1|||
146220959|NCT00736723|527323825|FG000|Overall Study|Withdrawal by Subject|4|||
146220960|NCT00736723|527323826|FG001|Overall Study|Withdrawal by Subject|3|||
146220961|NCT01799265|527323829|FG000|Overall Study|Lost to Follow-up|1|||
146220962|NCT01799265|527323830|FG001|Overall Study|Lost to Follow-up|0|||
146220963|NCT01799265|527323829|FG000|Overall Study|Protocol Violation|2|||
146220964|NCT01799265|527323830|FG001|Overall Study|Protocol Violation|1|||
146220965|NCT01799265|527323829|FG000|Overall Study|inadequate sleep study|0|||
146220966|NCT01799265|527323830|FG001|Overall Study|inadequate sleep study|2|||
146220967|NCT04049643|527323834|FG000|Overall Study|Lack of Efficacy|1|||
146220968|NCT04049643|527323835|FG001|Overall Study|Lack of Efficacy|1|||
146220969|NCT04049643|527323836|FG002|Overall Study|Lack of Efficacy|0|||
146220970|NCT04049643|527323834|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146220971|NCT04049643|527323835|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146220972|NCT04049643|527323836|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
146220973|NCT05028634|527326084|FG000|Overall Study|Withdrawal by Subject|0|||
146220974|NCT05028634|527326085|FG001|Overall Study|Withdrawal by Subject|1|||
146220975|NCT02140554|527326086|FG000|Overall Study|Withdrawal of consent|1|||
146220976|NCT02140554|527326087|FG001|Overall Study|Withdrawal of consent|0|||
146220977|NCT02140554|527326088|FG002|Overall Study|Withdrawal of consent|4|||
146220978|NCT02140554|527326086|FG000|Overall Study|Physician Decision|1|||
146220979|NCT02140554|527326087|FG001|Overall Study|Physician Decision|0|||
146220980|NCT02140554|527326088|FG002|Overall Study|Physician Decision|2|||
146220981|NCT02140554|527326086|FG000|Overall Study|Death|0|||
146220982|NCT02140554|527326087|FG001|Overall Study|Death|0|||
146220983|NCT02140554|527326088|FG002|Overall Study|Death|1|||
146220984|NCT02140554|527326086|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
146220985|NCT02140554|527326087|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
146220986|NCT02140554|527326088|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
146220987|NCT02100813|527326092|FG000|Overall Study|Adverse Event|0|||
146220988|NCT02100813|527326093|FG001|Overall Study|Adverse Event|0|||
146220989|NCT02100813|527326094|FG002|Overall Study|Adverse Event|0|||
146220990|NCT02100813|527326095|FG003|Overall Study|Adverse Event|0|||
146220991|NCT02100813|527326096|FG004|Overall Study|Adverse Event|0|||
146220992|NCT02100813|527326097|FG005|Overall Study|Adverse Event|0|||
146220993|NCT02100813|527326098|FG006|Overall Study|Adverse Event|0|||
146220994|NCT02100813|527326099|FG007|Overall Study|Adverse Event|1|||
146220995|NCT00506519|527326105|FG000|Overall Study|Death|4|||
146220996|NCT00506519|527326106|FG001|Overall Study|Death|6|||
146220997|NCT00506519|527326107|FG002|Overall Study|Death|0|||
146220998|NCT00506519|527326105|FG000|Overall Study|Adverse Event|1|||
146220999|NCT00506519|527326106|FG001|Overall Study|Adverse Event|0|||
146221000|NCT00506519|527326107|FG002|Overall Study|Adverse Event|0|||
146221001|NCT02975882|527326108|FG000|Overall Study|Adverse Event|1|||
146221002|NCT02975882|527326109|FG001|Overall Study|Adverse Event|2|||
146221003|NCT02975882|527326110|FG002|Overall Study|Adverse Event|1|||
146221004|NCT02975882|527326111|FG003|Overall Study|Adverse Event|1|||
146221005|NCT02975882|527326108|FG000|Overall Study|Death|0|||
146221006|NCT02975882|527326109|FG001|Overall Study|Death|1|||
146221007|NCT02975882|527326110|FG002|Overall Study|Death|0|||
146221008|NCT02975882|527326111|FG003|Overall Study|Death|0|||
146221009|NCT02975882|527326108|FG000|Overall Study|Lack of Efficacy|3|||
146221010|NCT02975882|527326109|FG001|Overall Study|Lack of Efficacy|7|||
146221011|NCT02975882|527326110|FG002|Overall Study|Lack of Efficacy|4|||
146221012|NCT02975882|527326111|FG003|Overall Study|Lack of Efficacy|3|||
146221013|NCT02975882|527326108|FG000|Overall Study|Physician Decision|0|||
146221014|NCT02975882|527326109|FG001|Overall Study|Physician Decision|2|||
146221015|NCT02975882|527326110|FG002|Overall Study|Physician Decision|4|||
146221016|NCT02975882|527326111|FG003|Overall Study|Physician Decision|2|||
146221017|NCT02975882|527326108|FG000|Overall Study|Ineligible|0|||
146221018|NCT02975882|527326109|FG001|Overall Study|Ineligible|1|||
146221019|NCT02975882|527326110|FG002|Overall Study|Ineligible|0|||
146221020|NCT02975882|527326111|FG003|Overall Study|Ineligible|0|||
146221021|NCT02105766|527326112|FG000|Overall Study|Physician Decision|1|||
146221022|NCT02105766|527326113|FG001|Overall Study|Physician Decision|1|||
146221023|NCT02105766|527326114|FG002|Overall Study|Physician Decision|0|||
146221024|NCT02105766|527326112|FG000|Overall Study|Lost to Follow-up|2|||
146221025|NCT02105766|527326113|FG001|Overall Study|Lost to Follow-up|0|||
146221026|NCT02105766|527326114|FG002|Overall Study|Lost to Follow-up|0|||
146221027|NCT02105766|527326112|FG000|Overall Study|Death|1|||
146221028|NCT02105766|527326113|FG001|Overall Study|Death|1|||
146221029|NCT02105766|527326114|FG002|Overall Study|Death|0|||
146221030|NCT02985957|527326115|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146221031|NCT02985957|527326116|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146221032|NCT02985957|527326117|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145960986|NCT00737100|526369458|FG001|Overall Study|Reason discontinued not explained above|1|||
145960987|NCT00737100|526369459|FG002|Overall Study|Reason discontinued not explained above|1|||
145960988|NCT02595502|526369462|FG000|Period 1|Adverse Event|0|||
145960989|NCT02595502|526369463|FG001|Period 1|Adverse Event|1|||
145960990|NCT02595502|526369462|FG000|Period 1|Withdrawal by Subject|1|||
145960991|NCT02595502|526369463|FG001|Period 1|Withdrawal by Subject|0|||
145960992|NCT02595502|526369462|FG000|Period 1|Lost to Follow-up|0|||
145960993|NCT02595502|526369463|FG001|Period 1|Lost to Follow-up|1|||
145960994|NCT02595502|526369462|FG000|Period 2|Adverse Event|1|||
145960995|NCT02595502|526369463|FG001|Period 2|Adverse Event|1|||
145960996|NCT02595502|526369462|FG000|Period 2|Received incorrect lens at Period 1|0|||
145960997|NCT02595502|526369463|FG001|Period 2|Received incorrect lens at Period 1|1|||
145960998|NCT02595502|526369462|FG000|Period 3|Protocol Violation|0|||
145960999|NCT02595502|526369463|FG001|Period 3|Protocol Violation|1|||
145961000|NCT02595502|526369462|FG000|Period 3|Lost to Follow-up|1|||
145961001|NCT02595502|526369463|FG001|Period 3|Lost to Follow-up|0|||
145961002|NCT02595502|526369462|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
145961003|NCT02595502|526369463|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
145961004|NCT03286218|526369464|FG000|Qualification Phase Period 1|Adverse Event|1|||
145961005|NCT03286218|526369465|FG001|Qualification Phase Period 1|Adverse Event|0|||
145961006|NCT03286218|526369466|FG002|Qualification Phase Period 1|Adverse Event|0|||
145961007|NCT03286218|526369467|FG003|Qualification Phase Period 1|Adverse Event|0|||
145961008|NCT03286218|526369468|FG004|Qualification Phase Period 1|Adverse Event|0|||
145961009|NCT03286218|526369469|FG005|Qualification Phase Period 1|Adverse Event|0|||
145961010|NCT03286218|526369470|FG006|Qualification Phase Period 1|Adverse Event|0|||
145961011|NCT03286218|526369471|FG007|Qualification Phase Period 1|Adverse Event|0|||
145961012|NCT03286218|526369472|FG008|Qualification Phase Period 1|Adverse Event|0|||
145961013|NCT03286218|526369473|FG009|Qualification Phase Period 1|Adverse Event|0|||
145961014|NCT03286218|526369474|FG010|Qualification Phase Period 1|Adverse Event|0|||
145961015|NCT03286218|526369475|FG011|Qualification Phase Period 1|Adverse Event|0|||
145961016|NCT03286218|526369464|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961017|NCT03286218|526369465|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
145961018|NCT03286218|526369466|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961019|NCT03286218|526369467|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961020|NCT03286218|526369468|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961021|NCT03286218|526369469|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961022|NCT03286218|526369470|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961023|NCT03286218|526369471|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961024|NCT03286218|526369472|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961025|NCT03286218|526369473|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961026|NCT03286218|526369474|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
146221033|NCT02985957|527326118|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146221034|NCT02985957|527326119|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146221035|NCT02985957|527326120|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146221036|NCT02985957|527326121|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146221037|NCT02985957|527326115|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146221038|NCT02985957|527326116|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146221039|NCT02985957|527326117|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
146221040|NCT02985957|527326118|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
146221041|NCT02985957|527326119|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
146221042|NCT02985957|527326120|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
146221043|NCT02985957|527326121|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
146288622|NCT02053792|527571419|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
146288623|NCT02053792|527571418|FG000|Overall Study|Lack of Efficacy|1|||
145961027|NCT03286218|526369475|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
145961028|NCT03286218|526369464|FG000|Qualification Phase Period 2|Adverse Event|0|||
145961029|NCT03286218|526369465|FG001|Qualification Phase Period 2|Adverse Event|1|||
145961030|NCT03286218|526369466|FG002|Qualification Phase Period 2|Adverse Event|0|||
145961031|NCT03286218|526369467|FG003|Qualification Phase Period 2|Adverse Event|0|||
145961032|NCT03286218|526369468|FG004|Qualification Phase Period 2|Adverse Event|0|||
145961033|NCT03286218|526369469|FG005|Qualification Phase Period 2|Adverse Event|0|||
145961034|NCT03286218|526369470|FG006|Qualification Phase Period 2|Adverse Event|0|||
145961035|NCT03286218|526369471|FG007|Qualification Phase Period 2|Adverse Event|0|||
145961036|NCT03286218|526369472|FG008|Qualification Phase Period 2|Adverse Event|0|||
145961037|NCT03286218|526369473|FG009|Qualification Phase Period 2|Adverse Event|0|||
145961038|NCT03286218|526369474|FG010|Qualification Phase Period 2|Adverse Event|0|||
145961039|NCT03286218|526369475|FG011|Qualification Phase Period 2|Adverse Event|0|||
145961040|NCT03286218|526369464|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
145961041|NCT03286218|526369465|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
145961042|NCT03286218|526369466|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146221044|NCT02985957|527326115|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221045|NCT02985957|527326116|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221046|NCT02985957|527326117|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221047|NCT02985957|527326118|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221048|NCT02985957|527326119|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221049|NCT02985957|527326120|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146221050|NCT02985957|527326121|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146221051|NCT02985957|527326115|FG000|Treatment Period|Death|0|||
146221052|NCT02985957|527326116|FG001|Treatment Period|Death|0|||
146221053|NCT02985957|527326117|FG002|Treatment Period|Death|0|||
146221054|NCT02985957|527326118|FG003|Treatment Period|Death|0|||
146221055|NCT02985957|527326119|FG004|Treatment Period|Death|1|||
146221056|NCT02985957|527326120|FG005|Treatment Period|Death|0|||
146221057|NCT02985957|527326121|FG006|Treatment Period|Death|0|||
146221058|NCT02985957|527326115|FG000|Treatment Period|Participant withdrew consent|0|||
146221059|NCT02985957|527326116|FG001|Treatment Period|Participant withdrew consent|0|||
146221060|NCT02985957|527326117|FG002|Treatment Period|Participant withdrew consent|0|||
146221061|NCT02985957|527326118|FG003|Treatment Period|Participant withdrew consent|1|||
146221062|NCT02985957|527326119|FG004|Treatment Period|Participant withdrew consent|3|||
146221063|NCT02985957|527326120|FG005|Treatment Period|Participant withdrew consent|0|||
146221064|NCT02985957|527326121|FG006|Treatment Period|Participant withdrew consent|1|||
146221065|NCT02985957|527326115|FG000|Treatment Period|Lost to Follow-up|0|||
146221066|NCT02985957|527326116|FG001|Treatment Period|Lost to Follow-up|0|||
146221067|NCT02985957|527326117|FG002|Treatment Period|Lost to Follow-up|0|||
146221068|NCT02985957|527326118|FG003|Treatment Period|Lost to Follow-up|0|||
146221069|NCT02985957|527326119|FG004|Treatment Period|Lost to Follow-up|1|||
146221070|NCT02985957|527326120|FG005|Treatment Period|Lost to Follow-up|0|||
146221071|NCT02985957|527326121|FG006|Treatment Period|Lost to Follow-up|0|||
146221072|NCT02985957|527326115|FG000|Treatment Period|Other reasons|0|||
146221073|NCT02985957|527326116|FG001|Treatment Period|Other reasons|0|||
146221074|NCT02985957|527326117|FG002|Treatment Period|Other reasons|1|||
146221075|NCT02985957|527326118|FG003|Treatment Period|Other reasons|3|||
146221076|NCT02985957|527326119|FG004|Treatment Period|Other reasons|6|||
146221077|NCT02985957|527326120|FG005|Treatment Period|Other reasons|0|||
146221078|NCT02985957|527326121|FG006|Treatment Period|Other reasons|1|||
146221079|NCT02985957|527326115|FG000|Treatment Period|Not reported|0|||
146221080|NCT02985957|527326116|FG001|Treatment Period|Not reported|1|||
146221081|NCT02985957|527326117|FG002|Treatment Period|Not reported|2|||
146221082|NCT02985957|527326118|FG003|Treatment Period|Not reported|5|||
145961043|NCT03286218|526369467|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961044|NCT03286218|526369468|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146085036|NCT04535167|526832047|FG002|Follow-Up|Lost to Follow-up|0|||
146221083|NCT02985957|527326119|FG004|Treatment Period|Not reported|0|||
146221084|NCT02985957|527326120|FG005|Treatment Period|Not reported|0|||
146221085|NCT02985957|527326121|FG006|Treatment Period|Not reported|0|||
146221086|NCT02985957|527326115|FG000|Treatment Period|Maximum clinical benefit|0|||
146221087|NCT02985957|527326116|FG001|Treatment Period|Maximum clinical benefit|0|||
146221088|NCT02985957|527326117|FG002|Treatment Period|Maximum clinical benefit|1|||
146221089|NCT02985957|527326118|FG003|Treatment Period|Maximum clinical benefit|1|||
146221090|NCT02985957|527326119|FG004|Treatment Period|Maximum clinical benefit|0|||
146221091|NCT02985957|527326120|FG005|Treatment Period|Maximum clinical benefit|0|||
146221092|NCT02985957|527326121|FG006|Treatment Period|Maximum clinical benefit|2|||
146221093|NCT02985957|527326115|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
146221094|NCT02985957|527326116|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
146221095|NCT02985957|527326117|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
146221096|NCT02985957|527326118|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
146221097|NCT02985957|527326119|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
146221098|NCT02985957|527326120|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
146221099|NCT02985957|527326121|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
146221100|NCT02985957|527326115|FG000|Treatment Period|Study drug toxicity|1|||
146221101|NCT02985957|527326116|FG001|Treatment Period|Study drug toxicity|23|||
146221102|NCT02985957|527326117|FG002|Treatment Period|Study drug toxicity|20|||
146221103|NCT02985957|527326118|FG003|Treatment Period|Study drug toxicity|11|||
146221104|NCT02985957|527326119|FG004|Treatment Period|Study drug toxicity|19|||
146221105|NCT02985957|527326120|FG005|Treatment Period|Study drug toxicity|3|||
146221106|NCT02985957|527326121|FG006|Treatment Period|Study drug toxicity|5|||
146221107|NCT02985957|527326115|FG000|Treatment Period|Disease progression|0|||
146221108|NCT02985957|527326116|FG001|Treatment Period|Disease progression|16|||
146221109|NCT02985957|527326117|FG002|Treatment Period|Disease progression|20|||
146221110|NCT02985957|527326118|FG003|Treatment Period|Disease progression|39|||
146221111|NCT02985957|527326119|FG004|Treatment Period|Disease progression|29|||
146288624|NCT02053792|527571419|FG001|Overall Study|Lack of Efficacy|0|||
146221112|NCT02985957|527326120|FG005|Treatment Period|Disease progression|11|||
146221113|NCT02985957|527326121|FG006|Treatment Period|Disease progression|28|||
146221114|NCT02985957|527326115|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
146221115|NCT02985957|527326116|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
146221116|NCT02985957|527326117|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
146221117|NCT02985957|527326118|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
146221118|NCT02985957|527326119|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
146221119|NCT02985957|527326120|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
146288625|NCT02053792|527571418|FG000|Overall Study|Adverse Event|1|||
146288626|NCT02053792|527571419|FG001|Overall Study|Adverse Event|0|||
146288627|NCT02053792|527571418|FG000|Overall Study|Withdrawal by Subject|2|||
146288628|NCT02053792|527571419|FG001|Overall Study|Withdrawal by Subject|2|||
146288629|NCT02053792|527571418|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
146288630|NCT02053792|527571419|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
146288631|NCT02053792|527571418|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
146288632|NCT02053792|527571419|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
146288633|NCT00790751|527571427|FG000|Overall Study|Protocol non-compliance|16|||
146288634|NCT00790751|527571428|FG001|Overall Study|Protocol non-compliance|16|||
146288635|NCT00790751|527571429|FG002|Overall Study|Protocol non-compliance|10|||
146288636|NCT00790751|527571430|FG003|Overall Study|Protocol non-compliance|11|||
146288637|NCT00790751|527571427|FG000|Overall Study|Lost to Follow-up|4|||
146288638|NCT00790751|527571428|FG001|Overall Study|Lost to Follow-up|9|||
146288639|NCT00790751|527571429|FG002|Overall Study|Lost to Follow-up|4|||
146288640|NCT00790751|527571430|FG003|Overall Study|Lost to Follow-up|5|||
146288641|NCT00790751|527571427|FG000|Overall Study|Adverse Event|5|||
146288642|NCT00790751|527571428|FG001|Overall Study|Adverse Event|3|||
146288643|NCT00790751|527571429|FG002|Overall Study|Adverse Event|5|||
146085037|NCT04535167|526832048|FG003|Follow-Up|Lost to Follow-up|1|||
146085038|NCT04535167|526832049|FG004|Follow-Up|Lost to Follow-up|0|||
146085039|NCT04535167|526832050|FG005|Follow-Up|Lost to Follow-up|0|||
146085040|NCT04535167|526832051|FG006|Follow-Up|Lost to Follow-up|0|||
146085041|NCT00075270|526832052|FG000|Overall Study|Withdrawal by Subject|28|||
146085042|NCT00075270|526832053|FG001|Overall Study|Withdrawal by Subject|21|||
146085043|NCT00075270|526832052|FG000|Overall Study|Lost to Follow-up|25|||
146085044|NCT00075270|526832053|FG001|Overall Study|Lost to Follow-up|28|||
146221120|NCT02985957|527326121|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
146221121|NCT02985957|527326115|FG000|Treatment Period|Poor/Non-Compliance|0|||
146221122|NCT02985957|527326116|FG001|Treatment Period|Poor/Non-Compliance|0|||
146221123|NCT02985957|527326117|FG002|Treatment Period|Poor/Non-Compliance|0|||
146288644|NCT00790751|527571430|FG003|Overall Study|Adverse Event|4|||
146288645|NCT00790751|527571427|FG000|Overall Study|Requirement for restricted medication|0|||
146288646|NCT00790751|527571428|FG001|Overall Study|Requirement for restricted medication|2|||
146288647|NCT00790751|527571429|FG002|Overall Study|Requirement for restricted medication|0|||
146288648|NCT00790751|527571430|FG003|Overall Study|Requirement for restricted medication|0|||
146288649|NCT00790751|527571427|FG000|Overall Study|Death|0|||
146288650|NCT00790751|527571428|FG001|Overall Study|Death|0|||
146288651|NCT00790751|527571429|FG002|Overall Study|Death|1|||
146288652|NCT00790751|527571430|FG003|Overall Study|Death|0|||
146288653|NCT00790751|527571427|FG000|Overall Study|Physician Decision|0|||
146288654|NCT00790751|527571428|FG001|Overall Study|Physician Decision|0|||
146221124|NCT02985957|527326118|FG003|Treatment Period|Poor/Non-Compliance|0|||
146288655|NCT00790751|527571429|FG002|Overall Study|Physician Decision|0|||
146288656|NCT00790751|527571430|FG003|Overall Study|Physician Decision|1|||
146288657|NCT05590884|527571431|FG000|Overall Study|Withdrawal by Subject|1|||
146288658|NCT05590884|527571432|FG001|Overall Study|Withdrawal by Subject|0|||
146288659|NCT05590884|527571433|FG002|Overall Study|Withdrawal by Subject|0|||
146288660|NCT04428151|527571434|FG000|Overall Study|Death|100|||
146288661|NCT04428151|527571435|FG001|Overall Study|Death|86|||
146288662|NCT04428151|527571436|FG002|Overall Study|Death|57|||
146288663|NCT04428151|527571434|FG000|Overall Study|Lost to Follow-up|1|||
146288664|NCT04428151|527571435|FG001|Overall Study|Lost to Follow-up|1|||
146085045|NCT00075270|526832052|FG000|Overall Study|Protocol Violation|0|||
146221125|NCT02985957|527326119|FG004|Treatment Period|Poor/Non-Compliance|1|||
146221126|NCT02985957|527326120|FG005|Treatment Period|Poor/Non-Compliance|1|||
146085046|NCT00075270|526832053|FG001|Overall Study|Protocol Violation|2|||
146085047|NCT00075270|526832052|FG000|Overall Study|Death|198|||
146221127|NCT02985957|527326121|FG006|Treatment Period|Poor/Non-Compliance|0|||
146085048|NCT00075270|526832053|FG001|Overall Study|Death|215|||
146221128|NCT02985957|527326115|FG000|Treatment Period|Continuing in Treatment Period|0|||
146221129|NCT02985957|527326116|FG001|Treatment Period|Continuing in Treatment Period|1|||
146221130|NCT02985957|527326117|FG002|Treatment Period|Continuing in Treatment Period|0|||
146221131|NCT02985957|527326118|FG003|Treatment Period|Continuing in Treatment Period|4|||
146288665|NCT04428151|527571436|FG002|Overall Study|Lost to Follow-up|0|||
146288666|NCT04428151|527571434|FG000|Overall Study|Withdrawal by Subject|2|||
146288667|NCT04428151|527571435|FG001|Overall Study|Withdrawal by Subject|2|||
146288668|NCT04428151|527571436|FG002|Overall Study|Withdrawal by Subject|3|||
146221132|NCT02985957|527326119|FG004|Treatment Period|Continuing in Treatment Period|4|||
146221133|NCT02985957|527326120|FG005|Treatment Period|Continuing in Treatment Period|0|||
146221134|NCT02985957|527326121|FG006|Treatment Period|Continuing in Treatment Period|0|||
146221135|NCT04342494|527326122|FG000|Overall Study|Questionnaire partially completed|1|||
146221136|NCT04342494|527326123|FG001|Overall Study|Questionnaire partially completed|0|||
146221137|NCT04342494|527326124|FG002|Overall Study|Questionnaire partially completed|2|||
146221138|NCT04342494|527326125|FG003|Overall Study|Questionnaire partially completed|0|||
146221139|NCT04342494|527326126|FG004|Overall Study|Questionnaire partially completed|1|||
146221140|NCT04342494|527326122|FG000|Overall Study|Lost to Follow-up|49|||
146221141|NCT04342494|527326123|FG001|Overall Study|Lost to Follow-up|38|||
146221142|NCT04342494|527326124|FG002|Overall Study|Lost to Follow-up|34|||
146221143|NCT04342494|527326125|FG003|Overall Study|Lost to Follow-up|34|||
146221144|NCT04342494|527326126|FG004|Overall Study|Lost to Follow-up|35|||
146221145|NCT00753545|527326130|FG000|Overall Study|Death|98|||
146221146|NCT00753545|527326131|FG001|Overall Study|Death|112|||
146221147|NCT00753545|527326130|FG000|Overall Study|Lost to Follow-up|2|||
146221148|NCT00753545|527326131|FG001|Overall Study|Lost to Follow-up|3|||
146221149|NCT00753545|527326130|FG000|Overall Study|Protocol Violation|1|||
146221150|NCT00753545|527326131|FG001|Overall Study|Protocol Violation|0|||
146221151|NCT00753545|527326130|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
146221152|NCT00753545|527326131|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
146221153|NCT02485938|527326132|FG000|Overall Study|Withdrawal of consent|2|||
146221154|NCT02485938|527326133|FG001|Overall Study|Withdrawal of consent|0|||
146221155|NCT04633122|527326134|FG000|Overall Study|Remained on treatment|19|||
146221156|NCT04633122|527326135|FG001|Overall Study|Remained on treatment|14|||
146221157|NCT04633122|527326134|FG000|Overall Study|Survival follow-up stopped|22|||
146221158|NCT04633122|527326135|FG001|Overall Study|Survival follow-up stopped|25|||
146221159|NCT04799899|527326136|FG000|Overall Study|Lost to Follow-up|2|||
146221160|NCT04799899|527326137|FG001|Overall Study|Lost to Follow-up|4|||
146221161|NCT03339713|527326140|FG000|Overall Study|Lost to Follow-up|2|||
146221162|NCT03339713|527326141|FG001|Overall Study|Lost to Follow-up|1|||
146221163|NCT03339713|527326140|FG000|Overall Study|Protocol Violation|1|||
146221164|NCT03339713|527326141|FG001|Overall Study|Protocol Violation|0|||
146221165|NCT03339713|527326140|FG000|Overall Study|Withdrawal by Subject|1|||
146221166|NCT03339713|527326141|FG001|Overall Study|Withdrawal by Subject|1|||
146221167|NCT04858321|527326148|FG000|Overall Study|Withdrawal by Subject|3|||
146221168|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
146221169|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
146221170|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
146221171|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
146221172|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
146221173|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
146221174|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Death|6|||
146221175|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Death|0|||
146221176|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Death|0|||
146221177|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
146221178|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
146221179|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
146221180|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
146221181|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
146221182|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
146221183|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
146221184|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
146221185|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
146221186|NCT01539083|527326149|FG000|Before Randomization (VCD Induction)|Other|5|||
146221187|NCT01539083|527326150|FG001|Before Randomization (VCD Induction)|Other|0|||
146221188|NCT01539083|527326151|FG002|Before Randomization (VCD Induction)|Other|0|||
146221189|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
146221190|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
146221191|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
146221192|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Other|0|||
146221193|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Other|1|||
146221194|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Other|1|||
146221195|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
146221196|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
146221197|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
146221198|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
146221199|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
146221200|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
146221201|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
146288669|NCT04428151|527571434|FG000|Overall Study|Participant Ongoing in Study|41|||
146221202|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
146221203|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
146221204|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
146221205|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
146221206|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
146221207|NCT01539083|527326149|FG000|After Randomization (TP and VTP)|Death|0|||
146221208|NCT01539083|527326150|FG001|After Randomization (TP and VTP)|Death|6|||
146221209|NCT01539083|527326151|FG002|After Randomization (TP and VTP)|Death|11|||
146221210|NCT05499377|527326160|FG000|Overall Study|Withdrawal by Subject|2|||
146221211|NCT05499377|527326161|FG001|Overall Study|Withdrawal by Subject|0|||
146221212|NCT05499377|527326160|FG000|Overall Study|Physician Decision|1|||
146221213|NCT05499377|527326161|FG001|Overall Study|Physician Decision|0|||
146221214|NCT05714761|527326162|FG000|Overall Study|Lost to Follow-up|3|||
146221215|NCT05714761|527326162|FG000|Overall Study|Withdrawal by Subject|3|||
146221216|NCT05714761|527326162|FG000|Overall Study|unblinding of sensor data|1|||
146221217|NCT05714761|527326162|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
146221218|NCT05714761|527326162|FG000|Overall Study|did not return second CGM sensor|4|||
146221219|NCT03092518|527326165|FG000|Overall Study|Ineligible|2|||
146221220|NCT02146378|527326166|FG000|Overall Study|No information of administration|2|||
146221221|NCT05089019|527326170|FG000|Period 1|Withdrawal by Subject|0|||
146221222|NCT05089019|527326171|FG001|Period 1|Withdrawal by Subject|1|||
146221223|NCT05089019|527326170|FG000|Washout Period|Adverse Event|3|||
146221224|NCT05089019|527326171|FG001|Washout Period|Adverse Event|4|||
146221225|NCT05089019|527326170|FG000|Washout Period|Lost to Follow-up|1|||
146221226|NCT05089019|527326171|FG001|Washout Period|Lost to Follow-up|0|||
146221227|NCT05089019|527326170|FG000|Washout Period|Physician Decision|2|||
146221228|NCT05089019|527326171|FG001|Washout Period|Physician Decision|0|||
146221229|NCT05089019|527326170|FG000|Washout Period|Withdrawal by Subject|6|||
146221230|NCT05089019|527326171|FG001|Washout Period|Withdrawal by Subject|3|||
146221231|NCT05089019|527326170|FG000|Period 2|Adverse Event|4|||
146221232|NCT05089019|527326171|FG001|Period 2|Adverse Event|2|||
146221233|NCT05089019|527326170|FG000|Period 2|Lost to Follow-up|1|||
146221234|NCT05089019|527326171|FG001|Period 2|Lost to Follow-up|0|||
146221235|NCT05089019|527326170|FG000|Period 2|Withdrawal by Subject|0|||
146221236|NCT05089019|527326171|FG001|Period 2|Withdrawal by Subject|1|||
146221237|NCT05170009|527326172|FG000|Overall Study|Physician Decision|0|||
146221238|NCT05170009|527326173|FG001|Overall Study|Physician Decision|1|||
146221239|NCT04925986|527326174|FG000|Overall Study|Death|0|||
146221240|NCT04925986|527326175|FG001|Overall Study|Death|0|||
146221241|NCT04925986|527326176|FG002|Overall Study|Death|2|||
146221242|NCT04925986|527326177|FG003|Overall Study|Death|0|||
146221243|NCT04925986|527326174|FG000|Overall Study|Lack of Efficacy|1|||
146221244|NCT04925986|527326175|FG001|Overall Study|Lack of Efficacy|2|||
146221245|NCT04925986|527326176|FG002|Overall Study|Lack of Efficacy|0|||
146221246|NCT04925986|527326177|FG003|Overall Study|Lack of Efficacy|1|||
146221247|NCT04925986|527326174|FG000|Overall Study|Withdrawal by Subject|0|||
146221248|NCT04925986|527326175|FG001|Overall Study|Withdrawal by Subject|0|||
146221249|NCT04925986|527326176|FG002|Overall Study|Withdrawal by Subject|1|||
146221250|NCT04925986|527326177|FG003|Overall Study|Withdrawal by Subject|2|||
146221251|NCT04629716|527326179|FG000|Overall Study|Lost to Follow-up|7|||
146221252|NCT04629716|527326180|FG001|Overall Study|Lost to Follow-up|3|||
146221253|NCT04770532|527326181|FG000|Overall Study|Withdrawal by Subject|0|||
146221254|NCT04770532|527326182|FG001|Overall Study|Withdrawal by Subject|3|||
146221255|NCT04770532|527326181|FG000|Overall Study|Physician Decision|1|||
146221256|NCT04770532|527326182|FG001|Overall Study|Physician Decision|0|||
146221257|NCT04770532|527326181|FG000|Overall Study|Death|2|||
146221258|NCT04770532|527326182|FG001|Overall Study|Death|2|||
146221259|NCT05457647|527326183|FG000|Overall Study|Lost to Follow-up|3|||
146085049|NCT00075270|526832052|FG000|Overall Study|Other/Unknown|9|||
146085050|NCT00075270|526832053|FG001|Overall Study|Other/Unknown|5|||
146085051|NCT00075270|526832052|FG000|Overall Study|Missing|26|||
146085052|NCT00075270|526832053|FG001|Overall Study|Missing|13|||
146085053|NCT02160002|526832054|FG000|Overall Study|Withdrawal by Subject|2|||
146085054|NCT02160002|526832055|FG001|Overall Study|Withdrawal by Subject|1|||
146085055|NCT00713310|526832058|FG000|Overall Study|Adverse Event|5|||
146085056|NCT00713310|526832059|FG001|Overall Study|Adverse Event|2|||
146221260|NCT02683447|527326184|FG000|Overall Study|Lost to Follow-up|2|||
146221261|NCT01943409|527326189|FG000|Overall Study|resumed oral/entral|24|||
145961045|NCT03286218|526369469|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961046|NCT03286218|526369470|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
146221262|NCT01943409|527326190|FG001|Overall Study|resumed oral/entral|20|||
146221263|NCT01943409|527326189|FG000|Overall Study|Protocol Violation|14|||
146085057|NCT00713310|526832058|FG000|Overall Study|Lack of Efficacy|0|||
146085058|NCT00713310|526832059|FG001|Overall Study|Lack of Efficacy|2|||
146221264|NCT01943409|527326190|FG001|Overall Study|Protocol Violation|24|||
146221265|NCT01943409|527326189|FG000|Overall Study|Death|3|||
146221266|NCT01943409|527326190|FG001|Overall Study|Death|1|||
146221267|NCT01943409|527326189|FG000|Overall Study|Withdrawal by Subject|4|||
146221268|NCT01943409|527326190|FG001|Overall Study|Withdrawal by Subject|3|||
146221269|NCT04542317|527326191|FG000|Overall Study|Care recipients passed away|18|||
146221270|NCT04542317|527326192|FG001|Overall Study|Care recipients passed away|13|||
146221271|NCT04542317|527326191|FG000|Overall Study|No longer a primary caregiver|5|||
146221272|NCT04542317|527326192|FG001|Overall Study|No longer a primary caregiver|1|||
146221273|NCT04542317|527326191|FG000|Overall Study|Withdrawal by Subject|4|||
146221274|NCT04542317|527326192|FG001|Overall Study|Withdrawal by Subject|2|||
146221275|NCT04542317|527326191|FG000|Overall Study|Caregivers passed away|0|||
146221276|NCT04542317|527326192|FG001|Overall Study|Caregivers passed away|2|||
146221277|NCT02310646|527326195|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
146221278|NCT02310646|527326196|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
146221279|NCT02310646|527326195|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
146221280|NCT02310646|527326196|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
146221281|NCT03021096|527326197|FG000|Overall Study|Lost to Follow-up|4|||
146221282|NCT03021096|527326197|FG000|Overall Study|Protocol Violation|2|||
146221283|NCT04700163|527326198|FG000|Overall Study|Lost to Follow-up|0|||
146221284|NCT04700163|527326199|FG001|Overall Study|Lost to Follow-up|0|||
146221285|NCT04700163|527326200|FG002|Overall Study|Lost to Follow-up|0|||
146221286|NCT04700163|527326201|FG003|Overall Study|Lost to Follow-up|0|||
146221287|NCT04700163|527326202|FG004|Overall Study|Lost to Follow-up|0|||
146221288|NCT04700163|527326203|FG005|Overall Study|Lost to Follow-up|1|||
146221289|NCT03496168|527326212|FG000|Overall Study|Other Reasons|1|||
146221290|NCT03496168|527326212|FG000|Overall Study|Adverse Event|1|||
146221291|NCT05543629|527326213|FG000|Overall Study|Death|1|||
146221292|NCT05543629|527326214|FG001|Overall Study|Death|0|||
146221293|NCT05543629|527326215|FG002|Overall Study|Death|1|||
146221294|NCT05543629|527326216|FG003|Overall Study|Death|0|||
146221295|NCT05543629|527326217|FG004|Overall Study|Death|0|||
146221296|NCT05543629|527326218|FG005|Overall Study|Death|1|||
146221297|NCT05543629|527326219|FG006|Overall Study|Death|2|||
146221298|NCT05543629|527326220|FG007|Overall Study|Death|2|||
146221299|NCT05543629|527326213|FG000|Overall Study|Other Reasons|0|||
146221300|NCT05543629|527326214|FG001|Overall Study|Other Reasons|0|||
146221301|NCT05543629|527326215|FG002|Overall Study|Other Reasons|0|||
146221302|NCT05543629|527326216|FG003|Overall Study|Other Reasons|0|||
146221303|NCT05543629|527326217|FG004|Overall Study|Other Reasons|1|||
146221304|NCT05543629|527326218|FG005|Overall Study|Other Reasons|0|||
146221305|NCT05543629|527326219|FG006|Overall Study|Other Reasons|0|||
146221306|NCT05543629|527326220|FG007|Overall Study|Other Reasons|0|||
146221307|NCT05543629|527326213|FG000|Overall Study|Physician Decision|0|||
146221308|NCT05543629|527326214|FG001|Overall Study|Physician Decision|0|||
146221309|NCT05543629|527326215|FG002|Overall Study|Physician Decision|3|||
146221310|NCT05543629|527326216|FG003|Overall Study|Physician Decision|0|||
146221311|NCT05543629|527326217|FG004|Overall Study|Physician Decision|0|||
146221312|NCT05543629|527326218|FG005|Overall Study|Physician Decision|0|||
146221313|NCT05543629|527326219|FG006|Overall Study|Physician Decision|1|||
146221314|NCT05543629|527326220|FG007|Overall Study|Physician Decision|0|||
146221315|NCT05543629|527326213|FG000|Overall Study|Study terminated by Sponsor|1|||
146221316|NCT05543629|527326214|FG001|Overall Study|Study terminated by Sponsor|0|||
146221317|NCT05543629|527326215|FG002|Overall Study|Study terminated by Sponsor|0|||
146221318|NCT05543629|527326216|FG003|Overall Study|Study terminated by Sponsor|1|||
146221319|NCT05543629|527326217|FG004|Overall Study|Study terminated by Sponsor|0|||
146221320|NCT05543629|527326218|FG005|Overall Study|Study terminated by Sponsor|4|||
146221321|NCT05543629|527326219|FG006|Overall Study|Study terminated by Sponsor|1|||
146221322|NCT05543629|527326220|FG007|Overall Study|Study terminated by Sponsor|0|||
146221323|NCT05543629|527326213|FG000|Overall Study|Withdrawal by Subject|1|||
146221324|NCT05543629|527326214|FG001|Overall Study|Withdrawal by Subject|1|||
146221325|NCT05543629|527326215|FG002|Overall Study|Withdrawal by Subject|0|||
146221326|NCT05543629|527326216|FG003|Overall Study|Withdrawal by Subject|2|||
146221327|NCT05543629|527326217|FG004|Overall Study|Withdrawal by Subject|1|||
146221328|NCT05543629|527326218|FG005|Overall Study|Withdrawal by Subject|1|||
146221329|NCT05543629|527326219|FG006|Overall Study|Withdrawal by Subject|1|||
146221330|NCT05543629|527326220|FG007|Overall Study|Withdrawal by Subject|1|||
146221331|NCT05543629|527326213|FG000|Overall Study|Not Reported|2|||
146221332|NCT05543629|527326214|FG001|Overall Study|Not Reported|2|||
146221333|NCT05543629|527326215|FG002|Overall Study|Not Reported|0|||
146221334|NCT05543629|527326216|FG003|Overall Study|Not Reported|0|||
146221335|NCT05543629|527326217|FG004|Overall Study|Not Reported|1|||
146221336|NCT05543629|527326218|FG005|Overall Study|Not Reported|1|||
146221337|NCT05543629|527326219|FG006|Overall Study|Not Reported|3|||
146221338|NCT05543629|527326220|FG007|Overall Study|Not Reported|0|||
146221339|NCT03313076|527326221|FG000|Overall Study|Withdrawal by Subject|2|||
146221340|NCT03313076|527326222|FG001|Overall Study|Withdrawal by Subject|0|||
146221341|NCT03313076|527326223|FG002|Overall Study|Withdrawal by Subject|0|||
146221342|NCT03313076|527326224|FG003|Overall Study|Withdrawal by Subject|0|||
146221343|NCT03313076|527326221|FG000|Overall Study|Lost to Follow-up|0|||
146221344|NCT03313076|527326222|FG001|Overall Study|Lost to Follow-up|2|||
146221345|NCT03313076|527326223|FG002|Overall Study|Lost to Follow-up|2|||
146221346|NCT03313076|527326224|FG003|Overall Study|Lost to Follow-up|2|||
146221347|NCT05869383|527326225|FG000|Overall Study|Withdrawal by Subject|2|||
146221348|NCT05869383|527326226|FG001|Overall Study|Withdrawal by Subject|0|||
146221349|NCT04137367|527326233|FG000|Overall Study|Lost to Follow-up|8|||
146221350|NCT04137367|527326234|FG001|Overall Study|Lost to Follow-up|6|||
146221351|NCT04137367|527326235|FG002|Overall Study|Lost to Follow-up|4|||
146221352|NCT03270501|527326236|FG000|Overall Study|Screen failure|6|||
146221353|NCT03270501|527326236|FG000|Overall Study|Lost to Follow-up|2|||
146221354|NCT03270501|527326236|FG000|Overall Study|Adverse Event|1|||
146221355|NCT04065841|527326239|FG000|Overall Study|Adverse Event|4|||
146221356|NCT04065841|527326240|FG001|Overall Study|Adverse Event|2|||
146221357|NCT04065841|527326241|FG002|Overall Study|Adverse Event|10|||
146221358|NCT04065841|527326242|FG003|Overall Study|Adverse Event|1|||
146221359|NCT04065841|527326239|FG000|Overall Study|Lost to Follow-up|1|||
146221360|NCT04065841|527326240|FG001|Overall Study|Lost to Follow-up|2|||
146221361|NCT04065841|527326241|FG002|Overall Study|Lost to Follow-up|2|||
146221362|NCT04065841|527326242|FG003|Overall Study|Lost to Follow-up|2|||
146221363|NCT04065841|527326239|FG000|Overall Study|Physician Decision|1|||
146221364|NCT04065841|527326240|FG001|Overall Study|Physician Decision|0|||
146221365|NCT04065841|527326241|FG002|Overall Study|Physician Decision|0|||
146221366|NCT04065841|527326242|FG003|Overall Study|Physician Decision|0|||
146221367|NCT04065841|527326239|FG000|Overall Study|Protocol Violation|0|||
146221368|NCT04065841|527326240|FG001|Overall Study|Protocol Violation|1|||
146221369|NCT04065841|527326241|FG002|Overall Study|Protocol Violation|0|||
146221370|NCT04065841|527326242|FG003|Overall Study|Protocol Violation|0|||
146221371|NCT04065841|527326239|FG000|Overall Study|Study terminated by Sponsor|22|||
146221372|NCT04065841|527326240|FG001|Overall Study|Study terminated by Sponsor|16|||
146221373|NCT04065841|527326241|FG002|Overall Study|Study terminated by Sponsor|28|||
146221374|NCT04065841|527326242|FG003|Overall Study|Study terminated by Sponsor|17|||
146221375|NCT04065841|527326239|FG000|Overall Study|Withdrawal by Subject|1|||
146221376|NCT04065841|527326240|FG001|Overall Study|Withdrawal by Subject|1|||
146221377|NCT04065841|527326241|FG002|Overall Study|Withdrawal by Subject|2|||
146221378|NCT04065841|527326242|FG003|Overall Study|Withdrawal by Subject|0|||
146221379|NCT04436276|527326244|FG000|Overall Study|Adverse Event|0|||
146221380|NCT04436276|527326245|FG001|Overall Study|Adverse Event|0|||
146221381|NCT04436276|527326246|FG002|Overall Study|Adverse Event|0|||
146221382|NCT04436276|527326247|FG003|Overall Study|Adverse Event|0|||
146221383|NCT04436276|527326248|FG004|Overall Study|Adverse Event|0|||
146221384|NCT04436276|527326249|FG005|Overall Study|Adverse Event|0|||
146221385|NCT04436276|527326250|FG006|Overall Study|Adverse Event|0|||
146221386|NCT04436276|527326251|FG007|Overall Study|Adverse Event|0|||
146221387|NCT04436276|527326252|FG008|Overall Study|Adverse Event|0|||
146221388|NCT04436276|527326253|FG009|Overall Study|Adverse Event|0|||
146221389|NCT04436276|527326254|FG010|Overall Study|Adverse Event|0|||
146221390|NCT04436276|527326255|FG011|Overall Study|Adverse Event|0|||
146221391|NCT04436276|527326256|FG012|Overall Study|Adverse Event|0|||
146221392|NCT04436276|527326257|FG013|Overall Study|Adverse Event|0|||
146221393|NCT04436276|527326258|FG014|Overall Study|Adverse Event|0|||
146221394|NCT04436276|527326259|FG015|Overall Study|Adverse Event|0|||
146221395|NCT04436276|527326260|FG016|Overall Study|Adverse Event|1|||
146221396|NCT04436276|527326261|FG017|Overall Study|Adverse Event|0|||
146221397|NCT04436276|527326262|FG018|Overall Study|Adverse Event|0|||
146288670|NCT04428151|527571435|FG001|Overall Study|Participant Ongoing in Study|53|||
146288671|NCT04428151|527571436|FG002|Overall Study|Participant Ongoing in Study|28|||
146288672|NCT04976621|527571437|FG000|Overall Study|Lost to Follow-up|2|||
146288673|NCT04976621|527571438|FG001|Overall Study|Lost to Follow-up|2|||
146288674|NCT04976621|527571437|FG000|Overall Study|Withdrawal by Subject|1|||
146288675|NCT04976621|527571438|FG001|Overall Study|Withdrawal by Subject|1|||
146288676|NCT04443153|527571439|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
146288677|NCT04443153|527571440|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
146221398|NCT04436276|527326263|FG019|Overall Study|Adverse Event|0|||
146221399|NCT04436276|527326264|FG020|Overall Study|Adverse Event|0|||
146221400|NCT04436276|527326265|FG021|Overall Study|Adverse Event|0|||
146221401|NCT04436276|527326266|FG022|Overall Study|Adverse Event|0|||
146221402|NCT04436276|527326244|FG000|Overall Study|Death|0|||
146221403|NCT04436276|527326245|FG001|Overall Study|Death|0|||
146221404|NCT04436276|527326246|FG002|Overall Study|Death|0|||
146221405|NCT04436276|527326247|FG003|Overall Study|Death|0|||
146288678|NCT04443153|527571439|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
146221406|NCT04436276|527326248|FG004|Overall Study|Death|0|||
146221407|NCT04436276|527326249|FG005|Overall Study|Death|0|||
146221408|NCT04436276|527326250|FG006|Overall Study|Death|0|||
146221409|NCT04436276|527326251|FG007|Overall Study|Death|0|||
146221410|NCT04436276|527326252|FG008|Overall Study|Death|0|||
146221411|NCT04436276|527326253|FG009|Overall Study|Death|0|||
146221412|NCT04436276|527326254|FG010|Overall Study|Death|0|||
146221413|NCT04436276|527326255|FG011|Overall Study|Death|0|||
146221414|NCT04436276|527326256|FG012|Overall Study|Death|1|||
146221415|NCT04436276|527326257|FG013|Overall Study|Death|0|||
146221416|NCT04436276|527326258|FG014|Overall Study|Death|1|||
146221417|NCT04436276|527326259|FG015|Overall Study|Death|0|||
146221418|NCT04436276|527326260|FG016|Overall Study|Death|0|||
146221419|NCT04436276|527326261|FG017|Overall Study|Death|0|||
146221420|NCT04436276|527326262|FG018|Overall Study|Death|0|||
146221421|NCT04436276|527326263|FG019|Overall Study|Death|2|||
146221422|NCT04436276|527326264|FG020|Overall Study|Death|0|||
145882414|NCT00642811|526074804|FG002|Overall Study|Severe Non-compliance to protocol|0|||
145882415|NCT00642811|526074805|FG003|Overall Study|Severe Non-compliance to protocol|0|||
145882416|NCT00642811|526074806|FG004|Overall Study|Severe Non-compliance to protocol|0|||
145882417|NCT00642811|526074807|FG005|Overall Study|Severe Non-compliance to protocol|0|||
145882418|NCT00642811|526074802|FG000|Overall Study|Other|0|||
145882419|NCT00642811|526074803|FG001|Overall Study|Other|1|||
145882420|NCT00642811|526074804|FG002|Overall Study|Other|0|||
145882421|NCT00642811|526074805|FG003|Overall Study|Other|1|||
145882422|NCT00642811|526074806|FG004|Overall Study|Other|0|||
145882423|NCT00642811|526074807|FG005|Overall Study|Other|0|||
146085059|NCT00713310|526832058|FG000|Overall Study|Withdrawal by Subject|0|||
146085060|NCT00713310|526832059|FG001|Overall Study|Withdrawal by Subject|2|||
146221423|NCT04436276|527326265|FG021|Overall Study|Death|1|||
146221424|NCT04436276|527326266|FG022|Overall Study|Death|0|||
146221425|NCT04436276|527326244|FG000|Overall Study|Lost to Follow-up|0|||
146221426|NCT04436276|527326245|FG001|Overall Study|Lost to Follow-up|2|||
146221427|NCT04436276|527326246|FG002|Overall Study|Lost to Follow-up|2|||
146221428|NCT04436276|527326247|FG003|Overall Study|Lost to Follow-up|1|||
146221429|NCT04436276|527326248|FG004|Overall Study|Lost to Follow-up|4|||
146221430|NCT04436276|527326249|FG005|Overall Study|Lost to Follow-up|1|||
146221431|NCT04436276|527326250|FG006|Overall Study|Lost to Follow-up|0|||
146221432|NCT04436276|527326251|FG007|Overall Study|Lost to Follow-up|0|||
146221433|NCT04436276|527326252|FG008|Overall Study|Lost to Follow-up|1|||
146221434|NCT04436276|527326253|FG009|Overall Study|Lost to Follow-up|0|||
146221435|NCT04436276|527326254|FG010|Overall Study|Lost to Follow-up|5|||
146221436|NCT04436276|527326255|FG011|Overall Study|Lost to Follow-up|5|||
146221437|NCT04436276|527326256|FG012|Overall Study|Lost to Follow-up|4|||
146221438|NCT04436276|527326257|FG013|Overall Study|Lost to Follow-up|1|||
146221439|NCT04436276|527326258|FG014|Overall Study|Lost to Follow-up|7|||
146221440|NCT04436276|527326259|FG015|Overall Study|Lost to Follow-up|7|||
146221441|NCT04436276|527326260|FG016|Overall Study|Lost to Follow-up|1|||
146221442|NCT04436276|527326261|FG017|Overall Study|Lost to Follow-up|0|||
146221443|NCT04436276|527326262|FG018|Overall Study|Lost to Follow-up|1|||
146221444|NCT04436276|527326263|FG019|Overall Study|Lost to Follow-up|1|||
146221445|NCT04436276|527326264|FG020|Overall Study|Lost to Follow-up|2|||
146221446|NCT04436276|527326265|FG021|Overall Study|Lost to Follow-up|1|||
146221447|NCT04436276|527326266|FG022|Overall Study|Lost to Follow-up|1|||
146221448|NCT04436276|527326244|FG000|Overall Study|Physician Decision|1|||
146221449|NCT04436276|527326245|FG001|Overall Study|Physician Decision|0|||
146221450|NCT04436276|527326246|FG002|Overall Study|Physician Decision|2|||
146221451|NCT04436276|527326247|FG003|Overall Study|Physician Decision|1|||
146221452|NCT04436276|527326248|FG004|Overall Study|Physician Decision|0|||
146221453|NCT04436276|527326249|FG005|Overall Study|Physician Decision|0|||
146221454|NCT04436276|527326250|FG006|Overall Study|Physician Decision|0|||
146221455|NCT04436276|527326251|FG007|Overall Study|Physician Decision|0|||
146221456|NCT04436276|527326252|FG008|Overall Study|Physician Decision|0|||
146221457|NCT04436276|527326253|FG009|Overall Study|Physician Decision|0|||
146221458|NCT04436276|527326254|FG010|Overall Study|Physician Decision|0|||
146085061|NCT05508074|526832060|FG000|Overall Study|Death|2|||
146221459|NCT04436276|527326255|FG011|Overall Study|Physician Decision|1|||
146221460|NCT04436276|527326256|FG012|Overall Study|Physician Decision|2|||
146221461|NCT04436276|527326257|FG013|Overall Study|Physician Decision|0|||
146221462|NCT04436276|527326258|FG014|Overall Study|Physician Decision|0|||
146221463|NCT04436276|527326259|FG015|Overall Study|Physician Decision|0|||
146221464|NCT04436276|527326260|FG016|Overall Study|Physician Decision|0|||
146221465|NCT04436276|527326261|FG017|Overall Study|Physician Decision|0|||
146085062|NCT05508074|526832061|FG001|Overall Study|Death|5|||
146221466|NCT04436276|527326262|FG018|Overall Study|Physician Decision|0|||
146221467|NCT04436276|527326263|FG019|Overall Study|Physician Decision|0|||
146221468|NCT04436276|527326264|FG020|Overall Study|Physician Decision|1|||
146221469|NCT04436276|527326265|FG021|Overall Study|Physician Decision|2|||
146221470|NCT04436276|527326266|FG022|Overall Study|Physician Decision|0|||
146221471|NCT04436276|527326244|FG000|Overall Study|Protocol Violation|0|||
145882424|NCT04553406|526074810|FG000|Overall Study|Study Discontinuation|0|||
145882425|NCT04553406|526074811|FG001|Overall Study|Study Discontinuation|1|||
145882426|NCT00772148|526074812|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
146221472|NCT04436276|527326245|FG001|Overall Study|Protocol Violation|0|||
146221473|NCT04436276|527326246|FG002|Overall Study|Protocol Violation|0|||
146221474|NCT04436276|527326247|FG003|Overall Study|Protocol Violation|0|||
146221475|NCT04436276|527326248|FG004|Overall Study|Protocol Violation|0|||
146221476|NCT04436276|527326249|FG005|Overall Study|Protocol Violation|0|||
146221477|NCT04436276|527326250|FG006|Overall Study|Protocol Violation|0|||
146221478|NCT04436276|527326251|FG007|Overall Study|Protocol Violation|0|||
146221479|NCT04436276|527326252|FG008|Overall Study|Protocol Violation|0|||
146221480|NCT04436276|527326253|FG009|Overall Study|Protocol Violation|0|||
146221481|NCT04436276|527326254|FG010|Overall Study|Protocol Violation|0|||
146221482|NCT04436276|527326255|FG011|Overall Study|Protocol Violation|0|||
146221483|NCT04436276|527326256|FG012|Overall Study|Protocol Violation|0|||
146221484|NCT04436276|527326257|FG013|Overall Study|Protocol Violation|1|||
146221485|NCT04436276|527326258|FG014|Overall Study|Protocol Violation|0|||
146221486|NCT04436276|527326259|FG015|Overall Study|Protocol Violation|1|||
146221487|NCT04436276|527326260|FG016|Overall Study|Protocol Violation|0|||
146221488|NCT04436276|527326261|FG017|Overall Study|Protocol Violation|0|||
146221489|NCT04436276|527326262|FG018|Overall Study|Protocol Violation|0|||
146221490|NCT04436276|527326263|FG019|Overall Study|Protocol Violation|0|||
146221491|NCT04436276|527326264|FG020|Overall Study|Protocol Violation|0|||
146221492|NCT04436276|527326265|FG021|Overall Study|Protocol Violation|0|||
146221493|NCT04436276|527326266|FG022|Overall Study|Protocol Violation|0|||
146221494|NCT04436276|527326244|FG000|Overall Study|Withdrawal by Subject|25|||
146221495|NCT04436276|527326245|FG001|Overall Study|Withdrawal by Subject|22|||
146221496|NCT04436276|527326246|FG002|Overall Study|Withdrawal by Subject|24|||
146221497|NCT04436276|527326247|FG003|Overall Study|Withdrawal by Subject|23|||
146221498|NCT04436276|527326248|FG004|Overall Study|Withdrawal by Subject|14|||
146221499|NCT04436276|527326249|FG005|Overall Study|Withdrawal by Subject|0|||
146221500|NCT04436276|527326250|FG006|Overall Study|Withdrawal by Subject|0|||
146221501|NCT04436276|527326251|FG007|Overall Study|Withdrawal by Subject|1|||
146221502|NCT04436276|527326252|FG008|Overall Study|Withdrawal by Subject|0|||
146221503|NCT04436276|527326253|FG009|Overall Study|Withdrawal by Subject|1|||
146221504|NCT04436276|527326254|FG010|Overall Study|Withdrawal by Subject|17|||
146221505|NCT04436276|527326255|FG011|Overall Study|Withdrawal by Subject|7|||
146221506|NCT04436276|527326256|FG012|Overall Study|Withdrawal by Subject|10|||
146221507|NCT04436276|527326257|FG013|Overall Study|Withdrawal by Subject|6|||
146221508|NCT04436276|527326258|FG014|Overall Study|Withdrawal by Subject|20|||
146221509|NCT04436276|527326259|FG015|Overall Study|Withdrawal by Subject|6|||
146221510|NCT04436276|527326260|FG016|Overall Study|Withdrawal by Subject|11|||
146221511|NCT04436276|527326261|FG017|Overall Study|Withdrawal by Subject|4|||
146221512|NCT04436276|527326262|FG018|Overall Study|Withdrawal by Subject|14|||
146221513|NCT04436276|527326263|FG019|Overall Study|Withdrawal by Subject|24|||
146221514|NCT04436276|527326264|FG020|Overall Study|Withdrawal by Subject|24|||
146221515|NCT04436276|527326265|FG021|Overall Study|Withdrawal by Subject|16|||
146221516|NCT04436276|527326266|FG022|Overall Study|Withdrawal by Subject|14|||
146221517|NCT04436276|527326244|FG000|Overall Study|Other|3|||
146221518|NCT04436276|527326245|FG001|Overall Study|Other|2|||
146221519|NCT04436276|527326246|FG002|Overall Study|Other|5|||
146221520|NCT04436276|527326247|FG003|Overall Study|Other|9|||
146221521|NCT04436276|527326248|FG004|Overall Study|Other|23|||
146221522|NCT04436276|527326249|FG005|Overall Study|Other|1|||
146221523|NCT04436276|527326250|FG006|Overall Study|Other|0|||
146221524|NCT04436276|527326251|FG007|Overall Study|Other|0|||
146221525|NCT04436276|527326252|FG008|Overall Study|Other|0|||
146221526|NCT04436276|527326253|FG009|Overall Study|Other|0|||
146221527|NCT04436276|527326254|FG010|Overall Study|Other|3|||
146221528|NCT04436276|527326255|FG011|Overall Study|Other|1|||
146221529|NCT04436276|527326256|FG012|Overall Study|Other|1|||
146221530|NCT04436276|527326257|FG013|Overall Study|Other|2|||
146221531|NCT04436276|527326258|FG014|Overall Study|Other|3|||
146221532|NCT04436276|527326259|FG015|Overall Study|Other|0|||
146221533|NCT04436276|527326260|FG016|Overall Study|Other|0|||
146221534|NCT04436276|527326261|FG017|Overall Study|Other|6|||
146221535|NCT04436276|527326262|FG018|Overall Study|Other|1|||
146221536|NCT04436276|527326263|FG019|Overall Study|Other|0|||
146221537|NCT04436276|527326264|FG020|Overall Study|Other|2|||
146221538|NCT04436276|527326265|FG021|Overall Study|Other|2|||
146221539|NCT04436276|527326266|FG022|Overall Study|Other|60|||
146221540|NCT00324805|527326267|FG000|Overall Study|Adverse Event|62|||
146221541|NCT00324805|527326268|FG001|Overall Study|Adverse Event|203|||
146221542|NCT00324805|527326267|FG000|Overall Study|Progression|7|||
146221543|NCT00324805|527326268|FG001|Overall Study|Progression|35|||
146085063|NCT05508074|526832060|FG000|Overall Study|Withdrawal by Subject|1|||
146085064|NCT05508074|526832061|FG001|Overall Study|Withdrawal by Subject|2|||
146085065|NCT05508074|526832060|FG000|Overall Study|Adverse Event|0|||
146085066|NCT05508074|526832061|FG001|Overall Study|Adverse Event|1|||
146221544|NCT00324805|527326267|FG000|Overall Study|Withdrawal by Subject|51|||
146221545|NCT00324805|527326268|FG001|Overall Study|Withdrawal by Subject|174|||
146221546|NCT00324805|527326267|FG000|Overall Study|Death|6|||
146221547|NCT00324805|527326268|FG001|Overall Study|Death|9|||
146221548|NCT00324805|527326267|FG000|Overall Study|Alternative therapy|4|||
146221549|NCT00324805|527326268|FG001|Overall Study|Alternative therapy|8|||
146221550|NCT00324805|527326267|FG000|Overall Study|Other complicating disease|1|||
146221551|NCT00324805|527326268|FG001|Overall Study|Other complicating disease|9|||
146221552|NCT00324805|527326267|FG000|Overall Study|Other reasons|7|||
146221553|NCT00324805|527326268|FG001|Overall Study|Other reasons|26|||
146221554|NCT00324805|527326267|FG000|Overall Study|Other|0|||
146221555|NCT00324805|527326268|FG001|Overall Study|Other|2|||
146221556|NCT00324805|527326267|FG000|Overall Study|Did not start therapy|12|||
146221557|NCT00324805|527326268|FG001|Overall Study|Did not start therapy|17|||
145961047|NCT03286218|526369471|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961048|NCT03286218|526369472|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961049|NCT03286218|526369473|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961050|NCT03286218|526369474|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961051|NCT03286218|526369475|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145961052|NCT03286218|526369464|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
146221558|NCT03931174|527326270|FG000|Providers|Staff left organization|26|||
146221559|NCT03931174|527326271|FG001|Providers|Staff left organization|25|||
146221560|NCT03931174|527326270|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
146221561|NCT03931174|527326271|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
146221562|NCT03931174|527326270|FG000|Providers|Lost to Follow-up|4|||
146221563|NCT03931174|527326271|FG001|Providers|Lost to Follow-up|4|||
146221564|NCT03931174|527326270|FG000|Patients|Post-consent screening failure|1|||
146221565|NCT03931174|527326271|FG001|Patients|Post-consent screening failure|1|||
146221566|NCT03931174|527326270|FG000|Patients|Death|1|||
146221567|NCT03931174|527326271|FG001|Patients|Death|1|||
146221568|NCT03931174|527326270|FG000|Patients|Lost to Follow-up|60|||
146221569|NCT03931174|527326271|FG001|Patients|Lost to Follow-up|89|||
146221570|NCT03322267|527326272|FG000|Overall Study|Lack of Efficacy|11|||
146221571|NCT03322267|527326272|FG000|Overall Study|Adverse Event|1|||
146221572|NCT03322267|527326272|FG000|Overall Study|Withdrawal by Subject|2|||
146221573|NCT05792085|527326273|FG000|Overall Study|Death|0|||
146221574|NCT05792085|527326274|FG001|Overall Study|Death|0|||
146221575|NCT05792085|527326275|FG002|Overall Study|Death|0|||
146221576|NCT05792085|527326276|FG003|Overall Study|Death|0|||
146221577|NCT05792085|527326277|FG004|Overall Study|Death|1|||
146221578|NCT05228457|527326280|FG000|Overall Study|Withdrawal by Subject|1|||
146221579|NCT05228457|527326281|FG001|Overall Study|Withdrawal by Subject|1|||
146221580|NCT03492216|527326288|FG000|Overall Study|Death|1|||
146221581|NCT03492216|527326289|FG001|Overall Study|Death|0|||
146221582|NCT03492216|527326290|FG002|Overall Study|Death|4|||
146221583|NCT03492216|527326291|FG003|Overall Study|Death|0|||
146221584|NCT03492216|527326288|FG000|Overall Study|Withdrawal by Subject|5|||
146221585|NCT03492216|527326289|FG001|Overall Study|Withdrawal by Subject|3|||
146221586|NCT03492216|527326290|FG002|Overall Study|Withdrawal by Subject|1|||
146221587|NCT03492216|527326291|FG003|Overall Study|Withdrawal by Subject|1|||
146221588|NCT03492216|527326288|FG000|Overall Study|Lost to Follow-up|9|||
146221589|NCT03492216|527326289|FG001|Overall Study|Lost to Follow-up|2|||
146221590|NCT03492216|527326290|FG002|Overall Study|Lost to Follow-up|7|||
146221591|NCT03492216|527326291|FG003|Overall Study|Lost to Follow-up|8|||
146221592|NCT03492216|527326288|FG000|Overall Study|Moved|5|||
146221593|NCT03492216|527326289|FG001|Overall Study|Moved|3|||
146221594|NCT03492216|527326290|FG002|Overall Study|Moved|3|||
146221595|NCT03492216|527326291|FG003|Overall Study|Moved|5|||
146221596|NCT03492216|527326288|FG000|Overall Study|Too ill|0|||
146221597|NCT03492216|527326289|FG001|Overall Study|Too ill|1|||
146221598|NCT03492216|527326290|FG002|Overall Study|Too ill|0|||
146221599|NCT03492216|527326291|FG003|Overall Study|Too ill|0|||
146221600|NCT03492216|527326288|FG000|Overall Study|Incarcerated|0|||
146221601|NCT03492216|527326289|FG001|Overall Study|Incarcerated|0|||
146221602|NCT03492216|527326290|FG002|Overall Study|Incarcerated|2|||
146221603|NCT03492216|527326291|FG003|Overall Study|Incarcerated|0|||
146221604|NCT04797897|527326292|FG000|Overall Study|Study Termination by Sponsor|1|||
146221605|NCT04797897|527326293|FG001|Overall Study|Study Termination by Sponsor|1|||
146221606|NCT03774082|527326295|FG000|Overall Study|Death|6|||
146221607|NCT03774082|527326296|FG001|Overall Study|Death|3|||
146221608|NCT03774082|527326297|FG002|Overall Study|Death|2|||
145961053|NCT03286218|526369465|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
145961054|NCT03286218|526369466|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
145961055|NCT03286218|526369467|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
145961056|NCT03286218|526369468|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
146221609|NCT03774082|527326295|FG000|Overall Study|Subject decision|0|||
146221610|NCT03774082|527326296|FG001|Overall Study|Subject decision|3|||
146221611|NCT03774082|527326297|FG002|Overall Study|Subject decision|0|||
146221612|NCT03774082|527326295|FG000|Overall Study|Lost to Follow-up|2|||
146221613|NCT03774082|527326296|FG001|Overall Study|Lost to Follow-up|0|||
146221614|NCT03774082|527326297|FG002|Overall Study|Lost to Follow-up|0|||
146221615|NCT03774082|527326295|FG000|Overall Study|Guardian decision|0|||
146221616|NCT03774082|527326296|FG001|Overall Study|Guardian decision|0|||
146221617|NCT03774082|527326297|FG002|Overall Study|Guardian decision|1|||
146221618|NCT03774082|527326295|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
146221619|NCT03774082|527326296|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
146221620|NCT03774082|527326297|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
146221621|NCT05030233|527326298|FG000|Overall Study|withdrawn for transfer|1|||
146221622|NCT05030233|527326299|FG001|Overall Study|withdrawn for transfer|0|||
146221623|NCT04437615|527326300|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
146221624|NCT04728347|527327960|FG000|Overall Study|Sponsor decision|0|||
146221625|NCT04728347|527327961|FG001|Overall Study|Sponsor decision|0|||
146221626|NCT04728347|527327962|FG002|Overall Study|Sponsor decision|1|||
146221627|NCT04728347|527327963|FG003|Overall Study|Sponsor decision|0|||
146221628|NCT01186367|527327964|FG000|Overall Study|Lost to Follow-up|7|||
146221629|NCT01186367|527327965|FG001|Overall Study|Lost to Follow-up|4|||
146221630|NCT01186367|527327966|FG002|Overall Study|Lost to Follow-up|7|||
146221631|NCT01186367|527327964|FG000|Overall Study|Did not receive study treatment|0|||
146221632|NCT01186367|527327965|FG001|Overall Study|Did not receive study treatment|1|||
146221633|NCT01186367|527327966|FG002|Overall Study|Did not receive study treatment|0|||
146221634|NCT03867500|527327967|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
146221635|NCT01098812|527327968|FG000|Overall Study|Death|2|||
146221636|NCT01098812|527327969|FG001|Overall Study|Death|0|||
146221637|NCT01098812|527327970|FG002|Overall Study|Death|1|||
146221638|NCT01098812|527327968|FG000|Overall Study|Lost to Follow-up|0|||
146221639|NCT01098812|527327969|FG001|Overall Study|Lost to Follow-up|1|||
146221640|NCT01098812|527327970|FG002|Overall Study|Lost to Follow-up|0|||
146221641|NCT04149704|527327986|FG000|Three Month Follow-up|Death|2|||
146221642|NCT04149704|527327987|FG001|Three Month Follow-up|Death|0|||
146221643|NCT04149704|527327988|FG002|Three Month Follow-up|Death|0|||
146221644|NCT04149704|527327989|FG003|Three Month Follow-up|Death|0|||
146221645|NCT04149704|527327986|FG000|Three Month Follow-up|Lost to Follow-up|1|||
146221646|NCT04149704|527327987|FG001|Three Month Follow-up|Lost to Follow-up|4|||
146221647|NCT04149704|527327988|FG002|Three Month Follow-up|Lost to Follow-up|5|||
146221648|NCT04149704|527327989|FG003|Three Month Follow-up|Lost to Follow-up|5|||
146221649|NCT04149704|527327986|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
146221650|NCT04149704|527327987|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
146221651|NCT04149704|527327988|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
146221652|NCT04149704|527327989|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
146221653|NCT04149704|527327986|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
146221654|NCT04149704|527327987|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
146221655|NCT04149704|527327988|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
146221656|NCT04149704|527327989|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
146221657|NCT04632992|527327996|FG000|Overall Study|Adverse Event|0|||
146221658|NCT04632992|527327997|FG001|Overall Study|Adverse Event|0|||
146221659|NCT04632992|527327998|FG002|Overall Study|Adverse Event|0|||
146221660|NCT04632992|527327999|FG003|Overall Study|Adverse Event|0|||
146221661|NCT04632992|527328000|FG004|Overall Study|Adverse Event|0|||
146221662|NCT04632992|527328001|FG005|Overall Study|Adverse Event|0|||
146221663|NCT04632992|527328002|FG006|Overall Study|Adverse Event|0|||
146221664|NCT04632992|527328003|FG007|Overall Study|Adverse Event|0|||
146221665|NCT04632992|527328004|FG008|Overall Study|Adverse Event|0|||
146221666|NCT04632992|527328005|FG009|Overall Study|Adverse Event|0|||
146221667|NCT04632992|527328006|FG010|Overall Study|Adverse Event|0|||
146221668|NCT04632992|527328007|FG011|Overall Study|Adverse Event|0|||
146221669|NCT04632992|527328008|FG012|Overall Study|Adverse Event|1|||
146221670|NCT04632992|527328009|FG013|Overall Study|Adverse Event|0|||
146221671|NCT04632992|527327996|FG000|Overall Study|Death|17|||
146221672|NCT04632992|527327997|FG001|Overall Study|Death|1|||
146221673|NCT04632992|527327998|FG002|Overall Study|Death|14|||
146221674|NCT04632992|527327999|FG003|Overall Study|Death|14|||
146221675|NCT04632992|527328000|FG004|Overall Study|Death|13|||
146221676|NCT04632992|527328001|FG005|Overall Study|Death|6|||
146221677|NCT04632992|527328002|FG006|Overall Study|Death|7|||
146221678|NCT04632992|527328003|FG007|Overall Study|Death|12|||
146221679|NCT04632992|527328004|FG008|Overall Study|Death|15|||
146221680|NCT04632992|527328005|FG009|Overall Study|Death|20|||
146221681|NCT04632992|527328006|FG010|Overall Study|Death|8|||
146221682|NCT04632992|527328007|FG011|Overall Study|Death|2|||
146221683|NCT04632992|527328008|FG012|Overall Study|Death|10|||
146221684|NCT04632992|527328009|FG013|Overall Study|Death|1|||
146221685|NCT04632992|527327996|FG000|Overall Study|Lost to Follow-up|1|||
146221686|NCT04632992|527327997|FG001|Overall Study|Lost to Follow-up|0|||
146221687|NCT04632992|527327998|FG002|Overall Study|Lost to Follow-up|1|||
146221688|NCT04632992|527327999|FG003|Overall Study|Lost to Follow-up|0|||
146221689|NCT04632992|527328000|FG004|Overall Study|Lost to Follow-up|2|||
145882427|NCT00772148|526074813|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
145882428|NCT00772148|526074812|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
145882429|NCT00772148|526074813|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
145882430|NCT00772148|526074812|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
145882431|NCT00772148|526074813|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
145882432|NCT00772148|526074812|FG000|Maintenance Phase (Week 52)|Death|2|||
145882433|NCT00772148|526074813|FG001|Maintenance Phase (Week 52)|Death|2|||
145882434|NCT00772148|526074812|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
145882435|NCT00772148|526074813|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
145882436|NCT00772148|526074812|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
146221690|NCT04632992|527328001|FG005|Overall Study|Lost to Follow-up|0|||
146221691|NCT04632992|527328002|FG006|Overall Study|Lost to Follow-up|1|||
146221692|NCT04632992|527328003|FG007|Overall Study|Lost to Follow-up|1|||
146221693|NCT04632992|527328004|FG008|Overall Study|Lost to Follow-up|1|||
146221694|NCT04632992|527328005|FG009|Overall Study|Lost to Follow-up|1|||
146221695|NCT04632992|527328006|FG010|Overall Study|Lost to Follow-up|2|||
146221696|NCT04632992|527328007|FG011|Overall Study|Lost to Follow-up|0|||
146221697|NCT04632992|527328008|FG012|Overall Study|Lost to Follow-up|0|||
146221698|NCT04632992|527328009|FG013|Overall Study|Lost to Follow-up|0|||
146221699|NCT04632992|527327996|FG000|Overall Study|Reason not Specified|2|||
146221700|NCT04632992|527327997|FG001|Overall Study|Reason not Specified|0|||
146221701|NCT04632992|527327998|FG002|Overall Study|Reason not Specified|1|||
146221702|NCT04632992|527327999|FG003|Overall Study|Reason not Specified|1|||
146221703|NCT04632992|527328000|FG004|Overall Study|Reason not Specified|0|||
146221704|NCT04632992|527328001|FG005|Overall Study|Reason not Specified|0|||
146221705|NCT04632992|527328002|FG006|Overall Study|Reason not Specified|0|||
146221706|NCT04632992|527328003|FG007|Overall Study|Reason not Specified|0|||
146221707|NCT04632992|527328004|FG008|Overall Study|Reason not Specified|0|||
146221708|NCT04632992|527328005|FG009|Overall Study|Reason not Specified|0|||
146221709|NCT04632992|527328006|FG010|Overall Study|Reason not Specified|1|||
146221710|NCT04632992|527328007|FG011|Overall Study|Reason not Specified|0|||
146221711|NCT04632992|527328008|FG012|Overall Study|Reason not Specified|0|||
146221712|NCT04632992|527328009|FG013|Overall Study|Reason not Specified|0|||
146221713|NCT04632992|527327996|FG000|Overall Study|Physician Decision|0|||
145882437|NCT00772148|526074813|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
145882438|NCT00772148|526074812|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
145882439|NCT00772148|526074813|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
145882440|NCT01525628|526074816|FG000|Overall Study|Adverse Event|1|||
146221714|NCT04632992|527327997|FG001|Overall Study|Physician Decision|0|||
146221715|NCT04632992|527327998|FG002|Overall Study|Physician Decision|0|||
146221716|NCT04632992|527327999|FG003|Overall Study|Physician Decision|2|||
146221717|NCT04632992|527328000|FG004|Overall Study|Physician Decision|1|||
146221718|NCT04632992|527328001|FG005|Overall Study|Physician Decision|0|||
146221719|NCT04632992|527328002|FG006|Overall Study|Physician Decision|0|||
146221720|NCT04632992|527328003|FG007|Overall Study|Physician Decision|0|||
146221721|NCT04632992|527328004|FG008|Overall Study|Physician Decision|0|||
146221722|NCT04632992|527328005|FG009|Overall Study|Physician Decision|0|||
146221723|NCT04632992|527328006|FG010|Overall Study|Physician Decision|0|||
146221724|NCT04632992|527328007|FG011|Overall Study|Physician Decision|0|||
146221725|NCT04632992|527328008|FG012|Overall Study|Physician Decision|3|||
146221726|NCT04632992|527328009|FG013|Overall Study|Physician Decision|0|||
146221727|NCT04632992|527327996|FG000|Overall Study|Progressive Disease|0|||
146221728|NCT04632992|527327997|FG001|Overall Study|Progressive Disease|0|||
146221729|NCT04632992|527327998|FG002|Overall Study|Progressive Disease|0|||
146221730|NCT04632992|527327999|FG003|Overall Study|Progressive Disease|0|||
146221731|NCT04632992|527328000|FG004|Overall Study|Progressive Disease|1|||
146221732|NCT04632992|527328001|FG005|Overall Study|Progressive Disease|0|||
146221733|NCT04632992|527328002|FG006|Overall Study|Progressive Disease|0|||
146221734|NCT04632992|527328003|FG007|Overall Study|Progressive Disease|0|||
146221735|NCT04632992|527328004|FG008|Overall Study|Progressive Disease|0|||
146221736|NCT04632992|527328005|FG009|Overall Study|Progressive Disease|1|||
146221737|NCT04632992|527328006|FG010|Overall Study|Progressive Disease|1|||
145882441|NCT01525628|526074817|FG001|Overall Study|Adverse Event|1|||
145882442|NCT01525628|526074818|FG002|Overall Study|Adverse Event|2|||
145882443|NCT01525628|526074819|FG003|Overall Study|Adverse Event|0|||
145882444|NCT01525628|526074820|FG004|Overall Study|Adverse Event|1|||
145882445|NCT01525628|526074816|FG000|Overall Study|Lack of Efficacy|0|||
145882446|NCT01525628|526074817|FG001|Overall Study|Lack of Efficacy|2|||
145882447|NCT01525628|526074818|FG002|Overall Study|Lack of Efficacy|2|||
146221738|NCT04632992|527328007|FG011|Overall Study|Progressive Disease|0|||
146221739|NCT04632992|527328008|FG012|Overall Study|Progressive Disease|2|||
146221740|NCT04632992|527328009|FG013|Overall Study|Progressive Disease|0|||
146221741|NCT04632992|527327996|FG000|Overall Study|Withdrawal by Subject|4|||
145882448|NCT01525628|526074819|FG003|Overall Study|Lack of Efficacy|1|||
145882449|NCT01525628|526074820|FG004|Overall Study|Lack of Efficacy|2|||
146221742|NCT04632992|527327997|FG001|Overall Study|Withdrawal by Subject|1|||
146221743|NCT04632992|527327998|FG002|Overall Study|Withdrawal by Subject|5|||
146221744|NCT04632992|527327999|FG003|Overall Study|Withdrawal by Subject|4|||
146221745|NCT04632992|527328000|FG004|Overall Study|Withdrawal by Subject|3|||
146221746|NCT04632992|527328001|FG005|Overall Study|Withdrawal by Subject|3|||
146221747|NCT04632992|527328002|FG006|Overall Study|Withdrawal by Subject|0|||
146221748|NCT04632992|527328003|FG007|Overall Study|Withdrawal by Subject|5|||
146221749|NCT04632992|527328004|FG008|Overall Study|Withdrawal by Subject|0|||
146221750|NCT04632992|527328005|FG009|Overall Study|Withdrawal by Subject|2|||
146221751|NCT04632992|527328006|FG010|Overall Study|Withdrawal by Subject|8|||
146221752|NCT04632992|527328007|FG011|Overall Study|Withdrawal by Subject|0|||
145882450|NCT01525628|526074816|FG000|Overall Study|Protocol Violation|0|||
146221753|NCT04632992|527328008|FG012|Overall Study|Withdrawal by Subject|1|||
146221754|NCT04632992|527328009|FG013|Overall Study|Withdrawal by Subject|1|||
146221755|NCT02268253|527328010|FG000|Stage 1|Withdrawal by Subject|1|||
146221756|NCT02268253|527328011|FG001|Stage 1|Withdrawal by Subject|0|||
146221757|NCT02268253|527328012|FG002|Stage 1|Withdrawal by Subject|0|||
146221758|NCT02268253|527328013|FG003|Stage 1|Withdrawal by Subject|0|||
146221759|NCT02268253|527328014|FG004|Stage 1|Withdrawal by Subject|0|||
146221760|NCT02268253|527328015|FG005|Stage 1|Withdrawal by Subject|0|||
146221761|NCT02268253|527328016|FG006|Stage 1|Withdrawal by Subject|0|||
146221762|NCT02268253|527328010|FG000|Stage 1|Death|0|||
146221763|NCT02268253|527328011|FG001|Stage 1|Death|2|||
146221764|NCT02268253|527328012|FG002|Stage 1|Death|2|||
146221765|NCT02268253|527328013|FG003|Stage 1|Death|2|||
146221766|NCT02268253|527328014|FG004|Stage 1|Death|1|||
146221767|NCT02268253|527328015|FG005|Stage 1|Death|1|||
146221768|NCT02268253|527328016|FG006|Stage 1|Death|0|||
146221769|NCT02268253|527328010|FG000|Stage 2|Disease Recurrence/ Progression|0|||
146221770|NCT02268253|527328011|FG001|Stage 2|Disease Recurrence/ Progression|0|||
146221771|NCT02268253|527328012|FG002|Stage 2|Disease Recurrence/ Progression|1|||
146221772|NCT02268253|527328013|FG003|Stage 2|Disease Recurrence/ Progression|0|||
146221773|NCT02268253|527328014|FG004|Stage 2|Disease Recurrence/ Progression|0|||
146221774|NCT02268253|527328015|FG005|Stage 2|Disease Recurrence/ Progression|0|||
146221775|NCT02268253|527328016|FG006|Stage 2|Disease Recurrence/ Progression|0|||
146221776|NCT02268253|527328010|FG000|Stage 2|Withdrawal by Subject|0|||
146221777|NCT02268253|527328011|FG001|Stage 2|Withdrawal by Subject|0|||
146221778|NCT02268253|527328012|FG002|Stage 2|Withdrawal by Subject|2|||
146221779|NCT02268253|527328013|FG003|Stage 2|Withdrawal by Subject|0|||
146221780|NCT02268253|527328014|FG004|Stage 2|Withdrawal by Subject|0|||
146221781|NCT02268253|527328015|FG005|Stage 2|Withdrawal by Subject|2|||
146221782|NCT02268253|527328016|FG006|Stage 2|Withdrawal by Subject|0|||
146221783|NCT02268253|527328010|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146221784|NCT02268253|527328011|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146221785|NCT02268253|527328012|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
146221786|NCT02268253|527328013|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146221787|NCT02268253|527328014|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146221788|NCT02268253|527328015|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
146221789|NCT02268253|527328016|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
146221790|NCT02268253|527328010|FG000|Stage 2|Death|0|||
146221791|NCT02268253|527328011|FG001|Stage 2|Death|0|||
146221792|NCT02268253|527328012|FG002|Stage 2|Death|19|||
146221793|NCT02268253|527328013|FG003|Stage 2|Death|0|||
146221794|NCT02268253|527328014|FG004|Stage 2|Death|0|||
146221795|NCT02268253|527328015|FG005|Stage 2|Death|20|||
146221796|NCT02268253|527328016|FG006|Stage 2|Death|1|||
146221797|NCT02268253|527328010|FG000|Stage 2|Lost to Follow-up|0|||
146221798|NCT02268253|527328011|FG001|Stage 2|Lost to Follow-up|0|||
146221799|NCT02268253|527328012|FG002|Stage 2|Lost to Follow-up|0|||
146221800|NCT02268253|527328013|FG003|Stage 2|Lost to Follow-up|0|||
146221801|NCT02268253|527328014|FG004|Stage 2|Lost to Follow-up|0|||
146221802|NCT02268253|527328015|FG005|Stage 2|Lost to Follow-up|4|||
146221803|NCT02268253|527328016|FG006|Stage 2|Lost to Follow-up|0|||
146221804|NCT02268253|527328010|FG000|Stage 2|Transferred to Hospice|0|||
146221805|NCT02268253|527328011|FG001|Stage 2|Transferred to Hospice|0|||
146221806|NCT02268253|527328012|FG002|Stage 2|Transferred to Hospice|0|||
146221807|NCT02268253|527328013|FG003|Stage 2|Transferred to Hospice|0|||
146221808|NCT02268253|527328014|FG004|Stage 2|Transferred to Hospice|0|||
146221809|NCT02268253|527328015|FG005|Stage 2|Transferred to Hospice|2|||
146221810|NCT02268253|527328016|FG006|Stage 2|Transferred to Hospice|0|||
146221811|NCT02268253|527328010|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
146221812|NCT02268253|527328011|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
146221813|NCT02268253|527328012|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
146221814|NCT02268253|527328013|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
146221815|NCT02268253|527328014|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
146221816|NCT02268253|527328015|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
146221817|NCT02268253|527328016|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
146221818|NCT02268253|527328010|FG000|Stage 3A|Withdrawal by Subject|0|||
146221819|NCT02268253|527328011|FG001|Stage 3A|Withdrawal by Subject|0|||
146221820|NCT02268253|527328012|FG002|Stage 3A|Withdrawal by Subject|2|||
146221821|NCT02268253|527328013|FG003|Stage 3A|Withdrawal by Subject|0|||
146221822|NCT02268253|527328014|FG004|Stage 3A|Withdrawal by Subject|0|||
146221823|NCT02268253|527328015|FG005|Stage 3A|Withdrawal by Subject|0|||
146221824|NCT02268253|527328016|FG006|Stage 3A|Withdrawal by Subject|0|||
146221825|NCT02268253|527328010|FG000|Stage 3A|Physician Decision|0|||
146221826|NCT02268253|527328011|FG001|Stage 3A|Physician Decision|0|||
146221827|NCT02268253|527328012|FG002|Stage 3A|Physician Decision|2|||
146221828|NCT02268253|527328013|FG003|Stage 3A|Physician Decision|0|||
146221829|NCT02268253|527328014|FG004|Stage 3A|Physician Decision|0|||
146221830|NCT02268253|527328015|FG005|Stage 3A|Physician Decision|0|||
146221831|NCT02268253|527328016|FG006|Stage 3A|Physician Decision|0|||
146221832|NCT02268253|527328010|FG000|Stage 3A|Study Terminated by Sponsor|0|||
146221833|NCT02268253|527328011|FG001|Stage 3A|Study Terminated by Sponsor|0|||
146221834|NCT02268253|527328012|FG002|Stage 3A|Study Terminated by Sponsor|2|||
146221835|NCT02268253|527328013|FG003|Stage 3A|Study Terminated by Sponsor|0|||
146221836|NCT02268253|527328014|FG004|Stage 3A|Study Terminated by Sponsor|0|||
146221837|NCT02268253|527328015|FG005|Stage 3A|Study Terminated by Sponsor|0|||
146221838|NCT02268253|527328016|FG006|Stage 3A|Study Terminated by Sponsor|0|||
146221839|NCT02268253|527328010|FG000|Stage 3A|Lost to Follow-up|0|||
146221840|NCT02268253|527328011|FG001|Stage 3A|Lost to Follow-up|0|||
146221841|NCT02268253|527328012|FG002|Stage 3A|Lost to Follow-up|1|||
146221842|NCT02268253|527328013|FG003|Stage 3A|Lost to Follow-up|0|||
146221843|NCT02268253|527328014|FG004|Stage 3A|Lost to Follow-up|0|||
146221844|NCT02268253|527328015|FG005|Stage 3A|Lost to Follow-up|0|||
146221845|NCT02268253|527328016|FG006|Stage 3A|Lost to Follow-up|0|||
146221846|NCT02268253|527328010|FG000|Stage 3A|Death|0|||
146221847|NCT02268253|527328011|FG001|Stage 3A|Death|0|||
146221848|NCT02268253|527328012|FG002|Stage 3A|Death|5|||
146221849|NCT02268253|527328013|FG003|Stage 3A|Death|0|||
146221850|NCT02268253|527328014|FG004|Stage 3A|Death|0|||
146221851|NCT02268253|527328015|FG005|Stage 3A|Death|0|||
146221852|NCT02268253|527328016|FG006|Stage 3A|Death|0|||
146221853|NCT04096040|527328026|FG000|Overall Study|Protocol Violation|12|||
146221854|NCT04096040|527328026|FG000|Overall Study|Non-compliant site|4|||
146221855|NCT03603600|527328029|FG000|Overall Study|Withdrawal by Subject|5|||
146221856|NCT03603600|527328030|FG001|Overall Study|Withdrawal by Subject|7|||
146221857|NCT03603600|527328029|FG000|Overall Study|Lost to Follow-up|2|||
146221858|NCT03603600|527328030|FG001|Overall Study|Lost to Follow-up|3|||
146221859|NCT03603600|527328029|FG000|Overall Study|Death|3|||
146221860|NCT03603600|527328030|FG001|Overall Study|Death|1|||
146221861|NCT03603600|527328029|FG000|Overall Study|Physician Decision|2|||
146221862|NCT03603600|527328030|FG001|Overall Study|Physician Decision|1|||
146221863|NCT03603600|527328029|FG000|Overall Study|Other reason|1|||
146221864|NCT03603600|527328030|FG001|Overall Study|Other reason|0|||
146221865|NCT04973254|527328031|FG000|Overall Study|Not adherent|0|||
146221866|NCT04973254|527328032|FG001|Overall Study|Not adherent|1|||
146221867|NCT04973254|527328033|FG002|Overall Study|Not adherent|0|||
146221868|NCT04044768|527328034|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
146221869|NCT04044768|527328035|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
146221870|NCT03808818|527328036|FG000|Overall Study|Death|6|||
146221871|NCT03808818|527328037|FG001|Overall Study|Death|6|||
146221872|NCT03808818|527328036|FG000|Overall Study|Withdrawal by Subject|7|||
146221873|NCT03808818|527328037|FG001|Overall Study|Withdrawal by Subject|18|||
146221874|NCT03808818|527328036|FG000|Overall Study|Lost to Follow-up|31|||
146221875|NCT03808818|527328037|FG001|Overall Study|Lost to Follow-up|33|||
146221876|NCT05415722|527328038|FG000|Overall Study|Lost to Follow-up|0|||
146221877|NCT05415722|527328039|FG001|Overall Study|Lost to Follow-up|2|||
146221878|NCT05415722|527328040|FG002|Overall Study|Lost to Follow-up|0|||
146221879|NCT05415722|527328041|FG003|Overall Study|Lost to Follow-up|1|||
146221880|NCT05415722|527328042|FG004|Overall Study|Lost to Follow-up|0|||
146221881|NCT05415722|527328043|FG005|Overall Study|Lost to Follow-up|0|||
146221882|NCT05415722|527328044|FG006|Overall Study|Lost to Follow-up|1|||
146221883|NCT05415722|527328038|FG000|Overall Study|Physician Decision|0|||
146221884|NCT05415722|527328039|FG001|Overall Study|Physician Decision|0|||
146221885|NCT05415722|527328040|FG002|Overall Study|Physician Decision|0|||
146221886|NCT05415722|527328041|FG003|Overall Study|Physician Decision|1|||
146221887|NCT05415722|527328042|FG004|Overall Study|Physician Decision|0|||
146221888|NCT05415722|527328043|FG005|Overall Study|Physician Decision|0|||
146221889|NCT05415722|527328044|FG006|Overall Study|Physician Decision|1|||
146221890|NCT05415722|527328038|FG000|Overall Study|Protocol Violation|0|||
146221891|NCT05415722|527328039|FG001|Overall Study|Protocol Violation|0|||
146221892|NCT05415722|527328040|FG002|Overall Study|Protocol Violation|0|||
145882451|NCT01525628|526074817|FG001|Overall Study|Protocol Violation|0|||
145882452|NCT01525628|526074818|FG002|Overall Study|Protocol Violation|1|||
145882453|NCT01525628|526074819|FG003|Overall Study|Protocol Violation|0|||
145882454|NCT01525628|526074820|FG004|Overall Study|Protocol Violation|0|||
146221893|NCT05415722|527328041|FG003|Overall Study|Protocol Violation|1|||
146221894|NCT05415722|527328042|FG004|Overall Study|Protocol Violation|0|||
146221895|NCT05415722|527328043|FG005|Overall Study|Protocol Violation|0|||
146221896|NCT05415722|527328044|FG006|Overall Study|Protocol Violation|0|||
146221897|NCT05415722|527328038|FG000|Overall Study|Sponsor Discretion|0|||
146221898|NCT05415722|527328039|FG001|Overall Study|Sponsor Discretion|0|||
146221899|NCT05415722|527328040|FG002|Overall Study|Sponsor Discretion|0|||
146221900|NCT05415722|527328041|FG003|Overall Study|Sponsor Discretion|0|||
146221901|NCT05415722|527328042|FG004|Overall Study|Sponsor Discretion|1|||
146221902|NCT05415722|527328043|FG005|Overall Study|Sponsor Discretion|1|||
145882455|NCT01525628|526074816|FG000|Overall Study|Lost to Follow-up|1|||
145882456|NCT01525628|526074817|FG001|Overall Study|Lost to Follow-up|1|||
145882457|NCT01525628|526074818|FG002|Overall Study|Lost to Follow-up|0|||
145882458|NCT01525628|526074819|FG003|Overall Study|Lost to Follow-up|0|||
146221903|NCT05415722|527328044|FG006|Overall Study|Sponsor Discretion|0|||
146221904|NCT05415722|527328038|FG000|Overall Study|Withdrawal by Subject|0|||
146221905|NCT05415722|527328039|FG001|Overall Study|Withdrawal by Subject|1|||
146221906|NCT05415722|527328040|FG002|Overall Study|Withdrawal by Subject|0|||
146221907|NCT05415722|527328041|FG003|Overall Study|Withdrawal by Subject|1|||
146221908|NCT05415722|527328042|FG004|Overall Study|Withdrawal by Subject|1|||
146221909|NCT05415722|527328043|FG005|Overall Study|Withdrawal by Subject|0|||
146221910|NCT05415722|527328044|FG006|Overall Study|Withdrawal by Subject|1|||
146221911|NCT03031470|527328049|FG000|Overall Study|Adverse Event|3|||
146221912|NCT03031470|527328050|FG001|Overall Study|Adverse Event|0|||
146221913|NCT03031470|527328049|FG000|Overall Study|Death|3|||
146221914|NCT03031470|527328050|FG001|Overall Study|Death|1|||
146221915|NCT03031470|527328049|FG000|Overall Study|Lost to Follow-up|1|||
146221916|NCT03031470|527328050|FG001|Overall Study|Lost to Follow-up|1|||
146221917|NCT03031470|527328049|FG000|Overall Study|Withdrawal by Subject|1|||
146221918|NCT03031470|527328050|FG001|Overall Study|Withdrawal by Subject|0|||
145961057|NCT03286218|526369469|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
145961058|NCT03286218|526369470|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
145961059|NCT03286218|526369471|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
145961060|NCT03286218|526369472|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
145961061|NCT03286218|526369473|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
145961062|NCT03286218|526369474|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
145961063|NCT03286218|526369475|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
145961064|NCT03286218|526369464|FG000|Qualification Phase Period 2|Protocol Violation|2|||
145961065|NCT03286218|526369465|FG001|Qualification Phase Period 2|Protocol Violation|0|||
145961066|NCT03286218|526369466|FG002|Qualification Phase Period 2|Protocol Violation|0|||
145961067|NCT03286218|526369467|FG003|Qualification Phase Period 2|Protocol Violation|0|||
145961068|NCT03286218|526369468|FG004|Qualification Phase Period 2|Protocol Violation|0|||
145961069|NCT03286218|526369469|FG005|Qualification Phase Period 2|Protocol Violation|0|||
145961070|NCT03286218|526369470|FG006|Qualification Phase Period 2|Protocol Violation|0|||
145961071|NCT03286218|526369471|FG007|Qualification Phase Period 2|Protocol Violation|0|||
145961072|NCT03286218|526369472|FG008|Qualification Phase Period 2|Protocol Violation|0|||
145961073|NCT03286218|526369473|FG009|Qualification Phase Period 2|Protocol Violation|0|||
145961074|NCT03286218|526369474|FG010|Qualification Phase Period 2|Protocol Violation|0|||
145961075|NCT03286218|526369475|FG011|Qualification Phase Period 2|Protocol Violation|0|||
145961076|NCT03286218|526369464|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
145961077|NCT03286218|526369465|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
145961078|NCT03286218|526369466|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961079|NCT03286218|526369467|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961080|NCT03286218|526369468|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961081|NCT03286218|526369469|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961082|NCT03286218|526369470|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961083|NCT03286218|526369471|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961084|NCT03286218|526369472|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961085|NCT03286218|526369473|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961086|NCT03286218|526369474|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961087|NCT03286218|526369475|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
145961088|NCT03286218|526369464|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961089|NCT03286218|526369465|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961090|NCT03286218|526369466|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
145961091|NCT03286218|526369467|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
145961092|NCT03286218|526369468|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961093|NCT03286218|526369469|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
146221919|NCT03031470|527328049|FG000|Overall Study|Protocol entry criteria not met|0|||
145882459|NCT01525628|526074820|FG004|Overall Study|Lost to Follow-up|0|||
145882460|NCT01525628|526074816|FG000|Overall Study|Withdrawal by Subject|0|||
145882461|NCT01525628|526074817|FG001|Overall Study|Withdrawal by Subject|1|||
145882462|NCT01525628|526074818|FG002|Overall Study|Withdrawal by Subject|0|||
145882463|NCT01525628|526074819|FG003|Overall Study|Withdrawal by Subject|0|||
145882464|NCT01525628|526074820|FG004|Overall Study|Withdrawal by Subject|0|||
145882465|NCT01525628|526074816|FG000|Overall Study|Other reason not defined above|0|||
145882466|NCT01525628|526074817|FG001|Overall Study|Other reason not defined above|0|||
145882467|NCT01525628|526074818|FG002|Overall Study|Other reason not defined above|0|||
145882468|NCT01525628|526074819|FG003|Overall Study|Other reason not defined above|3|||
145882469|NCT01525628|526074820|FG004|Overall Study|Other reason not defined above|0|||
145882470|NCT03573336|526074821|FG000|Overall Study|Study terminated|2|||
145882471|NCT03573336|526074822|FG001|Overall Study|Study terminated|4|||
145882472|NCT03573336|526074823|FG002|Overall Study|Study terminated|2|||
145882473|NCT00787605|526074824|FG000|Overall Study|Administrative Problems|3|||
145882474|NCT00787605|526074825|FG001|Overall Study|Administrative Problems|0|||
145882475|NCT00787605|526074824|FG000|Overall Study|Adverse Event|14|||
146221920|NCT03031470|527328050|FG001|Overall Study|Protocol entry criteria not met|1|||
146221921|NCT03031470|527328049|FG000|Overall Study|Cancel the operation|0|||
145882476|NCT00787605|526074825|FG001|Overall Study|Adverse Event|25|||
145882477|NCT00787605|526074824|FG000|Overall Study|Lost to Follow-up|3|||
145882478|NCT00787605|526074825|FG001|Overall Study|Lost to Follow-up|6|||
145882479|NCT00787605|526074824|FG000|Overall Study|Protocol Violation|7|||
146221922|NCT03031470|527328050|FG001|Overall Study|Cancel the operation|1|||
146221923|NCT02489903|527328051|FG000|Screening|Screen Failure|24|||
146221924|NCT02489903|527328052|FG001|Screening|Screen Failure|0|||
146221925|NCT02489903|527328053|FG002|Screening|Screen Failure|0|||
146221926|NCT02489903|527328054|FG003|Screening|Screen Failure|8|||
146221927|NCT02489903|527328051|FG000|Randomized and Received Treatment|Protocol Violation|0|||
146221928|NCT02489903|527328052|FG001|Randomized and Received Treatment|Protocol Violation|1|||
146221929|NCT02489903|527328053|FG002|Randomized and Received Treatment|Protocol Violation|0|||
146221930|NCT02489903|527328054|FG003|Randomized and Received Treatment|Protocol Violation|0|||
146221931|NCT02489903|527328051|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
146221932|NCT02489903|527328052|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
146221933|NCT02489903|527328053|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
146221934|NCT02489903|527328054|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
146221935|NCT02489903|527328051|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
146221936|NCT02489903|527328052|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
146221937|NCT02489903|527328053|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
146221938|NCT02489903|527328054|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
145961094|NCT03286218|526369470|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961095|NCT03286218|526369471|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961096|NCT03286218|526369472|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961097|NCT03286218|526369473|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961098|NCT03286218|526369474|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
145961099|NCT03286218|526369475|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
145961100|NCT03286218|526369464|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961101|NCT03286218|526369465|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961102|NCT03286218|526369466|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961103|NCT03286218|526369467|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961104|NCT03286218|526369468|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961105|NCT03286218|526369469|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961106|NCT03286218|526369470|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961107|NCT03286218|526369471|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961108|NCT03286218|526369472|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961109|NCT03286218|526369473|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
145961110|NCT03286218|526369474|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
146221939|NCT02489903|527328051|FG000|Randomized and Received Treatment|Death|10|||
146221940|NCT02489903|527328052|FG001|Randomized and Received Treatment|Death|1|||
146221941|NCT02489903|527328053|FG002|Randomized and Received Treatment|Death|0|||
146221942|NCT02489903|527328054|FG003|Randomized and Received Treatment|Death|0|||
146221943|NCT03848065|527328055|FG000|Overall Study|Death|0|||
146221944|NCT03848065|527328056|FG001|Overall Study|Death|1|||
145882480|NCT00787605|526074825|FG001|Overall Study|Protocol Violation|3|||
145882481|NCT00787605|526074824|FG000|Overall Study|Withdrawal by Subject|6|||
145882482|NCT00787605|526074825|FG001|Overall Study|Withdrawal by Subject|13|||
145882483|NCT00787605|526074824|FG000|Overall Study|Lack of Efficacy|13|||
145882484|NCT00787605|526074825|FG001|Overall Study|Lack of Efficacy|9|||
145882485|NCT03108820|526074826|FG000|Overall Study|Lost to Follow-up|30|||
145882486|NCT03108820|526074827|FG001|Overall Study|Lost to Follow-up|28|||
145961111|NCT03286218|526369475|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
145961112|NCT00227539|526369478|FG000|Overall Study|Protocol Violation|1|||
146221945|NCT03848065|527328057|FG002|Overall Study|Death|0|||
146221946|NCT03848065|527328055|FG000|Overall Study|Lost to Follow-up|0|||
146221947|NCT03848065|527328056|FG001|Overall Study|Lost to Follow-up|0|||
146221948|NCT03848065|527328057|FG002|Overall Study|Lost to Follow-up|1|||
146221949|NCT03848065|527328055|FG000|Overall Study|Physician Decision|0|||
146221950|NCT03848065|527328056|FG001|Overall Study|Physician Decision|0|||
146221951|NCT03848065|527328057|FG002|Overall Study|Physician Decision|1|||
146221952|NCT04564742|527328062|FG000|Overall Study|Lost to Follow-up|1|||
146221953|NCT04564742|527328063|FG001|Overall Study|Lost to Follow-up|0|||
146221954|NCT04564742|527328062|FG000|Overall Study|Consent Withdrawal|4|||
146221955|NCT04564742|527328063|FG001|Overall Study|Consent Withdrawal|4|||
146221956|NCT05126433|527328067|FG000|Overall Study|Withdrawal by Subject|3|||
146288679|NCT04443153|527571440|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
145961113|NCT02689804|526369479|FG000|Overall Study|Withdrawal by Subject|2|||
146221957|NCT05126433|527328068|FG001|Overall Study|Withdrawal by Subject|0|||
146221958|NCT05126433|527328069|FG002|Overall Study|Withdrawal by Subject|4|||
146221959|NCT05126433|527328067|FG000|Overall Study|Death|9|||
146221960|NCT05126433|527328068|FG001|Overall Study|Death|3|||
146221961|NCT05126433|527328069|FG002|Overall Study|Death|5|||
146221962|NCT05126433|527328067|FG000|Overall Study|Study Terminated by sponsor|0|||
146221963|NCT05126433|527328068|FG001|Overall Study|Study Terminated by sponsor|1|||
146221964|NCT05126433|527328069|FG002|Overall Study|Study Terminated by sponsor|2|||
146221965|NCT05126433|527328067|FG000|Overall Study|Progressive Disease|1|||
145882487|NCT03108820|526074826|FG000|Overall Study|Withdrawal by Subject|32|||
145882488|NCT03108820|526074827|FG001|Overall Study|Withdrawal by Subject|24|||
145882489|NCT03108820|526074826|FG000|Overall Study|Death|6|||
145882490|NCT03108820|526074827|FG001|Overall Study|Death|11|||
145882491|NCT00089973|526074835|FG000|Overall Study|Adverse Event|3|||
145882492|NCT00089973|526074835|FG000|Overall Study|Withdrawal by Subject|1|||
145882493|NCT00089973|526074835|FG000|Overall Study|Disease progression|45|||
145882494|NCT00089973|526074835|FG000|Overall Study|Death|1|||
145882495|NCT01223027|526074836|FG000|Overall Study|Adverse Event|20|||
145882496|NCT01223027|526074837|FG001|Overall Study|Adverse Event|10|||
145882497|NCT01223027|526074836|FG000|Overall Study|Death|42|||
145882498|NCT01223027|526074837|FG001|Overall Study|Death|42|||
145882499|NCT01223027|526074836|FG000|Overall Study|Lost to Follow-up|2|||
145882500|NCT01223027|526074837|FG001|Overall Study|Lost to Follow-up|1|||
145882501|NCT01223027|526074836|FG000|Overall Study|Physician Decision|4|||
146221966|NCT05126433|527328068|FG001|Overall Study|Progressive Disease|4|||
146221967|NCT05126433|527328069|FG002|Overall Study|Progressive Disease|3|||
146221968|NCT05126433|527328067|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
146221969|NCT05126433|527328068|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
146221970|NCT05126433|527328069|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
146221971|NCT00764751|527328070|FG000|Overall Study|Adverse Event|1|||
146221972|NCT00764751|527328071|FG001|Overall Study|Adverse Event|1|||
146221973|NCT00764751|527328070|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
146221974|NCT00764751|527328071|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
146221975|NCT04948697|527328085|FG000|Overall Study|Progressive disease|27|||
146221976|NCT04948697|527328086|FG001|Overall Study|Progressive disease|18|||
146221977|NCT04948697|527328085|FG000|Overall Study|Adverse Event|14|||
146221978|NCT04948697|527328086|FG001|Overall Study|Adverse Event|4|||
146221979|NCT04948697|527328085|FG000|Overall Study|Participant moved to long term extension study|7|||
146221980|NCT04948697|527328086|FG001|Overall Study|Participant moved to long term extension study|4|||
146221981|NCT04948697|527328085|FG000|Overall Study|Withdrawal by Subject|10|||
146221982|NCT04948697|527328086|FG001|Overall Study|Withdrawal by Subject|0|||
146221983|NCT04948697|527328085|FG000|Overall Study|Closed by Sponsor|3|||
146221984|NCT04948697|527328086|FG001|Overall Study|Closed by Sponsor|2|||
146221985|NCT04948697|527328085|FG000|Overall Study|Physician Decision|0|||
146221986|NCT04948697|527328086|FG001|Overall Study|Physician Decision|2|||
146221987|NCT04948697|527328085|FG000|Overall Study|Lost to Follow-up|0|||
146221988|NCT04948697|527328086|FG001|Overall Study|Lost to Follow-up|1|||
146221989|NCT04948697|527328085|FG000|Overall Study|Other-Miscellaneous|1|||
146221990|NCT04948697|527328086|FG001|Overall Study|Other-Miscellaneous|0|||
146221991|NCT04948697|527328085|FG000|Overall Study|Randomized but not treated|0|||
146221992|NCT04948697|527328086|FG001|Overall Study|Randomized but not treated|1|||
146221993|NCT04599062|527328088|FG000|Overall Study|Physician Decision|1|||
146221994|NCT04599062|527328089|FG001|Overall Study|Physician Decision|0|||
146221995|NCT01175356|527328092|FG000|Overall Study|Death|1|||
146221996|NCT01175356|527328092|FG000|Overall Study|Lack of Efficacy|12|||
146221997|NCT01175356|527328092|FG000|Overall Study|Lost to Follow-up|1|||
146221998|NCT01175356|527328092|FG000|Overall Study|Physician Decision|23|||
146221999|NCT01175356|527328092|FG000|Overall Study|Ineligible|1|||
146222000|NCT01175356|527328092|FG000|Overall Study|Treatment Slot Not Available|18|||
146222001|NCT01175356|527328092|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
146222002|NCT01175356|527328092|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
146222003|NCT01175356|527328092|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
146222004|NCT01175356|527328092|FG000|Overall Study|Inadequate stem cell for transplant|1|||
146222005|NCT01175356|527328092|FG000|Overall Study|Initiation other tx prior to completion|9|||
146222006|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
145882502|NCT01223027|526074837|FG001|Overall Study|Physician Decision|8|||
145882503|NCT01223027|526074836|FG000|Overall Study|Progressive Disease|167|||
145882504|NCT01223027|526074837|FG001|Overall Study|Progressive Disease|183|||
145882505|NCT01223027|526074836|FG000|Overall Study|Protocol Violation|2|||
145882506|NCT01223027|526074837|FG001|Overall Study|Protocol Violation|1|||
145882507|NCT01223027|526074836|FG000|Overall Study|Subject/guardian decicion|18|||
145882508|NCT01223027|526074837|FG001|Overall Study|Subject/guardian decicion|16|||
145882509|NCT01223027|526074836|FG000|Overall Study|New therapy for study indication|17|||
145882510|NCT01223027|526074837|FG001|Overall Study|New therapy for study indication|8|||
145882511|NCT01223027|526074836|FG000|Overall Study|Study terminated by sponsor|2|||
145882512|NCT01223027|526074837|FG001|Overall Study|Study terminated by sponsor|8|||
146222007|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
146222008|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
146222009|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
146222010|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
146222011|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146222012|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
145882513|NCT02419573|526076968|FG000|Overall Study|Lost to Follow-up|3|||
145882514|NCT02419573|526076969|FG001|Overall Study|Lost to Follow-up|0|||
145882515|NCT02419573|526076968|FG000|Overall Study|Withdrawal by Subject|1|||
145882516|NCT02419573|526076969|FG001|Overall Study|Withdrawal by Subject|0|||
146222013|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
146085067|NCT05508074|526832060|FG000|Overall Study|Physician Decision|0|||
146222014|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146222015|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
146222016|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
146222017|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
146222018|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
146222019|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
146222020|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
146222021|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
146222022|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146222023|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
146222024|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146222025|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
146222026|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146222027|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
146222028|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146222029|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146222030|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
146222031|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
146222032|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
146222033|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
146222034|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
146222035|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
146222036|NCT03852472|527328099|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
146222037|NCT03852472|527328100|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
146222038|NCT03852472|527328101|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
146222039|NCT03852472|527328102|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
146222040|NCT03852472|527328103|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
146222041|NCT03852472|527328099|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
146222042|NCT03852472|527328100|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
146222043|NCT03852472|527328101|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
146222044|NCT03852472|527328102|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
146222045|NCT03852472|527328103|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
146222046|NCT03852472|527328099|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
146222047|NCT03852472|527328100|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
146222048|NCT03852472|527328101|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
146222049|NCT03852472|527328102|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
146222050|NCT03852472|527328103|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
146222051|NCT03852472|527328099|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
146222052|NCT03852472|527328100|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
146222053|NCT03852472|527328101|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
146222054|NCT03852472|527328102|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
146222055|NCT03852472|527328103|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
146222056|NCT03852472|527328099|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
146222057|NCT03852472|527328100|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
146222058|NCT03852472|527328101|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
146222059|NCT03852472|527328102|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
146222060|NCT03852472|527328103|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
146222061|NCT03852472|527328099|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
146222062|NCT03852472|527328100|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
146222063|NCT03852472|527328101|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
146222064|NCT03852472|527328102|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
146222065|NCT03852472|527328103|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
146222066|NCT03852472|527328099|FG000|Period 2 - Week 44|Adverse Event|0|||
146222067|NCT03852472|527328100|FG001|Period 2 - Week 44|Adverse Event|3|||
146222068|NCT03852472|527328101|FG002|Period 2 - Week 44|Adverse Event|1|||
146222069|NCT03852472|527328102|FG003|Period 2 - Week 44|Adverse Event|2|||
146222070|NCT03852472|527328103|FG004|Period 2 - Week 44|Adverse Event|2|||
145961114|NCT02689804|526369480|FG001|Overall Study|Withdrawal by Subject|0|||
146222071|NCT03852472|527328099|FG000|Period 2 - Week 44|COVID-19 Related|0|||
146222072|NCT03852472|527328100|FG001|Period 2 - Week 44|COVID-19 Related|0|||
146222073|NCT03852472|527328101|FG002|Period 2 - Week 44|COVID-19 Related|0|||
146222074|NCT03852472|527328102|FG003|Period 2 - Week 44|COVID-19 Related|1|||
146222075|NCT03852472|527328103|FG004|Period 2 - Week 44|COVID-19 Related|0|||
146222076|NCT03852472|527328099|FG000|Period 2 - Week 44|Reason not stated|0|||
146222077|NCT03852472|527328100|FG001|Period 2 - Week 44|Reason not stated|0|||
146222078|NCT03852472|527328101|FG002|Period 2 - Week 44|Reason not stated|0|||
145961115|NCT00426764|526369482|FG000|Overall Study|Protocol Violation|1|||
145961116|NCT00426764|526369482|FG000|Overall Study|Withdrawal by Subject|4|||
145961117|NCT00426764|526369482|FG000|Overall Study|Physician Decision|6|||
146222079|NCT03852472|527328102|FG003|Period 2 - Week 44|Reason not stated|0|||
146222080|NCT03852472|527328103|FG004|Period 2 - Week 44|Reason not stated|1|||
146222081|NCT01919554|527328104|FG000|Overall Study|Withdrawal by Subject|0|||
146222082|NCT01919554|527328105|FG001|Overall Study|Withdrawal by Subject|0|||
146222083|NCT01919554|527328106|FG002|Overall Study|Withdrawal by Subject|1|||
146222084|NCT01919554|527328107|FG003|Overall Study|Withdrawal by Subject|1|||
146222085|NCT05977530|527328108|FG000|Overall Study|Withdrawal by Subject|1|||
146222086|NCT05977530|527328108|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
146222087|NCT04719832|527328111|FG000|Overall Study|Adverse Event|2|||
146222088|NCT04719832|527328112|FG001|Overall Study|Adverse Event|0|||
146222089|NCT04719832|527328111|FG000|Overall Study|Lack of Efficacy|2|||
146222090|NCT04719832|527328112|FG001|Overall Study|Lack of Efficacy|4|||
146222091|NCT04719832|527328111|FG000|Overall Study|Lost to Follow-up|0|||
146222092|NCT04719832|527328112|FG001|Overall Study|Lost to Follow-up|2|||
146222093|NCT04719832|527328111|FG000|Overall Study|Physician Decision|0|||
146222094|NCT04719832|527328112|FG001|Overall Study|Physician Decision|1|||
146222095|NCT04719832|527328111|FG000|Overall Study|Pregnancy|1|||
146222096|NCT04719832|527328112|FG001|Overall Study|Pregnancy|1|||
146222097|NCT04719832|527328111|FG000|Overall Study|Withdrawal by Subject|5|||
146222098|NCT04719832|527328112|FG001|Overall Study|Withdrawal by Subject|5|||
146222099|NCT04719832|527328111|FG000|Overall Study|Randomized, not treated|0|||
146222100|NCT04719832|527328112|FG001|Overall Study|Randomized, not treated|2|||
146222101|NCT04719832|527328111|FG000|Overall Study|GCP violations|4|||
146222102|NCT04719832|527328112|FG001|Overall Study|GCP violations|7|||
146222103|NCT01152450|527328113|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
146222104|NCT01152450|527328114|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
146222105|NCT01152450|527328115|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
146222106|NCT01152450|527328116|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
146222107|NCT01152450|527328117|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
146222108|NCT01152450|527328118|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
146222109|NCT01152450|527328113|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
146222110|NCT01152450|527328114|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
146222111|NCT01152450|527328115|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
146222112|NCT01152450|527328116|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
146222113|NCT01152450|527328117|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
146222114|NCT01152450|527328118|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
146222115|NCT01152450|527328113|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146222116|NCT01152450|527328114|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146222117|NCT01152450|527328115|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
146222118|NCT01152450|527328116|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146222119|NCT01152450|527328117|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146222120|NCT01152450|527328118|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
146222121|NCT03058289|527328119|FG000|Overall Study|Radiographic Deterioration|0|||
146222122|NCT03058289|527328120|FG001|Overall Study|Radiographic Deterioration|3|||
146222123|NCT03058289|527328121|FG002|Overall Study|Radiographic Deterioration|1|||
146222124|NCT03058289|527328122|FG003|Overall Study|Radiographic Deterioration|2|||
146222125|NCT03058289|527328123|FG004|Overall Study|Radiographic Deterioration|6|||
146222126|NCT03058289|527328124|FG005|Overall Study|Radiographic Deterioration|3|||
146222127|NCT03058289|527328125|FG006|Overall Study|Radiographic Deterioration|0|||
146222128|NCT03058289|527328126|FG007|Overall Study|Radiographic Deterioration|4|||
146222129|NCT03058289|527328127|FG008|Overall Study|Radiographic Deterioration|2|||
146222130|NCT03058289|527328119|FG000|Overall Study|Adverse Event|2|||
146222131|NCT03058289|527328120|FG001|Overall Study|Adverse Event|0|||
146222132|NCT03058289|527328121|FG002|Overall Study|Adverse Event|1|||
146222133|NCT03058289|527328122|FG003|Overall Study|Adverse Event|3|||
146222134|NCT03058289|527328123|FG004|Overall Study|Adverse Event|1|||
146222135|NCT03058289|527328124|FG005|Overall Study|Adverse Event|0|||
145961118|NCT00426764|526369482|FG000|Overall Study|Compassionate Use|1|||
145961119|NCT00426764|526369482|FG000|Overall Study|Progressive Disease|83|||
145961120|NCT00426764|526369482|FG000|Overall Study|Adverse Event|24|||
146222136|NCT03058289|527328125|FG006|Overall Study|Adverse Event|1|||
146222137|NCT03058289|527328126|FG007|Overall Study|Adverse Event|3|||
145961121|NCT00426764|526369482|FG000|Overall Study|Other|1|||
145961122|NCT00426764|526369482|FG000|Overall Study|Death|1|||
145961123|NCT00426764|526369482|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
146222138|NCT03058289|527328127|FG008|Overall Study|Adverse Event|0|||
146222139|NCT03058289|527328119|FG000|Overall Study|Withdrawal by Subject|0|||
146222140|NCT03058289|527328120|FG001|Overall Study|Withdrawal by Subject|0|||
146222141|NCT03058289|527328121|FG002|Overall Study|Withdrawal by Subject|0|||
146222142|NCT03058289|527328122|FG003|Overall Study|Withdrawal by Subject|2|||
146222143|NCT03058289|527328123|FG004|Overall Study|Withdrawal by Subject|0|||
146222144|NCT03058289|527328124|FG005|Overall Study|Withdrawal by Subject|2|||
146222145|NCT03058289|527328125|FG006|Overall Study|Withdrawal by Subject|0|||
146222146|NCT03058289|527328126|FG007|Overall Study|Withdrawal by Subject|4|||
146222147|NCT03058289|527328127|FG008|Overall Study|Withdrawal by Subject|1|||
146085068|NCT05508074|526832061|FG001|Overall Study|Physician Decision|1|||
146222148|NCT03058289|527328119|FG000|Overall Study|Physician Decision|1|||
146222149|NCT03058289|527328120|FG001|Overall Study|Physician Decision|0|||
146222150|NCT03058289|527328121|FG002|Overall Study|Physician Decision|0|||
146222151|NCT03058289|527328122|FG003|Overall Study|Physician Decision|2|||
146222152|NCT03058289|527328123|FG004|Overall Study|Physician Decision|1|||
146222153|NCT03058289|527328124|FG005|Overall Study|Physician Decision|0|||
146222154|NCT03058289|527328125|FG006|Overall Study|Physician Decision|2|||
146222155|NCT03058289|527328126|FG007|Overall Study|Physician Decision|3|||
146222156|NCT03058289|527328127|FG008|Overall Study|Physician Decision|0|||
146222157|NCT03058289|527328119|FG000|Overall Study|Clinical Deterioration|2|||
146222158|NCT03058289|527328120|FG001|Overall Study|Clinical Deterioration|0|||
146222159|NCT03058289|527328121|FG002|Overall Study|Clinical Deterioration|0|||
146222160|NCT03058289|527328122|FG003|Overall Study|Clinical Deterioration|2|||
146222161|NCT03058289|527328123|FG004|Overall Study|Clinical Deterioration|1|||
146222162|NCT03058289|527328124|FG005|Overall Study|Clinical Deterioration|1|||
146222163|NCT03058289|527328125|FG006|Overall Study|Clinical Deterioration|0|||
146222164|NCT03058289|527328126|FG007|Overall Study|Clinical Deterioration|3|||
146222165|NCT03058289|527328127|FG008|Overall Study|Clinical Deterioration|2|||
146222166|NCT03058289|527328119|FG000|Overall Study|Lost to Follow-up|0|||
146222167|NCT03058289|527328120|FG001|Overall Study|Lost to Follow-up|0|||
146222168|NCT03058289|527328121|FG002|Overall Study|Lost to Follow-up|0|||
146222169|NCT03058289|527328122|FG003|Overall Study|Lost to Follow-up|0|||
146222170|NCT03058289|527328123|FG004|Overall Study|Lost to Follow-up|1|||
146222171|NCT03058289|527328124|FG005|Overall Study|Lost to Follow-up|0|||
146222172|NCT03058289|527328125|FG006|Overall Study|Lost to Follow-up|0|||
146222173|NCT03058289|527328126|FG007|Overall Study|Lost to Follow-up|0|||
146222174|NCT03058289|527328127|FG008|Overall Study|Lost to Follow-up|0|||
146222175|NCT03058289|527328119|FG000|Overall Study|Refused Further Treatment|0|||
146222176|NCT03058289|527328120|FG001|Overall Study|Refused Further Treatment|0|||
146222177|NCT03058289|527328121|FG002|Overall Study|Refused Further Treatment|1|||
146222178|NCT03058289|527328122|FG003|Overall Study|Refused Further Treatment|0|||
146222179|NCT03058289|527328123|FG004|Overall Study|Refused Further Treatment|1|||
146222180|NCT03058289|527328124|FG005|Overall Study|Refused Further Treatment|0|||
146222181|NCT03058289|527328125|FG006|Overall Study|Refused Further Treatment|0|||
146222182|NCT03058289|527328126|FG007|Overall Study|Refused Further Treatment|0|||
146222183|NCT03058289|527328127|FG008|Overall Study|Refused Further Treatment|0|||
146222184|NCT03058289|527328119|FG000|Overall Study|Rapid Progression of Disease|0|||
146222185|NCT03058289|527328120|FG001|Overall Study|Rapid Progression of Disease|0|||
146222186|NCT03058289|527328121|FG002|Overall Study|Rapid Progression of Disease|0|||
146222187|NCT03058289|527328122|FG003|Overall Study|Rapid Progression of Disease|1|||
146222188|NCT03058289|527328123|FG004|Overall Study|Rapid Progression of Disease|0|||
146222189|NCT03058289|527328124|FG005|Overall Study|Rapid Progression of Disease|0|||
146222190|NCT03058289|527328125|FG006|Overall Study|Rapid Progression of Disease|0|||
146222191|NCT03058289|527328126|FG007|Overall Study|Rapid Progression of Disease|0|||
146222192|NCT03058289|527328127|FG008|Overall Study|Rapid Progression of Disease|0|||
146222193|NCT03084536|527328128|FG000|Overall Study|Determined to be ineligible|0|||
146222194|NCT03084536|527328129|FG001|Overall Study|Determined to be ineligible|0|||
146222195|NCT03084536|527328130|FG002|Overall Study|Determined to be ineligible|16|||
146222196|NCT03084536|527328128|FG000|Overall Study|Withdrawal by Subject|0|||
146222197|NCT03084536|527328129|FG001|Overall Study|Withdrawal by Subject|0|||
146222198|NCT03084536|527328130|FG002|Overall Study|Withdrawal by Subject|4|||
146222199|NCT03084536|527328128|FG000|Overall Study|Physician Decision|0|||
146222200|NCT03084536|527328129|FG001|Overall Study|Physician Decision|0|||
146222201|NCT03084536|527328130|FG002|Overall Study|Physician Decision|3|||
146222202|NCT03084536|527328128|FG000|Overall Study|Death|0|||
146222203|NCT03084536|527328129|FG001|Overall Study|Death|0|||
145961124|NCT00673257|526369483|FG000|Overall Study|Withdrawal by Subject|4|||
145961125|NCT00673257|526369483|FG000|Overall Study|Unable to obtain specimen|1|||
145961126|NCT01166750|526369490|FG000|Overall Study|Lost to Follow-up|1|||
146222204|NCT03084536|527328130|FG002|Overall Study|Death|1|||
146222205|NCT03084536|527328128|FG000|Overall Study|Lost to Follow-up|0|||
146222206|NCT03084536|527328129|FG001|Overall Study|Lost to Follow-up|0|||
146222207|NCT03084536|527328130|FG002|Overall Study|Lost to Follow-up|1|||
146222208|NCT03084536|527328128|FG000|Overall Study|Protocol Violation|0|||
146222209|NCT03084536|527328129|FG001|Overall Study|Protocol Violation|0|||
146222210|NCT03084536|527328130|FG002|Overall Study|Protocol Violation|1|||
146222211|NCT03084536|527328128|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
146222212|NCT03084536|527328129|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
146222213|NCT03084536|527328130|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
146222214|NCT05192109|527328135|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146222215|NCT05192109|527328136|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145961127|NCT01166750|526369491|FG001|Overall Study|Lost to Follow-up|0|||
146222216|NCT05192109|527328137|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146222217|NCT05192109|527328138|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146222218|NCT05192109|527328135|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
146222219|NCT05192109|527328136|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
146222220|NCT05192109|527328137|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146222221|NCT05192109|527328138|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
146222222|NCT04515849|527328139|FG000|Overall Study|Adverse Event|0|||
146222223|NCT04515849|527328140|FG001|Overall Study|Adverse Event|0|||
146222224|NCT04515849|527328141|FG002|Overall Study|Adverse Event|0|||
146222225|NCT04515849|527328142|FG003|Overall Study|Adverse Event|1|||
146222226|NCT04515849|527328143|FG004|Overall Study|Adverse Event|2|||
146222227|NCT04515849|527328139|FG000|Overall Study|Death|2|||
146222228|NCT04515849|527328140|FG001|Overall Study|Death|0|||
146222229|NCT04515849|527328141|FG002|Overall Study|Death|0|||
146222230|NCT04515849|527328142|FG003|Overall Study|Death|0|||
146288680|NCT04443153|527571439|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
146288681|NCT04443153|527571440|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
146288682|NCT04443153|527571439|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
146222231|NCT04515849|527328143|FG004|Overall Study|Death|0|||
146222232|NCT04515849|527328139|FG000|Overall Study|Other:family emergency|0|||
146222233|NCT04515849|527328140|FG001|Overall Study|Other:family emergency|0|||
146222234|NCT04515849|527328141|FG002|Overall Study|Other:family emergency|0|||
146222235|NCT04515849|527328142|FG003|Overall Study|Other:family emergency|1|||
146222236|NCT04515849|527328143|FG004|Overall Study|Other:family emergency|0|||
146222237|NCT04515849|527328139|FG000|Overall Study|Other:randomised by error|0|||
146222238|NCT04515849|527328140|FG001|Overall Study|Other:randomised by error|1|||
146222239|NCT04515849|527328141|FG002|Overall Study|Other:randomised by error|0|||
146222240|NCT04515849|527328142|FG003|Overall Study|Other:randomised by error|0|||
146222241|NCT04515849|527328143|FG004|Overall Study|Other:randomised by error|0|||
146222242|NCT04515849|527328139|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146222243|NCT04515849|527328140|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146222244|NCT04515849|527328141|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
146222245|NCT04515849|527328142|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
146222246|NCT04515849|527328143|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
145961128|NCT04396626|526369492|FG000|Overall Study|Premature termination of study|975|||
145961129|NCT02417753|526369493|FG000|Overall Study|Death|1|||
145961130|NCT02111174|526369494|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
145961131|NCT02111174|526369495|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
145961132|NCT02111174|526369494|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
145961133|NCT02111174|526369495|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
145961134|NCT02111174|526369494|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
145961135|NCT02111174|526369495|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
145961136|NCT02111174|526369494|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
145961137|NCT02111174|526369495|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
145961138|NCT00901342|526369496|FG000|Overall Study|Adverse Event|1|||
145961139|NCT00901342|526369496|FG000|Overall Study|Death|4|||
145961140|NCT00901342|526369496|FG000|Overall Study|Disease progression|1|||
145961141|NCT00901342|526369496|FG000|Overall Study|Withdrawal by Subject|9|||
145961142|NCT02849587|526369497|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
145961143|NCT02849587|526369498|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
145961144|NCT02849587|526369499|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
145961145|NCT02849587|526369497|FG000|Overall Study|Withdrawal by Subject|0|||
145961146|NCT02849587|526369498|FG001|Overall Study|Withdrawal by Subject|1|||
145961147|NCT02849587|526369499|FG002|Overall Study|Withdrawal by Subject|0|||
146222247|NCT04515849|527328139|FG000|Overall Study|Physician Decision|0|||
146222248|NCT04515849|527328140|FG001|Overall Study|Physician Decision|1|||
146288683|NCT04443153|527571440|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
146288684|NCT05182125|527571441|FG000|Overall Study|Withdrawal by Subject|0|||
146222249|NCT04515849|527328141|FG002|Overall Study|Physician Decision|0|||
146222250|NCT04515849|527328142|FG003|Overall Study|Physician Decision|0|||
146222251|NCT04515849|527328143|FG004|Overall Study|Physician Decision|0|||
146222252|NCT04515849|527328139|FG000|Overall Study|Withdrawal by Subject|1|||
146222253|NCT04515849|527328140|FG001|Overall Study|Withdrawal by Subject|2|||
146222254|NCT04515849|527328141|FG002|Overall Study|Withdrawal by Subject|1|||
146222255|NCT04515849|527328142|FG003|Overall Study|Withdrawal by Subject|0|||
146288685|NCT05182125|527571442|FG001|Overall Study|Withdrawal by Subject|0|||
146222256|NCT04515849|527328143|FG004|Overall Study|Withdrawal by Subject|0|||
146222257|NCT04828005|527328153|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
146222258|NCT04828005|527328154|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146222259|NCT04828005|527328155|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146222260|NCT04828005|527328156|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
146222261|NCT04828005|527328153|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
146222262|NCT04828005|527328154|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
146288686|NCT05182125|527571443|FG002|Overall Study|Withdrawal by Subject|0|||
146222263|NCT04828005|527328155|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
146222264|NCT04828005|527328156|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
146222265|NCT04828005|527328153|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146222266|NCT04828005|527328154|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146222267|NCT04828005|527328155|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
146222268|NCT04828005|527328156|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
146222269|NCT04828005|527328153|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
146222270|NCT04828005|527328154|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
146222271|NCT04828005|527328155|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
146222272|NCT04828005|527328156|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
146222273|NCT04828005|527328153|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146222274|NCT04828005|527328154|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146222275|NCT04828005|527328155|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
146222276|NCT04828005|527328156|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
146222277|NCT04828005|527328153|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146222278|NCT04828005|527328154|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146222279|NCT04828005|527328155|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
146222280|NCT04828005|527328156|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
146222281|NCT04828005|527328153|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
146222282|NCT04828005|527328154|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
146222283|NCT04828005|527328155|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
146222284|NCT04828005|527328156|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
146222285|NCT04828005|527328153|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146222286|NCT04828005|527328154|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146222287|NCT04828005|527328155|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
146222288|NCT04828005|527328156|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
146222289|NCT04828005|527328153|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146222290|NCT04828005|527328154|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146222291|NCT04828005|527328155|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
146222292|NCT04828005|527328156|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
146222293|NCT02696707|527329713|FG000|Per Protocol Population|Physician Decision|2|||
146222294|NCT02696707|527329714|FG001|Per Protocol Population|Physician Decision|1|||
146222295|NCT02696707|527329713|FG000|Per Protocol Population|Participant Decision|0|||
146222296|NCT02696707|527329714|FG001|Per Protocol Population|Participant Decision|2|||
146222297|NCT02696707|527329713|FG000|Completed Study as Planned|Reason = LVEF|2|||
146222298|NCT02696707|527329714|FG001|Completed Study as Planned|Reason = LVEF|2|||
146222299|NCT02696707|527329713|FG000|Completed Study as Planned|Protocol Violation|2|||
146222300|NCT02696707|527329714|FG001|Completed Study as Planned|Protocol Violation|6|||
146222301|NCT02696707|527329713|FG000|Completed Study as Planned|Metastatic disease|3|||
146222302|NCT02696707|527329714|FG001|Completed Study as Planned|Metastatic disease|0|||
146222303|NCT02696707|527329713|FG000|Completed Study as Planned|Location|1|||
146222304|NCT02696707|527329714|FG001|Completed Study as Planned|Location|1|||
146222305|NCT03869866|527329719|FG000|Overall Study|Protocol Violation|1|||
146222306|NCT03869866|527329719|FG000|Overall Study|Withdrawal by Subject|3|||
146222307|NCT06516705|527329720|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
146222308|NCT06516705|527329721|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
146222309|NCT06516705|527329720|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
146222310|NCT06516705|527329721|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
146222311|NCT06516705|527329720|FG000|T3 ( 3 Month After Education)|covid-19|1|||
146222312|NCT06516705|527329721|FG001|T3 ( 3 Month After Education)|covid-19|2|||
146222313|NCT06516705|527329720|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
146222314|NCT06516705|527329721|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
146222315|NCT06516705|527329720|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
146222316|NCT06516705|527329721|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
146222317|NCT06516705|527329720|FG000|T4 ( 6 Month After Education)|covid-19|3|||
146222318|NCT06516705|527329721|FG001|T4 ( 6 Month After Education)|covid-19|2|||
146222319|NCT06516705|527329720|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
145882517|NCT04501094|526076970|FG000|Overall Study|Death (unrelated to research)|1|||
145882518|NCT04501094|526076971|FG001|Overall Study|Death (unrelated to research)|0|||
145882519|NCT00784979|526076978|FG000|Overall Study|incomplete data|6|||
145882520|NCT00894933|526076979|FG000|Overall Study|Lost to Follow-up|2|||
145882521|NCT00894933|526076979|FG000|Overall Study|Cancelled Procedure|1|||
146222320|NCT06516705|527329721|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
146222321|NCT05579899|527329722|FG000|Overall Study|Lost to Follow-up|3|||
146222322|NCT05579899|527329723|FG001|Overall Study|Lost to Follow-up|1|||
146222323|NCT05579899|527329722|FG000|Overall Study|Adverse Event|0|||
146222324|NCT05579899|527329723|FG001|Overall Study|Adverse Event|3|||
145882522|NCT00894933|526076979|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
145882523|NCT00631007|526076983|FG000|Overall Study|Adverse Event|0|||
146222325|NCT05579899|527329722|FG000|Overall Study|Pregnancy|0|||
146222326|NCT05579899|527329723|FG001|Overall Study|Pregnancy|1|||
146222327|NCT05579899|527329722|FG000|Overall Study|Withdrawal by Subject|0|||
145882524|NCT00631007|526076984|FG001|Overall Study|Adverse Event|2|||
145882525|NCT00631007|526076985|FG002|Overall Study|Adverse Event|0|||
145882526|NCT00631007|526076986|FG003|Overall Study|Adverse Event|2|||
145882527|NCT00631007|526076987|FG004|Overall Study|Adverse Event|3|||
145882528|NCT00631007|526076988|FG005|Overall Study|Adverse Event|2|||
145882529|NCT00631007|526076983|FG000|Overall Study|Lost to Follow-up|2|||
145882530|NCT00631007|526076984|FG001|Overall Study|Lost to Follow-up|1|||
145882531|NCT00631007|526076985|FG002|Overall Study|Lost to Follow-up|2|||
145882532|NCT00631007|526076986|FG003|Overall Study|Lost to Follow-up|4|||
145882533|NCT00631007|526076987|FG004|Overall Study|Lost to Follow-up|5|||
145882534|NCT00631007|526076988|FG005|Overall Study|Lost to Follow-up|3|||
145882535|NCT00631007|526076983|FG000|Overall Study|Physician Decision|1|||
145882536|NCT00631007|526076984|FG001|Overall Study|Physician Decision|0|||
145882537|NCT00631007|526076985|FG002|Overall Study|Physician Decision|1|||
145882538|NCT00631007|526076986|FG003|Overall Study|Physician Decision|0|||
145882539|NCT00631007|526076987|FG004|Overall Study|Physician Decision|0|||
145882540|NCT00631007|526076988|FG005|Overall Study|Physician Decision|2|||
146222328|NCT05579899|527329723|FG001|Overall Study|Withdrawal by Subject|3|||
146222329|NCT05453773|527329724|FG000|Overall Study|Withdrawal by Subject|3|||
146222330|NCT05453773|527329724|FG000|Overall Study|Lost to Follow-up|3|||
146222331|NCT05453773|527329724|FG000|Overall Study|Difficult Blood Draw|3|||
146222332|NCT03023410|527329727|FG000|Overall Study|study termination|0|||
146222333|NCT03023410|527329728|FG001|Overall Study|study termination|1|||
146222334|NCT04963270|527329734|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
146222335|NCT04963270|527329735|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
146222336|NCT04963270|527329736|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
146222337|NCT04963270|527329737|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
146222338|NCT04963270|527329734|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146222339|NCT04963270|527329735|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
146222340|NCT04963270|527329736|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146222341|NCT04963270|527329737|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146222342|NCT04963270|527329734|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
146222343|NCT04963270|527329735|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146222344|NCT04963270|527329736|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146222345|NCT04963270|527329737|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146222346|NCT04963270|527329734|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
146222347|NCT04963270|527329735|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146222348|NCT04963270|527329736|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146222349|NCT04963270|527329737|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
146222350|NCT04963270|527329734|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146222351|NCT04963270|527329735|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
146222352|NCT04963270|527329736|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146222353|NCT04963270|527329737|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
146222354|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146222355|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146222356|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
146222357|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
146222358|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146222359|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146222360|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
146222361|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
146222362|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
146222363|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
146222364|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
146222365|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
146222366|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
146222367|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
146222368|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
146222369|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
145882541|NCT00631007|526076983|FG000|Overall Study|Persistent Hyperglycemia|2|||
145882542|NCT00631007|526076984|FG001|Overall Study|Persistent Hyperglycemia|2|||
145882543|NCT00631007|526076985|FG002|Overall Study|Persistent Hyperglycemia|5|||
145882544|NCT00631007|526076986|FG003|Overall Study|Persistent Hyperglycemia|1|||
145882545|NCT00631007|526076987|FG004|Overall Study|Persistent Hyperglycemia|2|||
145882546|NCT00631007|526076988|FG005|Overall Study|Persistent Hyperglycemia|5|||
146222370|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
146222371|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
145882547|NCT00631007|526076983|FG000|Overall Study|Withdrawal by Subject|4|||
145882548|NCT00631007|526076984|FG001|Overall Study|Withdrawal by Subject|5|||
145882549|NCT00631007|526076985|FG002|Overall Study|Withdrawal by Subject|2|||
145882550|NCT00631007|526076986|FG003|Overall Study|Withdrawal by Subject|2|||
146222372|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
146222373|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
146222374|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
146222375|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
146222376|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
146222377|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
146222378|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146222379|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146222380|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
146222381|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
146222382|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146222383|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146222384|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
146222385|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
146222386|NCT04963270|527329734|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146222387|NCT04963270|527329735|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146222388|NCT04963270|527329736|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
146222389|NCT04963270|527329737|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
146222390|NCT04802967|527329738|FG000|Part B|Withdrawal by Subject|0|||
146222391|NCT04802967|527329739|FG001|Part B|Withdrawal by Subject|0|||
146222392|NCT04802967|527329740|FG002|Part B|Withdrawal by Subject|0|||
146222393|NCT04802967|527329741|FG003|Part B|Withdrawal by Subject|0|||
146222394|NCT04802967|527329742|FG004|Part B|Withdrawal by Subject|0|||
146222395|NCT04802967|527329743|FG005|Part B|Withdrawal by Subject|1|||
146222396|NCT04802967|527329744|FG006|Part B|Withdrawal by Subject|0|||
146222397|NCT04802967|527329745|FG007|Part B|Withdrawal by Subject|0|||
146222398|NCT04802967|527329746|FG008|Part B|Withdrawal by Subject|0|||
146222399|NCT04802967|527329747|FG009|Part B|Withdrawal by Subject|0|||
146222400|NCT04195698|527329754|FG000|Overall Study|Adverse Event|4|||
146222401|NCT04195698|527329755|FG001|Overall Study|Adverse Event|11|||
146222402|NCT04195698|527329754|FG000|Overall Study|Withdrawal by Subject|9|||
146222403|NCT04195698|527329755|FG001|Overall Study|Withdrawal by Subject|10|||
146222404|NCT04195698|527329754|FG000|Overall Study|Lost to Follow-up|5|||
146222405|NCT04195698|527329755|FG001|Overall Study|Lost to Follow-up|4|||
146222406|NCT04195698|527329754|FG000|Overall Study|Lack of Efficacy|2|||
146222407|NCT04195698|527329755|FG001|Overall Study|Lack of Efficacy|10|||
146222408|NCT04195698|527329754|FG000|Overall Study|Other|5|||
146222409|NCT04195698|527329755|FG001|Overall Study|Other|4|||
146222410|NCT05459688|527329756|FG000|Overall Study|Lost to Follow-up|6|||
146222411|NCT05459688|527329756|FG000|Overall Study|Physician Decision|1|||
146222412|NCT05459688|527329756|FG000|Overall Study|Withdrawal by Subject|19|||
146222413|NCT05459688|527329756|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
146222414|NCT01129102|527329757|FG000|Overall Study|No study drug treatment|2|||
146222415|NCT01129102|527329758|FG001|Overall Study|No study drug treatment|3|||
146222416|NCT01129102|527329759|FG002|Overall Study|No study drug treatment|1|||
146222417|NCT01129102|527329757|FG000|Overall Study|Withdrawal by Subject|2|||
146222418|NCT01129102|527329758|FG001|Overall Study|Withdrawal by Subject|0|||
146222419|NCT01129102|527329759|FG002|Overall Study|Withdrawal by Subject|3|||
146222420|NCT01129102|527329757|FG000|Overall Study|Protocol Violation|0|||
146222421|NCT01129102|527329758|FG001|Overall Study|Protocol Violation|1|||
146222422|NCT01129102|527329759|FG002|Overall Study|Protocol Violation|1|||
146222423|NCT01129102|527329757|FG000|Overall Study|Pregnancy|0|||
146222424|NCT01129102|527329758|FG001|Overall Study|Pregnancy|0|||
146222425|NCT01129102|527329759|FG002|Overall Study|Pregnancy|1|||
146222426|NCT01129102|527329757|FG000|Overall Study|Adverse Event|2|||
146222427|NCT01129102|527329758|FG001|Overall Study|Adverse Event|2|||
146222428|NCT01129102|527329759|FG002|Overall Study|Adverse Event|1|||
146222429|NCT01129102|527329757|FG000|Overall Study|Lost to Follow-up|2|||
146222430|NCT01129102|527329758|FG001|Overall Study|Lost to Follow-up|0|||
146222431|NCT01129102|527329759|FG002|Overall Study|Lost to Follow-up|0|||
146222432|NCT03379675|527329762|FG000|Overall Study|Lost to Follow-up|0|||
146222433|NCT03379675|527329763|FG001|Overall Study|Lost to Follow-up|1|||
146222434|NCT03379675|527329764|FG002|Overall Study|Lost to Follow-up|0|||
146222435|NCT03379675|527329762|FG000|Overall Study|Adverse Event|2|||
146222436|NCT03379675|527329763|FG001|Overall Study|Adverse Event|0|||
146222437|NCT03379675|527329764|FG002|Overall Study|Adverse Event|0|||
146222438|NCT03379675|527329762|FG000|Overall Study|Withdrawal by Subject|2|||
146222439|NCT03379675|527329763|FG001|Overall Study|Withdrawal by Subject|1|||
146222440|NCT03379675|527329764|FG002|Overall Study|Withdrawal by Subject|2|||
146222441|NCT04332926|527329770|FG000|Overall Study|Withdrawal by Subject|6|||
146222442|NCT04332926|527329770|FG000|Overall Study|Physician Decision|6|||
146222443|NCT04376502|527329773|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
146222444|NCT02547233|527329774|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146222445|NCT02547233|527329775|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146222446|NCT02547233|527329774|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
146222447|NCT02547233|527329775|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
146222448|NCT02547233|527329774|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
146222449|NCT02547233|527329775|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
146222450|NCT02547233|527329774|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
146222451|NCT02547233|527329775|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
146222452|NCT02547233|527329774|FG000|12-month Follow-up|Withdrawal by Subject|10|||
146222453|NCT02547233|527329775|FG001|12-month Follow-up|Withdrawal by Subject|10|||
146222454|NCT02547233|527329774|FG000|12-month Follow-up|Lost to Follow-up|3|||
146222455|NCT02547233|527329775|FG001|12-month Follow-up|Lost to Follow-up|3|||
146222456|NCT02547233|527329774|FG000|12-month Follow-up|Lack of Efficacy|1|||
146222457|NCT02547233|527329775|FG001|12-month Follow-up|Lack of Efficacy|2|||
146222458|NCT02547233|527329774|FG000|12-month Follow-up|Protocol Violation|0|||
146222459|NCT02547233|527329775|FG001|12-month Follow-up|Protocol Violation|1|||
146222460|NCT02547233|527329774|FG000|12-month Follow-up|Other|0|||
146222461|NCT02547233|527329775|FG001|12-month Follow-up|Other|1|||
146222462|NCT06019559|527329776|FG000|Overall Study|Withdrawal by Subject|7|||
146222463|NCT06019559|527329777|FG001|Overall Study|Withdrawal by Subject|6|||
146222464|NCT06019559|527329778|FG002|Overall Study|Withdrawal by Subject|5|||
146222465|NCT06019559|527329776|FG000|Overall Study|Lost to Follow-up|2|||
146222466|NCT06019559|527329777|FG001|Overall Study|Lost to Follow-up|0|||
146222467|NCT06019559|527329778|FG002|Overall Study|Lost to Follow-up|3|||
146222468|NCT05949788|527329779|FG000|Overall Study|severe birth deformity|2|||
146222469|NCT05949788|527329780|FG001|Overall Study|severe birth deformity|7|||
146222470|NCT05949788|527329779|FG000|Overall Study|twin-twin transfusion syndrome|2|||
146222471|NCT05949788|527329780|FG001|Overall Study|twin-twin transfusion syndrome|7|||
146222472|NCT05949788|527329779|FG000|Overall Study|neonatal hemolytic disease|3|||
146222473|NCT05949788|527329780|FG001|Overall Study|neonatal hemolytic disease|8|||
146222474|NCT05949788|527329779|FG000|Overall Study|death within 14 days after birth|2|||
146222475|NCT05949788|527329780|FG001|Overall Study|death within 14 days after birth|6|||
146222476|NCT05949788|527329779|FG000|Overall Study|transfer to another hospital|2|||
146222477|NCT05949788|527329780|FG001|Overall Study|transfer to another hospital|6|||
146222478|NCT05213390|527329781|FG000|Overall Study|Withdrawal by Subject|2|||
146222479|NCT05213390|527329781|FG000|Overall Study|Lost to Follow-up|12|||
146222480|NCT05213390|527329781|FG000|Overall Study|Protocol Violation|9|||
146222481|NCT01824537|527329782|FG000|Overall Study|Lost to Follow-up|78|||
146222482|NCT01824537|527329783|FG001|Overall Study|Lost to Follow-up|87|||
146222483|NCT05362487|527329784|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
146222484|NCT06215521|527329785|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
146222485|NCT06215521|527329786|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
146222486|NCT06215521|527329787|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
146222487|NCT06215521|527329788|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
146222488|NCT06215521|527329789|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
146222489|NCT06215521|527329790|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
146222490|NCT04537715|527329797|FG000|Overall Study|Death|3|||
146222491|NCT04537715|527329798|FG001|Overall Study|Death|1|||
146222492|NCT04537715|527329797|FG000|Overall Study|Withdrawal by Subject|3|||
146222493|NCT04537715|527329798|FG001|Overall Study|Withdrawal by Subject|1|||
146222494|NCT04537715|527329797|FG000|Overall Study|Other|4|||
146222495|NCT04537715|527329798|FG001|Overall Study|Other|3|||
146222496|NCT04537715|527329797|FG000|Overall Study|Progressive disease|1|||
146222497|NCT04537715|527329798|FG001|Overall Study|Progressive disease|0|||
146222498|NCT02191618|527329799|FG000|Overall Study|Withdrawal by Subject|3|||
146222499|NCT02191618|527329799|FG000|Overall Study|Missed Visit|4|||
146222500|NCT04568603|527329802|FG000|Overall Study|Physician Decision|1|||
146222501|NCT05144009|527329803|FG000|Overall Study|Lost to Follow-up|0|||
146222502|NCT05144009|527329804|FG001|Overall Study|Lost to Follow-up|1|||
146222503|NCT05144009|527329803|FG000|Overall Study|Study Termination by the Sponsor|11|||
146222504|NCT05144009|527329804|FG001|Overall Study|Study Termination by the Sponsor|11|||
146222505|NCT05144009|527329803|FG000|Overall Study|Disease Progression|1|||
146222506|NCT05144009|527329804|FG001|Overall Study|Disease Progression|0|||
146222507|NCT05144009|527329803|FG000|Overall Study|Participant Decision|0|||
146222508|NCT05144009|527329804|FG001|Overall Study|Participant Decision|2|||
146222509|NCT05144009|527329803|FG000|Overall Study|Death|5|||
146222510|NCT05144009|527329804|FG001|Overall Study|Death|10|||
146222511|NCT05270408|527329809|FG000|Started Treatment|Withdrawal by Subject|0|||
146222512|NCT05270408|527329810|FG001|Started Treatment|Withdrawal by Subject|0|||
146222513|NCT05270408|527329811|FG002|Started Treatment|Withdrawal by Subject|3|||
146222514|NCT05270408|527329809|FG000|Started Treatment|Adverse Event|0|||
146222515|NCT05270408|527329810|FG001|Started Treatment|Adverse Event|0|||
146222516|NCT05270408|527329811|FG002|Started Treatment|Adverse Event|1|||
146222517|NCT05270408|527329809|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
146222518|NCT05270408|527329810|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
146222519|NCT05270408|527329811|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
146222520|NCT03768505|527329812|FG000|Overall Study|sponsor decision|76|||
146222521|NCT03768505|527329812|FG000|Overall Study|Death|35|||
145882551|NCT00631007|526076987|FG004|Overall Study|Withdrawal by Subject|1|||
145882552|NCT00631007|526076988|FG005|Overall Study|Withdrawal by Subject|3|||
145882553|NCT00631007|526076983|FG000|Overall Study|Other|2|||
145882554|NCT00631007|526076984|FG001|Overall Study|Other|1|||
145882555|NCT00631007|526076985|FG002|Overall Study|Other|0|||
145882556|NCT00631007|526076986|FG003|Overall Study|Other|0|||
145882557|NCT00631007|526076987|FG004|Overall Study|Other|1|||
145882558|NCT00631007|526076988|FG005|Overall Study|Other|0|||
145882559|NCT02674633|526076989|FG000|Overall Study|Lost to Follow-up|3|||
145882560|NCT02674633|526076990|FG001|Overall Study|Lost to Follow-up|2|||
145882561|NCT02674633|526076989|FG000|Overall Study|Physician Decision|1|||
145882562|NCT02674633|526076990|FG001|Overall Study|Physician Decision|0|||
145882563|NCT02674633|526076989|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145882564|NCT02674633|526076990|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145882565|NCT00683787|526076991|FG000|Overall Study|Progression|3|||
145882566|NCT00683787|526076992|FG001|Overall Study|Progression|3|||
145882567|NCT00683787|526076993|FG002|Overall Study|Progression|0|||
145882568|NCT00683787|526076991|FG000|Overall Study|Adverse Event|0|||
145882569|NCT00683787|526076992|FG001|Overall Study|Adverse Event|0|||
145882570|NCT00683787|526076993|FG002|Overall Study|Adverse Event|2|||
145882571|NCT00460109|526076994|FG000|Overall Study|Death|1|||
145882572|NCT01235715|526076995|FG000|Overall Study|Physician Decision|0|||
145882573|NCT01235715|526076996|FG001|Overall Study|Physician Decision|2|||
145882574|NCT03619876|526076997|FG000|Overall Study|Withdrawal by Subject|1|||
146085069|NCT05508074|526832060|FG000|Overall Study|wrongly randomized|0|||
146085070|NCT05508074|526832061|FG001|Overall Study|wrongly randomized|1|||
145882575|NCT03619876|526076998|FG001|Overall Study|Withdrawal by Subject|2|||
145882576|NCT03619876|526076997|FG000|Overall Study|Withdrawal due to incidental finding|0|||
145882577|NCT03619876|526076998|FG001|Overall Study|Withdrawal due to incidental finding|2|||
146085071|NCT05508074|526832060|FG000|Overall Study|non-compliance|0|||
145882578|NCT02344745|526076999|FG000|Overall Study|Data collection sheets were lost|2|||
145882579|NCT02344745|526077000|FG001|Overall Study|Data collection sheets were lost|0|||
145882580|NCT02788513|526077001|FG000|Overall Study|Withdrawal by Subject|3|||
145882581|NCT02788513|526077002|FG001|Overall Study|Withdrawal by Subject|0|||
145882582|NCT02788513|526077003|FG002|Overall Study|Withdrawal by Subject|2|||
145882583|NCT02788513|526077004|FG003|Overall Study|Withdrawal by Subject|3|||
145882584|NCT02788513|526077005|FG004|Overall Study|Withdrawal by Subject|1|||
145882585|NCT02788513|526077001|FG000|Overall Study|Lost to Follow-up|1|||
146222522|NCT03768505|527329812|FG000|Overall Study|Other -Various|30|||
146222523|NCT03768505|527329812|FG000|Overall Study|Withdrawal by Subject|22|||
146222524|NCT03768505|527329812|FG000|Overall Study|Lost to Follow-up|6|||
145882586|NCT02788513|526077002|FG001|Overall Study|Lost to Follow-up|0|||
145882587|NCT02788513|526077003|FG002|Overall Study|Lost to Follow-up|0|||
145882588|NCT02788513|526077004|FG003|Overall Study|Lost to Follow-up|0|||
145882589|NCT02788513|526077005|FG004|Overall Study|Lost to Follow-up|1|||
145882590|NCT02788513|526077001|FG000|Overall Study|Adverse Event|5|||
145882591|NCT02788513|526077002|FG001|Overall Study|Adverse Event|8|||
145882592|NCT02788513|526077003|FG002|Overall Study|Adverse Event|4|||
145882593|NCT02788513|526077004|FG003|Overall Study|Adverse Event|2|||
145882594|NCT02788513|526077005|FG004|Overall Study|Adverse Event|2|||
145882595|NCT02788513|526077001|FG000|Overall Study|Protocol Violation|0|||
145882596|NCT02788513|526077002|FG001|Overall Study|Protocol Violation|0|||
145882597|NCT02788513|526077003|FG002|Overall Study|Protocol Violation|1|||
145882598|NCT02788513|526077004|FG003|Overall Study|Protocol Violation|1|||
145882599|NCT02788513|526077005|FG004|Overall Study|Protocol Violation|0|||
145882600|NCT02788513|526077001|FG000|Overall Study|Subject decided to stop taking treatment|0|||
145882601|NCT02788513|526077002|FG001|Overall Study|Subject decided to stop taking treatment|0|||
145882602|NCT02788513|526077003|FG002|Overall Study|Subject decided to stop taking treatment|1|||
145882603|NCT02788513|526077004|FG003|Overall Study|Subject decided to stop taking treatment|0|||
145882604|NCT02788513|526077005|FG004|Overall Study|Subject decided to stop taking treatment|0|||
145882605|NCT02788513|526077001|FG000|Overall Study|Decision by the study team|0|||
145882606|NCT02788513|526077002|FG001|Overall Study|Decision by the study team|0|||
145882607|NCT02788513|526077003|FG002|Overall Study|Decision by the study team|0|||
146288687|NCT05182125|527571444|FG003|Overall Study|Withdrawal by Subject|0|||
146288688|NCT05182125|527571445|FG004|Overall Study|Withdrawal by Subject|2|||
146288689|NCT05182125|527571446|FG005|Overall Study|Withdrawal by Subject|0|||
146288690|NCT05182125|527571441|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
146288691|NCT05182125|527571442|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
146288692|NCT05182125|527571443|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
146288693|NCT05182125|527571444|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
146288694|NCT05182125|527571445|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
146288695|NCT05182125|527571446|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
146288696|NCT05182125|527571441|FG000|Overall Study|Death|0|||
146288697|NCT05182125|527571442|FG001|Overall Study|Death|0|||
146288698|NCT05182125|527571443|FG002|Overall Study|Death|0|||
146288699|NCT05182125|527571444|FG003|Overall Study|Death|0|||
146288700|NCT05182125|527571445|FG004|Overall Study|Death|1|||
146288701|NCT05182125|527571446|FG005|Overall Study|Death|0|||
146288702|NCT03519971|527571447|FG000|Overall Study|Death|142|||
146288703|NCT03519971|527571448|FG001|Overall Study|Death|69|||
146288704|NCT03519971|527571447|FG000|Overall Study|Lost to Follow-up|0|||
146288705|NCT03519971|527571448|FG001|Overall Study|Lost to Follow-up|1|||
146288706|NCT03519971|527571447|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
146288707|NCT03519971|527571448|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
145961148|NCT03380377|526369502|FG000|Overall Study|Physician Decision|1|||
146288708|NCT03519971|527571447|FG000|Overall Study|Withdrawal by Subject|3|||
146288709|NCT03519971|527571448|FG001|Overall Study|Withdrawal by Subject|2|||
146288710|NCT03519971|527571447|FG000|Overall Study|Other|1|||
146288711|NCT03519971|527571448|FG001|Overall Study|Other|0|||
145961149|NCT03380377|526369502|FG000|Overall Study|Withdrawal by Subject|1|||
145961150|NCT02716779|526369503|FG000|Monotherapy|Adverse Event|0|||
145961151|NCT02716779|526369504|FG001|Monotherapy|Adverse Event|1|||
145961152|NCT02716779|526369505|FG002|Monotherapy|Adverse Event|1|||
146222525|NCT05399459|527329818|FG000|Overall Study|Randomized but not treated|29|||
145961153|NCT02716779|526369503|FG000|Combination Therapy|Adverse Event|0|||
146222526|NCT05399459|527329819|FG001|Overall Study|Randomized but not treated|30|||
145961154|NCT02716779|526369504|FG001|Combination Therapy|Adverse Event|2|||
146222527|NCT05399459|527329820|FG002|Overall Study|Randomized but not treated|38|||
146222528|NCT05399459|527329818|FG000|Overall Study|Lost to Follow-up|1|||
146222529|NCT05399459|527329819|FG001|Overall Study|Lost to Follow-up|0|||
146222530|NCT05399459|527329820|FG002|Overall Study|Lost to Follow-up|0|||
146222531|NCT04992520|527329821|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
146222532|NCT04992520|527329822|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
146222533|NCT04992520|527329823|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
145882608|NCT02788513|526077004|FG003|Overall Study|Decision by the study team|0|||
146222534|NCT04992520|527329824|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
146222535|NCT04992520|527329825|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
146222536|NCT04992520|527329826|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
146222537|NCT04992520|527329821|FG000|Part A: First Challenge|Non-compliance|0|||
146222538|NCT04992520|527329822|FG001|Part A: First Challenge|Non-compliance|0|||
146222539|NCT04992520|527329823|FG002|Part A: First Challenge|Non-compliance|0|||
146222540|NCT04992520|527329824|FG003|Part A: First Challenge|Non-compliance|1|||
146222541|NCT04992520|527329825|FG004|Part A: First Challenge|Non-compliance|0|||
146222542|NCT04992520|527329826|FG005|Part A: First Challenge|Non-compliance|0|||
146222543|NCT04992520|527329821|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146222544|NCT04992520|527329822|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146222545|NCT04992520|527329823|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
145961155|NCT02716779|526369505|FG002|Combination Therapy|Adverse Event|1|||
145961156|NCT02600923|526369508|FG000|Overall Study|Death|10|||
145961157|NCT02600923|526369508|FG000|Overall Study|Adverse Event|3|||
145961158|NCT02600923|526369508|FG000|Overall Study|Global deterioration of health status|2|||
145961159|NCT02600923|526369508|FG000|Overall Study|Insufficient clinical response|6|||
145961160|NCT02600923|526369508|FG000|Overall Study|Lost to Follow-up|1|||
145961161|NCT02600923|526369508|FG000|Overall Study|Withdrawal by Subject|5|||
145961162|NCT02600923|526369508|FG000|Overall Study|Objective progression or relapse|50|||
145961163|NCT02600923|526369508|FG000|Overall Study|Study terminated by Sponsor|53|||
145882609|NCT02788513|526077005|FG004|Overall Study|Decision by the study team|1|||
145882610|NCT04982445|526077006|FG000|Overall Study|Protocol Violation|1|||
145882611|NCT04982445|526077006|FG000|Overall Study|Withdrawal by Subject|4|||
145882612|NCT04982445|526077006|FG000|Overall Study|Lost to Follow-up|1|||
145882613|NCT00835796|526077010|FG000|First Intervention|Withdrawal by Subject|0|||
145882614|NCT00835796|526077011|FG001|First Intervention|Withdrawal by Subject|1|||
145882615|NCT02327325|526077012|FG000|Overall Study|Withdrawal by Subject|1|||
145882616|NCT02327325|526077013|FG001|Overall Study|Withdrawal by Subject|4|||
145882617|NCT02327325|526077014|FG002|Overall Study|Withdrawal by Subject|4|||
145882618|NCT02327325|526077012|FG000|Overall Study|Excluded by Study Team|0|||
145882619|NCT02327325|526077013|FG001|Overall Study|Excluded by Study Team|0|||
145961164|NCT02600923|526369508|FG000|Overall Study|Not treated|1|||
145961165|NCT00792909|526369509|FG000|Overall Study|Withdrawal by Subject|0|||
145961166|NCT00792909|526369510|FG001|Overall Study|Withdrawal by Subject|1|||
145961167|NCT00792909|526369511|FG002|Overall Study|Withdrawal by Subject|0|||
145961168|NCT00385918|526369517|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
145961169|NCT00385918|526369518|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
145961170|NCT00385918|526369519|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
145961171|NCT00385918|526369517|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
145961172|NCT00385918|526369518|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
145961173|NCT00385918|526369519|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
145961174|NCT00385918|526369517|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
145961175|NCT00385918|526369518|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
145961176|NCT00385918|526369519|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
146222546|NCT04992520|527329824|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146222547|NCT04992520|527329825|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
146222548|NCT04992520|527329826|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
146222549|NCT04992520|527329821|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146222550|NCT04992520|527329822|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145882620|NCT02327325|526077014|FG002|Overall Study|Excluded by Study Team|1|||
145882621|NCT00651183|526077015|FG000|Overall Study|Lack of Efficacy|1|||
145961177|NCT00385918|526369517|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
145882622|NCT00651183|526077016|FG001|Overall Study|Lack of Efficacy|0|||
145961178|NCT00385918|526369518|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
145961179|NCT00385918|526369519|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
145961180|NCT00385918|526369517|FG000|Intervention Phase After Randomization|Physician Decision|1|||
145961181|NCT00385918|526369518|FG001|Intervention Phase After Randomization|Physician Decision|0|||
145961182|NCT00385918|526369519|FG002|Intervention Phase After Randomization|Physician Decision|0|||
145961183|NCT00385918|526369517|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
145961184|NCT00385918|526369518|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
146085072|NCT05508074|526832061|FG001|Overall Study|non-compliance|1|||
146222551|NCT04992520|527329823|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
146222552|NCT04992520|527329824|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146222553|NCT04992520|527329825|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146222554|NCT04992520|527329826|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
146222555|NCT05201079|527329827|FG000|Overall Study|Adverse Event|7|||
146222556|NCT05201079|527329828|FG001|Overall Study|Adverse Event|11|||
146222557|NCT05201079|527329827|FG000|Overall Study|Death|1|||
146085073|NCT05028361|526832062|FG000|Overall Study|Withdrawal by Subject|1|||
146085074|NCT05028361|526832063|FG001|Overall Study|Withdrawal by Subject|0|||
146222558|NCT05201079|527329828|FG001|Overall Study|Death|1|||
146222559|NCT05201079|527329827|FG000|Overall Study|Lack of Efficacy|0|||
146222560|NCT05201079|527329828|FG001|Overall Study|Lack of Efficacy|2|||
146222561|NCT05201079|527329827|FG000|Overall Study|Lost to Follow-up|0|||
146222562|NCT05201079|527329828|FG001|Overall Study|Lost to Follow-up|1|||
146222563|NCT05201079|527329827|FG000|Overall Study|Physician Decision|1|||
146222564|NCT05201079|527329828|FG001|Overall Study|Physician Decision|1|||
145882623|NCT00651183|526077015|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
145882624|NCT00651183|526077016|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
145882625|NCT00651183|526077015|FG000|Overall Study|Tolerability insufficient|5|||
145882626|NCT00651183|526077016|FG001|Overall Study|Tolerability insufficient|2|||
145882627|NCT00651183|526077015|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
146222565|NCT05201079|527329827|FG000|Overall Study|Protocol Violation|1|||
146222566|NCT05201079|527329828|FG001|Overall Study|Protocol Violation|0|||
146222567|NCT05201079|527329827|FG000|Overall Study|Withdrawal by Subject|1|||
146222568|NCT05201079|527329828|FG001|Overall Study|Withdrawal by Subject|0|||
146222569|NCT05201079|527329827|FG000|Overall Study|Forbidden medication|9|||
146222570|NCT05201079|527329828|FG001|Overall Study|Forbidden medication|5|||
146085075|NCT01993836|526832064|FG000|Overall Study|Surgery Cancelled|3|||
145882628|NCT00651183|526077016|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
145882629|NCT00651183|526077015|FG000|Overall Study|Withdrawal by Subject|6|||
145882630|NCT00651183|526077016|FG001|Overall Study|Withdrawal by Subject|3|||
145882631|NCT00651183|526077015|FG000|Overall Study|Lost to Follow-up|3|||
145882632|NCT00651183|526077016|FG001|Overall Study|Lost to Follow-up|1|||
145882633|NCT00651183|526077015|FG000|Overall Study|Other reasons|4|||
145882634|NCT00651183|526077016|FG001|Overall Study|Other reasons|2|||
145882635|NCT00651183|526077015|FG000|Overall Study|missing|1|||
145882636|NCT00651183|526077016|FG001|Overall Study|missing|0|||
145882637|NCT00763555|526077026|FG000|Overall Study|Adverse Event|2|||
146222571|NCT05201079|527329827|FG000|Overall Study|Transfer to another hospital|0|||
145882638|NCT00763555|526077027|FG001|Overall Study|Adverse Event|1|||
145882639|NCT00763555|526077026|FG000|Overall Study|Withdrawal by Subject|2|||
146085076|NCT01993836|526832065|FG001|Overall Study|Surgery Cancelled|0|||
146288712|NCT01078454|527571453|FG000|Overall Study|Adverse Event|1|||
146288713|NCT01078454|527571454|FG001|Overall Study|Adverse Event|1|||
146288714|NCT01078454|527571453|FG000|Overall Study|Death|0|||
146288715|NCT01078454|527571454|FG001|Overall Study|Death|1|||
146288716|NCT05227703|527571455|FG000|Overall Study|Adverse Event|2|||
146288717|NCT05227703|527571456|FG001|Overall Study|Adverse Event|6|||
146288718|NCT05227703|527571457|FG002|Overall Study|Adverse Event|4|||
146288719|NCT05227703|527571455|FG000|Overall Study|Lack of Efficacy|4|||
146288720|NCT05227703|527571456|FG001|Overall Study|Lack of Efficacy|0|||
146288721|NCT05227703|527571457|FG002|Overall Study|Lack of Efficacy|1|||
146288722|NCT05227703|527571455|FG000|Overall Study|Physician Decision|2|||
146288723|NCT05227703|527571456|FG001|Overall Study|Physician Decision|2|||
146288724|NCT05227703|527571457|FG002|Overall Study|Physician Decision|1|||
146288725|NCT05227703|527571455|FG000|Overall Study|Protocol Violation|2|||
146288726|NCT05227703|527571456|FG001|Overall Study|Protocol Violation|1|||
146288727|NCT05227703|527571457|FG002|Overall Study|Protocol Violation|0|||
146288728|NCT05227703|527571455|FG000|Overall Study|Withdrawal by Subject|17|||
146288729|NCT05227703|527571456|FG001|Overall Study|Withdrawal by Subject|26|||
146288730|NCT05227703|527571457|FG002|Overall Study|Withdrawal by Subject|32|||
146288731|NCT05227703|527571455|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
146288732|NCT05227703|527571456|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
145882640|NCT00763555|526077027|FG001|Overall Study|Withdrawal by Subject|6|||
145882641|NCT00763555|526077026|FG000|Overall Study|Lost to Follow-up|0|||
145882642|NCT00763555|526077027|FG001|Overall Study|Lost to Follow-up|3|||
145882643|NCT02510261|526077029|FG000|Overall Study|Adverse Event|5|||
145882644|NCT02510261|526077030|FG001|Overall Study|Adverse Event|8|||
145882645|NCT02510261|526077031|FG002|Overall Study|Adverse Event|0|||
145882646|NCT02510261|526077029|FG000|Overall Study|Physician Decision|1|||
146288733|NCT05227703|527571457|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
145882647|NCT02510261|526077030|FG001|Overall Study|Physician Decision|5|||
145882648|NCT02510261|526077031|FG002|Overall Study|Physician Decision|0|||
145882649|NCT02510261|526077029|FG000|Overall Study|Death|19|||
145882650|NCT02510261|526077030|FG001|Overall Study|Death|19|||
145882651|NCT02510261|526077031|FG002|Overall Study|Death|0|||
145882652|NCT02510261|526077029|FG000|Overall Study|Withdrawal by Subject|3|||
145882653|NCT02510261|526077030|FG001|Overall Study|Withdrawal by Subject|10|||
145882654|NCT02510261|526077031|FG002|Overall Study|Withdrawal by Subject|3|||
145882655|NCT01190930|526077035|FG000|Induction|Adverse Event|17|||
145882656|NCT01190930|526077036|FG001|Induction|Adverse Event|0|||
145882657|NCT01190930|526077037|FG002|Induction|Adverse Event|0|||
145882658|NCT01190930|526077038|FG003|Induction|Adverse Event|0|||
145882659|NCT01190930|526077039|FG004|Induction|Adverse Event|0|||
145882660|NCT01190930|526077040|FG005|Induction|Adverse Event|0|||
146288734|NCT05227703|527571455|FG000|Overall Study|Other|1|||
146288735|NCT05227703|527571456|FG001|Overall Study|Other|1|||
146288736|NCT05227703|527571457|FG002|Overall Study|Other|0|||
146288737|NCT04134845|527571459|FG000|Overall Study|withdrawl by PI|12|||
146288738|NCT04134845|527571460|FG001|Overall Study|withdrawl by PI|5|||
146288739|NCT03110224|527571461|FG000|Overall Study|Death|3|||
146222572|NCT05201079|527329828|FG001|Overall Study|Transfer to another hospital|1|||
146222573|NCT05201079|527329827|FG000|Overall Study|Clinical condition|1|||
146222574|NCT05201079|527329828|FG001|Overall Study|Clinical condition|0|||
146222575|NCT05201079|527329827|FG000|Overall Study|SAE and sepsis|1|||
146222576|NCT05201079|527329828|FG001|Overall Study|SAE and sepsis|0|||
146222577|NCT04145440|527329829|FG000|Overall Study|Physician Decision|3|||
146222578|NCT04145440|527329830|FG001|Overall Study|Physician Decision|0|||
146222579|NCT04145440|527329829|FG000|Overall Study|Use of prohibited therapy|2|||
146222580|NCT04145440|527329830|FG001|Overall Study|Use of prohibited therapy|3|||
146222581|NCT05281562|527329833|FG000|Overall Study|Ineligible patient|1|||
145882661|NCT01190930|526077041|FG006|Induction|Adverse Event|0|||
146222582|NCT05281562|527329834|FG001|Overall Study|Ineligible patient|0|||
146222583|NCT04880863|527329837|FG000|Overall Study|Adverse Event|1|||
146222584|NCT04880863|527329837|FG000|Overall Study|Patient decision|2|||
146222585|NCT04880863|527329837|FG000|Overall Study|Confirmed Disease Progression|15|||
146222586|NCT04880863|527329837|FG000|Overall Study|Death|3|||
146222587|NCT04880863|527329837|FG000|Overall Study|Physician Decision|4|||
146222588|NCT04880863|527329837|FG000|Overall Study|Unconfirmed Disease Progression|4|||
146222589|NCT04880863|527329837|FG000|Overall Study|Withdrawal by Subject|2|||
146222590|NCT04880863|527329837|FG000|Overall Study|Study discontinuation by the sponsor|4|||
146222591|NCT04880863|527329837|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
146222592|NCT04880863|527329837|FG000|Overall Study|Not received study drug NAP|2|||
146222593|NCT04898673|527329838|FG000|Overall Study|Screenfail|1|||
146222594|NCT04898673|527329839|FG001|Overall Study|Screenfail|0|||
146222595|NCT05239455|527329840|FG000|Overall Study|Adverse Event|1|||
146222596|NCT05239455|527329840|FG000|Overall Study|Sponsor Decision|5|||
146222597|NCT05239455|527329840|FG000|Overall Study|Incomplete Blood Collection|1|||
146222598|NCT03800654|527329841|FG000|Overall Study|Time constraints|3|||
146222599|NCT03800654|527329842|FG001|Overall Study|Time constraints|3|||
146222600|NCT03800654|527329843|FG002|Overall Study|Time constraints|3|||
146222601|NCT03800654|527329841|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
146222602|NCT03800654|527329842|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
146222603|NCT03800654|527329843|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
146222604|NCT03800654|527329841|FG000|Overall Study|Lost to Follow-up|2|||
146222605|NCT03800654|527329842|FG001|Overall Study|Lost to Follow-up|1|||
146222606|NCT03800654|527329843|FG002|Overall Study|Lost to Follow-up|6|||
146222607|NCT03800654|527329841|FG000|Overall Study|Medical Health Issue|0|||
146222608|NCT03800654|527329842|FG001|Overall Study|Medical Health Issue|0|||
146222609|NCT03800654|527329843|FG002|Overall Study|Medical Health Issue|1|||
146222610|NCT03800654|527329841|FG000|Overall Study|Personal Issues|0|||
146222611|NCT03800654|527329842|FG001|Overall Study|Personal Issues|2|||
146222612|NCT03800654|527329843|FG002|Overall Study|Personal Issues|0|||
146222613|NCT03800654|527329841|FG000|Overall Study|Protocol Violation|0|||
146222614|NCT03800654|527329842|FG001|Overall Study|Protocol Violation|1|||
146222615|NCT03800654|527329843|FG002|Overall Study|Protocol Violation|0|||
146222616|NCT04081103|527329845|FG000|Overall Study|Adverse Event|1|||
146222617|NCT04081103|527329846|FG001|Overall Study|Adverse Event|1|||
146222618|NCT04081103|527329847|FG002|Overall Study|Adverse Event|1|||
145882662|NCT01190930|526077042|FG007|Induction|Adverse Event|0|||
146222619|NCT04081103|527329845|FG000|Overall Study|Physician Decision|0|||
146222620|NCT04081103|527329846|FG001|Overall Study|Physician Decision|0|||
146222621|NCT04081103|527329847|FG002|Overall Study|Physician Decision|1|||
146222622|NCT03365882|527329850|FG000|Randomization|Still Receiving Protocol Treatment|2|||
146222623|NCT03365882|527329851|FG001|Randomization|Still Receiving Protocol Treatment|0|||
146222624|NCT03365882|527329850|FG000|Randomization|Adverse Event|1|||
146222625|NCT03365882|527329851|FG001|Randomization|Adverse Event|2|||
146222626|NCT03365882|527329850|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
146222627|NCT03365882|527329851|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
146222628|NCT03365882|527329850|FG000|Randomization|Progression/Relapse|21|||
146222629|NCT03365882|527329851|FG001|Randomization|Progression/Relapse|3|||
146222630|NCT03365882|527329850|FG000|Randomization|Death|1|||
146222631|NCT03365882|527329851|FG001|Randomization|Death|0|||
146222632|NCT03365882|527329850|FG000|Randomization|Other - Not Protocol Specified|1|||
146222633|NCT03365882|527329851|FG001|Randomization|Other - Not Protocol Specified|1|||
146222634|NCT03365882|527329850|FG000|Randomization|Major Protocol Deviation|0|||
146222635|NCT03365882|527329851|FG001|Randomization|Major Protocol Deviation|1|||
146222636|NCT03365882|527329850|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
146222637|NCT03365882|527329851|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
146222638|NCT03365882|527329850|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
146222639|NCT03365882|527329851|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
146222640|NCT03365882|527329850|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
146222641|NCT03365882|527329851|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
146222642|NCT03365882|527329850|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
146222643|NCT03365882|527329851|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
146222644|NCT03287817|527331529|FG000|Overall Study|Progressive disease|4|||
146222645|NCT03287817|527331530|FG001|Overall Study|Progressive disease|2|||
146222646|NCT03287817|527331531|FG002|Overall Study|Progressive disease|3|||
146222647|NCT03287817|527331532|FG003|Overall Study|Progressive disease|10|||
146222648|NCT03287817|527331533|FG004|Overall Study|Progressive disease|8|||
146222649|NCT03287817|527331529|FG000|Overall Study|Death|0|||
146222650|NCT03287817|527331530|FG001|Overall Study|Death|0|||
146222651|NCT03287817|527331531|FG002|Overall Study|Death|2|||
146222652|NCT03287817|527331532|FG003|Overall Study|Death|3|||
146222653|NCT03287817|527331533|FG004|Overall Study|Death|4|||
146222654|NCT03287817|527331529|FG000|Overall Study|Physician Decision|0|||
146222655|NCT03287817|527331530|FG001|Overall Study|Physician Decision|0|||
146222656|NCT03287817|527331531|FG002|Overall Study|Physician Decision|0|||
146222657|NCT03287817|527331532|FG003|Overall Study|Physician Decision|1|||
146222658|NCT03287817|527331533|FG004|Overall Study|Physician Decision|0|||
146222659|NCT03287817|527331529|FG000|Overall Study|Withdrawal by Subject|0|||
146222660|NCT03287817|527331530|FG001|Overall Study|Withdrawal by Subject|0|||
146222661|NCT03287817|527331531|FG002|Overall Study|Withdrawal by Subject|0|||
146222662|NCT03287817|527331532|FG003|Overall Study|Withdrawal by Subject|0|||
146222663|NCT03287817|527331533|FG004|Overall Study|Withdrawal by Subject|4|||
146222664|NCT06181227|527331534|FG000|Overall Study|Study terminated by sponsor|7|||
146222665|NCT06181227|527331535|FG001|Overall Study|Study terminated by sponsor|9|||
146222666|NCT05543915|527331536|FG000|Overall Study|Lost to Follow-up|0|||
146222667|NCT05543915|527331537|FG001|Overall Study|Lost to Follow-up|1|||
146222668|NCT00470704|527331540|FG000|Overall Study|Withdrawal by Subject|4|||
146222669|NCT00470704|527331541|FG001|Overall Study|Withdrawal by Subject|3|||
146222670|NCT00470704|527331540|FG000|Overall Study|Relapse/Progression|37|||
146222671|NCT00470704|527331541|FG001|Overall Study|Relapse/Progression|42|||
146222672|NCT00470704|527331540|FG000|Overall Study|toxicity|0|||
146222673|NCT00470704|527331541|FG001|Overall Study|toxicity|1|||
146222674|NCT02561247|527331542|FG000|Overall Study|Protocol Violation|1|||
146222675|NCT02561247|527331542|FG000|Overall Study|Withdrawal by Subject|1|||
146222676|NCT02561247|527331542|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
146222677|NCT04987320|527331544|FG000|Overall Study|Withdrawal by Subject|0|||
146222678|NCT04987320|527331545|FG001|Overall Study|Withdrawal by Subject|1|||
146222679|NCT00085735|527331546|FG000|Overall Study|Adverse Event|1|||
146222680|NCT00085735|527331547|FG001|Overall Study|Adverse Event|0|||
146222681|NCT00085735|527331548|FG002|Overall Study|Adverse Event|0|||
146222682|NCT00085735|527331549|FG003|Overall Study|Adverse Event|0|||
146222683|NCT00085735|527331550|FG004|Overall Study|Adverse Event|0|||
146222684|NCT00085735|527331551|FG005|Overall Study|Adverse Event|0|||
146222685|NCT00085735|527331546|FG000|Overall Study|Lack of Efficacy|2|||
146222686|NCT00085735|527331547|FG001|Overall Study|Lack of Efficacy|4|||
146222687|NCT00085735|527331548|FG002|Overall Study|Lack of Efficacy|6|||
146222688|NCT00085735|527331549|FG003|Overall Study|Lack of Efficacy|3|||
146222689|NCT00085735|527331550|FG004|Overall Study|Lack of Efficacy|4|||
146222690|NCT00085735|527331551|FG005|Overall Study|Lack of Efficacy|3|||
146222691|NCT00085735|527331546|FG000|Overall Study|Lost to Follow-up|0|||
146222692|NCT00085735|527331547|FG001|Overall Study|Lost to Follow-up|1|||
146222693|NCT00085735|527331548|FG002|Overall Study|Lost to Follow-up|0|||
146222694|NCT00085735|527331549|FG003|Overall Study|Lost to Follow-up|0|||
146222695|NCT00085735|527331550|FG004|Overall Study|Lost to Follow-up|1|||
146222696|NCT00085735|527331551|FG005|Overall Study|Lost to Follow-up|0|||
146222697|NCT00085735|527331546|FG000|Overall Study|Physician Decision|2|||
146222698|NCT00085735|527331547|FG001|Overall Study|Physician Decision|3|||
146222699|NCT00085735|527331548|FG002|Overall Study|Physician Decision|2|||
146222700|NCT00085735|527331549|FG003|Overall Study|Physician Decision|3|||
146222701|NCT00085735|527331550|FG004|Overall Study|Physician Decision|11|||
146222702|NCT00085735|527331551|FG005|Overall Study|Physician Decision|8|||
146222703|NCT00085735|527331546|FG000|Overall Study|Protocol Violation|1|||
146222704|NCT00085735|527331547|FG001|Overall Study|Protocol Violation|0|||
146222705|NCT00085735|527331548|FG002|Overall Study|Protocol Violation|0|||
146222706|NCT00085735|527331549|FG003|Overall Study|Protocol Violation|0|||
146222707|NCT00085735|527331550|FG004|Overall Study|Protocol Violation|0|||
146222708|NCT00085735|527331551|FG005|Overall Study|Protocol Violation|0|||
146222709|NCT00085735|527331546|FG000|Overall Study|Withdrawal by Subject|1|||
146222710|NCT00085735|527331547|FG001|Overall Study|Withdrawal by Subject|0|||
146222711|NCT00085735|527331548|FG002|Overall Study|Withdrawal by Subject|4|||
146222712|NCT00085735|527331549|FG003|Overall Study|Withdrawal by Subject|5|||
146222713|NCT00085735|527331550|FG004|Overall Study|Withdrawal by Subject|7|||
146222714|NCT00085735|527331551|FG005|Overall Study|Withdrawal by Subject|8|||
146222715|NCT00085735|527331546|FG000|Overall Study|Patient ineligible|1|||
146222716|NCT00085735|527331547|FG001|Overall Study|Patient ineligible|0|||
146222717|NCT00085735|527331548|FG002|Overall Study|Patient ineligible|3|||
146222718|NCT00085735|527331549|FG003|Overall Study|Patient ineligible|7|||
146222719|NCT00085735|527331550|FG004|Overall Study|Patient ineligible|17|||
146222720|NCT00085735|527331551|FG005|Overall Study|Patient ineligible|8|||
146222721|NCT00085735|527331546|FG000|Overall Study|Excess residual disease|2|||
146222722|NCT00085735|527331547|FG001|Overall Study|Excess residual disease|2|||
146222723|NCT00085735|527331548|FG002|Overall Study|Excess residual disease|1|||
146222724|NCT00085735|527331549|FG003|Overall Study|Excess residual disease|1|||
146222725|NCT00085735|527331550|FG004|Overall Study|Excess residual disease|1|||
146222726|NCT00085735|527331551|FG005|Overall Study|Excess residual disease|4|||
146222727|NCT00085735|527331546|FG000|Overall Study|Reason not documented|1|||
146222728|NCT00085735|527331547|FG001|Overall Study|Reason not documented|0|||
146288740|NCT03110224|527571461|FG000|Overall Study|Lost to Follow-up|132|||
146288741|NCT03110224|527571461|FG000|Overall Study|Physician Decision|2|||
146222729|NCT00085735|527331548|FG002|Overall Study|Reason not documented|1|||
146222730|NCT00085735|527331549|FG003|Overall Study|Reason not documented|0|||
146222731|NCT00085735|527331550|FG004|Overall Study|Reason not documented|1|||
146222732|NCT00085735|527331551|FG005|Overall Study|Reason not documented|0|||
146222733|NCT00085735|527331546|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
146222734|NCT00085735|527331547|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
146222735|NCT00085735|527331548|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
145882663|NCT01190930|526077043|FG008|Induction|Adverse Event|0|||
145882664|NCT01190930|526077044|FG009|Induction|Adverse Event|0|||
145882665|NCT01190930|526077035|FG000|Induction|Death|34|||
145882666|NCT01190930|526077036|FG001|Induction|Death|0|||
145882667|NCT01190930|526077037|FG002|Induction|Death|0|||
145882668|NCT01190930|526077038|FG003|Induction|Death|0|||
146222736|NCT00085735|527331549|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
146222737|NCT00085735|527331550|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
146222738|NCT00085735|527331551|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
146222739|NCT01824875|527331552|FG000|Overall Study|Disease progression|22|||
146222740|NCT01824875|527331553|FG001|Overall Study|Disease progression|15|||
146222741|NCT01824875|527331552|FG000|Overall Study|Withdrawal by Subject|5|||
146222742|NCT01824875|527331553|FG001|Overall Study|Withdrawal by Subject|4|||
146222743|NCT01824875|527331552|FG000|Overall Study|Adverse Event|4|||
146222744|NCT01824875|527331553|FG001|Overall Study|Adverse Event|10|||
146222745|NCT01824875|527331552|FG000|Overall Study|Alternative therapy|3|||
146222746|NCT01824875|527331553|FG001|Overall Study|Alternative therapy|0|||
146222747|NCT01824875|527331552|FG000|Overall Study|Complicating disease|1|||
146222748|NCT01824875|527331553|FG001|Overall Study|Complicating disease|0|||
146222749|NCT01824875|527331552|FG000|Overall Study|Physician Decision|0|||
146222750|NCT01824875|527331553|FG001|Overall Study|Physician Decision|1|||
146222751|NCT01824875|527331552|FG000|Overall Study|Non-compliance|1|||
146222752|NCT01824875|527331553|FG001|Overall Study|Non-compliance|1|||
146222753|NCT01824875|527331552|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
146222754|NCT01824875|527331553|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
146222755|NCT01824875|527331552|FG000|Overall Study|Administrative issues|0|||
146222756|NCT01824875|527331553|FG001|Overall Study|Administrative issues|2|||
146222757|NCT01824875|527331552|FG000|Overall Study|Ineligible or never started treatment|9|||
146222758|NCT01824875|527331553|FG001|Overall Study|Ineligible or never started treatment|5|||
146222759|NCT01824875|527331552|FG000|Overall Study|Other|0|||
146222760|NCT01824875|527331553|FG001|Overall Study|Other|2|||
146222761|NCT02817776|527331554|FG000|Overall Study|Excluded|33|||
146222762|NCT02817776|527331554|FG000|Overall Study|Lost to Follow-up|20|||
146222763|NCT02817776|527331554|FG000|Overall Study|Withdrawal by Subject|33|||
145882669|NCT01190930|526077039|FG004|Induction|Death|0|||
145882670|NCT01190930|526077040|FG005|Induction|Death|0|||
145882671|NCT01190930|526077041|FG006|Induction|Death|0|||
146222764|NCT02817776|527331554|FG000|Overall Study|Death|2|||
146222765|NCT05540665|527331555|FG000|Overall Study|Study terminated by sponsor|6|||
146288742|NCT03110224|527571461|FG000|Overall Study|Site Closed by Physician|35|||
146288743|NCT03110224|527571461|FG000|Overall Study|Site Closed by Sponsor|202|||
146288744|NCT03110224|527571461|FG000|Overall Study|Withdrawal by Subject|9|||
146288745|NCT05328167|527571462|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
146288746|NCT05328167|527571462|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
146288747|NCT00112047|527571463|FG000|Randomized Phase|Lost to Follow-up|26|||
146288748|NCT00112047|527571464|FG001|Randomized Phase|Lost to Follow-up|33|||
146288749|NCT00112047|527571463|FG000|Randomized Phase|Adverse Event|10|||
146288750|NCT00112047|527571464|FG001|Randomized Phase|Adverse Event|10|||
146288751|NCT00112047|527571463|FG000|Randomized Phase|Withrawal of consent|10|||
146288752|NCT00112047|527571464|FG001|Randomized Phase|Withrawal of consent|18|||
146288753|NCT00112047|527571463|FG000|Randomized Phase|Sub-optimal virological response|3|||
146288754|NCT00112047|527571464|FG001|Randomized Phase|Sub-optimal virological response|13|||
146288755|NCT00112047|527571463|FG000|Randomized Phase|Noncompliance|8|||
146288756|NCT00112047|527571464|FG001|Randomized Phase|Noncompliance|4|||
145882672|NCT01190930|526077042|FG007|Induction|Death|0|||
145882673|NCT01190930|526077043|FG008|Induction|Death|0|||
145882674|NCT01190930|526077044|FG009|Induction|Death|0|||
145882675|NCT01190930|526077035|FG000|Induction|Lost to Follow-up|1|||
145882676|NCT01190930|526077036|FG001|Induction|Lost to Follow-up|0|||
145882677|NCT01190930|526077037|FG002|Induction|Lost to Follow-up|0|||
145882678|NCT01190930|526077038|FG003|Induction|Lost to Follow-up|0|||
145882679|NCT01190930|526077039|FG004|Induction|Lost to Follow-up|0|||
145882680|NCT01190930|526077040|FG005|Induction|Lost to Follow-up|0|||
145882681|NCT01190930|526077041|FG006|Induction|Lost to Follow-up|0|||
145882682|NCT01190930|526077042|FG007|Induction|Lost to Follow-up|0|||
145882683|NCT01190930|526077043|FG008|Induction|Lost to Follow-up|0|||
145882684|NCT01190930|526077044|FG009|Induction|Lost to Follow-up|0|||
145882685|NCT01190930|526077035|FG000|Induction|Physician Decision|125|||
145882686|NCT01190930|526077036|FG001|Induction|Physician Decision|3|||
145882687|NCT01190930|526077037|FG002|Induction|Physician Decision|0|||
145882688|NCT01190930|526077038|FG003|Induction|Physician Decision|0|||
145882689|NCT01190930|526077039|FG004|Induction|Physician Decision|0|||
145882690|NCT01190930|526077040|FG005|Induction|Physician Decision|0|||
145882691|NCT01190930|526077041|FG006|Induction|Physician Decision|0|||
145882692|NCT01190930|526077042|FG007|Induction|Physician Decision|0|||
146288757|NCT00112047|527571463|FG000|Randomized Phase|Protocol Violation|2|||
146288758|NCT00112047|527571464|FG001|Randomized Phase|Protocol Violation|0|||
146288759|NCT00112047|527571463|FG000|Randomized Phase|Pregnancy|3|||
146222766|NCT05540665|527331556|FG001|Overall Study|Study terminated by sponsor|6|||
146222767|NCT05540665|527331557|FG002|Overall Study|Study terminated by sponsor|7|||
146222768|NCT03462030|527331560|FG000|Overall Study|Withdrawal by Subject|1|||
146222769|NCT03462030|527331561|FG001|Overall Study|Withdrawal by Subject|1|||
146222770|NCT02675751|527331562|FG000|Overall Study|Lost to Follow-up|16|||
146222771|NCT03371381|527331563|FG000|Overall Study|Death|5|||
146222772|NCT03371381|527331563|FG000|Overall Study|Study terminated by sponsor|3|||
145882693|NCT01190930|526077043|FG008|Induction|Physician Decision|0|||
145882694|NCT01190930|526077044|FG009|Induction|Physician Decision|0|||
145882695|NCT01190930|526077035|FG000|Induction|Withdrawal by Subject|9|||
145882696|NCT01190930|526077036|FG001|Induction|Withdrawal by Subject|0|||
145882697|NCT01190930|526077037|FG002|Induction|Withdrawal by Subject|0|||
145882698|NCT01190930|526077038|FG003|Induction|Withdrawal by Subject|0|||
145882699|NCT01190930|526077039|FG004|Induction|Withdrawal by Subject|0|||
145882700|NCT01190930|526077040|FG005|Induction|Withdrawal by Subject|0|||
145882701|NCT01190930|526077041|FG006|Induction|Withdrawal by Subject|0|||
145882702|NCT01190930|526077042|FG007|Induction|Withdrawal by Subject|0|||
145882703|NCT01190930|526077043|FG008|Induction|Withdrawal by Subject|0|||
145882704|NCT01190930|526077044|FG009|Induction|Withdrawal by Subject|0|||
145882705|NCT01190930|526077035|FG000|Induction|Refusal|235|||
145882706|NCT01190930|526077036|FG001|Induction|Refusal|0|||
145882707|NCT01190930|526077037|FG002|Induction|Refusal|0|||
145882708|NCT01190930|526077038|FG003|Induction|Refusal|0|||
145882709|NCT01190930|526077039|FG004|Induction|Refusal|0|||
145882710|NCT01190930|526077040|FG005|Induction|Refusal|0|||
145882711|NCT01190930|526077041|FG006|Induction|Refusal|0|||
145882712|NCT01190930|526077042|FG007|Induction|Refusal|0|||
145882713|NCT01190930|526077043|FG008|Induction|Refusal|0|||
145882714|NCT01190930|526077044|FG009|Induction|Refusal|0|||
145882715|NCT01190930|526077035|FG000|Induction|Inevaluable|23|||
145882716|NCT01190930|526077036|FG001|Induction|Inevaluable|1|||
145882717|NCT01190930|526077037|FG002|Induction|Inevaluable|0|||
145882718|NCT01190930|526077038|FG003|Induction|Inevaluable|0|||
145882719|NCT01190930|526077039|FG004|Induction|Inevaluable|0|||
145882720|NCT01190930|526077040|FG005|Induction|Inevaluable|0|||
145882721|NCT01190930|526077041|FG006|Induction|Inevaluable|0|||
145882722|NCT01190930|526077042|FG007|Induction|Inevaluable|0|||
145882723|NCT01190930|526077043|FG008|Induction|Inevaluable|0|||
145882724|NCT01190930|526077044|FG009|Induction|Inevaluable|0|||
145882725|NCT01190930|526077035|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
145882726|NCT01190930|526077036|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882727|NCT01190930|526077037|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882728|NCT01190930|526077038|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882729|NCT01190930|526077039|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882730|NCT01190930|526077040|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882731|NCT01190930|526077041|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882732|NCT01190930|526077042|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882733|NCT01190930|526077043|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882734|NCT01190930|526077044|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145882735|NCT01190930|526077035|FG000|Induction|High Risk Downs|80|||
145882736|NCT01190930|526077036|FG001|Induction|High Risk Downs|0|||
146222773|NCT03371381|527331563|FG000|Overall Study|Other|4|||
145882737|NCT01190930|526077037|FG002|Induction|High Risk Downs|0|||
145882738|NCT01190930|526077038|FG003|Induction|High Risk Downs|0|||
145882739|NCT01190930|526077039|FG004|Induction|High Risk Downs|0|||
145882740|NCT01190930|526077040|FG005|Induction|High Risk Downs|0|||
145882741|NCT01190930|526077041|FG006|Induction|High Risk Downs|0|||
146222774|NCT02979327|527331564|FG000|First Intervention|Protocol Violation|1|||
146222775|NCT02979327|527331565|FG001|First Intervention|Protocol Violation|0|||
146222776|NCT01073566|527331566|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
146222777|NCT01073566|527331567|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
146222778|NCT05672069|527331574|FG000|Overall Study|Implant removal|1|||
146222779|NCT05672069|527331574|FG000|Overall Study|Lost to Follow-up|2|||
146222780|NCT03858634|527331577|FG000|Overall Study|Withdrawal by Subject|1|||
145882742|NCT01190930|526077042|FG007|Induction|High Risk Downs|0|||
145882743|NCT01190930|526077043|FG008|Induction|High Risk Downs|0|||
145882744|NCT01190930|526077044|FG009|Induction|High Risk Downs|0|||
145882745|NCT01190930|526077035|FG000|Induction|Enrollment onto another COG Protocol|1|||
145882746|NCT01190930|526077036|FG001|Induction|Enrollment onto another COG Protocol|0|||
145882747|NCT01190930|526077037|FG002|Induction|Enrollment onto another COG Protocol|0|||
146222781|NCT03858634|527331578|FG001|Overall Study|Withdrawal by Subject|0|||
146288760|NCT00112047|527571464|FG001|Randomized Phase|Pregnancy|1|||
146288761|NCT00112047|527571463|FG000|Randomized Phase|Death|1|||
146288762|NCT00112047|527571464|FG001|Randomized Phase|Death|3|||
146288763|NCT00112047|527571463|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
146288764|NCT00112047|527571464|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
146288765|NCT00112047|527571463|FG000|Randomized Phase|Inability to swallow pills|0|||
146288766|NCT00112047|527571464|FG001|Randomized Phase|Inability to swallow pills|1|||
146288767|NCT00112047|527571463|FG000|Randomized Phase|Incarceration|3|||
146288768|NCT00112047|527571464|FG001|Randomized Phase|Incarceration|2|||
146288769|NCT00112047|527571463|FG000|Randomized Phase|Moved out of State|0|||
146288770|NCT00112047|527571464|FG001|Randomized Phase|Moved out of State|1|||
146288771|NCT00112047|527571463|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
146288772|NCT00112047|527571464|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
145882748|NCT01190930|526077038|FG003|Induction|Enrollment onto another COG Protocol|0|||
145882749|NCT01190930|526077039|FG004|Induction|Enrollment onto another COG Protocol|0|||
145882750|NCT01190930|526077040|FG005|Induction|Enrollment onto another COG Protocol|0|||
145882751|NCT01190930|526077041|FG006|Induction|Enrollment onto another COG Protocol|0|||
145882752|NCT01190930|526077042|FG007|Induction|Enrollment onto another COG Protocol|0|||
145882753|NCT01190930|526077043|FG008|Induction|Enrollment onto another COG Protocol|0|||
145882754|NCT01190930|526077044|FG009|Induction|Enrollment onto another COG Protocol|0|||
146288773|NCT00112047|527571463|FG000|Randomized Phase|High Hepatitis B DNA|0|||
146288774|NCT00112047|527571464|FG001|Randomized Phase|High Hepatitis B DNA|1|||
146288775|NCT00112047|527571463|FG000|Atripla Phase|Adverse Event|2|||
146288776|NCT00112047|527571464|FG001|Atripla Phase|Adverse Event|1|||
146222782|NCT03858634|527331577|FG000|Overall Study|Adverse Event|1|||
146222783|NCT03858634|527331578|FG001|Overall Study|Adverse Event|0|||
146222784|NCT03858634|527331577|FG000|Overall Study|Lost to Follow-up|0|||
146222785|NCT03858634|527331578|FG001|Overall Study|Lost to Follow-up|1|||
146222786|NCT03858634|527331577|FG000|Overall Study|Other, Not Specified|1|||
146222787|NCT03858634|527331578|FG001|Overall Study|Other, Not Specified|1|||
146222788|NCT03150173|527331579|FG000|Overall Study|Lost to Follow-up|13|||
146222789|NCT03150173|527331580|FG001|Overall Study|Lost to Follow-up|5|||
146222790|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
146222791|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
145882755|NCT01190930|526077035|FG000|Induction|Average Risk|1847|||
145882756|NCT01190930|526077036|FG001|Induction|Average Risk|0|||
145882757|NCT01190930|526077037|FG002|Induction|Average Risk|0|||
145882758|NCT01190930|526077038|FG003|Induction|Average Risk|0|||
145882759|NCT01190930|526077039|FG004|Induction|Average Risk|0|||
145882760|NCT01190930|526077040|FG005|Induction|Average Risk|0|||
145882761|NCT01190930|526077041|FG006|Induction|Average Risk|0|||
145882762|NCT01190930|526077042|FG007|Induction|Average Risk|0|||
145882763|NCT01190930|526077043|FG008|Induction|Average Risk|0|||
145882764|NCT01190930|526077044|FG009|Induction|Average Risk|0|||
145882765|NCT01190930|526077035|FG000|Induction|High Risk|1227|||
146222792|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
146222793|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
145882766|NCT01190930|526077036|FG001|Induction|High Risk|0|||
145882767|NCT01190930|526077037|FG002|Induction|High Risk|0|||
145882768|NCT01190930|526077038|FG003|Induction|High Risk|0|||
146222794|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
146222795|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
146222796|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
146222797|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
146222798|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
146222799|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
146222800|NCT03461276|527331582|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
146222801|NCT03461276|527331583|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
146222802|NCT03461276|527331582|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
146222803|NCT03461276|527331583|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
146222804|NCT03461276|527331582|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
146222805|NCT03461276|527331583|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
146222806|NCT03461276|527331582|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
146222807|NCT03461276|527331583|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
146222808|NCT03461276|527331582|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
146222809|NCT03461276|527331583|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
146222810|NCT01802788|527331585|FG000|Overall Study|Withdrawal by Subject|102|||
146222811|NCT01802788|527331586|FG001|Overall Study|Withdrawal by Subject|5|||
146222812|NCT01802788|527331585|FG000|Overall Study|Death|382|||
146222813|NCT01802788|527331586|FG001|Overall Study|Death|18|||
146222814|NCT01802788|527331585|FG000|Overall Study|Lost to Follow-up|31|||
146222815|NCT01802788|527331586|FG001|Overall Study|Lost to Follow-up|2|||
146222816|NCT01802788|527331585|FG000|Overall Study|Physician Decision|3|||
146222817|NCT01802788|527331586|FG001|Overall Study|Physician Decision|0|||
146222818|NCT01802788|527331585|FG000|Overall Study|Patient Non-Compliance|1|||
146222819|NCT01802788|527331586|FG001|Overall Study|Patient Non-Compliance|0|||
146222820|NCT01802788|527331585|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
146222821|NCT01802788|527331586|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
146222822|NCT01802788|527331585|FG000|Overall Study|Other Reasons|19|||
146222823|NCT01802788|527331586|FG001|Overall Study|Other Reasons|0|||
146222824|NCT02043678|527331587|FG000|Overall Study|Never treated|11|||
146222825|NCT02043678|527331588|FG001|Overall Study|Never treated|9|||
146222826|NCT02043678|527331587|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
146222827|NCT02043678|527331588|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
146222828|NCT02043678|527331587|FG000|Overall Study|AE without clinical PD|54|||
146222829|NCT02043678|527331588|FG001|Overall Study|AE without clinical PD|36|||
146222830|NCT02043678|527331587|FG000|Overall Study|Lost to Follow-up|1|||
146222831|NCT02043678|527331588|FG001|Overall Study|Lost to Follow-up|1|||
146222832|NCT02043678|527331587|FG000|Overall Study|Other|10|||
146222833|NCT02043678|527331588|FG001|Overall Study|Other|14|||
146222834|NCT02043678|527331587|FG000|Overall Study|Clinical PD|114|||
146222835|NCT02043678|527331588|FG001|Overall Study|Clinical PD|148|||
146222836|NCT02043678|527331587|FG000|Overall Study|Radiological PD|100|||
146222837|NCT02043678|527331588|FG001|Overall Study|Radiological PD|90|||
146222838|NCT02043678|527331587|FG000|Overall Study|Protocol-driven decision point|59|||
146222839|NCT02043678|527331588|FG001|Overall Study|Protocol-driven decision point|58|||
146222840|NCT02043678|527331587|FG000|Overall Study|Withdrawal by Subject|16|||
146222841|NCT02043678|527331588|FG001|Overall Study|Withdrawal by Subject|20|||
146222842|NCT02043678|527331587|FG000|Overall Study|Protocol Violation|1|||
146222843|NCT02043678|527331588|FG001|Overall Study|Protocol Violation|0|||
146222844|NCT02043678|527331587|FG000|Overall Study|Deterioration of general conditions|1|||
146222845|NCT02043678|527331588|FG001|Overall Study|Deterioration of general conditions|1|||
146222846|NCT02043678|527331587|FG000|Overall Study|Logistical difficulties|2|||
146222847|NCT02043678|527331588|FG001|Overall Study|Logistical difficulties|0|||
146222848|NCT02043678|527331587|FG000|Overall Study|Non-compliance with study drug|3|||
146222849|NCT02043678|527331588|FG001|Overall Study|Non-compliance with study drug|1|||
146222850|NCT02043678|527331587|FG000|Overall Study|Physician Decision|4|||
146222851|NCT02043678|527331588|FG001|Overall Study|Physician Decision|3|||
146222852|NCT02043678|527331587|FG000|Overall Study|Subject decision|0|||
146222853|NCT02043678|527331588|FG001|Overall Study|Subject decision|1|||
146222854|NCT02043678|527331587|FG000|Overall Study|Switching to other therapy|3|||
146222855|NCT02043678|527331588|FG001|Overall Study|Switching to other therapy|2|||
146288777|NCT00112047|527571463|FG000|Atripla Phase|Lost to Follow-up|5|||
146288778|NCT00112047|527571464|FG001|Atripla Phase|Lost to Follow-up|7|||
146288779|NCT00112047|527571463|FG000|Atripla Phase|Pregnancy|0|||
146288780|NCT00112047|527571464|FG001|Atripla Phase|Pregnancy|1|||
146288781|NCT00112047|527571463|FG000|Atripla Phase|Death|0|||
146288782|NCT00112047|527571464|FG001|Atripla Phase|Death|2|||
146288783|NCT00112047|527571463|FG000|Atripla Phase|Withdrew consent|7|||
146288784|NCT00112047|527571464|FG001|Atripla Phase|Withdrew consent|7|||
146288785|NCT00112047|527571463|FG000|Atripla Phase|Sub-optimal virological response|0|||
146288786|NCT00112047|527571464|FG001|Atripla Phase|Sub-optimal virological response|1|||
146288787|NCT00112047|527571463|FG000|Atripla Phase|Non-compliance|1|||
146288788|NCT00112047|527571464|FG001|Atripla Phase|Non-compliance|0|||
146288789|NCT00112047|527571463|FG000|Atripla Phase|Other|3|||
146288790|NCT00112047|527571464|FG001|Atripla Phase|Other|1|||
146288791|NCT01307579|527571465|FG000|Overall Study|Death|3|||
146288792|NCT01307579|527571466|FG001|Overall Study|Death|6|||
146288793|NCT01307579|527571465|FG000|Overall Study|Physician Decision|26|||
146288794|NCT01307579|527571466|FG001|Overall Study|Physician Decision|29|||
146288795|NCT01307579|527571465|FG000|Overall Study|Withdrawal by Subject|7|||
146288796|NCT01307579|527571466|FG001|Overall Study|Withdrawal by Subject|3|||
146288797|NCT01307579|527571465|FG000|Overall Study|Institutional diagnosis of IFD|21|||
146288798|NCT01307579|527571466|FG001|Overall Study|Institutional diagnosis of IFD|36|||
146288799|NCT01307579|527571465|FG000|Overall Study|Begin conditioning for HSCT|42|||
146288800|NCT01307579|527571466|FG001|Overall Study|Begin conditioning for HSCT|44|||
146288801|NCT01307579|527571465|FG000|Overall Study|Refractory or relapsed AML|38|||
146288802|NCT01307579|527571466|FG001|Overall Study|Refractory or relapsed AML|23|||
146288803|NCT01307579|527571465|FG000|Overall Study|Ineligible|3|||
146288804|NCT01307579|527571466|FG001|Overall Study|Ineligible|4|||
146288805|NCT03727438|527571467|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
146288806|NCT03727438|527571468|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
146288807|NCT03727438|527571467|FG000|Intervention Period|Excluded (health)|1|||
146288808|NCT03727438|527571468|FG001|Intervention Period|Excluded (health)|0|||
146288809|NCT03727438|527571467|FG000|Intervention Period|Withdrawal by Subject|3|||
146288810|NCT03727438|527571468|FG001|Intervention Period|Withdrawal by Subject|1|||
146288811|NCT03727438|527571467|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
146288812|NCT03727438|527571468|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
146288813|NCT03727438|527571467|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
146288814|NCT03727438|527571468|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
146288815|NCT03727438|527571467|FG000|8 Week Assessment|Withdrawal by Subject|6|||
146288816|NCT03727438|527571468|FG001|8 Week Assessment|Withdrawal by Subject|1|||
146288817|NCT03727438|527571467|FG000|6 mo Assessment|did not complete assessment|10|||
146288818|NCT03727438|527571468|FG001|6 mo Assessment|did not complete assessment|11|||
146288819|NCT05195489|527573252|FG000|Overall Study|Lost to Follow-up|1|||
146288820|NCT05195489|527573253|FG001|Overall Study|Lost to Follow-up|0|||
146288821|NCT05195489|527573252|FG000|Overall Study|Protocol Violation|0|||
146288822|NCT05195489|527573253|FG001|Overall Study|Protocol Violation|2|||
146288823|NCT05195489|527573252|FG000|Overall Study|Withdrawal by Subject|1|||
146288824|NCT05195489|527573253|FG001|Overall Study|Withdrawal by Subject|1|||
146288825|NCT05195489|527573252|FG000|Overall Study|Removed|0|||
146288826|NCT05195489|527573253|FG001|Overall Study|Removed|1|||
146288827|NCT01919814|527573255|FG000|Overall Study|Adverse Event|1|||
146288828|NCT01919814|527573256|FG001|Overall Study|Adverse Event|0|||
146288829|NCT01919814|527573255|FG000|Overall Study|Protocol Violation|1|||
146222856|NCT02043678|527331587|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
146222857|NCT02043678|527331588|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
146222858|NCT02043678|527331587|FG000|Overall Study|Missing|1|||
146288830|NCT01919814|527573256|FG001|Overall Study|Protocol Violation|0|||
146288831|NCT01919814|527573255|FG000|Overall Study|Withdrawal by Subject|1|||
146288832|NCT01919814|527573256|FG001|Overall Study|Withdrawal by Subject|0|||
146288833|NCT05220254|527573260|FG000|Overall Study|Withdrawal by Subject|4|||
146288834|NCT05220254|527573260|FG000|Overall Study|Removed due to ineligibility|1|||
146288835|NCT05220254|527573260|FG000|Overall Study|Lost to Follow-up|7|||
146288836|NCT04363801|527573263|FG000|Overall Study|Death|18|||
146288837|NCT04363801|527573264|FG001|Overall Study|Death|14|||
146288838|NCT04363801|527573265|FG002|Overall Study|Death|16|||
146288839|NCT04363801|527573266|FG003|Overall Study|Death|48|||
146288840|NCT04363801|527573267|FG004|Overall Study|Death|38|||
146288841|NCT04363801|527573263|FG000|Overall Study|Withdrawal by Subject|1|||
146288842|NCT04363801|527573264|FG001|Overall Study|Withdrawal by Subject|6|||
146288843|NCT04363801|527573265|FG002|Overall Study|Withdrawal by Subject|1|||
146288844|NCT04363801|527573266|FG003|Overall Study|Withdrawal by Subject|4|||
146288845|NCT04363801|527573267|FG004|Overall Study|Withdrawal by Subject|14|||
146288846|NCT04363801|527573263|FG000|Overall Study|Sponsor Decision|6|||
146288847|NCT04363801|527573264|FG001|Overall Study|Sponsor Decision|4|||
146288848|NCT04363801|527573265|FG002|Overall Study|Sponsor Decision|10|||
146288849|NCT04363801|527573266|FG003|Overall Study|Sponsor Decision|33|||
146288850|NCT04363801|527573267|FG004|Overall Study|Sponsor Decision|32|||
146288851|NCT04363801|527573263|FG000|Overall Study|Lost to Follow-up|0|||
146288852|NCT04363801|527573264|FG001|Overall Study|Lost to Follow-up|0|||
146288853|NCT04363801|527573265|FG002|Overall Study|Lost to Follow-up|1|||
146288854|NCT04363801|527573266|FG003|Overall Study|Lost to Follow-up|0|||
146288855|NCT04363801|527573267|FG004|Overall Study|Lost to Follow-up|1|||
146288856|NCT00250679|527573270|FG000|Overall Study|Adverse Event|12|||
146288857|NCT00250679|527573271|FG001|Overall Study|Adverse Event|15|||
146288858|NCT00250679|527573272|FG002|Overall Study|Adverse Event|16|||
146288859|NCT00250679|527573270|FG000|Overall Study|Protocol Violation|2|||
146288860|NCT00250679|527573271|FG001|Overall Study|Protocol Violation|4|||
146288861|NCT00250679|527573272|FG002|Overall Study|Protocol Violation|3|||
146288862|NCT00250679|527573270|FG000|Overall Study|Withdrawal by Subject|15|||
146288863|NCT00250679|527573271|FG001|Overall Study|Withdrawal by Subject|18|||
146288864|NCT00250679|527573272|FG002|Overall Study|Withdrawal by Subject|15|||
146288865|NCT00250679|527573270|FG000|Overall Study|Lost to Follow-up|3|||
146288866|NCT00250679|527573271|FG001|Overall Study|Lost to Follow-up|4|||
146288867|NCT00250679|527573272|FG002|Overall Study|Lost to Follow-up|2|||
146288868|NCT00250679|527573270|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
146288869|NCT00250679|527573271|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
146288870|NCT00250679|527573272|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
146288871|NCT00250679|527573270|FG000|Overall Study|Lack of Efficacy|0|||
146288872|NCT00250679|527573271|FG001|Overall Study|Lack of Efficacy|1|||
146288873|NCT00250679|527573272|FG002|Overall Study|Lack of Efficacy|3|||
146288874|NCT00250679|527573270|FG000|Overall Study|Technical Holter issues|1|||
146288875|NCT00250679|527573271|FG001|Overall Study|Technical Holter issues|0|||
146288876|NCT00250679|527573272|FG002|Overall Study|Technical Holter issues|2|||
146288877|NCT00250679|527573270|FG000|Overall Study|Moved|1|||
146288878|NCT00250679|527573271|FG001|Overall Study|Moved|1|||
146288879|NCT00250679|527573272|FG002|Overall Study|Moved|0|||
146288880|NCT00250679|527573270|FG000|Overall Study|Non-compliance|1|||
146288881|NCT00250679|527573271|FG001|Overall Study|Non-compliance|1|||
146288882|NCT00250679|527573272|FG002|Overall Study|Non-compliance|0|||
146288883|NCT00250679|527573270|FG000|Overall Study|various single events: hip surgery,diary|3|||
146288884|NCT00250679|527573271|FG001|Overall Study|various single events: hip surgery,diary|1|||
145882769|NCT01190930|526077039|FG004|Induction|High Risk|0|||
145882770|NCT01190930|526077040|FG005|Induction|High Risk|0|||
145882771|NCT01190930|526077041|FG006|Induction|High Risk|0|||
145882772|NCT01190930|526077042|FG007|Induction|High Risk|0|||
145882773|NCT01190930|526077043|FG008|Induction|High Risk|0|||
145882774|NCT01190930|526077044|FG009|Induction|High Risk|0|||
145882775|NCT01190930|526077035|FG000|Induction|Low Risk|443|||
145882776|NCT01190930|526077036|FG001|Induction|Low Risk|0|||
145882777|NCT01190930|526077037|FG002|Induction|Low Risk|0|||
145882778|NCT01190930|526077038|FG003|Induction|Low Risk|0|||
145882779|NCT01190930|526077039|FG004|Induction|Low Risk|0|||
145882780|NCT01190930|526077040|FG005|Induction|Low Risk|0|||
145882781|NCT01190930|526077041|FG006|Induction|Low Risk|0|||
145882782|NCT01190930|526077042|FG007|Induction|Low Risk|0|||
145882783|NCT01190930|526077043|FG008|Induction|Low Risk|0|||
145882784|NCT01190930|526077044|FG009|Induction|Low Risk|0|||
145882785|NCT01190930|526077035|FG000|Induction|Very High Risk|1012|||
145882786|NCT01190930|526077036|FG001|Induction|Very High Risk|0|||
145882787|NCT01190930|526077037|FG002|Induction|Very High Risk|0|||
145882788|NCT01190930|526077038|FG003|Induction|Very High Risk|0|||
145882789|NCT01190930|526077039|FG004|Induction|Very High Risk|0|||
145882790|NCT01190930|526077040|FG005|Induction|Very High Risk|0|||
145882791|NCT01190930|526077041|FG006|Induction|Very High Risk|0|||
145882792|NCT01190930|526077042|FG007|Induction|Very High Risk|0|||
145882793|NCT01190930|526077043|FG008|Induction|Very High Risk|0|||
145882794|NCT01190930|526077044|FG009|Induction|Very High Risk|0|||
145882795|NCT01190930|526077035|FG000|Induction|Philadelphia chromosome-positive|99|||
145882796|NCT01190930|526077036|FG001|Induction|Philadelphia chromosome-positive|0|||
145882797|NCT01190930|526077037|FG002|Induction|Philadelphia chromosome-positive|0|||
145882798|NCT01190930|526077038|FG003|Induction|Philadelphia chromosome-positive|0|||
145882799|NCT01190930|526077039|FG004|Induction|Philadelphia chromosome-positive|0|||
145882800|NCT01190930|526077040|FG005|Induction|Philadelphia chromosome-positive|0|||
145882801|NCT01190930|526077041|FG006|Induction|Philadelphia chromosome-positive|0|||
145882802|NCT01190930|526077042|FG007|Induction|Philadelphia chromosome-positive|0|||
145882803|NCT01190930|526077043|FG008|Induction|Philadelphia chromosome-positive|0|||
145882804|NCT01190930|526077044|FG009|Induction|Philadelphia chromosome-positive|0|||
145882805|NCT01190930|526077035|FG000|Induction|Incomplete Induction data|63|||
145882806|NCT01190930|526077036|FG001|Induction|Incomplete Induction data|0|||
145882807|NCT01190930|526077037|FG002|Induction|Incomplete Induction data|0|||
145882808|NCT01190930|526077038|FG003|Induction|Incomplete Induction data|0|||
145882809|NCT01190930|526077039|FG004|Induction|Incomplete Induction data|0|||
145882810|NCT01190930|526077040|FG005|Induction|Incomplete Induction data|0|||
145882811|NCT01190930|526077041|FG006|Induction|Incomplete Induction data|0|||
145882812|NCT01190930|526077042|FG007|Induction|Incomplete Induction data|0|||
145882813|NCT01190930|526077043|FG008|Induction|Incomplete Induction data|0|||
145882814|NCT01190930|526077044|FG009|Induction|Incomplete Induction data|0|||
145882815|NCT01190930|526077035|FG000|Induction|Progressive disease|0|||
145882816|NCT01190930|526077036|FG001|Induction|Progressive disease|1|||
145882817|NCT01190930|526077037|FG002|Induction|Progressive disease|0|||
146222859|NCT02043678|527331588|FG001|Overall Study|Missing|0|||
146222860|NCT02043678|527331587|FG000|Overall Study|Adverse Event|0|||
146222861|NCT02043678|527331588|FG001|Overall Study|Adverse Event|1|||
146222862|NCT03216057|527331589|FG000|Overall Study|Lost to Follow-up|2|||
146222863|NCT03216057|527331590|FG001|Overall Study|Lost to Follow-up|2|||
146222864|NCT03904147|527331595|FG000|Overall Study|Death|15|||
146222865|NCT03904147|527331596|FG001|Overall Study|Death|13|||
146222866|NCT03904147|527331597|FG002|Overall Study|Death|15|||
146222867|NCT03904147|527331595|FG000|Overall Study|Withdrawal by Subject|7|||
146222868|NCT03904147|527331596|FG001|Overall Study|Withdrawal by Subject|12|||
146222869|NCT03904147|527331597|FG002|Overall Study|Withdrawal by Subject|1|||
146222870|NCT03904147|527331595|FG000|Overall Study|1Y visit completed after 365 days|1|||
146222871|NCT03904147|527331596|FG001|Overall Study|1Y visit completed after 365 days|1|||
146222872|NCT03904147|527331597|FG002|Overall Study|1Y visit completed after 365 days|0|||
146222873|NCT05269667|527331598|FG000|Overall Study|Study Terminated by Sponsor|4|||
146222874|NCT04032704|527331602|FG000|Part A|Withdrawal by Subject|0|||
146222875|NCT04032704|527331603|FG001|Part A|Withdrawal by Subject|0|||
146222876|NCT04032704|527331604|FG002|Part A|Withdrawal by Subject|3|||
146222877|NCT04032704|527331605|FG003|Part A|Withdrawal by Subject|0|||
146222878|NCT04032704|527331606|FG004|Part A|Withdrawal by Subject|1|||
146222879|NCT04032704|527331607|FG005|Part A|Withdrawal by Subject|7|||
146222880|NCT04032704|527331608|FG006|Part A|Withdrawal by Subject|0|||
146222881|NCT04032704|527331609|FG007|Part A|Withdrawal by Subject|0|||
146222882|NCT04032704|527331610|FG008|Part A|Withdrawal by Subject|0|||
146222883|NCT04032704|527331611|FG009|Part A|Withdrawal by Subject|0|||
146222884|NCT04032704|527331612|FG010|Part A|Withdrawal by Subject|0|||
146222885|NCT04032704|527331613|FG011|Part A|Withdrawal by Subject|0|||
146222886|NCT04032704|527331614|FG012|Part A|Withdrawal by Subject|0|||
146222887|NCT04032704|527331615|FG013|Part A|Withdrawal by Subject|0|||
146222888|NCT04032704|527331616|FG014|Part A|Withdrawal by Subject|0|||
146222889|NCT04032704|527331617|FG015|Part A|Withdrawal by Subject|0|||
146222890|NCT04032704|527331618|FG016|Part A|Withdrawal by Subject|0|||
146222891|NCT04032704|527331619|FG017|Part A|Withdrawal by Subject|0|||
146222892|NCT04032704|527331602|FG000|Part A|Lost to Follow-up|1|||
146222893|NCT04032704|527331603|FG001|Part A|Lost to Follow-up|0|||
146222894|NCT04032704|527331604|FG002|Part A|Lost to Follow-up|0|||
146222895|NCT04032704|527331605|FG003|Part A|Lost to Follow-up|0|||
146222896|NCT04032704|527331606|FG004|Part A|Lost to Follow-up|0|||
146222897|NCT04032704|527331607|FG005|Part A|Lost to Follow-up|0|||
146222898|NCT04032704|527331608|FG006|Part A|Lost to Follow-up|0|||
146222899|NCT04032704|527331609|FG007|Part A|Lost to Follow-up|0|||
146222900|NCT04032704|527331610|FG008|Part A|Lost to Follow-up|0|||
146222901|NCT04032704|527331611|FG009|Part A|Lost to Follow-up|0|||
146222902|NCT04032704|527331612|FG010|Part A|Lost to Follow-up|0|||
146222903|NCT04032704|527331613|FG011|Part A|Lost to Follow-up|0|||
146222904|NCT04032704|527331614|FG012|Part A|Lost to Follow-up|0|||
146222905|NCT04032704|527331615|FG013|Part A|Lost to Follow-up|0|||
146222906|NCT04032704|527331616|FG014|Part A|Lost to Follow-up|0|||
146222907|NCT04032704|527331617|FG015|Part A|Lost to Follow-up|0|||
146222908|NCT04032704|527331618|FG016|Part A|Lost to Follow-up|0|||
146222909|NCT04032704|527331619|FG017|Part A|Lost to Follow-up|0|||
146222910|NCT04032704|527331602|FG000|Part A|Death|9|||
146222911|NCT04032704|527331603|FG001|Part A|Death|2|||
146222912|NCT04032704|527331604|FG002|Part A|Death|10|||
146222913|NCT04032704|527331605|FG003|Part A|Death|7|||
146222914|NCT04032704|527331606|FG004|Part A|Death|4|||
146085077|NCT01993836|526832066|FG002|Overall Study|Surgery Cancelled|0|||
146222915|NCT04032704|527331607|FG005|Part A|Death|5|||
146222916|NCT04032704|527331608|FG006|Part A|Death|0|||
146222917|NCT04032704|527331609|FG007|Part A|Death|0|||
146222918|NCT04032704|527331610|FG008|Part A|Death|0|||
146222919|NCT04032704|527331611|FG009|Part A|Death|0|||
146222920|NCT04032704|527331612|FG010|Part A|Death|0|||
146222921|NCT04032704|527331613|FG011|Part A|Death|0|||
146222922|NCT04032704|527331614|FG012|Part A|Death|0|||
146222923|NCT04032704|527331615|FG013|Part A|Death|0|||
146222924|NCT04032704|527331616|FG014|Part A|Death|0|||
146222925|NCT04032704|527331617|FG015|Part A|Death|0|||
146222926|NCT04032704|527331618|FG016|Part A|Death|0|||
146222927|NCT04032704|527331619|FG017|Part A|Death|0|||
146222928|NCT04032704|527331602|FG000|Part B|Other|0|||
146222929|NCT04032704|527331603|FG001|Part B|Other|0|||
146222930|NCT04032704|527331604|FG002|Part B|Other|0|||
146222931|NCT04032704|527331605|FG003|Part B|Other|0|||
146222932|NCT04032704|527331606|FG004|Part B|Other|0|||
146222933|NCT04032704|527331607|FG005|Part B|Other|0|||
146222934|NCT04032704|527331608|FG006|Part B|Other|0|||
145882818|NCT01190930|526077038|FG003|Induction|Progressive disease|0|||
145882819|NCT01190930|526077039|FG004|Induction|Progressive disease|0|||
145882820|NCT01190930|526077040|FG005|Induction|Progressive disease|0|||
145882821|NCT01190930|526077041|FG006|Induction|Progressive disease|0|||
145882822|NCT01190930|526077042|FG007|Induction|Progressive disease|0|||
145882823|NCT01190930|526077043|FG008|Induction|Progressive disease|0|||
145882824|NCT01190930|526077044|FG009|Induction|Progressive disease|0|||
145882825|NCT01190930|526077035|FG000|Induction|No treatment|3|||
145882826|NCT01190930|526077036|FG001|Induction|No treatment|0|||
145882827|NCT01190930|526077037|FG002|Induction|No treatment|0|||
145882828|NCT01190930|526077038|FG003|Induction|No treatment|0|||
145882829|NCT01190930|526077039|FG004|Induction|No treatment|0|||
145882830|NCT01190930|526077040|FG005|Induction|No treatment|0|||
145882831|NCT01190930|526077041|FG006|Induction|No treatment|0|||
145882832|NCT01190930|526077042|FG007|Induction|No treatment|0|||
145882833|NCT01190930|526077043|FG008|Induction|No treatment|0|||
145882834|NCT01190930|526077044|FG009|Induction|No treatment|0|||
145882835|NCT01190930|526077035|FG000|Induction|Ineligible|69|||
145882836|NCT01190930|526077036|FG001|Induction|Ineligible|4|||
145882837|NCT01190930|526077037|FG002|Induction|Ineligible|0|||
145882838|NCT01190930|526077038|FG003|Induction|Ineligible|0|||
145882839|NCT01190930|526077039|FG004|Induction|Ineligible|0|||
145882840|NCT01190930|526077040|FG005|Induction|Ineligible|0|||
145882841|NCT01190930|526077041|FG006|Induction|Ineligible|0|||
145882842|NCT01190930|526077042|FG007|Induction|Ineligible|0|||
145882843|NCT01190930|526077043|FG008|Induction|Ineligible|0|||
145882844|NCT01190930|526077044|FG009|Induction|Ineligible|0|||
145882845|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
145882846|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
145882847|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
145882848|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
145882849|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
146222935|NCT04032704|527331609|FG007|Part B|Other|1|||
146222936|NCT04032704|527331610|FG008|Part B|Other|2|||
146222937|NCT04032704|527331611|FG009|Part B|Other|1|||
146222938|NCT04032704|527331612|FG010|Part B|Other|1|||
146222939|NCT04032704|527331613|FG011|Part B|Other|1|||
146222940|NCT04032704|527331614|FG012|Part B|Other|5|||
145882850|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
145882851|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
145882852|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
145882853|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
145882854|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
145882855|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Death|0|||
145882856|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Death|0|||
145882857|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Death|8|||
145882858|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Death|4|||
145882859|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Death|0|||
145882860|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Death|0|||
145882861|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Death|0|||
145882862|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Death|0|||
145882863|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Death|0|||
145882864|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Death|0|||
145882865|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
145882866|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
145882867|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
145882868|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
145882869|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
145882870|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
145882871|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
145882872|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
145882873|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
145882874|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
145882875|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145882876|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
145882877|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
146222941|NCT04032704|527331615|FG013|Part B|Other|13|||
145882878|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
145882879|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
146222942|NCT04032704|527331616|FG014|Part B|Other|0|||
146222943|NCT04032704|527331617|FG015|Part B|Other|0|||
145882880|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145882881|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145882882|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145882883|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145882884|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
146222944|NCT04032704|527331618|FG016|Part B|Other|0|||
146222945|NCT04032704|527331619|FG017|Part B|Other|0|||
146288885|NCT00250679|527573272|FG002|Overall Study|various single events: hip surgery,diary|1|||
146288886|NCT00448279|527573273|FG000|Overall Study|Lost to Follow-up|2|||
146288887|NCT00448279|527573274|FG001|Overall Study|Lost to Follow-up|2|||
146288888|NCT00448279|527573273|FG000|Overall Study|Adverse Event|1|||
146288889|NCT00448279|527573274|FG001|Overall Study|Adverse Event|1|||
146288890|NCT00448279|527573273|FG000|Overall Study|Disease progression|16|||
146288891|NCT00448279|527573274|FG001|Overall Study|Disease progression|18|||
146288892|NCT00448279|527573273|FG000|Overall Study|Withdrawal by Subject|4|||
146288893|NCT00448279|527573274|FG001|Overall Study|Withdrawal by Subject|3|||
146288894|NCT00448279|527573273|FG000|Overall Study|Other|6|||
146288895|NCT00448279|527573274|FG001|Overall Study|Other|4|||
146288896|NCT00448279|527573273|FG000|Overall Study|Protocol Violation|0|||
146288897|NCT00448279|527573274|FG001|Overall Study|Protocol Violation|1|||
146288898|NCT03907410|527573275|FG000|Overall Study|Lost to Follow-up|4|||
146288899|NCT03907410|527573276|FG001|Overall Study|Lost to Follow-up|1|||
146288900|NCT03907410|527573277|FG002|Overall Study|Lost to Follow-up|1|||
146288901|NCT03907410|527573275|FG000|Overall Study|Lost to follow-up and research burden|0|||
146288902|NCT03907410|527573276|FG001|Overall Study|Lost to follow-up and research burden|0|||
146288903|NCT03907410|527573277|FG002|Overall Study|Lost to follow-up and research burden|1|||
146288904|NCT04776148|527573278|FG000|Overall Study|Death|249|||
146288905|NCT04776148|527573279|FG001|Overall Study|Death|260|||
146288906|NCT04776148|527573278|FG000|Overall Study|Lost to Follow-up|0|||
146288907|NCT04776148|527573279|FG001|Overall Study|Lost to Follow-up|1|||
146288908|NCT04776148|527573278|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146288909|NCT04776148|527573279|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146288910|NCT04776148|527573278|FG000|Overall Study|Withdrawal by Subject|3|||
146288911|NCT04776148|527573279|FG001|Overall Study|Withdrawal by Subject|4|||
146288912|NCT04776148|527573278|FG000|Overall Study|Sponsor Decision|30|||
146288913|NCT04776148|527573279|FG001|Overall Study|Sponsor Decision|15|||
146288914|NCT00666679|527573283|FG000|First Intervention|Lost to Follow-up|1|||
146288915|NCT00666679|527573284|FG001|First Intervention|Lost to Follow-up|0|||
146288916|NCT00666679|527573283|FG000|First Intervention|Protocol Violation|1|||
146288917|NCT00666679|527573284|FG001|First Intervention|Protocol Violation|0|||
146288918|NCT00666679|527573283|FG000|First Intervention|Withdrawal by Subject|1|||
146288919|NCT00666679|527573284|FG001|First Intervention|Withdrawal by Subject|0|||
146288920|NCT00666679|527573283|FG000|First Intervention|Randomized did not start treatment|1|||
146288921|NCT00666679|527573284|FG001|First Intervention|Randomized did not start treatment|1|||
146288922|NCT00666679|527573283|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
146288923|NCT00666679|527573284|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
146288924|NCT00666679|527573283|FG000|Washout Period of 1 Week|Protocol Violation|0|||
146288925|NCT00666679|527573284|FG001|Washout Period of 1 Week|Protocol Violation|1|||
146288926|NCT00666679|527573283|FG000|Second Intervention|Adverse Event|1|||
146288927|NCT00666679|527573284|FG001|Second Intervention|Adverse Event|0|||
146288928|NCT00666679|527573283|FG000|Second Intervention|Death|0|||
146288929|NCT00666679|527573284|FG001|Second Intervention|Death|1|||
146288930|NCT04882995|527573287|FG000|Overall Study|Withdrawal by Subject|1|||
146288931|NCT04882995|527573288|FG001|Overall Study|Withdrawal by Subject|2|||
146288932|NCT04882995|527573287|FG000|Overall Study|Protocol Violation|4|||
146288933|NCT04882995|527573288|FG001|Overall Study|Protocol Violation|4|||
146288934|NCT04882995|527573287|FG000|Overall Study|Surgery postponed due to COVID|1|||
146288935|NCT04882995|527573288|FG001|Overall Study|Surgery postponed due to COVID|1|||
146288936|NCT04371198|527573289|FG000|Overall Study|inadequate sample|4|||
146288937|NCT00440999|527573290|FG000|Overall Study|Adverse Event|0|||
146288938|NCT00440999|527573291|FG001|Overall Study|Adverse Event|2|||
146288939|NCT00440999|527573290|FG000|Overall Study|Lack of Efficacy|6|||
146288940|NCT00440999|527573291|FG001|Overall Study|Lack of Efficacy|7|||
146288941|NCT00440999|527573290|FG000|Overall Study|Lost to Follow-up|19|||
146288942|NCT00440999|527573291|FG001|Overall Study|Lost to Follow-up|12|||
146288943|NCT00440999|527573290|FG000|Overall Study|Protocol Violation|1|||
146288944|NCT00440999|527573291|FG001|Overall Study|Protocol Violation|0|||
146288945|NCT00440999|527573290|FG000|Overall Study|Withdrawal by Subject|2|||
146288946|NCT00440999|527573291|FG001|Overall Study|Withdrawal by Subject|5|||
146288947|NCT00440999|527573290|FG000|Overall Study|Subjets missed the visit|1|||
146288948|NCT00440999|527573291|FG001|Overall Study|Subjets missed the visit|0|||
146288949|NCT00440999|527573290|FG000|Overall Study|Mixed infection at entry|1|||
146288950|NCT00440999|527573291|FG001|Overall Study|Mixed infection at entry|0|||
146288951|NCT00440999|527573290|FG000|Overall Study|P. falciparum malaria|5|||
146288952|NCT00440999|527573291|FG001|Overall Study|P. falciparum malaria|14|||
146222946|NCT04032704|527331602|FG000|Part B|Study termination by Sponsor|0|||
146222947|NCT04032704|527331603|FG001|Part B|Study termination by Sponsor|0|||
146085078|NCT01993836|526832064|FG000|Overall Study|Physician Decision|2|||
146085079|NCT01993836|526832065|FG001|Overall Study|Physician Decision|1|||
146085080|NCT01993836|526832066|FG002|Overall Study|Physician Decision|0|||
146222948|NCT04032704|527331604|FG002|Part B|Study termination by Sponsor|0|||
146222949|NCT04032704|527331605|FG003|Part B|Study termination by Sponsor|0|||
146222950|NCT04032704|527331606|FG004|Part B|Study termination by Sponsor|0|||
146222951|NCT04032704|527331607|FG005|Part B|Study termination by Sponsor|0|||
146222952|NCT04032704|527331608|FG006|Part B|Study termination by Sponsor|0|||
146222953|NCT04032704|527331609|FG007|Part B|Study termination by Sponsor|0|||
146222954|NCT04032704|527331610|FG008|Part B|Study termination by Sponsor|1|||
146222955|NCT04032704|527331611|FG009|Part B|Study termination by Sponsor|0|||
146222956|NCT04032704|527331612|FG010|Part B|Study termination by Sponsor|0|||
146222957|NCT04032704|527331613|FG011|Part B|Study termination by Sponsor|0|||
146222958|NCT04032704|527331614|FG012|Part B|Study termination by Sponsor|0|||
146222959|NCT04032704|527331615|FG013|Part B|Study termination by Sponsor|0|||
146222960|NCT04032704|527331616|FG014|Part B|Study termination by Sponsor|0|||
146222961|NCT04032704|527331617|FG015|Part B|Study termination by Sponsor|0|||
146222962|NCT04032704|527331618|FG016|Part B|Study termination by Sponsor|0|||
146222963|NCT04032704|527331619|FG017|Part B|Study termination by Sponsor|0|||
146222964|NCT04032704|527331602|FG000|Part B|Withdrawal by Subject|0|||
146222965|NCT04032704|527331603|FG001|Part B|Withdrawal by Subject|0|||
146222966|NCT04032704|527331604|FG002|Part B|Withdrawal by Subject|0|||
146222967|NCT04032704|527331605|FG003|Part B|Withdrawal by Subject|0|||
146222968|NCT04032704|527331606|FG004|Part B|Withdrawal by Subject|0|||
146222969|NCT04032704|527331607|FG005|Part B|Withdrawal by Subject|0|||
146222970|NCT04032704|527331608|FG006|Part B|Withdrawal by Subject|3|||
146222971|NCT04032704|527331609|FG007|Part B|Withdrawal by Subject|2|||
146222972|NCT04032704|527331610|FG008|Part B|Withdrawal by Subject|2|||
146222973|NCT04032704|527331611|FG009|Part B|Withdrawal by Subject|1|||
146222974|NCT04032704|527331612|FG010|Part B|Withdrawal by Subject|4|||
146222975|NCT04032704|527331613|FG011|Part B|Withdrawal by Subject|6|||
146222976|NCT04032704|527331614|FG012|Part B|Withdrawal by Subject|2|||
146222977|NCT04032704|527331615|FG013|Part B|Withdrawal by Subject|1|||
146222978|NCT04032704|527331616|FG014|Part B|Withdrawal by Subject|0|||
146222979|NCT04032704|527331617|FG015|Part B|Withdrawal by Subject|1|||
146222980|NCT04032704|527331618|FG016|Part B|Withdrawal by Subject|0|||
146222981|NCT04032704|527331619|FG017|Part B|Withdrawal by Subject|0|||
146222982|NCT04032704|527331602|FG000|Part B|Lost to Follow-up|0|||
146222983|NCT04032704|527331603|FG001|Part B|Lost to Follow-up|0|||
146085081|NCT01993836|526832064|FG000|Overall Study|Death|0|||
146085082|NCT01993836|526832065|FG001|Overall Study|Death|2|||
146222984|NCT04032704|527331604|FG002|Part B|Lost to Follow-up|0|||
146222985|NCT04032704|527331605|FG003|Part B|Lost to Follow-up|0|||
146222986|NCT04032704|527331606|FG004|Part B|Lost to Follow-up|0|||
146085083|NCT01993836|526832066|FG002|Overall Study|Death|0|||
146222987|NCT04032704|527331607|FG005|Part B|Lost to Follow-up|0|||
146222988|NCT04032704|527331608|FG006|Part B|Lost to Follow-up|0|||
146222989|NCT04032704|527331609|FG007|Part B|Lost to Follow-up|0|||
146222990|NCT04032704|527331610|FG008|Part B|Lost to Follow-up|0|||
146222991|NCT04032704|527331611|FG009|Part B|Lost to Follow-up|0|||
146222992|NCT04032704|527331612|FG010|Part B|Lost to Follow-up|0|||
146222993|NCT04032704|527331613|FG011|Part B|Lost to Follow-up|1|||
146222994|NCT04032704|527331614|FG012|Part B|Lost to Follow-up|0|||
146222995|NCT04032704|527331615|FG013|Part B|Lost to Follow-up|0|||
146222996|NCT04032704|527331616|FG014|Part B|Lost to Follow-up|0|||
146222997|NCT04032704|527331617|FG015|Part B|Lost to Follow-up|0|||
146222998|NCT04032704|527331618|FG016|Part B|Lost to Follow-up|0|||
146222999|NCT04032704|527331619|FG017|Part B|Lost to Follow-up|0|||
146223000|NCT04032704|527331602|FG000|Part B|Death|0|||
146223001|NCT04032704|527331603|FG001|Part B|Death|0|||
146223002|NCT04032704|527331604|FG002|Part B|Death|0|||
146223003|NCT04032704|527331605|FG003|Part B|Death|0|||
146223004|NCT04032704|527331606|FG004|Part B|Death|0|||
146223005|NCT04032704|527331607|FG005|Part B|Death|0|||
146223006|NCT04032704|527331608|FG006|Part B|Death|13|||
146223007|NCT04032704|527331609|FG007|Part B|Death|13|||
146223008|NCT04032704|527331610|FG008|Part B|Death|14|||
146223009|NCT04032704|527331611|FG009|Part B|Death|12|||
146223010|NCT04032704|527331612|FG010|Part B|Death|12|||
146223011|NCT04032704|527331613|FG011|Part B|Death|13|||
146223012|NCT04032704|527331614|FG012|Part B|Death|7|||
146223013|NCT04032704|527331615|FG013|Part B|Death|17|||
146223014|NCT04032704|527331616|FG014|Part B|Death|2|||
146223015|NCT04032704|527331617|FG015|Part B|Death|1|||
146223016|NCT04032704|527331618|FG016|Part B|Death|2|||
146223017|NCT04032704|527331619|FG017|Part B|Death|2|||
146223018|NCT03625167|527331621|FG000|Overall Study|Protocol Violation|5|||
146223019|NCT02231164|527331622|FG000|Overall Study|Adverse Event|1|||
146223020|NCT02231164|527331623|FG001|Overall Study|Adverse Event|1|||
146223021|NCT02231164|527331622|FG000|Overall Study|Lack of Efficacy|4|||
146223022|NCT02231164|527331623|FG001|Overall Study|Lack of Efficacy|3|||
146223023|NCT02231164|527331622|FG000|Overall Study|Withdrawal by Subject|1|||
146223024|NCT02231164|527331623|FG001|Overall Study|Withdrawal by Subject|2|||
146223025|NCT06103188|527331625|FG000|Overall Study|Lost to Follow-up|1|||
146223026|NCT06103188|527331626|FG001|Overall Study|Lost to Follow-up|6|||
146223027|NCT06103188|527331627|FG002|Overall Study|Lost to Follow-up|4|||
146223028|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
146223029|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
146223030|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
146223031|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
146223032|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
146223033|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
146223034|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
146223035|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
146223036|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
146223037|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
146223038|NCT04103580|527331634|FG000|Phase 1 Active Caregiving|Other|3|||
146223039|NCT04103580|527331635|FG001|Phase 1 Active Caregiving|Other|3|||
146223040|NCT04103580|527331634|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
146223041|NCT04103580|527331635|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
146223042|NCT04103580|527331634|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
146223043|NCT04103580|527331635|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
146223044|NCT04103580|527331634|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
146223045|NCT04103580|527331635|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
146223046|NCT04103580|527331634|FG000|Phase 2 Bereavement|Other|8|||
146223047|NCT04103580|527331635|FG001|Phase 2 Bereavement|Other|6|||
146223048|NCT04248725|527331640|FG000|Post-Treatment|Lost to Follow-up|6|||
146223049|NCT04248725|527331641|FG001|Post-Treatment|Lost to Follow-up|5|||
146223050|NCT04248725|527331640|FG000|6-Month Follow Up|Lost to Follow-up|9|||
146223051|NCT04248725|527331641|FG001|6-Month Follow Up|Lost to Follow-up|8|||
146223052|NCT06457802|527331642|FG000|Overall Study|Early termination of study prior to participant completion|2|||
145961185|NCT00385918|526369519|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
146235069|NCT00622700|527378452|FG005|Extension Treatment Period|Adverse Event|6|||
146223053|NCT06457802|527331643|FG001|Overall Study|Early termination of study prior to participant completion|2|||
146223054|NCT04524442|527331645|FG000|Overall Study|Subject Decision|1|||
146223055|NCT01544114|527331653|FG000|Overall Study|Withdrawal by Subject|0|||
146223056|NCT01544114|527331654|FG001|Overall Study|Withdrawal by Subject|0|||
146223057|NCT01544114|527331655|FG002|Overall Study|Withdrawal by Subject|3|||
146223058|NCT01544114|527331653|FG000|Overall Study|Lost to Follow-up|0|||
146223059|NCT01544114|527331654|FG001|Overall Study|Lost to Follow-up|2|||
145882885|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Refusal|0|||
145882886|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Refusal|2|||
145882887|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Refusal|694|||
145882888|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Refusal|4|||
145882889|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Refusal|0|||
145882890|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Refusal|3|||
145882891|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Refusal|0|||
145882892|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Refusal|0|||
145882893|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Refusal|0|||
145882894|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Refusal|0|||
145882895|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
146223060|NCT01544114|527331655|FG002|Overall Study|Lost to Follow-up|0|||
146223061|NCT01544114|527331653|FG000|Overall Study|Adverse Event|1|||
146288953|NCT00440999|527573290|FG000|Overall Study|Subj left hosp without inform staff|0|||
146223062|NCT01544114|527331654|FG001|Overall Study|Adverse Event|1|||
146223063|NCT01544114|527331655|FG002|Overall Study|Adverse Event|2|||
145882896|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
145882897|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
145961186|NCT00128661|526369520|FG000|Overall Study|Adverse Event|14|||
145961187|NCT00128661|526369521|FG001|Overall Study|Adverse Event|11|||
145961188|NCT00128661|526369520|FG000|Overall Study|Lost to Follow-up|10|||
146223064|NCT01544114|527331653|FG000|Overall Study|Protocol Violation|0|||
146223065|NCT01544114|527331654|FG001|Overall Study|Protocol Violation|1|||
146223066|NCT01544114|527331655|FG002|Overall Study|Protocol Violation|0|||
146223067|NCT02601313|527331656|FG000|Overall Study|Death|2|||
146223068|NCT02601313|527331657|FG001|Overall Study|Death|41|||
145882898|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
146085084|NCT01993836|526832064|FG000|Overall Study|Withdrawal by Subject|12|||
146223069|NCT02601313|527331658|FG002|Overall Study|Death|6|||
146223070|NCT02601313|527331656|FG000|Overall Study|Enrolled but never treated|0|||
146288954|NCT00440999|527573291|FG001|Overall Study|Subj left hosp without inform staff|1|||
146288955|NCT04572841|527573292|FG000|Overall Study|Adverse Event|1|||
146288956|NCT04572841|527573293|FG001|Overall Study|Adverse Event|1|||
146288957|NCT04572841|527573292|FG000|Overall Study|Withdrawal by Subject|2|||
146288958|NCT04572841|527573293|FG001|Overall Study|Withdrawal by Subject|1|||
146288959|NCT05041101|527573294|FG000|Overall Study|Adverse Event|1|||
146288960|NCT05041101|527573295|FG001|Overall Study|Adverse Event|0|||
145882899|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
145882900|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
145882901|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
145882902|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
145882903|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
145882904|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
145882905|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
146288961|NCT05041101|527573296|FG002|Overall Study|Adverse Event|0|||
146288962|NCT05041101|527573294|FG000|Overall Study|Diease Progression|5|||
146223071|NCT02601313|527331657|FG001|Overall Study|Enrolled but never treated|6|||
146223072|NCT02601313|527331658|FG002|Overall Study|Enrolled but never treated|3|||
146223073|NCT02601313|527331656|FG000|Overall Study|Enrolled, did not initiate AC|4|||
146223074|NCT02601313|527331657|FG001|Overall Study|Enrolled, did not initiate AC|0|||
145882906|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
145882907|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882908|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882909|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882910|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145961189|NCT00128661|526369521|FG001|Overall Study|Lost to Follow-up|7|||
146288963|NCT05041101|527573295|FG001|Overall Study|Diease Progression|0|||
145882911|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882912|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882913|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882914|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145882915|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
145882916|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
145882917|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
145882918|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
145882919|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
145882920|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
145882921|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
145882922|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
145882923|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
145882924|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
145882925|NCT01190930|526077035|FG000|Post Induction Pre-Maintenance|Relapse|0|||
145882926|NCT01190930|526077036|FG001|Post Induction Pre-Maintenance|Relapse|0|||
145882927|NCT01190930|526077037|FG002|Post Induction Pre-Maintenance|Relapse|1|||
145882928|NCT01190930|526077038|FG003|Post Induction Pre-Maintenance|Relapse|0|||
145882929|NCT01190930|526077039|FG004|Post Induction Pre-Maintenance|Relapse|0|||
145882930|NCT01190930|526077040|FG005|Post Induction Pre-Maintenance|Relapse|0|||
146223075|NCT02601313|527331658|FG002|Overall Study|Enrolled, did not initiate AC|0|||
146223076|NCT02601313|527331656|FG000|Overall Study|Full consent withdrawal|0|||
146223077|NCT02601313|527331657|FG001|Overall Study|Full consent withdrawal|3|||
146223078|NCT02601313|527331658|FG002|Overall Study|Full consent withdrawal|2|||
146223079|NCT02601313|527331656|FG000|Overall Study|Lost to Follow-up|0|||
146223080|NCT02601313|527331657|FG001|Overall Study|Lost to Follow-up|1|||
146223081|NCT02601313|527331658|FG002|Overall Study|Lost to Follow-up|1|||
145882931|NCT01190930|526077041|FG006|Post Induction Pre-Maintenance|Relapse|0|||
145882932|NCT01190930|526077042|FG007|Post Induction Pre-Maintenance|Relapse|0|||
145882933|NCT01190930|526077043|FG008|Post Induction Pre-Maintenance|Relapse|0|||
145882934|NCT01190930|526077044|FG009|Post Induction Pre-Maintenance|Relapse|0|||
145882935|NCT01190930|526077035|FG000|Maintenance|Adverse Event|0|||
145882936|NCT01190930|526077036|FG001|Maintenance|Adverse Event|0|||
145882937|NCT01190930|526077037|FG002|Maintenance|Adverse Event|0|||
145882938|NCT01190930|526077038|FG003|Maintenance|Adverse Event|0|||
145882939|NCT01190930|526077039|FG004|Maintenance|Adverse Event|0|||
145882940|NCT01190930|526077040|FG005|Maintenance|Adverse Event|1|||
145882941|NCT01190930|526077041|FG006|Maintenance|Adverse Event|1|||
145882942|NCT01190930|526077042|FG007|Maintenance|Adverse Event|3|||
145882943|NCT01190930|526077043|FG008|Maintenance|Adverse Event|3|||
145882944|NCT01190930|526077044|FG009|Maintenance|Adverse Event|0|||
145882945|NCT01190930|526077035|FG000|Maintenance|Death|0|||
145882946|NCT01190930|526077036|FG001|Maintenance|Death|0|||
145882947|NCT01190930|526077037|FG002|Maintenance|Death|0|||
145882948|NCT01190930|526077038|FG003|Maintenance|Death|1|||
145882949|NCT01190930|526077039|FG004|Maintenance|Death|0|||
145882950|NCT01190930|526077040|FG005|Maintenance|Death|0|||
145882951|NCT01190930|526077041|FG006|Maintenance|Death|2|||
145882952|NCT01190930|526077042|FG007|Maintenance|Death|2|||
145882953|NCT01190930|526077043|FG008|Maintenance|Death|2|||
145961190|NCT00128661|526369520|FG000|Overall Study|Withdrawal by Subject|243|||
145961191|NCT00128661|526369521|FG001|Overall Study|Withdrawal by Subject|232|||
146085085|NCT01993836|526832065|FG001|Overall Study|Withdrawal by Subject|10|||
145882954|NCT01190930|526077044|FG009|Maintenance|Death|2|||
145882955|NCT01190930|526077035|FG000|Maintenance|Lost to Follow-up|0|||
145882956|NCT01190930|526077036|FG001|Maintenance|Lost to Follow-up|0|||
145882957|NCT01190930|526077037|FG002|Maintenance|Lost to Follow-up|0|||
145882958|NCT01190930|526077038|FG003|Maintenance|Lost to Follow-up|0|||
145882959|NCT01190930|526077039|FG004|Maintenance|Lost to Follow-up|0|||
145882960|NCT01190930|526077040|FG005|Maintenance|Lost to Follow-up|0|||
145882961|NCT01190930|526077041|FG006|Maintenance|Lost to Follow-up|1|||
145882962|NCT01190930|526077042|FG007|Maintenance|Lost to Follow-up|1|||
145882963|NCT01190930|526077043|FG008|Maintenance|Lost to Follow-up|1|||
145882964|NCT01190930|526077044|FG009|Maintenance|Lost to Follow-up|0|||
145882965|NCT01190930|526077035|FG000|Maintenance|Physician Decision|0|||
145882966|NCT01190930|526077036|FG001|Maintenance|Physician Decision|1|||
145882967|NCT01190930|526077037|FG002|Maintenance|Physician Decision|0|||
145882968|NCT01190930|526077038|FG003|Maintenance|Physician Decision|5|||
145882969|NCT01190930|526077039|FG004|Maintenance|Physician Decision|9|||
145882970|NCT01190930|526077040|FG005|Maintenance|Physician Decision|4|||
145882971|NCT01190930|526077041|FG006|Maintenance|Physician Decision|8|||
145882972|NCT01190930|526077042|FG007|Maintenance|Physician Decision|8|||
145882973|NCT01190930|526077043|FG008|Maintenance|Physician Decision|10|||
145882974|NCT01190930|526077044|FG009|Maintenance|Physician Decision|17|||
145882975|NCT01190930|526077035|FG000|Maintenance|Withdrawal by Subject|0|||
145882976|NCT01190930|526077036|FG001|Maintenance|Withdrawal by Subject|0|||
145882977|NCT01190930|526077037|FG002|Maintenance|Withdrawal by Subject|0|||
145882978|NCT01190930|526077038|FG003|Maintenance|Withdrawal by Subject|0|||
145961192|NCT00128661|526369520|FG000|Overall Study|Other|7|||
145961193|NCT00128661|526369521|FG001|Overall Study|Other|8|||
145961194|NCT01827592|526369525|FG000|Overall Study|Adverse Event|11|||
145961195|NCT01827592|526369526|FG001|Overall Study|Adverse Event|9|||
145961196|NCT01827592|526369527|FG002|Overall Study|Adverse Event|2|||
145961197|NCT01827592|526369525|FG000|Overall Study|Physician Decision|0|||
145961198|NCT01827592|526369526|FG001|Overall Study|Physician Decision|2|||
145961199|NCT01827592|526369527|FG002|Overall Study|Physician Decision|1|||
145961200|NCT01827592|526369525|FG000|Overall Study|Protocol Violation|2|||
145961201|NCT01827592|526369526|FG001|Overall Study|Protocol Violation|1|||
145961202|NCT01827592|526369527|FG002|Overall Study|Protocol Violation|0|||
145961203|NCT01827592|526369525|FG000|Overall Study|Lost to Follow-up|1|||
145961204|NCT01827592|526369526|FG001|Overall Study|Lost to Follow-up|2|||
145961205|NCT01827592|526369527|FG002|Overall Study|Lost to Follow-up|2|||
145961206|NCT01827592|526369525|FG000|Overall Study|Withdrawal by Subject|12|||
145961207|NCT01827592|526369526|FG001|Overall Study|Withdrawal by Subject|11|||
145961208|NCT01827592|526369527|FG002|Overall Study|Withdrawal by Subject|11|||
145961209|NCT01827592|526369525|FG000|Overall Study|Patient's substantial non-compliance|1|||
145961210|NCT01827592|526369526|FG001|Overall Study|Patient's substantial non-compliance|1|||
145961211|NCT01827592|526369527|FG002|Overall Study|Patient's substantial non-compliance|6|||
145961212|NCT01827592|526369525|FG000|Overall Study|Trial terminated by Sponsor|47|||
145961213|NCT01827592|526369526|FG001|Overall Study|Trial terminated by Sponsor|53|||
145961214|NCT01827592|526369527|FG002|Overall Study|Trial terminated by Sponsor|51|||
145961215|NCT01827592|526369525|FG000|Overall Study|Others|0|||
145961216|NCT01827592|526369526|FG001|Overall Study|Others|1|||
145961217|NCT01827592|526369527|FG002|Overall Study|Others|3|||
145961218|NCT00689338|526369530|FG000|Overall Study|Death|65|||
145961219|NCT00689338|526369530|FG000|Overall Study|Adverse Event|13|||
145961220|NCT00689338|526369530|FG000|Overall Study|Insufficient Clinical Response|1|||
145961221|NCT00689338|526369530|FG000|Overall Study|Lack of Efficacy|6|||
145961222|NCT00689338|526369530|FG000|Overall Study|Other|8|||
145961223|NCT00689338|526369530|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
145961224|NCT00689338|526369530|FG000|Overall Study|Lost to Follow-up|5|||
145961225|NCT00689338|526369530|FG000|Overall Study|Withdrawal by Subject|3|||
145961226|NCT00689338|526369530|FG000|Overall Study|Protocol Violation|15|||
145882979|NCT01190930|526077039|FG004|Maintenance|Withdrawal by Subject|0|||
145882980|NCT01190930|526077040|FG005|Maintenance|Withdrawal by Subject|0|||
145882981|NCT01190930|526077041|FG006|Maintenance|Withdrawal by Subject|2|||
145882982|NCT01190930|526077042|FG007|Maintenance|Withdrawal by Subject|1|||
145882983|NCT01190930|526077043|FG008|Maintenance|Withdrawal by Subject|4|||
145882984|NCT01190930|526077044|FG009|Maintenance|Withdrawal by Subject|1|||
145882985|NCT01190930|526077035|FG000|Maintenance|Refusal|0|||
145882986|NCT01190930|526077036|FG001|Maintenance|Refusal|1|||
145882987|NCT01190930|526077037|FG002|Maintenance|Refusal|0|||
145882988|NCT01190930|526077038|FG003|Maintenance|Refusal|2|||
145882989|NCT01190930|526077039|FG004|Maintenance|Refusal|0|||
145882990|NCT01190930|526077040|FG005|Maintenance|Refusal|4|||
145882991|NCT01190930|526077041|FG006|Maintenance|Refusal|5|||
145882992|NCT01190930|526077042|FG007|Maintenance|Refusal|17|||
145882993|NCT01190930|526077043|FG008|Maintenance|Refusal|13|||
145882994|NCT01190930|526077044|FG009|Maintenance|Refusal|6|||
145882995|NCT01190930|526077035|FG000|Maintenance|second malignant neoplasm|0|||
145882996|NCT01190930|526077036|FG001|Maintenance|second malignant neoplasm|0|||
145882997|NCT01190930|526077037|FG002|Maintenance|second malignant neoplasm|0|||
145882998|NCT01190930|526077038|FG003|Maintenance|second malignant neoplasm|1|||
145882999|NCT01190930|526077039|FG004|Maintenance|second malignant neoplasm|0|||
145883000|NCT01190930|526077040|FG005|Maintenance|second malignant neoplasm|1|||
145883001|NCT01190930|526077041|FG006|Maintenance|second malignant neoplasm|0|||
145883002|NCT01190930|526077042|FG007|Maintenance|second malignant neoplasm|0|||
145883003|NCT01190930|526077043|FG008|Maintenance|second malignant neoplasm|1|||
145883004|NCT01190930|526077044|FG009|Maintenance|second malignant neoplasm|0|||
145883005|NCT01190930|526077035|FG000|Maintenance|Inevaluable|0|||
145883006|NCT01190930|526077036|FG001|Maintenance|Inevaluable|0|||
145883007|NCT01190930|526077037|FG002|Maintenance|Inevaluable|0|||
145883008|NCT01190930|526077038|FG003|Maintenance|Inevaluable|0|||
145883009|NCT01190930|526077039|FG004|Maintenance|Inevaluable|0|||
145883010|NCT01190930|526077040|FG005|Maintenance|Inevaluable|1|||
145883011|NCT01190930|526077041|FG006|Maintenance|Inevaluable|1|||
145883012|NCT01190930|526077042|FG007|Maintenance|Inevaluable|1|||
145883013|NCT01190930|526077043|FG008|Maintenance|Inevaluable|0|||
145883014|NCT01190930|526077044|FG009|Maintenance|Inevaluable|0|||
145883015|NCT01190930|526077035|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
145883016|NCT01190930|526077036|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
145883017|NCT01190930|526077037|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
145883018|NCT01190930|526077038|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
145883019|NCT01190930|526077039|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
145883020|NCT01190930|526077040|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
145883021|NCT01190930|526077041|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
145883022|NCT01190930|526077042|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
145883023|NCT01190930|526077043|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
145883024|NCT01190930|526077044|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
145883025|NCT01190930|526077035|FG000|Maintenance|Relapse|0|||
145883026|NCT01190930|526077036|FG001|Maintenance|Relapse|0|||
145883027|NCT01190930|526077037|FG002|Maintenance|Relapse|0|||
145883028|NCT01190930|526077038|FG003|Maintenance|Relapse|2|||
145883029|NCT01190930|526077039|FG004|Maintenance|Relapse|0|||
145883030|NCT01190930|526077040|FG005|Maintenance|Relapse|1|||
145883031|NCT01190930|526077041|FG006|Maintenance|Relapse|6|||
145883032|NCT01190930|526077042|FG007|Maintenance|Relapse|13|||
145883033|NCT01190930|526077043|FG008|Maintenance|Relapse|11|||
145883034|NCT01190930|526077044|FG009|Maintenance|Relapse|11|||
145883035|NCT01190930|526077035|FG000|Maintenance|Still on therapy|0|||
145883036|NCT01190930|526077036|FG001|Maintenance|Still on therapy|8|||
145883037|NCT01190930|526077037|FG002|Maintenance|Still on therapy|0|||
145883038|NCT01190930|526077038|FG003|Maintenance|Still on therapy|29|||
146085086|NCT01993836|526832066|FG002|Overall Study|Withdrawal by Subject|5|||
146223082|NCT03459729|527331659|FG000|Overall Study|Physician Decision|2|||
146223083|NCT06182033|527331660|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
146223084|NCT06182033|527331661|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
146223085|NCT06182033|527331660|FG000|Overall Study|Target child relocation|1|||
146223086|NCT06182033|527331661|FG001|Overall Study|Target child relocation|1|||
146223087|NCT06182033|527331660|FG000|Overall Study|Withdrawal by Subject|1|||
146223088|NCT06182033|527331661|FG001|Overall Study|Withdrawal by Subject|0|||
146288964|NCT05041101|527573296|FG002|Overall Study|Diease Progression|0|||
146288965|NCT01205152|527573297|FG000|Overall Study|Death|1|||
146288966|NCT00249002|527573298|FG000|Overall Study|Adverse Event|2|||
146288967|NCT00249002|527573298|FG000|Overall Study|Study cancellation|3|||
146288968|NCT00249002|527573298|FG000|Overall Study|Other|2|||
146288969|NCT00069108|527573299|FG000|Overall Study|Withdrawal by Subject|5|||
146288970|NCT00069108|527573300|FG001|Overall Study|Withdrawal by Subject|9|||
145883039|NCT01190930|526077039|FG004|Maintenance|Still on therapy|0|||
145883040|NCT01190930|526077040|FG005|Maintenance|Still on therapy|0|||
145883041|NCT01190930|526077041|FG006|Maintenance|Still on therapy|0|||
146288971|NCT00069108|527573299|FG000|Overall Study|Adverse Event|64|||
146223089|NCT05704543|527331662|FG000|Overall Study|Withdrawal by Subject|1|||
146223090|NCT05704543|527331663|FG001|Overall Study|Withdrawal by Subject|1|||
145961227|NCT00808067|526369531|FG000|Overall Study|Major/minor bleed|30|||
145961228|NCT00808067|526369532|FG001|Overall Study|Major/minor bleed|44|||
146223091|NCT05704543|527331664|FG002|Overall Study|Withdrawal by Subject|0|||
146223092|NCT05704543|527331665|FG003|Overall Study|Withdrawal by Subject|2|||
146223093|NCT05704543|527331662|FG000|Overall Study|Lost to Follow-up|1|||
146223094|NCT05704543|527331663|FG001|Overall Study|Lost to Follow-up|2|||
146223095|NCT05704543|527331664|FG002|Overall Study|Lost to Follow-up|0|||
146223096|NCT05704543|527331665|FG003|Overall Study|Lost to Follow-up|0|||
146223097|NCT02151981|527331666|FG000|Overall Study|Death|184|||
146223098|NCT02151981|527331667|FG001|Overall Study|Death|88|||
145961229|NCT00808067|526369531|FG000|Overall Study|Outcome event - other|33|||
146223099|NCT02151981|527331666|FG000|Overall Study|Lost to Follow-up|7|||
146223100|NCT02151981|527331667|FG001|Overall Study|Lost to Follow-up|1|||
145883042|NCT01190930|526077042|FG007|Maintenance|Still on therapy|0|||
145883043|NCT01190930|526077043|FG008|Maintenance|Still on therapy|0|||
145883044|NCT01190930|526077044|FG009|Maintenance|Still on therapy|0|||
145883045|NCT02351167|526077047|FG000|Overall Study|Withdrawal by Subject|19|||
145883046|NCT02351167|526077048|FG001|Overall Study|Withdrawal by Subject|18|||
145883047|NCT02351167|526077049|FG002|Overall Study|Withdrawal by Subject|21|||
145883048|NCT00113919|526077051|FG000|Overall Study|Physician Decision|8|||
145883049|NCT00113919|526077051|FG000|Overall Study|Death|6|||
145883050|NCT02340962|526077052|FG000|Overall Study|Lost to Follow-up|1|||
145883051|NCT02340962|526077053|FG001|Overall Study|Lost to Follow-up|0|||
145883052|NCT02914457|526077056|FG000|Overall Study|Withdrawal by Subject|1|||
145883053|NCT02914457|526077056|FG000|Overall Study|Physician Decision|1|||
145883054|NCT02914457|526077056|FG000|Overall Study|No veins available for lead placement|1|||
145883055|NCT02914457|526077056|FG000|Overall Study|Electrical instability of patient|1|||
145883056|NCT02914457|526077056|FG000|Overall Study|ECG acquisition error due to sweating|1|||
145883057|NCT02914457|526077056|FG000|Overall Study|Protocol Violation|1|||
145883058|NCT01292837|526077062|FG000|Overall Study|Adverse Event|1|||
145883059|NCT01292837|526077062|FG000|Overall Study|Further treatment determined|1|||
145883060|NCT02174276|526077063|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
145883061|NCT02174276|526077064|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145883062|NCT02174276|526077065|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145883063|NCT02174276|526077066|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145883064|NCT02174276|526077063|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145883065|NCT02174276|526077064|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145883066|NCT02174276|526077065|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
145883067|NCT02174276|526077066|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145883068|NCT02174276|526077063|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
145883069|NCT02174276|526077064|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
145883070|NCT02174276|526077065|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
145883071|NCT02174276|526077066|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
145883072|NCT02174276|526077063|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145883073|NCT02174276|526077064|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145883074|NCT02174276|526077065|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
145883075|NCT02174276|526077066|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145883076|NCT02174276|526077063|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145883077|NCT02174276|526077064|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145883078|NCT02174276|526077065|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
145883079|NCT02174276|526077066|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145883080|NCT02174276|526077063|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
145883081|NCT02174276|526077064|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
145883082|NCT02174276|526077065|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
145883083|NCT02174276|526077066|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
145883084|NCT01206439|526077069|FG000|Overall Study|subject did not meet inclusion criteria|1|||
145883085|NCT05889039|526077070|FG000|Overall Study|error in completing survey|0|||
145883086|NCT05889039|526077071|FG001|Overall Study|error in completing survey|2|||
145883087|NCT05889039|526077072|FG002|Overall Study|error in completing survey|0|||
145883088|NCT05889039|526077073|FG003|Overall Study|error in completing survey|0|||
145883089|NCT05889039|526077070|FG000|Overall Study|Lost to Follow-up|4|||
145883090|NCT05889039|526077071|FG001|Overall Study|Lost to Follow-up|0|||
145883091|NCT05889039|526077072|FG002|Overall Study|Lost to Follow-up|0|||
145883092|NCT05889039|526077073|FG003|Overall Study|Lost to Follow-up|0|||
145883093|NCT02661022|526077075|FG000|Overall Study|Withdrawal by Subject|3|||
145883094|NCT02661022|526077076|FG001|Overall Study|Withdrawal by Subject|0|||
145883095|NCT02661022|526077075|FG000|Overall Study|Adverse Event|1|||
145883096|NCT02661022|526077076|FG001|Overall Study|Adverse Event|1|||
145883097|NCT02661022|526077075|FG000|Overall Study|Physician Decision|1|||
145883098|NCT02661022|526077076|FG001|Overall Study|Physician Decision|0|||
145883099|NCT02661022|526077075|FG000|Overall Study|Progressive Disease|2|||
145883100|NCT02661022|526077076|FG001|Overall Study|Progressive Disease|1|||
145961230|NCT00808067|526369532|FG001|Overall Study|Outcome event - other|25|||
146288972|NCT00069108|527573300|FG001|Overall Study|Adverse Event|42|||
145961231|NCT00808067|526369531|FG000|Overall Study|Adverse Event|111|||
145961232|NCT00808067|526369532|FG001|Overall Study|Adverse Event|121|||
145961233|NCT00808067|526369531|FG000|Overall Study|Hospitalization (not including surgery)|18|||
145961234|NCT00808067|526369532|FG001|Overall Study|Hospitalization (not including surgery)|17|||
145961235|NCT00808067|526369531|FG000|Overall Study|Hospitalization due to surgery|37|||
145961236|NCT00808067|526369532|FG001|Overall Study|Hospitalization due to surgery|40|||
145961237|NCT00808067|526369531|FG000|Overall Study|Reduced creatinine clearance|53|||
145961238|NCT00808067|526369532|FG001|Overall Study|Reduced creatinine clearance|55|||
145961239|NCT00808067|526369531|FG000|Overall Study|Elevated LFT results|7|||
145883101|NCT01055886|526077077|FG000|Overall Study|Withdrawal by Subject|4|||
145883102|NCT01055886|526077078|FG001|Overall Study|Withdrawal by Subject|9|||
145883103|NCT01055886|526077077|FG000|Overall Study|Lost to Follow-up|1|||
145883104|NCT01055886|526077078|FG001|Overall Study|Lost to Follow-up|1|||
145883105|NCT01055886|526077077|FG000|Overall Study|Withdrawal by PI|0|||
145883106|NCT01055886|526077078|FG001|Overall Study|Withdrawal by PI|1|||
145883107|NCT00609154|526077079|FG000|Overall Study|Protocol Violation|1|||
145883108|NCT00609154|526077080|FG001|Overall Study|Protocol Violation|2|||
145883109|NCT00609154|526077079|FG000|Overall Study|Unable to establish IV access|0|||
145883110|NCT00609154|526077080|FG001|Overall Study|Unable to establish IV access|4|||
145883111|NCT00609154|526077079|FG000|Overall Study|Adverse Event|0|||
145883112|NCT00609154|526077080|FG001|Overall Study|Adverse Event|2|||
145883113|NCT04531527|526077081|FG000|Overall Study|Found to be Ineligible|3|||
145883114|NCT00434837|526077087|FG000|Overall Study|Lost to Follow-up|20|||
145883115|NCT00434837|526077088|FG001|Overall Study|Lost to Follow-up|23|||
145883116|NCT00434837|526077089|FG002|Overall Study|Lost to Follow-up|30|||
145883117|NCT01785615|526077094|FG000|Dietary Phase|Lost to Follow-up|0|||
145883118|NCT01785615|526077095|FG001|Dietary Phase|Lost to Follow-up|0|||
145883119|NCT01785615|526077096|FG002|Dietary Phase|Lost to Follow-up|0|||
146085087|NCT00779259|526832067|FG000|Quinine Alone|Adverse Event|2|||
145883120|NCT01785615|526077097|FG003|Dietary Phase|Lost to Follow-up|24|||
145883121|NCT01881737|526077098|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
146223101|NCT02151981|527331666|FG000|Overall Study|Withdrawal by Subject|27|||
146223102|NCT02151981|527331667|FG001|Overall Study|Withdrawal by Subject|21|||
146223103|NCT02151981|527331666|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146223104|NCT02151981|527331667|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146223105|NCT02151981|527331666|FG000|Overall Study|Other reasons|1|||
146223106|NCT02151981|527331667|FG001|Overall Study|Other reasons|2|||
146223107|NCT05576155|527331675|FG000|Overall Study|Withdrawal by Subject|1|||
146223108|NCT05576155|527331676|FG001|Overall Study|Withdrawal by Subject|1|||
146223109|NCT05251909|527333606|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
146223110|NCT05251909|527333607|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
146223111|NCT03257410|527333608|FG000|Overall Study|Adverse Event|2|||
146223112|NCT03257410|527333609|FG001|Overall Study|Adverse Event|3|||
146223113|NCT03257410|527333608|FG000|Overall Study|Protocol Violation|1|||
146223114|NCT03257410|527333609|FG001|Overall Study|Protocol Violation|2|||
146223115|NCT03257410|527333608|FG000|Overall Study|Lost to Follow-up|1|||
146223116|NCT03257410|527333609|FG001|Overall Study|Lost to Follow-up|0|||
146223117|NCT03257410|527333608|FG000|Overall Study|Withdrawal by Subject|1|||
146223118|NCT03257410|527333609|FG001|Overall Study|Withdrawal by Subject|2|||
146223119|NCT03257410|527333608|FG000|Overall Study|Physician Decision|1|||
146223120|NCT03257410|527333609|FG001|Overall Study|Physician Decision|1|||
146223121|NCT03257410|527333608|FG000|Overall Study|Renal transplantation|2|||
146223122|NCT03257410|527333609|FG001|Overall Study|Renal transplantation|0|||
146223123|NCT03257410|527333608|FG000|Overall Study|Switch to peritoneal dialysis|1|||
146085088|NCT00686634|526832068|FG000|Overall Study|Protocol Violation|6|||
146223124|NCT03257410|527333609|FG001|Overall Study|Switch to peritoneal dialysis|0|||
146223125|NCT03257410|527333608|FG000|Overall Study|Death|3|||
145883122|NCT01881737|526077098|FG000|Overall Study|Withdrawal by Subject|1|||
145883123|NCT01881737|526077098|FG000|Overall Study|Worsening of baseline behavior|1|||
145883124|NCT02058160|526077103|FG000|Overall Study|Randomized but not treated|2|||
145883125|NCT02058160|526077104|FG001|Overall Study|Randomized but not treated|4|||
145883126|NCT02058160|526077103|FG000|Overall Study|Poor compliance to protocol|4|||
145883127|NCT02058160|526077104|FG001|Overall Study|Poor compliance to protocol|1|||
145883128|NCT02058160|526077103|FG000|Overall Study|Adverse Event|12|||
146223126|NCT03257410|527333609|FG001|Overall Study|Death|2|||
146223127|NCT03257410|527333608|FG000|Overall Study|Change to another dialysis center|2|||
146223128|NCT03257410|527333609|FG001|Overall Study|Change to another dialysis center|2|||
146223129|NCT03257410|527333608|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
146085089|NCT03490981|526832071|FG000|Overall Study|Lost to Follow-up|1|||
146085090|NCT03490981|526832072|FG001|Overall Study|Lost to Follow-up|2|||
146223130|NCT03257410|527333609|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
146223131|NCT03257410|527333608|FG000|Overall Study|Miscellaneous|2|||
146223132|NCT03257410|527333609|FG001|Overall Study|Miscellaneous|2|||
146223133|NCT03257410|527333608|FG000|Overall Study|Other|0|||
146223134|NCT03257410|527333609|FG001|Overall Study|Other|1|||
146223135|NCT00433329|527333610|FG000|Overall Study|Adverse Event|9|||
146223136|NCT00433329|527333610|FG000|Overall Study|Death|4|||
146223137|NCT00433329|527333610|FG000|Overall Study|Withdrew consent|3|||
146223138|NCT00433329|527333610|FG000|Overall Study|Discontinued sildenafil|2|||
146223139|NCT00433329|527333610|FG000|Overall Study|Moved out of state|1|||
146223140|NCT00433329|527333610|FG000|Overall Study|Lost to Follow-up|1|||
146223141|NCT00433329|527333610|FG000|Overall Study|Physician Decision|1|||
146223142|NCT03381196|527333613|FG000|Overall Study|Withdrawal by Subject|7|||
146223143|NCT03381196|527333614|FG001|Overall Study|Withdrawal by Subject|7|||
146223144|NCT03381196|527333613|FG000|Overall Study|Other|0|||
146223145|NCT03381196|527333614|FG001|Overall Study|Other|1|||
146223146|NCT03381196|527333613|FG000|Overall Study|Lost to Follow-up|5|||
146223147|NCT03381196|527333614|FG001|Overall Study|Lost to Follow-up|4|||
146223148|NCT03381196|527333613|FG000|Overall Study|Death|0|||
146223149|NCT03381196|527333614|FG001|Overall Study|Death|1|||
146223150|NCT03381196|527333613|FG000|Overall Study|Adverse Event|1|||
146223151|NCT03381196|527333614|FG001|Overall Study|Adverse Event|0|||
146223152|NCT03381196|527333613|FG000|Overall Study|Randomized, not treated|3|||
146223153|NCT03381196|527333614|FG001|Overall Study|Randomized, not treated|6|||
146223154|NCT02598388|527333615|FG000|Overall Study|Lost to Follow-up|1|||
146223155|NCT02598388|527333616|FG001|Overall Study|Lost to Follow-up|0|||
146223156|NCT02598388|527333617|FG002|Overall Study|Lost to Follow-up|1|||
146223157|NCT02598388|527333618|FG003|Overall Study|Lost to Follow-up|0|||
146223158|NCT02598388|527333619|FG004|Overall Study|Lost to Follow-up|5|||
146223159|NCT02598388|527333620|FG005|Overall Study|Lost to Follow-up|1|||
146223160|NCT02598388|527333621|FG006|Overall Study|Lost to Follow-up|2|||
146288973|NCT00069108|527573299|FG000|Overall Study|Death|6|||
146223161|NCT02598388|527333622|FG007|Overall Study|Lost to Follow-up|1|||
146223162|NCT02598388|527333623|FG008|Overall Study|Lost to Follow-up|0|||
146223163|NCT02598388|527333624|FG009|Overall Study|Lost to Follow-up|0|||
146223164|NCT02598388|527333625|FG010|Overall Study|Lost to Follow-up|1|||
146223165|NCT02598388|527333626|FG011|Overall Study|Lost to Follow-up|0|||
146223166|NCT02598388|527333615|FG000|Overall Study|Withdrawal by Subject|0|||
146223167|NCT02598388|527333616|FG001|Overall Study|Withdrawal by Subject|0|||
146223168|NCT02598388|527333617|FG002|Overall Study|Withdrawal by Subject|0|||
146223169|NCT02598388|527333618|FG003|Overall Study|Withdrawal by Subject|0|||
146223170|NCT02598388|527333619|FG004|Overall Study|Withdrawal by Subject|2|||
146223171|NCT02598388|527333620|FG005|Overall Study|Withdrawal by Subject|0|||
146223172|NCT02598388|527333621|FG006|Overall Study|Withdrawal by Subject|2|||
146223173|NCT02598388|527333622|FG007|Overall Study|Withdrawal by Subject|0|||
146223174|NCT02598388|527333623|FG008|Overall Study|Withdrawal by Subject|0|||
146223175|NCT02598388|527333624|FG009|Overall Study|Withdrawal by Subject|1|||
146223176|NCT02598388|527333625|FG010|Overall Study|Withdrawal by Subject|0|||
146288974|NCT00069108|527573300|FG001|Overall Study|Death|6|||
146288975|NCT00069108|527573299|FG000|Overall Study|Administration|15|||
146288976|NCT00069108|527573300|FG001|Overall Study|Administration|4|||
146288977|NCT00069108|527573299|FG000|Overall Study|Insufficient therapy|117|||
146288978|NCT00069108|527573300|FG001|Overall Study|Insufficient therapy|144|||
146288979|NCT00069108|527573299|FG000|Overall Study|Violation criteria|1|||
146288980|NCT00069108|527573300|FG001|Overall Study|Violation criteria|4|||
146288981|NCT00069108|527573299|FG000|Overall Study|Refused treatment|5|||
146288982|NCT00069108|527573300|FG001|Overall Study|Refused treatment|10|||
146288983|NCT02783768|527573301|FG000|Overall Study|Lost to Follow-up|1|||
146288984|NCT02783768|527573302|FG001|Overall Study|Lost to Follow-up|0|||
146288985|NCT01323647|527573303|FG000|Overall Study|Migrated/moved from study area|2|||
146288986|NCT01323647|527573304|FG001|Overall Study|Migrated/moved from study area|0|||
146288987|NCT01323647|527573303|FG000|Overall Study|Withdrawal by Subject|5|||
146288988|NCT01323647|527573304|FG001|Overall Study|Withdrawal by Subject|0|||
146288989|NCT01323647|527573303|FG000|Overall Study|Lost to Follow-up|2|||
146288990|NCT01323647|527573304|FG001|Overall Study|Lost to Follow-up|0|||
145883129|NCT02058160|526077104|FG001|Overall Study|Adverse Event|3|||
146223177|NCT02598388|527333626|FG011|Overall Study|Withdrawal by Subject|0|||
146223178|NCT02598388|527333615|FG000|Overall Study|Other|0|||
145883130|NCT02058160|526077103|FG000|Overall Study|Lost to Follow-up|1|||
145883131|NCT02058160|526077104|FG001|Overall Study|Lost to Follow-up|0|||
146223179|NCT02598388|527333616|FG001|Overall Study|Other|0|||
146288991|NCT00262951|527573305|FG000|Overall Study|Progressive disease/relapse|3|||
146288992|NCT00262951|527573305|FG000|Overall Study|Adverse Event|7|||
146223180|NCT02598388|527333617|FG002|Overall Study|Other|1|||
146223181|NCT02598388|527333618|FG003|Overall Study|Other|0|||
146223182|NCT02598388|527333619|FG004|Overall Study|Other|3|||
146223183|NCT02598388|527333620|FG005|Overall Study|Other|0|||
146223184|NCT02598388|527333621|FG006|Overall Study|Other|1|||
146223185|NCT02598388|527333622|FG007|Overall Study|Other|0|||
146223186|NCT02598388|527333623|FG008|Overall Study|Other|0|||
146223187|NCT02598388|527333624|FG009|Overall Study|Other|0|||
146223188|NCT02598388|527333625|FG010|Overall Study|Other|0|||
146223189|NCT02598388|527333626|FG011|Overall Study|Other|0|||
146223190|NCT02359890|527333630|FG000|Overall Study|Not meeting eligibility|4|||
146223191|NCT02359890|527333630|FG000|Overall Study|Never treated with study catheter|6|||
146223192|NCT03628924|527333631|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
146223193|NCT03628924|527333632|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146223194|NCT03628924|527333633|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146223195|NCT03628924|527333634|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146223196|NCT03628924|527333635|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146223197|NCT03628924|527333636|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146223198|NCT03628924|527333637|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
146288993|NCT00262951|527573305|FG000|Overall Study|Death|1|||
146223199|NCT03628924|527333631|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146288994|NCT00262951|527573305|FG000|Overall Study|Withdrawal by Subject|1|||
146223200|NCT03628924|527333632|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146223201|NCT03628924|527333633|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
146223202|NCT03628924|527333634|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146223203|NCT03628924|527333635|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146223204|NCT03628924|527333636|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146223205|NCT03628924|527333637|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146223206|NCT03628924|527333631|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
146223207|NCT03628924|527333632|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
146223208|NCT03628924|527333633|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
146223209|NCT03628924|527333634|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146223210|NCT03628924|527333635|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146223211|NCT03628924|527333636|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146223212|NCT03628924|527333637|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
146223213|NCT03628924|527333631|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223214|NCT03628924|527333632|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
146223215|NCT03628924|527333633|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223216|NCT03628924|527333634|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223217|NCT03628924|527333635|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223218|NCT03628924|527333636|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223219|NCT03628924|527333637|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146223220|NCT03628924|527333631|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
146223221|NCT03628924|527333632|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146223222|NCT03628924|527333633|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
146223223|NCT03628924|527333634|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146223224|NCT03628924|527333635|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146223225|NCT03628924|527333636|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146223226|NCT03628924|527333637|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
146223227|NCT03628924|527333631|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146223228|NCT03628924|527333632|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146223229|NCT03628924|527333633|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
146223230|NCT03628924|527333634|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146223231|NCT03628924|527333635|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146223232|NCT03628924|527333636|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
146223233|NCT03628924|527333637|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
146223234|NCT03628924|527333631|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146223235|NCT03628924|527333632|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146223236|NCT03628924|527333633|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146223237|NCT03628924|527333634|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
146223238|NCT03628924|527333635|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
146223239|NCT03628924|527333636|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
146223240|NCT03628924|527333637|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
146223241|NCT03628924|527333631|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146223242|NCT03628924|527333632|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146223243|NCT03628924|527333633|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146223244|NCT03628924|527333634|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146223245|NCT03628924|527333635|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146223246|NCT03628924|527333636|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
146223247|NCT03628924|527333637|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
146223248|NCT03628924|527333631|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146223249|NCT03628924|527333632|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146085091|NCT01107379|526832076|FG000|Overall Study|Withdrawal by Subject|18|||
146223250|NCT03628924|527333633|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
146085092|NCT01107379|526832076|FG000|Overall Study|Lost to Follow-up|3|||
146223251|NCT03628924|527333634|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
146223252|NCT03628924|527333635|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
146223253|NCT03628924|527333636|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
146223254|NCT03628924|527333637|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
146223255|NCT03628924|527333631|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146223256|NCT03628924|527333632|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146223257|NCT03628924|527333633|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146223258|NCT03628924|527333634|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
146223259|NCT03628924|527333635|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
146223260|NCT03628924|527333636|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
146223261|NCT03628924|527333637|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
146223262|NCT05256017|527333638|FG000|Treatment Period|Withdrawal by Subject|1|||
146223263|NCT05256017|527333639|FG001|Treatment Period|Withdrawal by Subject|1|||
146223264|NCT05256017|527333638|FG000|Follow-up|Lost to Follow-up|7|||
146223265|NCT05256017|527333639|FG001|Follow-up|Lost to Follow-up|1|||
146223266|NCT05256017|527333638|FG000|Follow-up|Withdrawal by Subject|1|||
146223267|NCT05256017|527333639|FG001|Follow-up|Withdrawal by Subject|0|||
146223268|NCT05256017|527333638|FG000|Follow-up|Death|0|||
146223269|NCT05256017|527333639|FG001|Follow-up|Death|1|||
146223270|NCT04663737|527333651|FG000|Overall Study|Withdrawal by Subject|2|||
146223271|NCT04663737|527333652|FG001|Overall Study|Withdrawal by Subject|0|||
146223272|NCT04016662|527333653|FG000|Run-In Phase|Death|1|||
146223273|NCT04016662|527333653|FG000|Run-In Phase|Withdrawal by Subject|11|||
146223274|NCT04016662|527333653|FG000|Run-In Phase|Not meeting screening eligibility|9|||
146223275|NCT04016662|527333653|FG000|Run-In Phase|Physician Decision|3|||
146223276|NCT04016662|527333653|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
146223277|NCT04016662|527333653|FG000|PLGS (12 Weeks)|Death|1|||
146223278|NCT04016662|527333653|FG000|SAP (12 Weeks)|Death|1|||
146223279|NCT03907878|527333654|FG000|Treatment Period|Withdrawal by Subject|5|||
146223280|NCT03907878|527333654|FG000|Treatment Period|Adverse Event|4|||
146223281|NCT03907878|527333654|FG000|Treatment Period|Lack of Efficacy|1|||
146223282|NCT03907878|527333654|FG000|Treatment Period|Protocol Violation|1|||
146223283|NCT03907878|527333654|FG000|Follow-up Period|Adverse Event|3|||
146223284|NCT03907878|527333654|FG000|Follow-up Period|Withdrawal by Subject|3|||
146223285|NCT04499924|527333655|FG000|Overall Study|Study termination by sponsor|4|||
146223286|NCT04499924|527333656|FG001|Overall Study|Study termination by sponsor|6|||
146223287|NCT04499924|527333655|FG000|Overall Study|Withdrawal by Subject|1|||
146223288|NCT04499924|527333656|FG001|Overall Study|Withdrawal by Subject|3|||
146223289|NCT02841579|527333664|FG000|Overall Study|Death|1|||
146223290|NCT02841579|527333664|FG000|Overall Study|Adverse Event|1|||
146223291|NCT02841579|527333664|FG000|Overall Study|Lack of Efficacy|9|||
146223292|NCT03011333|527333667|FG000|Overall Study|Lost to Follow-up|0|||
146223293|NCT03011333|527333668|FG001|Overall Study|Lost to Follow-up|1|||
146223294|NCT03011333|527333669|FG002|Overall Study|Lost to Follow-up|0|||
146223295|NCT03011333|527333670|FG003|Overall Study|Lost to Follow-up|1|||
146223296|NCT03011333|527333671|FG004|Overall Study|Lost to Follow-up|4|||
146223297|NCT03011333|527333672|FG005|Overall Study|Lost to Follow-up|4|||
146223298|NCT03011333|527333673|FG006|Overall Study|Lost to Follow-up|5|||
146223299|NCT02998268|527333674|FG000|Overall Study|Adverse Event|0|||
146223300|NCT02998268|527333675|FG001|Overall Study|Adverse Event|2|||
146223301|NCT02998268|527333674|FG000|Overall Study|Withdrawal by Subject|0|||
146223302|NCT02998268|527333675|FG001|Overall Study|Withdrawal by Subject|1|||
146223303|NCT04225273|527333676|FG000|Overall Study|Lost to Follow-up|3|||
146223304|NCT03652389|527333677|FG000|Overall Study|Lost to Follow-up|1|||
146223305|NCT03652389|527333678|FG001|Overall Study|Lost to Follow-up|5|||
146223306|NCT03652389|527333677|FG000|Overall Study|Withdrawal by Subject|5|||
146223307|NCT03652389|527333678|FG001|Overall Study|Withdrawal by Subject|1|||
145883132|NCT02058160|526077103|FG000|Overall Study|Other than specified above|12|||
145883133|NCT02058160|526077104|FG001|Overall Study|Other than specified above|6|||
145883134|NCT04106817|526077105|FG000|Overall Study|Lost to Follow-up|1|||
145883135|NCT04106817|526077106|FG001|Overall Study|Lost to Follow-up|0|||
145883136|NCT04106817|526077107|FG002|Overall Study|Lost to Follow-up|0|||
145883137|NCT03310619|526077108|FG000|Pre-Treatment Period|Death|1|||
145883138|NCT03310619|526077109|FG001|Pre-Treatment Period|Death|0|||
145883139|NCT03310619|526077110|FG002|Pre-Treatment Period|Death|0|||
145883140|NCT03310619|526077111|FG003|Pre-Treatment Period|Death|0|||
145883141|NCT03310619|526077112|FG004|Pre-Treatment Period|Death|1|||
145883142|NCT03310619|526077113|FG005|Pre-Treatment Period|Death|0|||
145883143|NCT03310619|526077114|FG006|Pre-Treatment Period|Death|0|||
146223308|NCT03652389|527333677|FG000|Overall Study|New diagnosis|2|||
146223309|NCT03652389|527333678|FG001|Overall Study|New diagnosis|0|||
146223310|NCT04413708|527333679|FG000|Overall Study|Lost to Follow-up|1|||
146223311|NCT04413708|527333680|FG001|Overall Study|Lost to Follow-up|2|||
146223312|NCT02815566|527333681|FG000|Overall Study|Adverse Event|1|||
146223313|NCT02815566|527333682|FG001|Overall Study|Adverse Event|1|||
146223314|NCT02815566|527333681|FG000|Overall Study|Withdrawal by Subject|1|||
145883144|NCT03310619|526077115|FG007|Pre-Treatment Period|Death|0|||
145883145|NCT03310619|526077108|FG000|Pre-Treatment Period|Other reasons|2|||
145883146|NCT03310619|526077109|FG001|Pre-Treatment Period|Other reasons|1|||
145883147|NCT03310619|526077110|FG002|Pre-Treatment Period|Other reasons|2|||
146223315|NCT02815566|527333682|FG001|Overall Study|Withdrawal by Subject|0|||
145883148|NCT03310619|526077111|FG003|Pre-Treatment Period|Other reasons|0|||
146223316|NCT02815566|527333681|FG000|Overall Study|Lost to Follow-up|0|||
146223317|NCT02815566|527333682|FG001|Overall Study|Lost to Follow-up|1|||
146223318|NCT02861300|527333685|FG000|Overall Study|Death|0|||
146223319|NCT02861300|527333686|FG001|Overall Study|Death|0|||
146223320|NCT02861300|527333687|FG002|Overall Study|Death|0|||
146223321|NCT02861300|527333688|FG003|Overall Study|Death|0|||
146223322|NCT02861300|527333689|FG004|Overall Study|Death|0|||
146223323|NCT02861300|527333690|FG005|Overall Study|Death|0|||
146223324|NCT02861300|527333691|FG006|Overall Study|Death|24|||
146223325|NCT02861300|527333685|FG000|Overall Study|Delay in treatment|0|||
146223326|NCT02861300|527333686|FG001|Overall Study|Delay in treatment|0|||
146223327|NCT02861300|527333687|FG002|Overall Study|Delay in treatment|0|||
146223328|NCT02861300|527333688|FG003|Overall Study|Delay in treatment|0|||
146223329|NCT02861300|527333689|FG004|Overall Study|Delay in treatment|0|||
146223330|NCT02861300|527333690|FG005|Overall Study|Delay in treatment|1|||
146223331|NCT02861300|527333691|FG006|Overall Study|Delay in treatment|0|||
146223332|NCT02861300|527333685|FG000|Overall Study|Disease Progression|0|||
146223333|NCT02861300|527333686|FG001|Overall Study|Disease Progression|1|||
146223334|NCT02861300|527333687|FG002|Overall Study|Disease Progression|0|||
146223335|NCT02861300|527333688|FG003|Overall Study|Disease Progression|0|||
146223336|NCT02861300|527333689|FG004|Overall Study|Disease Progression|0|||
146223337|NCT02861300|527333690|FG005|Overall Study|Disease Progression|0|||
146223338|NCT02861300|527333691|FG006|Overall Study|Disease Progression|2|||
146223339|NCT02861300|527333685|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
146223340|NCT02861300|527333686|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
146223341|NCT02861300|527333687|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
146223342|NCT02861300|527333688|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
146223343|NCT02861300|527333689|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
146223344|NCT02861300|527333690|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
146223345|NCT02861300|527333691|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
146223346|NCT02861300|527333685|FG000|Overall Study|Clinical Complications|0|||
146223347|NCT02861300|527333686|FG001|Overall Study|Clinical Complications|0|||
146223348|NCT02861300|527333687|FG002|Overall Study|Clinical Complications|0|||
146223349|NCT02861300|527333688|FG003|Overall Study|Clinical Complications|0|||
146223350|NCT02861300|527333689|FG004|Overall Study|Clinical Complications|0|||
146223351|NCT02861300|527333690|FG005|Overall Study|Clinical Complications|0|||
146223352|NCT02861300|527333691|FG006|Overall Study|Clinical Complications|1|||
146223353|NCT03133546|527333697|FG000|Overall Study|Death|46|||
146223354|NCT03133546|527333698|FG001|Overall Study|Death|43|||
146223355|NCT03133546|527333697|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
146223356|NCT03133546|527333698|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
146223357|NCT01501955|527333702|FG000|Overall Study|Withdrawal by Subject|1|||
146223358|NCT01501955|527333703|FG001|Overall Study|Withdrawal by Subject|0|||
146223359|NCT01501955|527333702|FG000|Overall Study|Adverse Event|1|||
146223360|NCT01501955|527333703|FG001|Overall Study|Adverse Event|3|||
146223361|NCT02993159|527333704|FG000|Overall Study|Withdrawal by Subject|1|||
146223362|NCT02993159|527333705|FG001|Overall Study|Withdrawal by Subject|3|||
146223363|NCT02993159|527333704|FG000|Overall Study|Protocol Violation|1|||
146223364|NCT02993159|527333705|FG001|Overall Study|Protocol Violation|0|||
146223365|NCT02993159|527333704|FG000|Overall Study|Opted out of surgery|2|||
146223366|NCT02993159|527333705|FG001|Overall Study|Opted out of surgery|0|||
146223367|NCT02993159|527333704|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
146223368|NCT02993159|527333705|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
146223369|NCT02993159|527333704|FG000|Overall Study|Physician Decision|0|||
146223370|NCT02993159|527333705|FG001|Overall Study|Physician Decision|1|||
146223371|NCT05034328|527333706|FG000|Overall Study|Protocol Violation|1|||
146223372|NCT05034328|527333707|FG001|Overall Study|Protocol Violation|0|||
146223373|NCT05034328|527333706|FG000|Overall Study|Lost to Follow-up|0|||
146223374|NCT05034328|527333707|FG001|Overall Study|Lost to Follow-up|10|||
146223375|NCT02969707|527333709|FG000|Overall Study|Withdrawal by Subject|6|||
146223376|NCT02969707|527333710|FG001|Overall Study|Withdrawal by Subject|5|||
146223377|NCT02969707|527333709|FG000|Overall Study|Severe anxiety|0|||
146223378|NCT02969707|527333710|FG001|Overall Study|Severe anxiety|1|||
146223379|NCT02969707|527333709|FG000|Overall Study|Positive toxicology screen|0|||
146223380|NCT02969707|527333710|FG001|Overall Study|Positive toxicology screen|2|||
146223381|NCT02969707|527333709|FG000|Overall Study|Claustrophobia|2|||
146223382|NCT02969707|527333710|FG001|Overall Study|Claustrophobia|2|||
146223383|NCT02969707|527333709|FG000|Overall Study|Non-compliance|1|||
146223384|NCT02969707|527333710|FG001|Overall Study|Non-compliance|2|||
146223385|NCT05583578|527333713|FG000|Overall Study|Withdrawal by Subject|2|||
146223386|NCT05583578|527333714|FG001|Overall Study|Withdrawal by Subject|0|||
146223387|NCT04313972|527333715|FG000|Overall Study|Withdrawal by Subject|0|||
146223388|NCT04313972|527333716|FG001|Overall Study|Withdrawal by Subject|1|||
146223389|NCT04314713|527333718|FG000|Overall Study|Lost to Follow-up|0|||
146223390|NCT04314713|527333719|FG001|Overall Study|Lost to Follow-up|0|||
146223391|NCT04314713|527333720|FG002|Overall Study|Lost to Follow-up|0|||
146223392|NCT04314713|527333721|FG003|Overall Study|Lost to Follow-up|1|||
146223393|NCT04314713|527333722|FG004|Overall Study|Lost to Follow-up|0|||
146223394|NCT04314713|527333723|FG005|Overall Study|Lost to Follow-up|0|||
146223395|NCT00248287|527333724|FG000|Overall Study|Adverse Event|11|||
146223396|NCT00248287|527333725|FG001|Overall Study|Adverse Event|10|||
146223397|NCT00248287|527333724|FG000|Overall Study|Death|1|||
146223398|NCT00248287|527333725|FG001|Overall Study|Death|0|||
146223399|NCT00248287|527333724|FG000|Overall Study|Lost to Follow-up|0|||
146223400|NCT00248287|527333725|FG001|Overall Study|Lost to Follow-up|1|||
146223401|NCT00248287|527333724|FG000|Overall Study|Investigator Request|4|||
146223402|NCT00248287|527333725|FG001|Overall Study|Investigator Request|3|||
146223403|NCT00248287|527333724|FG000|Overall Study|Patient Request|5|||
146223404|NCT00248287|527333725|FG001|Overall Study|Patient Request|3|||
146223405|NCT00248287|527333724|FG000|Overall Study|Other|3|||
146223406|NCT00248287|527333725|FG001|Overall Study|Other|2|||
146223407|NCT04830800|527333764|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
146223408|NCT04830800|527333765|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
146223409|NCT04830800|527333766|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
146223410|NCT04830800|527333767|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
146223411|NCT04830800|527333768|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
146223412|NCT03701763|527333769|FG000|Placebo-controlled Phase|Adverse Event|1|||
146223413|NCT03701763|527333770|FG001|Placebo-controlled Phase|Adverse Event|5|||
146223414|NCT03701763|527333771|FG002|Placebo-controlled Phase|Adverse Event|0|||
146223415|NCT03701763|527333772|FG003|Placebo-controlled Phase|Adverse Event|0|||
146223416|NCT03701763|527333769|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
146223417|NCT03701763|527333770|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
146223418|NCT03701763|527333771|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
146223419|NCT03701763|527333772|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
146223420|NCT03701763|527333769|FG000|Placebo-controlled Phase|Miscellaneous|2|||
146223421|NCT03701763|527333770|FG001|Placebo-controlled Phase|Miscellaneous|0|||
146223422|NCT03701763|527333771|FG002|Placebo-controlled Phase|Miscellaneous|0|||
146223423|NCT03701763|527333772|FG003|Placebo-controlled Phase|Miscellaneous|0|||
146223424|NCT03701763|527333769|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
146223425|NCT03701763|527333770|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
146223426|NCT03701763|527333771|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
146223427|NCT03701763|527333772|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
146223428|NCT03701763|527333769|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
146223429|NCT03701763|527333770|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
146223430|NCT03701763|527333771|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
146223431|NCT03701763|527333772|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
146223432|NCT03701763|527333769|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
146223433|NCT03701763|527333770|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
146223434|NCT03701763|527333771|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
146223435|NCT03701763|527333772|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
146223436|NCT03701763|527333769|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
146223437|NCT03701763|527333770|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
146223438|NCT03701763|527333771|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
146223439|NCT03701763|527333772|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
146223440|NCT03701763|527333769|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
146223441|NCT03701763|527333770|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
146223442|NCT03701763|527333771|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
146223443|NCT03701763|527333772|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
146223444|NCT03701763|527333769|FG000|Apremilast Extension Phase|Adverse Event|0|||
146223445|NCT03701763|527333770|FG001|Apremilast Extension Phase|Adverse Event|0|||
146223446|NCT03701763|527333771|FG002|Apremilast Extension Phase|Adverse Event|3|||
146223447|NCT03701763|527333772|FG003|Apremilast Extension Phase|Adverse Event|1|||
146223448|NCT03701763|527333769|FG000|Apremilast Extension Phase|Miscellaneous|0|||
146223449|NCT03701763|527333770|FG001|Apremilast Extension Phase|Miscellaneous|0|||
146223450|NCT03701763|527333771|FG002|Apremilast Extension Phase|Miscellaneous|2|||
146223451|NCT03701763|527333772|FG003|Apremilast Extension Phase|Miscellaneous|1|||
146223452|NCT03701763|527333769|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
146223453|NCT03701763|527333770|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
146223454|NCT03701763|527333771|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
146223455|NCT03701763|527333772|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
146223456|NCT03701763|527333769|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
146223457|NCT03701763|527333770|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
146223458|NCT03701763|527333771|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
146223459|NCT03701763|527333772|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
146223460|NCT03701763|527333769|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
146223461|NCT03701763|527333770|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
146223462|NCT03701763|527333771|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
146223463|NCT03701763|527333772|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
146223464|NCT03701763|527333769|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146223465|NCT03701763|527333770|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146223466|NCT03701763|527333771|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
146223467|NCT03701763|527333772|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
146223468|NCT03701763|527333769|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
146223469|NCT03701763|527333770|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
146223470|NCT03701763|527333771|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
146223471|NCT03701763|527333772|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
146223472|NCT03701763|527333769|FG000|14-Week Observational Follow-up Phase|Other|0|||
146223473|NCT03701763|527333770|FG001|14-Week Observational Follow-up Phase|Other|0|||
146223474|NCT03701763|527333771|FG002|14-Week Observational Follow-up Phase|Other|1|||
146223475|NCT03701763|527333772|FG003|14-Week Observational Follow-up Phase|Other|0|||
146223476|NCT03701763|527333769|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146223477|NCT03701763|527333770|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146223478|NCT03701763|527333771|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
146223479|NCT03701763|527333772|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
146223480|NCT03701763|527333769|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146223481|NCT03701763|527333770|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146223482|NCT03701763|527333771|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
146223483|NCT03701763|527333772|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
146223484|NCT04200456|527333773|FG000|Overall Study|Physician Decision|0|||
146223485|NCT04200456|527333774|FG001|Overall Study|Physician Decision|1|||
146223486|NCT04200456|527333773|FG000|Overall Study|Withdrawal by Subject|2|||
146223487|NCT04200456|527333774|FG001|Overall Study|Withdrawal by Subject|2|||
146223488|NCT04200456|527333773|FG000|Overall Study|Lack of Efficacy|1|||
146223489|NCT04200456|527333774|FG001|Overall Study|Lack of Efficacy|1|||
146223490|NCT04200456|527333773|FG000|Overall Study|Adverse event, non-fatal|0|||
146223491|NCT04200456|527333774|FG001|Overall Study|Adverse event, non-fatal|1|||
146223492|NCT04200456|527333773|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
146223493|NCT04200456|527333774|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
146223494|NCT03785964|527333775|FG000|Overall Study|Adverse Event|14|||
146223495|NCT03785964|527333776|FG001|Overall Study|Adverse Event|1|||
146223496|NCT03785964|527333775|FG000|Overall Study|Unqualified Clinical Progression|1|||
146223497|NCT03785964|527333776|FG001|Overall Study|Unqualified Clinical Progression|1|||
146223498|NCT03785964|527333775|FG000|Overall Study|Participant non-compliance|1|||
146223499|NCT03785964|527333776|FG001|Overall Study|Participant non-compliance|1|||
146223500|NCT03785964|527333775|FG000|Overall Study|Not treated|1|||
146223501|NCT03785964|527333776|FG001|Overall Study|Not treated|0|||
146223502|NCT03785964|527333775|FG000|Overall Study|Other reason|5|||
146223503|NCT03785964|527333776|FG001|Overall Study|Other reason|11|||
146223504|NCT03785964|527333775|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
146223505|NCT03785964|527333776|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
146223506|NCT02733159|527333782|FG000|Overall Study|Adverse Event|1|||
146223507|NCT02733159|527333782|FG000|Overall Study|Lack of disease progression|1|||
146223508|NCT03854227|527335744|FG000|Overall Study|Adverse Event|0|||
146223509|NCT03854227|527335745|FG001|Overall Study|Adverse Event|0|||
146223510|NCT03854227|527335746|FG002|Overall Study|Adverse Event|0|||
146223511|NCT03854227|527335747|FG003|Overall Study|Adverse Event|1|||
146223512|NCT03854227|527335748|FG004|Overall Study|Adverse Event|0|||
146223513|NCT03854227|527335749|FG005|Overall Study|Adverse Event|0|||
146223514|NCT03854227|527335750|FG006|Overall Study|Adverse Event|1|||
146223515|NCT03854227|527335751|FG007|Overall Study|Adverse Event|0|||
146223516|NCT03854227|527335752|FG008|Overall Study|Adverse Event|0|||
146223517|NCT03854227|527335753|FG009|Overall Study|Adverse Event|3|||
146223518|NCT03854227|527335754|FG010|Overall Study|Adverse Event|0|||
146223519|NCT03854227|527335755|FG011|Overall Study|Adverse Event|1|||
146223520|NCT03854227|527335744|FG000|Overall Study|Death|0|||
146223521|NCT03854227|527335745|FG001|Overall Study|Death|0|||
146223522|NCT03854227|527335746|FG002|Overall Study|Death|0|||
146223523|NCT03854227|527335747|FG003|Overall Study|Death|0|||
146223524|NCT03854227|527335748|FG004|Overall Study|Death|0|||
146223525|NCT03854227|527335749|FG005|Overall Study|Death|1|||
146223526|NCT03854227|527335750|FG006|Overall Study|Death|0|||
146223527|NCT03854227|527335751|FG007|Overall Study|Death|0|||
146223528|NCT03854227|527335752|FG008|Overall Study|Death|0|||
146223529|NCT03854227|527335753|FG009|Overall Study|Death|1|||
146223530|NCT03854227|527335754|FG010|Overall Study|Death|0|||
146223531|NCT03854227|527335755|FG011|Overall Study|Death|1|||
146223532|NCT03854227|527335744|FG000|Overall Study|Physician Decision|0|||
146223533|NCT03854227|527335745|FG001|Overall Study|Physician Decision|0|||
146223534|NCT03854227|527335746|FG002|Overall Study|Physician Decision|0|||
146223535|NCT03854227|527335747|FG003|Overall Study|Physician Decision|0|||
146223536|NCT03854227|527335748|FG004|Overall Study|Physician Decision|0|||
146223537|NCT03854227|527335749|FG005|Overall Study|Physician Decision|1|||
146223538|NCT03854227|527335750|FG006|Overall Study|Physician Decision|0|||
146223539|NCT03854227|527335751|FG007|Overall Study|Physician Decision|0|||
146223540|NCT03854227|527335752|FG008|Overall Study|Physician Decision|1|||
146223541|NCT03854227|527335753|FG009|Overall Study|Physician Decision|1|||
146223542|NCT03854227|527335754|FG010|Overall Study|Physician Decision|0|||
146223543|NCT03854227|527335755|FG011|Overall Study|Physician Decision|1|||
146223544|NCT03854227|527335744|FG000|Overall Study|Progressive disease|1|||
146223545|NCT03854227|527335745|FG001|Overall Study|Progressive disease|1|||
146223546|NCT03854227|527335746|FG002|Overall Study|Progressive disease|1|||
146223547|NCT03854227|527335747|FG003|Overall Study|Progressive disease|2|||
146223548|NCT03854227|527335748|FG004|Overall Study|Progressive disease|3|||
146223549|NCT03854227|527335749|FG005|Overall Study|Progressive disease|1|||
146223550|NCT03854227|527335750|FG006|Overall Study|Progressive disease|2|||
146223551|NCT03854227|527335751|FG007|Overall Study|Progressive disease|5|||
146223552|NCT03854227|527335752|FG008|Overall Study|Progressive disease|2|||
146223553|NCT03854227|527335753|FG009|Overall Study|Progressive disease|5|||
146223554|NCT03854227|527335754|FG010|Overall Study|Progressive disease|1|||
146223555|NCT03854227|527335755|FG011|Overall Study|Progressive disease|6|||
146223556|NCT03854227|527335744|FG000|Overall Study|Study terminated by sponsor|0|||
146223557|NCT03854227|527335745|FG001|Overall Study|Study terminated by sponsor|0|||
146223558|NCT03854227|527335746|FG002|Overall Study|Study terminated by sponsor|0|||
146223559|NCT03854227|527335747|FG003|Overall Study|Study terminated by sponsor|0|||
146223560|NCT03854227|527335748|FG004|Overall Study|Study terminated by sponsor|0|||
146223561|NCT03854227|527335749|FG005|Overall Study|Study terminated by sponsor|0|||
146223562|NCT03854227|527335750|FG006|Overall Study|Study terminated by sponsor|0|||
146223563|NCT03854227|527335751|FG007|Overall Study|Study terminated by sponsor|0|||
146223564|NCT03854227|527335752|FG008|Overall Study|Study terminated by sponsor|0|||
146223565|NCT03854227|527335753|FG009|Overall Study|Study terminated by sponsor|1|||
146223566|NCT03854227|527335754|FG010|Overall Study|Study terminated by sponsor|0|||
146223567|NCT03854227|527335755|FG011|Overall Study|Study terminated by sponsor|0|||
146223568|NCT03854227|527335744|FG000|Overall Study|Withdrawal by Subject|0|||
146223569|NCT03854227|527335745|FG001|Overall Study|Withdrawal by Subject|0|||
146223570|NCT03854227|527335746|FG002|Overall Study|Withdrawal by Subject|1|||
146223571|NCT03854227|527335747|FG003|Overall Study|Withdrawal by Subject|0|||
146223572|NCT03854227|527335748|FG004|Overall Study|Withdrawal by Subject|0|||
146223573|NCT03854227|527335749|FG005|Overall Study|Withdrawal by Subject|0|||
146223574|NCT03854227|527335750|FG006|Overall Study|Withdrawal by Subject|0|||
146223575|NCT03854227|527335751|FG007|Overall Study|Withdrawal by Subject|0|||
146223576|NCT03854227|527335752|FG008|Overall Study|Withdrawal by Subject|0|||
146223577|NCT03854227|527335753|FG009|Overall Study|Withdrawal by Subject|1|||
146223578|NCT03854227|527335754|FG010|Overall Study|Withdrawal by Subject|1|||
146223579|NCT03854227|527335755|FG011|Overall Study|Withdrawal by Subject|0|||
146223580|NCT03854227|527335744|FG000|Overall Study|Disease relapse|0|||
146223581|NCT03854227|527335745|FG001|Overall Study|Disease relapse|0|||
146223582|NCT03854227|527335746|FG002|Overall Study|Disease relapse|0|||
146223583|NCT03854227|527335747|FG003|Overall Study|Disease relapse|0|||
146223584|NCT03854227|527335748|FG004|Overall Study|Disease relapse|0|||
146223585|NCT03854227|527335749|FG005|Overall Study|Disease relapse|0|||
146223586|NCT03854227|527335750|FG006|Overall Study|Disease relapse|0|||
146223587|NCT03854227|527335751|FG007|Overall Study|Disease relapse|0|||
146223588|NCT03854227|527335752|FG008|Overall Study|Disease relapse|1|||
146223589|NCT03854227|527335753|FG009|Overall Study|Disease relapse|0|||
146223590|NCT03854227|527335754|FG010|Overall Study|Disease relapse|0|||
146223591|NCT03854227|527335755|FG011|Overall Study|Disease relapse|0|||
146223592|NCT03854227|527335744|FG000|Overall Study|Global deterioration of health status|0|||
146223593|NCT03854227|527335745|FG001|Overall Study|Global deterioration of health status|0|||
146223594|NCT03854227|527335746|FG002|Overall Study|Global deterioration of health status|0|||
146223595|NCT03854227|527335747|FG003|Overall Study|Global deterioration of health status|0|||
146223596|NCT03854227|527335748|FG004|Overall Study|Global deterioration of health status|0|||
146223597|NCT03854227|527335749|FG005|Overall Study|Global deterioration of health status|1|||
146223598|NCT03854227|527335750|FG006|Overall Study|Global deterioration of health status|0|||
146223599|NCT03854227|527335751|FG007|Overall Study|Global deterioration of health status|1|||
146223600|NCT03854227|527335752|FG008|Overall Study|Global deterioration of health status|0|||
146223601|NCT03854227|527335753|FG009|Overall Study|Global deterioration of health status|0|||
146223602|NCT03854227|527335754|FG010|Overall Study|Global deterioration of health status|0|||
146223603|NCT03854227|527335755|FG011|Overall Study|Global deterioration of health status|0|||
146223604|NCT03854227|527335744|FG000|Overall Study|Refused further treatment|0|||
146223605|NCT03854227|527335745|FG001|Overall Study|Refused further treatment|0|||
146223606|NCT03854227|527335746|FG002|Overall Study|Refused further treatment|0|||
146223607|NCT03854227|527335747|FG003|Overall Study|Refused further treatment|0|||
146223608|NCT03854227|527335748|FG004|Overall Study|Refused further treatment|0|||
146223609|NCT03854227|527335749|FG005|Overall Study|Refused further treatment|0|||
146223610|NCT03854227|527335750|FG006|Overall Study|Refused further treatment|0|||
146223611|NCT03854227|527335751|FG007|Overall Study|Refused further treatment|0|||
146223612|NCT03854227|527335752|FG008|Overall Study|Refused further treatment|0|||
146223613|NCT03854227|527335753|FG009|Overall Study|Refused further treatment|1|||
146223614|NCT03854227|527335754|FG010|Overall Study|Refused further treatment|0|||
146223615|NCT03854227|527335755|FG011|Overall Study|Refused further treatment|1|||
146223616|NCT03854227|527335744|FG000|Overall Study|Other|0|||
146223617|NCT03854227|527335745|FG001|Overall Study|Other|0|||
146223618|NCT03854227|527335746|FG002|Overall Study|Other|0|||
146223619|NCT03854227|527335747|FG003|Overall Study|Other|0|||
146223620|NCT03854227|527335748|FG004|Overall Study|Other|0|||
146223621|NCT03854227|527335749|FG005|Overall Study|Other|0|||
146223622|NCT03854227|527335750|FG006|Overall Study|Other|0|||
146223623|NCT03854227|527335751|FG007|Overall Study|Other|0|||
146223624|NCT03854227|527335752|FG008|Overall Study|Other|1|||
146223625|NCT03854227|527335753|FG009|Overall Study|Other|1|||
146223626|NCT03854227|527335754|FG010|Overall Study|Other|0|||
146223627|NCT03854227|527335755|FG011|Overall Study|Other|0|||
146223628|NCT03668236|527335756|FG000|90-day Follow-up|Withdrawal by Subject|3|||
146223629|NCT03668236|527335757|FG001|90-day Follow-up|Withdrawal by Subject|2|||
146223630|NCT03668236|527335756|FG000|90-day Follow-up|Lost to Follow-up|3|||
146223631|NCT03668236|527335757|FG001|90-day Follow-up|Lost to Follow-up|1|||
146223632|NCT03668236|527335756|FG000|Baseline Characteristics|Lost to Follow-up|9|||
146223633|NCT03668236|527335757|FG001|Baseline Characteristics|Lost to Follow-up|5|||
146223634|NCT03668236|527335756|FG000|1-year Follow-up|Withdrawal by Subject|17|||
146223635|NCT03668236|527335757|FG001|1-year Follow-up|Withdrawal by Subject|15|||
146223636|NCT06132282|527335758|FG000|Overall Study|Lost to Follow-up|31|||
146223637|NCT03748953|527335759|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
146223638|NCT03748953|527335760|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
146223639|NCT03748953|527335759|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
146223640|NCT03748953|527335760|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
146223641|NCT03748953|527335759|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
146223642|NCT03748953|527335760|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
146223643|NCT03748953|527335759|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
146223644|NCT03748953|527335760|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
146223645|NCT03748953|527335759|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
146223646|NCT03748953|527335760|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
146223647|NCT02276885|527335761|FG000|Overall Study|Withdrawal by Subject|2|||
146223648|NCT02276885|527335762|FG001|Overall Study|Withdrawal by Subject|0|||
146223649|NCT02276885|527335761|FG000|Overall Study|Lost to Follow-up|5|||
146223650|NCT02276885|527335762|FG001|Overall Study|Lost to Follow-up|2|||
146223651|NCT01593917|527335764|FG000|Overall Study|Death|67|||
146223652|NCT01593917|527335764|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
146223653|NCT01593917|527335764|FG000|Overall Study|Withdrawal by Subject|23|||
146223654|NCT01593917|527335764|FG000|Overall Study|Lost to Follow-up|12|||
146223655|NCT01593917|527335764|FG000|Overall Study|Protocol Violation|5|||
146223656|NCT01593917|527335764|FG000|Overall Study|Physician Decision|3|||
146223657|NCT03020199|527335771|FG000|Treatment Period|Adverse Event|0|||
146223658|NCT03020199|527335772|FG001|Treatment Period|Adverse Event|2|||
146223659|NCT03020199|527335771|FG000|Treatment Period|Lack of Efficacy|1|||
146085093|NCT04559529|526832077|FG000|First Intervention (1 Day)|Adverse Event|0|||
146223660|NCT03020199|527335772|FG001|Treatment Period|Lack of Efficacy|6|||
146223661|NCT03020199|527335771|FG000|Treatment Period|Lost to Follow-up|1|||
146223662|NCT03020199|527335772|FG001|Treatment Period|Lost to Follow-up|6|||
146223663|NCT03020199|527335771|FG000|Treatment Period|Physician Decision|0|||
146223664|NCT03020199|527335772|FG001|Treatment Period|Physician Decision|1|||
146223665|NCT03020199|527335771|FG000|Treatment Period|Subject/guardian decision|8|||
146223666|NCT03020199|527335772|FG001|Treatment Period|Subject/guardian decision|15|||
146223667|NCT03020199|527335771|FG000|Treatment Period|Subjects not treated|3|||
146223668|NCT03020199|527335772|FG001|Treatment Period|Subjects not treated|4|||
146223669|NCT03020199|527335771|FG000|Follow-up Period|Disease relapse|32|||
146223670|NCT03020199|527335772|FG001|Follow-up Period|Disease relapse|7|||
146223671|NCT03020199|527335771|FG000|Follow-up Period|Lack of Efficacy|1|||
146223672|NCT03020199|527335772|FG001|Follow-up Period|Lack of Efficacy|2|||
146223673|NCT03020199|527335771|FG000|Follow-up Period|Lost to Follow-up|4|||
146223674|NCT03020199|527335772|FG001|Follow-up Period|Lost to Follow-up|6|||
146223675|NCT03020199|527335771|FG000|Follow-up Period|Physician Decision|2|||
146223676|NCT03020199|527335772|FG001|Follow-up Period|Physician Decision|2|||
146223677|NCT03020199|527335771|FG000|Follow-up Period|Protocol Violation|1|||
146223678|NCT03020199|527335772|FG001|Follow-up Period|Protocol Violation|2|||
146223679|NCT03020199|527335771|FG000|Follow-up Period|Study terminated by Sponsor|6|||
146223680|NCT03020199|527335772|FG001|Follow-up Period|Study terminated by Sponsor|3|||
146223681|NCT03020199|527335771|FG000|Follow-up Period|Subject/guardian decision|14|||
146223682|NCT03020199|527335772|FG001|Follow-up Period|Subject/guardian decision|9|||
146223683|NCT05877976|527335773|FG000|Overall Study|Lost to Follow-up|31|||
146223684|NCT02714257|527335787|FG000|Overall Study|Withdrawal by Subject|6|||
146223685|NCT02714257|527335788|FG001|Overall Study|Withdrawal by Subject|11|||
146223686|NCT02714257|527335787|FG000|Overall Study|Death|3|||
146223687|NCT02714257|527335788|FG001|Overall Study|Death|4|||
146223688|NCT02714257|527335787|FG000|Overall Study|Lost to Follow-up|1|||
146223689|NCT02714257|527335788|FG001|Overall Study|Lost to Follow-up|6|||
146223690|NCT04568486|527335791|FG000|Overall Study|Withdrawal by Subject|26|||
146223691|NCT04568486|527335791|FG000|Overall Study|Lost to Follow-up|7|||
146223692|NCT01210807|527335794|FG000|Overall Study|Lost to Follow-up|1|||
146223693|NCT01210807|527335795|FG001|Overall Study|Lost to Follow-up|2|||
146223694|NCT01210807|527335794|FG000|Overall Study|Not implanted bilaterally|2|||
146223695|NCT01210807|527335795|FG001|Overall Study|Not implanted bilaterally|1|||
146223696|NCT05477186|527335798|FG000|Overall Study|Vaccine not administered|0|||
146223697|NCT05477186|527335799|FG001|Overall Study|Vaccine not administered|2|||
146223698|NCT05477186|527335800|FG002|Overall Study|Vaccine not administered|1|||
146223699|NCT05477186|527335801|FG003|Overall Study|Vaccine not administered|0|||
146223700|NCT05477186|527335802|FG004|Overall Study|Vaccine not administered|1|||
146223701|NCT05477186|527335803|FG005|Overall Study|Vaccine not administered|0|||
146223702|NCT05477186|527335804|FG006|Overall Study|Vaccine not administered|0|||
146223703|NCT05477186|527335798|FG000|Overall Study|Withdrawal by Subject|1|||
146223704|NCT05477186|527335799|FG001|Overall Study|Withdrawal by Subject|0|||
146223705|NCT05477186|527335800|FG002|Overall Study|Withdrawal by Subject|0|||
146223706|NCT05477186|527335801|FG003|Overall Study|Withdrawal by Subject|0|||
146223707|NCT05477186|527335802|FG004|Overall Study|Withdrawal by Subject|0|||
146223708|NCT05477186|527335803|FG005|Overall Study|Withdrawal by Subject|1|||
146223709|NCT05477186|527335804|FG006|Overall Study|Withdrawal by Subject|0|||
145883149|NCT03310619|526077112|FG004|Pre-Treatment Period|Other reasons|0|||
145883150|NCT03310619|526077113|FG005|Pre-Treatment Period|Other reasons|0|||
145883151|NCT03310619|526077114|FG006|Pre-Treatment Period|Other reasons|2|||
145883152|NCT03310619|526077115|FG007|Pre-Treatment Period|Other reasons|0|||
145883153|NCT03310619|526077108|FG000|Treatment Period|Death|1|||
145883154|NCT03310619|526077109|FG001|Treatment Period|Death|2|||
145883155|NCT03310619|526077110|FG002|Treatment Period|Death|0|||
145883156|NCT03310619|526077111|FG003|Treatment Period|Death|0|||
145883157|NCT03310619|526077112|FG004|Treatment Period|Death|1|||
145883158|NCT03310619|526077113|FG005|Treatment Period|Death|0|||
145883159|NCT03310619|526077114|FG006|Treatment Period|Death|2|||
145883160|NCT03310619|526077115|FG007|Treatment Period|Death|0|||
145883161|NCT03310619|526077108|FG000|Treatment Period|Adverse Event|0|||
145883162|NCT03310619|526077109|FG001|Treatment Period|Adverse Event|1|||
145883163|NCT03310619|526077110|FG002|Treatment Period|Adverse Event|4|||
145883164|NCT03310619|526077111|FG003|Treatment Period|Adverse Event|1|||
145883165|NCT03310619|526077112|FG004|Treatment Period|Adverse Event|0|||
145883166|NCT03310619|526077113|FG005|Treatment Period|Adverse Event|0|||
145883167|NCT03310619|526077114|FG006|Treatment Period|Adverse Event|0|||
145883168|NCT03310619|526077115|FG007|Treatment Period|Adverse Event|0|||
145883169|NCT03310619|526077108|FG000|Treatment Period|Withdrawal by participant|0|||
145883170|NCT03310619|526077109|FG001|Treatment Period|Withdrawal by participant|0|||
145883171|NCT03310619|526077110|FG002|Treatment Period|Withdrawal by participant|1|||
145883172|NCT03310619|526077111|FG003|Treatment Period|Withdrawal by participant|0|||
145883173|NCT03310619|526077112|FG004|Treatment Period|Withdrawal by participant|0|||
145883174|NCT03310619|526077113|FG005|Treatment Period|Withdrawal by participant|0|||
145883175|NCT03310619|526077114|FG006|Treatment Period|Withdrawal by participant|0|||
145883176|NCT03310619|526077115|FG007|Treatment Period|Withdrawal by participant|0|||
145883177|NCT03310619|526077108|FG000|Treatment Period|Lost to Follow-up|0|||
145883178|NCT03310619|526077109|FG001|Treatment Period|Lost to Follow-up|0|||
145883179|NCT03310619|526077110|FG002|Treatment Period|Lost to Follow-up|0|||
146223710|NCT05477186|527335798|FG000|Overall Study|Lost to Follow-up|1|||
146223711|NCT05477186|527335799|FG001|Overall Study|Lost to Follow-up|0|||
146223712|NCT05477186|527335800|FG002|Overall Study|Lost to Follow-up|2|||
146223713|NCT05477186|527335801|FG003|Overall Study|Lost to Follow-up|1|||
146223714|NCT05477186|527335802|FG004|Overall Study|Lost to Follow-up|1|||
146223715|NCT05477186|527335803|FG005|Overall Study|Lost to Follow-up|0|||
146223716|NCT05477186|527335804|FG006|Overall Study|Lost to Follow-up|2|||
146223717|NCT05496231|527335810|FG000|Overall Study|Adverse Event|1|||
146223718|NCT05496231|527335811|FG001|Overall Study|Adverse Event|1|||
145883180|NCT03310619|526077111|FG003|Treatment Period|Lost to Follow-up|0|||
145883181|NCT03310619|526077112|FG004|Treatment Period|Lost to Follow-up|0|||
145883182|NCT03310619|526077113|FG005|Treatment Period|Lost to Follow-up|0|||
145883183|NCT03310619|526077114|FG006|Treatment Period|Lost to Follow-up|0|||
145883184|NCT03310619|526077115|FG007|Treatment Period|Lost to Follow-up|1|||
145883185|NCT03310619|526077108|FG000|Treatment Period|Study terminated by sponsor|0|||
145961240|NCT00808067|526369532|FG001|Overall Study|Elevated LFT results|3|||
145961241|NCT00808067|526369531|FG000|Overall Study|Patient refused to take study medication|65|||
145961242|NCT00808067|526369532|FG001|Overall Study|Patient refused to take study medication|76|||
145961243|NCT00808067|526369531|FG000|Overall Study|Missing|1|||
145961244|NCT00808067|526369532|FG001|Overall Study|Missing|0|||
145961245|NCT00808067|526369531|FG000|Overall Study|Death|1|||
145961246|NCT00808067|526369532|FG001|Overall Study|Death|1|||
145961247|NCT00808067|526369531|FG000|Overall Study|Procedure|6|||
145961248|NCT00808067|526369532|FG001|Overall Study|Procedure|7|||
145961249|NCT00808067|526369531|FG000|Overall Study|Withdrawal by Subject|21|||
145961250|NCT00808067|526369532|FG001|Overall Study|Withdrawal by Subject|25|||
145961251|NCT00808067|526369531|FG000|Overall Study|Site closed|4|||
145961252|NCT00808067|526369532|FG001|Overall Study|Site closed|3|||
145961253|NCT00808067|526369531|FG000|Overall Study|Physician Decision|47|||
145961254|NCT00808067|526369532|FG001|Overall Study|Physician Decision|38|||
145961255|NCT00808067|526369531|FG000|Overall Study|Protocol Violation|3|||
146085094|NCT04559529|526832078|FG001|First Intervention (1 Day)|Adverse Event|0|||
146085095|NCT04559529|526832079|FG002|First Intervention (1 Day)|Adverse Event|0|||
146223719|NCT05496231|527335812|FG002|Overall Study|Adverse Event|0|||
146223720|NCT05496231|527335813|FG003|Overall Study|Adverse Event|4|||
146223721|NCT05496231|527335810|FG000|Overall Study|Withdrawal by Subject|5|||
146223722|NCT05496231|527335811|FG001|Overall Study|Withdrawal by Subject|5|||
146223723|NCT05496231|527335812|FG002|Overall Study|Withdrawal by Subject|4|||
146223724|NCT05496231|527335813|FG003|Overall Study|Withdrawal by Subject|11|||
146223725|NCT05496231|527335810|FG000|Overall Study|Migrated/moved from the study area|3|||
146223726|NCT05496231|527335811|FG001|Overall Study|Migrated/moved from the study area|5|||
145883186|NCT03310619|526077109|FG001|Treatment Period|Study terminated by sponsor|0|||
145883187|NCT03310619|526077110|FG002|Treatment Period|Study terminated by sponsor|0|||
145883188|NCT03310619|526077111|FG003|Treatment Period|Study terminated by sponsor|0|||
145883189|NCT03310619|526077112|FG004|Treatment Period|Study terminated by sponsor|0|||
145883190|NCT03310619|526077113|FG005|Treatment Period|Study terminated by sponsor|0|||
145883191|NCT03310619|526077114|FG006|Treatment Period|Study terminated by sponsor|0|||
145883192|NCT03310619|526077115|FG007|Treatment Period|Study terminated by sponsor|1|||
145883193|NCT03310619|526077108|FG000|Treatment Period|Physician Decision|0|||
145883194|NCT03310619|526077109|FG001|Treatment Period|Physician Decision|0|||
145883195|NCT03310619|526077110|FG002|Treatment Period|Physician Decision|0|||
145883196|NCT03310619|526077111|FG003|Treatment Period|Physician Decision|0|||
145883197|NCT03310619|526077112|FG004|Treatment Period|Physician Decision|3|||
145883198|NCT03310619|526077113|FG005|Treatment Period|Physician Decision|0|||
145883199|NCT03310619|526077114|FG006|Treatment Period|Physician Decision|0|||
145883200|NCT03310619|526077115|FG007|Treatment Period|Physician Decision|0|||
145883201|NCT03310619|526077108|FG000|Treatment Period|Other reasons|1|||
145883202|NCT03310619|526077109|FG001|Treatment Period|Other reasons|0|||
145883203|NCT03310619|526077110|FG002|Treatment Period|Other reasons|2|||
145883204|NCT03310619|526077111|FG003|Treatment Period|Other reasons|0|||
145883205|NCT03310619|526077112|FG004|Treatment Period|Other reasons|0|||
145883206|NCT03310619|526077113|FG005|Treatment Period|Other reasons|0|||
145883207|NCT03310619|526077114|FG006|Treatment Period|Other reasons|0|||
145883208|NCT03310619|526077115|FG007|Treatment Period|Other reasons|0|||
145883209|NCT00152516|526077116|FG000|Overall Study|Adverse Event|18|||
145883210|NCT00152516|526077116|FG000|Overall Study|Lack and Loss of Efficacy|30|||
145883211|NCT00152516|526077116|FG000|Overall Study|Lost to Follow-up|5|||
145883212|NCT00152516|526077116|FG000|Overall Study|Withdrawal by Subject|8|||
145883213|NCT00152516|526077116|FG000|Overall Study|Protocol Violation|3|||
145883214|NCT00152516|526077116|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
145883215|NCT00152516|526077116|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
145883216|NCT00152516|526077116|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
145883217|NCT00152516|526077116|FG000|Overall Study|Other: Non-Compliance|2|||
145883218|NCT00152516|526077116|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
145883219|NCT00152516|526077116|FG000|Overall Study|Other: Moved Out Of State|1|||
145883220|NCT00152516|526077116|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
145883221|NCT00152516|526077116|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
145883222|NCT01266603|526077119|FG000|Overall Study|Adverse Event|1|||
145961256|NCT00808067|526369532|FG001|Overall Study|Protocol Violation|11|||
145883223|NCT01266603|526077119|FG000|Overall Study|Lack of Efficacy|14|||
145883224|NCT01266603|526077119|FG000|Overall Study|Withdrawal by Subject|1|||
145883225|NCT01266603|526077119|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
145961257|NCT00808067|526369531|FG000|Overall Study|Patient elected|7|||
145961258|NCT00808067|526369532|FG001|Overall Study|Patient elected|9|||
146223727|NCT05496231|527335812|FG002|Overall Study|Migrated/moved from the study area|3|||
146223728|NCT05496231|527335813|FG003|Overall Study|Migrated/moved from the study area|3|||
146223729|NCT05496231|527335810|FG000|Overall Study|Lost to Follow-up|13|||
146223730|NCT05496231|527335811|FG001|Overall Study|Lost to Follow-up|6|||
146223731|NCT05496231|527335812|FG002|Overall Study|Lost to Follow-up|11|||
146223732|NCT05496231|527335813|FG003|Overall Study|Lost to Follow-up|6|||
146223733|NCT05496231|527335810|FG000|Overall Study|Other|9|||
146223734|NCT05496231|527335811|FG001|Overall Study|Other|7|||
146223735|NCT05496231|527335812|FG002|Overall Study|Other|7|||
146223736|NCT05496231|527335813|FG003|Overall Study|Other|8|||
146223737|NCT01733316|527335819|FG000|RP103 Phase|Non-compliance|1|||
146223738|NCT01733316|527335819|FG000|Long Term Extension Phase|Adverse Event|1|||
146223739|NCT01733316|527335819|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
146223740|NCT01733316|527335819|FG000|Long Term Extension Phase|Sponsor Decision|2|||
146223741|NCT05526430|527335820|FG000|Overall Study|Withdrawal by Subject|0|||
146223742|NCT05526430|527335821|FG001|Overall Study|Withdrawal by Subject|2|||
146223743|NCT05526430|527335822|FG002|Overall Study|Withdrawal by Subject|0|||
146223744|NCT05526430|527335823|FG003|Overall Study|Withdrawal by Subject|0|||
146223745|NCT02305888|527335828|FG000|Overall Study|Lost to Follow-up|0|||
146223746|NCT02305888|527335829|FG001|Overall Study|Lost to Follow-up|0|||
146223747|NCT02305888|527335830|FG002|Overall Study|Lost to Follow-up|1|||
146223748|NCT02305888|527335828|FG000|Overall Study|Adverse Event|0|||
146223749|NCT02305888|527335829|FG001|Overall Study|Adverse Event|1|||
146223750|NCT02305888|527335830|FG002|Overall Study|Adverse Event|0|||
146223751|NCT05940194|527335835|FG000|Overall Study|Adverse Event|0|||
146223752|NCT05940194|527335836|FG001|Overall Study|Adverse Event|1|||
146223753|NCT05940194|527335837|FG002|Overall Study|Adverse Event|0|||
146223754|NCT05940194|527335835|FG000|Overall Study|Migrated/Moved from the study area|2|||
146223755|NCT05940194|527335836|FG001|Overall Study|Migrated/Moved from the study area|2|||
146223756|NCT05940194|527335837|FG002|Overall Study|Migrated/Moved from the study area|4|||
146223757|NCT04914676|527335838|FG000|Overall Study|Study termination|3|||
146223758|NCT04914676|527335839|FG001|Overall Study|Study termination|0|||
146223759|NCT03024437|527335840|FG000|Overall Study|Adverse Event|0|||
146223760|NCT03024437|527335841|FG001|Overall Study|Adverse Event|1|||
146223761|NCT03024437|527335842|FG002|Overall Study|Adverse Event|3|||
146223762|NCT03024437|527335843|FG003|Overall Study|Adverse Event|5|||
146223763|NCT03024437|527335844|FG004|Overall Study|Adverse Event|0|||
146223764|NCT03024437|527335840|FG000|Overall Study|Physician Decision|1|||
146223765|NCT03024437|527335841|FG001|Overall Study|Physician Decision|0|||
146223766|NCT03024437|527335842|FG002|Overall Study|Physician Decision|0|||
146223767|NCT03024437|527335843|FG003|Overall Study|Physician Decision|1|||
146223768|NCT03024437|527335844|FG004|Overall Study|Physician Decision|0|||
146223769|NCT03024437|527335840|FG000|Overall Study|Disease progression, relapse|1|||
146223770|NCT03024437|527335841|FG001|Overall Study|Disease progression, relapse|0|||
146223771|NCT03024437|527335842|FG002|Overall Study|Disease progression, relapse|0|||
146223772|NCT03024437|527335843|FG003|Overall Study|Disease progression, relapse|3|||
146223773|NCT03024437|527335844|FG004|Overall Study|Disease progression, relapse|0|||
146223774|NCT03024437|527335840|FG000|Overall Study|Disease progression, refractory disease|4|||
146223775|NCT03024437|527335841|FG001|Overall Study|Disease progression, refractory disease|4|||
146223776|NCT03024437|527335842|FG002|Overall Study|Disease progression, refractory disease|2|||
146223777|NCT03024437|527335843|FG003|Overall Study|Disease progression, refractory disease|2|||
146223778|NCT03024437|527335844|FG004|Overall Study|Disease progression, refractory disease|1|||
146223779|NCT03024437|527335840|FG000|Overall Study|Newly diagnosed cancer|0|||
146223780|NCT03024437|527335841|FG001|Overall Study|Newly diagnosed cancer|0|||
146223781|NCT03024437|527335842|FG002|Overall Study|Newly diagnosed cancer|0|||
146223782|NCT03024437|527335843|FG003|Overall Study|Newly diagnosed cancer|1|||
146223783|NCT03024437|527335844|FG004|Overall Study|Newly diagnosed cancer|0|||
145961259|NCT00808067|526369531|FG000|Overall Study|Site closed for cause|19|||
146223784|NCT03024437|527335840|FG000|Overall Study|Moved out of state|0|||
146223785|NCT03024437|527335841|FG001|Overall Study|Moved out of state|1|||
146223786|NCT03024437|527335842|FG002|Overall Study|Moved out of state|0|||
146223787|NCT03024437|527335843|FG003|Overall Study|Moved out of state|0|||
146223788|NCT03024437|527335844|FG004|Overall Study|Moved out of state|0|||
146223789|NCT03024437|527335840|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146223790|NCT03024437|527335841|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146223791|NCT03024437|527335842|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
146223792|NCT03024437|527335843|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
146223793|NCT03024437|527335844|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
145961260|NCT00808067|526369532|FG001|Overall Study|Site closed for cause|19|||
146223794|NCT03085810|527335845|FG000|Main Study|Withdrawal by Subject|77|||
146223795|NCT03085810|527335846|FG001|Main Study|Withdrawal by Subject|0|||
146223796|NCT03085810|527335847|FG002|Main Study|Withdrawal by Subject|0|||
146223797|NCT03085810|527335845|FG000|Main Study|Terminated By Sponsor|14|||
146223798|NCT03085810|527335846|FG001|Main Study|Terminated By Sponsor|0|||
146223799|NCT03085810|527335847|FG002|Main Study|Terminated By Sponsor|0|||
146223800|NCT03085810|527335845|FG000|Main Study|Protocol Violation|15|||
146223801|NCT03085810|527335846|FG001|Main Study|Protocol Violation|0|||
146223802|NCT03085810|527335847|FG002|Main Study|Protocol Violation|0|||
146223803|NCT03085810|527335845|FG000|Main Study|Physician Decision|13|||
146223804|NCT03085810|527335846|FG001|Main Study|Physician Decision|0|||
146223805|NCT03085810|527335847|FG002|Main Study|Physician Decision|0|||
146223806|NCT03085810|527335845|FG000|Main Study|Lost to Follow-up|17|||
146223807|NCT03085810|527335846|FG001|Main Study|Lost to Follow-up|0|||
146223808|NCT03085810|527335847|FG002|Main Study|Lost to Follow-up|0|||
146223809|NCT03085810|527335845|FG000|Main Study|Adverse Event|25|||
146223810|NCT03085810|527335846|FG001|Main Study|Adverse Event|0|||
146223811|NCT03085810|527335847|FG002|Main Study|Adverse Event|0|||
146223812|NCT03085810|527335845|FG000|Main Study|Pregnancy|7|||
146223813|NCT03085810|527335846|FG001|Main Study|Pregnancy|0|||
146223814|NCT03085810|527335847|FG002|Main Study|Pregnancy|0|||
146223815|NCT03085810|527335845|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
146223816|NCT03085810|527335846|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
146223817|NCT03085810|527335847|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
146223818|NCT03085810|527335845|FG000|Main Study|Lack of Efficacy|10|||
146223819|NCT03085810|527335846|FG001|Main Study|Lack of Efficacy|0|||
146223820|NCT03085810|527335847|FG002|Main Study|Lack of Efficacy|0|||
146223821|NCT03085810|527335845|FG000|Main Study|Death|12|||
146223822|NCT03085810|527335846|FG001|Main Study|Death|0|||
146223823|NCT03085810|527335847|FG002|Main Study|Death|0|||
146223824|NCT03085810|527335845|FG000|Main Study|Disease progression|1|||
146223825|NCT03085810|527335846|FG001|Main Study|Disease progression|0|||
146223826|NCT03085810|527335847|FG002|Main Study|Disease progression|0|||
146223827|NCT03085810|527335845|FG000|Main Study|Site Closure|3|||
146223828|NCT03085810|527335846|FG001|Main Study|Site Closure|0|||
146223829|NCT03085810|527335847|FG002|Main Study|Site Closure|0|||
146223830|NCT03085810|527335845|FG000|Main Study|Planned pregnancy|17|||
146223831|NCT03085810|527335846|FG001|Main Study|Planned pregnancy|0|||
146223832|NCT03085810|527335847|FG002|Main Study|Planned pregnancy|0|||
146223833|NCT03085810|527335845|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
146223834|NCT03085810|527335846|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
146223835|NCT03085810|527335847|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
146223836|NCT03085810|527335845|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
146223837|NCT03085810|527335846|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
146223838|NCT03085810|527335847|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
146223839|NCT03085810|527335845|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
146223840|NCT03085810|527335846|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
146223841|NCT03085810|527335847|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
146223842|NCT03085810|527335845|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
146223843|NCT03085810|527335846|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
146223844|NCT03085810|527335847|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
146223845|NCT04625465|527335850|FG000|Overall Study|Lost to Follow-up|2|||
146223846|NCT04625465|527335851|FG001|Overall Study|Lost to Follow-up|2|||
146223847|NCT04625465|527335852|FG002|Overall Study|Lost to Follow-up|1|||
146223848|NCT04625465|527335853|FG003|Overall Study|Lost to Follow-up|0|||
146223849|NCT04625465|527335854|FG004|Overall Study|Lost to Follow-up|0|||
146223850|NCT04625465|527335855|FG005|Overall Study|Lost to Follow-up|2|||
146223851|NCT04625465|527335856|FG006|Overall Study|Lost to Follow-up|0|||
146223852|NCT04625465|527335857|FG007|Overall Study|Lost to Follow-up|0|||
146223853|NCT04625465|527335850|FG000|Overall Study|Death|1|||
146223854|NCT04625465|527335851|FG001|Overall Study|Death|0|||
146223855|NCT04625465|527335852|FG002|Overall Study|Death|0|||
146223856|NCT04625465|527335853|FG003|Overall Study|Death|0|||
146223857|NCT04625465|527335854|FG004|Overall Study|Death|0|||
146223858|NCT04625465|527335855|FG005|Overall Study|Death|0|||
146223859|NCT04625465|527335856|FG006|Overall Study|Death|0|||
146223860|NCT04625465|527335857|FG007|Overall Study|Death|0|||
146223861|NCT04625465|527335850|FG000|Overall Study|Withdrawal by Subject|1|||
146223862|NCT04625465|527335851|FG001|Overall Study|Withdrawal by Subject|0|||
146223863|NCT04625465|527335852|FG002|Overall Study|Withdrawal by Subject|4|||
146223864|NCT04625465|527335853|FG003|Overall Study|Withdrawal by Subject|4|||
146223865|NCT04625465|527335854|FG004|Overall Study|Withdrawal by Subject|4|||
146223866|NCT04625465|527335855|FG005|Overall Study|Withdrawal by Subject|0|||
146223867|NCT04625465|527335856|FG006|Overall Study|Withdrawal by Subject|0|||
146223868|NCT04625465|527335857|FG007|Overall Study|Withdrawal by Subject|0|||
146223869|NCT05566639|527335865|FG000|Overall Study|Adverse Event|1|||
146223870|NCT05566639|527335866|FG001|Overall Study|Adverse Event|1|||
146223871|NCT05566639|527335865|FG000|Overall Study|Serious Adverse Event|1|||
146223872|NCT05566639|527335866|FG001|Overall Study|Serious Adverse Event|3|||
146223873|NCT05566639|527335865|FG000|Overall Study|Death|44|||
146223874|NCT05566639|527335866|FG001|Overall Study|Death|45|||
146223875|NCT05566639|527335865|FG000|Overall Study|Lost to Follow-up|467|||
146223876|NCT05566639|527335866|FG001|Overall Study|Lost to Follow-up|461|||
146223877|NCT05566639|527335865|FG000|Overall Study|Physician Decision|45|||
146223878|NCT05566639|527335866|FG001|Overall Study|Physician Decision|44|||
145883226|NCT03259789|526077120|FG000|Overall Study|Adverse Event|3|||
145883227|NCT03259789|526077121|FG001|Overall Study|Adverse Event|2|||
146223879|NCT05566639|527335865|FG000|Overall Study|Protocol Deviation|4|||
146223880|NCT05566639|527335866|FG001|Overall Study|Protocol Deviation|4|||
146223881|NCT05566639|527335865|FG000|Overall Study|Withdrawal by Subject|277|||
146223882|NCT05566639|527335866|FG001|Overall Study|Withdrawal by Subject|271|||
146223883|NCT05566639|527335865|FG000|Overall Study|Other Than Specified|52|||
146223884|NCT05566639|527335866|FG001|Overall Study|Other Than Specified|64|||
146223885|NCT04054193|527335867|FG000|Cycle 1|Physician Decision|1|||
146223886|NCT04054193|527335867|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
146223887|NCT04054193|527335867|FG000|Cycle 1|Allocated but not treated|3|||
146223888|NCT04054193|527335867|FG000|Cycles 2-3|Physician Decision|2|||
146223889|NCT04054193|527335867|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
146223890|NCT04054193|527335867|FG000|Cycles 2-3|Various reasons|17|||
146223891|NCT05436262|527335870|FG000|Pre-Randomization|Withdrawal by Subject|1|||
146223892|NCT05436262|527335871|FG001|Pre-Randomization|Withdrawal by Subject|0|||
146223893|NCT05436262|527335872|FG002|Pre-Randomization|Withdrawal by Subject|0|||
146223894|NCT05436262|527335870|FG000|Randomization|Withdrawal by Subject|0|||
146223895|NCT05436262|527335871|FG001|Randomization|Withdrawal by Subject|1|||
146223896|NCT05436262|527335872|FG002|Randomization|Withdrawal by Subject|0|||
146223897|NCT03710603|527335873|FG000|Overall Study|Adverse Event|1|||
146223898|NCT03710603|527335874|FG001|Overall Study|Adverse Event|0|||
145883228|NCT03259789|526077122|FG002|Overall Study|Adverse Event|1|||
146223899|NCT03710603|527335873|FG000|Overall Study|Death|44|||
146223900|NCT03710603|527335874|FG001|Overall Study|Death|34|||
146223901|NCT03710603|527335873|FG000|Overall Study|Lost to Follow-up|3|||
146223902|NCT03710603|527335874|FG001|Overall Study|Lost to Follow-up|5|||
146223903|NCT03710603|527335873|FG000|Overall Study|Withdrawal by Subject|11|||
146223904|NCT03710603|527335874|FG001|Overall Study|Withdrawal by Subject|10|||
146223905|NCT04753697|527335875|FG000|Induction Phase|Withdrawal by Subject|12|||
146223906|NCT04753697|527335876|FG001|Induction Phase|Withdrawal by Subject|5|||
146223907|NCT04753697|527335877|FG002|Induction Phase|Withdrawal by Subject|6|||
145883229|NCT03259789|526077120|FG000|Overall Study|Withdrawal by Subject|9|||
146223908|NCT04753697|527335875|FG000|Induction Phase|Physician Decision|1|||
146223909|NCT04753697|527335876|FG001|Induction Phase|Physician Decision|0|||
146223910|NCT04753697|527335877|FG002|Induction Phase|Physician Decision|0|||
146223911|NCT04753697|527335875|FG000|Induction Phase|Lost to Follow-up|2|||
146223912|NCT04753697|527335876|FG001|Induction Phase|Lost to Follow-up|2|||
146223913|NCT04753697|527335877|FG002|Induction Phase|Lost to Follow-up|1|||
146223914|NCT04753697|527335875|FG000|Induction Phase|Lack of Efficacy|1|||
146223915|NCT04753697|527335876|FG001|Induction Phase|Lack of Efficacy|0|||
146223916|NCT04753697|527335877|FG002|Induction Phase|Lack of Efficacy|0|||
146223917|NCT04753697|527335875|FG000|Maintenance Phase|Physician Decision|0|||
146223918|NCT04753697|527335876|FG001|Maintenance Phase|Physician Decision|0|||
146223919|NCT04753697|527335877|FG002|Maintenance Phase|Physician Decision|1|||
146223920|NCT04753697|527335875|FG000|Maintenance Phase|Withdrawal by Subject|3|||
146223921|NCT04753697|527335876|FG001|Maintenance Phase|Withdrawal by Subject|4|||
146223922|NCT04753697|527335877|FG002|Maintenance Phase|Withdrawal by Subject|6|||
146223923|NCT04753697|527335875|FG000|Maintenance Phase|Lost to Follow-up|2|||
146223924|NCT04753697|527335876|FG001|Maintenance Phase|Lost to Follow-up|2|||
146223925|NCT04753697|527335877|FG002|Maintenance Phase|Lost to Follow-up|0|||
146223926|NCT04753697|527335875|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
146223927|NCT04753697|527335876|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
146223928|NCT04753697|527335877|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
146223929|NCT04753697|527335875|FG000|Maintenance Phase|Adverse Event|0|||
146223930|NCT04753697|527335876|FG001|Maintenance Phase|Adverse Event|1|||
146223931|NCT04753697|527335877|FG002|Maintenance Phase|Adverse Event|1|||
146223932|NCT04753697|527335875|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
146223933|NCT04753697|527335876|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146223934|NCT04753697|527335877|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146223935|NCT02626533|527335878|FG000|Overall Study|Protocol Violation|14|||
146223936|NCT02626533|527335878|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
146223937|NCT02626533|527335878|FG000|Overall Study|Withdrawal by Subject|1|||
146223938|NCT05070728|527335883|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
146223939|NCT05070728|527335884|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
146223940|NCT03599661|527335885|FG000|Overall Study|Lost to Follow-up|9|||
146223941|NCT05446168|527335888|FG000|Overall Study|Physician Decision|0|||
146223942|NCT05446168|527335889|FG001|Overall Study|Physician Decision|1|||
146223943|NCT03905798|527335893|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
146223944|NCT06473662|527335894|FG000|Overall Study|Withdrawal by Subject|1|||
146223945|NCT06473662|527335895|FG001|Overall Study|Withdrawal by Subject|6|||
146223946|NCT06473662|527335896|FG002|Overall Study|Withdrawal by Subject|5|||
146223947|NCT06473662|527335894|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
146223948|NCT06473662|527335895|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
146223949|NCT06473662|527335896|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
146223950|NCT06473662|527335894|FG000|Overall Study|Starting HbA1c below 7%|0|||
146223951|NCT06473662|527335895|FG001|Overall Study|Starting HbA1c below 7%|1|||
146223952|NCT06473662|527335896|FG002|Overall Study|Starting HbA1c below 7%|1|||
146223953|NCT06473662|527335894|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
146223954|NCT06473662|527335895|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
146223955|NCT06473662|527335896|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
146223956|NCT06473662|527335894|FG000|Overall Study|Did not take medication|2|||
145883230|NCT03259789|526077121|FG001|Overall Study|Withdrawal by Subject|5|||
146223957|NCT06473662|527335895|FG001|Overall Study|Did not take medication|3|||
146223958|NCT06473662|527335896|FG002|Overall Study|Did not take medication|2|||
146223959|NCT03463044|527335899|FG000|Overall Study|Lost to Follow-up|0|||
146223960|NCT03463044|527335900|FG001|Overall Study|Lost to Follow-up|0|||
146223961|NCT03463044|527335901|FG002|Overall Study|Lost to Follow-up|0|||
146223962|NCT03463044|527335902|FG003|Overall Study|Lost to Follow-up|0|||
146223963|NCT03463044|527335903|FG004|Overall Study|Lost to Follow-up|0|||
146223964|NCT03463044|527335904|FG005|Overall Study|Lost to Follow-up|0|||
146223965|NCT03463044|527335905|FG006|Overall Study|Lost to Follow-up|0|||
145883231|NCT03259789|526077122|FG002|Overall Study|Withdrawal by Subject|1|||
146223966|NCT03463044|527335906|FG007|Overall Study|Lost to Follow-up|1|||
146223967|NCT03463044|527335907|FG008|Overall Study|Lost to Follow-up|0|||
146223968|NCT03478956|527335913|FG000|Randomized Treatment Period|Adverse Event|1|||
146223969|NCT03478956|527335914|FG001|Randomized Treatment Period|Adverse Event|0|||
146223970|NCT03478956|527335915|FG002|Randomized Treatment Period|Adverse Event|0|||
146223971|NCT03478956|527335916|FG003|Randomized Treatment Period|Adverse Event|0|||
146223972|NCT03478956|527335913|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
146223973|NCT03478956|527335914|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
146223974|NCT03478956|527335915|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
146223975|NCT03478956|527335916|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
146223976|NCT03478956|527335913|FG000|Open Label Extension Period|Adverse Event|0|||
146223977|NCT03478956|527335914|FG001|Open Label Extension Period|Adverse Event|0|||
146223978|NCT03478956|527335915|FG002|Open Label Extension Period|Adverse Event|4|||
146223979|NCT03478956|527335916|FG003|Open Label Extension Period|Adverse Event|0|||
146223980|NCT03478956|527335913|FG000|Open Label Extension Period|Lack of Efficacy|0|||
145961261|NCT00808067|526369531|FG000|Overall Study|Other reason not defined above|5|||
146223981|NCT03478956|527335914|FG001|Open Label Extension Period|Lack of Efficacy|0|||
146223982|NCT03478956|527335915|FG002|Open Label Extension Period|Lack of Efficacy|8|||
146223983|NCT03478956|527335916|FG003|Open Label Extension Period|Lack of Efficacy|0|||
146223984|NCT03478956|527335913|FG000|Open Label Extension Period|Reason Not Provided|0|||
146223985|NCT03478956|527335914|FG001|Open Label Extension Period|Reason Not Provided|0|||
146223986|NCT03478956|527335915|FG002|Open Label Extension Period|Reason Not Provided|1|||
145961262|NCT00808067|526369532|FG001|Overall Study|Other reason not defined above|5|||
145961263|NCT00808067|526369531|FG000|Overall Study|Excluded from analysis|13|||
145961264|NCT00808067|526369532|FG001|Overall Study|Excluded from analysis|19|||
145961265|NCT02104895|526369537|FG000|Overall Study|Withdrawal by Subject|0|||
145961266|NCT02104895|526369538|FG001|Overall Study|Withdrawal by Subject|14|||
145961267|NCT02532283|526369542|FG000|Overall Study|Adverse Event|0|||
145961268|NCT02532283|526369543|FG001|Overall Study|Adverse Event|1|||
145961269|NCT02532283|526369542|FG000|Overall Study|Death|1|||
145961270|NCT02532283|526369543|FG001|Overall Study|Death|0|||
145961271|NCT02532283|526369542|FG000|Overall Study|Lost to Follow-up|0|||
145961272|NCT02532283|526369543|FG001|Overall Study|Lost to Follow-up|1|||
145961273|NCT02532283|526369542|FG000|Overall Study|Withdrawal by Subject|8|||
145961274|NCT02532283|526369543|FG001|Overall Study|Withdrawal by Subject|3|||
145961275|NCT01945944|526369546|FG000|Overall Study|Adverse Event|0|||
145961276|NCT01945944|526369547|FG001|Overall Study|Adverse Event|2|||
145961277|NCT01945944|526369546|FG000|Overall Study|Physician Decision|1|||
146085096|NCT04559529|526832080|FG003|First Intervention (1 Day)|Adverse Event|1|||
146085097|NCT04559529|526832077|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
146085098|NCT04559529|526832078|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
146223987|NCT03478956|527335916|FG003|Open Label Extension Period|Reason Not Provided|0|||
146223988|NCT03478956|527335913|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
146223989|NCT03478956|527335914|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
146223990|NCT03478956|527335915|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
146223991|NCT03478956|527335916|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
145961278|NCT01945944|526369547|FG001|Overall Study|Physician Decision|0|||
146223992|NCT03478956|527335913|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
146223993|NCT03478956|527335914|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
146223994|NCT03478956|527335915|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
146223995|NCT03478956|527335916|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
146223996|NCT03478956|527335913|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146223997|NCT03478956|527335914|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146223998|NCT03478956|527335915|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
146223999|NCT03478956|527335916|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
146224000|NCT01574274|527337547|FG000|Overall Study|Ineligible|0|||
146224001|NCT01574274|527337548|FG001|Overall Study|Ineligible|1|||
146224002|NCT01574274|527337547|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
146224003|NCT01574274|527337548|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
146224004|NCT01574274|527337547|FG000|Overall Study|Ph+ B-ALL|3|||
146224005|NCT01574274|527337548|FG001|Overall Study|Ph+ B-ALL|4|||
146224006|NCT01574274|527337547|FG000|Overall Study|Induction Death|2|||
146224007|NCT01574274|527337548|FG001|Overall Study|Induction Death|0|||
146224008|NCT01574274|527337547|FG000|Overall Study|Induction Failure|4|||
145883232|NCT03259789|526077120|FG000|Overall Study|Lost to Follow-up|5|||
145883233|NCT03259789|526077121|FG001|Overall Study|Lost to Follow-up|9|||
145883234|NCT03259789|526077122|FG002|Overall Study|Lost to Follow-up|4|||
145883235|NCT03259789|526077120|FG000|Overall Study|Physician Decision|0|||
145883236|NCT03259789|526077121|FG001|Overall Study|Physician Decision|1|||
145883237|NCT03259789|526077122|FG002|Overall Study|Physician Decision|0|||
145883238|NCT04291508|526077123|FG000|Overall Study|Withdrawal by Subject|1|||
145883239|NCT04291508|526077124|FG001|Overall Study|Withdrawal by Subject|0|||
145883240|NCT04291508|526077125|FG002|Overall Study|Withdrawal by Subject|1|||
145883241|NCT04291508|526077126|FG003|Overall Study|Withdrawal by Subject|0|||
145883242|NCT04291508|526077123|FG000|Overall Study|lost to follow up|4|||
145883243|NCT04291508|526077124|FG001|Overall Study|lost to follow up|0|||
145883244|NCT04291508|526077125|FG002|Overall Study|lost to follow up|1|||
145883245|NCT04291508|526077126|FG003|Overall Study|lost to follow up|0|||
145883246|NCT00398073|526077127|FG000|Overall Study|Withdrawal by Subject|1|||
145883247|NCT00398073|526077128|FG001|Overall Study|Withdrawal by Subject|0|||
145883248|NCT01263561|526077129|FG000|Overall Study|Death|1|||
145883249|NCT01263561|526077130|FG001|Overall Study|Death|2|||
145883250|NCT01475487|526077131|FG000|Overall Study|had to leave early for personal reasons|2|||
145883251|NCT01475487|526077132|FG001|Overall Study|had to leave early for personal reasons|1|||
145883252|NCT04428645|526077135|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
145883253|NCT03168906|526077138|FG000|Overall Study|Lack of Efficacy|6|||
145883254|NCT03168906|526077139|FG001|Overall Study|Lack of Efficacy|6|||
145883255|NCT01214239|526077140|FG000|Overall Study|Adverse Event|3|||
145883256|NCT01214239|526077141|FG001|Overall Study|Adverse Event|4|||
145883257|NCT01214239|526077140|FG000|Overall Study|Protocol Violation|2|||
145883258|NCT01214239|526077141|FG001|Overall Study|Protocol Violation|1|||
145883259|NCT01214239|526077140|FG000|Overall Study|Lost to Follow-up|1|||
145883260|NCT01214239|526077141|FG001|Overall Study|Lost to Follow-up|1|||
145883261|NCT01214239|526077140|FG000|Overall Study|Withdrawal by Subject|4|||
145883262|NCT01214239|526077141|FG001|Overall Study|Withdrawal by Subject|9|||
145883263|NCT01214239|526077140|FG000|Overall Study|Lack of Efficacy|1|||
145883264|NCT01214239|526077141|FG001|Overall Study|Lack of Efficacy|2|||
145883265|NCT01214239|526077140|FG000|Overall Study|patient's private reason|1|||
145883266|NCT01214239|526077141|FG001|Overall Study|patient's private reason|1|||
145883267|NCT00857818|526077142|FG000|Overall Study|Lack of Efficacy|1|||
145883268|NCT00857818|526077143|FG001|Overall Study|Lack of Efficacy|0|||
145883269|NCT00857818|526077142|FG000|Overall Study|Adverse Event|3|||
145883270|NCT00857818|526077143|FG001|Overall Study|Adverse Event|0|||
145883271|NCT00857818|526077142|FG000|Overall Study|Withdrawal by Subject|0|||
145883272|NCT00857818|526077143|FG001|Overall Study|Withdrawal by Subject|4|||
145883273|NCT00857818|526077142|FG000|Overall Study|Sponsor terminated study|6|||
145883274|NCT00857818|526077143|FG001|Overall Study|Sponsor terminated study|4|||
145883275|NCT00857818|526077142|FG000|Overall Study|Investigator decision|1|||
145883276|NCT00857818|526077143|FG001|Overall Study|Investigator decision|0|||
145883277|NCT02625974|526077144|FG000|Part 1|Lost to Follow-up|9|||
145883278|NCT02625974|526077145|FG001|Part 1|Lost to Follow-up|3|||
145883279|NCT02625974|526077144|FG000|Part 2|Lost to Follow-up|4|||
145883280|NCT02625974|526077145|FG001|Part 2|Lost to Follow-up|6|||
145883281|NCT02625974|526077144|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
145883282|NCT02625974|526077145|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
145883283|NCT01142661|526077146|FG000|Overall Study|Adverse Event|2|||
145883284|NCT01142661|526077146|FG000|Overall Study|Withdrawal by Subject|1|||
145883285|NCT01142661|526077146|FG000|Overall Study|Physician Decision|1|||
145883286|NCT02129062|526078400|FG000|Overall Study|Death|1|||
145883287|NCT02129062|526078400|FG000|Overall Study|Disease Progression|2|||
145883288|NCT00559637|526078402|FG000|Overall Study|Adverse Event|22|||
145883289|NCT00559637|526078402|FG000|Overall Study|Withdrawal by Subject|4|||
145883290|NCT00559637|526078402|FG000|Overall Study|Protocol Violation|6|||
145883291|NCT00559637|526078402|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
145883292|NCT00559637|526078402|FG000|Overall Study|Failure to return|6|||
145883293|NCT00559637|526078402|FG000|Overall Study|Insufficient response|3|||
145883294|NCT00559637|526078402|FG000|Overall Study|Started requiring dialysis after month 7|2|||
145883295|NCT00559637|526078402|FG000|Overall Study|Suspected lung cancer|1|||
145883296|NCT00559637|526078402|FG000|Overall Study|Participation in another study|1|||
145883297|NCT00559637|526078402|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
145883298|NCT00559637|526078402|FG000|Overall Study|Change of center|1|||
145883299|NCT00559637|526078402|FG000|Overall Study|Change of home|1|||
146085099|NCT04559529|526832079|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
146085100|NCT04559529|526832080|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
145883300|NCT00559637|526078402|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
145883301|NCT01923311|526078403|FG000|Overall Study|Pregnancy|1|||
145883302|NCT01923311|526078404|FG001|Overall Study|Pregnancy|0|||
145883303|NCT01923311|526078403|FG000|Overall Study|Investigator's Discretion|1|||
145883304|NCT01923311|526078404|FG001|Overall Study|Investigator's Discretion|0|||
145961279|NCT01945944|526369546|FG000|Overall Study|Withdrawal by Subject|0|||
145961280|NCT01945944|526369547|FG001|Overall Study|Withdrawal by Subject|1|||
146224009|NCT01574274|527337548|FG001|Overall Study|Induction Failure|1|||
146224010|NCT01574274|527337547|FG000|Overall Study|Adverse Event|16|||
146224011|NCT01574274|527337548|FG001|Overall Study|Adverse Event|13|||
146224012|NCT01574274|527337547|FG000|Overall Study|Remission Death|1|||
146224013|NCT01574274|527337548|FG001|Overall Study|Remission Death|0|||
146224014|NCT01574274|527337547|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
146224015|NCT01574274|527337548|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
146224016|NCT01574274|527337547|FG000|Overall Study|Other, unknown|3|||
146224017|NCT01574274|527337548|FG001|Overall Study|Other, unknown|2|||
146224018|NCT04676763|527337549|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
146224019|NCT04676763|527337550|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
146224020|NCT04676763|527337551|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
146224021|NCT04676763|527337549|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
146224022|NCT04676763|527337550|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
146224023|NCT04676763|527337551|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
146224024|NCT04676763|527337549|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
146224025|NCT04676763|527337550|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
146224026|NCT04676763|527337551|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
146224027|NCT03314454|527337554|FG000|Overall Study|Protocol Violation|1|||
146224028|NCT05808257|527337557|FG000|Overall Study|Lost to Follow-up|8|||
146224029|NCT05808257|527337558|FG001|Overall Study|Lost to Follow-up|8|||
146224030|NCT03656510|527337579|FG000|Overall Study|Lost to Follow-up|1|||
146224031|NCT03656510|527337580|FG001|Overall Study|Lost to Follow-up|0|||
146224032|NCT03656510|527337581|FG002|Overall Study|Lost to Follow-up|0|||
146224033|NCT03656510|527337582|FG003|Overall Study|Lost to Follow-up|0|||
146224034|NCT03656510|527337583|FG004|Overall Study|Lost to Follow-up|0|||
146224035|NCT03656510|527337584|FG005|Overall Study|Lost to Follow-up|0|||
146224036|NCT03656510|527337579|FG000|Overall Study|Withdrawal by Subject|1|||
146224037|NCT03656510|527337580|FG001|Overall Study|Withdrawal by Subject|1|||
146224038|NCT03656510|527337581|FG002|Overall Study|Withdrawal by Subject|0|||
146224039|NCT03656510|527337582|FG003|Overall Study|Withdrawal by Subject|1|||
146224040|NCT03656510|527337583|FG004|Overall Study|Withdrawal by Subject|0|||
146224041|NCT03656510|527337584|FG005|Overall Study|Withdrawal by Subject|0|||
146224042|NCT03819153|527337585|FG000|Overall Study|Withdrawal by Subject|20|||
146224043|NCT03819153|527337586|FG001|Overall Study|Withdrawal by Subject|28|||
146224044|NCT03819153|527337585|FG000|Overall Study|Lost to Follow-up|23|||
146224045|NCT03819153|527337586|FG001|Overall Study|Lost to Follow-up|30|||
146224046|NCT03974178|527337592|FG000|Overall Study|Death|0|||
146224047|NCT03974178|527337593|FG001|Overall Study|Death|1|||
146224048|NCT03899259|527337597|FG000|Overall Study|Adverse Event|5|||
146224049|NCT03899259|527337598|FG001|Overall Study|Adverse Event|4|||
146224050|NCT03899259|527337599|FG002|Overall Study|Adverse Event|6|||
146224051|NCT03899259|527337597|FG000|Overall Study|Lack of Efficacy|5|||
146224052|NCT03899259|527337598|FG001|Overall Study|Lack of Efficacy|0|||
146224053|NCT03899259|527337599|FG002|Overall Study|Lack of Efficacy|2|||
146224054|NCT03899259|527337597|FG000|Overall Study|Pregnancy|3|||
146224055|NCT03899259|527337598|FG001|Overall Study|Pregnancy|0|||
146224056|NCT03899259|527337599|FG002|Overall Study|Pregnancy|1|||
146224057|NCT03899259|527337597|FG000|Overall Study|Physician Decision|0|||
146224058|NCT03899259|527337598|FG001|Overall Study|Physician Decision|1|||
146224059|NCT03899259|527337599|FG002|Overall Study|Physician Decision|0|||
146224060|NCT03899259|527337597|FG000|Overall Study|Protocol Deviation|1|||
146224061|NCT03899259|527337598|FG001|Overall Study|Protocol Deviation|1|||
146224062|NCT03899259|527337599|FG002|Overall Study|Protocol Deviation|1|||
146224063|NCT03899259|527337597|FG000|Overall Study|Withdrawal by Subject|8|||
146224064|NCT03899259|527337598|FG001|Overall Study|Withdrawal by Subject|10|||
146224065|NCT03899259|527337599|FG002|Overall Study|Withdrawal by Subject|12|||
146224066|NCT03899259|527337597|FG000|Overall Study|Lost to Follow-up|5|||
146224067|NCT03899259|527337598|FG001|Overall Study|Lost to Follow-up|6|||
146224068|NCT03899259|527337599|FG002|Overall Study|Lost to Follow-up|2|||
146224069|NCT03899259|527337597|FG000|Overall Study|Lack of Adherence|1|||
146224070|NCT03899259|527337598|FG001|Overall Study|Lack of Adherence|0|||
146224071|NCT03899259|527337599|FG002|Overall Study|Lack of Adherence|0|||
146224072|NCT03899259|527337597|FG000|Overall Study|Screen Failure|1|||
146224073|NCT03899259|527337598|FG001|Overall Study|Screen Failure|0|||
146224074|NCT03899259|527337599|FG002|Overall Study|Screen Failure|0|||
146224075|NCT03899259|527337597|FG000|Overall Study|Ongoing Study Participation|127|||
146224076|NCT03899259|527337598|FG001|Overall Study|Ongoing Study Participation|134|||
146224077|NCT03899259|527337599|FG002|Overall Study|Ongoing Study Participation|210|||
146224078|NCT05670587|527337600|FG000|Overall Study|Withdrawal by Subject|3|||
146224079|NCT04508309|527337603|FG000|Overall Study|Death|0|||
146224080|NCT04508309|527337604|FG001|Overall Study|Death|0|||
146224081|NCT04508309|527337605|FG002|Overall Study|Death|0|||
146224082|NCT04508309|527337606|FG003|Overall Study|Death|0|||
146224083|NCT04508309|527337607|FG004|Overall Study|Death|1|||
146224084|NCT04508309|527337603|FG000|Overall Study|Lost to Follow-up|0|||
145883305|NCT01923311|526078403|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145883306|NCT01923311|526078404|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146224085|NCT04508309|527337604|FG001|Overall Study|Lost to Follow-up|0|||
146224086|NCT04508309|527337605|FG002|Overall Study|Lost to Follow-up|1|||
146224087|NCT04508309|527337606|FG003|Overall Study|Lost to Follow-up|1|||
146224088|NCT04508309|527337607|FG004|Overall Study|Lost to Follow-up|0|||
146224089|NCT04508309|527337603|FG000|Overall Study|Withdrawal by Subject|0|||
145883307|NCT01923311|526078403|FG000|Overall Study|Withdrew Consent|1|||
146224090|NCT04508309|527337604|FG001|Overall Study|Withdrawal by Subject|0|||
146224091|NCT04508309|527337605|FG002|Overall Study|Withdrawal by Subject|0|||
146224092|NCT04508309|527337606|FG003|Overall Study|Withdrawal by Subject|0|||
146224093|NCT04508309|527337607|FG004|Overall Study|Withdrawal by Subject|1|||
146224094|NCT05139810|527337608|FG000|Overall Study|Voluntary Withdrawal|2|||
146224095|NCT05139810|527337609|FG001|Overall Study|Voluntary Withdrawal|1|||
146224096|NCT05139810|527337610|FG002|Overall Study|Voluntary Withdrawal|0|||
146224097|NCT05139810|527337608|FG000|Overall Study|Pregnancy|1|||
146224098|NCT05139810|527337609|FG001|Overall Study|Pregnancy|0|||
146224099|NCT05139810|527337610|FG002|Overall Study|Pregnancy|0|||
146224100|NCT05139810|527337608|FG000|Overall Study|Roll Over to CS7|19|||
145883308|NCT01923311|526078404|FG001|Overall Study|Withdrew Consent|0|||
145883309|NCT01923311|526078403|FG000|Overall Study|Study Terminated by Sponsor|12|||
145883310|NCT01923311|526078404|FG001|Overall Study|Study Terminated by Sponsor|0|||
145883311|NCT03429049|526078408|FG000|Overall Study|Adverse Event|2|||
145883312|NCT03429049|526078409|FG001|Overall Study|Adverse Event|3|||
145883313|NCT03429049|526078408|FG000|Overall Study|Death|0|||
145883314|NCT03429049|526078409|FG001|Overall Study|Death|1|||
145883315|NCT03429049|526078408|FG000|Overall Study|Lack of Efficacy|4|||
145883316|NCT03429049|526078409|FG001|Overall Study|Lack of Efficacy|2|||
145883317|NCT03429049|526078408|FG000|Overall Study|Lost to Follow-up|9|||
145883318|NCT03429049|526078409|FG001|Overall Study|Lost to Follow-up|8|||
145883319|NCT03429049|526078408|FG000|Overall Study|Physician Decision|1|||
145883320|NCT03429049|526078409|FG001|Overall Study|Physician Decision|0|||
145883321|NCT03429049|526078408|FG000|Overall Study|Protocol Violation|3|||
145883322|NCT03429049|526078409|FG001|Overall Study|Protocol Violation|0|||
145883323|NCT03429049|526078408|FG000|Overall Study|Sponsor Decision|2|||
145883324|NCT03429049|526078409|FG001|Overall Study|Sponsor Decision|0|||
145883325|NCT03429049|526078408|FG000|Overall Study|Withdrawal by Subject|4|||
145883326|NCT03429049|526078409|FG001|Overall Study|Withdrawal by Subject|20|||
145883327|NCT03429049|526078408|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
145883328|NCT03429049|526078409|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
145883329|NCT04129944|526078411|FG000|Overall Study|Death|0|||
145883330|NCT04129944|526078412|FG001|Overall Study|Death|0|||
145883331|NCT04129944|526078413|FG002|Overall Study|Death|0|||
145883332|NCT04129944|526078414|FG003|Overall Study|Death|1|||
145883333|NCT04129944|526078411|FG000|Overall Study|Lost to Follow-up|1|||
145883334|NCT04129944|526078412|FG001|Overall Study|Lost to Follow-up|0|||
145883335|NCT04129944|526078413|FG002|Overall Study|Lost to Follow-up|0|||
145883336|NCT04129944|526078414|FG003|Overall Study|Lost to Follow-up|0|||
145883337|NCT04129944|526078411|FG000|Overall Study|Withdrawal by Subject|1|||
145883338|NCT04129944|526078412|FG001|Overall Study|Withdrawal by Subject|0|||
145883339|NCT04129944|526078413|FG002|Overall Study|Withdrawal by Subject|1|||
145883340|NCT04129944|526078414|FG003|Overall Study|Withdrawal by Subject|2|||
145883341|NCT02426541|526078417|FG000|Overall Study|Protocol Violation|1|||
145883342|NCT02426541|526078418|FG001|Overall Study|Protocol Violation|0|||
145883343|NCT04241133|526078422|FG000|Overall Study|COVID19 Precautions|14|||
145883344|NCT04241133|526078423|FG001|Overall Study|COVID19 Precautions|34|||
145883345|NCT02994394|526078424|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
145883346|NCT02994394|526078425|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
145883347|NCT02994394|526078426|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
145883348|NCT02994394|526078427|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
145883349|NCT02994394|526078428|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
145883350|NCT02994394|526078429|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
145883351|NCT02994394|526078424|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
145883352|NCT02994394|526078425|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
145883353|NCT02994394|526078426|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
145883354|NCT02994394|526078427|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
145883355|NCT02994394|526078428|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
145883356|NCT02994394|526078429|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
145883357|NCT00396630|526078430|FG000|Overall Study|Lost to Follow-up|1|||
146224101|NCT05139810|527337609|FG001|Overall Study|Roll Over to CS7|44|||
146224102|NCT05139810|527337610|FG002|Overall Study|Roll Over to CS7|20|||
146224103|NCT03240016|527337611|FG000|Overall Study|Adverse Event|9|||
146224104|NCT03240016|527337611|FG000|Overall Study|Withdrawal by Subject|7|||
145883358|NCT00396630|526078431|FG001|Overall Study|Lost to Follow-up|1|||
145883359|NCT00396630|526078430|FG000|Overall Study|Withdrawal by Subject|1|||
145883360|NCT00396630|526078431|FG001|Overall Study|Withdrawal by Subject|1|||
145883361|NCT00396630|526078430|FG000|Overall Study|Not vaccinated at Visit 3|3|||
145883362|NCT00396630|526078431|FG001|Overall Study|Not vaccinated at Visit 3|3|||
145883363|NCT02576717|526078432|FG000|Overall Study|Other Reasons|16|||
145883364|NCT02576717|526078433|FG001|Overall Study|Other Reasons|18|||
145883365|NCT02576717|526078434|FG002|Overall Study|Other Reasons|15|||
145883366|NCT02576717|526078432|FG000|Overall Study|Covid-19 Pandemic|0|||
145883367|NCT02576717|526078433|FG001|Overall Study|Covid-19 Pandemic|1|||
145883368|NCT02576717|526078434|FG002|Overall Study|Covid-19 Pandemic|1|||
145883369|NCT02576717|526078432|FG000|Overall Study|Sponsor Decision|0|||
145883370|NCT02576717|526078433|FG001|Overall Study|Sponsor Decision|0|||
145883371|NCT02576717|526078434|FG002|Overall Study|Sponsor Decision|1|||
145883372|NCT02576717|526078432|FG000|Overall Study|Physician Decision|3|||
145883373|NCT02576717|526078433|FG001|Overall Study|Physician Decision|8|||
145883374|NCT02576717|526078434|FG002|Overall Study|Physician Decision|9|||
145883375|NCT02576717|526078432|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
145883376|NCT02576717|526078433|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
145883377|NCT02576717|526078434|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
145883378|NCT02576717|526078432|FG000|Overall Study|Death|3|||
145883379|NCT02576717|526078433|FG001|Overall Study|Death|5|||
146224105|NCT03240016|527337611|FG000|Overall Study|Death|1|||
145883380|NCT02576717|526078434|FG002|Overall Study|Death|3|||
146224106|NCT03240016|527337611|FG000|Overall Study|Physician Decision|2|||
146224107|NCT05200403|527337612|FG000|Overall Study|Withdrawal by Subject|4|||
146224108|NCT05200403|527337613|FG001|Overall Study|Withdrawal by Subject|2|||
146224109|NCT05200403|527337614|FG002|Overall Study|Withdrawal by Subject|6|||
146224110|NCT05299723|527337615|FG000|Overall Study|Withdrawal by Subject|0|||
146224111|NCT05299723|527337616|FG001|Overall Study|Withdrawal by Subject|2|||
146224112|NCT05299723|527337617|FG002|Overall Study|Withdrawal by Subject|0|||
146224113|NCT05546411|527337618|FG000|Overall Study|Progressive Disease|1|||
146224114|NCT05546411|527337619|FG001|Overall Study|Progressive Disease|0|||
146224115|NCT05546411|527337618|FG000|Overall Study|Adverse Event|0|||
146224116|NCT05546411|527337619|FG001|Overall Study|Adverse Event|1|||
146224117|NCT05546411|527337618|FG000|Overall Study|Metastatic disease|1|||
146224118|NCT05546411|527337619|FG001|Overall Study|Metastatic disease|0|||
146224119|NCT02606422|527337620|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
146224120|NCT02606422|527337621|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
146224121|NCT02606422|527337620|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
146224122|NCT02606422|527337621|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
146224123|NCT02606422|527337620|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
146224124|NCT02606422|527337621|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
146224125|NCT02606422|527337620|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
146224126|NCT02606422|527337621|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
146224127|NCT02966873|527337623|FG000|Overall Study|Lost to Follow-up|16|||
146224128|NCT02966873|527337624|FG001|Overall Study|Lost to Follow-up|15|||
146224129|NCT03235544|527337625|FG000|Overall Study|Death|11|||
146224130|NCT03235544|527337626|FG001|Overall Study|Death|31|||
146224131|NCT03235544|527337627|FG002|Overall Study|Death|19|||
146224132|NCT03235544|527337628|FG003|Overall Study|Death|34|||
146224133|NCT03235544|527337625|FG000|Overall Study|Lost to Follow-up|0|||
146224134|NCT03235544|527337626|FG001|Overall Study|Lost to Follow-up|1|||
146224135|NCT03235544|527337627|FG002|Overall Study|Lost to Follow-up|1|||
146224136|NCT03235544|527337628|FG003|Overall Study|Lost to Follow-up|1|||
146224137|NCT03235544|527337625|FG000|Overall Study|Withdrawal by Subject|0|||
146224138|NCT03235544|527337626|FG001|Overall Study|Withdrawal by Subject|3|||
146224139|NCT03235544|527337627|FG002|Overall Study|Withdrawal by Subject|1|||
146224140|NCT03235544|527337628|FG003|Overall Study|Withdrawal by Subject|5|||
146224141|NCT03235544|527337625|FG000|Overall Study|Disease Progression|0|||
146224142|NCT03235544|527337626|FG001|Overall Study|Disease Progression|1|||
146224143|NCT03235544|527337627|FG002|Overall Study|Disease Progression|0|||
146224144|NCT03235544|527337628|FG003|Overall Study|Disease Progression|2|||
146224145|NCT03235544|527337625|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
146224146|NCT03235544|527337626|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
146224147|NCT03235544|527337627|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
146224148|NCT03235544|527337628|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
146224149|NCT03235544|527337625|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146224150|NCT03235544|527337626|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146224151|NCT03235544|527337627|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
146224152|NCT03235544|527337628|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
146224153|NCT00950742|527337629|FG000|Overall Study|Other Adverse Event|1|||
146224154|NCT00950742|527337630|FG001|Overall Study|Other Adverse Event|0|||
146224155|NCT00950742|527337629|FG000|Overall Study|Withdrawal by Subject|3|||
146224156|NCT00950742|527337630|FG001|Overall Study|Withdrawal by Subject|0|||
146224157|NCT00950742|527337629|FG000|Overall Study|Progressive Disease|6|||
146224158|NCT00950742|527337630|FG001|Overall Study|Progressive Disease|2|||
146224159|NCT00950742|527337629|FG000|Overall Study|Dose limiting toxicity|6|||
146224160|NCT00950742|527337630|FG001|Overall Study|Dose limiting toxicity|0|||
146224161|NCT01456949|527337632|FG000|Enrollment|PI death- incomplete data|6|||
146224162|NCT01456949|527337632|FG000|Enrollment|Death|1|||
146224163|NCT01456949|527337632|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
146224164|NCT01456949|527337632|FG000|Enrollment|Physician Decision|10|||
146224165|NCT01456949|527337632|FG000|Enrollment|Withdrawal by Subject|7|||
146224166|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
146224167|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
146224168|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
146224169|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
146224170|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
146224171|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
146224172|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
146224173|NCT01456949|527337632|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
146224174|NCT05002088|527337633|FG000|Overall Study|Withdrawal by Subject|9|||
146224175|NCT05002088|527337634|FG001|Overall Study|Withdrawal by Subject|0|||
146224176|NCT05002088|527337633|FG000|Overall Study|Lost to Follow-up|0|||
146224177|NCT05002088|527337634|FG001|Overall Study|Lost to Follow-up|1|||
146224178|NCT05002088|527337633|FG000|Overall Study|Death|16|||
146224179|NCT05002088|527337634|FG001|Overall Study|Death|2|||
146224180|NCT05002088|527337633|FG000|Overall Study|Protocol Violation|25|||
146224181|NCT05002088|527337634|FG001|Overall Study|Protocol Violation|7|||
146224182|NCT04068181|527337636|FG000|Overall Study|Death|17|||
146224183|NCT04068181|527337637|FG001|Overall Study|Death|12|||
146224184|NCT04068181|527337638|FG002|Overall Study|Death|4|||
146224185|NCT04068181|527337639|FG003|Overall Study|Death|7|||
146224186|NCT04068181|527337636|FG000|Overall Study|Lost to Follow-up|1|||
146224187|NCT04068181|527337637|FG001|Overall Study|Lost to Follow-up|0|||
146224188|NCT04068181|527337638|FG002|Overall Study|Lost to Follow-up|0|||
146224189|NCT04068181|527337639|FG003|Overall Study|Lost to Follow-up|0|||
146224190|NCT04068181|527337636|FG000|Overall Study|Withdrawal of consent from study|3|||
146224191|NCT04068181|527337637|FG001|Overall Study|Withdrawal of consent from study|0|||
146224192|NCT04068181|527337638|FG002|Overall Study|Withdrawal of consent from study|0|||
146224193|NCT04068181|527337639|FG003|Overall Study|Withdrawal of consent from study|0|||
145961281|NCT01817075|526369548|FG000|Overall Study|Adverse Event|7|||
146224194|NCT02723591|527337640|FG000|Overall Study|Adverse Event|48|||
146224195|NCT02723591|527337641|FG001|Overall Study|Adverse Event|40|||
145961282|NCT01817075|526369549|FG001|Overall Study|Adverse Event|5|||
146224196|NCT02723591|527337640|FG000|Overall Study|Death|2|||
146224197|NCT02723591|527337641|FG001|Overall Study|Death|2|||
145883381|NCT02576717|526078432|FG000|Overall Study|Lost to Follow-up|9|||
145883382|NCT02576717|526078433|FG001|Overall Study|Lost to Follow-up|10|||
145883383|NCT02576717|526078434|FG002|Overall Study|Lost to Follow-up|19|||
145883384|NCT02576717|526078432|FG000|Overall Study|Protocol Violation|4|||
146085101|NCT04559529|526832077|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
146085102|NCT04559529|526832078|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
146085103|NCT04559529|526832079|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
146085104|NCT04559529|526832080|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
146085105|NCT00924170|526832081|FG000|Overall Study|Refused further treatment|0|||
146085106|NCT00924170|526832082|FG001|Overall Study|Refused further treatment|1|||
146085107|NCT00924170|526832081|FG000|Overall Study|Physician Decision|0|||
146085108|NCT00924170|526832082|FG001|Overall Study|Physician Decision|1|||
146085109|NCT00924170|526832081|FG000|Overall Study|Progressive disease|3|||
146085110|NCT00924170|526832082|FG001|Overall Study|Progressive disease|6|||
146085111|NCT00924170|526832081|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
146085112|NCT00924170|526832082|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
146085113|NCT00924170|526832081|FG000|Overall Study|Death|1|||
146085114|NCT00924170|526832082|FG001|Overall Study|Death|0|||
146085115|NCT04098224|526832085|FG000|Overall Study|Adverse Event|1|||
146085116|NCT04098224|526832086|FG001|Overall Study|Adverse Event|0|||
146085117|NCT04098224|526832085|FG000|Overall Study|Physician Decision|1|||
146085118|NCT04098224|526832086|FG001|Overall Study|Physician Decision|0|||
146085119|NCT04098224|526832085|FG000|Overall Study|Patient not required enteral feeding|1|||
146085120|NCT04098224|526832086|FG001|Overall Study|Patient not required enteral feeding|0|||
146085121|NCT04098224|526832085|FG000|Overall Study|Patient failure nasogastric tube|1|||
146085122|NCT04098224|526832086|FG001|Overall Study|Patient failure nasogastric tube|0|||
146085123|NCT04098224|526832085|FG000|Overall Study|Patient early extubation|1|||
146085124|NCT04098224|526832086|FG001|Overall Study|Patient early extubation|3|||
146085125|NCT01203852|526832087|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
146085126|NCT01203852|526832087|FG000|Washout 2 Weeks|Physician Decision|46|||
146085127|NCT01878149|526832090|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
146085128|NCT01878149|526832091|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
145883385|NCT02576717|526078433|FG001|Overall Study|Protocol Violation|0|||
145883386|NCT02576717|526078434|FG002|Overall Study|Protocol Violation|5|||
146085129|NCT04672252|526832094|FG000|Overall Study|Protocol Violation|1|||
146085130|NCT04672252|526832095|FG001|Overall Study|Protocol Violation|0|||
146085131|NCT01738477|526832102|FG000|Overall Study|Lost to Follow-up|1|||
146085132|NCT01738477|526832103|FG001|Overall Study|Lost to Follow-up|4|||
146085133|NCT01302834|526832106|FG000|Overall Study|Protocol Violation|17|||
146085134|NCT01302834|526832107|FG001|Overall Study|Protocol Violation|23|||
146085135|NCT01302834|526832106|FG000|Overall Study|HIV positive|1|||
146085136|NCT01302834|526832107|FG001|Overall Study|HIV positive|3|||
146085137|NCT00899392|526832108|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
146085138|NCT00899392|526832109|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
146085139|NCT02437110|526832110|FG000|Screening|Lost to Follow-up|3|||
146085140|NCT02437110|526832110|FG000|Screening|Physician Decision|1|||
146085141|NCT02437110|526832110|FG000|ART|Adverse Event|3|||
146085142|NCT02437110|526832110|FG000|ART|Protocol Violation|3|||
146085143|NCT02437110|526832110|FG000|ART|Withdrawal by Subject|4|||
146085144|NCT02437110|526832110|FG000|ART|Lost to follow-up prior to start of intervention|1|||
146085145|NCT02437110|526832110|FG000|ART|Physician decision prior to start of intervention|2|||
146085146|NCT02437110|526832110|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
146085147|NCT02437110|526832110|FG000|Post-ART|Lost to Follow-up|3|||
146085148|NCT02437110|526832110|FG000|Post-ART|Protocol Violation|4|||
146085149|NCT02437110|526832110|FG000|Post-ART|Withdrawal by Subject|3|||
146085150|NCT03735238|526832111|FG000|Overall Study|Did not want to participate in research|3|||
146085151|NCT03735238|526832111|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
146085152|NCT01431638|526832112|FG000|Overall Study|Adverse Event|1|||
146085153|NCT01431638|526832113|FG001|Overall Study|Adverse Event|3|||
146085154|NCT01431638|526832114|FG002|Overall Study|Adverse Event|1|||
146085155|NCT01431638|526832112|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146085156|NCT01431638|526832113|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146085157|NCT01431638|526832114|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
146085158|NCT01431638|526832112|FG000|Overall Study|Participants condition no longer requires study drug|0|||
146085159|NCT01431638|526832113|FG001|Overall Study|Participants condition no longer requires study drug|1|||
146085160|NCT01431638|526832114|FG002|Overall Study|Participants condition no longer requires study drug|0|||
146085161|NCT01431638|526832112|FG000|Overall Study|Participant withdrew consent|14|||
146085162|NCT01431638|526832113|FG001|Overall Study|Participant withdrew consent|5|||
146085163|NCT01431638|526832114|FG002|Overall Study|Participant withdrew consent|8|||
146085164|NCT01431638|526832112|FG000|Overall Study|Lost to Follow-up|7|||
146085165|NCT01431638|526832113|FG001|Overall Study|Lost to Follow-up|9|||
146085166|NCT01431638|526832114|FG002|Overall Study|Lost to Follow-up|7|||
146085167|NCT01431638|526832112|FG000|Overall Study|Administrative problems|1|||
146085168|NCT01431638|526832113|FG001|Overall Study|Administrative problems|4|||
146085169|NCT01431638|526832114|FG002|Overall Study|Administrative problems|6|||
146085170|NCT01431638|526832112|FG000|Overall Study|Death|1|||
146085171|NCT01431638|526832113|FG001|Overall Study|Death|0|||
146085172|NCT01431638|526832114|FG002|Overall Study|Death|0|||
146085173|NCT01431638|526832112|FG000|Overall Study|Protocol deviation|1|||
146085174|NCT01431638|526832113|FG001|Overall Study|Protocol deviation|1|||
146085175|NCT01431638|526832114|FG002|Overall Study|Protocol deviation|4|||
146085176|NCT01431638|526832112|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
146085177|NCT01431638|526832113|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
146085178|NCT01431638|526832114|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
146085179|NCT01261780|526832115|FG000|Overall Study|Withdrawal by Subject|1|||
146085180|NCT01261780|526832116|FG001|Overall Study|Withdrawal by Subject|0|||
146085181|NCT01261780|526832115|FG000|Overall Study|Event not related to subject|1|||
146085182|NCT01261780|526832116|FG001|Overall Study|Event not related to subject|2|||
146085183|NCT03400956|526832118|FG000|Treatment Period 1|Adverse Event|0|||
146085184|NCT03400956|526832119|FG001|Treatment Period 1|Adverse Event|1|||
145883387|NCT02576717|526078432|FG000|Overall Study|Lack of Efficacy|24|||
145883388|NCT02576717|526078433|FG001|Overall Study|Lack of Efficacy|28|||
145883389|NCT02576717|526078434|FG002|Overall Study|Lack of Efficacy|20|||
145883390|NCT02576717|526078432|FG000|Overall Study|Adverse Event|26|||
145883391|NCT02576717|526078433|FG001|Overall Study|Adverse Event|32|||
145883392|NCT02576717|526078434|FG002|Overall Study|Adverse Event|26|||
145883393|NCT00399893|526078435|FG000|Overall Study|Withdrawal by Subject|1|||
146085185|NCT03400956|526832120|FG002|Treatment Period 1|Adverse Event|0|||
146085186|NCT03400956|526832118|FG000|Treatment Period 1|Lost to Follow-up|0|||
146085187|NCT03400956|526832119|FG001|Treatment Period 1|Lost to Follow-up|0|||
146085188|NCT03400956|526832120|FG002|Treatment Period 1|Lost to Follow-up|1|||
146085189|NCT03400956|526832118|FG000|Treatment Period 1|Protocol Violation|0|||
146085190|NCT03400956|526832119|FG001|Treatment Period 1|Protocol Violation|2|||
146085191|NCT03400956|526832120|FG002|Treatment Period 1|Protocol Violation|0|||
146085192|NCT03400956|526832118|FG000|Treatment Period 1|Study terminated by sponsor|3|||
146085193|NCT03400956|526832119|FG001|Treatment Period 1|Study terminated by sponsor|1|||
146085194|NCT03400956|526832120|FG002|Treatment Period 1|Study terminated by sponsor|1|||
145883394|NCT00399893|526078436|FG001|Overall Study|Withdrawal by Subject|0|||
146085195|NCT03400956|526832118|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146085196|NCT03400956|526832119|FG001|Treatment Period 1|Withdrawal by Subject|2|||
146085197|NCT03400956|526832120|FG002|Treatment Period 1|Withdrawal by Subject|4|||
146085198|NCT03400956|526832118|FG000|Treatment Period 1|Other|1|||
146085199|NCT03400956|526832119|FG001|Treatment Period 1|Other|2|||
146085200|NCT03400956|526832120|FG002|Treatment Period 1|Other|3|||
146085201|NCT03400956|526832118|FG000|Post-treatment Period 1|Adverse Event|0|||
146085202|NCT03400956|526832119|FG001|Post-treatment Period 1|Adverse Event|0|||
146085203|NCT03400956|526832120|FG002|Post-treatment Period 1|Adverse Event|1|||
146085204|NCT03400956|526832118|FG000|Post-treatment Period 1|Physician Decision|2|||
146085205|NCT03400956|526832119|FG001|Post-treatment Period 1|Physician Decision|3|||
146085206|NCT03400956|526832120|FG002|Post-treatment Period 1|Physician Decision|0|||
146085207|NCT03400956|526832118|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
146085208|NCT03400956|526832119|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
146085209|NCT03400956|526832120|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
146085210|NCT03400956|526832118|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
146085211|NCT03400956|526832119|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
146085212|NCT03400956|526832120|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
146085213|NCT03400956|526832118|FG000|Post-treatment Period 1|Other|4|||
146085214|NCT03400956|526832119|FG001|Post-treatment Period 1|Other|3|||
146085215|NCT03400956|526832120|FG002|Post-treatment Period 1|Other|4|||
146085216|NCT03400956|526832118|FG000|Treatment Period 2|Adverse Event|2|||
146085217|NCT03400956|526832119|FG001|Treatment Period 2|Adverse Event|1|||
146085218|NCT03400956|526832120|FG002|Treatment Period 2|Adverse Event|1|||
146085219|NCT03400956|526832118|FG000|Treatment Period 2|Lost to Follow-up|1|||
146085220|NCT03400956|526832119|FG001|Treatment Period 2|Lost to Follow-up|1|||
146085221|NCT03400956|526832120|FG002|Treatment Period 2|Lost to Follow-up|0|||
146085222|NCT03400956|526832118|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146085223|NCT03400956|526832119|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146085224|NCT03400956|526832120|FG002|Treatment Period 2|Withdrawal by Subject|3|||
146085225|NCT03400956|526832118|FG000|Treatment Period 2|Other|1|||
146085226|NCT03400956|526832119|FG001|Treatment Period 2|Other|1|||
146085227|NCT03400956|526832120|FG002|Treatment Period 2|Other|0|||
146085228|NCT03400956|526832118|FG000|Follow-up Period|Withdrawal by Subject|0|||
146085229|NCT03400956|526832119|FG001|Follow-up Period|Withdrawal by Subject|0|||
146085230|NCT03400956|526832120|FG002|Follow-up Period|Withdrawal by Subject|1|||
146085231|NCT03400956|526832118|FG000|Follow-up Period|Other|0|||
146085232|NCT03400956|526832119|FG001|Follow-up Period|Other|0|||
146085233|NCT03400956|526832120|FG002|Follow-up Period|Other|1|||
146085234|NCT02048241|526832121|FG000|Overall Study|Withdrawal by Subject|0|||
146085235|NCT02048241|526832122|FG001|Overall Study|Withdrawal by Subject|1|||
146085236|NCT03044574|526832125|FG000|Overall Study|Lost to Follow-up|37|||
146085237|NCT03044574|526832126|FG001|Overall Study|Lost to Follow-up|45|||
146085238|NCT01077375|526832138|FG000|Overall Study|Adverse Event|2|||
146085239|NCT01077375|526832139|FG001|Overall Study|Adverse Event|15|||
146085240|NCT01077375|526832138|FG000|Overall Study|Lack of Efficacy|6|||
146085241|NCT01077375|526832139|FG001|Overall Study|Lack of Efficacy|8|||
146085242|NCT01077375|526832138|FG000|Overall Study|Withdrawal by Subject|0|||
146085243|NCT01077375|526832139|FG001|Overall Study|Withdrawal by Subject|6|||
146085244|NCT01077375|526832138|FG000|Overall Study|Lost to Follow-up|2|||
146085245|NCT01077375|526832139|FG001|Overall Study|Lost to Follow-up|5|||
146085246|NCT01077375|526832138|FG000|Overall Study|Other Reason|0|||
146085247|NCT01077375|526832139|FG001|Overall Study|Other Reason|1|||
146085248|NCT03353740|526832143|FG000|Overall Study|Images for these participants not viable|52|||
146085249|NCT02232880|526832144|FG000|Overall Study|study stopped prior to randomization|1|||
146085250|NCT02233946|526833530|FG000|Baseline|Withdrawal by Subject|2|||
146085251|NCT02233946|526833531|FG001|Baseline|Withdrawal by Subject|0|||
145883395|NCT04412057|526078437|FG000|Overall Study|Death|3|||
145883396|NCT04412057|526078438|FG001|Overall Study|Death|7|||
145883397|NCT04412057|526078437|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
145883398|NCT04412057|526078438|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
145883399|NCT03330236|526078440|FG000|Overall Study|Death|2|||
146085252|NCT02233946|526833530|FG000|3-months Follow-up|Lost to Follow-up|53|||
145883400|NCT03330236|526078441|FG001|Overall Study|Death|1|||
145883401|NCT03330236|526078440|FG000|Overall Study|Withdrawal by Subject|2|||
145883402|NCT03330236|526078441|FG001|Overall Study|Withdrawal by Subject|4|||
146085253|NCT02233946|526833531|FG001|3-months Follow-up|Lost to Follow-up|29|||
146085254|NCT02233946|526833530|FG000|6-months Follow-up|Lost to Follow-up|21|||
145883403|NCT03330236|526078440|FG000|Overall Study|Lost to Follow-up|0|||
146085255|NCT02233946|526833531|FG001|6-months Follow-up|Lost to Follow-up|2|||
146085256|NCT02233946|526833530|FG000|9-month Follow-up|Lost to Follow-up|20|||
146085257|NCT02233946|526833531|FG001|9-month Follow-up|Lost to Follow-up|11|||
146085258|NCT02233946|526833530|FG000|12-month Follow-up|Lost to Follow-up|28|||
146085259|NCT02233946|526833531|FG001|12-month Follow-up|Lost to Follow-up|11|||
145883404|NCT03330236|526078441|FG001|Overall Study|Lost to Follow-up|2|||
146085260|NCT01879579|526833534|FG000|Overall Study|Phone incompatible with texting platform|3|||
146085261|NCT01879579|526833535|FG001|Overall Study|Phone incompatible with texting platform|0|||
145961283|NCT01817075|526369548|FG000|Overall Study|Physician Decision|9|||
145961284|NCT01817075|526369549|FG001|Overall Study|Physician Decision|12|||
145961285|NCT01817075|526369548|FG000|Overall Study|Withdrawal by Subject|31|||
145961286|NCT01817075|526369549|FG001|Overall Study|Withdrawal by Subject|15|||
145961287|NCT01817075|526369548|FG000|Overall Study|Received Sorafenib after enrollment|0|||
145961288|NCT01817075|526369549|FG001|Overall Study|Received Sorafenib after enrollment|1|||
145961289|NCT01817075|526369548|FG000|Overall Study|Ineligible|0|||
145961290|NCT01817075|526369549|FG001|Overall Study|Ineligible|2|||
145961291|NCT04376515|526369552|FG000|Overall Study|Found to have been vaccinated before study start|6|||
145961292|NCT04376515|526369553|FG001|Overall Study|Found to have been vaccinated before study start|6|||
145961293|NCT01683604|526369554|FG000|Overall Study|Adverse Event|2|||
145961294|NCT01683604|526369554|FG000|Overall Study|Lack of Efficacy|1|||
145961295|NCT01683604|526369554|FG000|Overall Study|Other|2|||
145961296|NCT01395810|526369557|FG000|Overall Study|Adverse Event|0|||
145961297|NCT01395810|526369558|FG001|Overall Study|Adverse Event|1|||
145961298|NCT01395810|526369559|FG002|Overall Study|Adverse Event|0|||
145961299|NCT01395810|526369560|FG003|Overall Study|Adverse Event|0|||
145961300|NCT01395810|526369557|FG000|Overall Study|Lack of Efficacy|0|||
145961301|NCT01395810|526369558|FG001|Overall Study|Lack of Efficacy|1|||
145961302|NCT01395810|526369559|FG002|Overall Study|Lack of Efficacy|0|||
145961303|NCT01395810|526369560|FG003|Overall Study|Lack of Efficacy|0|||
145961304|NCT01395810|526369557|FG000|Overall Study|Withdrawal criteria|0|||
145961305|NCT01395810|526369558|FG001|Overall Study|Withdrawal criteria|2|||
145961306|NCT01395810|526369559|FG002|Overall Study|Withdrawal criteria|0|||
145961307|NCT01395810|526369560|FG003|Overall Study|Withdrawal criteria|0|||
146224198|NCT02723591|527337640|FG000|Overall Study|Lack of Efficacy|4|||
146224199|NCT02723591|527337641|FG001|Overall Study|Lack of Efficacy|3|||
146224200|NCT02723591|527337640|FG000|Overall Study|Lost to Follow-up|1|||
146224201|NCT02723591|527337641|FG001|Overall Study|Lost to Follow-up|7|||
146224202|NCT02723591|527337640|FG000|Overall Study|Protocol Violation|20|||
146224203|NCT02723591|527337641|FG001|Overall Study|Protocol Violation|23|||
146224204|NCT02723591|527337640|FG000|Overall Study|Withdrawal by Subject|4|||
146224205|NCT02723591|527337641|FG001|Overall Study|Withdrawal by Subject|8|||
146224206|NCT02723591|527337640|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
146224207|NCT02723591|527337641|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
146224208|NCT02723591|527337640|FG000|Overall Study|Miscellaneous|5|||
146224209|NCT02723591|527337641|FG001|Overall Study|Miscellaneous|6|||
146224210|NCT03691935|527337642|FG000|Overall Study|Physician Decision|2|||
146224211|NCT03691935|527337643|FG001|Overall Study|Physician Decision|1|||
146224212|NCT03691935|527337642|FG000|Overall Study|Adverse Event|3|||
146224213|NCT03691935|527337643|FG001|Overall Study|Adverse Event|0|||
146224214|NCT04079218|527337644|FG000|Overall Study|Death|1|||
146224215|NCT04079218|527337645|FG001|Overall Study|Death|0|||
146224216|NCT04079218|527337644|FG000|Overall Study|Withdrawal by Subject|3|||
146224217|NCT04079218|527337645|FG001|Overall Study|Withdrawal by Subject|0|||
146224218|NCT04079218|527337644|FG000|Overall Study|Physician Decision|4|||
146224219|NCT04079218|527337645|FG001|Overall Study|Physician Decision|0|||
146224220|NCT04079218|527337644|FG000|Overall Study|Lost to Follow-up|0|||
146224221|NCT04079218|527337645|FG001|Overall Study|Lost to Follow-up|1|||
146224222|NCT05907174|527337651|FG000|3-Month Assessment|Withdrawal by Subject|0|||
145883405|NCT03330236|526078440|FG000|Overall Study|Physician Decision|2|||
146085262|NCT01879579|526833534|FG000|Overall Study|Did not enroll in texting platform|1|||
146085263|NCT01879579|526833535|FG001|Overall Study|Did not enroll in texting platform|0|||
146224223|NCT05907174|527337652|FG001|3-Month Assessment|Withdrawal by Subject|0|||
146224224|NCT05907174|527337653|FG002|3-Month Assessment|Withdrawal by Subject|0|||
146224225|NCT05907174|527337654|FG003|3-Month Assessment|Withdrawal by Subject|1|||
146224226|NCT05907174|527337651|FG000|3-Month Assessment|Lost to Follow-up|1|||
146224227|NCT05907174|527337652|FG001|3-Month Assessment|Lost to Follow-up|1|||
146224228|NCT05907174|527337653|FG002|3-Month Assessment|Lost to Follow-up|1|||
146224229|NCT05907174|527337654|FG003|3-Month Assessment|Lost to Follow-up|1|||
145883406|NCT03330236|526078441|FG001|Overall Study|Physician Decision|0|||
146224230|NCT05907174|527337651|FG000|6-Month Assessment|Death|0|||
145961308|NCT01395810|526369557|FG000|Overall Study|Unclassified|2|||
145961309|NCT01395810|526369558|FG001|Overall Study|Unclassified|0|||
145961310|NCT01395810|526369559|FG002|Overall Study|Unclassified|0|||
145961311|NCT01395810|526369560|FG003|Overall Study|Unclassified|0|||
145961312|NCT03877224|526369564|FG000|Overall Study|Death|3|||
145961313|NCT03877224|526369565|FG001|Overall Study|Death|2|||
145961314|NCT03877224|526369564|FG000|Overall Study|Withdrawal by Subject|1|||
146224231|NCT05907174|527337652|FG001|6-Month Assessment|Death|0|||
146224232|NCT05907174|527337653|FG002|6-Month Assessment|Death|3|||
146224233|NCT05907174|527337654|FG003|6-Month Assessment|Death|0|||
146224234|NCT05907174|527337651|FG000|6-Month Assessment|Withdrawal by Subject|0|||
146224235|NCT05907174|527337652|FG001|6-Month Assessment|Withdrawal by Subject|0|||
146224236|NCT05907174|527337653|FG002|6-Month Assessment|Withdrawal by Subject|1|||
146224237|NCT05907174|527337654|FG003|6-Month Assessment|Withdrawal by Subject|1|||
146224238|NCT05907174|527337651|FG000|6-Month Assessment|Lost to Follow-up|0|||
146224239|NCT05907174|527337652|FG001|6-Month Assessment|Lost to Follow-up|1|||
146224240|NCT05907174|527337653|FG002|6-Month Assessment|Lost to Follow-up|1|||
146224241|NCT05907174|527337654|FG003|6-Month Assessment|Lost to Follow-up|1|||
146224242|NCT04498390|527337655|FG000|Overall Study|Adverse Event|0|||
146224243|NCT04498390|527337656|FG001|Overall Study|Adverse Event|0|||
146224244|NCT04498390|527337657|FG002|Overall Study|Adverse Event|1|||
146224245|NCT04498390|527337658|FG003|Overall Study|Adverse Event|0|||
146224246|NCT04498390|527337659|FG004|Overall Study|Adverse Event|0|||
146224247|NCT04498390|527337655|FG000|Overall Study|Withdrawal by Subject|0|||
146224248|NCT04498390|527337656|FG001|Overall Study|Withdrawal by Subject|0|||
146224249|NCT04498390|527337657|FG002|Overall Study|Withdrawal by Subject|0|||
146224250|NCT04498390|527337658|FG003|Overall Study|Withdrawal by Subject|1|||
146224251|NCT04498390|527337659|FG004|Overall Study|Withdrawal by Subject|0|||
146224252|NCT01275677|527337662|FG000|Overall Study|Not at risk for recurrence.|1|||
146224253|NCT01275677|527337663|FG001|Overall Study|Not at risk for recurrence.|1|||
146224254|NCT01275677|527337662|FG000|Overall Study|No follow-up|26|||
146224255|NCT01275677|527337663|FG001|Overall Study|No follow-up|37|||
146224256|NCT01275677|527337662|FG000|Overall Study|No clinical follow up.|1|||
146224257|NCT01275677|527337663|FG001|Overall Study|No clinical follow up.|4|||
146224262|NCT03734679|527337666|FG000|Overall Study|Missed Visit|1|||
146224263|NCT01346540|527337670|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
146224264|NCT01346540|527337671|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
145961315|NCT03877224|526369565|FG001|Overall Study|Withdrawal by Subject|6|||
146224265|NCT01346540|527337670|FG000|Overall Study|Adverse Event|0|||
146224266|NCT01346540|527337671|FG001|Overall Study|Adverse Event|4|||
146224267|NCT04690582|527337672|FG000|Overall Study|Withdrawal by Subject|6|||
146224268|NCT04690582|527337673|FG001|Overall Study|Withdrawal by Subject|4|||
146224269|NCT04857723|527337678|FG000|Overall Study|Withdrawal by Subject|2|||
146224270|NCT04171141|527339783|FG000|Overall Study|Adverse Event|0|||
146224271|NCT04171141|527339784|FG001|Overall Study|Adverse Event|0|||
146224272|NCT04171141|527339785|FG002|Overall Study|Adverse Event|2|||
146224273|NCT04171141|527339786|FG003|Overall Study|Adverse Event|0|||
146224274|NCT04171141|527339787|FG004|Overall Study|Adverse Event|0|||
146224275|NCT04171141|527339788|FG005|Overall Study|Adverse Event|0|||
146224276|NCT04171141|527339789|FG006|Overall Study|Adverse Event|0|||
146224277|NCT04171141|527339790|FG007|Overall Study|Adverse Event|0|||
146224278|NCT04171141|527339791|FG008|Overall Study|Adverse Event|0|||
146224279|NCT04171141|527339792|FG009|Overall Study|Adverse Event|0|||
146224280|NCT04171141|527339793|FG010|Overall Study|Adverse Event|0|||
146224281|NCT04171141|527339794|FG011|Overall Study|Adverse Event|0|||
146224282|NCT04171141|527339795|FG012|Overall Study|Adverse Event|0|||
146224283|NCT04171141|527339796|FG013|Overall Study|Adverse Event|2|||
146224284|NCT04171141|527339797|FG014|Overall Study|Adverse Event|0|||
146224285|NCT04171141|527339798|FG015|Overall Study|Adverse Event|0|||
146224286|NCT04171141|527339783|FG000|Overall Study|Physician Decision|0|||
146224287|NCT04171141|527339784|FG001|Overall Study|Physician Decision|0|||
146224288|NCT04171141|527339785|FG002|Overall Study|Physician Decision|0|||
146224289|NCT04171141|527339786|FG003|Overall Study|Physician Decision|0|||
146224290|NCT04171141|527339787|FG004|Overall Study|Physician Decision|1|||
146224291|NCT04171141|527339788|FG005|Overall Study|Physician Decision|0|||
146224292|NCT04171141|527339789|FG006|Overall Study|Physician Decision|0|||
146224293|NCT04171141|527339790|FG007|Overall Study|Physician Decision|0|||
146224294|NCT04171141|527339791|FG008|Overall Study|Physician Decision|0|||
146224295|NCT04171141|527339792|FG009|Overall Study|Physician Decision|0|||
146224296|NCT04171141|527339793|FG010|Overall Study|Physician Decision|0|||
146224297|NCT04171141|527339794|FG011|Overall Study|Physician Decision|0|||
146224298|NCT04171141|527339795|FG012|Overall Study|Physician Decision|0|||
146224299|NCT04171141|527339796|FG013|Overall Study|Physician Decision|0|||
146224300|NCT04171141|527339797|FG014|Overall Study|Physician Decision|0|||
146224301|NCT04171141|527339798|FG015|Overall Study|Physician Decision|1|||
146224302|NCT04171141|527339783|FG000|Overall Study|Progressive disease|2|||
146224303|NCT04171141|527339784|FG001|Overall Study|Progressive disease|3|||
146224304|NCT04171141|527339785|FG002|Overall Study|Progressive disease|4|||
146224305|NCT04171141|527339786|FG003|Overall Study|Progressive disease|7|||
146224306|NCT04171141|527339787|FG004|Overall Study|Progressive disease|1|||
146224307|NCT04171141|527339788|FG005|Overall Study|Progressive disease|8|||
146224308|NCT04171141|527339789|FG006|Overall Study|Progressive disease|4|||
146224309|NCT04171141|527339790|FG007|Overall Study|Progressive disease|6|||
146224310|NCT04171141|527339791|FG008|Overall Study|Progressive disease|7|||
146224311|NCT04171141|527339792|FG009|Overall Study|Progressive disease|3|||
146224312|NCT04171141|527339793|FG010|Overall Study|Progressive disease|4|||
146224313|NCT04171141|527339794|FG011|Overall Study|Progressive disease|3|||
146224314|NCT04171141|527339795|FG012|Overall Study|Progressive disease|4|||
146224315|NCT04171141|527339796|FG013|Overall Study|Progressive disease|2|||
146224316|NCT04171141|527339797|FG014|Overall Study|Progressive disease|4|||
146224317|NCT04171141|527339798|FG015|Overall Study|Progressive disease|1|||
146224318|NCT04171141|527339783|FG000|Overall Study|Withdrawal by Subject|0|||
146224319|NCT04171141|527339784|FG001|Overall Study|Withdrawal by Subject|0|||
146224320|NCT04171141|527339785|FG002|Overall Study|Withdrawal by Subject|0|||
146224321|NCT04171141|527339786|FG003|Overall Study|Withdrawal by Subject|1|||
146224322|NCT04171141|527339787|FG004|Overall Study|Withdrawal by Subject|0|||
146224323|NCT04171141|527339788|FG005|Overall Study|Withdrawal by Subject|0|||
146224324|NCT04171141|527339789|FG006|Overall Study|Withdrawal by Subject|1|||
146224325|NCT04171141|527339790|FG007|Overall Study|Withdrawal by Subject|0|||
146224326|NCT04171141|527339791|FG008|Overall Study|Withdrawal by Subject|0|||
146224327|NCT04171141|527339792|FG009|Overall Study|Withdrawal by Subject|1|||
146224328|NCT04171141|527339793|FG010|Overall Study|Withdrawal by Subject|0|||
146224329|NCT04171141|527339794|FG011|Overall Study|Withdrawal by Subject|0|||
146224330|NCT04171141|527339795|FG012|Overall Study|Withdrawal by Subject|0|||
146224331|NCT04171141|527339796|FG013|Overall Study|Withdrawal by Subject|0|||
145961316|NCT03877224|526369564|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
145970790|NCT00726453|526407269|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
146224332|NCT04171141|527339797|FG014|Overall Study|Withdrawal by Subject|0|||
146224333|NCT04171141|527339798|FG015|Overall Study|Withdrawal by Subject|0|||
146224334|NCT04171141|527339783|FG000|Overall Study|Global deterioration of health status|0|||
146224335|NCT04171141|527339784|FG001|Overall Study|Global deterioration of health status|0|||
146224336|NCT04171141|527339785|FG002|Overall Study|Global deterioration of health status|0|||
146224337|NCT04171141|527339786|FG003|Overall Study|Global deterioration of health status|1|||
146224338|NCT04171141|527339787|FG004|Overall Study|Global deterioration of health status|0|||
146224339|NCT04171141|527339788|FG005|Overall Study|Global deterioration of health status|2|||
146224340|NCT04171141|527339789|FG006|Overall Study|Global deterioration of health status|1|||
146224341|NCT04171141|527339790|FG007|Overall Study|Global deterioration of health status|0|||
146224342|NCT04171141|527339791|FG008|Overall Study|Global deterioration of health status|1|||
146224343|NCT04171141|527339792|FG009|Overall Study|Global deterioration of health status|0|||
146224344|NCT04171141|527339793|FG010|Overall Study|Global deterioration of health status|0|||
146224345|NCT04171141|527339794|FG011|Overall Study|Global deterioration of health status|0|||
146224346|NCT04171141|527339795|FG012|Overall Study|Global deterioration of health status|0|||
146224347|NCT04171141|527339796|FG013|Overall Study|Global deterioration of health status|0|||
146224348|NCT04171141|527339797|FG014|Overall Study|Global deterioration of health status|1|||
146224349|NCT04171141|527339798|FG015|Overall Study|Global deterioration of health status|1|||
146224350|NCT04858451|527339801|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
146224351|NCT04858451|527339802|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224352|NCT04858451|527339803|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224353|NCT04858451|527339804|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224354|NCT04858451|527339805|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224355|NCT04858451|527339806|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224356|NCT04858451|527339807|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224357|NCT04858451|527339808|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224358|NCT04858451|527339809|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
146224359|NCT04858451|527339801|FG000|Part 2|Discontinued|0|||
146224360|NCT04858451|527339802|FG001|Part 2|Discontinued|0|||
146224361|NCT04858451|527339803|FG002|Part 2|Discontinued|0|||
146224362|NCT04858451|527339804|FG003|Part 2|Discontinued|0|||
146224363|NCT04858451|527339805|FG004|Part 2|Discontinued|0|||
146224364|NCT04858451|527339806|FG005|Part 2|Discontinued|0|||
146224365|NCT04858451|527339807|FG006|Part 2|Discontinued|0|||
146224366|NCT04858451|527339808|FG007|Part 2|Discontinued|0|||
146224367|NCT04858451|527339809|FG008|Part 2|Discontinued|63|||
146224368|NCT04119843|527339810|FG000|Overall Study|Adverse Event|3|||
146224369|NCT04119843|527339810|FG000|Overall Study|Death|1|||
146224370|NCT04233216|527339812|FG000|Overall Study|Lost to Follow-up|1|||
146224371|NCT04233216|527339813|FG001|Overall Study|Lost to Follow-up|0|||
146224372|NCT04233216|527339814|FG002|Overall Study|Lost to Follow-up|2|||
146224373|NCT04233216|527339815|FG003|Overall Study|Lost to Follow-up|0|||
146224374|NCT04233216|527339812|FG000|Overall Study|Physician Decision|0|||
146224375|NCT04233216|527339813|FG001|Overall Study|Physician Decision|3|||
146224376|NCT04233216|527339814|FG002|Overall Study|Physician Decision|0|||
146224377|NCT04233216|527339815|FG003|Overall Study|Physician Decision|2|||
146224378|NCT04233216|527339812|FG000|Overall Study|Withdrawal by Subject|0|||
146224379|NCT04233216|527339813|FG001|Overall Study|Withdrawal by Subject|2|||
146224380|NCT04233216|527339814|FG002|Overall Study|Withdrawal by Subject|1|||
146224381|NCT04233216|527339815|FG003|Overall Study|Withdrawal by Subject|0|||
146224382|NCT04231149|527339816|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146224383|NCT04231149|527339817|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
146224384|NCT04231149|527339818|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146224385|NCT04231149|527339819|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146224386|NCT04231149|527339820|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
146224387|NCT03252847|527339821|FG000|Overall Study|Withdrawal by Subject|0|||
146224388|NCT03252847|527339822|FG001|Overall Study|Withdrawal by Subject|0|||
146224389|NCT03252847|527339823|FG002|Overall Study|Withdrawal by Subject|1|||
146224390|NCT03252847|527339824|FG003|Overall Study|Withdrawal by Subject|0|||
146224391|NCT03252847|527339825|FG004|Overall Study|Withdrawal by Subject|0|||
146224392|NCT03252847|527339826|FG005|Overall Study|Withdrawal by Subject|0|||
146224393|NCT03252847|527339827|FG006|Overall Study|Withdrawal by Subject|0|||
146224394|NCT03252847|527339821|FG000|Overall Study|Other: Patient decision|0|||
146224395|NCT03252847|527339822|FG001|Overall Study|Other: Patient decision|0|||
146224396|NCT03252847|527339823|FG002|Overall Study|Other: Patient decision|0|||
146224397|NCT03252847|527339824|FG003|Overall Study|Other: Patient decision|0|||
146224398|NCT03252847|527339825|FG004|Overall Study|Other: Patient decision|1|||
146224399|NCT03252847|527339826|FG005|Overall Study|Other: Patient decision|0|||
146224400|NCT03252847|527339827|FG006|Overall Study|Other: Patient decision|0|||
146224401|NCT04979442|527339830|FG000|Overall Study|Death|43|||
146224402|NCT04979442|527339831|FG001|Overall Study|Death|30|||
146224403|NCT04979442|527339830|FG000|Overall Study|Withdrawal by Subject|8|||
146224404|NCT04979442|527339831|FG001|Overall Study|Withdrawal by Subject|13|||
146224405|NCT04979442|527339830|FG000|Overall Study|Physician Decision|1|||
146224406|NCT04979442|527339831|FG001|Overall Study|Physician Decision|1|||
146224407|NCT04979442|527339830|FG000|Overall Study|Lost to Follow-up|0|||
146224408|NCT04979442|527339831|FG001|Overall Study|Lost to Follow-up|2|||
146224409|NCT04979442|527339830|FG000|Overall Study|do not want to continue|0|||
146224410|NCT04979442|527339831|FG001|Overall Study|do not want to continue|1|||
146224411|NCT04298983|527339832|FG000|Overall Study|Adverse Event|4|||
146224412|NCT04298983|527339832|FG000|Overall Study|Lack of Efficacy|3|||
146224413|NCT04005794|527339833|FG000|Overall Study|Lost to Follow-up|0|||
146224414|NCT04005794|527339834|FG001|Overall Study|Lost to Follow-up|4|||
146224415|NCT04005794|527339835|FG002|Overall Study|Lost to Follow-up|0|||
146224416|NCT04042233|527339836|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
146224417|NCT04042233|527339837|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
146224418|NCT04042233|527339836|FG000|Overall Study|Protocol Violation|0|||
146224419|NCT04042233|527339837|FG001|Overall Study|Protocol Violation|2|||
146224420|NCT04907851|527339838|FG000|Overall Study|Consent withdrawn|1|||
146224421|NCT04907851|527339839|FG001|Overall Study|Consent withdrawn|2|||
146224422|NCT04907851|527339840|FG002|Overall Study|Consent withdrawn|0|||
146224423|NCT04907851|527339838|FG000|Overall Study|Death|5|||
146224424|NCT04907851|527339839|FG001|Overall Study|Death|15|||
146224425|NCT04907851|527339840|FG002|Overall Study|Death|10|||
146224426|NCT05297565|527339841|FG000|Overall Study|Other Reasons|0|||
146224427|NCT05297565|527339842|FG001|Overall Study|Other Reasons|1|||
146224428|NCT05297565|527339841|FG000|Overall Study|Physician Decision|0|||
146224429|NCT05297565|527339842|FG001|Overall Study|Physician Decision|1|||
146224430|NCT05297565|527339841|FG000|Overall Study|Disease recurrence|1|||
146224431|NCT05297565|527339842|FG001|Overall Study|Disease recurrence|0|||
146224432|NCT04850898|527339845|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
146224433|NCT04850898|527339846|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
146224434|NCT03511664|527339857|FG000|Overall Study|Death|457|||
146224435|NCT03511664|527339858|FG001|Overall Study|Death|201|||
146224436|NCT03511664|527339859|FG002|Overall Study|Death|21|||
146224437|NCT03511664|527339857|FG000|Overall Study|Withdrew consent|40|||
146224438|NCT03511664|527339858|FG001|Overall Study|Withdrew consent|63|||
146224439|NCT03511664|527339859|FG002|Overall Study|Withdrew consent|3|||
146224440|NCT03511664|527339857|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
146224441|NCT03511664|527339858|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
146224442|NCT03511664|527339859|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
146224443|NCT03511664|527339857|FG000|Overall Study|Lost to Follow-up|8|||
146224444|NCT03511664|527339858|FG001|Overall Study|Lost to Follow-up|5|||
146224445|NCT03511664|527339859|FG002|Overall Study|Lost to Follow-up|0|||
146224446|NCT03511664|527339857|FG000|Overall Study|Physician Decision|2|||
146224447|NCT03511664|527339858|FG001|Overall Study|Physician Decision|1|||
146224448|NCT03511664|527339859|FG002|Overall Study|Physician Decision|0|||
146224449|NCT03511664|527339857|FG000|Overall Study|Patient non-compliance|1|||
146224450|NCT03511664|527339858|FG001|Overall Study|Patient non-compliance|0|||
146224451|NCT03511664|527339859|FG002|Overall Study|Patient non-compliance|0|||
146224452|NCT01946789|527339860|FG000|Overall Study|Death|0|||
146224453|NCT01946789|527339861|FG001|Overall Study|Death|2|||
146224454|NCT01946789|527339862|FG002|Overall Study|Death|1|||
146224455|NCT01946789|527339863|FG003|Overall Study|Death|1|||
146224456|NCT01946789|527339864|FG004|Overall Study|Death|1|||
146224457|NCT01946789|527339865|FG005|Overall Study|Death|1|||
146224458|NCT01946789|527339866|FG006|Overall Study|Death|3|||
146224459|NCT01946789|527339867|FG007|Overall Study|Death|1|||
146224460|NCT01946789|527339868|FG008|Overall Study|Death|2|||
146224461|NCT01946789|527339860|FG000|Overall Study|Progressive Disease|0|||
146224462|NCT01946789|527339861|FG001|Overall Study|Progressive Disease|0|||
146224463|NCT01946789|527339862|FG002|Overall Study|Progressive Disease|1|||
146224464|NCT01946789|527339863|FG003|Overall Study|Progressive Disease|0|||
146224465|NCT01946789|527339864|FG004|Overall Study|Progressive Disease|0|||
146224466|NCT01946789|527339865|FG005|Overall Study|Progressive Disease|2|||
146224467|NCT01946789|527339866|FG006|Overall Study|Progressive Disease|0|||
146224468|NCT01946789|527339867|FG007|Overall Study|Progressive Disease|0|||
146224469|NCT01946789|527339868|FG008|Overall Study|Progressive Disease|0|||
146224470|NCT01946789|527339860|FG000|Overall Study|Withdrawal by Subject|0|||
146224471|NCT01946789|527339861|FG001|Overall Study|Withdrawal by Subject|0|||
146224472|NCT01946789|527339862|FG002|Overall Study|Withdrawal by Subject|0|||
146224473|NCT01946789|527339863|FG003|Overall Study|Withdrawal by Subject|2|||
145883407|NCT03330236|526078440|FG000|Overall Study|Protocol Violation|4|||
145883408|NCT03330236|526078441|FG001|Overall Study|Protocol Violation|3|||
145883409|NCT03330236|526078440|FG000|Overall Study|SedLine malfunction/blinding|19|||
145883410|NCT03330236|526078441|FG001|Overall Study|SedLine malfunction/blinding|14|||
145883411|NCT03330236|526078440|FG000|Overall Study|Volatile anesthetics used|11|||
145883412|NCT03330236|526078441|FG001|Overall Study|Volatile anesthetics used|8|||
145883413|NCT03330236|526078440|FG000|Overall Study|Surgery aborted/converted to open|60|||
145883414|NCT03330236|526078441|FG001|Overall Study|Surgery aborted/converted to open|52|||
145883415|NCT03710590|526078448|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
145883416|NCT03710590|526078449|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
145883417|NCT00407745|526078450|FG000|Overall Study|Lack of Efficacy|1|||
146224474|NCT01946789|527339864|FG004|Overall Study|Withdrawal by Subject|1|||
146224475|NCT01946789|527339865|FG005|Overall Study|Withdrawal by Subject|0|||
146224476|NCT01946789|527339866|FG006|Overall Study|Withdrawal by Subject|1|||
146224477|NCT01946789|527339867|FG007|Overall Study|Withdrawal by Subject|0|||
146224478|NCT01946789|527339868|FG008|Overall Study|Withdrawal by Subject|0|||
146224479|NCT05374798|527339887|FG000|Overall Study|Lost to Follow-up|2|||
146224480|NCT05374798|527339887|FG000|Overall Study|Withdrawal by Subject|2|||
146224481|NCT05374798|527339887|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
146224482|NCT04707625|527339888|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
146224483|NCT04471246|527339889|FG000|Overall Study|Lost to Follow-up|2|||
146224484|NCT04471246|527339890|FG001|Overall Study|Lost to Follow-up|2|||
146224485|NCT05764525|527339891|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
146224486|NCT05764525|527339892|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
146224487|NCT05764525|527339891|FG000|Overall Study|Withdrawal by Subject|4|||
146224488|NCT05764525|527339892|FG001|Overall Study|Withdrawal by Subject|8|||
146224489|NCT05764525|527339891|FG000|Overall Study|Physician Decision|1|||
146224490|NCT05764525|527339892|FG001|Overall Study|Physician Decision|0|||
146224491|NCT03334630|527339893|FG000|Overall Study|Withdrawal by Subject|7|||
146224492|NCT03334630|527339894|FG001|Overall Study|Withdrawal by Subject|7|||
146224493|NCT03334630|527339893|FG000|Overall Study|Lost to Follow-up|3|||
146224494|NCT03334630|527339894|FG001|Overall Study|Lost to Follow-up|1|||
146224495|NCT03334630|527339893|FG000|Overall Study|Adverse Event|0|||
146224496|NCT03334630|527339894|FG001|Overall Study|Adverse Event|1|||
146224497|NCT03334630|527339893|FG000|Overall Study|Physician Decision|1|||
146224498|NCT03334630|527339894|FG001|Overall Study|Physician Decision|1|||
146224499|NCT03334630|527339893|FG000|Overall Study|Enrollment closed|2|||
146224500|NCT03334630|527339894|FG001|Overall Study|Enrollment closed|1|||
146224501|NCT03334630|527339893|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
146224502|NCT03334630|527339894|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
146224503|NCT03334630|527339893|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
146224504|NCT03334630|527339894|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
146224505|NCT05093842|527339900|FG000|Overall Study|Pregnancy loss|1|||
146224506|NCT05093842|527339901|FG001|Overall Study|Pregnancy loss|1|||
146224507|NCT05093842|527339900|FG000|Overall Study|Lost to Follow-up|6|||
146224508|NCT05093842|527339901|FG001|Overall Study|Lost to Follow-up|0|||
146224509|NCT05093842|527339900|FG000|Overall Study|Physician Decision|0|||
146224510|NCT05093842|527339901|FG001|Overall Study|Physician Decision|1|||
146224511|NCT03910478|527339907|FG000|Overall Study|Death|13|||
146224512|NCT03910478|527339908|FG001|Overall Study|Death|6|||
146224513|NCT03910478|527339907|FG000|Overall Study|Withdrawal by Subject|23|||
146224514|NCT03910478|527339908|FG001|Overall Study|Withdrawal by Subject|2|||
146224515|NCT03910478|527339907|FG000|Overall Study|Physician Decision|5|||
146224516|NCT03910478|527339908|FG001|Overall Study|Physician Decision|0|||
146224517|NCT03910478|527339907|FG000|Overall Study|Protocol Violation|1|||
146224518|NCT03910478|527339908|FG001|Overall Study|Protocol Violation|0|||
146224519|NCT03910478|527339907|FG000|Overall Study|Failure to meet continuation criteria|2|||
146224520|NCT03910478|527339908|FG001|Overall Study|Failure to meet continuation criteria|0|||
146224521|NCT03910478|527339907|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
146224522|NCT03910478|527339908|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
146224523|NCT05293171|527339910|FG000|Washout 5 to 7 Days|Adverse Event|1|||
146224524|NCT05293171|527339911|FG001|Washout 5 to 7 Days|Adverse Event|1|||
146224525|NCT05293171|527339912|FG002|Washout 5 to 7 Days|Adverse Event|0|||
146224526|NCT05293171|527339913|FG003|Washout 5 to 7 Days|Adverse Event|0|||
146224527|NCT05293171|527339914|FG004|Washout 5 to 7 Days|Adverse Event|0|||
146224528|NCT05293171|527339915|FG005|Washout 5 to 7 Days|Adverse Event|0|||
146224529|NCT05293171|527339916|FG006|Washout 5 to 7 Days|Adverse Event|0|||
146224530|NCT05293171|527339917|FG007|Washout 5 to 7 Days|Adverse Event|0|||
146224531|NCT05293171|527339918|FG008|Washout 5 to 7 Days|Adverse Event|0|||
146224532|NCT05293171|527339919|FG009|Washout 5 to 7 Days|Adverse Event|0|||
146224533|NCT05293171|527339920|FG010|Washout 5 to 7 Days|Adverse Event|0|||
146224534|NCT05293171|527339921|FG011|Washout 5 to 7 Days|Adverse Event|0|||
146224535|NCT05293171|527339910|FG000|Washout 5 to 7 Days|Adverse Event|0|||
146224536|NCT05293171|527339911|FG001|Washout 5 to 7 Days|Adverse Event|0|||
146224537|NCT05293171|527339912|FG002|Washout 5 to 7 Days|Adverse Event|0|||
146224538|NCT05293171|527339913|FG003|Washout 5 to 7 Days|Adverse Event|0|||
146224539|NCT05293171|527339914|FG004|Washout 5 to 7 Days|Adverse Event|0|||
146224540|NCT05293171|527339915|FG005|Washout 5 to 7 Days|Adverse Event|1|||
146224541|NCT05293171|527339916|FG006|Washout 5 to 7 Days|Adverse Event|0|||
146224542|NCT05293171|527339917|FG007|Washout 5 to 7 Days|Adverse Event|0|||
145961317|NCT03877224|526369565|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
145961318|NCT03234036|526371089|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
145961319|NCT03234036|526371090|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
145961320|NCT03234036|526371091|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
146224543|NCT05293171|527339918|FG008|Washout 5 to 7 Days|Adverse Event|0|||
146224544|NCT05293171|527339919|FG009|Washout 5 to 7 Days|Adverse Event|0|||
146224545|NCT05293171|527339920|FG010|Washout 5 to 7 Days|Adverse Event|0|||
146224546|NCT05293171|527339921|FG011|Washout 5 to 7 Days|Adverse Event|0|||
146224547|NCT02052882|527339922|FG000|Overall Study|Not treated|11|||
146224548|NCT02052882|527339922|FG000|Overall Study|Protocol Violation|1|||
146224549|NCT02052882|527339922|FG000|Overall Study|Inadequate testing|1|||
146224550|NCT03987022|527339926|FG000|Overall Study|Lost to Follow-up|2|||
146224551|NCT03987022|527339927|FG001|Overall Study|Lost to Follow-up|2|||
146224552|NCT03987022|527339926|FG000|Overall Study|Withdrawal by Subject|1|||
146224553|NCT03987022|527339927|FG001|Overall Study|Withdrawal by Subject|0|||
146224554|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
146224555|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
145883418|NCT00407745|526078451|FG001|Overall Study|Lack of Efficacy|2|||
145883419|NCT00407745|526078450|FG000|Overall Study|Withdrawal by Subject|3|||
145883420|NCT00407745|526078451|FG001|Overall Study|Withdrawal by Subject|3|||
145883421|NCT00407745|526078450|FG000|Overall Study|Protocol Violation|5|||
145883422|NCT00407745|526078451|FG001|Overall Study|Protocol Violation|3|||
145883423|NCT00407745|526078450|FG000|Overall Study|Adverse Event|8|||
145883424|NCT00407745|526078451|FG001|Overall Study|Adverse Event|8|||
145883425|NCT00407745|526078450|FG000|Overall Study|Other|2|||
145883426|NCT00407745|526078451|FG001|Overall Study|Other|0|||
145883427|NCT00407745|526078450|FG000|Overall Study|Randomized, unknown if treated|0|||
145883428|NCT00407745|526078451|FG001|Overall Study|Randomized, unknown if treated|1|||
145883429|NCT00108082|526078452|FG000|Overall Study|Adverse Event|14|||
145883430|NCT00108082|526078453|FG001|Overall Study|Adverse Event|12|||
145883431|NCT00108082|526078454|FG002|Overall Study|Adverse Event|17|||
145883432|NCT00108082|526078452|FG000|Overall Study|Lost to Follow-up|6|||
145883433|NCT00108082|526078453|FG001|Overall Study|Lost to Follow-up|3|||
145883434|NCT00108082|526078454|FG002|Overall Study|Lost to Follow-up|7|||
145883435|NCT00108082|526078452|FG000|Overall Study|Consent Withdrawn|3|||
145883436|NCT00108082|526078453|FG001|Overall Study|Consent Withdrawn|3|||
145883437|NCT00108082|526078454|FG002|Overall Study|Consent Withdrawn|5|||
145883438|NCT00108082|526078452|FG000|Overall Study|Protocol Violation|1|||
145883439|NCT00108082|526078453|FG001|Overall Study|Protocol Violation|2|||
145883440|NCT00108082|526078454|FG002|Overall Study|Protocol Violation|0|||
145883441|NCT00108082|526078452|FG000|Overall Study|Lack of Efficacy|3|||
145883442|NCT00108082|526078453|FG001|Overall Study|Lack of Efficacy|1|||
145883443|NCT00108082|526078454|FG002|Overall Study|Lack of Efficacy|2|||
145883444|NCT00108082|526078452|FG000|Overall Study|Amendment 4: > Month 12|5|||
145883445|NCT00108082|526078453|FG001|Overall Study|Amendment 4: > Month 12|7|||
145883446|NCT00108082|526078454|FG002|Overall Study|Amendment 4: > Month 12|5|||
145883447|NCT00108082|526078452|FG000|Overall Study|Woman of Child-bearing Potential|2|||
145883448|NCT00108082|526078453|FG001|Overall Study|Woman of Child-bearing Potential|0|||
145883449|NCT00108082|526078454|FG002|Overall Study|Woman of Child-bearing Potential|2|||
145883450|NCT00108082|526078452|FG000|Overall Study|Incorrectly Randomized|0|||
145883451|NCT00108082|526078453|FG001|Overall Study|Incorrectly Randomized|0|||
145883452|NCT00108082|526078454|FG002|Overall Study|Incorrectly Randomized|2|||
145961321|NCT03234036|526371092|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
145961322|NCT02163395|526371093|FG000|Overall Study|Withdrawal by Subject|1|||
145961323|NCT02163395|526371093|FG000|Overall Study|Lost to Follow-up|3|||
146085264|NCT01879579|526833534|FG000|Overall Study|Did not initiate insulin treatment|1|||
146085265|NCT01879579|526833535|FG001|Overall Study|Did not initiate insulin treatment|0|||
146224556|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
146224557|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
146224558|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
146224559|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
146224560|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
146224561|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
146224562|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
146224563|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
146224564|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
146224565|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
146224566|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
146224567|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
146224568|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
146224569|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
146224570|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
146224571|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
146224572|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
146224573|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
146224574|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
146224575|NCT04800211|527339930|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
146224576|NCT04800211|527339931|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
146224577|NCT04800211|527339932|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
146224578|NCT04800211|527339930|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
146224579|NCT04800211|527339931|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
146224580|NCT04800211|527339932|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
146224581|NCT04800211|527339930|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
146224582|NCT04800211|527339931|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
146224583|NCT04800211|527339932|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
146224584|NCT04800211|527339930|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
146224585|NCT04800211|527339931|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
146224586|NCT04800211|527339932|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
145883453|NCT00108082|526078452|FG000|Overall Study|Non-compliance|1|||
145883454|NCT00108082|526078453|FG001|Overall Study|Non-compliance|0|||
146224587|NCT03088878|527339952|FG000|Overall Study|Adverse Event|0|||
146224588|NCT03088878|527339953|FG001|Overall Study|Adverse Event|0|||
146224589|NCT03088878|527339954|FG002|Overall Study|Adverse Event|0|||
146224590|NCT03088878|527339955|FG003|Overall Study|Adverse Event|0|||
146224591|NCT03088878|527339956|FG004|Overall Study|Adverse Event|4|||
146224592|NCT03088878|527339957|FG005|Overall Study|Adverse Event|2|||
146224593|NCT03088878|527339958|FG006|Overall Study|Adverse Event|1|||
146224594|NCT03088878|527339959|FG007|Overall Study|Adverse Event|0|||
146224595|NCT03088878|527339960|FG008|Overall Study|Adverse Event|0|||
146224596|NCT03088878|527339961|FG009|Overall Study|Adverse Event|0|||
146224597|NCT03088878|527339962|FG010|Overall Study|Adverse Event|0|||
146224598|NCT03088878|527339963|FG011|Overall Study|Adverse Event|0|||
146224599|NCT03088878|527339964|FG012|Overall Study|Adverse Event|5|||
146224600|NCT03088878|527339965|FG013|Overall Study|Adverse Event|3|||
146224601|NCT03088878|527339952|FG000|Overall Study|Clinical Progression|0|||
146224602|NCT03088878|527339953|FG001|Overall Study|Clinical Progression|0|||
146224603|NCT03088878|527339954|FG002|Overall Study|Clinical Progression|0|||
146224604|NCT03088878|527339955|FG003|Overall Study|Clinical Progression|0|||
146224605|NCT03088878|527339956|FG004|Overall Study|Clinical Progression|2|||
146224606|NCT03088878|527339957|FG005|Overall Study|Clinical Progression|0|||
146224607|NCT03088878|527339958|FG006|Overall Study|Clinical Progression|0|||
146224608|NCT03088878|527339959|FG007|Overall Study|Clinical Progression|0|||
146224609|NCT03088878|527339960|FG008|Overall Study|Clinical Progression|0|||
146224610|NCT03088878|527339961|FG009|Overall Study|Clinical Progression|0|||
146288995|NCT00262951|527573305|FG000|Overall Study|Alternative treatment|3|||
146288996|NCT00262951|527573305|FG000|Overall Study|Off treatment for other disease|1|||
146288997|NCT01853137|527573306|FG000|Overall Study|Lost to Follow-up|4|||
146288998|NCT01853137|527573307|FG001|Overall Study|Lost to Follow-up|1|||
146288999|NCT03401229|527573308|FG000|Overall Study|Lost to Follow-up|2|||
146224611|NCT03088878|527339962|FG010|Overall Study|Clinical Progression|0|||
146224612|NCT03088878|527339963|FG011|Overall Study|Clinical Progression|0|||
146224613|NCT03088878|527339964|FG012|Overall Study|Clinical Progression|0|||
146224614|NCT03088878|527339965|FG013|Overall Study|Clinical Progression|0|||
146224615|NCT03088878|527339952|FG000|Overall Study|Death|0|||
146224616|NCT03088878|527339953|FG001|Overall Study|Death|0|||
146224617|NCT03088878|527339954|FG002|Overall Study|Death|0|||
146224618|NCT03088878|527339955|FG003|Overall Study|Death|0|||
146224619|NCT03088878|527339956|FG004|Overall Study|Death|2|||
146224620|NCT03088878|527339957|FG005|Overall Study|Death|0|||
146224621|NCT03088878|527339958|FG006|Overall Study|Death|0|||
146224622|NCT03088878|527339959|FG007|Overall Study|Death|0|||
146224623|NCT03088878|527339960|FG008|Overall Study|Death|0|||
146224624|NCT03088878|527339961|FG009|Overall Study|Death|0|||
146224625|NCT03088878|527339962|FG010|Overall Study|Death|0|||
146224626|NCT03088878|527339963|FG011|Overall Study|Death|1|||
146224627|NCT03088878|527339964|FG012|Overall Study|Death|0|||
146224628|NCT03088878|527339965|FG013|Overall Study|Death|0|||
146224629|NCT03088878|527339952|FG000|Overall Study|Disease Progression|1|||
146224630|NCT03088878|527339953|FG001|Overall Study|Disease Progression|2|||
146224631|NCT03088878|527339954|FG002|Overall Study|Disease Progression|3|||
146224632|NCT03088878|527339955|FG003|Overall Study|Disease Progression|0|||
146224633|NCT03088878|527339956|FG004|Overall Study|Disease Progression|3|||
146224634|NCT03088878|527339957|FG005|Overall Study|Disease Progression|0|||
146224635|NCT03088878|527339958|FG006|Overall Study|Disease Progression|0|||
146224636|NCT03088878|527339959|FG007|Overall Study|Disease Progression|0|||
146224637|NCT03088878|527339960|FG008|Overall Study|Disease Progression|0|||
146224638|NCT03088878|527339961|FG009|Overall Study|Disease Progression|0|||
146224639|NCT03088878|527339962|FG010|Overall Study|Disease Progression|0|||
146224640|NCT03088878|527339963|FG011|Overall Study|Disease Progression|0|||
146224641|NCT03088878|527339964|FG012|Overall Study|Disease Progression|1|||
146224642|NCT03088878|527339965|FG013|Overall Study|Disease Progression|1|||
146224643|NCT03088878|527339952|FG000|Overall Study|Initiation of Alternative Treatment|0|||
146224644|NCT03088878|527339953|FG001|Overall Study|Initiation of Alternative Treatment|0|||
146224645|NCT03088878|527339954|FG002|Overall Study|Initiation of Alternative Treatment|0|||
146224646|NCT03088878|527339955|FG003|Overall Study|Initiation of Alternative Treatment|1|||
146224647|NCT03088878|527339956|FG004|Overall Study|Initiation of Alternative Treatment|0|||
146224648|NCT03088878|527339957|FG005|Overall Study|Initiation of Alternative Treatment|0|||
146224649|NCT03088878|527339958|FG006|Overall Study|Initiation of Alternative Treatment|0|||
146224650|NCT03088878|527339959|FG007|Overall Study|Initiation of Alternative Treatment|1|||
146224651|NCT03088878|527339960|FG008|Overall Study|Initiation of Alternative Treatment|1|||
146224652|NCT03088878|527339961|FG009|Overall Study|Initiation of Alternative Treatment|0|||
146224653|NCT03088878|527339962|FG010|Overall Study|Initiation of Alternative Treatment|0|||
146224654|NCT03088878|527339963|FG011|Overall Study|Initiation of Alternative Treatment|0|||
146224655|NCT03088878|527339964|FG012|Overall Study|Initiation of Alternative Treatment|0|||
146224656|NCT03088878|527339965|FG013|Overall Study|Initiation of Alternative Treatment|0|||
146224657|NCT03088878|527339952|FG000|Overall Study|Withdrawal by Subject|0|||
146224658|NCT03088878|527339953|FG001|Overall Study|Withdrawal by Subject|0|||
146224659|NCT03088878|527339954|FG002|Overall Study|Withdrawal by Subject|0|||
146224660|NCT03088878|527339955|FG003|Overall Study|Withdrawal by Subject|1|||
146224661|NCT03088878|527339956|FG004|Overall Study|Withdrawal by Subject|4|||
146224662|NCT03088878|527339957|FG005|Overall Study|Withdrawal by Subject|1|||
146224663|NCT03088878|527339958|FG006|Overall Study|Withdrawal by Subject|1|||
146224664|NCT03088878|527339959|FG007|Overall Study|Withdrawal by Subject|0|||
146224665|NCT03088878|527339960|FG008|Overall Study|Withdrawal by Subject|1|||
146224666|NCT03088878|527339961|FG009|Overall Study|Withdrawal by Subject|2|||
146224667|NCT03088878|527339962|FG010|Overall Study|Withdrawal by Subject|0|||
146224668|NCT03088878|527339963|FG011|Overall Study|Withdrawal by Subject|2|||
146224669|NCT03088878|527339964|FG012|Overall Study|Withdrawal by Subject|1|||
146224670|NCT03088878|527339965|FG013|Overall Study|Withdrawal by Subject|0|||
146224671|NCT03088878|527339952|FG000|Overall Study|Terminated by Sponsor|2|||
146224672|NCT03088878|527339953|FG001|Overall Study|Terminated by Sponsor|1|||
146224673|NCT03088878|527339954|FG002|Overall Study|Terminated by Sponsor|0|||
146224674|NCT03088878|527339955|FG003|Overall Study|Terminated by Sponsor|1|||
146224675|NCT03088878|527339956|FG004|Overall Study|Terminated by Sponsor|6|||
146224676|NCT03088878|527339957|FG005|Overall Study|Terminated by Sponsor|0|||
146224677|NCT03088878|527339958|FG006|Overall Study|Terminated by Sponsor|0|||
146224678|NCT03088878|527339959|FG007|Overall Study|Terminated by Sponsor|0|||
146224679|NCT03088878|527339960|FG008|Overall Study|Terminated by Sponsor|0|||
146224680|NCT03088878|527339961|FG009|Overall Study|Terminated by Sponsor|0|||
146224681|NCT03088878|527339962|FG010|Overall Study|Terminated by Sponsor|3|||
146224682|NCT03088878|527339963|FG011|Overall Study|Terminated by Sponsor|13|||
146224683|NCT03088878|527339964|FG012|Overall Study|Terminated by Sponsor|2|||
146224684|NCT03088878|527339965|FG013|Overall Study|Terminated by Sponsor|1|||
146224685|NCT03088878|527339952|FG000|Overall Study|Completed 2 years of Treatment|0|||
146224686|NCT03088878|527339953|FG001|Overall Study|Completed 2 years of Treatment|0|||
146224687|NCT03088878|527339954|FG002|Overall Study|Completed 2 years of Treatment|0|||
146224688|NCT03088878|527339955|FG003|Overall Study|Completed 2 years of Treatment|0|||
146224689|NCT03088878|527339956|FG004|Overall Study|Completed 2 years of Treatment|0|||
146224690|NCT03088878|527339957|FG005|Overall Study|Completed 2 years of Treatment|0|||
146224691|NCT03088878|527339958|FG006|Overall Study|Completed 2 years of Treatment|1|||
146224692|NCT03088878|527339959|FG007|Overall Study|Completed 2 years of Treatment|0|||
146224693|NCT03088878|527339960|FG008|Overall Study|Completed 2 years of Treatment|0|||
146224694|NCT03088878|527339961|FG009|Overall Study|Completed 2 years of Treatment|1|||
146224695|NCT03088878|527339962|FG010|Overall Study|Completed 2 years of Treatment|0|||
146224696|NCT03088878|527339963|FG011|Overall Study|Completed 2 years of Treatment|0|||
146224697|NCT03088878|527339964|FG012|Overall Study|Completed 2 years of Treatment|8|||
146224698|NCT03088878|527339965|FG013|Overall Study|Completed 2 years of Treatment|3|||
146224699|NCT03088878|527339952|FG000|Overall Study|Physician Decision|0|||
146224700|NCT03088878|527339953|FG001|Overall Study|Physician Decision|0|||
146224701|NCT03088878|527339954|FG002|Overall Study|Physician Decision|0|||
146224702|NCT03088878|527339955|FG003|Overall Study|Physician Decision|0|||
146224703|NCT03088878|527339956|FG004|Overall Study|Physician Decision|0|||
146224704|NCT03088878|527339957|FG005|Overall Study|Physician Decision|0|||
146224705|NCT03088878|527339958|FG006|Overall Study|Physician Decision|0|||
146224706|NCT03088878|527339959|FG007|Overall Study|Physician Decision|2|||
146224707|NCT03088878|527339960|FG008|Overall Study|Physician Decision|1|||
146224708|NCT03088878|527339961|FG009|Overall Study|Physician Decision|0|||
146224709|NCT03088878|527339962|FG010|Overall Study|Physician Decision|0|||
146224710|NCT03088878|527339963|FG011|Overall Study|Physician Decision|0|||
146224711|NCT03088878|527339964|FG012|Overall Study|Physician Decision|0|||
146224712|NCT03088878|527339965|FG013|Overall Study|Physician Decision|1|||
146224713|NCT03088878|527339952|FG000|Overall Study|COVID Related noncompliance|0|||
146224714|NCT03088878|527339953|FG001|Overall Study|COVID Related noncompliance|0|||
146224715|NCT03088878|527339954|FG002|Overall Study|COVID Related noncompliance|0|||
146224716|NCT03088878|527339955|FG003|Overall Study|COVID Related noncompliance|0|||
146224717|NCT03088878|527339956|FG004|Overall Study|COVID Related noncompliance|0|||
146224718|NCT03088878|527339957|FG005|Overall Study|COVID Related noncompliance|0|||
146224719|NCT03088878|527339958|FG006|Overall Study|COVID Related noncompliance|0|||
146224720|NCT03088878|527339959|FG007|Overall Study|COVID Related noncompliance|0|||
146224721|NCT03088878|527339960|FG008|Overall Study|COVID Related noncompliance|0|||
146224722|NCT03088878|527339961|FG009|Overall Study|COVID Related noncompliance|0|||
146224723|NCT03088878|527339962|FG010|Overall Study|COVID Related noncompliance|0|||
146224724|NCT03088878|527339963|FG011|Overall Study|COVID Related noncompliance|0|||
146224725|NCT03088878|527339964|FG012|Overall Study|COVID Related noncompliance|0|||
146224726|NCT03088878|527339965|FG013|Overall Study|COVID Related noncompliance|1|||
146224727|NCT03088878|527339952|FG000|Overall Study|Drug or Study Noncompliance|0|||
146224728|NCT03088878|527339953|FG001|Overall Study|Drug or Study Noncompliance|0|||
146224729|NCT03088878|527339954|FG002|Overall Study|Drug or Study Noncompliance|0|||
146224730|NCT03088878|527339955|FG003|Overall Study|Drug or Study Noncompliance|0|||
146224731|NCT03088878|527339956|FG004|Overall Study|Drug or Study Noncompliance|0|||
146224732|NCT03088878|527339957|FG005|Overall Study|Drug or Study Noncompliance|0|||
146224733|NCT03088878|527339958|FG006|Overall Study|Drug or Study Noncompliance|0|||
146224734|NCT03088878|527339959|FG007|Overall Study|Drug or Study Noncompliance|0|||
146224735|NCT03088878|527339960|FG008|Overall Study|Drug or Study Noncompliance|0|||
146224736|NCT03088878|527339961|FG009|Overall Study|Drug or Study Noncompliance|0|||
146224737|NCT03088878|527339962|FG010|Overall Study|Drug or Study Noncompliance|0|||
146224738|NCT03088878|527339963|FG011|Overall Study|Drug or Study Noncompliance|0|||
146224739|NCT03088878|527339964|FG012|Overall Study|Drug or Study Noncompliance|1|||
146224740|NCT03088878|527339965|FG013|Overall Study|Drug or Study Noncompliance|0|||
146224741|NCT02724969|527339966|FG000|Overall Study|Lost to Follow-up|12|||
146224742|NCT02724969|527339967|FG001|Overall Study|Lost to Follow-up|6|||
145883455|NCT00108082|526078454|FG002|Overall Study|Non-compliance|2|||
145883456|NCT00108082|526078452|FG000|Overall Study|Stopped Study Medication|0|||
145883457|NCT00108082|526078453|FG001|Overall Study|Stopped Study Medication|0|||
145883458|NCT00108082|526078454|FG002|Overall Study|Stopped Study Medication|1|||
145883459|NCT00108082|526078452|FG000|Overall Study|Site Closed Study|0|||
145883460|NCT00108082|526078453|FG001|Overall Study|Site Closed Study|2|||
146224743|NCT02724969|527339966|FG000|Overall Study|Withdrawal by Subject|3|||
146224744|NCT02724969|527339967|FG001|Overall Study|Withdrawal by Subject|3|||
146224745|NCT02724969|527339966|FG000|Overall Study|Infant demise|0|||
146224746|NCT02724969|527339967|FG001|Overall Study|Infant demise|2|||
146224747|NCT03362476|527339968|FG000|Overall Study|Withdrawal by Subject|0|||
146224748|NCT03362476|527339969|FG001|Overall Study|Withdrawal by Subject|1|||
145883461|NCT00108082|526078454|FG002|Overall Study|Site Closed Study|0|||
146224749|NCT01236781|527339970|FG000|Overall Study|Ineligible|2|||
145883462|NCT00108082|526078452|FG000|Overall Study|Protocol Amendment|0|||
146224750|NCT01236781|527339971|FG001|Overall Study|Ineligible|1|||
146224751|NCT01236781|527339970|FG000|Overall Study|Did not complete study imaging|5|||
146224752|NCT01236781|527339971|FG001|Overall Study|Did not complete study imaging|0|||
146224753|NCT04577963|527339972|FG000|Part 2|Death|0|||
146224754|NCT04577963|527339973|FG001|Part 2|Death|1|||
146224755|NCT04577963|527339974|FG002|Part 2|Death|8|||
146224756|NCT04577963|527339975|FG003|Part 2|Death|0|||
146224757|NCT04577963|527339976|FG004|Part 2|Death|20|||
146224758|NCT04577963|527339972|FG000|Part 2|Lost to Follow-up|0|||
146224759|NCT04577963|527339973|FG001|Part 2|Lost to Follow-up|0|||
146224760|NCT04577963|527339974|FG002|Part 2|Lost to Follow-up|0|||
146224761|NCT04577963|527339975|FG003|Part 2|Lost to Follow-up|0|||
146224762|NCT04577963|527339976|FG004|Part 2|Lost to Follow-up|2|||
146224763|NCT04577963|527339972|FG000|Part 2|Withdrawal by Subject|0|||
146224764|NCT04577963|527339973|FG001|Part 2|Withdrawal by Subject|0|||
146224765|NCT04577963|527339974|FG002|Part 2|Withdrawal by Subject|0|||
146224766|NCT04577963|527339975|FG003|Part 2|Withdrawal by Subject|0|||
146224767|NCT04577963|527339976|FG004|Part 2|Withdrawal by Subject|10|||
146224768|NCT04577963|527339972|FG000|Part 2|Progressive disease|0|||
146224769|NCT04577963|527339973|FG001|Part 2|Progressive disease|0|||
146224770|NCT04577963|527339974|FG002|Part 2|Progressive disease|0|||
146224771|NCT04577963|527339975|FG003|Part 2|Progressive disease|0|||
146224772|NCT04577963|527339976|FG004|Part 2|Progressive disease|2|||
146224773|NCT04577963|527339972|FG000|Part 2|Investigator decision|0|||
146224774|NCT04577963|527339973|FG001|Part 2|Investigator decision|0|||
146224775|NCT04577963|527339974|FG002|Part 2|Investigator decision|0|||
146224776|NCT04577963|527339975|FG003|Part 2|Investigator decision|0|||
146224777|NCT04577963|527339976|FG004|Part 2|Investigator decision|1|||
146224778|NCT04577963|527339972|FG000|Part 2|Sponsor terminated study|0|||
146224779|NCT04577963|527339973|FG001|Part 2|Sponsor terminated study|0|||
146224780|NCT04577963|527339974|FG002|Part 2|Sponsor terminated study|3|||
146224781|NCT04577963|527339975|FG003|Part 2|Sponsor terminated study|1|||
146224782|NCT04577963|527339976|FG004|Part 2|Sponsor terminated study|4|||
146224783|NCT02709161|527339977|FG000|Overall Study|Withdrawal by Subject|1|||
146224784|NCT02709161|527339978|FG001|Overall Study|Withdrawal by Subject|0|||
146224785|NCT05167864|527339981|FG000|Overall Study|Lost to Follow-up|7|||
146224786|NCT05167864|527339982|FG001|Overall Study|Lost to Follow-up|6|||
146224787|NCT05167864|527339983|FG002|Overall Study|Lost to Follow-up|7|||
146224788|NCT05167864|527339984|FG003|Overall Study|Lost to Follow-up|9|||
146224789|NCT04059185|527339987|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
146224790|NCT04059185|527339988|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
146224791|NCT04059185|527339989|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
146224792|NCT04059185|527339987|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
146224793|NCT04059185|527339988|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
146224794|NCT04059185|527339989|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
146224795|NCT04059185|527339987|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
146224796|NCT04059185|527339988|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
146224797|NCT04059185|527339989|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
146224798|NCT04059185|527339987|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
146224799|NCT04059185|527339988|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
146224800|NCT04059185|527339989|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
146224801|NCT04059185|527339987|FG000|Longitudinal Assessment-Adults Only|Death|4|||
146224802|NCT04059185|527339988|FG001|Longitudinal Assessment-Adults Only|Death|4|||
146224803|NCT04059185|527339989|FG002|Longitudinal Assessment-Adults Only|Death|3|||
146224804|NCT04587453|527339997|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
146224805|NCT04587453|527339998|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
146224806|NCT05309291|527340009|FG000|Overall Study|Adverse Event|0|||
145883463|NCT00108082|526078453|FG001|Overall Study|Protocol Amendment|1|||
146224807|NCT05309291|527340010|FG001|Overall Study|Adverse Event|1|||
146224808|NCT05209152|527340011|FG000|Overall Study|Sponsor decision|1|||
146224809|NCT05209152|527340012|FG001|Overall Study|Sponsor decision|2|||
146224810|NCT05209152|527340011|FG000|Overall Study|Death|3|||
146224811|NCT05209152|527340012|FG001|Overall Study|Death|1|||
146224812|NCT03221426|527340013|FG000|Overall Study|Ongoing in study|212|||
146224813|NCT03221426|527340014|FG001|Overall Study|Ongoing in study|193|||
146224814|NCT03221426|527340015|FG002|Overall Study|Ongoing in study|61|||
146224815|NCT03221426|527340016|FG003|Overall Study|Ongoing in study|55|||
146224816|NCT03221426|527340013|FG000|Overall Study|Withdrawal by Subject|12|||
146224817|NCT03221426|527340014|FG001|Overall Study|Withdrawal by Subject|4|||
146224818|NCT03221426|527340015|FG002|Overall Study|Withdrawal by Subject|2|||
146224819|NCT03221426|527340016|FG003|Overall Study|Withdrawal by Subject|3|||
145883464|NCT00108082|526078454|FG002|Overall Study|Protocol Amendment|0|||
146224820|NCT03221426|527340013|FG000|Overall Study|Lost to Follow-up|4|||
146224821|NCT03221426|527340014|FG001|Overall Study|Lost to Follow-up|1|||
146224822|NCT03221426|527340015|FG002|Overall Study|Lost to Follow-up|1|||
146224823|NCT03221426|527340016|FG003|Overall Study|Lost to Follow-up|0|||
146224824|NCT03221426|527340013|FG000|Overall Study|Death|174|||
146224825|NCT03221426|527340014|FG001|Overall Study|Death|204|||
146224826|NCT03221426|527340015|FG002|Overall Study|Death|36|||
146224827|NCT03221426|527340016|FG003|Overall Study|Death|45|||
146224828|NCT03663569|527341386|FG000|Overall Study|Discontinuation of study|11|||
146224829|NCT03663569|527341386|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
146224830|NCT03663569|527341386|FG000|Overall Study|Deceased patient|6|||
146224831|NCT03663569|527341386|FG000|Overall Study|Lost to Follow-up|18|||
146224832|NCT03663569|527341386|FG000|Overall Study|Withdrawal of consent|5|||
146224833|NCT03663569|527341386|FG000|Overall Study|Patient's request|11|||
146224834|NCT03663569|527341386|FG000|Overall Study|Adverse Event|4|||
146224835|NCT03663569|527341386|FG000|Overall Study|Not come to second visit|3|||
146224836|NCT03663569|527341386|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
146224837|NCT03663569|527341386|FG000|Overall Study|Serious adverse event|1|||
146224838|NCT03766685|527341387|FG000|Overall Study|Lost to Follow-up|1|||
146224839|NCT03766685|527341388|FG001|Overall Study|Lost to Follow-up|1|||
146224840|NCT03766685|527341389|FG002|Overall Study|Lost to Follow-up|0|||
146224841|NCT03766685|527341390|FG003|Overall Study|Lost to Follow-up|0|||
146224842|NCT03766685|527341387|FG000|Overall Study|Adverse Event, not fatal|0|||
146224843|NCT03766685|527341388|FG001|Overall Study|Adverse Event, not fatal|1|||
146224844|NCT03766685|527341389|FG002|Overall Study|Adverse Event, not fatal|0|||
146224845|NCT03766685|527341390|FG003|Overall Study|Adverse Event, not fatal|1|||
146224846|NCT03766685|527341387|FG000|Overall Study|Withdrawal by Subject|0|||
146224847|NCT03766685|527341388|FG001|Overall Study|Withdrawal by Subject|2|||
146224848|NCT03766685|527341389|FG002|Overall Study|Withdrawal by Subject|0|||
146224849|NCT03766685|527341390|FG003|Overall Study|Withdrawal by Subject|0|||
146224850|NCT03766685|527341387|FG000|Overall Study|Protocol Violation|0|||
146224851|NCT03766685|527341388|FG001|Overall Study|Protocol Violation|1|||
146224852|NCT03766685|527341389|FG002|Overall Study|Protocol Violation|0|||
146224853|NCT03766685|527341390|FG003|Overall Study|Protocol Violation|0|||
146224854|NCT03766685|527341387|FG000|Overall Study|Non-compliance|0|||
146224855|NCT03766685|527341388|FG001|Overall Study|Non-compliance|2|||
146224856|NCT03766685|527341389|FG002|Overall Study|Non-compliance|0|||
146224857|NCT03766685|527341390|FG003|Overall Study|Non-compliance|0|||
146224858|NCT02116530|527341391|FG000|Overall Study|Withdrawal by Subject|1|||
146224859|NCT02116530|527341392|FG001|Overall Study|Withdrawal by Subject|2|||
146224860|NCT02116530|527341391|FG000|Overall Study|Adverse Event|4|||
146224861|NCT02116530|527341392|FG001|Overall Study|Adverse Event|0|||
146224862|NCT02116530|527341391|FG000|Overall Study|Physician Decision|1|||
146224863|NCT02116530|527341392|FG001|Overall Study|Physician Decision|0|||
146224864|NCT02116530|527341391|FG000|Overall Study|Lost to Follow-up|1|||
146224865|NCT02116530|527341392|FG001|Overall Study|Lost to Follow-up|0|||
146224866|NCT02116530|527341391|FG000|Overall Study|Other Medical Problems|2|||
146224867|NCT02116530|527341392|FG001|Overall Study|Other Medical Problems|2|||
146224868|NCT02927236|527341395|FG000|Characterization Phase|Physician Decision|0|||
146224869|NCT02927236|527341396|FG001|Characterization Phase|Physician Decision|3|||
146224870|NCT02927236|527341397|FG002|Characterization Phase|Physician Decision|0|||
146224871|NCT02927236|527341398|FG003|Characterization Phase|Physician Decision|2|||
146224872|NCT02927236|527341395|FG000|Characterization Phase|Lost to Follow-up|0|||
146224873|NCT02927236|527341396|FG001|Characterization Phase|Lost to Follow-up|0|||
146224874|NCT02927236|527341397|FG002|Characterization Phase|Lost to Follow-up|0|||
146224875|NCT02927236|527341398|FG003|Characterization Phase|Lost to Follow-up|3|||
146224876|NCT02927236|527341395|FG000|Characterization Phase|Withdrawal by Subject|1|||
146224877|NCT02927236|527341396|FG001|Characterization Phase|Withdrawal by Subject|0|||
146224878|NCT02927236|527341397|FG002|Characterization Phase|Withdrawal by Subject|0|||
146224879|NCT02927236|527341398|FG003|Characterization Phase|Withdrawal by Subject|1|||
146224880|NCT02927236|527341395|FG000|Treatment Phase|Adverse Event|1|||
146224881|NCT02927236|527341396|FG001|Treatment Phase|Adverse Event|0|||
146224882|NCT02927236|527341397|FG002|Treatment Phase|Adverse Event|1|||
146224883|NCT02927236|527341398|FG003|Treatment Phase|Adverse Event|1|||
146224884|NCT02927236|527341395|FG000|Treatment Phase|Protocol Violation|3|||
146224885|NCT02927236|527341396|FG001|Treatment Phase|Protocol Violation|0|||
146224886|NCT02927236|527341397|FG002|Treatment Phase|Protocol Violation|0|||
146224887|NCT02927236|527341398|FG003|Treatment Phase|Protocol Violation|1|||
146224888|NCT02927236|527341395|FG000|Treatment Phase|Lost to Follow-up|1|||
146224889|NCT02927236|527341396|FG001|Treatment Phase|Lost to Follow-up|0|||
146224890|NCT02927236|527341397|FG002|Treatment Phase|Lost to Follow-up|0|||
146224891|NCT02927236|527341398|FG003|Treatment Phase|Lost to Follow-up|0|||
146224892|NCT02927236|527341395|FG000|Follow-up Phase|Lost to Follow-up|1|||
146224893|NCT02927236|527341396|FG001|Follow-up Phase|Lost to Follow-up|0|||
146224894|NCT02927236|527341397|FG002|Follow-up Phase|Lost to Follow-up|1|||
146224895|NCT02927236|527341398|FG003|Follow-up Phase|Lost to Follow-up|0|||
146224896|NCT05029622|527341399|FG000|Overall Study|Lost to Follow-up|1|||
146224897|NCT04770402|527341404|FG000|Overall Study|Lost to Follow-up|1|||
146224898|NCT04770402|527341405|FG001|Overall Study|Lost to Follow-up|2|||
146224899|NCT04770402|527341404|FG000|Overall Study|Non-compliance|1|||
146224900|NCT04770402|527341405|FG001|Overall Study|Non-compliance|0|||
146224901|NCT04770402|527341404|FG000|Overall Study|Withdrawal by Subject|0|||
146224902|NCT04770402|527341405|FG001|Overall Study|Withdrawal by Subject|1|||
146224903|NCT04117347|527341408|FG000|Overall Study|Adverse Event|0|||
146224904|NCT04117347|527341409|FG001|Overall Study|Adverse Event|0|||
146224905|NCT04117347|527341410|FG002|Overall Study|Adverse Event|1|||
146224906|NCT04117347|527341408|FG000|Overall Study|No time for study|0|||
146224907|NCT04117347|527341409|FG001|Overall Study|No time for study|2|||
146224908|NCT04117347|527341410|FG002|Overall Study|No time for study|0|||
146224909|NCT04117347|527341408|FG000|Overall Study|Family emergency|1|||
146224910|NCT04117347|527341409|FG001|Overall Study|Family emergency|0|||
146224911|NCT04117347|527341410|FG002|Overall Study|Family emergency|0|||
146224912|NCT05194956|527341411|FG000|Washout Period|Withdrawal by Subject|0|||
146224913|NCT05194956|527341412|FG001|Washout Period|Withdrawal by Subject|2|||
146224914|NCT03687086|527341413|FG000|Overall Study|Withdrawal by Subject|3|||
146224915|NCT03687086|527341414|FG001|Overall Study|Withdrawal by Subject|4|||
146224916|NCT03687086|527341413|FG000|Overall Study|Lost to Follow-up|1|||
146224917|NCT03687086|527341414|FG001|Overall Study|Lost to Follow-up|1|||
146224918|NCT03687086|527341413|FG000|Overall Study|Death|1|||
146224919|NCT03687086|527341414|FG001|Overall Study|Death|0|||
146224920|NCT03687086|527341413|FG000|Overall Study|Incomplete assessment|0|||
146224921|NCT03687086|527341414|FG001|Overall Study|Incomplete assessment|2|||
146224922|NCT02505984|527341415|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
146224923|NCT02505984|527341416|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
146224924|NCT02505984|527341415|FG000|Overall Study|Unreliable self-report data|1|||
146224925|NCT02505984|527341416|FG001|Overall Study|Unreliable self-report data|0|||
146224926|NCT02505984|527341415|FG000|Overall Study|Study blind opened during assessment|0|||
146224927|NCT02505984|527341416|FG001|Overall Study|Study blind opened during assessment|1|||
146224928|NCT02505984|527341415|FG000|Overall Study|Noncompliance with study protocol|0|||
146224929|NCT02505984|527341416|FG001|Overall Study|Noncompliance with study protocol|1|||
146224930|NCT02593773|527341427|FG000|Overall Study|Voluntary Withdrawal|3|||
146224931|NCT02593773|527341427|FG000|Overall Study|Study Terminated by Sponsor|31|||
146224932|NCT02593773|527341427|FG000|Overall Study|Death|1|||
146224933|NCT01928394|527341434|FG000|Treatment Period|Disease progression|17|||
146224934|NCT01928394|527341435|FG001|Treatment Period|Disease progression|2|||
146224935|NCT01928394|527341436|FG002|Treatment Period|Disease progression|12|||
146224936|NCT01928394|527341437|FG003|Treatment Period|Disease progression|48|||
146224937|NCT01928394|527341438|FG004|Treatment Period|Disease progression|3|||
146224938|NCT01928394|527341439|FG005|Treatment Period|Disease progression|25|||
146224939|NCT01928394|527341440|FG006|Treatment Period|Disease progression|38|||
146224940|NCT01928394|527341441|FG007|Treatment Period|Disease progression|16|||
146224941|NCT01928394|527341442|FG008|Treatment Period|Disease progression|3|||
146224942|NCT01928394|527341443|FG009|Treatment Period|Disease progression|11|||
146224943|NCT01928394|527341444|FG010|Treatment Period|Disease progression|22|||
146224944|NCT01928394|527341445|FG011|Treatment Period|Disease progression|73|||
146224945|NCT01928394|527341446|FG012|Treatment Period|Disease progression|38|||
146224946|NCT01928394|527341447|FG013|Treatment Period|Disease progression|118|||
146224947|NCT01928394|527341448|FG014|Treatment Period|Disease progression|59|||
146224948|NCT01928394|527341449|FG015|Treatment Period|Disease progression|1|||
146224949|NCT01928394|527341450|FG016|Treatment Period|Disease progression|43|||
146224950|NCT01928394|527341451|FG017|Treatment Period|Disease progression|56|||
146224951|NCT01928394|527341452|FG018|Treatment Period|Disease progression|50|||
146224952|NCT01928394|527341453|FG019|Treatment Period|Disease progression|71|||
146224953|NCT01928394|527341454|FG020|Treatment Period|Disease progression|30|||
146224954|NCT01928394|527341455|FG021|Treatment Period|Disease progression|31|||
146224955|NCT01928394|527341456|FG022|Treatment Period|Disease progression|31|||
146224956|NCT01928394|527341434|FG000|Treatment Period|Study drug toxicity|1|||
146224957|NCT01928394|527341435|FG001|Treatment Period|Study drug toxicity|1|||
146224958|NCT01928394|527341436|FG002|Treatment Period|Study drug toxicity|3|||
146224959|NCT01928394|527341437|FG003|Treatment Period|Study drug toxicity|3|||
146224960|NCT01928394|527341438|FG004|Treatment Period|Study drug toxicity|0|||
146224961|NCT01928394|527341439|FG005|Treatment Period|Study drug toxicity|9|||
146224962|NCT01928394|527341440|FG006|Treatment Period|Study drug toxicity|7|||
146224963|NCT01928394|527341441|FG007|Treatment Period|Study drug toxicity|1|||
146224964|NCT01928394|527341442|FG008|Treatment Period|Study drug toxicity|0|||
146224965|NCT01928394|527341443|FG009|Treatment Period|Study drug toxicity|5|||
146224966|NCT01928394|527341444|FG010|Treatment Period|Study drug toxicity|2|||
146224967|NCT01928394|527341445|FG011|Treatment Period|Study drug toxicity|3|||
146224968|NCT01928394|527341446|FG012|Treatment Period|Study drug toxicity|7|||
146224969|NCT01928394|527341447|FG013|Treatment Period|Study drug toxicity|5|||
146224970|NCT01928394|527341448|FG014|Treatment Period|Study drug toxicity|12|||
146224971|NCT01928394|527341449|FG015|Treatment Period|Study drug toxicity|0|||
146224972|NCT01928394|527341450|FG016|Treatment Period|Study drug toxicity|3|||
146224973|NCT01928394|527341451|FG017|Treatment Period|Study drug toxicity|3|||
146224974|NCT01928394|527341452|FG018|Treatment Period|Study drug toxicity|12|||
146224975|NCT01928394|527341453|FG019|Treatment Period|Study drug toxicity|15|||
146224976|NCT01928394|527341454|FG020|Treatment Period|Study drug toxicity|4|||
146224977|NCT01928394|527341455|FG021|Treatment Period|Study drug toxicity|7|||
146224978|NCT01928394|527341456|FG022|Treatment Period|Study drug toxicity|4|||
146224979|NCT01928394|527341434|FG000|Treatment Period|AE unrelated to study drug|0|||
146224980|NCT01928394|527341435|FG001|Treatment Period|AE unrelated to study drug|0|||
146224981|NCT01928394|527341436|FG002|Treatment Period|AE unrelated to study drug|2|||
146224982|NCT01928394|527341437|FG003|Treatment Period|AE unrelated to study drug|3|||
146224983|NCT01928394|527341438|FG004|Treatment Period|AE unrelated to study drug|0|||
146224984|NCT01928394|527341439|FG005|Treatment Period|AE unrelated to study drug|5|||
146224985|NCT01928394|527341440|FG006|Treatment Period|AE unrelated to study drug|1|||
146224986|NCT01928394|527341441|FG007|Treatment Period|AE unrelated to study drug|0|||
146224987|NCT01928394|527341442|FG008|Treatment Period|AE unrelated to study drug|0|||
146224988|NCT01928394|527341443|FG009|Treatment Period|AE unrelated to study drug|2|||
146224989|NCT01928394|527341444|FG010|Treatment Period|AE unrelated to study drug|0|||
146224990|NCT01928394|527341445|FG011|Treatment Period|AE unrelated to study drug|12|||
146224991|NCT01928394|527341446|FG012|Treatment Period|AE unrelated to study drug|6|||
146224992|NCT01928394|527341447|FG013|Treatment Period|AE unrelated to study drug|13|||
146224993|NCT01928394|527341448|FG014|Treatment Period|AE unrelated to study drug|6|||
146224994|NCT01928394|527341449|FG015|Treatment Period|AE unrelated to study drug|1|||
146224995|NCT01928394|527341450|FG016|Treatment Period|AE unrelated to study drug|1|||
146224996|NCT01928394|527341451|FG017|Treatment Period|AE unrelated to study drug|6|||
146224997|NCT01928394|527341452|FG018|Treatment Period|AE unrelated to study drug|3|||
146224998|NCT01928394|527341453|FG019|Treatment Period|AE unrelated to study drug|5|||
146224999|NCT01928394|527341454|FG020|Treatment Period|AE unrelated to study drug|1|||
146225000|NCT01928394|527341455|FG021|Treatment Period|AE unrelated to study drug|1|||
146225001|NCT01928394|527341456|FG022|Treatment Period|AE unrelated to study drug|0|||
146225002|NCT01928394|527341434|FG000|Treatment Period|Participant request to stop therapy|0|||
146225003|NCT01928394|527341435|FG001|Treatment Period|Participant request to stop therapy|0|||
146225004|NCT01928394|527341436|FG002|Treatment Period|Participant request to stop therapy|0|||
146225005|NCT01928394|527341437|FG003|Treatment Period|Participant request to stop therapy|0|||
146225006|NCT01928394|527341438|FG004|Treatment Period|Participant request to stop therapy|0|||
146225007|NCT01928394|527341439|FG005|Treatment Period|Participant request to stop therapy|3|||
146225008|NCT01928394|527341440|FG006|Treatment Period|Participant request to stop therapy|3|||
146225009|NCT01928394|527341441|FG007|Treatment Period|Participant request to stop therapy|0|||
146225010|NCT01928394|527341442|FG008|Treatment Period|Participant request to stop therapy|0|||
146225011|NCT01928394|527341443|FG009|Treatment Period|Participant request to stop therapy|0|||
146225012|NCT01928394|527341444|FG010|Treatment Period|Participant request to stop therapy|3|||
146289000|NCT03401229|527573309|FG001|Overall Study|Lost to Follow-up|1|||
146289001|NCT03401229|527573308|FG000|Overall Study|Other|1|||
146225013|NCT01928394|527341445|FG011|Treatment Period|Participant request to stop therapy|2|||
146225014|NCT01928394|527341446|FG012|Treatment Period|Participant request to stop therapy|1|||
146225015|NCT01928394|527341447|FG013|Treatment Period|Participant request to stop therapy|2|||
146289002|NCT03401229|527573309|FG001|Overall Study|Other|3|||
146225016|NCT01928394|527341448|FG014|Treatment Period|Participant request to stop therapy|4|||
146225017|NCT01928394|527341449|FG015|Treatment Period|Participant request to stop therapy|0|||
146225018|NCT01928394|527341450|FG016|Treatment Period|Participant request to stop therapy|1|||
146225019|NCT01928394|527341451|FG017|Treatment Period|Participant request to stop therapy|3|||
146225020|NCT01928394|527341452|FG018|Treatment Period|Participant request to stop therapy|1|||
146225021|NCT01928394|527341453|FG019|Treatment Period|Participant request to stop therapy|1|||
146225022|NCT01928394|527341454|FG020|Treatment Period|Participant request to stop therapy|3|||
146225023|NCT01928394|527341455|FG021|Treatment Period|Participant request to stop therapy|1|||
146225024|NCT01928394|527341456|FG022|Treatment Period|Participant request to stop therapy|3|||
146225025|NCT01928394|527341434|FG000|Treatment Period|Participant withdrew consent|0|||
146225026|NCT01928394|527341435|FG001|Treatment Period|Participant withdrew consent|0|||
146225027|NCT01928394|527341436|FG002|Treatment Period|Participant withdrew consent|1|||
146225028|NCT01928394|527341437|FG003|Treatment Period|Participant withdrew consent|1|||
146225029|NCT01928394|527341438|FG004|Treatment Period|Participant withdrew consent|0|||
146225030|NCT01928394|527341439|FG005|Treatment Period|Participant withdrew consent|1|||
146225031|NCT01928394|527341440|FG006|Treatment Period|Participant withdrew consent|0|||
146225032|NCT01928394|527341441|FG007|Treatment Period|Participant withdrew consent|1|||
146225033|NCT01928394|527341442|FG008|Treatment Period|Participant withdrew consent|0|||
146225034|NCT01928394|527341443|FG009|Treatment Period|Participant withdrew consent|0|||
146225035|NCT01928394|527341444|FG010|Treatment Period|Participant withdrew consent|1|||
146225036|NCT01928394|527341445|FG011|Treatment Period|Participant withdrew consent|1|||
146225037|NCT01928394|527341446|FG012|Treatment Period|Participant withdrew consent|1|||
146225038|NCT01928394|527341447|FG013|Treatment Period|Participant withdrew consent|0|||
146225039|NCT01928394|527341448|FG014|Treatment Period|Participant withdrew consent|2|||
146225040|NCT01928394|527341449|FG015|Treatment Period|Participant withdrew consent|0|||
146225041|NCT01928394|527341450|FG016|Treatment Period|Participant withdrew consent|2|||
146225042|NCT01928394|527341451|FG017|Treatment Period|Participant withdrew consent|1|||
146225043|NCT01928394|527341452|FG018|Treatment Period|Participant withdrew consent|1|||
146225044|NCT01928394|527341453|FG019|Treatment Period|Participant withdrew consent|1|||
146225045|NCT01928394|527341454|FG020|Treatment Period|Participant withdrew consent|0|||
146225046|NCT01928394|527341455|FG021|Treatment Period|Participant withdrew consent|2|||
146225047|NCT01928394|527341456|FG022|Treatment Period|Participant withdrew consent|0|||
146225048|NCT01928394|527341434|FG000|Treatment Period|Poor/non-compliance|0|||
146225049|NCT01928394|527341435|FG001|Treatment Period|Poor/non-compliance|0|||
146225050|NCT01928394|527341436|FG002|Treatment Period|Poor/non-compliance|0|||
146225051|NCT01928394|527341437|FG003|Treatment Period|Poor/non-compliance|1|||
146225052|NCT01928394|527341438|FG004|Treatment Period|Poor/non-compliance|0|||
146225053|NCT01928394|527341439|FG005|Treatment Period|Poor/non-compliance|0|||
146225054|NCT01928394|527341440|FG006|Treatment Period|Poor/non-compliance|0|||
146225055|NCT01928394|527341441|FG007|Treatment Period|Poor/non-compliance|0|||
146225056|NCT01928394|527341442|FG008|Treatment Period|Poor/non-compliance|0|||
146225057|NCT01928394|527341443|FG009|Treatment Period|Poor/non-compliance|0|||
146225058|NCT01928394|527341444|FG010|Treatment Period|Poor/non-compliance|0|||
146225059|NCT01928394|527341445|FG011|Treatment Period|Poor/non-compliance|0|||
146225060|NCT01928394|527341446|FG012|Treatment Period|Poor/non-compliance|1|||
146225061|NCT01928394|527341447|FG013|Treatment Period|Poor/non-compliance|0|||
146225062|NCT01928394|527341448|FG014|Treatment Period|Poor/non-compliance|1|||
146225063|NCT01928394|527341449|FG015|Treatment Period|Poor/non-compliance|0|||
146225064|NCT01928394|527341450|FG016|Treatment Period|Poor/non-compliance|0|||
146225065|NCT01928394|527341451|FG017|Treatment Period|Poor/non-compliance|1|||
146225066|NCT01928394|527341452|FG018|Treatment Period|Poor/non-compliance|0|||
146225067|NCT01928394|527341453|FG019|Treatment Period|Poor/non-compliance|1|||
146225068|NCT01928394|527341454|FG020|Treatment Period|Poor/non-compliance|0|||
146225069|NCT01928394|527341455|FG021|Treatment Period|Poor/non-compliance|0|||
146225070|NCT01928394|527341456|FG022|Treatment Period|Poor/non-compliance|0|||
146225071|NCT01928394|527341434|FG000|Treatment Period|other reason|0|||
146225072|NCT01928394|527341435|FG001|Treatment Period|other reason|0|||
146225073|NCT01928394|527341436|FG002|Treatment Period|other reason|0|||
146225074|NCT01928394|527341437|FG003|Treatment Period|other reason|0|||
146225075|NCT01928394|527341438|FG004|Treatment Period|other reason|0|||
146225076|NCT01928394|527341439|FG005|Treatment Period|other reason|0|||
146225077|NCT01928394|527341440|FG006|Treatment Period|other reason|0|||
145961324|NCT02163395|526371093|FG000|Overall Study|Adverse Event|1|||
145961325|NCT01145482|526371094|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146225078|NCT01928394|527341441|FG007|Treatment Period|other reason|0|||
146225079|NCT01928394|527341442|FG008|Treatment Period|other reason|0|||
145961326|NCT01145482|526371095|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146225080|NCT01928394|527341443|FG009|Treatment Period|other reason|0|||
146225081|NCT01928394|527341444|FG010|Treatment Period|other reason|1|||
146225082|NCT01928394|527341445|FG011|Treatment Period|other reason|1|||
146225083|NCT01928394|527341446|FG012|Treatment Period|other reason|1|||
146225084|NCT01928394|527341447|FG013|Treatment Period|other reason|0|||
146225085|NCT01928394|527341448|FG014|Treatment Period|other reason|1|||
146225086|NCT01928394|527341449|FG015|Treatment Period|other reason|0|||
146225087|NCT01928394|527341450|FG016|Treatment Period|other reason|0|||
146225088|NCT01928394|527341451|FG017|Treatment Period|other reason|0|||
146225089|NCT01928394|527341452|FG018|Treatment Period|other reason|2|||
146225090|NCT01928394|527341453|FG019|Treatment Period|other reason|2|||
146225091|NCT01928394|527341454|FG020|Treatment Period|other reason|0|||
146225092|NCT01928394|527341455|FG021|Treatment Period|other reason|0|||
146225093|NCT01928394|527341456|FG022|Treatment Period|other reason|0|||
146225094|NCT01928394|527341434|FG000|Treatment Period|Maximum clinical benefit|0|||
146225095|NCT01928394|527341435|FG001|Treatment Period|Maximum clinical benefit|0|||
146225096|NCT01928394|527341436|FG002|Treatment Period|Maximum clinical benefit|0|||
146225097|NCT01928394|527341437|FG003|Treatment Period|Maximum clinical benefit|0|||
146225098|NCT01928394|527341438|FG004|Treatment Period|Maximum clinical benefit|0|||
146225099|NCT01928394|527341439|FG005|Treatment Period|Maximum clinical benefit|0|||
146225100|NCT01928394|527341440|FG006|Treatment Period|Maximum clinical benefit|0|||
146225101|NCT01928394|527341441|FG007|Treatment Period|Maximum clinical benefit|0|||
146225102|NCT01928394|527341442|FG008|Treatment Period|Maximum clinical benefit|0|||
146225103|NCT01928394|527341443|FG009|Treatment Period|Maximum clinical benefit|0|||
145883465|NCT00108082|526078452|FG000|Overall Study|Study Medication Not Tapered|0|||
145883466|NCT00108082|526078453|FG001|Overall Study|Study Medication Not Tapered|1|||
145883467|NCT00108082|526078454|FG002|Overall Study|Study Medication Not Tapered|0|||
145883468|NCT00108082|526078452|FG000|Overall Study|Subject Left Site Location|1|||
145883469|NCT00108082|526078453|FG001|Overall Study|Subject Left Site Location|0|||
145883470|NCT00108082|526078454|FG002|Overall Study|Subject Left Site Location|0|||
145883471|NCT00108082|526078452|FG000|Overall Study|Investigator Not at Site|1|||
145883472|NCT00108082|526078453|FG001|Overall Study|Investigator Not at Site|0|||
145883473|NCT00108082|526078454|FG002|Overall Study|Investigator Not at Site|0|||
145883474|NCT00108082|526078452|FG000|Overall Study|Blood Pressure Not Controlled|1|||
145883475|NCT00108082|526078453|FG001|Overall Study|Blood Pressure Not Controlled|0|||
145883476|NCT00108082|526078454|FG002|Overall Study|Blood Pressure Not Controlled|0|||
145883477|NCT02940730|526078458|FG000|Intervention 2|Physician Decision|7|||
145883478|NCT02940730|526078459|FG001|Intervention 2|Physician Decision|0|||
145883479|NCT01522950|526078460|FG000|Overall Study|Withdrawal by Subject|3|||
146225104|NCT01928394|527341444|FG010|Treatment Period|Maximum clinical benefit|1|||
146225105|NCT01928394|527341445|FG011|Treatment Period|Maximum clinical benefit|1|||
146225106|NCT01928394|527341446|FG012|Treatment Period|Maximum clinical benefit|0|||
146225107|NCT01928394|527341447|FG013|Treatment Period|Maximum clinical benefit|0|||
146225108|NCT01928394|527341448|FG014|Treatment Period|Maximum clinical benefit|1|||
146289003|NCT03401229|527573308|FG000|Overall Study|Adverse Event|8|||
146225109|NCT01928394|527341449|FG015|Treatment Period|Maximum clinical benefit|0|||
146225110|NCT01928394|527341450|FG016|Treatment Period|Maximum clinical benefit|0|||
146225111|NCT01928394|527341451|FG017|Treatment Period|Maximum clinical benefit|1|||
146225112|NCT01928394|527341452|FG018|Treatment Period|Maximum clinical benefit|1|||
146225113|NCT01928394|527341453|FG019|Treatment Period|Maximum clinical benefit|0|||
145883480|NCT01522950|526078461|FG001|Overall Study|Withdrawal by Subject|2|||
146225114|NCT01928394|527341454|FG020|Treatment Period|Maximum clinical benefit|2|||
145883481|NCT01522950|526078462|FG002|Overall Study|Withdrawal by Subject|1|||
145883482|NCT01522950|526078460|FG000|Overall Study|Adverse Event|3|||
145883483|NCT01522950|526078461|FG001|Overall Study|Adverse Event|1|||
145883484|NCT01522950|526078462|FG002|Overall Study|Adverse Event|1|||
145883485|NCT01522950|526078460|FG000|Overall Study|Protocol Violation|0|||
145883486|NCT01522950|526078461|FG001|Overall Study|Protocol Violation|0|||
145883487|NCT01522950|526078462|FG002|Overall Study|Protocol Violation|2|||
145883488|NCT01522950|526078460|FG000|Overall Study|Death|0|||
145883489|NCT01522950|526078461|FG001|Overall Study|Death|1|||
145883490|NCT01522950|526078462|FG002|Overall Study|Death|1|||
145883491|NCT01522950|526078460|FG000|Overall Study|Study Medication Sensitivity|0|||
145883492|NCT01522950|526078461|FG001|Overall Study|Study Medication Sensitivity|1|||
145883493|NCT01522950|526078462|FG002|Overall Study|Study Medication Sensitivity|0|||
145883494|NCT01091103|526078466|FG000|Overall Study|Adverse Event|1|||
145883495|NCT01091103|526078466|FG000|Overall Study|Progressive Disease|3|||
145883496|NCT03449199|526078467|FG000|Overall Study|Lost to Follow-up|1|||
145883497|NCT03449199|526078468|FG001|Overall Study|Lost to Follow-up|1|||
145883498|NCT03449199|526078469|FG002|Overall Study|Lost to Follow-up|0|||
145883499|NCT03449199|526078467|FG000|Overall Study|Protocol Deviation|0|||
145883500|NCT03449199|526078468|FG001|Overall Study|Protocol Deviation|0|||
145883501|NCT03449199|526078469|FG002|Overall Study|Protocol Deviation|1|||
145883502|NCT03449199|526078467|FG000|Overall Study|Withdrawal by Subject|0|||
145883503|NCT03449199|526078468|FG001|Overall Study|Withdrawal by Subject|0|||
145883504|NCT03449199|526078469|FG002|Overall Study|Withdrawal by Subject|1|||
145883505|NCT03136406|526078470|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
145883506|NCT01045707|526078471|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
145883507|NCT01045707|526078472|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
145883508|NCT01045707|526078471|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
145883509|NCT01045707|526078472|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
145883510|NCT01045707|526078471|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
145883511|NCT01045707|526078472|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
145883512|NCT01045707|526078471|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
145883513|NCT01045707|526078472|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
145883514|NCT01045707|526078471|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
145883515|NCT01045707|526078472|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
145883516|NCT01045707|526078471|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
145883517|NCT01045707|526078472|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
145883518|NCT01045707|526078471|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
145883519|NCT01045707|526078472|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
145883520|NCT01045707|526078471|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
145883521|NCT01045707|526078472|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
145883522|NCT01045707|526078471|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
145883523|NCT01045707|526078472|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
145883524|NCT00348816|526078473|FG000|Overall Study|Noncompliance with radiation treatment|1|||
145883525|NCT00848042|526078474|FG000|Overall Study|Death|1|||
145883526|NCT00848042|526078475|FG001|Overall Study|Death|2|||
145883527|NCT00848042|526078476|FG002|Overall Study|Death|0|||
145883528|NCT00848042|526078474|FG000|Overall Study|Other Therapy|3|||
145883529|NCT00848042|526078475|FG001|Overall Study|Other Therapy|0|||
145883530|NCT00848042|526078476|FG002|Overall Study|Other Therapy|0|||
145883531|NCT02448563|526078480|FG000|Overall Study|Lost to Follow-up|16|||
145883532|NCT02448563|526078481|FG001|Overall Study|Lost to Follow-up|10|||
145883533|NCT02448563|526078480|FG000|Overall Study|Withdrawal by Subject|0|||
146225115|NCT01928394|527341455|FG021|Treatment Period|Maximum clinical benefit|0|||
146225116|NCT01928394|527341456|FG022|Treatment Period|Maximum clinical benefit|0|||
146225117|NCT01928394|527341434|FG000|Treatment Period|Lost to Follow-up|0|||
146225118|NCT01928394|527341435|FG001|Treatment Period|Lost to Follow-up|0|||
146225119|NCT01928394|527341436|FG002|Treatment Period|Lost to Follow-up|0|||
146225120|NCT01928394|527341437|FG003|Treatment Period|Lost to Follow-up|0|||
146225121|NCT01928394|527341438|FG004|Treatment Period|Lost to Follow-up|0|||
146225122|NCT01928394|527341439|FG005|Treatment Period|Lost to Follow-up|0|||
145883534|NCT02448563|526078481|FG001|Overall Study|Withdrawal by Subject|1|||
145883535|NCT00721955|526078482|FG000|Overall Study|Adverse Event|0|||
145883536|NCT00721955|526078483|FG001|Overall Study|Adverse Event|0|||
145883537|NCT00721955|526078484|FG002|Overall Study|Adverse Event|2|||
145883538|NCT00726895|526078488|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145883539|NCT00726895|526078489|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145883540|NCT01450800|526078503|FG000|Overall Study|Protocol Violation|1|||
145883541|NCT01450800|526078504|FG001|Overall Study|Protocol Violation|3|||
145883542|NCT03496298|526078505|FG000|Overall Study|Adverse Event|49|||
145883543|NCT03496298|526078506|FG001|Overall Study|Adverse Event|68|||
145883544|NCT03496298|526078507|FG002|Overall Study|Adverse Event|79|||
145883545|NCT03496298|526078505|FG000|Overall Study|Study terminated by Sponsor|1050|||
145883546|NCT03496298|526078506|FG001|Overall Study|Study terminated by Sponsor|1063|||
145883547|NCT03496298|526078507|FG002|Overall Study|Study terminated by Sponsor|1071|||
145883548|NCT03496298|526078505|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
145883549|NCT03496298|526078506|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
145883550|NCT03496298|526078507|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
145883551|NCT03496298|526078505|FG000|Overall Study|Withdrawal by Subject|176|||
145883552|NCT03496298|526078506|FG001|Overall Study|Withdrawal by Subject|154|||
145883553|NCT03496298|526078507|FG002|Overall Study|Withdrawal by Subject|151|||
145883554|NCT03496298|526078505|FG000|Overall Study|Other|29|||
145883555|NCT03496298|526078506|FG001|Overall Study|Other|20|||
145883556|NCT03496298|526078507|FG002|Overall Study|Other|23|||
145883557|NCT03496298|526078505|FG000|Overall Study|Randomized and not treated|1|||
145883558|NCT03496298|526078506|FG001|Overall Study|Randomized and not treated|1|||
145883559|NCT03496298|526078507|FG002|Overall Study|Randomized and not treated|1|||
145883560|NCT02608476|526078510|FG000|Overall Study|Withdrawal by Subject|30|||
145883561|NCT02608476|526078511|FG001|Overall Study|Withdrawal by Subject|37|||
145883562|NCT02608476|526078510|FG000|Overall Study|Lost to Follow-up|24|||
145883563|NCT02608476|526078511|FG001|Overall Study|Lost to Follow-up|24|||
145883564|NCT02608476|526078510|FG000|Overall Study|Adverse Event|2|||
145883565|NCT02608476|526078511|FG001|Overall Study|Adverse Event|8|||
145883566|NCT02608476|526078510|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
145883567|NCT02608476|526078511|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
145883568|NCT02608476|526078510|FG000|Overall Study|Noncompliance with treatment|1|||
145883569|NCT02608476|526078511|FG001|Overall Study|Noncompliance with treatment|5|||
145883570|NCT02608476|526078510|FG000|Overall Study|Lack of Efficacy|3|||
145883571|NCT02608476|526078511|FG001|Overall Study|Lack of Efficacy|1|||
145883572|NCT02608476|526078510|FG000|Overall Study|Other|0|||
145883573|NCT02608476|526078511|FG001|Overall Study|Other|1|||
145883574|NCT02608476|526078510|FG000|Overall Study|Physician Decision|1|||
145883575|NCT02608476|526078511|FG001|Overall Study|Physician Decision|0|||
145883576|NCT02608476|526078510|FG000|Overall Study|Pregnancy|0|||
145883577|NCT02608476|526078511|FG001|Overall Study|Pregnancy|1|||
145883578|NCT02608476|526078510|FG000|Overall Study|Progressive disease|1|||
145883579|NCT02608476|526078511|FG001|Overall Study|Progressive disease|0|||
145883580|NCT03185741|526078514|FG000|Baseline|Withdrawal by Subject|1|||
145883581|NCT03185741|526078515|FG001|Baseline|Withdrawal by Subject|3|||
145883582|NCT03185741|526078516|FG002|Baseline|Withdrawal by Subject|2|||
145883583|NCT03185741|526078514|FG000|Baseline|Lost to Follow-up|1|||
145883584|NCT03185741|526078515|FG001|Baseline|Lost to Follow-up|2|||
145883585|NCT03185741|526078516|FG002|Baseline|Lost to Follow-up|3|||
145883586|NCT03185741|526078514|FG000|3Month|Death|1|||
145883587|NCT03185741|526078515|FG001|3Month|Death|1|||
145883588|NCT03185741|526078516|FG002|3Month|Death|2|||
145883589|NCT03185741|526078514|FG000|3Month|Withdrawal by Subject|1|||
145883590|NCT03185741|526078515|FG001|3Month|Withdrawal by Subject|5|||
145883591|NCT03185741|526078516|FG002|3Month|Withdrawal by Subject|1|||
145883592|NCT03185741|526078514|FG000|3Month|Lost to Follow-up|7|||
145883593|NCT03185741|526078515|FG001|3Month|Lost to Follow-up|9|||
145883594|NCT03185741|526078516|FG002|3Month|Lost to Follow-up|8|||
146225123|NCT01928394|527341440|FG006|Treatment Period|Lost to Follow-up|0|||
146225124|NCT01928394|527341441|FG007|Treatment Period|Lost to Follow-up|0|||
146225125|NCT01928394|527341442|FG008|Treatment Period|Lost to Follow-up|0|||
146225126|NCT01928394|527341443|FG009|Treatment Period|Lost to Follow-up|0|||
146225127|NCT01928394|527341444|FG010|Treatment Period|Lost to Follow-up|0|||
146225128|NCT01928394|527341445|FG011|Treatment Period|Lost to Follow-up|0|||
146225129|NCT01928394|527341446|FG012|Treatment Period|Lost to Follow-up|0|||
146225130|NCT01928394|527341447|FG013|Treatment Period|Lost to Follow-up|0|||
146225131|NCT01928394|527341448|FG014|Treatment Period|Lost to Follow-up|0|||
146225132|NCT01928394|527341449|FG015|Treatment Period|Lost to Follow-up|0|||
146225133|NCT01928394|527341450|FG016|Treatment Period|Lost to Follow-up|0|||
146225134|NCT01928394|527341451|FG017|Treatment Period|Lost to Follow-up|0|||
146225135|NCT01928394|527341452|FG018|Treatment Period|Lost to Follow-up|0|||
146225136|NCT01928394|527341453|FG019|Treatment Period|Lost to Follow-up|0|||
146225137|NCT01928394|527341454|FG020|Treatment Period|Lost to Follow-up|0|||
146225138|NCT01928394|527341455|FG021|Treatment Period|Lost to Follow-up|0|||
146225139|NCT01928394|527341456|FG022|Treatment Period|Lost to Follow-up|1|||
146225140|NCT01928394|527341434|FG000|Treatment Period|Death|0|||
146225141|NCT01928394|527341435|FG001|Treatment Period|Death|0|||
146225142|NCT01928394|527341436|FG002|Treatment Period|Death|0|||
146225143|NCT01928394|527341437|FG003|Treatment Period|Death|0|||
146225144|NCT01928394|527341438|FG004|Treatment Period|Death|0|||
146225145|NCT01928394|527341439|FG005|Treatment Period|Death|0|||
146225146|NCT01928394|527341440|FG006|Treatment Period|Death|0|||
146085266|NCT01879579|526833534|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
146225147|NCT01928394|527341441|FG007|Treatment Period|Death|0|||
146225148|NCT01928394|527341442|FG008|Treatment Period|Death|0|||
146225149|NCT01928394|527341443|FG009|Treatment Period|Death|0|||
146225150|NCT01928394|527341444|FG010|Treatment Period|Death|0|||
146225151|NCT01928394|527341445|FG011|Treatment Period|Death|0|||
146225152|NCT01928394|527341446|FG012|Treatment Period|Death|0|||
146225153|NCT01928394|527341447|FG013|Treatment Period|Death|1|||
146225154|NCT01928394|527341448|FG014|Treatment Period|Death|2|||
146225155|NCT01928394|527341449|FG015|Treatment Period|Death|0|||
146225156|NCT01928394|527341450|FG016|Treatment Period|Death|0|||
146225157|NCT01928394|527341451|FG017|Treatment Period|Death|0|||
146225158|NCT01928394|527341452|FG018|Treatment Period|Death|0|||
146225159|NCT01928394|527341453|FG019|Treatment Period|Death|0|||
146085267|NCT01879579|526833535|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
146225160|NCT01928394|527341454|FG020|Treatment Period|Death|0|||
146225161|NCT01928394|527341455|FG021|Treatment Period|Death|0|||
146225162|NCT01928394|527341456|FG022|Treatment Period|Death|0|||
146225163|NCT01928394|527341434|FG000|Follow-up Period|Participant withdrew consent|3|||
146225164|NCT01928394|527341435|FG001|Follow-up Period|Participant withdrew consent|0|||
146225165|NCT01928394|527341436|FG002|Follow-up Period|Participant withdrew consent|1|||
146085268|NCT01879579|526833534|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
146085269|NCT01879579|526833535|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
146085270|NCT02927067|526833536|FG000|Overall Study|Withdrawn Consent|20|||
146225166|NCT01928394|527341437|FG003|Follow-up Period|Participant withdrew consent|4|||
146225167|NCT01928394|527341438|FG004|Follow-up Period|Participant withdrew consent|0|||
146289004|NCT03401229|527573309|FG001|Overall Study|Adverse Event|6|||
146289005|NCT03401229|527573308|FG000|Overall Study|Withdrawal by Subject|29|||
146289006|NCT03401229|527573309|FG001|Overall Study|Withdrawal by Subject|26|||
146289007|NCT03401229|527573308|FG000|Overall Study|COVID-19|0|||
146289008|NCT03401229|527573309|FG001|Overall Study|COVID-19|1|||
146289009|NCT01411215|527573310|FG000|Overall Study|Adverse Event|1|||
146289010|NCT01411215|527573311|FG001|Overall Study|Adverse Event|2|||
146225168|NCT01928394|527341439|FG005|Follow-up Period|Participant withdrew consent|2|||
146225169|NCT01928394|527341440|FG006|Follow-up Period|Participant withdrew consent|5|||
146225170|NCT01928394|527341441|FG007|Follow-up Period|Participant withdrew consent|1|||
146289011|NCT01411215|527573310|FG000|Overall Study|Lack of Efficacy|2|||
146289012|NCT01411215|527573311|FG001|Overall Study|Lack of Efficacy|4|||
146225171|NCT01928394|527341442|FG008|Follow-up Period|Participant withdrew consent|0|||
146289013|NCT01411215|527573310|FG000|Overall Study|Lost to Follow-up|12|||
146289014|NCT01411215|527573311|FG001|Overall Study|Lost to Follow-up|18|||
146225172|NCT01928394|527341443|FG009|Follow-up Period|Participant withdrew consent|0|||
146225173|NCT01928394|527341444|FG010|Follow-up Period|Participant withdrew consent|5|||
146225174|NCT01928394|527341445|FG011|Follow-up Period|Participant withdrew consent|8|||
146225175|NCT01928394|527341446|FG012|Follow-up Period|Participant withdrew consent|2|||
146225176|NCT01928394|527341447|FG013|Follow-up Period|Participant withdrew consent|12|||
146225177|NCT01928394|527341448|FG014|Follow-up Period|Participant withdrew consent|7|||
146225178|NCT01928394|527341449|FG015|Follow-up Period|Participant withdrew consent|0|||
146225179|NCT01928394|527341450|FG016|Follow-up Period|Participant withdrew consent|5|||
146225180|NCT01928394|527341451|FG017|Follow-up Period|Participant withdrew consent|3|||
146225181|NCT01928394|527341452|FG018|Follow-up Period|Participant withdrew consent|2|||
146225182|NCT01928394|527341453|FG019|Follow-up Period|Participant withdrew consent|7|||
146225183|NCT01928394|527341454|FG020|Follow-up Period|Participant withdrew consent|4|||
146225184|NCT01928394|527341455|FG021|Follow-up Period|Participant withdrew consent|6|||
146225185|NCT01928394|527341456|FG022|Follow-up Period|Participant withdrew consent|2|||
146225186|NCT01928394|527341434|FG000|Follow-up Period|Death|0|||
146225187|NCT01928394|527341435|FG001|Follow-up Period|Death|0|||
146225188|NCT01928394|527341436|FG002|Follow-up Period|Death|2|||
146225189|NCT01928394|527341437|FG003|Follow-up Period|Death|6|||
146225190|NCT01928394|527341438|FG004|Follow-up Period|Death|0|||
146225191|NCT01928394|527341439|FG005|Follow-up Period|Death|6|||
146225192|NCT01928394|527341440|FG006|Follow-up Period|Death|6|||
146225193|NCT01928394|527341441|FG007|Follow-up Period|Death|2|||
146225194|NCT01928394|527341442|FG008|Follow-up Period|Death|1|||
146225195|NCT01928394|527341443|FG009|Follow-up Period|Death|2|||
146225196|NCT01928394|527341444|FG010|Follow-up Period|Death|4|||
146225197|NCT01928394|527341445|FG011|Follow-up Period|Death|12|||
146225198|NCT01928394|527341446|FG012|Follow-up Period|Death|11|||
146225199|NCT01928394|527341447|FG013|Follow-up Period|Death|25|||
146225200|NCT01928394|527341448|FG014|Follow-up Period|Death|18|||
146225201|NCT01928394|527341449|FG015|Follow-up Period|Death|0|||
146225202|NCT01928394|527341450|FG016|Follow-up Period|Death|6|||
146225203|NCT01928394|527341451|FG017|Follow-up Period|Death|5|||
146225204|NCT01928394|527341452|FG018|Follow-up Period|Death|13|||
146225205|NCT01928394|527341453|FG019|Follow-up Period|Death|13|||
146225206|NCT01928394|527341454|FG020|Follow-up Period|Death|5|||
146225207|NCT01928394|527341455|FG021|Follow-up Period|Death|3|||
146225208|NCT01928394|527341456|FG022|Follow-up Period|Death|2|||
146225209|NCT01928394|527341434|FG000|Follow-up Period|other reason|0|||
146225210|NCT01928394|527341435|FG001|Follow-up Period|other reason|0|||
146225211|NCT01928394|527341436|FG002|Follow-up Period|other reason|0|||
146225212|NCT01928394|527341437|FG003|Follow-up Period|other reason|0|||
146225213|NCT01928394|527341438|FG004|Follow-up Period|other reason|0|||
146225214|NCT01928394|527341439|FG005|Follow-up Period|other reason|0|||
146225215|NCT01928394|527341440|FG006|Follow-up Period|other reason|1|||
146225216|NCT01928394|527341441|FG007|Follow-up Period|other reason|3|||
146225217|NCT01928394|527341442|FG008|Follow-up Period|other reason|0|||
146225218|NCT01928394|527341443|FG009|Follow-up Period|other reason|0|||
146225219|NCT01928394|527341444|FG010|Follow-up Period|other reason|2|||
146225220|NCT01928394|527341445|FG011|Follow-up Period|other reason|1|||
146225221|NCT01928394|527341446|FG012|Follow-up Period|other reason|0|||
146225222|NCT01928394|527341447|FG013|Follow-up Period|other reason|1|||
146225223|NCT01928394|527341448|FG014|Follow-up Period|other reason|4|||
146225224|NCT01928394|527341449|FG015|Follow-up Period|other reason|0|||
146225225|NCT01928394|527341450|FG016|Follow-up Period|other reason|2|||
146225226|NCT01928394|527341451|FG017|Follow-up Period|other reason|0|||
146225227|NCT01928394|527341452|FG018|Follow-up Period|other reason|1|||
146225228|NCT01928394|527341453|FG019|Follow-up Period|other reason|1|||
146225229|NCT01928394|527341454|FG020|Follow-up Period|other reason|0|||
146225230|NCT01928394|527341455|FG021|Follow-up Period|other reason|0|||
146225231|NCT01928394|527341456|FG022|Follow-up Period|other reason|1|||
146225232|NCT01928394|527341434|FG000|Follow-up Period|Lost to Follow-up|0|||
146225233|NCT01928394|527341435|FG001|Follow-up Period|Lost to Follow-up|0|||
146225234|NCT01928394|527341436|FG002|Follow-up Period|Lost to Follow-up|0|||
146225235|NCT01928394|527341437|FG003|Follow-up Period|Lost to Follow-up|0|||
146225236|NCT01928394|527341438|FG004|Follow-up Period|Lost to Follow-up|0|||
146225237|NCT01928394|527341439|FG005|Follow-up Period|Lost to Follow-up|0|||
146225238|NCT01928394|527341440|FG006|Follow-up Period|Lost to Follow-up|0|||
146225239|NCT01928394|527341441|FG007|Follow-up Period|Lost to Follow-up|0|||
146225240|NCT01928394|527341442|FG008|Follow-up Period|Lost to Follow-up|0|||
146225241|NCT01928394|527341443|FG009|Follow-up Period|Lost to Follow-up|0|||
146225242|NCT01928394|527341444|FG010|Follow-up Period|Lost to Follow-up|0|||
146225243|NCT01928394|527341445|FG011|Follow-up Period|Lost to Follow-up|1|||
146225244|NCT01928394|527341446|FG012|Follow-up Period|Lost to Follow-up|1|||
146225245|NCT01928394|527341447|FG013|Follow-up Period|Lost to Follow-up|0|||
146225246|NCT01928394|527341448|FG014|Follow-up Period|Lost to Follow-up|1|||
146225247|NCT01928394|527341449|FG015|Follow-up Period|Lost to Follow-up|0|||
146225248|NCT01928394|527341450|FG016|Follow-up Period|Lost to Follow-up|1|||
146225249|NCT01928394|527341451|FG017|Follow-up Period|Lost to Follow-up|0|||
146225250|NCT01928394|527341452|FG018|Follow-up Period|Lost to Follow-up|0|||
146225251|NCT01928394|527341453|FG019|Follow-up Period|Lost to Follow-up|0|||
146225252|NCT01928394|527341454|FG020|Follow-up Period|Lost to Follow-up|0|||
146225253|NCT01928394|527341455|FG021|Follow-up Period|Lost to Follow-up|0|||
146225254|NCT01928394|527341456|FG022|Follow-up Period|Lost to Follow-up|1|||
146225255|NCT05485779|527341459|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225256|NCT05485779|527341460|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225257|NCT05485779|527341461|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225258|NCT05485779|527341462|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225259|NCT05485779|527341463|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225260|NCT05485779|527341464|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225261|NCT05485779|527341465|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225262|NCT05485779|527341466|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
146225263|NCT05485779|527341467|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
146225264|NCT05485779|527341468|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225265|NCT05485779|527341469|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
146225266|NCT05485779|527341459|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225267|NCT05485779|527341460|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225268|NCT05485779|527341461|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225269|NCT05485779|527341462|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225270|NCT05485779|527341463|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225271|NCT05485779|527341464|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225272|NCT05485779|527341465|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225273|NCT05485779|527341466|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225274|NCT05485779|527341467|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225275|NCT05485779|527341468|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
146225276|NCT05485779|527341469|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
146225277|NCT05485779|527341459|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225278|NCT05485779|527341460|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225279|NCT05485779|527341461|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225280|NCT05485779|527341462|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
146225281|NCT05485779|527341463|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225282|NCT05485779|527341464|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225283|NCT05485779|527341465|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225284|NCT05485779|527341466|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225285|NCT05485779|527341467|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225286|NCT05485779|527341468|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225287|NCT05485779|527341469|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
146225288|NCT03030261|527341471|FG000|Overall Study|Still receiving continuation therapy|5|||
146225289|NCT05170841|527341474|FG000|Single Dose Phase|Adverse Event|1|||
146225290|NCT05170841|527341475|FG001|Single Dose Phase|Adverse Event|2|||
146225291|NCT05170841|527341476|FG002|Single Dose Phase|Adverse Event|0|||
146225292|NCT05170841|527341477|FG003|Single Dose Phase|Adverse Event|2|||
146225293|NCT05170841|527341474|FG000|Multiple Dose Phase|Adverse Event|1|||
146225294|NCT05170841|527341475|FG001|Multiple Dose Phase|Adverse Event|2|||
146225295|NCT05170841|527341476|FG002|Multiple Dose Phase|Adverse Event|1|||
146225296|NCT05170841|527341477|FG003|Multiple Dose Phase|Adverse Event|4|||
146225297|NCT05170841|527341474|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
146225298|NCT05170841|527341475|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
146225299|NCT05170841|527341476|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
146225300|NCT05170841|527341477|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
146225301|NCT05123586|527341480|FG000|Overall Study|Physician Decision|1|||
146225302|NCT05123586|527341481|FG001|Overall Study|Physician Decision|1|||
146225303|NCT05123586|527341480|FG000|Overall Study|Withdrawal by Subject|0|||
146225304|NCT05123586|527341481|FG001|Overall Study|Withdrawal by Subject|3|||
146225305|NCT02240238|527341489|FG000|Phase 1|Adverse Event|0|||
146225306|NCT02240238|527341490|FG001|Phase 1|Adverse Event|0|||
146225307|NCT02240238|527341491|FG002|Phase 1|Adverse Event|0|||
146225308|NCT02240238|527341492|FG003|Phase 1|Adverse Event|0|||
146225309|NCT02240238|527341493|FG004|Phase 1|Adverse Event|0|||
146225310|NCT02240238|527341494|FG005|Phase 1|Adverse Event|0|||
146225311|NCT02240238|527341495|FG006|Phase 1|Adverse Event|3|||
146225312|NCT02240238|527341496|FG007|Phase 1|Adverse Event|1|||
146225313|NCT02240238|527341497|FG008|Phase 1|Adverse Event|0|||
146225314|NCT02240238|527341498|FG009|Phase 1|Adverse Event|0|||
146225315|NCT02240238|527341499|FG010|Phase 1|Adverse Event|0|||
146225316|NCT02240238|527341500|FG011|Phase 1|Adverse Event|0|||
146225317|NCT02240238|527341489|FG000|Phase 1|Death|0|||
146225318|NCT02240238|527341490|FG001|Phase 1|Death|0|||
146225319|NCT02240238|527341491|FG002|Phase 1|Death|0|||
146225320|NCT02240238|527341492|FG003|Phase 1|Death|0|||
146225321|NCT02240238|527341493|FG004|Phase 1|Death|0|||
146225322|NCT02240238|527341494|FG005|Phase 1|Death|1|||
146225323|NCT02240238|527341495|FG006|Phase 1|Death|0|||
146225324|NCT02240238|527341496|FG007|Phase 1|Death|0|||
146225325|NCT02240238|527341497|FG008|Phase 1|Death|0|||
146225326|NCT02240238|527341498|FG009|Phase 1|Death|0|||
146225327|NCT02240238|527341499|FG010|Phase 1|Death|0|||
146225328|NCT02240238|527341500|FG011|Phase 1|Death|0|||
146225329|NCT02240238|527341489|FG000|Phase 1|Sponsor termination|0|||
146225330|NCT02240238|527341490|FG001|Phase 1|Sponsor termination|0|||
146225331|NCT02240238|527341491|FG002|Phase 1|Sponsor termination|0|||
146225332|NCT02240238|527341492|FG003|Phase 1|Sponsor termination|0|||
146225333|NCT02240238|527341493|FG004|Phase 1|Sponsor termination|0|||
146225334|NCT02240238|527341494|FG005|Phase 1|Sponsor termination|1|||
146225335|NCT02240238|527341495|FG006|Phase 1|Sponsor termination|0|||
146225336|NCT02240238|527341496|FG007|Phase 1|Sponsor termination|0|||
146225337|NCT02240238|527341497|FG008|Phase 1|Sponsor termination|0|||
146225338|NCT02240238|527341498|FG009|Phase 1|Sponsor termination|0|||
146225339|NCT02240238|527341499|FG010|Phase 1|Sponsor termination|0|||
146225340|NCT02240238|527341500|FG011|Phase 1|Sponsor termination|0|||
146225341|NCT02240238|527341489|FG000|Phase 1|Withdrawal by Subject|0|||
146225342|NCT02240238|527341490|FG001|Phase 1|Withdrawal by Subject|0|||
146225343|NCT02240238|527341491|FG002|Phase 1|Withdrawal by Subject|0|||
146225344|NCT02240238|527341492|FG003|Phase 1|Withdrawal by Subject|0|||
146225345|NCT02240238|527341493|FG004|Phase 1|Withdrawal by Subject|0|||
146225346|NCT02240238|527341494|FG005|Phase 1|Withdrawal by Subject|2|||
146225347|NCT02240238|527341495|FG006|Phase 1|Withdrawal by Subject|0|||
146225348|NCT02240238|527341496|FG007|Phase 1|Withdrawal by Subject|0|||
146225349|NCT02240238|527341497|FG008|Phase 1|Withdrawal by Subject|0|||
146225350|NCT02240238|527341498|FG009|Phase 1|Withdrawal by Subject|0|||
146225351|NCT02240238|527341499|FG010|Phase 1|Withdrawal by Subject|0|||
146225352|NCT02240238|527341500|FG011|Phase 1|Withdrawal by Subject|0|||
146225353|NCT02240238|527341489|FG000|Phase 1|Physician Decision|0|||
146225354|NCT02240238|527341490|FG001|Phase 1|Physician Decision|0|||
146225355|NCT02240238|527341491|FG002|Phase 1|Physician Decision|0|||
146225356|NCT02240238|527341492|FG003|Phase 1|Physician Decision|0|||
146225357|NCT02240238|527341493|FG004|Phase 1|Physician Decision|0|||
146225358|NCT02240238|527341494|FG005|Phase 1|Physician Decision|2|||
146225359|NCT02240238|527341495|FG006|Phase 1|Physician Decision|0|||
146225360|NCT02240238|527341496|FG007|Phase 1|Physician Decision|0|||
145883595|NCT03185741|526078514|FG000|3Month|Unavailable for 3Month|11|||
146225361|NCT02240238|527341497|FG008|Phase 1|Physician Decision|0|||
146225362|NCT02240238|527341498|FG009|Phase 1|Physician Decision|0|||
146225363|NCT02240238|527341499|FG010|Phase 1|Physician Decision|0|||
145883596|NCT03185741|526078515|FG001|3Month|Unavailable for 3Month|10|||
145883597|NCT03185741|526078516|FG002|3Month|Unavailable for 3Month|11|||
145883598|NCT03185741|526078514|FG000|3Month|Protocol Violation|0|||
146225364|NCT02240238|527341500|FG011|Phase 1|Physician Decision|0|||
146225365|NCT02240238|527341489|FG000|Phase 2|Adverse Event|0|||
146225366|NCT02240238|527341490|FG001|Phase 2|Adverse Event|0|||
146225367|NCT02240238|527341491|FG002|Phase 2|Adverse Event|0|||
146225368|NCT02240238|527341492|FG003|Phase 2|Adverse Event|0|||
146225369|NCT02240238|527341493|FG004|Phase 2|Adverse Event|0|||
146225370|NCT02240238|527341494|FG005|Phase 2|Adverse Event|0|||
146225371|NCT02240238|527341495|FG006|Phase 2|Adverse Event|0|||
146225372|NCT02240238|527341496|FG007|Phase 2|Adverse Event|0|||
146225373|NCT02240238|527341497|FG008|Phase 2|Adverse Event|0|||
146225374|NCT02240238|527341498|FG009|Phase 2|Adverse Event|7|||
146225375|NCT02240238|527341499|FG010|Phase 2|Adverse Event|14|||
146225376|NCT02240238|527341500|FG011|Phase 2|Adverse Event|2|||
146225377|NCT02240238|527341489|FG000|Phase 2|Death|0|||
146225378|NCT02240238|527341490|FG001|Phase 2|Death|0|||
146225379|NCT02240238|527341491|FG002|Phase 2|Death|0|||
146225380|NCT02240238|527341492|FG003|Phase 2|Death|0|||
146225381|NCT02240238|527341493|FG004|Phase 2|Death|0|||
146225382|NCT02240238|527341494|FG005|Phase 2|Death|0|||
146225383|NCT02240238|527341495|FG006|Phase 2|Death|0|||
146225384|NCT02240238|527341496|FG007|Phase 2|Death|0|||
146225385|NCT02240238|527341497|FG008|Phase 2|Death|0|||
146225386|NCT02240238|527341498|FG009|Phase 2|Death|3|||
146225387|NCT02240238|527341499|FG010|Phase 2|Death|2|||
146225388|NCT02240238|527341500|FG011|Phase 2|Death|1|||
146225389|NCT02240238|527341489|FG000|Phase 2|Disease progression|0|||
146225390|NCT02240238|527341490|FG001|Phase 2|Disease progression|0|||
146225391|NCT02240238|527341491|FG002|Phase 2|Disease progression|0|||
146225392|NCT02240238|527341492|FG003|Phase 2|Disease progression|0|||
146225393|NCT02240238|527341493|FG004|Phase 2|Disease progression|0|||
146225394|NCT02240238|527341494|FG005|Phase 2|Disease progression|0|||
146225395|NCT02240238|527341495|FG006|Phase 2|Disease progression|0|||
146225396|NCT02240238|527341496|FG007|Phase 2|Disease progression|0|||
146225397|NCT02240238|527341497|FG008|Phase 2|Disease progression|0|||
146225398|NCT02240238|527341498|FG009|Phase 2|Disease progression|5|||
146225399|NCT02240238|527341499|FG010|Phase 2|Disease progression|11|||
146225400|NCT02240238|527341500|FG011|Phase 2|Disease progression|1|||
146225401|NCT02240238|527341489|FG000|Phase 2|Withdrawal by Subject|0|||
146225402|NCT02240238|527341490|FG001|Phase 2|Withdrawal by Subject|0|||
146225403|NCT02240238|527341491|FG002|Phase 2|Withdrawal by Subject|0|||
146225404|NCT02240238|527341492|FG003|Phase 2|Withdrawal by Subject|0|||
146225405|NCT02240238|527341493|FG004|Phase 2|Withdrawal by Subject|0|||
146225406|NCT02240238|527341494|FG005|Phase 2|Withdrawal by Subject|0|||
146225407|NCT02240238|527341495|FG006|Phase 2|Withdrawal by Subject|0|||
146225408|NCT02240238|527341496|FG007|Phase 2|Withdrawal by Subject|0|||
146225409|NCT02240238|527341497|FG008|Phase 2|Withdrawal by Subject|0|||
146225410|NCT02240238|527341498|FG009|Phase 2|Withdrawal by Subject|1|||
146225411|NCT02240238|527341499|FG010|Phase 2|Withdrawal by Subject|1|||
146225412|NCT02240238|527341500|FG011|Phase 2|Withdrawal by Subject|0|||
146225413|NCT02240238|527341489|FG000|Phase 2|Physician Decision|0|||
146225414|NCT02240238|527341490|FG001|Phase 2|Physician Decision|0|||
146225415|NCT02240238|527341491|FG002|Phase 2|Physician Decision|0|||
146225416|NCT02240238|527341492|FG003|Phase 2|Physician Decision|0|||
146225417|NCT02240238|527341493|FG004|Phase 2|Physician Decision|0|||
146225418|NCT02240238|527341494|FG005|Phase 2|Physician Decision|0|||
146225419|NCT02240238|527341495|FG006|Phase 2|Physician Decision|0|||
146225420|NCT02240238|527341496|FG007|Phase 2|Physician Decision|0|||
146225421|NCT02240238|527341497|FG008|Phase 2|Physician Decision|0|||
146225422|NCT02240238|527341498|FG009|Phase 2|Physician Decision|1|||
146225423|NCT02240238|527341499|FG010|Phase 2|Physician Decision|3|||
146225424|NCT02240238|527341500|FG011|Phase 2|Physician Decision|0|||
146225425|NCT02240238|527341489|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225426|NCT02240238|527341490|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225427|NCT02240238|527341491|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225428|NCT02240238|527341492|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225429|NCT02240238|527341493|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225430|NCT02240238|527341494|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225431|NCT02240238|527341495|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225432|NCT02240238|527341496|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145961327|NCT02735980|526371100|FG000|Overall Study|Adverse Event|0|||
145961328|NCT02735980|526371101|FG001|Overall Study|Adverse Event|4|||
145961329|NCT02735980|526371102|FG002|Overall Study|Adverse Event|1|||
145961330|NCT02735980|526371100|FG000|Overall Study|Death|5|||
145961331|NCT02735980|526371101|FG001|Overall Study|Death|4|||
145961332|NCT02735980|526371102|FG002|Overall Study|Death|0|||
145961333|NCT02735980|526371100|FG000|Overall Study|Physician Decision|3|||
146225433|NCT02240238|527341497|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225434|NCT02240238|527341498|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
146225435|NCT02240238|527341499|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225436|NCT02240238|527341500|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
146225437|NCT02240238|527341489|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225438|NCT02240238|527341490|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225439|NCT02240238|527341491|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225440|NCT02240238|527341492|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225441|NCT02240238|527341493|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145961334|NCT02735980|526371101|FG001|Overall Study|Physician Decision|1|||
145961335|NCT02735980|526371102|FG002|Overall Study|Physician Decision|0|||
146225442|NCT02240238|527341494|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225443|NCT02240238|527341495|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225444|NCT02240238|527341496|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225445|NCT02240238|527341497|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225446|NCT02240238|527341498|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
146225447|NCT02240238|527341499|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225448|NCT02240238|527341500|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
146225449|NCT02240238|527341489|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225450|NCT02240238|527341490|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225451|NCT02240238|527341491|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225452|NCT02240238|527341492|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225453|NCT02240238|527341493|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225454|NCT02240238|527341494|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225455|NCT02240238|527341495|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225456|NCT02240238|527341496|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225457|NCT02240238|527341497|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225458|NCT02240238|527341498|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225459|NCT02240238|527341499|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
146225460|NCT02240238|527341500|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
146225461|NCT02240238|527341489|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225462|NCT02240238|527341490|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225463|NCT02240238|527341491|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225464|NCT02240238|527341492|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225465|NCT02240238|527341493|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225466|NCT02240238|527341494|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225467|NCT02240238|527341495|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225468|NCT02240238|527341496|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225469|NCT02240238|527341497|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225470|NCT02240238|527341498|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225471|NCT02240238|527341499|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
146225472|NCT02240238|527341500|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
146225473|NCT02240238|527341489|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225474|NCT02240238|527341490|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225475|NCT02240238|527341491|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225476|NCT02240238|527341492|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225477|NCT02240238|527341493|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225478|NCT02240238|527341494|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225479|NCT02240238|527341495|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225480|NCT02240238|527341496|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225481|NCT02240238|527341497|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225482|NCT02240238|527341498|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225483|NCT02240238|527341499|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
146225484|NCT02240238|527341500|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
146225485|NCT02240238|527341489|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225486|NCT02240238|527341490|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225487|NCT02240238|527341491|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225488|NCT02240238|527341492|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225489|NCT02240238|527341493|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225490|NCT02240238|527341494|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225491|NCT02240238|527341495|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225492|NCT02240238|527341496|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225493|NCT02240238|527341497|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225494|NCT02240238|527341498|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225495|NCT02240238|527341499|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
146235070|NCT00622700|527378453|FG006|Extension Treatment Period|Adverse Event|8|||
146235071|NCT00622700|527378447|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146235072|NCT00622700|527378448|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146235073|NCT00622700|527378449|FG002|Extension Treatment Period|Lack of Efficacy|0|||
146289015|NCT01411215|527573310|FG000|Overall Study|Did not meet entrance criteria|0|||
146289016|NCT01411215|527573311|FG001|Overall Study|Did not meet entrance criteria|1|||
146289017|NCT01411215|527573310|FG000|Overall Study|Study terminated by sponsor|2|||
146225496|NCT02240238|527341500|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
146225497|NCT02240238|527341489|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225498|NCT02240238|527341490|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225499|NCT02240238|527341491|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225500|NCT02240238|527341492|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225501|NCT02240238|527341493|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225502|NCT02240238|527341494|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225503|NCT02240238|527341495|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225504|NCT02240238|527341496|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225505|NCT02240238|527341497|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225506|NCT02240238|527341498|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225507|NCT02240238|527341499|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
146225508|NCT02240238|527341500|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
146225509|NCT02240238|527341489|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225510|NCT02240238|527341490|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225511|NCT02240238|527341491|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225512|NCT02240238|527341492|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225513|NCT02240238|527341493|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225514|NCT02240238|527341494|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225515|NCT02240238|527341495|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225516|NCT02240238|527341496|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225517|NCT02240238|527341497|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225518|NCT02240238|527341498|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225519|NCT02240238|527341499|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
146225520|NCT02240238|527341500|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
146225521|NCT05216406|527341515|FG000|Overall Study|Lost to Follow-up|8|||
146225522|NCT05216406|527341516|FG001|Overall Study|Lost to Follow-up|9|||
146225523|NCT04270942|527341520|FG000|Overall Study|Death|1|||
146225524|NCT03672916|527341528|FG000|Overall Study|Death|6|||
146225525|NCT03672916|527341528|FG000|Overall Study|Lost to Follow-up|29|||
146225526|NCT03672916|527341528|FG000|Overall Study|Adverse Event|6|||
146225527|NCT03672916|527341528|FG000|Overall Study|Withdrawal by Subject|11|||
146225528|NCT04797195|527341529|FG000|Overall Study|Death|8|||
146225529|NCT04797195|527341530|FG001|Overall Study|Death|15|||
146225530|NCT04797195|527341529|FG000|Overall Study|Change from PD|15|||
146225531|NCT04797195|527341530|FG001|Overall Study|Change from PD|15|||
146225532|NCT04797195|527341529|FG000|Overall Study|Withdrawal by Subject|3|||
146225533|NCT04797195|527341530|FG001|Overall Study|Withdrawal by Subject|2|||
146225534|NCT05623228|527341532|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
146225535|NCT05623228|527341533|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225536|NCT05623228|527341534|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225537|NCT05623228|527341535|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225538|NCT05623228|527341536|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225539|NCT05623228|527341537|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225540|NCT05623228|527341538|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225541|NCT05623228|527341539|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
146225542|NCT05623228|527341532|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146289018|NCT01411215|527573311|FG001|Overall Study|Study terminated by sponsor|15|||
146289019|NCT01411215|527573310|FG000|Overall Study|Protocol Violation|3|||
146289020|NCT01411215|527573311|FG001|Overall Study|Protocol Violation|5|||
146289021|NCT01411215|527573310|FG000|Overall Study|Withdrawal by Subject|34|||
146289022|NCT01411215|527573311|FG001|Overall Study|Withdrawal by Subject|21|||
146289023|NCT01411215|527573310|FG000|Overall Study|Other|12|||
146289024|NCT01411215|527573311|FG001|Overall Study|Other|17|||
146289025|NCT01411215|527573310|FG000|Overall Study|Screen failure|0|||
146289026|NCT01411215|527573311|FG001|Overall Study|Screen failure|1|||
146289027|NCT00848926|527573312|FG000|Treatment Period|Progressive disease|45|||
146225543|NCT05623228|527341533|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145883599|NCT03185741|526078515|FG001|3Month|Protocol Violation|0|||
146289028|NCT00848926|527573312|FG000|Treatment Period|Adverse Event|20|||
145883600|NCT03185741|526078516|FG002|3Month|Protocol Violation|3|||
146225544|NCT05623228|527341534|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146225545|NCT05623228|527341535|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
146225546|NCT05623228|527341536|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146289029|NCT00848926|527573312|FG000|Treatment Period|Physician Decision|12|||
146289030|NCT00848926|527573312|FG000|Treatment Period|Withdrawal by Subject|7|||
146289031|NCT00848926|527573312|FG000|Follow-up Period|Lost to Follow-up|7|||
146225547|NCT05623228|527341537|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146225548|NCT05623228|527341538|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146225549|NCT05623228|527341539|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
146225550|NCT04737330|527341541|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
146225551|NCT04737330|527341542|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
146225552|NCT04737330|527341541|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
146225553|NCT04737330|527341542|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
146225554|NCT04737330|527341541|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
146225555|NCT04737330|527341542|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
146225556|NCT04737330|527341541|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
146225557|NCT04737330|527341542|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
146225558|NCT04737330|527341541|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
146225559|NCT04737330|527341542|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
146225560|NCT04737330|527341541|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
146225561|NCT04737330|527341542|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
146225562|NCT02823145|527341543|FG000|Enrollment|Other|1|||
146225563|NCT02823145|527341544|FG001|Enrollment|Other|0|||
146225564|NCT02823145|527341543|FG000|Treatment|Adverse Event|0|||
146225565|NCT02823145|527341544|FG001|Treatment|Adverse Event|11|||
146225566|NCT02823145|527341543|FG000|Treatment|Death|0|||
146225567|NCT02823145|527341544|FG001|Treatment|Death|3|||
146225568|NCT02823145|527341543|FG000|Treatment|Family Decision|0|||
146225569|NCT02823145|527341544|FG001|Treatment|Family Decision|1|||
146225570|NCT02823145|527341543|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
146225571|NCT02823145|527341544|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
146225572|NCT02823145|527341543|FG000|Treatment|Lack of Efficacy|0|||
146225573|NCT02823145|527341544|FG001|Treatment|Lack of Efficacy|48|||
146225574|NCT02823145|527341543|FG000|Treatment|Non-Compliance With E-Diary|0|||
146225575|NCT02823145|527341544|FG001|Treatment|Non-Compliance With E-Diary|1|||
146225576|NCT02823145|527341543|FG000|Treatment|Physician Decision|0|||
146225577|NCT02823145|527341544|FG001|Treatment|Physician Decision|2|||
146225578|NCT02823145|527341543|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
146225579|NCT02823145|527341544|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
146225580|NCT02823145|527341543|FG000|Treatment|Subject needed to take prohibited medication|0|||
146225581|NCT02823145|527341544|FG001|Treatment|Subject needed to take prohibited medication|1|||
146225582|NCT02823145|527341543|FG000|Treatment|Subject transferred to direct access programme|0|||
146225583|NCT02823145|527341544|FG001|Treatment|Subject transferred to direct access programme|1|||
146225584|NCT02823145|527341543|FG000|Treatment|Switching to commercially available drug|0|||
146225585|NCT02823145|527341544|FG001|Treatment|Switching to commercially available drug|11|||
146225586|NCT02823145|527341543|FG000|Treatment|Transitioned to commercial supply of medication|0|||
146225587|NCT02823145|527341544|FG001|Treatment|Transitioned to commercial supply of medication|1|||
146225588|NCT02823145|527341543|FG000|Treatment|Withdrawal By Caregiver|0|||
146225589|NCT02823145|527341544|FG001|Treatment|Withdrawal By Caregiver|1|||
146225590|NCT02823145|527341543|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
146225591|NCT02823145|527341544|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
146225592|NCT02823145|527341543|FG000|Treatment|Withdrawal by Subject|0|||
146225593|NCT02823145|527341544|FG001|Treatment|Withdrawal by Subject|16|||
146225594|NCT02823145|527341543|FG000|Treatment|Reason unknown|0|||
146225595|NCT02823145|527341544|FG001|Treatment|Reason unknown|1|||
146225596|NCT04741776|527341545|FG000|Overall Study|Withdrawal by Subject|7|||
146225597|NCT04741776|527341546|FG001|Overall Study|Withdrawal by Subject|10|||
146225598|NCT04741776|527341547|FG002|Overall Study|Withdrawal by Subject|10|||
146225599|NCT04741776|527341548|FG003|Overall Study|Withdrawal by Subject|17|||
146225600|NCT04741776|527341545|FG000|Overall Study|Death|0|||
146225601|NCT04741776|527341546|FG001|Overall Study|Death|0|||
146225602|NCT04741776|527341547|FG002|Overall Study|Death|1|||
146225603|NCT04741776|527341548|FG003|Overall Study|Death|0|||
146225604|NCT02852655|527341549|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
146225605|NCT02852655|527341550|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
146225606|NCT02852655|527341551|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
146225607|NCT02852655|527341549|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
146225608|NCT02852655|527341550|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
146225609|NCT02852655|527341551|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
146225610|NCT02852655|527341549|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
146225611|NCT02852655|527341550|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
146225612|NCT02852655|527341551|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
146225613|NCT02852655|527341549|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
146225614|NCT02852655|527341550|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
146225615|NCT02852655|527341551|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
146225616|NCT02852655|527341549|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
146225617|NCT02852655|527341550|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
146225618|NCT02852655|527341551|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
146225619|NCT02852655|527341549|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
146225620|NCT02852655|527341550|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
146225621|NCT02852655|527341551|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
146225622|NCT02852655|527341549|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
146225623|NCT02852655|527341550|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
146225624|NCT02852655|527341551|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
146225625|NCT02852655|527341549|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
146225626|NCT02852655|527341550|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
146225627|NCT02852655|527341551|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
146225628|NCT02852655|527341549|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
146225629|NCT02852655|527341550|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
146225630|NCT02852655|527341551|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
146225631|NCT04086121|527341556|FG000|Overall Study|Other than listed|8|||
146225632|NCT04086121|527341556|FG000|Overall Study|Withdrawal by Subject|3|||
146225633|NCT04086121|527341556|FG000|Overall Study|Lost to Follow-up|2|||
146225634|NCT04086121|527341556|FG000|Overall Study|Adverse Event|1|||
146225635|NCT05292391|527341557|FG000|Overall Study|Lost to Follow-up|0|||
146225636|NCT05292391|527341558|FG001|Overall Study|Lost to Follow-up|0|||
146225637|NCT05292391|527341559|FG002|Overall Study|Lost to Follow-up|0|||
146225638|NCT05292391|527341560|FG003|Overall Study|Lost to Follow-up|1|||
146225639|NCT05292391|527341561|FG004|Overall Study|Lost to Follow-up|0|||
146225640|NCT00104676|527343632|FG000|Overall Study|Death|3|||
146225641|NCT00104676|527343633|FG001|Overall Study|Death|2|||
146225642|NCT00104676|527343632|FG000|Overall Study|Withdrawal by Subject|0|||
146225643|NCT00104676|527343633|FG001|Overall Study|Withdrawal by Subject|2|||
146225644|NCT00104676|527343632|FG000|Overall Study|treatment interruption|4|||
146225645|NCT00104676|527343633|FG001|Overall Study|treatment interruption|10|||
146225646|NCT05622812|527343634|FG000|Overall Study|Withdrawal by Subject|1|||
146225647|NCT05622812|527343635|FG001|Overall Study|Withdrawal by Subject|4|||
146225648|NCT05622812|527343634|FG000|Overall Study|Lost to Follow-up|2|||
146225649|NCT05622812|527343635|FG001|Overall Study|Lost to Follow-up|1|||
146225650|NCT01197378|527343639|FG000|Overall Study|Adverse Event|3|||
146225651|NCT01197378|527343639|FG000|Overall Study|Withdrawal by Subject|1|||
146225652|NCT01197378|527343639|FG000|Overall Study|Physician Decision|1|||
146225653|NCT01197378|527343639|FG000|Overall Study|Other|2|||
146225654|NCT06232590|527343643|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
146225655|NCT06232590|527343644|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
146225656|NCT01959607|527343645|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
146225657|NCT01959607|527343646|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
146225658|NCT01959607|527343647|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146225659|NCT01959607|527343648|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
146225660|NCT03913442|527343649|FG000|Overall Study|Adverse Event|0|||
146225661|NCT03913442|527343650|FG001|Overall Study|Adverse Event|3|||
146225662|NCT03913442|527343649|FG000|Overall Study|Withdrawal by Subject|5|||
146225663|NCT03913442|527343650|FG001|Overall Study|Withdrawal by Subject|5|||
146225664|NCT03913442|527343649|FG000|Overall Study|Terminations|2|||
146225665|NCT03913442|527343650|FG001|Overall Study|Terminations|1|||
146225666|NCT03913442|527343649|FG000|Overall Study|Lost to Follow-up|2|||
146225667|NCT03913442|527343650|FG001|Overall Study|Lost to Follow-up|2|||
146225668|NCT02433379|527343651|FG000|Overall Study|Screen Failures|55|||
146225669|NCT02433379|527343651|FG000|Overall Study|Death|57|||
146225670|NCT02433379|527343651|FG000|Overall Study|Total Withdrawals|209|||
146225671|NCT03952338|527343652|FG000|Overall Study|Lost to Follow-up|11|||
146225672|NCT03952338|527343653|FG001|Overall Study|Lost to Follow-up|17|||
146225673|NCT03952338|527343652|FG000|Overall Study|Withdrawal by Subject|1|||
146225674|NCT03952338|527343653|FG001|Overall Study|Withdrawal by Subject|1|||
146225675|NCT03952338|527343652|FG000|Overall Study|Protocol Violation|1|||
146225676|NCT03952338|527343653|FG001|Overall Study|Protocol Violation|0|||
146225677|NCT00592852|527343654|FG000|Overall Study|Non-compliance|1|||
146225678|NCT00592852|527343654|FG000|Overall Study|Adverse Event|3|||
146225679|NCT00592852|527343654|FG000|Overall Study|Found ineligible|1|||
146225680|NCT00592852|527343654|FG000|Overall Study|Withdrawal by Subject|1|||
146225681|NCT05274074|527343663|FG000|Overall Study|Lost to Follow-up|2|||
146225682|NCT05274074|527343664|FG001|Overall Study|Lost to Follow-up|3|||
146225683|NCT05274074|527343663|FG000|Overall Study|Withdrawal by Subject|1|||
146225684|NCT05274074|527343664|FG001|Overall Study|Withdrawal by Subject|2|||
146225685|NCT01828099|527343665|FG000|Treatment Period|Adverse Event|24|||
146225686|NCT01828099|527343666|FG001|Treatment Period|Adverse Event|23|||
146225687|NCT01828099|527343665|FG000|Treatment Period|Death|10|||
146225688|NCT01828099|527343666|FG001|Treatment Period|Death|12|||
146225689|NCT01828099|527343665|FG000|Treatment Period|Lost to Follow-up|2|||
146225690|NCT01828099|527343666|FG001|Treatment Period|Lost to Follow-up|1|||
146225691|NCT01828099|527343665|FG000|Treatment Period|Non-compliance with study treatment|1|||
146225692|NCT01828099|527343666|FG001|Treatment Period|Non-compliance with study treatment|0|||
146225693|NCT01828099|527343665|FG000|Treatment Period|Physician Decision|17|||
146225694|NCT01828099|527343666|FG001|Treatment Period|Physician Decision|16|||
146225695|NCT01828099|527343665|FG000|Treatment Period|Progressive disease|99|||
146225696|NCT01828099|527343666|FG001|Treatment Period|Progressive disease|107|||
146225697|NCT01828099|527343665|FG000|Treatment Period|Subject/guardian decision|22|||
146225698|NCT01828099|527343666|FG001|Treatment Period|Subject/guardian decision|26|||
146225699|NCT01828099|527343665|FG000|Treatment Period|Study terminated by Sponsor|13|||
146225700|NCT01828099|527343666|FG001|Treatment Period|Study terminated by Sponsor|1|||
146225701|NCT01828099|527343665|FG000|Treatment Period|Protocol deviation|1|||
146225702|NCT01828099|527343666|FG001|Treatment Period|Protocol deviation|0|||
146225703|NCT01828099|527343665|FG000|Treatment Period|No longer requires treatment|0|||
146225704|NCT01828099|527343666|FG001|Treatment Period|No longer requires treatment|1|||
146225705|NCT01828099|527343665|FG000|Extension-treatment Phase|Adverse Event|0|||
146225706|NCT01828099|527343666|FG001|Extension-treatment Phase|Adverse Event|17|||
146225707|NCT01828099|527343665|FG000|Extension-treatment Phase|Death|0|||
146225708|NCT01828099|527343666|FG001|Extension-treatment Phase|Death|11|||
146225709|NCT01828099|527343665|FG000|Extension-treatment Phase|Physician Decision|0|||
146225710|NCT01828099|527343666|FG001|Extension-treatment Phase|Physician Decision|5|||
146225711|NCT01828099|527343665|FG000|Extension-treatment Phase|Progressive disease|0|||
146225712|NCT01828099|527343666|FG001|Extension-treatment Phase|Progressive disease|54|||
146225713|NCT01828099|527343665|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
146225714|NCT01828099|527343666|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
146225715|NCT01828099|527343665|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
146225716|NCT01828099|527343666|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
146225717|NCT05934942|527343667|FG000|Run-in Period|Not treated|1|||
146225718|NCT05934942|527343667|FG000|Run-in Period|Withdrawal by Subject|1|||
146225719|NCT05645757|527343668|FG000|Overall Study|Enrolled but treatment not administered|0|||
146225720|NCT05645757|527343669|FG001|Overall Study|Enrolled but treatment not administered|0|||
146225721|NCT05645757|527343670|FG002|Overall Study|Enrolled but treatment not administered|0|||
146225722|NCT05645757|527343671|FG003|Overall Study|Enrolled but treatment not administered|0|||
146225723|NCT05645757|527343672|FG004|Overall Study|Enrolled but treatment not administered|1|||
146225724|NCT05645757|527343673|FG005|Overall Study|Enrolled but treatment not administered|1|||
146225725|NCT05645757|527343674|FG006|Overall Study|Enrolled but treatment not administered|0|||
146225726|NCT05645757|527343675|FG007|Overall Study|Enrolled but treatment not administered|0|||
146225727|NCT03924635|527343676|FG000|Overall Study|Withdrawal by Subject|2|||
146225728|NCT03924635|527343677|FG001|Overall Study|Withdrawal by Subject|4|||
146225729|NCT00539591|527343678|FG000|Overall Study|Toxicity|3|||
146225730|NCT00539591|527343679|FG001|Overall Study|Toxicity|0|||
146225731|NCT00539591|527343680|FG002|Overall Study|Toxicity|0|||
146225732|NCT00539591|527343678|FG000|Overall Study|Disease progression|2|||
146225733|NCT00539591|527343679|FG001|Overall Study|Disease progression|2|||
146225734|NCT00539591|527343680|FG002|Overall Study|Disease progression|3|||
146225735|NCT04362254|527343681|FG000|Overall Study|Adverse Event|1|||
146225736|NCT04362254|527343681|FG000|Overall Study|Protocol Violation|1|||
146225737|NCT04362254|527343681|FG000|Overall Study|Due to early termination of the trial|10|||
146225738|NCT04568434|527343682|FG000|Overall Study|Voluntary Withdrawal|0|||
146225739|NCT04568434|527343683|FG001|Overall Study|Voluntary Withdrawal|1|||
146225740|NCT04568434|527343684|FG002|Overall Study|Voluntary Withdrawal|1|||
146225741|NCT04568434|527343682|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
146225742|NCT04568434|527343683|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
146225743|NCT04568434|527343684|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
146225744|NCT04568434|527343682|FG000|Overall Study|Investigator Judgement|1|||
146225745|NCT04568434|527343683|FG001|Overall Study|Investigator Judgement|0|||
146225746|NCT04568434|527343684|FG002|Overall Study|Investigator Judgement|0|||
146225747|NCT05469464|527343685|FG000|Overall Study|Withdrawal by Subject|8|||
146225748|NCT05469464|527343686|FG001|Overall Study|Withdrawal by Subject|7|||
146225749|NCT05469464|527343687|FG002|Overall Study|Withdrawal by Subject|4|||
146225750|NCT05469464|527343688|FG003|Overall Study|Withdrawal by Subject|5|||
146225751|NCT05469464|527343685|FG000|Overall Study|Adverse Event|8|||
146225752|NCT05469464|527343686|FG001|Overall Study|Adverse Event|14|||
145883601|NCT03185741|526078514|FG000|6Month|Death|1|||
146225753|NCT05469464|527343687|FG002|Overall Study|Adverse Event|13|||
146225754|NCT05469464|527343688|FG003|Overall Study|Adverse Event|2|||
146225755|NCT05469464|527343685|FG000|Overall Study|Lost to Follow-up|2|||
146225756|NCT05469464|527343686|FG001|Overall Study|Lost to Follow-up|5|||
146225757|NCT05469464|527343687|FG002|Overall Study|Lost to Follow-up|3|||
146225758|NCT05469464|527343688|FG003|Overall Study|Lost to Follow-up|3|||
146225759|NCT05469464|527343685|FG000|Overall Study|Lack of Efficacy|4|||
146225760|NCT05469464|527343686|FG001|Overall Study|Lack of Efficacy|1|||
146225761|NCT05469464|527343687|FG002|Overall Study|Lack of Efficacy|2|||
146225762|NCT05469464|527343688|FG003|Overall Study|Lack of Efficacy|2|||
146225763|NCT05469464|527343685|FG000|Overall Study|Physician Decision|0|||
146225764|NCT05469464|527343686|FG001|Overall Study|Physician Decision|0|||
146225765|NCT05469464|527343687|FG002|Overall Study|Physician Decision|0|||
146225766|NCT05469464|527343688|FG003|Overall Study|Physician Decision|1|||
146225767|NCT02038777|527343689|FG000|Overall Study|Death|0|||
146225768|NCT02038777|527343690|FG001|Overall Study|Death|2|||
146225769|NCT02038777|527343691|FG002|Overall Study|Death|0|||
146225770|NCT02038777|527343692|FG003|Overall Study|Death|1|||
146225771|NCT02038777|527343693|FG004|Overall Study|Death|2|||
146225772|NCT02038777|527343694|FG005|Overall Study|Death|4|||
146225773|NCT02038777|527343695|FG006|Overall Study|Death|0|||
146225774|NCT02038777|527343696|FG007|Overall Study|Death|11|||
146225775|NCT02038777|527343689|FG000|Overall Study|Lost to Follow-up|0|||
146225776|NCT02038777|527343690|FG001|Overall Study|Lost to Follow-up|0|||
146225777|NCT02038777|527343691|FG002|Overall Study|Lost to Follow-up|0|||
146225778|NCT02038777|527343692|FG003|Overall Study|Lost to Follow-up|1|||
146225779|NCT02038777|527343693|FG004|Overall Study|Lost to Follow-up|0|||
146225780|NCT02038777|527343694|FG005|Overall Study|Lost to Follow-up|0|||
146225781|NCT02038777|527343695|FG006|Overall Study|Lost to Follow-up|0|||
146225782|NCT02038777|527343696|FG007|Overall Study|Lost to Follow-up|0|||
146225783|NCT02038777|527343689|FG000|Overall Study|Other|0|||
146225784|NCT02038777|527343690|FG001|Overall Study|Other|1|||
146225785|NCT02038777|527343691|FG002|Overall Study|Other|0|||
146225786|NCT02038777|527343692|FG003|Overall Study|Other|2|||
146225787|NCT02038777|527343693|FG004|Overall Study|Other|1|||
146225788|NCT02038777|527343694|FG005|Overall Study|Other|0|||
146225789|NCT02038777|527343695|FG006|Overall Study|Other|0|||
146225790|NCT02038777|527343696|FG007|Overall Study|Other|0|||
146225791|NCT02038777|527343689|FG000|Overall Study|Randomized but not treated|0|||
146225792|NCT02038777|527343690|FG001|Overall Study|Randomized but not treated|1|||
146225793|NCT02038777|527343691|FG002|Overall Study|Randomized but not treated|0|||
146225794|NCT02038777|527343692|FG003|Overall Study|Randomized but not treated|0|||
146225795|NCT02038777|527343693|FG004|Overall Study|Randomized but not treated|0|||
146225796|NCT02038777|527343694|FG005|Overall Study|Randomized but not treated|0|||
146225797|NCT02038777|527343695|FG006|Overall Study|Randomized but not treated|0|||
146225798|NCT02038777|527343696|FG007|Overall Study|Randomized but not treated|0|||
146225799|NCT02038777|527343689|FG000|Overall Study|Started Chemotherapy|1|||
146225800|NCT02038777|527343690|FG001|Overall Study|Started Chemotherapy|0|||
146225801|NCT02038777|527343691|FG002|Overall Study|Started Chemotherapy|3|||
146225802|NCT02038777|527343692|FG003|Overall Study|Started Chemotherapy|0|||
146225803|NCT02038777|527343693|FG004|Overall Study|Started Chemotherapy|0|||
146225804|NCT02038777|527343694|FG005|Overall Study|Started Chemotherapy|0|||
146225805|NCT02038777|527343695|FG006|Overall Study|Started Chemotherapy|0|||
146225806|NCT02038777|527343696|FG007|Overall Study|Started Chemotherapy|0|||
146225807|NCT02038777|527343689|FG000|Overall Study|participation terminated by sponsor|0|||
146225808|NCT02038777|527343690|FG001|Overall Study|participation terminated by sponsor|0|||
146225809|NCT02038777|527343691|FG002|Overall Study|participation terminated by sponsor|0|||
146225810|NCT02038777|527343692|FG003|Overall Study|participation terminated by sponsor|0|||
146225811|NCT02038777|527343693|FG004|Overall Study|participation terminated by sponsor|0|||
146225812|NCT02038777|527343694|FG005|Overall Study|participation terminated by sponsor|0|||
146225813|NCT02038777|527343695|FG006|Overall Study|participation terminated by sponsor|1|||
146225814|NCT02038777|527343696|FG007|Overall Study|participation terminated by sponsor|1|||
146225815|NCT04299464|527343697|FG000|Overall Study|Adverse Event|1|||
146225816|NCT04299464|527343698|FG001|Overall Study|Adverse Event|0|||
146225817|NCT04299464|527343699|FG002|Overall Study|Adverse Event|2|||
146225818|NCT04299464|527343697|FG000|Overall Study|Non-compliance with Study Drug|1|||
146225819|NCT04299464|527343698|FG001|Overall Study|Non-compliance with Study Drug|0|||
146225820|NCT04299464|527343699|FG002|Overall Study|Non-compliance with Study Drug|0|||
146225821|NCT04299464|527343697|FG000|Overall Study|Reason not Specified|0|||
146225822|NCT04299464|527343698|FG001|Overall Study|Reason not Specified|1|||
146225823|NCT04299464|527343699|FG002|Overall Study|Reason not Specified|3|||
146225824|NCT04299464|527343697|FG000|Overall Study|Physician Decision|0|||
146225825|NCT04299464|527343698|FG001|Overall Study|Physician Decision|1|||
145961336|NCT02735980|526371100|FG000|Overall Study|Screen failure|1|||
145961337|NCT02735980|526371101|FG001|Overall Study|Screen failure|0|||
145961338|NCT02735980|526371102|FG002|Overall Study|Screen failure|0|||
146225826|NCT04299464|527343699|FG002|Overall Study|Physician Decision|1|||
146225827|NCT04299464|527343697|FG000|Overall Study|Withdrawal by Subject|0|||
146225828|NCT04299464|527343698|FG001|Overall Study|Withdrawal by Subject|2|||
146225829|NCT04299464|527343699|FG002|Overall Study|Withdrawal by Subject|1|||
146225830|NCT04826471|527343700|FG000|Overall Study|Lost to Follow-up|2|||
145961339|NCT02735980|526371100|FG000|Overall Study|Withdrawal by Subject|1|||
146225831|NCT04826471|527343700|FG000|Overall Study|Protocol Violation|3|||
146225832|NCT04826471|527343700|FG000|Overall Study|Withdrawal by Subject|1|||
146225833|NCT05370040|527343707|FG000|Overall Study|Lost to Follow-up|0|||
146225834|NCT05370040|527343708|FG001|Overall Study|Lost to Follow-up|0|||
146225835|NCT05370040|527343709|FG002|Overall Study|Lost to Follow-up|1|||
146225836|NCT05370040|527343710|FG003|Overall Study|Lost to Follow-up|0|||
146225837|NCT05370040|527343711|FG004|Overall Study|Lost to Follow-up|1|||
146225838|NCT05370040|527343712|FG005|Overall Study|Lost to Follow-up|0|||
146225839|NCT04971109|527343716|FG000|Overall Study|Adverse Event|4|||
146225840|NCT04971109|527343717|FG001|Overall Study|Adverse Event|3|||
146225841|NCT04971109|527343716|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
146225842|NCT04971109|527343717|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
146225843|NCT04971109|527343716|FG000|Overall Study|Lost to Follow-up|8|||
146225844|NCT04971109|527343717|FG001|Overall Study|Lost to Follow-up|2|||
146225845|NCT04971109|527343716|FG000|Overall Study|Physician Decision|5|||
146225846|NCT04971109|527343717|FG001|Overall Study|Physician Decision|0|||
146225847|NCT04971109|527343716|FG000|Overall Study|Protocol Violation|0|||
146225848|NCT04971109|527343717|FG001|Overall Study|Protocol Violation|1|||
146225849|NCT04971109|527343716|FG000|Overall Study|Withdrawal by Subject|18|||
146225850|NCT04971109|527343717|FG001|Overall Study|Withdrawal by Subject|3|||
146225851|NCT04971109|527343716|FG000|Overall Study|Subject was randomized in error|1|||
146225852|NCT04971109|527343717|FG001|Overall Study|Subject was randomized in error|0|||
146225853|NCT03209973|527343718|FG000|Overall Study|Withdrawal by Subject|7|||
146225854|NCT03209973|527343718|FG000|Overall Study|Lost to Follow-up|2|||
146225855|NCT03209973|527343718|FG000|Overall Study|Death|8|||
146225856|NCT03209973|527343718|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
146225857|NCT03209973|527343718|FG000|Overall Study|Sponsor Decision|18|||
146225858|NCT03209973|527343718|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
146225859|NCT03209973|527343718|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
146225860|NCT04024020|527343720|FG000|Overall Study|Withdrawal by Subject|2|||
146225861|NCT04024020|527343721|FG001|Overall Study|Withdrawal by Subject|2|||
146225862|NCT00746096|527343725|FG000|Overall Study|Adverse Event|1|||
146225863|NCT00746096|527343726|FG001|Overall Study|Adverse Event|0|||
145961340|NCT02735980|526371101|FG001|Overall Study|Withdrawal by Subject|2|||
145961341|NCT02735980|526371102|FG002|Overall Study|Withdrawal by Subject|0|||
145961342|NCT00528424|526371106|FG000|Overall Study|Lost to Follow-up|13|||
146085271|NCT02927067|526833537|FG001|Overall Study|Withdrawn Consent|12|||
146225864|NCT00746096|527343725|FG000|Overall Study|Withdrawal by Subject|5|||
146225865|NCT00746096|527343726|FG001|Overall Study|Withdrawal by Subject|1|||
145961343|NCT00528424|526371106|FG000|Overall Study|Withdrew consent|2|||
146225866|NCT00746096|527343725|FG000|Overall Study|Lost to Follow-up|2|||
146225867|NCT00746096|527343726|FG001|Overall Study|Lost to Follow-up|1|||
146225868|NCT00746096|527343725|FG000|Overall Study|Protocol Violation|1|||
146225869|NCT00746096|527343726|FG001|Overall Study|Protocol Violation|0|||
146225870|NCT00746096|527343725|FG000|Overall Study|No study drug treatment|1|||
145883602|NCT03185741|526078515|FG001|6Month|Death|1|||
146225871|NCT00746096|527343726|FG001|Overall Study|No study drug treatment|1|||
146225872|NCT01651403|527343729|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
146225873|NCT01651403|527343730|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
146225874|NCT01651403|527343729|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
146225875|NCT01651403|527343730|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
146225876|NCT01651403|527343729|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
146225877|NCT01651403|527343730|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
146225878|NCT01651403|527343729|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
145883603|NCT03185741|526078516|FG002|6Month|Death|2|||
146225879|NCT01651403|527343730|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
145883604|NCT03185741|526078514|FG000|6Month|Withdrawal by Subject|2|||
146225880|NCT01651403|527343729|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
146225881|NCT01651403|527343730|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
145883605|NCT03185741|526078515|FG001|6Month|Withdrawal by Subject|3|||
145961344|NCT00528424|526371106|FG000|Overall Study|Administrative reason|2|||
145961345|NCT00528424|526371106|FG000|Overall Study|Other|12|||
145961346|NCT03713684|526371107|FG000|Overall Study|Adverse Event|1|||
145961347|NCT03713684|526371108|FG001|Overall Study|Adverse Event|3|||
145961348|NCT03713684|526371109|FG002|Overall Study|Adverse Event|1|||
145961349|NCT03713684|526371110|FG003|Overall Study|Adverse Event|0|||
145961350|NCT03713684|526371107|FG000|Overall Study|Poor compliance to protocol|2|||
145961351|NCT03713684|526371108|FG001|Overall Study|Poor compliance to protocol|1|||
145961352|NCT03713684|526371109|FG002|Overall Study|Poor compliance to protocol|0|||
145961353|NCT03713684|526371110|FG003|Overall Study|Poor compliance to protocol|1|||
145961354|NCT03713684|526371107|FG000|Overall Study|Withdrawal by Subject|14|||
145961355|NCT03713684|526371108|FG001|Overall Study|Withdrawal by Subject|6|||
145961356|NCT03713684|526371109|FG002|Overall Study|Withdrawal by Subject|14|||
146085272|NCT02927067|526833536|FG000|Overall Study|Death|18|||
146085273|NCT02927067|526833537|FG001|Overall Study|Death|31|||
146085274|NCT02927067|526833536|FG000|Overall Study|Adverse Event|13|||
146225882|NCT01651403|527343729|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
146225883|NCT01651403|527343730|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
146225884|NCT05090683|527343733|FG000|Overall Study|Lost to Follow-up|10|||
146225885|NCT05090683|527343734|FG001|Overall Study|Lost to Follow-up|2|||
146225886|NCT05090683|527343733|FG000|Overall Study|Withdrawal by Subject|15|||
146225887|NCT05090683|527343734|FG001|Overall Study|Withdrawal by Subject|0|||
146225888|NCT04032847|527343735|FG000|Overall Study|Study termination by sponsor|8|||
146225889|NCT04032847|527343736|FG001|Overall Study|Study termination by sponsor|0|||
146225890|NCT04032847|527343737|FG002|Overall Study|Study termination by sponsor|4|||
146225891|NCT04032847|527343735|FG000|Overall Study|Death|12|||
146225892|NCT04032847|527343736|FG001|Overall Study|Death|0|||
146225893|NCT04032847|527343737|FG002|Overall Study|Death|0|||
146225894|NCT04032847|527343735|FG000|Overall Study|Progressive disease|2|||
146225895|NCT04032847|527343736|FG001|Overall Study|Progressive disease|0|||
146225896|NCT04032847|527343737|FG002|Overall Study|Progressive disease|1|||
146225897|NCT03325985|527343738|FG000|Overall Study|Lost to Follow-up|122|||
146225898|NCT03325985|527343739|FG001|Overall Study|Lost to Follow-up|26|||
146225899|NCT03325985|527343740|FG002|Overall Study|Lost to Follow-up|141|||
146225900|NCT03325985|527343741|FG003|Overall Study|Lost to Follow-up|28|||
146225901|NCT03325985|527343738|FG000|Overall Study|Death|99|||
146225902|NCT03325985|527343739|FG001|Overall Study|Death|36|||
146225903|NCT03325985|527343740|FG002|Overall Study|Death|94|||
146225904|NCT03325985|527343741|FG003|Overall Study|Death|32|||
146225905|NCT03213665|527343742|FG000|Overall Study|Adverse Event|1|||
146225906|NCT03213665|527343742|FG000|Overall Study|Physician Decision|2|||
146225907|NCT03213665|527343742|FG000|Overall Study|Withdrawal by Subject|3|||
146225908|NCT03213665|527343742|FG000|Overall Study|Progressive Disease|13|||
146225909|NCT03056573|527343743|FG000|Overall Study|Death|2|||
146225910|NCT03056573|527343744|FG001|Overall Study|Death|4|||
146225911|NCT03056573|527343743|FG000|Overall Study|Withdrawal by Subject|2|||
146225912|NCT03056573|527343744|FG001|Overall Study|Withdrawal by Subject|0|||
146225913|NCT03056573|527343743|FG000|Overall Study|Lost to Follow-up|1|||
146225914|NCT03056573|527343744|FG001|Overall Study|Lost to Follow-up|1|||
146225915|NCT03034356|527343745|FG000|Baseline|Lost to Follow-up|2|||
146225916|NCT03034356|527343746|FG001|Baseline|Lost to Follow-up|4|||
146225917|NCT03034356|527343745|FG000|Baseline|Withdrawal by Subject|2|||
146225918|NCT03034356|527343746|FG001|Baseline|Withdrawal by Subject|0|||
146225919|NCT03034356|527343745|FG000|Baseline|Physician Decision|0|||
146225920|NCT03034356|527343746|FG001|Baseline|Physician Decision|1|||
146225921|NCT03034356|527343745|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
145961357|NCT03713684|526371110|FG003|Overall Study|Withdrawal by Subject|16|||
146085275|NCT02927067|526833537|FG001|Overall Study|Adverse Event|10|||
146225922|NCT03034356|527343746|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
146225923|NCT03034356|527343745|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
146225924|NCT03034356|527343746|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
146225925|NCT03034356|527343745|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
146225926|NCT03034356|527343746|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
145961358|NCT03713684|526371107|FG000|Overall Study|Other than specified|69|||
145961359|NCT03713684|526371108|FG001|Overall Study|Other than specified|77|||
145961360|NCT03713684|526371109|FG002|Overall Study|Other than specified|73|||
146225927|NCT03034356|527343745|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
146225928|NCT03034356|527343746|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
146225929|NCT02684227|527343748|FG000|Overall Study|Adverse Event|1|||
146225930|NCT02684227|527343749|FG001|Overall Study|Adverse Event|7|||
146225931|NCT02684227|527343748|FG000|Overall Study|Death|0|||
146225932|NCT02684227|527343749|FG001|Overall Study|Death|2|||
146225933|NCT02684227|527343748|FG000|Overall Study|Withdrawal by Subject|0|||
146225934|NCT02684227|527343749|FG001|Overall Study|Withdrawal by Subject|1|||
146225935|NCT02684227|527343748|FG000|Overall Study|Progressive Disease|0|||
146225936|NCT02684227|527343749|FG001|Overall Study|Progressive Disease|2|||
146225937|NCT04689256|527343750|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
146225938|NCT04689256|527343751|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
146225939|NCT04428203|527343754|FG000|Overall Study|Adverse Event|1|||
146225940|NCT04428203|527343755|FG001|Overall Study|Adverse Event|0|||
146225941|NCT04428203|527343756|FG002|Overall Study|Adverse Event|0|||
146225942|NCT04428203|527343754|FG000|Overall Study|Withdrawal by Subject|1|||
146225943|NCT04428203|527343755|FG001|Overall Study|Withdrawal by Subject|0|||
146225944|NCT04428203|527343756|FG002|Overall Study|Withdrawal by Subject|1|||
146225945|NCT00323856|527343767|FG000|Overall Study|Withdrawal by Subject|1|||
146225946|NCT00323856|527343767|FG000|Overall Study|Was uncooperative and noncompliant|1|||
146225947|NCT00323856|527343767|FG000|Overall Study|Reason not specified|1|||
146225948|NCT00323856|527343767|FG000|Overall Study|Missing|2|||
146225949|NCT05809453|527345417|FG000|Overall Study|Withdrawal by Subject|1|||
146225950|NCT05809453|527345418|FG001|Overall Study|Withdrawal by Subject|0|||
146225951|NCT05809453|527345419|FG002|Overall Study|Withdrawal by Subject|0|||
146225952|NCT05809453|527345420|FG003|Overall Study|Withdrawal by Subject|0|||
146225953|NCT03916185|527345424|FG000|Overall Study|Lost to Follow-up|0|||
146225954|NCT03916185|527345425|FG001|Overall Study|Lost to Follow-up|1|||
146225955|NCT03916185|527345426|FG002|Overall Study|Lost to Follow-up|0|||
146225956|NCT03916185|527345427|FG003|Overall Study|Lost to Follow-up|0|||
146225957|NCT03916185|527345424|FG000|Overall Study|Moved|1|||
146225958|NCT03916185|527345425|FG001|Overall Study|Moved|0|||
146225959|NCT03916185|527345426|FG002|Overall Study|Moved|0|||
146225960|NCT03916185|527345427|FG003|Overall Study|Moved|1|||
146225961|NCT03916185|527345424|FG000|Overall Study|Not Able to Get to Clinic|1|||
146225962|NCT03916185|527345425|FG001|Overall Study|Not Able to Get to Clinic|0|||
146225963|NCT03916185|527345426|FG002|Overall Study|Not Able to Get to Clinic|0|||
146225964|NCT03916185|527345427|FG003|Overall Study|Not Able to Get to Clinic|0|||
146225965|NCT02844465|527345431|FG000|Overall Study|Screen Failure|36|||
146225966|NCT02844465|527345431|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
146225967|NCT02844465|527345431|FG000|Overall Study|Withdrawal by Subject|5|||
146225968|NCT02844465|527345431|FG000|Overall Study|Lost to Follow-up|1|||
146225969|NCT02844465|527345431|FG000|Overall Study|Retreatment|1|||
146225970|NCT05671653|527345433|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
146225971|NCT05671653|527345434|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
146225972|NCT05671653|527345435|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
146225973|NCT05671653|527345436|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
146225974|NCT05671653|527345437|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
146225975|NCT05671653|527345438|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
146225976|NCT05671653|527345439|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
146225977|NCT05671653|527345440|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
146225978|NCT05671653|527345441|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
146225979|NCT05671653|527345442|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
146225980|NCT05671653|527345443|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
146225981|NCT05671653|527345444|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
146225982|NCT05671653|527345445|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
146225983|NCT05671653|527345433|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225984|NCT05671653|527345434|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225985|NCT05671653|527345435|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225986|NCT05671653|527345436|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225987|NCT05671653|527345437|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225988|NCT05671653|527345438|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
146225989|NCT05671653|527345439|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225990|NCT05671653|527345440|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225991|NCT05671653|527345441|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225992|NCT05671653|527345442|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225993|NCT05671653|527345443|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225994|NCT05671653|527345444|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225995|NCT05671653|527345445|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
146225996|NCT05671653|527345433|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146225997|NCT05671653|527345434|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146225998|NCT05671653|527345435|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146225999|NCT05671653|527345436|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226000|NCT05671653|527345437|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226001|NCT05671653|527345438|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
146226002|NCT05671653|527345439|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226003|NCT05671653|527345440|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226004|NCT05671653|527345441|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226005|NCT05671653|527345442|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226006|NCT05671653|527345443|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226007|NCT05671653|527345444|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226008|NCT05671653|527345445|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
146226009|NCT05671653|527345433|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226010|NCT05671653|527345434|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226011|NCT05671653|527345435|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226012|NCT05671653|527345436|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226013|NCT05671653|527345437|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145961361|NCT03713684|526371110|FG003|Overall Study|Other than specified|70|||
146226014|NCT05671653|527345438|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226015|NCT05671653|527345439|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145883606|NCT03185741|526078516|FG002|6Month|Withdrawal by Subject|1|||
146226016|NCT05671653|527345440|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226017|NCT05671653|527345441|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
146226018|NCT05671653|527345442|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145883607|NCT03185741|526078514|FG000|6Month|Lost to Follow-up|16|||
145883608|NCT03185741|526078515|FG001|6Month|Lost to Follow-up|15|||
146226019|NCT05671653|527345443|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226020|NCT05671653|527345444|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226021|NCT05671653|527345445|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
146226022|NCT05671653|527345433|FG000|Cohort 2 Period 2|Adverse Event|0|||
146226023|NCT05671653|527345434|FG001|Cohort 2 Period 2|Adverse Event|0|||
146226024|NCT05671653|527345435|FG002|Cohort 2 Period 2|Adverse Event|0|||
146226025|NCT05671653|527345436|FG003|Cohort 2 Period 2|Adverse Event|0|||
146226026|NCT05671653|527345437|FG004|Cohort 2 Period 2|Adverse Event|0|||
146226027|NCT05671653|527345438|FG005|Cohort 2 Period 2|Adverse Event|0|||
146226028|NCT05671653|527345439|FG006|Cohort 2 Period 2|Adverse Event|0|||
145883609|NCT03185741|526078516|FG002|6Month|Lost to Follow-up|16|||
145883610|NCT01488448|526078517|FG000|Overall Study|Withdrawal by Subject|3|||
145883611|NCT01488448|526078518|FG001|Overall Study|Withdrawal by Subject|1|||
145883612|NCT01488448|526078517|FG000|Overall Study|Adverse Event|9|||
145883613|NCT01488448|526078518|FG001|Overall Study|Adverse Event|4|||
145883614|NCT01488448|526078517|FG000|Overall Study|Physician Decision|4|||
145883615|NCT01488448|526078518|FG001|Overall Study|Physician Decision|9|||
145883616|NCT01488448|526078517|FG000|Overall Study|Protocol Violation|4|||
145883617|NCT01488448|526078518|FG001|Overall Study|Protocol Violation|3|||
145883618|NCT00654641|526078519|FG000|Overall Study|Lost to Follow-up|2|||
145883619|NCT00654641|526078520|FG001|Overall Study|Lost to Follow-up|3|||
145883620|NCT01992094|526078521|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
145883621|NCT01992094|526078522|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
145883622|NCT01992094|526078523|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
145883623|NCT01992094|526078521|FG000|Overall Study|Adverse Event|1|||
145883624|NCT01992094|526078522|FG001|Overall Study|Adverse Event|0|||
145883625|NCT01992094|526078523|FG002|Overall Study|Adverse Event|0|||
145883626|NCT01992094|526078521|FG000|Overall Study|Death|5|||
145883627|NCT01992094|526078522|FG001|Overall Study|Death|5|||
145883628|NCT01992094|526078523|FG002|Overall Study|Death|2|||
145883629|NCT01992094|526078521|FG000|Overall Study|Lost to Follow-up|26|||
145883630|NCT01992094|526078522|FG001|Overall Study|Lost to Follow-up|9|||
145883631|NCT01992094|526078523|FG002|Overall Study|Lost to Follow-up|13|||
145883632|NCT01992094|526078521|FG000|Overall Study|OTHER|4|||
145883633|NCT01992094|526078522|FG001|Overall Study|OTHER|0|||
145883634|NCT01992094|526078523|FG002|Overall Study|OTHER|0|||
146226029|NCT05671653|527345440|FG007|Cohort 2 Period 2|Adverse Event|0|||
146226030|NCT05671653|527345441|FG008|Cohort 2 Period 2|Adverse Event|0|||
146226031|NCT05671653|527345442|FG009|Cohort 2 Period 2|Adverse Event|0|||
146226032|NCT05671653|527345443|FG010|Cohort 2 Period 2|Adverse Event|1|||
146289032|NCT00848926|527573312|FG000|Follow-up Period|Withdrawal by Subject|3|||
145883635|NCT01992094|526078521|FG000|Overall Study|Protocol Violation|1|||
145883636|NCT01992094|526078522|FG001|Overall Study|Protocol Violation|0|||
145883637|NCT01992094|526078523|FG002|Overall Study|Protocol Violation|1|||
146226033|NCT05671653|527345444|FG011|Cohort 2 Period 2|Adverse Event|0|||
146226034|NCT05671653|527345445|FG012|Cohort 2 Period 2|Adverse Event|0|||
145883638|NCT01992094|526078521|FG000|Overall Study|Withdrawal by Subject|7|||
145883639|NCT01992094|526078522|FG001|Overall Study|Withdrawal by Subject|3|||
146085276|NCT02927067|526833536|FG000|Overall Study|Noncompliance|5|||
146226035|NCT05671653|527345433|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
146226036|NCT05671653|527345434|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
146226037|NCT05671653|527345435|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
146226038|NCT05671653|527345436|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
145883640|NCT01992094|526078523|FG002|Overall Study|Withdrawal by Subject|4|||
146226039|NCT05671653|527345437|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
146226040|NCT05671653|527345438|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
146226041|NCT05671653|527345439|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
146226042|NCT05671653|527345440|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
146226043|NCT05671653|527345441|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
146226044|NCT05671653|527345442|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
146226045|NCT05671653|527345443|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
146226046|NCT05671653|527345444|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
146226047|NCT05671653|527345445|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
146226048|NCT05671653|527345433|FG000|Cohort 2 Period 2|Pregnancy|0|||
146085277|NCT02927067|526833537|FG001|Overall Study|Noncompliance|2|||
146085278|NCT02927067|526833536|FG000|Overall Study|Reason not Specified|4|||
146085279|NCT02927067|526833537|FG001|Overall Study|Reason not Specified|6|||
146226049|NCT05671653|527345434|FG001|Cohort 2 Period 2|Pregnancy|0|||
146226050|NCT05671653|527345435|FG002|Cohort 2 Period 2|Pregnancy|0|||
146226051|NCT05671653|527345436|FG003|Cohort 2 Period 2|Pregnancy|0|||
146226052|NCT05671653|527345437|FG004|Cohort 2 Period 2|Pregnancy|0|||
146226053|NCT05671653|527345438|FG005|Cohort 2 Period 2|Pregnancy|0|||
146226054|NCT05671653|527345439|FG006|Cohort 2 Period 2|Pregnancy|0|||
146226055|NCT05671653|527345440|FG007|Cohort 2 Period 2|Pregnancy|0|||
145961362|NCT02515630|526371111|FG000|Overall Study|Withdrawal by Subject|5|||
145961363|NCT02515630|526371111|FG000|Overall Study|Adverse Event|4|||
145961364|NCT02515630|526371111|FG000|Overall Study|Physician Decision|4|||
145961365|NCT02515630|526371111|FG000|Overall Study|Death|2|||
145961366|NCT02515630|526371111|FG000|Overall Study|Disease Progression|1|||
145961367|NCT00458003|526371112|FG000|Overall Study|Non protocol spinal anesthesia|1|||
145961368|NCT00458003|526371113|FG001|Overall Study|Non protocol spinal anesthesia|1|||
145961369|NCT02154139|526371118|FG000|Overall Study|Injection not administered|2|||
146085280|NCT02292784|526833540|FG000|Overall Study|Lost to Follow-up|1|||
146085281|NCT02292784|526833541|FG001|Overall Study|Lost to Follow-up|17|||
146226056|NCT05671653|527345441|FG008|Cohort 2 Period 2|Pregnancy|0|||
145961370|NCT02154139|526371118|FG000|Overall Study|Other|2|||
146085282|NCT02292784|526833542|FG002|Overall Study|Lost to Follow-up|18|||
145883641|NCT01321697|526078524|FG000|Overall Study|Study Terminated|7|||
145883642|NCT01049581|526078527|FG000|Overall Study|Lost to Follow-up|2|||
145883643|NCT01049581|526078528|FG001|Overall Study|Lost to Follow-up|1|||
145883644|NCT00810602|526078529|FG000|Overall Study|Withdrawal by Subject|8|||
145883645|NCT00810602|526078530|FG001|Overall Study|Withdrawal by Subject|3|||
145883646|NCT03840382|526078534|FG000|Overall Study|Lost to Follow-up|11|||
145883647|NCT02839798|526080264|FG000|Overall Study|Withdrawal by Subject|2|||
145883648|NCT04703855|526080265|FG000|Overall Study|Heart Transplant|1|||
145883649|NCT05258630|526080267|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
145883650|NCT05258630|526080268|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
145883651|NCT05258630|526080267|FG000|Overall Study|Lost to Follow-up|0|||
145883652|NCT05258630|526080268|FG001|Overall Study|Lost to Follow-up|2|||
145883653|NCT03431337|526080269|FG000|Overall Study|Lost to Follow-up|21|||
145883654|NCT03431337|526080270|FG001|Overall Study|Lost to Follow-up|19|||
145883655|NCT03431337|526080269|FG000|Overall Study|Withdrawal by Subject|8|||
145883656|NCT03431337|526080270|FG001|Overall Study|Withdrawal by Subject|3|||
145883657|NCT00401245|526080271|FG000|Double Blind Titration Phase|Adverse Event|3|||
145883658|NCT00401245|526080272|FG001|Double Blind Titration Phase|Adverse Event|2|||
145883659|NCT00401245|526080273|FG002|Double Blind Titration Phase|Adverse Event|5|||
145883660|NCT00401245|526080274|FG003|Double Blind Titration Phase|Adverse Event|12|||
145883661|NCT00401245|526080275|FG004|Double Blind Titration Phase|Adverse Event|0|||
145883662|NCT00401245|526080276|FG005|Double Blind Titration Phase|Adverse Event|0|||
145883663|NCT00401245|526080277|FG006|Double Blind Titration Phase|Adverse Event|0|||
145883664|NCT00401245|526080278|FG007|Double Blind Titration Phase|Adverse Event|0|||
145883665|NCT00401245|526080271|FG000|Double Blind Titration Phase|Other|0|||
145883666|NCT00401245|526080272|FG001|Double Blind Titration Phase|Other|0|||
145883667|NCT00401245|526080273|FG002|Double Blind Titration Phase|Other|1|||
145883668|NCT00401245|526080274|FG003|Double Blind Titration Phase|Other|0|||
145883669|NCT00401245|526080275|FG004|Double Blind Titration Phase|Other|0|||
146085283|NCT02292784|526833540|FG000|Overall Study|Withdrawal by Subject|0|||
146226057|NCT05671653|527345442|FG009|Cohort 2 Period 2|Pregnancy|0|||
146226058|NCT05671653|527345443|FG010|Cohort 2 Period 2|Pregnancy|1|||
146226059|NCT05671653|527345444|FG011|Cohort 2 Period 2|Pregnancy|0|||
145883670|NCT00401245|526080276|FG005|Double Blind Titration Phase|Other|0|||
145883671|NCT00401245|526080277|FG006|Double Blind Titration Phase|Other|0|||
145883672|NCT00401245|526080278|FG007|Double Blind Titration Phase|Other|0|||
145883673|NCT00401245|526080271|FG000|Double Blind Titration Phase|Protocol Violation|0|||
145883674|NCT00401245|526080272|FG001|Double Blind Titration Phase|Protocol Violation|0|||
145883675|NCT00401245|526080273|FG002|Double Blind Titration Phase|Protocol Violation|0|||
145883676|NCT00401245|526080274|FG003|Double Blind Titration Phase|Protocol Violation|1|||
145883677|NCT00401245|526080275|FG004|Double Blind Titration Phase|Protocol Violation|0|||
145961371|NCT02154139|526371118|FG000|Overall Study|Investigator transferred|3|||
145961372|NCT00473655|526371119|FG000|Overall Study|Lost to Follow-up|9|||
145961373|NCT00473655|526371120|FG001|Overall Study|Lost to Follow-up|5|||
145961374|NCT00473655|526371121|FG002|Overall Study|Lost to Follow-up|8|||
145961375|NCT02087774|526371123|FG000|Overall Study|Were absent day of data collection|8|||
145961376|NCT02087774|526371124|FG001|Overall Study|Were absent day of data collection|20|||
145961377|NCT00243919|526371132|FG000|Overall Study|Death|3|||
145961378|NCT00243919|526371133|FG001|Overall Study|Death|4|||
145961379|NCT00243919|526371134|FG002|Overall Study|Death|6|||
145961380|NCT00243919|526371132|FG000|Overall Study|Withdrawal by Subject|6|||
145961381|NCT00243919|526371133|FG001|Overall Study|Withdrawal by Subject|6|||
145961382|NCT00243919|526371134|FG002|Overall Study|Withdrawal by Subject|2|||
145961383|NCT00243919|526371132|FG000|Overall Study|Lost to Follow-up|6|||
145961384|NCT00243919|526371133|FG001|Overall Study|Lost to Follow-up|7|||
145961385|NCT00243919|526371134|FG002|Overall Study|Lost to Follow-up|3|||
145961386|NCT00243919|526371132|FG000|Overall Study|Administrative Error|1|||
145961387|NCT00243919|526371133|FG001|Overall Study|Administrative Error|0|||
145961388|NCT00243919|526371134|FG002|Overall Study|Administrative Error|0|||
145961389|NCT00243919|526371132|FG000|Overall Study|Physician Decision|1|||
145961390|NCT00243919|526371133|FG001|Overall Study|Physician Decision|1|||
145961391|NCT00243919|526371134|FG002|Overall Study|Physician Decision|0|||
145961392|NCT04919317|526371135|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
145961393|NCT04919317|526371136|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
145961394|NCT04919317|526371135|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
145961395|NCT04919317|526371136|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
145961396|NCT00230048|526371137|FG000|Overall Study|Lost to Follow-up|13|||
145961397|NCT00230048|526371138|FG001|Overall Study|Lost to Follow-up|18|||
145961398|NCT03225170|526371141|FG000|Overall Study|Lost to Follow-up|4|||
145961399|NCT03225170|526371142|FG001|Overall Study|Lost to Follow-up|4|||
145961400|NCT03225170|526371143|FG002|Overall Study|Lost to Follow-up|0|||
145961401|NCT03225170|526371141|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
145961402|NCT03225170|526371142|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
145961403|NCT03225170|526371143|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
145961404|NCT01529606|526371144|FG000|Overall Study|Lost to Follow-up|21|||
145961405|NCT01529606|526371145|FG001|Overall Study|Lost to Follow-up|18|||
145961406|NCT01746862|526371146|FG000|Overall Study|Withdrawal by Subject|1|||
145961407|NCT01746862|526371147|FG001|Overall Study|Withdrawal by Subject|1|||
145961408|NCT01746862|526371146|FG000|Overall Study|Protocol Violation|1|||
145961409|NCT01746862|526371147|FG001|Overall Study|Protocol Violation|0|||
145961410|NCT01746862|526371146|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
145961411|NCT01746862|526371147|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
145961412|NCT01746862|526371146|FG000|Overall Study|Entered puberty during the study|1|||
145961413|NCT01746862|526371147|FG001|Overall Study|Entered puberty during the study|0|||
145961414|NCT00731822|526371151|FG000|Overall Study|Adverse Event|2|||
145961415|NCT00731822|526371152|FG001|Overall Study|Adverse Event|1|||
145961416|NCT00731822|526371151|FG000|Overall Study|Protocol Violation|1|||
146226060|NCT05671653|527345445|FG012|Cohort 2 Period 2|Pregnancy|0|||
145961417|NCT00731822|526371152|FG001|Overall Study|Protocol Violation|0|||
145961418|NCT00731822|526371151|FG000|Overall Study|Lost to Follow-up|1|||
145961419|NCT00731822|526371152|FG001|Overall Study|Lost to Follow-up|0|||
145961420|NCT05209880|526371154|FG000|1-Month Follow-up|Spoke with Doctor|5|||
146226061|NCT05671653|527345433|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
145961421|NCT05209880|526371155|FG001|1-Month Follow-up|Spoke with Doctor|5|||
145961422|NCT05209880|526371154|FG000|1-Month Follow-up|Lost to Follow-up|7|||
145961423|NCT05209880|526371155|FG001|1-Month Follow-up|Lost to Follow-up|9|||
145961424|NCT05209880|526371154|FG000|1-Month Follow-up|Discontinued|0|||
145961425|NCT05209880|526371155|FG001|1-Month Follow-up|Discontinued|1|||
145961426|NCT05209880|526371154|FG000|3-Month Follow-up|Spoke with Doctor|17|||
145961427|NCT05209880|526371155|FG001|3-Month Follow-up|Spoke with Doctor|7|||
145961428|NCT05209880|526371154|FG000|3-Month Follow-up|Lost to Follow-up|8|||
145961429|NCT05209880|526371155|FG001|3-Month Follow-up|Lost to Follow-up|10|||
145961430|NCT05209880|526371154|FG000|3-Month Follow-up|Discontinued|1|||
145961431|NCT05209880|526371155|FG001|3-Month Follow-up|Discontinued|3|||
145961432|NCT05209880|526371154|FG000|6-Month Follow-up|Spoke with Doctor|25|||
145961433|NCT05209880|526371155|FG001|6-Month Follow-up|Spoke with Doctor|14|||
145961434|NCT05209880|526371154|FG000|6-Month Follow-up|Lost to Follow-up|9|||
145961435|NCT05209880|526371155|FG001|6-Month Follow-up|Lost to Follow-up|14|||
145961436|NCT05209880|526371154|FG000|6-Month Follow-up|Discontinued|1|||
145961437|NCT05209880|526371155|FG001|6-Month Follow-up|Discontinued|3|||
145961438|NCT05635045|526371158|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145961439|NCT05635045|526371159|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145961440|NCT05635045|526371160|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
145961441|NCT05635045|526371161|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145961442|NCT03143101|526371165|FG000|Overall Study|Withdrawal by Subject|0|||
145961443|NCT03143101|526371166|FG001|Overall Study|Withdrawal by Subject|1|||
145961444|NCT03143101|526371167|FG002|Overall Study|Withdrawal by Subject|0|||
145961445|NCT03143101|526371165|FG000|Overall Study|Lost to Follow-up|2|||
145961446|NCT03143101|526371166|FG001|Overall Study|Lost to Follow-up|2|||
145961447|NCT03143101|526371167|FG002|Overall Study|Lost to Follow-up|0|||
145961448|NCT05227118|526371170|FG000|Overall Study|Adverse Event|0|||
146289033|NCT00848926|527573312|FG000|Follow-up Period|Other|2|||
145961449|NCT05227118|526371171|FG001|Overall Study|Adverse Event|0|||
145961450|NCT05227118|526371172|FG002|Overall Study|Adverse Event|1|||
145961451|NCT05227118|526371173|FG003|Overall Study|Adverse Event|0|||
145961452|NCT05227118|526371170|FG000|Overall Study|Withdrawal by Subject|0|||
145961453|NCT05227118|526371171|FG001|Overall Study|Withdrawal by Subject|0|||
145961454|NCT05227118|526371172|FG002|Overall Study|Withdrawal by Subject|2|||
145961455|NCT05227118|526371173|FG003|Overall Study|Withdrawal by Subject|0|||
145961456|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
146226062|NCT05671653|527345434|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226063|NCT05671653|527345435|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226064|NCT05671653|527345436|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226065|NCT05671653|527345437|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226066|NCT05671653|527345438|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226067|NCT05671653|527345439|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226068|NCT05671653|527345440|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226069|NCT05671653|527345441|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226070|NCT05671653|527345442|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226071|NCT05671653|527345443|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
146226072|NCT05671653|527345444|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226073|NCT05671653|527345445|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
146226074|NCT05671653|527345433|FG000|Cohort 2 Period 2|Other|0|||
146226075|NCT05671653|527345434|FG001|Cohort 2 Period 2|Other|0|||
146226076|NCT05671653|527345435|FG002|Cohort 2 Period 2|Other|0|||
146226077|NCT05671653|527345436|FG003|Cohort 2 Period 2|Other|0|||
146226078|NCT05671653|527345437|FG004|Cohort 2 Period 2|Other|0|||
146226079|NCT05671653|527345438|FG005|Cohort 2 Period 2|Other|0|||
146226080|NCT05671653|527345439|FG006|Cohort 2 Period 2|Other|0|||
146226081|NCT05671653|527345440|FG007|Cohort 2 Period 2|Other|0|||
146226082|NCT05671653|527345441|FG008|Cohort 2 Period 2|Other|0|||
146226083|NCT05671653|527345442|FG009|Cohort 2 Period 2|Other|0|||
146226084|NCT05671653|527345443|FG010|Cohort 2 Period 2|Other|1|||
146226085|NCT05671653|527345444|FG011|Cohort 2 Period 2|Other|0|||
146226086|NCT05671653|527345445|FG012|Cohort 2 Period 2|Other|0|||
146226087|NCT05671653|527345433|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226088|NCT05671653|527345434|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226089|NCT05671653|527345435|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226090|NCT05671653|527345436|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226091|NCT05671653|527345437|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226092|NCT05671653|527345438|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226093|NCT05671653|527345439|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226094|NCT05671653|527345440|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226095|NCT05671653|527345441|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226096|NCT05671653|527345442|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226097|NCT05671653|527345443|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145961457|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
145961458|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
145961459|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
145961460|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
145961461|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
145961462|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
145961463|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
145961464|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
145961465|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
145961466|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
145961467|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
145961468|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
146085284|NCT02292784|526833541|FG001|Overall Study|Withdrawal by Subject|3|||
146085285|NCT02292784|526833542|FG002|Overall Study|Withdrawal by Subject|3|||
145961469|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145961470|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145961471|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
146226098|NCT05671653|527345444|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
146226099|NCT05671653|527345445|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
146226100|NCT02460458|527345450|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
146226101|NCT02460458|527345450|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
146085286|NCT00134784|526833543|FG000|Overall Study|Withdrawal by Subject|2|||
146085287|NCT00134784|526833544|FG001|Overall Study|Withdrawal by Subject|2|||
146226102|NCT02460458|527345450|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
145883678|NCT00401245|526080276|FG005|Double Blind Titration Phase|Protocol Violation|0|||
145883679|NCT00401245|526080277|FG006|Double Blind Titration Phase|Protocol Violation|0|||
145883680|NCT00401245|526080278|FG007|Double Blind Titration Phase|Protocol Violation|0|||
145883681|NCT00401245|526080271|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
145883682|NCT00401245|526080272|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
145883683|NCT00401245|526080273|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
145883684|NCT00401245|526080274|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
145883685|NCT00401245|526080275|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
145883686|NCT00401245|526080276|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
145883687|NCT00401245|526080277|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
145883688|NCT00401245|526080278|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
146226103|NCT02460458|527345450|FG000|First Prospective Phase|Lost to Follow-up|84|||
146226104|NCT02460458|527345450|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
146226105|NCT03220035|527345451|FG000|Overall Study|Adverse Event|1|||
146226106|NCT03220035|527345451|FG000|Overall Study|Protocol Violation|1|||
146226107|NCT03220035|527345451|FG000|Overall Study|Progressive Disease|2|||
146226108|NCT00696111|527345452|FG000|Overall Study|Withdrawal by Subject|17|||
146226109|NCT05299073|527345453|FG000|Overall Study|Withdrawal by Subject|0|||
146226110|NCT05299073|527345454|FG001|Overall Study|Withdrawal by Subject|0|||
146226111|NCT05299073|527345455|FG002|Overall Study|Withdrawal by Subject|1|||
146226112|NCT05299073|527345453|FG000|Overall Study|Adverse Event|0|||
146226113|NCT05299073|527345454|FG001|Overall Study|Adverse Event|1|||
146226114|NCT05299073|527345455|FG002|Overall Study|Adverse Event|0|||
146226115|NCT05299073|527345453|FG000|Overall Study|Lost to Follow-up|0|||
146226116|NCT05299073|527345454|FG001|Overall Study|Lost to Follow-up|1|||
146226117|NCT05299073|527345455|FG002|Overall Study|Lost to Follow-up|0|||
146226118|NCT02589795|527345457|FG000|Overall Study|Lost to Follow-up|1|||
146226119|NCT02589795|527345458|FG001|Overall Study|Lost to Follow-up|0|||
146226120|NCT02589795|527345459|FG002|Overall Study|Lost to Follow-up|0|||
146226121|NCT02589795|527345457|FG000|Overall Study|Withdrawal by Subject|0|||
146226122|NCT02589795|527345458|FG001|Overall Study|Withdrawal by Subject|0|||
146226123|NCT02589795|527345459|FG002|Overall Study|Withdrawal by Subject|2|||
146226124|NCT02589795|527345457|FG000|Overall Study|Protocol Violation|0|||
146226125|NCT02589795|527345458|FG001|Overall Study|Protocol Violation|0|||
146226126|NCT02589795|527345459|FG002|Overall Study|Protocol Violation|1|||
146226127|NCT04909801|527345460|FG000|Overall Study|Lack of Efficacy|2|||
146226128|NCT04909801|527345461|FG001|Overall Study|Lack of Efficacy|1|||
146085288|NCT00134784|526833545|FG002|Overall Study|Withdrawal by Subject|2|||
146085289|NCT00134784|526833546|FG003|Overall Study|Withdrawal by Subject|1|||
146085290|NCT02919969|526833547|FG000|Overall Study|Lack of Efficacy|22|||
146085291|NCT02919969|526833547|FG000|Overall Study|Death|4|||
145961472|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145961473|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145961474|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
145961475|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145961476|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145961477|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145961478|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145961479|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145961480|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
145961481|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961482|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146085292|NCT02919969|526833547|FG000|Overall Study|Physician Decision|3|||
146085293|NCT02919969|526833547|FG000|Overall Study|Withdrawal by Subject|2|||
146085294|NCT03621475|526833548|FG000|Overall Study|No longer required restraints at initiation|0|||
146226129|NCT04909801|527345460|FG000|Overall Study|Adverse Event|1|||
146226130|NCT04909801|527345461|FG001|Overall Study|Adverse Event|2|||
146226131|NCT04909801|527345460|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146226132|NCT04909801|527345461|FG001|Overall Study|Participant request to discontinue study treatment|2|||
146226133|NCT04909801|527345460|FG000|Overall Study|Withdrawal by Subject|2|||
146226134|NCT04909801|527345461|FG001|Overall Study|Withdrawal by Subject|1|||
146226135|NCT04909801|527345460|FG000|Overall Study|other reasons|1|||
146226136|NCT04909801|527345461|FG001|Overall Study|other reasons|1|||
146226137|NCT04550221|527345464|FG000|Overall Study|Lost to Follow-up|0|||
146226138|NCT04550221|527345465|FG001|Overall Study|Lost to Follow-up|4|||
146226139|NCT04550221|527345464|FG000|Overall Study|Withdrawn|3|||
146226140|NCT04550221|527345465|FG001|Overall Study|Withdrawn|0|||
146226141|NCT04550221|527345464|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
146226142|NCT04550221|527345465|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
146226143|NCT04811040|527345466|FG000|Overall Study|Lost to Follow-up|2|||
146226144|NCT04811040|527345467|FG001|Overall Study|Lost to Follow-up|0|||
145961483|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146226145|NCT04811040|527345468|FG002|Overall Study|Lost to Follow-up|0|||
146226146|NCT04811040|527345469|FG003|Overall Study|Lost to Follow-up|0|||
146085295|NCT03621475|526833549|FG001|Overall Study|No longer required restraints at initiation|1|||
146226147|NCT04811040|527345466|FG000|Overall Study|Withdrew consent|1|||
146226148|NCT04811040|527345467|FG001|Overall Study|Withdrew consent|1|||
146226149|NCT04811040|527345468|FG002|Overall Study|Withdrew consent|0|||
146226150|NCT04811040|527345469|FG003|Overall Study|Withdrew consent|0|||
146226151|NCT04447040|527345471|FG000|Overall Study|Lost to Follow-up|2|||
145883689|NCT00401245|526080271|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883690|NCT00401245|526080272|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
145883691|NCT00401245|526080273|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883692|NCT00401245|526080274|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
145883693|NCT00401245|526080275|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883694|NCT00401245|526080276|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883695|NCT00401245|526080277|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883696|NCT00401245|526080278|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145883697|NCT00401245|526080271|FG000|Open Label Phase|Adverse Event|5|||
145883698|NCT00401245|526080272|FG001|Open Label Phase|Adverse Event|14|||
145883699|NCT00401245|526080273|FG002|Open Label Phase|Adverse Event|6|||
145883700|NCT00401245|526080274|FG003|Open Label Phase|Adverse Event|7|||
145883701|NCT00401245|526080275|FG004|Open Label Phase|Adverse Event|0|||
145883702|NCT00401245|526080276|FG005|Open Label Phase|Adverse Event|0|||
145883703|NCT00401245|526080277|FG006|Open Label Phase|Adverse Event|0|||
145883704|NCT00401245|526080278|FG007|Open Label Phase|Adverse Event|0|||
145883705|NCT00401245|526080271|FG000|Open Label Phase|Lost to Follow-up|5|||
146085296|NCT01842633|526833550|FG000|Overall Study|Screen Failure|1|||
146085297|NCT01842633|526833551|FG001|Overall Study|Screen Failure|0|||
146085298|NCT01842633|526833552|FG002|Overall Study|Screen Failure|0|||
146085299|NCT01842633|526833550|FG000|Overall Study|Adverse Event|1|||
146085300|NCT01842633|526833551|FG001|Overall Study|Adverse Event|1|||
145883706|NCT00401245|526080272|FG001|Open Label Phase|Lost to Follow-up|7|||
145961484|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961485|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961486|NCT01435759|526371174|FG000|Antidepressant Lead-in Phase|Other|119|||
145961487|NCT01435759|526371175|FG001|Antidepressant Lead-in Phase|Other|0|||
145961488|NCT01435759|526371176|FG002|Antidepressant Lead-in Phase|Other|0|||
145961489|NCT01435759|526371177|FG003|Antidepressant Lead-in Phase|Other|0|||
145961490|NCT01435759|526371178|FG004|Antidepressant Lead-in Phase|Other|0|||
145961491|NCT01435759|526371179|FG005|Antidepressant Lead-in Phase|Other|0|||
145961492|NCT01435759|526371174|FG000|Double-blind Phase|Adverse Event|7|||
145961493|NCT01435759|526371175|FG001|Double-blind Phase|Adverse Event|0|||
145961494|NCT01435759|526371176|FG002|Double-blind Phase|Adverse Event|1|||
145961495|NCT01435759|526371177|FG003|Double-blind Phase|Adverse Event|1|||
145961496|NCT01435759|526371178|FG004|Double-blind Phase|Adverse Event|1|||
145961497|NCT01435759|526371179|FG005|Double-blind Phase|Adverse Event|3|||
145961498|NCT01435759|526371174|FG000|Double-blind Phase|Protocol Violation|2|||
145961499|NCT01435759|526371175|FG001|Double-blind Phase|Protocol Violation|0|||
145961500|NCT01435759|526371176|FG002|Double-blind Phase|Protocol Violation|1|||
145961501|NCT01435759|526371177|FG003|Double-blind Phase|Protocol Violation|2|||
145961502|NCT01435759|526371178|FG004|Double-blind Phase|Protocol Violation|0|||
146085301|NCT01842633|526833552|FG002|Overall Study|Adverse Event|0|||
145883707|NCT00401245|526080273|FG002|Open Label Phase|Lost to Follow-up|5|||
145961503|NCT01435759|526371179|FG005|Double-blind Phase|Protocol Violation|1|||
145961504|NCT01435759|526371174|FG000|Double-blind Phase|Withdrawal by Subject|17|||
145961505|NCT01435759|526371175|FG001|Double-blind Phase|Withdrawal by Subject|4|||
145961506|NCT01435759|526371176|FG002|Double-blind Phase|Withdrawal by Subject|3|||
145961507|NCT01435759|526371177|FG003|Double-blind Phase|Withdrawal by Subject|4|||
145961508|NCT01435759|526371178|FG004|Double-blind Phase|Withdrawal by Subject|2|||
146085302|NCT01842633|526833550|FG000|Overall Study|Withdrawal by Subject|0|||
146085303|NCT01842633|526833551|FG001|Overall Study|Withdrawal by Subject|1|||
146085304|NCT01842633|526833552|FG002|Overall Study|Withdrawal by Subject|0|||
146085305|NCT01842633|526833550|FG000|Overall Study|Technical issues|1|||
146085306|NCT01842633|526833551|FG001|Overall Study|Technical issues|0|||
146085307|NCT01842633|526833552|FG002|Overall Study|Technical issues|0|||
146085308|NCT00706849|526833558|FG000|Treatment Period|Adverse Event|0|||
146085309|NCT00706849|526833559|FG001|Treatment Period|Adverse Event|9|||
146085310|NCT00706849|526833558|FG000|Treatment Period|Other|0|||
146085311|NCT00706849|526833559|FG001|Treatment Period|Other|1|||
146085312|NCT00706849|526833558|FG000|Follow-up Period|Withdrawal by Subject|0|||
146085313|NCT00706849|526833559|FG001|Follow-up Period|Withdrawal by Subject|2|||
146085314|NCT00706849|526833558|FG000|Follow-up Period|Protocol non-compliance|0|||
146085315|NCT00706849|526833559|FG001|Follow-up Period|Protocol non-compliance|1|||
146085316|NCT02616601|526833560|FG000|Overall Study|Withdrawal by Subject|4|||
146085317|NCT02616601|526833561|FG001|Overall Study|Withdrawal by Subject|4|||
146085318|NCT02616601|526833562|FG002|Overall Study|Withdrawal by Subject|3|||
146085319|NCT02616601|526833560|FG000|Overall Study|Adverse Event|2|||
146085320|NCT02616601|526833561|FG001|Overall Study|Adverse Event|0|||
146085321|NCT02616601|526833562|FG002|Overall Study|Adverse Event|2|||
146085322|NCT02616601|526833560|FG000|Overall Study|Death|1|||
146085323|NCT02616601|526833561|FG001|Overall Study|Death|0|||
146085324|NCT02616601|526833562|FG002|Overall Study|Death|0|||
146085325|NCT02616601|526833560|FG000|Overall Study|Lost to Follow-up|1|||
146085326|NCT02616601|526833561|FG001|Overall Study|Lost to Follow-up|0|||
146085327|NCT02616601|526833562|FG002|Overall Study|Lost to Follow-up|1|||
146085328|NCT02616601|526833560|FG000|Overall Study|Non-Compliance with Test Article|1|||
146085329|NCT02616601|526833561|FG001|Overall Study|Non-Compliance with Test Article|0|||
146085330|NCT02616601|526833562|FG002|Overall Study|Non-Compliance with Test Article|1|||
146085331|NCT03718299|526833563|FG000|Overall Study|Adverse Event|1|||
146289034|NCT02203695|527573313|FG000|Overall Study|Patient withdrew consent|1|||
146289035|NCT02203695|527573314|FG001|Overall Study|Patient withdrew consent|1|||
146085332|NCT03718299|526833563|FG000|Overall Study|Withdrawal by Subject|6|||
146085333|NCT03718299|526833563|FG000|Overall Study|Physician Decision|2|||
146085334|NCT03718299|526833563|FG000|Overall Study|Lost to Follow-up|1|||
146085335|NCT04389970|526833564|FG000|Overall Study|Lost to Follow-up|1|||
146289036|NCT02203695|527573313|FG000|Overall Study|Started non-study treatment|1|||
145961509|NCT01435759|526371179|FG005|Double-blind Phase|Withdrawal by Subject|2|||
145961510|NCT01435759|526371174|FG000|Double-blind Phase|Lost to Follow-up|31|||
145961511|NCT01435759|526371175|FG001|Double-blind Phase|Lost to Follow-up|1|||
145961512|NCT01435759|526371176|FG002|Double-blind Phase|Lost to Follow-up|2|||
145961513|NCT01435759|526371177|FG003|Double-blind Phase|Lost to Follow-up|0|||
145961514|NCT01435759|526371178|FG004|Double-blind Phase|Lost to Follow-up|3|||
145961515|NCT01435759|526371179|FG005|Double-blind Phase|Lost to Follow-up|3|||
145961516|NCT01435759|526371174|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
145961517|NCT01435759|526371175|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961518|NCT01435759|526371176|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961519|NCT01435759|526371177|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961520|NCT01435759|526371178|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
145961521|NCT01435759|526371179|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145961522|NCT01435759|526371174|FG000|Double-blind Phase|Other|8|||
145961523|NCT01435759|526371175|FG001|Double-blind Phase|Other|2|||
145961524|NCT01435759|526371176|FG002|Double-blind Phase|Other|0|||
145961525|NCT01435759|526371177|FG003|Double-blind Phase|Other|2|||
145961526|NCT01435759|526371178|FG004|Double-blind Phase|Other|0|||
145961527|NCT01435759|526371179|FG005|Double-blind Phase|Other|0|||
145961528|NCT03727841|526371185|FG000|Overall Study|Physician Decision|3|||
145961529|NCT03727841|526371186|FG001|Overall Study|Physician Decision|1|||
145961530|NCT01601496|526371187|FG000|Overall Study|Physician Decision|1|||
145961531|NCT01601496|526371187|FG000|Overall Study|Withdrawal by Subject|1|||
145961532|NCT01601496|526371187|FG000|Overall Study|Lost to Follow-up|6|||
145961533|NCT01601496|526371187|FG000|Overall Study|Death|4|||
146226152|NCT04447040|527345472|FG001|Overall Study|Lost to Follow-up|1|||
146226153|NCT04447040|527345473|FG002|Overall Study|Lost to Follow-up|3|||
146226154|NCT04447040|527345474|FG003|Overall Study|Lost to Follow-up|3|||
146226155|NCT04447040|527345475|FG004|Overall Study|Lost to Follow-up|1|||
146226156|NCT04447040|527345476|FG005|Overall Study|Lost to Follow-up|3|||
146226157|NCT04447040|527345471|FG000|Overall Study|Withdrawal by Subject|0|||
146226158|NCT04447040|527345472|FG001|Overall Study|Withdrawal by Subject|1|||
145961534|NCT01601496|526371187|FG000|Overall Study|Other: patient refusal to continue|3|||
145961535|NCT03243305|526371188|FG000|Overall Study|Lost to Follow-up|250|||
145961536|NCT03243305|526371188|FG000|Overall Study|Withdrawal by Subject|170|||
145961537|NCT03243305|526371188|FG000|Overall Study|Pregnancy|104|||
145961538|NCT03243305|526371188|FG000|Overall Study|Non-Compliance with Study Drug|38|||
146085336|NCT01343823|526833565|FG000|Overall Study|Study Terminated|1|||
145961539|NCT03243305|526371188|FG000|Overall Study|Adverse Event|23|||
146085337|NCT01343823|526833566|FG001|Overall Study|Study Terminated|0|||
145961540|NCT03243305|526371188|FG000|Overall Study|No sexually active|26|||
146226159|NCT04447040|527345473|FG002|Overall Study|Withdrawal by Subject|1|||
146226160|NCT04447040|527345474|FG003|Overall Study|Withdrawal by Subject|1|||
146226161|NCT04447040|527345475|FG004|Overall Study|Withdrawal by Subject|0|||
146226162|NCT04447040|527345476|FG005|Overall Study|Withdrawal by Subject|0|||
146226163|NCT01208662|527345477|FG000|Induction and Consolidation|Disease Progression|23|||
146226164|NCT01208662|527345478|FG001|Induction and Consolidation|Disease Progression|13|||
146226165|NCT01208662|527345479|FG002|Induction and Consolidation|Disease Progression|0|||
146226166|NCT01208662|527345477|FG000|Induction and Consolidation|Adverse Event|16|||
146226167|NCT01208662|527345478|FG001|Induction and Consolidation|Adverse Event|18|||
146226168|NCT01208662|527345479|FG002|Induction and Consolidation|Adverse Event|2|||
146226169|NCT01208662|527345477|FG000|Induction and Consolidation|MD or Participant Decision|16|||
146226170|NCT01208662|527345478|FG001|Induction and Consolidation|MD or Participant Decision|34|||
146226171|NCT01208662|527345479|FG002|Induction and Consolidation|MD or Participant Decision|4|||
146226172|NCT01208662|527345477|FG000|Induction and Consolidation|Death|1|||
146226173|NCT01208662|527345478|FG001|Induction and Consolidation|Death|3|||
146226174|NCT01208662|527345479|FG002|Induction and Consolidation|Death|1|||
146226175|NCT01208662|527345477|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
146226176|NCT01208662|527345478|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
146226177|NCT01208662|527345479|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
146226178|NCT01208662|527345477|FG000|Maintenance|Disease Progression|156|||
146226179|NCT01208662|527345478|FG001|Maintenance|Disease Progression|102|||
146226180|NCT01208662|527345479|FG002|Maintenance|Disease Progression|0|||
146226181|NCT01208662|527345477|FG000|Maintenance|Adverse Event|12|||
146226182|NCT01208662|527345478|FG001|Maintenance|Adverse Event|28|||
146226183|NCT01208662|527345479|FG002|Maintenance|Adverse Event|0|||
146226184|NCT01208662|527345477|FG000|Maintenance|MD or Participant Decision|24|||
146226185|NCT01208662|527345478|FG001|Maintenance|MD or Participant Decision|36|||
146226186|NCT01208662|527345479|FG002|Maintenance|MD or Participant Decision|0|||
146226187|NCT01208662|527345477|FG000|Maintenance|Death|0|||
146226188|NCT01208662|527345478|FG001|Maintenance|Death|3|||
146085338|NCT01343823|526833567|FG002|Overall Study|Study Terminated|0|||
146085339|NCT01343823|526833568|FG003|Overall Study|Study Terminated|1|||
146085340|NCT01343823|526833565|FG000|Overall Study|Withdrawal by Subject|1|||
146085341|NCT01343823|526833566|FG001|Overall Study|Withdrawal by Subject|0|||
146085342|NCT01343823|526833567|FG002|Overall Study|Withdrawal by Subject|0|||
146085343|NCT01343823|526833568|FG003|Overall Study|Withdrawal by Subject|0|||
146085344|NCT02047318|526833580|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
146085345|NCT02047318|526833580|FG000|Core Study Period|Adverse Event|1|||
146085346|NCT02047318|526833580|FG000|Core Study Period|Withdrawal by caregiver|3|||
146085347|NCT02047318|526833580|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
146085348|NCT02296138|526833581|FG000|Overall Study|Adverse Event|348|||
146085349|NCT02296138|526833582|FG001|Overall Study|Adverse Event|259|||
146085350|NCT02296138|526833581|FG000|Overall Study|Lack of Efficacy|59|||
146085351|NCT02296138|526833582|FG001|Overall Study|Lack of Efficacy|37|||
146085352|NCT02296138|526833581|FG000|Overall Study|Protocol Violation|35|||
146085353|NCT02296138|526833582|FG001|Overall Study|Protocol Violation|36|||
146085354|NCT02296138|526833581|FG000|Overall Study|Lost to Follow-up|9|||
146085355|NCT02296138|526833582|FG001|Overall Study|Lost to Follow-up|12|||
146085356|NCT02296138|526833581|FG000|Overall Study|Withdrawal by Subject|184|||
146085357|NCT02296138|526833582|FG001|Overall Study|Withdrawal by Subject|131|||
146085358|NCT02296138|526833581|FG000|Overall Study|Not Treated|1|||
146085359|NCT02296138|526833582|FG001|Overall Study|Not Treated|1|||
146085360|NCT02296138|526833581|FG000|Overall Study|Patients with data irregularities|10|||
146085361|NCT02296138|526833582|FG001|Overall Study|Patients with data irregularities|11|||
146085362|NCT02296138|526833581|FG000|Overall Study|Other than specified|15|||
146085363|NCT02296138|526833582|FG001|Overall Study|Other than specified|13|||
146085364|NCT01653132|526833583|FG000|First Intervention|Protocol Violation|1|||
146085365|NCT01653132|526833584|FG001|First Intervention|Protocol Violation|0|||
146085366|NCT02677324|526833585|FG000|Overall Study|Disease Progression|6|||
146085367|NCT02677324|526833585|FG000|Overall Study|Inability to Swallow pills|1|||
146085368|NCT02677324|526833585|FG000|Overall Study|Non-compliance|1|||
146085369|NCT02677324|526833585|FG000|Overall Study|Lack of Efficacy|1|||
146085370|NCT02677324|526833585|FG000|Overall Study|Medical insurance coverage|1|||
146085371|NCT02677324|526833585|FG000|Overall Study|Adverse Event|1|||
146085372|NCT02677324|526833585|FG000|Overall Study|IgM Myeloma diagnosis|1|||
146085373|NCT00761150|526833588|FG000|Open-label Period|Adverse Event|36|||
146085374|NCT00761150|526833589|FG001|Open-label Period|Adverse Event|0|||
146085375|NCT00761150|526833590|FG002|Open-label Period|Adverse Event|0|||
146085376|NCT00761150|526833588|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
146085377|NCT00761150|526833589|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
146085378|NCT00761150|526833590|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
146226189|NCT01208662|527345479|FG002|Maintenance|Death|0|||
146226190|NCT01208662|527345477|FG000|Maintenance|Discontinued for other reasons|21|||
146226191|NCT01208662|527345478|FG001|Maintenance|Discontinued for other reasons|31|||
146226192|NCT01208662|527345479|FG002|Maintenance|Discontinued for other reasons|0|||
146226193|NCT01208662|527345477|FG000|Maintenance|Still on Treatment|78|||
146226194|NCT01208662|527345478|FG001|Maintenance|Still on Treatment|89|||
146226195|NCT01208662|527345479|FG002|Maintenance|Still on Treatment|0|||
146226196|NCT04076618|527345480|FG000|Overall Study|Lost to Follow-up|2|||
146226197|NCT04076618|527345481|FG001|Overall Study|Lost to Follow-up|1|||
146226198|NCT04076618|527345482|FG002|Overall Study|Lost to Follow-up|3|||
145883708|NCT00401245|526080274|FG003|Open Label Phase|Lost to Follow-up|4|||
145883709|NCT00401245|526080275|FG004|Open Label Phase|Lost to Follow-up|0|||
145883710|NCT00401245|526080276|FG005|Open Label Phase|Lost to Follow-up|0|||
145883711|NCT00401245|526080277|FG006|Open Label Phase|Lost to Follow-up|0|||
145883712|NCT00401245|526080278|FG007|Open Label Phase|Lost to Follow-up|0|||
145883713|NCT00401245|526080271|FG000|Open Label Phase|Other|4|||
146226199|NCT04076618|527345480|FG000|Overall Study|Withdrawal by Subject|3|||
146226200|NCT04076618|527345481|FG001|Overall Study|Withdrawal by Subject|1|||
146226201|NCT04076618|527345482|FG002|Overall Study|Withdrawal by Subject|2|||
146226202|NCT04076618|527345480|FG000|Overall Study|Relocated out of state|0|||
146226203|NCT04076618|527345481|FG001|Overall Study|Relocated out of state|2|||
145883714|NCT00401245|526080272|FG001|Open Label Phase|Other|8|||
145883715|NCT00401245|526080273|FG002|Open Label Phase|Other|7|||
145883716|NCT00401245|526080274|FG003|Open Label Phase|Other|8|||
145883717|NCT00401245|526080275|FG004|Open Label Phase|Other|0|||
145883718|NCT00401245|526080276|FG005|Open Label Phase|Other|0|||
145883719|NCT00401245|526080277|FG006|Open Label Phase|Other|0|||
145883720|NCT00401245|526080278|FG007|Open Label Phase|Other|0|||
145961541|NCT03243305|526371188|FG000|Overall Study|Physician Decision|22|||
145883721|NCT00401245|526080271|FG000|Open Label Phase|Protocol Violation|0|||
146226204|NCT04076618|527345482|FG002|Overall Study|Relocated out of state|0|||
146226205|NCT04076618|527345480|FG000|Overall Study|COVID concerns|0|||
146226206|NCT04076618|527345481|FG001|Overall Study|COVID concerns|1|||
146226207|NCT04076618|527345482|FG002|Overall Study|COVID concerns|0|||
145961542|NCT03243305|526371188|FG000|Overall Study|Protocol Violation|22|||
145961543|NCT03243305|526371188|FG000|Overall Study|Study method no longer primary method|12|||
145961544|NCT03243305|526371188|FG000|Overall Study|Study Terminated by Sponsor|1|||
145961545|NCT03243305|526371188|FG000|Overall Study|Early terminations|267|||
145961546|NCT00871234|526371193|FG000|Overall Study|Adverse Event|2|||
145961547|NCT00871234|526371193|FG000|Overall Study|Lost to Follow-up|3|||
145961548|NCT02782741|526371194|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
145961549|NCT02782741|526371195|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
145961550|NCT02782741|526371196|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
145961551|NCT02782741|526371194|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
145961552|NCT02782741|526371195|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
145961553|NCT02782741|526371196|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
145961554|NCT02782741|526371194|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
145961555|NCT02782741|526371195|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
145961556|NCT02782741|526371196|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
145961557|NCT02782741|526371194|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
145961558|NCT02782741|526371195|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
145961559|NCT02782741|526371196|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
145961560|NCT02782741|526371194|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
145961561|NCT02782741|526371195|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
145961562|NCT02782741|526371196|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
145961563|NCT04157088|526371197|FG000|Overall Study|Study terminated by sponsor|23|||
145961564|NCT04157088|526371197|FG000|Overall Study|Withdrawal by Subject|4|||
145961565|NCT04157088|526371197|FG000|Overall Study|Lost to Follow-up|2|||
145961566|NCT04157088|526371197|FG000|Overall Study|Death|1|||
145961567|NCT02421419|526371198|FG000|Overall Study|Physician Decision|0|||
145961568|NCT02421419|526371199|FG001|Overall Study|Physician Decision|0|||
145961569|NCT02421419|526371200|FG002|Overall Study|Physician Decision|1|||
145961570|NCT01676701|526371201|FG000|Overall Study|Protocol Violation|1|||
145961571|NCT01676701|526371202|FG001|Overall Study|Protocol Violation|0|||
145961572|NCT01676701|526371201|FG000|Overall Study|Sponsor Decision|3|||
145961573|NCT01676701|526371202|FG001|Overall Study|Sponsor Decision|4|||
146226208|NCT04076618|527345480|FG000|Overall Study|Adverse Event|0|||
146226209|NCT04076618|527345481|FG001|Overall Study|Adverse Event|0|||
145961574|NCT02115607|526371203|FG000|Overall Study|Withdrawal by Subject|1|||
145961575|NCT00196105|526371207|FG000|Overall Study|Lost to Follow-up|4|||
145961576|NCT00196105|526371208|FG001|Overall Study|Lost to Follow-up|5|||
145961577|NCT00196105|526371209|FG002|Overall Study|Lost to Follow-up|7|||
145961578|NCT04863872|526371210|FG000|Overall Study|Withdrawal by Subject|4|||
145961579|NCT04863872|526371211|FG001|Overall Study|Withdrawal by Subject|15|||
146085379|NCT00761150|526833588|FG000|Open-label Period|Lost to Follow-up|7|||
146085380|NCT00761150|526833589|FG001|Open-label Period|Lost to Follow-up|0|||
146085381|NCT00761150|526833590|FG002|Open-label Period|Lost to Follow-up|0|||
146085382|NCT00761150|526833588|FG000|Open-label Period|Lack of Efficacy|4|||
146085383|NCT00761150|526833589|FG001|Open-label Period|Lack of Efficacy|0|||
146085384|NCT00761150|526833590|FG002|Open-label Period|Lack of Efficacy|0|||
146085385|NCT00761150|526833588|FG000|Open-label Period|Withdrawal by Subject|5|||
146226210|NCT04076618|527345482|FG002|Overall Study|Adverse Event|2|||
146226211|NCT00321048|527345483|FG000|Overall Study|Withdrawal by Subject|6|||
146226212|NCT00321048|527345484|FG001|Overall Study|Withdrawal by Subject|8|||
146226213|NCT04433208|527345485|FG000|Overall Study|Withdrawal by Subject|0|||
146226214|NCT04433208|527345486|FG001|Overall Study|Withdrawal by Subject|1|||
146226215|NCT04433208|527345487|FG002|Overall Study|Withdrawal by Subject|1|||
146226216|NCT04433208|527345488|FG003|Overall Study|Withdrawal by Subject|0|||
145883722|NCT00401245|526080272|FG001|Open Label Phase|Protocol Violation|1|||
146226217|NCT04433208|527345489|FG004|Overall Study|Withdrawal by Subject|2|||
145883723|NCT00401245|526080273|FG002|Open Label Phase|Protocol Violation|0|||
145883724|NCT00401245|526080274|FG003|Open Label Phase|Protocol Violation|1|||
146085386|NCT00761150|526833589|FG001|Open-label Period|Withdrawal by Subject|0|||
145883725|NCT00401245|526080275|FG004|Open Label Phase|Protocol Violation|0|||
145883726|NCT00401245|526080276|FG005|Open Label Phase|Protocol Violation|0|||
146289037|NCT02203695|527573314|FG001|Overall Study|Started non-study treatment|0|||
145883727|NCT00401245|526080277|FG006|Open Label Phase|Protocol Violation|0|||
145883728|NCT00401245|526080278|FG007|Open Label Phase|Protocol Violation|0|||
145883729|NCT00401245|526080271|FG000|Open Label Phase|Withdrawal by Subject|3|||
145883730|NCT00401245|526080272|FG001|Open Label Phase|Withdrawal by Subject|3|||
145883731|NCT00401245|526080273|FG002|Open Label Phase|Withdrawal by Subject|2|||
145883732|NCT00401245|526080274|FG003|Open Label Phase|Withdrawal by Subject|1|||
145883733|NCT00401245|526080275|FG004|Open Label Phase|Withdrawal by Subject|0|||
146289038|NCT01000636|527573316|FG000|Overall Study|Withdrawal by Subject|1|||
146289039|NCT01000636|527573316|FG000|Overall Study|Adverse Event|1|||
146289040|NCT03451162|527573317|FG000|Overall Study|Lost to Follow-up|1|||
146289041|NCT03451162|527573318|FG001|Overall Study|Lost to Follow-up|0|||
146289042|NCT03451162|527573319|FG002|Overall Study|Lost to Follow-up|0|||
146289043|NCT03451162|527573320|FG003|Overall Study|Lost to Follow-up|0|||
146289044|NCT03451162|527573321|FG004|Overall Study|Lost to Follow-up|0|||
145883734|NCT00401245|526080276|FG005|Open Label Phase|Withdrawal by Subject|0|||
145883735|NCT00401245|526080277|FG006|Open Label Phase|Withdrawal by Subject|0|||
145883736|NCT00401245|526080278|FG007|Open Label Phase|Withdrawal by Subject|0|||
145883737|NCT00401245|526080271|FG000|Open Label Phase|Lack of Efficacy|4|||
145883738|NCT00401245|526080272|FG001|Open Label Phase|Lack of Efficacy|2|||
145883739|NCT00401245|526080273|FG002|Open Label Phase|Lack of Efficacy|3|||
145883740|NCT00401245|526080274|FG003|Open Label Phase|Lack of Efficacy|0|||
145883741|NCT00401245|526080275|FG004|Open Label Phase|Lack of Efficacy|0|||
145883742|NCT00401245|526080276|FG005|Open Label Phase|Lack of Efficacy|0|||
145883743|NCT00401245|526080277|FG006|Open Label Phase|Lack of Efficacy|0|||
145883744|NCT00401245|526080278|FG007|Open Label Phase|Lack of Efficacy|0|||
145883745|NCT00401245|526080271|FG000|Double Blind Tapering Phase|Adverse Event|0|||
145883746|NCT00401245|526080272|FG001|Double Blind Tapering Phase|Adverse Event|0|||
145883747|NCT00401245|526080273|FG002|Double Blind Tapering Phase|Adverse Event|0|||
145883748|NCT00401245|526080274|FG003|Double Blind Tapering Phase|Adverse Event|0|||
145883749|NCT00401245|526080275|FG004|Double Blind Tapering Phase|Adverse Event|1|||
145883750|NCT00401245|526080276|FG005|Double Blind Tapering Phase|Adverse Event|1|||
145883751|NCT00401245|526080277|FG006|Double Blind Tapering Phase|Adverse Event|2|||
145883752|NCT00401245|526080278|FG007|Double Blind Tapering Phase|Adverse Event|4|||
145883753|NCT00401245|526080271|FG000|Double Blind Tapering Phase|Investigator request|0|||
145883754|NCT00401245|526080272|FG001|Double Blind Tapering Phase|Investigator request|0|||
145883755|NCT00401245|526080273|FG002|Double Blind Tapering Phase|Investigator request|0|||
145883756|NCT00401245|526080274|FG003|Double Blind Tapering Phase|Investigator request|0|||
145883757|NCT00401245|526080275|FG004|Double Blind Tapering Phase|Investigator request|0|||
145883758|NCT00401245|526080276|FG005|Double Blind Tapering Phase|Investigator request|0|||
145883759|NCT00401245|526080277|FG006|Double Blind Tapering Phase|Investigator request|0|||
145883760|NCT00401245|526080278|FG007|Double Blind Tapering Phase|Investigator request|1|||
145883761|NCT00401245|526080271|FG000|Double Blind Tapering Phase|Other|0|||
145883762|NCT00401245|526080272|FG001|Double Blind Tapering Phase|Other|0|||
145883763|NCT00401245|526080273|FG002|Double Blind Tapering Phase|Other|0|||
145883764|NCT00401245|526080274|FG003|Double Blind Tapering Phase|Other|0|||
145883765|NCT00401245|526080275|FG004|Double Blind Tapering Phase|Other|1|||
145883766|NCT00401245|526080276|FG005|Double Blind Tapering Phase|Other|0|||
145883767|NCT00401245|526080277|FG006|Double Blind Tapering Phase|Other|2|||
145883768|NCT00401245|526080278|FG007|Double Blind Tapering Phase|Other|2|||
145883769|NCT00401245|526080271|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145883770|NCT00401245|526080272|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145883771|NCT00401245|526080273|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145883772|NCT00401245|526080274|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145883773|NCT00401245|526080275|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
145883774|NCT00401245|526080276|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
145883775|NCT00401245|526080277|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
145883776|NCT00401245|526080278|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145883777|NCT00401245|526080271|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883778|NCT00401245|526080272|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883779|NCT00401245|526080273|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883780|NCT00401245|526080274|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883781|NCT00401245|526080275|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883782|NCT00401245|526080276|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
145883783|NCT00401245|526080277|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
145883784|NCT00401245|526080278|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
146289045|NCT03451162|527573317|FG000|Overall Study|Physician Decision|0|||
145883785|NCT01560819|526080282|FG000|Overall Study|Physician Decision|1|||
145883786|NCT01560819|526080283|FG001|Overall Study|Physician Decision|0|||
145883787|NCT02014441|526080284|FG000|Overall Study|Withdrawal by Subject|12|||
145883788|NCT01363011|526080285|FG000|Main Study|Adverse Event|2|||
145883789|NCT01363011|526080286|FG001|Main Study|Adverse Event|3|||
145883790|NCT01363011|526080285|FG000|Main Study|Investigator's Discretion|1|||
146289046|NCT03451162|527573318|FG001|Overall Study|Physician Decision|1|||
145883791|NCT01363011|526080286|FG001|Main Study|Investigator's Discretion|1|||
145883792|NCT01363011|526080285|FG000|Main Study|Withdrew Consent|1|||
145883793|NCT01363011|526080286|FG001|Main Study|Withdrew Consent|4|||
145883794|NCT01363011|526080285|FG000|Main Study|Protocol Violation|0|||
145883795|NCT01363011|526080286|FG001|Main Study|Protocol Violation|1|||
145883796|NCT01363011|526080285|FG000|Extension Phase|Adverse Event|1|||
145883797|NCT01363011|526080286|FG001|Extension Phase|Adverse Event|1|||
145883798|NCT01363011|526080285|FG000|Extension Phase|Lack of Efficacy|0|||
145883799|NCT01363011|526080286|FG001|Extension Phase|Lack of Efficacy|1|||
145883800|NCT01363011|526080285|FG000|Extension Phase|Investigator's Discretion|2|||
145883801|NCT01363011|526080286|FG001|Extension Phase|Investigator's Discretion|2|||
145883802|NCT01363011|526080285|FG000|Extension Phase|Withdrew Consent|0|||
145883803|NCT01363011|526080286|FG001|Extension Phase|Withdrew Consent|1|||
145883804|NCT01363011|526080285|FG000|Extension Phase|Lost to Follow-up|0|||
145883805|NCT01363011|526080286|FG001|Extension Phase|Lost to Follow-up|2|||
145883806|NCT01363011|526080285|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
145883807|NCT01363011|526080286|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
145883808|NCT00114231|526080288|FG000|Overall Study|No consent|2|||
145883809|NCT00114231|526080289|FG001|Overall Study|No consent|0|||
145883810|NCT00114231|526080288|FG000|Overall Study|QARC requirement not met|1|||
145883811|NCT00114231|526080289|FG001|Overall Study|QARC requirement not met|0|||
145883812|NCT00114231|526080288|FG000|Overall Study|Suspected metastatic disease|1|||
145883813|NCT00114231|526080289|FG001|Overall Study|Suspected metastatic disease|0|||
145883814|NCT00114231|526080288|FG000|Overall Study|No adenocarcinoma|1|||
145883815|NCT00114231|526080289|FG001|Overall Study|No adenocarcinoma|0|||
145883816|NCT00114231|526080288|FG000|Overall Study|Low creatinine clearance|0|||
145883817|NCT00114231|526080289|FG001|Overall Study|Low creatinine clearance|1|||
145883818|NCT00114231|526080288|FG000|Overall Study|Tumor size > 4cm|1|||
145883819|NCT00114231|526080289|FG001|Overall Study|Tumor size > 4cm|0|||
145883820|NCT00114231|526080288|FG000|Overall Study|Tumor fixed on digital exam|0|||
145883821|NCT00114231|526080289|FG001|Overall Study|Tumor fixed on digital exam|1|||
145883822|NCT00114231|526080288|FG000|Overall Study|No Absolute Neutrophil Count|2|||
145883823|NCT00114231|526080289|FG001|Overall Study|No Absolute Neutrophil Count|0|||
145883824|NCT00114231|526080288|FG000|Overall Study|Biopsy done after registration|1|||
145883825|NCT00114231|526080289|FG001|Overall Study|Biopsy done after registration|0|||
145883826|NCT01961882|526080294|FG000|Overall Study|Adverse Event|3|||
145883827|NCT01961882|526080295|FG001|Overall Study|Adverse Event|2|||
145883828|NCT01961882|526080294|FG000|Overall Study|Physician Decision|1|||
145883829|NCT01961882|526080295|FG001|Overall Study|Physician Decision|0|||
145883830|NCT01961882|526080294|FG000|Overall Study|Withdrawal by Subject|4|||
145883831|NCT01961882|526080295|FG001|Overall Study|Withdrawal by Subject|1|||
145883832|NCT01961882|526080294|FG000|Overall Study|Relapse of AML|39|||
145883833|NCT01961882|526080295|FG001|Overall Study|Relapse of AML|37|||
145883834|NCT01961882|526080294|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
145883835|NCT01961882|526080295|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
145883836|NCT01961882|526080294|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
145883837|NCT01961882|526080295|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
145883838|NCT01901848|526080296|FG000|Randomized and Treated|Lost to Follow-up|3|||
145883839|NCT01901848|526080297|FG001|Randomized and Treated|Lost to Follow-up|6|||
145883840|NCT01901848|526080296|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
145883841|NCT01901848|526080297|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
145883842|NCT01729026|526080298|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
146085387|NCT00761150|526833590|FG002|Open-label Period|Withdrawal by Subject|0|||
146085388|NCT00761150|526833588|FG000|Open-label Period|Noncompliance|2|||
146085389|NCT00761150|526833589|FG001|Open-label Period|Noncompliance|0|||
146226218|NCT04433208|527345490|FG005|Overall Study|Withdrawal by Subject|1|||
146226219|NCT04433208|527345485|FG000|Overall Study|Lost to Follow-up|0|||
146226220|NCT04433208|527345486|FG001|Overall Study|Lost to Follow-up|0|||
146226221|NCT04433208|527345487|FG002|Overall Study|Lost to Follow-up|0|||
145883843|NCT01729026|526080299|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
145883844|NCT01729026|526080298|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
145883845|NCT01729026|526080299|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
145883846|NCT02488824|526080300|FG000|Overall Study|Adverse Event|1|||
145883847|NCT02488824|526080301|FG001|Overall Study|Adverse Event|1|||
145883848|NCT02668822|526080306|FG000|Overall Study|Protocol Violation|2|||
146226222|NCT04433208|527345488|FG003|Overall Study|Lost to Follow-up|0|||
146226223|NCT04433208|527345489|FG004|Overall Study|Lost to Follow-up|0|||
146226224|NCT04433208|527345490|FG005|Overall Study|Lost to Follow-up|1|||
146226225|NCT02296684|527345502|FG000|Overall Study|Withdrawal by Subject|0|||
146226226|NCT02296684|527345503|FG001|Overall Study|Withdrawal by Subject|1|||
146226227|NCT02296684|527345504|FG002|Overall Study|Withdrawal by Subject|1|||
146226228|NCT02296684|527345502|FG000|Overall Study|Death|2|||
146226229|NCT02296684|527345503|FG001|Overall Study|Death|0|||
146226230|NCT02296684|527345504|FG002|Overall Study|Death|0|||
146226231|NCT03571581|527345505|FG000|Overall Study|Death|2|||
146226232|NCT03571581|527345505|FG000|Overall Study|Withdrawal by Subject|2|||
146226233|NCT04141891|527345506|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
145883849|NCT02668822|526080307|FG001|Overall Study|Protocol Violation|0|||
145883850|NCT02668822|526080306|FG000|Overall Study|Study Terminated by Sponsor|7|||
145883851|NCT02668822|526080307|FG001|Overall Study|Study Terminated by Sponsor|9|||
145883852|NCT03036839|526080308|FG000|Overall Study|Adverse Event|0|||
145883853|NCT03036839|526080309|FG001|Overall Study|Adverse Event|0|||
145883854|NCT03036839|526080310|FG002|Overall Study|Adverse Event|1|||
145883855|NCT03036839|526080308|FG000|Overall Study|Death|3|||
145883856|NCT03036839|526080309|FG001|Overall Study|Death|0|||
145883857|NCT03036839|526080310|FG002|Overall Study|Death|3|||
145883858|NCT03036839|526080308|FG000|Overall Study|Withdrew Consent|0|||
146226234|NCT04141891|527345507|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
145883859|NCT03036839|526080309|FG001|Overall Study|Withdrew Consent|0|||
145883860|NCT03036839|526080310|FG002|Overall Study|Withdrew Consent|1|||
145883861|NCT00412737|526080311|FG000|Overall Study|Death|1|||
145883862|NCT00412737|526080312|FG001|Overall Study|Death|0|||
145883863|NCT00412737|526080311|FG000|Overall Study|Adverse Event|3|||
145883864|NCT00412737|526080312|FG001|Overall Study|Adverse Event|2|||
145883865|NCT00412737|526080311|FG000|Overall Study|Refused Treatment|6|||
145883866|NCT00412737|526080312|FG001|Overall Study|Refused Treatment|2|||
145883867|NCT00412737|526080311|FG000|Overall Study|Failure to Return|6|||
145883868|NCT00412737|526080312|FG001|Overall Study|Failure to Return|2|||
145883869|NCT00298740|526080313|FG000|Overall Study|Lack of Efficacy|6|||
145883870|NCT00298740|526080313|FG000|Overall Study|Withdrawal by Subject|3|||
145883871|NCT01064531|526080314|FG000|Overall Study|Lost to Follow-up|0|||
145883872|NCT01064531|526080315|FG001|Overall Study|Lost to Follow-up|2|||
145883873|NCT01064531|526080314|FG000|Overall Study|Physician Decision|0|||
145883874|NCT01064531|526080315|FG001|Overall Study|Physician Decision|1|||
145883875|NCT01064531|526080314|FG000|Overall Study|Withdrawal by Subject|2|||
145883876|NCT01064531|526080315|FG001|Overall Study|Withdrawal by Subject|2|||
145883877|NCT01064531|526080314|FG000|Overall Study|Revision due to femoral stem loosening|1|||
145883878|NCT01064531|526080315|FG001|Overall Study|Revision due to femoral stem loosening|0|||
145883879|NCT01064531|526080314|FG000|Overall Study|Revision due to dislocation|0|||
146226235|NCT04141891|527345506|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
146226236|NCT04141891|527345507|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
146226237|NCT04141891|527345506|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
146226238|NCT04141891|527345507|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
146226239|NCT04141891|527345506|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
145883880|NCT01064531|526080315|FG001|Overall Study|Revision due to dislocation|1|||
145883881|NCT01064531|526080314|FG000|Overall Study|Death|0|||
145883882|NCT01064531|526080315|FG001|Overall Study|Death|1|||
145883883|NCT01270620|526080319|FG000|Overall Study|Withdrawal by Subject|1|||
145883884|NCT01270620|526080320|FG001|Overall Study|Withdrawal by Subject|3|||
145883885|NCT00684567|526080321|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
145883886|NCT00684567|526080321|FG000|Monotherapy Period|Adverse Event|2|||
145961580|NCT04863872|526371210|FG000|Overall Study|Death|5|||
145883887|NCT00684567|526080321|FG000|Monotherapy Period|Death|1|||
146226240|NCT04141891|527345507|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
146226241|NCT04141891|527345506|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
146226242|NCT04141891|527345507|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
146226243|NCT04141891|527345506|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
146226244|NCT04141891|527345507|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
146226245|NCT04141891|527345506|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
146226246|NCT04141891|527345507|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
146226247|NCT04141891|527345506|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
146226248|NCT04141891|527345507|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
146226249|NCT04141891|527345506|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
146226250|NCT04141891|527345507|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
146226251|NCT04141891|527345506|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
146226252|NCT04141891|527345507|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
146226253|NCT04141891|527345506|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
146226254|NCT04141891|527345507|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
146226255|NCT04141891|527345506|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
146226256|NCT04141891|527345507|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
146226257|NCT04141891|527345506|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
146226258|NCT04141891|527345507|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
146226259|NCT04141891|527345506|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
146226260|NCT04141891|527345507|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
146226261|NCT03626220|527345508|FG000|Overall Study|Withdrawal by Subject|2|||
146226262|NCT03626220|527345509|FG001|Overall Study|Withdrawal by Subject|0|||
146226263|NCT05565820|527345518|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
146226264|NCT05565820|527345519|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
146226265|NCT05565820|527345518|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
146226266|NCT05565820|527345519|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
146226267|NCT03295721|527345520|FG000|Overall Study|Adverse Event|1|||
146226268|NCT03295721|527345521|FG001|Overall Study|Adverse Event|0|||
146226269|NCT03295721|527345522|FG002|Overall Study|Adverse Event|0|||
146226270|NCT03295721|527345520|FG000|Overall Study|Lost to Follow-up|1|||
146226271|NCT03295721|527345521|FG001|Overall Study|Lost to Follow-up|1|||
146226272|NCT03295721|527345522|FG002|Overall Study|Lost to Follow-up|1|||
146226273|NCT03295721|527345520|FG000|Overall Study|Withdrawal by Subject|1|||
146226274|NCT03295721|527345521|FG001|Overall Study|Withdrawal by Subject|0|||
146226275|NCT03295721|527345522|FG002|Overall Study|Withdrawal by Subject|1|||
146226276|NCT03295721|527345520|FG000|Overall Study|Death|0|||
146226277|NCT03295721|527345521|FG001|Overall Study|Death|0|||
146226278|NCT03295721|527345522|FG002|Overall Study|Death|1|||
146226279|NCT00429364|527345525|FG000|Overall Study|Withdrawal by Subject|11|||
146226280|NCT00429364|527345526|FG001|Overall Study|Withdrawal by Subject|5|||
146226281|NCT00429364|527345525|FG000|Overall Study|Physician Decision|4|||
146226282|NCT00429364|527345526|FG001|Overall Study|Physician Decision|2|||
146226283|NCT00429364|527345525|FG000|Overall Study|Lost to Follow-up|7|||
146226284|NCT00429364|527345526|FG001|Overall Study|Lost to Follow-up|6|||
146226285|NCT00429364|527345525|FG000|Overall Study|Death|0|||
146226286|NCT00429364|527345526|FG001|Overall Study|Death|1|||
146226287|NCT00429364|527345525|FG000|Overall Study|Underwent aortic root surgery|10|||
146226288|NCT00429364|527345526|FG001|Overall Study|Underwent aortic root surgery|18|||
146226289|NCT00429364|527345525|FG000|Overall Study|Pregnancy|0|||
146226290|NCT00429364|527345526|FG001|Overall Study|Pregnancy|1|||
146226291|NCT04871529|527345527|FG000|Overall Study|Withdrawal by Subject|0|||
146226292|NCT04871529|527345528|FG001|Overall Study|Withdrawal by Subject|1|||
146226293|NCT04871529|527345527|FG000|Overall Study|Death|0|||
146226294|NCT04871529|527345528|FG001|Overall Study|Death|1|||
146226295|NCT04871529|527345527|FG000|Overall Study|Not protocol specified|0|||
146226296|NCT04871529|527345528|FG001|Overall Study|Not protocol specified|1|||
146226297|NCT05184452|527345529|FG000|Overall Study|Lost to Follow-up|0|||
146226298|NCT05184452|527345530|FG001|Overall Study|Lost to Follow-up|0|||
146226299|NCT05184452|527345531|FG002|Overall Study|Lost to Follow-up|0|||
146226300|NCT05184452|527345532|FG003|Overall Study|Lost to Follow-up|0|||
146226301|NCT05184452|527345533|FG004|Overall Study|Lost to Follow-up|0|||
146226302|NCT05184452|527345534|FG005|Overall Study|Lost to Follow-up|2|||
146226303|NCT05184452|527345535|FG006|Overall Study|Lost to Follow-up|0|||
145883888|NCT00684567|526080321|FG000|Monotherapy Period|Progression of primary disease|11|||
145883889|NCT00906373|526080322|FG000|Overall Study|Withdrawal by Subject|0|||
145883890|NCT00906373|526080323|FG001|Overall Study|Withdrawal by Subject|5|||
146226304|NCT05184452|527345536|FG007|Overall Study|Lost to Follow-up|0|||
146226305|NCT05184452|527345537|FG008|Overall Study|Lost to Follow-up|0|||
146226306|NCT05184452|527345538|FG009|Overall Study|Lost to Follow-up|1|||
146289047|NCT03451162|527573319|FG002|Overall Study|Physician Decision|0|||
145883891|NCT00906373|526080322|FG000|Overall Study|Other|0|||
145883892|NCT00906373|526080323|FG001|Overall Study|Other|1|||
146226307|NCT05184452|527345529|FG000|Overall Study|Withdrawal by Subject|0|||
146226308|NCT05184452|527345530|FG001|Overall Study|Withdrawal by Subject|0|||
146226309|NCT05184452|527345531|FG002|Overall Study|Withdrawal by Subject|0|||
146226310|NCT05184452|527345532|FG003|Overall Study|Withdrawal by Subject|0|||
146226311|NCT05184452|527345533|FG004|Overall Study|Withdrawal by Subject|0|||
146226312|NCT05184452|527345534|FG005|Overall Study|Withdrawal by Subject|1|||
146226313|NCT05184452|527345535|FG006|Overall Study|Withdrawal by Subject|0|||
146226314|NCT05184452|527345536|FG007|Overall Study|Withdrawal by Subject|0|||
146226315|NCT05184452|527345537|FG008|Overall Study|Withdrawal by Subject|0|||
146226316|NCT05184452|527345538|FG009|Overall Study|Withdrawal by Subject|1|||
146226317|NCT05586490|527345539|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146226318|NCT05586490|527345540|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146226319|NCT05586490|527345541|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
146226320|NCT05586490|527345542|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146226321|NCT05586490|527345543|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
146226322|NCT05586490|527345539|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
146226323|NCT05586490|527345540|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146226324|NCT05586490|527345541|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146226325|NCT05586490|527345542|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146226326|NCT05586490|527345543|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
146226327|NCT05586490|527345539|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
146226328|NCT05586490|527345540|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146226329|NCT05586490|527345541|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146226330|NCT05586490|527345542|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146226331|NCT05586490|527345543|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
146226332|NCT05267470|527345544|FG000|Overall Study|Decision by sponsor|0|||
146226333|NCT05267470|527345545|FG001|Overall Study|Decision by sponsor|3|||
146226334|NCT05267470|527345546|FG002|Overall Study|Decision by sponsor|19|||
146226335|NCT05267470|527345547|FG003|Overall Study|Decision by sponsor|7|||
146226336|NCT05267470|527345548|FG004|Overall Study|Decision by sponsor|3|||
146226337|NCT05267470|527345544|FG000|Overall Study|Withdrawal by Subject|1|||
146226338|NCT05267470|527345545|FG001|Overall Study|Withdrawal by Subject|1|||
146226339|NCT05267470|527345546|FG002|Overall Study|Withdrawal by Subject|2|||
145883893|NCT00906373|526080322|FG000|Overall Study|Still on treatment at cutoff date|0|||
145883894|NCT00906373|526080323|FG001|Overall Study|Still on treatment at cutoff date|2|||
145883895|NCT01597479|526080324|FG000|Overall Study|Protocol Violation|1|||
145883896|NCT01597479|526080325|FG001|Overall Study|Protocol Violation|0|||
145883897|NCT01597479|526080324|FG000|Overall Study|Lost to Follow-up|1|||
145883898|NCT01597479|526080325|FG001|Overall Study|Lost to Follow-up|0|||
145883899|NCT04317599|526080326|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
145883900|NCT04317599|526080326|FG000|Overall Study|treatment outside standard of care|4|||
145883901|NCT00809965|526080327|FG000|Overall Study|Death|194|||
145883902|NCT00809965|526080328|FG001|Overall Study|Death|147|||
145883903|NCT00809965|526080329|FG002|Overall Study|Death|196|||
145883904|NCT00809965|526080327|FG000|Overall Study|Lost to Follow-up|17|||
145883905|NCT00809965|526080328|FG001|Overall Study|Lost to Follow-up|10|||
145883906|NCT00809965|526080329|FG002|Overall Study|Lost to Follow-up|18|||
145883907|NCT00809965|526080327|FG000|Overall Study|Withdrawal by Subject|405|||
145883908|NCT00809965|526080328|FG001|Overall Study|Withdrawal by Subject|448|||
145883909|NCT00809965|526080329|FG002|Overall Study|Withdrawal by Subject|441|||
145883910|NCT00809965|526080327|FG000|Overall Study|Other Reason|167|||
145883911|NCT00809965|526080328|FG001|Overall Study|Other Reason|170|||
145883912|NCT00809965|526080329|FG002|Overall Study|Other Reason|189|||
145883913|NCT01628549|526080332|FG000|Overall Study|Adverse Event|1|||
145883914|NCT01628549|526080333|FG001|Overall Study|Adverse Event|1|||
145883915|NCT01628549|526080334|FG002|Overall Study|Adverse Event|0|||
145883916|NCT01628549|526080335|FG003|Overall Study|Adverse Event|4|||
145883917|NCT01628549|526080332|FG000|Overall Study|Lost to Follow-up|3|||
145883918|NCT01628549|526080333|FG001|Overall Study|Lost to Follow-up|4|||
145883919|NCT01628549|526080334|FG002|Overall Study|Lost to Follow-up|3|||
145883920|NCT01628549|526080335|FG003|Overall Study|Lost to Follow-up|3|||
145961581|NCT04863872|526371211|FG001|Overall Study|Death|2|||
145961582|NCT04863872|526371210|FG000|Overall Study|Lost to Follow-up|2|||
146226340|NCT05267470|527345547|FG003|Overall Study|Withdrawal by Subject|2|||
146226341|NCT05267470|527345548|FG004|Overall Study|Withdrawal by Subject|0|||
146226342|NCT05267470|527345544|FG000|Overall Study|Death|3|||
146226343|NCT05267470|527345545|FG001|Overall Study|Death|5|||
146226344|NCT05267470|527345546|FG002|Overall Study|Death|8|||
146226345|NCT05267470|527345547|FG003|Overall Study|Death|18|||
145883921|NCT01628549|526080332|FG000|Overall Study|Withdrawal by Subject|3|||
145883922|NCT01628549|526080333|FG001|Overall Study|Withdrawal by Subject|4|||
145883923|NCT01628549|526080334|FG002|Overall Study|Withdrawal by Subject|4|||
145883924|NCT01628549|526080335|FG003|Overall Study|Withdrawal by Subject|1|||
145883925|NCT01628549|526080332|FG000|Overall Study|Protocol Violation|2|||
145961583|NCT04863872|526371211|FG001|Overall Study|Lost to Follow-up|1|||
145883926|NCT01628549|526080333|FG001|Overall Study|Protocol Violation|1|||
145883927|NCT01628549|526080334|FG002|Overall Study|Protocol Violation|1|||
146226346|NCT05267470|527345548|FG004|Overall Study|Death|1|||
146226347|NCT05267470|527345544|FG000|Overall Study|Lost to Follow-up|0|||
146226348|NCT05267470|527345545|FG001|Overall Study|Lost to Follow-up|0|||
146226349|NCT05267470|527345546|FG002|Overall Study|Lost to Follow-up|0|||
146226350|NCT05267470|527345547|FG003|Overall Study|Lost to Follow-up|1|||
146226351|NCT05267470|527345548|FG004|Overall Study|Lost to Follow-up|0|||
146226352|NCT05828017|527345549|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
146226353|NCT05425420|527345552|FG000|Overall Study|Physician Decision|1|||
146226354|NCT05425420|527345552|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
146226355|NCT04571619|527345553|FG000|Phase 1|Death|22|||
146226356|NCT04571619|527345554|FG001|Phase 1|Death|18|||
146226357|NCT04571619|527345553|FG000|Phase 1|Withdrawal by Subject|7|||
146226358|NCT04571619|527345554|FG001|Phase 1|Withdrawal by Subject|2|||
146226359|NCT04571619|527345553|FG000|Phase 2|Death|13|||
146226360|NCT04571619|527345554|FG001|Phase 2|Death|16|||
146226361|NCT04571619|527345553|FG000|Phase 2|Withdrawal by Subject|6|||
146226362|NCT04571619|527345554|FG001|Phase 2|Withdrawal by Subject|4|||
146226363|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
146226364|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
146226365|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
146226366|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
146226367|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
146226368|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
146226369|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
146226370|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
145961584|NCT04058028|526371212|FG000|Overall Study|Withdrawal of Consent from Study|12|||
145961585|NCT04058028|526371213|FG001|Overall Study|Withdrawal of Consent from Study|8|||
145961586|NCT04058028|526371214|FG002|Overall Study|Withdrawal of Consent from Study|6|||
145961587|NCT04058028|526371215|FG003|Overall Study|Withdrawal of Consent from Study|7|||
145961588|NCT04058028|526371212|FG000|Overall Study|Decision by Sponsor|13|||
145961589|NCT04058028|526371213|FG001|Overall Study|Decision by Sponsor|4|||
145961590|NCT04058028|526371214|FG002|Overall Study|Decision by Sponsor|1|||
145961591|NCT04058028|526371215|FG003|Overall Study|Decision by Sponsor|35|||
145961592|NCT04058028|526371212|FG000|Overall Study|Lost to Follow-up|1|||
145961593|NCT04058028|526371213|FG001|Overall Study|Lost to Follow-up|1|||
145961594|NCT04058028|526371214|FG002|Overall Study|Lost to Follow-up|1|||
145961595|NCT04058028|526371215|FG003|Overall Study|Lost to Follow-up|0|||
145961596|NCT04058028|526371212|FG000|Overall Study|Death|0|||
145961597|NCT04058028|526371213|FG001|Overall Study|Death|1|||
145961598|NCT04058028|526371214|FG002|Overall Study|Death|0|||
145961599|NCT04058028|526371215|FG003|Overall Study|Death|0|||
145961600|NCT00102596|526371216|FG000|Part A|Screen failures|6|||
145961601|NCT00102596|526371217|FG001|Part A|Screen failures|0|||
145961602|NCT00102596|526371216|FG000|Part A|Adverse Event|1|||
145961603|NCT00102596|526371217|FG001|Part A|Adverse Event|0|||
145961604|NCT01275144|526371218|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
145961605|NCT01275144|526371219|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
146226371|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
146226372|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
146226373|NCT02361216|527345555|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
145961606|NCT05607576|526371221|FG000|Overall Study|immediate sensor error|2|||
145961607|NCT05607576|526371221|FG000|Overall Study|Physician Decision|2|||
145961608|NCT02998151|526371222|FG000|Overall Study|Withdrawal by Subject|3|||
145961609|NCT02998151|526371222|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
145961610|NCT02998151|526371222|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
146226374|NCT02361216|527345556|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
146226375|NCT05452460|527347047|FG000|Overall Study|Lost to Follow-up|3|||
146226376|NCT05452460|527347048|FG001|Overall Study|Lost to Follow-up|3|||
146226377|NCT05452460|527347047|FG000|Overall Study|Did not receive intervention|1|||
146226378|NCT05452460|527347048|FG001|Overall Study|Did not receive intervention|0|||
146226379|NCT03676192|527347051|FG000|Induction Study Period|Adverse Event|21|||
146226380|NCT03676192|527347052|FG001|Induction Study Period|Adverse Event|20|||
146226381|NCT03676192|527347051|FG000|Induction Study Period|Death|23|||
146226382|NCT03676192|527347052|FG001|Induction Study Period|Death|20|||
146226383|NCT03676192|527347051|FG000|Induction Study Period|Lost to Follow-up|3|||
146226384|NCT03676192|527347052|FG001|Induction Study Period|Lost to Follow-up|3|||
146226385|NCT03676192|527347051|FG000|Induction Study Period|Physician Decision|6|||
146226386|NCT03676192|527347052|FG001|Induction Study Period|Physician Decision|3|||
146226387|NCT03676192|527347051|FG000|Induction Study Period|Progressive Disease|32|||
146226388|NCT03676192|527347052|FG001|Induction Study Period|Progressive Disease|21|||
146226389|NCT03676192|527347051|FG000|Induction Study Period|Protocol Violation|1|||
146226390|NCT03676192|527347052|FG001|Induction Study Period|Protocol Violation|2|||
146226391|NCT03676192|527347051|FG000|Induction Study Period|Withdrawal by Subject|20|||
146226392|NCT03676192|527347052|FG001|Induction Study Period|Withdrawal by Subject|15|||
146226393|NCT03386578|527347054|FG000|PK Component|Lost to Follow-up|0|||
146226394|NCT03386578|527347055|FG001|PK Component|Lost to Follow-up|1|||
146226395|NCT03386578|527347056|FG002|PK Component|Lost to Follow-up|0|||
146226396|NCT03386578|527347057|FG003|PK Component|Lost to Follow-up|0|||
146226397|NCT03386578|527347058|FG004|PK Component|Lost to Follow-up|0|||
146226398|NCT03386578|527347059|FG005|PK Component|Lost to Follow-up|0|||
146226399|NCT03386578|527347060|FG006|PK Component|Lost to Follow-up|1|||
146226400|NCT03386578|527347061|FG007|PK Component|Lost to Follow-up|0|||
146226401|NCT03386578|527347062|FG008|PK Component|Lost to Follow-up|0|||
146226402|NCT03386578|527347063|FG009|PK Component|Lost to Follow-up|0|||
146226403|NCT03386578|527347054|FG000|PK Component|Stillbirth/Abortion|0|||
146226404|NCT03386578|527347055|FG001|PK Component|Stillbirth/Abortion|0|||
146226405|NCT03386578|527347056|FG002|PK Component|Stillbirth/Abortion|0|||
146226406|NCT03386578|527347057|FG003|PK Component|Stillbirth/Abortion|0|||
146226407|NCT03386578|527347058|FG004|PK Component|Stillbirth/Abortion|0|||
146226408|NCT03386578|527347059|FG005|PK Component|Stillbirth/Abortion|2|||
146226409|NCT03386578|527347060|FG006|PK Component|Stillbirth/Abortion|0|||
146226410|NCT03386578|527347061|FG007|PK Component|Stillbirth/Abortion|0|||
146226411|NCT03386578|527347062|FG008|PK Component|Stillbirth/Abortion|0|||
146226412|NCT03386578|527347063|FG009|PK Component|Stillbirth/Abortion|0|||
146226413|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146226414|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146226415|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
146226416|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
146226417|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146226418|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145883928|NCT01628549|526080335|FG003|Overall Study|Protocol Violation|0|||
145883929|NCT01628549|526080332|FG000|Overall Study|withdrawn for noncompliance|0|||
145883930|NCT01628549|526080333|FG001|Overall Study|withdrawn for noncompliance|2|||
145883931|NCT01628549|526080334|FG002|Overall Study|withdrawn for noncompliance|1|||
145883932|NCT01628549|526080335|FG003|Overall Study|withdrawn for noncompliance|0|||
145883933|NCT01628549|526080332|FG000|Overall Study|abnormal laboratory test results|0|||
145883934|NCT01628549|526080333|FG001|Overall Study|abnormal laboratory test results|0|||
145883935|NCT01628549|526080334|FG002|Overall Study|abnormal laboratory test results|1|||
145883936|NCT01628549|526080335|FG003|Overall Study|abnormal laboratory test results|0|||
145883937|NCT01628549|526080332|FG000|Overall Study|positive pregnancy test|0|||
145883938|NCT01628549|526080333|FG001|Overall Study|positive pregnancy test|0|||
145883939|NCT01628549|526080334|FG002|Overall Study|positive pregnancy test|0|||
145883940|NCT01628549|526080335|FG003|Overall Study|positive pregnancy test|1|||
145883941|NCT01999894|526080336|FG000|Overall Study|Adverse Event|9|||
145883942|NCT01999894|526080336|FG000|Overall Study|Lack of Efficacy|5|||
145883943|NCT01999894|526080336|FG000|Overall Study|Protocol Violation|1|||
145883944|NCT01999894|526080336|FG000|Overall Study|Withdrawal by Subject|7|||
145883945|NCT01999894|526080336|FG000|Overall Study|Lost to Follow-up|10|||
145883946|NCT01999894|526080336|FG000|Overall Study|Other Reason|3|||
145883947|NCT01999894|526080336|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
145883948|NCT00194792|526080339|FG000|Overall Study|Withdrawal by Subject|1|||
145883949|NCT00372996|526080341|FG000|Overall Study|Death|11|||
145883950|NCT00372996|526080342|FG001|Overall Study|Death|4|||
145883951|NCT00372996|526080343|FG002|Overall Study|Death|8|||
145883952|NCT00372996|526080344|FG003|Overall Study|Death|7|||
145883953|NCT00372996|526080341|FG000|Overall Study|Lost to Follow-up|0|||
145883954|NCT00372996|526080342|FG001|Overall Study|Lost to Follow-up|2|||
145883955|NCT00372996|526080343|FG002|Overall Study|Lost to Follow-up|0|||
145883956|NCT00372996|526080344|FG003|Overall Study|Lost to Follow-up|1|||
145883957|NCT00372996|526080341|FG000|Overall Study|Withdrawal by Subject|12|||
145883958|NCT00372996|526080342|FG001|Overall Study|Withdrawal by Subject|6|||
145961611|NCT00735007|526371228|FG000|Overall Study|Adverse Event|4|||
146226419|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145883959|NCT00372996|526080343|FG002|Overall Study|Withdrawal by Subject|9|||
145961612|NCT00735007|526371228|FG000|Overall Study|Protocol Violation|1|||
145961613|NCT03811821|526371229|FG000|Overall Study|Adverse Event|1|||
145883960|NCT00372996|526080344|FG003|Overall Study|Withdrawal by Subject|5|||
145883961|NCT00372996|526080341|FG000|Overall Study|Study Terminated by Sponsor|4|||
145883962|NCT00372996|526080342|FG001|Overall Study|Study Terminated by Sponsor|0|||
145883963|NCT00372996|526080343|FG002|Overall Study|Study Terminated by Sponsor|4|||
145961614|NCT03811821|526371230|FG001|Overall Study|Adverse Event|1|||
145961615|NCT03811821|526371229|FG000|Overall Study|Withdrawal by Subject|5|||
145961616|NCT03811821|526371230|FG001|Overall Study|Withdrawal by Subject|4|||
145961617|NCT03811821|526371229|FG000|Overall Study|Lost to Follow-up|2|||
145961618|NCT03811821|526371230|FG001|Overall Study|Lost to Follow-up|2|||
145961619|NCT03811821|526371229|FG000|Overall Study|Contraindication for treatment|0|||
145961620|NCT03811821|526371230|FG001|Overall Study|Contraindication for treatment|1|||
145961621|NCT03811821|526371229|FG000|Overall Study|Tolerability|0|||
145961622|NCT03811821|526371230|FG001|Overall Study|Tolerability|3|||
145961623|NCT03811821|526371229|FG000|Overall Study|Comorbidities|0|||
145961624|NCT03811821|526371230|FG001|Overall Study|Comorbidities|2|||
146289048|NCT03451162|527573320|FG003|Overall Study|Physician Decision|0|||
146289049|NCT03451162|527573321|FG004|Overall Study|Physician Decision|0|||
145961625|NCT05027815|526371234|FG000|Overall Study|Death|2|||
145961626|NCT05027815|526371235|FG001|Overall Study|Death|1|||
145961627|NCT00447902|526371239|FG000|Overall Study|Adverse Event|0|||
145961628|NCT00447902|526371240|FG001|Overall Study|Adverse Event|3|||
145961629|NCT00447902|526371239|FG000|Overall Study|Protocol Violation|1|||
145961630|NCT00447902|526371240|FG001|Overall Study|Protocol Violation|0|||
146289050|NCT03451162|527573317|FG000|Overall Study|Withdrawal by Subject|1|||
145961631|NCT00447902|526371239|FG000|Overall Study|Withdrawal by Subject|0|||
146289051|NCT03451162|527573318|FG001|Overall Study|Withdrawal by Subject|1|||
146226420|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
146226421|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
146226422|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
146226423|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226424|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226425|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
146226426|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
146226427|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226428|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226429|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226430|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
146226431|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
146226432|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
146226433|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Death|0|||
146226434|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Death|0|||
146226435|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Death|1|||
146226436|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Death|0|||
146226437|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Death|0|||
146226438|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Death|0|||
146226439|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Death|0|||
145883964|NCT00372996|526080344|FG003|Overall Study|Study Terminated by Sponsor|0|||
145883965|NCT00372996|526080341|FG000|Overall Study|Other|10|||
145883966|NCT00372996|526080342|FG001|Overall Study|Other|2|||
145883967|NCT00372996|526080343|FG002|Overall Study|Other|7|||
145883968|NCT00372996|526080344|FG003|Overall Study|Other|7|||
145883969|NCT01186016|526080345|FG000|Overall Study|Withdrawal by Subject|46|||
145883970|NCT01186016|526080346|FG001|Overall Study|Withdrawal by Subject|29|||
145883971|NCT01077258|526080351|FG000|Overall Study|Lost to Follow-up|1390|||
145883972|NCT01077258|526080351|FG000|Overall Study|Adverse drug reaction|218|||
145883973|NCT01077258|526080351|FG000|Overall Study|Lack of Efficacy|663|||
145883974|NCT01077258|526080351|FG000|Overall Study|Clinical remission|37|||
145883975|NCT01077258|526080351|FG000|Overall Study|Other reasons|260|||
145883976|NCT00515216|526080352|FG000|Overall Study|Withdrawal by Subject|1|||
145883977|NCT01115933|526080355|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
145883978|NCT01086969|526080364|FG000|Overall Study|Withdrawal by Subject|1|||
145883979|NCT01086969|526080365|FG001|Overall Study|Withdrawal by Subject|2|||
145883980|NCT01086969|526080366|FG002|Overall Study|Withdrawal by Subject|0|||
145883981|NCT02418754|526080373|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145883982|NCT02418754|526080374|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
145883983|NCT02418754|526080375|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145883984|NCT02418754|526080376|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145883985|NCT02418754|526080377|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145883986|NCT02418754|526080373|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
145883987|NCT02418754|526080374|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
145883988|NCT02418754|526080375|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
145883989|NCT02418754|526080376|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
145883990|NCT02418754|526080377|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
145883991|NCT02418754|526080373|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
145883992|NCT02418754|526080374|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145883993|NCT02418754|526080375|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145883994|NCT02418754|526080376|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145883995|NCT02418754|526080377|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145883996|NCT02418754|526080373|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145883997|NCT02418754|526080374|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
145883998|NCT02418754|526080375|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
145883999|NCT02418754|526080376|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145884000|NCT02418754|526080377|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145884001|NCT02418754|526080373|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145884002|NCT02418754|526080374|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145884003|NCT02418754|526080375|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
145884004|NCT02418754|526080376|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
146226440|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Death|9|||
146226441|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Death|5|||
146226442|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Death|0|||
145884005|NCT02418754|526080377|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145884006|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
145884007|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
145884008|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
145884009|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
146226443|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146226444|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146226445|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146226446|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
146226447|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146226448|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145961632|NCT00447902|526371240|FG001|Overall Study|Withdrawal by Subject|1|||
145961633|NCT00447902|526371239|FG000|Overall Study|included patients who discontinued|1|||
146226449|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145884010|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
145884011|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
145884012|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145884013|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145884014|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145884015|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145884016|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
145884017|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
145884018|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
145884019|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
145884020|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
145884021|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
145884022|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
145884023|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
145884024|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
145884025|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
145884026|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
145884027|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
145884028|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
145884029|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
145884030|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
145884031|NCT02418754|526080373|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145884032|NCT02418754|526080374|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
145884033|NCT02418754|526080375|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145884034|NCT02418754|526080376|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
145884035|NCT02418754|526080377|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145884036|NCT00250705|526080380|FG000|Overall Study|Lack of Efficacy|2|||
145884037|NCT00129116|526080389|FG000|Primary Phase|Lost to Follow-up|1|||
145884038|NCT00129116|526080390|FG001|Primary Phase|Lost to Follow-up|1|||
145884039|NCT00129116|526080391|FG002|Primary Phase|Lost to Follow-up|0|||
145884040|NCT00129116|526080392|FG003|Primary Phase|Lost to Follow-up|1|||
145884041|NCT00129116|526080393|FG004|Primary Phase|Lost to Follow-up|1|||
145884042|NCT00129116|526080389|FG000|Primary Phase|Protocol Violation|0|||
145884043|NCT00129116|526080390|FG001|Primary Phase|Protocol Violation|1|||
145884044|NCT00129116|526080391|FG002|Primary Phase|Protocol Violation|0|||
145884045|NCT00129116|526080392|FG003|Primary Phase|Protocol Violation|0|||
145884046|NCT00129116|526080393|FG004|Primary Phase|Protocol Violation|0|||
145884047|NCT00129116|526080389|FG000|Primary Phase|Adverse Event|1|||
145884048|NCT00129116|526080390|FG001|Primary Phase|Adverse Event|1|||
145884049|NCT00129116|526080391|FG002|Primary Phase|Adverse Event|0|||
145884050|NCT00129116|526080392|FG003|Primary Phase|Adverse Event|0|||
145884051|NCT00129116|526080393|FG004|Primary Phase|Adverse Event|0|||
145884052|NCT00129116|526080389|FG000|Primary Phase|Withdrawal by Subject|0|||
145884053|NCT00129116|526080390|FG001|Primary Phase|Withdrawal by Subject|1|||
146226450|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145884054|NCT00129116|526080391|FG002|Primary Phase|Withdrawal by Subject|0|||
145884055|NCT00129116|526080392|FG003|Primary Phase|Withdrawal by Subject|0|||
145884056|NCT00129116|526080393|FG004|Primary Phase|Withdrawal by Subject|0|||
145884057|NCT00129116|526080389|FG000|Primary Phase|Other|0|||
146226451|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
146226452|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
146226453|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226454|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226455|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226456|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226457|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226458|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226459|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226460|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
146226461|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
146226462|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
146226463|NCT03386578|527347054|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226464|NCT03386578|527347055|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226465|NCT03386578|527347056|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226466|NCT03386578|527347057|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226467|NCT03386578|527347058|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226468|NCT03386578|527347059|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226469|NCT03386578|527347060|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226470|NCT03386578|527347061|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
146226471|NCT03386578|527347062|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
146226472|NCT03386578|527347063|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
146226473|NCT02694822|527347064|FG000|Phase 1|Death|2|||
145961634|NCT00447902|526371240|FG001|Overall Study|included patients who discontinued|1|||
145961635|NCT00447902|526371239|FG000|Overall Study|Lack of Efficacy|2|||
145961636|NCT00447902|526371240|FG001|Overall Study|Lack of Efficacy|1|||
145961637|NCT03110354|526373489|FG000|Overall Study|Death|1|||
145961638|NCT03110354|526373490|FG001|Overall Study|Death|0|||
145961639|NCT03110354|526373491|FG002|Overall Study|Death|0|||
145961640|NCT03110354|526373492|FG003|Overall Study|Death|1|||
145961641|NCT03110354|526373493|FG004|Overall Study|Death|0|||
145961642|NCT03110354|526373489|FG000|Overall Study|Start of new therapy|0|||
145961643|NCT03110354|526373490|FG001|Overall Study|Start of new therapy|0|||
145961644|NCT03110354|526373491|FG002|Overall Study|Start of new therapy|0|||
145961645|NCT03110354|526373492|FG003|Overall Study|Start of new therapy|0|||
145961646|NCT03110354|526373493|FG004|Overall Study|Start of new therapy|1|||
145961647|NCT03110354|526373489|FG000|Overall Study|Failure to achieve response|2|||
145961648|NCT03110354|526373490|FG001|Overall Study|Failure to achieve response|3|||
145961649|NCT03110354|526373491|FG002|Overall Study|Failure to achieve response|0|||
145961650|NCT03110354|526373492|FG003|Overall Study|Failure to achieve response|2|||
145961651|NCT03110354|526373493|FG004|Overall Study|Failure to achieve response|1|||
145961652|NCT03110354|526373489|FG000|Overall Study|Progressive disease|1|||
145961653|NCT03110354|526373490|FG001|Overall Study|Progressive disease|1|||
145961654|NCT03110354|526373491|FG002|Overall Study|Progressive disease|3|||
145961655|NCT03110354|526373492|FG003|Overall Study|Progressive disease|4|||
145961656|NCT03110354|526373493|FG004|Overall Study|Progressive disease|2|||
145961657|NCT03110354|526373489|FG000|Overall Study|Adverse Event|0|||
146226474|NCT02694822|527347065|FG001|Phase 1|Death|1|||
146226475|NCT02694822|527347066|FG002|Phase 1|Death|6|||
146226476|NCT02694822|527347067|FG003|Phase 1|Death|6|||
146226477|NCT02694822|527347068|FG004|Phase 1|Death|3|||
146226478|NCT02694822|527347069|FG005|Phase 1|Death|0|||
146289052|NCT03451162|527573319|FG002|Overall Study|Withdrawal by Subject|0|||
145961658|NCT03110354|526373490|FG001|Overall Study|Adverse Event|0|||
145961659|NCT03110354|526373491|FG002|Overall Study|Adverse Event|0|||
145961660|NCT03110354|526373492|FG003|Overall Study|Adverse Event|2|||
145961661|NCT03110354|526373493|FG004|Overall Study|Adverse Event|2|||
146226479|NCT02694822|527347064|FG000|Phase 1|Withdrawal by Subject|2|||
146085390|NCT00761150|526833590|FG002|Open-label Period|Noncompliance|0|||
146085391|NCT00761150|526833588|FG000|Open-label Period|Other|5|||
146085392|NCT00761150|526833589|FG001|Open-label Period|Other|0|||
146085393|NCT00761150|526833590|FG002|Open-label Period|Other|0|||
146085394|NCT00761150|526833588|FG000|Double-blind Period|Lack of Efficacy|0|||
146085395|NCT00761150|526833589|FG001|Double-blind Period|Lack of Efficacy|2|||
146085396|NCT00761150|526833590|FG002|Double-blind Period|Lack of Efficacy|19|||
146085397|NCT00761150|526833588|FG000|Double-blind Period|Adverse Event|0|||
146085398|NCT00761150|526833589|FG001|Double-blind Period|Adverse Event|3|||
146085399|NCT00761150|526833590|FG002|Double-blind Period|Adverse Event|3|||
146085400|NCT00761150|526833588|FG000|Double-blind Period|Withdrawal by Subject|0|||
146085401|NCT00761150|526833589|FG001|Double-blind Period|Withdrawal by Subject|3|||
146085402|NCT00761150|526833590|FG002|Double-blind Period|Withdrawal by Subject|2|||
146085403|NCT00761150|526833588|FG000|Double-blind Period|Lost to Follow-up|0|||
146085404|NCT00761150|526833589|FG001|Double-blind Period|Lost to Follow-up|2|||
146085405|NCT00761150|526833590|FG002|Double-blind Period|Lost to Follow-up|1|||
146085406|NCT00761150|526833588|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
146085407|NCT00761150|526833589|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
146085408|NCT00761150|526833590|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
146085409|NCT00761150|526833588|FG000|Double-blind Period|Noncompliance|0|||
146085410|NCT00761150|526833589|FG001|Double-blind Period|Noncompliance|1|||
146085411|NCT00761150|526833590|FG002|Double-blind Period|Noncompliance|0|||
146085412|NCT00761150|526833588|FG000|Double-blind Period|Other|0|||
146085413|NCT00761150|526833589|FG001|Double-blind Period|Other|3|||
146085414|NCT00761150|526833590|FG002|Double-blind Period|Other|3|||
146085415|NCT03312751|526833591|FG000|Overall Study|Death|7|||
146085416|NCT03312751|526833592|FG001|Overall Study|Death|9|||
146085417|NCT03312751|526833591|FG000|Overall Study|Study discontinuation due to other reason|0|||
146085418|NCT03312751|526833592|FG001|Overall Study|Study discontinuation due to other reason|1|||
146085419|NCT00282464|526833593|FG000|Overall Study|Adverse Event|26|||
146085420|NCT00282464|526833594|FG001|Overall Study|Adverse Event|20|||
146085421|NCT00282464|526833593|FG000|Overall Study|Lack of Efficacy|8|||
146085422|NCT00282464|526833594|FG001|Overall Study|Lack of Efficacy|8|||
146085423|NCT00282464|526833593|FG000|Overall Study|Lost to Follow-up|10|||
146085424|NCT00282464|526833594|FG001|Overall Study|Lost to Follow-up|10|||
146085425|NCT00282464|526833593|FG000|Overall Study|Withdrawal by Subject|24|||
146085426|NCT00282464|526833594|FG001|Overall Study|Withdrawal by Subject|10|||
146085427|NCT00282464|526833593|FG000|Overall Study|laboratory abnormality|1|||
146085428|NCT00282464|526833594|FG001|Overall Study|laboratory abnormality|2|||
146085429|NCT00282464|526833593|FG000|Overall Study|Protocol Violation|0|||
146085430|NCT00282464|526833594|FG001|Overall Study|Protocol Violation|7|||
146085431|NCT00282464|526833593|FG000|Overall Study|Patient moved|1|||
146085432|NCT00282464|526833594|FG001|Overall Study|Patient moved|0|||
146085433|NCT00282464|526833593|FG000|Overall Study|patient non-compliant|3|||
146085434|NCT00282464|526833594|FG001|Overall Study|patient non-compliant|0|||
146085435|NCT00282464|526833593|FG000|Overall Study|patient no show|0|||
146085436|NCT00282464|526833594|FG001|Overall Study|patient no show|1|||
146085437|NCT00282464|526833593|FG000|Overall Study|patient incarcerated|0|||
146085438|NCT00282464|526833594|FG001|Overall Study|patient incarcerated|1|||
146085439|NCT00282464|526833593|FG000|Overall Study|family crisis|0|||
146085440|NCT00282464|526833594|FG001|Overall Study|family crisis|1|||
146226480|NCT02694822|527347065|FG001|Phase 1|Withdrawal by Subject|2|||
145961662|NCT03110354|526373489|FG000|Overall Study|Other|0|||
145961663|NCT03110354|526373490|FG001|Overall Study|Other|0|||
145961664|NCT03110354|526373491|FG002|Overall Study|Other|0|||
145961665|NCT03110354|526373492|FG003|Overall Study|Other|1|||
145961666|NCT03110354|526373493|FG004|Overall Study|Other|1|||
145961667|NCT01298700|526373494|FG000|Overall Study|Adverse Event|50|||
145961668|NCT01298700|526373495|FG001|Overall Study|Adverse Event|51|||
145961669|NCT01298700|526373494|FG000|Overall Study|Lack of Efficacy|9|||
145961670|NCT01298700|526373495|FG001|Overall Study|Lack of Efficacy|14|||
145961671|NCT01298700|526373494|FG000|Overall Study|Lost to Follow-up|5|||
146226481|NCT02694822|527347066|FG002|Phase 1|Withdrawal by Subject|4|||
146085441|NCT00282464|526833593|FG000|Overall Study|dispensed wrong kit|0|||
146085442|NCT00282464|526833594|FG001|Overall Study|dispensed wrong kit|1|||
146085443|NCT00282464|526833593|FG000|Overall Study|dropped due to missed visits|0|||
146085444|NCT00282464|526833594|FG001|Overall Study|dropped due to missed visits|1|||
146085445|NCT00475423|526833595|FG000|Overall Study|Protocol Violation|5|||
146085446|NCT00475423|526833595|FG000|Overall Study|Adverse Event|4|||
145961672|NCT01298700|526373495|FG001|Overall Study|Lost to Follow-up|2|||
146085447|NCT00475423|526833595|FG000|Overall Study|Withdrawal by Subject|6|||
146085448|NCT00475423|526833595|FG000|Overall Study|Lack of Efficacy|8|||
146085449|NCT00475423|526833595|FG000|Overall Study|Death|1|||
146085450|NCT00475423|526833595|FG000|Overall Study|Reason not specified|1|||
146085451|NCT00475423|526833595|FG000|Overall Study|Lost to Follow-up|7|||
146085452|NCT01214174|526833596|FG000|Overall Study|Withdrawal by Subject|0|||
145961673|NCT01298700|526373494|FG000|Overall Study|Withdrawal by Subject|12|||
146085453|NCT01214174|526833597|FG001|Overall Study|Withdrawal by Subject|0|||
145884058|NCT00129116|526080390|FG001|Primary Phase|Other|0|||
145884059|NCT00129116|526080391|FG002|Primary Phase|Other|1|||
145884060|NCT00129116|526080392|FG003|Primary Phase|Other|0|||
145884061|NCT00129116|526080393|FG004|Primary Phase|Other|0|||
145884062|NCT00129116|526080389|FG000|Booster Phase|Lost to Follow-up|2|||
145884063|NCT00129116|526080390|FG001|Booster Phase|Lost to Follow-up|0|||
145884064|NCT00129116|526080391|FG002|Booster Phase|Lost to Follow-up|0|||
145884065|NCT00129116|526080392|FG003|Booster Phase|Lost to Follow-up|0|||
145884066|NCT00129116|526080393|FG004|Booster Phase|Lost to Follow-up|1|||
145884067|NCT00879684|526080394|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
145884068|NCT00879684|526080395|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
145884069|NCT00879684|526080396|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
145961674|NCT01298700|526373495|FG001|Overall Study|Withdrawal by Subject|9|||
145961675|NCT01298700|526373494|FG000|Overall Study|Protocol Violation|6|||
145961676|NCT01298700|526373495|FG001|Overall Study|Protocol Violation|4|||
145961677|NCT01298700|526373494|FG000|Overall Study|Other Miscellaneous Reasons|16|||
145961678|NCT01298700|526373495|FG001|Overall Study|Other Miscellaneous Reasons|15|||
145961679|NCT01298700|526373494|FG000|Overall Study|Did not Receive Study Drug|3|||
145961680|NCT01298700|526373495|FG001|Overall Study|Did not Receive Study Drug|5|||
145961681|NCT04006145|526373496|FG000|Overall Study|Lost to Follow-up|0|||
145961682|NCT04006145|526373497|FG001|Overall Study|Lost to Follow-up|1|||
145961683|NCT04006145|526373496|FG000|Overall Study|Other|1|||
145961684|NCT04006145|526373497|FG001|Overall Study|Other|2|||
145961685|NCT00010257|526373500|FG000|Overall Study|Withdrawal by Subject|1|||
145961686|NCT00010257|526373501|FG001|Overall Study|Withdrawal by Subject|0|||
145961687|NCT02063672|526373502|FG000|Overall Study|Ongoing Follow-up|27|||
145961688|NCT02063672|526373503|FG001|Overall Study|Ongoing Follow-up|14|||
145961689|NCT02063672|526373502|FG000|Overall Study|Death|5|||
145961690|NCT02063672|526373503|FG001|Overall Study|Death|3|||
145961691|NCT02063672|526373502|FG000|Overall Study|Lost to Follow-up|1|||
145961692|NCT02063672|526373503|FG001|Overall Study|Lost to Follow-up|3|||
145961693|NCT02063672|526373502|FG000|Overall Study|Withdrawal by Subject|2|||
145961694|NCT02063672|526373503|FG001|Overall Study|Withdrawal by Subject|2|||
145961695|NCT01307787|526373505|FG000|Overall Study|Withdrawal by Subject|2|||
145961696|NCT01307787|526373506|FG001|Overall Study|Withdrawal by Subject|0|||
145961697|NCT01965327|526373507|FG000|Overall Study|Physician Decision|2|||
145961698|NCT02498678|526373508|FG000|Overall Study|interference from the surgical team|0|||
145961699|NCT02498678|526373509|FG001|Overall Study|interference from the surgical team|2|||
145961700|NCT01405560|526373510|FG000|Overall Study|Physician Decision|1|||
145961701|NCT01484951|526373514|FG000|Overall Study|Adverse Event|3|||
145961702|NCT01484951|526373514|FG000|Overall Study|Personal Reasons|1|||
145961703|NCT01484951|526373514|FG000|Overall Study|Non-Compliance|1|||
145961704|NCT02169505|526373515|FG000|Overall Study|Withdrawal by Subject|1|||
145961705|NCT02035553|526373516|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
146226482|NCT02694822|527347067|FG003|Phase 1|Withdrawal by Subject|8|||
145884070|NCT00879684|526080397|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
145884071|NCT00879684|526080398|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
145961706|NCT02035553|526373517|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
146226483|NCT02694822|527347068|FG004|Phase 1|Withdrawal by Subject|1|||
146226484|NCT02694822|527347069|FG005|Phase 1|Withdrawal by Subject|0|||
146226485|NCT02694822|527347064|FG000|Phase 2|Death|0|||
146226486|NCT02694822|527347065|FG001|Phase 2|Death|0|||
146226487|NCT02694822|527347066|FG002|Phase 2|Death|0|||
146226488|NCT02694822|527347067|FG003|Phase 2|Death|0|||
146226489|NCT02694822|527347068|FG004|Phase 2|Death|0|||
146226490|NCT02694822|527347069|FG005|Phase 2|Death|26|||
146226491|NCT02694822|527347064|FG000|Phase 2|Withdrawal by Subject|0|||
146226492|NCT02694822|527347065|FG001|Phase 2|Withdrawal by Subject|0|||
146226493|NCT02694822|527347066|FG002|Phase 2|Withdrawal by Subject|0|||
146226494|NCT02694822|527347067|FG003|Phase 2|Withdrawal by Subject|0|||
146226495|NCT02694822|527347068|FG004|Phase 2|Withdrawal by Subject|0|||
146226496|NCT02694822|527347069|FG005|Phase 2|Withdrawal by Subject|13|||
146226497|NCT02694822|527347064|FG000|Phase 2|Administrative Study Closure|0|||
146226498|NCT02694822|527347065|FG001|Phase 2|Administrative Study Closure|0|||
146226499|NCT02694822|527347066|FG002|Phase 2|Administrative Study Closure|0|||
146226500|NCT02694822|527347067|FG003|Phase 2|Administrative Study Closure|0|||
146226501|NCT02694822|527347068|FG004|Phase 2|Administrative Study Closure|0|||
146289053|NCT03451162|527573320|FG003|Overall Study|Withdrawal by Subject|0|||
146289054|NCT03451162|527573321|FG004|Overall Study|Withdrawal by Subject|0|||
145884072|NCT00879684|526080399|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
145884073|NCT00879684|526080400|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
146226502|NCT02694822|527347069|FG005|Phase 2|Administrative Study Closure|2|||
146226503|NCT02694822|527347064|FG000|Phase 2|Lost to Follow-up|0|||
146226504|NCT02694822|527347065|FG001|Phase 2|Lost to Follow-up|0|||
146226505|NCT02694822|527347066|FG002|Phase 2|Lost to Follow-up|0|||
146226506|NCT02694822|527347067|FG003|Phase 2|Lost to Follow-up|0|||
146226507|NCT02694822|527347068|FG004|Phase 2|Lost to Follow-up|0|||
146226508|NCT02694822|527347069|FG005|Phase 2|Lost to Follow-up|1|||
146226509|NCT02694822|527347064|FG000|Phase 2|Participant Transferred to Another Site|0|||
146226510|NCT02694822|527347065|FG001|Phase 2|Participant Transferred to Another Site|0|||
146226511|NCT02694822|527347066|FG002|Phase 2|Participant Transferred to Another Site|0|||
146226512|NCT02694822|527347067|FG003|Phase 2|Participant Transferred to Another Site|0|||
146226513|NCT02694822|527347068|FG004|Phase 2|Participant Transferred to Another Site|0|||
146226514|NCT02694822|527347069|FG005|Phase 2|Participant Transferred to Another Site|1|||
146226515|NCT02424617|527347070|FG000|Overall Study|Adverse Event|0|||
146226516|NCT02424617|527347071|FG001|Overall Study|Adverse Event|1|||
146226517|NCT02424617|527347072|FG002|Overall Study|Adverse Event|0|||
146226518|NCT02424617|527347073|FG003|Overall Study|Adverse Event|0|||
146226519|NCT02424617|527347070|FG000|Overall Study|Investigator Decision|0|||
146226520|NCT02424617|527347071|FG001|Overall Study|Investigator Decision|0|||
146226521|NCT02424617|527347072|FG002|Overall Study|Investigator Decision|0|||
146226522|NCT02424617|527347073|FG003|Overall Study|Investigator Decision|1|||
146226523|NCT02424617|527347070|FG000|Overall Study|Withdrawal by Subject|1|||
146226524|NCT02424617|527347071|FG001|Overall Study|Withdrawal by Subject|1|||
146226525|NCT02424617|527347072|FG002|Overall Study|Withdrawal by Subject|0|||
146226526|NCT02424617|527347073|FG003|Overall Study|Withdrawal by Subject|1|||
146226527|NCT02424617|527347070|FG000|Overall Study|Progressive Disease|7|||
146226528|NCT02424617|527347071|FG001|Overall Study|Progressive Disease|6|||
146226529|NCT02424617|527347072|FG002|Overall Study|Progressive Disease|11|||
146226530|NCT02424617|527347073|FG003|Overall Study|Progressive Disease|10|||
146226531|NCT02424617|527347070|FG000|Overall Study|Other|0|||
146226532|NCT02424617|527347071|FG001|Overall Study|Other|0|||
146226533|NCT02424617|527347072|FG002|Overall Study|Other|0|||
146226534|NCT02424617|527347073|FG003|Overall Study|Other|1|||
146226535|NCT01868997|527347074|FG000|Overall Study|Adverse Event|2|||
146226536|NCT01868997|527347075|FG001|Overall Study|Adverse Event|5|||
146226537|NCT01868997|527347074|FG000|Overall Study|Lack of Efficacy|2|||
146226538|NCT01868997|527347075|FG001|Overall Study|Lack of Efficacy|0|||
146226539|NCT01868997|527347074|FG000|Overall Study|Other|3|||
146226540|NCT01868997|527347075|FG001|Overall Study|Other|1|||
146226541|NCT01960452|527347076|FG000|Overall Study|Withdrawal by Subject|2|||
146226542|NCT01960452|527347077|FG001|Overall Study|Withdrawal by Subject|1|||
146226543|NCT01960452|527347076|FG000|Overall Study|Sleep apnea in Night 1|1|||
146226544|NCT01960452|527347077|FG001|Overall Study|Sleep apnea in Night 1|0|||
146226545|NCT01960452|527347076|FG000|Overall Study|Poor Sleep in Night 1|0|||
146226546|NCT01960452|527347077|FG001|Overall Study|Poor Sleep in Night 1|2|||
145884074|NCT00879684|526080394|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
145884075|NCT00879684|526080395|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
145884076|NCT00879684|526080396|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
145884077|NCT00879684|526080397|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
145884078|NCT00879684|526080398|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
145884079|NCT00879684|526080399|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
145884080|NCT00879684|526080400|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
146226547|NCT01960452|527347076|FG000|Overall Study|No Sex/Age Match Night 1|1|||
146226548|NCT01960452|527347077|FG001|Overall Study|No Sex/Age Match Night 1|0|||
146226549|NCT01960452|527347076|FG000|Overall Study|No Sex/Age Match Night 2|0|||
146226550|NCT01960452|527347077|FG001|Overall Study|No Sex/Age Match Night 2|2|||
146226551|NCT01960452|527347076|FG000|Overall Study|Technical Difficulties Night 2|2|||
146226552|NCT01960452|527347077|FG001|Overall Study|Technical Difficulties Night 2|0|||
146226553|NCT04066205|527347078|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
146226554|NCT04066205|527347079|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
146226555|NCT04066205|527347078|FG000|T2 Immediate Post-Intervention|did not respond|5|||
146226556|NCT04066205|527347079|FG001|T2 Immediate Post-Intervention|did not respond|3|||
146226557|NCT04778397|527347081|FG000|Overall Study|Death|59|||
146226558|NCT04778397|527347082|FG001|Overall Study|Death|54|||
146226559|NCT04778397|527347083|FG002|Overall Study|Death|11|||
146226560|NCT04778397|527347084|FG003|Overall Study|Death|9|||
146226561|NCT04778397|527347081|FG000|Overall Study|Study Terminated by Sponsor|34|||
146226562|NCT04778397|527347082|FG001|Overall Study|Study Terminated by Sponsor|42|||
146226563|NCT04778397|527347083|FG002|Overall Study|Study Terminated by Sponsor|15|||
146226564|NCT04778397|527347084|FG003|Overall Study|Study Terminated by Sponsor|12|||
146226565|NCT04778397|527347081|FG000|Overall Study|Withdrew Consent|5|||
146226566|NCT04778397|527347082|FG001|Overall Study|Withdrew Consent|4|||
146226567|NCT04778397|527347083|FG002|Overall Study|Withdrew Consent|1|||
146226568|NCT04778397|527347084|FG003|Overall Study|Withdrew Consent|1|||
146226569|NCT04778397|527347081|FG000|Overall Study|Reason Not Specified|1|||
146226570|NCT04778397|527347082|FG001|Overall Study|Reason Not Specified|3|||
145884081|NCT00879684|526080394|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
145884082|NCT00879684|526080395|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
145884083|NCT00879684|526080396|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
145884084|NCT00879684|526080397|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
145884085|NCT00879684|526080398|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
145884086|NCT00879684|526080399|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
145884087|NCT00879684|526080400|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
145884088|NCT00879684|526080394|FG000|Stage 1: Dose Escalation|Death|0|||
145884089|NCT00879684|526080395|FG001|Stage 1: Dose Escalation|Death|0|||
145884090|NCT00879684|526080396|FG002|Stage 1: Dose Escalation|Death|1|||
145884091|NCT00879684|526080397|FG003|Stage 1: Dose Escalation|Death|0|||
145884092|NCT00879684|526080398|FG004|Stage 1: Dose Escalation|Death|0|||
145884093|NCT00879684|526080399|FG005|Stage 1: Dose Escalation|Death|0|||
145884094|NCT00879684|526080400|FG006|Stage 1: Dose Escalation|Death|0|||
145884095|NCT00879684|526080394|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884096|NCT00879684|526080395|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884097|NCT00879684|526080396|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884098|NCT00879684|526080397|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884099|NCT00879684|526080398|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884100|NCT00879684|526080399|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145884101|NCT00879684|526080400|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
145884102|NCT00879684|526080394|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
145884103|NCT00879684|526080395|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
145884104|NCT00879684|526080396|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
145884105|NCT00879684|526080397|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
146226571|NCT04778397|527347083|FG002|Overall Study|Reason Not Specified|0|||
146226572|NCT04778397|527347084|FG003|Overall Study|Reason Not Specified|2|||
146226573|NCT04778397|527347081|FG000|Overall Study|Lost to Follow-up|2|||
146226574|NCT04778397|527347082|FG001|Overall Study|Lost to Follow-up|1|||
146226575|NCT04778397|527347083|FG002|Overall Study|Lost to Follow-up|0|||
146226576|NCT04778397|527347084|FG003|Overall Study|Lost to Follow-up|1|||
146226577|NCT04294641|527347085|FG000|Overall Study|Screen failure|4|||
146085454|NCT01214174|526833598|FG002|Overall Study|Withdrawal by Subject|1|||
146085455|NCT02496676|526833603|FG000|Phase 1 - Period 1|Adverse Event|0|||
146085456|NCT02496676|526833604|FG001|Phase 1 - Period 1|Adverse Event|1|||
146085457|NCT02496676|526833603|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
146085458|NCT02496676|526833604|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
146226578|NCT01627574|527347087|FG000|Overall Study|Withdrawal by Subject|8|||
145961707|NCT02035553|526373516|FG000|Overall Study|Adverse Event|10|||
145961708|NCT02035553|526373517|FG001|Overall Study|Adverse Event|6|||
145961709|NCT02035553|526373516|FG000|Overall Study|Physician Decision|3|||
145961710|NCT02035553|526373517|FG001|Overall Study|Physician Decision|2|||
145961711|NCT02035553|526373516|FG000|Overall Study|Lack of Efficacy|1|||
145961712|NCT02035553|526373517|FG001|Overall Study|Lack of Efficacy|1|||
146226579|NCT01627574|527347088|FG001|Overall Study|Withdrawal by Subject|5|||
146226580|NCT01627574|527347087|FG000|Overall Study|Lost to Follow-up|13|||
146226581|NCT01627574|527347088|FG001|Overall Study|Lost to Follow-up|13|||
146226582|NCT03249090|527347098|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
146226583|NCT03249090|527347099|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
146226584|NCT03249090|527347098|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
146226585|NCT03249090|527347099|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
146226586|NCT03249090|527347098|FG000|3 Month Time Point|Voluntary withdrawal|6|||
146226587|NCT03249090|527347099|FG001|3 Month Time Point|Voluntary withdrawal|3|||
146226588|NCT03249090|527347098|FG000|3 Month Time Point|Changed oncology practice|4|||
145961713|NCT02035553|526373516|FG000|Overall Study|Withdrawal by Subject|4|||
146226589|NCT03249090|527347099|FG001|3 Month Time Point|Changed oncology practice|2|||
146226590|NCT03249090|527347098|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
146226591|NCT03249090|527347099|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
145961714|NCT02035553|526373517|FG001|Overall Study|Withdrawal by Subject|7|||
145961715|NCT02035553|526373516|FG000|Overall Study|Non-compliance with Study Drug|0|||
145961716|NCT02035553|526373517|FG001|Overall Study|Non-compliance with Study Drug|1|||
145961717|NCT02035553|526373516|FG000|Overall Study|Lost to Follow-up|0|||
145961718|NCT02035553|526373517|FG001|Overall Study|Lost to Follow-up|1|||
145961719|NCT02035553|526373516|FG000|Overall Study|Other Reason|0|||
145961720|NCT02035553|526373517|FG001|Overall Study|Other Reason|4|||
145961721|NCT01854697|526373518|FG000|Overall Study|Adverse Event|1|||
145961722|NCT01854697|526373519|FG001|Overall Study|Adverse Event|0|||
145961723|NCT01854697|526373520|FG002|Overall Study|Adverse Event|0|||
145961724|NCT01854697|526373521|FG003|Overall Study|Adverse Event|0|||
145961725|NCT01854697|526373522|FG004|Overall Study|Adverse Event|1|||
145961726|NCT01854697|526373518|FG000|Overall Study|Lost to Follow-up|4|||
145961727|NCT01854697|526373519|FG001|Overall Study|Lost to Follow-up|1|||
145961728|NCT01854697|526373520|FG002|Overall Study|Lost to Follow-up|1|||
145961729|NCT01854697|526373521|FG003|Overall Study|Lost to Follow-up|2|||
145961730|NCT01854697|526373522|FG004|Overall Study|Lost to Follow-up|0|||
145961731|NCT01854697|526373518|FG000|Overall Study|To enter another AbbVie study|1|||
145961732|NCT01854697|526373519|FG001|Overall Study|To enter another AbbVie study|0|||
145961733|NCT01854697|526373520|FG002|Overall Study|To enter another AbbVie study|0|||
145961734|NCT01854697|526373521|FG003|Overall Study|To enter another AbbVie study|0|||
145961735|NCT01854697|526373522|FG004|Overall Study|To enter another AbbVie study|1|||
145961736|NCT01854697|526373518|FG000|Overall Study|Withdrew Consent|0|||
145961737|NCT01854697|526373519|FG001|Overall Study|Withdrew Consent|1|||
145961738|NCT01854697|526373520|FG002|Overall Study|Withdrew Consent|0|||
145961739|NCT01854697|526373521|FG003|Overall Study|Withdrew Consent|1|||
145961740|NCT01854697|526373522|FG004|Overall Study|Withdrew Consent|0|||
145961741|NCT01854697|526373518|FG000|Overall Study|Other|0|||
146226592|NCT03249090|527347098|FG000|12 Month Time Point|Voluntary withdrawal|35|||
146226593|NCT03249090|527347099|FG001|12 Month Time Point|Voluntary withdrawal|4|||
146226594|NCT03249090|527347098|FG000|12 Month Time Point|Changed oncology practice|20|||
146226595|NCT03249090|527347099|FG001|12 Month Time Point|Changed oncology practice|9|||
146226596|NCT04359654|527347102|FG000|Overall Study|Withdrawal by Subject|1|||
145961742|NCT01854697|526373519|FG001|Overall Study|Other|1|||
146085459|NCT02514473|526833608|FG000|Overall Study|Adverse Event|0|||
146226597|NCT04359654|527347103|FG001|Overall Study|Withdrawal by Subject|0|||
146226598|NCT04359654|527347102|FG000|Overall Study|Adverse Event|0|||
145961743|NCT01854697|526373520|FG002|Overall Study|Other|1|||
145961744|NCT01854697|526373521|FG003|Overall Study|Other|0|||
146226599|NCT04359654|527347103|FG001|Overall Study|Adverse Event|1|||
145961745|NCT01854697|526373522|FG004|Overall Study|Other|0|||
145961746|NCT04176939|526373529|FG000|Overall Study|Withdrawal by Subject|5|||
145961747|NCT04176939|526373529|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
146226600|NCT06122194|527347104|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
145961748|NCT04176939|526373529|FG000|Overall Study|Lost to Follow-up|2|||
146226601|NCT06122194|527347105|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
145961749|NCT04176939|526373529|FG000|Overall Study|Unspecified reason|4|||
145961750|NCT04176939|526373529|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
146085460|NCT02514473|526833609|FG001|Overall Study|Adverse Event|2|||
146085461|NCT02514473|526833608|FG000|Overall Study|Withdrawal by Subject|2|||
146085462|NCT02514473|526833609|FG001|Overall Study|Withdrawal by Subject|1|||
146226602|NCT06122194|527347106|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
146226603|NCT06122194|527347107|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
146226604|NCT04314778|527347108|FG000|Overall Study|Lost to Follow-up|5|||
146226605|NCT04314778|527347109|FG001|Overall Study|Lost to Follow-up|3|||
146226606|NCT05218096|527347110|FG000|Primary Evaluation|Withdrawal by Subject|0|||
146226607|NCT05218096|527347111|FG001|Primary Evaluation|Withdrawal by Subject|0|||
146226608|NCT05218096|527347112|FG002|Primary Evaluation|Withdrawal by Subject|2|||
146226609|NCT05218096|527347113|FG003|Primary Evaluation|Withdrawal by Subject|0|||
145961751|NCT02869789|526373530|FG000|Overall Study|Disease progression|184|||
145961752|NCT02869789|526373531|FG001|Overall Study|Disease progression|109|||
145961753|NCT02869789|526373532|FG002|Overall Study|Disease progression|260|||
145961754|NCT02869789|526373533|FG003|Overall Study|Disease progression|19|||
145961755|NCT02869789|526373530|FG000|Overall Study|Study drug toxicity|90|||
145961756|NCT02869789|526373531|FG001|Overall Study|Study drug toxicity|32|||
145961757|NCT02869789|526373532|FG002|Overall Study|Study drug toxicity|55|||
145961758|NCT02869789|526373533|FG003|Overall Study|Study drug toxicity|14|||
145961759|NCT02869789|526373530|FG000|Overall Study|Death|7|||
145961760|NCT02869789|526373531|FG001|Overall Study|Death|3|||
145961761|NCT02869789|526373532|FG002|Overall Study|Death|5|||
145961762|NCT02869789|526373533|FG003|Overall Study|Death|1|||
145961763|NCT02869789|526373530|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
145961764|NCT02869789|526373531|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
145961765|NCT02869789|526373532|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
145961766|NCT02869789|526373533|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
145961767|NCT02869789|526373530|FG000|Overall Study|Participant request to discontinue study treatment|10|||
145961768|NCT02869789|526373531|FG001|Overall Study|Participant request to discontinue study treatment|5|||
145961769|NCT02869789|526373532|FG002|Overall Study|Participant request to discontinue study treatment|5|||
145961770|NCT02869789|526373533|FG003|Overall Study|Participant request to discontinue study treatment|3|||
145961771|NCT02869789|526373530|FG000|Overall Study|Withdrawal by Subject|5|||
145961772|NCT02869789|526373531|FG001|Overall Study|Withdrawal by Subject|2|||
145961773|NCT02869789|526373532|FG002|Overall Study|Withdrawal by Subject|7|||
146226610|NCT05218096|527347114|FG004|Primary Evaluation|Withdrawal by Subject|0|||
146226611|NCT05218096|527347110|FG000|Primary Evaluation|Physician Decision|1|||
146226612|NCT05218096|527347111|FG001|Primary Evaluation|Physician Decision|0|||
146226613|NCT05218096|527347112|FG002|Primary Evaluation|Physician Decision|0|||
146226614|NCT05218096|527347113|FG003|Primary Evaluation|Physician Decision|0|||
146226615|NCT05218096|527347114|FG004|Primary Evaluation|Physician Decision|0|||
146226616|NCT05218096|527347110|FG000|Extended Treatment|Clinical Deterioration|1|||
146226617|NCT05218096|527347111|FG001|Extended Treatment|Clinical Deterioration|1|||
146226618|NCT05218096|527347112|FG002|Extended Treatment|Clinical Deterioration|0|||
146226619|NCT05218096|527347113|FG003|Extended Treatment|Clinical Deterioration|0|||
146226620|NCT05218096|527347114|FG004|Extended Treatment|Clinical Deterioration|0|||
146226621|NCT05218096|527347110|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
146226622|NCT05218096|527347111|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
146226623|NCT05218096|527347112|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
146226624|NCT05218096|527347113|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
146226625|NCT05218096|527347114|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
146226626|NCT05218096|527347110|FG000|Extended Treatment|Withdrawal by Subject|1|||
146226627|NCT05218096|527347111|FG001|Extended Treatment|Withdrawal by Subject|3|||
145961774|NCT02869789|526373533|FG003|Overall Study|Withdrawal by Subject|2|||
145961775|NCT02869789|526373530|FG000|Overall Study|Lost to Follow-up|0|||
145961776|NCT02869789|526373531|FG001|Overall Study|Lost to Follow-up|0|||
146085463|NCT02514473|526833608|FG000|Overall Study|Lost to Follow-up|0|||
145961777|NCT02869789|526373532|FG002|Overall Study|Lost to Follow-up|2|||
145961778|NCT02869789|526373533|FG003|Overall Study|Lost to Follow-up|0|||
145961779|NCT02869789|526373530|FG000|Overall Study|Maximum clinical benefit|5|||
145961780|NCT02869789|526373531|FG001|Overall Study|Maximum clinical benefit|2|||
145961781|NCT02869789|526373532|FG002|Overall Study|Maximum clinical benefit|1|||
146085464|NCT02514473|526833609|FG001|Overall Study|Lost to Follow-up|1|||
146085465|NCT02514473|526833608|FG000|Overall Study|Other|1|||
146226628|NCT05218096|527347112|FG002|Extended Treatment|Withdrawal by Subject|0|||
146226629|NCT05218096|527347113|FG003|Extended Treatment|Withdrawal by Subject|2|||
146226630|NCT05218096|527347114|FG004|Extended Treatment|Withdrawal by Subject|2|||
146226631|NCT05218096|527347110|FG000|Extended Treatment|Lack of Efficacy|3|||
146289055|NCT03305731|527573322|FG000|Overall Study|Protocol Violation|1|||
145961782|NCT02869789|526373533|FG003|Overall Study|Maximum clinical benefit|0|||
145961783|NCT02869789|526373530|FG000|Overall Study|Poor/Non-compliance|0|||
145961784|NCT02869789|526373531|FG001|Overall Study|Poor/Non-compliance|2|||
146226632|NCT05218096|527347111|FG001|Extended Treatment|Lack of Efficacy|0|||
146226633|NCT05218096|527347112|FG002|Extended Treatment|Lack of Efficacy|0|||
145961785|NCT02869789|526373532|FG002|Overall Study|Poor/Non-compliance|1|||
145961786|NCT02869789|526373533|FG003|Overall Study|Poor/Non-compliance|0|||
145961787|NCT02869789|526373530|FG000|Overall Study|Participant no longer meets study criteria|0|||
145961788|NCT02869789|526373531|FG001|Overall Study|Participant no longer meets study criteria|1|||
145961789|NCT02869789|526373532|FG002|Overall Study|Participant no longer meets study criteria|1|||
145961790|NCT02869789|526373533|FG003|Overall Study|Participant no longer meets study criteria|0|||
145961791|NCT02869789|526373530|FG000|Overall Study|Administrative reason by sponsor|0|||
145961792|NCT02869789|526373531|FG001|Overall Study|Administrative reason by sponsor|0|||
145961793|NCT02869789|526373532|FG002|Overall Study|Administrative reason by sponsor|1|||
145961794|NCT02869789|526373533|FG003|Overall Study|Administrative reason by sponsor|0|||
146226634|NCT05218096|527347113|FG003|Extended Treatment|Lack of Efficacy|0|||
146226635|NCT05218096|527347114|FG004|Extended Treatment|Lack of Efficacy|0|||
146226636|NCT05218096|527347110|FG000|Extended Treatment|Physician Decision|0|||
146226637|NCT05218096|527347111|FG001|Extended Treatment|Physician Decision|1|||
146226638|NCT05218096|527347112|FG002|Extended Treatment|Physician Decision|0|||
146226639|NCT05218096|527347113|FG003|Extended Treatment|Physician Decision|0|||
146226640|NCT05218096|527347114|FG004|Extended Treatment|Physician Decision|0|||
146226641|NCT05218096|527347110|FG000|Open-label Extension|Adverse Event|1|||
146226642|NCT05218096|527347111|FG001|Open-label Extension|Adverse Event|0|||
146226643|NCT05218096|527347112|FG002|Open-label Extension|Adverse Event|0|||
145961795|NCT02869789|526373530|FG000|Overall Study|Other reasons|4|||
145961796|NCT02869789|526373531|FG001|Overall Study|Other reasons|8|||
145961797|NCT02869789|526373532|FG002|Overall Study|Other reasons|6|||
145961798|NCT02869789|526373533|FG003|Overall Study|Other reasons|0|||
145961799|NCT00676403|526373534|FG000|Overall Study|Adverse Event|1|||
145961800|NCT00676403|526373535|FG001|Overall Study|Adverse Event|2|||
145961801|NCT00676403|526373536|FG002|Overall Study|Adverse Event|0|||
145961802|NCT00676403|526373537|FG003|Overall Study|Adverse Event|5|||
145961803|NCT00676403|526373538|FG004|Overall Study|Adverse Event|1|||
145961804|NCT00676403|526373539|FG005|Overall Study|Adverse Event|2|||
145961805|NCT00676403|526373534|FG000|Overall Study|Lost to Follow-up|0|||
145961806|NCT00676403|526373535|FG001|Overall Study|Lost to Follow-up|0|||
145961807|NCT00676403|526373536|FG002|Overall Study|Lost to Follow-up|0|||
145961808|NCT00676403|526373537|FG003|Overall Study|Lost to Follow-up|0|||
145961809|NCT00676403|526373538|FG004|Overall Study|Lost to Follow-up|0|||
145961810|NCT00676403|526373539|FG005|Overall Study|Lost to Follow-up|1|||
145961811|NCT00676403|526373534|FG000|Overall Study|Reason Unspecified|1|||
145961812|NCT00676403|526373535|FG001|Overall Study|Reason Unspecified|0|||
145961813|NCT00676403|526373536|FG002|Overall Study|Reason Unspecified|1|||
145961814|NCT00676403|526373537|FG003|Overall Study|Reason Unspecified|0|||
145961815|NCT00676403|526373538|FG004|Overall Study|Reason Unspecified|0|||
145961816|NCT00676403|526373539|FG005|Overall Study|Reason Unspecified|1|||
145961817|NCT00676403|526373534|FG000|Overall Study|Withdrawal by Subject|0|||
145961818|NCT00676403|526373535|FG001|Overall Study|Withdrawal by Subject|0|||
145961819|NCT00676403|526373536|FG002|Overall Study|Withdrawal by Subject|0|||
145961820|NCT00676403|526373537|FG003|Overall Study|Withdrawal by Subject|0|||
145961821|NCT00676403|526373538|FG004|Overall Study|Withdrawal by Subject|0|||
145961822|NCT00676403|526373539|FG005|Overall Study|Withdrawal by Subject|1|||
145961823|NCT00297648|526373541|FG000|Overall Study|Adverse Event|13|||
145961824|NCT00297648|526373541|FG000|Overall Study|Lack of Efficacy|18|||
146085466|NCT02514473|526833609|FG001|Overall Study|Other|1|||
146085467|NCT00548405|526833610|FG000|Overall Study|Adverse Event|6|||
146226644|NCT05218096|527347113|FG003|Open-label Extension|Adverse Event|0|||
146226645|NCT05218096|527347114|FG004|Open-label Extension|Adverse Event|1|||
146085468|NCT00548405|526833611|FG001|Overall Study|Adverse Event|2|||
146085469|NCT00548405|526833612|FG002|Overall Study|Adverse Event|0|||
146085470|NCT00548405|526833610|FG000|Overall Study|Lack of Efficacy|6|||
145961825|NCT00297648|526373541|FG000|Overall Study|Lost to Follow-up|1|||
145961826|NCT00297648|526373541|FG000|Overall Study|Withdrawal by Subject|3|||
145961827|NCT00297648|526373541|FG000|Overall Study|Other: Incompliance|1|||
145961828|NCT02127658|526373549|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
145961829|NCT02127658|526373550|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
145961830|NCT02127658|526373549|FG000|Overall Study|Withdrawal by Subject|0|||
145961831|NCT02127658|526373550|FG001|Overall Study|Withdrawal by Subject|2|||
145961832|NCT02127658|526373549|FG000|Overall Study|Physician Decision|0|||
145961833|NCT02127658|526373550|FG001|Overall Study|Physician Decision|1|||
145961834|NCT03834493|526373551|FG000|Overall Study|Participants Ongoing|311|||
145961835|NCT03834493|526373552|FG001|Overall Study|Participants Ongoing|324|||
145961836|NCT03834493|526373551|FG000|Overall Study|Withdrawal by Subject|20|||
145961837|NCT03834493|526373552|FG001|Overall Study|Withdrawal by Subject|17|||
145961838|NCT03834493|526373551|FG000|Overall Study|Physician Decision|1|||
145961839|NCT03834493|526373552|FG001|Overall Study|Physician Decision|0|||
145961840|NCT03834493|526373551|FG000|Overall Study|Death|289|||
145961841|NCT03834493|526373552|FG001|Overall Study|Death|282|||
145961842|NCT04144322|526373554|FG000|Overall Study|Lack of Efficacy|2|||
145961843|NCT04144322|526373555|FG001|Overall Study|Lack of Efficacy|2|||
145961844|NCT02277028|526373556|FG000|Overall Study|Lost to Follow-up|1|||
145961845|NCT02277028|526373557|FG001|Overall Study|Lost to Follow-up|0|||
145961846|NCT02277028|526373556|FG000|Overall Study|Withdrawal by Subject|0|||
145961847|NCT02277028|526373557|FG001|Overall Study|Withdrawal by Subject|1|||
145961848|NCT02718911|526373558|FG000|Overall Study|Adverse Event|0|||
145961849|NCT02718911|526373559|FG001|Overall Study|Adverse Event|0|||
145961850|NCT02718911|526373560|FG002|Overall Study|Adverse Event|0|||
145961851|NCT02718911|526373561|FG003|Overall Study|Adverse Event|0|||
145961852|NCT02718911|526373562|FG004|Overall Study|Adverse Event|0|||
145961853|NCT02718911|526373563|FG005|Overall Study|Adverse Event|0|||
145961854|NCT02718911|526373564|FG006|Overall Study|Adverse Event|0|||
145961855|NCT02718911|526373565|FG007|Overall Study|Adverse Event|0|||
145961856|NCT02718911|526373566|FG008|Overall Study|Adverse Event|0|||
145961857|NCT02718911|526373567|FG009|Overall Study|Adverse Event|2|||
145961858|NCT02718911|526373558|FG000|Overall Study|Death|2|||
145961859|NCT02718911|526373559|FG001|Overall Study|Death|3|||
145961860|NCT02718911|526373560|FG002|Overall Study|Death|1|||
145961861|NCT02718911|526373561|FG003|Overall Study|Death|0|||
145961862|NCT02718911|526373562|FG004|Overall Study|Death|1|||
145961863|NCT02718911|526373563|FG005|Overall Study|Death|3|||
145961864|NCT02718911|526373564|FG006|Overall Study|Death|1|||
146226646|NCT05218096|527347110|FG000|Open-label Extension|Pregnancy|0|||
146226647|NCT05218096|527347111|FG001|Open-label Extension|Pregnancy|0|||
146226648|NCT05218096|527347112|FG002|Open-label Extension|Pregnancy|0|||
146226649|NCT05218096|527347113|FG003|Open-label Extension|Pregnancy|0|||
146226650|NCT05218096|527347114|FG004|Open-label Extension|Pregnancy|1|||
146226651|NCT05218096|527347110|FG000|Open-label Extension|Lack of Efficacy|1|||
146226652|NCT05218096|527347111|FG001|Open-label Extension|Lack of Efficacy|2|||
146226653|NCT05218096|527347112|FG002|Open-label Extension|Lack of Efficacy|0|||
146226654|NCT05218096|527347113|FG003|Open-label Extension|Lack of Efficacy|0|||
146226655|NCT05218096|527347114|FG004|Open-label Extension|Lack of Efficacy|0|||
146226656|NCT05218096|527347110|FG000|Open-label Extension|Lost to Follow-up|1|||
146226657|NCT05218096|527347111|FG001|Open-label Extension|Lost to Follow-up|0|||
146226658|NCT05218096|527347112|FG002|Open-label Extension|Lost to Follow-up|0|||
146226659|NCT05218096|527347113|FG003|Open-label Extension|Lost to Follow-up|0|||
146226660|NCT05218096|527347114|FG004|Open-label Extension|Lost to Follow-up|0|||
146226661|NCT05218096|527347110|FG000|Open-label Extension|Death|0|||
146226662|NCT05218096|527347111|FG001|Open-label Extension|Death|0|||
145884106|NCT00879684|526080398|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
145884107|NCT00879684|526080399|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
145884108|NCT00879684|526080400|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
145884109|NCT00879684|526080394|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145884110|NCT00879684|526080395|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
146085471|NCT00548405|526833611|FG001|Overall Study|Lack of Efficacy|0|||
146085472|NCT00548405|526833612|FG002|Overall Study|Lack of Efficacy|0|||
146085473|NCT00548405|526833610|FG000|Overall Study|Physician Decision|3|||
146085474|NCT00548405|526833611|FG001|Overall Study|Physician Decision|4|||
145884111|NCT00879684|526080396|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145884112|NCT00879684|526080397|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145884113|NCT00879684|526080398|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145884114|NCT00879684|526080399|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
146226663|NCT05218096|527347112|FG002|Open-label Extension|Death|0|||
145884115|NCT00879684|526080400|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
145884116|NCT00708682|526080401|FG000|Infant Series|Adverse Event|1|||
145884117|NCT00708682|526080401|FG000|Infant Series|Lost to Follow-up|4|||
145884118|NCT00708682|526080401|FG000|Infant Series|Protocol Violation|1|||
145884119|NCT00708682|526080401|FG000|Infant Series|Parent/legal guardian request|6|||
146085475|NCT00548405|526833612|FG002|Overall Study|Physician Decision|1|||
146226664|NCT05218096|527347113|FG003|Open-label Extension|Death|1|||
146226665|NCT05218096|527347114|FG004|Open-label Extension|Death|0|||
146226666|NCT05218096|527347110|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
145884120|NCT00708682|526080401|FG000|Infant Series|Failed to return|2|||
145884121|NCT00708682|526080401|FG000|Infant Series|Other|19|||
145884122|NCT00708682|526080401|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
145884123|NCT00708682|526080401|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
146289056|NCT03658668|527573323|FG000|Overall Study|Time Commitment|1|||
145884124|NCT00708682|526080401|FG000|Toddler Dose|Lost to Follow-up|3|||
145884125|NCT00708682|526080401|FG000|Toddler Dose|Failed to Return|4|||
145884126|NCT01148225|526080404|FG000|Overall Study|Other|185|||
145884127|NCT03689894|526080405|FG000|Overall Study|Adverse Event|1|||
145884128|NCT02413294|526080406|FG000|Overall Study|Withdrawal by Subject|1|||
145884129|NCT00434590|526080407|FG000|Overall Study|Administrative problems|5|||
145884130|NCT00434590|526080408|FG001|Overall Study|Administrative problems|5|||
145884131|NCT02780167|526082419|FG000|Overall Study|Adverse Event|9|||
145884132|NCT02780167|526082420|FG001|Overall Study|Adverse Event|8|||
145884133|NCT02780167|526082421|FG002|Overall Study|Adverse Event|8|||
145884134|NCT02780167|526082422|FG003|Overall Study|Adverse Event|12|||
145884135|NCT02780167|526082423|FG004|Overall Study|Adverse Event|8|||
145884136|NCT02780167|526082419|FG000|Overall Study|Lack of Efficacy|6|||
145884137|NCT02780167|526082420|FG001|Overall Study|Lack of Efficacy|5|||
145884138|NCT02780167|526082421|FG002|Overall Study|Lack of Efficacy|6|||
145884139|NCT02780167|526082422|FG003|Overall Study|Lack of Efficacy|1|||
145884140|NCT02780167|526082423|FG004|Overall Study|Lack of Efficacy|0|||
145884141|NCT02780167|526082419|FG000|Overall Study|Lost to Follow-up|2|||
145884142|NCT02780167|526082420|FG001|Overall Study|Lost to Follow-up|0|||
145884143|NCT02780167|526082421|FG002|Overall Study|Lost to Follow-up|1|||
145884144|NCT02780167|526082422|FG003|Overall Study|Lost to Follow-up|0|||
145884145|NCT02780167|526082423|FG004|Overall Study|Lost to Follow-up|0|||
145884146|NCT02780167|526082419|FG000|Overall Study|Does not meet entrance criteria|0|||
145884147|NCT02780167|526082420|FG001|Overall Study|Does not meet entrance criteria|0|||
145884148|NCT02780167|526082421|FG002|Overall Study|Does not meet entrance criteria|1|||
145884149|NCT02780167|526082422|FG003|Overall Study|Does not meet entrance criteria|0|||
145961865|NCT02718911|526373565|FG007|Overall Study|Death|1|||
145961866|NCT02718911|526373566|FG008|Overall Study|Death|4|||
145884150|NCT02780167|526082423|FG004|Overall Study|Does not meet entrance criteria|0|||
145884151|NCT02780167|526082419|FG000|Overall Study|No longer meets eligibility criteria|0|||
145884152|NCT02780167|526082420|FG001|Overall Study|No longer meets eligibility criteria|0|||
145884153|NCT02780167|526082421|FG002|Overall Study|No longer meets eligibility criteria|0|||
145884154|NCT02780167|526082422|FG003|Overall Study|No longer meets eligibility criteria|1|||
145884155|NCT02780167|526082423|FG004|Overall Study|No longer meets eligibility criteria|1|||
145884156|NCT02780167|526082419|FG000|Overall Study|Protocol Violation|5|||
145884157|NCT02780167|526082420|FG001|Overall Study|Protocol Violation|5|||
145961867|NCT02718911|526373567|FG009|Overall Study|Death|3|||
146226667|NCT05218096|527347111|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
146226668|NCT05218096|527347112|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
146226669|NCT05218096|527347113|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
146226670|NCT05218096|527347114|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
146226671|NCT05646355|527347115|FG000|Overall Study|Lost to Follow-up|1|||
146226672|NCT05646355|527347116|FG001|Overall Study|Lost to Follow-up|0|||
146226673|NCT05646355|527347115|FG000|Overall Study|translated materials not available for pilot|2|||
146226674|NCT05646355|527347116|FG001|Overall Study|translated materials not available for pilot|0|||
146226675|NCT05646355|527347115|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
146226676|NCT05646355|527347116|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
146226677|NCT04685135|527347117|FG000|Overall Study|Death|126|||
146226678|NCT04685135|527347118|FG001|Overall Study|Death|53|||
146226679|NCT04685135|527347117|FG000|Overall Study|Withdrawal by Subject|12|||
146226680|NCT04685135|527347118|FG001|Overall Study|Withdrawal by Subject|16|||
146226681|NCT05863156|527347120|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
146226682|NCT05863156|527347121|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
146226683|NCT05863156|527347122|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
146226684|NCT03711474|527347123|FG000|Overall Study|Physician Decision|2|||
146226685|NCT03711474|527347124|FG001|Overall Study|Physician Decision|0|||
146226686|NCT05974501|527347125|FG000|Overall Study|Physician Decision|0|||
146226687|NCT05974501|527347126|FG001|Overall Study|Physician Decision|1|||
146226688|NCT03655028|527347129|FG000|12-weeks Follow up|Death|1|||
146226689|NCT03655028|527347130|FG001|12-weeks Follow up|Death|0|||
146226690|NCT03655028|527347129|FG000|12-weeks Follow up|Physician Decision|3|||
146226691|NCT03655028|527347130|FG001|12-weeks Follow up|Physician Decision|3|||
146226692|NCT03655028|527347129|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
145961868|NCT02718911|526373558|FG000|Overall Study|Lost to Follow-up|0|||
146226693|NCT03655028|527347130|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
146226694|NCT03655028|527347129|FG000|12-weeks Follow up|Lost to Follow-up|4|||
145884158|NCT02780167|526082421|FG002|Overall Study|Protocol Violation|1|||
145884159|NCT02780167|526082422|FG003|Overall Study|Protocol Violation|1|||
145884160|NCT02780167|526082423|FG004|Overall Study|Protocol Violation|2|||
145884161|NCT02780167|526082419|FG000|Overall Study|Withdrawal by Subject|6|||
145884162|NCT02780167|526082420|FG001|Overall Study|Withdrawal by Subject|4|||
145884163|NCT02780167|526082421|FG002|Overall Study|Withdrawal by Subject|4|||
145884164|NCT02780167|526082422|FG003|Overall Study|Withdrawal by Subject|3|||
145884165|NCT02780167|526082423|FG004|Overall Study|Withdrawal by Subject|4|||
145884166|NCT02780167|526082419|FG000|Overall Study|Other|0|||
145884167|NCT02780167|526082420|FG001|Overall Study|Other|0|||
145884168|NCT02780167|526082421|FG002|Overall Study|Other|3|||
145884169|NCT02780167|526082422|FG003|Overall Study|Other|1|||
145884170|NCT02780167|526082423|FG004|Overall Study|Other|2|||
145884171|NCT02315066|526082424|FG000|Overall Study|Lost to Follow-up|0|||
145884172|NCT02315066|526082425|FG001|Overall Study|Lost to Follow-up|1|||
145884173|NCT02315066|526082426|FG002|Overall Study|Lost to Follow-up|1|||
145884174|NCT02315066|526082427|FG003|Overall Study|Lost to Follow-up|0|||
145884175|NCT02315066|526082428|FG004|Overall Study|Lost to Follow-up|1|||
145884176|NCT02315066|526082429|FG005|Overall Study|Lost to Follow-up|0|||
146085476|NCT00548405|526833610|FG000|Overall Study|Pregnancy|1|||
145884177|NCT02315066|526082430|FG006|Overall Study|Lost to Follow-up|2|||
145884178|NCT02315066|526082431|FG007|Overall Study|Lost to Follow-up|1|||
145884179|NCT02315066|526082432|FG008|Overall Study|Lost to Follow-up|0|||
145884180|NCT02315066|526082433|FG009|Overall Study|Lost to Follow-up|0|||
146226695|NCT03655028|527347130|FG001|12-weeks Follow up|Lost to Follow-up|4|||
145961869|NCT02718911|526373559|FG001|Overall Study|Lost to Follow-up|0|||
145961870|NCT02718911|526373560|FG002|Overall Study|Lost to Follow-up|0|||
145961871|NCT02718911|526373561|FG003|Overall Study|Lost to Follow-up|0|||
145961872|NCT02718911|526373562|FG004|Overall Study|Lost to Follow-up|0|||
145961873|NCT02718911|526373563|FG005|Overall Study|Lost to Follow-up|0|||
145961874|NCT02718911|526373564|FG006|Overall Study|Lost to Follow-up|0|||
145961875|NCT02718911|526373565|FG007|Overall Study|Lost to Follow-up|0|||
145961876|NCT02718911|526373566|FG008|Overall Study|Lost to Follow-up|1|||
146085477|NCT00548405|526833611|FG001|Overall Study|Pregnancy|0|||
146085478|NCT00548405|526833612|FG002|Overall Study|Pregnancy|0|||
146226696|NCT03655028|527347129|FG000|24-weeks|Lost to Follow-up|1|||
146226697|NCT03655028|527347130|FG001|24-weeks|Lost to Follow-up|1|||
146226698|NCT03655028|527347129|FG000|24-weeks|Death|0|||
146226699|NCT03655028|527347130|FG001|24-weeks|Death|1|||
146226700|NCT03513302|527347131|FG000|First Intervention (14 Days)|Screen failure|15|||
146226701|NCT03513302|527347132|FG001|First Intervention (14 Days)|Screen failure|16|||
146226702|NCT05256654|527347133|FG000|Overall Study|Adverse Event|0|||
145961877|NCT02718911|526373567|FG009|Overall Study|Lost to Follow-up|0|||
146226703|NCT05256654|527347134|FG001|Overall Study|Adverse Event|0|||
146226704|NCT05256654|527347135|FG002|Overall Study|Adverse Event|1|||
146226705|NCT05256654|527347136|FG003|Overall Study|Adverse Event|0|||
146226706|NCT05256654|527347133|FG000|Overall Study|Lost to Follow-up|0|||
146226707|NCT05256654|527347134|FG001|Overall Study|Lost to Follow-up|0|||
146226708|NCT05256654|527347135|FG002|Overall Study|Lost to Follow-up|0|||
146226709|NCT05256654|527347136|FG003|Overall Study|Lost to Follow-up|1|||
146226710|NCT05256654|527347133|FG000|Overall Study|Withdrawal by Subject|1|||
145961878|NCT02718911|526373558|FG000|Overall Study|Physician Decision|2|||
145961879|NCT02718911|526373559|FG001|Overall Study|Physician Decision|0|||
145961880|NCT02718911|526373560|FG002|Overall Study|Physician Decision|1|||
145961881|NCT02718911|526373561|FG003|Overall Study|Physician Decision|1|||
145961882|NCT02718911|526373562|FG004|Overall Study|Physician Decision|0|||
145961883|NCT02718911|526373563|FG005|Overall Study|Physician Decision|0|||
145961884|NCT02718911|526373564|FG006|Overall Study|Physician Decision|0|||
145961885|NCT02718911|526373565|FG007|Overall Study|Physician Decision|1|||
145961886|NCT02718911|526373566|FG008|Overall Study|Physician Decision|2|||
145961887|NCT02718911|526373567|FG009|Overall Study|Physician Decision|1|||
145961888|NCT02718911|526373558|FG000|Overall Study|Withdrawal by Subject|0|||
145961889|NCT02718911|526373559|FG001|Overall Study|Withdrawal by Subject|0|||
145961890|NCT02718911|526373560|FG002|Overall Study|Withdrawal by Subject|0|||
145961891|NCT02718911|526373561|FG003|Overall Study|Withdrawal by Subject|0|||
145961892|NCT02718911|526373562|FG004|Overall Study|Withdrawal by Subject|1|||
145961893|NCT02718911|526373563|FG005|Overall Study|Withdrawal by Subject|0|||
145961894|NCT02718911|526373564|FG006|Overall Study|Withdrawal by Subject|0|||
145961895|NCT02718911|526373565|FG007|Overall Study|Withdrawal by Subject|0|||
145961896|NCT02718911|526373566|FG008|Overall Study|Withdrawal by Subject|1|||
145961897|NCT02718911|526373567|FG009|Overall Study|Withdrawal by Subject|4|||
145961898|NCT02718911|526373558|FG000|Overall Study|Reason Not Collected|0|||
145961899|NCT02718911|526373559|FG001|Overall Study|Reason Not Collected|0|||
146085479|NCT00548405|526833610|FG000|Overall Study|Protocol Violation|1|||
146226711|NCT05256654|527347134|FG001|Overall Study|Withdrawal by Subject|2|||
146226712|NCT05256654|527347135|FG002|Overall Study|Withdrawal by Subject|1|||
146226713|NCT05256654|527347136|FG003|Overall Study|Withdrawal by Subject|3|||
146226714|NCT05256654|527347133|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
145961900|NCT02718911|526373560|FG002|Overall Study|Reason Not Collected|1|||
145961901|NCT02718911|526373561|FG003|Overall Study|Reason Not Collected|0|||
146226715|NCT05256654|527347134|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
146226716|NCT05256654|527347135|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
146226717|NCT05256654|527347136|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
146226718|NCT05256654|527347133|FG000|Overall Study|Other|0|||
146226719|NCT05256654|527347134|FG001|Overall Study|Other|0|||
146226720|NCT05256654|527347135|FG002|Overall Study|Other|0|||
146226721|NCT05256654|527347136|FG003|Overall Study|Other|1|||
146226722|NCT04862416|527347145|FG000|Overall Study|Withdrawal by Subject|0|||
146226723|NCT04862416|527347146|FG001|Overall Study|Withdrawal by Subject|1|||
146226724|NCT04862416|527347147|FG002|Overall Study|Withdrawal by Subject|0|||
146226725|NCT04862416|527347148|FG003|Overall Study|Withdrawal by Subject|1|||
146226726|NCT04862416|527347149|FG004|Overall Study|Withdrawal by Subject|0|||
146226727|NCT04862416|527347150|FG005|Overall Study|Withdrawal by Subject|0|||
146226728|NCT04862416|527347151|FG006|Overall Study|Withdrawal by Subject|0|||
146226729|NCT04862416|527347152|FG007|Overall Study|Withdrawal by Subject|0|||
146226730|NCT03852550|527347153|FG000|Overall Study|Lost to Follow-up|4|||
146226731|NCT03852550|527347154|FG001|Overall Study|Lost to Follow-up|3|||
146226732|NCT03852550|527347153|FG000|Overall Study|Only parent outcomes completed|0|||
146226733|NCT03852550|527347154|FG001|Overall Study|Only parent outcomes completed|1|||
146226734|NCT03852550|527347153|FG000|Overall Study|Withdrawal by Subject|1|||
146226735|NCT03852550|527347154|FG001|Overall Study|Withdrawal by Subject|0|||
146226736|NCT04295512|527347157|FG000|Overall Study|Lack of family response to schedule assessment|0|||
146226737|NCT04295512|527347158|FG001|Overall Study|Lack of family response to schedule assessment|0|||
146226738|NCT04295512|527347159|FG002|Overall Study|Lack of family response to schedule assessment|0|||
146226739|NCT04295512|527347160|FG003|Overall Study|Lack of family response to schedule assessment|2|||
146226740|NCT04295512|527347157|FG000|Overall Study|Therapist did not refer eligible family|7|||
146226741|NCT04295512|527347158|FG001|Overall Study|Therapist did not refer eligible family|7|||
146226742|NCT04295512|527347159|FG002|Overall Study|Therapist did not refer eligible family|0|||
146226743|NCT04295512|527347160|FG003|Overall Study|Therapist did not refer eligible family|0|||
146226744|NCT01009788|527347171|FG000|Overall Study|Withdrawal by Subject|1|||
146226745|NCT01009788|527347172|FG001|Overall Study|Withdrawal by Subject|0|||
146226746|NCT01309672|527347174|FG000|Overall Study|Lack of Efficacy|20|||
146226747|NCT01309672|527347174|FG000|Overall Study|Other|9|||
146226748|NCT01309672|527347174|FG000|Overall Study|Adverse Event|5|||
146226749|NCT01309672|527347174|FG000|Overall Study|Withdrawal by Subject|3|||
146226750|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
146226751|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
146226752|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
146226753|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
146226754|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
146226755|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
146226756|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
146226757|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
146226758|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
146226759|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
146226760|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
146226761|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
146226762|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
146226763|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
146226764|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
146226765|NCT01254864|527347175|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
146226766|NCT01254864|527347176|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
146226767|NCT01254864|527347177|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
146226768|NCT01254864|527347175|FG000|Randomization Phase|Adverse Event|0|||
146226769|NCT01254864|527347176|FG001|Randomization Phase|Adverse Event|5|||
146226770|NCT01254864|527347177|FG002|Randomization Phase|Adverse Event|17|||
146226771|NCT01254864|527347175|FG000|Randomization Phase|Death|0|||
146226772|NCT01254864|527347176|FG001|Randomization Phase|Death|1|||
146226773|NCT01254864|527347177|FG002|Randomization Phase|Death|0|||
146226774|NCT01254864|527347175|FG000|Randomization Phase|Lost to Follow-up|0|||
146226775|NCT01254864|527347176|FG001|Randomization Phase|Lost to Follow-up|0|||
146226776|NCT01254864|527347177|FG002|Randomization Phase|Lost to Follow-up|1|||
146226777|NCT01254864|527347175|FG000|Randomization Phase|Physician Decision|0|||
146226778|NCT01254864|527347176|FG001|Randomization Phase|Physician Decision|20|||
146226779|NCT01254864|527347177|FG002|Randomization Phase|Physician Decision|25|||
146226780|NCT01254864|527347175|FG000|Randomization Phase|Withdrawal by Subject|0|||
146226781|NCT01254864|527347176|FG001|Randomization Phase|Withdrawal by Subject|4|||
146226782|NCT01254864|527347177|FG002|Randomization Phase|Withdrawal by Subject|2|||
146226783|NCT01254864|527347175|FG000|Randomization Phase|Non-Compliance|0|||
146226784|NCT01254864|527347176|FG001|Randomization Phase|Non-Compliance|1|||
146226785|NCT01254864|527347177|FG002|Randomization Phase|Non-Compliance|0|||
146226786|NCT01254864|527347175|FG000|Randomization Phase|Comorbidities|0|||
146226787|NCT01254864|527347176|FG001|Randomization Phase|Comorbidities|2|||
146226788|NCT01254864|527347177|FG002|Randomization Phase|Comorbidities|1|||
146226789|NCT04625725|527347181|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
146226790|NCT04625725|527347182|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146226791|NCT04625725|527347183|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146226792|NCT04625725|527347184|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146226793|NCT04625725|527347185|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145884181|NCT02315066|526082434|FG010|Overall Study|Lost to Follow-up|1|||
145884182|NCT02315066|526082435|FG011|Overall Study|Lost to Follow-up|2|||
145884183|NCT02315066|526082436|FG012|Overall Study|Lost to Follow-up|0|||
145884184|NCT02315066|526082437|FG013|Overall Study|Lost to Follow-up|4|||
146226794|NCT04625725|527347186|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
146226795|NCT04625725|527347181|FG000|Provent Main Study|Withdrawal by Subject|242|||
146226796|NCT04625725|527347182|FG001|Provent Main Study|Withdrawal by Subject|144|||
146226797|NCT04625725|527347183|FG002|Provent Main Study|Withdrawal by Subject|0|||
146226798|NCT04625725|527347184|FG003|Provent Main Study|Withdrawal by Subject|0|||
146226799|NCT04625725|527347185|FG004|Provent Main Study|Withdrawal by Subject|0|||
145884185|NCT02315066|526082424|FG000|Overall Study|Death|2|||
145884186|NCT02315066|526082425|FG001|Overall Study|Death|7|||
145884187|NCT02315066|526082426|FG002|Overall Study|Death|6|||
145884188|NCT02315066|526082427|FG003|Overall Study|Death|11|||
146226800|NCT04625725|527347186|FG005|Provent Main Study|Withdrawal by Subject|0|||
146226801|NCT04625725|527347181|FG000|Provent Main Study|Physician Decision|5|||
146226802|NCT04625725|527347182|FG001|Provent Main Study|Physician Decision|0|||
146226803|NCT04625725|527347183|FG002|Provent Main Study|Physician Decision|0|||
146226804|NCT04625725|527347184|FG003|Provent Main Study|Physician Decision|0|||
146226805|NCT04625725|527347185|FG004|Provent Main Study|Physician Decision|0|||
146226806|NCT04625725|527347186|FG005|Provent Main Study|Physician Decision|0|||
146226807|NCT04625725|527347181|FG000|Provent Main Study|Protocol Violation|1|||
146226808|NCT04625725|527347182|FG001|Provent Main Study|Protocol Violation|0|||
146226809|NCT04625725|527347183|FG002|Provent Main Study|Protocol Violation|0|||
146226810|NCT04625725|527347184|FG003|Provent Main Study|Protocol Violation|0|||
146226811|NCT04625725|527347185|FG004|Provent Main Study|Protocol Violation|0|||
146226812|NCT04625725|527347186|FG005|Provent Main Study|Protocol Violation|0|||
146226813|NCT04625725|527347181|FG000|Provent Main Study|Lost to Follow-up|357|||
146226814|NCT04625725|527347182|FG001|Provent Main Study|Lost to Follow-up|200|||
146226815|NCT04625725|527347183|FG002|Provent Main Study|Lost to Follow-up|0|||
146226816|NCT04625725|527347184|FG003|Provent Main Study|Lost to Follow-up|0|||
146226817|NCT04625725|527347185|FG004|Provent Main Study|Lost to Follow-up|0|||
146226818|NCT04625725|527347186|FG005|Provent Main Study|Lost to Follow-up|0|||
146226819|NCT04625725|527347181|FG000|Provent Main Study|Death|22|||
146226820|NCT04625725|527347182|FG001|Provent Main Study|Death|10|||
146226821|NCT04625725|527347183|FG002|Provent Main Study|Death|0|||
146226822|NCT04625725|527347184|FG003|Provent Main Study|Death|0|||
146226823|NCT04625725|527347185|FG004|Provent Main Study|Death|0|||
145884189|NCT02315066|526082428|FG004|Overall Study|Death|10|||
146226824|NCT04625725|527347186|FG005|Provent Main Study|Death|0|||
146226825|NCT04625725|527347181|FG000|Provent Main Study|Adverse Event|2|||
146226826|NCT04625725|527347182|FG001|Provent Main Study|Adverse Event|1|||
146226827|NCT04625725|527347183|FG002|Provent Main Study|Adverse Event|0|||
146226828|NCT04625725|527347184|FG003|Provent Main Study|Adverse Event|0|||
146226829|NCT04625725|527347185|FG004|Provent Main Study|Adverse Event|0|||
145884190|NCT02315066|526082429|FG005|Overall Study|Death|3|||
145884191|NCT02315066|526082430|FG006|Overall Study|Death|9|||
146226830|NCT04625725|527347186|FG005|Provent Main Study|Adverse Event|0|||
146226831|NCT04625725|527347181|FG000|Provent Main Study|Participants dosed in sub-study|310|||
146226832|NCT04625725|527347182|FG001|Provent Main Study|Participants dosed in sub-study|193|||
146226833|NCT04625725|527347183|FG002|Provent Main Study|Participants dosed in sub-study|0|||
146226834|NCT04625725|527347184|FG003|Provent Main Study|Participants dosed in sub-study|0|||
146226835|NCT04625725|527347185|FG004|Provent Main Study|Participants dosed in sub-study|0|||
146226836|NCT04625725|527347186|FG005|Provent Main Study|Participants dosed in sub-study|0|||
146226837|NCT04625725|527347181|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
145961902|NCT02718911|526373562|FG004|Overall Study|Reason Not Collected|0|||
145961903|NCT02718911|526373563|FG005|Overall Study|Reason Not Collected|0|||
145961904|NCT02718911|526373564|FG006|Overall Study|Reason Not Collected|2|||
145961905|NCT02718911|526373565|FG007|Overall Study|Reason Not Collected|1|||
145961906|NCT02718911|526373566|FG008|Overall Study|Reason Not Collected|4|||
145961907|NCT02718911|526373567|FG009|Overall Study|Reason Not Collected|9|||
145961908|NCT04817332|526373568|FG000|Overall Study|Lost to Follow-up|3|||
145961909|NCT04817332|526373569|FG001|Overall Study|Lost to Follow-up|3|||
145961910|NCT04817332|526373568|FG000|Overall Study|Protocol Violation|2|||
146226838|NCT04625725|527347182|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
146226839|NCT04625725|527347183|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146226840|NCT04625725|527347184|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146226841|NCT04625725|527347185|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146226842|NCT04625725|527347186|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
146226843|NCT04625725|527347181|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
146226844|NCT04625725|527347182|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
146226845|NCT04625725|527347183|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
145961911|NCT04817332|526373569|FG001|Overall Study|Protocol Violation|0|||
145961912|NCT01867008|526373570|FG000|Overall Study|Withdrawal by Subject|1|||
145961913|NCT00983372|526373571|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
145961914|NCT00983372|526373571|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
145961915|NCT00983372|526373571|FG000|Diltiazem ER Alone|Adverse Event|1|||
146226846|NCT04625725|527347184|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146226847|NCT04625725|527347185|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146226848|NCT04625725|527347186|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
146226849|NCT04625725|527347181|FG000|Provent Main Study|INCARCERATION|3|||
146226850|NCT04625725|527347182|FG001|Provent Main Study|INCARCERATION|0|||
146226851|NCT04625725|527347183|FG002|Provent Main Study|INCARCERATION|0|||
146226852|NCT04625725|527347184|FG003|Provent Main Study|INCARCERATION|0|||
146226853|NCT04625725|527347185|FG004|Provent Main Study|INCARCERATION|0|||
145961916|NCT02131064|526373578|FG000|Overall Study|Death|5|||
145961917|NCT02131064|526373579|FG001|Overall Study|Death|6|||
146226854|NCT04625725|527347186|FG005|Provent Main Study|INCARCERATION|0|||
146226855|NCT04625725|527347181|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
146226856|NCT04625725|527347182|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
146226857|NCT04625725|527347183|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146226858|NCT04625725|527347184|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146226859|NCT04625725|527347185|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146226860|NCT04625725|527347186|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
146226861|NCT04625725|527347181|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
146226862|NCT04625725|527347182|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
146226863|NCT04625725|527347183|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146226864|NCT04625725|527347184|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146226865|NCT04625725|527347185|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146226866|NCT04625725|527347186|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
146226867|NCT04625725|527347181|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
146226868|NCT04625725|527347182|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
146226869|NCT04625725|527347183|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145961918|NCT02131064|526373578|FG000|Overall Study|Lost to Follow-up|4|||
145961919|NCT02131064|526373579|FG001|Overall Study|Lost to Follow-up|8|||
146226870|NCT04625725|527347184|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146226871|NCT04625725|527347185|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145884192|NCT02315066|526082431|FG007|Overall Study|Death|9|||
145884193|NCT02315066|526082432|FG008|Overall Study|Death|10|||
145884194|NCT02315066|526082433|FG009|Overall Study|Death|8|||
145884195|NCT02315066|526082434|FG010|Overall Study|Death|10|||
145884196|NCT02315066|526082435|FG011|Overall Study|Death|7|||
145884197|NCT02315066|526082436|FG012|Overall Study|Death|8|||
145884198|NCT02315066|526082437|FG013|Overall Study|Death|21|||
145884199|NCT02315066|526082424|FG000|Overall Study|Other|0|||
145884200|NCT02315066|526082425|FG001|Overall Study|Other|0|||
145884201|NCT02315066|526082426|FG002|Overall Study|Other|0|||
145884202|NCT02315066|526082427|FG003|Overall Study|Other|0|||
145884203|NCT02315066|526082428|FG004|Overall Study|Other|0|||
145884204|NCT02315066|526082429|FG005|Overall Study|Other|0|||
145884205|NCT02315066|526082430|FG006|Overall Study|Other|0|||
145884206|NCT02315066|526082431|FG007|Overall Study|Other|1|||
146085480|NCT00548405|526833611|FG001|Overall Study|Protocol Violation|0|||
145884207|NCT02315066|526082432|FG008|Overall Study|Other|1|||
145884208|NCT02315066|526082433|FG009|Overall Study|Other|2|||
145884209|NCT02315066|526082434|FG010|Overall Study|Other|0|||
146085481|NCT00548405|526833612|FG002|Overall Study|Protocol Violation|0|||
145884210|NCT02315066|526082435|FG011|Overall Study|Other|0|||
145884211|NCT02315066|526082436|FG012|Overall Study|Other|0|||
146226872|NCT04625725|527347186|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
146226873|NCT04625725|527347181|FG000|Provent Main Study|MISSING REASON|0|||
146226874|NCT04625725|527347182|FG001|Provent Main Study|MISSING REASON|1|||
146226875|NCT04625725|527347183|FG002|Provent Main Study|MISSING REASON|0|||
146226876|NCT04625725|527347184|FG003|Provent Main Study|MISSING REASON|0|||
145884212|NCT02315066|526082437|FG013|Overall Study|Other|0|||
146226877|NCT04625725|527347185|FG004|Provent Main Study|MISSING REASON|0|||
146226878|NCT04625725|527347186|FG005|Provent Main Study|MISSING REASON|0|||
146085482|NCT00548405|526833610|FG000|Overall Study|Withdrawal by Subject|36|||
146226879|NCT04625725|527347181|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146226880|NCT04625725|527347182|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146226881|NCT04625725|527347183|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
146226882|NCT04625725|527347184|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
146226883|NCT04625725|527347185|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145884213|NCT02315066|526082424|FG000|Overall Study|Subject refused further follow-up|0|||
146085483|NCT00548405|526833611|FG001|Overall Study|Withdrawal by Subject|12|||
146289057|NCT03658668|527573324|FG001|Overall Study|Time Commitment|1|||
146289058|NCT01952054|527573325|FG000|Overall Study|Physician Decision|1|||
145884214|NCT02315066|526082425|FG001|Overall Study|Subject refused further follow-up|2|||
145884215|NCT02315066|526082426|FG002|Overall Study|Subject refused further follow-up|2|||
145884216|NCT02315066|526082427|FG003|Overall Study|Subject refused further follow-up|0|||
145884217|NCT02315066|526082428|FG004|Overall Study|Subject refused further follow-up|0|||
145884218|NCT02315066|526082429|FG005|Overall Study|Subject refused further follow-up|0|||
145884219|NCT02315066|526082430|FG006|Overall Study|Subject refused further follow-up|2|||
145884220|NCT02315066|526082431|FG007|Overall Study|Subject refused further follow-up|3|||
145884221|NCT02315066|526082432|FG008|Overall Study|Subject refused further follow-up|0|||
145884222|NCT02315066|526082433|FG009|Overall Study|Subject refused further follow-up|1|||
145884223|NCT02315066|526082434|FG010|Overall Study|Subject refused further follow-up|1|||
145884224|NCT02315066|526082435|FG011|Overall Study|Subject refused further follow-up|2|||
145884225|NCT02315066|526082436|FG012|Overall Study|Subject refused further follow-up|2|||
145884226|NCT02315066|526082437|FG013|Overall Study|Subject refused further follow-up|4|||
145884227|NCT02315066|526082424|FG000|Overall Study|Study ongoing at date of cut-off|0|||
145884228|NCT02315066|526082425|FG001|Overall Study|Study ongoing at date of cut-off|0|||
145884229|NCT02315066|526082426|FG002|Overall Study|Study ongoing at date of cut-off|0|||
146226884|NCT04625725|527347186|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145884230|NCT02315066|526082427|FG003|Overall Study|Study ongoing at date of cut-off|0|||
145884231|NCT02315066|526082428|FG004|Overall Study|Study ongoing at date of cut-off|0|||
145884232|NCT02315066|526082429|FG005|Overall Study|Study ongoing at date of cut-off|0|||
145884233|NCT02315066|526082430|FG006|Overall Study|Study ongoing at date of cut-off|0|||
145884234|NCT02315066|526082431|FG007|Overall Study|Study ongoing at date of cut-off|0|||
145884235|NCT02315066|526082432|FG008|Overall Study|Study ongoing at date of cut-off|0|||
145884236|NCT02315066|526082433|FG009|Overall Study|Study ongoing at date of cut-off|0|||
145884237|NCT02315066|526082434|FG010|Overall Study|Study ongoing at date of cut-off|0|||
146289059|NCT01136772|527573326|FG000|Overall Study|Adverse Event|15|||
145884238|NCT02315066|526082435|FG011|Overall Study|Study ongoing at date of cut-off|0|||
145884239|NCT02315066|526082436|FG012|Overall Study|Study ongoing at date of cut-off|0|||
145884240|NCT02315066|526082437|FG013|Overall Study|Study ongoing at date of cut-off|1|||
145884241|NCT01142908|526082438|FG000|Overall Study|Lost to Follow-up|19|||
145884242|NCT01142908|526082439|FG001|Overall Study|Lost to Follow-up|13|||
145884243|NCT01142908|526082438|FG000|Overall Study|Death|1|||
145884244|NCT01142908|526082439|FG001|Overall Study|Death|4|||
145884245|NCT01142908|526082438|FG000|Overall Study|Excluded - did not meet criteria|9|||
145884246|NCT01142908|526082439|FG001|Overall Study|Excluded - did not meet criteria|5|||
145884247|NCT01142908|526082438|FG000|Overall Study|Withdrawal by Subject|3|||
145884248|NCT01142908|526082439|FG001|Overall Study|Withdrawal by Subject|0|||
145884249|NCT00337428|526082441|FG000|Overall Study|Withdrawal by Subject|1|||
145884250|NCT00337428|526082442|FG001|Overall Study|Withdrawal by Subject|2|||
145884251|NCT00337428|526082441|FG000|Overall Study|Lack of Time|1|||
145884252|NCT00337428|526082442|FG001|Overall Study|Lack of Time|1|||
145884253|NCT00337428|526082441|FG000|Overall Study|Unwilling to Continue|1|||
145884254|NCT00337428|526082442|FG001|Overall Study|Unwilling to Continue|0|||
145884255|NCT00337428|526082441|FG000|Overall Study|Anorexia|1|||
145884256|NCT00337428|526082442|FG001|Overall Study|Anorexia|0|||
145884257|NCT04205162|526082443|FG000|Overall Study|Lost to Follow-up|1|||
145884258|NCT04205162|526082444|FG001|Overall Study|Lost to Follow-up|0|||
145884259|NCT04205162|526082443|FG000|Overall Study|Withdrawal by Subject|2|||
145884260|NCT04205162|526082444|FG001|Overall Study|Withdrawal by Subject|0|||
145884261|NCT04205162|526082443|FG000|Overall Study|University closure due to COVID-19|1|||
145884262|NCT04205162|526082444|FG001|Overall Study|University closure due to COVID-19|0|||
145884263|NCT00529217|526082445|FG000|Overall Study|Lack of Efficacy|2|||
145884264|NCT00529217|526082445|FG000|Overall Study|Unable to adhere to study schedule|2|||
145884265|NCT00779402|526082446|FG000|Treatment Phase 1|Disease Progression|1|||
145884266|NCT00779402|526082447|FG001|Treatment Phase 1|Disease Progression|0|||
145884267|NCT00779402|526082446|FG000|Treatment Phase 1|Adverse Event|2|||
145884268|NCT00779402|526082447|FG001|Treatment Phase 1|Adverse Event|0|||
145884269|NCT00779402|526082446|FG000|Treatment Phase 1|Protocol Violation|1|||
145884270|NCT00779402|526082447|FG001|Treatment Phase 1|Protocol Violation|0|||
145884271|NCT00779402|526082446|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
145884272|NCT00779402|526082447|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
145884273|NCT00779402|526082446|FG000|Treatment Phase 1|Lost to Follow-up|0|||
145884274|NCT00779402|526082447|FG001|Treatment Phase 1|Lost to Follow-up|1|||
145884275|NCT00779402|526082446|FG000|Treatment Phase 1|Death|0|||
145884276|NCT00779402|526082447|FG001|Treatment Phase 1|Death|1|||
145884277|NCT00779402|526082446|FG000|Treatment Phase 1|Intercurrent Illness|1|||
145884278|NCT00779402|526082447|FG001|Treatment Phase 1|Intercurrent Illness|1|||
145884279|NCT00779402|526082446|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
145884280|NCT00779402|526082447|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
145884281|NCT00779402|526082446|FG000|Treatment Phase 1|Other|4|||
145884282|NCT00779402|526082447|FG001|Treatment Phase 1|Other|2|||
145961920|NCT02131064|526373578|FG000|Overall Study|Withdrawal by Subject|14|||
145961921|NCT02131064|526373579|FG001|Overall Study|Withdrawal by Subject|18|||
145961922|NCT02131064|526373578|FG000|Overall Study|Other|2|||
145961923|NCT02131064|526373579|FG001|Overall Study|Other|2|||
145961924|NCT00570401|526373585|FG000|Overall Study|Adverse Event|2|||
145961925|NCT01710020|526373586|FG000|Period 1|Protocol Violation|1|||
145961926|NCT01764841|526373587|FG000|Overall Study|Logistical Difficulties|0|||
145961927|NCT01764841|526373588|FG001|Overall Study|Logistical Difficulties|1|||
145961928|NCT01764841|526373589|FG002|Overall Study|Logistical Difficulties|0|||
145961929|NCT01764841|526373590|FG003|Overall Study|Logistical Difficulties|0|||
145961930|NCT01764841|526373587|FG000|Overall Study|Death|3|||
145961931|NCT01764841|526373588|FG001|Overall Study|Death|0|||
145961932|NCT01764841|526373589|FG002|Overall Study|Death|1|||
145961933|NCT01764841|526373590|FG003|Overall Study|Death|4|||
145961934|NCT01764841|526373587|FG000|Overall Study|No Follow Up|1|||
145961935|NCT01764841|526373588|FG001|Overall Study|No Follow Up|0|||
145961936|NCT01764841|526373589|FG002|Overall Study|No Follow Up|1|||
145961937|NCT01764841|526373590|FG003|Overall Study|No Follow Up|0|||
145961938|NCT01764841|526373587|FG000|Overall Study|Protocol Violation|0|||
145961939|NCT01764841|526373588|FG001|Overall Study|Protocol Violation|1|||
145961940|NCT01764841|526373589|FG002|Overall Study|Protocol Violation|0|||
145961941|NCT01764841|526373590|FG003|Overall Study|Protocol Violation|0|||
145961942|NCT01764841|526373587|FG000|Overall Study|Withdrawal by Subject|16|||
145961943|NCT01764841|526373588|FG001|Overall Study|Withdrawal by Subject|24|||
145961944|NCT01764841|526373589|FG002|Overall Study|Withdrawal by Subject|11|||
145961945|NCT01764841|526373590|FG003|Overall Study|Withdrawal by Subject|15|||
145961946|NCT01764841|526373587|FG000|Overall Study|Lost to Follow-up|3|||
145961947|NCT01764841|526373588|FG001|Overall Study|Lost to Follow-up|0|||
145961948|NCT01764841|526373589|FG002|Overall Study|Lost to Follow-up|1|||
145961949|NCT01764841|526373590|FG003|Overall Study|Lost to Follow-up|0|||
145961950|NCT00549549|526373591|FG000|Overall Study|Adverse Event|5|||
145961951|NCT00549549|526373592|FG001|Overall Study|Adverse Event|3|||
145961952|NCT00549549|526373593|FG002|Overall Study|Adverse Event|1|||
145961953|NCT00549549|526373594|FG003|Overall Study|Adverse Event|9|||
145961954|NCT00549549|526373591|FG000|Overall Study|Lack of Efficacy|9|||
145961955|NCT00549549|526373592|FG001|Overall Study|Lack of Efficacy|6|||
145961956|NCT00549549|526373593|FG002|Overall Study|Lack of Efficacy|4|||
145961957|NCT00549549|526373594|FG003|Overall Study|Lack of Efficacy|2|||
145961958|NCT00549549|526373591|FG000|Overall Study|Lost to Follow-up|1|||
145961959|NCT00549549|526373592|FG001|Overall Study|Lost to Follow-up|0|||
145961960|NCT00549549|526373593|FG002|Overall Study|Lost to Follow-up|1|||
145961961|NCT00549549|526373594|FG003|Overall Study|Lost to Follow-up|2|||
145961962|NCT00549549|526373591|FG000|Overall Study|Withdrawal by Subject|0|||
145961963|NCT00549549|526373592|FG001|Overall Study|Withdrawal by Subject|4|||
145961964|NCT00549549|526373593|FG002|Overall Study|Withdrawal by Subject|1|||
145961965|NCT00549549|526373594|FG003|Overall Study|Withdrawal by Subject|0|||
145961966|NCT00549549|526373591|FG000|Overall Study|Other|9|||
145884283|NCT00779402|526082446|FG000|Treatment Phase 1|Closure of Study|3|||
145961967|NCT00549549|526373592|FG001|Overall Study|Other|9|||
145961968|NCT00549549|526373593|FG002|Overall Study|Other|9|||
145961969|NCT00549549|526373594|FG003|Overall Study|Other|11|||
145961970|NCT00549549|526373591|FG000|Overall Study|Randomized but not treated|0|||
145961971|NCT00549549|526373592|FG001|Overall Study|Randomized but not treated|0|||
145884284|NCT00779402|526082447|FG001|Treatment Phase 1|Closure of Study|2|||
145884285|NCT00779402|526082446|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
145884286|NCT00779402|526082447|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
146085484|NCT00548405|526833612|FG002|Overall Study|Withdrawal by Subject|5|||
145884287|NCT00779402|526082446|FG000|Surveillance Phase|Protocol Violation|0|||
145884288|NCT00779402|526082447|FG001|Surveillance Phase|Protocol Violation|1|||
145961972|NCT00549549|526373593|FG002|Overall Study|Randomized but not treated|1|||
145961973|NCT00549549|526373594|FG003|Overall Study|Randomized but not treated|1|||
145961974|NCT04010461|526373598|FG000|Overall Study|COVID based withdrawal|5|||
145961975|NCT04010461|526373598|FG000|Overall Study|Withdrawal by Subject|5|||
145961976|NCT04010461|526373598|FG000|Overall Study|Adverse Event|1|||
145961977|NCT04010461|526373598|FG000|Overall Study|No Motor Threshold obtainable|1|||
145961978|NCT04010461|526373598|FG000|Overall Study|Physician Decision|1|||
145884289|NCT00779402|526082446|FG000|Surveillance Phase|Patient refused to continue|22|||
145884290|NCT00779402|526082447|FG001|Surveillance Phase|Patient refused to continue|14|||
145884291|NCT00779402|526082446|FG000|Surveillance Phase|Lost to Follow-up|2|||
145884292|NCT00779402|526082447|FG001|Surveillance Phase|Lost to Follow-up|1|||
145884293|NCT00779402|526082446|FG000|Surveillance Phase|Death|0|||
145884294|NCT00779402|526082447|FG001|Surveillance Phase|Death|1|||
145884295|NCT00779402|526082446|FG000|Surveillance Phase|Intercurrent Illness|2|||
145884296|NCT00779402|526082447|FG001|Surveillance Phase|Intercurrent Illness|0|||
145884297|NCT00779402|526082446|FG000|Surveillance Phase|Other|5|||
145884298|NCT00779402|526082447|FG001|Surveillance Phase|Other|5|||
145884299|NCT00779402|526082446|FG000|Surveillance Phase|Withdrawal by Subject|4|||
145884300|NCT00779402|526082447|FG001|Surveillance Phase|Withdrawal by Subject|1|||
146226885|NCT04625725|527347181|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146226886|NCT04625725|527347182|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146226887|NCT04625725|527347183|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
146226888|NCT04625725|527347184|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146226889|NCT04625725|527347185|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146226890|NCT04625725|527347186|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
146226891|NCT04625725|527347181|FG000|Provent Sub Study|Lost to Follow-up|0|||
146226892|NCT04625725|527347182|FG001|Provent Sub Study|Lost to Follow-up|0|||
146226893|NCT04625725|527347183|FG002|Provent Sub Study|Lost to Follow-up|20|||
146226894|NCT04625725|527347184|FG003|Provent Sub Study|Lost to Follow-up|10|||
146226895|NCT04625725|527347185|FG004|Provent Sub Study|Lost to Follow-up|6|||
146226896|NCT04625725|527347186|FG005|Provent Sub Study|Lost to Follow-up|4|||
146226897|NCT04625725|527347181|FG000|Provent Sub Study|Death|0|||
146226898|NCT04625725|527347182|FG001|Provent Sub Study|Death|0|||
146226899|NCT04625725|527347183|FG002|Provent Sub Study|Death|8|||
146226900|NCT04625725|527347184|FG003|Provent Sub Study|Death|5|||
146226901|NCT04625725|527347185|FG004|Provent Sub Study|Death|0|||
146226902|NCT04625725|527347186|FG005|Provent Sub Study|Death|1|||
146226903|NCT04625725|527347181|FG000|Provent Sub Study|Adverse Event|0|||
146226904|NCT04625725|527347182|FG001|Provent Sub Study|Adverse Event|0|||
146226905|NCT04625725|527347183|FG002|Provent Sub Study|Adverse Event|0|||
146226906|NCT04625725|527347184|FG003|Provent Sub Study|Adverse Event|0|||
146226907|NCT04625725|527347185|FG004|Provent Sub Study|Adverse Event|0|||
146226908|NCT04625725|527347186|FG005|Provent Sub Study|Adverse Event|1|||
146226909|NCT04625725|527347181|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146226910|NCT04625725|527347182|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146226911|NCT04625725|527347183|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146226912|NCT04625725|527347184|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146226913|NCT04625725|527347185|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
146226914|NCT04625725|527347186|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
146226915|NCT04625725|527347181|FG000|Provent Sub Study|Withdrawal by Subject|0|||
146226916|NCT04625725|527347182|FG001|Provent Sub Study|Withdrawal by Subject|0|||
146226917|NCT04625725|527347183|FG002|Provent Sub Study|Withdrawal by Subject|11|||
145884301|NCT00779402|526082446|FG000|Surveillance Phase|Closure of study|5|||
145884302|NCT00779402|526082447|FG001|Surveillance Phase|Closure of study|6|||
145884303|NCT00779402|526082446|FG000|Surveillance Phase|Completed Protocol Visits|3|||
145884304|NCT00779402|526082447|FG001|Surveillance Phase|Completed Protocol Visits|2|||
145961979|NCT02227784|526373599|FG000|Double-Blind Phase|Adverse Event|3|||
145961980|NCT02227784|526373600|FG001|Double-Blind Phase|Adverse Event|2|||
145961981|NCT02227784|526373601|FG002|Double-Blind Phase|Adverse Event|1|||
145961982|NCT02227784|526373602|FG003|Double-Blind Phase|Adverse Event|3|||
145961983|NCT02227784|526373603|FG004|Double-Blind Phase|Adverse Event|0|||
145961984|NCT02227784|526373599|FG000|Double-Blind Phase|Physician Decision|1|||
145961985|NCT02227784|526373600|FG001|Double-Blind Phase|Physician Decision|0|||
145961986|NCT02227784|526373601|FG002|Double-Blind Phase|Physician Decision|0|||
145961987|NCT02227784|526373602|FG003|Double-Blind Phase|Physician Decision|1|||
145961988|NCT02227784|526373603|FG004|Double-Blind Phase|Physician Decision|0|||
146085485|NCT00548405|526833610|FG000|Overall Study|Lost to Follow-up|1|||
146085486|NCT00548405|526833611|FG001|Overall Study|Lost to Follow-up|1|||
146085487|NCT00548405|526833612|FG002|Overall Study|Lost to Follow-up|2|||
146085488|NCT00548405|526833610|FG000|Overall Study|Death|0|||
146085489|NCT00548405|526833611|FG001|Overall Study|Death|1|||
146085490|NCT00548405|526833612|FG002|Overall Study|Death|1|||
146085491|NCT00548405|526833610|FG000|Overall Study|Sponsor decision|1|||
146085492|NCT00548405|526833611|FG001|Overall Study|Sponsor decision|0|||
146085493|NCT00548405|526833612|FG002|Overall Study|Sponsor decision|0|||
146085494|NCT00548405|526833610|FG000|Overall Study|Randomized but not treated|1|||
146226918|NCT04625725|527347184|FG003|Provent Sub Study|Withdrawal by Subject|13|||
145961989|NCT02227784|526373599|FG000|Double-Blind Phase|Protocol Violation|0|||
146085495|NCT00548405|526833611|FG001|Overall Study|Randomized but not treated|0|||
146226919|NCT04625725|527347185|FG004|Provent Sub Study|Withdrawal by Subject|5|||
146226920|NCT04625725|527347186|FG005|Provent Sub Study|Withdrawal by Subject|6|||
145884305|NCT00779402|526082446|FG000|Long-term Follow-up|Patient refused to continue|2|||
145884306|NCT00779402|526082447|FG001|Long-term Follow-up|Patient refused to continue|0|||
145884307|NCT00779402|526082446|FG000|Long-term Follow-up|Other|5|||
145884308|NCT00779402|526082447|FG001|Long-term Follow-up|Other|0|||
145884309|NCT00779402|526082446|FG000|Long-term Follow-up|Closure of Study|8|||
145884310|NCT00779402|526082447|FG001|Long-term Follow-up|Closure of Study|4|||
145884311|NCT00779402|526082446|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
145884312|NCT00779402|526082447|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
145884313|NCT01519947|526082452|FG000|Overall Study|Death|0|||
145884314|NCT01519947|526082453|FG001|Overall Study|Death|0|||
145884315|NCT01519947|526082454|FG002|Overall Study|Death|0|||
145884316|NCT01519947|526082455|FG003|Overall Study|Death|1|||
145884317|NCT01519947|526082452|FG000|Overall Study|Protocol Violation|0|||
145884318|NCT01519947|526082453|FG001|Overall Study|Protocol Violation|0|||
145884319|NCT01519947|526082454|FG002|Overall Study|Protocol Violation|2|||
145884320|NCT01519947|526082455|FG003|Overall Study|Protocol Violation|1|||
145884321|NCT01519947|526082452|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
145884322|NCT01519947|526082453|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
145884323|NCT01519947|526082454|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
145884324|NCT01519947|526082455|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
145884325|NCT01519947|526082452|FG000|Overall Study|Development of Anemia|0|||
145884326|NCT01519947|526082453|FG001|Overall Study|Development of Anemia|1|||
145884327|NCT01519947|526082454|FG002|Overall Study|Development of Anemia|0|||
145884328|NCT01519947|526082455|FG003|Overall Study|Development of Anemia|1|||
145884329|NCT01519947|526082452|FG000|Overall Study|Blood Transfusion|0|||
145884330|NCT01519947|526082453|FG001|Overall Study|Blood Transfusion|1|||
145884331|NCT01519947|526082454|FG002|Overall Study|Blood Transfusion|1|||
145884332|NCT01519947|526082455|FG003|Overall Study|Blood Transfusion|0|||
145884333|NCT01519947|526082452|FG000|Overall Study|Withdrawal by Subject|0|||
145884334|NCT01519947|526082453|FG001|Overall Study|Withdrawal by Subject|1|||
145884335|NCT01519947|526082454|FG002|Overall Study|Withdrawal by Subject|0|||
145884336|NCT01519947|526082455|FG003|Overall Study|Withdrawal by Subject|1|||
145884337|NCT01519947|526082452|FG000|Overall Study|Lost to Follow-up|0|||
145884338|NCT01519947|526082453|FG001|Overall Study|Lost to Follow-up|0|||
145884339|NCT01519947|526082454|FG002|Overall Study|Lost to Follow-up|3|||
146226921|NCT04625725|527347181|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146226922|NCT04625725|527347182|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146226923|NCT04625725|527347183|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146226924|NCT04625725|527347184|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146226925|NCT04625725|527347185|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
146226926|NCT04625725|527347186|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
146226927|NCT03556293|527347192|FG000|Overall Study|Ineligible for analysis|1904|||
146226928|NCT03556293|527347193|FG001|Overall Study|Ineligible for analysis|1471|||
146226929|NCT03556293|527347194|FG002|Overall Study|Ineligible for analysis|1091|||
146226930|NCT03556293|527347195|FG003|Overall Study|Ineligible for analysis|1269|||
146226931|NCT05104463|527347196|FG000|Overall Study|Adverse Event|1|||
146226932|NCT05104463|527347197|FG001|Overall Study|Adverse Event|1|||
146226933|NCT05104463|527347196|FG000|Overall Study|Lost to Follow-up|1|||
146226934|NCT05104463|527347197|FG001|Overall Study|Lost to Follow-up|1|||
146226935|NCT05104463|527347196|FG000|Overall Study|Physician Decision|1|||
146226936|NCT05104463|527347197|FG001|Overall Study|Physician Decision|0|||
146226937|NCT05104463|527347196|FG000|Overall Study|Protocol Violation|0|||
146226938|NCT05104463|527347197|FG001|Overall Study|Protocol Violation|2|||
146226939|NCT05104463|527347196|FG000|Overall Study|Withdrawal by Subject|1|||
146226940|NCT05104463|527347197|FG001|Overall Study|Withdrawal by Subject|1|||
146226941|NCT04132518|527347200|FG000|Overall Study|Prematurely withdrawn from the study|0|||
146226942|NCT04132518|527347201|FG001|Overall Study|Prematurely withdrawn from the study|9|||
146226943|NCT04132518|527347202|FG002|Overall Study|Prematurely withdrawn from the study|1|||
146226944|NCT04056611|527347206|FG000|Overall Study|Physician Decision|1|||
146226945|NCT02631746|527347207|FG000|Overall Study|Lack of Efficacy|3|||
146226946|NCT04183283|527348824|FG000|Period 1|Withdrawal by Subject|0|||
146226947|NCT04183283|527348825|FG001|Period 1|Withdrawal by Subject|1|||
146226948|NCT04183283|527348826|FG002|Period 1|Withdrawal by Subject|0|||
146226949|NCT04183283|527348827|FG003|Period 1|Withdrawal by Subject|0|||
146226950|NCT04183283|527348824|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
146226951|NCT04183283|527348825|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
146226952|NCT04183283|527348826|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
146226953|NCT04183283|527348827|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
146226954|NCT04730739|527348830|FG000|Overall Study|Death|1|||
146226955|NCT03308877|527348831|FG000|Overall Study|Lost to Follow-up|32|||
146226956|NCT03308877|527348832|FG001|Overall Study|Lost to Follow-up|28|||
146226957|NCT03523572|527348847|FG000|Dose Escalation|Progressive disease|1|||
146226958|NCT03523572|527348848|FG001|Dose Escalation|Progressive disease|0|||
146226959|NCT03523572|527348849|FG002|Dose Escalation|Progressive disease|0|||
146226960|NCT03523572|527348850|FG003|Dose Escalation|Progressive disease|0|||
146226961|NCT03523572|527348851|FG004|Dose Escalation|Progressive disease|0|||
146226962|NCT03523572|527348852|FG005|Dose Escalation|Progressive disease|0|||
146226963|NCT03523572|527348847|FG000|Dose Escalation|Clinical Progression|0|||
146226964|NCT03523572|527348848|FG001|Dose Escalation|Clinical Progression|1|||
146226965|NCT03523572|527348849|FG002|Dose Escalation|Clinical Progression|0|||
146226966|NCT03523572|527348850|FG003|Dose Escalation|Clinical Progression|0|||
146226967|NCT03523572|527348851|FG004|Dose Escalation|Clinical Progression|0|||
146226968|NCT03523572|527348852|FG005|Dose Escalation|Clinical Progression|0|||
146226969|NCT03523572|527348847|FG000|Dose Escalation|Adverse Event|2|||
145884340|NCT01519947|526082455|FG003|Overall Study|Lost to Follow-up|2|||
145884341|NCT01519947|526082452|FG000|Overall Study|Poor Response|1|||
146226970|NCT03523572|527348848|FG001|Dose Escalation|Adverse Event|0|||
145884342|NCT01519947|526082453|FG001|Overall Study|Poor Response|0|||
146226971|NCT03523572|527348849|FG002|Dose Escalation|Adverse Event|0|||
146226972|NCT03523572|527348850|FG003|Dose Escalation|Adverse Event|0|||
146226973|NCT03523572|527348851|FG004|Dose Escalation|Adverse Event|0|||
146226974|NCT03523572|527348852|FG005|Dose Escalation|Adverse Event|0|||
146226975|NCT03523572|527348847|FG000|Dose Escalation|Physician Decision|1|||
146226976|NCT03523572|527348848|FG001|Dose Escalation|Physician Decision|1|||
146226977|NCT03523572|527348849|FG002|Dose Escalation|Physician Decision|0|||
146226978|NCT03523572|527348850|FG003|Dose Escalation|Physician Decision|0|||
146226979|NCT03523572|527348851|FG004|Dose Escalation|Physician Decision|0|||
146226980|NCT03523572|527348852|FG005|Dose Escalation|Physician Decision|0|||
146226981|NCT03523572|527348847|FG000|Dose Expansion|Progressive Disease|0|||
146226982|NCT03523572|527348848|FG001|Dose Expansion|Progressive Disease|0|||
146226983|NCT03523572|527348849|FG002|Dose Expansion|Progressive Disease|9|||
146226984|NCT03523572|527348850|FG003|Dose Expansion|Progressive Disease|11|||
146226985|NCT03523572|527348851|FG004|Dose Expansion|Progressive Disease|15|||
146226986|NCT03523572|527348852|FG005|Dose Expansion|Progressive Disease|2|||
146226987|NCT03523572|527348847|FG000|Dose Expansion|Clinical Progression|0|||
146226988|NCT03523572|527348848|FG001|Dose Expansion|Clinical Progression|0|||
145884343|NCT01519947|526082454|FG002|Overall Study|Poor Response|0|||
145961990|NCT02227784|526373600|FG001|Double-Blind Phase|Protocol Violation|0|||
145884344|NCT01519947|526082455|FG003|Overall Study|Poor Response|1|||
145884345|NCT01519947|526082452|FG000|Overall Study|Adverse Event|1|||
145884346|NCT01519947|526082453|FG001|Overall Study|Adverse Event|0|||
145884347|NCT01519947|526082454|FG002|Overall Study|Adverse Event|1|||
145884348|NCT01519947|526082455|FG003|Overall Study|Adverse Event|1|||
145884349|NCT00693225|526082456|FG000|Overall Study|Lost to Follow-up|1|||
145884350|NCT00693225|526082457|FG001|Overall Study|Lost to Follow-up|2|||
145884351|NCT00693225|526082456|FG000|Overall Study|Adverse Event|1|||
145884352|NCT00693225|526082457|FG001|Overall Study|Adverse Event|3|||
145884353|NCT01315028|526082458|FG000|Overall Study|Lost to Follow-up|1|||
145884354|NCT01315028|526082459|FG001|Overall Study|Lost to Follow-up|0|||
145884355|NCT01315028|526082458|FG000|Overall Study|Death|0|||
145884356|NCT01315028|526082459|FG001|Overall Study|Death|1|||
145884357|NCT01386125|526082462|FG000|Overall Study|Lost to Follow-up|3|||
145884358|NCT01386125|526082463|FG001|Overall Study|Lost to Follow-up|9|||
145884359|NCT01386125|526082462|FG000|Overall Study|Physician Decision|0|||
145884360|NCT01386125|526082463|FG001|Overall Study|Physician Decision|1|||
145884361|NCT01386125|526082462|FG000|Overall Study|Protocol Violation|5|||
145884362|NCT01386125|526082463|FG001|Overall Study|Protocol Violation|7|||
145884363|NCT01386125|526082462|FG000|Overall Study|Disease Progress|1|||
145884364|NCT01386125|526082463|FG001|Overall Study|Disease Progress|2|||
145884365|NCT01386125|526082462|FG000|Overall Study|Withdrawal by Subject|13|||
145884366|NCT01386125|526082463|FG001|Overall Study|Withdrawal by Subject|12|||
145884367|NCT01386125|526082462|FG000|Overall Study|Adverse Event|2|||
145884368|NCT01386125|526082463|FG001|Overall Study|Adverse Event|5|||
145884369|NCT01386125|526082462|FG000|Overall Study|Lack of Efficacy|0|||
145884370|NCT01386125|526082463|FG001|Overall Study|Lack of Efficacy|1|||
145884371|NCT01386125|526082462|FG000|Overall Study|Participant Leaving Country|1|||
145884372|NCT01386125|526082463|FG001|Overall Study|Participant Leaving Country|0|||
145884373|NCT01098539|526082464|FG000|Overall Study|Adverse Event|26|||
145884374|NCT01098539|526082465|FG001|Overall Study|Adverse Event|26|||
145884375|NCT01098539|526082464|FG000|Overall Study|Protocol Violation|1|||
145884376|NCT01098539|526082465|FG001|Overall Study|Protocol Violation|4|||
145884377|NCT01098539|526082464|FG000|Overall Study|Noncompliance|3|||
145884378|NCT01098539|526082465|FG001|Overall Study|Noncompliance|5|||
145884379|NCT01098539|526082464|FG000|Overall Study|Lost to Follow-up|4|||
145884380|NCT01098539|526082465|FG001|Overall Study|Lost to Follow-up|4|||
145884381|NCT01098539|526082464|FG000|Overall Study|Withdrawal by Subject|12|||
145884382|NCT01098539|526082465|FG001|Overall Study|Withdrawal by Subject|26|||
145884383|NCT01098539|526082464|FG000|Overall Study|Physician Decision|5|||
145884384|NCT01098539|526082465|FG001|Overall Study|Physician Decision|3|||
145884385|NCT03843125|526082466|FG000|Overall Study|Adverse Event|17|||
145884386|NCT03843125|526082467|FG001|Overall Study|Adverse Event|13|||
145884387|NCT03843125|526082468|FG002|Overall Study|Adverse Event|5|||
145884388|NCT03843125|526082469|FG003|Overall Study|Adverse Event|9|||
145884389|NCT03843125|526082466|FG000|Overall Study|Death|0|||
145884390|NCT03843125|526082467|FG001|Overall Study|Death|6|||
145961991|NCT02227784|526373601|FG002|Double-Blind Phase|Protocol Violation|1|||
145884391|NCT03843125|526082468|FG002|Overall Study|Death|2|||
145884392|NCT03843125|526082469|FG003|Overall Study|Death|0|||
145884393|NCT03843125|526082466|FG000|Overall Study|Lack of Efficacy|14|||
145961992|NCT02227784|526373602|FG003|Double-Blind Phase|Protocol Violation|1|||
146226989|NCT03523572|527348849|FG002|Dose Expansion|Clinical Progression|2|||
145961993|NCT02227784|526373603|FG004|Double-Blind Phase|Protocol Violation|0|||
145961994|NCT02227784|526373599|FG000|Double-Blind Phase|Sponsor Decision|34|||
145961995|NCT02227784|526373600|FG001|Double-Blind Phase|Sponsor Decision|15|||
145961996|NCT02227784|526373601|FG002|Double-Blind Phase|Sponsor Decision|14|||
145961997|NCT02227784|526373602|FG003|Double-Blind Phase|Sponsor Decision|32|||
145961998|NCT02227784|526373603|FG004|Double-Blind Phase|Sponsor Decision|0|||
145961999|NCT02227784|526373599|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
145962000|NCT02227784|526373600|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
145962001|NCT02227784|526373601|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
145962002|NCT02227784|526373602|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
145962003|NCT02227784|526373603|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145962004|NCT02227784|526373599|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145962005|NCT02227784|526373600|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145962006|NCT02227784|526373601|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145962007|NCT02227784|526373602|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145962008|NCT02227784|526373603|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
145962009|NCT02227784|526373599|FG000|Open-Label Extension Phase (OLE)|Death|0|||
145962010|NCT02227784|526373600|FG001|Open-Label Extension Phase (OLE)|Death|0|||
145962011|NCT02227784|526373601|FG002|Open-Label Extension Phase (OLE)|Death|0|||
145962012|NCT02227784|526373602|FG003|Open-Label Extension Phase (OLE)|Death|0|||
145962013|NCT02227784|526373603|FG004|Open-Label Extension Phase (OLE)|Death|1|||
145962014|NCT02227784|526373599|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145962015|NCT02227784|526373600|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145962016|NCT02227784|526373601|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145962017|NCT02227784|526373602|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145962018|NCT02227784|526373603|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
145962019|NCT02227784|526373599|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145962020|NCT02227784|526373600|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145962021|NCT02227784|526373601|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145962022|NCT02227784|526373602|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145962023|NCT02227784|526373603|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
145962024|NCT02155699|526373604|FG000|Overall Study|Withdrawal by Subject|0|||
145962025|NCT02155699|526373605|FG001|Overall Study|Withdrawal by Subject|3|||
145962026|NCT02155699|526373606|FG002|Overall Study|Withdrawal by Subject|6|||
145962027|NCT02155699|526373607|FG003|Overall Study|Withdrawal by Subject|1|||
145962028|NCT02155699|526373604|FG000|Overall Study|Lost to Follow-up|0|||
145962029|NCT02155699|526373605|FG001|Overall Study|Lost to Follow-up|0|||
145962030|NCT02155699|526373606|FG002|Overall Study|Lost to Follow-up|0|||
145962031|NCT02155699|526373607|FG003|Overall Study|Lost to Follow-up|3|||
145962032|NCT02155699|526373604|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
145962033|NCT02155699|526373605|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
145962034|NCT02155699|526373606|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
145962035|NCT02155699|526373607|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
145962036|NCT00485069|526373608|FG000|Overall Study|Adverse Event|10|||
145962037|NCT00485069|526373609|FG001|Overall Study|Adverse Event|4|||
145962038|NCT00485069|526373608|FG000|Overall Study|Lack of Efficacy|2|||
145962039|NCT00485069|526373609|FG001|Overall Study|Lack of Efficacy|1|||
145962040|NCT00485069|526373608|FG000|Overall Study|Protocol Violation|0|||
145962041|NCT00485069|526373609|FG001|Overall Study|Protocol Violation|1|||
145962042|NCT00485069|526373608|FG000|Overall Study|Withdrawal by Subject|6|||
145962043|NCT00485069|526373609|FG001|Overall Study|Withdrawal by Subject|6|||
145962044|NCT02688933|526373612|FG000|Overall Study|Adverse Event|3|||
145962045|NCT02688933|526373613|FG001|Overall Study|Adverse Event|1|||
145962046|NCT02688933|526373612|FG000|Overall Study|Lack of Efficacy|2|||
145962047|NCT02688933|526373613|FG001|Overall Study|Lack of Efficacy|2|||
145962048|NCT02688933|526373612|FG000|Overall Study|Poor compliance to protocol|7|||
145962049|NCT02688933|526373613|FG001|Overall Study|Poor compliance to protocol|4|||
146226990|NCT03523572|527348850|FG003|Dose Expansion|Clinical Progression|2|||
146226991|NCT03523572|527348851|FG004|Dose Expansion|Clinical Progression|2|||
146226992|NCT03523572|527348852|FG005|Dose Expansion|Clinical Progression|0|||
146226993|NCT03523572|527348847|FG000|Dose Expansion|Adverse Event|0|||
146226994|NCT03523572|527348848|FG001|Dose Expansion|Adverse Event|0|||
146226995|NCT03523572|527348849|FG002|Dose Expansion|Adverse Event|10|||
146085496|NCT00548405|526833612|FG002|Overall Study|Randomized but not treated|0|||
146085497|NCT01624870|526833613|FG000|Overall Study|Death|19|||
146085498|NCT01624870|526833613|FG000|Overall Study|Withdrawal by Subject|1|||
146085499|NCT01624870|526833613|FG000|Overall Study|CoreValve not implanted|6|||
146085500|NCT01624870|526833613|FG000|Overall Study|Lost to follow up|1|||
146085501|NCT02582684|526833618|FG000|Overall Study|Unable to contact subject/parent|4|||
146085502|NCT02582684|526833618|FG000|Overall Study|Subject not able to get to clinic|10|||
146085503|NCT02582684|526833618|FG000|Overall Study|Subject withdrew consent|1|||
146085504|NCT02582684|526833618|FG000|Overall Study|Found to be ineligible after enrollment|2|||
146085505|NCT03836001|526833619|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
146085506|NCT03836001|526833620|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
146085507|NCT03836001|526833621|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
146085508|NCT03836001|526833619|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
146085509|NCT03836001|526833620|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
146085510|NCT03836001|526833621|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
146085511|NCT03836001|526833619|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
146085512|NCT03836001|526833620|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
146085513|NCT03836001|526833621|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
146085514|NCT03836001|526833619|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
146085515|NCT03836001|526833620|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
146085516|NCT03836001|526833621|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
146085517|NCT01642732|526833622|FG000|Overall Study|Withdrawal by Subject|1|||
146085518|NCT03562767|526833627|FG000|Overall Study|Physician Decision|2|||
146085519|NCT03562767|526833628|FG001|Overall Study|Physician Decision|0|||
146085520|NCT03562767|526833629|FG002|Overall Study|Physician Decision|0|||
146085521|NCT03562767|526833627|FG000|Overall Study|Logistic Reason|1|||
146085522|NCT03562767|526833628|FG001|Overall Study|Logistic Reason|3|||
146085523|NCT03562767|526833629|FG002|Overall Study|Logistic Reason|0|||
146085524|NCT04658940|526833635|FG000|Overall Study|Withdrawal by Subject|1|||
146085525|NCT01700439|526833636|FG000|Overall Study|Lost to Follow-up|47|||
146085526|NCT01700439|526833636|FG000|Overall Study|Withdrawal by Subject|183|||
146085527|NCT01700439|526833636|FG000|Overall Study|Death|186|||
146085528|NCT01829243|526833637|FG000|First Intervention|Screen Failure|4|||
146085529|NCT01829243|526833638|FG001|First Intervention|Screen Failure|2|||
146085530|NCT00053898|526833641|FG000|Overall Study|No follow-up data from any source|9|||
146085531|NCT00053898|526833642|FG001|Overall Study|No follow-up data from any source|12|||
146085532|NCT00053898|526833641|FG000|Overall Study|Follow-up from telephone contact only|5|||
146085533|NCT00053898|526833642|FG001|Overall Study|Follow-up from telephone contact only|1|||
146085534|NCT00266877|526833643|FG000|Overall Study|Death|1|||
146085535|NCT00266877|526833644|FG001|Overall Study|Death|1|||
146085536|NCT00266877|526833645|FG002|Overall Study|Death|1|||
146085537|NCT00266877|526833643|FG000|Overall Study|Adverse Event|6|||
146085538|NCT00266877|526833644|FG001|Overall Study|Adverse Event|4|||
146085539|NCT00266877|526833645|FG002|Overall Study|Adverse Event|1|||
146085540|NCT00266877|526833643|FG000|Overall Study|Physician Decision|2|||
146085541|NCT00266877|526833644|FG001|Overall Study|Physician Decision|1|||
146085542|NCT00266877|526833645|FG002|Overall Study|Physician Decision|1|||
146085543|NCT00266877|526833643|FG000|Overall Study|Withdrawal by Subject|3|||
146085544|NCT00266877|526833644|FG001|Overall Study|Withdrawal by Subject|1|||
146085545|NCT00266877|526833645|FG002|Overall Study|Withdrawal by Subject|1|||
146085546|NCT00266877|526833643|FG000|Overall Study|Disease Progression|72|||
146085547|NCT00266877|526833644|FG001|Overall Study|Disease Progression|37|||
146085548|NCT00266877|526833645|FG002|Overall Study|Disease Progression|23|||
146085549|NCT00266877|526833643|FG000|Overall Study|Symptomatic Deterioration|6|||
146085550|NCT00266877|526833644|FG001|Overall Study|Symptomatic Deterioration|3|||
146085551|NCT00266877|526833645|FG002|Overall Study|Symptomatic Deterioration|1|||
146085552|NCT00266877|526833643|FG000|Overall Study|Hospitalization|1|||
146085553|NCT00266877|526833644|FG001|Overall Study|Hospitalization|0|||
146085554|NCT00266877|526833645|FG002|Overall Study|Hospitalization|0|||
146085555|NCT00266877|526833643|FG000|Overall Study|Concomitant Radiotherapy|0|||
146085556|NCT00266877|526833644|FG001|Overall Study|Concomitant Radiotherapy|1|||
146085557|NCT00266877|526833645|FG002|Overall Study|Concomitant Radiotherapy|0|||
146085558|NCT00821327|526833650|FG000|Overall Study|Adverse Event|13|||
146085559|NCT00821327|526833650|FG000|Overall Study|Patient Request|1|||
146085560|NCT00821327|526833650|FG000|Overall Study|Investigator Request|2|||
146085561|NCT00821327|526833650|FG000|Overall Study|Sponsor Request|1|||
146085562|NCT00821327|526833650|FG000|Overall Study|Disease Progression|13|||
146085563|NCT00821327|526833650|FG000|Overall Study|Other/Unknown|5|||
146085564|NCT02119676|526833651|FG000|Overall Study|Adverse Event|9|||
146085565|NCT02119676|526833652|FG001|Overall Study|Adverse Event|17|||
146226996|NCT03523572|527348850|FG003|Dose Expansion|Adverse Event|1|||
146226997|NCT03523572|527348851|FG004|Dose Expansion|Adverse Event|5|||
146226998|NCT03523572|527348852|FG005|Dose Expansion|Adverse Event|2|||
146226999|NCT03523572|527348847|FG000|Dose Expansion|Withdrawal by Subject|0|||
146227000|NCT03523572|527348848|FG001|Dose Expansion|Withdrawal by Subject|0|||
146227001|NCT03523572|527348849|FG002|Dose Expansion|Withdrawal by Subject|1|||
146227002|NCT03523572|527348850|FG003|Dose Expansion|Withdrawal by Subject|1|||
146227003|NCT03523572|527348851|FG004|Dose Expansion|Withdrawal by Subject|0|||
146227004|NCT03523572|527348852|FG005|Dose Expansion|Withdrawal by Subject|0|||
146227005|NCT03523572|527348847|FG000|Dose Expansion|Physician Decision|0|||
146227006|NCT03523572|527348848|FG001|Dose Expansion|Physician Decision|0|||
146227007|NCT03523572|527348849|FG002|Dose Expansion|Physician Decision|1|||
146227008|NCT03523572|527348850|FG003|Dose Expansion|Physician Decision|0|||
146227009|NCT03523572|527348851|FG004|Dose Expansion|Physician Decision|1|||
146227010|NCT03523572|527348852|FG005|Dose Expansion|Physician Decision|0|||
146227011|NCT03523572|527348847|FG000|Dose Expansion|Miscellaneous|0|||
146227012|NCT03523572|527348848|FG001|Dose Expansion|Miscellaneous|0|||
146227013|NCT03523572|527348849|FG002|Dose Expansion|Miscellaneous|0|||
146227014|NCT03523572|527348850|FG003|Dose Expansion|Miscellaneous|0|||
146227015|NCT03523572|527348851|FG004|Dose Expansion|Miscellaneous|3|||
146227016|NCT03523572|527348852|FG005|Dose Expansion|Miscellaneous|0|||
146227017|NCT05269966|527348853|FG000|Overall Study|Adverse Event|4|||
146227018|NCT05269966|527348853|FG000|Overall Study|Withdrawal by Subject|1|||
146227019|NCT05269966|527348853|FG000|Overall Study|Lost to Follow-up|4|||
146227020|NCT05269966|527348853|FG000|Overall Study|Physician Decision|1|||
146227021|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146227022|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146227023|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146227024|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146227025|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146227026|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146227027|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
146227028|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
146227029|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
146227030|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
146227031|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
146227032|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
146227033|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146227034|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
146227035|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146227036|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
146227037|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227038|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227039|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227040|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227041|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227042|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
146227043|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
146227044|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
146227045|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227046|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145884394|NCT03843125|526082467|FG001|Overall Study|Lack of Efficacy|11|||
145884395|NCT03843125|526082468|FG002|Overall Study|Lack of Efficacy|9|||
145884396|NCT03843125|526082469|FG003|Overall Study|Lack of Efficacy|4|||
145884397|NCT03843125|526082466|FG000|Overall Study|Lost to Follow-up|3|||
145884398|NCT03843125|526082467|FG001|Overall Study|Lost to Follow-up|4|||
145884399|NCT03843125|526082468|FG002|Overall Study|Lost to Follow-up|0|||
145884400|NCT03843125|526082469|FG003|Overall Study|Lost to Follow-up|2|||
145884401|NCT03843125|526082466|FG000|Overall Study|Other|12|||
145884402|NCT03843125|526082467|FG001|Overall Study|Other|14|||
145884403|NCT03843125|526082468|FG002|Overall Study|Other|3|||
145884404|NCT03843125|526082469|FG003|Overall Study|Other|4|||
145884405|NCT03843125|526082466|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
145884406|NCT03843125|526082467|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
145884407|NCT03843125|526082468|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
145884408|NCT03843125|526082469|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
145884409|NCT03843125|526082466|FG000|Overall Study|Study Terminated by Sponsor|318|||
145884410|NCT03843125|526082467|FG001|Overall Study|Study Terminated by Sponsor|318|||
145884411|NCT03843125|526082468|FG002|Overall Study|Study Terminated by Sponsor|163|||
145884412|NCT03843125|526082469|FG003|Overall Study|Study Terminated by Sponsor|163|||
145884413|NCT03843125|526082466|FG000|Overall Study|Withdrawal by Subject|23|||
145884414|NCT03843125|526082467|FG001|Overall Study|Withdrawal by Subject|12|||
145884415|NCT03843125|526082468|FG002|Overall Study|Withdrawal by Subject|6|||
145884416|NCT03843125|526082469|FG003|Overall Study|Withdrawal by Subject|9|||
145884417|NCT03843125|526082466|FG000|Overall Study|Missing data|0|||
145884418|NCT03843125|526082467|FG001|Overall Study|Missing data|1|||
145884419|NCT03843125|526082468|FG002|Overall Study|Missing data|1|||
145884420|NCT03843125|526082469|FG003|Overall Study|Missing data|0|||
145884421|NCT03173560|526082470|FG000|Overall Study|Death|70|||
145884422|NCT03173560|526082471|FG001|Overall Study|Death|60|||
145884423|NCT03173560|526082470|FG000|Overall Study|Lost to Follow-up|1|||
145884424|NCT03173560|526082471|FG001|Overall Study|Lost to Follow-up|4|||
145884425|NCT03173560|526082470|FG000|Overall Study|Withdrawal by Subject|10|||
145884426|NCT03173560|526082471|FG001|Overall Study|Withdrawal by Subject|5|||
145884427|NCT03173560|526082470|FG000|Overall Study|Other|0|||
145884428|NCT03173560|526082471|FG001|Overall Study|Other|1|||
145884429|NCT04254809|526082473|FG000|Overall Study|Lost to Follow-up|5|||
145884430|NCT04254809|526082474|FG001|Overall Study|Lost to Follow-up|10|||
145884431|NCT01928615|526082475|FG000|Overall Study|Study Terminated by Sponsor|2|||
145884432|NCT02972515|526082476|FG000|Overall Study|Lost to Follow-up|78|||
145884433|NCT03023137|526082481|FG000|Overall Study|Multiple pregnancy|2|||
145884434|NCT03023137|526082482|FG001|Overall Study|Multiple pregnancy|4|||
145884435|NCT03023137|526082481|FG000|Overall Study|Lost to Follow-up|1|||
145884436|NCT03023137|526082482|FG001|Overall Study|Lost to Follow-up|1|||
145884437|NCT03023137|526082481|FG000|Overall Study|Protocol Violation|0|||
145884438|NCT03023137|526082482|FG001|Overall Study|Protocol Violation|4|||
145884439|NCT03023137|526082481|FG000|Overall Study|Lost the baby in a car accident|1|||
145884440|NCT03023137|526082482|FG001|Overall Study|Lost the baby in a car accident|0|||
145884441|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
145884442|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
145884443|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
145884444|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
145884445|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
145884446|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
146085566|NCT02119676|526833653|FG002|Overall Study|Adverse Event|10|||
146085567|NCT02119676|526833654|FG003|Overall Study|Adverse Event|10|||
146085568|NCT02119676|526833651|FG000|Overall Study|Disease progression|53|||
146085569|NCT02119676|526833652|FG001|Overall Study|Disease progression|55|||
146085570|NCT02119676|526833653|FG002|Overall Study|Disease progression|68|||
146085571|NCT02119676|526833654|FG003|Overall Study|Disease progression|73|||
146085572|NCT02119676|526833651|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
146085573|NCT02119676|526833652|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
146085574|NCT02119676|526833653|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
146085575|NCT02119676|526833654|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
146085576|NCT02119676|526833651|FG000|Overall Study|Physician Decision|4|||
146085577|NCT02119676|526833652|FG001|Overall Study|Physician Decision|2|||
146085578|NCT02119676|526833653|FG002|Overall Study|Physician Decision|3|||
146085579|NCT02119676|526833654|FG003|Overall Study|Physician Decision|2|||
146085580|NCT02119676|526833651|FG000|Overall Study|Death|9|||
146085581|NCT02119676|526833652|FG001|Overall Study|Death|3|||
146085582|NCT02119676|526833653|FG002|Overall Study|Death|2|||
146085583|NCT02119676|526833654|FG003|Overall Study|Death|1|||
146085584|NCT02119676|526833651|FG000|Overall Study|Noncompliance|0|||
146085585|NCT02119676|526833652|FG001|Overall Study|Noncompliance|1|||
146085586|NCT02119676|526833653|FG002|Overall Study|Noncompliance|0|||
146085587|NCT02119676|526833654|FG003|Overall Study|Noncompliance|0|||
146085588|NCT02119676|526833651|FG000|Overall Study|Lost to Follow-up|0|||
146085589|NCT02119676|526833652|FG001|Overall Study|Lost to Follow-up|0|||
146085590|NCT02119676|526833653|FG002|Overall Study|Lost to Follow-up|1|||
146085591|NCT02119676|526833654|FG003|Overall Study|Lost to Follow-up|0|||
146085592|NCT02119676|526833651|FG000|Overall Study|Protocol deviation|0|||
146085593|NCT02119676|526833652|FG001|Overall Study|Protocol deviation|0|||
146085594|NCT02119676|526833653|FG002|Overall Study|Protocol deviation|1|||
146085595|NCT02119676|526833654|FG003|Overall Study|Protocol deviation|0|||
146085596|NCT02119676|526833651|FG000|Overall Study|Other, unspecified|2|||
146085597|NCT02119676|526833652|FG001|Overall Study|Other, unspecified|1|||
146085598|NCT02119676|526833653|FG002|Overall Study|Other, unspecified|3|||
146085599|NCT02119676|526833654|FG003|Overall Study|Other, unspecified|4|||
146085600|NCT02119676|526833651|FG000|Overall Study|Did not receive study med|2|||
146085601|NCT02119676|526833652|FG001|Overall Study|Did not receive study med|2|||
146085602|NCT02119676|526833653|FG002|Overall Study|Did not receive study med|4|||
146085603|NCT02119676|526833654|FG003|Overall Study|Did not receive study med|5|||
146085604|NCT01089361|526833655|FG000|Overall Study|Death|1|||
146227047|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227048|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227049|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227050|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227051|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
146227052|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
146227053|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146227054|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
146227055|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
146227056|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
145884447|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
145884448|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
145884449|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
145884450|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
145884451|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
145884452|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
145884453|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
145884454|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
145884455|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
145884456|NCT02250651|526082483|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
145884457|NCT02250651|526082484|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
145884458|NCT02250651|526082485|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
145884459|NCT02250651|526082483|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
145884460|NCT02250651|526082484|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
145962050|NCT02688933|526373612|FG000|Overall Study|Hypoglycemia|2|||
146085605|NCT01089361|526833656|FG001|Overall Study|Death|0|||
146085606|NCT00278915|526833659|FG000|Overall Study|Disease progression|1|||
146085607|NCT01007253|526833660|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
146085608|NCT01007253|526833661|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146085609|NCT01007253|526833662|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146085610|NCT01007253|526833663|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
146085611|NCT02093351|526834990|FG000|Part A|Adverse Event|0|||
146085612|NCT02093351|526834991|FG001|Part A|Adverse Event|1|||
146085613|NCT02093351|526834992|FG002|Part A|Adverse Event|1|||
146227057|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
146227058|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146227059|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
146227060|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
146227061|NCT02315703|527348861|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
146227062|NCT02315703|527348862|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
146227063|NCT02315703|527348863|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
146227064|NCT02315703|527348864|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
146227065|NCT02315703|527348865|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
146227066|NCT02315703|527348866|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
146227067|NCT02315703|527348867|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
146227068|NCT02315703|527348868|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
146227069|NCT02315703|527348861|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
146227070|NCT02315703|527348862|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
146227071|NCT02315703|527348863|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227072|NCT02315703|527348864|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227073|NCT02315703|527348865|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227074|NCT02315703|527348866|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227075|NCT02315703|527348867|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227076|NCT02315703|527348868|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
146227077|NCT02315703|527348861|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227078|NCT02315703|527348862|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
146227079|NCT02315703|527348863|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227080|NCT02315703|527348864|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227081|NCT02315703|527348865|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227082|NCT02315703|527348866|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227083|NCT02315703|527348867|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227084|NCT02315703|527348868|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
146227085|NCT02315703|527348861|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
146227086|NCT02315703|527348862|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
146227087|NCT02315703|527348863|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
146227088|NCT02315703|527348864|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
146227089|NCT02315703|527348865|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
146227090|NCT02315703|527348866|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
146227091|NCT02315703|527348867|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
146227092|NCT02315703|527348868|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
146227093|NCT05147116|527348869|FG000|Overall Study|Withdrawal by Subject|0|||
146227094|NCT05147116|527348870|FG001|Overall Study|Withdrawal by Subject|1|||
146227095|NCT03625115|527348871|FG000|Overall Study|Withdrawal by Subject|4|||
146227096|NCT03625115|527348872|FG001|Overall Study|Withdrawal by Subject|7|||
146227097|NCT03625115|527348871|FG000|Overall Study|Lost to Follow-up|17|||
146227098|NCT03625115|527348872|FG001|Overall Study|Lost to Follow-up|24|||
146227099|NCT04197336|527348873|FG000|Overall Study|Withdrawal by Subject|1|||
146227100|NCT04304144|527348874|FG000|DLT Observation Period|Physician Decision|0|||
146227101|NCT04304144|527348875|FG001|DLT Observation Period|Physician Decision|1|||
146227102|NCT04304144|527348876|FG002|DLT Observation Period|Physician Decision|0|||
146227103|NCT04304144|527348877|FG003|DLT Observation Period|Physician Decision|0|||
146227104|NCT04304144|527348874|FG000|Continued Treatment Period|Adverse Event|0|||
146227105|NCT04304144|527348875|FG001|Continued Treatment Period|Adverse Event|1|||
146227106|NCT04304144|527348876|FG002|Continued Treatment Period|Adverse Event|0|||
146227107|NCT04304144|527348877|FG003|Continued Treatment Period|Adverse Event|0|||
146227108|NCT04304144|527348874|FG000|Continued Treatment Period|Death|0|||
146227109|NCT04304144|527348875|FG001|Continued Treatment Period|Death|0|||
146227110|NCT04304144|527348876|FG002|Continued Treatment Period|Death|1|||
146227111|NCT04304144|527348877|FG003|Continued Treatment Period|Death|2|||
146227112|NCT04304144|527348874|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
146227113|NCT04304144|527348875|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
146227114|NCT04304144|527348876|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
146227115|NCT04304144|527348877|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
145962051|NCT02688933|526373613|FG001|Overall Study|Hypoglycemia|0|||
146227116|NCT04304144|527348874|FG000|Continued Treatment Period|Other than specified|2|||
146227117|NCT04304144|527348875|FG001|Continued Treatment Period|Other than specified|0|||
146289060|NCT01136772|527573327|FG001|Overall Study|Adverse Event|14|||
145884461|NCT02250651|526082485|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
145884462|NCT02250651|526082483|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
145884463|NCT02250651|526082484|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
145884464|NCT02250651|526082485|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
145884465|NCT02250651|526082483|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
145884466|NCT02250651|526082484|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
145884467|NCT02250651|526082485|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
145884468|NCT02250651|526082483|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
145884469|NCT02250651|526082484|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
145884470|NCT02250651|526082485|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
145884471|NCT02250651|526082483|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
145884472|NCT02250651|526082484|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
145884473|NCT02250651|526082485|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
145884474|NCT02250651|526082483|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
145884475|NCT02250651|526082484|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
145884476|NCT02250651|526082485|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
145884477|NCT02250651|526082483|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
145884478|NCT02250651|526082484|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
145884479|NCT02250651|526082485|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
145884480|NCT02250651|526082483|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
145884481|NCT02250651|526082484|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
145884482|NCT02250651|526082485|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
145884483|NCT02250651|526082483|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
145884484|NCT02250651|526082484|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
145884485|NCT02250651|526082485|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
145884486|NCT00732160|526082489|FG000|Overall Study|Adverse Event|1|||
145884487|NCT00732160|526082490|FG001|Overall Study|Adverse Event|0|||
145884488|NCT00732160|526082491|FG002|Overall Study|Adverse Event|1|||
145884489|NCT00732160|526082492|FG003|Overall Study|Adverse Event|1|||
145884490|NCT00732160|526082489|FG000|Overall Study|scheduling|4|||
145884491|NCT00732160|526082490|FG001|Overall Study|scheduling|4|||
145884492|NCT00732160|526082491|FG002|Overall Study|scheduling|2|||
145884493|NCT00732160|526082492|FG003|Overall Study|scheduling|1|||
145884494|NCT00676494|526082493|FG000|Overall Study|Missed Visit|8|||
145884495|NCT00676494|526082493|FG000|Overall Study|Withdrawal by Subject|6|||
145884496|NCT02795676|526082494|FG000|Overall Study|Adverse Event|2|||
145884497|NCT02795676|526082495|FG001|Overall Study|Adverse Event|0|||
145884498|NCT02795676|526082494|FG000|Overall Study|Withdrawal by Subject|3|||
145884499|NCT02795676|526082495|FG001|Overall Study|Withdrawal by Subject|1|||
145884500|NCT01203917|526082496|FG000|Overall Study|Death|29|||
145884501|NCT01203917|526082496|FG000|Overall Study|Lost to Follow-up|2|||
145884502|NCT01203917|526082496|FG000|Overall Study|Withdrawal by Subject|3|||
145884503|NCT01203917|526082496|FG000|Overall Study|Due to objective disease progression|1|||
145884504|NCT01203917|526082496|FG000|Overall Study|Due to EGFR M+I patient|1|||
145884505|NCT01264835|526082497|FG000|Overall Study|Lost to Follow-up|1|||
145884506|NCT02427399|526082501|FG000|Overall Study|Protocol Violation|14|||
145884507|NCT02427399|526082502|FG001|Overall Study|Protocol Violation|16|||
145884508|NCT02427399|526082503|FG002|Overall Study|Protocol Violation|12|||
145884509|NCT02427399|526082504|FG003|Overall Study|Protocol Violation|18|||
145884510|NCT02427399|526082505|FG004|Overall Study|Protocol Violation|15|||
145884511|NCT04660032|526082506|FG000|Overall Study|Protocol Violation|1|||
145884512|NCT04660032|526082507|FG001|Overall Study|Protocol Violation|1|||
145884513|NCT00090753|526082508|FG000|First Treatment Period|Adverse Event|20|||
145884514|NCT00090753|526082509|FG001|First Treatment Period|Adverse Event|8|||
145962052|NCT02688933|526373612|FG000|Overall Study|Other than Specified|14|||
145962053|NCT02688933|526373613|FG001|Overall Study|Other than Specified|25|||
145962054|NCT02688933|526373612|FG000|Overall Study|Lost to Follow-up|1|||
145962055|NCT02688933|526373613|FG001|Overall Study|Lost to Follow-up|5|||
145962056|NCT00828113|526373614|FG000|Overall Study|Withdrawal by Subject|27|||
145962057|NCT00828113|526373615|FG001|Overall Study|Withdrawal by Subject|26|||
145962058|NCT00828113|526373614|FG000|Overall Study|Lost to Follow-up|3|||
145962059|NCT00828113|526373615|FG001|Overall Study|Lost to Follow-up|5|||
145962060|NCT01365130|526373616|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
145962061|NCT05547386|526373617|FG000|Overall Study|Withdrawal by Subject|7|||
145962062|NCT04622969|526373618|FG000|Overall Study|Withdrawal by Subject|2|||
145962063|NCT04622969|526373619|FG001|Overall Study|Withdrawal by Subject|3|||
145962064|NCT05616013|526373620|FG000|Overall Study|Adverse Event|6|||
145962065|NCT05616013|526373621|FG001|Overall Study|Adverse Event|12|||
145962066|NCT05616013|526373622|FG002|Overall Study|Adverse Event|8|||
145962067|NCT05616013|526373623|FG003|Overall Study|Adverse Event|4|||
145962068|NCT05616013|526373624|FG004|Overall Study|Adverse Event|6|||
145962069|NCT05616013|526373625|FG005|Overall Study|Adverse Event|8|||
145962070|NCT05616013|526373626|FG006|Overall Study|Adverse Event|3|||
145962071|NCT05616013|526373627|FG007|Overall Study|Adverse Event|6|||
145962072|NCT05616013|526373628|FG008|Overall Study|Adverse Event|1|||
145962073|NCT05616013|526373620|FG000|Overall Study|Lost to Follow-up|5|||
145962074|NCT05616013|526373621|FG001|Overall Study|Lost to Follow-up|4|||
145962075|NCT05616013|526373622|FG002|Overall Study|Lost to Follow-up|3|||
145962076|NCT05616013|526373623|FG003|Overall Study|Lost to Follow-up|2|||
145962077|NCT05616013|526373624|FG004|Overall Study|Lost to Follow-up|0|||
145962078|NCT05616013|526373625|FG005|Overall Study|Lost to Follow-up|5|||
145962079|NCT05616013|526373626|FG006|Overall Study|Lost to Follow-up|2|||
145962080|NCT05616013|526373627|FG007|Overall Study|Lost to Follow-up|1|||
145962081|NCT05616013|526373628|FG008|Overall Study|Lost to Follow-up|2|||
145962082|NCT05616013|526373620|FG000|Overall Study|Non-compliance with study requirements|2|||
145962083|NCT05616013|526373621|FG001|Overall Study|Non-compliance with study requirements|2|||
145962084|NCT05616013|526373622|FG002|Overall Study|Non-compliance with study requirements|2|||
145962085|NCT05616013|526373623|FG003|Overall Study|Non-compliance with study requirements|3|||
145962086|NCT05616013|526373624|FG004|Overall Study|Non-compliance with study requirements|0|||
145962087|NCT05616013|526373625|FG005|Overall Study|Non-compliance with study requirements|2|||
145962088|NCT05616013|526373626|FG006|Overall Study|Non-compliance with study requirements|1|||
145962089|NCT05616013|526373627|FG007|Overall Study|Non-compliance with study requirements|1|||
145962090|NCT05616013|526373628|FG008|Overall Study|Non-compliance with study requirements|4|||
145962091|NCT05616013|526373620|FG000|Overall Study|Withdrawal by Subject|11|||
145962092|NCT05616013|526373621|FG001|Overall Study|Withdrawal by Subject|9|||
145962093|NCT05616013|526373622|FG002|Overall Study|Withdrawal by Subject|8|||
145962094|NCT05616013|526373623|FG003|Overall Study|Withdrawal by Subject|6|||
145962095|NCT05616013|526373624|FG004|Overall Study|Withdrawal by Subject|3|||
145962096|NCT05616013|526373625|FG005|Overall Study|Withdrawal by Subject|4|||
146289061|NCT01136772|527573326|FG000|Overall Study|Lack of Efficacy|42|||
145962097|NCT05616013|526373626|FG006|Overall Study|Withdrawal by Subject|6|||
145962098|NCT05616013|526373627|FG007|Overall Study|Withdrawal by Subject|5|||
146085614|NCT02093351|526834993|FG003|Part A|Adverse Event|0|||
146085615|NCT02093351|526834990|FG000|Part A|Condition under investigation worsened|2|||
146085616|NCT02093351|526834991|FG001|Part A|Condition under investigation worsened|0|||
146085617|NCT02093351|526834992|FG002|Part A|Condition under investigation worsened|2|||
146085618|NCT02093351|526834993|FG003|Part A|Condition under investigation worsened|0|||
146085619|NCT02093351|526834990|FG000|Part A|Death|0|||
146085620|NCT02093351|526834991|FG001|Part A|Death|1|||
146085621|NCT02093351|526834992|FG002|Part A|Death|0|||
146085622|NCT02093351|526834993|FG003|Part A|Death|0|||
146085623|NCT02093351|526834990|FG000|Part B|Patient decision|0|||
146085624|NCT02093351|526834991|FG001|Part B|Patient decision|0|||
146085625|NCT02093351|526834992|FG002|Part B|Patient decision|0|||
146085626|NCT02093351|526834993|FG003|Part B|Patient decision|3|||
146085627|NCT02093351|526834990|FG000|Part B|Disease progression|0|||
146227118|NCT04304144|527348876|FG002|Continued Treatment Period|Other than specified|1|||
146227119|NCT04304144|527348877|FG003|Continued Treatment Period|Other than specified|1|||
146085628|NCT02093351|526834991|FG001|Part B|Disease progression|0|||
146227120|NCT04101357|527348878|FG000|Overall Study|Death|1|||
146227121|NCT04101357|527348879|FG001|Overall Study|Death|1|||
146085629|NCT02093351|526834992|FG002|Part B|Disease progression|0|||
146085630|NCT02093351|526834993|FG003|Part B|Disease progression|4|||
146085631|NCT02093351|526834990|FG000|Part B|Complete response|0|||
146085632|NCT02093351|526834991|FG001|Part B|Complete response|0|||
146085633|NCT02093351|526834992|FG002|Part B|Complete response|0|||
146227122|NCT04101357|527348880|FG002|Overall Study|Death|1|||
146227123|NCT04101357|527348881|FG003|Overall Study|Death|2|||
146085634|NCT02093351|526834993|FG003|Part B|Complete response|1|||
146085635|NCT02093351|526834990|FG000|Part B|Adverse event + disease progression|0|||
146085636|NCT02093351|526834991|FG001|Part B|Adverse event + disease progression|0|||
146085637|NCT02093351|526834992|FG002|Part B|Adverse event + disease progression|0|||
146085638|NCT02093351|526834993|FG003|Part B|Adverse event + disease progression|1|||
146085639|NCT02093351|526834990|FG000|Part B|Lack of therapeutic response|0|||
146085640|NCT02093351|526834991|FG001|Part B|Lack of therapeutic response|0|||
146085641|NCT02093351|526834992|FG002|Part B|Lack of therapeutic response|0|||
146085642|NCT02093351|526834993|FG003|Part B|Lack of therapeutic response|12|||
146085643|NCT02093351|526834990|FG000|Part B|Condition under investigation worsened|0|||
146085644|NCT02093351|526834991|FG001|Part B|Condition under investigation worsened|0|||
146085645|NCT02093351|526834992|FG002|Part B|Condition under investigation worsened|0|||
146085646|NCT02093351|526834993|FG003|Part B|Condition under investigation worsened|39|||
146085647|NCT02093351|526834990|FG000|Part B|Adverse Event|0|||
146085648|NCT02093351|526834991|FG001|Part B|Adverse Event|0|||
146085649|NCT02093351|526834992|FG002|Part B|Adverse Event|0|||
146085650|NCT02093351|526834993|FG003|Part B|Adverse Event|2|||
146085651|NCT02093351|526834990|FG000|Part B|Death|0|||
146085652|NCT02093351|526834991|FG001|Part B|Death|0|||
146085653|NCT02093351|526834992|FG002|Part B|Death|0|||
146085654|NCT02093351|526834993|FG003|Part B|Death|1|||
146085655|NCT01099709|526834994|FG000|Period 1|Withdrawal by Subject|0|||
146085656|NCT01099709|526834995|FG001|Period 1|Withdrawal by Subject|1|||
146085657|NCT01099709|526834994|FG000|Period 1|Positive cotinine test|0|||
146085658|NCT01099709|526834995|FG001|Period 1|Positive cotinine test|1|||
146085659|NCT01099709|526834994|FG000|Period 1|Adverse Event|1|||
146085660|NCT01099709|526834995|FG001|Period 1|Adverse Event|0|||
146085661|NCT01611454|526834996|FG000|Overall Study|Lack of Efficacy|18|||
146085662|NCT01611454|526834997|FG001|Overall Study|Lack of Efficacy|10|||
146085663|NCT00920907|526834998|FG000|Induction Period|Adverse Event|0|||
146085664|NCT00920907|526834999|FG001|Induction Period|Adverse Event|2|||
146085665|NCT00920907|526834998|FG000|Induction Period|Death|1|||
146085666|NCT00920907|526834999|FG001|Induction Period|Death|1|||
146085667|NCT00920907|526834998|FG000|Induction Period|Disease Progression|12|||
146085668|NCT00920907|526834999|FG001|Induction Period|Disease Progression|11|||
146085669|NCT00920907|526834998|FG000|Induction Period|Study Drug Toxicity|8|||
146085670|NCT00920907|526834999|FG001|Induction Period|Study Drug Toxicity|6|||
146085671|NCT00920907|526834998|FG000|Induction Period|No longer meets study criteria|0|||
146085672|NCT00920907|526834999|FG001|Induction Period|No longer meets study criteria|1|||
146085673|NCT00920907|526834998|FG000|Induction Period|Withdrawal by Subject|1|||
146085674|NCT00920907|526834999|FG001|Induction Period|Withdrawal by Subject|1|||
146085675|NCT00920907|526834998|FG000|Maintenance Period|Disease Progression|3|||
146085676|NCT00920907|526834999|FG001|Maintenance Period|Disease Progression|7|||
146085677|NCT00920907|526834998|FG000|Maintenance Period|Administrative (study closure)|7|||
146085678|NCT00920907|526834999|FG001|Maintenance Period|Administrative (study closure)|2|||
146085679|NCT00920907|526834998|FG000|Maintenance Period|Study Drug Toxicity|0|||
146085680|NCT00920907|526834999|FG001|Maintenance Period|Study Drug Toxicity|2|||
146085681|NCT00920907|526834998|FG000|Maintenance Period|Death|1|||
146085682|NCT00920907|526834999|FG001|Maintenance Period|Death|1|||
146085683|NCT00920907|526834998|FG000|Maintenance Period|Withdrawal by Subject|1|||
146085684|NCT00920907|526834999|FG001|Maintenance Period|Withdrawal by Subject|0|||
146085685|NCT00920907|526834998|FG000|Maintenance Period|Adverse Event|0|||
146085686|NCT00920907|526834999|FG001|Maintenance Period|Adverse Event|1|||
146085687|NCT01275339|526835000|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
146085688|NCT01275339|526835001|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
146085689|NCT01275339|526835002|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
146085690|NCT01275339|526835003|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
146085691|NCT01275339|526835000|FG000|Overall Study|Withdrawal by Subject|0|||
146085692|NCT01275339|526835001|FG001|Overall Study|Withdrawal by Subject|0|||
146085693|NCT01275339|526835002|FG002|Overall Study|Withdrawal by Subject|1|||
146085694|NCT01275339|526835003|FG003|Overall Study|Withdrawal by Subject|0|||
146085695|NCT02311582|526835004|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146085696|NCT02311582|526835005|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146085697|NCT02311582|526835006|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
146085698|NCT02311582|526835007|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
146085699|NCT02311582|526835008|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
146085700|NCT03404960|526835010|FG000|Overall Study|Adverse Event|0|||
146085701|NCT03404960|526835011|FG001|Overall Study|Adverse Event|2|||
146085702|NCT03404960|526835010|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
146085703|NCT03404960|526835011|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
146085704|NCT03404960|526835010|FG000|Overall Study|Bowel obstruction|0|||
146085705|NCT03404960|526835011|FG001|Overall Study|Bowel obstruction|1|||
146085706|NCT03404960|526835010|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
146085707|NCT03404960|526835011|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
146085708|NCT03422627|526835014|FG000|Overall Study|Protocol-specified Criteria|1|||
146085709|NCT03422627|526835015|FG001|Overall Study|Protocol-specified Criteria|1|||
145884515|NCT00090753|526082508|FG000|First Treatment Period|Death|88|||
145884516|NCT00090753|526082509|FG001|First Treatment Period|Death|62|||
145884517|NCT00090753|526082508|FG000|First Treatment Period|Lack of Efficacy|2|||
145884518|NCT00090753|526082509|FG001|First Treatment Period|Lack of Efficacy|1|||
145884519|NCT00090753|526082508|FG000|First Treatment Period|Refused Treatment|32|||
145884520|NCT00090753|526082509|FG001|First Treatment Period|Refused Treatment|25|||
145884521|NCT00090753|526082508|FG000|First Treatment Period|Lost to Follow-up|4|||
145884522|NCT00090753|526082509|FG001|First Treatment Period|Lost to Follow-up|4|||
145884523|NCT00090753|526082508|FG000|First Treatment Period|Renal Transplant|70|||
145884524|NCT00090753|526082509|FG001|First Treatment Period|Renal Transplant|50|||
145884525|NCT00090753|526082508|FG000|First Treatment Period|Mircera Commercialization|1|||
145884526|NCT00090753|526082509|FG001|First Treatment Period|Mircera Commercialization|0|||
145884527|NCT00090753|526082508|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
145884528|NCT00090753|526082509|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
145884529|NCT00090753|526082508|FG000|Extended Treatment Period|Adverse Event|11|||
145884530|NCT00090753|526082509|FG001|Extended Treatment Period|Adverse Event|0|||
145884531|NCT00090753|526082508|FG000|Extended Treatment Period|Death|58|||
145884532|NCT00090753|526082509|FG001|Extended Treatment Period|Death|30|||
145884533|NCT00090753|526082508|FG000|Extended Treatment Period|Lack of Efficacy|1|||
145884534|NCT00090753|526082509|FG001|Extended Treatment Period|Lack of Efficacy|0|||
145884535|NCT00090753|526082508|FG000|Extended Treatment Period|Refused Treatment|18|||
145884536|NCT00090753|526082509|FG001|Extended Treatment Period|Refused Treatment|12|||
145884537|NCT00090753|526082508|FG000|Extended Treatment Period|Lost to Follow-up|3|||
145884538|NCT00090753|526082509|FG001|Extended Treatment Period|Lost to Follow-up|1|||
145884539|NCT00090753|526082508|FG000|Extended Treatment Period|Renal Transplant|15|||
145884540|NCT00090753|526082509|FG001|Extended Treatment Period|Renal Transplant|12|||
145884541|NCT00090753|526082508|FG000|Extended Treatment Period|Mircera Commercialization|188|||
145884542|NCT00090753|526082509|FG001|Extended Treatment Period|Mircera Commercialization|93|||
145884543|NCT00090753|526082508|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
145884544|NCT00090753|526082509|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
145884545|NCT01466036|526082512|FG000|Overall Study|Death|1|||
145884546|NCT01466036|526082513|FG001|Overall Study|Death|1|||
145884547|NCT01466036|526082512|FG000|Overall Study|Physician Decision|0|||
145884548|NCT01466036|526082513|FG001|Overall Study|Physician Decision|4|||
145884549|NCT01466036|526082512|FG000|Overall Study|Adverse Event|2|||
145884550|NCT01466036|526082513|FG001|Overall Study|Adverse Event|6|||
145884551|NCT01466036|526082512|FG000|Overall Study|Withdrawal by Subject|2|||
145884552|NCT01466036|526082513|FG001|Overall Study|Withdrawal by Subject|8|||
145884553|NCT01466036|526082512|FG000|Overall Study|progression/relapse|14|||
145884554|NCT01466036|526082513|FG001|Overall Study|progression/relapse|21|||
145884555|NCT01466036|526082512|FG000|Overall Study|prolonged treatment delay|1|||
145884556|NCT01466036|526082513|FG001|Overall Study|prolonged treatment delay|1|||
145884557|NCT01609582|526082514|FG000|Overall Study|Adverse Event|20|||
145884558|NCT01609582|526082515|FG001|Overall Study|Adverse Event|18|||
145884559|NCT01609582|526082514|FG000|Overall Study|Lost to Follow-up|10|||
145884560|NCT01609582|526082515|FG001|Overall Study|Lost to Follow-up|10|||
145884561|NCT01609582|526082514|FG000|Overall Study|Withdrawal by Subject|21|||
145884562|NCT01609582|526082515|FG001|Overall Study|Withdrawal by Subject|15|||
145884563|NCT01609582|526082514|FG000|Overall Study|Study Terminated by Sponsor|1543|||
145884564|NCT01609582|526082515|FG001|Overall Study|Study Terminated by Sponsor|1548|||
145884565|NCT01609582|526082514|FG000|Overall Study|Other|9|||
145884566|NCT01609582|526082515|FG001|Overall Study|Other|10|||
145884567|NCT01609582|526082514|FG000|Overall Study|Randomized, but not treated|0|||
145884568|NCT01609582|526082515|FG001|Overall Study|Randomized, but not treated|3|||
145884569|NCT00819767|526082516|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145884570|NCT00819767|526082517|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145884571|NCT00685750|526082520|FG000|Overall Study|Tumor sampling failure|0|||
145884572|NCT00685750|526082521|FG001|Overall Study|Tumor sampling failure|0|||
145884573|NCT00685750|526082522|FG002|Overall Study|Tumor sampling failure|1|||
145884574|NCT00685750|526082523|FG003|Overall Study|Tumor sampling failure|0|||
146289062|NCT01136772|527573327|FG001|Overall Study|Lack of Efficacy|39|||
146289063|NCT01136772|527573326|FG000|Overall Study|Administrative|14|||
146289064|NCT01136772|527573327|FG001|Overall Study|Administrative|12|||
146289065|NCT01136772|527573326|FG000|Overall Study|Withdrawal by Subject|33|||
146289066|NCT01136772|527573327|FG001|Overall Study|Withdrawal by Subject|36|||
146289067|NCT01136772|527573326|FG000|Overall Study|Did not receive injection|10|||
146289068|NCT01136772|527573327|FG001|Overall Study|Did not receive injection|7|||
146289069|NCT01136772|527573326|FG000|Overall Study|Did not follow up after first injection|2|||
146289070|NCT01136772|527573327|FG001|Overall Study|Did not follow up after first injection|2|||
145884575|NCT00685750|526082524|FG004|Overall Study|Tumor sampling failure|0|||
145884576|NCT00685750|526082525|FG005|Overall Study|Tumor sampling failure|0|||
145884577|NCT00685750|526082526|FG006|Overall Study|Tumor sampling failure|0|||
145884578|NCT00685750|526082520|FG000|Overall Study|Patient didn't receive the treatment|0|||
145884579|NCT00685750|526082521|FG001|Overall Study|Patient didn't receive the treatment|0|||
145884580|NCT00685750|526082522|FG002|Overall Study|Patient didn't receive the treatment|0|||
145884581|NCT00685750|526082523|FG003|Overall Study|Patient didn't receive the treatment|0|||
145884582|NCT00685750|526082524|FG004|Overall Study|Patient didn't receive the treatment|0|||
145884583|NCT00685750|526082525|FG005|Overall Study|Patient didn't receive the treatment|0|||
145884584|NCT00685750|526082526|FG006|Overall Study|Patient didn't receive the treatment|1|||
145884585|NCT00685750|526082520|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145884586|NCT00685750|526082521|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145884587|NCT00685750|526082522|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145884588|NCT00685750|526082523|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
145884589|NCT00685750|526082524|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
145884590|NCT00685750|526082525|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
145884591|NCT00685750|526082526|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
145884592|NCT04974580|526082527|FG000|Overall Study|Lost to Follow-up|33|||
145884593|NCT04974580|526082528|FG001|Overall Study|Lost to Follow-up|39|||
145884594|NCT04974580|526082529|FG002|Overall Study|Lost to Follow-up|30|||
145884595|NCT04974580|526082530|FG003|Overall Study|Lost to Follow-up|29|||
145884596|NCT00587431|526082531|FG000|Overall Study|Adverse Event|1|||
145884597|NCT00587431|526082532|FG001|Overall Study|Adverse Event|0|||
145884598|NCT00587431|526082531|FG000|Overall Study|Withdrawal by Subject|0|||
145884599|NCT00587431|526082532|FG001|Overall Study|Withdrawal by Subject|1|||
145884600|NCT05467982|526082533|FG000|Overall Study|Death|0|||
145884601|NCT05467982|526082534|FG001|Overall Study|Death|1|||
145884602|NCT05467982|526082533|FG000|Overall Study|Lost to Follow-up|3|||
145884603|NCT05467982|526082534|FG001|Overall Study|Lost to Follow-up|1|||
145884604|NCT00761176|526082562|FG000|Overall Study|Death|1|||
145884605|NCT00761176|526082563|FG001|Overall Study|Death|0|||
145884606|NCT00761176|526082562|FG000|Overall Study|Withdrawal by Subject|1|||
145884607|NCT00761176|526082563|FG001|Overall Study|Withdrawal by Subject|1|||
145884608|NCT02762994|526082564|FG000|Overall Study|Withdrawal by Subject|0|||
145884609|NCT02762994|526082565|FG001|Overall Study|Withdrawal by Subject|1|||
145884610|NCT02762994|526082566|FG002|Overall Study|Withdrawal by Subject|2|||
145884611|NCT02762994|526082567|FG003|Overall Study|Withdrawal by Subject|0|||
145884612|NCT02762994|526082564|FG000|Overall Study|Protocol Violation|1|||
145884613|NCT02762994|526082565|FG001|Overall Study|Protocol Violation|0|||
145884614|NCT02762994|526082566|FG002|Overall Study|Protocol Violation|0|||
145884615|NCT02762994|526082567|FG003|Overall Study|Protocol Violation|2|||
145884616|NCT05103657|526082570|FG000|Overall Study|Other reasons than listed|9|||
145884617|NCT05103657|526082571|FG001|Overall Study|Other reasons than listed|8|||
145884618|NCT05103657|526082570|FG000|Overall Study|Protocol deviation|2|||
146227124|NCT04101357|527348882|FG004|Overall Study|Death|4|||
146227125|NCT04101357|527348883|FG005|Overall Study|Death|11|||
146227126|NCT04101357|527348884|FG006|Overall Study|Death|4|||
146227127|NCT04101357|527348885|FG007|Overall Study|Death|4|||
146227128|NCT04101357|527348886|FG008|Overall Study|Death|5|||
146227129|NCT04101357|527348887|FG009|Overall Study|Death|2|||
146227130|NCT04101357|527348888|FG010|Overall Study|Death|3|||
146227131|NCT04101357|527348878|FG000|Overall Study|Trial closure|0|||
146227132|NCT04101357|527348879|FG001|Overall Study|Trial closure|0|||
146227133|NCT04101357|527348880|FG002|Overall Study|Trial closure|0|||
146227134|NCT04101357|527348881|FG003|Overall Study|Trial closure|0|||
146227135|NCT04101357|527348882|FG004|Overall Study|Trial closure|0|||
146227136|NCT04101357|527348883|FG005|Overall Study|Trial closure|2|||
146227137|NCT04101357|527348884|FG006|Overall Study|Trial closure|2|||
146227138|NCT04101357|527348885|FG007|Overall Study|Trial closure|0|||
146227139|NCT04101357|527348886|FG008|Overall Study|Trial closure|0|||
146227140|NCT04101357|527348887|FG009|Overall Study|Trial closure|0|||
146227141|NCT04101357|527348888|FG010|Overall Study|Trial closure|1|||
146227142|NCT04101357|527348878|FG000|Overall Study|Lost to Follow-up|0|||
146227143|NCT04101357|527348879|FG001|Overall Study|Lost to Follow-up|0|||
146227144|NCT04101357|527348880|FG002|Overall Study|Lost to Follow-up|0|||
146227145|NCT04101357|527348881|FG003|Overall Study|Lost to Follow-up|1|||
146227146|NCT04101357|527348882|FG004|Overall Study|Lost to Follow-up|0|||
146227147|NCT04101357|527348883|FG005|Overall Study|Lost to Follow-up|0|||
146227148|NCT04101357|527348884|FG006|Overall Study|Lost to Follow-up|0|||
146227149|NCT04101357|527348885|FG007|Overall Study|Lost to Follow-up|1|||
146227150|NCT04101357|527348886|FG008|Overall Study|Lost to Follow-up|0|||
146227151|NCT04101357|527348887|FG009|Overall Study|Lost to Follow-up|0|||
146227152|NCT04101357|527348888|FG010|Overall Study|Lost to Follow-up|0|||
146227153|NCT04101357|527348878|FG000|Overall Study|Withdrawal by Subject|1|||
146227154|NCT04101357|527348879|FG001|Overall Study|Withdrawal by Subject|0|||
146227155|NCT04101357|527348880|FG002|Overall Study|Withdrawal by Subject|0|||
146227156|NCT04101357|527348881|FG003|Overall Study|Withdrawal by Subject|0|||
146227157|NCT04101357|527348882|FG004|Overall Study|Withdrawal by Subject|0|||
146227158|NCT04101357|527348883|FG005|Overall Study|Withdrawal by Subject|0|||
146227159|NCT04101357|527348884|FG006|Overall Study|Withdrawal by Subject|0|||
146227160|NCT04101357|527348885|FG007|Overall Study|Withdrawal by Subject|0|||
146227161|NCT04101357|527348886|FG008|Overall Study|Withdrawal by Subject|1|||
146227162|NCT04101357|527348887|FG009|Overall Study|Withdrawal by Subject|1|||
146227163|NCT04101357|527348888|FG010|Overall Study|Withdrawal by Subject|0|||
145962099|NCT05616013|526373628|FG008|Overall Study|Withdrawal by Subject|4|||
145962100|NCT05616013|526373620|FG000|Overall Study|Physician Decision|0|||
145962101|NCT05616013|526373621|FG001|Overall Study|Physician Decision|0|||
145962102|NCT05616013|526373622|FG002|Overall Study|Physician Decision|1|||
145962103|NCT05616013|526373623|FG003|Overall Study|Physician Decision|0|||
145962104|NCT05616013|526373624|FG004|Overall Study|Physician Decision|0|||
146085710|NCT03422627|526835016|FG002|Overall Study|Protocol-specified Criteria|0|||
146085711|NCT03422627|526835017|FG003|Overall Study|Protocol-specified Criteria|0|||
146085712|NCT03422627|526835018|FG004|Overall Study|Protocol-specified Criteria|2|||
146085713|NCT03422627|526835014|FG000|Overall Study|Requirement for Alternative Therapy|1|||
146227164|NCT04101357|527348878|FG000|Overall Study|Other|0|||
146227165|NCT04101357|527348879|FG001|Overall Study|Other|0|||
146227166|NCT04101357|527348880|FG002|Overall Study|Other|0|||
146227167|NCT04101357|527348881|FG003|Overall Study|Other|0|||
146227168|NCT04101357|527348882|FG004|Overall Study|Other|0|||
146227169|NCT04101357|527348883|FG005|Overall Study|Other|1|||
146227170|NCT04101357|527348884|FG006|Overall Study|Other|2|||
146227171|NCT04101357|527348885|FG007|Overall Study|Other|1|||
146227172|NCT04101357|527348886|FG008|Overall Study|Other|0|||
146227173|NCT04101357|527348887|FG009|Overall Study|Other|0|||
145884619|NCT05103657|526082571|FG001|Overall Study|Protocol deviation|2|||
145884620|NCT05103657|526082570|FG000|Overall Study|No reason available|5|||
145884621|NCT05103657|526082571|FG001|Overall Study|No reason available|4|||
145884622|NCT05103657|526082570|FG000|Overall Study|Burden of study procedures|3|||
145884623|NCT05103657|526082571|FG001|Overall Study|Burden of study procedures|1|||
145884624|NCT05103657|526082570|FG000|Overall Study|Perceived lack of efficacy|1|||
145884625|NCT05103657|526082571|FG001|Overall Study|Perceived lack of efficacy|1|||
145884626|NCT05103657|526082570|FG000|Overall Study|Adverse Event|6|||
145884627|NCT05103657|526082571|FG001|Overall Study|Adverse Event|14|||
145884628|NCT05103657|526082570|FG000|Overall Study|Not Treated|1|||
145884629|NCT05103657|526082571|FG001|Overall Study|Not Treated|1|||
145884630|NCT02020967|526082572|FG000|Overall Study|Withdrawal by Subject|51|||
145884631|NCT00585312|526082573|FG000|Overall Study|Adverse Event|3|||
145884632|NCT00585312|526082574|FG001|Overall Study|Adverse Event|0|||
145884633|NCT00585312|526082573|FG000|Overall Study|Lack of Efficacy|6|||
145884634|NCT00585312|526082574|FG001|Overall Study|Lack of Efficacy|11|||
145884635|NCT00585312|526082573|FG000|Overall Study|Lost to Follow-up|1|||
145884636|NCT00585312|526082574|FG001|Overall Study|Lost to Follow-up|1|||
145884637|NCT00585312|526082573|FG000|Overall Study|Reason not specified|2|||
145884638|NCT00585312|526082574|FG001|Overall Study|Reason not specified|0|||
145884639|NCT00585312|526082573|FG000|Overall Study|Withdrawal by Subject|5|||
145884640|NCT00585312|526082574|FG001|Overall Study|Withdrawal by Subject|1|||
145884641|NCT00585312|526082573|FG000|Overall Study|Study terminated by the sponsor|34|||
145884642|NCT00585312|526082574|FG001|Overall Study|Study terminated by the sponsor|31|||
145884643|NCT04234464|526082575|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
145884644|NCT04234464|526082576|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
145884645|NCT00983528|526082577|FG000|Overall Study|Death|4|||
145884646|NCT00983528|526082577|FG000|Overall Study|Lost to Follow-up|1|||
145884647|NCT00983528|526082577|FG000|Overall Study|Study Terminated|1|||
145884648|NCT00330460|526082582|FG000|Overall Study|Physician Decision|1|||
145884649|NCT00330460|526082583|FG001|Overall Study|Physician Decision|0|||
145884650|NCT00330460|526082582|FG000|Overall Study|Adverse Event|10|||
145884651|NCT00330460|526082583|FG001|Overall Study|Adverse Event|8|||
145884652|NCT00330460|526082582|FG000|Overall Study|Withdrawal by Subject|18|||
145884653|NCT00330460|526082583|FG001|Overall Study|Withdrawal by Subject|17|||
145884654|NCT00330460|526082582|FG000|Overall Study|Death|1|||
145884655|NCT00330460|526082583|FG001|Overall Study|Death|1|||
145884656|NCT00330460|526082582|FG000|Overall Study|Ineligibility determined|1|||
145884657|NCT00330460|526082583|FG001|Overall Study|Ineligibility determined|3|||
145884658|NCT00330460|526082582|FG000|Overall Study|Lost to Follow-up|8|||
145884659|NCT00330460|526082583|FG001|Overall Study|Lost to Follow-up|3|||
145884660|NCT00330460|526082582|FG000|Overall Study|Noncompliance|2|||
145884661|NCT00330460|526082583|FG001|Overall Study|Noncompliance|1|||
145884662|NCT00330460|526082582|FG000|Overall Study|Other|1|||
145884663|NCT00330460|526082583|FG001|Overall Study|Other|0|||
145884664|NCT03712124|526082584|FG000|Overall Study|Protocol Violation|1|||
146227174|NCT04101357|527348888|FG010|Overall Study|Other|0|||
145884665|NCT03712124|526082585|FG001|Overall Study|Protocol Violation|0|||
145884666|NCT00105157|526082587|FG000|Double-Blind (DB)|Never Treated|1|||
145962105|NCT05616013|526373625|FG005|Overall Study|Physician Decision|1|||
146227175|NCT04101357|527348878|FG000|Overall Study|Enrolled but not treated|0|||
146227176|NCT04101357|527348879|FG001|Overall Study|Enrolled but not treated|0|||
146227177|NCT04101357|527348880|FG002|Overall Study|Enrolled but not treated|0|||
146227178|NCT04101357|527348881|FG003|Overall Study|Enrolled but not treated|0|||
146227179|NCT04101357|527348882|FG004|Overall Study|Enrolled but not treated|0|||
146227180|NCT04101357|527348883|FG005|Overall Study|Enrolled but not treated|1|||
146227181|NCT04101357|527348884|FG006|Overall Study|Enrolled but not treated|1|||
146227182|NCT04101357|527348885|FG007|Overall Study|Enrolled but not treated|0|||
146227183|NCT04101357|527348886|FG008|Overall Study|Enrolled but not treated|0|||
146227184|NCT04101357|527348887|FG009|Overall Study|Enrolled but not treated|0|||
146227185|NCT04101357|527348888|FG010|Overall Study|Enrolled but not treated|0|||
146227186|NCT05868382|527348889|FG000|Overall Study|Lost to Follow-up|5|||
146227187|NCT05868382|527348890|FG001|Overall Study|Lost to Follow-up|0|||
146227188|NCT05868382|527348891|FG002|Overall Study|Lost to Follow-up|6|||
146227189|NCT05868382|527348892|FG003|Overall Study|Lost to Follow-up|4|||
146227190|NCT05868382|527348893|FG004|Overall Study|Lost to Follow-up|2|||
146227191|NCT05868382|527348894|FG005|Overall Study|Lost to Follow-up|6|||
146227192|NCT05868382|527348889|FG000|Overall Study|Withdrawal by Subject|1|||
146227193|NCT05868382|527348890|FG001|Overall Study|Withdrawal by Subject|0|||
146227194|NCT05868382|527348891|FG002|Overall Study|Withdrawal by Subject|0|||
146227195|NCT05868382|527348892|FG003|Overall Study|Withdrawal by Subject|0|||
146227196|NCT05868382|527348893|FG004|Overall Study|Withdrawal by Subject|1|||
146227197|NCT05868382|527348894|FG005|Overall Study|Withdrawal by Subject|0|||
146227198|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
146227199|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
146227200|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
146227201|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
146227202|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
146227203|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
146085714|NCT03422627|526835015|FG001|Overall Study|Requirement for Alternative Therapy|1|||
146085715|NCT03422627|526835016|FG002|Overall Study|Requirement for Alternative Therapy|2|||
146085716|NCT03422627|526835017|FG003|Overall Study|Requirement for Alternative Therapy|0|||
146085717|NCT03422627|526835018|FG004|Overall Study|Requirement for Alternative Therapy|0|||
146227204|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
146227205|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Death|0|||
146085718|NCT03422627|526835014|FG000|Overall Study|Disease Progression|1|||
146085719|NCT03422627|526835015|FG001|Overall Study|Disease Progression|0|||
146085720|NCT03422627|526835016|FG002|Overall Study|Disease Progression|1|||
146085721|NCT03422627|526835017|FG003|Overall Study|Disease Progression|2|||
146085722|NCT03422627|526835018|FG004|Overall Study|Disease Progression|0|||
146085723|NCT03422627|526835014|FG000|Overall Study|Adverse Event|2|||
146085724|NCT03422627|526835015|FG001|Overall Study|Adverse Event|1|||
146085725|NCT03422627|526835016|FG002|Overall Study|Adverse Event|0|||
146085726|NCT03422627|526835017|FG003|Overall Study|Adverse Event|0|||
146085727|NCT03422627|526835018|FG004|Overall Study|Adverse Event|2|||
146085728|NCT03422627|526835014|FG000|Overall Study|Ineligibility Determined|0|||
146085729|NCT03422627|526835015|FG001|Overall Study|Ineligibility Determined|1|||
146085730|NCT03422627|526835016|FG002|Overall Study|Ineligibility Determined|0|||
146085731|NCT03422627|526835017|FG003|Overall Study|Ineligibility Determined|0|||
146085732|NCT03422627|526835018|FG004|Overall Study|Ineligibility Determined|0|||
146085733|NCT03422627|526835014|FG000|Overall Study|Death|0|||
146085734|NCT03422627|526835015|FG001|Overall Study|Death|1|||
146085735|NCT03422627|526835016|FG002|Overall Study|Death|1|||
146085736|NCT03422627|526835017|FG003|Overall Study|Death|0|||
146085737|NCT03422627|526835018|FG004|Overall Study|Death|0|||
146085738|NCT03422627|526835014|FG000|Overall Study|Withdrawal by Subject|0|||
146085739|NCT03422627|526835015|FG001|Overall Study|Withdrawal by Subject|0|||
146085740|NCT03422627|526835016|FG002|Overall Study|Withdrawal by Subject|0|||
146085741|NCT03422627|526835017|FG003|Overall Study|Withdrawal by Subject|1|||
146085742|NCT03422627|526835018|FG004|Overall Study|Withdrawal by Subject|0|||
146085743|NCT02455557|526835019|FG000|Overall Study|Withdrawal by Subject|2|||
146085744|NCT04656275|526835020|FG000|Overall Study|Study terminated by sponsor|2|||
146227206|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Death|1|||
146085745|NCT04656275|526835021|FG001|Overall Study|Study terminated by sponsor|4|||
146227207|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Death|0|||
146227208|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Death|0|||
146227209|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Death|0|||
146227210|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Death|0|||
146085746|NCT00934648|526835025|FG000|Overall Study|Failure to return|8|||
146227211|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Death|0|||
146227212|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
146227213|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146227214|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146227215|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146227216|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145962106|NCT05616013|526373626|FG006|Overall Study|Physician Decision|3|||
146085747|NCT00934648|526835025|FG000|Overall Study|Withdrawal by Subject|1|||
146227217|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146227218|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
146227219|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227220|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
146227221|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227222|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227223|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227224|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227225|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
146227226|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Other|1|||
146227227|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Other|0|||
146227228|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Other|0|||
146227229|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Other|0|||
146227230|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Other|0|||
146227231|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Other|0|||
146227232|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Other|0|||
146227233|NCT04585815|527348895|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
146227234|NCT04585815|527348896|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
146227235|NCT04585815|527348897|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146227236|NCT04585815|527348898|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146227237|NCT04585815|527348899|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146227238|NCT04585815|527348900|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146227239|NCT04585815|527348901|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
146227240|NCT04585815|527348895|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227241|NCT04585815|527348896|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
146227242|NCT04585815|527348897|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227243|NCT04585815|527348898|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227244|NCT04585815|527348899|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227245|NCT04585815|527348900|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227246|NCT04585815|527348901|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
146227247|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
145962107|NCT05616013|526373627|FG007|Overall Study|Physician Decision|0|||
145962108|NCT05616013|526373628|FG008|Overall Study|Physician Decision|0|||
145962109|NCT05616013|526373620|FG000|Overall Study|Protocol Violation|0|||
145962110|NCT05616013|526373621|FG001|Overall Study|Protocol Violation|0|||
145962111|NCT05616013|526373622|FG002|Overall Study|Protocol Violation|0|||
145962112|NCT05616013|526373623|FG003|Overall Study|Protocol Violation|0|||
145962113|NCT05616013|526373624|FG004|Overall Study|Protocol Violation|0|||
145962114|NCT05616013|526373625|FG005|Overall Study|Protocol Violation|0|||
145962115|NCT05616013|526373626|FG006|Overall Study|Protocol Violation|1|||
145962116|NCT05616013|526373627|FG007|Overall Study|Protocol Violation|0|||
145962117|NCT05616013|526373628|FG008|Overall Study|Protocol Violation|2|||
145962118|NCT05616013|526373620|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
145962119|NCT05616013|526373621|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962120|NCT05616013|526373622|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962121|NCT05616013|526373623|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962122|NCT05616013|526373624|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962123|NCT05616013|526373625|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962124|NCT05616013|526373626|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962125|NCT05616013|526373627|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962126|NCT05616013|526373628|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
145962127|NCT05616013|526373620|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
145962128|NCT05616013|526373621|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962129|NCT05616013|526373622|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962130|NCT05616013|526373623|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962131|NCT05616013|526373624|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962132|NCT05616013|526373625|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962133|NCT05616013|526373626|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962134|NCT05616013|526373627|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962135|NCT05616013|526373628|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145962136|NCT05616013|526373620|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
145962137|NCT05616013|526373621|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145962138|NCT05616013|526373622|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146227248|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
145962139|NCT05616013|526373623|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145962140|NCT05616013|526373624|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146227249|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
146227250|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
146227251|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
145884667|NCT00105157|526082588|FG001|Double-Blind (DB)|Never Treated|0|||
145884668|NCT00105157|526082589|FG002|Double-Blind (DB)|Never Treated|0|||
145884669|NCT00105157|526082590|FG003|Double-Blind (DB)|Never Treated|0|||
145884670|NCT00105157|526082587|FG000|Double-Blind (DB)|Adverse Event|2|||
146085748|NCT02195687|526835026|FG000|Overall Study|Personal Reasons|1|||
146085749|NCT02195687|526835027|FG001|Overall Study|Personal Reasons|1|||
146227252|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
146227253|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
146227254|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Death|0|||
146227255|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Death|0|||
146227256|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Death|0|||
146227257|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Death|1|||
146227258|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Death|0|||
146227259|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Death|0|||
146227260|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Death|0|||
146227261|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146227262|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146227263|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146227264|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
146227265|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146227266|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
146227267|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
146227268|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146227269|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146227270|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146227271|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
146227272|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146085750|NCT02195687|526835026|FG000|Overall Study|Lost to Follow-up|4|||
146227273|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
146227274|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145884671|NCT00105157|526082588|FG001|Double-Blind (DB)|Adverse Event|0|||
145884672|NCT00105157|526082589|FG002|Double-Blind (DB)|Adverse Event|1|||
145884673|NCT00105157|526082590|FG003|Double-Blind (DB)|Adverse Event|1|||
145884674|NCT00105157|526082587|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
145884675|NCT00105157|526082588|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
145884676|NCT00105157|526082589|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
145884677|NCT00105157|526082590|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
145884678|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Adverse Event|3|||
145884679|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Adverse Event|1|||
145884680|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Adverse Event|0|||
145884681|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Adverse Event|0|||
145884682|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
145884683|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
145884684|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
145884685|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
145884686|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
145884687|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
145884688|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
145884689|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
145884690|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
145884691|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
145884692|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
145884693|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
146085751|NCT02195687|526835027|FG001|Overall Study|Lost to Follow-up|1|||
146227275|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227276|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227277|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227278|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227279|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227280|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
146227281|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
146227282|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
146227283|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
146227284|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
146227285|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
146227286|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
146227287|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
146227288|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
146227289|NCT04585815|527348895|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
146227290|NCT04585815|527348896|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
146227291|NCT04585815|527348897|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
146227292|NCT04585815|527348898|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
146227293|NCT04585815|527348899|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
146227294|NCT04585815|527348900|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
146227295|NCT04585815|527348901|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
146227296|NCT04585815|527348895|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146227297|NCT04585815|527348896|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146227298|NCT04585815|527348897|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146227299|NCT04585815|527348898|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
146227300|NCT04585815|527348899|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
146227301|NCT04585815|527348900|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
146227302|NCT04585815|527348901|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
146227303|NCT04585815|527348895|FG000|Sub-study B- Follow-up Phase|Death|0|||
145884694|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
146227304|NCT04585815|527348896|FG001|Sub-study B- Follow-up Phase|Death|0|||
146227305|NCT04585815|527348897|FG002|Sub-study B- Follow-up Phase|Death|1|||
146227306|NCT04585815|527348898|FG003|Sub-study B- Follow-up Phase|Death|3|||
146227307|NCT04585815|527348899|FG004|Sub-study B- Follow-up Phase|Death|0|||
146227308|NCT04585815|527348900|FG005|Sub-study B- Follow-up Phase|Death|0|||
145884695|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
146227309|NCT04585815|527348901|FG006|Sub-study B- Follow-up Phase|Death|1|||
146227310|NCT02497950|527348904|FG000|Overall Study|Death|209|||
146085752|NCT04369924|526835030|FG000|Overall Study|Lost to Follow-up|302|||
145884696|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
145884697|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
145884698|NCT00105157|526082587|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
145884699|NCT00105157|526082588|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
145884700|NCT00105157|526082589|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
145884701|NCT00105157|526082590|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
145884702|NCT00105157|526082587|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145884703|NCT00105157|526082588|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145884704|NCT00105157|526082589|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145884705|NCT00105157|526082590|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
145884706|NCT00105157|526082587|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
145884707|NCT00105157|526082588|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
145884708|NCT00105157|526082589|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
145884709|NCT00105157|526082590|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
145884710|NCT00105157|526082587|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
145884711|NCT00105157|526082588|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
145884712|NCT00105157|526082589|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
145884713|NCT00105157|526082590|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
145884714|NCT00105157|526082587|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145884715|NCT00105157|526082588|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145884716|NCT00105157|526082589|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145884717|NCT00105157|526082590|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
145884718|NCT00105157|526082587|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145884719|NCT00105157|526082588|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
145884720|NCT00105157|526082589|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145884721|NCT00105157|526082590|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145884722|NCT00127166|526082591|FG000|Period I|Protocol Violation|0|||
145884723|NCT00127166|526082592|FG001|Period I|Protocol Violation|2|||
145884724|NCT00127166|526082591|FG000|Period I|Withdrawal by Subject|2|||
145884725|NCT00127166|526082592|FG001|Period I|Withdrawal by Subject|0|||
145884726|NCT00127166|526082591|FG000|Period I|Patient did not meet inclusion criteria|1|||
145884727|NCT00127166|526082592|FG001|Period I|Patient did not meet inclusion criteria|0|||
145884728|NCT00127166|526082591|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
145884729|NCT00127166|526082592|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
145884730|NCT00127166|526082591|FG000|Period II|Withdrawal by Subject|2|||
145884731|NCT00127166|526082592|FG001|Period II|Withdrawal by Subject|0|||
145884732|NCT00127166|526082591|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
145884733|NCT00127166|526082592|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
145884734|NCT02030535|526082596|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
145884735|NCT01169038|526082598|FG000|Overall Study|Death|1|||
145884736|NCT01169038|526082598|FG000|Overall Study|Adverse Event|5|||
145884737|NCT01169038|526082598|FG000|Overall Study|Required antibiotic administration|1|||
145884738|NCT03257254|526082599|FG000|Overall Study|Withdrawal by Subject|7|||
145884739|NCT03257254|526082599|FG000|Overall Study|Lost to Follow-up|9|||
145884740|NCT03257254|526082599|FG000|Overall Study|Study discontinued by sponsor|5|||
145884741|NCT02329431|526082600|FG000|Overall Study|Lost to Follow-up|20|||
145884742|NCT02329431|526082601|FG001|Overall Study|Lost to Follow-up|13|||
145884743|NCT01557582|526082602|FG000|Overall Study|Protocol Violation|4|||
145884744|NCT01557582|526082602|FG000|Overall Study|Operator error|2|||
145884745|NCT02843659|526082603|FG000|Overall Study|Subject Withdrew Consent|0|||
145884746|NCT02843659|526082604|FG001|Overall Study|Subject Withdrew Consent|0|||
145884747|NCT02843659|526082605|FG002|Overall Study|Subject Withdrew Consent|1|||
145884748|NCT02843659|526082603|FG000|Overall Study|Administrative Reason by Sponsor|4|||
145884749|NCT02843659|526082604|FG001|Overall Study|Administrative Reason by Sponsor|5|||
145884750|NCT02843659|526082605|FG002|Overall Study|Administrative Reason by Sponsor|4|||
145884751|NCT02843659|526082603|FG000|Overall Study|Adverse Event|0|||
145884752|NCT02843659|526082604|FG001|Overall Study|Adverse Event|1|||
145884753|NCT02843659|526082605|FG002|Overall Study|Adverse Event|0|||
145884754|NCT03203642|526082606|FG000|Overall Study|Adverse Event|3|||
145884755|NCT03203642|526082607|FG001|Overall Study|Adverse Event|1|||
145884756|NCT03203642|526082606|FG000|Overall Study|Withdrawal by Subject|6|||
145884757|NCT03203642|526082607|FG001|Overall Study|Withdrawal by Subject|6|||
145884758|NCT03203642|526082606|FG000|Overall Study|Lost to Follow-up|2|||
145884759|NCT03203642|526082607|FG001|Overall Study|Lost to Follow-up|1|||
145884760|NCT03203642|526082606|FG000|Overall Study|Termination of the study by sponsor|1|||
146227311|NCT02497950|527348904|FG000|Overall Study|Transplanted|85|||
146227312|NCT02497950|527348904|FG000|Overall Study|Explanted|8|||
145884761|NCT03203642|526082607|FG001|Overall Study|Termination of the study by sponsor|1|||
145884762|NCT03203642|526082606|FG000|Overall Study|Participant moved|0|||
146227313|NCT02497950|527348904|FG000|Overall Study|Device Permanently Deactivated|4|||
146227314|NCT02497950|527348904|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
146227315|NCT02497950|527348904|FG000|Overall Study|Lost to Follow-up|6|||
146227316|NCT02497950|527348904|FG000|Overall Study|Withdrawal by Subject|2|||
146227317|NCT02497950|527348904|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
146227318|NCT02497950|527348904|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
146227319|NCT04660539|527348905|FG000|Overall Study|Adverse Event|10|||
146227320|NCT04660539|527348905|FG000|Overall Study|Lack of Efficacy|4|||
146227321|NCT04660539|527348905|FG000|Overall Study|Lost to Follow-up|5|||
146227322|NCT04660539|527348905|FG000|Overall Study|Non-Compliance With Study Drug|3|||
146227323|NCT04660539|527348905|FG000|Overall Study|Reason not Specified|12|||
146227324|NCT04660539|527348905|FG000|Overall Study|Pregnancy|2|||
146227325|NCT04660539|527348905|FG000|Overall Study|Protocol Violation|2|||
146227326|NCT04660539|527348905|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
146227327|NCT04660539|527348905|FG000|Overall Study|Withdrawal by Subject|21|||
146227328|NCT05618587|527348906|FG000|Overall Study|Lost to Follow-up|2|||
146227329|NCT05618587|527348907|FG001|Overall Study|Lost to Follow-up|0|||
146227330|NCT05204654|527348913|FG000|Overall Study|Study terminated due to time restraint|2|||
146227331|NCT05204654|527348914|FG001|Overall Study|Study terminated due to time restraint|2|||
146227332|NCT01221948|527348915|FG000|Overall Study|Physician Decision|5|||
146227333|NCT01221948|527348915|FG000|Overall Study|Withdrawal by Subject|2|||
146227334|NCT01221948|527348915|FG000|Overall Study|not disclosed|2|||
146227335|NCT01221948|527348915|FG000|Overall Study|Death|1|||
146227336|NCT01221948|527348915|FG000|Overall Study|Protocol Violation|4|||
146227337|NCT03756662|527348916|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
146227338|NCT05207956|527348923|FG000|Overall Study|Lost to follow up|1|||
146227339|NCT05207956|527348924|FG001|Overall Study|Lost to follow up|2|||
146227340|NCT01828112|527348927|FG000|Treatment Phase|Adverse Event|7|||
146227341|NCT01828112|527348928|FG001|Treatment Phase|Adverse Event|8|||
146227342|NCT01828112|527348929|FG002|Treatment Phase|Adverse Event|0|||
146227343|NCT01828112|527348927|FG000|Treatment Phase|Death|9|||
146227344|NCT01828112|527348928|FG001|Treatment Phase|Death|5|||
146227345|NCT01828112|527348929|FG002|Treatment Phase|Death|0|||
146227346|NCT01828112|527348927|FG000|Treatment Phase|No longer required treatment|0|||
146227347|NCT01828112|527348928|FG001|Treatment Phase|No longer required treatment|1|||
146227348|NCT01828112|527348929|FG002|Treatment Phase|No longer required treatment|0|||
146227349|NCT01828112|527348927|FG000|Treatment Phase|Physician Decision|6|||
146227350|NCT01828112|527348928|FG001|Treatment Phase|Physician Decision|7|||
146227351|NCT01828112|527348929|FG002|Treatment Phase|Physician Decision|0|||
146227352|NCT01828112|527348927|FG000|Treatment Phase|Pregnancy|1|||
146227353|NCT01828112|527348928|FG001|Treatment Phase|Pregnancy|0|||
146227354|NCT01828112|527348929|FG002|Treatment Phase|Pregnancy|0|||
145884763|NCT03203642|526082607|FG001|Overall Study|Participant moved|1|||
146227355|NCT01828112|527348927|FG000|Treatment Phase|Progressive disease|79|||
146227356|NCT01828112|527348928|FG001|Treatment Phase|Progressive disease|87|||
146227357|NCT01828112|527348929|FG002|Treatment Phase|Progressive disease|0|||
146227358|NCT01828112|527348927|FG000|Treatment Phase|Study terminated by sponsor|1|||
146227359|NCT01828112|527348928|FG001|Treatment Phase|Study terminated by sponsor|0|||
146227360|NCT01828112|527348929|FG002|Treatment Phase|Study terminated by sponsor|0|||
146227361|NCT01828112|527348927|FG000|Treatment Phase|Subject/guardian decision|12|||
146227362|NCT01828112|527348928|FG001|Treatment Phase|Subject/guardian decision|8|||
146227363|NCT01828112|527348929|FG002|Treatment Phase|Subject/guardian decision|0|||
146085753|NCT04369924|526835031|FG001|Overall Study|Lost to Follow-up|339|||
146227364|NCT01828112|527348927|FG000|Extension Treatment Phase|Adverse Event|0|||
146227365|NCT01828112|527348928|FG001|Extension Treatment Phase|Adverse Event|0|||
146227366|NCT01828112|527348929|FG002|Extension Treatment Phase|Adverse Event|6|||
146227367|NCT01828112|527348927|FG000|Extension Treatment Phase|Death|0|||
146227368|NCT01828112|527348928|FG001|Extension Treatment Phase|Death|0|||
146227369|NCT01828112|527348929|FG002|Extension Treatment Phase|Death|17|||
146227370|NCT01828112|527348927|FG000|Extension Treatment Phase|Physician Decision|0|||
146227371|NCT01828112|527348928|FG001|Extension Treatment Phase|Physician Decision|0|||
145884764|NCT03203642|526082606|FG000|Overall Study|Investigator's decision|3|||
146227372|NCT01828112|527348929|FG002|Extension Treatment Phase|Physician Decision|5|||
146227373|NCT01828112|527348927|FG000|Extension Treatment Phase|Progressive disease|0|||
146227374|NCT01828112|527348928|FG001|Extension Treatment Phase|Progressive disease|0|||
146227375|NCT01828112|527348929|FG002|Extension Treatment Phase|Progressive disease|46|||
146227376|NCT01828112|527348927|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
146227377|NCT01828112|527348928|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
146227378|NCT01828112|527348929|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
146227379|NCT01828112|527348927|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
146227380|NCT01828112|527348928|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
146227381|NCT01828112|527348929|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
146227382|NCT04308681|527348935|FG000|Pre-Treatment|Not reported|1|||
146227383|NCT04308681|527348936|FG001|Pre-Treatment|Not reported|1|||
146227384|NCT04308681|527348937|FG002|Pre-Treatment|Not reported|0|||
146227385|NCT04308681|527348938|FG003|Pre-Treatment|Not reported|0|||
146227386|NCT04308681|527348939|FG004|Pre-Treatment|Not reported|0|||
146227387|NCT04308681|527348940|FG005|Pre-Treatment|Not reported|2|||
146227388|NCT04308681|527348941|FG006|Pre-Treatment|Not reported|0|||
146227389|NCT04308681|527348942|FG007|Pre-Treatment|Not reported|0|||
146227390|NCT04308681|527348935|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
146227391|NCT04308681|527348936|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
146227392|NCT04308681|527348937|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
146227393|NCT04308681|527348938|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
146227394|NCT04308681|527348939|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
146227395|NCT04308681|527348940|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
146227396|NCT04308681|527348941|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
146227397|NCT04308681|527348942|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
146227398|NCT04308681|527348935|FG000|Treatment up to Week 26|Other reasons|2|||
146227399|NCT04308681|527348936|FG001|Treatment up to Week 26|Other reasons|0|||
146227400|NCT04308681|527348937|FG002|Treatment up to Week 26|Other reasons|0|||
146227401|NCT04308681|527348938|FG003|Treatment up to Week 26|Other reasons|0|||
146227402|NCT04308681|527348939|FG004|Treatment up to Week 26|Other reasons|1|||
146227403|NCT04308681|527348940|FG005|Treatment up to Week 26|Other reasons|1|||
146227404|NCT04308681|527348941|FG006|Treatment up to Week 26|Other reasons|0|||
146227405|NCT04308681|527348942|FG007|Treatment up to Week 26|Other reasons|0|||
146227406|NCT04308681|527348935|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146227407|NCT04308681|527348936|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146227408|NCT04308681|527348937|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
146227409|NCT04308681|527348938|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146227410|NCT04308681|527348939|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146227411|NCT04308681|527348940|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146227412|NCT04308681|527348941|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
146227413|NCT04308681|527348942|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
146227414|NCT04308681|527348935|FG000|Treatment up to Week 26|Adverse Event|6|||
146227415|NCT04308681|527348936|FG001|Treatment up to Week 26|Adverse Event|5|||
146227416|NCT04308681|527348937|FG002|Treatment up to Week 26|Adverse Event|5|||
146227417|NCT04308681|527348938|FG003|Treatment up to Week 26|Adverse Event|0|||
146227418|NCT04308681|527348939|FG004|Treatment up to Week 26|Adverse Event|6|||
146227419|NCT04308681|527348940|FG005|Treatment up to Week 26|Adverse Event|1|||
146227420|NCT04308681|527348941|FG006|Treatment up to Week 26|Adverse Event|0|||
145884765|NCT03203642|526082607|FG001|Overall Study|Investigator's decision|0|||
145884766|NCT03203642|526082606|FG000|Overall Study|Other than above specified|0|||
145884767|NCT03203642|526082607|FG001|Overall Study|Other than above specified|1|||
145884768|NCT03180528|526084290|FG000|Overall Study|Adverse Event|1|||
145884769|NCT03180528|526084290|FG000|Overall Study|Withdrawal by Subject|1|||
145884770|NCT03180528|526084290|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
145884771|NCT02447887|526084291|FG000|Overall Study|Study was terminated|3|||
146227421|NCT04308681|527348942|FG007|Treatment up to Week 26|Adverse Event|0|||
145884772|NCT00109837|526084292|FG000|Overall Study|Adverse Event|2|||
146227422|NCT04308681|527348935|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227423|NCT04308681|527348936|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
146227424|NCT04308681|527348937|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
146289071|NCT01127139|527573328|FG000|Overall Study|Adverse Event|40|||
146227425|NCT04308681|527348938|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227426|NCT04308681|527348939|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227427|NCT04308681|527348940|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227428|NCT04308681|527348941|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227429|NCT04308681|527348942|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
146227430|NCT04308681|527348935|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
146227431|NCT04308681|527348936|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
146227432|NCT04308681|527348937|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
146227433|NCT04308681|527348938|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
146227434|NCT04308681|527348939|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
146227435|NCT04308681|527348940|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
146227436|NCT04308681|527348941|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
146227437|NCT04308681|527348942|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
146227438|NCT04308681|527348935|FG000|OTE - 26 Weeks|Death|0|||
146227439|NCT04308681|527348936|FG001|OTE - 26 Weeks|Death|1|||
146227440|NCT04308681|527348937|FG002|OTE - 26 Weeks|Death|0|||
146227441|NCT04308681|527348938|FG003|OTE - 26 Weeks|Death|0|||
146227442|NCT04308681|527348939|FG004|OTE - 26 Weeks|Death|0|||
146227443|NCT04308681|527348940|FG005|OTE - 26 Weeks|Death|0|||
146227444|NCT04308681|527348941|FG006|OTE - 26 Weeks|Death|1|||
146227445|NCT04308681|527348942|FG007|OTE - 26 Weeks|Death|0|||
146227446|NCT04308681|527348935|FG000|OTE - 26 Weeks|Adverse Event|0|||
146227447|NCT04308681|527348936|FG001|OTE - 26 Weeks|Adverse Event|2|||
146227448|NCT04308681|527348937|FG002|OTE - 26 Weeks|Adverse Event|8|||
146227449|NCT04308681|527348938|FG003|OTE - 26 Weeks|Adverse Event|3|||
146227450|NCT04308681|527348939|FG004|OTE - 26 Weeks|Adverse Event|0|||
146227451|NCT04308681|527348940|FG005|OTE - 26 Weeks|Adverse Event|1|||
146227452|NCT04308681|527348941|FG006|OTE - 26 Weeks|Adverse Event|2|||
146227453|NCT04308681|527348942|FG007|OTE - 26 Weeks|Adverse Event|0|||
146227454|NCT04308681|527348935|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146227455|NCT04308681|527348936|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146227456|NCT04308681|527348937|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146227457|NCT04308681|527348938|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146227458|NCT04308681|527348939|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146227459|NCT04308681|527348940|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
146227460|NCT04308681|527348941|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146227461|NCT04308681|527348942|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
146227462|NCT02446236|527348943|FG000|Overall Study|Screen Failure|1|||
146227463|NCT02446236|527348944|FG001|Overall Study|Screen Failure|0|||
146227464|NCT02446236|527348945|FG002|Overall Study|Screen Failure|1|||
146227465|NCT02446236|527348943|FG000|Overall Study|Actively Receiving Therapy|0|||
146227466|NCT02446236|527348944|FG001|Overall Study|Actively Receiving Therapy|0|||
146227467|NCT02446236|527348945|FG002|Overall Study|Actively Receiving Therapy|1|||
146227468|NCT05873556|527348950|FG000|Overall Study|Lost to Follow-up|4|||
146227469|NCT05873556|527348951|FG001|Overall Study|Lost to Follow-up|1|||
146227470|NCT03606408|527348952|FG000|Overall Study|Adverse Event|13|||
146227471|NCT03606408|527348952|FG000|Overall Study|Withdrawal by Subject|7|||
146227472|NCT03606408|527348952|FG000|Overall Study|Physician Decision|4|||
146227473|NCT03606408|527348952|FG000|Overall Study|Lack of Efficacy|2|||
146227474|NCT03606408|527348952|FG000|Overall Study|Death|1|||
146227475|NCT03606408|527348952|FG000|Overall Study|new therapy for study indication|1|||
146227476|NCT04862234|527348953|FG000|Overall Study|Surgery cancellation|1|||
146227477|NCT04862234|527348954|FG001|Overall Study|Surgery cancellation|2|||
146227478|NCT04862234|527348953|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
146227479|NCT04862234|527348954|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
146227480|NCT04862234|527348953|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
146227481|NCT04862234|527348954|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
146227482|NCT03292484|527348960|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
146227483|NCT03292484|527348960|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
146227484|NCT03292484|527348960|FG000|Overall Study|Protocol Violation|2|||
146227485|NCT03292484|527348960|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
146227486|NCT03292484|527348960|FG000|Overall Study|Sponsor decision|349|||
146227487|NCT03292484|527348960|FG000|Overall Study|Lost to Follow-up|7|||
146227488|NCT03292484|527348960|FG000|Overall Study|Coronavirus Disease 2019|1|||
146227489|NCT03292484|527348960|FG000|Overall Study|Other|20|||
146227490|NCT05069896|527348962|FG000|Overall Study|Adverse Event|0|||
146227491|NCT05069896|527348963|FG001|Overall Study|Adverse Event|1|||
146227492|NCT05069896|527348964|FG002|Overall Study|Adverse Event|1|||
146227493|NCT05069896|527348965|FG003|Overall Study|Adverse Event|0|||
146227494|NCT05069896|527348966|FG004|Overall Study|Adverse Event|0|||
146227495|NCT05069896|527348967|FG005|Overall Study|Adverse Event|0|||
146227496|NCT05069896|527348962|FG000|Overall Study|Lost to Follow-up|0|||
145884773|NCT00109837|526084292|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
145884774|NCT00109837|526084292|FG000|Overall Study|Death|1|||
145884775|NCT00109837|526084292|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
145884776|NCT00109837|526084292|FG000|Overall Study|Not treated|1|||
145884777|NCT00109837|526084292|FG000|Overall Study|Ineligible|1|||
145884778|NCT01563237|526084294|FG000|Overall Study|Lost to Follow-up|6|||
145884779|NCT01563237|526084295|FG001|Overall Study|Lost to Follow-up|0|||
145884780|NCT01563237|526084294|FG000|Overall Study|Withdrawal by Subject|1|||
145884781|NCT01563237|526084295|FG001|Overall Study|Withdrawal by Subject|0|||
145884782|NCT01563237|526084294|FG000|Overall Study|Adverse Event|1|||
145884783|NCT01563237|526084295|FG001|Overall Study|Adverse Event|0|||
145884784|NCT01563237|526084294|FG000|Overall Study|Medical Reasons|1|||
145884785|NCT01563237|526084295|FG001|Overall Study|Medical Reasons|0|||
145884786|NCT01563237|526084294|FG000|Overall Study|Death|1|||
145884787|NCT01563237|526084295|FG001|Overall Study|Death|0|||
145884788|NCT00988208|526084300|FG000|Overall Study|Adverse Event|71|||
145884789|NCT00988208|526084301|FG001|Overall Study|Adverse Event|122|||
145884790|NCT00988208|526084300|FG000|Overall Study|Disease Progression|103|||
145884791|NCT00988208|526084301|FG001|Overall Study|Disease Progression|89|||
145884792|NCT00988208|526084300|FG000|Overall Study|Withdrawal by Subject|50|||
145884793|NCT00988208|526084301|FG001|Overall Study|Withdrawal by Subject|57|||
145884794|NCT00988208|526084300|FG000|Overall Study|Death|9|||
145884795|NCT00988208|526084301|FG001|Overall Study|Death|15|||
145884796|NCT00988208|526084300|FG000|Overall Study|Lost to Follow-up|2|||
145884797|NCT00988208|526084301|FG001|Overall Study|Lost to Follow-up|3|||
145884798|NCT00988208|526084300|FG000|Overall Study|Protocol Violation|9|||
145884799|NCT00988208|526084301|FG001|Overall Study|Protocol Violation|2|||
145884800|NCT00988208|526084300|FG000|Overall Study|Sponsor Decision|102|||
145884801|NCT00988208|526084301|FG001|Overall Study|Sponsor Decision|78|||
145884802|NCT00988208|526084300|FG000|Overall Study|Clinical Progression|17|||
145884803|NCT00988208|526084301|FG001|Overall Study|Clinical Progression|16|||
145884804|NCT00988208|526084300|FG000|Overall Study|Biochemical Progression|21|||
145884805|NCT00988208|526084301|FG001|Overall Study|Biochemical Progression|7|||
146085754|NCT03828370|526835032|FG000|3 Month Follow-up|Lost to Follow-up|4|||
145884806|NCT00988208|526084300|FG000|Overall Study|Clinical Deterioration|7|||
145962141|NCT05616013|526373625|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146227497|NCT05069896|527348963|FG001|Overall Study|Lost to Follow-up|0|||
146227498|NCT05069896|527348964|FG002|Overall Study|Lost to Follow-up|1|||
146227499|NCT05069896|527348965|FG003|Overall Study|Lost to Follow-up|0|||
146227500|NCT05069896|527348966|FG004|Overall Study|Lost to Follow-up|1|||
145884807|NCT00988208|526084301|FG001|Overall Study|Clinical Deterioration|14|||
145884808|NCT00988208|526084300|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
145884809|NCT00988208|526084301|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
145884810|NCT00988208|526084300|FG000|Overall Study|Other|8|||
145884811|NCT00988208|526084301|FG001|Overall Study|Other|3|||
145884812|NCT01201759|526084304|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
145884813|NCT01201759|526084305|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
145884814|NCT01201759|526084304|FG000|Visit 3 - Washout|Adverse Event|0|||
146227501|NCT05069896|527348967|FG005|Overall Study|Lost to Follow-up|2|||
146227502|NCT04068831|527348968|FG000|Overall Study|Disease Progression|10|||
146227503|NCT04068831|527348969|FG001|Overall Study|Disease Progression|8|||
146227504|NCT02839265|527348971|FG000|Overall Study|Screen Failure|2|||
146227505|NCT02839265|527348971|FG000|Overall Study|Death|1|||
146227506|NCT02839265|527348971|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
145884815|NCT01201759|526084305|FG001|Visit 3 - Washout|Adverse Event|3|||
145884816|NCT01201759|526084304|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
145884817|NCT01201759|526084305|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
145884818|NCT01201759|526084304|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
145884819|NCT01201759|526084305|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
145884820|NCT00317642|526084306|FG000|Overall Study|Not Received Either Study Drug|1|||
145884821|NCT00317642|526084307|FG001|Overall Study|Not Received Either Study Drug|3|||
145884822|NCT00317642|526084306|FG000|Overall Study|Physician Decision|15|||
145884823|NCT00317642|526084307|FG001|Overall Study|Physician Decision|7|||
145884824|NCT00317642|526084306|FG000|Overall Study|Participant declined treatment|14|||
145884825|NCT00317642|526084307|FG001|Overall Study|Participant declined treatment|3|||
145884826|NCT00317642|526084306|FG000|Overall Study|Adverse Event|17|||
145884827|NCT00317642|526084307|FG001|Overall Study|Adverse Event|5|||
145884828|NCT00317642|526084306|FG000|Overall Study|Treatment Failure|56|||
145884829|NCT00317642|526084307|FG001|Overall Study|Treatment Failure|102|||
145884830|NCT00317642|526084306|FG000|Overall Study|Disease Recurrence|1|||
145884831|NCT00317642|526084307|FG001|Overall Study|Disease Recurrence|2|||
145884832|NCT00317642|526084306|FG000|Overall Study|Death|14|||
145884833|NCT00317642|526084307|FG001|Overall Study|Death|7|||
145884834|NCT00317642|526084306|FG000|Overall Study|Not Continue to Consolidation|2|||
145884835|NCT00317642|526084307|FG001|Overall Study|Not Continue to Consolidation|0|||
145884836|NCT00317642|526084306|FG000|Overall Study|Withdrawal by Subject|0|||
145884837|NCT00317642|526084307|FG001|Overall Study|Withdrawal by Subject|1|||
145884838|NCT00317642|526084306|FG000|Overall Study|Referred For Transplantation|1|||
145884839|NCT00317642|526084307|FG001|Overall Study|Referred For Transplantation|0|||
145884840|NCT00317642|526084306|FG000|Overall Study|AML Not Centrally Confirmed|1|||
145884841|NCT00317642|526084307|FG001|Overall Study|AML Not Centrally Confirmed|5|||
145884842|NCT02744755|526084308|FG000|Study Period 1|Protocol Violation|2|||
145884843|NCT02744755|526084309|FG001|Study Period 1|Protocol Violation|1|||
145884844|NCT02744755|526084308|FG000|Study Period 1|not defined|0|||
145884845|NCT02744755|526084309|FG001|Study Period 1|not defined|1|||
145884846|NCT02744755|526084308|FG000|Study Period 1|Pregnancy|1|||
145884847|NCT02744755|526084309|FG001|Study Period 1|Pregnancy|0|||
145884848|NCT02744755|526084308|FG000|Study Period 1|Adverse Event|1|||
145884849|NCT02744755|526084309|FG001|Study Period 1|Adverse Event|1|||
145884850|NCT02744755|526084308|FG000|Study Period 1|Lost to Follow-up|1|||
145884851|NCT02744755|526084309|FG001|Study Period 1|Lost to Follow-up|1|||
145884852|NCT02744755|526084308|FG000|Study Period 1|Lack of Efficacy|1|||
146227507|NCT04167553|527348974|FG000|Overall Study|Withdrawal by Subject|1|||
146227508|NCT04167553|527348975|FG001|Overall Study|Withdrawal by Subject|0|||
146227509|NCT04167553|527348976|FG002|Overall Study|Withdrawal by Subject|1|||
146227510|NCT04167553|527348977|FG003|Overall Study|Withdrawal by Subject|2|||
146227511|NCT04167553|527348978|FG004|Overall Study|Withdrawal by Subject|1|||
145884853|NCT02744755|526084309|FG001|Study Period 1|Lack of Efficacy|0|||
145884854|NCT02744755|526084308|FG000|Study Period 1|Withdrawal by Subject|8|||
145884855|NCT02744755|526084309|FG001|Study Period 1|Withdrawal by Subject|4|||
145884856|NCT02744755|526084308|FG000|Study Period 2|Adverse Event|5|||
145884857|NCT02744755|526084309|FG001|Study Period 2|Adverse Event|0|||
145884858|NCT02744755|526084308|FG000|Study Period 2|Protocol Violation|1|||
145884859|NCT02744755|526084309|FG001|Study Period 2|Protocol Violation|0|||
145884860|NCT02744755|526084308|FG000|Study Period 2|not defined|3|||
146227512|NCT04167553|527348979|FG005|Overall Study|Withdrawal by Subject|0|||
145884861|NCT02744755|526084309|FG001|Study Period 2|not defined|2|||
145884862|NCT02744755|526084308|FG000|Study Period 2|Lost to Follow-up|0|||
145884863|NCT02744755|526084309|FG001|Study Period 2|Lost to Follow-up|2|||
146085755|NCT03828370|526835033|FG001|3 Month Follow-up|Lost to Follow-up|12|||
146085756|NCT03828370|526835032|FG000|9 Month Follow up|Lost to Follow-up|12|||
146227513|NCT04167553|527348980|FG006|Overall Study|Withdrawal by Subject|0|||
146289072|NCT01127139|527573328|FG000|Overall Study|Incompliance|12|||
146289073|NCT01127139|527573328|FG000|Overall Study|Lack of Efficacy|4|||
146289074|NCT01127139|527573328|FG000|Overall Study|Reason not specified|1|||
146227514|NCT04167553|527348974|FG000|Overall Study|Physician Decision|0|||
146227515|NCT04167553|527348975|FG001|Overall Study|Physician Decision|0|||
146227516|NCT04167553|527348976|FG002|Overall Study|Physician Decision|0|||
146227517|NCT04167553|527348977|FG003|Overall Study|Physician Decision|0|||
146227518|NCT04167553|527348978|FG004|Overall Study|Physician Decision|2|||
146227519|NCT04167553|527348979|FG005|Overall Study|Physician Decision|2|||
146227520|NCT04167553|527348980|FG006|Overall Study|Physician Decision|0|||
146227521|NCT04167553|527348974|FG000|Overall Study|Lost to Follow-up|0|||
146227522|NCT04167553|527348975|FG001|Overall Study|Lost to Follow-up|0|||
145962142|NCT05616013|526373626|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
146227523|NCT04167553|527348976|FG002|Overall Study|Lost to Follow-up|2|||
146227524|NCT04167553|527348977|FG003|Overall Study|Lost to Follow-up|0|||
146227525|NCT04167553|527348978|FG004|Overall Study|Lost to Follow-up|0|||
146227526|NCT04167553|527348979|FG005|Overall Study|Lost to Follow-up|0|||
146289075|NCT01498653|527573330|FG000|Overall Study|Adverse Event|2|||
146085757|NCT03828370|526835033|FG001|9 Month Follow up|Lost to Follow-up|20|||
146227527|NCT04167553|527348980|FG006|Overall Study|Lost to Follow-up|0|||
146227528|NCT05660434|527348982|FG000|Overall Study|Never obtained study materials|2|||
146227529|NCT05660434|527348983|FG001|Overall Study|Never obtained study materials|1|||
146227530|NCT04479761|527348998|FG000|Overall Study|could not perform the balance tasks|1|||
146227531|NCT04479761|527348999|FG001|Overall Study|could not perform the balance tasks|0|||
146227532|NCT04479761|527349000|FG002|Overall Study|could not perform the balance tasks|0|||
146227533|NCT04479761|527348998|FG000|Overall Study|Adverse Event|1|||
146227534|NCT04479761|527348999|FG001|Overall Study|Adverse Event|0|||
146227535|NCT04479761|527349000|FG002|Overall Study|Adverse Event|0|||
146227536|NCT04479761|527348998|FG000|Overall Study|one control did not meet screening criteria|0|||
146227537|NCT04479761|527348999|FG001|Overall Study|one control did not meet screening criteria|0|||
146227538|NCT04479761|527349000|FG002|Overall Study|one control did not meet screening criteria|1|||
146227539|NCT04479761|527348998|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
146227540|NCT04479761|527348999|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
146227541|NCT04479761|527349000|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
146227542|NCT03106740|527350388|FG000|Overall Study|Lost to Follow-up|2|||
146227543|NCT03106740|527350389|FG001|Overall Study|Lost to Follow-up|2|||
146227544|NCT03106740|527350388|FG000|Overall Study|Withdrawal by Subject|2|||
146227545|NCT03106740|527350389|FG001|Overall Study|Withdrawal by Subject|4|||
146227546|NCT03106740|527350388|FG000|Overall Study|Physician Decision|0|||
146227547|NCT03106740|527350389|FG001|Overall Study|Physician Decision|1|||
146227548|NCT03106740|527350388|FG000|Overall Study|Partial data|1|||
146227549|NCT03106740|527350389|FG001|Overall Study|Partial data|0|||
146227550|NCT04565990|527350390|FG000|Overall Study|Death|5|||
146227551|NCT04565990|527350390|FG000|Overall Study|Lost to Follow-up|1|||
146227552|NCT04565990|527350390|FG000|Overall Study|Withdrawal by Subject|1|||
146227553|NCT04797858|527350391|FG000|Overall Study|Withdrawal by Subject|0|||
146227554|NCT04797858|527350392|FG001|Overall Study|Withdrawal by Subject|1|||
146227555|NCT04797858|527350391|FG000|Overall Study|Excluded due to administrative error|7|||
146227556|NCT04797858|527350392|FG001|Overall Study|Excluded due to administrative error|8|||
146227557|NCT03476343|527350411|FG000|Overall Study|Clinical exam moved to another scanner|7|||
146227558|NCT03476343|527350411|FG000|Overall Study|Clinical order cancelled|4|||
146227559|NCT03476343|527350411|FG000|Overall Study|Neonate did not settle down for the scan|1|||
146227560|NCT03442309|527350412|FG000|Overall Study|Lost to Follow-up|1676|||
146227561|NCT03442309|527350413|FG001|Overall Study|Lost to Follow-up|1642|||
146227562|NCT05290493|527350422|FG000|Overall Study|Withdrawal by Subject|2|||
146227563|NCT05290493|527350423|FG001|Overall Study|Withdrawal by Subject|2|||
146085758|NCT00290407|526835034|FG000|Overall Study|Physician Decision|2|||
146227564|NCT05290493|527350422|FG000|Overall Study|Adverse Event|1|||
146227565|NCT05290493|527350423|FG001|Overall Study|Adverse Event|0|||
146227566|NCT05012163|527350427|FG000|Overall Study|Protocol Violation|0|||
146227567|NCT05012163|527350428|FG001|Overall Study|Protocol Violation|0|||
146227568|NCT05012163|527350429|FG002|Overall Study|Protocol Violation|1|||
146227569|NCT05012163|527350430|FG003|Overall Study|Protocol Violation|1|||
146227570|NCT04003246|527350433|FG000|Overall Study|Death|9|||
146227571|NCT05524402|527350445|FG000|Overall Study|Withdrawal by Subject|3|||
146227572|NCT05524402|527350446|FG001|Overall Study|Withdrawal by Subject|1|||
146227573|NCT05524402|527350445|FG000|Overall Study|Lost to Follow-up|2|||
146227574|NCT05524402|527350446|FG001|Overall Study|Lost to Follow-up|1|||
146227575|NCT03381586|527350447|FG000|Overall Study|Adverse Event|1|||
146227576|NCT03381586|527350448|FG001|Overall Study|Adverse Event|1|||
146227577|NCT03381586|527350447|FG000|Overall Study|Protocol Violation|1|||
146227578|NCT03381586|527350448|FG001|Overall Study|Protocol Violation|0|||
146227579|NCT03381586|527350447|FG000|Overall Study|Withdrawal by Subject|1|||
146227580|NCT03381586|527350448|FG001|Overall Study|Withdrawal by Subject|2|||
146227581|NCT03673501|527350452|FG000|Overall Study|Participants ongoing.|36|||
146227582|NCT03673501|527350453|FG001|Overall Study|Participants ongoing.|24|||
146227583|NCT05237284|527350454|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
145884864|NCT02744755|526084308|FG000|Study Period 2|Withdrawal by Subject|2|||
145884865|NCT02744755|526084309|FG001|Study Period 2|Withdrawal by Subject|2|||
145884866|NCT02744755|526084308|FG000|Study Period 2|Lack of Efficacy|3|||
145884867|NCT02744755|526084309|FG001|Study Period 2|Lack of Efficacy|2|||
145884868|NCT02916693|526084310|FG000|Overall Study|Lost to Follow-up|7|||
145884869|NCT03180801|526084311|FG000|Overall Study|Physician Decision|3|||
145884870|NCT03180801|526084312|FG001|Overall Study|Physician Decision|3|||
145884871|NCT03180801|526084313|FG002|Overall Study|Physician Decision|1|||
146085759|NCT01933789|526835043|FG000|Overall Study|Death|0|||
146227584|NCT05237284|527350455|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
146227585|NCT05237284|527350456|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
146227586|NCT05237284|527350457|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
145884872|NCT03180801|526084311|FG000|Overall Study|Non-compliance|1|||
145884873|NCT03180801|526084312|FG001|Overall Study|Non-compliance|4|||
146085760|NCT01933789|526835044|FG001|Overall Study|Death|0|||
146289076|NCT01498653|527573331|FG001|Overall Study|Adverse Event|2|||
145884874|NCT03180801|526084313|FG002|Overall Study|Non-compliance|0|||
146085761|NCT01933789|526835045|FG002|Overall Study|Death|0|||
146085762|NCT01933789|526835046|FG003|Overall Study|Death|0|||
146085763|NCT01933789|526835047|FG004|Overall Study|Death|21|||
146085764|NCT01933789|526835048|FG005|Overall Study|Death|32|||
146085765|NCT01933789|526835049|FG006|Overall Study|Death|0|||
146085766|NCT01933789|526835050|FG007|Overall Study|Death|0|||
146085767|NCT01933789|526835051|FG008|Overall Study|Death|0|||
146085768|NCT01933789|526835043|FG000|Overall Study|Lost to Follow-up|0|||
146085769|NCT01933789|526835044|FG001|Overall Study|Lost to Follow-up|0|||
146085770|NCT01933789|526835045|FG002|Overall Study|Lost to Follow-up|0|||
146085771|NCT01933789|526835046|FG003|Overall Study|Lost to Follow-up|1|||
146085772|NCT01933789|526835047|FG004|Overall Study|Lost to Follow-up|8|||
146085773|NCT01933789|526835048|FG005|Overall Study|Lost to Follow-up|9|||
146085774|NCT01933789|526835049|FG006|Overall Study|Lost to Follow-up|1|||
146085775|NCT01933789|526835050|FG007|Overall Study|Lost to Follow-up|4|||
146085776|NCT01933789|526835051|FG008|Overall Study|Lost to Follow-up|0|||
146085777|NCT01933789|526835043|FG000|Overall Study|Withdrawal by Subject|2|||
146085778|NCT01933789|526835044|FG001|Overall Study|Withdrawal by Subject|1|||
146085779|NCT01933789|526835045|FG002|Overall Study|Withdrawal by Subject|0|||
146085780|NCT01933789|526835046|FG003|Overall Study|Withdrawal by Subject|0|||
146085781|NCT01933789|526835047|FG004|Overall Study|Withdrawal by Subject|17|||
146085782|NCT01933789|526835048|FG005|Overall Study|Withdrawal by Subject|16|||
146085783|NCT01933789|526835049|FG006|Overall Study|Withdrawal by Subject|1|||
146085784|NCT01933789|526835050|FG007|Overall Study|Withdrawal by Subject|4|||
146085785|NCT01933789|526835051|FG008|Overall Study|Withdrawal by Subject|0|||
146085786|NCT01933789|526835043|FG000|Overall Study|Became Ineligible|4|||
146085787|NCT01933789|526835044|FG001|Overall Study|Became Ineligible|0|||
146085788|NCT01933789|526835045|FG002|Overall Study|Became Ineligible|0|||
146085789|NCT01933789|526835046|FG003|Overall Study|Became Ineligible|0|||
146085790|NCT01933789|526835047|FG004|Overall Study|Became Ineligible|13|||
146085791|NCT01933789|526835048|FG005|Overall Study|Became Ineligible|10|||
146085792|NCT01933789|526835049|FG006|Overall Study|Became Ineligible|13|||
146085793|NCT01933789|526835050|FG007|Overall Study|Became Ineligible|6|||
146085794|NCT01933789|526835051|FG008|Overall Study|Became Ineligible|0|||
146085795|NCT01925989|526835054|FG000|Period 1|Sponsor Decision|1|||
146085796|NCT01925989|526835055|FG001|Period 1|Sponsor Decision|1|||
146085797|NCT01925989|526835056|FG002|Period 1|Sponsor Decision|0|||
146085798|NCT01925989|526835054|FG000|Period 1|Withdrawal by Subject|0|||
146085799|NCT01925989|526835055|FG001|Period 1|Withdrawal by Subject|1|||
146085800|NCT01925989|526835056|FG002|Period 1|Withdrawal by Subject|0|||
146085801|NCT00868517|526835057|FG000|Overall Study|Withdrawal by Subject|3|||
146085802|NCT00868517|526835058|FG001|Overall Study|Withdrawal by Subject|3|||
145884875|NCT03180801|526084311|FG000|Overall Study|Inoculation Target Reached|1|||
146085803|NCT00868517|526835059|FG002|Overall Study|Withdrawal by Subject|2|||
146085804|NCT00868517|526835057|FG000|Overall Study|Protocol Violation|1|||
146085805|NCT00868517|526835058|FG001|Overall Study|Protocol Violation|1|||
146085806|NCT00868517|526835059|FG002|Overall Study|Protocol Violation|0|||
146085807|NCT05442775|526835060|FG000|Overall Study|Trial terminated|61|||
146085808|NCT05442775|526835060|FG000|Overall Study|Lack of Efficacy|4|||
146085809|NCT05442775|526835060|FG000|Overall Study|Withdrawal by Subject|4|||
146085810|NCT05442775|526835060|FG000|Overall Study|Death|1|||
146085811|NCT05442775|526835060|FG000|Overall Study|Participant removed at Sponsor request|1|||
146085812|NCT02963831|526835062|FG000|Overall Study|Progressive Disease|3|||
145884876|NCT03180801|526084312|FG001|Overall Study|Inoculation Target Reached|1|||
145884877|NCT03180801|526084313|FG002|Overall Study|Inoculation Target Reached|3|||
145884878|NCT03180801|526084311|FG000|Overall Study|Adverse Event|1|||
145884879|NCT03180801|526084312|FG001|Overall Study|Adverse Event|0|||
145884880|NCT03180801|526084313|FG002|Overall Study|Adverse Event|2|||
145884881|NCT03180801|526084311|FG000|Overall Study|Withdrawal by Subject|2|||
145884882|NCT03180801|526084312|FG001|Overall Study|Withdrawal by Subject|2|||
145884883|NCT03180801|526084313|FG002|Overall Study|Withdrawal by Subject|1|||
145884884|NCT03180801|526084311|FG000|Overall Study|Lost to Follow-up|0|||
145884885|NCT03180801|526084312|FG001|Overall Study|Lost to Follow-up|2|||
145884886|NCT03180801|526084313|FG002|Overall Study|Lost to Follow-up|3|||
145884887|NCT04364737|526084315|FG000|Overall Study|Withdrawal by Subject|4|||
146085813|NCT02963831|526835063|FG001|Overall Study|Progressive Disease|3|||
146085814|NCT02963831|526835064|FG002|Overall Study|Progressive Disease|16|||
145884888|NCT04364737|526084316|FG001|Overall Study|Withdrawal by Subject|9|||
145884889|NCT04364737|526084315|FG000|Overall Study|Lost to Follow-up|1|||
145884890|NCT04364737|526084316|FG001|Overall Study|Lost to Follow-up|1|||
146085815|NCT02963831|526835065|FG003|Overall Study|Progressive Disease|27|||
146085816|NCT02963831|526835062|FG000|Overall Study|Withdrawal by Subject|1|||
146085817|NCT02963831|526835063|FG001|Overall Study|Withdrawal by Subject|0|||
146085818|NCT02963831|526835064|FG002|Overall Study|Withdrawal by Subject|2|||
146085819|NCT02963831|526835065|FG003|Overall Study|Withdrawal by Subject|4|||
146085820|NCT02963831|526835062|FG000|Overall Study|Adverse Event|0|||
146085821|NCT02963831|526835063|FG001|Overall Study|Adverse Event|1|||
146085822|NCT02963831|526835064|FG002|Overall Study|Adverse Event|1|||
146085823|NCT02963831|526835065|FG003|Overall Study|Adverse Event|2|||
146085824|NCT02963831|526835062|FG000|Overall Study|Death|0|||
146085825|NCT02963831|526835063|FG001|Overall Study|Death|0|||
146227587|NCT05237284|527350454|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
146227588|NCT05237284|527350455|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
146227589|NCT05237284|527350456|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
146227590|NCT05237284|527350457|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
146227591|NCT05237284|527350454|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146227592|NCT05237284|527350455|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
146227593|NCT05237284|527350456|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146227594|NCT05237284|527350457|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
146227595|NCT05237284|527350454|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
146227596|NCT05237284|527350455|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
146227597|NCT05237284|527350456|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
146227598|NCT05237284|527350457|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
146227599|NCT05237284|527350454|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
146227600|NCT05237284|527350455|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
146227601|NCT05237284|527350456|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
146227602|NCT05237284|527350457|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
146227603|NCT05237284|527350454|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
146227604|NCT05237284|527350455|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
146227605|NCT05237284|527350456|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
146227606|NCT05237284|527350457|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
146227607|NCT05237284|527350454|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
146227608|NCT05237284|527350455|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
146227609|NCT05237284|527350456|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
146227610|NCT05237284|527350457|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
146227611|NCT05237284|527350454|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146227612|NCT05237284|527350455|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146227613|NCT05237284|527350456|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
146227614|NCT05237284|527350457|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
146227615|NCT05237284|527350454|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
146227616|NCT05237284|527350455|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
146227617|NCT05237284|527350456|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
146227618|NCT05237284|527350457|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
146227619|NCT04599634|527350458|FG000|Overall Study|Dose limiting toxicity|0|||
146227620|NCT04599634|527350459|FG001|Overall Study|Dose limiting toxicity|0|||
146227621|NCT04599634|527350460|FG002|Overall Study|Dose limiting toxicity|2|||
146227622|NCT04599634|527350461|FG003|Overall Study|Dose limiting toxicity|0|||
146227623|NCT03714815|527350464|FG000|Overall Study|Physician Decision|2|||
146227624|NCT03714815|527350464|FG000|Overall Study|Withdrawal by Subject|2|||
146227625|NCT03714815|527350464|FG000|Overall Study|Death|11|||
146227626|NCT03733925|527350469|FG000|Overall Study|Lost to Follow-up|1|||
146085826|NCT02963831|526835064|FG002|Overall Study|Death|0|||
146085827|NCT02963831|526835065|FG003|Overall Study|Death|2|||
146085828|NCT01966432|526835066|FG000|Overall Study|Lost to Follow-up|3|||
146085829|NCT01966432|526835067|FG001|Overall Study|Lost to Follow-up|2|||
146227627|NCT03733925|527350469|FG000|Overall Study|Withdrawal by Subject|2|||
146227628|NCT03733925|527350469|FG000|Overall Study|Adverse Event|2|||
146227629|NCT03733925|527350469|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146227630|NCT03213873|527350470|FG000|Overall Study|Withdrawal by Subject|8|||
146227631|NCT03213873|527350471|FG001|Overall Study|Withdrawal by Subject|9|||
146227632|NCT03213873|527350470|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
146227633|NCT03213873|527350471|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
146227634|NCT03213873|527350470|FG000|Overall Study|Lost to Follow-up|0|||
146227635|NCT03213873|527350471|FG001|Overall Study|Lost to Follow-up|2|||
146227636|NCT04709419|527350478|FG000|Overall Study|Physician Decision|1|||
146227637|NCT04709419|527350479|FG001|Overall Study|Physician Decision|0|||
146227638|NCT05683340|527350480|FG000|Overall Study|Adverse Event|1|||
146227639|NCT05683340|527350481|FG001|Overall Study|Adverse Event|1|||
146227640|NCT05683340|527350480|FG000|Overall Study|Protocol Violation|1|||
146227641|NCT05683340|527350481|FG001|Overall Study|Protocol Violation|0|||
146227642|NCT05683340|527350480|FG000|Overall Study|Withdrawal by Subject|0|||
146227643|NCT05683340|527350481|FG001|Overall Study|Withdrawal by Subject|2|||
146227644|NCT02224144|527350482|FG000|Overall Study|Lost to Follow-up|3|||
146227645|NCT02224144|527350483|FG001|Overall Study|Lost to Follow-up|1|||
146227646|NCT02224144|527350482|FG000|Overall Study|Death|2|||
146227647|NCT02224144|527350483|FG001|Overall Study|Death|0|||
146227648|NCT02224144|527350482|FG000|Overall Study|Withdrawal by Subject|0|||
146227649|NCT02224144|527350483|FG001|Overall Study|Withdrawal by Subject|1|||
146227650|NCT03505008|527350484|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
146227651|NCT03505008|527350485|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
146227652|NCT03505008|527350486|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
146227653|NCT03505008|527350487|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
146227654|NCT03505008|527350484|FG000|Before Week 24 Randomization|Adverse Event|10|||
146227655|NCT03505008|527350485|FG001|Before Week 24 Randomization|Adverse Event|0|||
146227656|NCT03505008|527350486|FG002|Before Week 24 Randomization|Adverse Event|0|||
146227657|NCT03505008|527350487|FG003|Before Week 24 Randomization|Adverse Event|0|||
146227658|NCT03505008|527350484|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
146227659|NCT03505008|527350485|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
146227660|NCT03505008|527350486|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
146227661|NCT03505008|527350487|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
146227662|NCT03505008|527350484|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
146227663|NCT03505008|527350485|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146227664|NCT03505008|527350486|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146227665|NCT03505008|527350487|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
146227666|NCT03505008|527350484|FG000|Before Week 24 Randomization|Physician Decision|2|||
146227667|NCT03505008|527350485|FG001|Before Week 24 Randomization|Physician Decision|0|||
146227668|NCT03505008|527350486|FG002|Before Week 24 Randomization|Physician Decision|0|||
146227669|NCT03505008|527350487|FG003|Before Week 24 Randomization|Physician Decision|0|||
146227670|NCT03505008|527350484|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
146227671|NCT03505008|527350485|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
146227672|NCT03505008|527350486|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
146227673|NCT03505008|527350487|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
146227674|NCT03505008|527350484|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
146227675|NCT03505008|527350485|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146227676|NCT03505008|527350486|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146227677|NCT03505008|527350487|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
146227678|NCT03505008|527350484|FG000|Before Week 24 Randomization|Complication|1|||
146227679|NCT03505008|527350485|FG001|Before Week 24 Randomization|Complication|0|||
146227680|NCT03505008|527350486|FG002|Before Week 24 Randomization|Complication|0|||
146227681|NCT03505008|527350487|FG003|Before Week 24 Randomization|Complication|0|||
146227682|NCT03505008|527350484|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
146227683|NCT03505008|527350485|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
145884891|NCT01220609|526084317|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
145884892|NCT01220609|526084317|FG000|Overall Study|Ineligible- Wrong cell type|1|||
145884893|NCT01220609|526084317|FG000|Overall Study|Ineligible-Never treated|1|||
145884894|NCT00868296|526084320|FG000|Overall Study|Adverse Event|0|||
145884895|NCT00868296|526084321|FG001|Overall Study|Adverse Event|2|||
145884896|NCT00868296|526084320|FG000|Overall Study|Withdrawal by Subject|0|||
145884897|NCT00868296|526084321|FG001|Overall Study|Withdrawal by Subject|1|||
145884898|NCT00112294|526084322|FG000|Overall Study|Still on study|5|||
145884899|NCT00112294|526084323|FG001|Overall Study|Still on study|0|||
145884900|NCT00035555|526084324|FG000|Overall Study|Adverse Event|5|||
145884901|NCT00035555|526084325|FG001|Overall Study|Adverse Event|8|||
145884902|NCT00035555|526084326|FG002|Overall Study|Adverse Event|9|||
145884903|NCT00035555|526084324|FG000|Overall Study|Allograft loss|1|||
145884904|NCT00035555|526084325|FG001|Overall Study|Allograft loss|1|||
145884905|NCT00035555|526084326|FG002|Overall Study|Allograft loss|2|||
145884906|NCT00035555|526084324|FG000|Overall Study|Death|0|||
145884907|NCT00035555|526084325|FG001|Overall Study|Death|0|||
145884908|NCT00035555|526084326|FG002|Overall Study|Death|2|||
145884909|NCT00035555|526084324|FG000|Overall Study|Lost to Follow-up|0|||
145884910|NCT00035555|526084325|FG001|Overall Study|Lost to Follow-up|0|||
145884911|NCT00035555|526084326|FG002|Overall Study|Lost to Follow-up|1|||
145884912|NCT00035555|526084324|FG000|Overall Study|Noncompliance|0|||
145884913|NCT00035555|526084325|FG001|Overall Study|Noncompliance|1|||
145884914|NCT00035555|526084326|FG002|Overall Study|Noncompliance|1|||
145884915|NCT00035555|526084324|FG000|Overall Study|Prohibited medication|1|||
145884916|NCT00035555|526084325|FG001|Overall Study|Prohibited medication|1|||
145884917|NCT00035555|526084326|FG002|Overall Study|Prohibited medication|0|||
145884918|NCT00035555|526084324|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
145884919|NCT00035555|526084325|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
145884920|NCT00035555|526084326|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
145884921|NCT00035555|526084324|FG000|Overall Study|Withdrawal by Subject|2|||
145884922|NCT00035555|526084325|FG001|Overall Study|Withdrawal by Subject|0|||
145884923|NCT00035555|526084326|FG002|Overall Study|Withdrawal by Subject|2|||
145884924|NCT00035555|526084324|FG000|Overall Study|Investigator deemed not a good candidate|0|||
145884925|NCT00035555|526084325|FG001|Overall Study|Investigator deemed not a good candidate|0|||
145884926|NCT00035555|526084326|FG002|Overall Study|Investigator deemed not a good candidate|1|||
145884927|NCT00035555|526084324|FG000|Overall Study|Received cyclosporin in error|0|||
145884928|NCT00035555|526084325|FG001|Overall Study|Received cyclosporin in error|0|||
145884929|NCT00035555|526084326|FG002|Overall Study|Received cyclosporin in error|1|||
146227684|NCT03505008|527350486|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
146227685|NCT03505008|527350487|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
145884930|NCT02618382|526084327|FG000|Overall Study|Physician Decision|1|||
145884931|NCT02618382|526084327|FG000|Overall Study|Withdrawal by Subject|1|||
145884932|NCT02618382|526084327|FG000|Overall Study|Protocol Violation|1|||
145884933|NCT00605176|526084339|FG000|Overall Study|Adverse Event|2|||
145884934|NCT00605176|526084340|FG001|Overall Study|Adverse Event|1|||
145884935|NCT00605176|526084341|FG002|Overall Study|Adverse Event|3|||
145884936|NCT00605176|526084339|FG000|Overall Study|Withdrawal by Subject|4|||
145884937|NCT00605176|526084340|FG001|Overall Study|Withdrawal by Subject|2|||
145884938|NCT00605176|526084341|FG002|Overall Study|Withdrawal by Subject|4|||
145884939|NCT00605176|526084339|FG000|Overall Study|Lost to Follow-up|2|||
146227686|NCT03505008|527350484|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
146227687|NCT03505008|527350485|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
146227688|NCT03505008|527350486|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
146227689|NCT03505008|527350487|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
146227690|NCT03505008|527350484|FG000|After Week 24 Randomization|Adverse Event|0|||
146227691|NCT03505008|527350485|FG001|After Week 24 Randomization|Adverse Event|1|||
146227692|NCT03505008|527350486|FG002|After Week 24 Randomization|Adverse Event|2|||
146227693|NCT03505008|527350487|FG003|After Week 24 Randomization|Adverse Event|2|||
146227694|NCT03505008|527350484|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
146227695|NCT03505008|527350485|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
146227696|NCT03505008|527350486|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
146227697|NCT03505008|527350487|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
146227698|NCT03505008|527350484|FG000|After Week 24 Randomization|Protocol Violation|0|||
146227699|NCT03505008|527350485|FG001|After Week 24 Randomization|Protocol Violation|0|||
146227700|NCT03505008|527350486|FG002|After Week 24 Randomization|Protocol Violation|1|||
146227701|NCT03505008|527350487|FG003|After Week 24 Randomization|Protocol Violation|0|||
145884940|NCT00605176|526084340|FG001|Overall Study|Lost to Follow-up|2|||
145884941|NCT00605176|526084341|FG002|Overall Study|Lost to Follow-up|1|||
145884942|NCT00605176|526084339|FG000|Overall Study|Non-complicance with study procedures|1|||
146227702|NCT03276676|527350490|FG000|Overall Study|Withdrawal by Subject|2|||
146227703|NCT03276676|527350491|FG001|Overall Study|Withdrawal by Subject|1|||
146227704|NCT02962076|527350493|FG000|Overall Study|MHED tracer not available|5|||
146227705|NCT02962076|527350493|FG000|Overall Study|Protocol Violation|1|||
146227706|NCT02962076|527350493|FG000|Overall Study|Physician Decision|1|||
146227707|NCT03583333|527350494|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
146227708|NCT03583333|527350495|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
146227709|NCT03583333|527350494|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
146227710|NCT03583333|527350495|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
146227711|NCT03583333|527350494|FG000|Overall Study|Withdrawal by Subject|9|||
146227712|NCT03583333|527350495|FG001|Overall Study|Withdrawal by Subject|5|||
146227713|NCT03583333|527350494|FG000|Overall Study|Physician Decision|3|||
146227714|NCT03583333|527350495|FG001|Overall Study|Physician Decision|2|||
146227715|NCT03583333|527350494|FG000|Overall Study|Death|12|||
146227716|NCT03583333|527350495|FG001|Overall Study|Death|7|||
146227717|NCT03824366|527350503|FG000|Overall Study|Death|1|||
146227718|NCT03824366|527350503|FG000|Overall Study|Previously unidentified metal artifact|1|||
146227719|NCT03824366|527350503|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
146227720|NCT03824366|527350503|FG000|Overall Study|Withdrawal by Subject|1|||
146227721|NCT04544007|527350506|FG000|Overall Study|Withdrawal by Subject|1|||
146227722|NCT04544007|527350506|FG000|Overall Study|Confirmed Progressive Disease|1|||
146227723|NCT02988661|527350511|FG000|Overall Study|Death|2|||
146227724|NCT02988661|527350512|FG001|Overall Study|Death|18|||
146227725|NCT02988661|527350511|FG000|Overall Study|Lost to Follow-up|0|||
146227726|NCT02988661|527350512|FG001|Overall Study|Lost to Follow-up|33|||
146227727|NCT02988661|527350511|FG000|Overall Study|Withdrawal by Subject|0|||
146227728|NCT02988661|527350512|FG001|Overall Study|Withdrawal by Subject|6|||
146227729|NCT02988661|527350511|FG000|Overall Study|Unable to complete the 18-month survey|1|||
146227730|NCT02988661|527350512|FG001|Overall Study|Unable to complete the 18-month survey|27|||
146227731|NCT02323880|527350515|FG000|Overall Study|Adverse Event|2|||
146227732|NCT02323880|527350516|FG001|Overall Study|Adverse Event|0|||
146227733|NCT02323880|527350517|FG002|Overall Study|Adverse Event|1|||
146227734|NCT02323880|527350518|FG003|Overall Study|Adverse Event|1|||
146227735|NCT02323880|527350519|FG004|Overall Study|Adverse Event|1|||
146227736|NCT02323880|527350520|FG005|Overall Study|Adverse Event|0|||
146227737|NCT02323880|527350521|FG006|Overall Study|Adverse Event|1|||
146227738|NCT02323880|527350522|FG007|Overall Study|Adverse Event|0|||
146227739|NCT02323880|527350515|FG000|Overall Study|Death|0|||
146227740|NCT02323880|527350516|FG001|Overall Study|Death|0|||
146227741|NCT02323880|527350517|FG002|Overall Study|Death|0|||
146227742|NCT02323880|527350518|FG003|Overall Study|Death|0|||
146227743|NCT02323880|527350519|FG004|Overall Study|Death|0|||
146227744|NCT02323880|527350520|FG005|Overall Study|Death|1|||
146227745|NCT02323880|527350521|FG006|Overall Study|Death|0|||
146227746|NCT02323880|527350522|FG007|Overall Study|Death|0|||
146227747|NCT02323880|527350515|FG000|Overall Study|Lack of Efficacy|4|||
146227748|NCT02323880|527350516|FG001|Overall Study|Lack of Efficacy|11|||
146227749|NCT02323880|527350517|FG002|Overall Study|Lack of Efficacy|5|||
146227750|NCT02323880|527350518|FG003|Overall Study|Lack of Efficacy|5|||
146227751|NCT02323880|527350519|FG004|Overall Study|Lack of Efficacy|4|||
146227752|NCT02323880|527350520|FG005|Overall Study|Lack of Efficacy|8|||
146227753|NCT02323880|527350521|FG006|Overall Study|Lack of Efficacy|4|||
146227754|NCT02323880|527350522|FG007|Overall Study|Lack of Efficacy|6|||
146227755|NCT02323880|527350515|FG000|Overall Study|Physician Decision|0|||
146227756|NCT02323880|527350516|FG001|Overall Study|Physician Decision|0|||
146227757|NCT02323880|527350517|FG002|Overall Study|Physician Decision|0|||
145884943|NCT00605176|526084340|FG001|Overall Study|Non-complicance with study procedures|0|||
146227758|NCT02323880|527350518|FG003|Overall Study|Physician Decision|0|||
146227759|NCT02323880|527350519|FG004|Overall Study|Physician Decision|1|||
146227760|NCT02323880|527350520|FG005|Overall Study|Physician Decision|1|||
146227761|NCT02323880|527350521|FG006|Overall Study|Physician Decision|1|||
146227762|NCT02323880|527350522|FG007|Overall Study|Physician Decision|0|||
146227763|NCT02323880|527350515|FG000|Overall Study|Withdrawal by Subject|0|||
146227764|NCT02323880|527350516|FG001|Overall Study|Withdrawal by Subject|2|||
146227765|NCT02323880|527350517|FG002|Overall Study|Withdrawal by Subject|0|||
146227766|NCT02323880|527350518|FG003|Overall Study|Withdrawal by Subject|0|||
146227767|NCT02323880|527350519|FG004|Overall Study|Withdrawal by Subject|0|||
146227768|NCT02323880|527350520|FG005|Overall Study|Withdrawal by Subject|0|||
146227769|NCT02323880|527350521|FG006|Overall Study|Withdrawal by Subject|0|||
146085830|NCT01966432|526835068|FG002|Overall Study|Lost to Follow-up|5|||
146085831|NCT01966432|526835066|FG000|Overall Study|Withdrawal by Subject|1|||
146085832|NCT01966432|526835067|FG001|Overall Study|Withdrawal by Subject|3|||
146085833|NCT01966432|526835068|FG002|Overall Study|Withdrawal by Subject|0|||
146085834|NCT01966432|526835066|FG000|Overall Study|Subject Incarcerated|0|||
146085835|NCT01966432|526835067|FG001|Overall Study|Subject Incarcerated|0|||
146227770|NCT02323880|527350522|FG007|Overall Study|Withdrawal by Subject|0|||
146227771|NCT05736458|527350529|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
146227772|NCT05736458|527350530|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
146227773|NCT05736458|527350531|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
146227774|NCT05736458|527350529|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
146227775|NCT05736458|527350530|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
146227776|NCT05736458|527350531|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
146227777|NCT05736458|527350529|FG000|TMS/fMRI #1|Physician Decision|0|||
146227778|NCT05736458|527350530|FG001|TMS/fMRI #1|Physician Decision|0|||
146227779|NCT05736458|527350531|FG002|TMS/fMRI #1|Physician Decision|2|||
146227780|NCT05736458|527350529|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
146227781|NCT05736458|527350530|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
146227782|NCT05736458|527350531|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
146227783|NCT05100628|527350533|FG000|Overall Study|Progressive Disease|1|||
146227784|NCT05100628|527350534|FG001|Overall Study|Progressive Disease|0|||
146227785|NCT05100628|527350535|FG002|Overall Study|Progressive Disease|0|||
146227786|NCT05100628|527350536|FG003|Overall Study|Progressive Disease|0|||
146227787|NCT05100628|527350533|FG000|Overall Study|Study Terminated by Sponsor|0|||
146227788|NCT05100628|527350534|FG001|Overall Study|Study Terminated by Sponsor|0|||
146227789|NCT05100628|527350535|FG002|Overall Study|Study Terminated by Sponsor|3|||
146227790|NCT05100628|527350536|FG003|Overall Study|Study Terminated by Sponsor|0|||
146227791|NCT05100628|527350533|FG000|Overall Study|unkown|0|||
146227792|NCT05100628|527350534|FG001|Overall Study|unkown|1|||
146227793|NCT05100628|527350535|FG002|Overall Study|unkown|0|||
146227794|NCT05100628|527350536|FG003|Overall Study|unkown|0|||
146227795|NCT04230681|527350537|FG000|Overall Study|Physician Decision|2|||
146227796|NCT04230681|527350538|FG001|Overall Study|Physician Decision|3|||
146227797|NCT04230681|527350537|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
146227798|NCT04230681|527350538|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
146227799|NCT04230681|527350537|FG000|Overall Study|IV inadvertently removed|0|||
146227800|NCT04230681|527350538|FG001|Overall Study|IV inadvertently removed|1|||
146227801|NCT04414722|527351957|FG000|Overall Study|Lost to Follow-up|3|||
146227802|NCT04414722|527351958|FG001|Overall Study|Lost to Follow-up|4|||
146227803|NCT04414722|527351959|FG002|Overall Study|Lost to Follow-up|3|||
146227804|NCT04414722|527351960|FG003|Overall Study|Lost to Follow-up|2|||
146227805|NCT04414722|527351961|FG004|Overall Study|Lost to Follow-up|3|||
146227806|NCT04414722|527351957|FG000|Overall Study|Withdrawal by Subject|6|||
146227807|NCT04414722|527351958|FG001|Overall Study|Withdrawal by Subject|3|||
146227808|NCT04414722|527351959|FG002|Overall Study|Withdrawal by Subject|1|||
146227809|NCT04414722|527351960|FG003|Overall Study|Withdrawal by Subject|5|||
146227810|NCT04414722|527351961|FG004|Overall Study|Withdrawal by Subject|1|||
146227811|NCT04414722|527351957|FG000|Overall Study|Physician Decision|0|||
146227812|NCT04414722|527351958|FG001|Overall Study|Physician Decision|1|||
146227813|NCT04414722|527351959|FG002|Overall Study|Physician Decision|2|||
146227814|NCT04414722|527351960|FG003|Overall Study|Physician Decision|0|||
146227815|NCT04414722|527351961|FG004|Overall Study|Physician Decision|0|||
146227816|NCT04414722|527351957|FG000|Overall Study|Non-participatory|0|||
146227817|NCT04414722|527351958|FG001|Overall Study|Non-participatory|1|||
146227818|NCT04414722|527351959|FG002|Overall Study|Non-participatory|1|||
146227819|NCT04414722|527351960|FG003|Overall Study|Non-participatory|0|||
146227820|NCT04414722|527351961|FG004|Overall Study|Non-participatory|0|||
146227821|NCT04766892|527351963|FG000|Overall Study|Withdrawal by Subject|1|||
146227822|NCT04766892|527351963|FG000|Overall Study|Lost to Follow-up|1|||
146227823|NCT04766892|527351963|FG000|Overall Study|Adverse Event|3|||
146227824|NCT04766892|527351963|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
146227825|NCT05906784|527351964|FG000|Overall Study|Lost to Follow-up|2|||
146227826|NCT05906784|527351965|FG001|Overall Study|Lost to Follow-up|1|||
146227827|NCT05906784|527351966|FG002|Overall Study|Lost to Follow-up|1|||
146227828|NCT05906784|527351967|FG003|Overall Study|Lost to Follow-up|1|||
146227829|NCT02668692|527351968|FG000|Overall Study|Adverse Event|1|||
146227830|NCT02668692|527351969|FG001|Overall Study|Adverse Event|0|||
146227831|NCT05280574|527351974|FG000|Overall Study|Withdrawal by Subject|0|||
146227832|NCT05280574|527351975|FG001|Overall Study|Withdrawal by Subject|2|||
146227833|NCT05280574|527351976|FG002|Overall Study|Withdrawal by Subject|0|||
146227834|NCT05838027|527351979|FG000|Overall Study|Lost to Follow-up|5|||
146227835|NCT05838027|527351980|FG001|Overall Study|Lost to Follow-up|1|||
146227836|NCT05838027|527351979|FG000|Overall Study|Withdrawal by Subject|1|||
146227837|NCT05838027|527351980|FG001|Overall Study|Withdrawal by Subject|0|||
146289077|NCT01498653|527573330|FG000|Overall Study|Lack of Efficacy|12|||
146085836|NCT01966432|526835068|FG002|Overall Study|Subject Incarcerated|1|||
145884944|NCT00605176|526084341|FG002|Overall Study|Non-complicance with study procedures|0|||
145884945|NCT00605176|526084339|FG000|Overall Study|Use of concomitant therapy|1|||
145884946|NCT00605176|526084340|FG001|Overall Study|Use of concomitant therapy|0|||
145884947|NCT00605176|526084341|FG002|Overall Study|Use of concomitant therapy|1|||
145884948|NCT00605176|526084339|FG000|Overall Study|Other (not due to AE)|1|||
145884949|NCT00605176|526084340|FG001|Overall Study|Other (not due to AE)|1|||
145884950|NCT00605176|526084341|FG002|Overall Study|Other (not due to AE)|0|||
145884951|NCT01808248|526084342|FG000|Overall Study|Lack of Efficacy|3|||
145884952|NCT01808248|526084342|FG000|Overall Study|Withdrawal by Subject|1|||
145884953|NCT01808248|526084342|FG000|Overall Study|Lost to Follow-up|1|||
145884954|NCT03507686|526084343|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
145884955|NCT03507686|526084344|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
145884956|NCT03507686|526084343|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
145884957|NCT03507686|526084344|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
145884958|NCT03507686|526084343|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
145884959|NCT03507686|526084344|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
145884960|NCT03507686|526084343|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
145884961|NCT03507686|526084344|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
145884962|NCT03507686|526084343|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
145884963|NCT03507686|526084344|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
145884964|NCT03507686|526084343|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
145884965|NCT03507686|526084344|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
145884966|NCT00109850|526084347|FG000|Overall Study|Adverse Event|1|||
145884967|NCT00109850|526084347|FG000|Overall Study|Death|2|||
145884968|NCT00109850|526084347|FG000|Overall Study|Ineligible|1|||
145884969|NCT00476593|526084348|FG000|Overall Study|Lost to Follow-up|10|||
145884970|NCT00476593|526084349|FG001|Overall Study|Lost to Follow-up|2|||
145884971|NCT00476593|526084350|FG002|Overall Study|Lost to Follow-up|8|||
145884972|NCT00476593|526084351|FG003|Overall Study|Lost to Follow-up|22|||
145884973|NCT03635983|526084352|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
145884974|NCT03635983|526084353|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
145884975|NCT03635983|526084352|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145884976|NCT03635983|526084353|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145884977|NCT03635983|526084352|FG000|Pre-Treatment Period|Other reasons|0|||
145884978|NCT03635983|526084353|FG001|Pre-Treatment Period|Other reasons|1|||
145884979|NCT03635983|526084352|FG000|Pre-Treatment Period|Disease Progression|0|||
145884980|NCT03635983|526084353|FG001|Pre-Treatment Period|Disease Progression|1|||
145884981|NCT03635983|526084352|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
145884982|NCT03635983|526084353|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
145884983|NCT03635983|526084352|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
145884984|NCT03635983|526084353|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
145884985|NCT03635983|526084352|FG000|Treatment Period|Withdrawal by Subject|3|||
145884986|NCT03635983|526084353|FG001|Treatment Period|Withdrawal by Subject|5|||
145884987|NCT03635983|526084352|FG000|Treatment Period|Death|3|||
145884988|NCT03635983|526084353|FG001|Treatment Period|Death|5|||
145884989|NCT03635983|526084352|FG000|Treatment Period|Poor/Non-compliance|2|||
145884990|NCT03635983|526084353|FG001|Treatment Period|Poor/Non-compliance|1|||
145884991|NCT03635983|526084352|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
145884992|NCT03635983|526084353|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
145884993|NCT03635983|526084352|FG000|Treatment Period|Other reasons|7|||
145884994|NCT03635983|526084353|FG001|Treatment Period|Other reasons|4|||
145884995|NCT03635983|526084352|FG000|Treatment Period|Disease progression|230|||
145884996|NCT03635983|526084353|FG001|Treatment Period|Disease progression|201|||
145884997|NCT03635983|526084352|FG000|Treatment Period|Study drug toxicity|35|||
145884998|NCT03635983|526084353|FG001|Treatment Period|Study drug toxicity|36|||
145884999|NCT03635983|526084352|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
145885000|NCT03635983|526084353|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
145885001|NCT03635983|526084352|FG000|Treatment Period|Maximum clinical benefit|3|||
145885002|NCT03635983|526084353|FG001|Treatment Period|Maximum clinical benefit|5|||
145885003|NCT03635983|526084352|FG000|Treatment Period|Administrative reason by the sponsor|1|||
145885004|NCT03635983|526084353|FG001|Treatment Period|Administrative reason by the sponsor|2|||
145885005|NCT03635983|526084352|FG000|Treatment Period|Lost to Follow-up|0|||
145885006|NCT03635983|526084353|FG001|Treatment Period|Lost to Follow-up|1|||
145885007|NCT03430011|526084354|FG000|Pre-Treatment|Death|1|||
145885008|NCT03430011|526084355|FG001|Pre-Treatment|Death|0|||
145885009|NCT03430011|526084356|FG002|Pre-Treatment|Death|0|||
145885010|NCT03430011|526084357|FG003|Pre-Treatment|Death|0|||
145885011|NCT03430011|526084358|FG004|Pre-Treatment|Death|1|||
145885012|NCT03430011|526084359|FG005|Pre-Treatment|Death|0|||
145885013|NCT03430011|526084360|FG006|Pre-Treatment|Death|1|||
145885014|NCT03430011|526084361|FG007|Pre-Treatment|Death|0|||
145885015|NCT03430011|526084354|FG000|Pre-Treatment|Screen Fail|0|||
145885016|NCT03430011|526084355|FG001|Pre-Treatment|Screen Fail|0|||
145962143|NCT05616013|526373627|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145962144|NCT05616013|526373628|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145962145|NCT05616013|526373620|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962146|NCT05616013|526373621|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
145962147|NCT05616013|526373622|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962148|NCT05616013|526373623|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962149|NCT05616013|526373624|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962150|NCT05616013|526373625|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962151|NCT05616013|526373626|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962152|NCT05616013|526373627|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962153|NCT05616013|526373628|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145962154|NCT05616013|526373620|FG000|Overall Study|Participant Decision, Time Constraints|0|||
145962155|NCT05616013|526373621|FG001|Overall Study|Participant Decision, Time Constraints|1|||
145962156|NCT05616013|526373622|FG002|Overall Study|Participant Decision, Time Constraints|0|||
145962157|NCT05616013|526373623|FG003|Overall Study|Participant Decision, Time Constraints|0|||
145962158|NCT05616013|526373624|FG004|Overall Study|Participant Decision, Time Constraints|0|||
145962159|NCT05616013|526373625|FG005|Overall Study|Participant Decision, Time Constraints|0|||
145962160|NCT05616013|526373626|FG006|Overall Study|Participant Decision, Time Constraints|0|||
145962161|NCT05616013|526373627|FG007|Overall Study|Participant Decision, Time Constraints|0|||
145962162|NCT05616013|526373628|FG008|Overall Study|Participant Decision, Time Constraints|0|||
145962163|NCT05616013|526373620|FG000|Overall Study|Prohibited Concomitant Medication|0|||
145962164|NCT05616013|526373621|FG001|Overall Study|Prohibited Concomitant Medication|0|||
145962165|NCT05616013|526373622|FG002|Overall Study|Prohibited Concomitant Medication|1|||
145962166|NCT05616013|526373623|FG003|Overall Study|Prohibited Concomitant Medication|0|||
145962167|NCT05616013|526373624|FG004|Overall Study|Prohibited Concomitant Medication|0|||
145962168|NCT05616013|526373625|FG005|Overall Study|Prohibited Concomitant Medication|0|||
145962169|NCT05616013|526373626|FG006|Overall Study|Prohibited Concomitant Medication|0|||
145962170|NCT05616013|526373627|FG007|Overall Study|Prohibited Concomitant Medication|0|||
145962171|NCT05616013|526373628|FG008|Overall Study|Prohibited Concomitant Medication|0|||
145962172|NCT05616013|526373620|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962173|NCT05616013|526373621|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962174|NCT05616013|526373622|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
145962175|NCT05616013|526373623|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962176|NCT05616013|526373624|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
146227838|NCT02780700|527351981|FG000|Overall Study|Progressive disease|1|||
146227839|NCT03926130|527351982|FG000|Overall Study|Adverse Event|9|||
146227840|NCT03926130|527351983|FG001|Overall Study|Adverse Event|11|||
146227841|NCT03926130|527351984|FG002|Overall Study|Adverse Event|2|||
146227842|NCT03926130|527351985|FG003|Overall Study|Adverse Event|0|||
145885017|NCT03430011|526084356|FG002|Pre-Treatment|Screen Fail|0|||
145885018|NCT03430011|526084357|FG003|Pre-Treatment|Screen Fail|0|||
145885019|NCT03430011|526084358|FG004|Pre-Treatment|Screen Fail|1|||
145885020|NCT03430011|526084359|FG005|Pre-Treatment|Screen Fail|0|||
145885021|NCT03430011|526084360|FG006|Pre-Treatment|Screen Fail|0|||
145885022|NCT03430011|526084361|FG007|Pre-Treatment|Screen Fail|0|||
145885023|NCT03430011|526084354|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885024|NCT03430011|526084355|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885025|NCT03430011|526084356|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
145885026|NCT03430011|526084357|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885027|NCT03430011|526084358|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885028|NCT03430011|526084359|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885029|NCT03430011|526084360|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885030|NCT03430011|526084361|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
145885031|NCT03430011|526084354|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
145885032|NCT03430011|526084355|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
145885033|NCT03430011|526084356|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
145885034|NCT03430011|526084357|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
145885035|NCT03430011|526084358|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
145885036|NCT03430011|526084359|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
145962177|NCT05616013|526373625|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962178|NCT05616013|526373626|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962179|NCT05616013|526373627|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962180|NCT05616013|526373628|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
145962181|NCT05616013|526373620|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962182|NCT05616013|526373621|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962183|NCT05616013|526373622|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962184|NCT05616013|526373623|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
145962185|NCT05616013|526373624|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962186|NCT05616013|526373625|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962187|NCT05616013|526373626|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962188|NCT05616013|526373627|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962189|NCT05616013|526373628|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145962190|NCT05616013|526373620|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962191|NCT05616013|526373621|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962192|NCT05616013|526373622|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962193|NCT05616013|526373623|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962194|NCT05616013|526373624|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962195|NCT05616013|526373625|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962196|NCT05616013|526373626|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
145962197|NCT05616013|526373627|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962198|NCT05616013|526373628|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145962199|NCT05616013|526373620|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962200|NCT05616013|526373621|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962201|NCT05616013|526373622|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962202|NCT05616013|526373623|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962203|NCT05616013|526373624|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962204|NCT05616013|526373625|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962205|NCT05616013|526373626|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962206|NCT05616013|526373627|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145962207|NCT05616013|526373628|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
145962208|NCT05616013|526373620|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962209|NCT05616013|526373621|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962210|NCT05616013|526373622|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962211|NCT05616013|526373623|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962212|NCT05616013|526373624|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
145885037|NCT03430011|526084360|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
145885038|NCT03430011|526084361|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
145885039|NCT03430011|526084354|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
145885040|NCT03430011|526084355|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
145885041|NCT03430011|526084356|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
146227843|NCT03926130|527351982|FG000|Overall Study|Death|2|||
146227844|NCT03926130|527351983|FG001|Overall Study|Death|0|||
146227845|NCT03926130|527351984|FG002|Overall Study|Death|1|||
146227846|NCT03926130|527351985|FG003|Overall Study|Death|0|||
145962213|NCT05616013|526373625|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962214|NCT05616013|526373626|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962215|NCT05616013|526373627|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
145962216|NCT05616013|526373628|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
145962217|NCT05116202|526373629|FG000|Overall Study|Study Terminated by Sponsor|21|||
145962218|NCT05116202|526373630|FG001|Overall Study|Study Terminated by Sponsor|38|||
145962219|NCT05116202|526373631|FG002|Overall Study|Study Terminated by Sponsor|17|||
145962220|NCT05116202|526373632|FG003|Overall Study|Study Terminated by Sponsor|18|||
145962221|NCT05116202|526373633|FG004|Overall Study|Study Terminated by Sponsor|0|||
145962222|NCT05116202|526373629|FG000|Overall Study|Withdrawal by Subject|0|||
145962223|NCT05116202|526373630|FG001|Overall Study|Withdrawal by Subject|1|||
145962224|NCT05116202|526373631|FG002|Overall Study|Withdrawal by Subject|1|||
145962225|NCT05116202|526373632|FG003|Overall Study|Withdrawal by Subject|1|||
145962226|NCT05116202|526373633|FG004|Overall Study|Withdrawal by Subject|1|||
145962227|NCT05116202|526373629|FG000|Overall Study|Lost to Follow-up|0|||
145962228|NCT05116202|526373630|FG001|Overall Study|Lost to Follow-up|0|||
145962229|NCT05116202|526373631|FG002|Overall Study|Lost to Follow-up|0|||
145962230|NCT05116202|526373632|FG003|Overall Study|Lost to Follow-up|0|||
145962231|NCT05116202|526373633|FG004|Overall Study|Lost to Follow-up|2|||
145962232|NCT05116202|526373629|FG000|Overall Study|Death|1|||
145962233|NCT05116202|526373630|FG001|Overall Study|Death|1|||
145962234|NCT05116202|526373631|FG002|Overall Study|Death|2|||
145962235|NCT05116202|526373632|FG003|Overall Study|Death|1|||
145962236|NCT05116202|526373633|FG004|Overall Study|Death|5|||
145962237|NCT05067972|526373634|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
145962238|NCT05067972|526373635|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
145962239|NCT05067972|526373636|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
145962240|NCT05067972|526373637|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
145962241|NCT05067972|526373638|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
145962242|NCT05067972|526373639|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
145962243|NCT05067972|526373640|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
145962244|NCT05067972|526373634|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
145962245|NCT05067972|526373635|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
145962246|NCT05067972|526373636|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
145962247|NCT05067972|526373637|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
145962248|NCT05067972|526373638|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
145962249|NCT05067972|526373639|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
145962250|NCT05067972|526373640|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
145962251|NCT05067972|526373634|FG000|Part 1: Treatment|Progressive Disease|3|||
145962252|NCT05067972|526373635|FG001|Part 1: Treatment|Progressive Disease|3|||
145962253|NCT05067972|526373636|FG002|Part 1: Treatment|Progressive Disease|4|||
145962254|NCT05067972|526373637|FG003|Part 1: Treatment|Progressive Disease|2|||
145962255|NCT05067972|526373638|FG004|Part 1: Treatment|Progressive Disease|3|||
145962256|NCT05067972|526373639|FG005|Part 1: Treatment|Progressive Disease|0|||
145962257|NCT05067972|526373640|FG006|Part 1: Treatment|Progressive Disease|2|||
145962258|NCT05067972|526373634|FG000|Part 1: Treatment|Physician Decision|0|||
145962259|NCT05067972|526373635|FG001|Part 1: Treatment|Physician Decision|0|||
145962260|NCT05067972|526373636|FG002|Part 1: Treatment|Physician Decision|0|||
145962261|NCT05067972|526373637|FG003|Part 1: Treatment|Physician Decision|1|||
145962262|NCT05067972|526373638|FG004|Part 1: Treatment|Physician Decision|0|||
145962263|NCT05067972|526373639|FG005|Part 1: Treatment|Physician Decision|0|||
145962264|NCT05067972|526373640|FG006|Part 1: Treatment|Physician Decision|0|||
145962265|NCT05067972|526373634|FG000|Part 1: Treatment|Death|0|||
145962266|NCT05067972|526373635|FG001|Part 1: Treatment|Death|0|||
145962267|NCT05067972|526373636|FG002|Part 1: Treatment|Death|0|||
145962268|NCT05067972|526373637|FG003|Part 1: Treatment|Death|2|||
145962269|NCT05067972|526373638|FG004|Part 1: Treatment|Death|0|||
145962270|NCT05067972|526373639|FG005|Part 1: Treatment|Death|0|||
145962271|NCT05067972|526373640|FG006|Part 1: Treatment|Death|0|||
145962272|NCT05067972|526373634|FG000|Part 1: Treatment|Adverse Event|0|||
146227847|NCT03926130|527351982|FG000|Overall Study|Lack of Efficacy|14|||
146227848|NCT03926130|527351983|FG001|Overall Study|Lack of Efficacy|11|||
146227849|NCT03926130|527351984|FG002|Overall Study|Lack of Efficacy|7|||
146227850|NCT03926130|527351985|FG003|Overall Study|Lack of Efficacy|1|||
146227851|NCT03926130|527351982|FG000|Overall Study|Lost to Follow-up|0|||
146227852|NCT03926130|527351983|FG001|Overall Study|Lost to Follow-up|7|||
146227853|NCT03926130|527351984|FG002|Overall Study|Lost to Follow-up|1|||
146227854|NCT03926130|527351985|FG003|Overall Study|Lost to Follow-up|0|||
146227855|NCT03926130|527351982|FG000|Overall Study|As Reported by Investigator|2|||
146227856|NCT03926130|527351983|FG001|Overall Study|As Reported by Investigator|6|||
146227857|NCT03926130|527351984|FG002|Overall Study|As Reported by Investigator|6|||
146227858|NCT03926130|527351985|FG003|Overall Study|As Reported by Investigator|0|||
146227859|NCT03926130|527351982|FG000|Overall Study|Physician Decision|3|||
146227860|NCT03926130|527351983|FG001|Overall Study|Physician Decision|2|||
146227861|NCT03926130|527351984|FG002|Overall Study|Physician Decision|1|||
146227862|NCT03926130|527351985|FG003|Overall Study|Physician Decision|0|||
146227863|NCT03926130|527351982|FG000|Overall Study|Pregnancy|2|||
146227864|NCT03926130|527351983|FG001|Overall Study|Pregnancy|2|||
146227865|NCT03926130|527351984|FG002|Overall Study|Pregnancy|1|||
146227866|NCT03926130|527351985|FG003|Overall Study|Pregnancy|0|||
146227867|NCT03926130|527351982|FG000|Overall Study|Withdrawal by Subject|20|||
146227868|NCT03926130|527351983|FG001|Overall Study|Withdrawal by Subject|28|||
146227869|NCT03926130|527351984|FG002|Overall Study|Withdrawal by Subject|18|||
146227870|NCT03926130|527351985|FG003|Overall Study|Withdrawal by Subject|1|||
146227871|NCT03926130|527351982|FG000|Overall Study|Non-Compliance|1|||
146227872|NCT03926130|527351983|FG001|Overall Study|Non-Compliance|1|||
146227873|NCT03926130|527351984|FG002|Overall Study|Non-Compliance|0|||
146227874|NCT03926130|527351985|FG003|Overall Study|Non-Compliance|0|||
146227875|NCT03926130|527351982|FG000|Overall Study|Disposition Not Captured|0|||
146227876|NCT03926130|527351983|FG001|Overall Study|Disposition Not Captured|2|||
146227877|NCT03926130|527351984|FG002|Overall Study|Disposition Not Captured|1|||
146227878|NCT03926130|527351985|FG003|Overall Study|Disposition Not Captured|0|||
146227879|NCT03640286|527351995|FG000|Overall Study|Adverse Event|6|||
146227880|NCT03640286|527351996|FG001|Overall Study|Adverse Event|6|||
146227881|NCT03640286|527351995|FG000|Overall Study|Lost to Follow-up|3|||
146227882|NCT03640286|527351996|FG001|Overall Study|Lost to Follow-up|6|||
146227883|NCT03640286|527351995|FG000|Overall Study|Pregnancy|1|||
146227884|NCT03640286|527351996|FG001|Overall Study|Pregnancy|0|||
146227885|NCT03640286|527351995|FG000|Overall Study|Withdrawal by Subject|10|||
146227886|NCT03640286|527351996|FG001|Overall Study|Withdrawal by Subject|10|||
146227887|NCT03640286|527351995|FG000|Overall Study|Non-compliance|4|||
146227888|NCT03640286|527351996|FG001|Overall Study|Non-compliance|10|||
146227889|NCT03640286|527351995|FG000|Overall Study|Medication change|1|||
146227890|NCT03640286|527351996|FG001|Overall Study|Medication change|0|||
146227891|NCT03640286|527351995|FG000|Overall Study|Other|1|||
146227892|NCT03640286|527351996|FG001|Overall Study|Other|2|||
146227893|NCT03640286|527351995|FG000|Overall Study|Joined another lifestyle program|0|||
146227894|NCT03640286|527351996|FG001|Overall Study|Joined another lifestyle program|1|||
146227895|NCT03181516|527351998|FG000|Overall Study|Withdrawal by Subject|14|||
146227896|NCT03181516|527351999|FG001|Overall Study|Withdrawal by Subject|7|||
146227897|NCT03181516|527351998|FG000|Overall Study|Lost to Follow-up|2|||
146227898|NCT03181516|527351999|FG001|Overall Study|Lost to Follow-up|2|||
146227899|NCT04580914|527352002|FG000|Overall Study|Withdrawal by Subject|6|||
146227900|NCT04580914|527352002|FG000|Overall Study|Lost to Follow-up|2|||
146227901|NCT05715528|527352003|FG000|Overall Study|Randomized but never treated|11|||
146227902|NCT05715528|527352004|FG001|Overall Study|Randomized but never treated|13|||
146227903|NCT05715528|527352003|FG000|Overall Study|Withdrew consent|7|||
146227904|NCT05715528|527352004|FG001|Overall Study|Withdrew consent|15|||
146227905|NCT05715528|527352003|FG000|Overall Study|Lost to Follow-up|5|||
146227906|NCT05715528|527352004|FG001|Overall Study|Lost to Follow-up|13|||
146227907|NCT05715528|527352003|FG000|Overall Study|Investigator's discretion|3|||
146227908|NCT05715528|527352004|FG001|Overall Study|Investigator's discretion|1|||
146227909|NCT05715528|527352003|FG000|Overall Study|Protocol Violation|2|||
146227910|NCT05715528|527352004|FG001|Overall Study|Protocol Violation|0|||
146227911|NCT05715528|527352003|FG000|Overall Study|Non-compliance with study drug|0|||
146227912|NCT05715528|527352004|FG001|Overall Study|Non-compliance with study drug|1|||
146227913|NCT03118518|527352005|FG000|Overall Study|Early Exit after treatment|2|||
146227914|NCT03118518|527352006|FG001|Overall Study|Early Exit after treatment|8|||
146227915|NCT03118518|527352005|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
146227916|NCT03118518|527352006|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
146289078|NCT01498653|527573331|FG001|Overall Study|Lack of Efficacy|26|||
145885042|NCT03430011|526084357|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
145885043|NCT03430011|526084358|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
145885044|NCT03430011|526084359|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
145885045|NCT03430011|526084360|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
145885046|NCT03430011|526084361|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
145885047|NCT03430011|526084354|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
145885048|NCT03430011|526084355|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
145885049|NCT03430011|526084356|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
145885050|NCT03430011|526084357|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
145885051|NCT03430011|526084358|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
145885052|NCT03430011|526084359|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
145885053|NCT03430011|526084360|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
145885054|NCT03430011|526084361|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
145885055|NCT03430011|526084354|FG000|JCARH125 Treatment|Death|4|||
145885056|NCT03430011|526084355|FG001|JCARH125 Treatment|Death|19|||
145885057|NCT03430011|526084356|FG002|JCARH125 Treatment|Death|10|||
145885058|NCT03430011|526084357|FG003|JCARH125 Treatment|Death|8|||
145885059|NCT03430011|526084358|FG004|JCARH125 Treatment|Death|5|||
145885060|NCT03430011|526084359|FG005|JCARH125 Treatment|Death|3|||
145885061|NCT03430011|526084360|FG006|JCARH125 Treatment|Death|4|||
145885062|NCT03430011|526084361|FG007|JCARH125 Treatment|Death|2|||
145885063|NCT03430011|526084354|FG000|JCARH125 Treatment|Other reasons|1|||
145885064|NCT03430011|526084355|FG001|JCARH125 Treatment|Other reasons|0|||
145885065|NCT03430011|526084356|FG002|JCARH125 Treatment|Other reasons|4|||
145885066|NCT03430011|526084357|FG003|JCARH125 Treatment|Other reasons|2|||
145885067|NCT03430011|526084358|FG004|JCARH125 Treatment|Other reasons|2|||
145885068|NCT03430011|526084359|FG005|JCARH125 Treatment|Other reasons|1|||
145885069|NCT03430011|526084360|FG006|JCARH125 Treatment|Other reasons|3|||
145885070|NCT03430011|526084361|FG007|JCARH125 Treatment|Other reasons|2|||
145885071|NCT04126343|526084363|FG000|Overall Study|Adverse Event|0|||
145885072|NCT04126343|526084364|FG001|Overall Study|Adverse Event|0|||
145885073|NCT04126343|526084365|FG002|Overall Study|Adverse Event|0|||
145885074|NCT04126343|526084366|FG003|Overall Study|Adverse Event|0|||
145885075|NCT04126343|526084367|FG004|Overall Study|Adverse Event|0|||
145885076|NCT04126343|526084368|FG005|Overall Study|Adverse Event|1|||
145885077|NCT04126343|526084363|FG000|Overall Study|Withdrawal by Subject|0|||
145885078|NCT04126343|526084364|FG001|Overall Study|Withdrawal by Subject|0|||
145885079|NCT04126343|526084365|FG002|Overall Study|Withdrawal by Subject|0|||
145885080|NCT04126343|526084366|FG003|Overall Study|Withdrawal by Subject|1|||
146227917|NCT02998528|527352012|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
146227918|NCT02998528|527352013|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
146227919|NCT02998528|527352014|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
146227920|NCT02998528|527352012|FG000|Randomization Period|Participant withdrew consent|0|||
146227921|NCT02998528|527352013|FG001|Randomization Period|Participant withdrew consent|3|||
145885081|NCT04126343|526084367|FG004|Overall Study|Withdrawal by Subject|0|||
145885082|NCT04126343|526084368|FG005|Overall Study|Withdrawal by Subject|0|||
146227922|NCT02998528|527352014|FG002|Randomization Period|Participant withdrew consent|0|||
145885083|NCT04126343|526084363|FG000|Overall Study|Related to COVID-19 pandemic|3|||
145885084|NCT04126343|526084364|FG001|Overall Study|Related to COVID-19 pandemic|4|||
146227923|NCT02998528|527352012|FG000|Randomization Period|Participant no longer meets study criteria|1|||
145885085|NCT04126343|526084365|FG002|Overall Study|Related to COVID-19 pandemic|3|||
145885086|NCT04126343|526084366|FG003|Overall Study|Related to COVID-19 pandemic|3|||
145885087|NCT04126343|526084367|FG004|Overall Study|Related to COVID-19 pandemic|3|||
145885088|NCT04126343|526084368|FG005|Overall Study|Related to COVID-19 pandemic|3|||
145885089|NCT02941523|526084375|FG000|Monotherapy|Withdrawal by Subject|0|||
145885090|NCT02941523|526084376|FG001|Monotherapy|Withdrawal by Subject|1|||
145885091|NCT02941523|526084375|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
145885092|NCT02941523|526084376|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
145885093|NCT02941523|526084375|FG000|Carboplatin Combination Therapy|Death|1|||
145885094|NCT02941523|526084376|FG001|Carboplatin Combination Therapy|Death|2|||
145885095|NCT02941523|526084375|FG000|Carboplatin Combination Therapy|Disease progression|2|||
145885096|NCT02941523|526084376|FG001|Carboplatin Combination Therapy|Disease progression|0|||
145885097|NCT02941523|526084375|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
145885098|NCT02941523|526084376|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
145885099|NCT02539368|526084377|FG000|Overall Study|Death|4|||
145885100|NCT02539368|526084378|FG001|Overall Study|Death|2|||
145885101|NCT02539368|526084379|FG002|Overall Study|Death|1|||
145885102|NCT02539368|526084380|FG003|Overall Study|Death|0|||
145885103|NCT02539368|526084381|FG004|Overall Study|Death|0|||
145885104|NCT02539368|526084377|FG000|Overall Study|Withdrawal by Subject|44|||
145885105|NCT02539368|526084378|FG001|Overall Study|Withdrawal by Subject|35|||
145885106|NCT02539368|526084379|FG002|Overall Study|Withdrawal by Subject|9|||
145885107|NCT02539368|526084380|FG003|Overall Study|Withdrawal by Subject|1|||
145885108|NCT02539368|526084381|FG004|Overall Study|Withdrawal by Subject|3|||
145885109|NCT02539368|526084377|FG000|Overall Study|Physician Decision|49|||
145885110|NCT02539368|526084378|FG001|Overall Study|Physician Decision|15|||
145885111|NCT02539368|526084379|FG002|Overall Study|Physician Decision|7|||
145885112|NCT02539368|526084380|FG003|Overall Study|Physician Decision|0|||
145885113|NCT02539368|526084381|FG004|Overall Study|Physician Decision|2|||
145885114|NCT02539368|526084377|FG000|Overall Study|Lost to Follow-up|96|||
145885115|NCT02539368|526084378|FG001|Overall Study|Lost to Follow-up|21|||
145885116|NCT02539368|526084379|FG002|Overall Study|Lost to Follow-up|16|||
145885117|NCT02539368|526084380|FG003|Overall Study|Lost to Follow-up|4|||
145885118|NCT02539368|526084381|FG004|Overall Study|Lost to Follow-up|3|||
145885119|NCT02539368|526084377|FG000|Overall Study|Adverse Event|44|||
145885120|NCT02539368|526084378|FG001|Overall Study|Adverse Event|5|||
146227924|NCT02998528|527352013|FG001|Randomization Period|Participant no longer meets study criteria|3|||
146227925|NCT02998528|527352014|FG002|Randomization Period|Participant no longer meets study criteria|2|||
146227926|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
146227927|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
146227928|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
146227929|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
145885121|NCT02539368|526084379|FG002|Overall Study|Adverse Event|9|||
145885122|NCT02539368|526084380|FG003|Overall Study|Adverse Event|0|||
145885123|NCT02539368|526084381|FG004|Overall Study|Adverse Event|3|||
145885124|NCT02539368|526084377|FG000|Overall Study|Participant Non-compliant|13|||
145885125|NCT02539368|526084378|FG001|Overall Study|Participant Non-compliant|2|||
145885126|NCT02539368|526084379|FG002|Overall Study|Participant Non-compliant|1|||
145885127|NCT02539368|526084380|FG003|Overall Study|Participant Non-compliant|1|||
146227930|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
145885128|NCT02539368|526084381|FG004|Overall Study|Participant Non-compliant|0|||
145885129|NCT02539368|526084377|FG000|Overall Study|Other|145|||
145885130|NCT02539368|526084378|FG001|Overall Study|Other|18|||
145885131|NCT02539368|526084379|FG002|Overall Study|Other|24|||
145885132|NCT02539368|526084380|FG003|Overall Study|Other|1|||
145885133|NCT02539368|526084381|FG004|Overall Study|Other|3|||
146227931|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
146227932|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
146227933|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
146227934|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
146227935|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
146227936|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
146227937|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
146227938|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
146227939|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
146227940|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
146227941|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Death|1|||
146227942|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Death|0|||
146227943|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Death|0|||
146227944|NCT02998528|527352012|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
146227945|NCT02998528|527352013|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
146227946|NCT02998528|527352014|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
146227947|NCT02998528|527352012|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
146227948|NCT02998528|527352013|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
146227949|NCT02998528|527352014|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
146227950|NCT02998528|527352012|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
146227951|NCT02998528|527352013|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
146227952|NCT02998528|527352014|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
145885134|NCT02539368|526084377|FG000|Overall Study|Missing|10|||
145885135|NCT02539368|526084378|FG001|Overall Study|Missing|3|||
145885136|NCT02539368|526084379|FG002|Overall Study|Missing|0|||
146227953|NCT02998528|527352012|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
146227954|NCT02998528|527352013|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
146227955|NCT02998528|527352014|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
146227956|NCT02998528|527352012|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
146227957|NCT02998528|527352013|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
146227958|NCT02998528|527352014|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
146227959|NCT02998528|527352012|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
146227960|NCT02998528|527352013|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
145885137|NCT02539368|526084380|FG003|Overall Study|Missing|0|||
145885138|NCT02539368|526084381|FG004|Overall Study|Missing|0|||
145885139|NCT01020526|526084383|FG000|Overall Study|Withdrawal by Subject|5|||
146227961|NCT02998528|527352014|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
146227962|NCT03485729|527352017|FG000|Overall Study|Withdrawal by Subject|0|||
146227963|NCT03485729|527352018|FG001|Overall Study|Withdrawal by Subject|0|||
146227964|NCT03485729|527352019|FG002|Overall Study|Withdrawal by Subject|1|||
146227965|NCT03485729|527352017|FG000|Overall Study|Disease progression|8|||
146227966|NCT03485729|527352018|FG001|Overall Study|Disease progression|13|||
146227967|NCT03485729|527352019|FG002|Overall Study|Disease progression|1|||
146227968|NCT03485729|527352017|FG000|Overall Study|Hospice care|1|||
146227969|NCT03485729|527352018|FG001|Overall Study|Hospice care|0|||
146227970|NCT03485729|527352019|FG002|Overall Study|Hospice care|0|||
146227971|NCT03485729|527352017|FG000|Overall Study|Poor performance status|1|||
146227972|NCT03485729|527352018|FG001|Overall Study|Poor performance status|0|||
146227973|NCT03485729|527352019|FG002|Overall Study|Poor performance status|0|||
146227974|NCT03485729|527352017|FG000|Overall Study|Illness|0|||
146227975|NCT03485729|527352018|FG001|Overall Study|Illness|1|||
146227976|NCT03485729|527352019|FG002|Overall Study|Illness|0|||
146227977|NCT05035654|527352020|FG000|Overall Study|Physician Decision|0|||
146227978|NCT05035654|527352021|FG001|Overall Study|Physician Decision|1|||
146227979|NCT05035654|527352022|FG002|Overall Study|Physician Decision|0|||
146227980|NCT05035654|527352020|FG000|Overall Study|Adverse Event|0|||
146227981|NCT05035654|527352021|FG001|Overall Study|Adverse Event|1|||
146227982|NCT05035654|527352022|FG002|Overall Study|Adverse Event|0|||
146227983|NCT05035654|527352020|FG000|Overall Study|Withdrawal by Subject|0|||
146227984|NCT05035654|527352021|FG001|Overall Study|Withdrawal by Subject|0|||
146227985|NCT05035654|527352022|FG002|Overall Study|Withdrawal by Subject|4|||
146227986|NCT05035654|527352020|FG000|Overall Study|Bilateral Dislodgement|1|||
145885140|NCT01020526|526084383|FG000|Overall Study|Other reasons|3|||
145885141|NCT01020526|526084383|FG000|Overall Study|Insufficient clinical response|3|||
145885142|NCT01020526|526084383|FG000|Overall Study|Lost to Follow-up|1|||
145885143|NCT01020526|526084383|FG000|Overall Study|Adverse Event|2|||
145885144|NCT01899326|526084384|FG000|Overall Study|Withdrawal by Subject|1|||
145885145|NCT01899326|526084384|FG000|Overall Study|Adverse Event|2|||
145885146|NCT01899326|526084384|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
145885147|NCT00373425|526084386|FG000|Overall Study|Relapse of NSCLC|116|||
145885148|NCT00373425|526084387|FG001|Overall Study|Relapse of NSCLC|104|||
146227987|NCT05035654|527352021|FG001|Overall Study|Bilateral Dislodgement|0|||
146227988|NCT05035654|527352022|FG002|Overall Study|Bilateral Dislodgement|0|||
146227989|NCT05856435|527352026|FG000|Overall Study|Lost to Follow-up|6|||
146227990|NCT04934072|527352027|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
146227991|NCT04934072|527352028|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
146227992|NCT04934072|527352029|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
146227993|NCT04934072|527352030|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
146227994|NCT04934072|527352031|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
146227995|NCT04934072|527352027|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
145885149|NCT00373425|526084388|FG002|Overall Study|Relapse of NSCLC|19|||
145885150|NCT00373425|526084389|FG003|Overall Study|Relapse of NSCLC|2|||
145885151|NCT00373425|526084390|FG004|Overall Study|Relapse of NSCLC|26|||
145885152|NCT00373425|526084386|FG000|Overall Study|Adverse Event|191|||
145885153|NCT00373425|526084387|FG001|Overall Study|Adverse Event|22|||
145885154|NCT00373425|526084388|FG002|Overall Study|Adverse Event|59|||
145885155|NCT00373425|526084389|FG003|Overall Study|Adverse Event|0|||
145885156|NCT00373425|526084390|FG004|Overall Study|Adverse Event|34|||
146085837|NCT01966432|526835066|FG000|Overall Study|SBIRT program ended|1|||
146227996|NCT04934072|527352028|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
146289079|NCT01498653|527573330|FG000|Overall Study|Protocol Violation|0|||
146085838|NCT01966432|526835067|FG001|Overall Study|SBIRT program ended|8|||
146227997|NCT04934072|527352029|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146227998|NCT04934072|527352030|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146227999|NCT04934072|527352031|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
146228000|NCT04934072|527352027|FG000|Day 0 to Week 52|Other|3|||
146228001|NCT04934072|527352028|FG001|Day 0 to Week 52|Other|1|||
146228002|NCT04934072|527352029|FG002|Day 0 to Week 52|Other|0|||
145962273|NCT05067972|526373635|FG001|Part 1: Treatment|Adverse Event|0|||
145962274|NCT05067972|526373636|FG002|Part 1: Treatment|Adverse Event|0|||
145962275|NCT05067972|526373637|FG003|Part 1: Treatment|Adverse Event|0|||
145962276|NCT05067972|526373638|FG004|Part 1: Treatment|Adverse Event|0|||
145962277|NCT05067972|526373639|FG005|Part 1: Treatment|Adverse Event|2|||
145962278|NCT05067972|526373640|FG006|Part 1: Treatment|Adverse Event|1|||
145962279|NCT05067972|526373634|FG000|Part 1: Follow-up|Adverse Event|0|||
145962280|NCT05067972|526373635|FG001|Part 1: Follow-up|Adverse Event|0|||
145962281|NCT05067972|526373636|FG002|Part 1: Follow-up|Adverse Event|0|||
145962282|NCT05067972|526373637|FG003|Part 1: Follow-up|Adverse Event|0|||
145962283|NCT05067972|526373638|FG004|Part 1: Follow-up|Adverse Event|0|||
145962284|NCT05067972|526373639|FG005|Part 1: Follow-up|Adverse Event|1|||
145962285|NCT05067972|526373640|FG006|Part 1: Follow-up|Adverse Event|0|||
145962286|NCT05067972|526373634|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
145962287|NCT05067972|526373635|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
146228003|NCT04934072|527352030|FG003|Day 0 to Week 52|Other|0|||
146228004|NCT04934072|527352031|FG004|Day 0 to Week 52|Other|0|||
146228005|NCT04934072|527352027|FG000|Day 0 to Week 52|Adverse Event|1|||
146228006|NCT04934072|527352028|FG001|Day 0 to Week 52|Adverse Event|3|||
145962288|NCT05067972|526373636|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
146228007|NCT04934072|527352029|FG002|Day 0 to Week 52|Adverse Event|0|||
146228008|NCT04934072|527352030|FG003|Day 0 to Week 52|Adverse Event|0|||
146228009|NCT04934072|527352031|FG004|Day 0 to Week 52|Adverse Event|0|||
146228010|NCT04934072|527352027|FG000|Week 52 to Week 78|Adverse Event|0|||
146228011|NCT04934072|527352028|FG001|Week 52 to Week 78|Adverse Event|0|||
146228012|NCT04934072|527352029|FG002|Week 52 to Week 78|Adverse Event|0|||
146228013|NCT04934072|527352030|FG003|Week 52 to Week 78|Adverse Event|1|||
146228014|NCT04934072|527352031|FG004|Week 52 to Week 78|Adverse Event|1|||
146228015|NCT04934072|527352027|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
146228016|NCT04934072|527352028|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
146228017|NCT04934072|527352029|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
146228018|NCT04934072|527352030|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
146228019|NCT04934072|527352031|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
146228020|NCT04934072|527352027|FG000|Week 52 to Week 78|Other|0|||
146228021|NCT04934072|527352028|FG001|Week 52 to Week 78|Other|0|||
146228022|NCT04934072|527352029|FG002|Week 52 to Week 78|Other|1|||
146228023|NCT04934072|527352030|FG003|Week 52 to Week 78|Other|0|||
146228024|NCT04934072|527352031|FG004|Week 52 to Week 78|Other|0|||
146228025|NCT02828358|527352034|FG000|Overall Study|Physician Decision|7|||
146228026|NCT02828358|527352035|FG001|Overall Study|Physician Decision|1|||
146228027|NCT02828358|527352034|FG000|Overall Study|Treatment Failure|6|||
146228028|NCT02828358|527352035|FG001|Overall Study|Treatment Failure|0|||
146228029|NCT02828358|527352034|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
146228030|NCT02828358|527352035|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
146228031|NCT02828358|527352034|FG000|Overall Study|Refusal of further protocol therapy|2|||
146228032|NCT02828358|527352035|FG001|Overall Study|Refusal of further protocol therapy|0|||
146228033|NCT02828358|527352034|FG000|Overall Study|Relapse|25|||
146228034|NCT02828358|527352035|FG001|Overall Study|Relapse|0|||
146228035|NCT02828358|527352034|FG000|Overall Study|Still on therapy|5|||
146228036|NCT02828358|527352035|FG001|Overall Study|Still on therapy|0|||
146228037|NCT04218851|527352036|FG000|Overall Study|Death|1|||
146228038|NCT04218851|527352037|FG001|Overall Study|Death|3|||
146228039|NCT03174275|527352038|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
146228040|NCT03174275|527352038|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
146228041|NCT03174275|527352038|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
146228042|NCT03174275|527352038|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
146228043|NCT03174275|527352038|FG000|Adjuvant Chemotherapy|Progression|1|||
146228044|NCT03174275|527352038|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
146228045|NCT03174275|527352038|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
146228046|NCT03174275|527352038|FG000|Adjuvant Durvalumab|Progression|1|||
146228047|NCT03174275|527352038|FG000|Adjuvant Durvalumab|Adverse Event|3|||
146228048|NCT03174275|527352038|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
146228049|NCT03174275|527352038|FG000|Adjuvant Radiotherapy|Progression|1|||
146228050|NCT03174275|527352038|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
146228051|NCT02413489|527352039|FG000|Overall Study|Death|11|||
146228052|NCT02413489|527352040|FG001|Overall Study|Death|3|||
146228053|NCT02413489|527352041|FG002|Overall Study|Death|4|||
146228054|NCT02413489|527352039|FG000|Overall Study|Withdrawal by Subject|2|||
146228055|NCT02413489|527352040|FG001|Overall Study|Withdrawal by Subject|0|||
146228056|NCT02413489|527352041|FG002|Overall Study|Withdrawal by Subject|0|||
146228057|NCT02413489|527352039|FG000|Overall Study|Study Terminated By Sponsor|2|||
146228058|NCT02413489|527352040|FG001|Overall Study|Study Terminated By Sponsor|13|||
146228059|NCT02413489|527352041|FG002|Overall Study|Study Terminated By Sponsor|1|||
146228060|NCT05285137|527352042|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
146228061|NCT05285137|527352043|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146228062|NCT05285137|527352044|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
146228063|NCT05285137|527352045|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
146228064|NCT05285137|527352046|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
146228065|NCT05285137|527352047|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
146228066|NCT05285137|527352048|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
146228067|NCT05285137|527352049|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
146228068|NCT05285137|527352050|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
146228069|NCT05285137|527352042|FG000|Overall Study|Lost to Follow-up|0|||
146228070|NCT05285137|527352043|FG001|Overall Study|Lost to Follow-up|0|||
146228071|NCT05285137|527352044|FG002|Overall Study|Lost to Follow-up|1|||
146228072|NCT05285137|527352045|FG003|Overall Study|Lost to Follow-up|3|||
146228073|NCT05285137|527352046|FG004|Overall Study|Lost to Follow-up|0|||
146228074|NCT05285137|527352047|FG005|Overall Study|Lost to Follow-up|0|||
146228075|NCT05285137|527352048|FG006|Overall Study|Lost to Follow-up|1|||
146228076|NCT05285137|527352049|FG007|Overall Study|Lost to Follow-up|0|||
146228077|NCT05285137|527352050|FG008|Overall Study|Lost to Follow-up|0|||
146228078|NCT05285137|527352042|FG000|Overall Study|Physician Decision|0|||
146228079|NCT05285137|527352043|FG001|Overall Study|Physician Decision|1|||
146228080|NCT05285137|527352044|FG002|Overall Study|Physician Decision|0|||
146228081|NCT05285137|527352045|FG003|Overall Study|Physician Decision|0|||
146228082|NCT05285137|527352046|FG004|Overall Study|Physician Decision|0|||
146228083|NCT05285137|527352047|FG005|Overall Study|Physician Decision|0|||
146228084|NCT05285137|527352048|FG006|Overall Study|Physician Decision|0|||
146228085|NCT05285137|527352049|FG007|Overall Study|Physician Decision|0|||
146228086|NCT05285137|527352050|FG008|Overall Study|Physician Decision|0|||
146228087|NCT05285137|527352042|FG000|Overall Study|Pregnancy|0|||
146228088|NCT05285137|527352043|FG001|Overall Study|Pregnancy|0|||
146228089|NCT05285137|527352044|FG002|Overall Study|Pregnancy|0|||
146228090|NCT05285137|527352045|FG003|Overall Study|Pregnancy|0|||
146228091|NCT05285137|527352046|FG004|Overall Study|Pregnancy|0|||
146228092|NCT05285137|527352047|FG005|Overall Study|Pregnancy|0|||
146289080|NCT01498653|527573331|FG001|Overall Study|Protocol Violation|4|||
146289081|NCT01498653|527573330|FG000|Overall Study|Lost to Follow-up|1|||
146289082|NCT01498653|527573331|FG001|Overall Study|Lost to Follow-up|0|||
146289083|NCT01498653|527573330|FG000|Overall Study|Physician Decision|2|||
146289084|NCT01498653|527573331|FG001|Overall Study|Physician Decision|0|||
146289085|NCT01498653|527573330|FG000|Overall Study|Withdrawal by Subject|2|||
146289086|NCT01498653|527573331|FG001|Overall Study|Withdrawal by Subject|3|||
146289087|NCT00836095|527573337|FG000|Overall Study|Physician Decision|0|||
146289088|NCT00836095|527573338|FG001|Overall Study|Physician Decision|3|||
145962289|NCT05067972|526373637|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
146289089|NCT01602562|527573339|FG000|Overall Study|Adverse Event|3|||
146289090|NCT01602562|527573340|FG001|Overall Study|Adverse Event|1|||
146289091|NCT01602562|527573339|FG000|Overall Study|Physician Decision|1|||
146289092|NCT01602562|527573340|FG001|Overall Study|Physician Decision|1|||
146289093|NCT01602562|527573339|FG000|Overall Study|Withdrawal by Subject|1|||
146289094|NCT01602562|527573340|FG001|Overall Study|Withdrawal by Subject|1|||
146289095|NCT04964414|527573342|FG000|Overall Study|Lost to Follow-up|10|||
146289096|NCT04964414|527573343|FG001|Overall Study|Lost to Follow-up|8|||
146289097|NCT04964414|527573342|FG000|Overall Study|Withdrawal by Subject|1|||
146289098|NCT04964414|527573343|FG001|Overall Study|Withdrawal by Subject|1|||
146289099|NCT00819390|527573344|FG000|Overall Study|Lost to Follow-up|1|||
146289100|NCT00819390|527573345|FG001|Overall Study|Lost to Follow-up|1|||
146289101|NCT00819390|527573346|FG002|Overall Study|Lost to Follow-up|0|||
146289102|NCT00819390|527573347|FG003|Overall Study|Lost to Follow-up|0|||
146289103|NCT00819390|527573344|FG000|Overall Study|Withdrawal by Subject|2|||
146289104|NCT00819390|527573345|FG001|Overall Study|Withdrawal by Subject|0|||
146289105|NCT00819390|527573346|FG002|Overall Study|Withdrawal by Subject|0|||
146289106|NCT00819390|527573347|FG003|Overall Study|Withdrawal by Subject|0|||
146289107|NCT00819390|527573344|FG000|Overall Study|Adverse Event|0|||
145962290|NCT05067972|526373638|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
145962291|NCT05067972|526373639|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
145962292|NCT05067972|526373640|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
145962293|NCT05067972|526373634|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
146228093|NCT05285137|527352048|FG006|Overall Study|Pregnancy|1|||
146228094|NCT05285137|527352049|FG007|Overall Study|Pregnancy|0|||
146228095|NCT05285137|527352050|FG008|Overall Study|Pregnancy|0|||
146228096|NCT05285137|527352042|FG000|Overall Study|Withdrawal by Subject|0|||
146228097|NCT05285137|527352043|FG001|Overall Study|Withdrawal by Subject|1|||
146289108|NCT00819390|527573345|FG001|Overall Study|Adverse Event|0|||
146289109|NCT00819390|527573346|FG002|Overall Study|Adverse Event|1|||
146289110|NCT00819390|527573347|FG003|Overall Study|Adverse Event|0|||
146289111|NCT01191268|527573348|FG000|Overall Study|Withdrawal by Subject|19|||
146289112|NCT01191268|527573349|FG001|Overall Study|Withdrawal by Subject|25|||
146289113|NCT01191268|527573350|FG002|Overall Study|Withdrawal by Subject|21|||
146289114|NCT01191268|527573348|FG000|Overall Study|Adverse Event|21|||
146289115|NCT01191268|527573349|FG001|Overall Study|Adverse Event|13|||
146289116|NCT01191268|527573350|FG002|Overall Study|Adverse Event|8|||
146228098|NCT05285137|527352044|FG002|Overall Study|Withdrawal by Subject|2|||
146228099|NCT05285137|527352045|FG003|Overall Study|Withdrawal by Subject|1|||
146228100|NCT05285137|527352046|FG004|Overall Study|Withdrawal by Subject|0|||
146228101|NCT05285137|527352047|FG005|Overall Study|Withdrawal by Subject|0|||
146228102|NCT05285137|527352048|FG006|Overall Study|Withdrawal by Subject|0|||
146228103|NCT05285137|527352049|FG007|Overall Study|Withdrawal by Subject|0|||
146289117|NCT01191268|527573348|FG000|Overall Study|Physician Decision|6|||
146289118|NCT01191268|527573349|FG001|Overall Study|Physician Decision|8|||
145962294|NCT05067972|526373635|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145962295|NCT05067972|526373636|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145962296|NCT05067972|526373637|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145962297|NCT05067972|526373638|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145962298|NCT05067972|526373639|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
145962299|NCT05067972|526373640|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145962300|NCT05067972|526373634|FG000|Part 1: Follow-up|Physician Decision|0|||
145962301|NCT05067972|526373635|FG001|Part 1: Follow-up|Physician Decision|0|||
145962302|NCT05067972|526373636|FG002|Part 1: Follow-up|Physician Decision|0|||
145962303|NCT05067972|526373637|FG003|Part 1: Follow-up|Physician Decision|1|||
145962304|NCT05067972|526373638|FG004|Part 1: Follow-up|Physician Decision|0|||
145962305|NCT05067972|526373639|FG005|Part 1: Follow-up|Physician Decision|0|||
145962306|NCT05067972|526373640|FG006|Part 1: Follow-up|Physician Decision|0|||
145962307|NCT05067972|526373634|FG000|Part 1: Follow-up|Death|1|||
145962308|NCT05067972|526373635|FG001|Part 1: Follow-up|Death|2|||
145962309|NCT05067972|526373636|FG002|Part 1: Follow-up|Death|1|||
145962310|NCT05067972|526373637|FG003|Part 1: Follow-up|Death|0|||
145962311|NCT05067972|526373638|FG004|Part 1: Follow-up|Death|1|||
145962312|NCT05067972|526373639|FG005|Part 1: Follow-up|Death|0|||
145962313|NCT05067972|526373640|FG006|Part 1: Follow-up|Death|1|||
145962314|NCT04391842|526373641|FG000|Overall Study|Withdrawal by Subject|2|||
145962315|NCT00810199|526373642|FG000|Overall Study|Adverse Event|24|||
145962316|NCT00810199|526373643|FG001|Overall Study|Adverse Event|26|||
145962317|NCT00810199|526373642|FG000|Overall Study|Death|4|||
145962318|NCT00810199|526373643|FG001|Overall Study|Death|6|||
145962319|NCT00810199|526373642|FG000|Overall Study|Withdrew consent|9|||
145962320|NCT00810199|526373643|FG001|Overall Study|Withdrew consent|12|||
145962321|NCT00810199|526373642|FG000|Overall Study|Insufficient therapeutic response|5|||
145962322|NCT00810199|526373643|FG001|Overall Study|Insufficient therapeutic response|14|||
145962323|NCT00810199|526373642|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
145962324|NCT00810199|526373643|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
145962325|NCT00810199|526373642|FG000|Overall Study|Administrative/Other|5|||
145962326|NCT00810199|526373643|FG001|Overall Study|Administrative/Other|6|||
145962327|NCT00810199|526373642|FG000|Overall Study|Protocol Violation|2|||
145962328|NCT00810199|526373643|FG001|Overall Study|Protocol Violation|6|||
145962329|NCT00810199|526373642|FG000|Overall Study|Failure to return|1|||
145962330|NCT00810199|526373643|FG001|Overall Study|Failure to return|4|||
145962331|NCT00810199|526373642|FG000|Overall Study|Did not receive study drug|2|||
145962332|NCT00810199|526373643|FG001|Overall Study|Did not receive study drug|1|||
146289119|NCT01191268|527573350|FG002|Overall Study|Physician Decision|9|||
146289120|NCT01191268|527573348|FG000|Overall Study|Lost to Follow-up|8|||
146289121|NCT01191268|527573349|FG001|Overall Study|Lost to Follow-up|5|||
146289122|NCT01191268|527573350|FG002|Overall Study|Lost to Follow-up|9|||
146289123|NCT01191268|527573348|FG000|Overall Study|Entry Criteria Not Met|3|||
146289124|NCT01191268|527573349|FG001|Overall Study|Entry Criteria Not Met|1|||
146289125|NCT01191268|527573350|FG002|Overall Study|Entry Criteria Not Met|1|||
146289126|NCT01191268|527573348|FG000|Overall Study|Death|0|||
146289127|NCT01191268|527573349|FG001|Overall Study|Death|1|||
146289128|NCT01191268|527573350|FG002|Overall Study|Death|3|||
146289129|NCT01191268|527573348|FG000|Overall Study|Protocol Violation|1|||
146289130|NCT01191268|527573349|FG001|Overall Study|Protocol Violation|0|||
146289131|NCT01191268|527573350|FG002|Overall Study|Protocol Violation|1|||
146289132|NCT01191268|527573348|FG000|Overall Study|Sponsor Decision|0|||
146289133|NCT01191268|527573349|FG001|Overall Study|Sponsor Decision|2|||
146289134|NCT01191268|527573350|FG002|Overall Study|Sponsor Decision|0|||
146289135|NCT03333837|527573355|FG000|Overall Study|Adverse Event|2|||
146289136|NCT03333837|527573356|FG001|Overall Study|Adverse Event|1|||
146289137|NCT03333837|527573357|FG002|Overall Study|Adverse Event|1|||
146289138|NCT03333837|527573358|FG003|Overall Study|Adverse Event|1|||
146289139|NCT03333837|527573359|FG004|Overall Study|Adverse Event|0|||
146289140|NCT03333837|527573355|FG000|Overall Study|Caregiver withdrew|0|||
146228104|NCT05285137|527352050|FG008|Overall Study|Withdrawal by Subject|1|||
145885157|NCT00373425|526084386|FG000|Overall Study|Patient request|35|||
146228105|NCT03717935|527352051|FG000|Overall Study|Withdrawal by Subject|0|||
146228106|NCT03717935|527352052|FG001|Overall Study|Withdrawal by Subject|2|||
146228107|NCT01820611|527352057|FG000|Overall Study|Death|8|||
146228108|NCT01820611|527352057|FG000|Overall Study|Adverse Event|1|||
146228109|NCT01820611|527352057|FG000|Overall Study|Withdrawal by Subject|9|||
146228110|NCT05970861|527352058|FG000|Overall Study|Physician Decision|4|||
146228111|NCT05970861|527352059|FG001|Overall Study|Physician Decision|4|||
146228112|NCT05970861|527352058|FG000|Overall Study|Lost to Follow-up|4|||
145885158|NCT00373425|526084387|FG001|Overall Study|Patient request|18|||
145885159|NCT00373425|526084388|FG002|Overall Study|Patient request|43|||
145885160|NCT00373425|526084389|FG003|Overall Study|Patient request|6|||
145885161|NCT00373425|526084390|FG004|Overall Study|Patient request|7|||
146289141|NCT03333837|527573356|FG001|Overall Study|Caregiver withdrew|2|||
146289142|NCT03333837|527573357|FG002|Overall Study|Caregiver withdrew|1|||
146289143|NCT03333837|527573358|FG003|Overall Study|Caregiver withdrew|0|||
145962333|NCT00992017|526373645|FG000|Overall Study|Lost to Follow-up|2|||
146228113|NCT05970861|527352059|FG001|Overall Study|Lost to Follow-up|3|||
146228114|NCT04456296|527352060|FG000|Overall Study|Withdrawal by Subject|14|||
146289144|NCT03333837|527573359|FG004|Overall Study|Caregiver withdrew|0|||
146289145|NCT03333837|527573355|FG000|Overall Study|Withdrawal by Subject|0|||
146289146|NCT03333837|527573356|FG001|Overall Study|Withdrawal by Subject|0|||
145885162|NCT00373425|526084386|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
145885163|NCT00373425|526084387|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
145885164|NCT00373425|526084388|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
145885165|NCT00373425|526084389|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
145885166|NCT00373425|526084390|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
145885167|NCT00373425|526084386|FG000|Overall Study|Death|7|||
145885168|NCT00373425|526084387|FG001|Overall Study|Death|0|||
145885169|NCT00373425|526084388|FG002|Overall Study|Death|3|||
145885170|NCT00373425|526084389|FG003|Overall Study|Death|1|||
145885171|NCT00373425|526084390|FG004|Overall Study|Death|0|||
145885172|NCT03558139|526084391|FG000|Overall Study|Consent Withdrawn|1|||
145885173|NCT03558139|526084392|FG001|Overall Study|Consent Withdrawn|1|||
145885174|NCT03558139|526084393|FG002|Overall Study|Consent Withdrawn|4|||
145885175|NCT03558139|526084391|FG000|Overall Study|Death|5|||
145885176|NCT03558139|526084392|FG001|Overall Study|Death|3|||
145885177|NCT03558139|526084393|FG002|Overall Study|Death|8|||
145885178|NCT03558139|526084391|FG000|Overall Study|Lost to Follow-up|0|||
145885179|NCT03558139|526084392|FG001|Overall Study|Lost to Follow-up|0|||
145885180|NCT03558139|526084393|FG002|Overall Study|Lost to Follow-up|3|||
145885181|NCT03558139|526084391|FG000|Overall Study|Study Ended Per Protocol|0|||
145885182|NCT03558139|526084392|FG001|Overall Study|Study Ended Per Protocol|3|||
145962334|NCT00992017|526373645|FG000|Overall Study|Withdrawal by Subject|2|||
145962335|NCT00992017|526373645|FG000|Overall Study|Unable to get to clinic|5|||
145962336|NCT00992017|526373645|FG000|Overall Study|Not adhere to study requirements|1|||
145962337|NCT02864407|526373646|FG000|Overall Study|Protocol Violation|3|||
145962338|NCT02864407|526373646|FG000|Overall Study|Lost to Follow-up|115|||
145962339|NCT02864407|526373646|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
145962340|NCT02864407|526373646|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
145962341|NCT02864407|526373646|FG000|Overall Study|Consent prior to the contract date|1|||
145962342|NCT02287038|526373656|FG000|Overall Study|Stopped attending appointments|3|||
145962343|NCT02287038|526373657|FG001|Overall Study|Stopped attending appointments|2|||
145962344|NCT02287038|526373656|FG000|Overall Study|Anxiety after starting medication|0|||
145962345|NCT02287038|526373657|FG001|Overall Study|Anxiety after starting medication|1|||
145962346|NCT02287038|526373656|FG000|Overall Study|Nausea after starting medication|1|||
145962347|NCT02287038|526373657|FG001|Overall Study|Nausea after starting medication|0|||
145962348|NCT02287038|526373656|FG000|Overall Study|Abnormal ECG after starting medication|1|||
145962349|NCT02287038|526373657|FG001|Overall Study|Abnormal ECG after starting medication|0|||
145885183|NCT03558139|526084393|FG002|Overall Study|Study Ended Per Protocol|6|||
145885184|NCT00551616|526084396|FG000|Overall Study|Lost to Follow-up|48|||
145885185|NCT00551616|526084397|FG001|Overall Study|Lost to Follow-up|40|||
146228115|NCT04456296|527352061|FG001|Overall Study|Withdrawal by Subject|21|||
146228116|NCT04456296|527352062|FG002|Overall Study|Withdrawal by Subject|21|||
146228117|NCT04456296|527352060|FG000|Overall Study|Adverse Event|2|||
146228118|NCT04456296|527352061|FG001|Overall Study|Adverse Event|2|||
146228119|NCT04456296|527352062|FG002|Overall Study|Adverse Event|2|||
146228120|NCT04456296|527352060|FG000|Overall Study|Death|1|||
146228121|NCT04456296|527352061|FG001|Overall Study|Death|0|||
146228122|NCT04456296|527352062|FG002|Overall Study|Death|0|||
146228123|NCT04456296|527352060|FG000|Overall Study|Lost to Follow-up|3|||
146228124|NCT04456296|527352061|FG001|Overall Study|Lost to Follow-up|5|||
146228125|NCT04456296|527352062|FG002|Overall Study|Lost to Follow-up|6|||
146228126|NCT04456296|527352060|FG000|Overall Study|Other than specified|0|||
146228127|NCT04456296|527352061|FG001|Overall Study|Other than specified|1|||
146228128|NCT04456296|527352062|FG002|Overall Study|Other than specified|4|||
146228129|NCT04456296|527352060|FG000|Overall Study|Randomized, not treated|2|||
146228130|NCT04456296|527352061|FG001|Overall Study|Randomized, not treated|1|||
146228131|NCT04456296|527352062|FG002|Overall Study|Randomized, not treated|0|||
146228132|NCT01199133|527352069|FG000|Year 1|Adverse Event|16|||
146228133|NCT01199133|527352070|FG001|Year 1|Adverse Event|4|||
146228134|NCT01199133|527352069|FG000|Year 1|Withdrawal by Subject|8|||
146228135|NCT01199133|527352070|FG001|Year 1|Withdrawal by Subject|4|||
146228136|NCT01199133|527352069|FG000|Year 1|Any other reason not above-mentioned|6|||
146228137|NCT01199133|527352070|FG001|Year 1|Any other reason not above-mentioned|7|||
146228138|NCT01199133|527352069|FG000|Year 2|Adverse Event|1|||
146228139|NCT01199133|527352070|FG001|Year 2|Adverse Event|0|||
146228140|NCT01199133|527352069|FG000|Year 2|Withdrawal by Subject|1|||
146228141|NCT01199133|527352070|FG001|Year 2|Withdrawal by Subject|1|||
146228142|NCT01199133|527352069|FG000|Year 2|Any other reason not above-mentioned|1|||
146228143|NCT01199133|527352070|FG001|Year 2|Any other reason not above-mentioned|2|||
146228144|NCT01447719|527352073|FG000|Overall Study|Image acquisition failure|2|||
146228145|NCT01447719|527352073|FG000|Overall Study|Invalid image or not imaged|3|||
146228146|NCT01447719|527352073|FG000|Overall Study|Subject still living at end of study|79|||
146228147|NCT01447719|527352073|FG000|Overall Study|Withdrawal by Subject|2|||
146228148|NCT01447719|527352073|FG000|Overall Study|Family withdrew autopsy consent|7|||
146228149|NCT02575950|527352076|FG000|Overall Study|Withdrawal by Subject|0|||
146228150|NCT02575950|527352077|FG001|Overall Study|Withdrawal by Subject|0|||
146228151|NCT02575950|527352078|FG002|Overall Study|Withdrawal by Subject|0|||
146228152|NCT02575950|527352079|FG003|Overall Study|Withdrawal by Subject|2|||
146228153|NCT02575950|527352076|FG000|Overall Study|Lost to Follow-up|0|||
146228154|NCT02575950|527352077|FG001|Overall Study|Lost to Follow-up|1|||
145962350|NCT05502302|526373665|FG000|Overall Study|Lost to Follow-up|6|||
145962351|NCT05502302|526373665|FG000|Overall Study|Death|2|||
146228155|NCT02575950|527352078|FG002|Overall Study|Lost to Follow-up|0|||
146228156|NCT02575950|527352079|FG003|Overall Study|Lost to Follow-up|3|||
145962352|NCT02155985|526373677|FG000|Overall Study|Withdrawal by Subject|0|||
145962353|NCT02155985|526373678|FG001|Overall Study|Withdrawal by Subject|0|||
145962354|NCT02155985|526373679|FG002|Overall Study|Withdrawal by Subject|1|||
145962355|NCT02155985|526373677|FG000|Overall Study|Lost to Follow-up|1|||
145962356|NCT02155985|526373678|FG001|Overall Study|Lost to Follow-up|0|||
145962357|NCT02155985|526373679|FG002|Overall Study|Lost to Follow-up|0|||
145962358|NCT02573259|526373680|FG000|Overall Study|Death|1|||
145962359|NCT02573259|526373681|FG001|Overall Study|Death|6|||
145962360|NCT02573259|526373682|FG002|Overall Study|Death|5|||
145962361|NCT02573259|526373683|FG003|Overall Study|Death|6|||
145962362|NCT02573259|526373684|FG004|Overall Study|Death|9|||
145962363|NCT02573259|526373685|FG005|Overall Study|Death|32|||
145962364|NCT02573259|526373686|FG006|Overall Study|Death|21|||
145962365|NCT02573259|526373680|FG000|Overall Study|Lost to Follow-up|0|||
145962366|NCT02573259|526373681|FG001|Overall Study|Lost to Follow-up|0|||
145962367|NCT02573259|526373682|FG002|Overall Study|Lost to Follow-up|0|||
145962368|NCT02573259|526373683|FG003|Overall Study|Lost to Follow-up|0|||
145962369|NCT02573259|526373684|FG004|Overall Study|Lost to Follow-up|0|||
145962370|NCT02573259|526373685|FG005|Overall Study|Lost to Follow-up|2|||
145962371|NCT02573259|526373686|FG006|Overall Study|Lost to Follow-up|1|||
145962372|NCT02573259|526373680|FG000|Overall Study|Participant refused further follow-up|0|||
145962373|NCT02573259|526373681|FG001|Overall Study|Participant refused further follow-up|2|||
145962374|NCT02573259|526373682|FG002|Overall Study|Participant refused further follow-up|1|||
145962375|NCT02573259|526373683|FG003|Overall Study|Participant refused further follow-up|0|||
145962376|NCT02573259|526373684|FG004|Overall Study|Participant refused further follow-up|3|||
145962377|NCT02573259|526373685|FG005|Overall Study|Participant refused further follow-up|20|||
145962378|NCT02573259|526373686|FG006|Overall Study|Participant refused further follow-up|7|||
145962379|NCT02573259|526373680|FG000|Overall Study|Other|0|||
145962380|NCT02573259|526373681|FG001|Overall Study|Other|0|||
145962381|NCT02573259|526373682|FG002|Overall Study|Other|0|||
145962382|NCT02573259|526373683|FG003|Overall Study|Other|0|||
145962383|NCT02573259|526373684|FG004|Overall Study|Other|1|||
145962384|NCT02573259|526373685|FG005|Overall Study|Other|4|||
145962385|NCT02573259|526373686|FG006|Overall Study|Other|5|||
145962386|NCT00751140|526373687|FG000|Overall Study|benign angioma excluded from analysis|1|||
145962387|NCT02667301|526373688|FG000|Overall Study|Adverse Event|1|||
145962388|NCT02667301|526373688|FG000|Overall Study|Lack of Efficacy|1|||
145962389|NCT01883895|526373692|FG000|Overall Study|Lost to Follow-up|2|||
145962390|NCT02895295|526373693|FG000|Overall Study|Survey Non-response|71|||
145962391|NCT02895295|526373694|FG001|Overall Study|Survey Non-response|94|||
145962392|NCT02895295|526373695|FG002|Overall Study|Survey Non-response|92|||
145962393|NCT04414787|526373700|FG000|Overall Study|Patient Death|18|||
145962394|NCT04414787|526373701|FG001|Overall Study|Patient Death|18|||
145962395|NCT04414787|526373702|FG002|Overall Study|Patient Death|15|||
145962396|NCT04414787|526373703|FG003|Overall Study|Patient Death|15|||
145962397|NCT04414787|526373700|FG000|Overall Study|Patient Hospitalization|1|||
145962398|NCT04414787|526373701|FG001|Overall Study|Patient Hospitalization|1|||
145962399|NCT04414787|526373702|FG002|Overall Study|Patient Hospitalization|2|||
145962400|NCT04414787|526373703|FG003|Overall Study|Patient Hospitalization|2|||
145962401|NCT04414787|526373700|FG000|Overall Study|Lost to Follow-up|7|||
145962402|NCT04414787|526373701|FG001|Overall Study|Lost to Follow-up|7|||
145962403|NCT04414787|526373702|FG002|Overall Study|Lost to Follow-up|5|||
145962404|NCT04414787|526373703|FG003|Overall Study|Lost to Follow-up|5|||
145962405|NCT04414787|526373700|FG000|Overall Study|Residence in post-acute care facility|3|||
145962406|NCT04414787|526373701|FG001|Overall Study|Residence in post-acute care facility|3|||
145962407|NCT04414787|526373702|FG002|Overall Study|Residence in post-acute care facility|5|||
145962408|NCT04414787|526373703|FG003|Overall Study|Residence in post-acute care facility|5|||
145962409|NCT00490919|526373704|FG000|Open-label Run-in Period|Adverse Event|239|||
145962410|NCT00490919|526373705|FG001|Open-label Run-in Period|Adverse Event|0|||
145962411|NCT00490919|526373706|FG002|Open-label Run-in Period|Adverse Event|0|||
145962412|NCT00490919|526373704|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
145962413|NCT00490919|526373705|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
145962414|NCT00490919|526373706|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
145962415|NCT00490919|526373704|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
145962416|NCT00490919|526373705|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
145962417|NCT00490919|526373706|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
145962418|NCT00490919|526373704|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
145962419|NCT00490919|526373705|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
145962420|NCT00490919|526373706|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
145962421|NCT00490919|526373704|FG000|Open-label Run-in Period|Administrative|40|||
145962422|NCT00490919|526373705|FG001|Open-label Run-in Period|Administrative|0|||
145962423|NCT00490919|526373706|FG002|Open-label Run-in Period|Administrative|0|||
145962424|NCT00490919|526373704|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
145962425|NCT00490919|526373705|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
145962426|NCT00490919|526373706|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
145962427|NCT00490919|526373704|FG000|Double-blind Phase|Adverse Event|0|||
146289147|NCT03333837|527573357|FG002|Overall Study|Withdrawal by Subject|1|||
146289148|NCT03333837|527573358|FG003|Overall Study|Withdrawal by Subject|1|||
146289149|NCT03333837|527573359|FG004|Overall Study|Withdrawal by Subject|3|||
146289150|NCT03333837|527573355|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146289151|NCT03333837|527573356|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146289152|NCT03333837|527573357|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
146289153|NCT03333837|527573358|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146289154|NCT03333837|527573359|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
146289155|NCT00705523|527573360|FG000|Overall Study|Lost to Follow-up|2|||
146289156|NCT00705523|527573361|FG001|Overall Study|Lost to Follow-up|3|||
146289157|NCT01013285|527573363|FG000|Overall Study|Death|48|||
146289158|NCT01013285|527573364|FG001|Overall Study|Death|89|||
145885186|NCT02752802|526084398|FG000|Overall Study|Contrast Volume Not Collected|1|||
146085839|NCT01966432|526835068|FG002|Overall Study|SBIRT program ended|20|||
146085840|NCT02815280|526835075|FG000|Double-Blind Phase|Adverse Event|1|||
146085841|NCT02815280|526835076|FG001|Double-Blind Phase|Adverse Event|1|||
146085842|NCT02815280|526835075|FG000|Double-Blind Phase|Lost to Follow-up|10|||
145885187|NCT02752802|526084399|FG001|Overall Study|Contrast Volume Not Collected|0|||
145885188|NCT00569777|526084400|FG000|Overall Study|Withdrawal by Subject|4|||
145885189|NCT00569777|526084401|FG001|Overall Study|Withdrawal by Subject|0|||
146228157|NCT04271046|527352080|FG000|Overall Study|Death|0|||
146228158|NCT04271046|527352081|FG001|Overall Study|Death|2|||
146228159|NCT04271046|527352082|FG002|Overall Study|Death|0|||
146228160|NCT04271046|527352083|FG003|Overall Study|Death|2|||
146228161|NCT04271046|527352080|FG000|Overall Study|Lost to Follow-up|12|||
146228162|NCT04271046|527352081|FG001|Overall Study|Lost to Follow-up|12|||
146228163|NCT04271046|527352082|FG002|Overall Study|Lost to Follow-up|11|||
146228164|NCT04271046|527352083|FG003|Overall Study|Lost to Follow-up|11|||
146228165|NCT04271046|527352080|FG000|Overall Study|Patient with Dementia Died|2|||
146228166|NCT04271046|527352081|FG001|Overall Study|Patient with Dementia Died|0|||
146228167|NCT04271046|527352082|FG002|Overall Study|Patient with Dementia Died|2|||
146228168|NCT04271046|527352083|FG003|Overall Study|Patient with Dementia Died|0|||
146228169|NCT04271046|527352080|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
146228170|NCT04271046|527352081|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
146228171|NCT04271046|527352082|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
146228172|NCT04271046|527352083|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
146235074|NCT00622700|527378450|FG003|Extension Treatment Period|Lack of Efficacy|2|||
146085843|NCT02815280|526835076|FG001|Double-Blind Phase|Lost to Follow-up|9|||
146085844|NCT02815280|526835075|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
146085845|NCT02815280|526835076|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
146235075|NCT00622700|527378451|FG004|Extension Treatment Period|Lack of Efficacy|8|||
146235076|NCT00622700|527378452|FG005|Extension Treatment Period|Lack of Efficacy|1|||
146235077|NCT00622700|527378453|FG006|Extension Treatment Period|Lack of Efficacy|9|||
146235078|NCT00622700|527378447|FG000|Extension Treatment Period|Protocol Violation|0|||
146235079|NCT00622700|527378448|FG001|Extension Treatment Period|Protocol Violation|0|||
146289159|NCT02112708|527573376|FG000|Baseline|Physician Decision|16|||
146085846|NCT02815280|526835075|FG000|Double-Blind Phase|Protocol Violation|2|||
146228173|NCT05976334|527353196|FG000|Part B|Death|0|||
146228174|NCT05976334|527353197|FG001|Part B|Death|1|||
146228175|NCT05976334|527353196|FG000|Part B|Study Terminated by Sponsor|0|||
146228176|NCT05976334|527353197|FG001|Part B|Study Terminated by Sponsor|1|||
146228177|NCT05976334|527353196|FG000|Part B|Reason Not Specified|0|||
146228178|NCT05976334|527353197|FG001|Part B|Reason Not Specified|1|||
146228179|NCT05363163|527353198|FG000|Overall Study|Withdrawal by Subject|13|||
146228180|NCT01314105|527353202|FG000|Overall Study|Progressive Disease|6|||
146228181|NCT01314105|527353203|FG001|Overall Study|Progressive Disease|10|||
146228182|NCT01314105|527353202|FG000|Overall Study|Refused to continue taking medication|0|||
146228183|NCT01314105|527353203|FG001|Overall Study|Refused to continue taking medication|1|||
146228184|NCT01314105|527353202|FG000|Overall Study|Other Adverse Event|1|||
146228185|NCT01314105|527353203|FG001|Overall Study|Other Adverse Event|1|||
146228186|NCT04526886|527353204|FG000|Overall Study|Physician Decision|4|||
146289160|NCT02112708|527573377|FG001|Baseline|Physician Decision|11|||
146289161|NCT02112708|527573376|FG000|Baseline|Lost to Follow-up|12|||
146289162|NCT02112708|527573377|FG001|Baseline|Lost to Follow-up|0|||
146289163|NCT02112708|527573376|FG000|4 Month|Death|0|||
146289164|NCT02112708|527573377|FG001|4 Month|Death|1|||
146289165|NCT02112708|527573376|FG000|4 Month|Withdrawal by Subject|12|||
146085847|NCT02815280|526835076|FG001|Double-Blind Phase|Protocol Violation|2|||
146289166|NCT02112708|527573377|FG001|4 Month|Withdrawal by Subject|0|||
146289167|NCT03866473|527573378|FG000|Phase 1|Death|1|||
146289168|NCT03866473|527573379|FG001|Phase 1|Death|0|||
146289169|NCT03866473|527573378|FG000|Phase 2|Death|0|||
146289170|NCT03866473|527573379|FG001|Phase 2|Death|2|||
146289171|NCT03866473|527573378|FG000|Phase 2|Dropped|1|||
146289172|NCT03866473|527573379|FG001|Phase 2|Dropped|1|||
146289173|NCT03866473|527573378|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
146289174|NCT03866473|527573379|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
146289175|NCT04948333|527573383|FG000|Overall Study|Adverse Event|6|||
146289176|NCT04948333|527573384|FG001|Overall Study|Adverse Event|4|||
146289177|NCT04948333|527573385|FG002|Overall Study|Adverse Event|0|||
146289178|NCT04948333|527573386|FG003|Overall Study|Adverse Event|2|||
146289179|NCT04948333|527573383|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146289180|NCT04948333|527573384|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146085848|NCT02815280|526835075|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
146228187|NCT04820322|527353214|FG000|Overall Study|Adverse Event|1|||
146228188|NCT04820322|527353215|FG001|Overall Study|Adverse Event|0|||
146228189|NCT03156465|527353216|FG000|Overall Study|Withdrawal by Subject|2|||
146228190|NCT04880733|527353217|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
146228191|NCT04880733|527353218|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
146228192|NCT04880733|527353219|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
146228193|NCT04880733|527353217|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
146228194|NCT04880733|527353218|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
146228195|NCT04880733|527353219|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
146228196|NCT04880733|527353217|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
146289181|NCT04948333|527573385|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146289182|NCT04948333|527573386|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146289183|NCT04948333|527573383|FG000|Overall Study|Progressive Disease|1|||
146289184|NCT04948333|527573384|FG001|Overall Study|Progressive Disease|5|||
145885190|NCT00569777|526084400|FG000|Overall Study|Adverse Event|3|||
145885191|NCT00569777|526084401|FG001|Overall Study|Adverse Event|0|||
145885192|NCT00569777|526084400|FG000|Overall Study|Lost to Follow-up|1|||
145885193|NCT00569777|526084401|FG001|Overall Study|Lost to Follow-up|0|||
145885194|NCT00569777|526084400|FG000|Overall Study|scheduled eye surgery|0|||
145885195|NCT00569777|526084401|FG001|Overall Study|scheduled eye surgery|1|||
146085849|NCT02815280|526835076|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
145885196|NCT00569777|526084400|FG000|Overall Study|did not meet exclusion criteria|1|||
146085850|NCT02815280|526835075|FG000|Open-Label Phase|Adverse Event|2|||
146085851|NCT02815280|526835076|FG001|Open-Label Phase|Adverse Event|3|||
146085852|NCT02815280|526835075|FG000|Open-Label Phase|Lost to Follow-up|18|||
146085853|NCT02815280|526835076|FG001|Open-Label Phase|Lost to Follow-up|9|||
146085854|NCT02815280|526835075|FG000|Open-Label Phase|Withdrawal by Subject|33|||
146085855|NCT02815280|526835076|FG001|Open-Label Phase|Withdrawal by Subject|18|||
146085856|NCT02815280|526835075|FG000|Open-Label Phase|Protocol Violation|3|||
146085857|NCT02815280|526835076|FG001|Open-Label Phase|Protocol Violation|0|||
146085858|NCT02815280|526835075|FG000|Open-Label Phase|Administrative|26|||
146085859|NCT02815280|526835076|FG001|Open-Label Phase|Administrative|12|||
146085860|NCT02815280|526835075|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
146085861|NCT02815280|526835076|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
146085862|NCT02106923|526835088|FG000|Overall Study|Protocol Violation|0|||
146085863|NCT02106923|526835089|FG001|Overall Study|Protocol Violation|0|||
146085864|NCT02106923|526835090|FG002|Overall Study|Protocol Violation|0|||
146228197|NCT04880733|527353218|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
146228198|NCT04880733|527353219|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
146228199|NCT04880733|527353217|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
146228200|NCT04880733|527353218|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
146228201|NCT04880733|527353219|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
146228202|NCT04880733|527353217|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
146228203|NCT04880733|527353218|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
146228204|NCT04880733|527353219|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
146228205|NCT05533190|527353221|FG000|Overall Study|Lost to Follow-up|19|||
146228206|NCT05533190|527353222|FG001|Overall Study|Lost to Follow-up|7|||
146228207|NCT05533190|527353221|FG000|Overall Study|Failed to download app|1|||
146228208|NCT05533190|527353222|FG001|Overall Study|Failed to download app|0|||
146228209|NCT05533190|527353221|FG000|Overall Study|Thought app was a scam|1|||
146228210|NCT05533190|527353222|FG001|Overall Study|Thought app was a scam|0|||
146228211|NCT05533190|527353221|FG000|Overall Study|Withdrawal by Subject|2|||
146228212|NCT05533190|527353222|FG001|Overall Study|Withdrawal by Subject|0|||
146228213|NCT03213678|527353231|FG000|Overall Study|Death|1|||
146228214|NCT03213678|527353231|FG000|Overall Study|Physician Decision|1|||
146228215|NCT03213678|527353231|FG000|Overall Study|Progressive disease|16|||
146228216|NCT03988621|527353233|FG000|Overall Study|Lost to Follow-up|16|||
146228217|NCT03988621|527353234|FG001|Overall Study|Lost to Follow-up|17|||
146228218|NCT03988621|527353233|FG000|Overall Study|Withdrawal by Subject|14|||
146228219|NCT03988621|527353234|FG001|Overall Study|Withdrawal by Subject|7|||
146228220|NCT03988621|527353233|FG000|Overall Study|Patient Lost to Follow Up|15|||
146228221|NCT03988621|527353234|FG001|Overall Study|Patient Lost to Follow Up|15|||
146228222|NCT03988621|527353233|FG000|Overall Study|Patient death|1|||
146228223|NCT03988621|527353234|FG001|Overall Study|Patient death|5|||
146228224|NCT05013385|527353235|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
146228225|NCT04247802|527353236|FG000|Overall Study|Withdrawal by Subject|1|||
146228226|NCT04247802|527353237|FG001|Overall Study|Withdrawal by Subject|3|||
146228227|NCT04247802|527353236|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
146228228|NCT04247802|527353237|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
146228229|NCT03252288|527353239|FG000|Overall Study|Death|1|||
146085865|NCT02106923|526835091|FG003|Overall Study|Protocol Violation|0|||
146085866|NCT02106923|526835092|FG004|Overall Study|Protocol Violation|0|||
146085867|NCT02106923|526835093|FG005|Overall Study|Protocol Violation|1|||
146085868|NCT03485495|526835094|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
146085869|NCT03485495|526835095|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
146228230|NCT03252288|527353240|FG001|Overall Study|Death|0|||
146228231|NCT03252288|527353241|FG002|Overall Study|Death|0|||
146228232|NCT03252288|527353239|FG000|Overall Study|Death|11|||
146228233|NCT03252288|527353240|FG001|Overall Study|Death|0|||
146228234|NCT03252288|527353241|FG002|Overall Study|Death|0|||
146228235|NCT03252288|527353239|FG000|Overall Study|Withdrawal by Subject|2|||
146228236|NCT03252288|527353240|FG001|Overall Study|Withdrawal by Subject|0|||
146228237|NCT03252288|527353241|FG002|Overall Study|Withdrawal by Subject|0|||
146228238|NCT03252288|527353239|FG000|Overall Study|Lost to Follow-up|79|||
146228239|NCT03252288|527353240|FG001|Overall Study|Lost to Follow-up|0|||
146228240|NCT03252288|527353241|FG002|Overall Study|Lost to Follow-up|0|||
146228241|NCT03252288|527353239|FG000|Overall Study|Loss of baseline data on tablets|6|||
146228242|NCT03252288|527353240|FG001|Overall Study|Loss of baseline data on tablets|0|||
146228243|NCT03252288|527353241|FG002|Overall Study|Loss of baseline data on tablets|0|||
146228244|NCT02905331|527353243|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
146228245|NCT02905331|527353244|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
146228246|NCT02905331|527353245|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
146228247|NCT02905331|527353243|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
146228248|NCT02905331|527353244|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
146228249|NCT02905331|527353245|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
146228250|NCT02905331|527353243|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
146228251|NCT02905331|527353244|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
146228252|NCT02905331|527353245|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
146228253|NCT02905331|527353243|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
146228254|NCT02905331|527353244|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
146228255|NCT02905331|527353245|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
146228256|NCT02905331|527353243|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
146228257|NCT02905331|527353244|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
146228258|NCT02905331|527353245|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
146228259|NCT03334695|527353246|FG000|Overall Study|Lost to Follow-up|3|||
146228260|NCT03334695|527353247|FG001|Overall Study|Lost to Follow-up|3|||
146228261|NCT03334695|527353246|FG000|Overall Study|Physician Decision|1|||
146228262|NCT03334695|527353247|FG001|Overall Study|Physician Decision|2|||
146228263|NCT03334695|527353246|FG000|Overall Study|Protocol Violation|0|||
146228264|NCT03334695|527353247|FG001|Overall Study|Protocol Violation|1|||
146228265|NCT02542631|527353248|FG000|Overall Study|Adverse Event|1|||
146228266|NCT02542631|527353249|FG001|Overall Study|Adverse Event|1|||
146228267|NCT02542631|527353248|FG000|Overall Study|Sponsor Termination|1|||
146228268|NCT02542631|527353249|FG001|Overall Study|Sponsor Termination|0|||
146228269|NCT02542631|527353248|FG000|Overall Study|Withdrawal by Subject|11|||
146228270|NCT02542631|527353249|FG001|Overall Study|Withdrawal by Subject|16|||
146228271|NCT02542631|527353248|FG000|Overall Study|Protocol Violation|1|||
146228272|NCT02542631|527353249|FG001|Overall Study|Protocol Violation|1|||
146228273|NCT02542631|527353248|FG000|Overall Study|Physician Decision|6|||
146228274|NCT02542631|527353249|FG001|Overall Study|Physician Decision|4|||
146228275|NCT02542631|527353248|FG000|Overall Study|Lost to Follow-up|6|||
146228276|NCT02542631|527353249|FG001|Overall Study|Lost to Follow-up|5|||
146228277|NCT02542631|527353248|FG000|Overall Study|Death|1|||
146228278|NCT02542631|527353249|FG001|Overall Study|Death|2|||
146228279|NCT02542631|527353248|FG000|Overall Study|Other|2|||
146228280|NCT02542631|527353249|FG001|Overall Study|Other|1|||
146228281|NCT02542631|527353248|FG000|Overall Study|Used Prohibited Medication|2|||
146228282|NCT02542631|527353249|FG001|Overall Study|Used Prohibited Medication|1|||
146228283|NCT02641730|527353250|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
146228284|NCT02641730|527353251|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146228285|NCT02641730|527353252|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
146228286|NCT02641730|527353253|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
146289185|NCT04948333|527573385|FG002|Overall Study|Progressive Disease|0|||
146289186|NCT04948333|527573386|FG003|Overall Study|Progressive Disease|0|||
146289187|NCT04948333|527573383|FG000|Overall Study|Physician Decision|2|||
146289188|NCT04948333|527573384|FG001|Overall Study|Physician Decision|2|||
146289189|NCT04948333|527573385|FG002|Overall Study|Physician Decision|0|||
146289190|NCT04948333|527573386|FG003|Overall Study|Physician Decision|0|||
146289191|NCT04948333|527573383|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
146228287|NCT02641730|527353254|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
146228288|NCT02641730|527353250|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146228289|NCT02641730|527353251|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146228290|NCT02641730|527353252|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146228291|NCT02641730|527353253|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
146228292|NCT02641730|527353254|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
146228293|NCT02641730|527353250|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146228294|NCT02641730|527353251|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
146228295|NCT02641730|527353252|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146228296|NCT02641730|527353253|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
146228297|NCT02641730|527353254|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
146289192|NCT04948333|527573384|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
145885197|NCT00569777|526084401|FG001|Overall Study|did not meet exclusion criteria|2|||
145885198|NCT00569777|526084400|FG000|Overall Study|pregnant|1|||
145885199|NCT00569777|526084401|FG001|Overall Study|pregnant|0|||
145885200|NCT01835548|526084406|FG000|Dose Optimization Period|Adverse Event|0|||
145885201|NCT01835548|526084407|FG001|Dose Optimization Period|Adverse Event|0|||
145885202|NCT01835548|526084408|FG002|Dose Optimization Period|Adverse Event|1|||
145885203|NCT01835548|526084406|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
146085870|NCT01323920|526835096|FG000|Overall Study|Death|5|||
145885204|NCT01835548|526084407|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
145885205|NCT01835548|526084408|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
145885206|NCT01835548|526084406|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145885207|NCT01835548|526084407|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145885208|NCT01835548|526084408|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145885209|NCT01835548|526084406|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145885210|NCT01835548|526084407|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145885211|NCT01835548|526084408|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145885212|NCT02490800|526084409|FG000|Overall Study|Adverse Event|0|||
145885213|NCT02490800|526084410|FG001|Overall Study|Adverse Event|0|||
145885214|NCT02490800|526084411|FG002|Overall Study|Adverse Event|0|||
145885215|NCT02490800|526084412|FG003|Overall Study|Adverse Event|2|||
145885216|NCT02490800|526084413|FG004|Overall Study|Adverse Event|3|||
145885217|NCT02490800|526084414|FG005|Overall Study|Adverse Event|2|||
145885218|NCT02490800|526084415|FG006|Overall Study|Adverse Event|0|||
145885219|NCT02490800|526084416|FG007|Overall Study|Adverse Event|0|||
145885220|NCT02490800|526084417|FG008|Overall Study|Adverse Event|0|||
145885221|NCT02490800|526084418|FG009|Overall Study|Adverse Event|0|||
145885222|NCT02490800|526084419|FG010|Overall Study|Adverse Event|0|||
145885223|NCT02490800|526084420|FG011|Overall Study|Adverse Event|2|||
145885224|NCT02490800|526084421|FG012|Overall Study|Adverse Event|2|||
145885225|NCT02490800|526084409|FG000|Overall Study|Withdrawal by Subject|0|||
145885226|NCT02490800|526084410|FG001|Overall Study|Withdrawal by Subject|0|||
145885227|NCT02490800|526084411|FG002|Overall Study|Withdrawal by Subject|0|||
145885228|NCT02490800|526084412|FG003|Overall Study|Withdrawal by Subject|1|||
145885229|NCT02490800|526084413|FG004|Overall Study|Withdrawal by Subject|0|||
145885230|NCT02490800|526084414|FG005|Overall Study|Withdrawal by Subject|0|||
145885231|NCT02490800|526084415|FG006|Overall Study|Withdrawal by Subject|0|||
145885232|NCT02490800|526084416|FG007|Overall Study|Withdrawal by Subject|0|||
145885233|NCT02490800|526084417|FG008|Overall Study|Withdrawal by Subject|1|||
145885234|NCT02490800|526084418|FG009|Overall Study|Withdrawal by Subject|0|||
145885235|NCT02490800|526084419|FG010|Overall Study|Withdrawal by Subject|0|||
145885236|NCT02490800|526084420|FG011|Overall Study|Withdrawal by Subject|0|||
145885237|NCT02490800|526084421|FG012|Overall Study|Withdrawal by Subject|0|||
145885238|NCT02490800|526084409|FG000|Overall Study|Progressive disease|3|||
145885239|NCT02490800|526084410|FG001|Overall Study|Progressive disease|3|||
146228298|NCT02641730|527353250|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146228299|NCT02641730|527353251|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146228300|NCT02641730|527353252|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145885240|NCT02490800|526084411|FG002|Overall Study|Progressive disease|3|||
145885241|NCT02490800|526084412|FG003|Overall Study|Progressive disease|4|||
145885242|NCT02490800|526084413|FG004|Overall Study|Progressive disease|4|||
145885243|NCT02490800|526084414|FG005|Overall Study|Progressive disease|1|||
146085871|NCT01323920|526835096|FG000|Overall Study|Withdrawal by Subject|1|||
146085872|NCT03915860|526835098|FG000|Overall Study|Adverse Event|3|||
146085873|NCT03915860|526835098|FG000|Overall Study|Withdrawal by Subject|6|||
146085874|NCT03915860|526835098|FG000|Overall Study|Lost to Follow-up|2|||
146085875|NCT03915860|526835098|FG000|Overall Study|Other than specified|3|||
146085876|NCT01009281|526835099|FG000|Overall Study|Administrative problems|7|||
146085877|NCT03901456|526835101|FG000|Overall Study|Withdrawal by Subject|0|||
146085878|NCT03901456|526835102|FG001|Overall Study|Withdrawal by Subject|0|||
146085879|NCT03901456|526835103|FG002|Overall Study|Withdrawal by Subject|1|||
146085880|NCT03901456|526835101|FG000|Overall Study|Lost to Follow-up|0|||
146085881|NCT03901456|526835102|FG001|Overall Study|Lost to Follow-up|1|||
146085882|NCT03901456|526835103|FG002|Overall Study|Lost to Follow-up|0|||
146085883|NCT02217527|526835106|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
146085884|NCT02217527|526835107|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
146085885|NCT02217527|526835106|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
146085886|NCT02217527|526835107|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
146085887|NCT00402233|526835108|FG000|Overall Study|Adverse Event|1|||
146085888|NCT00402233|526835109|FG001|Overall Study|Adverse Event|7|||
146085889|NCT00402233|526835110|FG002|Overall Study|Adverse Event|9|||
146085890|NCT00402233|526835111|FG003|Overall Study|Adverse Event|9|||
146085891|NCT00402233|526835108|FG000|Overall Study|Protocol Violation|0|||
146085892|NCT00402233|526835109|FG001|Overall Study|Protocol Violation|1|||
146085893|NCT00402233|526835110|FG002|Overall Study|Protocol Violation|0|||
146085894|NCT00402233|526835111|FG003|Overall Study|Protocol Violation|0|||
146085895|NCT00402233|526835108|FG000|Overall Study|Withdrawal by Subject|2|||
146085896|NCT00402233|526835109|FG001|Overall Study|Withdrawal by Subject|1|||
146085897|NCT00402233|526835110|FG002|Overall Study|Withdrawal by Subject|2|||
146085898|NCT00402233|526835111|FG003|Overall Study|Withdrawal by Subject|2|||
146085899|NCT00402233|526835108|FG000|Overall Study|Worsening of disease under study|2|||
146085900|NCT00402233|526835109|FG001|Overall Study|Worsening of disease under study|0|||
146085901|NCT00402233|526835110|FG002|Overall Study|Worsening of disease under study|0|||
146085902|NCT00402233|526835111|FG003|Overall Study|Worsening of disease under study|0|||
146085903|NCT00402233|526835108|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146085904|NCT00402233|526835109|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146085905|NCT00402233|526835110|FG002|Overall Study|Worsening of other pre-existing disease|0|||
146085906|NCT00402233|526835111|FG003|Overall Study|Worsening of other pre-existing disease|0|||
146085907|NCT00938886|526835112|FG000|Overall Study|Death|0|||
146085908|NCT00938886|526835113|FG001|Overall Study|Death|1|||
146085909|NCT00938886|526835112|FG000|Overall Study|Withdrawal by Subject|4|||
146085910|NCT00938886|526835113|FG001|Overall Study|Withdrawal by Subject|7|||
146085911|NCT00938886|526835112|FG000|Overall Study|Lost to Follow-up|3|||
146085912|NCT00938886|526835113|FG001|Overall Study|Lost to Follow-up|2|||
146085913|NCT03579602|526835114|FG000|Overall Study|Subject unable to receive study drug|0|||
146085914|NCT03579602|526835115|FG001|Overall Study|Subject unable to receive study drug|2|||
146085915|NCT03579602|526835114|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
146085916|NCT03579602|526835115|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
146085917|NCT02518464|526835117|FG000|Overall Study|Adverse Event|2|||
146085918|NCT01120067|526835120|FG000|Overall Study|Lost to Follow-up|3|||
146085919|NCT01120067|526835121|FG001|Overall Study|Lost to Follow-up|1|||
146085920|NCT01120067|526835120|FG000|Overall Study|fail to engage >3 sessions|2|||
146085921|NCT01120067|526835121|FG001|Overall Study|fail to engage >3 sessions|0|||
146085922|NCT03021564|526835125|FG000|Overall Study|Death|84|||
146085923|NCT03021564|526835126|FG001|Overall Study|Death|466|||
146085924|NCT03021564|526835125|FG000|Overall Study|Lost to Follow-up|0|||
146228301|NCT02641730|527353253|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146228302|NCT02641730|527353254|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146228303|NCT02641730|527353250|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
146228304|NCT02641730|527353251|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
146228305|NCT02641730|527353252|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
146228306|NCT02641730|527353253|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
146228307|NCT02641730|527353254|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
146228308|NCT02641730|527353250|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
146228309|NCT02641730|527353251|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
146228310|NCT02641730|527353252|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
146228311|NCT02641730|527353253|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
146228312|NCT02641730|527353254|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
146289193|NCT04948333|527573385|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
146289194|NCT04948333|527573386|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
146289195|NCT04948333|527573383|FG000|Overall Study|Withdrawal by Subject|2|||
146289196|NCT04948333|527573384|FG001|Overall Study|Withdrawal by Subject|0|||
145885244|NCT02490800|526084415|FG006|Overall Study|Progressive disease|4|||
145885245|NCT02490800|526084416|FG007|Overall Study|Progressive disease|3|||
145885246|NCT02490800|526084417|FG008|Overall Study|Progressive disease|6|||
145885247|NCT02490800|526084418|FG009|Overall Study|Progressive disease|2|||
146228313|NCT05460871|527353255|FG000|Overall Study|Withdrawal by Subject|1|||
145885248|NCT02490800|526084419|FG010|Overall Study|Progressive disease|7|||
146228314|NCT05460871|527353256|FG001|Overall Study|Withdrawal by Subject|2|||
146289197|NCT04948333|527573385|FG002|Overall Study|Withdrawal by Subject|0|||
146289198|NCT04948333|527573386|FG003|Overall Study|Withdrawal by Subject|1|||
146289199|NCT04948333|527573383|FG000|Overall Study|Protocol Violation|0|||
146289200|NCT04948333|527573384|FG001|Overall Study|Protocol Violation|1|||
146289201|NCT04948333|527573385|FG002|Overall Study|Protocol Violation|0|||
146085925|NCT03021564|526835126|FG001|Overall Study|Lost to Follow-up|2|||
146085926|NCT02889562|526835127|FG000|Overall Study|Physician Decision|0|||
146085927|NCT02889562|526835128|FG001|Overall Study|Physician Decision|1|||
146085928|NCT02889562|526835127|FG000|Overall Study|Withdrawal by Subject|0|||
146085929|NCT02889562|526835128|FG001|Overall Study|Withdrawal by Subject|1|||
146085930|NCT01470989|526835131|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
146085931|NCT01470989|526835132|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
146085932|NCT01470989|526835131|FG000|Overall Study|Adverse Event|2|||
146085933|NCT01470989|526835132|FG001|Overall Study|Adverse Event|5|||
146085934|NCT01470989|526835131|FG000|Overall Study|Abnormal laboratory value|1|||
146085935|NCT01470989|526835132|FG001|Overall Study|Abnormal laboratory value|1|||
146085936|NCT01470989|526835131|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146085937|NCT01470989|526835132|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146085938|NCT01470989|526835131|FG000|Overall Study|Withdrawal by Subject|19|||
146085939|NCT01470989|526835132|FG001|Overall Study|Withdrawal by Subject|17|||
146085940|NCT01470989|526835131|FG000|Overall Study|Lost to Follow-up|18|||
146085941|NCT01470989|526835132|FG001|Overall Study|Lost to Follow-up|13|||
146289202|NCT04948333|527573386|FG003|Overall Study|Protocol Violation|0|||
146289203|NCT04948333|527573383|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
146289204|NCT04948333|527573384|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
146289205|NCT04948333|527573385|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
146289206|NCT04948333|527573386|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
146085942|NCT01470989|526835131|FG000|Overall Study|Administrative problems|2|||
146085943|NCT01470989|526835132|FG001|Overall Study|Administrative problems|4|||
146085944|NCT01470989|526835131|FG000|Overall Study|Death|2|||
146085945|NCT01470989|526835132|FG001|Overall Study|Death|2|||
146085946|NCT01470989|526835131|FG000|Overall Study|Protocol deviation|1|||
146085947|NCT01470989|526835132|FG001|Overall Study|Protocol deviation|2|||
146085948|NCT00969280|526835133|FG000|Overall Study|Protocol Violation|2|||
146228315|NCT02938923|527353257|FG000|Overall Study|Death|1|||
146228316|NCT02938923|527353258|FG001|Overall Study|Death|0|||
146228317|NCT02938923|527353259|FG002|Overall Study|Death|0|||
146228318|NCT02938923|527353257|FG000|Overall Study|Physician Decision|0|||
146228319|NCT02938923|527353258|FG001|Overall Study|Physician Decision|2|||
146228320|NCT02938923|527353259|FG002|Overall Study|Physician Decision|0|||
146228321|NCT02938923|527353257|FG000|Overall Study|Withdrawal by Subject|0|||
146228322|NCT02938923|527353258|FG001|Overall Study|Withdrawal by Subject|1|||
146228323|NCT02938923|527353259|FG002|Overall Study|Withdrawal by Subject|1|||
146228324|NCT00721149|527353260|FG000|Overall Study|Physician Decision|1|||
146228325|NCT04129554|527353262|FG000|Overall Study|Withdrawal by Subject|4|||
146228326|NCT04129554|527353263|FG001|Overall Study|Withdrawal by Subject|3|||
146228327|NCT04129554|527353262|FG000|Overall Study|Other|0|||
146228328|NCT04129554|527353263|FG001|Overall Study|Other|2|||
146228329|NCT01570361|527353264|FG000|Overall Study|Subject discontinued|1|||
146228330|NCT01570361|527353265|FG001|Overall Study|Subject discontinued|2|||
146228331|NCT01570361|527353264|FG000|Overall Study|Sponsor closing the study|51|||
146228332|NCT01570361|527353265|FG001|Overall Study|Sponsor closing the study|50|||
146228333|NCT01570361|527353264|FG000|Overall Study|Subject excluded|5|||
146228334|NCT01570361|527353265|FG001|Overall Study|Subject excluded|3|||
146228335|NCT01570361|527353264|FG000|Overall Study|Subject withdrew consent|14|||
146228336|NCT01570361|527353265|FG001|Overall Study|Subject withdrew consent|9|||
146228337|NCT01570361|527353264|FG000|Overall Study|Adverse Event|2|||
146228338|NCT01570361|527353265|FG001|Overall Study|Adverse Event|1|||
146228339|NCT01570361|527353264|FG000|Overall Study|Lost to Follow-up|4|||
146228340|NCT01570361|527353265|FG001|Overall Study|Lost to Follow-up|4|||
146228341|NCT01570361|527353264|FG000|Overall Study|Death|5|||
146228342|NCT01570361|527353265|FG001|Overall Study|Death|4|||
146228343|NCT01570361|527353264|FG000|Overall Study|Other|0|||
146228344|NCT01570361|527353265|FG001|Overall Study|Other|2|||
146228345|NCT05158504|527353268|FG000|Overall Study|Lost to Follow-up|2|||
146228346|NCT05158504|527353269|FG001|Overall Study|Lost to Follow-up|3|||
146228347|NCT03606512|527353270|FG000|Overall Study|Lost to Follow-up|0|||
146228348|NCT03606512|527353271|FG001|Overall Study|Lost to Follow-up|1|||
145962428|NCT00490919|526373705|FG001|Double-blind Phase|Adverse Event|40|||
145962429|NCT00490919|526373706|FG002|Double-blind Phase|Adverse Event|20|||
145962430|NCT00490919|526373704|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145962431|NCT00490919|526373705|FG001|Double-blind Phase|Withdrawal by Subject|10|||
145962432|NCT00490919|526373706|FG002|Double-blind Phase|Withdrawal by Subject|11|||
145962433|NCT00490919|526373704|FG000|Double-blind Phase|Lost to Follow-up|0|||
145962434|NCT00490919|526373705|FG001|Double-blind Phase|Lost to Follow-up|8|||
145962435|NCT00490919|526373706|FG002|Double-blind Phase|Lost to Follow-up|11|||
145962436|NCT00490919|526373704|FG000|Double-blind Phase|Lack of Efficacy|0|||
145962437|NCT00490919|526373705|FG001|Double-blind Phase|Lack of Efficacy|22|||
145962438|NCT00490919|526373706|FG002|Double-blind Phase|Lack of Efficacy|36|||
145962439|NCT00490919|526373704|FG000|Double-blind Phase|Administrative|0|||
145962440|NCT00490919|526373705|FG001|Double-blind Phase|Administrative|6|||
145962441|NCT00490919|526373706|FG002|Double-blind Phase|Administrative|6|||
145962442|NCT02481050|526375328|FG000|Overall Study|Adverse Event|1|||
145962443|NCT02481050|526375328|FG000|Overall Study|Disease Progression|47|||
146228349|NCT03606512|527353270|FG000|Overall Study|'moved from study area|0|||
146228350|NCT03606512|527353271|FG001|Overall Study|'moved from study area|1|||
146228351|NCT05513937|527353272|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146228352|NCT05513937|527353273|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
146228353|NCT05513937|527353274|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146228354|NCT05513937|527353275|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
146228355|NCT05513937|527353272|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
146228356|NCT05513937|527353273|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
146228357|NCT05513937|527353274|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
146228358|NCT05513937|527353275|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
145962444|NCT02481050|526375328|FG000|Overall Study|Withdrawal by Subject|7|||
146228359|NCT05513937|527353272|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
146228360|NCT05513937|527353273|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146228361|NCT05513937|527353274|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146228362|NCT05513937|527353275|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
146228363|NCT05513937|527353272|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
145962445|NCT02481050|526375328|FG000|Overall Study|Other|3|||
145962446|NCT01386606|526375329|FG000|Overall Study|Adverse Event|0|||
145962447|NCT01386606|526375330|FG001|Overall Study|Adverse Event|1|||
145962448|NCT01386606|526375331|FG002|Overall Study|Adverse Event|0|||
146228364|NCT05513937|527353273|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
146228365|NCT05513937|527353274|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
145962449|NCT01386606|526375332|FG003|Overall Study|Adverse Event|0|||
146228366|NCT05513937|527353275|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
146228367|NCT05513937|527353272|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146228368|NCT05513937|527353273|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146228369|NCT05513937|527353274|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
146228370|NCT05513937|527353275|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
146228371|NCT05513937|527353272|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146228372|NCT05513937|527353273|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146228373|NCT05513937|527353274|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
146228374|NCT05513937|527353275|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
146228375|NCT02846545|527353276|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
146228376|NCT02846545|527353277|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
146228377|NCT02846545|527353276|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
146228378|NCT02846545|527353277|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
146228379|NCT02846545|527353276|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
146228380|NCT02846545|527353277|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
146228381|NCT02846545|527353276|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
146228382|NCT02846545|527353277|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
146228383|NCT02846545|527353276|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
146228384|NCT02846545|527353277|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
146228385|NCT03993392|527353282|FG000|Overall Study|Withdrawal by Subject|3|||
146228386|NCT03993392|527353282|FG000|Overall Study|Lost to Follow-up|2|||
146228387|NCT03993392|527353282|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
146228388|NCT02518048|527353288|FG000|Overall Study|Withdrawal by Subject|1|||
146228389|NCT05654662|527353289|FG000|Overall Study|Withdrawal by Subject|1|||
146228390|NCT05654662|527353290|FG001|Overall Study|Withdrawal by Subject|0|||
146228391|NCT05654662|527353289|FG000|Overall Study|A death in the family|1|||
146228392|NCT05654662|527353290|FG001|Overall Study|A death in the family|0|||
146228393|NCT05962814|527353291|FG000|Overall Study|failed eligibility|1|||
146228394|NCT03057054|527353292|FG000|Overall Study|Death|4|||
146228395|NCT03057054|527353293|FG001|Overall Study|Death|4|||
146228396|NCT03057054|527353292|FG000|Overall Study|Withdrawal by Subject|6|||
146228397|NCT03057054|527353293|FG001|Overall Study|Withdrawal by Subject|3|||
146228398|NCT03057054|527353292|FG000|Overall Study|Ineligible|1|||
146228399|NCT03057054|527353293|FG001|Overall Study|Ineligible|1|||
146228400|NCT05507437|527354883|FG000|Overall Study|Withdrawal by Subject|1|||
146228401|NCT05507437|527354884|FG001|Overall Study|Withdrawal by Subject|1|||
146228402|NCT05507437|527354883|FG000|Overall Study|Death|3|||
146228403|NCT05507437|527354884|FG001|Overall Study|Death|0|||
146228404|NCT06262477|527354885|FG000|Overall Study|Withdrawal by Subject|1|||
146228405|NCT06262477|527354886|FG001|Overall Study|Withdrawal by Subject|0|||
146228406|NCT06262477|527354885|FG000|Overall Study|Adverse Event|0|||
146228407|NCT06262477|527354886|FG001|Overall Study|Adverse Event|1|||
146228408|NCT06262477|527354885|FG000|Overall Study|Lost to Follow-up|0|||
146228409|NCT06262477|527354886|FG001|Overall Study|Lost to Follow-up|1|||
146228410|NCT01064440|527354887|FG000|Overall Study|Lost to Follow-up|1|||
146228411|NCT01064440|527354888|FG001|Overall Study|Lost to Follow-up|1|||
145962450|NCT01386606|526375329|FG000|Overall Study|Withdrawal by Subject|0|||
145962451|NCT01386606|526375330|FG001|Overall Study|Withdrawal by Subject|1|||
145962452|NCT01386606|526375331|FG002|Overall Study|Withdrawal by Subject|1|||
145962453|NCT01386606|526375332|FG003|Overall Study|Withdrawal by Subject|0|||
145962454|NCT01386606|526375329|FG000|Overall Study|Protocol Violation|1|||
145962455|NCT01386606|526375330|FG001|Overall Study|Protocol Violation|0|||
145962456|NCT01386606|526375331|FG002|Overall Study|Protocol Violation|1|||
145962457|NCT01386606|526375332|FG003|Overall Study|Protocol Violation|1|||
145962458|NCT01386606|526375329|FG000|Overall Study|Lost to Follow-up|2|||
145962459|NCT01386606|526375330|FG001|Overall Study|Lost to Follow-up|0|||
145962460|NCT01386606|526375331|FG002|Overall Study|Lost to Follow-up|0|||
145962461|NCT01386606|526375332|FG003|Overall Study|Lost to Follow-up|0|||
145962462|NCT01386606|526375329|FG000|Overall Study|Subject incarcerated|0|||
145962463|NCT01386606|526375330|FG001|Overall Study|Subject incarcerated|1|||
145962464|NCT01386606|526375331|FG002|Overall Study|Subject incarcerated|0|||
145962465|NCT01386606|526375332|FG003|Overall Study|Subject incarcerated|0|||
145962466|NCT01386606|526375329|FG000|Overall Study|Unable to draw PK|1|||
145962467|NCT01386606|526375330|FG001|Overall Study|Unable to draw PK|0|||
145962468|NCT01386606|526375331|FG002|Overall Study|Unable to draw PK|0|||
145962469|NCT01386606|526375332|FG003|Overall Study|Unable to draw PK|0|||
145962470|NCT01386606|526375329|FG000|Overall Study|T levels too high|0|||
145962471|NCT01386606|526375330|FG001|Overall Study|T levels too high|1|||
145962472|NCT01386606|526375331|FG002|Overall Study|T levels too high|1|||
145962473|NCT01386606|526375332|FG003|Overall Study|T levels too high|0|||
145962474|NCT04113694|526375333|FG000|Overall Study|Adverse Event|2|||
145962475|NCT04113694|526375333|FG000|Overall Study|Lost to Follow-up|2|||
145962476|NCT04113694|526375333|FG000|Overall Study|Withdrawal by Subject|6|||
145962477|NCT04113694|526375333|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
145962478|NCT01228591|526375334|FG000|Baseline|Lack of Efficacy|1|||
145962479|NCT01228591|526375335|FG001|Baseline|Lack of Efficacy|2|||
145962480|NCT02723188|526375336|FG000|Overall Study|Withdrawal by Subject|1|||
145962481|NCT02723188|526375337|FG001|Overall Study|Withdrawal by Subject|0|||
145962482|NCT02723188|526375338|FG002|Overall Study|Withdrawal by Subject|0|||
145962483|NCT01095835|526375339|FG000|Overall Study|Adverse Event|8|||
145962484|NCT01095835|526375340|FG001|Overall Study|Adverse Event|6|||
145962485|NCT01095835|526375341|FG002|Overall Study|Adverse Event|6|||
145962486|NCT01095835|526375339|FG000|Overall Study|Lack of Efficacy|0|||
145962487|NCT01095835|526375340|FG001|Overall Study|Lack of Efficacy|1|||
145962488|NCT01095835|526375341|FG002|Overall Study|Lack of Efficacy|0|||
145962489|NCT01095835|526375339|FG000|Overall Study|Physician Decision|0|||
145962490|NCT01095835|526375340|FG001|Overall Study|Physician Decision|0|||
145962491|NCT01095835|526375341|FG002|Overall Study|Physician Decision|1|||
145962492|NCT01095835|526375339|FG000|Overall Study|Withdrawal by Subject|1|||
145962493|NCT01095835|526375340|FG001|Overall Study|Withdrawal by Subject|3|||
146228412|NCT01064440|527354889|FG002|Overall Study|Lost to Follow-up|1|||
145962494|NCT01095835|526375341|FG002|Overall Study|Withdrawal by Subject|0|||
145962495|NCT01095835|526375339|FG000|Overall Study|Non study compliance|0|||
145962496|NCT01095835|526375340|FG001|Overall Study|Non study compliance|0|||
145962497|NCT01095835|526375341|FG002|Overall Study|Non study compliance|1|||
145962498|NCT01095835|526375339|FG000|Overall Study|Protocol Violation|1|||
145962499|NCT01095835|526375340|FG001|Overall Study|Protocol Violation|2|||
145962500|NCT01095835|526375341|FG002|Overall Study|Protocol Violation|0|||
146228413|NCT01064440|527354887|FG000|Overall Study|Non-compliance|0|||
145962501|NCT00116688|526375349|FG000|Overall Study|Protocol deviation|1|||
145962502|NCT00116688|526375350|FG001|Overall Study|Protocol deviation|0|||
145962503|NCT00116688|526375349|FG000|Overall Study|Noncompliance|3|||
145962504|NCT00116688|526375350|FG001|Overall Study|Noncompliance|1|||
145962505|NCT00116688|526375349|FG000|Overall Study|Adverse Event|11|||
146228414|NCT01064440|527354888|FG001|Overall Study|Non-compliance|1|||
146228415|NCT01064440|527354889|FG002|Overall Study|Non-compliance|0|||
146228416|NCT01064440|527354887|FG000|Overall Study|Death|1|||
146228417|NCT01064440|527354888|FG001|Overall Study|Death|0|||
146228418|NCT01064440|527354889|FG002|Overall Study|Death|1|||
146228419|NCT01064440|527354887|FG000|Overall Study|Withdrawal by Subject|0|||
145885249|NCT02490800|526084420|FG011|Overall Study|Progressive disease|1|||
146228420|NCT01064440|527354888|FG001|Overall Study|Withdrawal by Subject|1|||
146228421|NCT01064440|527354889|FG002|Overall Study|Withdrawal by Subject|1|||
145885250|NCT02490800|526084421|FG012|Overall Study|Progressive disease|10|||
146228422|NCT01064440|527354887|FG000|Overall Study|Other: amputation|1|||
146228423|NCT01064440|527354888|FG001|Overall Study|Other: amputation|0|||
146228424|NCT01064440|527354889|FG002|Overall Study|Other: amputation|0|||
146228425|NCT04108130|527354890|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
146228426|NCT04108130|527354891|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
146228427|NCT04108130|527354890|FG000|Overall Study|Consent Withdrawn|9|||
146228428|NCT04108130|527354891|FG001|Overall Study|Consent Withdrawn|6|||
146228429|NCT04108130|527354890|FG000|Overall Study|Surgery Cancelled|4|||
146228430|NCT04108130|527354891|FG001|Overall Study|Surgery Cancelled|4|||
146228431|NCT04108130|527354890|FG000|Overall Study|Found Ineligible for Study|4|||
146228432|NCT04108130|527354891|FG001|Overall Study|Found Ineligible for Study|3|||
146228433|NCT04108130|527354890|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
146228434|NCT04108130|527354891|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
146228435|NCT04108130|527354890|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
146228436|NCT04108130|527354891|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
146228437|NCT05507333|527354892|FG000|Overall Study|Protocol Violation|1|||
146228438|NCT01880515|527354896|FG000|Overall Study|Lost to Follow-up|3|||
146228439|NCT01880515|527354897|FG001|Overall Study|Lost to Follow-up|2|||
146228440|NCT01880515|527354896|FG000|Overall Study|Disease Progression|5|||
146228441|NCT01880515|527354897|FG001|Overall Study|Disease Progression|7|||
146228442|NCT05247034|527354899|FG000|Overall Study|Lost to Follow-up|3|||
146228443|NCT05247034|527354900|FG001|Overall Study|Lost to Follow-up|2|||
146228444|NCT05247034|527354899|FG000|Overall Study|Organizational problems when attending appointments|1|||
146228445|NCT05247034|527354900|FG001|Overall Study|Organizational problems when attending appointments|0|||
146228446|NCT04136912|527354907|FG000|Overall Study|Operational reasons|0|||
146228447|NCT04136912|527354908|FG001|Overall Study|Operational reasons|0|||
146228448|NCT04136912|527354909|FG002|Overall Study|Operational reasons|2|||
146228449|NCT04615273|527354910|FG000|Overall Study|Withdrawal by Subject|3|||
146228450|NCT04615273|527354911|FG001|Overall Study|Withdrawal by Subject|1|||
146228451|NCT04615273|527354912|FG002|Overall Study|Withdrawal by Subject|2|||
146228452|NCT04615273|527354910|FG000|Overall Study|Adverse Event|1|||
146228453|NCT04615273|527354911|FG001|Overall Study|Adverse Event|0|||
146228454|NCT04615273|527354912|FG002|Overall Study|Adverse Event|1|||
146228455|NCT04615273|527354910|FG000|Overall Study|Lost to Follow-up|0|||
146228456|NCT04615273|527354911|FG001|Overall Study|Lost to Follow-up|1|||
146228457|NCT04615273|527354912|FG002|Overall Study|Lost to Follow-up|0|||
146228458|NCT04615273|527354910|FG000|Overall Study|Physician Decision|0|||
146228459|NCT04615273|527354911|FG001|Overall Study|Physician Decision|0|||
146228460|NCT04615273|527354912|FG002|Overall Study|Physician Decision|1|||
146228461|NCT04615273|527354910|FG000|Overall Study|Other|0|||
146228462|NCT04615273|527354911|FG001|Overall Study|Other|1|||
146228463|NCT04615273|527354912|FG002|Overall Study|Other|0|||
146228464|NCT04615273|527354910|FG000|Overall Study|Randomized but not treated|1|||
146228465|NCT04615273|527354911|FG001|Overall Study|Randomized but not treated|3|||
146228466|NCT04615273|527354912|FG002|Overall Study|Randomized but not treated|1|||
146228467|NCT03677141|527354913|FG000|Overall Study|Death|2|||
146228468|NCT03677141|527354914|FG001|Overall Study|Death|1|||
146228469|NCT03677141|527354915|FG002|Overall Study|Death|6|||
146228470|NCT03677141|527354916|FG003|Overall Study|Death|9|||
146228471|NCT03677141|527354917|FG004|Overall Study|Death|5|||
146228472|NCT03677141|527354918|FG005|Overall Study|Death|3|||
146228473|NCT03677141|527354913|FG000|Overall Study|Lost to Follow-up|0|||
146228474|NCT03677141|527354914|FG001|Overall Study|Lost to Follow-up|0|||
146228475|NCT03677141|527354915|FG002|Overall Study|Lost to Follow-up|0|||
146228476|NCT03677141|527354916|FG003|Overall Study|Lost to Follow-up|2|||
146228477|NCT03677141|527354917|FG004|Overall Study|Lost to Follow-up|0|||
146228478|NCT03677141|527354918|FG005|Overall Study|Lost to Follow-up|0|||
146228479|NCT03677141|527354913|FG000|Overall Study|Screen failure or enrolled in error|0|||
146228480|NCT03677141|527354914|FG001|Overall Study|Screen failure or enrolled in error|0|||
146228481|NCT03677141|527354915|FG002|Overall Study|Screen failure or enrolled in error|0|||
146228482|NCT03677141|527354916|FG003|Overall Study|Screen failure or enrolled in error|0|||
146228483|NCT03677141|527354917|FG004|Overall Study|Screen failure or enrolled in error|2|||
146228484|NCT03677141|527354918|FG005|Overall Study|Screen failure or enrolled in error|0|||
146228485|NCT03677141|527354913|FG000|Overall Study|Physician Decision|0|||
146228486|NCT03677141|527354914|FG001|Overall Study|Physician Decision|0|||
146228487|NCT03677141|527354915|FG002|Overall Study|Physician Decision|0|||
146228488|NCT03677141|527354916|FG003|Overall Study|Physician Decision|0|||
146228489|NCT03677141|527354917|FG004|Overall Study|Physician Decision|1|||
146228490|NCT03677141|527354918|FG005|Overall Study|Physician Decision|0|||
146228491|NCT03677141|527354913|FG000|Overall Study|Withdrawal by Subject|0|||
146228492|NCT03677141|527354914|FG001|Overall Study|Withdrawal by Subject|0|||
146228493|NCT03677141|527354915|FG002|Overall Study|Withdrawal by Subject|1|||
146228494|NCT03677141|527354916|FG003|Overall Study|Withdrawal by Subject|1|||
146228495|NCT03677141|527354917|FG004|Overall Study|Withdrawal by Subject|1|||
146228496|NCT03677141|527354918|FG005|Overall Study|Withdrawal by Subject|0|||
146228497|NCT04999111|527354926|FG000|Overall Study|Lost to Follow-up|21|||
146228498|NCT04999111|527354927|FG001|Overall Study|Lost to Follow-up|16|||
146228499|NCT04999111|527354928|FG002|Overall Study|Lost to Follow-up|2|||
145885251|NCT02490800|526084409|FG000|Overall Study|Patient enrolled in post-trial access|0|||
145885252|NCT02490800|526084410|FG001|Overall Study|Patient enrolled in post-trial access|0|||
146085949|NCT00969280|526835134|FG001|Overall Study|Protocol Violation|1|||
146228500|NCT04999111|527354929|FG003|Overall Study|Lost to Follow-up|26|||
145885253|NCT02490800|526084411|FG002|Overall Study|Patient enrolled in post-trial access|0|||
145885254|NCT02490800|526084412|FG003|Overall Study|Patient enrolled in post-trial access|0|||
145885255|NCT02490800|526084413|FG004|Overall Study|Patient enrolled in post-trial access|0|||
145885256|NCT02490800|526084414|FG005|Overall Study|Patient enrolled in post-trial access|0|||
145885257|NCT02490800|526084415|FG006|Overall Study|Patient enrolled in post-trial access|0|||
145885258|NCT02490800|526084416|FG007|Overall Study|Patient enrolled in post-trial access|0|||
145885259|NCT02490800|526084417|FG008|Overall Study|Patient enrolled in post-trial access|0|||
145885260|NCT02490800|526084418|FG009|Overall Study|Patient enrolled in post-trial access|1|||
145885261|NCT02490800|526084419|FG010|Overall Study|Patient enrolled in post-trial access|1|||
145885262|NCT02490800|526084420|FG011|Overall Study|Patient enrolled in post-trial access|0|||
145885263|NCT02490800|526084421|FG012|Overall Study|Patient enrolled in post-trial access|6|||
145885264|NCT00537017|526084422|FG000|Treatment Phase|Adverse Event|19|||
145885265|NCT00537017|526084422|FG000|Treatment Phase|Withdrawal by Subject|13|||
145885266|NCT00537017|526084422|FG000|Treatment Phase|Protocol Violation|2|||
145885267|NCT00537017|526084422|FG000|Follow-up Phase|Withdrawal by Subject|9|||
145885268|NCT03365791|526084424|FG000|Overall Study|Adverse Event|5|||
145885269|NCT03365791|526084424|FG000|Overall Study|Death|1|||
145885270|NCT03365791|526084424|FG000|Overall Study|Lost to Follow-up|1|||
145885271|NCT03365791|526084424|FG000|Overall Study|Physician Decision|9|||
145885272|NCT03365791|526084424|FG000|Overall Study|Progressive disease|51|||
145885273|NCT03365791|526084424|FG000|Overall Study|Subject/guardian decision|5|||
145885274|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
145885275|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885276|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885277|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885278|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885279|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885280|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885281|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885282|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145885283|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
145885284|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
146228501|NCT04999111|527354930|FG004|Overall Study|Lost to Follow-up|30|||
146228502|NCT04999111|527354931|FG005|Overall Study|Lost to Follow-up|6|||
145885285|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145885286|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
146228503|NCT04999111|527354926|FG000|Overall Study|Physician Decision|1|||
145885287|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
146228504|NCT04999111|527354927|FG001|Overall Study|Physician Decision|3|||
146228505|NCT04999111|527354928|FG002|Overall Study|Physician Decision|0|||
146228506|NCT04999111|527354929|FG003|Overall Study|Physician Decision|1|||
146228507|NCT04999111|527354930|FG004|Overall Study|Physician Decision|2|||
146228508|NCT04999111|527354931|FG005|Overall Study|Physician Decision|0|||
146228509|NCT04999111|527354926|FG000|Overall Study|Withdrawal by Subject|23|||
146228510|NCT04999111|527354927|FG001|Overall Study|Withdrawal by Subject|29|||
146228511|NCT04999111|527354928|FG002|Overall Study|Withdrawal by Subject|15|||
146228512|NCT04999111|527354929|FG003|Overall Study|Withdrawal by Subject|30|||
146228513|NCT04999111|527354930|FG004|Overall Study|Withdrawal by Subject|35|||
146228514|NCT04999111|527354931|FG005|Overall Study|Withdrawal by Subject|10|||
146228515|NCT04999111|527354926|FG000|Overall Study|Other|6|||
146228516|NCT04999111|527354927|FG001|Overall Study|Other|6|||
146228517|NCT04999111|527354928|FG002|Overall Study|Other|3|||
146228518|NCT04999111|527354929|FG003|Overall Study|Other|8|||
146228519|NCT04999111|527354930|FG004|Overall Study|Other|8|||
146228520|NCT04999111|527354931|FG005|Overall Study|Other|5|||
146228521|NCT04999111|527354926|FG000|Overall Study|Non-compliance with study schedule|1|||
146228522|NCT04999111|527354927|FG001|Overall Study|Non-compliance with study schedule|0|||
146228523|NCT04999111|527354928|FG002|Overall Study|Non-compliance with study schedule|0|||
146228524|NCT04999111|527354929|FG003|Overall Study|Non-compliance with study schedule|1|||
146228525|NCT04999111|527354930|FG004|Overall Study|Non-compliance with study schedule|1|||
146228526|NCT04999111|527354931|FG005|Overall Study|Non-compliance with study schedule|1|||
146228527|NCT04999111|527354926|FG000|Overall Study|Randomized but not vaccinated|1|||
146228528|NCT04999111|527354927|FG001|Overall Study|Randomized but not vaccinated|2|||
146228529|NCT04999111|527354928|FG002|Overall Study|Randomized but not vaccinated|0|||
146228530|NCT04999111|527354929|FG003|Overall Study|Randomized but not vaccinated|3|||
146228531|NCT04999111|527354930|FG004|Overall Study|Randomized but not vaccinated|3|||
146228532|NCT04999111|527354931|FG005|Overall Study|Randomized but not vaccinated|0|||
146228533|NCT04999111|527354926|FG000|Overall Study|Adverse Event|1|||
146228534|NCT04999111|527354927|FG001|Overall Study|Adverse Event|1|||
146228535|NCT04999111|527354928|FG002|Overall Study|Adverse Event|0|||
146228536|NCT04999111|527354929|FG003|Overall Study|Adverse Event|0|||
146228537|NCT04999111|527354930|FG004|Overall Study|Adverse Event|0|||
146228538|NCT04999111|527354931|FG005|Overall Study|Adverse Event|0|||
146228539|NCT04999111|527354926|FG000|Overall Study|Initiated prohibited medication|0|||
146228540|NCT04999111|527354927|FG001|Overall Study|Initiated prohibited medication|0|||
146228541|NCT04999111|527354928|FG002|Overall Study|Initiated prohibited medication|0|||
145885288|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145885289|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145885290|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145885291|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
146228542|NCT04999111|527354929|FG003|Overall Study|Initiated prohibited medication|0|||
146228543|NCT04999111|527354930|FG004|Overall Study|Initiated prohibited medication|1|||
146228544|NCT04999111|527354931|FG005|Overall Study|Initiated prohibited medication|0|||
146228545|NCT02437136|527354937|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
145962506|NCT00116688|526375350|FG001|Overall Study|Adverse Event|0|||
146228546|NCT02437136|527354938|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146228547|NCT02437136|527354939|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146228548|NCT02437136|527354940|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145962507|NCT00116688|526375349|FG000|Overall Study|Withdrawal by Subject|26|||
145962508|NCT00116688|526375350|FG001|Overall Study|Withdrawal by Subject|2|||
145962509|NCT00116688|526375349|FG000|Overall Study|Requirement for alternative therapy|11|||
145962510|NCT00116688|526375350|FG001|Overall Study|Requirement for alternative therapy|1|||
145962511|NCT00116688|526375349|FG000|Overall Study|Physician Decision|7|||
145962512|NCT00116688|526375350|FG001|Overall Study|Physician Decision|0|||
145962513|NCT00116688|526375349|FG000|Overall Study|Lost to Follow-up|3|||
145962514|NCT00116688|526375350|FG001|Overall Study|Lost to Follow-up|0|||
145962515|NCT00116688|526375349|FG000|Overall Study|Death|15|||
145962516|NCT00116688|526375350|FG001|Overall Study|Death|0|||
145962517|NCT00116688|526375349|FG000|Overall Study|Protocol-specified criteria|3|||
145962518|NCT00116688|526375350|FG001|Overall Study|Protocol-specified criteria|0|||
145962519|NCT00116688|526375349|FG000|Overall Study|Pregnancy|1|||
145962520|NCT00116688|526375350|FG001|Overall Study|Pregnancy|0|||
145962521|NCT00116688|526375349|FG000|Overall Study|Other|11|||
145962522|NCT00116688|526375350|FG001|Overall Study|Other|0|||
145962523|NCT01775670|526375355|FG000|Overall Study|Lost to Follow-up|1|||
145962524|NCT01775670|526375356|FG001|Overall Study|Lost to Follow-up|1|||
145962525|NCT00643760|526375357|FG000|Overall Study|Adverse Event|11|||
145962526|NCT00643760|526375358|FG001|Overall Study|Adverse Event|5|||
145962527|NCT00643760|526375359|FG002|Overall Study|Adverse Event|12|||
145962528|NCT00643760|526375360|FG003|Overall Study|Adverse Event|21|||
145962529|NCT00643760|526375361|FG004|Overall Study|Adverse Event|6|||
145962530|NCT00643760|526375357|FG000|Overall Study|Lack of Efficacy|3|||
145962531|NCT00643760|526375358|FG001|Overall Study|Lack of Efficacy|1|||
145962532|NCT00643760|526375359|FG002|Overall Study|Lack of Efficacy|0|||
145962533|NCT00643760|526375360|FG003|Overall Study|Lack of Efficacy|4|||
145962534|NCT00643760|526375361|FG004|Overall Study|Lack of Efficacy|3|||
145962535|NCT00643760|526375357|FG000|Overall Study|Protocol Violation|7|||
145962536|NCT00643760|526375358|FG001|Overall Study|Protocol Violation|6|||
145962537|NCT00643760|526375359|FG002|Overall Study|Protocol Violation|4|||
145962538|NCT00643760|526375360|FG003|Overall Study|Protocol Violation|4|||
145962539|NCT00643760|526375361|FG004|Overall Study|Protocol Violation|6|||
145962540|NCT00643760|526375357|FG000|Overall Study|Lost to Follow-up|6|||
145962541|NCT00643760|526375358|FG001|Overall Study|Lost to Follow-up|2|||
145962542|NCT00643760|526375359|FG002|Overall Study|Lost to Follow-up|1|||
145962543|NCT00643760|526375360|FG003|Overall Study|Lost to Follow-up|3|||
145962544|NCT00643760|526375361|FG004|Overall Study|Lost to Follow-up|3|||
146228549|NCT02437136|527354941|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146228550|NCT02437136|527354942|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146228551|NCT02437136|527354943|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
146228552|NCT02437136|527354937|FG000|Expansion (Phase 2)|Death|0|||
146228553|NCT02437136|527354938|FG001|Expansion (Phase 2)|Death|0|||
145885292|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
145885293|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
146228554|NCT02437136|527354939|FG002|Expansion (Phase 2)|Death|0|||
146228555|NCT02437136|527354940|FG003|Expansion (Phase 2)|Death|6|||
146228556|NCT02437136|527354941|FG004|Expansion (Phase 2)|Death|37|||
146228557|NCT02437136|527354942|FG005|Expansion (Phase 2)|Death|29|||
146228558|NCT02437136|527354943|FG006|Expansion (Phase 2)|Death|24|||
146228559|NCT02437136|527354937|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
146228560|NCT02437136|527354938|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
146228561|NCT02437136|527354939|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
146228562|NCT02437136|527354940|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
146228563|NCT02437136|527354941|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
146228564|NCT02437136|527354942|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
146228565|NCT02437136|527354943|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
146228566|NCT02437136|527354937|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
146228567|NCT02437136|527354938|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
146228568|NCT02437136|527354939|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
146228569|NCT02437136|527354940|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
146228570|NCT02437136|527354941|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
146228571|NCT02437136|527354942|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
146228572|NCT02437136|527354943|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
146228573|NCT02056834|527354946|FG000|Overall Study|Lost to Follow-up|7|||
146228574|NCT06106022|527354947|FG000|Overall Study|Lost to Follow-up|1|||
146228575|NCT06106022|527354948|FG001|Overall Study|Lost to Follow-up|0|||
146228576|NCT06106022|527354947|FG000|Overall Study|Voluntary Withdrawal|0|||
146228577|NCT06106022|527354948|FG001|Overall Study|Voluntary Withdrawal|2|||
146228578|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
146228579|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
146228580|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228581|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228582|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228583|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228584|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228585|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228586|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228587|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228588|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228589|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
146228590|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228591|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
146228592|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228593|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228594|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228595|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228596|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228597|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228598|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228599|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228600|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228601|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
146228602|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
146228603|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
146228604|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228605|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228606|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228607|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228608|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228609|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228610|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228611|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228612|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228613|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
146228614|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228615|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
146228616|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228617|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228618|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228619|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228620|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228621|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228622|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228623|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228624|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228625|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
146228626|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228627|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
146228628|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228629|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228630|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228631|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228632|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228633|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228634|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228635|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228636|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228637|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
146228638|NCT03536884|527354953|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228639|NCT03536884|527354954|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
146228640|NCT03536884|527354955|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228641|NCT03536884|527354956|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228642|NCT03536884|527354957|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228643|NCT03536884|527354958|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228644|NCT03536884|527354959|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228645|NCT03536884|527354960|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228646|NCT03536884|527354961|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228647|NCT03536884|527354962|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228648|NCT03536884|527354963|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228649|NCT03536884|527354964|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
146228650|NCT03536884|527354953|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228651|NCT03536884|527354954|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228652|NCT03536884|527354955|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
146228653|NCT03536884|527354956|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228654|NCT03536884|527354957|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
146228655|NCT03536884|527354958|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228656|NCT03536884|527354959|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228657|NCT03536884|527354960|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228658|NCT03536884|527354961|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228659|NCT03536884|527354962|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228660|NCT03536884|527354963|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228661|NCT03536884|527354964|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
146228662|NCT03536884|527354953|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228663|NCT03536884|527354954|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228664|NCT03536884|527354955|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
146228665|NCT03536884|527354956|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
146228666|NCT03536884|527354957|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
146228667|NCT03536884|527354958|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228668|NCT03536884|527354959|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228669|NCT03536884|527354960|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228670|NCT03536884|527354961|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228671|NCT03536884|527354962|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228672|NCT03536884|527354963|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228673|NCT03536884|527354964|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
146228674|NCT03536884|527354953|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228675|NCT03536884|527354954|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228676|NCT03536884|527354955|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228677|NCT03536884|527354956|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
146228678|NCT03536884|527354957|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
146228679|NCT03536884|527354958|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228680|NCT03536884|527354959|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228681|NCT03536884|527354960|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228682|NCT03536884|527354961|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228683|NCT03536884|527354962|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228684|NCT03536884|527354963|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228685|NCT03536884|527354964|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
146228686|NCT03536884|527354953|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228687|NCT03536884|527354954|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228688|NCT03536884|527354955|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
146228689|NCT03536884|527354956|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
146228690|NCT03536884|527354957|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
146228691|NCT03536884|527354958|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228692|NCT03536884|527354959|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228693|NCT03536884|527354960|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228694|NCT03536884|527354961|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228695|NCT03536884|527354962|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228696|NCT03536884|527354963|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228697|NCT03536884|527354964|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
146228698|NCT03536884|527354953|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145885294|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885295|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885296|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
146228699|NCT03536884|527354954|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228700|NCT03536884|527354955|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
146228701|NCT03536884|527354956|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
146228702|NCT03536884|527354957|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
146228703|NCT03536884|527354958|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228704|NCT03536884|527354959|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228705|NCT03536884|527354960|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228706|NCT03536884|527354961|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228707|NCT03536884|527354962|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228708|NCT03536884|527354963|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228709|NCT03536884|527354964|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
146228710|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228711|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228712|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228713|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228714|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228715|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
146228716|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
146228717|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
146228718|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
146228719|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228720|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228721|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
146228722|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228723|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228724|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228725|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228726|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228727|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146228728|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146228729|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
146228730|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
146228731|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228732|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228733|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
146228734|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228735|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228736|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228737|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228738|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228739|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
146228740|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228741|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
146228742|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228743|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228744|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228745|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
146228746|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228747|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228748|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228749|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228750|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228751|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
146228752|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228753|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
146228754|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
146228755|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228756|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228757|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
146228758|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228759|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228760|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228761|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228762|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228763|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
146228764|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
146228765|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
146228766|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
146228767|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228768|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228769|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
146228770|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228771|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228772|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228773|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228774|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228775|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
146228776|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228777|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228778|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228779|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228780|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228781|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
146228782|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228783|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228784|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228785|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228786|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228787|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228788|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
146228789|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228790|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228791|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228792|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228793|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
146228794|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228795|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228796|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228797|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228798|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146085950|NCT00969280|526835133|FG000|Overall Study|Withdrawal by Subject|0|||
146085951|NCT00969280|526835134|FG001|Overall Study|Withdrawal by Subject|1|||
145885297|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885298|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885299|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885300|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145885301|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
145885302|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885303|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885304|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885305|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885306|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885307|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885308|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885309|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145885310|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
145885311|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885312|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145962545|NCT00643760|526375357|FG000|Overall Study|Investigator Discretion|0|||
145962546|NCT00643760|526375358|FG001|Overall Study|Investigator Discretion|0|||
146228799|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228800|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
146228801|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228802|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228803|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145885313|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885314|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885315|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885316|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885317|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885318|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145885319|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
145885320|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885321|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885322|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885323|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885324|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885325|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885326|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885327|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145885328|NCT00739973|526084425|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
145885329|NCT00739973|526084426|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885330|NCT00739973|526084427|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885331|NCT00739973|526084428|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885332|NCT00739973|526084429|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885333|NCT00739973|526084430|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885334|NCT00739973|526084431|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885335|NCT00739973|526084432|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885336|NCT00739973|526084433|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145885337|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145885338|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145885339|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
145885340|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
145885341|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
145885342|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145885343|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
145885344|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
145885345|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
145885346|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885347|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885348|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885349|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885350|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
145885351|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885352|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885353|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
145885354|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145885355|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
145885356|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
145885357|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885358|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885359|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885360|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885361|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885362|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885363|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145885364|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
145885365|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
145885366|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
145885367|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
145885368|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145885369|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145885370|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
145962547|NCT00643760|526375359|FG002|Overall Study|Investigator Discretion|0|||
145962548|NCT00643760|526375360|FG003|Overall Study|Investigator Discretion|2|||
145962549|NCT00643760|526375361|FG004|Overall Study|Investigator Discretion|0|||
145962550|NCT00643760|526375357|FG000|Overall Study|Withdrawal by Subject|3|||
146228804|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228805|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
146228806|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228807|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228808|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228809|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228810|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228811|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
146228812|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228813|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228814|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228815|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228816|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228817|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
146228818|NCT03536884|527354953|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228819|NCT03536884|527354954|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228820|NCT03536884|527354955|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228821|NCT03536884|527354956|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228822|NCT03536884|527354957|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228823|NCT03536884|527354958|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228824|NCT03536884|527354959|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228825|NCT03536884|527354960|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228826|NCT03536884|527354961|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
146228827|NCT03536884|527354962|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228828|NCT03536884|527354963|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228829|NCT03536884|527354964|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
146228830|NCT03536884|527354953|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228831|NCT03536884|527354954|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228832|NCT03536884|527354955|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228833|NCT03536884|527354956|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228834|NCT03536884|527354957|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228835|NCT03536884|527354958|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228836|NCT03536884|527354959|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228837|NCT03536884|527354960|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228838|NCT03536884|527354961|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
146228839|NCT03536884|527354962|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
146228840|NCT03536884|527354963|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
146228841|NCT03536884|527354964|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
146228842|NCT03536884|527354953|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228843|NCT03536884|527354954|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228844|NCT03536884|527354955|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228845|NCT03536884|527354956|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145885371|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
146228846|NCT03536884|527354957|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145885372|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145885373|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
146228847|NCT03536884|527354958|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228848|NCT03536884|527354959|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228849|NCT03536884|527354960|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228850|NCT03536884|527354961|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
146228851|NCT03536884|527354962|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146228852|NCT03536884|527354963|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146228853|NCT03536884|527354964|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
146228854|NCT03536884|527354953|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228855|NCT03536884|527354954|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228856|NCT03536884|527354955|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228857|NCT03536884|527354956|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228858|NCT03536884|527354957|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228859|NCT03536884|527354958|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228860|NCT03536884|527354959|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228861|NCT03536884|527354960|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228862|NCT03536884|527354961|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228863|NCT03536884|527354962|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228864|NCT03536884|527354963|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
146228865|NCT03536884|527354964|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
146228866|NCT03536884|527354953|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228867|NCT03536884|527354954|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228868|NCT03536884|527354955|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228869|NCT03536884|527354956|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228870|NCT03536884|527354957|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228871|NCT03536884|527354958|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228872|NCT03536884|527354959|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228873|NCT03536884|527354960|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228874|NCT03536884|527354961|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228875|NCT03536884|527354962|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228876|NCT03536884|527354963|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
146228877|NCT03536884|527354964|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
146228878|NCT03536884|527354953|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228879|NCT03536884|527354954|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228880|NCT03536884|527354955|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228881|NCT03536884|527354956|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228882|NCT03536884|527354957|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228883|NCT03536884|527354958|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228884|NCT03536884|527354959|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228885|NCT03536884|527354960|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228886|NCT03536884|527354961|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228887|NCT03536884|527354962|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228888|NCT03536884|527354963|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
146228889|NCT03536884|527354964|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
145962551|NCT00643760|526375358|FG001|Overall Study|Withdrawal by Subject|1|||
146228890|NCT02909686|527354967|FG000|Overall Study|Physician Decision|3|||
146228891|NCT02909686|527354967|FG000|Overall Study|Withdrawal by Subject|2|||
146228892|NCT02473445|527354968|FG000|Overall Study|Withdrawal by Subject|2|||
145962552|NCT00643760|526375359|FG002|Overall Study|Withdrawal by Subject|2|||
145962553|NCT00643760|526375360|FG003|Overall Study|Withdrawal by Subject|4|||
145962554|NCT00643760|526375361|FG004|Overall Study|Withdrawal by Subject|1|||
145962555|NCT00789321|526375362|FG000|Overall Study|Adverse Event|0|||
145962556|NCT00789321|526375363|FG001|Overall Study|Adverse Event|1|||
145962557|NCT00104052|526375364|FG000|Overall Study|Adverse Event|1|||
145962558|NCT00104052|526375364|FG000|Overall Study|Lack of Efficacy|26|||
145962559|NCT00104052|526375364|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
145962560|NCT03652818|526375367|FG000|Overall Study|Adverse Event|1|||
145962561|NCT03652818|526375368|FG001|Overall Study|Adverse Event|0|||
145962562|NCT03652818|526375369|FG002|Overall Study|Adverse Event|0|||
145962563|NCT03652818|526375370|FG003|Overall Study|Adverse Event|0|||
146228893|NCT02473445|527354968|FG000|Overall Study|Sponsor Decision|20|||
146228894|NCT03484819|527354969|FG000|Overall Study|Death|2|||
146228895|NCT03484819|527354969|FG000|Overall Study|Adverse Event|2|||
146228896|NCT03484819|527354969|FG000|Overall Study|Physician Decision|1|||
146228897|NCT03484819|527354969|FG000|Overall Study|Withdrawal by Subject|2|||
146228898|NCT03484819|527354969|FG000|Overall Study|Disease Progression|4|||
146228899|NCT03484819|527354969|FG000|Overall Study|Complicating Condition|1|||
146228900|NCT02990338|527354970|FG000|Overall Study|Randomized and not treated|4|||
146228901|NCT02990338|527354971|FG001|Overall Study|Randomized and not treated|2|||
146228902|NCT02990338|527354970|FG000|Overall Study|Adverse Event|23|||
146228903|NCT02990338|527354971|FG001|Overall Study|Adverse Event|22|||
146228904|NCT02990338|527354970|FG000|Overall Study|Progressive disease|118|||
146228905|NCT02990338|527354971|FG001|Overall Study|Progressive disease|107|||
145962564|NCT03652818|526375371|FG004|Overall Study|Adverse Event|0|||
145962565|NCT03652818|526375367|FG000|Overall Study|Physician Decision|1|||
146228906|NCT02990338|527354970|FG000|Overall Study|Poor compliance to protocol|0|||
146228907|NCT02990338|527354971|FG001|Overall Study|Poor compliance to protocol|1|||
146228908|NCT02990338|527354970|FG000|Overall Study|Withdrawal by Subject|6|||
146228909|NCT02990338|527354971|FG001|Overall Study|Withdrawal by Subject|8|||
146228910|NCT02990338|527354970|FG000|Overall Study|Physician's decision|2|||
146228911|NCT02990338|527354971|FG001|Overall Study|Physician's decision|6|||
146228912|NCT02990338|527354970|FG000|Overall Study|Treatment extension study|0|||
146228913|NCT02990338|527354971|FG001|Overall Study|Treatment extension study|6|||
146228914|NCT02990338|527354970|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
146228915|NCT02990338|527354971|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
146228916|NCT02990338|527354970|FG000|Overall Study|Continue with therapy available commercially|0|||
146228917|NCT02990338|527354971|FG001|Overall Study|Continue with therapy available commercially|1|||
146228918|NCT04186819|527354972|FG000|Overall Study|Adverse Event|1|||
146228919|NCT04186819|527354972|FG000|Overall Study|Lost to Follow-up|1|||
146228920|NCT04186819|527354972|FG000|Overall Study|Opted for EBRT|1|||
146228921|NCT04186819|527354972|FG000|Overall Study|Opted SBRT|1|||
146228922|NCT04186819|527354972|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
146228923|NCT04186819|527354972|FG000|Overall Study|Physician Decision|1|||
146228924|NCT04186819|527354972|FG000|Overall Study|RP Delayed|1|||
146228925|NCT04186819|527354972|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
146228926|NCT04186819|527354972|FG000|Overall Study|Subject declined for financial reasons|1|||
146228927|NCT04186819|527354972|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
146228928|NCT04186819|527354972|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
146228929|NCT04186819|527354972|FG000|Overall Study|The subject opted for other treatment option|2|||
146228930|NCT04186819|527354972|FG000|Overall Study|The subject opted for other treatment options|1|||
146228931|NCT04186819|527354972|FG000|Overall Study|Withdrawal by Subject|3|||
146228932|NCT04186819|527354972|FG000|Overall Study|Reason not specified|1|||
146228933|NCT05900154|527354973|FG000|Follow-Up Period|Lost to Follow-up|1|||
146228934|NCT05900154|527354974|FG001|Follow-Up Period|Lost to Follow-up|2|||
146228935|NCT05900154|527354975|FG002|Follow-Up Period|Lost to Follow-up|1|||
146228936|NCT05900154|527354976|FG003|Follow-Up Period|Lost to Follow-up|0|||
146228937|NCT05900154|527354977|FG004|Follow-Up Period|Lost to Follow-up|1|||
146228938|NCT05900154|527354978|FG005|Follow-Up Period|Lost to Follow-up|1|||
146228939|NCT04102111|527354987|FG000|Overall Study|Withdrawal by Subject|2|||
145962566|NCT03652818|526375368|FG001|Overall Study|Physician Decision|0|||
145962567|NCT03652818|526375369|FG002|Overall Study|Physician Decision|0|||
145962568|NCT03652818|526375370|FG003|Overall Study|Physician Decision|0|||
145962569|NCT03652818|526375371|FG004|Overall Study|Physician Decision|0|||
145962570|NCT03652818|526375367|FG000|Overall Study|Lost to Follow-up|0|||
145962571|NCT03652818|526375368|FG001|Overall Study|Lost to Follow-up|1|||
145962572|NCT03652818|526375369|FG002|Overall Study|Lost to Follow-up|2|||
146228940|NCT04102111|527354988|FG001|Overall Study|Withdrawal by Subject|3|||
145962573|NCT03652818|526375370|FG003|Overall Study|Lost to Follow-up|1|||
145962574|NCT03652818|526375371|FG004|Overall Study|Lost to Follow-up|1|||
146228941|NCT04102111|527354987|FG000|Overall Study|Adverse Event|1|||
146228942|NCT04102111|527354988|FG001|Overall Study|Adverse Event|1|||
146228943|NCT04102111|527354987|FG000|Overall Study|Study terminated by sponsor|1|||
145962575|NCT03964207|526375372|FG000|First Treatment|Withdrawal by Subject|1|||
145962576|NCT03964207|526375373|FG001|First Treatment|Withdrawal by Subject|2|||
145962577|NCT03964207|526375372|FG000|First Treatment|Protocol Violation|1|||
145962578|NCT03964207|526375373|FG001|First Treatment|Protocol Violation|0|||
145962579|NCT03964207|526375372|FG000|First Treatment|Lost to Follow-up|1|||
145962580|NCT03964207|526375373|FG001|First Treatment|Lost to Follow-up|0|||
145962581|NCT03964207|526375372|FG000|Second Treatment|Lost to Follow-up|0|||
145962582|NCT03964207|526375373|FG001|Second Treatment|Lost to Follow-up|1|||
145962583|NCT03964207|526375372|FG000|Second Treatment|Adverse Event|1|||
145962584|NCT03964207|526375373|FG001|Second Treatment|Adverse Event|2|||
145962585|NCT00830219|526375374|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145962586|NCT00830219|526375375|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145962587|NCT01294423|526375380|FG000|Overall Study|Adverse Event|1|||
146228944|NCT04102111|527354988|FG001|Overall Study|Study terminated by sponsor|3|||
146228945|NCT04583280|527354990|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
145962588|NCT01294423|526375381|FG001|Overall Study|Adverse Event|2|||
146228946|NCT04583280|527354991|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
145962589|NCT01294423|526375382|FG002|Overall Study|Adverse Event|3|||
145962590|NCT01294423|526375380|FG000|Overall Study|Withdrawal by Subject|1|||
146228947|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
146228948|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
145962591|NCT01294423|526375381|FG001|Overall Study|Withdrawal by Subject|2|||
145962592|NCT01294423|526375382|FG002|Overall Study|Withdrawal by Subject|2|||
145962593|NCT01294423|526375380|FG000|Overall Study|subject no longer meets study criteria|2|||
145962594|NCT01294423|526375381|FG001|Overall Study|subject no longer meets study criteria|5|||
145962595|NCT01294423|526375382|FG002|Overall Study|subject no longer meets study criteria|2|||
145962596|NCT01294423|526375380|FG000|Overall Study|poor/non-compliance|1|||
145962597|NCT01294423|526375381|FG001|Overall Study|poor/non-compliance|0|||
145962598|NCT01294423|526375382|FG002|Overall Study|poor/non-compliance|1|||
145962599|NCT01241279|526375383|FG000|Overall Study|Lost to Follow-up|0|||
145962600|NCT01241279|526375384|FG001|Overall Study|Lost to Follow-up|1|||
145962601|NCT00239720|526375388|FG000|Overall Study|Adverse Event|1|||
145962602|NCT00239720|526375389|FG001|Overall Study|Adverse Event|0|||
145962603|NCT00239720|526375388|FG000|Overall Study|Lost to Follow-up|0|||
145962604|NCT00239720|526375389|FG001|Overall Study|Lost to Follow-up|1|||
145962605|NCT01811732|526375390|FG000|Overall Study|Lost to Follow-up|24|||
145962606|NCT01811732|526375391|FG001|Overall Study|Lost to Follow-up|30|||
145962607|NCT01811732|526375390|FG000|Overall Study|Withdrawal by Subject|16|||
145962608|NCT01811732|526375391|FG001|Overall Study|Withdrawal by Subject|10|||
145962609|NCT01811732|526375390|FG000|Overall Study|Adverse Event|3|||
145962610|NCT01811732|526375391|FG001|Overall Study|Adverse Event|9|||
145962611|NCT01811732|526375390|FG000|Overall Study|Lack of Efficacy|3|||
145962612|NCT01811732|526375391|FG001|Overall Study|Lack of Efficacy|1|||
145962613|NCT01811732|526375390|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
145962614|NCT01811732|526375391|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
145962615|NCT01811732|526375390|FG000|Overall Study|Physician Decision|2|||
145962616|NCT01811732|526375391|FG001|Overall Study|Physician Decision|0|||
145962617|NCT01811732|526375390|FG000|Overall Study|Death|1|||
145962618|NCT01811732|526375391|FG001|Overall Study|Death|1|||
145962619|NCT01811732|526375390|FG000|Overall Study|Insufficient venous access|0|||
145962620|NCT01811732|526375391|FG001|Overall Study|Insufficient venous access|1|||
145962621|NCT01811732|526375390|FG000|Overall Study|Protocol Violation|0|||
145962622|NCT01811732|526375391|FG001|Overall Study|Protocol Violation|1|||
145962623|NCT01811732|526375390|FG000|Overall Study|Subject incarcerated|1|||
145962624|NCT01811732|526375391|FG001|Overall Study|Subject incarcerated|2|||
146228949|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
145962625|NCT01811732|526375390|FG000|Overall Study|Admitted to another facility|1|||
145962626|NCT01811732|526375391|FG001|Overall Study|Admitted to another facility|0|||
145962627|NCT01811732|526375390|FG000|Overall Study|Correct study drug not available on site|1|||
145962628|NCT01811732|526375391|FG001|Overall Study|Correct study drug not available on site|0|||
145962629|NCT01699750|526375394|FG000|Overall Study|Withdrew Consent|0|||
145962630|NCT01699750|526375395|FG001|Overall Study|Withdrew Consent|1|||
145962631|NCT01699750|526375394|FG000|Overall Study|Other|0|||
145962632|NCT01699750|526375395|FG001|Overall Study|Other|2|||
145962633|NCT02452047|526375396|FG000|Overall Study|Adverse Event|0|||
145962634|NCT02452047|526375397|FG001|Overall Study|Adverse Event|1|||
145962635|NCT02452047|526375398|FG002|Overall Study|Adverse Event|1|||
145962636|NCT02452047|526375396|FG000|Overall Study|Death|1|||
145962637|NCT02452047|526375397|FG001|Overall Study|Death|3|||
145962638|NCT02452047|526375398|FG002|Overall Study|Death|1|||
145962639|NCT02452047|526375396|FG000|Overall Study|Physician Decision|1|||
145962640|NCT02452047|526375397|FG001|Overall Study|Physician Decision|0|||
145962641|NCT02452047|526375398|FG002|Overall Study|Physician Decision|0|||
145962642|NCT02452047|526375396|FG000|Overall Study|Lost to Follow-up|1|||
145962643|NCT02452047|526375397|FG001|Overall Study|Lost to Follow-up|1|||
145962644|NCT02452047|526375398|FG002|Overall Study|Lost to Follow-up|0|||
145962645|NCT02452047|526375396|FG000|Overall Study|Withdrawal by Subject|1|||
145962646|NCT02452047|526375397|FG001|Overall Study|Withdrawal by Subject|0|||
145962647|NCT02452047|526375398|FG002|Overall Study|Withdrawal by Subject|0|||
145962648|NCT01868646|526375399|FG000|Overall Study|Do not meet inclusion criteria|3|||
145962649|NCT01868646|526375400|FG001|Overall Study|Do not meet inclusion criteria|5|||
145962650|NCT01831427|526375401|FG000|Overall Study|Adverse Event|0|||
145962651|NCT01831427|526375402|FG001|Overall Study|Adverse Event|1|||
145962652|NCT01831427|526375403|FG002|Overall Study|Adverse Event|0|||
145962653|NCT01831427|526375404|FG003|Overall Study|Adverse Event|0|||
145962654|NCT01831427|526375405|FG004|Overall Study|Adverse Event|0|||
145962655|NCT01831427|526375406|FG005|Overall Study|Adverse Event|1|||
145962656|NCT01831427|526375407|FG006|Overall Study|Adverse Event|0|||
145962657|NCT01831427|526375408|FG007|Overall Study|Adverse Event|1|||
145962658|NCT01831427|526375409|FG008|Overall Study|Adverse Event|0|||
145962659|NCT01831427|526375410|FG009|Overall Study|Adverse Event|0|||
145962660|NCT01831427|526375411|FG010|Overall Study|Adverse Event|2|||
145962661|NCT01831427|526375401|FG000|Overall Study|Investigator's Discretion|0|||
145962662|NCT01831427|526375402|FG001|Overall Study|Investigator's Discretion|0|||
145962663|NCT01831427|526375403|FG002|Overall Study|Investigator's Discretion|0|||
145962664|NCT01831427|526375404|FG003|Overall Study|Investigator's Discretion|1|||
145962665|NCT01831427|526375405|FG004|Overall Study|Investigator's Discretion|0|||
145962666|NCT01831427|526375406|FG005|Overall Study|Investigator's Discretion|0|||
145962667|NCT01831427|526375407|FG006|Overall Study|Investigator's Discretion|0|||
145962668|NCT01831427|526375408|FG007|Overall Study|Investigator's Discretion|0|||
145962669|NCT01831427|526375409|FG008|Overall Study|Investigator's Discretion|0|||
145962670|NCT01831427|526375410|FG009|Overall Study|Investigator's Discretion|0|||
145962671|NCT01831427|526375411|FG010|Overall Study|Investigator's Discretion|0|||
145962672|NCT01831427|526375401|FG000|Overall Study|Withdrew Consent|0|||
145962673|NCT01831427|526375402|FG001|Overall Study|Withdrew Consent|0|||
145962674|NCT01831427|526375403|FG002|Overall Study|Withdrew Consent|0|||
145962675|NCT01831427|526375404|FG003|Overall Study|Withdrew Consent|0|||
145962676|NCT01831427|526375405|FG004|Overall Study|Withdrew Consent|0|||
145962677|NCT01831427|526375406|FG005|Overall Study|Withdrew Consent|0|||
145962678|NCT01831427|526375407|FG006|Overall Study|Withdrew Consent|2|||
145962679|NCT01831427|526375408|FG007|Overall Study|Withdrew Consent|0|||
145962680|NCT01831427|526375409|FG008|Overall Study|Withdrew Consent|0|||
145962681|NCT01831427|526375410|FG009|Overall Study|Withdrew Consent|1|||
145962682|NCT01831427|526375411|FG010|Overall Study|Withdrew Consent|1|||
145962683|NCT00917124|526375412|FG000|Overall Study|Protocol Violation|4|||
145962684|NCT00917124|526375413|FG001|Overall Study|Protocol Violation|6|||
145962685|NCT01607593|526375418|FG000|Overall Study|Adverse Event|15|||
145962686|NCT01607593|526375418|FG000|Overall Study|Lack of Efficacy|16|||
145962687|NCT01607593|526375418|FG000|Overall Study|Lost to Follow-up|25|||
145962688|NCT01607593|526375418|FG000|Overall Study|Continuation|33|||
145962689|NCT01607593|526375418|FG000|Overall Study|Other|4|||
145962690|NCT02771275|526375422|FG000|Overall Study|Reoperation|3|||
146228950|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
146228951|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
145962691|NCT02771275|526375422|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
145962692|NCT00483652|526375423|FG000|Double-blind Treatment Period|Protocol Violation|2|||
145962693|NCT00483652|526375424|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145962694|NCT00483652|526375423|FG000|Double-blind Treatment Period|Adverse Event|3|||
145962695|NCT00483652|526375424|FG001|Double-blind Treatment Period|Adverse Event|4|||
145962696|NCT00483652|526375423|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
145962697|NCT00483652|526375424|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
145962698|NCT00483652|526375423|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
146228952|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
146228953|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
146228954|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
146228955|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
146228956|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
146228957|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
146228958|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
146228959|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
146228960|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
146228961|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
146228962|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
146228963|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
146228964|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
146228965|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
146228966|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
146228967|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
146228968|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
146228969|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
146228970|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
146228971|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
146228972|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
146228973|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
146228974|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
146228975|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
146228976|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
146228977|NCT04614948|527354992|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
146228978|NCT04614948|527354993|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
146228979|NCT04614948|527354994|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
146228980|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
146228981|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
146228982|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
146228983|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
146228984|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
146228985|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
146228986|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
146228987|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
146228988|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
146228989|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
146228990|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
146228991|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
146228992|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
146228993|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
146228994|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
146228995|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
146228996|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
146228997|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
146228998|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
146228999|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
146229000|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
146229001|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
146229002|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
146229003|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
146229004|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
146229005|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
146229006|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
146229007|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
146229008|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
146229009|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
146229010|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
146229011|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
146229012|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
146229013|NCT04614948|527354992|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
146229014|NCT04614948|527354993|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
146229015|NCT04614948|527354994|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
146229016|NCT00631475|527354995|FG000|Overall Study|Death|18|||
146229017|NCT00631475|527354995|FG000|Overall Study|Adverse Event|14|||
146229018|NCT00631475|527354995|FG000|Overall Study|Withdrew consent|5|||
146229019|NCT00631475|527354995|FG000|Overall Study|Preparation for lung transplant|8|||
146229020|NCT00303459|527354996|FG000|Overall Study|Death|33|||
146229021|NCT00303459|527354997|FG001|Overall Study|Death|44|||
146229022|NCT00303459|527354996|FG000|Overall Study|Withdrawal of consent|32|||
146229023|NCT00303459|527354997|FG001|Overall Study|Withdrawal of consent|26|||
146229024|NCT00303459|527354996|FG000|Overall Study|Lost to Follow-up|5|||
146229025|NCT00303459|527354997|FG001|Overall Study|Lost to Follow-up|4|||
146229026|NCT00303459|527354996|FG000|Overall Study|Administrative reason|7|||
146229027|NCT00303459|527354997|FG001|Overall Study|Administrative reason|7|||
146229028|NCT00303459|527354996|FG000|Overall Study|Decision by the investigator|5|||
146229029|NCT00303459|527354997|FG001|Overall Study|Decision by the investigator|7|||
146229030|NCT00303459|527354996|FG000|Overall Study|Lung transplantation|1|||
146229031|NCT00303459|527354997|FG001|Overall Study|Lung transplantation|1|||
146229032|NCT03691298|527355000|FG000|Overall Study|Lost to Follow-up|8|||
146229033|NCT03691298|527355000|FG000|Overall Study|Sponsor terminated study|2|||
146229034|NCT02492711|527355004|FG000|Overall Study|Adverse Event|9|||
146229035|NCT02492711|527355005|FG001|Overall Study|Adverse Event|9|||
146229036|NCT02492711|527355006|FG002|Overall Study|Adverse Event|2|||
146229037|NCT02492711|527355004|FG000|Overall Study|Death|3|||
146229038|NCT02492711|527355005|FG001|Overall Study|Death|3|||
146289207|NCT03170349|527573398|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
145885374|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885375|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
145885376|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885377|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145962699|NCT00483652|526375424|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
145962700|NCT03191799|526375425|FG000|Overall Study|Withdrawal by Subject|4|||
145962701|NCT03191799|526375425|FG000|Overall Study|Physician Decision|2|||
145962702|NCT03191799|526375425|FG000|Overall Study|Lost to Follow-up|1|||
145962703|NCT03191799|526375425|FG000|Overall Study|Death|2|||
145962704|NCT00126594|526375427|FG000|Overall Study|Ineligible|2|||
145962705|NCT00126594|526375428|FG001|Overall Study|Ineligible|0|||
145962706|NCT00126594|526375427|FG000|Overall Study|Withdrawal by Subject|0|||
145962707|NCT00126594|526375428|FG001|Overall Study|Withdrawal by Subject|4|||
145962708|NCT00126594|526375427|FG000|Overall Study|Physician Decision|1|||
145962709|NCT00126594|526375428|FG001|Overall Study|Physician Decision|3|||
145962710|NCT00126594|526375427|FG000|Overall Study|Adverse Event|7|||
145962711|NCT00126594|526375428|FG001|Overall Study|Adverse Event|5|||
145962712|NCT00126594|526375427|FG000|Overall Study|Non-compliance|0|||
145962713|NCT00126594|526375428|FG001|Overall Study|Non-compliance|1|||
145962714|NCT00126594|526375427|FG000|Overall Study|Disease Progression|29|||
145962715|NCT00126594|526375428|FG001|Overall Study|Disease Progression|24|||
145962716|NCT00468585|526375429|FG000|Overall Study|Patient not treated|1|||
145962717|NCT00468585|526375430|FG001|Overall Study|Patient not treated|0|||
145962718|NCT00468585|526375431|FG002|Overall Study|Patient not treated|1|||
145962719|NCT00468585|526375432|FG003|Overall Study|Patient not treated|0|||
145962720|NCT00468585|526375429|FG000|Overall Study|Patient found to be ineligible|0|||
145962721|NCT00468585|526375430|FG001|Overall Study|Patient found to be ineligible|0|||
145885378|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885379|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885380|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885381|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145885382|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145885383|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
145885384|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145885385|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
145885386|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145962722|NCT00468585|526375431|FG002|Overall Study|Patient found to be ineligible|1|||
145962723|NCT00468585|526375432|FG003|Overall Study|Patient found to be ineligible|0|||
145962724|NCT00468585|526375429|FG000|Overall Study|Adverse Event|0|||
146229039|NCT02492711|527355006|FG002|Overall Study|Death|0|||
145962725|NCT00468585|526375430|FG001|Overall Study|Adverse Event|0|||
146229040|NCT02492711|527355004|FG000|Overall Study|Withdrawal by Subject|10|||
145885387|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145885388|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
145885389|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
145885390|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145885391|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
145885392|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145885393|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
145885394|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
145885395|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145885396|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145885397|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
145885398|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
145885399|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
145885400|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885401|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885402|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885403|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885404|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885405|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885406|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
145885407|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885408|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145885409|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
145885410|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145885411|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
145885412|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145885413|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145885414|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
145885415|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145885416|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145885417|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145885418|NCT00739973|526084425|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885419|NCT00739973|526084426|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
145885420|NCT00739973|526084427|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885421|NCT00739973|526084428|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885422|NCT00739973|526084429|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885423|NCT00739973|526084430|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885424|NCT00739973|526084431|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
145885425|NCT00739973|526084432|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885426|NCT00739973|526084433|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145885427|NCT00987831|526084434|FG000|Overall Study|Never flared in 12 months|1|||
145885428|NCT00987831|526084435|FG001|Overall Study|Never flared in 12 months|0|||
145885429|NCT00987831|526084436|FG002|Overall Study|Never flared in 12 months|0|||
145885430|NCT00987831|526084434|FG000|Overall Study|Lost to Follow-up|0|||
145885431|NCT00987831|526084435|FG001|Overall Study|Lost to Follow-up|3|||
145885432|NCT00987831|526084436|FG002|Overall Study|Lost to Follow-up|0|||
145885433|NCT04149535|526084439|FG000|Overall Study|Death|11|||
145885434|NCT04149535|526084440|FG001|Overall Study|Death|7|||
145885435|NCT04149535|526084439|FG000|Overall Study|Physician Decision|10|||
145885436|NCT04149535|526084440|FG001|Overall Study|Physician Decision|4|||
145962726|NCT00468585|526375431|FG002|Overall Study|Adverse Event|1|||
145962727|NCT00468585|526375432|FG003|Overall Study|Adverse Event|0|||
145962728|NCT00468585|526375429|FG000|Overall Study|Withdrawal by Subject|0|||
145962729|NCT00468585|526375430|FG001|Overall Study|Withdrawal by Subject|0|||
146289208|NCT03170349|527573398|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
146229041|NCT02492711|527355005|FG001|Overall Study|Withdrawal by Subject|16|||
146229042|NCT02492711|527355006|FG002|Overall Study|Withdrawal by Subject|5|||
146229043|NCT02492711|527355004|FG000|Overall Study|Physician Decision|10|||
146229044|NCT02492711|527355005|FG001|Overall Study|Physician Decision|6|||
146229045|NCT02492711|527355006|FG002|Overall Study|Physician Decision|4|||
146229046|NCT02492711|527355004|FG000|Overall Study|Lost to Follow-up|0|||
146229047|NCT02492711|527355005|FG001|Overall Study|Lost to Follow-up|0|||
146229048|NCT02492711|527355006|FG002|Overall Study|Lost to Follow-up|1|||
146229049|NCT02492711|527355004|FG000|Overall Study|study treatment delay|2|||
146229050|NCT02492711|527355005|FG001|Overall Study|study treatment delay|1|||
146229051|NCT02492711|527355006|FG002|Overall Study|study treatment delay|0|||
146229052|NCT02492711|527355004|FG000|Overall Study|change in chemotherapy|0|||
146229053|NCT02492711|527355005|FG001|Overall Study|change in chemotherapy|1|||
146229054|NCT02492711|527355006|FG002|Overall Study|change in chemotherapy|0|||
146229055|NCT02492711|527355004|FG000|Overall Study|never treated|2|||
146229056|NCT02492711|527355005|FG001|Overall Study|never treated|4|||
146229057|NCT02492711|527355006|FG002|Overall Study|never treated|0|||
146229058|NCT02492711|527355004|FG000|Overall Study|Other|0|||
146229059|NCT02492711|527355005|FG001|Overall Study|Other|0|||
146229060|NCT02492711|527355006|FG002|Overall Study|Other|1|||
146229061|NCT03663205|527355007|FG000|Overall Study|Death|144|||
146229062|NCT03663205|527355008|FG001|Overall Study|Death|69|||
146229063|NCT03663205|527355007|FG000|Overall Study|Sponsor decision|53|||
146229064|NCT03663205|527355008|FG001|Overall Study|Sponsor decision|19|||
146229065|NCT03663205|527355007|FG000|Overall Study|Withdrawal by Subject|8|||
146229066|NCT03663205|527355008|FG001|Overall Study|Withdrawal by Subject|11|||
146229067|NCT03663205|527355007|FG000|Overall Study|Lost to Follow-up|7|||
146229068|NCT03663205|527355008|FG001|Overall Study|Lost to Follow-up|9|||
146229069|NCT03663205|527355007|FG000|Overall Study|Transferred to long term extension study|11|||
146229070|NCT03663205|527355008|FG001|Overall Study|Transferred to long term extension study|3|||
146229071|NCT04633538|527355013|FG000|Overall Study|Death|1|||
146229072|NCT04633538|527355013|FG000|Overall Study|Lost to Follow-up|3|||
146229073|NCT04633538|527355013|FG000|Overall Study|Withdrawal by Subject|1|||
146229074|NCT02938520|527355014|FG000|Overall Study|On-going at the time of analysis|258|||
146229075|NCT02938520|527355015|FG001|Overall Study|On-going at the time of analysis|261|||
146229076|NCT02938520|527355014|FG000|Overall Study|Physician Decision|2|||
146229077|NCT02938520|527355015|FG001|Overall Study|Physician Decision|5|||
146229078|NCT02938520|527355014|FG000|Overall Study|Lost to Follow-up|2|||
146229079|NCT02938520|527355015|FG001|Overall Study|Lost to Follow-up|2|||
146229080|NCT02938520|527355014|FG000|Overall Study|Withdrawal by Subject|7|||
146229081|NCT02938520|527355015|FG001|Overall Study|Withdrawal by Subject|7|||
146229082|NCT02938520|527355014|FG000|Overall Study|Protocol Violation|0|||
146229083|NCT02938520|527355015|FG001|Overall Study|Protocol Violation|1|||
146229084|NCT02938520|527355014|FG000|Overall Study|Lack of Efficacy|5|||
146229085|NCT02938520|527355015|FG001|Overall Study|Lack of Efficacy|3|||
146229086|NCT02938520|527355014|FG000|Overall Study|Adverse Event|9|||
146229087|NCT02938520|527355015|FG001|Overall Study|Adverse Event|4|||
146229088|NCT03245840|527355016|FG000|Overall Study|Adverse Event|6|||
146229089|NCT03245840|527355017|FG001|Overall Study|Adverse Event|0|||
146229090|NCT03245840|527355016|FG000|Overall Study|Death|2|||
146229091|NCT03245840|527355017|FG001|Overall Study|Death|0|||
146229092|NCT03245840|527355016|FG000|Overall Study|Withdrawal by Subject|31|||
146229093|NCT03245840|527355017|FG001|Overall Study|Withdrawal by Subject|1|||
146229094|NCT03245840|527355016|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146229095|NCT03245840|527355017|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146229096|NCT03245840|527355016|FG000|Overall Study|Physician Decision|4|||
146229097|NCT03245840|527355017|FG001|Overall Study|Physician Decision|1|||
146229098|NCT03245840|527355016|FG000|Overall Study|Study Terminated by Sponsor|56|||
146229099|NCT03245840|527355017|FG001|Overall Study|Study Terminated by Sponsor|6|||
146229100|NCT03245840|527355016|FG000|Overall Study|Site Terminated by Sponsor|4|||
146229101|NCT03245840|527355017|FG001|Overall Study|Site Terminated by Sponsor|0|||
146229102|NCT03245840|527355016|FG000|Overall Study|Lost to Follow-up|12|||
146229103|NCT03245840|527355017|FG001|Overall Study|Lost to Follow-up|2|||
146229104|NCT03245840|527355016|FG000|Overall Study|Pregnancy|2|||
146229105|NCT03245840|527355017|FG001|Overall Study|Pregnancy|0|||
146229106|NCT03245840|527355016|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146229107|NCT03245840|527355017|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146229108|NCT03245840|527355016|FG000|Overall Study|Not treated|1|||
146229109|NCT03245840|527355017|FG001|Overall Study|Not treated|1|||
146229110|NCT01130883|527356491|FG000|Overall Study|Patient Noncompliance|6|||
146229111|NCT01130883|527356491|FG000|Overall Study|Reason Unknown|1|||
146229112|NCT01130883|527356491|FG000|Overall Study|Adverse Event|3|||
145962730|NCT00468585|526375431|FG002|Overall Study|Withdrawal by Subject|2|||
145962731|NCT00468585|526375432|FG003|Overall Study|Withdrawal by Subject|1|||
145962732|NCT01290718|526375437|FG000|Overall Study|Early termination of the study|4|||
145962733|NCT00891813|526375440|FG000|Overall Study|Adverse Event|3|||
145962734|NCT00891813|526375440|FG000|Overall Study|Withdrawal by Subject|1|||
145962735|NCT00891813|526375440|FG000|Overall Study|Patient Noncompliance|6|||
145962736|NCT00891813|526375440|FG000|Overall Study|Protocol Violation|2|||
145962737|NCT02456727|526375443|FG000|Overall Study|Lost to Follow-up|63|||
145962738|NCT02456727|526375444|FG001|Overall Study|Lost to Follow-up|65|||
145962739|NCT02456727|526375443|FG000|Overall Study|Death|2|||
146229113|NCT02585323|527356492|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
146229114|NCT02585323|527356493|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
146229115|NCT02585323|527356492|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
146229116|NCT02585323|527356493|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
146229117|NCT02585323|527356492|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
146229118|NCT02585323|527356493|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
146229119|NCT02585323|527356492|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
146229120|NCT02585323|527356493|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
146229121|NCT03972150|527356496|FG000|Overall Study|Adverse Event|0|||
146229122|NCT03972150|527356497|FG001|Overall Study|Adverse Event|1|||
146229123|NCT03972150|527356498|FG002|Overall Study|Adverse Event|1|||
146229124|NCT03972150|527356499|FG003|Overall Study|Adverse Event|0|||
146229125|NCT03972150|527356500|FG004|Overall Study|Adverse Event|0|||
146229126|NCT03972150|527356496|FG000|Overall Study|Progressive disease|3|||
146229127|NCT03972150|527356497|FG001|Overall Study|Progressive disease|5|||
146229128|NCT03972150|527356498|FG002|Overall Study|Progressive disease|2|||
146229129|NCT03972150|527356499|FG003|Overall Study|Progressive disease|2|||
146229130|NCT03972150|527356500|FG004|Overall Study|Progressive disease|3|||
146229131|NCT03505710|527356501|FG000|Overall Study|Progressive Disease|24|||
146229132|NCT03505710|527356502|FG001|Overall Study|Progressive Disease|17|||
146229133|NCT03505710|527356503|FG002|Overall Study|Progressive Disease|43|||
146229134|NCT03505710|527356501|FG000|Overall Study|Clinical Progression|6|||
146229135|NCT03505710|527356502|FG001|Overall Study|Clinical Progression|8|||
145885437|NCT04149535|526084439|FG000|Overall Study|Withdrawal by Subject|6|||
145885438|NCT04149535|526084440|FG001|Overall Study|Withdrawal by Subject|7|||
145885439|NCT04149535|526084439|FG000|Overall Study|Not described|2|||
145885440|NCT04149535|526084440|FG001|Overall Study|Not described|0|||
145885441|NCT02175368|526084441|FG000|Overall Study|Lost to Follow-up|1|||
145885442|NCT02875028|526084442|FG000|Washout Period|Withdrawal by Subject|0|||
145885443|NCT02875028|526084443|FG001|Washout Period|Withdrawal by Subject|1|||
145885444|NCT05068284|526084444|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
145885445|NCT05068284|526084445|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
145885446|NCT05068284|526084446|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885447|NCT05068284|526084447|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885448|NCT05068284|526084448|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885449|NCT05068284|526084449|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885450|NCT05068284|526084450|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885451|NCT05068284|526084451|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145885452|NCT05068284|526084444|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885453|NCT05068284|526084445|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885454|NCT05068284|526084446|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
145885455|NCT05068284|526084447|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885456|NCT05068284|526084448|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885457|NCT05068284|526084449|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885458|NCT05068284|526084450|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885459|NCT05068284|526084451|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145885460|NCT05068284|526084444|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
145885461|NCT05068284|526084445|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
146229136|NCT03505710|527356503|FG002|Overall Study|Clinical Progression|3|||
146229137|NCT03505710|527356501|FG000|Overall Study|Adverse Event|12|||
146229138|NCT03505710|527356502|FG001|Overall Study|Adverse Event|6|||
146229139|NCT03505710|527356503|FG002|Overall Study|Adverse Event|28|||
146229140|NCT03505710|527356501|FG000|Overall Study|Withdrawal by Subject|1|||
146229141|NCT03505710|527356502|FG001|Overall Study|Withdrawal by Subject|3|||
146229142|NCT03505710|527356503|FG002|Overall Study|Withdrawal by Subject|7|||
146229143|NCT03505710|527356501|FG000|Overall Study|Physician Decision|1|||
146229144|NCT03505710|527356502|FG001|Overall Study|Physician Decision|1|||
145885462|NCT05068284|526084446|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
146229145|NCT03505710|527356503|FG002|Overall Study|Physician Decision|2|||
146229146|NCT03505710|527356501|FG000|Overall Study|Death|4|||
145885463|NCT05068284|526084447|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
146229147|NCT03505710|527356502|FG001|Overall Study|Death|5|||
146229148|NCT03505710|527356503|FG002|Overall Study|Death|6|||
146229149|NCT03505710|527356501|FG000|Overall Study|Other Reasons|1|||
145962740|NCT02456727|526375444|FG001|Overall Study|Death|1|||
145962741|NCT02456727|526375443|FG000|Overall Study|Withdrawal by Subject|1|||
145962742|NCT02456727|526375444|FG001|Overall Study|Withdrawal by Subject|10|||
145962743|NCT02456727|526375443|FG000|Overall Study|Never Initiated Treatment|43|||
145962744|NCT02456727|526375444|FG001|Overall Study|Never Initiated Treatment|30|||
145962745|NCT02513550|526375445|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
146229150|NCT03505710|527356502|FG001|Overall Study|Other Reasons|1|||
145885464|NCT05068284|526084448|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
145885465|NCT05068284|526084449|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145885466|NCT05068284|526084450|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145885467|NCT05068284|526084451|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145885468|NCT05068284|526084444|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145885469|NCT05068284|526084445|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145885470|NCT05068284|526084446|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
145885471|NCT05068284|526084447|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145885472|NCT05068284|526084448|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
145885473|NCT05068284|526084449|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145885474|NCT05068284|526084450|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
146229151|NCT03505710|527356503|FG002|Overall Study|Other Reasons|1|||
146229152|NCT03505710|527356501|FG000|Overall Study|Study Terminated by Sponsor|0|||
146229153|NCT03505710|527356502|FG001|Overall Study|Study Terminated by Sponsor|0|||
146229154|NCT03505710|527356503|FG002|Overall Study|Study Terminated by Sponsor|1|||
146229155|NCT03981926|527356504|FG000|Overall Study|Lost to Follow-up|5|||
146229156|NCT03981926|527356505|FG001|Overall Study|Lost to Follow-up|9|||
146229157|NCT06262347|527356506|FG000|Overall Study|Lost to Follow-up|4|||
146229158|NCT06262347|527356507|FG001|Overall Study|Lost to Follow-up|3|||
146229159|NCT06262347|527356506|FG000|Overall Study|Withdrawal by Subject|0|||
146229160|NCT06262347|527356507|FG001|Overall Study|Withdrawal by Subject|1|||
146229161|NCT05464069|527356508|FG000|Overall Study|Protocol Violation|3|||
146229162|NCT05464069|527356509|FG001|Overall Study|Protocol Violation|2|||
146229163|NCT04089865|527356520|FG000|Overall Study|Withdrawal by Subject|2|||
146229164|NCT04089865|527356521|FG001|Overall Study|Withdrawal by Subject|2|||
146229165|NCT04089865|527356522|FG002|Overall Study|Withdrawal by Subject|7|||
146229166|NCT04089865|527356523|FG003|Overall Study|Withdrawal by Subject|2|||
146229167|NCT05524116|527356543|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
146229168|NCT05524116|527356544|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
146229169|NCT05524116|527356543|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
146229170|NCT05524116|527356544|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
146229171|NCT05524116|527356543|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
146229172|NCT05524116|527356544|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
146229173|NCT05524116|527356543|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
146229174|NCT05524116|527356544|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
146229175|NCT05524116|527356543|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
146229176|NCT05524116|527356544|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
146229177|NCT03580356|527356546|FG000|Treatment Period|Withdrawal by Subject|13|||
146229178|NCT03580356|527356547|FG001|Treatment Period|Withdrawal by Subject|0|||
146229179|NCT03580356|527356548|FG002|Treatment Period|Withdrawal by Subject|13|||
146229180|NCT03580356|527356549|FG003|Treatment Period|Withdrawal by Subject|1|||
146229181|NCT03580356|527356550|FG004|Treatment Period|Withdrawal by Subject|17|||
146229182|NCT03580356|527356551|FG005|Treatment Period|Withdrawal by Subject|0|||
146229183|NCT03580356|527356552|FG006|Treatment Period|Withdrawal by Subject|5|||
146229184|NCT03580356|527356553|FG007|Treatment Period|Withdrawal by Subject|0|||
146229185|NCT03580356|527356546|FG000|Treatment Period|Adverse Event|10|||
146229186|NCT03580356|527356547|FG001|Treatment Period|Adverse Event|0|||
146229187|NCT03580356|527356548|FG002|Treatment Period|Adverse Event|13|||
146229188|NCT03580356|527356549|FG003|Treatment Period|Adverse Event|0|||
146229189|NCT03580356|527356550|FG004|Treatment Period|Adverse Event|5|||
146229190|NCT03580356|527356551|FG005|Treatment Period|Adverse Event|0|||
146229191|NCT03580356|527356552|FG006|Treatment Period|Adverse Event|8|||
146229192|NCT03580356|527356553|FG007|Treatment Period|Adverse Event|0|||
146229193|NCT03580356|527356546|FG000|Treatment Period|Protocol Violation|5|||
146229194|NCT03580356|527356547|FG001|Treatment Period|Protocol Violation|0|||
146229195|NCT03580356|527356548|FG002|Treatment Period|Protocol Violation|6|||
146229196|NCT03580356|527356549|FG003|Treatment Period|Protocol Violation|1|||
146229197|NCT03580356|527356550|FG004|Treatment Period|Protocol Violation|9|||
146229198|NCT03580356|527356551|FG005|Treatment Period|Protocol Violation|1|||
146229199|NCT03580356|527356552|FG006|Treatment Period|Protocol Violation|1|||
146229200|NCT03580356|527356553|FG007|Treatment Period|Protocol Violation|0|||
146229201|NCT03580356|527356546|FG000|Treatment Period|Lack of Efficacy|6|||
146229202|NCT03580356|527356547|FG001|Treatment Period|Lack of Efficacy|0|||
146229203|NCT03580356|527356548|FG002|Treatment Period|Lack of Efficacy|2|||
146229204|NCT03580356|527356549|FG003|Treatment Period|Lack of Efficacy|0|||
146229205|NCT03580356|527356550|FG004|Treatment Period|Lack of Efficacy|3|||
146229206|NCT03580356|527356551|FG005|Treatment Period|Lack of Efficacy|0|||
146229207|NCT03580356|527356552|FG006|Treatment Period|Lack of Efficacy|3|||
146229208|NCT03580356|527356553|FG007|Treatment Period|Lack of Efficacy|0|||
146229209|NCT03580356|527356546|FG000|Treatment Period|Pregnancy|1|||
146229210|NCT03580356|527356547|FG001|Treatment Period|Pregnancy|0|||
146229211|NCT03580356|527356548|FG002|Treatment Period|Pregnancy|7|||
146229212|NCT03580356|527356549|FG003|Treatment Period|Pregnancy|0|||
146229213|NCT03580356|527356550|FG004|Treatment Period|Pregnancy|2|||
146229214|NCT03580356|527356551|FG005|Treatment Period|Pregnancy|0|||
146229215|NCT03580356|527356552|FG006|Treatment Period|Pregnancy|1|||
146229216|NCT03580356|527356553|FG007|Treatment Period|Pregnancy|0|||
145885475|NCT05068284|526084451|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145885476|NCT05068284|526084444|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885477|NCT05068284|526084445|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885478|NCT05068284|526084446|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885479|NCT05068284|526084447|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
145885480|NCT05068284|526084448|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885481|NCT05068284|526084449|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885482|NCT05068284|526084450|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885483|NCT05068284|526084451|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145885484|NCT05068284|526084444|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885485|NCT05068284|526084445|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885486|NCT05068284|526084446|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
145885487|NCT05068284|526084447|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
145885488|NCT05068284|526084448|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885489|NCT05068284|526084449|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885490|NCT05068284|526084450|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885491|NCT05068284|526084451|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145885492|NCT05068284|526084444|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145885493|NCT05068284|526084445|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145885494|NCT05068284|526084446|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
145885495|NCT05068284|526084447|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145885496|NCT05068284|526084448|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145885497|NCT05068284|526084449|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
146229217|NCT03580356|527356546|FG000|Treatment Period|Physician Decision|2|||
145885498|NCT05068284|526084450|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
146085952|NCT00969280|526835133|FG000|Overall Study|infection of influenza A(H1N1)|0|||
146229218|NCT03580356|527356547|FG001|Treatment Period|Physician Decision|0|||
146229219|NCT03580356|527356548|FG002|Treatment Period|Physician Decision|1|||
146229220|NCT03580356|527356549|FG003|Treatment Period|Physician Decision|0|||
146229221|NCT03580356|527356550|FG004|Treatment Period|Physician Decision|4|||
146229222|NCT03580356|527356551|FG005|Treatment Period|Physician Decision|0|||
146229223|NCT03580356|527356552|FG006|Treatment Period|Physician Decision|2|||
146229224|NCT03580356|527356553|FG007|Treatment Period|Physician Decision|0|||
146229225|NCT03580356|527356546|FG000|Treatment Period|Lost to Follow-up|1|||
146229226|NCT03580356|527356547|FG001|Treatment Period|Lost to Follow-up|1|||
146229227|NCT03580356|527356548|FG002|Treatment Period|Lost to Follow-up|1|||
146229228|NCT03580356|527356549|FG003|Treatment Period|Lost to Follow-up|0|||
146229229|NCT03580356|527356550|FG004|Treatment Period|Lost to Follow-up|3|||
146229230|NCT03580356|527356551|FG005|Treatment Period|Lost to Follow-up|0|||
146229231|NCT03580356|527356552|FG006|Treatment Period|Lost to Follow-up|1|||
146229232|NCT03580356|527356553|FG007|Treatment Period|Lost to Follow-up|0|||
146229233|NCT03580356|527356546|FG000|Treatment Period|Death|0|||
145885499|NCT05068284|526084451|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145885500|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
145885501|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885502|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885503|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885504|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885505|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145962746|NCT02513550|526375446|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
146085953|NCT00969280|526835134|FG001|Overall Study|infection of influenza A(H1N1)|1|||
146085954|NCT00217464|526835135|FG000|Overall Study|Progression|15|||
146085955|NCT00217464|526835135|FG000|Overall Study|Other|2|||
146085956|NCT02486718|526835136|FG000|Enrollment Phase|Death|19|||
146229234|NCT03580356|527356547|FG001|Treatment Period|Death|0|||
146229235|NCT03580356|527356548|FG002|Treatment Period|Death|1|||
146229236|NCT03580356|527356549|FG003|Treatment Period|Death|0|||
146229237|NCT03580356|527356550|FG004|Treatment Period|Death|0|||
146085957|NCT02486718|526835137|FG001|Enrollment Phase|Death|0|||
146085958|NCT02486718|526835138|FG002|Enrollment Phase|Death|0|||
146085959|NCT02486718|526835136|FG000|Enrollment Phase|Symptomatic deterioration|1|||
146085960|NCT02486718|526835137|FG001|Enrollment Phase|Symptomatic deterioration|0|||
146085961|NCT02486718|526835138|FG002|Enrollment Phase|Symptomatic deterioration|0|||
146085962|NCT02486718|526835136|FG000|Enrollment Phase|Withdrawal by Subject|86|||
146085963|NCT02486718|526835137|FG001|Enrollment Phase|Withdrawal by Subject|0|||
146085964|NCT02486718|526835138|FG002|Enrollment Phase|Withdrawal by Subject|0|||
146085965|NCT02486718|526835136|FG000|Enrollment Phase|Protocol Violation|18|||
146085966|NCT02486718|526835137|FG001|Enrollment Phase|Protocol Violation|0|||
146085967|NCT02486718|526835138|FG002|Enrollment Phase|Protocol Violation|0|||
146085968|NCT02486718|526835136|FG000|Enrollment Phase|Physician Decision|18|||
146085969|NCT02486718|526835137|FG001|Enrollment Phase|Physician Decision|0|||
146085970|NCT02486718|526835138|FG002|Enrollment Phase|Physician Decision|0|||
146085971|NCT02486718|526835136|FG000|Enrollment Phase|Reason not provided|41|||
146085972|NCT02486718|526835137|FG001|Enrollment Phase|Reason not provided|0|||
146085973|NCT02486718|526835138|FG002|Enrollment Phase|Reason not provided|0|||
146085974|NCT02486718|526835136|FG000|Enrollment Phase|Disease relapse|54|||
145885506|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885507|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145885508|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
145885509|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145885510|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145885511|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145885512|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145885513|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
145885514|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
145885515|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145885516|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
145885517|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885518|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885519|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885520|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885521|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885522|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
145885523|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145885524|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
145885525|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885526|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885527|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885528|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
146085975|NCT02486718|526835137|FG001|Enrollment Phase|Disease relapse|0|||
146085976|NCT02486718|526835138|FG002|Enrollment Phase|Disease relapse|0|||
146085977|NCT02486718|526835136|FG000|Enrollment Phase|Lost to Follow-up|4|||
145885529|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885530|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885531|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145885532|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
145885533|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885534|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885535|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885536|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885537|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885538|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885539|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145885540|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
145885541|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145885542|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145885543|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145885544|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145885545|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
145885546|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
145885547|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
145885548|NCT05068284|526084444|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885549|NCT05068284|526084445|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885550|NCT05068284|526084446|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885551|NCT05068284|526084447|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885552|NCT05068284|526084448|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885553|NCT05068284|526084449|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885554|NCT05068284|526084450|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
145885555|NCT05068284|526084451|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
145885556|NCT04100096|526086293|FG000|Overall Study|Adverse Event|19|||
145885557|NCT04100096|526086294|FG001|Overall Study|Adverse Event|7|||
145885558|NCT04100096|526086293|FG000|Overall Study|Lack of Efficacy|0|||
145885559|NCT04100096|526086294|FG001|Overall Study|Lack of Efficacy|1|||
145885560|NCT04100096|526086293|FG000|Overall Study|Lost to Follow-up|13|||
146229238|NCT03580356|527356551|FG005|Treatment Period|Death|0|||
146229239|NCT03580356|527356552|FG006|Treatment Period|Death|0|||
146229240|NCT03580356|527356553|FG007|Treatment Period|Death|0|||
145885561|NCT04100096|526086294|FG001|Overall Study|Lost to Follow-up|11|||
145885562|NCT04100096|526086293|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145885563|NCT04100096|526086294|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145885564|NCT04100096|526086293|FG000|Overall Study|Protocol Deviation|1|||
145885565|NCT04100096|526086294|FG001|Overall Study|Protocol Deviation|1|||
145885566|NCT04100096|526086293|FG000|Overall Study|Withdrawal by Participant|13|||
145885567|NCT04100096|526086294|FG001|Overall Study|Withdrawal by Participant|15|||
145885568|NCT00991510|526086297|FG000|Period I (Days 1-14)|Adverse Event|1|||
145885569|NCT00991510|526086298|FG001|Period I (Days 1-14)|Adverse Event|0|||
145885570|NCT00991510|526086297|FG000|Period III (Days 29-112)|Adverse Event|1|||
145885571|NCT00991510|526086298|FG001|Period III (Days 29-112)|Adverse Event|1|||
145885572|NCT02211014|526086299|FG000|Overall Study|Adverse Event|0|||
145885573|NCT02211014|526086300|FG001|Overall Study|Adverse Event|2|||
145885574|NCT02211014|526086299|FG000|Overall Study|Physician Decision|1|||
145885575|NCT02211014|526086300|FG001|Overall Study|Physician Decision|2|||
145885576|NCT02211014|526086299|FG000|Overall Study|Started another cancer therapy|1|||
145885577|NCT02211014|526086300|FG001|Overall Study|Started another cancer therapy|0|||
145885578|NCT02211014|526086299|FG000|Overall Study|Withdrawal by Subject|0|||
145885579|NCT02211014|526086300|FG001|Overall Study|Withdrawal by Subject|1|||
145885580|NCT02211014|526086299|FG000|Overall Study|In agreement with patient, no benefit|0|||
145885581|NCT02211014|526086300|FG001|Overall Study|In agreement with patient, no benefit|1|||
145885582|NCT00966381|526086301|FG000|Overall Study|Withdrawal by Subject|2|||
146229241|NCT03580356|527356546|FG000|Treatment Period|Technical problems|0|||
146229242|NCT03580356|527356547|FG001|Treatment Period|Technical problems|0|||
146229243|NCT03580356|527356548|FG002|Treatment Period|Technical problems|0|||
145885583|NCT00966381|526086302|FG001|Overall Study|Withdrawal by Subject|2|||
145885584|NCT01124695|526086303|FG000|Overall Study|Disease progression|77|||
145885585|NCT01124695|526086303|FG000|Overall Study|Adverse Event|11|||
145885586|NCT01124695|526086303|FG000|Overall Study|Death|1|||
145885587|NCT01124695|526086303|FG000|Overall Study|Withdrawal by Subject|7|||
145885588|NCT01124695|526086303|FG000|Overall Study|Physician Decision|3|||
146229244|NCT03580356|527356549|FG003|Treatment Period|Technical problems|0|||
146229245|NCT03580356|527356550|FG004|Treatment Period|Technical problems|1|||
146229246|NCT03580356|527356551|FG005|Treatment Period|Technical problems|0|||
145962747|NCT02513550|526375447|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
145962748|NCT02513550|526375448|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
145962749|NCT02513550|526375449|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
145962750|NCT02513550|526375450|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
146229247|NCT03580356|527356552|FG006|Treatment Period|Technical problems|0|||
146229248|NCT03580356|527356553|FG007|Treatment Period|Technical problems|0|||
145885589|NCT01124695|526086303|FG000|Overall Study|Alternative therapy|9|||
146229249|NCT03580356|527356546|FG000|Treatment Period|Misrandomized, no treatment|0|||
146229250|NCT03580356|527356547|FG001|Treatment Period|Misrandomized, no treatment|0|||
146229251|NCT03580356|527356548|FG002|Treatment Period|Misrandomized, no treatment|1|||
146229252|NCT03580356|527356549|FG003|Treatment Period|Misrandomized, no treatment|0|||
146229253|NCT03580356|527356550|FG004|Treatment Period|Misrandomized, no treatment|2|||
146289209|NCT03170349|527573398|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
146289210|NCT03170349|527573398|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
146289211|NCT03170349|527573398|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
145885590|NCT01124695|526086303|FG000|Overall Study|No documentation that patient went off treatment|4|||
145885591|NCT01124695|526086303|FG000|Overall Study|Ineligible|9|||
145885592|NCT01124695|526086303|FG000|Overall Study|Ineligible and never start treatment|2|||
145885593|NCT01796964|526086307|FG000|Overall Study|Adverse Event|1|||
145885594|NCT01796964|526086308|FG001|Overall Study|Adverse Event|1|||
145885595|NCT01796964|526086307|FG000|Overall Study|Death|1|||
145885596|NCT01796964|526086308|FG001|Overall Study|Death|0|||
145885597|NCT01796964|526086307|FG000|Overall Study|Protocol Violation|0|||
145885598|NCT01796964|526086308|FG001|Overall Study|Protocol Violation|1|||
145885599|NCT01796964|526086307|FG000|Overall Study|Withdrawal by Subject|1|||
145885600|NCT01796964|526086308|FG001|Overall Study|Withdrawal by Subject|1|||
145885601|NCT04025684|526086309|FG000|Overall Study|Withdrawal by Subject|1|||
145885602|NCT04025684|526086310|FG001|Overall Study|Withdrawal by Subject|1|||
145885603|NCT04025684|526086311|FG002|Overall Study|Withdrawal by Subject|0|||
145885604|NCT04025684|526086312|FG003|Overall Study|Withdrawal by Subject|0|||
145885605|NCT04025684|526086309|FG000|Overall Study|Multiple reasons|1|||
145885606|NCT04025684|526086310|FG001|Overall Study|Multiple reasons|3|||
145885607|NCT04025684|526086311|FG002|Overall Study|Multiple reasons|0|||
145885608|NCT04025684|526086312|FG003|Overall Study|Multiple reasons|1|||
146085978|NCT02486718|526835137|FG001|Enrollment Phase|Lost to Follow-up|0|||
146085979|NCT02486718|526835138|FG002|Enrollment Phase|Lost to Follow-up|0|||
146085980|NCT02486718|526835136|FG000|Enrollment Phase|Adverse Event|34|||
146085981|NCT02486718|526835137|FG001|Enrollment Phase|Adverse Event|0|||
146229254|NCT03580356|527356551|FG005|Treatment Period|Misrandomized, no treatment|0|||
146229255|NCT03580356|527356552|FG006|Treatment Period|Misrandomized, no treatment|0|||
146229256|NCT03580356|527356553|FG007|Treatment Period|Misrandomized, no treatment|0|||
146229257|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
146229258|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
146229259|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
146229260|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
146229261|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
146229262|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
146229263|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
146229264|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
146229265|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
146229266|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146229267|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
146229268|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146229269|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
145885609|NCT00794417|526086325|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145885610|NCT00794417|526086326|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145885611|NCT00794417|526086327|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
146085982|NCT02486718|526835138|FG002|Enrollment Phase|Adverse Event|0|||
146085983|NCT02486718|526835136|FG000|Randomized Phase|Withdrawal by Subject|0|||
146085984|NCT02486718|526835137|FG001|Randomized Phase|Withdrawal by Subject|44|||
146085985|NCT02486718|526835138|FG002|Randomized Phase|Withdrawal by Subject|47|||
146229270|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145962751|NCT02513550|526375445|FG000|Double Blind Treatment Period|Adverse Event|5|||
145962752|NCT02513550|526375446|FG001|Double Blind Treatment Period|Adverse Event|13|||
145885612|NCT00794417|526086328|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145885613|NCT00794417|526086325|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
145885614|NCT00794417|526086326|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
145885615|NCT00794417|526086327|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
145885616|NCT00794417|526086328|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
145885617|NCT00794417|526086325|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145885618|NCT00794417|526086326|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145962753|NCT02513550|526375447|FG002|Double Blind Treatment Period|Adverse Event|17|||
145962754|NCT02513550|526375448|FG003|Double Blind Treatment Period|Adverse Event|0|||
145962755|NCT02513550|526375449|FG004|Double Blind Treatment Period|Adverse Event|1|||
145962756|NCT02513550|526375450|FG005|Double Blind Treatment Period|Adverse Event|0|||
145962757|NCT02513550|526375445|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
145962758|NCT02513550|526375446|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
145962759|NCT02513550|526375447|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
145962760|NCT02513550|526375448|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
145962761|NCT02513550|526375449|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
145962762|NCT02513550|526375450|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
145962763|NCT02513550|526375445|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
145962764|NCT02513550|526375446|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
145962765|NCT02513550|526375447|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
145962766|NCT02513550|526375448|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
145962767|NCT02513550|526375449|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
145962768|NCT02513550|526375450|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
145962769|NCT02513550|526375445|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145962770|NCT02513550|526375446|FG001|Double Blind Treatment Period|Protocol Violation|1|||
145962771|NCT02513550|526375447|FG002|Double Blind Treatment Period|Protocol Violation|4|||
145962772|NCT02513550|526375448|FG003|Double Blind Treatment Period|Protocol Violation|0|||
145962773|NCT02513550|526375449|FG004|Double Blind Treatment Period|Protocol Violation|0|||
145962774|NCT02513550|526375450|FG005|Double Blind Treatment Period|Protocol Violation|0|||
145962775|NCT02513550|526375445|FG000|Double Blind Treatment Period|Physician Decision|2|||
145962776|NCT02513550|526375446|FG001|Double Blind Treatment Period|Physician Decision|0|||
145962777|NCT02513550|526375447|FG002|Double Blind Treatment Period|Physician Decision|4|||
145962778|NCT02513550|526375448|FG003|Double Blind Treatment Period|Physician Decision|0|||
145962779|NCT02513550|526375449|FG004|Double Blind Treatment Period|Physician Decision|0|||
145962780|NCT02513550|526375450|FG005|Double Blind Treatment Period|Physician Decision|0|||
145962781|NCT02513550|526375445|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
145962782|NCT02513550|526375446|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
145962783|NCT02513550|526375447|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
145962784|NCT02513550|526375448|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
145962785|NCT02513550|526375449|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
145962786|NCT02513550|526375450|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
145962787|NCT02513550|526375445|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145962788|NCT02513550|526375446|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145962789|NCT02513550|526375447|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
145962790|NCT02513550|526375448|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145962791|NCT02513550|526375449|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145962792|NCT02513550|526375450|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145962793|NCT02513550|526375445|FG000|Double Blind Treatment Period|Due to personal business|2|||
146229271|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145962794|NCT02513550|526375446|FG001|Double Blind Treatment Period|Due to personal business|0|||
146229272|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
146229273|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
146229274|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
146229275|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
146085986|NCT02486718|526835136|FG000|Randomized Phase|Protocol Violation|0|||
146085987|NCT02486718|526835137|FG001|Randomized Phase|Protocol Violation|2|||
146085988|NCT02486718|526835138|FG002|Randomized Phase|Protocol Violation|0|||
146085989|NCT02486718|526835136|FG000|Randomized Phase|Physician Decision|0|||
146229276|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
146229277|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
145962795|NCT02513550|526375447|FG002|Double Blind Treatment Period|Due to personal business|1|||
145885619|NCT00794417|526086327|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145885620|NCT00794417|526086328|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
145885621|NCT00794417|526086325|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
145885622|NCT00794417|526086326|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
145885623|NCT00794417|526086327|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
146085990|NCT02486718|526835137|FG001|Randomized Phase|Physician Decision|0|||
145885624|NCT00794417|526086328|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
145885625|NCT00794417|526086325|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145885626|NCT00794417|526086326|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145885627|NCT00794417|526086327|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145885628|NCT00794417|526086328|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
145885629|NCT00794417|526086325|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145885630|NCT00794417|526086326|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145885631|NCT00794417|526086327|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145885632|NCT00794417|526086328|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
145885633|NCT02695719|526086335|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
145885634|NCT02695719|526086336|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
145885635|NCT02695719|526086335|FG000|Overall Study|Significant Protocol Deviation|0|||
145885636|NCT02695719|526086336|FG001|Overall Study|Significant Protocol Deviation|1|||
145885637|NCT02695719|526086335|FG000|Overall Study|Voluntary Withdrawal|1|||
145885638|NCT02695719|526086336|FG001|Overall Study|Voluntary Withdrawal|0|||
145885639|NCT01534078|526086339|FG000|Overall Study|Death|1|||
145885640|NCT01534078|526086339|FG000|Overall Study|Withdrawal by Subject|1|||
145885641|NCT01049412|526086340|FG000|Period I|Withdrawal by Subject|4|||
145885642|NCT01049412|526086341|FG001|Period I|Withdrawal by Subject|6|||
145885643|NCT01049412|526086340|FG000|Period I|Lost to Follow-up|2|||
145885644|NCT01049412|526086341|FG001|Period I|Lost to Follow-up|2|||
145885645|NCT01049412|526086340|FG000|Period I|Physician Decision|0|||
145885646|NCT01049412|526086341|FG001|Period I|Physician Decision|3|||
145885647|NCT01049412|526086340|FG000|Period I|Protocol Violation|1|||
146085991|NCT02486718|526835138|FG002|Randomized Phase|Physician Decision|3|||
146085992|NCT02486718|526835136|FG000|Randomized Phase|Lost to Follow-up|0|||
145885648|NCT01049412|526086341|FG001|Period I|Protocol Violation|2|||
145885649|NCT01049412|526086340|FG000|Period I|Adverse Event|1|||
146229278|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
146229279|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
146229280|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
146229281|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229282|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229283|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
146229284|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229285|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
146229286|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229287|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229288|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
146229289|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
146229290|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
146229291|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
146229292|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
146229293|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
146229294|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
146229295|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
146229296|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
146229297|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
146229298|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
146229299|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
146229300|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
146229301|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
146229302|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
146229303|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
146229304|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
146229305|NCT03580356|527356546|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
146229306|NCT03580356|527356547|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
146229307|NCT03580356|527356548|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
146229308|NCT03580356|527356549|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
146229309|NCT03580356|527356550|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
146289212|NCT03170349|527573398|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
146289213|NCT03170349|527573398|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
146229310|NCT03580356|527356551|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
146229311|NCT03580356|527356552|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
146229312|NCT03580356|527356553|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
146229313|NCT02834390|527356554|FG000|Induction Phase|Progressive disease|0|||
146085993|NCT02486718|526835137|FG001|Randomized Phase|Lost to Follow-up|5|||
146085994|NCT02486718|526835138|FG002|Randomized Phase|Lost to Follow-up|11|||
145885650|NCT01049412|526086341|FG001|Period I|Adverse Event|0|||
145885651|NCT01049412|526086340|FG000|Period II|Withdrawal by Subject|2|||
146085995|NCT02486718|526835136|FG000|Randomized Phase|Disease Relapse|0|||
146085996|NCT02486718|526835137|FG001|Randomized Phase|Disease Relapse|1|||
145885652|NCT01049412|526086341|FG001|Period II|Withdrawal by Subject|3|||
145885653|NCT01049412|526086340|FG000|Period II|Adverse Event|1|||
145885654|NCT01049412|526086341|FG001|Period II|Adverse Event|0|||
145885655|NCT01049412|526086340|FG000|Period II|Lost to Follow-up|1|||
145885656|NCT01049412|526086341|FG001|Period II|Lost to Follow-up|0|||
145885657|NCT05966090|526086342|FG000|Overall Study|Lost to Follow-up|6|||
145885658|NCT05966090|526086343|FG001|Overall Study|Lost to Follow-up|6|||
145885659|NCT05966090|526086342|FG000|Overall Study|Adverse Event|1|||
145885660|NCT05966090|526086343|FG001|Overall Study|Adverse Event|1|||
145885661|NCT05966090|526086342|FG000|Overall Study|Withdrawal by Subject|1|||
145885662|NCT05966090|526086343|FG001|Overall Study|Withdrawal by Subject|1|||
145885663|NCT05966090|526086342|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145885664|NCT05966090|526086343|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145885665|NCT05966090|526086342|FG000|Overall Study|Other|1|||
145885666|NCT05966090|526086343|FG001|Overall Study|Other|1|||
145885667|NCT03235479|526086346|FG000|Overall Study|Lost to Follow-up|8|||
145885668|NCT03235479|526086347|FG001|Overall Study|Lost to Follow-up|11|||
145885669|NCT03235479|526086346|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
145885670|NCT03235479|526086347|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
145885671|NCT03235479|526086346|FG000|Overall Study|Pregnancy|1|||
145885672|NCT03235479|526086347|FG001|Overall Study|Pregnancy|0|||
145885673|NCT03235479|526086346|FG000|Overall Study|Protocol Deviation|1|||
145885674|NCT03235479|526086347|FG001|Overall Study|Protocol Deviation|3|||
145885675|NCT03235479|526086346|FG000|Overall Study|Technical Problems|3|||
145885676|NCT03235479|526086347|FG001|Overall Study|Technical Problems|2|||
145885677|NCT03235479|526086346|FG000|Overall Study|Withdrawal by Subject|2|||
145885678|NCT03235479|526086347|FG001|Overall Study|Withdrawal by Subject|2|||
145885679|NCT03235479|526086346|FG000|Overall Study|Other Reasons|3|||
145885680|NCT03235479|526086347|FG001|Overall Study|Other Reasons|5|||
145885681|NCT02001051|526086350|FG000|Overall Study|Deemed not eligible following enrollment|0|||
145885682|NCT02001051|526086351|FG001|Overall Study|Deemed not eligible following enrollment|1|||
145885683|NCT00309985|526086358|FG000|Overall Study|Disease progression|12|||
145885684|NCT00309985|526086359|FG001|Overall Study|Disease progression|0|||
145885685|NCT00309985|526086358|FG000|Overall Study|Adverse Event|30|||
145885686|NCT00309985|526086359|FG001|Overall Study|Adverse Event|0|||
145885687|NCT00309985|526086358|FG000|Overall Study|Death|2|||
145885688|NCT00309985|526086359|FG001|Overall Study|Death|0|||
145885689|NCT00309985|526086358|FG000|Overall Study|Withdrawal by Subject|5|||
145885690|NCT00309985|526086359|FG001|Overall Study|Withdrawal by Subject|1|||
145885691|NCT00309985|526086358|FG000|Overall Study|Physician Decision|3|||
145885692|NCT00309985|526086359|FG001|Overall Study|Physician Decision|0|||
145885693|NCT00309985|526086358|FG000|Overall Study|Never started treatment|7|||
146085997|NCT02486718|526835138|FG002|Randomized Phase|Disease Relapse|0|||
146085998|NCT02486718|526835136|FG000|Randomized Phase|Death|0|||
146085999|NCT02486718|526835137|FG001|Randomized Phase|Death|154|||
145885694|NCT00309985|526086359|FG001|Overall Study|Never started treatment|0|||
145885695|NCT00309985|526086358|FG000|Overall Study|Complicating disease|1|||
145885696|NCT00309985|526086359|FG001|Overall Study|Complicating disease|0|||
145885697|NCT00309985|526086358|FG000|Overall Study|Non-compliance|1|||
145885698|NCT00309985|526086359|FG001|Overall Study|Non-compliance|0|||
145885699|NCT00309985|526086358|FG000|Overall Study|Chemotherapy discontinued only|1|||
145885700|NCT00309985|526086359|FG001|Overall Study|Chemotherapy discontinued only|0|||
145885701|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
145885702|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
145885703|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
145885704|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145885705|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
145885706|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
145885707|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145885708|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145885709|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
145885710|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
145885711|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145885712|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145885713|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
145885714|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
145885715|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145885716|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145885717|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Death|2|||
146229314|NCT02834390|527356555|FG001|Induction Phase|Progressive disease|1|||
146229315|NCT02834390|527356554|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
146086000|NCT02486718|526835138|FG002|Randomized Phase|Death|155|||
146229316|NCT02834390|527356555|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
146229317|NCT02834390|527356554|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
146229318|NCT02834390|527356555|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
146229319|NCT02834390|527356554|FG000|Consolidation Phase|Physician Decision|1|||
146229320|NCT02834390|527356555|FG001|Consolidation Phase|Physician Decision|1|||
146229321|NCT05424380|527356578|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
146229322|NCT05424380|527356579|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146229323|NCT05424380|527356580|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145885718|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Death|1|||
145885719|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Death|0|||
145885720|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Death|0|||
145885721|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
145885722|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
145885723|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
145885724|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
145885725|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
145885726|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145885727|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145885728|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
146086001|NCT02486718|526835136|FG000|Randomized Phase|Ongoing|0|||
146086002|NCT02486718|526835137|FG001|Randomized Phase|Ongoing|301|||
146086003|NCT02486718|526835138|FG002|Randomized Phase|Ongoing|282|||
145885729|NCT03110380|526086369|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145885730|NCT03110380|526086370|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
145885731|NCT03110380|526086371|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145885732|NCT03110380|526086372|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145885733|NCT03110380|526086369|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145885734|NCT03110380|526086370|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145885735|NCT03110380|526086371|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
145885736|NCT03110380|526086372|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
145885737|NCT03110380|526086369|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
145885738|NCT03110380|526086370|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
145885739|NCT03110380|526086371|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
145885740|NCT03110380|526086372|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
145885741|NCT03110380|526086369|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145885742|NCT03110380|526086370|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145885743|NCT03110380|526086371|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145885744|NCT03110380|526086372|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
145885745|NCT01714739|526086373|FG000|Overall Study|Disease progression|3|||
145885746|NCT01714739|526086374|FG001|Overall Study|Disease progression|5|||
145885747|NCT01714739|526086375|FG002|Overall Study|Disease progression|5|||
145885748|NCT01714739|526086376|FG003|Overall Study|Disease progression|204|||
145885749|NCT01714739|526086377|FG004|Overall Study|Disease progression|1|||
145885750|NCT01714739|526086378|FG005|Overall Study|Disease progression|3|||
145885751|NCT01714739|526086379|FG006|Overall Study|Disease progression|5|||
145885752|NCT01714739|526086373|FG000|Overall Study|Study drug toxicity|1|||
146229324|NCT05424380|527356581|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146229325|NCT05424380|527356582|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146229326|NCT05424380|527356583|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
146229327|NCT05424380|527356578|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
146229328|NCT05424380|527356579|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146229329|NCT05424380|527356580|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146229330|NCT05424380|527356581|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146229331|NCT05424380|527356582|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146229332|NCT05424380|527356583|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
146229333|NCT05424380|527356578|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
146229334|NCT05424380|527356579|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146229335|NCT05424380|527356580|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146229336|NCT05424380|527356581|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146229337|NCT05424380|527356582|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146229338|NCT05424380|527356583|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
146229339|NCT05424380|527356578|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146229340|NCT05424380|527356579|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
146229341|NCT05424380|527356580|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146229342|NCT05424380|527356581|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146229343|NCT05424380|527356582|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146229344|NCT05424380|527356583|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
146229345|NCT05424380|527356578|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146229346|NCT05424380|527356579|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
146229347|NCT05424380|527356580|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145885753|NCT01714739|526086374|FG001|Overall Study|Study drug toxicity|1|||
145885754|NCT01714739|526086375|FG002|Overall Study|Study drug toxicity|1|||
145885755|NCT01714739|526086376|FG003|Overall Study|Study drug toxicity|15|||
145885756|NCT01714739|526086377|FG004|Overall Study|Study drug toxicity|0|||
145885757|NCT01714739|526086378|FG005|Overall Study|Study drug toxicity|0|||
145885758|NCT01714739|526086379|FG006|Overall Study|Study drug toxicity|5|||
145885759|NCT01714739|526086373|FG000|Overall Study|Death|0|||
145885760|NCT01714739|526086374|FG001|Overall Study|Death|0|||
145885761|NCT01714739|526086375|FG002|Overall Study|Death|0|||
145885762|NCT01714739|526086376|FG003|Overall Study|Death|1|||
145885763|NCT01714739|526086377|FG004|Overall Study|Death|0|||
145885764|NCT01714739|526086378|FG005|Overall Study|Death|0|||
145885765|NCT01714739|526086379|FG006|Overall Study|Death|0|||
145885766|NCT01714739|526086373|FG000|Overall Study|Adverse Event unrelated to drug|0|||
145885767|NCT01714739|526086374|FG001|Overall Study|Adverse Event unrelated to drug|0|||
145885768|NCT01714739|526086375|FG002|Overall Study|Adverse Event unrelated to drug|3|||
145885769|NCT01714739|526086376|FG003|Overall Study|Adverse Event unrelated to drug|21|||
145885770|NCT01714739|526086377|FG004|Overall Study|Adverse Event unrelated to drug|0|||
145885771|NCT01714739|526086378|FG005|Overall Study|Adverse Event unrelated to drug|0|||
145885772|NCT01714739|526086379|FG006|Overall Study|Adverse Event unrelated to drug|0|||
145885773|NCT01714739|526086373|FG000|Overall Study|Participant request to stop therapy|0|||
145885774|NCT01714739|526086374|FG001|Overall Study|Participant request to stop therapy|1|||
145885775|NCT01714739|526086375|FG002|Overall Study|Participant request to stop therapy|0|||
145885776|NCT01714739|526086376|FG003|Overall Study|Participant request to stop therapy|6|||
145885777|NCT01714739|526086377|FG004|Overall Study|Participant request to stop therapy|0|||
145885778|NCT01714739|526086378|FG005|Overall Study|Participant request to stop therapy|0|||
145885779|NCT01714739|526086379|FG006|Overall Study|Participant request to stop therapy|0|||
145885780|NCT01714739|526086373|FG000|Overall Study|Participant withdrew consent|0|||
145885781|NCT01714739|526086374|FG001|Overall Study|Participant withdrew consent|1|||
145885782|NCT01714739|526086375|FG002|Overall Study|Participant withdrew consent|0|||
145885783|NCT01714739|526086376|FG003|Overall Study|Participant withdrew consent|8|||
145885784|NCT01714739|526086377|FG004|Overall Study|Participant withdrew consent|0|||
145885785|NCT01714739|526086378|FG005|Overall Study|Participant withdrew consent|0|||
145885786|NCT01714739|526086379|FG006|Overall Study|Participant withdrew consent|0|||
145885787|NCT01714739|526086373|FG000|Overall Study|Lost to Follow-up|0|||
145885788|NCT01714739|526086374|FG001|Overall Study|Lost to Follow-up|0|||
145885789|NCT01714739|526086375|FG002|Overall Study|Lost to Follow-up|0|||
145885790|NCT01714739|526086376|FG003|Overall Study|Lost to Follow-up|1|||
145885791|NCT01714739|526086377|FG004|Overall Study|Lost to Follow-up|0|||
146229348|NCT05424380|527356581|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
146229349|NCT05424380|527356582|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145885792|NCT01714739|526086378|FG005|Overall Study|Lost to Follow-up|0|||
145885793|NCT01714739|526086379|FG006|Overall Study|Lost to Follow-up|0|||
145885794|NCT01714739|526086373|FG000|Overall Study|Maximum clinical benefit|0|||
145885795|NCT01714739|526086374|FG001|Overall Study|Maximum clinical benefit|1|||
145885796|NCT01714739|526086375|FG002|Overall Study|Maximum clinical benefit|1|||
145885797|NCT01714739|526086376|FG003|Overall Study|Maximum clinical benefit|3|||
145885798|NCT01714739|526086377|FG004|Overall Study|Maximum clinical benefit|0|||
145885799|NCT01714739|526086378|FG005|Overall Study|Maximum clinical benefit|0|||
145885800|NCT01714739|526086379|FG006|Overall Study|Maximum clinical benefit|0|||
145885801|NCT01714739|526086373|FG000|Overall Study|Poor/non-comliance|0|||
145885802|NCT01714739|526086374|FG001|Overall Study|Poor/non-comliance|1|||
145885803|NCT01714739|526086375|FG002|Overall Study|Poor/non-comliance|0|||
145885804|NCT01714739|526086376|FG003|Overall Study|Poor/non-comliance|1|||
145885805|NCT01714739|526086377|FG004|Overall Study|Poor/non-comliance|0|||
145885806|NCT01714739|526086378|FG005|Overall Study|Poor/non-comliance|0|||
145885807|NCT01714739|526086379|FG006|Overall Study|Poor/non-comliance|0|||
145885808|NCT01714739|526086373|FG000|Overall Study|No longer meets study criteria|0|||
145885809|NCT01714739|526086374|FG001|Overall Study|No longer meets study criteria|0|||
145885810|NCT01714739|526086375|FG002|Overall Study|No longer meets study criteria|0|||
145885811|NCT01714739|526086376|FG003|Overall Study|No longer meets study criteria|1|||
146229350|NCT05424380|527356583|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145885812|NCT01714739|526086377|FG004|Overall Study|No longer meets study criteria|0|||
145885813|NCT01714739|526086378|FG005|Overall Study|No longer meets study criteria|0|||
145885814|NCT01714739|526086379|FG006|Overall Study|No longer meets study criteria|0|||
145885815|NCT01714739|526086373|FG000|Overall Study|Other reason|0|||
145885816|NCT01714739|526086374|FG001|Overall Study|Other reason|0|||
145885817|NCT01714739|526086375|FG002|Overall Study|Other reason|0|||
145885818|NCT01714739|526086376|FG003|Overall Study|Other reason|3|||
145885819|NCT01714739|526086377|FG004|Overall Study|Other reason|1|||
146086004|NCT00527488|526835143|FG000|Overall Study|Withdrawn prior to dosing|0|||
145885820|NCT01714739|526086378|FG005|Overall Study|Other reason|0|||
145885821|NCT01714739|526086379|FG006|Overall Study|Other reason|0|||
145885822|NCT02274948|526086386|FG000|Overall Study|Lost to Follow-up|28|||
145885823|NCT02274948|526086387|FG001|Overall Study|Lost to Follow-up|25|||
145885824|NCT02274948|526086386|FG000|Overall Study|Withdrawal by Subject|64|||
145885825|NCT02274948|526086387|FG001|Overall Study|Withdrawal by Subject|58|||
145885826|NCT02274948|526086386|FG000|Overall Study|Stopped on family Practitioner advice|2|||
145885827|NCT02274948|526086387|FG001|Overall Study|Stopped on family Practitioner advice|5|||
145885828|NCT02274948|526086386|FG000|Overall Study|Left the area|4|||
145885829|NCT02274948|526086387|FG001|Overall Study|Left the area|3|||
145885830|NCT00707434|526086388|FG000|Overall Study|Adverse Event|1|||
145885831|NCT03585959|526086389|FG000|Overall Study|Physician Decision|1|||
145885832|NCT03585959|526086389|FG000|Overall Study|Unsuccessful Procedure|2|||
145885833|NCT02531594|526086390|FG000|Overall Study|Withdrawal by Subject|7|||
145885834|NCT02531594|526086391|FG001|Overall Study|Withdrawal by Subject|8|||
145885835|NCT00614822|526086392|FG000|Overall Study|Adverse Event|3|||
145885836|NCT03750695|526086393|FG000|Overall Study|Lost to Follow-up|0|||
145885837|NCT03750695|526086394|FG001|Overall Study|Lost to Follow-up|1|||
145885838|NCT04480307|526086395|FG000|Overall Study|Withdrawal by Subject|0|||
145885839|NCT04480307|526086396|FG001|Overall Study|Withdrawal by Subject|1|||
145885840|NCT04480307|526086397|FG002|Overall Study|Withdrawal by Subject|0|||
145885841|NCT04480307|526086398|FG003|Overall Study|Withdrawal by Subject|0|||
145885842|NCT04480307|526086395|FG000|Overall Study|Adverse Event|0|||
145885843|NCT04480307|526086396|FG001|Overall Study|Adverse Event|0|||
145885844|NCT04480307|526086397|FG002|Overall Study|Adverse Event|0|||
145885845|NCT04480307|526086398|FG003|Overall Study|Adverse Event|1|||
145885846|NCT01256060|526086401|FG000|Overall Study|Lost to Follow-up|0|||
145885847|NCT01256060|526086402|FG001|Overall Study|Lost to Follow-up|1|||
145885848|NCT01256060|526086403|FG002|Overall Study|Lost to Follow-up|0|||
145885849|NCT01256060|526086404|FG003|Overall Study|Lost to Follow-up|0|||
145885850|NCT00220727|526086405|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
145885851|NCT00220727|526086406|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
145885852|NCT02508116|526086407|FG000|Overall Study|Lost to Follow-up|2|||
145885853|NCT02508116|526086408|FG001|Overall Study|Lost to Follow-up|3|||
145885854|NCT02508116|526086407|FG000|Overall Study|Withdrawal by Subject|3|||
145885855|NCT02508116|526086408|FG001|Overall Study|Withdrawal by Subject|2|||
145885856|NCT02508116|526086407|FG000|Overall Study|Protocol Violation|1|||
145885857|NCT02508116|526086408|FG001|Overall Study|Protocol Violation|2|||
145885858|NCT02508116|526086407|FG000|Overall Study|Physician Decision|2|||
145885859|NCT02508116|526086408|FG001|Overall Study|Physician Decision|0|||
145885860|NCT01857206|526086409|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
145885861|NCT01857206|526086410|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
145885862|NCT01857206|526086409|FG000|Overall Study|Lost to Follow-up|9|||
145885863|NCT01857206|526086410|FG001|Overall Study|Lost to Follow-up|6|||
145885864|NCT01857206|526086409|FG000|Overall Study|Unclassified|3|||
145885865|NCT01857206|526086410|FG001|Overall Study|Unclassified|3|||
145885866|NCT01857206|526086409|FG000|Overall Study|Withdrawal by Subject|1|||
145885867|NCT01857206|526086410|FG001|Overall Study|Withdrawal by Subject|0|||
145885868|NCT00575380|526086415|FG000|Overall Study|Withdrawal by Subject|1|||
145885869|NCT00575380|526086416|FG001|Overall Study|Withdrawal by Subject|0|||
145885870|NCT00575380|526086415|FG000|Overall Study|Adverse Event|0|||
145885871|NCT00575380|526086416|FG001|Overall Study|Adverse Event|1|||
145885872|NCT00575380|526086415|FG000|Overall Study|Various|0|||
145885873|NCT00575380|526086416|FG001|Overall Study|Various|2|||
145885874|NCT00559364|526086418|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
145885875|NCT00559364|526086419|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
145885876|NCT01235442|526086420|FG000|Overall Study|Lost to Follow-up|12|||
145885877|NCT01235442|526086421|FG001|Overall Study|Lost to Follow-up|10|||
145885878|NCT01235442|526086420|FG000|Overall Study|Death|0|||
145885879|NCT01235442|526086421|FG001|Overall Study|Death|2|||
145885880|NCT01235442|526086420|FG000|Overall Study|Pregnancy|1|||
145885881|NCT01235442|526086421|FG001|Overall Study|Pregnancy|1|||
145885882|NCT01235442|526086420|FG000|Overall Study|Ineligibility determined|5|||
145885883|NCT01235442|526086421|FG001|Overall Study|Ineligibility determined|4|||
145885884|NCT01235442|526086420|FG000|Overall Study|Protocol Violation|3|||
145885885|NCT01235442|526086421|FG001|Overall Study|Protocol Violation|3|||
145885886|NCT01235442|526086420|FG000|Overall Study|Adverse Event|4|||
145885887|NCT01235442|526086421|FG001|Overall Study|Adverse Event|6|||
145885888|NCT01235442|526086420|FG000|Overall Study|Withdrawal by Subject|15|||
145885889|NCT01235442|526086421|FG001|Overall Study|Withdrawal by Subject|9|||
145885890|NCT01235442|526086420|FG000|Overall Study|Lack of Efficacy|1|||
145885891|NCT01235442|526086421|FG001|Overall Study|Lack of Efficacy|3|||
145885892|NCT01235442|526086420|FG000|Overall Study|Noncompliance|1|||
145885893|NCT01235442|526086421|FG001|Overall Study|Noncompliance|2|||
145885894|NCT01235442|526086420|FG000|Overall Study|Administrative decision|1|||
145885895|NCT01235442|526086421|FG001|Overall Study|Administrative decision|2|||
146229351|NCT05424380|527356578|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146229352|NCT05424380|527356579|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145962796|NCT02513550|526375448|FG003|Double Blind Treatment Period|Due to personal business|0|||
145962797|NCT02513550|526375449|FG004|Double Blind Treatment Period|Due to personal business|0|||
145962798|NCT02513550|526375450|FG005|Double Blind Treatment Period|Due to personal business|0|||
145962799|NCT02513550|526375445|FG000|Double Blind Treatment Period|Death|1|||
145962800|NCT02513550|526375446|FG001|Double Blind Treatment Period|Death|0|||
145962801|NCT02513550|526375447|FG002|Double Blind Treatment Period|Death|2|||
146229353|NCT05424380|527356580|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
145885896|NCT01235442|526086420|FG000|Overall Study|Other unspecified|1|||
145885897|NCT01235442|526086421|FG001|Overall Study|Other unspecified|2|||
145885898|NCT01857973|526086422|FG000|Overall Study|Subject did not meet required BG range|3|||
145885899|NCT01857973|526086422|FG000|Overall Study|drop out after 3 failed attempts|1|||
145885900|NCT01857973|526086422|FG000|Overall Study|Physician Decision|1|||
145885901|NCT01701973|526086423|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885902|NCT01701973|526086424|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
145885903|NCT01701973|526086425|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885904|NCT01701973|526086426|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885905|NCT01701973|526086427|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885906|NCT01701973|526086428|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885907|NCT01701973|526086429|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885908|NCT01701973|526086430|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145885909|NCT00602537|526086437|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
145885910|NCT00602537|526086438|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
145885911|NCT00602537|526086437|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
145885912|NCT00602537|526086438|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
145885913|NCT00602537|526086437|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
145885914|NCT00602537|526086438|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
145885915|NCT00602537|526086437|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
145885916|NCT00602537|526086438|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
145885917|NCT00602537|526086437|FG000|Follow Up Study Comparison|Adverse Event|1|||
145885918|NCT00602537|526086438|FG001|Follow Up Study Comparison|Adverse Event|0|||
145885919|NCT00602537|526086437|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
145885920|NCT00602537|526086438|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
145885921|NCT00602537|526086437|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
145885922|NCT00602537|526086438|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
145885923|NCT00388037|526086439|FG000|Overall Study|Protocol Violation|1|||
145885924|NCT04330157|526086442|FG000|Overall Study|Protocol Violation|4|||
145885925|NCT04330157|526086442|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
145885926|NCT04499482|526086443|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
145885927|NCT04314843|526086444|FG000|Overall Study|Death|2|||
145885928|NCT04314843|526086445|FG001|Overall Study|Death|2|||
145885929|NCT04314843|526086444|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
145885930|NCT04314843|526086445|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
145885931|NCT02808819|526086446|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
145885932|NCT02808819|526086447|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
145885933|NCT02808819|526086446|FG000|Overall Study|Withdrawal by Subject|10|||
145885934|NCT02808819|526086447|FG001|Overall Study|Withdrawal by Subject|13|||
145885935|NCT02808819|526086446|FG000|Overall Study|Site terminated by sponsor|2|||
145885936|NCT02808819|526086447|FG001|Overall Study|Site terminated by sponsor|0|||
145962802|NCT02513550|526375448|FG003|Double Blind Treatment Period|Death|0|||
145962803|NCT02513550|526375449|FG004|Double Blind Treatment Period|Death|0|||
145962804|NCT02513550|526375450|FG005|Double Blind Treatment Period|Death|0|||
145962805|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
145962806|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
145962807|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
145962808|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145962809|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145962810|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145962811|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
145962812|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
145962813|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
145962814|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
146086005|NCT00527488|526835144|FG001|Overall Study|Withdrawn prior to dosing|1|||
146086006|NCT00527488|526835145|FG002|Overall Study|Withdrawn prior to dosing|1|||
145885937|NCT02808819|526086446|FG000|Overall Study|Pregnancy|1|||
145885938|NCT02808819|526086447|FG001|Overall Study|Pregnancy|0|||
145885939|NCT02808819|526086446|FG000|Overall Study|Lost to Follow-up|1|||
146229354|NCT05424380|527356581|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145962815|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
145962816|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
145962817|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
145962818|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
145962819|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
145962820|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145962821|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145962822|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145962823|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
145962824|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
145962825|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
145962826|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
145962827|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
145962828|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
145962829|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
145962830|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
145962831|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
145962832|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
145962833|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
146229355|NCT05424380|527356582|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146229356|NCT05424380|527356583|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
146229357|NCT05424380|527356578|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146229358|NCT05424380|527356579|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146229359|NCT05424380|527356580|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
146229360|NCT05424380|527356581|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145885940|NCT02808819|526086447|FG001|Overall Study|Lost to Follow-up|6|||
146229361|NCT05424380|527356582|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146229362|NCT05424380|527356583|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
146229363|NCT05424380|527356578|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146229364|NCT05424380|527356579|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146229365|NCT05424380|527356580|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
146229366|NCT05424380|527356581|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146229367|NCT05424380|527356582|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146229368|NCT05424380|527356583|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
146229369|NCT05424380|527356578|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229370|NCT05424380|527356579|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229371|NCT05424380|527356580|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229372|NCT05424380|527356581|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
146229373|NCT05424380|527356582|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229374|NCT05424380|527356583|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229375|NCT05424380|527356578|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146229376|NCT05424380|527356579|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146229377|NCT05424380|527356580|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146229378|NCT05424380|527356581|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
146229379|NCT05424380|527356582|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146229380|NCT05424380|527356583|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
146229381|NCT05424380|527356578|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146229382|NCT05424380|527356579|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146229383|NCT05424380|527356580|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146229384|NCT05424380|527356581|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
146229385|NCT05424380|527356582|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146229386|NCT05424380|527356583|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
146229387|NCT05424380|527356578|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146229388|NCT05424380|527356579|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146229389|NCT05424380|527356580|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146229390|NCT05424380|527356581|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146229391|NCT05424380|527356582|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
146229392|NCT05424380|527356583|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
146229393|NCT05424380|527356578|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229394|NCT05424380|527356579|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229395|NCT05424380|527356580|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229396|NCT05424380|527356581|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229397|NCT05424380|527356582|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
146229398|NCT05424380|527356583|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
146229399|NCT05424380|527356578|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146229400|NCT05424380|527356579|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146229401|NCT05424380|527356580|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146229402|NCT05424380|527356581|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146229403|NCT05424380|527356582|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
146229404|NCT05424380|527356583|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
146229405|NCT00844415|527356590|FG000|Overall Study|Withdrawal by Subject|1|||
146229406|NCT03015532|527356591|FG000|Overall Study|Adverse Event|0|||
146229407|NCT03015532|527356592|FG001|Overall Study|Adverse Event|0|||
146229408|NCT03015532|527356593|FG002|Overall Study|Adverse Event|0|||
146229409|NCT03015532|527356594|FG003|Overall Study|Adverse Event|0|||
146229410|NCT03015532|527356595|FG004|Overall Study|Adverse Event|0|||
146229411|NCT03015532|527356596|FG005|Overall Study|Adverse Event|2|||
146229412|NCT03015532|527356597|FG006|Overall Study|Adverse Event|1|||
146229413|NCT03015532|527356598|FG007|Overall Study|Adverse Event|0|||
146229414|NCT03015532|527356591|FG000|Overall Study|Withdrawal by Subject|0|||
146229415|NCT03015532|527356592|FG001|Overall Study|Withdrawal by Subject|0|||
146229416|NCT03015532|527356593|FG002|Overall Study|Withdrawal by Subject|0|||
146229417|NCT03015532|527356594|FG003|Overall Study|Withdrawal by Subject|0|||
146289214|NCT03170349|527573398|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
145885941|NCT02808819|526086446|FG000|Overall Study|Protocol Violation|0|||
146086007|NCT00527488|526835146|FG003|Overall Study|Withdrawn prior to dosing|0|||
146229418|NCT03015532|527356595|FG004|Overall Study|Withdrawal by Subject|0|||
146229419|NCT03015532|527356596|FG005|Overall Study|Withdrawal by Subject|0|||
146229420|NCT03015532|527356597|FG006|Overall Study|Withdrawal by Subject|1|||
146229421|NCT03015532|527356598|FG007|Overall Study|Withdrawal by Subject|0|||
146229422|NCT04778410|527356599|FG000|Safety Run-in Period|Death|5|||
146229423|NCT04778410|527356600|FG001|Safety Run-in Period|Death|6|||
146229424|NCT04778410|527356601|FG002|Safety Run-in Period|Death|0|||
146229425|NCT04778410|527356602|FG003|Safety Run-in Period|Death|0|||
146229426|NCT04778410|527356603|FG004|Safety Run-in Period|Death|0|||
146229427|NCT04778410|527356604|FG005|Safety Run-in Period|Death|0|||
146229428|NCT04778410|527356599|FG000|Phase 2 Period|Death|0|||
146229429|NCT04778410|527356600|FG001|Phase 2 Period|Death|0|||
146229430|NCT04778410|527356601|FG002|Phase 2 Period|Death|0|||
146229431|NCT04778410|527356602|FG003|Phase 2 Period|Death|5|||
146229432|NCT04778410|527356603|FG004|Phase 2 Period|Death|18|||
146229433|NCT04778410|527356604|FG005|Phase 2 Period|Death|0|||
146229434|NCT04778410|527356599|FG000|Phase 2 Period|Lost to Follow-up|0|||
146229435|NCT04778410|527356600|FG001|Phase 2 Period|Lost to Follow-up|0|||
146229436|NCT04778410|527356601|FG002|Phase 2 Period|Lost to Follow-up|0|||
145885942|NCT02808819|526086447|FG001|Overall Study|Protocol Violation|1|||
146229437|NCT04778410|527356602|FG003|Phase 2 Period|Lost to Follow-up|1|||
146229438|NCT04778410|527356603|FG004|Phase 2 Period|Lost to Follow-up|1|||
145885943|NCT02808819|526086446|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
145885944|NCT02808819|526086447|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
146229439|NCT04778410|527356604|FG005|Phase 2 Period|Lost to Follow-up|0|||
146229440|NCT04778410|527356599|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
146229441|NCT04778410|527356600|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
145885945|NCT02808819|526086446|FG000|Overall Study|Death|1|||
145885946|NCT02808819|526086447|FG001|Overall Study|Death|0|||
146229442|NCT04778410|527356601|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
146229443|NCT04778410|527356602|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
146229444|NCT04778410|527356603|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
146086008|NCT02545543|526835147|FG000|Overall Study|Lost to Follow-up|67|||
146086009|NCT02545543|526835148|FG001|Overall Study|Lost to Follow-up|25|||
146086010|NCT02545543|526835147|FG000|Overall Study|Physician Decision|3|||
146229445|NCT04778410|527356604|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
146086011|NCT02545543|526835148|FG001|Overall Study|Physician Decision|0|||
146086012|NCT02545543|526835147|FG000|Overall Study|Withdrawal by Subject|9|||
145885947|NCT02808819|526086446|FG000|Overall Study|Adverse Event|3|||
145885948|NCT02808819|526086447|FG001|Overall Study|Adverse Event|4|||
145885949|NCT01396421|526086454|FG000|Overall Study|Lost to Follow-up|0|||
145885950|NCT01396421|526086455|FG001|Overall Study|Lost to Follow-up|0|||
145885951|NCT01396421|526086456|FG002|Overall Study|Lost to Follow-up|0|||
145885952|NCT01396421|526086457|FG003|Overall Study|Lost to Follow-up|1|||
145885953|NCT01396421|526086454|FG000|Overall Study|Adverse Event|17|||
145885954|NCT01396421|526086455|FG001|Overall Study|Adverse Event|15|||
145885955|NCT01396421|526086456|FG002|Overall Study|Adverse Event|12|||
145885956|NCT01396421|526086457|FG003|Overall Study|Adverse Event|32|||
145885957|NCT01396421|526086454|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
145885958|NCT01396421|526086455|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
145885959|NCT01396421|526086456|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
145885960|NCT01396421|526086457|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
145885961|NCT01396421|526086454|FG000|Overall Study|Physician Decision|1|||
145885962|NCT01396421|526086455|FG001|Overall Study|Physician Decision|1|||
145885963|NCT01396421|526086456|FG002|Overall Study|Physician Decision|0|||
145885964|NCT01396421|526086457|FG003|Overall Study|Physician Decision|3|||
145885965|NCT01396421|526086454|FG000|Overall Study|Withdrawal by Subject|31|||
145885966|NCT01396421|526086455|FG001|Overall Study|Withdrawal by Subject|24|||
145885967|NCT01396421|526086456|FG002|Overall Study|Withdrawal by Subject|13|||
145885968|NCT01396421|526086457|FG003|Overall Study|Withdrawal by Subject|21|||
145885969|NCT01396421|526086454|FG000|Overall Study|Protocol Deviation|2|||
145885970|NCT01396421|526086455|FG001|Overall Study|Protocol Deviation|1|||
145885971|NCT01396421|526086456|FG002|Overall Study|Protocol Deviation|1|||
145885972|NCT01396421|526086457|FG003|Overall Study|Protocol Deviation|0|||
145885973|NCT01396421|526086454|FG000|Overall Study|Lack of Efficacy|7|||
145885974|NCT01396421|526086455|FG001|Overall Study|Lack of Efficacy|17|||
145885975|NCT01396421|526086456|FG002|Overall Study|Lack of Efficacy|7|||
145885976|NCT01396421|526086457|FG003|Overall Study|Lack of Efficacy|18|||
145885977|NCT01610063|526086458|FG000|Overall Study|Lost to Follow-up|42|||
145885978|NCT01610063|526086459|FG001|Overall Study|Lost to Follow-up|20|||
145885979|NCT03314662|526086460|FG000|Overall Study|Withdrawal by Subject|1|||
145885980|NCT03314662|526086461|FG001|Overall Study|Withdrawal by Subject|1|||
145885981|NCT03314662|526086462|FG002|Overall Study|Withdrawal by Subject|1|||
145885982|NCT03314662|526086460|FG000|Overall Study|Lost to Follow-up|5|||
145885983|NCT03314662|526086461|FG001|Overall Study|Lost to Follow-up|4|||
145885984|NCT03314662|526086462|FG002|Overall Study|Lost to Follow-up|4|||
145885985|NCT03314662|526086460|FG000|Overall Study|Death|2|||
145885986|NCT03314662|526086461|FG001|Overall Study|Death|0|||
145885987|NCT03314662|526086462|FG002|Overall Study|Death|0|||
145885988|NCT01867606|526086465|FG000|Overall Study|Withdrawal by Subject|10|||
145885989|NCT01867606|526086466|FG001|Overall Study|Withdrawal by Subject|14|||
145885990|NCT01867606|526086465|FG000|Overall Study|Protocol Violation|0|||
145885991|NCT01867606|526086466|FG001|Overall Study|Protocol Violation|1|||
145885992|NCT01378962|526086467|FG000|Overall Study|Death|14|||
145885993|NCT01378962|526086467|FG000|Overall Study|Lost to Follow-up|1|||
145885994|NCT01378962|526086467|FG000|Overall Study|Other|2|||
145885995|NCT01588548|526086473|FG000|Overall Study|Withdrawal by Subject|0|||
145885996|NCT01588548|526086474|FG001|Overall Study|Withdrawal by Subject|1|||
145885997|NCT01588548|526086475|FG002|Overall Study|Withdrawal by Subject|1|||
145885998|NCT01588548|526086476|FG003|Overall Study|Withdrawal by Subject|1|||
145885999|NCT01588548|526086477|FG004|Overall Study|Withdrawal by Subject|2|||
145886000|NCT01588548|526086478|FG005|Overall Study|Withdrawal by Subject|3|||
145886001|NCT01588548|526086473|FG000|Overall Study|Adverse Event|0|||
145886002|NCT01588548|526086474|FG001|Overall Study|Adverse Event|0|||
145886003|NCT01588548|526086475|FG002|Overall Study|Adverse Event|1|||
145886004|NCT01588548|526086476|FG003|Overall Study|Adverse Event|2|||
145886005|NCT01588548|526086477|FG004|Overall Study|Adverse Event|1|||
145886006|NCT01588548|526086478|FG005|Overall Study|Adverse Event|0|||
145886007|NCT01588548|526086473|FG000|Overall Study|Condition Under Investigation Worsened|3|||
145886008|NCT01588548|526086474|FG001|Overall Study|Condition Under Investigation Worsened|6|||
145886009|NCT01588548|526086475|FG002|Overall Study|Condition Under Investigation Worsened|4|||
145886010|NCT01588548|526086476|FG003|Overall Study|Condition Under Investigation Worsened|4|||
145886011|NCT01588548|526086477|FG004|Overall Study|Condition Under Investigation Worsened|3|||
145886012|NCT01588548|526086478|FG005|Overall Study|Condition Under Investigation Worsened|3|||
145886013|NCT01634854|526086481|FG000|Overall Study|Cesarean delivery|2|||
145886014|NCT01634854|526086482|FG001|Overall Study|Cesarean delivery|7|||
145886015|NCT02219308|526086483|FG000|Overall Study|Withdrawal by Subject|1|||
145886016|NCT02219308|526086484|FG001|Overall Study|Withdrawal by Subject|2|||
145886017|NCT01989676|526088251|FG000|Overall Study|Death|52|||
145886018|NCT01989676|526088252|FG001|Overall Study|Death|60|||
145886019|NCT01989676|526088251|FG000|Overall Study|Protocol Violation|2|||
145886020|NCT01989676|526088252|FG001|Overall Study|Protocol Violation|1|||
145886021|NCT01989676|526088251|FG000|Overall Study|Lost to Follow-up|8|||
145886022|NCT01989676|526088252|FG001|Overall Study|Lost to Follow-up|18|||
145886023|NCT01989676|526088251|FG000|Overall Study|No longer willing to participate in study|26|||
145886024|NCT01989676|526088252|FG001|Overall Study|No longer willing to participate in study|26|||
146229446|NCT04778410|527356599|FG000|Phase 2 Period|Withdrew Consent|0|||
146229447|NCT04778410|527356600|FG001|Phase 2 Period|Withdrew Consent|0|||
146229448|NCT04778410|527356601|FG002|Phase 2 Period|Withdrew Consent|0|||
146229449|NCT04778410|527356602|FG003|Phase 2 Period|Withdrew Consent|0|||
146229450|NCT04778410|527356603|FG004|Phase 2 Period|Withdrew Consent|2|||
146229451|NCT04778410|527356604|FG005|Phase 2 Period|Withdrew Consent|0|||
146229452|NCT01121588|527356608|FG000|Overall Study|Death|5|||
146229453|NCT01121588|527356609|FG001|Overall Study|Death|3|||
146229454|NCT01121588|527356610|FG002|Overall Study|Death|13|||
146229455|NCT01121588|527356608|FG000|Overall Study|Study Terminated by Sponsor|1|||
145886025|NCT01989676|526088251|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
145886026|NCT01989676|526088252|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
145886027|NCT01989676|526088251|FG000|Overall Study|Other|4|||
145886028|NCT01989676|526088252|FG001|Overall Study|Other|3|||
145886029|NCT03941834|526088253|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
145886030|NCT03941834|526088254|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
145886031|NCT03941834|526088255|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
145886032|NCT03941834|526088253|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
146229456|NCT01121588|527356609|FG001|Overall Study|Study Terminated by Sponsor|1|||
146229457|NCT01121588|527356610|FG002|Overall Study|Study Terminated by Sponsor|0|||
145962834|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
145962835|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Death|0|||
145962836|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Death|0|||
145962837|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Death|1|||
145962838|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Death|0|||
145962839|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Death|0|||
145962840|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Death|0|||
145962841|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
145962842|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
146086013|NCT02545543|526835148|FG001|Overall Study|Withdrawal by Subject|8|||
146086014|NCT02545543|526835147|FG000|Overall Study|Noncomplaince|1|||
146086015|NCT02545543|526835148|FG001|Overall Study|Noncomplaince|0|||
145886033|NCT03941834|526088254|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
146289215|NCT03170349|527573398|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
146289216|NCT03170349|527573398|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
146289217|NCT03170349|527573398|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
146289218|NCT03170349|527573398|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
145886034|NCT03941834|526088255|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
145886035|NCT03941834|526088253|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
145886036|NCT03941834|526088254|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
145886037|NCT03941834|526088255|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
145886038|NCT03941834|526088253|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
145886039|NCT03941834|526088254|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
145886040|NCT03941834|526088255|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
145886041|NCT03941834|526088253|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
145886042|NCT03941834|526088254|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
145886043|NCT03941834|526088255|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
145886044|NCT03941834|526088253|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
145886045|NCT03941834|526088254|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
145962843|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
145962844|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
145962845|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
145886046|NCT03941834|526088255|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
145886047|NCT02688387|526088256|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886048|NCT02688387|526088257|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886049|NCT02688387|526088258|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
145886050|NCT02688387|526088259|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886051|NCT02688387|526088260|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886052|NCT02688387|526088261|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886053|NCT02688387|526088262|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886054|NCT02688387|526088263|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886055|NCT02688387|526088264|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886056|NCT02688387|526088265|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886057|NCT02688387|526088266|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886058|NCT02688387|526088267|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886059|NCT02688387|526088268|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886060|NCT02688387|526088269|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886061|NCT02688387|526088270|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886062|NCT02688387|526088271|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886063|NCT02688387|526088272|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886064|NCT02688387|526088273|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886065|NCT02688387|526088274|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886066|NCT02688387|526088275|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886067|NCT02688387|526088276|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886068|NCT02688387|526088277|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145886069|NCT02688387|526088256|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886070|NCT02688387|526088257|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886071|NCT02688387|526088258|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886072|NCT02688387|526088259|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
145886073|NCT02688387|526088260|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886074|NCT02688387|526088261|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886075|NCT02688387|526088262|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886076|NCT02688387|526088263|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886077|NCT02688387|526088264|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886078|NCT02688387|526088265|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886079|NCT02688387|526088266|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886080|NCT02688387|526088267|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886081|NCT02688387|526088268|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886082|NCT02688387|526088269|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146229458|NCT01121588|527356608|FG000|Overall Study|Participant Refused Further Followup|2|||
146229459|NCT01121588|527356609|FG001|Overall Study|Participant Refused Further Followup|0|||
146229460|NCT01121588|527356610|FG002|Overall Study|Participant Refused Further Followup|2|||
146229461|NCT01121588|527356608|FG000|Overall Study|Lost to Follow-up|0|||
146229462|NCT01121588|527356609|FG001|Overall Study|Lost to Follow-up|1|||
146229463|NCT01121588|527356610|FG002|Overall Study|Lost to Follow-up|1|||
146229464|NCT01121588|527356608|FG000|Overall Study|Non-Specified Reasons|9|||
146229465|NCT01121588|527356609|FG001|Overall Study|Non-Specified Reasons|4|||
146229466|NCT01121588|527356610|FG002|Overall Study|Non-Specified Reasons|2|||
146229467|NCT02944968|527356613|FG000|Overall Study|Subject excluded before study procedure|1|||
146229468|NCT02944968|527356613|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
146229469|NCT04424316|527356614|FG000|Overall Study|Adverse Event|0|||
146229470|NCT04424316|527356615|FG001|Overall Study|Adverse Event|1|||
146229471|NCT04424316|527356616|FG002|Overall Study|Adverse Event|0|||
146229472|NCT04424316|527356617|FG003|Overall Study|Adverse Event|0|||
146229473|NCT04424316|527356614|FG000|Overall Study|Death|1|||
146229474|NCT04424316|527356615|FG001|Overall Study|Death|0|||
146229475|NCT04424316|527356616|FG002|Overall Study|Death|8|||
146229476|NCT04424316|527356617|FG003|Overall Study|Death|14|||
146229477|NCT04424316|527356614|FG000|Overall Study|Lost to Follow-up|93|||
146229478|NCT04424316|527356615|FG001|Overall Study|Lost to Follow-up|88|||
146229479|NCT04424316|527356616|FG002|Overall Study|Lost to Follow-up|224|||
146229480|NCT04424316|527356617|FG003|Overall Study|Lost to Follow-up|211|||
146229481|NCT04424316|527356614|FG000|Overall Study|No longer met eligibility criteria|1|||
146229482|NCT04424316|527356615|FG001|Overall Study|No longer met eligibility criteria|0|||
146229483|NCT04424316|527356616|FG002|Overall Study|No longer met eligibility criteria|0|||
146229484|NCT04424316|527356617|FG003|Overall Study|No longer met eligibility criteria|0|||
146229485|NCT04424316|527356614|FG000|Overall Study|Other|15|||
146229486|NCT04424316|527356615|FG001|Overall Study|Other|11|||
146229487|NCT04424316|527356616|FG002|Overall Study|Other|34|||
146229488|NCT04424316|527356617|FG003|Overall Study|Other|45|||
146229489|NCT04424316|527356614|FG000|Overall Study|Physician Decision|1|||
146229490|NCT04424316|527356615|FG001|Overall Study|Physician Decision|0|||
146229491|NCT04424316|527356616|FG002|Overall Study|Physician Decision|1|||
146229492|NCT04424316|527356617|FG003|Overall Study|Physician Decision|1|||
146229493|NCT04424316|527356614|FG000|Overall Study|Protocol Violation|0|||
146086016|NCT02545543|526835147|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
146086017|NCT02545543|526835148|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
146086018|NCT00622739|526836511|FG000|Overall Study|Physician Decision|1|||
146086019|NCT00622739|526836512|FG001|Overall Study|Physician Decision|0|||
146086020|NCT00622739|526836511|FG000|Overall Study|Adverse Event|1|||
146086021|NCT00622739|526836512|FG001|Overall Study|Adverse Event|2|||
146086022|NCT00622739|526836511|FG000|Overall Study|Lack of Efficacy|0|||
146086023|NCT00622739|526836512|FG001|Overall Study|Lack of Efficacy|2|||
146086024|NCT00622739|526836511|FG000|Overall Study|Withdrawal by Subject|0|||
146086025|NCT00622739|526836512|FG001|Overall Study|Withdrawal by Subject|1|||
146086026|NCT00622739|526836511|FG000|Overall Study|Lost to Follow-up|0|||
146086027|NCT00622739|526836512|FG001|Overall Study|Lost to Follow-up|1|||
146086028|NCT03123185|526836520|FG000|Overall Study|Withdrawal by Subject|0|||
146086029|NCT03123185|526836521|FG001|Overall Study|Withdrawal by Subject|0|||
146086030|NCT03123185|526836522|FG002|Overall Study|Withdrawal by Subject|0|||
146086031|NCT03123185|526836523|FG003|Overall Study|Withdrawal by Subject|0|||
146086032|NCT03123185|526836524|FG004|Overall Study|Withdrawal by Subject|0|||
146086033|NCT03123185|526836525|FG005|Overall Study|Withdrawal by Subject|0|||
146086034|NCT03123185|526836526|FG006|Overall Study|Withdrawal by Subject|0|||
146086035|NCT03123185|526836527|FG007|Overall Study|Withdrawal by Subject|0|||
146086036|NCT03123185|526836528|FG008|Overall Study|Withdrawal by Subject|0|||
146229494|NCT04424316|527356615|FG001|Overall Study|Protocol Violation|1|||
146229495|NCT04424316|527356616|FG002|Overall Study|Protocol Violation|0|||
146229496|NCT04424316|527356617|FG003|Overall Study|Protocol Violation|0|||
146229497|NCT04424316|527356614|FG000|Overall Study|Withdrawal by Subject|71|||
146086037|NCT03123185|526836529|FG009|Overall Study|Withdrawal by Subject|0|||
146086038|NCT03123185|526836530|FG010|Overall Study|Withdrawal by Subject|0|||
146086039|NCT03123185|526836531|FG011|Overall Study|Withdrawal by Subject|0|||
146086040|NCT03123185|526836532|FG012|Overall Study|Withdrawal by Subject|1|||
146086041|NCT03123185|526836533|FG013|Overall Study|Withdrawal by Subject|0|||
146086042|NCT00718081|526836534|FG000|Overall Study|Adverse Event|0|||
146086043|NCT00718081|526836535|FG001|Overall Study|Adverse Event|1|||
146086044|NCT00718081|526836536|FG002|Overall Study|Adverse Event|0|||
146229498|NCT04424316|527356615|FG001|Overall Study|Withdrawal by Subject|77|||
146229499|NCT04424316|527356616|FG002|Overall Study|Withdrawal by Subject|0|||
146229500|NCT04424316|527356617|FG003|Overall Study|Withdrawal by Subject|0|||
146229501|NCT04424316|527356614|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146229502|NCT04424316|527356615|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146229503|NCT04424316|527356616|FG002|Overall Study|Withdrawal by parent/guardian|74|||
146229504|NCT04424316|527356617|FG003|Overall Study|Withdrawal by parent/guardian|81|||
146229505|NCT04424316|527356614|FG000|Overall Study|Randomized but not vaccinated|13|||
146229506|NCT04424316|527356615|FG001|Overall Study|Randomized but not vaccinated|21|||
146229507|NCT04424316|527356616|FG002|Overall Study|Randomized but not vaccinated|0|||
146229508|NCT04424316|527356617|FG003|Overall Study|Randomized but not vaccinated|0|||
146229509|NCT04424316|527356614|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
146229510|NCT04424316|527356615|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
146229511|NCT04424316|527356616|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
146229512|NCT04424316|527356617|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
146229513|NCT05890105|527356618|FG000|Overall Study|Adverse Event|1|||
146229514|NCT05890105|527356619|FG001|Overall Study|Adverse Event|0|||
146229515|NCT05890105|527356620|FG002|Overall Study|Adverse Event|0|||
146229516|NCT05890105|527356618|FG000|Overall Study|Other|1|||
146229517|NCT05890105|527356619|FG001|Overall Study|Other|2|||
146229518|NCT05890105|527356620|FG002|Overall Study|Other|0|||
146229519|NCT04505410|527356622|FG000|Overall Study|Adverse Event|2|||
146229520|NCT04505410|527356623|FG001|Overall Study|Adverse Event|0|||
146229521|NCT04505410|527356622|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
146229522|NCT04505410|527356623|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
146229523|NCT04505410|527356622|FG000|Overall Study|did not want to follow diet|1|||
146229524|NCT04505410|527356623|FG001|Overall Study|did not want to follow diet|0|||
146229525|NCT04505410|527356622|FG000|Overall Study|flare up of ulcerative colitis|0|||
146229526|NCT04505410|527356623|FG001|Overall Study|flare up of ulcerative colitis|1|||
146229527|NCT04505410|527356622|FG000|Overall Study|Lost to Follow-up|0|||
146229528|NCT04505410|527356623|FG001|Overall Study|Lost to Follow-up|2|||
146229529|NCT04505410|527356622|FG000|Overall Study|Lost to Follow-up|1|||
146229530|NCT04505410|527356623|FG001|Overall Study|Lost to Follow-up|0|||
146229531|NCT04505410|527356622|FG000|Overall Study|initiated another diet on their own|0|||
146229532|NCT04505410|527356623|FG001|Overall Study|initiated another diet on their own|2|||
146229533|NCT05123027|527356628|FG000|Overall Study|Lost to Follow-up|17|||
146229534|NCT05123027|527356629|FG001|Overall Study|Lost to Follow-up|22|||
146229535|NCT05123027|527356628|FG000|Overall Study|Incarceration|3|||
146229536|NCT05123027|527356629|FG001|Overall Study|Incarceration|4|||
146229537|NCT05123027|527356628|FG000|Overall Study|Death|2|||
146229538|NCT05123027|527356629|FG001|Overall Study|Death|2|||
146229539|NCT05123027|527356628|FG000|Overall Study|Other|2|||
146229540|NCT05123027|527356629|FG001|Overall Study|Other|0|||
146229541|NCT05311176|527358223|FG000|Overall Study|Death|6|||
146229542|NCT05311176|527358223|FG000|Overall Study|Sponsor discontinued the study|1|||
146229543|NCT05552508|527358226|FG000|Overall Study|Adverse Event|3|||
145962846|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
146229544|NCT04605159|527358227|FG000|Overall Study|Adverse Event|6|||
145962847|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145962848|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
146229545|NCT04605159|527358228|FG001|Overall Study|Adverse Event|3|||
146229546|NCT04605159|527358229|FG002|Overall Study|Adverse Event|21|||
146229547|NCT04605159|527358230|FG003|Overall Study|Adverse Event|4|||
145962849|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
146289219|NCT03170349|527573398|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
146289220|NCT03170349|527573398|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
146229548|NCT04605159|527358227|FG000|Overall Study|Lost to Follow-up|74|||
145962850|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145962851|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145962852|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145962853|NCT02513550|526375445|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
145962854|NCT02513550|526375446|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
145962855|NCT02513550|526375447|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
145962856|NCT02513550|526375448|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
145962857|NCT02513550|526375449|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
145962858|NCT02513550|526375450|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
145962859|NCT02059239|526375454|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
145962860|NCT02059239|526375455|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
145962861|NCT02059239|526375454|FG000|Overall Study|Physician Decision|1|||
145962862|NCT02059239|526375455|FG001|Overall Study|Physician Decision|0|||
145962863|NCT01268267|526375457|FG000|Overall Study|Protocol Violation|1|||
145962864|NCT01222104|526375458|FG000|Overall Study|Lost to Follow-up|37|||
145962865|NCT01222104|526375458|FG000|Overall Study|Death|10|||
145962866|NCT01418339|526375459|FG000|Overall Study|Adverse Event|5|||
145962867|NCT01418339|526375460|FG001|Overall Study|Adverse Event|2|||
145962868|NCT01418339|526375459|FG000|Overall Study|Subject Withdrew Consent|1|||
145962869|NCT01418339|526375460|FG001|Overall Study|Subject Withdrew Consent|2|||
145962870|NCT01418339|526375459|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
145962871|NCT01418339|526375460|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
145962872|NCT02204917|526375463|FG000|Overall Study|Protocol Violation|1|||
145962873|NCT00909844|526375464|FG000|Overall Study|Adverse Event|1|||
145962874|NCT00909844|526375464|FG000|Overall Study|Withdrawal by Subject|1|||
145962875|NCT00909844|526375464|FG000|Overall Study|Lost to Follow-up|2|||
145962876|NCT02219685|526375465|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
145962877|NCT02219685|526375466|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
145962878|NCT02219685|526375465|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
145962879|NCT02219685|526375466|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
145962880|NCT00698815|526375467|FG000|Overall Study|Death|1|||
145962881|NCT00698815|526375468|FG001|Overall Study|Death|2|||
145962882|NCT00698815|526375469|FG002|Overall Study|Death|4|||
145962883|NCT00698815|526375467|FG000|Overall Study|Withdrawal by Subject|6|||
145962884|NCT00698815|526375468|FG001|Overall Study|Withdrawal by Subject|3|||
145962885|NCT00698815|526375469|FG002|Overall Study|Withdrawal by Subject|2|||
145962886|NCT00698815|526375467|FG000|Overall Study|MD discretion|2|||
145962887|NCT00698815|526375468|FG001|Overall Study|MD discretion|7|||
145962888|NCT00698815|526375469|FG002|Overall Study|MD discretion|2|||
145962889|NCT00698815|526375467|FG000|Overall Study|Did not receive protocol treatment|1|||
145962890|NCT00698815|526375468|FG001|Overall Study|Did not receive protocol treatment|2|||
145962891|NCT00698815|526375469|FG002|Overall Study|Did not receive protocol treatment|2|||
145962892|NCT00706004|526375470|FG000|Overall Study|Did not meet eligibility criteria|2|||
145962893|NCT03575702|526375475|FG000|Overall Study|Withdrawal by Subject|1|||
145962894|NCT03575702|526375476|FG001|Overall Study|Withdrawal by Subject|1|||
145962895|NCT03575702|526375475|FG000|Overall Study|Lost to Follow-up|1|||
145962896|NCT03575702|526375476|FG001|Overall Study|Lost to Follow-up|2|||
146229549|NCT04605159|527358228|FG001|Overall Study|Lost to Follow-up|45|||
146229550|NCT04605159|527358229|FG002|Overall Study|Lost to Follow-up|119|||
146229551|NCT04605159|527358230|FG003|Overall Study|Lost to Follow-up|80|||
146229552|NCT04605159|527358227|FG000|Overall Study|Protocol Violation|4|||
146229553|NCT04605159|527358228|FG001|Overall Study|Protocol Violation|5|||
146229554|NCT04605159|527358229|FG002|Overall Study|Protocol Violation|2|||
146229555|NCT04605159|527358230|FG003|Overall Study|Protocol Violation|0|||
146229556|NCT04605159|527358227|FG000|Overall Study|Withdrawal by Subject|66|||
146229557|NCT04605159|527358228|FG001|Overall Study|Withdrawal by Subject|37|||
146229558|NCT04605159|527358229|FG002|Overall Study|Withdrawal by Subject|68|||
146229559|NCT04605159|527358230|FG003|Overall Study|Withdrawal by Subject|50|||
146229560|NCT04605159|527358227|FG000|Overall Study|Migrated / moved from the study area|32|||
145962897|NCT03575702|526375475|FG000|Overall Study|Protocol Violation|0|||
146229561|NCT04605159|527358228|FG001|Overall Study|Migrated / moved from the study area|22|||
146229562|NCT04605159|527358229|FG002|Overall Study|Migrated / moved from the study area|41|||
145962898|NCT03575702|526375476|FG001|Overall Study|Protocol Violation|1|||
145962899|NCT03575702|526375475|FG000|Overall Study|Patient non compliance|4|||
145962900|NCT03575702|526375476|FG001|Overall Study|Patient non compliance|0|||
145962901|NCT01545388|526375477|FG000|Overall Study|Adverse Event|2|||
145962902|NCT01545388|526375478|FG001|Overall Study|Adverse Event|4|||
145962903|NCT01545388|526375479|FG002|Overall Study|Adverse Event|1|||
145962904|NCT01545388|526375477|FG000|Overall Study|Lack of Efficacy|3|||
145962905|NCT01545388|526375478|FG001|Overall Study|Lack of Efficacy|2|||
145962906|NCT01545388|526375479|FG002|Overall Study|Lack of Efficacy|5|||
145962907|NCT01545388|526375477|FG000|Overall Study|Participant moved or relocated|1|||
145962908|NCT01545388|526375478|FG001|Overall Study|Participant moved or relocated|0|||
145962909|NCT01545388|526375479|FG002|Overall Study|Participant moved or relocated|0|||
145962910|NCT01545388|526375477|FG000|Overall Study|Withdrawal by Subject|1|||
145962911|NCT01545388|526375478|FG001|Overall Study|Withdrawal by Subject|4|||
146289221|NCT03170349|527573398|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
145886083|NCT02688387|526088270|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886084|NCT02688387|526088271|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886085|NCT02688387|526088272|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886086|NCT02688387|526088273|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886087|NCT02688387|526088274|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886088|NCT02688387|526088275|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886089|NCT02688387|526088276|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886090|NCT02688387|526088277|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886091|NCT02688387|526088256|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886092|NCT02688387|526088257|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
145886093|NCT02688387|526088258|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886094|NCT02688387|526088259|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886095|NCT02688387|526088260|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886096|NCT02688387|526088261|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886097|NCT02688387|526088262|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886098|NCT02688387|526088263|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886099|NCT02688387|526088264|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886100|NCT02688387|526088265|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886101|NCT02688387|526088266|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886102|NCT02688387|526088267|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886103|NCT02688387|526088268|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886104|NCT02688387|526088269|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886105|NCT02688387|526088270|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886106|NCT02688387|526088271|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886107|NCT02688387|526088272|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886108|NCT02688387|526088273|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886109|NCT02688387|526088274|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886110|NCT02688387|526088275|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886111|NCT02688387|526088276|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886112|NCT02688387|526088277|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145886113|NCT02688387|526088256|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886114|NCT02688387|526088257|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886115|NCT02688387|526088258|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
145886116|NCT02688387|526088259|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886117|NCT02688387|526088260|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
145886118|NCT02688387|526088261|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
146086045|NCT00718081|526836534|FG000|Overall Study|Lack of Efficacy|7|||
146289222|NCT03170349|527573398|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
146289223|NCT03440320|527575219|FG000|Overall Study|Withdrawal by Subject|0|||
146289224|NCT03440320|527575220|FG001|Overall Study|Withdrawal by Subject|1|||
146289225|NCT00409773|527575221|FG000|Overall Study|Adverse Event|3|||
146289226|NCT00409773|527575222|FG001|Overall Study|Adverse Event|4|||
146289227|NCT00409773|527575223|FG002|Overall Study|Adverse Event|4|||
146289228|NCT00409773|527575224|FG003|Overall Study|Adverse Event|2|||
146289229|NCT00409773|527575225|FG004|Overall Study|Adverse Event|6|||
146289230|NCT00409773|527575221|FG000|Overall Study|Lost to Follow-up|6|||
146289231|NCT00409773|527575222|FG001|Overall Study|Lost to Follow-up|1|||
146289232|NCT00409773|527575223|FG002|Overall Study|Lost to Follow-up|2|||
146289233|NCT00409773|527575224|FG003|Overall Study|Lost to Follow-up|3|||
146229563|NCT04605159|527358230|FG003|Overall Study|Migrated / moved from the study area|21|||
146229564|NCT04605159|527358227|FG000|Overall Study|Other|1|||
146229565|NCT04605159|527358228|FG001|Overall Study|Other|2|||
146229566|NCT04605159|527358229|FG002|Overall Study|Other|7|||
146229567|NCT04605159|527358230|FG003|Overall Study|Other|3|||
146229568|NCT05172232|527358234|FG000|Overall Study|Lost to Follow-up|3|||
146229569|NCT04629339|527358238|FG000|Overall Study|Death|1|||
146229570|NCT04629339|527358239|FG001|Overall Study|Death|0|||
146229571|NCT04629339|527358240|FG002|Overall Study|Death|2|||
146229572|NCT04629339|527358241|FG003|Overall Study|Death|2|||
146229573|NCT04629339|527358242|FG004|Overall Study|Death|0|||
146229574|NCT04629339|527358238|FG000|Overall Study|Disease Progression|0|||
146229575|NCT04629339|527358239|FG001|Overall Study|Disease Progression|0|||
146229576|NCT04629339|527358240|FG002|Overall Study|Disease Progression|1|||
146229577|NCT04629339|527358241|FG003|Overall Study|Disease Progression|1|||
146229578|NCT04629339|527358242|FG004|Overall Study|Disease Progression|0|||
146229579|NCT04629339|527358238|FG000|Overall Study|Lost to Follow-up|0|||
146229580|NCT04629339|527358239|FG001|Overall Study|Lost to Follow-up|0|||
146229581|NCT04629339|527358240|FG002|Overall Study|Lost to Follow-up|0|||
146229582|NCT04629339|527358241|FG003|Overall Study|Lost to Follow-up|1|||
146229583|NCT04629339|527358242|FG004|Overall Study|Lost to Follow-up|0|||
146229584|NCT04629339|527358238|FG000|Overall Study|Physician Decision|0|||
146229585|NCT04629339|527358239|FG001|Overall Study|Physician Decision|1|||
146229586|NCT04629339|527358240|FG002|Overall Study|Physician Decision|0|||
146229587|NCT04629339|527358241|FG003|Overall Study|Physician Decision|0|||
146229588|NCT04629339|527358242|FG004|Overall Study|Physician Decision|0|||
146229589|NCT04629339|527358238|FG000|Overall Study|Study Terminated by Sponsor|0|||
146229590|NCT04629339|527358239|FG001|Overall Study|Study Terminated by Sponsor|0|||
146229591|NCT04629339|527358240|FG002|Overall Study|Study Terminated by Sponsor|0|||
146229592|NCT04629339|527358241|FG003|Overall Study|Study Terminated by Sponsor|1|||
146229593|NCT04629339|527358242|FG004|Overall Study|Study Terminated by Sponsor|0|||
146229594|NCT04629339|527358238|FG000|Overall Study|Withdrawal by Subject|0|||
146229595|NCT04629339|527358239|FG001|Overall Study|Withdrawal by Subject|0|||
146229596|NCT04629339|527358240|FG002|Overall Study|Withdrawal by Subject|2|||
146229597|NCT04629339|527358241|FG003|Overall Study|Withdrawal by Subject|2|||
146229598|NCT04629339|527358242|FG004|Overall Study|Withdrawal by Subject|0|||
146229599|NCT03914469|527358247|FG000|Overall Study|Lost to Follow-up|1|||
146229600|NCT03914469|527358248|FG001|Overall Study|Lost to Follow-up|4|||
146229601|NCT00677365|527358250|FG000|Overall Study|Adverse Event|2|||
146229602|NCT00677365|527358251|FG001|Overall Study|Adverse Event|1|||
146229603|NCT00677365|527358252|FG002|Overall Study|Adverse Event|1|||
145962912|NCT01545388|526375479|FG002|Overall Study|Withdrawal by Subject|2|||
145962913|NCT01545388|526375477|FG000|Overall Study|Other|1|||
145962914|NCT01545388|526375478|FG001|Overall Study|Other|1|||
145962915|NCT01545388|526375479|FG002|Overall Study|Other|0|||
145962916|NCT01900444|526375480|FG000|Overall Study|Protocol Violation|2|||
145962917|NCT01900444|526375480|FG000|Overall Study|Lost to Follow-up|1|||
145962918|NCT00072384|526375481|FG000|Overall Study|Physician Decision|1|||
145962919|NCT00072384|526375481|FG000|Overall Study|Ineligible|8|||
146229604|NCT00677365|527358253|FG003|Overall Study|Adverse Event|2|||
146229605|NCT00677365|527358250|FG000|Overall Study|Withdrawal by Subject|0|||
146229606|NCT00677365|527358251|FG001|Overall Study|Withdrawal by Subject|0|||
146229607|NCT00677365|527358252|FG002|Overall Study|Withdrawal by Subject|1|||
146229608|NCT00677365|527358253|FG003|Overall Study|Withdrawal by Subject|0|||
146229609|NCT00677365|527358250|FG000|Overall Study|Other reason|0|||
146229610|NCT00677365|527358251|FG001|Overall Study|Other reason|0|||
146229611|NCT00677365|527358252|FG002|Overall Study|Other reason|0|||
145962920|NCT01825200|526375482|FG000|Overall Study|Lost to Follow-up|5|||
145962921|NCT01825200|526375483|FG001|Overall Study|Lost to Follow-up|6|||
145962922|NCT01825200|526375482|FG000|Overall Study|Withdrawal by Subject|0|||
146289234|NCT00409773|527575225|FG004|Overall Study|Lost to Follow-up|1|||
146289235|NCT00409773|527575221|FG000|Overall Study|Physician Decision|0|||
146289236|NCT00409773|527575222|FG001|Overall Study|Physician Decision|0|||
146289237|NCT00409773|527575223|FG002|Overall Study|Physician Decision|0|||
146289238|NCT00409773|527575224|FG003|Overall Study|Physician Decision|2|||
146289239|NCT00409773|527575225|FG004|Overall Study|Physician Decision|0|||
146289240|NCT00409773|527575221|FG000|Overall Study|Protocol Violation|0|||
146289241|NCT00409773|527575222|FG001|Overall Study|Protocol Violation|2|||
146289242|NCT00409773|527575223|FG002|Overall Study|Protocol Violation|3|||
146289243|NCT00409773|527575224|FG003|Overall Study|Protocol Violation|3|||
146289244|NCT00409773|527575225|FG004|Overall Study|Protocol Violation|1|||
145886119|NCT02688387|526088262|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886120|NCT02688387|526088263|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886121|NCT02688387|526088264|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886122|NCT02688387|526088265|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886123|NCT02688387|526088266|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886124|NCT02688387|526088267|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886125|NCT02688387|526088268|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886126|NCT02688387|526088269|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886127|NCT02688387|526088270|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145962923|NCT01825200|526375483|FG001|Overall Study|Withdrawal by Subject|1|||
145962924|NCT01255163|526375484|FG000|Overall Study|Withdrawal by Subject|1|||
145962925|NCT01255163|526375485|FG001|Overall Study|Withdrawal by Subject|0|||
146289245|NCT00409773|527575221|FG000|Overall Study|Withdrawal by Subject|0|||
146289246|NCT00409773|527575222|FG001|Overall Study|Withdrawal by Subject|0|||
146289247|NCT00409773|527575223|FG002|Overall Study|Withdrawal by Subject|0|||
146289248|NCT00409773|527575224|FG003|Overall Study|Withdrawal by Subject|2|||
146289249|NCT00409773|527575225|FG004|Overall Study|Withdrawal by Subject|1|||
146289250|NCT00409773|527575221|FG000|Overall Study|Lack of Eligibility|0|||
146289251|NCT00409773|527575222|FG001|Overall Study|Lack of Eligibility|0|||
146289252|NCT00409773|527575223|FG002|Overall Study|Lack of Eligibility|0|||
146289253|NCT00409773|527575224|FG003|Overall Study|Lack of Eligibility|0|||
146289254|NCT00409773|527575225|FG004|Overall Study|Lack of Eligibility|1|||
146289255|NCT01201343|527575226|FG000|Overall Study|Adverse Event|6|||
146289256|NCT01201343|527575226|FG000|Overall Study|Withdrawal by Subject|5|||
146289257|NCT01201343|527575226|FG000|Overall Study|Lost to Follow-up|2|||
146289258|NCT01201343|527575226|FG000|Overall Study|Lack of Efficacy|2|||
146289259|NCT01201343|527575226|FG000|Overall Study|Participant wrongly included in trial|1|||
146289260|NCT01201343|527575226|FG000|Overall Study|Randomized, not treated|3|||
146289261|NCT01440374|527575227|FG000|Part 1: Open-label Phase|Adverse Event|5|||
146289262|NCT01440374|527575228|FG001|Part 1: Open-label Phase|Adverse Event|0|||
146289263|NCT01440374|527575229|FG002|Part 1: Open-label Phase|Adverse Event|0|||
145962926|NCT01255163|526375484|FG000|Overall Study|Lost to Follow-up|2|||
145962927|NCT01255163|526375485|FG001|Overall Study|Lost to Follow-up|0|||
145962928|NCT01255163|526375484|FG000|Overall Study|Adverse Event|0|||
145962929|NCT01255163|526375485|FG001|Overall Study|Adverse Event|2|||
145962930|NCT01255163|526375484|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
145962931|NCT01255163|526375485|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
145962932|NCT00791999|526375491|FG000|Overall Study|Protocol planed withdrawal|14|||
145962933|NCT00791999|526375492|FG001|Overall Study|Protocol planed withdrawal|11|||
145962934|NCT00791999|526375493|FG002|Overall Study|Protocol planed withdrawal|11|||
145962935|NCT00791999|526375494|FG003|Overall Study|Protocol planed withdrawal|45|||
145962936|NCT00791999|526375491|FG000|Overall Study|Withdrawal by Subject|0|||
145962937|NCT00791999|526375492|FG001|Overall Study|Withdrawal by Subject|1|||
145962938|NCT00791999|526375493|FG002|Overall Study|Withdrawal by Subject|0|||
145962939|NCT00791999|526375494|FG003|Overall Study|Withdrawal by Subject|2|||
145962940|NCT00791999|526375491|FG000|Overall Study|Protocol Violation|3|||
145962941|NCT00791999|526375492|FG001|Overall Study|Protocol Violation|0|||
145962942|NCT00791999|526375493|FG002|Overall Study|Protocol Violation|1|||
145962943|NCT00791999|526375494|FG003|Overall Study|Protocol Violation|0|||
146289264|NCT01440374|527575230|FG003|Part 1: Open-label Phase|Adverse Event|0|||
146289265|NCT01440374|527575227|FG000|Part 1: Open-label Phase|Physician Decision|1|||
146289266|NCT01440374|527575228|FG001|Part 1: Open-label Phase|Physician Decision|0|||
145962944|NCT00791999|526375491|FG000|Overall Study|Adverse Event|3|||
146289267|NCT01440374|527575229|FG002|Part 1: Open-label Phase|Physician Decision|0|||
146289268|NCT01440374|527575230|FG003|Part 1: Open-label Phase|Physician Decision|0|||
146289269|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
146289270|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
146289271|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
146289272|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
146289273|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
146289274|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
146289275|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
146229612|NCT00677365|527358253|FG003|Overall Study|Other reason|1|||
146229613|NCT05422885|527358254|FG000|Overall Study|Lost to Follow-up|1|||
146229614|NCT05422885|527358254|FG000|Overall Study|Withdrawal by Subject|2|||
146229615|NCT04084574|527358255|FG000|Overall Study|Lost to Follow-up|1|||
146229616|NCT04084574|527358256|FG001|Overall Study|Lost to Follow-up|0|||
146229617|NCT04084574|527358255|FG000|Overall Study|Physician Decision|1|||
146229618|NCT04084574|527358256|FG001|Overall Study|Physician Decision|0|||
146229619|NCT04084574|527358255|FG000|Overall Study|Relocated out of state|1|||
146229620|NCT04084574|527358256|FG001|Overall Study|Relocated out of state|0|||
146229621|NCT00942877|527358257|FG000|Overall Study|Refused further treatment|1|||
146229622|NCT00942877|527358258|FG001|Overall Study|Refused further treatment|1|||
146229623|NCT00942877|527358257|FG000|Overall Study|Patient was not treated|1|||
146229624|NCT00942877|527358258|FG001|Overall Study|Patient was not treated|0|||
146229625|NCT00942877|527358257|FG000|Overall Study|Adverse Event|1|||
146229626|NCT00942877|527358258|FG001|Overall Study|Adverse Event|0|||
146229627|NCT00942877|527358257|FG000|Overall Study|Progressive disease|42|||
146229628|NCT00942877|527358258|FG001|Overall Study|Progressive disease|3|||
146229629|NCT01385202|527358259|FG000|Overall Study|Lost to Follow-up|6|||
146229630|NCT01385202|527358259|FG000|Overall Study|Not Eligible|11|||
146229631|NCT01385202|527358259|FG000|Overall Study|Withdrawn|1|||
146229632|NCT02874742|527358260|FG000|Overall Study|Death|0|||
146229633|NCT02874742|527358261|FG001|Overall Study|Death|1|||
146229634|NCT02874742|527358262|FG002|Overall Study|Death|0|||
146229635|NCT02874742|527358260|FG000|Overall Study|Lost to Follow-up|5|||
146229636|NCT02874742|527358261|FG001|Overall Study|Lost to Follow-up|4|||
146229637|NCT02874742|527358262|FG002|Overall Study|Lost to Follow-up|1|||
146229638|NCT02874742|527358260|FG000|Overall Study|Withdrawal by Subject|17|||
146229639|NCT02874742|527358261|FG001|Overall Study|Withdrawal by Subject|8|||
146229640|NCT02874742|527358262|FG002|Overall Study|Withdrawal by Subject|0|||
146229641|NCT02874742|527358260|FG000|Overall Study|Other|4|||
146229642|NCT02874742|527358261|FG001|Overall Study|Other|1|||
146229643|NCT02874742|527358262|FG002|Overall Study|Other|0|||
146229644|NCT02874742|527358260|FG000|Overall Study|Progressive Disease|1|||
146229645|NCT02874742|527358261|FG001|Overall Study|Progressive Disease|0|||
146086046|NCT00718081|526836535|FG001|Overall Study|Lack of Efficacy|3|||
146086047|NCT00718081|526836536|FG002|Overall Study|Lack of Efficacy|21|||
146086048|NCT00815516|526836537|FG000|Overall Study|Death|3|||
146086049|NCT00815516|526836538|FG001|Overall Study|Death|1|||
146086050|NCT00815516|526836537|FG000|Overall Study|Physician Decision|1|||
146086051|NCT00815516|526836538|FG001|Overall Study|Physician Decision|0|||
146086052|NCT03468543|526836552|FG000|Overall Study|Protocol stopping rules met|3|||
146086053|NCT00470158|526836553|FG000|Overall Study|Death|0|||
146086054|NCT00470158|526836554|FG001|Overall Study|Death|0|||
146086055|NCT00470158|526836555|FG002|Overall Study|Death|0|||
146086056|NCT00470158|526836556|FG003|Overall Study|Death|0|||
146086057|NCT00470158|526836557|FG004|Overall Study|Death|2|||
146086058|NCT00470158|526836553|FG000|Overall Study|Lost to Follow-up|7|||
146086059|NCT00470158|526836554|FG001|Overall Study|Lost to Follow-up|8|||
146086060|NCT00470158|526836555|FG002|Overall Study|Lost to Follow-up|8|||
146086061|NCT00470158|526836556|FG003|Overall Study|Lost to Follow-up|5|||
146086062|NCT00470158|526836557|FG004|Overall Study|Lost to Follow-up|4|||
146229646|NCT02874742|527358262|FG002|Overall Study|Progressive Disease|0|||
146229647|NCT02874742|527358260|FG000|Overall Study|Screen Failure|0|||
146229648|NCT02874742|527358261|FG001|Overall Study|Screen Failure|2|||
146229649|NCT02874742|527358262|FG002|Overall Study|Screen Failure|0|||
146229650|NCT00964392|527358267|FG000|Overall Study|Withdrawal by Subject|4|||
146229651|NCT00964392|527358268|FG001|Overall Study|Withdrawal by Subject|6|||
146229652|NCT00964392|527358267|FG000|Overall Study|Lost to Follow-up|4|||
146086063|NCT00470158|526836553|FG000|Overall Study|Protocol Violation|1|||
146229653|NCT00964392|527358268|FG001|Overall Study|Lost to Follow-up|10|||
146229654|NCT00964392|527358267|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
146229655|NCT00964392|527358268|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
146229656|NCT00964392|527358267|FG000|Overall Study|Not completed|44|||
146229657|NCT00964392|527358268|FG001|Overall Study|Not completed|168|||
146229658|NCT04055012|527358269|FG000|Overall Study|Withdrawal by Subject|1|||
146229659|NCT04055012|527358270|FG001|Overall Study|Withdrawal by Subject|3|||
145962945|NCT00791999|526375492|FG001|Overall Study|Adverse Event|3|||
146229660|NCT04055012|527358271|FG002|Overall Study|Withdrawal by Subject|1|||
146229661|NCT04055012|527358272|FG003|Overall Study|Withdrawal by Subject|0|||
146229662|NCT04055012|527358269|FG000|Overall Study|Metformin Recall|1|||
146086064|NCT00470158|526836554|FG001|Overall Study|Protocol Violation|0|||
146086065|NCT00470158|526836555|FG002|Overall Study|Protocol Violation|0|||
146086066|NCT00470158|526836556|FG003|Overall Study|Protocol Violation|0|||
146086067|NCT00470158|526836557|FG004|Overall Study|Protocol Violation|0|||
146229663|NCT04055012|527358270|FG001|Overall Study|Metformin Recall|1|||
146289276|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
146289277|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
146289278|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
146289279|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
146289280|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
146289281|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146229664|NCT04055012|527358271|FG002|Overall Study|Metformin Recall|1|||
146229665|NCT04055012|527358272|FG003|Overall Study|Metformin Recall|0|||
146229666|NCT02577354|527358275|FG000|Overall Study|Lack of Efficacy|4|||
146229667|NCT02577354|527358276|FG001|Overall Study|Lack of Efficacy|4|||
146229668|NCT02577354|527358275|FG000|Overall Study|Lost to Follow-up|3|||
146229669|NCT02577354|527358276|FG001|Overall Study|Lost to Follow-up|1|||
146229670|NCT02577354|527358275|FG000|Overall Study|Missed Visit|4|||
146229671|NCT02577354|527358276|FG001|Overall Study|Missed Visit|3|||
146229672|NCT02577354|527358275|FG000|Overall Study|Adverse Event|4|||
146229673|NCT02577354|527358276|FG001|Overall Study|Adverse Event|5|||
146229674|NCT05070741|527358282|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
146229675|NCT03582033|527358283|FG000|Part A|Other|0|||
146229676|NCT03582033|527358284|FG001|Part A|Other|0|||
146229677|NCT03582033|527358285|FG002|Part A|Other|0|||
145886128|NCT02688387|526088271|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
146229678|NCT03582033|527358286|FG003|Part A|Other|0|||
146229679|NCT03582033|527358287|FG004|Part A|Other|2|||
146229680|NCT03582033|527358288|FG005|Part A|Other|0|||
146229681|NCT03582033|527358289|FG006|Part A|Other|0|||
146229682|NCT03582033|527358290|FG007|Part A|Other|0|||
146229683|NCT03582033|527358291|FG008|Part A|Other|0|||
146229684|NCT03582033|527358292|FG009|Part A|Other|0|||
146229685|NCT03582033|527358283|FG000|Part A|Death|1|||
146229686|NCT03582033|527358284|FG001|Part A|Death|1|||
146229687|NCT03582033|527358285|FG002|Part A|Death|2|||
146229688|NCT03582033|527358286|FG003|Part A|Death|4|||
146229689|NCT03582033|527358287|FG004|Part A|Death|11|||
146229690|NCT03582033|527358288|FG005|Part A|Death|0|||
146229691|NCT03582033|527358289|FG006|Part A|Death|0|||
146229692|NCT03582033|527358290|FG007|Part A|Death|0|||
146229693|NCT03582033|527358291|FG008|Part A|Death|0|||
146229694|NCT03582033|527358292|FG009|Part A|Death|0|||
146289282|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
146289283|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146289284|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
146289285|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
146289286|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
146289287|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
146289288|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
146289289|NCT01440374|527575227|FG000|Part 2; Double-blind Phase|Not treated|0|||
146289290|NCT01440374|527575228|FG001|Part 2; Double-blind Phase|Not treated|0|||
146289291|NCT01440374|527575229|FG002|Part 2; Double-blind Phase|Not treated|1|||
146289292|NCT01440374|527575230|FG003|Part 2; Double-blind Phase|Not treated|0|||
146289293|NCT01440374|527575227|FG000|Part 3: Extension|Withdrawal by Subject|0|||
146289294|NCT01440374|527575228|FG001|Part 3: Extension|Withdrawal by Subject|0|||
146289295|NCT01440374|527575229|FG002|Part 3: Extension|Withdrawal by Subject|0|||
146289296|NCT01440374|527575230|FG003|Part 3: Extension|Withdrawal by Subject|5|||
146289297|NCT01440374|527575227|FG000|Part 3: Extension|Adverse Event|0|||
146289298|NCT01440374|527575228|FG001|Part 3: Extension|Adverse Event|0|||
146289299|NCT01440374|527575229|FG002|Part 3: Extension|Adverse Event|0|||
146289300|NCT01440374|527575230|FG003|Part 3: Extension|Adverse Event|13|||
146289301|NCT01440374|527575227|FG000|Part 3: Extension|Physician Decision|0|||
146289302|NCT01440374|527575228|FG001|Part 3: Extension|Physician Decision|0|||
146289303|NCT01440374|527575229|FG002|Part 3: Extension|Physician Decision|0|||
146289304|NCT01440374|527575230|FG003|Part 3: Extension|Physician Decision|14|||
146289305|NCT01036763|527575231|FG000|Overall Study|Adverse Event|25|||
146289306|NCT01036763|527575231|FG000|Overall Study|Lost to Follow-up|28|||
145962946|NCT00791999|526375493|FG002|Overall Study|Adverse Event|7|||
145962947|NCT00791999|526375494|FG003|Overall Study|Adverse Event|3|||
145962948|NCT00791999|526375491|FG000|Overall Study|Lack of Efficacy|0|||
145962949|NCT00791999|526375492|FG001|Overall Study|Lack of Efficacy|1|||
145962950|NCT00791999|526375493|FG002|Overall Study|Lack of Efficacy|0|||
145962951|NCT00791999|526375494|FG003|Overall Study|Lack of Efficacy|2|||
145962952|NCT00791999|526375491|FG000|Overall Study|Reason other than those above|1|||
145962953|NCT00791999|526375492|FG001|Overall Study|Reason other than those above|0|||
145962954|NCT00791999|526375493|FG002|Overall Study|Reason other than those above|1|||
145962955|NCT00791999|526375494|FG003|Overall Study|Reason other than those above|0|||
145962956|NCT00248651|526375497|FG000|Overall Study|Withdrawal by Subject|28|||
145962957|NCT00248651|526375498|FG001|Overall Study|Withdrawal by Subject|40|||
146229695|NCT03582033|527358283|FG000|Part A|Lost to Follow-up|0|||
146229696|NCT03582033|527358284|FG001|Part A|Lost to Follow-up|0|||
146229697|NCT03582033|527358285|FG002|Part A|Lost to Follow-up|0|||
146229698|NCT03582033|527358286|FG003|Part A|Lost to Follow-up|0|||
146229699|NCT03582033|527358287|FG004|Part A|Lost to Follow-up|1|||
146229700|NCT03582033|527358288|FG005|Part A|Lost to Follow-up|0|||
145962958|NCT00248651|526375499|FG002|Overall Study|Withdrawal by Subject|32|||
145962959|NCT02357459|526377993|FG000|Overall Study|Adverse Event|0|||
145962960|NCT02357459|526377994|FG001|Overall Study|Adverse Event|1|||
145962961|NCT02357459|526377995|FG002|Overall Study|Adverse Event|1|||
145962962|NCT02357459|526377993|FG000|Overall Study|Withdrawal by Subject|5|||
145962963|NCT02357459|526377994|FG001|Overall Study|Withdrawal by Subject|3|||
145962964|NCT02357459|526377995|FG002|Overall Study|Withdrawal by Subject|3|||
145962965|NCT02357459|526377993|FG000|Overall Study|Physician Decision|0|||
145962966|NCT02357459|526377994|FG001|Overall Study|Physician Decision|2|||
145962967|NCT02357459|526377995|FG002|Overall Study|Physician Decision|0|||
145962968|NCT02357459|526377993|FG000|Overall Study|Protocol Violation|1|||
145962969|NCT02357459|526377994|FG001|Overall Study|Protocol Violation|1|||
145962970|NCT02357459|526377995|FG002|Overall Study|Protocol Violation|0|||
145962971|NCT02357459|526377993|FG000|Overall Study|Lost to Follow-up|1|||
145962972|NCT02357459|526377994|FG001|Overall Study|Lost to Follow-up|3|||
146229701|NCT03582033|527358289|FG006|Part A|Lost to Follow-up|0|||
146229702|NCT03582033|527358290|FG007|Part A|Lost to Follow-up|0|||
146229703|NCT03582033|527358291|FG008|Part A|Lost to Follow-up|0|||
146229704|NCT03582033|527358292|FG009|Part A|Lost to Follow-up|0|||
146289307|NCT01036763|527575231|FG000|Overall Study|Other reason (not specified)|40|||
146289308|NCT04812548|527575233|FG000|Overall Study|Adverse Event|2|||
146289309|NCT04812548|527575234|FG001|Overall Study|Adverse Event|7|||
146289310|NCT04812548|527575233|FG000|Overall Study|HSCT Planned|2|||
146289311|NCT04812548|527575234|FG001|Overall Study|HSCT Planned|3|||
145962973|NCT02357459|526377995|FG002|Overall Study|Lost to Follow-up|0|||
145962974|NCT02357459|526377993|FG000|Overall Study|Lack of Efficacy|7|||
145962975|NCT02357459|526377994|FG001|Overall Study|Lack of Efficacy|4|||
146229705|NCT03582033|527358283|FG000|Part A|Study terminated by sponsor|0|||
146289312|NCT04812548|527575233|FG000|Overall Study|Progressive Disease|0|||
146289313|NCT04812548|527575234|FG001|Overall Study|Progressive Disease|2|||
146289314|NCT04812548|527575233|FG000|Overall Study|Death|0|||
145962976|NCT02357459|526377995|FG002|Overall Study|Lack of Efficacy|4|||
145962977|NCT02357459|526377993|FG000|Overall Study|Patient Relocated|2|||
145962978|NCT02357459|526377994|FG001|Overall Study|Patient Relocated|0|||
145962979|NCT02357459|526377995|FG002|Overall Study|Patient Relocated|0|||
145962980|NCT02357459|526377993|FG000|Overall Study|Instruction from PCP|1|||
146289315|NCT04812548|527575234|FG001|Overall Study|Death|1|||
146086068|NCT01249118|526836558|FG000|First Washout Period|Physician Decision|0|||
146086069|NCT01249118|526836559|FG001|First Washout Period|Physician Decision|1|||
146086070|NCT01249118|526836560|FG002|First Washout Period|Physician Decision|0|||
146086071|NCT00880685|526836561|FG000|Memantine 10mg|Lost to Follow-up|2|||
146086072|NCT00880685|526836561|FG000|Memantine 20mg|Withdrawal by Subject|1|||
146086073|NCT04179890|526836562|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
146086074|NCT04179890|526836563|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
146086075|NCT04179890|526836562|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
146086076|NCT04179890|526836563|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
146086077|NCT04179890|526836562|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
146086078|NCT04179890|526836563|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
146086079|NCT04179890|526836562|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
146086080|NCT04179890|526836563|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
146086081|NCT04179890|526836562|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
146086082|NCT04179890|526836563|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
146086083|NCT04179890|526836562|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
146086084|NCT04179890|526836563|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
146086085|NCT04179890|526836562|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
146086086|NCT04179890|526836563|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
146086087|NCT04179890|526836562|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
146086088|NCT04179890|526836563|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
146086089|NCT04179890|526836562|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
146086090|NCT04179890|526836563|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
146086091|NCT00978432|526836565|FG000|Overall Study|Withdrawal by Subject|0|||
146086092|NCT00978432|526836566|FG001|Overall Study|Withdrawal by Subject|0|||
146086093|NCT00978432|526836567|FG002|Overall Study|Withdrawal by Subject|1|||
146086094|NCT00978432|526836565|FG000|Overall Study|Lack of Efficacy|1|||
146086095|NCT00978432|526836566|FG001|Overall Study|Lack of Efficacy|1|||
146086096|NCT00978432|526836567|FG002|Overall Study|Lack of Efficacy|3|||
146086097|NCT00978432|526836565|FG000|Overall Study|Adverse Event|2|||
146086098|NCT00978432|526836566|FG001|Overall Study|Adverse Event|0|||
146086099|NCT00978432|526836567|FG002|Overall Study|Adverse Event|1|||
146086100|NCT02579928|526836568|FG000|Overall Study|Withdrawal by Subject|1|||
146086101|NCT02579928|526836569|FG001|Overall Study|Withdrawal by Subject|0|||
146086102|NCT04300751|526836572|FG000|Overall Study|Withdrawal by Subject|1|||
146229706|NCT03582033|527358284|FG001|Part A|Study terminated by sponsor|0|||
146229707|NCT03582033|527358285|FG002|Part A|Study terminated by sponsor|0|||
146229708|NCT03582033|527358286|FG003|Part A|Study terminated by sponsor|2|||
146229709|NCT03582033|527358287|FG004|Part A|Study terminated by sponsor|1|||
146229710|NCT03582033|527358288|FG005|Part A|Study terminated by sponsor|0|||
146229711|NCT03582033|527358289|FG006|Part A|Study terminated by sponsor|0|||
146289316|NCT04812548|527575233|FG000|Overall Study|Post Study Access to Treatment|0|||
146289317|NCT04812548|527575234|FG001|Overall Study|Post Study Access to Treatment|1|||
145962981|NCT02357459|526377994|FG001|Overall Study|Instruction from PCP|0|||
145962982|NCT02357459|526377995|FG002|Overall Study|Instruction from PCP|0|||
145962983|NCT02357459|526377993|FG000|Overall Study|Incarceration|0|||
145962984|NCT02357459|526377994|FG001|Overall Study|Incarceration|0|||
145962985|NCT02357459|526377995|FG002|Overall Study|Incarceration|1|||
145962986|NCT02357459|526377993|FG000|Overall Study|Pre-planned Knee surgery|0|||
145962987|NCT02357459|526377994|FG001|Overall Study|Pre-planned Knee surgery|0|||
145962988|NCT02357459|526377995|FG002|Overall Study|Pre-planned Knee surgery|2|||
145962989|NCT02357459|526377993|FG000|Overall Study|Job Commitments|0|||
145962990|NCT02357459|526377994|FG001|Overall Study|Job Commitments|0|||
145962991|NCT02357459|526377995|FG002|Overall Study|Job Commitments|1|||
145962992|NCT03246347|526377996|FG000|Overall Study|On Study|23|||
145962993|NCT01548599|526377997|FG000|Overall Study|Lost to Follow-up|0|||
145962994|NCT01548599|526377998|FG001|Overall Study|Lost to Follow-up|1|||
145962995|NCT01548599|526377997|FG000|Overall Study|Withdrawal by Subject|4|||
145962996|NCT01548599|526377998|FG001|Overall Study|Withdrawal by Subject|0|||
145962997|NCT01548599|526377997|FG000|Overall Study|Death|2|||
145962998|NCT01548599|526377998|FG001|Overall Study|Death|1|||
145962999|NCT02188160|526377999|FG000|Overall Study|Adverse Event|1|||
145963000|NCT02188160|526378000|FG001|Overall Study|Adverse Event|0|||
145963001|NCT02188160|526377999|FG000|Overall Study|Use of an excluded medication|0|||
145963002|NCT02188160|526378000|FG001|Overall Study|Use of an excluded medication|1|||
145963003|NCT00916578|526378003|FG000|Overall Study|Physician Decision|2|||
145963004|NCT00916578|526378003|FG000|Overall Study|Withdrawal by Subject|3|||
146086103|NCT04972630|526836577|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
145963005|NCT00916578|526378003|FG000|Overall Study|Insurance Denial|2|||
145963006|NCT01022203|526378008|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
146086104|NCT04972630|526836578|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
146086105|NCT04972630|526836579|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
146086106|NCT00246571|526836580|FG000|Overall Study|Adverse Event|7|||
146086107|NCT00246571|526836581|FG001|Overall Study|Adverse Event|0|||
146086108|NCT00246571|526836580|FG000|Overall Study|Protocol Violation|0|||
146086109|NCT00246571|526836581|FG001|Overall Study|Protocol Violation|1|||
146086110|NCT00246571|526836580|FG000|Overall Study|Withdrawal by Subject|2|||
146086111|NCT00246571|526836581|FG001|Overall Study|Withdrawal by Subject|3|||
146086112|NCT00246571|526836580|FG000|Overall Study|Lack of Efficacy|84|||
146086113|NCT00246571|526836581|FG001|Overall Study|Lack of Efficacy|21|||
146086114|NCT00246571|526836580|FG000|Overall Study|Death|17|||
146086115|NCT00246571|526836581|FG001|Overall Study|Death|3|||
146086116|NCT00246571|526836580|FG000|Overall Study|Sponsor|0|||
146086117|NCT00246571|526836581|FG001|Overall Study|Sponsor|1|||
146086118|NCT00246571|526836580|FG000|Overall Study|Did not meet entrance criteria|2|||
146086119|NCT00246571|526836581|FG001|Overall Study|Did not meet entrance criteria|1|||
146086120|NCT00246571|526836580|FG000|Overall Study|Laboratory abnormalities|1|||
146086121|NCT00246571|526836581|FG001|Overall Study|Laboratory abnormalities|0|||
146086122|NCT00246571|526836580|FG000|Overall Study|Crossover participants|0|||
146086123|NCT00246571|526836581|FG001|Overall Study|Crossover participants|74|||
146086124|NCT06390839|526836582|FG000|Overall Study|Ineligible|2|||
146086125|NCT06390839|526836582|FG000|Overall Study|Never start protocol therapy|3|||
146086126|NCT06390839|526836582|FG000|Overall Study|Adverse Event|1|||
146086127|NCT06390839|526836582|FG000|Overall Study|Alternative therapy|2|||
146086128|NCT06390839|526836582|FG000|Overall Study|Death|3|||
146086129|NCT06390839|526836582|FG000|Overall Study|Disease progression|28|||
146086130|NCT06390839|526836582|FG000|Overall Study|Withdrawal by Subject|2|||
146086131|NCT06390839|526836582|FG000|Overall Study|Complicating disease|1|||
146086132|NCT06390839|526836582|FG000|Overall Study|Noncompliance|1|||
146086133|NCT02720094|526836588|FG000|Overall Study|Ongoing|2210|||
146086134|NCT02720094|526836589|FG001|Overall Study|Ongoing|2203|||
146086135|NCT02720094|526836588|FG000|Overall Study|Scheduled exit visit/end of study|2|||
146086136|NCT02720094|526836589|FG001|Overall Study|Scheduled exit visit/end of study|1|||
146086137|NCT02720094|526836588|FG000|Overall Study|Death|4|||
146086138|NCT02720094|526836589|FG001|Overall Study|Death|7|||
146086139|NCT02720094|526836588|FG000|Overall Study|Withdrawal by Subject|55|||
146086140|NCT02720094|526836589|FG001|Overall Study|Withdrawal by Subject|56|||
146086141|NCT02720094|526836588|FG000|Overall Study|Lost to Follow-up|2|||
146086142|NCT02720094|526836589|FG001|Overall Study|Lost to Follow-up|7|||
146086143|NCT02720094|526836588|FG000|Overall Study|Physician Decision|1|||
146086144|NCT02720094|526836589|FG001|Overall Study|Physician Decision|3|||
146086145|NCT02720094|526836588|FG000|Overall Study|Inappropriate enrollment|1|||
146086146|NCT02720094|526836589|FG001|Overall Study|Inappropriate enrollment|3|||
146086147|NCT02720094|526836588|FG000|Overall Study|Relocation|1|||
146086148|NCT02720094|526836589|FG001|Overall Study|Relocation|1|||
146086149|NCT00732940|526836596|FG000|Overall Study|Withdrawal by Subject|1|||
146086150|NCT00732940|526836597|FG001|Overall Study|Withdrawal by Subject|2|||
146086151|NCT00732940|526836596|FG000|Overall Study|Adverse Event|0|||
146086152|NCT00732940|526836597|FG001|Overall Study|Adverse Event|1|||
146086153|NCT00732940|526836596|FG000|Overall Study|Lost to Follow-up|1|||
146086154|NCT00732940|526836597|FG001|Overall Study|Lost to Follow-up|0|||
146086155|NCT00459979|526836601|FG000|Overall Study|Withdrawal by Subject|1|||
146289318|NCT04812548|527575233|FG000|Overall Study|Withdrawal by Subject|0|||
146086156|NCT00459979|526836601|FG000|Overall Study|Protocol Violation|1|||
146086157|NCT00989573|526836602|FG000|Overall Study|Adverse Event|8|||
146086158|NCT00989573|526836603|FG001|Overall Study|Adverse Event|12|||
146086159|NCT00989573|526836604|FG002|Overall Study|Adverse Event|4|||
146086160|NCT00989573|526836602|FG000|Overall Study|Physician Decision|0|||
146086161|NCT00989573|526836603|FG001|Overall Study|Physician Decision|2|||
146086162|NCT00989573|526836604|FG002|Overall Study|Physician Decision|0|||
146086163|NCT00989573|526836602|FG000|Overall Study|Protocol Violation|1|||
146086164|NCT00989573|526836603|FG001|Overall Study|Protocol Violation|1|||
146086165|NCT00989573|526836604|FG002|Overall Study|Protocol Violation|1|||
146086166|NCT00989573|526836602|FG000|Overall Study|Withdrawal by Subject|4|||
146086167|NCT00989573|526836603|FG001|Overall Study|Withdrawal by Subject|7|||
146086168|NCT00989573|526836604|FG002|Overall Study|Withdrawal by Subject|3|||
146289319|NCT04812548|527575234|FG001|Overall Study|Withdrawal by Subject|1|||
146289320|NCT04812548|527575233|FG000|Overall Study|Physician Decision|1|||
146289321|NCT04812548|527575234|FG001|Overall Study|Physician Decision|0|||
146289322|NCT02141984|527575238|FG000|Overall Study|Lack of Efficacy|2|||
146289323|NCT03938545|527575239|FG000|Overall Study|Lost to Follow-up|0|||
146289324|NCT03938545|527575240|FG001|Overall Study|Lost to Follow-up|0|||
146289325|NCT03938545|527575241|FG002|Overall Study|Lost to Follow-up|0|||
146289326|NCT03938545|527575242|FG003|Overall Study|Lost to Follow-up|1|||
146289327|NCT03938545|527575239|FG000|Overall Study|Non-compliance with study drug|0|||
146289328|NCT03938545|527575240|FG001|Overall Study|Non-compliance with study drug|0|||
146289329|NCT03938545|527575241|FG002|Overall Study|Non-compliance with study drug|1|||
146289330|NCT03938545|527575242|FG003|Overall Study|Non-compliance with study drug|0|||
146289331|NCT03938545|527575239|FG000|Overall Study|Pregnancy|1|||
146289332|NCT03938545|527575240|FG001|Overall Study|Pregnancy|0|||
146289333|NCT03938545|527575241|FG002|Overall Study|Pregnancy|0|||
146289334|NCT03938545|527575242|FG003|Overall Study|Pregnancy|0|||
146289335|NCT03938545|527575239|FG000|Overall Study|Study terminated by sponsor|6|||
146289336|NCT03938545|527575240|FG001|Overall Study|Study terminated by sponsor|4|||
146289337|NCT03938545|527575241|FG002|Overall Study|Study terminated by sponsor|2|||
146289338|NCT03938545|527575242|FG003|Overall Study|Study terminated by sponsor|4|||
146289339|NCT03938545|527575239|FG000|Overall Study|Withdrawal by Subject|0|||
146229712|NCT03582033|527358290|FG007|Part A|Study terminated by sponsor|0|||
146229713|NCT03582033|527358291|FG008|Part A|Study terminated by sponsor|0|||
146229714|NCT03582033|527358292|FG009|Part A|Study terminated by sponsor|0|||
146229715|NCT03582033|527358283|FG000|Part A|Withdrawal by Subject|1|||
146229716|NCT03582033|527358284|FG001|Part A|Withdrawal by Subject|1|||
146229717|NCT03582033|527358285|FG002|Part A|Withdrawal by Subject|0|||
146229718|NCT03582033|527358286|FG003|Part A|Withdrawal by Subject|1|||
146229719|NCT03582033|527358287|FG004|Part A|Withdrawal by Subject|7|||
146229720|NCT03582033|527358288|FG005|Part A|Withdrawal by Subject|0|||
146229721|NCT03582033|527358289|FG006|Part A|Withdrawal by Subject|0|||
146229722|NCT03582033|527358290|FG007|Part A|Withdrawal by Subject|0|||
146229723|NCT03582033|527358291|FG008|Part A|Withdrawal by Subject|0|||
146229724|NCT03582033|527358292|FG009|Part A|Withdrawal by Subject|0|||
146229725|NCT03582033|527358283|FG000|Part B|Death|0|||
146229726|NCT03582033|527358284|FG001|Part B|Death|0|||
146229727|NCT03582033|527358285|FG002|Part B|Death|0|||
146229728|NCT03582033|527358286|FG003|Part B|Death|0|||
146229729|NCT03582033|527358287|FG004|Part B|Death|0|||
146229730|NCT03582033|527358288|FG005|Part B|Death|2|||
146229731|NCT03582033|527358289|FG006|Part B|Death|0|||
146229732|NCT03582033|527358290|FG007|Part B|Death|0|||
146229733|NCT03582033|527358291|FG008|Part B|Death|0|||
145886129|NCT02688387|526088272|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886130|NCT02688387|526088273|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886131|NCT02688387|526088274|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886132|NCT02688387|526088275|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886133|NCT02688387|526088276|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886134|NCT02688387|526088277|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145886135|NCT02688387|526088256|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
145886136|NCT02688387|526088257|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886137|NCT02688387|526088258|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886138|NCT02688387|526088259|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886139|NCT02688387|526088260|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886140|NCT02688387|526088261|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886141|NCT02688387|526088262|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886142|NCT02688387|526088263|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886143|NCT02688387|526088264|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886144|NCT02688387|526088265|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886145|NCT02688387|526088266|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886146|NCT02688387|526088267|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886147|NCT02688387|526088268|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886148|NCT02688387|526088269|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886149|NCT02688387|526088270|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886150|NCT02688387|526088271|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886151|NCT02688387|526088272|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886152|NCT02688387|526088273|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886153|NCT02688387|526088274|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886154|NCT02688387|526088275|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886155|NCT02688387|526088276|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886156|NCT02688387|526088277|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145886157|NCT02688387|526088256|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
146086169|NCT05214573|526836607|FG000|Overall Study|Physician Decision|5924|||
146229734|NCT03582033|527358292|FG009|Part B|Death|0|||
146229735|NCT03582033|527358283|FG000|Part B|Study terminated by sponsor|0|||
146229736|NCT03582033|527358284|FG001|Part B|Study terminated by sponsor|0|||
146229737|NCT03582033|527358285|FG002|Part B|Study terminated by sponsor|0|||
146229738|NCT03582033|527358286|FG003|Part B|Study terminated by sponsor|0|||
146229739|NCT03582033|527358287|FG004|Part B|Study terminated by sponsor|0|||
146229740|NCT03582033|527358288|FG005|Part B|Study terminated by sponsor|12|||
146229741|NCT03582033|527358289|FG006|Part B|Study terminated by sponsor|0|||
146229742|NCT03582033|527358290|FG007|Part B|Study terminated by sponsor|0|||
146229743|NCT03582033|527358291|FG008|Part B|Study terminated by sponsor|0|||
146229744|NCT03582033|527358292|FG009|Part B|Study terminated by sponsor|0|||
146229745|NCT03582033|527358283|FG000|Part B|Withdrawal by Subject|0|||
146229746|NCT03582033|527358284|FG001|Part B|Withdrawal by Subject|0|||
146229747|NCT03582033|527358285|FG002|Part B|Withdrawal by Subject|0|||
146229748|NCT03582033|527358286|FG003|Part B|Withdrawal by Subject|0|||
146229749|NCT03582033|527358287|FG004|Part B|Withdrawal by Subject|0|||
146229750|NCT03582033|527358288|FG005|Part B|Withdrawal by Subject|6|||
146229751|NCT03582033|527358289|FG006|Part B|Withdrawal by Subject|0|||
146229752|NCT03582033|527358290|FG007|Part B|Withdrawal by Subject|0|||
146229753|NCT03582033|527358291|FG008|Part B|Withdrawal by Subject|0|||
146229754|NCT03582033|527358292|FG009|Part B|Withdrawal by Subject|0|||
146229755|NCT03582033|527358283|FG000|Part C|Other|0|||
146229756|NCT03582033|527358284|FG001|Part C|Other|0|||
146229757|NCT03582033|527358285|FG002|Part C|Other|0|||
146229758|NCT03582033|527358286|FG003|Part C|Other|0|||
146229759|NCT03582033|527358287|FG004|Part C|Other|0|||
146229760|NCT03582033|527358288|FG005|Part C|Other|0|||
145886158|NCT02688387|526088257|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886159|NCT02688387|526088258|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886160|NCT02688387|526088259|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886161|NCT02688387|526088260|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886162|NCT02688387|526088261|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886163|NCT02688387|526088262|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886164|NCT02688387|526088263|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886165|NCT02688387|526088264|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886166|NCT02688387|526088265|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886167|NCT02688387|526088266|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
146229761|NCT03582033|527358289|FG006|Part C|Other|2|||
146229762|NCT03582033|527358290|FG007|Part C|Other|0|||
146229763|NCT03582033|527358291|FG008|Part C|Other|0|||
146229764|NCT03582033|527358292|FG009|Part C|Other|0|||
146229765|NCT03582033|527358283|FG000|Part C|Death|0|||
146229766|NCT03582033|527358284|FG001|Part C|Death|0|||
146229767|NCT03582033|527358285|FG002|Part C|Death|0|||
146229768|NCT03582033|527358286|FG003|Part C|Death|0|||
146229769|NCT03582033|527358287|FG004|Part C|Death|0|||
146229770|NCT03582033|527358288|FG005|Part C|Death|0|||
146229771|NCT03582033|527358289|FG006|Part C|Death|6|||
146229772|NCT03582033|527358290|FG007|Part C|Death|1|||
146229773|NCT03582033|527358291|FG008|Part C|Death|2|||
146229774|NCT03582033|527358292|FG009|Part C|Death|0|||
146229775|NCT03582033|527358283|FG000|Part C|Study terminated by sponsor|0|||
146229776|NCT03582033|527358284|FG001|Part C|Study terminated by sponsor|0|||
146229777|NCT03582033|527358285|FG002|Part C|Study terminated by sponsor|0|||
146229778|NCT03582033|527358286|FG003|Part C|Study terminated by sponsor|0|||
146229779|NCT03582033|527358287|FG004|Part C|Study terminated by sponsor|0|||
146229780|NCT03582033|527358288|FG005|Part C|Study terminated by sponsor|0|||
146229781|NCT03582033|527358289|FG006|Part C|Study terminated by sponsor|3|||
146229782|NCT03582033|527358290|FG007|Part C|Study terminated by sponsor|3|||
146229783|NCT03582033|527358291|FG008|Part C|Study terminated by sponsor|2|||
146229784|NCT03582033|527358292|FG009|Part C|Study terminated by sponsor|0|||
146229785|NCT03582033|527358283|FG000|Part C|Withdrawal by Subject|0|||
146229786|NCT03582033|527358284|FG001|Part C|Withdrawal by Subject|0|||
146229787|NCT03582033|527358285|FG002|Part C|Withdrawal by Subject|0|||
146229788|NCT03582033|527358286|FG003|Part C|Withdrawal by Subject|0|||
146229789|NCT03582033|527358287|FG004|Part C|Withdrawal by Subject|0|||
146229790|NCT03582033|527358288|FG005|Part C|Withdrawal by Subject|0|||
146229791|NCT03582033|527358289|FG006|Part C|Withdrawal by Subject|1|||
146229792|NCT03582033|527358290|FG007|Part C|Withdrawal by Subject|2|||
146229793|NCT03582033|527358291|FG008|Part C|Withdrawal by Subject|1|||
146229794|NCT03582033|527358292|FG009|Part C|Withdrawal by Subject|0|||
146229795|NCT03582033|527358283|FG000|Part D|Death|0|||
146229796|NCT03582033|527358284|FG001|Part D|Death|0|||
146229797|NCT03582033|527358285|FG002|Part D|Death|0|||
146229798|NCT03582033|527358286|FG003|Part D|Death|0|||
146229799|NCT03582033|527358287|FG004|Part D|Death|0|||
146229800|NCT03582033|527358288|FG005|Part D|Death|0|||
146229801|NCT03582033|527358289|FG006|Part D|Death|0|||
146229802|NCT03582033|527358290|FG007|Part D|Death|0|||
146229803|NCT03582033|527358291|FG008|Part D|Death|0|||
146229804|NCT03582033|527358292|FG009|Part D|Death|1|||
146229805|NCT03582033|527358283|FG000|Part D|Study terminated by sponsor|0|||
146229806|NCT03582033|527358284|FG001|Part D|Study terminated by sponsor|0|||
146229807|NCT03582033|527358285|FG002|Part D|Study terminated by sponsor|0|||
146229808|NCT03582033|527358286|FG003|Part D|Study terminated by sponsor|0|||
146229809|NCT03582033|527358287|FG004|Part D|Study terminated by sponsor|0|||
146229810|NCT03582033|527358288|FG005|Part D|Study terminated by sponsor|0|||
146229811|NCT03582033|527358289|FG006|Part D|Study terminated by sponsor|0|||
146229812|NCT03582033|527358290|FG007|Part D|Study terminated by sponsor|0|||
146229813|NCT03582033|527358291|FG008|Part D|Study terminated by sponsor|0|||
146229814|NCT03582033|527358292|FG009|Part D|Study terminated by sponsor|4|||
146229815|NCT04109066|527358293|FG000|Pre-treatment|Participant withdrew consent|2|||
146229816|NCT04109066|527358294|FG001|Pre-treatment|Participant withdrew consent|0|||
146229817|NCT04109066|527358293|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
146229818|NCT04109066|527358294|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
145886168|NCT02688387|526088267|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886169|NCT02688387|526088268|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886170|NCT02688387|526088269|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886171|NCT02688387|526088270|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886172|NCT02688387|526088271|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886173|NCT02688387|526088272|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886174|NCT02688387|526088273|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886175|NCT02688387|526088274|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886176|NCT02688387|526088275|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886177|NCT02688387|526088276|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886178|NCT02688387|526088277|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145886179|NCT02688387|526088256|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146086170|NCT05214573|526836608|FG001|Overall Study|Physician Decision|0|||
146229819|NCT04109066|527358293|FG000|Treatment|Lack of Efficacy|2|||
146229820|NCT04109066|527358294|FG001|Treatment|Lack of Efficacy|4|||
146229821|NCT04109066|527358293|FG000|Treatment|Adverse Event|23|||
146229822|NCT04109066|527358294|FG001|Treatment|Adverse Event|7|||
146229823|NCT04109066|527358293|FG000|Treatment|Participant request to discontinue Study treatment|15|||
146289340|NCT03938545|527575240|FG001|Overall Study|Withdrawal by Subject|1|||
146229824|NCT04109066|527358294|FG001|Treatment|Participant request to discontinue Study treatment|14|||
146229825|NCT04109066|527358293|FG000|Treatment|Withdrawal by Subject|8|||
146229826|NCT04109066|527358294|FG001|Treatment|Withdrawal by Subject|8|||
146229827|NCT04109066|527358293|FG000|Treatment|Death|3|||
146229828|NCT04109066|527358294|FG001|Treatment|Death|0|||
146229829|NCT04109066|527358293|FG000|Treatment|Participant no longer meets study criteria|2|||
146229830|NCT04109066|527358294|FG001|Treatment|Participant no longer meets study criteria|2|||
146229831|NCT04109066|527358293|FG000|Treatment|Administrative reasons by sponsor|2|||
146229832|NCT04109066|527358294|FG001|Treatment|Administrative reasons by sponsor|3|||
146229833|NCT04109066|527358293|FG000|Treatment|Other reasons|17|||
146229834|NCT04109066|527358294|FG001|Treatment|Other reasons|23|||
146229835|NCT04109066|527358293|FG000|Treatment|Disease Progression|4|||
146229836|NCT04109066|527358294|FG001|Treatment|Disease Progression|7|||
146229837|NCT04109066|527358293|FG000|Treatment|Study drug toxicity|12|||
146229838|NCT04109066|527358294|FG001|Treatment|Study drug toxicity|5|||
146229839|NCT04109066|527358293|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
146229840|NCT04109066|527358294|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
146229841|NCT04109066|527358293|FG000|Treatment|Disease Recurrence|0|||
146229842|NCT04109066|527358294|FG001|Treatment|Disease Recurrence|2|||
146229843|NCT04109066|527358293|FG000|Treatment|Not reported|4|||
146229844|NCT04109066|527358294|FG001|Treatment|Not reported|8|||
146229845|NCT06010836|527358295|FG000|Overall Study|Lost to Follow-up|2|||
146229846|NCT06010836|527358296|FG001|Overall Study|Lost to Follow-up|2|||
146229847|NCT06010836|527358295|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
146229848|NCT06010836|527358296|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
146229849|NCT06010836|527358295|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
146229850|NCT06010836|527358296|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
146229851|NCT06010836|527358295|FG000|Overall Study|Did not receive intervention discussion|0|||
146289341|NCT03938545|527575241|FG002|Overall Study|Withdrawal by Subject|0|||
146229852|NCT06010836|527358296|FG001|Overall Study|Did not receive intervention discussion|4|||
146229853|NCT05953740|527358304|FG000|Period 1|Physician Decision|0|||
146229854|NCT05953740|527358305|FG001|Period 1|Physician Decision|1|||
146229855|NCT05953740|527358306|FG002|Period 1|Physician Decision|0|||
146086171|NCT00814801|526836609|FG000|Overall Study|Adverse Event|15|||
146086172|NCT00814801|526836610|FG001|Overall Study|Adverse Event|16|||
146086173|NCT00814801|526836611|FG002|Overall Study|Adverse Event|19|||
146086174|NCT00814801|526836609|FG000|Overall Study|Withdrawal by Subject|9|||
146086175|NCT00814801|526836610|FG001|Overall Study|Withdrawal by Subject|11|||
146086176|NCT00814801|526836611|FG002|Overall Study|Withdrawal by Subject|14|||
146086177|NCT00814801|526836609|FG000|Overall Study|Inappropriate as a subject|1|||
146086178|NCT00814801|526836610|FG001|Overall Study|Inappropriate as a subject|1|||
146229856|NCT05953740|527358307|FG003|Period 1|Physician Decision|0|||
146229857|NCT05953740|527358308|FG004|Period 1|Physician Decision|0|||
146086179|NCT00814801|526836611|FG002|Overall Study|Inappropriate as a subject|1|||
146086180|NCT00814801|526836609|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
146229858|NCT05953740|527358309|FG005|Period 1|Physician Decision|0|||
146229859|NCT05953740|527358310|FG006|Period 1|Physician Decision|0|||
146229860|NCT05953740|527358311|FG007|Period 1|Physician Decision|0|||
146229861|NCT05953740|527358304|FG000|Period 2|Withdrawal by Subject|0|||
146229862|NCT05953740|527358305|FG001|Period 2|Withdrawal by Subject|1|||
146229863|NCT05953740|527358306|FG002|Period 2|Withdrawal by Subject|1|||
146229864|NCT05953740|527358307|FG003|Period 2|Withdrawal by Subject|0|||
146229865|NCT05953740|527358308|FG004|Period 2|Withdrawal by Subject|0|||
146229866|NCT05953740|527358309|FG005|Period 2|Withdrawal by Subject|0|||
146229867|NCT05953740|527358310|FG006|Period 2|Withdrawal by Subject|0|||
146229868|NCT05953740|527358311|FG007|Period 2|Withdrawal by Subject|0|||
146229869|NCT04206787|527358312|FG000|Overall Study|Other than listed|2|||
146229870|NCT04206787|527358312|FG000|Overall Study|Investigator decision|1|||
146229871|NCT04206787|527358312|FG000|Overall Study|Death|25|||
146229872|NCT04206787|527358312|FG000|Overall Study|Lost to Follow-up|9|||
146229873|NCT04206787|527358312|FG000|Overall Study|Withdrawal of consent|9|||
146229874|NCT02865538|527358316|FG000|Overall Study|Withdrawal by Subject|0|||
146229875|NCT02865538|527358317|FG001|Overall Study|Withdrawal by Subject|0|||
146229876|NCT02865538|527358318|FG002|Overall Study|Withdrawal by Subject|1|||
146229877|NCT02865538|527358319|FG003|Overall Study|Withdrawal by Subject|0|||
146229878|NCT02865538|527358320|FG004|Overall Study|Withdrawal by Subject|0|||
146086181|NCT00814801|526836610|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
146086182|NCT00814801|526836611|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
146086183|NCT00814801|526836609|FG000|Overall Study|Missing or change of caregiver|6|||
146229879|NCT02865538|527358316|FG000|Overall Study|Lost to Follow-up|1|||
146229880|NCT02865538|527358317|FG001|Overall Study|Lost to Follow-up|0|||
146229881|NCT02865538|527358318|FG002|Overall Study|Lost to Follow-up|0|||
146229882|NCT02865538|527358319|FG003|Overall Study|Lost to Follow-up|0|||
146229883|NCT02865538|527358320|FG004|Overall Study|Lost to Follow-up|0|||
146229884|NCT04389957|527359538|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
146229885|NCT04389957|527359539|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
146229886|NCT04389957|527359540|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
146229887|NCT04389957|527359541|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
146229888|NCT04389957|527359542|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
146229889|NCT05405985|527359543|FG000|Overall Study|Withdrawal by Subject|1|||
146229890|NCT05405985|527359544|FG001|Overall Study|Withdrawal by Subject|0|||
146229891|NCT03571386|527359545|FG000|Overall Study|scheduling conflict|4|||
146229892|NCT03571386|527359546|FG001|Overall Study|scheduling conflict|0|||
146229893|NCT03571386|527359545|FG000|Overall Study|Withdrawal by Subject|15|||
145963007|NCT01022203|526378009|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
145963008|NCT01022203|526378008|FG000|Post Treatment Assessment|Physician Decision|2|||
145963009|NCT01022203|526378009|FG001|Post Treatment Assessment|Physician Decision|0|||
145963010|NCT01022203|526378008|FG000|Post Treatment Assessment|Adverse Event|0|||
145963011|NCT01022203|526378009|FG001|Post Treatment Assessment|Adverse Event|2|||
145963012|NCT01022203|526378008|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
145963013|NCT01022203|526378009|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
145963014|NCT03638128|526378012|FG000|Overall Study|Withdrawal by Subject|1|||
145963015|NCT03638128|526378013|FG001|Overall Study|Withdrawal by Subject|7|||
145963016|NCT03638128|526378014|FG002|Overall Study|Withdrawal by Subject|6|||
145963017|NCT03638128|526378012|FG000|Overall Study|Sponsor Decision|15|||
145963018|NCT03638128|526378013|FG001|Overall Study|Sponsor Decision|12|||
145963019|NCT03638128|526378014|FG002|Overall Study|Sponsor Decision|19|||
145963020|NCT03638128|526378012|FG000|Overall Study|Lost to Follow-up|0|||
145963021|NCT03638128|526378013|FG001|Overall Study|Lost to Follow-up|0|||
145963022|NCT03638128|526378014|FG002|Overall Study|Lost to Follow-up|1|||
145963023|NCT03163446|526378015|FG000|Overall Study|Unable to return for Day 180 visit|2|||
145963024|NCT03163446|526378016|FG001|Overall Study|Unable to return for Day 180 visit|0|||
146229894|NCT03571386|527359546|FG001|Overall Study|Withdrawal by Subject|5|||
146229895|NCT04451772|527359547|FG000|Overall Study|Adverse Event|1|||
145963025|NCT03163446|526378015|FG000|Overall Study|Withdrawal by Subject|2|||
145963026|NCT03163446|526378016|FG001|Overall Study|Withdrawal by Subject|6|||
145963027|NCT03163446|526378015|FG000|Overall Study|Death|16|||
146229896|NCT04451772|527359548|FG001|Overall Study|Adverse Event|0|||
146229897|NCT04451772|527359549|FG002|Overall Study|Adverse Event|1|||
145963028|NCT03163446|526378016|FG001|Overall Study|Death|5|||
145963029|NCT03163446|526378015|FG000|Overall Study|Lost to Follow-up|6|||
145963030|NCT03163446|526378016|FG001|Overall Study|Lost to Follow-up|5|||
145963031|NCT03163446|526378015|FG000|Overall Study|Physician Decision|1|||
145963032|NCT03163446|526378016|FG001|Overall Study|Physician Decision|1|||
145963033|NCT03163446|526378015|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
145963034|NCT03163446|526378016|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
145963035|NCT00611806|526378018|FG000|Overall Study|Withdrawal by Subject|8|||
145963036|NCT00611806|526378019|FG001|Overall Study|Withdrawal by Subject|2|||
145963037|NCT00611806|526378018|FG000|Overall Study|Adverse Event|2|||
145963038|NCT00611806|526378019|FG001|Overall Study|Adverse Event|1|||
145963039|NCT00611806|526378018|FG000|Overall Study|Lost to Follow-up|6|||
145963040|NCT00611806|526378019|FG001|Overall Study|Lost to Follow-up|0|||
145963041|NCT00329108|526378020|FG000|Overall Study|Adverse Event|2|||
145963042|NCT00329108|526378021|FG001|Overall Study|Adverse Event|2|||
145963043|NCT00329108|526378020|FG000|Overall Study|Lack of Efficacy|3|||
145963044|NCT00329108|526378021|FG001|Overall Study|Lack of Efficacy|3|||
145963045|NCT00329108|526378020|FG000|Overall Study|Withdrawal by Subject|0|||
145963046|NCT00329108|526378021|FG001|Overall Study|Withdrawal by Subject|2|||
145963047|NCT00329108|526378020|FG000|Overall Study|symptomatic deterioration|1|||
145963048|NCT00329108|526378021|FG001|Overall Study|symptomatic deterioration|1|||
145963049|NCT00329108|526378020|FG000|Overall Study|Subject no longer willing to participate|2|||
145963050|NCT00329108|526378021|FG001|Overall Study|Subject no longer willing to participate|2|||
145963051|NCT00329108|526378020|FG000|Overall Study|study terminated by sponsor|1|||
145886180|NCT02688387|526088257|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146289342|NCT03938545|527575242|FG003|Overall Study|Withdrawal by Subject|0|||
146289343|NCT03938545|527575239|FG000|Overall Study|Adverse Event|1|||
146289344|NCT03938545|527575240|FG001|Overall Study|Adverse Event|0|||
146289345|NCT03938545|527575241|FG002|Overall Study|Adverse Event|0|||
146289346|NCT03938545|527575242|FG003|Overall Study|Adverse Event|0|||
146289347|NCT01060540|527575243|FG000|Overall Study|Withdrawal by Subject|10|||
146229898|NCT04451772|527359550|FG003|Overall Study|Adverse Event|1|||
146229899|NCT04451772|527359551|FG004|Overall Study|Adverse Event|0|||
146229900|NCT04451772|527359552|FG005|Overall Study|Adverse Event|3|||
146229901|NCT04451772|527359547|FG000|Overall Study|Withdrawal by Subject|2|||
146229902|NCT04451772|527359548|FG001|Overall Study|Withdrawal by Subject|7|||
146289348|NCT01060540|527575244|FG001|Overall Study|Withdrawal by Subject|20|||
146289349|NCT01060540|527575243|FG000|Overall Study|Lost to Follow-up|52|||
146289350|NCT01060540|527575244|FG001|Overall Study|Lost to Follow-up|43|||
146289351|NCT01060540|527575243|FG000|Overall Study|Death|2|||
146289352|NCT01060540|527575244|FG001|Overall Study|Death|1|||
146289353|NCT01060540|527575243|FG000|Overall Study|Physician Decision|0|||
146289354|NCT01060540|527575244|FG001|Overall Study|Physician Decision|1|||
145963052|NCT00329108|526378021|FG001|Overall Study|study terminated by sponsor|0|||
145963053|NCT00329108|526378020|FG000|Overall Study|withdrew patient after SAE resolved|1|||
145963054|NCT00329108|526378021|FG001|Overall Study|withdrew patient after SAE resolved|0|||
145963055|NCT00329108|526378020|FG000|Overall Study|Protocol Violation|0|||
145963056|NCT00329108|526378021|FG001|Overall Study|Protocol Violation|2|||
145963057|NCT00903201|526378022|FG000|Overall Study|Adverse Event|1|||
145963058|NCT00903201|526378023|FG001|Overall Study|Adverse Event|4|||
145963059|NCT00903201|526378024|FG002|Overall Study|Adverse Event|0|||
145963060|NCT00903201|526378022|FG000|Overall Study|Protocol Violation|2|||
145963061|NCT00903201|526378023|FG001|Overall Study|Protocol Violation|1|||
145963062|NCT00903201|526378024|FG002|Overall Study|Protocol Violation|0|||
145963063|NCT00903201|526378022|FG000|Overall Study|Lost to Follow-up|0|||
145963064|NCT00903201|526378023|FG001|Overall Study|Lost to Follow-up|1|||
145963065|NCT00903201|526378024|FG002|Overall Study|Lost to Follow-up|0|||
145963066|NCT00903201|526378022|FG000|Overall Study|Physician Decision|1|||
145963067|NCT00903201|526378023|FG001|Overall Study|Physician Decision|0|||
146086184|NCT00814801|526836610|FG001|Overall Study|Missing or change of caregiver|2|||
146086185|NCT00814801|526836611|FG002|Overall Study|Missing or change of caregiver|4|||
146086186|NCT00814801|526836609|FG000|Overall Study|Non-compliance|0|||
146086187|NCT00814801|526836610|FG001|Overall Study|Non-compliance|1|||
145886181|NCT02688387|526088258|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886182|NCT02688387|526088259|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146289355|NCT01222507|527575248|FG000|Overall Study|Physician Decision|1|||
146289356|NCT01222507|527575248|FG000|Overall Study|Withdrawal by Subject|1|||
146289357|NCT00320541|527575250|FG000|Overall Study|Adverse Event|21|||
146289358|NCT00320541|527575251|FG001|Overall Study|Adverse Event|19|||
146289359|NCT00320541|527575250|FG000|Overall Study|Protocol Violation|0|||
146289360|NCT00320541|527575251|FG001|Overall Study|Protocol Violation|1|||
146289361|NCT00320541|527575250|FG000|Overall Study|Withdrawal by Subject|12|||
146289362|NCT00320541|527575251|FG001|Overall Study|Withdrawal by Subject|16|||
146289363|NCT00320541|527575250|FG000|Overall Study|Physician Decision|9|||
146289364|NCT00320541|527575251|FG001|Overall Study|Physician Decision|13|||
146289365|NCT00320541|527575250|FG000|Overall Study|Other|3|||
146289366|NCT00320541|527575251|FG001|Overall Study|Other|4|||
146289367|NCT00320541|527575250|FG000|Overall Study|Sponsor Decision|2|||
146289368|NCT00320541|527575251|FG001|Overall Study|Sponsor Decision|1|||
146289369|NCT00320541|527575250|FG000|Overall Study|Death due to Study Disease|1|||
146289370|NCT00320541|527575251|FG001|Overall Study|Death due to Study Disease|3|||
146289371|NCT00320541|527575250|FG000|Overall Study|Death due to Adverse Event(s)|1|||
146289372|NCT00320541|527575251|FG001|Overall Study|Death due to Adverse Event(s)|0|||
146289373|NCT00320541|527575250|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
146289374|NCT00320541|527575251|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
146289375|NCT02401867|527575252|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
146289376|NCT02401867|527575252|FG000|Analysis|Cervical assay could not be conducted|9|||
146289377|NCT01650246|527575253|FG000|Overall Study|Adverse Event|23|||
146289378|NCT01650246|527575253|FG000|Overall Study|Protocol Violation|5|||
146289379|NCT01650246|527575253|FG000|Overall Study|Sponsor terminated study|53|||
146289380|NCT01650246|527575253|FG000|Overall Study|Lost to Follow-up|5|||
146289381|NCT01650246|527575253|FG000|Overall Study|Withdrawal by Subject|26|||
146289382|NCT01650246|527575253|FG000|Overall Study|Death|1|||
146289383|NCT01650246|527575253|FG000|Overall Study|Lack of Efficacy|30|||
146289384|NCT00081770|527575254|FG000|Overall Study|Adverse Event|130|||
146289385|NCT00081770|527575255|FG001|Overall Study|Adverse Event|98|||
146289386|NCT00081770|527575256|FG002|Overall Study|Adverse Event|136|||
146289387|NCT00081770|527575254|FG000|Overall Study|Lack of Efficacy|262|||
146289388|NCT00081770|527575255|FG001|Overall Study|Lack of Efficacy|357|||
145886183|NCT02688387|526088260|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886184|NCT02688387|526088261|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146086188|NCT00814801|526836611|FG002|Overall Study|Non-compliance|1|||
146289389|NCT00081770|527575256|FG002|Overall Study|Lack of Efficacy|211|||
146289390|NCT00081770|527575254|FG000|Overall Study|Lost to Follow-up|45|||
146289391|NCT00081770|527575255|FG001|Overall Study|Lost to Follow-up|34|||
146289392|NCT00081770|527575256|FG002|Overall Study|Lost to Follow-up|45|||
146289393|NCT00081770|527575254|FG000|Overall Study|Protocol Violation|15|||
146289394|NCT00081770|527575255|FG001|Overall Study|Protocol Violation|10|||
146289395|NCT00081770|527575256|FG002|Overall Study|Protocol Violation|10|||
146289396|NCT00081770|527575254|FG000|Overall Study|Withdrawal by Subject|45|||
146289397|NCT00081770|527575255|FG001|Overall Study|Withdrawal by Subject|40|||
146289398|NCT00081770|527575256|FG002|Overall Study|Withdrawal by Subject|42|||
146229903|NCT04451772|527359549|FG002|Overall Study|Withdrawal by Subject|2|||
146229904|NCT04451772|527359550|FG003|Overall Study|Withdrawal by Subject|1|||
146229905|NCT04451772|527359551|FG004|Overall Study|Withdrawal by Subject|1|||
146229906|NCT04451772|527359552|FG005|Overall Study|Withdrawal by Subject|0|||
146229907|NCT04451772|527359547|FG000|Overall Study|Other, not specified|1|||
146229908|NCT04451772|527359548|FG001|Overall Study|Other, not specified|2|||
146229909|NCT04451772|527359549|FG002|Overall Study|Other, not specified|1|||
146229910|NCT04451772|527359550|FG003|Overall Study|Other, not specified|0|||
146229911|NCT04451772|527359551|FG004|Overall Study|Other, not specified|0|||
146229912|NCT04451772|527359552|FG005|Overall Study|Other, not specified|1|||
146229913|NCT04451772|527359547|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
146229914|NCT04451772|527359548|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
146229915|NCT04451772|527359549|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
146229916|NCT04451772|527359550|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
146229917|NCT04451772|527359551|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
146229918|NCT04451772|527359552|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
146229919|NCT04311632|527359553|FG000|Overall Study|Withdrawal by Subject|0|||
146229920|NCT04311632|527359554|FG001|Overall Study|Withdrawal by Subject|0|||
146229921|NCT04311632|527359555|FG002|Overall Study|Withdrawal by Subject|1|||
146229922|NCT04632225|527359556|FG000|Overall Study|Withdrawal by Subject|2|||
146229923|NCT04632225|527359557|FG001|Overall Study|Withdrawal by Subject|2|||
146229924|NCT02278211|527359558|FG000|Overall Study|Unable to analyse PET scan|2|||
146229925|NCT03858517|527359559|FG000|Overall Study|Adverse Event|1|||
146229926|NCT03858517|527359559|FG000|Overall Study|Lost to Follow-up|1|||
146229927|NCT03858517|527359559|FG000|Overall Study|removed for being incarcerated|1|||
146229928|NCT03858517|527359559|FG000|Overall Study|Sponsor Closure|48|||
146229929|NCT06037668|527359560|FG000|Overall Study|Lost to Follow-up|1|||
146229930|NCT06037668|527359561|FG001|Overall Study|Lost to Follow-up|1|||
146229931|NCT06037668|527359560|FG000|Overall Study|Protocol Violation|1|||
146229932|NCT06037668|527359561|FG001|Overall Study|Protocol Violation|0|||
146229933|NCT06037668|527359560|FG000|Overall Study|Withdrawal by Subject|1|||
146229934|NCT06037668|527359561|FG001|Overall Study|Withdrawal by Subject|0|||
146229935|NCT06037668|527359560|FG000|Overall Study|Other Study Discontinuation Reason|1|||
146229936|NCT06037668|527359561|FG001|Overall Study|Other Study Discontinuation Reason|0|||
146229937|NCT05224544|527359562|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
146229938|NCT05224544|527359563|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
146229939|NCT04804540|527359564|FG000|Overall Study|Adverse Event|26|||
146229940|NCT04804540|527359565|FG001|Overall Study|Adverse Event|13|||
146229941|NCT01828021|527359566|FG000|Overall Study|Adverse Event|5|||
146229942|NCT01828021|527359566|FG000|Overall Study|Lack of Efficacy|17|||
146229943|NCT01828021|527359566|FG000|Overall Study|Withdrawal by Subject|2|||
146229944|NCT01828021|527359566|FG000|Overall Study|Ileal obstruction, unrelated|1|||
146229945|NCT04881461|527359567|FG000|Overall Study|Adverse Event|2|||
146229946|NCT04881461|527359568|FG001|Overall Study|Adverse Event|4|||
146229947|NCT04881461|527359567|FG000|Overall Study|Withdrawal by Subject|19|||
145886185|NCT02688387|526088262|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886186|NCT02688387|526088263|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886187|NCT02688387|526088264|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886188|NCT02688387|526088265|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146289399|NCT00081770|527575254|FG000|Overall Study|Did not meet protocol eligibility|2|||
146289400|NCT00081770|527575255|FG001|Overall Study|Did not meet protocol eligibility|0|||
146289401|NCT00081770|527575256|FG002|Overall Study|Did not meet protocol eligibility|3|||
146289402|NCT00081770|527575254|FG000|Overall Study|Administrative|1|||
146289403|NCT00081770|527575255|FG001|Overall Study|Administrative|0|||
146289404|NCT00081770|527575256|FG002|Overall Study|Administrative|1|||
146289405|NCT00081770|527575254|FG000|Overall Study|Other|2|||
145886189|NCT02688387|526088266|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886190|NCT02688387|526088267|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146289406|NCT00081770|527575255|FG001|Overall Study|Other|7|||
146086189|NCT00814801|526836609|FG000|Overall Study|Other|2|||
146086190|NCT00814801|526836610|FG001|Overall Study|Other|6|||
146086191|NCT00814801|526836611|FG002|Overall Study|Other|4|||
146086192|NCT02520089|526836614|FG000|Overall Study|Lost to Follow-up|3|||
146086193|NCT02520089|526836615|FG001|Overall Study|Lost to Follow-up|4|||
146086194|NCT02216812|526836618|FG000|Overall Study|Lost to Follow-up|10|||
146086195|NCT02216812|526836619|FG001|Overall Study|Lost to Follow-up|5|||
146086196|NCT02829944|526836623|FG000|Overall Study|Physician Decision|0|||
146086197|NCT02829944|526836624|FG001|Overall Study|Physician Decision|1|||
146086198|NCT02829944|526836623|FG000|Overall Study|Screen Failure|2|||
146086199|NCT02829944|526836624|FG001|Overall Study|Screen Failure|2|||
146086200|NCT02829944|526836623|FG000|Overall Study|Inadequate Neuraxial Block|1|||
146086201|NCT02829944|526836624|FG001|Overall Study|Inadequate Neuraxial Block|1|||
146086202|NCT02829944|526836623|FG000|Overall Study|Withdrawal by Subject|2|||
146086203|NCT02829944|526836624|FG001|Overall Study|Withdrawal by Subject|1|||
146086204|NCT02829944|526836623|FG000|Overall Study|Catheter Displacement|1|||
146086205|NCT02829944|526836624|FG001|Overall Study|Catheter Displacement|0|||
146086206|NCT02829944|526836623|FG000|Overall Study|Catheter broke|0|||
146086207|NCT02829944|526836624|FG001|Overall Study|Catheter broke|1|||
146086208|NCT02829944|526836623|FG000|Overall Study|Staff unavailable|0|||
146086209|NCT02829944|526836624|FG001|Overall Study|Staff unavailable|1|||
146086210|NCT04675151|526836625|FG000|Overall Study|Protocol Violation|1|||
146086211|NCT04675151|526836626|FG001|Overall Study|Protocol Violation|0|||
146086212|NCT04675151|526836627|FG002|Overall Study|Protocol Violation|0|||
146086213|NCT04675151|526836628|FG003|Overall Study|Protocol Violation|1|||
146086214|NCT04035486|526836629|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
146086215|NCT04035486|526836630|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
146086216|NCT04035486|526836631|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
145963068|NCT00903201|526378024|FG002|Overall Study|Physician Decision|1|||
146086217|NCT04035486|526836632|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
146086218|NCT04035486|526836629|FG000|Overall Study|Death|6|||
146086219|NCT04035486|526836630|FG001|Overall Study|Death|3|||
146086220|NCT04035486|526836631|FG002|Overall Study|Death|70|||
146086221|NCT04035486|526836632|FG003|Overall Study|Death|77|||
146086222|NCT04035486|526836629|FG000|Overall Study|Screen Failure|0|||
146086223|NCT04035486|526836630|FG001|Overall Study|Screen Failure|0|||
146086224|NCT04035486|526836631|FG002|Overall Study|Screen Failure|1|||
146086225|NCT04035486|526836632|FG003|Overall Study|Screen Failure|1|||
146086226|NCT04035486|526836629|FG000|Overall Study|Withdrawal by Subject|1|||
146086227|NCT04035486|526836630|FG001|Overall Study|Withdrawal by Subject|1|||
146086228|NCT04035486|526836631|FG002|Overall Study|Withdrawal by Subject|11|||
146086229|NCT04035486|526836632|FG003|Overall Study|Withdrawal by Subject|9|||
146086230|NCT01730937|526836633|FG000|Overall Study|Protocol Violation|5|||
146086231|NCT01730937|526836634|FG001|Overall Study|Protocol Violation|11|||
146086232|NCT03947684|526836635|FG000|Overall Study|Lost to Follow-up|13|||
146229948|NCT04881461|527359568|FG001|Overall Study|Withdrawal by Subject|19|||
146229949|NCT04881461|527359567|FG000|Overall Study|Lost to Follow-up|4|||
146229950|NCT04881461|527359568|FG001|Overall Study|Lost to Follow-up|4|||
146229951|NCT04881461|527359567|FG000|Overall Study|Lack of Efficacy|1|||
146229952|NCT04881461|527359568|FG001|Overall Study|Lack of Efficacy|0|||
146229953|NCT04881461|527359567|FG000|Overall Study|"Reason stated as other in CRF"|1|||
146229954|NCT04881461|527359568|FG001|Overall Study|"Reason stated as other in CRF"|2|||
146229955|NCT02997202|527359569|FG000|Overall Study|Miscellaneous|2|||
146229956|NCT02997202|527359570|FG001|Overall Study|Miscellaneous|2|||
145886191|NCT02688387|526088268|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
146229957|NCT02997202|527359569|FG000|Overall Study|Withdrawal by Subject|8|||
146229958|NCT02997202|527359570|FG001|Overall Study|Withdrawal by Subject|12|||
146229959|NCT02997202|527359569|FG000|Overall Study|Lost to Follow-up|5|||
146229960|NCT02997202|527359570|FG001|Overall Study|Lost to Follow-up|3|||
145886192|NCT02688387|526088269|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886193|NCT02688387|526088270|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
146086233|NCT03947684|526836636|FG001|Overall Study|Lost to Follow-up|5|||
146086234|NCT03947684|526836637|FG002|Overall Study|Lost to Follow-up|1|||
145963069|NCT00903201|526378022|FG000|Overall Study|Withdrawal by Subject|1|||
145963070|NCT00903201|526378023|FG001|Overall Study|Withdrawal by Subject|0|||
145963071|NCT00903201|526378024|FG002|Overall Study|Withdrawal by Subject|1|||
146086235|NCT03947684|526836635|FG000|Overall Study|Withdrawal by Subject|11|||
146086236|NCT03947684|526836636|FG001|Overall Study|Withdrawal by Subject|4|||
146086237|NCT03947684|526836637|FG002|Overall Study|Withdrawal by Subject|0|||
146086238|NCT03947684|526836635|FG000|Overall Study|Physician Decision|1|||
146086239|NCT03947684|526836636|FG001|Overall Study|Physician Decision|0|||
146086240|NCT03947684|526836637|FG002|Overall Study|Physician Decision|0|||
146086241|NCT03947684|526836635|FG000|Overall Study|Lack of adherence to study protocol|2|||
146086242|NCT03947684|526836636|FG001|Overall Study|Lack of adherence to study protocol|0|||
146086243|NCT03947684|526836637|FG002|Overall Study|Lack of adherence to study protocol|0|||
146086244|NCT03875235|526836638|FG000|Overall Study|Ongoing study treatment|63|||
146086245|NCT03875235|526836639|FG001|Overall Study|Ongoing study treatment|20|||
146086246|NCT03875235|526836638|FG000|Overall Study|Off treatment|77|||
146086247|NCT03875235|526836639|FG001|Overall Study|Off treatment|91|||
146086248|NCT03875235|526836638|FG000|Overall Study|Withdrawal by Subject|3|||
146086249|NCT03875235|526836639|FG001|Overall Study|Withdrawal by Subject|10|||
146086250|NCT03875235|526836638|FG000|Overall Study|Death|198|||
146229961|NCT02997202|527359569|FG000|Overall Study|Death|41|||
146086251|NCT03875235|526836639|FG001|Overall Study|Death|223|||
146229962|NCT02997202|527359570|FG001|Overall Study|Death|45|||
146086252|NCT01395784|526836649|FG000|Overall Study|Lost to Follow-up|7|||
146086253|NCT01395784|526836649|FG000|Overall Study|Withdrawal by Subject|3|||
146229963|NCT04158739|527359574|FG000|Overall Study|Adverse Event|1|||
146086254|NCT01395784|526836649|FG000|Overall Study|Physician Decision|5|||
146229964|NCT04158739|527359575|FG001|Overall Study|Adverse Event|0|||
146229965|NCT04158739|527359574|FG000|Overall Study|Death|0|||
146229966|NCT04158739|527359575|FG001|Overall Study|Death|1|||
146229967|NCT04158739|527359574|FG000|Overall Study|Lack of Efficacy|3|||
146229968|NCT04158739|527359575|FG001|Overall Study|Lack of Efficacy|7|||
146229969|NCT04158739|527359574|FG000|Overall Study|Physician Decision|0|||
146229970|NCT04158739|527359575|FG001|Overall Study|Physician Decision|1|||
146229971|NCT04158739|527359574|FG000|Overall Study|Withdrawal by Subject|3|||
146229972|NCT04158739|527359575|FG001|Overall Study|Withdrawal by Subject|0|||
146229973|NCT02782676|527359578|FG000|Overall Study|Lost to Follow-up|0|||
146229974|NCT02782676|527359579|FG001|Overall Study|Lost to Follow-up|1|||
146229975|NCT03652272|527359580|FG000|3 Month|Withdrawal by Subject|1|||
146229976|NCT03652272|527359581|FG001|3 Month|Withdrawal by Subject|1|||
146229977|NCT03652272|527359580|FG000|3 Month|Lost to Follow-up|16|||
146229978|NCT03652272|527359581|FG001|3 Month|Lost to Follow-up|14|||
145963072|NCT01094288|526378025|FG000|Overall Study|Adverse Event|0|||
145963073|NCT01094288|526378026|FG001|Overall Study|Adverse Event|3|||
145963074|NCT01094288|526378027|FG002|Overall Study|Adverse Event|1|||
145963075|NCT01094288|526378028|FG003|Overall Study|Adverse Event|1|||
145963076|NCT01094288|526378029|FG004|Overall Study|Adverse Event|0|||
145963077|NCT01094288|526378030|FG005|Overall Study|Adverse Event|0|||
145963078|NCT01094288|526378031|FG006|Overall Study|Adverse Event|0|||
145963079|NCT01094288|526378032|FG007|Overall Study|Adverse Event|0|||
145963080|NCT01094288|526378025|FG000|Overall Study|Withdrawal by Subject|0|||
145963081|NCT01094288|526378026|FG001|Overall Study|Withdrawal by Subject|1|||
145963082|NCT01094288|526378027|FG002|Overall Study|Withdrawal by Subject|2|||
145963083|NCT01094288|526378028|FG003|Overall Study|Withdrawal by Subject|0|||
145963084|NCT01094288|526378029|FG004|Overall Study|Withdrawal by Subject|0|||
145963085|NCT01094288|526378030|FG005|Overall Study|Withdrawal by Subject|0|||
145963086|NCT01094288|526378031|FG006|Overall Study|Withdrawal by Subject|0|||
145963087|NCT01094288|526378032|FG007|Overall Study|Withdrawal by Subject|2|||
145963088|NCT01094288|526378025|FG000|Overall Study|Initiation of Alternative Therapy|0|||
145963089|NCT01094288|526378026|FG001|Overall Study|Initiation of Alternative Therapy|0|||
145963090|NCT01094288|526378027|FG002|Overall Study|Initiation of Alternative Therapy|1|||
145963091|NCT01094288|526378028|FG003|Overall Study|Initiation of Alternative Therapy|0|||
145963092|NCT01094288|526378029|FG004|Overall Study|Initiation of Alternative Therapy|0|||
145963093|NCT01094288|526378030|FG005|Overall Study|Initiation of Alternative Therapy|0|||
145963094|NCT01094288|526378031|FG006|Overall Study|Initiation of Alternative Therapy|0|||
145963095|NCT01094288|526378032|FG007|Overall Study|Initiation of Alternative Therapy|0|||
145963096|NCT01094288|526378025|FG000|Overall Study|Reason not Specified|2|||
145963097|NCT01094288|526378026|FG001|Overall Study|Reason not Specified|3|||
145963098|NCT01094288|526378027|FG002|Overall Study|Reason not Specified|0|||
145963099|NCT01094288|526378028|FG003|Overall Study|Reason not Specified|1|||
146229979|NCT02326974|527359582|FG000|Overall Study|Withdrawal by Subject|2|||
146229980|NCT02326974|527359582|FG000|Overall Study|failed heterogenity evaluation|5|||
146229981|NCT04214834|527359588|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
146229982|NCT04214834|527359589|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
146229983|NCT04924400|527359592|FG000|Overall Study|Lost to Follow-up|3|||
146229984|NCT04924400|527359593|FG001|Overall Study|Lost to Follow-up|0|||
146229985|NCT03812614|527359594|FG000|Intervention|Withdrawal by Subject|7|||
146229986|NCT03812614|527359595|FG001|Intervention|Withdrawal by Subject|2|||
146229987|NCT03812614|527359596|FG002|Intervention|Withdrawal by Subject|7|||
146229988|NCT03812614|527359597|FG003|Intervention|Withdrawal by Subject|2|||
146229989|NCT03812614|527359594|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
146229990|NCT03812614|527359595|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
146229991|NCT03812614|527359596|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
146229992|NCT03812614|527359597|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
146229993|NCT03812614|527359594|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
146229994|NCT03812614|527359595|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
146229995|NCT03812614|527359596|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
146229996|NCT03812614|527359597|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
146229997|NCT03812614|527359594|FG000|6-month Follow-up|Lost to Follow-up|0|||
146229998|NCT03812614|527359595|FG001|6-month Follow-up|Lost to Follow-up|0|||
146229999|NCT03812614|527359596|FG002|6-month Follow-up|Lost to Follow-up|12|||
146230000|NCT03812614|527359597|FG003|6-month Follow-up|Lost to Follow-up|8|||
146230001|NCT03812614|527359594|FG000|12-month Follow-up|Lost to Follow-up|18|||
146230002|NCT03812614|527359595|FG001|12-month Follow-up|Lost to Follow-up|17|||
146230003|NCT03812614|527359596|FG002|12-month Follow-up|Lost to Follow-up|5|||
146230004|NCT03812614|527359597|FG003|12-month Follow-up|Lost to Follow-up|2|||
146230005|NCT05205161|527359598|FG000|Overall Study|Study terminated by sponsor|3|||
146230006|NCT05205161|527359599|FG001|Overall Study|Study terminated by sponsor|3|||
146230007|NCT05205161|527359600|FG002|Overall Study|Study terminated by sponsor|1|||
146230008|NCT05652010|527359601|FG000|First Intervention|Withdrawal by Subject|0|||
146230009|NCT05652010|527359602|FG001|First Intervention|Withdrawal by Subject|1|||
146230010|NCT05652010|527359601|FG000|Second Intervention|Withdrawal by Subject|1|||
146230011|NCT05652010|527359602|FG001|Second Intervention|Withdrawal by Subject|0|||
145886194|NCT02688387|526088271|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886195|NCT02688387|526088272|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886196|NCT02688387|526088273|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886197|NCT02688387|526088274|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886198|NCT02688387|526088275|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886199|NCT02688387|526088276|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886200|NCT02688387|526088277|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145886201|NCT02688387|526088256|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886202|NCT02688387|526088257|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
146230012|NCT05451693|527359604|FG000|Overall Study|Withdrawal by Subject|1|||
146289407|NCT00081770|527575256|FG002|Overall Study|Other|8|||
145886203|NCT02688387|526088258|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886204|NCT02688387|526088259|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886205|NCT02688387|526088260|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886206|NCT02688387|526088261|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886207|NCT02688387|526088262|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886208|NCT02688387|526088263|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886209|NCT02688387|526088264|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886210|NCT02688387|526088265|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886211|NCT02688387|526088266|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886212|NCT02688387|526088267|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886213|NCT02688387|526088268|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886214|NCT02688387|526088269|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886215|NCT02688387|526088270|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886216|NCT02688387|526088271|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886217|NCT02688387|526088272|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886218|NCT02688387|526088273|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886219|NCT02688387|526088274|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886220|NCT02688387|526088275|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886221|NCT02688387|526088276|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
145886222|NCT02688387|526088277|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145886223|NCT02688387|526088256|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886224|NCT02688387|526088257|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886225|NCT02688387|526088258|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886226|NCT02688387|526088259|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886227|NCT02688387|526088260|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886228|NCT02688387|526088261|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886229|NCT02688387|526088262|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886230|NCT02688387|526088263|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886231|NCT02688387|526088264|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886232|NCT02688387|526088265|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886233|NCT02688387|526088266|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886234|NCT02688387|526088267|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886235|NCT02688387|526088268|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145963100|NCT01094288|526378029|FG004|Overall Study|Reason not Specified|0|||
145963101|NCT01094288|526378030|FG005|Overall Study|Reason not Specified|0|||
146289408|NCT01640054|527575269|FG000|Overall Study|Study-specific disc criteria|1|||
146289409|NCT01640054|527575269|FG000|Overall Study|Lack of Efficacy|3|||
146289410|NCT01640054|527575269|FG000|Overall Study|Adverse Event|2|||
146289411|NCT02080221|527575271|FG000|Overall Study|Withdrawal by Subject|1|||
146289412|NCT02080221|527575271|FG000|Overall Study|Clinical Progression of Disease|1|||
146289413|NCT03184870|527575275|FG000|Initial Treatment|Death|6|||
146289414|NCT03184870|527575276|FG001|Initial Treatment|Death|6|||
146289415|NCT03184870|527575277|FG002|Initial Treatment|Death|8|||
145886236|NCT02688387|526088269|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
146289416|NCT03184870|527575278|FG003|Initial Treatment|Death|8|||
146289417|NCT03184870|527575279|FG004|Initial Treatment|Death|6|||
146289418|NCT03184870|527575280|FG005|Initial Treatment|Death|6|||
145886237|NCT02688387|526088270|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886238|NCT02688387|526088271|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886239|NCT02688387|526088272|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886240|NCT02688387|526088273|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886241|NCT02688387|526088274|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
145886242|NCT02688387|526088275|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145886243|NCT02688387|526088276|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
145886244|NCT02688387|526088277|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
146289419|NCT03184870|527575281|FG006|Initial Treatment|Death|6|||
146289420|NCT03184870|527575282|FG007|Initial Treatment|Death|7|||
146289421|NCT03184870|527575283|FG008|Initial Treatment|Death|1|||
146289422|NCT03184870|527575284|FG009|Initial Treatment|Death|2|||
146289423|NCT03184870|527575285|FG010|Initial Treatment|Death|26|||
146289424|NCT03184870|527575286|FG011|Initial Treatment|Death|28|||
146289425|NCT03184870|527575287|FG012|Initial Treatment|Death|10|||
146289426|NCT03184870|527575288|FG013|Initial Treatment|Death|33|||
146289427|NCT03184870|527575289|FG014|Initial Treatment|Death|34|||
146289428|NCT03184870|527575290|FG015|Initial Treatment|Death|26|||
146289429|NCT03184870|527575291|FG016|Initial Treatment|Death|20|||
146289430|NCT03184870|527575292|FG017|Initial Treatment|Death|18|||
146289431|NCT03184870|527575275|FG000|Initial Treatment|Other Reasons|2|||
146289432|NCT03184870|527575276|FG001|Initial Treatment|Other Reasons|2|||
146289433|NCT03184870|527575277|FG002|Initial Treatment|Other Reasons|0|||
146289434|NCT03184870|527575278|FG003|Initial Treatment|Other Reasons|1|||
146289435|NCT03184870|527575279|FG004|Initial Treatment|Other Reasons|0|||
146289436|NCT03184870|527575280|FG005|Initial Treatment|Other Reasons|0|||
146289437|NCT03184870|527575281|FG006|Initial Treatment|Other Reasons|0|||
146289438|NCT03184870|527575282|FG007|Initial Treatment|Other Reasons|2|||
146289439|NCT03184870|527575283|FG008|Initial Treatment|Other Reasons|0|||
146289440|NCT03184870|527575284|FG009|Initial Treatment|Other Reasons|0|||
146289441|NCT03184870|527575285|FG010|Initial Treatment|Other Reasons|4|||
146289442|NCT03184870|527575286|FG011|Initial Treatment|Other Reasons|2|||
146289443|NCT03184870|527575287|FG012|Initial Treatment|Other Reasons|2|||
146289444|NCT03184870|527575288|FG013|Initial Treatment|Other Reasons|0|||
146289445|NCT03184870|527575289|FG014|Initial Treatment|Other Reasons|0|||
146289446|NCT03184870|527575290|FG015|Initial Treatment|Other Reasons|1|||
146289447|NCT03184870|527575291|FG016|Initial Treatment|Other Reasons|0|||
145886245|NCT02688387|526088256|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886246|NCT02688387|526088257|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886247|NCT02688387|526088258|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886248|NCT02688387|526088259|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886249|NCT02688387|526088260|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
146289448|NCT03184870|527575292|FG017|Initial Treatment|Other Reasons|2|||
145886250|NCT02688387|526088261|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
146086255|NCT05772702|526836650|FG000|Overall Study|Adverse Event|1|||
146289449|NCT03184870|527575275|FG000|Initial Treatment|Lost to Follow-up|2|||
146289450|NCT03184870|527575276|FG001|Initial Treatment|Lost to Follow-up|0|||
146289451|NCT03184870|527575277|FG002|Initial Treatment|Lost to Follow-up|0|||
146289452|NCT03184870|527575278|FG003|Initial Treatment|Lost to Follow-up|1|||
146289453|NCT03184870|527575279|FG004|Initial Treatment|Lost to Follow-up|1|||
146289454|NCT03184870|527575280|FG005|Initial Treatment|Lost to Follow-up|1|||
146230013|NCT05451693|527359605|FG001|Overall Study|Withdrawal by Subject|1|||
146230014|NCT05741294|527359606|FG000|Overall Study|Lost to Follow-up|3|||
146230015|NCT05741294|527359606|FG000|Overall Study|Protocol deviation|3|||
146230016|NCT05741294|527359606|FG000|Overall Study|Withdrawal by Subject|1|||
146230017|NCT04707768|527359621|FG000|Overall Study|Adverse Event|9|||
146230018|NCT04707768|527359622|FG001|Overall Study|Adverse Event|18|||
146230019|NCT04707768|527359623|FG002|Overall Study|Adverse Event|3|||
146230020|NCT04707768|527359621|FG000|Overall Study|Investigator's Discretion|8|||
146230021|NCT04707768|527359622|FG001|Overall Study|Investigator's Discretion|4|||
146230022|NCT04707768|527359623|FG002|Overall Study|Investigator's Discretion|3|||
146230023|NCT04707768|527359621|FG000|Overall Study|Withdrawal by Subject|6|||
146230024|NCT04707768|527359622|FG001|Overall Study|Withdrawal by Subject|8|||
146230025|NCT04707768|527359623|FG002|Overall Study|Withdrawal by Subject|2|||
146230026|NCT04707768|527359621|FG000|Overall Study|Lack of Efficacy|1|||
146230027|NCT04707768|527359622|FG001|Overall Study|Lack of Efficacy|3|||
146230028|NCT04707768|527359623|FG002|Overall Study|Lack of Efficacy|0|||
146230029|NCT04707768|527359621|FG000|Overall Study|Lost to Follow-up|0|||
146230030|NCT04707768|527359622|FG001|Overall Study|Lost to Follow-up|0|||
146230031|NCT04707768|527359623|FG002|Overall Study|Lost to Follow-up|3|||
146230032|NCT04707768|527359621|FG000|Overall Study|Death|13|||
146230033|NCT04707768|527359622|FG001|Overall Study|Death|11|||
146230034|NCT04707768|527359623|FG002|Overall Study|Death|13|||
146230035|NCT04707768|527359621|FG000|Overall Study|Protocol Violation|2|||
146230036|NCT04707768|527359622|FG001|Overall Study|Protocol Violation|1|||
146230037|NCT04707768|527359623|FG002|Overall Study|Protocol Violation|0|||
146230038|NCT04707768|527359621|FG000|Overall Study|Non Compliance with Study Drug|1|||
146230039|NCT04707768|527359622|FG001|Overall Study|Non Compliance with Study Drug|0|||
146230040|NCT04707768|527359623|FG002|Overall Study|Non Compliance with Study Drug|0|||
146230041|NCT04707768|527359621|FG000|Overall Study|Transplant|4|||
146230042|NCT04707768|527359622|FG001|Overall Study|Transplant|4|||
146230043|NCT04707768|527359623|FG002|Overall Study|Transplant|8|||
146230044|NCT04707768|527359621|FG000|Overall Study|Other|9|||
146230045|NCT04707768|527359622|FG001|Overall Study|Other|5|||
146230046|NCT04707768|527359623|FG002|Overall Study|Other|2|||
146230047|NCT02510235|527359624|FG000|Overall Study|Withdrawal by Subject|1|||
145963102|NCT01094288|526378031|FG006|Overall Study|Reason not Specified|0|||
145963103|NCT01094288|526378032|FG007|Overall Study|Reason not Specified|0|||
145963104|NCT01094288|526378025|FG000|Overall Study|Ongoing Participants|0|||
145963105|NCT01094288|526378026|FG001|Overall Study|Ongoing Participants|3|||
145963106|NCT01094288|526378027|FG002|Overall Study|Ongoing Participants|0|||
145963107|NCT01094288|526378028|FG003|Overall Study|Ongoing Participants|0|||
145963108|NCT01094288|526378029|FG004|Overall Study|Ongoing Participants|0|||
145963109|NCT01094288|526378030|FG005|Overall Study|Ongoing Participants|0|||
145963110|NCT01094288|526378031|FG006|Overall Study|Ongoing Participants|0|||
145963111|NCT01094288|526378032|FG007|Overall Study|Ongoing Participants|0|||
145963112|NCT02611882|526378035|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
145963113|NCT02611882|526378036|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
145963114|NCT02611882|526378037|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
145963115|NCT01389232|526378038|FG000|Overall Study|Had scaffold removed|15|||
145963116|NCT01389232|526378038|FG000|Overall Study|Personal reasons|2|||
145963117|NCT01389232|526378038|FG000|Overall Study|Adverse Event|1|||
145963118|NCT01389232|526378038|FG000|Overall Study|Death|1|||
145963119|NCT01317940|526378039|FG000|Overall Study|Death|1|||
145963120|NCT01317940|526378040|FG001|Overall Study|Death|0|||
145963121|NCT01317940|526378041|FG002|Overall Study|Death|1|||
145963122|NCT01317940|526378042|FG003|Overall Study|Death|0|||
146230048|NCT02510235|527359625|FG001|Overall Study|Withdrawal by Subject|0|||
146230049|NCT05008055|527359626|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
146230050|NCT05008055|527359627|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
146230051|NCT05008055|527359628|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
146230052|NCT03011034|527359633|FG000|Overall Study|Adverse Event|1|||
145963123|NCT01317940|526378043|FG004|Overall Study|Death|0|||
146086256|NCT04268823|526836651|FG000|Overall Study|Adverse Event|1|||
146086257|NCT04268823|526836652|FG001|Overall Study|Adverse Event|0|||
146086258|NCT04268823|526836651|FG000|Overall Study|Participant Decision|1|||
146086259|NCT04268823|526836652|FG001|Overall Study|Participant Decision|0|||
146086260|NCT05247398|526837907|FG000|Overall Study|Withdrawal by Subject|1|||
146086261|NCT04251156|526837908|FG000|Overall Study|Lost to Follow-up|1|||
146230053|NCT03011034|527359634|FG001|Overall Study|Adverse Event|0|||
146230054|NCT03735979|527359636|FG000|Overall Study|Lost to Follow-up|1|||
146086262|NCT04251156|526837909|FG001|Overall Study|Lost to Follow-up|1|||
146230055|NCT03735979|527359637|FG001|Overall Study|Lost to Follow-up|12|||
146230056|NCT03735979|527359638|FG002|Overall Study|Lost to Follow-up|14|||
146230057|NCT03735979|527359636|FG000|Overall Study|Withdrawal by Subject|1|||
146230058|NCT03735979|527359637|FG001|Overall Study|Withdrawal by Subject|5|||
146230059|NCT03735979|527359638|FG002|Overall Study|Withdrawal by Subject|2|||
146230060|NCT03735979|527359636|FG000|Overall Study|Not due to the above reasons|1|||
146230061|NCT03735979|527359637|FG001|Overall Study|Not due to the above reasons|0|||
146230062|NCT03735979|527359638|FG002|Overall Study|Not due to the above reasons|0|||
146230063|NCT00319111|527359641|FG000|Overall Study|Adverse Event|20|||
146230064|NCT00319111|527359641|FG000|Overall Study|Withdrawal of consent|11|||
146230065|NCT00319111|527359641|FG000|Overall Study|Death|9|||
146086263|NCT04251156|526837908|FG000|Overall Study|Withdrawal by Subject|4|||
146230066|NCT00319111|527359641|FG000|Overall Study|Lack of clinical improvement|4|||
146230067|NCT00319111|527359641|FG000|Overall Study|Administrative|2|||
146086264|NCT04251156|526837909|FG001|Overall Study|Withdrawal by Subject|4|||
146230068|NCT00319111|527359641|FG000|Overall Study|Treatment failure|1|||
145963124|NCT01317940|526378044|FG005|Overall Study|Death|0|||
145963125|NCT01317940|526378039|FG000|Overall Study|Lost to Follow-up|0|||
145963126|NCT01317940|526378040|FG001|Overall Study|Lost to Follow-up|0|||
145963127|NCT01317940|526378041|FG002|Overall Study|Lost to Follow-up|1|||
146230069|NCT01438853|527359642|FG000|Overall Study|Death|0|||
146230070|NCT01438853|527359643|FG001|Overall Study|Death|0|||
146230071|NCT01438853|527359644|FG002|Overall Study|Death|0|||
146230072|NCT01438853|527359645|FG003|Overall Study|Death|1|||
146230073|NCT01438853|527359642|FG000|Overall Study|Withdrawal by Subject|0|||
146230074|NCT01438853|527359643|FG001|Overall Study|Withdrawal by Subject|0|||
146230075|NCT01438853|527359644|FG002|Overall Study|Withdrawal by Subject|1|||
146230076|NCT01438853|527359645|FG003|Overall Study|Withdrawal by Subject|0|||
146230077|NCT02919917|527359646|FG000|Overall Study|Withdrawal by Subject|4|||
146230078|NCT02919917|527359647|FG001|Overall Study|Withdrawal by Subject|8|||
146230079|NCT04743973|527359648|FG000|Overall Study|Withdrawal by Subject|5|||
146230080|NCT03165955|527359649|FG000|Treatment|Withdrawal by Subject|3|||
146230081|NCT03165955|527359649|FG000|Treatment|Death|1|||
146230082|NCT03165955|527359649|FG000|Treatment|Adverse Event|1|||
146230083|NCT03165955|527359649|FG000|Treatment|Progressive disease|3|||
146230084|NCT04761198|527359652|FG000|Overall Study|Progressive Disease|1|||
146230085|NCT04761198|527359653|FG001|Overall Study|Progressive Disease|0|||
146230086|NCT04761198|527359654|FG002|Overall Study|Progressive Disease|0|||
146230087|NCT04761198|527359655|FG003|Overall Study|Progressive Disease|1|||
146230088|NCT04761198|527359656|FG004|Overall Study|Progressive Disease|4|||
146230089|NCT04761198|527359657|FG005|Overall Study|Progressive Disease|1|||
146230090|NCT04761198|527359658|FG006|Overall Study|Progressive Disease|2|||
146230091|NCT04761198|527359652|FG000|Overall Study|Protocol Violation|0|||
146230092|NCT04761198|527359653|FG001|Overall Study|Protocol Violation|0|||
146230093|NCT04761198|527359654|FG002|Overall Study|Protocol Violation|0|||
146230094|NCT04761198|527359655|FG003|Overall Study|Protocol Violation|0|||
146230095|NCT04761198|527359656|FG004|Overall Study|Protocol Violation|1|||
146230096|NCT04761198|527359657|FG005|Overall Study|Protocol Violation|0|||
146230097|NCT04761198|527359658|FG006|Overall Study|Protocol Violation|0|||
146230098|NCT04761198|527359652|FG000|Overall Study|Death|2|||
146230099|NCT04761198|527359653|FG001|Overall Study|Death|1|||
146230100|NCT04761198|527359654|FG002|Overall Study|Death|2|||
146230101|NCT04761198|527359655|FG003|Overall Study|Death|5|||
146230102|NCT04761198|527359656|FG004|Overall Study|Death|14|||
146230103|NCT04761198|527359657|FG005|Overall Study|Death|2|||
146230104|NCT04761198|527359658|FG006|Overall Study|Death|5|||
146230105|NCT04761198|527359652|FG000|Overall Study|Lost to Follow-up|0|||
146230106|NCT04761198|527359653|FG001|Overall Study|Lost to Follow-up|0|||
146230107|NCT04761198|527359654|FG002|Overall Study|Lost to Follow-up|0|||
146230108|NCT04761198|527359655|FG003|Overall Study|Lost to Follow-up|0|||
146230109|NCT04761198|527359656|FG004|Overall Study|Lost to Follow-up|1|||
146230110|NCT04761198|527359657|FG005|Overall Study|Lost to Follow-up|0|||
146230111|NCT04761198|527359658|FG006|Overall Study|Lost to Follow-up|0|||
146230112|NCT04761198|527359652|FG000|Overall Study|Withdrawal by Subject|2|||
146230113|NCT04761198|527359653|FG001|Overall Study|Withdrawal by Subject|0|||
146230114|NCT04761198|527359654|FG002|Overall Study|Withdrawal by Subject|1|||
146230115|NCT04761198|527359655|FG003|Overall Study|Withdrawal by Subject|0|||
146230116|NCT04761198|527359656|FG004|Overall Study|Withdrawal by Subject|2|||
146230117|NCT04761198|527359657|FG005|Overall Study|Withdrawal by Subject|0|||
146230118|NCT04761198|527359658|FG006|Overall Study|Withdrawal by Subject|1|||
146230119|NCT04761198|527359652|FG000|Overall Study|Study Terminated by Sponsor|6|||
146230120|NCT04761198|527359653|FG001|Overall Study|Study Terminated by Sponsor|0|||
146230121|NCT04761198|527359654|FG002|Overall Study|Study Terminated by Sponsor|5|||
146230122|NCT04761198|527359655|FG003|Overall Study|Study Terminated by Sponsor|3|||
146230123|NCT04761198|527359656|FG004|Overall Study|Study Terminated by Sponsor|10|||
146230124|NCT04761198|527359657|FG005|Overall Study|Study Terminated by Sponsor|1|||
146230125|NCT04761198|527359658|FG006|Overall Study|Study Terminated by Sponsor|2|||
146289455|NCT03184870|527575281|FG006|Initial Treatment|Lost to Follow-up|0|||
146230126|NCT02994927|527359659|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146289456|NCT03184870|527575282|FG007|Initial Treatment|Lost to Follow-up|2|||
146230127|NCT02994927|527359660|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146230128|NCT02994927|527359659|FG000|Overall Study|Did not meet eligibility criteria|0|||
146230129|NCT02994927|527359660|FG001|Overall Study|Did not meet eligibility criteria|1|||
146230130|NCT02994927|527359659|FG000|Overall Study|Physician Decision|4|||
146230131|NCT02994927|527359660|FG001|Overall Study|Physician Decision|3|||
146230132|NCT02994927|527359659|FG000|Overall Study|Death|4|||
146230133|NCT02994927|527359660|FG001|Overall Study|Death|2|||
146230134|NCT02994927|527359659|FG000|Overall Study|Adverse Event|2|||
146230135|NCT02994927|527359660|FG001|Overall Study|Adverse Event|1|||
145963128|NCT01317940|526378042|FG003|Overall Study|Lost to Follow-up|1|||
146086265|NCT04214288|526837910|FG000|Overall Study|Ongoing in the study|41|||
146086266|NCT04214288|526837911|FG001|Overall Study|Ongoing in the study|51|||
146086267|NCT04214288|526837912|FG002|Overall Study|Ongoing in the study|12|||
146086268|NCT04214288|526837913|FG003|Overall Study|Ongoing in the study|39|||
146086269|NCT04214288|526837910|FG000|Overall Study|Adverse Event|1|||
146086270|NCT04214288|526837911|FG001|Overall Study|Adverse Event|0|||
146086271|NCT04214288|526837912|FG002|Overall Study|Adverse Event|0|||
146086272|NCT04214288|526837913|FG003|Overall Study|Adverse Event|0|||
146086273|NCT04214288|526837910|FG000|Overall Study|Death|22|||
146086274|NCT04214288|526837911|FG001|Overall Study|Death|13|||
146086275|NCT04214288|526837912|FG002|Overall Study|Death|7|||
146086276|NCT04214288|526837913|FG003|Overall Study|Death|19|||
146086277|NCT04214288|526837910|FG000|Overall Study|Lost to Follow-up|1|||
146086278|NCT04214288|526837911|FG001|Overall Study|Lost to Follow-up|2|||
146086279|NCT04214288|526837912|FG002|Overall Study|Lost to Follow-up|1|||
146086280|NCT04214288|526837913|FG003|Overall Study|Lost to Follow-up|0|||
146086281|NCT04214288|526837910|FG000|Overall Study|Other|1|||
146086282|NCT04214288|526837911|FG001|Overall Study|Other|2|||
146086283|NCT04214288|526837912|FG002|Overall Study|Other|0|||
146086284|NCT04214288|526837913|FG003|Overall Study|Other|6|||
146086285|NCT04214288|526837910|FG000|Overall Study|Protocol Violation|0|||
146086286|NCT04214288|526837911|FG001|Overall Study|Protocol Violation|1|||
146086287|NCT04214288|526837912|FG002|Overall Study|Protocol Violation|0|||
146086288|NCT04214288|526837913|FG003|Overall Study|Protocol Violation|0|||
146086289|NCT04214288|526837910|FG000|Overall Study|Withdrawal by Subject|8|||
146086290|NCT04214288|526837911|FG001|Overall Study|Withdrawal by Subject|4|||
146086291|NCT04214288|526837912|FG002|Overall Study|Withdrawal by Subject|0|||
146086292|NCT04214288|526837913|FG003|Overall Study|Withdrawal by Subject|9|||
146086293|NCT00807027|526837914|FG000|Overall Study|Withdrawal by Subject|13|||
146230136|NCT02994927|527359659|FG000|Overall Study|Withdrawal by Subject|3|||
146230137|NCT02994927|527359660|FG001|Overall Study|Withdrawal by Subject|6|||
146230138|NCT02994927|527359659|FG000|Overall Study|Lost to Follow-up|2|||
146230139|NCT02994927|527359660|FG001|Overall Study|Lost to Follow-up|1|||
146230140|NCT00626795|527359661|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
146230141|NCT00626795|527359662|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
146230142|NCT00626795|527359663|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
146230143|NCT00626795|527359661|FG000|Blinded Treatment|Lack of Efficacy|2|||
146230144|NCT00626795|527359662|FG001|Blinded Treatment|Lack of Efficacy|0|||
146230145|NCT00626795|527359663|FG002|Blinded Treatment|Lack of Efficacy|0|||
146230146|NCT00626795|527359661|FG000|Blinded Treatment|Unacceptable adverse event|0|||
146230147|NCT00626795|527359662|FG001|Blinded Treatment|Unacceptable adverse event|0|||
146230148|NCT00626795|527359663|FG002|Blinded Treatment|Unacceptable adverse event|1|||
146230149|NCT00626795|527359661|FG000|Blinded Treatment|Protocol Violation|0|||
146230150|NCT00626795|527359662|FG001|Blinded Treatment|Protocol Violation|1|||
146230151|NCT00626795|527359663|FG002|Blinded Treatment|Protocol Violation|1|||
146230152|NCT00626795|527359661|FG000|Blinded Treatment|Withdrawal by Subject|1|||
146230153|NCT00626795|527359662|FG001|Blinded Treatment|Withdrawal by Subject|1|||
146230154|NCT00626795|527359663|FG002|Blinded Treatment|Withdrawal by Subject|0|||
146230155|NCT00626795|527359661|FG000|Blinded Treatment|Other reasons|2|||
146230156|NCT00626795|527359662|FG001|Blinded Treatment|Other reasons|0|||
146230157|NCT00626795|527359663|FG002|Blinded Treatment|Other reasons|2|||
146230158|NCT00626795|527359661|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
146230159|NCT00626795|527359662|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
146086294|NCT00807027|526837915|FG001|Overall Study|Withdrawal by Subject|14|||
146086295|NCT00807027|526837914|FG000|Overall Study|Protocol Violation|1|||
146230160|NCT00626795|527359663|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
146230161|NCT03533257|527359671|FG000|Overall Study|Adverse Event|4|||
146086296|NCT00807027|526837915|FG001|Overall Study|Protocol Violation|1|||
146230162|NCT03533257|527359672|FG001|Overall Study|Adverse Event|2|||
146086297|NCT00807027|526837914|FG000|Overall Study|Adverse Event|2|||
146086298|NCT00807027|526837915|FG001|Overall Study|Adverse Event|2|||
146086299|NCT03997383|526837916|FG000|Double-blind Treatment Period|Adverse Event|4|||
146086300|NCT03997383|526837917|FG001|Double-blind Treatment Period|Adverse Event|3|||
145963129|NCT01317940|526378043|FG004|Overall Study|Lost to Follow-up|1|||
145963130|NCT01317940|526378044|FG005|Overall Study|Lost to Follow-up|0|||
145963131|NCT01317940|526378039|FG000|Overall Study|Change in therapy plan|0|||
145963132|NCT01317940|526378040|FG001|Overall Study|Change in therapy plan|0|||
145963133|NCT01317940|526378041|FG002|Overall Study|Change in therapy plan|3|||
145963134|NCT01317940|526378042|FG003|Overall Study|Change in therapy plan|0|||
145963135|NCT01317940|526378043|FG004|Overall Study|Change in therapy plan|0|||
145963136|NCT01317940|526378044|FG005|Overall Study|Change in therapy plan|0|||
145963137|NCT00945243|526378046|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
145963138|NCT03256578|526378047|FG000|Overall Study|Excluded Post Randomization|66|||
145963139|NCT03256578|526378048|FG001|Overall Study|Excluded Post Randomization|56|||
145963140|NCT02371616|526378049|FG000|Overall Study|Protocol Violation|2|||
145963141|NCT02371616|526378050|FG001|Overall Study|Protocol Violation|1|||
145963142|NCT02371616|526378049|FG000|Overall Study|Adverse Event|0|||
145963143|NCT02371616|526378050|FG001|Overall Study|Adverse Event|1|||
145963144|NCT02371616|526378049|FG000|Overall Study|Withdrawal of Consent|1|||
145963145|NCT02371616|526378050|FG001|Overall Study|Withdrawal of Consent|0|||
145963146|NCT02371616|526378049|FG000|Overall Study|Other (Not specified)|1|||
145963147|NCT02371616|526378050|FG001|Overall Study|Other (Not specified)|5|||
145963148|NCT00754741|526378053|FG000|Overall Study|Died or disenrolled|57|||
145963149|NCT00754741|526378054|FG001|Overall Study|Died or disenrolled|69|||
146230163|NCT03533257|527359671|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
146230164|NCT03533257|527359672|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
146230165|NCT05525104|527359673|FG000|Overall Study|Failed caudal analgesia|1|||
146230166|NCT05525104|527359674|FG001|Overall Study|Failed caudal analgesia|3|||
146230167|NCT05525104|527359673|FG000|Overall Study|Premedication needed|0|||
146230168|NCT05525104|527359674|FG001|Overall Study|Premedication needed|1|||
146230169|NCT05525104|527359673|FG000|Overall Study|Protocol Violation|10|||
146230170|NCT05525104|527359674|FG001|Overall Study|Protocol Violation|0|||
146230171|NCT05525104|527359673|FG000|Overall Study|Cancelled operation|1|||
146230172|NCT05525104|527359674|FG001|Overall Study|Cancelled operation|0|||
146230173|NCT02039401|527359675|FG000|Overall Study|Adverse Event|0|||
146230174|NCT02039401|527359676|FG001|Overall Study|Adverse Event|1|||
145886251|NCT02688387|526088262|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886252|NCT02688387|526088263|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886253|NCT02688387|526088264|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886254|NCT02688387|526088265|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886255|NCT02688387|526088266|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886256|NCT02688387|526088267|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886257|NCT02688387|526088268|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886258|NCT02688387|526088269|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886259|NCT02688387|526088270|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886260|NCT02688387|526088271|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886261|NCT02688387|526088272|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886262|NCT02688387|526088273|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886263|NCT02688387|526088274|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145963150|NCT00754741|526378055|FG002|Overall Study|Died or disenrolled|54|||
145963151|NCT04152200|526378057|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
145963152|NCT04152200|526378058|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
145963153|NCT04969289|526378059|FG000|Overall Study|Lost to Follow-up|13|||
145963154|NCT04969289|526378060|FG001|Overall Study|Lost to Follow-up|9|||
145963155|NCT00593814|526378061|FG000|Overall Study|Death|7|||
145963156|NCT00593814|526378062|FG001|Overall Study|Death|0|||
145963157|NCT00593814|526378061|FG000|Overall Study|Withdrawal by Subject|7|||
145963158|NCT00593814|526378062|FG001|Overall Study|Withdrawal by Subject|0|||
145963159|NCT00593814|526378061|FG000|Overall Study|Lost to Follow-up|7|||
145963160|NCT00593814|526378062|FG001|Overall Study|Lost to Follow-up|0|||
145963161|NCT00593814|526378061|FG000|Overall Study|Physician Decision|3|||
145963162|NCT00593814|526378062|FG001|Overall Study|Physician Decision|0|||
145963163|NCT02699996|526378063|FG000|Overall Study|Withdrawal by Subject|5|||
145963164|NCT02699996|526378064|FG001|Overall Study|Withdrawal by Subject|2|||
145963165|NCT01921517|526378065|FG000|Overall Study|Lost to Follow-up|5|||
145963166|NCT01921517|526378066|FG001|Overall Study|Lost to Follow-up|0|||
145963167|NCT01921517|526378065|FG000|Overall Study|Newly diagnosed health concern|2|||
145963168|NCT01921517|526378066|FG001|Overall Study|Newly diagnosed health concern|0|||
145963169|NCT01921517|526378065|FG000|Overall Study|Physician Decision|0|||
145963170|NCT01921517|526378066|FG001|Overall Study|Physician Decision|2|||
145963171|NCT01921517|526378065|FG000|Overall Study|Withdrawal by Subject|7|||
145963172|NCT01921517|526378066|FG001|Overall Study|Withdrawal by Subject|3|||
145963173|NCT01921517|526378065|FG000|Overall Study|Subject missed final imaging|1|||
146230175|NCT04678856|527359677|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
146230176|NCT04678856|527359678|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
146230177|NCT04678856|527359677|FG000|Overall Study|Withdrawal by Subject|5|||
146230178|NCT04678856|527359678|FG001|Overall Study|Withdrawal by Subject|1|||
146230179|NCT01917084|527360530|FG000|Overall Study|Withdrawal by Subject|1|||
146230180|NCT03681262|527360543|FG000|Overall Study|Continuing on study|3|||
146230181|NCT03681262|527360544|FG001|Overall Study|Continuing on study|3|||
146230182|NCT03681262|527360543|FG000|Overall Study|Lost to Follow-up|1|||
145886264|NCT02688387|526088275|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
145886265|NCT02688387|526088276|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886266|NCT02688387|526088277|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145886267|NCT00802178|526088280|FG000|Overall Study|Lack of Efficacy|36|||
146230183|NCT03681262|527360544|FG001|Overall Study|Lost to Follow-up|0|||
146230184|NCT04631016|527360558|FG000|Overall Study|Adverse Event|3|||
146230185|NCT04631016|527360559|FG001|Overall Study|Adverse Event|0|||
146230186|NCT04631016|527360558|FG000|Overall Study|Withdrawal by Subject|5|||
146230187|NCT04631016|527360559|FG001|Overall Study|Withdrawal by Subject|4|||
146230188|NCT04631016|527360558|FG000|Overall Study|Reason unspecified|1|||
146230189|NCT04631016|527360559|FG001|Overall Study|Reason unspecified|0|||
146230190|NCT04631016|527360558|FG000|Overall Study|Failure to meet randomization criteria|2|||
146230191|NCT04631016|527360559|FG001|Overall Study|Failure to meet randomization criteria|1|||
146230192|NCT04490109|527360560|FG000|Overall Study|Lost to Follow-up|3|||
146230193|NCT04490109|527360561|FG001|Overall Study|Lost to Follow-up|10|||
146230194|NCT04490109|527360562|FG002|Overall Study|Lost to Follow-up|4|||
146230195|NCT04490109|527360560|FG000|Overall Study|Withdrawal by Subject|8|||
146230196|NCT04490109|527360561|FG001|Overall Study|Withdrawal by Subject|6|||
146230197|NCT04490109|527360562|FG002|Overall Study|Withdrawal by Subject|9|||
146230198|NCT04490109|527360560|FG000|Overall Study|Physician Decision|0|||
146230199|NCT04490109|527360561|FG001|Overall Study|Physician Decision|2|||
146230200|NCT04490109|527360562|FG002|Overall Study|Physician Decision|3|||
146230201|NCT04490109|527360560|FG000|Overall Study|Adverse Event|2|||
146230202|NCT04490109|527360561|FG001|Overall Study|Adverse Event|1|||
146230203|NCT04490109|527360562|FG002|Overall Study|Adverse Event|0|||
146230204|NCT04490109|527360560|FG000|Overall Study|Significant Non-Compliance|2|||
146230205|NCT04490109|527360561|FG001|Overall Study|Significant Non-Compliance|4|||
146230206|NCT04490109|527360562|FG002|Overall Study|Significant Non-Compliance|4|||
146230207|NCT04490109|527360560|FG000|Overall Study|Significant Clinical Event|0|||
146230208|NCT04490109|527360561|FG001|Overall Study|Significant Clinical Event|1|||
146230209|NCT04490109|527360562|FG002|Overall Study|Significant Clinical Event|0|||
146230210|NCT04490109|527360560|FG000|Overall Study|Other Reason|4|||
146230211|NCT04490109|527360561|FG001|Overall Study|Other Reason|1|||
146230212|NCT04490109|527360562|FG002|Overall Study|Other Reason|1|||
146230213|NCT04163991|527360563|FG000|Overall Study|Adverse Event|0|||
146230214|NCT04163991|527360564|FG001|Overall Study|Adverse Event|0|||
145886268|NCT00802178|526088280|FG000|Overall Study|Insufficient tolerability (IT)|17|||
146230215|NCT04163991|527360565|FG002|Overall Study|Adverse Event|0|||
146230216|NCT04163991|527360566|FG003|Overall Study|Adverse Event|1|||
146230217|NCT04163991|527360567|FG004|Overall Study|Adverse Event|0|||
146230218|NCT04163991|527360563|FG000|Overall Study|Death|0|||
146230219|NCT04163991|527360564|FG001|Overall Study|Death|0|||
146230220|NCT04163991|527360565|FG002|Overall Study|Death|1|||
146230221|NCT04163991|527360566|FG003|Overall Study|Death|0|||
146230222|NCT04163991|527360567|FG004|Overall Study|Death|0|||
146230223|NCT04163991|527360563|FG000|Overall Study|Lost to Follow-up|0|||
146230224|NCT04163991|527360564|FG001|Overall Study|Lost to Follow-up|1|||
146230225|NCT04163991|527360565|FG002|Overall Study|Lost to Follow-up|0|||
146230226|NCT04163991|527360566|FG003|Overall Study|Lost to Follow-up|0|||
146230227|NCT04163991|527360567|FG004|Overall Study|Lost to Follow-up|0|||
146230228|NCT04163991|527360563|FG000|Overall Study|Withdrawal by Subject|1|||
146230229|NCT04163991|527360564|FG001|Overall Study|Withdrawal by Subject|1|||
146230230|NCT04163991|527360565|FG002|Overall Study|Withdrawal by Subject|3|||
146230231|NCT04163991|527360566|FG003|Overall Study|Withdrawal by Subject|1|||
146230232|NCT04163991|527360567|FG004|Overall Study|Withdrawal by Subject|1|||
146230233|NCT04163991|527360563|FG000|Overall Study|Other, Not Specified|0|||
146230234|NCT04163991|527360564|FG001|Overall Study|Other, Not Specified|1|||
146230235|NCT04163991|527360565|FG002|Overall Study|Other, Not Specified|1|||
146230236|NCT04163991|527360566|FG003|Overall Study|Other, Not Specified|1|||
146230237|NCT04163991|527360567|FG004|Overall Study|Other, Not Specified|0|||
146230238|NCT03372057|527360568|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
146230239|NCT03372057|527360569|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
146230240|NCT03372057|527360570|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
146230241|NCT03372057|527360568|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
146230242|NCT03372057|527360569|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
146230243|NCT03372057|527360570|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
146230244|NCT03372057|527360568|FG000|Dose Optimization Phase|Death|16|||
146230245|NCT03372057|527360569|FG001|Dose Optimization Phase|Death|11|||
146230246|NCT03372057|527360570|FG002|Dose Optimization Phase|Death|0|||
146230247|NCT03372057|527360568|FG000|Expansion Phase|Withdrawal by Subject|0|||
146230248|NCT03372057|527360569|FG001|Expansion Phase|Withdrawal by Subject|0|||
146230249|NCT03372057|527360570|FG002|Expansion Phase|Withdrawal by Subject|4|||
146230250|NCT03372057|527360568|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
146230251|NCT03372057|527360569|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
146230252|NCT03372057|527360570|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
146230253|NCT03372057|527360568|FG000|Expansion Phase|Death|0|||
146230254|NCT03372057|527360569|FG001|Expansion Phase|Death|0|||
146230255|NCT03372057|527360570|FG002|Expansion Phase|Death|78|||
146230256|NCT03372057|527360568|FG000|Expansion Phase|Progressive Disease|0|||
146230257|NCT03372057|527360569|FG001|Expansion Phase|Progressive Disease|0|||
146230258|NCT03372057|527360570|FG002|Expansion Phase|Progressive Disease|1|||
146230259|NCT03372057|527360568|FG000|Expansion Phase|Adverse Event|0|||
146230260|NCT03372057|527360569|FG001|Expansion Phase|Adverse Event|0|||
146230261|NCT03372057|527360570|FG002|Expansion Phase|Adverse Event|1|||
146230262|NCT03880955|527360571|FG000|Overall Study|Adverse Event|1|||
146230263|NCT03880955|527360571|FG000|Overall Study|Death|1|||
146230264|NCT03880955|527360571|FG000|Overall Study|Lost to Follow-up|12|||
146230265|NCT03880955|527360571|FG000|Overall Study|Withdrawal by Subject|4|||
146230266|NCT03880955|527360571|FG000|Overall Study|Missing- Study Site Closed|27|||
146230267|NCT03817983|527360572|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
146230268|NCT03817983|527360573|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
146230269|NCT03817983|527360574|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
146230270|NCT03744676|527360575|FG000|Pre-Treatment Phase|Disease related complications|2|||
146230271|NCT03744676|527360575|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
146230272|NCT03744676|527360575|FG000|Pre-Treatment Phase|Death|7|||
146230273|NCT03744676|527360575|FG000|Pre-Treatment Phase|Other Reasons|7|||
146230274|NCT03744676|527360575|FG000|Treatment Phase|Participant withdrew consent|8|||
146230275|NCT03744676|527360575|FG000|Treatment Phase|Death|33|||
146230276|NCT03744676|527360575|FG000|Treatment Phase|other reasons|6|||
146230277|NCT04078152|527360576|FG000|Overall Study|Other|83|||
146230278|NCT04078152|527360577|FG001|Overall Study|Other|22|||
146230279|NCT04078152|527360578|FG002|Overall Study|Other|25|||
146230280|NCT04078152|527360576|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
146230281|NCT04078152|527360577|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
146230282|NCT04078152|527360578|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
146230283|NCT04078152|527360576|FG000|Overall Study|Withdrawal by Subject|5|||
146230284|NCT04078152|527360577|FG001|Overall Study|Withdrawal by Subject|0|||
146230285|NCT04078152|527360578|FG002|Overall Study|Withdrawal by Subject|1|||
146230286|NCT04078152|527360576|FG000|Overall Study|Death|10|||
146230287|NCT04078152|527360577|FG001|Overall Study|Death|2|||
146230288|NCT04078152|527360578|FG002|Overall Study|Death|12|||
146230289|NCT04078152|527360576|FG000|Overall Study|Adverse Event|1|||
146230290|NCT04078152|527360577|FG001|Overall Study|Adverse Event|0|||
146230291|NCT04078152|527360578|FG002|Overall Study|Adverse Event|0|||
146230292|NCT00450216|527360580|FG000|Overall Study|Adverse Event|38|||
146230293|NCT00450216|527360581|FG001|Overall Study|Adverse Event|23|||
146230294|NCT00450216|527360580|FG000|Overall Study|Withdrawal by Subject|48|||
146230295|NCT00450216|527360581|FG001|Overall Study|Withdrawal by Subject|26|||
146230296|NCT00450216|527360580|FG000|Overall Study|Lost to Follow-up|16|||
146230297|NCT00450216|527360581|FG001|Overall Study|Lost to Follow-up|9|||
146230298|NCT00450216|527360580|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
146230299|NCT00450216|527360581|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
146230300|NCT00450216|527360580|FG000|Overall Study|misc|21|||
146230301|NCT00450216|527360581|FG001|Overall Study|misc|20|||
146230302|NCT05112900|527360585|FG000|Overall Study|Withdrawal by Subject|960|||
146230303|NCT05112900|527360586|FG001|Overall Study|Withdrawal by Subject|921|||
146230304|NCT05112900|527360587|FG002|Overall Study|Withdrawal by Subject|968|||
146230305|NCT04330040|527360591|FG000|Overall Study|Other: Adverse event|5|||
146230306|NCT04330040|527360592|FG001|Overall Study|Other: Adverse event|0|||
146230307|NCT04330040|527360593|FG002|Overall Study|Other: Adverse event|0|||
146230308|NCT04330040|527360591|FG000|Overall Study|Disease progression|38|||
146230309|NCT04330040|527360592|FG001|Overall Study|Disease progression|10|||
146230310|NCT04330040|527360593|FG002|Overall Study|Disease progression|0|||
146230311|NCT04330040|527360591|FG000|Overall Study|Physician Decision|5|||
146230312|NCT04330040|527360592|FG001|Overall Study|Physician Decision|3|||
146230313|NCT04330040|527360593|FG002|Overall Study|Physician Decision|0|||
146230314|NCT04330040|527360591|FG000|Overall Study|Lost to Follow-up|1|||
146230315|NCT04330040|527360592|FG001|Overall Study|Lost to Follow-up|1|||
146230316|NCT04330040|527360593|FG002|Overall Study|Lost to Follow-up|0|||
146230317|NCT04330040|527360591|FG000|Overall Study|Death|2|||
146230318|NCT04330040|527360592|FG001|Overall Study|Death|1|||
146230319|NCT04330040|527360593|FG002|Overall Study|Death|0|||
146230320|NCT04330040|527360591|FG000|Overall Study|Withdrawal by Subject|3|||
146230321|NCT04330040|527360592|FG001|Overall Study|Withdrawal by Subject|3|||
146230322|NCT04330040|527360593|FG002|Overall Study|Withdrawal by Subject|0|||
146230323|NCT04330040|527360591|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
146230324|NCT04330040|527360592|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
146230325|NCT04330040|527360593|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
146230326|NCT04330040|527360591|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
146230327|NCT04330040|527360592|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
146230328|NCT04330040|527360593|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
146230329|NCT04330040|527360591|FG000|Overall Study|Other: Disease progression|1|||
146230330|NCT04330040|527360592|FG001|Overall Study|Other: Disease progression|0|||
146230331|NCT04330040|527360593|FG002|Overall Study|Other: Disease progression|0|||
146230332|NCT04330040|527360591|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
146230333|NCT04330040|527360592|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
146230334|NCT04330040|527360593|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
146230335|NCT04330040|527360591|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
146230336|NCT04330040|527360592|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
146230337|NCT04330040|527360593|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
146230338|NCT04330040|527360591|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
146230339|NCT04330040|527360592|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
146235080|NCT00622700|527378449|FG002|Extension Treatment Period|Protocol Violation|0|||
146289457|NCT03184870|527575283|FG008|Initial Treatment|Lost to Follow-up|0|||
146289458|NCT03184870|527575284|FG009|Initial Treatment|Lost to Follow-up|0|||
146289459|NCT03184870|527575285|FG010|Initial Treatment|Lost to Follow-up|2|||
146289460|NCT03184870|527575286|FG011|Initial Treatment|Lost to Follow-up|0|||
146289461|NCT03184870|527575287|FG012|Initial Treatment|Lost to Follow-up|2|||
146289462|NCT03184870|527575288|FG013|Initial Treatment|Lost to Follow-up|2|||
146289463|NCT03184870|527575289|FG014|Initial Treatment|Lost to Follow-up|0|||
146289464|NCT03184870|527575290|FG015|Initial Treatment|Lost to Follow-up|0|||
146289465|NCT03184870|527575291|FG016|Initial Treatment|Lost to Follow-up|2|||
146289466|NCT03184870|527575292|FG017|Initial Treatment|Lost to Follow-up|2|||
146289467|NCT03184870|527575275|FG000|Initial Treatment|Withdrawal by Subject|0|||
146289468|NCT03184870|527575276|FG001|Initial Treatment|Withdrawal by Subject|0|||
146289469|NCT03184870|527575277|FG002|Initial Treatment|Withdrawal by Subject|2|||
146289470|NCT03184870|527575278|FG003|Initial Treatment|Withdrawal by Subject|1|||
146289471|NCT03184870|527575279|FG004|Initial Treatment|Withdrawal by Subject|1|||
146289472|NCT03184870|527575280|FG005|Initial Treatment|Withdrawal by Subject|0|||
146289473|NCT03184870|527575281|FG006|Initial Treatment|Withdrawal by Subject|1|||
146289474|NCT03184870|527575282|FG007|Initial Treatment|Withdrawal by Subject|0|||
146289475|NCT03184870|527575283|FG008|Initial Treatment|Withdrawal by Subject|0|||
146289476|NCT03184870|527575284|FG009|Initial Treatment|Withdrawal by Subject|0|||
146289477|NCT03184870|527575285|FG010|Initial Treatment|Withdrawal by Subject|0|||
146289478|NCT03184870|527575286|FG011|Initial Treatment|Withdrawal by Subject|2|||
146289479|NCT03184870|527575287|FG012|Initial Treatment|Withdrawal by Subject|3|||
146289480|NCT03184870|527575288|FG013|Initial Treatment|Withdrawal by Subject|0|||
146289481|NCT03184870|527575289|FG014|Initial Treatment|Withdrawal by Subject|1|||
146289482|NCT03184870|527575290|FG015|Initial Treatment|Withdrawal by Subject|5|||
146289483|NCT03184870|527575291|FG016|Initial Treatment|Withdrawal by Subject|2|||
146289484|NCT03184870|527575292|FG017|Initial Treatment|Withdrawal by Subject|2|||
146289485|NCT03184870|527575275|FG000|Initial Treatment|Moved to crossover treatment|0|||
146289486|NCT03184870|527575276|FG001|Initial Treatment|Moved to crossover treatment|0|||
146289487|NCT03184870|527575277|FG002|Initial Treatment|Moved to crossover treatment|0|||
146289488|NCT03184870|527575278|FG003|Initial Treatment|Moved to crossover treatment|0|||
146289489|NCT03184870|527575279|FG004|Initial Treatment|Moved to crossover treatment|0|||
146289490|NCT03184870|527575280|FG005|Initial Treatment|Moved to crossover treatment|0|||
146289491|NCT03184870|527575281|FG006|Initial Treatment|Moved to crossover treatment|0|||
146289492|NCT03184870|527575282|FG007|Initial Treatment|Moved to crossover treatment|0|||
146289493|NCT03184870|527575283|FG008|Initial Treatment|Moved to crossover treatment|0|||
146289494|NCT03184870|527575284|FG009|Initial Treatment|Moved to crossover treatment|0|||
146289495|NCT03184870|527575285|FG010|Initial Treatment|Moved to crossover treatment|0|||
146289496|NCT03184870|527575286|FG011|Initial Treatment|Moved to crossover treatment|0|||
146289497|NCT03184870|527575287|FG012|Initial Treatment|Moved to crossover treatment|9|||
146289498|NCT03184870|527575288|FG013|Initial Treatment|Moved to crossover treatment|0|||
146289499|NCT03184870|527575289|FG014|Initial Treatment|Moved to crossover treatment|0|||
146289500|NCT03184870|527575290|FG015|Initial Treatment|Moved to crossover treatment|0|||
146289501|NCT03184870|527575291|FG016|Initial Treatment|Moved to crossover treatment|0|||
146289502|NCT03184870|527575292|FG017|Initial Treatment|Moved to crossover treatment|0|||
146289503|NCT03184870|527575275|FG000|Crossover Treatment|Other reasons|0|||
146086301|NCT03997383|526837916|FG000|Double-blind Treatment Period|Death|4|||
146086302|NCT03997383|526837917|FG001|Double-blind Treatment Period|Death|4|||
146289504|NCT03184870|527575276|FG001|Crossover Treatment|Other reasons|0|||
146086303|NCT03997383|526837916|FG000|Double-blind Treatment Period|Physician Decision|2|||
146289505|NCT03184870|527575277|FG002|Crossover Treatment|Other reasons|0|||
146289506|NCT03184870|527575278|FG003|Crossover Treatment|Other reasons|0|||
146289507|NCT03184870|527575279|FG004|Crossover Treatment|Other reasons|0|||
146289508|NCT03184870|527575280|FG005|Crossover Treatment|Other reasons|0|||
146289509|NCT03184870|527575281|FG006|Crossover Treatment|Other reasons|0|||
146289510|NCT03184870|527575282|FG007|Crossover Treatment|Other reasons|0|||
146289511|NCT03184870|527575283|FG008|Crossover Treatment|Other reasons|0|||
146289512|NCT03184870|527575284|FG009|Crossover Treatment|Other reasons|0|||
146289513|NCT03184870|527575285|FG010|Crossover Treatment|Other reasons|0|||
146289514|NCT03184870|527575286|FG011|Crossover Treatment|Other reasons|0|||
146289515|NCT03184870|527575287|FG012|Crossover Treatment|Other reasons|0|||
146289516|NCT03184870|527575288|FG013|Crossover Treatment|Other reasons|0|||
146289517|NCT03184870|527575289|FG014|Crossover Treatment|Other reasons|0|||
146289518|NCT03184870|527575290|FG015|Crossover Treatment|Other reasons|0|||
146289519|NCT03184870|527575291|FG016|Crossover Treatment|Other reasons|0|||
146289520|NCT03184870|527575292|FG017|Crossover Treatment|Other reasons|2|||
146289521|NCT03184870|527575275|FG000|Crossover Treatment|Death|0|||
146086304|NCT03997383|526837917|FG001|Double-blind Treatment Period|Physician Decision|0|||
146289522|NCT03184870|527575276|FG001|Crossover Treatment|Death|0|||
146289523|NCT03184870|527575277|FG002|Crossover Treatment|Death|0|||
146289524|NCT03184870|527575278|FG003|Crossover Treatment|Death|0|||
146289525|NCT03184870|527575279|FG004|Crossover Treatment|Death|0|||
146289526|NCT03184870|527575280|FG005|Crossover Treatment|Death|0|||
146289527|NCT03184870|527575281|FG006|Crossover Treatment|Death|0|||
146289528|NCT03184870|527575282|FG007|Crossover Treatment|Death|0|||
146289529|NCT03184870|527575283|FG008|Crossover Treatment|Death|0|||
146289530|NCT03184870|527575284|FG009|Crossover Treatment|Death|0|||
146289531|NCT03184870|527575285|FG010|Crossover Treatment|Death|0|||
146289532|NCT03184870|527575286|FG011|Crossover Treatment|Death|0|||
146289533|NCT03184870|527575287|FG012|Crossover Treatment|Death|0|||
146289534|NCT03184870|527575288|FG013|Crossover Treatment|Death|0|||
146289535|NCT03184870|527575289|FG014|Crossover Treatment|Death|0|||
146289536|NCT03184870|527575290|FG015|Crossover Treatment|Death|0|||
146289537|NCT03184870|527575291|FG016|Crossover Treatment|Death|0|||
146289538|NCT03184870|527575292|FG017|Crossover Treatment|Death|7|||
146289539|NCT03786783|527575293|FG000|Overall Study|Death|1|||
146289540|NCT03786783|527575293|FG000|Overall Study|Physician Decision|6|||
146289541|NCT03786783|527575293|FG000|Overall Study|Withdrawal by Subject|2|||
146289542|NCT03786783|527575293|FG000|Overall Study|Disease Progression|7|||
146230340|NCT04330040|527360593|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
146230341|NCT02461134|527360595|FG000|Overall Study|Adverse Event|1|||
146230342|NCT04499521|527360598|FG000|Overall Study|Disease Progression|1|||
146230343|NCT04499521|527360599|FG001|Overall Study|Disease Progression|0|||
146230344|NCT03734029|527360600|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
146230345|NCT03734029|527360601|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
146230346|NCT03734029|527360600|FG000|Overall Study|Adverse Event|60|||
146230347|NCT03734029|527360601|FG001|Overall Study|Adverse Event|14|||
146230348|NCT03734029|527360600|FG000|Overall Study|Withdrawal by Subject|12|||
146230349|NCT03734029|527360601|FG001|Overall Study|Withdrawal by Subject|11|||
146230350|NCT03734029|527360600|FG000|Overall Study|Clinical progression by investigator|10|||
146230351|NCT03734029|527360601|FG001|Overall Study|Clinical progression by investigator|8|||
146230352|NCT03734029|527360600|FG000|Overall Study|Death|5|||
146289543|NCT03786783|527575293|FG000|Overall Study|Patient/Parent Refusal|4|||
146289544|NCT04754477|527575294|FG000|Overall Study|Withdrawal by Subject|1|||
146289545|NCT06469242|527575295|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
146289546|NCT06469242|527575296|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
146289547|NCT06469242|527575295|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
146289548|NCT06469242|527575296|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
146289549|NCT00690820|527575297|FG000|Period 1|Withdrawal by Subject|0|||
146289550|NCT00690820|527575298|FG001|Period 1|Withdrawal by Subject|1|||
146289551|NCT05333224|527575299|FG000|Overall Study - Infants|Lost to Follow-up|1|||
146289552|NCT05333224|527575300|FG001|Overall Study - Infants|Lost to Follow-up|1|||
146289553|NCT01768117|527575302|FG000|Overall Study|Lost to Follow-up|1|||
146289554|NCT01768117|527575302|FG000|Overall Study|Withdrawal by Subject|2|||
146289555|NCT01768117|527575302|FG000|Overall Study|Protocol Violation|3|||
146289556|NCT00966277|527575304|FG000|Overall Study|Withdrawal by Subject|3|||
146289557|NCT00966277|527575305|FG001|Overall Study|Withdrawal by Subject|0|||
146289558|NCT00966277|527575304|FG000|Overall Study|Ineligible|1|||
146289559|NCT00966277|527575305|FG001|Overall Study|Ineligible|3|||
146289560|NCT00966277|527575304|FG000|Overall Study|Treatment Plan Changed|0|||
146289561|NCT00966277|527575305|FG001|Overall Study|Treatment Plan Changed|1|||
146289562|NCT03881553|527575309|FG000|Overall Study|Discharged prior to participation|1|||
146289563|NCT03881553|527575310|FG001|Overall Study|Discharged prior to participation|1|||
146289564|NCT03881553|527575311|FG002|Overall Study|Discharged prior to participation|0|||
146289565|NCT03881553|527575309|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
146289566|NCT03881553|527575310|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
146289567|NCT03881553|527575311|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
146289568|NCT01718353|527575312|FG000|Overall Study|Lost to Follow-up|0|||
146289569|NCT01718353|527575313|FG001|Overall Study|Lost to Follow-up|1|||
146289570|NCT01718353|527575312|FG000|Overall Study|Principal Investigator's Decision|10|||
146289571|NCT01718353|527575313|FG001|Overall Study|Principal Investigator's Decision|4|||
146289572|NCT01718353|527575312|FG000|Overall Study|Randomized but not treated|2|||
146289573|NCT01718353|527575313|FG001|Overall Study|Randomized but not treated|0|||
146289574|NCT01959516|527575314|FG000|Epoch 1|Adverse Event|4|||
146289575|NCT01959516|527575315|FG001|Epoch 1|Adverse Event|1|||
146289576|NCT01959516|527575314|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
146289577|NCT01959516|527575315|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
146289578|NCT01959516|527575314|FG000|Epoch 1|Subject withdrew consent|3|||
146289579|NCT01959516|527575315|FG001|Epoch 1|Subject withdrew consent|2|||
146289580|NCT01959516|527575314|FG000|Epoch 1|Administrative problems|1|||
146289581|NCT01959516|527575315|FG001|Epoch 1|Administrative problems|0|||
146289582|NCT01959516|527575314|FG000|Epoch 1|Use of prohibited treatment|1|||
146289583|NCT01959516|527575315|FG001|Epoch 1|Use of prohibited treatment|0|||
146289584|NCT01959516|527575314|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
146289585|NCT01959516|527575315|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
146289586|NCT01959516|527575314|FG000|Epoch 1|Protocol deviation|0|||
146230353|NCT03734029|527360601|FG001|Overall Study|Death|2|||
146289587|NCT01959516|527575315|FG001|Epoch 1|Protocol deviation|1|||
146289588|NCT01959516|527575314|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
146289589|NCT01959516|527575315|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
146086305|NCT03997383|526837916|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
146086306|NCT03997383|526837917|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
146230354|NCT03734029|527360600|FG000|Overall Study|Physician Decision|4|||
146230355|NCT03734029|527360601|FG001|Overall Study|Physician Decision|3|||
146230356|NCT03734029|527360600|FG000|Overall Study|Other|2|||
146230357|NCT03734029|527360601|FG001|Overall Study|Other|0|||
146230358|NCT03734029|527360600|FG000|Overall Study|Lost to Follow-up|0|||
146230359|NCT03734029|527360601|FG001|Overall Study|Lost to Follow-up|1|||
146230360|NCT03734029|527360600|FG000|Overall Study|Randomized, but not treated|2|||
146230361|NCT03734029|527360601|FG001|Overall Study|Randomized, but not treated|12|||
146230362|NCT04244175|527361317|FG000|Overall Study|Adverse Event|3|||
146230363|NCT04244175|527361318|FG001|Overall Study|Adverse Event|2|||
146230364|NCT04244175|527361319|FG002|Overall Study|Adverse Event|5|||
146230365|NCT04244175|527361317|FG000|Overall Study|Lack of Efficacy|1|||
146230366|NCT04244175|527361318|FG001|Overall Study|Lack of Efficacy|0|||
146230367|NCT04244175|527361319|FG002|Overall Study|Lack of Efficacy|1|||
146230368|NCT04244175|527361317|FG000|Overall Study|Lost to Follow-up|1|||
146230369|NCT04244175|527361318|FG001|Overall Study|Lost to Follow-up|0|||
146230370|NCT04244175|527361319|FG002|Overall Study|Lost to Follow-up|0|||
146230371|NCT04244175|527361317|FG000|Overall Study|Non-compliance with study drug|1|||
146230372|NCT04244175|527361318|FG001|Overall Study|Non-compliance with study drug|0|||
146230373|NCT04244175|527361319|FG002|Overall Study|Non-compliance with study drug|1|||
146230374|NCT04244175|527361317|FG000|Overall Study|Protocol deviation|0|||
146230375|NCT04244175|527361318|FG001|Overall Study|Protocol deviation|1|||
146230376|NCT04244175|527361319|FG002|Overall Study|Protocol deviation|0|||
146230377|NCT04244175|527361317|FG000|Overall Study|Withdrawal by Subject|1|||
146230378|NCT04244175|527361318|FG001|Overall Study|Withdrawal by Subject|3|||
146230379|NCT04244175|527361319|FG002|Overall Study|Withdrawal by Subject|1|||
146230380|NCT04244175|527361317|FG000|Overall Study|Other, not specified|0|||
146230381|NCT04244175|527361318|FG001|Overall Study|Other, not specified|1|||
146230382|NCT04244175|527361319|FG002|Overall Study|Other, not specified|2|||
146230383|NCT04427007|527361320|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
146230384|NCT04427007|527361321|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
146230385|NCT04165213|527361332|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
146230386|NCT04165213|527361333|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
146230387|NCT04165213|527361332|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
146230388|NCT04165213|527361333|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
146230389|NCT04165213|527361332|FG000|Clinician Enrollment|Termination from site|0|||
146230390|NCT04165213|527361333|FG001|Clinician Enrollment|Termination from site|1|||
146230391|NCT04165213|527361332|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
146230392|NCT04165213|527361333|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
146230393|NCT04165213|527361332|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
146230394|NCT04165213|527361333|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
146230395|NCT04165213|527361332|FG000|Caregiver Enrollment|Physician Decision|1|||
146230396|NCT04165213|527361333|FG001|Caregiver Enrollment|Physician Decision|0|||
146230397|NCT04165213|527361332|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
146230398|NCT04165213|527361333|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
146230399|NCT04165213|527361332|FG000|Caregiver Enrollment|PLWD death|2|||
146230400|NCT04165213|527361333|FG001|Caregiver Enrollment|PLWD death|0|||
146230401|NCT04165213|527361332|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
146230402|NCT04165213|527361333|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
146230403|NCT04165213|527361332|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
146230404|NCT04165213|527361333|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
146230405|NCT04165213|527361332|FG000|PLWD Enrollment|Lost to Follow-up|1|||
146230406|NCT04165213|527361333|FG001|PLWD Enrollment|Lost to Follow-up|1|||
146230407|NCT04165213|527361332|FG000|PLWD Enrollment|Physician Decision|1|||
146230408|NCT04165213|527361333|FG001|PLWD Enrollment|Physician Decision|0|||
146230409|NCT04165213|527361332|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
146230410|NCT04165213|527361333|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
146086307|NCT03997383|526837916|FG000|Open-label Extension Period|Ongoing|148|||
145963174|NCT01921517|526378066|FG001|Overall Study|Subject missed final imaging|4|||
146230411|NCT04165213|527361332|FG000|PLWD Enrollment|Death|2|||
146230412|NCT04165213|527361333|FG001|PLWD Enrollment|Death|0|||
146230413|NCT04165213|527361332|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
146230414|NCT04165213|527361333|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
146230415|NCT04464564|527361334|FG000|Period A (Placebo lead-in)|Other|5|||
146230416|NCT04464564|527361335|FG001|Period A (Placebo lead-in)|Other|0|||
146230417|NCT04464564|527361336|FG002|Period A (Placebo lead-in)|Other|0|||
146230418|NCT04464564|527361337|FG003|Period A (Placebo lead-in)|Other|0|||
146230419|NCT04464564|527361334|FG000|Period B (Randomization Period)|Adverse Event|0|||
146230420|NCT04464564|527361335|FG001|Period B (Randomization Period)|Adverse Event|1|||
146230421|NCT04464564|527361336|FG002|Period B (Randomization Period)|Adverse Event|2|||
146230422|NCT04464564|527361337|FG003|Period B (Randomization Period)|Adverse Event|8|||
146230423|NCT04464564|527361334|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
146230424|NCT04464564|527361335|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
146230425|NCT04464564|527361336|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
146230426|NCT04464564|527361337|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
146230427|NCT04464564|527361334|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
146230428|NCT04464564|527361335|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
146230429|NCT04464564|527361336|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
146230430|NCT04464564|527361337|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
146230431|NCT04464564|527361334|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
146230432|NCT04464564|527361335|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
146230433|NCT04464564|527361336|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
146230434|NCT04464564|527361337|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
146230435|NCT04464564|527361334|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
146230436|NCT04464564|527361335|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
146230437|NCT04464564|527361336|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
146230438|NCT04464564|527361337|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
146230439|NCT04464564|527361334|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
146230440|NCT04464564|527361335|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
146230441|NCT04464564|527361336|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
146230442|NCT04464564|527361337|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
146230443|NCT04464564|527361334|FG000|Period B (Randomization Period)|Reason not Specified|0|||
146230444|NCT04464564|527361335|FG001|Period B (Randomization Period)|Reason not Specified|3|||
146230445|NCT04464564|527361336|FG002|Period B (Randomization Period)|Reason not Specified|3|||
146230446|NCT04464564|527361337|FG003|Period B (Randomization Period)|Reason not Specified|3|||
146230447|NCT04282980|527361340|FG000|Overall Study|Remained on treatment|6|||
146230448|NCT04282980|527361340|FG000|Overall Study|Survival follow-up|11|||
146230449|NCT04282980|527361340|FG000|Overall Study|Withdrawal of informed consent|1|||
146230450|NCT04282980|527361340|FG000|Overall Study|Lost to Follow-up|1|||
146230451|NCT05007080|527361341|FG000|Overall Study|Lost to Follow-up|0|||
146230452|NCT05007080|527361342|FG001|Overall Study|Lost to Follow-up|1|||
146230453|NCT05007080|527361343|FG002|Overall Study|Lost to Follow-up|0|||
146230454|NCT05007080|527361344|FG003|Overall Study|Lost to Follow-up|1|||
146230455|NCT05007080|527361345|FG004|Overall Study|Lost to Follow-up|1|||
146230456|NCT05007080|527361346|FG005|Overall Study|Lost to Follow-up|1|||
146230457|NCT05007080|527361341|FG000|Overall Study|Death|0|||
146230458|NCT05007080|527361342|FG001|Overall Study|Death|1|||
146230459|NCT05007080|527361343|FG002|Overall Study|Death|0|||
146230460|NCT05007080|527361344|FG003|Overall Study|Death|0|||
146230461|NCT05007080|527361345|FG004|Overall Study|Death|0|||
146230462|NCT05007080|527361346|FG005|Overall Study|Death|0|||
146230463|NCT05007080|527361341|FG000|Overall Study|Withdrawal by Subject|1|||
146289590|NCT01959516|527575314|FG000|Epoch 2|Subject withdrew consent|1|||
146289591|NCT01959516|527575315|FG001|Epoch 2|Subject withdrew consent|0|||
146289592|NCT01959516|527575314|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
146289593|NCT01959516|527575315|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
146289594|NCT01477333|527575316|FG000|Overall Study|Adverse Event|1|||
146289595|NCT01477333|527575316|FG000|Overall Study|Withdrawal by Subject|1|||
146289596|NCT01477333|527575316|FG000|Overall Study|Clinical Deterioration|1|||
146289597|NCT00455325|527575317|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
146289598|NCT00455325|527575318|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
146289599|NCT00455325|527575319|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
146289600|NCT00455325|527575320|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
146289601|NCT00455325|527575317|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
146289602|NCT00455325|527575318|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
146289603|NCT00455325|527575319|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
146289604|NCT00455325|527575320|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
146289605|NCT00455325|527575317|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
146289606|NCT00455325|527575318|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
146289607|NCT00455325|527575319|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
146289608|NCT00455325|527575320|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
146289609|NCT00455325|527575317|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
146289610|NCT00455325|527575318|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146289611|NCT00455325|527575319|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146289612|NCT00455325|527575320|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
146289613|NCT00455325|527575317|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
146289614|NCT00455325|527575318|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
146289615|NCT00455325|527575319|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
146289616|NCT00455325|527575320|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
145963175|NCT04069715|526378069|FG000|Overall Study|Lost to Follow-up|1|||
145963176|NCT04069715|526378070|FG001|Overall Study|Lost to Follow-up|1|||
146230464|NCT05007080|527361342|FG001|Overall Study|Withdrawal by Subject|2|||
146230465|NCT05007080|527361343|FG002|Overall Study|Withdrawal by Subject|0|||
146230466|NCT05007080|527361344|FG003|Overall Study|Withdrawal by Subject|2|||
146230467|NCT05007080|527361345|FG004|Overall Study|Withdrawal by Subject|1|||
146230468|NCT05007080|527361346|FG005|Overall Study|Withdrawal by Subject|1|||
146230469|NCT05007080|527361341|FG000|Overall Study|Other|1|||
146230470|NCT05007080|527361342|FG001|Overall Study|Other|0|||
145963177|NCT04069715|526378069|FG000|Overall Study|Physician Decision|1|||
146230471|NCT05007080|527361343|FG002|Overall Study|Other|1|||
146230472|NCT05007080|527361344|FG003|Overall Study|Other|1|||
146230473|NCT05007080|527361345|FG004|Overall Study|Other|0|||
146230474|NCT05007080|527361346|FG005|Overall Study|Other|2|||
146230475|NCT05007080|527361341|FG000|Overall Study|Randomized not vaccinated|0|||
146230476|NCT05007080|527361342|FG001|Overall Study|Randomized not vaccinated|0|||
146230477|NCT05007080|527361343|FG002|Overall Study|Randomized not vaccinated|0|||
146230478|NCT05007080|527361344|FG003|Overall Study|Randomized not vaccinated|0|||
146230479|NCT05007080|527361345|FG004|Overall Study|Randomized not vaccinated|0|||
146230480|NCT05007080|527361346|FG005|Overall Study|Randomized not vaccinated|1|||
146230481|NCT04173247|527361350|FG000|Overall Study|Withdrawal by Subject|0|||
146230482|NCT04173247|527361351|FG001|Overall Study|Withdrawal by Subject|2|||
146230483|NCT04173247|527361350|FG000|Overall Study|Death|1|||
146230484|NCT04173247|527361351|FG001|Overall Study|Death|0|||
146230485|NCT04173247|527361350|FG000|Overall Study|Physician Decision|1|||
146230486|NCT04173247|527361351|FG001|Overall Study|Physician Decision|0|||
146230487|NCT02163694|527361352|FG000|Overall Study|Adverse event- related to progression|4|||
146230488|NCT02163694|527361353|FG001|Overall Study|Adverse event- related to progression|10|||
146230489|NCT02163694|527361352|FG000|Overall Study|Adverse event- not related to progression|7|||
146230490|NCT02163694|527361353|FG001|Overall Study|Adverse event- not related to progression|22|||
146230491|NCT02163694|527361352|FG000|Overall Study|Withdrew consent|13|||
146230492|NCT02163694|527361353|FG001|Overall Study|Withdrew consent|28|||
146230493|NCT02163694|527361352|FG000|Overall Study|Lost to Follow-up|2|||
146230494|NCT02163694|527361353|FG001|Overall Study|Lost to Follow-up|2|||
146230495|NCT02163694|527361352|FG000|Overall Study|Sponsor discontinued study|3|||
146230496|NCT02163694|527361353|FG001|Overall Study|Sponsor discontinued study|29|||
146230497|NCT02163694|527361352|FG000|Overall Study|Progressive disease per protocol|125|||
146230498|NCT02163694|527361353|FG001|Overall Study|Progressive disease per protocol|224|||
146230499|NCT02163694|527361352|FG000|Overall Study|Other, not specified|17|||
146230500|NCT02163694|527361353|FG001|Overall Study|Other, not specified|22|||
146230501|NCT02163694|527361352|FG000|Overall Study|Randomized but Not Treated|1|||
146230502|NCT02163694|527361353|FG001|Overall Study|Randomized but Not Treated|0|||
146230503|NCT02163694|527361352|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
146230504|NCT02163694|527361353|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
146230505|NCT03884101|527361354|FG000|Overall Study|Participant Ongoing in Study|202|||
146230506|NCT03884101|527361355|FG001|Overall Study|Participant Ongoing in Study|186|||
146230507|NCT03884101|527361354|FG000|Overall Study|Death|212|||
146230508|NCT03884101|527361355|FG001|Overall Study|Death|224|||
146230509|NCT03884101|527361354|FG000|Overall Study|Lost to Follow-up|0|||
146230510|NCT03884101|527361355|FG001|Overall Study|Lost to Follow-up|1|||
146230511|NCT03884101|527361354|FG000|Overall Study|Withdrawal by Subject|6|||
146230512|NCT03884101|527361355|FG001|Overall Study|Withdrawal by Subject|11|||
146230513|NCT03370913|527361356|FG000|Overall Study|Death|1|||
146230514|NCT03370913|527361356|FG000|Overall Study|Lost to Follow-up|1|||
146230515|NCT04967599|527361359|FG000|Overall Study|Lost to Follow-up|35|||
146289617|NCT00455325|527575317|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146289618|NCT00455325|527575318|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
146289619|NCT00455325|527575319|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146289620|NCT00455325|527575320|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
146289621|NCT00455325|527575317|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146289622|NCT00455325|527575318|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146289623|NCT00455325|527575319|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
146289624|NCT00455325|527575320|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
146289625|NCT04620811|527575321|FG000|Overall Study|Withdrawal by Subject|18|||
146289626|NCT04620811|527575322|FG001|Overall Study|Withdrawal by Subject|15|||
146289627|NCT04620811|527575321|FG000|Overall Study|Adverse Event|6|||
146289628|NCT04620811|527575322|FG001|Overall Study|Adverse Event|11|||
145963178|NCT04069715|526378070|FG001|Overall Study|Physician Decision|1|||
145963179|NCT04069715|526378069|FG000|Overall Study|Withdrawal by Subject|3|||
145963180|NCT04069715|526378070|FG001|Overall Study|Withdrawal by Subject|3|||
146289629|NCT04620811|527575321|FG000|Overall Study|Lost to Follow-up|4|||
146230516|NCT04967599|527361360|FG001|Overall Study|Lost to Follow-up|19|||
146230517|NCT04967599|527361361|FG002|Overall Study|Lost to Follow-up|23|||
146230518|NCT04369911|527361362|FG000|Overall Study|Lost to Follow-up|3|||
146230519|NCT04369911|527361363|FG001|Overall Study|Lost to Follow-up|3|||
146230520|NCT04369911|527361362|FG000|Overall Study|Withdrawal by Subject|1|||
146230521|NCT04369911|527361363|FG001|Overall Study|Withdrawal by Subject|2|||
146230522|NCT02624050|527361368|FG000|Overall Study|Physician Decision|4|||
146230523|NCT02624050|527361369|FG001|Overall Study|Physician Decision|0|||
146230524|NCT02624050|527361368|FG000|Overall Study|Protocol Violation|2|||
146230525|NCT02624050|527361369|FG001|Overall Study|Protocol Violation|0|||
146230526|NCT03279978|527361371|FG000|Overall Study|Withdrawal by Subject|0|||
146230527|NCT03279978|527361372|FG001|Overall Study|Withdrawal by Subject|1|||
146230528|NCT03279978|527361373|FG002|Overall Study|Withdrawal by Subject|0|||
146230529|NCT03279978|527361374|FG003|Overall Study|Withdrawal by Subject|0|||
146230530|NCT03279978|527361375|FG004|Overall Study|Withdrawal by Subject|0|||
146230531|NCT03279978|527361376|FG005|Overall Study|Withdrawal by Subject|0|||
146230532|NCT03279978|527361377|FG006|Overall Study|Withdrawal by Subject|0|||
146230533|NCT03279978|527361378|FG007|Overall Study|Withdrawal by Subject|0|||
146230534|NCT03279978|527361379|FG008|Overall Study|Withdrawal by Subject|0|||
146230535|NCT03279978|527361380|FG009|Overall Study|Withdrawal by Subject|1|||
146230536|NCT03279978|527361371|FG000|Overall Study|Lost to Follow-up|1|||
146230537|NCT03279978|527361372|FG001|Overall Study|Lost to Follow-up|0|||
146230538|NCT03279978|527361373|FG002|Overall Study|Lost to Follow-up|1|||
146230539|NCT03279978|527361374|FG003|Overall Study|Lost to Follow-up|0|||
146230540|NCT03279978|527361375|FG004|Overall Study|Lost to Follow-up|0|||
146230541|NCT03279978|527361376|FG005|Overall Study|Lost to Follow-up|0|||
146230542|NCT03279978|527361377|FG006|Overall Study|Lost to Follow-up|0|||
146230543|NCT03279978|527361378|FG007|Overall Study|Lost to Follow-up|0|||
146230544|NCT03279978|527361379|FG008|Overall Study|Lost to Follow-up|0|||
146230545|NCT03279978|527361380|FG009|Overall Study|Lost to Follow-up|0|||
146230546|NCT03279978|527361371|FG000|Overall Study|Other than stated above|0|||
146230547|NCT03279978|527361372|FG001|Overall Study|Other than stated above|0|||
146230548|NCT03279978|527361373|FG002|Overall Study|Other than stated above|0|||
146230549|NCT03279978|527361374|FG003|Overall Study|Other than stated above|0|||
146230550|NCT03279978|527361375|FG004|Overall Study|Other than stated above|0|||
146230551|NCT03279978|527361376|FG005|Overall Study|Other than stated above|0|||
146230552|NCT03279978|527361377|FG006|Overall Study|Other than stated above|1|||
146230553|NCT03279978|527361378|FG007|Overall Study|Other than stated above|0|||
146230554|NCT03279978|527361379|FG008|Overall Study|Other than stated above|0|||
146230555|NCT03279978|527361380|FG009|Overall Study|Other than stated above|0|||
146230556|NCT03493542|527361381|FG000|Base Study|Withdrawal by Subject|0|||
146230557|NCT03493542|527361382|FG001|Base Study|Withdrawal by Subject|4|||
146230558|NCT03493542|527361383|FG002|Base Study|Withdrawal by Subject|0|||
146230559|NCT03493542|527361381|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
146230560|NCT03493542|527361382|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
146230561|NCT03493542|527361383|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
146230562|NCT03493542|527361381|FG000|Extension Study|Withdrawal by Subject|0|||
146230563|NCT03493542|527361382|FG001|Extension Study|Withdrawal by Subject|0|||
146230564|NCT03493542|527361383|FG002|Extension Study|Withdrawal by Subject|25|||
146230565|NCT01756300|527361389|FG000|Overall Study|Death|1|||
146230566|NCT01756300|527361389|FG000|Overall Study|Withdrawal by Subject|1|||
146230567|NCT02095691|527362058|FG000|Overall Study|Physician Decision|1|||
146230568|NCT00887198|527362059|FG000|Randomized Period|Ongoing|42|||
146230569|NCT00887198|527362060|FG001|Randomized Period|Ongoing|0|||
146230570|NCT00887198|527362061|FG002|Randomized Period|Ongoing|0|||
146230571|NCT00887198|527362059|FG000|Randomized Period|Adverse Event|50|||
146230572|NCT00887198|527362060|FG001|Randomized Period|Adverse Event|33|||
146230573|NCT00887198|527362061|FG002|Randomized Period|Adverse Event|0|||
146230574|NCT00887198|527362059|FG000|Randomized Period|Lost to Follow-up|1|||
146230575|NCT00887198|527362060|FG001|Randomized Period|Lost to Follow-up|0|||
146230576|NCT00887198|527362061|FG002|Randomized Period|Lost to Follow-up|0|||
146230577|NCT00887198|527362059|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
146230578|NCT00887198|527362060|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
146230579|NCT00887198|527362061|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
146230580|NCT00887198|527362059|FG000|Randomized Period|Withdrawal by Subject|41|||
146230581|NCT00887198|527362060|FG001|Randomized Period|Withdrawal by Subject|56|||
146230582|NCT00887198|527362061|FG002|Randomized Period|Withdrawal by Subject|0|||
146230583|NCT00887198|527362059|FG000|Randomized Period|Progressive disease|366|||
146230584|NCT00887198|527362060|FG001|Randomized Period|Progressive disease|370|||
146230585|NCT00887198|527362061|FG002|Randomized Period|Progressive disease|0|||
146230586|NCT00887198|527362059|FG000|Randomized Period|Other|42|||
146230587|NCT00887198|527362060|FG001|Randomized Period|Other|30|||
146230588|NCT00887198|527362061|FG002|Randomized Period|Other|0|||
146230589|NCT00887198|527362059|FG000|Randomized Period|Randomized, Not treated|4|||
146230590|NCT00887198|527362060|FG001|Randomized Period|Randomized, Not treated|2|||
146230591|NCT00887198|527362061|FG002|Randomized Period|Randomized, Not treated|0|||
146289630|NCT04620811|527575322|FG001|Overall Study|Lost to Follow-up|8|||
146289631|NCT04620811|527575321|FG000|Overall Study|Physician Decision|1|||
146289632|NCT04620811|527575322|FG001|Overall Study|Physician Decision|4|||
146289633|NCT04620811|527575321|FG000|Overall Study|Sponsor Decision|0|||
146289634|NCT04620811|527575322|FG001|Overall Study|Sponsor Decision|1|||
146289635|NCT04620811|527575321|FG000|Overall Study|Elevation of ALT or AST|1|||
146289636|NCT04620811|527575322|FG001|Overall Study|Elevation of ALT or AST|0|||
146289637|NCT04620811|527575321|FG000|Overall Study|Other|3|||
146289638|NCT04620811|527575322|FG001|Overall Study|Other|5|||
146289639|NCT01078675|527575324|FG000|Overall Study|Withdrawal by Subject|7|||
146289640|NCT01078675|527575325|FG001|Overall Study|Withdrawal by Subject|3|||
146289641|NCT01078675|527575324|FG000|Overall Study|Protocol Violation|56|||
146289642|NCT01078675|527575325|FG001|Overall Study|Protocol Violation|0|||
146289643|NCT01078675|527575324|FG000|Overall Study|Provided in CRF for specific reasons|2|||
146289644|NCT01078675|527575325|FG001|Overall Study|Provided in CRF for specific reasons|3|||
146289645|NCT01078675|527575324|FG000|Overall Study|Adverse Event|3|||
146289646|NCT01078675|527575325|FG001|Overall Study|Adverse Event|0|||
146289647|NCT00928746|527575334|FG000|Overall Study|Adverse Event|2|||
146289648|NCT00928746|527575334|FG000|Overall Study|Protocol Violation|1|||
146289649|NCT00928746|527575334|FG000|Overall Study|Withdrawal by Subject|1|||
146289650|NCT00928746|527575334|FG000|Overall Study|Other|2|||
146230592|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
146230593|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
146230594|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
146230595|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
146230596|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
146230597|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
146230598|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
146230599|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
146230600|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
146230601|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
146230602|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
146230603|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
146230604|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
146230605|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
146230606|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
146230607|NCT00887198|527362059|FG000|Cross Over (Placebo to AA)|Other|0|||
146230608|NCT00887198|527362060|FG001|Cross Over (Placebo to AA)|Other|0|||
146230609|NCT00887198|527362061|FG002|Cross Over (Placebo to AA)|Other|19|||
146230610|NCT05147584|527362062|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
146230611|NCT05830799|527362068|FG000|Overall Study|Withdrawal by Subject|1|||
146230612|NCT04560179|527362071|FG000|Overall Study|Physician Decision|1|||
146230613|NCT04560179|527362072|FG001|Overall Study|Physician Decision|0|||
146230614|NCT04560179|527362073|FG002|Overall Study|Physician Decision|0|||
146230615|NCT04560179|527362074|FG003|Overall Study|Physician Decision|0|||
146230616|NCT04560179|527362075|FG004|Overall Study|Physician Decision|0|||
146230617|NCT04560179|527362071|FG000|Overall Study|Adverse Event|0|||
146230618|NCT04560179|527362072|FG001|Overall Study|Adverse Event|0|||
146230619|NCT04560179|527362073|FG002|Overall Study|Adverse Event|0|||
146230620|NCT04560179|527362074|FG003|Overall Study|Adverse Event|1|||
146230621|NCT04560179|527362075|FG004|Overall Study|Adverse Event|0|||
146230622|NCT04214418|527362076|FG000|Overall Study|Withdrawal by Subject|1|||
146230623|NCT04214418|527362077|FG001|Overall Study|Withdrawal by Subject|0|||
146230624|NCT04214418|527362078|FG002|Overall Study|Withdrawal by Subject|0|||
146230625|NCT04214418|527362079|FG003|Overall Study|Withdrawal by Subject|0|||
146230626|NCT04214418|527362080|FG004|Overall Study|Withdrawal by Subject|0|||
146230627|NCT04214418|527362081|FG005|Overall Study|Withdrawal by Subject|0|||
146230628|NCT04214418|527362076|FG000|Overall Study|Adverse Event|0|||
146230629|NCT04214418|527362077|FG001|Overall Study|Adverse Event|2|||
146230630|NCT04214418|527362078|FG002|Overall Study|Adverse Event|0|||
146230631|NCT04214418|527362079|FG003|Overall Study|Adverse Event|0|||
146230632|NCT04214418|527362080|FG004|Overall Study|Adverse Event|0|||
146230633|NCT04214418|527362081|FG005|Overall Study|Adverse Event|0|||
146289651|NCT02004353|527575337|FG000|Overall Study|Voluntary participation|1334|||
146289652|NCT01759368|527575347|FG000|Overall Study|Lost to Follow-up|1|||
146289653|NCT01759368|527575348|FG001|Overall Study|Lost to Follow-up|0|||
146289654|NCT03110185|527575350|FG000|Overall Study|Death|0|||
146289655|NCT03110185|527575351|FG001|Overall Study|Death|1|||
146230634|NCT04214418|527362076|FG000|Overall Study|Death|1|||
146230635|NCT04214418|527362077|FG001|Overall Study|Death|0|||
146230636|NCT04214418|527362078|FG002|Overall Study|Death|0|||
146230637|NCT04214418|527362079|FG003|Overall Study|Death|0|||
146230638|NCT04214418|527362080|FG004|Overall Study|Death|0|||
146230639|NCT04214418|527362081|FG005|Overall Study|Death|0|||
146230640|NCT05454514|527362089|FG000|Overall Study|Withdrawal by Subject|4|||
146289656|NCT03110185|527575350|FG000|Overall Study|Withdrawal by Subject|2|||
146289657|NCT03110185|527575351|FG001|Overall Study|Withdrawal by Subject|7|||
145963181|NCT03205150|526378071|FG000|Overall Study|Protocol deviation|1|||
146230641|NCT05541484|527362092|FG000|Overall Study|Withdrawal by Subject|1|||
146230642|NCT05541484|527362093|FG001|Overall Study|Withdrawal by Subject|0|||
146230643|NCT05785130|527362096|FG000|Overall Study|Withdrawal by Subject|1|||
146230644|NCT05785130|527362097|FG001|Overall Study|Withdrawal by Subject|0|||
146230645|NCT05785130|527362096|FG000|Overall Study|Lack of Efficacy|0|||
146230646|NCT05785130|527362097|FG001|Overall Study|Lack of Efficacy|1|||
146230647|NCT04157517|527362098|FG000|Overall Study|Death|1|||
146230648|NCT04157517|527362099|FG001|Overall Study|Death|2|||
146230649|NCT04157517|527362100|FG002|Overall Study|Death|2|||
146230650|NCT04157517|527362101|FG003|Overall Study|Death|3|||
146230651|NCT04157517|527362102|FG004|Overall Study|Death|3|||
146230652|NCT04157517|527362103|FG005|Overall Study|Death|4|||
146230653|NCT04157517|527362104|FG006|Overall Study|Death|1|||
146230654|NCT04157517|527362105|FG007|Overall Study|Death|2|||
146230655|NCT04157517|527362106|FG008|Overall Study|Death|4|||
146230656|NCT04157517|527362107|FG009|Overall Study|Death|0|||
146230657|NCT04157517|527362098|FG000|Overall Study|Withdrawal by Subject|1|||
146230658|NCT04157517|527362099|FG001|Overall Study|Withdrawal by Subject|1|||
146230659|NCT04157517|527362100|FG002|Overall Study|Withdrawal by Subject|1|||
146230660|NCT04157517|527362101|FG003|Overall Study|Withdrawal by Subject|0|||
146230661|NCT04157517|527362102|FG004|Overall Study|Withdrawal by Subject|0|||
146230662|NCT04157517|527362103|FG005|Overall Study|Withdrawal by Subject|1|||
146230663|NCT04157517|527362104|FG006|Overall Study|Withdrawal by Subject|0|||
146230664|NCT04157517|527362105|FG007|Overall Study|Withdrawal by Subject|0|||
146230665|NCT04157517|527362106|FG008|Overall Study|Withdrawal by Subject|1|||
146230666|NCT04157517|527362107|FG009|Overall Study|Withdrawal by Subject|0|||
146230667|NCT04157517|527362098|FG000|Overall Study|Other|1|||
146230668|NCT04157517|527362099|FG001|Overall Study|Other|0|||
146230669|NCT04157517|527362100|FG002|Overall Study|Other|0|||
146230670|NCT04157517|527362101|FG003|Overall Study|Other|0|||
146230671|NCT04157517|527362102|FG004|Overall Study|Other|0|||
146230672|NCT04157517|527362103|FG005|Overall Study|Other|1|||
146230673|NCT04157517|527362104|FG006|Overall Study|Other|2|||
146230674|NCT04157517|527362105|FG007|Overall Study|Other|7|||
146230675|NCT04157517|527362106|FG008|Overall Study|Other|7|||
146230676|NCT04157517|527362107|FG009|Overall Study|Other|0|||
146230677|NCT04159519|527362112|FG000|Overall Study|Adverse Event|1|||
146230678|NCT04159519|527362113|FG001|Overall Study|Adverse Event|1|||
146230679|NCT04159519|527362112|FG000|Overall Study|Lack of Efficacy|1|||
146230680|NCT04159519|527362113|FG001|Overall Study|Lack of Efficacy|0|||
146230681|NCT04159519|527362112|FG000|Overall Study|Discontinued from study|1|||
146230682|NCT04159519|527362113|FG001|Overall Study|Discontinued from study|0|||
146230683|NCT04159519|527362112|FG000|Overall Study|Protocol Violation|1|||
146230684|NCT04159519|527362113|FG001|Overall Study|Protocol Violation|1|||
146230685|NCT04159519|527362112|FG000|Overall Study|Withdrawal by Subject|4|||
146230686|NCT04159519|527362113|FG001|Overall Study|Withdrawal by Subject|4|||
146230687|NCT04780581|527362114|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
146230688|NCT04780581|527362115|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
145963182|NCT03205150|526378072|FG001|Overall Study|Protocol deviation|3|||
146230689|NCT04780581|527362114|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
146230690|NCT04780581|527362115|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
146230691|NCT01651000|527362116|FG000|Overall Study|Adverse Event|2|||
145963183|NCT03205150|526378073|FG002|Overall Study|Protocol deviation|0|||
146230692|NCT01651000|527362117|FG001|Overall Study|Adverse Event|8|||
146230693|NCT01651000|527362116|FG000|Overall Study|Lost to Follow-up|3|||
146230694|NCT01651000|527362117|FG001|Overall Study|Lost to Follow-up|2|||
146230695|NCT01651000|527362116|FG000|Overall Study|Protocol Violation|0|||
146230696|NCT01651000|527362117|FG001|Overall Study|Protocol Violation|3|||
146230697|NCT01651000|527362116|FG000|Overall Study|Withdrawal by Subject|2|||
146230698|NCT01651000|527362117|FG001|Overall Study|Withdrawal by Subject|10|||
146230699|NCT01651000|527362116|FG000|Overall Study|Subject noncompliance|0|||
146230700|NCT01651000|527362117|FG001|Overall Study|Subject noncompliance|3|||
146230701|NCT01651000|527362116|FG000|Overall Study|Lack of Efficacy|1|||
146230702|NCT01651000|527362117|FG001|Overall Study|Lack of Efficacy|1|||
146230703|NCT01651000|527362116|FG000|Overall Study|Physician Decision|1|||
146230704|NCT01651000|527362117|FG001|Overall Study|Physician Decision|0|||
146230705|NCT01651000|527362116|FG000|Overall Study|Administrative reason|1|||
146230706|NCT01651000|527362117|FG001|Overall Study|Administrative reason|0|||
146230707|NCT01651000|527362116|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
146230708|NCT01651000|527362117|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
146230709|NCT02765412|527362118|FG000|Overall Study|Death|482|||
146230710|NCT02765412|527362119|FG001|Overall Study|Death|855|||
146230711|NCT03781089|527362769|FG000|Overall Study|Constipation|1|||
146230712|NCT03781089|527362770|FG001|Overall Study|Constipation|0|||
146230713|NCT03781089|527362769|FG000|Overall Study|Positive pregnancy test|0|||
146230714|NCT03781089|527362770|FG001|Overall Study|Positive pregnancy test|1|||
146230715|NCT03417284|527362771|FG000|Overall Study|Inadequate supply on study drug|1|||
146230716|NCT03417284|527362772|FG001|Overall Study|Inadequate supply on study drug|0|||
146230717|NCT03417284|527362773|FG002|Overall Study|Inadequate supply on study drug|0|||
146230718|NCT03417284|527362774|FG003|Overall Study|Inadequate supply on study drug|0|||
146230719|NCT03417284|527362771|FG000|Overall Study|Disease Progression|0|||
146230720|NCT03417284|527362772|FG001|Overall Study|Disease Progression|0|||
146230721|NCT03417284|527362773|FG002|Overall Study|Disease Progression|1|||
146230722|NCT03417284|527362774|FG003|Overall Study|Disease Progression|0|||
146230723|NCT03636490|527362775|FG000|Overall Study|Dropped out or incomplete data|141|||
146230724|NCT02246127|527362776|FG000|First Course Treatment|Adverse Event|9|||
146230725|NCT02246127|527362777|FG001|First Course Treatment|Adverse Event|7|||
146230726|NCT02246127|527362776|FG000|First Course Treatment|Withdrawal by Subject|6|||
146230727|NCT02246127|527362777|FG001|First Course Treatment|Withdrawal by Subject|7|||
146230728|NCT02246127|527362776|FG000|First Course Treatment|Physician Decision|9|||
146230729|NCT02246127|527362777|FG001|First Course Treatment|Physician Decision|9|||
146230730|NCT02246127|527362776|FG000|First Course Treatment|Death|3|||
146230731|NCT02246127|527362777|FG001|First Course Treatment|Death|3|||
146230732|NCT02246127|527362776|FG000|First Course Treatment|Not reported reasons|6|||
146230733|NCT02246127|527362777|FG001|First Course Treatment|Not reported reasons|7|||
146230734|NCT02246127|527362776|FG000|First Course Treatment|Not treated|3|||
146230735|NCT02246127|527362777|FG001|First Course Treatment|Not treated|3|||
146230736|NCT03635567|527362778|FG000|Overall Study|Lost to Follow-up|4|||
146230737|NCT03635567|527362779|FG001|Overall Study|Lost to Follow-up|1|||
146230738|NCT03635567|527362778|FG000|Overall Study|Withdrawal by Subject|11|||
146230739|NCT03635567|527362779|FG001|Overall Study|Withdrawal by Subject|16|||
146230740|NCT03635567|527362778|FG000|Overall Study|Sponsor Decision|99|||
146230741|NCT03635567|527362779|FG001|Overall Study|Sponsor Decision|57|||
146230742|NCT03635567|527362778|FG000|Overall Study|Death|194|||
146230743|NCT03635567|527362779|FG001|Overall Study|Death|235|||
146230744|NCT03662022|527362786|FG000|Year 1 2019|prevalent case|83|||
146230745|NCT03662022|527362787|FG001|Year 1 2019|prevalent case|116|||
146230746|NCT03662022|527362788|FG002|Year 1 2019|prevalent case|158|||
146230747|NCT03662022|527362789|FG003|Year 1 2019|prevalent case|99|||
146230748|NCT03662022|527362786|FG000|Year 2 2020|incident case|18|||
146230749|NCT03662022|527362787|FG001|Year 2 2020|incident case|18|||
146230750|NCT03662022|527362788|FG002|Year 2 2020|incident case|16|||
146230751|NCT03662022|527362789|FG003|Year 2 2020|incident case|26|||
146230752|NCT03662022|527362786|FG000|Year 2 2020|other case|18|||
146230753|NCT03662022|527362787|FG001|Year 2 2020|other case|16|||
146230754|NCT03662022|527362788|FG002|Year 2 2020|other case|16|||
146230755|NCT03662022|527362789|FG003|Year 2 2020|other case|24|||
146230756|NCT03662022|527362786|FG000|Year 2 2020|Lost to Follow-up|1633|||
146230757|NCT03662022|527362787|FG001|Year 2 2020|Lost to Follow-up|1183|||
146230758|NCT03662022|527362788|FG002|Year 2 2020|Lost to Follow-up|1381|||
146230759|NCT03662022|527362789|FG003|Year 2 2020|Lost to Follow-up|2858|||
146230760|NCT03662022|527362786|FG000|Year 3 2021|incident case|24|||
146230761|NCT03662022|527362787|FG001|Year 3 2021|incident case|27|||
146230762|NCT03662022|527362788|FG002|Year 3 2021|incident case|24|||
146230763|NCT03662022|527362789|FG003|Year 3 2021|incident case|11|||
146230764|NCT03662022|527362786|FG000|Year 3 2021|other case|4|||
146230765|NCT03662022|527362787|FG001|Year 3 2021|other case|15|||
146230766|NCT03662022|527362788|FG002|Year 3 2021|other case|10|||
146230767|NCT03662022|527362789|FG003|Year 3 2021|other case|14|||
146230768|NCT03662022|527362786|FG000|Year 3 2021|Lost to Follow-up|179|||
146230769|NCT03662022|527362787|FG001|Year 3 2021|Lost to Follow-up|244|||
146230770|NCT03662022|527362788|FG002|Year 3 2021|Lost to Follow-up|480|||
146230771|NCT03662022|527362789|FG003|Year 3 2021|Lost to Follow-up|477|||
146230772|NCT03662022|527362786|FG000|Year 4 2022|incident case|25|||
146230773|NCT03662022|527362787|FG001|Year 4 2022|incident case|41|||
146230774|NCT03662022|527362788|FG002|Year 4 2022|incident case|28|||
146230775|NCT03662022|527362789|FG003|Year 4 2022|incident case|7|||
146230776|NCT03662022|527362786|FG000|Year 4 2022|other case|8|||
146230777|NCT03662022|527362787|FG001|Year 4 2022|other case|19|||
146230778|NCT03662022|527362788|FG002|Year 4 2022|other case|13|||
146230779|NCT03662022|527362789|FG003|Year 4 2022|other case|7|||
146230780|NCT03662022|527362786|FG000|Year 4 2022|Lost to Follow-up|986|||
146230781|NCT03662022|527362787|FG001|Year 4 2022|Lost to Follow-up|1079|||
146230782|NCT03662022|527362788|FG002|Year 4 2022|Lost to Follow-up|1236|||
146230783|NCT03662022|527362789|FG003|Year 4 2022|Lost to Follow-up|1826|||
146230784|NCT03248479|527362790|FG000|Overall Study|Death|12|||
146230785|NCT03248479|527362791|FG001|Overall Study|Death|44|||
146230786|NCT03248479|527362792|FG002|Overall Study|Death|1|||
146230787|NCT03248479|527362793|FG003|Overall Study|Death|72|||
146230788|NCT03248479|527362794|FG004|Overall Study|Death|17|||
146230789|NCT03248479|527362795|FG005|Overall Study|Death|6|||
146230790|NCT03248479|527362796|FG006|Overall Study|Death|1|||
146230791|NCT03248479|527362797|FG007|Overall Study|Death|14|||
146230792|NCT03248479|527362798|FG008|Overall Study|Death|3|||
146230793|NCT03248479|527362799|FG009|Overall Study|Death|7|||
146230794|NCT03248479|527362800|FG010|Overall Study|Death|3|||
146230795|NCT03248479|527362801|FG011|Overall Study|Death|1|||
146230796|NCT03248479|527362802|FG012|Overall Study|Death|1|||
146230797|NCT03248479|527362790|FG000|Overall Study|Study terminated by sponsor|12|||
146230798|NCT03248479|527362791|FG001|Overall Study|Study terminated by sponsor|15|||
146230799|NCT03248479|527362792|FG002|Overall Study|Study terminated by sponsor|0|||
146230800|NCT03248479|527362793|FG003|Overall Study|Study terminated by sponsor|5|||
145886269|NCT00802178|526088280|FG000|Overall Study|Withdrawal by Subject|18|||
145886270|NCT00802178|526088280|FG000|Overall Study|Other|32|||
145886271|NCT00802178|526088280|FG000|Overall Study|Lack of efficacy and patient wish|1|||
145886272|NCT00802178|526088280|FG000|Overall Study|IT and patient wish|8|||
145886273|NCT00802178|526088280|FG000|Overall Study|Patients wish and other reason|1|||
145886274|NCT01606228|526088281|FG000|Overall Study|Lost to Follow-up|20|||
145886275|NCT01606228|526088281|FG000|Overall Study|Withdrawal by Subject|3|||
145886276|NCT01606228|526088281|FG000|Overall Study|Non-compliant|3|||
145886277|NCT01606228|526088281|FG000|Overall Study|Lack of Efficacy|2|||
145886278|NCT01606228|526088281|FG000|Overall Study|Adverse Event|1|||
145886279|NCT01115855|526088282|FG000|Overall Study|Adverse Event|16|||
145886280|NCT01115855|526088283|FG001|Overall Study|Adverse Event|18|||
145886281|NCT01115855|526088282|FG000|Overall Study|Death|6|||
145886282|NCT01115855|526088283|FG001|Overall Study|Death|5|||
145886283|NCT01115855|526088282|FG000|Overall Study|Lab Abnormality|1|||
145886284|NCT01115855|526088283|FG001|Overall Study|Lab Abnormality|1|||
145886285|NCT01115855|526088282|FG000|Overall Study|Protocol Violation|0|||
145886286|NCT01115855|526088283|FG001|Overall Study|Protocol Violation|1|||
145886287|NCT01115855|526088282|FG000|Overall Study|Withdrawal by Subject|5|||
145886288|NCT01115855|526088283|FG001|Overall Study|Withdrawal by Subject|5|||
145886289|NCT01115855|526088282|FG000|Overall Study|Other|8|||
145886290|NCT01115855|526088283|FG001|Overall Study|Other|6|||
145886291|NCT00831233|526088284|FG000|Overall Study|Adverse Event|0|||
145886292|NCT00831233|526088285|FG001|Overall Study|Adverse Event|1|||
145886293|NCT00831233|526088284|FG000|Overall Study|Protocol Violation|1|||
145886294|NCT00831233|526088285|FG001|Overall Study|Protocol Violation|0|||
145886295|NCT00831233|526088284|FG000|Overall Study|Selection Criteria Not Met|2|||
145886296|NCT00831233|526088285|FG001|Overall Study|Selection Criteria Not Met|0|||
145886297|NCT02356211|526088286|FG000|Overall Study|Withdrawal by Subject|2|||
145886298|NCT02356211|526088287|FG001|Overall Study|Withdrawal by Subject|2|||
145886299|NCT02356211|526088286|FG000|Overall Study|ineligible|1|||
145886300|NCT02356211|526088287|FG001|Overall Study|ineligible|8|||
145886301|NCT01976728|526088288|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
146230801|NCT03248479|527362794|FG004|Overall Study|Study terminated by sponsor|0|||
146230802|NCT03248479|527362795|FG005|Overall Study|Study terminated by sponsor|0|||
146230803|NCT03248479|527362796|FG006|Overall Study|Study terminated by sponsor|0|||
145886302|NCT01976728|526088289|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
145886303|NCT01976728|526088290|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
145886304|NCT01976728|526088291|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
146230804|NCT03248479|527362797|FG007|Overall Study|Study terminated by sponsor|1|||
146230805|NCT03248479|527362798|FG008|Overall Study|Study terminated by sponsor|1|||
146230806|NCT03248479|527362799|FG009|Overall Study|Study terminated by sponsor|0|||
146289658|NCT03110185|527575350|FG000|Overall Study|Time Constraints|0|||
146289659|NCT03110185|527575351|FG001|Overall Study|Time Constraints|6|||
146289660|NCT03110185|527575350|FG000|Overall Study|Conflict with care|5|||
146289661|NCT03110185|527575351|FG001|Overall Study|Conflict with care|12|||
146289662|NCT03110185|527575350|FG000|Overall Study|Protocol Violation|1|||
146289663|NCT03110185|527575351|FG001|Overall Study|Protocol Violation|4|||
146289664|NCT03110185|527575350|FG000|Overall Study|MRI Incompatible|2|||
146289665|NCT03110185|527575351|FG001|Overall Study|MRI Incompatible|0|||
146289666|NCT03110185|527575350|FG000|Overall Study|Patient Refusal|0|||
146289667|NCT03110185|527575351|FG001|Overall Study|Patient Refusal|1|||
146289668|NCT02641496|527575352|FG000|Overall Study|Lost to Follow-up|13|||
146289669|NCT02641496|527575353|FG001|Overall Study|Lost to Follow-up|12|||
146289670|NCT02641496|527575352|FG000|Overall Study|Withdrawal by Subject|1|||
146289671|NCT02641496|527575353|FG001|Overall Study|Withdrawal by Subject|0|||
146289672|NCT03075410|527575356|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
146289673|NCT03075410|527575357|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289674|NCT03075410|527575358|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
146289675|NCT03075410|527575359|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289676|NCT03075410|527575360|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289677|NCT03075410|527575361|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289678|NCT03075410|527575362|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289679|NCT03075410|527575363|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289680|NCT03075410|527575364|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
146289681|NCT03075410|527575356|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
146289682|NCT03075410|527575357|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289683|NCT03075410|527575358|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289684|NCT03075410|527575359|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289685|NCT03075410|527575360|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289686|NCT03075410|527575361|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289687|NCT03075410|527575362|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289688|NCT03075410|527575363|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289689|NCT03075410|527575364|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
146289690|NCT01427751|527575365|FG000|Overall Study|Adverse Event|18|||
146289691|NCT01427751|527575366|FG001|Overall Study|Adverse Event|2|||
146289692|NCT01427751|527575365|FG000|Overall Study|No further treatment benefit expected|5|||
146289693|NCT01427751|527575366|FG001|Overall Study|No further treatment benefit expected|1|||
146289694|NCT01427751|527575365|FG000|Overall Study|Lost to Follow-up|3|||
146289695|NCT01427751|527575366|FG001|Overall Study|Lost to Follow-up|1|||
146289696|NCT01427751|527575365|FG000|Overall Study|Withdrawal of consent|2|||
146289697|NCT01427751|527575366|FG001|Overall Study|Withdrawal of consent|2|||
146289698|NCT01427751|527575365|FG000|Overall Study|Protocol Violation|6|||
146289699|NCT01427751|527575366|FG001|Overall Study|Protocol Violation|4|||
146289700|NCT01427751|527575365|FG000|Overall Study|Death|2|||
145886305|NCT01546922|526088296|FG000|First Period of 10 Weeks|Protocol Violation|3|||
145886306|NCT01546922|526088297|FG001|First Period of 10 Weeks|Protocol Violation|1|||
145886307|NCT01546922|526088296|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
145886308|NCT01546922|526088297|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
146289701|NCT01427751|527575366|FG001|Overall Study|Death|0|||
146289702|NCT01427751|527575365|FG000|Overall Study|Other miscellaneous reasons|6|||
146289703|NCT01427751|527575366|FG001|Overall Study|Other miscellaneous reasons|4|||
146289704|NCT01028027|527575367|FG000|Overall Study|Lost to Follow-up|4|||
146289705|NCT01028027|527575368|FG001|Overall Study|Lost to Follow-up|1|||
146289706|NCT01028027|527575367|FG000|Overall Study|Withdrawal by Subject|5|||
146289707|NCT01028027|527575368|FG001|Overall Study|Withdrawal by Subject|3|||
146289708|NCT01028027|527575367|FG000|Overall Study|Adverse Event|4|||
146289709|NCT01028027|527575368|FG001|Overall Study|Adverse Event|7|||
146289710|NCT01028027|527575367|FG000|Overall Study|Protocol Violation|3|||
146289711|NCT01028027|527575368|FG001|Overall Study|Protocol Violation|1|||
146289712|NCT01028027|527575367|FG000|Overall Study|Lack of Efficacy|0|||
146289713|NCT01028027|527575368|FG001|Overall Study|Lack of Efficacy|1|||
146289714|NCT05330312|527575370|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
146289715|NCT05330312|527575371|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
146289716|NCT05330312|527575372|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
146289717|NCT05330312|527575370|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
146289718|NCT05330312|527575371|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
146289719|NCT05330312|527575372|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
146289720|NCT05330312|527575370|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
146289721|NCT05330312|527575371|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
146289722|NCT05330312|527575372|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
146289723|NCT05330312|527575370|FG000|Pivotal Investigation - Part 2|Death|1|||
146289724|NCT05330312|527575371|FG001|Pivotal Investigation - Part 2|Death|4|||
146289725|NCT05330312|527575372|FG002|Pivotal Investigation - Part 2|Death|0|||
146086308|NCT03997383|526837917|FG001|Open-label Extension Period|Ongoing|151|||
146086309|NCT03997383|526837916|FG000|Open-label Extension Period|Adverse Event|4|||
146289726|NCT02572843|527575373|FG000|Accrual|Brain metastasis retrospectively detected|1|||
146289727|NCT02572843|527575373|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
146294421|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Adverse Event|8|||
145963184|NCT03205150|526378071|FG000|Overall Study|Patient/guardian decision|0|||
145963185|NCT03205150|526378072|FG001|Overall Study|Patient/guardian decision|3|||
145963186|NCT03205150|526378073|FG002|Overall Study|Patient/guardian decision|0|||
145963187|NCT03205150|526378071|FG000|Overall Study|Adverse Event|1|||
145963188|NCT03205150|526378072|FG001|Overall Study|Adverse Event|1|||
145963189|NCT03205150|526378073|FG002|Overall Study|Adverse Event|1|||
145963190|NCT03205150|526378071|FG000|Overall Study|Lost to Follow-up|0|||
145963191|NCT03205150|526378072|FG001|Overall Study|Lost to Follow-up|0|||
145963192|NCT03205150|526378073|FG002|Overall Study|Lost to Follow-up|1|||
145963193|NCT02486692|526378076|FG000|Overall Study|did not login for randomization|4|||
145963194|NCT02486692|526378077|FG001|Overall Study|did not login for randomization|7|||
145963195|NCT03353792|526378095|FG000|Overall Study|Lost to Follow-up|1|||
146230807|NCT03248479|527362800|FG010|Overall Study|Study terminated by sponsor|5|||
146230808|NCT03248479|527362801|FG011|Overall Study|Study terminated by sponsor|4|||
146230809|NCT03248479|527362802|FG012|Overall Study|Study terminated by sponsor|0|||
146230810|NCT03248479|527362790|FG000|Overall Study|Consent withdrawn|6|||
146230811|NCT03248479|527362791|FG001|Overall Study|Consent withdrawn|3|||
146230812|NCT03248479|527362792|FG002|Overall Study|Consent withdrawn|0|||
146230813|NCT03248479|527362793|FG003|Overall Study|Consent withdrawn|9|||
146230814|NCT03248479|527362794|FG004|Overall Study|Consent withdrawn|1|||
146230815|NCT03248479|527362795|FG005|Overall Study|Consent withdrawn|0|||
146230816|NCT03248479|527362796|FG006|Overall Study|Consent withdrawn|0|||
146230817|NCT03248479|527362797|FG007|Overall Study|Consent withdrawn|1|||
146230818|NCT03248479|527362798|FG008|Overall Study|Consent withdrawn|0|||
146230819|NCT03248479|527362799|FG009|Overall Study|Consent withdrawn|3|||
146230820|NCT03248479|527362800|FG010|Overall Study|Consent withdrawn|1|||
146230821|NCT03248479|527362801|FG011|Overall Study|Consent withdrawn|0|||
146230822|NCT03248479|527362802|FG012|Overall Study|Consent withdrawn|1|||
146230823|NCT03248479|527362790|FG000|Overall Study|Lost to Follow-up|2|||
146230824|NCT03248479|527362791|FG001|Overall Study|Lost to Follow-up|1|||
146230825|NCT03248479|527362792|FG002|Overall Study|Lost to Follow-up|0|||
146230826|NCT03248479|527362793|FG003|Overall Study|Lost to Follow-up|0|||
146230827|NCT03248479|527362794|FG004|Overall Study|Lost to Follow-up|0|||
146230828|NCT03248479|527362795|FG005|Overall Study|Lost to Follow-up|0|||
146230829|NCT03248479|527362796|FG006|Overall Study|Lost to Follow-up|0|||
146230830|NCT03248479|527362797|FG007|Overall Study|Lost to Follow-up|0|||
146230831|NCT03248479|527362798|FG008|Overall Study|Lost to Follow-up|0|||
146230832|NCT03248479|527362799|FG009|Overall Study|Lost to Follow-up|0|||
146230833|NCT03248479|527362800|FG010|Overall Study|Lost to Follow-up|0|||
146230834|NCT03248479|527362801|FG011|Overall Study|Lost to Follow-up|0|||
146230835|NCT03248479|527362802|FG012|Overall Study|Lost to Follow-up|1|||
146230836|NCT03248479|527362790|FG000|Overall Study|Not reported|0|||
146230837|NCT03248479|527362791|FG001|Overall Study|Not reported|0|||
146230838|NCT03248479|527362792|FG002|Overall Study|Not reported|0|||
146230839|NCT03248479|527362793|FG003|Overall Study|Not reported|1|||
146230840|NCT03248479|527362794|FG004|Overall Study|Not reported|1|||
146230841|NCT03248479|527362795|FG005|Overall Study|Not reported|0|||
146230842|NCT03248479|527362796|FG006|Overall Study|Not reported|0|||
146230843|NCT03248479|527362797|FG007|Overall Study|Not reported|1|||
146230844|NCT03248479|527362798|FG008|Overall Study|Not reported|1|||
146230845|NCT03248479|527362799|FG009|Overall Study|Not reported|0|||
146230846|NCT03248479|527362800|FG010|Overall Study|Not reported|0|||
146230847|NCT03248479|527362801|FG011|Overall Study|Not reported|0|||
146230848|NCT03248479|527362802|FG012|Overall Study|Not reported|0|||
146230849|NCT04679389|527362803|FG000|Overall Study|Adverse Event|1|||
146230850|NCT04679389|527362804|FG001|Overall Study|Adverse Event|0|||
145963196|NCT03353792|526378096|FG001|Overall Study|Lost to Follow-up|0|||
145963197|NCT03353792|526378095|FG000|Overall Study|Participant Unable to Manage Device|1|||
146230851|NCT04679389|527362803|FG000|Overall Study|Protocol Violation|2|||
146230852|NCT04679389|527362804|FG001|Overall Study|Protocol Violation|0|||
146230853|NCT04679389|527362803|FG000|Overall Study|Physician Decision|3|||
146230854|NCT04679389|527362804|FG001|Overall Study|Physician Decision|5|||
146230855|NCT04679389|527362803|FG000|Overall Study|Withdrawal by Subject|5|||
146230856|NCT04679389|527362804|FG001|Overall Study|Withdrawal by Subject|7|||
146230857|NCT03418740|527362822|FG000|Overall Study|Lost to Follow-up|13|||
146230858|NCT03418740|527362822|FG000|Overall Study|Scheduling Issues|7|||
146230859|NCT03418740|527362822|FG000|Overall Study|Withdrawal by Subject|2|||
146230860|NCT03418740|527362822|FG000|Overall Study|Unable to Continue Consent|1|||
146230861|NCT05215054|527362827|FG000|Overall Study|Lost to Follow-up|1|||
146230862|NCT05215054|527362828|FG001|Overall Study|Lost to Follow-up|1|||
146230863|NCT05215054|527362827|FG000|Overall Study|Protocol Violation|1|||
146230864|NCT05215054|527362828|FG001|Overall Study|Protocol Violation|1|||
146230865|NCT05215054|527362827|FG000|Overall Study|Withdrawal by Subject|4|||
146230866|NCT05215054|527362828|FG001|Overall Study|Withdrawal by Subject|4|||
146230867|NCT01475786|527362829|FG000|Overall Study|Adverse Event|0|||
146230868|NCT01475786|527362830|FG001|Overall Study|Adverse Event|1|||
146230869|NCT01475786|527362831|FG002|Overall Study|Adverse Event|0|||
146230870|NCT01475786|527362829|FG000|Overall Study|Lost to Follow-up|1|||
146230871|NCT01475786|527362830|FG001|Overall Study|Lost to Follow-up|2|||
146230872|NCT01475786|527362831|FG002|Overall Study|Lost to Follow-up|1|||
146230873|NCT01475786|527362829|FG000|Overall Study|Withdrawal by Subject|0|||
146230874|NCT01475786|527362830|FG001|Overall Study|Withdrawal by Subject|1|||
146230875|NCT01475786|527362831|FG002|Overall Study|Withdrawal by Subject|1|||
146230876|NCT01475786|527362829|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
146230877|NCT01475786|527362830|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
146230878|NCT01475786|527362831|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
146230879|NCT01897441|527362832|FG000|Overall Study|Lost to Follow-up|0|||
146230880|NCT01897441|527362833|FG001|Overall Study|Lost to Follow-up|0|||
146230881|NCT01897441|527362834|FG002|Overall Study|Lost to Follow-up|1|||
146230882|NCT01897441|527362835|FG003|Overall Study|Lost to Follow-up|0|||
146230883|NCT01897441|527362836|FG004|Overall Study|Lost to Follow-up|0|||
146230884|NCT01897441|527362837|FG005|Overall Study|Lost to Follow-up|0|||
146230885|NCT01897441|527362832|FG000|Overall Study|Withdrawal by Subject|0|||
146289728|NCT02572843|527575373|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
146230886|NCT01897441|527362833|FG001|Overall Study|Withdrawal by Subject|0|||
146230887|NCT01897441|527362834|FG002|Overall Study|Withdrawal by Subject|0|||
146230888|NCT01897441|527362835|FG003|Overall Study|Withdrawal by Subject|0|||
146230889|NCT01897441|527362836|FG004|Overall Study|Withdrawal by Subject|1|||
146230890|NCT01897441|527362837|FG005|Overall Study|Withdrawal by Subject|0|||
146230891|NCT01897441|527362832|FG000|Overall Study|Withdrawn by Provider|0|||
146230892|NCT01897441|527362833|FG001|Overall Study|Withdrawn by Provider|2|||
146230893|NCT01897441|527362834|FG002|Overall Study|Withdrawn by Provider|0|||
146230894|NCT01897441|527362835|FG003|Overall Study|Withdrawn by Provider|0|||
146230895|NCT01897441|527362836|FG004|Overall Study|Withdrawn by Provider|0|||
146230896|NCT01897441|527362837|FG005|Overall Study|Withdrawn by Provider|0|||
146230897|NCT04633278|527363597|FG000|Overall Study|Adverse Event|1|||
146230898|NCT04633278|527363598|FG001|Overall Study|Adverse Event|0|||
146230899|NCT04633278|527363597|FG000|Overall Study|Withdrawal by Subject|1|||
146230900|NCT04633278|527363598|FG001|Overall Study|Withdrawal by Subject|0|||
146230901|NCT04633278|527363597|FG000|Overall Study|Death|11|||
146230902|NCT04633278|527363598|FG001|Overall Study|Death|7|||
146230903|NCT04633278|527363597|FG000|Overall Study|Sponsor Decision|3|||
146230904|NCT04633278|527363598|FG001|Overall Study|Sponsor Decision|0|||
146289729|NCT02572843|527575373|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
146289730|NCT02572843|527575373|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
146289731|NCT02572843|527575373|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
146289732|NCT02572843|527575373|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
146289733|NCT02572843|527575373|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
146289734|NCT02572843|527575373|FG000|Surgery|lost to follow up|7|||
146289735|NCT02572843|527575373|FG000|Surgery|Death|1|||
146289736|NCT03464097|527575378|FG000|Overall Study|Withdrawal by Subject|15|||
146289737|NCT03464097|527575379|FG001|Overall Study|Withdrawal by Subject|13|||
146289738|NCT03464097|527575380|FG002|Overall Study|Withdrawal by Subject|11|||
146289739|NCT03464097|527575378|FG000|Overall Study|Study terminated by sponsor|47|||
146289740|NCT03464097|527575379|FG001|Overall Study|Study terminated by sponsor|44|||
146289741|NCT03464097|527575380|FG002|Overall Study|Study terminated by sponsor|40|||
146289742|NCT03464097|527575378|FG000|Overall Study|Pregnancy|0|||
146289743|NCT03464097|527575379|FG001|Overall Study|Pregnancy|1|||
146289744|NCT03464097|527575380|FG002|Overall Study|Pregnancy|0|||
146289745|NCT03464097|527575378|FG000|Overall Study|Other reasons|5|||
146289746|NCT03464097|527575379|FG001|Overall Study|Other reasons|12|||
146289747|NCT03464097|527575380|FG002|Overall Study|Other reasons|14|||
146289748|NCT03464097|527575378|FG000|Overall Study|Lost to Follow-up|0|||
146289749|NCT03464097|527575379|FG001|Overall Study|Lost to Follow-up|1|||
146289750|NCT03464097|527575380|FG002|Overall Study|Lost to Follow-up|1|||
146289751|NCT03464097|527575378|FG000|Overall Study|Lack of Efficacy|11|||
146289752|NCT03464097|527575379|FG001|Overall Study|Lack of Efficacy|18|||
146289753|NCT03464097|527575380|FG002|Overall Study|Lack of Efficacy|30|||
146289754|NCT03464097|527575378|FG000|Overall Study|Death|1|||
146289755|NCT03464097|527575379|FG001|Overall Study|Death|0|||
146289756|NCT03464097|527575380|FG002|Overall Study|Death|0|||
146289757|NCT03464097|527575378|FG000|Overall Study|Adverse Event|13|||
146289758|NCT03464097|527575379|FG001|Overall Study|Adverse Event|6|||
146289759|NCT03464097|527575380|FG002|Overall Study|Adverse Event|8|||
146289760|NCT03035201|527575381|FG000|Overall Study|Death|9|||
146289761|NCT03035201|527575382|FG001|Overall Study|Death|12|||
146086310|NCT03997383|526837917|FG001|Open-label Extension Period|Adverse Event|1|||
146086311|NCT03997383|526837916|FG000|Open-label Extension Period|Death|8|||
146086312|NCT03997383|526837917|FG001|Open-label Extension Period|Death|9|||
146289762|NCT03035201|527575383|FG002|Overall Study|Death|9|||
146289763|NCT03035201|527575384|FG003|Overall Study|Death|10|||
146289764|NCT03035201|527575381|FG000|Overall Study|Withdrawal by Subject|51|||
146289765|NCT03035201|527575382|FG001|Overall Study|Withdrawal by Subject|49|||
146289766|NCT03035201|527575383|FG002|Overall Study|Withdrawal by Subject|37|||
146289767|NCT03035201|527575384|FG003|Overall Study|Withdrawal by Subject|46|||
146289768|NCT03035201|527575381|FG000|Overall Study|Lost to Follow-up|67|||
146289769|NCT03035201|527575382|FG001|Overall Study|Lost to Follow-up|51|||
146289770|NCT03035201|527575383|FG002|Overall Study|Lost to Follow-up|64|||
146289771|NCT03035201|527575384|FG003|Overall Study|Lost to Follow-up|69|||
146289772|NCT05572021|527575391|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
146289773|NCT05572021|527575392|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
146086313|NCT03997383|526837916|FG000|Open-label Extension Period|Physician Decision|1|||
146086314|NCT03997383|526837917|FG001|Open-label Extension Period|Physician Decision|1|||
146086315|NCT03997383|526837916|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
146086316|NCT03997383|526837917|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
146086317|NCT03997383|526837916|FG000|Open-label Extension Period|Reason Not Specified|2|||
146086318|NCT03997383|526837917|FG001|Open-label Extension Period|Reason Not Specified|0|||
146086319|NCT04798781|526837918|FG000|Overall Study|Withdrawal by Subject|1|||
146086320|NCT05954143|526837919|FG000|Overall Study|Progressive Disease|1|||
146086321|NCT05954143|526837920|FG001|Overall Study|Progressive Disease|0|||
146086322|NCT05954143|526837919|FG000|Overall Study|Physician Decision|1|||
146086323|NCT05954143|526837920|FG001|Overall Study|Physician Decision|0|||
146086324|NCT05954143|526837919|FG000|Overall Study|Study Terminated by Sponsor|2|||
146086325|NCT05954143|526837920|FG001|Overall Study|Study Terminated by Sponsor|4|||
146086326|NCT05954143|526837919|FG000|Overall Study|Death|1|||
146086327|NCT05954143|526837920|FG001|Overall Study|Death|0|||
146086328|NCT05954143|526837919|FG000|Overall Study|Withdrawal by Subject|0|||
146086329|NCT05954143|526837920|FG001|Overall Study|Withdrawal by Subject|1|||
146086330|NCT05954143|526837919|FG000|Overall Study|Other|1|||
146086331|NCT05954143|526837920|FG001|Overall Study|Other|0|||
146086332|NCT01129024|526837921|FG000|Overall Study|Physician Decision|5|||
146086333|NCT01129024|526837921|FG000|Overall Study|Study Terminated by Sponsor|8|||
146086334|NCT01129024|526837921|FG000|Overall Study|Withdrawal by Subject|2|||
146086335|NCT01129024|526837921|FG000|Overall Study|Lack of Efficacy|3|||
146086336|NCT01129024|526837921|FG000|Overall Study|Needed a Platelet Transfusion|1|||
146086337|NCT02361580|526837922|FG000|Overall Study|Lost to Follow-up|6|||
146086338|NCT02361580|526837923|FG001|Overall Study|Lost to Follow-up|3|||
146086339|NCT00924781|526837924|FG000|Overall Study|Study terminated by sponsor|12|||
146086340|NCT00924781|526837925|FG001|Overall Study|Study terminated by sponsor|10|||
146086341|NCT00708201|526837926|FG000|Overall Study|Adverse Event|4|||
146086342|NCT00708201|526837927|FG001|Overall Study|Adverse Event|4|||
146086343|NCT00708201|526837926|FG000|Overall Study|Withdrawal by Subject|1|||
146086344|NCT00708201|526837927|FG001|Overall Study|Withdrawal by Subject|1|||
146086345|NCT00708201|526837926|FG000|Overall Study|Lost to Follow-up|2|||
146086346|NCT00708201|526837927|FG001|Overall Study|Lost to Follow-up|0|||
146086347|NCT00708201|526837926|FG000|Overall Study|Protocol Violation|0|||
146086348|NCT00708201|526837927|FG001|Overall Study|Protocol Violation|1|||
146086349|NCT00761748|526837928|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
146086350|NCT00761748|526837929|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
146086351|NCT00761748|526837928|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
146086352|NCT00761748|526837929|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
146230905|NCT04633278|527363597|FG000|Overall Study|Not Listed|1|||
146230906|NCT04633278|527363598|FG001|Overall Study|Not Listed|0|||
146230907|NCT00942734|527363607|FG000|Overall Study|Adverse Event|2|||
146230908|NCT00942734|527363607|FG000|Overall Study|Protocol Violation|3|||
146230909|NCT00942734|527363607|FG000|Overall Study|Disease Progression|2|||
146230910|NCT00942734|527363607|FG000|Overall Study|Physician Decision|1|||
146230911|NCT06655818|527363608|FG000|Overall Study|Withdrawal by Subject|1|||
146230912|NCT00319046|527363609|FG000|Overall Study|withdrawal of subject's consent|7|||
146230913|NCT00319046|527363609|FG000|Overall Study|administrative reason|1|||
146230914|NCT04496752|527363620|FG000|Second Assessment|Lost to Follow-up|3|||
146230915|NCT04496752|527363621|FG001|Second Assessment|Lost to Follow-up|3|||
146230916|NCT04496752|527363620|FG000|Second Assessment|Adverse Event|2|||
146230917|NCT04496752|527363621|FG001|Second Assessment|Adverse Event|0|||
146230918|NCT04675034|527363622|FG000|Overall Study|Lost to Follow-up|1|||
146230919|NCT04675034|527363623|FG001|Overall Study|Lost to Follow-up|1|||
146230920|NCT04675034|527363624|FG002|Overall Study|Lost to Follow-up|0|||
146230921|NCT04675034|527363625|FG003|Overall Study|Lost to Follow-up|2|||
146230922|NCT04675034|527363626|FG004|Overall Study|Lost to Follow-up|0|||
146230923|NCT04675034|527363622|FG000|Overall Study|Protocol Violation|1|||
146230924|NCT04675034|527363623|FG001|Overall Study|Protocol Violation|0|||
146230925|NCT04675034|527363624|FG002|Overall Study|Protocol Violation|0|||
146230926|NCT04675034|527363625|FG003|Overall Study|Protocol Violation|1|||
146230927|NCT04675034|527363626|FG004|Overall Study|Protocol Violation|3|||
146230928|NCT04675034|527363622|FG000|Overall Study|Withdrawal by Subject|9|||
146230929|NCT04675034|527363623|FG001|Overall Study|Withdrawal by Subject|3|||
146230930|NCT04675034|527363624|FG002|Overall Study|Withdrawal by Subject|4|||
146230931|NCT04675034|527363625|FG003|Overall Study|Withdrawal by Subject|8|||
146289774|NCT04576455|527575393|FG000|Overall Study|Ongoing in the Study|48|||
146086353|NCT01857310|526837930|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
146086354|NCT01857310|526837931|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
146086355|NCT02554279|526837932|FG000|Overall Study|Adverse Event|2|||
146086356|NCT02554279|526837933|FG001|Overall Study|Adverse Event|5|||
146230932|NCT04675034|527363626|FG004|Overall Study|Withdrawal by Subject|6|||
146230933|NCT03547271|527363633|FG000|Overall Study|Adverse Event|1|||
146230934|NCT03547271|527363634|FG001|Overall Study|Adverse Event|1|||
146230935|NCT03547271|527363635|FG002|Overall Study|Adverse Event|0|||
146230936|NCT03547271|527363636|FG003|Overall Study|Adverse Event|0|||
146230937|NCT03547271|527363633|FG000|Overall Study|Protocol deviation|5|||
146289775|NCT04576455|527575394|FG001|Overall Study|Ongoing in the Study|58|||
146289776|NCT04576455|527575393|FG000|Overall Study|Death|83|||
146289777|NCT04576455|527575394|FG001|Overall Study|Death|77|||
146289778|NCT04576455|527575393|FG000|Overall Study|Lost to Follow-up|4|||
146289779|NCT04576455|527575394|FG001|Overall Study|Lost to Follow-up|5|||
146289780|NCT04576455|527575393|FG000|Overall Study|Withdrawal by Subject|16|||
146289781|NCT04576455|527575394|FG001|Overall Study|Withdrawal by Subject|12|||
146289782|NCT03432260|527575395|FG000|Overall Study|Lost to Follow-up|1|||
146289783|NCT03432260|527575396|FG001|Overall Study|Lost to Follow-up|1|||
146289784|NCT03432260|527575397|FG002|Overall Study|Lost to Follow-up|0|||
146289785|NCT03432260|527575398|FG003|Overall Study|Lost to Follow-up|0|||
146289786|NCT03432260|527575399|FG004|Overall Study|Lost to Follow-up|1|||
145963198|NCT03353792|526378096|FG001|Overall Study|Participant Unable to Manage Device|0|||
146230938|NCT03547271|527363634|FG001|Overall Study|Protocol deviation|7|||
146230939|NCT03547271|527363635|FG002|Overall Study|Protocol deviation|3|||
146230940|NCT03547271|527363636|FG003|Overall Study|Protocol deviation|0|||
146230941|NCT03547271|527363633|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
146230942|NCT03547271|527363634|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
146230943|NCT03547271|527363635|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146230944|NCT03547271|527363636|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
146230945|NCT03547271|527363633|FG000|Overall Study|Lost to Follow-up|3|||
146230946|NCT03547271|527363634|FG001|Overall Study|Lost to Follow-up|3|||
146230947|NCT03547271|527363635|FG002|Overall Study|Lost to Follow-up|1|||
146230948|NCT03547271|527363636|FG003|Overall Study|Lost to Follow-up|0|||
146230949|NCT03522298|527363637|FG000|Overall Study|Adverse Event|1|||
146230950|NCT03522298|527363638|FG001|Overall Study|Adverse Event|0|||
146230951|NCT03522298|527363639|FG002|Overall Study|Adverse Event|0|||
146230952|NCT03522298|527363640|FG003|Overall Study|Adverse Event|1|||
146230953|NCT03522298|527363637|FG000|Overall Study|Death|2|||
146230954|NCT03522298|527363638|FG001|Overall Study|Death|4|||
146230955|NCT03522298|527363639|FG002|Overall Study|Death|8|||
146230956|NCT03522298|527363640|FG003|Overall Study|Death|8|||
146230957|NCT03522298|527363637|FG000|Overall Study|Patient decision|0|||
146230958|NCT03522298|527363638|FG001|Overall Study|Patient decision|2|||
146230959|NCT03522298|527363639|FG002|Overall Study|Patient decision|2|||
146230960|NCT03522298|527363640|FG003|Overall Study|Patient decision|2|||
146230961|NCT04795245|527363641|FG000|Overall Study|Unkown reason|7|||
146230962|NCT04795245|527363641|FG000|Overall Study|Death|17|||
146230963|NCT04795245|527363641|FG000|Overall Study|Other than listed|19|||
146230964|NCT04795245|527363641|FG000|Overall Study|Adverse Event|143|||
146230965|NCT04795245|527363641|FG000|Overall Study|Progressive disease|512|||
146230966|NCT04795245|527363641|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
146230967|NCT03904576|527363642|FG000|Washout Period|Protocol Violation|1|||
146230968|NCT03904576|527363643|FG001|Washout Period|Protocol Violation|1|||
146230969|NCT05718687|527363644|FG000|Overall Study|Withdrawal by Subject|3|||
146230970|NCT01499368|527363645|FG000|Overall Study|Did not meet I/E criteria|8|||
146230971|NCT01499368|527363646|FG001|Overall Study|Did not meet I/E criteria|4|||
146230972|NCT01499368|527363647|FG002|Overall Study|Did not meet I/E criteria|4|||
146230973|NCT01499368|527363645|FG000|Overall Study|Prohibited Concomitant medication|1|||
146230974|NCT01499368|527363646|FG001|Overall Study|Prohibited Concomitant medication|1|||
146230975|NCT01499368|527363647|FG002|Overall Study|Prohibited Concomitant medication|0|||
146230976|NCT01499368|527363645|FG000|Overall Study|Withdrawal by Subject|11|||
146230977|NCT01499368|527363646|FG001|Overall Study|Withdrawal by Subject|10|||
146230978|NCT01499368|527363647|FG002|Overall Study|Withdrawal by Subject|8|||
145963199|NCT00536510|526378099|FG000|Overall Study|Adverse Event|27|||
146230979|NCT01499368|527363645|FG000|Overall Study|Lost to Follow-up|3|||
146230980|NCT01499368|527363646|FG001|Overall Study|Lost to Follow-up|2|||
146289787|NCT02186847|527575400|FG000|Overall Study|Protocol Violation|3|||
146230981|NCT01499368|527363647|FG002|Overall Study|Lost to Follow-up|5|||
146230982|NCT01499368|527363645|FG000|Overall Study|Adverse Event|4|||
146230983|NCT01499368|527363646|FG001|Overall Study|Adverse Event|0|||
146230984|NCT01499368|527363647|FG002|Overall Study|Adverse Event|2|||
146230985|NCT01499368|527363645|FG000|Overall Study|Physician Decision|0|||
146230986|NCT01499368|527363646|FG001|Overall Study|Physician Decision|1|||
146289788|NCT02186847|527575401|FG001|Overall Study|Protocol Violation|0|||
146289789|NCT04873232|527575405|FG000|Overall Study|Lost to Follow-up|1|||
146289790|NCT04873232|527575406|FG001|Overall Study|Lost to Follow-up|4|||
146289791|NCT04873232|527575405|FG000|Overall Study|Withdrawal by Subject|1|||
146289792|NCT04873232|527575406|FG001|Overall Study|Withdrawal by Subject|0|||
146289793|NCT01912456|527577272|FG000|Period 1|Physician Decision|0|||
146289794|NCT01912456|527577273|FG001|Period 1|Physician Decision|0|||
146289795|NCT01912456|527577274|FG002|Period 1|Physician Decision|1|||
146289796|NCT01912456|527577275|FG003|Period 1|Physician Decision|0|||
146289797|NCT01912456|527577272|FG000|Period 1|non-compliance|1|||
146289798|NCT01912456|527577273|FG001|Period 1|non-compliance|0|||
146289799|NCT01912456|527577274|FG002|Period 1|non-compliance|0|||
146289800|NCT01912456|527577275|FG003|Period 1|non-compliance|1|||
146289801|NCT01912456|527577272|FG000|Period 1|Adverse Event|1|||
146289802|NCT01912456|527577273|FG001|Period 1|Adverse Event|0|||
146289803|NCT01912456|527577274|FG002|Period 1|Adverse Event|0|||
146289804|NCT01912456|527577275|FG003|Period 1|Adverse Event|1|||
146289805|NCT01912456|527577272|FG000|Period 1|Withdrawal by Subject|0|||
146289806|NCT01912456|527577273|FG001|Period 1|Withdrawal by Subject|1|||
146289807|NCT01912456|527577274|FG002|Period 1|Withdrawal by Subject|1|||
146289808|NCT01912456|527577275|FG003|Period 1|Withdrawal by Subject|1|||
146289809|NCT01912456|527577272|FG000|Period 2|Lack of Efficacy|0|||
146289810|NCT01912456|527577273|FG001|Period 2|Lack of Efficacy|2|||
146289811|NCT01912456|527577274|FG002|Period 2|Lack of Efficacy|0|||
146289812|NCT01912456|527577275|FG003|Period 2|Lack of Efficacy|0|||
146289813|NCT01912456|527577272|FG000|Period 2|Adverse Event|0|||
146289814|NCT01912456|527577273|FG001|Period 2|Adverse Event|0|||
146289815|NCT01912456|527577274|FG002|Period 2|Adverse Event|0|||
146289816|NCT01912456|527577275|FG003|Period 2|Adverse Event|1|||
146289817|NCT00171704|527577280|FG000|Overall Study|Adverse Event|24|||
146289818|NCT00171704|527577281|FG001|Overall Study|Adverse Event|33|||
146289819|NCT00171704|527577280|FG000|Overall Study|Disease Progression|14|||
146289820|NCT00171704|527577281|FG001|Overall Study|Disease Progression|9|||
146289821|NCT00171704|527577280|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
146289822|NCT00171704|527577281|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
146289823|NCT00171704|527577280|FG000|Overall Study|Administrative Problems|2|||
146289824|NCT00171704|527577281|FG001|Overall Study|Administrative Problems|1|||
146289825|NCT00171704|527577280|FG000|Overall Study|Death|2|||
146289826|NCT00171704|527577281|FG001|Overall Study|Death|2|||
146289827|NCT00171704|527577280|FG000|Overall Study|Withdrawal by Subject|1|||
146289828|NCT00171704|527577281|FG001|Overall Study|Withdrawal by Subject|3|||
146289829|NCT00171704|527577280|FG000|Overall Study|Protocol Violation|0|||
146289830|NCT00171704|527577281|FG001|Overall Study|Protocol Violation|1|||
146230987|NCT01499368|527363647|FG002|Overall Study|Physician Decision|0|||
146230988|NCT01499368|527363645|FG000|Overall Study|Deviation from visit window|0|||
146230989|NCT01499368|527363646|FG001|Overall Study|Deviation from visit window|0|||
146230990|NCT01499368|527363647|FG002|Overall Study|Deviation from visit window|1|||
146230991|NCT01499368|527363645|FG000|Overall Study|Error of Prescriptions|0|||
145963200|NCT00536510|526378100|FG001|Overall Study|Adverse Event|4|||
145963201|NCT00536510|526378099|FG000|Overall Study|Lost to Follow-up|11|||
145963202|NCT00536510|526378100|FG001|Overall Study|Lost to Follow-up|8|||
146230992|NCT01499368|527363646|FG001|Overall Study|Error of Prescriptions|0|||
145963203|NCT00536510|526378099|FG000|Overall Study|Protocol Violation|4|||
146230993|NCT01499368|527363647|FG002|Overall Study|Error of Prescriptions|1|||
145963204|NCT00536510|526378100|FG001|Overall Study|Protocol Violation|5|||
145963205|NCT00536510|526378099|FG000|Overall Study|Withdrawal by Subject|16|||
146289831|NCT02647320|527577284|FG000|Overall Study|Adverse Event|0|||
146289832|NCT02647320|527577285|FG001|Overall Study|Adverse Event|1|||
146289833|NCT02647320|527577286|FG002|Overall Study|Adverse Event|3|||
146289834|NCT02647320|527577287|FG003|Overall Study|Adverse Event|2|||
146289835|NCT02647320|527577288|FG004|Overall Study|Adverse Event|1|||
146289836|NCT02647320|527577284|FG000|Overall Study|Protocol Violation|0|||
146289837|NCT02647320|527577285|FG001|Overall Study|Protocol Violation|0|||
146289838|NCT02647320|527577286|FG002|Overall Study|Protocol Violation|3|||
146289839|NCT02647320|527577287|FG003|Overall Study|Protocol Violation|0|||
146289840|NCT02647320|527577288|FG004|Overall Study|Protocol Violation|0|||
146289841|NCT02647320|527577284|FG000|Overall Study|Withdrawal by Subject|7|||
146289842|NCT02647320|527577285|FG001|Overall Study|Withdrawal by Subject|4|||
146289843|NCT02647320|527577286|FG002|Overall Study|Withdrawal by Subject|2|||
146289844|NCT02647320|527577287|FG003|Overall Study|Withdrawal by Subject|2|||
146289845|NCT02647320|527577288|FG004|Overall Study|Withdrawal by Subject|7|||
146289846|NCT02647320|527577284|FG000|Overall Study|Persistent hyperglycemia|0|||
146289847|NCT02647320|527577285|FG001|Overall Study|Persistent hyperglycemia|1|||
146289848|NCT02647320|527577286|FG002|Overall Study|Persistent hyperglycemia|1|||
146289849|NCT02647320|527577287|FG003|Overall Study|Persistent hyperglycemia|1|||
146289850|NCT02647320|527577288|FG004|Overall Study|Persistent hyperglycemia|1|||
146289851|NCT02647320|527577284|FG000|Overall Study|Study terminated by sponsor|1|||
146289852|NCT02647320|527577285|FG001|Overall Study|Study terminated by sponsor|1|||
146289853|NCT02647320|527577286|FG002|Overall Study|Study terminated by sponsor|1|||
146289854|NCT02647320|527577287|FG003|Overall Study|Study terminated by sponsor|1|||
146289855|NCT02647320|527577288|FG004|Overall Study|Study terminated by sponsor|2|||
146289856|NCT02647320|527577284|FG000|Overall Study|Reason not provided|0|||
146289857|NCT02647320|527577285|FG001|Overall Study|Reason not provided|0|||
146289858|NCT02647320|527577286|FG002|Overall Study|Reason not provided|1|||
146289859|NCT02647320|527577287|FG003|Overall Study|Reason not provided|0|||
146289860|NCT02647320|527577288|FG004|Overall Study|Reason not provided|2|||
146289861|NCT02647320|527577284|FG000|Overall Study|Lost to Follow-up|1|||
146289862|NCT02647320|527577285|FG001|Overall Study|Lost to Follow-up|1|||
146289863|NCT02647320|527577286|FG002|Overall Study|Lost to Follow-up|0|||
146289864|NCT02647320|527577287|FG003|Overall Study|Lost to Follow-up|0|||
146289865|NCT02647320|527577288|FG004|Overall Study|Lost to Follow-up|0|||
146289866|NCT02647320|527577284|FG000|Overall Study|Develop anemia|1|||
146289867|NCT02647320|527577285|FG001|Overall Study|Develop anemia|0|||
146289868|NCT02647320|527577286|FG002|Overall Study|Develop anemia|0|||
146289869|NCT02647320|527577287|FG003|Overall Study|Develop anemia|0|||
146289870|NCT02647320|527577288|FG004|Overall Study|Develop anemia|0|||
146289871|NCT02647320|527577284|FG000|Overall Study|Lack of Efficacy|0|||
146289872|NCT02647320|527577285|FG001|Overall Study|Lack of Efficacy|0|||
146289873|NCT02647320|527577286|FG002|Overall Study|Lack of Efficacy|0|||
146289874|NCT02647320|527577287|FG003|Overall Study|Lack of Efficacy|1|||
146289875|NCT02647320|527577288|FG004|Overall Study|Lack of Efficacy|0|||
146289876|NCT02647320|527577284|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
146289877|NCT02647320|527577285|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
146289878|NCT02647320|527577286|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
146289879|NCT02647320|527577287|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
146289880|NCT02647320|527577288|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
146289881|NCT00596427|527577289|FG000|Overall Study|Withdrawal by Subject|2|||
146289882|NCT00596427|527577290|FG001|Overall Study|Withdrawal by Subject|2|||
146289883|NCT00596427|527577289|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
146289884|NCT00596427|527577290|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
146289885|NCT00596427|527577289|FG000|Overall Study|Protocol Violation|1|||
146289886|NCT00596427|527577290|FG001|Overall Study|Protocol Violation|0|||
146086357|NCT02554279|526837932|FG000|Overall Study|Lost to Follow-up|3|||
146289887|NCT03435497|527577295|FG000|Overall Study|Lost to Follow-up|1|||
146289888|NCT03435497|527577296|FG001|Overall Study|Lost to Follow-up|0|||
146289889|NCT03435497|527577295|FG000|Overall Study|Death|1|||
146289890|NCT03435497|527577296|FG001|Overall Study|Death|0|||
146289891|NCT03435497|527577295|FG000|Overall Study|Withdrawal by Subject|0|||
146289892|NCT03435497|527577296|FG001|Overall Study|Withdrawal by Subject|4|||
146289893|NCT03435497|527577295|FG000|Overall Study|Wrong survey administered|0|||
146289894|NCT03435497|527577296|FG001|Overall Study|Wrong survey administered|2|||
146289895|NCT02795429|527577297|FG000|Overall Study|Adverse Event|1|||
146289896|NCT02795429|527577298|FG001|Overall Study|Adverse Event|2|||
146289897|NCT02795429|527577299|FG002|Overall Study|Adverse Event|1|||
146289898|NCT02795429|527577300|FG003|Overall Study|Adverse Event|2|||
146289899|NCT02795429|527577301|FG004|Overall Study|Adverse Event|1|||
146289900|NCT02795429|527577297|FG000|Overall Study|Death|1|||
146289901|NCT02795429|527577298|FG001|Overall Study|Death|0|||
146289902|NCT02795429|527577299|FG002|Overall Study|Death|1|||
146289903|NCT02795429|527577300|FG003|Overall Study|Death|2|||
146289904|NCT02795429|527577301|FG004|Overall Study|Death|1|||
146289905|NCT02795429|527577297|FG000|Overall Study|Physician Decision|0|||
146289906|NCT02795429|527577298|FG001|Overall Study|Physician Decision|0|||
146289907|NCT02795429|527577299|FG002|Overall Study|Physician Decision|2|||
146289908|NCT02795429|527577300|FG003|Overall Study|Physician Decision|1|||
146289909|NCT02795429|527577301|FG004|Overall Study|Physician Decision|5|||
146289910|NCT02795429|527577297|FG000|Overall Study|Progressive disease|3|||
146289911|NCT02795429|527577298|FG001|Overall Study|Progressive disease|7|||
146289912|NCT02795429|527577299|FG002|Overall Study|Progressive disease|6|||
146289913|NCT02795429|527577300|FG003|Overall Study|Progressive disease|26|||
146289914|NCT02795429|527577301|FG004|Overall Study|Progressive disease|20|||
146289915|NCT02795429|527577297|FG000|Overall Study|Subject/guardian decision|1|||
146289916|NCT02795429|527577298|FG001|Overall Study|Subject/guardian decision|1|||
146289917|NCT02795429|527577299|FG002|Overall Study|Subject/guardian decision|1|||
146289918|NCT02795429|527577300|FG003|Overall Study|Subject/guardian decision|1|||
146289919|NCT02795429|527577301|FG004|Overall Study|Subject/guardian decision|3|||
146289920|NCT04281004|527577302|FG000|Overall Study|Physician Decision|1|||
146289921|NCT04281004|527577303|FG001|Overall Study|Physician Decision|0|||
146289922|NCT00701779|527577304|FG000|Overall Study|Adverse Event|6|||
146289923|NCT00701779|527577304|FG000|Overall Study|Lost to Follow-up|1|||
146289924|NCT00701779|527577304|FG000|Overall Study|Withdrawal by Subject|2|||
145963206|NCT00536510|526378100|FG001|Overall Study|Withdrawal by Subject|9|||
145963207|NCT00536510|526378099|FG000|Overall Study|Flushing with Product|20|||
145963208|NCT00536510|526378100|FG001|Overall Study|Flushing with Product|0|||
145963209|NCT00536510|526378099|FG000|Overall Study|Laboratory Adverse Event|2|||
145963210|NCT00536510|526378100|FG001|Overall Study|Laboratory Adverse Event|1|||
145963211|NCT00536510|526378099|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
145963212|NCT00536510|526378100|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
145963213|NCT01249417|526378101|FG000|Randomised Population|Study treatment not received|0|||
145963214|NCT01249417|526378102|FG001|Randomised Population|Study treatment not received|0|||
145963215|NCT01249417|526378103|FG002|Randomised Population|Study treatment not received|2|||
145963216|NCT01249417|526378101|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
145963217|NCT01249417|526378102|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
145963218|NCT01249417|526378103|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
145963219|NCT01249417|526378101|FG000|Treatment Phase - ITT Population|Other|0|||
145963220|NCT01249417|526378102|FG001|Treatment Phase - ITT Population|Other|0|||
145963221|NCT01249417|526378103|FG002|Treatment Phase - ITT Population|Other|1|||
145963222|NCT01249417|526378101|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
145963223|NCT01249417|526378102|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
145963224|NCT01249417|526378103|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
145963225|NCT01249417|526378101|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
145963226|NCT01249417|526378102|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
145963227|NCT01249417|526378103|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
145963228|NCT01249417|526378101|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
145963229|NCT01249417|526378102|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
145963230|NCT01249417|526378103|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
145963231|NCT01783743|526378104|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
146289925|NCT03442985|527577305|FG000|Overall Study|Sponsor Request|55|||
145963232|NCT01783743|526378105|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
146289926|NCT03442985|527577306|FG001|Overall Study|Sponsor Request|60|||
146289927|NCT03442985|527577307|FG002|Overall Study|Sponsor Request|54|||
146289928|NCT03442985|527577305|FG000|Overall Study|Lost to Follow-up|5|||
146289929|NCT03442985|527577306|FG001|Overall Study|Lost to Follow-up|2|||
146289930|NCT03442985|527577307|FG002|Overall Study|Lost to Follow-up|7|||
146289931|NCT03442985|527577305|FG000|Overall Study|Withdrawal by Subject|2|||
146289932|NCT03442985|527577306|FG001|Overall Study|Withdrawal by Subject|3|||
146289933|NCT03442985|527577307|FG002|Overall Study|Withdrawal by Subject|4|||
146289934|NCT03442985|527577305|FG000|Overall Study|Adverse Event|0|||
146289935|NCT03442985|527577306|FG001|Overall Study|Adverse Event|1|||
146230994|NCT03990883|527363648|FG000|Blinded Treatment Phase|Adverse Event|1|||
146230995|NCT03990883|527363649|FG001|Blinded Treatment Phase|Adverse Event|1|||
146230996|NCT03990883|527363650|FG002|Blinded Treatment Phase|Adverse Event|0|||
146230997|NCT03990883|527363648|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
146230998|NCT03990883|527363649|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
146230999|NCT03990883|527363650|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
146231000|NCT03990883|527363648|FG000|Blinded Treatment Phase|Physician Decision|1|||
146086358|NCT02554279|526837933|FG001|Overall Study|Lost to Follow-up|2|||
146231001|NCT03990883|527363649|FG001|Blinded Treatment Phase|Physician Decision|0|||
146231002|NCT03990883|527363650|FG002|Blinded Treatment Phase|Physician Decision|0|||
146231003|NCT03990883|527363648|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
146231004|NCT03990883|527363649|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
146231005|NCT03990883|527363650|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
146231006|NCT03990883|527363648|FG000|Blinded Treatment Phase|COVID-19|3|||
146231007|NCT03990883|527363649|FG001|Blinded Treatment Phase|COVID-19|2|||
146231008|NCT03990883|527363650|FG002|Blinded Treatment Phase|COVID-19|0|||
146231009|NCT03990883|527363648|FG000|Blinded Treatment Phase|Personal Reasons|6|||
146231010|NCT03990883|527363649|FG001|Blinded Treatment Phase|Personal Reasons|3|||
146231011|NCT03990883|527363650|FG002|Blinded Treatment Phase|Personal Reasons|0|||
146231012|NCT03990883|527363648|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
146231013|NCT03990883|527363649|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
146231014|NCT03990883|527363650|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
146231015|NCT03990883|527363648|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
146231016|NCT03990883|527363649|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
146231017|NCT03990883|527363650|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
146231018|NCT03990883|527363648|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
146231019|NCT03990883|527363649|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
146231020|NCT03990883|527363650|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
146231021|NCT05132400|527364358|FG000|Overall Study|Withdrawal by Subject|14|||
146231022|NCT05132400|527364359|FG001|Overall Study|Withdrawal by Subject|8|||
146231023|NCT05132400|527364358|FG000|Overall Study|Lost to Follow-up|132|||
146231024|NCT05132400|527364359|FG001|Overall Study|Lost to Follow-up|121|||
146231025|NCT02076009|527364361|FG000|Overall Study|Death|172|||
146231026|NCT02076009|527364362|FG001|Overall Study|Death|153|||
146231027|NCT02076009|527364361|FG000|Overall Study|Withdrawal by Subject|16|||
146231028|NCT02076009|527364362|FG001|Overall Study|Withdrawal by Subject|12|||
146231029|NCT02076009|527364361|FG000|Overall Study|Lost to Follow-up|4|||
146231030|NCT02076009|527364362|FG001|Overall Study|Lost to Follow-up|2|||
146231031|NCT02076009|527364361|FG000|Overall Study|Progressive Disease|1|||
146231032|NCT02076009|527364362|FG001|Overall Study|Progressive Disease|0|||
146231033|NCT02076009|527364361|FG000|Overall Study|Physician Decision|0|||
146231034|NCT02076009|527364362|FG001|Overall Study|Physician Decision|1|||
146231035|NCT02076009|527364361|FG000|Overall Study|End of data collection|90|||
146231036|NCT02076009|527364362|FG001|Overall Study|End of data collection|118|||
146231037|NCT05988398|527364366|FG000|Overall Study|Lack of time|21|||
146231038|NCT05988398|527364367|FG001|Overall Study|Lack of time|0|||
146231039|NCT05988398|527364366|FG000|Overall Study|Absent from school|0|||
146231040|NCT05988398|527364367|FG001|Overall Study|Absent from school|38|||
146231041|NCT05988398|527364366|FG000|Overall Study|Chose not to participate|0|||
146231042|NCT05988398|527364367|FG001|Overall Study|Chose not to participate|42|||
146231043|NCT05988398|527364366|FG000|Overall Study|Other commitments (e.g., sports)|0|||
146231044|NCT05988398|527364367|FG001|Overall Study|Other commitments (e.g., sports)|25|||
146231045|NCT04408755|527364368|FG000|Period A (Placebo lead-in)|Other|11|||
146231046|NCT04408755|527364369|FG001|Period A (Placebo lead-in)|Other|0|||
146231047|NCT04408755|527364370|FG002|Period A (Placebo lead-in)|Other|0|||
146231048|NCT04408755|527364371|FG003|Period A (Placebo lead-in)|Other|0|||
146231049|NCT04408755|527364368|FG000|Period B (Randomization Period)|Adverse Event|0|||
146231050|NCT04408755|527364369|FG001|Period B (Randomization Period)|Adverse Event|3|||
146231051|NCT04408755|527364370|FG002|Period B (Randomization Period)|Adverse Event|0|||
146231052|NCT04408755|527364371|FG003|Period B (Randomization Period)|Adverse Event|1|||
146231053|NCT04408755|527364368|FG000|Period B (Randomization Period)|Death|0|||
146231054|NCT04408755|527364369|FG001|Period B (Randomization Period)|Death|0|||
146231055|NCT04408755|527364370|FG002|Period B (Randomization Period)|Death|1|||
146231056|NCT04408755|527364371|FG003|Period B (Randomization Period)|Death|0|||
146289936|NCT03442985|527577307|FG002|Overall Study|Adverse Event|0|||
146231057|NCT04408755|527364368|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
146231058|NCT04408755|527364369|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
146231059|NCT04408755|527364370|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
146231060|NCT04408755|527364371|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
146231061|NCT04408755|527364368|FG000|Period B (Randomization Period)|Physician Decision|0|||
146231062|NCT04408755|527364369|FG001|Period B (Randomization Period)|Physician Decision|0|||
146231063|NCT04408755|527364370|FG002|Period B (Randomization Period)|Physician Decision|1|||
146231064|NCT04408755|527364371|FG003|Period B (Randomization Period)|Physician Decision|0|||
146231065|NCT04408755|527364368|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
146231066|NCT04408755|527364369|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
146231067|NCT04408755|527364370|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
146231068|NCT04408755|527364371|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
146231069|NCT04408755|527364368|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
146231070|NCT04408755|527364369|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146231071|NCT04408755|527364370|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146231072|NCT04408755|527364371|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
146231073|NCT04408755|527364368|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
146231074|NCT04408755|527364369|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
146231075|NCT04408755|527364370|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
146231076|NCT04408755|527364371|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
146231077|NCT04408755|527364368|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
146231078|NCT04408755|527364369|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
146231079|NCT04408755|527364370|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
146231080|NCT04408755|527364371|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
146231081|NCT04408755|527364368|FG000|Period B (Randomization Period)|Reason not Specified|0|||
146289937|NCT01620255|527577311|FG000|Overall Study|Withdrawal by Subject|4|||
146231082|NCT04408755|527364369|FG001|Period B (Randomization Period)|Reason not Specified|1|||
146289938|NCT01620255|527577312|FG001|Overall Study|Withdrawal by Subject|1|||
146289939|NCT01620255|527577313|FG002|Overall Study|Withdrawal by Subject|1|||
146289940|NCT01620255|527577314|FG003|Overall Study|Withdrawal by Subject|2|||
146289941|NCT01620255|527577315|FG004|Overall Study|Withdrawal by Subject|4|||
146289942|NCT01620255|527577311|FG000|Overall Study|Participant underwent fecal transplant|0|||
146289943|NCT01620255|527577312|FG001|Overall Study|Participant underwent fecal transplant|0|||
146289944|NCT01620255|527577313|FG002|Overall Study|Participant underwent fecal transplant|1|||
146289945|NCT01620255|527577314|FG003|Overall Study|Participant underwent fecal transplant|0|||
146289946|NCT01620255|527577315|FG004|Overall Study|Participant underwent fecal transplant|0|||
146289947|NCT01620255|527577311|FG000|Overall Study|Non-compliance|0|||
146289948|NCT01620255|527577312|FG001|Overall Study|Non-compliance|1|||
146289949|NCT01620255|527577313|FG002|Overall Study|Non-compliance|0|||
146289950|NCT01620255|527577314|FG003|Overall Study|Non-compliance|0|||
146289951|NCT01620255|527577315|FG004|Overall Study|Non-compliance|0|||
146289952|NCT01620255|527577311|FG000|Overall Study|Adverse Event|0|||
146289953|NCT01620255|527577312|FG001|Overall Study|Adverse Event|4|||
146289954|NCT01620255|527577313|FG002|Overall Study|Adverse Event|0|||
146289955|NCT01620255|527577314|FG003|Overall Study|Adverse Event|1|||
146289956|NCT01620255|527577315|FG004|Overall Study|Adverse Event|1|||
146289957|NCT01620255|527577311|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
146289958|NCT01620255|527577312|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
146289959|NCT01620255|527577313|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
146289960|NCT01620255|527577314|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
146289961|NCT01620255|527577315|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
146289962|NCT01557283|527577316|FG000|Overall Study|Lost to Follow-up|7|||
146289963|NCT01557283|527577316|FG000|Overall Study|Non-responder|19|||
146289964|NCT01557283|527577316|FG000|Overall Study|Adverse Event|7|||
146289965|NCT01557283|527577316|FG000|Overall Study|Lack of Efficacy|1|||
146289966|NCT01557283|527577316|FG000|Overall Study|Non-compliance|1|||
146289967|NCT01557283|527577316|FG000|Overall Study|Withdrawal by Subject|1|||
146289968|NCT01557283|527577316|FG000|Overall Study|Participant's weight too high for dose|1|||
146289969|NCT01557283|527577316|FG000|Overall Study|Worsening of psoriasis|1|||
146289970|NCT01557283|527577316|FG000|Overall Study|Other|6|||
146289971|NCT01716117|527577317|FG000|Overall Study|Death|5|||
146289972|NCT01716117|527577318|FG001|Overall Study|Death|2|||
146289973|NCT01716117|527577317|FG000|Overall Study|Withdrawal by Subject|2|||
146289974|NCT01716117|527577318|FG001|Overall Study|Withdrawal by Subject|0|||
146289975|NCT03645057|527577321|FG000|Randomization to Baseline|Lost to Follow-up|1|||
145963233|NCT01783743|526378104|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
145963234|NCT01783743|526378105|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
145963235|NCT01783743|526378104|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
145963236|NCT01783743|526378105|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
145963237|NCT05556148|526378106|FG000|Overall Study|Early Termination|29|||
145963238|NCT05556148|526378106|FG000|Overall Study|Baseline Tasks Expired|4|||
146289976|NCT03645057|527577322|FG001|Randomization to Baseline|Lost to Follow-up|0|||
146289977|NCT03645057|527577323|FG002|Randomization to Baseline|Lost to Follow-up|1|||
145963239|NCT05556148|526378106|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
146289978|NCT03645057|527577324|FG003|Randomization to Baseline|Lost to Follow-up|0|||
146289979|NCT03645057|527577321|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
146289980|NCT03645057|527577322|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
146289981|NCT03645057|527577323|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
146289982|NCT03645057|527577324|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
146289983|NCT03645057|527577321|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
146231083|NCT04408755|527364370|FG002|Period B (Randomization Period)|Reason not Specified|0|||
146231084|NCT04408755|527364371|FG003|Period B (Randomization Period)|Reason not Specified|2|||
146231085|NCT00412607|527364372|FG000|Overall Study|Withdrawal by Subject|9|||
146231086|NCT00412607|527364372|FG000|Overall Study|Lost to Follow-up|19|||
146231087|NCT00412607|527364372|FG000|Overall Study|Death|61|||
146231088|NCT00412607|527364372|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
146231089|NCT05836012|527364381|FG000|Overall Study|Lost to Follow-up|1|||
146289984|NCT03645057|527577322|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
146289985|NCT03645057|527577323|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
146289986|NCT03645057|527577324|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
146289987|NCT03645057|527577321|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
146289988|NCT03645057|527577322|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
146289989|NCT03645057|527577323|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
146289990|NCT03645057|527577324|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
146289991|NCT01873495|527577325|FG000|Overall Study|Withdrawal by Subject|1|||
146289992|NCT01873495|527577325|FG000|Overall Study|Physician Decision|3|||
146289993|NCT01873495|527577325|FG000|Overall Study|Adverse Event|1|||
146289994|NCT01873495|527577325|FG000|Overall Study|Removed for Transplantation|1|||
146289995|NCT01873495|527577325|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
146289996|NCT01206777|527577326|FG000|Overall Study|Death|1|||
146289997|NCT01206777|527577326|FG000|Overall Study|Adverse Event|1|||
146289998|NCT00879762|527577329|FG000|Overall Study|Lost to Follow-up|3|||
146289999|NCT00879762|527577330|FG001|Overall Study|Lost to Follow-up|1|||
146290000|NCT04981366|527577331|FG000|Overall Study|Withdrawal by Subject|5|||
146290001|NCT04981366|527577332|FG001|Overall Study|Withdrawal by Subject|4|||
146290002|NCT04981366|527577333|FG002|Overall Study|Withdrawal by Subject|8|||
146290003|NCT04981366|527577331|FG000|Overall Study|Health issues unrelated to the trial|1|||
146290004|NCT04981366|527577332|FG001|Overall Study|Health issues unrelated to the trial|2|||
146231090|NCT05836012|527364382|FG001|Overall Study|Lost to Follow-up|0|||
145963240|NCT05556148|526378106|FG000|Overall Study|No Longer Wished to Participate|1|||
145963241|NCT05556148|526378106|FG000|Overall Study|Bacterial Conjunctivitis|1|||
145963242|NCT00728494|526378119|FG000|Overall Study|Adverse Event|7|||
145963243|NCT00728494|526378120|FG001|Overall Study|Adverse Event|0|||
145963244|NCT00728494|526378119|FG000|Overall Study|Withdrawal by Subject|0|||
145963245|NCT00728494|526378120|FG001|Overall Study|Withdrawal by Subject|2|||
146290005|NCT04981366|527577333|FG002|Overall Study|Health issues unrelated to the trial|0|||
146290006|NCT00881608|527577334|FG000|Overall Study|Study prematurely terminated|11|||
145963246|NCT00728494|526378119|FG000|Overall Study|Lack of Efficacy|2|||
145963247|NCT00728494|526378120|FG001|Overall Study|Lack of Efficacy|4|||
145963248|NCT00728494|526378119|FG000|Overall Study|No data available|0|||
145963249|NCT00728494|526378120|FG001|Overall Study|No data available|1|||
145963250|NCT03769649|526378121|FG000|Overall Study|Lost to Follow-up|4|||
145963251|NCT00853762|526378122|FG000|Overall Study|Premature Termination|16|||
146290007|NCT03214094|527577335|FG000|Overall Study|Case Report Forms Uncollected|14|||
146290008|NCT03214094|527577335|FG000|Overall Study|Protocol Deviation|46|||
145963252|NCT00853762|526378123|FG001|Overall Study|Premature Termination|15|||
145963253|NCT00853762|526378124|FG002|Overall Study|Premature Termination|14|||
145963254|NCT00853762|526378125|FG003|Overall Study|Premature Termination|21|||
145963255|NCT00853762|526378122|FG000|Overall Study|Protocol Violation|0|||
145963256|NCT00853762|526378123|FG001|Overall Study|Protocol Violation|0|||
145963257|NCT00853762|526378124|FG002|Overall Study|Protocol Violation|0|||
146086359|NCT02554279|526837932|FG000|Overall Study|Withdrawal by Subject|6|||
146086360|NCT02554279|526837933|FG001|Overall Study|Withdrawal by Subject|4|||
146086361|NCT02554279|526837932|FG000|Overall Study|Protocol Violation|2|||
146231091|NCT05836012|527364381|FG000|Overall Study|Withdrawal by Subject|1|||
146231092|NCT05836012|527364382|FG001|Overall Study|Withdrawal by Subject|3|||
146086362|NCT02554279|526837933|FG001|Overall Study|Protocol Violation|1|||
146231093|NCT05836012|527364381|FG000|Overall Study|Reason not included in pre-specified categories|2|||
146231094|NCT05836012|527364382|FG001|Overall Study|Reason not included in pre-specified categories|1|||
146231095|NCT05985395|527364383|FG000|Overall Study|Physician Decision|2|||
146231096|NCT05985395|527364384|FG001|Overall Study|Physician Decision|1|||
146231097|NCT05985395|527364383|FG000|Overall Study|Withdrawal by Subject|1|||
146231098|NCT05985395|527364384|FG001|Overall Study|Withdrawal by Subject|0|||
146231099|NCT04908930|527364387|FG000|Overall Study|Lost to Follow-up|1|||
146290009|NCT01313637|527577338|FG000|Overall Study|Adverse Event|17|||
146290010|NCT01313637|527577339|FG001|Overall Study|Adverse Event|24|||
146290011|NCT01313637|527577340|FG002|Overall Study|Adverse Event|25|||
146290012|NCT01313637|527577341|FG003|Overall Study|Adverse Event|18|||
146290013|NCT01313637|527577338|FG000|Overall Study|Lack of Efficacy|44|||
145963258|NCT00853762|526378125|FG003|Overall Study|Protocol Violation|1|||
146086363|NCT02554279|526837932|FG000|Overall Study|Other reason|19|||
145963259|NCT00853762|526378122|FG000|Overall Study|Withdrawal by Subject|0|||
145963260|NCT00853762|526378123|FG001|Overall Study|Withdrawal by Subject|0|||
146231100|NCT04908930|527364388|FG001|Overall Study|Lost to Follow-up|1|||
146231101|NCT04908930|527364389|FG002|Overall Study|Lost to Follow-up|0|||
146231102|NCT04908930|527364390|FG003|Overall Study|Lost to Follow-up|0|||
146231103|NCT04908930|527364391|FG004|Overall Study|Lost to Follow-up|0|||
146231104|NCT04908930|527364387|FG000|Overall Study|hardware in mouth|1|||
146231105|NCT04908930|527364388|FG001|Overall Study|hardware in mouth|1|||
146231106|NCT04908930|527364389|FG002|Overall Study|hardware in mouth|0|||
146231107|NCT04908930|527364390|FG003|Overall Study|hardware in mouth|0|||
146290014|NCT01313637|527577339|FG001|Overall Study|Lack of Efficacy|38|||
146290015|NCT01313637|527577340|FG002|Overall Study|Lack of Efficacy|37|||
146290016|NCT01313637|527577341|FG003|Overall Study|Lack of Efficacy|24|||
146290017|NCT01313637|527577338|FG000|Overall Study|Protocol Violation|4|||
146290018|NCT01313637|527577339|FG001|Overall Study|Protocol Violation|3|||
146290019|NCT01313637|527577340|FG002|Overall Study|Protocol Violation|11|||
146290020|NCT01313637|527577341|FG003|Overall Study|Protocol Violation|5|||
146290021|NCT01313637|527577338|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
146290022|NCT01313637|527577339|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
146290023|NCT01313637|527577340|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
145963261|NCT00853762|526378124|FG002|Overall Study|Withdrawal by Subject|1|||
145963262|NCT00853762|526378125|FG003|Overall Study|Withdrawal by Subject|0|||
145963263|NCT00853762|526378122|FG000|Overall Study|Other|0|||
145963264|NCT00853762|526378123|FG001|Overall Study|Other|2|||
145963265|NCT00853762|526378124|FG002|Overall Study|Other|0|||
145963266|NCT00853762|526378125|FG003|Overall Study|Other|0|||
145963267|NCT00853762|526378122|FG000|Overall Study|Randomised but not Treated|0|||
145963268|NCT00853762|526378123|FG001|Overall Study|Randomised but not Treated|2|||
145963269|NCT00853762|526378124|FG002|Overall Study|Randomised but not Treated|2|||
145963270|NCT00853762|526378125|FG003|Overall Study|Randomised but not Treated|0|||
145963271|NCT00748241|526378127|FG000|Overall Study|Implant failure|1|||
145963272|NCT00748241|526378127|FG000|Overall Study|Lost to Follow-up|5|||
145963273|NCT00748241|526378127|FG000|Overall Study|Death|2|||
145963274|NCT01408706|526378128|FG000|Overall Study|Physician Decision|1|||
145963275|NCT01408706|526378129|FG001|Overall Study|Physician Decision|0|||
145963276|NCT00888654|526378130|FG000|Overall Study|Problems swallowing oral meds.|1|||
145963277|NCT00888654|526378130|FG000|Overall Study|Not enough oral meds before surgery|3|||
146231108|NCT04908930|527364391|FG004|Overall Study|hardware in mouth|0|||
146231109|NCT04908930|527364387|FG000|Overall Study|wrong team|1|||
146231110|NCT04908930|527364388|FG001|Overall Study|wrong team|0|||
146231111|NCT04908930|527364389|FG002|Overall Study|wrong team|0|||
146231112|NCT04908930|527364390|FG003|Overall Study|wrong team|0|||
146290024|NCT01313637|527577341|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
145886309|NCT01546922|526088296|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
145886310|NCT01546922|526088297|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
145886311|NCT01546922|526088296|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
145886312|NCT01546922|526088297|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
145886313|NCT01546922|526088296|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
145886314|NCT01546922|526088297|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
145886315|NCT01613378|526088298|FG000|Overall Study|Lack of Efficacy|13|||
145886316|NCT01613378|526088298|FG000|Overall Study|Adverse Event|11|||
145886317|NCT01613378|526088298|FG000|Overall Study|Withdrawal by Subject|8|||
145886318|NCT01613378|526088298|FG000|Overall Study|Death|2|||
145886319|NCT01613378|526088298|FG000|Overall Study|Lost to Follow-up|1|||
145886320|NCT01613378|526088298|FG000|Overall Study|Other Reason|4|||
145963278|NCT00888654|526378130|FG000|Overall Study|Surgery aborted|2|||
145963279|NCT00888654|526378130|FG000|Overall Study|Withdrawal by Subject|1|||
145963280|NCT00888654|526378130|FG000|Overall Study|Inelig. due to contraindication of med|1|||
146231113|NCT04908930|527364391|FG004|Overall Study|wrong team|0|||
146231114|NCT04908930|527364387|FG000|Overall Study|quit team|2|||
146231115|NCT04908930|527364388|FG001|Overall Study|quit team|4|||
145886321|NCT02000531|526088299|FG000|Overall Study|Lost to Follow-up|1|||
145886322|NCT02000531|526088300|FG001|Overall Study|Lost to Follow-up|0|||
145886323|NCT02000531|526088299|FG000|Overall Study|Discontinued due to data cut-off|3|||
145886324|NCT02000531|526088300|FG001|Overall Study|Discontinued due to data cut-off|8|||
145886325|NCT01345318|526088307|FG000|Overall Study|Adverse Event|16|||
145886326|NCT01345318|526088307|FG000|Overall Study|Lack of Efficacy|17|||
145886327|NCT01345318|526088307|FG000|Overall Study|Lost to Follow-up|2|||
145886328|NCT01345318|526088307|FG000|Overall Study|Protocol Violation|1|||
145886329|NCT01345318|526088307|FG000|Overall Study|Withdrawal by Subject|41|||
145886330|NCT01345318|526088307|FG000|Overall Study|Other|3|||
145886331|NCT00743509|526088308|FG000|Overall Study|Withdrawal by Subject|2|||
145886332|NCT01239472|526088309|FG000|Overall Study|Withdrawal by Subject|5|||
145886333|NCT01239472|526088310|FG001|Overall Study|Withdrawal by Subject|1|||
145886334|NCT01239472|526088309|FG000|Overall Study|Adverse Event|0|||
145886335|NCT01239472|526088310|FG001|Overall Study|Adverse Event|1|||
145886336|NCT01239472|526088309|FG000|Overall Study|Lack of Efficacy|0|||
145886337|NCT01239472|526088310|FG001|Overall Study|Lack of Efficacy|1|||
145886338|NCT00573170|526088314|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
145886339|NCT00573170|526088315|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
145886340|NCT00573170|526088316|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
145886341|NCT00573170|526088317|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
145886342|NCT00573170|526088318|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
146231116|NCT04908930|527364389|FG002|Overall Study|quit team|0|||
146231117|NCT04908930|527364390|FG003|Overall Study|quit team|0|||
146231118|NCT04908930|527364391|FG004|Overall Study|quit team|0|||
146231119|NCT04908930|527364387|FG000|Overall Study|Withdrawal by Subject|1|||
146231120|NCT04908930|527364388|FG001|Overall Study|Withdrawal by Subject|2|||
146231121|NCT04908930|527364389|FG002|Overall Study|Withdrawal by Subject|0|||
146231122|NCT04908930|527364390|FG003|Overall Study|Withdrawal by Subject|0|||
146231123|NCT04908930|527364391|FG004|Overall Study|Withdrawal by Subject|0|||
146231124|NCT04908930|527364387|FG000|Overall Study|parent not liking program|0|||
146231125|NCT04908930|527364388|FG001|Overall Study|parent not liking program|1|||
146231126|NCT04908930|527364389|FG002|Overall Study|parent not liking program|0|||
146231127|NCT04908930|527364390|FG003|Overall Study|parent not liking program|0|||
146231128|NCT04908930|527364391|FG004|Overall Study|parent not liking program|0|||
146231129|NCT02777593|527364394|FG000|Overall Study|Still in study|1|||
146231130|NCT02777593|527364395|FG001|Overall Study|Still in study|32|||
146231131|NCT02777593|527364396|FG002|Overall Study|Still in study|3|||
146231132|NCT02777593|527364397|FG003|Overall Study|Still in study|6|||
146231133|NCT02777593|527364398|FG004|Overall Study|Still in study|5|||
146231134|NCT02777593|527364394|FG000|Overall Study|Death|21|||
146231135|NCT02777593|527364395|FG001|Overall Study|Death|28|||
146231136|NCT02777593|527364396|FG002|Overall Study|Death|0|||
146231137|NCT02777593|527364397|FG003|Overall Study|Death|5|||
146231138|NCT02777593|527364398|FG004|Overall Study|Death|0|||
146231139|NCT02777593|527364394|FG000|Overall Study|Withdrawal by Subject|8|||
146231140|NCT02777593|527364395|FG001|Overall Study|Withdrawal by Subject|4|||
146231141|NCT02777593|527364396|FG002|Overall Study|Withdrawal by Subject|1|||
146231142|NCT02777593|527364397|FG003|Overall Study|Withdrawal by Subject|1|||
146231143|NCT02777593|527364398|FG004|Overall Study|Withdrawal by Subject|0|||
146231144|NCT02777593|527364394|FG000|Overall Study|Lost to Follow-up|8|||
146231145|NCT02777593|527364395|FG001|Overall Study|Lost to Follow-up|16|||
146231146|NCT02777593|527364396|FG002|Overall Study|Lost to Follow-up|5|||
146231147|NCT02777593|527364397|FG003|Overall Study|Lost to Follow-up|0|||
146231148|NCT02777593|527364398|FG004|Overall Study|Lost to Follow-up|1|||
146231149|NCT02777593|527364394|FG000|Overall Study|Physician Decision|2|||
146231150|NCT02777593|527364395|FG001|Overall Study|Physician Decision|2|||
146231151|NCT02777593|527364396|FG002|Overall Study|Physician Decision|0|||
146231152|NCT02777593|527364397|FG003|Overall Study|Physician Decision|0|||
146231153|NCT02777593|527364398|FG004|Overall Study|Physician Decision|0|||
146231154|NCT02777593|527364394|FG000|Overall Study|Discontinued due to Other|1|||
146231155|NCT02777593|527364395|FG001|Overall Study|Discontinued due to Other|0|||
146231156|NCT02777593|527364396|FG002|Overall Study|Discontinued due to Other|0|||
146231157|NCT02777593|527364397|FG003|Overall Study|Discontinued due to Other|0|||
146231158|NCT02777593|527364398|FG004|Overall Study|Discontinued due to Other|0|||
146231159|NCT06065735|527364399|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
146231160|NCT06065735|527364400|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
146231161|NCT06065735|527364401|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
146231162|NCT06065735|527364399|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
146231163|NCT06065735|527364400|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
146231164|NCT06065735|527364401|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
145886343|NCT00573170|526088319|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
145886344|NCT00573170|526088314|FG000|First Washout Period|Adverse Event|1|||
146231165|NCT06065735|527364399|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
145886345|NCT00573170|526088315|FG001|First Washout Period|Adverse Event|1|||
146231166|NCT06065735|527364400|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
146231167|NCT06065735|527364401|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
146231168|NCT06065735|527364399|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
146231169|NCT06065735|527364400|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
146231170|NCT06065735|527364401|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
146231171|NCT06065735|527364399|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
146231172|NCT06065735|527364400|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
146231173|NCT06065735|527364401|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
146231174|NCT02532621|527364402|FG000|Overall Study|Death|3|||
146231175|NCT02532621|527364402|FG000|Overall Study|Lost to Follow-up|3|||
146231176|NCT02532621|527364402|FG000|Overall Study|Withdrawal by Subject|6|||
146231177|NCT02532621|527364402|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
146231178|NCT02532621|527364402|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
146231179|NCT02933489|527364405|FG000|Overall Study|Ineligible|3|||
146231180|NCT02933489|527364406|FG001|Overall Study|Ineligible|3|||
146231181|NCT02933489|527364405|FG000|Overall Study|Withdrawal by Subject|27|||
146231182|NCT02933489|527364406|FG001|Overall Study|Withdrawal by Subject|18|||
145963281|NCT00888654|526378130|FG000|Overall Study|Change in surg date|1|||
145963282|NCT00888654|526378130|FG000|Overall Study|Stopped meds due to headaches|1|||
145963283|NCT02974868|526378131|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
145963284|NCT02974868|526378132|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
145963285|NCT02974868|526378133|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
145963286|NCT02974868|526378134|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
145963287|NCT02974868|526378131|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
145963288|NCT02974868|526378132|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
145963289|NCT02974868|526378133|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
145963290|NCT02974868|526378134|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
145963291|NCT02974868|526378131|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
145963292|NCT02974868|526378132|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
145963293|NCT02974868|526378133|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
145963294|NCT02974868|526378134|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
145963295|NCT02974868|526378131|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
145963296|NCT02974868|526378132|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
145963297|NCT02974868|526378133|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
145963298|NCT02974868|526378134|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
145963299|NCT02674516|526378135|FG000|Overall Study|Lost to Follow-up|3|||
145963300|NCT02674516|526378136|FG001|Overall Study|Lost to Follow-up|0|||
145963301|NCT02674516|526378135|FG000|Overall Study|Protocol Violation|0|||
146231183|NCT02933489|527364405|FG000|Overall Study|Unable to complete exams (other)|14|||
146231184|NCT02933489|527364406|FG001|Overall Study|Unable to complete exams (other)|7|||
146231185|NCT05485935|527364407|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
145963302|NCT02674516|526378136|FG001|Overall Study|Protocol Violation|4|||
146231186|NCT05485935|527364408|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
146231187|NCT05485935|527364407|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
146231188|NCT05485935|527364408|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
146231189|NCT05485935|527364407|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
146231190|NCT05485935|527364408|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
146231191|NCT05485935|527364407|FG000|Period 2 (T2 and V3)|loss of contact|0|||
146231192|NCT05485935|527364408|FG001|Period 2 (T2 and V3)|loss of contact|1|||
146231193|NCT04093869|527364410|FG000|Overall Study|Death|0|||
146231194|NCT04093869|527364411|FG001|Overall Study|Death|1|||
146231195|NCT04093869|527364410|FG000|Overall Study|Withdrawal by Subject|1|||
146231196|NCT04093869|527364411|FG001|Overall Study|Withdrawal by Subject|0|||
146231197|NCT03250676|527364416|FG000|Overall Study|Adverse Event|0|||
146231198|NCT03250676|527364417|FG001|Overall Study|Adverse Event|0|||
146231199|NCT03250676|527364418|FG002|Overall Study|Adverse Event|0|||
146231200|NCT03250676|527364419|FG003|Overall Study|Adverse Event|1|||
146231201|NCT03250676|527364420|FG004|Overall Study|Adverse Event|2|||
146231202|NCT03250676|527364421|FG005|Overall Study|Adverse Event|9|||
146231203|NCT03250676|527364416|FG000|Overall Study|Withdrawal by Subject|1|||
146231204|NCT03250676|527364417|FG001|Overall Study|Withdrawal by Subject|0|||
146231205|NCT03250676|527364418|FG002|Overall Study|Withdrawal by Subject|0|||
146231206|NCT03250676|527364419|FG003|Overall Study|Withdrawal by Subject|1|||
145963303|NCT02674516|526378135|FG000|Overall Study|Knowledge of study hypothesis|1|||
146086364|NCT02554279|526837933|FG001|Overall Study|Other reason|6|||
146231207|NCT03250676|527364420|FG004|Overall Study|Withdrawal by Subject|1|||
146231208|NCT03250676|527364421|FG005|Overall Study|Withdrawal by Subject|2|||
146231209|NCT03250676|527364416|FG000|Overall Study|Physician Decision|0|||
146231210|NCT03250676|527364417|FG001|Overall Study|Physician Decision|0|||
146231211|NCT03250676|527364418|FG002|Overall Study|Physician Decision|0|||
146231212|NCT03250676|527364419|FG003|Overall Study|Physician Decision|2|||
146231213|NCT03250676|527364420|FG004|Overall Study|Physician Decision|0|||
146231214|NCT03250676|527364421|FG005|Overall Study|Physician Decision|3|||
146231215|NCT03250676|527364416|FG000|Overall Study|Withdrawal of consent|0|||
146231216|NCT03250676|527364417|FG001|Overall Study|Withdrawal of consent|0|||
146231217|NCT03250676|527364418|FG002|Overall Study|Withdrawal of consent|2|||
146231218|NCT03250676|527364419|FG003|Overall Study|Withdrawal of consent|0|||
146231219|NCT03250676|527364420|FG004|Overall Study|Withdrawal of consent|0|||
146231220|NCT03250676|527364421|FG005|Overall Study|Withdrawal of consent|2|||
146231221|NCT03250676|527364416|FG000|Overall Study|Other|1|||
146231222|NCT03250676|527364417|FG001|Overall Study|Other|0|||
146231223|NCT03250676|527364418|FG002|Overall Study|Other|0|||
146231224|NCT03250676|527364419|FG003|Overall Study|Other|0|||
146086365|NCT00812487|526837934|FG000|Overall Study|Lost to Follow-up|2|||
146231225|NCT03250676|527364420|FG004|Overall Study|Other|0|||
146231226|NCT03250676|527364421|FG005|Overall Study|Other|0|||
146231227|NCT03250676|527364416|FG000|Overall Study|Disease progression|4|||
146231228|NCT03250676|527364417|FG001|Overall Study|Disease progression|12|||
146231229|NCT03250676|527364418|FG002|Overall Study|Disease progression|9|||
146231230|NCT03250676|527364419|FG003|Overall Study|Disease progression|7|||
146231231|NCT03250676|527364420|FG004|Overall Study|Disease progression|4|||
146231232|NCT03250676|527364421|FG005|Overall Study|Disease progression|88|||
146231233|NCT04626427|527364424|FG000|Overall Study|Death|1|||
146231234|NCT04626427|527364424|FG000|Overall Study|Withdrawal by Subject|1|||
146231235|NCT04626427|527364424|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
146231236|NCT04626427|527364424|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
146231237|NCT01553149|527364425|FG000|Overall Study|Adverse Event|0|||
146231238|NCT01553149|527364426|FG001|Overall Study|Adverse Event|9|||
146231239|NCT01553149|527364425|FG000|Overall Study|Physician Decision|5|||
146231240|NCT01553149|527364426|FG001|Overall Study|Physician Decision|10|||
146231241|NCT01553149|527364425|FG000|Overall Study|Ineligible|0|||
146231242|NCT01553149|527364426|FG001|Overall Study|Ineligible|1|||
146231243|NCT02325154|527364427|FG000|Overall Study|Physician Decision|1|||
146231244|NCT01265537|527364428|FG000|Overall Study|Adverse Event|2|||
146231245|NCT01265537|527364429|FG001|Overall Study|Adverse Event|1|||
146231246|NCT01265537|527364428|FG000|Overall Study|Physician Decision|0|||
146231247|NCT01265537|527364429|FG001|Overall Study|Physician Decision|1|||
146231248|NCT05866926|527364430|FG000|Overall Study|Death|16|||
146231249|NCT05866926|527364431|FG001|Overall Study|Death|9|||
146231250|NCT05866926|527364430|FG000|Overall Study|Lost to Follow-up|0|||
146231251|NCT05866926|527364431|FG001|Overall Study|Lost to Follow-up|1|||
146231252|NCT05866926|527364430|FG000|Overall Study|Adverse Event|1|||
146231253|NCT05866926|527364431|FG001|Overall Study|Adverse Event|0|||
146231254|NCT05866926|527364430|FG000|Overall Study|Withdrawal by Subject|5|||
146231255|NCT05866926|527364431|FG001|Overall Study|Withdrawal by Subject|1|||
146231256|NCT05866926|527364430|FG000|Overall Study|Disease progression|1|||
146231257|NCT05866926|527364431|FG001|Overall Study|Disease progression|0|||
146231258|NCT05866926|527364430|FG000|Overall Study|other causes|2|||
146231259|NCT05866926|527364431|FG001|Overall Study|other causes|1|||
146231260|NCT04595331|527365352|FG000|Overall Study|Withdrawal by Subject|0|||
146231261|NCT04595331|527365353|FG001|Overall Study|Withdrawal by Subject|1|||
146231262|NCT04595331|527365352|FG000|Overall Study|Lost to Follow-up|0|||
146231263|NCT04595331|527365353|FG001|Overall Study|Lost to Follow-up|5|||
146290025|NCT01313637|527577338|FG000|Overall Study|Lost to Follow-up|0|||
146231264|NCT04595331|527365352|FG000|Overall Study|Medical reason|0|||
146231265|NCT04595331|527365353|FG001|Overall Study|Medical reason|1|||
146231266|NCT05412004|527365354|FG000|Overall Study|Adverse Event|0|||
146231267|NCT05412004|527365355|FG001|Overall Study|Adverse Event|2|||
146231268|NCT05412004|527365356|FG002|Overall Study|Adverse Event|1|||
146231269|NCT05412004|527365357|FG003|Overall Study|Adverse Event|5|||
145963304|NCT02674516|526378136|FG001|Overall Study|Knowledge of study hypothesis|0|||
145963305|NCT00490035|526378137|FG000|Overall Study|AE, non-serious non-fatal|3|||
145963306|NCT00490035|526378138|FG001|Overall Study|AE, non-serious non-fatal|4|||
145963307|NCT00490035|526378139|FG002|Overall Study|AE, non-serious non-fatal|4|||
145963308|NCT00490035|526378140|FG003|Overall Study|AE, non-serious non-fatal|5|||
145963309|NCT00490035|526378137|FG000|Overall Study|Lost to Follow-up|2|||
145963310|NCT00490035|526378138|FG001|Overall Study|Lost to Follow-up|0|||
145963311|NCT00490035|526378139|FG002|Overall Study|Lost to Follow-up|1|||
145963312|NCT00490035|526378140|FG003|Overall Study|Lost to Follow-up|0|||
145963313|NCT00490035|526378137|FG000|Overall Study|Withdrawal by Subject|2|||
145963314|NCT00490035|526378138|FG001|Overall Study|Withdrawal by Subject|1|||
145963315|NCT00490035|526378139|FG002|Overall Study|Withdrawal by Subject|1|||
145963316|NCT00490035|526378140|FG003|Overall Study|Withdrawal by Subject|0|||
145963317|NCT00490035|526378137|FG000|Overall Study|Other reason|0|||
145963318|NCT00490035|526378138|FG001|Overall Study|Other reason|1|||
145963319|NCT00490035|526378139|FG002|Overall Study|Other reason|3|||
145963320|NCT00490035|526378140|FG003|Overall Study|Other reason|1|||
145963321|NCT00490035|526378137|FG000|Overall Study|AE, serious fatal|1|||
145963322|NCT00490035|526378138|FG001|Overall Study|AE, serious fatal|0|||
145963323|NCT00490035|526378139|FG002|Overall Study|AE, serious fatal|0|||
145963324|NCT00490035|526378140|FG003|Overall Study|AE, serious fatal|0|||
145963325|NCT00490035|526378137|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
145963326|NCT00490035|526378138|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
145963327|NCT00490035|526378139|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
145963328|NCT00490035|526378140|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
146086366|NCT00812487|526837935|FG001|Overall Study|Lost to Follow-up|0|||
146086367|NCT00812487|526837934|FG000|Overall Study|Withdrawal by Subject|3|||
146086368|NCT00812487|526837935|FG001|Overall Study|Withdrawal by Subject|2|||
146086369|NCT00812487|526837934|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
146231270|NCT05412004|527365354|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146231271|NCT05412004|527365355|FG001|Overall Study|Assigned Treatment by Mistake|10|||
146231272|NCT05412004|527365356|FG002|Overall Study|Assigned Treatment by Mistake|2|||
146231273|NCT05412004|527365357|FG003|Overall Study|Assigned Treatment by Mistake|5|||
146231274|NCT05412004|527365354|FG000|Overall Study|Lost to Follow-up|3|||
146231275|NCT05412004|527365355|FG001|Overall Study|Lost to Follow-up|0|||
146231276|NCT05412004|527365356|FG002|Overall Study|Lost to Follow-up|0|||
146231277|NCT05412004|527365357|FG003|Overall Study|Lost to Follow-up|0|||
146231278|NCT05412004|527365354|FG000|Overall Study|Patient could not travel to site|0|||
146231279|NCT05412004|527365355|FG001|Overall Study|Patient could not travel to site|1|||
146231280|NCT05412004|527365356|FG002|Overall Study|Patient could not travel to site|0|||
146231281|NCT05412004|527365357|FG003|Overall Study|Patient could not travel to site|0|||
146231282|NCT05412004|527365354|FG000|Overall Study|Physician Decision|0|||
146231283|NCT05412004|527365355|FG001|Overall Study|Physician Decision|1|||
146231284|NCT05412004|527365356|FG002|Overall Study|Physician Decision|0|||
146231285|NCT05412004|527365357|FG003|Overall Study|Physician Decision|0|||
146231286|NCT05412004|527365354|FG000|Overall Study|Pregnancy|0|||
146231287|NCT05412004|527365355|FG001|Overall Study|Pregnancy|1|||
146231288|NCT05412004|527365356|FG002|Overall Study|Pregnancy|0|||
146231289|NCT05412004|527365357|FG003|Overall Study|Pregnancy|0|||
146231290|NCT05412004|527365354|FG000|Overall Study|Protocol Violation|1|||
146231291|NCT05412004|527365355|FG001|Overall Study|Protocol Violation|0|||
146231292|NCT05412004|527365356|FG002|Overall Study|Protocol Violation|0|||
146231293|NCT05412004|527365357|FG003|Overall Study|Protocol Violation|0|||
146231294|NCT05412004|527365354|FG000|Overall Study|Withdrawal by Subject|4|||
146231295|NCT05412004|527365355|FG001|Overall Study|Withdrawal by Subject|19|||
146231296|NCT05412004|527365356|FG002|Overall Study|Withdrawal by Subject|4|||
146231297|NCT05412004|527365357|FG003|Overall Study|Withdrawal by Subject|14|||
146231298|NCT05412004|527365354|FG000|Overall Study|Screen Failure|0|||
146231299|NCT05412004|527365355|FG001|Overall Study|Screen Failure|0|||
146231300|NCT05412004|527365356|FG002|Overall Study|Screen Failure|0|||
146231301|NCT05412004|527365357|FG003|Overall Study|Screen Failure|1|||
146231302|NCT05412004|527365354|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
146231303|NCT05412004|527365355|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
146231304|NCT05412004|527365356|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
145963329|NCT00490035|526378137|FG000|Overall Study|AE of unknown type|0|||
146290026|NCT01313637|527577339|FG001|Overall Study|Lost to Follow-up|2|||
145963330|NCT00490035|526378138|FG001|Overall Study|AE of unknown type|0|||
145963331|NCT00490035|526378139|FG002|Overall Study|AE of unknown type|2|||
146231305|NCT05412004|527365357|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
146231306|NCT04644029|527365358|FG000|Overall Study|Death|1|||
146231307|NCT04644029|527365359|FG001|Overall Study|Death|0|||
146231308|NCT04644029|527365358|FG000|Overall Study|Physician Decision|1|||
146231309|NCT04644029|527365359|FG001|Overall Study|Physician Decision|2|||
146231310|NCT04644029|527365358|FG000|Overall Study|Withdrawal by Subject|21|||
146231311|NCT04644029|527365359|FG001|Overall Study|Withdrawal by Subject|19|||
146231312|NCT04644029|527365358|FG000|Overall Study|Lost to Follow-up|31|||
146231313|NCT04644029|527365359|FG001|Overall Study|Lost to Follow-up|34|||
146231314|NCT04644029|527365358|FG000|Overall Study|Study Terminated by Sponsor|308|||
146231315|NCT04644029|527365359|FG001|Overall Study|Study Terminated by Sponsor|309|||
146231316|NCT04644029|527365358|FG000|Overall Study|Randomized in Error|2|||
146231317|NCT04644029|527365359|FG001|Overall Study|Randomized in Error|1|||
146231318|NCT04644029|527365358|FG000|Overall Study|Other|0|||
146231319|NCT04644029|527365359|FG001|Overall Study|Other|1|||
146231320|NCT05020353|527365360|FG000|Overall Study|Protocol Violation|7|||
146231321|NCT05020353|527365360|FG000|Overall Study|Withdrawal by Subject|33|||
146231322|NCT02611687|527365362|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
146231323|NCT02611687|527365363|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
146231324|NCT03934931|527365364|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
146231325|NCT03934931|527365365|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
146231326|NCT03934931|527365366|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
146231327|NCT03786926|527365373|FG000|Overall Study|Adverse Event|0|||
146231328|NCT03786926|527365374|FG001|Overall Study|Adverse Event|0|||
146231329|NCT03786926|527365375|FG002|Overall Study|Adverse Event|0|||
146231330|NCT03786926|527365376|FG003|Overall Study|Adverse Event|0|||
146231331|NCT03786926|527365377|FG004|Overall Study|Adverse Event|0|||
146231332|NCT03786926|527365378|FG005|Overall Study|Adverse Event|0|||
146231333|NCT03786926|527365379|FG006|Overall Study|Adverse Event|0|||
146231334|NCT03786926|527365380|FG007|Overall Study|Adverse Event|1|||
146231335|NCT03786926|527365381|FG008|Overall Study|Adverse Event|1|||
146231336|NCT03786926|527365382|FG009|Overall Study|Adverse Event|0|||
146231337|NCT03786926|527365383|FG010|Overall Study|Adverse Event|1|||
146231338|NCT03786926|527365373|FG000|Overall Study|Progressive disease|3|||
146231339|NCT03786926|527365374|FG001|Overall Study|Progressive disease|0|||
146231340|NCT03786926|527365375|FG002|Overall Study|Progressive disease|3|||
146231341|NCT03786926|527365376|FG003|Overall Study|Progressive disease|1|||
146231342|NCT03786926|527365377|FG004|Overall Study|Progressive disease|2|||
146231343|NCT03786926|527365378|FG005|Overall Study|Progressive disease|2|||
146231344|NCT03786926|527365379|FG006|Overall Study|Progressive disease|1|||
146231345|NCT03786926|527365380|FG007|Overall Study|Progressive disease|6|||
146231346|NCT03786926|527365381|FG008|Overall Study|Progressive disease|1|||
146231347|NCT03786926|527365382|FG009|Overall Study|Progressive disease|1|||
146231348|NCT03786926|527365383|FG010|Overall Study|Progressive disease|1|||
146231349|NCT03786926|527365373|FG000|Overall Study|Death|0|||
146231350|NCT03786926|527365374|FG001|Overall Study|Death|1|||
146231351|NCT03786926|527365375|FG002|Overall Study|Death|1|||
146231352|NCT03786926|527365376|FG003|Overall Study|Death|0|||
146231353|NCT03786926|527365377|FG004|Overall Study|Death|0|||
146231354|NCT03786926|527365378|FG005|Overall Study|Death|0|||
146231355|NCT03786926|527365379|FG006|Overall Study|Death|0|||
146231356|NCT03786926|527365380|FG007|Overall Study|Death|0|||
146231357|NCT03786926|527365381|FG008|Overall Study|Death|0|||
146231358|NCT03786926|527365382|FG009|Overall Study|Death|1|||
146231359|NCT03786926|527365383|FG010|Overall Study|Death|2|||
146231360|NCT03786926|527365373|FG000|Overall Study|Physician Decision|0|||
146231361|NCT03786926|527365374|FG001|Overall Study|Physician Decision|1|||
146231362|NCT03786926|527365375|FG002|Overall Study|Physician Decision|0|||
146231363|NCT03786926|527365376|FG003|Overall Study|Physician Decision|1|||
146231364|NCT03786926|527365377|FG004|Overall Study|Physician Decision|2|||
146231365|NCT03786926|527365378|FG005|Overall Study|Physician Decision|0|||
146231366|NCT03786926|527365379|FG006|Overall Study|Physician Decision|0|||
146231367|NCT03786926|527365380|FG007|Overall Study|Physician Decision|2|||
146231368|NCT03786926|527365381|FG008|Overall Study|Physician Decision|1|||
146231369|NCT03786926|527365382|FG009|Overall Study|Physician Decision|1|||
146231370|NCT03786926|527365383|FG010|Overall Study|Physician Decision|0|||
146231371|NCT03786926|527365373|FG000|Overall Study|Withdrawal by Subject|0|||
146231372|NCT03786926|527365374|FG001|Overall Study|Withdrawal by Subject|1|||
146231373|NCT03786926|527365375|FG002|Overall Study|Withdrawal by Subject|1|||
146231374|NCT03786926|527365376|FG003|Overall Study|Withdrawal by Subject|0|||
146231375|NCT03786926|527365377|FG004|Overall Study|Withdrawal by Subject|0|||
146231376|NCT03786926|527365378|FG005|Overall Study|Withdrawal by Subject|0|||
146231377|NCT03786926|527365379|FG006|Overall Study|Withdrawal by Subject|1|||
146290027|NCT01313637|527577340|FG002|Overall Study|Lost to Follow-up|1|||
146290028|NCT01313637|527577341|FG003|Overall Study|Lost to Follow-up|3|||
146290029|NCT01313637|527577338|FG000|Overall Study|Withdrawal by Subject|11|||
146290030|NCT01313637|527577339|FG001|Overall Study|Withdrawal by Subject|13|||
146290031|NCT01313637|527577340|FG002|Overall Study|Withdrawal by Subject|18|||
146290032|NCT01313637|527577341|FG003|Overall Study|Withdrawal by Subject|15|||
146290033|NCT00795951|527577342|FG000|Overall Study|Lost to Follow-up|1|||
146290034|NCT00795951|527577342|FG000|Overall Study|Withdrawal by Subject|1|||
146290035|NCT00655486|527577348|FG000|Overall Study|Adverse Event|10|||
146290036|NCT00655486|527577348|FG000|Overall Study|Lack of Efficacy|8|||
146290037|NCT00655486|527577348|FG000|Overall Study|Withdrawal by Subject|4|||
146290038|NCT00655486|527577348|FG000|Overall Study|Protocol Violation|1|||
146290039|NCT00655486|527577348|FG000|Overall Study|Unsatisfactory compliance|2|||
146290040|NCT00655486|527577348|FG000|Overall Study|Other: Pregnancy|1|||
146290041|NCT00655486|527577348|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
146231378|NCT03786926|527365380|FG007|Overall Study|Withdrawal by Subject|0|||
146231379|NCT03786926|527365381|FG008|Overall Study|Withdrawal by Subject|1|||
146231380|NCT03786926|527365382|FG009|Overall Study|Withdrawal by Subject|0|||
146231381|NCT03786926|527365383|FG010|Overall Study|Withdrawal by Subject|1|||
146231382|NCT03786926|527365373|FG000|Overall Study|Study terminated by Sponsor|0|||
146231383|NCT03786926|527365374|FG001|Overall Study|Study terminated by Sponsor|0|||
146231384|NCT03786926|527365375|FG002|Overall Study|Study terminated by Sponsor|0|||
146231385|NCT03786926|527365376|FG003|Overall Study|Study terminated by Sponsor|0|||
146231386|NCT03786926|527365377|FG004|Overall Study|Study terminated by Sponsor|1|||
146231387|NCT03786926|527365378|FG005|Overall Study|Study terminated by Sponsor|0|||
146231388|NCT03786926|527365379|FG006|Overall Study|Study terminated by Sponsor|0|||
146231389|NCT03786926|527365380|FG007|Overall Study|Study terminated by Sponsor|4|||
146231390|NCT03786926|527365381|FG008|Overall Study|Study terminated by Sponsor|0|||
146231391|NCT03786926|527365382|FG009|Overall Study|Study terminated by Sponsor|0|||
146231392|NCT03786926|527365383|FG010|Overall Study|Study terminated by Sponsor|0|||
146231393|NCT03786926|527365373|FG000|Overall Study|Anti-neoplasm treatment|0|||
146231394|NCT03786926|527365374|FG001|Overall Study|Anti-neoplasm treatment|0|||
146231395|NCT03786926|527365375|FG002|Overall Study|Anti-neoplasm treatment|0|||
146231396|NCT03786926|527365376|FG003|Overall Study|Anti-neoplasm treatment|0|||
146231397|NCT03786926|527365377|FG004|Overall Study|Anti-neoplasm treatment|1|||
146290042|NCT00655486|527577348|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
146290043|NCT04218084|527577349|FG000|Overall Study|Adverse Event|7|||
146290044|NCT04218084|527577350|FG001|Overall Study|Adverse Event|2|||
146290045|NCT04218084|527577349|FG000|Overall Study|Withdrawal of Consent|4|||
146290046|NCT04218084|527577350|FG001|Overall Study|Withdrawal of Consent|5|||
145963332|NCT00490035|526378140|FG003|Overall Study|AE of unknown type|0|||
146290047|NCT04218084|527577349|FG000|Overall Study|Physician Decision|1|||
146290048|NCT04218084|527577350|FG001|Overall Study|Physician Decision|1|||
146290049|NCT04218084|527577349|FG000|Overall Study|Lost to Follow-up|1|||
146231398|NCT03786926|527365378|FG005|Overall Study|Anti-neoplasm treatment|0|||
146231399|NCT03786926|527365379|FG006|Overall Study|Anti-neoplasm treatment|1|||
146231400|NCT03786926|527365380|FG007|Overall Study|Anti-neoplasm treatment|0|||
146290050|NCT04218084|527577350|FG001|Overall Study|Lost to Follow-up|1|||
146231401|NCT03786926|527365381|FG008|Overall Study|Anti-neoplasm treatment|0|||
146231402|NCT03786926|527365382|FG009|Overall Study|Anti-neoplasm treatment|0|||
146231403|NCT03786926|527365383|FG010|Overall Study|Anti-neoplasm treatment|0|||
146231404|NCT03786926|527365373|FG000|Overall Study|Other|0|||
146231405|NCT03786926|527365374|FG001|Overall Study|Other|0|||
146231406|NCT03786926|527365375|FG002|Overall Study|Other|0|||
146231407|NCT03786926|527365376|FG003|Overall Study|Other|1|||
146231408|NCT03786926|527365377|FG004|Overall Study|Other|0|||
146231409|NCT03786926|527365378|FG005|Overall Study|Other|1|||
146231410|NCT03786926|527365379|FG006|Overall Study|Other|0|||
146231411|NCT03786926|527365380|FG007|Overall Study|Other|0|||
146231412|NCT03786926|527365381|FG008|Overall Study|Other|2|||
146231413|NCT03786926|527365382|FG009|Overall Study|Other|0|||
146231414|NCT03786926|527365383|FG010|Overall Study|Other|0|||
146231415|NCT05875701|527365388|FG000|Overall Study|Lost to Follow-up|2|||
146231416|NCT05875701|527365389|FG001|Overall Study|Lost to Follow-up|0|||
146231417|NCT05875701|527365388|FG000|Overall Study|Withdrawal by Subject|1|||
146231418|NCT05875701|527365389|FG001|Overall Study|Withdrawal by Subject|1|||
146231419|NCT03816397|527365396|FG000|Overall Study|Censored at interim analysis date.|13|||
146231420|NCT03816397|527365397|FG001|Overall Study|Censored at interim analysis date.|6|||
146231421|NCT03816397|527365396|FG000|Overall Study|Withdrawal by Subject|1|||
146231422|NCT03816397|527365397|FG001|Overall Study|Withdrawal by Subject|1|||
146231423|NCT03884439|527365409|FG000|Overall Study|No informed consent for publication of study results|38|||
146231424|NCT03884439|527365409|FG000|Overall Study|Contract violation/deficiency|7|||
146231425|NCT02806726|527365417|FG000|Overall Study|Lost to Follow-up|1|||
146231426|NCT05129501|527365418|FG000|Overall Study|Lost to Follow-up|54|||
146231427|NCT05129501|527365419|FG001|Overall Study|Lost to Follow-up|41|||
146231428|NCT03092674|527365420|FG000|Overall Study|Adverse Event or Side Effects|1|||
146231429|NCT03092674|527365421|FG001|Overall Study|Adverse Event or Side Effects|4|||
146231430|NCT03092674|527365422|FG002|Overall Study|Adverse Event or Side Effects|4|||
146231431|NCT03092674|527365420|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
146231432|NCT03092674|527365421|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
146231433|NCT03092674|527365422|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
146231434|NCT03092674|527365420|FG000|Overall Study|Progression/Relapse|5|||
146231435|NCT03092674|527365421|FG001|Overall Study|Progression/Relapse|4|||
146231436|NCT03092674|527365422|FG002|Overall Study|Progression/Relapse|8|||
146231437|NCT03092674|527365420|FG000|Overall Study|Death|4|||
146231438|NCT03092674|527365421|FG001|Overall Study|Death|8|||
146231439|NCT03092674|527365422|FG002|Overall Study|Death|2|||
146231440|NCT03092674|527365420|FG000|Overall Study|Other - Not Protocol Specified|11|||
146231441|NCT03092674|527365421|FG001|Overall Study|Other - Not Protocol Specified|8|||
146231442|NCT03092674|527365422|FG002|Overall Study|Other - Not Protocol Specified|8|||
146231443|NCT01527188|527365423|FG000|Overall Study|Adverse Event|5|||
146231444|NCT01527188|527365424|FG001|Overall Study|Adverse Event|5|||
145963333|NCT06058390|526378141|FG000|Overall Study|Lost to Follow-up|0|||
146231445|NCT01527188|527365425|FG002|Overall Study|Adverse Event|11|||
146231446|NCT01527188|527365426|FG003|Overall Study|Adverse Event|0|||
146231447|NCT01527188|527365423|FG000|Overall Study|Withdrawal by Subject|3|||
146231448|NCT01527188|527365424|FG001|Overall Study|Withdrawal by Subject|6|||
146231449|NCT01527188|527365425|FG002|Overall Study|Withdrawal by Subject|4|||
146231450|NCT01527188|527365426|FG003|Overall Study|Withdrawal by Subject|4|||
146231451|NCT01527188|527365423|FG000|Overall Study|Any other reason not above-mentioned|6|||
146231452|NCT01527188|527365424|FG001|Overall Study|Any other reason not above-mentioned|7|||
146231453|NCT01527188|527365425|FG002|Overall Study|Any other reason not above-mentioned|8|||
146231454|NCT01527188|527365426|FG003|Overall Study|Any other reason not above-mentioned|8|||
146231455|NCT03982186|527365429|FG000|Overall Study|Lost to Follow-up|0|||
146231456|NCT03982186|527365430|FG001|Overall Study|Lost to Follow-up|1|||
146231457|NCT03982186|527365431|FG002|Overall Study|Lost to Follow-up|2|||
146231458|NCT03982186|527365432|FG003|Overall Study|Lost to Follow-up|1|||
146231459|NCT03982186|527365433|FG004|Overall Study|Lost to Follow-up|1|||
146231460|NCT03982186|527365434|FG005|Overall Study|Lost to Follow-up|0|||
146231461|NCT03982186|527365429|FG000|Overall Study|Physician Decision|0|||
146231462|NCT03982186|527365430|FG001|Overall Study|Physician Decision|1|||
146231463|NCT03982186|527365431|FG002|Overall Study|Physician Decision|0|||
146231464|NCT03982186|527365432|FG003|Overall Study|Physician Decision|0|||
146231465|NCT03982186|527365433|FG004|Overall Study|Physician Decision|0|||
146231466|NCT03982186|527365434|FG005|Overall Study|Physician Decision|0|||
146290051|NCT04218084|527577349|FG000|Overall Study|Non-compliance with study drug|1|||
146290052|NCT04218084|527577350|FG001|Overall Study|Non-compliance with study drug|1|||
146290053|NCT04218084|527577349|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
145963334|NCT06058390|526378142|FG001|Overall Study|Lost to Follow-up|0|||
145963335|NCT06058390|526378143|FG002|Overall Study|Lost to Follow-up|2|||
145963336|NCT06058390|526378144|FG003|Overall Study|Lost to Follow-up|1|||
145963337|NCT06058390|526378141|FG000|Overall Study|Physician Decision|0|||
145963338|NCT06058390|526378142|FG001|Overall Study|Physician Decision|0|||
145963339|NCT06058390|526378143|FG002|Overall Study|Physician Decision|0|||
145963340|NCT06058390|526378144|FG003|Overall Study|Physician Decision|1|||
145963341|NCT06058390|526378141|FG000|Overall Study|Participants did not receive any study intervention|0|||
146290054|NCT04218084|527577350|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
146231467|NCT03982186|527365429|FG000|Overall Study|Withdrawal by Subject|3|||
146231468|NCT03982186|527365430|FG001|Overall Study|Withdrawal by Subject|4|||
146290055|NCT04218084|527577349|FG000|Overall Study|Other|0|||
146231469|NCT03982186|527365431|FG002|Overall Study|Withdrawal by Subject|1|||
146231470|NCT03982186|527365432|FG003|Overall Study|Withdrawal by Subject|7|||
146290056|NCT04218084|527577350|FG001|Overall Study|Other|1|||
146290057|NCT04218084|527577349|FG000|Overall Study|Ongoing at data cut-off date|62|||
146231471|NCT03982186|527365433|FG004|Overall Study|Withdrawal by Subject|2|||
146231472|NCT03982186|527365434|FG005|Overall Study|Withdrawal by Subject|0|||
146231473|NCT03982186|527365429|FG000|Overall Study|Randomized and not treated|0|||
146231474|NCT03982186|527365430|FG001|Overall Study|Randomized and not treated|0|||
146231475|NCT03982186|527365431|FG002|Overall Study|Randomized and not treated|0|||
146231476|NCT03982186|527365432|FG003|Overall Study|Randomized and not treated|1|||
146231477|NCT03982186|527365433|FG004|Overall Study|Randomized and not treated|0|||
146231478|NCT03982186|527365434|FG005|Overall Study|Randomized and not treated|0|||
146231479|NCT05267639|527366273|FG000|Overall Study|Withdrawal by Subject|1|||
146231480|NCT05267639|527366274|FG001|Overall Study|Withdrawal by Subject|0|||
146231481|NCT03512301|527366284|FG000|Overall Study|Protocol Violation|2|||
146231482|NCT03512301|527366284|FG000|Overall Study|Did Not Qualify|3|||
146231483|NCT03512301|527366284|FG000|Overall Study|Age-ineligible|1|||
146231484|NCT03512301|527366284|FG000|Overall Study|Inadequate fluency with the English language|3|||
146231485|NCT00739908|527366291|FG000|Overall Study|Adverse Event|5|||
146231486|NCT00739908|527366292|FG001|Overall Study|Adverse Event|6|||
146231487|NCT00739908|527366291|FG000|Overall Study|Withdrawal by Subject|4|||
146231488|NCT00739908|527366292|FG001|Overall Study|Withdrawal by Subject|2|||
146231489|NCT00739908|527366291|FG000|Overall Study|Lost to Follow-up|14|||
146231490|NCT00739908|527366292|FG001|Overall Study|Lost to Follow-up|9|||
146231491|NCT00739908|527366291|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
146231492|NCT00739908|527366292|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
146231493|NCT00739908|527366291|FG000|Overall Study|Non-Compliance With Study Medication|0|||
146231494|NCT00739908|527366292|FG001|Overall Study|Non-Compliance With Study Medication|3|||
146231495|NCT00739908|527366291|FG000|Overall Study|Lack of Efficacy|0|||
146231496|NCT00739908|527366292|FG001|Overall Study|Lack of Efficacy|1|||
146231497|NCT00739908|527366291|FG000|Overall Study|Relocation|0|||
146231498|NCT00739908|527366292|FG001|Overall Study|Relocation|1|||
146231499|NCT05157841|527366293|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
146231500|NCT05157841|527366294|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
146231501|NCT05157841|527366295|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
146231502|NCT05157841|527366293|FG000|Part A (14 Days)|Adverse Event|1|||
146231503|NCT05157841|527366294|FG001|Part A (14 Days)|Adverse Event|0|||
146231504|NCT05157841|527366295|FG002|Part A (14 Days)|Adverse Event|0|||
146231505|NCT05157841|527366293|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
146231506|NCT05157841|527366294|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
146231507|NCT05157841|527366295|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
146231508|NCT02075554|527366299|FG000|Overall Study|Lost to Follow-up|7|||
146231509|NCT02075554|527366299|FG000|Overall Study|Withdrawal by Subject|5|||
146290058|NCT04218084|527577350|FG001|Overall Study|Ongoing at data cut-off date|58|||
146290059|NCT00986674|527577351|FG000|Overall Study|Lack of Efficacy|28|||
146231510|NCT02075554|527366299|FG000|Overall Study|Physician Decision|3|||
146231511|NCT04933474|527366305|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
146231512|NCT04933474|527366306|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
146231513|NCT04933474|527366305|FG000|Overall Study|Lost to Follow-up|19|||
146231514|NCT04933474|527366306|FG001|Overall Study|Lost to Follow-up|9|||
146231515|NCT04933474|527366305|FG000|Overall Study|Life Burden - unable to participate|6|||
146231516|NCT04933474|527366306|FG001|Overall Study|Life Burden - unable to participate|2|||
146231517|NCT04933474|527366305|FG000|Overall Study|Disease Burden - unable to participate|4|||
146231518|NCT04933474|527366306|FG001|Overall Study|Disease Burden - unable to participate|1|||
146231519|NCT04933474|527366305|FG000|Overall Study|Surgery/Hospitalization|1|||
146231520|NCT04933474|527366306|FG001|Overall Study|Surgery/Hospitalization|2|||
146231521|NCT04933474|527366305|FG000|Overall Study|Dissatisfied with Intervention|1|||
146231522|NCT04933474|527366306|FG001|Overall Study|Dissatisfied with Intervention|1|||
146231523|NCT04933474|527366305|FG000|Overall Study|Withdrew interest in participation|1|||
146231524|NCT04933474|527366306|FG001|Overall Study|Withdrew interest in participation|0|||
146231525|NCT04933474|527366305|FG000|Overall Study|Had previously enrolled in the study|0|||
146231526|NCT04933474|527366306|FG001|Overall Study|Had previously enrolled in the study|1|||
146231527|NCT01773993|527366307|FG000|Overall Study|No Visit After Treatment|35|||
146231528|NCT04993677|527366308|FG000|Overall Study|Lost to Follow-up|1|||
146231529|NCT04993677|527366309|FG001|Overall Study|Lost to Follow-up|0|||
146231530|NCT04993677|527366310|FG002|Overall Study|Lost to Follow-up|0|||
146231531|NCT04993677|527366311|FG003|Overall Study|Lost to Follow-up|0|||
146231532|NCT04993677|527366308|FG000|Overall Study|Death|11|||
146231533|NCT04993677|527366309|FG001|Overall Study|Death|8|||
146231534|NCT04993677|527366310|FG002|Overall Study|Death|3|||
146231535|NCT04993677|527366311|FG003|Overall Study|Death|1|||
146231536|NCT04993677|527366308|FG000|Overall Study|Subject withdrawal of consent|4|||
146231537|NCT04993677|527366309|FG001|Overall Study|Subject withdrawal of consent|3|||
146231538|NCT04993677|527366310|FG002|Overall Study|Subject withdrawal of consent|0|||
146231539|NCT04993677|527366311|FG003|Overall Study|Subject withdrawal of consent|2|||
146231540|NCT04993677|527366308|FG000|Overall Study|Study termination by sponsor|3|||
146231541|NCT04993677|527366309|FG001|Overall Study|Study termination by sponsor|25|||
146231542|NCT04993677|527366310|FG002|Overall Study|Study termination by sponsor|3|||
146231543|NCT04993677|527366311|FG003|Overall Study|Study termination by sponsor|3|||
146231544|NCT04993677|527366308|FG000|Overall Study|Other|2|||
146231545|NCT04993677|527366309|FG001|Overall Study|Other|3|||
146231546|NCT04993677|527366310|FG002|Overall Study|Other|3|||
146231547|NCT04993677|527366311|FG003|Overall Study|Other|2|||
146231548|NCT04174170|527366312|FG000|Placebo Run-in Period|Not Randomized|38|||
146231549|NCT04174170|527366313|FG001|Placebo Run-in Period|Not Randomized|0|||
146231550|NCT04174170|527366314|FG002|Placebo Run-in Period|Not Randomized|0|||
146231551|NCT04174170|527366315|FG003|Placebo Run-in Period|Not Randomized|0|||
146231552|NCT04174170|527366312|FG000|Double Blind Treatment Period|Adverse Event|0|||
146231553|NCT04174170|527366313|FG001|Double Blind Treatment Period|Adverse Event|9|||
146231554|NCT04174170|527366314|FG002|Double Blind Treatment Period|Adverse Event|9|||
146290060|NCT00986674|527577352|FG001|Overall Study|Lack of Efficacy|25|||
146290061|NCT00986674|527577353|FG002|Overall Study|Lack of Efficacy|23|||
146231555|NCT04174170|527366315|FG003|Double Blind Treatment Period|Adverse Event|8|||
146290062|NCT00986674|527577351|FG000|Overall Study|Adverse Event|4|||
146290063|NCT00986674|527577352|FG001|Overall Study|Adverse Event|8|||
146290064|NCT00986674|527577353|FG002|Overall Study|Adverse Event|9|||
146231556|NCT04174170|527366312|FG000|Double Blind Treatment Period|Death|0|||
146290065|NCT00986674|527577351|FG000|Overall Study|Death|5|||
145886346|NCT00573170|526088316|FG002|First Washout Period|Adverse Event|0|||
145886347|NCT00573170|526088317|FG003|First Washout Period|Adverse Event|0|||
145886348|NCT00573170|526088318|FG004|First Washout Period|Adverse Event|0|||
145886349|NCT00573170|526088319|FG005|First Washout Period|Adverse Event|1|||
145886350|NCT00573170|526088314|FG000|First Washout Period|Lack of Efficacy|0|||
145886351|NCT00573170|526088315|FG001|First Washout Period|Lack of Efficacy|0|||
146290066|NCT00986674|527577352|FG001|Overall Study|Death|0|||
146290067|NCT00986674|527577353|FG002|Overall Study|Death|4|||
146290068|NCT00986674|527577351|FG000|Overall Study|Withdrawal by Subject|6|||
145886352|NCT00573170|526088316|FG002|First Washout Period|Lack of Efficacy|0|||
145886353|NCT00573170|526088317|FG003|First Washout Period|Lack of Efficacy|0|||
145886354|NCT00573170|526088318|FG004|First Washout Period|Lack of Efficacy|0|||
145886355|NCT00573170|526088319|FG005|First Washout Period|Lack of Efficacy|1|||
145886356|NCT00573170|526088314|FG000|First Washout Period|Lost to Follow-up|1|||
146290069|NCT00986674|527577352|FG001|Overall Study|Withdrawal by Subject|2|||
146290070|NCT00986674|527577353|FG002|Overall Study|Withdrawal by Subject|1|||
145886357|NCT00573170|526088315|FG001|First Washout Period|Lost to Follow-up|1|||
145886358|NCT00573170|526088316|FG002|First Washout Period|Lost to Follow-up|0|||
146086370|NCT00812487|526837935|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
146086371|NCT00812487|526837934|FG000|Overall Study|Protocol Violation|0|||
146086372|NCT00812487|526837935|FG001|Overall Study|Protocol Violation|1|||
146086373|NCT00998764|526837936|FG000|Overall Study|Lack of Efficacy|3|||
146086374|NCT00998764|526837937|FG001|Overall Study|Lack of Efficacy|6|||
146086375|NCT00998764|526837936|FG000|Overall Study|Adverse Event|17|||
146086376|NCT00998764|526837937|FG001|Overall Study|Adverse Event|12|||
146086377|NCT00998764|526837936|FG000|Overall Study|Withdrawal by Subject|19|||
146086378|NCT00998764|526837937|FG001|Overall Study|Withdrawal by Subject|25|||
146086379|NCT00998764|526837936|FG000|Overall Study|Physician Decision|3|||
146086380|NCT00998764|526837937|FG001|Overall Study|Physician Decision|3|||
146086381|NCT00998764|526837936|FG000|Overall Study|Death|3|||
146086382|NCT00998764|526837937|FG001|Overall Study|Death|1|||
146086383|NCT00998764|526837936|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
146086384|NCT00998764|526837937|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
146086385|NCT00998764|526837936|FG000|Overall Study|Protocol Violation|0|||
146086386|NCT00998764|526837937|FG001|Overall Study|Protocol Violation|1|||
146086387|NCT00998764|526837936|FG000|Overall Study|Failed to Return|1|||
146290071|NCT00986674|527577351|FG000|Overall Study|alternative therapy|0|||
146290072|NCT00986674|527577352|FG001|Overall Study|alternative therapy|0|||
146290073|NCT00986674|527577353|FG002|Overall Study|alternative therapy|1|||
146290074|NCT00986674|527577351|FG000|Overall Study|not start protocol therapy|4|||
146290075|NCT00986674|527577352|FG001|Overall Study|not start protocol therapy|3|||
146290076|NCT00986674|527577353|FG002|Overall Study|not start protocol therapy|1|||
146086388|NCT00998764|526837937|FG001|Overall Study|Failed to Return|1|||
146290077|NCT00986674|527577351|FG000|Overall Study|unknown/not specify|0|||
146290078|NCT00986674|527577352|FG001|Overall Study|unknown/not specify|7|||
146290079|NCT00986674|527577353|FG002|Overall Study|unknown/not specify|9|||
146290080|NCT02435966|527577356|FG000|Overall Study|Withdrawal by Subject|0|||
146086389|NCT00998764|526837936|FG000|Overall Study|Lost to Follow-up|1|||
145963342|NCT06058390|526378142|FG001|Overall Study|Participants did not receive any study intervention|0|||
145963343|NCT06058390|526378143|FG002|Overall Study|Participants did not receive any study intervention|0|||
145963344|NCT06058390|526378144|FG003|Overall Study|Participants did not receive any study intervention|1|||
145963345|NCT03589807|526378147|FG000|Overall Study|Lost to Follow-up|0|||
146290081|NCT02435966|527577357|FG001|Overall Study|Withdrawal by Subject|1|||
145963346|NCT03589807|526378148|FG001|Overall Study|Lost to Follow-up|2|||
145963347|NCT03589807|526378149|FG002|Overall Study|Lost to Follow-up|2|||
145963348|NCT03589807|526378150|FG003|Overall Study|Lost to Follow-up|3|||
145963349|NCT03589807|526378151|FG004|Overall Study|Lost to Follow-up|1|||
145963350|NCT03589807|526378152|FG005|Overall Study|Lost to Follow-up|1|||
145963351|NCT03589807|526378147|FG000|Overall Study|Withdrawal by Subject|0|||
145963352|NCT03589807|526378148|FG001|Overall Study|Withdrawal by Subject|5|||
145963353|NCT03589807|526378149|FG002|Overall Study|Withdrawal by Subject|0|||
145963354|NCT03589807|526378150|FG003|Overall Study|Withdrawal by Subject|0|||
145963355|NCT03589807|526378151|FG004|Overall Study|Withdrawal by Subject|0|||
145963356|NCT03589807|526378152|FG005|Overall Study|Withdrawal by Subject|0|||
145963357|NCT03589807|526378147|FG000|Overall Study|Protocol Violation|0|||
145963358|NCT03589807|526378148|FG001|Overall Study|Protocol Violation|0|||
145963359|NCT03589807|526378149|FG002|Overall Study|Protocol Violation|0|||
145963360|NCT03589807|526378150|FG003|Overall Study|Protocol Violation|1|||
145963361|NCT03589807|526378151|FG004|Overall Study|Protocol Violation|0|||
145963362|NCT03589807|526378152|FG005|Overall Study|Protocol Violation|0|||
145963363|NCT03589807|526378147|FG000|Overall Study|Enrolled but treatment not administered|0|||
145963364|NCT03589807|526378148|FG001|Overall Study|Enrolled but treatment not administered|0|||
145963365|NCT03589807|526378149|FG002|Overall Study|Enrolled but treatment not administered|0|||
145963366|NCT03589807|526378150|FG003|Overall Study|Enrolled but treatment not administered|0|||
145963367|NCT03589807|526378151|FG004|Overall Study|Enrolled but treatment not administered|1|||
145963368|NCT03589807|526378152|FG005|Overall Study|Enrolled but treatment not administered|0|||
145963369|NCT01534273|526378153|FG000|Period 1|Physician Decision|0|||
145963370|NCT01534273|526378154|FG001|Period 1|Physician Decision|0|||
145963371|NCT01534273|526378155|FG002|Period 1|Physician Decision|0|||
145963372|NCT01534273|526378156|FG003|Period 1|Physician Decision|1|||
145963373|NCT01534273|526378157|FG004|Period 1|Physician Decision|0|||
145886359|NCT00573170|526088317|FG003|First Washout Period|Lost to Follow-up|2|||
145886360|NCT00573170|526088318|FG004|First Washout Period|Lost to Follow-up|0|||
145886361|NCT00573170|526088319|FG005|First Washout Period|Lost to Follow-up|2|||
146231557|NCT04174170|527366313|FG001|Double Blind Treatment Period|Death|1|||
146231558|NCT04174170|527366314|FG002|Double Blind Treatment Period|Death|0|||
146231559|NCT04174170|527366315|FG003|Double Blind Treatment Period|Death|0|||
146231560|NCT04174170|527366312|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146231561|NCT04174170|527366313|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
145963374|NCT01534273|526378158|FG005|Period 1|Physician Decision|0|||
145963375|NCT01534273|526378159|FG006|Period 1|Physician Decision|0|||
145963376|NCT01619865|526378160|FG000|Overall Study|Adverse Event|1|||
145963377|NCT01619865|526378160|FG000|Overall Study|Death|2|||
145963378|NCT01619865|526378160|FG000|Overall Study|subject not able to comply|1|||
145963379|NCT03586050|526378161|FG000|Overall Study|Death|3|||
145963380|NCT03586050|526378161|FG000|Overall Study|Withdrawal by Subject|2|||
145963381|NCT01494818|526378162|FG000|Overall Study|Relocation|1|||
145963382|NCT01494818|526378163|FG001|Overall Study|Relocation|2|||
145963383|NCT01494818|526378162|FG000|Overall Study|Lost to Follow-up|1|||
145963384|NCT01494818|526378163|FG001|Overall Study|Lost to Follow-up|0|||
145963385|NCT00593918|526378164|FG000|Overall Study|Withdrawal by Subject|5|||
145963386|NCT00593918|526378165|FG001|Overall Study|Withdrawal by Subject|24|||
145963387|NCT01211145|526378169|FG000|Overall Study|Reason not specified|3|||
145963388|NCT01211145|526378170|FG001|Overall Study|Reason not specified|2|||
145963389|NCT01211145|526378171|FG002|Overall Study|Reason not specified|2|||
145963390|NCT01211145|526378172|FG003|Overall Study|Reason not specified|1|||
145963391|NCT01211145|526378169|FG000|Overall Study|Lost to Follow-up|3|||
145963392|NCT01211145|526378170|FG001|Overall Study|Lost to Follow-up|2|||
145963393|NCT01211145|526378171|FG002|Overall Study|Lost to Follow-up|1|||
145963394|NCT01211145|526378172|FG003|Overall Study|Lost to Follow-up|2|||
145963395|NCT01211145|526378169|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145963396|NCT01211145|526378170|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145963397|NCT01211145|526378171|FG002|Overall Study|Study-specific withdrawal criteria|0|||
145963398|NCT01211145|526378172|FG003|Overall Study|Study-specific withdrawal criteria|0|||
145963399|NCT01211145|526378169|FG000|Overall Study|Severe noncompliance to protocol|1|||
145963400|NCT01211145|526378170|FG001|Overall Study|Severe noncompliance to protocol|0|||
145963401|NCT01211145|526378171|FG002|Overall Study|Severe noncompliance to protocol|0|||
145963402|NCT01211145|526378172|FG003|Overall Study|Severe noncompliance to protocol|0|||
145963403|NCT01211145|526378169|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
145963404|NCT01211145|526378170|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
145963405|NCT01211145|526378171|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
145963406|NCT01211145|526378172|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
145963407|NCT01211145|526378169|FG000|Overall Study|Patient decision|2|||
145963408|NCT01211145|526378170|FG001|Overall Study|Patient decision|1|||
145963409|NCT01211145|526378171|FG002|Overall Study|Patient decision|0|||
146231562|NCT04174170|527366314|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
145963410|NCT01211145|526378172|FG003|Overall Study|Patient decision|2|||
145963411|NCT00427908|526378173|FG000|Primary Phase|Lost to Follow-up|4|||
145963412|NCT00427908|526378174|FG001|Primary Phase|Lost to Follow-up|0|||
145963413|NCT00427908|526378175|FG002|Primary Phase|Lost to Follow-up|2|||
146231563|NCT04174170|527366315|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
146231564|NCT04174170|527366312|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
146086390|NCT00998764|526837937|FG001|Overall Study|Lost to Follow-up|1|||
145886362|NCT00573170|526088314|FG000|First Washout Period|Withdrawal by Subject|2|||
145886363|NCT00573170|526088315|FG001|First Washout Period|Withdrawal by Subject|0|||
145886364|NCT00573170|526088316|FG002|First Washout Period|Withdrawal by Subject|0|||
145886365|NCT00573170|526088317|FG003|First Washout Period|Withdrawal by Subject|2|||
145886366|NCT00573170|526088318|FG004|First Washout Period|Withdrawal by Subject|3|||
145886367|NCT00573170|526088319|FG005|First Washout Period|Withdrawal by Subject|3|||
145886368|NCT00573170|526088314|FG000|First Washout Period|Other|4|||
145886369|NCT00573170|526088315|FG001|First Washout Period|Other|0|||
145886370|NCT00573170|526088316|FG002|First Washout Period|Other|1|||
145886371|NCT00573170|526088317|FG003|First Washout Period|Other|1|||
145963414|NCT00427908|526378176|FG003|Primary Phase|Lost to Follow-up|0|||
145963415|NCT00427908|526378173|FG000|Primary Phase|Withdrawal by Subject|1|||
145886372|NCT00573170|526088318|FG004|First Washout Period|Other|0|||
145963416|NCT00427908|526378174|FG001|Primary Phase|Withdrawal by Subject|2|||
145963417|NCT00427908|526378175|FG002|Primary Phase|Withdrawal by Subject|1|||
145963418|NCT00427908|526378176|FG003|Primary Phase|Withdrawal by Subject|0|||
145963419|NCT00427908|526378173|FG000|Primary Phase|Adverse Event|0|||
146231565|NCT04174170|527366313|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
146231566|NCT04174170|527366314|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
146231567|NCT04174170|527366315|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
146231568|NCT04174170|527366312|FG000|Double Blind Treatment Period|Physician Decision|0|||
146231569|NCT04174170|527366313|FG001|Double Blind Treatment Period|Physician Decision|1|||
146231570|NCT04174170|527366314|FG002|Double Blind Treatment Period|Physician Decision|0|||
146231571|NCT04174170|527366315|FG003|Double Blind Treatment Period|Physician Decision|1|||
146231572|NCT04174170|527366312|FG000|Double Blind Treatment Period|Pregnancy|0|||
146231573|NCT04174170|527366313|FG001|Double Blind Treatment Period|Pregnancy|1|||
146231574|NCT04174170|527366314|FG002|Double Blind Treatment Period|Pregnancy|0|||
146231575|NCT04174170|527366315|FG003|Double Blind Treatment Period|Pregnancy|1|||
146231576|NCT04174170|527366312|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
146231577|NCT04174170|527366313|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
146231578|NCT04174170|527366314|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
146231579|NCT04174170|527366315|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
146231580|NCT04174170|527366312|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146231581|NCT04174170|527366313|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
146231582|NCT04174170|527366314|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
146231583|NCT04174170|527366315|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
146231584|NCT04174170|527366312|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
146231585|NCT04174170|527366313|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
146231586|NCT04174170|527366314|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
146231587|NCT04174170|527366315|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
146231588|NCT04664881|527366316|FG000|Overall Study|Withdrawal by Subject|1|||
146231589|NCT04664881|527366317|FG001|Overall Study|Withdrawal by Subject|8|||
146231590|NCT04664881|527366316|FG000|Overall Study|Physician Decision|0|||
146231591|NCT04664881|527366317|FG001|Overall Study|Physician Decision|5|||
146231592|NCT04664881|527366316|FG000|Overall Study|Lost to Follow-up|1|||
146231593|NCT04664881|527366317|FG001|Overall Study|Lost to Follow-up|0|||
146231594|NCT04772534|527366330|FG000|Overall Study|Physician Decision|1|||
146231595|NCT04772534|527366331|FG001|Overall Study|Physician Decision|0|||
146231596|NCT04772534|527366332|FG002|Overall Study|Physician Decision|0|||
146231597|NCT04772534|527366330|FG000|Overall Study|Withdrawal by Subject|3|||
146231598|NCT04772534|527366331|FG001|Overall Study|Withdrawal by Subject|0|||
146231599|NCT04772534|527366332|FG002|Overall Study|Withdrawal by Subject|1|||
146231600|NCT04194450|527366333|FG000|Overall Study|not eligible|1|||
146231601|NCT04194450|527366334|FG001|Overall Study|not eligible|0|||
146231602|NCT00308997|527366353|FG000|Overall Study|Subject feigned clinical data|0|||
146231603|NCT00308997|527366354|FG001|Overall Study|Subject feigned clinical data|1|||
146231604|NCT00308997|527366353|FG000|Overall Study|Unable to tolerate intervention|1|||
146231605|NCT00308997|527366354|FG001|Overall Study|Unable to tolerate intervention|0|||
146231606|NCT04490356|527366355|FG000|Overall Study|Lost to Follow-up|1|||
146086391|NCT00998764|526837936|FG000|Overall Study|Loss of Caregiver|0|||
146086392|NCT00998764|526837937|FG001|Overall Study|Loss of Caregiver|3|||
146086393|NCT00998764|526837936|FG000|Overall Study|Other|4|||
146086394|NCT00998764|526837937|FG001|Overall Study|Other|4|||
146086395|NCT00998764|526837936|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
146086396|NCT00998764|526837937|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
146086397|NCT04761627|526837940|FG000|Run-in Period|Death|1|||
146086398|NCT04761627|526837941|FG001|Run-in Period|Death|0|||
146086399|NCT04761627|526837942|FG002|Run-in Period|Death|0|||
146086400|NCT04761627|526837940|FG000|Run-in Period|Required alternative therapy|2|||
146086401|NCT04761627|526837941|FG001|Run-in Period|Required alternative therapy|0|||
146086402|NCT04761627|526837942|FG002|Run-in Period|Required alternative therapy|0|||
146086403|NCT04761627|526837940|FG000|Run-in Period|Lost to Follow-up|2|||
146086404|NCT04761627|526837941|FG001|Run-in Period|Lost to Follow-up|0|||
146086405|NCT04761627|526837942|FG002|Run-in Period|Lost to Follow-up|0|||
146086406|NCT04761627|526837940|FG000|Run-in Period|Protocol Violation|3|||
146086407|NCT04761627|526837941|FG001|Run-in Period|Protocol Violation|0|||
146086408|NCT04761627|526837942|FG002|Run-in Period|Protocol Violation|0|||
146086409|NCT04761627|526837940|FG000|Run-in Period|Abnormal liver function|1|||
146086410|NCT04761627|526837941|FG001|Run-in Period|Abnormal liver function|0|||
146086411|NCT04761627|526837942|FG002|Run-in Period|Abnormal liver function|0|||
146086412|NCT04761627|526837940|FG000|Run-in Period|Adverse Event|6|||
146086413|NCT04761627|526837941|FG001|Run-in Period|Adverse Event|0|||
146086414|NCT04761627|526837942|FG002|Run-in Period|Adverse Event|0|||
146086415|NCT04761627|526837940|FG000|Run-in Period|Withdrawal by Subject|7|||
146086416|NCT04761627|526837941|FG001|Run-in Period|Withdrawal by Subject|0|||
146086417|NCT04761627|526837942|FG002|Run-in Period|Withdrawal by Subject|0|||
146086418|NCT04761627|526837940|FG000|Run-in Period|Did not meet PASI 50|15|||
146086419|NCT04761627|526837941|FG001|Run-in Period|Did not meet PASI 50|0|||
146086420|NCT04761627|526837942|FG002|Run-in Period|Did not meet PASI 50|0|||
146086421|NCT04761627|526837940|FG000|Run-in Period|Study site closure|2|||
146086422|NCT04761627|526837941|FG001|Run-in Period|Study site closure|0|||
146086423|NCT04761627|526837942|FG002|Run-in Period|Study site closure|0|||
146086424|NCT04761627|526837940|FG000|Run-in Period|Pregnancy|2|||
146231607|NCT03733626|527366361|FG000|Overall Study|Physician Decision|4|||
146231608|NCT03733626|527366362|FG001|Overall Study|Physician Decision|4|||
146231609|NCT01220531|527366363|FG000|Overall Study|Death|7|||
146231610|NCT01220531|527366363|FG000|Overall Study|Lost to Follow-up|1|||
146086425|NCT04761627|526837941|FG001|Run-in Period|Pregnancy|0|||
146086426|NCT04761627|526837942|FG002|Run-in Period|Pregnancy|0|||
146086427|NCT04761627|526837940|FG000|Post-randomization Period|Military service|0|||
146086428|NCT04761627|526837941|FG001|Post-randomization Period|Military service|1|||
146086429|NCT04761627|526837942|FG002|Post-randomization Period|Military service|0|||
146231611|NCT00709956|527366364|FG000|Overall Study|Withdrawal by Subject|1|||
146231612|NCT00709956|527366365|FG001|Overall Study|Withdrawal by Subject|1|||
146231613|NCT00709956|527366364|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
146231614|NCT00709956|527366365|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
146231615|NCT01105091|527366366|FG000|Overall Study|Death|2|||
146231616|NCT01105091|527366367|FG001|Overall Study|Death|0|||
146231617|NCT03215706|527366368|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146231618|NCT03215706|527366369|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146231619|NCT03215706|527366368|FG000|Randomization|participant withdrew consent|1|||
146231620|NCT03215706|527366369|FG001|Randomization|participant withdrew consent|3|||
146231621|NCT03215706|527366368|FG000|Randomization|no longer meets study criteria|1|||
146231622|NCT03215706|527366369|FG001|Randomization|no longer meets study criteria|4|||
146231623|NCT03215706|527366368|FG000|Randomization|other reasons|0|||
146231624|NCT03215706|527366369|FG001|Randomization|other reasons|2|||
146231625|NCT03215706|527366368|FG000|Treatment Period|Disease Progression|150|||
146290082|NCT02435966|527577358|FG002|Overall Study|Withdrawal by Subject|0|||
145963420|NCT00427908|526378174|FG001|Primary Phase|Adverse Event|1|||
145963421|NCT00427908|526378175|FG002|Primary Phase|Adverse Event|0|||
145963422|NCT00427908|526378176|FG003|Primary Phase|Adverse Event|0|||
145963423|NCT04202497|526378180|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
145963424|NCT04202497|526378181|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145963425|NCT04202497|526378182|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145963426|NCT04202497|526378183|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145963427|NCT04344301|526378184|FG000|Overall Study|Withdrawal by Subject|1|||
145963428|NCT04344301|526378185|FG001|Overall Study|Withdrawal by Subject|0|||
145963429|NCT04344301|526378184|FG000|Overall Study|Death|0|||
145963430|NCT04344301|526378185|FG001|Overall Study|Death|1|||
145963431|NCT03028142|526380094|FG000|Overall Study|Adverse Event|1|||
145963432|NCT03028142|526380095|FG001|Overall Study|Adverse Event|1|||
146290083|NCT02745392|527577362|FG000|Overall Study|Lost to Follow-up|0|||
146290084|NCT02745392|527577363|FG001|Overall Study|Lost to Follow-up|1|||
146290085|NCT02745392|527577364|FG002|Overall Study|Lost to Follow-up|0|||
146290086|NCT02745392|527577365|FG003|Overall Study|Lost to Follow-up|0|||
146290087|NCT02513303|527577366|FG000|Overall Study|Withdrawal by Subject|9|||
146290088|NCT02513303|527577367|FG001|Overall Study|Withdrawal by Subject|7|||
146290089|NCT02513303|527577368|FG002|Overall Study|Withdrawal by Subject|2|||
146290090|NCT02513303|527577366|FG000|Overall Study|Lost to Follow-up|2|||
146290091|NCT02513303|527577367|FG001|Overall Study|Lost to Follow-up|4|||
146290092|NCT02513303|527577368|FG002|Overall Study|Lost to Follow-up|0|||
146290093|NCT02513303|527577366|FG000|Overall Study|Adverse Event|0|||
146290094|NCT02513303|527577367|FG001|Overall Study|Adverse Event|1|||
146290095|NCT02513303|527577368|FG002|Overall Study|Adverse Event|0|||
146290096|NCT02513303|527577366|FG000|Overall Study|Physician Decision|1|||
146290097|NCT02513303|527577367|FG001|Overall Study|Physician Decision|1|||
146290098|NCT02513303|527577368|FG002|Overall Study|Physician Decision|0|||
146290099|NCT02513303|527577366|FG000|Overall Study|Death|8|||
146290100|NCT02513303|527577367|FG001|Overall Study|Death|4|||
146290101|NCT02513303|527577368|FG002|Overall Study|Death|2|||
146290102|NCT01691768|527577369|FG000|Overall Study|Death|0|||
145886373|NCT00573170|526088319|FG005|First Washout Period|Other|0|||
146290103|NCT01691768|527577370|FG001|Overall Study|Death|2|||
146290104|NCT01691768|527577369|FG000|Overall Study|Lost to Follow-up|4|||
146290105|NCT01691768|527577370|FG001|Overall Study|Lost to Follow-up|3|||
146290106|NCT01691768|527577369|FG000|Overall Study|Withdrawal by Subject|10|||
146290107|NCT01691768|527577370|FG001|Overall Study|Withdrawal by Subject|9|||
146231626|NCT03215706|527366369|FG001|Treatment Period|Disease Progression|142|||
146231627|NCT03215706|527366368|FG000|Treatment Period|Study Drug Toxicity|53|||
146231628|NCT03215706|527366369|FG001|Treatment Period|Study Drug Toxicity|21|||
146231629|NCT03215706|527366368|FG000|Treatment Period|Death|2|||
146231630|NCT03215706|527366369|FG001|Treatment Period|Death|1|||
145886374|NCT00573170|526088314|FG000|Second Washout Period|Adverse Event|1|||
145886375|NCT00573170|526088315|FG001|Second Washout Period|Adverse Event|0|||
145886376|NCT00573170|526088316|FG002|Second Washout Period|Adverse Event|0|||
145886377|NCT00573170|526088317|FG003|Second Washout Period|Adverse Event|0|||
145886378|NCT00573170|526088318|FG004|Second Washout Period|Adverse Event|1|||
145886379|NCT00573170|526088319|FG005|Second Washout Period|Adverse Event|0|||
145886380|NCT00573170|526088314|FG000|Second Washout Period|Protocol Violation|2|||
145886381|NCT00573170|526088315|FG001|Second Washout Period|Protocol Violation|1|||
146290108|NCT01691768|527577369|FG000|Overall Study|Relocated|0|||
146231631|NCT03215706|527366368|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
146231632|NCT03215706|527366369|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
145963433|NCT03028142|526380096|FG002|Overall Study|Adverse Event|0|||
145963434|NCT03028142|526380097|FG003|Overall Study|Adverse Event|0|||
145963435|NCT03028142|526380098|FG004|Overall Study|Adverse Event|0|||
145963436|NCT03028142|526380099|FG005|Overall Study|Adverse Event|1|||
145963437|NCT03028142|526380094|FG000|Overall Study|Withdrawal by Subject|0|||
145963438|NCT03028142|526380095|FG001|Overall Study|Withdrawal by Subject|0|||
145963439|NCT03028142|526380096|FG002|Overall Study|Withdrawal by Subject|0|||
145963440|NCT03028142|526380097|FG003|Overall Study|Withdrawal by Subject|0|||
145963441|NCT03028142|526380098|FG004|Overall Study|Withdrawal by Subject|1|||
145963442|NCT03028142|526380099|FG005|Overall Study|Withdrawal by Subject|0|||
145963443|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
145963444|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
146086430|NCT04761627|526837940|FG000|Post-randomization Period|Adverse Event|0|||
146086431|NCT04761627|526837941|FG001|Post-randomization Period|Adverse Event|4|||
146086432|NCT04761627|526837942|FG002|Post-randomization Period|Adverse Event|2|||
146231633|NCT03215706|527366368|FG000|Treatment Period|Request to D/C treatment|1|||
146086433|NCT04761627|526837940|FG000|Post-randomization Period|Lost to Follow-up|0|||
146231634|NCT03215706|527366369|FG001|Treatment Period|Request to D/C treatment|6|||
146231635|NCT03215706|527366368|FG000|Treatment Period|Participant withdrew consent|3|||
145963445|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
146231636|NCT03215706|527366369|FG001|Treatment Period|Participant withdrew consent|4|||
145963446|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
145963447|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
145963448|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
145963449|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
145963450|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
145963451|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
145963452|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
145963453|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
145963454|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
145963455|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
145963456|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
146231637|NCT03215706|527366368|FG000|Treatment Period|Lost to Follow-up|0|||
146231638|NCT03215706|527366369|FG001|Treatment Period|Lost to Follow-up|1|||
146231639|NCT03215706|527366368|FG000|Treatment Period|Other Reasons|4|||
146231640|NCT03215706|527366369|FG001|Treatment Period|Other Reasons|5|||
146231641|NCT03215706|527366368|FG000|Treatment Period|Ongoing in the treatment period|105|||
146231642|NCT03215706|527366369|FG001|Treatment Period|Ongoing in the treatment period|43|||
146290109|NCT01691768|527577370|FG001|Overall Study|Relocated|1|||
146231643|NCT03705793|527366999|FG000|Overall Study|Lost to Follow-up|3|||
146231644|NCT03705793|527367000|FG001|Overall Study|Lost to Follow-up|4|||
146290110|NCT01691768|527577369|FG000|Overall Study|Investigator decision|1|||
146231645|NCT03705793|527366999|FG000|Overall Study|Withdrawal by Subject|2|||
146290111|NCT01691768|527577370|FG001|Overall Study|Investigator decision|1|||
146290112|NCT01959334|527577373|FG000|Second Dose|Adverse Event|1|||
146290113|NCT01959334|527577374|FG001|Second Dose|Adverse Event|0|||
146290114|NCT01959334|527577373|FG000|Third Dose|Adverse Event|0|||
146290115|NCT01959334|527577374|FG001|Third Dose|Adverse Event|1|||
146290116|NCT02294227|527577375|FG000|Overall Study|Death|0|||
146290117|NCT02294227|527577376|FG001|Overall Study|Death|0|||
146290118|NCT02294227|527577377|FG002|Overall Study|Death|1|||
146290119|NCT02294227|527577375|FG000|Overall Study|Subject/Guardian Decision|6|||
146290120|NCT02294227|527577376|FG001|Overall Study|Subject/Guardian Decision|3|||
146290121|NCT02294227|527577377|FG002|Overall Study|Subject/Guardian Decision|7|||
146290122|NCT02294227|527577375|FG000|Overall Study|Physician Decision|1|||
146290123|NCT02294227|527577376|FG001|Overall Study|Physician Decision|2|||
146290124|NCT02294227|527577377|FG002|Overall Study|Physician Decision|1|||
146290125|NCT02294227|527577375|FG000|Overall Study|Lost to Follow-up|1|||
146290126|NCT02294227|527577376|FG001|Overall Study|Lost to Follow-up|0|||
146290127|NCT02294227|527577377|FG002|Overall Study|Lost to Follow-up|0|||
146290128|NCT02294227|527577375|FG000|Overall Study|Lack of Efficacy|11|||
146290129|NCT02294227|527577376|FG001|Overall Study|Lack of Efficacy|12|||
146290130|NCT02294227|527577377|FG002|Overall Study|Lack of Efficacy|8|||
146290131|NCT02294227|527577375|FG000|Overall Study|Adverse Event|6|||
146290132|NCT02294227|527577376|FG001|Overall Study|Adverse Event|8|||
146290133|NCT02294227|527577377|FG002|Overall Study|Adverse Event|2|||
146290134|NCT01768637|527577381|FG000|Overall Study|Lost to Follow-up|2|||
146290135|NCT01768637|527577382|FG001|Overall Study|Lost to Follow-up|7|||
146290136|NCT01768637|527577381|FG000|Overall Study|Difficult blood draw|1|||
146290137|NCT01768637|527577382|FG001|Overall Study|Difficult blood draw|0|||
146290138|NCT01007448|527577383|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
146290139|NCT01007448|527577384|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
146290140|NCT01007448|527577383|FG000|Overall Study|Staph Skin Infection Flare|1|||
146290141|NCT01007448|527577384|FG001|Overall Study|Staph Skin Infection Flare|0|||
146290142|NCT01007448|527577383|FG000|Overall Study|Participant Leaving the Country|1|||
146290143|NCT01007448|527577384|FG001|Overall Study|Participant Leaving the Country|0|||
146290144|NCT01007448|527577383|FG000|Overall Study|Participant Given Prohibited Medication|1|||
146290145|NCT01007448|527577384|FG001|Overall Study|Participant Given Prohibited Medication|0|||
146290146|NCT01007448|527577383|FG000|Overall Study|Progressive Disease|1|||
146290147|NCT01007448|527577384|FG001|Overall Study|Progressive Disease|2|||
146290148|NCT01007448|527577383|FG000|Overall Study|Lack of Efficacy|2|||
146290149|NCT01007448|527577384|FG001|Overall Study|Lack of Efficacy|0|||
146290150|NCT01007448|527577383|FG000|Overall Study|Withdrawal by Subject|2|||
146290151|NCT01007448|527577384|FG001|Overall Study|Withdrawal by Subject|3|||
146231646|NCT03705793|527367000|FG001|Overall Study|Withdrawal by Subject|1|||
146231647|NCT00447980|527367001|FG000|Overall Study|Withdrawal by Subject|1|||
146231648|NCT00447980|527367002|FG001|Overall Study|Withdrawal by Subject|1|||
146231649|NCT00447980|527367003|FG002|Overall Study|Withdrawal by Subject|4|||
146231650|NCT00447980|527367004|FG003|Overall Study|Withdrawal by Subject|4|||
146231651|NCT00447980|527367001|FG000|Overall Study|Lost to Follow-up|1|||
146231652|NCT00447980|527367002|FG001|Overall Study|Lost to Follow-up|1|||
146231653|NCT00447980|527367003|FG002|Overall Study|Lost to Follow-up|0|||
146231654|NCT00447980|527367004|FG003|Overall Study|Lost to Follow-up|0|||
146231655|NCT00447980|527367001|FG000|Overall Study|Did not proceed with surgery|3|||
146231656|NCT00447980|527367002|FG001|Overall Study|Did not proceed with surgery|3|||
146231657|NCT00447980|527367003|FG002|Overall Study|Did not proceed with surgery|2|||
146231658|NCT00447980|527367004|FG003|Overall Study|Did not proceed with surgery|2|||
146290152|NCT01007448|527577383|FG000|Overall Study|Adverse Event|1|||
146290153|NCT01007448|527577384|FG001|Overall Study|Adverse Event|4|||
145963457|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
145963458|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
145963459|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
145963460|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
145963461|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
145963462|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
145963463|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
145963464|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
145963465|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
145963466|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
145963467|NCT01198002|526380100|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
145963468|NCT01198002|526380101|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
145963469|NCT01198002|526380102|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
145963470|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
145963471|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
145963472|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
145963473|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
145963474|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
146086434|NCT04761627|526837941|FG001|Post-randomization Period|Lost to Follow-up|6|||
146086435|NCT04761627|526837942|FG002|Post-randomization Period|Lost to Follow-up|6|||
146290154|NCT02481947|527577385|FG000|Overall Study|Withdrawal by Subject|24|||
146290155|NCT02481947|527577386|FG001|Overall Study|Withdrawal by Subject|10|||
146290156|NCT02481947|527577385|FG000|Overall Study|Lost to Follow-up|11|||
146290157|NCT02481947|527577386|FG001|Overall Study|Lost to Follow-up|5|||
146290158|NCT02481947|527577385|FG000|Overall Study|Adverse Event|6|||
146290159|NCT02481947|527577386|FG001|Overall Study|Adverse Event|11|||
146290160|NCT02481947|527577385|FG000|Overall Study|Physician Decision|4|||
146290161|NCT02481947|527577386|FG001|Overall Study|Physician Decision|5|||
146290162|NCT02481947|527577385|FG000|Overall Study|Protocol Violation|1|||
146290163|NCT02481947|527577386|FG001|Overall Study|Protocol Violation|5|||
146290164|NCT00887432|527577387|FG000|Overall Study|Start Excluded Therapy|3|||
146290165|NCT00887432|527577388|FG001|Overall Study|Start Excluded Therapy|0|||
146290166|NCT00887432|527577387|FG000|Overall Study|Did not complete treatment|6|||
146290167|NCT00887432|527577388|FG001|Overall Study|Did not complete treatment|8|||
145963475|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
146086436|NCT04761627|526837940|FG000|Post-randomization Period|Withdrawal by Subject|0|||
146290168|NCT00887432|527577387|FG000|Overall Study|Protocol Violation|2|||
146086437|NCT04761627|526837941|FG001|Post-randomization Period|Withdrawal by Subject|7|||
146290169|NCT00887432|527577388|FG001|Overall Study|Protocol Violation|3|||
146290170|NCT00887432|527577387|FG000|Overall Study|Withdrawal by Subject|3|||
146086438|NCT04761627|526837942|FG002|Post-randomization Period|Withdrawal by Subject|6|||
146290171|NCT00887432|527577388|FG001|Overall Study|Withdrawal by Subject|2|||
146290172|NCT00887432|527577387|FG000|Overall Study|Lost to Follow-up|1|||
146290173|NCT00887432|527577388|FG001|Overall Study|Lost to Follow-up|0|||
146290174|NCT00887432|527577387|FG000|Overall Study|No reason provided|0|||
146290175|NCT00887432|527577388|FG001|Overall Study|No reason provided|1|||
146290176|NCT00899548|527577389|FG000|Overall Study|Physician Decision|3|||
146290177|NCT01337115|527577390|FG000|Overall Study|Protocol Violation|2|||
146290178|NCT01337115|527577391|FG001|Overall Study|Protocol Violation|0|||
146290179|NCT03426267|527577397|FG000|Overall Study|Physician Decision|1|||
146290180|NCT03426267|527577398|FG001|Overall Study|Physician Decision|4|||
146290181|NCT03426267|527577397|FG000|Overall Study|Lost to Follow-up|1|||
146290182|NCT03426267|527577398|FG001|Overall Study|Lost to Follow-up|0|||
146290183|NCT03426267|527577397|FG000|Overall Study|Withdrawal by Subject|4|||
146290184|NCT03426267|527577398|FG001|Overall Study|Withdrawal by Subject|10|||
146290185|NCT03426267|527577397|FG000|Overall Study|Protocol Violation|1|||
146290186|NCT03426267|527577398|FG001|Overall Study|Protocol Violation|3|||
146290187|NCT03426267|527577397|FG000|Overall Study|Adverse Event|9|||
146290188|NCT03426267|527577398|FG001|Overall Study|Adverse Event|27|||
146290189|NCT03426267|527577397|FG000|Overall Study|Prohibited Treatment Intake|2|||
146290190|NCT03426267|527577398|FG001|Overall Study|Prohibited Treatment Intake|3|||
146290191|NCT03426267|527577397|FG000|Overall Study|Lack of Efficacy|0|||
146290192|NCT03426267|527577398|FG001|Overall Study|Lack of Efficacy|25|||
146290193|NCT03426267|527577397|FG000|Overall Study|other|3|||
146290194|NCT03426267|527577398|FG001|Overall Study|other|0|||
146290195|NCT01636960|527577403|FG000|Induction Phase|Adverse Event|2|||
146290196|NCT01636960|527577403|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
146290197|NCT01636960|527577403|FG000|Maintenance Phase|Adverse Event|3|||
146290198|NCT01636960|527577403|FG000|Maintenance Phase|Progressive disease|1|||
146290199|NCT01209780|527577404|FG000|Overall Study|Adverse Event|0|||
146290200|NCT01209780|527577405|FG001|Overall Study|Adverse Event|1|||
146290201|NCT01209780|527577406|FG002|Overall Study|Adverse Event|0|||
146290202|NCT01209780|527577407|FG003|Overall Study|Adverse Event|0|||
146290203|NCT01209780|527577408|FG004|Overall Study|Adverse Event|0|||
146290204|NCT01209780|527577404|FG000|Overall Study|Withdrawal by Subject|9|||
146290205|NCT01209780|527577405|FG001|Overall Study|Withdrawal by Subject|2|||
146290206|NCT01209780|527577406|FG002|Overall Study|Withdrawal by Subject|1|||
146290207|NCT01209780|527577407|FG003|Overall Study|Withdrawal by Subject|1|||
146290208|NCT01209780|527577408|FG004|Overall Study|Withdrawal by Subject|0|||
146290209|NCT01209780|527577404|FG000|Overall Study|Lost to Follow-up|17|||
146290210|NCT01209780|527577405|FG001|Overall Study|Lost to Follow-up|12|||
146290211|NCT01209780|527577406|FG002|Overall Study|Lost to Follow-up|3|||
146290212|NCT01209780|527577407|FG003|Overall Study|Lost to Follow-up|9|||
146290213|NCT01209780|527577408|FG004|Overall Study|Lost to Follow-up|4|||
146290214|NCT01209780|527577404|FG000|Overall Study|Protocol Violation|0|||
146290215|NCT01209780|527577405|FG001|Overall Study|Protocol Violation|1|||
146290216|NCT01209780|527577406|FG002|Overall Study|Protocol Violation|0|||
146290217|NCT01209780|527577407|FG003|Overall Study|Protocol Violation|0|||
146290218|NCT01209780|527577408|FG004|Overall Study|Protocol Violation|0|||
146290219|NCT01209780|527577404|FG000|Overall Study|Inappropriate enrollment|0|||
146290220|NCT01209780|527577405|FG001|Overall Study|Inappropriate enrollment|2|||
146290221|NCT01209780|527577406|FG002|Overall Study|Inappropriate enrollment|0|||
146290222|NCT01209780|527577407|FG003|Overall Study|Inappropriate enrollment|0|||
146290223|NCT01209780|527577408|FG004|Overall Study|Inappropriate enrollment|1|||
146290224|NCT01580969|527577409|FG000|Overall Study|Physician Decision|3|||
146290225|NCT01580969|527577410|FG001|Overall Study|Physician Decision|0|||
146290226|NCT01580969|527577411|FG002|Overall Study|Physician Decision|0|||
146290227|NCT01745848|527577412|FG000|Overall Study|Adverse Event|6|||
146290228|NCT00448123|527577413|FG000|Overall Study|Lost to Follow-up|9|||
146290229|NCT00448123|527577414|FG001|Overall Study|Lost to Follow-up|6|||
146290230|NCT00448123|527577413|FG000|Overall Study|Physician Decision|6|||
146290231|NCT00448123|527577414|FG001|Overall Study|Physician Decision|6|||
146290232|NCT02027623|527577415|FG000|Overall Study|Lost to Follow-up|3|||
145963476|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
145963477|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
146231659|NCT02720068|527367005|FG000|Overall Study|Adverse Event|0|||
146231660|NCT02720068|527367006|FG001|Overall Study|Adverse Event|0|||
146231661|NCT02720068|527367007|FG002|Overall Study|Adverse Event|0|||
146231662|NCT02720068|527367008|FG003|Overall Study|Adverse Event|0|||
146231663|NCT02720068|527367009|FG004|Overall Study|Adverse Event|0|||
146231664|NCT02720068|527367010|FG005|Overall Study|Adverse Event|0|||
146231665|NCT02720068|527367011|FG006|Overall Study|Adverse Event|0|||
146231666|NCT02720068|527367012|FG007|Overall Study|Adverse Event|0|||
146231667|NCT02720068|527367013|FG008|Overall Study|Adverse Event|0|||
146231668|NCT02720068|527367014|FG009|Overall Study|Adverse Event|0|||
146231669|NCT02720068|527367015|FG010|Overall Study|Adverse Event|0|||
146231670|NCT02720068|527367016|FG011|Overall Study|Adverse Event|1|||
146231671|NCT02720068|527367017|FG012|Overall Study|Adverse Event|0|||
146231672|NCT02720068|527367018|FG013|Overall Study|Adverse Event|0|||
146231673|NCT02720068|527367019|FG014|Overall Study|Adverse Event|0|||
146231674|NCT02720068|527367020|FG015|Overall Study|Adverse Event|0|||
146231675|NCT02720068|527367021|FG016|Overall Study|Adverse Event|0|||
146231676|NCT02720068|527367022|FG017|Overall Study|Adverse Event|0|||
146231677|NCT02720068|527367005|FG000|Overall Study|Death|1|||
146231678|NCT02720068|527367006|FG001|Overall Study|Death|3|||
146231679|NCT02720068|527367007|FG002|Overall Study|Death|2|||
146231680|NCT02720068|527367008|FG003|Overall Study|Death|1|||
146231681|NCT02720068|527367009|FG004|Overall Study|Death|2|||
145963478|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
145963479|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
145963480|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
145963481|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
145963482|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
145963483|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
145963484|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
146231682|NCT02720068|527367010|FG005|Overall Study|Death|1|||
146231683|NCT02720068|527367011|FG006|Overall Study|Death|2|||
146231684|NCT02720068|527367012|FG007|Overall Study|Death|2|||
146231685|NCT02720068|527367013|FG008|Overall Study|Death|3|||
146231686|NCT02720068|527367014|FG009|Overall Study|Death|1|||
146231687|NCT02720068|527367015|FG010|Overall Study|Death|20|||
146231688|NCT02720068|527367016|FG011|Overall Study|Death|166|||
146231689|NCT02720068|527367017|FG012|Overall Study|Death|34|||
146231690|NCT02720068|527367018|FG013|Overall Study|Death|30|||
146290233|NCT02027623|527577416|FG001|Overall Study|Lost to Follow-up|3|||
146290234|NCT02027623|527577415|FG000|Overall Study|Withdrawal by Subject|6|||
146290235|NCT02027623|527577416|FG001|Overall Study|Withdrawal by Subject|9|||
146290236|NCT01886378|527577419|FG000|Overall Study|Adverse Event|1|||
146290237|NCT01886378|527577419|FG000|Overall Study|Withdrawal by Subject|4|||
146290238|NCT02318797|527577420|FG000|Overall Study|Death|3|||
146290239|NCT02318797|527577421|FG001|Overall Study|Death|6|||
146231691|NCT02720068|527367019|FG014|Overall Study|Death|45|||
146231692|NCT02720068|527367020|FG015|Overall Study|Death|16|||
146231693|NCT02720068|527367021|FG016|Overall Study|Death|20|||
146231694|NCT02720068|527367022|FG017|Overall Study|Death|28|||
146231695|NCT02720068|527367005|FG000|Overall Study|Lost to Follow-up|0|||
146231696|NCT02720068|527367006|FG001|Overall Study|Lost to Follow-up|0|||
146231697|NCT02720068|527367007|FG002|Overall Study|Lost to Follow-up|0|||
146231698|NCT02720068|527367008|FG003|Overall Study|Lost to Follow-up|0|||
146231699|NCT02720068|527367009|FG004|Overall Study|Lost to Follow-up|0|||
146231700|NCT02720068|527367010|FG005|Overall Study|Lost to Follow-up|0|||
146231701|NCT02720068|527367011|FG006|Overall Study|Lost to Follow-up|0|||
146231702|NCT02720068|527367012|FG007|Overall Study|Lost to Follow-up|0|||
146231703|NCT02720068|527367013|FG008|Overall Study|Lost to Follow-up|0|||
146231704|NCT02720068|527367014|FG009|Overall Study|Lost to Follow-up|0|||
146231705|NCT02720068|527367015|FG010|Overall Study|Lost to Follow-up|0|||
146231706|NCT02720068|527367016|FG011|Overall Study|Lost to Follow-up|1|||
146231707|NCT02720068|527367017|FG012|Overall Study|Lost to Follow-up|0|||
146231708|NCT02720068|527367018|FG013|Overall Study|Lost to Follow-up|1|||
146231709|NCT02720068|527367019|FG014|Overall Study|Lost to Follow-up|2|||
146231710|NCT02720068|527367020|FG015|Overall Study|Lost to Follow-up|0|||
146231711|NCT02720068|527367021|FG016|Overall Study|Lost to Follow-up|0|||
146231712|NCT02720068|527367022|FG017|Overall Study|Lost to Follow-up|1|||
146231713|NCT02720068|527367005|FG000|Overall Study|Physician Decision|0|||
146231714|NCT02720068|527367006|FG001|Overall Study|Physician Decision|0|||
146231715|NCT02720068|527367007|FG002|Overall Study|Physician Decision|0|||
146231716|NCT02720068|527367008|FG003|Overall Study|Physician Decision|1|||
146231717|NCT02720068|527367009|FG004|Overall Study|Physician Decision|0|||
146231718|NCT02720068|527367010|FG005|Overall Study|Physician Decision|0|||
146231719|NCT02720068|527367011|FG006|Overall Study|Physician Decision|0|||
146231720|NCT02720068|527367012|FG007|Overall Study|Physician Decision|0|||
146231721|NCT02720068|527367013|FG008|Overall Study|Physician Decision|0|||
146231722|NCT02720068|527367014|FG009|Overall Study|Physician Decision|0|||
146231723|NCT02720068|527367015|FG010|Overall Study|Physician Decision|0|||
146231724|NCT02720068|527367016|FG011|Overall Study|Physician Decision|1|||
146231725|NCT02720068|527367017|FG012|Overall Study|Physician Decision|0|||
146231726|NCT02720068|527367018|FG013|Overall Study|Physician Decision|0|||
146231727|NCT02720068|527367019|FG014|Overall Study|Physician Decision|0|||
146231728|NCT02720068|527367020|FG015|Overall Study|Physician Decision|0|||
146231729|NCT02720068|527367021|FG016|Overall Study|Physician Decision|0|||
146231730|NCT02720068|527367022|FG017|Overall Study|Physician Decision|1|||
146231731|NCT02720068|527367005|FG000|Overall Study|Progressive Disease|2|||
146231732|NCT02720068|527367006|FG001|Overall Study|Progressive Disease|3|||
146231733|NCT02720068|527367007|FG002|Overall Study|Progressive Disease|1|||
146231734|NCT02720068|527367008|FG003|Overall Study|Progressive Disease|1|||
146231735|NCT02720068|527367009|FG004|Overall Study|Progressive Disease|1|||
146231736|NCT02720068|527367010|FG005|Overall Study|Progressive Disease|2|||
146231737|NCT02720068|527367011|FG006|Overall Study|Progressive Disease|1|||
146231738|NCT02720068|527367012|FG007|Overall Study|Progressive Disease|1|||
146231739|NCT02720068|527367013|FG008|Overall Study|Progressive Disease|0|||
146231740|NCT02720068|527367014|FG009|Overall Study|Progressive Disease|1|||
146231741|NCT02720068|527367015|FG010|Overall Study|Progressive Disease|0|||
146231742|NCT02720068|527367016|FG011|Overall Study|Progressive Disease|4|||
146231743|NCT02720068|527367017|FG012|Overall Study|Progressive Disease|1|||
146231744|NCT02720068|527367018|FG013|Overall Study|Progressive Disease|0|||
146231745|NCT02720068|527367019|FG014|Overall Study|Progressive Disease|0|||
146231746|NCT02720068|527367020|FG015|Overall Study|Progressive Disease|0|||
146231747|NCT02720068|527367021|FG016|Overall Study|Progressive Disease|0|||
146231748|NCT02720068|527367022|FG017|Overall Study|Progressive Disease|0|||
146231749|NCT02720068|527367005|FG000|Overall Study|Sponsor Decision|0|||
146231750|NCT02720068|527367006|FG001|Overall Study|Sponsor Decision|0|||
146290240|NCT02318797|527577420|FG000|Overall Study|Lost to Follow-up|85|||
146290241|NCT02318797|527577421|FG001|Overall Study|Lost to Follow-up|96|||
146086439|NCT04761627|526837940|FG000|Post-randomization Period|Pregnancy|0|||
146086440|NCT04761627|526837941|FG001|Post-randomization Period|Pregnancy|0|||
146086441|NCT04761627|526837942|FG002|Post-randomization Period|Pregnancy|1|||
146086442|NCT04761627|526837940|FG000|Post-randomization Period|Study site closure|0|||
146086443|NCT04761627|526837941|FG001|Post-randomization Period|Study site closure|0|||
146086444|NCT04761627|526837942|FG002|Post-randomization Period|Study site closure|1|||
146231751|NCT02720068|527367007|FG002|Overall Study|Sponsor Decision|0|||
146086445|NCT04761627|526837940|FG000|Post-randomization Period|Family planning|0|||
145963485|NCT01198002|526380100|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
146231752|NCT02720068|527367008|FG003|Overall Study|Sponsor Decision|0|||
146231753|NCT02720068|527367009|FG004|Overall Study|Sponsor Decision|0|||
146231754|NCT02720068|527367010|FG005|Overall Study|Sponsor Decision|0|||
146231755|NCT02720068|527367011|FG006|Overall Study|Sponsor Decision|0|||
146231756|NCT02720068|527367012|FG007|Overall Study|Sponsor Decision|0|||
146231757|NCT02720068|527367013|FG008|Overall Study|Sponsor Decision|0|||
146231758|NCT02720068|527367014|FG009|Overall Study|Sponsor Decision|0|||
146231759|NCT02720068|527367015|FG010|Overall Study|Sponsor Decision|0|||
146231760|NCT02720068|527367016|FG011|Overall Study|Sponsor Decision|6|||
146231761|NCT02720068|527367017|FG012|Overall Study|Sponsor Decision|3|||
146231762|NCT02720068|527367018|FG013|Overall Study|Sponsor Decision|2|||
146231763|NCT02720068|527367019|FG014|Overall Study|Sponsor Decision|4|||
146231764|NCT02720068|527367020|FG015|Overall Study|Sponsor Decision|4|||
146231765|NCT02720068|527367021|FG016|Overall Study|Sponsor Decision|0|||
146231766|NCT02720068|527367022|FG017|Overall Study|Sponsor Decision|8|||
146231767|NCT02720068|527367005|FG000|Overall Study|Withdrawal by Subject|0|||
146231768|NCT02720068|527367006|FG001|Overall Study|Withdrawal by Subject|0|||
146231769|NCT02720068|527367007|FG002|Overall Study|Withdrawal by Subject|0|||
146231770|NCT02720068|527367008|FG003|Overall Study|Withdrawal by Subject|0|||
146231771|NCT02720068|527367009|FG004|Overall Study|Withdrawal by Subject|0|||
146231772|NCT02720068|527367010|FG005|Overall Study|Withdrawal by Subject|0|||
146231773|NCT02720068|527367011|FG006|Overall Study|Withdrawal by Subject|0|||
146231774|NCT02720068|527367012|FG007|Overall Study|Withdrawal by Subject|0|||
146231775|NCT02720068|527367013|FG008|Overall Study|Withdrawal by Subject|0|||
146231776|NCT02720068|527367014|FG009|Overall Study|Withdrawal by Subject|1|||
146231777|NCT02720068|527367015|FG010|Overall Study|Withdrawal by Subject|0|||
146231778|NCT02720068|527367016|FG011|Overall Study|Withdrawal by Subject|27|||
146231779|NCT02720068|527367017|FG012|Overall Study|Withdrawal by Subject|2|||
146231780|NCT02720068|527367018|FG013|Overall Study|Withdrawal by Subject|8|||
146231781|NCT02720068|527367019|FG014|Overall Study|Withdrawal by Subject|7|||
146231782|NCT02720068|527367020|FG015|Overall Study|Withdrawal by Subject|0|||
146231783|NCT02720068|527367021|FG016|Overall Study|Withdrawal by Subject|0|||
146231784|NCT02720068|527367022|FG017|Overall Study|Withdrawal by Subject|2|||
146231785|NCT02720068|527367005|FG000|Overall Study|Protocol Violation|0|||
146231786|NCT02720068|527367006|FG001|Overall Study|Protocol Violation|0|||
146231787|NCT02720068|527367007|FG002|Overall Study|Protocol Violation|0|||
146290242|NCT01275131|527577427|FG000|Period 1|Withdrawal by Subject|1|||
146290243|NCT01275131|527577428|FG001|Period 1|Withdrawal by Subject|0|||
146290244|NCT01275131|527577429|FG002|Period 1|Withdrawal by Subject|3|||
146290245|NCT01275131|527577430|FG003|Period 1|Withdrawal by Subject|2|||
146290246|NCT01275131|527577427|FG000|Period 1|Physician Decision|1|||
146290247|NCT01275131|527577428|FG001|Period 1|Physician Decision|0|||
146290248|NCT01275131|527577429|FG002|Period 1|Physician Decision|0|||
145963486|NCT01198002|526380101|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
145963487|NCT01198002|526380102|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
145963488|NCT03102762|526380103|FG000|Overall Study|Lost to Follow-up|1|||
146290249|NCT01275131|527577430|FG003|Period 1|Physician Decision|0|||
146290250|NCT01275131|527577427|FG000|Period 2 (Crossover)|Adverse Event|0|||
146290251|NCT01275131|527577428|FG001|Period 2 (Crossover)|Adverse Event|1|||
146290252|NCT01275131|527577429|FG002|Period 2 (Crossover)|Adverse Event|0|||
146290253|NCT01275131|527577430|FG003|Period 2 (Crossover)|Adverse Event|0|||
146290254|NCT01275131|527577427|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
146290255|NCT01275131|527577428|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
146290256|NCT01275131|527577429|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
146290257|NCT01275131|527577430|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
146290258|NCT00001962|527578918|FG000|Overall Study|Lack of Efficacy|18|||
146290259|NCT00001962|527578918|FG000|Overall Study|Lack of Accrual|6|||
146290260|NCT00001962|527578918|FG000|Overall Study|Death|1|||
146290261|NCT00001962|527578918|FG000|Overall Study|Lost to Follow-up|2|||
146290262|NCT00001962|527578918|FG000|Overall Study|Adverse Event|1|||
146290263|NCT00816400|527578919|FG000|Overall Study|Death|2|||
146290264|NCT00816400|527578920|FG001|Overall Study|Death|3|||
146290265|NCT00816400|527578921|FG002|Overall Study|Death|3|||
146290266|NCT00816400|527578922|FG003|Overall Study|Death|3|||
146290267|NCT00816400|527578923|FG004|Overall Study|Death|2|||
146290268|NCT00816400|527578924|FG005|Overall Study|Death|3|||
146290269|NCT00816400|527578925|FG006|Overall Study|Death|2|||
146290270|NCT00816400|527578926|FG007|Overall Study|Death|5|||
145886382|NCT00573170|526088316|FG002|Second Washout Period|Protocol Violation|1|||
145886383|NCT00573170|526088317|FG003|Second Washout Period|Protocol Violation|0|||
145886384|NCT00573170|526088318|FG004|Second Washout Period|Protocol Violation|0|||
145886385|NCT00573170|526088319|FG005|Second Washout Period|Protocol Violation|0|||
145886386|NCT00573170|526088314|FG000|Second Washout Period|Withdrawal by Subject|1|||
145886387|NCT00573170|526088315|FG001|Second Washout Period|Withdrawal by Subject|1|||
146290271|NCT00816400|527578927|FG008|Overall Study|Death|6|||
146290272|NCT00816400|527578919|FG000|Overall Study|In hospice care at the end of the study|0|||
146290273|NCT00816400|527578920|FG001|Overall Study|In hospice care at the end of the study|0|||
146290274|NCT00816400|527578921|FG002|Overall Study|In hospice care at the end of the study|2|||
146231788|NCT02720068|527367008|FG003|Overall Study|Protocol Violation|0|||
146231789|NCT02720068|527367009|FG004|Overall Study|Protocol Violation|0|||
146231790|NCT02720068|527367010|FG005|Overall Study|Protocol Violation|0|||
146231791|NCT02720068|527367011|FG006|Overall Study|Protocol Violation|0|||
146086446|NCT04761627|526837941|FG001|Post-randomization Period|Family planning|1|||
146086447|NCT04761627|526837942|FG002|Post-randomization Period|Family planning|0|||
146086448|NCT01117792|526837943|FG000|Overall Study|Death|1|||
146086449|NCT01117792|526837943|FG000|Overall Study|Adverse Event|3|||
146086450|NCT05867342|526837944|FG000|Overall Study|Investigator Decision|3|||
146086451|NCT05867342|526837945|FG001|Overall Study|Investigator Decision|3|||
146086452|NCT00723203|526837946|FG000|Overall Study|Withdrawal by Subject|3|||
146231792|NCT02720068|527367012|FG007|Overall Study|Protocol Violation|0|||
146231793|NCT02720068|527367013|FG008|Overall Study|Protocol Violation|0|||
146231794|NCT02720068|527367014|FG009|Overall Study|Protocol Violation|0|||
146231795|NCT02720068|527367015|FG010|Overall Study|Protocol Violation|1|||
145963489|NCT03102762|526380104|FG001|Overall Study|Lost to Follow-up|0|||
146231796|NCT02720068|527367016|FG011|Overall Study|Protocol Violation|0|||
146231797|NCT02720068|527367017|FG012|Overall Study|Protocol Violation|0|||
146231798|NCT02720068|527367018|FG013|Overall Study|Protocol Violation|0|||
146231799|NCT02720068|527367019|FG014|Overall Study|Protocol Violation|1|||
145963490|NCT01232790|526380111|FG000|Randomization|Withdrawal by Subject|2|||
145963491|NCT01232790|526380112|FG001|Randomization|Withdrawal by Subject|0|||
145963492|NCT01232790|526380111|FG000|Randomization|Protocol Violation|0|||
145963493|NCT01232790|526380112|FG001|Randomization|Protocol Violation|1|||
145963494|NCT01232790|526380111|FG000|Randomization|Physician Decision|0|||
145963495|NCT01232790|526380112|FG001|Randomization|Physician Decision|1|||
145963496|NCT01232790|526380111|FG000|Initial Assessment|Withdrawal by Subject|0|||
145963497|NCT01232790|526380112|FG001|Initial Assessment|Withdrawal by Subject|1|||
145963498|NCT01232790|526380111|FG000|First Crossover|Withdrawal by Subject|1|||
146231800|NCT02720068|527367020|FG015|Overall Study|Protocol Violation|0|||
146231801|NCT02720068|527367021|FG016|Overall Study|Protocol Violation|1|||
146086453|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
146231802|NCT02720068|527367022|FG017|Overall Study|Protocol Violation|0|||
146231803|NCT02467270|527367035|FG000|Overall Study|Participants Never Treated|0|||
146086454|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
146231804|NCT02467270|527367036|FG001|Overall Study|Participants Never Treated|1|||
146231805|NCT02467270|527367037|FG002|Overall Study|Participants Never Treated|0|||
146231806|NCT02467270|527367035|FG000|Overall Study|Ongoing|50|||
145963499|NCT01232790|526380112|FG001|First Crossover|Withdrawal by Subject|0|||
145963500|NCT01232790|526380111|FG000|Second Crossover|Withdrawal by Subject|1|||
145963501|NCT01232790|526380112|FG001|Second Crossover|Withdrawal by Subject|2|||
145963502|NCT03322293|526380113|FG000|Overall Study|Lost to Follow-up|0|||
145963503|NCT03322293|526380114|FG001|Overall Study|Lost to Follow-up|0|||
145963504|NCT03322293|526380115|FG002|Overall Study|Lost to Follow-up|1|||
145963505|NCT01239797|526380116|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
145963506|NCT01239797|526380117|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
145963507|NCT01239797|526380116|FG000|Randomized Participants|Participant withdrew consent|1|||
145963508|NCT01239797|526380117|FG001|Randomized Participants|Participant withdrew consent|7|||
145963509|NCT01239797|526380116|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
145963510|NCT01239797|526380117|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
145963511|NCT01239797|526380116|FG000|Treated Participants|Disease progression|185|||
145963512|NCT01239797|526380117|FG001|Treated Participants|Disease progression|185|||
145963513|NCT01239797|526380116|FG000|Treated Participants|Study drug toxicity|39|||
145963514|NCT01239797|526380117|FG001|Treated Participants|Study drug toxicity|45|||
145963515|NCT01239797|526380116|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
145963516|NCT01239797|526380117|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
145963517|NCT01239797|526380116|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
145963518|NCT01239797|526380117|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
145963519|NCT01239797|526380116|FG000|Treated Participants|Administrative reason by sponsor|13|||
145963520|NCT01239797|526380117|FG001|Treated Participants|Administrative reason by sponsor|4|||
145963521|NCT01239797|526380116|FG000|Treated Participants|Other reasons|14|||
145963522|NCT01239797|526380117|FG001|Treated Participants|Other reasons|14|||
145963523|NCT01239797|526380116|FG000|Treated Participants|Participant withdrew consent|6|||
145963524|NCT01239797|526380117|FG001|Treated Participants|Participant withdrew consent|11|||
145963525|NCT01239797|526380116|FG000|Treated Participants|Death|1|||
145963526|NCT01239797|526380117|FG001|Treated Participants|Death|1|||
145963527|NCT01239797|526380116|FG000|Treated Participants|Participant no longer meets study criteria|1|||
145963528|NCT01239797|526380117|FG001|Treated Participants|Participant no longer meets study criteria|1|||
145963529|NCT01239797|526380116|FG000|Treated Participants|Poor/non-compliance|0|||
145963530|NCT01239797|526380117|FG001|Treated Participants|Poor/non-compliance|1|||
145963531|NCT04456686|526380124|FG000|Overall Study|Adverse Event|2|||
145963532|NCT04456686|526380125|FG001|Overall Study|Adverse Event|1|||
145963533|NCT04456686|526380124|FG000|Overall Study|Lack of Efficacy|3|||
145963534|NCT04456686|526380125|FG001|Overall Study|Lack of Efficacy|1|||
145963535|NCT04456686|526380124|FG000|Overall Study|Withdrew consent|3|||
145963536|NCT04456686|526380125|FG001|Overall Study|Withdrew consent|1|||
145963537|NCT04456686|526380124|FG000|Overall Study|Physician Decision|2|||
146086455|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
146086456|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
146086457|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
146086458|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
146086459|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
146086460|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
146086461|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
146086462|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
146086463|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
146086464|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
146086465|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
146086466|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
146290275|NCT00816400|527578922|FG003|Overall Study|In hospice care at the end of the study|0|||
146086467|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
146086468|NCT00274924|526837950|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
146086469|NCT00274924|526837951|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
146086470|NCT00274924|526837952|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
146086471|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
146086472|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
146290276|NCT00816400|527578923|FG004|Overall Study|In hospice care at the end of the study|0|||
146290277|NCT00816400|527578924|FG005|Overall Study|In hospice care at the end of the study|0|||
146290278|NCT00816400|527578925|FG006|Overall Study|In hospice care at the end of the study|0|||
146290279|NCT00816400|527578926|FG007|Overall Study|In hospice care at the end of the study|0|||
146290280|NCT00816400|527578927|FG008|Overall Study|In hospice care at the end of the study|0|||
146290281|NCT01786174|527578928|FG000|Overall Study|Discontinued Study Drug|2|||
145963538|NCT04456686|526380125|FG001|Overall Study|Physician Decision|2|||
146086473|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
146086474|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
146086475|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
146086476|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
146086477|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
146086478|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
146086479|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
146086480|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
146086481|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
146086482|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
146086483|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
146086484|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
146086485|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
146086486|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
146086487|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
146086488|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
146086489|NCT00274924|526837950|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
146086490|NCT00274924|526837951|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
146086491|NCT00274924|526837952|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
146086492|NCT01055496|526837953|FG000|Overall Study|Withdrawal by Subject|2|||
146086493|NCT01055496|526837954|FG001|Overall Study|Withdrawal by Subject|4|||
146086494|NCT01055496|526837953|FG000|Overall Study|Death|13|||
146086495|NCT01055496|526837954|FG001|Overall Study|Death|23|||
146086496|NCT01055496|526837953|FG000|Overall Study|Lost to Follow-up|0|||
146086497|NCT01055496|526837954|FG001|Overall Study|Lost to Follow-up|2|||
146086498|NCT01055496|526837953|FG000|Overall Study|Other - Unspecified|0|||
146086499|NCT01055496|526837954|FG001|Overall Study|Other - Unspecified|1|||
146086500|NCT00584740|526837955|FG000|Overall Study|Adverse Event|1|||
146086501|NCT00584740|526837956|FG001|Overall Study|Adverse Event|1|||
146086502|NCT00584740|526837955|FG000|Overall Study|Lack of Efficacy|8|||
146086503|NCT00584740|526837956|FG001|Overall Study|Lack of Efficacy|2|||
146086504|NCT00584740|526837955|FG000|Overall Study|Withdrawal by Subject|3|||
146086505|NCT00584740|526837956|FG001|Overall Study|Withdrawal by Subject|2|||
146086506|NCT00584740|526837955|FG000|Overall Study|Lost to Follow-up|0|||
146086507|NCT00584740|526837956|FG001|Overall Study|Lost to Follow-up|1|||
146290282|NCT01786174|527578929|FG001|Overall Study|Discontinued Study Drug|0|||
146290283|NCT00876694|527578932|FG000|Overall Study|Adverse Event|10|||
146290284|NCT00876694|527578933|FG001|Overall Study|Adverse Event|7|||
146290285|NCT00876694|527578932|FG000|Overall Study|Subject withdrew consent|6|||
146290286|NCT00876694|527578933|FG001|Overall Study|Subject withdrew consent|4|||
146290287|NCT00876694|527578932|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146290288|NCT00876694|527578933|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146290289|NCT00876694|527578932|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146290290|NCT00876694|527578933|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146290291|NCT00876694|527578932|FG000|Overall Study|Administrative problems|1|||
146290292|NCT00876694|527578933|FG001|Overall Study|Administrative problems|1|||
146290293|NCT00876694|527578932|FG000|Overall Study|Death|1|||
145963539|NCT04456686|526380124|FG000|Overall Study|Withdrawal by Subject|5|||
145963540|NCT04456686|526380125|FG001|Overall Study|Withdrawal by Subject|1|||
146290294|NCT00876694|527578933|FG001|Overall Study|Death|0|||
145963541|NCT04456686|526380124|FG000|Overall Study|Protocol Violation|0|||
145963542|NCT04456686|526380125|FG001|Overall Study|Protocol Violation|1|||
145963543|NCT02858401|526380131|FG000|Overall Study|Withdrew Consent|0|||
145963544|NCT02858401|526380132|FG001|Overall Study|Withdrew Consent|0|||
146290295|NCT01386788|527578936|FG000|Overall Study|Lost to Follow-up|2|||
146290296|NCT00120406|527578941|FG000|Overall Study|Death|9|||
146290297|NCT00120406|527578942|FG001|Overall Study|Death|4|||
146290298|NCT00120406|527578941|FG000|Overall Study|Withdrawal by Subject|5|||
145963545|NCT02858401|526380133|FG002|Overall Study|Withdrew Consent|0|||
145963546|NCT02858401|526380134|FG003|Overall Study|Withdrew Consent|0|||
145963547|NCT02858401|526380135|FG004|Overall Study|Withdrew Consent|0|||
145963548|NCT02858401|526380136|FG005|Overall Study|Withdrew Consent|1|||
145963549|NCT02858401|526380137|FG006|Overall Study|Withdrew Consent|0|||
145963550|NCT02858401|526380131|FG000|Overall Study|Lost to Follow-up|0|||
145963551|NCT02858401|526380132|FG001|Overall Study|Lost to Follow-up|1|||
145963552|NCT02858401|526380133|FG002|Overall Study|Lost to Follow-up|0|||
145963553|NCT02858401|526380134|FG003|Overall Study|Lost to Follow-up|0|||
145963554|NCT02858401|526380135|FG004|Overall Study|Lost to Follow-up|0|||
145963555|NCT02858401|526380136|FG005|Overall Study|Lost to Follow-up|0|||
145963556|NCT02858401|526380137|FG006|Overall Study|Lost to Follow-up|0|||
145963557|NCT03722576|526380138|FG000|Overall Study|Withdrawal by Subject|3|||
145963558|NCT03722576|526380138|FG000|Overall Study|Adverse Event|2|||
145963559|NCT03722576|526380138|FG000|Overall Study|Physician Decision|1|||
145963560|NCT03722576|526380138|FG000|Overall Study|Lost to Follow-up|1|||
145963561|NCT03885908|526380139|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
145963562|NCT03885908|526380140|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
145963563|NCT03885908|526380139|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
145963564|NCT03885908|526380140|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
145963565|NCT03885908|526380139|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
145963566|NCT03885908|526380140|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
145963567|NCT03885908|526380139|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
145963568|NCT03885908|526380140|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
145963569|NCT03669549|526380141|FG000|Overall Study|Adverse Event|4|||
145963570|NCT03669549|526380141|FG000|Overall Study|Withdrawal by Subject|1|||
145963571|NCT03669549|526380141|FG000|Overall Study|Study terminated by the Sponsor|1|||
145963572|NCT01064479|526380143|FG000|Overall Study|Death|10|||
145963573|NCT01064479|526380144|FG001|Overall Study|Death|11|||
145963574|NCT01064479|526380143|FG000|Overall Study|Withdrawal by Subject|2|||
145963575|NCT01064479|526380144|FG001|Overall Study|Withdrawal by Subject|2|||
145963576|NCT01064479|526380143|FG000|Overall Study|Disease progression|1|||
145963577|NCT01064479|526380144|FG001|Overall Study|Disease progression|1|||
145963578|NCT01064479|526380143|FG000|Overall Study|Toxicity|1|||
145963579|NCT01064479|526380144|FG001|Overall Study|Toxicity|1|||
146231807|NCT02467270|527367036|FG001|Overall Study|Ongoing|41|||
146231808|NCT02467270|527367037|FG002|Overall Study|Ongoing|43|||
146231809|NCT02467270|527367035|FG000|Overall Study|Adverse Event|16|||
146231810|NCT02467270|527367036|FG001|Overall Study|Adverse Event|15|||
146231811|NCT02467270|527367037|FG002|Overall Study|Adverse Event|14|||
146231812|NCT02467270|527367035|FG000|Overall Study|Progressive Disease|7|||
146231813|NCT02467270|527367036|FG001|Overall Study|Progressive Disease|7|||
146231814|NCT02467270|527367037|FG002|Overall Study|Progressive Disease|4|||
146290299|NCT00120406|527578942|FG001|Overall Study|Withdrawal by Subject|7|||
146290300|NCT00120406|527578941|FG000|Overall Study|Lost to Follow-up|5|||
146290301|NCT00120406|527578942|FG001|Overall Study|Lost to Follow-up|2|||
146290302|NCT00120406|527578941|FG000|Overall Study|received non-study stent|0|||
146290303|NCT00120406|527578942|FG001|Overall Study|received non-study stent|2|||
146290304|NCT00120406|527578941|FG000|Overall Study|patient moved but has not withdrawn|0|||
146290305|NCT00120406|527578942|FG001|Overall Study|patient moved but has not withdrawn|1|||
146290306|NCT01155375|527578943|FG000|Overall Study|Adverse Event|1|||
146290307|NCT01155375|527578944|FG001|Overall Study|Adverse Event|0|||
146290308|NCT00762970|527578945|FG000|Overall Study|Withdrawal by Subject|7|||
146290309|NCT00762970|527578946|FG001|Overall Study|Withdrawal by Subject|4|||
146290310|NCT00762970|527578947|FG002|Overall Study|Withdrawal by Subject|0|||
146290311|NCT00762970|527578945|FG000|Overall Study|Protocol Violation|3|||
146290312|NCT00762970|527578946|FG001|Overall Study|Protocol Violation|1|||
146290313|NCT00762970|527578947|FG002|Overall Study|Protocol Violation|1|||
146290314|NCT00762970|527578945|FG000|Overall Study|Lost to Follow-up|1|||
146290315|NCT00762970|527578946|FG001|Overall Study|Lost to Follow-up|2|||
146290316|NCT00762970|527578947|FG002|Overall Study|Lost to Follow-up|0|||
146290317|NCT00762970|527578945|FG000|Overall Study|Difficulty of handling lens|1|||
146290318|NCT00762970|527578946|FG001|Overall Study|Difficulty of handling lens|2|||
146290319|NCT00762970|527578947|FG002|Overall Study|Difficulty of handling lens|0|||
146290320|NCT00975507|527578948|FG000|Overall Study|Adverse Event|1|||
146290321|NCT00975507|527578949|FG001|Overall Study|Adverse Event|0|||
146290322|NCT00975507|527578948|FG000|Overall Study|Lost to Follow-up|7|||
146290323|NCT00975507|527578949|FG001|Overall Study|Lost to Follow-up|1|||
146290324|NCT00975507|527578948|FG000|Overall Study|Protocol Violation|2|||
146290325|NCT00975507|527578949|FG001|Overall Study|Protocol Violation|0|||
146290326|NCT00975507|527578948|FG000|Overall Study|Withdrawal by Subject|10|||
146290327|NCT00975507|527578949|FG001|Overall Study|Withdrawal by Subject|3|||
146290328|NCT01295034|527578950|FG000|Overall Study|Lost to Follow-up|5|||
146290329|NCT01295034|527578951|FG001|Overall Study|Lost to Follow-up|5|||
146290330|NCT03818204|527578952|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290331|NCT03818204|527578953|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290332|NCT03818204|527578954|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290333|NCT03818204|527578955|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290334|NCT03818204|527578956|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
146290335|NCT03818204|527578957|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290336|NCT03818204|527578958|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290337|NCT03818204|527578959|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290338|NCT03818204|527578960|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290339|NCT03818204|527578961|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290340|NCT03818204|527578962|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290341|NCT03818204|527578963|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290342|NCT03818204|527578964|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290343|NCT03818204|527578965|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
146290344|NCT03818204|527578966|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290345|NCT03818204|527578967|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290346|NCT03818204|527578968|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290347|NCT03818204|527578969|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290348|NCT03818204|527578970|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
146290349|NCT03818204|527578952|FG000|Overall Study|Physician Decision|0|||
146290350|NCT03818204|527578953|FG001|Overall Study|Physician Decision|0|||
146290351|NCT03818204|527578954|FG002|Overall Study|Physician Decision|0|||
146290352|NCT03818204|527578955|FG003|Overall Study|Physician Decision|0|||
146290353|NCT03818204|527578956|FG004|Overall Study|Physician Decision|0|||
146290354|NCT03818204|527578957|FG005|Overall Study|Physician Decision|0|||
146290355|NCT03818204|527578958|FG006|Overall Study|Physician Decision|0|||
146290356|NCT03818204|527578959|FG007|Overall Study|Physician Decision|0|||
146290357|NCT03818204|527578960|FG008|Overall Study|Physician Decision|0|||
146290358|NCT03818204|527578961|FG009|Overall Study|Physician Decision|0|||
146290359|NCT03818204|527578962|FG010|Overall Study|Physician Decision|0|||
146231815|NCT02467270|527367035|FG000|Overall Study|Death|2|||
146290360|NCT03818204|527578963|FG011|Overall Study|Physician Decision|0|||
146231816|NCT02467270|527367036|FG001|Overall Study|Death|0|||
146231817|NCT02467270|527367037|FG002|Overall Study|Death|2|||
145963580|NCT01064479|526380143|FG000|Overall Study|Other|1|||
145963581|NCT01064479|526380144|FG001|Overall Study|Other|2|||
145963582|NCT01663402|526380148|FG000|Overall Study|Randomized but not treated|19|||
145963583|NCT01663402|526380149|FG001|Overall Study|Randomized but not treated|11|||
145963584|NCT01663402|526380148|FG000|Overall Study|Adverse Event|347|||
145963585|NCT01663402|526380149|FG001|Overall Study|Adverse Event|362|||
145963586|NCT01663402|526380148|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
145963587|NCT01663402|526380149|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
145963588|NCT01663402|526380148|FG000|Overall Study|Poor compliance to protocol|529|||
145963589|NCT01663402|526380149|FG001|Overall Study|Poor compliance to protocol|454|||
145963590|NCT01663402|526380148|FG000|Overall Study|Physician Decision|77|||
145963591|NCT01663402|526380149|FG001|Overall Study|Physician Decision|62|||
146086508|NCT01673282|526837957|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
146086509|NCT01673282|526837958|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
146231818|NCT02467270|527367035|FG000|Overall Study|Lack of Efficacy|12|||
146231819|NCT02467270|527367036|FG001|Overall Study|Lack of Efficacy|18|||
145963592|NCT01663402|526380148|FG000|Overall Study|Site terminated by sponsor|1|||
146231820|NCT02467270|527367037|FG002|Overall Study|Lack of Efficacy|23|||
146231821|NCT02467270|527367035|FG000|Overall Study|Non-compliance With Study Drug|0|||
146231822|NCT02467270|527367036|FG001|Overall Study|Non-compliance With Study Drug|2|||
146231823|NCT02467270|527367037|FG002|Overall Study|Non-compliance With Study Drug|1|||
146231824|NCT02467270|527367035|FG000|Overall Study|Lost to Follow-up|2|||
146231825|NCT02467270|527367036|FG001|Overall Study|Lost to Follow-up|1|||
146231826|NCT02467270|527367037|FG002|Overall Study|Lost to Follow-up|0|||
146231827|NCT02467270|527367035|FG000|Overall Study|Pregnancy|0|||
146231828|NCT02467270|527367036|FG001|Overall Study|Pregnancy|1|||
146231829|NCT02467270|527367037|FG002|Overall Study|Pregnancy|0|||
146231830|NCT02467270|527367035|FG000|Overall Study|Physician Decision|0|||
146231831|NCT02467270|527367036|FG001|Overall Study|Physician Decision|4|||
146231832|NCT02467270|527367037|FG002|Overall Study|Physician Decision|1|||
146231833|NCT02467270|527367035|FG000|Overall Study|Withdrawal by Subject|4|||
146231834|NCT02467270|527367036|FG001|Overall Study|Withdrawal by Subject|3|||
146231835|NCT02467270|527367037|FG002|Overall Study|Withdrawal by Subject|5|||
146231836|NCT02467270|527367035|FG000|Overall Study|Reason not Specified|1|||
146231837|NCT02467270|527367036|FG001|Overall Study|Reason not Specified|2|||
146231838|NCT02467270|527367037|FG002|Overall Study|Reason not Specified|1|||
146231839|NCT04281498|527367048|FG000|Overall Study|Progression of disease|1|||
146231840|NCT04281498|527367048|FG000|Overall Study|Planned SCT|1|||
146231841|NCT04281498|527367048|FG000|Overall Study|Alternative Treatment|1|||
146231842|NCT03142009|527367051|FG000|Overall Study|Lost to Follow-up|45|||
146231843|NCT03142009|527367052|FG001|Overall Study|Lost to Follow-up|30|||
146231844|NCT03587805|527367053|FG000|Overall Study|Adverse Event|72|||
146231845|NCT03587805|527367053|FG000|Overall Study|Death|1|||
146231846|NCT03587805|527367053|FG000|Overall Study|Lost to Follow-up|78|||
146231847|NCT03587805|527367053|FG000|Overall Study|Withdrawal by Subject|105|||
146231848|NCT03587805|527367053|FG000|Overall Study|Lack of Efficacy|119|||
146231849|NCT03587805|527367053|FG000|Overall Study|Reason unknown|26|||
146231850|NCT03587805|527367053|FG000|Overall Study|COVID_19 pandemic|4|||
146231851|NCT03587805|527367053|FG000|Overall Study|Various reasons|121|||
146231852|NCT03587805|527367053|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146231853|NCT03008382|527367056|FG000|Overall Study|Withdrawal by Subject|2|||
146231854|NCT03008382|527367057|FG001|Overall Study|Withdrawal by Subject|5|||
145963593|NCT01663402|526380149|FG001|Overall Study|Site terminated by sponsor|3|||
145963594|NCT01663402|526380148|FG000|Overall Study|Participant moved|139|||
145963595|NCT01663402|526380149|FG001|Overall Study|Participant moved|104|||
145963596|NCT01663402|526380148|FG000|Overall Study|Withdrawal by Subject|118|||
145963597|NCT01663402|526380149|FG001|Overall Study|Withdrawal by Subject|91|||
145963598|NCT01663402|526380148|FG000|Overall Study|Related to study drug administration|96|||
145963599|NCT01663402|526380149|FG001|Overall Study|Related to study drug administration|105|||
145963600|NCT01663402|526380148|FG000|Overall Study|Lost to Follow-up|17|||
145963601|NCT01663402|526380149|FG001|Overall Study|Lost to Follow-up|15|||
145963602|NCT01663402|526380148|FG000|Overall Study|Other than specified above|172|||
145963603|NCT01663402|526380149|FG001|Overall Study|Other than specified above|147|||
145963604|NCT03903172|526380152|FG000|Overall Study|screen fail|4|||
145963605|NCT03903172|526380153|FG001|Overall Study|screen fail|1|||
145963606|NCT02495389|526380154|FG000|Overall Study|Withdrawal by Subject|40|||
145963607|NCT01802385|526380158|FG000|Overall Study|Death|106|||
145963608|NCT01802385|526380159|FG001|Overall Study|Death|120|||
145963609|NCT05559905|526380160|FG000|Overall Study|Withdrawal by Subject|1|||
145963610|NCT05559905|526380161|FG001|Overall Study|Withdrawal by Subject|0|||
145963611|NCT05559905|526380162|FG002|Overall Study|Withdrawal by Subject|0|||
145963612|NCT05559905|526380160|FG000|Overall Study|Not Reported|1|||
145963613|NCT05559905|526380161|FG001|Overall Study|Not Reported|0|||
145963614|NCT05559905|526380162|FG002|Overall Study|Not Reported|0|||
145963615|NCT04003103|526380163|FG000|Overall Study|Death|1|||
145963616|NCT04003103|526380164|FG001|Overall Study|Death|0|||
145963617|NCT04003103|526380165|FG002|Overall Study|Death|0|||
145963618|NCT04003103|526380163|FG000|Overall Study|Lost to Follow-up|4|||
145963619|NCT04003103|526380164|FG001|Overall Study|Lost to Follow-up|3|||
145963620|NCT04003103|526380165|FG002|Overall Study|Lost to Follow-up|2|||
145963621|NCT04003103|526380163|FG000|Overall Study|Withdrawal by Subject|10|||
145963622|NCT04003103|526380164|FG001|Overall Study|Withdrawal by Subject|1|||
145963623|NCT04003103|526380165|FG002|Overall Study|Withdrawal by Subject|1|||
146086510|NCT01673282|526837957|FG000|Overall Study|Lack of Efficacy|9|||
146086511|NCT01673282|526837958|FG001|Overall Study|Lack of Efficacy|2|||
146086512|NCT01673282|526837957|FG000|Overall Study|Lost to Follow-up|11|||
146086513|NCT01673282|526837958|FG001|Overall Study|Lost to Follow-up|10|||
146086514|NCT01673282|526837957|FG000|Overall Study|Withdrawal by Subject|3|||
146086515|NCT01673282|526837958|FG001|Overall Study|Withdrawal by Subject|3|||
146086516|NCT01673282|526837957|FG000|Overall Study|Other|1|||
146086517|NCT01673282|526837958|FG001|Overall Study|Other|6|||
146086518|NCT02915874|526837959|FG000|Overall Study|Lost to Follow-up|5|||
146086519|NCT02915874|526837960|FG001|Overall Study|Lost to Follow-up|4|||
146086520|NCT02915874|526837959|FG000|Overall Study|Withdrawal by Subject|1|||
146086521|NCT02915874|526837960|FG001|Overall Study|Withdrawal by Subject|1|||
146086522|NCT02915874|526837959|FG000|Overall Study|Started New Anxiety Medication|0|||
146086523|NCT02915874|526837960|FG001|Overall Study|Started New Anxiety Medication|1|||
146086524|NCT05318183|526837962|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
146086525|NCT05318183|526837963|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
146086526|NCT05318183|526837962|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
146086527|NCT05318183|526837963|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146086528|NCT05318183|526837962|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
146086529|NCT05318183|526837963|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
146231855|NCT03008382|527367058|FG002|Overall Study|Withdrawal by Subject|2|||
146231856|NCT03008382|527367059|FG003|Overall Study|Withdrawal by Subject|0|||
146231857|NCT03008382|527367056|FG000|Overall Study|Protocol Violation|1|||
146231858|NCT03008382|527367057|FG001|Overall Study|Protocol Violation|0|||
146231859|NCT03008382|527367058|FG002|Overall Study|Protocol Violation|0|||
146231860|NCT03008382|527367059|FG003|Overall Study|Protocol Violation|0|||
146231861|NCT03008382|527367056|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
146231862|NCT03008382|527367057|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
146086530|NCT05318183|526837962|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
146086531|NCT05318183|526837963|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
146086532|NCT01046825|526837964|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146086533|NCT01046825|526837965|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
146086534|NCT01046825|526837966|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146086535|NCT01046825|526837967|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146086536|NCT01046825|526837968|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
146231863|NCT03008382|527367058|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
146231864|NCT03008382|527367059|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
146086537|NCT01046825|526837964|FG000|Overall Study|Physician Decision|0|||
146231865|NCT03008382|527367056|FG000|Overall Study|Lost to Follow-up|0|||
146231866|NCT03008382|527367057|FG001|Overall Study|Lost to Follow-up|0|||
146231867|NCT03008382|527367058|FG002|Overall Study|Lost to Follow-up|1|||
145963624|NCT04003103|526380163|FG000|Overall Study|Status not recorded|0|||
145963625|NCT04003103|526380164|FG001|Overall Study|Status not recorded|2|||
145963626|NCT04003103|526380165|FG002|Overall Study|Status not recorded|0|||
145963627|NCT05518539|526380166|FG000|Overall Study|Lost to Follow-up|6|||
145963628|NCT00338741|526380169|FG000|Overall Study|Lost to Follow-up|2|||
145963629|NCT00338741|526380170|FG001|Overall Study|Lost to Follow-up|0|||
145963630|NCT00617357|526380171|FG000|Overall Study|Lost to Follow-up|7|||
145963631|NCT00617357|526380171|FG000|Overall Study|Death|5|||
145963632|NCT00617357|526380171|FG000|Overall Study|insurance concerns|2|||
145963633|NCT00617357|526380171|FG000|Overall Study|Withdrawal by Subject|1|||
145963634|NCT00617357|526380171|FG000|Overall Study|Physician Decision|1|||
145963635|NCT01747499|526380172|FG000|Overall Study|Steroid refractory aGvHD|1|||
145963636|NCT01747499|526380173|FG001|Overall Study|Steroid refractory aGvHD|0|||
145963637|NCT01747499|526380174|FG002|Overall Study|Steroid refractory aGvHD|0|||
145963638|NCT01747499|526380175|FG003|Overall Study|Steroid refractory aGvHD|1|||
145963639|NCT01747499|526380176|FG004|Overall Study|Steroid refractory aGvHD|4|||
145963640|NCT01747499|526380172|FG000|Overall Study|Physician Decision|0|||
146231868|NCT03008382|527367059|FG003|Overall Study|Lost to Follow-up|0|||
146231869|NCT03008382|527367056|FG000|Overall Study|Screenfail|0|||
145963641|NCT01747499|526380173|FG001|Overall Study|Physician Decision|1|||
145963642|NCT01747499|526380174|FG002|Overall Study|Physician Decision|0|||
146231870|NCT03008382|527367057|FG001|Overall Study|Screenfail|0|||
146231871|NCT03008382|527367058|FG002|Overall Study|Screenfail|2|||
146231872|NCT03008382|527367059|FG003|Overall Study|Screenfail|0|||
146231873|NCT00945724|527367061|FG000|Overall Study|Withdrawal by Subject|2|||
145886388|NCT00573170|526088316|FG002|Second Washout Period|Withdrawal by Subject|2|||
145886389|NCT00573170|526088317|FG003|Second Washout Period|Withdrawal by Subject|0|||
145886390|NCT00573170|526088318|FG004|Second Washout Period|Withdrawal by Subject|1|||
146086538|NCT01046825|526837965|FG001|Overall Study|Physician Decision|1|||
146086539|NCT01046825|526837966|FG002|Overall Study|Physician Decision|2|||
146086540|NCT01046825|526837967|FG003|Overall Study|Physician Decision|0|||
146086541|NCT01046825|526837968|FG004|Overall Study|Physician Decision|0|||
146086542|NCT01046825|526837964|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146086543|NCT01046825|526837965|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146086544|NCT01046825|526837966|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
146086545|NCT01046825|526837967|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146086546|NCT01046825|526837968|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
146231874|NCT00945724|527367061|FG000|Overall Study|Physician Decision|1|||
146231875|NCT00945724|527367061|FG000|Overall Study|Adverse Event|5|||
146231876|NCT00945724|527367061|FG000|Overall Study|Second malignancy|1|||
146231877|NCT05180539|527367671|FG000|Overall Study|Lost to Follow-up|27|||
146231878|NCT05180539|527367672|FG001|Overall Study|Lost to Follow-up|30|||
146231879|NCT00994643|527367675|FG000|Overall Study|Withdrawal by Subject|1|||
146231880|NCT04518943|527367677|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
146231881|NCT04518943|527367678|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
146231882|NCT04518943|527367679|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
146231883|NCT04518943|527367680|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
146231884|NCT04518943|527367681|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
146231885|NCT04518943|527367682|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
146231886|NCT04518943|527367683|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
146231887|NCT04518943|527367684|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
146231888|NCT04518943|527367685|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
146231889|NCT04518943|527367686|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
146231890|NCT04518943|527367687|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
146231891|NCT04518943|527367688|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
146231892|NCT04518943|527367689|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
146231893|NCT04518943|527367690|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
146231894|NCT04518943|527367691|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
146231895|NCT04518943|527367692|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
146231896|NCT00968149|527367693|FG000|Overall Study|Adverse Event|5|||
146231897|NCT00968149|527367694|FG001|Overall Study|Adverse Event|1|||
146231898|NCT00968149|527367693|FG000|Overall Study|Lack of Efficacy|0|||
146231899|NCT00968149|527367694|FG001|Overall Study|Lack of Efficacy|4|||
146231900|NCT00968149|527367693|FG000|Overall Study|Lost to Follow-up|0|||
146231901|NCT00968149|527367694|FG001|Overall Study|Lost to Follow-up|1|||
146231902|NCT00968149|527367693|FG000|Overall Study|Protocol Violation|4|||
146231903|NCT00968149|527367694|FG001|Overall Study|Protocol Violation|0|||
146231904|NCT00968149|527367693|FG000|Overall Study|Withdrawal by Subject|2|||
146231905|NCT00968149|527367694|FG001|Overall Study|Withdrawal by Subject|0|||
146231906|NCT04757753|527367695|FG000|Overall Study|Lost to Follow-up|7|||
146231907|NCT04757753|527367696|FG001|Overall Study|Lost to Follow-up|7|||
146231908|NCT04757753|527367695|FG000|Overall Study|Withdrawal by Subject|0|||
146231909|NCT04757753|527367696|FG001|Overall Study|Withdrawal by Subject|3|||
146231910|NCT04757753|527367695|FG000|Overall Study|Endodontic treatment failure|1|||
146231911|NCT04757753|527367696|FG001|Overall Study|Endodontic treatment failure|2|||
146231912|NCT04757753|527367695|FG000|Overall Study|Tooth fracture/extraction|3|||
146231913|NCT04757753|527367696|FG001|Overall Study|Tooth fracture/extraction|0|||
146231914|NCT03201939|527367699|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
146231915|NCT03201939|527367700|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
146231916|NCT03333915|527367701|FG000|Overall Study|Lost to Follow-up|0|||
146231917|NCT03333915|527367702|FG001|Overall Study|Lost to Follow-up|0|||
146231918|NCT03333915|527367703|FG002|Overall Study|Lost to Follow-up|1|||
146231919|NCT03333915|527367704|FG003|Overall Study|Lost to Follow-up|0|||
146231920|NCT03333915|527367705|FG004|Overall Study|Lost to Follow-up|0|||
146231921|NCT03333915|527367701|FG000|Overall Study|Disease Progression|0|||
146231922|NCT03333915|527367702|FG001|Overall Study|Disease Progression|1|||
146231923|NCT03333915|527367703|FG002|Overall Study|Disease Progression|0|||
146231924|NCT03333915|527367704|FG003|Overall Study|Disease Progression|0|||
146231925|NCT03333915|527367705|FG004|Overall Study|Disease Progression|0|||
146231926|NCT03333915|527367701|FG000|Overall Study|Death|0|||
146231927|NCT03333915|527367702|FG001|Overall Study|Death|0|||
145886391|NCT00573170|526088319|FG005|Second Washout Period|Withdrawal by Subject|0|||
146231928|NCT03333915|527367703|FG002|Overall Study|Death|0|||
146231929|NCT03333915|527367704|FG003|Overall Study|Death|37|||
146231930|NCT03333915|527367705|FG004|Overall Study|Death|18|||
146231931|NCT03333915|527367701|FG000|Overall Study|Sponsor's Decision|0|||
145963643|NCT01747499|526380175|FG003|Overall Study|Physician Decision|0|||
145963644|NCT01747499|526380176|FG004|Overall Study|Physician Decision|2|||
145963645|NCT01747499|526380172|FG000|Overall Study|Death|0|||
145963646|NCT01747499|526380173|FG001|Overall Study|Death|0|||
145963647|NCT01747499|526380174|FG002|Overall Study|Death|0|||
145963648|NCT01747499|526380175|FG003|Overall Study|Death|1|||
145963649|NCT01747499|526380176|FG004|Overall Study|Death|1|||
145963650|NCT01747499|526380172|FG000|Overall Study|Withdrawal by Subject|0|||
145963651|NCT01747499|526380173|FG001|Overall Study|Withdrawal by Subject|0|||
145963652|NCT01747499|526380174|FG002|Overall Study|Withdrawal by Subject|0|||
145963653|NCT01747499|526380175|FG003|Overall Study|Withdrawal by Subject|0|||
145963654|NCT01747499|526380176|FG004|Overall Study|Withdrawal by Subject|6|||
145963655|NCT01747499|526380172|FG000|Overall Study|Developed AML and death|0|||
145963656|NCT01747499|526380173|FG001|Overall Study|Developed AML and death|0|||
145963657|NCT01747499|526380174|FG002|Overall Study|Developed AML and death|0|||
145963658|NCT01747499|526380175|FG003|Overall Study|Developed AML and death|0|||
145963659|NCT01747499|526380176|FG004|Overall Study|Developed AML and death|1|||
145963660|NCT01747499|526380172|FG000|Overall Study|Determined not to be eligible|0|||
145963661|NCT01747499|526380173|FG001|Overall Study|Determined not to be eligible|0|||
145963662|NCT01747499|526380174|FG002|Overall Study|Determined not to be eligible|0|||
145963663|NCT01747499|526380175|FG003|Overall Study|Determined not to be eligible|0|||
145963664|NCT01747499|526380176|FG004|Overall Study|Determined not to be eligible|1|||
145963665|NCT00072410|526380177|FG000|Overall Study|Progressive disease|0|||
145963666|NCT00072410|526380178|FG001|Overall Study|Progressive disease|3|||
145963667|NCT03834506|526380183|FG000|Overall Study|Death|336|||
145963668|NCT03834506|526380184|FG001|Overall Study|Death|326|||
145963669|NCT03834506|526380183|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145963670|NCT03834506|526380184|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145963671|NCT03834506|526380183|FG000|Overall Study|Withdrawal by Subject|10|||
146231932|NCT03333915|527367702|FG001|Overall Study|Sponsor's Decision|0|||
146231933|NCT03333915|527367703|FG002|Overall Study|Sponsor's Decision|0|||
146231934|NCT03333915|527367704|FG003|Overall Study|Sponsor's Decision|48|||
146231935|NCT03333915|527367705|FG004|Overall Study|Sponsor's Decision|4|||
145963672|NCT03834506|526380184|FG001|Overall Study|Withdrawal by Subject|8|||
145963673|NCT03834506|526380183|FG000|Overall Study|Sponsor decision|165|||
145963674|NCT03834506|526380184|FG001|Overall Study|Sponsor decision|178|||
145963675|NCT03834506|526380183|FG000|Overall Study|Physician Decision|3|||
145963676|NCT03834506|526380184|FG001|Overall Study|Physician Decision|1|||
145963677|NCT03834506|526380183|FG000|Overall Study|Lost to Follow-up|0|||
145963678|NCT03834506|526380184|FG001|Overall Study|Lost to Follow-up|1|||
146231936|NCT03333915|527367701|FG000|Overall Study|Withdrawal by Subject|0|||
145963679|NCT01819727|526380187|FG000|Overall Study|Adverse Event|8|||
146231937|NCT03333915|527367702|FG001|Overall Study|Withdrawal by Subject|0|||
145963680|NCT01819727|526380188|FG001|Overall Study|Adverse Event|9|||
145963681|NCT01819727|526380187|FG000|Overall Study|Death|1|||
146231938|NCT03333915|527367703|FG002|Overall Study|Withdrawal by Subject|0|||
146231939|NCT03333915|527367704|FG003|Overall Study|Withdrawal by Subject|5|||
146231940|NCT03333915|527367705|FG004|Overall Study|Withdrawal by Subject|1|||
146231941|NCT03872466|527367708|FG000|Overall Study|Withdrawal by Subject|1|||
145886392|NCT00573170|526088314|FG000|Second Washout Period|Lost to Follow-up|0|||
145886393|NCT00573170|526088315|FG001|Second Washout Period|Lost to Follow-up|0|||
145886394|NCT00573170|526088316|FG002|Second Washout Period|Lost to Follow-up|0|||
145886395|NCT00573170|526088317|FG003|Second Washout Period|Lost to Follow-up|1|||
145886396|NCT00573170|526088318|FG004|Second Washout Period|Lost to Follow-up|0|||
145886397|NCT00573170|526088319|FG005|Second Washout Period|Lost to Follow-up|0|||
145886398|NCT00573170|526088314|FG000|Second Washout Period|Other|1|||
145886399|NCT00573170|526088315|FG001|Second Washout Period|Other|2|||
145886400|NCT00573170|526088316|FG002|Second Washout Period|Other|1|||
145886401|NCT00573170|526088317|FG003|Second Washout Period|Other|4|||
145886402|NCT00573170|526088318|FG004|Second Washout Period|Other|6|||
145886403|NCT00573170|526088319|FG005|Second Washout Period|Other|2|||
145886404|NCT00573170|526088314|FG000|Third Treatment Period|Withdrawal by Subject|1|||
145886405|NCT00573170|526088315|FG001|Third Treatment Period|Withdrawal by Subject|0|||
145886406|NCT00573170|526088316|FG002|Third Treatment Period|Withdrawal by Subject|0|||
145886407|NCT00573170|526088317|FG003|Third Treatment Period|Withdrawal by Subject|0|||
145886408|NCT00573170|526088318|FG004|Third Treatment Period|Withdrawal by Subject|0|||
145886409|NCT00573170|526088319|FG005|Third Treatment Period|Withdrawal by Subject|0|||
145886410|NCT00573170|526088314|FG000|Third Treatment Period|Lost to Follow-up|0|||
145886411|NCT00573170|526088315|FG001|Third Treatment Period|Lost to Follow-up|0|||
145886412|NCT00573170|526088316|FG002|Third Treatment Period|Lost to Follow-up|0|||
145886413|NCT00573170|526088317|FG003|Third Treatment Period|Lost to Follow-up|0|||
145886414|NCT00573170|526088318|FG004|Third Treatment Period|Lost to Follow-up|0|||
145886415|NCT00573170|526088319|FG005|Third Treatment Period|Lost to Follow-up|2|||
145886416|NCT00804141|526088320|FG000|Overall Study|Adverse Event|157|||
145886417|NCT00804141|526088320|FG000|Overall Study|Death|4|||
145886418|NCT00804141|526088320|FG000|Overall Study|Failed to return|96|||
145886419|NCT00804141|526088320|FG000|Overall Study|Investigator request|8|||
145886420|NCT00804141|526088320|FG000|Overall Study|Protocol Violation|85|||
145886421|NCT00804141|526088320|FG000|Overall Study|Withdrawal by Subject|131|||
145886422|NCT00804141|526088320|FG000|Overall Study|Lack of Efficacy|46|||
145886423|NCT00804141|526088320|FG000|Overall Study|Other than specified|30|||
145886424|NCT00804141|526088320|FG000|Overall Study|Enrolled but not treated|6|||
146290361|NCT03818204|527578964|FG012|Overall Study|Physician Decision|0|||
146290362|NCT03818204|527578965|FG013|Overall Study|Physician Decision|0|||
146290363|NCT03818204|527578966|FG014|Overall Study|Physician Decision|1|||
146290364|NCT03818204|527578967|FG015|Overall Study|Physician Decision|0|||
146290365|NCT03818204|527578968|FG016|Overall Study|Physician Decision|0|||
146290366|NCT03818204|527578969|FG017|Overall Study|Physician Decision|0|||
146290367|NCT03818204|527578970|FG018|Overall Study|Physician Decision|0|||
146290368|NCT00887250|527578971|FG000|Overall Study|Adverse Event|3|||
146290369|NCT00887250|527578972|FG001|Overall Study|Adverse Event|0|||
146290370|NCT00887250|527578973|FG002|Overall Study|Adverse Event|7|||
146290371|NCT00887250|527578971|FG000|Overall Study|Lack of Efficacy|9|||
146290372|NCT00887250|527578972|FG001|Overall Study|Lack of Efficacy|6|||
146290373|NCT00887250|527578973|FG002|Overall Study|Lack of Efficacy|1|||
146290374|NCT00887250|527578971|FG000|Overall Study|Lost to Follow-up|2|||
146290375|NCT00887250|527578972|FG001|Overall Study|Lost to Follow-up|3|||
146290376|NCT00887250|527578973|FG002|Overall Study|Lost to Follow-up|1|||
146290377|NCT00887250|527578971|FG000|Overall Study|Protocol Violation|2|||
146290378|NCT00887250|527578972|FG001|Overall Study|Protocol Violation|2|||
146290379|NCT00887250|527578973|FG002|Overall Study|Protocol Violation|1|||
146290380|NCT00887250|527578971|FG000|Overall Study|Withdrawal by Subject|2|||
146290381|NCT00887250|527578972|FG001|Overall Study|Withdrawal by Subject|1|||
146290382|NCT00887250|527578973|FG002|Overall Study|Withdrawal by Subject|2|||
146290383|NCT00887250|527578971|FG000|Overall Study|Patient uncooperative|0|||
146290384|NCT00887250|527578972|FG001|Overall Study|Patient uncooperative|0|||
146290385|NCT00887250|527578973|FG002|Overall Study|Patient uncooperative|1|||
146290386|NCT05754333|527578974|FG000|Overall Study|Miscellaneous|3|||
146290387|NCT05754333|527578975|FG001|Overall Study|Miscellaneous|0|||
146290388|NCT05754333|527578976|FG002|Overall Study|Miscellaneous|0|||
146290389|NCT05754333|527578977|FG003|Overall Study|Miscellaneous|0|||
146290390|NCT05754333|527578974|FG000|Overall Study|Lost to Follow-up|2|||
146290391|NCT05754333|527578975|FG001|Overall Study|Lost to Follow-up|1|||
146290392|NCT05754333|527578976|FG002|Overall Study|Lost to Follow-up|0|||
146290393|NCT05754333|527578977|FG003|Overall Study|Lost to Follow-up|1|||
146290394|NCT03864146|527578978|FG000|Overall Study|Lost to Follow-up|14|||
146290395|NCT03864146|527578979|FG001|Overall Study|Lost to Follow-up|23|||
145963682|NCT01819727|526380188|FG001|Overall Study|Death|0|||
146290396|NCT03864146|527578978|FG000|Overall Study|Withdrawal by Subject|3|||
146290397|NCT03864146|527578979|FG001|Overall Study|Withdrawal by Subject|2|||
146290398|NCT00824161|527578980|FG000|Overall Study|Withdrawal by Subject|1|||
146290399|NCT00824161|527578980|FG000|Overall Study|Screen Failure|1|||
146290400|NCT01112306|527578981|FG000|Overall Study|Death|175|||
146290401|NCT01112306|527578981|FG000|Overall Study|Lost to Follow-up|9|||
146231942|NCT03872466|527367709|FG001|Overall Study|Withdrawal by Subject|0|||
146231943|NCT03872466|527367708|FG000|Overall Study|Physician Decision|2|||
146231944|NCT03872466|527367709|FG001|Overall Study|Physician Decision|0|||
146231945|NCT01778686|527367710|FG000|Overall Study|Adverse Event|0|||
146231946|NCT01778686|527367711|FG001|Overall Study|Adverse Event|0|||
146231947|NCT01778686|527367712|FG002|Overall Study|Adverse Event|1|||
145886425|NCT02418455|526088321|FG000|48-Week Treatment Period|Other- Not Specified|1|||
145886426|NCT02418455|526088321|FG000|Continuation Period|Sponsor Decision|7|||
145886427|NCT01546519|526088325|FG000|Overall Study|Adverse Event|0|||
145886428|NCT01546519|526088326|FG001|Overall Study|Adverse Event|0|||
145886429|NCT01546519|526088327|FG002|Overall Study|Adverse Event|1|||
145886430|NCT01546519|526088328|FG003|Overall Study|Adverse Event|1|||
145886431|NCT01546519|526088325|FG000|Overall Study|Death|0|||
145886432|NCT01546519|526088326|FG001|Overall Study|Death|1|||
145886433|NCT01546519|526088327|FG002|Overall Study|Death|3|||
145886434|NCT01546519|526088328|FG003|Overall Study|Death|1|||
145886435|NCT01546519|526088325|FG000|Overall Study|related to disease progression|2|||
145886436|NCT01546519|526088326|FG001|Overall Study|related to disease progression|2|||
145886437|NCT01546519|526088327|FG002|Overall Study|related to disease progression|2|||
145886438|NCT01546519|526088328|FG003|Overall Study|related to disease progression|1|||
145886439|NCT01546519|526088325|FG000|Overall Study|Physician Decision|6|||
145886440|NCT01546519|526088326|FG001|Overall Study|Physician Decision|5|||
145886441|NCT01546519|526088327|FG002|Overall Study|Physician Decision|2|||
145886442|NCT01546519|526088328|FG003|Overall Study|Physician Decision|3|||
145886443|NCT01546519|526088325|FG000|Overall Study|Withdrawal by Subject|1|||
145886444|NCT01546519|526088326|FG001|Overall Study|Withdrawal by Subject|0|||
146231948|NCT04012567|527367713|FG000|Overall Study|Lost to Follow-up|0|||
146231949|NCT04012567|527367714|FG001|Overall Study|Lost to Follow-up|1|||
146231950|NCT04012567|527367713|FG000|Overall Study|Withdrawal by Subject|1|||
146231951|NCT04012567|527367714|FG001|Overall Study|Withdrawal by Subject|0|||
145886445|NCT01546519|526088327|FG002|Overall Study|Withdrawal by Subject|0|||
146290402|NCT01112306|527578981|FG000|Overall Study|Withdrawal by Subject|31|||
146290403|NCT01112306|527578981|FG000|Overall Study|Other|70|||
145886446|NCT01546519|526088328|FG003|Overall Study|Withdrawal by Subject|0|||
145886447|NCT00263887|526088329|FG000|Overall Study|Withdrawal by Subject|1|||
146290404|NCT00211185|527578990|FG000|Overall Study|Death|2|||
146290405|NCT00211185|527578990|FG000|Overall Study|Disease progression|7|||
146290406|NCT00211185|527578990|FG000|Overall Study|Withdrawal by Subject|6|||
146290407|NCT00211185|527578990|FG000|Overall Study|Physician Decision|5|||
146290408|NCT00842985|527578991|FG000|Screening|Did not meet entrance requirements|27|||
146290409|NCT00842985|527578991|FG000|First Intervention|Withdrawal by Subject|3|||
146290410|NCT00842985|527578991|FG000|First Intervention|Protocol Violation|3|||
146290411|NCT00842985|527578991|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
146290412|NCT00842985|527578991|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
146290413|NCT01037244|527578992|FG000|Overall Study|Adverse Event|3|||
146290414|NCT01037244|527578993|FG001|Overall Study|Adverse Event|2|||
146290415|NCT01037244|527578994|FG002|Overall Study|Adverse Event|6|||
146290416|NCT01037244|527578995|FG003|Overall Study|Adverse Event|3|||
146290417|NCT01037244|527578992|FG000|Overall Study|Lack of Efficacy|1|||
146290418|NCT01037244|527578993|FG001|Overall Study|Lack of Efficacy|1|||
146290419|NCT01037244|527578994|FG002|Overall Study|Lack of Efficacy|0|||
146290420|NCT01037244|527578995|FG003|Overall Study|Lack of Efficacy|1|||
146290421|NCT01037244|527578992|FG000|Overall Study|Lost to Follow-up|3|||
146290422|NCT01037244|527578993|FG001|Overall Study|Lost to Follow-up|3|||
146290423|NCT01037244|527578994|FG002|Overall Study|Lost to Follow-up|4|||
146290424|NCT01037244|527578995|FG003|Overall Study|Lost to Follow-up|4|||
146290425|NCT01037244|527578992|FG000|Overall Study|Withdrawal by Subject|1|||
146290426|NCT01037244|527578993|FG001|Overall Study|Withdrawal by Subject|5|||
146290427|NCT01037244|527578994|FG002|Overall Study|Withdrawal by Subject|3|||
146290428|NCT01037244|527578995|FG003|Overall Study|Withdrawal by Subject|5|||
146290429|NCT01037244|527578992|FG000|Overall Study|Partner Withdrew Consent|2|||
146290430|NCT01037244|527578993|FG001|Overall Study|Partner Withdrew Consent|1|||
146290431|NCT01037244|527578994|FG002|Overall Study|Partner Withdrew Consent|0|||
146290432|NCT01037244|527578995|FG003|Overall Study|Partner Withdrew Consent|0|||
146086547|NCT01046825|526837964|FG000|Overall Study|Found to be ineligible|0|||
146086548|NCT01046825|526837965|FG001|Overall Study|Found to be ineligible|1|||
146086549|NCT01046825|526837966|FG002|Overall Study|Found to be ineligible|0|||
146086550|NCT01046825|526837967|FG003|Overall Study|Found to be ineligible|0|||
146086551|NCT01046825|526837968|FG004|Overall Study|Found to be ineligible|0|||
146086552|NCT01046825|526837964|FG000|Overall Study|Death|0|||
146086553|NCT01046825|526837965|FG001|Overall Study|Death|0|||
146086554|NCT01046825|526837966|FG002|Overall Study|Death|0|||
146086555|NCT01046825|526837967|FG003|Overall Study|Death|1|||
146086556|NCT01046825|526837968|FG004|Overall Study|Death|0|||
146086557|NCT01046825|526837964|FG000|Overall Study|Did not submit biology samples|0|||
146231952|NCT06059443|527367715|FG000|Overall Study|Withdrawal by Subject|2|||
146231953|NCT06059443|527367716|FG001|Overall Study|Withdrawal by Subject|0|||
146231954|NCT06059443|527367715|FG000|Overall Study|Lost to Follow-up|2|||
146231955|NCT06059443|527367716|FG001|Overall Study|Lost to Follow-up|2|||
146231956|NCT05771467|527367717|FG000|Overall Study|Lost to Follow-up|6|||
146231957|NCT05771467|527367718|FG001|Overall Study|Lost to Follow-up|3|||
146231958|NCT04940624|527367722|FG000|Overall Study|Adverse Event|4|||
146231959|NCT04940624|527367723|FG001|Overall Study|Adverse Event|11|||
146231960|NCT04940624|527367722|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146231961|NCT04940624|527367723|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146231962|NCT04940624|527367722|FG000|Overall Study|Physician Decision|1|||
146231963|NCT04940624|527367723|FG001|Overall Study|Physician Decision|0|||
146231964|NCT04940624|527367722|FG000|Overall Study|Lost to Follow-up|1|||
146231965|NCT04940624|527367723|FG001|Overall Study|Lost to Follow-up|0|||
146231966|NCT04940624|527367722|FG000|Overall Study|Reason Not Specified|1|||
146231967|NCT04940624|527367723|FG001|Overall Study|Reason Not Specified|0|||
146231968|NCT02206828|527367728|FG000|Overall Study|Lost to Follow-up|7|||
146231969|NCT00113360|527368407|FG000|Overall Study|Adverse Event|3|||
146231970|NCT00113360|527368407|FG000|Overall Study|Subject required surgery|1|||
146231971|NCT00113360|527368407|FG000|Overall Study|Did not meet eligibility criteria|3|||
146231972|NCT02231749|527368415|FG000|Overall Study|Disease progression|229|||
146231973|NCT02231749|527368416|FG001|Overall Study|Disease progression|297|||
146231974|NCT02231749|527368415|FG000|Overall Study|Study Drug Toxicity|134|||
146231975|NCT02231749|527368416|FG001|Overall Study|Study Drug Toxicity|63|||
146086558|NCT01046825|526837965|FG001|Overall Study|Did not submit biology samples|0|||
146086559|NCT01046825|526837966|FG002|Overall Study|Did not submit biology samples|0|||
146086560|NCT01046825|526837967|FG003|Overall Study|Did not submit biology samples|0|||
146231976|NCT02231749|527368415|FG000|Overall Study|Death|1|||
146231977|NCT02231749|527368416|FG001|Overall Study|Death|1|||
146231978|NCT02231749|527368415|FG000|Overall Study|AE unrelated to Study drug|32|||
146231979|NCT02231749|527368416|FG001|Overall Study|AE unrelated to Study drug|31|||
146231980|NCT02231749|527368415|FG000|Overall Study|Participant's request to discontinue|10|||
146086561|NCT01046825|526837968|FG004|Overall Study|Did not submit biology samples|13|||
146086562|NCT06400251|526837970|FG000|Overall Study|Never Start Protocol Therapy|1|||
146231981|NCT02231749|527368416|FG001|Overall Study|Participant's request to discontinue|21|||
145886448|NCT00263887|526088330|FG001|Overall Study|Withdrawal by Subject|1|||
145886449|NCT00263887|526088329|FG000|Overall Study|Lung transplantation|1|||
146231982|NCT02231749|527368415|FG000|Overall Study|Participant withdrew Consent|8|||
146231983|NCT02231749|527368416|FG001|Overall Study|Participant withdrew Consent|15|||
146231984|NCT02231749|527368415|FG000|Overall Study|Lost to Follow-up|1|||
146231985|NCT02231749|527368416|FG001|Overall Study|Lost to Follow-up|2|||
146231986|NCT02231749|527368415|FG000|Overall Study|Maximum Clinical Benefit|5|||
146231987|NCT02231749|527368416|FG001|Overall Study|Maximum Clinical Benefit|8|||
146231988|NCT02231749|527368415|FG000|Overall Study|Poor/Non-Compliance|0|||
146231989|NCT02231749|527368416|FG001|Overall Study|Poor/Non-Compliance|3|||
146231990|NCT02231749|527368415|FG000|Overall Study|Pregnancy|1|||
146231991|NCT02231749|527368416|FG001|Overall Study|Pregnancy|0|||
146290433|NCT01037244|527578992|FG000|Overall Study|Various|3|||
146290434|NCT01037244|527578993|FG001|Overall Study|Various|2|||
146290435|NCT01037244|527578994|FG002|Overall Study|Various|1|||
146290436|NCT01037244|527578995|FG003|Overall Study|Various|1|||
146290437|NCT04507126|527578996|FG000|Overall Study|Withdrawal by Subject|1|||
146290438|NCT04507126|527578996|FG000|Overall Study|Protocol Violation|2|||
146290439|NCT04507126|527578996|FG000|Overall Study|Physician Decision|1|||
146290440|NCT02875977|527578998|FG000|Overall Study|Lost to Follow-up|42|||
146290441|NCT02875977|527578999|FG001|Overall Study|Lost to Follow-up|29|||
146290442|NCT03421431|527579002|FG000|Overall Study|Adverse Event|2|||
146290443|NCT03421431|527579003|FG001|Overall Study|Adverse Event|1|||
146290444|NCT03421431|527579004|FG002|Overall Study|Adverse Event|12|||
146290445|NCT03421431|527579002|FG000|Overall Study|Lost to Follow-up|1|||
146290446|NCT03421431|527579003|FG001|Overall Study|Lost to Follow-up|1|||
146290447|NCT03421431|527579004|FG002|Overall Study|Lost to Follow-up|1|||
146290448|NCT03421431|527579002|FG000|Overall Study|Withdrawal by Subject|3|||
146290449|NCT03421431|527579003|FG001|Overall Study|Withdrawal by Subject|2|||
146290450|NCT03421431|527579004|FG002|Overall Study|Withdrawal by Subject|1|||
146290451|NCT03421431|527579002|FG000|Overall Study|Protocol Violation|0|||
146290452|NCT03421431|527579003|FG001|Overall Study|Protocol Violation|1|||
146290453|NCT03421431|527579004|FG002|Overall Study|Protocol Violation|0|||
146290454|NCT03421431|527579002|FG000|Overall Study|Participant met Stopping Rules|0|||
146290455|NCT03421431|527579003|FG001|Overall Study|Participant met Stopping Rules|1|||
146290456|NCT03421431|527579004|FG002|Overall Study|Participant met Stopping Rules|0|||
146290457|NCT00141726|527579005|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
146290458|NCT02216357|527579006|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
146290459|NCT02216357|527579007|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
146290460|NCT00235326|527579012|FG000|Overall Study|Lost to Follow-up|746|||
146290461|NCT00235326|527579013|FG001|Overall Study|Lost to Follow-up|1400|||
146290462|NCT01178671|527579014|FG000|Overall Study|Adverse Event|4|||
146290463|NCT01178671|527579015|FG001|Overall Study|Adverse Event|6|||
146290464|NCT01178671|527579014|FG000|Overall Study|Protocol Violation|1|||
146290465|NCT01178671|527579015|FG001|Overall Study|Protocol Violation|1|||
146290466|NCT01178671|527579014|FG000|Overall Study|Lack of Efficacy|0|||
146290467|NCT01178671|527579015|FG001|Overall Study|Lack of Efficacy|1|||
146290468|NCT01178671|527579014|FG000|Overall Study|Lost to Follow-up|3|||
146290469|NCT01178671|527579015|FG001|Overall Study|Lost to Follow-up|1|||
146290470|NCT01178671|527579014|FG000|Overall Study|Physician Decision|4|||
146290471|NCT01178671|527579015|FG001|Overall Study|Physician Decision|6|||
146290472|NCT01313689|527579016|FG000|24-Week Randomization 1|Adverse Event|10|||
146290473|NCT01313689|527579017|FG001|24-Week Randomization 1|Adverse Event|5|||
146290474|NCT01313689|527579018|FG002|24-Week Randomization 1|Adverse Event|0|||
146290475|NCT01313689|527579019|FG003|24-Week Randomization 1|Adverse Event|0|||
146290476|NCT01313689|527579020|FG004|24-Week Randomization 1|Adverse Event|0|||
146290477|NCT01313689|527579016|FG000|24-Week Randomization 1|Physician Decision|4|||
146290478|NCT01313689|527579017|FG001|24-Week Randomization 1|Physician Decision|5|||
146290479|NCT01313689|527579018|FG002|24-Week Randomization 1|Physician Decision|0|||
146290480|NCT01313689|527579019|FG003|24-Week Randomization 1|Physician Decision|0|||
146290481|NCT01313689|527579020|FG004|24-Week Randomization 1|Physician Decision|0|||
146290482|NCT01313689|527579016|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
146290483|NCT01313689|527579017|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
146290484|NCT01313689|527579018|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
146290485|NCT01313689|527579019|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
146290486|NCT01313689|527579020|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
146290487|NCT01313689|527579016|FG000|24-Week Randomization 2|Adverse Event|0|||
146290488|NCT01313689|527579017|FG001|24-Week Randomization 2|Adverse Event|0|||
146290489|NCT01313689|527579018|FG002|24-Week Randomization 2|Adverse Event|2|||
146290490|NCT01313689|527579019|FG003|24-Week Randomization 2|Adverse Event|0|||
145886450|NCT00263887|526088330|FG001|Overall Study|Lung transplantation|2|||
145886451|NCT00263887|526088329|FG000|Overall Study|Too ill to attend visit|1|||
146290491|NCT01313689|527579020|FG004|24-Week Randomization 2|Adverse Event|8|||
146290492|NCT01313689|527579016|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
145886452|NCT00263887|526088330|FG001|Overall Study|Too ill to attend visit|0|||
145886453|NCT00263887|526088329|FG000|Overall Study|Adverse Event|0|||
145886454|NCT00263887|526088330|FG001|Overall Study|Adverse Event|2|||
145886455|NCT00263887|526088329|FG000|Overall Study|Disease progression|0|||
145886456|NCT00263887|526088330|FG001|Overall Study|Disease progression|1|||
145886457|NCT00263887|526088329|FG000|Overall Study|Lack of Efficacy|0|||
145886458|NCT00263887|526088330|FG001|Overall Study|Lack of Efficacy|1|||
145886459|NCT04364763|526088331|FG000|Overall Study|Death|1|||
145886460|NCT04364763|526088332|FG001|Overall Study|Death|2|||
145886461|NCT04364763|526088331|FG000|Overall Study|Lost to Follow-up|1|||
145886462|NCT04364763|526088332|FG001|Overall Study|Lost to Follow-up|0|||
145886463|NCT02359864|526088334|FG000|Overall Study|Withdrawal by Subject|1|||
145886464|NCT02359864|526088335|FG001|Overall Study|Withdrawal by Subject|0|||
145886465|NCT00725764|526088336|FG000|Overall Study|Withdrawal by Subject|2|||
145886466|NCT00725764|526088336|FG000|Overall Study|Physician Decision|1|||
145886467|NCT00725764|526088336|FG000|Overall Study|Progressive Disease|7|||
145886468|NCT00725764|526088336|FG000|Overall Study|Lost to Follow-up|1|||
145886469|NCT00725764|526088336|FG000|Overall Study|Death|1|||
145886470|NCT00725764|526088336|FG000|Overall Study|Participant non compliant with protocol|1|||
145886471|NCT00725764|526088336|FG000|Overall Study|Decline in performance status|1|||
145886472|NCT00985231|526088349|FG000|Overall Study|ineligible|1|||
145886473|NCT00985231|526088350|FG001|Overall Study|ineligible|0|||
145886474|NCT00985231|526088349|FG000|Overall Study|Protocol Violation|1|||
145886475|NCT00985231|526088350|FG001|Overall Study|Protocol Violation|0|||
145886476|NCT00985231|526088349|FG000|Overall Study|Withdrawal by Subject|1|||
145886477|NCT00985231|526088350|FG001|Overall Study|Withdrawal by Subject|0|||
145886478|NCT00985231|526088349|FG000|Overall Study|Lost to Follow-up|0|||
145886479|NCT00985231|526088350|FG001|Overall Study|Lost to Follow-up|1|||
145886480|NCT00985231|526088349|FG000|Overall Study|Study related symptoms & complaints|0|||
145886481|NCT00985231|526088350|FG001|Overall Study|Study related symptoms & complaints|2|||
145886482|NCT00983476|526088356|FG000|Overall Study|Did not receive intervention|17|||
145886483|NCT00983476|526088357|FG001|Overall Study|Did not receive intervention|22|||
145886484|NCT00983476|526088358|FG002|Overall Study|Did not receive intervention|0|||
145886485|NCT00084799|526088364|FG000|Overall Study|Disease Progression|1|||
145886486|NCT00084799|526088365|FG001|Overall Study|Disease Progression|0|||
145886487|NCT02663882|526088366|FG000|Overall Study|Lost to Follow-up|4|||
145886488|NCT02663882|526088367|FG001|Overall Study|Lost to Follow-up|2|||
145886489|NCT02412722|526088370|FG000|Overall Study|Adverse Event|0|||
145886490|NCT02412722|526088371|FG001|Overall Study|Adverse Event|2|||
145886491|NCT02412722|526088372|FG002|Overall Study|Adverse Event|0|||
145886492|NCT02412722|526088373|FG003|Overall Study|Adverse Event|3|||
145886493|NCT02412722|526088374|FG004|Overall Study|Adverse Event|0|||
145886494|NCT02412722|526088375|FG005|Overall Study|Adverse Event|3|||
145963683|NCT01819727|526380187|FG000|Overall Study|Lost to Follow-up|1|||
145963684|NCT01819727|526380188|FG001|Overall Study|Lost to Follow-up|1|||
145963685|NCT01819727|526380187|FG000|Overall Study|Physician Decision|3|||
145963686|NCT01819727|526380188|FG001|Overall Study|Physician Decision|2|||
145963687|NCT01819727|526380187|FG000|Overall Study|Pregnancy|1|||
145963688|NCT01819727|526380188|FG001|Overall Study|Pregnancy|0|||
145963689|NCT01819727|526380187|FG000|Overall Study|Protocol Violation|0|||
145963690|NCT01819727|526380188|FG001|Overall Study|Protocol Violation|2|||
145963691|NCT01819727|526380187|FG000|Overall Study|Study Terminated by Sponsor|0|||
145963692|NCT01819727|526380188|FG001|Overall Study|Study Terminated by Sponsor|1|||
145963693|NCT01819727|526380187|FG000|Overall Study|Withdrawal by Subject|6|||
145963694|NCT01819727|526380188|FG001|Overall Study|Withdrawal by Subject|11|||
145963695|NCT01819727|526380187|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
146231992|NCT02231749|527368415|FG000|Overall Study|other|0|||
146231993|NCT02231749|527368416|FG001|Overall Study|other|8|||
146231994|NCT02231749|527368415|FG000|Overall Study|No longer meets Study Criteria|1|||
146231995|NCT02231749|527368416|FG001|Overall Study|No longer meets Study Criteria|0|||
146231996|NCT03705390|527368418|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
145963696|NCT01819727|526380188|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
145963697|NCT01819727|526380187|FG000|Overall Study|Quit due to lack of health benifits|0|||
145963698|NCT01819727|526380188|FG001|Overall Study|Quit due to lack of health benifits|1|||
145963699|NCT01939314|526380191|FG000|Overall Study|Withdrawal by Subject|3|||
145963700|NCT01939314|526380192|FG001|Overall Study|Withdrawal by Subject|1|||
145963701|NCT01939314|526380191|FG000|Overall Study|Protocol Violation|1|||
145963702|NCT01939314|526380192|FG001|Overall Study|Protocol Violation|0|||
145963703|NCT01939314|526380191|FG000|Overall Study|Pregnancy|0|||
145963704|NCT01939314|526380192|FG001|Overall Study|Pregnancy|1|||
145963705|NCT01939314|526380191|FG000|Overall Study|Lost to Follow-up|5|||
145963706|NCT01939314|526380192|FG001|Overall Study|Lost to Follow-up|6|||
145963707|NCT03644017|526380193|FG000|Overall Study|Access Abandonment|5|||
145963708|NCT03644017|526380193|FG000|Overall Study|Kidney Transplant|2|||
145963709|NCT02700048|526380194|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
145963710|NCT02700048|526380195|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
145963711|NCT02175225|526380196|FG000|Overall Study|Withdrawal by Subject|1|||
145963712|NCT02175225|526380197|FG001|Overall Study|Withdrawal by Subject|2|||
145963713|NCT02175225|526380196|FG000|Overall Study|Lost to Follow-up|6|||
145963714|NCT02175225|526380197|FG001|Overall Study|Lost to Follow-up|7|||
145963715|NCT02175225|526380196|FG000|Overall Study|Study drug not administered|1|||
145963716|NCT02175225|526380197|FG001|Overall Study|Study drug not administered|2|||
145963717|NCT02340000|526380198|FG000|Time Period 1|Withdrawal by Subject|6|||
145963718|NCT02340000|526380199|FG001|Time Period 1|Withdrawal by Subject|8|||
145963719|NCT02340000|526380198|FG000|Time Period 1|Lost to Follow-up|6|||
145963720|NCT02340000|526380199|FG001|Time Period 1|Lost to Follow-up|7|||
145963721|NCT02340000|526380198|FG000|Time Period 2|Withdrawal by Subject|9|||
145963722|NCT02340000|526380199|FG001|Time Period 2|Withdrawal by Subject|7|||
145963723|NCT02340000|526380198|FG000|Time Period 2|Lost to Follow-up|10|||
145963724|NCT02340000|526380199|FG001|Time Period 2|Lost to Follow-up|8|||
145963725|NCT00969228|526380204|FG000|Overall Study|Adverse Event|1|||
145963726|NCT00969228|526380205|FG001|Overall Study|Adverse Event|0|||
145963727|NCT00969228|526380204|FG000|Overall Study|Withdrawal by Subject|4|||
145963728|NCT00969228|526380205|FG001|Overall Study|Withdrawal by Subject|0|||
145963729|NCT00969228|526380204|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
145963730|NCT00969228|526380205|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
145963731|NCT01107925|526380207|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
145963732|NCT01107925|526380208|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146086563|NCT06400251|526837970|FG000|Overall Study|Ineligible|2|||
146086564|NCT06400251|526837970|FG000|Overall Study|Mutation Status Not Confirmed|3|||
146086565|NCT06400251|526837970|FG000|Overall Study|Disease Progression|25|||
146086566|NCT06400251|526837970|FG000|Overall Study|Adverse Event|1|||
146086567|NCT06400251|526837970|FG000|Overall Study|Complicating Disease|1|||
146086568|NCT06400251|526837970|FG000|Overall Study|Physician Decision|2|||
146086569|NCT01150474|526837971|FG000|Overall Study|Withdrawal by Subject|5|||
146086570|NCT01150474|526837972|FG001|Overall Study|Withdrawal by Subject|2|||
146086571|NCT01150474|526837971|FG000|Overall Study|Cancer found|1|||
146086572|NCT01150474|526837972|FG001|Overall Study|Cancer found|0|||
146086573|NCT01150474|526837971|FG000|Overall Study|Multiple Studies|0|||
146086574|NCT01150474|526837972|FG001|Overall Study|Multiple Studies|1|||
146086575|NCT01150474|526837971|FG000|Overall Study|Rectotomy|1|||
146231997|NCT03705390|527368418|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
146231998|NCT02989662|527368420|FG000|Overall Study|Lost to Follow-up|0|||
146231999|NCT02989662|527368421|FG001|Overall Study|Lost to Follow-up|0|||
146232000|NCT02989662|527368422|FG002|Overall Study|Lost to Follow-up|0|||
146232001|NCT02989662|527368423|FG003|Overall Study|Lost to Follow-up|2|||
146232002|NCT02989662|527368420|FG000|Overall Study|Physician Decision|3|||
146232003|NCT02989662|527368421|FG001|Overall Study|Physician Decision|0|||
146232004|NCT02989662|527368422|FG002|Overall Study|Physician Decision|0|||
146232005|NCT02989662|527368423|FG003|Overall Study|Physician Decision|0|||
146232006|NCT02989662|527368420|FG000|Overall Study|Withdrawal by Subject|1|||
146232007|NCT02989662|527368421|FG001|Overall Study|Withdrawal by Subject|0|||
146232008|NCT02989662|527368422|FG002|Overall Study|Withdrawal by Subject|0|||
146232009|NCT02989662|527368423|FG003|Overall Study|Withdrawal by Subject|0|||
146232010|NCT00328783|527368424|FG000|Overall Study|Could not tolerate ABC|21|||
146232011|NCT00328783|527368424|FG000|Overall Study|No heart in RT field|4|||
146232012|NCT00328783|527368424|FG000|Overall Study|Withdrawal by Subject|1|||
146232013|NCT00357682|527368425|FG000|Overall Study|Did not receive allocated Treatment|10|||
146232014|NCT00357682|527368426|FG001|Overall Study|Did not receive allocated Treatment|9|||
146232015|NCT00357682|527368427|FG002|Overall Study|Did not receive allocated Treatment|9|||
146232016|NCT00357682|527368428|FG003|Overall Study|Did not receive allocated Treatment|10|||
145886495|NCT02412722|526088370|FG000|Overall Study|Progressive Disease|6|||
145886496|NCT02412722|526088371|FG001|Overall Study|Progressive Disease|4|||
146086576|NCT01150474|526837972|FG001|Overall Study|Rectotomy|0|||
146086577|NCT01150474|526837971|FG000|Overall Study|Drug did not arrive in time|1|||
146232017|NCT00357682|527368425|FG000|Overall Study|Withdrew consent|6|||
146232018|NCT00357682|527368426|FG001|Overall Study|Withdrew consent|6|||
146232019|NCT00357682|527368427|FG002|Overall Study|Withdrew consent|5|||
146232020|NCT00357682|527368428|FG003|Overall Study|Withdrew consent|5|||
146232021|NCT00357682|527368425|FG000|Overall Study|Lost to Follow-up|39|||
146086578|NCT01150474|526837972|FG001|Overall Study|Drug did not arrive in time|0|||
146086579|NCT01150474|526837971|FG000|Overall Study|Drug not administered|1|||
146086580|NCT01150474|526837972|FG001|Overall Study|Drug not administered|0|||
146086581|NCT01150474|526837971|FG000|Overall Study|Surgery Changed|1|||
146086582|NCT01150474|526837972|FG001|Overall Study|Surgery Changed|0|||
146086583|NCT00219544|526837973|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
145886497|NCT02412722|526088372|FG002|Overall Study|Progressive Disease|4|||
145886498|NCT02412722|526088373|FG003|Overall Study|Progressive Disease|9|||
145886499|NCT02412722|526088374|FG004|Overall Study|Progressive Disease|3|||
145886500|NCT02412722|526088375|FG005|Overall Study|Progressive Disease|3|||
145886501|NCT02412722|526088370|FG000|Overall Study|Withdrawal by Subject|2|||
145886502|NCT02412722|526088371|FG001|Overall Study|Withdrawal by Subject|0|||
145886503|NCT02412722|526088372|FG002|Overall Study|Withdrawal by Subject|1|||
145886504|NCT02412722|526088373|FG003|Overall Study|Withdrawal by Subject|2|||
145886505|NCT02412722|526088374|FG004|Overall Study|Withdrawal by Subject|1|||
145886506|NCT02412722|526088375|FG005|Overall Study|Withdrawal by Subject|1|||
145886507|NCT02412722|526088370|FG000|Overall Study|Lost to Follow-up|0|||
145886508|NCT02412722|526088371|FG001|Overall Study|Lost to Follow-up|0|||
145886509|NCT02412722|526088372|FG002|Overall Study|Lost to Follow-up|0|||
145886510|NCT02412722|526088373|FG003|Overall Study|Lost to Follow-up|0|||
146290493|NCT01313689|527579017|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
145886511|NCT02412722|526088374|FG004|Overall Study|Lost to Follow-up|1|||
145886512|NCT02412722|526088375|FG005|Overall Study|Lost to Follow-up|0|||
145886513|NCT02412722|526088370|FG000|Overall Study|Received drug in run-in and discontinued|0|||
145886514|NCT02412722|526088371|FG001|Overall Study|Received drug in run-in and discontinued|2|||
145886515|NCT02412722|526088372|FG002|Overall Study|Received drug in run-in and discontinued|0|||
145886516|NCT02412722|526088373|FG003|Overall Study|Received drug in run-in and discontinued|0|||
145886517|NCT02412722|526088374|FG004|Overall Study|Received drug in run-in and discontinued|0|||
145886518|NCT02412722|526088375|FG005|Overall Study|Received drug in run-in and discontinued|0|||
145886519|NCT02412722|526088370|FG000|Overall Study|Reason not Specified|3|||
145886520|NCT02412722|526088371|FG001|Overall Study|Reason not Specified|0|||
145886521|NCT02412722|526088372|FG002|Overall Study|Reason not Specified|2|||
145963733|NCT01107925|526380209|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
146232022|NCT00357682|527368426|FG001|Overall Study|Lost to Follow-up|33|||
145886522|NCT02412722|526088373|FG003|Overall Study|Reason not Specified|1|||
145963734|NCT01107925|526380210|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145963735|NCT01107925|526380211|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
145886523|NCT02412722|526088374|FG004|Overall Study|Reason not Specified|2|||
145886524|NCT02412722|526088375|FG005|Overall Study|Reason not Specified|6|||
145886525|NCT04449341|526088376|FG000|Overall Study|Protocol Violation|1|||
145886526|NCT04449341|526088377|FG001|Overall Study|Protocol Violation|0|||
145886527|NCT00869440|526088378|FG000|Overall Study|Withdrawal by Subject|1|||
145886528|NCT00869440|526088379|FG001|Overall Study|Withdrawal by Subject|0|||
145886529|NCT00869440|526088380|FG002|Overall Study|Withdrawal by Subject|0|||
145886530|NCT00869440|526088381|FG003|Overall Study|Withdrawal by Subject|0|||
145963736|NCT01107925|526380212|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145963737|NCT01107925|526380207|FG000|Period 2|Withdrawal by Subject|0|||
145963738|NCT01107925|526380208|FG001|Period 2|Withdrawal by Subject|1|||
145963739|NCT01107925|526380209|FG002|Period 2|Withdrawal by Subject|0|||
145963740|NCT01107925|526380210|FG003|Period 2|Withdrawal by Subject|0|||
145963741|NCT01107925|526380211|FG004|Period 2|Withdrawal by Subject|0|||
145963742|NCT01107925|526380212|FG005|Period 2|Withdrawal by Subject|1|||
145963743|NCT03311945|526380213|FG000|Overall Study|Adverse Event|2|||
145963744|NCT03311945|526380213|FG000|Overall Study|Lack of Efficacy|1|||
145963745|NCT04877990|526380214|FG000|Treatment|Other reasons|3|||
145963746|NCT04877990|526380215|FG001|Treatment|Other reasons|1|||
146086584|NCT00219544|526837974|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
145886531|NCT00869440|526088378|FG000|Overall Study|Physician Decision|1|||
145886532|NCT00869440|526088379|FG001|Overall Study|Physician Decision|1|||
145886533|NCT00869440|526088380|FG002|Overall Study|Physician Decision|0|||
145963747|NCT04877990|526380214|FG000|Treatment|Administrative reasons by sponsor|17|||
145963748|NCT04877990|526380215|FG001|Treatment|Administrative reasons by sponsor|33|||
145963749|NCT04877990|526380214|FG000|Treatment|Withdrawal by Subject|2|||
145963750|NCT04877990|526380215|FG001|Treatment|Withdrawal by Subject|6|||
145963751|NCT04877990|526380214|FG000|Treatment|Adverse Event|2|||
146232023|NCT00357682|527368427|FG002|Overall Study|Lost to Follow-up|26|||
146232024|NCT00357682|527368428|FG003|Overall Study|Lost to Follow-up|35|||
145886534|NCT00869440|526088381|FG003|Overall Study|Physician Decision|0|||
145886535|NCT01083680|526088383|FG000|Overall Study|Lost to Follow-up|2758|||
145886536|NCT01083680|526088383|FG000|Overall Study|Withdrawal by Subject|1086|||
145886537|NCT03546647|526088384|FG000|Overall Study|Adverse Event|1|||
145886538|NCT03546647|526088385|FG001|Overall Study|Adverse Event|0|||
145886539|NCT00124462|526088388|FG000|Overall Study|Lost to Follow-up|3|||
145886540|NCT00124462|526088389|FG001|Overall Study|Lost to Follow-up|3|||
145886541|NCT00124462|526088388|FG000|Overall Study|Physician Decision|3|||
146232025|NCT00357682|527368425|FG000|Overall Study|Adverse Event|24|||
146232026|NCT00357682|527368426|FG001|Overall Study|Adverse Event|32|||
146232027|NCT00357682|527368427|FG002|Overall Study|Adverse Event|22|||
145886542|NCT00124462|526088389|FG001|Overall Study|Physician Decision|4|||
145886543|NCT00124462|526088388|FG000|Overall Study|Withdrawal by Subject|4|||
145886544|NCT00124462|526088389|FG001|Overall Study|Withdrawal by Subject|5|||
145886545|NCT00124462|526088388|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
145886546|NCT00124462|526088389|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
145886547|NCT02400476|526088390|FG000|Overall Study|Adverse Event|57|||
145886548|NCT02400476|526088391|FG001|Overall Study|Adverse Event|10|||
145886549|NCT02400476|526088392|FG002|Overall Study|Adverse Event|22|||
145886550|NCT02400476|526088393|FG003|Overall Study|Adverse Event|19|||
145886551|NCT02400476|526088394|FG004|Overall Study|Adverse Event|5|||
145886552|NCT02400476|526088395|FG005|Overall Study|Adverse Event|8|||
145886553|NCT02400476|526088390|FG000|Overall Study|Withdrawal by Subject|4|||
145886554|NCT02400476|526088391|FG001|Overall Study|Withdrawal by Subject|1|||
145886555|NCT02400476|526088392|FG002|Overall Study|Withdrawal by Subject|12|||
145886556|NCT02400476|526088393|FG003|Overall Study|Withdrawal by Subject|7|||
145886557|NCT02400476|526088394|FG004|Overall Study|Withdrawal by Subject|5|||
145886558|NCT02400476|526088395|FG005|Overall Study|Withdrawal by Subject|5|||
145886559|NCT02400476|526088390|FG000|Overall Study|Lost to Follow-up|0|||
145886560|NCT02400476|526088391|FG001|Overall Study|Lost to Follow-up|0|||
145886561|NCT02400476|526088392|FG002|Overall Study|Lost to Follow-up|0|||
145886562|NCT02400476|526088393|FG003|Overall Study|Lost to Follow-up|1|||
145886563|NCT02400476|526088394|FG004|Overall Study|Lost to Follow-up|3|||
145886564|NCT02400476|526088395|FG005|Overall Study|Lost to Follow-up|1|||
145886565|NCT02400476|526088390|FG000|Overall Study|Physician Decision|0|||
145886566|NCT02400476|526088391|FG001|Overall Study|Physician Decision|0|||
145886567|NCT02400476|526088392|FG002|Overall Study|Physician Decision|1|||
145886568|NCT02400476|526088393|FG003|Overall Study|Physician Decision|1|||
145886569|NCT02400476|526088394|FG004|Overall Study|Physician Decision|0|||
145886570|NCT02400476|526088395|FG005|Overall Study|Physician Decision|1|||
145886571|NCT02400476|526088390|FG000|Overall Study|Other, Disease Progression|0|||
145886572|NCT02400476|526088391|FG001|Overall Study|Other, Disease Progression|1|||
145886573|NCT02400476|526088392|FG002|Overall Study|Other, Disease Progression|2|||
145886574|NCT02400476|526088393|FG003|Overall Study|Other, Disease Progression|1|||
145886575|NCT02400476|526088394|FG004|Overall Study|Other, Disease Progression|2|||
145886576|NCT02400476|526088395|FG005|Overall Study|Other, Disease Progression|1|||
145886577|NCT02400476|526088390|FG000|Overall Study|Other, Decreased Quality of Life|0|||
145886578|NCT02400476|526088391|FG001|Overall Study|Other, Decreased Quality of Life|0|||
145886579|NCT02400476|526088392|FG002|Overall Study|Other, Decreased Quality of Life|2|||
145886580|NCT02400476|526088393|FG003|Overall Study|Other, Decreased Quality of Life|0|||
145886581|NCT02400476|526088394|FG004|Overall Study|Other, Decreased Quality of Life|0|||
145886582|NCT02400476|526088395|FG005|Overall Study|Other, Decreased Quality of Life|0|||
145886583|NCT02400476|526088390|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145886584|NCT02400476|526088391|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145886585|NCT02400476|526088392|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
145886586|NCT02400476|526088393|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
145886587|NCT02400476|526088394|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145886588|NCT02400476|526088395|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145886589|NCT02487082|526088396|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
145886590|NCT02487082|526088397|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
145886591|NCT02487082|526088396|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
145886592|NCT02487082|526088397|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
145886593|NCT00003531|526088398|FG000|Overall Study|Not evaluable|10|||
145886594|NCT00588731|526088399|FG000|Overall Study|Withdrawal by Subject|3|||
145886595|NCT00588731|526088400|FG001|Overall Study|Withdrawal by Subject|2|||
145886596|NCT00251316|526088401|FG000|Overall Study|Physician Decision|2|||
145886597|NCT00251316|526088402|FG001|Overall Study|Physician Decision|3|||
145886598|NCT00346164|526088403|FG000|Overall Study|Adverse Event|0|||
145886599|NCT00346164|526088404|FG001|Overall Study|Adverse Event|0|||
145886600|NCT00346164|526088405|FG002|Overall Study|Adverse Event|0|||
145886601|NCT00346164|526088406|FG003|Overall Study|Adverse Event|1|||
145886602|NCT00346164|526088403|FG000|Overall Study|Lack of Efficacy|0|||
145886603|NCT00346164|526088404|FG001|Overall Study|Lack of Efficacy|1|||
145886604|NCT00346164|526088405|FG002|Overall Study|Lack of Efficacy|7|||
145886605|NCT00346164|526088406|FG003|Overall Study|Lack of Efficacy|25|||
145886606|NCT00346164|526088403|FG000|Overall Study|Physician Decision|0|||
145886607|NCT00346164|526088404|FG001|Overall Study|Physician Decision|1|||
145886608|NCT00346164|526088405|FG002|Overall Study|Physician Decision|2|||
145886609|NCT00346164|526088406|FG003|Overall Study|Physician Decision|27|||
145886610|NCT00346164|526088403|FG000|Overall Study|Protocol Violation|6|||
145886611|NCT00346164|526088404|FG001|Overall Study|Protocol Violation|2|||
145886612|NCT00346164|526088405|FG002|Overall Study|Protocol Violation|10|||
145886613|NCT00346164|526088406|FG003|Overall Study|Protocol Violation|4|||
145886614|NCT00346164|526088403|FG000|Overall Study|Withdrawal by Subject|0|||
145886615|NCT00346164|526088404|FG001|Overall Study|Withdrawal by Subject|0|||
145886616|NCT00346164|526088405|FG002|Overall Study|Withdrawal by Subject|2|||
145886617|NCT00346164|526088406|FG003|Overall Study|Withdrawal by Subject|0|||
145886618|NCT00346164|526088403|FG000|Overall Study|Ineligible|11|||
145886619|NCT00346164|526088404|FG001|Overall Study|Ineligible|2|||
146232028|NCT00357682|527368428|FG003|Overall Study|Adverse Event|27|||
146232029|NCT00357682|527368425|FG000|Overall Study|Physician Decision|32|||
146232030|NCT00357682|527368426|FG001|Overall Study|Physician Decision|20|||
146232031|NCT00357682|527368427|FG002|Overall Study|Physician Decision|24|||
146232032|NCT00357682|527368428|FG003|Overall Study|Physician Decision|30|||
146232033|NCT00357682|527368425|FG000|Overall Study|Patient decision|73|||
146232034|NCT00357682|527368426|FG001|Overall Study|Patient decision|80|||
146232035|NCT00357682|527368427|FG002|Overall Study|Patient decision|51|||
145886620|NCT00346164|526088405|FG002|Overall Study|Ineligible|2|||
146232036|NCT00357682|527368428|FG003|Overall Study|Patient decision|59|||
146232037|NCT00357682|527368425|FG000|Overall Study|Other reason|157|||
146232038|NCT00357682|527368426|FG001|Overall Study|Other reason|130|||
145886621|NCT00346164|526088406|FG003|Overall Study|Ineligible|23|||
146232039|NCT00357682|527368427|FG002|Overall Study|Other reason|114|||
146232040|NCT00357682|527368428|FG003|Overall Study|Other reason|99|||
146232041|NCT03660930|527368430|FG000|Overall Study|Adverse Event|0|||
146232042|NCT03660930|527368431|FG001|Overall Study|Adverse Event|0|||
146232043|NCT03660930|527368432|FG002|Overall Study|Adverse Event|0|||
146232044|NCT03660930|527368433|FG003|Overall Study|Adverse Event|2|||
146232045|NCT03660930|527368434|FG004|Overall Study|Adverse Event|0|||
146232046|NCT03660930|527368435|FG005|Overall Study|Adverse Event|1|||
146232047|NCT03660930|527368436|FG006|Overall Study|Adverse Event|0|||
146232048|NCT03660930|527368437|FG007|Overall Study|Adverse Event|0|||
146232049|NCT03660930|527368430|FG000|Overall Study|Withdrawal by Subject|0|||
146232050|NCT03660930|527368431|FG001|Overall Study|Withdrawal by Subject|0|||
146232051|NCT03660930|527368432|FG002|Overall Study|Withdrawal by Subject|0|||
145886622|NCT00346164|526088403|FG000|Overall Study|Refusal of further protocol therapy|0|||
145886623|NCT00346164|526088404|FG001|Overall Study|Refusal of further protocol therapy|1|||
145886624|NCT00346164|526088405|FG002|Overall Study|Refusal of further protocol therapy|3|||
145886625|NCT00346164|526088406|FG003|Overall Study|Refusal of further protocol therapy|15|||
145886626|NCT00346164|526088403|FG000|Overall Study|Inability to start week 16 tx on time|0|||
146232052|NCT03660930|527368433|FG003|Overall Study|Withdrawal by Subject|0|||
146232053|NCT03660930|527368434|FG004|Overall Study|Withdrawal by Subject|0|||
146232054|NCT03660930|527368435|FG005|Overall Study|Withdrawal by Subject|1|||
146232055|NCT03660930|527368436|FG006|Overall Study|Withdrawal by Subject|0|||
146232056|NCT03660930|527368437|FG007|Overall Study|Withdrawal by Subject|0|||
146232057|NCT02656706|527368440|FG000|Overall Study|Insurance Denial|1|||
146232058|NCT03725332|527368441|FG000|Overall Study|Adverse Event|5|||
146232059|NCT03725332|527368442|FG001|Overall Study|Adverse Event|10|||
146232060|NCT03725332|527368441|FG000|Overall Study|Death|1|||
146232061|NCT03725332|527368442|FG001|Overall Study|Death|3|||
146232062|NCT03725332|527368441|FG000|Overall Study|Lost to Follow-up|43|||
146232063|NCT03725332|527368442|FG001|Overall Study|Lost to Follow-up|122|||
146232064|NCT03725332|527368441|FG000|Overall Study|Withdrawal by Subject|0|||
146232065|NCT03725332|527368442|FG001|Overall Study|Withdrawal by Subject|1|||
146232066|NCT03725332|527368441|FG000|Overall Study|Duplicate enrollment|0|||
146232067|NCT03725332|527368442|FG001|Overall Study|Duplicate enrollment|1|||
146232068|NCT03725332|527368441|FG000|Overall Study|Did not consent|0|||
146232069|NCT03725332|527368442|FG001|Overall Study|Did not consent|1|||
146232070|NCT03242915|527368449|FG000|Overall Study|Adverse Event|5|||
146232071|NCT03242915|527368450|FG001|Overall Study|Adverse Event|1|||
146232072|NCT03242915|527368449|FG000|Overall Study|Withdrawal by Subject|0|||
146232073|NCT03242915|527368450|FG001|Overall Study|Withdrawal by Subject|2|||
146232074|NCT03242915|527368449|FG000|Overall Study|Physician Decision|4|||
146232075|NCT03242915|527368450|FG001|Overall Study|Physician Decision|1|||
146232076|NCT02726386|527368451|FG000|Overall Study|Adverse Event|17|||
146232077|NCT02726386|527368452|FG001|Overall Study|Adverse Event|20|||
145886627|NCT00346164|526088404|FG001|Overall Study|Inability to start week 16 tx on time|0|||
145886628|NCT00346164|526088405|FG002|Overall Study|Inability to start week 16 tx on time|0|||
145886629|NCT00346164|526088406|FG003|Overall Study|Inability to start week 16 tx on time|11|||
145886630|NCT03297294|526088407|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
145886631|NCT03297294|526088408|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
145886632|NCT03297294|526088409|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145886633|NCT03297294|526088410|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145886634|NCT03297294|526088411|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145886635|NCT03297294|526088407|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
145886636|NCT03297294|526088408|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
145886637|NCT03297294|526088409|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145886638|NCT03297294|526088410|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145886639|NCT03297294|526088411|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145886640|NCT03297294|526088407|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
145886641|NCT03297294|526088408|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
145886642|NCT03297294|526088409|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145886643|NCT03297294|526088410|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145886644|NCT03297294|526088411|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145886645|NCT03297294|526088407|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
145886646|NCT03297294|526088408|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
145886647|NCT03297294|526088409|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145886648|NCT03297294|526088410|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145886649|NCT03297294|526088411|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145886650|NCT03297294|526088407|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145886651|NCT03297294|526088408|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145886652|NCT03297294|526088409|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145886653|NCT03297294|526088410|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
145886654|NCT03297294|526088411|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145886655|NCT01198873|526088412|FG000|Overall Study|Adverse Event|4|||
145886656|NCT01198873|526088413|FG001|Overall Study|Adverse Event|7|||
145886657|NCT01198873|526088412|FG000|Overall Study|Study closure|29|||
145886658|NCT01198873|526088413|FG001|Overall Study|Study closure|23|||
145886659|NCT01198873|526088412|FG000|Overall Study|Other than above|4|||
145886660|NCT01198873|526088413|FG001|Overall Study|Other than above|2|||
145886661|NCT03139240|526088414|FG000|Overall Study|Lost to Follow-up|0|||
145886662|NCT03139240|526088415|FG001|Overall Study|Lost to Follow-up|1|||
145886663|NCT03139240|526088416|FG002|Overall Study|Lost to Follow-up|1|||
145886664|NCT03139240|526088417|FG003|Overall Study|Lost to Follow-up|0|||
145886665|NCT04569786|526088418|FG000|Overall Study|Lost to Follow-up|1|||
145886666|NCT04569786|526088419|FG001|Overall Study|Lost to Follow-up|0|||
145886667|NCT04569786|526088420|FG002|Overall Study|Lost to Follow-up|4|||
145886668|NCT04569786|526088421|FG003|Overall Study|Lost to Follow-up|1|||
145886669|NCT04569786|526088422|FG004|Overall Study|Lost to Follow-up|0|||
145886670|NCT04569786|526088418|FG000|Overall Study|Withdrawal by Subject|0|||
145886671|NCT04569786|526088419|FG001|Overall Study|Withdrawal by Subject|0|||
145886672|NCT04569786|526088420|FG002|Overall Study|Withdrawal by Subject|0|||
145886673|NCT04569786|526088421|FG003|Overall Study|Withdrawal by Subject|5|||
146232078|NCT02726386|527368451|FG000|Overall Study|Withdrawal by Subject|14|||
146232079|NCT02726386|527368452|FG001|Overall Study|Withdrawal by Subject|28|||
146232080|NCT02726386|527368451|FG000|Overall Study|Other reasons|7|||
145886674|NCT04569786|526088422|FG004|Overall Study|Withdrawal by Subject|1|||
145886675|NCT04569786|526088418|FG000|Overall Study|Physician Decision|0|||
145886676|NCT04569786|526088419|FG001|Overall Study|Physician Decision|0|||
145886677|NCT04569786|526088420|FG002|Overall Study|Physician Decision|0|||
145886678|NCT04569786|526088421|FG003|Overall Study|Physician Decision|1|||
145886679|NCT04569786|526088422|FG004|Overall Study|Physician Decision|0|||
145886680|NCT02692482|526088423|FG000|Overall Study|Death|2|||
145886681|NCT02692482|526088424|FG001|Overall Study|Death|2|||
145886682|NCT02692482|526088423|FG000|Overall Study|Withdrawal by Subject|1|||
145963752|NCT04877990|526380215|FG001|Treatment|Adverse Event|1|||
146232081|NCT02726386|527368452|FG001|Overall Study|Other reasons|8|||
146232082|NCT05424718|527368468|FG000|Overall Study|Lost to Follow-up|5|||
146086585|NCT00219544|526837973|FG000|Single Blind Treatment Period|Adverse Event|9|||
146232083|NCT05424718|527368469|FG001|Overall Study|Lost to Follow-up|4|||
145963753|NCT01619878|526380216|FG000|6 Week Follow-up Phase|Adverse Event|1|||
145963754|NCT01619878|526380216|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
145963755|NCT01619878|526380216|FG000|Follow-up at 12 Months of Age|Death|2|||
145963756|NCT01305564|526380219|FG000|Overall Study|Death|21|||
145963757|NCT01305564|526380219|FG000|Overall Study|Lost to Follow-up|12|||
145963758|NCT01305564|526380219|FG000|Overall Study|Withdrawal by Subject|1|||
145963759|NCT01305564|526380219|FG000|Overall Study|Physician Decision|3|||
145963760|NCT00919633|526380232|FG000|Overall Study|Adverse Event|1|||
145963761|NCT00919633|526380233|FG001|Overall Study|Adverse Event|9|||
145963762|NCT00919633|526380234|FG002|Overall Study|Adverse Event|12|||
145963763|NCT00919633|526380235|FG003|Overall Study|Adverse Event|10|||
145963764|NCT00919633|526380232|FG000|Overall Study|Death|0|||
146086586|NCT00219544|526837974|FG001|Single Blind Treatment Period|Adverse Event|0|||
146086587|NCT00219544|526837973|FG000|Single Blind Treatment Period|Protocol Violation|4|||
145963765|NCT00919633|526380233|FG001|Overall Study|Death|0|||
145963766|NCT00919633|526380234|FG002|Overall Study|Death|2|||
145963767|NCT00919633|526380235|FG003|Overall Study|Death|0|||
145963768|NCT00919633|526380232|FG000|Overall Study|Lack of Efficacy|17|||
146232084|NCT04046549|527368470|FG000|Overall Study|Adverse Event|1|||
145886683|NCT02692482|526088424|FG001|Overall Study|Withdrawal by Subject|2|||
145886684|NCT00292227|526088429|FG000|Patch Period|Adverse Event|1|||
145886685|NCT00292227|526088430|FG001|Patch Period|Adverse Event|0|||
145886686|NCT00292227|526088431|FG002|Patch Period|Adverse Event|2|||
145886687|NCT00292227|526088429|FG000|Patch Period|Withdrawal by Subject|0|||
145886688|NCT00292227|526088430|FG001|Patch Period|Withdrawal by Subject|0|||
145886689|NCT00292227|526088431|FG002|Patch Period|Withdrawal by Subject|1|||
145886690|NCT03253094|526088434|FG000|Overall Study|Adverse Event|2|||
145886691|NCT03253094|526088435|FG001|Overall Study|Adverse Event|0|||
145886692|NCT03253094|526088436|FG002|Overall Study|Adverse Event|0|||
145886693|NCT03253094|526088437|FG003|Overall Study|Adverse Event|0|||
145886694|NCT03253094|526088438|FG004|Overall Study|Adverse Event|0|||
145886695|NCT03253094|526088439|FG005|Overall Study|Adverse Event|0|||
145886696|NCT03253094|526088434|FG000|Overall Study|Lack of Efficacy|0|||
145886697|NCT03253094|526088435|FG001|Overall Study|Lack of Efficacy|0|||
145886698|NCT03253094|526088436|FG002|Overall Study|Lack of Efficacy|2|||
145886699|NCT03253094|526088437|FG003|Overall Study|Lack of Efficacy|1|||
145886700|NCT03253094|526088438|FG004|Overall Study|Lack of Efficacy|2|||
145886701|NCT03253094|526088439|FG005|Overall Study|Lack of Efficacy|1|||
145886702|NCT03253094|526088434|FG000|Overall Study|Lost to Follow-up|0|||
145886703|NCT03253094|526088435|FG001|Overall Study|Lost to Follow-up|0|||
145886704|NCT03253094|526088436|FG002|Overall Study|Lost to Follow-up|1|||
145886705|NCT03253094|526088437|FG003|Overall Study|Lost to Follow-up|1|||
145886706|NCT03253094|526088438|FG004|Overall Study|Lost to Follow-up|0|||
145886707|NCT03253094|526088439|FG005|Overall Study|Lost to Follow-up|1|||
145886708|NCT03253094|526088434|FG000|Overall Study|Physician Decision|1|||
145886709|NCT03253094|526088435|FG001|Overall Study|Physician Decision|0|||
145886710|NCT03253094|526088436|FG002|Overall Study|Physician Decision|0|||
145886711|NCT03253094|526088437|FG003|Overall Study|Physician Decision|1|||
145886712|NCT03253094|526088438|FG004|Overall Study|Physician Decision|0|||
145886713|NCT03253094|526088439|FG005|Overall Study|Physician Decision|2|||
145886714|NCT03253094|526088434|FG000|Overall Study|Withdrawal by Subject|1|||
145886715|NCT03253094|526088435|FG001|Overall Study|Withdrawal by Subject|2|||
145886716|NCT03253094|526088436|FG002|Overall Study|Withdrawal by Subject|1|||
145886717|NCT03253094|526088437|FG003|Overall Study|Withdrawal by Subject|0|||
145886718|NCT03253094|526088438|FG004|Overall Study|Withdrawal by Subject|3|||
145886719|NCT03253094|526088439|FG005|Overall Study|Withdrawal by Subject|0|||
145886720|NCT03253094|526088434|FG000|Overall Study|Other|0|||
145886721|NCT03253094|526088435|FG001|Overall Study|Other|1|||
145886722|NCT03253094|526088436|FG002|Overall Study|Other|2|||
145886723|NCT03253094|526088437|FG003|Overall Study|Other|1|||
145886724|NCT03253094|526088438|FG004|Overall Study|Other|0|||
145886725|NCT03253094|526088439|FG005|Overall Study|Other|0|||
145886726|NCT00480324|526090224|FG000|Overall Study|Adverse Event|1|||
145886727|NCT00480324|526090225|FG001|Overall Study|Adverse Event|1|||
145886728|NCT00480324|526090224|FG000|Overall Study|Protocol Violation|0|||
145886729|NCT00480324|526090225|FG001|Overall Study|Protocol Violation|1|||
145886730|NCT00480324|526090224|FG000|Overall Study|Withdrawal by Subject|14|||
145886731|NCT00480324|526090225|FG001|Overall Study|Withdrawal by Subject|5|||
145886732|NCT00480324|526090224|FG000|Overall Study|Lost to Follow-up|17|||
145886733|NCT00480324|526090225|FG001|Overall Study|Lost to Follow-up|8|||
145886734|NCT00480324|526090224|FG000|Overall Study|Subject's mother pregnant|0|||
145886735|NCT00480324|526090225|FG001|Overall Study|Subject's mother pregnant|1|||
145886736|NCT00784134|526090226|FG000|Overall Study|Lost to Follow-up|3|||
145886737|NCT00784134|526090227|FG001|Overall Study|Lost to Follow-up|6|||
145886738|NCT03785145|526090228|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
145886739|NCT03785145|526090229|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
145886740|NCT03785145|526090228|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
145886741|NCT03785145|526090229|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
145886742|NCT03785145|526090228|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
145886743|NCT03785145|526090229|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
145886744|NCT03785145|526090228|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
145886745|NCT03785145|526090229|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
145886746|NCT03785145|526090228|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
145886747|NCT03785145|526090229|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
145886748|NCT03785145|526090228|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
145886749|NCT03785145|526090229|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
145886750|NCT03785145|526090228|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
145886751|NCT03785145|526090229|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
145886752|NCT03785145|526090228|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
145886753|NCT03785145|526090229|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
145886754|NCT03785145|526090228|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
145886755|NCT03785145|526090229|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
145886756|NCT03785145|526090228|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
145886757|NCT03785145|526090229|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
145886758|NCT03785145|526090228|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
146232085|NCT04046549|527368470|FG000|Overall Study|Physician Decision|1|||
146232086|NCT04046549|527368470|FG000|Overall Study|Withdrawal by Subject|3|||
145963769|NCT00919633|526380233|FG001|Overall Study|Lack of Efficacy|3|||
145963770|NCT00919633|526380234|FG002|Overall Study|Lack of Efficacy|2|||
145963771|NCT00919633|526380235|FG003|Overall Study|Lack of Efficacy|3|||
145963772|NCT00919633|526380232|FG000|Overall Study|Withdrawal by Subject|1|||
145963773|NCT00919633|526380233|FG001|Overall Study|Withdrawal by Subject|2|||
145963774|NCT00919633|526380234|FG002|Overall Study|Withdrawal by Subject|4|||
145963775|NCT00919633|526380235|FG003|Overall Study|Withdrawal by Subject|3|||
145963776|NCT00919633|526380232|FG000|Overall Study|Lost to Follow-up|3|||
145963777|NCT00919633|526380233|FG001|Overall Study|Lost to Follow-up|1|||
145963778|NCT00919633|526380234|FG002|Overall Study|Lost to Follow-up|0|||
145963779|NCT00919633|526380235|FG003|Overall Study|Lost to Follow-up|2|||
145963780|NCT00919633|526380232|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
145963781|NCT00919633|526380233|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
145963782|NCT00919633|526380234|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
145963783|NCT00919633|526380235|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
145963784|NCT00919633|526380232|FG000|Overall Study|Protocol Violation|0|||
145963785|NCT00919633|526380233|FG001|Overall Study|Protocol Violation|0|||
145963786|NCT00919633|526380234|FG002|Overall Study|Protocol Violation|0|||
145963787|NCT00919633|526380235|FG003|Overall Study|Protocol Violation|1|||
145963788|NCT00919633|526380232|FG000|Overall Study|Physician Decision|0|||
145963789|NCT00919633|526380233|FG001|Overall Study|Physician Decision|0|||
145963790|NCT00919633|526380234|FG002|Overall Study|Physician Decision|0|||
145963791|NCT00919633|526380235|FG003|Overall Study|Physician Decision|1|||
145963792|NCT00919633|526380232|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
145963793|NCT00919633|526380233|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
145963794|NCT00919633|526380234|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
145963795|NCT00919633|526380235|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
145963796|NCT00919633|526380232|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
145963797|NCT00919633|526380233|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
145963798|NCT00919633|526380234|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
145963799|NCT00919633|526380235|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
145963800|NCT01949142|526380236|FG000|Overall Study|Withdrawal of consent|1|||
145963801|NCT01949142|526380237|FG001|Overall Study|Withdrawal of consent|0|||
145963802|NCT01949142|526380236|FG000|Overall Study|Lost to Follow-up|1|||
145963803|NCT01949142|526380237|FG001|Overall Study|Lost to Follow-up|1|||
145963804|NCT01949142|526380236|FG000|Overall Study|Parent changed their mind|1|||
145963805|NCT01949142|526380237|FG001|Overall Study|Parent changed their mind|0|||
145963806|NCT00960804|526380238|FG000|Overall Study|Adverse Event|1|||
145963807|NCT00960804|526380239|FG001|Overall Study|Adverse Event|0|||
145963808|NCT00960804|526380240|FG002|Overall Study|Adverse Event|0|||
145963809|NCT00960804|526380238|FG000|Overall Study|Withdrawal by Subject|1|||
145963810|NCT00960804|526380239|FG001|Overall Study|Withdrawal by Subject|0|||
145963811|NCT00960804|526380240|FG002|Overall Study|Withdrawal by Subject|0|||
145963812|NCT00960804|526380238|FG000|Overall Study|Study terminated by the sponsor|5|||
145963813|NCT00960804|526380239|FG001|Overall Study|Study terminated by the sponsor|4|||
145963814|NCT00960804|526380240|FG002|Overall Study|Study terminated by the sponsor|10|||
145963815|NCT02007720|526380241|FG000|Overall Study|Withdrawal by Subject|9|||
145963816|NCT02007720|526380242|FG001|Overall Study|Withdrawal by Subject|11|||
145963817|NCT02007720|526380241|FG000|Overall Study|study terminated by sponsor|58|||
146232087|NCT04046549|527368470|FG000|Overall Study|Other, Not Specified|5|||
146232088|NCT03782116|527368475|FG000|Completed Intervetion|Lost to Follow-up|11|||
146232089|NCT03782116|527368476|FG001|Completed Intervetion|Lost to Follow-up|7|||
145963818|NCT02007720|526380242|FG001|Overall Study|study terminated by sponsor|54|||
145963819|NCT02007720|526380241|FG000|Overall Study|technical problem|4|||
145963820|NCT02007720|526380242|FG001|Overall Study|technical problem|2|||
145963821|NCT02007720|526380241|FG000|Overall Study|patient followd less than 165 days|11|||
145963822|NCT02007720|526380242|FG001|Overall Study|patient followd less than 165 days|5|||
145963823|NCT05630196|526382006|FG000|Overall Study|Adverse Event|2|||
145963824|NCT05630196|526382007|FG001|Overall Study|Adverse Event|1|||
145963825|NCT05630196|526382006|FG000|Overall Study|Lost to Follow-up|1|||
146232090|NCT03782116|527368475|FG000|Completed Intervetion|Withdrawal by Subject|6|||
145963826|NCT05630196|526382007|FG001|Overall Study|Lost to Follow-up|1|||
145963827|NCT05630196|526382006|FG000|Overall Study|Protocol Violation|2|||
145963828|NCT05630196|526382007|FG001|Overall Study|Protocol Violation|3|||
145963829|NCT05630196|526382006|FG000|Overall Study|Physician Decision|1|||
145963830|NCT05630196|526382007|FG001|Overall Study|Physician Decision|0|||
145963831|NCT05630196|526382006|FG000|Overall Study|Withdrawal by Subject|3|||
145963832|NCT05630196|526382007|FG001|Overall Study|Withdrawal by Subject|4|||
145963833|NCT01655901|526382011|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145963834|NCT01655901|526382012|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145963835|NCT01655901|526382013|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145963836|NCT01655901|526382014|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
145963837|NCT01655901|526382015|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145963838|NCT01655901|526382016|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
145963839|NCT00352118|526382017|FG000|Overall Study|Physician Decision|4|||
145963840|NCT00870727|526382018|FG000|Overall Study|Lost to Follow-up|0|||
145963841|NCT00870727|526382019|FG001|Overall Study|Lost to Follow-up|1|||
145963842|NCT00870727|526382018|FG000|Overall Study|Lack of Efficacy|1|||
145963843|NCT00870727|526382019|FG001|Overall Study|Lack of Efficacy|3|||
145963844|NCT00870727|526382018|FG000|Overall Study|Adverse Event|0|||
145963845|NCT00870727|526382019|FG001|Overall Study|Adverse Event|1|||
145963846|NCT01712516|526382020|FG000|Overall Study|Technical problems|0|||
145963847|NCT01712516|526382021|FG001|Overall Study|Technical problems|0|||
145963848|NCT01712516|526382022|FG002|Overall Study|Technical problems|0|||
145963849|NCT01712516|526382023|FG003|Overall Study|Technical problems|2|||
145963850|NCT01712516|526382020|FG000|Overall Study|Lost to Follow-up|0|||
145963851|NCT01712516|526382021|FG001|Overall Study|Lost to Follow-up|0|||
145963852|NCT01712516|526382022|FG002|Overall Study|Lost to Follow-up|2|||
145963853|NCT01712516|526382023|FG003|Overall Study|Lost to Follow-up|1|||
145963854|NCT01712516|526382020|FG000|Overall Study|Death|0|||
145963855|NCT01712516|526382021|FG001|Overall Study|Death|1|||
145963856|NCT01712516|526382022|FG002|Overall Study|Death|0|||
145963857|NCT01712516|526382023|FG003|Overall Study|Death|0|||
145963858|NCT01712516|526382020|FG000|Overall Study|Protocol deviation|1|||
145963859|NCT01712516|526382021|FG001|Overall Study|Protocol deviation|0|||
145963860|NCT01712516|526382022|FG002|Overall Study|Protocol deviation|1|||
145963861|NCT01712516|526382023|FG003|Overall Study|Protocol deviation|0|||
145963862|NCT01712516|526382020|FG000|Overall Study|Physician Decision|2|||
145963863|NCT01712516|526382021|FG001|Overall Study|Physician Decision|0|||
145963864|NCT01712516|526382022|FG002|Overall Study|Physician Decision|0|||
145963865|NCT01712516|526382023|FG003|Overall Study|Physician Decision|1|||
145963866|NCT01712516|526382020|FG000|Overall Study|Withdrawal by Subject|3|||
145963867|NCT01712516|526382021|FG001|Overall Study|Withdrawal by Subject|9|||
145963868|NCT01712516|526382022|FG002|Overall Study|Withdrawal by Subject|3|||
145963869|NCT01712516|526382023|FG003|Overall Study|Withdrawal by Subject|9|||
145963870|NCT01251952|526382024|FG000|Overall Study|Adverse Event|1|||
145963871|NCT00496769|526382025|FG000|Double Blind|>=1 reason assigned per patient|558|||
145963872|NCT00496769|526382026|FG001|Double Blind|>=1 reason assigned per patient|649|||
145963873|NCT00496769|526382027|FG002|Double Blind|>=1 reason assigned per patient|0|||
145963874|NCT00496769|526382025|FG000|Open Label|>=1 reason assigned per patient|0|||
146232091|NCT03782116|527368476|FG001|Completed Intervetion|Withdrawal by Subject|5|||
146232092|NCT03782116|527368475|FG000|Included in Analysis|Protocol Violation|5|||
146232093|NCT03782116|527368476|FG001|Included in Analysis|Protocol Violation|5|||
146232094|NCT03150862|527368482|FG000|Overall Study|Death|2|||
145963875|NCT00496769|526382026|FG001|Open Label|>=1 reason assigned per patient|0|||
145963876|NCT00496769|526382027|FG002|Open Label|>=1 reason assigned per patient|1011|||
145963877|NCT02810418|526382031|FG000|Arm A Dose Escalation|Adverse Event|2|||
145963878|NCT02810418|526382032|FG001|Arm A Dose Escalation|Adverse Event|1|||
145963879|NCT02810418|526382033|FG002|Arm A Dose Escalation|Adverse Event|0|||
145963880|NCT02810418|526382034|FG003|Arm A Dose Escalation|Adverse Event|0|||
145963881|NCT02810418|526382035|FG004|Arm A Dose Escalation|Adverse Event|0|||
145963882|NCT02810418|526382036|FG005|Arm A Dose Escalation|Adverse Event|0|||
145963883|NCT02810418|526382037|FG006|Arm A Dose Escalation|Adverse Event|0|||
145963884|NCT02810418|526382031|FG000|Dose Expansion|Adverse Event|0|||
145963885|NCT02810418|526382032|FG001|Dose Expansion|Adverse Event|1|||
145963886|NCT02810418|526382033|FG002|Dose Expansion|Adverse Event|1|||
145963887|NCT02810418|526382034|FG003|Dose Expansion|Adverse Event|0|||
145963888|NCT02810418|526382035|FG004|Dose Expansion|Adverse Event|0|||
145963889|NCT02810418|526382036|FG005|Dose Expansion|Adverse Event|0|||
145963890|NCT02810418|526382037|FG006|Dose Expansion|Adverse Event|0|||
145963891|NCT02810418|526382031|FG000|Dose Expansion|Physician Decision|0|||
145963892|NCT02810418|526382032|FG001|Dose Expansion|Physician Decision|0|||
145963893|NCT02810418|526382033|FG002|Dose Expansion|Physician Decision|2|||
145963894|NCT02810418|526382034|FG003|Dose Expansion|Physician Decision|0|||
145963895|NCT02810418|526382035|FG004|Dose Expansion|Physician Decision|0|||
145963896|NCT02810418|526382036|FG005|Dose Expansion|Physician Decision|0|||
145963897|NCT02810418|526382037|FG006|Dose Expansion|Physician Decision|0|||
146232095|NCT03150862|527368483|FG001|Overall Study|Death|7|||
146232096|NCT03150862|527368484|FG002|Overall Study|Death|8|||
146232097|NCT03150862|527368485|FG003|Overall Study|Death|27|||
146232098|NCT03150862|527368486|FG004|Overall Study|Death|4|||
146232099|NCT03150862|527368487|FG005|Overall Study|Death|8|||
146232100|NCT03150862|527368488|FG006|Overall Study|Death|6|||
146232101|NCT03150862|527368489|FG007|Overall Study|Death|21|||
146232102|NCT03150862|527368482|FG000|Overall Study|Withdrawal by Subject|1|||
146232103|NCT03150862|527368483|FG001|Overall Study|Withdrawal by Subject|1|||
146232104|NCT03150862|527368484|FG002|Overall Study|Withdrawal by Subject|0|||
146232105|NCT03150862|527368485|FG003|Overall Study|Withdrawal by Subject|3|||
145963898|NCT02810418|526382031|FG000|Arm B Dose Escalation|Adverse Event|0|||
145963899|NCT02810418|526382032|FG001|Arm B Dose Escalation|Adverse Event|0|||
145963900|NCT02810418|526382033|FG002|Arm B Dose Escalation|Adverse Event|0|||
145963901|NCT02810418|526382034|FG003|Arm B Dose Escalation|Adverse Event|0|||
146232106|NCT03150862|527368486|FG004|Overall Study|Withdrawal by Subject|1|||
146232107|NCT03150862|527368487|FG005|Overall Study|Withdrawal by Subject|1|||
146232108|NCT03150862|527368488|FG006|Overall Study|Withdrawal by Subject|1|||
146232109|NCT03150862|527368489|FG007|Overall Study|Withdrawal by Subject|3|||
145963902|NCT02810418|526382035|FG004|Arm B Dose Escalation|Adverse Event|1|||
146232110|NCT03150862|527368482|FG000|Overall Study|Lost to Follow-up|0|||
146232111|NCT03150862|527368483|FG001|Overall Study|Lost to Follow-up|0|||
146232112|NCT03150862|527368484|FG002|Overall Study|Lost to Follow-up|1|||
145886759|NCT03785145|526090229|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
145886760|NCT00097786|526090230|FG000|Overall Study|lost to follow-up for all-cause death|296|||
145886761|NCT00097786|526090231|FG001|Overall Study|lost to follow-up for all-cause death|292|||
145886762|NCT00097786|526090232|FG002|Overall Study|lost to follow-up for all-cause death|313|||
145886763|NCT00097786|526090233|FG003|Overall Study|lost to follow-up for all-cause death|310|||
145886764|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
145886765|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
145886766|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
145886767|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
145886768|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
145886769|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
145886770|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
145886771|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
145886772|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
145886773|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145886774|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145886775|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145886776|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
145886777|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
146232113|NCT03150862|527368485|FG003|Overall Study|Lost to Follow-up|0|||
146086588|NCT00219544|526837974|FG001|Single Blind Treatment Period|Protocol Violation|0|||
146232114|NCT03150862|527368486|FG004|Overall Study|Lost to Follow-up|0|||
146232115|NCT03150862|527368487|FG005|Overall Study|Lost to Follow-up|0|||
146232116|NCT03150862|527368488|FG006|Overall Study|Lost to Follow-up|0|||
146232117|NCT03150862|527368489|FG007|Overall Study|Lost to Follow-up|2|||
146232118|NCT03150862|527368482|FG000|Overall Study|Sponsor's decision|0|||
146232119|NCT03150862|527368483|FG001|Overall Study|Sponsor's decision|0|||
146232120|NCT03150862|527368484|FG002|Overall Study|Sponsor's decision|0|||
146232121|NCT03150862|527368485|FG003|Overall Study|Sponsor's decision|10|||
146232122|NCT03150862|527368486|FG004|Overall Study|Sponsor's decision|3|||
146232123|NCT03150862|527368487|FG005|Overall Study|Sponsor's decision|0|||
146232124|NCT03150862|527368488|FG006|Overall Study|Sponsor's decision|1|||
146232125|NCT03150862|527368489|FG007|Overall Study|Sponsor's decision|1|||
146232126|NCT03150862|527368482|FG000|Overall Study|Change in Methylation status|0|||
146232127|NCT03150862|527368483|FG001|Overall Study|Change in Methylation status|0|||
146232128|NCT03150862|527368484|FG002|Overall Study|Change in Methylation status|0|||
146232129|NCT03150862|527368485|FG003|Overall Study|Change in Methylation status|0|||
146232130|NCT03150862|527368486|FG004|Overall Study|Change in Methylation status|1|||
145963903|NCT02810418|526382036|FG005|Arm B Dose Escalation|Adverse Event|2|||
145963904|NCT02810418|526382037|FG006|Arm B Dose Escalation|Adverse Event|0|||
145963905|NCT02224625|526382038|FG000|Irritation|Adverse Event|6|||
145963906|NCT02224625|526382038|FG000|Sensitization|Adverse Event|55|||
145963907|NCT01573000|526382039|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
146232131|NCT03150862|527368487|FG005|Overall Study|Change in Methylation status|0|||
145963908|NCT01573000|526382040|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
145963909|NCT01573000|526382039|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
145963910|NCT01573000|526382040|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
146086589|NCT00219544|526837973|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
146232132|NCT03150862|527368488|FG006|Overall Study|Change in Methylation status|0|||
146232133|NCT03150862|527368489|FG007|Overall Study|Change in Methylation status|0|||
146232134|NCT03150862|527368482|FG000|Overall Study|Roll over in to Long Term Extension|0|||
146232135|NCT03150862|527368483|FG001|Overall Study|Roll over in to Long Term Extension|0|||
146232136|NCT03150862|527368484|FG002|Overall Study|Roll over in to Long Term Extension|0|||
146232137|NCT03150862|527368485|FG003|Overall Study|Roll over in to Long Term Extension|0|||
146232138|NCT03150862|527368486|FG004|Overall Study|Roll over in to Long Term Extension|0|||
146232139|NCT03150862|527368487|FG005|Overall Study|Roll over in to Long Term Extension|0|||
146232140|NCT03150862|527368488|FG006|Overall Study|Roll over in to Long Term Extension|0|||
146232141|NCT03150862|527368489|FG007|Overall Study|Roll over in to Long Term Extension|1|||
146232142|NCT03150862|527368482|FG000|Overall Study|Progressive Disease|0|||
146232143|NCT03150862|527368483|FG001|Overall Study|Progressive Disease|0|||
145963911|NCT01573000|526382039|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
145963912|NCT01573000|526382040|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
145963913|NCT01573000|526382039|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
145963914|NCT01573000|526382040|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
145963915|NCT01573000|526382039|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
145963916|NCT01573000|526382040|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
146232144|NCT03150862|527368484|FG002|Overall Study|Progressive Disease|0|||
146232145|NCT03150862|527368485|FG003|Overall Study|Progressive Disease|0|||
145963917|NCT01573000|526382039|FG000|Crossover Phase|Lack of Efficacy|0|||
145963918|NCT01573000|526382040|FG001|Crossover Phase|Lack of Efficacy|13|||
145963919|NCT01573000|526382039|FG000|Crossover Phase|Lost to Follow-up|0|||
145963920|NCT01573000|526382040|FG001|Crossover Phase|Lost to Follow-up|2|||
146232146|NCT03150862|527368486|FG004|Overall Study|Progressive Disease|0|||
146232147|NCT03150862|527368487|FG005|Overall Study|Progressive Disease|0|||
146232148|NCT03150862|527368488|FG006|Overall Study|Progressive Disease|0|||
146232149|NCT03150862|527368489|FG007|Overall Study|Progressive Disease|2|||
145963921|NCT01573000|526382039|FG000|Crossover Phase|Death|0|||
146232150|NCT04039113|527368494|FG000|Overall Study|Withdrawal by Subject|8|||
146232151|NCT04039113|527368495|FG001|Overall Study|Withdrawal by Subject|11|||
146232152|NCT04039113|527368494|FG000|Overall Study|Lost to Follow-up|1|||
145886778|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
145886779|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
145886780|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145886781|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145886782|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
146232153|NCT04039113|527368495|FG001|Overall Study|Lost to Follow-up|1|||
146232154|NCT04039113|527368494|FG000|Overall Study|Adverse Event|2|||
146232155|NCT04039113|527368495|FG001|Overall Study|Adverse Event|2|||
146232156|NCT04039113|527368494|FG000|Overall Study|Death|2|||
145963922|NCT01573000|526382040|FG001|Crossover Phase|Death|3|||
146232157|NCT04039113|527368495|FG001|Overall Study|Death|4|||
145963923|NCT01573000|526382039|FG000|Long-Term Follow-Up|Death|3|||
145963924|NCT01573000|526382040|FG001|Long-Term Follow-Up|Death|0|||
145963925|NCT01573000|526382039|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
145886783|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145886784|NCT02960438|526090234|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
145886785|NCT02960438|526090235|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
145886786|NCT02960438|526090236|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
145886787|NCT02960438|526090237|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
145886788|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
145886789|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
145886790|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
145886791|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
145886792|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145886793|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145886794|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
145886795|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145886796|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145886797|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145886798|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
145886799|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145886800|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
145886801|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
145963926|NCT01573000|526382040|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
145963927|NCT01100853|526382046|FG000|Overall Study|Lost to Follow-up|11|||
145963928|NCT01100853|526382047|FG001|Overall Study|Lost to Follow-up|6|||
145963929|NCT01100853|526382046|FG000|Overall Study|Received <4 study injections|10|||
145963930|NCT01100853|526382047|FG001|Overall Study|Received <4 study injections|13|||
145963931|NCT01100853|526382046|FG000|Overall Study|Withdrawal by Subject|6|||
145963932|NCT01100853|526382047|FG001|Overall Study|Withdrawal by Subject|4|||
145963933|NCT01384877|526382048|FG000|Treatment 2|Lost to Follow-up|2|||
145886802|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
145886803|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
145886804|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
145963934|NCT01384877|526382049|FG001|Treatment 2|Lost to Follow-up|2|||
145886805|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
145963935|NCT04161391|526382052|FG000|Overall Study|Adverse Event|0|||
145963936|NCT04161391|526382053|FG001|Overall Study|Adverse Event|1|||
145963937|NCT04161391|526382054|FG002|Overall Study|Adverse Event|0|||
145963938|NCT04161391|526382055|FG003|Overall Study|Adverse Event|1|||
146232158|NCT04039113|527368494|FG000|Overall Study|Site Closure|6|||
146232159|NCT04039113|527368495|FG001|Overall Study|Site Closure|0|||
146232160|NCT04039113|527368494|FG000|Overall Study|Failure to meet randomisation criteria|4|||
146232161|NCT04039113|527368495|FG001|Overall Study|Failure to meet randomisation criteria|0|||
146232162|NCT00353496|527368496|FG000|Overall Study|Adverse Event|1|||
146232163|NCT00353496|527368497|FG001|Overall Study|Adverse Event|0|||
146232164|NCT00353496|527368496|FG000|Overall Study|Protocol Violation|2|||
145963939|NCT04161391|526382056|FG004|Overall Study|Adverse Event|0|||
146232165|NCT00353496|527368497|FG001|Overall Study|Protocol Violation|2|||
146232166|NCT00353496|527368496|FG000|Overall Study|Withdrawal by Subject|3|||
146290494|NCT01313689|527579018|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
145886806|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
145886807|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
145886808|NCT02960438|526090234|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
145886809|NCT02960438|526090235|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
145886810|NCT02960438|526090236|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
145886811|NCT02960438|526090237|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
145886812|NCT03686150|526090238|FG000|Overall Study|Withdrawal by Subject|1|||
145886813|NCT03686150|526090239|FG001|Overall Study|Withdrawal by Subject|1|||
145886814|NCT03686150|526090240|FG002|Overall Study|Withdrawal by Subject|1|||
145886815|NCT03686150|526090241|FG003|Overall Study|Withdrawal by Subject|0|||
145886816|NCT03686150|526090242|FG004|Overall Study|Withdrawal by Subject|1|||
145886817|NCT03686150|526090243|FG005|Overall Study|Withdrawal by Subject|2|||
145886818|NCT03686150|526090238|FG000|Overall Study|Physician Decision|1|||
145886819|NCT03686150|526090239|FG001|Overall Study|Physician Decision|0|||
145886820|NCT03686150|526090240|FG002|Overall Study|Physician Decision|0|||
145886821|NCT03686150|526090241|FG003|Overall Study|Physician Decision|0|||
145886822|NCT03686150|526090242|FG004|Overall Study|Physician Decision|0|||
145886823|NCT03686150|526090243|FG005|Overall Study|Physician Decision|1|||
145886824|NCT03686150|526090238|FG000|Overall Study|Lost to Follow-up|0|||
145886825|NCT03686150|526090239|FG001|Overall Study|Lost to Follow-up|1|||
145886826|NCT03686150|526090240|FG002|Overall Study|Lost to Follow-up|0|||
145886827|NCT03686150|526090241|FG003|Overall Study|Lost to Follow-up|0|||
145886828|NCT03686150|526090242|FG004|Overall Study|Lost to Follow-up|0|||
145886829|NCT03686150|526090243|FG005|Overall Study|Lost to Follow-up|0|||
145886830|NCT02443324|526090245|FG000|Overall Study|Death|4|||
145886831|NCT02443324|526090246|FG001|Overall Study|Death|1|||
145886832|NCT02443324|526090247|FG002|Overall Study|Death|0|||
145886833|NCT02443324|526090248|FG003|Overall Study|Death|3|||
145886834|NCT02443324|526090249|FG004|Overall Study|Death|1|||
145886835|NCT02443324|526090250|FG005|Overall Study|Death|3|||
145886836|NCT02443324|526090251|FG006|Overall Study|Death|2|||
145886837|NCT02443324|526090245|FG000|Overall Study|Lost to Follow-up|0|||
145886838|NCT02443324|526090246|FG001|Overall Study|Lost to Follow-up|0|||
145886839|NCT02443324|526090247|FG002|Overall Study|Lost to Follow-up|0|||
145886840|NCT02443324|526090248|FG003|Overall Study|Lost to Follow-up|1|||
145886841|NCT02443324|526090249|FG004|Overall Study|Lost to Follow-up|0|||
145886842|NCT02443324|526090250|FG005|Overall Study|Lost to Follow-up|1|||
145886843|NCT02443324|526090251|FG006|Overall Study|Lost to Follow-up|0|||
145886844|NCT02443324|526090245|FG000|Overall Study|Physician Decision|0|||
145886845|NCT02443324|526090246|FG001|Overall Study|Physician Decision|3|||
145886846|NCT02443324|526090247|FG002|Overall Study|Physician Decision|5|||
145886847|NCT02443324|526090248|FG003|Overall Study|Physician Decision|1|||
145886848|NCT02443324|526090249|FG004|Overall Study|Physician Decision|1|||
145886849|NCT02443324|526090250|FG005|Overall Study|Physician Decision|0|||
145886850|NCT02443324|526090251|FG006|Overall Study|Physician Decision|2|||
145886851|NCT02443324|526090245|FG000|Overall Study|Progressive Disease|20|||
145886852|NCT02443324|526090246|FG001|Overall Study|Progressive Disease|20|||
145886853|NCT02443324|526090247|FG002|Overall Study|Progressive Disease|13|||
145886854|NCT02443324|526090248|FG003|Overall Study|Progressive Disease|10|||
145886855|NCT02443324|526090249|FG004|Overall Study|Progressive Disease|13|||
145886856|NCT02443324|526090250|FG005|Overall Study|Progressive Disease|17|||
145886857|NCT02443324|526090251|FG006|Overall Study|Progressive Disease|10|||
145886858|NCT02443324|526090245|FG000|Overall Study|Withdrawal by Subject|0|||
145886859|NCT02443324|526090246|FG001|Overall Study|Withdrawal by Subject|0|||
145886860|NCT02443324|526090247|FG002|Overall Study|Withdrawal by Subject|3|||
145886861|NCT02443324|526090248|FG003|Overall Study|Withdrawal by Subject|1|||
145886862|NCT02443324|526090249|FG004|Overall Study|Withdrawal by Subject|1|||
145886863|NCT02443324|526090250|FG005|Overall Study|Withdrawal by Subject|0|||
145886864|NCT02443324|526090251|FG006|Overall Study|Withdrawal by Subject|1|||
145886865|NCT02443324|526090245|FG000|Overall Study|Adverse Event|0|||
145886866|NCT02443324|526090246|FG001|Overall Study|Adverse Event|1|||
145886867|NCT02443324|526090247|FG002|Overall Study|Adverse Event|3|||
145886868|NCT02443324|526090248|FG003|Overall Study|Adverse Event|0|||
145886869|NCT02443324|526090249|FG004|Overall Study|Adverse Event|4|||
145886870|NCT02443324|526090250|FG005|Overall Study|Adverse Event|3|||
145886871|NCT02443324|526090251|FG006|Overall Study|Adverse Event|3|||
145886872|NCT02443324|526090245|FG000|Overall Study|Enrolled but Never Treated|0|||
145886873|NCT02443324|526090246|FG001|Overall Study|Enrolled but Never Treated|0|||
145886874|NCT02443324|526090247|FG002|Overall Study|Enrolled but Never Treated|1|||
145886875|NCT02443324|526090248|FG003|Overall Study|Enrolled but Never Treated|0|||
146086590|NCT00219544|526837974|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
146086591|NCT00219544|526837973|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
145886876|NCT02443324|526090249|FG004|Overall Study|Enrolled but Never Treated|1|||
145886877|NCT02443324|526090250|FG005|Overall Study|Enrolled but Never Treated|0|||
145886878|NCT02443324|526090251|FG006|Overall Study|Enrolled but Never Treated|1|||
145886879|NCT01647711|526090252|FG000|Overall Study|Progressive disease|6|||
145886880|NCT01647711|526090253|FG001|Overall Study|Progressive disease|2|||
145886881|NCT01647711|526090254|FG002|Overall Study|Progressive disease|6|||
145886882|NCT01647711|526090255|FG003|Overall Study|Progressive disease|8|||
145886883|NCT01647711|526090256|FG004|Overall Study|Progressive disease|2|||
145886884|NCT01647711|526090252|FG000|Overall Study|Other adverse event|0|||
145886885|NCT01647711|526090253|FG001|Overall Study|Other adverse event|0|||
145886886|NCT01647711|526090254|FG002|Overall Study|Other adverse event|2|||
145886887|NCT01647711|526090255|FG003|Overall Study|Other adverse event|0|||
145886888|NCT01647711|526090256|FG004|Overall Study|Other adverse event|2|||
145886889|NCT01647711|526090252|FG000|Overall Study|Protocol Violation|0|||
145886890|NCT01647711|526090253|FG001|Overall Study|Protocol Violation|0|||
145886891|NCT01647711|526090254|FG002|Overall Study|Protocol Violation|0|||
145963940|NCT04161391|526382057|FG005|Overall Study|Adverse Event|0|||
146086592|NCT00219544|526837974|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
145886892|NCT01647711|526090255|FG003|Overall Study|Protocol Violation|0|||
145886893|NCT01647711|526090256|FG004|Overall Study|Protocol Violation|1|||
145886894|NCT01647711|526090252|FG000|Overall Study|Refused to continue taking medication|0|||
145963941|NCT04161391|526382058|FG006|Overall Study|Adverse Event|0|||
146232167|NCT00353496|527368497|FG001|Overall Study|Withdrawal by Subject|4|||
146232168|NCT00353496|527368496|FG000|Overall Study|Physician Decision|6|||
146232169|NCT00353496|527368497|FG001|Overall Study|Physician Decision|9|||
146232170|NCT00353496|527368496|FG000|Overall Study|Not otherwise specified|4|||
146232171|NCT00353496|527368497|FG001|Overall Study|Not otherwise specified|2|||
146232172|NCT04129164|527368937|FG000|Overall Study|Non-compliance with procedures|0|||
146232173|NCT04129164|527368938|FG001|Overall Study|Non-compliance with procedures|0|||
146232174|NCT04129164|527368939|FG002|Overall Study|Non-compliance with procedures|2|||
146232175|NCT04129164|527368940|FG003|Overall Study|Non-compliance with procedures|0|||
146232176|NCT04129164|527368937|FG000|Overall Study|Adverse Event|0|||
146232177|NCT04129164|527368938|FG001|Overall Study|Adverse Event|0|||
146232178|NCT04129164|527368939|FG002|Overall Study|Adverse Event|2|||
146232179|NCT04129164|527368940|FG003|Overall Study|Adverse Event|0|||
146232180|NCT04129164|527368937|FG000|Overall Study|Pregnancy|0|||
145963942|NCT04161391|526382059|FG007|Overall Study|Adverse Event|3|||
145963943|NCT04161391|526382060|FG008|Overall Study|Adverse Event|0|||
145963944|NCT04161391|526382052|FG000|Overall Study|Death|0|||
145963945|NCT04161391|526382053|FG001|Overall Study|Death|0|||
145963946|NCT04161391|526382054|FG002|Overall Study|Death|0|||
145963947|NCT04161391|526382055|FG003|Overall Study|Death|0|||
145963948|NCT04161391|526382056|FG004|Overall Study|Death|0|||
145963949|NCT04161391|526382057|FG005|Overall Study|Death|0|||
145963950|NCT04161391|526382058|FG006|Overall Study|Death|0|||
145963951|NCT04161391|526382059|FG007|Overall Study|Death|1|||
145963952|NCT04161391|526382060|FG008|Overall Study|Death|0|||
145963953|NCT04161391|526382052|FG000|Overall Study|Physician Decision|0|||
145963954|NCT04161391|526382053|FG001|Overall Study|Physician Decision|0|||
145963955|NCT04161391|526382054|FG002|Overall Study|Physician Decision|1|||
145963956|NCT04161391|526382055|FG003|Overall Study|Physician Decision|2|||
145963957|NCT04161391|526382056|FG004|Overall Study|Physician Decision|0|||
145963958|NCT04161391|526382057|FG005|Overall Study|Physician Decision|0|||
145963959|NCT04161391|526382058|FG006|Overall Study|Physician Decision|2|||
146086593|NCT00219544|526837973|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
146086594|NCT00219544|526837974|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
145963960|NCT04161391|526382059|FG007|Overall Study|Physician Decision|0|||
145963961|NCT04161391|526382060|FG008|Overall Study|Physician Decision|0|||
145963962|NCT04161391|526382052|FG000|Overall Study|Progressive Disease|4|||
145963963|NCT04161391|526382053|FG001|Overall Study|Progressive Disease|3|||
145963964|NCT04161391|526382054|FG002|Overall Study|Progressive Disease|3|||
145886895|NCT01647711|526090253|FG001|Overall Study|Refused to continue taking medication|0|||
145886896|NCT01647711|526090254|FG002|Overall Study|Refused to continue taking medication|0|||
145886897|NCT01647711|526090255|FG003|Overall Study|Refused to continue taking medication|2|||
145886898|NCT01647711|526090256|FG004|Overall Study|Refused to continue taking medication|1|||
145886899|NCT01647711|526090252|FG000|Overall Study|Other reason not defined|0|||
145886900|NCT01647711|526090253|FG001|Overall Study|Other reason not defined|1|||
145886901|NCT01647711|526090254|FG002|Overall Study|Other reason not defined|1|||
145886902|NCT01647711|526090255|FG003|Overall Study|Other reason not defined|1|||
145886903|NCT01647711|526090256|FG004|Overall Study|Other reason not defined|0|||
145886904|NCT02070757|526090260|FG000|Overall Study|Adverse Event|107|||
145886905|NCT02070757|526090261|FG001|Overall Study|Adverse Event|99|||
145886906|NCT02070757|526090260|FG000|Overall Study|Lost to Follow-up|7|||
145886907|NCT02070757|526090261|FG001|Overall Study|Lost to Follow-up|4|||
145886908|NCT02070757|526090260|FG000|Overall Study|Protocol Violation|0|||
145886909|NCT02070757|526090261|FG001|Overall Study|Protocol Violation|4|||
145886910|NCT02070757|526090260|FG000|Overall Study|Withdrawal by Subject|1|||
145886911|NCT02070757|526090261|FG001|Overall Study|Withdrawal by Subject|3|||
145886912|NCT02070757|526090260|FG000|Overall Study|Investigator Decision|0|||
145886913|NCT02070757|526090261|FG001|Overall Study|Investigator Decision|2|||
145886914|NCT02070757|526090260|FG000|Overall Study|Discharged from Study Hospital|2|||
145886915|NCT02070757|526090261|FG001|Overall Study|Discharged from Study Hospital|2|||
145886916|NCT01844531|526090262|FG000|Overall Study|Withdrawal by Subject|0|||
145886917|NCT01844531|526090263|FG001|Overall Study|Withdrawal by Subject|1|||
145886918|NCT01844531|526090264|FG002|Overall Study|Withdrawal by Subject|0|||
145886919|NCT01844531|526090265|FG003|Overall Study|Withdrawal by Subject|0|||
145886920|NCT00418522|526090267|FG000|Overall Study|Adverse Event|7|||
145886921|NCT00418522|526090268|FG001|Overall Study|Adverse Event|1|||
145886922|NCT00418522|526090267|FG000|Overall Study|Lack of Efficacy|1|||
145886923|NCT00418522|526090268|FG001|Overall Study|Lack of Efficacy|3|||
145886924|NCT00418522|526090267|FG000|Overall Study|Lost to Follow-up|10|||
145886925|NCT00418522|526090268|FG001|Overall Study|Lost to Follow-up|4|||
145886926|NCT00418522|526090267|FG000|Overall Study|Withdrawal by Subject|31|||
145886927|NCT00418522|526090268|FG001|Overall Study|Withdrawal by Subject|7|||
145886928|NCT00418522|526090267|FG000|Overall Study|Other|27|||
145886929|NCT00418522|526090268|FG001|Overall Study|Other|23|||
145963965|NCT04161391|526382055|FG003|Overall Study|Progressive Disease|5|||
145963966|NCT04161391|526382056|FG004|Overall Study|Progressive Disease|3|||
145963967|NCT04161391|526382057|FG005|Overall Study|Progressive Disease|3|||
145963968|NCT04161391|526382058|FG006|Overall Study|Progressive Disease|5|||
145886930|NCT00418522|526090267|FG000|Overall Study|Randomized but did not receive treatment|7|||
145886931|NCT00418522|526090268|FG001|Overall Study|Randomized but did not receive treatment|4|||
145886932|NCT01652729|526090269|FG000|Overall Study|Withdrawal by Subject|14|||
145886933|NCT01652729|526090270|FG001|Overall Study|Withdrawal by Subject|7|||
145886934|NCT01652729|526090271|FG002|Overall Study|Withdrawal by Subject|7|||
146086595|NCT01163032|526837975|FG000|Randomization Phase|Withdrawal by Subject|2|||
146086596|NCT01163032|526837976|FG001|Randomization Phase|Withdrawal by Subject|3|||
146086597|NCT01163032|526837977|FG002|Randomization Phase|Withdrawal by Subject|0|||
146086598|NCT01163032|526837975|FG000|Randomization Phase|Adverse Event|3|||
145886935|NCT01652729|526090269|FG000|Overall Study|Adverse Event|4|||
145886936|NCT01652729|526090270|FG001|Overall Study|Adverse Event|0|||
145886937|NCT01652729|526090271|FG002|Overall Study|Adverse Event|3|||
145886938|NCT01652729|526090269|FG000|Overall Study|Physician Decision|1|||
145886939|NCT01652729|526090270|FG001|Overall Study|Physician Decision|0|||
145886940|NCT01652729|526090271|FG002|Overall Study|Physician Decision|1|||
145886941|NCT01652729|526090269|FG000|Overall Study|Protocol Violation|1|||
145886942|NCT01652729|526090270|FG001|Overall Study|Protocol Violation|0|||
145886943|NCT01652729|526090271|FG002|Overall Study|Protocol Violation|0|||
145886944|NCT01652729|526090269|FG000|Overall Study|Lost to Follow-up|6|||
145886945|NCT01652729|526090270|FG001|Overall Study|Lost to Follow-up|6|||
145963969|NCT04161391|526382059|FG007|Overall Study|Progressive Disease|2|||
145963970|NCT04161391|526382060|FG008|Overall Study|Progressive Disease|2|||
145963971|NCT01162343|526382061|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
145963972|NCT01162343|526382061|FG000|Overall Study|Refused psychiatrist assessment|12|||
146232181|NCT04129164|527368938|FG001|Overall Study|Pregnancy|0|||
146232182|NCT04129164|527368939|FG002|Overall Study|Pregnancy|0|||
146232183|NCT04129164|527368940|FG003|Overall Study|Pregnancy|1|||
146232184|NCT04129164|527368937|FG000|Overall Study|Withdrawal by Subject|3|||
146232185|NCT04129164|527368938|FG001|Overall Study|Withdrawal by Subject|2|||
146232186|NCT04129164|527368939|FG002|Overall Study|Withdrawal by Subject|4|||
146232187|NCT04129164|527368940|FG003|Overall Study|Withdrawal by Subject|6|||
146232188|NCT04129164|527368937|FG000|Overall Study|Death|0|||
146232189|NCT04129164|527368938|FG001|Overall Study|Death|1|||
146232190|NCT04129164|527368939|FG002|Overall Study|Death|0|||
146232191|NCT04129164|527368940|FG003|Overall Study|Death|0|||
146232192|NCT04129164|527368937|FG000|Overall Study|Lost to Follow-up|0|||
146086599|NCT01163032|526837976|FG001|Randomization Phase|Adverse Event|3|||
145963973|NCT01130272|526382062|FG000|Overall Study|Adverse Event|2|||
145963974|NCT01130272|526382063|FG001|Overall Study|Adverse Event|5|||
145963975|NCT01130272|526382064|FG002|Overall Study|Adverse Event|6|||
145963976|NCT01130272|526382065|FG003|Overall Study|Adverse Event|22|||
145963977|NCT01130272|526382066|FG004|Overall Study|Adverse Event|7|||
145963978|NCT01130272|526382062|FG000|Overall Study|IVRS-confirmed constipation|0|||
145963979|NCT01130272|526382063|FG001|Overall Study|IVRS-confirmed constipation|1|||
146290495|NCT01313689|527579019|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
146290496|NCT01313689|527579020|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
146290497|NCT01313689|527579016|FG000|24-Week Randomization 2|Physician Decision|0|||
146290498|NCT01313689|527579017|FG001|24-Week Randomization 2|Physician Decision|0|||
146290499|NCT01313689|527579018|FG002|24-Week Randomization 2|Physician Decision|0|||
146290500|NCT01313689|527579019|FG003|24-Week Randomization 2|Physician Decision|0|||
146290501|NCT01313689|527579020|FG004|24-Week Randomization 2|Physician Decision|4|||
146290502|NCT00551460|527579023|FG000|Overall Study|Adverse Event|1|||
146290503|NCT00551460|527579023|FG000|Overall Study|Withdrawal by Subject|1|||
146290504|NCT00551460|527579023|FG000|Overall Study|Physician Decision|1|||
146290505|NCT00551460|527579023|FG000|Overall Study|Death|7|||
146290506|NCT00551460|527579023|FG000|Overall Study|Ineligible|4|||
146290507|NCT00551460|527579023|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
146290508|NCT04781387|527579024|FG000|Overall Study|Withdrawal by Subject|1|||
146290509|NCT04781387|527579025|FG001|Overall Study|Withdrawal by Subject|0|||
146290510|NCT04781387|527579026|FG002|Overall Study|Withdrawal by Subject|1|||
146290511|NCT04781387|527579024|FG000|Overall Study|Lost to Follow-up|1|||
146290512|NCT04781387|527579025|FG001|Overall Study|Lost to Follow-up|0|||
146290513|NCT04781387|527579026|FG002|Overall Study|Lost to Follow-up|0|||
146290514|NCT01079741|527579031|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146290515|NCT01079741|527579032|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
146290516|NCT01079741|527579033|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146290517|NCT01079741|527579034|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146290518|NCT01079741|527579035|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
146290519|NCT01079741|527579031|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146290520|NCT01079741|527579032|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146290521|NCT01079741|527579033|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146290522|NCT01079741|527579034|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
146290523|NCT01079741|527579035|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
146290524|NCT02709096|527579036|FG000|Overall Study|non-compliance|1|||
146290525|NCT02709096|527579037|FG001|Overall Study|non-compliance|1|||
146290526|NCT00406653|527579038|FG000|Induction Period|Adverse Event|1|||
146290527|NCT00406653|527579039|FG001|Induction Period|Adverse Event|10|||
146290528|NCT00406653|527579040|FG002|Induction Period|Adverse Event|4|||
146290529|NCT00406653|527579041|FG003|Induction Period|Adverse Event|11|||
146290530|NCT00406653|527579042|FG004|Induction Period|Adverse Event|0|||
146290531|NCT00406653|527579043|FG005|Induction Period|Adverse Event|0|||
146290532|NCT00406653|527579044|FG006|Induction Period|Adverse Event|0|||
146290533|NCT00406653|527579038|FG000|Induction Period|Lack of Efficacy|11|||
146290534|NCT00406653|527579039|FG001|Induction Period|Lack of Efficacy|14|||
146290535|NCT00406653|527579040|FG002|Induction Period|Lack of Efficacy|8|||
146290536|NCT00406653|527579041|FG003|Induction Period|Lack of Efficacy|10|||
146290537|NCT00406653|527579042|FG004|Induction Period|Lack of Efficacy|0|||
146290538|NCT00406653|527579043|FG005|Induction Period|Lack of Efficacy|0|||
146290539|NCT00406653|527579044|FG006|Induction Period|Lack of Efficacy|0|||
146290540|NCT00406653|527579038|FG000|Induction Period|Lost to Follow-up|0|||
146290541|NCT00406653|527579039|FG001|Induction Period|Lost to Follow-up|2|||
146290542|NCT00406653|527579040|FG002|Induction Period|Lost to Follow-up|0|||
146290543|NCT00406653|527579041|FG003|Induction Period|Lost to Follow-up|0|||
146290544|NCT00406653|527579042|FG004|Induction Period|Lost to Follow-up|0|||
146290545|NCT00406653|527579043|FG005|Induction Period|Lost to Follow-up|0|||
146290546|NCT00406653|527579044|FG006|Induction Period|Lost to Follow-up|0|||
146290547|NCT00406653|527579038|FG000|Induction Period|Withdrawal of Consent|2|||
146290548|NCT00406653|527579039|FG001|Induction Period|Withdrawal of Consent|5|||
146290549|NCT00406653|527579040|FG002|Induction Period|Withdrawal of Consent|1|||
146290550|NCT00406653|527579041|FG003|Induction Period|Withdrawal of Consent|2|||
146290551|NCT00406653|527579042|FG004|Induction Period|Withdrawal of Consent|0|||
146290552|NCT00406653|527579043|FG005|Induction Period|Withdrawal of Consent|0|||
146290553|NCT00406653|527579044|FG006|Induction Period|Withdrawal of Consent|0|||
146290554|NCT00406653|527579038|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290555|NCT00406653|527579039|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290556|NCT00406653|527579040|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290557|NCT00406653|527579041|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
145963980|NCT01130272|526382064|FG002|Overall Study|IVRS-confirmed constipation|1|||
145963981|NCT01130272|526382065|FG003|Overall Study|IVRS-confirmed constipation|2|||
146290558|NCT00406653|527579042|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290559|NCT00406653|527579043|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290560|NCT00406653|527579044|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
146290561|NCT00406653|527579038|FG000|Induction Period|Pregnancy|1|||
146290562|NCT00406653|527579039|FG001|Induction Period|Pregnancy|0|||
146290563|NCT00406653|527579040|FG002|Induction Period|Pregnancy|0|||
146290564|NCT00406653|527579041|FG003|Induction Period|Pregnancy|0|||
146290565|NCT00406653|527579042|FG004|Induction Period|Pregnancy|0|||
146290566|NCT00406653|527579043|FG005|Induction Period|Pregnancy|0|||
146290567|NCT00406653|527579044|FG006|Induction Period|Pregnancy|0|||
146290568|NCT00406653|527579038|FG000|Induction Period|Declined participation but followup done|0|||
146290569|NCT00406653|527579039|FG001|Induction Period|Declined participation but followup done|2|||
146290570|NCT00406653|527579040|FG002|Induction Period|Declined participation but followup done|1|||
146290571|NCT00406653|527579041|FG003|Induction Period|Declined participation but followup done|1|||
146290572|NCT00406653|527579042|FG004|Induction Period|Declined participation but followup done|0|||
146290573|NCT00406653|527579043|FG005|Induction Period|Declined participation but followup done|0|||
146290574|NCT00406653|527579044|FG006|Induction Period|Declined participation but followup done|0|||
146290575|NCT00406653|527579038|FG000|Induction Period|Given prohibited drug|0|||
146290576|NCT00406653|527579039|FG001|Induction Period|Given prohibited drug|1|||
146290577|NCT00406653|527579040|FG002|Induction Period|Given prohibited drug|2|||
145886946|NCT01652729|526090271|FG002|Overall Study|Lost to Follow-up|3|||
145886947|NCT01652729|526090269|FG000|Overall Study|Administrative|1|||
145886948|NCT01652729|526090270|FG001|Overall Study|Administrative|0|||
145886949|NCT01652729|526090271|FG002|Overall Study|Administrative|0|||
145886950|NCT00483548|526090272|FG000|Overall Study|Randomized; not treated with study drug|1|||
145886951|NCT00483548|526090273|FG001|Overall Study|Randomized; not treated with study drug|3|||
145886952|NCT00483548|526090272|FG000|Overall Study|Adverse Event|25|||
145886953|NCT00483548|526090273|FG001|Overall Study|Adverse Event|14|||
145886954|NCT00483548|526090272|FG000|Overall Study|Laboratory abnormality|1|||
146290578|NCT00406653|527579041|FG003|Induction Period|Given prohibited drug|0|||
146290579|NCT00406653|527579042|FG004|Induction Period|Given prohibited drug|0|||
146290580|NCT00406653|527579043|FG005|Induction Period|Given prohibited drug|0|||
146290581|NCT00406653|527579044|FG006|Induction Period|Given prohibited drug|0|||
145886955|NCT00483548|526090273|FG001|Overall Study|Laboratory abnormality|2|||
146290582|NCT00406653|527579038|FG000|Induction Period|Incarcerated|0|||
146290583|NCT00406653|527579039|FG001|Induction Period|Incarcerated|0|||
146290584|NCT00406653|527579040|FG002|Induction Period|Incarcerated|1|||
146290585|NCT00406653|527579041|FG003|Induction Period|Incarcerated|0|||
146290586|NCT00406653|527579042|FG004|Induction Period|Incarcerated|0|||
146290587|NCT00406653|527579043|FG005|Induction Period|Incarcerated|0|||
146290588|NCT00406653|527579044|FG006|Induction Period|Incarcerated|0|||
146290589|NCT00406653|527579038|FG000|Induction Period|Patient relocated|0|||
146290590|NCT00406653|527579039|FG001|Induction Period|Patient relocated|0|||
146290591|NCT00406653|527579040|FG002|Induction Period|Patient relocated|1|||
146290592|NCT00406653|527579041|FG003|Induction Period|Patient relocated|0|||
146290593|NCT00406653|527579042|FG004|Induction Period|Patient relocated|0|||
146290594|NCT00406653|527579043|FG005|Induction Period|Patient relocated|0|||
146290595|NCT00406653|527579044|FG006|Induction Period|Patient relocated|0|||
146290596|NCT00406653|527579038|FG000|Maintenance Period|Adverse Event|0|||
146290597|NCT00406653|527579039|FG001|Maintenance Period|Adverse Event|0|||
146290598|NCT00406653|527579040|FG002|Maintenance Period|Adverse Event|0|||
146290599|NCT00406653|527579041|FG003|Maintenance Period|Adverse Event|0|||
146290600|NCT00406653|527579042|FG004|Maintenance Period|Adverse Event|1|||
146290601|NCT00406653|527579043|FG005|Maintenance Period|Adverse Event|1|||
146290602|NCT00406653|527579044|FG006|Maintenance Period|Adverse Event|0|||
146290603|NCT00406653|527579038|FG000|Maintenance Period|Lack of Efficacy|0|||
146290604|NCT00406653|527579039|FG001|Maintenance Period|Lack of Efficacy|0|||
146290605|NCT00406653|527579040|FG002|Maintenance Period|Lack of Efficacy|0|||
146290606|NCT00406653|527579041|FG003|Maintenance Period|Lack of Efficacy|0|||
146290607|NCT00406653|527579042|FG004|Maintenance Period|Lack of Efficacy|20|||
146290608|NCT00406653|527579043|FG005|Maintenance Period|Lack of Efficacy|26|||
146290609|NCT00406653|527579044|FG006|Maintenance Period|Lack of Efficacy|0|||
146290610|NCT00406653|527579038|FG000|Maintenance Period|Lost to Follow-up|0|||
146290611|NCT00406653|527579039|FG001|Maintenance Period|Lost to Follow-up|0|||
145886956|NCT00483548|526090272|FG000|Overall Study|Lack of Efficacy|4|||
145886957|NCT00483548|526090273|FG001|Overall Study|Lack of Efficacy|8|||
145886958|NCT00483548|526090272|FG000|Overall Study|Protocol Violation|11|||
145886959|NCT00483548|526090273|FG001|Overall Study|Protocol Violation|7|||
145886960|NCT00483548|526090272|FG000|Overall Study|Pregnancy|1|||
145886961|NCT00483548|526090273|FG001|Overall Study|Pregnancy|0|||
145886962|NCT00483548|526090272|FG000|Overall Study|Protocol required discontinuation|6|||
145886963|NCT00483548|526090273|FG001|Overall Study|Protocol required discontinuation|6|||
145886964|NCT00483548|526090272|FG000|Overall Study|Unable to comply with protocol schedule|1|||
145886965|NCT00483548|526090273|FG001|Overall Study|Unable to comply with protocol schedule|0|||
145886966|NCT00483548|526090272|FG000|Overall Study|Non-compliance with medication|2|||
145886967|NCT00483548|526090273|FG001|Overall Study|Non-compliance with medication|0|||
145886968|NCT00483548|526090272|FG000|Overall Study|Lost to Follow-up|3|||
145886969|NCT00483548|526090273|FG001|Overall Study|Lost to Follow-up|4|||
145886970|NCT00483548|526090272|FG000|Overall Study|Withdrawal by Subject|5|||
146290612|NCT00406653|527579040|FG002|Maintenance Period|Lost to Follow-up|0|||
146290613|NCT00406653|527579041|FG003|Maintenance Period|Lost to Follow-up|0|||
146290614|NCT00406653|527579042|FG004|Maintenance Period|Lost to Follow-up|2|||
146290615|NCT00406653|527579043|FG005|Maintenance Period|Lost to Follow-up|1|||
146290616|NCT00406653|527579044|FG006|Maintenance Period|Lost to Follow-up|0|||
146290617|NCT00406653|527579038|FG000|Maintenance Period|Withdrawal of Consent|0|||
146290618|NCT00406653|527579039|FG001|Maintenance Period|Withdrawal of Consent|0|||
146290619|NCT00406653|527579040|FG002|Maintenance Period|Withdrawal of Consent|0|||
146290620|NCT00406653|527579041|FG003|Maintenance Period|Withdrawal of Consent|0|||
146290621|NCT00406653|527579042|FG004|Maintenance Period|Withdrawal of Consent|2|||
146290622|NCT00406653|527579043|FG005|Maintenance Period|Withdrawal of Consent|0|||
145886971|NCT00483548|526090273|FG001|Overall Study|Withdrawal by Subject|2|||
145886972|NCT01280617|526090276|FG000|Overall Study|Adverse Event|0|||
145886973|NCT01280617|526090277|FG001|Overall Study|Adverse Event|1|||
146086600|NCT01163032|526837977|FG002|Randomization Phase|Adverse Event|0|||
145963982|NCT01130272|526382066|FG004|Overall Study|IVRS-confirmed constipation|0|||
145963983|NCT01130272|526382062|FG000|Overall Study|Rescue medications due to diarrhea|3|||
145963984|NCT01130272|526382063|FG001|Overall Study|Rescue medications due to diarrhea|5|||
145963985|NCT01130272|526382064|FG002|Overall Study|Rescue medications due to diarrhea|8|||
145963986|NCT01130272|526382065|FG003|Overall Study|Rescue medications due to diarrhea|8|||
146290623|NCT00406653|527579044|FG006|Maintenance Period|Withdrawal of Consent|0|||
145963987|NCT01130272|526382066|FG004|Overall Study|Rescue medications due to diarrhea|6|||
145963988|NCT01130272|526382062|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
145963989|NCT01130272|526382063|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
145963990|NCT01130272|526382064|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
145963991|NCT01130272|526382065|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
145963992|NCT01130272|526382066|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
145963993|NCT01130272|526382062|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145963994|NCT01130272|526382063|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145963995|NCT01130272|526382064|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145963996|NCT01130272|526382065|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
145963997|NCT01130272|526382066|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145963998|NCT01130272|526382062|FG000|Overall Study|Protocol Violation|0|||
146290624|NCT00406653|527579038|FG000|Maintenance Period|Pregnancy|0|||
145963999|NCT01130272|526382063|FG001|Overall Study|Protocol Violation|0|||
145886974|NCT00572039|526090278|FG000|Overall Study|Withdrawal by Subject|9|||
145886975|NCT00572039|526090279|FG001|Overall Study|Withdrawal by Subject|6|||
145886976|NCT00572039|526090278|FG000|Overall Study|Death|2|||
145886977|NCT00572039|526090279|FG001|Overall Study|Death|3|||
145886978|NCT00572039|526090278|FG000|Overall Study|Ill|5|||
145886979|NCT00572039|526090279|FG001|Overall Study|Ill|1|||
145886980|NCT03756883|526090280|FG000|Overall Study|Adverse Event|2|||
145886981|NCT03756883|526090281|FG001|Overall Study|Adverse Event|2|||
145886982|NCT03756883|526090282|FG002|Overall Study|Adverse Event|2|||
146290625|NCT00406653|527579039|FG001|Maintenance Period|Pregnancy|0|||
146290626|NCT00406653|527579040|FG002|Maintenance Period|Pregnancy|0|||
146290627|NCT00406653|527579041|FG003|Maintenance Period|Pregnancy|0|||
146290628|NCT00406653|527579042|FG004|Maintenance Period|Pregnancy|0|||
146290629|NCT00406653|527579043|FG005|Maintenance Period|Pregnancy|1|||
146290630|NCT00406653|527579044|FG006|Maintenance Period|Pregnancy|0|||
146290631|NCT00406653|527579038|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
146290632|NCT00406653|527579039|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
146290633|NCT00406653|527579040|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
146290634|NCT00406653|527579041|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
146290635|NCT00406653|527579042|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
146290636|NCT00406653|527579043|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
146290637|NCT00406653|527579044|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
146290638|NCT00406653|527579038|FG000|Maintenance Period|Error in disease score evaluation|0|||
146290639|NCT00406653|527579039|FG001|Maintenance Period|Error in disease score evaluation|0|||
146290640|NCT00406653|527579040|FG002|Maintenance Period|Error in disease score evaluation|0|||
146290641|NCT00406653|527579041|FG003|Maintenance Period|Error in disease score evaluation|0|||
145886983|NCT03756883|526090280|FG000|Overall Study|Lack of Efficacy|0|||
146290642|NCT00406653|527579042|FG004|Maintenance Period|Error in disease score evaluation|1|||
146290643|NCT00406653|527579043|FG005|Maintenance Period|Error in disease score evaluation|0|||
146290644|NCT00406653|527579044|FG006|Maintenance Period|Error in disease score evaluation|0|||
145964000|NCT01130272|526382064|FG002|Overall Study|Protocol Violation|3|||
145964001|NCT01130272|526382065|FG003|Overall Study|Protocol Violation|5|||
145964002|NCT01130272|526382066|FG004|Overall Study|Protocol Violation|5|||
145964003|NCT01130272|526382062|FG000|Overall Study|Lost to Follow-up|4|||
145964004|NCT01130272|526382063|FG001|Overall Study|Lost to Follow-up|3|||
145964005|NCT01130272|526382064|FG002|Overall Study|Lost to Follow-up|4|||
145964006|NCT01130272|526382065|FG003|Overall Study|Lost to Follow-up|7|||
145964007|NCT01130272|526382066|FG004|Overall Study|Lost to Follow-up|6|||
145964008|NCT01130272|526382062|FG000|Overall Study|Withdrawal by Subject|4|||
145964009|NCT01130272|526382063|FG001|Overall Study|Withdrawal by Subject|11|||
146290645|NCT00406653|527579038|FG000|Open-Label Period|Death|0|||
146290646|NCT00406653|527579039|FG001|Open-Label Period|Death|0|||
145886984|NCT03756883|526090281|FG001|Overall Study|Lack of Efficacy|1|||
146290647|NCT00406653|527579040|FG002|Open-Label Period|Death|0|||
146290648|NCT00406653|527579041|FG003|Open-Label Period|Death|0|||
146290649|NCT00406653|527579042|FG004|Open-Label Period|Death|0|||
146290650|NCT00406653|527579043|FG005|Open-Label Period|Death|0|||
146290651|NCT00406653|527579044|FG006|Open-Label Period|Death|1|||
146290652|NCT00406653|527579038|FG000|Open-Label Period|Adverse Event|0|||
146290653|NCT00406653|527579039|FG001|Open-Label Period|Adverse Event|0|||
146290654|NCT00406653|527579040|FG002|Open-Label Period|Adverse Event|0|||
146290655|NCT00406653|527579041|FG003|Open-Label Period|Adverse Event|0|||
146290656|NCT00406653|527579042|FG004|Open-Label Period|Adverse Event|0|||
146290657|NCT00406653|527579043|FG005|Open-Label Period|Adverse Event|0|||
146290658|NCT00406653|527579044|FG006|Open-Label Period|Adverse Event|18|||
146290659|NCT00406653|527579038|FG000|Open-Label Period|Lack of Efficacy|0|||
146290660|NCT00406653|527579039|FG001|Open-Label Period|Lack of Efficacy|0|||
146290661|NCT00406653|527579040|FG002|Open-Label Period|Lack of Efficacy|0|||
145964010|NCT01130272|526382064|FG002|Overall Study|Withdrawal by Subject|10|||
146290662|NCT00406653|527579041|FG003|Open-Label Period|Lack of Efficacy|0|||
146290663|NCT00406653|527579042|FG004|Open-Label Period|Lack of Efficacy|0|||
146290664|NCT00406653|527579043|FG005|Open-Label Period|Lack of Efficacy|0|||
146290665|NCT00406653|527579044|FG006|Open-Label Period|Lack of Efficacy|160|||
145964011|NCT01130272|526382065|FG003|Overall Study|Withdrawal by Subject|9|||
146232193|NCT04129164|527368938|FG001|Overall Study|Lost to Follow-up|1|||
145964012|NCT01130272|526382066|FG004|Overall Study|Withdrawal by Subject|8|||
145964013|NCT01130272|526382062|FG000|Overall Study|Physician Decision|1|||
145964014|NCT01130272|526382063|FG001|Overall Study|Physician Decision|1|||
145964015|NCT01130272|526382064|FG002|Overall Study|Physician Decision|0|||
146086601|NCT01163032|526837975|FG000|Randomization Phase|Protocol Violation|0|||
146086602|NCT01163032|526837976|FG001|Randomization Phase|Protocol Violation|1|||
146290666|NCT00406653|527579038|FG000|Open-Label Period|Lost to Follow-up|0|||
146290667|NCT00406653|527579039|FG001|Open-Label Period|Lost to Follow-up|0|||
146290668|NCT00406653|527579040|FG002|Open-Label Period|Lost to Follow-up|0|||
146290669|NCT00406653|527579041|FG003|Open-Label Period|Lost to Follow-up|0|||
146290670|NCT00406653|527579042|FG004|Open-Label Period|Lost to Follow-up|0|||
146290671|NCT00406653|527579043|FG005|Open-Label Period|Lost to Follow-up|0|||
146290672|NCT00406653|527579044|FG006|Open-Label Period|Lost to Follow-up|6|||
146290673|NCT00406653|527579038|FG000|Open-Label Period|Withdrawal of Consent|0|||
146290674|NCT00406653|527579039|FG001|Open-Label Period|Withdrawal of Consent|0|||
146290675|NCT00406653|527579040|FG002|Open-Label Period|Withdrawal of Consent|0|||
146290676|NCT00406653|527579041|FG003|Open-Label Period|Withdrawal of Consent|0|||
146290677|NCT00406653|527579042|FG004|Open-Label Period|Withdrawal of Consent|0|||
146290678|NCT00406653|527579043|FG005|Open-Label Period|Withdrawal of Consent|0|||
146290679|NCT00406653|527579044|FG006|Open-Label Period|Withdrawal of Consent|11|||
146290680|NCT00406653|527579038|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290681|NCT00406653|527579039|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290682|NCT00406653|527579040|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290683|NCT00406653|527579041|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290684|NCT00406653|527579042|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290685|NCT00406653|527579043|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
146290686|NCT00406653|527579044|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
146290687|NCT00406653|527579038|FG000|Open-Label Period|Pregnancy|0|||
146290688|NCT00406653|527579039|FG001|Open-Label Period|Pregnancy|0|||
146290689|NCT00406653|527579040|FG002|Open-Label Period|Pregnancy|0|||
146290690|NCT00406653|527579041|FG003|Open-Label Period|Pregnancy|0|||
146290691|NCT00406653|527579042|FG004|Open-Label Period|Pregnancy|0|||
146290692|NCT00406653|527579043|FG005|Open-Label Period|Pregnancy|0|||
146290693|NCT00406653|527579044|FG006|Open-Label Period|Pregnancy|2|||
146290694|NCT00406653|527579038|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
146290695|NCT00406653|527579039|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
146290696|NCT00406653|527579040|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
145886985|NCT03756883|526090282|FG002|Overall Study|Lack of Efficacy|2|||
145886986|NCT03756883|526090280|FG000|Overall Study|Lost to Follow-up|3|||
145886987|NCT03756883|526090281|FG001|Overall Study|Lost to Follow-up|3|||
145886988|NCT03756883|526090282|FG002|Overall Study|Lost to Follow-up|0|||
145886989|NCT03756883|526090280|FG000|Overall Study|Protocol Violation|2|||
146290697|NCT00406653|527579041|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
146290698|NCT00406653|527579042|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
146290699|NCT00406653|527579043|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
146290700|NCT00406653|527579044|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
146290701|NCT00406653|527579038|FG000|Open-Label Period|Declined participation but followup done|0|||
146290702|NCT00406653|527579039|FG001|Open-Label Period|Declined participation but followup done|0|||
146290703|NCT00406653|527579040|FG002|Open-Label Period|Declined participation but followup done|0|||
146290704|NCT00406653|527579041|FG003|Open-Label Period|Declined participation but followup done|0|||
146290705|NCT00406653|527579042|FG004|Open-Label Period|Declined participation but followup done|0|||
146290706|NCT00406653|527579043|FG005|Open-Label Period|Declined participation but followup done|0|||
146290707|NCT00406653|527579044|FG006|Open-Label Period|Declined participation but followup done|8|||
146290708|NCT00406653|527579038|FG000|Open-Label Period|Discontinued by Sponsor|0|||
146290709|NCT00406653|527579039|FG001|Open-Label Period|Discontinued by Sponsor|0|||
146290710|NCT00406653|527579040|FG002|Open-Label Period|Discontinued by Sponsor|0|||
146290711|NCT00406653|527579041|FG003|Open-Label Period|Discontinued by Sponsor|0|||
146290712|NCT00406653|527579042|FG004|Open-Label Period|Discontinued by Sponsor|0|||
146290713|NCT00406653|527579043|FG005|Open-Label Period|Discontinued by Sponsor|0|||
146290714|NCT00406653|527579044|FG006|Open-Label Period|Discontinued by Sponsor|1|||
146290715|NCT00406653|527579038|FG000|Open-Label Period|Refused followup|0|||
146290716|NCT00406653|527579039|FG001|Open-Label Period|Refused followup|0|||
145964016|NCT01130272|526382065|FG003|Overall Study|Physician Decision|1|||
145964017|NCT01130272|526382066|FG004|Overall Study|Physician Decision|2|||
145964018|NCT01130272|526382062|FG000|Overall Study|Sponsor decision|6|||
145964019|NCT01130272|526382063|FG001|Overall Study|Sponsor decision|15|||
145964020|NCT01130272|526382064|FG002|Overall Study|Sponsor decision|16|||
145964021|NCT01130272|526382065|FG003|Overall Study|Sponsor decision|13|||
145964022|NCT01130272|526382066|FG004|Overall Study|Sponsor decision|16|||
145964023|NCT01130272|526382062|FG000|Overall Study|Study arm discontinued|38|||
145964024|NCT01130272|526382063|FG001|Overall Study|Study arm discontinued|0|||
145964025|NCT01130272|526382064|FG002|Overall Study|Study arm discontinued|0|||
145964026|NCT01130272|526382065|FG003|Overall Study|Study arm discontinued|0|||
145964027|NCT01130272|526382066|FG004|Overall Study|Study arm discontinued|0|||
145964028|NCT01548404|526382067|FG000|Overall Study|Adverse Event|3|||
145964029|NCT01548404|526382068|FG001|Overall Study|Adverse Event|1|||
145964030|NCT01548404|526382067|FG000|Overall Study|Physician Decision|2|||
145964031|NCT01548404|526382068|FG001|Overall Study|Physician Decision|1|||
145964032|NCT01548404|526382067|FG000|Overall Study|Inadequate response to study treatment|23|||
145964033|NCT01548404|526382068|FG001|Overall Study|Inadequate response to study treatment|7|||
145964034|NCT01548404|526382067|FG000|Overall Study|Lost to Follow-up|2|||
145964035|NCT01548404|526382068|FG001|Overall Study|Lost to Follow-up|0|||
145964036|NCT01548404|526382067|FG000|Overall Study|Withdrawal by Subject|0|||
145964037|NCT01548404|526382068|FG001|Overall Study|Withdrawal by Subject|3|||
145964038|NCT01548404|526382067|FG000|Overall Study|Other than specified above|0|||
145964039|NCT01548404|526382068|FG001|Overall Study|Other than specified above|2|||
145964040|NCT00641056|526382069|FG000|Overall Study|Adverse Event|12|||
146290717|NCT00406653|527579040|FG002|Open-Label Period|Refused followup|0|||
146290718|NCT00406653|527579041|FG003|Open-Label Period|Refused followup|0|||
146290719|NCT00406653|527579042|FG004|Open-Label Period|Refused followup|0|||
146290720|NCT00406653|527579043|FG005|Open-Label Period|Refused followup|0|||
146290721|NCT00406653|527579044|FG006|Open-Label Period|Refused followup|1|||
146290722|NCT00953745|527579045|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
146290723|NCT00953745|527579046|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
146290724|NCT00953745|527579045|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
146290725|NCT00953745|527579046|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
146290726|NCT00953745|527579045|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
146290727|NCT00953745|527579046|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
146290728|NCT00953745|527579045|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
146290729|NCT00953745|527579046|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
146290730|NCT00953745|527579045|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
146290731|NCT00953745|527579046|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
146290732|NCT00953745|527579045|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
146290733|NCT00953745|527579046|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
146290734|NCT02427464|527579050|FG000|Overall Study|Adverse Event|6|||
146290735|NCT02427464|527579051|FG001|Overall Study|Adverse Event|1|||
146290736|NCT02427464|527579050|FG000|Overall Study|Lost to Follow-up|16|||
146290737|NCT02427464|527579051|FG001|Overall Study|Lost to Follow-up|5|||
146290738|NCT02427464|527579050|FG000|Overall Study|Physician Decision|2|||
146290739|NCT02427464|527579051|FG001|Overall Study|Physician Decision|0|||
146290740|NCT02427464|527579050|FG000|Overall Study|Withdrawal by Subject|10|||
146290741|NCT02427464|527579051|FG001|Overall Study|Withdrawal by Subject|8|||
146290742|NCT02427464|527579050|FG000|Overall Study|Noncompliance|16|||
146290743|NCT02427464|527579051|FG001|Overall Study|Noncompliance|10|||
146290744|NCT04737187|527579053|FG000|Overall Study|Switched to marketed drug|32|||
146290745|NCT04737187|527579054|FG001|Overall Study|Switched to marketed drug|4|||
146290746|NCT04737187|527579053|FG000|Overall Study|Radiological Progressive Disease|145|||
146290747|NCT04737187|527579054|FG001|Overall Study|Radiological Progressive Disease|146|||
145886990|NCT03756883|526090281|FG001|Overall Study|Protocol Violation|0|||
145886991|NCT03756883|526090282|FG002|Overall Study|Protocol Violation|1|||
145886992|NCT03756883|526090280|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
146290748|NCT04737187|527579053|FG000|Overall Study|Clinical Progressive Disease|20|||
146290749|NCT04737187|527579054|FG001|Overall Study|Clinical Progressive Disease|20|||
146290750|NCT04737187|527579053|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
146290751|NCT04737187|527579054|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
146290752|NCT04737187|527579053|FG000|Overall Study|Adverse Event|16|||
145886993|NCT03756883|526090281|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
146290753|NCT04737187|527579054|FG001|Overall Study|Adverse Event|16|||
146290754|NCT04737187|527579053|FG000|Overall Study|Physician Decision|2|||
146290755|NCT04737187|527579054|FG001|Overall Study|Physician Decision|0|||
146290756|NCT04737187|527579053|FG000|Overall Study|Withdrawal by Subject|5|||
146086603|NCT01163032|526837977|FG002|Randomization Phase|Protocol Violation|0|||
146290757|NCT04737187|527579054|FG001|Overall Study|Withdrawal by Subject|8|||
145886994|NCT03756883|526090282|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
145886995|NCT03756883|526090280|FG000|Overall Study|Withdrawal by Subject|4|||
145886996|NCT03756883|526090281|FG001|Overall Study|Withdrawal by Subject|1|||
145886997|NCT03756883|526090282|FG002|Overall Study|Withdrawal by Subject|0|||
145886998|NCT03756883|526090280|FG000|Overall Study|Other Reasons|2|||
145886999|NCT03756883|526090281|FG001|Overall Study|Other Reasons|4|||
145887000|NCT03756883|526090282|FG002|Overall Study|Other Reasons|0|||
145887001|NCT01355302|526090286|FG000|Phase 1b|Death|4|||
145887002|NCT01355302|526090287|FG001|Phase 1b|Death|0|||
146290758|NCT03756129|527579055|FG000|Overall Study|Adverse Event|1|||
146290759|NCT03756129|527579056|FG001|Overall Study|Adverse Event|1|||
146086604|NCT01163032|526837975|FG000|Randomization Phase|Various*|5|||
146290760|NCT03756129|527579057|FG002|Overall Study|Adverse Event|0|||
146290761|NCT03756129|527579058|FG003|Overall Study|Adverse Event|2|||
146290762|NCT03756129|527579059|FG004|Overall Study|Adverse Event|0|||
146290763|NCT03756129|527579060|FG005|Overall Study|Adverse Event|0|||
146290764|NCT03756129|527579055|FG000|Overall Study|Withdrawal by Subject|2|||
146290765|NCT03756129|527579056|FG001|Overall Study|Withdrawal by Subject|1|||
146290766|NCT03756129|527579057|FG002|Overall Study|Withdrawal by Subject|3|||
146290767|NCT03756129|527579058|FG003|Overall Study|Withdrawal by Subject|1|||
145887003|NCT01355302|526090288|FG002|Phase 1b|Death|0|||
145887004|NCT01355302|526090286|FG000|Phase 1b|Study terminated by sponsor|2|||
145887005|NCT01355302|526090287|FG001|Phase 1b|Study terminated by sponsor|0|||
145887006|NCT01355302|526090288|FG002|Phase 1b|Study terminated by sponsor|0|||
145887007|NCT01557920|526090289|FG000|Overall Study|Withdrawal by Subject|2|||
145887008|NCT01557920|526090290|FG001|Overall Study|Withdrawal by Subject|3|||
145887009|NCT01557920|526090289|FG000|Overall Study|Lack of Efficacy|1|||
145887010|NCT01557920|526090290|FG001|Overall Study|Lack of Efficacy|0|||
145887011|NCT04220775|526090295|FG000|Overall Study|Adverse Event|1|||
145887012|NCT04220775|526090296|FG001|Overall Study|Adverse Event|0|||
145887013|NCT04220775|526090295|FG000|Overall Study|Disease Progression|1|||
145887014|NCT04220775|526090296|FG001|Overall Study|Disease Progression|0|||
145887015|NCT00089076|526090297|FG000|Overall Study|Alternate Therapy|1|||
145887016|NCT00089076|526090297|FG000|Overall Study|Withdrawal by Subject|2|||
145887017|NCT00089076|526090297|FG000|Overall Study|Progression|7|||
145887018|NCT00808509|526090298|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
145887019|NCT00808509|526090299|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
145887020|NCT00808509|526090298|FG000|Randomized Phase|Reduced methotrexate dose|1|||
145887021|NCT00808509|526090299|FG001|Randomized Phase|Reduced methotrexate dose|2|||
145887022|NCT00808509|526090298|FG000|Randomized Phase|Patient refused rescue therapy|0|||
146290768|NCT03756129|527579059|FG004|Overall Study|Withdrawal by Subject|1|||
145964041|NCT00641056|526382070|FG001|Overall Study|Adverse Event|2|||
145964042|NCT00641056|526382069|FG000|Overall Study|Lost to Follow-up|2|||
145964043|NCT00641056|526382070|FG001|Overall Study|Lost to Follow-up|1|||
145964044|NCT00641056|526382069|FG000|Overall Study|Physician Decision|3|||
145964045|NCT00641056|526382070|FG001|Overall Study|Physician Decision|1|||
146290769|NCT03756129|527579060|FG005|Overall Study|Withdrawal by Subject|3|||
146290770|NCT03756129|527579055|FG000|Overall Study|Lost to Follow-up|0|||
146290771|NCT03756129|527579056|FG001|Overall Study|Lost to Follow-up|0|||
146290772|NCT03756129|527579057|FG002|Overall Study|Lost to Follow-up|0|||
146290773|NCT03756129|527579058|FG003|Overall Study|Lost to Follow-up|0|||
146290774|NCT03756129|527579059|FG004|Overall Study|Lost to Follow-up|0|||
146290775|NCT03756129|527579060|FG005|Overall Study|Lost to Follow-up|1|||
145964046|NCT00641056|526382069|FG000|Overall Study|Protocol Violation|2|||
145964047|NCT00641056|526382070|FG001|Overall Study|Protocol Violation|0|||
146290776|NCT03756129|527579055|FG000|Overall Study|Physician Decision|0|||
146290777|NCT03756129|527579056|FG001|Overall Study|Physician Decision|0|||
146290778|NCT03756129|527579057|FG002|Overall Study|Physician Decision|0|||
146290779|NCT03756129|527579058|FG003|Overall Study|Physician Decision|0|||
146290780|NCT03756129|527579059|FG004|Overall Study|Physician Decision|0|||
146290781|NCT03756129|527579060|FG005|Overall Study|Physician Decision|1|||
146290782|NCT03567434|527579061|FG000|Overall Study|Lost to Follow-up|1|||
146290783|NCT03567434|527579062|FG001|Overall Study|Lost to Follow-up|3|||
146290784|NCT01439360|527579063|FG000|Overall Study|Adverse Event|4|||
146290785|NCT01439360|527579064|FG001|Overall Study|Adverse Event|16|||
146290786|NCT01439360|527579063|FG000|Overall Study|Lost to Follow-up|43|||
146290787|NCT01439360|527579064|FG001|Overall Study|Lost to Follow-up|58|||
146290788|NCT01439360|527579063|FG000|Overall Study|Others|10|||
146290789|NCT01439360|527579064|FG001|Overall Study|Others|5|||
146290790|NCT01439360|527579063|FG000|Overall Study|Protocol Violation|1|||
146290791|NCT01439360|527579064|FG001|Overall Study|Protocol Violation|0|||
146290792|NCT01439360|527579063|FG000|Overall Study|Withdrawal by Subject|140|||
146290793|NCT01439360|527579064|FG001|Overall Study|Withdrawal by Subject|129|||
146290794|NCT00345293|527579065|FG000|Overall Study|Unable to access line for sample|1|||
146290795|NCT00345293|527579066|FG001|Overall Study|Unable to access line for sample|0|||
146290796|NCT00345293|527579065|FG000|Overall Study|Withdrawal by Subject|1|||
146290797|NCT00345293|527579066|FG001|Overall Study|Withdrawal by Subject|0|||
146290798|NCT03319849|527579067|FG000|Overall Study|Adverse Event|1|||
146290799|NCT03319849|527579068|FG001|Overall Study|Adverse Event|0|||
146290800|NCT03319849|527579067|FG000|Overall Study|Physician Decision|0|||
146290801|NCT03319849|527579068|FG001|Overall Study|Physician Decision|1|||
146290802|NCT03319849|527579067|FG000|Overall Study|Withdrawal by Subject|0|||
146290803|NCT03319849|527579068|FG001|Overall Study|Withdrawal by Subject|1|||
146290804|NCT03319849|527579067|FG000|Overall Study|COVID-19|0|||
146290805|NCT03319849|527579068|FG001|Overall Study|COVID-19|1|||
146290806|NCT03319849|527579067|FG000|Overall Study|Other|1|||
146290807|NCT03319849|527579068|FG001|Overall Study|Other|2|||
146290808|NCT03319849|527579067|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
146290809|NCT03319849|527579068|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
146290810|NCT03319849|527579067|FG000|Overall Study|Lost to Follow-up|0|||
146290811|NCT03319849|527579068|FG001|Overall Study|Lost to Follow-up|2|||
146290812|NCT01340196|527580442|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
146290813|NCT00604279|527580447|FG000|Overall Study|Lack of Efficacy|22|||
146290814|NCT00604279|527580448|FG001|Overall Study|Lack of Efficacy|9|||
146290815|NCT00604279|527580447|FG000|Overall Study|Lost to Follow-up|9|||
146290816|NCT00604279|527580448|FG001|Overall Study|Lost to Follow-up|14|||
146290817|NCT00604279|527580447|FG000|Overall Study|Pregnancy|2|||
146290818|NCT00604279|527580448|FG001|Overall Study|Pregnancy|0|||
146290819|NCT00604279|527580447|FG000|Overall Study|Protocol Violation|3|||
146290820|NCT00604279|527580448|FG001|Overall Study|Protocol Violation|1|||
146290821|NCT00604279|527580447|FG000|Overall Study|Withdrawal by Subject|16|||
146290822|NCT00604279|527580448|FG001|Overall Study|Withdrawal by Subject|5|||
146290823|NCT00604279|527580447|FG000|Overall Study|Adverse Event|4|||
146290824|NCT00604279|527580448|FG001|Overall Study|Adverse Event|5|||
146290825|NCT00604279|527580447|FG000|Overall Study|Other|8|||
146290826|NCT00604279|527580448|FG001|Overall Study|Other|4|||
146290827|NCT00601419|527580449|FG000|Overall Study|Lost to Follow-up|3|||
146290828|NCT00601419|527580449|FG000|Overall Study|Missed Visits|1|||
146290829|NCT01614197|527580450|FG000|Overall Study|Withdrawal by Subject|0|||
146290830|NCT01614197|527580451|FG001|Overall Study|Withdrawal by Subject|1|||
146290831|NCT01614197|527580452|FG002|Overall Study|Withdrawal by Subject|0|||
146290832|NCT01614197|527580453|FG003|Overall Study|Withdrawal by Subject|0|||
146290833|NCT03628898|527580455|FG000|Overall Study|Device deficiency|1|||
146290834|NCT01217957|527580456|FG000|Phase 1|Withdrawal by Patient|1|||
146290835|NCT01217957|527580457|FG001|Phase 1|Withdrawal by Patient|0|||
146290836|NCT01217957|527580458|FG002|Phase 1|Withdrawal by Patient|1|||
146290837|NCT01217957|527580459|FG003|Phase 1|Withdrawal by Patient|1|||
146290838|NCT01217957|527580460|FG004|Phase 1|Withdrawal by Patient|0|||
146290839|NCT01217957|527580456|FG000|Phase 2|Withdrawal by Patient|0|||
146290840|NCT01217957|527580457|FG001|Phase 2|Withdrawal by Patient|0|||
146290841|NCT01217957|527580458|FG002|Phase 2|Withdrawal by Patient|0|||
146290842|NCT01217957|527580459|FG003|Phase 2|Withdrawal by Patient|0|||
146290843|NCT01217957|527580460|FG004|Phase 2|Withdrawal by Patient|1|||
146290844|NCT00971932|527580461|FG000|Overall Study|Withdrawal by Subject|1|||
146086605|NCT01163032|526837976|FG001|Randomization Phase|Various*|4|||
145887023|NCT00808509|526090299|FG001|Randomized Phase|Patient refused rescue therapy|3|||
145887024|NCT02169791|526090300|FG000|Overall Study|Death|6|||
145887025|NCT02169791|526090300|FG000|Overall Study|patient withdrew consent|1|||
145887026|NCT03170869|526090301|FG000|Overall Study|Protocol Violation|5|||
145887027|NCT03170869|526090301|FG000|Overall Study|Early study termination|3|||
145887028|NCT01175473|526090302|FG000|Overall Study|Adverse Event|2|||
145887029|NCT01175473|526090303|FG001|Overall Study|Adverse Event|2|||
145887030|NCT03942211|526090308|FG000|Overall Study|Death|1|||
145887031|NCT03942211|526090309|FG001|Overall Study|Death|0|||
145887032|NCT03942211|526090308|FG000|Overall Study|Study terminated by sponsor|5|||
145887033|NCT03942211|526090309|FG001|Overall Study|Study terminated by sponsor|3|||
145887034|NCT03942211|526090308|FG000|Overall Study|Adverse Event|0|||
145887035|NCT03942211|526090309|FG001|Overall Study|Adverse Event|1|||
145887036|NCT01955044|526090310|FG000|Overall Study|Death|1|||
145887037|NCT01955044|526090311|FG001|Overall Study|Death|1|||
145887038|NCT01955044|526090312|FG002|Overall Study|Death|0|||
145887039|NCT02260258|526090316|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
145887040|NCT02260258|526090317|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
145887041|NCT00690482|526090318|FG000|Overall Study|Adverse Event|2|||
145887042|NCT00690482|526090319|FG001|Overall Study|Adverse Event|1|||
145887043|NCT00690482|526090318|FG000|Overall Study|Incorrect enrolment|0|||
145887044|NCT00690482|526090319|FG001|Overall Study|Incorrect enrolment|1|||
145887045|NCT00690482|526090318|FG000|Overall Study|Study-specific discontinuation criteria|1|||
145887046|NCT00690482|526090319|FG001|Overall Study|Study-specific discontinuation criteria|0|||
145887047|NCT00690482|526090318|FG000|Overall Study|Intake of prohibited medicine|1|||
145887048|NCT00690482|526090319|FG001|Overall Study|Intake of prohibited medicine|0|||
145887049|NCT00690482|526090318|FG000|Overall Study|withdrew consent at rand.day|0|||
145887050|NCT00690482|526090319|FG001|Overall Study|withdrew consent at rand.day|1|||
145887051|NCT00724373|526090320|FG000|Overall Study|Adverse Event|41|||
145887052|NCT00724373|526090320|FG000|Overall Study|Lack of Efficacy|82|||
145887053|NCT00724373|526090320|FG000|Overall Study|Lost to Follow-up|7|||
145887054|NCT00724373|526090320|FG000|Overall Study|Non-compliance|2|||
145887055|NCT00724373|526090320|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
145887056|NCT00724373|526090320|FG000|Overall Study|Participant moved away|1|||
145887057|NCT00724373|526090320|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
145887058|NCT00724373|526090320|FG000|Overall Study|Only to have 24 week regimen|1|||
145887059|NCT00724373|526090320|FG000|Overall Study|Viral Relapse|1|||
145887060|NCT00724373|526090320|FG000|Overall Study|Acute HCV infection|1|||
145887061|NCT00724373|526090320|FG000|Overall Study|Drug Relapse|1|||
145887062|NCT00724373|526090320|FG000|Overall Study|Tolerability|23|||
145887063|NCT01506908|526090321|FG000|Overall Study|Adverse Event|1|||
145887064|NCT01506908|526090322|FG001|Overall Study|Adverse Event|0|||
145887065|NCT00925301|526090333|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
146232194|NCT04129164|527368939|FG002|Overall Study|Lost to Follow-up|0|||
146232195|NCT04129164|527368940|FG003|Overall Study|Lost to Follow-up|0|||
146232196|NCT03653364|527368941|FG000|Overall Study|Withdrawal by Subject|1|||
146232197|NCT03653364|527368941|FG000|Overall Study|Enrolled in Error|1|||
146232198|NCT03653364|527368941|FG000|Overall Study|Death|1|||
146232199|NCT04174560|527368953|FG000|Overall Study|Lost to Follow-up|1|||
146232200|NCT04174560|527368954|FG001|Overall Study|Lost to Follow-up|0|||
146232201|NCT04174560|527368955|FG002|Overall Study|Lost to Follow-up|0|||
146232202|NCT04174560|527368956|FG003|Overall Study|Lost to Follow-up|0|||
146232203|NCT04174560|527368953|FG000|Overall Study|Withdrawal by Subject|0|||
146232204|NCT04174560|527368954|FG001|Overall Study|Withdrawal by Subject|0|||
146232205|NCT04174560|527368955|FG002|Overall Study|Withdrawal by Subject|2|||
146232206|NCT04174560|527368956|FG003|Overall Study|Withdrawal by Subject|0|||
146232207|NCT05934292|527368960|FG000|Overall Study|Lost to Follow-up|0|||
146232208|NCT05934292|527368961|FG001|Overall Study|Lost to Follow-up|0|||
146232209|NCT05934292|527368962|FG002|Overall Study|Lost to Follow-up|1|||
146232210|NCT05934292|527368963|FG003|Overall Study|Lost to Follow-up|0|||
146232211|NCT04479787|527368964|FG000|Through 6 Months|Withdrawal by Subject|16|||
146232212|NCT04479787|527368965|FG001|Through 6 Months|Withdrawal by Subject|14|||
146232213|NCT04479787|527368964|FG000|Through 6 Months|Unsuccessful Trial|17|||
146232214|NCT04479787|527368965|FG001|Through 6 Months|Unsuccessful Trial|0|||
146232215|NCT04479787|527368964|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
146232216|NCT04479787|527368965|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
146232217|NCT04479787|527368964|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
146232218|NCT04479787|527368965|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
146232219|NCT04479787|527368964|FG000|Through 6 Months|Lost to Follow-up|3|||
146232220|NCT04479787|527368965|FG001|Through 6 Months|Lost to Follow-up|2|||
146232221|NCT04479787|527368964|FG000|Through 6 Months|Death|3|||
146232222|NCT04479787|527368965|FG001|Through 6 Months|Death|0|||
146086606|NCT01163032|526837977|FG002|Randomization Phase|Various*|0|||
146232223|NCT04479787|527368964|FG000|Through 6 Months|Inclusion/Exclusion|2|||
146232224|NCT04479787|527368965|FG001|Through 6 Months|Inclusion/Exclusion|1|||
146086607|NCT01163032|526837975|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
146086608|NCT01163032|526837976|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
146290845|NCT00971932|527580461|FG000|Overall Study|Investigator's decision|2|||
146290846|NCT00971932|527580461|FG000|Overall Study|Ongoing|4|||
146290847|NCT00288509|527580466|FG000|Treatment Cycle 1|Adverse Event|1|||
146290848|NCT00288509|527580466|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
146290849|NCT00288509|527580466|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
146290850|NCT00288509|527580466|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
146290851|NCT00288509|527580466|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
146290852|NCT00288509|527580466|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
146290853|NCT00288509|527580466|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
146290854|NCT00288509|527580466|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
146290855|NCT00288509|527580466|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
146290856|NCT00288509|527580466|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
145887066|NCT00925301|526090334|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
145887067|NCT00925301|526090335|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
145887068|NCT00925301|526090336|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
145887069|NCT00925301|526090333|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145887070|NCT00925301|526090334|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
145887071|NCT00925301|526090335|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145887072|NCT00925301|526090336|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145887073|NCT00925301|526090333|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145887074|NCT00925301|526090334|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145887075|NCT00925301|526090335|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
145887076|NCT00925301|526090336|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145887077|NCT00925301|526090333|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
145887078|NCT00925301|526090334|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
145887079|NCT00925301|526090335|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
145887080|NCT00925301|526090336|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
145887081|NCT00925301|526090333|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
145887082|NCT00925301|526090334|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
145887083|NCT00925301|526090335|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
146290857|NCT00288509|527580466|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
146290858|NCT00288509|527580466|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
146290859|NCT00288509|527580466|FG000|Treatment Cycle 4|Physician Decision|4|||
145887084|NCT00925301|526090336|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
145887085|NCT00925301|526090333|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
146086609|NCT01163032|526837977|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
146290860|NCT00288509|527580466|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
146290861|NCT02382016|527580467|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
145964048|NCT00641056|526382069|FG000|Overall Study|Entry Criteria Not Met|3|||
145964049|NCT00641056|526382070|FG001|Overall Study|Entry Criteria Not Met|0|||
145964050|NCT00641056|526382069|FG000|Overall Study|Subject Decision|6|||
145964051|NCT00641056|526382070|FG001|Overall Study|Subject Decision|19|||
145964052|NCT00641056|526382069|FG000|Overall Study|Sponsor Decision|1|||
145964053|NCT00641056|526382070|FG001|Overall Study|Sponsor Decision|2|||
145964054|NCT00896493|526382073|FG000|Overall Study|Early disease relapse|3|||
145964055|NCT02026141|526382076|FG000|Overall Study|Protocol Violation|0|||
145964056|NCT02026141|526382077|FG001|Overall Study|Protocol Violation|1|||
145964057|NCT03074695|526382080|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
145964058|NCT03074695|526382081|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
145964059|NCT03074695|526382080|FG000|Overall Study|Research staff not available|1|||
145964060|NCT03074695|526382081|FG001|Overall Study|Research staff not available|2|||
145964061|NCT03074695|526382080|FG000|Overall Study|Did not receive neuraxial block|2|||
145964062|NCT03074695|526382081|FG001|Overall Study|Did not receive neuraxial block|2|||
145964063|NCT01774981|526382082|FG000|Overall Study|Adverse Event|0|||
145964064|NCT01774981|526382083|FG001|Overall Study|Adverse Event|0|||
145964065|NCT01774981|526382084|FG002|Overall Study|Adverse Event|0|||
145964066|NCT01774981|526382085|FG003|Overall Study|Adverse Event|0|||
145964067|NCT01774981|526382086|FG004|Overall Study|Adverse Event|0|||
145964068|NCT01774981|526382087|FG005|Overall Study|Adverse Event|1|||
145964069|NCT01774981|526382088|FG006|Overall Study|Adverse Event|0|||
145964070|NCT01774981|526382089|FG007|Overall Study|Adverse Event|0|||
145964071|NCT01774981|526382082|FG000|Overall Study|Withdrawal by Subject|0|||
145964072|NCT01774981|526382083|FG001|Overall Study|Withdrawal by Subject|0|||
145964073|NCT01774981|526382084|FG002|Overall Study|Withdrawal by Subject|0|||
145964074|NCT01774981|526382085|FG003|Overall Study|Withdrawal by Subject|0|||
145964075|NCT01774981|526382086|FG004|Overall Study|Withdrawal by Subject|0|||
145964076|NCT01774981|526382087|FG005|Overall Study|Withdrawal by Subject|0|||
145964077|NCT01774981|526382088|FG006|Overall Study|Withdrawal by Subject|0|||
145964078|NCT01774981|526382089|FG007|Overall Study|Withdrawal by Subject|1|||
145964079|NCT01774981|526382082|FG000|Overall Study|Death|0|||
145964080|NCT01774981|526382083|FG001|Overall Study|Death|0|||
145964081|NCT01774981|526382084|FG002|Overall Study|Death|0|||
145964082|NCT01774981|526382085|FG003|Overall Study|Death|0|||
145964083|NCT01774981|526382086|FG004|Overall Study|Death|1|||
145964084|NCT01774981|526382087|FG005|Overall Study|Death|0|||
145964085|NCT01774981|526382088|FG006|Overall Study|Death|0|||
145964086|NCT01774981|526382089|FG007|Overall Study|Death|0|||
145964087|NCT00902577|526382090|FG000|Overall Study|Withdrawal by Subject|6|||
145964088|NCT00902577|526382090|FG000|Overall Study|FMISO production failure|2|||
145964089|NCT00083915|526382091|FG000|Overall Study|Death|6|||
145964090|NCT00083915|526382092|FG001|Overall Study|Death|3|||
145964091|NCT00083915|526382091|FG000|Overall Study|Physician Decision|11|||
145964092|NCT00083915|526382092|FG001|Overall Study|Physician Decision|6|||
145964093|NCT00083915|526382091|FG000|Overall Study|Withdrawal by Subject|8|||
145964094|NCT00083915|526382092|FG001|Overall Study|Withdrawal by Subject|3|||
145964095|NCT00083915|526382091|FG000|Overall Study|disease progression|18|||
146290862|NCT02382016|527580468|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
145887086|NCT00925301|526090334|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
145887087|NCT00925301|526090335|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
145887088|NCT00925301|526090336|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
145887089|NCT00925301|526090333|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145887090|NCT00925301|526090334|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145887091|NCT00925301|526090335|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145887092|NCT00925301|526090336|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
145887093|NCT03043560|526090337|FG000|Overall Study|Discontinued Intervention|1|||
145887094|NCT03043560|526090338|FG001|Overall Study|Discontinued Intervention|2|||
145887095|NCT03043560|526090337|FG000|Overall Study|Lost to Follow-up|0|||
145887096|NCT03043560|526090338|FG001|Overall Study|Lost to Follow-up|1|||
145887097|NCT01117766|526090339|FG000|First Intervention|Adverse Event|0|||
145887098|NCT01117766|526090340|FG001|First Intervention|Adverse Event|1|||
145887099|NCT01117766|526090339|FG000|First Intervention|Protocol Violation|1|||
145887100|NCT01117766|526090340|FG001|First Intervention|Protocol Violation|0|||
145887101|NCT01117766|526090339|FG000|Washout Period|Protocol Violation|0|||
145887102|NCT01117766|526090340|FG001|Washout Period|Protocol Violation|2|||
145887103|NCT01117766|526090339|FG000|Second Intervention|Lost to Follow-up|1|||
145887104|NCT01117766|526090340|FG001|Second Intervention|Lost to Follow-up|0|||
145887105|NCT01117766|526090339|FG000|Second Intervention|Other|1|||
145887106|NCT01117766|526090340|FG001|Second Intervention|Other|2|||
145887107|NCT01117766|526090339|FG000|Second Intervention|Adverse Event|0|||
145887108|NCT01117766|526090340|FG001|Second Intervention|Adverse Event|2|||
145887109|NCT01117766|526090339|FG000|Second Intervention|Withdrawal by Subject|0|||
145887110|NCT01117766|526090340|FG001|Second Intervention|Withdrawal by Subject|1|||
145887111|NCT04405739|526090341|FG000|Overall Study|Adverse Event|0|||
145887112|NCT04405739|526090342|FG001|Overall Study|Adverse Event|1|||
145964096|NCT00083915|526382092|FG001|Overall Study|disease progression|23|||
145964097|NCT00083915|526382091|FG000|Overall Study|Failure to collect|3|||
145964098|NCT00083915|526382092|FG001|Overall Study|Failure to collect|0|||
145964099|NCT00083915|526382091|FG000|Overall Study|No response|3|||
145964100|NCT00083915|526382092|FG001|Overall Study|No response|1|||
145964101|NCT00083915|526382091|FG000|Overall Study|Insurance issues|1|||
145964102|NCT00083915|526382092|FG001|Overall Study|Insurance issues|1|||
145964103|NCT02000921|526382097|FG000|Overall Study|Withdrawal by Subject|3|||
145964104|NCT02000921|526382098|FG001|Overall Study|Withdrawal by Subject|10|||
145964105|NCT02000921|526382099|FG002|Overall Study|Withdrawal by Subject|5|||
145964106|NCT02000921|526382097|FG000|Overall Study|Lost to Follow-up|2|||
145964107|NCT02000921|526382098|FG001|Overall Study|Lost to Follow-up|4|||
145964108|NCT02000921|526382099|FG002|Overall Study|Lost to Follow-up|5|||
145964109|NCT02000921|526382097|FG000|Overall Study|Physician Decision|0|||
145964110|NCT02000921|526382098|FG001|Overall Study|Physician Decision|2|||
145964111|NCT02000921|526382099|FG002|Overall Study|Physician Decision|0|||
145964112|NCT02914834|526382100|FG000|Overall Study|Study halted due to COVID|1|||
145964113|NCT02914834|526382101|FG001|Overall Study|Study halted due to COVID|1|||
145964114|NCT02914834|526382100|FG000|Overall Study|1 subject withdrew|0|||
145964115|NCT02914834|526382101|FG001|Overall Study|1 subject withdrew|1|||
145964116|NCT02631941|526382102|FG000|Overall Study|Physician Decision|0|||
146232225|NCT04479787|527368964|FG000|Through 6 Months|Subject Became Pregnant|1|||
146232226|NCT04479787|527368965|FG001|Through 6 Months|Subject Became Pregnant|1|||
146232227|NCT04479787|527368964|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
146232228|NCT04479787|527368965|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
146232229|NCT04479787|527368964|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
146232230|NCT04479787|527368965|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
146232231|NCT04479787|527368964|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
145964117|NCT02631941|526382103|FG001|Overall Study|Physician Decision|1|||
146232232|NCT04479787|527368965|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
146232233|NCT04479787|527368964|FG000|After 6 Months|Withdrawal by Subject|3|||
146232234|NCT04479787|527368965|FG001|After 6 Months|Withdrawal by Subject|13|||
146232235|NCT04479787|527368964|FG000|After 6 Months|Unsuccessful Trial|0|||
146232236|NCT04479787|527368965|FG001|After 6 Months|Unsuccessful Trial|7|||
146232237|NCT04479787|527368964|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
146232238|NCT04479787|527368965|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
146232239|NCT04479787|527368964|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
146232240|NCT04479787|527368965|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
146232241|NCT04479787|527368964|FG000|After 6 Months|Death|2|||
146232242|NCT04479787|527368965|FG001|After 6 Months|Death|0|||
146232243|NCT04479787|527368964|FG000|After 6 Months|Lost to Follow-up|1|||
146232244|NCT04479787|527368965|FG001|After 6 Months|Lost to Follow-up|1|||
146232245|NCT04479787|527368964|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
146232246|NCT04479787|527368965|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
146232247|NCT04479787|527368964|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
146232248|NCT04479787|527368965|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
146232249|NCT04479787|527368964|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
146232250|NCT04479787|527368965|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
146232251|NCT04479787|527368964|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
146232252|NCT04479787|527368965|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
146232253|NCT05714059|527368968|FG000|Overall Study|Withdrawal by Subject|2|||
146232254|NCT05714059|527368969|FG001|Overall Study|Withdrawal by Subject|2|||
146232255|NCT05714059|527368968|FG000|Overall Study|Adverse Event|0|||
146232256|NCT05714059|527368969|FG001|Overall Study|Adverse Event|1|||
145964118|NCT02631941|526382104|FG002|Overall Study|Physician Decision|0|||
145964119|NCT02631941|526382105|FG003|Overall Study|Physician Decision|0|||
145964120|NCT02631941|526382106|FG004|Overall Study|Physician Decision|0|||
145964121|NCT02631941|526382107|FG005|Overall Study|Physician Decision|0|||
145964122|NCT02631941|526382108|FG006|Overall Study|Physician Decision|0|||
146086610|NCT01163032|526837975|FG000|Open Label Extension Phase|Adverse Event|0|||
146086611|NCT01163032|526837976|FG001|Open Label Extension Phase|Adverse Event|0|||
146086612|NCT01163032|526837977|FG002|Open Label Extension Phase|Adverse Event|3|||
146086613|NCT01163032|526837975|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
146086614|NCT01163032|526837976|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
146086615|NCT01163032|526837977|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
146086616|NCT01163032|526837975|FG000|Open Label Extension Phase|Protocol Violation|0|||
146086617|NCT01163032|526837976|FG001|Open Label Extension Phase|Protocol Violation|0|||
146086618|NCT01163032|526837977|FG002|Open Label Extension Phase|Protocol Violation|1|||
146086619|NCT01163032|526837975|FG000|Open Label Extension Phase|Study Termination|0|||
145887113|NCT04405739|526090343|FG002|Overall Study|Adverse Event|0|||
145887114|NCT04405739|526090344|FG003|Overall Study|Adverse Event|0|||
145887115|NCT04405739|526090341|FG000|Overall Study|Lost to Follow-up|0|||
145887116|NCT04405739|526090342|FG001|Overall Study|Lost to Follow-up|2|||
145887117|NCT04405739|526090343|FG002|Overall Study|Lost to Follow-up|1|||
145887118|NCT04405739|526090344|FG003|Overall Study|Lost to Follow-up|3|||
145887119|NCT04405739|526090341|FG000|Overall Study|Withdrawal by Subject|0|||
145887120|NCT04405739|526090342|FG001|Overall Study|Withdrawal by Subject|2|||
145887121|NCT04405739|526090343|FG002|Overall Study|Withdrawal by Subject|1|||
145887122|NCT04405739|526090344|FG003|Overall Study|Withdrawal by Subject|1|||
145887123|NCT04405739|526090341|FG000|Overall Study|Death|0|||
145887124|NCT04405739|526090342|FG001|Overall Study|Death|0|||
145887125|NCT04405739|526090343|FG002|Overall Study|Death|1|||
145887126|NCT04405739|526090344|FG003|Overall Study|Death|0|||
145887127|NCT04405739|526090341|FG000|Overall Study|Transferred to rehab|0|||
145887128|NCT04405739|526090342|FG001|Overall Study|Transferred to rehab|0|||
145887129|NCT04405739|526090343|FG002|Overall Study|Transferred to rehab|0|||
145887130|NCT04405739|526090344|FG003|Overall Study|Transferred to rehab|1|||
145887131|NCT04405739|526090341|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
145887132|NCT04405739|526090342|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
145887133|NCT04405739|526090343|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
145887134|NCT04405739|526090344|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
145887135|NCT01436643|526090345|FG000|2-week Pre-treatment|Abnormal test result|0|||
145887136|NCT01436643|526090346|FG001|2-week Pre-treatment|Abnormal test result|0|||
145887137|NCT01436643|526090347|FG002|2-week Pre-treatment|Abnormal test result|0|||
145887138|NCT01436643|526090348|FG003|2-week Pre-treatment|Abnormal test result|1|||
145887139|NCT01436643|526090345|FG000|2-week Pre-treatment|Adverse Event|0|||
145887140|NCT01436643|526090346|FG001|2-week Pre-treatment|Adverse Event|0|||
145887141|NCT01436643|526090347|FG002|2-week Pre-treatment|Adverse Event|0|||
145887142|NCT01436643|526090348|FG003|2-week Pre-treatment|Adverse Event|5|||
145887143|NCT01436643|526090345|FG000|2-week Pre-treatment|Protocol Violation|0|||
145887144|NCT01436643|526090346|FG001|2-week Pre-treatment|Protocol Violation|0|||
145887145|NCT01436643|526090347|FG002|2-week Pre-treatment|Protocol Violation|0|||
145887146|NCT01436643|526090348|FG003|2-week Pre-treatment|Protocol Violation|4|||
145887147|NCT01436643|526090345|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
145887148|NCT01436643|526090346|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
145887149|NCT01436643|526090347|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
145887150|NCT01436643|526090348|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
145887151|NCT01436643|526090345|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
145887152|NCT01436643|526090346|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
145887153|NCT01436643|526090347|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
146086620|NCT01163032|526837976|FG001|Open Label Extension Phase|Study Termination|0|||
146086621|NCT01163032|526837977|FG002|Open Label Extension Phase|Study Termination|7|||
145964123|NCT02631941|526382109|FG007|Overall Study|Physician Decision|0|||
145964124|NCT02631941|526382110|FG008|Overall Study|Physician Decision|0|||
145964125|NCT02631941|526382111|FG009|Overall Study|Physician Decision|0|||
145964126|NCT02631941|526382102|FG000|Overall Study|Adverse Event|0|||
145964127|NCT02631941|526382103|FG001|Overall Study|Adverse Event|1|||
145964128|NCT02631941|526382104|FG002|Overall Study|Adverse Event|0|||
145964129|NCT02631941|526382105|FG003|Overall Study|Adverse Event|0|||
145964130|NCT02631941|526382106|FG004|Overall Study|Adverse Event|0|||
145964131|NCT02631941|526382107|FG005|Overall Study|Adverse Event|0|||
145964132|NCT02631941|526382108|FG006|Overall Study|Adverse Event|0|||
145964133|NCT02631941|526382109|FG007|Overall Study|Adverse Event|0|||
145964134|NCT02631941|526382110|FG008|Overall Study|Adverse Event|0|||
145964135|NCT02631941|526382111|FG009|Overall Study|Adverse Event|0|||
145964136|NCT02631941|526382102|FG000|Overall Study|Withdrawal by Subject|0|||
145964137|NCT02631941|526382103|FG001|Overall Study|Withdrawal by Subject|0|||
145964138|NCT02631941|526382104|FG002|Overall Study|Withdrawal by Subject|0|||
145964139|NCT02631941|526382105|FG003|Overall Study|Withdrawal by Subject|0|||
145964140|NCT02631941|526382106|FG004|Overall Study|Withdrawal by Subject|1|||
145964141|NCT02631941|526382107|FG005|Overall Study|Withdrawal by Subject|0|||
145964142|NCT02631941|526382108|FG006|Overall Study|Withdrawal by Subject|0|||
145964143|NCT02631941|526382109|FG007|Overall Study|Withdrawal by Subject|1|||
145964144|NCT02631941|526382110|FG008|Overall Study|Withdrawal by Subject|0|||
145964145|NCT02631941|526382111|FG009|Overall Study|Withdrawal by Subject|0|||
145964146|NCT02631941|526382102|FG000|Overall Study|Lost to Follow-up|0|||
145964147|NCT02631941|526382103|FG001|Overall Study|Lost to Follow-up|0|||
145964148|NCT02631941|526382104|FG002|Overall Study|Lost to Follow-up|0|||
145964149|NCT02631941|526382105|FG003|Overall Study|Lost to Follow-up|0|||
145964150|NCT02631941|526382106|FG004|Overall Study|Lost to Follow-up|0|||
145964151|NCT02631941|526382107|FG005|Overall Study|Lost to Follow-up|0|||
145964152|NCT02631941|526382108|FG006|Overall Study|Lost to Follow-up|0|||
145964153|NCT02631941|526382109|FG007|Overall Study|Lost to Follow-up|0|||
145964154|NCT02631941|526382110|FG008|Overall Study|Lost to Follow-up|1|||
145964155|NCT02631941|526382111|FG009|Overall Study|Lost to Follow-up|0|||
145964156|NCT01240382|526382112|FG000|Overall Study|Adverse Event|2|||
145964157|NCT01240382|526382113|FG001|Overall Study|Adverse Event|1|||
145964158|NCT01240382|526382112|FG000|Overall Study|Lack of Efficacy|0|||
145964159|NCT01240382|526382113|FG001|Overall Study|Lack of Efficacy|2|||
145964160|NCT01240382|526382112|FG000|Overall Study|Fear of adverse events|0|||
145964161|NCT01240382|526382113|FG001|Overall Study|Fear of adverse events|1|||
145964162|NCT03585270|526382117|FG000|Overall Study|Withdrawal by Subject|2|||
145964163|NCT03585270|526382118|FG001|Overall Study|Withdrawal by Subject|6|||
145964164|NCT03585270|526382117|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
145964165|NCT03585270|526382118|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
145964166|NCT03585270|526382117|FG000|Overall Study|Adverse Event|5|||
145964167|NCT03585270|526382118|FG001|Overall Study|Adverse Event|2|||
145964168|NCT03585270|526382117|FG000|Overall Study|Lost to Follow-up|1|||
145964169|NCT03585270|526382118|FG001|Overall Study|Lost to Follow-up|4|||
145964170|NCT03585270|526382117|FG000|Overall Study|Death|5|||
145964171|NCT03585270|526382118|FG001|Overall Study|Death|3|||
145964172|NCT03585270|526382117|FG000|Overall Study|Other reasons|2|||
145964173|NCT03585270|526382118|FG001|Overall Study|Other reasons|2|||
145964174|NCT02053493|526382119|FG000|Overall Study|Withdrawal by Subject|1|||
145964175|NCT02053493|526382120|FG001|Overall Study|Withdrawal by Subject|1|||
145964176|NCT01791985|526382123|FG000|Overall Study|Adverse Event|7|||
145964177|NCT01791985|526382123|FG000|Overall Study|Withdrawal by Subject|1|||
145964178|NCT05214118|526382135|FG000|Overall Study|Lost to Follow-up|0|||
145964179|NCT05214118|526382136|FG001|Overall Study|Lost to Follow-up|2|||
145964180|NCT05214118|526382135|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
146290863|NCT02382016|527580467|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
146290864|NCT02382016|527580468|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
146290865|NCT02382016|527580467|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
146290866|NCT02382016|527580468|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
146290867|NCT02382016|527580467|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
146290868|NCT02382016|527580468|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
146290869|NCT02382016|527580467|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
146290870|NCT02382016|527580468|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
146290871|NCT02382016|527580467|FG000|Open-label (OL) Treatment Period|Death|4|||
146290872|NCT02382016|527580468|FG001|Open-label (OL) Treatment Period|Death|0|||
146290873|NCT02382016|527580467|FG000|OL Extension Period|Physician Decision|3|||
146290874|NCT02382016|527580468|FG001|OL Extension Period|Physician Decision|0|||
146290875|NCT02382016|527580467|FG000|OL Extension Period|Death|2|||
146290876|NCT02382016|527580468|FG001|OL Extension Period|Death|0|||
145964181|NCT05214118|526382136|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
145964182|NCT05214118|526382135|FG000|Overall Study|moved|1|||
145964183|NCT05214118|526382136|FG001|Overall Study|moved|0|||
145964184|NCT03217591|526382137|FG000|Overall Study|Adverse Event|1|||
145964185|NCT03217591|526382138|FG001|Overall Study|Adverse Event|2|||
145887154|NCT01436643|526090348|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
145887155|NCT01436643|526090345|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
145887156|NCT01436643|526090346|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
146232257|NCT05714059|527368968|FG000|Overall Study|Lost to Follow-up|0|||
145887157|NCT01436643|526090347|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
145887158|NCT01436643|526090348|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
145887159|NCT05766787|526090349|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
145887160|NCT05766787|526090350|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
145887161|NCT05766787|526090349|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
145887162|NCT05766787|526090350|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
145887163|NCT05766787|526090349|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
145887164|NCT05766787|526090350|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
145887165|NCT00438659|526090351|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
145887166|NCT00438659|526090352|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
145887167|NCT00438659|526090351|FG000|Overall Study|Cancel|5|||
145887168|NCT00438659|526090352|FG001|Overall Study|Cancel|2|||
145887169|NCT02056652|526090353|FG000|Overall Study|Withdrawal by Subject|1|||
145887170|NCT02056652|526090354|FG001|Overall Study|Withdrawal by Subject|0|||
145887171|NCT02056652|526090353|FG000|Overall Study|Lost to Follow-up|0|||
145887172|NCT02056652|526090354|FG001|Overall Study|Lost to Follow-up|3|||
145887173|NCT01917968|526090355|FG000|Overall Study|Death|3|||
145887174|NCT01917968|526090356|FG001|Overall Study|Death|2|||
145887175|NCT01917968|526090355|FG000|Overall Study|Lost to Follow-up|21|||
145887176|NCT01917968|526090356|FG001|Overall Study|Lost to Follow-up|39|||
145887177|NCT01917968|526090355|FG000|Overall Study|Physician Decision|1|||
145887178|NCT01917968|526090356|FG001|Overall Study|Physician Decision|2|||
145887179|NCT01917968|526090355|FG000|Overall Study|Withdrawal by Subject|20|||
145887180|NCT01917968|526090356|FG001|Overall Study|Withdrawal by Subject|35|||
145887181|NCT01917968|526090355|FG000|Overall Study|Subject Relocation|5|||
145887182|NCT01917968|526090356|FG001|Overall Study|Subject Relocation|1|||
145887183|NCT01917968|526090355|FG000|Overall Study|36M Missed Visit|3|||
145887184|NCT01917968|526090356|FG001|Overall Study|36M Missed Visit|2|||
145887185|NCT01917968|526090355|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
145964186|NCT03217591|526382139|FG002|Overall Study|Adverse Event|6|||
145964187|NCT03217591|526382137|FG000|Overall Study|Withdrawal by Subject|0|||
145964188|NCT03217591|526382138|FG001|Overall Study|Withdrawal by Subject|1|||
145964189|NCT03217591|526382139|FG002|Overall Study|Withdrawal by Subject|3|||
145964190|NCT03217591|526382137|FG000|Overall Study|Lost to Follow-up|1|||
145964191|NCT03217591|526382138|FG001|Overall Study|Lost to Follow-up|0|||
145964192|NCT03217591|526382139|FG002|Overall Study|Lost to Follow-up|0|||
145964193|NCT03217591|526382137|FG000|Overall Study|Protocol Violation|1|||
145964194|NCT03217591|526382138|FG001|Overall Study|Protocol Violation|0|||
145964195|NCT03217591|526382139|FG002|Overall Study|Protocol Violation|1|||
145964196|NCT04467515|526382142|FG000|Overall Study|Lost to Follow-up|1|||
145964197|NCT04467515|526382143|FG001|Overall Study|Lost to Follow-up|0|||
145964198|NCT04467515|526382144|FG002|Overall Study|Lost to Follow-up|0|||
145964199|NCT04467515|526382142|FG000|Overall Study|Withdrawal by Subject|1|||
145964200|NCT04467515|526382143|FG001|Overall Study|Withdrawal by Subject|0|||
145964201|NCT04467515|526382144|FG002|Overall Study|Withdrawal by Subject|1|||
145964202|NCT04467515|526382142|FG000|Overall Study|Progressive Disease|0|||
145964203|NCT04467515|526382143|FG001|Overall Study|Progressive Disease|1|||
145964204|NCT04467515|526382144|FG002|Overall Study|Progressive Disease|3|||
145964205|NCT04467515|526382142|FG000|Overall Study|Death|0|||
145964206|NCT04467515|526382143|FG001|Overall Study|Death|1|||
145964207|NCT04467515|526382144|FG002|Overall Study|Death|0|||
145964208|NCT03014206|526382147|FG000|Overall Study|Registration Violation|12|||
145964209|NCT01091246|526382148|FG000|Overall Study|Lost to Follow-up|23|||
145964210|NCT01091246|526382149|FG001|Overall Study|Lost to Follow-up|11|||
145964211|NCT01091246|526382150|FG002|Overall Study|Lost to Follow-up|7|||
145964212|NCT01091246|526382148|FG000|Overall Study|Adverse Event|1|||
145964213|NCT01091246|526382149|FG001|Overall Study|Adverse Event|0|||
145887186|NCT01917968|526090356|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
145887187|NCT01917968|526090355|FG000|Overall Study|Change in Family Circumstances|0|||
145964214|NCT01091246|526382150|FG002|Overall Study|Adverse Event|1|||
145964215|NCT01091246|526382148|FG000|Overall Study|Withdrawal by Subject|9|||
145964216|NCT01091246|526382149|FG001|Overall Study|Withdrawal by Subject|5|||
145964217|NCT01091246|526382150|FG002|Overall Study|Withdrawal by Subject|4|||
145964218|NCT01091246|526382148|FG000|Overall Study|Subject not dosed|2|||
145964219|NCT01091246|526382149|FG001|Overall Study|Subject not dosed|0|||
145964220|NCT01091246|526382150|FG002|Overall Study|Subject not dosed|1|||
145887188|NCT01917968|526090356|FG001|Overall Study|Change in Family Circumstances|1|||
145887189|NCT01917968|526090355|FG000|Overall Study|No Data Available|0|||
145887190|NCT01917968|526090356|FG001|Overall Study|No Data Available|2|||
145887191|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
145887192|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
145887193|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
145887194|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
145887195|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
145887196|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
145887197|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
145887198|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
145887199|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
145887200|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
145887201|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
145887202|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
145887203|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
145887204|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
145887205|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
145887206|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
145887207|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
145887208|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
145887209|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
145964221|NCT04577794|526382151|FG000|Overall Study|Adverse Event|1|||
146232258|NCT05714059|527368969|FG001|Overall Study|Lost to Follow-up|1|||
146232259|NCT05714059|527368968|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
146232260|NCT05714059|527368969|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
146232261|NCT05714059|527368968|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
146232262|NCT05714059|527368969|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
146232263|NCT04899674|527368970|FG000|Test|Adverse Event|1|||
145964222|NCT04577794|526382152|FG001|Overall Study|Adverse Event|1|||
145964223|NCT01676012|526382154|FG000|Overall Study|Adverse Event|2|||
145964224|NCT01676012|526382154|FG000|Overall Study|incomplete set of videos|1|||
145964225|NCT02849080|526382159|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
145964226|NCT02849080|526382160|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
145964227|NCT02849080|526382161|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
145964228|NCT02849080|526382162|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
145964229|NCT02849080|526382159|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
145964230|NCT02849080|526382160|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
145964231|NCT02849080|526382161|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
145964232|NCT02849080|526382162|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
145964233|NCT02849080|526382159|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
145964234|NCT02849080|526382160|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
145964235|NCT02849080|526382161|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
145964236|NCT02849080|526382162|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
145964237|NCT02849080|526382159|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
145964238|NCT02849080|526382160|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145964239|NCT02849080|526382161|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145964240|NCT02849080|526382162|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145964241|NCT02849080|526382159|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
145964242|NCT02849080|526382160|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
145964243|NCT02849080|526382161|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
145964244|NCT02849080|526382162|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
146086622|NCT01163032|526837975|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
146086623|NCT01163032|526837976|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
146086624|NCT01163032|526837977|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
146086625|NCT01037088|526837980|FG000|Overall Study|Withdrawal by Subject|3|||
146086626|NCT01958827|526837981|FG000|Overall Study|Adverse Event|3|||
146086627|NCT01958827|526837981|FG000|Overall Study|Lack of Efficacy|6|||
146086628|NCT01958827|526837981|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
146086629|NCT03036800|526837982|FG000|Overall Study|Protocol Violation|1|||
146086630|NCT03036800|526837983|FG001|Overall Study|Protocol Violation|0|||
146086631|NCT03036800|526837982|FG000|Overall Study|Non-compliance|1|||
146086632|NCT03036800|526837983|FG001|Overall Study|Non-compliance|0|||
146086633|NCT03036800|526837982|FG000|Overall Study|Lost to Follow-up|1|||
146086634|NCT03036800|526837983|FG001|Overall Study|Lost to Follow-up|0|||
146086635|NCT03036800|526837982|FG000|Overall Study|Death|1|||
146086636|NCT03036800|526837983|FG001|Overall Study|Death|0|||
146086637|NCT03036800|526837982|FG000|Overall Study|Tolerance|5|||
146086638|NCT03036800|526837983|FG001|Overall Study|Tolerance|0|||
146086639|NCT03036800|526837982|FG000|Overall Study|Unknown/no reason given|50|||
146086640|NCT03036800|526837983|FG001|Overall Study|Unknown/no reason given|39|||
146232264|NCT03774472|527368971|FG000|Overall Study|Physician Decision|1|||
146232265|NCT03774472|527368972|FG001|Overall Study|Physician Decision|0|||
146232266|NCT03774472|527368973|FG002|Overall Study|Physician Decision|0|||
146232267|NCT03774472|527368971|FG000|Overall Study|Progression prior to 4 weeks|0|||
146086641|NCT01077154|526837988|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
146086642|NCT01077154|526837989|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
146086643|NCT01077154|526837988|FG000|Overall Study|Withdrawal by Subject|369|||
146086644|NCT01077154|526837989|FG001|Overall Study|Withdrawal by Subject|385|||
145964245|NCT02849080|526382159|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
145964246|NCT02849080|526382160|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145964247|NCT02849080|526382161|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145964248|NCT02849080|526382162|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145964249|NCT04460326|526382169|FG000|Completed at Least 4 Meals|Early discharge|5|||
145964250|NCT04460326|526382170|FG001|Completed at Least 4 Meals|Early discharge|5|||
145964251|NCT04460326|526382169|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
145964252|NCT04460326|526382170|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
145964253|NCT04460326|526382169|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
145964254|NCT04460326|526382170|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
145964255|NCT04460326|526382169|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
145964256|NCT04460326|526382170|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
145964257|NCT04460326|526382169|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
145964258|NCT04460326|526382170|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
145964259|NCT04460326|526382169|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
145964260|NCT04460326|526382170|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
145964261|NCT03160716|526382171|FG000|Overall Study|Lost to Follow-up|1|||
145964262|NCT01628848|526382172|FG000|Overall Study|Adverse Event|9|||
145964263|NCT01628848|526382173|FG001|Overall Study|Adverse Event|7|||
145964264|NCT01628848|526382172|FG000|Overall Study|Lack of Efficacy|0|||
145964265|NCT01628848|526382173|FG001|Overall Study|Lack of Efficacy|4|||
145964266|NCT01628848|526382172|FG000|Overall Study|Withdrawal by Subject|0|||
145964267|NCT01628848|526382173|FG001|Overall Study|Withdrawal by Subject|2|||
145964268|NCT01628848|526382172|FG000|Overall Study|Physician Decision|3|||
145964269|NCT01628848|526382173|FG001|Overall Study|Physician Decision|1|||
145964270|NCT04794751|526382177|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
145964271|NCT04794751|526382178|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
145964272|NCT04794751|526382177|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
145964273|NCT04794751|526382178|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
145964274|NCT04794751|526382177|FG000|Period 1|Protocol Violation|0|||
145964275|NCT04794751|526382178|FG001|Period 1|Protocol Violation|2|||
145964276|NCT04794751|526382177|FG000|Period 1|Withdrawal by Subject|0|||
145964277|NCT04794751|526382178|FG001|Period 1|Withdrawal by Subject|1|||
145964278|NCT04794751|526382177|FG000|Period 2|Withdrawal by Subject|0|||
145964279|NCT04794751|526382178|FG001|Period 2|Withdrawal by Subject|1|||
145964280|NCT04794751|526382177|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
145964281|NCT04794751|526382178|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
145964282|NCT04794751|526382177|FG000|Period 2|Protocol Violation|1|||
145964283|NCT04794751|526382178|FG001|Period 2|Protocol Violation|0|||
145964284|NCT02283658|526382179|FG000|Overall Study|Withdrawal by Subject|1|||
145964285|NCT03528551|526382181|FG000|Overall Study|Lost to Follow-up|0|||
145964286|NCT03528551|526382182|FG001|Overall Study|Lost to Follow-up|1|||
145964287|NCT03528551|526382183|FG002|Overall Study|Lost to Follow-up|0|||
145964288|NCT03528551|526382181|FG000|Overall Study|Transferred to other arm/group|2|||
145964289|NCT03528551|526382182|FG001|Overall Study|Transferred to other arm/group|3|||
145964290|NCT03528551|526382183|FG002|Overall Study|Transferred to other arm/group|0|||
145964291|NCT03528551|526382181|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145964292|NCT03528551|526382182|FG001|Overall Study|Withdrawal by parent/guardian|5|||
145964293|NCT03528551|526382183|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145964294|NCT03528551|526382181|FG000|Overall Study|Protocol Violation|0|||
145964295|NCT03528551|526382182|FG001|Overall Study|Protocol Violation|3|||
145964296|NCT03528551|526382183|FG002|Overall Study|Protocol Violation|0|||
145964297|NCT03528551|526382181|FG000|Overall Study|Withdrawal by Subject|0|||
145964298|NCT03528551|526382182|FG001|Overall Study|Withdrawal by Subject|7|||
145964299|NCT03528551|526382183|FG002|Overall Study|Withdrawal by Subject|0|||
145964300|NCT01789047|526382184|FG000|Overall Study|Adverse Event|3|||
145964301|NCT01789047|526382185|FG001|Overall Study|Adverse Event|2|||
145964302|NCT01789047|526382184|FG000|Overall Study|Withdrawal by Subject|1|||
145964303|NCT01789047|526382185|FG001|Overall Study|Withdrawal by Subject|2|||
145964304|NCT02668640|526382186|FG000|Overall Study|Lost to Follow-up|13|||
145964305|NCT02668640|526382186|FG000|Overall Study|Other, not specified|1|||
145964306|NCT02322749|526382187|FG000|Period 2|Adverse Event|0|||
145964307|NCT02322749|526382188|FG001|Period 2|Adverse Event|0|||
145964308|NCT02322749|526382189|FG002|Period 2|Adverse Event|0|||
145964309|NCT02322749|526382190|FG003|Period 2|Adverse Event|1|||
146290877|NCT02382016|527580467|FG000|OL Extension Period|Withdrawal by Subject|1|||
146290878|NCT02382016|527580468|FG001|OL Extension Period|Withdrawal by Subject|0|||
146290879|NCT00084266|527580469|FG000|Overall Study|Death|42|||
146290880|NCT00084266|527580470|FG001|Overall Study|Death|39|||
146290881|NCT00084266|527580469|FG000|Overall Study|Adverse Event|8|||
146290882|NCT00084266|527580470|FG001|Overall Study|Adverse Event|5|||
146290883|NCT00084266|527580469|FG000|Overall Study|Lack of Efficacy|2|||
146290884|NCT00084266|527580470|FG001|Overall Study|Lack of Efficacy|4|||
146290885|NCT00084266|527580469|FG000|Overall Study|Lost to Follow-up|5|||
146290886|NCT00084266|527580470|FG001|Overall Study|Lost to Follow-up|3|||
146290887|NCT00084266|527580469|FG000|Overall Study|Participant not willing to participate|3|||
146290888|NCT00084266|527580470|FG001|Overall Study|Participant not willing to participate|8|||
146290889|NCT00084266|527580469|FG000|Overall Study|Other|360|||
146290890|NCT00084266|527580470|FG001|Overall Study|Other|344|||
146290891|NCT00084266|527580469|FG000|Overall Study|Randomized not treated|21|||
146290892|NCT00084266|527580470|FG001|Overall Study|Randomized not treated|20|||
146290893|NCT00063154|527580475|FG000|Overall Study|Disease progression|27|||
146290894|NCT00063154|527580475|FG000|Overall Study|Adverse Event|2|||
146290895|NCT00063154|527580475|FG000|Overall Study|Physician Decision|10|||
146290896|NCT00063154|527580475|FG000|Overall Study|Death|3|||
146290897|NCT00063154|527580475|FG000|Overall Study|Reason unspecified|1|||
146290898|NCT00063154|527580475|FG000|Overall Study|Did not receive treatment|8|||
146290899|NCT01122862|527580476|FG000|Period 1|Protocol Violation|0|||
146290900|NCT01122862|527580477|FG001|Period 1|Protocol Violation|1|||
145887210|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
145887211|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
145887212|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
145887213|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
145887214|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
145887215|NCT01435928|526090357|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
145887216|NCT01435928|526090358|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
145887217|NCT01435928|526090359|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
145887218|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
145887219|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
145887220|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
145887221|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
145887222|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
145887223|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
145887224|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
145887225|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
145887226|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
145887227|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
145887228|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
145887229|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
145887230|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
145887231|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
145887232|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
145887233|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
145887234|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
145887235|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
145887236|NCT01435928|526090357|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
145887237|NCT01435928|526090358|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
145887238|NCT01435928|526090359|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
145887239|NCT03234608|526090361|FG000|Overall Study|Lost to Follow-up|23|||
145887240|NCT03234608|526090362|FG001|Overall Study|Lost to Follow-up|21|||
145887241|NCT02105701|526090363|FG000|Overall Study|Lost to Follow-up|1|||
145887242|NCT02105701|526090364|FG001|Overall Study|Lost to Follow-up|0|||
146290901|NCT01122862|527580478|FG002|Period 1|Protocol Violation|0|||
146290902|NCT01122862|527580476|FG000|Period 2|Adverse Event|0|||
146290903|NCT01122862|527580477|FG001|Period 2|Adverse Event|0|||
146290904|NCT01122862|527580478|FG002|Period 2|Adverse Event|1|||
146290905|NCT00846391|527580479|FG000|Overall Study|Physician Decision|0|||
145964310|NCT02322749|526382191|FG004|Period 2|Adverse Event|0|||
145964311|NCT02322749|526382192|FG005|Period 2|Adverse Event|0|||
145964312|NCT02322749|526382187|FG000|Period 2|Withdrawal by Subject|0|||
145964313|NCT02322749|526382188|FG001|Period 2|Withdrawal by Subject|0|||
145964314|NCT02322749|526382189|FG002|Period 2|Withdrawal by Subject|0|||
145964315|NCT02322749|526382190|FG003|Period 2|Withdrawal by Subject|1|||
145964316|NCT02322749|526382191|FG004|Period 2|Withdrawal by Subject|0|||
145964317|NCT02322749|526382192|FG005|Period 2|Withdrawal by Subject|0|||
145964318|NCT02322749|526382187|FG000|Period 3|Withdrawal by Subject|0|||
146232268|NCT03774472|527368972|FG001|Overall Study|Progression prior to 4 weeks|1|||
146232269|NCT03774472|527368973|FG002|Overall Study|Progression prior to 4 weeks|0|||
146232270|NCT03774472|527368971|FG000|Overall Study|Withdrawal by Subject|0|||
146232271|NCT03774472|527368972|FG001|Overall Study|Withdrawal by Subject|1|||
146232272|NCT03774472|527368973|FG002|Overall Study|Withdrawal by Subject|0|||
146232273|NCT05039021|527369475|FG000|Overall Study|Death|1|||
146232274|NCT05039021|527369475|FG000|Overall Study|Lost to Follow-up|3|||
146232275|NCT02566889|527369478|FG000|Overall Study|Withdrawal by Subject|3|||
146232276|NCT02566889|527369479|FG001|Overall Study|Withdrawal by Subject|1|||
146232277|NCT02566889|527369478|FG000|Overall Study|Adverse Event|4|||
146232278|NCT02566889|527369479|FG001|Overall Study|Adverse Event|2|||
146232279|NCT02566889|527369478|FG000|Overall Study|Other|6|||
146232280|NCT02566889|527369479|FG001|Overall Study|Other|2|||
146232281|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Other|0|||
146232282|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Other|2|||
146232283|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Other|1|||
146232284|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Other|2|||
145964319|NCT02322749|526382188|FG001|Period 3|Withdrawal by Subject|0|||
145964320|NCT02322749|526382189|FG002|Period 3|Withdrawal by Subject|1|||
145887243|NCT02105701|526090365|FG002|Overall Study|Lost to Follow-up|2|||
145887244|NCT02105701|526090366|FG003|Overall Study|Lost to Follow-up|1|||
145887245|NCT02105701|526090363|FG000|Overall Study|Protocol Violation|0|||
145887246|NCT02105701|526090364|FG001|Overall Study|Protocol Violation|0|||
145887247|NCT02105701|526090365|FG002|Overall Study|Protocol Violation|1|||
145887248|NCT02105701|526090366|FG003|Overall Study|Protocol Violation|0|||
145887249|NCT02105701|526090363|FG000|Overall Study|Withdrawal by Subject|2|||
145887250|NCT02105701|526090364|FG001|Overall Study|Withdrawal by Subject|1|||
145887251|NCT02105701|526090365|FG002|Overall Study|Withdrawal by Subject|0|||
145887252|NCT02105701|526090366|FG003|Overall Study|Withdrawal by Subject|1|||
145887253|NCT02105701|526090363|FG000|Overall Study|Death|1|||
145887254|NCT02105701|526090364|FG001|Overall Study|Death|0|||
145887255|NCT02105701|526090365|FG002|Overall Study|Death|0|||
145887256|NCT02105701|526090366|FG003|Overall Study|Death|0|||
145887257|NCT01362296|526090367|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
145887258|NCT01362296|526090368|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
145887259|NCT01362296|526090369|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
145887260|NCT01362296|526090370|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
145887261|NCT01362296|526090367|FG000|Randomized Phase (RP)|Physician Decision|1|||
145887262|NCT01362296|526090368|FG001|Randomized Phase (RP)|Physician Decision|9|||
145887263|NCT01362296|526090369|FG002|Randomized Phase (RP)|Physician Decision|0|||
145887264|NCT01362296|526090370|FG003|Randomized Phase (RP)|Physician Decision|0|||
145887265|NCT01362296|526090367|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
145887266|NCT01362296|526090368|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
145887267|NCT01362296|526090369|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
145887268|NCT01362296|526090370|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
145887269|NCT01362296|526090367|FG000|Randomized Phase (RP)|Adverse Event|20|||
145887270|NCT01362296|526090368|FG001|Randomized Phase (RP)|Adverse Event|4|||
145964321|NCT02322749|526382190|FG003|Period 3|Withdrawal by Subject|0|||
145964322|NCT02322749|526382191|FG004|Period 3|Withdrawal by Subject|0|||
146232285|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Other|2|||
145964323|NCT02322749|526382192|FG005|Period 3|Withdrawal by Subject|0|||
145964324|NCT00073918|526382193|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
145964325|NCT00073918|526382193|FG000|Overall Study|Rapid disease progression|2|||
145964326|NCT00073918|526382193|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
145964327|NCT01190813|526382194|FG000|Overall Study|Lost to Follow-up|1|||
145964328|NCT01190813|526382195|FG001|Overall Study|Lost to Follow-up|2|||
145964329|NCT01190813|526382194|FG000|Overall Study|Withdrawal by Subject|2|||
145964330|NCT01190813|526382195|FG001|Overall Study|Withdrawal by Subject|1|||
145964331|NCT01190813|526382194|FG000|Overall Study|Refused study treatment after randomized|1|||
145964332|NCT01190813|526382195|FG001|Overall Study|Refused study treatment after randomized|0|||
145964333|NCT01190813|526382194|FG000|Overall Study|Adverse Event|0|||
145964334|NCT01190813|526382195|FG001|Overall Study|Adverse Event|1|||
145964335|NCT04821830|526382198|FG000|Overall Study|Withdrawal by Subject|1|||
145964336|NCT04821830|526382199|FG001|Overall Study|Withdrawal by Subject|0|||
145964337|NCT00557466|526383305|FG000|Overall Study|Adverse Event|3|||
145964338|NCT00557466|526383306|FG001|Overall Study|Adverse Event|1|||
145964339|NCT00557466|526383307|FG002|Overall Study|Adverse Event|4|||
145964340|NCT00557466|526383308|FG003|Overall Study|Adverse Event|1|||
145964341|NCT00557466|526383309|FG004|Overall Study|Adverse Event|2|||
145964342|NCT00557466|526383310|FG005|Overall Study|Adverse Event|4|||
145964343|NCT00557466|526383305|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145964344|NCT00557466|526383306|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145964345|NCT00557466|526383307|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145964346|NCT00557466|526383308|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145964347|NCT00557466|526383309|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145964348|NCT00557466|526383310|FG005|Overall Study|Abnormal laboratory value(s)|0|||
145964349|NCT00557466|526383305|FG000|Overall Study|Protocol deviation|0|||
145964350|NCT00557466|526383306|FG001|Overall Study|Protocol deviation|1|||
145964351|NCT00557466|526383307|FG002|Overall Study|Protocol deviation|0|||
145964352|NCT00557466|526383308|FG003|Overall Study|Protocol deviation|2|||
145964353|NCT00557466|526383309|FG004|Overall Study|Protocol deviation|0|||
145964354|NCT00557466|526383310|FG005|Overall Study|Protocol deviation|0|||
145964355|NCT00557466|526383305|FG000|Overall Study|Subject withdrew consent|0|||
145964356|NCT00557466|526383306|FG001|Overall Study|Subject withdrew consent|0|||
145964357|NCT00557466|526383307|FG002|Overall Study|Subject withdrew consent|0|||
145964358|NCT00557466|526383308|FG003|Overall Study|Subject withdrew consent|0|||
145964359|NCT00557466|526383309|FG004|Overall Study|Subject withdrew consent|1|||
145964360|NCT00557466|526383310|FG005|Overall Study|Subject withdrew consent|2|||
145964361|NCT00557466|526383305|FG000|Overall Study|Administrative problems|0|||
145964362|NCT00557466|526383306|FG001|Overall Study|Administrative problems|1|||
145964363|NCT00557466|526383307|FG002|Overall Study|Administrative problems|1|||
145964364|NCT00557466|526383308|FG003|Overall Study|Administrative problems|0|||
145964365|NCT00557466|526383309|FG004|Overall Study|Administrative problems|0|||
145964366|NCT00557466|526383310|FG005|Overall Study|Administrative problems|0|||
145964367|NCT00557466|526383305|FG000|Overall Study|Abnormal test procedure results|0|||
145964368|NCT00557466|526383306|FG001|Overall Study|Abnormal test procedure results|0|||
145964369|NCT00557466|526383307|FG002|Overall Study|Abnormal test procedure results|1|||
145964370|NCT00557466|526383308|FG003|Overall Study|Abnormal test procedure results|0|||
145964371|NCT00557466|526383309|FG004|Overall Study|Abnormal test procedure results|0|||
146086645|NCT01077154|526837988|FG000|Overall Study|Death|215|||
146086646|NCT01077154|526837989|FG001|Overall Study|Death|214|||
145964372|NCT00557466|526383310|FG005|Overall Study|Abnormal test procedure results|0|||
145964373|NCT00557466|526383305|FG000|Overall Study|Lost to Follow-up|0|||
145964374|NCT00557466|526383306|FG001|Overall Study|Lost to Follow-up|0|||
145964375|NCT00557466|526383307|FG002|Overall Study|Lost to Follow-up|0|||
145964376|NCT00557466|526383308|FG003|Overall Study|Lost to Follow-up|1|||
146232286|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Other|0|||
146232287|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Other|0|||
145964377|NCT00557466|526383309|FG004|Overall Study|Lost to Follow-up|0|||
145964378|NCT00557466|526383310|FG005|Overall Study|Lost to Follow-up|0|||
145964379|NCT02308046|526383313|FG000|Overall Study|Negative yeast culture at Baseline|32|||
145964380|NCT02308046|526383314|FG001|Overall Study|Negative yeast culture at Baseline|33|||
145964381|NCT02308046|526383313|FG000|Overall Study|Positive for STD at Baseline|1|||
145964382|NCT02308046|526383314|FG001|Overall Study|Positive for STD at Baseline|2|||
145964383|NCT02308046|526383313|FG000|Overall Study|Lost to Follow-up|1|||
145964384|NCT02308046|526383314|FG001|Overall Study|Lost to Follow-up|3|||
145964385|NCT01181167|526383317|FG000|Overall Study|Adverse Event|11|||
145964386|NCT01181167|526383318|FG001|Overall Study|Adverse Event|21|||
145964387|NCT01181167|526383317|FG000|Overall Study|Lost to Follow-up|1|||
145964388|NCT01181167|526383318|FG001|Overall Study|Lost to Follow-up|0|||
145964389|NCT01181167|526383317|FG000|Overall Study|Physician Decision|2|||
145964390|NCT01181167|526383318|FG001|Overall Study|Physician Decision|3|||
146232288|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Other|0|||
145964391|NCT01181167|526383317|FG000|Overall Study|Protocol Violation|3|||
146232289|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Other|0|||
146232290|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Other|0|||
146232291|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Other|0|||
145964392|NCT01181167|526383318|FG001|Overall Study|Protocol Violation|0|||
146086647|NCT01077154|526837988|FG000|Overall Study|Lost to Follow-up|43|||
145964393|NCT01181167|526383317|FG000|Overall Study|Withdrawal by Subject|6|||
145964394|NCT01181167|526383318|FG001|Overall Study|Withdrawal by Subject|8|||
145964395|NCT00301834|526383319|FG000|Overall Study|Death|1|||
145964396|NCT02870868|526383320|FG000|Overall Study|Withdrawal by Subject|2|||
145964397|NCT02870868|526383321|FG001|Overall Study|Withdrawal by Subject|1|||
145964398|NCT04040439|526383322|FG000|Overall Study|Invalid registration|11|||
145964399|NCT04040439|526383322|FG000|Overall Study|No IC* on publication of study results|2|||
145964400|NCT01117870|526383327|FG000|Overall Study|Inability to place needle|1|||
145964401|NCT01117870|526383328|FG001|Overall Study|Inability to place needle|0|||
145964402|NCT01309386|526383329|FG000|Overall Study|Other|2|||
145964403|NCT01309386|526383330|FG001|Overall Study|Other|0|||
145964404|NCT01309386|526383329|FG000|Overall Study|Withdrawal by Subject|2|||
145964405|NCT01309386|526383330|FG001|Overall Study|Withdrawal by Subject|0|||
145964406|NCT01309386|526383329|FG000|Overall Study|Progressive disease|9|||
145964407|NCT01309386|526383330|FG001|Overall Study|Progressive disease|11|||
145964408|NCT01309386|526383329|FG000|Overall Study|Physician Decision|1|||
145964409|NCT01309386|526383330|FG001|Overall Study|Physician Decision|1|||
145964410|NCT01309386|526383329|FG000|Overall Study|Lack of Efficacy|3|||
145964411|NCT01309386|526383330|FG001|Overall Study|Lack of Efficacy|1|||
145964412|NCT01309386|526383329|FG000|Overall Study|Adverse Event|5|||
145964413|NCT01309386|526383330|FG001|Overall Study|Adverse Event|8|||
145964414|NCT00723229|526383331|FG000|First Intervention|Lost to Follow-up|7|||
145964415|NCT00723229|526383332|FG001|First Intervention|Lost to Follow-up|3|||
145964416|NCT01674725|526383333|FG000|Overall Study|Adverse Event|1|||
145964417|NCT01674725|526383334|FG001|Overall Study|Adverse Event|0|||
145964418|NCT01674725|526383333|FG000|Overall Study|Did not receive study drug|1|||
145964419|NCT01674725|526383334|FG001|Overall Study|Did not receive study drug|0|||
145964420|NCT01674725|526383333|FG000|Overall Study|Withdrawal by Subject|1|||
145964421|NCT01674725|526383334|FG001|Overall Study|Withdrawal by Subject|0|||
145964422|NCT01674725|526383333|FG000|Overall Study|Lost to Follow-up|0|||
145964423|NCT01674725|526383334|FG001|Overall Study|Lost to Follow-up|1|||
145964424|NCT00960193|526383339|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
145964425|NCT01324102|526383340|FG000|Overall Study|illness|1|||
145964426|NCT01324102|526383341|FG001|Overall Study|illness|6|||
145964427|NCT03238417|526383342|FG000|Overall|non-response|955|||
145964428|NCT03238417|526383343|FG001|Overall|non-response|1920|||
145964429|NCT03238417|526383342|FG000|Overall|partial completion|48|||
145964430|NCT03238417|526383343|FG001|Overall|partial completion|68|||
145964431|NCT03238417|526383342|FG000|Baseline|Partial completion|17|||
145964432|NCT03238417|526383343|FG001|Baseline|Partial completion|48|||
145964433|NCT03238417|526383342|FG000|Baseline|non-response|372|||
145964434|NCT03238417|526383343|FG001|Baseline|non-response|669|||
145964435|NCT03238417|526383342|FG000|12-month|non-response|296|||
145964436|NCT03238417|526383343|FG001|12-month|non-response|669|||
145964437|NCT03238417|526383342|FG000|12-month|partial completion|23|||
145964438|NCT03238417|526383343|FG001|12-month|partial completion|37|||
145964439|NCT03238417|526383342|FG000|24-month|non-response|287|||
145964440|NCT03238417|526383343|FG001|24-month|non-response|594|||
145964441|NCT03238417|526383342|FG000|24-month|partial completion|8|||
145964442|NCT03238417|526383343|FG001|24-month|partial completion|31|||
145964443|NCT01249131|526383344|FG000|Washout Period of 10 Days|Adverse Event|0|||
145964444|NCT01249131|526383345|FG001|Washout Period of 10 Days|Adverse Event|0|||
145964445|NCT01249131|526383346|FG002|Washout Period of 10 Days|Adverse Event|0|||
145964446|NCT01249131|526383347|FG003|Washout Period of 10 Days|Adverse Event|0|||
145964447|NCT01249131|526383348|FG004|Washout Period of 10 Days|Adverse Event|1|||
145964448|NCT01249131|526383349|FG005|Washout Period of 10 Days|Adverse Event|0|||
145964449|NCT00719901|526383350|FG000|Overall Study|Adverse Event|5|||
145964450|NCT00719901|526383350|FG000|Overall Study|Withdrawal by Subject|1|||
145964451|NCT00719901|526383350|FG000|Overall Study|Alternate Treatment|1|||
145964452|NCT00719901|526383350|FG000|Overall Study|Disease Progression|3|||
145964453|NCT00719901|526383350|FG000|Overall Study|Availability of Study Drug|1|||
145964454|NCT00192114|526383351|FG000|Overall Study|Objective Tumor Progression|19|||
145964455|NCT00192114|526383351|FG000|Overall Study|Adverse Event|2|||
145964456|NCT00192114|526383351|FG000|Overall Study|Clinical Progression|2|||
145964457|NCT00192114|526383351|FG000|Overall Study|Death|1|||
145964458|NCT02643693|526383352|FG000|Overall Study|Physician Decision|0|||
145964459|NCT02643693|526383353|FG001|Overall Study|Physician Decision|1|||
145964460|NCT02643693|526383354|FG002|Overall Study|Physician Decision|0|||
145964461|NCT02643693|526383355|FG003|Overall Study|Physician Decision|0|||
145964462|NCT02643693|526383356|FG004|Overall Study|Physician Decision|0|||
145964463|NCT02643693|526383357|FG005|Overall Study|Physician Decision|0|||
145964464|NCT02643693|526383352|FG000|Overall Study|Withdrawal by Subject|0|||
145964465|NCT02643693|526383353|FG001|Overall Study|Withdrawal by Subject|1|||
145964466|NCT02643693|526383354|FG002|Overall Study|Withdrawal by Subject|0|||
145964467|NCT02643693|526383355|FG003|Overall Study|Withdrawal by Subject|0|||
145964468|NCT02643693|526383356|FG004|Overall Study|Withdrawal by Subject|0|||
145964469|NCT02643693|526383357|FG005|Overall Study|Withdrawal by Subject|0|||
145964470|NCT02643693|526383352|FG000|Overall Study|Protocol Adherence Issues|2|||
145964471|NCT02643693|526383353|FG001|Overall Study|Protocol Adherence Issues|0|||
145964472|NCT02643693|526383354|FG002|Overall Study|Protocol Adherence Issues|1|||
145964473|NCT02643693|526383355|FG003|Overall Study|Protocol Adherence Issues|0|||
145964474|NCT02643693|526383356|FG004|Overall Study|Protocol Adherence Issues|0|||
145964475|NCT02643693|526383357|FG005|Overall Study|Protocol Adherence Issues|1|||
145964476|NCT00492297|526383358|FG000|Treatment|Death|2|||
145964477|NCT00492297|526383358|FG000|Treatment|Study terminated by sponsor|3|||
145964478|NCT00492297|526383358|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
145964479|NCT00492297|526383358|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
145964480|NCT00492297|526383358|FG000|Survival Only Follow-up|Death|46|||
145964481|NCT00492297|526383358|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
145964482|NCT00492297|526383358|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
145964483|NCT00113607|526383359|FG000|Overall Study|Adverse Event|40|||
145964484|NCT00113607|526383360|FG001|Overall Study|Adverse Event|71|||
145964485|NCT00113607|526383359|FG000|Overall Study|Death|8|||
145964486|NCT00113607|526383360|FG001|Overall Study|Death|8|||
145964487|NCT00113607|526383359|FG000|Overall Study|Withdrawal by Subject|50|||
145964488|NCT00113607|526383360|FG001|Overall Study|Withdrawal by Subject|58|||
145964489|NCT00113607|526383359|FG000|Overall Study|Lost to Follow-up|0|||
145964490|NCT00113607|526383360|FG001|Overall Study|Lost to Follow-up|2|||
145964491|NCT00113607|526383359|FG000|Overall Study|Disease Progression|180|||
145964492|NCT00113607|526383360|FG001|Overall Study|Disease Progression|142|||
145964493|NCT00113607|526383359|FG000|Overall Study|Complete Response (Confirmed)|14|||
145964494|NCT00113607|526383360|FG001|Overall Study|Complete Response (Confirmed)|24|||
145964495|NCT00113607|526383359|FG000|Overall Study|Other|43|||
145964496|NCT00113607|526383360|FG001|Overall Study|Other|32|||
145964497|NCT00749398|526383362|FG000|Overall Study|Lack of Efficacy|7|||
145964498|NCT00749398|526383362|FG000|Overall Study|Adverse Event|4|||
145964499|NCT00749398|526383362|FG000|Overall Study|Serious adverse event|11|||
145964500|NCT00749398|526383362|FG000|Overall Study|Withdrawal by Subject|17|||
145964501|NCT00749398|526383362|FG000|Overall Study|Lost to Follow-up|11|||
145964502|NCT00749398|526383362|FG000|Overall Study|Reason not specified|2|||
145964503|NCT00749398|526383362|FG000|Overall Study|Unknown reason|1|||
145964504|NCT05002972|526383368|FG000|Overall Study|Withdrawal by Subject|2|||
145964505|NCT01664091|526383369|FG000|Overall Study|Death|1|||
145964506|NCT01664091|526383369|FG000|Overall Study|Disease Progression|2|||
145964507|NCT01664091|526383369|FG000|Overall Study|Lost to Follow-up|2|||
145964508|NCT01664091|526383369|FG000|Overall Study|Withdrawal by Subject|1|||
145964509|NCT01172873|526383372|FG000|Overall Study|Withdrawal by Subject|3|||
145964510|NCT01172873|526383373|FG001|Overall Study|Withdrawal by Subject|2|||
145964511|NCT04613518|526383376|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
145964512|NCT04613518|526383377|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
145964513|NCT04613518|526383378|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
145964514|NCT04613518|526383376|FG000|Double-Blind Treatment Period|Adverse Event|2|||
145964515|NCT04613518|526383377|FG001|Double-Blind Treatment Period|Adverse Event|0|||
145964516|NCT04613518|526383378|FG002|Double-Blind Treatment Period|Adverse Event|1|||
145964517|NCT04613518|526383376|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
145964518|NCT04613518|526383377|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
145964519|NCT04613518|526383378|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
145964520|NCT04613518|526383376|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
145964521|NCT04613518|526383377|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
145964522|NCT04613518|526383378|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
145964523|NCT04613518|526383376|FG000|Double-Blind Treatment Period|Other Reasons|2|||
145964524|NCT04613518|526383377|FG001|Double-Blind Treatment Period|Other Reasons|0|||
146086648|NCT01077154|526837989|FG001|Overall Study|Lost to Follow-up|35|||
145964525|NCT04613518|526383378|FG002|Double-Blind Treatment Period|Other Reasons|0|||
145964526|NCT04613518|526383376|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
145964527|NCT04613518|526383377|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
145964528|NCT04613518|526383378|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
145964529|NCT04613518|526383376|FG000|Open-Label Treatment Period|Adverse Event|1|||
145964530|NCT04613518|526383377|FG001|Open-Label Treatment Period|Adverse Event|0|||
145887271|NCT01362296|526090369|FG002|Randomized Phase (RP)|Adverse Event|0|||
145887272|NCT01362296|526090370|FG003|Randomized Phase (RP)|Adverse Event|0|||
145887273|NCT01362296|526090367|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
145887274|NCT01362296|526090368|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
145887275|NCT01362296|526090369|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
145887276|NCT01362296|526090370|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
145887277|NCT01362296|526090367|FG000|Crossover Phase|PD including Death due to PD|0|||
145887278|NCT01362296|526090368|FG001|Crossover Phase|PD including Death due to PD|0|||
145887279|NCT01362296|526090369|FG002|Crossover Phase|PD including Death due to PD|16|||
145887280|NCT01362296|526090370|FG003|Crossover Phase|PD including Death due to PD|1|||
145887281|NCT01362296|526090367|FG000|Crossover Phase|Withdrawal by Subject|0|||
145887282|NCT01362296|526090368|FG001|Crossover Phase|Withdrawal by Subject|0|||
145887283|NCT01362296|526090369|FG002|Crossover Phase|Withdrawal by Subject|2|||
145887284|NCT01362296|526090370|FG003|Crossover Phase|Withdrawal by Subject|1|||
145887285|NCT01362296|526090367|FG000|Crossover Phase|Adverse Event|0|||
145887286|NCT01362296|526090368|FG001|Crossover Phase|Adverse Event|0|||
145887287|NCT01362296|526090369|FG002|Crossover Phase|Adverse Event|4|||
145887288|NCT01362296|526090370|FG003|Crossover Phase|Adverse Event|0|||
145887289|NCT01362296|526090367|FG000|Crossover Phase|Study Closed/Terminated|0|||
145887290|NCT01362296|526090368|FG001|Crossover Phase|Study Closed/Terminated|0|||
145887291|NCT01362296|526090369|FG002|Crossover Phase|Study Closed/Terminated|1|||
145887292|NCT01362296|526090370|FG003|Crossover Phase|Study Closed/Terminated|0|||
145887293|NCT03693950|526090371|FG000|Overall Study|Withdrawal by Subject|1|||
145887294|NCT03693950|526090372|FG001|Overall Study|Withdrawal by Subject|0|||
145887295|NCT00576303|526090373|FG000|Dose Titration Period|Early withdrawal|17|||
145887296|NCT00576303|526090373|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
145887297|NCT00576303|526090373|FG000|Long Term Safety Period|Early withdrawal|16|||
145887298|NCT00824369|526090374|FG000|Overall Study|Nolonger willing to participate in study|1|||
145887299|NCT00824369|526090375|FG001|Overall Study|Nolonger willing to participate in study|0|||
145887300|NCT00824369|526090376|FG002|Overall Study|Nolonger willing to participate in study|1|||
145887301|NCT00824369|526090377|FG003|Overall Study|Nolonger willing to participate in study|2|||
145887302|NCT00824369|526090378|FG004|Overall Study|Nolonger willing to participate in study|0|||
145887303|NCT00824369|526090379|FG005|Overall Study|Nolonger willing to participate in study|1|||
145887304|NCT00824369|526090374|FG000|Overall Study|Lost to Follow-up|0|||
145887305|NCT00824369|526090375|FG001|Overall Study|Lost to Follow-up|0|||
145887306|NCT00824369|526090376|FG002|Overall Study|Lost to Follow-up|0|||
145887307|NCT00824369|526090377|FG003|Overall Study|Lost to Follow-up|0|||
145887308|NCT00824369|526090378|FG004|Overall Study|Lost to Follow-up|1|||
145887309|NCT00824369|526090379|FG005|Overall Study|Lost to Follow-up|0|||
145887310|NCT00442546|526090380|FG000|Overall Study|Adverse Event|11|||
145887311|NCT00442546|526090381|FG001|Overall Study|Adverse Event|17|||
145887312|NCT00442546|526090382|FG002|Overall Study|Adverse Event|13|||
145887313|NCT00442546|526090380|FG000|Overall Study|Lost to Follow-up|1|||
145887314|NCT00442546|526090381|FG001|Overall Study|Lost to Follow-up|2|||
145887315|NCT00442546|526090382|FG002|Overall Study|Lost to Follow-up|1|||
145887316|NCT00442546|526090380|FG000|Overall Study|Other|4|||
145887317|NCT00442546|526090381|FG001|Overall Study|Other|9|||
145887318|NCT00442546|526090382|FG002|Overall Study|Other|6|||
145887319|NCT00442546|526090380|FG000|Overall Study|Withdrawal by Subject|5|||
145887320|NCT00442546|526090381|FG001|Overall Study|Withdrawal by Subject|5|||
145887321|NCT00442546|526090382|FG002|Overall Study|Withdrawal by Subject|7|||
145887322|NCT00442546|526090380|FG000|Overall Study|Randomized But Not Treated|5|||
145887323|NCT00442546|526090381|FG001|Overall Study|Randomized But Not Treated|4|||
145887324|NCT00442546|526090382|FG002|Overall Study|Randomized But Not Treated|6|||
145887325|NCT00248170|526090383|FG000|Overall Study|Withdrawal by Subject|71|||
145887326|NCT00248170|526090384|FG001|Overall Study|Withdrawal by Subject|79|||
145887327|NCT00248170|526090383|FG000|Overall Study|Protocol Violation|35|||
145887328|NCT00248170|526090384|FG001|Overall Study|Protocol Violation|30|||
145887329|NCT00248170|526090383|FG000|Overall Study|Lost to Follow-up|28|||
145887330|NCT00248170|526090384|FG001|Overall Study|Lost to Follow-up|35|||
145964531|NCT04613518|526383378|FG002|Open-Label Treatment Period|Adverse Event|3|||
145964532|NCT04613518|526383376|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
145964533|NCT04613518|526383377|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
145964534|NCT04613518|526383378|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
145964535|NCT04613518|526383376|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
145964536|NCT04613518|526383377|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
145964537|NCT04613518|526383378|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
145964538|NCT04613518|526383376|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
145964539|NCT04613518|526383377|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
145964540|NCT04613518|526383378|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
145964541|NCT04613518|526383376|FG000|Open-Label Treatment Period|Other reasons|1|||
145964542|NCT04613518|526383377|FG001|Open-Label Treatment Period|Other reasons|0|||
145964543|NCT04613518|526383378|FG002|Open-Label Treatment Period|Other reasons|0|||
145964544|NCT01076543|526383380|FG000|Overall Study|Withdrawal by Subject|2|||
145964545|NCT01076543|526383381|FG001|Overall Study|Withdrawal by Subject|0|||
145964546|NCT01076543|526383382|FG002|Overall Study|Withdrawal by Subject|0|||
145964547|NCT01076543|526383383|FG003|Overall Study|Withdrawal by Subject|0|||
145964548|NCT01076543|526383384|FG004|Overall Study|Withdrawal by Subject|0|||
145964549|NCT01076543|526383385|FG005|Overall Study|Withdrawal by Subject|0|||
145964550|NCT01077323|526383386|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
145964551|NCT01077323|526383387|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
145964552|NCT01077323|526383388|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
145964553|NCT01077323|526383386|FG000|Overall Study|Dispensing of drug in baseline period|0|||
145964554|NCT01077323|526383387|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
145964555|NCT01077323|526383388|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
145964556|NCT01077323|526383386|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
145964557|NCT01077323|526383387|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
145964558|NCT01077323|526383388|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
145964559|NCT02144701|526383389|FG000|Overall Study|development of relapse, GVHD or death|9|||
145964560|NCT02144701|526383390|FG001|Overall Study|development of relapse, GVHD or death|3|||
145964561|NCT02616783|526383391|FG000|Overall Study|Randomized but Not Treated|1|||
145964562|NCT02616783|526383392|FG001|Overall Study|Randomized but Not Treated|0|||
145964563|NCT02616783|526383391|FG000|Overall Study|Adverse Event|1|||
145964564|NCT02616783|526383392|FG001|Overall Study|Adverse Event|0|||
145964565|NCT02616783|526383391|FG000|Overall Study|Death|1|||
145964566|NCT02616783|526383392|FG001|Overall Study|Death|0|||
145964567|NCT02616783|526383391|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145964568|NCT02616783|526383392|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145964569|NCT02616783|526383391|FG000|Overall Study|Protocol Violation|1|||
145964570|NCT02616783|526383392|FG001|Overall Study|Protocol Violation|1|||
145964571|NCT02616783|526383391|FG000|Overall Study|Withdrew Consent|1|||
145964572|NCT02616783|526383392|FG001|Overall Study|Withdrew Consent|1|||
145964573|NCT01103323|526383393|FG000|Without/Before Drug Switch|Adverse Event|50|||
145964574|NCT01103323|526383394|FG001|Without/Before Drug Switch|Adverse Event|7|||
145964575|NCT01103323|526383393|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
145964576|NCT01103323|526383394|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
145964577|NCT01103323|526383393|FG000|Without/Before Drug Switch|Protocol Violation|2|||
145964578|NCT01103323|526383394|FG001|Without/Before Drug Switch|Protocol Violation|0|||
145964579|NCT01103323|526383393|FG000|Without/Before Drug Switch|Physician Decision|2|||
145964580|NCT01103323|526383394|FG001|Without/Before Drug Switch|Physician Decision|0|||
145964581|NCT01103323|526383393|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
145964582|NCT01103323|526383394|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
145964583|NCT01103323|526383393|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
145964584|NCT01103323|526383394|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
145964585|NCT01103323|526383393|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
145964586|NCT01103323|526383394|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
145964587|NCT00372424|526383395|FG000|Overall Study|Adverse Event|2|||
145964588|NCT00372424|526383395|FG000|Overall Study|Withdrawal by Subject|1|||
145964589|NCT00372424|526383395|FG000|Overall Study|Death|1|||
145964590|NCT00372424|526383395|FG000|Overall Study|Objective Progression or Relapse|14|||
145964591|NCT00372424|526383395|FG000|Overall Study|Other|7|||
145964592|NCT00372424|526383395|FG000|Overall Study|Enrolled, Not Treated|1|||
145964593|NCT03797898|526383404|FG000|Overall Study|Lost to Follow-up|60|||
145964594|NCT03797898|526383405|FG001|Overall Study|Lost to Follow-up|69|||
145964595|NCT03797898|526383404|FG000|Overall Study|Withdrawal by Subject|9|||
145964596|NCT03797898|526383405|FG001|Overall Study|Withdrawal by Subject|7|||
145964597|NCT03797898|526383404|FG000|Overall Study|Became ineligible|5|||
145964598|NCT03797898|526383405|FG001|Overall Study|Became ineligible|2|||
145964599|NCT02314728|526383406|FG000|Overall Study|Protocol Violation|1|||
145964600|NCT02314728|526383407|FG001|Overall Study|Protocol Violation|0|||
145964601|NCT02314728|526383406|FG000|Overall Study|Lost to Follow-up|0|||
145964602|NCT02314728|526383407|FG001|Overall Study|Lost to Follow-up|1|||
145887331|NCT00248170|526090383|FG000|Overall Study|Disease progression|196|||
145887332|NCT00248170|526090384|FG001|Overall Study|Disease progression|216|||
145887333|NCT00248170|526090383|FG000|Overall Study|Death|28|||
145887334|NCT00248170|526090384|FG001|Overall Study|Death|47|||
145887335|NCT00248170|526090383|FG000|Overall Study|Adverse Event|311|||
145887336|NCT00248170|526090384|FG001|Overall Study|Adverse Event|296|||
145887337|NCT00248170|526090383|FG000|Overall Study|Administrative problems|22|||
146086649|NCT01077154|526837988|FG000|Overall Study|Noncompliance|22|||
145887338|NCT00248170|526090384|FG001|Overall Study|Administrative problems|25|||
145887339|NCT00248170|526090383|FG000|Overall Study|Abnormal test procedure(s) result|49|||
145964603|NCT01614470|526383408|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
145964604|NCT01614470|526383409|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145964605|NCT01614470|526383410|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145964606|NCT01614470|526383408|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
145964607|NCT01614470|526383409|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
145964608|NCT01614470|526383410|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
145964609|NCT00086190|526383411|FG000|Overall Study|Adverse Event|6|||
145964610|NCT00086190|526383412|FG001|Overall Study|Adverse Event|2|||
145964611|NCT00086190|526383413|FG002|Overall Study|Adverse Event|2|||
145964612|NCT00086190|526383411|FG000|Overall Study|Withdrawal by Subject|0|||
145964613|NCT00086190|526383412|FG001|Overall Study|Withdrawal by Subject|2|||
145964614|NCT00086190|526383413|FG002|Overall Study|Withdrawal by Subject|2|||
145964615|NCT00086190|526383411|FG000|Overall Study|Protocol Violation|1|||
145964616|NCT00086190|526383412|FG001|Overall Study|Protocol Violation|0|||
145964617|NCT00086190|526383413|FG002|Overall Study|Protocol Violation|0|||
145964618|NCT00086190|526383411|FG000|Overall Study|Moved|1|||
145964619|NCT00086190|526383412|FG001|Overall Study|Moved|0|||
145964620|NCT00086190|526383413|FG002|Overall Study|Moved|0|||
145964621|NCT00086190|526383411|FG000|Overall Study|Worsening depression|0|||
145964622|NCT00086190|526383412|FG001|Overall Study|Worsening depression|0|||
145964623|NCT00086190|526383413|FG002|Overall Study|Worsening depression|2|||
145964624|NCT00249834|526383414|FG000|Overall Study|Ovarian stimulation failed|1|||
145964625|NCT00249834|526383415|FG001|Overall Study|Ovarian stimulation failed|0|||
145964626|NCT00249834|526383416|FG002|Overall Study|Ovarian stimulation failed|0|||
145964627|NCT00249834|526383417|FG003|Overall Study|Ovarian stimulation failed|0|||
145964628|NCT00249834|526383418|FG004|Overall Study|Ovarian stimulation failed|0|||
145964629|NCT00249834|526383419|FG005|Overall Study|Ovarian stimulation failed|0|||
145964630|NCT00249834|526383420|FG006|Overall Study|Ovarian stimulation failed|0|||
145964631|NCT00249834|526383421|FG007|Overall Study|Ovarian stimulation failed|0|||
145964632|NCT00249834|526383414|FG000|Overall Study|Failure of down-regulation|0|||
145964633|NCT00249834|526383415|FG001|Overall Study|Failure of down-regulation|0|||
145964634|NCT00249834|526383416|FG002|Overall Study|Failure of down-regulation|0|||
145964635|NCT00249834|526383417|FG003|Overall Study|Failure of down-regulation|0|||
145964636|NCT00249834|526383418|FG004|Overall Study|Failure of down-regulation|0|||
145964637|NCT00249834|526383419|FG005|Overall Study|Failure of down-regulation|0|||
145964638|NCT00249834|526383420|FG006|Overall Study|Failure of down-regulation|1|||
145964639|NCT00249834|526383421|FG007|Overall Study|Failure of down-regulation|0|||
145964640|NCT00249834|526383414|FG000|Overall Study|Protocol Violation|0|||
145964641|NCT00249834|526383415|FG001|Overall Study|Protocol Violation|19|||
145964642|NCT00249834|526383416|FG002|Overall Study|Protocol Violation|14|||
145964643|NCT00249834|526383417|FG003|Overall Study|Protocol Violation|8|||
146290906|NCT00846391|527580480|FG001|Overall Study|Physician Decision|0|||
145964644|NCT00249834|526383418|FG004|Overall Study|Protocol Violation|5|||
145964645|NCT00249834|526383419|FG005|Overall Study|Protocol Violation|2|||
145964646|NCT00249834|526383420|FG006|Overall Study|Protocol Violation|0|||
145964647|NCT00249834|526383421|FG007|Overall Study|Protocol Violation|0|||
145964648|NCT03902613|526383423|FG000|Overall Study|Physician Decision|1|||
145964649|NCT00069264|526383428|FG000|Overall Study|Adverse Event|3|||
145964650|NCT00069264|526383428|FG000|Overall Study|Progressive Disease|23|||
145964651|NCT00069264|526383428|FG000|Overall Study|Withdrawal by Subject|3|||
145964652|NCT00069264|526383428|FG000|Overall Study|Discon Therapy|3|||
145964653|NCT01526785|526383429|FG000|Overall Study|Study Terminated by Sponsor|8|||
145964654|NCT01526785|526383429|FG000|Overall Study|Death|2|||
145964655|NCT01526785|526383429|FG000|Overall Study|Physician Decision|1|||
145964656|NCT01526785|526383429|FG000|Overall Study|Withdrawal by Subject|2|||
145964657|NCT04265261|526383433|FG000|Overall Study|Adverse Event|2|||
145964658|NCT04265261|526383434|FG001|Overall Study|Adverse Event|0|||
145964659|NCT04265261|526383435|FG002|Overall Study|Adverse Event|0|||
145964660|NCT04265261|526383433|FG000|Overall Study|Death|1|||
145964661|NCT04265261|526383434|FG001|Overall Study|Death|0|||
145964662|NCT04265261|526383435|FG002|Overall Study|Death|0|||
145964663|NCT04265261|526383433|FG000|Overall Study|Lost to Follow-up|4|||
145964664|NCT04265261|526383434|FG001|Overall Study|Lost to Follow-up|1|||
145964665|NCT04265261|526383435|FG002|Overall Study|Lost to Follow-up|3|||
145964666|NCT04265261|526383433|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145964667|NCT04265261|526383434|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145964668|NCT04265261|526383435|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145964669|NCT04265261|526383433|FG000|Overall Study|Physician Decision|0|||
145964670|NCT04265261|526383434|FG001|Overall Study|Physician Decision|0|||
145964671|NCT04265261|526383435|FG002|Overall Study|Physician Decision|1|||
145964672|NCT04265261|526383433|FG000|Overall Study|Protocol Deviation|0|||
145964673|NCT04265261|526383434|FG001|Overall Study|Protocol Deviation|2|||
145964674|NCT04265261|526383435|FG002|Overall Study|Protocol Deviation|0|||
145964675|NCT04265261|526383433|FG000|Overall Study|Withdrawal by Subject|2|||
145964676|NCT04265261|526383434|FG001|Overall Study|Withdrawal by Subject|1|||
145964677|NCT04265261|526383435|FG002|Overall Study|Withdrawal by Subject|4|||
145964678|NCT02990000|526385310|FG000|Overall Study|Failed to provide data beyond baseline|36|||
145964679|NCT02990000|526385311|FG001|Overall Study|Failed to provide data beyond baseline|34|||
145964680|NCT00922636|526385312|FG000|Overall Study|Adverse Event|3|||
145964681|NCT00922636|526385313|FG001|Overall Study|Adverse Event|3|||
145964682|NCT00922636|526385314|FG002|Overall Study|Adverse Event|2|||
145964683|NCT00922636|526385315|FG003|Overall Study|Adverse Event|3|||
145964684|NCT00922636|526385316|FG004|Overall Study|Adverse Event|2|||
145964685|NCT00922636|526385312|FG000|Overall Study|Lack of Efficacy|1|||
145964686|NCT00922636|526385313|FG001|Overall Study|Lack of Efficacy|7|||
145964687|NCT00922636|526385314|FG002|Overall Study|Lack of Efficacy|3|||
145964688|NCT00922636|526385315|FG003|Overall Study|Lack of Efficacy|2|||
145964689|NCT00922636|526385316|FG004|Overall Study|Lack of Efficacy|4|||
145964690|NCT00922636|526385312|FG000|Overall Study|Sponsor Decision|0|||
145964691|NCT00922636|526385313|FG001|Overall Study|Sponsor Decision|0|||
145964692|NCT00922636|526385314|FG002|Overall Study|Sponsor Decision|2|||
145964693|NCT00922636|526385315|FG003|Overall Study|Sponsor Decision|0|||
145964694|NCT00922636|526385316|FG004|Overall Study|Sponsor Decision|0|||
145964695|NCT00922636|526385312|FG000|Overall Study|Withdrawal by Subject|0|||
145964696|NCT00922636|526385313|FG001|Overall Study|Withdrawal by Subject|0|||
145964697|NCT00922636|526385314|FG002|Overall Study|Withdrawal by Subject|5|||
145964698|NCT00922636|526385315|FG003|Overall Study|Withdrawal by Subject|2|||
145964699|NCT00922636|526385316|FG004|Overall Study|Withdrawal by Subject|4|||
145964700|NCT00922636|526385312|FG000|Overall Study|Protocol Violation|0|||
145964701|NCT00922636|526385313|FG001|Overall Study|Protocol Violation|0|||
145964702|NCT00922636|526385314|FG002|Overall Study|Protocol Violation|2|||
145964703|NCT00922636|526385315|FG003|Overall Study|Protocol Violation|2|||
145964704|NCT00922636|526385316|FG004|Overall Study|Protocol Violation|0|||
145964705|NCT00922636|526385312|FG000|Overall Study|Entry Criteria Not Met|0|||
145964706|NCT00922636|526385313|FG001|Overall Study|Entry Criteria Not Met|0|||
145964707|NCT00922636|526385314|FG002|Overall Study|Entry Criteria Not Met|1|||
145964708|NCT00922636|526385315|FG003|Overall Study|Entry Criteria Not Met|1|||
145964709|NCT00922636|526385316|FG004|Overall Study|Entry Criteria Not Met|0|||
145964710|NCT00922636|526385312|FG000|Overall Study|Parent/Caregiver Decision|2|||
145964711|NCT00922636|526385313|FG001|Overall Study|Parent/Caregiver Decision|4|||
145964712|NCT00922636|526385314|FG002|Overall Study|Parent/Caregiver Decision|3|||
145964713|NCT00922636|526385315|FG003|Overall Study|Parent/Caregiver Decision|5|||
145964714|NCT00922636|526385316|FG004|Overall Study|Parent/Caregiver Decision|2|||
145964715|NCT00922636|526385312|FG000|Overall Study|Lost to Follow-up|1|||
145964716|NCT00922636|526385313|FG001|Overall Study|Lost to Follow-up|2|||
145964717|NCT00922636|526385314|FG002|Overall Study|Lost to Follow-up|2|||
145964718|NCT00922636|526385315|FG003|Overall Study|Lost to Follow-up|2|||
145964719|NCT00922636|526385316|FG004|Overall Study|Lost to Follow-up|4|||
145964720|NCT02812186|526385317|FG000|Period 1|Post randomization screen failure|5|||
145964721|NCT02812186|526385318|FG001|Period 1|Post randomization screen failure|9|||
145964722|NCT02812186|526385317|FG000|Period 1|nonevaluable data sets|6|||
145964723|NCT02812186|526385318|FG001|Period 1|nonevaluable data sets|6|||
145964724|NCT00161213|526385319|FG000|Overall Study|Withdrawal by Subject|1|||
145964725|NCT00161213|526385319|FG000|Overall Study|Evaluable for toxicity but not response|1|||
145964726|NCT03103503|526385320|FG000|Overall Study|Death|64|||
145964727|NCT03103503|526385320|FG000|Overall Study|Physician Decision|57|||
145964728|NCT03103503|526385320|FG000|Overall Study|Withdrawal by Subject|10|||
145964729|NCT03103503|526385320|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
145964730|NCT03103503|526385320|FG000|Overall Study|Lost to Follow-up|3|||
145964731|NCT03103503|526385320|FG000|Overall Study|Study Closure|757|||
145964732|NCT03342001|526385324|FG000|Overall Study|Adverse Event|1|||
145964733|NCT03342001|526385324|FG000|Overall Study|Lost to Follow-up|1|||
145964734|NCT01433159|526385326|FG000|Overall Study|Adverse Event|1|||
145964735|NCT01433159|526385327|FG001|Overall Study|Adverse Event|0|||
145964736|NCT01433159|526385326|FG000|Overall Study|Physician Decision|1|||
145964737|NCT01433159|526385327|FG001|Overall Study|Physician Decision|0|||
145964738|NCT01433159|526385326|FG000|Overall Study|Protocol Violation|0|||
145964739|NCT01433159|526385327|FG001|Overall Study|Protocol Violation|1|||
145964740|NCT02579629|526385343|FG000|Overall Study|Withdrawal by Subject|0|||
145964741|NCT02579629|526385344|FG001|Overall Study|Withdrawal by Subject|1|||
145964742|NCT02579629|526385345|FG002|Overall Study|Withdrawal by Subject|0|||
145964743|NCT02579629|526385343|FG000|Overall Study|Screen Failure|2|||
145964744|NCT02579629|526385344|FG001|Overall Study|Screen Failure|0|||
145964745|NCT02579629|526385345|FG002|Overall Study|Screen Failure|2|||
145964746|NCT01930539|526385346|FG000|Overall Study|Withdrawal by Subject|2|||
145964747|NCT01930539|526385347|FG001|Overall Study|Withdrawal by Subject|2|||
145964748|NCT01190891|526385348|FG000|Overall Study|Protocol Violation|1|||
145964749|NCT01190891|526385349|FG001|Overall Study|Protocol Violation|0|||
145964750|NCT01190891|526385348|FG000|Overall Study|Withdrawal by Subject|5|||
145964751|NCT01190891|526385349|FG001|Overall Study|Withdrawal by Subject|0|||
145964752|NCT01926028|526385350|FG000|Overall Study|Lost to Follow-up|7|||
145964753|NCT01926028|526385351|FG001|Overall Study|Lost to Follow-up|6|||
145964754|NCT01926028|526385352|FG002|Overall Study|Lost to Follow-up|0|||
145964755|NCT01926028|526385350|FG000|Overall Study|Physician Decision|1|||
145964756|NCT01926028|526385351|FG001|Overall Study|Physician Decision|5|||
145964757|NCT01926028|526385352|FG002|Overall Study|Physician Decision|0|||
145964758|NCT01926028|526385350|FG000|Overall Study|Withdrawal by Subject|9|||
145964759|NCT01926028|526385351|FG001|Overall Study|Withdrawal by Subject|9|||
145964760|NCT01926028|526385352|FG002|Overall Study|Withdrawal by Subject|2|||
145964761|NCT01926028|526385350|FG000|Overall Study|Non compliance or other reasons|4|||
145964762|NCT01926028|526385351|FG001|Overall Study|Non compliance or other reasons|2|||
145964763|NCT01926028|526385352|FG002|Overall Study|Non compliance or other reasons|0|||
145964764|NCT00737048|526385353|FG000|Overall Study|Physician Decision|0|||
146290907|NCT00846391|527580481|FG002|Overall Study|Physician Decision|1|||
145964765|NCT00737048|526385354|FG001|Overall Study|Physician Decision|0|||
145964766|NCT00737048|526385355|FG002|Overall Study|Physician Decision|1|||
145964767|NCT00737048|526385353|FG000|Overall Study|Adverse Event|0|||
145964768|NCT00737048|526385354|FG001|Overall Study|Adverse Event|1|||
145964769|NCT00737048|526385355|FG002|Overall Study|Adverse Event|0|||
145964770|NCT00737048|526385353|FG000|Overall Study|Worsening of the symptoms|3|||
146290908|NCT00846391|527580479|FG000|Overall Study|Study Terminated by Sponsor|1|||
145964771|NCT00737048|526385354|FG001|Overall Study|Worsening of the symptoms|5|||
145964772|NCT00737048|526385355|FG002|Overall Study|Worsening of the symptoms|3|||
145964773|NCT04635839|526385356|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
146232292|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Other|0|||
146232293|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Other|0|||
146232294|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Other|0|||
146232295|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Other|0|||
146232296|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Other|0|||
146232297|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Other|0|||
145964774|NCT04635839|526385357|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
145964775|NCT02737358|526385358|FG000|Overall Study|Withdrawal by Subject|7|||
145964776|NCT02737358|526385359|FG001|Overall Study|Withdrawal by Subject|12|||
145964777|NCT02737358|526385358|FG000|Overall Study|Lost to Follow-up|2|||
145964778|NCT02737358|526385359|FG001|Overall Study|Lost to Follow-up|3|||
145964779|NCT00744939|526385361|FG000|Overall Study|Withdrawal by Subject|9|||
145964780|NCT00744939|526385361|FG000|Overall Study|Protocol Violation|13|||
145964781|NCT00744939|526385361|FG000|Overall Study|Death|24|||
145964782|NCT00744939|526385361|FG000|Overall Study|distance|4|||
145964783|NCT00744939|526385361|FG000|Overall Study|Lost to Follow-up|12|||
145964784|NCT00744939|526385361|FG000|Overall Study|Medical history exclusionary|1|||
145964785|NCT00744939|526385361|FG000|Overall Study|Did not receive Magnevist|7|||
145964786|NCT00744939|526385361|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
145964787|NCT00744939|526385361|FG000|Overall Study|coma|1|||
145964788|NCT00744939|526385361|FG000|Overall Study|incorrect race|1|||
145964789|NCT01248455|526385364|FG000|Overall Study|switched to alternate treatment|1|||
145964790|NCT00426270|526385365|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
145964791|NCT00426270|526385365|FG000|Overall Study|Adverse Event|5|||
145964792|NCT01587885|526385366|FG000|Treatment Period 1|Failure to Return|0|||
145964793|NCT01587885|526385367|FG001|Treatment Period 1|Failure to Return|1|||
145964794|NCT01587885|526385366|FG000|Treatment Period 1|Protocol Violation|0|||
145964795|NCT01587885|526385367|FG001|Treatment Period 1|Protocol Violation|2|||
145964796|NCT02062437|526385369|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
145964797|NCT02062437|526385369|FG000|Overall Study|Patient not available for the 2y visit|18|||
145964798|NCT02062437|526385369|FG000|Overall Study|Death|2|||
145964799|NCT02062437|526385369|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
145964800|NCT02900352|526385370|FG000|Overall Study|Lost to Follow-up|28|||
145964801|NCT02900352|526385371|FG001|Overall Study|Lost to Follow-up|17|||
145964802|NCT02089347|526385372|FG000|Overall Study|Protocol Violation|1|||
145964803|NCT02089347|526385373|FG001|Overall Study|Protocol Violation|0|||
145964804|NCT00001566|526385374|FG000|Overall Study|patients' choice to discontinue protocol|3|||
145964805|NCT00001566|526385374|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
145964806|NCT00001566|526385374|FG000|Overall Study|Death|13|||
145964807|NCT00001566|526385374|FG000|Overall Study|Lost to Follow-up|1|||
145964808|NCT00001566|526385374|FG000|Overall Study|unable to complete initial apheresis|1|||
145964809|NCT03439137|526385379|FG000|Overall Study|Adverse Event|16|||
145964810|NCT03439137|526385380|FG001|Overall Study|Adverse Event|12|||
145964811|NCT03439137|526385379|FG000|Overall Study|Physician Decision|0|||
145964812|NCT03439137|526385380|FG001|Overall Study|Physician Decision|5|||
145964813|NCT03439137|526385379|FG000|Overall Study|Withdrawal by Subject|14|||
145964814|NCT03439137|526385380|FG001|Overall Study|Withdrawal by Subject|4|||
145964815|NCT03439137|526385379|FG000|Overall Study|Conducting rescue therapy|2|||
145964816|NCT03439137|526385380|FG001|Overall Study|Conducting rescue therapy|1|||
145964817|NCT03439137|526385379|FG000|Overall Study|Difficult to control Hb|10|||
145964818|NCT03439137|526385380|FG001|Overall Study|Difficult to control Hb|2|||
145964819|NCT03439137|526385379|FG000|Overall Study|Initiation of a renal transplant|0|||
145964820|NCT03439137|526385380|FG001|Overall Study|Initiation of a renal transplant|2|||
145964821|NCT01225549|526385385|FG000|Period 4 - Washout|Disallowed medication|0|||
145964822|NCT01225549|526385386|FG001|Period 4 - Washout|Disallowed medication|1|||
145964823|NCT01225549|526385387|FG002|Period 4 - Washout|Disallowed medication|0|||
145964824|NCT01225549|526385388|FG003|Period 4 - Washout|Disallowed medication|0|||
145964825|NCT01225549|526385389|FG004|Period 4 - Washout|Disallowed medication|0|||
145964826|NCT01225549|526385390|FG005|Period 4 - Washout|Disallowed medication|0|||
145964827|NCT01225549|526385391|FG006|Period 4 - Washout|Disallowed medication|0|||
145964828|NCT01225549|526385392|FG007|Period 4 - Washout|Disallowed medication|0|||
145964829|NCT01225549|526385393|FG008|Period 4 - Washout|Disallowed medication|0|||
145964830|NCT01225549|526385394|FG009|Period 4 - Washout|Disallowed medication|0|||
145964831|NCT01225549|526385385|FG000|Period 6 - Washout|Disallowed medication|0|||
145964832|NCT01225549|526385386|FG001|Period 6 - Washout|Disallowed medication|0|||
145964833|NCT01225549|526385387|FG002|Period 6 - Washout|Disallowed medication|0|||
145964834|NCT01225549|526385388|FG003|Period 6 - Washout|Disallowed medication|1|||
145964835|NCT01225549|526385389|FG004|Period 6 - Washout|Disallowed medication|0|||
145964836|NCT01225549|526385390|FG005|Period 6 - Washout|Disallowed medication|0|||
145964837|NCT01225549|526385391|FG006|Period 6 - Washout|Disallowed medication|0|||
145964838|NCT01225549|526385392|FG007|Period 6 - Washout|Disallowed medication|0|||
145964839|NCT01225549|526385393|FG008|Period 6 - Washout|Disallowed medication|0|||
145964840|NCT01225549|526385394|FG009|Period 6 - Washout|Disallowed medication|0|||
145964841|NCT00473083|526385397|FG000|Overall Study|Adverse Event|1|||
145964842|NCT00473083|526385398|FG001|Overall Study|Adverse Event|0|||
145964843|NCT00473083|526385399|FG002|Overall Study|Adverse Event|0|||
146232298|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
145964844|NCT02915835|526385400|FG000|Overall Study|Physician Decision|1|||
145964845|NCT02915835|526385401|FG001|Overall Study|Physician Decision|0|||
145964846|NCT02915835|526385400|FG000|Overall Study|Withdrawal by Subject|0|||
145964847|NCT02915835|526385401|FG001|Overall Study|Withdrawal by Subject|1|||
145964848|NCT01184872|526385402|FG000|Overall Study|Adverse Event|3|||
145964849|NCT01184872|526385403|FG001|Overall Study|Adverse Event|4|||
145964850|NCT01184872|526385402|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145964851|NCT01184872|526385403|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145964852|NCT01184872|526385402|FG000|Overall Study|Withdrawal by Subject|2|||
145964853|NCT01184872|526385403|FG001|Overall Study|Withdrawal by Subject|0|||
145964854|NCT01184872|526385402|FG000|Overall Study|Lost to Follow-up|0|||
145964855|NCT01184872|526385403|FG001|Overall Study|Lost to Follow-up|1|||
145964856|NCT01184872|526385402|FG000|Overall Study|Administrative problems|1|||
145964857|NCT01184872|526385403|FG001|Overall Study|Administrative problems|1|||
145964858|NCT01184872|526385402|FG000|Overall Study|Protocol deviation|1|||
145964859|NCT01184872|526385403|FG001|Overall Study|Protocol deviation|0|||
145964860|NCT03426345|526385404|FG000|Overall Study|Adverse Event|4|||
145964861|NCT03426345|526385405|FG001|Overall Study|Adverse Event|4|||
145964862|NCT03426345|526385404|FG000|Overall Study|Lack of Efficacy|1|||
145964863|NCT03426345|526385405|FG001|Overall Study|Lack of Efficacy|0|||
145964864|NCT03426345|526385404|FG000|Overall Study|Withdrawal by Subject|5|||
145964865|NCT03426345|526385405|FG001|Overall Study|Withdrawal by Subject|6|||
145964866|NCT03426345|526385404|FG000|Overall Study|Lost to Follow-up|3|||
145964867|NCT03426345|526385405|FG001|Overall Study|Lost to Follow-up|1|||
145964868|NCT03426345|526385404|FG000|Overall Study|Protocol Deviation|3|||
145964869|NCT03426345|526385405|FG001|Overall Study|Protocol Deviation|4|||
145964870|NCT03426345|526385404|FG000|Overall Study|Reason Not Specified|1|||
145964871|NCT03426345|526385405|FG001|Overall Study|Reason Not Specified|2|||
145964872|NCT03426345|526385404|FG000|Overall Study|Missing Completion Status|1|||
145964873|NCT03426345|526385405|FG001|Overall Study|Missing Completion Status|0|||
145964874|NCT00433836|526385406|FG000|Overall Study|Adverse Event|7|||
145964875|NCT00433836|526385407|FG001|Overall Study|Adverse Event|0|||
145964876|NCT00433836|526385406|FG000|Overall Study|Lost to Follow-up|3|||
145964877|NCT00433836|526385407|FG001|Overall Study|Lost to Follow-up|0|||
145964878|NCT00433836|526385406|FG000|Overall Study|Withdrawal by Subject|2|||
145964879|NCT00433836|526385407|FG001|Overall Study|Withdrawal by Subject|1|||
145964880|NCT00433836|526385406|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145964881|NCT00433836|526385407|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145964882|NCT00433836|526385406|FG000|Overall Study|Protocol Violation|0|||
145964883|NCT00433836|526385407|FG001|Overall Study|Protocol Violation|2|||
146232299|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
146232300|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
145964884|NCT00433836|526385406|FG000|Overall Study|Condition no longer requires study drug|0|||
145964885|NCT00433836|526385407|FG001|Overall Study|Condition no longer requires study drug|1|||
145964886|NCT00433836|526385406|FG000|Overall Study|Abnormal laboratory values|0|||
145964887|NCT00433836|526385407|FG001|Overall Study|Abnormal laboratory values|1|||
145964888|NCT02446691|526385408|FG000|Overall Study|Withdrawal by Subject|2|||
145964889|NCT02446691|526385408|FG000|Overall Study|Lost to Follow-up|8|||
145964890|NCT02446691|526385408|FG000|Overall Study|Protocol Violation|1|||
145964891|NCT00323063|526385410|FG000|Overall Study|Adverse Event|1|||
145964892|NCT00323063|526385411|FG001|Overall Study|Adverse Event|0|||
145964893|NCT00323063|526385410|FG000|Overall Study|brain mets discovered prior to treatment|1|||
145964894|NCT00323063|526385411|FG001|Overall Study|brain mets discovered prior to treatment|0|||
145964895|NCT04275336|526385412|FG000|Overall Study|First venipuncture failed|4|||
145964896|NCT04275336|526385413|FG001|Overall Study|First venipuncture failed|6|||
145964897|NCT04275336|526385414|FG002|Overall Study|First venipuncture failed|5|||
145964898|NCT04275336|526385412|FG000|Overall Study|Unscheduled venipuncture|9|||
145964899|NCT04275336|526385413|FG001|Overall Study|Unscheduled venipuncture|13|||
145964900|NCT04275336|526385414|FG002|Overall Study|Unscheduled venipuncture|7|||
145964901|NCT04275336|526385412|FG000|Overall Study|Failed specimen of saliva|4|||
145964902|NCT04275336|526385413|FG001|Overall Study|Failed specimen of saliva|3|||
145964903|NCT04275336|526385414|FG002|Overall Study|Failed specimen of saliva|4|||
145964904|NCT03055936|526385415|FG000|Overall Study|Adverse Event|0|||
145964905|NCT03055936|526385416|FG001|Overall Study|Adverse Event|1|||
145964906|NCT03055936|526385417|FG002|Overall Study|Adverse Event|1|||
146232301|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
146232302|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
145964907|NCT03055936|526385418|FG003|Overall Study|Adverse Event|1|||
145964908|NCT03055936|526385415|FG000|Overall Study|Personal reason|2|||
145964909|NCT03055936|526385416|FG001|Overall Study|Personal reason|0|||
145964910|NCT03055936|526385417|FG002|Overall Study|Personal reason|1|||
145964911|NCT03055936|526385418|FG003|Overall Study|Personal reason|0|||
145964912|NCT03167242|526385422|FG000|Overall Study|Patient/Guardian Decision|0|||
145964913|NCT03167242|526385423|FG001|Overall Study|Patient/Guardian Decision|1|||
145964914|NCT03167242|526385424|FG002|Overall Study|Patient/Guardian Decision|2|||
145964915|NCT03167242|526385425|FG003|Overall Study|Patient/Guardian Decision|1|||
145964916|NCT03167242|526385426|FG004|Overall Study|Patient/Guardian Decision|1|||
145964917|NCT03167242|526385427|FG005|Overall Study|Patient/Guardian Decision|1|||
145964918|NCT03167242|526385428|FG006|Overall Study|Patient/Guardian Decision|0|||
145964919|NCT03167242|526385429|FG007|Overall Study|Patient/Guardian Decision|0|||
145964920|NCT03167242|526385430|FG008|Overall Study|Patient/Guardian Decision|0|||
145964921|NCT03167242|526385431|FG009|Overall Study|Patient/Guardian Decision|0|||
145964922|NCT03167242|526385432|FG010|Overall Study|Patient/Guardian Decision|1|||
145964923|NCT03167242|526385433|FG011|Overall Study|Patient/Guardian Decision|0|||
145964924|NCT03167242|526385422|FG000|Overall Study|Lost to Follow-up|0|||
145964925|NCT03167242|526385423|FG001|Overall Study|Lost to Follow-up|0|||
145964926|NCT03167242|526385424|FG002|Overall Study|Lost to Follow-up|1|||
145964927|NCT03167242|526385425|FG003|Overall Study|Lost to Follow-up|0|||
145964928|NCT03167242|526385426|FG004|Overall Study|Lost to Follow-up|0|||
145964929|NCT03167242|526385427|FG005|Overall Study|Lost to Follow-up|1|||
145964930|NCT03167242|526385428|FG006|Overall Study|Lost to Follow-up|2|||
145964931|NCT03167242|526385429|FG007|Overall Study|Lost to Follow-up|1|||
145964932|NCT03167242|526385430|FG008|Overall Study|Lost to Follow-up|0|||
145964933|NCT03167242|526385431|FG009|Overall Study|Lost to Follow-up|0|||
145964934|NCT03167242|526385432|FG010|Overall Study|Lost to Follow-up|1|||
145964935|NCT03167242|526385433|FG011|Overall Study|Lost to Follow-up|1|||
145964936|NCT03167242|526385422|FG000|Overall Study|Reason not provided|0|||
145964937|NCT03167242|526385423|FG001|Overall Study|Reason not provided|0|||
145964938|NCT03167242|526385424|FG002|Overall Study|Reason not provided|0|||
145964939|NCT03167242|526385425|FG003|Overall Study|Reason not provided|0|||
145964940|NCT03167242|526385426|FG004|Overall Study|Reason not provided|0|||
145964941|NCT03167242|526385427|FG005|Overall Study|Reason not provided|0|||
145964942|NCT03167242|526385428|FG006|Overall Study|Reason not provided|0|||
145964943|NCT03167242|526385429|FG007|Overall Study|Reason not provided|0|||
145964944|NCT03167242|526385430|FG008|Overall Study|Reason not provided|1|||
145964945|NCT03167242|526385431|FG009|Overall Study|Reason not provided|0|||
145964946|NCT03167242|526385432|FG010|Overall Study|Reason not provided|0|||
145964947|NCT03167242|526385433|FG011|Overall Study|Reason not provided|0|||
145964948|NCT02984982|526385441|FG000|Overall Study|Adverse Event|2|||
145964949|NCT02984982|526385442|FG001|Overall Study|Adverse Event|5|||
145964950|NCT02984982|526385441|FG000|Overall Study|Poor Compliance to Protocol|4|||
145964951|NCT02984982|526385442|FG001|Overall Study|Poor Compliance to Protocol|4|||
145964952|NCT02984982|526385441|FG000|Overall Study|Withdrawal by Subject|2|||
145964953|NCT02984982|526385442|FG001|Overall Study|Withdrawal by Subject|0|||
145964954|NCT02984982|526385441|FG000|Overall Study|Randomized but not treated|0|||
145964955|NCT02984982|526385442|FG001|Overall Study|Randomized but not treated|1|||
145964956|NCT02153918|526385443|FG000|Overall Study|Refused further treatment|1|||
145964957|NCT03327324|526385444|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964958|NCT03327324|526385445|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145964959|NCT03327324|526385446|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964960|NCT03327324|526385447|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145964961|NCT03327324|526385448|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964962|NCT03327324|526385449|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
145964963|NCT03327324|526385444|FG000|Baseline (Month 0-Month 3)|Refused|0|||
145964964|NCT03327324|526385445|FG001|Baseline (Month 0-Month 3)|Refused|0|||
145964965|NCT03327324|526385446|FG002|Baseline (Month 0-Month 3)|Refused|0|||
145964966|NCT03327324|526385447|FG003|Baseline (Month 0-Month 3)|Refused|0|||
145964967|NCT03327324|526385448|FG004|Baseline (Month 0-Month 3)|Refused|1|||
145964968|NCT03327324|526385449|FG005|Baseline (Month 0-Month 3)|Refused|0|||
145964969|NCT03327324|526385444|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145964970|NCT03327324|526385445|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
145964971|NCT03327324|526385446|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145964972|NCT03327324|526385447|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145964973|NCT03327324|526385448|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145964974|NCT03327324|526385449|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145964975|NCT03327324|526385444|FG000|Baseline (Month 0-Month 3)|Death|0|||
145964976|NCT03327324|526385445|FG001|Baseline (Month 0-Month 3)|Death|0|||
145964977|NCT03327324|526385446|FG002|Baseline (Month 0-Month 3)|Death|0|||
145964978|NCT03327324|526385447|FG003|Baseline (Month 0-Month 3)|Death|0|||
145964979|NCT03327324|526385448|FG004|Baseline (Month 0-Month 3)|Death|1|||
145964980|NCT03327324|526385449|FG005|Baseline (Month 0-Month 3)|Death|0|||
145964981|NCT03327324|526385444|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
146086650|NCT01077154|526837989|FG001|Overall Study|Noncompliance|20|||
145964982|NCT03327324|526385445|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145964983|NCT03327324|526385446|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145970791|NCT00726453|526407270|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
146086651|NCT01077154|526837988|FG000|Overall Study|Disease Progression|18|||
146086652|NCT01077154|526837989|FG001|Overall Study|Disease Progression|20|||
146086653|NCT01077154|526837988|FG000|Overall Study|Ineligibility Determined|10|||
146086654|NCT01077154|526837989|FG001|Overall Study|Ineligibility Determined|14|||
146086655|NCT01077154|526837988|FG000|Overall Study|Other|14|||
146086656|NCT01077154|526837989|FG001|Overall Study|Other|11|||
146086657|NCT01077154|526837988|FG000|Overall Study|Adverse Event|9|||
146086658|NCT01077154|526837989|FG001|Overall Study|Adverse Event|9|||
146086659|NCT01077154|526837988|FG000|Overall Study|Administrative Decision|1|||
145887340|NCT00248170|526090384|FG001|Overall Study|Abnormal test procedure(s) result|61|||
145887341|NCT00248170|526090383|FG000|Overall Study|Abnormal laboratory values|4|||
145887342|NCT00248170|526090384|FG001|Overall Study|Abnormal laboratory values|0|||
145887343|NCT00248170|526090383|FG000|Overall Study|Protocol deviation|17|||
146086660|NCT01077154|526837989|FG001|Overall Study|Administrative Decision|6|||
146086661|NCT01077154|526837988|FG000|Overall Study|Protocol Deviation|1|||
146086662|NCT01077154|526837989|FG001|Overall Study|Protocol Deviation|0|||
146086663|NCT02207946|526837990|FG000|Overall Study|Lost to Follow-up|1|||
146086664|NCT02207946|526837991|FG001|Overall Study|Lost to Follow-up|0|||
146232303|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
146232304|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232305|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232306|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232307|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232308|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232309|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232310|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145887344|NCT00248170|526090384|FG001|Overall Study|Protocol deviation|19|||
145887345|NCT03123783|526090387|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887346|NCT03123783|526090388|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
145887347|NCT03123783|526090389|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887348|NCT03123783|526090390|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887349|NCT03123783|526090391|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887350|NCT03123783|526090392|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887351|NCT03123783|526090393|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145887352|NCT03123783|526090387|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
145887353|NCT03123783|526090388|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
145964984|NCT03327324|526385447|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145964985|NCT03327324|526385448|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145964986|NCT03327324|526385449|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
145964987|NCT03327324|526385444|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964988|NCT03327324|526385445|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964989|NCT03327324|526385446|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145964990|NCT03327324|526385447|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964991|NCT03327324|526385448|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964992|NCT03327324|526385449|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145964993|NCT03327324|526385444|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
145964994|NCT03327324|526385445|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145964995|NCT03327324|526385446|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145964996|NCT03327324|526385447|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
145964997|NCT03327324|526385448|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145964998|NCT03327324|526385449|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
145964999|NCT03327324|526385444|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
145965000|NCT03327324|526385445|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145965001|NCT03327324|526385446|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145965002|NCT03327324|526385447|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145965003|NCT03327324|526385448|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145965004|NCT03327324|526385449|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145965005|NCT03327324|526385444|FG000|Intervention (Month 3-Month 6)|Death|1|||
145965006|NCT03327324|526385445|FG001|Intervention (Month 3-Month 6)|Death|0|||
145965007|NCT03327324|526385446|FG002|Intervention (Month 3-Month 6)|Death|1|||
146086665|NCT02207946|526837990|FG000|Overall Study|Adverse Event|0|||
146086666|NCT02207946|526837991|FG001|Overall Study|Adverse Event|1|||
146086667|NCT03764033|526837999|FG000|Treatment Phase|Withdrawal by Subject|8|||
146086668|NCT03764033|526838000|FG001|Treatment Phase|Withdrawal by Subject|3|||
145887354|NCT03123783|526090389|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
145965008|NCT03327324|526385447|FG003|Intervention (Month 3-Month 6)|Death|1|||
145965009|NCT03327324|526385448|FG004|Intervention (Month 3-Month 6)|Death|1|||
145965010|NCT03327324|526385449|FG005|Intervention (Month 3-Month 6)|Death|0|||
145965011|NCT03327324|526385444|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965012|NCT03327324|526385445|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965013|NCT03327324|526385446|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965014|NCT03327324|526385447|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965015|NCT03327324|526385448|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965016|NCT03327324|526385449|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
145965017|NCT03327324|526385444|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145965018|NCT03327324|526385445|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145965019|NCT03327324|526385446|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145965020|NCT03327324|526385447|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145965021|NCT03327324|526385448|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145965022|NCT03327324|526385449|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145965023|NCT03327324|526385444|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
145965024|NCT03327324|526385445|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
145965025|NCT03327324|526385446|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145965026|NCT03327324|526385447|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145965027|NCT03327324|526385448|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145965028|NCT03327324|526385449|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145965029|NCT03327324|526385444|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145965030|NCT03327324|526385445|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145965031|NCT03327324|526385446|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145965032|NCT03327324|526385447|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145965033|NCT03327324|526385448|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145965034|NCT03327324|526385449|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145965035|NCT03327324|526385444|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965036|NCT03327324|526385445|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965037|NCT03327324|526385446|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965038|NCT03327324|526385447|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
145965039|NCT03327324|526385448|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
146232311|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232312|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145965040|NCT03327324|526385449|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145965041|NCT03327324|526385444|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
145965042|NCT03327324|526385445|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145965043|NCT03327324|526385446|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145965044|NCT03327324|526385447|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145965045|NCT03327324|526385448|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145965046|NCT03327324|526385449|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145965047|NCT03327324|526385444|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
145965048|NCT03327324|526385445|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145965049|NCT03327324|526385446|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145965050|NCT03327324|526385447|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145965051|NCT03327324|526385448|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145965052|NCT03327324|526385449|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145965053|NCT02848664|526385452|FG000|Overall Study|Withdrawal by Subject|2|||
145965054|NCT02848664|526385452|FG000|Overall Study|Adverse Event|1|||
146232313|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232314|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
146232315|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232316|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
146232317|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146232318|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232319|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146290909|NCT00846391|527580480|FG001|Overall Study|Study Terminated by Sponsor|2|||
146290910|NCT00846391|527580481|FG002|Overall Study|Study Terminated by Sponsor|2|||
145965055|NCT02848664|526385452|FG000|Overall Study|no assistance for device training|1|||
145965056|NCT00732069|526385453|FG000|Washout After First Study Drug|Adverse Event|1|||
145965057|NCT00732069|526385454|FG001|Washout After First Study Drug|Adverse Event|0|||
145965058|NCT00732069|526385455|FG002|Washout After First Study Drug|Adverse Event|0|||
145965059|NCT00732069|526385456|FG003|Washout After First Study Drug|Adverse Event|0|||
145965060|NCT00732069|526385457|FG004|Washout After First Study Drug|Adverse Event|0|||
145965061|NCT00732069|526385458|FG005|Washout After First Study Drug|Adverse Event|0|||
145965062|NCT00577317|526385459|FG000|Overall Study|Study Terminated|0|||
145965063|NCT00577317|526385460|FG001|Overall Study|Study Terminated|2|||
145965064|NCT01405898|526385464|FG000|Overall Study|Withdrawal by Subject|2|||
145965065|NCT01405898|526385465|FG001|Overall Study|Withdrawal by Subject|2|||
145965066|NCT01687218|526385466|FG000|Overall Study|Withdrawal by Subject|2|||
145965067|NCT01687218|526385467|FG001|Overall Study|Withdrawal by Subject|3|||
145965068|NCT01687218|526385468|FG002|Overall Study|Withdrawal by Subject|0|||
145965069|NCT01687218|526385469|FG003|Overall Study|Withdrawal by Subject|1|||
145965070|NCT01687218|526385470|FG004|Overall Study|Withdrawal by Subject|1|||
145965071|NCT01687218|526385471|FG005|Overall Study|Withdrawal by Subject|0|||
145965072|NCT01687218|526385466|FG000|Overall Study|Relocated, no follow-up planned|1|||
145965073|NCT01687218|526385467|FG001|Overall Study|Relocated, no follow-up planned|0|||
145965074|NCT01687218|526385468|FG002|Overall Study|Relocated, no follow-up planned|1|||
145965075|NCT01687218|526385469|FG003|Overall Study|Relocated, no follow-up planned|1|||
145965076|NCT01687218|526385470|FG004|Overall Study|Relocated, no follow-up planned|0|||
145965077|NCT01687218|526385471|FG005|Overall Study|Relocated, no follow-up planned|0|||
145965078|NCT00846586|526385479|FG000|Overall Study|Adverse Event|20|||
145965079|NCT00846586|526385480|FG001|Overall Study|Adverse Event|10|||
145965080|NCT00846586|526385479|FG000|Overall Study|Subject withdrew consent|8|||
145965081|NCT00846586|526385480|FG001|Overall Study|Subject withdrew consent|10|||
145965082|NCT00846586|526385479|FG000|Overall Study|Administrative problems|5|||
145965083|NCT00846586|526385480|FG001|Overall Study|Administrative problems|4|||
145965084|NCT00846586|526385479|FG000|Overall Study|Death|2|||
145965085|NCT00846586|526385480|FG001|Overall Study|Death|0|||
145965086|NCT00846586|526385479|FG000|Overall Study|Protocol deviation|2|||
145965087|NCT00846586|526385480|FG001|Overall Study|Protocol deviation|6|||
145965088|NCT00846586|526385479|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145965089|NCT00846586|526385480|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145965090|NCT00846586|526385479|FG000|Overall Study|Lost to Follow-up|1|||
145965091|NCT00846586|526385480|FG001|Overall Study|Lost to Follow-up|4|||
145965092|NCT00846586|526385479|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145965093|NCT00846586|526385480|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145965094|NCT00875810|526385481|FG000|Overall Study|Withdrawal by Subject|1|||
145965095|NCT00875810|526385481|FG000|Overall Study|Physician Decision|3|||
145965096|NCT00875810|526385481|FG000|Overall Study|Lost to Follow-up|39|||
145965097|NCT00875810|526385481|FG000|Overall Study|Patient enroled but not implanted|2|||
145965098|NCT00875810|526385481|FG000|Overall Study|Device explanted|1|||
145965099|NCT00780975|526385482|FG000|Overall Study|Progressive disease|3|||
145965100|NCT00780975|526385482|FG000|Overall Study|Toxicity|5|||
145965101|NCT01061606|526385483|FG000|Overall Study|Adverse Event|1|||
145965102|NCT01061606|526385483|FG000|Overall Study|Death|1|||
145965103|NCT01061606|526385483|FG000|Overall Study|Disease Progression|4|||
145965104|NCT01061606|526385483|FG000|Overall Study|alternative therapy|2|||
145965105|NCT01204671|526385484|FG000|Overall Study|Adverse Event|4|||
145965106|NCT01204671|526385485|FG001|Overall Study|Adverse Event|3|||
145965107|NCT01204671|526385486|FG002|Overall Study|Adverse Event|3|||
145965108|NCT01204671|526385487|FG003|Overall Study|Adverse Event|3|||
146232320|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
146232321|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145965109|NCT01204671|526385488|FG004|Overall Study|Adverse Event|1|||
145965110|NCT01204671|526385484|FG000|Overall Study|Withdrawal by Subject|2|||
145965111|NCT01204671|526385485|FG001|Overall Study|Withdrawal by Subject|3|||
145965112|NCT01204671|526385486|FG002|Overall Study|Withdrawal by Subject|4|||
145965113|NCT01204671|526385487|FG003|Overall Study|Withdrawal by Subject|5|||
145965114|NCT01204671|526385488|FG004|Overall Study|Withdrawal by Subject|3|||
145965115|NCT01204671|526385484|FG000|Overall Study|Lost to Follow-up|7|||
145965116|NCT01204671|526385485|FG001|Overall Study|Lost to Follow-up|8|||
145965117|NCT01204671|526385486|FG002|Overall Study|Lost to Follow-up|6|||
145965118|NCT01204671|526385487|FG003|Overall Study|Lost to Follow-up|4|||
145965119|NCT01204671|526385488|FG004|Overall Study|Lost to Follow-up|0|||
145965120|NCT01204671|526385484|FG000|Overall Study|Unknown Completion Status|1|||
145965121|NCT01204671|526385485|FG001|Overall Study|Unknown Completion Status|1|||
145965122|NCT01204671|526385486|FG002|Overall Study|Unknown Completion Status|0|||
145965123|NCT01204671|526385487|FG003|Overall Study|Unknown Completion Status|0|||
145965124|NCT01204671|526385488|FG004|Overall Study|Unknown Completion Status|0|||
145965125|NCT01204671|526385484|FG000|Overall Study|Physician Decision|0|||
145965126|NCT01204671|526385485|FG001|Overall Study|Physician Decision|0|||
145965127|NCT01204671|526385486|FG002|Overall Study|Physician Decision|0|||
145965128|NCT01204671|526385487|FG003|Overall Study|Physician Decision|1|||
145965129|NCT01204671|526385488|FG004|Overall Study|Physician Decision|0|||
145965130|NCT03106077|526385491|FG000|Overall Study|Screen Failure|94|||
145965131|NCT03106077|526385492|FG001|Overall Study|Screen Failure|0|||
145965132|NCT01274533|526385493|FG000|Overall Study|Withdrawal by Subject|1|||
145965133|NCT01274533|526385493|FG000|Overall Study|Non-compliance|1|||
145965134|NCT01274533|526385493|FG000|Overall Study|Disease progression|2|||
145965135|NCT03669588|526385494|FG000|Overall Study|Adverse Event|1|||
145965136|NCT03669588|526385495|FG001|Overall Study|Adverse Event|0|||
145965137|NCT03669588|526385494|FG000|Overall Study|Physician Decision|0|||
145965138|NCT03669588|526385495|FG001|Overall Study|Physician Decision|1|||
145965139|NCT03669588|526385494|FG000|Overall Study|Protocol Violation|1|||
145965140|NCT03669588|526385495|FG001|Overall Study|Protocol Violation|0|||
145965141|NCT03669588|526385494|FG000|Overall Study|Sponsor Decision|1|||
145965142|NCT03669588|526385495|FG001|Overall Study|Sponsor Decision|1|||
145965143|NCT03669588|526385494|FG000|Overall Study|Withdrawal by Subject|1|||
145965144|NCT03669588|526385495|FG001|Overall Study|Withdrawal by Subject|4|||
145965145|NCT03669588|526385494|FG000|Overall Study|Rescue Therapy Needed|0|||
145965146|NCT03669588|526385495|FG001|Overall Study|Rescue Therapy Needed|1|||
145965147|NCT02008526|526385496|FG000|Overall Study|Death|0|||
145965148|NCT02008526|526385497|FG001|Overall Study|Death|2|||
145965149|NCT02008526|526385498|FG002|Overall Study|Death|1|||
145965150|NCT02008526|526385496|FG000|Overall Study|Withdrawal by Subject|3|||
145965151|NCT02008526|526385497|FG001|Overall Study|Withdrawal by Subject|3|||
145965152|NCT02008526|526385498|FG002|Overall Study|Withdrawal by Subject|2|||
145965153|NCT02008526|526385496|FG000|Overall Study|Lost to Follow-up|5|||
145965154|NCT02008526|526385497|FG001|Overall Study|Lost to Follow-up|9|||
145965155|NCT02008526|526385498|FG002|Overall Study|Lost to Follow-up|6|||
145965156|NCT00492726|526385499|FG000|Overall Study|Adverse Event|10|||
145965157|NCT00492726|526385500|FG001|Overall Study|Adverse Event|6|||
145965158|NCT00492726|526385499|FG000|Overall Study|Death|7|||
145965159|NCT00492726|526385500|FG001|Overall Study|Death|2|||
145965160|NCT00492726|526385499|FG000|Overall Study|Lack of Efficacy|0|||
145965161|NCT00492726|526385500|FG001|Overall Study|Lack of Efficacy|2|||
145965162|NCT00492726|526385499|FG000|Overall Study|Lost to Follow-up|27|||
145965163|NCT00492726|526385500|FG001|Overall Study|Lost to Follow-up|19|||
145965164|NCT00492726|526385499|FG000|Overall Study|Physician Decision|0|||
145965165|NCT00492726|526385500|FG001|Overall Study|Physician Decision|1|||
145965166|NCT00492726|526385499|FG000|Overall Study|Withdrawal by Subject|6|||
145965167|NCT00492726|526385500|FG001|Overall Study|Withdrawal by Subject|3|||
145965168|NCT00492726|526385499|FG000|Overall Study|Non compliant with study medication|0|||
145965169|NCT00492726|526385500|FG001|Overall Study|Non compliant with study medication|3|||
145965170|NCT04386902|526385501|FG000|Overall Study|Withdrawal by Subject|5|||
145965171|NCT04386902|526385501|FG000|Overall Study|Technical problems in the recording|5|||
145965172|NCT01100502|526385502|FG000|Overall Study|Withdrawal by Subject|18|||
145965173|NCT01100502|526385503|FG001|Overall Study|Withdrawal by Subject|25|||
145965174|NCT01100502|526385502|FG000|Overall Study|Lost to Follow-up|13|||
145965175|NCT01100502|526385503|FG001|Overall Study|Lost to Follow-up|28|||
145965176|NCT01100502|526385502|FG000|Overall Study|Site request to end participation in study|0|||
145965177|NCT01100502|526385503|FG001|Overall Study|Site request to end participation in study|1|||
145965178|NCT01100502|526385502|FG000|Overall Study|Death|45|||
145965179|NCT01100502|526385503|FG001|Overall Study|Death|40|||
145965180|NCT00721799|526385504|FG000|Overall Study|Withdrawal by Subject|7|||
145965181|NCT00721799|526385504|FG000|Overall Study|withdraw by subject after scan 1|1|||
145965182|NCT05158140|526385506|FG000|Overall Study|Death|0|||
145965183|NCT05158140|526385507|FG001|Overall Study|Death|0|||
145965184|NCT05158140|526385508|FG002|Overall Study|Death|0|||
145965185|NCT05158140|526385509|FG003|Overall Study|Death|1|||
145965186|NCT05158140|526385506|FG000|Overall Study|Lost to Follow-up|3|||
145965187|NCT05158140|526385507|FG001|Overall Study|Lost to Follow-up|6|||
145965188|NCT05158140|526385508|FG002|Overall Study|Lost to Follow-up|4|||
145965189|NCT05158140|526385509|FG003|Overall Study|Lost to Follow-up|3|||
145965190|NCT05158140|526385506|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145965191|NCT05158140|526385507|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145965192|NCT05158140|526385508|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
145965193|NCT05158140|526385509|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145965194|NCT05158140|526385506|FG000|Overall Study|Withdrawal by Subject|3|||
145965195|NCT05158140|526385507|FG001|Overall Study|Withdrawal by Subject|7|||
145965196|NCT05158140|526385508|FG002|Overall Study|Withdrawal by Subject|3|||
145965197|NCT05158140|526385509|FG003|Overall Study|Withdrawal by Subject|7|||
145965198|NCT00807365|526385513|FG000|Overall Study|Study Terminated|5|||
145965199|NCT01121263|526385515|FG000|Overall Study|Death|3|||
145965200|NCT01121263|526385516|FG001|Overall Study|Death|2|||
145965201|NCT01121263|526385515|FG000|Overall Study|Lost to Follow-up|22|||
145965202|NCT01121263|526385516|FG001|Overall Study|Lost to Follow-up|12|||
145965203|NCT01121263|526385515|FG000|Overall Study|Withdrawal by Subject|0|||
145965204|NCT01121263|526385516|FG001|Overall Study|Withdrawal by Subject|1|||
145965205|NCT03810456|526385517|FG000|Treatment|Urgent Family Matters|3|||
145965206|NCT03810456|526385518|FG001|Treatment|Urgent Family Matters|0|||
145965207|NCT03810456|526385519|FG002|Treatment|Urgent Family Matters|0|||
145965208|NCT03810456|526385517|FG000|Treatment|Scheduling Conflicts|0|||
145965209|NCT03810456|526385518|FG001|Treatment|Scheduling Conflicts|11|||
145965210|NCT03810456|526385519|FG002|Treatment|Scheduling Conflicts|0|||
145965211|NCT03810456|526385517|FG000|Treatment|No Longer Interested|0|||
145965212|NCT03810456|526385518|FG001|Treatment|No Longer Interested|12|||
145965213|NCT03810456|526385519|FG002|Treatment|No Longer Interested|0|||
145965214|NCT03810456|526385517|FG000|Treatment|Transportation Issues|0|||
145965215|NCT03810456|526385518|FG001|Treatment|Transportation Issues|1|||
145965216|NCT03810456|526385519|FG002|Treatment|Transportation Issues|0|||
145965217|NCT03810456|526385517|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
145965218|NCT03810456|526385518|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
145965219|NCT03810456|526385519|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
145965220|NCT03810456|526385517|FG000|1 Month Follow-Up|Relocated to Different State|1|||
145965221|NCT03810456|526385518|FG001|1 Month Follow-Up|Relocated to Different State|0|||
145965222|NCT03810456|526385519|FG002|1 Month Follow-Up|Relocated to Different State|1|||
145965223|NCT03810456|526385517|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
145965224|NCT03810456|526385518|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
145965225|NCT03810456|526385519|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
145965226|NCT03810456|526385517|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
145965227|NCT03810456|526385518|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
145965228|NCT03810456|526385519|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
145965229|NCT03810456|526385517|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
145965230|NCT03810456|526385518|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
145965231|NCT03810456|526385519|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
145965232|NCT03810456|526385517|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
145965233|NCT03810456|526385518|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
145965234|NCT03810456|526385519|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
145965235|NCT03810456|526385517|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
145965236|NCT03810456|526385518|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
145965237|NCT03810456|526385519|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
145965238|NCT02100124|526385524|FG000|Overall Study|Lost to Follow-up|5|||
145965239|NCT02100124|526385525|FG001|Overall Study|Lost to Follow-up|11|||
145965240|NCT02100124|526385526|FG002|Overall Study|Lost to Follow-up|3|||
145965241|NCT02100124|526385524|FG000|Overall Study|Withdrawal by Subject|1|||
145965242|NCT02100124|526385525|FG001|Overall Study|Withdrawal by Subject|0|||
145965243|NCT02100124|526385526|FG002|Overall Study|Withdrawal by Subject|0|||
145965244|NCT04350827|526385527|FG000|Overall Study|Lost to Follow-up|1|||
145965245|NCT04350827|526385528|FG001|Overall Study|Lost to Follow-up|2|||
145965246|NCT02997163|526387472|FG000|Overall Study|Adverse Event|1|||
145965247|NCT02997163|526387473|FG001|Overall Study|Adverse Event|0|||
145965248|NCT02997163|526387474|FG002|Overall Study|Adverse Event|0|||
145965249|NCT02997163|526387475|FG003|Overall Study|Adverse Event|1|||
145965250|NCT02337764|526387476|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
145965251|NCT02337764|526387476|FG000|Overall Study|Voluntary Withdrawal|12|||
145965252|NCT02337764|526387476|FG000|Overall Study|Lack of Efficacy|2|||
145965253|NCT01739335|526387486|FG000|Overall Study|Lost to Follow-up|7|||
145965254|NCT01739335|526387487|FG001|Overall Study|Lost to Follow-up|4|||
145887355|NCT03123783|526090390|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
145887356|NCT03123783|526090391|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
145887357|NCT03123783|526090392|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
145887358|NCT03123783|526090393|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
145887359|NCT03123783|526090387|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
145887360|NCT03123783|526090388|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
145965255|NCT01739335|526387486|FG000|Overall Study|Ineligible patient randomized|0|||
145965256|NCT01739335|526387487|FG001|Overall Study|Ineligible patient randomized|1|||
145965257|NCT00288912|526387488|FG000|Overall Study|Developed exclusion criterion|4|||
145965258|NCT00288912|526387489|FG001|Overall Study|Developed exclusion criterion|6|||
145965259|NCT00288912|526387490|FG002|Overall Study|Developed exclusion criterion|7|||
145965260|NCT00288912|526387488|FG000|Overall Study|Lost to Follow-up|9|||
145965261|NCT00288912|526387489|FG001|Overall Study|Lost to Follow-up|6|||
145965262|NCT00288912|526387490|FG002|Overall Study|Lost to Follow-up|9|||
145965263|NCT00288912|526387488|FG000|Overall Study|Withdrawal by Subject|4|||
145965264|NCT00288912|526387489|FG001|Overall Study|Withdrawal by Subject|5|||
145965265|NCT00288912|526387490|FG002|Overall Study|Withdrawal by Subject|12|||
145965266|NCT00183430|526387493|FG000|Overall Study|Adverse Event|1|||
145965267|NCT00183430|526387494|FG001|Overall Study|Adverse Event|0|||
145887361|NCT03123783|526090389|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
145887362|NCT03123783|526090390|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
145887363|NCT03123783|526090391|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
145965268|NCT00183430|526387493|FG000|Overall Study|Lost to Follow-up|3|||
145965269|NCT00183430|526387494|FG001|Overall Study|Lost to Follow-up|0|||
145965270|NCT00183430|526387493|FG000|Overall Study|did not meet inclusion criteria|1|||
145965271|NCT00183430|526387494|FG001|Overall Study|did not meet inclusion criteria|0|||
145965272|NCT00183430|526387493|FG000|Overall Study|Withdrawal by Subject|1|||
145965273|NCT00183430|526387494|FG001|Overall Study|Withdrawal by Subject|0|||
145965274|NCT00883181|526387505|FG000|Overall Study|Hematological Adverse Event|26|||
145965275|NCT00883181|526387505|FG000|Overall Study|Non-hematological Adverse Event|55|||
145965276|NCT00883181|526387505|FG000|Overall Study|Disease Progression|94|||
145965277|NCT00883181|526387505|FG000|Overall Study|Administrative Reason|24|||
145965278|NCT00883181|526387505|FG000|Overall Study|Withdrawal by Subject|4|||
145965279|NCT00883181|526387505|FG000|Overall Study|Death|31|||
145965280|NCT00883181|526387505|FG000|Overall Study|Other|38|||
145965281|NCT00883181|526387505|FG000|Overall Study|Protocol Deviation|3|||
145965282|NCT00883181|526387505|FG000|Overall Study|Noncompliance|3|||
145965283|NCT01218308|526387506|FG000|Overall Study|Adverse Event|1|||
145965284|NCT01218308|526387507|FG001|Overall Study|Adverse Event|2|||
145965285|NCT01218308|526387506|FG000|Overall Study|Protocol Violation|0|||
145887364|NCT03123783|526090392|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
145887365|NCT03123783|526090393|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
145887366|NCT03123783|526090387|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145887367|NCT03123783|526090388|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145887368|NCT03123783|526090389|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145887369|NCT03123783|526090390|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145965286|NCT01218308|526387507|FG001|Overall Study|Protocol Violation|2|||
145965287|NCT01218308|526387506|FG000|Overall Study|Withdrawal by Subject|61|||
145965288|NCT01218308|526387507|FG001|Overall Study|Withdrawal by Subject|64|||
145965289|NCT01218308|526387506|FG000|Overall Study|Lost to Follow-up|27|||
145965290|NCT01218308|526387507|FG001|Overall Study|Lost to Follow-up|31|||
145965291|NCT01218308|526387506|FG000|Overall Study|Other|14|||
145965292|NCT01218308|526387507|FG001|Overall Study|Other|21|||
145965293|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
145970792|NCT00726453|526407269|FG000|38 mm Length Group|Death|0|||
145890975|NCT01207440|526107570|FG000|Overall Study|Reason Not Specified|10|||
145887370|NCT03123783|526090391|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
145887371|NCT03123783|526090392|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145887372|NCT03123783|526090393|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145887373|NCT03581188|526092561|FG000|Overall Study|Inclusion criteria not met|3|||
145887374|NCT03581188|526092562|FG001|Overall Study|Inclusion criteria not met|2|||
145887375|NCT03581188|526092561|FG000|Overall Study|Lost to Follow-up|5|||
145887376|NCT03581188|526092562|FG001|Overall Study|Lost to Follow-up|5|||
145887377|NCT03581188|526092561|FG000|Overall Study|Discontinued intervention|11|||
145887378|NCT03581188|526092562|FG001|Overall Study|Discontinued intervention|8|||
145887379|NCT01619579|526092563|FG000|Overall Study|Withdrawal by Subject|0|||
145887380|NCT01619579|526092564|FG001|Overall Study|Withdrawal by Subject|3|||
145887381|NCT02012452|526092566|FG000|Overall Study|Lost to Follow-up|2|||
145887382|NCT02012452|526092567|FG001|Overall Study|Lost to Follow-up|1|||
145887383|NCT02012452|526092566|FG000|Overall Study|Withdrawal by Subject|4|||
145887384|NCT02012452|526092567|FG001|Overall Study|Withdrawal by Subject|0|||
145887385|NCT02190279|526092568|FG000|Overall Study|Withdrawal consent|1|||
145887386|NCT02190279|526092569|FG001|Overall Study|Withdrawal consent|0|||
145887387|NCT02190279|526092570|FG002|Overall Study|Withdrawal consent|1|||
145887388|NCT02190279|526092568|FG000|Overall Study|Lost to Follow-up|2|||
145887389|NCT02190279|526092569|FG001|Overall Study|Lost to Follow-up|0|||
145887390|NCT02190279|526092570|FG002|Overall Study|Lost to Follow-up|0|||
145887391|NCT02190279|526092568|FG000|Overall Study|Refused further treatment|0|||
145887392|NCT02190279|526092569|FG001|Overall Study|Refused further treatment|0|||
145887393|NCT02190279|526092570|FG002|Overall Study|Refused further treatment|1|||
145887394|NCT02190279|526092568|FG000|Overall Study|Screening failure|0|||
145887395|NCT02190279|526092569|FG001|Overall Study|Screening failure|0|||
145887396|NCT02190279|526092570|FG002|Overall Study|Screening failure|1|||
145887397|NCT02938442|526092571|FG000|Overall Study|Death|0|||
145887398|NCT02938442|526092572|FG001|Overall Study|Death|1|||
145887399|NCT02938442|526092571|FG000|Overall Study|Lost to Follow-up|0|||
145887400|NCT02938442|526092572|FG001|Overall Study|Lost to Follow-up|1|||
145887401|NCT02938442|526092571|FG000|Overall Study|Physician Decision|0|||
145887402|NCT02938442|526092572|FG001|Overall Study|Physician Decision|1|||
145887403|NCT02938442|526092571|FG000|Overall Study|Withdrawal by Subject|2|||
145887404|NCT02938442|526092572|FG001|Overall Study|Withdrawal by Subject|0|||
145887405|NCT04403399|526092573|FG000|Period 2|Physician Decision|0|||
145887406|NCT04403399|526092574|FG001|Period 2|Physician Decision|1|||
145887407|NCT01316419|526092576|FG000|Overall Study|Not treated|103|||
145887408|NCT01316419|526092576|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
145887409|NCT01316419|526092576|FG000|Overall Study|Lost to Follow-up|19|||
145887410|NCT00983918|526092585|FG000|Overall Study|conversion to open cholecystectomy|0|||
145887411|NCT00983918|526092586|FG001|Overall Study|conversion to open cholecystectomy|2|||
145887412|NCT00983918|526092587|FG002|Overall Study|conversion to open cholecystectomy|2|||
145887413|NCT00983918|526092588|FG003|Overall Study|conversion to open cholecystectomy|2|||
145887414|NCT03346070|526092598|FG000|Overall Study|Death|0|||
145887415|NCT03346070|526092599|FG001|Overall Study|Death|0|||
145887416|NCT03346070|526092600|FG002|Overall Study|Death|0|||
145887417|NCT03346070|526092601|FG003|Overall Study|Death|0|||
145887418|NCT03346070|526092602|FG004|Overall Study|Death|1|||
145887419|NCT03346070|526092598|FG000|Overall Study|Lost to Follow-up|0|||
145965294|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145965295|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145965296|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145965297|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145965298|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
145965299|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145965300|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145965301|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145965302|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145965303|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
145965304|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145965305|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145965306|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145965307|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145965308|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
145965309|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145965310|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145965311|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145965312|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145965313|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
145965314|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145965315|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145965316|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145965317|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145965318|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
145965319|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145965320|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145965321|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145965322|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145965323|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
145965324|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145965325|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145965326|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145965327|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145965328|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
145965329|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145965330|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145965331|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145965332|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145965333|NCT02709746|526387508|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
145965334|NCT02709746|526387509|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145965335|NCT02709746|526387510|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145965336|NCT02709746|526387511|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145965337|NCT02709746|526387512|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145965338|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145965339|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
145965340|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145965341|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145965342|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
145965343|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
145965344|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
145965345|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
145965346|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
145965347|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
145965348|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
145965349|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
145965350|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
145965351|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
145965352|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
145965353|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
145965354|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
145965355|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
146086669|NCT03764033|526837999|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
146086670|NCT03764033|526838000|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
146086671|NCT03764033|526837999|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
146086672|NCT03764033|526838000|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
146086673|NCT01006603|526838003|FG000|Overall Study|Withdrawal by Subject|17|||
146086674|NCT01006603|526838004|FG001|Overall Study|Withdrawal by Subject|19|||
145887420|NCT03346070|526092599|FG001|Overall Study|Lost to Follow-up|1|||
145887421|NCT03346070|526092600|FG002|Overall Study|Lost to Follow-up|2|||
145887422|NCT03346070|526092601|FG003|Overall Study|Lost to Follow-up|0|||
145887423|NCT03346070|526092602|FG004|Overall Study|Lost to Follow-up|0|||
145887424|NCT03346070|526092598|FG000|Overall Study|Physician Decision|0|||
145887425|NCT03346070|526092599|FG001|Overall Study|Physician Decision|0|||
145887426|NCT03346070|526092600|FG002|Overall Study|Physician Decision|0|||
145887427|NCT03346070|526092601|FG003|Overall Study|Physician Decision|1|||
145887428|NCT03346070|526092602|FG004|Overall Study|Physician Decision|1|||
145887429|NCT03346070|526092598|FG000|Overall Study|Withdrawal by Subject|1|||
145887430|NCT03346070|526092599|FG001|Overall Study|Withdrawal by Subject|0|||
145887431|NCT03346070|526092600|FG002|Overall Study|Withdrawal by Subject|0|||
145887432|NCT03346070|526092601|FG003|Overall Study|Withdrawal by Subject|1|||
145887433|NCT03346070|526092602|FG004|Overall Study|Withdrawal by Subject|0|||
145887434|NCT03346070|526092598|FG000|Overall Study|Study medication not received as planned|2|||
145887435|NCT03346070|526092599|FG001|Overall Study|Study medication not received as planned|3|||
145887436|NCT03346070|526092600|FG002|Overall Study|Study medication not received as planned|2|||
145887437|NCT03346070|526092601|FG003|Overall Study|Study medication not received as planned|3|||
145887438|NCT03346070|526092602|FG004|Overall Study|Study medication not received as planned|2|||
145887439|NCT03346070|526092598|FG000|Overall Study|Screen Failure|0|||
145887440|NCT03346070|526092599|FG001|Overall Study|Screen Failure|0|||
145887441|NCT03346070|526092600|FG002|Overall Study|Screen Failure|0|||
145887442|NCT03346070|526092601|FG003|Overall Study|Screen Failure|1|||
145887443|NCT03346070|526092602|FG004|Overall Study|Screen Failure|1|||
145887444|NCT04086641|526092605|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
145887445|NCT04086641|526092606|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
145887446|NCT00255151|526092607|FG000|Overall Study|Adverse Event|10|||
145887447|NCT00255151|526092608|FG001|Overall Study|Adverse Event|6|||
145887448|NCT00255151|526092609|FG002|Overall Study|Adverse Event|9|||
145887449|NCT00255151|526092607|FG000|Overall Study|Lost to Follow-up|4|||
145887450|NCT00255151|526092608|FG001|Overall Study|Lost to Follow-up|3|||
145887451|NCT00255151|526092609|FG002|Overall Study|Lost to Follow-up|4|||
145887452|NCT00255151|526092607|FG000|Overall Study|Withdrawal by Subject|18|||
145887453|NCT00255151|526092608|FG001|Overall Study|Withdrawal by Subject|17|||
145887454|NCT00255151|526092609|FG002|Overall Study|Withdrawal by Subject|8|||
145887455|NCT00255151|526092607|FG000|Overall Study|Noncompliance|0|||
145887456|NCT00255151|526092608|FG001|Overall Study|Noncompliance|1|||
145887457|NCT00255151|526092609|FG002|Overall Study|Noncompliance|2|||
145887458|NCT00255151|526092607|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
145887459|NCT00255151|526092608|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
145887460|NCT00255151|526092609|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
145887461|NCT00255151|526092607|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
145887462|NCT00255151|526092608|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
145887463|NCT00255151|526092609|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
145887464|NCT00255151|526092607|FG000|Overall Study|Possible Barrett's Esophagus|1|||
145887465|NCT00255151|526092608|FG001|Overall Study|Possible Barrett's Esophagus|3|||
145887466|NCT00255151|526092609|FG002|Overall Study|Possible Barrett's Esophagus|8|||
145887467|NCT00255151|526092607|FG000|Overall Study|Esophageal Stricture|0|||
145887468|NCT00255151|526092608|FG001|Overall Study|Esophageal Stricture|0|||
145887469|NCT00255151|526092609|FG002|Overall Study|Esophageal Stricture|1|||
145887470|NCT00255151|526092607|FG000|Overall Study|Therapeutic Failure|11|||
145887471|NCT00255151|526092608|FG001|Overall Study|Therapeutic Failure|2|||
145887472|NCT00255151|526092609|FG002|Overall Study|Therapeutic Failure|3|||
145887473|NCT00792623|526092610|FG000|Overall Study|Adverse Event|2|||
145887474|NCT00792623|526092610|FG000|Overall Study|Withdrawal by Subject|5|||
145887475|NCT01685073|526092611|FG000|Overall Study|Lost to Follow-up|6|||
145887476|NCT01685073|526092612|FG001|Overall Study|Lost to Follow-up|8|||
145887477|NCT01685073|526092611|FG000|Overall Study|Withdrawal by Subject|24|||
145887478|NCT01685073|526092612|FG001|Overall Study|Withdrawal by Subject|24|||
145887479|NCT01011556|526092615|FG000|Overall Study|Adverse Event|1|||
145887480|NCT01011556|526092616|FG001|Overall Study|Adverse Event|3|||
145887481|NCT01011556|526092617|FG002|Overall Study|Adverse Event|2|||
145887482|NCT01011556|526092618|FG003|Overall Study|Adverse Event|1|||
145887483|NCT01011556|526092615|FG000|Overall Study|Lost to Follow-up|1|||
145887484|NCT01011556|526092616|FG001|Overall Study|Lost to Follow-up|0|||
145887485|NCT01011556|526092617|FG002|Overall Study|Lost to Follow-up|0|||
145887486|NCT01011556|526092618|FG003|Overall Study|Lost to Follow-up|0|||
145887487|NCT01011556|526092615|FG000|Overall Study|Physician Decision|1|||
145887488|NCT01011556|526092616|FG001|Overall Study|Physician Decision|0|||
145887489|NCT01011556|526092617|FG002|Overall Study|Physician Decision|0|||
145887490|NCT01011556|526092618|FG003|Overall Study|Physician Decision|1|||
145887491|NCT01011556|526092615|FG000|Overall Study|Protocol Violation|0|||
145887492|NCT01011556|526092616|FG001|Overall Study|Protocol Violation|1|||
145887493|NCT01011556|526092617|FG002|Overall Study|Protocol Violation|0|||
145887494|NCT01011556|526092618|FG003|Overall Study|Protocol Violation|0|||
145887495|NCT01011556|526092615|FG000|Overall Study|Withdrawal by Subject|1|||
145887496|NCT01011556|526092616|FG001|Overall Study|Withdrawal by Subject|2|||
145887497|NCT01011556|526092617|FG002|Overall Study|Withdrawal by Subject|4|||
145887498|NCT01011556|526092618|FG003|Overall Study|Withdrawal by Subject|4|||
145887499|NCT01011556|526092615|FG000|Overall Study|Sponsor decision|0|||
145887500|NCT01011556|526092616|FG001|Overall Study|Sponsor decision|1|||
145887501|NCT01011556|526092617|FG002|Overall Study|Sponsor decision|1|||
145887502|NCT01011556|526092618|FG003|Overall Study|Sponsor decision|2|||
145887503|NCT01011556|526092615|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
145887504|NCT01011556|526092616|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
145887505|NCT01011556|526092617|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
145887506|NCT01011556|526092618|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
145887507|NCT02147587|526092622|FG000|Overall Study|Adverse Event|9|||
145887508|NCT02147587|526092623|FG001|Overall Study|Adverse Event|4|||
145887509|NCT02147587|526092622|FG000|Overall Study|Lack of Efficacy|2|||
145887510|NCT02147587|526092623|FG001|Overall Study|Lack of Efficacy|1|||
145887511|NCT00931463|526092632|FG000|Overall Study|Death|8|||
145887512|NCT00931463|526092633|FG001|Overall Study|Death|4|||
145887513|NCT00931463|526092632|FG000|Overall Study|Withdrawal by Subject|5|||
145887514|NCT00931463|526092633|FG001|Overall Study|Withdrawal by Subject|0|||
145887515|NCT00931463|526092632|FG000|Overall Study|Lost to Follow-up|4|||
145887516|NCT00931463|526092633|FG001|Overall Study|Lost to Follow-up|1|||
145887517|NCT00436917|526092634|FG000|Overall Study|Withdrawal by Subject|13|||
145887518|NCT00436917|526092634|FG000|Overall Study|Adverse Event|2|||
145887519|NCT00436917|526092634|FG000|Overall Study|Physician Decision|1|||
145887520|NCT00436917|526092634|FG000|Overall Study|Death|1|||
145887521|NCT00436917|526092634|FG000|Overall Study|Lost to Follow-up|1|||
145887522|NCT00436917|526092634|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
145887523|NCT00436917|526092634|FG000|Overall Study|Increased creatinine|1|||
145887524|NCT00436917|526092634|FG000|Overall Study|Personal conflicts of patient|1|||
145887525|NCT01009515|526092643|FG000|Overall Study|Withdrawal by Subject|3|||
145887526|NCT01501110|526092645|FG000|Overall Study|Death|0|||
145887527|NCT01501110|526092646|FG001|Overall Study|Death|1|||
145887528|NCT01040793|526092655|FG000|Overall Study|Adverse Event|5|||
145887529|NCT01040793|526092656|FG001|Overall Study|Adverse Event|3|||
145887530|NCT01040793|526092657|FG002|Overall Study|Adverse Event|0|||
145887531|NCT01040793|526092658|FG003|Overall Study|Adverse Event|2|||
145887532|NCT01040793|526092659|FG004|Overall Study|Adverse Event|2|||
145887533|NCT01040793|526092660|FG005|Overall Study|Adverse Event|1|||
145887534|NCT01040793|526092655|FG000|Overall Study|Protocol Violation|1|||
145887535|NCT01040793|526092656|FG001|Overall Study|Protocol Violation|1|||
145887536|NCT01040793|526092657|FG002|Overall Study|Protocol Violation|1|||
145887537|NCT01040793|526092658|FG003|Overall Study|Protocol Violation|0|||
145887538|NCT01040793|526092659|FG004|Overall Study|Protocol Violation|1|||
145887539|NCT01040793|526092660|FG005|Overall Study|Protocol Violation|0|||
145887540|NCT01040793|526092655|FG000|Overall Study|Lost to Follow-up|0|||
145887541|NCT01040793|526092656|FG001|Overall Study|Lost to Follow-up|1|||
145887542|NCT01040793|526092657|FG002|Overall Study|Lost to Follow-up|1|||
146086675|NCT01006603|526838003|FG000|Overall Study|Lost to Follow-up|0|||
145887543|NCT01040793|526092658|FG003|Overall Study|Lost to Follow-up|0|||
145887544|NCT01040793|526092659|FG004|Overall Study|Lost to Follow-up|0|||
145887545|NCT01040793|526092660|FG005|Overall Study|Lost to Follow-up|0|||
145887546|NCT01040793|526092655|FG000|Overall Study|Withdrawal by Subject|0|||
145887547|NCT01040793|526092656|FG001|Overall Study|Withdrawal by Subject|0|||
145887548|NCT01040793|526092657|FG002|Overall Study|Withdrawal by Subject|0|||
145887549|NCT01040793|526092658|FG003|Overall Study|Withdrawal by Subject|2|||
145887550|NCT01040793|526092659|FG004|Overall Study|Withdrawal by Subject|0|||
145887551|NCT01040793|526092660|FG005|Overall Study|Withdrawal by Subject|0|||
145887552|NCT01040793|526092655|FG000|Overall Study|Other reasons not listed above|0|||
145887553|NCT01040793|526092656|FG001|Overall Study|Other reasons not listed above|0|||
146086676|NCT01006603|526838004|FG001|Overall Study|Lost to Follow-up|1|||
145887554|NCT01040793|526092657|FG002|Overall Study|Other reasons not listed above|1|||
145887555|NCT01040793|526092658|FG003|Overall Study|Other reasons not listed above|0|||
145970793|NCT00726453|526407270|FG001|38 mm Length Group|Death|3|||
145965356|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
145965357|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
145965358|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
145965359|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
145965360|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
145965361|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
145965362|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
145965363|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
145965364|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145965365|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145965366|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145965367|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
145965368|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145965369|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145965370|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
145965371|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145965372|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145965373|NCT02709746|526387508|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
145965374|NCT02709746|526387509|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
145965375|NCT02709746|526387510|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
145965376|NCT02709746|526387511|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
145965377|NCT02709746|526387512|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
145965378|NCT00752089|526387513|FG000|Overall Study|Adverse Event|1|||
145965379|NCT00752089|526387513|FG000|Overall Study|Protocol Deviation|2|||
145965380|NCT00752089|526387513|FG000|Overall Study|Could not attend visit 9|1|||
146086677|NCT01006603|526838003|FG000|Overall Study|Safety reason|1|||
146086678|NCT01006603|526838004|FG001|Overall Study|Safety reason|1|||
146086679|NCT01006603|526838003|FG000|Overall Study|Protocol Violation|1|||
146086680|NCT01006603|526838004|FG001|Overall Study|Protocol Violation|3|||
146086681|NCT01006603|526838003|FG000|Overall Study|Incorrect enrolment|0|||
146086682|NCT01006603|526838004|FG001|Overall Study|Incorrect enrolment|2|||
146086683|NCT01006603|526838003|FG000|Overall Study|Adverse Event|15|||
146086684|NCT01006603|526838004|FG001|Overall Study|Adverse Event|7|||
146086685|NCT01006603|526838003|FG000|Overall Study|Death|1|||
146086686|NCT01006603|526838004|FG001|Overall Study|Death|1|||
146086687|NCT01006603|526838003|FG000|Overall Study|Study specific discontinuation criteria|33|||
146086688|NCT01006603|526838004|FG001|Overall Study|Study specific discontinuation criteria|34|||
146086689|NCT01006603|526838003|FG000|Overall Study|Other|3|||
146086690|NCT01006603|526838004|FG001|Overall Study|Other|7|||
146087767|NCT04393298|526841817|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
146087768|NCT04393298|526841818|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
146087769|NCT04393298|526841819|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
146087770|NCT04393298|526841820|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
146087771|NCT04393298|526841821|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
146087772|NCT04393298|526841822|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
146087773|NCT04393298|526841823|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
146087774|NCT04393298|526841824|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
146087775|NCT03754972|526841827|FG000|Overall Study|Protocol Violation|25|||
146087776|NCT05128929|526841831|FG000|Overall Study|Adverse Event|0|||
146087777|NCT05128929|526841832|FG001|Overall Study|Adverse Event|1|||
146087778|NCT02987660|526841835|FG000|Overall Study|Study terminated by sponsor|10|||
146087779|NCT02987660|526841836|FG001|Overall Study|Study terminated by sponsor|10|||
146087780|NCT05007717|526841837|FG000|Overall Study|Death|3|||
146087781|NCT05007717|526841838|FG001|Overall Study|Death|2|||
146087782|NCT03553836|526841839|FG000|Overall Study|Ongoing in Study|460|||
146087783|NCT03553836|526841840|FG001|Overall Study|Ongoing in Study|459|||
146087784|NCT03553836|526841839|FG000|Overall Study|Withdrawal by Subject|9|||
146290911|NCT02699983|527580482|FG000|Overall Study|Withdrawal by Subject|1|||
145965381|NCT00752089|526387513|FG000|Overall Study|Not capable of wearing partial denture|1|||
145965382|NCT00752089|526387513|FG000|Overall Study|Cannot continue the study|1|||
145965383|NCT00386334|526387516|FG000|Double Blind Period|Adverse Event|9|||
145965384|NCT00386334|526387517|FG001|Double Blind Period|Adverse Event|14|||
145965385|NCT00386334|526387516|FG000|Double Blind Period|Protocol Violation|1|||
145965386|NCT00386334|526387517|FG001|Double Blind Period|Protocol Violation|1|||
145965387|NCT00386334|526387516|FG000|Double Blind Period|Withdrawal by Subject|9|||
145965388|NCT00386334|526387517|FG001|Double Blind Period|Withdrawal by Subject|13|||
146087785|NCT03553836|526841840|FG001|Overall Study|Withdrawal by Subject|10|||
146087786|NCT03553836|526841839|FG000|Overall Study|Lost to Follow-up|1|||
146087787|NCT03553836|526841840|FG001|Overall Study|Lost to Follow-up|3|||
146087788|NCT03553836|526841839|FG000|Overall Study|Death|17|||
146087789|NCT03553836|526841840|FG001|Overall Study|Death|17|||
146087790|NCT04062123|526841841|FG000|Overall Study|Withdrawal by Subject|0|||
145965389|NCT00386334|526387516|FG000|Double Blind Period|Lack of Efficacy|20|||
145965390|NCT00386334|526387517|FG001|Double Blind Period|Lack of Efficacy|11|||
145965391|NCT00386334|526387516|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
145965392|NCT00386334|526387517|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
145965393|NCT00386334|526387516|FG000|Double Blind Period|Other|3|||
145887556|NCT01040793|526092659|FG004|Overall Study|Other reasons not listed above|1|||
145887557|NCT01040793|526092660|FG005|Overall Study|Other reasons not listed above|0|||
145887558|NCT03573817|526092662|FG000|Overall Study|Adverse Event|0|||
145887559|NCT03573817|526092663|FG001|Overall Study|Adverse Event|2|||
145887560|NCT03573817|526092662|FG000|Overall Study|Protocol Violation|0|||
145887561|NCT03573817|526092663|FG001|Overall Study|Protocol Violation|1|||
145887562|NCT03573817|526092662|FG000|Overall Study|Withdrawal by Subject|1|||
145887563|NCT03573817|526092663|FG001|Overall Study|Withdrawal by Subject|1|||
145887564|NCT03554317|526092664|FG000|Overall Study|Withdrawal by Subject|1|||
145887565|NCT03554317|526092664|FG000|Overall Study|PSA Progression|3|||
145887566|NCT03554317|526092664|FG000|Overall Study|Radiographic Progression|4|||
145887567|NCT00612677|526092667|FG000|Overall Study|study closed before treatment started|1|||
145887568|NCT00860743|526092668|FG000|Overall Study|Withdrawal by Subject|3|||
145887569|NCT00860743|526092669|FG001|Overall Study|Withdrawal by Subject|0|||
145887570|NCT00823199|526092670|FG000|Overall Study|Withdrawal by Subject|2|||
145887571|NCT01640184|526092675|FG000|Overall Study|Death|1|||
145887572|NCT01640184|526092676|FG001|Overall Study|Death|0|||
145887573|NCT01640184|526092677|FG002|Overall Study|Death|0|||
145887574|NCT01640184|526092675|FG000|Overall Study|Lost to Follow-up|4|||
145887575|NCT01640184|526092676|FG001|Overall Study|Lost to Follow-up|1|||
145887576|NCT01640184|526092677|FG002|Overall Study|Lost to Follow-up|0|||
145887577|NCT01640184|526092675|FG000|Overall Study|Physician Decision|3|||
145887578|NCT01640184|526092676|FG001|Overall Study|Physician Decision|0|||
145887579|NCT01640184|526092677|FG002|Overall Study|Physician Decision|0|||
145887580|NCT01640184|526092675|FG000|Overall Study|Withdrawal by Subject|0|||
145887581|NCT01640184|526092676|FG001|Overall Study|Withdrawal by Subject|1|||
145887582|NCT01640184|526092677|FG002|Overall Study|Withdrawal by Subject|1|||
145887583|NCT01640184|526092675|FG000|Overall Study|Protocol Violation|0|||
145887584|NCT01640184|526092676|FG001|Overall Study|Protocol Violation|0|||
145887585|NCT01640184|526092677|FG002|Overall Study|Protocol Violation|1|||
145887586|NCT01684878|526092678|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
145887587|NCT01684878|526092679|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
145887588|NCT01684878|526092680|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
145887589|NCT01684878|526092681|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
145887590|NCT01684878|526092678|FG000|Part 1: Safety Run in Phase|Death|15|||
145887591|NCT01684878|526092679|FG001|Part 1: Safety Run in Phase|Death|20|||
145887592|NCT01684878|526092680|FG002|Part 1: Safety Run in Phase|Death|0|||
145887593|NCT01684878|526092681|FG003|Part 1: Safety Run in Phase|Death|0|||
145887594|NCT01684878|526092678|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145887595|NCT01684878|526092679|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
145887596|NCT01684878|526092680|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145887597|NCT01684878|526092681|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145887598|NCT01684878|526092678|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
145887599|NCT01684878|526092679|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
145887600|NCT01684878|526092680|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
145887601|NCT01684878|526092681|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
145887602|NCT01684878|526092678|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
145887603|NCT01684878|526092679|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
145887604|NCT01684878|526092680|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
145887605|NCT01684878|526092681|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
145887606|NCT01684878|526092678|FG000|Part 2: Randomized Phase|Death|0|||
145887607|NCT01684878|526092679|FG001|Part 2: Randomized Phase|Death|0|||
145887608|NCT01684878|526092680|FG002|Part 2: Randomized Phase|Death|62|||
145887609|NCT01684878|526092681|FG003|Part 2: Randomized Phase|Death|68|||
145887610|NCT01684878|526092678|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
145887611|NCT01684878|526092679|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
145887612|NCT01684878|526092680|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
145887613|NCT01684878|526092681|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
145887614|NCT01684878|526092678|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
145887615|NCT01684878|526092679|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
145887616|NCT01684878|526092680|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
145887617|NCT01684878|526092681|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
145887618|NCT01435031|526092685|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
145887619|NCT01435031|526092685|FG000|ITT at 1 Month|Death|1|||
145887620|NCT01435031|526092685|FG000|ITT at 1 Month|Lost to Follow-up|4|||
145887621|NCT01435031|526092685|FG000|ITT at 6 Months|Death|2|||
145887622|NCT01435031|526092685|FG000|ITT at 6 Months|Lost to Follow-up|3|||
145965394|NCT00386334|526387517|FG001|Double Blind Period|Other|3|||
145965395|NCT00386334|526387516|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
145965396|NCT00386334|526387517|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
145965397|NCT01245101|526387521|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
145965398|NCT01245101|526387522|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
145965399|NCT01245101|526387521|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
145965400|NCT01245101|526387522|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
145965401|NCT01245101|526387521|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
145965402|NCT01245101|526387522|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
145965403|NCT01122173|526387523|FG000|Overall Study|Lost to Follow-up|3|||
145965404|NCT01122173|526387523|FG000|Overall Study|Withdrawal by Subject|3|||
145965405|NCT01122173|526387523|FG000|Overall Study|Left study for other reasons|3|||
145965406|NCT02133508|526387524|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
145965407|NCT02133508|526387524|FG000|Overall Study|Death|12|||
145965408|NCT02133508|526387524|FG000|Overall Study|Lost to Follow-up|2|||
145965409|NCT03093181|526387527|FG000|Overall Study|Withdrawal by Subject|2|||
145965410|NCT03093181|526387528|FG001|Overall Study|Withdrawal by Subject|1|||
145965411|NCT03093181|526387529|FG002|Overall Study|Withdrawal by Subject|2|||
145965412|NCT03093181|526387527|FG000|Overall Study|Other (Not specified)|1|||
145965413|NCT03093181|526387528|FG001|Overall Study|Other (Not specified)|0|||
145965414|NCT03093181|526387529|FG002|Overall Study|Other (Not specified)|0|||
145965415|NCT03093181|526387527|FG000|Overall Study|Adverse Event|0|||
145965416|NCT03093181|526387528|FG001|Overall Study|Adverse Event|1|||
145965417|NCT03093181|526387529|FG002|Overall Study|Adverse Event|0|||
145965418|NCT03093181|526387527|FG000|Overall Study|Other (Protocol violation)|0|||
145965419|NCT03093181|526387528|FG001|Overall Study|Other (Protocol violation)|0|||
145965420|NCT03093181|526387529|FG002|Overall Study|Other (Protocol violation)|1|||
145965421|NCT04210986|526387532|FG000|Overall Study|Lost to Follow-up|5|||
145965422|NCT04210986|526387533|FG001|Overall Study|Lost to Follow-up|2|||
145965423|NCT04210986|526387532|FG000|Overall Study|Withdrawal by Subject|3|||
145965424|NCT04210986|526387533|FG001|Overall Study|Withdrawal by Subject|1|||
145965425|NCT04210986|526387532|FG000|Overall Study|Protocol Violation|1|||
145965426|NCT04210986|526387533|FG001|Overall Study|Protocol Violation|1|||
145965427|NCT04210986|526387532|FG000|Overall Study|Physician Decision|0|||
145965428|NCT04210986|526387533|FG001|Overall Study|Physician Decision|1|||
145965429|NCT02378662|526387534|FG000|Overall Study|Early Discontinuation|2|||
145965430|NCT02378662|526387535|FG001|Overall Study|Early Discontinuation|0|||
145965431|NCT01159574|526387536|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
145965432|NCT01159574|526387536|FG000|Treatment Phase|Adverse Event|3|||
145965433|NCT01159574|526387536|FG000|Treatment Phase|Death|6|||
145965434|NCT01159574|526387536|FG000|Treatment Phase|Physician Decision|2|||
145965435|NCT01159574|526387536|FG000|Treatment Phase|Withdrawal by Subject|7|||
145965436|NCT01159574|526387536|FG000|Treatment Phase|still on treatment|2|||
145965437|NCT01159574|526387536|FG000|Follow Up Phase|Lost to Follow-up|2|||
145965438|NCT01159574|526387536|FG000|Follow Up Phase|still being followed for overall surviva|18|||
145965439|NCT03555149|526387537|FG000|Overall Study|Death|18|||
145965440|NCT03555149|526387538|FG001|Overall Study|Death|15|||
145965441|NCT03555149|526387539|FG002|Overall Study|Death|15|||
145965442|NCT03555149|526387540|FG003|Overall Study|Death|4|||
145965443|NCT03555149|526387541|FG004|Overall Study|Death|4|||
145965444|NCT03555149|526387542|FG005|Overall Study|Death|11|||
145965445|NCT03555149|526387543|FG006|Overall Study|Death|12|||
145965446|NCT03555149|526387544|FG007|Overall Study|Death|1|||
145965447|NCT03555149|526387537|FG000|Overall Study|Lost to Follow-up|1|||
145965448|NCT03555149|526387538|FG001|Overall Study|Lost to Follow-up|0|||
145965449|NCT03555149|526387539|FG002|Overall Study|Lost to Follow-up|0|||
145965450|NCT03555149|526387540|FG003|Overall Study|Lost to Follow-up|0|||
145965451|NCT03555149|526387541|FG004|Overall Study|Lost to Follow-up|0|||
145965452|NCT03555149|526387542|FG005|Overall Study|Lost to Follow-up|1|||
145965453|NCT03555149|526387543|FG006|Overall Study|Lost to Follow-up|0|||
145965454|NCT03555149|526387544|FG007|Overall Study|Lost to Follow-up|0|||
145965455|NCT03555149|526387537|FG000|Overall Study|Physician Decision|1|||
145965456|NCT03555149|526387538|FG001|Overall Study|Physician Decision|0|||
145965457|NCT03555149|526387539|FG002|Overall Study|Physician Decision|0|||
145965458|NCT03555149|526387540|FG003|Overall Study|Physician Decision|0|||
145965459|NCT03555149|526387541|FG004|Overall Study|Physician Decision|0|||
145965460|NCT03555149|526387542|FG005|Overall Study|Physician Decision|0|||
145965461|NCT03555149|526387543|FG006|Overall Study|Physician Decision|0|||
145965462|NCT03555149|526387544|FG007|Overall Study|Physician Decision|0|||
145965463|NCT03555149|526387537|FG000|Overall Study|Study Terminated By Sponsor|1|||
145965464|NCT03555149|526387538|FG001|Overall Study|Study Terminated By Sponsor|0|||
145965465|NCT03555149|526387539|FG002|Overall Study|Study Terminated By Sponsor|0|||
145965466|NCT03555149|526387540|FG003|Overall Study|Study Terminated By Sponsor|0|||
145965467|NCT03555149|526387541|FG004|Overall Study|Study Terminated By Sponsor|0|||
145965468|NCT03555149|526387542|FG005|Overall Study|Study Terminated By Sponsor|2|||
145965469|NCT03555149|526387543|FG006|Overall Study|Study Terminated By Sponsor|3|||
145965470|NCT03555149|526387544|FG007|Overall Study|Study Terminated By Sponsor|1|||
145965471|NCT03555149|526387537|FG000|Overall Study|Withdrawal by Subject|3|||
145965472|NCT03555149|526387538|FG001|Overall Study|Withdrawal by Subject|0|||
145965473|NCT03555149|526387539|FG002|Overall Study|Withdrawal by Subject|0|||
145965474|NCT03555149|526387540|FG003|Overall Study|Withdrawal by Subject|2|||
145965475|NCT03555149|526387541|FG004|Overall Study|Withdrawal by Subject|0|||
145965476|NCT03555149|526387542|FG005|Overall Study|Withdrawal by Subject|1|||
145965477|NCT03555149|526387543|FG006|Overall Study|Withdrawal by Subject|0|||
145965478|NCT03555149|526387544|FG007|Overall Study|Withdrawal by Subject|0|||
145965479|NCT02666222|526387548|FG000|Overall Study|Death|2|||
145965480|NCT01474486|526387557|FG000|Overall Study|Death|2|||
145965481|NCT01474486|526387557|FG000|Overall Study|Withdrawal by Subject|4|||
145965482|NCT01474486|526387557|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
145965483|NCT03863353|526387558|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
145965484|NCT03863353|526387559|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
145965485|NCT04079790|526387560|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
145965486|NCT04079790|526387561|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145965487|NCT04079790|526387562|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145965488|NCT04079790|526387563|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145965489|NCT04079790|526387560|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145965490|NCT04079790|526387561|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145965491|NCT04079790|526387562|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
145965492|NCT04079790|526387563|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145965493|NCT04079790|526387560|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145965494|NCT04079790|526387561|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145965495|NCT04079790|526387562|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
145965496|NCT04079790|526387563|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145965497|NCT05817669|526387564|FG000|Overall Study|Prohibited medication used|1|||
145965498|NCT05817669|526387565|FG001|Overall Study|Prohibited medication used|2|||
145965499|NCT05817669|526387564|FG000|Overall Study|Adverse Event|1|||
145965500|NCT05817669|526387565|FG001|Overall Study|Adverse Event|0|||
145965501|NCT05817669|526387564|FG000|Overall Study|Withdrawal by Subject|1|||
145965502|NCT05817669|526387565|FG001|Overall Study|Withdrawal by Subject|2|||
146232322|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232323|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232324|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232325|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232326|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232327|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232328|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232329|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232330|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232331|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
146232332|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Death|2|||
146232333|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Death|1|||
146232334|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Death|1|||
146232335|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Death|0|||
146232336|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Death|0|||
146232337|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Death|0|||
146232338|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Death|0|||
146232339|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Death|0|||
146232340|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Death|0|||
146232341|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Death|0|||
146232342|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Death|0|||
146232343|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Death|0|||
146232344|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Death|0|||
146232345|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Death|0|||
146232346|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Death|0|||
146232347|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Death|0|||
146232348|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Death|0|||
145965503|NCT03810183|526387567|FG000|Overall Study|Study terminated by Sponsor|2|||
145965504|NCT03810183|526387568|FG001|Overall Study|Study terminated by Sponsor|1|||
145965505|NCT01038687|526387569|FG000|Overall Study|Adverse Event|0|||
145965506|NCT01038687|526387570|FG001|Overall Study|Adverse Event|2|||
145965507|NCT01038687|526387571|FG002|Overall Study|Adverse Event|1|||
145965508|NCT05222880|526387572|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145965509|NCT05222880|526387572|FG000|Overall Study|Withdrew Consent during Study|1|||
145965510|NCT05222880|526387572|FG000|Overall Study|COVID-19 Related|1|||
145965511|NCT05401565|526387573|FG000|Overall Study|Lost to Follow-up|1|||
145965512|NCT05401565|526387574|FG001|Overall Study|Lost to Follow-up|0|||
145965513|NCT05401565|526387573|FG000|Overall Study|Adverse Event|2|||
145965514|NCT05401565|526387574|FG001|Overall Study|Adverse Event|0|||
145965515|NCT03177148|526387589|FG000|Overall Study|Lost to Follow-up|50|||
145965516|NCT03177148|526387590|FG001|Overall Study|Lost to Follow-up|1|||
145965517|NCT03177148|526387589|FG000|Overall Study|Death|1|||
145965518|NCT03177148|526387590|FG001|Overall Study|Death|0|||
145965519|NCT02563899|526387591|FG000|Overall Study|Protocol Violation|1|||
145965520|NCT02563899|526387592|FG001|Overall Study|Protocol Violation|0|||
145965521|NCT02563899|526387593|FG002|Overall Study|Protocol Violation|0|||
145965522|NCT02563899|526387594|FG003|Overall Study|Protocol Violation|0|||
145965523|NCT02563899|526387591|FG000|Overall Study|Withdrawal by Subject|0|||
145965524|NCT02563899|526387592|FG001|Overall Study|Withdrawal by Subject|0|||
145965525|NCT02563899|526387593|FG002|Overall Study|Withdrawal by Subject|1|||
145965526|NCT02563899|526387594|FG003|Overall Study|Withdrawal by Subject|0|||
145965527|NCT02033759|526387603|FG000|Overall Study|Withdrawal by Subject|2|||
145965528|NCT02033759|526387604|FG001|Overall Study|Withdrawal by Subject|1|||
145965529|NCT02033759|526387603|FG000|Overall Study|Protocol Violation|1|||
145965530|NCT02033759|526387604|FG001|Overall Study|Protocol Violation|1|||
145965531|NCT00975416|526389601|FG000|Overall Study|early discharge from tx|3|||
145965532|NCT00975416|526389602|FG001|Overall Study|early discharge from tx|5|||
145965533|NCT00106002|526389604|FG000|Overall Study|Did not take any study drug|1|||
145965534|NCT00106002|526389604|FG000|Overall Study|Ineligible after Registration|1|||
145965535|NCT01026493|526389613|FG000|Overall Study|Protocol Violation|0|||
145965536|NCT01026493|526389614|FG001|Overall Study|Protocol Violation|1|||
145965537|NCT01026493|526389615|FG002|Overall Study|Protocol Violation|0|||
145965538|NCT01026493|526389616|FG003|Overall Study|Protocol Violation|0|||
145965539|NCT01026493|526389617|FG004|Overall Study|Protocol Violation|2|||
145965540|NCT01026493|526389618|FG005|Overall Study|Protocol Violation|3|||
145965541|NCT01026493|526389619|FG006|Overall Study|Protocol Violation|4|||
145965542|NCT01026493|526389620|FG007|Overall Study|Protocol Violation|1|||
145965543|NCT03154086|526389624|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965544|NCT03154086|526389625|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965545|NCT03154086|526389626|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965546|NCT03154086|526389627|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
145965547|NCT03154086|526389628|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965548|NCT03154086|526389629|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965549|NCT03154086|526389630|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965550|NCT03154086|526389631|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965551|NCT03154086|526389632|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965552|NCT03154086|526389633|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965553|NCT03154086|526389634|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965554|NCT03154086|526389635|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965555|NCT03154086|526389636|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965556|NCT03154086|526389637|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965557|NCT03154086|526389638|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145965558|NCT03154086|526389624|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965559|NCT03154086|526389625|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
145965560|NCT03154086|526389626|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965561|NCT03154086|526389627|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965562|NCT03154086|526389628|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965563|NCT03154086|526389629|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965564|NCT03154086|526389630|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965565|NCT03154086|526389631|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965566|NCT03154086|526389632|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965567|NCT03154086|526389633|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965568|NCT03154086|526389634|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965569|NCT03154086|526389635|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965570|NCT03154086|526389636|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965571|NCT03154086|526389637|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965572|NCT03154086|526389638|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145965573|NCT03154086|526389624|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965574|NCT03154086|526389625|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965575|NCT03154086|526389626|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
145965576|NCT03154086|526389627|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965577|NCT03154086|526389628|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965578|NCT03154086|526389629|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965579|NCT03154086|526389630|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965580|NCT03154086|526389631|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965581|NCT03154086|526389632|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965582|NCT03154086|526389633|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965583|NCT03154086|526389634|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965584|NCT03154086|526389635|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965585|NCT03154086|526389636|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965586|NCT03154086|526389637|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965587|NCT03154086|526389638|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145965588|NCT03154086|526389624|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
145965589|NCT03154086|526389625|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965590|NCT03154086|526389626|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965591|NCT03154086|526389627|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965592|NCT03154086|526389628|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965593|NCT03154086|526389629|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965594|NCT03154086|526389630|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965595|NCT03154086|526389631|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965596|NCT03154086|526389632|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965597|NCT03154086|526389633|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965598|NCT03154086|526389634|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965599|NCT03154086|526389635|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965600|NCT03154086|526389636|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965601|NCT03154086|526389637|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965602|NCT03154086|526389638|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145965603|NCT03154086|526389624|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965604|NCT03154086|526389625|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965605|NCT03154086|526389626|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965606|NCT03154086|526389627|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965607|NCT03154086|526389628|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965608|NCT03154086|526389629|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965609|NCT03154086|526389630|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146086691|NCT00884377|526838355|FG000|Overall Study|Withdrawal by Subject|1|||
146232349|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232350|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
146232351|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232352|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232353|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
146232354|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
146232355|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232356|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232357|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232358|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232359|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232360|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232361|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232362|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232363|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232364|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
146232365|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
146290912|NCT02699983|527580483|FG001|Overall Study|Withdrawal by Subject|0|||
145965610|NCT03154086|526389631|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965611|NCT03154086|526389632|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
146232366|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232367|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232368|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232369|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232370|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
146232371|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
145887623|NCT01435031|526092685|FG000|ITT at 1 Year|Death|1|||
146232372|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232373|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232374|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232375|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232376|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232377|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232378|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232379|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232380|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232381|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232382|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
146232383|NCT02719574|527369480|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146086692|NCT00884377|526838356|FG001|Overall Study|Withdrawal by Subject|0|||
146086693|NCT00884377|526838355|FG000|Overall Study|Could not confirm diagnosis|1|||
146086694|NCT00884377|526838356|FG001|Overall Study|Could not confirm diagnosis|0|||
146232384|NCT02719574|527369481|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232385|NCT02719574|527369482|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
146232386|NCT02719574|527369483|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232387|NCT02719574|527369484|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232388|NCT02719574|527369485|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232389|NCT02719574|527369486|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232390|NCT02719574|527369487|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232391|NCT02719574|527369488|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232392|NCT02719574|527369489|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232393|NCT02719574|527369490|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232394|NCT02719574|527369491|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232395|NCT02719574|527369492|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232396|NCT02719574|527369493|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232397|NCT02719574|527369494|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232398|NCT02719574|527369495|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146086695|NCT00884377|526838355|FG000|Overall Study|Physician Decision|0|||
145887624|NCT01435031|526092685|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
146232399|NCT02719574|527369496|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
146232400|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232401|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232402|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232403|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145887625|NCT01435031|526092685|FG000|ITT at 1 Year|Lost to Follow-up|6|||
145887626|NCT01435031|526092685|FG000|ITT at 2 Years|Death|7|||
145887627|NCT01435031|526092685|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
145887628|NCT01435031|526092685|FG000|ITT at 2 Years|Lost to Follow-up|4|||
145887629|NCT01435031|526092685|FG000|ITT at 3 Years|Death|5|||
145887630|NCT01435031|526092685|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
145887631|NCT01435031|526092685|FG000|ITT at 3 Years|Lost to Follow-up|4|||
145887632|NCT01435031|526092685|FG000|ITT at 4 Years|Death|4|||
145887633|NCT01435031|526092685|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
145887634|NCT01435031|526092685|FG000|ITT at 4 Years|Lost to Follow-up|1|||
145887635|NCT02927834|526092686|FG000|Overall Study|Lost to Follow-up|1|||
145887636|NCT02927834|526092687|FG001|Overall Study|Lost to Follow-up|2|||
145887637|NCT02927834|526092688|FG002|Overall Study|Lost to Follow-up|2|||
145887638|NCT00613730|526092692|FG000|Overall Study|Disease progression|2|||
145887639|NCT00613730|526092692|FG000|Overall Study|Administrative decision|1|||
145887640|NCT00479388|526092693|FG000|Overall Study|Adverse Event|90|||
145887641|NCT00479388|526092694|FG001|Overall Study|Adverse Event|45|||
145887642|NCT00479388|526092693|FG000|Overall Study|Lost to Follow-up|0|||
145887643|NCT00479388|526092694|FG001|Overall Study|Lost to Follow-up|2|||
145887644|NCT00479388|526092693|FG000|Overall Study|Protocol Violation|10|||
145887645|NCT00479388|526092694|FG001|Overall Study|Protocol Violation|9|||
145887646|NCT00479388|526092693|FG000|Overall Study|Withdrawal by Subject|32|||
145887647|NCT00479388|526092694|FG001|Overall Study|Withdrawal by Subject|17|||
146232404|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232405|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146290913|NCT02070588|527580489|FG000|Overall Study|Withdrawal by Subject|29|||
145887648|NCT01876368|526092697|FG000|Overall Study|Adverse Event|2|||
145887649|NCT01876368|526092698|FG001|Overall Study|Adverse Event|5|||
145887650|NCT01876368|526092697|FG000|Overall Study|Lack of Efficacy|1|||
146290914|NCT02070588|527580490|FG001|Overall Study|Withdrawal by Subject|1|||
145887651|NCT01876368|526092698|FG001|Overall Study|Lack of Efficacy|0|||
145887652|NCT01876368|526092697|FG000|Overall Study|Lost to Follow-up|0|||
145887653|NCT01876368|526092698|FG001|Overall Study|Lost to Follow-up|1|||
145887654|NCT01876368|526092697|FG000|Overall Study|Non-compliance with study treatment|0|||
146086696|NCT00884377|526838356|FG001|Overall Study|Physician Decision|1|||
145887655|NCT01876368|526092698|FG001|Overall Study|Non-compliance with study treatment|1|||
145965612|NCT03154086|526389633|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965613|NCT03154086|526389634|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965614|NCT03154086|526389635|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965615|NCT03154086|526389636|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145887656|NCT01876368|526092697|FG000|Overall Study|Physician Decision|0|||
145887657|NCT01876368|526092698|FG001|Overall Study|Physician Decision|2|||
145887658|NCT01876368|526092697|FG000|Overall Study|Protocol deviation|3|||
145887659|NCT01876368|526092698|FG001|Overall Study|Protocol deviation|3|||
145887660|NCT01876368|526092697|FG000|Overall Study|Subject/guardian decision|3|||
145887661|NCT01876368|526092698|FG001|Overall Study|Subject/guardian decision|1|||
145887662|NCT02563769|526092699|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
145887663|NCT02563769|526092700|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
145887664|NCT02563769|526092701|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
145887665|NCT00104247|526092704|FG000|Overall Study|Withdrawal by Subject|1|||
145887666|NCT00104247|526092705|FG001|Overall Study|Withdrawal by Subject|0|||
145887667|NCT00104247|526092704|FG000|Overall Study|Noncompliant with dosing|0|||
145887668|NCT00104247|526092705|FG001|Overall Study|Noncompliant with dosing|1|||
145887669|NCT01644149|526092706|FG000|Overall Study|Withdrawal by Subject|1|||
145887670|NCT01644149|526092707|FG001|Overall Study|Withdrawal by Subject|0|||
145887671|NCT01644149|526092706|FG000|Overall Study|Lost to Follow-up|3|||
145887672|NCT01644149|526092707|FG001|Overall Study|Lost to Follow-up|1|||
145887673|NCT04798482|526092710|FG000|Overall Study|Physician Decision|1|||
145887674|NCT04798482|526092710|FG000|Overall Study|Lost eligibility|1|||
145887675|NCT01930175|526092716|FG000|Core Study|Lost to Follow-up|0|||
145887676|NCT01930175|526092717|FG001|Core Study|Lost to Follow-up|1|||
145887677|NCT01930175|526092718|FG002|Core Study|Lost to Follow-up|0|||
145887678|NCT01930175|526092716|FG000|Core Study|Adverse Event|0|||
145887679|NCT01930175|526092717|FG001|Core Study|Adverse Event|0|||
145887680|NCT01930175|526092718|FG002|Core Study|Adverse Event|1|||
145887681|NCT00605917|526092719|FG000|Overall Study|Protocol Violation|79|||
145887682|NCT00890552|526092721|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
145887683|NCT00890552|526092721|FG000|On-treatment|Early prog disease/ death|10|||
145887684|NCT03718117|526092723|FG000|Overall Study|Death|12|||
145887685|NCT03718117|526092724|FG001|Overall Study|Death|11|||
145887686|NCT03718117|526092725|FG002|Overall Study|Death|0|||
145887687|NCT03718117|526092723|FG000|Overall Study|Other|0|||
145887688|NCT03718117|526092724|FG001|Overall Study|Other|1|||
145887689|NCT03718117|526092725|FG002|Overall Study|Other|0|||
145965616|NCT03154086|526389637|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
146086697|NCT02316548|526838357|FG000|Overall Study|Protocol Violation|0|||
145887690|NCT03718117|526092723|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
145887691|NCT03718117|526092724|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
145887692|NCT03718117|526092725|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
145887693|NCT03718117|526092723|FG000|Overall Study|Participant not met eligibility criteria|0|||
145887694|NCT03718117|526092724|FG001|Overall Study|Participant not met eligibility criteria|0|||
145887695|NCT03718117|526092725|FG002|Overall Study|Participant not met eligibility criteria|2|||
145887696|NCT01382251|526092726|FG000|Overall Study|Surgeries cancelled or delayed|16|||
145965617|NCT03154086|526389638|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145965618|NCT03154086|526389624|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965619|NCT03154086|526389625|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965620|NCT03154086|526389626|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965621|NCT03154086|526389627|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965622|NCT03154086|526389628|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965623|NCT03154086|526389629|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965624|NCT03154086|526389630|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965625|NCT03154086|526389631|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
145965626|NCT03154086|526389632|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965627|NCT03154086|526389633|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965628|NCT03154086|526389634|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965629|NCT03154086|526389635|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965630|NCT03154086|526389636|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965631|NCT03154086|526389637|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965632|NCT03154086|526389638|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145965633|NCT03154086|526389624|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
145965634|NCT03154086|526389625|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
145965635|NCT03154086|526389626|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
145965636|NCT03154086|526389627|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
145965637|NCT03154086|526389628|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
145965638|NCT03154086|526389629|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
145965639|NCT03154086|526389630|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
145965640|NCT03154086|526389631|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
145965641|NCT03154086|526389632|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
145965642|NCT03154086|526389633|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
145965643|NCT03154086|526389634|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
145965644|NCT03154086|526389635|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
145965645|NCT03154086|526389636|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
145965646|NCT03154086|526389637|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
145965647|NCT03154086|526389638|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
145965648|NCT04076917|526389639|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
145965649|NCT04076917|526389639|FG000|Overall Study|Study closure|13|||
145965650|NCT04076917|526389639|FG000|Overall Study|Physician Decision|3|||
145965651|NCT04076917|526389639|FG000|Overall Study|Death|1|||
145965652|NCT04076917|526389639|FG000|Overall Study|Lost to Follow-up|1|||
145965653|NCT04076917|526389639|FG000|Overall Study|Withdrawal by Subject|1|||
145965654|NCT04076917|526389639|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
145965655|NCT01701245|526389642|FG000|Overall Study|Protocol Violation|1|||
145965656|NCT01701245|526389643|FG001|Overall Study|Protocol Violation|3|||
145965657|NCT01701245|526389642|FG000|Overall Study|Did not complete the open label period|11|||
145965658|NCT01701245|526389643|FG001|Overall Study|Did not complete the open label period|12|||
146290915|NCT02070588|527580491|FG002|Overall Study|Withdrawal by Subject|0|||
146290916|NCT02070588|527580489|FG000|Overall Study|Writhdrawal due to early termination|9|||
145965659|NCT02295644|526389653|FG000|Overall Study|Did not meet inclusion criterion|0|||
145965660|NCT02295644|526389654|FG001|Overall Study|Did not meet inclusion criterion|0|||
145965661|NCT02295644|526389655|FG002|Overall Study|Did not meet inclusion criterion|1|||
146290917|NCT02070588|527580490|FG001|Overall Study|Writhdrawal due to early termination|0|||
146290918|NCT02070588|527580491|FG002|Overall Study|Writhdrawal due to early termination|0|||
145965662|NCT02295644|526389656|FG003|Overall Study|Did not meet inclusion criterion|2|||
145965663|NCT03504917|526389657|FG000|Blinded Treatment Period|Protocol Violation|1|||
145965664|NCT03504917|526389658|FG001|Blinded Treatment Period|Protocol Violation|0|||
145965665|NCT03504917|526389657|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
145965666|NCT03504917|526389658|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
145965667|NCT03504917|526389657|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
145965668|NCT03504917|526389658|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
146290919|NCT02070588|527580489|FG000|Overall Study|Adverse Event|1|||
145887697|NCT01382251|526092727|FG001|Overall Study|Surgeries cancelled or delayed|16|||
145887698|NCT01382251|526092726|FG000|Overall Study|Lost to Follow-up|4|||
145887699|NCT01382251|526092727|FG001|Overall Study|Lost to Follow-up|4|||
145887700|NCT01382251|526092726|FG000|Overall Study|Contacted after study closed|1|||
145887701|NCT01382251|526092727|FG001|Overall Study|Contacted after study closed|1|||
145887702|NCT01117987|526092728|FG000|Overall Study|Protocol deviation|0|||
145887703|NCT01117987|526092729|FG001|Overall Study|Protocol deviation|1|||
145887704|NCT01117987|526092728|FG000|Overall Study|Subject no longer requires study drug|1|||
145887705|NCT01117987|526092729|FG001|Overall Study|Subject no longer requires study drug|0|||
145887706|NCT01117987|526092728|FG000|Overall Study|Lost to Follow-up|1|||
145887707|NCT01117987|526092729|FG001|Overall Study|Lost to Follow-up|1|||
145887708|NCT01117987|526092728|FG000|Overall Study|Abnormal test procedure result|2|||
145887709|NCT01117987|526092729|FG001|Overall Study|Abnormal test procedure result|0|||
145887710|NCT01117987|526092728|FG000|Overall Study|Lack of Efficacy|3|||
145887711|NCT01117987|526092729|FG001|Overall Study|Lack of Efficacy|4|||
145887712|NCT01117987|526092728|FG000|Overall Study|Death|5|||
145887713|NCT01117987|526092729|FG001|Overall Study|Death|10|||
145887714|NCT01117987|526092728|FG000|Overall Study|Withdrawal by Subject|5|||
145887715|NCT01117987|526092729|FG001|Overall Study|Withdrawal by Subject|10|||
145887716|NCT01117987|526092728|FG000|Overall Study|Adverse Event|19|||
145887717|NCT01117987|526092729|FG001|Overall Study|Adverse Event|26|||
145887718|NCT01117987|526092728|FG000|Overall Study|Administrative problems|25|||
145887719|NCT01117987|526092729|FG001|Overall Study|Administrative problems|22|||
145887720|NCT04232540|526092733|FG000|Overall Study|Lost to Follow-up|1|||
145887721|NCT04232540|526092734|FG001|Overall Study|Lost to Follow-up|0|||
145887722|NCT02339090|526092740|FG000|Overall Study|Adverse Event|1|||
145887723|NCT02339090|526092741|FG001|Overall Study|Adverse Event|0|||
145887724|NCT02339090|526092740|FG000|Overall Study|Lost to Follow-up|0|||
145887725|NCT02339090|526092741|FG001|Overall Study|Lost to Follow-up|1|||
145887726|NCT02339090|526092740|FG000|Overall Study|Non-compliance With Study Drug|0|||
145887727|NCT02339090|526092741|FG001|Overall Study|Non-compliance With Study Drug|1|||
145887728|NCT02339090|526092740|FG000|Overall Study|Withdrawal by Subject|2|||
145887729|NCT02339090|526092741|FG001|Overall Study|Withdrawal by Subject|1|||
145887730|NCT02339090|526092740|FG000|Overall Study|Poor Growth|3|||
145887731|NCT02339090|526092741|FG001|Overall Study|Poor Growth|0|||
145887732|NCT02339090|526092740|FG000|Overall Study|Randomized but not treated|0|||
146086698|NCT02316548|526838358|FG001|Overall Study|Protocol Violation|1|||
146232406|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
145887733|NCT02339090|526092741|FG001|Overall Study|Randomized but not treated|2|||
145887734|NCT02737592|526092742|FG000|Overall Study|Withdrawal by Subject|1|||
145887735|NCT00749411|526092749|FG000|Overall Study|Adverse Event|0|||
145887736|NCT00749411|526092750|FG001|Overall Study|Adverse Event|2|||
145887737|NCT00749411|526092749|FG000|Overall Study|Lack of Efficacy|0|||
145887738|NCT00749411|526092750|FG001|Overall Study|Lack of Efficacy|1|||
145887739|NCT00749411|526092749|FG000|Overall Study|Protocol Violation|1|||
145887740|NCT00749411|526092750|FG001|Overall Study|Protocol Violation|1|||
145887741|NCT00749411|526092749|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145887742|NCT00749411|526092750|FG001|Overall Study|Protocol-defined stopping criteria|1|||
145887743|NCT00880087|526094930|FG000|Overall Study|Lost to Follow-up|0|||
145887744|NCT00880087|526094931|FG001|Overall Study|Lost to Follow-up|2|||
145887745|NCT01005329|526094935|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
145887746|NCT00126126|526094938|FG000|Overall Study|Lost to Follow-up|0|||
145887747|NCT00126126|526094939|FG001|Overall Study|Lost to Follow-up|2|||
145887748|NCT02225665|526094943|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
145887749|NCT02225665|526094944|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
145887750|NCT02225665|526094943|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
145887751|NCT02225665|526094944|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
145887752|NCT01470417|526094947|FG000|Overall Study|Disease progression|0|||
145887753|NCT01470417|526094948|FG001|Overall Study|Disease progression|2|||
145887754|NCT02973321|526094951|FG000|Overall Study|Other than specified|0|||
145887755|NCT02973321|526094952|FG001|Overall Study|Other than specified|5|||
145887756|NCT02973321|526094953|FG002|Overall Study|Other than specified|3|||
145887757|NCT02973321|526094954|FG003|Overall Study|Other than specified|3|||
145887758|NCT02973321|526094955|FG004|Overall Study|Other than specified|1|||
145887759|NCT02973321|526094951|FG000|Overall Study|Lack of Efficacy|0|||
145887760|NCT02973321|526094952|FG001|Overall Study|Lack of Efficacy|0|||
145887761|NCT02973321|526094953|FG002|Overall Study|Lack of Efficacy|0|||
145887762|NCT02973321|526094954|FG003|Overall Study|Lack of Efficacy|0|||
145887763|NCT02973321|526094955|FG004|Overall Study|Lack of Efficacy|1|||
145887764|NCT02973321|526094951|FG000|Overall Study|Adverse Event|1|||
145887765|NCT02973321|526094952|FG001|Overall Study|Adverse Event|10|||
145887766|NCT02973321|526094953|FG002|Overall Study|Adverse Event|11|||
145887767|NCT02973321|526094954|FG003|Overall Study|Adverse Event|13|||
145887768|NCT02973321|526094955|FG004|Overall Study|Adverse Event|3|||
145887769|NCT01098110|526094957|FG000|Overall Study|Withdrawal by Subject|14|||
145887770|NCT01098110|526094958|FG001|Overall Study|Withdrawal by Subject|24|||
145887771|NCT01098110|526094959|FG002|Overall Study|Withdrawal by Subject|19|||
145887772|NCT01098110|526094957|FG000|Overall Study|Adverse Event|30|||
145887773|NCT01098110|526094958|FG001|Overall Study|Adverse Event|32|||
145887774|NCT01098110|526094959|FG002|Overall Study|Adverse Event|43|||
145887775|NCT01098110|526094957|FG000|Overall Study|Lack of Efficacy|13|||
145887776|NCT01098110|526094958|FG001|Overall Study|Lack of Efficacy|9|||
145887777|NCT01098110|526094959|FG002|Overall Study|Lack of Efficacy|27|||
145887778|NCT01098110|526094957|FG000|Overall Study|Other|4|||
145887779|NCT01098110|526094958|FG001|Overall Study|Other|7|||
145887780|NCT01098110|526094959|FG002|Overall Study|Other|5|||
145887781|NCT01098110|526094957|FG000|Overall Study|Untreated|1|||
145887782|NCT01098110|526094958|FG001|Overall Study|Untreated|1|||
145965669|NCT03504917|526389657|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
145965670|NCT03504917|526389658|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
145887783|NCT01098110|526094959|FG002|Overall Study|Untreated|0|||
145887784|NCT00865514|526094960|FG000|Overall Study|Infusion cost exceeded funding|2|||
145887785|NCT03649412|526094961|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
145887786|NCT03649412|526094962|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
145887787|NCT03649412|526094961|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
145887788|NCT03649412|526094962|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
145887789|NCT03649412|526094961|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
145887790|NCT03649412|526094962|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145887791|NCT03649412|526094961|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
145887792|NCT03649412|526094962|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
145887793|NCT03649412|526094961|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
145887794|NCT03649412|526094962|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
145887795|NCT03649412|526094961|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
145887796|NCT03649412|526094962|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
145965671|NCT03504917|526389657|FG000|Blinded Treatment Period|Adverse Event|4|||
145965672|NCT03504917|526389658|FG001|Blinded Treatment Period|Adverse Event|4|||
145965673|NCT03504917|526389657|FG000|Blinded Treatment Period|Physician Decision|1|||
145965674|NCT03504917|526389658|FG001|Blinded Treatment Period|Physician Decision|0|||
145965675|NCT03504917|526389657|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
145965676|NCT03504917|526389658|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
145965677|NCT03504917|526389657|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
145965678|NCT03504917|526389658|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
145965679|NCT03504917|526389657|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
145965680|NCT03504917|526389658|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
145965681|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
145965682|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
145965683|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
145965684|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
145965685|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
145965686|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
145965687|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
145965688|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
145965689|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
145965690|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
145965691|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
146290920|NCT02070588|527580490|FG001|Overall Study|Adverse Event|0|||
146290921|NCT02070588|527580491|FG002|Overall Study|Adverse Event|0|||
146290922|NCT01790126|527580497|FG000|Overall Study|PSA Progression|12|||
146290923|NCT01790126|527580498|FG001|Overall Study|PSA Progression|16|||
146290924|NCT01790126|527580499|FG002|Overall Study|PSA Progression|16|||
146290925|NCT01790126|527580497|FG000|Overall Study|Other|5|||
145965692|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
145965693|NCT03504917|526389657|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
145965694|NCT03504917|526389658|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
145965695|NCT04219189|526389659|FG000|Overall Study|Withdrawal by Subject|1|||
145965696|NCT04219189|526389660|FG001|Overall Study|Withdrawal by Subject|2|||
145965697|NCT04219189|526389659|FG000|Overall Study|Protocol Violation|0|||
145965698|NCT04219189|526389660|FG001|Overall Study|Protocol Violation|1|||
145965699|NCT04219189|526389659|FG000|Overall Study|Lost to Follow-up|0|||
145965700|NCT04219189|526389660|FG001|Overall Study|Lost to Follow-up|1|||
145965701|NCT04219189|526389659|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
145965702|NCT04219189|526389660|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
145965703|NCT01299584|526389661|FG000|Overall Study|Protocol Violation|9|||
145965704|NCT00572832|526389662|FG000|Overall Study|Lost to Follow-up|0|||
145965705|NCT00572832|526389663|FG001|Overall Study|Lost to Follow-up|11|||
145965706|NCT00572832|526389662|FG000|Overall Study|Pregnancy|0|||
145965707|NCT00572832|526389663|FG001|Overall Study|Pregnancy|1|||
145965708|NCT00324155|526389667|FG000|Enrolled and Randomized|No longer met study criteria|3|||
145965709|NCT00324155|526389668|FG001|Enrolled and Randomized|No longer met study criteria|0|||
145965710|NCT00324155|526389667|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
145965711|NCT00324155|526389668|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
145965712|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
145965713|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
145965714|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
145965715|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
145965716|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Death|8|||
145965717|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Death|15|||
145965718|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
145965719|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
145965720|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
145965721|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
145965722|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
145965723|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
145965724|NCT00324155|526389667|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
145965725|NCT00324155|526389668|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
145965726|NCT00324155|526389667|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
145965727|NCT00324155|526389668|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
145965728|NCT00324155|526389667|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
146290926|NCT01790126|527580498|FG001|Overall Study|Other|4|||
145965729|NCT00324155|526389668|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
146290927|NCT01790126|527580499|FG002|Overall Study|Other|8|||
145887797|NCT02865395|526094963|FG000|Overall Study|Physician Decision|6|||
145887798|NCT02865395|526094964|FG001|Overall Study|Physician Decision|10|||
145887799|NCT02865395|526094965|FG002|Overall Study|Physician Decision|7|||
145887800|NCT00530348|526094966|FG000|Overall Study|Adverse Event|5|||
145887801|NCT00530348|526094967|FG001|Overall Study|Adverse Event|1|||
145887802|NCT00530348|526094966|FG000|Overall Study|Death|0|||
145887803|NCT00530348|526094967|FG001|Overall Study|Death|1|||
145887804|NCT00530348|526094966|FG000|Overall Study|Lack of Efficacy|2|||
145887805|NCT00530348|526094967|FG001|Overall Study|Lack of Efficacy|0|||
145887806|NCT00530348|526094966|FG000|Overall Study|Lost to Follow-up|0|||
145887807|NCT00530348|526094967|FG001|Overall Study|Lost to Follow-up|2|||
145887808|NCT00530348|526094966|FG000|Overall Study|Physician Decision|1|||
145887809|NCT00530348|526094967|FG001|Overall Study|Physician Decision|2|||
145887810|NCT00530348|526094966|FG000|Overall Study|Pregnancy|1|||
145887811|NCT00530348|526094967|FG001|Overall Study|Pregnancy|0|||
145887812|NCT00530348|526094966|FG000|Overall Study|Withdrawal by Subject|12|||
145887813|NCT00530348|526094967|FG001|Overall Study|Withdrawal by Subject|12|||
145887814|NCT00530348|526094966|FG000|Overall Study|Randomised in error|1|||
145887815|NCT00530348|526094967|FG001|Overall Study|Randomised in error|0|||
145887816|NCT00530348|526094966|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
145887817|NCT00530348|526094967|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
145887818|NCT03920280|526094968|FG000|Overall Study|Adverse Event|2|||
145887819|NCT03920280|526094969|FG001|Overall Study|Adverse Event|3|||
145887820|NCT03920280|526094968|FG000|Overall Study|Lost to Follow-up|0|||
145887821|NCT03920280|526094969|FG001|Overall Study|Lost to Follow-up|1|||
145887822|NCT03920280|526094968|FG000|Overall Study|Withdrawal by Subject|1|||
145887823|NCT03920280|526094969|FG001|Overall Study|Withdrawal by Subject|1|||
145887824|NCT03920280|526094968|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
145887825|NCT03920280|526094969|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
145887826|NCT02075606|526094972|FG000|Overall Study|Adverse Event|5|||
145887827|NCT02075606|526094972|FG000|Overall Study|Withdrawal by Subject|1|||
145887828|NCT02075606|526094972|FG000|Overall Study|Death|1|||
145887829|NCT02075606|526094972|FG000|Overall Study|Investigator's decision|1|||
145887830|NCT02075606|526094972|FG000|Overall Study|Symptom management|1|||
145887831|NCT02075606|526094972|FG000|Overall Study|Increasing Symptoms|1|||
145887832|NCT01439724|526094975|FG000|Overall Study|missing consultation|9|||
145887833|NCT01439724|526094976|FG001|Overall Study|missing consultation|8|||
145887834|NCT04019054|526094977|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
145887835|NCT04019054|526094978|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
145887836|NCT04019054|526094977|FG000|Overall Study|Withdrawal by Subject|3|||
145887837|NCT04019054|526094978|FG001|Overall Study|Withdrawal by Subject|1|||
145887838|NCT01261624|526094984|FG000|Week 0 to Week 12|Disease Progression|1|||
145887839|NCT01261624|526094985|FG001|Week 0 to Week 12|Disease Progression|1|||
145887840|NCT01261624|526094984|FG000|Week 0 to Week 12|Insufficient Response|0|||
145887841|NCT01261624|526094985|FG001|Week 0 to Week 12|Insufficient Response|2|||
145887842|NCT01261624|526094984|FG000|Week 13 to Week 24|Insufficient Response|0|||
145887843|NCT01261624|526094985|FG001|Week 13 to Week 24|Insufficient Response|1|||
145887844|NCT00271024|526094986|FG000|Overall Study|Lost Interest|3|||
145887845|NCT00271024|526094987|FG001|Overall Study|Lost Interest|4|||
145887846|NCT00271024|526094988|FG002|Overall Study|Lost Interest|2|||
145887847|NCT00271024|526094989|FG003|Overall Study|Lost Interest|3|||
145887848|NCT00271024|526094986|FG000|Overall Study|Unknown/Unspecified|11|||
145887849|NCT00271024|526094987|FG001|Overall Study|Unknown/Unspecified|11|||
145887850|NCT00271024|526094988|FG002|Overall Study|Unknown/Unspecified|8|||
145887851|NCT00271024|526094989|FG003|Overall Study|Unknown/Unspecified|4|||
145887852|NCT00271024|526094986|FG000|Overall Study|Protocol Violation|1|||
145887853|NCT00271024|526094987|FG001|Overall Study|Protocol Violation|6|||
145887854|NCT00271024|526094988|FG002|Overall Study|Protocol Violation|5|||
145887855|NCT00271024|526094989|FG003|Overall Study|Protocol Violation|11|||
145887856|NCT00271024|526094986|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
145887857|NCT00271024|526094987|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
145887858|NCT00271024|526094988|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
145887859|NCT00271024|526094989|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
145887860|NCT00271024|526094986|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
145887861|NCT00271024|526094987|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
145887862|NCT00271024|526094988|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
145887863|NCT00271024|526094989|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
145887864|NCT00508027|526095000|FG000|Dose Level 1|Lost to Follow-up|4|||
145887865|NCT00508027|526095000|FG000|Dose Level 1|Withdrawal by Subject|2|||
145887866|NCT00508027|526095000|FG000|Dose Level 1|Physician Decision|2|||
145887867|NCT00508027|526095000|FG000|Dose Level 2|Lost to Follow-up|2|||
145887868|NCT00508027|526095000|FG000|Dose Level 2|Withdrawal by Subject|2|||
145965730|NCT00324155|526389667|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
145965731|NCT00324155|526389668|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
145965732|NCT00324155|526389667|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
145965733|NCT00324155|526389668|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
145965734|NCT00324155|526389667|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
145965735|NCT00324155|526389668|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
145965736|NCT00324155|526389667|FG000|Follow-up Phase|On-going participants still on drug|11|||
145965737|NCT00324155|526389668|FG001|Follow-up Phase|On-going participants still on drug|6|||
145965738|NCT00390689|526389669|FG000|Overall Study|Adverse Event|2|||
145965739|NCT00390689|526389670|FG001|Overall Study|Adverse Event|5|||
145965740|NCT00390689|526389671|FG002|Overall Study|Adverse Event|2|||
145965741|NCT00390689|526389669|FG000|Overall Study|Lack of Efficacy|0|||
145965742|NCT00390689|526389670|FG001|Overall Study|Lack of Efficacy|0|||
145965743|NCT00390689|526389671|FG002|Overall Study|Lack of Efficacy|1|||
145965744|NCT00390689|526389669|FG000|Overall Study|Protocol Violation|1|||
145965745|NCT00390689|526389670|FG001|Overall Study|Protocol Violation|0|||
145965746|NCT00390689|526389671|FG002|Overall Study|Protocol Violation|0|||
145965747|NCT00390689|526389669|FG000|Overall Study|Investigator's judgement|2|||
145965748|NCT00390689|526389670|FG001|Overall Study|Investigator's judgement|0|||
145965749|NCT00390689|526389671|FG002|Overall Study|Investigator's judgement|0|||
145965750|NCT01253161|526389672|FG000|Overall Study|Adverse Event|1|||
145965751|NCT03101020|526389674|FG000|Overall Study|Lack of time to participate|1|||
145965752|NCT03101020|526389675|FG001|Overall Study|Lack of time to participate|0|||
145965753|NCT03101020|526389674|FG000|Overall Study|Ran over by a car|0|||
145965754|NCT03101020|526389675|FG001|Overall Study|Ran over by a car|1|||
145965755|NCT03101020|526389674|FG000|Overall Study|Withdrawal by Subject|0|||
145965756|NCT03101020|526389675|FG001|Overall Study|Withdrawal by Subject|2|||
145965757|NCT01924533|526389676|FG000|Overall Study|Death|181|||
145965758|NCT01924533|526389677|FG001|Overall Study|Death|200|||
145965759|NCT01924533|526389676|FG000|Overall Study|Lost to Follow-up|0|||
145965760|NCT01924533|526389677|FG001|Overall Study|Lost to Follow-up|1|||
145965761|NCT01924533|526389676|FG000|Overall Study|Withdrawal by Subject|7|||
145965762|NCT01924533|526389677|FG001|Overall Study|Withdrawal by Subject|3|||
145965763|NCT01924533|526389676|FG000|Overall Study|Other Eligibility criteria|1|||
145965764|NCT01924533|526389677|FG001|Overall Study|Other Eligibility criteria|1|||
145965765|NCT04233879|526389678|FG000|Overall Study|Death|2|||
145965766|NCT04233879|526389679|FG001|Overall Study|Death|0|||
145965767|NCT04233879|526389678|FG000|Overall Study|Lost to Follow-up|3|||
145965768|NCT04233879|526389679|FG001|Overall Study|Lost to Follow-up|8|||
145965769|NCT04233879|526389678|FG000|Overall Study|Physician Decision|4|||
145965770|NCT04233879|526389679|FG001|Overall Study|Physician Decision|4|||
145965771|NCT04233879|526389678|FG000|Overall Study|Withdrawal by Subject|7|||
145965772|NCT04233879|526389679|FG001|Overall Study|Withdrawal by Subject|10|||
145965773|NCT04233879|526389678|FG000|Overall Study|Other|281|||
145965774|NCT04233879|526389679|FG001|Overall Study|Other|279|||
145965775|NCT03292016|526389680|FG000|Second Washout|Adverse Event|0|||
145965776|NCT03292016|526389681|FG001|Second Washout|Adverse Event|1|||
145965777|NCT03292016|526389682|FG002|Second Washout|Adverse Event|0|||
145965778|NCT03292016|526389683|FG003|Second Washout|Adverse Event|0|||
146290928|NCT01790126|527580497|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
146086699|NCT05171816|526838361|FG000|Overall Study|Death|18|||
146086700|NCT05171816|526838362|FG001|Overall Study|Death|16|||
146086701|NCT02937571|526838363|FG000|Overall Study|Adverse Event|0|||
146086702|NCT02937571|526838364|FG001|Overall Study|Adverse Event|0|||
146086703|NCT02937571|526838365|FG002|Overall Study|Adverse Event|4|||
146086704|NCT02937571|526838363|FG000|Overall Study|Withdrawal by Subject|0|||
146086705|NCT02937571|526838364|FG001|Overall Study|Withdrawal by Subject|0|||
145887869|NCT01719562|526095001|FG000|Overall Study|Lost to Follow-up|1|||
145887870|NCT01719562|526095002|FG001|Overall Study|Lost to Follow-up|0|||
145887871|NCT01719562|526095001|FG000|Overall Study|Death|1|||
145887872|NCT01719562|526095002|FG001|Overall Study|Death|0|||
145887873|NCT01719562|526095001|FG000|Overall Study|New cancer diagnosis|1|||
145887874|NCT01719562|526095002|FG001|Overall Study|New cancer diagnosis|0|||
146290929|NCT01790126|527580498|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
146290930|NCT01790126|527580499|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
146290931|NCT01790126|527580497|FG000|Overall Study|Withdrawal by Physician|1|||
146290932|NCT01790126|527580498|FG001|Overall Study|Withdrawal by Physician|1|||
146290933|NCT01790126|527580499|FG002|Overall Study|Withdrawal by Physician|2|||
146290934|NCT01790126|527580497|FG000|Overall Study|Withdrawal by Subject|3|||
146290935|NCT01790126|527580498|FG001|Overall Study|Withdrawal by Subject|1|||
146290936|NCT01790126|527580499|FG002|Overall Study|Withdrawal by Subject|2|||
146290937|NCT01790126|527580497|FG000|Overall Study|Lost to Follow-up|1|||
146290938|NCT01790126|527580498|FG001|Overall Study|Lost to Follow-up|0|||
146290939|NCT01790126|527580499|FG002|Overall Study|Lost to Follow-up|1|||
146290940|NCT01790126|527580497|FG000|Overall Study|Adverse Event|0|||
146290941|NCT01790126|527580498|FG001|Overall Study|Adverse Event|2|||
145887875|NCT02013531|526095005|FG000|Overall Study|Lost to Follow-up|3|||
145887876|NCT02013531|526095005|FG000|Overall Study|Met Withdrawal Criteria|1|||
145887877|NCT02013531|526095005|FG000|Overall Study|Withdrawal by Subject|1|||
146290942|NCT01790126|527580499|FG002|Overall Study|Adverse Event|0|||
146290943|NCT01790126|527580497|FG000|Overall Study|Death|2|||
146290944|NCT01790126|527580498|FG001|Overall Study|Death|0|||
146290945|NCT01790126|527580499|FG002|Overall Study|Death|0|||
146290946|NCT01790126|527580497|FG000|Overall Study|Radiographic Progression|3|||
146290947|NCT01790126|527580498|FG001|Overall Study|Radiographic Progression|1|||
145887878|NCT03877926|526095006|FG000|Overall Study|Adverse Event|1|||
145887879|NCT03877926|526095007|FG001|Overall Study|Adverse Event|0|||
145887880|NCT03877926|526095008|FG002|Overall Study|Adverse Event|0|||
145887881|NCT03877926|526095009|FG003|Overall Study|Adverse Event|0|||
145887882|NCT03877926|526095006|FG000|Overall Study|Death|2|||
145887883|NCT03877926|526095007|FG001|Overall Study|Death|2|||
145887884|NCT03877926|526095008|FG002|Overall Study|Death|2|||
145887885|NCT03877926|526095009|FG003|Overall Study|Death|0|||
145887886|NCT03877926|526095006|FG000|Overall Study|Lost to Follow-up|41|||
145887887|NCT03877926|526095007|FG001|Overall Study|Lost to Follow-up|52|||
145887888|NCT03877926|526095008|FG002|Overall Study|Lost to Follow-up|45|||
146290948|NCT01790126|527580499|FG002|Overall Study|Radiographic Progression|0|||
146290949|NCT00679627|527580501|FG000|Overall Study|Death|41|||
146290950|NCT00679627|527580502|FG001|Overall Study|Death|29|||
146290951|NCT00679627|527580501|FG000|Overall Study|Adverse Event|43|||
146290952|NCT00679627|527580502|FG001|Overall Study|Adverse Event|53|||
146290953|NCT00679627|527580501|FG000|Overall Study|Withdrawal by Subject|168|||
145887889|NCT03877926|526095009|FG003|Overall Study|Lost to Follow-up|17|||
145887890|NCT03877926|526095006|FG000|Overall Study|Physician Decision|2|||
145887891|NCT03877926|526095007|FG001|Overall Study|Physician Decision|0|||
145887892|NCT03877926|526095008|FG002|Overall Study|Physician Decision|2|||
145887893|NCT03877926|526095009|FG003|Overall Study|Physician Decision|0|||
145887894|NCT03877926|526095006|FG000|Overall Study|Withdrawal by Subject|18|||
145887895|NCT03877926|526095007|FG001|Overall Study|Withdrawal by Subject|21|||
145887896|NCT03877926|526095008|FG002|Overall Study|Withdrawal by Subject|12|||
145887897|NCT03877926|526095009|FG003|Overall Study|Withdrawal by Subject|4|||
145887898|NCT03877926|526095006|FG000|Overall Study|Other - Various|4|||
145887899|NCT03877926|526095007|FG001|Overall Study|Other - Various|1|||
145887900|NCT03877926|526095008|FG002|Overall Study|Other - Various|1|||
145887901|NCT03877926|526095009|FG003|Overall Study|Other - Various|0|||
145887902|NCT03877926|526095006|FG000|Overall Study|Not Treated|3|||
145887903|NCT03877926|526095007|FG001|Overall Study|Not Treated|1|||
145887904|NCT03877926|526095008|FG002|Overall Study|Not Treated|1|||
145887905|NCT03877926|526095009|FG003|Overall Study|Not Treated|0|||
145887906|NCT00939627|526095011|FG000|Overall Study|Disease Progression|16|||
145887907|NCT00939627|526095012|FG001|Overall Study|Disease Progression|12|||
145887908|NCT00939627|526095013|FG002|Overall Study|Disease Progression|0|||
146290954|NCT00679627|527580502|FG001|Overall Study|Withdrawal by Subject|172|||
146290955|NCT00679627|527580501|FG000|Overall Study|Lost to Follow-up|22|||
145887909|NCT00939627|526095011|FG000|Overall Study|Adverse Event|6|||
145887910|NCT00939627|526095012|FG001|Overall Study|Adverse Event|7|||
145887911|NCT00939627|526095013|FG002|Overall Study|Adverse Event|0|||
145887912|NCT00939627|526095011|FG000|Overall Study|Death|0|||
145887913|NCT00939627|526095012|FG001|Overall Study|Death|2|||
145887914|NCT00939627|526095013|FG002|Overall Study|Death|0|||
145887915|NCT00939627|526095011|FG000|Overall Study|Withdrawal by Subject|2|||
145887916|NCT00939627|526095012|FG001|Overall Study|Withdrawal by Subject|4|||
145887917|NCT00939627|526095013|FG002|Overall Study|Withdrawal by Subject|0|||
145887918|NCT00939627|526095011|FG000|Overall Study|Other complicating disease|1|||
145887919|NCT00939627|526095012|FG001|Overall Study|Other complicating disease|1|||
145887920|NCT00939627|526095013|FG002|Overall Study|Other complicating disease|0|||
145887921|NCT00939627|526095011|FG000|Overall Study|Not compliant|2|||
145887922|NCT00939627|526095012|FG001|Overall Study|Not compliant|0|||
145887923|NCT00939627|526095013|FG002|Overall Study|Not compliant|0|||
145887924|NCT00939627|526095011|FG000|Overall Study|No off-tx reason given|0|||
145887925|NCT00939627|526095012|FG001|Overall Study|No off-tx reason given|2|||
145887926|NCT00939627|526095013|FG002|Overall Study|No off-tx reason given|0|||
145887927|NCT00537199|526095016|FG000|Overall Study|Study Terminated|1|||
145887928|NCT02039063|526095019|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
145887929|NCT02039063|526095020|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
145887930|NCT02039063|526095021|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
145887931|NCT02039063|526095022|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
145887932|NCT02039063|526095019|FG000|Treatment Phase|Progression of disease|0|||
145887933|NCT02039063|526095020|FG001|Treatment Phase|Progression of disease|0|||
145887934|NCT02039063|526095021|FG002|Treatment Phase|Progression of disease|1|||
145887935|NCT02039063|526095022|FG003|Treatment Phase|Progression of disease|1|||
145887936|NCT02039063|526095019|FG000|Extension Phase|Inadequate therapeutic effect|0|||
145887937|NCT02039063|526095020|FG001|Extension Phase|Inadequate therapeutic effect|1|||
145887938|NCT02039063|526095021|FG002|Extension Phase|Inadequate therapeutic effect|2|||
145887939|NCT02039063|526095022|FG003|Extension Phase|Inadequate therapeutic effect|0|||
145887940|NCT02039063|526095019|FG000|Extension Phase|Progression of disease|0|||
145887941|NCT02039063|526095020|FG001|Extension Phase|Progression of disease|0|||
145887942|NCT02039063|526095021|FG002|Extension Phase|Progression of disease|0|||
145887943|NCT02039063|526095022|FG003|Extension Phase|Progression of disease|1|||
145887944|NCT02039063|526095019|FG000|Extension Phase|Adverse Event|0|||
145887945|NCT02039063|526095020|FG001|Extension Phase|Adverse Event|0|||
145887946|NCT02039063|526095021|FG002|Extension Phase|Adverse Event|1|||
145887947|NCT02039063|526095022|FG003|Extension Phase|Adverse Event|0|||
145887948|NCT00467831|526095025|FG000|Overall Study|Death|2|||
145887949|NCT00467831|526095025|FG000|Overall Study|Withdrawal by Subject|1|||
145887950|NCT01832402|526095028|FG000|Overall Study|Lost to Follow-up|2|||
145887951|NCT01832402|526095029|FG001|Overall Study|Lost to Follow-up|0|||
145887952|NCT01832402|526095028|FG000|Overall Study|Withdrawal by Subject|3|||
145887953|NCT01832402|526095029|FG001|Overall Study|Withdrawal by Subject|3|||
145965779|NCT03292016|526389684|FG004|Second Washout|Adverse Event|0|||
145965780|NCT03292016|526389685|FG005|Second Washout|Adverse Event|0|||
145965781|NCT01909804|526389686|FG000|Overall Study|Randomized but Never Treated|0|||
145887954|NCT01832402|526095028|FG000|Overall Study|Declining Performance status|2|||
145965782|NCT01909804|526389687|FG001|Overall Study|Randomized but Never Treated|0|||
145887955|NCT01832402|526095029|FG001|Overall Study|Declining Performance status|1|||
145887956|NCT02776553|526095031|FG000|Overall Study|Lost to Follow-up|1|||
145887957|NCT02776553|526095032|FG001|Overall Study|Lost to Follow-up|0|||
145887958|NCT02776553|526095031|FG000|Overall Study|got liver transplant|1|||
145887959|NCT02776553|526095032|FG001|Overall Study|got liver transplant|2|||
145965783|NCT01909804|526389688|FG002|Overall Study|Randomized but Never Treated|0|||
145887960|NCT02776553|526095031|FG000|Overall Study|had other surgery|1|||
145887961|NCT02776553|526095032|FG001|Overall Study|had other surgery|0|||
145887962|NCT02776553|526095031|FG000|Overall Study|Protocol Violation|0|||
145965784|NCT01909804|526389689|FG003|Overall Study|Randomized but Never Treated|0|||
145965785|NCT01909804|526389690|FG004|Overall Study|Randomized but Never Treated|0|||
145965786|NCT01909804|526389691|FG005|Overall Study|Randomized but Never Treated|0|||
145965787|NCT01909804|526389692|FG006|Overall Study|Randomized but Never Treated|1|||
145965788|NCT01909804|526389693|FG007|Overall Study|Randomized but Never Treated|0|||
145965789|NCT01909804|526389694|FG008|Overall Study|Randomized but Never Treated|0|||
145965790|NCT01909804|526389695|FG009|Overall Study|Randomized but Never Treated|0|||
145965791|NCT01909804|526389696|FG010|Overall Study|Randomized but Never Treated|0|||
145965792|NCT01909804|526389697|FG011|Overall Study|Randomized but Never Treated|1|||
145965793|NCT01909804|526389686|FG000|Overall Study|Death|0|||
145965794|NCT01909804|526389687|FG001|Overall Study|Death|0|||
145965795|NCT01909804|526389688|FG002|Overall Study|Death|0|||
145965796|NCT01909804|526389689|FG003|Overall Study|Death|0|||
145965797|NCT01909804|526389690|FG004|Overall Study|Death|0|||
145965798|NCT01909804|526389691|FG005|Overall Study|Death|0|||
146232407|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
146232408|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
146232409|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232410|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232411|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145965799|NCT01909804|526389692|FG006|Overall Study|Death|0|||
145965800|NCT01909804|526389693|FG007|Overall Study|Death|0|||
145887963|NCT02776553|526095032|FG001|Overall Study|Protocol Violation|1|||
145887964|NCT01998243|526095033|FG000|Overall Study|Pregnancy|0|||
145887965|NCT01998243|526095034|FG001|Overall Study|Pregnancy|1|||
145887966|NCT01998243|526095033|FG000|Overall Study|Protocol Violation|5|||
145887967|NCT01998243|526095034|FG001|Overall Study|Protocol Violation|2|||
145887968|NCT01998243|526095033|FG000|Overall Study|Withdrawal by Subject|3|||
145887969|NCT01998243|526095034|FG001|Overall Study|Withdrawal by Subject|4|||
145887970|NCT02492841|526095035|FG000|Overall Study|Lost to Follow-up|34|||
145887971|NCT02492841|526095036|FG001|Overall Study|Lost to Follow-up|31|||
145887972|NCT02492841|526095037|FG002|Overall Study|Lost to Follow-up|35|||
145887973|NCT02820740|526095038|FG000|Overall Study|Did not have procedure|2|||
145887974|NCT04965389|526095039|FG000|Overall Study|Other reasons|1|||
145887975|NCT04965389|526095040|FG001|Overall Study|Other reasons|0|||
145887976|NCT04965389|526095041|FG002|Overall Study|Other reasons|0|||
145887977|NCT04965389|526095042|FG003|Overall Study|Other reasons|0|||
146232412|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145887978|NCT04965389|526095039|FG000|Overall Study|Participant withdrew consent|0|||
145887979|NCT04965389|526095040|FG001|Overall Study|Participant withdrew consent|1|||
145887980|NCT04965389|526095041|FG002|Overall Study|Participant withdrew consent|0|||
145887981|NCT04965389|526095042|FG003|Overall Study|Participant withdrew consent|0|||
145887982|NCT04965389|526095039|FG000|Overall Study|Poor/Non-compliance|0|||
145887983|NCT04965389|526095040|FG001|Overall Study|Poor/Non-compliance|1|||
145887984|NCT04965389|526095041|FG002|Overall Study|Poor/Non-compliance|0|||
145887985|NCT04965389|526095042|FG003|Overall Study|Poor/Non-compliance|0|||
145887986|NCT03903159|526095043|FG000|Overall Study|Discharged with Staff Approval|2|||
145887987|NCT03903159|526095043|FG000|Overall Study|Discharged at Staff Request|2|||
145887988|NCT03903159|526095043|FG000|Overall Study|Discharged Against Staff Advice|1|||
145887989|NCT00206102|526095049|FG000|Overall Study|Adverse Event|119|||
145887990|NCT00206102|526095050|FG001|Overall Study|Adverse Event|82|||
145887991|NCT00206102|526095049|FG000|Overall Study|Protocol Violation|0|||
145887992|NCT00206102|526095050|FG001|Overall Study|Protocol Violation|2|||
145887993|NCT00206102|526095049|FG000|Overall Study|Lack of therapeutic response|16|||
145887994|NCT00206102|526095050|FG001|Overall Study|Lack of therapeutic response|11|||
145887995|NCT00206102|526095049|FG000|Overall Study|Lost to Follow-up|95|||
146086706|NCT02937571|526838365|FG002|Overall Study|Withdrawal by Subject|3|||
146086707|NCT04391569|526838366|FG000|Overall Study|Death|15|||
146086708|NCT04391569|526838367|FG001|Overall Study|Death|10|||
146232413|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232414|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145887996|NCT00206102|526095050|FG001|Overall Study|Lost to Follow-up|66|||
146232415|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145887997|NCT00206102|526095049|FG000|Overall Study|Withdrawal by Subject|118|||
145887998|NCT00206102|526095050|FG001|Overall Study|Withdrawal by Subject|101|||
146086709|NCT04391569|526838366|FG000|Overall Study|Withdrawal by Subject|1|||
146232416|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
146232417|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145887999|NCT00206102|526095049|FG000|Overall Study|Study-specific discontinuation criteria|18|||
145965801|NCT01909804|526389694|FG008|Overall Study|Death|0|||
146290956|NCT00679627|527580502|FG001|Overall Study|Lost to Follow-up|26|||
146290957|NCT00679627|527580501|FG000|Overall Study|Early Study Closure|425|||
146290958|NCT00679627|527580502|FG001|Overall Study|Early Study Closure|405|||
146290959|NCT00511472|527580506|FG000|Overall Study|Clinical Adverse Event|1|||
146290960|NCT00511472|527580507|FG001|Overall Study|Clinical Adverse Event|2|||
146290961|NCT00511472|527580506|FG000|Overall Study|Laboratory Adverse Event|0|||
146290962|NCT00511472|527580507|FG001|Overall Study|Laboratory Adverse Event|2|||
146290963|NCT00511472|527580506|FG000|Overall Study|Not reported|2|||
146290964|NCT00511472|527580507|FG001|Overall Study|Not reported|2|||
146290965|NCT00446992|527580508|FG000|Overall Study|Adverse Event|11|||
146290966|NCT00446992|527580508|FG000|Overall Study|Lost to Follow-up|5|||
146290967|NCT00818649|527580509|FG000|Overall Study|Declining performance status|2|||
146290968|NCT00818649|527580509|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
146290969|NCT00818649|527580509|FG000|Overall Study|Adverse Event|1|||
146290970|NCT00505284|527580510|FG000|Overall Study|Adverse Event|3|||
146290971|NCT00505284|527580511|FG001|Overall Study|Adverse Event|7|||
146290972|NCT00505284|527580512|FG002|Overall Study|Adverse Event|9|||
146290973|NCT00505284|527580513|FG003|Overall Study|Adverse Event|14|||
146290974|NCT00505284|527580514|FG004|Overall Study|Adverse Event|22|||
146290975|NCT00505284|527580510|FG000|Overall Study|Protocol Violation|0|||
146290976|NCT00505284|527580511|FG001|Overall Study|Protocol Violation|1|||
146290977|NCT00505284|527580512|FG002|Overall Study|Protocol Violation|1|||
146290978|NCT00505284|527580513|FG003|Overall Study|Protocol Violation|0|||
146290979|NCT00505284|527580514|FG004|Overall Study|Protocol Violation|0|||
146290980|NCT00505284|527580510|FG000|Overall Study|Withdrawal by Subject|2|||
146290981|NCT00505284|527580511|FG001|Overall Study|Withdrawal by Subject|6|||
146290982|NCT00505284|527580512|FG002|Overall Study|Withdrawal by Subject|1|||
146290983|NCT00505284|527580513|FG003|Overall Study|Withdrawal by Subject|0|||
146290984|NCT00505284|527580514|FG004|Overall Study|Withdrawal by Subject|6|||
146290985|NCT00505284|527580510|FG000|Overall Study|Lack of Efficacy|0|||
146290986|NCT00505284|527580511|FG001|Overall Study|Lack of Efficacy|1|||
146290987|NCT00505284|527580512|FG002|Overall Study|Lack of Efficacy|1|||
146290988|NCT00505284|527580513|FG003|Overall Study|Lack of Efficacy|1|||
146290989|NCT00505284|527580514|FG004|Overall Study|Lack of Efficacy|1|||
146290990|NCT00505284|527580510|FG000|Overall Study|Physician Decision|0|||
146290991|NCT00505284|527580511|FG001|Overall Study|Physician Decision|1|||
146290992|NCT00505284|527580512|FG002|Overall Study|Physician Decision|0|||
146290993|NCT00505284|527580513|FG003|Overall Study|Physician Decision|0|||
146290994|NCT00505284|527580514|FG004|Overall Study|Physician Decision|0|||
146290995|NCT00505284|527580510|FG000|Overall Study|Other|5|||
146290996|NCT00505284|527580511|FG001|Overall Study|Other|0|||
146290997|NCT00505284|527580512|FG002|Overall Study|Other|0|||
146290998|NCT00505284|527580513|FG003|Overall Study|Other|4|||
146290999|NCT00505284|527580514|FG004|Overall Study|Other|4|||
146291000|NCT03513588|527580515|FG000|Overall Study|Lost to Follow-up|0|||
146291001|NCT03513588|527580516|FG001|Overall Study|Lost to Follow-up|1|||
146291002|NCT03513588|527580517|FG002|Overall Study|Lost to Follow-up|1|||
146291003|NCT03513588|527580515|FG000|Overall Study|Study dosing paused by sponsor|1|||
146291004|NCT03513588|527580516|FG001|Overall Study|Study dosing paused by sponsor|1|||
146291005|NCT03513588|527580517|FG002|Overall Study|Study dosing paused by sponsor|0|||
146291006|NCT03513588|527580515|FG000|Overall Study|Death|0|||
146291007|NCT03513588|527580516|FG001|Overall Study|Death|0|||
146291008|NCT03513588|527580517|FG002|Overall Study|Death|1|||
146291009|NCT00940108|527580518|FG000|Overall Study|Adverse Event|2|||
146291010|NCT00940108|527580519|FG001|Overall Study|Adverse Event|4|||
146291011|NCT00940108|527580520|FG002|Overall Study|Adverse Event|0|||
146291012|NCT00940108|527580521|FG003|Overall Study|Adverse Event|2|||
146291013|NCT00940108|527580518|FG000|Overall Study|Withdrew Consent|2|||
146291014|NCT00940108|527580519|FG001|Overall Study|Withdrew Consent|1|||
146291015|NCT00940108|527580520|FG002|Overall Study|Withdrew Consent|0|||
146291016|NCT00940108|527580521|FG003|Overall Study|Withdrew Consent|1|||
146291017|NCT00940108|527580518|FG000|Overall Study|Dose 2 contraindicated|1|||
146291018|NCT00940108|527580519|FG001|Overall Study|Dose 2 contraindicated|1|||
146291019|NCT00940108|527580520|FG002|Overall Study|Dose 2 contraindicated|0|||
146291020|NCT00940108|527580521|FG003|Overall Study|Dose 2 contraindicated|1|||
146291021|NCT00940108|527580518|FG000|Overall Study|Declined further vaccination|0|||
146291022|NCT00940108|527580519|FG001|Overall Study|Declined further vaccination|1|||
146291023|NCT00940108|527580520|FG002|Overall Study|Declined further vaccination|3|||
146291024|NCT00940108|527580521|FG003|Overall Study|Declined further vaccination|0|||
146291025|NCT00940108|527580518|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
146291026|NCT00940108|527580519|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
146291027|NCT00940108|527580520|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
146291028|NCT00940108|527580521|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
146291029|NCT00940108|527580518|FG000|Overall Study|Viral illness after Dose 1|0|||
146291030|NCT00940108|527580519|FG001|Overall Study|Viral illness after Dose 1|1|||
146291031|NCT00940108|527580520|FG002|Overall Study|Viral illness after Dose 1|0|||
146291032|NCT00940108|527580521|FG003|Overall Study|Viral illness after Dose 1|0|||
146291033|NCT00940108|527580518|FG000|Overall Study|Diagnosed with H1N1|0|||
146291034|NCT00940108|527580519|FG001|Overall Study|Diagnosed with H1N1|0|||
146291035|NCT00940108|527580520|FG002|Overall Study|Diagnosed with H1N1|0|||
146291036|NCT00940108|527580521|FG003|Overall Study|Diagnosed with H1N1|1|||
146291037|NCT01740323|527580525|FG000|Overall Study|Adverse Event|1|||
146291038|NCT01740323|527580526|FG001|Overall Study|Adverse Event|0|||
146291039|NCT01740323|527580525|FG000|Overall Study|Randomized but did not take study drug|1|||
146291040|NCT01740323|527580526|FG001|Overall Study|Randomized but did not take study drug|0|||
146291041|NCT02434939|527580531|FG000|Overall Study|Lack of Efficacy|34|||
146291042|NCT02434939|527580532|FG001|Overall Study|Lack of Efficacy|48|||
146291043|NCT02434939|527580531|FG000|Overall Study|Withdrawal by Subject|3|||
146291044|NCT02434939|527580532|FG001|Overall Study|Withdrawal by Subject|0|||
146291045|NCT02434939|527580531|FG000|Overall Study|Adverse Event|0|||
146291046|NCT02434939|527580532|FG001|Overall Study|Adverse Event|1|||
146291047|NCT06338462|527580533|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
146291048|NCT00069238|527580537|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
146291049|NCT00069238|527580538|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
146291050|NCT00069238|527580539|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
146291051|NCT00069238|527580537|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
146291052|NCT00069238|527580538|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
146291053|NCT00069238|527580539|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
146291054|NCT00069238|527580537|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
146291055|NCT00069238|527580538|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
146291056|NCT00069238|527580539|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
146291057|NCT01668667|527580553|FG000|Overall Study|Adverse Event|3|||
146291058|NCT01668667|527580554|FG001|Overall Study|Adverse Event|6|||
146291059|NCT01668667|527580555|FG002|Overall Study|Adverse Event|4|||
146291060|NCT01668667|527580556|FG003|Overall Study|Adverse Event|4|||
146291061|NCT01668667|527580553|FG000|Overall Study|Lack of Efficacy|3|||
146291062|NCT01668667|527580554|FG001|Overall Study|Lack of Efficacy|2|||
146291063|NCT01668667|527580555|FG002|Overall Study|Lack of Efficacy|2|||
146291064|NCT01668667|527580556|FG003|Overall Study|Lack of Efficacy|3|||
146291065|NCT01668667|527580553|FG000|Overall Study|Protocol Violation|6|||
146291066|NCT01668667|527580554|FG001|Overall Study|Protocol Violation|10|||
146291067|NCT01668667|527580555|FG002|Overall Study|Protocol Violation|12|||
146291068|NCT01668667|527580556|FG003|Overall Study|Protocol Violation|5|||
146291069|NCT01668667|527580553|FG000|Overall Study|Lost to Follow-up|9|||
146291070|NCT01668667|527580554|FG001|Overall Study|Lost to Follow-up|4|||
146291071|NCT01668667|527580555|FG002|Overall Study|Lost to Follow-up|7|||
146291072|NCT01668667|527580556|FG003|Overall Study|Lost to Follow-up|6|||
146291073|NCT01668667|527580553|FG000|Overall Study|Physician Decision|3|||
146291074|NCT01668667|527580554|FG001|Overall Study|Physician Decision|0|||
146291075|NCT01668667|527580555|FG002|Overall Study|Physician Decision|1|||
146291076|NCT01668667|527580556|FG003|Overall Study|Physician Decision|0|||
146291077|NCT01668667|527580553|FG000|Overall Study|Withdrawal by Subject|7|||
146291078|NCT01668667|527580554|FG001|Overall Study|Withdrawal by Subject|4|||
146291079|NCT01668667|527580555|FG002|Overall Study|Withdrawal by Subject|5|||
146291080|NCT01668667|527580556|FG003|Overall Study|Withdrawal by Subject|5|||
146291081|NCT00511901|527580558|FG000|Overall Study|Withdrawal by Subject|1|||
146291082|NCT00511901|527580559|FG001|Overall Study|Withdrawal by Subject|3|||
146291083|NCT04640077|527580563|FG000|Period 1|Withdrawal by Subject|4|||
146291084|NCT04640077|527580564|FG001|Period 1|Withdrawal by Subject|5|||
146291085|NCT04640077|527580565|FG002|Period 1|Withdrawal by Subject|0|||
146291086|NCT04640077|527580563|FG000|Period 1|Adverse Event|1|||
146291087|NCT04640077|527580564|FG001|Period 1|Adverse Event|1|||
146291088|NCT04640077|527580565|FG002|Period 1|Adverse Event|0|||
146291089|NCT04640077|527580563|FG000|Period 1|Screen Failure|2|||
146291090|NCT04640077|527580564|FG001|Period 1|Screen Failure|0|||
146291091|NCT04640077|527580565|FG002|Period 1|Screen Failure|0|||
146291092|NCT04640077|527580563|FG000|Period 2|Withdrawal by Subject|0|||
146291093|NCT04640077|527580564|FG001|Period 2|Withdrawal by Subject|0|||
146291094|NCT04640077|527580565|FG002|Period 2|Withdrawal by Subject|18|||
146291095|NCT04640077|527580563|FG000|Period 2|Adverse Event|0|||
146291096|NCT04640077|527580564|FG001|Period 2|Adverse Event|0|||
146291097|NCT04640077|527580565|FG002|Period 2|Adverse Event|6|||
146291098|NCT04640077|527580563|FG000|Period 2|Lost to Follow-up|0|||
146291099|NCT04640077|527580564|FG001|Period 2|Lost to Follow-up|0|||
146291100|NCT04640077|527580565|FG002|Period 2|Lost to Follow-up|2|||
146291101|NCT04640077|527580563|FG000|Period 2|Death|0|||
146291102|NCT04640077|527580564|FG001|Period 2|Death|0|||
146291103|NCT04640077|527580565|FG002|Period 2|Death|2|||
146291104|NCT04640077|527580563|FG000|Period 2|Progressive Disease|0|||
146291105|NCT04640077|527580564|FG001|Period 2|Progressive Disease|0|||
146291106|NCT04640077|527580565|FG002|Period 2|Progressive Disease|1|||
146291107|NCT04640077|527580563|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
146291108|NCT04640077|527580564|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
146291109|NCT04640077|527580565|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
146291110|NCT01257425|527580566|FG000|Overall Study|Lack of Efficacy|3|||
146291111|NCT01257425|527580567|FG001|Overall Study|Lack of Efficacy|3|||
146291112|NCT01257425|527580566|FG000|Overall Study|Adverse Event|1|||
146291113|NCT01257425|527580567|FG001|Overall Study|Adverse Event|1|||
146291114|NCT01257425|527580566|FG000|Overall Study|Protocol Violation|1|||
146291115|NCT01257425|527580567|FG001|Overall Study|Protocol Violation|1|||
146291116|NCT01257425|527580566|FG000|Overall Study|Withdrawal by Subject|0|||
146291117|NCT01257425|527580567|FG001|Overall Study|Withdrawal by Subject|1|||
146291118|NCT01257425|527580566|FG000|Overall Study|Death|1|||
146291119|NCT01257425|527580567|FG001|Overall Study|Death|0|||
146291120|NCT00368992|527580571|FG000|Overall Study|Ineligible|5|||
146291121|NCT00368992|527580571|FG000|Overall Study|Refused treatment|3|||
146291122|NCT00368992|527580571|FG000|Overall Study|Lack of Efficacy|63|||
146291123|NCT00368992|527580571|FG000|Overall Study|Adverse Event|26|||
146291124|NCT00368992|527580571|FG000|Overall Study|Death|4|||
146291125|NCT00368992|527580571|FG000|Overall Study|Other|9|||
146291126|NCT01013597|527580578|FG000|Overall Study|Withdrawal by Subject|1|||
146291127|NCT00427895|527580579|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291128|NCT00427895|527580580|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291129|NCT00427895|527580581|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291130|NCT00427895|527580582|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
146291131|NCT00427895|527580583|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291132|NCT00427895|527580584|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291133|NCT00427895|527580585|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291134|NCT00427895|527580586|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
146291135|NCT00427895|527580579|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146291136|NCT00427895|527580580|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146291137|NCT00427895|527580581|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146232418|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232419|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145888000|NCT00206102|526095050|FG001|Overall Study|Study-specific discontinuation criteria|17|||
145888001|NCT00206102|526095049|FG000|Overall Study|None of those categories|42|||
145888002|NCT00206102|526095050|FG001|Overall Study|None of those categories|36|||
145888003|NCT04117945|526095051|FG000|Overall Study|Death|1|||
145888004|NCT04117945|526095052|FG001|Overall Study|Death|0|||
145888005|NCT04117945|526095051|FG000|Overall Study|Withdrawal by Subject|3|||
145888006|NCT04117945|526095052|FG001|Overall Study|Withdrawal by Subject|1|||
145888007|NCT04117945|526095051|FG000|Overall Study|Disease Progression|0|||
145888008|NCT04117945|526095052|FG001|Overall Study|Disease Progression|2|||
145888009|NCT04117945|526095051|FG000|Overall Study|Ineligible|8|||
145888010|NCT04117945|526095052|FG001|Overall Study|Ineligible|7|||
145888011|NCT00562120|526095058|FG000|First Intervention Period|Adverse Event|1|||
145888012|NCT00562120|526095059|FG001|First Intervention Period|Adverse Event|0|||
145888013|NCT00562120|526095060|FG002|First Intervention Period|Adverse Event|0|||
145888014|NCT00562120|526095061|FG003|First Intervention Period|Adverse Event|0|||
145888015|NCT00562120|526095058|FG000|First Intervention Period|Randomized but not Treated|1|||
145888016|NCT00562120|526095059|FG001|First Intervention Period|Randomized but not Treated|0|||
145888017|NCT00562120|526095060|FG002|First Intervention Period|Randomized but not Treated|0|||
145888018|NCT00562120|526095061|FG003|First Intervention Period|Randomized but not Treated|0|||
145888019|NCT02148445|526095062|FG000|Overall Study|Death|1|||
145888020|NCT02148445|526095063|FG001|Overall Study|Death|3|||
145888021|NCT03450629|526095064|FG000|Overall Study|Adverse Event|15|||
145888022|NCT03450629|526095065|FG001|Overall Study|Adverse Event|14|||
145888023|NCT03450629|526095064|FG000|Overall Study|Physician Decision|2|||
145888024|NCT03450629|526095065|FG001|Overall Study|Physician Decision|2|||
145888025|NCT03450629|526095064|FG000|Overall Study|Lack of Efficacy|2|||
145888026|NCT03450629|526095065|FG001|Overall Study|Lack of Efficacy|0|||
145888027|NCT03450629|526095064|FG000|Overall Study|Lost to Follow-up|4|||
145888028|NCT03450629|526095065|FG001|Overall Study|Lost to Follow-up|2|||
145888029|NCT03450629|526095064|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145888030|NCT03450629|526095065|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
145888031|NCT03450629|526095064|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145888032|NCT03450629|526095065|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145888033|NCT03450629|526095064|FG000|Overall Study|Protocol Violation|11|||
145888034|NCT03450629|526095065|FG001|Overall Study|Protocol Violation|8|||
145888035|NCT03450629|526095064|FG000|Overall Study|Withdrawal by Subject|12|||
145888036|NCT03450629|526095065|FG001|Overall Study|Withdrawal by Subject|6|||
145888037|NCT04230876|526095066|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
145888038|NCT04230876|526095067|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
146232420|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146086710|NCT04391569|526838367|FG001|Overall Study|Withdrawal by Subject|0|||
146086711|NCT04391569|526838366|FG000|Overall Study|Lost to Follow-up|3|||
145965802|NCT01909804|526389695|FG009|Overall Study|Death|0|||
145965803|NCT01909804|526389696|FG010|Overall Study|Death|1|||
145965804|NCT01909804|526389697|FG011|Overall Study|Death|0|||
145965805|NCT01909804|526389686|FG000|Overall Study|Lack of Efficacy|4|||
145965806|NCT01909804|526389687|FG001|Overall Study|Lack of Efficacy|1|||
145965807|NCT01909804|526389688|FG002|Overall Study|Lack of Efficacy|0|||
145965808|NCT01909804|526389689|FG003|Overall Study|Lack of Efficacy|0|||
145965809|NCT01909804|526389690|FG004|Overall Study|Lack of Efficacy|7|||
145965810|NCT01909804|526389691|FG005|Overall Study|Lack of Efficacy|3|||
145965811|NCT01909804|526389692|FG006|Overall Study|Lack of Efficacy|1|||
145965812|NCT01909804|526389693|FG007|Overall Study|Lack of Efficacy|1|||
145965813|NCT01909804|526389694|FG008|Overall Study|Lack of Efficacy|0|||
145965814|NCT01909804|526389695|FG009|Overall Study|Lack of Efficacy|1|||
145965815|NCT01909804|526389696|FG010|Overall Study|Lack of Efficacy|0|||
145965816|NCT01909804|526389697|FG011|Overall Study|Lack of Efficacy|1|||
146232421|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232422|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232423|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
146232424|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
146232425|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232426|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232427|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232428|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232429|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232430|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232431|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232432|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232433|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
146232434|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|Death|0|||
146232435|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|Death|0|||
146232436|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|Death|0|||
146232437|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|Death|0|||
146232438|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|Death|0|||
146232439|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|Death|0|||
146232440|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|Death|1|||
146232441|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|Death|6|||
146232442|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|Death|0|||
146232443|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|Death|0|||
146232444|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|Death|0|||
145965817|NCT01909804|526389686|FG000|Overall Study|Withdrew Consent|0|||
145965818|NCT01909804|526389687|FG001|Overall Study|Withdrew Consent|0|||
145965819|NCT01909804|526389688|FG002|Overall Study|Withdrew Consent|0|||
145965820|NCT01909804|526389689|FG003|Overall Study|Withdrew Consent|0|||
145965821|NCT01909804|526389690|FG004|Overall Study|Withdrew Consent|1|||
145965822|NCT01909804|526389691|FG005|Overall Study|Withdrew Consent|1|||
145965823|NCT01909804|526389692|FG006|Overall Study|Withdrew Consent|0|||
145965824|NCT01909804|526389693|FG007|Overall Study|Withdrew Consent|0|||
146232445|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|Death|0|||
146232446|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|Death|0|||
146232447|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|Death|0|||
146232448|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|Death|0|||
146232449|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|Death|0|||
146232450|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|Death|0|||
146232451|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232452|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232453|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232454|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232455|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
145965825|NCT01909804|526389694|FG008|Overall Study|Withdrew Consent|0|||
145965826|NCT01909804|526389695|FG009|Overall Study|Withdrew Consent|0|||
146086712|NCT04391569|526838367|FG001|Overall Study|Lost to Follow-up|2|||
146232456|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232457|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
146232458|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
146232459|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232460|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232461|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232462|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
145965827|NCT01909804|526389696|FG010|Overall Study|Withdrew Consent|0|||
145965828|NCT01909804|526389697|FG011|Overall Study|Withdrew Consent|0|||
145965829|NCT01909804|526389686|FG000|Overall Study|Protocol Violation|0|||
145965830|NCT01909804|526389687|FG001|Overall Study|Protocol Violation|0|||
146086713|NCT04391569|526838366|FG000|Overall Study|Lack of Efficacy|0|||
146291138|NCT00427895|527580582|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146291139|NCT00427895|527580583|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145888039|NCT02093923|526095069|FG000|Overall Study|Lost to Follow-up|0|||
145888040|NCT02093923|526095070|FG001|Overall Study|Lost to Follow-up|0|||
145888041|NCT02093923|526095071|FG002|Overall Study|Lost to Follow-up|0|||
145888042|NCT02093923|526095072|FG003|Overall Study|Lost to Follow-up|1|||
146291140|NCT00427895|527580584|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145888043|NCT02093923|526095073|FG004|Overall Study|Lost to Follow-up|0|||
145888044|NCT02093923|526095069|FG000|Overall Study|Screen failure after randomization|0|||
145888045|NCT02093923|526095070|FG001|Overall Study|Screen failure after randomization|0|||
145888046|NCT02093923|526095071|FG002|Overall Study|Screen failure after randomization|0|||
145888047|NCT02093923|526095072|FG003|Overall Study|Screen failure after randomization|1|||
145888048|NCT02093923|526095073|FG004|Overall Study|Screen failure after randomization|0|||
145888049|NCT03438006|526095074|FG000|Overall Study|Adverse Event|1|||
145888050|NCT03438006|526095074|FG000|Overall Study|Lost to Follow-up|67|||
145888051|NCT03438006|526095074|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
145888052|NCT03438006|526095074|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
145888053|NCT01662362|526095089|FG000|Overall Study|Lost to Follow-up|38|||
145888054|NCT01181531|526095090|FG000|Overall Study|Other|17|||
145888055|NCT01181531|526095091|FG001|Overall Study|Other|12|||
145888056|NCT01181531|526095090|FG000|Overall Study|Partial consent by subject withdrawn|0|||
146232463|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232464|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232465|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232466|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232467|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
146232468|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
145888057|NCT01181531|526095091|FG001|Overall Study|Partial consent by subject withdrawn|1|||
145888058|NCT01181531|526095090|FG000|Overall Study|Physician Decision|3|||
145888059|NCT01181531|526095091|FG001|Overall Study|Physician Decision|1|||
145888060|NCT01181531|526095090|FG000|Overall Study|Noncompliance|2|||
145888061|NCT01181531|526095091|FG001|Overall Study|Noncompliance|2|||
145888062|NCT01181531|526095090|FG000|Overall Study|Ineligibility determined|1|||
145888063|NCT01181531|526095091|FG001|Overall Study|Ineligibility determined|2|||
145888064|NCT01181531|526095090|FG000|Overall Study|Protocol Specified Criteria|15|||
145888065|NCT01181531|526095091|FG001|Overall Study|Protocol Specified Criteria|8|||
145888066|NCT01181531|526095090|FG000|Overall Study|Pregnancy|0|||
145888067|NCT01181531|526095091|FG001|Overall Study|Pregnancy|1|||
145888068|NCT01181531|526095090|FG000|Overall Study|Withdrawal by Subject|8|||
145888069|NCT01181531|526095091|FG001|Overall Study|Withdrawal by Subject|7|||
145888070|NCT01181531|526095090|FG000|Overall Study|Protocol Violation|6|||
145888071|NCT01181531|526095091|FG001|Overall Study|Protocol Violation|6|||
145888072|NCT01181531|526095090|FG000|Overall Study|Death|9|||
145888073|NCT01181531|526095091|FG001|Overall Study|Death|12|||
145888074|NCT01181531|526095090|FG000|Overall Study|Adverse Event|0|||
145888075|NCT01181531|526095091|FG001|Overall Study|Adverse Event|1|||
145888076|NCT03183141|526095097|FG000|Overall Study|Withdrawal by Subject|2|||
145888077|NCT03183141|526095098|FG001|Overall Study|Withdrawal by Subject|4|||
145888078|NCT03183141|526095097|FG000|Overall Study|Death|0|||
145888079|NCT03183141|526095098|FG001|Overall Study|Death|8|||
145888080|NCT02756637|526095099|FG000|Overall Study|Not eligible for initial SWOG study|10|||
145888081|NCT02756637|526095100|FG001|Overall Study|Not eligible for initial SWOG study|10|||
145888082|NCT02756637|526095099|FG000|Overall Study|No available NLR value|44|||
145888083|NCT02756637|526095100|FG001|Overall Study|No available NLR value|44|||
145888084|NCT02756637|526095099|FG000|Overall Study|Did not complete curative therapy|33|||
145888085|NCT02756637|526095100|FG001|Overall Study|Did not complete curative therapy|0|||
145888086|NCT01507090|526095101|FG000|Overall Study|incomplete dataset|18|||
145888087|NCT04678817|526096405|FG000|Overall Study|Lost to Follow-up|28|||
145888088|NCT04678817|526096406|FG001|Overall Study|Lost to Follow-up|0|||
145888089|NCT04678817|526096407|FG002|Overall Study|Lost to Follow-up|0|||
145888090|NCT02124902|526096413|FG000|Overall Study|Adverse Event|7|||
145888091|NCT02124902|526096414|FG001|Overall Study|Adverse Event|2|||
146232469|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232470|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
145888092|NCT02124902|526096413|FG000|Overall Study|Went to alternative treatment|4|||
145888093|NCT02124902|526096414|FG001|Overall Study|Went to alternative treatment|0|||
146291141|NCT00427895|527580585|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
146291142|NCT00427895|527580586|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
146291143|NCT00427895|527580579|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291144|NCT00427895|527580580|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291145|NCT00427895|527580581|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291146|NCT00427895|527580582|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291147|NCT00427895|527580583|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291148|NCT00427895|527580584|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291149|NCT00427895|527580585|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
146291150|NCT00427895|527580586|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
146291151|NCT00427895|527580579|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
146291152|NCT00427895|527580580|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
146291153|NCT00427895|527580581|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
146291154|NCT00427895|527580582|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
146291155|NCT00427895|527580583|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
146291156|NCT00427895|527580584|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
146291157|NCT00427895|527580585|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
146291158|NCT00427895|527580586|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
146291159|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146291160|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
146291161|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
146291162|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
146291163|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146291164|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146291165|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146291166|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
146291167|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
146291168|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146291169|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
146291170|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
146291171|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146291172|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146291173|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146291174|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
146291175|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
146291176|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
146291177|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291178|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291179|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291180|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291181|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291182|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
146291183|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
146291184|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
146291185|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
146291186|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
146291187|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146291188|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146291189|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146291190|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
146291191|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291192|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291193|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291194|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
146291195|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291196|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291197|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291198|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
146291199|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
146291200|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
145965831|NCT01909804|526389688|FG002|Overall Study|Protocol Violation|0|||
145965832|NCT01909804|526389689|FG003|Overall Study|Protocol Violation|0|||
145965833|NCT01909804|526389690|FG004|Overall Study|Protocol Violation|0|||
145965834|NCT01909804|526389691|FG005|Overall Study|Protocol Violation|0|||
145965835|NCT01909804|526389692|FG006|Overall Study|Protocol Violation|0|||
145965836|NCT01909804|526389693|FG007|Overall Study|Protocol Violation|0|||
145965837|NCT01909804|526389694|FG008|Overall Study|Protocol Violation|0|||
145965838|NCT01909804|526389695|FG009|Overall Study|Protocol Violation|0|||
145965839|NCT01909804|526389696|FG010|Overall Study|Protocol Violation|0|||
145965840|NCT01909804|526389697|FG011|Overall Study|Protocol Violation|1|||
145965841|NCT02895347|526389698|FG000|Overall Study|Withdrawal by Subject|3|||
145965842|NCT02895347|526389699|FG001|Overall Study|Withdrawal by Subject|1|||
145965843|NCT01673178|526389703|FG000|Overall Study|Lost to Follow-up|0|||
145965844|NCT01673178|526389704|FG001|Overall Study|Lost to Follow-up|1|||
145965845|NCT01673178|526389705|FG002|Overall Study|Lost to Follow-up|0|||
145965846|NCT01673178|526389706|FG003|Overall Study|Lost to Follow-up|0|||
145965847|NCT01673178|526389707|FG004|Overall Study|Lost to Follow-up|0|||
145965848|NCT01673178|526389703|FG000|Overall Study|Withdrawal by Subject|0|||
145965849|NCT01673178|526389704|FG001|Overall Study|Withdrawal by Subject|0|||
145965850|NCT01673178|526389705|FG002|Overall Study|Withdrawal by Subject|1|||
145965851|NCT01673178|526389706|FG003|Overall Study|Withdrawal by Subject|4|||
145965852|NCT01673178|526389707|FG004|Overall Study|Withdrawal by Subject|2|||
145965853|NCT01673178|526389703|FG000|Overall Study|Protocol Violation|1|||
145965854|NCT01673178|526389704|FG001|Overall Study|Protocol Violation|1|||
145965855|NCT01673178|526389705|FG002|Overall Study|Protocol Violation|0|||
145965856|NCT01673178|526389706|FG003|Overall Study|Protocol Violation|1|||
145965857|NCT01673178|526389707|FG004|Overall Study|Protocol Violation|0|||
145965858|NCT01673178|526389703|FG000|Overall Study|Adverse Event|1|||
145965859|NCT01673178|526389704|FG001|Overall Study|Adverse Event|0|||
145965860|NCT01673178|526389705|FG002|Overall Study|Adverse Event|0|||
145965861|NCT01673178|526389706|FG003|Overall Study|Adverse Event|2|||
145965862|NCT01673178|526389707|FG004|Overall Study|Adverse Event|0|||
145965863|NCT01673178|526389703|FG000|Overall Study|Other|1|||
145965864|NCT01673178|526389704|FG001|Overall Study|Other|0|||
145965865|NCT01673178|526389705|FG002|Overall Study|Other|2|||
145965866|NCT01673178|526389706|FG003|Overall Study|Other|1|||
145965867|NCT01673178|526389707|FG004|Overall Study|Other|0|||
145965868|NCT00931632|526389709|FG000|Overall Study|Withdrawal by Subject|2|||
145965869|NCT00931632|526389710|FG001|Overall Study|Withdrawal by Subject|3|||
145965870|NCT00931632|526389709|FG000|Overall Study|Adverse Event|19|||
145965871|NCT00931632|526389710|FG001|Overall Study|Adverse Event|15|||
145965872|NCT01419314|526389712|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
145965873|NCT01419314|526389713|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
145965874|NCT01419314|526389712|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
145965875|NCT01419314|526389713|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
145965876|NCT01419314|526389712|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
145965877|NCT01419314|526389713|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
145965878|NCT00402727|526389716|FG000|Overall Study|Adverse Event|10|||
145965879|NCT00402727|526389717|FG001|Overall Study|Adverse Event|6|||
145965880|NCT00402727|526389716|FG000|Overall Study|Death|1|||
145965881|NCT00402727|526389717|FG001|Overall Study|Death|0|||
145965882|NCT00402727|526389716|FG000|Overall Study|Lack of Efficacy|1|||
145965883|NCT00402727|526389717|FG001|Overall Study|Lack of Efficacy|3|||
145965884|NCT00402727|526389716|FG000|Overall Study|Lost to Follow-up|24|||
145965885|NCT00402727|526389717|FG001|Overall Study|Lost to Follow-up|11|||
145965886|NCT00402727|526389716|FG000|Overall Study|Physician Decision|1|||
145965887|NCT00402727|526389717|FG001|Overall Study|Physician Decision|1|||
145965888|NCT00402727|526389716|FG000|Overall Study|Protocol Violation|0|||
145965889|NCT00402727|526389717|FG001|Overall Study|Protocol Violation|4|||
145965890|NCT00402727|526389716|FG000|Overall Study|Withdrawal by Subject|3|||
145965891|NCT00402727|526389717|FG001|Overall Study|Withdrawal by Subject|7|||
145965892|NCT00402727|526389716|FG000|Overall Study|supply problems|2|||
145965893|NCT00402727|526389717|FG001|Overall Study|supply problems|1|||
145965894|NCT00402727|526389716|FG000|Overall Study|non-compliance|0|||
146086714|NCT04391569|526838367|FG001|Overall Study|Lack of Efficacy|1|||
145965895|NCT00402727|526389717|FG001|Overall Study|non-compliance|1|||
145965896|NCT03372798|526389718|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
145965897|NCT03372798|526389719|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
145965898|NCT03372798|526389718|FG000|Overall Study|Failure of imaging probe|0|||
145965899|NCT03372798|526389719|FG001|Overall Study|Failure of imaging probe|1|||
145965900|NCT03139552|526389736|FG000|Overall Study|unable to attend tasting due to schedule|3|||
145965901|NCT00887484|526389749|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
145965902|NCT00887484|526389749|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
145965903|NCT00887484|526389749|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
145965904|NCT01316224|526389754|FG000|Overall Study|Protocol Violation|3|||
145965905|NCT01316224|526389754|FG000|Overall Study|Adverse Event|3|||
145965906|NCT01316224|526389754|FG000|Overall Study|Lack of Efficacy|1|||
145970794|NCT02690727|526407271|FG000|Overall Study|Adverse Event|2|||
145888094|NCT02124902|526096413|FG000|Overall Study|Withdrawal by Subject|2|||
145888095|NCT02124902|526096414|FG001|Overall Study|Withdrawal by Subject|1|||
145888096|NCT02124902|526096413|FG000|Overall Study|Physician Decision|2|||
145888097|NCT02124902|526096414|FG001|Overall Study|Physician Decision|0|||
145888098|NCT02124902|526096413|FG000|Overall Study|Not eligible|1|||
146232471|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232472|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232473|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232474|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
146232475|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
146232476|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232477|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232478|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232479|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232480|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232481|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232482|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232483|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232484|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
146232485|NCT02719574|527369480|FG000|Phase 1 (Dose Expansion)|Other|0|||
146232486|NCT02719574|527369481|FG001|Phase 1 (Dose Expansion)|Other|0|||
146232487|NCT02719574|527369482|FG002|Phase 1 (Dose Expansion)|Other|0|||
146232488|NCT02719574|527369483|FG003|Phase 1 (Dose Expansion)|Other|0|||
146232489|NCT02719574|527369484|FG004|Phase 1 (Dose Expansion)|Other|0|||
146232490|NCT02719574|527369485|FG005|Phase 1 (Dose Expansion)|Other|0|||
146232491|NCT02719574|527369486|FG006|Phase 1 (Dose Expansion)|Other|1|||
146232492|NCT02719574|527369487|FG007|Phase 1 (Dose Expansion)|Other|7|||
146232493|NCT02719574|527369488|FG008|Phase 1 (Dose Expansion)|Other|0|||
146232494|NCT02719574|527369489|FG009|Phase 1 (Dose Expansion)|Other|0|||
146232495|NCT02719574|527369490|FG010|Phase 1 (Dose Expansion)|Other|0|||
146232496|NCT02719574|527369491|FG011|Phase 1 (Dose Expansion)|Other|0|||
146232497|NCT02719574|527369492|FG012|Phase 1 (Dose Expansion)|Other|0|||
146232498|NCT02719574|527369493|FG013|Phase 1 (Dose Expansion)|Other|0|||
146232499|NCT02719574|527369494|FG014|Phase 1 (Dose Expansion)|Other|0|||
146232500|NCT02719574|527369495|FG015|Phase 1 (Dose Expansion)|Other|0|||
146232501|NCT02719574|527369496|FG016|Phase 1 (Dose Expansion)|Other|0|||
146232502|NCT02719574|527369480|FG000|Phase 2|Protocol Defined Disease Progression|0|||
146232503|NCT02719574|527369481|FG001|Phase 2|Protocol Defined Disease Progression|0|||
146232504|NCT02719574|527369482|FG002|Phase 2|Protocol Defined Disease Progression|0|||
146232505|NCT02719574|527369483|FG003|Phase 2|Protocol Defined Disease Progression|0|||
146232506|NCT02719574|527369484|FG004|Phase 2|Protocol Defined Disease Progression|0|||
146232507|NCT02719574|527369485|FG005|Phase 2|Protocol Defined Disease Progression|0|||
146232508|NCT02719574|527369486|FG006|Phase 2|Protocol Defined Disease Progression|0|||
146232509|NCT02719574|527369487|FG007|Phase 2|Protocol Defined Disease Progression|0|||
146232510|NCT02719574|527369488|FG008|Phase 2|Protocol Defined Disease Progression|0|||
146232511|NCT02719574|527369489|FG009|Phase 2|Protocol Defined Disease Progression|65|||
146232512|NCT02719574|527369490|FG010|Phase 2|Protocol Defined Disease Progression|8|||
146232513|NCT02719574|527369491|FG011|Phase 2|Protocol Defined Disease Progression|2|||
146232514|NCT02719574|527369492|FG012|Phase 2|Protocol Defined Disease Progression|4|||
146232515|NCT02719574|527369493|FG013|Phase 2|Protocol Defined Disease Progression|9|||
146232516|NCT02719574|527369494|FG014|Phase 2|Protocol Defined Disease Progression|11|||
146232517|NCT02719574|527369495|FG015|Phase 2|Protocol Defined Disease Progression|3|||
146232518|NCT02719574|527369496|FG016|Phase 2|Protocol Defined Disease Progression|4|||
146232519|NCT02719574|527369480|FG000|Phase 2|Adverse Event|0|||
146232520|NCT02719574|527369481|FG001|Phase 2|Adverse Event|0|||
146232521|NCT02719574|527369482|FG002|Phase 2|Adverse Event|0|||
146232522|NCT02719574|527369483|FG003|Phase 2|Adverse Event|0|||
146232523|NCT02719574|527369484|FG004|Phase 2|Adverse Event|0|||
146232524|NCT02719574|527369485|FG005|Phase 2|Adverse Event|0|||
146232525|NCT02719574|527369486|FG006|Phase 2|Adverse Event|0|||
146232526|NCT02719574|527369487|FG007|Phase 2|Adverse Event|0|||
146232527|NCT02719574|527369488|FG008|Phase 2|Adverse Event|0|||
146232528|NCT02719574|527369489|FG009|Phase 2|Adverse Event|27|||
146232529|NCT02719574|527369490|FG010|Phase 2|Adverse Event|0|||
146232530|NCT02719574|527369491|FG011|Phase 2|Adverse Event|1|||
146232531|NCT02719574|527369492|FG012|Phase 2|Adverse Event|1|||
146232532|NCT02719574|527369493|FG013|Phase 2|Adverse Event|1|||
146232533|NCT02719574|527369494|FG014|Phase 2|Adverse Event|2|||
146232534|NCT02719574|527369495|FG015|Phase 2|Adverse Event|2|||
145965907|NCT01316224|526389754|FG000|Overall Study|Withdrawal by Subject|1|||
145965908|NCT01316224|526389754|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
145965909|NCT01316224|526389754|FG000|Overall Study|Other|1|||
145965910|NCT00264147|526389755|FG000|Treatment I Period|Adverse Event|3|||
145965911|NCT00264147|526389756|FG001|Treatment I Period|Adverse Event|6|||
145965912|NCT00264147|526389757|FG002|Treatment I Period|Adverse Event|3|||
145965913|NCT00264147|526389758|FG003|Treatment I Period|Adverse Event|5|||
145965914|NCT00264147|526389759|FG004|Treatment I Period|Adverse Event|7|||
145965915|NCT00264147|526389760|FG005|Treatment I Period|Adverse Event|0|||
145965916|NCT00264147|526389755|FG000|Treatment I Period|Laboratory Adverse Event|0|||
145965917|NCT00264147|526389756|FG001|Treatment I Period|Laboratory Adverse Event|0|||
145965918|NCT00264147|526389757|FG002|Treatment I Period|Laboratory Adverse Event|0|||
145965919|NCT00264147|526389758|FG003|Treatment I Period|Laboratory Adverse Event|1|||
145965920|NCT00264147|526389759|FG004|Treatment I Period|Laboratory Adverse Event|0|||
145965921|NCT00264147|526389760|FG005|Treatment I Period|Laboratory Adverse Event|0|||
145965922|NCT00264147|526389755|FG000|Treatment I Period|Lack of Efficacy|6|||
145965923|NCT00264147|526389756|FG001|Treatment I Period|Lack of Efficacy|2|||
145965924|NCT00264147|526389757|FG002|Treatment I Period|Lack of Efficacy|8|||
145965925|NCT00264147|526389758|FG003|Treatment I Period|Lack of Efficacy|0|||
145965926|NCT00264147|526389759|FG004|Treatment I Period|Lack of Efficacy|1|||
145965927|NCT00264147|526389760|FG005|Treatment I Period|Lack of Efficacy|0|||
145965928|NCT00264147|526389755|FG000|Treatment I Period|Lost to Follow-up|1|||
145965929|NCT00264147|526389756|FG001|Treatment I Period|Lost to Follow-up|0|||
145965930|NCT00264147|526389757|FG002|Treatment I Period|Lost to Follow-up|0|||
145965931|NCT00264147|526389758|FG003|Treatment I Period|Lost to Follow-up|1|||
145965932|NCT00264147|526389759|FG004|Treatment I Period|Lost to Follow-up|1|||
145965933|NCT00264147|526389760|FG005|Treatment I Period|Lost to Follow-up|0|||
145965934|NCT00264147|526389755|FG000|Treatment I Period|Protocol Violation|2|||
145965935|NCT00264147|526389756|FG001|Treatment I Period|Protocol Violation|2|||
145965936|NCT00264147|526389757|FG002|Treatment I Period|Protocol Violation|0|||
145965937|NCT00264147|526389758|FG003|Treatment I Period|Protocol Violation|0|||
145965938|NCT00264147|526389759|FG004|Treatment I Period|Protocol Violation|0|||
145965939|NCT00264147|526389760|FG005|Treatment I Period|Protocol Violation|0|||
145965940|NCT00264147|526389755|FG000|Treatment I Period|Withdrawal by Subject|2|||
145965941|NCT00264147|526389756|FG001|Treatment I Period|Withdrawal by Subject|0|||
145965942|NCT00264147|526389757|FG002|Treatment I Period|Withdrawal by Subject|0|||
145965943|NCT00264147|526389758|FG003|Treatment I Period|Withdrawal by Subject|2|||
145965944|NCT00264147|526389759|FG004|Treatment I Period|Withdrawal by Subject|2|||
145965945|NCT00264147|526389760|FG005|Treatment I Period|Withdrawal by Subject|0|||
145965946|NCT00264147|526389755|FG000|Treatment I Period|Patient out of town for an extended time|0|||
145965947|NCT00264147|526389756|FG001|Treatment I Period|Patient out of town for an extended time|1|||
145965948|NCT00264147|526389757|FG002|Treatment I Period|Patient out of town for an extended time|0|||
145965949|NCT00264147|526389758|FG003|Treatment I Period|Patient out of town for an extended time|0|||
145965950|NCT00264147|526389759|FG004|Treatment I Period|Patient out of town for an extended time|0|||
145965951|NCT00264147|526389760|FG005|Treatment I Period|Patient out of town for an extended time|0|||
145965952|NCT00264147|526389755|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145965953|NCT00264147|526389756|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145965954|NCT00264147|526389757|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
145965955|NCT00264147|526389758|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145965956|NCT00264147|526389759|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145965957|NCT00264147|526389760|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145965958|NCT00264147|526389755|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
145965959|NCT00264147|526389756|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
145965960|NCT00264147|526389757|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
145965961|NCT00264147|526389758|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
145965962|NCT00264147|526389759|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
145965963|NCT00264147|526389760|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
145965964|NCT00264147|526389755|FG000|Treatment II Period|Adverse Event|0|||
145965965|NCT00264147|526389756|FG001|Treatment II Period|Adverse Event|0|||
145965966|NCT00264147|526389757|FG002|Treatment II Period|Adverse Event|0|||
145965967|NCT00264147|526389758|FG003|Treatment II Period|Adverse Event|0|||
145965968|NCT00264147|526389759|FG004|Treatment II Period|Adverse Event|9|||
145965969|NCT00264147|526389760|FG005|Treatment II Period|Adverse Event|9|||
145965970|NCT00264147|526389755|FG000|Treatment II Period|Laboratory Adverse Event|0|||
145965971|NCT00264147|526389756|FG001|Treatment II Period|Laboratory Adverse Event|0|||
145965972|NCT00264147|526389757|FG002|Treatment II Period|Laboratory Adverse Event|0|||
145965973|NCT00264147|526389758|FG003|Treatment II Period|Laboratory Adverse Event|0|||
145965974|NCT00264147|526389759|FG004|Treatment II Period|Laboratory Adverse Event|0|||
145965975|NCT00264147|526389760|FG005|Treatment II Period|Laboratory Adverse Event|1|||
145965976|NCT00264147|526389755|FG000|Treatment II Period|Lack of Efficacy|0|||
145965977|NCT00264147|526389756|FG001|Treatment II Period|Lack of Efficacy|0|||
145965978|NCT00264147|526389757|FG002|Treatment II Period|Lack of Efficacy|0|||
146291201|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
146291202|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
146291203|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146291204|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146291205|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146291206|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
146291207|NCT00427895|527580579|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146291208|NCT00427895|527580580|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146291209|NCT00427895|527580581|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
146291210|NCT00427895|527580582|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
146291211|NCT00427895|527580583|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146291212|NCT00427895|527580584|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145965979|NCT00264147|526389758|FG003|Treatment II Period|Lack of Efficacy|0|||
146291213|NCT00427895|527580585|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146291214|NCT00427895|527580586|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
146291215|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146291216|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
145965980|NCT00264147|526389759|FG004|Treatment II Period|Lack of Efficacy|20|||
145965981|NCT00264147|526389760|FG005|Treatment II Period|Lack of Efficacy|19|||
145965982|NCT00264147|526389755|FG000|Treatment II Period|Lost to Follow-up|0|||
145965983|NCT00264147|526389756|FG001|Treatment II Period|Lost to Follow-up|0|||
145965984|NCT00264147|526389757|FG002|Treatment II Period|Lost to Follow-up|0|||
145965985|NCT00264147|526389758|FG003|Treatment II Period|Lost to Follow-up|0|||
145965986|NCT00264147|526389759|FG004|Treatment II Period|Lost to Follow-up|1|||
145965987|NCT00264147|526389760|FG005|Treatment II Period|Lost to Follow-up|1|||
145965988|NCT00264147|526389755|FG000|Treatment II Period|Withdrawal by Subject|0|||
145965989|NCT00264147|526389756|FG001|Treatment II Period|Withdrawal by Subject|0|||
145965990|NCT00264147|526389757|FG002|Treatment II Period|Withdrawal by Subject|0|||
145965991|NCT00264147|526389758|FG003|Treatment II Period|Withdrawal by Subject|0|||
145965992|NCT00264147|526389759|FG004|Treatment II Period|Withdrawal by Subject|3|||
145965993|NCT00264147|526389760|FG005|Treatment II Period|Withdrawal by Subject|2|||
145965994|NCT00264147|526389755|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
145965995|NCT00264147|526389756|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
145965996|NCT00264147|526389757|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
145965997|NCT00264147|526389758|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
145965998|NCT00264147|526389759|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
145965999|NCT00264147|526389760|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
145966000|NCT00449163|526389763|FG000|Overall Study|Physician Decision|3|||
145966001|NCT02949947|526389771|FG000|Overall Study|Non Compliance|0|||
145966002|NCT02949947|526389772|FG001|Overall Study|Non Compliance|1|||
145966003|NCT02949947|526389771|FG000|Overall Study|Insurance change|1|||
145966004|NCT02949947|526389772|FG001|Overall Study|Insurance change|0|||
145966005|NCT02230891|526389774|FG000|Baseline|Did not meet inclusion|0|||
145966006|NCT02230891|526389775|FG001|Baseline|Did not meet inclusion|1|||
145966007|NCT02230891|526389776|FG002|Baseline|Did not meet inclusion|1|||
145966008|NCT02230891|526389774|FG000|2 Week|Withdrawal by Subject|2|||
145966009|NCT02230891|526389775|FG001|2 Week|Withdrawal by Subject|2|||
145966010|NCT02230891|526389776|FG002|2 Week|Withdrawal by Subject|0|||
145966011|NCT02230891|526389774|FG000|2 Week|Consent withdrawn|1|||
145966012|NCT02230891|526389775|FG001|2 Week|Consent withdrawn|0|||
145966013|NCT02230891|526389776|FG002|2 Week|Consent withdrawn|0|||
145966014|NCT02230891|526389774|FG000|6 Month|Withdrawal by Subject|1|||
145966015|NCT02230891|526389775|FG001|6 Month|Withdrawal by Subject|1|||
145966016|NCT02230891|526389776|FG002|6 Month|Withdrawal by Subject|1|||
145966017|NCT02230891|526389774|FG000|6 Month|Physician Decision|0|||
145966018|NCT02230891|526389775|FG001|6 Month|Physician Decision|2|||
145966019|NCT02230891|526389776|FG002|6 Month|Physician Decision|0|||
145966020|NCT02230891|526389774|FG000|12 Month|Death|1|||
145966021|NCT02230891|526389775|FG001|12 Month|Death|0|||
145966022|NCT02230891|526389776|FG002|12 Month|Death|0|||
145966023|NCT02230891|526389774|FG000|12 Month|Lost to Follow-up|0|||
145966024|NCT02230891|526389775|FG001|12 Month|Lost to Follow-up|1|||
145966025|NCT02230891|526389776|FG002|12 Month|Lost to Follow-up|0|||
145966026|NCT02230891|526389774|FG000|12 Month|Withdrawal by Subject|0|||
145966027|NCT02230891|526389775|FG001|12 Month|Withdrawal by Subject|2|||
145966028|NCT02230891|526389776|FG002|12 Month|Withdrawal by Subject|0|||
145966029|NCT02230891|526389774|FG000|18 Month End of Study|Death|0|||
145966030|NCT02230891|526389775|FG001|18 Month End of Study|Death|0|||
146291217|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
146291218|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
146291219|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146291220|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146291221|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146291222|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
146291223|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
146291224|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
146291225|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145888099|NCT02124902|526096414|FG001|Overall Study|Not eligible|0|||
146291226|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
146291227|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146291228|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146291229|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146291230|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
146291231|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
146291232|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
146291233|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
146291234|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
146291235|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146291236|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146291237|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146291238|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
146291239|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146291240|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
146291241|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146291242|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145888100|NCT02124902|526096413|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
145888101|NCT02124902|526096414|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
145888102|NCT00546910|526096418|FG000|Overall Study|Adverse Event|2|||
145888103|NCT00546910|526096419|FG001|Overall Study|Adverse Event|3|||
145888104|NCT00546910|526096418|FG000|Overall Study|Lack of Efficacy|5|||
145888105|NCT00546910|526096419|FG001|Overall Study|Lack of Efficacy|7|||
145888106|NCT00546910|526096418|FG000|Overall Study|Physician Decision|0|||
145888107|NCT00546910|526096419|FG001|Overall Study|Physician Decision|1|||
145888108|NCT00546910|526096418|FG000|Overall Study|Withdrawal by Subject|2|||
145888109|NCT00546910|526096419|FG001|Overall Study|Withdrawal by Subject|0|||
145888110|NCT01467479|526096420|FG000|Overall Study|No Study Medication|1|||
145888111|NCT01467479|526096421|FG001|Overall Study|No Study Medication|0|||
145888112|NCT01467479|526096422|FG002|Overall Study|No Study Medication|2|||
145888113|NCT01467479|526096420|FG000|Overall Study|Adverse Event|1|||
145888114|NCT01467479|526096421|FG001|Overall Study|Adverse Event|2|||
145888115|NCT01467479|526096422|FG002|Overall Study|Adverse Event|0|||
145888116|NCT01467479|526096420|FG000|Overall Study|Death|0|||
145888117|NCT01467479|526096421|FG001|Overall Study|Death|0|||
145888118|NCT01467479|526096422|FG002|Overall Study|Death|1|||
145888119|NCT01467479|526096420|FG000|Overall Study|Lost to Follow-up|2|||
145888120|NCT01467479|526096421|FG001|Overall Study|Lost to Follow-up|5|||
145888121|NCT01467479|526096422|FG002|Overall Study|Lost to Follow-up|3|||
145888122|NCT01467479|526096420|FG000|Overall Study|Withdrawal of Consent|3|||
145888123|NCT01467479|526096421|FG001|Overall Study|Withdrawal of Consent|7|||
145888124|NCT01467479|526096422|FG002|Overall Study|Withdrawal of Consent|7|||
145888125|NCT01467479|526096420|FG000|Overall Study|Study Terminated by Sponsor|1|||
145888126|NCT01467479|526096421|FG001|Overall Study|Study Terminated by Sponsor|3|||
145888127|NCT01467479|526096422|FG002|Overall Study|Study Terminated by Sponsor|3|||
146291243|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146291244|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145888128|NCT01467479|526096420|FG000|Overall Study|Other|1|||
145888129|NCT01467479|526096421|FG001|Overall Study|Other|0|||
145888130|NCT01467479|526096422|FG002|Overall Study|Other|0|||
145888131|NCT02284347|526096432|FG000|Overall Study|Lost to Follow-up|2|||
145888132|NCT02284347|526096432|FG000|Overall Study|Withdrawn prior to treatment|1|||
146291245|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146291246|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
146291247|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Death|1|||
146291248|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Death|0|||
146291249|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Death|0|||
146291250|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Death|0|||
146291251|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Death|0|||
146291252|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Death|0|||
146291253|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Death|0|||
146291254|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Death|0|||
146291255|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146291256|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145966031|NCT02230891|526389776|FG002|18 Month End of Study|Death|1|||
145966032|NCT02230891|526389774|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
145966033|NCT02230891|526389775|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
145966034|NCT02230891|526389776|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
145966035|NCT04158219|526389779|FG000|Overall Study|Lost to Follow-up|1|||
145966036|NCT01814007|526389781|FG000|Overall Study|Withdrawal by Subject|1|||
145966037|NCT04194814|526389782|FG000|Overall Study|Physician Decision|3|||
145966038|NCT04194814|526389783|FG001|Overall Study|Physician Decision|0|||
145966039|NCT04194814|526389782|FG000|Overall Study|Withdrawal by Subject|0|||
145966040|NCT04194814|526389783|FG001|Overall Study|Withdrawal by Subject|2|||
145966041|NCT00434252|526391780|FG000|Overall Study|Lack of Efficacy|50|||
145966042|NCT00434252|526391781|FG001|Overall Study|Lack of Efficacy|100|||
145966043|NCT00434252|526391780|FG000|Overall Study|Adverse Event|6|||
145966044|NCT00434252|526391781|FG001|Overall Study|Adverse Event|13|||
145966045|NCT00434252|526391780|FG000|Overall Study|Death|1|||
145966046|NCT00434252|526391781|FG001|Overall Study|Death|2|||
145966047|NCT00434252|526391780|FG000|Overall Study|Lost to Follow-up|0|||
145966048|NCT00434252|526391781|FG001|Overall Study|Lost to Follow-up|1|||
145966049|NCT00434252|526391780|FG000|Overall Study|Physician Decision|4|||
145966050|NCT00434252|526391781|FG001|Overall Study|Physician Decision|8|||
145966051|NCT00434252|526391780|FG000|Overall Study|Withdrawal by Subject|3|||
145966052|NCT00434252|526391781|FG001|Overall Study|Withdrawal by Subject|7|||
145966053|NCT00720278|526391799|FG000|Overall Study|Adverse Event|5|||
145966054|NCT00720278|526391800|FG001|Overall Study|Adverse Event|3|||
145966055|NCT00720278|526391801|FG002|Overall Study|Adverse Event|4|||
145966056|NCT00720278|526391799|FG000|Overall Study|Withdrawal by Subject|0|||
145966057|NCT00720278|526391800|FG001|Overall Study|Withdrawal by Subject|1|||
145966058|NCT00720278|526391801|FG002|Overall Study|Withdrawal by Subject|0|||
145966059|NCT00720278|526391799|FG000|Overall Study|Lost to Follow-up|0|||
145966060|NCT00720278|526391800|FG001|Overall Study|Lost to Follow-up|0|||
145966061|NCT00720278|526391801|FG002|Overall Study|Lost to Follow-up|1|||
145966062|NCT00720278|526391799|FG000|Overall Study|Non-compliance|1|||
145966063|NCT00720278|526391800|FG001|Overall Study|Non-compliance|0|||
145966064|NCT00720278|526391801|FG002|Overall Study|Non-compliance|0|||
145966065|NCT00720278|526391799|FG000|Overall Study|eligibility criteria violation|1|||
145966066|NCT00720278|526391800|FG001|Overall Study|eligibility criteria violation|0|||
145966067|NCT00720278|526391801|FG002|Overall Study|eligibility criteria violation|1|||
145966068|NCT03630393|526391807|FG000|Overall Study|Death|1|||
145966069|NCT03630393|526391808|FG001|Overall Study|Death|0|||
145966070|NCT00408499|526391809|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145966071|NCT00408499|526391810|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145966072|NCT00408499|526391811|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
145966073|NCT00408499|526391812|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145966074|NCT00408499|526391813|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145966075|NCT00408499|526391809|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
145966076|NCT00408499|526391810|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
146291257|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
146291258|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
146291259|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145966077|NCT00408499|526391811|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
146291260|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145966078|NCT00408499|526391812|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
145966079|NCT00408499|526391813|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
145966080|NCT00408499|526391809|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
145966081|NCT00408499|526391810|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
145966082|NCT00408499|526391811|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
146291261|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
146291262|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145966083|NCT00408499|526391812|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
145966084|NCT00408499|526391813|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
146291263|NCT00427895|527580579|FG000|Vax 1/Year 1 Follow-up|Other|0|||
145966085|NCT00408499|526391809|FG000|Phase II- MTD Expansion|Adverse Event|0|||
146291264|NCT00427895|527580580|FG001|Vax 1/Year 1 Follow-up|Other|0|||
146291265|NCT00427895|527580581|FG002|Vax 1/Year 1 Follow-up|Other|0|||
146291266|NCT00427895|527580582|FG003|Vax 1/Year 1 Follow-up|Other|2|||
146291267|NCT00427895|527580583|FG004|Vax 1/Year 1 Follow-up|Other|0|||
146291268|NCT00427895|527580584|FG005|Vax 1/Year 1 Follow-up|Other|0|||
146291269|NCT00427895|527580585|FG006|Vax 1/Year 1 Follow-up|Other|0|||
146291270|NCT00427895|527580586|FG007|Vax 1/Year 1 Follow-up|Other|0|||
146291271|NCT00427895|527580579|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
146291272|NCT00427895|527580580|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
146291273|NCT00427895|527580581|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
146291274|NCT00427895|527580582|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
146291275|NCT00427895|527580583|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146291276|NCT00427895|527580584|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146291277|NCT00427895|527580585|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146291278|NCT00427895|527580586|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
146291279|NCT03573401|527580587|FG000|Overall Study|Withdrawal by Subject|2|||
145966086|NCT00408499|526391810|FG001|Phase II- MTD Expansion|Adverse Event|0|||
145966087|NCT00408499|526391811|FG002|Phase II- MTD Expansion|Adverse Event|0|||
145966088|NCT00408499|526391812|FG003|Phase II- MTD Expansion|Adverse Event|0|||
145966089|NCT00408499|526391813|FG004|Phase II- MTD Expansion|Adverse Event|9|||
145966090|NCT00408499|526391809|FG000|Phase II- MTD Expansion|Death|0|||
145966091|NCT00408499|526391810|FG001|Phase II- MTD Expansion|Death|0|||
145966092|NCT00408499|526391811|FG002|Phase II- MTD Expansion|Death|0|||
145966093|NCT00408499|526391812|FG003|Phase II- MTD Expansion|Death|0|||
145966094|NCT00408499|526391813|FG004|Phase II- MTD Expansion|Death|2|||
145966095|NCT00408499|526391809|FG000|Phase II- MTD Expansion|Physician Decision|0|||
145966096|NCT00408499|526391810|FG001|Phase II- MTD Expansion|Physician Decision|0|||
145966097|NCT00408499|526391811|FG002|Phase II- MTD Expansion|Physician Decision|0|||
145966098|NCT00408499|526391812|FG003|Phase II- MTD Expansion|Physician Decision|0|||
145966099|NCT00408499|526391813|FG004|Phase II- MTD Expansion|Physician Decision|1|||
145966100|NCT00408499|526391809|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145966101|NCT00408499|526391810|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145966102|NCT00408499|526391811|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145966103|NCT00408499|526391812|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145966104|NCT00408499|526391813|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
145966105|NCT00408499|526391809|FG000|Phase II- MTD Expansion|treatment delay|0|||
145966106|NCT00408499|526391810|FG001|Phase II- MTD Expansion|treatment delay|0|||
145966107|NCT00408499|526391811|FG002|Phase II- MTD Expansion|treatment delay|0|||
145966108|NCT00408499|526391812|FG003|Phase II- MTD Expansion|treatment delay|0|||
145966109|NCT00408499|526391813|FG004|Phase II- MTD Expansion|treatment delay|3|||
145966110|NCT01586195|526391817|FG000|Overall Study|Death|11|||
145966111|NCT01586195|526391817|FG000|Overall Study|Withdrawal of Consent|5|||
145966112|NCT01586195|526391817|FG000|Overall Study|Started new anti-melanoma therapy|1|||
145966113|NCT01586195|526391817|FG000|Overall Study|Reason not specified|9|||
145966114|NCT00997334|526391818|FG000|Overall Study|still on therapy|12|||
145966115|NCT00997334|526391818|FG000|Overall Study|Adverse Event|3|||
145966116|NCT00997334|526391818|FG000|Overall Study|Patient non-compliance|1|||
145966117|NCT00997334|526391818|FG000|Overall Study|Withdrawal by Subject|3|||
145966118|NCT00997334|526391818|FG000|Overall Study|Death|2|||
145966119|NCT00997334|526391818|FG000|Overall Study|Urgent Palliative Care|2|||
145966120|NCT00997334|526391818|FG000|Overall Study|No lesion amenable|1|||
145966121|NCT00997334|526391818|FG000|Overall Study|Ineligible|1|||
145966122|NCT03499795|526391823|FG000|Overall Study|Adverse Event|1|||
145966123|NCT03499795|526391823|FG000|Overall Study|Lost to Follow-up|1|||
145966124|NCT04748718|526391826|FG000|Overall Study|Lost to Follow-up|50|||
145966125|NCT01450813|526391827|FG000|Overall Study|Physician Decision|1|||
145966126|NCT01450813|526391828|FG001|Overall Study|Physician Decision|1|||
145966127|NCT01450813|526391829|FG002|Overall Study|Physician Decision|0|||
145966128|NCT01450813|526391830|FG003|Overall Study|Physician Decision|3|||
146291280|NCT03573401|527580588|FG001|Overall Study|Withdrawal by Subject|0|||
146291281|NCT03573401|527580587|FG000|Overall Study|Subject non-compliance with study schedule|1|||
145966129|NCT01935089|526391832|FG000|Overall Study|Adverse Event|2|||
145966130|NCT01935089|526391832|FG000|Overall Study|Withdrawal by Subject|1|||
145966131|NCT01483118|526391833|FG000|Overall Study|Lost to Follow-up|12|||
145966132|NCT01483118|526391834|FG001|Overall Study|Lost to Follow-up|16|||
145966133|NCT00785356|526391835|FG000|Overall Study|Study prematurely terminated|8|||
145966134|NCT01079780|526391836|FG000|Overall Study|Disease progression|43|||
145966135|NCT01079780|526391837|FG001|Overall Study|Disease progression|7|||
145966136|NCT01079780|526391838|FG002|Overall Study|Disease progression|31|||
146232535|NCT02719574|527369496|FG016|Phase 2|Adverse Event|3|||
146232536|NCT02719574|527369480|FG000|Phase 2|Other|0|||
146232537|NCT02719574|527369481|FG001|Phase 2|Other|0|||
146232538|NCT02719574|527369482|FG002|Phase 2|Other|0|||
146232539|NCT02719574|527369483|FG003|Phase 2|Other|0|||
146232540|NCT02719574|527369484|FG004|Phase 2|Other|0|||
146232541|NCT02719574|527369485|FG005|Phase 2|Other|0|||
146232542|NCT02719574|527369486|FG006|Phase 2|Other|0|||
146232543|NCT02719574|527369487|FG007|Phase 2|Other|0|||
146232544|NCT02719574|527369488|FG008|Phase 2|Other|0|||
146232545|NCT02719574|527369489|FG009|Phase 2|Other|20|||
146232546|NCT02719574|527369490|FG010|Phase 2|Other|7|||
146232547|NCT02719574|527369491|FG011|Phase 2|Other|0|||
146232548|NCT02719574|527369492|FG012|Phase 2|Other|5|||
146232549|NCT02719574|527369493|FG013|Phase 2|Other|7|||
146232550|NCT02719574|527369494|FG014|Phase 2|Other|0|||
146232551|NCT02719574|527369495|FG015|Phase 2|Other|1|||
146232552|NCT02719574|527369496|FG016|Phase 2|Other|4|||
146232553|NCT02719574|527369480|FG000|Phase 2|Transplant|0|||
146232554|NCT02719574|527369481|FG001|Phase 2|Transplant|0|||
146232555|NCT02719574|527369482|FG002|Phase 2|Transplant|0|||
146232556|NCT02719574|527369483|FG003|Phase 2|Transplant|0|||
146232557|NCT02719574|527369484|FG004|Phase 2|Transplant|0|||
146232558|NCT02719574|527369485|FG005|Phase 2|Transplant|0|||
146232559|NCT02719574|527369486|FG006|Phase 2|Transplant|0|||
146232560|NCT02719574|527369487|FG007|Phase 2|Transplant|0|||
146232561|NCT02719574|527369488|FG008|Phase 2|Transplant|0|||
146232562|NCT02719574|527369489|FG009|Phase 2|Transplant|15|||
146232563|NCT02719574|527369490|FG010|Phase 2|Transplant|2|||
146232564|NCT02719574|527369491|FG011|Phase 2|Transplant|0|||
146232565|NCT02719574|527369492|FG012|Phase 2|Transplant|6|||
146232566|NCT02719574|527369493|FG013|Phase 2|Transplant|1|||
146232567|NCT02719574|527369494|FG014|Phase 2|Transplant|1|||
146232568|NCT02719574|527369495|FG015|Phase 2|Transplant|0|||
146232569|NCT02719574|527369496|FG016|Phase 2|Transplant|0|||
146232570|NCT02719574|527369480|FG000|Phase 2|Death|0|||
146232571|NCT02719574|527369481|FG001|Phase 2|Death|0|||
146232572|NCT02719574|527369482|FG002|Phase 2|Death|0|||
146232573|NCT02719574|527369483|FG003|Phase 2|Death|0|||
146232574|NCT02719574|527369484|FG004|Phase 2|Death|0|||
146232575|NCT02719574|527369485|FG005|Phase 2|Death|0|||
146232576|NCT02719574|527369486|FG006|Phase 2|Death|0|||
146232577|NCT02719574|527369487|FG007|Phase 2|Death|0|||
146232578|NCT02719574|527369488|FG008|Phase 2|Death|0|||
146232579|NCT02719574|527369489|FG009|Phase 2|Death|14|||
146232580|NCT02719574|527369490|FG010|Phase 2|Death|0|||
146232581|NCT02719574|527369491|FG011|Phase 2|Death|0|||
146232582|NCT02719574|527369492|FG012|Phase 2|Death|1|||
146232583|NCT02719574|527369493|FG013|Phase 2|Death|1|||
146232584|NCT02719574|527369494|FG014|Phase 2|Death|2|||
146232585|NCT02719574|527369495|FG015|Phase 2|Death|0|||
146232586|NCT02719574|527369496|FG016|Phase 2|Death|0|||
146232587|NCT02719574|527369480|FG000|Phase 2|Investigator Decision|0|||
146291282|NCT03573401|527580588|FG001|Overall Study|Subject non-compliance with study schedule|0|||
146291283|NCT03573401|527580587|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
146232588|NCT02719574|527369481|FG001|Phase 2|Investigator Decision|0|||
146232589|NCT02719574|527369482|FG002|Phase 2|Investigator Decision|0|||
146232590|NCT02719574|527369483|FG003|Phase 2|Investigator Decision|0|||
146232591|NCT02719574|527369484|FG004|Phase 2|Investigator Decision|0|||
146232592|NCT02719574|527369485|FG005|Phase 2|Investigator Decision|0|||
146232593|NCT02719574|527369486|FG006|Phase 2|Investigator Decision|0|||
146232594|NCT02719574|527369487|FG007|Phase 2|Investigator Decision|0|||
146232595|NCT02719574|527369488|FG008|Phase 2|Investigator Decision|0|||
146232596|NCT02719574|527369489|FG009|Phase 2|Investigator Decision|6|||
146232597|NCT02719574|527369490|FG010|Phase 2|Investigator Decision|1|||
146232598|NCT02719574|527369491|FG011|Phase 2|Investigator Decision|2|||
146232599|NCT02719574|527369492|FG012|Phase 2|Investigator Decision|3|||
146291284|NCT03573401|527580588|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
146291285|NCT03573401|527580587|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
146291286|NCT03573401|527580588|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
146291287|NCT00355056|527582220|FG000|Randomization Period|Early Termination|4|||
146291288|NCT00355056|527582221|FG001|Randomization Period|Early Termination|6|||
146291289|NCT00995020|527582225|FG000|Overall Study|margin analysis not performed|2|||
146291290|NCT00995020|527582226|FG001|Overall Study|margin analysis not performed|5|||
146291291|NCT00995020|527582225|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
146291292|NCT00995020|527582226|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
146291293|NCT00730171|527582231|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
146291294|NCT00730171|527582231|FG000|Overall Study|Adverse Event|193|||
146291295|NCT00730171|527582231|FG000|Overall Study|Protocol Violation|48|||
146291296|NCT00730171|527582231|FG000|Overall Study|Withdrawal by Subject|202|||
146291297|NCT00730171|527582231|FG000|Overall Study|Lost to Follow-up|121|||
146291298|NCT00730171|527582231|FG000|Overall Study|Insufficient Therapeutic Response|141|||
146291299|NCT00730171|527582231|FG000|Overall Study|Other|61|||
146291300|NCT01729156|527582232|FG000|Overall Study|Withdrawal by Subject|1|||
146291301|NCT01729156|527582233|FG001|Overall Study|Withdrawal by Subject|0|||
146291302|NCT01729156|527582234|FG002|Overall Study|Withdrawal by Subject|0|||
146291303|NCT01215422|527582235|FG000|Overall Study|Relocation|1|||
146291304|NCT01215422|527582236|FG001|Overall Study|Relocation|0|||
146291305|NCT01215422|527582237|FG002|Overall Study|Relocation|0|||
146291306|NCT01215422|527582238|FG003|Overall Study|Relocation|0|||
146291307|NCT01215422|527582235|FG000|Overall Study|Failed intubations|0|||
146291308|NCT01215422|527582236|FG001|Overall Study|Failed intubations|0|||
146291309|NCT01215422|527582237|FG002|Overall Study|Failed intubations|3|||
146291310|NCT01215422|527582238|FG003|Overall Study|Failed intubations|8|||
146291311|NCT01215422|527582235|FG000|Overall Study|Did not complete all intubations|7|||
146291312|NCT01215422|527582236|FG001|Overall Study|Did not complete all intubations|0|||
146291313|NCT01215422|527582237|FG002|Overall Study|Did not complete all intubations|0|||
146291314|NCT01215422|527582238|FG003|Overall Study|Did not complete all intubations|0|||
146291315|NCT01256658|527582239|FG000|Period 1|Lost to Follow-up|837|||
146291316|NCT01256658|527582240|FG001|Period 1|Lost to Follow-up|661|||
146291317|NCT01256658|527582239|FG000|Period 1|Withdrawal by Subject|35|||
146291318|NCT01256658|527582240|FG001|Period 1|Withdrawal by Subject|43|||
146291319|NCT01256658|527582239|FG000|Period 1|Death|48|||
146291320|NCT01256658|527582240|FG001|Period 1|Death|44|||
146291321|NCT00719563|527582245|FG000|Overall Study|Adverse Event|16|||
146291322|NCT00719563|527582246|FG001|Overall Study|Adverse Event|13|||
146291323|NCT00719563|527582245|FG000|Overall Study|Medical condition changed|3|||
146291324|NCT00719563|527582246|FG001|Overall Study|Medical condition changed|5|||
146291325|NCT00719563|527582245|FG000|Overall Study|Lack of Efficacy|3|||
146291326|NCT00719563|527582246|FG001|Overall Study|Lack of Efficacy|7|||
146291327|NCT00719563|527582245|FG000|Overall Study|Personal reasons|6|||
146291328|NCT00719563|527582246|FG001|Overall Study|Personal reasons|7|||
146291329|NCT00719563|527582245|FG000|Overall Study|Unknown reasons|4|||
146291330|NCT00719563|527582246|FG001|Overall Study|Unknown reasons|6|||
146291331|NCT00719563|527582245|FG000|Overall Study|Noncompliant|1|||
146291332|NCT00719563|527582246|FG001|Overall Study|Noncompliant|1|||
146291333|NCT00719563|527582245|FG000|Overall Study|Lost to Follow-up|5|||
146291334|NCT00719563|527582246|FG001|Overall Study|Lost to Follow-up|3|||
146291335|NCT02986334|527582247|FG000|Overall Study|Withdrawal by Subject|0|||
146291336|NCT02986334|527582248|FG001|Overall Study|Withdrawal by Subject|1|||
146291337|NCT02986334|527582249|FG002|Overall Study|Withdrawal by Subject|2|||
146291338|NCT02986334|527582247|FG000|Overall Study|Lost to Follow-up|1|||
146291339|NCT02986334|527582248|FG001|Overall Study|Lost to Follow-up|2|||
146291340|NCT02986334|527582249|FG002|Overall Study|Lost to Follow-up|1|||
146291341|NCT02986334|527582247|FG000|Overall Study|Adverse Event|0|||
146291342|NCT02986334|527582248|FG001|Overall Study|Adverse Event|2|||
146291343|NCT02986334|527582249|FG002|Overall Study|Adverse Event|1|||
146291344|NCT02986334|527582247|FG000|Overall Study|non compliance in phone ratings|2|||
145888133|NCT01684215|526096436|FG000|Phase 1, Part 1|Adverse Event|1|||
145888134|NCT01684215|526096437|FG001|Phase 1, Part 1|Adverse Event|0|||
146291345|NCT02986334|527582248|FG001|Overall Study|non compliance in phone ratings|1|||
146291346|NCT02986334|527582249|FG002|Overall Study|non compliance in phone ratings|2|||
146291347|NCT02986334|527582247|FG000|Overall Study|undisclosed comorbidities|0|||
146291348|NCT02986334|527582248|FG001|Overall Study|undisclosed comorbidities|1|||
145888135|NCT01684215|526096438|FG002|Phase 1, Part 1|Adverse Event|0|||
146291349|NCT02986334|527582249|FG002|Overall Study|undisclosed comorbidities|1|||
146291350|NCT01146054|527582250|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
146291351|NCT01146054|527582250|FG000|Overall Study|Rapid tumor progression|2|||
146291352|NCT01146054|527582250|FG000|Overall Study|Other illness precluded treatment|2|||
146291353|NCT01146054|527582250|FG000|Overall Study|Lost to Follow-up|1|||
146291354|NCT05580588|527582251|FG000|Overall Study|Lack of Efficacy|12|||
146291355|NCT00712673|527582254|FG000|Overall Study|Adverse Event|3|||
146291356|NCT00712673|527582255|FG001|Overall Study|Adverse Event|3|||
146291357|NCT00712673|527582256|FG002|Overall Study|Adverse Event|21|||
146291358|NCT00712673|527582257|FG003|Overall Study|Adverse Event|26|||
146291359|NCT00712673|527582254|FG000|Overall Study|Lack of Efficacy|2|||
146291360|NCT00712673|527582255|FG001|Overall Study|Lack of Efficacy|8|||
146291361|NCT00712673|527582256|FG002|Overall Study|Lack of Efficacy|8|||
146291362|NCT00712673|527582257|FG003|Overall Study|Lack of Efficacy|6|||
146291363|NCT00712673|527582254|FG000|Overall Study|Poor Compliance to Protocol|3|||
146291364|NCT00712673|527582255|FG001|Overall Study|Poor Compliance to Protocol|3|||
146291365|NCT00712673|527582256|FG002|Overall Study|Poor Compliance to Protocol|4|||
146291366|NCT00712673|527582257|FG003|Overall Study|Poor Compliance to Protocol|16|||
146291367|NCT00712673|527582254|FG000|Overall Study|Lost to Follow-up|1|||
146291368|NCT00712673|527582255|FG001|Overall Study|Lost to Follow-up|0|||
146291369|NCT00712673|527582256|FG002|Overall Study|Lost to Follow-up|2|||
146291370|NCT00712673|527582257|FG003|Overall Study|Lost to Follow-up|0|||
146291371|NCT00712673|527582254|FG000|Overall Study|Withdrawal by Subject|6|||
146291372|NCT00712673|527582255|FG001|Overall Study|Withdrawal by Subject|7|||
146291373|NCT00712673|527582256|FG002|Overall Study|Withdrawal by Subject|15|||
146291374|NCT00712673|527582257|FG003|Overall Study|Withdrawal by Subject|20|||
146291375|NCT00712673|527582254|FG000|Overall Study|Familial and Personal Reasons|5|||
146291376|NCT00712673|527582255|FG001|Overall Study|Familial and Personal Reasons|0|||
146291377|NCT00712673|527582256|FG002|Overall Study|Familial and Personal Reasons|5|||
146291378|NCT00712673|527582257|FG003|Overall Study|Familial and Personal Reasons|2|||
146291379|NCT00712673|527582254|FG000|Overall Study|Investigator's Decision|1|||
146291380|NCT00712673|527582255|FG001|Overall Study|Investigator's Decision|0|||
146291381|NCT00712673|527582256|FG002|Overall Study|Investigator's Decision|0|||
146291382|NCT00712673|527582257|FG003|Overall Study|Investigator's Decision|0|||
146291383|NCT00712673|527582254|FG000|Overall Study|Protocol Violation|0|||
146291384|NCT00712673|527582255|FG001|Overall Study|Protocol Violation|0|||
146291385|NCT00712673|527582256|FG002|Overall Study|Protocol Violation|2|||
146291386|NCT00712673|527582257|FG003|Overall Study|Protocol Violation|0|||
146291387|NCT03603028|527582258|FG000|Overall Study|Withdrawal by Subject|1|||
146291388|NCT02963610|527582261|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
146291389|NCT02924064|527582263|FG000|Overall Study|Adverse Event|2|||
146291390|NCT02924064|527582264|FG001|Overall Study|Adverse Event|2|||
146291391|NCT02924064|527582263|FG000|Overall Study|Lost to Follow-up|0|||
146291392|NCT02924064|527582264|FG001|Overall Study|Lost to Follow-up|2|||
146291393|NCT02924064|527582263|FG000|Overall Study|Physician Decision|0|||
146291394|NCT02924064|527582264|FG001|Overall Study|Physician Decision|2|||
146291395|NCT02924064|527582263|FG000|Overall Study|Protocol Violation|1|||
146291396|NCT02924064|527582264|FG001|Overall Study|Protocol Violation|3|||
146291397|NCT02924064|527582263|FG000|Overall Study|Withdrawal by Subject|4|||
146291398|NCT02924064|527582264|FG001|Overall Study|Withdrawal by Subject|5|||
146291399|NCT02924064|527582263|FG000|Overall Study|Other|17|||
146291400|NCT02924064|527582264|FG001|Overall Study|Other|29|||
146291401|NCT03575143|527582265|FG000|Overall Study|Lost to Follow-up|0|||
146291402|NCT03575143|527582266|FG001|Overall Study|Lost to Follow-up|0|||
146291403|NCT03575143|527582267|FG002|Overall Study|Lost to Follow-up|4|||
146291404|NCT03575143|527582265|FG000|Overall Study|Withdrawal by Subject|0|||
146291405|NCT03575143|527582266|FG001|Overall Study|Withdrawal by Subject|0|||
146291406|NCT03575143|527582267|FG002|Overall Study|Withdrawal by Subject|5|||
146291407|NCT03575143|527582265|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
146291408|NCT03575143|527582266|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
146291409|NCT03575143|527582267|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
146291410|NCT03021954|527582268|FG000|Overall Study|Lost to Follow-up|10|||
146291411|NCT03021954|527582269|FG001|Overall Study|Lost to Follow-up|43|||
146291412|NCT03021954|527582268|FG000|Overall Study|Subjects had avulsion trauma|4|||
146291413|NCT03021954|527582269|FG001|Overall Study|Subjects had avulsion trauma|1|||
146291414|NCT01001832|527582270|FG000|Short-term Period|Adverse Event|2|||
146291415|NCT01001832|527582271|FG001|Short-term Period|Adverse Event|3|||
146291416|NCT01001832|527582270|FG000|Long-term Period|Adverse Event|2|||
146291417|NCT01001832|527582271|FG001|Long-term Period|Adverse Event|1|||
146291418|NCT01001832|527582270|FG000|Long-term Period|Withdrawal by Subject|1|||
146291419|NCT01001832|527582271|FG001|Long-term Period|Withdrawal by Subject|0|||
146291420|NCT01001832|527582270|FG000|Long-term Period|Lack of Efficacy|0|||
146291421|NCT01001832|527582271|FG001|Long-term Period|Lack of Efficacy|2|||
146291422|NCT01001832|527582270|FG000|Long-term Period|Other|1|||
146291423|NCT01001832|527582271|FG001|Long-term Period|Other|2|||
146291424|NCT01001832|527582270|FG000|Follow-up Period|Withdrawal by Subject|1|||
146291425|NCT01001832|527582271|FG001|Follow-up Period|Withdrawal by Subject|0|||
146291426|NCT01001832|527582270|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
146291427|NCT01001832|527582271|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
146291428|NCT01001832|527582270|FG000|Follow-up Period|Other|2|||
146291429|NCT01001832|527582271|FG001|Follow-up Period|Other|1|||
146291430|NCT00051363|527582275|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
146291431|NCT00051363|527582276|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
146291432|NCT00051363|527582275|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
146291433|NCT00051363|527582276|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
146291434|NCT00051363|527582275|FG000|Overall Study|Death|2|||
146291435|NCT00051363|527582276|FG001|Overall Study|Death|2|||
146291436|NCT00051363|527582275|FG000|Overall Study|Excluded Pre-Randomization|2|||
146291437|NCT00051363|527582276|FG001|Overall Study|Excluded Pre-Randomization|5|||
146291438|NCT01242800|527582277|FG000|Overall Study|Patient refusal|0|||
146291439|NCT01242800|527582278|FG001|Overall Study|Patient refusal|10|||
146291440|NCT01242800|527582277|FG000|Overall Study|Physician Decision|0|||
146291441|NCT01242800|527582278|FG001|Overall Study|Physician Decision|1|||
146291442|NCT01242800|527582277|FG000|Overall Study|Disease progression|0|||
146291443|NCT01242800|527582278|FG001|Overall Study|Disease progression|3|||
146291444|NCT01242800|527582277|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
146291445|NCT01242800|527582278|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
146291446|NCT01242800|527582277|FG000|Overall Study|Reasons not reported|0|||
146291447|NCT01242800|527582278|FG001|Overall Study|Reasons not reported|4|||
146291448|NCT02640157|527582280|FG000|Overall Study|Adverse Event|2|||
146291449|NCT02640157|527582281|FG001|Overall Study|Adverse Event|2|||
146291450|NCT02640157|527582282|FG002|Overall Study|Adverse Event|1|||
146291451|NCT02640157|527582280|FG000|Overall Study|Withdrew consent|2|||
146291452|NCT02640157|527582281|FG001|Overall Study|Withdrew consent|0|||
146291453|NCT02640157|527582282|FG002|Overall Study|Withdrew consent|2|||
146291454|NCT02640157|527582280|FG000|Overall Study|Lost to Follow-up|9|||
146291455|NCT02640157|527582281|FG001|Overall Study|Lost to Follow-up|2|||
146291456|NCT02640157|527582282|FG002|Overall Study|Lost to Follow-up|7|||
146291457|NCT02640157|527582280|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
146291458|NCT02640157|527582281|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
146291459|NCT02640157|527582282|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
146291460|NCT00710021|527582283|FG000|Overall Study|Lost to Follow-up|1|||
146291461|NCT00710021|527582284|FG001|Overall Study|Lost to Follow-up|0|||
146291462|NCT00710021|527582285|FG002|Overall Study|Lost to Follow-up|0|||
146291463|NCT00710021|527582283|FG000|Overall Study|Subject's Decision|0|||
146291464|NCT00710021|527582284|FG001|Overall Study|Subject's Decision|1|||
146291465|NCT00710021|527582285|FG002|Overall Study|Subject's Decision|0|||
146291466|NCT00710021|527582283|FG000|Overall Study|Subject misrandomized|0|||
146291467|NCT00710021|527582284|FG001|Overall Study|Subject misrandomized|1|||
146291468|NCT00710021|527582285|FG002|Overall Study|Subject misrandomized|1|||
146291469|NCT00710021|527582283|FG000|Overall Study|Physician Decision|0|||
146291470|NCT00710021|527582284|FG001|Overall Study|Physician Decision|1|||
146291471|NCT00710021|527582285|FG002|Overall Study|Physician Decision|0|||
146291472|NCT01679405|527582286|FG000|Overall Study|Death|2|||
146291473|NCT01679405|527582287|FG001|Overall Study|Death|5|||
146291474|NCT04677179|527582288|FG000|Induction Treatment Period|Adverse Event|1|||
146291475|NCT04677179|527582289|FG001|Induction Treatment Period|Adverse Event|0|||
146291476|NCT04677179|527582290|FG002|Induction Treatment Period|Adverse Event|0|||
146291477|NCT04677179|527582291|FG003|Induction Treatment Period|Adverse Event|0|||
146291478|NCT04677179|527582292|FG004|Induction Treatment Period|Adverse Event|0|||
146291479|NCT04677179|527582293|FG005|Induction Treatment Period|Adverse Event|0|||
146291480|NCT04677179|527582294|FG006|Induction Treatment Period|Adverse Event|0|||
146291481|NCT04677179|527582295|FG007|Induction Treatment Period|Adverse Event|0|||
146291482|NCT04677179|527582296|FG008|Induction Treatment Period|Adverse Event|0|||
146291483|NCT04677179|527582297|FG009|Induction Treatment Period|Adverse Event|0|||
146291484|NCT04677179|527582288|FG000|Induction Treatment Period|Physician Decision|1|||
146291485|NCT04677179|527582289|FG001|Induction Treatment Period|Physician Decision|0|||
146291486|NCT04677179|527582290|FG002|Induction Treatment Period|Physician Decision|1|||
146291487|NCT04677179|527582291|FG003|Induction Treatment Period|Physician Decision|0|||
146291488|NCT04677179|527582292|FG004|Induction Treatment Period|Physician Decision|0|||
146291489|NCT04677179|527582293|FG005|Induction Treatment Period|Physician Decision|0|||
146291490|NCT04677179|527582294|FG006|Induction Treatment Period|Physician Decision|0|||
146291491|NCT04677179|527582295|FG007|Induction Treatment Period|Physician Decision|0|||
145888136|NCT01684215|526096439|FG003|Phase 1, Part 1|Adverse Event|0|||
146291492|NCT04677179|527582296|FG008|Induction Treatment Period|Physician Decision|0|||
146291493|NCT04677179|527582297|FG009|Induction Treatment Period|Physician Decision|0|||
145888137|NCT01684215|526096436|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
145888138|NCT01684215|526096437|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
146291494|NCT04677179|527582288|FG000|Induction Treatment Period|Protocol Violation|0|||
146291495|NCT04677179|527582289|FG001|Induction Treatment Period|Protocol Violation|1|||
146291496|NCT04677179|527582290|FG002|Induction Treatment Period|Protocol Violation|0|||
146291497|NCT04677179|527582291|FG003|Induction Treatment Period|Protocol Violation|0|||
146291498|NCT04677179|527582292|FG004|Induction Treatment Period|Protocol Violation|0|||
146291499|NCT04677179|527582293|FG005|Induction Treatment Period|Protocol Violation|0|||
146291500|NCT04677179|527582294|FG006|Induction Treatment Period|Protocol Violation|0|||
146291501|NCT04677179|527582295|FG007|Induction Treatment Period|Protocol Violation|0|||
146291502|NCT04677179|527582296|FG008|Induction Treatment Period|Protocol Violation|0|||
146291503|NCT04677179|527582297|FG009|Induction Treatment Period|Protocol Violation|0|||
146291504|NCT04677179|527582288|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
146291505|NCT04677179|527582289|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
145888139|NCT01684215|526096438|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
145888140|NCT01684215|526096439|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
145888141|NCT01684215|526096436|FG000|Phase 1, Part 2|Adverse Event|0|||
145888142|NCT01684215|526096437|FG001|Phase 1, Part 2|Adverse Event|0|||
145888143|NCT01684215|526096438|FG002|Phase 1, Part 2|Adverse Event|1|||
145888144|NCT01684215|526096439|FG003|Phase 1, Part 2|Adverse Event|0|||
145888145|NCT01684215|526096436|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145888146|NCT01684215|526096437|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145888147|NCT01684215|526096438|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
145888148|NCT01684215|526096439|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145888149|NCT01684215|526096436|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
145888150|NCT01684215|526096437|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
145888151|NCT01684215|526096438|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
145888152|NCT01684215|526096439|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
145888153|NCT01684215|526096436|FG000|Phase 2|Death|0|||
145888154|NCT01684215|526096437|FG001|Phase 2|Death|0|||
145888155|NCT01684215|526096438|FG002|Phase 2|Death|0|||
145888156|NCT01684215|526096439|FG003|Phase 2|Death|8|||
145888157|NCT01684215|526096436|FG000|Phase 2|Study terminated by sponsor|0|||
145888158|NCT01684215|526096437|FG001|Phase 2|Study terminated by sponsor|0|||
145888159|NCT01684215|526096438|FG002|Phase 2|Study terminated by sponsor|0|||
145888160|NCT01684215|526096439|FG003|Phase 2|Study terminated by sponsor|30|||
145888161|NCT01684215|526096436|FG000|Phase 2|Enrolled but not treated|0|||
145888162|NCT01684215|526096437|FG001|Phase 2|Enrolled but not treated|0|||
145888163|NCT01684215|526096438|FG002|Phase 2|Enrolled but not treated|0|||
145888164|NCT01684215|526096439|FG003|Phase 2|Enrolled but not treated|1|||
145888165|NCT01684215|526096436|FG000|Phase 2|Lost to Follow-up|0|||
145888166|NCT01684215|526096437|FG001|Phase 2|Lost to Follow-up|0|||
145888167|NCT01684215|526096438|FG002|Phase 2|Lost to Follow-up|0|||
145888168|NCT01684215|526096439|FG003|Phase 2|Lost to Follow-up|4|||
145888169|NCT01301482|526096440|FG000|Overall Study|Withdrawal by Subject|1|||
145888170|NCT01213836|526096453|FG000|Period 1, First Intervention|Adverse Event|2|||
145888171|NCT01213836|526096454|FG001|Period 1, First Intervention|Adverse Event|1|||
145888172|NCT01213836|526096453|FG000|Period 1, First Intervention|Protocol Violation|0|||
145888173|NCT01213836|526096454|FG001|Period 1, First Intervention|Protocol Violation|1|||
145888174|NCT01213836|526096453|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
145888175|NCT01213836|526096454|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
145888176|NCT00706095|526096461|FG000|Overall Study|Progressive Disease|4|||
145888177|NCT00706095|526096462|FG001|Overall Study|Progressive Disease|5|||
145888178|NCT00706095|526096463|FG002|Overall Study|Progressive Disease|3|||
145888179|NCT00706095|526096461|FG000|Overall Study|Clinical Progression|1|||
145888180|NCT00706095|526096462|FG001|Overall Study|Clinical Progression|2|||
145888181|NCT00706095|526096463|FG002|Overall Study|Clinical Progression|2|||
145888182|NCT00706095|526096461|FG000|Overall Study|Withdrawal by Subject|1|||
145888183|NCT00706095|526096462|FG001|Overall Study|Withdrawal by Subject|0|||
145888184|NCT00706095|526096463|FG002|Overall Study|Withdrawal by Subject|0|||
145888185|NCT02129647|526096474|FG000|Overall Study|Adverse Event|2|||
145888186|NCT02129647|526096474|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
145888187|NCT00986570|526096475|FG000|Overall Study|Lost to Follow-up|6|||
145888188|NCT00986570|526096475|FG000|Overall Study|Potential bias for objective assessment|1|||
145888189|NCT01311557|526096476|FG000|Overall Study|Serious adverse event|0|||
145888190|NCT01311557|526096477|FG001|Overall Study|Serious adverse event|1|||
145888191|NCT01311557|526096476|FG000|Overall Study|Protocol Violation|4|||
145888192|NCT01311557|526096477|FG001|Overall Study|Protocol Violation|2|||
145888193|NCT01311557|526096476|FG000|Overall Study|Lost to Follow-up|0|||
145888194|NCT01311557|526096477|FG001|Overall Study|Lost to Follow-up|1|||
145888195|NCT01311557|526096476|FG000|Overall Study|Withdrawal by Subject|1|||
145888196|NCT01311557|526096477|FG001|Overall Study|Withdrawal by Subject|2|||
145888197|NCT00608517|526096478|FG000|Overall Study|Death|1|||
145888198|NCT00608517|526096479|FG001|Overall Study|Death|0|||
145888199|NCT00608517|526096480|FG002|Overall Study|Death|0|||
145888200|NCT01833533|526096481|FG000|Overall Study|Adverse Event|0|||
145888201|NCT01833533|526096482|FG001|Overall Study|Adverse Event|1|||
145888202|NCT01833533|526096481|FG000|Overall Study|Lost to Follow-up|4|||
145888203|NCT01833533|526096482|FG001|Overall Study|Lost to Follow-up|9|||
145888204|NCT01833533|526096481|FG000|Overall Study|To Enter an Extension Study|0|||
145888205|NCT01833533|526096482|FG001|Overall Study|To Enter an Extension Study|4|||
145888206|NCT01833533|526096481|FG000|Overall Study|Other|2|||
145888207|NCT01833533|526096482|FG001|Overall Study|Other|7|||
145888208|NCT05212883|526096485|FG000|Overall Study|Invalid test result|125|||
145888209|NCT02502734|526096486|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
145888210|NCT02502734|526096487|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
145888211|NCT02502734|526096486|FG000|Washout Period|Adverse Event|1|||
145888212|NCT02502734|526096487|FG001|Washout Period|Adverse Event|0|||
145888213|NCT01740791|526096491|FG000|Overall Study|Randomized but never treated|5|||
145966137|NCT01079780|526391836|FG000|Overall Study|Adverse Event|13|||
145966138|NCT01079780|526391837|FG001|Overall Study|Adverse Event|5|||
145966139|NCT01079780|526391838|FG002|Overall Study|Adverse Event|7|||
145966140|NCT01079780|526391836|FG000|Overall Study|Death|2|||
145966141|NCT01079780|526391837|FG001|Overall Study|Death|0|||
145966142|NCT01079780|526391838|FG002|Overall Study|Death|2|||
145966143|NCT01079780|526391836|FG000|Overall Study|Withdrawal by Subject|6|||
145966144|NCT01079780|526391837|FG001|Overall Study|Withdrawal by Subject|4|||
145966145|NCT01079780|526391838|FG002|Overall Study|Withdrawal by Subject|4|||
145966146|NCT01079780|526391836|FG000|Overall Study|Alternative therapy|2|||
145966147|NCT01079780|526391837|FG001|Overall Study|Alternative therapy|0|||
145966148|NCT01079780|526391838|FG002|Overall Study|Alternative therapy|2|||
145966149|NCT01079780|526391836|FG000|Overall Study|Physician Decision|1|||
145966150|NCT01079780|526391837|FG001|Overall Study|Physician Decision|0|||
145966151|NCT01079780|526391838|FG002|Overall Study|Physician Decision|1|||
145966152|NCT01079780|526391836|FG000|Overall Study|Error made in lesion measurement|1|||
145966153|NCT01079780|526391837|FG001|Overall Study|Error made in lesion measurement|0|||
145966154|NCT01079780|526391838|FG002|Overall Study|Error made in lesion measurement|0|||
145966155|NCT01079780|526391836|FG000|Overall Study|Patient had surgery|1|||
145966156|NCT01079780|526391837|FG001|Overall Study|Patient had surgery|0|||
145966157|NCT01079780|526391838|FG002|Overall Study|Patient had surgery|0|||
145966158|NCT01079780|526391836|FG000|Overall Study|Treatment cycle delay|0|||
145966159|NCT01079780|526391837|FG001|Overall Study|Treatment cycle delay|0|||
145966160|NCT01079780|526391838|FG002|Overall Study|Treatment cycle delay|1|||
145966161|NCT01079780|526391836|FG000|Overall Study|Never started treatment|1|||
145966162|NCT01079780|526391837|FG001|Overall Study|Never started treatment|0|||
145966163|NCT01079780|526391838|FG002|Overall Study|Never started treatment|2|||
145966164|NCT01178294|526391844|FG000|Overall Study|Adverse Event|4|||
145966165|NCT01178294|526391844|FG000|Overall Study|Lost to Follow-up|2|||
145966166|NCT01178294|526391844|FG000|Overall Study|Lack of Efficacy|1|||
145966167|NCT01178294|526391844|FG000|Overall Study|Death|1|||
145966168|NCT01178294|526391844|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
145966169|NCT01178294|526391844|FG000|Overall Study|Subject status is terminal|1|||
145966170|NCT01178294|526391844|FG000|Overall Study|Completion status could not be verified|1|||
145966171|NCT02783066|526391845|FG000|Overall Study|Withdrawal by Subject|13|||
145966172|NCT02051296|526391846|FG000|Overall Study|Lost to Follow-up|1|||
145966173|NCT02051296|526391847|FG001|Overall Study|Lost to Follow-up|2|||
145966174|NCT02051296|526391846|FG000|Overall Study|withdraw prior to treatment|7|||
145966175|NCT02051296|526391847|FG001|Overall Study|withdraw prior to treatment|7|||
145966176|NCT05379920|526391848|FG000|Overall Study|Lost to Follow-up|0|||
145966177|NCT05379920|526391849|FG001|Overall Study|Lost to Follow-up|5|||
145966178|NCT05379920|526391850|FG002|Overall Study|Lost to Follow-up|0|||
145966179|NCT05379920|526391851|FG003|Overall Study|Lost to Follow-up|0|||
145966180|NCT03176771|526391854|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
145966181|NCT03176771|526391855|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
145966182|NCT03176771|526391856|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
145966183|NCT03176771|526391857|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
145966184|NCT03176771|526391858|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
145966185|NCT03176771|526391854|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145966186|NCT03176771|526391855|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
145966187|NCT03176771|526391856|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145966188|NCT03176771|526391857|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145966189|NCT03176771|526391858|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145966190|NCT03176771|526391854|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
145966191|NCT03176771|526391855|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
145966192|NCT03176771|526391856|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
145966193|NCT03176771|526391857|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
145966194|NCT03176771|526391858|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
145966195|NCT03176771|526391854|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145966196|NCT03176771|526391855|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145966197|NCT03176771|526391856|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
145966198|NCT03176771|526391857|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145966199|NCT03176771|526391858|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145966200|NCT03176771|526391854|FG000|Double-Blind Extension Period|Adverse Event|0|||
145966201|NCT03176771|526391855|FG001|Double-Blind Extension Period|Adverse Event|0|||
145966202|NCT03176771|526391856|FG002|Double-Blind Extension Period|Adverse Event|0|||
145966203|NCT03176771|526391857|FG003|Double-Blind Extension Period|Adverse Event|15|||
145966204|NCT03176771|526391858|FG004|Double-Blind Extension Period|Adverse Event|18|||
145966205|NCT03176771|526391854|FG000|Double-Blind Extension Period|Death|0|||
145966206|NCT03176771|526391855|FG001|Double-Blind Extension Period|Death|0|||
145966207|NCT03176771|526391856|FG002|Double-Blind Extension Period|Death|0|||
145966208|NCT03176771|526391857|FG003|Double-Blind Extension Period|Death|3|||
145966209|NCT03176771|526391858|FG004|Double-Blind Extension Period|Death|4|||
146291506|NCT04677179|527582290|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
146291507|NCT04677179|527582291|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
146291508|NCT04677179|527582292|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
146291509|NCT04677179|527582293|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
146291510|NCT04677179|527582294|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
146291511|NCT04677179|527582295|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
146291512|NCT04677179|527582296|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
146291513|NCT04677179|527582297|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
146291514|NCT04677179|527582288|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
146291515|NCT04677179|527582289|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
146291516|NCT04677179|527582290|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
146291517|NCT04677179|527582291|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
146291518|NCT04677179|527582292|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
146291519|NCT04677179|527582293|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
146291520|NCT04677179|527582294|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
146291521|NCT04677179|527582295|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
146291522|NCT04677179|527582296|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
146291523|NCT04677179|527582297|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
146291524|NCT04677179|527582288|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
146291525|NCT04677179|527582289|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
146291526|NCT04677179|527582290|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
146291527|NCT04677179|527582291|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
146291528|NCT04677179|527582292|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
146291529|NCT04677179|527582293|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
146291530|NCT04677179|527582294|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
146291531|NCT04677179|527582295|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
146291532|NCT04677179|527582296|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
146291533|NCT04677179|527582297|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
146291534|NCT04677179|527582288|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291535|NCT04677179|527582289|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291536|NCT04677179|527582290|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291537|NCT04677179|527582291|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
146291538|NCT04677179|527582292|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291539|NCT04677179|527582293|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291540|NCT04677179|527582294|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291541|NCT04677179|527582295|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291542|NCT04677179|527582296|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291543|NCT04677179|527582297|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
146291544|NCT04677179|527582288|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291545|NCT04677179|527582289|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291546|NCT04677179|527582290|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291547|NCT04677179|527582291|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
146291548|NCT04677179|527582292|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
146291549|NCT04677179|527582293|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
146291550|NCT04677179|527582294|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291551|NCT04677179|527582295|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291552|NCT04677179|527582296|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291553|NCT04677179|527582297|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
146291554|NCT04677179|527582288|FG000|Extension Treatment Period|Lack of Efficacy|0|||
146291555|NCT04677179|527582289|FG001|Extension Treatment Period|Lack of Efficacy|0|||
146291556|NCT04677179|527582290|FG002|Extension Treatment Period|Lack of Efficacy|0|||
146291557|NCT04677179|527582291|FG003|Extension Treatment Period|Lack of Efficacy|0|||
146291558|NCT04677179|527582292|FG004|Extension Treatment Period|Lack of Efficacy|0|||
146291559|NCT04677179|527582293|FG005|Extension Treatment Period|Lack of Efficacy|0|||
146291560|NCT04677179|527582294|FG006|Extension Treatment Period|Lack of Efficacy|6|||
146291561|NCT04677179|527582295|FG007|Extension Treatment Period|Lack of Efficacy|0|||
146291562|NCT04677179|527582296|FG008|Extension Treatment Period|Lack of Efficacy|0|||
146291563|NCT04677179|527582297|FG009|Extension Treatment Period|Lack of Efficacy|0|||
146291564|NCT04677179|527582288|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146291565|NCT04677179|527582289|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146291566|NCT04677179|527582290|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146291567|NCT04677179|527582291|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
146291568|NCT04677179|527582292|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
146291569|NCT04677179|527582293|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
146291570|NCT04677179|527582294|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
146291571|NCT04677179|527582295|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
146291572|NCT04677179|527582296|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
146291573|NCT04677179|527582297|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
145966210|NCT03176771|526391854|FG000|Double-Blind Extension Period|Physician Decision|0|||
145966211|NCT03176771|526391855|FG001|Double-Blind Extension Period|Physician Decision|0|||
145966212|NCT03176771|526391856|FG002|Double-Blind Extension Period|Physician Decision|0|||
145966213|NCT03176771|526391857|FG003|Double-Blind Extension Period|Physician Decision|3|||
145966214|NCT03176771|526391858|FG004|Double-Blind Extension Period|Physician Decision|1|||
145966215|NCT03176771|526391854|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
145966216|NCT03176771|526391855|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
145966217|NCT03176771|526391856|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
145966218|NCT03176771|526391857|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
145966219|NCT03176771|526391858|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
145966220|NCT02265510|526391860|FG000|Overall Study|Withdrawal by Subject|1|||
145966221|NCT02265510|526391861|FG001|Overall Study|Withdrawal by Subject|1|||
145966222|NCT02265510|526391862|FG002|Overall Study|Withdrawal by Subject|2|||
145966223|NCT02265510|526391863|FG003|Overall Study|Withdrawal by Subject|1|||
145966224|NCT02265510|526391864|FG004|Overall Study|Withdrawal by Subject|0|||
145966225|NCT02265510|526391865|FG005|Overall Study|Withdrawal by Subject|2|||
145966226|NCT02265510|526391866|FG006|Overall Study|Withdrawal by Subject|0|||
145966227|NCT02265510|526391867|FG007|Overall Study|Withdrawal by Subject|2|||
145966228|NCT02265510|526391868|FG008|Overall Study|Withdrawal by Subject|0|||
145966229|NCT02265510|526391869|FG009|Overall Study|Withdrawal by Subject|0|||
145966230|NCT02265510|526391870|FG010|Overall Study|Withdrawal by Subject|0|||
145966231|NCT02265510|526391871|FG011|Overall Study|Withdrawal by Subject|0|||
145966232|NCT02265510|526391872|FG012|Overall Study|Withdrawal by Subject|1|||
145966233|NCT02265510|526391873|FG013|Overall Study|Withdrawal by Subject|0|||
145966234|NCT02265510|526391860|FG000|Overall Study|Disease Progression|0|||
145966235|NCT02265510|526391861|FG001|Overall Study|Disease Progression|1|||
145966236|NCT02265510|526391862|FG002|Overall Study|Disease Progression|2|||
145966237|NCT02265510|526391863|FG003|Overall Study|Disease Progression|1|||
145966238|NCT02265510|526391864|FG004|Overall Study|Disease Progression|1|||
145966239|NCT02265510|526391865|FG005|Overall Study|Disease Progression|0|||
145966240|NCT02265510|526391866|FG006|Overall Study|Disease Progression|0|||
145966241|NCT02265510|526391867|FG007|Overall Study|Disease Progression|0|||
145966242|NCT02265510|526391868|FG008|Overall Study|Disease Progression|0|||
145966243|NCT02265510|526391869|FG009|Overall Study|Disease Progression|0|||
145966244|NCT02265510|526391870|FG010|Overall Study|Disease Progression|0|||
145966245|NCT02265510|526391871|FG011|Overall Study|Disease Progression|0|||
145966246|NCT02265510|526391872|FG012|Overall Study|Disease Progression|0|||
145966247|NCT02265510|526391873|FG013|Overall Study|Disease Progression|0|||
145966248|NCT02265510|526391860|FG000|Overall Study|Death|2|||
145966249|NCT02265510|526391861|FG001|Overall Study|Death|0|||
145966250|NCT02265510|526391862|FG002|Overall Study|Death|2|||
145966251|NCT02265510|526391863|FG003|Overall Study|Death|2|||
145966252|NCT02265510|526391864|FG004|Overall Study|Death|1|||
145966253|NCT02265510|526391865|FG005|Overall Study|Death|3|||
145966254|NCT02265510|526391866|FG006|Overall Study|Death|2|||
145966255|NCT02265510|526391867|FG007|Overall Study|Death|1|||
145966256|NCT02265510|526391868|FG008|Overall Study|Death|3|||
145966257|NCT02265510|526391869|FG009|Overall Study|Death|3|||
145966258|NCT02265510|526391870|FG010|Overall Study|Death|4|||
145966259|NCT02265510|526391871|FG011|Overall Study|Death|12|||
145966260|NCT02265510|526391872|FG012|Overall Study|Death|7|||
145966261|NCT02265510|526391873|FG013|Overall Study|Death|6|||
145966262|NCT02265510|526391860|FG000|Overall Study|Lost to Follow-up|0|||
145966263|NCT02265510|526391861|FG001|Overall Study|Lost to Follow-up|0|||
145966264|NCT02265510|526391862|FG002|Overall Study|Lost to Follow-up|0|||
145966265|NCT02265510|526391863|FG003|Overall Study|Lost to Follow-up|0|||
145966266|NCT02265510|526391864|FG004|Overall Study|Lost to Follow-up|1|||
145966267|NCT02265510|526391865|FG005|Overall Study|Lost to Follow-up|0|||
145966268|NCT02265510|526391866|FG006|Overall Study|Lost to Follow-up|0|||
145966269|NCT02265510|526391867|FG007|Overall Study|Lost to Follow-up|0|||
145966270|NCT02265510|526391868|FG008|Overall Study|Lost to Follow-up|0|||
145966271|NCT02265510|526391869|FG009|Overall Study|Lost to Follow-up|2|||
145966272|NCT02265510|526391870|FG010|Overall Study|Lost to Follow-up|0|||
145966273|NCT02265510|526391871|FG011|Overall Study|Lost to Follow-up|0|||
145966274|NCT02265510|526391872|FG012|Overall Study|Lost to Follow-up|0|||
145966275|NCT02265510|526391873|FG013|Overall Study|Lost to Follow-up|2|||
145966276|NCT02265510|526391860|FG000|Overall Study|Other|0|||
145966277|NCT02265510|526391861|FG001|Overall Study|Other|1|||
145966278|NCT02265510|526391862|FG002|Overall Study|Other|0|||
145966279|NCT02265510|526391863|FG003|Overall Study|Other|0|||
145966280|NCT02265510|526391864|FG004|Overall Study|Other|0|||
145966281|NCT02265510|526391865|FG005|Overall Study|Other|0|||
145966282|NCT02265510|526391866|FG006|Overall Study|Other|0|||
145966283|NCT02265510|526391867|FG007|Overall Study|Other|0|||
145966284|NCT02265510|526391868|FG008|Overall Study|Other|0|||
145966285|NCT02265510|526391869|FG009|Overall Study|Other|0|||
145966286|NCT02265510|526391870|FG010|Overall Study|Other|0|||
145966287|NCT02265510|526391871|FG011|Overall Study|Other|0|||
145966288|NCT02265510|526391872|FG012|Overall Study|Other|0|||
146291574|NCT04677179|527582288|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
146291575|NCT04677179|527582289|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
146291576|NCT04677179|527582290|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
146291577|NCT04677179|527582291|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
146291578|NCT04677179|527582292|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
146291579|NCT04677179|527582293|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
146291580|NCT04677179|527582294|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
146291581|NCT04677179|527582295|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
146291582|NCT04677179|527582296|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
146291583|NCT04677179|527582297|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
146291584|NCT04677179|527582288|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
146291585|NCT04677179|527582289|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
146291586|NCT04677179|527582290|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
146291587|NCT04677179|527582291|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
146291588|NCT04677179|527582292|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
146291589|NCT04677179|527582293|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
146291590|NCT04677179|527582294|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
146291591|NCT04677179|527582295|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
146291592|NCT04677179|527582296|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
146291593|NCT04677179|527582297|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
146291594|NCT04677179|527582288|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291595|NCT04677179|527582289|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291596|NCT04677179|527582290|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291597|NCT04677179|527582291|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291598|NCT04677179|527582292|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291599|NCT04677179|527582293|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291600|NCT04677179|527582294|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291601|NCT04677179|527582295|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
146291602|NCT04677179|527582296|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
145966289|NCT02265510|526391873|FG013|Overall Study|Other|0|||
146291603|NCT04677179|527582297|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
146291604|NCT04677179|527582288|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145966290|NCT02265510|526391860|FG000|Overall Study|Study Terminated by Sponsor|0|||
145966291|NCT02265510|526391861|FG001|Overall Study|Study Terminated by Sponsor|0|||
145966292|NCT02265510|526391862|FG002|Overall Study|Study Terminated by Sponsor|0|||
145966293|NCT02265510|526391863|FG003|Overall Study|Study Terminated by Sponsor|0|||
145966294|NCT02265510|526391864|FG004|Overall Study|Study Terminated by Sponsor|0|||
145966295|NCT02265510|526391865|FG005|Overall Study|Study Terminated by Sponsor|1|||
145966296|NCT02265510|526391866|FG006|Overall Study|Study Terminated by Sponsor|1|||
145966297|NCT02265510|526391867|FG007|Overall Study|Study Terminated by Sponsor|1|||
145966298|NCT02265510|526391868|FG008|Overall Study|Study Terminated by Sponsor|1|||
145966299|NCT02265510|526391869|FG009|Overall Study|Study Terminated by Sponsor|2|||
145966300|NCT02265510|526391870|FG010|Overall Study|Study Terminated by Sponsor|1|||
145966301|NCT02265510|526391871|FG011|Overall Study|Study Terminated by Sponsor|4|||
145966302|NCT02265510|526391872|FG012|Overall Study|Study Terminated by Sponsor|1|||
145966303|NCT02265510|526391873|FG013|Overall Study|Study Terminated by Sponsor|2|||
145966304|NCT01004614|526391874|FG000|Washout|Withdrawal by Subject|0|||
145966305|NCT01004614|526391875|FG001|Washout|Withdrawal by Subject|1|||
145966306|NCT01004614|526391876|FG002|Washout|Withdrawal by Subject|0|||
145966307|NCT01004614|526391877|FG003|Washout|Withdrawal by Subject|0|||
145966308|NCT02530385|526391878|FG000|Overall Study|Withdrawal by Subject|0|||
145966309|NCT02530385|526391879|FG001|Overall Study|Withdrawal by Subject|1|||
145966310|NCT01569022|526391881|FG000|First Intervention|Lost to Follow-up|2|||
145966311|NCT01569022|526391882|FG001|First Intervention|Lost to Follow-up|1|||
145966312|NCT01569022|526391881|FG000|Second Intervention|Lost to Follow-up|2|||
145966313|NCT01569022|526391882|FG001|Second Intervention|Lost to Follow-up|2|||
145966314|NCT02111083|526391887|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
145966315|NCT02111083|526391888|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
145966316|NCT00116142|526391889|FG000|Overall Study|Adverse Event|8|||
145966317|NCT00116142|526391890|FG001|Overall Study|Adverse Event|7|||
145966318|NCT00116142|526391889|FG000|Overall Study|Protocol Violation|2|||
145966319|NCT00116142|526391890|FG001|Overall Study|Protocol Violation|1|||
145966320|NCT00116142|526391889|FG000|Overall Study|Withdrawal by Subject|5|||
145966321|NCT00116142|526391890|FG001|Overall Study|Withdrawal by Subject|5|||
145966322|NCT00116142|526391889|FG000|Overall Study|Physician Decision|3|||
146086715|NCT04391569|526838366|FG000|Overall Study|Participant discharged to hospice facility|0|||
145966323|NCT00116142|526391890|FG001|Overall Study|Physician Decision|1|||
145966324|NCT00116142|526391889|FG000|Overall Study|Delayed Radiation Therapy|1|||
145966325|NCT00116142|526391890|FG001|Overall Study|Delayed Radiation Therapy|0|||
145966326|NCT00116142|526391889|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
146086716|NCT04391569|526838367|FG001|Overall Study|Participant discharged to hospice facility|1|||
145966327|NCT00116142|526391890|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
146291605|NCT04677179|527582289|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291606|NCT04677179|527582290|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291607|NCT04677179|527582291|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291608|NCT04677179|527582292|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291609|NCT04677179|527582293|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291610|NCT04677179|527582294|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291611|NCT04677179|527582295|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
146291612|NCT04677179|527582296|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291613|NCT04677179|527582297|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
146291614|NCT04677179|527582288|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291615|NCT04677179|527582289|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291616|NCT04677179|527582290|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291617|NCT04677179|527582291|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291618|NCT04677179|527582292|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291619|NCT04677179|527582293|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291620|NCT04677179|527582294|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291621|NCT04677179|527582295|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
146291622|NCT04677179|527582296|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
146291623|NCT04677179|527582297|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
146291624|NCT04677179|527582288|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291625|NCT04677179|527582289|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291626|NCT04677179|527582290|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291627|NCT04677179|527582291|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291628|NCT04677179|527582292|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291629|NCT04677179|527582293|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291630|NCT04677179|527582294|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
146291631|NCT04677179|527582295|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
146291632|NCT04677179|527582296|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
146291633|NCT04677179|527582297|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
146291634|NCT03581825|527582302|FG000|Period 1|Lens Discomfort|1|||
146291635|NCT03581825|527582303|FG001|Period 1|Lens Discomfort|0|||
146291636|NCT03581825|527582302|FG000|Period 2|Unsatisfactory Vision to Test|0|||
146291637|NCT03581825|527582303|FG001|Period 2|Unsatisfactory Vision to Test|1|||
146291638|NCT03261700|527582304|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
146291639|NCT03261700|527582305|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
146291640|NCT00585195|527582308|FG000|Overall Study|Adverse Event|0|||
146291641|NCT00585195|527582309|FG001|Overall Study|Adverse Event|0|||
146291642|NCT00585195|527582310|FG002|Overall Study|Adverse Event|0|||
146291643|NCT00585195|527582311|FG003|Overall Study|Adverse Event|0|||
146291644|NCT00585195|527582312|FG004|Overall Study|Adverse Event|2|||
146291645|NCT00585195|527582313|FG005|Overall Study|Adverse Event|1|||
146291646|NCT00585195|527582314|FG006|Overall Study|Adverse Event|0|||
146291647|NCT00585195|527582315|FG007|Overall Study|Adverse Event|1|||
146291648|NCT00585195|527582316|FG008|Overall Study|Adverse Event|0|||
146291649|NCT00585195|527582317|FG009|Overall Study|Adverse Event|0|||
146291650|NCT00585195|527582318|FG010|Overall Study|Adverse Event|3|||
146291651|NCT00585195|527582319|FG011|Overall Study|Adverse Event|0|||
146291652|NCT00585195|527582320|FG012|Overall Study|Adverse Event|8|||
146291653|NCT00585195|527582321|FG013|Overall Study|Adverse Event|6|||
146291654|NCT00585195|527582322|FG014|Overall Study|Adverse Event|4|||
146291655|NCT00585195|527582323|FG015|Overall Study|Adverse Event|1|||
146291656|NCT00585195|527582324|FG016|Overall Study|Adverse Event|14|||
146291657|NCT00585195|527582325|FG017|Overall Study|Adverse Event|9|||
146291658|NCT00585195|527582326|FG018|Overall Study|Adverse Event|2|||
146291659|NCT00585195|527582327|FG019|Overall Study|Adverse Event|3|||
146291660|NCT00585195|527582328|FG020|Overall Study|Adverse Event|1|||
146291661|NCT00585195|527582308|FG000|Overall Study|Progressive Disease|2|||
146291662|NCT00585195|527582309|FG001|Overall Study|Progressive Disease|2|||
146291663|NCT00585195|527582310|FG002|Overall Study|Progressive Disease|5|||
146291664|NCT00585195|527582311|FG003|Overall Study|Progressive Disease|4|||
146291665|NCT00585195|527582312|FG004|Overall Study|Progressive Disease|6|||
146291666|NCT00585195|527582313|FG005|Overall Study|Progressive Disease|4|||
146291667|NCT00585195|527582314|FG006|Overall Study|Progressive Disease|6|||
146291668|NCT00585195|527582315|FG007|Overall Study|Progressive Disease|3|||
146291669|NCT00585195|527582316|FG008|Overall Study|Progressive Disease|0|||
146291670|NCT00585195|527582317|FG009|Overall Study|Progressive Disease|5|||
146291671|NCT00585195|527582318|FG010|Overall Study|Progressive Disease|2|||
146291672|NCT00585195|527582319|FG011|Overall Study|Progressive Disease|25|||
146291673|NCT00585195|527582320|FG012|Overall Study|Progressive Disease|29|||
146291674|NCT00585195|527582321|FG013|Overall Study|Progressive Disease|26|||
146291675|NCT00585195|527582322|FG014|Overall Study|Progressive Disease|21|||
145888214|NCT01740791|526096492|FG001|Overall Study|Randomized but never treated|3|||
146086717|NCT04391569|526838366|FG000|Overall Study|Participant family decision|1|||
146291676|NCT00585195|527582323|FG015|Overall Study|Progressive Disease|12|||
146291677|NCT00585195|527582324|FG016|Overall Study|Progressive Disease|94|||
146291678|NCT00585195|527582325|FG017|Overall Study|Progressive Disease|42|||
146291679|NCT00585195|527582326|FG018|Overall Study|Progressive Disease|4|||
146291680|NCT00585195|527582327|FG019|Overall Study|Progressive Disease|9|||
146291681|NCT00585195|527582328|FG020|Overall Study|Progressive Disease|8|||
146291682|NCT00585195|527582308|FG000|Overall Study|Withdrawal by Subject|1|||
146291683|NCT00585195|527582309|FG001|Overall Study|Withdrawal by Subject|1|||
146291684|NCT00585195|527582310|FG002|Overall Study|Withdrawal by Subject|2|||
146291685|NCT00585195|527582311|FG003|Overall Study|Withdrawal by Subject|2|||
146291686|NCT00585195|527582312|FG004|Overall Study|Withdrawal by Subject|0|||
146291687|NCT00585195|527582313|FG005|Overall Study|Withdrawal by Subject|0|||
146291688|NCT00585195|527582314|FG006|Overall Study|Withdrawal by Subject|0|||
146291689|NCT00585195|527582315|FG007|Overall Study|Withdrawal by Subject|1|||
146291690|NCT00585195|527582316|FG008|Overall Study|Withdrawal by Subject|0|||
146291691|NCT00585195|527582317|FG009|Overall Study|Withdrawal by Subject|0|||
146291692|NCT00585195|527582318|FG010|Overall Study|Withdrawal by Subject|3|||
146291693|NCT00585195|527582319|FG011|Overall Study|Withdrawal by Subject|8|||
146291694|NCT00585195|527582320|FG012|Overall Study|Withdrawal by Subject|15|||
146291695|NCT00585195|527582321|FG013|Overall Study|Withdrawal by Subject|0|||
146291696|NCT00585195|527582322|FG014|Overall Study|Withdrawal by Subject|3|||
146291697|NCT00585195|527582323|FG015|Overall Study|Withdrawal by Subject|0|||
146291698|NCT00585195|527582324|FG016|Overall Study|Withdrawal by Subject|7|||
146291699|NCT00585195|527582325|FG017|Overall Study|Withdrawal by Subject|1|||
146291700|NCT00585195|527582326|FG018|Overall Study|Withdrawal by Subject|2|||
146291701|NCT00585195|527582327|FG019|Overall Study|Withdrawal by Subject|2|||
146291702|NCT00585195|527582328|FG020|Overall Study|Withdrawal by Subject|0|||
146291703|NCT00585195|527582308|FG000|Overall Study|Other|0|||
146291704|NCT00585195|527582309|FG001|Overall Study|Other|1|||
146291705|NCT00585195|527582310|FG002|Overall Study|Other|1|||
146291706|NCT00585195|527582311|FG003|Overall Study|Other|1|||
146291707|NCT00585195|527582312|FG004|Overall Study|Other|0|||
146291708|NCT00585195|527582313|FG005|Overall Study|Other|1|||
146291709|NCT00585195|527582314|FG006|Overall Study|Other|0|||
146291710|NCT00585195|527582315|FG007|Overall Study|Other|0|||
146291711|NCT00585195|527582316|FG008|Overall Study|Other|2|||
146291712|NCT00585195|527582317|FG009|Overall Study|Other|1|||
146291713|NCT00585195|527582318|FG010|Overall Study|Other|0|||
146291714|NCT00585195|527582319|FG011|Overall Study|Other|19|||
146291715|NCT00585195|527582320|FG012|Overall Study|Other|24|||
146291716|NCT00585195|527582321|FG013|Overall Study|Other|7|||
146291717|NCT00585195|527582322|FG014|Overall Study|Other|11|||
146291718|NCT00585195|527582323|FG015|Overall Study|Other|3|||
146291719|NCT00585195|527582324|FG016|Overall Study|Other|28|||
146291720|NCT00585195|527582325|FG017|Overall Study|Other|12|||
146291721|NCT00585195|527582326|FG018|Overall Study|Other|10|||
146291722|NCT00585195|527582327|FG019|Overall Study|Other|4|||
146291723|NCT00585195|527582328|FG020|Overall Study|Other|2|||
146291724|NCT00585195|527582308|FG000|Overall Study|Randomized not treated|0|||
146291725|NCT00585195|527582309|FG001|Overall Study|Randomized not treated|0|||
146291726|NCT00585195|527582310|FG002|Overall Study|Randomized not treated|1|||
146291727|NCT00585195|527582311|FG003|Overall Study|Randomized not treated|0|||
146291728|NCT00585195|527582312|FG004|Overall Study|Randomized not treated|1|||
146291729|NCT00585195|527582313|FG005|Overall Study|Randomized not treated|0|||
146291730|NCT00585195|527582314|FG006|Overall Study|Randomized not treated|1|||
146291731|NCT00585195|527582315|FG007|Overall Study|Randomized not treated|0|||
146291732|NCT00585195|527582316|FG008|Overall Study|Randomized not treated|0|||
146291733|NCT00585195|527582317|FG009|Overall Study|Randomized not treated|0|||
146291734|NCT00585195|527582318|FG010|Overall Study|Randomized not treated|2|||
145966328|NCT00116142|526391889|FG000|Overall Study|Patient stopped due to depression|0|||
145966329|NCT00116142|526391890|FG001|Overall Study|Patient stopped due to depression|1|||
146291735|NCT00585195|527582319|FG011|Overall Study|Randomized not treated|0|||
146291736|NCT00585195|527582320|FG012|Overall Study|Randomized not treated|0|||
146291737|NCT00585195|527582321|FG013|Overall Study|Randomized not treated|0|||
146291738|NCT00585195|527582322|FG014|Overall Study|Randomized not treated|0|||
146291739|NCT00585195|527582323|FG015|Overall Study|Randomized not treated|1|||
146291740|NCT00585195|527582324|FG016|Overall Study|Randomized not treated|0|||
146291741|NCT00585195|527582325|FG017|Overall Study|Randomized not treated|1|||
146291742|NCT00585195|527582326|FG018|Overall Study|Randomized not treated|3|||
146291743|NCT00585195|527582327|FG019|Overall Study|Randomized not treated|0|||
146291744|NCT00585195|527582328|FG020|Overall Study|Randomized not treated|2|||
146291745|NCT00585195|527582308|FG000|Overall Study|Death|0|||
145970795|NCT02690727|526407272|FG001|Overall Study|Adverse Event|2|||
146291746|NCT00585195|527582309|FG001|Overall Study|Death|0|||
146291747|NCT00585195|527582310|FG002|Overall Study|Death|0|||
146291748|NCT00585195|527582311|FG003|Overall Study|Death|0|||
146291749|NCT00585195|527582312|FG004|Overall Study|Death|0|||
146291750|NCT00585195|527582313|FG005|Overall Study|Death|0|||
146291751|NCT00585195|527582314|FG006|Overall Study|Death|0|||
146291752|NCT00585195|527582315|FG007|Overall Study|Death|0|||
146291753|NCT00585195|527582316|FG008|Overall Study|Death|1|||
146291754|NCT00585195|527582317|FG009|Overall Study|Death|0|||
146291755|NCT00585195|527582318|FG010|Overall Study|Death|1|||
146291756|NCT00585195|527582319|FG011|Overall Study|Death|1|||
146291757|NCT00585195|527582320|FG012|Overall Study|Death|7|||
146291758|NCT00585195|527582321|FG013|Overall Study|Death|2|||
146291759|NCT00585195|527582322|FG014|Overall Study|Death|8|||
146291760|NCT00585195|527582323|FG015|Overall Study|Death|2|||
146291761|NCT00585195|527582324|FG016|Overall Study|Death|11|||
146291762|NCT00585195|527582325|FG017|Overall Study|Death|0|||
146291763|NCT00585195|527582326|FG018|Overall Study|Death|0|||
146291764|NCT00585195|527582327|FG019|Overall Study|Death|0|||
146291765|NCT00585195|527582328|FG020|Overall Study|Death|1|||
146291766|NCT00585195|527582308|FG000|Overall Study|Lost to Follow-up|0|||
146291767|NCT00585195|527582309|FG001|Overall Study|Lost to Follow-up|0|||
146291768|NCT00585195|527582310|FG002|Overall Study|Lost to Follow-up|0|||
146291769|NCT00585195|527582311|FG003|Overall Study|Lost to Follow-up|0|||
146291770|NCT00585195|527582312|FG004|Overall Study|Lost to Follow-up|0|||
146291771|NCT00585195|527582313|FG005|Overall Study|Lost to Follow-up|0|||
146291772|NCT00585195|527582314|FG006|Overall Study|Lost to Follow-up|0|||
146291773|NCT00585195|527582315|FG007|Overall Study|Lost to Follow-up|0|||
146291774|NCT00585195|527582316|FG008|Overall Study|Lost to Follow-up|0|||
146291775|NCT00585195|527582317|FG009|Overall Study|Lost to Follow-up|0|||
146291776|NCT00585195|527582318|FG010|Overall Study|Lost to Follow-up|0|||
146291777|NCT00585195|527582319|FG011|Overall Study|Lost to Follow-up|0|||
146291778|NCT00585195|527582320|FG012|Overall Study|Lost to Follow-up|1|||
146291779|NCT00585195|527582321|FG013|Overall Study|Lost to Follow-up|0|||
146291780|NCT00585195|527582322|FG014|Overall Study|Lost to Follow-up|0|||
146291781|NCT00585195|527582323|FG015|Overall Study|Lost to Follow-up|0|||
146291782|NCT00585195|527582324|FG016|Overall Study|Lost to Follow-up|0|||
146291783|NCT00585195|527582325|FG017|Overall Study|Lost to Follow-up|2|||
146291784|NCT00585195|527582326|FG018|Overall Study|Lost to Follow-up|0|||
146291785|NCT00585195|527582327|FG019|Overall Study|Lost to Follow-up|0|||
146291786|NCT00585195|527582328|FG020|Overall Study|Lost to Follow-up|0|||
146291787|NCT00585195|527582308|FG000|Overall Study|Site Terminated by Sponsor|0|||
146291788|NCT00585195|527582309|FG001|Overall Study|Site Terminated by Sponsor|0|||
146291789|NCT00585195|527582310|FG002|Overall Study|Site Terminated by Sponsor|0|||
146291790|NCT00585195|527582311|FG003|Overall Study|Site Terminated by Sponsor|0|||
146291791|NCT00585195|527582312|FG004|Overall Study|Site Terminated by Sponsor|0|||
146291792|NCT00585195|527582313|FG005|Overall Study|Site Terminated by Sponsor|0|||
146291793|NCT00585195|527582314|FG006|Overall Study|Site Terminated by Sponsor|0|||
146291794|NCT00585195|527582315|FG007|Overall Study|Site Terminated by Sponsor|0|||
146291795|NCT00585195|527582316|FG008|Overall Study|Site Terminated by Sponsor|0|||
146291796|NCT00585195|527582317|FG009|Overall Study|Site Terminated by Sponsor|0|||
146291797|NCT00585195|527582318|FG010|Overall Study|Site Terminated by Sponsor|0|||
146291798|NCT00585195|527582319|FG011|Overall Study|Site Terminated by Sponsor|0|||
146291799|NCT00585195|527582320|FG012|Overall Study|Site Terminated by Sponsor|1|||
146291800|NCT00585195|527582321|FG013|Overall Study|Site Terminated by Sponsor|0|||
146291801|NCT00585195|527582322|FG014|Overall Study|Site Terminated by Sponsor|0|||
146291802|NCT00585195|527582323|FG015|Overall Study|Site Terminated by Sponsor|0|||
146291803|NCT00585195|527582324|FG016|Overall Study|Site Terminated by Sponsor|0|||
146291804|NCT00585195|527582325|FG017|Overall Study|Site Terminated by Sponsor|0|||
146291805|NCT00585195|527582326|FG018|Overall Study|Site Terminated by Sponsor|0|||
146291806|NCT00585195|527582327|FG019|Overall Study|Site Terminated by Sponsor|0|||
146291807|NCT00585195|527582328|FG020|Overall Study|Site Terminated by Sponsor|0|||
146291808|NCT00585195|527582308|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
146291809|NCT00585195|527582309|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
146291810|NCT00585195|527582310|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
146291811|NCT00585195|527582311|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
146291812|NCT00585195|527582312|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
146291813|NCT00585195|527582313|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
146291814|NCT00585195|527582314|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
146291815|NCT00585195|527582315|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
145888215|NCT01740791|526096493|FG002|Overall Study|Randomized but never treated|2|||
146291816|NCT00585195|527582316|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
146291817|NCT00585195|527582317|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
146291818|NCT00585195|527582318|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
146291819|NCT00585195|527582319|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
146291820|NCT00585195|527582320|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
146291821|NCT00585195|527582321|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
146291822|NCT00585195|527582322|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
146291823|NCT00585195|527582323|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
146291824|NCT00585195|527582324|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
146291825|NCT00585195|527582325|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
146291826|NCT00585195|527582326|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
146291827|NCT00585195|527582327|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
146291828|NCT00585195|527582328|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
146291829|NCT02796560|527582334|FG000|Overall Study|Adverse Event|2|||
146291830|NCT02796560|527582335|FG001|Overall Study|Adverse Event|0|||
146291831|NCT02796560|527582334|FG000|Overall Study|Withdrawal by Subject|2|||
146291832|NCT02796560|527582335|FG001|Overall Study|Withdrawal by Subject|2|||
146291833|NCT02533570|527582336|FG000|Overall Study|Adverse Event|0|||
146291834|NCT02533570|527582337|FG001|Overall Study|Adverse Event|1|||
146291835|NCT02533570|527582338|FG002|Overall Study|Adverse Event|1|||
146291836|NCT00529958|527582339|FG000|2-Year Follow-up|Lost to Follow-up|1|||
146291837|NCT00529958|527582340|FG001|2-Year Follow-up|Lost to Follow-up|2|||
146291838|NCT00529958|527582341|FG002|2-Year Follow-up|Lost to Follow-up|2|||
146291839|NCT00529958|527582339|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
146291840|NCT00529958|527582340|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
146291841|NCT00529958|527582341|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
146291842|NCT00529958|527582339|FG000|5-Year Follow-up|Lost to Follow-up|2|||
146291843|NCT00529958|527582340|FG001|5-Year Follow-up|Lost to Follow-up|3|||
146291844|NCT00529958|527582341|FG002|5-Year Follow-up|Lost to Follow-up|1|||
146291845|NCT00529958|527582339|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
146291846|NCT00529958|527582340|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
146291847|NCT00529958|527582341|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
146291848|NCT03816332|527582342|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
146291849|NCT03816332|527582342|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
146291850|NCT03534284|527582345|FG000|Overall Study|Death|2|||
146291851|NCT03534284|527582346|FG001|Overall Study|Death|3|||
146291852|NCT03534284|527582347|FG002|Overall Study|Death|3|||
146291853|NCT03534284|527582345|FG000|Overall Study|Withdrawal by Subject|5|||
146291854|NCT03534284|527582346|FG001|Overall Study|Withdrawal by Subject|0|||
146291855|NCT03534284|527582347|FG002|Overall Study|Withdrawal by Subject|0|||
146291856|NCT03316300|527582348|FG000|Overall Study|Withdrawal by Subject|3|||
146291857|NCT03316300|527582349|FG001|Overall Study|Withdrawal by Subject|2|||
146291858|NCT03316300|527582348|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
146291859|NCT03316300|527582349|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
146291860|NCT03316300|527582348|FG000|Overall Study|Adverse Event|1|||
146291861|NCT03316300|527582349|FG001|Overall Study|Adverse Event|0|||
146291862|NCT03316300|527582348|FG000|Overall Study|COVID-19|0|||
146291863|NCT03316300|527582349|FG001|Overall Study|COVID-19|1|||
146291864|NCT03164564|527582350|FG000|Overall Study|Death|3|||
146291865|NCT03164564|527582351|FG001|Overall Study|Death|0|||
146291866|NCT03164564|527582350|FG000|Overall Study|Withdrawal by Subject|20|||
146291867|NCT03164564|527582351|FG001|Overall Study|Withdrawal by Subject|15|||
146291868|NCT03164564|527582350|FG000|Overall Study|Lost to Follow-up|2|||
146291869|NCT03164564|527582351|FG001|Overall Study|Lost to Follow-up|0|||
146291870|NCT03164564|527582350|FG000|Overall Study|Physician Decision|0|||
146291871|NCT03164564|527582351|FG001|Overall Study|Physician Decision|1|||
146291872|NCT03164564|527582350|FG000|Overall Study|Adverse Event|0|||
146291873|NCT03164564|527582351|FG001|Overall Study|Adverse Event|1|||
146291874|NCT03164564|527582350|FG000|Overall Study|Ongoing|1586|||
146291875|NCT03164564|527582351|FG001|Overall Study|Ongoing|1586|||
146291876|NCT01910181|527582352|FG000|Overall Study|Death|37|||
146291877|NCT01910181|527582352|FG000|Overall Study|Lost to Follow-up|3|||
146291878|NCT01910181|527582352|FG000|Overall Study|Study Terminated by Sponsor|6|||
146291879|NCT02656823|527582353|FG000|Overall Study|Adverse Event|3|||
146291880|NCT02656823|527582353|FG000|Overall Study|Lost to Follow-up|2|||
146291881|NCT01340651|527582357|FG000|Overall Study|Adverse Event|3|||
146291882|NCT01340651|527582357|FG000|Overall Study|Consent Withdrawn|2|||
146291883|NCT01340651|527582357|FG000|Overall Study|Commercial Supply per Sponsor|12|||
146291884|NCT01315353|527582358|FG000|Overall Study|Death|2|||
146291885|NCT01315353|527582359|FG001|Overall Study|Death|1|||
146291886|NCT01315353|527582360|FG002|Overall Study|Death|0|||
146291887|NCT01315353|527582358|FG000|Overall Study|Withdrawal by Subject|2|||
146291888|NCT01315353|527582359|FG001|Overall Study|Withdrawal by Subject|6|||
146291889|NCT01315353|527582360|FG002|Overall Study|Withdrawal by Subject|1|||
146291890|NCT01315353|527582358|FG000|Overall Study|Lost to Follow-up|13|||
146291891|NCT01315353|527582359|FG001|Overall Study|Lost to Follow-up|6|||
146291892|NCT01315353|527582360|FG002|Overall Study|Lost to Follow-up|6|||
146291893|NCT01315353|527582358|FG000|Overall Study|Unwilling to adhere to requirements|5|||
146291894|NCT01315353|527582359|FG001|Overall Study|Unwilling to adhere to requirements|5|||
146291895|NCT01315353|527582360|FG002|Overall Study|Unwilling to adhere to requirements|4|||
146291896|NCT01315353|527582358|FG000|Overall Study|Site closing|7|||
146291897|NCT01315353|527582359|FG001|Overall Study|Site closing|4|||
146291898|NCT01315353|527582360|FG002|Overall Study|Site closing|0|||
146291899|NCT01315353|527582358|FG000|Overall Study|Taken off study by site in error|0|||
146291900|NCT01315353|527582359|FG001|Overall Study|Taken off study by site in error|1|||
146291901|NCT01315353|527582360|FG002|Overall Study|Taken off study by site in error|0|||
146291902|NCT01315353|527582358|FG000|Overall Study|Inadvertent randomization/assignment|0|||
146291903|NCT01315353|527582359|FG001|Overall Study|Inadvertent randomization/assignment|0|||
146291904|NCT01315353|527582360|FG002|Overall Study|Inadvertent randomization/assignment|2|||
146291905|NCT01009580|527582361|FG000|Overall Study|Adverse Event|4|||
146232600|NCT02719574|527369493|FG013|Phase 2|Investigator Decision|1|||
146232601|NCT02719574|527369494|FG014|Phase 2|Investigator Decision|3|||
146232602|NCT02719574|527369495|FG015|Phase 2|Investigator Decision|2|||
146232603|NCT02719574|527369496|FG016|Phase 2|Investigator Decision|0|||
146232604|NCT02719574|527369480|FG000|Phase 2|Withdrawal by Subject|0|||
146232605|NCT02719574|527369481|FG001|Phase 2|Withdrawal by Subject|0|||
146232606|NCT02719574|527369482|FG002|Phase 2|Withdrawal by Subject|0|||
146232607|NCT02719574|527369483|FG003|Phase 2|Withdrawal by Subject|0|||
146232608|NCT02719574|527369484|FG004|Phase 2|Withdrawal by Subject|0|||
146232609|NCT02719574|527369485|FG005|Phase 2|Withdrawal by Subject|0|||
146232610|NCT02719574|527369486|FG006|Phase 2|Withdrawal by Subject|0|||
146232611|NCT02719574|527369487|FG007|Phase 2|Withdrawal by Subject|0|||
146232612|NCT02719574|527369488|FG008|Phase 2|Withdrawal by Subject|0|||
146232613|NCT02719574|527369489|FG009|Phase 2|Withdrawal by Subject|5|||
146232614|NCT02719574|527369490|FG010|Phase 2|Withdrawal by Subject|0|||
146232615|NCT02719574|527369491|FG011|Phase 2|Withdrawal by Subject|0|||
146232616|NCT02719574|527369492|FG012|Phase 2|Withdrawal by Subject|0|||
146232617|NCT02719574|527369493|FG013|Phase 2|Withdrawal by Subject|1|||
146232618|NCT02719574|527369494|FG014|Phase 2|Withdrawal by Subject|1|||
146232619|NCT02719574|527369495|FG015|Phase 2|Withdrawal by Subject|2|||
146232620|NCT02719574|527369496|FG016|Phase 2|Withdrawal by Subject|0|||
146232621|NCT02719574|527369480|FG000|Phase 2|Protocol Violation|0|||
146232622|NCT02719574|527369481|FG001|Phase 2|Protocol Violation|0|||
146232623|NCT02719574|527369482|FG002|Phase 2|Protocol Violation|0|||
146232624|NCT02719574|527369483|FG003|Phase 2|Protocol Violation|0|||
146232625|NCT02719574|527369484|FG004|Phase 2|Protocol Violation|0|||
146232626|NCT02719574|527369485|FG005|Phase 2|Protocol Violation|0|||
146232627|NCT02719574|527369486|FG006|Phase 2|Protocol Violation|0|||
146232628|NCT02719574|527369487|FG007|Phase 2|Protocol Violation|0|||
146232629|NCT02719574|527369488|FG008|Phase 2|Protocol Violation|0|||
146232630|NCT02719574|527369489|FG009|Phase 2|Protocol Violation|1|||
146232631|NCT02719574|527369490|FG010|Phase 2|Protocol Violation|0|||
146232632|NCT02719574|527369491|FG011|Phase 2|Protocol Violation|0|||
146232633|NCT02719574|527369492|FG012|Phase 2|Protocol Violation|0|||
146232634|NCT02719574|527369493|FG013|Phase 2|Protocol Violation|0|||
146232635|NCT02719574|527369494|FG014|Phase 2|Protocol Violation|0|||
146232636|NCT02719574|527369495|FG015|Phase 2|Protocol Violation|0|||
146232637|NCT02719574|527369496|FG016|Phase 2|Protocol Violation|0|||
146232638|NCT00495677|527369501|FG000|Stage 1 (25 Days)|Adverse Event|0|||
146232639|NCT00495677|527369502|FG001|Stage 1 (25 Days)|Adverse Event|0|||
146232640|NCT00495677|527369503|FG002|Stage 1 (25 Days)|Adverse Event|1|||
146232641|NCT00495677|527369504|FG003|Stage 1 (25 Days)|Adverse Event|0|||
146232642|NCT00495677|527369505|FG004|Stage 1 (25 Days)|Adverse Event|0|||
146232643|NCT00495677|527369506|FG005|Stage 1 (25 Days)|Adverse Event|0|||
146232644|NCT00495677|527369507|FG006|Stage 1 (25 Days)|Adverse Event|0|||
146232645|NCT02111096|527369508|FG000|Overall Study|Adverse Event|4|||
146232646|NCT02111096|527369509|FG001|Overall Study|Adverse Event|1|||
146232647|NCT02111096|527369510|FG002|Overall Study|Adverse Event|2|||
146232648|NCT02111096|527369508|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146232649|NCT02111096|527369509|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146232650|NCT02111096|527369510|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146232651|NCT02111096|527369508|FG000|Overall Study|Lost to Follow Up|1|||
146232652|NCT02111096|527369509|FG001|Overall Study|Lost to Follow Up|1|||
146232653|NCT02111096|527369510|FG002|Overall Study|Lost to Follow Up|1|||
146232654|NCT02111096|527369508|FG000|Overall Study|Physician Decision|0|||
146232655|NCT02111096|527369509|FG001|Overall Study|Physician Decision|1|||
146232656|NCT02111096|527369510|FG002|Overall Study|Physician Decision|0|||
146232657|NCT02111096|527369508|FG000|Overall Study|Protocol Violation|1|||
146232658|NCT02111096|527369509|FG001|Overall Study|Protocol Violation|0|||
146232659|NCT02111096|527369510|FG002|Overall Study|Protocol Violation|1|||
146232660|NCT02111096|527369508|FG000|Overall Study|Terminated by Sponsor|53|||
146232661|NCT02111096|527369509|FG001|Overall Study|Terminated by Sponsor|35|||
146232662|NCT02111096|527369510|FG002|Overall Study|Terminated by Sponsor|54|||
146232663|NCT02111096|527369508|FG000|Overall Study|Withdrawal by Subject|4|||
146232664|NCT02111096|527369509|FG001|Overall Study|Withdrawal by Subject|2|||
146232665|NCT02111096|527369510|FG002|Overall Study|Withdrawal by Subject|8|||
146232666|NCT03983382|527369517|FG000|Overall Study|Death|1|||
146232667|NCT03983382|527369517|FG000|Overall Study|Lost to Follow-up|3|||
146232668|NCT03983382|527369517|FG000|Overall Study|Physician Decision|2|||
146232669|NCT03983382|527369517|FG000|Overall Study|Withdrawal by Subject|10|||
146232670|NCT03983382|527369517|FG000|Overall Study|Change in cancer treatment|2|||
146232671|NCT04908514|527369526|FG000|Overall Study|Lost to Follow-up|2|||
146232672|NCT04908514|527369526|FG000|Overall Study|Withdrawal by Subject|1|||
146232673|NCT04059406|527369528|FG000|Overall Study|Early Treatment Termination|5|||
146232674|NCT04059406|527369529|FG001|Overall Study|Early Treatment Termination|5|||
146232675|NCT04059406|527369530|FG002|Overall Study|Early Treatment Termination|15|||
146232676|NCT03140670|527370650|FG000|Overall Study|Withdrawal by Subject|2|||
145966330|NCT00116142|526391889|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
145966331|NCT00116142|526391890|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
145966332|NCT00116142|526391889|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
145966333|NCT00116142|526391890|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
145966334|NCT00116142|526391889|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
145966335|NCT00116142|526391890|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
145966336|NCT00644059|526391891|FG000|Overall Study|Lost to Follow-up|37|||
145966337|NCT00644059|526391892|FG001|Overall Study|Lost to Follow-up|34|||
145966338|NCT00644059|526391893|FG002|Overall Study|Lost to Follow-up|16|||
145966339|NCT00644059|526391891|FG000|Overall Study|Withdrawal by Subject|52|||
145966340|NCT00644059|526391892|FG001|Overall Study|Withdrawal by Subject|60|||
145966341|NCT00644059|526391893|FG002|Overall Study|Withdrawal by Subject|30|||
145966342|NCT00644059|526391891|FG000|Overall Study|Adverse Event|8|||
145966343|NCT00644059|526391892|FG001|Overall Study|Adverse Event|5|||
145966344|NCT00644059|526391893|FG002|Overall Study|Adverse Event|1|||
145966345|NCT00644059|526391891|FG000|Overall Study|Inappropriate Enrollment|1|||
145966346|NCT00644059|526391892|FG001|Overall Study|Inappropriate Enrollment|3|||
145966347|NCT00644059|526391893|FG002|Overall Study|Inappropriate Enrollment|0|||
145966348|NCT00644059|526391891|FG000|Overall Study|Protocol Deviation/violation|20|||
145966349|NCT00644059|526391892|FG001|Overall Study|Protocol Deviation/violation|19|||
145966350|NCT00644059|526391893|FG002|Overall Study|Protocol Deviation/violation|15|||
145966351|NCT00644059|526391891|FG000|Overall Study|Unable to classify|6|||
145966352|NCT00644059|526391892|FG001|Overall Study|Unable to classify|2|||
145966353|NCT00644059|526391893|FG002|Overall Study|Unable to classify|3|||
145966354|NCT03558516|526391894|FG000|Overall Study|Protocol Violation|2|||
145966355|NCT03558516|526391895|FG001|Overall Study|Protocol Violation|2|||
145966356|NCT01462942|526391898|FG000|Overall Study|Adverse Event|7|||
145966357|NCT01462942|526391899|FG001|Overall Study|Adverse Event|12|||
145966358|NCT01462942|526391900|FG002|Overall Study|Adverse Event|10|||
145966359|NCT01462942|526391901|FG003|Overall Study|Adverse Event|11|||
145966360|NCT01462942|526391902|FG004|Overall Study|Adverse Event|11|||
145966361|NCT01462942|526391898|FG000|Overall Study|Other, including COPD exacerbation|3|||
145966362|NCT01462942|526391899|FG001|Overall Study|Other, including COPD exacerbation|5|||
145966363|NCT01462942|526391900|FG002|Overall Study|Other, including COPD exacerbation|2|||
145966364|NCT01462942|526391901|FG003|Overall Study|Other, including COPD exacerbation|8|||
145966365|NCT01462942|526391902|FG004|Overall Study|Other, including COPD exacerbation|5|||
145966366|NCT01462942|526391898|FG000|Overall Study|Withdrawal by Subject|14|||
145966367|NCT01462942|526391899|FG001|Overall Study|Withdrawal by Subject|10|||
145966368|NCT01462942|526391900|FG002|Overall Study|Withdrawal by Subject|14|||
145966369|NCT01462942|526391901|FG003|Overall Study|Withdrawal by Subject|16|||
145966370|NCT01462942|526391902|FG004|Overall Study|Withdrawal by Subject|19|||
145966371|NCT01462942|526391898|FG000|Overall Study|Lack of Efficacy|6|||
146232677|NCT03140670|527370650|FG000|Overall Study|Lost to Follow-up|1|||
146232678|NCT03140670|527370650|FG000|Overall Study|Physician Decision|1|||
146232679|NCT00220805|527370651|FG000|Overall Study|Adverse Event|1|||
146232680|NCT00220805|527370652|FG001|Overall Study|Adverse Event|3|||
146232681|NCT00220805|527370651|FG000|Overall Study|Withdrawal by Subject|3|||
146232682|NCT00220805|527370652|FG001|Overall Study|Withdrawal by Subject|0|||
146232683|NCT00220805|527370651|FG000|Overall Study|Lack of Efficacy|1|||
146232684|NCT00220805|527370652|FG001|Overall Study|Lack of Efficacy|0|||
146232685|NCT00220805|527370651|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
146232686|NCT00220805|527370652|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
146232687|NCT02325466|527370653|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
146232688|NCT02325466|527370654|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
146232689|NCT02325466|527370655|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
146232690|NCT02325466|527370653|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
146232691|NCT02325466|527370654|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
146232692|NCT02325466|527370655|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
146232693|NCT02325466|527370653|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
146232694|NCT02325466|527370654|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
146232695|NCT02325466|527370655|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
146232696|NCT02325466|527370653|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
146232697|NCT02325466|527370654|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
146232698|NCT02325466|527370655|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
146232699|NCT02325466|527370653|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
145966372|NCT01462942|526391899|FG001|Overall Study|Lack of Efficacy|0|||
145966373|NCT01462942|526391900|FG002|Overall Study|Lack of Efficacy|4|||
145966374|NCT01462942|526391901|FG003|Overall Study|Lack of Efficacy|5|||
145966375|NCT01462942|526391902|FG004|Overall Study|Lack of Efficacy|3|||
145966376|NCT01462942|526391898|FG000|Overall Study|Lost to Follow-up|0|||
145966377|NCT01462942|526391899|FG001|Overall Study|Lost to Follow-up|1|||
145966378|NCT01462942|526391900|FG002|Overall Study|Lost to Follow-up|1|||
145966379|NCT01462942|526391901|FG003|Overall Study|Lost to Follow-up|1|||
146291906|NCT01009580|527582362|FG001|Overall Study|Adverse Event|4|||
146291907|NCT01009580|527582361|FG000|Overall Study|Lack of Efficacy|0|||
146291908|NCT01009580|527582362|FG001|Overall Study|Lack of Efficacy|1|||
146291909|NCT01009580|527582361|FG000|Overall Study|Protocol Violation|2|||
146291910|NCT01009580|527582362|FG001|Overall Study|Protocol Violation|3|||
146291911|NCT01009580|527582361|FG000|Overall Study|Withdrawal Criteria|4|||
146291912|NCT01009580|527582362|FG001|Overall Study|Withdrawal Criteria|6|||
146291913|NCT01009580|527582361|FG000|Overall Study|Unclassified|17|||
146291914|NCT01009580|527582362|FG001|Overall Study|Unclassified|21|||
146291915|NCT04469270|527582363|FG000|Overall Study|Adverse Event|2|||
146291916|NCT04469270|527582364|FG001|Overall Study|Adverse Event|0|||
146291917|NCT04469270|527582363|FG000|Overall Study|Lost to Follow-up|4|||
146291918|NCT04469270|527582364|FG001|Overall Study|Lost to Follow-up|3|||
146291919|NCT04469270|527582363|FG000|Overall Study|Withdrawal by Subject|7|||
146291920|NCT04469270|527582364|FG001|Overall Study|Withdrawal by Subject|3|||
146291921|NCT04469270|527582363|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
146291922|NCT04469270|527582364|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
146291923|NCT04469270|527582363|FG000|Overall Study|missing|1|||
146291924|NCT04469270|527582364|FG001|Overall Study|missing|0|||
146291925|NCT01880528|527582367|FG000|Overall Study|Other|1|||
146291926|NCT01880528|527582368|FG001|Overall Study|Other|1|||
146291927|NCT02254278|527582369|FG000|Overall Study|Protocol Violation|1|||
146291928|NCT02254278|527582370|FG001|Overall Study|Protocol Violation|1|||
146291929|NCT05437510|527582375|FG000|Overall Study|Adverse Event|2|||
146291930|NCT05437510|527582376|FG001|Overall Study|Adverse Event|1|||
146291931|NCT05437510|527582375|FG000|Overall Study|Protocol Deviation|1|||
146291932|NCT05437510|527582376|FG001|Overall Study|Protocol Deviation|6|||
146291933|NCT05437510|527582375|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
146291934|NCT05437510|527582376|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
146291935|NCT05437510|527582375|FG000|Overall Study|Lost to Follow-up|265|||
146291936|NCT05437510|527582376|FG001|Overall Study|Lost to Follow-up|358|||
146291937|NCT01072877|527584267|FG000|Overall Study|Lost to Follow-up|1|||
146291938|NCT01072877|527584268|FG001|Overall Study|Lost to Follow-up|1|||
146291939|NCT01072877|527584269|FG002|Overall Study|Lost to Follow-up|0|||
146291940|NCT01072877|527584270|FG003|Overall Study|Lost to Follow-up|2|||
146291941|NCT01072877|527584271|FG004|Overall Study|Lost to Follow-up|0|||
146291942|NCT02245672|527584272|FG000|Overall Study|Adverse Event|4|||
146291943|NCT02245672|527584273|FG001|Overall Study|Adverse Event|4|||
146291944|NCT02245672|527584274|FG002|Overall Study|Adverse Event|4|||
146291945|NCT02245672|527584272|FG000|Overall Study|Lost to Follow-up|3|||
146291946|NCT02245672|527584273|FG001|Overall Study|Lost to Follow-up|5|||
146291947|NCT02245672|527584274|FG002|Overall Study|Lost to Follow-up|1|||
146291948|NCT02245672|527584272|FG000|Overall Study|Withdrawal by Subject|6|||
146291949|NCT02245672|527584273|FG001|Overall Study|Withdrawal by Subject|3|||
146291950|NCT02245672|527584274|FG002|Overall Study|Withdrawal by Subject|0|||
146291951|NCT02245672|527584272|FG000|Overall Study|Randomized in error (not treated)|0|||
146291952|NCT02245672|527584273|FG001|Overall Study|Randomized in error (not treated)|1|||
146291953|NCT02245672|527584274|FG002|Overall Study|Randomized in error (not treated)|0|||
146291954|NCT01765192|527584275|FG000|Treatment Period 1|Adverse Event|0|||
146291955|NCT01765192|527584276|FG001|Treatment Period 1|Adverse Event|1|||
146291956|NCT01765192|527584275|FG000|Washout Period|Voluntary Withdrawal|1|||
146291957|NCT01765192|527584276|FG001|Washout Period|Voluntary Withdrawal|1|||
146291958|NCT01765192|527584275|FG000|Washout Period|Reason not specified|1|||
146291959|NCT01765192|527584276|FG001|Washout Period|Reason not specified|0|||
146291960|NCT01765192|527584275|FG000|Treatment Period 2|Reason not specified|0|||
146291961|NCT01765192|527584276|FG001|Treatment Period 2|Reason not specified|2|||
146291962|NCT01765192|527584275|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
146291963|NCT01765192|527584276|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
146291964|NCT00294554|527584278|FG000|Overall Study|Lack of Efficacy|0|||
146291965|NCT00294554|527584279|FG001|Overall Study|Lack of Efficacy|1|||
145966380|NCT01462942|526391902|FG004|Overall Study|Lost to Follow-up|1|||
146291966|NCT00294554|527584278|FG000|Overall Study|Physician Decision|0|||
146291967|NCT00294554|527584279|FG001|Overall Study|Physician Decision|1|||
146291968|NCT00462865|527584280|FG000|Overall Study|Adverse Event|1|||
146291969|NCT04142450|527584281|FG000|Overall Study|Screen Failure|1|||
146291970|NCT04142450|527584281|FG000|Overall Study|Lost to Follow-up|1|||
145966381|NCT01462942|526391898|FG000|Overall Study|Protocol Violation|4|||
145966382|NCT01462942|526391899|FG001|Overall Study|Protocol Violation|6|||
146291971|NCT06336603|527584282|FG000|Overall Study|Withdrawal by Subject|1|||
146291972|NCT06336603|527584282|FG000|Overall Study|Lost to Follow-up|2|||
146291973|NCT04335812|527584285|FG000|Overall Study|Withdrawal by Subject|1|||
146291974|NCT04335812|527584286|FG001|Overall Study|Withdrawal by Subject|3|||
146291975|NCT04335812|527584285|FG000|Overall Study|Lost to Follow-up|12|||
146291976|NCT04335812|527584286|FG001|Overall Study|Lost to Follow-up|12|||
146291977|NCT04335812|527584285|FG000|Overall Study|Did not engage in the intervention|22|||
146291978|NCT04335812|527584286|FG001|Overall Study|Did not engage in the intervention|18|||
146291979|NCT02901041|527584292|FG000|Overall Study|Withdrawal by PI|4|||
146291980|NCT02901041|527584293|FG001|Overall Study|Withdrawal by PI|8|||
146291981|NCT02901041|527584292|FG000|Overall Study|Withdrawal by Subject|7|||
146291982|NCT02901041|527584293|FG001|Overall Study|Withdrawal by Subject|3|||
146291983|NCT01480674|527584297|FG000|Overall Study|Death|23|||
146291984|NCT01480674|527584297|FG000|Overall Study|Lost to Follow-up|2|||
146291985|NCT01480674|527584297|FG000|Overall Study|visit not done|10|||
146291986|NCT03249714|527584298|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
146291987|NCT03249714|527584299|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
145966383|NCT01462942|526391900|FG002|Overall Study|Protocol Violation|9|||
145966384|NCT01462942|526391901|FG003|Overall Study|Protocol Violation|9|||
145966385|NCT01462942|526391902|FG004|Overall Study|Protocol Violation|6|||
145966386|NCT02737722|526391905|FG000|Overall Study|Physician Decision|0|||
145966387|NCT02737722|526391906|FG001|Overall Study|Physician Decision|0|||
145966388|NCT02737722|526391907|FG002|Overall Study|Physician Decision|1|||
145966389|NCT02737722|526391908|FG003|Overall Study|Physician Decision|0|||
145966390|NCT02662569|526391909|FG000|Overall Study|Withdrawal by Subject|6|||
145966391|NCT02662569|526391910|FG001|Overall Study|Withdrawal by Subject|1|||
145966392|NCT02662569|526391911|FG002|Overall Study|Withdrawal by Subject|6|||
145966393|NCT02662569|526391912|FG003|Overall Study|Withdrawal by Subject|4|||
145966394|NCT02662569|526391909|FG000|Overall Study|Lost to Follow-up|1|||
145966395|NCT02662569|526391910|FG001|Overall Study|Lost to Follow-up|0|||
145966396|NCT02662569|526391911|FG002|Overall Study|Lost to Follow-up|0|||
145966397|NCT02662569|526391912|FG003|Overall Study|Lost to Follow-up|0|||
145966398|NCT01774591|526391915|FG000|Overall Study|Physician Decision|1|||
145966399|NCT01774591|526391916|FG001|Overall Study|Physician Decision|1|||
145966400|NCT01774591|526391915|FG000|Overall Study|Withdrawal by Subject|0|||
145966401|NCT01774591|526391916|FG001|Overall Study|Withdrawal by Subject|1|||
145966402|NCT01774591|526391915|FG000|Overall Study|Adverse Event|0|||
145966403|NCT01774591|526391916|FG001|Overall Study|Adverse Event|2|||
145966404|NCT00630916|526391917|FG000|Overall Study|Death|110|||
145966405|NCT00630916|526391917|FG000|Overall Study|Explant|8|||
145966406|NCT00630916|526391917|FG000|Overall Study|Lost to Follow-up|5|||
145966407|NCT00630916|526391917|FG000|Overall Study|Withdrawal by Subject|30|||
145966408|NCT00630916|526391917|FG000|Overall Study|Protocol Violation|7|||
145966409|NCT00630916|526391917|FG000|Overall Study|Physician Decision|47|||
145966410|NCT00630916|526391917|FG000|Overall Study|Lack of Efficacy|3|||
145966411|NCT02147626|526391918|FG000|Overall Study|Lost to Follow-up|4|||
145966412|NCT02147626|526391919|FG001|Overall Study|Lost to Follow-up|4|||
145966413|NCT02147626|526391918|FG000|Overall Study|Pregnancy|1|||
145966414|NCT02147626|526391919|FG001|Overall Study|Pregnancy|2|||
145966415|NCT02147626|526391918|FG000|Overall Study|Withdrawal by Subject|0|||
145966416|NCT02147626|526391919|FG001|Overall Study|Withdrawal by Subject|1|||
145966417|NCT03786380|526391920|FG000|Overall Study|Adverse Event|1|||
145966418|NCT03786380|526391921|FG001|Overall Study|Adverse Event|0|||
145966419|NCT03786380|526391922|FG002|Overall Study|Adverse Event|0|||
145966420|NCT03786380|526391923|FG003|Overall Study|Adverse Event|3|||
145966421|NCT03786380|526391924|FG004|Overall Study|Adverse Event|1|||
145966422|NCT03786380|526391920|FG000|Overall Study|Lack of Efficacy|0|||
145966423|NCT03786380|526391921|FG001|Overall Study|Lack of Efficacy|0|||
145966424|NCT03786380|526391922|FG002|Overall Study|Lack of Efficacy|0|||
145966425|NCT03786380|526391923|FG003|Overall Study|Lack of Efficacy|0|||
145966426|NCT03786380|526391924|FG004|Overall Study|Lack of Efficacy|1|||
145966427|NCT03786380|526391920|FG000|Overall Study|Withdrawal by Subject|1|||
145966428|NCT03786380|526391921|FG001|Overall Study|Withdrawal by Subject|2|||
145966429|NCT03786380|526391922|FG002|Overall Study|Withdrawal by Subject|2|||
145966430|NCT03786380|526391923|FG003|Overall Study|Withdrawal by Subject|1|||
145966431|NCT03786380|526391924|FG004|Overall Study|Withdrawal by Subject|2|||
145966432|NCT03786380|526391920|FG000|Overall Study|Lost to Follow-up|3|||
145966433|NCT03786380|526391921|FG001|Overall Study|Lost to Follow-up|0|||
145966434|NCT03786380|526391922|FG002|Overall Study|Lost to Follow-up|1|||
145888216|NCT01740791|526096494|FG003|Overall Study|Randomized but never treated|2|||
145966435|NCT03786380|526391923|FG003|Overall Study|Lost to Follow-up|2|||
145888217|NCT01740791|526096495|FG004|Overall Study|Randomized but never treated|1|||
145888218|NCT01740791|526096496|FG005|Overall Study|Randomized but never treated|3|||
145888219|NCT01740791|526096491|FG000|Overall Study|Lost to Follow-up|2|||
145888220|NCT01740791|526096492|FG001|Overall Study|Lost to Follow-up|0|||
145888221|NCT01740791|526096493|FG002|Overall Study|Lost to Follow-up|2|||
145888222|NCT01740791|526096494|FG003|Overall Study|Lost to Follow-up|3|||
145888223|NCT01740791|526096495|FG004|Overall Study|Lost to Follow-up|2|||
145888224|NCT01740791|526096496|FG005|Overall Study|Lost to Follow-up|3|||
145966436|NCT03786380|526391924|FG004|Overall Study|Lost to Follow-up|0|||
145966437|NCT03786380|526391920|FG000|Overall Study|Physician Decision|0|||
145966438|NCT03786380|526391921|FG001|Overall Study|Physician Decision|0|||
145966439|NCT03786380|526391922|FG002|Overall Study|Physician Decision|1|||
145966440|NCT03786380|526391923|FG003|Overall Study|Physician Decision|0|||
145966441|NCT03786380|526391924|FG004|Overall Study|Physician Decision|0|||
146291988|NCT03249714|527584298|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
145966442|NCT03786380|526391920|FG000|Overall Study|Study Terminated by the Sponsor|30|||
145966443|NCT03786380|526391921|FG001|Overall Study|Study Terminated by the Sponsor|20|||
146291989|NCT03249714|527584299|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
146291990|NCT03249714|527584298|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
146291991|NCT03249714|527584299|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
146291992|NCT03249714|527584298|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
146291993|NCT03249714|527584299|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
146291994|NCT00655863|527584307|FG000|Overall Study|Lost to Follow-up|0|||
146291995|NCT00655863|527584308|FG001|Overall Study|Lost to Follow-up|0|||
146291996|NCT00655863|527584309|FG002|Overall Study|Lost to Follow-up|1|||
146291997|NCT01138007|527584310|FG000|Overall Study|Adverse Event|4|||
146291998|NCT01138007|527584311|FG001|Overall Study|Adverse Event|12|||
146291999|NCT01138007|527584312|FG002|Overall Study|Adverse Event|9|||
146292000|NCT01138007|527584310|FG000|Overall Study|Lack of Efficacy|2|||
146292001|NCT01138007|527584311|FG001|Overall Study|Lack of Efficacy|0|||
146292002|NCT01138007|527584312|FG002|Overall Study|Lack of Efficacy|6|||
146292003|NCT01138007|527584310|FG000|Overall Study|Protocol Violation|2|||
146292004|NCT01138007|527584311|FG001|Overall Study|Protocol Violation|3|||
146292005|NCT01138007|527584312|FG002|Overall Study|Protocol Violation|2|||
146292006|NCT01138007|527584310|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
146292007|NCT01138007|527584311|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
146292008|NCT01138007|527584312|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
146292009|NCT01138007|527584310|FG000|Overall Study|Lost to Follow-up|3|||
146292010|NCT01138007|527584311|FG001|Overall Study|Lost to Follow-up|3|||
146292011|NCT01138007|527584312|FG002|Overall Study|Lost to Follow-up|5|||
146292012|NCT01138007|527584310|FG000|Overall Study|Physician Decision|0|||
146292013|NCT01138007|527584311|FG001|Overall Study|Physician Decision|5|||
146292014|NCT01138007|527584312|FG002|Overall Study|Physician Decision|3|||
146292015|NCT01138007|527584310|FG000|Overall Study|Withdrawal by Subject|5|||
146292016|NCT01138007|527584311|FG001|Overall Study|Withdrawal by Subject|6|||
146292017|NCT01138007|527584312|FG002|Overall Study|Withdrawal by Subject|15|||
146292018|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
146292019|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
146292020|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
146292021|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
146292022|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
146292023|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
146292024|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
146292025|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
146292026|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
146292027|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
146292028|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
146292029|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
146292030|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
146292031|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
146292032|NCT03548987|527584313|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
146292033|NCT03548987|527584314|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
146292034|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
146292035|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
146292036|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
146292037|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
146292038|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
146292039|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
146292040|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
146292041|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
146292042|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
146292043|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
146292044|NCT03548987|527584313|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
146292045|NCT03548987|527584314|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
145966444|NCT03786380|526391922|FG002|Overall Study|Study Terminated by the Sponsor|50|||
145888225|NCT01740791|526096491|FG000|Overall Study|Withdrew Consent|4|||
146292226|NCT04661878|527584325|FG000|Overall Study|Lost to Follow-up|6|||
146292227|NCT04661878|527584326|FG001|Overall Study|Lost to Follow-up|5|||
146292228|NCT00640016|527584329|FG000|Overall Study|Withdrawal by Subject|0|||
146292229|NCT00640016|527584330|FG001|Overall Study|Withdrawal by Subject|1|||
146292230|NCT00640016|527584331|FG002|Overall Study|Withdrawal by Subject|0|||
146292231|NCT00640016|527584332|FG003|Overall Study|Withdrawal by Subject|0|||
146292232|NCT00640016|527584329|FG000|Overall Study|Study termination|2|||
146292233|NCT00640016|527584330|FG001|Overall Study|Study termination|1|||
146292234|NCT00640016|527584331|FG002|Overall Study|Study termination|3|||
146292235|NCT00640016|527584332|FG003|Overall Study|Study termination|2|||
146292236|NCT00640016|527584329|FG000|Overall Study|Adverse Event|0|||
146292237|NCT00640016|527584330|FG001|Overall Study|Adverse Event|0|||
146292238|NCT00640016|527584331|FG002|Overall Study|Adverse Event|0|||
146292239|NCT00640016|527584332|FG003|Overall Study|Adverse Event|1|||
146292240|NCT01287065|527584333|FG000|Treatment Period 1|Adverse Event|0|||
146292241|NCT01287065|527584334|FG001|Treatment Period 1|Adverse Event|0|||
146292242|NCT01287065|527584335|FG002|Treatment Period 1|Adverse Event|0|||
146292243|NCT01287065|527584336|FG003|Treatment Period 1|Adverse Event|0|||
146292244|NCT01287065|527584337|FG004|Treatment Period 1|Adverse Event|1|||
146292245|NCT01287065|527584338|FG005|Treatment Period 1|Adverse Event|0|||
146292246|NCT01287065|527584333|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146292247|NCT01287065|527584334|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146292248|NCT01287065|527584335|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146292249|NCT01287065|527584336|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146292250|NCT01287065|527584337|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146292251|NCT01287065|527584338|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146292252|NCT01259726|527584339|FG000|Overall Study|Death|1|||
146292253|NCT01259726|527584340|FG001|Overall Study|Death|0|||
146292254|NCT01259726|527584341|FG002|Overall Study|Death|0|||
146292255|NCT01259726|527584342|FG003|Overall Study|Death|0|||
145888226|NCT01740791|526096492|FG001|Overall Study|Withdrew Consent|0|||
145888227|NCT01740791|526096493|FG002|Overall Study|Withdrew Consent|1|||
145888228|NCT01740791|526096494|FG003|Overall Study|Withdrew Consent|2|||
145888229|NCT01740791|526096495|FG004|Overall Study|Withdrew Consent|0|||
145888230|NCT01740791|526096496|FG005|Overall Study|Withdrew Consent|3|||
145888231|NCT01740791|526096491|FG000|Overall Study|Investigator's discretion|1|||
145888232|NCT01740791|526096492|FG001|Overall Study|Investigator's discretion|0|||
145888233|NCT01740791|526096493|FG002|Overall Study|Investigator's discretion|1|||
145888234|NCT01740791|526096494|FG003|Overall Study|Investigator's discretion|0|||
145888235|NCT01740791|526096495|FG004|Overall Study|Investigator's discretion|0|||
145888236|NCT01740791|526096496|FG005|Overall Study|Investigator's discretion|1|||
145888237|NCT01740791|526096491|FG000|Overall Study|Adverse Event|0|||
145888238|NCT01740791|526096492|FG001|Overall Study|Adverse Event|0|||
145888239|NCT01740791|526096493|FG002|Overall Study|Adverse Event|0|||
145888240|NCT01740791|526096494|FG003|Overall Study|Adverse Event|0|||
145888241|NCT01740791|526096495|FG004|Overall Study|Adverse Event|0|||
145888242|NCT01740791|526096496|FG005|Overall Study|Adverse Event|1|||
145888243|NCT01463982|526096497|FG000|Overall Study|Withdrawal by Subject|0|||
145888244|NCT01463982|526096498|FG001|Overall Study|Withdrawal by Subject|1|||
145888245|NCT01463982|526096499|FG002|Overall Study|Withdrawal by Subject|1|||
145888246|NCT01463982|526096500|FG003|Overall Study|Withdrawal by Subject|0|||
145888247|NCT01463982|526096497|FG000|Overall Study|Treatment delay over 5 week|0|||
145888248|NCT01463982|526096498|FG001|Overall Study|Treatment delay over 5 week|0|||
145888249|NCT01463982|526096499|FG002|Overall Study|Treatment delay over 5 week|1|||
145888250|NCT01463982|526096500|FG003|Overall Study|Treatment delay over 5 week|0|||
145888251|NCT03417830|526096503|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
145888252|NCT03417830|526096504|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
145888253|NCT00941720|526096509|FG000|Overall Study|Withdrawal by Subject|1|||
145888254|NCT00941720|526096509|FG000|Overall Study|Insurance denied participation|11|||
145888255|NCT00941720|526096509|FG000|Overall Study|ineligible|2|||
145888256|NCT03827018|526096512|FG000|Overall Study|Adverse Event|1|||
145888257|NCT03827018|526096513|FG001|Overall Study|Adverse Event|0|||
145888258|NCT03827018|526096512|FG000|Overall Study|Withdrawal by Subject|2|||
145888259|NCT03827018|526096513|FG001|Overall Study|Withdrawal by Subject|2|||
145888260|NCT03827018|526096512|FG000|Overall Study|Lack of Efficacy|0|||
145888261|NCT03827018|526096513|FG001|Overall Study|Lack of Efficacy|1|||
145966445|NCT03786380|526391923|FG003|Overall Study|Study Terminated by the Sponsor|57|||
146292256|NCT01259726|527584339|FG000|Overall Study|Physician Decision|2|||
146292257|NCT01259726|527584340|FG001|Overall Study|Physician Decision|0|||
146292258|NCT01259726|527584341|FG002|Overall Study|Physician Decision|1|||
146292259|NCT01259726|527584342|FG003|Overall Study|Physician Decision|1|||
146292260|NCT01259726|527584339|FG000|Overall Study|Withdrawal by Subject|1|||
146086718|NCT04391569|526838367|FG001|Overall Study|Participant family decision|0|||
146232700|NCT02325466|527370654|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
145966446|NCT03786380|526391924|FG004|Overall Study|Study Terminated by the Sponsor|23|||
145966447|NCT03786380|526391920|FG000|Overall Study|Reason Not Specified|0|||
145966448|NCT03786380|526391921|FG001|Overall Study|Reason Not Specified|0|||
145966449|NCT03786380|526391922|FG002|Overall Study|Reason Not Specified|0|||
145966450|NCT03786380|526391923|FG003|Overall Study|Reason Not Specified|0|||
145966451|NCT03786380|526391924|FG004|Overall Study|Reason Not Specified|1|||
145966452|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
145966453|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966454|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966455|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966456|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966457|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966458|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145966459|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
145966460|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966461|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966462|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966463|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966464|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966465|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145966466|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966467|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
145966468|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966469|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966470|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966471|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966472|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145966473|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966474|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966475|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
145966476|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966477|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966478|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966479|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145966480|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966481|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966482|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
145966483|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966484|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966485|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966486|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145966487|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966488|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966489|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
145966490|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966491|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966492|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966493|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145966494|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966495|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966496|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966497|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
145966498|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966499|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966500|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145966501|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966502|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966503|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966504|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
145966505|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966506|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966507|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145966508|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
146292261|NCT01259726|527584340|FG001|Overall Study|Withdrawal by Subject|3|||
146292262|NCT01259726|527584341|FG002|Overall Study|Withdrawal by Subject|2|||
146292263|NCT01259726|527584342|FG003|Overall Study|Withdrawal by Subject|1|||
146292264|NCT01259726|527584339|FG000|Overall Study|Lost to Follow-up|1|||
146292265|NCT01259726|527584340|FG001|Overall Study|Lost to Follow-up|1|||
146292266|NCT01259726|527584341|FG002|Overall Study|Lost to Follow-up|1|||
146292267|NCT01259726|527584342|FG003|Overall Study|Lost to Follow-up|3|||
146292268|NCT00887679|527584344|FG000|Overall Study|Withdrawal by Subject|1|||
146292269|NCT00887679|527584344|FG000|Overall Study|Lost to Follow-up|4|||
146292270|NCT00887679|527584344|FG000|Overall Study|Physician Decision|5|||
146292271|NCT01009203|527584345|FG000|Overall Study|Withdrawal by Subject|1|||
146292272|NCT01009203|527584345|FG000|Overall Study|Adverse Event|5|||
146292273|NCT01009203|527584345|FG000|Overall Study|Treatment-unrelated death|1|||
146292274|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
145966509|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145966510|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145966511|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145966512|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
145966513|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145966514|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145966515|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966516|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966517|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966518|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966519|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
145966520|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966521|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145966522|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966523|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966524|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966525|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966526|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
145966527|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966528|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145966529|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966530|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966531|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966532|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966533|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
145966534|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966535|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145966536|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966537|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966538|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966539|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966540|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966541|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
145966542|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145966543|NCT01791595|526391929|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966544|NCT01791595|526391930|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966545|NCT01791595|526391931|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966546|NCT01791595|526391932|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966547|NCT01791595|526391933|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966548|NCT01791595|526391934|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
145966549|NCT01791595|526391935|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145966550|NCT01791595|526391929|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146292275|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
146292276|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
146292277|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
146292278|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
145966551|NCT01791595|526391930|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145966552|NCT01791595|526391931|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
146292279|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
146292280|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
145966553|NCT01791595|526391932|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145966554|NCT01791595|526391933|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145966555|NCT01791595|526391934|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145966556|NCT01791595|526391935|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
145966557|NCT01791595|526391929|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966558|NCT01791595|526391930|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966559|NCT01791595|526391931|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966560|NCT01791595|526391932|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966561|NCT01791595|526391933|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966562|NCT01791595|526391934|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145966563|NCT01791595|526391935|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
145966564|NCT01791595|526391929|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966565|NCT01791595|526391930|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966566|NCT01791595|526391931|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966567|NCT01791595|526391932|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966568|NCT01791595|526391933|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966569|NCT01791595|526391934|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145966570|NCT01791595|526391935|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
145966571|NCT01791595|526391929|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966572|NCT01791595|526391930|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966573|NCT01791595|526391931|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966574|NCT01791595|526391932|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966575|NCT01791595|526391933|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966576|NCT01791595|526391934|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145966577|NCT01791595|526391935|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
145966578|NCT03118934|526391936|FG000|Overall Study|Adverse Event|0|||
145966579|NCT03118934|526391937|FG001|Overall Study|Adverse Event|0|||
145966580|NCT03118934|526391938|FG002|Overall Study|Adverse Event|0|||
145966581|NCT03118934|526391939|FG003|Overall Study|Adverse Event|0|||
145966582|NCT03118934|526391940|FG004|Overall Study|Adverse Event|0|||
145966583|NCT03118934|526391941|FG005|Overall Study|Adverse Event|1|||
145966584|NCT03118934|526391936|FG000|Overall Study|Physician Decision|0|||
145966585|NCT03118934|526391937|FG001|Overall Study|Physician Decision|0|||
145966586|NCT03118934|526391938|FG002|Overall Study|Physician Decision|0|||
145966587|NCT03118934|526391939|FG003|Overall Study|Physician Decision|0|||
145966588|NCT03118934|526391940|FG004|Overall Study|Physician Decision|0|||
145966589|NCT03118934|526391941|FG005|Overall Study|Physician Decision|1|||
145966590|NCT03118934|526391936|FG000|Overall Study|Discontinued prior to exposure|0|||
145966591|NCT03118934|526391937|FG001|Overall Study|Discontinued prior to exposure|1|||
145966592|NCT03118934|526391938|FG002|Overall Study|Discontinued prior to exposure|1|||
145966593|NCT03118934|526391939|FG003|Overall Study|Discontinued prior to exposure|1|||
145966594|NCT03118934|526391940|FG004|Overall Study|Discontinued prior to exposure|2|||
145966595|NCT03118934|526391941|FG005|Overall Study|Discontinued prior to exposure|0|||
145966596|NCT03080935|526391942|FG000|Overall Study|Death|34|||
145966597|NCT03080935|526391943|FG001|Overall Study|Death|50|||
145966598|NCT03080935|526391942|FG000|Overall Study|Lost to Follow-up|5|||
145966599|NCT03080935|526391943|FG001|Overall Study|Lost to Follow-up|4|||
145966600|NCT03080935|526391942|FG000|Overall Study|Withdrawal by Subject|11|||
145966601|NCT03080935|526391943|FG001|Overall Study|Withdrawal by Subject|15|||
145966602|NCT02175121|526391944|FG000|Overall Study|Lack of Efficacy|1|||
145966603|NCT02175121|526391945|FG001|Overall Study|Lack of Efficacy|0|||
145966604|NCT02175121|526391946|FG002|Overall Study|Lack of Efficacy|0|||
145966605|NCT02175121|526391947|FG003|Overall Study|Lack of Efficacy|0|||
145966606|NCT02175121|526391948|FG004|Overall Study|Lack of Efficacy|0|||
145966607|NCT02175121|526391944|FG000|Overall Study|Lost to Follow-up|0|||
145966608|NCT02175121|526391945|FG001|Overall Study|Lost to Follow-up|1|||
145966609|NCT02175121|526391946|FG002|Overall Study|Lost to Follow-up|0|||
145966610|NCT02175121|526391947|FG003|Overall Study|Lost to Follow-up|1|||
145966611|NCT02175121|526391948|FG004|Overall Study|Lost to Follow-up|0|||
145966612|NCT02175121|526391944|FG000|Overall Study|Personal emergency|0|||
145966613|NCT02175121|526391945|FG001|Overall Study|Personal emergency|0|||
145966614|NCT02175121|526391946|FG002|Overall Study|Personal emergency|0|||
145966615|NCT02175121|526391947|FG003|Overall Study|Personal emergency|0|||
145966616|NCT02175121|526391948|FG004|Overall Study|Personal emergency|1|||
145966617|NCT02175121|526391944|FG000|Overall Study|Schedule conflict|0|||
145966618|NCT02175121|526391945|FG001|Overall Study|Schedule conflict|0|||
145966619|NCT02175121|526391946|FG002|Overall Study|Schedule conflict|1|||
145966620|NCT02175121|526391947|FG003|Overall Study|Schedule conflict|0|||
145966621|NCT02175121|526391948|FG004|Overall Study|Schedule conflict|0|||
145966622|NCT02175121|526391944|FG000|Overall Study|Time issues|0|||
145966623|NCT02175121|526391945|FG001|Overall Study|Time issues|0|||
145966624|NCT02175121|526391946|FG002|Overall Study|Time issues|1|||
146086719|NCT04391569|526838366|FG000|Overall Study|Participant discharged prematurely|1|||
145966625|NCT02175121|526391947|FG003|Overall Study|Time issues|0|||
146086720|NCT04391569|526838367|FG001|Overall Study|Participant discharged prematurely|0|||
145966626|NCT02175121|526391948|FG004|Overall Study|Time issues|0|||
145966627|NCT02027025|526391953|FG000|Overall Study|Adverse Event|0|||
145966628|NCT02027025|526391954|FG001|Overall Study|Adverse Event|1|||
145966629|NCT02027025|526391955|FG002|Overall Study|Adverse Event|1|||
145966630|NCT02027025|526391953|FG000|Overall Study|Protocol Violation|1|||
145966631|NCT02027025|526391954|FG001|Overall Study|Protocol Violation|0|||
145966632|NCT02027025|526391955|FG002|Overall Study|Protocol Violation|0|||
145966633|NCT02027025|526391953|FG000|Overall Study|Lost to Follow-up|0|||
145966634|NCT02027025|526391954|FG001|Overall Study|Lost to Follow-up|2|||
145966635|NCT02027025|526391955|FG002|Overall Study|Lost to Follow-up|0|||
145966636|NCT02027025|526391953|FG000|Overall Study|Withdrawal by Subject|0|||
145966637|NCT02027025|526391954|FG001|Overall Study|Withdrawal by Subject|1|||
146086723|NCT05856760|526838369|FG000|Overall Study|Adverse Event|2|||
146086724|NCT05856760|526838369|FG000|Overall Study|Physician Decision|1|||
146086725|NCT05856760|526838369|FG000|Overall Study|Protocol Violation|1|||
146086726|NCT05856760|526838369|FG000|Overall Study|Withdrawal by Subject|3|||
146086727|NCT01892722|526838372|FG000|Overall Study|Protocol deviation|0|||
146086728|NCT01892722|526838373|FG001|Overall Study|Protocol deviation|1|||
146086729|NCT01892722|526838372|FG000|Overall Study|Administrative problems|0|||
146086730|NCT01892722|526838373|FG001|Overall Study|Administrative problems|1|||
146086731|NCT01892722|526838372|FG000|Overall Study|Patient/guardian decision|0|||
146086732|NCT01892722|526838373|FG001|Overall Study|Patient/guardian decision|2|||
146086733|NCT01892722|526838372|FG000|Overall Study|Physician Decision|1|||
146086734|NCT01892722|526838373|FG001|Overall Study|Physician Decision|2|||
146086735|NCT01892722|526838372|FG000|Overall Study|Adverse Event|3|||
146086736|NCT01892722|526838373|FG001|Overall Study|Adverse Event|2|||
146086737|NCT01892722|526838372|FG000|Overall Study|Lack of Efficacy|0|||
146086738|NCT01892722|526838373|FG001|Overall Study|Lack of Efficacy|7|||
146086739|NCT01892722|526838372|FG000|Overall Study|Withdrawal by Subject|3|||
146086740|NCT01892722|526838373|FG001|Overall Study|Withdrawal by Subject|5|||
146086741|NCT05568888|526838374|FG000|Overall Study|Physician Decision|1|||
146086742|NCT05568888|526838375|FG001|Overall Study|Physician Decision|0|||
146086743|NCT05568888|526838374|FG000|Overall Study|Protocol Deviation|2|||
146086744|NCT05568888|526838375|FG001|Overall Study|Protocol Deviation|1|||
146086745|NCT05568888|526838374|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
146086746|NCT05568888|526838375|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
146086747|NCT05568888|526838374|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
146086748|NCT05568888|526838375|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
146086749|NCT05568888|526838374|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
146086750|NCT05568888|526838375|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
146086751|NCT02477696|526838378|FG000|Overall Study|Death|89|||
146086752|NCT02477696|526838379|FG001|Overall Study|Death|106|||
146086753|NCT02477696|526838378|FG000|Overall Study|Lost to Follow-up|7|||
146086754|NCT02477696|526838379|FG001|Overall Study|Lost to Follow-up|5|||
146086755|NCT02477696|526838378|FG000|Overall Study|Withdrawal by Subject|37|||
146086756|NCT02477696|526838379|FG001|Overall Study|Withdrawal by Subject|34|||
146086757|NCT02477696|526838378|FG000|Overall Study|Physician Decision|7|||
146086758|NCT02477696|526838379|FG001|Overall Study|Physician Decision|9|||
146086759|NCT02477696|526838378|FG000|Overall Study|Study terminated by sponsor|103|||
146086760|NCT02477696|526838379|FG001|Overall Study|Study terminated by sponsor|99|||
145966638|NCT02027025|526391955|FG002|Overall Study|Withdrawal by Subject|0|||
145966639|NCT02027025|526391953|FG000|Overall Study|Sponsor's decision|0|||
145966640|NCT02027025|526391954|FG001|Overall Study|Sponsor's decision|1|||
145966641|NCT02027025|526391955|FG002|Overall Study|Sponsor's decision|0|||
145966642|NCT04249427|526391958|FG000|Overall Study|Adverse Event|3|||
145966643|NCT04249427|526391959|FG001|Overall Study|Adverse Event|1|||
145966644|NCT04249427|526391958|FG000|Overall Study|Lack of Efficacy|0|||
145966645|NCT04249427|526391959|FG001|Overall Study|Lack of Efficacy|1|||
145966646|NCT04249427|526391958|FG000|Overall Study|Withdrawal by Subject|1|||
145966647|NCT04249427|526391959|FG001|Overall Study|Withdrawal by Subject|2|||
145966648|NCT03886272|526391960|FG000|Period 1|Withdrawal by Subject|0|||
145966649|NCT03886272|526391961|FG001|Period 1|Withdrawal by Subject|0|||
145966650|NCT03886272|526391962|FG002|Period 1|Withdrawal by Subject|0|||
146086761|NCT02477696|526838378|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
145966651|NCT03886272|526391963|FG003|Period 1|Withdrawal by Subject|0|||
145966652|NCT03886272|526391964|FG004|Period 1|Withdrawal by Subject|0|||
146086762|NCT02477696|526838379|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
146086763|NCT02477696|526838378|FG000|Overall Study|Missing/Unknown|2|||
145966653|NCT03886272|526391965|FG005|Period 1|Withdrawal by Subject|1|||
146292281|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
146292282|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
146292283|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
146292284|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
146292285|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
146292286|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
146292287|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
146292288|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
146292289|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
146292290|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
146292291|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
146292292|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
146292293|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
146292294|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
146292295|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
146292296|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
146292297|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
146292298|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
146292299|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
146292300|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
146292301|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
146292302|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
146292303|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
146292304|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Other|10|||
146292305|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Other|7|||
146292306|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Other|8|||
146292307|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Other|8|||
146292308|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Other|0|||
146292309|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
146292310|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
146292311|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
146292312|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
146292313|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
146292314|NCT00615836|527584346|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
146292315|NCT00615836|527584347|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146292316|NCT00615836|527584348|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146292317|NCT00615836|527584349|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146292318|NCT00615836|527584350|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
146292319|NCT01630434|527584351|FG000|Overall Study|Donor lungs turned down|1|||
146292320|NCT01630434|527584352|FG001|Overall Study|Donor lungs turned down|0|||
146292321|NCT01630434|527584351|FG000|Overall Study|Protocol Violation|9|||
146292322|NCT01630434|527584352|FG001|Overall Study|Protocol Violation|4|||
146292323|NCT01630434|527584351|FG000|Overall Study|Death|20|||
146292324|NCT01630434|527584352|FG001|Overall Study|Death|26|||
146292325|NCT00687973|527584353|FG000|Overall Study|Adverse Event|18|||
146292326|NCT00687973|527584354|FG001|Overall Study|Adverse Event|28|||
146292327|NCT00687973|527584353|FG000|Overall Study|Lack of Efficacy|2|||
146292328|NCT00687973|527584354|FG001|Overall Study|Lack of Efficacy|3|||
145966654|NCT03886272|526391966|FG006|Period 1|Withdrawal by Subject|0|||
146292329|NCT00687973|527584353|FG000|Overall Study|Protocol Violation|1|||
146292330|NCT00687973|527584354|FG001|Overall Study|Protocol Violation|2|||
146292331|NCT00687973|527584353|FG000|Overall Study|Administrative Reasons|0|||
146292332|NCT00687973|527584354|FG001|Overall Study|Administrative Reasons|2|||
146292333|NCT00687973|527584353|FG000|Overall Study|Withdrawal by Subject|3|||
146292334|NCT00687973|527584354|FG001|Overall Study|Withdrawal by Subject|3|||
146292335|NCT02578862|527584356|FG000|Overall Study|Withdrawal by Subject|0|||
146292336|NCT02578862|527584357|FG001|Overall Study|Withdrawal by Subject|1|||
146292337|NCT02578862|527584356|FG000|Overall Study|Unplanned unilateral procedure|0|||
146292338|NCT02578862|527584357|FG001|Overall Study|Unplanned unilateral procedure|1|||
146292339|NCT02076178|527584361|FG000|Oral Phase|Adverse Event|0|||
146292340|NCT02076178|527584362|FG001|Oral Phase|Adverse Event|7|||
146292341|NCT02076178|527584361|FG000|Oral Phase|Withdrawal by Subject|0|||
146292342|NCT02076178|527584362|FG001|Oral Phase|Withdrawal by Subject|4|||
146292343|NCT02076178|527584361|FG000|Oral Phase|Physician Decision|0|||
146292344|NCT02076178|527584362|FG001|Oral Phase|Physician Decision|1|||
146292345|NCT02076178|527584361|FG000|Injection Phase|Protocol defined stopping criteria|1|||
146292346|NCT02076178|527584362|FG001|Injection Phase|Protocol defined stopping criteria|0|||
146292347|NCT02076178|527584361|FG000|Injection Phase|Withdrawal by Subject|0|||
146292348|NCT02076178|527584362|FG001|Injection Phase|Withdrawal by Subject|3|||
146292349|NCT02076178|527584361|FG000|Injection Phase|Physician Decision|0|||
146292350|NCT02076178|527584362|FG001|Injection Phase|Physician Decision|3|||
146292351|NCT02076178|527584361|FG000|Injection Phase|Lost to Follow-up|0|||
146292352|NCT02076178|527584362|FG001|Injection Phase|Lost to Follow-up|1|||
146292353|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
145966655|NCT02557399|526391969|FG000|Overall Study|Adverse Event|6|||
145966656|NCT02557399|526391970|FG001|Overall Study|Adverse Event|5|||
145966657|NCT02557399|526391969|FG000|Overall Study|Protocol Violation|0|||
145966658|NCT02557399|526391970|FG001|Overall Study|Protocol Violation|1|||
145966659|NCT02557399|526391969|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145966660|NCT02557399|526391970|FG001|Overall Study|Protocol-defined stopping criteria|1|||
145966661|NCT02557399|526391969|FG000|Overall Study|Withdrawal by Subject|1|||
145966662|NCT02557399|526391970|FG001|Overall Study|Withdrawal by Subject|1|||
145966663|NCT03608826|526391971|FG000|Overall Study|Death|3|||
145966664|NCT03608826|526391971|FG000|Overall Study|Heart Transplant|3|||
145966665|NCT03608826|526391971|FG000|Overall Study|Physician Decision|4|||
145966666|NCT03044314|526391973|FG000|Overall Study|Physician Decision|2|||
145966667|NCT03044314|526391973|FG000|Overall Study|Withdrawal by Subject|1|||
145966668|NCT03044314|526391973|FG000|Overall Study|Connector tubing not available|1|||
145966669|NCT03122171|526391974|FG000|Overall Study|Withdrawal by Subject|1|||
145966670|NCT03234465|526391975|FG000|Overall Study|Adverse Event|4|||
145966671|NCT03234465|526391976|FG001|Overall Study|Adverse Event|2|||
145966672|NCT03234465|526391975|FG000|Overall Study|Death|0|||
146292354|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
146292355|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Death|0|||
146292356|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Death|2|||
146292357|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146292358|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
146292359|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
145966673|NCT03234465|526391976|FG001|Overall Study|Death|1|||
146292360|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
146292361|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
145966674|NCT03234465|526391975|FG000|Overall Study|Lost to Follow-up|1|||
145966675|NCT03234465|526391976|FG001|Overall Study|Lost to Follow-up|1|||
146292362|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
146292363|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
145966676|NCT03234465|526391975|FG000|Overall Study|Withdrawal by Subject|12|||
145966677|NCT03234465|526391976|FG001|Overall Study|Withdrawal by Subject|27|||
146292364|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
146292365|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
146292366|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
146292367|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
146292368|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
146292369|NCT00343252|527584363|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
146292370|NCT00343252|527584364|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
146292371|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
146292372|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
146292373|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Death|3|||
146292374|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Death|3|||
146292375|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146292376|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146292377|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
146292378|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
146292379|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
146292380|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
146292381|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
146292382|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
146292383|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
146292384|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
146292385|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
146292386|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
146292387|NCT00343252|527584363|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
146292388|NCT00343252|527584364|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
146292389|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
146292390|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
146292391|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Death|4|||
146292392|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Death|5|||
146292393|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
146086764|NCT02477696|526838379|FG001|Overall Study|Missing/Unknown|0|||
146086765|NCT04153149|526838382|FG000|Double Blind Period|Death|63|||
146292394|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
146292395|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
146292396|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
146292397|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
146292398|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
146292399|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
146292400|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
146292401|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
146292402|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
146292403|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
146292404|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
146292405|NCT00343252|527584363|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
146292406|NCT00343252|527584364|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
146292407|NCT00731120|527584365|FG000|Overall Study|Adverse Event|7|||
146292408|NCT00731120|527584366|FG001|Overall Study|Adverse Event|6|||
146292409|NCT00731120|527584367|FG002|Overall Study|Adverse Event|8|||
146292410|NCT00731120|527584365|FG000|Overall Study|Lack of Efficacy|4|||
146292411|NCT00731120|527584366|FG001|Overall Study|Lack of Efficacy|5|||
146292412|NCT00731120|527584367|FG002|Overall Study|Lack of Efficacy|4|||
146292413|NCT00731120|527584365|FG000|Overall Study|Noncompliance with Study Drug|3|||
146292414|NCT00731120|527584366|FG001|Overall Study|Noncompliance with Study Drug|3|||
146292415|NCT00731120|527584367|FG002|Overall Study|Noncompliance with Study Drug|1|||
146292416|NCT00731120|527584365|FG000|Overall Study|Protocol Deviations|1|||
146292417|NCT00731120|527584366|FG001|Overall Study|Protocol Deviations|6|||
146292418|NCT00731120|527584367|FG002|Overall Study|Protocol Deviations|1|||
146292419|NCT00731120|527584365|FG000|Overall Study|Withdrawal of Consent|13|||
146292420|NCT00731120|527584366|FG001|Overall Study|Withdrawal of Consent|8|||
146292421|NCT00731120|527584367|FG002|Overall Study|Withdrawal of Consent|4|||
146086766|NCT04153149|526838383|FG001|Double Blind Period|Death|49|||
146292422|NCT00731120|527584365|FG000|Overall Study|Lost to Follow-up|10|||
146292423|NCT00731120|527584366|FG001|Overall Study|Lost to Follow-up|15|||
146086767|NCT04153149|526838384|FG002|Double Blind Period|Death|0|||
146086768|NCT04153149|526838385|FG003|Double Blind Period|Death|0|||
146292424|NCT00731120|527584367|FG002|Overall Study|Lost to Follow-up|17|||
146292425|NCT00731120|527584365|FG000|Overall Study|Other|4|||
146292426|NCT00731120|527584366|FG001|Overall Study|Other|0|||
146292427|NCT00731120|527584367|FG002|Overall Study|Other|1|||
146292428|NCT01142596|527584368|FG000|Overall Study|Withdrawal by Subject|9|||
146292429|NCT01142596|527584369|FG001|Overall Study|Withdrawal by Subject|35|||
146292430|NCT01142596|527584368|FG000|Overall Study|Adverse Event|8|||
146292431|NCT01142596|527584369|FG001|Overall Study|Adverse Event|35|||
146292432|NCT01142596|527584368|FG000|Overall Study|Lack of Efficacy|5|||
146292433|NCT01142596|527584369|FG001|Overall Study|Lack of Efficacy|9|||
146292434|NCT01142596|527584368|FG000|Overall Study|Lost to Follow-up|2|||
146292435|NCT01142596|527584369|FG001|Overall Study|Lost to Follow-up|3|||
146292436|NCT01142596|527584368|FG000|Overall Study|Other reason (not specified)|5|||
146292437|NCT01142596|527584369|FG001|Overall Study|Other reason (not specified)|4|||
146292438|NCT03181451|527584372|FG000|Overall Study|Adverse Event|0|||
146292439|NCT03181451|527584373|FG001|Overall Study|Adverse Event|1|||
146292440|NCT03181451|527584374|FG002|Overall Study|Adverse Event|0|||
146292441|NCT03181451|527584372|FG000|Overall Study|Withdrawal by Subject|0|||
146292442|NCT03181451|527584373|FG001|Overall Study|Withdrawal by Subject|1|||
146292443|NCT03181451|527584374|FG002|Overall Study|Withdrawal by Subject|0|||
146292444|NCT01012713|527584377|FG000|Overall Study|Lack of Efficacy|3|||
146292445|NCT01596621|527584379|FG000|Overall Study|Death|4|||
146292446|NCT01596621|527584379|FG000|Overall Study|Withdrawal by Subject|9|||
146292447|NCT01596621|527584379|FG000|Overall Study|Disease Progression|49|||
146292448|NCT01596621|527584379|FG000|Overall Study|Lost to Follow-up|3|||
145966678|NCT03234465|526391975|FG000|Overall Study|Symptomatic deterioration|0|||
145966679|NCT03234465|526391976|FG001|Overall Study|Symptomatic deterioration|1|||
145966680|NCT03234465|526391975|FG000|Overall Study|Non-compliance|2|||
145966681|NCT03234465|526391976|FG001|Overall Study|Non-compliance|0|||
145966682|NCT03234465|526391975|FG000|Overall Study|Other|14|||
145966683|NCT03234465|526391976|FG001|Overall Study|Other|8|||
145966684|NCT00606307|526391979|FG000|Overall Study|Adverse Event|2|||
145966685|NCT00606307|526391979|FG000|Overall Study|Withdrawal by Subject|2|||
145966686|NCT00606307|526391979|FG000|Overall Study|Disease progression|6|||
145966687|NCT00606307|526391979|FG000|Overall Study|QTc prolongation|1|||
145966688|NCT03368807|526391980|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
145966689|NCT03368807|526391980|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
146292449|NCT01596621|527584379|FG000|Overall Study|Other than specified|13|||
146292450|NCT01536015|527584380|FG000|Overall Study|Adverse Event|1|||
146292451|NCT01536015|527584381|FG001|Overall Study|Adverse Event|4|||
146292452|NCT01536015|527584380|FG000|Overall Study|Lost to Follow-up|0|||
145966690|NCT03368807|526391980|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
145966691|NCT03368807|526391980|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
146292453|NCT01536015|527584381|FG001|Overall Study|Lost to Follow-up|1|||
145966692|NCT01677741|526391999|FG000|Overall Study|Death|0|||
145966693|NCT01677741|526392000|FG001|Overall Study|Death|0|||
145966694|NCT01677741|526392001|FG002|Overall Study|Death|0|||
145966695|NCT01677741|526392002|FG003|Overall Study|Death|1|||
145966696|NCT01677741|526392003|FG004|Overall Study|Death|0|||
145966697|NCT01677741|526392004|FG005|Overall Study|Death|1|||
145966698|NCT01677741|526392005|FG006|Overall Study|Death|0|||
145966699|NCT01677741|526392006|FG007|Overall Study|Death|0|||
145966700|NCT01677741|526391999|FG000|Overall Study|Withdrawal by Subject|2|||
145966701|NCT01677741|526392000|FG001|Overall Study|Withdrawal by Subject|7|||
145966702|NCT01677741|526392001|FG002|Overall Study|Withdrawal by Subject|5|||
145966703|NCT01677741|526392002|FG003|Overall Study|Withdrawal by Subject|4|||
145966704|NCT01677741|526392003|FG004|Overall Study|Withdrawal by Subject|11|||
145966705|NCT01677741|526392004|FG005|Overall Study|Withdrawal by Subject|20|||
145966706|NCT01677741|526392005|FG006|Overall Study|Withdrawal by Subject|4|||
145966707|NCT01677741|526392006|FG007|Overall Study|Withdrawal by Subject|2|||
145966708|NCT01677741|526391999|FG000|Overall Study|Enrolled in a rollover study|0|||
145966709|NCT01677741|526392000|FG001|Overall Study|Enrolled in a rollover study|3|||
145966710|NCT01677741|526392001|FG002|Overall Study|Enrolled in a rollover study|2|||
145966711|NCT01677741|526392002|FG003|Overall Study|Enrolled in a rollover study|1|||
145966712|NCT01677741|526392003|FG004|Overall Study|Enrolled in a rollover study|6|||
145966713|NCT01677741|526392004|FG005|Overall Study|Enrolled in a rollover study|6|||
145966714|NCT01677741|526392005|FG006|Overall Study|Enrolled in a rollover study|7|||
145966715|NCT01677741|526392006|FG007|Overall Study|Enrolled in a rollover study|0|||
145966716|NCT01677741|526391999|FG000|Overall Study|Progressive disease|1|||
145966717|NCT01677741|526392000|FG001|Overall Study|Progressive disease|0|||
145966718|NCT01677741|526392001|FG002|Overall Study|Progressive disease|1|||
145966719|NCT01677741|526392002|FG003|Overall Study|Progressive disease|0|||
145966720|NCT01677741|526392003|FG004|Overall Study|Progressive disease|0|||
145966721|NCT01677741|526392004|FG005|Overall Study|Progressive disease|1|||
145966722|NCT01677741|526392005|FG006|Overall Study|Progressive disease|0|||
145966723|NCT01677741|526392006|FG007|Overall Study|Progressive disease|0|||
145966724|NCT00720499|526392007|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
145966725|NCT00720499|526392008|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145966726|NCT00720499|526392007|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
145966727|NCT00720499|526392008|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
145966728|NCT00720499|526392007|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
145966729|NCT00720499|526392008|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
145966730|NCT01973218|526392009|FG000|Overall Study|Adverse Event|1|||
145966731|NCT01973218|526392010|FG001|Overall Study|Adverse Event|0|||
145966732|NCT01973218|526392009|FG000|Overall Study|Withdrawal by Subject|1|||
145966733|NCT01973218|526392010|FG001|Overall Study|Withdrawal by Subject|0|||
145966734|NCT02247466|526392011|FG000|Overall Study|Procedure changed to open surgery|0|||
145966735|NCT02247466|526392012|FG001|Overall Study|Procedure changed to open surgery|3|||
145966736|NCT04356937|526392014|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
145966737|NCT04356937|526392015|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
145966738|NCT01324947|526392016|FG000|Overall Study|Adverse Event|7|||
145966739|NCT01324947|526392016|FG000|Overall Study|Death|10|||
145966740|NCT01324947|526392016|FG000|Overall Study|Other|3|||
145966741|NCT01324947|526392016|FG000|Overall Study|Progressive Disease|50|||
145966742|NCT01324947|526392016|FG000|Overall Study|Withdrawal by Subject|3|||
145966743|NCT01324947|526392016|FG000|Overall Study|1 discontinued before starting drug|1|||
145966744|NCT02873689|526393383|FG000|Overall Study|Lack of Efficacy|1|||
145966745|NCT02873689|526393384|FG001|Overall Study|Lack of Efficacy|0|||
145966746|NCT02873689|526393383|FG000|Overall Study|Withdrawal by Subject|2|||
145966747|NCT02873689|526393384|FG001|Overall Study|Withdrawal by Subject|2|||
145966748|NCT02873689|526393383|FG000|Overall Study|Protocol Violation|1|||
145966749|NCT02873689|526393384|FG001|Overall Study|Protocol Violation|0|||
145966750|NCT02873689|526393383|FG000|Overall Study|Adverse Event|2|||
145966751|NCT02873689|526393384|FG001|Overall Study|Adverse Event|2|||
145966752|NCT02873689|526393383|FG000|Overall Study|Randomized but not Treated|1|||
145966753|NCT02873689|526393384|FG001|Overall Study|Randomized but not Treated|1|||
145966754|NCT00350545|526393385|FG000|Overall Study|Withdrawal by Subject|2|||
145966755|NCT00266708|526393396|FG000|Overall Study|No renal function|1|||
145966756|NCT00266708|526393397|FG001|Overall Study|No renal function|1|||
145966757|NCT00266708|526393396|FG000|Overall Study|Refused biopsy|3|||
145966758|NCT00266708|526393397|FG001|Overall Study|Refused biopsy|6|||
145966759|NCT00266708|526393396|FG000|Overall Study|Asthma|0|||
146292454|NCT01536015|527584380|FG000|Overall Study|Inclusion Criterion not met|2|||
145888262|NCT03078478|526096515|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
145888263|NCT03078478|526096516|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
145888264|NCT03078478|526096515|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
145888265|NCT03078478|526096516|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
145888266|NCT03078478|526096515|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
145888267|NCT03078478|526096516|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
145888268|NCT03078478|526096515|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
145888269|NCT03078478|526096516|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
145888270|NCT03078478|526096515|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
145888271|NCT03078478|526096516|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
145888272|NCT03078478|526096515|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
145888273|NCT03078478|526096516|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
145888274|NCT03078478|526096515|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
145888275|NCT03078478|526096516|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
145888276|NCT03078478|526096515|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
145888277|NCT03078478|526096516|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
145888278|NCT02792218|526096517|FG000|Overall Study|Patient/guardian decision|15|||
145888279|NCT02792218|526096518|FG001|Overall Study|Patient/guardian decision|42|||
145888280|NCT02792218|526096517|FG000|Overall Study|Adverse Event|15|||
145888281|NCT02792218|526096518|FG001|Overall Study|Adverse Event|14|||
145888282|NCT02792218|526096517|FG000|Overall Study|Lost to Follow-up|10|||
145888283|NCT02792218|526096518|FG001|Overall Study|Lost to Follow-up|5|||
145888284|NCT02792218|526096517|FG000|Overall Study|Lack of Efficacy|1|||
145888285|NCT02792218|526096518|FG001|Overall Study|Lack of Efficacy|12|||
145888286|NCT02792218|526096517|FG000|Overall Study|Physician Decision|4|||
145888287|NCT02792218|526096518|FG001|Overall Study|Physician Decision|4|||
145888288|NCT02792218|526096517|FG000|Overall Study|Protocol deviation|3|||
145888289|NCT02792218|526096518|FG001|Overall Study|Protocol deviation|2|||
145888290|NCT02792218|526096517|FG000|Overall Study|New therapy for study indication|0|||
145888291|NCT02792218|526096518|FG001|Overall Study|New therapy for study indication|1|||
145888292|NCT02792218|526096517|FG000|Overall Study|Non-compliance with study treatment|0|||
145888293|NCT02792218|526096518|FG001|Overall Study|Non-compliance with study treatment|1|||
145888294|NCT02792218|526096517|FG000|Overall Study|Pregnancy|1|||
145888295|NCT02792218|526096518|FG001|Overall Study|Pregnancy|0|||
145888296|NCT00955721|526096519|FG000|Overall Study|Physician Decision|1|||
145888297|NCT00955721|526096520|FG001|Overall Study|Physician Decision|0|||
145888298|NCT00955721|526096519|FG000|Overall Study|Death|1|||
145888299|NCT00955721|526096520|FG001|Overall Study|Death|0|||
145888300|NCT00955721|526096519|FG000|Overall Study|Withdrawal by Subject|1|||
145888301|NCT00955721|526096520|FG001|Overall Study|Withdrawal by Subject|0|||
145888302|NCT01253317|526096525|FG000|Overall Study|Adverse Event|2|||
145888303|NCT04034355|526096530|FG000|Overall Study|Study terminated by Sponsor|10|||
145888304|NCT04034355|526096531|FG001|Overall Study|Study terminated by Sponsor|17|||
145888305|NCT04034355|526096530|FG000|Overall Study|Withdrawal by Subject|12|||
145888306|NCT04034355|526096531|FG001|Overall Study|Withdrawal by Subject|11|||
145888307|NCT04034355|526096530|FG000|Overall Study|Site terminated by Sponsor|4|||
145888308|NCT04034355|526096531|FG001|Overall Study|Site terminated by Sponsor|5|||
145888309|NCT04034355|526096530|FG000|Overall Study|Adverse Event|2|||
145888310|NCT04034355|526096531|FG001|Overall Study|Adverse Event|0|||
145888311|NCT04034355|526096530|FG000|Overall Study|Death|1|||
145888312|NCT04034355|526096531|FG001|Overall Study|Death|1|||
145888313|NCT04034355|526096530|FG000|Overall Study|Not reported|2|||
145888314|NCT04034355|526096531|FG001|Overall Study|Not reported|0|||
145888315|NCT04034355|526096530|FG000|Overall Study|Lost to Follow-up|1|||
145888316|NCT04034355|526096531|FG001|Overall Study|Lost to Follow-up|0|||
145888317|NCT04034355|526096530|FG000|Overall Study|Physician Decision|1|||
145888318|NCT04034355|526096531|FG001|Overall Study|Physician Decision|0|||
145888319|NCT04034355|526096530|FG000|Overall Study|Protocol Violation|0|||
145888320|NCT04034355|526096531|FG001|Overall Study|Protocol Violation|1|||
145888321|NCT04034355|526096530|FG000|Overall Study|Progressive disease|1|||
145888322|NCT04034355|526096531|FG001|Overall Study|Progressive disease|0|||
146086769|NCT04153149|526838382|FG000|Double Blind Period|Withdrawal by Subject|16|||
146086770|NCT04153149|526838383|FG001|Double Blind Period|Withdrawal by Subject|11|||
146086771|NCT04153149|526838384|FG002|Double Blind Period|Withdrawal by Subject|0|||
146086772|NCT04153149|526838385|FG003|Double Blind Period|Withdrawal by Subject|0|||
146086773|NCT04153149|526838382|FG000|Double Blind Period|Adverse Event|6|||
146086774|NCT04153149|526838383|FG001|Double Blind Period|Adverse Event|2|||
146086775|NCT04153149|526838384|FG002|Double Blind Period|Adverse Event|0|||
145966760|NCT00266708|526393397|FG001|Overall Study|Asthma|2|||
145966761|NCT02791269|526393398|FG000|Overall Study|Lost to Follow-up|0|||
145966762|NCT02791269|526393399|FG001|Overall Study|Lost to Follow-up|1|||
145966763|NCT02351934|526393400|FG000|Allocation|POD weight<pre-op weight|3|||
145966764|NCT02351934|526393401|FG001|Allocation|POD weight<pre-op weight|0|||
145966765|NCT02351934|526393400|FG000|Allocation|Hypotension preventing administration|2|||
145966766|NCT02351934|526393401|FG001|Allocation|Hypotension preventing administration|0|||
145966767|NCT02351934|526393400|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
145966768|NCT02351934|526393401|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
145966769|NCT02351934|526393400|FG000|Follow-Up|POD weight<pre-op weight|3|||
145966770|NCT02351934|526393401|FG001|Follow-Up|POD weight<pre-op weight|0|||
145966771|NCT02351934|526393400|FG000|Follow-Up|Acute Kidney Injury|1|||
145966772|NCT02351934|526393401|FG001|Follow-Up|Acute Kidney Injury|0|||
145966773|NCT02351934|526393400|FG000|Follow-Up|Early dismissal|3|||
145966774|NCT02351934|526393401|FG001|Follow-Up|Early dismissal|0|||
145966775|NCT02351934|526393400|FG000|Follow-Up|Hypotension|3|||
145966776|NCT02351934|526393401|FG001|Follow-Up|Hypotension|0|||
145966777|NCT02351934|526393400|FG000|Follow-Up|No documentation|2|||
145966778|NCT02351934|526393401|FG001|Follow-Up|No documentation|0|||
145966779|NCT02351934|526393400|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
145966780|NCT02351934|526393401|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
145966781|NCT02351934|526393400|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
145966782|NCT02351934|526393401|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
145966783|NCT02683109|526393402|FG000|Overall Study|Adverse Event|1|||
145966784|NCT02683109|526393403|FG001|Overall Study|Adverse Event|0|||
145966785|NCT00368251|526393404|FG000|Overall Study|SAE, non-fatal|1|||
145966786|NCT00368251|526393405|FG001|Overall Study|SAE, non-fatal|0|||
145966787|NCT00368251|526393406|FG002|Overall Study|SAE, non-fatal|0|||
145966788|NCT00368251|526393404|FG000|Overall Study|AE, non-serious non-fatal|0|||
145966789|NCT00368251|526393405|FG001|Overall Study|AE, non-serious non-fatal|0|||
145966790|NCT00368251|526393406|FG002|Overall Study|AE, non-serious non-fatal|1|||
145966791|NCT01373164|526393408|FG000|Overall Study|Lost to Follow-up|0|||
145966792|NCT01373164|526393409|FG001|Overall Study|Lost to Follow-up|0|||
145966793|NCT01373164|526393410|FG002|Overall Study|Lost to Follow-up|1|||
145966794|NCT01373164|526393411|FG003|Overall Study|Lost to Follow-up|2|||
145966795|NCT01373164|526393412|FG004|Overall Study|Lost to Follow-up|0|||
145966796|NCT01373164|526393408|FG000|Overall Study|Withdrawal by Subject|0|||
145966797|NCT01373164|526393409|FG001|Overall Study|Withdrawal by Subject|1|||
145966798|NCT01373164|526393410|FG002|Overall Study|Withdrawal by Subject|0|||
145966799|NCT01373164|526393411|FG003|Overall Study|Withdrawal by Subject|10|||
145966800|NCT01373164|526393412|FG004|Overall Study|Withdrawal by Subject|2|||
145966801|NCT02669849|526393413|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145966802|NCT02669849|526393414|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145966803|NCT02669849|526393415|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
145966804|NCT02669849|526393413|FG000|Overall Study|Lost to Follow-up|1|||
145966805|NCT02669849|526393414|FG001|Overall Study|Lost to Follow-up|0|||
145966806|NCT02669849|526393415|FG002|Overall Study|Lost to Follow-up|3|||
145966807|NCT02669849|526393413|FG000|Overall Study|Death|1|||
145966808|NCT02669849|526393414|FG001|Overall Study|Death|1|||
145966809|NCT02669849|526393415|FG002|Overall Study|Death|2|||
145966810|NCT02669849|526393413|FG000|Overall Study|Study terminated by sponsor|16|||
145966811|NCT02669849|526393414|FG001|Overall Study|Study terminated by sponsor|1|||
145966812|NCT02669849|526393415|FG002|Overall Study|Study terminated by sponsor|14|||
145966813|NCT02669849|526393413|FG000|Overall Study|Other|0|||
145966814|NCT02669849|526393414|FG001|Overall Study|Other|0|||
145966815|NCT02669849|526393415|FG002|Overall Study|Other|2|||
145966816|NCT03408899|526393418|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
145966817|NCT04745351|526393419|FG000|Overall Study|Death|51|||
145966818|NCT04745351|526393420|FG001|Overall Study|Death|25|||
145966819|NCT04745351|526393419|FG000|Overall Study|Lost to Follow-up|9|||
145966820|NCT04745351|526393420|FG001|Overall Study|Lost to Follow-up|3|||
145966821|NCT04745351|526393419|FG000|Overall Study|Randomized but Never Treated|3|||
145966822|NCT04745351|526393420|FG001|Overall Study|Randomized but Never Treated|3|||
145966823|NCT04745351|526393419|FG000|Overall Study|Adverse Event|4|||
146086776|NCT04153149|526838385|FG003|Double Blind Period|Adverse Event|0|||
145966824|NCT04745351|526393420|FG001|Overall Study|Adverse Event|0|||
145966825|NCT04745351|526393419|FG000|Overall Study|Withdrew Consent|1|||
145966826|NCT04745351|526393420|FG001|Overall Study|Withdrew Consent|2|||
145966827|NCT04745351|526393419|FG000|Overall Study|Investigator's Discretion|2|||
145966828|NCT04745351|526393420|FG001|Overall Study|Investigator's Discretion|0|||
146292455|NCT01536015|527584381|FG001|Overall Study|Inclusion Criterion not met|0|||
146292456|NCT01536015|527584380|FG000|Overall Study|Study closure|5|||
145888323|NCT01552369|526097758|FG000|Overall Study|Did not consent to extended follow up|8|||
145888324|NCT01552369|526097759|FG001|Overall Study|Did not consent to extended follow up|9|||
145888325|NCT01915940|526097760|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
145888326|NCT01915940|526097761|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
146292457|NCT01536015|527584381|FG001|Overall Study|Study closure|5|||
146292458|NCT04508023|527584382|FG000|Overall Study|Withdrawal by Subject|1|||
146292459|NCT04508023|527584383|FG001|Overall Study|Withdrawal by Subject|2|||
146292460|NCT02988622|527584387|FG000|Overall Study|Lost to Follow-up|17|||
146292461|NCT02447172|527584388|FG000|Overall Study|Adverse Event|11|||
146292462|NCT02447172|527584389|FG001|Overall Study|Adverse Event|8|||
146292463|NCT02447172|527584390|FG002|Overall Study|Adverse Event|7|||
146292464|NCT02447172|527584388|FG000|Overall Study|Death|3|||
146292465|NCT02447172|527584389|FG001|Overall Study|Death|1|||
146292466|NCT02447172|527584390|FG002|Overall Study|Death|0|||
146292467|NCT02447172|527584388|FG000|Overall Study|Protocol Violation|2|||
146292468|NCT02447172|527584389|FG001|Overall Study|Protocol Violation|1|||
146292469|NCT02447172|527584390|FG002|Overall Study|Protocol Violation|2|||
146292470|NCT02447172|527584388|FG000|Overall Study|Lost to Follow-up|7|||
146292471|NCT02447172|527584389|FG001|Overall Study|Lost to Follow-up|4|||
146292472|NCT02447172|527584390|FG002|Overall Study|Lost to Follow-up|4|||
146292473|NCT02447172|527584388|FG000|Overall Study|Withdrawal by Subject|5|||
146292474|NCT02447172|527584389|FG001|Overall Study|Withdrawal by Subject|1|||
146292475|NCT02447172|527584390|FG002|Overall Study|Withdrawal by Subject|3|||
146292476|NCT02447172|527584388|FG000|Overall Study|protocol specific treatment unrelated|3|||
146292477|NCT02447172|527584389|FG001|Overall Study|protocol specific treatment unrelated|0|||
146292478|NCT02447172|527584390|FG002|Overall Study|protocol specific treatment unrelated|2|||
146292479|NCT01204398|527584394|FG000|Overall Study|Adverse Event|1|||
146292480|NCT03562247|527584395|FG000|Overall Study|Lost to Follow-up|3|||
146292481|NCT03562247|527584396|FG001|Overall Study|Lost to Follow-up|1|||
146292482|NCT03562247|527584397|FG002|Overall Study|Lost to Follow-up|1|||
146292483|NCT00983931|527584398|FG000|14 Day Washout Period|Physician Decision|1|||
146292484|NCT01723254|527584399|FG000|Overall Study|Conflict with work schedule|0|||
146292485|NCT01723254|527584400|FG001|Overall Study|Conflict with work schedule|0|||
146292486|NCT01723254|527584401|FG002|Overall Study|Conflict with work schedule|0|||
146292487|NCT01723254|527584402|FG003|Overall Study|Conflict with work schedule|0|||
146292488|NCT01723254|527584403|FG004|Overall Study|Conflict with work schedule|0|||
146292489|NCT01723254|527584404|FG005|Overall Study|Conflict with work schedule|0|||
146292490|NCT01723254|527584405|FG006|Overall Study|Conflict with work schedule|0|||
146292491|NCT01723254|527584406|FG007|Overall Study|Conflict with work schedule|1|||
146292492|NCT01723254|527584399|FG000|Overall Study|Personal issues|0|||
146292493|NCT01723254|527584400|FG001|Overall Study|Personal issues|0|||
146292494|NCT01723254|527584401|FG002|Overall Study|Personal issues|0|||
146292495|NCT01723254|527584402|FG003|Overall Study|Personal issues|0|||
146292496|NCT01723254|527584403|FG004|Overall Study|Personal issues|0|||
146292497|NCT01723254|527584404|FG005|Overall Study|Personal issues|1|||
146292498|NCT01723254|527584405|FG006|Overall Study|Personal issues|0|||
146292499|NCT01723254|527584406|FG007|Overall Study|Personal issues|0|||
146292500|NCT01723254|527584399|FG000|Overall Study|No longer have time to participate|0|||
146292501|NCT01723254|527584400|FG001|Overall Study|No longer have time to participate|0|||
146292502|NCT01723254|527584401|FG002|Overall Study|No longer have time to participate|0|||
146292503|NCT01723254|527584402|FG003|Overall Study|No longer have time to participate|1|||
146292504|NCT01723254|527584403|FG004|Overall Study|No longer have time to participate|0|||
146292505|NCT01723254|527584404|FG005|Overall Study|No longer have time to participate|0|||
146292506|NCT01723254|527584405|FG006|Overall Study|No longer have time to participate|0|||
146292507|NCT01723254|527584406|FG007|Overall Study|No longer have time to participate|0|||
146292508|NCT01723254|527584399|FG000|Overall Study|Move/Left to another country/city|0|||
146292509|NCT01723254|527584400|FG001|Overall Study|Move/Left to another country/city|0|||
146292510|NCT01723254|527584401|FG002|Overall Study|Move/Left to another country/city|2|||
146292511|NCT01723254|527584402|FG003|Overall Study|Move/Left to another country/city|1|||
146292512|NCT01723254|527584403|FG004|Overall Study|Move/Left to another country/city|1|||
146292513|NCT01723254|527584404|FG005|Overall Study|Move/Left to another country/city|0|||
146292514|NCT01723254|527584405|FG006|Overall Study|Move/Left to another country/city|0|||
146292515|NCT01723254|527584406|FG007|Overall Study|Move/Left to another country/city|0|||
146292516|NCT01723254|527584399|FG000|Overall Study|Protocol Violation|0|||
146292517|NCT01723254|527584400|FG001|Overall Study|Protocol Violation|1|||
146292518|NCT01723254|527584401|FG002|Overall Study|Protocol Violation|0|||
146292519|NCT01723254|527584402|FG003|Overall Study|Protocol Violation|0|||
146292520|NCT01723254|527584403|FG004|Overall Study|Protocol Violation|0|||
146292521|NCT01723254|527584404|FG005|Overall Study|Protocol Violation|0|||
146292522|NCT01723254|527584405|FG006|Overall Study|Protocol Violation|0|||
146292523|NCT01723254|527584406|FG007|Overall Study|Protocol Violation|0|||
146292524|NCT01723254|527584399|FG000|Overall Study|Withdrawal by Subject|1|||
146292525|NCT01723254|527584400|FG001|Overall Study|Withdrawal by Subject|2|||
146292526|NCT01723254|527584401|FG002|Overall Study|Withdrawal by Subject|1|||
146292527|NCT01723254|527584402|FG003|Overall Study|Withdrawal by Subject|0|||
146292528|NCT01723254|527584403|FG004|Overall Study|Withdrawal by Subject|1|||
146292529|NCT01723254|527584404|FG005|Overall Study|Withdrawal by Subject|1|||
146292530|NCT01723254|527584405|FG006|Overall Study|Withdrawal by Subject|1|||
146292531|NCT01723254|527584406|FG007|Overall Study|Withdrawal by Subject|2|||
146292532|NCT02668185|527584407|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
146292533|NCT02668185|527584408|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
146292534|NCT02668185|527584407|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
146292535|NCT02668185|527584408|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
146292536|NCT02668185|527584407|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
146292537|NCT02668185|527584408|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
146292538|NCT02668185|527584407|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
146292539|NCT02668185|527584408|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
146292540|NCT00770341|527584409|FG000|Overall Study|Did not meet eligibility criteria|1|||
146292541|NCT00770341|527584410|FG001|Overall Study|Did not meet eligibility criteria|0|||
146292542|NCT00770341|527584411|FG002|Overall Study|Did not meet eligibility criteria|0|||
146292543|NCT00770341|527584409|FG000|Overall Study|Withdrawal by Subject|0|||
146292544|NCT00770341|527584410|FG001|Overall Study|Withdrawal by Subject|1|||
146292545|NCT00770341|527584411|FG002|Overall Study|Withdrawal by Subject|0|||
146292546|NCT00770341|527584409|FG000|Overall Study|Clinical Adverse Event|3|||
146292547|NCT00770341|527584410|FG001|Overall Study|Clinical Adverse Event|1|||
146292548|NCT00770341|527584411|FG002|Overall Study|Clinical Adverse Event|2|||
146292549|NCT00770341|527584409|FG000|Overall Study|Laboratory adverse event|3|||
146292550|NCT00770341|527584410|FG001|Overall Study|Laboratory adverse event|3|||
145888327|NCT01915940|526097762|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
145888328|NCT01915940|526097760|FG000|Treatment Period|Decision of Participant|0|||
146292551|NCT00770341|527584411|FG002|Overall Study|Laboratory adverse event|0|||
146292552|NCT00770341|527584409|FG000|Overall Study|Lack of Efficacy|3|||
146292553|NCT00770341|527584410|FG001|Overall Study|Lack of Efficacy|0|||
146292554|NCT00770341|527584411|FG002|Overall Study|Lack of Efficacy|1|||
146292555|NCT00770341|527584409|FG000|Overall Study|Other|1|||
146292556|NCT00770341|527584410|FG001|Overall Study|Other|0|||
146292557|NCT00770341|527584411|FG002|Overall Study|Other|0|||
145888329|NCT01915940|526097761|FG001|Treatment Period|Decision of Participant|1|||
146292558|NCT00770341|527584409|FG000|Overall Study|Not treated|1|||
146292559|NCT00770341|527584410|FG001|Overall Study|Not treated|0|||
145888330|NCT01915940|526097762|FG002|Treatment Period|Decision of Participant|3|||
145888331|NCT01915940|526097760|FG000|Treatment Period|Adverse Event|0|||
145888332|NCT01915940|526097761|FG001|Treatment Period|Adverse Event|9|||
145888333|NCT01915940|526097762|FG002|Treatment Period|Adverse Event|1|||
145888334|NCT01915940|526097760|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
145888335|NCT01915940|526097761|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
145888336|NCT01915940|526097762|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
145888337|NCT00614926|526097766|FG000|Overall Study|Burden of travel|1|||
145888338|NCT00614926|526097767|FG001|Overall Study|Burden of travel|0|||
145888339|NCT00614926|526097766|FG000|Overall Study|Adverse Event|3|||
145888340|NCT00614926|526097767|FG001|Overall Study|Adverse Event|0|||
145888341|NCT02999984|526097775|FG000|Overall Study|Treatment Failure|1|||
145888342|NCT04039919|526097778|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145888343|NCT04039919|526097779|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145888344|NCT04039919|526097780|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145888345|NCT04039919|526097781|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145888346|NCT04039919|526097782|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145888347|NCT04039919|526097778|FG000|Treatment Period 1|Sponsor's decision|0|||
145888348|NCT04039919|526097779|FG001|Treatment Period 1|Sponsor's decision|0|||
145888349|NCT04039919|526097780|FG002|Treatment Period 1|Sponsor's decision|0|||
145888350|NCT04039919|526097781|FG003|Treatment Period 1|Sponsor's decision|0|||
145888351|NCT04039919|526097782|FG004|Treatment Period 1|Sponsor's decision|16|||
145888352|NCT04039919|526097778|FG000|Treatment Period 5|Withdrawal by Subject|1|||
145888353|NCT04039919|526097779|FG001|Treatment Period 5|Withdrawal by Subject|0|||
145888354|NCT04039919|526097780|FG002|Treatment Period 5|Withdrawal by Subject|0|||
145888355|NCT04039919|526097781|FG003|Treatment Period 5|Withdrawal by Subject|0|||
145888356|NCT04039919|526097782|FG004|Treatment Period 5|Withdrawal by Subject|0|||
145888357|NCT00754013|526097783|FG000|Overall Study|Lost to Follow-up|1|||
145888358|NCT00754013|526097784|FG001|Overall Study|Lost to Follow-up|1|||
145888359|NCT00754013|526097783|FG000|Overall Study|didn't return after study termed|3|||
145888360|NCT00754013|526097784|FG001|Overall Study|didn't return after study termed|4|||
145888361|NCT02310789|526097785|FG000|Overall Study|Adverse Event|1|||
145888362|NCT01197417|526097786|FG000|Overall Study|Physician Decision|3|||
145888363|NCT01197417|526097787|FG001|Overall Study|Physician Decision|2|||
145888364|NCT01197417|526097786|FG000|Overall Study|Withdrawal by Subject|2|||
145888365|NCT01197417|526097787|FG001|Overall Study|Withdrawal by Subject|4|||
145888366|NCT01197417|526097786|FG000|Overall Study|Site miscommunication|0|||
145888367|NCT01197417|526097787|FG001|Overall Study|Site miscommunication|1|||
145888368|NCT01197417|526097786|FG000|Overall Study|Subject transferred to intensive care|0|||
145888369|NCT01197417|526097787|FG001|Overall Study|Subject transferred to intensive care|1|||
145888370|NCT01197417|526097786|FG000|Overall Study|Not consented in time to receive drug|0|||
145888371|NCT01197417|526097787|FG001|Overall Study|Not consented in time to receive drug|1|||
145888372|NCT01197417|526097786|FG000|Overall Study|Hypotension|1|||
145888373|NCT01197417|526097787|FG001|Overall Study|Hypotension|2|||
145888374|NCT01197417|526097786|FG000|Overall Study|Found to be ineligible|2|||
145888375|NCT01197417|526097787|FG001|Overall Study|Found to be ineligible|5|||
145888376|NCT01197417|526097786|FG000|Overall Study|No 25-hour magnesium level|0|||
145888377|NCT01197417|526097787|FG001|Overall Study|No 25-hour magnesium level|2|||
145888378|NCT03250299|526097788|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
145888379|NCT03250299|526097789|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
145888380|NCT03250299|526097790|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
145888381|NCT03250299|526097791|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
145888382|NCT03250299|526097792|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
145888383|NCT03250299|526097788|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
145888384|NCT03250299|526097789|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
145888385|NCT03250299|526097790|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
145888386|NCT03250299|526097791|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
145888387|NCT03250299|526097792|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
145888388|NCT03250299|526097788|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145888389|NCT03250299|526097789|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145888390|NCT03250299|526097790|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
145888391|NCT03250299|526097791|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145888392|NCT03250299|526097792|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145888393|NCT03250299|526097788|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
146232701|NCT02325466|527370655|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
145888394|NCT03250299|526097789|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
145888395|NCT03250299|526097790|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
145888396|NCT03250299|526097791|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
145888397|NCT03250299|526097792|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
145888398|NCT01546142|526097797|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
145888399|NCT01546142|526097798|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
145888400|NCT01546142|526097797|FG000|Overall Study|Subject Noncompliance|1|||
145888401|NCT01546142|526097798|FG001|Overall Study|Subject Noncompliance|1|||
145888402|NCT01546142|526097797|FG000|Overall Study|Adverse Event|6|||
145888403|NCT01546142|526097798|FG001|Overall Study|Adverse Event|3|||
146232702|NCT02325466|527370653|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
146232703|NCT02325466|527370654|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
146232704|NCT02325466|527370655|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
146232705|NCT02325466|527370653|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
146232706|NCT02325466|527370654|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
146232707|NCT02325466|527370655|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
146232708|NCT02325466|527370653|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
146232709|NCT02325466|527370654|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
146232710|NCT02325466|527370655|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
146232711|NCT02325466|527370653|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
146232712|NCT02325466|527370654|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
146232713|NCT02325466|527370655|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
146232714|NCT03699163|527370656|FG000|Overall Study|Physician Decision|12|||
146232715|NCT03699163|527370657|FG001|Overall Study|Physician Decision|0|||
146232716|NCT03699163|527370656|FG000|Overall Study|failed QC measures|205|||
146232717|NCT03699163|527370657|FG001|Overall Study|failed QC measures|206|||
146232718|NCT01964300|527370663|FG000|Overall Study|Ineligible after enrollment|0|||
146232719|NCT01964300|527370664|FG001|Overall Study|Ineligible after enrollment|1|||
146232720|NCT01964300|527370663|FG000|Overall Study|Adverse Event|1|||
146232721|NCT01964300|527370664|FG001|Overall Study|Adverse Event|1|||
146232722|NCT01964300|527370663|FG000|Overall Study|Lack of Efficacy|3|||
146232723|NCT01964300|527370664|FG001|Overall Study|Lack of Efficacy|5|||
146232724|NCT01964300|527370663|FG000|Overall Study|Withdrawal by Subject|0|||
146232725|NCT01964300|527370664|FG001|Overall Study|Withdrawal by Subject|1|||
146232726|NCT01964300|527370663|FG000|Overall Study|To receive alternative therapy|1|||
146232727|NCT01964300|527370664|FG001|Overall Study|To receive alternative therapy|2|||
146232728|NCT01964300|527370663|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
146232729|NCT01964300|527370664|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
146232730|NCT01964300|527370663|FG000|Overall Study|Weight criteria not met|0|||
146232731|NCT01964300|527370664|FG001|Overall Study|Weight criteria not met|1|||
146232732|NCT00557492|527370665|FG000|Overall Study|Change in health insurance|1|||
146232733|NCT03621735|527370667|FG000|Overall Study|Withdrawal by Subject|13|||
146232734|NCT03621735|527370668|FG001|Overall Study|Withdrawal by Subject|13|||
146232735|NCT03875313|527370674|FG000|Overall Study|Withdrawal by Subject|1|||
146232736|NCT03875313|527370675|FG001|Overall Study|Withdrawal by Subject|3|||
146232737|NCT03875313|527370676|FG002|Overall Study|Withdrawal by Subject|0|||
146232738|NCT03875313|527370677|FG003|Overall Study|Withdrawal by Subject|0|||
146232739|NCT03875313|527370678|FG004|Overall Study|Withdrawal by Subject|0|||
146232740|NCT03875313|527370674|FG000|Overall Study|Death|0|||
145888404|NCT01546142|526097797|FG000|Overall Study|Lost to Follow-up|20|||
145888405|NCT01546142|526097798|FG001|Overall Study|Lost to Follow-up|15|||
145888406|NCT01546142|526097797|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
145888407|NCT01546142|526097798|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
145888408|NCT01546142|526097797|FG000|Overall Study|Subject Randomized but Not Treated|1|||
145888409|NCT01546142|526097798|FG001|Overall Study|Subject Randomized but Not Treated|0|||
145888410|NCT04213209|526097808|FG000|Overall Study|Protocol Violation|1|||
145888411|NCT04213209|526097809|FG001|Overall Study|Protocol Violation|0|||
145888412|NCT04213209|526097810|FG002|Overall Study|Protocol Violation|0|||
145888413|NCT04213209|526097811|FG003|Overall Study|Protocol Violation|0|||
145888414|NCT04213209|526097812|FG004|Overall Study|Protocol Violation|0|||
145888415|NCT04213209|526097813|FG005|Overall Study|Protocol Violation|0|||
145888416|NCT02065713|526097817|FG000|Overall Study|Adverse Event|0|||
145888417|NCT02065713|526097818|FG001|Overall Study|Adverse Event|1|||
145888418|NCT02065713|526097817|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145888419|NCT02065713|526097818|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145888420|NCT00685802|526097823|FG000|Washout Period of 7 Days|Protocol Violation|2|||
145888421|NCT00685802|526097824|FG001|Washout Period of 7 Days|Protocol Violation|0|||
145888422|NCT00685802|526097823|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145888423|NCT00685802|526097824|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145888424|NCT00619359|526097825|FG000|Overall Study|Adverse Event|32|||
145888425|NCT00619359|526097826|FG001|Overall Study|Adverse Event|36|||
145888426|NCT00619359|526097825|FG000|Overall Study|Lost to Follow-up|12|||
145888427|NCT00619359|526097826|FG001|Overall Study|Lost to Follow-up|16|||
145888428|NCT00619359|526097825|FG000|Overall Study|Physician Decision|0|||
145888429|NCT00619359|526097826|FG001|Overall Study|Physician Decision|7|||
145888430|NCT00619359|526097825|FG000|Overall Study|Protocol Violation|1|||
145888431|NCT00619359|526097826|FG001|Overall Study|Protocol Violation|1|||
145888432|NCT00619359|526097825|FG000|Overall Study|Withdrawal by Subject|19|||
145888433|NCT00619359|526097826|FG001|Overall Study|Withdrawal by Subject|20|||
145888434|NCT00619359|526097825|FG000|Overall Study|Progressive Disease|3|||
145888435|NCT00619359|526097826|FG001|Overall Study|Progressive Disease|1|||
145888436|NCT00103038|526097827|FG000|Overall Study|Withdrawal by Subject|8|||
145888437|NCT00103038|526097827|FG000|Overall Study|Screen failure|3|||
146292560|NCT00770341|527584411|FG002|Overall Study|Not treated|0|||
146292561|NCT05269355|527584418|FG000|Overall Study|Progressive Disease|104|||
146292562|NCT05269355|527584419|FG001|Overall Study|Progressive Disease|68|||
146292563|NCT05269355|527584418|FG000|Overall Study|Study Terminated by Sponsor|87|||
146292564|NCT05269355|527584419|FG001|Overall Study|Study Terminated by Sponsor|29|||
146292565|NCT05269355|527584418|FG000|Overall Study|Adverse Event|15|||
146292566|NCT05269355|527584419|FG001|Overall Study|Adverse Event|8|||
146292567|NCT05269355|527584418|FG000|Overall Study|Withdrawal by Subject|18|||
146292568|NCT05269355|527584419|FG001|Overall Study|Withdrawal by Subject|5|||
146292569|NCT05269355|527584418|FG000|Overall Study|Physician Decision|6|||
146292570|NCT05269355|527584419|FG001|Overall Study|Physician Decision|4|||
146292571|NCT05269355|527584418|FG000|Overall Study|Death|3|||
146292572|NCT05269355|527584419|FG001|Overall Study|Death|5|||
146292573|NCT05269355|527584418|FG000|Overall Study|Other Than Specified|5|||
146292574|NCT05269355|527584419|FG001|Overall Study|Other Than Specified|1|||
146292575|NCT05269355|527584418|FG000|Overall Study|Randomized But Not Treated|1|||
146292576|NCT05269355|527584419|FG001|Overall Study|Randomized But Not Treated|0|||
146292577|NCT01050790|527584420|FG000|Overall Study|Adverse Event|1|||
146292578|NCT03705832|527584421|FG000|Overall Study|Physician Decision|0|||
146292579|NCT03705832|527584422|FG001|Overall Study|Physician Decision|1|||
146292580|NCT03705832|527584421|FG000|Overall Study|Withdrawal by Subject|1|||
146292581|NCT03705832|527584422|FG001|Overall Study|Withdrawal by Subject|0|||
146292582|NCT00081497|527584423|FG000|Overall Study|Adverse Event|2|||
146292583|NCT00081497|527584424|FG001|Overall Study|Adverse Event|0|||
146292584|NCT00081497|527584423|FG000|Overall Study|Death|0|||
146292585|NCT00081497|527584424|FG001|Overall Study|Death|1|||
146292586|NCT00081497|527584423|FG000|Overall Study|Withdrawal by Subject|1|||
146292587|NCT00081497|527584424|FG001|Overall Study|Withdrawal by Subject|0|||
146292588|NCT00081497|527584423|FG000|Overall Study|Non-compliance|0|||
146292589|NCT00081497|527584424|FG001|Overall Study|Non-compliance|1|||
146292590|NCT02390245|527584425|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
146292591|NCT02390245|527584426|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
146292592|NCT02390245|527584427|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
146292593|NCT02390245|527584425|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
146292594|NCT02390245|527584426|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
146292595|NCT02390245|527584427|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
146292596|NCT02768870|527585860|FG000|Overall Study|Death|1|||
146292597|NCT02768870|527585860|FG000|Overall Study|Reoperation|6|||
146292598|NCT02768870|527585860|FG000|Overall Study|Lost to Follow-up|1|||
146292599|NCT02768870|527585860|FG000|Overall Study|Exit|4|||
146292600|NCT01774110|527585861|FG000|Overall Study|Lost to Follow-up|7|||
146292601|NCT02683941|527585862|FG000|Double-blind Phase|Adverse Event|0|||
146292602|NCT02683941|527585863|FG001|Double-blind Phase|Adverse Event|1|||
146292603|NCT02683941|527585862|FG000|Double-blind Phase|Withdrawal by Subject|4|||
146292604|NCT02683941|527585863|FG001|Double-blind Phase|Withdrawal by Subject|2|||
146292605|NCT02683941|527585862|FG000|Double-blind Phase|Lost to Follow-up|1|||
146292606|NCT02683941|527585863|FG001|Double-blind Phase|Lost to Follow-up|0|||
146292607|NCT02683941|527585862|FG000|Double-blind Phase|Disease Progression|5|||
146292608|NCT02683941|527585863|FG001|Double-blind Phase|Disease Progression|2|||
146292609|NCT02683941|527585862|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
146292610|NCT02683941|527585863|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
146292611|NCT02683941|527585862|FG000|Open-label Treatment Phase|Disease Progression|1|||
146292612|NCT02683941|527585863|FG001|Open-label Treatment Phase|Disease Progression|2|||
146292613|NCT02683941|527585862|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
146292614|NCT02683941|527585863|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
146292615|NCT02683941|527585862|FG000|Open-label Treatment Phase|Other|1|||
146292616|NCT02683941|527585863|FG001|Open-label Treatment Phase|Other|0|||
146292617|NCT02683941|527585862|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
146292618|NCT02683941|527585863|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
146292619|NCT02683941|527585862|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
146292620|NCT02683941|527585863|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
146292621|NCT02683941|527585862|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
146292622|NCT02683941|527585863|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
146292623|NCT02683941|527585862|FG000|Open-label Follow-up Phase|Other|8|||
146292624|NCT02683941|527585863|FG001|Open-label Follow-up Phase|Other|1|||
146292625|NCT00261846|527585864|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
146292626|NCT00261846|527585865|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
146292627|NCT00261846|527585866|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
146292628|NCT00261846|527585867|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292629|NCT00261846|527585868|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292630|NCT00261846|527585869|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292631|NCT00261846|527585870|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145966829|NCT04745351|526393419|FG000|Overall Study|Protocol Violation|1|||
146292632|NCT00261846|527585871|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292633|NCT00261846|527585872|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292634|NCT00261846|527585873|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292635|NCT00261846|527585874|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292636|NCT00261846|527585875|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
146292637|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292638|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292639|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292640|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
146292641|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292642|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292643|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292644|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292645|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
146292646|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292647|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292648|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
146292649|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292650|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292651|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292652|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
146292653|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
146292654|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
146292655|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
146292656|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
146292657|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292658|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
146292659|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292660|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
146292661|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292662|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292663|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292664|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
146292665|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146292666|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292667|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146292668|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292669|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
146292670|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146292671|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
146292672|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
146292673|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
146292674|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
146292675|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
146292676|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
146292677|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
146292678|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
146292679|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
146292680|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
146292681|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
146292682|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
146292683|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
146292684|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
146292685|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
146292686|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
146292687|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
146292688|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
146292689|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
146292690|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
146292691|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
146292692|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
146292693|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
146292694|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
146292695|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
146292696|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
146292697|NCT00261846|527585864|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
146292698|NCT00261846|527585865|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
146292699|NCT00261846|527585866|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
146292700|NCT00261846|527585867|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
146292701|NCT00261846|527585868|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
146292702|NCT00261846|527585869|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
146292703|NCT00261846|527585870|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
146292704|NCT00261846|527585871|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
146292705|NCT00261846|527585872|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
146292706|NCT00261846|527585873|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
146292707|NCT00261846|527585874|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
146292708|NCT00261846|527585875|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
146292709|NCT00325039|527585879|FG000|Overall Study|Lost to Follow-up|18|||
146292710|NCT00325039|527585880|FG001|Overall Study|Lost to Follow-up|14|||
146292711|NCT01776424|527585882|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
146292712|NCT01776424|527585883|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
146292713|NCT01776424|527585884|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
146292714|NCT01776424|527585882|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
146292715|NCT01776424|527585883|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
146292716|NCT01776424|527585884|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
146292717|NCT01776424|527585882|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
146292718|NCT01776424|527585883|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
146292719|NCT01776424|527585884|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
146292720|NCT01776424|527585882|FG000|LTOLE Part (Open Label)|Refused|5|||
146292721|NCT01776424|527585883|FG001|LTOLE Part (Open Label)|Refused|2|||
146292722|NCT01776424|527585884|FG002|LTOLE Part (Open Label)|Refused|11|||
146292723|NCT01776424|527585882|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
146292724|NCT01776424|527585883|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
146292725|NCT01776424|527585884|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
146292726|NCT02121834|527585887|FG000|Overall Study|Protocol Violation|0|||
146292727|NCT02121834|527585888|FG001|Overall Study|Protocol Violation|1|||
146292728|NCT02121834|527585889|FG002|Overall Study|Protocol Violation|0|||
146292729|NCT02121834|527585890|FG003|Overall Study|Protocol Violation|0|||
146292730|NCT02121834|527585891|FG004|Overall Study|Protocol Violation|0|||
146292731|NCT02121834|527585892|FG005|Overall Study|Protocol Violation|0|||
146292732|NCT02121834|527585893|FG006|Overall Study|Protocol Violation|0|||
146292733|NCT02121834|527585887|FG000|Overall Study|Withdrawal by Subject|0|||
146292734|NCT02121834|527585888|FG001|Overall Study|Withdrawal by Subject|1|||
146292735|NCT02121834|527585889|FG002|Overall Study|Withdrawal by Subject|1|||
146292736|NCT02121834|527585890|FG003|Overall Study|Withdrawal by Subject|0|||
146292737|NCT02121834|527585891|FG004|Overall Study|Withdrawal by Subject|0|||
146292738|NCT02121834|527585892|FG005|Overall Study|Withdrawal by Subject|0|||
146292739|NCT02121834|527585893|FG006|Overall Study|Withdrawal by Subject|0|||
146292740|NCT02121834|527585887|FG000|Overall Study|Lost to Follow-up|0|||
146292741|NCT02121834|527585888|FG001|Overall Study|Lost to Follow-up|0|||
146292742|NCT02121834|527585889|FG002|Overall Study|Lost to Follow-up|1|||
146292743|NCT02121834|527585890|FG003|Overall Study|Lost to Follow-up|0|||
146292744|NCT02121834|527585891|FG004|Overall Study|Lost to Follow-up|0|||
146292745|NCT02121834|527585892|FG005|Overall Study|Lost to Follow-up|0|||
146292746|NCT02121834|527585893|FG006|Overall Study|Lost to Follow-up|0|||
146292747|NCT02075541|527585898|FG000|Overall Study|Serious Adverse Event|1|||
146292748|NCT02075541|527585899|FG001|Overall Study|Serious Adverse Event|4|||
146292749|NCT02075541|527585898|FG000|Overall Study|Protocol Violation|1|||
146292750|NCT02075541|527585899|FG001|Overall Study|Protocol Violation|0|||
146292751|NCT02075541|527585898|FG000|Overall Study|Withdrawal by Subject|1|||
146292752|NCT02075541|527585899|FG001|Overall Study|Withdrawal by Subject|3|||
146292753|NCT02075541|527585898|FG000|Overall Study|Sponsor study termination|0|||
146292754|NCT02075541|527585899|FG001|Overall Study|Sponsor study termination|1|||
146292755|NCT02075541|527585898|FG000|Overall Study|Other- unable to perform study procedure|1|||
146292756|NCT02075541|527585899|FG001|Overall Study|Other- unable to perform study procedure|0|||
146292757|NCT02019927|527585903|FG000|Overall Study|Lost to Follow-up|2|||
146292758|NCT02019927|527585904|FG001|Overall Study|Lost to Follow-up|4|||
146292759|NCT02019927|527585905|FG002|Overall Study|Lost to Follow-up|1|||
146292760|NCT02019927|527585906|FG003|Overall Study|Lost to Follow-up|2|||
146292761|NCT02019927|527585907|FG004|Overall Study|Lost to Follow-up|3|||
146292762|NCT02019927|527585908|FG005|Overall Study|Lost to Follow-up|1|||
146292763|NCT01054846|527585909|FG000|Overall Study|Lost to Follow-up|76|||
146292764|NCT01054846|527585910|FG001|Overall Study|Lost to Follow-up|17|||
146292765|NCT00394953|527585913|FG000|First Treatment Period|Adverse Event|1|||
146292766|NCT00394953|527585914|FG001|First Treatment Period|Adverse Event|2|||
146292767|NCT00394953|527585913|FG000|First Treatment Period|Death|6|||
146292768|NCT00394953|527585914|FG001|First Treatment Period|Death|7|||
146292769|NCT00394953|527585913|FG000|First Treatment Period|Lack of Efficacy|1|||
146292770|NCT00394953|527585914|FG001|First Treatment Period|Lack of Efficacy|1|||
146292771|NCT00394953|527585913|FG000|First Treatment Period|Withdrawal by Subject|6|||
146292772|NCT00394953|527585914|FG001|First Treatment Period|Withdrawal by Subject|3|||
146292773|NCT00394953|527585913|FG000|First Treatment Period|Lost to Follow-up|0|||
146292774|NCT00394953|527585914|FG001|First Treatment Period|Lost to Follow-up|1|||
146292775|NCT00394953|527585913|FG000|First Treatment Period|Renal transplant|11|||
146292776|NCT00394953|527585914|FG001|First Treatment Period|Renal transplant|7|||
146292777|NCT00394953|527585913|FG000|First Treatment Period|Not defined|4|||
145966830|NCT04745351|526393420|FG001|Overall Study|Protocol Violation|0|||
145966831|NCT01863771|526393421|FG000|Induction Phase|Adverse Event|9|||
145966832|NCT01863771|526393422|FG001|Induction Phase|Adverse Event|0|||
145966833|NCT01863771|526393423|FG002|Induction Phase|Adverse Event|0|||
145966834|NCT01863771|526393424|FG003|Induction Phase|Adverse Event|0|||
145966835|NCT01863771|526393421|FG000|Induction Phase|Lack of Efficacy|10|||
145966836|NCT01863771|526393422|FG001|Induction Phase|Lack of Efficacy|0|||
145966837|NCT01863771|526393423|FG002|Induction Phase|Lack of Efficacy|0|||
145966838|NCT01863771|526393424|FG003|Induction Phase|Lack of Efficacy|0|||
145966839|NCT01863771|526393421|FG000|Induction Phase|Withdrawal by Subject|2|||
145966840|NCT01863771|526393422|FG001|Induction Phase|Withdrawal by Subject|0|||
145966841|NCT01863771|526393423|FG002|Induction Phase|Withdrawal by Subject|0|||
145966842|NCT01863771|526393424|FG003|Induction Phase|Withdrawal by Subject|0|||
145966843|NCT01863771|526393421|FG000|Maintenance Phase|Adverse Event|0|||
145966844|NCT01863771|526393422|FG001|Maintenance Phase|Adverse Event|0|||
145966845|NCT01863771|526393423|FG002|Maintenance Phase|Adverse Event|1|||
145966846|NCT01863771|526393424|FG003|Maintenance Phase|Adverse Event|1|||
145966847|NCT01863771|526393421|FG000|Maintenance Phase|Lack of Efficacy|0|||
145966848|NCT01863771|526393422|FG001|Maintenance Phase|Lack of Efficacy|3|||
145966849|NCT01863771|526393423|FG002|Maintenance Phase|Lack of Efficacy|7|||
145966850|NCT01863771|526393424|FG003|Maintenance Phase|Lack of Efficacy|38|||
145966851|NCT01863771|526393421|FG000|Maintenance Phase|Physician Decision|0|||
145966852|NCT01863771|526393422|FG001|Maintenance Phase|Physician Decision|0|||
145966853|NCT01863771|526393423|FG002|Maintenance Phase|Physician Decision|2|||
145966854|NCT01863771|526393424|FG003|Maintenance Phase|Physician Decision|1|||
145966855|NCT01863771|526393421|FG000|Maintenance Phase|Pregnancy|0|||
145966856|NCT01863771|526393422|FG001|Maintenance Phase|Pregnancy|1|||
145966857|NCT01863771|526393423|FG002|Maintenance Phase|Pregnancy|0|||
145966858|NCT01863771|526393424|FG003|Maintenance Phase|Pregnancy|0|||
145966859|NCT01863771|526393421|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145966860|NCT01863771|526393422|FG001|Maintenance Phase|Withdrawal by Subject|1|||
145966861|NCT01863771|526393423|FG002|Maintenance Phase|Withdrawal by Subject|2|||
145966862|NCT01863771|526393424|FG003|Maintenance Phase|Withdrawal by Subject|3|||
145966863|NCT03636256|526393425|FG000|Overall Study|Lost to Follow-up|3|||
145966864|NCT03636256|526393426|FG001|Overall Study|Lost to Follow-up|0|||
145966865|NCT03636256|526393427|FG002|Overall Study|Lost to Follow-up|2|||
145966866|NCT03636256|526393428|FG003|Overall Study|Lost to Follow-up|1|||
145966867|NCT03636256|526393429|FG004|Overall Study|Lost to Follow-up|0|||
145966868|NCT03636256|526393430|FG005|Overall Study|Lost to Follow-up|4|||
145966869|NCT03636256|526393431|FG006|Overall Study|Lost to Follow-up|2|||
145966870|NCT03636256|526393432|FG007|Overall Study|Lost to Follow-up|0|||
145966871|NCT03636256|526393433|FG008|Overall Study|Lost to Follow-up|4|||
145966872|NCT03636256|526393425|FG000|Overall Study|Withdrawal by Subject|0|||
145966873|NCT03636256|526393426|FG001|Overall Study|Withdrawal by Subject|0|||
145966874|NCT03636256|526393427|FG002|Overall Study|Withdrawal by Subject|0|||
145966875|NCT03636256|526393428|FG003|Overall Study|Withdrawal by Subject|0|||
145966876|NCT03636256|526393429|FG004|Overall Study|Withdrawal by Subject|0|||
145966877|NCT03636256|526393430|FG005|Overall Study|Withdrawal by Subject|0|||
145966878|NCT03636256|526393431|FG006|Overall Study|Withdrawal by Subject|0|||
145966879|NCT03636256|526393432|FG007|Overall Study|Withdrawal by Subject|0|||
145966880|NCT03636256|526393433|FG008|Overall Study|Withdrawal by Subject|1|||
145966881|NCT02426684|526393434|FG000|Overall Study|Physician Decision|1|||
145966882|NCT01118299|526393435|FG000|Overall Study|Death|7|||
145966883|NCT01118299|526393436|FG001|Overall Study|Death|5|||
145966884|NCT01118299|526393435|FG000|Overall Study|Withdrawal by Subject|8|||
145966885|NCT01118299|526393436|FG001|Overall Study|Withdrawal by Subject|8|||
145966886|NCT01118299|526393435|FG000|Overall Study|Lost to Follow-up|2|||
145966887|NCT01118299|526393436|FG001|Overall Study|Lost to Follow-up|1|||
145966888|NCT01118299|526393435|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
145966889|NCT01118299|526393436|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
145966890|NCT02932943|526393437|FG000|Overall Study|Lost to Follow-up|0|||
145966891|NCT02932943|526393438|FG001|Overall Study|Lost to Follow-up|2|||
145966892|NCT02932943|526393437|FG000|Overall Study|Adverse Event|2|||
145966893|NCT02932943|526393438|FG001|Overall Study|Adverse Event|2|||
145966894|NCT02932943|526393437|FG000|Overall Study|Withdrawal by Subject|3|||
145966895|NCT02932943|526393438|FG001|Overall Study|Withdrawal by Subject|3|||
145966896|NCT02337491|526393439|FG000|Overall Study|Death|1|||
145966897|NCT02337491|526393440|FG001|Overall Study|Death|1|||
145966898|NCT02337491|526393439|FG000|Overall Study|Adverse Event|0|||
145966899|NCT02337491|526393440|FG001|Overall Study|Adverse Event|1|||
145966900|NCT02337491|526393439|FG000|Overall Study|Withdrawal by Subject|3|||
145966901|NCT02337491|526393440|FG001|Overall Study|Withdrawal by Subject|0|||
145966902|NCT02337491|526393439|FG000|Overall Study|Progressive Disease|44|||
145966903|NCT02337491|526393440|FG001|Overall Study|Progressive Disease|28|||
145966904|NCT02337491|526393439|FG000|Overall Study|On Treatment|2|||
145966905|NCT02337491|526393440|FG001|Overall Study|On Treatment|0|||
145966906|NCT00551369|526393442|FG000|Overall Study|Protocol Violation|5|||
146292778|NCT00394953|527585914|FG001|First Treatment Period|Not defined|1|||
146292779|NCT00394953|527585913|FG000|Second Treatment Period|Adverse Event|2|||
146292780|NCT00394953|527585914|FG001|Second Treatment Period|Adverse Event|5|||
146292781|NCT00394953|527585913|FG000|Second Treatment Period|Death|8|||
146292782|NCT00394953|527585914|FG001|Second Treatment Period|Death|4|||
146292783|NCT00394953|527585913|FG000|Second Treatment Period|Lack of Efficacy|9|||
146292784|NCT00394953|527585914|FG001|Second Treatment Period|Lack of Efficacy|47|||
146292785|NCT00394953|527585913|FG000|Second Treatment Period|Withdrawal by Subject|3|||
146292786|NCT00394953|527585914|FG001|Second Treatment Period|Withdrawal by Subject|3|||
146292787|NCT00394953|527585913|FG000|Second Treatment Period|Lost to Follow-up|0|||
146292788|NCT00394953|527585914|FG001|Second Treatment Period|Lost to Follow-up|1|||
146292789|NCT00394953|527585913|FG000|Second Treatment Period|Renal transplant|4|||
146292790|NCT00394953|527585914|FG001|Second Treatment Period|Renal transplant|6|||
146292791|NCT00394953|527585913|FG000|Second Treatment Period|Not defined|3|||
146292792|NCT00394953|527585914|FG001|Second Treatment Period|Not defined|8|||
146292793|NCT00928447|527585921|FG000|Overall Study|Withdrawal by Subject|1|||
146292794|NCT00928447|527585921|FG000|Overall Study|Investigator's decision|1|||
146292795|NCT01259284|527585924|FG000|Overall Study|Study Termination|2|||
146292796|NCT01259284|527585925|FG001|Overall Study|Study Termination|0|||
146292797|NCT01259284|527585926|FG002|Overall Study|Study Termination|0|||
146292798|NCT02196714|527585934|FG000|Overall Study|Protocol Violation|0|||
146292799|NCT02196714|527585935|FG001|Overall Study|Protocol Violation|0|||
146292800|NCT02196714|527585936|FG002|Overall Study|Protocol Violation|1|||
146292801|NCT02196714|527585937|FG003|Overall Study|Protocol Violation|0|||
146292802|NCT01592864|527585939|FG000|Overall Study|Withdrawal by Subject|0|||
146292803|NCT01592864|527585940|FG001|Overall Study|Withdrawal by Subject|1|||
146292804|NCT01326533|527585944|FG000|Overall Study|Lost to Follow-up|2|||
146292805|NCT01326533|527585945|FG001|Overall Study|Lost to Follow-up|0|||
146292806|NCT01326533|527585944|FG000|Overall Study|Withdrawal by Subject|1|||
146292807|NCT01326533|527585945|FG001|Overall Study|Withdrawal by Subject|0|||
146292808|NCT01326533|527585944|FG000|Overall Study|Adverse Event|1|||
146292809|NCT01326533|527585945|FG001|Overall Study|Adverse Event|0|||
146292810|NCT01201265|527585946|FG000|Overall Study|Death|14|||
146292811|NCT01201265|527585946|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146292812|NCT01201265|527585946|FG000|Overall Study|Lost to Follow-up|10|||
146292813|NCT01201265|527585946|FG000|Overall Study|Withdrawal by Subject|7|||
146292814|NCT01201265|527585946|FG000|Overall Study|Disease Progression|4|||
146292815|NCT03343301|527585947|FG000|Overall Study|Withdrawal by Subject|1|||
146292816|NCT03343301|527585948|FG001|Overall Study|Withdrawal by Subject|1|||
146292817|NCT03343301|527585947|FG000|Overall Study|Death|0|||
146292818|NCT03343301|527585948|FG001|Overall Study|Death|2|||
146292819|NCT03343301|527585947|FG000|Overall Study|Other|0|||
146292820|NCT03343301|527585948|FG001|Overall Study|Other|6|||
146292821|NCT03343301|527585947|FG000|Overall Study|Missing|2|||
146292822|NCT03343301|527585948|FG001|Overall Study|Missing|0|||
146292823|NCT00723021|527585959|FG000|Intervention Period 4|Adverse Event|0|||
146292824|NCT00723021|527585960|FG001|Intervention Period 4|Adverse Event|0|||
146292825|NCT00723021|527585961|FG002|Intervention Period 4|Adverse Event|0|||
146292826|NCT00723021|527585962|FG003|Intervention Period 4|Adverse Event|0|||
146292827|NCT00723021|527585963|FG004|Intervention Period 4|Adverse Event|1|||
146292828|NCT04002401|527585966|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
146292829|NCT04002401|527585966|FG000|Overall Study|Death|10|||
146292830|NCT04002401|527585966|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
146292831|NCT04002401|527585966|FG000|Overall Study|Enrolled but Never Treated|1|||
146292832|NCT04002401|527585966|FG000|Overall Study|Lost to Follow-up|1|||
146292833|NCT02337751|527585967|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
146292834|NCT02337751|527585968|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
146292835|NCT02337751|527585967|FG000|Overall Study|Voluntary Withdrawal|6|||
146292836|NCT02337751|527585968|FG001|Overall Study|Voluntary Withdrawal|8|||
146292837|NCT02337751|527585967|FG000|Overall Study|Lack of Efficacy|2|||
146292838|NCT02337751|527585968|FG001|Overall Study|Lack of Efficacy|5|||
146292839|NCT02337751|527585967|FG000|Overall Study|Investigator's Judgement|1|||
146292840|NCT02337751|527585968|FG001|Overall Study|Investigator's Judgement|0|||
146292841|NCT02881957|527585973|FG000|Overall Study|Comfort care|0|||
146292842|NCT02881957|527585974|FG001|Overall Study|Comfort care|1|||
146292843|NCT02881957|527585973|FG000|Overall Study|Concurrent trial enrollment|0|||
146292844|NCT02881957|527585974|FG001|Overall Study|Concurrent trial enrollment|1|||
146292845|NCT02881957|527585973|FG000|Overall Study|Discharged within 48 hours|0|||
146292846|NCT02881957|527585974|FG001|Overall Study|Discharged within 48 hours|1|||
146292847|NCT02881957|527585973|FG000|Overall Study|Withdrawal by Subject|2|||
146292848|NCT02881957|527585974|FG001|Overall Study|Withdrawal by Subject|1|||
146292849|NCT02881957|527585973|FG000|Overall Study|Protocol Violation|1|||
146292850|NCT02881957|527585974|FG001|Overall Study|Protocol Violation|0|||
146292851|NCT00959647|527585981|FG000|Overall Study|Adverse Event|2|||
146292852|NCT00959647|527585981|FG000|Overall Study|Progressive disease|6|||
146292853|NCT00959647|527585981|FG000|Overall Study|Study terminated by sponsor|4|||
146292854|NCT00959647|527585981|FG000|Overall Study|Withdrawal by Subject|7|||
146292855|NCT05959629|527585984|FG000|Overall Study|partially necrotic/technical issues|2|||
146292856|NCT05959629|527585985|FG001|Overall Study|partially necrotic/technical issues|2|||
146292857|NCT01717989|527587544|FG000|Overall Study|Ineligibility determined|6|||
146292858|NCT01717989|527587544|FG000|Overall Study|Protocol deviation|6|||
146292859|NCT01717989|527587544|FG000|Overall Study|Withdrawal by Subject|11|||
146292860|NCT01717989|527587544|FG000|Overall Study|Physician Decision|2|||
146292861|NCT01717989|527587544|FG000|Overall Study|Lost to Follow-up|11|||
146292862|NCT01717989|527587544|FG000|Overall Study|Death|439|||
146292863|NCT01717989|527587544|FG000|Overall Study|Protocol-specified criteria|551|||
146292864|NCT01717989|527587544|FG000|Overall Study|Other|40|||
146292865|NCT03224325|527587545|FG000|Overall Study|Adverse Event|1|||
146292866|NCT03224325|527587546|FG001|Overall Study|Adverse Event|0|||
146292867|NCT03224325|527587547|FG002|Overall Study|Adverse Event|0|||
146292868|NCT03224325|527587548|FG003|Overall Study|Adverse Event|0|||
146292869|NCT03224325|527587549|FG004|Overall Study|Adverse Event|0|||
146292870|NCT03224325|527587550|FG005|Overall Study|Adverse Event|0|||
146292871|NCT03224325|527587551|FG006|Overall Study|Adverse Event|1|||
146292872|NCT03224325|527587545|FG000|Overall Study|Withdrawal by Subject|0|||
146292873|NCT03224325|527587546|FG001|Overall Study|Withdrawal by Subject|0|||
146292874|NCT03224325|527587547|FG002|Overall Study|Withdrawal by Subject|0|||
146292875|NCT03224325|527587548|FG003|Overall Study|Withdrawal by Subject|1|||
146292876|NCT03224325|527587549|FG004|Overall Study|Withdrawal by Subject|0|||
146292877|NCT03224325|527587550|FG005|Overall Study|Withdrawal by Subject|0|||
146292878|NCT03224325|527587551|FG006|Overall Study|Withdrawal by Subject|0|||
146292879|NCT02864381|527587552|FG000|Overall Study|Death|58|||
146292880|NCT02864381|527587553|FG001|Overall Study|Death|61|||
146292881|NCT02864381|527587552|FG000|Overall Study|Withdrew Consent|5|||
146292882|NCT02864381|527587553|FG001|Overall Study|Withdrew Consent|6|||
146292883|NCT02864381|527587552|FG000|Overall Study|Reason Unknown|7|||
146292884|NCT02864381|527587553|FG001|Overall Study|Reason Unknown|3|||
146292885|NCT02864381|527587552|FG000|Overall Study|Lost to Follow-up|1|||
146292886|NCT02864381|527587553|FG001|Overall Study|Lost to Follow-up|1|||
146292887|NCT02864381|527587552|FG000|Overall Study|Investigator's Discretion|1|||
146292888|NCT02864381|527587553|FG001|Overall Study|Investigator's Discretion|0|||
146292889|NCT02864381|527587552|FG000|Overall Study|Protocol Violation|0|||
146292890|NCT02864381|527587553|FG001|Overall Study|Protocol Violation|1|||
146292891|NCT02120625|527587555|FG000|Overall Study|Physician Decision|2|||
146292892|NCT02525861|527587556|FG000|Overall Study|Adverse Event|1|||
146292893|NCT02525861|527587557|FG001|Overall Study|Adverse Event|0|||
146292894|NCT02525861|527587556|FG000|Overall Study|Withdrawal by Subject|0|||
146292895|NCT02525861|527587557|FG001|Overall Study|Withdrawal by Subject|1|||
146292896|NCT02525861|527587556|FG000|Overall Study|Physician Decision|0|||
146292897|NCT02525861|527587557|FG001|Overall Study|Physician Decision|1|||
146292898|NCT03278106|527587561|FG000|Overall Study|No protocol treatment|1|||
146292899|NCT01607554|527587563|FG000|Overall Study|Disease progression|2|||
146292900|NCT03952806|527587564|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
146292901|NCT03952806|527587565|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
146292902|NCT03952806|527587564|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
146292903|NCT03952806|527587565|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
146292904|NCT03952806|527587564|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
146292905|NCT03952806|527587565|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
146292906|NCT03952806|527587564|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
146292907|NCT03952806|527587565|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
146292908|NCT03952806|527587564|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
146292909|NCT03952806|527587565|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
146292910|NCT03952806|527587564|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
146292911|NCT03952806|527587565|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
146292912|NCT03952806|527587564|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
146292913|NCT03952806|527587565|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
146292914|NCT03952806|527587564|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
146292915|NCT03952806|527587565|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
146292916|NCT03952806|527587564|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
146292917|NCT03952806|527587565|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
146292918|NCT03952806|527587564|FG000|OLE Phase (48 Weeks)|Other|16|||
145888438|NCT00103038|526097827|FG000|Overall Study|Death|1|||
146292919|NCT03952806|527587565|FG001|OLE Phase (48 Weeks)|Other|13|||
146292920|NCT01137955|527587566|FG000|Overall Study|Withdrawal by Subject|5|||
146292921|NCT01137955|527587567|FG001|Overall Study|Withdrawal by Subject|4|||
146292922|NCT01211197|527587570|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146292923|NCT01211197|527587571|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146292924|NCT01211197|527587572|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
146292925|NCT01211197|527587573|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146292926|NCT01211197|527587574|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
146292927|NCT01211197|527587575|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145888439|NCT00103038|526097827|FG000|Overall Study|Physician Decision|1|||
146292928|NCT01211197|527587570|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
146292929|NCT01211197|527587571|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
146292930|NCT01211197|527587572|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
146292931|NCT01211197|527587573|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
146292932|NCT01211197|527587574|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
146292933|NCT01211197|527587575|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
146292934|NCT02168842|527587578|FG000|Overall Study|Withdrawal by Subject|5|||
146292935|NCT02168842|527587579|FG001|Overall Study|Withdrawal by Subject|3|||
146292936|NCT02168842|527587578|FG000|Overall Study|Lost to Follow-up|0|||
146292937|NCT02168842|527587579|FG001|Overall Study|Lost to Follow-up|2|||
146292938|NCT02168842|527587578|FG000|Overall Study|Death|2|||
146292939|NCT02168842|527587579|FG001|Overall Study|Death|1|||
146292940|NCT02168842|527587578|FG000|Overall Study|Physician Decision|1|||
146292941|NCT02168842|527587579|FG001|Overall Study|Physician Decision|2|||
146292942|NCT02147353|527587580|FG000|Overall Study|Lost to Follow-up|2|||
146292943|NCT02147353|527587581|FG001|Overall Study|Lost to Follow-up|0|||
145888440|NCT01731886|526097828|FG000|Overall Study|Death|1|||
145888441|NCT01731886|526097829|FG001|Overall Study|Death|0|||
145888442|NCT01731886|526097828|FG000|Overall Study|Never started treatment|0|||
145888443|NCT01731886|526097829|FG001|Overall Study|Never started treatment|1|||
145888444|NCT01731886|526097828|FG000|Overall Study|Non-compliant|1|||
145888445|NCT01731886|526097829|FG001|Overall Study|Non-compliant|0|||
146292944|NCT02147353|527587580|FG000|Overall Study|unable to make visits|4|||
146292945|NCT02147353|527587581|FG001|Overall Study|unable to make visits|0|||
146292946|NCT02147353|527587580|FG000|Overall Study|medication noncompliance|3|||
146292947|NCT02147353|527587581|FG001|Overall Study|medication noncompliance|0|||
146292948|NCT00892723|527587585|FG000|Overall Study|Lost to Follow-up|1|||
146292949|NCT00892723|527587586|FG001|Overall Study|Lost to Follow-up|3|||
146292950|NCT00892723|527587587|FG002|Overall Study|Lost to Follow-up|1|||
146292951|NCT00892723|527587585|FG000|Overall Study|Withdrawal by Subject|1|||
146292952|NCT00892723|527587586|FG001|Overall Study|Withdrawal by Subject|1|||
146292953|NCT00892723|527587587|FG002|Overall Study|Withdrawal by Subject|1|||
146292954|NCT01026454|527587588|FG000|Second Intervention|Pregnancy|1|||
146292955|NCT01026454|527587589|FG001|Second Intervention|Pregnancy|1|||
146292956|NCT01971203|527587590|FG000|Overall Study|Protocol Violation|3|||
146292957|NCT01971203|527587591|FG001|Overall Study|Protocol Violation|2|||
146292958|NCT01971203|527587590|FG000|Overall Study|Withdrawal by Subject|5|||
146292959|NCT01971203|527587591|FG001|Overall Study|Withdrawal by Subject|6|||
146292960|NCT01971203|527587590|FG000|Overall Study|Adverse Event|1|||
146292961|NCT01971203|527587591|FG001|Overall Study|Adverse Event|0|||
146292962|NCT04079803|527587592|FG000|Overall Study|Withdrawal by Subject|0|||
146292963|NCT04079803|527587593|FG001|Overall Study|Withdrawal by Subject|0|||
145888446|NCT02280187|526097830|FG000|Overall Study|Lost to Follow-up|218|||
145888447|NCT00268892|526097833|FG000|Overall Study|Adverse Event|14|||
145888448|NCT00268892|526097834|FG001|Overall Study|Adverse Event|17|||
145888449|NCT00268892|526097835|FG002|Overall Study|Adverse Event|20|||
145888450|NCT00268892|526097833|FG000|Overall Study|Lack of Efficacy|1|||
145888451|NCT00268892|526097834|FG001|Overall Study|Lack of Efficacy|3|||
145888452|NCT00268892|526097835|FG002|Overall Study|Lack of Efficacy|0|||
145888453|NCT00268892|526097833|FG000|Overall Study|Withdrawal by Subject|14|||
145888454|NCT00268892|526097834|FG001|Overall Study|Withdrawal by Subject|15|||
145888455|NCT00268892|526097835|FG002|Overall Study|Withdrawal by Subject|13|||
145888456|NCT00268892|526097833|FG000|Overall Study|Physician Decision|0|||
145888457|NCT00268892|526097834|FG001|Overall Study|Physician Decision|1|||
145888458|NCT00268892|526097835|FG002|Overall Study|Physician Decision|0|||
145888459|NCT00268892|526097833|FG000|Overall Study|Lost to Follow-up|5|||
145888460|NCT00268892|526097834|FG001|Overall Study|Lost to Follow-up|2|||
145888461|NCT00268892|526097835|FG002|Overall Study|Lost to Follow-up|4|||
145888462|NCT00268892|526097833|FG000|Overall Study|Protocol Violation|0|||
145888463|NCT00268892|526097834|FG001|Overall Study|Protocol Violation|1|||
145888464|NCT00268892|526097835|FG002|Overall Study|Protocol Violation|0|||
145888465|NCT00268892|526097833|FG000|Overall Study|Disease Progression|1|||
145888466|NCT00268892|526097834|FG001|Overall Study|Disease Progression|1|||
145888467|NCT00268892|526097835|FG002|Overall Study|Disease Progression|0|||
145888468|NCT00268892|526097833|FG000|Overall Study|Trial Site Closed|4|||
145888469|NCT00268892|526097834|FG001|Overall Study|Trial Site Closed|2|||
145888470|NCT00268892|526097835|FG002|Overall Study|Trial Site Closed|2|||
145888471|NCT02470091|526097842|FG000|Overall Study|Withdrawal by Subject|1|||
145888472|NCT02470091|526097843|FG001|Overall Study|Withdrawal by Subject|0|||
145888473|NCT02470091|526097842|FG000|Overall Study|Ineligible|0|||
145888474|NCT02470091|526097843|FG001|Overall Study|Ineligible|2|||
145888475|NCT01192399|526097854|FG000|Overall Study|Lack of Efficacy|2|||
145888476|NCT00303667|526097855|FG000|Overall Study|Death|0|||
145888477|NCT00303667|526097856|FG001|Overall Study|Death|4|||
145888478|NCT02691741|526097857|FG000|Overall Study|Adverse Event|0|||
145888479|NCT02691741|526097858|FG001|Overall Study|Adverse Event|2|||
145888480|NCT02691741|526097857|FG000|Overall Study|Lost to Follow-up|1|||
146292964|NCT04079803|527587594|FG002|Overall Study|Withdrawal by Subject|1|||
146292965|NCT03353350|527587595|FG000|30-week Core Treatment Period|Protocol Violation|1|||
146292966|NCT03353350|527587596|FG001|30-week Core Treatment Period|Protocol Violation|1|||
146292967|NCT03353350|527587597|FG002|30-week Core Treatment Period|Protocol Violation|1|||
146292968|NCT03353350|527587598|FG003|30-week Core Treatment Period|Protocol Violation|0|||
146292969|NCT03353350|527587595|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146292970|NCT03353350|527587596|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146292971|NCT03353350|527587597|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
146292972|NCT03353350|527587598|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
146292973|NCT03353350|527587595|FG000|30-week Core Treatment Period|Adverse Event|0|||
146292974|NCT03353350|527587596|FG001|30-week Core Treatment Period|Adverse Event|4|||
146292975|NCT03353350|527587597|FG002|30-week Core Treatment Period|Adverse Event|2|||
146292976|NCT03353350|527587598|FG003|30-week Core Treatment Period|Adverse Event|3|||
146292977|NCT03353350|527587595|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
145966907|NCT00551369|526393442|FG000|Overall Study|Withdrawal by Subject|1|||
145966908|NCT00551369|526393442|FG000|Overall Study|Not treated per protocol and re|1|||
145966909|NCT02251275|526393443|FG000|Overall Study|Adverse Event|23|||
145966910|NCT02251275|526393444|FG001|Overall Study|Adverse Event|60|||
145966911|NCT02251275|526393445|FG002|Overall Study|Adverse Event|28|||
145966912|NCT02251275|526393446|FG003|Overall Study|Adverse Event|0|||
145966913|NCT02251275|526393447|FG004|Overall Study|Adverse Event|0|||
145966914|NCT02251275|526393443|FG000|Overall Study|Lost to Follow-up|5|||
145966915|NCT02251275|526393444|FG001|Overall Study|Lost to Follow-up|6|||
145966916|NCT02251275|526393445|FG002|Overall Study|Lost to Follow-up|4|||
145966917|NCT02251275|526393446|FG003|Overall Study|Lost to Follow-up|0|||
145966918|NCT02251275|526393447|FG004|Overall Study|Lost to Follow-up|0|||
145966919|NCT02251275|526393443|FG000|Overall Study|Physician Decision|19|||
145966920|NCT02251275|526393444|FG001|Overall Study|Physician Decision|30|||
145966921|NCT02251275|526393445|FG002|Overall Study|Physician Decision|26|||
145966922|NCT02251275|526393446|FG003|Overall Study|Physician Decision|0|||
145966923|NCT02251275|526393447|FG004|Overall Study|Physician Decision|1|||
145966924|NCT02251275|526393443|FG000|Overall Study|Protocol Deviation|0|||
145966925|NCT02251275|526393444|FG001|Overall Study|Protocol Deviation|0|||
145966926|NCT02251275|526393445|FG002|Overall Study|Protocol Deviation|1|||
145966927|NCT02251275|526393446|FG003|Overall Study|Protocol Deviation|0|||
145966928|NCT02251275|526393447|FG004|Overall Study|Protocol Deviation|0|||
145966929|NCT02251275|526393443|FG000|Overall Study|Withdrawal by Subject|25|||
145966930|NCT02251275|526393444|FG001|Overall Study|Withdrawal by Subject|51|||
145966931|NCT02251275|526393445|FG002|Overall Study|Withdrawal by Subject|35|||
145966932|NCT02251275|526393446|FG003|Overall Study|Withdrawal by Subject|1|||
145966933|NCT02251275|526393447|FG004|Overall Study|Withdrawal by Subject|0|||
145966934|NCT02152007|526393448|FG000|Overall Study|Withdrawal by Subject|1|||
145966935|NCT01302899|526393453|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
145966936|NCT01302899|526393454|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
145966937|NCT01302899|526393453|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
145966938|NCT01302899|526393454|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
145966939|NCT02497469|526393455|FG000|Overall Study|Randomized but not Treated|0|||
145966940|NCT02497469|526393456|FG001|Overall Study|Randomized but not Treated|2|||
145966941|NCT02497469|526393455|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
145966942|NCT02497469|526393456|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
145966943|NCT02497469|526393455|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
145966944|NCT02497469|526393456|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
145966945|NCT02497469|526393455|FG000|Overall Study|Significant Protocol Deviation|4|||
145966946|NCT02497469|526393456|FG001|Overall Study|Significant Protocol Deviation|5|||
145966947|NCT02497469|526393455|FG000|Overall Study|Lost to Follow-up|14|||
145966948|NCT02497469|526393456|FG001|Overall Study|Lost to Follow-up|4|||
145966949|NCT02497469|526393455|FG000|Overall Study|Voluntary Withdrawal|39|||
145966950|NCT02497469|526393456|FG001|Overall Study|Voluntary Withdrawal|41|||
145966951|NCT02497469|526393455|FG000|Overall Study|Pregnancy|1|||
145966952|NCT02497469|526393456|FG001|Overall Study|Pregnancy|1|||
145966953|NCT02497469|526393455|FG000|Overall Study|Lack of Efficacy|86|||
145966954|NCT02497469|526393456|FG001|Overall Study|Lack of Efficacy|40|||
145966955|NCT02497469|526393455|FG000|Overall Study|Reason not Specified|6|||
145966956|NCT02497469|526393456|FG001|Overall Study|Reason not Specified|6|||
145966957|NCT00472420|526393457|FG000|Induction Treatment Period|Physician Decision|9|||
146292978|NCT03353350|527587596|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
146292979|NCT03353350|527587597|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
146292980|NCT03353350|527587598|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
145966958|NCT00472420|526393457|FG000|Induction Treatment Period|Adverse Event|3|||
145966959|NCT00472420|526393457|FG000|Induction Treatment Period|Non-compliance|1|||
145966960|NCT00472420|526393457|FG000|Induction Treatment Period|Death|3|||
145966961|NCT00472420|526393457|FG000|Follow-up Period|Death|5|||
145966962|NCT00472420|526393457|FG000|Follow-up Period|Physician Decision|9|||
145966963|NCT00472420|526393457|FG000|Follow-up Period|Lost to Follow-up|2|||
145966964|NCT00472420|526393457|FG000|Follow-up Period|Protocol Violation|1|||
145966965|NCT02785939|526393465|FG000|Overall Study|Progression|25|||
145966966|NCT02785939|526393466|FG001|Overall Study|Progression|8|||
146232741|NCT03875313|527370675|FG001|Overall Study|Death|0|||
145966967|NCT02785939|526393465|FG000|Overall Study|Adverse Event|3|||
145966968|NCT02785939|526393466|FG001|Overall Study|Adverse Event|1|||
145966969|NCT02785939|526393465|FG000|Overall Study|Death|1|||
145966970|NCT02785939|526393466|FG001|Overall Study|Death|0|||
145966971|NCT02785939|526393465|FG000|Overall Study|Refusal|1|||
145966972|NCT02785939|526393466|FG001|Overall Study|Refusal|0|||
145966973|NCT02785939|526393465|FG000|Overall Study|Deteriorating health|1|||
145966974|NCT02785939|526393466|FG001|Overall Study|Deteriorating health|0|||
145966975|NCT02785939|526393465|FG000|Overall Study|Not protocol specified|0|||
145966976|NCT02785939|526393466|FG001|Overall Study|Not protocol specified|1|||
145966977|NCT01787552|526393469|FG000|Overall Study|Withdrawal by Subject|2|||
145966978|NCT01787552|526393470|FG001|Overall Study|Withdrawal by Subject|0|||
145966979|NCT01787552|526393471|FG002|Overall Study|Withdrawal by Subject|0|||
145966980|NCT01787552|526393472|FG003|Overall Study|Withdrawal by Subject|4|||
145966981|NCT01787552|526393469|FG000|Overall Study|Physician Decision|2|||
145966982|NCT01787552|526393470|FG001|Overall Study|Physician Decision|2|||
145966983|NCT01787552|526393471|FG002|Overall Study|Physician Decision|1|||
145966984|NCT01787552|526393472|FG003|Overall Study|Physician Decision|2|||
145966985|NCT01787552|526393469|FG000|Overall Study|Death|0|||
145966986|NCT01787552|526393470|FG001|Overall Study|Death|0|||
145966987|NCT01787552|526393471|FG002|Overall Study|Death|0|||
145966988|NCT01787552|526393472|FG003|Overall Study|Death|1|||
145966989|NCT01787552|526393469|FG000|Overall Study|Adverse Event|2|||
145966990|NCT01787552|526393470|FG001|Overall Study|Adverse Event|5|||
145966991|NCT01787552|526393471|FG002|Overall Study|Adverse Event|2|||
145966992|NCT01787552|526393472|FG003|Overall Study|Adverse Event|16|||
145966993|NCT01787552|526393469|FG000|Overall Study|Study terminated by Sponsor|0|||
145966994|NCT01787552|526393470|FG001|Overall Study|Study terminated by Sponsor|0|||
145966995|NCT01787552|526393471|FG002|Overall Study|Study terminated by Sponsor|1|||
145966996|NCT01787552|526393472|FG003|Overall Study|Study terminated by Sponsor|3|||
145966997|NCT01787552|526393469|FG000|Overall Study|Progressive Disease|2|||
145966998|NCT01787552|526393470|FG001|Overall Study|Progressive Disease|2|||
145966999|NCT01787552|526393471|FG002|Overall Study|Progressive Disease|1|||
145967000|NCT01787552|526393472|FG003|Overall Study|Progressive Disease|1|||
145967001|NCT05412134|526393476|FG000|Overall Study|Lost to Follow-up|2|||
145967002|NCT05412134|526393477|FG001|Overall Study|Lost to Follow-up|0|||
145967003|NCT00423046|526393479|FG000|Overall Study|Other|340|||
145967004|NCT00423046|526393480|FG001|Overall Study|Other|345|||
145967005|NCT01118052|526393489|FG000|Overall Study|Never treated|2|||
145967006|NCT00843492|526393492|FG000|Overall Study|Adverse Event|0|||
145967007|NCT00843492|526393493|FG001|Overall Study|Adverse Event|3|||
145967008|NCT00843492|526393492|FG000|Overall Study|Lost to Follow-up|4|||
145967009|NCT00843492|526393493|FG001|Overall Study|Lost to Follow-up|4|||
145967010|NCT00843492|526393492|FG000|Overall Study|Withdrawal by Subject|0|||
145967011|NCT00843492|526393493|FG001|Overall Study|Withdrawal by Subject|4|||
145967012|NCT00843492|526393492|FG000|Overall Study|Immobilization Stopped|1|||
146232742|NCT03875313|527370676|FG002|Overall Study|Death|0|||
146232743|NCT03875313|527370677|FG003|Overall Study|Death|0|||
146232744|NCT03875313|527370678|FG004|Overall Study|Death|1|||
146232745|NCT03875313|527370674|FG000|Overall Study|Lost to Follow-up|0|||
146232746|NCT03875313|527370675|FG001|Overall Study|Lost to Follow-up|0|||
146232747|NCT03875313|527370676|FG002|Overall Study|Lost to Follow-up|0|||
146232748|NCT03875313|527370677|FG003|Overall Study|Lost to Follow-up|0|||
146232749|NCT03875313|527370678|FG004|Overall Study|Lost to Follow-up|1|||
146232750|NCT03875313|527370674|FG000|Overall Study|Study Termination by Sponsor|0|||
146232751|NCT03875313|527370675|FG001|Overall Study|Study Termination by Sponsor|1|||
146232752|NCT03875313|527370676|FG002|Overall Study|Study Termination by Sponsor|1|||
146232753|NCT03875313|527370677|FG003|Overall Study|Study Termination by Sponsor|0|||
146232754|NCT03875313|527370678|FG004|Overall Study|Study Termination by Sponsor|1|||
146232755|NCT03875313|527370674|FG000|Overall Study|New Anticancer Treatment|0|||
146232756|NCT03875313|527370675|FG001|Overall Study|New Anticancer Treatment|1|||
146232757|NCT03875313|527370676|FG002|Overall Study|New Anticancer Treatment|2|||
146232758|NCT03875313|527370677|FG003|Overall Study|New Anticancer Treatment|1|||
146232759|NCT03875313|527370678|FG004|Overall Study|New Anticancer Treatment|0|||
146232760|NCT03875313|527370674|FG000|Overall Study|Other, Not Specified|2|||
146232761|NCT03875313|527370675|FG001|Overall Study|Other, Not Specified|11|||
146232762|NCT03875313|527370676|FG002|Overall Study|Other, Not Specified|3|||
146232763|NCT03875313|527370677|FG003|Overall Study|Other, Not Specified|3|||
146232764|NCT03875313|527370678|FG004|Overall Study|Other, Not Specified|1|||
146232765|NCT04121546|527370679|FG000|Overall Study|Lost to Follow-up|1|||
146232766|NCT04121546|527370680|FG001|Overall Study|Lost to Follow-up|3|||
146232767|NCT00686595|527370681|FG000|Overall Study|Adverse Event|3|||
146232768|NCT00686595|527370681|FG000|Overall Study|Protocol Violation|1|||
146232769|NCT00686595|527370681|FG000|Overall Study|Lost to Follow-up|1|||
146232770|NCT00686595|527370681|FG000|Overall Study|Lack of Efficacy|1|||
146232771|NCT00686595|527370681|FG000|Overall Study|Poor Compliance|1|||
146232772|NCT03286114|527370687|FG000|Overall Study|Adverse Event|6|||
146292981|NCT03353350|527587595|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
146292982|NCT03353350|527587596|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
146292983|NCT03353350|527587597|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
145967013|NCT00843492|526393493|FG001|Overall Study|Immobilization Stopped|0|||
145967014|NCT00843492|526393492|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
145967015|NCT00843492|526393493|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
145967016|NCT00843492|526393492|FG000|Overall Study|Orthopedic Surgery|0|||
145967017|NCT00843492|526393493|FG001|Overall Study|Orthopedic Surgery|2|||
145967018|NCT00843492|526393492|FG000|Overall Study|Visit Not Performed|1|||
145967019|NCT00843492|526393493|FG001|Overall Study|Visit Not Performed|0|||
145967020|NCT00843492|526393492|FG000|Overall Study|Deep-vein Thrombosis|1|||
145967021|NCT00843492|526393493|FG001|Overall Study|Deep-vein Thrombosis|0|||
145967022|NCT00369343|526393494|FG000|Double-blind Phase|Adverse Event|19|||
145967023|NCT00369343|526393495|FG001|Double-blind Phase|Adverse Event|4|||
145967024|NCT00369343|526393494|FG000|Double-blind Phase|Failed to return|2|||
145967025|NCT00369343|526393495|FG001|Double-blind Phase|Failed to return|0|||
145967026|NCT00369343|526393494|FG000|Double-blind Phase|Lost to Follow-up|9|||
145967027|NCT00369343|526393495|FG001|Double-blind Phase|Lost to Follow-up|2|||
145967028|NCT00369343|526393494|FG000|Double-blind Phase|Protocol Violation|2|||
145967029|NCT00369343|526393495|FG001|Double-blind Phase|Protocol Violation|0|||
145967030|NCT00369343|526393494|FG000|Double-blind Phase|Withdrawal by Subject|8|||
145967031|NCT00369343|526393495|FG001|Double-blind Phase|Withdrawal by Subject|6|||
145967032|NCT00369343|526393494|FG000|Double-blind Phase|Lack of Efficacy|0|||
145967033|NCT00369343|526393495|FG001|Double-blind Phase|Lack of Efficacy|4|||
145967034|NCT00369343|526393494|FG000|Double-blind Phase|Protocol deviation|4|||
145967035|NCT00369343|526393495|FG001|Double-blind Phase|Protocol deviation|0|||
145967036|NCT00369343|526393494|FG000|Open-label Phase|Adverse Event|19|||
145967037|NCT00369343|526393495|FG001|Open-label Phase|Adverse Event|7|||
146292984|NCT03353350|527587598|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
146292985|NCT03353350|527587595|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
146292986|NCT03353350|527587596|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
145888481|NCT02691741|526097858|FG001|Overall Study|Lost to Follow-up|0|||
145888482|NCT02691741|526097857|FG000|Overall Study|Physician Decision|0|||
145888483|NCT02691741|526097858|FG001|Overall Study|Physician Decision|1|||
145888484|NCT02691741|526097857|FG000|Overall Study|Withdrawal by Subject|0|||
145888485|NCT02691741|526097858|FG001|Overall Study|Withdrawal by Subject|4|||
145888486|NCT02139124|526097859|FG000|Overall Study|Adverse Event|2|||
145888487|NCT02139124|526097860|FG001|Overall Study|Adverse Event|0|||
145888488|NCT02139124|526097861|FG002|Overall Study|Adverse Event|1|||
145888489|NCT02139124|526097862|FG003|Overall Study|Adverse Event|2|||
145888490|NCT02139124|526097863|FG004|Overall Study|Adverse Event|5|||
145888491|NCT02139124|526097859|FG000|Overall Study|Withdrawal by Subject|2|||
145888492|NCT02139124|526097860|FG001|Overall Study|Withdrawal by Subject|2|||
145888493|NCT02139124|526097861|FG002|Overall Study|Withdrawal by Subject|2|||
145888494|NCT02139124|526097862|FG003|Overall Study|Withdrawal by Subject|2|||
145888495|NCT02139124|526097863|FG004|Overall Study|Withdrawal by Subject|3|||
145888496|NCT02139124|526097859|FG000|Overall Study|Protocol Violation|0|||
145888497|NCT02139124|526097860|FG001|Overall Study|Protocol Violation|0|||
145888498|NCT02139124|526097861|FG002|Overall Study|Protocol Violation|0|||
145888499|NCT02139124|526097862|FG003|Overall Study|Protocol Violation|1|||
145888500|NCT02139124|526097863|FG004|Overall Study|Protocol Violation|1|||
145888501|NCT02139124|526097859|FG000|Overall Study|non-compliant|1|||
145888502|NCT02139124|526097860|FG001|Overall Study|non-compliant|0|||
145888503|NCT02139124|526097861|FG002|Overall Study|non-compliant|0|||
145888504|NCT02139124|526097862|FG003|Overall Study|non-compliant|2|||
145888505|NCT02139124|526097863|FG004|Overall Study|non-compliant|0|||
145888506|NCT02139124|526097859|FG000|Overall Study|incarceration|0|||
145888507|NCT02139124|526097860|FG001|Overall Study|incarceration|0|||
145888508|NCT02139124|526097861|FG002|Overall Study|incarceration|1|||
145888509|NCT02139124|526097862|FG003|Overall Study|incarceration|0|||
145888510|NCT02139124|526097863|FG004|Overall Study|incarceration|0|||
145888511|NCT02139124|526097859|FG000|Overall Study|subject moved|1|||
145888512|NCT02139124|526097860|FG001|Overall Study|subject moved|0|||
145888513|NCT02139124|526097861|FG002|Overall Study|subject moved|0|||
145888514|NCT02139124|526097862|FG003|Overall Study|subject moved|0|||
145888515|NCT02139124|526097863|FG004|Overall Study|subject moved|0|||
145888516|NCT02139124|526097859|FG000|Overall Study|Lost to Follow-up|3|||
145888517|NCT02139124|526097860|FG001|Overall Study|Lost to Follow-up|2|||
145888518|NCT02139124|526097861|FG002|Overall Study|Lost to Follow-up|0|||
145888519|NCT02139124|526097862|FG003|Overall Study|Lost to Follow-up|5|||
145888520|NCT02139124|526097863|FG004|Overall Study|Lost to Follow-up|4|||
145888521|NCT02244424|526097864|FG000|Overall Study|Lost to Follow-up|20|||
145888522|NCT02244424|526097865|FG001|Overall Study|Lost to Follow-up|10|||
145888523|NCT00402025|526097866|FG000|Overall Study|Adverse Event|0|||
145967038|NCT00369343|526393494|FG000|Open-label Phase|Failed to return|4|||
145888524|NCT00402025|526097867|FG001|Overall Study|Adverse Event|0|||
145888525|NCT00402025|526097868|FG002|Overall Study|Adverse Event|2|||
146292987|NCT03353350|527587597|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
146292988|NCT03353350|527587598|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
146292989|NCT03353350|527587595|FG000|26-week Treatment Extension Period|Adverse Event|1|||
146292990|NCT03353350|527587596|FG001|26-week Treatment Extension Period|Adverse Event|0|||
146292991|NCT03353350|527587597|FG002|26-week Treatment Extension Period|Adverse Event|0|||
146292992|NCT03353350|527587598|FG003|26-week Treatment Extension Period|Adverse Event|1|||
146292993|NCT03353350|527587595|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
146292994|NCT03353350|527587596|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
146292995|NCT03353350|527587597|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
146292996|NCT03353350|527587598|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
146292997|NCT03037619|527587599|FG000|Overall Study|Lost to Follow-up|0|||
146292998|NCT03037619|527587600|FG001|Overall Study|Lost to Follow-up|1|||
146292999|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
146293000|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
146293001|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
146293002|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
146293003|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
146293004|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
146293005|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
146293006|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
146293007|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
146293008|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
146293009|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
146293010|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
146293011|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
146293012|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
146293013|NCT01294683|527587603|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
146293014|NCT01294683|527587604|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
146293015|NCT01294683|527587603|FG000|Post Crossover (Period III)|Adverse Event|6|||
146293016|NCT01294683|527587604|FG001|Post Crossover (Period III)|Adverse Event|6|||
146293017|NCT01294683|527587603|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
146293018|NCT01294683|527587604|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
146293019|NCT01294683|527587603|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
145967039|NCT00369343|526393495|FG001|Open-label Phase|Failed to return|0|||
145967040|NCT00369343|526393494|FG000|Open-label Phase|Physician Decision|2|||
145967041|NCT00369343|526393495|FG001|Open-label Phase|Physician Decision|0|||
145967042|NCT00369343|526393494|FG000|Open-label Phase|Lost to Follow-up|5|||
145967043|NCT00369343|526393495|FG001|Open-label Phase|Lost to Follow-up|3|||
145967044|NCT00369343|526393494|FG000|Open-label Phase|inadvertently reported study completers|3|||
145967045|NCT00369343|526393495|FG001|Open-label Phase|inadvertently reported study completers|2|||
145967046|NCT00369343|526393494|FG000|Open-label Phase|Protocol Violation|1|||
145967047|NCT00369343|526393495|FG001|Open-label Phase|Protocol Violation|3|||
145967048|NCT00369343|526393494|FG000|Open-label Phase|Withdrawal by Subject|15|||
145967049|NCT00369343|526393495|FG001|Open-label Phase|Withdrawal by Subject|6|||
145967050|NCT00369343|526393494|FG000|Open-label Phase|Lack of Efficacy|4|||
145967051|NCT00369343|526393495|FG001|Open-label Phase|Lack of Efficacy|3|||
145967052|NCT00369343|526393494|FG000|Open-label Phase|Lack of continuance tolerability|3|||
145967053|NCT00369343|526393495|FG001|Open-label Phase|Lack of continuance tolerability|4|||
145967054|NCT00369343|526393494|FG000|Open-label Phase|did not take study drug|1|||
145967055|NCT00369343|526393495|FG001|Open-label Phase|did not take study drug|2|||
145967056|NCT00794664|526393496|FG000|Treatment Period|Withdrawal by Subject|0|||
145967057|NCT00794664|526393497|FG001|Treatment Period|Withdrawal by Subject|2|||
145967058|NCT00794664|526393496|FG000|Treatment Period|Protocol non-compliance|0|||
145967059|NCT00794664|526393497|FG001|Treatment Period|Protocol non-compliance|1|||
145967060|NCT00794664|526393496|FG000|Treatment Period|Other|0|||
145967061|NCT00794664|526393497|FG001|Treatment Period|Other|1|||
145967062|NCT00794664|526393496|FG000|Treatment Period|Adverse Event|1|||
145967063|NCT00794664|526393497|FG001|Treatment Period|Adverse Event|8|||
145967064|NCT00794664|526393496|FG000|Follow-up Period|Other|1|||
145967065|NCT00794664|526393497|FG001|Follow-up Period|Other|2|||
145967066|NCT00794664|526393496|FG000|Follow-up Period|Withdrawal by Subject|0|||
145967067|NCT00794664|526393497|FG001|Follow-up Period|Withdrawal by Subject|2|||
145967068|NCT00794664|526393496|FG000|Follow-up Period|Protocol non-compliance|0|||
145967069|NCT00794664|526393497|FG001|Follow-up Period|Protocol non-compliance|1|||
145967070|NCT00828711|526393500|FG000|Overall Study|Lost to Follow-up|1|||
145967071|NCT00828711|526393501|FG001|Overall Study|Lost to Follow-up|0|||
145967072|NCT00828711|526393502|FG002|Overall Study|Lost to Follow-up|0|||
145967073|NCT01618968|526393503|FG000|Overall Study|Adverse Event|1|||
145967074|NCT01618968|526393504|FG001|Overall Study|Adverse Event|0|||
145967075|NCT01618968|526393505|FG002|Overall Study|Adverse Event|0|||
145967076|NCT01618968|526393506|FG003|Overall Study|Adverse Event|0|||
145967077|NCT01618968|526393503|FG000|Overall Study|Death|0|||
145967078|NCT01618968|526393504|FG001|Overall Study|Death|0|||
145967079|NCT01618968|526393505|FG002|Overall Study|Death|0|||
145967080|NCT01618968|526393506|FG003|Overall Study|Death|1|||
145967081|NCT03087058|526393512|FG000|Overall Study|Withdrawal by Subject|2|||
145967082|NCT03087058|526393513|FG001|Overall Study|Withdrawal by Subject|0|||
145967083|NCT03087058|526393514|FG002|Overall Study|Withdrawal by Subject|0|||
145967084|NCT00769561|526393516|FG000|Overall Study|Withdrawal by Subject|2|||
145967085|NCT00769561|526393517|FG001|Overall Study|Withdrawal by Subject|2|||
145967086|NCT00769561|526393516|FG000|Overall Study|Lost to Follow-up|1|||
145967087|NCT00769561|526393517|FG001|Overall Study|Lost to Follow-up|3|||
145967088|NCT01441973|526393527|FG000|Overall Study|Disease progression|8|||
145967089|NCT01441973|526393528|FG001|Overall Study|Disease progression|6|||
145967090|NCT01441973|526393527|FG000|Overall Study|Adverse event unrelated to study drug|3|||
145967091|NCT01441973|526393528|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145967092|NCT01441973|526393527|FG000|Overall Study|Participant request to discontinue|1|||
145967093|NCT01441973|526393528|FG001|Overall Study|Participant request to discontinue|1|||
145967094|NCT01441973|526393527|FG000|Overall Study|Poor compliance/noncompliance|0|||
145967095|NCT01441973|526393528|FG001|Overall Study|Poor compliance/noncompliance|1|||
145967096|NCT01441973|526393527|FG000|Overall Study|Administrative reason by sponsor|3|||
145967097|NCT01441973|526393528|FG001|Overall Study|Administrative reason by sponsor|5|||
145967098|NCT01441973|526393527|FG000|Overall Study|Participant withdrew consent|0|||
145967099|NCT01441973|526393528|FG001|Overall Study|Participant withdrew consent|1|||
145967100|NCT00617279|526393532|FG000|Overall Study|Study terminated by Sponsor|10|||
145967101|NCT00617279|526393533|FG001|Overall Study|Study terminated by Sponsor|15|||
145967102|NCT00617279|526393532|FG000|Overall Study|Graft abandonment|2|||
145967103|NCT00617279|526393533|FG001|Overall Study|Graft abandonment|0|||
145967104|NCT00617279|526393532|FG000|Overall Study|Lost to Follow-up|1|||
145967105|NCT00617279|526393533|FG001|Overall Study|Lost to Follow-up|0|||
145967106|NCT00617279|526393532|FG000|Overall Study|Death|1|||
145967107|NCT00617279|526393533|FG001|Overall Study|Death|2|||
145967108|NCT01855958|526395336|FG000|Overall Study|Withdrawal by Subject|1|||
145967109|NCT01855958|526395337|FG001|Overall Study|Withdrawal by Subject|0|||
145967110|NCT00499122|526395338|FG000|Overall Study|Withdrawal by Subject|2|||
145967111|NCT03312738|526395339|FG000|Overall Study|Progressive disease|58|||
145967112|NCT03312738|526395340|FG001|Overall Study|Progressive disease|67|||
146293020|NCT01294683|527587604|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
146293021|NCT01294683|527587603|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
146293022|NCT01294683|527587604|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
146293023|NCT01794923|527587605|FG000|Overall Study|Adverse Event|0|||
146293024|NCT01794923|527587606|FG001|Overall Study|Adverse Event|0|||
146293025|NCT01794923|527587607|FG002|Overall Study|Adverse Event|1|||
146293026|NCT01881750|527587612|FG000|Overall Study|Changes in concomitant therapies|2|||
146293027|NCT01881750|527587613|FG001|Overall Study|Changes in concomitant therapies|3|||
146293028|NCT01881750|527587612|FG000|Overall Study|Lost to Follow-up|0|||
146293029|NCT01881750|527587613|FG001|Overall Study|Lost to Follow-up|1|||
146293030|NCT00307125|527587616|FG000|Screening Phase|Adverse Event|1|||
146293031|NCT00307125|527587617|FG001|Screening Phase|Adverse Event|0|||
146293032|NCT00307125|527587618|FG002|Screening Phase|Adverse Event|0|||
146293033|NCT00307125|527587616|FG000|Screening Phase|Protocol Violation|27|||
146293034|NCT00307125|527587617|FG001|Screening Phase|Protocol Violation|0|||
146293035|NCT00307125|527587618|FG002|Screening Phase|Protocol Violation|0|||
146293036|NCT00307125|527587616|FG000|Screening Phase|Lost to Follow-up|87|||
146293037|NCT00307125|527587617|FG001|Screening Phase|Lost to Follow-up|0|||
146293038|NCT00307125|527587618|FG002|Screening Phase|Lost to Follow-up|0|||
146293039|NCT00307125|527587616|FG000|Screening Phase|Death|10|||
146293040|NCT00307125|527587617|FG001|Screening Phase|Death|0|||
146293041|NCT00307125|527587618|FG002|Screening Phase|Death|0|||
146293042|NCT00307125|527587616|FG000|Screening Phase|Withdrawal by Subject|77|||
146293043|NCT00307125|527587617|FG001|Screening Phase|Withdrawal by Subject|0|||
146293044|NCT00307125|527587618|FG002|Screening Phase|Withdrawal by Subject|0|||
146293045|NCT00307125|527587616|FG000|Screening Phase|Physician Decision|26|||
146293046|NCT00307125|527587617|FG001|Screening Phase|Physician Decision|0|||
146293047|NCT00307125|527587618|FG002|Screening Phase|Physician Decision|0|||
146293048|NCT00307125|527587616|FG000|Screening Phase|Sponsor Decision|4|||
146293049|NCT00307125|527587617|FG001|Screening Phase|Sponsor Decision|0|||
146293050|NCT00307125|527587618|FG002|Screening Phase|Sponsor Decision|0|||
146293051|NCT00307125|527587616|FG000|Screening Phase|Study Terminated|17|||
146293052|NCT00307125|527587617|FG001|Screening Phase|Study Terminated|0|||
146293053|NCT00307125|527587618|FG002|Screening Phase|Study Terminated|0|||
145888526|NCT00402025|526097866|FG000|Overall Study|Death|0|||
145888527|NCT00402025|526097867|FG001|Overall Study|Death|1|||
145888528|NCT00402025|526097868|FG002|Overall Study|Death|5|||
145888529|NCT00402025|526097866|FG000|Overall Study|Disease Progression|1|||
145888530|NCT00402025|526097867|FG001|Overall Study|Disease Progression|1|||
146293054|NCT00307125|527587616|FG000|Screening Phase|Graft Loss|3|||
146293055|NCT00307125|527587617|FG001|Screening Phase|Graft Loss|0|||
146293056|NCT00307125|527587618|FG002|Screening Phase|Graft Loss|0|||
146293057|NCT00307125|527587616|FG000|Screening Phase|Graft Failure|8|||
146293058|NCT00307125|527587617|FG001|Screening Phase|Graft Failure|0|||
145888531|NCT00402025|526097868|FG002|Overall Study|Disease Progression|2|||
146293059|NCT00307125|527587618|FG002|Screening Phase|Graft Failure|0|||
146293060|NCT00307125|527587616|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
146293061|NCT00307125|527587617|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
146293062|NCT00307125|527587618|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
146293063|NCT00307125|527587616|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
146232773|NCT03286114|527370687|FG000|Overall Study|Death|3|||
146232774|NCT01260896|527370693|FG000|First Intervention|Withdrawn Due to Emesis|2|||
146232775|NCT01260896|527370694|FG001|First Intervention|Withdrawn Due to Emesis|0|||
146232776|NCT00982644|527370695|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
146232777|NCT00982644|527370696|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
146232778|NCT00982644|527370695|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
146232779|NCT00982644|527370696|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
146232780|NCT00982644|527370695|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
146232781|NCT00982644|527370696|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
146232782|NCT00982644|527370695|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
146232783|NCT00982644|527370696|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
146232784|NCT00982644|527370695|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
146232785|NCT00982644|527370696|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
146232786|NCT00982644|527370695|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
146232787|NCT00982644|527370696|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
146232788|NCT00982644|527370695|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
146232789|NCT00982644|527370696|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
146232790|NCT00982644|527370695|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
146232791|NCT00982644|527370696|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
146232792|NCT00982644|527370695|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
146232793|NCT00982644|527370696|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
146232794|NCT00982644|527370695|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
146232795|NCT00982644|527370696|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
146232796|NCT00943917|527370699|FG000|Stage I|Adverse Event|1|||
146232797|NCT00943917|527370700|FG001|Stage I|Adverse Event|2|||
146232798|NCT00943917|527370701|FG002|Stage I|Adverse Event|2|||
146232799|NCT00943917|527370702|FG003|Stage I|Adverse Event|0|||
146232800|NCT00943917|527370703|FG004|Stage I|Adverse Event|0|||
146232801|NCT00943917|527370704|FG005|Stage I|Adverse Event|0|||
146232802|NCT00943917|527370705|FG006|Stage I|Adverse Event|0|||
146232803|NCT00943917|527370706|FG007|Stage I|Adverse Event|0|||
146232804|NCT00943917|527370707|FG008|Stage I|Adverse Event|0|||
146232805|NCT00943917|527370708|FG009|Stage I|Adverse Event|0|||
146232806|NCT00943917|527370709|FG010|Stage I|Adverse Event|0|||
146232807|NCT00943917|527370710|FG011|Stage I|Adverse Event|0|||
146293064|NCT00307125|527587617|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
146293065|NCT00307125|527587618|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
146293066|NCT00307125|527587616|FG000|Screening Phase|Moved or transferred facilities|34|||
146293067|NCT00307125|527587617|FG001|Screening Phase|Moved or transferred facilities|0|||
146293068|NCT00307125|527587618|FG002|Screening Phase|Moved or transferred facilities|0|||
146293069|NCT00307125|527587616|FG000|Screening Phase|Received Pancreas Transplant|8|||
146293070|NCT00307125|527587617|FG001|Screening Phase|Received Pancreas Transplant|0|||
146293071|NCT00307125|527587618|FG002|Screening Phase|Received Pancreas Transplant|0|||
146293072|NCT00307125|527587616|FG000|Screening Phase|Ineligible for pilot|4|||
146293073|NCT00307125|527587617|FG001|Screening Phase|Ineligible for pilot|0|||
146293074|NCT00307125|527587618|FG002|Screening Phase|Ineligible for pilot|0|||
146293075|NCT00307125|527587616|FG000|Screening Phase|Try to get pregnant|1|||
145888532|NCT00402025|526097866|FG000|Overall Study|Physician Decision|1|||
145888533|NCT00402025|526097867|FG001|Overall Study|Physician Decision|1|||
146293076|NCT00307125|527587617|FG001|Screening Phase|Try to get pregnant|0|||
146293077|NCT00307125|527587618|FG002|Screening Phase|Try to get pregnant|0|||
146293078|NCT00307125|527587616|FG000|Screening Phase|Developed acute leukemia|1|||
146293079|NCT00307125|527587617|FG001|Screening Phase|Developed acute leukemia|0|||
146293080|NCT00307125|527587618|FG002|Screening Phase|Developed acute leukemia|0|||
146293081|NCT00307125|527587616|FG000|Screening Phase|Metastatic colon cancer|1|||
146293082|NCT00307125|527587617|FG001|Screening Phase|Metastatic colon cancer|0|||
146293083|NCT00307125|527587618|FG002|Screening Phase|Metastatic colon cancer|0|||
146293084|NCT00307125|527587616|FG000|Screening Phase|Malignancy|1|||
146293085|NCT00307125|527587617|FG001|Screening Phase|Malignancy|0|||
146293086|NCT00307125|527587618|FG002|Screening Phase|Malignancy|0|||
145888534|NCT00402025|526097868|FG002|Overall Study|Physician Decision|0|||
146293087|NCT00307125|527587616|FG000|Screening Phase|PAK|1|||
146293088|NCT00307125|527587617|FG001|Screening Phase|PAK|0|||
146293089|NCT00307125|527587618|FG002|Screening Phase|PAK|0|||
146293090|NCT00307125|527587616|FG000|Screening Phase|Ineligible|1|||
146293091|NCT00307125|527587617|FG001|Screening Phase|Ineligible|0|||
146293092|NCT00307125|527587618|FG002|Screening Phase|Ineligible|0|||
146293093|NCT00307125|527587616|FG000|Screening Phase|Screen Error|1|||
146293094|NCT00307125|527587617|FG001|Screening Phase|Screen Error|0|||
146293095|NCT00307125|527587618|FG002|Screening Phase|Screen Error|0|||
146293096|NCT00307125|527587616|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
146293097|NCT00307125|527587617|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
146293098|NCT00307125|527587618|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
146293099|NCT00307125|527587616|FG000|Screening Phase|AMR and treated with rituximab|1|||
146293100|NCT00307125|527587617|FG001|Screening Phase|AMR and treated with rituximab|0|||
146293101|NCT00307125|527587618|FG002|Screening Phase|AMR and treated with rituximab|0|||
146293102|NCT00307125|527587616|FG000|Screening Phase|Coronary artery bypass|1|||
146293103|NCT00307125|527587617|FG001|Screening Phase|Coronary artery bypass|0|||
146293104|NCT00307125|527587618|FG002|Screening Phase|Coronary artery bypass|0|||
146293105|NCT00307125|527587616|FG000|Pilot Phase|Lost to Follow-up|0|||
146293106|NCT00307125|527587617|FG001|Pilot Phase|Lost to Follow-up|1|||
146293107|NCT00307125|527587618|FG002|Pilot Phase|Lost to Follow-up|0|||
146293108|NCT00307125|527587616|FG000|Pilot Phase|Withdrawal by Subject|0|||
146293109|NCT00307125|527587617|FG001|Pilot Phase|Withdrawal by Subject|1|||
146293110|NCT00307125|527587618|FG002|Pilot Phase|Withdrawal by Subject|1|||
146293111|NCT00807235|527587621|FG000|Overall Study|Adverse Event|1|||
146293112|NCT00807235|527587622|FG001|Overall Study|Adverse Event|0|||
146293113|NCT00926211|527587623|FG000|Overall Study|Lost to Follow-up|1|||
146293114|NCT01032382|527587626|FG000|Overall Study|Disease dissemination|1|||
146293115|NCT01032382|527587627|FG001|Overall Study|Disease dissemination|1|||
146293116|NCT01032382|527587626|FG000|Overall Study|Treatment failure|3|||
146293117|NCT01032382|527587627|FG001|Overall Study|Treatment failure|1|||
146293118|NCT01032382|527587626|FG000|Overall Study|Index lesion relapse|1|||
146293119|NCT01032382|527587627|FG001|Overall Study|Index lesion relapse|3|||
146293120|NCT02571049|527587628|FG000|Screening|Did not meet entry criteria|2|||
146293121|NCT02571049|527587629|FG001|Screening|Did not meet entry criteria|2|||
146293122|NCT02571049|527587628|FG000|Randomization|No migraine attack|0|||
146293123|NCT02571049|527587629|FG001|Randomization|No migraine attack|1|||
146293124|NCT02571049|527587628|FG000|Randomization|Adverse Event|0|||
146293125|NCT02571049|527587629|FG001|Randomization|Adverse Event|1|||
145888535|NCT00402025|526097866|FG000|Overall Study|Participant Decision|0|||
145888536|NCT00402025|526097867|FG001|Overall Study|Participant Decision|0|||
145888537|NCT00402025|526097868|FG002|Overall Study|Participant Decision|1|||
145888538|NCT03366194|526097873|FG000|Overall Study|Lost to Follow-up|2|||
146293126|NCT00985153|527587630|FG000|Overall Study|Lost to Follow-up|16|||
146293127|NCT00985153|527587631|FG001|Overall Study|Lost to Follow-up|19|||
146293128|NCT00985153|527587632|FG002|Overall Study|Lost to Follow-up|17|||
146293129|NCT00985153|527587633|FG003|Overall Study|Lost to Follow-up|20|||
146293130|NCT00985153|527587630|FG000|Overall Study|Protocol Violation|3|||
146293131|NCT00985153|527587631|FG001|Overall Study|Protocol Violation|2|||
146293132|NCT00985153|527587632|FG002|Overall Study|Protocol Violation|4|||
146293133|NCT00985153|527587633|FG003|Overall Study|Protocol Violation|3|||
146293134|NCT00985153|527587630|FG000|Overall Study|Withdrawal by Subject|6|||
146293135|NCT00985153|527587631|FG001|Overall Study|Withdrawal by Subject|11|||
146293136|NCT00985153|527587632|FG002|Overall Study|Withdrawal by Subject|11|||
146293137|NCT00985153|527587633|FG003|Overall Study|Withdrawal by Subject|10|||
146293138|NCT00985153|527587630|FG000|Overall Study|Missed One or More Bleeds|7|||
146293139|NCT00985153|527587631|FG001|Overall Study|Missed One or More Bleeds|7|||
146293140|NCT00985153|527587632|FG002|Overall Study|Missed One or More Bleeds|8|||
145888539|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145888540|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
145888541|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145888542|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145888543|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
145888544|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
146293141|NCT00985153|527587633|FG003|Overall Study|Missed One or More Bleeds|10|||
146293142|NCT00985153|527587630|FG000|Overall Study|Incomplete Safety Follow-up|3|||
145888545|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
145888546|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
146293143|NCT00985153|527587631|FG001|Overall Study|Incomplete Safety Follow-up|5|||
146086777|NCT04153149|526838382|FG000|Double Blind Period|Lost to Follow-up|2|||
145888547|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
145888548|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145888549|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145888550|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145888551|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Death|0|||
145888552|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Death|1|||
145888553|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Death|0|||
145888554|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Death|0|||
145888555|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
145888556|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
145888557|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
145888558|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
145888559|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
145888560|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145888561|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145888562|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145888563|NCT00545688|526097881|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
145888564|NCT00545688|526097882|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
145888565|NCT00545688|526097883|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
145888566|NCT00545688|526097884|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
145888567|NCT00545688|526097881|FG000|Adjuvant Treatment Period|Disease Progression|3|||
145888568|NCT00545688|526097882|FG001|Adjuvant Treatment Period|Disease Progression|3|||
145888569|NCT00545688|526097883|FG002|Adjuvant Treatment Period|Disease Progression|0|||
145888570|NCT00545688|526097884|FG003|Adjuvant Treatment Period|Disease Progression|7|||
145888571|NCT00545688|526097881|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
145888572|NCT00545688|526097882|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
145888573|NCT00545688|526097883|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
145888574|NCT00545688|526097884|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
145888575|NCT00545688|526097881|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
145888576|NCT00545688|526097882|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
145888577|NCT00545688|526097883|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
145888578|NCT00545688|526097884|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
145888579|NCT00545688|526097881|FG000|Adjuvant Treatment Period|Adverse Event|0|||
145967113|NCT03312738|526395339|FG000|Overall Study|Patient/guardian decision|13|||
145967114|NCT03312738|526395340|FG001|Overall Study|Patient/guardian decision|5|||
145967115|NCT03312738|526395339|FG000|Overall Study|Adverse Event|5|||
145967116|NCT03312738|526395340|FG001|Overall Study|Adverse Event|3|||
145967117|NCT03312738|526395339|FG000|Overall Study|Protocol deviation|2|||
145967118|NCT03312738|526395340|FG001|Overall Study|Protocol deviation|0|||
145967119|NCT03312738|526395339|FG000|Overall Study|Technical problems|0|||
145967120|NCT03312738|526395340|FG001|Overall Study|Technical problems|1|||
145967121|NCT03312738|526395339|FG000|Overall Study|Physician Decision|2|||
145967122|NCT03312738|526395340|FG001|Overall Study|Physician Decision|3|||
145967123|NCT02466399|526395347|FG000|Overall Study|Adverse Event|1|||
145967124|NCT02466399|526395348|FG001|Overall Study|Adverse Event|0|||
145967125|NCT02466399|526395347|FG000|Overall Study|Early exit due to family emergency|1|||
145967126|NCT02466399|526395348|FG001|Overall Study|Early exit due to family emergency|0|||
145967127|NCT04539275|526395349|FG000|Overall Study|Death|2|||
145967128|NCT04539275|526395350|FG001|Overall Study|Death|4|||
145967129|NCT04539275|526395349|FG000|Overall Study|Lost to Follow-up|1|||
145967130|NCT04539275|526395350|FG001|Overall Study|Lost to Follow-up|1|||
145967131|NCT04539275|526395349|FG000|Overall Study|Withdrawal by Subject|3|||
145967132|NCT04539275|526395350|FG001|Overall Study|Withdrawal by Subject|0|||
145967133|NCT00607893|526395351|FG000|Overall Study|Lost to Follow-up|4|||
145967134|NCT00607893|526395352|FG001|Overall Study|Lost to Follow-up|0|||
145967135|NCT00607893|526395351|FG000|Overall Study|withdrew due to loss of interest|0|||
145967136|NCT00607893|526395352|FG001|Overall Study|withdrew due to loss of interest|1|||
145967137|NCT00607893|526395351|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
145967138|NCT00607893|526395352|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
145967139|NCT00607893|526395351|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
145967140|NCT00607893|526395352|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
145967141|NCT00607893|526395351|FG000|Overall Study|Declined to be treated|1|||
145967142|NCT00607893|526395352|FG001|Overall Study|Declined to be treated|0|||
145967143|NCT00607893|526395351|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
145967144|NCT00607893|526395352|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
145967145|NCT01799941|526395353|FG000|Overall Study|Adverse Event|34|||
145967146|NCT01799941|526395353|FG000|Overall Study|Withdrawal by Subject|21|||
145967147|NCT01799941|526395353|FG000|Overall Study|Death|2|||
145967148|NCT01799941|526395353|FG000|Overall Study|Investigator Decision|4|||
145967149|NCT01799941|526395353|FG000|Overall Study|Lack of Efficacy|3|||
145967150|NCT01799941|526395353|FG000|Overall Study|Lost to Follow-up|17|||
145967151|NCT01799941|526395353|FG000|Overall Study|Other|15|||
145967152|NCT00606008|526395361|FG000|Overall Study|Adverse Event|1|||
145967153|NCT00606008|526395361|FG000|Overall Study|Withdrawal by Subject|4|||
145967154|NCT02014272|526395367|FG000|Intervention Period 1|Withdrawal by Subject|1|||
145967155|NCT02014272|526395368|FG001|Intervention Period 1|Withdrawal by Subject|0|||
145967156|NCT02014272|526395367|FG000|Intervention Period 1|Adverse Event|0|||
145967157|NCT02014272|526395368|FG001|Intervention Period 1|Adverse Event|1|||
145967158|NCT00547339|526395369|FG000|Overall Study|Physician Decision|0|||
145967159|NCT00547339|526395370|FG001|Overall Study|Physician Decision|0|||
145967160|NCT00547339|526395371|FG002|Overall Study|Physician Decision|1|||
145967161|NCT00547339|526395372|FG003|Overall Study|Physician Decision|0|||
145967162|NCT02369653|526395373|FG000|Overall Study|Lost to Follow-up|0|||
145967163|NCT02369653|526395374|FG001|Overall Study|Lost to Follow-up|1|||
145967164|NCT02369653|526395373|FG000|Overall Study|Administrative reason by sponsor|0|||
145967165|NCT02369653|526395374|FG001|Overall Study|Administrative reason by sponsor|1|||
145967166|NCT02369653|526395373|FG000|Overall Study|Death|1|||
145967167|NCT02369653|526395374|FG001|Overall Study|Death|2|||
146086778|NCT04153149|526838383|FG001|Double Blind Period|Lost to Follow-up|1|||
146232808|NCT00943917|527370711|FG012|Stage I|Adverse Event|0|||
145967168|NCT02369653|526395373|FG000|Overall Study|Participant withdrew consent|13|||
146232809|NCT00943917|527370712|FG013|Stage I|Adverse Event|0|||
146293144|NCT00985153|527587632|FG002|Overall Study|Incomplete Safety Follow-up|4|||
146293145|NCT00985153|527587633|FG003|Overall Study|Incomplete Safety Follow-up|4|||
146293146|NCT01055262|527587636|FG000|Overall Study|Adverse Event|5|||
146293147|NCT01055262|527587636|FG000|Overall Study|Protocol Violation|3|||
146293148|NCT01055262|527587636|FG000|Overall Study|Uncooperativeness|1|||
146293149|NCT03370471|527587637|FG000|Overall Study|Withdrawal by Subject|6|||
146293150|NCT03370471|527587638|FG001|Overall Study|Withdrawal by Subject|1|||
146293151|NCT03370471|527587637|FG000|Overall Study|Unable to access veins for blood draw|0|||
145888580|NCT00545688|526097882|FG001|Adjuvant Treatment Period|Adverse Event|3|||
145888581|NCT00545688|526097883|FG002|Adjuvant Treatment Period|Adverse Event|2|||
145888582|NCT00545688|526097884|FG003|Adjuvant Treatment Period|Adverse Event|2|||
145888583|NCT00545688|526097881|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
145888584|NCT00545688|526097882|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
146293152|NCT03370471|527587638|FG001|Overall Study|Unable to access veins for blood draw|1|||
146293153|NCT03370471|527587637|FG000|Overall Study|Screen fail|1|||
145967169|NCT02369653|526395374|FG001|Overall Study|Participant withdrew consent|3|||
145967170|NCT01458587|526395375|FG000|Overall Study|Withdrawal by Subject|1|||
146232810|NCT00943917|527370713|FG014|Stage I|Adverse Event|0|||
146232811|NCT00943917|527370699|FG000|Stage I|Lost to Follow-up|0|||
146232812|NCT00943917|527370700|FG001|Stage I|Lost to Follow-up|0|||
145967171|NCT01458587|526395376|FG001|Overall Study|Withdrawal by Subject|0|||
145967172|NCT01603602|526395377|FG000|Overall Study|Adverse Event|1|||
145967173|NCT01603602|526395378|FG001|Overall Study|Adverse Event|0|||
145967174|NCT01603602|526395379|FG002|Overall Study|Adverse Event|0|||
145967175|NCT01603602|526395377|FG000|Overall Study|Personal Reasons|1|||
146232813|NCT00943917|527370701|FG002|Stage I|Lost to Follow-up|1|||
146232814|NCT00943917|527370702|FG003|Stage I|Lost to Follow-up|0|||
146232815|NCT00943917|527370703|FG004|Stage I|Lost to Follow-up|0|||
146232816|NCT00943917|527370704|FG005|Stage I|Lost to Follow-up|0|||
146232817|NCT00943917|527370705|FG006|Stage I|Lost to Follow-up|0|||
146232818|NCT00943917|527370706|FG007|Stage I|Lost to Follow-up|0|||
146232819|NCT00943917|527370707|FG008|Stage I|Lost to Follow-up|0|||
146232820|NCT00943917|527370708|FG009|Stage I|Lost to Follow-up|0|||
146232821|NCT00943917|527370709|FG010|Stage I|Lost to Follow-up|0|||
146232822|NCT00943917|527370710|FG011|Stage I|Lost to Follow-up|0|||
146232823|NCT00943917|527370711|FG012|Stage I|Lost to Follow-up|0|||
146232824|NCT00943917|527370712|FG013|Stage I|Lost to Follow-up|0|||
146232825|NCT00943917|527370713|FG014|Stage I|Lost to Follow-up|0|||
146232826|NCT00943917|527370699|FG000|Stage I|hyperglycemia|0|||
145967176|NCT01603602|526395378|FG001|Overall Study|Personal Reasons|0|||
145967177|NCT01603602|526395379|FG002|Overall Study|Personal Reasons|1|||
145888585|NCT00545688|526097883|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
145888586|NCT00545688|526097884|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
145888587|NCT00545688|526097881|FG000|Follow-Up Period|Death|4|||
145888588|NCT00545688|526097882|FG001|Follow-Up Period|Death|2|||
145888589|NCT00545688|526097883|FG002|Follow-Up Period|Death|2|||
145888590|NCT00545688|526097884|FG003|Follow-Up Period|Death|6|||
145888591|NCT00545688|526097881|FG000|Follow-Up Period|Disease Progression|6|||
145888592|NCT00545688|526097882|FG001|Follow-Up Period|Disease Progression|5|||
145888593|NCT00545688|526097883|FG002|Follow-Up Period|Disease Progression|9|||
145888594|NCT00545688|526097884|FG003|Follow-Up Period|Disease Progression|9|||
145888595|NCT00545688|526097881|FG000|Follow-Up Period|Refused Treatment|6|||
145888596|NCT00545688|526097882|FG001|Follow-Up Period|Refused Treatment|2|||
145888597|NCT00545688|526097883|FG002|Follow-Up Period|Refused Treatment|0|||
145888598|NCT00545688|526097884|FG003|Follow-Up Period|Refused Treatment|2|||
145888599|NCT00545688|526097881|FG000|Follow-Up Period|Lost to Follow-up|3|||
145888600|NCT00545688|526097882|FG001|Follow-Up Period|Lost to Follow-up|3|||
145888601|NCT00545688|526097883|FG002|Follow-Up Period|Lost to Follow-up|3|||
145888602|NCT00545688|526097884|FG003|Follow-Up Period|Lost to Follow-up|1|||
145888603|NCT00545688|526097881|FG000|Follow-Up Period|Unspecified Reason|2|||
145888604|NCT00545688|526097882|FG001|Follow-Up Period|Unspecified Reason|5|||
145888605|NCT00545688|526097883|FG002|Follow-Up Period|Unspecified Reason|6|||
145888606|NCT00545688|526097884|FG003|Follow-Up Period|Unspecified Reason|8|||
145967178|NCT00958074|526395381|FG000|Overall Study|Withdrawal by Subject|0|||
145888607|NCT00545688|526097881|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
145888608|NCT00545688|526097882|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
145888609|NCT00545688|526097883|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
145888610|NCT00545688|526097884|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
145888611|NCT01961687|526099013|FG000|Overall Study|Lost to Follow-up|19|||
145888612|NCT01961687|526099013|FG000|Overall Study|Re-operation|17|||
145888613|NCT01961687|526099013|FG000|Overall Study|Death|7|||
145888614|NCT01961687|526099013|FG000|Overall Study|Withdrawal by Subject|6|||
145888615|NCT01961687|526099013|FG000|Overall Study|Adverse Event|6|||
145888616|NCT01961687|526099013|FG000|Overall Study|Moved to area without study site|2|||
145888617|NCT01961687|526099013|FG000|Overall Study|Sponsor decision|2|||
145888618|NCT01961687|526099013|FG000|Overall Study|Physician Decision|1|||
146232827|NCT00943917|527370700|FG001|Stage I|hyperglycemia|0|||
146232828|NCT00943917|527370701|FG002|Stage I|hyperglycemia|1|||
146232829|NCT00943917|527370702|FG003|Stage I|hyperglycemia|0|||
146232830|NCT00943917|527370703|FG004|Stage I|hyperglycemia|0|||
146232831|NCT00943917|527370704|FG005|Stage I|hyperglycemia|0|||
146232832|NCT00943917|527370705|FG006|Stage I|hyperglycemia|0|||
146232833|NCT00943917|527370706|FG007|Stage I|hyperglycemia|0|||
146232834|NCT00943917|527370707|FG008|Stage I|hyperglycemia|0|||
146232835|NCT00943917|527370708|FG009|Stage I|hyperglycemia|0|||
146232836|NCT00943917|527370709|FG010|Stage I|hyperglycemia|0|||
146232837|NCT00943917|527370710|FG011|Stage I|hyperglycemia|0|||
146232838|NCT00943917|527370711|FG012|Stage I|hyperglycemia|0|||
146232839|NCT00943917|527370712|FG013|Stage I|hyperglycemia|0|||
146232840|NCT00943917|527370713|FG014|Stage I|hyperglycemia|0|||
146232841|NCT00943917|527370699|FG000|Stage I|A1C elevation|1|||
146232842|NCT00943917|527370700|FG001|Stage I|A1C elevation|0|||
146232843|NCT00943917|527370701|FG002|Stage I|A1C elevation|0|||
146232844|NCT00943917|527370702|FG003|Stage I|A1C elevation|0|||
146232845|NCT00943917|527370703|FG004|Stage I|A1C elevation|0|||
146232846|NCT00943917|527370704|FG005|Stage I|A1C elevation|0|||
146232847|NCT00943917|527370705|FG006|Stage I|A1C elevation|0|||
146232848|NCT00943917|527370706|FG007|Stage I|A1C elevation|0|||
146232849|NCT00943917|527370707|FG008|Stage I|A1C elevation|0|||
146232850|NCT00943917|527370708|FG009|Stage I|A1C elevation|0|||
146232851|NCT00943917|527370709|FG010|Stage I|A1C elevation|0|||
146232852|NCT00943917|527370710|FG011|Stage I|A1C elevation|0|||
146232853|NCT00943917|527370711|FG012|Stage I|A1C elevation|0|||
146232854|NCT00943917|527370712|FG013|Stage I|A1C elevation|0|||
146232855|NCT00943917|527370713|FG014|Stage I|A1C elevation|0|||
146232856|NCT00943917|527370699|FG000|Stage I|Withdrawal by Subject|2|||
146232857|NCT00943917|527370700|FG001|Stage I|Withdrawal by Subject|1|||
146232858|NCT00943917|527370701|FG002|Stage I|Withdrawal by Subject|2|||
146232859|NCT00943917|527370702|FG003|Stage I|Withdrawal by Subject|0|||
146232860|NCT00943917|527370703|FG004|Stage I|Withdrawal by Subject|0|||
146232861|NCT00943917|527370704|FG005|Stage I|Withdrawal by Subject|0|||
146232862|NCT00943917|527370705|FG006|Stage I|Withdrawal by Subject|0|||
146232863|NCT00943917|527370706|FG007|Stage I|Withdrawal by Subject|0|||
146232864|NCT00943917|527370707|FG008|Stage I|Withdrawal by Subject|0|||
146232865|NCT00943917|527370708|FG009|Stage I|Withdrawal by Subject|0|||
146232866|NCT00943917|527370709|FG010|Stage I|Withdrawal by Subject|0|||
146232867|NCT00943917|527370710|FG011|Stage I|Withdrawal by Subject|0|||
146232868|NCT00943917|527370711|FG012|Stage I|Withdrawal by Subject|0|||
146232869|NCT00943917|527370712|FG013|Stage I|Withdrawal by Subject|0|||
146232870|NCT00943917|527370713|FG014|Stage I|Withdrawal by Subject|0|||
146232871|NCT00943917|527370699|FG000|Stage II|Adverse Event|0|||
146232872|NCT00943917|527370700|FG001|Stage II|Adverse Event|0|||
146232873|NCT00943917|527370701|FG002|Stage II|Adverse Event|0|||
146232874|NCT00943917|527370702|FG003|Stage II|Adverse Event|0|||
146232875|NCT00943917|527370703|FG004|Stage II|Adverse Event|0|||
146232876|NCT00943917|527370704|FG005|Stage II|Adverse Event|1|||
146232877|NCT00943917|527370705|FG006|Stage II|Adverse Event|3|||
146232878|NCT00943917|527370706|FG007|Stage II|Adverse Event|0|||
146232879|NCT00943917|527370707|FG008|Stage II|Adverse Event|1|||
146232880|NCT00943917|527370708|FG009|Stage II|Adverse Event|0|||
146232881|NCT00943917|527370709|FG010|Stage II|Adverse Event|0|||
146232882|NCT00943917|527370710|FG011|Stage II|Adverse Event|0|||
146232883|NCT00943917|527370711|FG012|Stage II|Adverse Event|0|||
146232884|NCT00943917|527370712|FG013|Stage II|Adverse Event|0|||
146232885|NCT00943917|527370713|FG014|Stage II|Adverse Event|0|||
146232886|NCT00943917|527370699|FG000|Stage II|Withdrawal by Subject|0|||
146232887|NCT00943917|527370700|FG001|Stage II|Withdrawal by Subject|0|||
145967179|NCT00958074|526395382|FG001|Overall Study|Withdrawal by Subject|1|||
145967180|NCT03712280|526395385|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
145967181|NCT03712280|526395386|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
146232888|NCT00943917|527370701|FG002|Stage II|Withdrawal by Subject|0|||
145967182|NCT03712280|526395387|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
145967183|NCT03712280|526395388|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
145967184|NCT03712280|526395385|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
145967185|NCT03712280|526395386|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
145967186|NCT03712280|526395387|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
145967187|NCT03712280|526395388|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
145967188|NCT03712280|526395385|FG000|Overall Study|Adverse Event|0|||
145967189|NCT03712280|526395386|FG001|Overall Study|Adverse Event|0|||
145967190|NCT03712280|526395387|FG002|Overall Study|Adverse Event|1|||
145967191|NCT03712280|526395388|FG003|Overall Study|Adverse Event|0|||
145967192|NCT03530293|526395392|FG000|Pre-randomization|Adverse Event|12|||
145967193|NCT03530293|526395393|FG001|Pre-randomization|Adverse Event|0|||
145967194|NCT03530293|526395394|FG002|Pre-randomization|Adverse Event|0|||
145967195|NCT03530293|526395392|FG000|Pre-randomization|Protocol Violation|2|||
145967196|NCT03530293|526395393|FG001|Pre-randomization|Protocol Violation|0|||
145967197|NCT03530293|526395394|FG002|Pre-randomization|Protocol Violation|0|||
145967198|NCT03530293|526395392|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
145967199|NCT03530293|526395393|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
145967200|NCT03530293|526395394|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
145967201|NCT03530293|526395392|FG000|Pre-randomization|Withdrawal by Subject|5|||
145967202|NCT03530293|526395393|FG001|Pre-randomization|Withdrawal by Subject|0|||
145967203|NCT03530293|526395394|FG002|Pre-randomization|Withdrawal by Subject|0|||
145967204|NCT03530293|526395392|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
145967205|NCT03530293|526395393|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
145967206|NCT03530293|526395394|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
145967207|NCT03530293|526395392|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
145967208|NCT03530293|526395393|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
145967209|NCT03530293|526395394|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
145967210|NCT03530293|526395392|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
145967211|NCT03530293|526395393|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
145967212|NCT03530293|526395394|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
145967213|NCT03530293|526395392|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
145967214|NCT03530293|526395393|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
145967215|NCT03530293|526395394|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
145967216|NCT03530293|526395392|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
145967217|NCT03530293|526395393|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
145967218|NCT03530293|526395394|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
145967219|NCT01663623|526395395|FG000|Overall Study|Adverse Event|3|||
145967220|NCT01663623|526395396|FG001|Overall Study|Adverse Event|7|||
145967221|NCT01663623|526395395|FG000|Overall Study|Lack of Efficacy|5|||
145967222|NCT01663623|526395396|FG001|Overall Study|Lack of Efficacy|6|||
145967223|NCT01663623|526395395|FG000|Overall Study|Protocol Violation|0|||
145967224|NCT01663623|526395396|FG001|Overall Study|Protocol Violation|1|||
145967225|NCT01663623|526395395|FG000|Overall Study|Other-Study closed/terminated|1|||
145967226|NCT01663623|526395396|FG001|Overall Study|Other-Study closed/terminated|1|||
145967227|NCT01663623|526395395|FG000|Overall Study|Physician Decision|1|||
146232889|NCT00943917|527370702|FG003|Stage II|Withdrawal by Subject|0|||
145967228|NCT01663623|526395396|FG001|Overall Study|Physician Decision|4|||
145967229|NCT01663623|526395395|FG000|Overall Study|Withdrawal by Subject|2|||
145967230|NCT01663623|526395396|FG001|Overall Study|Withdrawal by Subject|1|||
145967231|NCT03307174|526395397|FG000|Overall Study|Unplanned ICU Administrion|5|||
145967232|NCT03307174|526395398|FG001|Overall Study|Unplanned ICU Administrion|3|||
145967233|NCT03307174|526395397|FG000|Overall Study|Aborted Surgery|1|||
145967234|NCT03307174|526395398|FG001|Overall Study|Aborted Surgery|2|||
145967235|NCT03307174|526395397|FG000|Overall Study|Hypotension|6|||
146086779|NCT04153149|526838384|FG002|Double Blind Period|Lost to Follow-up|0|||
146086780|NCT04153149|526838385|FG003|Double Blind Period|Lost to Follow-up|0|||
146086781|NCT04153149|526838382|FG000|Double Blind Period|Withdrawal by guardian|0|||
146293154|NCT03370471|527587638|FG001|Overall Study|Screen fail|0|||
146293155|NCT00561951|527587640|FG000|Overall Study|Adverse Event|11|||
146293156|NCT00561951|527587641|FG001|Overall Study|Adverse Event|14|||
145967236|NCT03307174|526395398|FG001|Overall Study|Hypotension|0|||
145967237|NCT03307174|526395397|FG000|Overall Study|Nonfunctional epidural|1|||
145967238|NCT03307174|526395398|FG001|Overall Study|Nonfunctional epidural|1|||
145967239|NCT03307174|526395397|FG000|Overall Study|Planned epidural removal|1|||
145967240|NCT03307174|526395398|FG001|Overall Study|Planned epidural removal|0|||
145967241|NCT03307174|526395397|FG000|Overall Study|Intrathecal catheter placement|0|||
145967242|NCT03307174|526395398|FG001|Overall Study|Intrathecal catheter placement|1|||
146232890|NCT00943917|527370703|FG004|Stage II|Withdrawal by Subject|0|||
146086782|NCT04153149|526838383|FG001|Double Blind Period|Withdrawal by guardian|2|||
146232891|NCT00943917|527370704|FG005|Stage II|Withdrawal by Subject|1|||
145967243|NCT00863707|526395399|FG000|Overall Study|Randomized, but drug not received|4|||
145967244|NCT00863707|526395400|FG001|Overall Study|Randomized, but drug not received|3|||
146293157|NCT00561951|527587642|FG002|Overall Study|Adverse Event|14|||
146293158|NCT00561951|527587640|FG000|Overall Study|Lack of Efficacy|5|||
146293159|NCT00561951|527587641|FG001|Overall Study|Lack of Efficacy|3|||
146293160|NCT00561951|527587642|FG002|Overall Study|Lack of Efficacy|2|||
146293161|NCT00561951|527587640|FG000|Overall Study|Lost to Follow-up|1|||
146293162|NCT00561951|527587641|FG001|Overall Study|Lost to Follow-up|1|||
145967245|NCT01142336|526395401|FG000|Overall Study|Adverse Event|1|||
146293163|NCT00561951|527587642|FG002|Overall Study|Lost to Follow-up|0|||
146293164|NCT00561951|527587640|FG000|Overall Study|Withdrawal by Subject|10|||
146293165|NCT00561951|527587641|FG001|Overall Study|Withdrawal by Subject|9|||
146293166|NCT00561951|527587642|FG002|Overall Study|Withdrawal by Subject|10|||
146293167|NCT00561951|527587640|FG000|Overall Study|Protocol Violation|4|||
146293168|NCT00561951|527587641|FG001|Overall Study|Protocol Violation|3|||
146293169|NCT00561951|527587642|FG002|Overall Study|Protocol Violation|4|||
146293170|NCT00561951|527587640|FG000|Overall Study|Physician Decision|1|||
146293171|NCT00561951|527587641|FG001|Overall Study|Physician Decision|0|||
146293172|NCT00561951|527587642|FG002|Overall Study|Physician Decision|0|||
146293173|NCT00561951|527587640|FG000|Overall Study|Pregnancy|0|||
146293174|NCT00561951|527587641|FG001|Overall Study|Pregnancy|1|||
146293175|NCT00561951|527587642|FG002|Overall Study|Pregnancy|0|||
146293176|NCT00561951|527587640|FG000|Overall Study|Meet Withdrawal Criterion|0|||
146293177|NCT00561951|527587641|FG001|Overall Study|Meet Withdrawal Criterion|1|||
146293178|NCT00561951|527587642|FG002|Overall Study|Meet Withdrawal Criterion|1|||
146293179|NCT00561951|527587640|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
146293180|NCT00561951|527587641|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
146293181|NCT00561951|527587642|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
146293182|NCT01765179|527587643|FG000|Overall Study|Adverse Event|3|||
146293183|NCT01765179|527587643|FG000|Overall Study|Lost to Follow-up|5|||
146293184|NCT01765179|527587643|FG000|Overall Study|Non-compliance with study drug|2|||
146293185|NCT01765179|527587643|FG000|Overall Study|Protocol Violation|1|||
146293186|NCT01765179|527587643|FG000|Overall Study|Withdrawal by Subject|8|||
146293187|NCT01765179|527587643|FG000|Overall Study|Hematocrit >54%|3|||
146293188|NCT01765179|527587643|FG000|Overall Study|prohibited med|1|||
146293189|NCT01765179|527587643|FG000|Overall Study|Out of country unable to finish study|1|||
146293190|NCT01765179|527587643|FG000|Overall Study|lack of venous access|1|||
146293191|NCT01765179|527587643|FG000|Overall Study|work conflict|1|||
146293192|NCT01765179|527587643|FG000|Overall Study|Ca elevated 10.6|1|||
145967246|NCT01142336|526395402|FG001|Overall Study|Adverse Event|1|||
145967247|NCT01142336|526395401|FG000|Overall Study|Lost to Follow-up|0|||
145967248|NCT01142336|526395402|FG001|Overall Study|Lost to Follow-up|1|||
145967249|NCT01704261|526395403|FG000|Overall Study|Withdrawal by Subject|12|||
145967250|NCT01704261|526395404|FG001|Overall Study|Withdrawal by Subject|15|||
145967251|NCT01704261|526395403|FG000|Overall Study|Lost to Follow-up|1|||
145967252|NCT01704261|526395404|FG001|Overall Study|Lost to Follow-up|0|||
145967253|NCT02722967|526395405|FG000|Overall Study|Adverse Event|1|||
145967254|NCT02722967|526395406|FG001|Overall Study|Adverse Event|0|||
145967255|NCT02722967|526395407|FG002|Overall Study|Adverse Event|0|||
145967256|NCT02722967|526395405|FG000|Overall Study|Lost to Follow-up|0|||
145967257|NCT02722967|526395406|FG001|Overall Study|Lost to Follow-up|1|||
145967258|NCT02722967|526395407|FG002|Overall Study|Lost to Follow-up|0|||
145967259|NCT02722967|526395405|FG000|Overall Study|Non-compliance with patch wearing|2|||
145967260|NCT02722967|526395406|FG001|Overall Study|Non-compliance with patch wearing|1|||
145967261|NCT02722967|526395407|FG002|Overall Study|Non-compliance with patch wearing|1|||
145967262|NCT02722967|526395405|FG000|Overall Study|Withdrawal by Subject|1|||
145967263|NCT02722967|526395406|FG001|Overall Study|Withdrawal by Subject|0|||
145967264|NCT02722967|526395407|FG002|Overall Study|Withdrawal by Subject|1|||
145967265|NCT02722967|526395405|FG000|Overall Study|Physician Decision|1|||
145967266|NCT02722967|526395406|FG001|Overall Study|Physician Decision|0|||
145967267|NCT02722967|526395407|FG002|Overall Study|Physician Decision|0|||
145967268|NCT02722967|526395405|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
146293193|NCT00392327|527587657|FG000|Overall Study|Death|1|||
145967269|NCT02722967|526395406|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
145967270|NCT02722967|526395407|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
146086783|NCT04153149|526838384|FG002|Double Blind Period|Withdrawal by guardian|0|||
146293194|NCT00392327|527587658|FG001|Overall Study|Death|0|||
146293195|NCT00392327|527587659|FG002|Overall Study|Death|1|||
145967271|NCT02783911|526395411|FG000|Overall Study|Lost to Follow-up|3|||
145967272|NCT02783911|526395412|FG001|Overall Study|Lost to Follow-up|32|||
145967273|NCT01218802|526395418|FG000|Overall Study|Lost to Follow-up|5|||
145967274|NCT01218802|526395419|FG001|Overall Study|Lost to Follow-up|6|||
145967275|NCT01218802|526395418|FG000|Overall Study|Withdrawal by Subject|3|||
146293196|NCT00392327|527587660|FG003|Overall Study|Death|0|||
146293197|NCT00392327|527587661|FG004|Overall Study|Death|0|||
146293198|NCT00392327|527587662|FG005|Overall Study|Death|0|||
146293199|NCT00392327|527587663|FG006|Overall Study|Death|0|||
146293200|NCT00392327|527587664|FG007|Overall Study|Death|0|||
146293201|NCT00392327|527587657|FG000|Overall Study|Lack of Efficacy|8|||
146293202|NCT00392327|527587658|FG001|Overall Study|Lack of Efficacy|8|||
145967276|NCT01218802|526395419|FG001|Overall Study|Withdrawal by Subject|10|||
145967277|NCT01218802|526395418|FG000|Overall Study|Adverse Event|0|||
145967278|NCT01218802|526395419|FG001|Overall Study|Adverse Event|2|||
145967279|NCT01218802|526395418|FG000|Overall Study|Incarcerated|2|||
145967280|NCT01218802|526395419|FG001|Overall Study|Incarcerated|0|||
145967281|NCT01041859|526395423|FG000|Open-Label Titration|Adverse Event|69|||
145967282|NCT01041859|526395424|FG001|Open-Label Titration|Adverse Event|0|||
145967283|NCT01041859|526395425|FG002|Open-Label Titration|Adverse Event|0|||
145967284|NCT01041859|526395423|FG000|Open-Label Titration|Lack of Efficacy|3|||
145967285|NCT01041859|526395424|FG001|Open-Label Titration|Lack of Efficacy|0|||
145967286|NCT01041859|526395425|FG002|Open-Label Titration|Lack of Efficacy|0|||
145967287|NCT01041859|526395423|FG000|Open-Label Titration|Lost to Follow-up|1|||
145967288|NCT01041859|526395424|FG001|Open-Label Titration|Lost to Follow-up|0|||
145967289|NCT01041859|526395425|FG002|Open-Label Titration|Lost to Follow-up|0|||
145967290|NCT01041859|526395423|FG000|Open-Label Titration|Physician Decision|1|||
145967291|NCT01041859|526395424|FG001|Open-Label Titration|Physician Decision|0|||
145967292|NCT01041859|526395425|FG002|Open-Label Titration|Physician Decision|0|||
145967293|NCT01041859|526395423|FG000|Open-Label Titration|Protocol Violation|1|||
145967294|NCT01041859|526395424|FG001|Open-Label Titration|Protocol Violation|0|||
145967295|NCT01041859|526395425|FG002|Open-Label Titration|Protocol Violation|0|||
145967296|NCT01041859|526395423|FG000|Open-Label Titration|Other|7|||
145967297|NCT01041859|526395424|FG001|Open-Label Titration|Other|0|||
145967298|NCT01041859|526395425|FG002|Open-Label Titration|Other|0|||
145967299|NCT01041859|526395423|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
145967300|NCT01041859|526395424|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
145967301|NCT01041859|526395425|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
145967302|NCT01041859|526395423|FG000|Open-Label Titration|Withdrawal by Subject|11|||
145967303|NCT01041859|526395424|FG001|Open-Label Titration|Withdrawal by Subject|0|||
145967304|NCT01041859|526395425|FG002|Open-Label Titration|Withdrawal by Subject|0|||
145967305|NCT01041859|526395423|FG000|Double-Blind Maintenance|Adverse Event|0|||
145967306|NCT01041859|526395424|FG001|Double-Blind Maintenance|Adverse Event|23|||
145967307|NCT01041859|526395425|FG002|Double-Blind Maintenance|Adverse Event|13|||
145967308|NCT01041859|526395423|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
145967309|NCT01041859|526395424|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
145967310|NCT01041859|526395425|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
145967311|NCT01041859|526395423|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
145967312|NCT01041859|526395424|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
145967313|NCT01041859|526395425|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
145967314|NCT01041859|526395423|FG000|Double-Blind Maintenance|Physician Decision|0|||
145967315|NCT01041859|526395424|FG001|Double-Blind Maintenance|Physician Decision|2|||
145967316|NCT01041859|526395425|FG002|Double-Blind Maintenance|Physician Decision|1|||
145967317|NCT01041859|526395423|FG000|Double-Blind Maintenance|Protocol Violation|0|||
145967318|NCT01041859|526395424|FG001|Double-Blind Maintenance|Protocol Violation|1|||
145967319|NCT01041859|526395425|FG002|Double-Blind Maintenance|Protocol Violation|3|||
145967320|NCT01041859|526395423|FG000|Double-Blind Maintenance|Other|0|||
145967321|NCT01041859|526395424|FG001|Double-Blind Maintenance|Other|6|||
145967322|NCT01041859|526395425|FG002|Double-Blind Maintenance|Other|2|||
145967323|NCT01041859|526395423|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
145967324|NCT01041859|526395424|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
145967325|NCT01041859|526395425|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
145967326|NCT01041859|526395423|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
145967327|NCT01041859|526395424|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
145967328|NCT01041859|526395425|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
145967329|NCT03329885|526395428|FG000|Overall Study|Sponsor discontinued the study early|0|||
145967330|NCT03329885|526395429|FG001|Overall Study|Sponsor discontinued the study early|0|||
145967331|NCT03329885|526395430|FG002|Overall Study|Sponsor discontinued the study early|0|||
145967332|NCT03329885|526395431|FG003|Overall Study|Sponsor discontinued the study early|0|||
145967333|NCT03329885|526395432|FG004|Overall Study|Sponsor discontinued the study early|0|||
145967334|NCT03329885|526395433|FG005|Overall Study|Sponsor discontinued the study early|0|||
145967335|NCT03329885|526395434|FG006|Overall Study|Sponsor discontinued the study early|1|||
145967336|NCT03329885|526395435|FG007|Overall Study|Sponsor discontinued the study early|1|||
145967337|NCT03329885|526395436|FG008|Overall Study|Sponsor discontinued the study early|0|||
145967338|NCT03883386|526395438|FG000|First Assignment|Lost to Follow-up|1|||
146293203|NCT00392327|527587659|FG002|Overall Study|Lack of Efficacy|9|||
146086784|NCT04153149|526838385|FG003|Double Blind Period|Withdrawal by guardian|0|||
146086785|NCT04153149|526838382|FG000|Double Blind Period|Reason Not Specified|5|||
145967339|NCT03883386|526395439|FG001|First Assignment|Lost to Follow-up|0|||
145967340|NCT03883386|526395438|FG000|First Assignment|Withdrawal by Subject|1|||
145967341|NCT03883386|526395439|FG001|First Assignment|Withdrawal by Subject|1|||
145967342|NCT01326871|526395440|FG000|Overall Study|Major surgery|0|||
145967343|NCT01326871|526395441|FG001|Overall Study|Major surgery|1|||
145967344|NCT01326871|526395442|FG002|Overall Study|Major surgery|0|||
145967345|NCT01326871|526395440|FG000|Overall Study|SAE and death|0|||
145967346|NCT01326871|526395441|FG001|Overall Study|SAE and death|2|||
145967347|NCT01326871|526395442|FG002|Overall Study|SAE and death|0|||
145967348|NCT01326871|526395440|FG000|Overall Study|Physician decision and decreased performance status|0|||
145967349|NCT01326871|526395441|FG001|Overall Study|Physician decision and decreased performance status|1|||
145967350|NCT01326871|526395442|FG002|Overall Study|Physician decision and decreased performance status|0|||
145967351|NCT01326871|526395440|FG000|Overall Study|Disease progression|0|||
145967352|NCT01326871|526395441|FG001|Overall Study|Disease progression|11|||
145967353|NCT01326871|526395442|FG002|Overall Study|Disease progression|5|||
145967354|NCT01326871|526395440|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
145967355|NCT01326871|526395441|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
145967356|NCT01326871|526395442|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
145967357|NCT01326871|526395440|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
145967358|NCT01326871|526395441|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
145967359|NCT01326871|526395442|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
145967360|NCT01326871|526395440|FG000|Overall Study|Withdrawal by Subject|0|||
145888619|NCT01961687|526099013|FG000|Overall Study|Unable to meet follow-up requirements|1|||
145888620|NCT00544817|526099014|FG000|Combined Modality|Lack of Efficacy|2|||
145888621|NCT00544817|526099014|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
145888622|NCT00544817|526099014|FG000|Combined Modality|Adverse Event|2|||
145888623|NCT00544817|526099014|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
145888624|NCT00544817|526099014|FG000|No Treatment Interval|Lack of Efficacy|8|||
145888625|NCT00544817|526099014|FG000|No Treatment Interval|Physician Decision|3|||
145888626|NCT00544817|526099014|FG000|No Treatment Interval|Adverse Event|1|||
145888627|NCT00544817|526099014|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
145888628|NCT00544817|526099014|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
145888629|NCT00544817|526099014|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
145888630|NCT02813421|526099015|FG000|Overall Study|Withdrawal by Subject|1|||
145888631|NCT02813421|526099016|FG001|Overall Study|Withdrawal by Subject|2|||
145967361|NCT01326871|526395441|FG001|Overall Study|Withdrawal by Subject|1|||
146086786|NCT04153149|526838383|FG001|Double Blind Period|Reason Not Specified|4|||
145888632|NCT02813421|526099015|FG000|Overall Study|Lost to Follow-up|1|||
145888633|NCT02813421|526099016|FG001|Overall Study|Lost to Follow-up|1|||
145888634|NCT00977548|526099017|FG000|Overall Study|Ineligible|4|||
146086787|NCT04153149|526838384|FG002|Double Blind Period|Reason Not Specified|0|||
145888635|NCT00977548|526099017|FG000|Overall Study|Adverse Event|8|||
145888636|NCT00977548|526099017|FG000|Overall Study|Withdrawal by Subject|1|||
145888637|NCT01042535|526099018|FG000|Overall Study|disease progression prior to treatment|3|||
145888638|NCT01042535|526099018|FG000|Overall Study|disease progression during treatment|3|||
145888639|NCT01042535|526099018|FG000|Overall Study|complications from other disease|2|||
145888640|NCT00107042|526099021|FG000|Overall Study|Lost to Follow-up|9|||
145888641|NCT00107042|526099022|FG001|Overall Study|Lost to Follow-up|7|||
145888642|NCT00107042|526099021|FG000|Overall Study|Withdrawal by Subject|6|||
145888643|NCT00107042|526099022|FG001|Overall Study|Withdrawal by Subject|1|||
145888644|NCT00107042|526099021|FG000|Overall Study|Moved out of area|5|||
145888645|NCT00107042|526099022|FG001|Overall Study|Moved out of area|3|||
145888646|NCT00107042|526099021|FG000|Overall Study|Pregnancy|1|||
145888647|NCT00107042|526099022|FG001|Overall Study|Pregnancy|1|||
145888648|NCT00107042|526099021|FG000|Overall Study|Inadvertent enrollment|0|||
145888649|NCT00107042|526099022|FG001|Overall Study|Inadvertent enrollment|1|||
145967362|NCT01326871|526395442|FG002|Overall Study|Withdrawal by Subject|0|||
145967363|NCT01326871|526395440|FG000|Overall Study|DLT|0|||
145967364|NCT01326871|526395441|FG001|Overall Study|DLT|2|||
145967365|NCT01326871|526395442|FG002|Overall Study|DLT|0|||
145967366|NCT01326871|526395440|FG000|Overall Study|SAE, disease progression and subject decision|0|||
145967367|NCT01326871|526395441|FG001|Overall Study|SAE, disease progression and subject decision|1|||
145967368|NCT01326871|526395442|FG002|Overall Study|SAE, disease progression and subject decision|0|||
145967369|NCT01326871|526395440|FG000|Overall Study|Death|0|||
145967370|NCT01326871|526395441|FG001|Overall Study|Death|1|||
145967371|NCT01326871|526395442|FG002|Overall Study|Death|0|||
145967372|NCT01326871|526395440|FG000|Overall Study|Other|0|||
145967373|NCT01326871|526395441|FG001|Overall Study|Other|3|||
145967374|NCT01326871|526395442|FG002|Overall Study|Other|0|||
145967375|NCT01326871|526395440|FG000|Overall Study|SAE and disease progression|0|||
145967376|NCT01326871|526395441|FG001|Overall Study|SAE and disease progression|0|||
145967377|NCT01326871|526395442|FG002|Overall Study|SAE and disease progression|1|||
145967378|NCT01326871|526395440|FG000|Overall Study|SAE and physician decision|0|||
145967379|NCT01326871|526395441|FG001|Overall Study|SAE and physician decision|0|||
145967380|NCT01326871|526395442|FG002|Overall Study|SAE and physician decision|1|||
145967381|NCT01326871|526395440|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
145967382|NCT01326871|526395441|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
145967383|NCT01326871|526395442|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
145967384|NCT01326871|526395440|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
145967385|NCT01326871|526395441|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
145967386|NCT01326871|526395442|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
145967387|NCT01326871|526395440|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
145967388|NCT01326871|526395441|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
145967389|NCT01326871|526395442|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
145967390|NCT01326871|526395440|FG000|Overall Study|Physician Decision|0|||
145967391|NCT01326871|526395441|FG001|Overall Study|Physician Decision|0|||
145967392|NCT01326871|526395442|FG002|Overall Study|Physician Decision|1|||
145967393|NCT01326871|526395440|FG000|Overall Study|SAE|0|||
145967394|NCT01326871|526395441|FG001|Overall Study|SAE|0|||
145967395|NCT01326871|526395442|FG002|Overall Study|SAE|1|||
145888650|NCT00107042|526099021|FG000|Overall Study|vaccinated outside window|1|||
145888651|NCT00107042|526099022|FG001|Overall Study|vaccinated outside window|1|||
145888652|NCT00107042|526099021|FG000|Overall Study|Disallowed medications|0|||
145888653|NCT00107042|526099022|FG001|Overall Study|Disallowed medications|2|||
145888654|NCT03919448|526099023|FG000|Overall Study|Withdrawal by Subject|1|||
145888655|NCT03919448|526099024|FG001|Overall Study|Withdrawal by Subject|0|||
145888656|NCT03919448|526099025|FG002|Overall Study|Withdrawal by Subject|0|||
145967396|NCT01326871|526395440|FG000|Overall Study|Disease progression and death|0|||
145967397|NCT01326871|526395441|FG001|Overall Study|Disease progression and death|0|||
145967398|NCT01326871|526395442|FG002|Overall Study|Disease progression and death|1|||
145967399|NCT01326871|526395440|FG000|Overall Study|Subject decision|0|||
145967400|NCT01326871|526395441|FG001|Overall Study|Subject decision|0|||
145967401|NCT01326871|526395442|FG002|Overall Study|Subject decision|1|||
145967402|NCT00251758|526395443|FG000|Overall Study|Adverse Event|7|||
145967403|NCT00251758|526395444|FG001|Overall Study|Adverse Event|9|||
145967404|NCT00251758|526395445|FG002|Overall Study|Adverse Event|11|||
145967405|NCT00251758|526395443|FG000|Overall Study|Lost to Follow-up|4|||
145967406|NCT00251758|526395444|FG001|Overall Study|Lost to Follow-up|2|||
145967407|NCT00251758|526395445|FG002|Overall Study|Lost to Follow-up|5|||
145967408|NCT00251758|526395443|FG000|Overall Study|Withdrawal by Subject|13|||
145888657|NCT03438539|526099027|FG000|Overall Study|Lost to Follow-up|8|||
145967409|NCT00251758|526395444|FG001|Overall Study|Withdrawal by Subject|7|||
145967410|NCT00251758|526395445|FG002|Overall Study|Withdrawal by Subject|3|||
145967411|NCT00251758|526395443|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145967412|NCT00251758|526395444|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
145967413|NCT00251758|526395445|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
145967414|NCT00251758|526395443|FG000|Overall Study|Lack of Efficacy|3|||
145967415|NCT00251758|526395444|FG001|Overall Study|Lack of Efficacy|0|||
145967416|NCT00251758|526395445|FG002|Overall Study|Lack of Efficacy|0|||
145967417|NCT00251758|526395443|FG000|Overall Study|Noncompliant|0|||
145967418|NCT00251758|526395444|FG001|Overall Study|Noncompliant|2|||
145888658|NCT03438539|526099028|FG001|Overall Study|Lost to Follow-up|4|||
145967419|NCT00251758|526395445|FG002|Overall Study|Noncompliant|2|||
145967420|NCT00251758|526395443|FG000|Overall Study|Pregnancy|0|||
145967421|NCT00251758|526395444|FG001|Overall Study|Pregnancy|1|||
145967422|NCT00251758|526395445|FG002|Overall Study|Pregnancy|0|||
145967423|NCT00251758|526395443|FG000|Overall Study|Per Subject Request|0|||
145967424|NCT00251758|526395444|FG001|Overall Study|Per Subject Request|0|||
145967425|NCT00251758|526395445|FG002|Overall Study|Per Subject Request|1|||
145967426|NCT00251758|526395443|FG000|Overall Study|Per Investigator Request|1|||
145967427|NCT00251758|526395444|FG001|Overall Study|Per Investigator Request|0|||
145967428|NCT00251758|526395445|FG002|Overall Study|Per Investigator Request|0|||
145967429|NCT01387269|526395446|FG000|Overall Study|Death|38|||
145967430|NCT01387269|526395447|FG001|Overall Study|Death|20|||
145967431|NCT01387269|526395446|FG000|Overall Study|Other|8|||
145967432|NCT01387269|526395447|FG001|Overall Study|Other|7|||
145967433|NCT01387269|526395446|FG000|Overall Study|Unrelated AE|12|||
145967434|NCT01387269|526395447|FG001|Overall Study|Unrelated AE|3|||
145967435|NCT01387269|526395446|FG000|Overall Study|Withdrawal by patient|32|||
145967436|NCT01387269|526395447|FG001|Overall Study|Withdrawal by patient|10|||
145967437|NCT01387269|526395446|FG000|Overall Study|Study drug-related AE|1|||
145967438|NCT01387269|526395447|FG001|Overall Study|Study drug-related AE|0|||
145888659|NCT03438539|526099029|FG002|Overall Study|Lost to Follow-up|10|||
145888660|NCT03438539|526099030|FG003|Overall Study|Lost to Follow-up|9|||
145888661|NCT03438539|526099031|FG004|Overall Study|Lost to Follow-up|3|||
145888662|NCT03438539|526099032|FG005|Overall Study|Lost to Follow-up|8|||
145888663|NCT01221090|526099033|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
145888664|NCT01221090|526099034|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
145888665|NCT01221090|526099035|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
145888666|NCT01221090|526099036|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
145888667|NCT01221090|526099033|FG000|Overall Study|Withdrawal by Subject|0|||
145888668|NCT01221090|526099034|FG001|Overall Study|Withdrawal by Subject|22|||
145888669|NCT01221090|526099035|FG002|Overall Study|Withdrawal by Subject|27|||
145888670|NCT01221090|526099036|FG003|Overall Study|Withdrawal by Subject|2|||
145888671|NCT00440466|526099037|FG000|Overall Study|Death|3|||
145888672|NCT00440466|526099038|FG001|Overall Study|Death|2|||
145888673|NCT00440466|526099039|FG002|Overall Study|Death|9|||
145888674|NCT00440466|526099037|FG000|Overall Study|Adverse Event|3|||
145888675|NCT00440466|526099038|FG001|Overall Study|Adverse Event|4|||
145888676|NCT00440466|526099039|FG002|Overall Study|Adverse Event|11|||
145888677|NCT00440466|526099037|FG000|Overall Study|Lost to Follow-up|1|||
145888678|NCT00440466|526099038|FG001|Overall Study|Lost to Follow-up|0|||
145888679|NCT00440466|526099039|FG002|Overall Study|Lost to Follow-up|2|||
145888680|NCT00440466|526099037|FG000|Overall Study|Physician Decision|2|||
145888681|NCT00440466|526099038|FG001|Overall Study|Physician Decision|0|||
145888682|NCT00440466|526099039|FG002|Overall Study|Physician Decision|1|||
145888683|NCT00440466|526099037|FG000|Overall Study|Protocol Violation|2|||
145888684|NCT00440466|526099038|FG001|Overall Study|Protocol Violation|0|||
145888685|NCT00440466|526099039|FG002|Overall Study|Protocol Violation|4|||
145888686|NCT00440466|526099037|FG000|Overall Study|Withdrawal by Subject|2|||
145888687|NCT00440466|526099038|FG001|Overall Study|Withdrawal by Subject|5|||
145888688|NCT00440466|526099039|FG002|Overall Study|Withdrawal by Subject|9|||
145888689|NCT00440466|526099037|FG000|Overall Study|Began Dialysis|0|||
145888690|NCT00440466|526099038|FG001|Overall Study|Began Dialysis|0|||
145888691|NCT00440466|526099039|FG002|Overall Study|Began Dialysis|1|||
145888692|NCT00440466|526099037|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
145888693|NCT00440466|526099038|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
145888694|NCT00440466|526099039|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
145888695|NCT00892281|526099048|FG000|Overall Study|Adverse Event|65|||
145888696|NCT00892281|526099049|FG001|Overall Study|Adverse Event|8|||
145888697|NCT00892281|526099048|FG000|Overall Study|Lost to Follow-up|81|||
145888698|NCT00892281|526099049|FG001|Overall Study|Lost to Follow-up|8|||
145888699|NCT00892281|526099048|FG000|Overall Study|Pregnancy|1|||
145888700|NCT00892281|526099049|FG001|Overall Study|Pregnancy|0|||
145888701|NCT00892281|526099048|FG000|Overall Study|Protocol Violation|7|||
145888702|NCT00892281|526099049|FG001|Overall Study|Protocol Violation|2|||
145888703|NCT00892281|526099048|FG000|Overall Study|Withdrawal by Subject|86|||
145888704|NCT00892281|526099049|FG001|Overall Study|Withdrawal by Subject|14|||
145967439|NCT01387269|526395446|FG000|Overall Study|Lost to Follow-up|1|||
145967440|NCT01387269|526395447|FG001|Overall Study|Lost to Follow-up|0|||
145967441|NCT01200329|526395449|FG000|Overall Study|Lack of financial coverage|2|||
145967442|NCT01200329|526395449|FG000|Overall Study|Progressive disease|1|||
145967443|NCT03641508|526395452|FG000|First Injection|Lost to Follow-up|2|||
145967444|NCT03641508|526395453|FG001|First Injection|Lost to Follow-up|0|||
145967445|NCT02404545|526395454|FG000|Overall Study|Sponsor Termination|6|||
145967446|NCT02404545|526395455|FG001|Overall Study|Sponsor Termination|6|||
145967447|NCT02577029|526395458|FG000|Overall Study|Adverse Event|1|||
145967448|NCT02577029|526395459|FG001|Overall Study|Adverse Event|0|||
145967449|NCT02577029|526395460|FG002|Overall Study|Adverse Event|2|||
145967450|NCT02577029|526395461|FG003|Overall Study|Adverse Event|0|||
145967451|NCT02577029|526395462|FG004|Overall Study|Adverse Event|1|||
145967452|NCT02577029|526395463|FG005|Overall Study|Adverse Event|0|||
145967453|NCT02577029|526395464|FG006|Overall Study|Adverse Event|0|||
145967454|NCT02577029|526395465|FG007|Overall Study|Adverse Event|0|||
145967455|NCT02577029|526395458|FG000|Overall Study|Withdrawal by Subject|0|||
145967456|NCT02577029|526395459|FG001|Overall Study|Withdrawal by Subject|0|||
145967457|NCT02577029|526395460|FG002|Overall Study|Withdrawal by Subject|0|||
145967458|NCT02577029|526395461|FG003|Overall Study|Withdrawal by Subject|0|||
145967459|NCT02577029|526395462|FG004|Overall Study|Withdrawal by Subject|0|||
145967460|NCT02577029|526395463|FG005|Overall Study|Withdrawal by Subject|1|||
145967461|NCT02577029|526395464|FG006|Overall Study|Withdrawal by Subject|0|||
145967462|NCT02577029|526395465|FG007|Overall Study|Withdrawal by Subject|0|||
145967463|NCT02577029|526395458|FG000|Overall Study|Sponsor Termination of the Study|9|||
145967464|NCT02577029|526395459|FG001|Overall Study|Sponsor Termination of the Study|2|||
145967465|NCT02577029|526395460|FG002|Overall Study|Sponsor Termination of the Study|5|||
145967466|NCT02577029|526395461|FG003|Overall Study|Sponsor Termination of the Study|12|||
145967467|NCT02577029|526395462|FG004|Overall Study|Sponsor Termination of the Study|10|||
145967468|NCT02577029|526395463|FG005|Overall Study|Sponsor Termination of the Study|12|||
145967469|NCT02577029|526395464|FG006|Overall Study|Sponsor Termination of the Study|12|||
145967470|NCT02577029|526395465|FG007|Overall Study|Sponsor Termination of the Study|12|||
145967471|NCT02078817|526395466|FG000|Overall Study|Withdrawal by Subject|1|||
145967472|NCT00855218|526395467|FG000|Overall Study|Adverse Event|43|||
145967473|NCT00855218|526395468|FG001|Overall Study|Adverse Event|27|||
145967474|NCT00855218|526395467|FG000|Overall Study|Withdrawal by Subject|10|||
145967475|NCT00855218|526395468|FG001|Overall Study|Withdrawal by Subject|6|||
145967476|NCT00855218|526395467|FG000|Overall Study|Physician Decision|18|||
145967477|NCT00855218|526395468|FG001|Overall Study|Physician Decision|11|||
145967478|NCT00855218|526395467|FG000|Overall Study|Lost to Follow-up|0|||
145967479|NCT00855218|526395468|FG001|Overall Study|Lost to Follow-up|1|||
145967480|NCT00855218|526395467|FG000|Overall Study|Protocol Violation|5|||
145967481|NCT00855218|526395468|FG001|Overall Study|Protocol Violation|9|||
145967482|NCT00855218|526395467|FG000|Overall Study|non-compliant with study drug|3|||
145967483|NCT00855218|526395468|FG001|Overall Study|non-compliant with study drug|1|||
145967484|NCT00855218|526395467|FG000|Overall Study|patient convenience|2|||
145967485|NCT00855218|526395468|FG001|Overall Study|patient convenience|0|||
145967486|NCT00855218|526395467|FG000|Overall Study|technical problems|2|||
145967487|NCT00855218|526395468|FG001|Overall Study|technical problems|1|||
145967488|NCT00855218|526395467|FG000|Overall Study|Still treated with study medication|0|||
145967489|NCT00855218|526395468|FG001|Overall Study|Still treated with study medication|1|||
145967490|NCT00855218|526395467|FG000|Overall Study|Untreatable disease progression|54|||
145967491|NCT00855218|526395468|FG001|Overall Study|Untreatable disease progression|67|||
145967492|NCT00855218|526395467|FG000|Overall Study|Second malignancy|0|||
145967493|NCT00855218|526395468|FG001|Overall Study|Second malignancy|1|||
145967494|NCT00855218|526395467|FG000|Overall Study|Progression measurement proven|7|||
145967495|NCT00855218|526395468|FG001|Overall Study|Progression measurement proven|15|||
145967496|NCT00855218|526395467|FG000|Overall Study|Clinical endpoint reached|10|||
145967497|NCT00855218|526395468|FG001|Overall Study|Clinical endpoint reached|13|||
145967498|NCT03824561|526395471|FG000|Overall Study|Protocol Violation|19|||
145967499|NCT03191552|526395472|FG000|Overall Study|Lost to Follow-up|1|||
145967500|NCT03191552|526395473|FG001|Overall Study|Lost to Follow-up|0|||
145967501|NCT03191552|526395474|FG002|Overall Study|Lost to Follow-up|0|||
145967502|NCT03191552|526395472|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
145967503|NCT03191552|526395473|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
145967504|NCT03191552|526395474|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
145967505|NCT02370511|526395475|FG000|Overall Study|Death|10|||
145967506|NCT02370511|526395476|FG001|Overall Study|Death|7|||
145967507|NCT02370511|526395477|FG002|Overall Study|Death|1|||
145967508|NCT02370511|526395475|FG000|Overall Study|Withdrawal by Subject|2|||
145967509|NCT02370511|526395476|FG001|Overall Study|Withdrawal by Subject|0|||
145967510|NCT02370511|526395477|FG002|Overall Study|Withdrawal by Subject|0|||
145967511|NCT02370511|526395475|FG000|Overall Study|Lost to Follow-up|0|||
145967512|NCT02370511|526395476|FG001|Overall Study|Lost to Follow-up|4|||
145967513|NCT02370511|526395477|FG002|Overall Study|Lost to Follow-up|0|||
146086788|NCT04153149|526838385|FG003|Double Blind Period|Reason Not Specified|0|||
145967514|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
145967515|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145967516|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145967517|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145967518|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
145967519|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145967520|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145967521|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145967522|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
145967523|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145967524|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145967525|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145967526|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
145967527|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
145967528|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
146293204|NCT00392327|527587660|FG003|Overall Study|Lack of Efficacy|6|||
146293205|NCT00392327|527587661|FG004|Overall Study|Lack of Efficacy|3|||
146293206|NCT00392327|527587662|FG005|Overall Study|Lack of Efficacy|3|||
146293207|NCT00392327|527587663|FG006|Overall Study|Lack of Efficacy|3|||
146293208|NCT00392327|527587664|FG007|Overall Study|Lack of Efficacy|3|||
146293209|NCT00392327|527587657|FG000|Overall Study|Physician Decision|3|||
145967529|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
145967530|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
145967531|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145967532|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146293210|NCT00392327|527587658|FG001|Overall Study|Physician Decision|5|||
145967533|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145967534|NCT01149655|526395478|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
145967535|NCT01149655|526395479|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145967536|NCT01149655|526395480|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145967537|NCT01149655|526395481|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145967538|NCT01149655|526395478|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145967539|NCT01149655|526395479|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
145967540|NCT01149655|526395480|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145967541|NCT01149655|526395481|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145967542|NCT01149655|526395478|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145967543|NCT01149655|526395479|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
145967544|NCT01149655|526395480|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145967545|NCT01149655|526395481|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145967546|NCT01149655|526395478|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
145967547|NCT01149655|526395479|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
145967548|NCT01149655|526395480|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
146293211|NCT00392327|527587659|FG002|Overall Study|Physician Decision|2|||
145967549|NCT01149655|526395481|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
145967550|NCT01149655|526395478|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
145967551|NCT01149655|526395479|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
145967552|NCT01149655|526395480|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
146293212|NCT00392327|527587660|FG003|Overall Study|Physician Decision|2|||
146293213|NCT00392327|527587661|FG004|Overall Study|Physician Decision|0|||
145967553|NCT01149655|526395481|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
145967554|NCT01149655|526395478|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145967555|NCT01149655|526395479|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
145967556|NCT01149655|526395480|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145967557|NCT01149655|526395481|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145967558|NCT01149655|526395478|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
145967559|NCT01149655|526395479|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
145967560|NCT01149655|526395480|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
145967561|NCT01149655|526395481|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
145967562|NCT01149655|526395478|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
145967563|NCT01149655|526395479|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
145967564|NCT01149655|526395480|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
145967565|NCT01149655|526395481|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
145967566|NCT01149655|526395478|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
145967567|NCT01149655|526395479|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
146293214|NCT00392327|527587662|FG005|Overall Study|Physician Decision|1|||
145888705|NCT00892281|526099048|FG000|Overall Study|Subject failed to return for final visit|2|||
145888706|NCT00892281|526099049|FG001|Overall Study|Subject failed to return for final visit|0|||
145888707|NCT00892281|526099048|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
145888708|NCT00892281|526099049|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
145888709|NCT00892281|526099048|FG000|Overall Study|Final visit completed 4 weeks late|0|||
145888710|NCT00892281|526099049|FG001|Overall Study|Final visit completed 4 weeks late|1|||
145888711|NCT00892281|526099048|FG000|Overall Study|Subject completed day after study closed|1|||
145888712|NCT00892281|526099049|FG001|Overall Study|Subject completed day after study closed|0|||
145888713|NCT00892281|526099048|FG000|Overall Study|Family emergency|1|||
145888714|NCT00892281|526099049|FG001|Overall Study|Family emergency|0|||
145888715|NCT00892281|526099048|FG000|Overall Study|Last visit not done - death in family|1|||
145888716|NCT00892281|526099049|FG001|Overall Study|Last visit not done - death in family|0|||
145888717|NCT00892281|526099048|FG000|Overall Study|Did not meet incl/excl criteria|1|||
145888718|NCT00892281|526099049|FG001|Overall Study|Did not meet incl/excl criteria|0|||
145888719|NCT00892281|526099048|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
145888720|NCT00892281|526099049|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
145888721|NCT00892281|526099048|FG000|Overall Study|Unable to redeem the drug voucher|1|||
145888722|NCT00892281|526099049|FG001|Overall Study|Unable to redeem the drug voucher|0|||
145888723|NCT00892281|526099048|FG000|Overall Study|Subject not good candidate for study|1|||
145967568|NCT01149655|526395480|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
145967569|NCT01149655|526395481|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
145967570|NCT01149655|526395478|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
145967571|NCT01149655|526395479|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
145967572|NCT01149655|526395480|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
145967573|NCT01149655|526395481|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
145888724|NCT00892281|526099049|FG001|Overall Study|Subject not good candidate for study|0|||
145888725|NCT00892281|526099048|FG000|Overall Study|Subject did not return for any visits|1|||
145888726|NCT00892281|526099049|FG001|Overall Study|Subject did not return for any visits|0|||
145888727|NCT00892281|526099048|FG000|Overall Study|Subject missed several visits/lost meds|1|||
145888728|NCT00892281|526099049|FG001|Overall Study|Subject missed several visits/lost meds|0|||
145888729|NCT00892281|526099048|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
145888730|NCT00892281|526099049|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
145888731|NCT00892281|526099048|FG000|Overall Study|Scheduled for knee replacement|0|||
145888732|NCT00892281|526099049|FG001|Overall Study|Scheduled for knee replacement|1|||
145888733|NCT00892281|526099048|FG000|Overall Study|PI complained of inadequate compensation|3|||
145888734|NCT00892281|526099049|FG001|Overall Study|PI complained of inadequate compensation|0|||
145888735|NCT00892281|526099048|FG000|Overall Study|Subject lost interest in program|0|||
145888736|NCT00892281|526099049|FG001|Overall Study|Subject lost interest in program|1|||
145888737|NCT00892281|526099048|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
145888738|NCT00892281|526099049|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
145888739|NCT00892281|526099048|FG000|Overall Study|Death in family|1|||
145888740|NCT00892281|526099049|FG001|Overall Study|Death in family|0|||
145888741|NCT00892281|526099048|FG000|Overall Study|Lack of efficacy of study product|2|||
145888742|NCT00892281|526099049|FG001|Overall Study|Lack of efficacy of study product|0|||
145888743|NCT00892281|526099048|FG000|Overall Study|Subject not seen by PI at final visit|1|||
145888744|NCT00892281|526099049|FG001|Overall Study|Subject not seen by PI at final visit|0|||
145888745|NCT00892281|526099048|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
145888746|NCT00892281|526099049|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
145888747|NCT00892281|526099048|FG000|Overall Study|Missed multiple visits|1|||
145888748|NCT00892281|526099049|FG001|Overall Study|Missed multiple visits|0|||
145888749|NCT00892281|526099048|FG000|Overall Study|Missed visits rescheduled out of window|1|||
145888750|NCT00892281|526099049|FG001|Overall Study|Missed visits rescheduled out of window|0|||
145888751|NCT00892281|526099048|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
145888752|NCT00892281|526099049|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
145888753|NCT00892281|526099048|FG000|Overall Study|Subject had history of drug abuse|1|||
145888754|NCT00892281|526099049|FG001|Overall Study|Subject had history of drug abuse|0|||
145888755|NCT00892281|526099048|FG000|Overall Study|Rash on hand|1|||
145888756|NCT00892281|526099049|FG001|Overall Study|Rash on hand|0|||
145888757|NCT00892281|526099048|FG000|Overall Study|Visit 4 date out of window|1|||
145888758|NCT00892281|526099049|FG001|Overall Study|Visit 4 date out of window|0|||
145888759|NCT00655850|526099050|FG000|Overall Study|Death|2|||
145888760|NCT00655850|526099050|FG000|Overall Study|Withdrawal by Subject|1|||
145888761|NCT02459665|526099051|FG000|Overall Study|Withdrawal by Subject|0|||
145888762|NCT02459665|526099052|FG001|Overall Study|Withdrawal by Subject|1|||
145888763|NCT02459665|526099053|FG002|Overall Study|Withdrawal by Subject|1|||
145888764|NCT02459665|526099054|FG003|Overall Study|Withdrawal by Subject|2|||
145888765|NCT01048502|526099057|FG000|Overall Study|Lost to Follow-up|2|||
145888766|NCT01048502|526099058|FG001|Overall Study|Lost to Follow-up|0|||
145888767|NCT01048502|526099059|FG002|Overall Study|Lost to Follow-up|0|||
145888768|NCT01048502|526099060|FG003|Overall Study|Lost to Follow-up|0|||
145888769|NCT01048502|526099057|FG000|Overall Study|Adverse Event|1|||
145888770|NCT01048502|526099058|FG001|Overall Study|Adverse Event|0|||
145888771|NCT01048502|526099059|FG002|Overall Study|Adverse Event|0|||
145888772|NCT01048502|526099060|FG003|Overall Study|Adverse Event|0|||
145888773|NCT01048502|526099057|FG000|Overall Study|Withdrawal by Subject|1|||
145888774|NCT01048502|526099058|FG001|Overall Study|Withdrawal by Subject|4|||
145888775|NCT01048502|526099059|FG002|Overall Study|Withdrawal by Subject|5|||
145888776|NCT01048502|526099060|FG003|Overall Study|Withdrawal by Subject|3|||
145888777|NCT01048502|526099057|FG000|Overall Study|Physician Decision|0|||
145888778|NCT01048502|526099058|FG001|Overall Study|Physician Decision|3|||
146086789|NCT04153149|526838382|FG000|Double Blind Period|Physician Decision|2|||
145967574|NCT01149655|526395478|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
145967575|NCT01149655|526395479|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
145967576|NCT01149655|526395480|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
145967577|NCT01149655|526395481|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
146232892|NCT00943917|527370705|FG006|Stage II|Withdrawal by Subject|0|||
145888779|NCT01048502|526099059|FG002|Overall Study|Physician Decision|0|||
145888780|NCT01048502|526099060|FG003|Overall Study|Physician Decision|1|||
145888781|NCT01333072|526099061|FG000|Overall Study|Lost to Follow-up|3|||
145888782|NCT01333072|526099062|FG001|Overall Study|Lost to Follow-up|0|||
145888783|NCT01333072|526099061|FG000|Overall Study|Adverse Event|2|||
145888784|NCT01333072|526099062|FG001|Overall Study|Adverse Event|4|||
145888785|NCT01333072|526099061|FG000|Overall Study|Physician Decision|1|||
145888786|NCT01333072|526099062|FG001|Overall Study|Physician Decision|0|||
145888787|NCT00493454|526099064|FG000|Overall Study|Withdrawal by Subject|1|||
145888788|NCT03095118|526099073|FG000|Overall Study|Adverse Event|1|||
145888789|NCT03095118|526099073|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
145888790|NCT01483625|526099074|FG000|Overall Study|Adverse Event|1|||
145888791|NCT01483625|526099075|FG001|Overall Study|Adverse Event|1|||
145888792|NCT01483625|526099074|FG000|Overall Study|Refused to continue medication|2|||
145888793|NCT01483625|526099075|FG001|Overall Study|Refused to continue medication|1|||
145888794|NCT01483625|526099074|FG000|Overall Study|Due to other reason|1|||
145888795|NCT01483625|526099075|FG001|Overall Study|Due to other reason|0|||
145888796|NCT04668274|526099076|FG000|Part 1 Study Period 1|Adverse Event|3|||
145888797|NCT04668274|526099077|FG001|Part 1 Study Period 1|Adverse Event|0|||
145888798|NCT04668274|526099078|FG002|Part 1 Study Period 1|Adverse Event|0|||
145888799|NCT04668274|526099079|FG003|Part 1 Study Period 1|Adverse Event|0|||
145888800|NCT04668274|526099076|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
145888801|NCT04668274|526099077|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
145888802|NCT04668274|526099078|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
145888803|NCT04668274|526099079|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
145888804|NCT04668274|526099076|FG000|Part 1 Study Period 2|Other|0|||
145888805|NCT04668274|526099077|FG001|Part 1 Study Period 2|Other|1|||
145888806|NCT04668274|526099078|FG002|Part 1 Study Period 2|Other|0|||
145888807|NCT04668274|526099079|FG003|Part 1 Study Period 2|Other|0|||
145888808|NCT04668274|526099076|FG000|Part 1 Study Period 3|Adverse Event|0|||
145888809|NCT04668274|526099077|FG001|Part 1 Study Period 3|Adverse Event|0|||
145888810|NCT04668274|526099078|FG002|Part 1 Study Period 3|Adverse Event|1|||
145888811|NCT04668274|526099079|FG003|Part 1 Study Period 3|Adverse Event|0|||
145888812|NCT04668274|526099076|FG000|Part 1 Study Period 3|Other|0|||
145888813|NCT04668274|526099077|FG001|Part 1 Study Period 3|Other|0|||
145888814|NCT04668274|526099078|FG002|Part 1 Study Period 3|Other|2|||
145888815|NCT04668274|526099079|FG003|Part 1 Study Period 3|Other|0|||
145888816|NCT04668274|526099076|FG000|Part 2 Study Period 4|Other|0|||
145888817|NCT04668274|526099077|FG001|Part 2 Study Period 4|Other|0|||
145888818|NCT04668274|526099078|FG002|Part 2 Study Period 4|Other|0|||
145888819|NCT04668274|526099079|FG003|Part 2 Study Period 4|Other|1|||
145888820|NCT02363439|526099080|FG000|Overall Study|Lack of Efficacy|4|||
145888821|NCT01682148|526099086|FG000|Overall Study|Withdrawal by Subject|2|||
145888822|NCT01682148|526099087|FG001|Overall Study|Withdrawal by Subject|0|||
145888823|NCT01682148|526099086|FG000|Overall Study|Lost to Follow-up|1|||
145888824|NCT01682148|526099087|FG001|Overall Study|Lost to Follow-up|2|||
145888825|NCT01682148|526099086|FG000|Overall Study|Protocol Violation|1|||
145888826|NCT01682148|526099087|FG001|Overall Study|Protocol Violation|1|||
145888827|NCT00171340|526099088|FG000|Overall Study|Adverse Event|46|||
145888828|NCT00171340|526099089|FG001|Overall Study|Adverse Event|42|||
145888829|NCT00171340|526099088|FG000|Overall Study|Lack of Efficacy|29|||
145888830|NCT00171340|526099089|FG001|Overall Study|Lack of Efficacy|41|||
145888831|NCT00171340|526099088|FG000|Overall Study|Protocol Violation|7|||
145888832|NCT00171340|526099089|FG001|Overall Study|Protocol Violation|8|||
145888833|NCT00171340|526099088|FG000|Overall Study|Withdrawal by Subject|22|||
145888834|NCT00171340|526099089|FG001|Overall Study|Withdrawal by Subject|19|||
145888835|NCT00171340|526099088|FG000|Overall Study|Lost to Follow-up|0|||
145888836|NCT00171340|526099089|FG001|Overall Study|Lost to Follow-up|5|||
145888837|NCT00171340|526099088|FG000|Overall Study|Abnormal Laboratory Results|2|||
145888838|NCT00171340|526099089|FG001|Overall Study|Abnormal Laboratory Results|0|||
145888839|NCT00171340|526099088|FG000|Overall Study|Abnormal Test Procedure Results|6|||
145888840|NCT00171340|526099089|FG001|Overall Study|Abnormal Test Procedure Results|11|||
145888841|NCT00171340|526099088|FG000|Overall Study|No Longer Required Study Drug|1|||
145888842|NCT00171340|526099089|FG001|Overall Study|No Longer Required Study Drug|1|||
145888843|NCT00171340|526099088|FG000|Overall Study|Administrative Problems|5|||
145888844|NCT00171340|526099089|FG001|Overall Study|Administrative Problems|2|||
145888845|NCT00171340|526099088|FG000|Overall Study|Death|6|||
145888846|NCT00171340|526099089|FG001|Overall Study|Death|6|||
145888847|NCT01056640|526099090|FG000|Overall Study|Withdrawal by Subject|11|||
145888848|NCT01056640|526099091|FG001|Overall Study|Withdrawal by Subject|8|||
145888849|NCT01056640|526099090|FG000|Overall Study|Death|15|||
145888850|NCT01056640|526099091|FG001|Overall Study|Death|4|||
145888851|NCT01803269|526099092|FG000|Overall Study|Withdrawal by Subject|3|||
145888852|NCT01803269|526099093|FG001|Overall Study|Withdrawal by Subject|0|||
145888853|NCT01803269|526099094|FG002|Overall Study|Withdrawal by Subject|0|||
145888854|NCT02087176|526099095|FG000|Overall Study|Withdrawal by Subject|1|||
145888855|NCT02087176|526099095|FG000|Overall Study|Death|10|||
145888856|NCT02087176|526099095|FG000|Overall Study|Censored|19|||
145888857|NCT02087176|526099095|FG000|Overall Study|Study Terminated by Sponsor|2|||
145888858|NCT00285584|526099096|FG000|Month 3|Lost to Follow-up|3|||
145888859|NCT00285584|526099097|FG001|Month 3|Lost to Follow-up|3|||
145888860|NCT00285584|526099096|FG000|Month 3|Withdrawal by Subject|1|||
145888861|NCT00285584|526099097|FG001|Month 3|Withdrawal by Subject|0|||
145888862|NCT00285584|526099096|FG000|Month 6|Lost to Follow-up|0|||
145888863|NCT00285584|526099097|FG001|Month 6|Lost to Follow-up|1|||
145888864|NCT03812991|526099098|FG000|Overall Study|Lost to Follow-up|3|||
145888865|NCT03812991|526099099|FG001|Overall Study|Lost to Follow-up|1|||
145888866|NCT01884688|526099104|FG000|Overall Study|Screen Failure|2|||
145888867|NCT04099641|526099108|FG000|Overall Study|Death|46|||
145967578|NCT01265498|526395484|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
145888868|NCT04099641|526099109|FG001|Overall Study|Death|12|||
145967579|NCT01265498|526395485|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
145967580|NCT00921024|526395489|FG000|Overall Study|Lost to Follow-up|2|||
145967581|NCT00921024|526395490|FG001|Overall Study|Lost to Follow-up|0|||
145967582|NCT00921024|526395489|FG000|Overall Study|Received concomittant therapy|2|||
145888869|NCT04099641|526099108|FG000|Overall Study|Lost to Follow-up|1|||
145888870|NCT04099641|526099109|FG001|Overall Study|Lost to Follow-up|0|||
145888871|NCT04099641|526099108|FG000|Overall Study|Withdrawal by Subject|2|||
145888872|NCT04099641|526099109|FG001|Overall Study|Withdrawal by Subject|0|||
145967583|NCT00921024|526395490|FG001|Overall Study|Received concomittant therapy|0|||
145888873|NCT00895037|526099110|FG000|Overall Study|Death|0|||
145888874|NCT00895037|526099111|FG001|Overall Study|Death|2|||
145888875|NCT00895037|526099112|FG002|Overall Study|Death|1|||
145888876|NCT01029392|526099120|FG000|Overall Study|Withdrawal by Subject|18|||
145888877|NCT01029392|526099121|FG001|Overall Study|Withdrawal by Subject|11|||
145967584|NCT00921024|526395489|FG000|Overall Study|Withdrawal by Subject|0|||
145967585|NCT00921024|526395490|FG001|Overall Study|Withdrawal by Subject|3|||
145967586|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Other than specified|2|||
145967587|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Other than specified|4|||
145967588|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
145967589|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
145967590|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Pregnancy|0|||
145967591|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Pregnancy|2|||
145967592|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Physician Decision|1|||
145888878|NCT01029392|526099120|FG000|Overall Study|Physician Decision|2|||
145888879|NCT01029392|526099121|FG001|Overall Study|Physician Decision|0|||
145888880|NCT01103479|526099122|FG000|Overall Study|Up to date with CRC screening|1|||
145888881|NCT01103479|526099123|FG001|Overall Study|Up to date with CRC screening|9|||
145888882|NCT01103479|526099124|FG002|Overall Study|Up to date with CRC screening|12|||
145888883|NCT01103479|526099122|FG000|Overall Study|Family history of CRC|1|||
145888884|NCT01103479|526099123|FG001|Overall Study|Family history of CRC|0|||
145888885|NCT01103479|526099124|FG002|Overall Study|Family history of CRC|2|||
145888886|NCT01103479|526099122|FG000|Overall Study|Active cancer|1|||
145888887|NCT01103479|526099123|FG001|Overall Study|Active cancer|0|||
145888888|NCT01103479|526099124|FG002|Overall Study|Active cancer|0|||
145888889|NCT01103479|526099122|FG000|Overall Study|Saw non-study physician|2|||
145888890|NCT01103479|526099123|FG001|Overall Study|Saw non-study physician|0|||
145888891|NCT01103479|526099124|FG002|Overall Study|Saw non-study physician|0|||
145888892|NCT01523587|526099125|FG000|Overall Study|Other than listed|5|||
146086790|NCT04153149|526838383|FG001|Double Blind Period|Physician Decision|0|||
145888893|NCT01523587|526099126|FG001|Overall Study|Other than listed|5|||
145888894|NCT01523587|526099125|FG000|Overall Study|Worsening of underlying cancer disease|19|||
145888895|NCT01523587|526099126|FG001|Overall Study|Worsening of underlying cancer disease|34|||
145888896|NCT01523587|526099125|FG000|Overall Study|Adverse Event|68|||
145888897|NCT01523587|526099126|FG001|Overall Study|Adverse Event|52|||
145888898|NCT01523587|526099125|FG000|Overall Study|Protocol Violation|5|||
145888899|NCT01523587|526099126|FG001|Overall Study|Protocol Violation|3|||
145888900|NCT01523587|526099125|FG000|Overall Study|Lost to Follow-up|2|||
145888901|NCT01523587|526099126|FG001|Overall Study|Lost to Follow-up|2|||
145888902|NCT01523587|526099125|FG000|Overall Study|Withdrawal by Subject|28|||
145888903|NCT01523587|526099126|FG001|Overall Study|Withdrawal by Subject|20|||
145888904|NCT01523587|526099125|FG000|Overall Study|Withdrew due to Progressive disease|265|||
145888905|NCT01523587|526099126|FG001|Overall Study|Withdrew due to Progressive disease|279|||
145888906|NCT01523587|526099125|FG000|Overall Study|Randomised but bot treated|6|||
145888907|NCT01523587|526099126|FG001|Overall Study|Randomised but bot treated|2|||
145888908|NCT01298778|526099127|FG000|Overall Study|Lost to Follow-up|2|||
145888909|NCT01298778|526099128|FG001|Overall Study|Lost to Follow-up|3|||
145888910|NCT01298778|526099127|FG000|Overall Study|Incorrect use of VAS|1|||
145888911|NCT01298778|526099128|FG001|Overall Study|Incorrect use of VAS|0|||
145888912|NCT01298778|526099127|FG000|Overall Study|Withdrawal by Subject|0|||
145888913|NCT01298778|526099128|FG001|Overall Study|Withdrawal by Subject|1|||
145888914|NCT01298778|526099127|FG000|Overall Study|Protocol Violation|0|||
145888915|NCT01298778|526099128|FG001|Overall Study|Protocol Violation|1|||
145888916|NCT01298778|526099127|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
145888917|NCT01298778|526099128|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
145888918|NCT00536484|526099129|FG000|Overall Study|Adverse Event|21|||
145888919|NCT00536484|526099130|FG001|Overall Study|Adverse Event|34|||
145888920|NCT00536484|526099129|FG000|Overall Study|Withdrawal by Subject|11|||
145888921|NCT00536484|526099130|FG001|Overall Study|Withdrawal by Subject|11|||
145888922|NCT00536484|526099129|FG000|Overall Study|Lost to Follow-up|8|||
145967593|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Physician Decision|1|||
145967594|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
145967595|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
145967596|NCT02003144|526395497|FG000|Open Label Maintenance Phase|Adverse Event|2|||
145967597|NCT02003144|526395498|FG001|Open Label Maintenance Phase|Adverse Event|1|||
145967598|NCT02034006|526397556|FG000|Overall Study|Withdrawal by Subject|7|||
145967599|NCT02034006|526397556|FG000|Overall Study|Lost to Follow-up|5|||
145967600|NCT02034006|526397556|FG000|Overall Study|Death|1|||
145967601|NCT02034006|526397556|FG000|Overall Study|Pregnancy|1|||
145967602|NCT03098979|526397560|FG000|Overall Study|Adverse Event|1|||
145967603|NCT03098979|526397561|FG001|Overall Study|Adverse Event|0|||
145967604|NCT03098979|526397562|FG002|Overall Study|Adverse Event|1|||
145967605|NCT03098979|526397563|FG003|Overall Study|Adverse Event|4|||
145967606|NCT03098979|526397564|FG004|Overall Study|Adverse Event|6|||
145967607|NCT03098979|526397565|FG005|Overall Study|Adverse Event|1|||
145967608|NCT03098979|526397560|FG000|Overall Study|Withdrawal by Subject|2|||
145967609|NCT03098979|526397561|FG001|Overall Study|Withdrawal by Subject|1|||
145967610|NCT03098979|526397562|FG002|Overall Study|Withdrawal by Subject|1|||
145967611|NCT03098979|526397563|FG003|Overall Study|Withdrawal by Subject|1|||
145967612|NCT03098979|526397564|FG004|Overall Study|Withdrawal by Subject|2|||
145967613|NCT03098979|526397565|FG005|Overall Study|Withdrawal by Subject|1|||
145967614|NCT03098979|526397560|FG000|Overall Study|Death|1|||
145967615|NCT03098979|526397561|FG001|Overall Study|Death|0|||
145967616|NCT03098979|526397562|FG002|Overall Study|Death|2|||
145967617|NCT03098979|526397563|FG003|Overall Study|Death|0|||
145967618|NCT03098979|526397564|FG004|Overall Study|Death|1|||
145967619|NCT03098979|526397565|FG005|Overall Study|Death|0|||
145967620|NCT03098979|526397560|FG000|Overall Study|Physician Decision|2|||
145967621|NCT03098979|526397561|FG001|Overall Study|Physician Decision|1|||
145967622|NCT03098979|526397562|FG002|Overall Study|Physician Decision|0|||
145967623|NCT03098979|526397563|FG003|Overall Study|Physician Decision|0|||
145967624|NCT03098979|526397564|FG004|Overall Study|Physician Decision|0|||
145967625|NCT03098979|526397565|FG005|Overall Study|Physician Decision|0|||
145967626|NCT03098979|526397560|FG000|Overall Study|Non-compliance|0|||
145967627|NCT03098979|526397561|FG001|Overall Study|Non-compliance|0|||
145967628|NCT03098979|526397562|FG002|Overall Study|Non-compliance|0|||
145888923|NCT00536484|526099130|FG001|Overall Study|Lost to Follow-up|6|||
145888924|NCT00536484|526099129|FG000|Overall Study|Lack of Efficacy|16|||
145888925|NCT00536484|526099130|FG001|Overall Study|Lack of Efficacy|5|||
145888926|NCT00536484|526099129|FG000|Overall Study|Other|4|||
145888927|NCT00536484|526099130|FG001|Overall Study|Other|0|||
145967629|NCT03098979|526397563|FG003|Overall Study|Non-compliance|0|||
145967630|NCT03098979|526397564|FG004|Overall Study|Non-compliance|0|||
145967631|NCT03098979|526397565|FG005|Overall Study|Non-compliance|1|||
145967632|NCT03098979|526397560|FG000|Overall Study|Protocol Violation|0|||
145967633|NCT03098979|526397561|FG001|Overall Study|Protocol Violation|0|||
145967634|NCT03098979|526397562|FG002|Overall Study|Protocol Violation|0|||
145967635|NCT03098979|526397563|FG003|Overall Study|Protocol Violation|0|||
145967636|NCT03098979|526397564|FG004|Overall Study|Protocol Violation|0|||
145967637|NCT03098979|526397565|FG005|Overall Study|Protocol Violation|1|||
145967638|NCT03736967|526397566|FG000|Overall Study|Withdrawal by Subject|26|||
146086791|NCT04153149|526838384|FG002|Double Blind Period|Physician Decision|0|||
146086792|NCT04153149|526838385|FG003|Double Blind Period|Physician Decision|0|||
146086793|NCT04153149|526838382|FG000|Open Label Extension Period|Death|0|||
146086794|NCT04153149|526838383|FG001|Open Label Extension Period|Death|0|||
146086795|NCT04153149|526838384|FG002|Open Label Extension Period|Death|7|||
146086796|NCT04153149|526838385|FG003|Open Label Extension Period|Death|3|||
145967639|NCT03736967|526397567|FG001|Overall Study|Withdrawal by Subject|25|||
145967640|NCT03736967|526397568|FG002|Overall Study|Withdrawal by Subject|23|||
145967641|NCT03736967|526397569|FG003|Overall Study|Withdrawal by Subject|26|||
145967642|NCT03736967|526397566|FG000|Overall Study|Lost to Follow-up|3|||
145967643|NCT03736967|526397567|FG001|Overall Study|Lost to Follow-up|2|||
145967644|NCT03736967|526397568|FG002|Overall Study|Lost to Follow-up|1|||
145967645|NCT03736967|526397569|FG003|Overall Study|Lost to Follow-up|1|||
145967646|NCT03736967|526397566|FG000|Overall Study|Physician Decision|1|||
145967647|NCT03736967|526397567|FG001|Overall Study|Physician Decision|0|||
145967648|NCT03736967|526397568|FG002|Overall Study|Physician Decision|0|||
145967649|NCT03736967|526397569|FG003|Overall Study|Physician Decision|1|||
145967650|NCT03736967|526397566|FG000|Overall Study|Adverse Event|0|||
145967651|NCT03736967|526397567|FG001|Overall Study|Adverse Event|1|||
145967652|NCT03736967|526397568|FG002|Overall Study|Adverse Event|0|||
145967653|NCT03736967|526397569|FG003|Overall Study|Adverse Event|1|||
145967654|NCT03736967|526397566|FG000|Overall Study|Death|0|||
145967655|NCT03736967|526397567|FG001|Overall Study|Death|0|||
145967656|NCT03736967|526397568|FG002|Overall Study|Death|0|||
145967657|NCT03736967|526397569|FG003|Overall Study|Death|1|||
145967658|NCT03736967|526397566|FG000|Overall Study|Randomized but never treated|1|||
145967659|NCT03736967|526397567|FG001|Overall Study|Randomized but never treated|0|||
145967660|NCT03736967|526397568|FG002|Overall Study|Randomized but never treated|0|||
145967661|NCT03736967|526397569|FG003|Overall Study|Randomized but never treated|0|||
145967662|NCT02419807|526397570|FG000|Overall Study|Withdrawal by Subject|4|||
145967663|NCT02419807|526397570|FG000|Overall Study|Physician Decision|1|||
145967664|NCT02419807|526397570|FG000|Overall Study|Protocol Violation|5|||
145967665|NCT03587636|526397571|FG000|Overall Study|Lost to Follow-up|2|||
145967666|NCT03587636|526397572|FG001|Overall Study|Lost to Follow-up|5|||
146086797|NCT04153149|526838382|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
146086798|NCT04153149|526838383|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
145967667|NCT01006629|526397573|FG000|Overall Study|Adverse Event|1|||
146086799|NCT04153149|526838384|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
146293215|NCT00392327|527587663|FG006|Overall Study|Physician Decision|5|||
146293216|NCT00392327|527587664|FG007|Overall Study|Physician Decision|3|||
146293217|NCT00392327|527587657|FG000|Overall Study|Protocol Violation|0|||
146293218|NCT00392327|527587658|FG001|Overall Study|Protocol Violation|0|||
146293219|NCT00392327|527587659|FG002|Overall Study|Protocol Violation|1|||
146293220|NCT00392327|527587660|FG003|Overall Study|Protocol Violation|0|||
146293221|NCT00392327|527587661|FG004|Overall Study|Protocol Violation|0|||
146293222|NCT00392327|527587662|FG005|Overall Study|Protocol Violation|0|||
146293223|NCT00392327|527587663|FG006|Overall Study|Protocol Violation|0|||
146293224|NCT00392327|527587664|FG007|Overall Study|Protocol Violation|0|||
146293225|NCT00392327|527587657|FG000|Overall Study|Withdrawal by Subject|3|||
146293226|NCT00392327|527587658|FG001|Overall Study|Withdrawal by Subject|2|||
146293227|NCT00392327|527587659|FG002|Overall Study|Withdrawal by Subject|4|||
146293228|NCT00392327|527587660|FG003|Overall Study|Withdrawal by Subject|6|||
146293229|NCT00392327|527587661|FG004|Overall Study|Withdrawal by Subject|0|||
146293230|NCT00392327|527587662|FG005|Overall Study|Withdrawal by Subject|1|||
146293231|NCT00392327|527587663|FG006|Overall Study|Withdrawal by Subject|1|||
146293232|NCT00392327|527587664|FG007|Overall Study|Withdrawal by Subject|5|||
146293233|NCT00392327|527587657|FG000|Overall Study|Ineligible|0|||
146293234|NCT00392327|527587658|FG001|Overall Study|Ineligible|4|||
146293235|NCT00392327|527587659|FG002|Overall Study|Ineligible|3|||
146293236|NCT00392327|527587660|FG003|Overall Study|Ineligible|2|||
146293237|NCT00392327|527587661|FG004|Overall Study|Ineligible|0|||
146293238|NCT00392327|527587662|FG005|Overall Study|Ineligible|0|||
145967668|NCT01006629|526397573|FG000|Overall Study|Parent refused to continue participation|1|||
145967669|NCT01006629|526397573|FG000|Overall Study|Parent unable to perform site visit|4|||
146293239|NCT00392327|527587663|FG006|Overall Study|Ineligible|0|||
146293240|NCT00392327|527587664|FG007|Overall Study|Ineligible|0|||
145888928|NCT00384176|526099132|FG000|Overall Study|Death|239|||
145967670|NCT04459338|526397576|FG000|Overall Study|Loss of IV during study|1|||
145888929|NCT00384176|526099133|FG001|Overall Study|Death|247|||
145967671|NCT04459338|526397577|FG001|Overall Study|Loss of IV during study|0|||
145967672|NCT02665117|526397578|FG000|Overall Study|Physician Decision|1|||
145888930|NCT00384176|526099134|FG002|Overall Study|Death|105|||
145888931|NCT00384176|526099132|FG000|Overall Study|Withdrawal by Subject|52|||
145888932|NCT00384176|526099133|FG001|Overall Study|Withdrawal by Subject|48|||
145888933|NCT00384176|526099134|FG002|Overall Study|Withdrawal by Subject|22|||
145888934|NCT00384176|526099132|FG000|Overall Study|Lost to Follow-up|16|||
145888935|NCT00384176|526099133|FG001|Overall Study|Lost to Follow-up|18|||
145888936|NCT00384176|526099134|FG002|Overall Study|Lost to Follow-up|4|||
145888937|NCT00384176|526099132|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
145888938|NCT00384176|526099133|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
145888939|NCT00384176|526099134|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
145888940|NCT00384176|526099132|FG000|Overall Study|Longer QTC as Visit 1|1|||
145888941|NCT00384176|526099133|FG001|Overall Study|Longer QTC as Visit 1|0|||
145888942|NCT00384176|526099134|FG002|Overall Study|Longer QTC as Visit 1|0|||
145888943|NCT00384176|526099132|FG000|Overall Study|Toxicity of treatment|1|||
145888944|NCT00384176|526099133|FG001|Overall Study|Toxicity of treatment|0|||
145888945|NCT00384176|526099134|FG002|Overall Study|Toxicity of treatment|0|||
145888946|NCT00384176|526099132|FG000|Overall Study|Did not receive study treatment|0|||
145888947|NCT00384176|526099133|FG001|Overall Study|Did not receive study treatment|1|||
145888948|NCT00384176|526099134|FG002|Overall Study|Did not receive study treatment|1|||
145888949|NCT00384176|526099132|FG000|Overall Study|Physician Decision|0|||
145888950|NCT00384176|526099133|FG001|Overall Study|Physician Decision|2|||
145888951|NCT00384176|526099134|FG002|Overall Study|Physician Decision|0|||
145888952|NCT00384176|526099132|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
145888953|NCT00384176|526099133|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
145888954|NCT00384176|526099134|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
145967673|NCT02665117|526397579|FG001|Overall Study|Physician Decision|0|||
145967674|NCT00784875|526397580|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
145967675|NCT00784875|526397581|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
146293241|NCT00178126|527587665|FG000|Overall Study|Lost to Follow-up|21|||
146293242|NCT00178126|527587666|FG001|Overall Study|Lost to Follow-up|21|||
146293243|NCT00178126|527587665|FG000|Overall Study|did not receive intervention|4|||
146293244|NCT00178126|527587666|FG001|Overall Study|did not receive intervention|6|||
146293245|NCT01281969|527587669|FG000|Overall Study|not randomized didn't meet criteria|0|||
146293246|NCT01281969|527587670|FG001|Overall Study|not randomized didn't meet criteria|0|||
145967676|NCT00784875|526397582|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
145967677|NCT00784875|526397583|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
145967678|NCT00784875|526397580|FG000|Period A - Baseline|Adverse Event|0|||
145888955|NCT01425528|526099135|FG000|Overall Study|Withdrawal by Subject|1|||
145888956|NCT01425528|526099136|FG001|Overall Study|Withdrawal by Subject|1|||
145888957|NCT00307931|526099137|FG000|Overall Study|Adverse Event|1|||
145888958|NCT02243293|526099138|FG000|Overall Study|Adverse Event|1|||
145888959|NCT02243293|526099139|FG001|Overall Study|Adverse Event|0|||
145888960|NCT02243293|526099140|FG002|Overall Study|Adverse Event|0|||
145888961|NCT02243293|526099141|FG003|Overall Study|Adverse Event|0|||
145888962|NCT02243293|526099142|FG004|Overall Study|Adverse Event|0|||
145888963|NCT02243293|526099143|FG005|Overall Study|Adverse Event|0|||
145888964|NCT02243293|526099144|FG006|Overall Study|Adverse Event|0|||
145888965|NCT02243293|526099145|FG007|Overall Study|Adverse Event|0|||
145888966|NCT02243293|526099146|FG008|Overall Study|Adverse Event|0|||
145888967|NCT02243293|526099147|FG009|Overall Study|Adverse Event|0|||
145888968|NCT02243293|526099148|FG010|Overall Study|Adverse Event|0|||
145888969|NCT02243293|526099149|FG011|Overall Study|Adverse Event|0|||
145888970|NCT02243293|526099150|FG012|Overall Study|Adverse Event|0|||
145888971|NCT02243293|526099151|FG013|Overall Study|Adverse Event|0|||
145888972|NCT02243293|526099152|FG014|Overall Study|Adverse Event|0|||
145888973|NCT02243293|526099153|FG015|Overall Study|Adverse Event|1|||
145888974|NCT02243293|526099154|FG016|Overall Study|Adverse Event|0|||
145888975|NCT02243293|526099155|FG017|Overall Study|Adverse Event|0|||
145888976|NCT02243293|526099156|FG018|Overall Study|Adverse Event|0|||
145888977|NCT02243293|526099157|FG019|Overall Study|Adverse Event|0|||
145888978|NCT02243293|526099158|FG020|Overall Study|Adverse Event|1|||
145888979|NCT02243293|526099159|FG021|Overall Study|Adverse Event|0|||
145888980|NCT02243293|526099138|FG000|Overall Study|Withdrawal by Subject|1|||
145888981|NCT02243293|526099139|FG001|Overall Study|Withdrawal by Subject|0|||
145888982|NCT02243293|526099140|FG002|Overall Study|Withdrawal by Subject|0|||
145888983|NCT02243293|526099141|FG003|Overall Study|Withdrawal by Subject|0|||
145888984|NCT02243293|526099142|FG004|Overall Study|Withdrawal by Subject|0|||
145888985|NCT02243293|526099143|FG005|Overall Study|Withdrawal by Subject|0|||
145888986|NCT02243293|526099144|FG006|Overall Study|Withdrawal by Subject|0|||
145888987|NCT02243293|526099145|FG007|Overall Study|Withdrawal by Subject|0|||
145888988|NCT02243293|526099146|FG008|Overall Study|Withdrawal by Subject|0|||
145888989|NCT02243293|526099147|FG009|Overall Study|Withdrawal by Subject|1|||
145888990|NCT02243293|526099148|FG010|Overall Study|Withdrawal by Subject|0|||
145888991|NCT02243293|526099149|FG011|Overall Study|Withdrawal by Subject|1|||
145888992|NCT02243293|526099150|FG012|Overall Study|Withdrawal by Subject|0|||
145888993|NCT02243293|526099151|FG013|Overall Study|Withdrawal by Subject|0|||
145888994|NCT02243293|526099152|FG014|Overall Study|Withdrawal by Subject|0|||
145888995|NCT02243293|526099153|FG015|Overall Study|Withdrawal by Subject|0|||
145888996|NCT02243293|526099154|FG016|Overall Study|Withdrawal by Subject|0|||
145888997|NCT02243293|526099155|FG017|Overall Study|Withdrawal by Subject|0|||
145888998|NCT02243293|526099156|FG018|Overall Study|Withdrawal by Subject|0|||
145888999|NCT02243293|526099157|FG019|Overall Study|Withdrawal by Subject|0|||
145889000|NCT02243293|526099158|FG020|Overall Study|Withdrawal by Subject|0|||
145889001|NCT02243293|526099159|FG021|Overall Study|Withdrawal by Subject|1|||
145889002|NCT02243293|526099138|FG000|Overall Study|Lost to Follow-up|0|||
145889003|NCT02243293|526099139|FG001|Overall Study|Lost to Follow-up|1|||
145967679|NCT00784875|526397581|FG001|Period A - Baseline|Adverse Event|0|||
145889004|NCT02243293|526099140|FG002|Overall Study|Lost to Follow-up|1|||
145889005|NCT02243293|526099141|FG003|Overall Study|Lost to Follow-up|1|||
145889006|NCT02243293|526099142|FG004|Overall Study|Lost to Follow-up|0|||
145889007|NCT02243293|526099143|FG005|Overall Study|Lost to Follow-up|0|||
145889008|NCT02243293|526099144|FG006|Overall Study|Lost to Follow-up|3|||
145889009|NCT02243293|526099145|FG007|Overall Study|Lost to Follow-up|0|||
145889010|NCT02243293|526099146|FG008|Overall Study|Lost to Follow-up|0|||
145889011|NCT02243293|526099147|FG009|Overall Study|Lost to Follow-up|0|||
145889012|NCT02243293|526099148|FG010|Overall Study|Lost to Follow-up|0|||
146232893|NCT00943917|527370706|FG007|Stage II|Withdrawal by Subject|0|||
145889013|NCT02243293|526099149|FG011|Overall Study|Lost to Follow-up|2|||
145967680|NCT00784875|526397582|FG002|Period A - Baseline|Adverse Event|0|||
145967681|NCT00784875|526397583|FG003|Period A - Baseline|Adverse Event|8|||
145967682|NCT00784875|526397580|FG000|Period A - Baseline|Protocol Violation|0|||
146293247|NCT01281969|527587671|FG002|Overall Study|not randomized didn't meet criteria|7|||
146293248|NCT01281969|527587669|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
146293249|NCT01281969|527587670|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
145967683|NCT00784875|526397581|FG001|Period A - Baseline|Protocol Violation|0|||
145967684|NCT00784875|526397582|FG002|Period A - Baseline|Protocol Violation|0|||
146293250|NCT01281969|527587671|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
146293251|NCT01281969|527587669|FG000|Overall Study|not randomized, child consent not given|0|||
146293252|NCT01281969|527587670|FG001|Overall Study|not randomized, child consent not given|0|||
146293253|NCT01281969|527587671|FG002|Overall Study|not randomized, child consent not given|2|||
146293254|NCT01323634|527587672|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
146293255|NCT01323634|527587673|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
146293256|NCT01323634|527587674|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
146293257|NCT01323634|527587672|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
146293258|NCT01323634|527587673|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
146293259|NCT01323634|527587674|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
146293260|NCT01323634|527587672|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
146293261|NCT01323634|527587673|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146293262|NCT01323634|527587674|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146293263|NCT01323634|527587672|FG000|2-week Run-in Period|Physician Decision|5|||
146293264|NCT01323634|527587673|FG001|2-week Run-in Period|Physician Decision|0|||
146293265|NCT01323634|527587674|FG002|2-week Run-in Period|Physician Decision|0|||
146293266|NCT01323634|527587672|FG000|2-week Run-in Period|Protocol Violation|1|||
146293267|NCT01323634|527587673|FG001|2-week Run-in Period|Protocol Violation|0|||
146293268|NCT01323634|527587674|FG002|2-week Run-in Period|Protocol Violation|0|||
146293269|NCT01323634|527587672|FG000|2-week Run-in Period|Adverse Event|1|||
146293270|NCT01323634|527587673|FG001|2-week Run-in Period|Adverse Event|0|||
146293271|NCT01323634|527587674|FG002|2-week Run-in Period|Adverse Event|0|||
146293272|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
146293273|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
146293274|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
146293275|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146293276|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
146293277|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
146293278|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
146293279|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
146293280|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
146293281|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145967685|NCT00784875|526397583|FG003|Period A - Baseline|Protocol Violation|25|||
145967686|NCT00784875|526397580|FG000|Period A - Baseline|Withdrawal by Subject|0|||
145967687|NCT00784875|526397581|FG001|Period A - Baseline|Withdrawal by Subject|0|||
145967688|NCT00784875|526397582|FG002|Period A - Baseline|Withdrawal by Subject|0|||
145967689|NCT00784875|526397583|FG003|Period A - Baseline|Withdrawal by Subject|27|||
145967690|NCT00784875|526397580|FG000|Period A - Baseline|Physician Decision|0|||
145967691|NCT00784875|526397581|FG001|Period A - Baseline|Physician Decision|0|||
145967692|NCT00784875|526397582|FG002|Period A - Baseline|Physician Decision|0|||
145967693|NCT00784875|526397583|FG003|Period A - Baseline|Physician Decision|2|||
145967694|NCT00784875|526397580|FG000|Period A - Baseline|Sponsor Decision|0|||
145967695|NCT00784875|526397581|FG001|Period A - Baseline|Sponsor Decision|0|||
145967696|NCT00784875|526397582|FG002|Period A - Baseline|Sponsor Decision|0|||
145967697|NCT00784875|526397583|FG003|Period A - Baseline|Sponsor Decision|113|||
145967698|NCT00784875|526397580|FG000|Period A - Baseline|Lost to Follow-up|0|||
145967699|NCT00784875|526397581|FG001|Period A - Baseline|Lost to Follow-up|0|||
145967700|NCT00784875|526397582|FG002|Period A - Baseline|Lost to Follow-up|0|||
145967701|NCT00784875|526397583|FG003|Period A - Baseline|Lost to Follow-up|2|||
145967702|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
145967703|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
145967704|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
145967705|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
145967706|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
145967707|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
145967708|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
145967709|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
145967710|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
145967711|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
145967712|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
145967713|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
145967714|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145967715|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
145967716|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145967717|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145967718|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
145967719|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
145967720|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
145967721|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
145967722|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
145967723|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
145967724|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
145967725|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
145967726|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
145967727|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
145967728|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
145967729|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
145967730|NCT00784875|526397580|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145967731|NCT00784875|526397581|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145967732|NCT00784875|526397582|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
145967733|NCT00784875|526397583|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145967734|NCT00784875|526397580|FG000|Period C|Adverse Event|1|||
145967735|NCT00784875|526397581|FG001|Period C|Adverse Event|0|||
145967736|NCT00784875|526397582|FG002|Period C|Adverse Event|4|||
145967737|NCT00784875|526397583|FG003|Period C|Adverse Event|2|||
145967738|NCT00784875|526397580|FG000|Period C|Protocol Violation|0|||
145967739|NCT00784875|526397581|FG001|Period C|Protocol Violation|0|||
145967740|NCT00784875|526397582|FG002|Period C|Protocol Violation|1|||
145967741|NCT00784875|526397583|FG003|Period C|Protocol Violation|2|||
145967742|NCT00784875|526397580|FG000|Period C|Lack of Efficacy|0|||
145967743|NCT00784875|526397581|FG001|Period C|Lack of Efficacy|0|||
145967744|NCT00784875|526397582|FG002|Period C|Lack of Efficacy|1|||
145967745|NCT00784875|526397583|FG003|Period C|Lack of Efficacy|0|||
145967746|NCT00784875|526397580|FG000|Period C|Withdrawal by Subject|1|||
145967747|NCT00784875|526397581|FG001|Period C|Withdrawal by Subject|1|||
145967748|NCT00784875|526397582|FG002|Period C|Withdrawal by Subject|2|||
145967749|NCT00784875|526397583|FG003|Period C|Withdrawal by Subject|0|||
145967750|NCT00784875|526397580|FG000|Period C|Physician Decision|0|||
145889014|NCT02243293|526099150|FG012|Overall Study|Lost to Follow-up|0|||
145889015|NCT02243293|526099151|FG013|Overall Study|Lost to Follow-up|0|||
145889016|NCT02243293|526099152|FG014|Overall Study|Lost to Follow-up|0|||
145889017|NCT02243293|526099153|FG015|Overall Study|Lost to Follow-up|0|||
145889018|NCT02243293|526099154|FG016|Overall Study|Lost to Follow-up|3|||
145889019|NCT02243293|526099155|FG017|Overall Study|Lost to Follow-up|1|||
145889020|NCT02243293|526099156|FG018|Overall Study|Lost to Follow-up|0|||
145889021|NCT02243293|526099157|FG019|Overall Study|Lost to Follow-up|0|||
145889022|NCT02243293|526099158|FG020|Overall Study|Lost to Follow-up|1|||
145889023|NCT02243293|526099159|FG021|Overall Study|Lost to Follow-up|2|||
145889024|NCT02243293|526099138|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
145889025|NCT02243293|526099139|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
145889026|NCT02243293|526099140|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
145889027|NCT02243293|526099141|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
145889028|NCT02243293|526099142|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
145889029|NCT02243293|526099143|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
145889030|NCT02243293|526099144|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
145967751|NCT00784875|526397581|FG001|Period C|Physician Decision|0|||
145967752|NCT00784875|526397582|FG002|Period C|Physician Decision|1|||
146293282|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146293283|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
146293284|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
146293285|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
145967753|NCT00784875|526397583|FG003|Period C|Physician Decision|1|||
145967754|NCT00784875|526397580|FG000|Period C|Sponsor Decision|5|||
145967755|NCT00784875|526397581|FG001|Period C|Sponsor Decision|5|||
145967756|NCT00784875|526397582|FG002|Period C|Sponsor Decision|4|||
145967757|NCT00784875|526397583|FG003|Period C|Sponsor Decision|2|||
145967758|NCT00784875|526397580|FG000|Period D|Adverse Event|0|||
145967759|NCT00784875|526397581|FG001|Period D|Adverse Event|2|||
145967760|NCT00784875|526397582|FG002|Period D|Adverse Event|2|||
145967761|NCT00784875|526397583|FG003|Period D|Adverse Event|0|||
145967762|NCT00784875|526397580|FG000|Period D|Protocol Violation|1|||
145967763|NCT00784875|526397581|FG001|Period D|Protocol Violation|0|||
145967764|NCT00784875|526397582|FG002|Period D|Protocol Violation|0|||
146086800|NCT04153149|526838385|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
145967765|NCT00784875|526397583|FG003|Period D|Protocol Violation|0|||
145967766|NCT00784875|526397580|FG000|Period D|Withdrawal by Subject|2|||
145967767|NCT00784875|526397581|FG001|Period D|Withdrawal by Subject|0|||
145967768|NCT00784875|526397582|FG002|Period D|Withdrawal by Subject|2|||
145967769|NCT00784875|526397583|FG003|Period D|Withdrawal by Subject|0|||
145967770|NCT00784875|526397580|FG000|Period D|Physician Decision|0|||
145967771|NCT00784875|526397581|FG001|Period D|Physician Decision|1|||
145967772|NCT00784875|526397582|FG002|Period D|Physician Decision|0|||
145967773|NCT00784875|526397583|FG003|Period D|Physician Decision|0|||
145967774|NCT00784875|526397580|FG000|Period D|Sponsor Decision|1|||
145967775|NCT00784875|526397581|FG001|Period D|Sponsor Decision|1|||
145967776|NCT00784875|526397582|FG002|Period D|Sponsor Decision|1|||
146086801|NCT04153149|526838382|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
146087791|NCT04062123|526841842|FG001|Overall Study|Withdrawal by Subject|1|||
145967777|NCT00784875|526397583|FG003|Period D|Sponsor Decision|0|||
145967778|NCT00784875|526397580|FG000|Period D|Lost to Follow-up|1|||
145967779|NCT00784875|526397581|FG001|Period D|Lost to Follow-up|0|||
145967780|NCT00784875|526397582|FG002|Period D|Lost to Follow-up|1|||
145967781|NCT00784875|526397583|FG003|Period D|Lost to Follow-up|1|||
145967782|NCT00095979|526397588|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
145967783|NCT04018066|526397589|FG000|Overall Study|participants started taking medications during the study period|3|||
145967784|NCT04018066|526397589|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
145967785|NCT02732639|526397592|FG000|Overall Study|Lost to Follow-up|1|||
145967786|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
145967787|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145967788|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145967789|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145967790|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
145967791|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145967792|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145967793|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145967794|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
145967795|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
145967796|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
145967797|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
145967798|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
145967799|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145967800|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145967801|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145967802|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
145967803|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
145967804|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
145967805|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
145967806|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
145967807|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145967808|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145967809|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145967810|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
145967811|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145967812|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145967813|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145967814|NCT01668797|526397593|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
145967815|NCT01668797|526397594|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145967816|NCT01668797|526397595|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145967817|NCT01668797|526397596|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145967818|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145967819|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
145967820|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145967821|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145967822|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145967823|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
145967824|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145967825|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145967826|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
146086802|NCT04153149|526838383|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
146293286|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
146293287|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
146293288|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
146293289|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
146293290|NCT01323634|527587672|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
146293291|NCT01323634|527587673|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
146293292|NCT01323634|527587674|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
146293293|NCT01575028|527587675|FG000|Overall Study|Physician Decision|0|||
146293294|NCT01575028|527587676|FG001|Overall Study|Physician Decision|1|||
146293295|NCT01182194|527587677|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
146293296|NCT01182194|527587678|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
146293297|NCT01585987|527587679|FG000|Randomized|Withdrawal by Subject|0|||
146293298|NCT01585987|527587680|FG001|Randomized|Withdrawal by Subject|4|||
146293299|NCT01585987|527587679|FG000|Randomized|No longer met criteria|0|||
146293300|NCT01585987|527587680|FG001|Randomized|No longer met criteria|2|||
146293301|NCT01585987|527587679|FG000|Treated|Disease Progression|39|||
146293302|NCT01585987|527587680|FG001|Treated|Disease Progression|36|||
146293303|NCT01585987|527587679|FG000|Treated|Study Drug Toxicity|9|||
146293304|NCT01585987|527587680|FG001|Treated|Study Drug Toxicity|5|||
146293305|NCT01585987|527587679|FG000|Treated|Adverse Event|3|||
146293306|NCT01585987|527587680|FG001|Treated|Adverse Event|0|||
146293307|NCT01585987|527587679|FG000|Treated|Withdrawal by Subject|1|||
146293308|NCT01585987|527587680|FG001|Treated|Withdrawal by Subject|2|||
146293309|NCT01585987|527587679|FG000|Treated|Death|1|||
146293310|NCT01585987|527587680|FG001|Treated|Death|0|||
146293311|NCT01585987|527587679|FG000|Treated|Lost to Follow-up|0|||
146293312|NCT01585987|527587680|FG001|Treated|Lost to Follow-up|1|||
146293313|NCT01585987|527587679|FG000|Treated|Maximum Clinical Benefit|0|||
146293314|NCT01585987|527587680|FG001|Treated|Maximum Clinical Benefit|1|||
146293315|NCT01585987|527587679|FG000|Treated|Non-Specified|1|||
146293316|NCT01585987|527587680|FG001|Treated|Non-Specified|2|||
146293317|NCT01585987|527587679|FG000|Treated|Subject Request|0|||
146293318|NCT01585987|527587680|FG001|Treated|Subject Request|1|||
146293319|NCT01585987|527587679|FG000|Treated|Poor/Non-Compliance|0|||
146293320|NCT01585987|527587680|FG001|Treated|Poor/Non-Compliance|1|||
146293321|NCT02739360|527587684|FG000|Overall Study|Adverse Event|1|||
146293322|NCT02739360|527587684|FG000|Overall Study|Study terminated by Sponsor|2|||
146293323|NCT01163916|527587685|FG000|Overall Study|Withdrawal by Subject|2|||
146293324|NCT01163916|527587686|FG001|Overall Study|Withdrawal by Subject|0|||
146293325|NCT01163916|527587687|FG002|Overall Study|Withdrawal by Subject|2|||
146293326|NCT01163916|527587685|FG000|Overall Study|Adverse Event|2|||
146293327|NCT01163916|527587686|FG001|Overall Study|Adverse Event|0|||
146293328|NCT01163916|527587687|FG002|Overall Study|Adverse Event|1|||
146293329|NCT01163916|527587685|FG000|Overall Study|Lack of Efficacy|2|||
146293330|NCT01163916|527587686|FG001|Overall Study|Lack of Efficacy|0|||
146293331|NCT01163916|527587687|FG002|Overall Study|Lack of Efficacy|1|||
146293332|NCT01163916|527587685|FG000|Overall Study|Other|24|||
146293333|NCT01163916|527587686|FG001|Overall Study|Other|4|||
146293334|NCT01163916|527587687|FG002|Overall Study|Other|16|||
146293335|NCT00026208|527587688|FG000|Overall Study|Complications of auto accident|1|||
146293336|NCT00026208|527587689|FG001|Overall Study|Complications of auto accident|0|||
146293337|NCT00423930|527587691|FG000|Overall Study|Withdrawal by Subject|2|||
146293338|NCT02903368|527587692|FG000|Part 1|Adverse Event|3|||
146293339|NCT02903368|527587693|FG001|Part 1|Adverse Event|0|||
146293340|NCT02903368|527587694|FG002|Part 1|Adverse Event|0|||
146293341|NCT02903368|527587695|FG003|Part 1|Adverse Event|0|||
146293342|NCT02903368|527587692|FG000|Part 1|Withdrawal by Subject|1|||
146293343|NCT02903368|527587693|FG001|Part 1|Withdrawal by Subject|0|||
146293344|NCT02903368|527587694|FG002|Part 1|Withdrawal by Subject|0|||
146293345|NCT02903368|527587695|FG003|Part 1|Withdrawal by Subject|0|||
146293346|NCT02903368|527587692|FG000|Part 2|Adverse Event|0|||
146293347|NCT02903368|527587693|FG001|Part 2|Adverse Event|0|||
146293348|NCT02903368|527587694|FG002|Part 2|Adverse Event|5|||
146293349|NCT02903368|527587695|FG003|Part 2|Adverse Event|0|||
146293350|NCT02903368|527587692|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146293351|NCT02903368|527587693|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146293352|NCT02903368|527587694|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
146293353|NCT02903368|527587695|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
146293354|NCT02903368|527587692|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146293355|NCT02903368|527587693|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146293356|NCT02903368|527587694|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
146293357|NCT02903368|527587695|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
146293358|NCT02903368|527587692|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
146293359|NCT02903368|527587693|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
146293360|NCT02903368|527587694|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
146293361|NCT02903368|527587695|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
146293362|NCT06515483|527587696|FG000|Overall Study|Subject withdraw due to family issues|1|||
146293363|NCT06515483|527587697|FG001|Overall Study|Subject withdraw due to family issues|0|||
146293364|NCT00147823|527587698|FG000|Overall Study|Lost to Follow-up|6|||
146293365|NCT00147823|527587699|FG001|Overall Study|Lost to Follow-up|12|||
146293366|NCT00147823|527587698|FG000|Overall Study|Physician Decision|1|||
146293367|NCT00147823|527587699|FG001|Overall Study|Physician Decision|0|||
146293368|NCT00147823|527587698|FG000|Overall Study|Withdrawal by Subject|0|||
146293369|NCT00147823|527587699|FG001|Overall Study|Withdrawal by Subject|1|||
146293370|NCT00147823|527587698|FG000|Overall Study|Did not receive vitoss due to infection|6|||
146293371|NCT00147823|527587699|FG001|Overall Study|Did not receive vitoss due to infection|2|||
146293372|NCT00720941|527589978|FG000|Overall Study|Protocol Violation|1|||
145967827|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
145967828|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
145967829|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
145967830|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145967831|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
145967832|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145967833|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145967834|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
145967835|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
145967836|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
145967837|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
145967838|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145967839|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
145967840|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145967841|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145967842|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145967843|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
145967844|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145967845|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145967846|NCT01668797|526397593|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145967847|NCT01668797|526397594|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
145967848|NCT01668797|526397595|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145967849|NCT01668797|526397596|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145967850|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
145967851|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
145967852|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
145967853|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
145967854|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
145967855|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
145967856|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
145967857|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
145967858|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
145967859|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
145967860|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
145967861|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
145967862|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
145967863|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
145967864|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
145967865|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
145967866|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145967867|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145967868|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
145967869|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145967870|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
145967871|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
145967872|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
145967873|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
145967874|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
145967875|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
145967876|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
145967877|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
145967878|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
145967879|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
145967880|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
145967881|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
145967882|NCT01668797|526397593|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
145967883|NCT01668797|526397594|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
145967884|NCT01668797|526397595|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
145967885|NCT01668797|526397596|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
145967886|NCT02515227|526397597|FG000|Overall Study|Adverse Event|0|||
145967887|NCT02515227|526397598|FG001|Overall Study|Adverse Event|2|||
145967888|NCT02515227|526397597|FG000|Overall Study|Progressive disease|2|||
145967889|NCT02515227|526397598|FG001|Overall Study|Progressive disease|9|||
146086803|NCT04153149|526838384|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
145967890|NCT00686972|526397602|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
145967891|NCT03502798|526397603|FG000|Overall Study|equipment failure|0|||
145967892|NCT03502798|526397604|FG001|Overall Study|equipment failure|7|||
145967893|NCT01027845|526397606|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
145967894|NCT01027845|526397607|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
145967895|NCT01027845|526397608|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
145967896|NCT01027845|526397609|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
145967897|NCT01027845|526397606|FG000|Primary Vaccination Phase|Adverse Event|1|||
145967898|NCT01027845|526397607|FG001|Primary Vaccination Phase|Adverse Event|0|||
145967899|NCT01027845|526397608|FG002|Primary Vaccination Phase|Adverse Event|0|||
145967900|NCT01027845|526397609|FG003|Primary Vaccination Phase|Adverse Event|0|||
145967901|NCT01027845|526397606|FG000|Primary Vaccination Phase|Protocol Violation|1|||
145967902|NCT01027845|526397607|FG001|Primary Vaccination Phase|Protocol Violation|0|||
145967903|NCT01027845|526397608|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145967904|NCT01027845|526397609|FG003|Primary Vaccination Phase|Protocol Violation|0|||
145967905|NCT01027845|526397606|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
145967906|NCT01027845|526397607|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
145967907|NCT01027845|526397608|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
145967908|NCT01027845|526397609|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
145967909|NCT01027845|526397606|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
145967910|NCT01027845|526397607|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
145967911|NCT01027845|526397608|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
145967912|NCT01027845|526397609|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
145967913|NCT01027845|526397606|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
145967914|NCT01027845|526397607|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
145967915|NCT01027845|526397608|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
145967916|NCT01027845|526397609|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
145967917|NCT01603277|526397611|FG000|Overall Study|Adverse Event|1|||
145967918|NCT01603277|526397612|FG001|Overall Study|Adverse Event|2|||
145967919|NCT01603277|526397611|FG000|Overall Study|Physician Decision|0|||
145967920|NCT01603277|526397612|FG001|Overall Study|Physician Decision|1|||
145967921|NCT01603277|526397611|FG000|Overall Study|Protocol Violation|6|||
145967922|NCT01603277|526397612|FG001|Overall Study|Protocol Violation|10|||
145967923|NCT01603277|526397611|FG000|Overall Study|Withdrawal by Subject|5|||
145967924|NCT01603277|526397612|FG001|Overall Study|Withdrawal by Subject|4|||
145967925|NCT01603277|526397611|FG000|Overall Study|Non-Compliance|2|||
145967926|NCT01603277|526397612|FG001|Overall Study|Non-Compliance|1|||
145967927|NCT04465422|526397625|FG000|Overall Study|Lost to Follow-up|0|||
145967928|NCT04465422|526397626|FG001|Overall Study|Lost to Follow-up|2|||
145967929|NCT01692119|526397629|FG000|Overall Study|Protocol Violation|3|||
145967930|NCT01692119|526397630|FG001|Overall Study|Protocol Violation|1|||
145967931|NCT01692119|526397629|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
145967932|NCT01692119|526397630|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
145967933|NCT00112957|526397637|FG000|Overall Study|Progressive disease|18|||
145967934|NCT00112957|526397637|FG000|Overall Study|Physician Decision|1|||
145967935|NCT01192815|526397641|FG000|Overall Study|Withdrawal by Subject|1|||
145967936|NCT01192815|526397641|FG000|Overall Study|Lack of Efficacy|1|||
145967937|NCT03444584|526397642|FG000|Overall Study|Withdrawal by Subject|0|||
145967938|NCT03444584|526397643|FG001|Overall Study|Withdrawal by Subject|1|||
145967939|NCT03444584|526397642|FG000|Overall Study|Other|0|||
145967940|NCT03444584|526397643|FG001|Overall Study|Other|1|||
145967941|NCT03451045|526397644|FG000|Overall Study|Lack of Efficacy|3|||
145967942|NCT03451045|526397645|FG001|Overall Study|Lack of Efficacy|2|||
145967943|NCT03451045|526397646|FG002|Overall Study|Lack of Efficacy|2|||
145967944|NCT03451045|526397644|FG000|Overall Study|Physician Decision|1|||
145967945|NCT03451045|526397645|FG001|Overall Study|Physician Decision|1|||
145967946|NCT03451045|526397646|FG002|Overall Study|Physician Decision|1|||
145967947|NCT03451045|526397644|FG000|Overall Study|Withdrawal by Subject|4|||
145967948|NCT03451045|526397645|FG001|Overall Study|Withdrawal by Subject|0|||
145967949|NCT03451045|526397646|FG002|Overall Study|Withdrawal by Subject|5|||
145967950|NCT03451045|526397644|FG000|Overall Study|Pregnancy|0|||
145967951|NCT03451045|526397645|FG001|Overall Study|Pregnancy|0|||
145967952|NCT03451045|526397646|FG002|Overall Study|Pregnancy|2|||
145967953|NCT03451045|526397644|FG000|Overall Study|Adverse Event|7|||
145967954|NCT03451045|526397645|FG001|Overall Study|Adverse Event|1|||
145967955|NCT03451045|526397646|FG002|Overall Study|Adverse Event|3|||
145967956|NCT03451045|526397644|FG000|Overall Study|Non-compliance with study|2|||
145967957|NCT03451045|526397645|FG001|Overall Study|Non-compliance with study|0|||
145967958|NCT03451045|526397646|FG002|Overall Study|Non-compliance with study|1|||
145967959|NCT03451045|526397644|FG000|Overall Study|any other reason|10|||
145967960|NCT03451045|526397645|FG001|Overall Study|any other reason|2|||
145967961|NCT03451045|526397646|FG002|Overall Study|any other reason|13|||
145967962|NCT02391337|526397647|FG000|6 Months Follow-up|Death|5|||
145967963|NCT02391337|526397648|FG001|6 Months Follow-up|Death|4|||
145967964|NCT02391337|526397647|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
145967965|NCT02391337|526397648|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
145967966|NCT02391337|526397647|FG000|12 Months Follow-up|Death|2|||
145967967|NCT02391337|526397648|FG001|12 Months Follow-up|Death|0|||
145967968|NCT02391337|526397647|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
145967969|NCT02391337|526397648|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
145967970|NCT02391337|526397647|FG000|12 Months Follow-up|Lost to Follow-up|0|||
145967971|NCT02391337|526397648|FG001|12 Months Follow-up|Lost to Follow-up|2|||
145967972|NCT01286129|526397649|FG000|Overall Study|Withdrawal by Subject|4|||
145967973|NCT01286129|526397650|FG001|Overall Study|Withdrawal by Subject|1|||
145967974|NCT01286129|526397649|FG000|Overall Study|Could not comply with study requirements|4|||
145967975|NCT01286129|526397650|FG001|Overall Study|Could not comply with study requirements|4|||
145967976|NCT00830128|526397651|FG000|Overall Study|Adverse Event|5|||
145967977|NCT00830128|526397651|FG000|Overall Study|Lack of Efficacy|7|||
145967978|NCT00830128|526397651|FG000|Overall Study|Protocol Violation|1|||
145967979|NCT00830128|526397651|FG000|Overall Study|Withdrawal by Subject|2|||
145967980|NCT00830128|526397651|FG000|Overall Study|Family obligation|1|||
145967981|NCT00830128|526397651|FG000|Overall Study|Relocation|1|||
145967982|NCT00830128|526397651|FG000|Overall Study|Work obligation|1|||
145967983|NCT00830128|526397651|FG000|Overall Study|Operating a vehicle|1|||
145967984|NCT04142242|526397656|FG000|Stage I|Non-compliance with the protocol|1|||
145967985|NCT04142242|526397657|FG001|Stage I|Non-compliance with the protocol|0|||
145967986|NCT04142242|526397658|FG002|Stage I|Non-compliance with the protocol|0|||
145967987|NCT04142242|526397659|FG003|Stage I|Non-compliance with the protocol|0|||
145967988|NCT04142242|526397660|FG004|Stage I|Non-compliance with the protocol|0|||
145967989|NCT04142242|526397661|FG005|Stage I|Non-compliance with the protocol|1|||
145967990|NCT04142242|526397656|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145967991|NCT04142242|526397657|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
145967992|NCT04142242|526397658|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145967993|NCT04142242|526397659|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145967994|NCT04142242|526397660|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145967995|NCT04142242|526397661|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145967996|NCT04142242|526397656|FG000|Stage II|Non-compliance with the protocol|0|||
145967997|NCT04142242|526397657|FG001|Stage II|Non-compliance with the protocol|0|||
145967998|NCT04142242|526397658|FG002|Stage II|Non-compliance with the protocol|0|||
145967999|NCT04142242|526397659|FG003|Stage II|Non-compliance with the protocol|2|||
145968000|NCT04142242|526397660|FG004|Stage II|Non-compliance with the protocol|0|||
145968001|NCT04142242|526397661|FG005|Stage II|Non-compliance with the protocol|0|||
145968002|NCT04142242|526397656|FG000|Stage II|Lost to Follow-up|0|||
145968003|NCT04142242|526397657|FG001|Stage II|Lost to Follow-up|0|||
145968004|NCT04142242|526397658|FG002|Stage II|Lost to Follow-up|1|||
145968005|NCT04142242|526397659|FG003|Stage II|Lost to Follow-up|2|||
145968006|NCT04142242|526397660|FG004|Stage II|Lost to Follow-up|0|||
145968007|NCT04142242|526397661|FG005|Stage II|Lost to Follow-up|0|||
145968008|NCT04142242|526397656|FG000|Stage II|Withdrawal by Subject|0|||
145968009|NCT04142242|526397657|FG001|Stage II|Withdrawal by Subject|0|||
145968010|NCT04142242|526397658|FG002|Stage II|Withdrawal by Subject|5|||
145968011|NCT04142242|526397659|FG003|Stage II|Withdrawal by Subject|9|||
145968012|NCT04142242|526397660|FG004|Stage II|Withdrawal by Subject|0|||
145968013|NCT04142242|526397661|FG005|Stage II|Withdrawal by Subject|0|||
145968014|NCT00846053|526397664|FG000|Overall Study|Physician Decision|3|||
145968015|NCT00846053|526397665|FG001|Overall Study|Physician Decision|0|||
145968016|NCT00111761|526397666|FG000|Part 1|Physician Decision|0|||
145968017|NCT00111761|526397667|FG001|Part 1|Physician Decision|1|||
145968018|NCT00111761|526397666|FG000|Part 1|Death|0|||
145968019|NCT00111761|526397667|FG001|Part 1|Death|2|||
145968020|NCT00111761|526397666|FG000|Part 1|Other|0|||
145968021|NCT00111761|526397667|FG001|Part 1|Other|1|||
145968022|NCT00111761|526397666|FG000|Part 1|Withdrawal by Subject|0|||
145968023|NCT00111761|526397667|FG001|Part 1|Withdrawal by Subject|1|||
145968024|NCT00111761|526397666|FG000|Part 2|Adverse Event|1|||
145968025|NCT00111761|526397667|FG001|Part 2|Adverse Event|0|||
145968026|NCT00111761|526397666|FG000|Part 2|Physician Decision|1|||
145968027|NCT00111761|526397667|FG001|Part 2|Physician Decision|0|||
145968028|NCT00111761|526397666|FG000|Part 2|Death|1|||
145968029|NCT00111761|526397667|FG001|Part 2|Death|0|||
145968030|NCT00111761|526397666|FG000|Part 2|Disease progression|3|||
145968031|NCT00111761|526397667|FG001|Part 2|Disease progression|0|||
146293373|NCT00720941|527589979|FG001|Overall Study|Protocol Violation|2|||
146293374|NCT00720941|527589978|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
146293375|NCT00720941|527589979|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
145968032|NCT00111761|526397666|FG000|Part 2|Protocol-specified criteria|1|||
145968033|NCT00111761|526397667|FG001|Part 2|Protocol-specified criteria|0|||
145968034|NCT00111761|526397666|FG000|Part 2|Other|1|||
145968035|NCT00111761|526397667|FG001|Part 2|Other|0|||
145968036|NCT00467519|526397674|FG000|Overall Study|Protocol Violation|8|||
145889031|NCT02243293|526099145|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
145968037|NCT00467519|526397675|FG001|Overall Study|Protocol Violation|4|||
145889032|NCT02243293|526099146|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
145968038|NCT00467519|526397674|FG000|Overall Study|Lost to Follow-up|2|||
145968039|NCT00467519|526397675|FG001|Overall Study|Lost to Follow-up|9|||
145968040|NCT00467519|526397674|FG000|Overall Study|Withdrawal by Subject|4|||
145968041|NCT00467519|526397675|FG001|Overall Study|Withdrawal by Subject|10|||
145968042|NCT01123655|526397678|FG000|Overall Study|Medication for RA had to be changed|1|||
145968043|NCT01123655|526397679|FG001|Overall Study|Medication for RA had to be changed|0|||
145968044|NCT01123655|526397680|FG002|Overall Study|Medication for RA had to be changed|0|||
145968045|NCT01123655|526397678|FG000|Overall Study|new illness|0|||
145968046|NCT01123655|526397679|FG001|Overall Study|new illness|1|||
145968047|NCT01123655|526397680|FG002|Overall Study|new illness|0|||
145968048|NCT01123655|526397678|FG000|Overall Study|began prohibitive drug|0|||
145968049|NCT01123655|526397679|FG001|Overall Study|began prohibitive drug|0|||
145968050|NCT01123655|526397680|FG002|Overall Study|began prohibitive drug|1|||
145968051|NCT00062166|526397681|FG000|Overall Study|Withdrawal by Subject|6|||
145968052|NCT01776554|526397684|FG000|Overall Study|Adverse Event|1|||
145968053|NCT01776554|526397685|FG001|Overall Study|Adverse Event|0|||
145968054|NCT01776554|526397684|FG000|Overall Study|Withdrawal by Subject|3|||
145968055|NCT01776554|526397685|FG001|Overall Study|Withdrawal by Subject|8|||
145968056|NCT01776554|526397684|FG000|Overall Study|Lost to Follow-up|6|||
145968057|NCT01776554|526397685|FG001|Overall Study|Lost to Follow-up|9|||
145968058|NCT01776554|526397684|FG000|Overall Study|Administrative Reason|2|||
145889033|NCT02243293|526099147|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
145889034|NCT02243293|526099148|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
145889035|NCT02243293|526099149|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
145889036|NCT02243293|526099150|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
145889037|NCT02243293|526099151|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
145889038|NCT02243293|526099152|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
145889039|NCT02243293|526099153|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
145889040|NCT02243293|526099154|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
145889041|NCT02243293|526099155|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
145968059|NCT01776554|526397685|FG001|Overall Study|Administrative Reason|5|||
145968060|NCT01776554|526397684|FG000|Overall Study|Protocol Violation|1|||
145968061|NCT01776554|526397685|FG001|Overall Study|Protocol Violation|0|||
145968062|NCT01776554|526397684|FG000|Overall Study|Unclassified|4|||
145968063|NCT01776554|526397685|FG001|Overall Study|Unclassified|1|||
146232894|NCT00943917|527370707|FG008|Stage II|Withdrawal by Subject|0|||
145968064|NCT02475369|526397686|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
145968065|NCT02475369|526397687|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
145968066|NCT01991795|526397690|FG000|Overall Study|Lost to Follow-up|6|||
145968067|NCT01991795|526397691|FG001|Overall Study|Lost to Follow-up|4|||
145968068|NCT01991795|526397690|FG000|Overall Study|Withdrawal by Subject|117|||
145968069|NCT01991795|526397691|FG001|Overall Study|Withdrawal by Subject|94|||
145968070|NCT01991795|526397690|FG000|Overall Study|Site prematurely closed by sponsor|26|||
145968071|NCT01991795|526397691|FG001|Overall Study|Site prematurely closed by sponsor|25|||
145968072|NCT04798027|526397692|FG000|Overall Study|Protocol Violation|0|||
145968073|NCT04798027|526397693|FG001|Overall Study|Protocol Violation|0|||
145968074|NCT04798027|526397694|FG002|Overall Study|Protocol Violation|0|||
145968075|NCT04798027|526397695|FG003|Overall Study|Protocol Violation|0|||
145968076|NCT04798027|526397696|FG004|Overall Study|Protocol Violation|1|||
145968077|NCT04798027|526397697|FG005|Overall Study|Protocol Violation|0|||
145968078|NCT04798027|526397698|FG006|Overall Study|Protocol Violation|0|||
145968079|NCT04798027|526397699|FG007|Overall Study|Protocol Violation|1|||
145968080|NCT04798027|526397700|FG008|Overall Study|Protocol Violation|0|||
145968081|NCT04798027|526397692|FG000|Overall Study|Withdrawal by Subject|1|||
145968082|NCT04798027|526397693|FG001|Overall Study|Withdrawal by Subject|0|||
145968083|NCT04798027|526397694|FG002|Overall Study|Withdrawal by Subject|1|||
145968084|NCT04798027|526397695|FG003|Overall Study|Withdrawal by Subject|1|||
145968085|NCT04798027|526397696|FG004|Overall Study|Withdrawal by Subject|1|||
145968086|NCT04798027|526397697|FG005|Overall Study|Withdrawal by Subject|1|||
145968087|NCT04798027|526397698|FG006|Overall Study|Withdrawal by Subject|3|||
145968088|NCT04798027|526397699|FG007|Overall Study|Withdrawal by Subject|2|||
145968089|NCT04798027|526397700|FG008|Overall Study|Withdrawal by Subject|2|||
145968090|NCT04798027|526397692|FG000|Overall Study|Lost to Follow-up|1|||
145968091|NCT04798027|526397693|FG001|Overall Study|Lost to Follow-up|3|||
145968092|NCT04798027|526397694|FG002|Overall Study|Lost to Follow-up|0|||
145968093|NCT04798027|526397695|FG003|Overall Study|Lost to Follow-up|0|||
145968094|NCT04798027|526397696|FG004|Overall Study|Lost to Follow-up|0|||
145968095|NCT04798027|526397697|FG005|Overall Study|Lost to Follow-up|1|||
145968096|NCT04798027|526397698|FG006|Overall Study|Lost to Follow-up|0|||
145968097|NCT04798027|526397699|FG007|Overall Study|Lost to Follow-up|0|||
145968098|NCT04798027|526397700|FG008|Overall Study|Lost to Follow-up|1|||
145968099|NCT04798027|526397692|FG000|Overall Study|Withdrawal by Sponsor|8|||
145968100|NCT04798027|526397693|FG001|Overall Study|Withdrawal by Sponsor|22|||
145968101|NCT04798027|526397694|FG002|Overall Study|Withdrawal by Sponsor|9|||
145968102|NCT04798027|526397695|FG003|Overall Study|Withdrawal by Sponsor|26|||
145968103|NCT04798027|526397696|FG004|Overall Study|Withdrawal by Sponsor|24|||
145968104|NCT04798027|526397697|FG005|Overall Study|Withdrawal by Sponsor|11|||
145968105|NCT04798027|526397698|FG006|Overall Study|Withdrawal by Sponsor|25|||
145968106|NCT04798027|526397699|FG007|Overall Study|Withdrawal by Sponsor|26|||
145968107|NCT04798027|526397700|FG008|Overall Study|Withdrawal by Sponsor|11|||
145968108|NCT00885118|526397701|FG000|Overall Study|Adverse Event|1|||
145968109|NCT00885118|526397702|FG001|Overall Study|Adverse Event|0|||
145968110|NCT00885118|526397703|FG002|Overall Study|Adverse Event|0|||
145968111|NCT00885118|526397704|FG003|Overall Study|Adverse Event|0|||
145968112|NCT00885118|526397705|FG004|Overall Study|Adverse Event|0|||
145968113|NCT00885118|526397701|FG000|Overall Study|Withdrawal by Subject|0|||
145968114|NCT00885118|526397702|FG001|Overall Study|Withdrawal by Subject|0|||
145968115|NCT00885118|526397703|FG002|Overall Study|Withdrawal by Subject|0|||
145968116|NCT00885118|526397704|FG003|Overall Study|Withdrawal by Subject|0|||
145968117|NCT00885118|526397705|FG004|Overall Study|Withdrawal by Subject|1|||
145968118|NCT00885118|526397701|FG000|Overall Study|Other reason not defined above|0|||
145968119|NCT00885118|526397702|FG001|Overall Study|Other reason not defined above|0|||
145968120|NCT00885118|526397703|FG002|Overall Study|Other reason not defined above|1|||
145968121|NCT00885118|526397704|FG003|Overall Study|Other reason not defined above|0|||
145968122|NCT00885118|526397705|FG004|Overall Study|Other reason not defined above|0|||
145968123|NCT03642990|526397706|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
145968124|NCT03642990|526397706|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
145968125|NCT00094445|526397707|FG000|Overall Study|Withdrawal by Subject|3|||
145968126|NCT00094445|526397707|FG000|Overall Study|Lost to Follow-up|1|||
145968127|NCT00094445|526397707|FG000|Overall Study|Progressive Disease|2|||
145968128|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
145968129|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
145968130|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
145968131|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
145968132|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
145968133|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
145968134|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
145968135|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145968136|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145968137|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145968138|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
145968139|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
145968140|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145968141|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145968142|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145968143|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
145968144|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
145968145|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145968146|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145968147|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145968148|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
145968149|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
145968150|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145968151|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145968152|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145968153|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
145968154|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
145968155|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145968156|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145968157|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145968158|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
145968159|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
145968160|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145968161|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145968162|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145968163|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
145968164|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
145968165|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145968166|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145968167|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145968168|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
145968169|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145968170|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145968171|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145968172|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145968173|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
145968174|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
145968175|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
145968176|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
145968177|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
145968178|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
145968179|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
145968180|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
145968181|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
145968182|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
145968183|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
145968184|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145968185|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145968186|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145968187|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145968188|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
145968189|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145968190|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145968191|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145968192|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145968193|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145968194|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
145968195|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145968196|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145968197|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145968198|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
145968199|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
145968200|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
145968201|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
145968202|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
145968203|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
146232895|NCT00943917|527370708|FG009|Stage II|Withdrawal by Subject|0|||
145968204|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
145968205|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145968206|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145968207|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145968208|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
145968209|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145968210|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145968211|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145968212|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145968213|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145968214|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
145968215|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145968216|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145968217|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145968218|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
145968219|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145968220|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145968221|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145968222|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145968223|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
146086804|NCT04153149|526838385|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
146086805|NCT04153149|526838382|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
146086806|NCT04153149|526838383|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
146086807|NCT04153149|526838384|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
146232896|NCT00943917|527370709|FG010|Stage II|Withdrawal by Subject|0|||
146232897|NCT00943917|527370710|FG011|Stage II|Withdrawal by Subject|0|||
145968224|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
145968225|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145968226|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145968227|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145968228|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
145968229|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145968230|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145968231|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145968232|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145968233|NCT02717195|526397708|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
145968234|NCT02717195|526397709|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145968235|NCT02717195|526397710|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145968236|NCT02717195|526397711|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145968237|NCT02717195|526397712|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145968238|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
145968239|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
146232898|NCT00943917|527370711|FG012|Stage II|Withdrawal by Subject|0|||
145968240|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
145968241|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
145968242|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
145968243|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
145968244|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
145968245|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
145968246|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
145968247|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
145968248|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
145968249|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
145968250|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
145968251|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
145968252|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
145968253|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145968254|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145968255|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
145968256|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145968257|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
145968258|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145968259|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145968260|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
145968261|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
145968262|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
145968263|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145968264|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145968265|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145968266|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
145968267|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
145968268|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145968269|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
146232899|NCT00943917|527370712|FG013|Stage II|Withdrawal by Subject|0|||
146232900|NCT00943917|527370713|FG014|Stage II|Withdrawal by Subject|0|||
146232901|NCT00943917|527370699|FG000|Stage II|Pregnancy|0|||
146293376|NCT00720941|527589978|FG000|Overall Study|Lost to Follow-up|20|||
146293377|NCT00720941|527589979|FG001|Overall Study|Lost to Follow-up|15|||
146293378|NCT00720941|527589978|FG000|Overall Study|Physician Decision|14|||
146293379|NCT00720941|527589979|FG001|Overall Study|Physician Decision|12|||
146293380|NCT00720941|527589978|FG000|Overall Study|Withdrawal by Subject|29|||
146293381|NCT00720941|527589979|FG001|Overall Study|Withdrawal by Subject|36|||
146293382|NCT02544217|527589980|FG000|Overall Study|Withdrawal by Subject|1|||
146293383|NCT02544217|527589981|FG001|Overall Study|Withdrawal by Subject|1|||
146293384|NCT02544217|527589982|FG002|Overall Study|Withdrawal by Subject|0|||
146293385|NCT02544217|527589983|FG003|Overall Study|Withdrawal by Subject|0|||
146293386|NCT02544217|527589984|FG004|Overall Study|Withdrawal by Subject|0|||
146293387|NCT02544217|527589985|FG005|Overall Study|Withdrawal by Subject|0|||
146293388|NCT00937833|527589986|FG000|Overall Study|Protocol Violation|1|||
146293389|NCT00937833|527589987|FG001|Overall Study|Protocol Violation|2|||
146293390|NCT00937833|527589986|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
146293391|NCT00937833|527589987|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
146293392|NCT00937833|527589986|FG000|Overall Study|Lost to Follow-up|10|||
146293393|NCT00937833|527589987|FG001|Overall Study|Lost to Follow-up|8|||
146293394|NCT00937833|527589986|FG000|Overall Study|Withdrawal by Subject|4|||
146293395|NCT00937833|527589987|FG001|Overall Study|Withdrawal by Subject|6|||
146293396|NCT00818389|527589988|FG000|Overall Study|Death|1|||
146293397|NCT00818389|527589989|FG001|Overall Study|Death|3|||
146293398|NCT00818389|527589988|FG000|Overall Study|ALS Disease Progression|1|||
146293399|NCT00818389|527589989|FG001|Overall Study|ALS Disease Progression|0|||
146293400|NCT00818389|527589988|FG000|Overall Study|Withdrawal by Subject|2|||
146293401|NCT00818389|527589989|FG001|Overall Study|Withdrawal by Subject|2|||
146293402|NCT00818389|527589988|FG000|Overall Study|Adverse Event|0|||
146293403|NCT00818389|527589989|FG001|Overall Study|Adverse Event|1|||
146293404|NCT03840486|527589990|FG000|Overall Study|Withdrawal by Subject|0|||
146293405|NCT03840486|527589991|FG001|Overall Study|Withdrawal by Subject|1|||
146293406|NCT03840486|527589992|FG002|Overall Study|Withdrawal by Subject|0|||
146293407|NCT03840486|527589993|FG003|Overall Study|Withdrawal by Subject|0|||
146293408|NCT03840486|527589994|FG004|Overall Study|Withdrawal by Subject|0|||
146293409|NCT03840486|527589995|FG005|Overall Study|Withdrawal by Subject|0|||
146293410|NCT03840486|527589996|FG006|Overall Study|Withdrawal by Subject|0|||
146293411|NCT03840486|527589997|FG007|Overall Study|Withdrawal by Subject|0|||
146293412|NCT03840486|527589998|FG008|Overall Study|Withdrawal by Subject|0|||
146293413|NCT03840486|527589999|FG009|Overall Study|Withdrawal by Subject|0|||
146293414|NCT03840486|527590000|FG010|Overall Study|Withdrawal by Subject|0|||
146293415|NCT03840486|527590001|FG011|Overall Study|Withdrawal by Subject|0|||
146293416|NCT04442737|527590004|FG000|Overall Study|Lost to Follow-up|1|||
146293417|NCT04442737|527590005|FG001|Overall Study|Lost to Follow-up|3|||
146293418|NCT04442737|527590004|FG000|Overall Study|Withdrawal by Subject|3|||
146293419|NCT04442737|527590005|FG001|Overall Study|Withdrawal by Subject|2|||
146293420|NCT04442737|527590004|FG000|Overall Study|Adverse Event|3|||
146293421|NCT04442737|527590005|FG001|Overall Study|Adverse Event|2|||
146293422|NCT04442737|527590004|FG000|Overall Study|Death|0|||
146293423|NCT04442737|527590005|FG001|Overall Study|Death|1|||
146293424|NCT04442737|527590004|FG000|Overall Study|Protocol Violation|0|||
146293425|NCT04442737|527590005|FG001|Overall Study|Protocol Violation|2|||
146293426|NCT04442737|527590004|FG000|Overall Study|Other|1|||
146293427|NCT04442737|527590005|FG001|Overall Study|Other|1|||
146293428|NCT02982187|527590009|FG000|Overall Study|Withdrawal by Subject|0|||
146293429|NCT02982187|527590010|FG001|Overall Study|Withdrawal by Subject|0|||
146293430|NCT02982187|527590011|FG002|Overall Study|Withdrawal by Subject|0|||
146293431|NCT02982187|527590012|FG003|Overall Study|Withdrawal by Subject|0|||
146293432|NCT02982187|527590013|FG004|Overall Study|Withdrawal by Subject|0|||
146293433|NCT02982187|527590014|FG005|Overall Study|Withdrawal by Subject|0|||
146293434|NCT02982187|527590015|FG006|Overall Study|Withdrawal by Subject|1|||
146293435|NCT02982187|527590016|FG007|Overall Study|Withdrawal by Subject|0|||
146293436|NCT02604433|527590017|FG000|Overall Study|Withdrawal by Subject|37|||
146293437|NCT02604433|527590018|FG001|Overall Study|Withdrawal by Subject|16|||
146293438|NCT02604433|527590017|FG000|Overall Study|Adverse Event|4|||
146293439|NCT02604433|527590018|FG001|Overall Study|Adverse Event|0|||
146293440|NCT02604433|527590017|FG000|Overall Study|Other reasons|3|||
145968270|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
145968271|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145968272|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145968273|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
145968274|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
145968275|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
145968276|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
145968277|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
145968278|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145968279|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145968280|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145968281|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
145968282|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
145968283|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145889042|NCT02243293|526099156|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
145889043|NCT02243293|526099157|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
145889044|NCT02243293|526099158|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
145889045|NCT02243293|526099159|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
145889046|NCT02243293|526099138|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
145889047|NCT02243293|526099139|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
145889048|NCT02243293|526099140|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
145889049|NCT02243293|526099141|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
145889050|NCT02243293|526099142|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
145889051|NCT02243293|526099143|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
145889052|NCT02243293|526099144|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
145889053|NCT02243293|526099145|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
145889054|NCT02243293|526099146|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
145889055|NCT02243293|526099147|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
145889056|NCT02243293|526099148|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
145889057|NCT02243293|526099149|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
145889058|NCT02243293|526099150|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
145889059|NCT02243293|526099151|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
145889060|NCT02243293|526099152|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
145889061|NCT02243293|526099153|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
145889062|NCT02243293|526099154|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
145889063|NCT02243293|526099155|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
145889064|NCT02243293|526099156|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
145889065|NCT02243293|526099157|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
145889066|NCT02243293|526099158|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
145889067|NCT02243293|526099159|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
145889068|NCT03069417|526099160|FG000|Overall Study|Lost to Follow-up|2|||
145889069|NCT03069417|526099161|FG001|Overall Study|Lost to Follow-up|0|||
145889070|NCT03069417|526099160|FG000|Overall Study|Reason Unknown|4|||
145968284|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145968285|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145968286|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145968287|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
145968288|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
145968289|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
145889071|NCT03069417|526099161|FG001|Overall Study|Reason Unknown|7|||
145889072|NCT02953678|526099165|FG000|Overall Study|Adverse Event|20|||
145889073|NCT02953678|526099165|FG000|Overall Study|Death|7|||
145889074|NCT02953678|526099165|FG000|Overall Study|Physician Decision|23|||
145889075|NCT02953678|526099165|FG000|Overall Study|Progressive Disease of GVHD|7|||
145889076|NCT02953678|526099165|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
145889077|NCT02953678|526099165|FG000|Overall Study|Withdrawal by participant|3|||
145889078|NCT02953678|526099165|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
145889079|NCT02953678|526099165|FG000|Overall Study|Participants were transferred to commercial product.|3|||
145890976|NCT01207440|526107571|FG001|Overall Study|Reason Not Specified|10|||
145890977|NCT01207440|526107572|FG002|Overall Study|Reason Not Specified|7|||
145890978|NCT01207440|526107573|FG003|Overall Study|Reason Not Specified|0|||
145890979|NCT01207440|526107574|FG004|Overall Study|Reason Not Specified|4|||
145890980|NCT01207440|526107575|FG005|Overall Study|Reason Not Specified|3|||
145890981|NCT01207440|526107576|FG006|Overall Study|Reason Not Specified|0|||
145890982|NCT03341000|526107577|FG000|Overall Study|Adverse Event|1|||
145890983|NCT01592721|526107578|FG000|Long-term Follow-up|Death|1|||
145890984|NCT02148913|526107585|FG000|Overall Study|Death|0|||
145890985|NCT02148913|526107586|FG001|Overall Study|Death|1|||
145890986|NCT02148913|526107587|FG002|Overall Study|Death|0|||
145890987|NCT02148913|526107588|FG003|Overall Study|Death|0|||
145968290|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
145968291|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
145968292|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
145968293|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145968294|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145968295|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145968296|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145968297|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
145968298|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145968299|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145968300|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
145968301|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145968302|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145968303|NCT02717195|526397708|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145890988|NCT01287039|526107589|FG000|Overall Study|Noncompliance with study procedures|0|||
145890989|NCT01287039|526107590|FG001|Overall Study|Noncompliance with study procedures|1|||
146086808|NCT04153149|526838385|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
146086809|NCT02003365|526838816|FG000|Overall Study|Lost to Follow-up|0|||
146086810|NCT02003365|526838817|FG001|Overall Study|Lost to Follow-up|0|||
145968304|NCT02717195|526397709|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145968305|NCT02717195|526397710|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145968306|NCT02717195|526397711|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
145968307|NCT02717195|526397712|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
145968308|NCT03092752|526397715|FG000|Overall Study|Aged <40 years|14209|||
145968309|NCT03092752|526397715|FG000|Overall Study|At least one claim with T2DM|61299|||
146086811|NCT02003365|526838818|FG002|Overall Study|Lost to Follow-up|1|||
146086812|NCT00625742|526838819|FG000|Overall Study|Disease Progression|2|||
145968310|NCT03092752|526397715|FG000|Overall Study|Having no claim of study drugs|29282|||
145968311|NCT03092752|526397715|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
145968312|NCT03092752|526397715|FG000|Overall Study|<6 month history|245900|||
145968313|NCT03882918|526397716|FG000|Overall Study|Study terminated by sponsor|98|||
145968314|NCT03882918|526397716|FG000|Overall Study|Protocol Violation|1|||
145968315|NCT03882918|526397716|FG000|Overall Study|Other|9|||
145889080|NCT01937351|526101702|FG000|Overall Study|Withdrawal by Subject|4|||
145889081|NCT01937351|526101703|FG001|Overall Study|Withdrawal by Subject|2|||
145889082|NCT01937351|526101702|FG000|Overall Study|Death|1|||
145889083|NCT01937351|526101703|FG001|Overall Study|Death|0|||
145889084|NCT01937351|526101702|FG000|Overall Study|Not treated w device, per protocol fail|4|||
145889085|NCT01937351|526101703|FG001|Overall Study|Not treated w device, per protocol fail|0|||
145889086|NCT01730040|526101704|FG000|Overall Study|Randomized but not treated|0|||
145889087|NCT01730040|526101705|FG001|Overall Study|Randomized but not treated|0|||
145889088|NCT01730040|526101706|FG002|Overall Study|Randomized but not treated|0|||
145889089|NCT01730040|526101707|FG003|Overall Study|Randomized but not treated|0|||
145889090|NCT01730040|526101708|FG004|Overall Study|Randomized but not treated|0|||
145889091|NCT01730040|526101709|FG005|Overall Study|Randomized but not treated|1|||
145889092|NCT01730040|526101710|FG006|Overall Study|Randomized but not treated|0|||
145889093|NCT01730040|526101704|FG000|Overall Study|Subject moved|0|||
146086813|NCT00625742|526838819|FG000|Overall Study|Withdrawal by Subject|1|||
146293441|NCT02604433|527590018|FG001|Overall Study|Other reasons|5|||
146293442|NCT02604433|527590017|FG000|Overall Study|Death|4|||
146293443|NCT02604433|527590018|FG001|Overall Study|Death|1|||
146086814|NCT00625742|526838819|FG000|Overall Study|Adverse Event|4|||
146086815|NCT00625742|526838819|FG000|Overall Study|Lost to Follow-up|4|||
146086816|NCT00625742|526838819|FG000|Overall Study|Ineligible|1|||
146086817|NCT00371761|526838820|FG000|Overall Study|Adverse Event|1|||
146086818|NCT00371761|526838821|FG001|Overall Study|Adverse Event|1|||
146086819|NCT00371761|526838820|FG000|Overall Study|Withdrawal by Subject|1|||
146086820|NCT00371761|526838821|FG001|Overall Study|Withdrawal by Subject|3|||
146086821|NCT00371761|526838820|FG000|Overall Study|Investigator Judgment|2|||
146086822|NCT00371761|526838821|FG001|Overall Study|Investigator Judgment|3|||
146086823|NCT00371761|526838820|FG000|Overall Study|Study termination|4|||
146086824|NCT00371761|526838821|FG001|Overall Study|Study termination|3|||
146086825|NCT03675321|526838823|FG000|Overall Study|Lack of Efficacy|2|||
146086826|NCT03675321|526838824|FG001|Overall Study|Lack of Efficacy|2|||
146086827|NCT03675321|526838823|FG000|Overall Study|Withdrawal by Subject|1|||
146086828|NCT03675321|526838824|FG001|Overall Study|Withdrawal by Subject|3|||
146086829|NCT05040971|526838825|FG000|Overall Study|Withdrawal by Subject|0|||
146086830|NCT05040971|526838826|FG001|Overall Study|Withdrawal by Subject|2|||
146086831|NCT05040971|526838825|FG000|Overall Study|Lost to Follow-up|8|||
146086832|NCT05040971|526838826|FG001|Overall Study|Lost to Follow-up|3|||
146086833|NCT05040971|526838825|FG000|Overall Study|Death|2|||
146086834|NCT05040971|526838826|FG001|Overall Study|Death|0|||
146086835|NCT00773838|526838848|FG000|Overall Study|Adverse Event|29|||
146293444|NCT02604433|527590017|FG000|Overall Study|Transition to Rollover Protocol|169|||
146293445|NCT02604433|527590018|FG001|Overall Study|Transition to Rollover Protocol|82|||
145889094|NCT01730040|526101705|FG001|Overall Study|Subject moved|0|||
146293446|NCT02604433|527590017|FG000|Overall Study|Physician Decision|1|||
146293447|NCT02604433|527590018|FG001|Overall Study|Physician Decision|1|||
145889095|NCT01730040|526101706|FG002|Overall Study|Subject moved|1|||
146086836|NCT00773838|526838848|FG000|Overall Study|Lost to Follow-up|1|||
146086837|NCT00773838|526838848|FG000|Overall Study|Physician Decision|8|||
146086838|NCT00773838|526838848|FG000|Overall Study|Progressive Disease|82|||
146086839|NCT00773838|526838848|FG000|Overall Study|Protocol Violation|2|||
146293448|NCT02604433|527590017|FG000|Overall Study|Lack of Efficacy|0|||
146293449|NCT02604433|527590018|FG001|Overall Study|Lack of Efficacy|1|||
145889096|NCT01730040|526101707|FG003|Overall Study|Subject moved|0|||
146086840|NCT00773838|526838848|FG000|Overall Study|Withdrawal by Subject|21|||
146086841|NCT01589770|526838850|FG000|Overall Study|EGFR <60ml/min|6|||
145968316|NCT03882918|526397716|FG000|Overall Study|Lack of Efficacy|14|||
145968317|NCT03882918|526397716|FG000|Overall Study|Adverse Event|13|||
145968318|NCT03882918|526397716|FG000|Overall Study|Withdrawal by Subject|5|||
145968319|NCT06996301|526397717|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
145968320|NCT06996301|526397718|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
145968321|NCT06996301|526397717|FG000|Overall Study|Patients with discordant diagnostic results|107|||
145968322|NCT06996301|526397718|FG001|Overall Study|Patients with discordant diagnostic results|90|||
145968323|NCT06996301|526397717|FG000|Overall Study|Lost to Follow-up|31|||
145968324|NCT06996301|526397718|FG001|Overall Study|Lost to Follow-up|56|||
145968325|NCT06996301|526397717|FG000|Overall Study|Withdrawal by Subject|12|||
145968326|NCT06996301|526397718|FG001|Overall Study|Withdrawal by Subject|7|||
145968327|NCT04030598|526397719|FG000|Overall Study|Voluntary Withdrawal|0|||
145968328|NCT04030598|526397720|FG001|Overall Study|Voluntary Withdrawal|1|||
145968329|NCT04030598|526397721|FG002|Overall Study|Voluntary Withdrawal|0|||
145968330|NCT03141359|526397722|FG000|Overall Study|Death|32|||
145968331|NCT03141359|526397722|FG000|Overall Study|Still On Study (in follow up)|29|||
145968332|NCT01296412|526397723|FG000|Overall Study|Adverse Event|8|||
145968333|NCT01296412|526397724|FG001|Overall Study|Adverse Event|29|||
145968334|NCT01296412|526397723|FG000|Overall Study|Lack of Efficacy|1|||
145968335|NCT01296412|526397724|FG001|Overall Study|Lack of Efficacy|0|||
145968336|NCT01296412|526397723|FG000|Overall Study|Lost to Follow-up|10|||
145968337|NCT01296412|526397724|FG001|Overall Study|Lost to Follow-up|7|||
145968338|NCT01296412|526397723|FG000|Overall Study|Non-compliance with study drug|1|||
145968339|NCT01296412|526397724|FG001|Overall Study|Non-compliance with study drug|2|||
145968340|NCT01296412|526397723|FG000|Overall Study|Other reason not specified|20|||
145968341|NCT01296412|526397724|FG001|Overall Study|Other reason not specified|15|||
145968342|NCT01296412|526397723|FG000|Overall Study|Physician Decision|1|||
145968343|NCT01296412|526397724|FG001|Overall Study|Physician Decision|3|||
145968344|NCT01296412|526397723|FG000|Overall Study|Pregnancy|0|||
145968345|NCT01296412|526397724|FG001|Overall Study|Pregnancy|1|||
145968346|NCT01296412|526397723|FG000|Overall Study|Withdrawal by Subject|10|||
145968347|NCT01296412|526397724|FG001|Overall Study|Withdrawal by Subject|13|||
145968348|NCT02160626|526397725|FG000|Overall Study|Adverse Event|1|||
145968349|NCT02160626|526397726|FG001|Overall Study|Adverse Event|0|||
145968350|NCT02160626|526397727|FG002|Overall Study|Adverse Event|0|||
145968351|NCT02160626|526397725|FG000|Overall Study|Schedule not conducive to study visits|0|||
145968352|NCT02160626|526397726|FG001|Overall Study|Schedule not conducive to study visits|0|||
145968353|NCT02160626|526397727|FG002|Overall Study|Schedule not conducive to study visits|1|||
145968354|NCT02160626|526397725|FG000|Overall Study|Withdrawal by Subject|0|||
145968355|NCT02160626|526397726|FG001|Overall Study|Withdrawal by Subject|1|||
145968356|NCT02160626|526397727|FG002|Overall Study|Withdrawal by Subject|0|||
145968357|NCT04239924|526397733|FG000|Overall Study|Lost to Follow-up|2|||
145968358|NCT00666237|526397734|FG000|Overall Study|Death|5|||
145968359|NCT00666237|526397735|FG001|Overall Study|Death|5|||
145968360|NCT00666237|526397734|FG000|Overall Study|Lost to Follow-up|29|||
145968361|NCT00666237|526397735|FG001|Overall Study|Lost to Follow-up|25|||
145968362|NCT00750269|526399603|FG000|Overall Study|Protocol Violation|0|||
145968363|NCT00750269|526399604|FG001|Overall Study|Protocol Violation|1|||
145968364|NCT00750269|526399605|FG002|Overall Study|Protocol Violation|1|||
145968365|NCT00750269|526399606|FG003|Overall Study|Protocol Violation|2|||
145968366|NCT00750269|526399607|FG004|Overall Study|Protocol Violation|4|||
145968367|NCT00750269|526399603|FG000|Overall Study|Withdrawal by Subject|0|||
145968368|NCT00750269|526399604|FG001|Overall Study|Withdrawal by Subject|0|||
145968369|NCT00750269|526399605|FG002|Overall Study|Withdrawal by Subject|2|||
145968370|NCT00750269|526399606|FG003|Overall Study|Withdrawal by Subject|2|||
145968371|NCT00750269|526399607|FG004|Overall Study|Withdrawal by Subject|2|||
145968372|NCT00750269|526399603|FG000|Overall Study|Physician Decision|0|||
145968373|NCT00750269|526399604|FG001|Overall Study|Physician Decision|0|||
145968374|NCT00750269|526399605|FG002|Overall Study|Physician Decision|0|||
145968375|NCT00750269|526399606|FG003|Overall Study|Physician Decision|0|||
145968376|NCT00750269|526399607|FG004|Overall Study|Physician Decision|2|||
145968377|NCT00750269|526399603|FG000|Overall Study|Patient too large for positioning|0|||
145968378|NCT00750269|526399604|FG001|Overall Study|Patient too large for positioning|0|||
145968379|NCT00750269|526399605|FG002|Overall Study|Patient too large for positioning|1|||
145968380|NCT00750269|526399606|FG003|Overall Study|Patient too large for positioning|0|||
145968381|NCT00750269|526399607|FG004|Overall Study|Patient too large for positioning|0|||
145968382|NCT00750269|526399603|FG000|Overall Study|Site error|0|||
145968383|NCT00750269|526399604|FG001|Overall Study|Site error|0|||
145968384|NCT00750269|526399605|FG002|Overall Study|Site error|0|||
145968385|NCT00750269|526399606|FG003|Overall Study|Site error|1|||
145968386|NCT00750269|526399607|FG004|Overall Study|Site error|0|||
145968387|NCT00750269|526399603|FG000|Overall Study|SBRT plan could not be drawn|0|||
145968388|NCT00750269|526399604|FG001|Overall Study|SBRT plan could not be drawn|0|||
145968389|NCT00750269|526399605|FG002|Overall Study|SBRT plan could not be drawn|0|||
146293450|NCT03437278|527590019|FG000|Overall Study|Adverse Event|0|||
146293451|NCT03437278|527590020|FG001|Overall Study|Adverse Event|0|||
146293452|NCT03437278|527590021|FG002|Overall Study|Adverse Event|1|||
145968390|NCT00750269|526399606|FG003|Overall Study|SBRT plan could not be drawn|0|||
145968391|NCT00750269|526399607|FG004|Overall Study|SBRT plan could not be drawn|1|||
145968392|NCT00750269|526399603|FG000|Overall Study|Fiducials could not be placed|0|||
145968393|NCT00750269|526399604|FG001|Overall Study|Fiducials could not be placed|0|||
145968394|NCT00750269|526399605|FG002|Overall Study|Fiducials could not be placed|0|||
145968395|NCT00750269|526399606|FG003|Overall Study|Fiducials could not be placed|0|||
145968396|NCT00750269|526399607|FG004|Overall Study|Fiducials could not be placed|1|||
145968397|NCT02934178|526399608|FG000|Received Vaccination 2|Death|0|||
145968398|NCT02934178|526399609|FG001|Received Vaccination 2|Death|1|||
145968399|NCT02934178|526399608|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
145968400|NCT02934178|526399609|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
145968401|NCT01898078|526399613|FG000|Overall Study|Progressive Disease|1|||
145968402|NCT01898078|526399614|FG001|Overall Study|Progressive Disease|5|||
145968403|NCT01898078|526399613|FG000|Overall Study|Adverse Event|2|||
145968404|NCT01898078|526399614|FG001|Overall Study|Adverse Event|1|||
145968405|NCT01898078|526399613|FG000|Overall Study|Withdrawal by Subject|1|||
145968406|NCT01898078|526399614|FG001|Overall Study|Withdrawal by Subject|1|||
145968407|NCT01898078|526399613|FG000|Overall Study|Symptomatic Deterioration|2|||
145968408|NCT01898078|526399614|FG001|Overall Study|Symptomatic Deterioration|0|||
145968409|NCT01898078|526399613|FG000|Overall Study|Reason not Specified|0|||
145968410|NCT01898078|526399614|FG001|Overall Study|Reason not Specified|1|||
145968411|NCT01075048|526399616|FG000|Overall Study|Death|4|||
145968412|NCT01075048|526399617|FG001|Overall Study|Death|17|||
145968413|NCT01075048|526399618|FG002|Overall Study|Death|12|||
145968414|NCT01075048|526399616|FG000|Overall Study|Start of other or new therapy|4|||
145968415|NCT01075048|526399617|FG001|Overall Study|Start of other or new therapy|36|||
145968416|NCT01075048|526399618|FG002|Overall Study|Start of other or new therapy|46|||
145968417|NCT01075048|526399616|FG000|Overall Study|Withdrawal by Subject|1|||
145968418|NCT01075048|526399617|FG001|Overall Study|Withdrawal by Subject|6|||
145968419|NCT01075048|526399618|FG002|Overall Study|Withdrawal by Subject|3|||
145968420|NCT01075048|526399616|FG000|Overall Study|Lost to Follow-up|0|||
145968421|NCT01075048|526399617|FG001|Overall Study|Lost to Follow-up|1|||
145968422|NCT01075048|526399618|FG002|Overall Study|Lost to Follow-up|1|||
145968423|NCT00296244|526399623|FG000|Overall Study|Underwent retransplant|0|||
145968424|NCT00296244|526399624|FG001|Overall Study|Underwent retransplant|1|||
145968425|NCT00761319|526399627|FG000|Overall Study|Protocol Violation|21|||
145968426|NCT00761319|526399628|FG001|Overall Study|Protocol Violation|14|||
145968427|NCT00761319|526399627|FG000|Overall Study|Adverse Event|11|||
145968428|NCT00761319|526399628|FG001|Overall Study|Adverse Event|7|||
145968429|NCT00761319|526399627|FG000|Overall Study|Withdrawal by Subject|8|||
145968430|NCT00761319|526399628|FG001|Overall Study|Withdrawal by Subject|7|||
145968431|NCT00761319|526399627|FG000|Overall Study|Noncompliance|4|||
145968432|NCT00761319|526399628|FG001|Overall Study|Noncompliance|3|||
145968433|NCT00761319|526399627|FG000|Overall Study|Lost to Follow-up|1|||
145968434|NCT00761319|526399628|FG001|Overall Study|Lost to Follow-up|1|||
145968435|NCT00761319|526399627|FG000|Overall Study|Nonspecified|2|||
146293453|NCT03437278|527590019|FG000|Overall Study|Progressive disease|1|||
146293454|NCT03437278|527590020|FG001|Overall Study|Progressive disease|0|||
146293455|NCT03437278|527590021|FG002|Overall Study|Progressive disease|0|||
146293456|NCT03437278|527590019|FG000|Overall Study|Physician Decision|1|||
146293457|NCT03437278|527590020|FG001|Overall Study|Physician Decision|0|||
146293458|NCT03437278|527590021|FG002|Overall Study|Physician Decision|1|||
146293459|NCT01128738|527590022|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
146293460|NCT01128738|527590023|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
146293461|NCT01128738|527590022|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
146293462|NCT01128738|527590023|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
146293463|NCT01128738|527590022|FG000|Second TP|Lost to Follow-up|0|||
146293464|NCT01128738|527590023|FG001|Second TP|Lost to Follow-up|1|||
146293465|NCT01128738|527590022|FG000|Second TP|Withdrawal by Subject|0|||
146293466|NCT01128738|527590023|FG001|Second TP|Withdrawal by Subject|2|||
146293467|NCT00973362|527590024|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
146293468|NCT00973362|527590025|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
146293469|NCT00973362|527590024|FG000|Baseline Evaluation|No colposcopy visit|62|||
146293470|NCT00973362|527590025|FG001|Baseline Evaluation|No colposcopy visit|0|||
146293471|NCT00973362|527590024|FG000|Baseline Evaluation|Inevaluable|686|||
146293472|NCT00973362|527590025|FG001|Baseline Evaluation|Inevaluable|223|||
146293473|NCT00973362|527590024|FG000|3-Year Follow-up|Lost to Follow-up|17|||
146293474|NCT00973362|527590025|FG001|3-Year Follow-up|Lost to Follow-up|0|||
146293475|NCT05116046|527590026|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146293476|NCT05116046|527590027|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146293477|NCT05116046|527590028|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146293478|NCT05116046|527590026|FG000|Overall Study|Study terminated by sponsor|14|||
146293479|NCT05116046|527590027|FG001|Overall Study|Study terminated by sponsor|16|||
146293480|NCT05116046|527590028|FG002|Overall Study|Study terminated by sponsor|1|||
146293481|NCT02974088|527590029|FG000|Overall Study|Lost to Follow-up|0|||
146293482|NCT02974088|527590030|FG001|Overall Study|Lost to Follow-up|2|||
146293483|NCT02974088|527590029|FG000|Overall Study|Adverse Event|0|||
146293484|NCT02974088|527590030|FG001|Overall Study|Adverse Event|1|||
146293485|NCT00150969|527590031|FG000|24 Month Main Study|Adverse Event|3|||
146293486|NCT00150969|527590032|FG001|24 Month Main Study|Adverse Event|4|||
146293487|NCT00150969|527590031|FG000|24 Month Main Study|Death|1|||
146293488|NCT00150969|527590032|FG001|24 Month Main Study|Death|1|||
146293489|NCT00150969|527590031|FG000|24 Month Main Study|Lack of Efficacy|1|||
146293490|NCT00150969|527590032|FG001|24 Month Main Study|Lack of Efficacy|8|||
146293491|NCT00150969|527590031|FG000|24 Month Main Study|Lost to Follow-up|3|||
146293492|NCT00150969|527590032|FG001|24 Month Main Study|Lost to Follow-up|2|||
146293493|NCT00150969|527590031|FG000|24 Month Main Study|Protocol Violation|4|||
146293494|NCT00150969|527590032|FG001|24 Month Main Study|Protocol Violation|2|||
146293495|NCT00150969|527590031|FG000|24 Month Main Study|Withdrawal by Subject|7|||
146293496|NCT00150969|527590032|FG001|24 Month Main Study|Withdrawal by Subject|4|||
146293497|NCT00150969|527590031|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
146293498|NCT00150969|527590032|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
146293499|NCT00150969|527590031|FG000|24-48 Month Extension|Lack of Efficacy|0|||
146293500|NCT00150969|527590032|FG001|24-48 Month Extension|Lack of Efficacy|1|||
146293501|NCT00150969|527590031|FG000|24-48 Month Extension|Adverse Event|1|||
146293502|NCT00150969|527590032|FG001|24-48 Month Extension|Adverse Event|3|||
146293503|NCT00150969|527590031|FG000|24-48 Month Extension|Other Reason|81|||
146293504|NCT00150969|527590032|FG001|24-48 Month Extension|Other Reason|91|||
146293505|NCT00146757|527590033|FG000|Overall Study|Death|1|||
145889097|NCT01730040|526101708|FG004|Overall Study|Subject moved|0|||
145889098|NCT01730040|526101709|FG005|Overall Study|Subject moved|0|||
145889099|NCT01730040|526101710|FG006|Overall Study|Subject moved|1|||
145889100|NCT01730040|526101704|FG000|Overall Study|Physician Decision|0|||
145889101|NCT01730040|526101705|FG001|Overall Study|Physician Decision|0|||
145889102|NCT01730040|526101706|FG002|Overall Study|Physician Decision|0|||
145889103|NCT01730040|526101707|FG003|Overall Study|Physician Decision|0|||
145889104|NCT01730040|526101708|FG004|Overall Study|Physician Decision|0|||
145889105|NCT01730040|526101709|FG005|Overall Study|Physician Decision|1|||
145889106|NCT01730040|526101710|FG006|Overall Study|Physician Decision|1|||
145889107|NCT01730040|526101704|FG000|Overall Study|Other than specified|7|||
145889108|NCT01730040|526101705|FG001|Overall Study|Other than specified|8|||
145889109|NCT01730040|526101706|FG002|Overall Study|Other than specified|5|||
145889110|NCT01730040|526101707|FG003|Overall Study|Other than specified|5|||
145889111|NCT01730040|526101708|FG004|Overall Study|Other than specified|5|||
145889112|NCT01730040|526101709|FG005|Overall Study|Other than specified|4|||
145889113|NCT01730040|526101710|FG006|Overall Study|Other than specified|4|||
145889114|NCT01730040|526101704|FG000|Overall Study|Adverse Event|4|||
145889115|NCT01730040|526101705|FG001|Overall Study|Adverse Event|3|||
145889116|NCT01730040|526101706|FG002|Overall Study|Adverse Event|5|||
146293506|NCT00146757|527590034|FG001|Overall Study|Death|0|||
145889117|NCT01730040|526101707|FG003|Overall Study|Adverse Event|3|||
145889118|NCT01730040|526101708|FG004|Overall Study|Adverse Event|1|||
145889119|NCT01730040|526101709|FG005|Overall Study|Adverse Event|1|||
145968436|NCT00761319|526399628|FG001|Overall Study|Nonspecified|2|||
146086842|NCT01589770|526838851|FG001|Overall Study|EGFR <60ml/min|4|||
146086843|NCT01589770|526838850|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
146086844|NCT01589770|526838851|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
146086845|NCT02283177|526838854|FG000|Overall Study|Withdrawal by Subject|1|||
146086846|NCT02283177|526838855|FG001|Overall Study|Withdrawal by Subject|1|||
146086847|NCT01101191|526838856|FG000|Period 1|Withdrawal by Subject|1|||
146086848|NCT01101191|526838857|FG001|Period 1|Withdrawal by Subject|0|||
146086849|NCT01101191|526838856|FG000|Period 1|Adverse Event|1|||
146086850|NCT01101191|526838857|FG001|Period 1|Adverse Event|2|||
146086851|NCT02751931|526838860|FG000|Overall Study|Adverse Event|3|||
146086852|NCT02751931|526838861|FG001|Overall Study|Adverse Event|0|||
146086853|NCT02751931|526838860|FG000|Overall Study|Other: Miscelleneous|10|||
146086854|NCT02751931|526838861|FG001|Overall Study|Other: Miscelleneous|8|||
146086855|NCT01602666|526838867|FG000|Induction Chemotherapy|Death|2|||
146086856|NCT01602666|526838868|FG001|Induction Chemotherapy|Death|1|||
146086857|NCT01602666|526838867|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
146086858|NCT01602666|526838868|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
146086859|NCT01602666|526838867|FG000|Induction Chemotherapy|Physician Decision|12|||
146086860|NCT01602666|526838868|FG001|Induction Chemotherapy|Physician Decision|5|||
146086861|NCT01602666|526838867|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
146086862|NCT01602666|526838868|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
146086863|NCT01602666|526838867|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
146086864|NCT01602666|526838868|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
146086865|NCT01602666|526838867|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
146086866|NCT01602666|526838868|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
146086867|NCT01602666|526838867|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
145968437|NCT00761319|526399627|FG000|Overall Study|Missing|1|||
145968438|NCT00761319|526399628|FG001|Overall Study|Missing|0|||
145968439|NCT01125930|526399629|FG000|Overall Study|Adverse Event|0|||
145968440|NCT01125930|526399630|FG001|Overall Study|Adverse Event|1|||
145968441|NCT01125930|526399629|FG000|Overall Study|Withdrawal by Subject|1|||
145968442|NCT01125930|526399630|FG001|Overall Study|Withdrawal by Subject|6|||
145968443|NCT01125930|526399629|FG000|Overall Study|Protocol Violation|0|||
145968444|NCT01125930|526399630|FG001|Overall Study|Protocol Violation|1|||
145968445|NCT01125930|526399629|FG000|Overall Study|Lost to Follow-up|0|||
145968446|NCT01125930|526399630|FG001|Overall Study|Lost to Follow-up|2|||
145968447|NCT03617588|526399633|FG000|Overall Study|Withdrawal by Subject|1|||
145968448|NCT03617588|526399634|FG001|Overall Study|Withdrawal by Subject|0|||
145968449|NCT01715831|526399637|FG000|Overall Study|Adverse Event|1|||
145968450|NCT03261401|526399638|FG000|Overall Study|Withdrawal by Subject|0|||
145968451|NCT03261401|526399639|FG001|Overall Study|Withdrawal by Subject|0|||
145968452|NCT03261401|526399640|FG002|Overall Study|Withdrawal by Subject|0|||
145968453|NCT03261401|526399641|FG003|Overall Study|Withdrawal by Subject|0|||
145968454|NCT03261401|526399642|FG004|Overall Study|Withdrawal by Subject|0|||
145968455|NCT03261401|526399643|FG005|Overall Study|Withdrawal by Subject|1|||
145968456|NCT03261401|526399644|FG006|Overall Study|Withdrawal by Subject|0|||
145968457|NCT03261401|526399645|FG007|Overall Study|Withdrawal by Subject|0|||
145968458|NCT03261401|526399646|FG008|Overall Study|Withdrawal by Subject|0|||
145968459|NCT03261401|526399647|FG009|Overall Study|Withdrawal by Subject|0|||
145968460|NCT03261401|526399648|FG010|Overall Study|Withdrawal by Subject|0|||
145968461|NCT03261401|526399649|FG011|Overall Study|Withdrawal by Subject|0|||
145968462|NCT03261401|526399650|FG012|Overall Study|Withdrawal by Subject|0|||
145968463|NCT03261401|526399638|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
145968464|NCT03261401|526399639|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
145968465|NCT03261401|526399640|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
145968466|NCT03261401|526399641|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
145968467|NCT03261401|526399642|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
145968468|NCT03261401|526399643|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
145968469|NCT03261401|526399644|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
145968470|NCT03261401|526399645|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
145968471|NCT03261401|526399646|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
145968472|NCT03261401|526399647|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
146086868|NCT01602666|526838868|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
146086869|NCT01602666|526838867|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
146086870|NCT01602666|526838868|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
146232902|NCT00943917|527370700|FG001|Stage II|Pregnancy|0|||
146232903|NCT00943917|527370701|FG002|Stage II|Pregnancy|0|||
145968473|NCT03261401|526399648|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
145968474|NCT03261401|526399649|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
145968475|NCT03261401|526399650|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
145968476|NCT00900562|526399653|FG000|Overall Study|Progressive disease|9|||
145968477|NCT00900562|526399654|FG001|Overall Study|Progressive disease|5|||
145968478|NCT00900562|526399653|FG000|Overall Study|Toxicity|1|||
146086871|NCT01602666|526838867|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
145968479|NCT00900562|526399654|FG001|Overall Study|Toxicity|0|||
145968480|NCT00900562|526399653|FG000|Overall Study|Death|1|||
145968481|NCT00900562|526399654|FG001|Overall Study|Death|1|||
145968482|NCT00900562|526399653|FG000|Overall Study|Withdrawal by Subject|0|||
145968483|NCT00900562|526399654|FG001|Overall Study|Withdrawal by Subject|1|||
145968484|NCT00900562|526399653|FG000|Overall Study|Unrelated adverse event|1|||
145968485|NCT00900562|526399654|FG001|Overall Study|Unrelated adverse event|0|||
145968486|NCT01516216|526399655|FG000|Overall Study|Adverse Event|2|||
145968487|NCT01516216|526399656|FG001|Overall Study|Adverse Event|4|||
145968488|NCT01516216|526399655|FG000|Overall Study|Disease Progression|38|||
145968489|NCT01516216|526399656|FG001|Overall Study|Disease Progression|34|||
145968490|NCT01516216|526399655|FG000|Overall Study|Withdrawal by Subject|9|||
145968491|NCT01516216|526399656|FG001|Overall Study|Withdrawal by Subject|11|||
145968492|NCT01516216|526399655|FG000|Overall Study|Potentially Curative Resection|6|||
145968493|NCT01516216|526399656|FG001|Overall Study|Potentially Curative Resection|12|||
145968494|NCT01516216|526399655|FG000|Overall Study|Nonadherence|2|||
145968495|NCT01516216|526399656|FG001|Overall Study|Nonadherence|3|||
145968496|NCT01516216|526399655|FG000|Overall Study|Physician Decision|6|||
145968497|NCT01516216|526399656|FG001|Overall Study|Physician Decision|3|||
145968498|NCT01516216|526399655|FG000|Overall Study|Prolonged Treatment Delay|5|||
145968499|NCT01516216|526399656|FG001|Overall Study|Prolonged Treatment Delay|1|||
145968500|NCT01516216|526399655|FG000|Overall Study|Intercurrent Illness|1|||
145968501|NCT01516216|526399656|FG001|Overall Study|Intercurrent Illness|0|||
145968502|NCT01516216|526399655|FG000|Overall Study|Death|1|||
145968503|NCT01516216|526399656|FG001|Overall Study|Death|1|||
145968504|NCT00316004|526399657|FG000|Overall Study|Subject was not given study fluid.|14|||
145968505|NCT00316004|526399658|FG001|Overall Study|Subject was not given study fluid.|14|||
145968506|NCT00316004|526399659|FG002|Overall Study|Subject was not given study fluid.|21|||
145968507|NCT01065818|526399660|FG000|Overall Study|Withdrawal by Subject|1|||
145968508|NCT01065818|526399660|FG000|Overall Study|Not a candidate for surgery|1|||
145968509|NCT03157089|526399661|FG000|Overall Study|Treated only with pembrolizumab|1|||
145968510|NCT03157089|526399662|FG001|Overall Study|Treated only with pembrolizumab|0|||
145968511|NCT03157089|526399661|FG000|Overall Study|Adverse Event|5|||
145968512|NCT03157089|526399662|FG001|Overall Study|Adverse Event|4|||
145968513|NCT03157089|526399661|FG000|Overall Study|Progressive disease|6|||
145968514|NCT03157089|526399662|FG001|Overall Study|Progressive disease|8|||
145968515|NCT00977197|526399667|FG000|Overall Study|Withdrawal by Subject|3|||
145968516|NCT00977197|526399668|FG001|Overall Study|Withdrawal by Subject|4|||
145968517|NCT00977197|526399667|FG000|Overall Study|Adverse Event|3|||
145968518|NCT00977197|526399668|FG001|Overall Study|Adverse Event|1|||
145968519|NCT00977197|526399667|FG000|Overall Study|Lack of Efficacy|1|||
145968520|NCT00977197|526399668|FG001|Overall Study|Lack of Efficacy|0|||
145968521|NCT00977197|526399667|FG000|Overall Study|Lost to Follow-up|1|||
145968522|NCT00977197|526399668|FG001|Overall Study|Lost to Follow-up|3|||
145968523|NCT00977197|526399667|FG000|Overall Study|Nonadherence|1|||
145968524|NCT00977197|526399668|FG001|Overall Study|Nonadherence|1|||
146232904|NCT00943917|527370702|FG003|Stage II|Pregnancy|0|||
146293507|NCT00146757|527590033|FG000|Overall Study|Adverse Event|1|||
146293508|NCT00146757|527590034|FG001|Overall Study|Adverse Event|0|||
146293509|NCT02893930|527590040|FG000|Overall Study|Adverse Event|3|||
146293510|NCT02893930|527590040|FG000|Overall Study|Death|1|||
146293511|NCT02893930|527590040|FG000|Overall Study|Disease progression|5|||
146293512|NCT02893930|527590040|FG000|Overall Study|Withdrawal by Subject|2|||
146293513|NCT02893930|527590040|FG000|Overall Study|Physician Decision|1|||
146087792|NCT04062123|526841843|FG002|Overall Study|Withdrawal by Subject|0|||
146293514|NCT02893930|527590040|FG000|Overall Study|Ineligible|1|||
146293515|NCT02349360|527590041|FG000|Overall Study|Withdrawal by Subject|0|||
145968525|NCT01432951|526399669|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
145968526|NCT00853385|526399670|FG000|Overall Study|Death|0|||
145968527|NCT00853385|526399671|FG001|Overall Study|Death|0|||
145968528|NCT00853385|526399672|FG002|Overall Study|Death|0|||
145968529|NCT00853385|526399673|FG003|Overall Study|Death|0|||
145968530|NCT00853385|526399674|FG004|Overall Study|Death|1|||
145968531|NCT00853385|526399670|FG000|Overall Study|Adverse Event|24|||
145968532|NCT00853385|526399671|FG001|Overall Study|Adverse Event|24|||
145968533|NCT00853385|526399672|FG002|Overall Study|Adverse Event|2|||
145968534|NCT00853385|526399673|FG003|Overall Study|Adverse Event|5|||
146086872|NCT01602666|526838868|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
145968535|NCT00853385|526399674|FG004|Overall Study|Adverse Event|22|||
145968536|NCT00853385|526399670|FG000|Overall Study|Lack of Efficacy|6|||
145968537|NCT00853385|526399671|FG001|Overall Study|Lack of Efficacy|7|||
145968538|NCT00853385|526399672|FG002|Overall Study|Lack of Efficacy|3|||
145968539|NCT00853385|526399673|FG003|Overall Study|Lack of Efficacy|3|||
145968540|NCT00853385|526399674|FG004|Overall Study|Lack of Efficacy|6|||
145968541|NCT00853385|526399670|FG000|Overall Study|Lost to Follow-up|2|||
145968542|NCT00853385|526399671|FG001|Overall Study|Lost to Follow-up|1|||
146086873|NCT01602666|526838867|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
146086874|NCT01602666|526838868|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
146086875|NCT01602666|526838867|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
146086876|NCT01602666|526838868|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
146086877|NCT01163318|526838869|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
145968543|NCT00853385|526399672|FG002|Overall Study|Lost to Follow-up|0|||
145968544|NCT00853385|526399673|FG003|Overall Study|Lost to Follow-up|0|||
145968545|NCT00853385|526399674|FG004|Overall Study|Lost to Follow-up|0|||
145968546|NCT00853385|526399670|FG000|Overall Study|Withdrawal by Subject|4|||
145968547|NCT00853385|526399671|FG001|Overall Study|Withdrawal by Subject|2|||
145968548|NCT00853385|526399672|FG002|Overall Study|Withdrawal by Subject|0|||
145968549|NCT00853385|526399673|FG003|Overall Study|Withdrawal by Subject|1|||
145968550|NCT00853385|526399674|FG004|Overall Study|Withdrawal by Subject|1|||
145968551|NCT00853385|526399670|FG000|Overall Study|Other|18|||
145968552|NCT00853385|526399671|FG001|Overall Study|Other|9|||
145968553|NCT00853385|526399672|FG002|Overall Study|Other|4|||
145968554|NCT00853385|526399673|FG003|Overall Study|Other|4|||
145968555|NCT00853385|526399674|FG004|Overall Study|Other|12|||
145968556|NCT00941928|526399675|FG000|Overall Study|Withdrawal by Subject|1|||
145968557|NCT00941928|526399675|FG000|Overall Study|Disease Progression|1|||
145968558|NCT02300610|526399680|FG000|Overall Study|Withdrawal by Subject|1|||
145968559|NCT02300610|526399681|FG001|Overall Study|Withdrawal by Subject|0|||
146086878|NCT01163318|526838869|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
146086879|NCT01163318|526838869|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
145968560|NCT02300610|526399682|FG002|Overall Study|Withdrawal by Subject|1|||
145968561|NCT01829347|526399683|FG000|VTI-210|Death|5|||
145968562|NCT01829347|526399684|FG001|VTI-210|Death|3|||
145968563|NCT01829347|526399683|FG000|VTI-210|Withdrawal by Subject|1|||
145968564|NCT01829347|526399684|FG001|VTI-210|Withdrawal by Subject|0|||
145968565|NCT01829347|526399683|FG000|VTI-210E|Death|2|||
146086880|NCT01163318|526838869|FG000|Overall Study|Participants Without Case Report Form|7|||
146232905|NCT00943917|527370703|FG004|Stage II|Pregnancy|0|||
146232906|NCT00943917|527370704|FG005|Stage II|Pregnancy|1|||
146232907|NCT00943917|527370705|FG006|Stage II|Pregnancy|0|||
146232908|NCT00943917|527370706|FG007|Stage II|Pregnancy|0|||
146232909|NCT00943917|527370707|FG008|Stage II|Pregnancy|0|||
146232910|NCT00943917|527370708|FG009|Stage II|Pregnancy|0|||
146232911|NCT00943917|527370709|FG010|Stage II|Pregnancy|0|||
146232912|NCT00943917|527370710|FG011|Stage II|Pregnancy|0|||
146232913|NCT00943917|527370711|FG012|Stage II|Pregnancy|0|||
146232914|NCT00943917|527370712|FG013|Stage II|Pregnancy|0|||
146232915|NCT00943917|527370713|FG014|Stage II|Pregnancy|0|||
146232916|NCT00943917|527370699|FG000|Stage II Continuation|Adverse Event|0|||
146232917|NCT00943917|527370700|FG001|Stage II Continuation|Adverse Event|0|||
146232918|NCT00943917|527370701|FG002|Stage II Continuation|Adverse Event|0|||
146232919|NCT00943917|527370702|FG003|Stage II Continuation|Adverse Event|0|||
146232920|NCT00943917|527370703|FG004|Stage II Continuation|Adverse Event|0|||
146232921|NCT00943917|527370704|FG005|Stage II Continuation|Adverse Event|0|||
146232922|NCT00943917|527370705|FG006|Stage II Continuation|Adverse Event|0|||
146232923|NCT00943917|527370706|FG007|Stage II Continuation|Adverse Event|0|||
146232924|NCT00943917|527370707|FG008|Stage II Continuation|Adverse Event|0|||
146232925|NCT00943917|527370708|FG009|Stage II Continuation|Adverse Event|0|||
146232926|NCT00943917|527370709|FG010|Stage II Continuation|Adverse Event|0|||
146232927|NCT00943917|527370710|FG011|Stage II Continuation|Adverse Event|1|||
146232928|NCT00943917|527370711|FG012|Stage II Continuation|Adverse Event|2|||
146232929|NCT00943917|527370712|FG013|Stage II Continuation|Adverse Event|1|||
145968566|NCT01829347|526399684|FG001|VTI-210E|Death|1|||
145968567|NCT01829347|526399683|FG000|VTI-210E|Study terminated prematurely|1|||
145968568|NCT01829347|526399684|FG001|VTI-210E|Study terminated prematurely|5|||
146232930|NCT00943917|527370713|FG014|Stage II Continuation|Adverse Event|1|||
146293516|NCT02349360|527590042|FG001|Overall Study|Withdrawal by Subject|1|||
146293517|NCT01498289|527590052|FG000|Overall Study|Adverse Event|16|||
146293518|NCT01498289|527590053|FG001|Overall Study|Adverse Event|18|||
146293519|NCT01498289|527590052|FG000|Overall Study|Death|6|||
146293520|NCT01498289|527590053|FG001|Overall Study|Death|8|||
146293521|NCT01498289|527590052|FG000|Overall Study|Withdrawal unrelated to AE|16|||
146293522|NCT01498289|527590053|FG001|Overall Study|Withdrawal unrelated to AE|16|||
146293523|NCT01498289|527590052|FG000|Overall Study|Progression/relapse|53|||
146293524|NCT01498289|527590053|FG001|Overall Study|Progression/relapse|59|||
146293525|NCT01498289|527590052|FG000|Overall Study|Not protocol specified|7|||
146293526|NCT01498289|527590053|FG001|Overall Study|Not protocol specified|2|||
146293527|NCT01498289|527590052|FG000|Overall Study|Reason under review|0|||
146293528|NCT01498289|527590053|FG001|Overall Study|Reason under review|1|||
146293529|NCT01423253|527590054|FG000|Overall Study|Adverse Event|2|||
146293530|NCT01423253|527590054|FG000|Overall Study|Lack of Efficacy|2|||
146293531|NCT01423253|527590054|FG000|Overall Study|Lost to Follow-up|1|||
146293532|NCT01423253|527590054|FG000|Overall Study|Protocol Violation|2|||
146293533|NCT01423253|527590054|FG000|Overall Study|Withdrawal by Subject|2|||
146293534|NCT02804178|527590055|FG000|Overall Study|Adverse Event|1|||
146293535|NCT01290601|527590056|FG000|Overall Study|Adverse Event|0|||
146293536|NCT01290601|527590057|FG001|Overall Study|Adverse Event|2|||
146293537|NCT01290601|527590058|FG002|Overall Study|Adverse Event|0|||
146293538|NCT01290601|527590059|FG003|Overall Study|Adverse Event|0|||
146293539|NCT01290601|527590056|FG000|Overall Study|Lack of Efficacy|2|||
146293540|NCT01290601|527590057|FG001|Overall Study|Lack of Efficacy|1|||
146293541|NCT01290601|527590058|FG002|Overall Study|Lack of Efficacy|0|||
146293542|NCT01290601|527590059|FG003|Overall Study|Lack of Efficacy|0|||
146293543|NCT01290601|527590056|FG000|Overall Study|Lost to Follow-up|7|||
146293544|NCT01290601|527590057|FG001|Overall Study|Lost to Follow-up|2|||
146293545|NCT01290601|527590058|FG002|Overall Study|Lost to Follow-up|0|||
146293546|NCT01290601|527590059|FG003|Overall Study|Lost to Follow-up|0|||
146293547|NCT01290601|527590056|FG000|Overall Study|Other|1|||
146293548|NCT01290601|527590057|FG001|Overall Study|Other|0|||
145968569|NCT00856180|526399688|FG000|Overall Study|Adverse Event|4|||
145968570|NCT00856180|526399688|FG000|Overall Study|Progressive Disease|16|||
145968571|NCT00929669|526399689|FG000|Overall Study|elevated glucose levels|1|||
145968572|NCT02714153|526399690|FG000|Overall Study|Death|1|||
145968573|NCT01901185|526399691|FG000|Overall Study|Withdrawal by Subject|2|||
145968574|NCT00296335|526399692|FG000|Overall Study|Recurrence|3|||
145968575|NCT00296335|526399693|FG001|Overall Study|Recurrence|51|||
145968576|NCT00296335|526399692|FG000|Overall Study|Adverse Event|17|||
145968577|NCT00296335|526399693|FG001|Overall Study|Adverse Event|27|||
145968578|NCT00296335|526399692|FG000|Overall Study|Lost to Follow-up|7|||
146232931|NCT00943917|527370699|FG000|Stage II Continuation|Withdrawal by Subject|0|||
146232932|NCT00943917|527370700|FG001|Stage II Continuation|Withdrawal by Subject|0|||
146232933|NCT00943917|527370701|FG002|Stage II Continuation|Withdrawal by Subject|0|||
146232934|NCT00943917|527370702|FG003|Stage II Continuation|Withdrawal by Subject|0|||
146232935|NCT00943917|527370703|FG004|Stage II Continuation|Withdrawal by Subject|0|||
146232936|NCT00943917|527370704|FG005|Stage II Continuation|Withdrawal by Subject|0|||
146232937|NCT00943917|527370705|FG006|Stage II Continuation|Withdrawal by Subject|0|||
146232938|NCT00943917|527370706|FG007|Stage II Continuation|Withdrawal by Subject|0|||
146232939|NCT00943917|527370707|FG008|Stage II Continuation|Withdrawal by Subject|0|||
146232940|NCT00943917|527370708|FG009|Stage II Continuation|Withdrawal by Subject|0|||
146232941|NCT00943917|527370709|FG010|Stage II Continuation|Withdrawal by Subject|0|||
146232942|NCT00943917|527370710|FG011|Stage II Continuation|Withdrawal by Subject|0|||
146232943|NCT00943917|527370711|FG012|Stage II Continuation|Withdrawal by Subject|0|||
146232944|NCT00943917|527370712|FG013|Stage II Continuation|Withdrawal by Subject|1|||
146232945|NCT00943917|527370713|FG014|Stage II Continuation|Withdrawal by Subject|3|||
146232946|NCT00943917|527370699|FG000|Stage II Continuation|Protocol Violation|0|||
146232947|NCT00943917|527370700|FG001|Stage II Continuation|Protocol Violation|0|||
146232948|NCT00943917|527370701|FG002|Stage II Continuation|Protocol Violation|0|||
146232949|NCT00943917|527370702|FG003|Stage II Continuation|Protocol Violation|0|||
146293549|NCT01290601|527590058|FG002|Overall Study|Other|0|||
146293550|NCT01290601|527590059|FG003|Overall Study|Other|0|||
146293551|NCT01290601|527590056|FG000|Overall Study|Protocol Violation|1|||
145968579|NCT00296335|526399693|FG001|Overall Study|Lost to Follow-up|33|||
145968580|NCT00296335|526399692|FG000|Overall Study|Physician Decision|3|||
145968581|NCT00296335|526399693|FG001|Overall Study|Physician Decision|11|||
145968582|NCT01670292|526399694|FG000|Overall Study|Lost to Follow-up|14|||
146232950|NCT00943917|527370703|FG004|Stage II Continuation|Protocol Violation|0|||
146293552|NCT01290601|527590057|FG001|Overall Study|Protocol Violation|0|||
146293553|NCT01290601|527590058|FG002|Overall Study|Protocol Violation|0|||
146293554|NCT01290601|527590059|FG003|Overall Study|Protocol Violation|0|||
145968583|NCT04494646|526399697|FG000|Overall Study|Adverse Event|0|||
146293555|NCT00986440|527590067|FG000|Overall Study|Progressive disease|27|||
146293556|NCT00986440|527590068|FG001|Overall Study|Progressive disease|37|||
146293557|NCT00986440|527590067|FG000|Overall Study|Serious adverse event or adverse event|9|||
146293558|NCT00986440|527590068|FG001|Overall Study|Serious adverse event or adverse event|2|||
145968584|NCT04494646|526399698|FG001|Overall Study|Adverse Event|1|||
145968585|NCT04494646|526399697|FG000|Overall Study|Withdrawal by Subject|0|||
145968586|NCT04494646|526399698|FG001|Overall Study|Withdrawal by Subject|1|||
145968587|NCT03054428|526399704|FG000|Overall Study|Physician Decision|0|||
145968588|NCT03054428|526399705|FG001|Overall Study|Physician Decision|1|||
145968589|NCT03054428|526399706|FG002|Overall Study|Physician Decision|1|||
145968590|NCT03054428|526399704|FG000|Overall Study|Lack of Efficacy|3|||
145968591|NCT03054428|526399705|FG001|Overall Study|Lack of Efficacy|1|||
145968592|NCT03054428|526399706|FG002|Overall Study|Lack of Efficacy|0|||
145968593|NCT03054428|526399704|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
145968594|NCT03054428|526399705|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
145968595|NCT03054428|526399706|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
145968596|NCT03054428|526399704|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
145968597|NCT03054428|526399705|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
145968598|NCT03054428|526399706|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
145968599|NCT03054428|526399704|FG000|Overall Study|Transitioned to OLE study|76|||
145968600|NCT03054428|526399705|FG001|Overall Study|Transitioned to OLE study|76|||
145968601|NCT03054428|526399706|FG002|Overall Study|Transitioned to OLE study|73|||
145968602|NCT03054428|526399704|FG000|Overall Study|Withdrawal by Subject|3|||
145968603|NCT03054428|526399705|FG001|Overall Study|Withdrawal by Subject|2|||
145968604|NCT03054428|526399706|FG002|Overall Study|Withdrawal by Subject|3|||
145968605|NCT03054428|526399704|FG000|Overall Study|Lost to Follow-up|0|||
145968606|NCT03054428|526399705|FG001|Overall Study|Lost to Follow-up|0|||
145968607|NCT03054428|526399706|FG002|Overall Study|Lost to Follow-up|1|||
145968608|NCT01499810|526399707|FG000|Overall Study|Lost to Follow-up|10|||
146232951|NCT00943917|527370704|FG005|Stage II Continuation|Protocol Violation|0|||
146232952|NCT00943917|527370705|FG006|Stage II Continuation|Protocol Violation|0|||
146232953|NCT00943917|527370706|FG007|Stage II Continuation|Protocol Violation|0|||
146232954|NCT00943917|527370707|FG008|Stage II Continuation|Protocol Violation|0|||
145968609|NCT01499810|526399707|FG000|Overall Study|Protocol Violation|1|||
145968610|NCT01499810|526399707|FG000|Overall Study|Withdrawal by Subject|1|||
146232955|NCT00943917|527370708|FG009|Stage II Continuation|Protocol Violation|1|||
146232956|NCT00943917|527370709|FG010|Stage II Continuation|Protocol Violation|0|||
146232957|NCT00943917|527370710|FG011|Stage II Continuation|Protocol Violation|1|||
146232958|NCT00943917|527370711|FG012|Stage II Continuation|Protocol Violation|0|||
146232959|NCT00943917|527370712|FG013|Stage II Continuation|Protocol Violation|0|||
146232960|NCT00943917|527370713|FG014|Stage II Continuation|Protocol Violation|0|||
146232961|NCT00943917|527370699|FG000|Stage II Continuation|hypoglycemia|0|||
146232962|NCT00943917|527370700|FG001|Stage II Continuation|hypoglycemia|0|||
146232963|NCT00943917|527370701|FG002|Stage II Continuation|hypoglycemia|0|||
146232964|NCT00943917|527370702|FG003|Stage II Continuation|hypoglycemia|0|||
146232965|NCT00943917|527370703|FG004|Stage II Continuation|hypoglycemia|0|||
146232966|NCT00943917|527370704|FG005|Stage II Continuation|hypoglycemia|0|||
146232967|NCT00943917|527370705|FG006|Stage II Continuation|hypoglycemia|0|||
146232968|NCT00943917|527370706|FG007|Stage II Continuation|hypoglycemia|0|||
146232969|NCT00943917|527370707|FG008|Stage II Continuation|hypoglycemia|0|||
146232970|NCT00943917|527370708|FG009|Stage II Continuation|hypoglycemia|0|||
146232971|NCT00943917|527370709|FG010|Stage II Continuation|hypoglycemia|0|||
146232972|NCT00943917|527370710|FG011|Stage II Continuation|hypoglycemia|0|||
146232973|NCT00943917|527370711|FG012|Stage II Continuation|hypoglycemia|1|||
146232974|NCT00943917|527370712|FG013|Stage II Continuation|hypoglycemia|0|||
146232975|NCT00943917|527370713|FG014|Stage II Continuation|hypoglycemia|0|||
146232976|NCT00943917|527370699|FG000|Stage II Continuation|A1C elevation|0|||
146232977|NCT00943917|527370700|FG001|Stage II Continuation|A1C elevation|0|||
146232978|NCT00943917|527370701|FG002|Stage II Continuation|A1C elevation|0|||
146232979|NCT00943917|527370702|FG003|Stage II Continuation|A1C elevation|0|||
146232980|NCT00943917|527370703|FG004|Stage II Continuation|A1C elevation|0|||
146232981|NCT00943917|527370704|FG005|Stage II Continuation|A1C elevation|0|||
146232982|NCT00943917|527370705|FG006|Stage II Continuation|A1C elevation|0|||
146232983|NCT00943917|527370706|FG007|Stage II Continuation|A1C elevation|0|||
146232984|NCT00943917|527370707|FG008|Stage II Continuation|A1C elevation|0|||
146232985|NCT00943917|527370708|FG009|Stage II Continuation|A1C elevation|0|||
146232986|NCT00943917|527370709|FG010|Stage II Continuation|A1C elevation|0|||
145968611|NCT05117060|526399710|FG000|Overall Study|Adverse Event|3|||
146232987|NCT00943917|527370710|FG011|Stage II Continuation|A1C elevation|0|||
146232988|NCT00943917|527370711|FG012|Stage II Continuation|A1C elevation|0|||
146232989|NCT00943917|527370712|FG013|Stage II Continuation|A1C elevation|1|||
146232990|NCT00943917|527370713|FG014|Stage II Continuation|A1C elevation|0|||
146293559|NCT00986440|527590067|FG000|Overall Study|Withdrawal by Subject|1|||
146232991|NCT01171976|527370714|FG000|Overall Study|Protocol Violation|0|||
146232992|NCT01171976|527370715|FG001|Overall Study|Protocol Violation|0|||
146232993|NCT01171976|527370716|FG002|Overall Study|Protocol Violation|1|||
145968612|NCT05117060|526399711|FG001|Overall Study|Adverse Event|5|||
145968613|NCT05117060|526399712|FG002|Overall Study|Adverse Event|6|||
146232994|NCT01171976|527370714|FG000|Overall Study|Death|2|||
146232995|NCT01171976|527370715|FG001|Overall Study|Death|4|||
145968614|NCT05117060|526399713|FG003|Overall Study|Adverse Event|1|||
145968615|NCT05117060|526399710|FG000|Overall Study|Lost to Follow-up|0|||
145968616|NCT05117060|526399711|FG001|Overall Study|Lost to Follow-up|0|||
145968617|NCT05117060|526399712|FG002|Overall Study|Lost to Follow-up|0|||
145968618|NCT05117060|526399713|FG003|Overall Study|Lost to Follow-up|1|||
145968619|NCT05117060|526399710|FG000|Overall Study|Lack of Efficacy|4|||
145968620|NCT05117060|526399711|FG001|Overall Study|Lack of Efficacy|5|||
145968621|NCT05117060|526399712|FG002|Overall Study|Lack of Efficacy|2|||
145968622|NCT05117060|526399713|FG003|Overall Study|Lack of Efficacy|6|||
145968623|NCT05117060|526399710|FG000|Overall Study|Withdrawal by Subject|8|||
145968624|NCT05117060|526399711|FG001|Overall Study|Withdrawal by Subject|5|||
145968625|NCT05117060|526399712|FG002|Overall Study|Withdrawal by Subject|5|||
145968626|NCT05117060|526399713|FG003|Overall Study|Withdrawal by Subject|6|||
145968627|NCT05117060|526399710|FG000|Overall Study|Other|2|||
145968628|NCT05117060|526399711|FG001|Overall Study|Other|1|||
145968629|NCT05117060|526399712|FG002|Overall Study|Other|3|||
145968630|NCT05117060|526399713|FG003|Overall Study|Other|1|||
145968631|NCT05079321|526399714|FG000|Overall Study|Withdrawal by Subject|2|||
145968632|NCT05079321|526399715|FG001|Overall Study|Withdrawal by Subject|2|||
145968633|NCT05079321|526399714|FG000|Overall Study|Lost to Follow-up|0|||
145968634|NCT05079321|526399715|FG001|Overall Study|Lost to Follow-up|1|||
145968635|NCT01884597|526399716|FG000|Overall Study|Adverse Event|0|||
145968636|NCT01884597|526399717|FG001|Overall Study|Adverse Event|0|||
145968637|NCT01884597|526399718|FG002|Overall Study|Adverse Event|1|||
145889120|NCT01730040|526101710|FG006|Overall Study|Adverse Event|2|||
145889121|NCT01730040|526101704|FG000|Overall Study|Poor compliance to protocol|2|||
145889122|NCT01730040|526101705|FG001|Overall Study|Poor compliance to protocol|4|||
145889123|NCT01730040|526101706|FG002|Overall Study|Poor compliance to protocol|0|||
145889124|NCT01730040|526101707|FG003|Overall Study|Poor compliance to protocol|0|||
145889125|NCT01730040|526101708|FG004|Overall Study|Poor compliance to protocol|0|||
145889126|NCT01730040|526101709|FG005|Overall Study|Poor compliance to protocol|0|||
145889127|NCT01730040|526101710|FG006|Overall Study|Poor compliance to protocol|1|||
145889128|NCT04776746|526101711|FG000|Overall Study|Study terminated by sponsor|61|||
145889129|NCT04776746|526101711|FG000|Overall Study|Adverse Event|5|||
145968638|NCT01884597|526399716|FG000|Overall Study|Lack of Efficacy|1|||
146232996|NCT01171976|527370716|FG002|Overall Study|Death|1|||
146232997|NCT01171976|527370714|FG000|Overall Study|Lost to Follow-up|4|||
146232998|NCT01171976|527370715|FG001|Overall Study|Lost to Follow-up|0|||
146232999|NCT01171976|527370716|FG002|Overall Study|Lost to Follow-up|2|||
146233000|NCT01171976|527370714|FG000|Overall Study|Withdrawal by Subject|1|||
146233001|NCT01171976|527370715|FG001|Overall Study|Withdrawal by Subject|5|||
146233002|NCT01171976|527370716|FG002|Overall Study|Withdrawal by Subject|6|||
146233003|NCT01171976|527370714|FG000|Overall Study|Abnormal test result|1|||
146233004|NCT01171976|527370715|FG001|Overall Study|Abnormal test result|0|||
145968639|NCT01884597|526399717|FG001|Overall Study|Lack of Efficacy|0|||
145968640|NCT01884597|526399718|FG002|Overall Study|Lack of Efficacy|0|||
145968641|NCT01884597|526399716|FG000|Overall Study|Death|0|||
145968642|NCT01884597|526399717|FG001|Overall Study|Death|1|||
145968643|NCT01884597|526399718|FG002|Overall Study|Death|0|||
145968644|NCT02097823|526399719|FG000|Overall Study|Withdrawal by Subject|1|||
145968645|NCT02097823|526399720|FG001|Overall Study|Withdrawal by Subject|1|||
145968646|NCT01081626|526399721|FG000|Overall Study|Dosing error|1|||
145968647|NCT01081626|526399722|FG001|Overall Study|Dosing error|1|||
145968648|NCT01081626|526399721|FG000|Overall Study|Missing Estradiol|25|||
145968649|NCT01081626|526399722|FG001|Overall Study|Missing Estradiol|28|||
145968650|NCT01081626|526399721|FG000|Overall Study|Low antral follicle count|1|||
145968651|NCT01081626|526399722|FG001|Overall Study|Low antral follicle count|0|||
145968652|NCT01081626|526399721|FG000|Overall Study|Overstimulation|0|||
145968653|NCT01081626|526399722|FG001|Overall Study|Overstimulation|1|||
145968654|NCT01081626|526399721|FG000|Overall Study|Lost to Follow-up|0|||
145968655|NCT01081626|526399722|FG001|Overall Study|Lost to Follow-up|1|||
145968656|NCT01081626|526399721|FG000|Overall Study|Other|33|||
145968657|NCT01081626|526399722|FG001|Overall Study|Other|30|||
145968658|NCT01419535|526399724|FG000|Overall Study|could not maintain iv line|1|||
145968659|NCT01419535|526399725|FG001|Overall Study|could not maintain iv line|1|||
145968660|NCT01419535|526399724|FG000|Overall Study|Withdrawal by Subject|0|||
145968661|NCT01419535|526399725|FG001|Overall Study|Withdrawal by Subject|1|||
145968662|NCT05965752|526399728|FG000|Overall Study|Adverse Event|0|||
145968663|NCT05965752|526399729|FG001|Overall Study|Adverse Event|1|||
145968664|NCT05965752|526399730|FG002|Overall Study|Adverse Event|0|||
145968665|NCT05965752|526399731|FG003|Overall Study|Adverse Event|1|||
145968666|NCT05965752|526399732|FG004|Overall Study|Adverse Event|3|||
145968667|NCT05965752|526399728|FG000|Overall Study|Lost to Follow-up|2|||
145968668|NCT05965752|526399729|FG001|Overall Study|Lost to Follow-up|0|||
145968669|NCT05965752|526399730|FG002|Overall Study|Lost to Follow-up|1|||
145968670|NCT05965752|526399731|FG003|Overall Study|Lost to Follow-up|1|||
145968671|NCT05965752|526399732|FG004|Overall Study|Lost to Follow-up|1|||
145968672|NCT05965752|526399728|FG000|Overall Study|Withdrawal by Subject|2|||
145968673|NCT05965752|526399729|FG001|Overall Study|Withdrawal by Subject|2|||
145968674|NCT05965752|526399730|FG002|Overall Study|Withdrawal by Subject|1|||
145968675|NCT05965752|526399731|FG003|Overall Study|Withdrawal by Subject|5|||
145968676|NCT05965752|526399732|FG004|Overall Study|Withdrawal by Subject|0|||
145968677|NCT05965752|526399728|FG000|Overall Study|Disease Relapse|1|||
145968678|NCT05965752|526399729|FG001|Overall Study|Disease Relapse|0|||
145968679|NCT05965752|526399730|FG002|Overall Study|Disease Relapse|1|||
145968680|NCT05965752|526399731|FG003|Overall Study|Disease Relapse|0|||
145968681|NCT05965752|526399732|FG004|Overall Study|Disease Relapse|0|||
145968682|NCT05965752|526399728|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145968683|NCT05965752|526399729|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
145968684|NCT05965752|526399730|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145968685|NCT05965752|526399731|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
145968686|NCT05965752|526399732|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
145968687|NCT05965752|526399728|FG000|Overall Study|Unable to Return for Study Visits|0|||
145968688|NCT05965752|526399729|FG001|Overall Study|Unable to Return for Study Visits|1|||
145968689|NCT05965752|526399730|FG002|Overall Study|Unable to Return for Study Visits|0|||
145968690|NCT05965752|526399731|FG003|Overall Study|Unable to Return for Study Visits|3|||
145968691|NCT05965752|526399732|FG004|Overall Study|Unable to Return for Study Visits|1|||
145968692|NCT05965752|526399728|FG000|Overall Study|Early Termination|0|||
145968693|NCT05965752|526399729|FG001|Overall Study|Early Termination|0|||
145968694|NCT05965752|526399730|FG002|Overall Study|Early Termination|1|||
145968695|NCT05965752|526399731|FG003|Overall Study|Early Termination|0|||
146086881|NCT01163318|526838869|FG000|Overall Study|Multiple Reasons Per Participant|224|||
145968696|NCT05965752|526399732|FG004|Overall Study|Early Termination|0|||
145968697|NCT05965752|526399728|FG000|Overall Study|Reported Unwanted Symptoms|0|||
146086882|NCT00562627|526840249|FG000|Overall Study|Protocol Violation|1|||
146233005|NCT01171976|527370716|FG002|Overall Study|Abnormal test result|0|||
146233006|NCT01171976|527370714|FG000|Overall Study|Adverse Event|6|||
145968698|NCT05965752|526399729|FG001|Overall Study|Reported Unwanted Symptoms|0|||
145968699|NCT05965752|526399730|FG002|Overall Study|Reported Unwanted Symptoms|0|||
145968700|NCT05965752|526399731|FG003|Overall Study|Reported Unwanted Symptoms|0|||
145968701|NCT05965752|526399732|FG004|Overall Study|Reported Unwanted Symptoms|1|||
145968702|NCT05965752|526399728|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
146086883|NCT00562627|526840250|FG001|Overall Study|Protocol Violation|1|||
146086884|NCT00562627|526840251|FG002|Overall Study|Protocol Violation|1|||
146086885|NCT01155479|526840252|FG000|Part I|Adverse Event|13|||
146086886|NCT01155479|526840253|FG001|Part I|Adverse Event|8|||
146233007|NCT01171976|527370715|FG001|Overall Study|Adverse Event|2|||
146086887|NCT01155479|526840254|FG002|Part I|Adverse Event|18|||
146086888|NCT01155479|526840255|FG003|Part I|Adverse Event|7|||
146086889|NCT01155479|526840256|FG004|Part I|Adverse Event|6|||
146086890|NCT01155479|526840252|FG000|Part I|Administrative|2|||
146086891|NCT01155479|526840253|FG001|Part I|Administrative|2|||
146086892|NCT01155479|526840254|FG002|Part I|Administrative|2|||
146086893|NCT01155479|526840255|FG003|Part I|Administrative|0|||
146086894|NCT01155479|526840256|FG004|Part I|Administrative|0|||
146086895|NCT01155479|526840252|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
146086896|NCT01155479|526840253|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
146086897|NCT01155479|526840254|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
146086898|NCT01155479|526840255|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
146086899|NCT01155479|526840256|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
146086900|NCT01155479|526840252|FG000|Part I|Withdrawal by Subject|11|||
145968703|NCT05965752|526399729|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145968704|NCT05965752|526399730|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145968705|NCT05965752|526399731|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145968706|NCT05965752|526399732|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
145968707|NCT01274351|526399734|FG000|Overall Study|Lost to Follow-up|1|||
145968708|NCT01274351|526399734|FG000|Overall Study|patient not compliant with the protocol|1|||
145968709|NCT01274351|526399734|FG000|Overall Study|Pregnancy|1|||
145968710|NCT01274351|526399734|FG000|Overall Study|Death|2|||
146086901|NCT01155479|526840253|FG001|Part I|Withdrawal by Subject|13|||
146086902|NCT01155479|526840254|FG002|Part I|Withdrawal by Subject|8|||
146086903|NCT01155479|526840255|FG003|Part I|Withdrawal by Subject|8|||
146086904|NCT01155479|526840256|FG004|Part I|Withdrawal by Subject|9|||
146086905|NCT01155479|526840252|FG000|Part I|Lost to Follow-up|0|||
146233008|NCT01171976|527370716|FG002|Overall Study|Adverse Event|5|||
146233009|NCT00003222|527370721|FG000|Overall Study|Physician Decision|0|||
146233010|NCT00003222|527370722|FG001|Overall Study|Physician Decision|1|||
146233011|NCT03767335|527370734|FG000|Overall Study|Physician Decision|1|||
146233012|NCT03767335|527370735|FG001|Overall Study|Physician Decision|1|||
146233013|NCT03767335|527370736|FG002|Overall Study|Physician Decision|0|||
146233014|NCT03767335|527370734|FG000|Overall Study|Withdrawal by Subject|0|||
146233015|NCT03767335|527370735|FG001|Overall Study|Withdrawal by Subject|0|||
146233016|NCT03767335|527370736|FG002|Overall Study|Withdrawal by Subject|6|||
146233017|NCT03767335|527370734|FG000|Overall Study|Participant excluded from efficacy population|0|||
146233018|NCT03767335|527370735|FG001|Overall Study|Participant excluded from efficacy population|0|||
146233019|NCT03767335|527370736|FG002|Overall Study|Participant excluded from efficacy population|1|||
146233020|NCT03767335|527370734|FG000|Overall Study|Death|0|||
146233021|NCT03767335|527370735|FG001|Overall Study|Death|0|||
146233022|NCT03767335|527370736|FG002|Overall Study|Death|2|||
146233023|NCT03767335|527370734|FG000|Overall Study|Progressive Disease|2|||
146233024|NCT03767335|527370735|FG001|Overall Study|Progressive Disease|2|||
146233025|NCT03767335|527370736|FG002|Overall Study|Progressive Disease|2|||
146233026|NCT03767335|527370734|FG000|Overall Study|Disease progression needing additional medication|0|||
146233027|NCT03767335|527370735|FG001|Overall Study|Disease progression needing additional medication|0|||
146233028|NCT03767335|527370736|FG002|Overall Study|Disease progression needing additional medication|17|||
146233029|NCT03767335|527370734|FG000|Overall Study|Sponsor decision|0|||
146233030|NCT03767335|527370735|FG001|Overall Study|Sponsor decision|0|||
146233031|NCT03767335|527370736|FG002|Overall Study|Sponsor decision|2|||
146233032|NCT03767335|527370734|FG000|Overall Study|Other Medical Reasons|0|||
146233033|NCT03767335|527370735|FG001|Overall Study|Other Medical Reasons|0|||
146233034|NCT03767335|527370736|FG002|Overall Study|Other Medical Reasons|3|||
146233035|NCT01313559|527370737|FG000|Overall Study|Withdrawal by Subject|1|||
146233036|NCT01313559|527370738|FG001|Overall Study|Withdrawal by Subject|2|||
146086906|NCT01155479|526840253|FG001|Part I|Lost to Follow-up|0|||
146086907|NCT01155479|526840254|FG002|Part I|Lost to Follow-up|1|||
146086908|NCT01155479|526840255|FG003|Part I|Lost to Follow-up|1|||
146086909|NCT01155479|526840256|FG004|Part I|Lost to Follow-up|0|||
146233037|NCT01313559|527370737|FG000|Overall Study|Disease progression|1|||
146086910|NCT01155479|526840252|FG000|Part I|Treatment Failure|3|||
146086911|NCT01155479|526840253|FG001|Part I|Treatment Failure|0|||
146086912|NCT01155479|526840254|FG002|Part I|Treatment Failure|3|||
146086913|NCT01155479|526840255|FG003|Part I|Treatment Failure|1|||
146086914|NCT01155479|526840256|FG004|Part I|Treatment Failure|2|||
146086915|NCT01155479|526840252|FG000|Part I|Did Not Receive Treatment|4|||
146086916|NCT01155479|526840253|FG001|Part I|Did Not Receive Treatment|2|||
146086917|NCT01155479|526840254|FG002|Part I|Did Not Receive Treatment|2|||
146086918|NCT01155479|526840255|FG003|Part I|Did Not Receive Treatment|6|||
146086919|NCT01155479|526840256|FG004|Part I|Did Not Receive Treatment|1|||
146086920|NCT01155479|526840252|FG000|Part I|Non-Compliance with Protocol|2|||
146086921|NCT01155479|526840253|FG001|Part I|Non-Compliance with Protocol|1|||
146086922|NCT01155479|526840254|FG002|Part I|Non-Compliance with Protocol|3|||
146086923|NCT01155479|526840255|FG003|Part I|Non-Compliance with Protocol|3|||
146233038|NCT01313559|527370738|FG001|Overall Study|Disease progression|0|||
146233039|NCT01313559|527370737|FG000|Overall Study|Rising PSA|2|||
145889130|NCT04776746|526101711|FG000|Overall Study|Death|4|||
146233040|NCT01313559|527370738|FG001|Overall Study|Rising PSA|0|||
146233041|NCT02754596|527370739|FG000|Overall Study|Withdrawal by Subject|3|||
145889131|NCT04776746|526101711|FG000|Overall Study|Lack of Efficacy|3|||
145889132|NCT04776746|526101711|FG000|Overall Study|Noncompliance with study drug|2|||
145889133|NCT04776746|526101711|FG000|Overall Study|Not related to COVID-19|2|||
145889134|NCT01223235|526101712|FG000|Overall Study|Withdrawal by Subject|1|||
145889135|NCT01360866|526101715|FG000|Overall Study|Lost to Follow-up|11|||
145889136|NCT01360866|526101716|FG001|Overall Study|Lost to Follow-up|28|||
145889137|NCT01360866|526101717|FG002|Overall Study|Lost to Follow-up|41|||
145889138|NCT01360866|526101718|FG003|Overall Study|Lost to Follow-up|0|||
145889139|NCT01360866|526101715|FG000|Overall Study|Adverse Event|56|||
145889140|NCT01360866|526101716|FG001|Overall Study|Adverse Event|61|||
145889141|NCT01360866|526101717|FG002|Overall Study|Adverse Event|134|||
145889142|NCT01360866|526101718|FG003|Overall Study|Adverse Event|6|||
145889143|NCT01360866|526101715|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
145889144|NCT01360866|526101716|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
145889145|NCT01360866|526101717|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
145889146|NCT01360866|526101718|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
145889147|NCT01360866|526101715|FG000|Overall Study|Withdrawn by Investigator|9|||
145889148|NCT01360866|526101716|FG001|Overall Study|Withdrawn by Investigator|8|||
145889149|NCT01360866|526101717|FG002|Overall Study|Withdrawn by Investigator|31|||
145889150|NCT01360866|526101718|FG003|Overall Study|Withdrawn by Investigator|2|||
145889151|NCT01360866|526101715|FG000|Overall Study|Withdrawal by participant|79|||
145889152|NCT01360866|526101716|FG001|Overall Study|Withdrawal by participant|89|||
145889153|NCT01360866|526101717|FG002|Overall Study|Withdrawal by participant|168|||
145889154|NCT01360866|526101718|FG003|Overall Study|Withdrawal by participant|8|||
145889155|NCT01360866|526101715|FG000|Overall Study|Protocol Deviation|25|||
145889156|NCT01360866|526101716|FG001|Overall Study|Protocol Deviation|33|||
145889157|NCT01360866|526101717|FG002|Overall Study|Protocol Deviation|61|||
145889158|NCT01360866|526101718|FG003|Overall Study|Protocol Deviation|2|||
145889159|NCT01360866|526101715|FG000|Overall Study|Lack of Efficacy|30|||
145889160|NCT01360866|526101716|FG001|Overall Study|Lack of Efficacy|40|||
145889161|NCT01360866|526101717|FG002|Overall Study|Lack of Efficacy|30|||
145889162|NCT01360866|526101718|FG003|Overall Study|Lack of Efficacy|4|||
145889163|NCT00099268|526101719|FG000|Overall Study|Withdrawal by Subject|46|||
145889164|NCT00099268|526101720|FG001|Overall Study|Withdrawal by Subject|28|||
145889165|NCT00099268|526101719|FG000|Overall Study|Adverse Event|19|||
145889166|NCT00099268|526101720|FG001|Overall Study|Adverse Event|19|||
145889167|NCT00099268|526101719|FG000|Overall Study|Protocol Violation|9|||
145889168|NCT00099268|526101720|FG001|Overall Study|Protocol Violation|8|||
145889169|NCT00099268|526101719|FG000|Overall Study|Lost to Follow-up|6|||
145889170|NCT00099268|526101720|FG001|Overall Study|Lost to Follow-up|4|||
145889171|NCT00099268|526101719|FG000|Overall Study|Lack of Efficacy|5|||
145889172|NCT00099268|526101720|FG001|Overall Study|Lack of Efficacy|18|||
145889173|NCT00099268|526101719|FG000|Overall Study|Administrative problems|4|||
145889174|NCT00099268|526101720|FG001|Overall Study|Administrative problems|4|||
145889175|NCT00099268|526101719|FG000|Overall Study|Death|3|||
145889176|NCT00099268|526101720|FG001|Overall Study|Death|1|||
145889177|NCT03702049|526101721|FG000|Overall Study|Lost to Follow-up|4|||
145889178|NCT03702049|526101721|FG000|Overall Study|Physician Decision|1|||
145889179|NCT00918463|526101729|FG000|Overall Study|Death|1|||
145889180|NCT00918463|526101729|FG000|Overall Study|Lack of Efficacy|1|||
145889181|NCT01014624|526101733|FG000|Overall Study|Adverse Event|0|||
145889182|NCT01014624|526101734|FG001|Overall Study|Adverse Event|1|||
145889183|NCT01014624|526101733|FG000|Overall Study|Protocol Violation|1|||
145889184|NCT01014624|526101734|FG001|Overall Study|Protocol Violation|0|||
145889185|NCT01014624|526101733|FG000|Overall Study|Withdrawal by Subject|1|||
145889186|NCT01014624|526101734|FG001|Overall Study|Withdrawal by Subject|0|||
145889187|NCT01117337|526101742|FG000|Overall Study|Lost to Follow-up|4|||
145889188|NCT01117337|526101743|FG001|Overall Study|Lost to Follow-up|0|||
145889189|NCT01045993|526101744|FG000|Overall Study|Treated-later found eligibility not met|0|||
145889190|NCT01045993|526101745|FG001|Overall Study|Treated-later found eligibility not met|1|||
146086924|NCT01155479|526840256|FG004|Part I|Non-Compliance with Protocol|2|||
146086925|NCT01155479|526840252|FG000|Part II|Adverse Event|7|||
146086926|NCT01155479|526840253|FG001|Part II|Adverse Event|6|||
146086927|NCT01155479|526840254|FG002|Part II|Adverse Event|8|||
146086928|NCT01155479|526840255|FG003|Part II|Adverse Event|3|||
146086929|NCT01155479|526840256|FG004|Part II|Adverse Event|4|||
146086930|NCT01155479|526840252|FG000|Part II|Administrative|43|||
146086931|NCT01155479|526840253|FG001|Part II|Administrative|49|||
146086932|NCT01155479|526840254|FG002|Part II|Administrative|36|||
146086933|NCT01155479|526840255|FG003|Part II|Administrative|38|||
146086934|NCT01155479|526840256|FG004|Part II|Administrative|46|||
146233042|NCT02754596|527370740|FG001|Overall Study|Withdrawal by Subject|4|||
146086935|NCT01155479|526840252|FG000|Part II|Withdrawal by Subject|8|||
146086936|NCT01155479|526840253|FG001|Part II|Withdrawal by Subject|4|||
146086937|NCT01155479|526840254|FG002|Part II|Withdrawal by Subject|12|||
146233043|NCT02754596|527370741|FG002|Overall Study|Withdrawal by Subject|0|||
146233044|NCT02754596|527370739|FG000|Overall Study|Physician Decision|1|||
146233045|NCT02754596|527370740|FG001|Overall Study|Physician Decision|1|||
146233046|NCT02754596|527370741|FG002|Overall Study|Physician Decision|1|||
146233047|NCT02754596|527370739|FG000|Overall Study|Lost to Follow-up|1|||
146233048|NCT02754596|527370740|FG001|Overall Study|Lost to Follow-up|1|||
146233049|NCT02754596|527370741|FG002|Overall Study|Lost to Follow-up|2|||
146233050|NCT02754596|527370739|FG000|Overall Study|Death|0|||
146233051|NCT02754596|527370740|FG001|Overall Study|Death|2|||
146233052|NCT02754596|527370741|FG002|Overall Study|Death|0|||
146233053|NCT02754596|527370739|FG000|Overall Study|Adverse Event|1|||
146233054|NCT02754596|527370740|FG001|Overall Study|Adverse Event|0|||
146233055|NCT02754596|527370741|FG002|Overall Study|Adverse Event|1|||
146233056|NCT02754596|527370739|FG000|Overall Study|Other|1|||
146233057|NCT02754596|527370740|FG001|Overall Study|Other|0|||
146233058|NCT02754596|527370741|FG002|Overall Study|Other|0|||
146233059|NCT03213457|527370744|FG000|Screening Period|Withdrawal by Subject|0|||
146233060|NCT03213457|527370745|FG001|Screening Period|Withdrawal by Subject|1|||
146233061|NCT03213457|527370746|FG002|Screening Period|Withdrawal by Subject|0|||
146233062|NCT03213457|527370744|FG000|Screening Period|Other|1|||
146233063|NCT03213457|527370745|FG001|Screening Period|Other|0|||
146233064|NCT03213457|527370746|FG002|Screening Period|Other|0|||
146233065|NCT03213457|527370744|FG000|Double-Blind Period|Adverse Event|3|||
146233066|NCT03213457|527370745|FG001|Double-Blind Period|Adverse Event|2|||
146233067|NCT03213457|527370746|FG002|Double-Blind Period|Adverse Event|7|||
146233068|NCT03213457|527370744|FG000|Double-Blind Period|Withdrawal by Subject|14|||
146233069|NCT03213457|527370745|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146233070|NCT03213457|527370746|FG002|Double-Blind Period|Withdrawal by Subject|14|||
146233071|NCT03213457|527370744|FG000|Double-Blind Period|Lost to Follow-up|2|||
146233072|NCT03213457|527370745|FG001|Double-Blind Period|Lost to Follow-up|3|||
146233073|NCT03213457|527370746|FG002|Double-Blind Period|Lost to Follow-up|9|||
146233074|NCT03213457|527370744|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146233075|NCT03213457|527370745|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146233076|NCT03213457|527370746|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
146233077|NCT03213457|527370744|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
146086938|NCT01155479|526840255|FG003|Part II|Withdrawal by Subject|7|||
145968711|NCT01274351|526399734|FG000|Overall Study|Withdrawal by Subject|3|||
145968712|NCT01274351|526399734|FG000|Overall Study|Adverse Event|8|||
145968713|NCT01274351|526399734|FG000|Overall Study|progression of disease|3|||
145968714|NCT01274351|526399734|FG000|Overall Study|hospitalization|1|||
145968715|NCT05399680|526400977|FG000|Overall Study|Lost to Follow-up|1|||
145968716|NCT05399680|526400978|FG001|Overall Study|Lost to Follow-up|0|||
145968717|NCT05399680|526400977|FG000|Overall Study|Death|0|||
145968718|NCT05399680|526400978|FG001|Overall Study|Death|1|||
145968719|NCT02659865|526400979|FG000|Period 1|Withdrawal by Subject|1|||
145968720|NCT02659865|526400980|FG001|Period 1|Withdrawal by Subject|0|||
145968721|NCT02659865|526400981|FG002|Period 1|Withdrawal by Subject|0|||
145968722|NCT02659865|526400982|FG003|Period 1|Withdrawal by Subject|0|||
145968723|NCT02659865|526400983|FG004|Period 1|Withdrawal by Subject|0|||
145968724|NCT02659865|526400979|FG000|Period 1|Adverse Event|0|||
145968725|NCT02659865|526400980|FG001|Period 1|Adverse Event|0|||
145968726|NCT02659865|526400981|FG002|Period 1|Adverse Event|0|||
145968727|NCT02659865|526400982|FG003|Period 1|Adverse Event|0|||
145968728|NCT02659865|526400983|FG004|Period 1|Adverse Event|1|||
145968729|NCT03370172|526400984|FG000|Overall Study|Withdrawal by Subject|0|||
146086939|NCT01155479|526840256|FG004|Part II|Withdrawal by Subject|3|||
146086940|NCT01155479|526840252|FG000|Part II|Lost to Follow-up|1|||
146086941|NCT01155479|526840253|FG001|Part II|Lost to Follow-up|0|||
145968730|NCT03370172|526400985|FG001|Overall Study|Withdrawal by Subject|1|||
145968731|NCT00753519|526400987|FG000|Overall Study|Withdrawal by Subject|0|||
145968732|NCT00753519|526400988|FG001|Overall Study|Withdrawal by Subject|2|||
145968733|NCT00959751|526400989|FG000|Overall Study|Lost to Follow-up|2|||
145968734|NCT00959751|526400990|FG001|Overall Study|Lost to Follow-up|3|||
145968735|NCT00959751|526400989|FG000|Overall Study|Consent Withdrawn|0|||
145968736|NCT00959751|526400990|FG001|Overall Study|Consent Withdrawn|1|||
145968737|NCT00959751|526400989|FG000|Overall Study|Non-compliance to Study Procedures|0|||
145968738|NCT00959751|526400990|FG001|Overall Study|Non-compliance to Study Procedures|1|||
145968739|NCT00959751|526400989|FG000|Overall Study|No migraine headache without aura|7|||
146233078|NCT03213457|527370745|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
146233079|NCT03213457|527370746|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
145968740|NCT00959751|526400990|FG001|Overall Study|No migraine headache without aura|7|||
146233080|NCT03213457|527370744|FG000|Double-Blind Period|Pregnancy|5|||
145968741|NCT03255187|526400991|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
145968742|NCT03255187|526400992|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
145968743|NCT03255187|526400991|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
145968744|NCT03255187|526400992|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
146233081|NCT03213457|527370745|FG001|Double-Blind Period|Pregnancy|0|||
145968745|NCT01715298|526400993|FG000|Overall Study|Lost to Follow-up|0|||
145968746|NCT01715298|526400994|FG001|Overall Study|Lost to Follow-up|2|||
145968747|NCT01715298|526400993|FG000|Overall Study|Patient/guardian decision|7|||
145968748|NCT01715298|526400994|FG001|Overall Study|Patient/guardian decision|9|||
145968749|NCT03248037|526400998|FG000|Overall Study|Withdrawal by Subject|6|||
145968750|NCT03248037|526400999|FG001|Overall Study|Withdrawal by Subject|9|||
146233082|NCT03213457|527370746|FG002|Double-Blind Period|Pregnancy|0|||
145968751|NCT03248037|526400998|FG000|Overall Study|Adverse Event|15|||
145968752|NCT03248037|526400999|FG001|Overall Study|Adverse Event|0|||
145968753|NCT02897349|526401003|FG000|Overall Study|Lost to Follow-up|2|||
145968754|NCT02897349|526401004|FG001|Overall Study|Lost to Follow-up|2|||
145968755|NCT02897349|526401003|FG000|Overall Study|Adverse Event|3|||
145968756|NCT02897349|526401004|FG001|Overall Study|Adverse Event|3|||
145968757|NCT02897349|526401003|FG000|Overall Study|Other than listed above|0|||
145968758|NCT02897349|526401004|FG001|Overall Study|Other than listed above|1|||
145968759|NCT03435055|526401007|FG000|Screening|Physician Decision|2|||
145968760|NCT03435055|526401007|FG000|Received Intervention|Did not complete nitrous administration|3|||
145968761|NCT01027949|526401013|FG000|Overall Study|Death|174|||
145968762|NCT01027949|526401013|FG000|Overall Study|Progressive Disease|163|||
145968763|NCT01027949|526401013|FG000|Overall Study|Adverse Event|172|||
145968764|NCT01027949|526401013|FG000|Overall Study|Withdrawal by Subject|113|||
145968765|NCT01027949|526401013|FG000|Overall Study|Lost to Follow-up|17|||
145968766|NCT01027949|526401013|FG000|Overall Study|Protocol Violation|13|||
145968767|NCT01027949|526401013|FG000|Overall Study|PI Decision|8|||
145968768|NCT01027949|526401013|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
145968769|NCT01027949|526401013|FG000|Overall Study|Non-compliance with Study Procedures|7|||
145968770|NCT01027949|526401013|FG000|Overall Study|Lung Transplant|5|||
145968771|NCT01027949|526401013|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
145968772|NCT01027949|526401013|FG000|Overall Study|Use of Excluded Medication|2|||
145968773|NCT01027949|526401013|FG000|Overall Study|Patient Self-discontinuation|1|||
146233083|NCT03213457|527370744|FG000|Double-Blind Period|Other|10|||
145968774|NCT01027949|526401013|FG000|Overall Study|Pregnancy|1|||
145968775|NCT01027949|526401013|FG000|Overall Study|Surgery|1|||
145968776|NCT02765035|526401016|FG000|First Intervention (90 Days)|Adverse Event|1|||
145968777|NCT02765035|526401017|FG001|First Intervention (90 Days)|Adverse Event|1|||
146233084|NCT03213457|527370745|FG001|Double-Blind Period|Other|3|||
146233085|NCT03213457|527370746|FG002|Double-Blind Period|Other|17|||
146233086|NCT03213457|527370744|FG000|Open-Label Period|Adverse Event|1|||
145968778|NCT02765035|526401016|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
145968779|NCT02765035|526401017|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
145968780|NCT00671749|526401021|FG000|Overall Study|Adverse Event|2|||
145968781|NCT00671749|526401021|FG000|Overall Study|Withdrawal by Subject|4|||
145968782|NCT00671749|526401021|FG000|Overall Study|Protocol Violation|1|||
145968783|NCT00671749|526401021|FG000|Overall Study|Lost to Follow-up|1|||
145968784|NCT01259245|526401027|FG000|Overall Study|Withdrawal by Subject|27|||
145968785|NCT01259245|526401028|FG001|Overall Study|Withdrawal by Subject|24|||
145968786|NCT01259245|526401027|FG000|Overall Study|Death|1|||
145968787|NCT01259245|526401028|FG001|Overall Study|Death|2|||
145968788|NCT03451071|526401031|FG000|First Vaccine|Withdrawal by Subject|1|||
145968789|NCT03451071|526401031|FG000|Second Vaccine|Lost to Follow-up|19|||
145968790|NCT03451071|526401031|FG000|Third Vaccine|Lost to Follow-up|22|||
145968791|NCT03451071|526401031|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
145968792|NCT02834975|526401032|FG000|Overall Study|Physician Decision|2|||
145968793|NCT02834975|526401032|FG000|Overall Study|Adverse Event|1|||
145968794|NCT02834975|526401032|FG000|Overall Study|Withdrawal by Subject|1|||
145968795|NCT02834975|526401032|FG000|Overall Study|Lack of Efficacy|1|||
145968796|NCT03363906|526401038|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
145968797|NCT03363906|526401039|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
145968798|NCT03363906|526401038|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
145968799|NCT03363906|526401039|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
145968800|NCT03363906|526401038|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
145968801|NCT03363906|526401039|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
145968802|NCT03363906|526401038|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
145968803|NCT03363906|526401039|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
145968804|NCT03937778|526401040|FG000|Overall Study|Withdrawal by Subject|1|||
145968805|NCT03937778|526401040|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
145968806|NCT02065557|526401043|FG000|Induction Period|Withdrawal by Subject|2|||
145968807|NCT02065557|526401044|FG001|Induction Period|Withdrawal by Subject|1|||
145968808|NCT02065557|526401045|FG002|Induction Period|Withdrawal by Subject|0|||
145968809|NCT02065557|526401046|FG003|Induction Period|Withdrawal by Subject|0|||
145968810|NCT02065557|526401047|FG004|Induction Period|Withdrawal by Subject|0|||
145968811|NCT02065557|526401048|FG005|Induction Period|Withdrawal by Subject|0|||
145968812|NCT02065557|526401043|FG000|Induction Period|Lack of Efficacy|2|||
145968813|NCT02065557|526401044|FG001|Induction Period|Lack of Efficacy|1|||
145968814|NCT02065557|526401045|FG002|Induction Period|Lack of Efficacy|1|||
145968815|NCT02065557|526401046|FG003|Induction Period|Lack of Efficacy|0|||
145968816|NCT02065557|526401047|FG004|Induction Period|Lack of Efficacy|0|||
145968817|NCT02065557|526401048|FG005|Induction Period|Lack of Efficacy|0|||
145968818|NCT02065557|526401043|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145968819|NCT02065557|526401044|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145968820|NCT02065557|526401045|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145968821|NCT02065557|526401046|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145968822|NCT02065557|526401047|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145968823|NCT02065557|526401048|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145968824|NCT02065557|526401043|FG000|Induction Period|Non-Responder at Week 8|4|||
145968825|NCT02065557|526401044|FG001|Induction Period|Non-Responder at Week 8|4|||
145968826|NCT02065557|526401045|FG002|Induction Period|Non-Responder at Week 8|0|||
145968827|NCT02065557|526401046|FG003|Induction Period|Non-Responder at Week 8|0|||
145968828|NCT02065557|526401047|FG004|Induction Period|Non-Responder at Week 8|0|||
145968829|NCT02065557|526401048|FG005|Induction Period|Non-Responder at Week 8|0|||
145968830|NCT02065557|526401043|FG000|Induction Period|Adverse Event|1|||
146086942|NCT01155479|526840254|FG002|Part II|Lost to Follow-up|0|||
146086943|NCT01155479|526840255|FG003|Part II|Lost to Follow-up|0|||
145968831|NCT02065557|526401044|FG001|Induction Period|Adverse Event|1|||
145968832|NCT02065557|526401045|FG002|Induction Period|Adverse Event|0|||
145968833|NCT02065557|526401046|FG003|Induction Period|Adverse Event|0|||
145968834|NCT02065557|526401047|FG004|Induction Period|Adverse Event|0|||
145968835|NCT02065557|526401048|FG005|Induction Period|Adverse Event|0|||
145968836|NCT02065557|526401043|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145968837|NCT02065557|526401044|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
146086944|NCT01155479|526840256|FG004|Part II|Lost to Follow-up|1|||
146233087|NCT03213457|527370745|FG001|Open-Label Period|Adverse Event|2|||
146086945|NCT01155479|526840252|FG000|Part II|Treatment Failure|0|||
146086946|NCT01155479|526840253|FG001|Part II|Treatment Failure|1|||
146086947|NCT01155479|526840254|FG002|Part II|Treatment Failure|2|||
146086948|NCT01155479|526840255|FG003|Part II|Treatment Failure|0|||
146086949|NCT01155479|526840256|FG004|Part II|Treatment Failure|1|||
146086950|NCT01155479|526840252|FG000|Part II|Non-Compliance with Protocol|0|||
146086951|NCT01155479|526840253|FG001|Part II|Non-Compliance with Protocol|1|||
146086952|NCT01155479|526840254|FG002|Part II|Non-Compliance with Protocol|0|||
146086953|NCT01155479|526840255|FG003|Part II|Non-Compliance with Protocol|2|||
146086954|NCT01155479|526840256|FG004|Part II|Non-Compliance with Protocol|0|||
146086955|NCT02360605|526840257|FG000|Overall Study|Withdrawal by Subject|4|||
146086956|NCT02360605|526840258|FG001|Overall Study|Withdrawal by Subject|9|||
146086957|NCT02360605|526840257|FG000|Overall Study|Lost to Follow-up|7|||
146086958|NCT02360605|526840258|FG001|Overall Study|Lost to Follow-up|8|||
146086959|NCT02360605|526840257|FG000|Overall Study|Death|0|||
146086960|NCT02360605|526840258|FG001|Overall Study|Death|1|||
146086961|NCT02497976|526840263|FG000|Overall Study|Withdrawal by Subject|2|||
146086962|NCT02497976|526840264|FG001|Overall Study|Withdrawal by Subject|0|||
146086963|NCT02497976|526840263|FG000|Overall Study|Moved out of area|0|||
146086964|NCT02497976|526840264|FG001|Overall Study|Moved out of area|1|||
146086965|NCT00058539|526840265|FG000|Overall Study|Disease progression|24|||
146086966|NCT00058539|526840265|FG000|Overall Study|Adverse Event|3|||
146086967|NCT00058539|526840265|FG000|Overall Study|Withdrawal by Subject|5|||
146086968|NCT00058539|526840265|FG000|Overall Study|Physician Decision|9|||
146086969|NCT00058539|526840265|FG000|Overall Study|Death|1|||
146086970|NCT01903525|526840268|FG000|Overall Study|Lost to Follow-up|5|||
146086971|NCT01903525|526840269|FG001|Overall Study|Lost to Follow-up|9|||
145968838|NCT02065557|526401045|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145968839|NCT02065557|526401046|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
145968840|NCT02065557|526401047|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
145968841|NCT02065557|526401048|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145968842|NCT02065557|526401043|FG000|Maintenance Period|Withdrawal by Subject|0|||
145968843|NCT02065557|526401044|FG001|Maintenance Period|Withdrawal by Subject|0|||
145968844|NCT02065557|526401045|FG002|Maintenance Period|Withdrawal by Subject|0|||
145968845|NCT02065557|526401046|FG003|Maintenance Period|Withdrawal by Subject|0|||
145968846|NCT02065557|526401047|FG004|Maintenance Period|Withdrawal by Subject|2|||
145968847|NCT02065557|526401048|FG005|Maintenance Period|Withdrawal by Subject|1|||
146086972|NCT01903525|526840268|FG000|Overall Study|Adverse Event|0|||
146086973|NCT01903525|526840269|FG001|Overall Study|Adverse Event|1|||
146086974|NCT03977454|526840270|FG000|Overall Study|immediate postoperative revision|2|||
146086975|NCT03977454|526840271|FG001|Overall Study|immediate postoperative revision|2|||
146086976|NCT01609478|526840276|FG000|Overall Study|Adverse Event|3|||
146086977|NCT01609478|526840277|FG001|Overall Study|Adverse Event|1|||
146086978|NCT01609478|526840278|FG002|Overall Study|Adverse Event|5|||
146086979|NCT01609478|526840276|FG000|Overall Study|Protocol Deviation|0|||
146086980|NCT01609478|526840277|FG001|Overall Study|Protocol Deviation|1|||
146086981|NCT01609478|526840278|FG002|Overall Study|Protocol Deviation|1|||
146086982|NCT01609478|526840276|FG000|Overall Study|Non-Compliance with study treatment|1|||
146086983|NCT01609478|526840277|FG001|Overall Study|Non-Compliance with study treatment|0|||
146086984|NCT01609478|526840278|FG002|Overall Study|Non-Compliance with study treatment|0|||
146086985|NCT01609478|526840276|FG000|Overall Study|Physician Decision|1|||
146086986|NCT01609478|526840277|FG001|Overall Study|Physician Decision|0|||
146086987|NCT01609478|526840278|FG002|Overall Study|Physician Decision|1|||
146086988|NCT01609478|526840276|FG000|Overall Study|Withdrawal by Subject|2|||
145968848|NCT02065557|526401043|FG000|Maintenance Period|Lack of Efficacy|0|||
145968849|NCT02065557|526401044|FG001|Maintenance Period|Lack of Efficacy|0|||
145968850|NCT02065557|526401045|FG002|Maintenance Period|Lack of Efficacy|0|||
145968851|NCT02065557|526401046|FG003|Maintenance Period|Lack of Efficacy|0|||
145968852|NCT02065557|526401047|FG004|Maintenance Period|Lack of Efficacy|5|||
146086989|NCT01609478|526840277|FG001|Overall Study|Withdrawal by Subject|0|||
146086990|NCT01609478|526840278|FG002|Overall Study|Withdrawal by Subject|2|||
146086991|NCT02241889|526840283|FG000|Overall Study|device issues|0|||
146086992|NCT02241889|526840284|FG001|Overall Study|device issues|0|||
146086993|NCT02241889|526840285|FG002|Overall Study|device issues|1|||
146086994|NCT02241889|526840286|FG003|Overall Study|device issues|0|||
146086995|NCT02241889|526840287|FG004|Overall Study|device issues|0|||
146086996|NCT02241889|526840288|FG005|Overall Study|device issues|0|||
146086997|NCT02241889|526840283|FG000|Overall Study|Withdrawal by Subject|0|||
146086998|NCT02241889|526840284|FG001|Overall Study|Withdrawal by Subject|0|||
145968853|NCT02065557|526401048|FG005|Maintenance Period|Lack of Efficacy|2|||
145968854|NCT02065557|526401043|FG000|Maintenance Period|Subject Non-Compliance|0|||
146086999|NCT02241889|526840285|FG002|Overall Study|Withdrawal by Subject|0|||
146087000|NCT02241889|526840286|FG003|Overall Study|Withdrawal by Subject|0|||
146087001|NCT02241889|526840287|FG004|Overall Study|Withdrawal by Subject|0|||
146087002|NCT02241889|526840288|FG005|Overall Study|Withdrawal by Subject|1|||
146087003|NCT01853618|526840289|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
146087004|NCT01853618|526840290|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
146087005|NCT01853618|526840291|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
146087006|NCT01853618|526840292|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
146087007|NCT01853618|526840293|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
146087008|NCT01853618|526840289|FG000|Overall Study|Progressive disease|1|||
146087009|NCT01853618|526840290|FG001|Overall Study|Progressive disease|1|||
146087010|NCT01853618|526840291|FG002|Overall Study|Progressive disease|1|||
146087011|NCT01853618|526840292|FG003|Overall Study|Progressive disease|1|||
146087012|NCT01853618|526840293|FG004|Overall Study|Progressive disease|2|||
146087013|NCT01853618|526840289|FG000|Overall Study|Physician Decision|0|||
146087014|NCT01853618|526840290|FG001|Overall Study|Physician Decision|1|||
146087015|NCT01853618|526840291|FG002|Overall Study|Physician Decision|1|||
146087016|NCT01853618|526840292|FG003|Overall Study|Physician Decision|0|||
146087017|NCT01853618|526840293|FG004|Overall Study|Physician Decision|0|||
146087018|NCT01853618|526840289|FG000|Overall Study|Refused further treatment|0|||
146087019|NCT01853618|526840290|FG001|Overall Study|Refused further treatment|0|||
146087020|NCT01853618|526840291|FG002|Overall Study|Refused further treatment|0|||
146087021|NCT01853618|526840292|FG003|Overall Study|Refused further treatment|0|||
146087022|NCT01853618|526840293|FG004|Overall Study|Refused further treatment|1|||
146087023|NCT01658813|526840294|FG000|Overall Study|Disease progression|3|||
146087024|NCT02398227|526840299|FG000|Overall Study|Lost to Follow-up|21|||
146087025|NCT02398227|526840300|FG001|Overall Study|Lost to Follow-up|12|||
146087026|NCT02398227|526840299|FG000|Overall Study|Withdrawal by Subject|5|||
146087027|NCT02398227|526840300|FG001|Overall Study|Withdrawal by Subject|6|||
146087028|NCT02398227|526840299|FG000|Overall Study|Removed from treatment and dropped out|1|||
146087029|NCT02398227|526840300|FG001|Overall Study|Removed from treatment and dropped out|0|||
146087030|NCT02009384|526840301|FG000|Overall Study|Death|2|||
146087031|NCT00722371|526840302|FG000|Overall Study|Adverse Event|6|||
146087032|NCT00722371|526840303|FG001|Overall Study|Adverse Event|13|||
146087033|NCT00722371|526840304|FG002|Overall Study|Adverse Event|9|||
146087034|NCT00722371|526840305|FG003|Overall Study|Adverse Event|10|||
146087035|NCT00722371|526840306|FG004|Overall Study|Adverse Event|6|||
146087036|NCT00722371|526840307|FG005|Overall Study|Adverse Event|8|||
146087037|NCT00722371|526840308|FG006|Overall Study|Adverse Event|4|||
146087038|NCT00722371|526840302|FG000|Overall Study|Contraindication|0|||
146087039|NCT00722371|526840303|FG001|Overall Study|Contraindication|0|||
146087040|NCT00722371|526840304|FG002|Overall Study|Contraindication|1|||
146087041|NCT00722371|526840305|FG003|Overall Study|Contraindication|0|||
146087042|NCT00722371|526840306|FG004|Overall Study|Contraindication|0|||
146087043|NCT00722371|526840307|FG005|Overall Study|Contraindication|0|||
146087044|NCT00722371|526840308|FG006|Overall Study|Contraindication|0|||
146087045|NCT00722371|526840302|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
146087046|NCT00722371|526840303|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
146087047|NCT00722371|526840304|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
146087048|NCT00722371|526840305|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
146087049|NCT00722371|526840306|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
146087050|NCT00722371|526840307|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
146087051|NCT00722371|526840308|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
146087052|NCT00722371|526840302|FG000|Overall Study|Excluded medication|0|||
146087053|NCT00722371|526840303|FG001|Overall Study|Excluded medication|1|||
146087054|NCT00722371|526840304|FG002|Overall Study|Excluded medication|1|||
146087055|NCT00722371|526840305|FG003|Overall Study|Excluded medication|0|||
146087056|NCT00722371|526840306|FG004|Overall Study|Excluded medication|0|||
146087057|NCT00722371|526840307|FG005|Overall Study|Excluded medication|0|||
146087058|NCT00722371|526840308|FG006|Overall Study|Excluded medication|1|||
146087059|NCT00722371|526840302|FG000|Overall Study|Hyperglycemia|2|||
145968855|NCT02065557|526401044|FG001|Maintenance Period|Subject Non-Compliance|0|||
145968856|NCT02065557|526401045|FG002|Maintenance Period|Subject Non-Compliance|0|||
145968857|NCT02065557|526401046|FG003|Maintenance Period|Subject Non-Compliance|0|||
145968858|NCT02065557|526401047|FG004|Maintenance Period|Subject Non-Compliance|0|||
145968859|NCT02065557|526401048|FG005|Maintenance Period|Subject Non-Compliance|1|||
145968860|NCT01200355|526401049|FG000|Overall Study|Death|7|||
145968861|NCT01200355|526401050|FG001|Overall Study|Death|2|||
145968862|NCT00250588|526401051|FG000|Overall Study|Withdrawal by Subject|3|||
146087060|NCT00722371|526840303|FG001|Overall Study|Hyperglycemia|6|||
146087061|NCT00722371|526840304|FG002|Overall Study|Hyperglycemia|4|||
146087062|NCT00722371|526840305|FG003|Overall Study|Hyperglycemia|2|||
146087063|NCT00722371|526840306|FG004|Overall Study|Hyperglycemia|5|||
146087064|NCT00722371|526840307|FG005|Overall Study|Hyperglycemia|1|||
146087065|NCT00722371|526840308|FG006|Overall Study|Hyperglycemia|1|||
146087066|NCT00722371|526840302|FG000|Overall Study|Hypoglycemia|1|||
146087067|NCT00722371|526840303|FG001|Overall Study|Hypoglycemia|0|||
146087068|NCT00722371|526840304|FG002|Overall Study|Hypoglycemia|0|||
146087069|NCT00722371|526840305|FG003|Overall Study|Hypoglycemia|0|||
145968863|NCT00250588|526401052|FG001|Overall Study|Withdrawal by Subject|6|||
145889191|NCT01045993|526101746|FG002|Overall Study|Treated-later found eligibility not met|0|||
145889192|NCT01045993|526101747|FG003|Overall Study|Treated-later found eligibility not met|0|||
145889193|NCT05506358|526101748|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
145889194|NCT05506358|526101749|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145889195|NCT05506358|526101750|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145889196|NCT05506358|526101751|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145889197|NCT05506358|526101752|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145889198|NCT05506358|526101748|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
145889199|NCT05506358|526101749|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145889200|NCT05506358|526101750|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145889201|NCT05506358|526101751|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145889202|NCT05506358|526101752|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145889203|NCT05506358|526101748|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145889204|NCT05506358|526101749|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145889205|NCT05506358|526101750|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145889206|NCT05506358|526101751|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
145889207|NCT05506358|526101752|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145889208|NCT05506358|526101748|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
145889209|NCT05506358|526101749|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
145889210|NCT05506358|526101750|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
145889211|NCT05506358|526101751|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
145889212|NCT05506358|526101752|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
145889213|NCT05506358|526101748|FG000|Overall Study|HbE trait|0|||
145889214|NCT05506358|526101749|FG001|Overall Study|HbE trait|0|||
145889215|NCT05506358|526101750|FG002|Overall Study|HbE trait|0|||
145889216|NCT05506358|526101751|FG003|Overall Study|HbE trait|1|||
145889217|NCT05506358|526101752|FG004|Overall Study|HbE trait|0|||
145889218|NCT01659736|526101753|FG000|Treatment Period|Adverse Event|1|||
145889219|NCT01659736|526101754|FG001|Treatment Period|Adverse Event|1|||
145889220|NCT01659736|526101753|FG000|Treatment Period|Protocol Violation|3|||
145889221|NCT01659736|526101754|FG001|Treatment Period|Protocol Violation|1|||
145889222|NCT01659736|526101753|FG000|Treatment Period|Withdrawal by Subject|1|||
145889223|NCT01659736|526101754|FG001|Treatment Period|Withdrawal by Subject|0|||
145889224|NCT01659736|526101753|FG000|3-month Follow-up|Lost to Follow-up|0|||
145889225|NCT01659736|526101754|FG001|3-month Follow-up|Lost to Follow-up|1|||
145889226|NCT02791893|526101764|FG000|Blinded Phase|Lost to Follow-up|2|||
145889227|NCT02791893|526101765|FG001|Blinded Phase|Lost to Follow-up|2|||
145889228|NCT02791893|526101764|FG000|Blinded Phase|Withdrawal by Subject|1|||
145889229|NCT02791893|526101765|FG001|Blinded Phase|Withdrawal by Subject|2|||
145889230|NCT02791893|526101764|FG000|Open Label Phase|Lost to Follow-up|3|||
145889231|NCT02791893|526101765|FG001|Open Label Phase|Lost to Follow-up|0|||
145889232|NCT02791893|526101764|FG000|Open Label Phase|Withdrawal by Subject|0|||
145889233|NCT02791893|526101765|FG001|Open Label Phase|Withdrawal by Subject|2|||
145889234|NCT01570283|526101766|FG000|Cohort 1: Dose Level 1|Death|0|||
145889235|NCT01570283|526101767|FG001|Cohort 1: Dose Level 1|Death|1|||
145889236|NCT01570283|526101768|FG002|Cohort 1: Dose Level 1|Death|0|||
145889237|NCT01570283|526101769|FG003|Cohort 1: Dose Level 1|Death|0|||
145889238|NCT01570283|526101770|FG004|Cohort 1: Dose Level 1|Death|0|||
145889239|NCT01570283|526101771|FG005|Cohort 1: Dose Level 1|Death|0|||
145889240|NCT01570283|526101766|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145889241|NCT01570283|526101767|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
145889242|NCT01570283|526101768|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145889243|NCT01570283|526101769|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145889244|NCT01570283|526101770|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145889245|NCT01570283|526101771|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145889246|NCT01570283|526101766|FG000|Cohort 2: Dose Level 2|Death|0|||
145889247|NCT01570283|526101767|FG001|Cohort 2: Dose Level 2|Death|0|||
145889248|NCT01570283|526101768|FG002|Cohort 2: Dose Level 2|Death|1|||
145889249|NCT01570283|526101769|FG003|Cohort 2: Dose Level 2|Death|0|||
145889250|NCT01570283|526101770|FG004|Cohort 2: Dose Level 2|Death|0|||
145889251|NCT01570283|526101771|FG005|Cohort 2: Dose Level 2|Death|0|||
145889252|NCT01570283|526101766|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145889253|NCT01570283|526101767|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145889254|NCT01570283|526101768|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145889255|NCT01570283|526101769|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
145889256|NCT01570283|526101770|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145889257|NCT01570283|526101771|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145889258|NCT01570283|526101766|FG000|Cohort 3: Dose Level 3|Death|0|||
145889259|NCT01570283|526101767|FG001|Cohort 3: Dose Level 3|Death|0|||
145889260|NCT01570283|526101768|FG002|Cohort 3: Dose Level 3|Death|0|||
145889261|NCT01570283|526101769|FG003|Cohort 3: Dose Level 3|Death|0|||
145889262|NCT01570283|526101770|FG004|Cohort 3: Dose Level 3|Death|0|||
145889263|NCT01570283|526101771|FG005|Cohort 3: Dose Level 3|Death|1|||
145889264|NCT01570283|526101766|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145889265|NCT01570283|526101767|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145889266|NCT01570283|526101768|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145968864|NCT00250588|526401053|FG002|Overall Study|Withdrawal by Subject|0|||
145968865|NCT00250588|526401051|FG000|Overall Study|Lost to Follow-up|6|||
145968866|NCT00250588|526401052|FG001|Overall Study|Lost to Follow-up|13|||
145968867|NCT00250588|526401053|FG002|Overall Study|Lost to Follow-up|13|||
145968868|NCT00706797|526401056|FG000|Overall Study|Lack of Efficacy|3|||
145968869|NCT00706797|526401057|FG001|Overall Study|Lack of Efficacy|0|||
145968870|NCT00706797|526401056|FG000|Overall Study|Adverse Event|0|||
146087070|NCT00722371|526840306|FG004|Overall Study|Hypoglycemia|0|||
146087071|NCT00722371|526840307|FG005|Overall Study|Hypoglycemia|0|||
146087072|NCT00722371|526840308|FG006|Overall Study|Hypoglycemia|0|||
146087073|NCT00722371|526840302|FG000|Overall Study|Lack of Efficacy|4|||
146087074|NCT00722371|526840303|FG001|Overall Study|Lack of Efficacy|6|||
146087075|NCT00722371|526840304|FG002|Overall Study|Lack of Efficacy|6|||
146087076|NCT00722371|526840305|FG003|Overall Study|Lack of Efficacy|6|||
146087077|NCT00722371|526840306|FG004|Overall Study|Lack of Efficacy|2|||
146087078|NCT00722371|526840307|FG005|Overall Study|Lack of Efficacy|3|||
146087079|NCT00722371|526840308|FG006|Overall Study|Lack of Efficacy|0|||
146087080|NCT00722371|526840302|FG000|Overall Study|Lost to Follow-up|11|||
146087081|NCT00722371|526840303|FG001|Overall Study|Lost to Follow-up|14|||
146087082|NCT00722371|526840304|FG002|Overall Study|Lost to Follow-up|21|||
146087083|NCT00722371|526840305|FG003|Overall Study|Lost to Follow-up|13|||
146087084|NCT00722371|526840306|FG004|Overall Study|Lost to Follow-up|8|||
146087085|NCT00722371|526840307|FG005|Overall Study|Lost to Follow-up|16|||
146087086|NCT00722371|526840308|FG006|Overall Study|Lost to Follow-up|13|||
146087087|NCT00722371|526840302|FG000|Overall Study|Physician Decision|5|||
146087088|NCT00722371|526840303|FG001|Overall Study|Physician Decision|2|||
145968871|NCT00706797|526401057|FG001|Overall Study|Adverse Event|3|||
145968872|NCT00706797|526401056|FG000|Overall Study|Withdrawal by Subject|8|||
145968873|NCT00706797|526401057|FG001|Overall Study|Withdrawal by Subject|1|||
145968874|NCT00706797|526401056|FG000|Overall Study|Death|1|||
145968875|NCT00706797|526401057|FG001|Overall Study|Death|0|||
145968876|NCT00706797|526401056|FG000|Overall Study|Discontinuation of study by sponsor|52|||
146233088|NCT03213457|527370746|FG002|Open-Label Period|Adverse Event|2|||
145968877|NCT00706797|526401057|FG001|Overall Study|Discontinuation of study by sponsor|63|||
145968878|NCT00706797|526401056|FG000|Overall Study|Protocol Violation|3|||
145968879|NCT00706797|526401057|FG001|Overall Study|Protocol Violation|2|||
145968880|NCT00706797|526401056|FG000|Overall Study|Lost to Follow-up|1|||
145968881|NCT00706797|526401057|FG001|Overall Study|Lost to Follow-up|2|||
145968882|NCT00706797|526401056|FG000|Overall Study|Other|1|||
145968883|NCT00706797|526401057|FG001|Overall Study|Other|0|||
145968884|NCT00485303|526401058|FG000|Overall Study|Adverse Event|5|||
145968885|NCT00485303|526401058|FG000|Overall Study|Progressive Disease|44|||
145968886|NCT00485303|526401058|FG000|Overall Study|Other|3|||
145968887|NCT00485303|526401058|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
145968888|NCT00485303|526401058|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
145968889|NCT01401322|526401064|FG000|Overall Study|Withdrawal by Subject|1|||
145968890|NCT01401322|526401064|FG000|Overall Study|Physician Decision|1|||
145968891|NCT00486044|526401065|FG000|Overall Study|Withdrawal by Subject|2|||
145968892|NCT00486044|526401066|FG001|Overall Study|Withdrawal by Subject|1|||
145968893|NCT00486044|526401065|FG000|Overall Study|Adverse Event|0|||
145968894|NCT00486044|526401066|FG001|Overall Study|Adverse Event|1|||
145968895|NCT00486044|526401065|FG000|Overall Study|Lost to Follow-up|0|||
145968896|NCT00486044|526401066|FG001|Overall Study|Lost to Follow-up|1|||
145968897|NCT00087178|526401068|FG000|Overall Study|No follow up data|5|||
145968898|NCT00087178|526401069|FG001|Overall Study|No follow up data|15|||
145968899|NCT00087178|526401068|FG000|Overall Study|No clinical assessment|1|||
145968900|NCT00087178|526401069|FG001|Overall Study|No clinical assessment|2|||
145968901|NCT00087178|526401068|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
145968902|NCT00087178|526401069|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
145968903|NCT03704064|526401070|FG000|Overall Study|Lost to Follow-up|8|||
145968904|NCT03704064|526401071|FG001|Overall Study|Lost to Follow-up|4|||
145968905|NCT03704064|526401070|FG000|Overall Study|Withdrawal by Subject|1|||
145968906|NCT03704064|526401071|FG001|Overall Study|Withdrawal by Subject|1|||
145968907|NCT03704064|526401070|FG000|Overall Study|No longer available for study visits|0|||
145968908|NCT03704064|526401071|FG001|Overall Study|No longer available for study visits|1|||
145968909|NCT03704064|526401070|FG000|Overall Study|Censoring event|1|||
145968910|NCT03704064|526401071|FG001|Overall Study|Censoring event|0|||
145968911|NCT00289276|526401074|FG000|Second Part of FAST Study (Expansion)|Death|0|||
145968912|NCT00289276|526401075|FG001|Second Part of FAST Study (Expansion)|Death|2|||
145968913|NCT00289276|526401074|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
145968914|NCT00289276|526401075|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
145968915|NCT01604785|526401076|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
145968916|NCT01604785|526401077|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
145968917|NCT00869960|526401078|FG000|Overall Study|Lost to Follow-up|2|||
145968918|NCT00726609|526401081|FG000|Overall Study|Adverse Event|10|||
145968919|NCT00726609|526401081|FG000|Overall Study|Withdrawal by Subject|2|||
145968920|NCT00726609|526401081|FG000|Overall Study|Lack of Efficacy|25|||
145968921|NCT00726609|526401081|FG000|Overall Study|Other|16|||
145968922|NCT00726609|526401081|FG000|Overall Study|Missing|42|||
145968923|NCT00726609|526401081|FG000|Overall Study|Other|3|||
145968924|NCT00746551|526401085|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
145968925|NCT00746551|526401086|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
145968926|NCT00746551|526401085|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
145968927|NCT00746551|526401086|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
146087089|NCT00722371|526840304|FG002|Overall Study|Physician Decision|2|||
146087090|NCT00722371|526840305|FG003|Overall Study|Physician Decision|5|||
145968928|NCT00746551|526401085|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
145968929|NCT00746551|526401086|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
145968930|NCT02029417|526401087|FG000|Overall Study|Death|1|||
145968931|NCT02029417|526401087|FG000|Overall Study|Adverse Event|1|||
146087091|NCT00722371|526840306|FG004|Overall Study|Physician Decision|2|||
146087092|NCT00722371|526840307|FG005|Overall Study|Physician Decision|3|||
146087093|NCT00722371|526840308|FG006|Overall Study|Physician Decision|4|||
145968932|NCT03040726|526401088|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
145968933|NCT03040726|526401089|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
145968934|NCT03040726|526401088|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
145968935|NCT03040726|526401089|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
145968936|NCT03040726|526401088|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
145968937|NCT03040726|526401089|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
145968938|NCT03040726|526401088|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
145968939|NCT03040726|526401089|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
145968940|NCT03040726|526401088|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
145968941|NCT03040726|526401089|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
145968942|NCT02908347|526401092|FG000|Overall Study|Adverse Event|0|||
145968943|NCT02908347|526401093|FG001|Overall Study|Adverse Event|1|||
145968944|NCT02908347|526401092|FG000|Overall Study|Lost to Follow-up|1|||
145968945|NCT02908347|526401093|FG001|Overall Study|Lost to Follow-up|0|||
145968946|NCT03104374|526401094|FG000|Period 1|Adverse Event|7|||
145968947|NCT03104374|526401095|FG001|Period 1|Adverse Event|7|||
145968948|NCT03104374|526401096|FG002|Period 1|Adverse Event|12|||
145968949|NCT03104374|526401097|FG003|Period 1|Adverse Event|14|||
145968950|NCT03104374|526401094|FG000|Period 1|Withdrawal by Subject|18|||
145968951|NCT03104374|526401095|FG001|Period 1|Withdrawal by Subject|9|||
145968952|NCT03104374|526401096|FG002|Period 1|Withdrawal by Subject|10|||
145968953|NCT03104374|526401097|FG003|Period 1|Withdrawal by Subject|17|||
145968954|NCT03104374|526401094|FG000|Period 1|Lost to Follow-up|4|||
145968955|NCT03104374|526401095|FG001|Period 1|Lost to Follow-up|4|||
145968956|NCT03104374|526401096|FG002|Period 1|Lost to Follow-up|6|||
145968957|NCT03104374|526401097|FG003|Period 1|Lost to Follow-up|8|||
145968958|NCT03104374|526401094|FG000|Period 1|Lack of Efficacy|6|||
145968959|NCT03104374|526401095|FG001|Period 1|Lack of Efficacy|7|||
145968960|NCT03104374|526401096|FG002|Period 1|Lack of Efficacy|12|||
145968961|NCT03104374|526401097|FG003|Period 1|Lack of Efficacy|6|||
145968962|NCT03104374|526401094|FG000|Period 1|Other|2|||
145968963|NCT03104374|526401095|FG001|Period 1|Other|2|||
145968964|NCT03104374|526401096|FG002|Period 1|Other|4|||
145968965|NCT03104374|526401097|FG003|Period 1|Other|7|||
145968966|NCT03104374|526401094|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145968967|NCT03104374|526401095|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145968968|NCT03104374|526401096|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145968969|NCT03104374|526401097|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
145968970|NCT03104374|526401094|FG000|Period 2|Adverse Event|4|||
145968971|NCT03104374|526401095|FG001|Period 2|Adverse Event|7|||
145968972|NCT03104374|526401096|FG002|Period 2|Adverse Event|10|||
145968973|NCT03104374|526401097|FG003|Period 2|Adverse Event|10|||
145968974|NCT03104374|526401094|FG000|Period 2|Withdrawal by Subject|3|||
145968975|NCT03104374|526401095|FG001|Period 2|Withdrawal by Subject|7|||
145968976|NCT03104374|526401096|FG002|Period 2|Withdrawal by Subject|13|||
145968977|NCT03104374|526401097|FG003|Period 2|Withdrawal by Subject|16|||
145968978|NCT03104374|526401094|FG000|Period 2|Lost to Follow-up|2|||
145968979|NCT03104374|526401095|FG001|Period 2|Lost to Follow-up|2|||
145968980|NCT03104374|526401096|FG002|Period 2|Lost to Follow-up|3|||
145968981|NCT03104374|526401097|FG003|Period 2|Lost to Follow-up|5|||
145968982|NCT03104374|526401094|FG000|Period 2|Lack of Efficacy|2|||
145968983|NCT03104374|526401095|FG001|Period 2|Lack of Efficacy|4|||
145968984|NCT03104374|526401096|FG002|Period 2|Lack of Efficacy|7|||
145968985|NCT03104374|526401097|FG003|Period 2|Lack of Efficacy|4|||
146233089|NCT03213457|527370744|FG000|Open-Label Period|Withdrawal by Subject|12|||
146233090|NCT03213457|527370745|FG001|Open-Label Period|Withdrawal by Subject|5|||
146233091|NCT03213457|527370746|FG002|Open-Label Period|Withdrawal by Subject|24|||
146233092|NCT03213457|527370744|FG000|Open-Label Period|Lost to Follow-up|1|||
146233093|NCT03213457|527370745|FG001|Open-Label Period|Lost to Follow-up|2|||
146233094|NCT03213457|527370746|FG002|Open-Label Period|Lost to Follow-up|8|||
146233095|NCT03213457|527370744|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146233096|NCT03213457|527370745|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
146233097|NCT03213457|527370746|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146233098|NCT03213457|527370744|FG000|Open-Label Period|Non-compliance with study procedures|1|||
146233099|NCT03213457|527370745|FG001|Open-Label Period|Non-compliance with study procedures|1|||
146233100|NCT03213457|527370746|FG002|Open-Label Period|Non-compliance with study procedures|2|||
145968986|NCT03104374|526401094|FG000|Period 2|COVID-19 Infection|0|||
145968987|NCT03104374|526401095|FG001|Period 2|COVID-19 Infection|0|||
145968988|NCT03104374|526401096|FG002|Period 2|COVID-19 Infection|1|||
145968989|NCT03104374|526401097|FG003|Period 2|COVID-19 Infection|0|||
145968990|NCT03104374|526401094|FG000|Period 2|Other|3|||
145968991|NCT03104374|526401095|FG001|Period 2|Other|2|||
145968992|NCT03104374|526401096|FG002|Period 2|Other|2|||
145968993|NCT03104374|526401097|FG003|Period 2|Other|4|||
145968994|NCT02121210|526401098|FG000|Overall Study|Adverse Event|5|||
145968995|NCT02121210|526401099|FG001|Overall Study|Adverse Event|7|||
145968996|NCT02121210|526401098|FG000|Overall Study|Lack of Efficacy|2|||
145968997|NCT02121210|526401099|FG001|Overall Study|Lack of Efficacy|0|||
145968998|NCT02121210|526401098|FG000|Overall Study|Other than specified above|0|||
145968999|NCT02121210|526401099|FG001|Overall Study|Other than specified above|2|||
145969000|NCT04609514|526401100|FG000|Overall Study|Lost to Follow-up|5|||
145969001|NCT04609514|526401101|FG001|Overall Study|Lost to Follow-up|4|||
145969002|NCT04609514|526401100|FG000|Overall Study|Withdrawal by PI|0|||
145969003|NCT04609514|526401101|FG001|Overall Study|Withdrawal by PI|2|||
145969004|NCT00909870|526401102|FG000|Overall Study|Adverse Event|13|||
145969005|NCT00909870|526401103|FG001|Overall Study|Adverse Event|7|||
145969006|NCT00909870|526401102|FG000|Overall Study|Protocol Violation|1|||
145969007|NCT00909870|526401103|FG001|Overall Study|Protocol Violation|2|||
145969008|NCT00909870|526401102|FG000|Overall Study|Withdrawal by Subject|5|||
145969009|NCT00909870|526401103|FG001|Overall Study|Withdrawal by Subject|8|||
145969010|NCT00909870|526401102|FG000|Overall Study|Lost to Follow-up|3|||
145969011|NCT00909870|526401103|FG001|Overall Study|Lost to Follow-up|3|||
145969012|NCT00909870|526401102|FG000|Overall Study|Physician Decision|0|||
145969013|NCT00909870|526401103|FG001|Overall Study|Physician Decision|2|||
145969014|NCT00909870|526401102|FG000|Overall Study|Other|1|||
145969015|NCT00909870|526401103|FG001|Overall Study|Other|5|||
145969016|NCT01652690|526401109|FG000|Overall Study|Withdrawal by Subject|16|||
145969017|NCT01652690|526401110|FG001|Overall Study|Withdrawal by Subject|4|||
145969018|NCT01652690|526401109|FG000|Overall Study|Other|8|||
145969019|NCT01652690|526401110|FG001|Overall Study|Other|9|||
145969020|NCT01652690|526401109|FG000|Overall Study|Lost to Follow-up|6|||
145969021|NCT01652690|526401110|FG001|Overall Study|Lost to Follow-up|6|||
145969022|NCT01652690|526401109|FG000|Overall Study|Death|5|||
145969023|NCT01652690|526401110|FG001|Overall Study|Death|2|||
145969024|NCT03225287|526401111|FG000|Overall Study|Adverse Event|0|||
145969025|NCT03225287|526401112|FG001|Overall Study|Adverse Event|0|||
145969026|NCT03225287|526401113|FG002|Overall Study|Adverse Event|1|||
145969027|NCT03225287|526401111|FG000|Overall Study|Protocol non-compliance|0|||
145969028|NCT03225287|526401112|FG001|Overall Study|Protocol non-compliance|0|||
145969029|NCT03225287|526401113|FG002|Overall Study|Protocol non-compliance|1|||
145969030|NCT03225287|526401111|FG000|Overall Study|Subject withdraws consent|3|||
145969031|NCT03225287|526401112|FG001|Overall Study|Subject withdraws consent|0|||
145969032|NCT03225287|526401113|FG002|Overall Study|Subject withdraws consent|0|||
145969033|NCT03225287|526401111|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
145969034|NCT03225287|526401112|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
145969035|NCT03225287|526401113|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
145969036|NCT03225287|526401111|FG000|Overall Study|Trial drug not effective|0|||
145969037|NCT03225287|526401112|FG001|Overall Study|Trial drug not effective|1|||
145969038|NCT03225287|526401113|FG002|Overall Study|Trial drug not effective|0|||
145969039|NCT03225287|526401111|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
145969040|NCT03225287|526401112|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
145969041|NCT03225287|526401113|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
145969042|NCT03225287|526401111|FG000|Overall Study|Stem cell transplantation|0|||
145969043|NCT03225287|526401112|FG001|Overall Study|Stem cell transplantation|1|||
145969044|NCT03225287|526401113|FG002|Overall Study|Stem cell transplantation|0|||
145969045|NCT02074514|526401115|FG000|Overall Study|Lack of Efficacy|3|||
145969046|NCT02074514|526401116|FG001|Overall Study|Lack of Efficacy|2|||
145969047|NCT02074514|526401115|FG000|Overall Study|Lost to Follow-up|0|||
145969048|NCT02074514|526401116|FG001|Overall Study|Lost to Follow-up|1|||
145969049|NCT02074514|526401115|FG000|Overall Study|Withdrew Consent|0|||
145969050|NCT02074514|526401116|FG001|Overall Study|Withdrew Consent|1|||
145969051|NCT01113749|526402924|FG000|Overall Study|Lost to Follow-up|1|||
145969052|NCT01113749|526402925|FG001|Overall Study|Lost to Follow-up|2|||
145969053|NCT03427892|526402926|FG000|Overall Study|Lost to Follow-up|2|||
145969054|NCT00703534|526402927|FG000|Overall Study|Adverse Event|14|||
146233101|NCT03213457|527370744|FG000|Open-Label Period|Exclusionary medications|0|||
146233102|NCT03213457|527370745|FG001|Open-Label Period|Exclusionary medications|0|||
146233103|NCT03213457|527370746|FG002|Open-Label Period|Exclusionary medications|1|||
145969055|NCT00703534|526402928|FG001|Overall Study|Adverse Event|3|||
145969056|NCT00703534|526402927|FG000|Overall Study|Withdrawal by Subject|8|||
145969057|NCT00703534|526402928|FG001|Overall Study|Withdrawal by Subject|7|||
145969058|NCT00703534|526402927|FG000|Overall Study|Incorrect Enrollment|6|||
146233104|NCT03213457|527370744|FG000|Open-Label Period|Other|1|||
146233105|NCT03213457|527370745|FG001|Open-Label Period|Other|1|||
146233106|NCT03213457|527370746|FG002|Open-Label Period|Other|6|||
146233107|NCT03213457|527370744|FG000|Follow-Up Period|Adverse Event|16|||
146233108|NCT03213457|527370745|FG001|Follow-Up Period|Adverse Event|8|||
146233109|NCT03213457|527370746|FG002|Follow-Up Period|Adverse Event|37|||
146233110|NCT03213457|527370744|FG000|Follow-Up Period|Withdrawal by Subject|18|||
146233111|NCT03213457|527370745|FG001|Follow-Up Period|Withdrawal by Subject|11|||
145969059|NCT00703534|526402928|FG001|Overall Study|Incorrect Enrollment|6|||
145969060|NCT00703534|526402927|FG000|Overall Study|Lost to Follow-up|1|||
145969061|NCT00703534|526402928|FG001|Overall Study|Lost to Follow-up|4|||
145969062|NCT00703534|526402927|FG000|Overall Study|Severe Non Compliance|1|||
145969063|NCT00703534|526402928|FG001|Overall Study|Severe Non Compliance|5|||
145969064|NCT01649765|526402929|FG000|Overall Study|Adverse Event|5|||
145969065|NCT01649765|526402930|FG001|Overall Study|Adverse Event|3|||
145969066|NCT01649765|526402929|FG000|Overall Study|Lack of Efficacy|1|||
145969067|NCT01649765|526402930|FG001|Overall Study|Lack of Efficacy|1|||
145969068|NCT01649765|526402929|FG000|Overall Study|Physician Decision|0|||
145969069|NCT01649765|526402930|FG001|Overall Study|Physician Decision|3|||
145969070|NCT01649765|526402929|FG000|Overall Study|Protocol Violation|1|||
145969071|NCT01649765|526402930|FG001|Overall Study|Protocol Violation|0|||
145969072|NCT01649765|526402929|FG000|Overall Study|Withdrawal by Subject|2|||
145969073|NCT01649765|526402930|FG001|Overall Study|Withdrawal by Subject|1|||
146233112|NCT03213457|527370746|FG002|Follow-Up Period|Withdrawal by Subject|55|||
146233113|NCT03213457|527370744|FG000|Follow-Up Period|Lost to Follow-up|28|||
146233114|NCT03213457|527370745|FG001|Follow-Up Period|Lost to Follow-up|15|||
146233115|NCT03213457|527370746|FG002|Follow-Up Period|Lost to Follow-up|50|||
146233116|NCT03213457|527370744|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
146233117|NCT03213457|527370745|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
146233118|NCT03213457|527370746|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
146233119|NCT03213457|527370744|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
145969074|NCT00961064|526402931|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
145969075|NCT00961064|526402931|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
145969076|NCT00961064|526402931|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
145969077|NCT00961064|526402931|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
145969078|NCT00961064|526402931|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
145969079|NCT00961064|526402931|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
145969080|NCT00961064|526402931|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
145969081|NCT00961064|526402931|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
146233120|NCT03213457|527370745|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
145969082|NCT01408641|526402932|FG000|Overall Study|Physician Decision|1|||
146293560|NCT00986440|527590068|FG001|Overall Study|Withdrawal by Subject|2|||
146087094|NCT00722371|526840302|FG000|Overall Study|Pregnancy|1|||
146087095|NCT00722371|526840303|FG001|Overall Study|Pregnancy|1|||
146087096|NCT00722371|526840304|FG002|Overall Study|Pregnancy|0|||
146087097|NCT00722371|526840305|FG003|Overall Study|Pregnancy|0|||
146087098|NCT00722371|526840306|FG004|Overall Study|Pregnancy|0|||
146087099|NCT00722371|526840307|FG005|Overall Study|Pregnancy|1|||
146087100|NCT00722371|526840308|FG006|Overall Study|Pregnancy|0|||
146087101|NCT00722371|526840302|FG000|Overall Study|Protocol Violation|6|||
146087102|NCT00722371|526840303|FG001|Overall Study|Protocol Violation|1|||
146087103|NCT00722371|526840304|FG002|Overall Study|Protocol Violation|0|||
146087104|NCT00722371|526840305|FG003|Overall Study|Protocol Violation|1|||
146087105|NCT00722371|526840306|FG004|Overall Study|Protocol Violation|4|||
146087106|NCT00722371|526840307|FG005|Overall Study|Protocol Violation|2|||
146087107|NCT00722371|526840308|FG006|Overall Study|Protocol Violation|1|||
146087108|NCT00722371|526840302|FG000|Overall Study|Withdrawal by Subject|18|||
146087109|NCT00722371|526840303|FG001|Overall Study|Withdrawal by Subject|27|||
146087110|NCT00722371|526840304|FG002|Overall Study|Withdrawal by Subject|19|||
146087111|NCT00722371|526840305|FG003|Overall Study|Withdrawal by Subject|23|||
146087112|NCT00722371|526840306|FG004|Overall Study|Withdrawal by Subject|19|||
146087113|NCT00722371|526840307|FG005|Overall Study|Withdrawal by Subject|18|||
146087114|NCT00722371|526840308|FG006|Overall Study|Withdrawal by Subject|26|||
146087115|NCT01092832|526840309|FG000|Overall Study|Other|1|||
146087116|NCT01092832|526840310|FG001|Overall Study|Other|0|||
146087117|NCT02674854|526840311|FG000|Overall Study|Adverse Event|17|||
146087118|NCT02674854|526840312|FG001|Overall Study|Adverse Event|15|||
146087119|NCT02674854|526840313|FG002|Overall Study|Adverse Event|5|||
145889267|NCT01570283|526101769|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
146087120|NCT02674854|526840311|FG000|Overall Study|Withdrawal by Subject|1|||
146087121|NCT02674854|526840312|FG001|Overall Study|Withdrawal by Subject|5|||
146087122|NCT02674854|526840313|FG002|Overall Study|Withdrawal by Subject|4|||
146087123|NCT02674854|526840311|FG000|Overall Study|No-compliant subject|1|||
145969083|NCT01408641|526402933|FG001|Overall Study|Physician Decision|0|||
145969084|NCT00715208|526402934|FG000|Overall Study|Withdrawal by Subject|1|||
145889268|NCT01570283|526101770|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145889269|NCT01570283|526101771|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
145889270|NCT03336242|526101779|FG000|Overall Study|Adverse Event|0|||
145889271|NCT03336242|526101780|FG001|Overall Study|Adverse Event|1|||
145889272|NCT03005067|526101784|FG000|Overall Study|Withdrawal by Subject|3|||
145889273|NCT03005067|526101785|FG001|Overall Study|Withdrawal by Subject|2|||
145889274|NCT03005067|526101784|FG000|Overall Study|Adverse Event|4|||
145889275|NCT03005067|526101785|FG001|Overall Study|Adverse Event|3|||
145969085|NCT00715208|526402935|FG001|Overall Study|Withdrawal by Subject|1|||
145969086|NCT00715208|526402934|FG000|Overall Study|Adverse Event|0|||
145889276|NCT03005067|526101784|FG000|Overall Study|Other (reason not specified)|3|||
145969087|NCT00715208|526402935|FG001|Overall Study|Adverse Event|6|||
145969088|NCT00715208|526402934|FG000|Overall Study|Lack of Efficacy|0|||
145969089|NCT00715208|526402935|FG001|Overall Study|Lack of Efficacy|2|||
145889277|NCT03005067|526101785|FG001|Overall Study|Other (reason not specified)|1|||
145889278|NCT03005067|526101784|FG000|Overall Study|Protocol Violation|0|||
145889279|NCT03005067|526101785|FG001|Overall Study|Protocol Violation|1|||
145889280|NCT01790113|526101790|FG000|Overall Study|Adverse Event|2|||
145889281|NCT01790113|526101791|FG001|Overall Study|Adverse Event|7|||
145889282|NCT01790113|526101790|FG000|Overall Study|Study ended due to FDA clearance|1|||
145889283|NCT01790113|526101791|FG001|Overall Study|Study ended due to FDA clearance|68|||
145889284|NCT02674386|526101792|FG000|Overall Study|Lost to Follow-up|0|||
145889285|NCT02674386|526101793|FG001|Overall Study|Lost to Follow-up|1|||
145889286|NCT02674386|526101794|FG002|Overall Study|Lost to Follow-up|1|||
145889287|NCT02674386|526101792|FG000|Overall Study|Withdrawal by Subject|0|||
145889288|NCT02674386|526101793|FG001|Overall Study|Withdrawal by Subject|4|||
145889289|NCT02674386|526101794|FG002|Overall Study|Withdrawal by Subject|0|||
145889290|NCT02674386|526101792|FG000|Overall Study|Other|0|||
145889291|NCT02674386|526101793|FG001|Overall Study|Other|1|||
145889292|NCT02674386|526101794|FG002|Overall Study|Other|0|||
145889293|NCT02674386|526101792|FG000|Overall Study|Enrolled but not evaluated|0|||
145889294|NCT02674386|526101793|FG001|Overall Study|Enrolled but not evaluated|4|||
145889295|NCT02674386|526101794|FG002|Overall Study|Enrolled but not evaluated|0|||
145889296|NCT02462486|526101799|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145889297|NCT02462486|526101800|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145889298|NCT02462486|526101801|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
145889299|NCT02462486|526101799|FG000|Overall Study|Adverse Event|53|||
145889300|NCT02462486|526101800|FG001|Overall Study|Adverse Event|48|||
145889301|NCT02462486|526101801|FG002|Overall Study|Adverse Event|21|||
145889302|NCT02462486|526101799|FG000|Overall Study|Lack of Efficacy|6|||
145889303|NCT02462486|526101800|FG001|Overall Study|Lack of Efficacy|12|||
145889304|NCT02462486|526101801|FG002|Overall Study|Lack of Efficacy|3|||
145889305|NCT02462486|526101799|FG000|Overall Study|Lost to Follow-up|3|||
145889306|NCT02462486|526101800|FG001|Overall Study|Lost to Follow-up|4|||
145889307|NCT02462486|526101801|FG002|Overall Study|Lost to Follow-up|2|||
145969090|NCT01294046|526402936|FG000|Overall Study|Infection and surgical explant|1|||
145969091|NCT01294046|526402936|FG000|Overall Study|Eligibility criteria expanded|1|||
145969092|NCT01294046|526402936|FG000|Overall Study|Stimulation response inadqequate|1|||
145969093|NCT01499511|526402937|FG000|Overall Study|Death|1|||
145969094|NCT01499511|526402938|FG001|Overall Study|Death|0|||
145969095|NCT00998946|526402939|FG000|Overall Study|Lost to Follow-up|1|||
145969096|NCT00998946|526402939|FG000|Overall Study|Withdrawal by Subject|1|||
145969097|NCT00998946|526402939|FG000|Overall Study|Death|2|||
145969098|NCT00998946|526402939|FG000|Overall Study|Reason Unspecified|3|||
145969099|NCT00998946|526402939|FG000|Overall Study|Enrolled but not Dosed|2|||
145969100|NCT01454284|526402941|FG000|Overall Study|Adverse Event|20|||
145969101|NCT01454284|526402942|FG001|Overall Study|Adverse Event|7|||
145969102|NCT01454284|526402941|FG000|Overall Study|Death|0|||
145969103|NCT01454284|526402942|FG001|Overall Study|Death|3|||
146293561|NCT00986440|527590067|FG000|Overall Study|Screen failure (not dosed)|4|||
145969104|NCT01454284|526402941|FG000|Overall Study|Lost to Follow-up|13|||
145969105|NCT01454284|526402942|FG001|Overall Study|Lost to Follow-up|8|||
145889308|NCT02462486|526101799|FG000|Overall Study|Withdrawal by Subject|25|||
145889309|NCT02462486|526101800|FG001|Overall Study|Withdrawal by Subject|22|||
145889310|NCT02462486|526101801|FG002|Overall Study|Withdrawal by Subject|19|||
145889311|NCT02462486|526101799|FG000|Overall Study|Protocol Violation|3|||
145889312|NCT02462486|526101800|FG001|Overall Study|Protocol Violation|1|||
145889313|NCT02462486|526101801|FG002|Overall Study|Protocol Violation|1|||
145969106|NCT01454284|526402941|FG000|Overall Study|Protocol Violation|9|||
145889314|NCT02462486|526101799|FG000|Overall Study|Reason not Specified|3|||
145889315|NCT02462486|526101800|FG001|Overall Study|Reason not Specified|4|||
145889316|NCT02462486|526101801|FG002|Overall Study|Reason not Specified|3|||
145889317|NCT02310763|526101802|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145889318|NCT02310763|526101803|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145889319|NCT02310763|526101804|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145889320|NCT02310763|526101802|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
145969107|NCT01454284|526402942|FG001|Overall Study|Protocol Violation|6|||
145969108|NCT01454284|526402941|FG000|Overall Study|Withdrawal by Subject|58|||
145969109|NCT01454284|526402942|FG001|Overall Study|Withdrawal by Subject|36|||
145969110|NCT01454284|526402941|FG000|Overall Study|Physician Decision|16|||
145969111|NCT01454284|526402942|FG001|Overall Study|Physician Decision|11|||
145969112|NCT01454284|526402941|FG000|Overall Study|Sponsor Decision|0|||
145969113|NCT01454284|526402942|FG001|Overall Study|Sponsor Decision|2|||
145969114|NCT02842866|526402943|FG000|Overall Study|Serious Adverse Event|0|||
145969115|NCT02842866|526402944|FG001|Overall Study|Serious Adverse Event|1|||
145969116|NCT02842866|526402943|FG000|Overall Study|Protocol Violation|4|||
145969117|NCT02842866|526402944|FG001|Overall Study|Protocol Violation|2|||
145969118|NCT02842866|526402943|FG000|Overall Study|Lost to Follow-up|2|||
145969119|NCT02842866|526402944|FG001|Overall Study|Lost to Follow-up|0|||
145969120|NCT02842866|526402943|FG000|Overall Study|Withdrawal by Subject|1|||
145969121|NCT02842866|526402944|FG001|Overall Study|Withdrawal by Subject|0|||
145969122|NCT01432327|526402945|FG000|Posttest 3 Months|depression|3|||
145969123|NCT01432327|526402946|FG001|Posttest 3 Months|depression|0|||
145969124|NCT01432327|526402947|FG002|Posttest 3 Months|depression|0|||
145969125|NCT01432327|526402948|FG003|Posttest 3 Months|depression|0|||
145969126|NCT01432327|526402945|FG000|Posttest 3 Months|Lost to Follow-up|1|||
145969127|NCT01432327|526402946|FG001|Posttest 3 Months|Lost to Follow-up|0|||
145969128|NCT01432327|526402947|FG002|Posttest 3 Months|Lost to Follow-up|2|||
145969129|NCT01432327|526402948|FG003|Posttest 3 Months|Lost to Follow-up|1|||
145969130|NCT01432327|526402945|FG000|Posttest 3 Months|Allergic reaction|0|||
145969131|NCT01432327|526402946|FG001|Posttest 3 Months|Allergic reaction|2|||
145969132|NCT01432327|526402947|FG002|Posttest 3 Months|Allergic reaction|0|||
145969133|NCT01432327|526402948|FG003|Posttest 3 Months|Allergic reaction|0|||
145969134|NCT01432327|526402945|FG000|Posttest 6 Months|Lost to Follow-up|0|||
145969135|NCT01432327|526402946|FG001|Posttest 6 Months|Lost to Follow-up|0|||
145969136|NCT01432327|526402947|FG002|Posttest 6 Months|Lost to Follow-up|3|||
145969137|NCT01432327|526402948|FG003|Posttest 6 Months|Lost to Follow-up|2|||
145969138|NCT01432327|526402945|FG000|Posttest 6 Months|Allergic reaction|0|||
145969139|NCT01432327|526402946|FG001|Posttest 6 Months|Allergic reaction|0|||
145969140|NCT01432327|526402947|FG002|Posttest 6 Months|Allergic reaction|1|||
145969141|NCT01432327|526402948|FG003|Posttest 6 Months|Allergic reaction|0|||
145969142|NCT01432327|526402945|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
145969143|NCT01432327|526402946|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
145969144|NCT01432327|526402947|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
145969145|NCT01432327|526402948|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
145969146|NCT01432327|526402945|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
145969147|NCT01432327|526402946|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
145969148|NCT01432327|526402947|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
145969149|NCT01432327|526402948|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
145969150|NCT01432327|526402945|FG000|Posttest 1 Year|Lost to Follow-up|0|||
145969151|NCT01432327|526402946|FG001|Posttest 1 Year|Lost to Follow-up|0|||
145969152|NCT01432327|526402947|FG002|Posttest 1 Year|Lost to Follow-up|4|||
145969153|NCT01432327|526402948|FG003|Posttest 1 Year|Lost to Follow-up|2|||
145969154|NCT01432327|526402945|FG000|Posttest 1 Year|Allergic reaction|0|||
145969155|NCT01432327|526402946|FG001|Posttest 1 Year|Allergic reaction|0|||
145889321|NCT02310763|526101803|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
145889322|NCT02310763|526101804|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
145889323|NCT02310763|526101802|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
145889324|NCT02310763|526101803|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
145889325|NCT02310763|526101804|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
146233121|NCT03213457|527370746|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
145969156|NCT01432327|526402947|FG002|Posttest 1 Year|Allergic reaction|1|||
145969157|NCT01432327|526402948|FG003|Posttest 1 Year|Allergic reaction|1|||
145969158|NCT00577408|526402949|FG000|Overall Study|Stopped attending study visits|9|||
145969159|NCT00577408|526402950|FG001|Overall Study|Stopped attending study visits|11|||
145969160|NCT00577408|526402949|FG000|Overall Study|Continued opioid use|3|||
145969161|NCT00577408|526402950|FG001|Overall Study|Continued opioid use|2|||
145969162|NCT00577408|526402949|FG000|Overall Study|Non-compliance with study meds|0|||
145969163|NCT00577408|526402950|FG001|Overall Study|Non-compliance with study meds|3|||
145969164|NCT00577408|526402949|FG000|Overall Study|Refused Oral Naltrexone|0|||
145969165|NCT00577408|526402950|FG001|Overall Study|Refused Oral Naltrexone|1|||
145969166|NCT00577408|526402949|FG000|Overall Study|Moved out of state|0|||
145969167|NCT00577408|526402950|FG001|Overall Study|Moved out of state|1|||
145969168|NCT00577408|526402949|FG000|Overall Study|Scheduling Issues|0|||
145969169|NCT00577408|526402950|FG001|Overall Study|Scheduling Issues|3|||
145969170|NCT00577408|526402949|FG000|Overall Study|Death|0|||
145969171|NCT00577408|526402950|FG001|Overall Study|Death|1|||
145969172|NCT00577408|526402949|FG000|Overall Study|Psychiatric hospitalization|0|||
145969173|NCT00577408|526402950|FG001|Overall Study|Psychiatric hospitalization|1|||
145969174|NCT03817528|526402953|FG000|Overall Study|Withdrawal by Subject|1|||
145969175|NCT03817528|526402953|FG000|Overall Study|Adverse Event|2|||
145969176|NCT00827567|526402960|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
145969177|NCT03482024|526402965|FG000|Overall Study|Physician Decision|1|||
145969178|NCT03482024|526402966|FG001|Overall Study|Physician Decision|0|||
145969179|NCT03482024|526402967|FG002|Overall Study|Physician Decision|0|||
145969180|NCT03482024|526402968|FG003|Overall Study|Physician Decision|0|||
145969181|NCT03482024|526402969|FG004|Overall Study|Physician Decision|0|||
145969182|NCT04810962|526402970|FG000|Overall Study|Adverse Event|0|||
145969183|NCT04810962|526402971|FG001|Overall Study|Adverse Event|1|||
145969184|NCT04810962|526402970|FG000|Overall Study|Lost to Follow-up|2|||
145969185|NCT04810962|526402971|FG001|Overall Study|Lost to Follow-up|1|||
145969186|NCT04810962|526402970|FG000|Overall Study|Physician Decision|1|||
145969187|NCT04810962|526402971|FG001|Overall Study|Physician Decision|0|||
145969188|NCT04810962|526402970|FG000|Overall Study|Withdrawal by Subject|1|||
145969189|NCT04810962|526402971|FG001|Overall Study|Withdrawal by Subject|3|||
145969190|NCT04810962|526402970|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
145969191|NCT04810962|526402971|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
145969192|NCT00368550|526402973|FG000|Overall Study|Adverse Event|7|||
145969193|NCT00368550|526402974|FG001|Overall Study|Adverse Event|4|||
145969194|NCT00368550|526402973|FG000|Overall Study|Lack of Efficacy|4|||
145969195|NCT00368550|526402974|FG001|Overall Study|Lack of Efficacy|9|||
145969196|NCT00368550|526402973|FG000|Overall Study|Withdrawal by Subject|17|||
145969197|NCT00368550|526402974|FG001|Overall Study|Withdrawal by Subject|10|||
145969198|NCT02410629|526402975|FG000|Overall Study|Family cannot commit to the study|2|||
145969199|NCT02410629|526402976|FG001|Overall Study|Family cannot commit to the study|1|||
145969200|NCT02410629|526402975|FG000|Overall Study|Subject returned to work|1|||
145969201|NCT02410629|526402976|FG001|Overall Study|Subject returned to work|0|||
145969202|NCT02410629|526402975|FG000|Overall Study|Subject moved back to home country|0|||
145969203|NCT02410629|526402976|FG001|Overall Study|Subject moved back to home country|1|||
145969204|NCT02410629|526402975|FG000|Overall Study|Subject underwent heart surgery|0|||
145969205|NCT02410629|526402976|FG001|Overall Study|Subject underwent heart surgery|1|||
145969206|NCT01206764|526402977|FG000|Overall Study|Adverse Event|20|||
145969207|NCT01206764|526402977|FG000|Overall Study|Abnormal laboratory value|2|||
145969208|NCT01206764|526402977|FG000|Overall Study|Abnormal test procedure result|1|||
145969209|NCT01206764|526402977|FG000|Overall Study|Patient withdrew consent|5|||
145969210|NCT01206764|526402977|FG000|Overall Study|Lost to Follow-up|6|||
145969211|NCT01206764|526402977|FG000|Overall Study|Death|11|||
145969212|NCT01206764|526402977|FG000|Overall Study|New cancer therapy|2|||
145969213|NCT01206764|526402977|FG000|Overall Study|Disease progression|88|||
145969214|NCT01206764|526402977|FG000|Overall Study|Protocol deviation|3|||
145969215|NCT00997893|526402978|FG000|Overall Study|Adverse Event|1|||
145969216|NCT00997893|526402979|FG001|Overall Study|Adverse Event|0|||
145969217|NCT00997893|526402980|FG002|Overall Study|Adverse Event|0|||
145969218|NCT00997893|526402978|FG000|Overall Study|Unable to meet study timelines|1|||
145969219|NCT00997893|526402979|FG001|Overall Study|Unable to meet study timelines|0|||
145969220|NCT00997893|526402980|FG002|Overall Study|Unable to meet study timelines|0|||
145969221|NCT00997893|526402978|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
145969222|NCT00997893|526402979|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
145969223|NCT00997893|526402980|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
145969224|NCT00226655|526402981|FG000|Overall Study|Death|13|||
145969225|NCT00226655|526402981|FG000|Overall Study|Withdrawal by Subject|15|||
145969226|NCT00226655|526402981|FG000|Overall Study|Adverse Event|35|||
145969227|NCT00226655|526402981|FG000|Overall Study|Physician Decision|6|||
145969228|NCT00226655|526402981|FG000|Overall Study|Clinical deterioration|10|||
145969229|NCT02309359|526402982|FG000|Overall Study|Adverse Event|4|||
145969230|NCT02309359|526402983|FG001|Overall Study|Adverse Event|5|||
145969231|NCT02309359|526402984|FG002|Overall Study|Adverse Event|5|||
145969232|NCT02309359|526402985|FG003|Overall Study|Adverse Event|4|||
145969233|NCT02309359|526402986|FG004|Overall Study|Adverse Event|4|||
145969234|NCT02309359|526402982|FG000|Overall Study|Death|1|||
145969235|NCT02309359|526402983|FG001|Overall Study|Death|0|||
145969236|NCT02309359|526402984|FG002|Overall Study|Death|0|||
145889326|NCT02310763|526101802|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
145889327|NCT02310763|526101803|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
145889328|NCT02310763|526101804|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
145889329|NCT02310763|526101802|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145889330|NCT02310763|526101803|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145889331|NCT02310763|526101804|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145889332|NCT02094261|526101807|FG000|Overall Study|Death|24|||
145889333|NCT02094261|526101807|FG000|Overall Study|Lost to Follow-up|1|||
145889334|NCT02094261|526101807|FG000|Overall Study|Withdrawal by Subject|4|||
145889335|NCT02094261|526101807|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
145889336|NCT01202877|526101810|FG000|Overall Study|Disease Progression|0|||
145889337|NCT01202877|526101811|FG001|Overall Study|Disease Progression|1|||
145889338|NCT01202877|526101812|FG002|Overall Study|Disease Progression|2|||
145969237|NCT02309359|526402985|FG003|Overall Study|Death|0|||
145969238|NCT02309359|526402986|FG004|Overall Study|Death|0|||
146087124|NCT02674854|526840312|FG001|Overall Study|No-compliant subject|0|||
146087125|NCT02674854|526840313|FG002|Overall Study|No-compliant subject|1|||
146087126|NCT02674854|526840311|FG000|Overall Study|Lost to Follow-up|1|||
146087127|NCT02674854|526840312|FG001|Overall Study|Lost to Follow-up|0|||
146087128|NCT02674854|526840313|FG002|Overall Study|Lost to Follow-up|2|||
146087129|NCT02674854|526840311|FG000|Overall Study|Lack of Efficacy|0|||
146087130|NCT02674854|526840312|FG001|Overall Study|Lack of Efficacy|3|||
146087131|NCT02674854|526840313|FG002|Overall Study|Lack of Efficacy|0|||
146087132|NCT02674854|526840311|FG000|Overall Study|Disallowed Concurrent Medication|2|||
145969239|NCT02309359|526402982|FG000|Overall Study|Withdrawal by Subject|2|||
145969240|NCT02309359|526402983|FG001|Overall Study|Withdrawal by Subject|2|||
145969241|NCT02309359|526402984|FG002|Overall Study|Withdrawal by Subject|4|||
145969242|NCT02309359|526402985|FG003|Overall Study|Withdrawal by Subject|4|||
145969243|NCT02309359|526402986|FG004|Overall Study|Withdrawal by Subject|0|||
145969244|NCT02309359|526402982|FG000|Overall Study|Lack of Efficacy|3|||
145969245|NCT02309359|526402983|FG001|Overall Study|Lack of Efficacy|1|||
145969246|NCT02309359|526402984|FG002|Overall Study|Lack of Efficacy|0|||
145969247|NCT02309359|526402985|FG003|Overall Study|Lack of Efficacy|0|||
145969248|NCT02309359|526402986|FG004|Overall Study|Lack of Efficacy|3|||
145969249|NCT02309359|526402982|FG000|Overall Study|Lost to Follow-up|0|||
145969250|NCT02309359|526402983|FG001|Overall Study|Lost to Follow-up|0|||
145969251|NCT02309359|526402984|FG002|Overall Study|Lost to Follow-up|0|||
145969252|NCT02309359|526402985|FG003|Overall Study|Lost to Follow-up|1|||
145969253|NCT02309359|526402986|FG004|Overall Study|Lost to Follow-up|0|||
145969254|NCT02309359|526402982|FG000|Overall Study|Other|2|||
145969255|NCT02309359|526402983|FG001|Overall Study|Other|0|||
145969256|NCT02309359|526402984|FG002|Overall Study|Other|2|||
145969257|NCT02309359|526402985|FG003|Overall Study|Other|3|||
145969258|NCT02309359|526402986|FG004|Overall Study|Other|2|||
146087133|NCT02674854|526840312|FG001|Overall Study|Disallowed Concurrent Medication|2|||
146087134|NCT02674854|526840313|FG002|Overall Study|Disallowed Concurrent Medication|0|||
146087135|NCT02674854|526840311|FG000|Overall Study|Protocol Violation|1|||
145969259|NCT00701363|526402987|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
145969260|NCT00701363|526402988|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145969261|NCT00701363|526402989|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145969262|NCT00701363|526402990|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145969263|NCT00701363|526402987|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
145969264|NCT00701363|526402988|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
145969265|NCT00701363|526402989|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
145969266|NCT00701363|526402990|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
145969267|NCT00701363|526402987|FG000|Treatment Phase 1|Adverse Event|7|||
145969268|NCT00701363|526402988|FG001|Treatment Phase 1|Adverse Event|0|||
145969269|NCT00701363|526402989|FG002|Treatment Phase 1|Adverse Event|0|||
145969270|NCT00701363|526402990|FG003|Treatment Phase 1|Adverse Event|0|||
145969271|NCT00701363|526402987|FG000|Treatment Phase 1|Protocol Violation|1|||
145969272|NCT00701363|526402988|FG001|Treatment Phase 1|Protocol Violation|0|||
145969273|NCT00701363|526402989|FG002|Treatment Phase 1|Protocol Violation|0|||
145969274|NCT00701363|526402990|FG003|Treatment Phase 1|Protocol Violation|0|||
145969275|NCT00701363|526402987|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
145969276|NCT00701363|526402988|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
145969277|NCT00701363|526402989|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
145969278|NCT00701363|526402990|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
145969279|NCT00701363|526402987|FG000|Treatment Phase 1|Lack of Efficacy|1|||
145969280|NCT00701363|526402988|FG001|Treatment Phase 1|Lack of Efficacy|0|||
145969281|NCT00701363|526402989|FG002|Treatment Phase 1|Lack of Efficacy|0|||
145969282|NCT00701363|526402990|FG003|Treatment Phase 1|Lack of Efficacy|0|||
145969283|NCT00701363|526402987|FG000|Treatment Phase 2|Adverse Event|0|||
145969284|NCT00701363|526402988|FG001|Treatment Phase 2|Adverse Event|0|||
145969285|NCT00701363|526402989|FG002|Treatment Phase 2|Adverse Event|1|||
145969286|NCT00701363|526402990|FG003|Treatment Phase 2|Adverse Event|0|||
145969287|NCT00701363|526402987|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
145889339|NCT01202877|526101810|FG000|Overall Study|Adverse Event|0|||
145889340|NCT01202877|526101811|FG001|Overall Study|Adverse Event|0|||
145889341|NCT01202877|526101812|FG002|Overall Study|Adverse Event|2|||
145889342|NCT01202877|526101810|FG000|Overall Study|Withdrawal by Subject|0|||
145889343|NCT01202877|526101811|FG001|Overall Study|Withdrawal by Subject|0|||
145889344|NCT01202877|526101812|FG002|Overall Study|Withdrawal by Subject|1|||
145889345|NCT01202877|526101810|FG000|Overall Study|Death|0|||
145889346|NCT01202877|526101811|FG001|Overall Study|Death|0|||
145969288|NCT00701363|526402988|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
145969289|NCT00701363|526402989|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
145889347|NCT01202877|526101812|FG002|Overall Study|Death|1|||
145889348|NCT00396331|526101813|FG000|Overall Study|Failed to mobilize - no transplant|8|||
145889349|NCT00396331|526101813|FG000|Overall Study|Did not go on to transplant|5|||
145969290|NCT00701363|526402990|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
146087136|NCT02674854|526840312|FG001|Overall Study|Protocol Violation|1|||
145889350|NCT00396331|526101813|FG000|Overall Study|Lost to Follow-up|3|||
145969291|NCT04759131|526402991|FG000|Overall Study|Investigator's discretion|1|||
145889351|NCT00396331|526101813|FG000|Overall Study|Death|16|||
145889352|NCT00680186|526101814|FG000|Overall Study|Adverse Event|47|||
145889353|NCT00680186|526101815|FG001|Overall Study|Adverse Event|44|||
145889354|NCT00680186|526101814|FG000|Overall Study|Protocol Violation|31|||
145889355|NCT00680186|526101815|FG001|Overall Study|Protocol Violation|26|||
145889356|NCT00680186|526101814|FG000|Overall Study|Lost to Follow-up|11|||
145889357|NCT00680186|526101815|FG001|Overall Study|Lost to Follow-up|6|||
145889358|NCT00680186|526101814|FG000|Overall Study|Withdrawal by Subject|32|||
145889359|NCT00680186|526101815|FG001|Overall Study|Withdrawal by Subject|39|||
145889360|NCT00680186|526101814|FG000|Overall Study|Other|4|||
145889361|NCT00680186|526101815|FG001|Overall Study|Other|1|||
145889362|NCT01351350|526101818|FG000|Overall Study|Disease Progression|5|||
145889363|NCT01351350|526101819|FG001|Overall Study|Disease Progression|13|||
145889364|NCT01351350|526101820|FG002|Overall Study|Disease Progression|6|||
145969292|NCT04759131|526402992|FG001|Overall Study|Investigator's discretion|0|||
145889365|NCT01351350|526101821|FG003|Overall Study|Disease Progression|8|||
145969293|NCT04759131|526402991|FG000|Overall Study|Subject withdrawal|1|||
145969294|NCT04759131|526402992|FG001|Overall Study|Subject withdrawal|0|||
145969295|NCT05144945|526402993|FG000|Overall Study|Withdrawal by Subject|1|||
145969296|NCT05144945|526402994|FG001|Overall Study|Withdrawal by Subject|0|||
145969297|NCT05853120|526402995|FG000|Overall Study|Lost to Follow-up|4|||
145969298|NCT05853120|526402996|FG001|Overall Study|Lost to Follow-up|4|||
145969299|NCT05853120|526402995|FG000|Overall Study|Physician Decision|3|||
145969300|NCT05853120|526402996|FG001|Overall Study|Physician Decision|0|||
145969301|NCT05853120|526402995|FG000|Overall Study|Withdrawal by Subject|5|||
145889366|NCT01351350|526101822|FG004|Overall Study|Disease Progression|5|||
145889367|NCT01351350|526101818|FG000|Overall Study|Adverse Event|1|||
145889368|NCT01351350|526101819|FG001|Overall Study|Adverse Event|10|||
145889369|NCT01351350|526101820|FG002|Overall Study|Adverse Event|1|||
145889370|NCT01351350|526101821|FG003|Overall Study|Adverse Event|2|||
145889371|NCT01351350|526101822|FG004|Overall Study|Adverse Event|0|||
145889372|NCT01351350|526101818|FG000|Overall Study|Participant Decision|2|||
145889373|NCT01351350|526101819|FG001|Overall Study|Participant Decision|6|||
145889374|NCT01351350|526101820|FG002|Overall Study|Participant Decision|3|||
145889375|NCT01351350|526101821|FG003|Overall Study|Participant Decision|3|||
145889376|NCT01351350|526101822|FG004|Overall Study|Participant Decision|2|||
145889377|NCT01351350|526101818|FG000|Overall Study|Enrolled but not Treated|0|||
145889378|NCT01351350|526101819|FG001|Overall Study|Enrolled but not Treated|0|||
145889379|NCT01351350|526101820|FG002|Overall Study|Enrolled but not Treated|1|||
145889380|NCT01351350|526101821|FG003|Overall Study|Enrolled but not Treated|0|||
145969302|NCT05853120|526402996|FG001|Overall Study|Withdrawal by Subject|2|||
145969303|NCT02592824|526402998|FG000|Overall Study|Protocol Violation|5|||
145889381|NCT01351350|526101822|FG004|Overall Study|Enrolled but not Treated|0|||
145889382|NCT00775528|526101825|FG000|Overall Study|Protocol Violation|1|||
145889383|NCT04647383|526101826|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
145889384|NCT04647383|526101827|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
145889385|NCT04647383|526101828|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
145889386|NCT04647383|526101829|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
145889387|NCT02709486|526101844|FG000|Overall Study|Adverse Event|2|||
145889388|NCT02709486|526101845|FG001|Overall Study|Adverse Event|5|||
145889389|NCT02709486|526101846|FG002|Overall Study|Adverse Event|3|||
145889390|NCT02709486|526101844|FG000|Overall Study|Death|0|||
145889391|NCT02709486|526101845|FG001|Overall Study|Death|0|||
145889392|NCT02709486|526101846|FG002|Overall Study|Death|2|||
145889393|NCT02709486|526101844|FG000|Overall Study|Insufficient clinical response|7|||
145889394|NCT02709486|526101845|FG001|Overall Study|Insufficient clinical response|3|||
145889395|NCT02709486|526101846|FG002|Overall Study|Insufficient clinical response|3|||
145889396|NCT02709486|526101844|FG000|Overall Study|Lost to Follow-up|3|||
145889397|NCT02709486|526101845|FG001|Overall Study|Lost to Follow-up|2|||
145889398|NCT02709486|526101846|FG002|Overall Study|Lost to Follow-up|2|||
145889399|NCT02709486|526101844|FG000|Overall Study|Other|0|||
145889400|NCT02709486|526101845|FG001|Overall Study|Other|2|||
145889401|NCT02709486|526101846|FG002|Overall Study|Other|3|||
145889402|NCT02709486|526101844|FG000|Overall Study|Withdrawal by Subject|32|||
145889403|NCT02709486|526101845|FG001|Overall Study|Withdrawal by Subject|22|||
145889404|NCT02709486|526101846|FG002|Overall Study|Withdrawal by Subject|32|||
145969304|NCT02592824|526402999|FG001|Overall Study|Protocol Violation|3|||
145969305|NCT02592824|526402998|FG000|Overall Study|Lost to Follow-up|2|||
145969306|NCT02592824|526402999|FG001|Overall Study|Lost to Follow-up|1|||
145969307|NCT00465517|526403000|FG000|Overall Study|Adverse Event|7|||
145969308|NCT00465517|526403001|FG001|Overall Study|Adverse Event|3|||
145969309|NCT00465517|526403000|FG000|Overall Study|Lost to Follow-up|1|||
145969310|NCT00465517|526403001|FG001|Overall Study|Lost to Follow-up|0|||
145969311|NCT00465517|526403000|FG000|Overall Study|Withdrawal by Subject|4|||
145969312|NCT00465517|526403001|FG001|Overall Study|Withdrawal by Subject|1|||
145969313|NCT00465179|526403004|FG000|Overall Study|Adverse Event|4|||
145969314|NCT00465179|526403004|FG000|Overall Study|Withdrawal by Subject|2|||
145969315|NCT00465179|526403004|FG000|Overall Study|Progression of Disease|47|||
146087137|NCT02674854|526840313|FG002|Overall Study|Protocol Violation|2|||
146087138|NCT02674854|526840311|FG000|Overall Study|Death|0|||
146087139|NCT02674854|526840312|FG001|Overall Study|Death|1|||
145969316|NCT00833755|526403008|FG000|Overall Study|Physician Decision|4|||
145969317|NCT00833755|526403009|FG001|Overall Study|Physician Decision|4|||
145969318|NCT00833755|526403010|FG002|Overall Study|Physician Decision|2|||
145969319|NCT00833755|526403011|FG003|Overall Study|Physician Decision|6|||
145969320|NCT00833755|526403008|FG000|Overall Study|Subject had scheduling issues|0|||
145969321|NCT00833755|526403009|FG001|Overall Study|Subject had scheduling issues|1|||
145969322|NCT00833755|526403010|FG002|Overall Study|Subject had scheduling issues|0|||
145969323|NCT00833755|526403011|FG003|Overall Study|Subject had scheduling issues|0|||
145969324|NCT00262925|526403012|FG000|Overall Study|Lack of Efficacy|3|||
145969325|NCT00262925|526403012|FG000|Overall Study|Adverse Event|4|||
145969326|NCT00262925|526403012|FG000|Overall Study|Death|2|||
145969327|NCT00262925|526403012|FG000|Overall Study|alternative therapy|1|||
145969328|NCT00262925|526403012|FG000|Overall Study|Other|1|||
145889405|NCT00606502|526101847|FG000|Randomization|Randomized but not treated|3|||
145889406|NCT00606502|526101848|FG001|Randomization|Randomized but not treated|0|||
145889407|NCT00606502|526101847|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
146087140|NCT02674854|526840313|FG002|Overall Study|Death|0|||
146087141|NCT02674854|526840311|FG000|Overall Study|Subject missed V6.2|1|||
146087142|NCT02674854|526840312|FG001|Overall Study|Subject missed V6.2|0|||
145889408|NCT00606502|526101848|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
145889409|NCT02443545|526101851|FG000|Overall Study|Adverse Event|1|||
145889410|NCT02443545|526101852|FG001|Overall Study|Adverse Event|1|||
145889411|NCT02443545|526101851|FG000|Overall Study|Lost to Follow-up|0|||
145889412|NCT02443545|526101852|FG001|Overall Study|Lost to Follow-up|2|||
145889413|NCT02443545|526101851|FG000|Overall Study|Physician Decision|3|||
145889414|NCT02443545|526101852|FG001|Overall Study|Physician Decision|0|||
145889415|NCT02443545|526101851|FG000|Overall Study|Protocol Violation|8|||
145889416|NCT02443545|526101852|FG001|Overall Study|Protocol Violation|1|||
145889417|NCT02443545|526101851|FG000|Overall Study|Pregnancy|1|||
145889418|NCT02443545|526101852|FG001|Overall Study|Pregnancy|1|||
145889419|NCT02443545|526101851|FG000|Overall Study|Withdrawal by Subject|6|||
145889420|NCT02443545|526101852|FG001|Overall Study|Withdrawal by Subject|3|||
145889421|NCT02443545|526101851|FG000|Overall Study|Termination of study|20|||
145889422|NCT02443545|526101852|FG001|Overall Study|Termination of study|11|||
145889423|NCT02549573|526101856|FG000|Overall Study|Withdrawal by Subject|0|||
145889424|NCT02549573|526101857|FG001|Overall Study|Withdrawal by Subject|2|||
145889425|NCT02549573|526101856|FG000|Overall Study|Protocol Violation|0|||
145889426|NCT02549573|526101857|FG001|Overall Study|Protocol Violation|1|||
145889427|NCT02083926|526101860|FG000|Overall Study|Withdrawal by Subject|1|||
145889428|NCT02083926|526101861|FG001|Overall Study|Withdrawal by Subject|0|||
145889429|NCT02610816|526101862|FG000|Phase 1|Withdrawal by Subject|2|||
145889430|NCT02610816|526101863|FG001|Phase 1|Withdrawal by Subject|6|||
145889431|NCT02610816|526101864|FG002|Phase 1|Withdrawal by Subject|0|||
145889432|NCT02610816|526101865|FG003|Phase 1|Withdrawal by Subject|0|||
145889433|NCT02610816|526101862|FG000|Phase 1|Lost to Follow-up|2|||
145889434|NCT02610816|526101863|FG001|Phase 1|Lost to Follow-up|1|||
145889435|NCT02610816|526101864|FG002|Phase 1|Lost to Follow-up|0|||
145889436|NCT02610816|526101865|FG003|Phase 1|Lost to Follow-up|0|||
145889437|NCT02610816|526101862|FG000|Phase 1|Physician Decision|0|||
145889438|NCT02610816|526101863|FG001|Phase 1|Physician Decision|1|||
145889439|NCT02610816|526101864|FG002|Phase 1|Physician Decision|0|||
145889440|NCT02610816|526101865|FG003|Phase 1|Physician Decision|0|||
145889441|NCT02610816|526101862|FG000|Phase 2|Withdrawal by Subject|0|||
145889442|NCT02610816|526101863|FG001|Phase 2|Withdrawal by Subject|0|||
145889443|NCT02610816|526101864|FG002|Phase 2|Withdrawal by Subject|9|||
145889444|NCT02610816|526101865|FG003|Phase 2|Withdrawal by Subject|3|||
145889445|NCT02610816|526101862|FG000|Phase 2|Lost to Follow-up|0|||
145889446|NCT02610816|526101863|FG001|Phase 2|Lost to Follow-up|0|||
145889447|NCT02610816|526101864|FG002|Phase 2|Lost to Follow-up|2|||
145889448|NCT02610816|526101865|FG003|Phase 2|Lost to Follow-up|0|||
145889449|NCT02610816|526101862|FG000|Phase 2|Physician Decision|0|||
145889450|NCT02610816|526101863|FG001|Phase 2|Physician Decision|0|||
145889451|NCT02610816|526101864|FG002|Phase 2|Physician Decision|0|||
145889452|NCT02610816|526101865|FG003|Phase 2|Physician Decision|2|||
145889453|NCT02610816|526101862|FG000|Phase 2|Pregnancy|0|||
145889454|NCT02610816|526101863|FG001|Phase 2|Pregnancy|0|||
145889455|NCT02610816|526101864|FG002|Phase 2|Pregnancy|0|||
145889456|NCT02610816|526101865|FG003|Phase 2|Pregnancy|1|||
145889457|NCT01855048|526101868|FG000|Overall Study|Withdrawal by Subject|0|||
145889458|NCT01855048|526101869|FG001|Overall Study|Withdrawal by Subject|1|||
145889459|NCT01855048|526101870|FG002|Overall Study|Withdrawal by Subject|0|||
145889460|NCT01855048|526101871|FG003|Overall Study|Withdrawal by Subject|0|||
145889461|NCT01855048|526101872|FG004|Overall Study|Withdrawal by Subject|1|||
145889462|NCT01855048|526101873|FG005|Overall Study|Withdrawal by Subject|0|||
145889463|NCT03465436|526101874|FG000|Period 1|Protocol Violation|0|||
145889464|NCT03465436|526101875|FG001|Period 1|Protocol Violation|0|||
145889465|NCT03465436|526101876|FG002|Period 1|Protocol Violation|1|||
145889466|NCT03465436|526101877|FG003|Period 1|Protocol Violation|0|||
145889467|NCT03465436|526101874|FG000|Period 2|Protocol Violation|0|||
146087143|NCT02674854|526840313|FG002|Overall Study|Subject missed V6.2|0|||
146087144|NCT02635646|526840315|FG000|Overall Study|Lost to Follow-up|24|||
146087145|NCT02635646|526840316|FG001|Overall Study|Lost to Follow-up|25|||
146087146|NCT02635646|526840315|FG000|Overall Study|Pregnancy|1|||
146087147|NCT02635646|526840316|FG001|Overall Study|Pregnancy|1|||
146087148|NCT00913692|526840317|FG000|Screening (4 Months)|Physician Decision|3|||
146087149|NCT00913692|526840317|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
146087150|NCT00913692|526840317|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
146087151|NCT03761797|526840318|FG000|Overall Study|Changing hospital|11|||
146087152|NCT03761797|526840318|FG000|Overall Study|Improvement/remission|6|||
146087153|NCT03761797|526840318|FG000|Overall Study|Withdrawal by Subject|19|||
146087154|NCT03761797|526840318|FG000|Overall Study|Lost to Follow-up|33|||
146087155|NCT03761797|526840318|FG000|Overall Study|Adverse Event|37|||
146087156|NCT03761797|526840318|FG000|Overall Study|Case report form (CRF) not collected|5|||
146087157|NCT03761797|526840318|FG000|Overall Study|No patient visit after entry|13|||
146087158|NCT03761797|526840318|FG000|Overall Study|Switch to other diabetes medication|10|||
146087159|NCT03761797|526840318|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
146087160|NCT03761797|526840318|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
146087161|NCT03761797|526840318|FG000|Overall Study|Insufficient effectives|2|||
146087162|NCT03761797|526840318|FG000|Overall Study|Excessive alcohol intake|1|||
146087163|NCT00879879|526840325|FG000|Overall Study|Death|1|||
146087164|NCT00879879|526840325|FG000|Overall Study|Withdrawal by Subject|1|||
146087165|NCT00879879|526840325|FG000|Overall Study|Physician Decision|1|||
146087166|NCT00645788|526840328|FG000|Overall Study|Did not receive study drug|1|||
146087167|NCT00645788|526840329|FG001|Overall Study|Did not receive study drug|1|||
146087168|NCT00645788|526840330|FG002|Overall Study|Did not receive study drug|0|||
146087169|NCT00645788|526840331|FG003|Overall Study|Did not receive study drug|0|||
146087170|NCT00645788|526840328|FG000|Overall Study|Adverse Event|4|||
146087171|NCT00645788|526840329|FG001|Overall Study|Adverse Event|9|||
146087172|NCT00645788|526840330|FG002|Overall Study|Adverse Event|5|||
146087173|NCT00645788|526840331|FG003|Overall Study|Adverse Event|3|||
146087174|NCT00645788|526840328|FG000|Overall Study|Lost to Follow-up|1|||
146087175|NCT00645788|526840329|FG001|Overall Study|Lost to Follow-up|0|||
146087176|NCT00645788|526840330|FG002|Overall Study|Lost to Follow-up|0|||
146087177|NCT00645788|526840331|FG003|Overall Study|Lost to Follow-up|0|||
146087178|NCT00645788|526840328|FG000|Overall Study|Protocol Violation|1|||
146087179|NCT00645788|526840329|FG001|Overall Study|Protocol Violation|0|||
146087180|NCT00645788|526840330|FG002|Overall Study|Protocol Violation|2|||
146087181|NCT00645788|526840331|FG003|Overall Study|Protocol Violation|0|||
146087182|NCT00645788|526840328|FG000|Overall Study|Withdrawal by Subject|0|||
146087183|NCT00645788|526840329|FG001|Overall Study|Withdrawal by Subject|1|||
146087184|NCT00645788|526840330|FG002|Overall Study|Withdrawal by Subject|0|||
146087185|NCT00645788|526840331|FG003|Overall Study|Withdrawal by Subject|2|||
146087186|NCT00645788|526840328|FG000|Overall Study|Pulmonary exacerbation|13|||
146087187|NCT00645788|526840329|FG001|Overall Study|Pulmonary exacerbation|16|||
146087188|NCT00645788|526840330|FG002|Overall Study|Pulmonary exacerbation|11|||
146087189|NCT00645788|526840331|FG003|Overall Study|Pulmonary exacerbation|9|||
146087190|NCT03149848|526840333|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
146087191|NCT03149848|526840333|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
146087192|NCT00400153|526840334|FG000|Overall Study|AE due to study disease worsening|14|||
146087193|NCT00400153|526840335|FG001|Overall Study|AE due to study disease worsening|19|||
145889468|NCT03465436|526101875|FG001|Period 2|Protocol Violation|1|||
145889469|NCT03465436|526101876|FG002|Period 2|Protocol Violation|0|||
145889470|NCT03465436|526101877|FG003|Period 2|Protocol Violation|0|||
145889471|NCT03465436|526101874|FG000|Period 3|Protocol Violation|1|||
145889472|NCT03465436|526101875|FG001|Period 3|Protocol Violation|1|||
145889473|NCT03465436|526101876|FG002|Period 3|Protocol Violation|0|||
145889474|NCT03465436|526101877|FG003|Period 3|Protocol Violation|0|||
146087194|NCT00400153|526840336|FG002|Overall Study|AE due to study disease worsening|20|||
146087195|NCT00400153|526840334|FG000|Overall Study|AE due to other disease worsening|2|||
146087196|NCT00400153|526840335|FG001|Overall Study|AE due to other disease worsening|1|||
146087197|NCT00400153|526840336|FG002|Overall Study|AE due to other disease worsening|0|||
146087198|NCT00400153|526840334|FG000|Overall Study|AE due to other condition|3|||
146087199|NCT00400153|526840335|FG001|Overall Study|AE due to other condition|14|||
145889475|NCT03465436|526101874|FG000|Period 4|Protocol Violation|0|||
145889476|NCT03465436|526101875|FG001|Period 4|Protocol Violation|0|||
146087200|NCT00400153|526840336|FG002|Overall Study|AE due to other condition|15|||
146087201|NCT00400153|526840334|FG000|Overall Study|Protocol Violation|7|||
146087202|NCT00400153|526840335|FG001|Overall Study|Protocol Violation|4|||
146087203|NCT00400153|526840336|FG002|Overall Study|Protocol Violation|9|||
146087204|NCT00400153|526840334|FG000|Overall Study|Lost to Follow-up|2|||
146087205|NCT00400153|526840335|FG001|Overall Study|Lost to Follow-up|1|||
145889477|NCT03465436|526101876|FG002|Period 4|Protocol Violation|1|||
146087206|NCT00400153|526840336|FG002|Overall Study|Lost to Follow-up|4|||
145889478|NCT03465436|526101877|FG003|Period 4|Protocol Violation|0|||
145889479|NCT01813071|526101878|FG000|Overall Study|Protocol Violation|0|||
145889480|NCT01813071|526101879|FG001|Overall Study|Protocol Violation|0|||
145889481|NCT01813071|526101880|FG002|Overall Study|Protocol Violation|0|||
145889482|NCT01813071|526101881|FG003|Overall Study|Protocol Violation|0|||
145889483|NCT01813071|526101882|FG004|Overall Study|Protocol Violation|1|||
145889484|NCT01813071|526101883|FG005|Overall Study|Protocol Violation|4|||
145889485|NCT01813071|526101884|FG006|Overall Study|Protocol Violation|2|||
145889486|NCT01813071|526101885|FG007|Overall Study|Protocol Violation|4|||
145889487|NCT01813071|526101886|FG008|Overall Study|Protocol Violation|2|||
145969329|NCT04682301|526403014|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
145889488|NCT01813071|526101878|FG000|Overall Study|Withdrawal by Subject|0|||
145969330|NCT04682301|526403014|FG000|Overall Study|Death|2|||
145969331|NCT00560404|526403015|FG000|Overall Study|Adverse Event|2|||
145969332|NCT00560404|526403016|FG001|Overall Study|Adverse Event|3|||
145969333|NCT00560404|526403015|FG000|Overall Study|Death|3|||
145969334|NCT00560404|526403016|FG001|Overall Study|Death|3|||
145969335|NCT00560404|526403015|FG000|Overall Study|Protocol Violation|12|||
145969336|NCT00560404|526403016|FG001|Overall Study|Protocol Violation|7|||
145969337|NCT00560404|526403015|FG000|Overall Study|Administrative Reasons|1|||
145969338|NCT00560404|526403016|FG001|Overall Study|Administrative Reasons|1|||
145969339|NCT00560404|526403015|FG000|Overall Study|Withdrew Consent|4|||
145969340|NCT00560404|526403016|FG001|Overall Study|Withdrew Consent|0|||
145969341|NCT00560404|526403015|FG000|Overall Study|Failure to return|1|||
145969342|NCT00560404|526403016|FG001|Overall Study|Failure to return|2|||
145969343|NCT00560404|526403015|FG000|Overall Study|Other withdrawal reason|13|||
145969344|NCT00560404|526403016|FG001|Overall Study|Other withdrawal reason|5|||
145969345|NCT05219162|526403017|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
145969346|NCT05219162|526403017|FG000|Overall Study|Withdrawal by Subject|23|||
145969347|NCT02187783|526403026|FG000|Overall Study|Adverse Event|8|||
145969348|NCT02187783|526403026|FG000|Overall Study|Death|3|||
145969349|NCT02187783|526403026|FG000|Overall Study|Progressive disease|80|||
145969350|NCT02187783|526403026|FG000|Overall Study|Protocol Violation|3|||
145969351|NCT02187783|526403026|FG000|Overall Study|Physician Decision|2|||
145969352|NCT02187783|526403026|FG000|Overall Study|Withdrawal by Subject|9|||
145969353|NCT02187783|526403026|FG000|Overall Study|Study terminated by sponsor|1|||
145969354|NCT00171249|526403027|FG000|Overall Study|Withdrawal by Subject|2|||
145969355|NCT00171249|526403028|FG001|Overall Study|Withdrawal by Subject|0|||
145969356|NCT00171249|526403029|FG002|Overall Study|Withdrawal by Subject|0|||
145969357|NCT00171249|526403030|FG003|Overall Study|Withdrawal by Subject|6|||
145969358|NCT00171249|526403031|FG004|Overall Study|Withdrawal by Subject|0|||
145969359|NCT00171249|526403032|FG005|Overall Study|Withdrawal by Subject|0|||
145969360|NCT00171249|526403033|FG006|Overall Study|Withdrawal by Subject|0|||
145969361|NCT00171249|526403027|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
145969362|NCT00171249|526403028|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145969363|NCT00171249|526403029|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
145969364|NCT00171249|526403030|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
145969365|NCT00171249|526403031|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145969366|NCT00171249|526403032|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
145969367|NCT00171249|526403033|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145969368|NCT00171249|526403027|FG000|Overall Study|Death|7|||
146233122|NCT03213457|527370744|FG000|Follow-Up Period|Pregnancy|7|||
146233123|NCT03213457|527370745|FG001|Follow-Up Period|Pregnancy|0|||
146233124|NCT03213457|527370746|FG002|Follow-Up Period|Pregnancy|18|||
145969369|NCT00171249|526403028|FG001|Overall Study|Death|1|||
146233125|NCT03213457|527370744|FG000|Follow-Up Period|Exclusionary medications|1|||
145969370|NCT00171249|526403029|FG002|Overall Study|Death|0|||
145969371|NCT00171249|526403030|FG003|Overall Study|Death|4|||
145969372|NCT00171249|526403031|FG004|Overall Study|Death|0|||
145969373|NCT00171249|526403032|FG005|Overall Study|Death|3|||
145969374|NCT00171249|526403033|FG006|Overall Study|Death|1|||
145969375|NCT00171249|526403027|FG000|Overall Study|Other|10|||
146293562|NCT00986440|527590068|FG001|Overall Study|Screen failure (not dosed)|2|||
146293563|NCT00421707|527590069|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
146293564|NCT00421707|527590070|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
146293565|NCT00421707|527590069|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
146293566|NCT00421707|527590070|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
146293567|NCT00421707|527590069|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
146293568|NCT00421707|527590070|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
146293569|NCT00421707|527590069|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
145889489|NCT01813071|526101879|FG001|Overall Study|Withdrawal by Subject|0|||
145889490|NCT01813071|526101880|FG002|Overall Study|Withdrawal by Subject|0|||
145889491|NCT01813071|526101881|FG003|Overall Study|Withdrawal by Subject|0|||
145889492|NCT01813071|526101882|FG004|Overall Study|Withdrawal by Subject|0|||
145889493|NCT01813071|526101883|FG005|Overall Study|Withdrawal by Subject|1|||
145889494|NCT01813071|526101884|FG006|Overall Study|Withdrawal by Subject|0|||
145889495|NCT01813071|526101885|FG007|Overall Study|Withdrawal by Subject|0|||
145889496|NCT01813071|526101886|FG008|Overall Study|Withdrawal by Subject|0|||
145889497|NCT01813071|526101878|FG000|Overall Study|Adverse Event|0|||
145889498|NCT01813071|526101879|FG001|Overall Study|Adverse Event|0|||
145889499|NCT01813071|526101880|FG002|Overall Study|Adverse Event|0|||
145889500|NCT01813071|526101881|FG003|Overall Study|Adverse Event|0|||
145889501|NCT01813071|526101882|FG004|Overall Study|Adverse Event|0|||
145889502|NCT01813071|526101883|FG005|Overall Study|Adverse Event|1|||
145889503|NCT01813071|526101884|FG006|Overall Study|Adverse Event|0|||
145889504|NCT01813071|526101885|FG007|Overall Study|Adverse Event|0|||
145889505|NCT01813071|526101886|FG008|Overall Study|Adverse Event|0|||
145889506|NCT01813071|526101878|FG000|Overall Study|Physician Decision|0|||
145889507|NCT01813071|526101879|FG001|Overall Study|Physician Decision|0|||
145889508|NCT01813071|526101880|FG002|Overall Study|Physician Decision|0|||
145969376|NCT00171249|526403028|FG001|Overall Study|Other|0|||
145969377|NCT00171249|526403029|FG002|Overall Study|Other|0|||
145969378|NCT00171249|526403030|FG003|Overall Study|Other|43|||
145969379|NCT00171249|526403031|FG004|Overall Study|Other|0|||
145969380|NCT00171249|526403032|FG005|Overall Study|Other|2|||
145969381|NCT00171249|526403033|FG006|Overall Study|Other|0|||
145969382|NCT00171249|526403027|FG000|Overall Study|No Longer Requires Study Drug|4|||
145969383|NCT00171249|526403028|FG001|Overall Study|No Longer Requires Study Drug|0|||
145969384|NCT00171249|526403029|FG002|Overall Study|No Longer Requires Study Drug|0|||
145969385|NCT00171249|526403030|FG003|Overall Study|No Longer Requires Study Drug|3|||
145969386|NCT00171249|526403031|FG004|Overall Study|No Longer Requires Study Drug|0|||
145969387|NCT00171249|526403032|FG005|Overall Study|No Longer Requires Study Drug|5|||
145969388|NCT00171249|526403033|FG006|Overall Study|No Longer Requires Study Drug|0|||
145969389|NCT00171249|526403027|FG000|Overall Study|Administrative Problems|1|||
145969390|NCT00171249|526403028|FG001|Overall Study|Administrative Problems|0|||
145969391|NCT00171249|526403029|FG002|Overall Study|Administrative Problems|0|||
145969392|NCT00171249|526403030|FG003|Overall Study|Administrative Problems|2|||
145969393|NCT00171249|526403031|FG004|Overall Study|Administrative Problems|0|||
145969394|NCT00171249|526403032|FG005|Overall Study|Administrative Problems|0|||
145969395|NCT00171249|526403033|FG006|Overall Study|Administrative Problems|0|||
145969396|NCT00171249|526403027|FG000|Overall Study|Adverse Event|3|||
145969397|NCT00171249|526403028|FG001|Overall Study|Adverse Event|1|||
145969398|NCT00171249|526403029|FG002|Overall Study|Adverse Event|0|||
145969399|NCT00171249|526403030|FG003|Overall Study|Adverse Event|15|||
145969400|NCT00171249|526403031|FG004|Overall Study|Adverse Event|0|||
145969401|NCT00171249|526403032|FG005|Overall Study|Adverse Event|2|||
145969402|NCT00171249|526403033|FG006|Overall Study|Adverse Event|0|||
145969403|NCT00171249|526403027|FG000|Overall Study|Lost to Follow-up|5|||
145969404|NCT00171249|526403028|FG001|Overall Study|Lost to Follow-up|0|||
145969405|NCT00171249|526403029|FG002|Overall Study|Lost to Follow-up|0|||
145969406|NCT00171249|526403030|FG003|Overall Study|Lost to Follow-up|9|||
145969407|NCT00171249|526403031|FG004|Overall Study|Lost to Follow-up|0|||
145969408|NCT00171249|526403032|FG005|Overall Study|Lost to Follow-up|0|||
145969409|NCT00171249|526403033|FG006|Overall Study|Lost to Follow-up|0|||
145969410|NCT00471497|526403034|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
145969411|NCT00471497|526403035|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
145969412|NCT00471497|526403036|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
146293570|NCT00421707|527590070|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
145889509|NCT01813071|526101881|FG003|Overall Study|Physician Decision|0|||
145889510|NCT01813071|526101882|FG004|Overall Study|Physician Decision|0|||
145969413|NCT00471497|526403034|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
145969414|NCT00471497|526403035|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
145889511|NCT01813071|526101883|FG005|Overall Study|Physician Decision|0|||
145889512|NCT01813071|526101884|FG006|Overall Study|Physician Decision|1|||
145889513|NCT01813071|526101885|FG007|Overall Study|Physician Decision|0|||
145969415|NCT00471497|526403036|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
145969416|NCT00471497|526403034|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
145969417|NCT00471497|526403035|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
146087207|NCT00400153|526840334|FG000|Overall Study|Withdrawal by Subject|12|||
146087208|NCT00400153|526840335|FG001|Overall Study|Withdrawal by Subject|11|||
146087209|NCT00400153|526840336|FG002|Overall Study|Withdrawal by Subject|10|||
146087210|NCT00400153|526840334|FG000|Overall Study|Other reasons - not mentioned above|8|||
146087211|NCT00400153|526840335|FG001|Overall Study|Other reasons - not mentioned above|5|||
146087212|NCT00400153|526840336|FG002|Overall Study|Other reasons - not mentioned above|3|||
146087213|NCT00327470|526840341|FG000|Overall Study|Randomized, but not treated|0|||
146087214|NCT00327470|526840342|FG001|Overall Study|Randomized, but not treated|2|||
146087215|NCT00327470|526840341|FG000|Overall Study|Adverse Event|9|||
146087216|NCT00327470|526840342|FG001|Overall Study|Adverse Event|14|||
146087217|NCT00327470|526840341|FG000|Overall Study|Lack of Efficacy|7|||
146087218|NCT00327470|526840342|FG001|Overall Study|Lack of Efficacy|19|||
146087219|NCT00327470|526840341|FG000|Overall Study|Other|5|||
146087220|NCT00327470|526840342|FG001|Overall Study|Other|9|||
146087221|NCT00327470|526840341|FG000|Overall Study|Lost to Follow-up|1|||
146087222|NCT00327470|526840342|FG001|Overall Study|Lost to Follow-up|3|||
146087223|NCT00327470|526840341|FG000|Overall Study|Withdrawal by Subject|6|||
146087224|NCT00327470|526840342|FG001|Overall Study|Withdrawal by Subject|12|||
146087225|NCT00327470|526840341|FG000|Overall Study|Death|1|||
146087226|NCT00327470|526840342|FG001|Overall Study|Death|4|||
146087227|NCT04738318|526840343|FG000|Overall Study|Protocol Violation|1|||
146087228|NCT04738318|526840344|FG001|Overall Study|Protocol Violation|0|||
146087229|NCT01226121|526840345|FG000|Overall Study|Lost to Follow-up|2|||
146087230|NCT01226121|526840346|FG001|Overall Study|Lost to Follow-up|0|||
146087231|NCT01226121|526840347|FG002|Overall Study|Lost to Follow-up|1|||
146087232|NCT04231981|526840348|FG000|Overall Study|Adverse Event|1|||
146087233|NCT04231981|526840348|FG000|Overall Study|Death|16|||
145969418|NCT00471497|526403036|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
145969419|NCT00471497|526403034|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
145969420|NCT00471497|526403035|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
145969421|NCT00471497|526403036|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
145969422|NCT00471497|526403034|FG000|Core Treatment Phase|Lost to Follow-up|6|||
145969423|NCT00471497|526403035|FG001|Core Treatment Phase|Lost to Follow-up|6|||
145969424|NCT00471497|526403036|FG002|Core Treatment Phase|Lost to Follow-up|3|||
145969425|NCT00471497|526403034|FG000|Core Treatment Phase|Death|3|||
145969426|NCT00471497|526403035|FG001|Core Treatment Phase|Death|9|||
145969427|NCT00471497|526403036|FG002|Core Treatment Phase|Death|3|||
145969428|NCT00471497|526403034|FG000|Core Treatment Phase|Disease Progression|10|||
145969429|NCT00471497|526403035|FG001|Core Treatment Phase|Disease Progression|2|||
145969430|NCT00471497|526403036|FG002|Core Treatment Phase|Disease Progression|4|||
145969431|NCT00471497|526403034|FG000|Core Treatment Phase|Protocol Violation|6|||
145969432|NCT00471497|526403035|FG001|Core Treatment Phase|Protocol Violation|15|||
145969433|NCT00471497|526403036|FG002|Core Treatment Phase|Protocol Violation|11|||
145969434|NCT00471497|526403034|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
145969435|NCT00471497|526403035|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
145969436|NCT00471497|526403036|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
145969437|NCT00471497|526403034|FG000|Core Treatment Phase|Administrative problems|14|||
145969438|NCT00471497|526403035|FG001|Core Treatment Phase|Administrative problems|14|||
145969439|NCT00471497|526403036|FG002|Core Treatment Phase|Administrative problems|12|||
145969440|NCT00471497|526403034|FG000|Core Treatment Phase|Adverse Event|43|||
145969441|NCT00471497|526403035|FG001|Core Treatment Phase|Adverse Event|53|||
145969442|NCT00471497|526403036|FG002|Core Treatment Phase|Adverse Event|89|||
145969443|NCT00471497|526403034|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
145969444|NCT00471497|526403035|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
145969445|NCT00471497|526403036|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
145969446|NCT00471497|526403034|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
145969447|NCT00471497|526403035|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
145969448|NCT00471497|526403036|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
145969449|NCT00471497|526403034|FG000|Extension Phase|Adverse Event|9|||
145969450|NCT00471497|526403035|FG001|Extension Phase|Adverse Event|5|||
145969451|NCT00471497|526403036|FG002|Extension Phase|Adverse Event|1|||
145969452|NCT00471497|526403034|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
146087234|NCT04231981|526840348|FG000|Overall Study|Lost to Follow-up|1|||
146087235|NCT02197234|526840349|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
146087236|NCT02197234|526840349|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
146087237|NCT02197234|526840349|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
146293571|NCT00421707|527590069|FG000|Period 2: Washout|Adverse Event|1|||
145969453|NCT00471497|526403035|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
145969454|NCT00471497|526403036|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
145969455|NCT00471497|526403034|FG000|Extension Phase|Withdrawal by Subject|3|||
145969456|NCT00471497|526403035|FG001|Extension Phase|Withdrawal by Subject|1|||
145969457|NCT00471497|526403036|FG002|Extension Phase|Withdrawal by Subject|0|||
145969458|NCT00471497|526403034|FG000|Extension Phase|Lost to Follow-up|2|||
145969459|NCT00471497|526403035|FG001|Extension Phase|Lost to Follow-up|0|||
145969460|NCT00471497|526403036|FG002|Extension Phase|Lost to Follow-up|0|||
145969461|NCT00471497|526403034|FG000|Extension Phase|Death|1|||
145969462|NCT00471497|526403035|FG001|Extension Phase|Death|0|||
145969463|NCT00471497|526403036|FG002|Extension Phase|Death|0|||
145969464|NCT00471497|526403034|FG000|Extension Phase|Disease progression|2|||
145969465|NCT00471497|526403035|FG001|Extension Phase|Disease progression|0|||
145969466|NCT00471497|526403036|FG002|Extension Phase|Disease progression|0|||
145969467|NCT00471497|526403034|FG000|Extension Phase|Protocol Violation|2|||
145969468|NCT00471497|526403035|FG001|Extension Phase|Protocol Violation|2|||
145969469|NCT00471497|526403036|FG002|Extension Phase|Protocol Violation|0|||
145969470|NCT00392223|526403037|FG000|Overall Study|Adverse Event|5|||
145969471|NCT00392223|526403038|FG001|Overall Study|Adverse Event|4|||
145969472|NCT00392223|526403037|FG000|Overall Study|Lost to Follow-up|1|||
145969473|NCT00392223|526403038|FG001|Overall Study|Lost to Follow-up|4|||
145969474|NCT00392223|526403037|FG000|Overall Study|Protocol Violation|0|||
145969475|NCT00392223|526403038|FG001|Overall Study|Protocol Violation|3|||
145969476|NCT00392223|526403037|FG000|Overall Study|Withdrawal by Subject|3|||
145969477|NCT00392223|526403038|FG001|Overall Study|Withdrawal by Subject|2|||
145969478|NCT03344757|526403040|FG000|Overall Study|Withdrawal by Subject|18|||
145969479|NCT03344757|526403041|FG001|Overall Study|Withdrawal by Subject|16|||
145969480|NCT03344757|526403040|FG000|Overall Study|Lost to Follow-up|0|||
145969481|NCT03344757|526403041|FG001|Overall Study|Lost to Follow-up|2|||
145969482|NCT00269152|526403044|FG000|Overall Study|Adverse Event|9|||
145969483|NCT00269152|526403045|FG001|Overall Study|Adverse Event|3|||
145969484|NCT00269152|526403044|FG000|Overall Study|Withdrawal by Subject|7|||
145969485|NCT00269152|526403045|FG001|Overall Study|Withdrawal by Subject|3|||
145969486|NCT00269152|526403044|FG000|Overall Study|Physician Decision|2|||
145969487|NCT00269152|526403045|FG001|Overall Study|Physician Decision|3|||
145969488|NCT00269152|526403044|FG000|Overall Study|Protocol Violation|0|||
145969489|NCT00269152|526403045|FG001|Overall Study|Protocol Violation|1|||
145969490|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
145969491|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
145969492|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969493|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969494|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969495|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969496|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969497|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969498|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969499|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145969500|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
146293572|NCT00421707|527590070|FG001|Period 2: Washout|Adverse Event|1|||
145969501|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
145969502|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969503|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145889514|NCT01813071|526101886|FG008|Overall Study|Physician Decision|0|||
145889515|NCT01813071|526101878|FG000|Overall Study|Met inc/exc criteria|0|||
145889516|NCT01813071|526101879|FG001|Overall Study|Met inc/exc criteria|0|||
145889517|NCT01813071|526101880|FG002|Overall Study|Met inc/exc criteria|0|||
145889518|NCT01813071|526101881|FG003|Overall Study|Met inc/exc criteria|0|||
145889519|NCT01813071|526101882|FG004|Overall Study|Met inc/exc criteria|0|||
145889520|NCT01813071|526101883|FG005|Overall Study|Met inc/exc criteria|1|||
145889521|NCT01813071|526101884|FG006|Overall Study|Met inc/exc criteria|0|||
145889522|NCT01813071|526101885|FG007|Overall Study|Met inc/exc criteria|1|||
145889523|NCT01813071|526101886|FG008|Overall Study|Met inc/exc criteria|1|||
145889524|NCT02697773|526101887|FG000|Overall Study|Adverse Event|2|||
145889525|NCT02697773|526101888|FG001|Overall Study|Adverse Event|1|||
145889526|NCT02697773|526101889|FG002|Overall Study|Adverse Event|2|||
145889527|NCT02697773|526101887|FG000|Overall Study|Death|0|||
145889528|NCT02697773|526101888|FG001|Overall Study|Death|0|||
145889529|NCT02697773|526101889|FG002|Overall Study|Death|2|||
145889530|NCT02697773|526101887|FG000|Overall Study|Lack of Efficacy|4|||
145889531|NCT02697773|526101888|FG001|Overall Study|Lack of Efficacy|6|||
145889532|NCT02697773|526101889|FG002|Overall Study|Lack of Efficacy|6|||
145889533|NCT02697773|526101887|FG000|Overall Study|Lost to Follow-up|5|||
145889534|NCT02697773|526101888|FG001|Overall Study|Lost to Follow-up|5|||
145889535|NCT02697773|526101889|FG002|Overall Study|Lost to Follow-up|7|||
145889536|NCT02697773|526101887|FG000|Overall Study|Other|15|||
145889537|NCT02697773|526101888|FG001|Overall Study|Other|11|||
145889538|NCT02697773|526101889|FG002|Overall Study|Other|10|||
145889539|NCT02697773|526101887|FG000|Overall Study|Protocol Violation|1|||
145889540|NCT02697773|526101888|FG001|Overall Study|Protocol Violation|1|||
145889541|NCT02697773|526101889|FG002|Overall Study|Protocol Violation|0|||
145889542|NCT02697773|526101887|FG000|Overall Study|Withdrawal by Subject|10|||
145889543|NCT02697773|526101888|FG001|Overall Study|Withdrawal by Subject|13|||
145889544|NCT02697773|526101889|FG002|Overall Study|Withdrawal by Subject|13|||
145889545|NCT02697773|526101887|FG000|Overall Study|Randomized but not treated|1|||
145889546|NCT02697773|526101888|FG001|Overall Study|Randomized but not treated|1|||
145889547|NCT02697773|526101889|FG002|Overall Study|Randomized but not treated|0|||
145889548|NCT00613834|526101890|FG000|Overall Study|Withdrawal by Subject|0|||
145889549|NCT00613834|526101891|FG001|Overall Study|Withdrawal by Subject|3|||
145889550|NCT00842530|526101892|FG000|Overall Study|Serious adverse event|0|||
145889551|NCT00842530|526101893|FG001|Overall Study|Serious adverse event|6|||
145889552|NCT00842530|526101892|FG000|Overall Study|Other adverse event|6|||
145889553|NCT00842530|526101893|FG001|Overall Study|Other adverse event|1|||
145889554|NCT00842530|526101892|FG000|Overall Study|Protocol Violation|32|||
145889555|NCT00842530|526101893|FG001|Overall Study|Protocol Violation|14|||
145889556|NCT00842530|526101892|FG000|Overall Study|Lost to Follow-up|6|||
145889557|NCT00842530|526101893|FG001|Overall Study|Lost to Follow-up|8|||
145889558|NCT00842530|526101892|FG000|Overall Study|Withdrawal by Subject|73|||
145889559|NCT00842530|526101893|FG001|Overall Study|Withdrawal by Subject|28|||
145889560|NCT02939950|526101894|FG000|Overall Study|Lost to Follow-up|13|||
145889561|NCT02939950|526101895|FG001|Overall Study|Lost to Follow-up|16|||
145889562|NCT02939950|526101894|FG000|Overall Study|Positive slit lamp findings|0|||
145889563|NCT02939950|526101895|FG001|Overall Study|Positive slit lamp findings|1|||
145889564|NCT02939950|526101894|FG000|Overall Study|Chalazion upper lid|0|||
145889565|NCT02939950|526101895|FG001|Overall Study|Chalazion upper lid|1|||
145889566|NCT02939950|526101894|FG000|Overall Study|Lack of motivation|0|||
146087238|NCT02197234|526840349|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
146087239|NCT02197234|526840349|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
146087240|NCT02197234|526840349|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
145889567|NCT02939950|526101895|FG001|Overall Study|Lack of motivation|2|||
145889568|NCT02939950|526101894|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
145889569|NCT02939950|526101895|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
145889570|NCT02939950|526101894|FG000|Overall Study|Military orders|1|||
145889571|NCT02939950|526101895|FG001|Overall Study|Military orders|0|||
145889572|NCT02939950|526101894|FG000|Overall Study|Participant Relocated|5|||
145889573|NCT02939950|526101895|FG001|Overall Study|Participant Relocated|3|||
145889574|NCT02939950|526101894|FG000|Overall Study|Study related symptoms|8|||
145889575|NCT02939950|526101895|FG001|Overall Study|Study related symptoms|8|||
145889576|NCT02939950|526101894|FG000|Overall Study|Unacceptable lens movement|2|||
145889577|NCT02939950|526101895|FG001|Overall Study|Unacceptable lens movement|0|||
145889578|NCT02939950|526101894|FG000|Overall Study|Protocol Violation|6|||
145889579|NCT02939950|526101895|FG001|Overall Study|Protocol Violation|3|||
145889580|NCT02939950|526101894|FG000|Overall Study|Physician Decision|2|||
145889581|NCT02939950|526101895|FG001|Overall Study|Physician Decision|0|||
145889582|NCT02939950|526101894|FG000|Overall Study|Pregnancy|6|||
145889583|NCT02939950|526101895|FG001|Overall Study|Pregnancy|7|||
145889584|NCT02939950|526101894|FG000|Overall Study|Withdrawal by Subject|12|||
145889585|NCT02939950|526101895|FG001|Overall Study|Withdrawal by Subject|28|||
145889586|NCT02939950|526101894|FG000|Overall Study|Adverse Event|7|||
145889587|NCT02939950|526101895|FG001|Overall Study|Adverse Event|3|||
145889588|NCT02939950|526101894|FG000|Overall Study|Randomized, not dispensed|1|||
145889589|NCT02939950|526101895|FG001|Overall Study|Randomized, not dispensed|0|||
145889590|NCT02939950|526101894|FG000|Overall Study|Ineligible at Baseline|2|||
145889591|NCT02939950|526101895|FG001|Overall Study|Ineligible at Baseline|8|||
145889592|NCT00440115|526101896|FG000|Overall Study|Death|7|||
146087241|NCT03370276|526840358|FG000|Overall Study|Death|0|||
146087242|NCT03370276|526840359|FG001|Overall Study|Death|2|||
146233126|NCT03213457|527370745|FG001|Follow-Up Period|Exclusionary medications|1|||
145889593|NCT00440115|526101897|FG001|Overall Study|Death|9|||
145889594|NCT00440115|526101898|FG002|Overall Study|Death|5|||
145889595|NCT00440115|526101896|FG000|Overall Study|Incarceration|0|||
145889596|NCT00440115|526101897|FG001|Overall Study|Incarceration|2|||
146233127|NCT03213457|527370746|FG002|Follow-Up Period|Exclusionary medications|5|||
145889597|NCT00440115|526101898|FG002|Overall Study|Incarceration|1|||
145889598|NCT03064438|526104006|FG000|Overall Study|Lost to Follow-up|1|||
145889599|NCT03064438|526104007|FG001|Overall Study|Lost to Follow-up|0|||
145889600|NCT03064438|526104006|FG000|Overall Study|Withdrawal by Subject|0|||
145889601|NCT03064438|526104007|FG001|Overall Study|Withdrawal by Subject|1|||
145889602|NCT02658487|526104012|FG000|Overall Study|Death|2|||
145889603|NCT02658487|526104012|FG000|Overall Study|Disease progression|10|||
145889604|NCT02658487|526104012|FG000|Overall Study|Alternative therapy|1|||
145889605|NCT02658487|526104012|FG000|Overall Study|Adverse Event|1|||
145889606|NCT02658487|526104012|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
145889607|NCT02658487|526104012|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
145889608|NCT01647958|526104013|FG000|Initial Study|Lost to Follow-up|2|||
145889609|NCT01647958|526104014|FG001|Initial Study|Lost to Follow-up|3|||
145889610|NCT01647958|526104013|FG000|Continuation Phase|treatment received during Overall Study|39|||
145889611|NCT01647958|526104014|FG001|Continuation Phase|treatment received during Overall Study|0|||
145889612|NCT01647958|526104013|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
145889613|NCT01647958|526104014|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
145889614|NCT01432574|526104015|FG000|Overall Study|Moved|2|||
145889615|NCT01432574|526104015|FG000|Overall Study|Not interested|1|||
145889616|NCT01475253|526104018|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
145889617|NCT01475253|526104019|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
145889618|NCT01475253|526104020|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
145889619|NCT01475253|526104021|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
145889620|NCT01475253|526104018|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
145889621|NCT01475253|526104019|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
145889622|NCT01475253|526104020|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
145889623|NCT01475253|526104021|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
145889624|NCT03135899|526104022|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889625|NCT03135899|526104023|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889626|NCT03135899|526104024|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889627|NCT03135899|526104025|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889628|NCT03135899|526104026|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889629|NCT03135899|526104027|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889630|NCT03135899|526104028|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
145889631|NCT03135899|526104029|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
145889632|NCT03135899|526104022|FG000|Overall Study|Withdrawal by Subject|0|||
145889633|NCT03135899|526104023|FG001|Overall Study|Withdrawal by Subject|0|||
145889634|NCT03135899|526104024|FG002|Overall Study|Withdrawal by Subject|0|||
145889635|NCT03135899|526104025|FG003|Overall Study|Withdrawal by Subject|0|||
145889636|NCT03135899|526104026|FG004|Overall Study|Withdrawal by Subject|0|||
145889637|NCT03135899|526104027|FG005|Overall Study|Withdrawal by Subject|2|||
145889638|NCT03135899|526104028|FG006|Overall Study|Withdrawal by Subject|0|||
145889639|NCT03135899|526104029|FG007|Overall Study|Withdrawal by Subject|0|||
145889640|NCT04146363|526104030|FG000|Induction Period|Adverse Event|1|||
145889641|NCT04146363|526104031|FG001|Induction Period|Adverse Event|2|||
145889642|NCT04146363|526104032|FG002|Induction Period|Adverse Event|0|||
145889643|NCT04146363|526104033|FG003|Induction Period|Adverse Event|0|||
145889644|NCT04146363|526104034|FG004|Induction Period|Adverse Event|0|||
145889645|NCT04146363|526104035|FG005|Induction Period|Adverse Event|0|||
145969504|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969505|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969506|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969507|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969508|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969509|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145969510|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
145969511|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969512|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969513|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969514|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969515|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969516|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969517|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969518|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969519|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145969520|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
145969521|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
145969522|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969523|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969524|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969525|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969526|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969527|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969528|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969529|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145969530|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
145969531|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
145889646|NCT04146363|526104036|FG006|Induction Period|Adverse Event|0|||
145889647|NCT04146363|526104037|FG007|Induction Period|Adverse Event|0|||
145889648|NCT04146363|526104038|FG008|Induction Period|Adverse Event|0|||
145889649|NCT04146363|526104039|FG009|Induction Period|Adverse Event|0|||
145889650|NCT04146363|526104040|FG010|Induction Period|Adverse Event|0|||
145969532|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969533|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969534|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969535|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969536|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969537|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969538|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969539|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145969540|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
145969541|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
145969542|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969543|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969544|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969545|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969546|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
146087243|NCT03370276|526840360|FG002|Overall Study|Death|5|||
145889651|NCT04146363|526104030|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
145889652|NCT04146363|526104031|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
145889653|NCT04146363|526104032|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
145889654|NCT04146363|526104033|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
145889655|NCT04146363|526104034|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
145969547|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969548|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969549|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145969550|NCT01232283|526403050|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
145969551|NCT01232283|526403051|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
145969552|NCT01232283|526403052|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969553|NCT01232283|526403053|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969554|NCT01232283|526403054|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969555|NCT01232283|526403055|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969556|NCT01232283|526403056|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969557|NCT01232283|526403057|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969558|NCT01232283|526403058|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969559|NCT01232283|526403059|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145969560|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969561|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969562|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
145969563|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
145969564|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969565|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969566|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969567|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969568|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969569|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145969570|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969571|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969572|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
145969573|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
145969574|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969575|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969576|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969577|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969578|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969579|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145969580|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969581|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969582|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
145969583|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969584|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145889656|NCT04146363|526104035|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
145889657|NCT04146363|526104036|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
145889658|NCT04146363|526104037|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
145889659|NCT04146363|526104038|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
145889660|NCT04146363|526104039|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
145889661|NCT04146363|526104040|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
145889662|NCT04146363|526104030|FG000|Induction Period|Lack of Efficacy|7|||
145889663|NCT04146363|526104031|FG001|Induction Period|Lack of Efficacy|2|||
145889664|NCT04146363|526104032|FG002|Induction Period|Lack of Efficacy|0|||
145889665|NCT04146363|526104033|FG003|Induction Period|Lack of Efficacy|0|||
145889666|NCT04146363|526104034|FG004|Induction Period|Lack of Efficacy|0|||
145889667|NCT04146363|526104035|FG005|Induction Period|Lack of Efficacy|0|||
145889668|NCT04146363|526104036|FG006|Induction Period|Lack of Efficacy|0|||
145889669|NCT04146363|526104037|FG007|Induction Period|Lack of Efficacy|0|||
145889670|NCT04146363|526104038|FG008|Induction Period|Lack of Efficacy|0|||
145889671|NCT04146363|526104039|FG009|Induction Period|Lack of Efficacy|0|||
145889672|NCT04146363|526104040|FG010|Induction Period|Lack of Efficacy|0|||
145889673|NCT04146363|526104030|FG000|Induction Period|Lost to Follow-up|1|||
145889674|NCT04146363|526104031|FG001|Induction Period|Lost to Follow-up|4|||
145889675|NCT04146363|526104032|FG002|Induction Period|Lost to Follow-up|0|||
145889676|NCT04146363|526104033|FG003|Induction Period|Lost to Follow-up|0|||
145889677|NCT04146363|526104034|FG004|Induction Period|Lost to Follow-up|0|||
145889678|NCT04146363|526104035|FG005|Induction Period|Lost to Follow-up|0|||
145889679|NCT04146363|526104036|FG006|Induction Period|Lost to Follow-up|0|||
145889680|NCT04146363|526104037|FG007|Induction Period|Lost to Follow-up|0|||
145889681|NCT04146363|526104038|FG008|Induction Period|Lost to Follow-up|0|||
145889682|NCT04146363|526104039|FG009|Induction Period|Lost to Follow-up|0|||
145889683|NCT04146363|526104040|FG010|Induction Period|Lost to Follow-up|0|||
145889684|NCT04146363|526104030|FG000|Induction Period|Positive quantiferon test|0|||
145889685|NCT04146363|526104031|FG001|Induction Period|Positive quantiferon test|1|||
145889686|NCT04146363|526104032|FG002|Induction Period|Positive quantiferon test|0|||
145889687|NCT04146363|526104033|FG003|Induction Period|Positive quantiferon test|0|||
145889688|NCT04146363|526104034|FG004|Induction Period|Positive quantiferon test|0|||
145889689|NCT04146363|526104035|FG005|Induction Period|Positive quantiferon test|0|||
145889690|NCT04146363|526104036|FG006|Induction Period|Positive quantiferon test|0|||
145889691|NCT04146363|526104037|FG007|Induction Period|Positive quantiferon test|0|||
145889692|NCT04146363|526104038|FG008|Induction Period|Positive quantiferon test|0|||
145889693|NCT04146363|526104039|FG009|Induction Period|Positive quantiferon test|0|||
145889694|NCT04146363|526104040|FG010|Induction Period|Positive quantiferon test|0|||
145889695|NCT04146363|526104030|FG000|Induction Period|Protocol Deviation|5|||
145889696|NCT04146363|526104031|FG001|Induction Period|Protocol Deviation|6|||
145889697|NCT04146363|526104032|FG002|Induction Period|Protocol Deviation|0|||
145889698|NCT04146363|526104033|FG003|Induction Period|Protocol Deviation|0|||
145889699|NCT04146363|526104034|FG004|Induction Period|Protocol Deviation|0|||
145889700|NCT04146363|526104035|FG005|Induction Period|Protocol Deviation|0|||
145889701|NCT04146363|526104036|FG006|Induction Period|Protocol Deviation|0|||
145889702|NCT04146363|526104037|FG007|Induction Period|Protocol Deviation|0|||
145889703|NCT04146363|526104038|FG008|Induction Period|Protocol Deviation|0|||
145889704|NCT04146363|526104039|FG009|Induction Period|Protocol Deviation|0|||
145889705|NCT04146363|526104040|FG010|Induction Period|Protocol Deviation|0|||
145889706|NCT04146363|526104030|FG000|Induction Period|Withdrawal by Subject|6|||
145889707|NCT04146363|526104031|FG001|Induction Period|Withdrawal by Subject|3|||
145889708|NCT04146363|526104032|FG002|Induction Period|Withdrawal by Subject|0|||
145889709|NCT04146363|526104033|FG003|Induction Period|Withdrawal by Subject|0|||
145889710|NCT04146363|526104034|FG004|Induction Period|Withdrawal by Subject|0|||
145889711|NCT04146363|526104035|FG005|Induction Period|Withdrawal by Subject|0|||
145889712|NCT04146363|526104036|FG006|Induction Period|Withdrawal by Subject|0|||
145889713|NCT04146363|526104037|FG007|Induction Period|Withdrawal by Subject|0|||
145889714|NCT04146363|526104038|FG008|Induction Period|Withdrawal by Subject|0|||
145889715|NCT04146363|526104039|FG009|Induction Period|Withdrawal by Subject|0|||
145889716|NCT04146363|526104040|FG010|Induction Period|Withdrawal by Subject|0|||
145889717|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889718|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889719|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889720|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889721|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889722|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889723|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
145889724|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
145889725|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889726|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889727|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
145889728|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889729|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889730|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889731|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146293573|NCT00421707|527590069|FG000|Period 2: Washout|Withdrawal by Subject|0|||
146293574|NCT00421707|527590070|FG001|Period 2: Washout|Withdrawal by Subject|1|||
145969585|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969586|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969587|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145889732|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889733|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889734|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889735|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
146087244|NCT04030026|526840361|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
146087245|NCT04030026|526840362|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
146087246|NCT04030026|526840361|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
146087247|NCT04030026|526840362|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
146087248|NCT04030026|526840361|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
146087249|NCT04030026|526840362|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
146087250|NCT04030026|526840361|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
146087251|NCT04030026|526840362|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
145969588|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969589|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145969590|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969591|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969592|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
145969593|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
145969594|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969595|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969596|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969597|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969598|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969599|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145969600|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969601|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969602|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
145969603|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
145969604|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969605|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969606|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969607|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969608|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969609|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145969610|NCT01232283|526403050|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
145969611|NCT01232283|526403051|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
145969612|NCT01232283|526403052|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
145969613|NCT01232283|526403053|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
145969614|NCT01232283|526403054|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
145969615|NCT01232283|526403055|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
145969616|NCT01232283|526403056|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
145969617|NCT01232283|526403057|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
146293575|NCT00421707|527590069|FG000|Period 2: Washout|Lost to Follow-up|0|||
145969618|NCT01232283|526403058|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
146293576|NCT00421707|527590070|FG001|Period 2: Washout|Lost to Follow-up|1|||
145969619|NCT01232283|526403059|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
145889736|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889737|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889738|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145889739|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889740|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889741|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889742|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889743|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889744|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889745|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
145889746|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
145889747|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889748|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889749|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145889750|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889751|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889752|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
145889753|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889754|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889755|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
145969620|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969621|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969622|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969623|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969624|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
145969625|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
145969626|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969627|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
145969628|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969629|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145969630|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969631|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969632|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969633|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969634|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
145969635|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969636|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
145969637|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
145969638|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969639|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145969640|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969641|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969642|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969643|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969644|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145969645|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145969646|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145969647|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
145969648|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969649|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145969650|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969651|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969652|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969653|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969654|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
145969655|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969656|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969657|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969658|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969659|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145969660|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969661|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
146233128|NCT03213457|527370744|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
145889756|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889757|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889758|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889759|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889760|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
145889761|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889762|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889763|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889764|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889765|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
145889766|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
145889767|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
145889768|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
145889769|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889770|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889771|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145889772|NCT04146363|526104030|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889773|NCT04146363|526104031|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889774|NCT04146363|526104032|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
145889775|NCT04146363|526104033|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889776|NCT04146363|526104034|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889777|NCT04146363|526104035|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
145889778|NCT04146363|526104036|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
145889779|NCT04146363|526104037|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
145889780|NCT04146363|526104038|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889781|NCT04146363|526104039|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889782|NCT04146363|526104040|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145889783|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889784|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889785|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889786|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889787|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889788|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889789|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889790|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889791|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
145889792|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
145889793|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
145889794|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889795|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889796|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889797|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889798|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889799|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889800|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889801|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145889802|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
145889803|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
145889804|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
145889805|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889806|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889807|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889808|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889809|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889810|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889811|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889812|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889813|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
145889814|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
145889815|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145889816|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889817|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889818|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889819|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889820|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
145969662|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969663|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969664|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
145969665|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969666|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
145969667|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
145969668|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969669|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145969670|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969671|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969672|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969673|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969674|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969675|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969676|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969677|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
145969678|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969679|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145969680|NCT01232283|526403050|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969681|NCT01232283|526403051|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969682|NCT01232283|526403052|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969683|NCT01232283|526403053|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969684|NCT01232283|526403054|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969685|NCT01232283|526403055|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
145969686|NCT01232283|526403056|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969687|NCT01232283|526403057|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969688|NCT01232283|526403058|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969689|NCT01232283|526403059|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145969690|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969691|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969692|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969693|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969694|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969695|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969696|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969697|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145969698|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
145969699|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
145969700|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969701|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969702|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969703|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969704|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969705|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969706|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969707|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145969708|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
145969709|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
145969710|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969711|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969712|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969713|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969714|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969715|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969716|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969717|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145969718|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
145969719|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
145969720|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969721|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969722|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969723|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969724|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
146233129|NCT03213457|527370745|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
146233130|NCT03213457|527370746|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
145889821|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889822|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889823|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889824|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
145889825|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
145889826|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
145889827|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889828|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889829|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889830|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889831|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889832|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889833|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889834|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145889835|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
145889836|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
145889837|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
145889838|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889839|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889840|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889841|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889842|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889843|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889844|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889845|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889846|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
146293577|NCT00421707|527590069|FG000|Period 2: Washout|Other: Pregnancy|0|||
145889847|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
145889848|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
145889849|NCT04146363|526104030|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889850|NCT04146363|526104031|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889851|NCT04146363|526104032|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889852|NCT04146363|526104033|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889853|NCT04146363|526104034|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889854|NCT04146363|526104035|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889855|NCT04146363|526104036|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889856|NCT04146363|526104037|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889857|NCT04146363|526104038|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889858|NCT04146363|526104039|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
145889859|NCT04146363|526104040|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145889860|NCT02914236|526104045|FG000|Overall Study|Lost to Follow-up|1|||
145889861|NCT02676284|526104046|FG000|Overall Study|Withdrawal by Subject|1|||
145889862|NCT00708708|526104048|FG000|Overall Study|Another therapy instead of Enbrel|141|||
145889863|NCT00708708|526104048|FG000|Overall Study|Lost to Follow-up|52|||
145889864|NCT00708708|526104048|FG000|Overall Study|Withdrawal by Subject|51|||
145889865|NCT00708708|526104048|FG000|Overall Study|Intolerance|42|||
145889866|NCT00708708|526104048|FG000|Overall Study|Another therapy along with Enbrel|15|||
145889867|NCT00708708|526104048|FG000|Overall Study|Other unspecified|11|||
145889868|NCT00708708|526104048|FG000|Overall Study|Good effectiveness|9|||
145889869|NCT00708708|526104048|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
145889870|NCT00708708|526104048|FG000|Overall Study|Administrative reasons|7|||
145889871|NCT00708708|526104048|FG000|Overall Study|Lack of effectiveness|4|||
145969725|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969726|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969727|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145969728|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
145969729|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
145969730|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969731|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969732|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969733|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969734|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969735|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969736|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969737|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145969738|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
145969739|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
145969740|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969741|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969742|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969743|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969744|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969745|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969746|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969747|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969748|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
145969749|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145969750|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969751|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969752|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969753|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969754|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969755|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969756|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969757|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969758|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
145969759|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145969760|NCT01232283|526403050|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969761|NCT01232283|526403051|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969762|NCT01232283|526403052|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969763|NCT01232283|526403053|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969764|NCT01232283|526403054|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969765|NCT01232283|526403055|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969766|NCT01232283|526403056|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969767|NCT01232283|526403057|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145969768|NCT01232283|526403058|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
145969769|NCT01232283|526403059|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
145969770|NCT01981616|526403060|FG000|Overall Study|Adverse Event|0|||
145969771|NCT01981616|526403061|FG001|Overall Study|Adverse Event|1|||
145969772|NCT01981616|526403060|FG000|Overall Study|Protocol Violation|1|||
145969773|NCT01981616|526403061|FG001|Overall Study|Protocol Violation|0|||
145969774|NCT01420536|526403062|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
145969775|NCT01420536|526403063|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
145969776|NCT00764790|526403064|FG000|Overall Study|Protocol Violation|0|||
145969777|NCT00764790|526403065|FG001|Overall Study|Protocol Violation|0|||
145969778|NCT00764790|526403066|FG002|Overall Study|Protocol Violation|1|||
145969779|NCT00764790|526403064|FG000|Overall Study|Withdrawal by Subject|10|||
145969780|NCT00764790|526403065|FG001|Overall Study|Withdrawal by Subject|12|||
145969781|NCT00764790|526403066|FG002|Overall Study|Withdrawal by Subject|6|||
145969782|NCT00764790|526403064|FG000|Overall Study|Lost to Follow-up|28|||
145969783|NCT00764790|526403065|FG001|Overall Study|Lost to Follow-up|29|||
145969784|NCT00764790|526403066|FG002|Overall Study|Lost to Follow-up|23|||
145969785|NCT01773928|526403067|FG000|Overall Study|Adverse Event|0|||
145969786|NCT01773928|526403068|FG001|Overall Study|Adverse Event|0|||
145969787|NCT01773928|526403069|FG002|Overall Study|Adverse Event|0|||
145969788|NCT01773928|526403070|FG003|Overall Study|Adverse Event|0|||
145969789|NCT01773928|526403071|FG004|Overall Study|Adverse Event|0|||
145969790|NCT01773928|526403072|FG005|Overall Study|Adverse Event|0|||
145969791|NCT01773928|526403073|FG006|Overall Study|Adverse Event|0|||
145969792|NCT01773928|526403074|FG007|Overall Study|Adverse Event|1|||
145969793|NCT01773928|526403075|FG008|Overall Study|Adverse Event|0|||
145889872|NCT00708708|526104048|FG000|Overall Study|Lack of compliance|3|||
145889873|NCT00708708|526104048|FG000|Overall Study|Pregnancy|3|||
145889874|NCT00708708|526104048|FG000|Overall Study|Adverse Event|3|||
145889875|NCT00708708|526104048|FG000|Overall Study|Missing values|392|||
145889876|NCT00856830|526104049|FG000|Irinotecan & Bendamustine|Death|0|||
145889877|NCT00856830|526104050|FG001|Irinotecan & Bendamustine|Death|0|||
145889878|NCT00856830|526104051|FG002|Irinotecan & Bendamustine|Death|0|||
145889879|NCT00856830|526104052|FG003|Irinotecan & Bendamustine|Death|2|||
145889880|NCT00856830|526104049|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
145889881|NCT00856830|526104050|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
145889882|NCT00856830|526104051|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
145889883|NCT00856830|526104052|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
145889884|NCT03768726|526104055|FG000|Treatment Phase|Adverse Event|2|||
145889885|NCT03768726|526104056|FG001|Treatment Phase|Adverse Event|2|||
145889886|NCT03768726|526104055|FG000|Treatment Phase|Lost to Follow-up|1|||
145889887|NCT03768726|526104056|FG001|Treatment Phase|Lost to Follow-up|0|||
145889888|NCT03768726|526104055|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
145889889|NCT03768726|526104056|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
145889890|NCT03768726|526104055|FG000|Treatment Phase|Withdrawal by Subject|3|||
145889891|NCT03768726|526104056|FG001|Treatment Phase|Withdrawal by Subject|1|||
145889892|NCT03768726|526104055|FG000|Follow-Up|Adverse Event|2|||
145889893|NCT03768726|526104056|FG001|Follow-Up|Adverse Event|2|||
145889894|NCT03768726|526104055|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
145889895|NCT03768726|526104056|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
145889896|NCT03768726|526104055|FG000|Follow-Up|Withdrawal by Subject|2|||
145889897|NCT03768726|526104056|FG001|Follow-Up|Withdrawal by Subject|0|||
145889898|NCT03768726|526104055|FG000|Follow-Up|Other|1|||
145889899|NCT03768726|526104056|FG001|Follow-Up|Other|0|||
145889900|NCT01286558|526104057|FG000|Overall Study|Adverse Event|1|||
145889901|NCT01286558|526104058|FG001|Overall Study|Adverse Event|1|||
145889902|NCT01286558|526104057|FG000|Overall Study|Withdrawal by Subject|0|||
145889903|NCT01286558|526104058|FG001|Overall Study|Withdrawal by Subject|1|||
145889904|NCT01787279|526104060|FG000|Overall Study|Lost to Follow-up|2|||
145889905|NCT01787279|526104060|FG000|Overall Study|Lack of Efficacy|1|||
145889906|NCT00140413|526104063|FG000|Overall Study|Lost to Follow-up|1|||
145889907|NCT00140413|526104064|FG001|Overall Study|Lost to Follow-up|0|||
145889908|NCT00140413|526104063|FG000|Overall Study|Withdrawal by Subject|2|||
145889909|NCT00140413|526104064|FG001|Overall Study|Withdrawal by Subject|0|||
145889910|NCT02694549|526104065|FG000|Overall Study|screen failures|2|||
145889911|NCT01567826|526104068|FG000|Overall Study|Lost to Follow-up|3|||
145889912|NCT01567826|526104069|FG001|Overall Study|Lost to Follow-up|2|||
145889913|NCT00865098|526104075|FG000|Overall Study|Progressive disease|1|||
145889914|NCT03265288|526104078|FG000|Overall Study|Adverse Event|0|||
145889915|NCT03265288|526104079|FG001|Overall Study|Adverse Event|1|||
145889916|NCT03265288|526104078|FG000|Overall Study|Withdrawal by Subject|13|||
145889917|NCT03265288|526104079|FG001|Overall Study|Withdrawal by Subject|5|||
145889918|NCT03265288|526104078|FG000|Overall Study|Drug Withdrawn|3|||
145889919|NCT03265288|526104079|FG001|Overall Study|Drug Withdrawn|3|||
145889920|NCT03265288|526104078|FG000|Overall Study|Any Other Reason|7|||
145889921|NCT03265288|526104079|FG001|Overall Study|Any Other Reason|3|||
145889922|NCT01715896|526104083|FG000|Overall Study|Lost to Follow-up|0|||
145889923|NCT01715896|526104084|FG001|Overall Study|Lost to Follow-up|2|||
145889924|NCT01715896|526104083|FG000|Overall Study|Withdrawal by Subject|1|||
145889925|NCT01715896|526104084|FG001|Overall Study|Withdrawal by Subject|4|||
145889926|NCT01715896|526104083|FG000|Overall Study|Other|2|||
145889927|NCT01715896|526104084|FG001|Overall Study|Other|5|||
145889928|NCT03575871|526104089|FG000|Overall Study|Adverse Event|5|||
145889929|NCT03575871|526104090|FG001|Overall Study|Adverse Event|5|||
145889930|NCT03575871|526104091|FG002|Overall Study|Adverse Event|8|||
145889931|NCT03575871|526104089|FG000|Overall Study|Death|1|||
145889932|NCT03575871|526104090|FG001|Overall Study|Death|0|||
145889933|NCT03575871|526104091|FG002|Overall Study|Death|0|||
145889934|NCT03575871|526104089|FG000|Overall Study|Lack of Efficacy|5|||
145889935|NCT03575871|526104090|FG001|Overall Study|Lack of Efficacy|4|||
145889936|NCT03575871|526104091|FG002|Overall Study|Lack of Efficacy|7|||
145889937|NCT03575871|526104089|FG000|Overall Study|Lost to Follow-up|1|||
145889938|NCT03575871|526104090|FG001|Overall Study|Lost to Follow-up|1|||
145889939|NCT03575871|526104091|FG002|Overall Study|Lost to Follow-up|1|||
145889940|NCT03575871|526104089|FG000|Overall Study|Protocol Deviation|1|||
145889941|NCT03575871|526104090|FG001|Overall Study|Protocol Deviation|1|||
145889942|NCT03575871|526104091|FG002|Overall Study|Protocol Deviation|1|||
145889943|NCT03575871|526104089|FG000|Overall Study|Withdrawal by Subject|6|||
145889944|NCT03575871|526104090|FG001|Overall Study|Withdrawal by Subject|1|||
145889945|NCT03575871|526104091|FG002|Overall Study|Withdrawal by Subject|9|||
145889946|NCT03575871|526104089|FG000|Overall Study|Other than specified|2|||
145889947|NCT03575871|526104090|FG001|Overall Study|Other than specified|2|||
145889948|NCT03575871|526104091|FG002|Overall Study|Other than specified|0|||
145889949|NCT02017860|526104092|FG000|Overall Study|Adverse Event|1|||
145889950|NCT02017860|526104092|FG000|Overall Study|Withdrawal by Subject|1|||
145889951|NCT00252174|526104099|FG000|Overall Study|Withdrawal by Subject|0|||
145969794|NCT01773928|526403067|FG000|Overall Study|Physician Decision|0|||
145969795|NCT01773928|526403068|FG001|Overall Study|Physician Decision|0|||
145969796|NCT01773928|526403069|FG002|Overall Study|Physician Decision|0|||
145969797|NCT01773928|526403070|FG003|Overall Study|Physician Decision|1|||
145969798|NCT01773928|526403071|FG004|Overall Study|Physician Decision|0|||
145969799|NCT01773928|526403072|FG005|Overall Study|Physician Decision|0|||
145969800|NCT01773928|526403073|FG006|Overall Study|Physician Decision|0|||
145969801|NCT01773928|526403074|FG007|Overall Study|Physician Decision|0|||
145969802|NCT01773928|526403075|FG008|Overall Study|Physician Decision|0|||
145969803|NCT01773928|526403067|FG000|Overall Study|Withdrawal by Subject|5|||
145969804|NCT01773928|526403068|FG001|Overall Study|Withdrawal by Subject|4|||
145969805|NCT01773928|526403069|FG002|Overall Study|Withdrawal by Subject|4|||
145969806|NCT01773928|526403070|FG003|Overall Study|Withdrawal by Subject|4|||
145969807|NCT01773928|526403071|FG004|Overall Study|Withdrawal by Subject|7|||
145969808|NCT01773928|526403072|FG005|Overall Study|Withdrawal by Subject|1|||
145969809|NCT01773928|526403073|FG006|Overall Study|Withdrawal by Subject|0|||
145969810|NCT01773928|526403074|FG007|Overall Study|Withdrawal by Subject|0|||
145969811|NCT01773928|526403075|FG008|Overall Study|Withdrawal by Subject|1|||
145969812|NCT01773928|526403067|FG000|Overall Study|Lost to Follow-up|0|||
145969813|NCT01773928|526403068|FG001|Overall Study|Lost to Follow-up|0|||
145969814|NCT01773928|526403069|FG002|Overall Study|Lost to Follow-up|0|||
145969815|NCT01773928|526403070|FG003|Overall Study|Lost to Follow-up|0|||
145969816|NCT01773928|526403071|FG004|Overall Study|Lost to Follow-up|0|||
145969817|NCT01773928|526403072|FG005|Overall Study|Lost to Follow-up|1|||
145969818|NCT01773928|526403073|FG006|Overall Study|Lost to Follow-up|0|||
145969819|NCT01773928|526403074|FG007|Overall Study|Lost to Follow-up|0|||
145969820|NCT01773928|526403075|FG008|Overall Study|Lost to Follow-up|0|||
145969821|NCT01773928|526403067|FG000|Overall Study|Subject misrepresented age|0|||
145969822|NCT01773928|526403068|FG001|Overall Study|Subject misrepresented age|1|||
145969823|NCT01773928|526403069|FG002|Overall Study|Subject misrepresented age|0|||
145969824|NCT01773928|526403070|FG003|Overall Study|Subject misrepresented age|0|||
145969825|NCT01773928|526403071|FG004|Overall Study|Subject misrepresented age|0|||
145969826|NCT01773928|526403072|FG005|Overall Study|Subject misrepresented age|0|||
145969827|NCT01773928|526403073|FG006|Overall Study|Subject misrepresented age|0|||
145969828|NCT01773928|526403074|FG007|Overall Study|Subject misrepresented age|0|||
145969829|NCT01773928|526403075|FG008|Overall Study|Subject misrepresented age|0|||
145969830|NCT01773928|526403067|FG000|Overall Study|Subject met exclusion criteria|0|||
145969831|NCT01773928|526403068|FG001|Overall Study|Subject met exclusion criteria|0|||
145969832|NCT01773928|526403069|FG002|Overall Study|Subject met exclusion criteria|0|||
145969833|NCT01773928|526403070|FG003|Overall Study|Subject met exclusion criteria|0|||
145969834|NCT01773928|526403071|FG004|Overall Study|Subject met exclusion criteria|0|||
145969835|NCT01773928|526403072|FG005|Overall Study|Subject met exclusion criteria|0|||
145969836|NCT01773928|526403073|FG006|Overall Study|Subject met exclusion criteria|0|||
145969837|NCT01773928|526403074|FG007|Overall Study|Subject met exclusion criteria|0|||
145969838|NCT01773928|526403075|FG008|Overall Study|Subject met exclusion criteria|1|||
145969839|NCT01773928|526403067|FG000|Overall Study|Randomized, had to leave, never returned|0|||
145969840|NCT01773928|526403068|FG001|Overall Study|Randomized, had to leave, never returned|0|||
145969841|NCT01773928|526403069|FG002|Overall Study|Randomized, had to leave, never returned|0|||
145969842|NCT01773928|526403070|FG003|Overall Study|Randomized, had to leave, never returned|1|||
145969843|NCT01773928|526403071|FG004|Overall Study|Randomized, had to leave, never returned|0|||
145969844|NCT01773928|526403072|FG005|Overall Study|Randomized, had to leave, never returned|0|||
145969845|NCT01773928|526403073|FG006|Overall Study|Randomized, had to leave, never returned|0|||
145969846|NCT01773928|526403074|FG007|Overall Study|Randomized, had to leave, never returned|0|||
145969847|NCT01773928|526403075|FG008|Overall Study|Randomized, had to leave, never returned|0|||
145969848|NCT01773928|526403067|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
145969849|NCT01773928|526403068|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
145969850|NCT01773928|526403069|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
145969851|NCT01773928|526403070|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
145969852|NCT01773928|526403071|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
145969853|NCT01773928|526403072|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
145969854|NCT01773928|526403073|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
145969855|NCT01773928|526403074|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
145969856|NCT01773928|526403075|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
145969857|NCT03533751|526403076|FG000|Overall Study|Withdrawal by Subject|12|||
145969858|NCT03533751|526403077|FG001|Overall Study|Withdrawal by Subject|6|||
145969859|NCT03533751|526403078|FG002|Overall Study|Withdrawal by Subject|11|||
145969860|NCT03533751|526403079|FG003|Overall Study|Withdrawal by Subject|9|||
145969861|NCT03533751|526403080|FG004|Overall Study|Withdrawal by Subject|10|||
145969862|NCT03533751|526403076|FG000|Overall Study|Adverse Event|4|||
145969863|NCT03533751|526403077|FG001|Overall Study|Adverse Event|7|||
145969864|NCT03533751|526403078|FG002|Overall Study|Adverse Event|2|||
145969865|NCT03533751|526403079|FG003|Overall Study|Adverse Event|4|||
145969866|NCT03533751|526403080|FG004|Overall Study|Adverse Event|5|||
145969867|NCT03533751|526403076|FG000|Overall Study|Physician Decision|0|||
145969868|NCT03533751|526403077|FG001|Overall Study|Physician Decision|2|||
145969869|NCT03533751|526403078|FG002|Overall Study|Physician Decision|1|||
145969870|NCT03533751|526403079|FG003|Overall Study|Physician Decision|2|||
145969871|NCT03533751|526403080|FG004|Overall Study|Physician Decision|1|||
145969872|NCT03533751|526403076|FG000|Overall Study|Sponsor Decision|0|||
145969873|NCT03533751|526403077|FG001|Overall Study|Sponsor Decision|0|||
145969874|NCT03533751|526403078|FG002|Overall Study|Sponsor Decision|1|||
145969875|NCT03533751|526403079|FG003|Overall Study|Sponsor Decision|1|||
145969876|NCT03533751|526403080|FG004|Overall Study|Sponsor Decision|0|||
145969877|NCT03533751|526403076|FG000|Overall Study|Lost to Follow-up|3|||
145969878|NCT03533751|526403077|FG001|Overall Study|Lost to Follow-up|7|||
145969879|NCT03533751|526403078|FG002|Overall Study|Lost to Follow-up|6|||
145969880|NCT03533751|526403079|FG003|Overall Study|Lost to Follow-up|4|||
145969881|NCT03533751|526403080|FG004|Overall Study|Lost to Follow-up|3|||
145969882|NCT03533751|526403076|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
145969883|NCT03533751|526403077|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
145969884|NCT03533751|526403078|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
145969885|NCT03533751|526403079|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
145969886|NCT03533751|526403080|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
145969887|NCT03533751|526403076|FG000|Overall Study|Other|0|||
145969888|NCT03533751|526403077|FG001|Overall Study|Other|2|||
145969889|NCT03533751|526403078|FG002|Overall Study|Other|1|||
145969890|NCT03533751|526403079|FG003|Overall Study|Other|0|||
145969891|NCT03533751|526403080|FG004|Overall Study|Other|3|||
145969892|NCT03082729|526403083|FG000|Overall Study|Lost to Follow-up|7|||
145969893|NCT03082729|526403083|FG000|Overall Study|Physician Decision|2|||
145969894|NCT03082729|526403083|FG000|Overall Study|Withdrawal by Subject|1|||
145969895|NCT03082729|526403083|FG000|Overall Study|Lack of Efficacy|9|||
145969896|NCT03082729|526403083|FG000|Overall Study|Adverse Event|4|||
145969897|NCT03082729|526403083|FG000|Overall Study|Protocol Violation|6|||
145969898|NCT03082729|526403083|FG000|Overall Study|Fear of study procedure|1|||
145969899|NCT03082729|526403083|FG000|Overall Study|Scheduling conflict|1|||
145969900|NCT01171534|526405327|FG000|Overall Study|Lost to Follow-up|0|||
145969901|NCT01171534|526405328|FG001|Overall Study|Lost to Follow-up|2|||
145969902|NCT01171534|526405327|FG000|Overall Study|screen failure|0|||
145969903|NCT01171534|526405328|FG001|Overall Study|screen failure|1|||
145969904|NCT03861039|526405329|FG000|Overall Study|Adverse Event|2|||
145969905|NCT03861039|526405330|FG001|Overall Study|Adverse Event|5|||
145969906|NCT03861039|526405331|FG002|Overall Study|Adverse Event|11|||
145969907|NCT03861039|526405329|FG000|Overall Study|Withdrawal by Subject|1|||
145969908|NCT03861039|526405330|FG001|Overall Study|Withdrawal by Subject|3|||
145969909|NCT03861039|526405331|FG002|Overall Study|Withdrawal by Subject|4|||
145969910|NCT00548327|526405333|FG000|Overall Study|Adverse Event|0|||
145969911|NCT00548327|526405334|FG001|Overall Study|Adverse Event|1|||
145969912|NCT01673386|526405335|FG000|Overall Study|Study terminated by sponsor|16|||
145969913|NCT01673386|526405336|FG001|Overall Study|Study terminated by sponsor|22|||
145969914|NCT01673386|526405335|FG000|Overall Study|Adverse Event|5|||
145969915|NCT01673386|526405336|FG001|Overall Study|Adverse Event|2|||
145969916|NCT01673386|526405335|FG000|Overall Study|Progressive disease|4|||
145969917|NCT01673386|526405336|FG001|Overall Study|Progressive disease|1|||
145969918|NCT01673386|526405335|FG000|Overall Study|Withdrawal by Subject|0|||
145969919|NCT01673386|526405336|FG001|Overall Study|Withdrawal by Subject|2|||
145969920|NCT00109343|526405337|FG000|Overall Study|Adverse Event|1|||
145969921|NCT00109343|526405338|FG001|Overall Study|Adverse Event|0|||
146233131|NCT03213457|527370744|FG000|Follow-Up Period|Other|14|||
145969922|NCT00109343|526405339|FG002|Overall Study|Adverse Event|2|||
145969923|NCT00109343|526405337|FG000|Overall Study|Lack of Efficacy|1|||
145969924|NCT00109343|526405338|FG001|Overall Study|Lack of Efficacy|0|||
145969925|NCT00109343|526405339|FG002|Overall Study|Lack of Efficacy|0|||
145969926|NCT00109343|526405337|FG000|Overall Study|Lost to Follow-up|35|||
145969927|NCT00109343|526405338|FG001|Overall Study|Lost to Follow-up|20|||
145969928|NCT00109343|526405339|FG002|Overall Study|Lost to Follow-up|14|||
145969929|NCT00109343|526405337|FG000|Overall Study|Protocol Violation|1|||
145969930|NCT00109343|526405338|FG001|Overall Study|Protocol Violation|2|||
145969931|NCT00109343|526405339|FG002|Overall Study|Protocol Violation|2|||
145969932|NCT00109343|526405337|FG000|Overall Study|Withdrawal by Subject|15|||
145969933|NCT00109343|526405338|FG001|Overall Study|Withdrawal by Subject|11|||
145969934|NCT00109343|526405339|FG002|Overall Study|Withdrawal by Subject|10|||
145969935|NCT00109343|526405337|FG000|Overall Study|Subject Moved|6|||
145969936|NCT00109343|526405338|FG001|Overall Study|Subject Moved|2|||
145969937|NCT00109343|526405339|FG002|Overall Study|Subject Moved|1|||
145969938|NCT00109343|526405337|FG000|Overall Study|Other|5|||
145969939|NCT00109343|526405338|FG001|Overall Study|Other|2|||
145969940|NCT00109343|526405339|FG002|Overall Study|Other|1|||
145969941|NCT02100631|526405340|FG000|Overall Study|Withdrawal by Subject|1|||
145969942|NCT02100631|526405341|FG001|Overall Study|Withdrawal by Subject|0|||
145969943|NCT02100631|526405342|FG002|Overall Study|Withdrawal by Subject|0|||
145969944|NCT02100631|526405340|FG000|Overall Study|Lost to Follow-up|3|||
145969945|NCT02100631|526405341|FG001|Overall Study|Lost to Follow-up|4|||
145969946|NCT02100631|526405342|FG002|Overall Study|Lost to Follow-up|0|||
145969947|NCT02100631|526405340|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
145969948|NCT02100631|526405341|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
145969949|NCT02100631|526405342|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
145969950|NCT03944616|526405343|FG000|Overall Study|Lost to Follow-up|0|||
145969951|NCT03944616|526405344|FG001|Overall Study|Lost to Follow-up|2|||
145969952|NCT01287936|526405345|FG000|Overall Study|Lost to Follow-up|0|||
145969953|NCT01287936|526405346|FG001|Overall Study|Lost to Follow-up|1|||
145969954|NCT01287936|526405347|FG002|Overall Study|Lost to Follow-up|1|||
145969955|NCT01721798|526405348|FG000|Overall Study|Death|0|||
145969956|NCT01721798|526405349|FG001|Overall Study|Death|0|||
145969957|NCT01721798|526405350|FG002|Overall Study|Death|1|||
145969958|NCT01721798|526405351|FG003|Overall Study|Death|1|||
145889952|NCT00252174|526104100|FG001|Overall Study|Withdrawal by Subject|1|||
145889953|NCT00252174|526104101|FG002|Overall Study|Withdrawal by Subject|0|||
145889954|NCT02224573|526104102|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
145889955|NCT02224573|526104103|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
145889956|NCT02224573|526104102|FG000|Treatment Phase|Started on Other IMP|1|||
145889957|NCT02224573|526104103|FG001|Treatment Phase|Started on Other IMP|0|||
145889958|NCT02224573|526104102|FG000|Treatment Phase|Participant Discontinued IMP|0|||
145889959|NCT02224573|526104103|FG001|Treatment Phase|Participant Discontinued IMP|1|||
145889960|NCT02224573|526104102|FG000|Treatment Phase|Lack of Efficacy|15|||
145889961|NCT02224573|526104103|FG001|Treatment Phase|Lack of Efficacy|8|||
145889962|NCT02224573|526104102|FG000|Treatment Phase|Began Commercial Product|1|||
145889963|NCT02224573|526104103|FG001|Treatment Phase|Began Commercial Product|0|||
145889964|NCT02224573|526104102|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
145889965|NCT02224573|526104103|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
145889966|NCT02224573|526104102|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
145889967|NCT02224573|526104103|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
145889968|NCT02224573|526104102|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
145889969|NCT02224573|526104103|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
145889970|NCT02224573|526104102|FG000|Treatment Phase|Continued Compassionate Use|1|||
145889971|NCT02224573|526104103|FG001|Treatment Phase|Continued Compassionate Use|0|||
145889972|NCT02224573|526104102|FG000|Treatment Phase|Lack of Efficiency|2|||
145889973|NCT02224573|526104103|FG001|Treatment Phase|Lack of Efficiency|1|||
145889974|NCT02224573|526104102|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
145889975|NCT02224573|526104103|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
145889976|NCT02224573|526104102|FG000|Treatment Phase|Participant Moved|2|||
145889977|NCT02224573|526104103|FG001|Treatment Phase|Participant Moved|0|||
145889978|NCT02224573|526104102|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
145889979|NCT02224573|526104103|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
145889980|NCT02224573|526104102|FG000|Treatment Phase|Refused Medication|1|||
145889981|NCT02224573|526104103|FG001|Treatment Phase|Refused Medication|1|||
145889982|NCT02224573|526104102|FG000|Treatment Phase|Adverse Event|26|||
145889983|NCT02224573|526104103|FG001|Treatment Phase|Adverse Event|38|||
145889984|NCT02224573|526104102|FG000|Treatment Phase|Placed in Group Home|0|||
145889985|NCT02224573|526104103|FG001|Treatment Phase|Placed in Group Home|1|||
145889986|NCT02224573|526104102|FG000|Treatment Phase|Pursued Other Trials|1|||
145889987|NCT02224573|526104103|FG001|Treatment Phase|Pursued Other Trials|0|||
145889988|NCT02224573|526104102|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
145889989|NCT02224573|526104103|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
145889990|NCT02224573|526104102|FG000|Treatment Phase|Lost to Follow-up|2|||
145889991|NCT02224573|526104103|FG001|Treatment Phase|Lost to Follow-up|1|||
145889992|NCT02224573|526104102|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
145889993|NCT02224573|526104103|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
145889994|NCT02224573|526104102|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
145889995|NCT02224573|526104103|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
145889996|NCT02224573|526104102|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
145889997|NCT02224573|526104103|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
145889998|NCT02224573|526104102|FG000|Taper Phase|Adverse Event|1|||
145889999|NCT02224573|526104103|FG001|Taper Phase|Adverse Event|1|||
145890000|NCT02546362|526104104|FG000|4-week Treatment Period|Lost to Follow-up|1|||
145890001|NCT02546362|526104104|FG000|4-week Treatment Period|Change in medication|2|||
145890002|NCT02546362|526104104|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
145890003|NCT02546362|526104104|FG000|12-week Treatment Period|Lost to Follow-up|2|||
145890004|NCT02546362|526104104|FG000|12-week Treatment Period|Change in medication|1|||
145890005|NCT01138826|526104105|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145890006|NCT01138826|526104106|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145890007|NCT01138826|526104107|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145890008|NCT01138826|526104108|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145890009|NCT01138826|526104109|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145890010|NCT01138826|526104110|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145890011|NCT05206448|526104111|FG000|Overall Study|Lost to Follow-up|2|||
145890012|NCT05206448|526104112|FG001|Overall Study|Lost to Follow-up|2|||
145890013|NCT05206448|526104111|FG000|Overall Study|Withdrawal by Subject|2|||
145890014|NCT05206448|526104112|FG001|Overall Study|Withdrawal by Subject|0|||
145890015|NCT05206448|526104111|FG000|Overall Study|found ineligible after randomization|1|||
145890016|NCT05206448|526104112|FG001|Overall Study|found ineligible after randomization|1|||
145890017|NCT05206448|526104111|FG000|Overall Study|unable to complete study due to personal constraints|1|||
145890018|NCT05206448|526104112|FG001|Overall Study|unable to complete study due to personal constraints|0|||
145890019|NCT05206448|526104111|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
145890020|NCT05206448|526104112|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
145890021|NCT01557842|526104116|FG000|Overall Study|Lost to Follow-up|0|||
145890022|NCT01557842|526104117|FG001|Overall Study|Lost to Follow-up|1|||
145890023|NCT01557842|526104116|FG000|Overall Study|Death|1|||
145890024|NCT01557842|526104117|FG001|Overall Study|Death|0|||
145890025|NCT01557842|526104116|FG000|Overall Study|Lack of Efficacy|0|||
145890026|NCT01557842|526104117|FG001|Overall Study|Lack of Efficacy|1|||
145969959|NCT01721798|526405348|FG000|Overall Study|Lost to Follow-up|2|||
145969960|NCT01721798|526405349|FG001|Overall Study|Lost to Follow-up|2|||
145890027|NCT01557842|526104116|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
145890028|NCT01557842|526104117|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
145890029|NCT01557842|526104116|FG000|Overall Study|Study Terminated by Sponsor|3|||
145890030|NCT01557842|526104117|FG001|Overall Study|Study Terminated by Sponsor|4|||
145890031|NCT01557842|526104116|FG000|Overall Study|Not Ablated|2|||
145890032|NCT01557842|526104117|FG001|Overall Study|Not Ablated|0|||
145890033|NCT02457611|526104118|FG000|Overall Study|Lost to Follow-up|3|||
145890034|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
145890035|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
145890036|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
145890037|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
145890038|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
145890039|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
145890040|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
145890041|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
145969961|NCT01721798|526405350|FG002|Overall Study|Lost to Follow-up|9|||
145969962|NCT01721798|526405351|FG003|Overall Study|Lost to Follow-up|9|||
145890042|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
145969963|NCT01721798|526405348|FG000|Overall Study|Pregnancy|0|||
145969964|NCT01721798|526405349|FG001|Overall Study|Pregnancy|0|||
145969965|NCT01721798|526405350|FG002|Overall Study|Pregnancy|1|||
145969966|NCT01721798|526405351|FG003|Overall Study|Pregnancy|1|||
145969967|NCT01721798|526405348|FG000|Overall Study|Withdrawal by Subject|1|||
145969968|NCT01721798|526405349|FG001|Overall Study|Withdrawal by Subject|0|||
145969969|NCT01721798|526405350|FG002|Overall Study|Withdrawal by Subject|2|||
145969970|NCT01721798|526405351|FG003|Overall Study|Withdrawal by Subject|1|||
145969971|NCT01721798|526405348|FG000|Overall Study|Not eligible for 24 month visit|1|||
145969972|NCT01721798|526405349|FG001|Overall Study|Not eligible for 24 month visit|0|||
145969973|NCT01721798|526405350|FG002|Overall Study|Not eligible for 24 month visit|8|||
145969974|NCT01721798|526405351|FG003|Overall Study|Not eligible for 24 month visit|7|||
145969975|NCT00427934|526405352|FG000|Overall Study|Adverse Event|1|||
145969976|NCT00427934|526405353|FG001|Overall Study|Adverse Event|0|||
145969977|NCT00427934|526405354|FG002|Overall Study|Adverse Event|5|||
145969978|NCT00427934|526405355|FG003|Overall Study|Adverse Event|4|||
145969979|NCT00427934|526405352|FG000|Overall Study|Lack of Efficacy|0|||
145969980|NCT00427934|526405353|FG001|Overall Study|Lack of Efficacy|0|||
145969981|NCT00427934|526405354|FG002|Overall Study|Lack of Efficacy|5|||
145969982|NCT00427934|526405355|FG003|Overall Study|Lack of Efficacy|2|||
146233132|NCT03213457|527370745|FG001|Follow-Up Period|Other|10|||
145890043|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
145890044|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
145890045|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
145890046|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
145890047|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
145890048|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
145890049|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
145890050|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
145969983|NCT00427934|526405352|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
145969984|NCT00427934|526405353|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
145969985|NCT00427934|526405354|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
145969986|NCT00427934|526405355|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
145969987|NCT00427934|526405352|FG000|Overall Study|Other|0|||
145969988|NCT00427934|526405353|FG001|Overall Study|Other|0|||
145969989|NCT00427934|526405354|FG002|Overall Study|Other|11|||
145969990|NCT00427934|526405355|FG003|Overall Study|Other|5|||
145969991|NCT00427934|526405352|FG000|Overall Study|Withdrawal by Subject|0|||
145969992|NCT00427934|526405353|FG001|Overall Study|Withdrawal by Subject|0|||
145969993|NCT00427934|526405354|FG002|Overall Study|Withdrawal by Subject|1|||
145969994|NCT00427934|526405355|FG003|Overall Study|Withdrawal by Subject|3|||
145969995|NCT02194465|526405356|FG000|Overall Study|Adverse Event|6|||
145969996|NCT02194465|526405357|FG001|Overall Study|Adverse Event|1|||
145969997|NCT02194465|526405358|FG002|Overall Study|Adverse Event|4|||
145969998|NCT02194465|526405359|FG003|Overall Study|Adverse Event|4|||
145969999|NCT02194465|526405360|FG004|Overall Study|Adverse Event|4|||
145970000|NCT02194465|526405361|FG005|Overall Study|Adverse Event|2|||
145970001|NCT02194465|526405362|FG006|Overall Study|Adverse Event|0|||
145970002|NCT02194465|526405356|FG000|Overall Study|Lost to Follow-up|0|||
146087252|NCT04030026|526840361|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
146087253|NCT04030026|526840362|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
146087254|NCT04030026|526840361|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
146087255|NCT04030026|526840362|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
146087256|NCT04030026|526840361|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
146087257|NCT04030026|526840362|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
146087258|NCT00811642|526840363|FG000|Overall Study|Adverse Event|3|||
146087259|NCT00811642|526840363|FG000|Overall Study|Protocol Violation|1|||
146087260|NCT00811642|526840363|FG000|Overall Study|Death|2|||
146087261|NCT00811642|526840363|FG000|Overall Study|Withdrawal by Subject|7|||
146087262|NCT00811642|526840363|FG000|Overall Study|Cumulative use of antifungal agent|2|||
146087263|NCT02361346|526840364|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087264|NCT02361346|526840365|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087265|NCT02361346|526840366|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087266|NCT02361346|526840367|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
146087267|NCT02361346|526840368|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087268|NCT02361346|526840369|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087269|NCT02361346|526840370|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087270|NCT02361346|526840371|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087271|NCT02361346|526840372|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
146087272|NCT02361346|526840364|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087273|NCT02361346|526840365|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087274|NCT02361346|526840366|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087275|NCT02361346|526840367|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087276|NCT02361346|526840368|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
146087277|NCT02361346|526840369|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087278|NCT02361346|526840370|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087279|NCT02361346|526840371|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087280|NCT02361346|526840372|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
146087281|NCT02361346|526840364|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
146087282|NCT02361346|526840365|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
146087283|NCT02361346|526840366|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
146087284|NCT02361346|526840367|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
146087285|NCT02361346|526840368|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
146087286|NCT02361346|526840369|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
146087287|NCT02361346|526840370|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
146087288|NCT02361346|526840371|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
146087289|NCT02361346|526840372|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
146087290|NCT02361346|526840364|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087291|NCT02361346|526840365|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087292|NCT02361346|526840366|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087293|NCT02361346|526840367|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087294|NCT02361346|526840368|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087295|NCT02361346|526840369|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087296|NCT02361346|526840370|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087297|NCT02361346|526840371|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
146087298|NCT02361346|526840372|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
146087299|NCT02361346|526840364|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087300|NCT02361346|526840365|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087301|NCT02361346|526840366|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087302|NCT02361346|526840367|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087303|NCT02361346|526840368|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087304|NCT02361346|526840369|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087305|NCT02361346|526840370|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
146087306|NCT02361346|526840371|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
146087307|NCT02361346|526840372|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145890051|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
145890052|NCT00384293|526104119|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
145890053|NCT00384293|526104120|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
145890054|NCT00384293|526104121|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
145890055|NCT00384293|526104119|FG000|Post-randomization Period|Adverse Event|0|||
145970003|NCT02194465|526405357|FG001|Overall Study|Lost to Follow-up|0|||
145970004|NCT02194465|526405358|FG002|Overall Study|Lost to Follow-up|0|||
145970005|NCT02194465|526405359|FG003|Overall Study|Lost to Follow-up|1|||
145970006|NCT02194465|526405360|FG004|Overall Study|Lost to Follow-up|0|||
145970007|NCT02194465|526405361|FG005|Overall Study|Lost to Follow-up|1|||
145970008|NCT02194465|526405362|FG006|Overall Study|Lost to Follow-up|0|||
145970009|NCT02194465|526405356|FG000|Overall Study|Physician Decision|1|||
145970010|NCT02194465|526405357|FG001|Overall Study|Physician Decision|0|||
145970011|NCT02194465|526405358|FG002|Overall Study|Physician Decision|0|||
145970012|NCT02194465|526405359|FG003|Overall Study|Physician Decision|0|||
145970013|NCT02194465|526405360|FG004|Overall Study|Physician Decision|0|||
145970014|NCT02194465|526405361|FG005|Overall Study|Physician Decision|0|||
145970015|NCT02194465|526405362|FG006|Overall Study|Physician Decision|0|||
145970016|NCT02194465|526405356|FG000|Overall Study|Protocol Violation|1|||
145970017|NCT02194465|526405357|FG001|Overall Study|Protocol Violation|1|||
145970018|NCT02194465|526405358|FG002|Overall Study|Protocol Violation|2|||
145970019|NCT02194465|526405359|FG003|Overall Study|Protocol Violation|1|||
145970020|NCT02194465|526405360|FG004|Overall Study|Protocol Violation|1|||
145970021|NCT02194465|526405361|FG005|Overall Study|Protocol Violation|0|||
145970022|NCT02194465|526405362|FG006|Overall Study|Protocol Violation|0|||
145890056|NCT00384293|526104120|FG001|Post-randomization Period|Adverse Event|23|||
145890057|NCT00384293|526104121|FG002|Post-randomization Period|Adverse Event|7|||
145890058|NCT00384293|526104119|FG000|Post-randomization Period|Lost to Follow-up|0|||
145890059|NCT00384293|526104120|FG001|Post-randomization Period|Lost to Follow-up|2|||
145890060|NCT00384293|526104121|FG002|Post-randomization Period|Lost to Follow-up|1|||
145890061|NCT00384293|526104119|FG000|Post-randomization Period|Protocol Violation|0|||
145890062|NCT00384293|526104120|FG001|Post-randomization Period|Protocol Violation|1|||
145890063|NCT00384293|526104121|FG002|Post-randomization Period|Protocol Violation|0|||
145890064|NCT00384293|526104119|FG000|Post-randomization Period|Withdrawal by Subject|0|||
145890065|NCT00384293|526104120|FG001|Post-randomization Period|Withdrawal by Subject|8|||
145890066|NCT00384293|526104121|FG002|Post-randomization Period|Withdrawal by Subject|6|||
145890067|NCT00384293|526104119|FG000|Post-randomization Period|Trial Termination|0|||
145890068|NCT00384293|526104120|FG001|Post-randomization Period|Trial Termination|180|||
145890069|NCT00384293|526104121|FG002|Post-randomization Period|Trial Termination|204|||
145890070|NCT00384293|526104119|FG000|Post-randomization Period|Patient Randomized in Error|0|||
145890071|NCT00384293|526104120|FG001|Post-randomization Period|Patient Randomized in Error|0|||
145890072|NCT00384293|526104121|FG002|Post-randomization Period|Patient Randomized in Error|1|||
145890073|NCT02010255|526104127|FG000|Overall Study|Death|0|||
145970023|NCT02194465|526405356|FG000|Overall Study|Withdrawal by Subject|1|||
145890074|NCT02010255|526104128|FG001|Overall Study|Death|1|||
145890075|NCT02010255|526104129|FG002|Overall Study|Death|4|||
145890076|NCT02010255|526104130|FG003|Overall Study|Death|4|||
145970024|NCT02194465|526405357|FG001|Overall Study|Withdrawal by Subject|3|||
145970025|NCT02194465|526405358|FG002|Overall Study|Withdrawal by Subject|1|||
145970026|NCT02194465|526405359|FG003|Overall Study|Withdrawal by Subject|2|||
145970027|NCT02194465|526405360|FG004|Overall Study|Withdrawal by Subject|2|||
145970028|NCT02194465|526405361|FG005|Overall Study|Withdrawal by Subject|1|||
145970029|NCT02194465|526405362|FG006|Overall Study|Withdrawal by Subject|2|||
145970030|NCT02194465|526405356|FG000|Overall Study|Discontinued follow-up period|0|||
145970031|NCT02194465|526405357|FG001|Overall Study|Discontinued follow-up period|2|||
145970032|NCT02194465|526405358|FG002|Overall Study|Discontinued follow-up period|1|||
145970033|NCT02194465|526405359|FG003|Overall Study|Discontinued follow-up period|0|||
145970034|NCT02194465|526405360|FG004|Overall Study|Discontinued follow-up period|2|||
145970035|NCT02194465|526405361|FG005|Overall Study|Discontinued follow-up period|0|||
145970036|NCT02194465|526405362|FG006|Overall Study|Discontinued follow-up period|0|||
145970037|NCT01648764|526405363|FG000|Overall Study|Progressive Disease|0|||
145970038|NCT01648764|526405364|FG001|Overall Study|Progressive Disease|1|||
145970039|NCT01648764|526405365|FG002|Overall Study|Progressive Disease|0|||
145970040|NCT01648764|526405366|FG003|Overall Study|Progressive Disease|0|||
145890077|NCT02010255|526104131|FG004|Overall Study|Death|2|||
145970041|NCT01648764|526405367|FG004|Overall Study|Progressive Disease|0|||
145970042|NCT01648764|526405368|FG005|Overall Study|Progressive Disease|1|||
145970043|NCT01648764|526405369|FG006|Overall Study|Progressive Disease|1|||
145970044|NCT01648764|526405370|FG007|Overall Study|Progressive Disease|0|||
145970045|NCT01648764|526405371|FG008|Overall Study|Progressive Disease|0|||
145970046|NCT01648764|526405372|FG009|Overall Study|Progressive Disease|2|||
145970047|NCT01648764|526405373|FG010|Overall Study|Progressive Disease|0|||
145970048|NCT01648764|526405374|FG011|Overall Study|Progressive Disease|1|||
145890078|NCT02010255|526104132|FG005|Overall Study|Death|0|||
145890079|NCT02010255|526104133|FG006|Overall Study|Death|1|||
145890080|NCT02010255|526104134|FG007|Overall Study|Death|1|||
145890081|NCT02010255|526104135|FG008|Overall Study|Death|1|||
145890082|NCT02010255|526104136|FG009|Overall Study|Death|0|||
145890083|NCT02010255|526104137|FG010|Overall Study|Death|1|||
145890084|NCT02010255|526104138|FG011|Overall Study|Death|1|||
145890085|NCT02010255|526104139|FG012|Overall Study|Death|0|||
145890086|NCT02010255|526104140|FG013|Overall Study|Death|0|||
145970049|NCT01648764|526405375|FG012|Overall Study|Progressive Disease|2|||
145970050|NCT01648764|526405376|FG013|Overall Study|Progressive Disease|1|||
145970051|NCT01648764|526405363|FG000|Overall Study|Adverse Event|0|||
145890087|NCT02010255|526104127|FG000|Overall Study|Lack of Efficacy|4|||
145890088|NCT02010255|526104128|FG001|Overall Study|Lack of Efficacy|1|||
145890089|NCT02010255|526104129|FG002|Overall Study|Lack of Efficacy|2|||
145890090|NCT02010255|526104130|FG003|Overall Study|Lack of Efficacy|1|||
145890091|NCT02010255|526104131|FG004|Overall Study|Lack of Efficacy|1|||
145890092|NCT02010255|526104132|FG005|Overall Study|Lack of Efficacy|0|||
145970052|NCT01648764|526405364|FG001|Overall Study|Adverse Event|0|||
145970053|NCT01648764|526405365|FG002|Overall Study|Adverse Event|0|||
145970054|NCT01648764|526405366|FG003|Overall Study|Adverse Event|0|||
145970055|NCT01648764|526405367|FG004|Overall Study|Adverse Event|0|||
145970056|NCT01648764|526405368|FG005|Overall Study|Adverse Event|1|||
146087308|NCT02361346|526840364|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087309|NCT02361346|526840365|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087310|NCT02361346|526840366|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087311|NCT02361346|526840367|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087312|NCT02361346|526840368|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087313|NCT02361346|526840369|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087314|NCT02361346|526840370|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087315|NCT02361346|526840371|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
146087316|NCT02361346|526840372|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
146087317|NCT03587727|526840374|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
146087318|NCT03587727|526840374|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
146087319|NCT04102189|526840375|FG000|Overall Study|Withdrawal by Subject|1|||
146087320|NCT04102189|526840376|FG001|Overall Study|Withdrawal by Subject|2|||
146087321|NCT04102189|526840375|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146087322|NCT04102189|526840376|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146087323|NCT04102189|526840375|FG000|Overall Study|Lost to Follow-up|1|||
146087324|NCT04102189|526840376|FG001|Overall Study|Lost to Follow-up|0|||
146087325|NCT00997438|526841795|FG000|Overall Study|Blood draw difficulty|2|||
146087326|NCT00997438|526841796|FG001|Overall Study|Blood draw difficulty|0|||
146087327|NCT00997438|526841797|FG002|Overall Study|Blood draw difficulty|1|||
146087328|NCT00997438|526841795|FG000|Overall Study|Withdrawal by Subject|1|||
146087329|NCT00997438|526841796|FG001|Overall Study|Withdrawal by Subject|1|||
146087330|NCT00997438|526841797|FG002|Overall Study|Withdrawal by Subject|0|||
146087331|NCT00997438|526841795|FG000|Overall Study|Exclusion criteria at visit 1|2|||
146087332|NCT00997438|526841796|FG001|Overall Study|Exclusion criteria at visit 1|2|||
146087333|NCT00997438|526841797|FG002|Overall Study|Exclusion criteria at visit 1|3|||
146087334|NCT02038829|526841798|FG000|Washout Period 1|Death|0|||
146087335|NCT02038829|526841799|FG001|Washout Period 1|Death|0|||
146087336|NCT02038829|526841800|FG002|Washout Period 1|Death|0|||
146087337|NCT02038829|526841801|FG003|Washout Period 1|Death|0|||
146087338|NCT02038829|526841802|FG004|Washout Period 1|Death|1|||
146087339|NCT02038829|526841803|FG005|Washout Period 1|Death|0|||
146087340|NCT02038829|526841804|FG006|Washout Period 1|Death|0|||
146087341|NCT02038829|526841805|FG007|Washout Period 1|Death|0|||
145970057|NCT01648764|526405369|FG006|Overall Study|Adverse Event|0|||
145970058|NCT01648764|526405370|FG007|Overall Study|Adverse Event|0|||
145970059|NCT01648764|526405371|FG008|Overall Study|Adverse Event|0|||
145970060|NCT01648764|526405372|FG009|Overall Study|Adverse Event|1|||
145970061|NCT01648764|526405373|FG010|Overall Study|Adverse Event|0|||
145970062|NCT01648764|526405374|FG011|Overall Study|Adverse Event|3|||
145970063|NCT01648764|526405375|FG012|Overall Study|Adverse Event|1|||
145970064|NCT01648764|526405376|FG013|Overall Study|Adverse Event|1|||
145970065|NCT01648764|526405363|FG000|Overall Study|Death|0|||
145970066|NCT01648764|526405364|FG001|Overall Study|Death|0|||
145970067|NCT01648764|526405365|FG002|Overall Study|Death|0|||
145970068|NCT01648764|526405366|FG003|Overall Study|Death|0|||
145970069|NCT01648764|526405367|FG004|Overall Study|Death|0|||
145970070|NCT01648764|526405368|FG005|Overall Study|Death|0|||
145970071|NCT01648764|526405369|FG006|Overall Study|Death|1|||
145970072|NCT01648764|526405370|FG007|Overall Study|Death|0|||
145970073|NCT01648764|526405371|FG008|Overall Study|Death|0|||
145970074|NCT01648764|526405372|FG009|Overall Study|Death|0|||
145970075|NCT01648764|526405373|FG010|Overall Study|Death|0|||
146087342|NCT02038829|526841806|FG008|Washout Period 1|Death|0|||
146087343|NCT02038829|526841807|FG009|Washout Period 1|Death|0|||
146087344|NCT02038829|526841808|FG010|Washout Period 1|Death|0|||
146087345|NCT02038829|526841809|FG011|Washout Period 1|Death|0|||
146087346|NCT02038829|526841798|FG000|Treatment Period 2|Adverse Event|0|||
146087347|NCT02038829|526841799|FG001|Treatment Period 2|Adverse Event|0|||
146087348|NCT02038829|526841800|FG002|Treatment Period 2|Adverse Event|0|||
146087349|NCT02038829|526841801|FG003|Treatment Period 2|Adverse Event|0|||
146087350|NCT02038829|526841802|FG004|Treatment Period 2|Adverse Event|0|||
146087351|NCT02038829|526841803|FG005|Treatment Period 2|Adverse Event|0|||
146087352|NCT02038829|526841804|FG006|Treatment Period 2|Adverse Event|0|||
146087353|NCT02038829|526841805|FG007|Treatment Period 2|Adverse Event|0|||
146087354|NCT02038829|526841806|FG008|Treatment Period 2|Adverse Event|0|||
146087355|NCT02038829|526841807|FG009|Treatment Period 2|Adverse Event|0|||
145970076|NCT01648764|526405374|FG011|Overall Study|Death|0|||
145970077|NCT01648764|526405375|FG012|Overall Study|Death|0|||
145970078|NCT01648764|526405376|FG013|Overall Study|Death|1|||
145970079|NCT01648764|526405363|FG000|Overall Study|Withdrawal by Subject|0|||
145970080|NCT01648764|526405364|FG001|Overall Study|Withdrawal by Subject|0|||
145970081|NCT01648764|526405365|FG002|Overall Study|Withdrawal by Subject|0|||
145970082|NCT01648764|526405366|FG003|Overall Study|Withdrawal by Subject|0|||
145970083|NCT01648764|526405367|FG004|Overall Study|Withdrawal by Subject|0|||
145970084|NCT01648764|526405368|FG005|Overall Study|Withdrawal by Subject|0|||
145970085|NCT01648764|526405369|FG006|Overall Study|Withdrawal by Subject|2|||
145970086|NCT01648764|526405370|FG007|Overall Study|Withdrawal by Subject|0|||
145970087|NCT01648764|526405371|FG008|Overall Study|Withdrawal by Subject|0|||
145970088|NCT01648764|526405372|FG009|Overall Study|Withdrawal by Subject|0|||
145970089|NCT01648764|526405373|FG010|Overall Study|Withdrawal by Subject|0|||
145970090|NCT01648764|526405374|FG011|Overall Study|Withdrawal by Subject|0|||
145970091|NCT01648764|526405375|FG012|Overall Study|Withdrawal by Subject|1|||
145970092|NCT01648764|526405376|FG013|Overall Study|Withdrawal by Subject|0|||
145970093|NCT01648764|526405363|FG000|Overall Study|Investigator Decision|0|||
145970094|NCT01648764|526405364|FG001|Overall Study|Investigator Decision|0|||
145970095|NCT01648764|526405365|FG002|Overall Study|Investigator Decision|0|||
145970096|NCT01648764|526405366|FG003|Overall Study|Investigator Decision|0|||
145970097|NCT01648764|526405367|FG004|Overall Study|Investigator Decision|0|||
145970098|NCT01648764|526405368|FG005|Overall Study|Investigator Decision|0|||
145970099|NCT01648764|526405369|FG006|Overall Study|Investigator Decision|1|||
145970100|NCT01648764|526405370|FG007|Overall Study|Investigator Decision|0|||
145970101|NCT01648764|526405371|FG008|Overall Study|Investigator Decision|0|||
145970102|NCT01648764|526405372|FG009|Overall Study|Investigator Decision|0|||
145970103|NCT01648764|526405373|FG010|Overall Study|Investigator Decision|0|||
145970104|NCT01648764|526405374|FG011|Overall Study|Investigator Decision|1|||
145970105|NCT01648764|526405375|FG012|Overall Study|Investigator Decision|0|||
145970106|NCT01648764|526405376|FG013|Overall Study|Investigator Decision|0|||
145970107|NCT00076570|526405377|FG000|Overall Study|Drug intolerance|8|||
145970108|NCT00076570|526405378|FG001|Overall Study|Drug intolerance|8|||
145970109|NCT00420745|526405379|FG000|Overall Study|Adverse Event|2|||
145970110|NCT00420745|526405380|FG001|Overall Study|Adverse Event|2|||
145970111|NCT00420745|526405379|FG000|Overall Study|Lost to Follow-up|10|||
145970112|NCT00420745|526405380|FG001|Overall Study|Lost to Follow-up|2|||
145970113|NCT00420745|526405379|FG000|Overall Study|Protocol Violation|1|||
145970114|NCT00420745|526405380|FG001|Overall Study|Protocol Violation|0|||
145970115|NCT00420745|526405379|FG000|Overall Study|Physician Decision|1|||
145970116|NCT00420745|526405380|FG001|Overall Study|Physician Decision|1|||
145970117|NCT00420745|526405379|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
145970118|NCT00420745|526405380|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
145970119|NCT00420745|526405379|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
145970120|NCT00420745|526405380|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
145970121|NCT02058095|526405383|FG000|Overall Study|Adverse Event|1|||
146087356|NCT02038829|526841808|FG010|Treatment Period 2|Adverse Event|1|||
146087357|NCT02038829|526841809|FG011|Treatment Period 2|Adverse Event|0|||
145970122|NCT02058095|526405384|FG001|Overall Study|Adverse Event|0|||
145970123|NCT01588509|526405387|FG000|Overall Study|Lost to Follow-up|1|||
145970124|NCT01588509|526405388|FG001|Overall Study|Lost to Follow-up|0|||
146087358|NCT02038829|526841798|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145970125|NCT00393367|526405391|FG000|Overall Study|Protocol Violation|2|||
145970126|NCT00393367|526405392|FG001|Overall Study|Protocol Violation|5|||
145970127|NCT00393367|526405391|FG000|Overall Study|Withdrawal by Subject|0|||
146087359|NCT02038829|526841799|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146087360|NCT02038829|526841800|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146087361|NCT02038829|526841801|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145970128|NCT00393367|526405392|FG001|Overall Study|Withdrawal by Subject|2|||
145970129|NCT00915525|526405393|FG000|Overall Study|Protocol Violation|9|||
145970130|NCT00915525|526405394|FG001|Overall Study|Protocol Violation|4|||
145970131|NCT00915525|526405393|FG000|Overall Study|Withdrawal by Subject|59|||
145970132|NCT00915525|526405394|FG001|Overall Study|Withdrawal by Subject|21|||
146087362|NCT02038829|526841802|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146293578|NCT00421707|527590070|FG001|Period 2: Washout|Other: Pregnancy|1|||
145890093|NCT02010255|526104133|FG006|Overall Study|Lack of Efficacy|0|||
145890094|NCT02010255|526104134|FG007|Overall Study|Lack of Efficacy|0|||
145890095|NCT02010255|526104135|FG008|Overall Study|Lack of Efficacy|0|||
145890096|NCT02010255|526104136|FG009|Overall Study|Lack of Efficacy|0|||
145890097|NCT02010255|526104137|FG010|Overall Study|Lack of Efficacy|1|||
145890098|NCT02010255|526104138|FG011|Overall Study|Lack of Efficacy|0|||
145890099|NCT02010255|526104139|FG012|Overall Study|Lack of Efficacy|0|||
145890100|NCT02010255|526104140|FG013|Overall Study|Lack of Efficacy|0|||
145890101|NCT02010255|526104127|FG000|Overall Study|Withdrew Consent|1|||
145890102|NCT02010255|526104128|FG001|Overall Study|Withdrew Consent|0|||
145890103|NCT02010255|526104129|FG002|Overall Study|Withdrew Consent|0|||
145890104|NCT02010255|526104130|FG003|Overall Study|Withdrew Consent|1|||
145890105|NCT02010255|526104131|FG004|Overall Study|Withdrew Consent|0|||
145890106|NCT02010255|526104132|FG005|Overall Study|Withdrew Consent|0|||
145890107|NCT02010255|526104133|FG006|Overall Study|Withdrew Consent|0|||
145890108|NCT02010255|526104134|FG007|Overall Study|Withdrew Consent|0|||
145890109|NCT02010255|526104135|FG008|Overall Study|Withdrew Consent|0|||
145890110|NCT02010255|526104136|FG009|Overall Study|Withdrew Consent|0|||
145890111|NCT02010255|526104137|FG010|Overall Study|Withdrew Consent|0|||
145890112|NCT02010255|526104138|FG011|Overall Study|Withdrew Consent|0|||
145890113|NCT02010255|526104139|FG012|Overall Study|Withdrew Consent|0|||
145890114|NCT02010255|526104140|FG013|Overall Study|Withdrew Consent|0|||
145890115|NCT02010255|526104127|FG000|Overall Study|Adverse Event|1|||
145890116|NCT02010255|526104128|FG001|Overall Study|Adverse Event|0|||
145890117|NCT02010255|526104129|FG002|Overall Study|Adverse Event|0|||
145890118|NCT02010255|526104130|FG003|Overall Study|Adverse Event|0|||
145890119|NCT02010255|526104131|FG004|Overall Study|Adverse Event|0|||
145890120|NCT02010255|526104132|FG005|Overall Study|Adverse Event|0|||
145890121|NCT02010255|526104133|FG006|Overall Study|Adverse Event|0|||
145890122|NCT02010255|526104134|FG007|Overall Study|Adverse Event|0|||
145890123|NCT02010255|526104135|FG008|Overall Study|Adverse Event|0|||
145890124|NCT02010255|526104136|FG009|Overall Study|Adverse Event|0|||
145890125|NCT02010255|526104137|FG010|Overall Study|Adverse Event|0|||
145890126|NCT02010255|526104138|FG011|Overall Study|Adverse Event|0|||
145890127|NCT02010255|526104139|FG012|Overall Study|Adverse Event|0|||
145890128|NCT02010255|526104140|FG013|Overall Study|Adverse Event|0|||
145890129|NCT02010255|526104127|FG000|Overall Study|Lost to Follow-up|0|||
145890130|NCT02010255|526104128|FG001|Overall Study|Lost to Follow-up|0|||
145890131|NCT02010255|526104129|FG002|Overall Study|Lost to Follow-up|1|||
145890132|NCT02010255|526104130|FG003|Overall Study|Lost to Follow-up|0|||
145890133|NCT02010255|526104131|FG004|Overall Study|Lost to Follow-up|1|||
145890134|NCT02010255|526104132|FG005|Overall Study|Lost to Follow-up|0|||
145890135|NCT02010255|526104133|FG006|Overall Study|Lost to Follow-up|0|||
145890136|NCT02010255|526104134|FG007|Overall Study|Lost to Follow-up|0|||
145890137|NCT02010255|526104135|FG008|Overall Study|Lost to Follow-up|0|||
145890138|NCT02010255|526104136|FG009|Overall Study|Lost to Follow-up|0|||
145890139|NCT02010255|526104137|FG010|Overall Study|Lost to Follow-up|0|||
145890140|NCT02010255|526104138|FG011|Overall Study|Lost to Follow-up|0|||
145890141|NCT02010255|526104139|FG012|Overall Study|Lost to Follow-up|0|||
145890142|NCT02010255|526104140|FG013|Overall Study|Lost to Follow-up|0|||
145890143|NCT02010255|526104127|FG000|Overall Study|Randomized but Not Treated|0|||
145890144|NCT02010255|526104128|FG001|Overall Study|Randomized but Not Treated|0|||
145890145|NCT02010255|526104129|FG002|Overall Study|Randomized but Not Treated|0|||
145890146|NCT02010255|526104130|FG003|Overall Study|Randomized but Not Treated|0|||
145890147|NCT02010255|526104131|FG004|Overall Study|Randomized but Not Treated|0|||
145890148|NCT02010255|526104132|FG005|Overall Study|Randomized but Not Treated|0|||
145890149|NCT02010255|526104133|FG006|Overall Study|Randomized but Not Treated|0|||
145890150|NCT02010255|526104134|FG007|Overall Study|Randomized but Not Treated|0|||
146293579|NCT00421707|527590069|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
146293580|NCT00421707|527590070|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
145890151|NCT02010255|526104135|FG008|Overall Study|Randomized but Not Treated|0|||
145890152|NCT02010255|526104136|FG009|Overall Study|Randomized but Not Treated|0|||
145890153|NCT02010255|526104137|FG010|Overall Study|Randomized but Not Treated|0|||
145890154|NCT02010255|526104138|FG011|Overall Study|Randomized but Not Treated|0|||
145890155|NCT02010255|526104139|FG012|Overall Study|Randomized but Not Treated|0|||
145890156|NCT02010255|526104140|FG013|Overall Study|Randomized but Not Treated|1|||
145890157|NCT00466726|526104141|FG000|Overall Study|Not evaluable for response|14|||
146087363|NCT02038829|526841803|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146087364|NCT02038829|526841804|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146087365|NCT02038829|526841805|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146087366|NCT02038829|526841806|FG008|Treatment Period 2|Withdrawal by Subject|0|||
146087367|NCT02038829|526841807|FG009|Treatment Period 2|Withdrawal by Subject|0|||
146087368|NCT02038829|526841808|FG010|Treatment Period 2|Withdrawal by Subject|0|||
146087369|NCT02038829|526841809|FG011|Treatment Period 2|Withdrawal by Subject|0|||
146087370|NCT02038829|526841798|FG000|Washout Period 2|Adverse Event|0|||
146087371|NCT02038829|526841799|FG001|Washout Period 2|Adverse Event|0|||
146087372|NCT02038829|526841800|FG002|Washout Period 2|Adverse Event|0|||
146087373|NCT02038829|526841801|FG003|Washout Period 2|Adverse Event|0|||
146087374|NCT02038829|526841802|FG004|Washout Period 2|Adverse Event|0|||
146087375|NCT02038829|526841803|FG005|Washout Period 2|Adverse Event|0|||
146087376|NCT02038829|526841804|FG006|Washout Period 2|Adverse Event|0|||
146087377|NCT02038829|526841805|FG007|Washout Period 2|Adverse Event|0|||
146087378|NCT02038829|526841806|FG008|Washout Period 2|Adverse Event|1|||
146087379|NCT02038829|526841807|FG009|Washout Period 2|Adverse Event|0|||
146087380|NCT02038829|526841808|FG010|Washout Period 2|Adverse Event|0|||
146087381|NCT02038829|526841809|FG011|Washout Period 2|Adverse Event|0|||
146087382|NCT02038829|526841798|FG000|Washout Period 2|Withdrawal by Subject|0|||
146087383|NCT02038829|526841799|FG001|Washout Period 2|Withdrawal by Subject|0|||
146087384|NCT02038829|526841800|FG002|Washout Period 2|Withdrawal by Subject|0|||
146087385|NCT02038829|526841801|FG003|Washout Period 2|Withdrawal by Subject|0|||
146087386|NCT02038829|526841802|FG004|Washout Period 2|Withdrawal by Subject|0|||
145970133|NCT00915525|526405393|FG000|Overall Study|Lost to Follow-up|27|||
145970134|NCT00915525|526405394|FG001|Overall Study|Lost to Follow-up|16|||
145970135|NCT00915525|526405393|FG000|Overall Study|Pregnancy|2|||
145970136|NCT00915525|526405394|FG001|Overall Study|Pregnancy|0|||
145970137|NCT00915525|526405393|FG000|Overall Study|Lack of Efficacy|15|||
145970138|NCT00915525|526405394|FG001|Overall Study|Lack of Efficacy|32|||
145970139|NCT00915525|526405393|FG000|Overall Study|Adverse Event|29|||
145970140|NCT00915525|526405394|FG001|Overall Study|Adverse Event|13|||
145970141|NCT00915525|526405393|FG000|Overall Study|Missing|12|||
145970142|NCT00915525|526405394|FG001|Overall Study|Missing|1|||
145970143|NCT00915525|526405393|FG000|Overall Study|Other Reason|35|||
145970144|NCT00915525|526405394|FG001|Overall Study|Other Reason|12|||
145970145|NCT00915525|526405393|FG000|Overall Study|Site Closed|27|||
145970146|NCT00915525|526405394|FG001|Overall Study|Site Closed|9|||
145970147|NCT00915525|526405393|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
145970148|NCT00915525|526405394|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
145970149|NCT00915525|526405393|FG000|Overall Study|Study Burden|28|||
145970150|NCT00915525|526405394|FG001|Overall Study|Study Burden|12|||
145970151|NCT00915525|526405393|FG000|Overall Study|Non-Compliance|3|||
145970152|NCT00915525|526405394|FG001|Overall Study|Non-Compliance|1|||
145970153|NCT00915525|526405393|FG000|Overall Study|Patient Moved|15|||
145970154|NCT00915525|526405394|FG001|Overall Study|Patient Moved|9|||
145970155|NCT01712178|526405395|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
145970156|NCT01712178|526405396|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
145970157|NCT01712178|526405395|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
145970158|NCT01712178|526405396|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
145970159|NCT01712178|526405395|FG000|Overall Study|Lost to Follow-up|0|||
145970160|NCT01712178|526405396|FG001|Overall Study|Lost to Follow-up|1|||
145970161|NCT00676143|526405399|FG000|Overall Study|Adverse Event|34|||
145970162|NCT00676143|526405400|FG001|Overall Study|Adverse Event|60|||
145970163|NCT00676143|526405399|FG000|Overall Study|Death|4|||
145970164|NCT00676143|526405400|FG001|Overall Study|Death|4|||
145970165|NCT00676143|526405399|FG000|Overall Study|Lack of Efficacy|0|||
145970166|NCT00676143|526405400|FG001|Overall Study|Lack of Efficacy|6|||
145970167|NCT00676143|526405399|FG000|Overall Study|Lost to Follow-up|0|||
145970168|NCT00676143|526405400|FG001|Overall Study|Lost to Follow-up|13|||
145970169|NCT00676143|526405399|FG000|Overall Study|Physician Decision|5|||
145970170|NCT00676143|526405400|FG001|Overall Study|Physician Decision|8|||
145970171|NCT00676143|526405399|FG000|Overall Study|Protocol Violation|4|||
145970172|NCT00676143|526405400|FG001|Overall Study|Protocol Violation|8|||
145970173|NCT00676143|526405399|FG000|Overall Study|Withdrawal by Subject|24|||
145970174|NCT00676143|526405400|FG001|Overall Study|Withdrawal by Subject|42|||
145970175|NCT00676143|526405399|FG000|Overall Study|Discontinuation of study by sponsor|65|||
145970176|NCT00676143|526405400|FG001|Overall Study|Discontinuation of study by sponsor|88|||
145970177|NCT00676143|526405399|FG000|Overall Study|Failed to return|2|||
145970178|NCT00676143|526405400|FG001|Overall Study|Failed to return|1|||
145970179|NCT00676143|526405399|FG000|Overall Study|Loss of caregiver|5|||
145970180|NCT00676143|526405400|FG001|Overall Study|Loss of caregiver|3|||
145970181|NCT00676143|526405399|FG000|Overall Study|Other|11|||
145970182|NCT00676143|526405400|FG001|Overall Study|Other|20|||
145970183|NCT00676143|526405399|FG000|Overall Study|Participant participation unknown|1|||
145970184|NCT00676143|526405400|FG001|Overall Study|Participant participation unknown|4|||
145970185|NCT00676143|526405399|FG000|Overall Study|Vasogenic edema recurrence|1|||
145970186|NCT00676143|526405400|FG001|Overall Study|Vasogenic edema recurrence|3|||
145970187|NCT02412657|526405408|FG000|Overall Study|Lost to Follow-up|1|||
145970188|NCT02412657|526405409|FG001|Overall Study|Lost to Follow-up|0|||
145970189|NCT02412657|526405410|FG002|Overall Study|Lost to Follow-up|0|||
145970190|NCT02412657|526405408|FG000|Overall Study|Protocol Violation|0|||
145970191|NCT02412657|526405409|FG001|Overall Study|Protocol Violation|2|||
145970192|NCT02412657|526405410|FG002|Overall Study|Protocol Violation|3|||
145970193|NCT01281306|526405414|FG000|Overall Study|Lack of Efficacy|0|||
145970194|NCT01281306|526405415|FG001|Overall Study|Lack of Efficacy|1|||
145970195|NCT01281306|526405416|FG002|Overall Study|Lack of Efficacy|3|||
145970196|NCT01281306|526405417|FG003|Overall Study|Lack of Efficacy|0|||
145970197|NCT01281306|526405418|FG004|Overall Study|Lack of Efficacy|2|||
145970198|NCT01281306|526405419|FG005|Overall Study|Lack of Efficacy|0|||
145970199|NCT01281306|526405420|FG006|Overall Study|Lack of Efficacy|1|||
145970200|NCT01281306|526405414|FG000|Overall Study|Withdrawal by Subject|1|||
145970201|NCT01281306|526405415|FG001|Overall Study|Withdrawal by Subject|0|||
145970202|NCT01281306|526405416|FG002|Overall Study|Withdrawal by Subject|2|||
145970203|NCT01281306|526405417|FG003|Overall Study|Withdrawal by Subject|4|||
145970204|NCT01281306|526405418|FG004|Overall Study|Withdrawal by Subject|1|||
145970205|NCT01281306|526405419|FG005|Overall Study|Withdrawal by Subject|3|||
145970206|NCT01281306|526405420|FG006|Overall Study|Withdrawal by Subject|1|||
145970207|NCT01281306|526405414|FG000|Overall Study|Protocol deviation|0|||
145970208|NCT01281306|526405415|FG001|Overall Study|Protocol deviation|1|||
145970209|NCT01281306|526405416|FG002|Overall Study|Protocol deviation|1|||
145970210|NCT01281306|526405417|FG003|Overall Study|Protocol deviation|1|||
145970211|NCT01281306|526405418|FG004|Overall Study|Protocol deviation|1|||
145970212|NCT01281306|526405419|FG005|Overall Study|Protocol deviation|0|||
145970213|NCT01281306|526405420|FG006|Overall Study|Protocol deviation|0|||
145970214|NCT01281306|526405414|FG000|Overall Study|Condition no longer requires study drug|1|||
145970215|NCT01281306|526405415|FG001|Overall Study|Condition no longer requires study drug|0|||
145970216|NCT01281306|526405416|FG002|Overall Study|Condition no longer requires study drug|0|||
145970217|NCT01281306|526405417|FG003|Overall Study|Condition no longer requires study drug|0|||
145970218|NCT01281306|526405418|FG004|Overall Study|Condition no longer requires study drug|0|||
145970219|NCT01281306|526405419|FG005|Overall Study|Condition no longer requires study drug|1|||
145970220|NCT01281306|526405420|FG006|Overall Study|Condition no longer requires study drug|1|||
145970221|NCT01281306|526405414|FG000|Overall Study|Lost to Follow-up|1|||
145970222|NCT01281306|526405415|FG001|Overall Study|Lost to Follow-up|0|||
145970223|NCT01281306|526405416|FG002|Overall Study|Lost to Follow-up|0|||
145970224|NCT01281306|526405417|FG003|Overall Study|Lost to Follow-up|2|||
145970225|NCT01281306|526405418|FG004|Overall Study|Lost to Follow-up|0|||
145970226|NCT01281306|526405419|FG005|Overall Study|Lost to Follow-up|0|||
145970227|NCT01281306|526405420|FG006|Overall Study|Lost to Follow-up|1|||
145970228|NCT01281306|526405414|FG000|Overall Study|Death|1|||
145970229|NCT01281306|526405415|FG001|Overall Study|Death|0|||
145970230|NCT01281306|526405416|FG002|Overall Study|Death|0|||
145970231|NCT01281306|526405417|FG003|Overall Study|Death|0|||
145970232|NCT01281306|526405418|FG004|Overall Study|Death|0|||
145970233|NCT01281306|526405419|FG005|Overall Study|Death|0|||
145970234|NCT01281306|526405420|FG006|Overall Study|Death|0|||
145970235|NCT01281306|526405414|FG000|Overall Study|Adverse Event|3|||
145970236|NCT01281306|526405415|FG001|Overall Study|Adverse Event|2|||
145970237|NCT01281306|526405416|FG002|Overall Study|Adverse Event|2|||
145970238|NCT01281306|526405417|FG003|Overall Study|Adverse Event|3|||
145970239|NCT01281306|526405418|FG004|Overall Study|Adverse Event|5|||
145970240|NCT01281306|526405419|FG005|Overall Study|Adverse Event|3|||
145970241|NCT01281306|526405420|FG006|Overall Study|Adverse Event|3|||
145970242|NCT01281306|526405414|FG000|Overall Study|Randomized in error|1|||
145970243|NCT01281306|526405415|FG001|Overall Study|Randomized in error|0|||
145970244|NCT01281306|526405416|FG002|Overall Study|Randomized in error|0|||
145970245|NCT01281306|526405417|FG003|Overall Study|Randomized in error|1|||
145970246|NCT01281306|526405418|FG004|Overall Study|Randomized in error|0|||
145970247|NCT01281306|526405419|FG005|Overall Study|Randomized in error|0|||
146293581|NCT00421707|527590069|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
145970248|NCT01281306|526405420|FG006|Overall Study|Randomized in error|0|||
145970249|NCT03185208|526405421|FG000|Overall Study|Did not start study medication|0|||
146087387|NCT02038829|526841803|FG005|Washout Period 2|Withdrawal by Subject|1|||
145970250|NCT03185208|526405422|FG001|Overall Study|Did not start study medication|3|||
146087388|NCT02038829|526841804|FG006|Washout Period 2|Withdrawal by Subject|0|||
146087389|NCT02038829|526841805|FG007|Washout Period 2|Withdrawal by Subject|0|||
146087390|NCT02038829|526841806|FG008|Washout Period 2|Withdrawal by Subject|0|||
146087391|NCT02038829|526841807|FG009|Washout Period 2|Withdrawal by Subject|0|||
146087392|NCT02038829|526841808|FG010|Washout Period 2|Withdrawal by Subject|0|||
146087393|NCT02038829|526841809|FG011|Washout Period 2|Withdrawal by Subject|0|||
146087394|NCT02038829|526841798|FG000|Treatment Period 4|Adverse Event|0|||
146087395|NCT02038829|526841799|FG001|Treatment Period 4|Adverse Event|1|||
146087396|NCT02038829|526841800|FG002|Treatment Period 4|Adverse Event|0|||
146087397|NCT02038829|526841801|FG003|Treatment Period 4|Adverse Event|0|||
146087398|NCT02038829|526841802|FG004|Treatment Period 4|Adverse Event|0|||
146087399|NCT02038829|526841803|FG005|Treatment Period 4|Adverse Event|0|||
146087400|NCT02038829|526841804|FG006|Treatment Period 4|Adverse Event|0|||
146087401|NCT02038829|526841805|FG007|Treatment Period 4|Adverse Event|0|||
146087402|NCT02038829|526841806|FG008|Treatment Period 4|Adverse Event|0|||
146087403|NCT02038829|526841807|FG009|Treatment Period 4|Adverse Event|0|||
146087404|NCT02038829|526841808|FG010|Treatment Period 4|Adverse Event|0|||
146087405|NCT02038829|526841809|FG011|Treatment Period 4|Adverse Event|0|||
146087406|NCT02038829|526841798|FG000|Washout Period 4|Adverse Event|0|||
146087407|NCT02038829|526841799|FG001|Washout Period 4|Adverse Event|0|||
146087408|NCT02038829|526841800|FG002|Washout Period 4|Adverse Event|0|||
146087409|NCT02038829|526841801|FG003|Washout Period 4|Adverse Event|0|||
146087410|NCT02038829|526841802|FG004|Washout Period 4|Adverse Event|0|||
146087411|NCT02038829|526841803|FG005|Washout Period 4|Adverse Event|0|||
146087412|NCT02038829|526841804|FG006|Washout Period 4|Adverse Event|1|||
146087413|NCT02038829|526841805|FG007|Washout Period 4|Adverse Event|0|||
146087414|NCT02038829|526841806|FG008|Washout Period 4|Adverse Event|0|||
146087415|NCT02038829|526841807|FG009|Washout Period 4|Adverse Event|0|||
146087416|NCT02038829|526841808|FG010|Washout Period 4|Adverse Event|0|||
146087417|NCT02038829|526841809|FG011|Washout Period 4|Adverse Event|0|||
146087418|NCT02038829|526841798|FG000|Treatment Period 6|Adverse Event|0|||
146087419|NCT02038829|526841799|FG001|Treatment Period 6|Adverse Event|0|||
146087420|NCT02038829|526841800|FG002|Treatment Period 6|Adverse Event|1|||
146087421|NCT02038829|526841801|FG003|Treatment Period 6|Adverse Event|0|||
146087422|NCT02038829|526841802|FG004|Treatment Period 6|Adverse Event|0|||
146087423|NCT02038829|526841803|FG005|Treatment Period 6|Adverse Event|0|||
146087424|NCT02038829|526841804|FG006|Treatment Period 6|Adverse Event|0|||
146087425|NCT02038829|526841805|FG007|Treatment Period 6|Adverse Event|0|||
146087426|NCT02038829|526841806|FG008|Treatment Period 6|Adverse Event|0|||
146087427|NCT02038829|526841807|FG009|Treatment Period 6|Adverse Event|0|||
146087428|NCT02038829|526841808|FG010|Treatment Period 6|Adverse Event|0|||
146087429|NCT02038829|526841809|FG011|Treatment Period 6|Adverse Event|0|||
146087430|NCT04393298|526841810|FG000|Overall Study|Adverse Event|0|||
146087431|NCT04393298|526841811|FG001|Overall Study|Adverse Event|0|||
146087432|NCT04393298|526841812|FG002|Overall Study|Adverse Event|0|||
146087433|NCT04393298|526841813|FG003|Overall Study|Adverse Event|0|||
146087434|NCT04393298|526841814|FG004|Overall Study|Adverse Event|1|||
146293582|NCT00421707|527590070|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
146087435|NCT04393298|526841815|FG005|Overall Study|Adverse Event|0|||
146087436|NCT04393298|526841816|FG006|Overall Study|Adverse Event|0|||
146087437|NCT04393298|526841817|FG007|Overall Study|Adverse Event|0|||
146087438|NCT04393298|526841818|FG008|Overall Study|Adverse Event|2|||
146087439|NCT04393298|526841819|FG009|Overall Study|Adverse Event|0|||
146087440|NCT04393298|526841820|FG010|Overall Study|Adverse Event|0|||
146087441|NCT04393298|526841821|FG011|Overall Study|Adverse Event|0|||
146087442|NCT04393298|526841822|FG012|Overall Study|Adverse Event|1|||
146087443|NCT04393298|526841823|FG013|Overall Study|Adverse Event|1|||
146087444|NCT04393298|526841824|FG014|Overall Study|Adverse Event|0|||
146087445|NCT04393298|526841810|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087446|NCT04393298|526841811|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087447|NCT04393298|526841812|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
146087448|NCT04393298|526841813|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087449|NCT04393298|526841814|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087450|NCT04393298|526841815|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087451|NCT04393298|526841816|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087452|NCT04393298|526841817|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087453|NCT04393298|526841818|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087454|NCT04393298|526841819|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087455|NCT04393298|526841820|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087456|NCT04393298|526841821|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087457|NCT04393298|526841822|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087458|NCT04393298|526841823|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
146087459|NCT04393298|526841824|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
146087460|NCT04393298|526841810|FG000|Overall Study|Lack of Efficacy|0|||
146087461|NCT04393298|526841811|FG001|Overall Study|Lack of Efficacy|0|||
146087462|NCT04393298|526841812|FG002|Overall Study|Lack of Efficacy|0|||
146087463|NCT04393298|526841813|FG003|Overall Study|Lack of Efficacy|0|||
146087464|NCT04393298|526841814|FG004|Overall Study|Lack of Efficacy|0|||
146087465|NCT04393298|526841815|FG005|Overall Study|Lack of Efficacy|0|||
146087466|NCT04393298|526841816|FG006|Overall Study|Lack of Efficacy|0|||
146087467|NCT04393298|526841817|FG007|Overall Study|Lack of Efficacy|0|||
146087468|NCT04393298|526841818|FG008|Overall Study|Lack of Efficacy|0|||
146087469|NCT04393298|526841819|FG009|Overall Study|Lack of Efficacy|0|||
146087470|NCT04393298|526841820|FG010|Overall Study|Lack of Efficacy|0|||
146087471|NCT04393298|526841821|FG011|Overall Study|Lack of Efficacy|0|||
146087472|NCT04393298|526841822|FG012|Overall Study|Lack of Efficacy|0|||
146087473|NCT04393298|526841823|FG013|Overall Study|Lack of Efficacy|0|||
146087474|NCT04393298|526841824|FG014|Overall Study|Lack of Efficacy|1|||
146087475|NCT04393298|526841810|FG000|Overall Study|Progression|1|||
146087476|NCT04393298|526841811|FG001|Overall Study|Progression|0|||
146087477|NCT04393298|526841812|FG002|Overall Study|Progression|0|||
146087478|NCT04393298|526841813|FG003|Overall Study|Progression|0|||
146087479|NCT04393298|526841814|FG004|Overall Study|Progression|0|||
146087480|NCT04393298|526841815|FG005|Overall Study|Progression|0|||
146087481|NCT04393298|526841816|FG006|Overall Study|Progression|0|||
146087482|NCT04393298|526841817|FG007|Overall Study|Progression|0|||
146087483|NCT04393298|526841818|FG008|Overall Study|Progression|0|||
146087484|NCT04393298|526841819|FG009|Overall Study|Progression|0|||
146087485|NCT04393298|526841820|FG010|Overall Study|Progression|1|||
146087486|NCT04393298|526841821|FG011|Overall Study|Progression|1|||
146087487|NCT04393298|526841822|FG012|Overall Study|Progression|0|||
146087488|NCT04393298|526841823|FG013|Overall Study|Progression|0|||
146087489|NCT04393298|526841824|FG014|Overall Study|Progression|0|||
146087490|NCT04393298|526841810|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
146087491|NCT04393298|526841811|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087492|NCT04393298|526841812|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087493|NCT04393298|526841813|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087494|NCT04393298|526841814|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087495|NCT04393298|526841815|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087496|NCT04393298|526841816|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087497|NCT04393298|526841817|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087498|NCT04393298|526841818|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087499|NCT04393298|526841819|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087500|NCT04393298|526841820|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087501|NCT04393298|526841821|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087502|NCT04393298|526841822|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087503|NCT04393298|526841823|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087504|NCT04393298|526841824|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
146087505|NCT04393298|526841810|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087506|NCT04393298|526841811|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
146087507|NCT04393298|526841812|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087508|NCT04393298|526841813|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087509|NCT04393298|526841814|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146233133|NCT03213457|527370746|FG002|Follow-Up Period|Other|31|||
146087510|NCT04393298|526841815|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146233134|NCT02951052|527370747|FG000|Overall Study|Adverse Event|13|||
145970251|NCT03834350|526405423|FG000|Overall Study|Withdrawal by Subject|1|||
145970252|NCT02701634|526405424|FG000|Overall Study|Adverse Event|2|||
145970253|NCT02701634|526405425|FG001|Overall Study|Adverse Event|3|||
145970254|NCT02701634|526405424|FG000|Overall Study|Death|1|||
145970255|NCT02701634|526405425|FG001|Overall Study|Death|0|||
145970256|NCT02701634|526405424|FG000|Overall Study|Investigator's Discretion|7|||
145970257|NCT02701634|526405425|FG001|Overall Study|Investigator's Discretion|4|||
145970258|NCT02701634|526405424|FG000|Overall Study|Study terminated by Sponsor|15|||
145970259|NCT02701634|526405425|FG001|Overall Study|Study terminated by Sponsor|17|||
145970260|NCT02701634|526405424|FG000|Overall Study|Withdrew Consent|6|||
145970261|NCT02701634|526405425|FG001|Overall Study|Withdrew Consent|7|||
145970262|NCT02701634|526405424|FG000|Overall Study|Randomized but not treated|1|||
145970263|NCT02701634|526405425|FG001|Overall Study|Randomized but not treated|0|||
145970264|NCT00961415|526405430|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
145970265|NCT00961415|526405431|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
145970266|NCT00961415|526405432|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
145970267|NCT00961415|526405430|FG000|Induction Treatment Phase|Death|77|||
145970268|NCT00961415|526405431|FG001|Induction Treatment Phase|Death|0|||
145970269|NCT00961415|526405432|FG002|Induction Treatment Phase|Death|0|||
145970270|NCT00961415|526405430|FG000|Induction Treatment Phase|Protocol Violation|1|||
145970271|NCT00961415|526405431|FG001|Induction Treatment Phase|Protocol Violation|0|||
145970272|NCT00961415|526405432|FG002|Induction Treatment Phase|Protocol Violation|0|||
145970273|NCT00961415|526405430|FG000|Induction Treatment Phase|Physician Decision|2|||
145970274|NCT00961415|526405431|FG001|Induction Treatment Phase|Physician Decision|0|||
145970275|NCT00961415|526405432|FG002|Induction Treatment Phase|Physician Decision|0|||
145970276|NCT00961415|526405430|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
145970277|NCT00961415|526405431|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
145970278|NCT00961415|526405432|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
145970279|NCT00961415|526405430|FG000|Induction Treatment Phase|Other Reason|5|||
145970280|NCT00961415|526405431|FG001|Induction Treatment Phase|Other Reason|0|||
145970281|NCT00961415|526405432|FG002|Induction Treatment Phase|Other Reason|0|||
145970282|NCT00961415|526405430|FG000|Maintenance Treatment Phase|Death|0|||
145970283|NCT00961415|526405431|FG001|Maintenance Treatment Phase|Death|42|||
145970284|NCT00961415|526405432|FG002|Maintenance Treatment Phase|Death|34|||
145970285|NCT00961415|526405430|FG000|Maintenance Treatment Phase|Investigators decision|0|||
145970286|NCT00961415|526405431|FG001|Maintenance Treatment Phase|Investigators decision|2|||
145970287|NCT00961415|526405432|FG002|Maintenance Treatment Phase|Investigators decision|0|||
145970288|NCT00961415|526405430|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145970289|NCT00961415|526405431|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
145970290|NCT00961415|526405432|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
145970291|NCT00961415|526405430|FG000|Maintenance Treatment Phase|Other reason|0|||
145970292|NCT00961415|526405431|FG001|Maintenance Treatment Phase|Other reason|1|||
145970293|NCT00961415|526405432|FG002|Maintenance Treatment Phase|Other reason|3|||
145970294|NCT01311661|526405435|FG000|Overall Study|Adverse Event|2|||
145970295|NCT01311661|526405435|FG000|Overall Study|Protocol Violation|3|||
145970296|NCT01311661|526405435|FG000|Overall Study|Withdrawal by Subject|2|||
145970297|NCT00284856|526405436|FG000|Overall Study|Adverse Event|3|||
145970298|NCT00284856|526405437|FG001|Overall Study|Adverse Event|3|||
145970299|NCT00284856|526405438|FG002|Overall Study|Adverse Event|3|||
145970300|NCT00284856|526405436|FG000|Overall Study|Lack of Efficacy|2|||
145970301|NCT00284856|526405437|FG001|Overall Study|Lack of Efficacy|1|||
145970302|NCT00284856|526405438|FG002|Overall Study|Lack of Efficacy|8|||
145970303|NCT00284856|526405436|FG000|Overall Study|Lost to Follow-up|25|||
145970304|NCT00284856|526405437|FG001|Overall Study|Lost to Follow-up|21|||
145970305|NCT00284856|526405438|FG002|Overall Study|Lost to Follow-up|22|||
145970306|NCT00284856|526405436|FG000|Overall Study|Protocol Violation|5|||
145970307|NCT00284856|526405437|FG001|Overall Study|Protocol Violation|4|||
145970308|NCT00284856|526405438|FG002|Overall Study|Protocol Violation|5|||
145970309|NCT00284856|526405436|FG000|Overall Study|Withdrawal by Subject|12|||
145970310|NCT00284856|526405437|FG001|Overall Study|Withdrawal by Subject|16|||
145970311|NCT00284856|526405438|FG002|Overall Study|Withdrawal by Subject|18|||
145970312|NCT00284856|526405436|FG000|Overall Study|Other|4|||
145970313|NCT00284856|526405437|FG001|Overall Study|Other|5|||
145970314|NCT00284856|526405438|FG002|Overall Study|Other|4|||
145970315|NCT03692949|526405439|FG000|Overall Study|Lost to Follow-up|0|||
145970316|NCT03692949|526405440|FG001|Overall Study|Lost to Follow-up|0|||
145970317|NCT03692949|526405441|FG002|Overall Study|Lost to Follow-up|0|||
145970318|NCT03692949|526405442|FG003|Overall Study|Lost to Follow-up|0|||
145970319|NCT03692949|526405443|FG004|Overall Study|Lost to Follow-up|0|||
145970320|NCT03692949|526405444|FG005|Overall Study|Lost to Follow-up|0|||
145970321|NCT03692949|526405445|FG006|Overall Study|Lost to Follow-up|0|||
145970322|NCT03692949|526405446|FG007|Overall Study|Lost to Follow-up|1|||
145970323|NCT03426878|526405454|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
145970324|NCT03426878|526405454|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
145970325|NCT03426878|526405454|FG000|Overall Study|Declined to receive results|3|||
145970326|NCT03426878|526405454|FG000|Overall Study|Received negative results by mailed letter|65|||
146233135|NCT02951052|527370748|FG001|Overall Study|Adverse Event|5|||
146233136|NCT02951052|527370747|FG000|Overall Study|Withdrawal by Subject|1|||
146233137|NCT02951052|527370748|FG001|Overall Study|Withdrawal by Subject|5|||
145970327|NCT03426878|526405454|FG000|Overall Study|Lost to Follow-up|177|||
145970328|NCT02855268|526405455|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
145970329|NCT02855268|526405456|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
145970330|NCT02855268|526405455|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
145970331|NCT02855268|526405456|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
145970332|NCT02855268|526405455|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
145970333|NCT02855268|526405456|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
145970334|NCT02855268|526405455|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
145970335|NCT02855268|526405456|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
145970336|NCT02855268|526405455|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
145970337|NCT02855268|526405456|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
145970338|NCT02855268|526405455|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
145970339|NCT02855268|526405456|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
145970340|NCT00402831|526405461|FG000|Overall Study|Lost to Follow-up|1|||
145970341|NCT00402831|526405462|FG001|Overall Study|Lost to Follow-up|2|||
145970342|NCT00402831|526405461|FG000|Overall Study|Non-compliance with protocol|0|||
145970343|NCT00402831|526405462|FG001|Overall Study|Non-compliance with protocol|1|||
145970344|NCT00671788|526405465|FG000|Overall Study|Adverse Event|8|||
145970345|NCT00671788|526405465|FG000|Overall Study|Refused further treatment|3|||
145970346|NCT00671788|526405465|FG000|Overall Study|Ineligible|1|||
145970347|NCT00671788|526405465|FG000|Overall Study|MD Decision|1|||
145970348|NCT00671788|526405465|FG000|Overall Study|Other|1|||
145970349|NCT02792504|526405468|FG000|Overall Study|Lost to Follow-up|24|||
145970350|NCT02792504|526405468|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
145970351|NCT01035138|526405469|FG000|Overall Study|Adverse Event|4|||
145970352|NCT01035138|526405470|FG001|Overall Study|Adverse Event|0|||
145970353|NCT01035138|526405471|FG002|Overall Study|Adverse Event|2|||
145970354|NCT01035138|526405469|FG000|Overall Study|Caregiver Decision|2|||
145970355|NCT01035138|526405470|FG001|Overall Study|Caregiver Decision|0|||
145970356|NCT01035138|526405471|FG002|Overall Study|Caregiver Decision|1|||
145970357|NCT01035138|526405469|FG000|Overall Study|Withdrawal by Subject|1|||
145970358|NCT01035138|526405470|FG001|Overall Study|Withdrawal by Subject|0|||
145970359|NCT01035138|526405471|FG002|Overall Study|Withdrawal by Subject|0|||
145970360|NCT01035138|526405469|FG000|Overall Study|Physician Decision|0|||
145970361|NCT01035138|526405470|FG001|Overall Study|Physician Decision|0|||
145970362|NCT01035138|526405471|FG002|Overall Study|Physician Decision|1|||
145970363|NCT01035138|526405469|FG000|Overall Study|Sponsor Decision|66|||
145970364|NCT01035138|526405470|FG001|Overall Study|Sponsor Decision|60|||
145970365|NCT01035138|526405471|FG002|Overall Study|Sponsor Decision|42|||
145970366|NCT01035138|526405469|FG000|Overall Study|Lost to Follow-up|0|||
145970367|NCT01035138|526405470|FG001|Overall Study|Lost to Follow-up|0|||
145970368|NCT01035138|526405471|FG002|Overall Study|Lost to Follow-up|1|||
145970369|NCT00848497|526405478|FG000|Overall Study|Screen failure|2|||
145970370|NCT00848497|526405479|FG001|Overall Study|Screen failure|0|||
145970371|NCT00848497|526405478|FG000|Overall Study|Withdrawal by Subject|0|||
145970372|NCT00848497|526405479|FG001|Overall Study|Withdrawal by Subject|1|||
145970373|NCT01832766|526405480|FG000|Washout|Lost to Follow-up|0|||
145970374|NCT01832766|526405481|FG001|Washout|Lost to Follow-up|1|||
145970375|NCT01114724|526405484|FG000|Overall Study|Death|8|||
145970376|NCT01114724|526405484|FG000|Overall Study|Lost to Follow-up|1|||
145970377|NCT01114724|526405484|FG000|Overall Study|Withdrawal by Subject|1|||
145970378|NCT04711005|526405494|FG000|Overall Study|Withdrawal by Subject|0|||
145970379|NCT04711005|526405495|FG001|Overall Study|Withdrawal by Subject|0|||
145970380|NCT04711005|526405496|FG002|Overall Study|Withdrawal by Subject|0|||
145970381|NCT04711005|526405497|FG003|Overall Study|Withdrawal by Subject|0|||
145970382|NCT04711005|526405498|FG004|Overall Study|Withdrawal by Subject|0|||
145970383|NCT04711005|526405499|FG005|Overall Study|Withdrawal by Subject|0|||
145970384|NCT04711005|526405500|FG006|Overall Study|Withdrawal by Subject|0|||
145970385|NCT04711005|526405501|FG007|Overall Study|Withdrawal by Subject|1|||
146233138|NCT02951052|527370747|FG000|Overall Study|Physician Decision|2|||
145970386|NCT04711005|526405502|FG008|Overall Study|Withdrawal by Subject|0|||
145970387|NCT04711005|526405503|FG009|Overall Study|Withdrawal by Subject|0|||
145970388|NCT04711005|526405494|FG000|Overall Study|Physician Decision|0|||
145970389|NCT04711005|526405495|FG001|Overall Study|Physician Decision|0|||
145970390|NCT04711005|526405496|FG002|Overall Study|Physician Decision|0|||
145970391|NCT04711005|526405497|FG003|Overall Study|Physician Decision|0|||
145970392|NCT04711005|526405498|FG004|Overall Study|Physician Decision|0|||
145970393|NCT04711005|526405499|FG005|Overall Study|Physician Decision|0|||
145970394|NCT04711005|526405500|FG006|Overall Study|Physician Decision|0|||
145970395|NCT04711005|526405501|FG007|Overall Study|Physician Decision|2|||
145970396|NCT04711005|526405502|FG008|Overall Study|Physician Decision|1|||
145970397|NCT04711005|526405503|FG009|Overall Study|Physician Decision|0|||
145970398|NCT03415178|526405510|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
145970399|NCT03415178|526405511|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
145970400|NCT03415178|526405510|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
145970401|NCT03415178|526405511|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
145970402|NCT02781324|526405512|FG000|Overall Study|Withdrawal by Subject|1|||
145970403|NCT02781324|526405513|FG001|Overall Study|Withdrawal by Subject|0|||
145970404|NCT02781324|526405512|FG000|Overall Study|Physician Decision|1|||
145970405|NCT02781324|526405513|FG001|Overall Study|Physician Decision|2|||
145970406|NCT00834041|526405514|FG000|Overall Study|Withdrawal by Subject|1|||
145970407|NCT00834041|526405515|FG001|Overall Study|Withdrawal by Subject|0|||
145970408|NCT00834041|526405514|FG000|Overall Study|Lost to Follow-up|0|||
145970409|NCT00834041|526405515|FG001|Overall Study|Lost to Follow-up|1|||
145970410|NCT03074500|526405516|FG000|Overall Study|Lost to Follow-up|1|||
145970411|NCT03074500|526405517|FG001|Overall Study|Lost to Follow-up|0|||
145970412|NCT03074500|526405518|FG002|Overall Study|Lost to Follow-up|0|||
145970413|NCT03074500|526405516|FG000|Overall Study|Lack of Efficacy|0|||
145970414|NCT03074500|526405517|FG001|Overall Study|Lack of Efficacy|1|||
145970415|NCT03074500|526405518|FG002|Overall Study|Lack of Efficacy|0|||
145970416|NCT03074500|526405516|FG000|Overall Study|Adverse Event|0|||
145970417|NCT03074500|526405517|FG001|Overall Study|Adverse Event|0|||
145970418|NCT03074500|526405518|FG002|Overall Study|Adverse Event|1|||
145970419|NCT03321721|526405519|FG000|Overall Study|Lost to Follow-up|4|||
145970420|NCT03321721|526405520|FG001|Overall Study|Lost to Follow-up|8|||
145970421|NCT03321721|526405521|FG002|Overall Study|Lost to Follow-up|11|||
145970422|NCT03608163|526405524|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
145970423|NCT03608163|526405525|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
145970424|NCT03353220|526405526|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
145970425|NCT03353220|526405527|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
145970426|NCT00661388|526405530|FG000|Overall Study|Adverse Event|14|||
145970427|NCT00661388|526405530|FG000|Overall Study|Protocol Violation|7|||
145970428|NCT00661388|526405530|FG000|Overall Study|Renal transplantation|1|||
145970429|NCT00661388|526405530|FG000|Overall Study|Dialysis initiation|1|||
145970430|NCT00661388|526405530|FG000|Overall Study|Administrative reasons|1|||
145970431|NCT04530630|526407198|FG000|Overall Study|Physician Decision|1|||
145970432|NCT03675308|526407201|FG000|Overall Study|Adverse Event|3|||
145970433|NCT03675308|526407202|FG001|Overall Study|Adverse Event|2|||
145970434|NCT03675308|526407201|FG000|Overall Study|Withdrawal by Subject|6|||
145970435|NCT03675308|526407202|FG001|Overall Study|Withdrawal by Subject|4|||
145970436|NCT03675308|526407201|FG000|Overall Study|Lost to Follow-up|3|||
145970437|NCT03675308|526407202|FG001|Overall Study|Lost to Follow-up|0|||
146233139|NCT02951052|527370748|FG001|Overall Study|Physician Decision|0|||
146233140|NCT02951052|527370747|FG000|Overall Study|Lost to Follow-up|1|||
146233141|NCT02951052|527370748|FG001|Overall Study|Lost to Follow-up|1|||
145970438|NCT03675308|526407201|FG000|Overall Study|Lack of Efficacy|1|||
145970439|NCT03675308|526407202|FG001|Overall Study|Lack of Efficacy|1|||
145970440|NCT03675308|526407201|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
145970441|NCT03675308|526407202|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
145970442|NCT03675308|526407201|FG000|Overall Study|Other|0|||
145970443|NCT03675308|526407202|FG001|Overall Study|Other|1|||
146087511|NCT04393298|526841816|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146233142|NCT02951052|527370747|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
145970444|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
145970445|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
145970446|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
145970447|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Death|1|||
145970448|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Death|1|||
145970449|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Death|0|||
145970450|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
145970451|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
145970452|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
145970453|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
145970454|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
145970455|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
145970456|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
145970457|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
145970458|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
145970459|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
145970460|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
145970461|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
145970462|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
145970463|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
145970464|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
145970465|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
145970466|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
145970467|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
145970468|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
145970469|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
145970470|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
145970471|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
145970472|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
145970473|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
145970474|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Other|10|||
145970475|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Other|4|||
145970476|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Other|0|||
145970477|NCT04006457|526407207|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
145970478|NCT04006457|526407208|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
145970479|NCT04006457|526407209|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
145970480|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
146087512|NCT04393298|526841817|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087513|NCT04393298|526841818|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087514|NCT04393298|526841819|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145970481|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
145970482|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
146087515|NCT04393298|526841820|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087516|NCT04393298|526841821|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087517|NCT04393298|526841822|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145970483|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
145970484|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
145970485|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
145970486|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
145970487|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
145970488|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
145970489|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
145970490|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
145970491|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
145970492|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
145970493|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
145970494|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
145970495|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Other|2|||
145970496|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Other|3|||
145970497|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Other|0|||
145970498|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
145970499|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
145970500|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
145970501|NCT04006457|526407207|FG000|Main Study: Treatment Period 2|Ongoing|86|||
145970502|NCT04006457|526407208|FG001|Main Study: Treatment Period 2|Ongoing|96|||
146087518|NCT04393298|526841823|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146233143|NCT02951052|527370748|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
146233144|NCT02951052|527370747|FG000|Overall Study|Protocol Violation|5|||
146233145|NCT02951052|527370748|FG001|Overall Study|Protocol Violation|3|||
146233146|NCT02951052|527370747|FG000|Overall Study|Lack of Efficacy|3|||
146233147|NCT02951052|527370748|FG001|Overall Study|Lack of Efficacy|4|||
146233148|NCT02951052|527370747|FG000|Overall Study|Ongoing|1|||
146233149|NCT02951052|527370748|FG001|Overall Study|Ongoing|0|||
146233150|NCT03473223|527370754|FG000|Overall Study|Lost to Follow-up|1|||
146233151|NCT03473223|527370755|FG001|Overall Study|Lost to Follow-up|1|||
146233152|NCT03473223|527370754|FG000|Overall Study|Withdrawal by Subject|47|||
146233153|NCT03473223|527370755|FG001|Overall Study|Withdrawal by Subject|42|||
146233154|NCT03473223|527370754|FG000|Overall Study|Indirect contact|32|||
146233155|NCT03473223|527370755|FG001|Overall Study|Indirect contact|29|||
146233156|NCT03473223|527370754|FG000|Overall Study|Other (Not specified)|32|||
146233157|NCT03473223|527370755|FG001|Overall Study|Other (Not specified)|20|||
146233158|NCT04755595|527370756|FG000|Overall Study|Lost to Follow-up|1|||
146233159|NCT00319696|527370757|FG000|Overall Study|Adverse Event|36|||
146233160|NCT00319696|527370757|FG000|Overall Study|withdrawal of consent|14|||
146233161|NCT00319696|527370757|FG000|Overall Study|administrative|7|||
146233162|NCT00319696|527370757|FG000|Overall Study|Lost to Follow-up|3|||
146233163|NCT00655499|527371436|FG000|Overall Study|not eligible|4|||
146233164|NCT01288443|527371439|FG000|Overall Study|Adverse Event|0|||
146233165|NCT01288443|527371440|FG001|Overall Study|Adverse Event|0|||
145970503|NCT04006457|526407209|FG002|Main Study: Treatment Period 2|Ongoing|0|||
145970504|NCT04006457|526407207|FG000|Main Study Observation Period|Adverse Event|1|||
145970505|NCT04006457|526407208|FG001|Main Study Observation Period|Adverse Event|1|||
145970506|NCT04006457|526407209|FG002|Main Study Observation Period|Adverse Event|0|||
145970507|NCT04006457|526407207|FG000|Main Study Observation Period|Lost to Follow-up|0|||
145970508|NCT04006457|526407208|FG001|Main Study Observation Period|Lost to Follow-up|1|||
145970509|NCT04006457|526407209|FG002|Main Study Observation Period|Lost to Follow-up|0|||
145970510|NCT04006457|526407207|FG000|Main Study Observation Period|Pregnancy|1|||
145970511|NCT04006457|526407208|FG001|Main Study Observation Period|Pregnancy|0|||
145970512|NCT04006457|526407209|FG002|Main Study Observation Period|Pregnancy|0|||
146233166|NCT01288443|527371441|FG002|Overall Study|Adverse Event|1|||
146233167|NCT01288443|527371442|FG003|Overall Study|Adverse Event|1|||
146233168|NCT01288443|527371443|FG004|Overall Study|Adverse Event|3|||
145970513|NCT04006457|526407207|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
146233169|NCT01288443|527371444|FG005|Overall Study|Adverse Event|1|||
146293583|NCT00421707|527590069|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
146293584|NCT00421707|527590070|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
146293585|NCT05056987|527590073|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
146293586|NCT05056987|527590074|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
146293587|NCT05056987|527590073|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
146293588|NCT05056987|527590074|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
146293589|NCT02409368|527590075|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
146293590|NCT02409368|527590076|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
146293591|NCT02409368|527590077|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
146293592|NCT02409368|527590078|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
146293593|NCT02409368|527590075|FG000|ECOG Reclassification|Death|1|||
146293594|NCT02409368|527590076|FG001|ECOG Reclassification|Death|5|||
146293595|NCT02409368|527590077|FG002|ECOG Reclassification|Death|0|||
145890158|NCT00350402|526104142|FG000|Overall Study|Lost to Follow-up|1|||
145890159|NCT00350402|526104143|FG001|Overall Study|Lost to Follow-up|1|||
145890160|NCT00645944|526104146|FG000|Randomized|Withdrawal by Subject|1|||
145890161|NCT00645944|526104147|FG001|Randomized|Withdrawal by Subject|2|||
145890162|NCT00645944|526104146|FG000|Received Medication|Adverse Event|2|||
145890163|NCT00645944|526104147|FG001|Received Medication|Adverse Event|1|||
145890164|NCT00645944|526104146|FG000|Received Medication|Withdrawal by Subject|1|||
145890165|NCT00645944|526104147|FG001|Received Medication|Withdrawal by Subject|1|||
145890166|NCT00645944|526104146|FG000|Received Medication|Lost to Follow-up|1|||
145890167|NCT00645944|526104147|FG001|Received Medication|Lost to Follow-up|0|||
145890168|NCT00645944|526104146|FG000|Received Medication|Protocol Violation|2|||
145890169|NCT00645944|526104147|FG001|Received Medication|Protocol Violation|1|||
145890170|NCT00834899|526104148|FG000|Overall Study|Withdrawal by Subject|1|||
145890171|NCT00834899|526104149|FG001|Overall Study|Withdrawal by Subject|1|||
145890172|NCT02377921|526104156|FG000|Overall Study|Subject non-compliance|1|||
145890173|NCT02377921|526104157|FG001|Overall Study|Subject non-compliance|1|||
145890174|NCT00706355|526104162|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
145890175|NCT00706355|526104163|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145890176|NCT00706355|526104164|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145890177|NCT00706355|526104165|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145890178|NCT00706355|526104162|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
145890179|NCT00706355|526104163|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145890180|NCT00706355|526104164|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145890181|NCT00706355|526104165|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145890182|NCT00706355|526104162|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
146293596|NCT02409368|527590078|FG003|ECOG Reclassification|Death|0|||
146293597|NCT02409368|527590075|FG000|ECOG Reclassification|Disease Progression|113|||
146293598|NCT02409368|527590076|FG001|ECOG Reclassification|Disease Progression|382|||
146293599|NCT02409368|527590077|FG002|ECOG Reclassification|Disease Progression|70|||
146293600|NCT02409368|527590078|FG003|ECOG Reclassification|Disease Progression|1|||
146293601|NCT02409368|527590075|FG000|ECOG Reclassification|Lost to Follow-up|1|||
146293602|NCT02409368|527590076|FG001|ECOG Reclassification|Lost to Follow-up|5|||
146293603|NCT02409368|527590077|FG002|ECOG Reclassification|Lost to Follow-up|0|||
146293604|NCT02409368|527590078|FG003|ECOG Reclassification|Lost to Follow-up|0|||
146293605|NCT02409368|527590075|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
145970514|NCT04006457|526407208|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
145970515|NCT04006457|526407209|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
145970516|NCT04006457|526407207|FG000|Main Study Observation Period|Other|8|||
145970517|NCT04006457|526407208|FG001|Main Study Observation Period|Other|16|||
145970518|NCT04006457|526407209|FG002|Main Study Observation Period|Other|0|||
145970519|NCT04006457|526407207|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
145970520|NCT04006457|526407208|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
145970521|NCT04006457|526407209|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
145970522|NCT04006457|526407207|FG000|Main Study Observation Period|Ongoing|2|||
145970523|NCT04006457|526407208|FG001|Main Study Observation Period|Ongoing|1|||
145970524|NCT04006457|526407209|FG002|Main Study Observation Period|Ongoing|0|||
145970525|NCT04006457|526407207|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
145970526|NCT04006457|526407208|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
145970527|NCT04006457|526407209|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
145970528|NCT03729362|526407210|FG000|Overall Study|Withdrawal by Subject|2|||
145970529|NCT03729362|526407211|FG001|Overall Study|Withdrawal by Subject|0|||
145970530|NCT03729362|526407210|FG000|Overall Study|Physician Decision|1|||
145970531|NCT03729362|526407211|FG001|Overall Study|Physician Decision|0|||
145970532|NCT03729362|526407210|FG000|Overall Study|COVID-19 Pandemic|1|||
145970533|NCT03729362|526407211|FG001|Overall Study|COVID-19 Pandemic|0|||
145970534|NCT03729362|526407210|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
146233170|NCT01288443|527371439|FG000|Overall Study|Poor compliance to protocol|0|||
146233171|NCT01288443|527371440|FG001|Overall Study|Poor compliance to protocol|0|||
146233172|NCT01288443|527371441|FG002|Overall Study|Poor compliance to protocol|0|||
146233173|NCT01288443|527371442|FG003|Overall Study|Poor compliance to protocol|0|||
146233174|NCT01288443|527371443|FG004|Overall Study|Poor compliance to protocol|0|||
146233175|NCT01288443|527371444|FG005|Overall Study|Poor compliance to protocol|1|||
146233176|NCT01288443|527371439|FG000|Overall Study|Participant Moved|0|||
146233177|NCT01288443|527371440|FG001|Overall Study|Participant Moved|0|||
146233178|NCT01288443|527371441|FG002|Overall Study|Participant Moved|0|||
145970535|NCT03729362|526407211|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
145970536|NCT03729362|526407210|FG000|Overall Study|Adverse Event|0|||
145970537|NCT03729362|526407211|FG001|Overall Study|Adverse Event|1|||
145970538|NCT03729362|526407210|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
145970539|NCT03729362|526407211|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
145970540|NCT02807259|526407213|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
145970541|NCT02807259|526407214|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
145970542|NCT02807259|526407213|FG000|Midline (3 Months)|migration, refusal, not available|30|||
145970543|NCT02807259|526407214|FG001|Midline (3 Months)|migration, refusal, not available|34|||
145970544|NCT02807259|526407213|FG000|Endline (3 Months)|migration, refusal, not available|35|||
145970545|NCT02807259|526407214|FG001|Endline (3 Months)|migration, refusal, not available|87|||
145970546|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
145970547|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
145970548|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
145970549|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
146233179|NCT01288443|527371442|FG003|Overall Study|Participant Moved|1|||
146233180|NCT01288443|527371443|FG004|Overall Study|Participant Moved|2|||
146233181|NCT01288443|527371444|FG005|Overall Study|Participant Moved|1|||
146233182|NCT01288443|527371439|FG000|Overall Study|Consent withdrawn by Participant|0|||
146233183|NCT01288443|527371440|FG001|Overall Study|Consent withdrawn by Participant|0|||
146233184|NCT01288443|527371441|FG002|Overall Study|Consent withdrawn by Participant|0|||
146233185|NCT01288443|527371442|FG003|Overall Study|Consent withdrawn by Participant|0|||
146233186|NCT01288443|527371443|FG004|Overall Study|Consent withdrawn by Participant|0|||
146293606|NCT02409368|527590076|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
146233187|NCT01288443|527371444|FG005|Overall Study|Consent withdrawn by Participant|1|||
146233188|NCT01288443|527371439|FG000|Overall Study|Lost to Follow-up|0|||
146233189|NCT01288443|527371440|FG001|Overall Study|Lost to Follow-up|1|||
146233190|NCT01288443|527371441|FG002|Overall Study|Lost to Follow-up|0|||
146293607|NCT02409368|527590077|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
146233191|NCT01288443|527371442|FG003|Overall Study|Lost to Follow-up|0|||
146233192|NCT01288443|527371443|FG004|Overall Study|Lost to Follow-up|0|||
145970550|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
145970551|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
145970552|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
145970553|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
145970554|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
145970555|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
145970556|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
145970557|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
145970558|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
145970559|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
145970560|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
145970561|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
146233193|NCT01288443|527371444|FG005|Overall Study|Lost to Follow-up|0|||
146233194|NCT01288443|527371439|FG000|Overall Study|Study drug auto-injector administration|0|||
146233195|NCT01288443|527371440|FG001|Overall Study|Study drug auto-injector administration|0|||
146233196|NCT01288443|527371441|FG002|Overall Study|Study drug auto-injector administration|0|||
146233197|NCT01288443|527371442|FG003|Overall Study|Study drug auto-injector administration|0|||
145970562|NCT00849056|526407215|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145970563|NCT00849056|526407216|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
145970564|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145970565|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
145970566|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
145970567|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
145970568|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
146233198|NCT01288443|527371443|FG004|Overall Study|Study drug auto-injector administration|1|||
146233199|NCT01288443|527371444|FG005|Overall Study|Study drug auto-injector administration|1|||
146233200|NCT01288443|527371439|FG000|Overall Study|Other than above|0|||
146233201|NCT01288443|527371440|FG001|Overall Study|Other than above|0|||
146233202|NCT01288443|527371441|FG002|Overall Study|Other than above|0|||
146233203|NCT01288443|527371442|FG003|Overall Study|Other than above|2|||
146233204|NCT01288443|527371443|FG004|Overall Study|Other than above|1|||
146233205|NCT01288443|527371444|FG005|Overall Study|Other than above|0|||
146233206|NCT01596972|527371445|FG000|Overall Study|Physician Decision|1|||
146233207|NCT01596972|527371446|FG001|Overall Study|Physician Decision|9|||
146233208|NCT01596972|527371445|FG000|Overall Study|Lost to Follow-up|0|||
146233209|NCT01596972|527371446|FG001|Overall Study|Lost to Follow-up|4|||
146233210|NCT01596972|527371445|FG000|Overall Study|Withdrawal by Subject|0|||
146233211|NCT01596972|527371446|FG001|Overall Study|Withdrawal by Subject|1|||
146233212|NCT01639131|527371448|FG000|Overall Study|Disease Progression|6|||
146233213|NCT03248492|527371450|FG000|Overall Study|Progressive Disease|24|||
146233214|NCT03248492|527371451|FG001|Overall Study|Progressive Disease|23|||
146233215|NCT03248492|527371452|FG002|Overall Study|Progressive Disease|11|||
146233216|NCT03248492|527371453|FG003|Overall Study|Progressive Disease|66|||
146233217|NCT03248492|527371454|FG004|Overall Study|Progressive Disease|1|||
146233218|NCT03248492|527371450|FG000|Overall Study|Adverse Event|14|||
146233219|NCT03248492|527371451|FG001|Overall Study|Adverse Event|13|||
146233220|NCT03248492|527371452|FG002|Overall Study|Adverse Event|9|||
146233221|NCT03248492|527371453|FG003|Overall Study|Adverse Event|22|||
146233222|NCT03248492|527371454|FG004|Overall Study|Adverse Event|2|||
146233223|NCT03248492|527371450|FG000|Overall Study|Withdrawal by Subject|5|||
146233224|NCT03248492|527371451|FG001|Overall Study|Withdrawal by Subject|4|||
146233225|NCT03248492|527371452|FG002|Overall Study|Withdrawal by Subject|0|||
146233226|NCT03248492|527371453|FG003|Overall Study|Withdrawal by Subject|8|||
146233227|NCT03248492|527371454|FG004|Overall Study|Withdrawal by Subject|1|||
146233228|NCT03248492|527371450|FG000|Overall Study|Physician Decision|1|||
146233229|NCT03248492|527371451|FG001|Overall Study|Physician Decision|1|||
146233230|NCT03248492|527371452|FG002|Overall Study|Physician Decision|1|||
146233231|NCT03248492|527371453|FG003|Overall Study|Physician Decision|7|||
146233232|NCT03248492|527371454|FG004|Overall Study|Physician Decision|0|||
146233233|NCT03248492|527371450|FG000|Overall Study|Death|1|||
146233234|NCT03248492|527371451|FG001|Overall Study|Death|1|||
146233235|NCT03248492|527371452|FG002|Overall Study|Death|0|||
146233236|NCT03248492|527371453|FG003|Overall Study|Death|6|||
146233237|NCT03248492|527371454|FG004|Overall Study|Death|0|||
146233238|NCT03248492|527371450|FG000|Overall Study|Study Terminated by Sponsor|3|||
146233239|NCT03248492|527371451|FG001|Overall Study|Study Terminated by Sponsor|1|||
146233240|NCT03248492|527371452|FG002|Overall Study|Study Terminated by Sponsor|0|||
146233241|NCT03248492|527371453|FG003|Overall Study|Study Terminated by Sponsor|7|||
146233242|NCT03248492|527371454|FG004|Overall Study|Study Terminated by Sponsor|0|||
146233243|NCT03248492|527371450|FG000|Overall Study|Other|2|||
146233244|NCT03248492|527371451|FG001|Overall Study|Other|5|||
146233245|NCT03248492|527371452|FG002|Overall Study|Other|0|||
146233246|NCT03248492|527371453|FG003|Overall Study|Other|14|||
146233247|NCT03248492|527371454|FG004|Overall Study|Other|0|||
146233248|NCT01315132|527371455|FG000|Overall Study|not treated due to disease progression|1|||
146233249|NCT04495621|527371456|FG000|Overall Study|Withdrawal by Subject|0|||
146233250|NCT04495621|527371457|FG001|Overall Study|Withdrawal by Subject|3|||
146233251|NCT04495621|527371456|FG000|Overall Study|Death|7|||
146233252|NCT04495621|527371457|FG001|Overall Study|Death|11|||
146233253|NCT04495621|527371456|FG000|Overall Study|Investigator Decision|0|||
146233254|NCT04495621|527371457|FG001|Overall Study|Investigator Decision|7|||
146233255|NCT04495621|527371456|FG000|Overall Study|Lost to Follow-up|0|||
146233256|NCT04495621|527371457|FG001|Overall Study|Lost to Follow-up|1|||
146233257|NCT05707351|527371463|FG000|Overall Study|Withdrawal by Subject|2|||
146233258|NCT05707351|527371463|FG000|Overall Study|Reason Not Specified|1|||
146233259|NCT05155306|527371478|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
146233260|NCT05155306|527371479|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
146233261|NCT05155306|527371480|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
146233262|NCT05155306|527371481|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
146233263|NCT05155306|527371478|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
146233264|NCT05155306|527371479|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
146233265|NCT05155306|527371480|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
146233266|NCT05155306|527371481|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
146233267|NCT04158141|527371482|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
146233268|NCT04158141|527371483|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
146233269|NCT04158141|527371484|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
146233270|NCT04158141|527371482|FG000|Step 1: Registration|Adverse Event|1|||
146233271|NCT04158141|527371483|FG001|Step 1: Registration|Adverse Event|0|||
146293608|NCT02409368|527590078|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
146293609|NCT02409368|527590075|FG000|ECOG Reclassification|Poor/non-compliance|0|||
146293610|NCT02409368|527590076|FG001|ECOG Reclassification|Poor/non-compliance|3|||
146293611|NCT02409368|527590077|FG002|ECOG Reclassification|Poor/non-compliance|2|||
146293612|NCT02409368|527590078|FG003|ECOG Reclassification|Poor/non-compliance|0|||
146293613|NCT02409368|527590075|FG000|ECOG Reclassification|Study drug toxicity|17|||
146293614|NCT02409368|527590076|FG001|ECOG Reclassification|Study drug toxicity|42|||
146293615|NCT02409368|527590077|FG002|ECOG Reclassification|Study drug toxicity|7|||
146293616|NCT02409368|527590078|FG003|ECOG Reclassification|Study drug toxicity|0|||
146293617|NCT02409368|527590075|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
146293618|NCT02409368|527590076|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
146293619|NCT02409368|527590077|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
146293620|NCT02409368|527590078|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
146293621|NCT02409368|527590075|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
146293622|NCT02409368|527590076|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
146293623|NCT02409368|527590077|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
146293624|NCT02409368|527590078|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
146293625|NCT02409368|527590075|FG000|ECOG Reclassification|Participant withdrew consent|2|||
146293626|NCT02409368|527590076|FG001|ECOG Reclassification|Participant withdrew consent|3|||
146293627|NCT02409368|527590077|FG002|ECOG Reclassification|Participant withdrew consent|4|||
146293628|NCT02409368|527590078|FG003|ECOG Reclassification|Participant withdrew consent|0|||
146293629|NCT02409368|527590075|FG000|ECOG Reclassification|Other Reasons|5|||
146293630|NCT02409368|527590076|FG001|ECOG Reclassification|Other Reasons|26|||
146293631|NCT02409368|527590077|FG002|ECOG Reclassification|Other Reasons|2|||
146293632|NCT02409368|527590078|FG003|ECOG Reclassification|Other Reasons|0|||
146293633|NCT02409368|527590075|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
146293634|NCT02409368|527590076|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
146293635|NCT02409368|527590077|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
146293636|NCT02409368|527590078|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
146293637|NCT01296347|527590079|FG000|Allocation|Withdrawal by Subject|1|||
146293638|NCT01296347|527590080|FG001|Allocation|Withdrawal by Subject|2|||
146233272|NCT04158141|527371484|FG002|Step 1: Registration|Adverse Event|0|||
146233273|NCT04158141|527371482|FG000|Step 1: Registration|Withdrawal by Subject|1|||
146233274|NCT04158141|527371483|FG001|Step 1: Registration|Withdrawal by Subject|0|||
146293639|NCT01296347|527590079|FG000|Allocation|Lack of Efficacy|1|||
146293640|NCT01296347|527590080|FG001|Allocation|Lack of Efficacy|2|||
146293641|NCT01296347|527590079|FG000|Allocation|not received infusion|1|||
146293642|NCT01296347|527590080|FG001|Allocation|not received infusion|0|||
146293643|NCT01296347|527590079|FG000|6 Week Follow up|Death|0|||
146293644|NCT01296347|527590080|FG001|6 Week Follow up|Death|1|||
146293645|NCT01296347|527590079|FG000|3 Month Follow up|Death|1|||
146233275|NCT04158141|527371484|FG002|Step 1: Registration|Withdrawal by Subject|0|||
146233276|NCT04158141|527371482|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
146293646|NCT01296347|527590080|FG001|3 Month Follow up|Death|0|||
146293647|NCT01296347|527590079|FG000|3 Month Follow up|Lost to Follow-up|0|||
146293648|NCT01296347|527590080|FG001|3 Month Follow up|Lost to Follow-up|1|||
146293649|NCT01296347|527590079|FG000|6 Month Follow up|Death|2|||
146293650|NCT01296347|527590080|FG001|6 Month Follow up|Death|1|||
146293651|NCT01296347|527590079|FG000|6 Month Follow up|Lost to Follow-up|0|||
146293652|NCT01296347|527590080|FG001|6 Month Follow up|Lost to Follow-up|1|||
146293653|NCT01296347|527590079|FG000|12 Month Follow up|Lost to Follow-up|3|||
146293654|NCT01296347|527590080|FG001|12 Month Follow up|Lost to Follow-up|1|||
146293655|NCT01296347|527590079|FG000|12 Month Follow up|Death|1|||
146293656|NCT01296347|527590080|FG001|12 Month Follow up|Death|1|||
146293657|NCT01296347|527590079|FG000|12 Month Follow up|Withdrawal by Subject|0|||
146293658|NCT01296347|527590080|FG001|12 Month Follow up|Withdrawal by Subject|1|||
146293659|NCT01948908|527590081|FG000|Overall Study|Protocol Violation|1|||
146293660|NCT01948908|527590082|FG001|Overall Study|Protocol Violation|0|||
146293661|NCT01948908|527590083|FG002|Overall Study|Protocol Violation|2|||
146293662|NCT02240693|527590084|FG000|Overall Study|Adverse Event|0|||
146293663|NCT02240693|527590085|FG001|Overall Study|Adverse Event|0|||
146293664|NCT02240693|527590086|FG002|Overall Study|Adverse Event|0|||
146293665|NCT02240693|527590087|FG003|Overall Study|Adverse Event|0|||
146293666|NCT02240693|527590088|FG004|Overall Study|Adverse Event|1|||
146293667|NCT02240693|527590084|FG000|Overall Study|Withdrawal by Subject|0|||
146293668|NCT02240693|527590085|FG001|Overall Study|Withdrawal by Subject|0|||
146293669|NCT02240693|527590086|FG002|Overall Study|Withdrawal by Subject|2|||
146293670|NCT02240693|527590087|FG003|Overall Study|Withdrawal by Subject|1|||
146293671|NCT02240693|527590088|FG004|Overall Study|Withdrawal by Subject|0|||
146293672|NCT02240693|527590084|FG000|Overall Study|Other than specified|0|||
146293673|NCT02240693|527590085|FG001|Overall Study|Other than specified|0|||
146293674|NCT02240693|527590086|FG002|Overall Study|Other than specified|2|||
146293675|NCT02240693|527590087|FG003|Overall Study|Other than specified|0|||
146293676|NCT02240693|527590088|FG004|Overall Study|Other than specified|0|||
145890183|NCT00706355|526104163|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
146293677|NCT02041520|527590090|FG000|Overall Study|Adverse Event|2|||
146293678|NCT02041520|527590091|FG001|Overall Study|Adverse Event|1|||
146293679|NCT02041520|527590090|FG000|Overall Study|Withdrawal by Subject|3|||
146293680|NCT02041520|527590091|FG001|Overall Study|Withdrawal by Subject|4|||
146293681|NCT02041520|527590090|FG000|Overall Study|Protocol Violation|1|||
146293682|NCT02041520|527590091|FG001|Overall Study|Protocol Violation|0|||
146293683|NCT02041520|527590090|FG000|Overall Study|Lost to Follow-up|0|||
146293684|NCT02041520|527590091|FG001|Overall Study|Lost to Follow-up|1|||
146293685|NCT02041520|527590090|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
146233277|NCT04158141|527371483|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
146233278|NCT04158141|527371484|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
146233279|NCT04121741|527371485|FG000|Overall Study|Protocol Violation|1|||
146233280|NCT04121741|527371486|FG001|Overall Study|Protocol Violation|0|||
146233281|NCT04121741|527371487|FG002|Overall Study|Protocol Violation|0|||
146233282|NCT04121741|527371488|FG003|Overall Study|Protocol Violation|0|||
146233283|NCT04121741|527371489|FG004|Overall Study|Protocol Violation|0|||
146233284|NCT04121741|527371490|FG005|Overall Study|Protocol Violation|0|||
146293686|NCT02041520|527590091|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
146293687|NCT00413972|527590094|FG000|Overall Study|Adverse Event|2|||
146293688|NCT00413972|527590095|FG001|Overall Study|Adverse Event|1|||
146293689|NCT00413972|527590096|FG002|Overall Study|Adverse Event|0|||
146293690|NCT00413972|527590097|FG003|Overall Study|Adverse Event|0|||
146293691|NCT00413972|527590094|FG000|Overall Study|Lost to Follow-up|1|||
146293692|NCT00413972|527590095|FG001|Overall Study|Lost to Follow-up|2|||
146293693|NCT00413972|527590096|FG002|Overall Study|Lost to Follow-up|1|||
146293694|NCT00413972|527590097|FG003|Overall Study|Lost to Follow-up|0|||
146293695|NCT00413972|527590094|FG000|Overall Study|Withdrawal by Subject|4|||
146293696|NCT00413972|527590095|FG001|Overall Study|Withdrawal by Subject|5|||
146293697|NCT00413972|527590096|FG002|Overall Study|Withdrawal by Subject|7|||
146293698|NCT00413972|527590097|FG003|Overall Study|Withdrawal by Subject|2|||
146293699|NCT00413972|527590094|FG000|Overall Study|Protocol Violation|0|||
146293700|NCT00413972|527590095|FG001|Overall Study|Protocol Violation|0|||
146293701|NCT00413972|527590096|FG002|Overall Study|Protocol Violation|2|||
146293702|NCT00413972|527590097|FG003|Overall Study|Protocol Violation|0|||
146293703|NCT00413972|527590094|FG000|Overall Study|Other|0|||
146293704|NCT00413972|527590095|FG001|Overall Study|Other|0|||
145890184|NCT00706355|526104164|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
145890185|NCT00706355|526104165|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
145890186|NCT00706355|526104162|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145890187|NCT00706355|526104163|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
145890188|NCT00706355|526104164|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145890189|NCT00706355|526104165|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145890190|NCT00706355|526104162|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145890191|NCT00706355|526104163|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
145890192|NCT00706355|526104164|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145890193|NCT00706355|526104165|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145890194|NCT00706355|526104162|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145890195|NCT00706355|526104163|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145890196|NCT00706355|526104164|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
146293705|NCT00413972|527590096|FG002|Overall Study|Other|0|||
146293706|NCT00413972|527590097|FG003|Overall Study|Other|1|||
146293707|NCT01759407|527590098|FG000|Overall Study|Protocol Violation|0|||
146293708|NCT01759407|527590099|FG001|Overall Study|Protocol Violation|2|||
146233285|NCT01084863|527371491|FG000|Main Study Treatment Period|Disease progression|11|||
146233286|NCT01084863|527371492|FG001|Main Study Treatment Period|Disease progression|7|||
146233287|NCT01084863|527371491|FG000|Main Study Treatment Period|Adverse Event|5|||
146233288|NCT01084863|527371492|FG001|Main Study Treatment Period|Adverse Event|3|||
146233289|NCT01084863|527371491|FG000|Main Study Treatment Period|Other Reason|0|||
146233290|NCT01084863|527371492|FG001|Main Study Treatment Period|Other Reason|1|||
146233291|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
146233292|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
146233293|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
146233294|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
146233295|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
146233296|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
146233297|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
146233298|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
146233299|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Other|0|||
146233300|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Other|1|||
146233301|NCT01084863|527371491|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
146233302|NCT01084863|527371492|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
146233303|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
146233304|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
146233305|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
146233306|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
146233307|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
146233308|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
146233309|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
146233310|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
146233311|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
146233312|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
146233313|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
146233314|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
146233315|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
146233316|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
146233317|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
146233318|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
146233319|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
146233320|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
146233321|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
146233322|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
146233323|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
146233324|NCT04505722|527371493|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
146233325|NCT04505722|527371494|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
146233326|NCT04505722|527371495|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
146233327|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
146233328|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
146233329|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
146233330|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
146233331|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
146233332|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
146233333|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
146233334|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
146233335|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
146233336|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
146233337|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
146233338|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
146233339|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
146293709|NCT02520284|527590100|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
146293710|NCT02520284|527590101|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
146293711|NCT02520284|527590102|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
146293712|NCT02520284|527590100|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146293713|NCT02520284|527590101|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146293714|NCT02520284|527590102|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
146293715|NCT02520284|527590100|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
146293716|NCT02520284|527590101|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
146293717|NCT02520284|527590102|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
146233340|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
146293718|NCT02520284|527590100|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
146233341|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
146233342|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
146233343|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
146233344|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
146233345|NCT04505722|527371493|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
146233346|NCT04505722|527371494|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
146233347|NCT04505722|527371495|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
146233348|NCT05827068|527371496|FG000|Overall Study|Lost to Follow-up|1|||
146233349|NCT05827068|527371497|FG001|Overall Study|Lost to Follow-up|4|||
146233350|NCT05827068|527371498|FG002|Overall Study|Lost to Follow-up|1|||
146233351|NCT05827068|527371499|FG003|Overall Study|Lost to Follow-up|1|||
146233352|NCT05827068|527371500|FG004|Overall Study|Lost to Follow-up|2|||
146233353|NCT05827068|527371501|FG005|Overall Study|Lost to Follow-up|4|||
146233354|NCT05827068|527371502|FG006|Overall Study|Lost to Follow-up|1|||
146233355|NCT05827068|527371496|FG000|Overall Study|Withdrawal by Subject|4|||
146293719|NCT02520284|527590101|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
146293720|NCT02520284|527590102|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
146293721|NCT02520284|527590100|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
146293722|NCT02520284|527590101|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
146293723|NCT02520284|527590102|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
146293724|NCT02520284|527590100|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
146293725|NCT02520284|527590101|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
146293726|NCT02520284|527590102|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
146293727|NCT02520284|527590100|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
146293728|NCT02520284|527590101|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
146293729|NCT02520284|527590102|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
146293730|NCT02520284|527590100|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
146293731|NCT02520284|527590101|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
146293732|NCT02520284|527590102|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
146293733|NCT02520284|527590100|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
146293734|NCT02520284|527590101|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
145890197|NCT00706355|526104165|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145890198|NCT00706355|526104162|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
146233356|NCT05827068|527371497|FG001|Overall Study|Withdrawal by Subject|0|||
146233357|NCT05827068|527371498|FG002|Overall Study|Withdrawal by Subject|1|||
146233358|NCT05827068|527371499|FG003|Overall Study|Withdrawal by Subject|2|||
146233359|NCT05827068|527371500|FG004|Overall Study|Withdrawal by Subject|3|||
145890199|NCT00706355|526104163|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
145890200|NCT00706355|526104164|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
145890201|NCT00706355|526104165|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
145890202|NCT00706355|526104162|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145890203|NCT00706355|526104163|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145890204|NCT00706355|526104164|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145890205|NCT00706355|526104165|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
145890206|NCT00706355|526104162|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145890207|NCT00706355|526104163|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145890208|NCT00706355|526104164|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145890209|NCT00706355|526104165|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
145890210|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
145890211|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
145890212|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
145890213|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
145890214|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
145890215|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
145890216|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
145890217|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
145890218|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
145890219|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
145890220|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
145890221|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
145890222|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
145890223|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
145890224|NCT02510014|526104166|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
145890225|NCT02510014|526104167|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
145890226|NCT02510014|526104166|FG000|Treatment Period|Adverse Event|11|||
145970569|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
146233360|NCT05827068|527371501|FG005|Overall Study|Withdrawal by Subject|0|||
146087519|NCT04393298|526841824|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
146087520|NCT04393298|526841810|FG000|Overall Study|Clinical Progression|0|||
146087521|NCT04393298|526841811|FG001|Overall Study|Clinical Progression|2|||
146087522|NCT04393298|526841812|FG002|Overall Study|Clinical Progression|0|||
146087523|NCT04393298|526841813|FG003|Overall Study|Clinical Progression|0|||
146087524|NCT04393298|526841814|FG004|Overall Study|Clinical Progression|0|||
146087525|NCT04393298|526841815|FG005|Overall Study|Clinical Progression|0|||
146087526|NCT04393298|526841816|FG006|Overall Study|Clinical Progression|0|||
146087527|NCT04393298|526841817|FG007|Overall Study|Clinical Progression|0|||
146087528|NCT04393298|526841818|FG008|Overall Study|Clinical Progression|0|||
146087529|NCT04393298|526841819|FG009|Overall Study|Clinical Progression|0|||
146087530|NCT04393298|526841820|FG010|Overall Study|Clinical Progression|0|||
146087531|NCT04393298|526841821|FG011|Overall Study|Clinical Progression|0|||
146087532|NCT04393298|526841822|FG012|Overall Study|Clinical Progression|0|||
146087533|NCT04393298|526841823|FG013|Overall Study|Clinical Progression|0|||
146087534|NCT04393298|526841824|FG014|Overall Study|Clinical Progression|0|||
146087535|NCT04393298|526841810|FG000|Overall Study|Disease Progression|0|||
146087536|NCT04393298|526841811|FG001|Overall Study|Disease Progression|1|||
146087537|NCT04393298|526841812|FG002|Overall Study|Disease Progression|0|||
146087538|NCT04393298|526841813|FG003|Overall Study|Disease Progression|0|||
146087539|NCT04393298|526841814|FG004|Overall Study|Disease Progression|0|||
146087540|NCT04393298|526841815|FG005|Overall Study|Disease Progression|3|||
146087541|NCT04393298|526841816|FG006|Overall Study|Disease Progression|2|||
146087542|NCT04393298|526841817|FG007|Overall Study|Disease Progression|1|||
146087543|NCT04393298|526841818|FG008|Overall Study|Disease Progression|2|||
146087544|NCT04393298|526841819|FG009|Overall Study|Disease Progression|1|||
146087545|NCT04393298|526841820|FG010|Overall Study|Disease Progression|0|||
146087546|NCT04393298|526841821|FG011|Overall Study|Disease Progression|3|||
146087547|NCT04393298|526841822|FG012|Overall Study|Disease Progression|0|||
146087548|NCT04393298|526841823|FG013|Overall Study|Disease Progression|0|||
146087549|NCT04393298|526841824|FG014|Overall Study|Disease Progression|1|||
146087550|NCT04393298|526841810|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087551|NCT04393298|526841811|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087552|NCT04393298|526841812|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
146087553|NCT04393298|526841813|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087554|NCT04393298|526841814|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087555|NCT04393298|526841815|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087556|NCT04393298|526841816|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087557|NCT04393298|526841817|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087558|NCT04393298|526841818|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087559|NCT04393298|526841819|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087560|NCT04393298|526841820|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087561|NCT04393298|526841821|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146087562|NCT04393298|526841822|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146233361|NCT05827068|527371502|FG006|Overall Study|Withdrawal by Subject|1|||
146233362|NCT05827068|527371496|FG000|Overall Study|Physician Decision|0|||
146233363|NCT05827068|527371497|FG001|Overall Study|Physician Decision|0|||
146233364|NCT05827068|527371498|FG002|Overall Study|Physician Decision|0|||
146233365|NCT05827068|527371499|FG003|Overall Study|Physician Decision|0|||
146233366|NCT05827068|527371500|FG004|Overall Study|Physician Decision|1|||
146233367|NCT05827068|527371501|FG005|Overall Study|Physician Decision|0|||
146233368|NCT05827068|527371502|FG006|Overall Study|Physician Decision|1|||
146233369|NCT05827068|527371496|FG000|Overall Study|Other Than Specified|0|||
146233370|NCT05827068|527371497|FG001|Overall Study|Other Than Specified|1|||
146233371|NCT05827068|527371498|FG002|Overall Study|Other Than Specified|0|||
146233372|NCT05827068|527371499|FG003|Overall Study|Other Than Specified|0|||
146233373|NCT05827068|527371500|FG004|Overall Study|Other Than Specified|0|||
146233374|NCT05827068|527371501|FG005|Overall Study|Other Than Specified|0|||
146233375|NCT05827068|527371502|FG006|Overall Study|Other Than Specified|0|||
146233376|NCT00319020|527371503|FG000|Overall Study|Death|2|||
146233377|NCT00319020|527371504|FG001|Overall Study|Death|2|||
146233378|NCT00319020|527371503|FG000|Overall Study|Withdrawal by Subject|4|||
146233379|NCT00319020|527371504|FG001|Overall Study|Withdrawal by Subject|1|||
146233380|NCT00319020|527371503|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
146233381|NCT00319020|527371504|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
146233382|NCT00319020|527371503|FG000|Overall Study|Administrative reason|0|||
146233383|NCT00319020|527371504|FG001|Overall Study|Administrative reason|5|||
146233384|NCT00319020|527371503|FG000|Overall Study|Disease progression|0|||
146087563|NCT04393298|526841823|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
146233385|NCT00319020|527371504|FG001|Overall Study|Disease progression|2|||
146233386|NCT00319020|527371503|FG000|Overall Study|Transplant|0|||
146233387|NCT00319020|527371504|FG001|Overall Study|Transplant|1|||
146233388|NCT00319020|527371503|FG000|Overall Study|Treatment failure|0|||
146233389|NCT00319020|527371504|FG001|Overall Study|Treatment failure|1|||
146233390|NCT00319020|527371503|FG000|Overall Study|Adverse Event|0|||
146233391|NCT00319020|527371504|FG001|Overall Study|Adverse Event|1|||
146233392|NCT04530487|527372191|FG000|Overall Study|Death|1|||
146233393|NCT04977583|527372192|FG000|Overall Study|Lost to Follow-up|8|||
146233394|NCT04977583|527372193|FG001|Overall Study|Lost to Follow-up|4|||
146233395|NCT04977583|527372194|FG002|Overall Study|Lost to Follow-up|13|||
146233396|NCT04977583|527372192|FG000|Overall Study|Withdrawal by Subject|3|||
146233397|NCT04977583|527372193|FG001|Overall Study|Withdrawal by Subject|2|||
146087564|NCT04393298|526841824|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145890227|NCT02510014|526104167|FG001|Treatment Period|Adverse Event|4|||
146233398|NCT04977583|527372194|FG002|Overall Study|Withdrawal by Subject|1|||
146233399|NCT02285270|527372202|FG000|Overall Study|Lost to Follow-up|1|||
146233400|NCT02285270|527372202|FG000|Overall Study|Physician Decision|3|||
146233401|NCT02285270|527372202|FG000|Overall Study|Determined to be ineligible|1|||
146233402|NCT00439270|527372203|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
146233403|NCT00439270|527372204|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
146233404|NCT00439270|527372205|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
146233405|NCT00439270|527372206|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
146233406|NCT00439270|527372207|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
146233407|NCT00439270|527372203|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146233408|NCT00439270|527372204|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
146233409|NCT00439270|527372205|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146087565|NCT04393298|526841810|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087566|NCT04393298|526841811|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087567|NCT04393298|526841812|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
146087568|NCT04393298|526841813|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087569|NCT04393298|526841814|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087570|NCT04393298|526841815|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087571|NCT04393298|526841816|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087572|NCT04393298|526841817|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087573|NCT04393298|526841818|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087574|NCT04393298|526841819|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087575|NCT04393298|526841820|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087576|NCT04393298|526841821|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087577|NCT04393298|526841822|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087578|NCT04393298|526841823|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087579|NCT04393298|526841824|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
146087580|NCT04393298|526841810|FG000|Overall Study|Progressive Disease (PD)|0|||
146087581|NCT04393298|526841811|FG001|Overall Study|Progressive Disease (PD)|0|||
146087582|NCT04393298|526841812|FG002|Overall Study|Progressive Disease (PD)|0|||
146087583|NCT04393298|526841813|FG003|Overall Study|Progressive Disease (PD)|3|||
146087584|NCT04393298|526841814|FG004|Overall Study|Progressive Disease (PD)|0|||
146087585|NCT04393298|526841815|FG005|Overall Study|Progressive Disease (PD)|0|||
146087586|NCT04393298|526841816|FG006|Overall Study|Progressive Disease (PD)|0|||
146087587|NCT04393298|526841817|FG007|Overall Study|Progressive Disease (PD)|0|||
146087588|NCT04393298|526841818|FG008|Overall Study|Progressive Disease (PD)|0|||
146087589|NCT04393298|526841819|FG009|Overall Study|Progressive Disease (PD)|0|||
146087590|NCT04393298|526841820|FG010|Overall Study|Progressive Disease (PD)|0|||
146087591|NCT04393298|526841821|FG011|Overall Study|Progressive Disease (PD)|0|||
146087592|NCT04393298|526841822|FG012|Overall Study|Progressive Disease (PD)|0|||
146087593|NCT04393298|526841823|FG013|Overall Study|Progressive Disease (PD)|0|||
146087594|NCT04393298|526841824|FG014|Overall Study|Progressive Disease (PD)|0|||
146087595|NCT04393298|526841810|FG000|Overall Study|Started a New Cancer Treatment|0|||
146087596|NCT04393298|526841811|FG001|Overall Study|Started a New Cancer Treatment|0|||
146087597|NCT04393298|526841812|FG002|Overall Study|Started a New Cancer Treatment|0|||
146087598|NCT04393298|526841813|FG003|Overall Study|Started a New Cancer Treatment|0|||
146087599|NCT04393298|526841814|FG004|Overall Study|Started a New Cancer Treatment|1|||
146087600|NCT04393298|526841815|FG005|Overall Study|Started a New Cancer Treatment|0|||
146087601|NCT04393298|526841816|FG006|Overall Study|Started a New Cancer Treatment|0|||
146087602|NCT04393298|526841817|FG007|Overall Study|Started a New Cancer Treatment|0|||
146087603|NCT04393298|526841818|FG008|Overall Study|Started a New Cancer Treatment|0|||
146087604|NCT04393298|526841819|FG009|Overall Study|Started a New Cancer Treatment|0|||
146087605|NCT04393298|526841820|FG010|Overall Study|Started a New Cancer Treatment|0|||
146087606|NCT04393298|526841821|FG011|Overall Study|Started a New Cancer Treatment|0|||
146087607|NCT04393298|526841822|FG012|Overall Study|Started a New Cancer Treatment|0|||
146087608|NCT04393298|526841823|FG013|Overall Study|Started a New Cancer Treatment|0|||
146087609|NCT04393298|526841824|FG014|Overall Study|Started a New Cancer Treatment|0|||
146087610|NCT04393298|526841810|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087611|NCT04393298|526841811|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087612|NCT04393298|526841812|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087613|NCT04393298|526841813|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087614|NCT04393298|526841814|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
146233410|NCT00439270|527372206|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146233411|NCT00439270|527372207|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
146233412|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
146233413|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
146233414|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
146233415|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
146233416|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
146233417|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146233418|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146233419|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146233420|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
146233421|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
146233422|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146233423|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146233424|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146233425|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
146233426|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
146233427|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146233428|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146233429|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146233430|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
146233431|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
146233432|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146233433|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146233434|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146233435|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
146233436|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
146233437|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146233438|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146233439|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146233440|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
146233441|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
146233442|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146233443|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146233444|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146233445|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
146233446|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
146233447|NCT00439270|527372203|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146233448|NCT00439270|527372204|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146233449|NCT00439270|527372205|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146233450|NCT00439270|527372206|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
146233451|NCT00439270|527372207|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
146233452|NCT04334317|527372208|FG000|Overall Study|Adverse Event|1|||
146233453|NCT04334317|527372209|FG001|Overall Study|Adverse Event|2|||
146233454|NCT04334317|527372210|FG002|Overall Study|Adverse Event|0|||
146233455|NCT04334317|527372211|FG003|Overall Study|Adverse Event|0|||
146233456|NCT04334317|527372208|FG000|Overall Study|Protocol Deviation|0|||
146233457|NCT04334317|527372209|FG001|Overall Study|Protocol Deviation|1|||
146233458|NCT04334317|527372210|FG002|Overall Study|Protocol Deviation|0|||
146233459|NCT04334317|527372211|FG003|Overall Study|Protocol Deviation|0|||
146233460|NCT04334317|527372208|FG000|Overall Study|Withdrawal by Subject|2|||
146233461|NCT04334317|527372209|FG001|Overall Study|Withdrawal by Subject|2|||
146233462|NCT04334317|527372210|FG002|Overall Study|Withdrawal by Subject|0|||
146233463|NCT04334317|527372211|FG003|Overall Study|Withdrawal by Subject|0|||
146233464|NCT03709706|527372213|FG000|Overall Study|Adverse Event|0|||
146233465|NCT03709706|527372214|FG001|Overall Study|Adverse Event|1|||
146233466|NCT03709706|527372213|FG000|Overall Study|Physician Decision|14|||
146233467|NCT03709706|527372214|FG001|Overall Study|Physician Decision|8|||
146233468|NCT03709706|527372213|FG000|Overall Study|Withdrawal by Subject|2|||
146233469|NCT03709706|527372214|FG001|Overall Study|Withdrawal by Subject|1|||
146233470|NCT03709706|527372213|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
146233471|NCT03709706|527372214|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
146233472|NCT03183050|527372215|FG000|Overall Study|Lost to Follow-up|23|||
146233473|NCT02797132|527372216|FG000|Part A (15 Days)|Adverse Event|1|||
146233474|NCT02797132|527372216|FG000|Part B (24 Weeks)|Adverse Event|3|||
146233475|NCT01371994|527372222|FG000|Overall Study|Adverse Event|3|||
146233476|NCT01371994|527372223|FG001|Overall Study|Adverse Event|6|||
146233477|NCT01371994|527372222|FG000|Overall Study|Lack of Efficacy|3|||
146233478|NCT01371994|527372223|FG001|Overall Study|Lack of Efficacy|0|||
145890228|NCT02510014|526104166|FG000|Treatment Period|Withdrawal symptoms|3|||
145890229|NCT02510014|526104167|FG001|Treatment Period|Withdrawal symptoms|0|||
145890230|NCT02510014|526104166|FG000|Treatment Period|Lost to Follow-up|80|||
145890231|NCT02510014|526104167|FG001|Treatment Period|Lost to Follow-up|19|||
145890232|NCT02510014|526104166|FG000|Treatment Period|Physician Decision|5|||
146233479|NCT01371994|527372222|FG000|Overall Study|Withdrawal by Subject|13|||
146233480|NCT01371994|527372223|FG001|Overall Study|Withdrawal by Subject|7|||
146233481|NCT01371994|527372222|FG000|Overall Study|Lost to Follow-up|1|||
146233482|NCT01371994|527372223|FG001|Overall Study|Lost to Follow-up|1|||
146233483|NCT01371994|527372222|FG000|Overall Study|Protocol Violation|24|||
146233484|NCT01371994|527372223|FG001|Overall Study|Protocol Violation|17|||
146233485|NCT01371994|527372222|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
146233486|NCT01371994|527372223|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
146233487|NCT01371994|527372222|FG000|Overall Study|Physician Decision|1|||
146087615|NCT04393298|526841815|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087616|NCT04393298|526841816|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087617|NCT04393298|526841817|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087618|NCT04393298|526841818|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087619|NCT04393298|526841819|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087620|NCT04393298|526841820|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087621|NCT04393298|526841821|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146233488|NCT01371994|527372223|FG001|Overall Study|Physician Decision|1|||
146233489|NCT01371994|527372222|FG000|Overall Study|Miscellaneous Reasons|6|||
146293735|NCT02520284|527590102|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
146293736|NCT02520284|527590100|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
146293737|NCT02520284|527590101|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
146293738|NCT02520284|527590102|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
146293739|NCT02520284|527590100|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
146233490|NCT01371994|527372223|FG001|Overall Study|Miscellaneous Reasons|4|||
146233491|NCT00087685|527372224|FG000|Overall Study|Adverse Event|5|||
146233492|NCT00087685|527372224|FG000|Overall Study|Non-Compliance|1|||
146233493|NCT00087685|527372224|FG000|Overall Study|Progressive Disease|5|||
146233494|NCT00087685|527372224|FG000|Overall Study|Withdrawal by Subject|3|||
146233495|NCT04018495|527372225|FG000|Overall Study|Physician Decision|1|||
146233496|NCT03275285|527372229|FG000|Overall Study|Ongoing|45|||
146233497|NCT03275285|527372230|FG001|Overall Study|Ongoing|69|||
146233498|NCT02500576|527372234|FG000|Overall Study|Adverse Event|0|||
146233499|NCT02500576|527372235|FG001|Overall Study|Adverse Event|1|||
146233500|NCT02500576|527372234|FG000|Overall Study|Death|2|||
146233501|NCT02500576|527372235|FG001|Overall Study|Death|1|||
146233502|NCT02500576|527372234|FG000|Overall Study|Lack of Efficacy|5|||
146233503|NCT02500576|527372235|FG001|Overall Study|Lack of Efficacy|5|||
146233504|NCT02500576|527372234|FG000|Overall Study|Withdrawal by Subject|1|||
146233505|NCT02500576|527372235|FG001|Overall Study|Withdrawal by Subject|1|||
146233506|NCT01983683|527372241|FG000|Overall Study|Withdrawal by Subject|14|||
146233507|NCT01983683|527372242|FG001|Overall Study|Withdrawal by Subject|18|||
146233508|NCT01983683|527372241|FG000|Overall Study|Death|11|||
146233509|NCT01983683|527372242|FG001|Overall Study|Death|15|||
146233510|NCT01983683|527372241|FG000|Overall Study|Physician Decision|8|||
146233511|NCT01983683|527372242|FG001|Overall Study|Physician Decision|9|||
146233512|NCT01983683|527372241|FG000|Overall Study|Lost to Follow-up|4|||
146233513|NCT01983683|527372242|FG001|Overall Study|Lost to Follow-up|8|||
146233514|NCT01983683|527372241|FG000|Overall Study|Sponsor Decision|1|||
146233515|NCT01983683|527372242|FG001|Overall Study|Sponsor Decision|1|||
146233516|NCT04926740|527372245|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
146233517|NCT04926740|527372246|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
146233518|NCT04926740|527372245|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
146293740|NCT02520284|527590101|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
146293741|NCT02520284|527590102|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
146293742|NCT01898923|527590103|FG000|Overall Study|Lack of Efficacy|5|||
146293743|NCT01898923|527590104|FG001|Overall Study|Lack of Efficacy|6|||
146293744|NCT01898923|527590103|FG000|Overall Study|Adverse Event|3|||
146293745|NCT01898923|527590104|FG001|Overall Study|Adverse Event|1|||
146293746|NCT01898923|527590103|FG000|Overall Study|Lost to Follow-up|0|||
146293747|NCT01898923|527590104|FG001|Overall Study|Lost to Follow-up|1|||
146293748|NCT01898923|527590103|FG000|Overall Study|Withdrawal by Subject|4|||
146293749|NCT01898923|527590104|FG001|Overall Study|Withdrawal by Subject|7|||
146293750|NCT01898923|527590103|FG000|Overall Study|Physician Decision|3|||
146293751|NCT01898923|527590104|FG001|Overall Study|Physician Decision|4|||
146293752|NCT01898923|527590103|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
146293753|NCT01898923|527590104|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
146293754|NCT02678247|527590105|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
146293755|NCT02678247|527590106|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
146293756|NCT02678247|527590105|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
146293757|NCT02678247|527590106|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
145890233|NCT02510014|526104167|FG001|Treatment Period|Physician Decision|0|||
146087622|NCT04393298|526841822|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087623|NCT04393298|526841823|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146233519|NCT04926740|527372246|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
146233520|NCT04980300|527372247|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
146233521|NCT04980300|527372248|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
146233522|NCT04980300|527372247|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
146233523|NCT04980300|527372248|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
146233524|NCT04980300|527372247|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
146233525|NCT04980300|527372248|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
146233526|NCT04980300|527372247|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
146087624|NCT04393298|526841824|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
146087625|NCT04393298|526841810|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087626|NCT04393298|526841811|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087627|NCT04393298|526841812|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087628|NCT04393298|526841813|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146233527|NCT04980300|527372248|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
146233528|NCT01574716|527373023|FG000|Part 1|Death|3|||
146233529|NCT01574716|527373024|FG001|Part 1|Death|1|||
146233530|NCT01574716|527373025|FG002|Part 1|Death|8|||
146233531|NCT01574716|527373026|FG003|Part 1|Death|0|||
146233532|NCT01574716|527373027|FG004|Part 1|Death|0|||
146233533|NCT01574716|527373023|FG000|Part 1|Discontinuation of study by sponsor|0|||
146233534|NCT01574716|527373024|FG001|Part 1|Discontinuation of study by sponsor|0|||
146233535|NCT01574716|527373025|FG002|Part 1|Discontinuation of study by sponsor|1|||
146233536|NCT01574716|527373026|FG003|Part 1|Discontinuation of study by sponsor|0|||
146233537|NCT01574716|527373027|FG004|Part 1|Discontinuation of study by sponsor|0|||
146233538|NCT01574716|527373023|FG000|Part 1|Withdrawal by Subject|0|||
146233539|NCT01574716|527373024|FG001|Part 1|Withdrawal by Subject|2|||
146233540|NCT01574716|527373025|FG002|Part 1|Withdrawal by Subject|0|||
146233541|NCT01574716|527373026|FG003|Part 1|Withdrawal by Subject|0|||
146233542|NCT01574716|527373027|FG004|Part 1|Withdrawal by Subject|0|||
146233543|NCT01574716|527373023|FG000|Part 1|Lost to Follow-up|0|||
146233544|NCT01574716|527373024|FG001|Part 1|Lost to Follow-up|1|||
146233545|NCT01574716|527373025|FG002|Part 1|Lost to Follow-up|0|||
146233546|NCT01574716|527373026|FG003|Part 1|Lost to Follow-up|0|||
146233547|NCT01574716|527373027|FG004|Part 1|Lost to Follow-up|0|||
146233548|NCT01574716|527373023|FG000|Part 2|Progressive disease|0|||
146233549|NCT01574716|527373024|FG001|Part 2|Progressive disease|0|||
146233550|NCT01574716|527373025|FG002|Part 2|Progressive disease|0|||
146233551|NCT01574716|527373026|FG003|Part 2|Progressive disease|1|||
146233552|NCT01574716|527373027|FG004|Part 2|Progressive disease|0|||
146233553|NCT01574716|527373023|FG000|Part 2|Death|0|||
146233554|NCT01574716|527373024|FG001|Part 2|Death|0|||
146233555|NCT01574716|527373025|FG002|Part 2|Death|0|||
146233556|NCT01574716|527373026|FG003|Part 2|Death|76|||
146233557|NCT01574716|527373027|FG004|Part 2|Death|35|||
146233558|NCT01574716|527373023|FG000|Part 2|Discontinuation of study by sponsor|0|||
146233559|NCT01574716|527373024|FG001|Part 2|Discontinuation of study by sponsor|0|||
146233560|NCT01574716|527373025|FG002|Part 2|Discontinuation of study by sponsor|0|||
146233561|NCT01574716|527373026|FG003|Part 2|Discontinuation of study by sponsor|51|||
146233562|NCT01574716|527373027|FG004|Part 2|Discontinuation of study by sponsor|31|||
145970570|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
145970571|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
145970572|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145970573|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145970574|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
145970575|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
145970576|NCT00849056|526407215|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
145970577|NCT00849056|526407216|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
145970578|NCT00274456|526407217|FG000|Overall Study|Still on treatment|2|||
145970579|NCT00274456|526407218|FG001|Overall Study|Still on treatment|3|||
145970580|NCT00274456|526407219|FG002|Overall Study|Still on treatment|5|||
145970581|NCT00274456|526407220|FG003|Overall Study|Still on treatment|1|||
145970582|NCT00274456|526407217|FG000|Overall Study|Unacceptable toxicity|10|||
145970583|NCT00274456|526407218|FG001|Overall Study|Unacceptable toxicity|5|||
145970584|NCT00274456|526407219|FG002|Overall Study|Unacceptable toxicity|12|||
145970585|NCT00274456|526407220|FG003|Overall Study|Unacceptable toxicity|16|||
145970586|NCT00274456|526407217|FG000|Overall Study|Adverse Event|0|||
145970587|NCT00274456|526407218|FG001|Overall Study|Adverse Event|1|||
145970588|NCT00274456|526407219|FG002|Overall Study|Adverse Event|2|||
145970589|NCT00274456|526407220|FG003|Overall Study|Adverse Event|2|||
145970590|NCT00274456|526407217|FG000|Overall Study|Physician Decision|7|||
145970591|NCT00274456|526407218|FG001|Overall Study|Physician Decision|5|||
145970592|NCT00274456|526407219|FG002|Overall Study|Physician Decision|6|||
145970593|NCT00274456|526407220|FG003|Overall Study|Physician Decision|13|||
145970594|NCT00274456|526407217|FG000|Overall Study|Lost to Follow-up|0|||
145970595|NCT00274456|526407218|FG001|Overall Study|Lost to Follow-up|0|||
145970596|NCT00274456|526407219|FG002|Overall Study|Lost to Follow-up|1|||
145970597|NCT00274456|526407220|FG003|Overall Study|Lost to Follow-up|0|||
145970598|NCT00274456|526407217|FG000|Overall Study|Withdrawal by Subject|18|||
146233563|NCT01574716|527373023|FG000|Part 2|Withdrawal by Subject|0|||
146233564|NCT01574716|527373024|FG001|Part 2|Withdrawal by Subject|0|||
146233565|NCT01574716|527373025|FG002|Part 2|Withdrawal by Subject|0|||
146233566|NCT01574716|527373026|FG003|Part 2|Withdrawal by Subject|5|||
146233567|NCT01574716|527373027|FG004|Part 2|Withdrawal by Subject|4|||
146233568|NCT01574716|527373023|FG000|Part 2|Brain metastases|0|||
146233569|NCT01574716|527373024|FG001|Part 2|Brain metastases|0|||
146233570|NCT01574716|527373025|FG002|Part 2|Brain metastases|0|||
146293758|NCT02678247|527590105|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
146293759|NCT02678247|527590106|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
146293760|NCT02678247|527590105|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
145970599|NCT00274456|526407218|FG001|Overall Study|Withdrawal by Subject|13|||
145970600|NCT00274456|526407219|FG002|Overall Study|Withdrawal by Subject|9|||
145970601|NCT00274456|526407220|FG003|Overall Study|Withdrawal by Subject|13|||
145970602|NCT00375752|526407224|FG000|Overall Study|Lack of Efficacy|4|||
145970603|NCT00375752|526407225|FG001|Overall Study|Lack of Efficacy|4|||
145970604|NCT00375752|526407224|FG000|Overall Study|Adverse Event|1|||
145970605|NCT00375752|526407225|FG001|Overall Study|Adverse Event|6|||
145970606|NCT00375752|526407224|FG000|Overall Study|Withdrawal by Subject|6|||
145970607|NCT00375752|526407225|FG001|Overall Study|Withdrawal by Subject|1|||
145970608|NCT00375752|526407224|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
145970609|NCT00375752|526407225|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
145970610|NCT00375752|526407224|FG000|Overall Study|Protocol Violation|0|||
145970611|NCT00375752|526407225|FG001|Overall Study|Protocol Violation|2|||
145970612|NCT00375752|526407224|FG000|Overall Study|Administrative Problems|0|||
145970613|NCT00375752|526407225|FG001|Overall Study|Administrative Problems|1|||
145970614|NCT01140906|526407232|FG000|Overall Study|Adverse Event|7|||
145970615|NCT01140906|526407233|FG001|Overall Study|Adverse Event|10|||
145970616|NCT01140906|526407234|FG002|Overall Study|Adverse Event|17|||
145970617|NCT01140906|526407235|FG003|Overall Study|Adverse Event|7|||
145970618|NCT01140906|526407232|FG000|Overall Study|Lack of Efficacy|6|||
145970619|NCT01140906|526407233|FG001|Overall Study|Lack of Efficacy|8|||
145970620|NCT01140906|526407234|FG002|Overall Study|Lack of Efficacy|2|||
145970621|NCT01140906|526407235|FG003|Overall Study|Lack of Efficacy|1|||
145970622|NCT01140906|526407232|FG000|Overall Study|Non-compliance|0|||
145970623|NCT01140906|526407233|FG001|Overall Study|Non-compliance|1|||
145970624|NCT01140906|526407234|FG002|Overall Study|Non-compliance|0|||
145970625|NCT01140906|526407235|FG003|Overall Study|Non-compliance|1|||
145970626|NCT01140906|526407232|FG000|Overall Study|Protocol Violation|5|||
145970627|NCT01140906|526407233|FG001|Overall Study|Protocol Violation|3|||
145970628|NCT01140906|526407234|FG002|Overall Study|Protocol Violation|2|||
145970629|NCT01140906|526407235|FG003|Overall Study|Protocol Violation|1|||
145970630|NCT01140906|526407232|FG000|Overall Study|Withdrawal of consent|6|||
145970631|NCT01140906|526407233|FG001|Overall Study|Withdrawal of consent|6|||
145970632|NCT01140906|526407234|FG002|Overall Study|Withdrawal of consent|2|||
145970633|NCT01140906|526407235|FG003|Overall Study|Withdrawal of consent|2|||
145970634|NCT01140906|526407232|FG000|Overall Study|Lost to Follow-up|1|||
145970635|NCT01140906|526407233|FG001|Overall Study|Lost to Follow-up|1|||
145970636|NCT01140906|526407234|FG002|Overall Study|Lost to Follow-up|0|||
145970637|NCT01140906|526407235|FG003|Overall Study|Lost to Follow-up|2|||
145970638|NCT01140906|526407232|FG000|Overall Study|Administrative or other reason|0|||
145970639|NCT01140906|526407233|FG001|Overall Study|Administrative or other reason|5|||
145970640|NCT01140906|526407234|FG002|Overall Study|Administrative or other reason|3|||
145970641|NCT01140906|526407235|FG003|Overall Study|Administrative or other reason|2|||
145970642|NCT00336544|526407236|FG000|Overall Study|Lack of Efficacy|8|||
145970643|NCT00336544|526407237|FG001|Overall Study|Lack of Efficacy|5|||
145970644|NCT00336544|526407236|FG000|Overall Study|Adverse Event|4|||
145970645|NCT00336544|526407237|FG001|Overall Study|Adverse Event|9|||
145970646|NCT00336544|526407236|FG000|Overall Study|Withdrawal by Subject|4|||
145970647|NCT00336544|526407237|FG001|Overall Study|Withdrawal by Subject|3|||
145970648|NCT00336544|526407236|FG000|Overall Study|Other|3|||
145970649|NCT00336544|526407237|FG001|Overall Study|Other|5|||
145970650|NCT00576758|526407238|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
145970651|NCT00576758|526407239|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
145970652|NCT00576758|526407238|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
145970653|NCT00576758|526407239|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
145970654|NCT00576758|526407238|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
145970655|NCT00576758|526407239|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
145970656|NCT00576758|526407238|FG000|Induction Treatment Period|Death|1|||
145970657|NCT00576758|526407239|FG001|Induction Treatment Period|Death|0|||
145970658|NCT00576758|526407238|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
145970659|NCT00576758|526407239|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
145970660|NCT00576758|526407238|FG000|Induction Treatment Period|Withdrew consent|1|||
145970661|NCT00576758|526407239|FG001|Induction Treatment Period|Withdrew consent|0|||
145970662|NCT00576758|526407238|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
145970663|NCT00576758|526407239|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
145970664|NCT00576758|526407238|FG000|Extension Treatment Period|Death|1|||
145970665|NCT00576758|526407239|FG001|Extension Treatment Period|Death|1|||
146293761|NCT02678247|527590106|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
145970666|NCT00576758|526407238|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
145970667|NCT00576758|526407239|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
145970668|NCT00576758|526407238|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
146233571|NCT01574716|527373026|FG003|Part 2|Brain metastases|1|||
146233572|NCT01574716|527373027|FG004|Part 2|Brain metastases|0|||
146233573|NCT01574716|527373023|FG000|Part 2|Lost to Follow-up|0|||
146233574|NCT01574716|527373024|FG001|Part 2|Lost to Follow-up|0|||
146233575|NCT01574716|527373025|FG002|Part 2|Lost to Follow-up|0|||
146233576|NCT01574716|527373026|FG003|Part 2|Lost to Follow-up|3|||
146233577|NCT01574716|527373027|FG004|Part 2|Lost to Follow-up|0|||
146233578|NCT01268306|527373031|FG000|Overall Study|Lost to Follow-up|1|||
146233579|NCT01105975|527373032|FG000|Overall Study|Adverse Event|2|||
146233580|NCT01105975|527373033|FG001|Overall Study|Adverse Event|1|||
146233581|NCT01105975|527373034|FG002|Overall Study|Adverse Event|5|||
146233582|NCT01105975|527373035|FG003|Overall Study|Adverse Event|1|||
146233583|NCT01105975|527373036|FG004|Overall Study|Adverse Event|0|||
146233584|NCT01105975|527373037|FG005|Overall Study|Adverse Event|1|||
146233585|NCT01105975|527373038|FG006|Overall Study|Adverse Event|2|||
146233586|NCT01105975|527373039|FG007|Overall Study|Adverse Event|4|||
146233587|NCT01105975|527373040|FG008|Overall Study|Adverse Event|1|||
146233588|NCT01105975|527373041|FG009|Overall Study|Adverse Event|4|||
146233589|NCT01105975|527373032|FG000|Overall Study|Withdrawal by Subject|2|||
146233590|NCT01105975|527373033|FG001|Overall Study|Withdrawal by Subject|2|||
146233591|NCT01105975|527373034|FG002|Overall Study|Withdrawal by Subject|2|||
146233592|NCT01105975|527373035|FG003|Overall Study|Withdrawal by Subject|0|||
146233593|NCT01105975|527373036|FG004|Overall Study|Withdrawal by Subject|4|||
146233594|NCT01105975|527373037|FG005|Overall Study|Withdrawal by Subject|1|||
146233595|NCT01105975|527373038|FG006|Overall Study|Withdrawal by Subject|2|||
146233596|NCT01105975|527373039|FG007|Overall Study|Withdrawal by Subject|1|||
146233597|NCT01105975|527373040|FG008|Overall Study|Withdrawal by Subject|0|||
146233598|NCT01105975|527373041|FG009|Overall Study|Withdrawal by Subject|3|||
146233599|NCT01105975|527373032|FG000|Overall Study|Lost to Follow-up|1|||
146233600|NCT01105975|527373033|FG001|Overall Study|Lost to Follow-up|0|||
146233601|NCT01105975|527373034|FG002|Overall Study|Lost to Follow-up|0|||
146233602|NCT01105975|527373035|FG003|Overall Study|Lost to Follow-up|1|||
146233603|NCT01105975|527373036|FG004|Overall Study|Lost to Follow-up|1|||
146233604|NCT01105975|527373037|FG005|Overall Study|Lost to Follow-up|0|||
146233605|NCT01105975|527373038|FG006|Overall Study|Lost to Follow-up|0|||
146233606|NCT01105975|527373039|FG007|Overall Study|Lost to Follow-up|0|||
146233607|NCT01105975|527373040|FG008|Overall Study|Lost to Follow-up|1|||
146233608|NCT01105975|527373041|FG009|Overall Study|Lost to Follow-up|0|||
146233609|NCT01105975|527373032|FG000|Overall Study|Physician Decision|0|||
146233610|NCT01105975|527373033|FG001|Overall Study|Physician Decision|0|||
146233611|NCT01105975|527373034|FG002|Overall Study|Physician Decision|0|||
146233612|NCT01105975|527373035|FG003|Overall Study|Physician Decision|0|||
146233613|NCT01105975|527373036|FG004|Overall Study|Physician Decision|0|||
146233614|NCT01105975|527373037|FG005|Overall Study|Physician Decision|0|||
146233615|NCT01105975|527373038|FG006|Overall Study|Physician Decision|2|||
146233616|NCT01105975|527373039|FG007|Overall Study|Physician Decision|0|||
146233617|NCT01105975|527373040|FG008|Overall Study|Physician Decision|0|||
146233618|NCT01105975|527373041|FG009|Overall Study|Physician Decision|0|||
146233619|NCT01105975|527373032|FG000|Overall Study|Protocol Violation|0|||
146233620|NCT01105975|527373033|FG001|Overall Study|Protocol Violation|2|||
146233621|NCT01105975|527373034|FG002|Overall Study|Protocol Violation|2|||
146233622|NCT01105975|527373035|FG003|Overall Study|Protocol Violation|0|||
146233623|NCT01105975|527373036|FG004|Overall Study|Protocol Violation|1|||
146233624|NCT01105975|527373037|FG005|Overall Study|Protocol Violation|1|||
146233625|NCT01105975|527373038|FG006|Overall Study|Protocol Violation|1|||
146233626|NCT01105975|527373039|FG007|Overall Study|Protocol Violation|1|||
146233627|NCT01105975|527373040|FG008|Overall Study|Protocol Violation|2|||
146233628|NCT01105975|527373041|FG009|Overall Study|Protocol Violation|2|||
146233629|NCT01105975|527373032|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146233630|NCT01105975|527373033|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146233631|NCT01105975|527373034|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146233632|NCT01105975|527373035|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146233633|NCT01105975|527373036|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146233634|NCT01105975|527373037|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
146233635|NCT01105975|527373038|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146233636|NCT01105975|527373039|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
146233637|NCT01105975|527373040|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
146233638|NCT01105975|527373041|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
146233639|NCT04868617|527373042|FG000|Overall Study|Death|1|||
146233640|NCT04868617|527373043|FG001|Overall Study|Death|0|||
146233641|NCT04868617|527373042|FG000|Overall Study|Adverse Event|1|||
146233642|NCT04868617|527373043|FG001|Overall Study|Adverse Event|0|||
146233643|NCT04868617|527373042|FG000|Overall Study|Withdrawal by Subject|1|||
146233644|NCT04868617|527373043|FG001|Overall Study|Withdrawal by Subject|0|||
146233645|NCT04868617|527373042|FG000|Overall Study|Device deficiency|1|||
146233646|NCT04868617|527373043|FG001|Overall Study|Device deficiency|0|||
146233647|NCT02502526|527373045|FG000|Overall Study|Lost to Follow-up|2|||
146233648|NCT02502526|527373046|FG001|Overall Study|Lost to Follow-up|2|||
146233649|NCT02502526|527373047|FG002|Overall Study|Lost to Follow-up|3|||
146233650|NCT02502526|527373045|FG000|Overall Study|Withdrawal by Subject|0|||
146233651|NCT02502526|527373046|FG001|Overall Study|Withdrawal by Subject|1|||
146233652|NCT02502526|527373047|FG002|Overall Study|Withdrawal by Subject|1|||
146233653|NCT02502526|527373045|FG000|Overall Study|Disqualified due to cataract grading|0|||
146233654|NCT02502526|527373046|FG001|Overall Study|Disqualified due to cataract grading|0|||
146233655|NCT02502526|527373047|FG002|Overall Study|Disqualified due to cataract grading|1|||
146233656|NCT02502526|527373045|FG000|Overall Study|Enrollment suspension|4|||
146233657|NCT02502526|527373046|FG001|Overall Study|Enrollment suspension|1|||
146233658|NCT02502526|527373047|FG002|Overall Study|Enrollment suspension|1|||
146233659|NCT00640159|527373050|FG000|Overall Study|Lost to Follow-up|2|||
146233660|NCT00112359|527373051|FG000|Overall Study|Unrelated adverse event|16|||
146233661|NCT00112359|527373052|FG001|Overall Study|Unrelated adverse event|8|||
146233662|NCT00112359|527373051|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
146233663|NCT00112359|527373052|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
146233664|NCT00112359|527373051|FG000|Overall Study|Related adverse event|5|||
146233665|NCT00112359|527373052|FG001|Overall Study|Related adverse event|3|||
146233666|NCT00112359|527373051|FG000|Overall Study|Lost to Follow-up|0|||
146233667|NCT00112359|527373052|FG001|Overall Study|Lost to Follow-up|1|||
146233668|NCT00112359|527373051|FG000|Overall Study|Personal/administrative|1|||
146233669|NCT00112359|527373052|FG001|Overall Study|Personal/administrative|1|||
146233670|NCT00112359|527373051|FG000|Overall Study|Other|3|||
146233671|NCT00112359|527373052|FG001|Overall Study|Other|0|||
146233672|NCT02284113|527373053|FG000|Overall Study|Adverse Event|1|||
146233673|NCT02284113|527373054|FG001|Overall Study|Adverse Event|0|||
146233674|NCT02284113|527373053|FG000|Overall Study|non-compliance|0|||
146233675|NCT02284113|527373054|FG001|Overall Study|non-compliance|1|||
146233676|NCT02284113|527373053|FG000|Overall Study|Withdrawal by Subject|0|||
146233677|NCT02284113|527373054|FG001|Overall Study|Withdrawal by Subject|1|||
146233678|NCT02284113|527373053|FG000|Overall Study|not provided|0|||
146233679|NCT02284113|527373054|FG001|Overall Study|not provided|1|||
146233680|NCT02284113|527373053|FG000|Overall Study|surgery cancelled|2|||
146233681|NCT02284113|527373054|FG001|Overall Study|surgery cancelled|0|||
146233682|NCT04191824|527373055|FG000|Overall Study|Death|13|||
146233683|NCT04191824|527373056|FG001|Overall Study|Death|12|||
146233684|NCT04191824|527373055|FG000|Overall Study|Lost to Follow-up|456|||
146233685|NCT04191824|527373056|FG001|Overall Study|Lost to Follow-up|435|||
146233686|NCT04191824|527373055|FG000|Overall Study|Physician Decision|2|||
146233687|NCT04191824|527373056|FG001|Overall Study|Physician Decision|1|||
146233688|NCT04191824|527373055|FG000|Overall Study|Protocol Violation|0|||
146233689|NCT04191824|527373056|FG001|Overall Study|Protocol Violation|2|||
146233690|NCT04191824|527373055|FG000|Overall Study|Withdrawal by Subject|16|||
146233691|NCT04191824|527373056|FG001|Overall Study|Withdrawal by Subject|18|||
146233692|NCT04191824|527373055|FG000|Overall Study|Early site closure|24|||
146233693|NCT04191824|527373056|FG001|Overall Study|Early site closure|22|||
146233694|NCT01218009|527373057|FG000|Overall Study|Protocol Violation|2|||
146233695|NCT01218009|527373058|FG001|Overall Study|Protocol Violation|1|||
146233696|NCT01218009|527373057|FG000|Overall Study|Withdrawal by Subject|3|||
146233697|NCT01218009|527373058|FG001|Overall Study|Withdrawal by Subject|1|||
146233698|NCT01218009|527373057|FG000|Overall Study|Sponsor terminated study|161|||
146233699|NCT01218009|527373058|FG001|Overall Study|Sponsor terminated study|163|||
146233700|NCT01324310|527373059|FG000|Overall Study|Adverse Event|1|||
146233701|NCT01324310|527373059|FG000|Overall Study|Disease Progression|1|||
146233702|NCT03170882|527373060|FG000|Overall Study|Death|17|||
145970669|NCT00576758|526407239|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
145970670|NCT00576758|526407238|FG000|Extension Treatment Period|Administrative/Other|3|||
145970671|NCT00576758|526407239|FG001|Extension Treatment Period|Administrative/Other|1|||
145970672|NCT00576758|526407238|FG000|Follow-up Period|Administrative/Other|6|||
145970673|NCT00576758|526407239|FG001|Follow-up Period|Administrative/Other|8|||
145970674|NCT00576758|526407238|FG000|Follow-up Period|Death|3|||
145970675|NCT00576758|526407239|FG001|Follow-up Period|Death|3|||
145970676|NCT00576758|526407238|FG000|Follow-up Period|Insufficient therapeutic response|16|||
145970677|NCT00576758|526407239|FG001|Follow-up Period|Insufficient therapeutic response|5|||
146233703|NCT03170882|527373061|FG001|Overall Study|Death|29|||
146233704|NCT03170882|527373060|FG000|Overall Study|Lost to Follow-up|0|||
146233705|NCT03170882|527373061|FG001|Overall Study|Lost to Follow-up|1|||
146233706|NCT03170882|527373060|FG000|Overall Study|Withdrawal by Subject|4|||
146233707|NCT03170882|527373061|FG001|Overall Study|Withdrawal by Subject|7|||
146233708|NCT03170882|527373060|FG000|Overall Study|Reason not Specified|28|||
146233709|NCT03170882|527373061|FG001|Overall Study|Reason not Specified|36|||
146293762|NCT02678247|527590105|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
146233710|NCT01830595|527373062|FG000|First Period|Withdrawal by Subject|1|||
146233711|NCT01830595|527373063|FG001|First Period|Withdrawal by Subject|3|||
146233712|NCT01830595|527373062|FG000|Washout|Withdrawal by Subject|2|||
146233713|NCT01830595|527373063|FG001|Washout|Withdrawal by Subject|2|||
146233714|NCT05116774|527373064|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
146233715|NCT05116774|527373065|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
146233716|NCT05116774|527373064|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
146233717|NCT05116774|527373065|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
146233718|NCT05116774|527373064|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
146233719|NCT05116774|527373065|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
146233720|NCT05116774|527373064|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
146233721|NCT05116774|527373065|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
146233722|NCT05521516|527373071|FG000|Overall Study|Withdrawal by Subject|1|||
146233723|NCT05521516|527373072|FG001|Overall Study|Withdrawal by Subject|1|||
146233724|NCT04305327|527373073|FG000|Overall Study|Study early termination|2|||
146233725|NCT04305327|527373074|FG001|Overall Study|Study early termination|5|||
146233726|NCT04305327|527373075|FG002|Overall Study|Study early termination|2|||
146233727|NCT04305327|527373076|FG003|Overall Study|Study early termination|2|||
146233728|NCT04305327|527373073|FG000|Overall Study|Withdrawal by Subject|0|||
146233729|NCT04305327|527373074|FG001|Overall Study|Withdrawal by Subject|1|||
146233730|NCT04305327|527373075|FG002|Overall Study|Withdrawal by Subject|0|||
146233731|NCT04305327|527373076|FG003|Overall Study|Withdrawal by Subject|0|||
146233732|NCT00115934|527373077|FG000|Overall Study|Lost to Follow-up|1|||
146233733|NCT00115934|527373078|FG001|Overall Study|Lost to Follow-up|0|||
146233734|NCT00115934|527373077|FG000|Overall Study|Did not receive intervention|3|||
146233735|NCT00115934|527373078|FG001|Overall Study|Did not receive intervention|2|||
146233736|NCT00747565|527373079|FG000|Overall Study|Withdrawal by Subject|10|||
146233737|NCT00747565|527373080|FG001|Overall Study|Withdrawal by Subject|6|||
146233738|NCT00747565|527373079|FG000|Overall Study|Lost to Follow-up|4|||
146233739|NCT00747565|527373080|FG001|Overall Study|Lost to Follow-up|1|||
146233740|NCT04882917|527373086|FG000|Overall Study|Adverse Event|0|||
146233741|NCT04882917|527373087|FG001|Overall Study|Adverse Event|1|||
146233742|NCT04882917|527373088|FG002|Overall Study|Adverse Event|2|||
146233743|NCT04882917|527373089|FG003|Overall Study|Adverse Event|2|||
146233744|NCT04882917|527373086|FG000|Overall Study|Withdrawal by Subject|1|||
146233745|NCT04882917|527373087|FG001|Overall Study|Withdrawal by Subject|0|||
146233746|NCT04882917|527373088|FG002|Overall Study|Withdrawal by Subject|2|||
146233747|NCT04882917|527373089|FG003|Overall Study|Withdrawal by Subject|1|||
146233748|NCT04882917|527373086|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
146233749|NCT04882917|527373087|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146233750|NCT04882917|527373088|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146233751|NCT04882917|527373089|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
146233752|NCT00227266|527373090|FG000|Overall Study|Withdrawal by Subject|0|||
146233753|NCT00227266|527373091|FG001|Overall Study|Withdrawal by Subject|0|||
146233754|NCT00227266|527373092|FG002|Overall Study|Withdrawal by Subject|1|||
146233755|NCT00227266|527373090|FG000|Overall Study|Protocol Violation|1|||
146233756|NCT00227266|527373091|FG001|Overall Study|Protocol Violation|0|||
146233757|NCT00227266|527373092|FG002|Overall Study|Protocol Violation|1|||
146233758|NCT00227266|527373090|FG000|Overall Study|Excessive weight gain|0|||
146233759|NCT00227266|527373091|FG001|Overall Study|Excessive weight gain|0|||
146233760|NCT00227266|527373092|FG002|Overall Study|Excessive weight gain|2|||
146233761|NCT05864209|527374051|FG000|Overall Study|Lost to Follow-up|2|||
146233762|NCT05864209|527374052|FG001|Overall Study|Lost to Follow-up|3|||
146233763|NCT00210106|527374069|FG000|Overall Study|Death|1|||
146233764|NCT00210106|527374069|FG000|Overall Study|Protocol Violation|13|||
146233765|NCT03876457|527374073|FG000|Overall Study|Lost to Follow-up|1|||
146233766|NCT03876457|527374074|FG001|Overall Study|Lost to Follow-up|3|||
146233767|NCT02422615|527374075|FG000|Treatment Period|Progressive disease|314|||
146233768|NCT02422615|527374076|FG001|Treatment Period|Progressive disease|200|||
146233769|NCT02422615|527374075|FG000|Treatment Period|Adverse Event|51|||
146233770|NCT02422615|527374076|FG001|Treatment Period|Adverse Event|9|||
146233771|NCT02422615|527374075|FG000|Treatment Period|Physician Decision|32|||
146233772|NCT02422615|527374076|FG001|Treatment Period|Physician Decision|8|||
146233773|NCT02422615|527374075|FG000|Treatment Period|Subject/guardian decision|38|||
146233774|NCT02422615|527374076|FG001|Treatment Period|Subject/guardian decision|8|||
146233775|NCT02422615|527374075|FG000|Treatment Period|Death|2|||
146293763|NCT02678247|527590106|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
146233776|NCT02422615|527374076|FG001|Treatment Period|Death|1|||
146233777|NCT02422615|527374075|FG000|Treatment Period|Technical problems|0|||
146233778|NCT02422615|527374076|FG001|Treatment Period|Technical problems|1|||
146233779|NCT02422615|527374075|FG000|Treatment Period|Protocol deviation|1|||
146233780|NCT02422615|527374076|FG001|Treatment Period|Protocol deviation|1|||
146233781|NCT02422615|527374075|FG000|Treatment Period|Study terminated as per protocol|46|||
146293764|NCT02678247|527590105|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
146233782|NCT02422615|527374076|FG001|Treatment Period|Study terminated as per protocol|14|||
146233783|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146233784|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146233785|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Death|2|||
146233786|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Death|1|||
146233787|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145970678|NCT00576758|526407238|FG000|Follow-up Period|Withdrew consent|2|||
146233788|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146233789|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
146233790|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
146233791|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
146233792|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
146233793|NCT02422615|527374075|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
146233794|NCT02422615|527374076|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
146233795|NCT01036724|527374077|FG000|Overall Study|Adverse Event|1|||
146233796|NCT01036724|527374078|FG001|Overall Study|Adverse Event|2|||
146233797|NCT01036724|527374077|FG000|Overall Study|Lack of Efficacy|1|||
146233798|NCT01036724|527374078|FG001|Overall Study|Lack of Efficacy|1|||
146233799|NCT01036724|527374077|FG000|Overall Study|Protocol Violation|4|||
146233800|NCT01036724|527374078|FG001|Overall Study|Protocol Violation|5|||
146233801|NCT02438137|527374080|FG000|Overall Study|Lost to Follow-up|3|||
146233802|NCT02438137|527374081|FG001|Overall Study|Lost to Follow-up|2|||
146233803|NCT02438137|527374080|FG000|Overall Study|Adverse Event|1|||
146233804|NCT02438137|527374081|FG001|Overall Study|Adverse Event|0|||
146233805|NCT02438137|527374080|FG000|Overall Study|Withdrawal by Subject|4|||
146233806|NCT02438137|527374081|FG001|Overall Study|Withdrawal by Subject|3|||
146233807|NCT02438137|527374080|FG000|Overall Study|Physician Decision|0|||
146233808|NCT02438137|527374081|FG001|Overall Study|Physician Decision|1|||
146233809|NCT00945321|527374082|FG000|Period 1|Adverse Event|0|||
146233810|NCT00945321|527374083|FG001|Period 1|Adverse Event|0|||
146233811|NCT00945321|527374084|FG002|Period 1|Adverse Event|0|||
146233812|NCT00945321|527374085|FG003|Period 1|Adverse Event|0|||
146233813|NCT00945321|527374086|FG004|Period 1|Adverse Event|1|||
146233814|NCT00945321|527374087|FG005|Period 1|Adverse Event|0|||
146233815|NCT00945321|527374082|FG000|Period 4|Lost to Follow-up|0|||
146233816|NCT00945321|527374083|FG001|Period 4|Lost to Follow-up|0|||
146233817|NCT00945321|527374084|FG002|Period 4|Lost to Follow-up|0|||
146233818|NCT00945321|527374085|FG003|Period 4|Lost to Follow-up|0|||
146233819|NCT00945321|527374086|FG004|Period 4|Lost to Follow-up|0|||
146233820|NCT00945321|527374087|FG005|Period 4|Lost to Follow-up|1|||
146233821|NCT00692913|527374088|FG000|Overall Study|Adverse Event|8|||
146233822|NCT00692913|527374089|FG001|Overall Study|Adverse Event|4|||
146233823|NCT00692913|527374088|FG000|Overall Study|Lost to Follow-up|3|||
146233824|NCT00692913|527374089|FG001|Overall Study|Lost to Follow-up|5|||
146233825|NCT00692913|527374088|FG000|Overall Study|Physician Decision|2|||
146233826|NCT00692913|527374089|FG001|Overall Study|Physician Decision|0|||
146233827|NCT00692913|527374088|FG000|Overall Study|Protocol Violation|1|||
146233828|NCT00692913|527374089|FG001|Overall Study|Protocol Violation|1|||
146233829|NCT00692913|527374088|FG000|Overall Study|Withdrawal by Subject|15|||
146233830|NCT00692913|527374089|FG001|Overall Study|Withdrawal by Subject|20|||
146233831|NCT04017611|527374090|FG000|Overall Study|Withdrawn prior to completion|1|||
146233832|NCT02291913|527374091|FG000|Overall Study|Progressive Disease|32|||
146233833|NCT02291913|527374091|FG000|Overall Study|Adverse Event|11|||
146233834|NCT02291913|527374091|FG000|Overall Study|Death|2|||
146233835|NCT02291913|527374091|FG000|Overall Study|Physician Decision|1|||
146233836|NCT02291913|527374091|FG000|Overall Study|Withdrawal by Subject|1|||
146233837|NCT02291913|527374091|FG000|Overall Study|Protocol Violation|1|||
146233838|NCT01637402|527374100|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
146233839|NCT01637402|527374101|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
146233840|NCT01637402|527374100|FG000|Standard Dose Regimen|Adverse Event|1|||
146233841|NCT01637402|527374101|FG001|Standard Dose Regimen|Adverse Event|0|||
146233842|NCT01637402|527374100|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
146233843|NCT01637402|527374101|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
146233844|NCT01637402|527374100|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
146233845|NCT01637402|527374101|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
146233846|NCT01637402|527374100|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
146233847|NCT01637402|527374101|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
146233848|NCT01637402|527374100|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
146233849|NCT01637402|527374101|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
146233850|NCT04876417|527374104|FG000|Overall Study|Lost to Follow-up|5|||
146233851|NCT04876417|527374105|FG001|Overall Study|Lost to Follow-up|8|||
145890234|NCT02510014|526104166|FG000|Treatment Period|Withdrawal by Subject|67|||
146233852|NCT04876417|527374106|FG002|Overall Study|Lost to Follow-up|0|||
146233853|NCT04876417|527374107|FG003|Overall Study|Lost to Follow-up|0|||
146233854|NCT01342367|527374108|FG000|Overall Study|Death|1|||
146233855|NCT01342367|527374109|FG001|Overall Study|Death|0|||
146233856|NCT01342367|527374108|FG000|Overall Study|Withdrawal by Subject|1|||
146233857|NCT01342367|527374109|FG001|Overall Study|Withdrawal by Subject|2|||
146233858|NCT02964741|527374110|FG000|Overall Study|Protocol Violation|1|||
146233859|NCT02964741|527374111|FG001|Overall Study|Protocol Violation|0|||
146233860|NCT02964741|527374112|FG002|Overall Study|Protocol Violation|0|||
146233861|NCT02964741|527374110|FG000|Overall Study|Withdrawal by Subject|0|||
146233862|NCT02964741|527374111|FG001|Overall Study|Withdrawal by Subject|1|||
146233863|NCT02964741|527374112|FG002|Overall Study|Withdrawal by Subject|0|||
146233864|NCT02964741|527374110|FG000|Overall Study|claustrophobia|1|||
146233865|NCT02964741|527374111|FG001|Overall Study|claustrophobia|0|||
146233866|NCT02964741|527374112|FG002|Overall Study|claustrophobia|0|||
146233867|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
146233868|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146233869|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146233870|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
146233871|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
146233872|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146233873|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146293765|NCT02678247|527590106|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
146293766|NCT02225353|527590108|FG000|Overall Study|Lost to Follow-up|0|||
145890235|NCT02510014|526104167|FG001|Treatment Period|Withdrawal by Subject|24|||
145890236|NCT02510014|526104166|FG000|Treatment Period|Withdrawn by the investigator|7|||
145890237|NCT02510014|526104167|FG001|Treatment Period|Withdrawn by the investigator|1|||
145890238|NCT02510014|526104166|FG000|Treatment Period|Protocol Violation|4|||
145890239|NCT02510014|526104167|FG001|Treatment Period|Protocol Violation|4|||
145890240|NCT02510014|526104166|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
145890241|NCT02510014|526104167|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
145890242|NCT00854373|526104168|FG000|Overall Study|Withdrawal by Subject|1|||
145890243|NCT00854373|526104169|FG001|Overall Study|Withdrawal by Subject|3|||
145890244|NCT00854373|526104168|FG000|Overall Study|Forgot to take study drug|1|||
145890245|NCT00854373|526104169|FG001|Overall Study|Forgot to take study drug|1|||
145890246|NCT02377063|526104173|FG000|Overall Study|Non-compliance|5|||
145890247|NCT01524913|526104174|FG000|Overall Study|Lost to Follow-up|4|||
145890248|NCT01524913|526104175|FG001|Overall Study|Lost to Follow-up|0|||
145890249|NCT01524913|526104176|FG002|Overall Study|Lost to Follow-up|0|||
145890250|NCT00702208|526104177|FG000|Overall Study|Lost to Follow-up|28|||
145890251|NCT00702208|526104177|FG000|Overall Study|Did not self-lavage|1|||
145890252|NCT00702208|526104177|FG000|Overall Study|Unsatisfactory colposcopy|2|||
145890253|NCT04553913|526104178|FG000|Overall Study|patient's block resolved prior to PACU|1|||
145890254|NCT04553913|526104178|FG000|Overall Study|did not use the device properly|5|||
145890255|NCT01172821|526104179|FG000|Overall Study|Adverse Event|5|||
145890256|NCT01172821|526104180|FG001|Overall Study|Adverse Event|2|||
145890257|NCT01172821|526104181|FG002|Overall Study|Adverse Event|2|||
145890258|NCT01172821|526104182|FG003|Overall Study|Adverse Event|7|||
145890259|NCT01172821|526104179|FG000|Overall Study|Protocol Violation|0|||
145890260|NCT01172821|526104180|FG001|Overall Study|Protocol Violation|2|||
145890261|NCT01172821|526104181|FG002|Overall Study|Protocol Violation|1|||
145890262|NCT01172821|526104182|FG003|Overall Study|Protocol Violation|2|||
145890263|NCT01172821|526104179|FG000|Overall Study|Lost to Follow-up|4|||
145890264|NCT01172821|526104180|FG001|Overall Study|Lost to Follow-up|1|||
145890265|NCT01172821|526104181|FG002|Overall Study|Lost to Follow-up|2|||
145890266|NCT01172821|526104182|FG003|Overall Study|Lost to Follow-up|2|||
145890267|NCT01172821|526104179|FG000|Overall Study|Withdrawal by Subject|2|||
145890268|NCT01172821|526104180|FG001|Overall Study|Withdrawal by Subject|3|||
145890269|NCT01172821|526104181|FG002|Overall Study|Withdrawal by Subject|3|||
145890270|NCT01172821|526104182|FG003|Overall Study|Withdrawal by Subject|3|||
145890271|NCT01172821|526104179|FG000|Overall Study|Other|3|||
145890272|NCT01172821|526104180|FG001|Overall Study|Other|4|||
145890273|NCT01172821|526104181|FG002|Overall Study|Other|5|||
145890274|NCT01172821|526104182|FG003|Overall Study|Other|3|||
145890275|NCT00710749|526104184|FG000|First Intervention|Withdrawal by Subject|1|||
145890276|NCT00710749|526104185|FG001|First Intervention|Withdrawal by Subject|0|||
145970679|NCT00576758|526407239|FG001|Follow-up Period|Withdrew consent|1|||
145970680|NCT01316614|526407240|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
145970681|NCT01316614|526407240|FG000|Overall Study|Cytology slides not available for review|4|||
146233874|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
146233875|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
146233876|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
146233877|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
146233878|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
145890277|NCT02985879|526104188|FG000|Overall Study|Adverse Event|7|||
146233879|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
146233880|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146233881|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146233882|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
146233883|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
146233884|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146233885|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146233886|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
146233887|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
146233888|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146233889|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146233890|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
146233891|NCT01074294|527374116|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
146233892|NCT01074294|527374117|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146233893|NCT01074294|527374118|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146233894|NCT01074294|527374119|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
146233895|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
146233896|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
146233897|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
146233898|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
146233899|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
146233900|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
146233901|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
146233902|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
146233903|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146233904|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
146233905|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146233906|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
146233907|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
146233908|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
146233909|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
146233910|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
146233911|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
146233912|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
146233913|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
146233914|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
146233915|NCT01074294|527374116|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
146233916|NCT01074294|527374117|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
146233917|NCT01074294|527374118|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
145890278|NCT02985879|526104189|FG001|Overall Study|Adverse Event|9|||
145890279|NCT02985879|526104190|FG002|Overall Study|Adverse Event|7|||
145890280|NCT02985879|526104188|FG000|Overall Study|Withdrew consent|6|||
145890281|NCT02985879|526104189|FG001|Overall Study|Withdrew consent|8|||
145890282|NCT02985879|526104190|FG002|Overall Study|Withdrew consent|10|||
145890283|NCT02985879|526104188|FG000|Overall Study|Lost to Follow-up|1|||
145890284|NCT02985879|526104189|FG001|Overall Study|Lost to Follow-up|0|||
145890285|NCT02985879|526104190|FG002|Overall Study|Lost to Follow-up|2|||
145890286|NCT02985879|526104188|FG000|Overall Study|Other, not specified|62|||
145890287|NCT02985879|526104189|FG001|Overall Study|Other, not specified|58|||
145890288|NCT02985879|526104190|FG002|Overall Study|Other, not specified|58|||
145890289|NCT04974619|526105738|FG000|Overall Study|Lost to Follow-up|0|||
145890290|NCT04974619|526105739|FG001|Overall Study|Lost to Follow-up|0|||
145890291|NCT04974619|526105740|FG002|Overall Study|Lost to Follow-up|1|||
145890292|NCT04974619|526105738|FG000|Overall Study|Withdrawal by Subject|0|||
145890293|NCT04974619|526105739|FG001|Overall Study|Withdrawal by Subject|0|||
146233918|NCT01074294|527374119|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
146233919|NCT00312208|527374120|FG000|Overall Study|Adverse Event|97|||
146233920|NCT00312208|527374121|FG001|Overall Study|Adverse Event|61|||
145890294|NCT04974619|526105740|FG002|Overall Study|Withdrawal by Subject|1|||
145890295|NCT04974619|526105738|FG000|Overall Study|Protocol Violation|0|||
145890296|NCT04974619|526105739|FG001|Overall Study|Protocol Violation|1|||
145890297|NCT04974619|526105740|FG002|Overall Study|Protocol Violation|0|||
145890298|NCT03959527|526105747|FG000|Overall Study|Withdrawal by Subject|8|||
145890299|NCT03959527|526105748|FG001|Overall Study|Withdrawal by Subject|3|||
145890300|NCT03959527|526105747|FG000|Overall Study|Lost to Follow-up|31|||
145890301|NCT03959527|526105748|FG001|Overall Study|Lost to Follow-up|15|||
145890302|NCT03959527|526105747|FG000|Overall Study|Did not meet eligibility criteria|1|||
145890303|NCT03959527|526105748|FG001|Overall Study|Did not meet eligibility criteria|1|||
145970682|NCT01316614|526407240|FG000|Overall Study|Cystic lesion|5|||
145970683|NCT01316614|526407240|FG000|Overall Study|Inadequate number of passes|2|||
145970684|NCT01316614|526407240|FG000|Overall Study|Medically unstable|1|||
145970685|NCT03427411|526407241|FG000|Overall Study|Screen failure - platelets too low|0|||
145970686|NCT03427411|526407242|FG001|Overall Study|Screen failure - platelets too low|1|||
145970687|NCT00903968|526407243|FG000|Overall Study|Adverse Event|0|||
145970688|NCT00903968|526407244|FG001|Overall Study|Adverse Event|0|||
145970689|NCT00903968|526407245|FG002|Overall Study|Adverse Event|0|||
145970690|NCT00903968|526407246|FG003|Overall Study|Adverse Event|0|||
145970691|NCT00903968|526407247|FG004|Overall Study|Adverse Event|0|||
145970692|NCT00903968|526407248|FG005|Overall Study|Adverse Event|0|||
146087629|NCT04393298|526841814|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087630|NCT04393298|526841815|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
146087631|NCT04393298|526841816|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087632|NCT04393298|526841817|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087633|NCT04393298|526841818|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087634|NCT04393298|526841819|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087635|NCT04393298|526841820|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087636|NCT04393298|526841821|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087637|NCT04393298|526841822|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087638|NCT04393298|526841823|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087639|NCT04393298|526841824|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
146087640|NCT04393298|526841810|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087641|NCT04393298|526841811|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087642|NCT04393298|526841812|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087643|NCT04393298|526841813|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087644|NCT04393298|526841814|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087645|NCT04393298|526841815|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
146087646|NCT04393298|526841816|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146293767|NCT02225353|527590109|FG001|Overall Study|Lost to Follow-up|1|||
146293768|NCT02225353|527590110|FG002|Overall Study|Lost to Follow-up|3|||
145970693|NCT00903968|526407249|FG006|Overall Study|Adverse Event|1|||
145970694|NCT00903968|526407250|FG007|Overall Study|Adverse Event|8|||
145970695|NCT00903968|526407243|FG000|Overall Study|DLT|0|||
145970696|NCT00903968|526407244|FG001|Overall Study|DLT|0|||
145970697|NCT00903968|526407245|FG002|Overall Study|DLT|0|||
145970698|NCT00903968|526407246|FG003|Overall Study|DLT|0|||
145970699|NCT00903968|526407247|FG004|Overall Study|DLT|0|||
145970700|NCT00903968|526407248|FG005|Overall Study|DLT|0|||
145970701|NCT00903968|526407249|FG006|Overall Study|DLT|2|||
146293769|NCT02225353|527590108|FG000|Overall Study|Protocol Violation|4|||
146293770|NCT02225353|527590109|FG001|Overall Study|Protocol Violation|5|||
146293771|NCT02225353|527590110|FG002|Overall Study|Protocol Violation|12|||
146293772|NCT02910739|527590111|FG000|Overall Study|Adverse Event|1|||
146293773|NCT02910739|527590112|FG001|Overall Study|Adverse Event|0|||
146293774|NCT02910739|527590113|FG002|Overall Study|Adverse Event|0|||
146293775|NCT02910739|527590114|FG003|Overall Study|Adverse Event|0|||
146293776|NCT04223856|527590119|FG000|Overall Study|Progressive disease|153|||
146293777|NCT04223856|527590120|FG001|Overall Study|Progressive disease|73|||
146293778|NCT04223856|527590119|FG000|Overall Study|Adverse Event|97|||
146293779|NCT04223856|527590120|FG001|Overall Study|Adverse Event|62|||
146293780|NCT04223856|527590119|FG000|Overall Study|Physician Decision|9|||
146293781|NCT04223856|527590120|FG001|Overall Study|Physician Decision|28|||
146293782|NCT04223856|527590119|FG000|Overall Study|Withdrawal by Subject|22|||
146293783|NCT04223856|527590120|FG001|Overall Study|Withdrawal by Subject|24|||
146293784|NCT04223856|527590119|FG000|Overall Study|Other|7|||
146293785|NCT04223856|527590120|FG001|Overall Study|Other|2|||
146293786|NCT04223856|527590119|FG000|Overall Study|Randomized but not treated|2|||
146293787|NCT04223856|527590120|FG001|Overall Study|Randomized but not treated|11|||
146293788|NCT04223856|527590119|FG000|Overall Study|On-treatment|144|||
146293789|NCT04223856|527590120|FG001|Overall Study|On-treatment|0|||
146293790|NCT03226275|527590121|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146293791|NCT03226275|527590122|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146293792|NCT03226275|527590123|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
146293793|NCT03226275|527590124|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
146293794|NCT03226275|527590121|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
146293795|NCT03226275|527590122|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
146293796|NCT03226275|527590123|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
145970702|NCT00903968|526407250|FG007|Overall Study|DLT|0|||
146087647|NCT04393298|526841817|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087648|NCT04393298|526841818|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145970703|NCT00903968|526407243|FG000|Overall Study|Withdrawal by Subject|1|||
145970704|NCT00903968|526407244|FG001|Overall Study|Withdrawal by Subject|0|||
145970705|NCT00903968|526407245|FG002|Overall Study|Withdrawal by Subject|1|||
146293797|NCT03226275|527590124|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
145890304|NCT03959527|526105747|FG000|Overall Study|Protocol Violation|10|||
146293798|NCT03442114|527590125|FG000|Overall Study|Lost to Follow-up|13|||
146293799|NCT03442114|527590126|FG001|Overall Study|Lost to Follow-up|13|||
146293800|NCT03442114|527590125|FG000|Overall Study|Physician Decision|2|||
146293801|NCT03442114|527590126|FG001|Overall Study|Physician Decision|2|||
146293802|NCT03442114|527590125|FG000|Overall Study|Protocol Violation|0|||
146293803|NCT03442114|527590126|FG001|Overall Study|Protocol Violation|2|||
146293804|NCT03442114|527590125|FG000|Overall Study|Withdrawal by Subject|1|||
146293805|NCT03442114|527590126|FG001|Overall Study|Withdrawal by Subject|3|||
146293806|NCT03442114|527590125|FG000|Overall Study|Guardianship Change|0|||
146293807|NCT03442114|527590126|FG001|Overall Study|Guardianship Change|1|||
146293808|NCT05677893|527591922|FG000|Overall Study|Withdrawal by Subject|0|||
146293809|NCT05677893|527591923|FG001|Overall Study|Withdrawal by Subject|0|||
146293810|NCT05677893|527591924|FG002|Overall Study|Withdrawal by Subject|0|||
146293811|NCT05677893|527591925|FG003|Overall Study|Withdrawal by Subject|0|||
146293812|NCT05677893|527591926|FG004|Overall Study|Withdrawal by Subject|1|||
146293813|NCT05677893|527591927|FG005|Overall Study|Withdrawal by Subject|1|||
146293814|NCT05677893|527591928|FG006|Overall Study|Withdrawal by Subject|0|||
146293815|NCT05677893|527591922|FG000|Overall Study|Others|1|||
146293816|NCT05677893|527591923|FG001|Overall Study|Others|0|||
146293817|NCT05677893|527591924|FG002|Overall Study|Others|0|||
146293818|NCT05677893|527591925|FG003|Overall Study|Others|0|||
146293819|NCT05677893|527591926|FG004|Overall Study|Others|0|||
146293820|NCT05677893|527591927|FG005|Overall Study|Others|0|||
146293821|NCT05677893|527591928|FG006|Overall Study|Others|0|||
146293822|NCT03217266|527591929|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
146293823|NCT03217266|527591930|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146293824|NCT03217266|527591931|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146293825|NCT03217266|527591932|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
146293826|NCT03217266|527591929|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
146293827|NCT03217266|527591930|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
146293828|NCT03217266|527591931|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
146293829|NCT03217266|527591932|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
146293830|NCT03217266|527591929|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
146293831|NCT03217266|527591930|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
146293832|NCT03217266|527591931|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
146293833|NCT03217266|527591932|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
146293834|NCT02101034|527591933|FG000|Overall Study|Enrolled but did not start treatment|0|||
146293835|NCT02101034|527591934|FG001|Overall Study|Enrolled but did not start treatment|0|||
146293836|NCT02101034|527591935|FG002|Overall Study|Enrolled but did not start treatment|1|||
146293837|NCT02101034|527591936|FG003|Overall Study|Enrolled but did not start treatment|0|||
146293838|NCT02101034|527591937|FG004|Overall Study|Enrolled but did not start treatment|0|||
146293839|NCT01390181|527591938|FG000|Overall Study|Lost to Follow-up|1|||
146293840|NCT01390181|527591938|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
146293841|NCT01101477|527591949|FG000|Overall Study|Protocol Violation|5|||
146293842|NCT01101477|527591950|FG001|Overall Study|Protocol Violation|3|||
146293843|NCT01101477|527591951|FG002|Overall Study|Protocol Violation|1|||
146293844|NCT00146328|527591953|FG000|Overall Study|Adverse Event|39|||
146293845|NCT00146328|527591954|FG001|Overall Study|Adverse Event|48|||
146293846|NCT00146328|527591955|FG002|Overall Study|Adverse Event|79|||
145890305|NCT03959527|526105748|FG001|Overall Study|Protocol Violation|5|||
145890306|NCT01688466|526105749|FG000|Overall Study|Withdrawal by Subject|2|||
145890307|NCT01688466|526105750|FG001|Overall Study|Withdrawal by Subject|1|||
145890308|NCT01688466|526105749|FG000|Overall Study|Death|0|||
145890309|NCT01688466|526105750|FG001|Overall Study|Death|1|||
145890310|NCT01688466|526105749|FG000|Overall Study|Adverse Event|0|||
145890311|NCT01688466|526105750|FG001|Overall Study|Adverse Event|4|||
145890312|NCT01688466|526105749|FG000|Overall Study|Not evaluable|0|||
145890313|NCT01688466|526105750|FG001|Overall Study|Not evaluable|1|||
145890314|NCT01000610|526105755|FG000|Overall Study|Adverse Event|1|||
145890315|NCT01000610|526105755|FG000|Overall Study|Lost to Follow-up|4|||
145890316|NCT01000610|526105755|FG000|Overall Study|Treatment failure|1|||
145890317|NCT00595335|526105760|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
145890318|NCT00595335|526105761|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
145890319|NCT00595335|526105760|FG000|Baseline to Six Months|Disease Progression|1|||
145890320|NCT00595335|526105761|FG001|Baseline to Six Months|Disease Progression|1|||
145890321|NCT00595335|526105760|FG000|Baseline to Six Months|Adverse Event|1|||
146293847|NCT00146328|527591953|FG000|Overall Study|Protocol Violation|11|||
146293848|NCT00146328|527591954|FG001|Overall Study|Protocol Violation|6|||
146293849|NCT00146328|527591955|FG002|Overall Study|Protocol Violation|12|||
146293850|NCT00146328|527591953|FG000|Overall Study|Lost to Follow-up|7|||
146293851|NCT00146328|527591954|FG001|Overall Study|Lost to Follow-up|4|||
146293852|NCT00146328|527591955|FG002|Overall Study|Lost to Follow-up|7|||
145890322|NCT00595335|526105761|FG001|Baseline to Six Months|Adverse Event|0|||
145890323|NCT00595335|526105760|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
146233921|NCT00312208|527374120|FG000|Overall Study|Protocol Violation|5|||
145890324|NCT00595335|526105761|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
145890325|NCT00595335|526105760|FG000|Six Months to Twelve Months|Disease Progression|1|||
145890326|NCT00595335|526105761|FG001|Six Months to Twelve Months|Disease Progression|0|||
145890327|NCT00493779|526105773|FG000|Overall Study|Logistical issue at site|1|||
145890328|NCT02516410|526105775|FG000|Overall Study|Adverse Event|0|||
146233922|NCT00312208|527374121|FG001|Overall Study|Protocol Violation|3|||
145890329|NCT02516410|526105776|FG001|Overall Study|Adverse Event|1|||
145890330|NCT02516410|526105775|FG000|Overall Study|Withdrawal by Subject|0|||
145890331|NCT02516410|526105776|FG001|Overall Study|Withdrawal by Subject|1|||
145890332|NCT06005597|526105777|FG000|Overall Study|Lost to Follow-up|1|||
145890333|NCT06005597|526105778|FG001|Overall Study|Lost to Follow-up|2|||
145890334|NCT06005597|526105779|FG002|Overall Study|Lost to Follow-up|1|||
145890335|NCT06005597|526105780|FG003|Overall Study|Lost to Follow-up|2|||
145890336|NCT06005597|526105777|FG000|Overall Study|Death|1|||
145890337|NCT06005597|526105778|FG001|Overall Study|Death|1|||
145890338|NCT06005597|526105779|FG002|Overall Study|Death|1|||
145890339|NCT06005597|526105780|FG003|Overall Study|Death|0|||
145890340|NCT00754442|526105781|FG000|Overall Study|Withdrawal by Subject|5|||
145890341|NCT00754442|526105782|FG001|Overall Study|Withdrawal by Subject|3|||
145890342|NCT05611996|526105783|FG000|Overall Study|Ineligible|1|||
145890343|NCT05611996|526105783|FG000|Overall Study|Withdrawal by Subject|9|||
145890344|NCT04479475|526105784|FG000|Overall Study|Withdrawal by Subject|7|||
145890345|NCT05560763|526105785|FG000|Overall Study|Withdrawal by Subject|4|||
145890346|NCT06972251|526105786|FG000|Overall Study|Withdrawal by Subject|1|||
145890347|NCT06972251|526105787|FG001|Overall Study|Withdrawal by Subject|0|||
145890348|NCT06972251|526105786|FG000|Overall Study|Lost to Follow-up|10|||
145890349|NCT06972251|526105787|FG001|Overall Study|Lost to Follow-up|2|||
145890350|NCT03451006|526105788|FG000|Overall Study|Withdrawal by Subject|2|||
145890351|NCT03451006|526105789|FG001|Overall Study|Withdrawal by Subject|2|||
146233923|NCT00312208|527374120|FG000|Overall Study|Death|2|||
146233924|NCT00312208|527374121|FG001|Overall Study|Death|1|||
146233925|NCT00312208|527374120|FG000|Overall Study|Lack of Efficacy|7|||
146233926|NCT00312208|527374121|FG001|Overall Study|Lack of Efficacy|4|||
146233927|NCT00312208|527374120|FG000|Overall Study|Lost to Follow-up|3|||
146233928|NCT00312208|527374121|FG001|Overall Study|Lost to Follow-up|5|||
146233929|NCT00312208|527374120|FG000|Overall Study|Withdrawal by Subject|53|||
146233930|NCT00312208|527374121|FG001|Overall Study|Withdrawal by Subject|42|||
146233931|NCT00312208|527374120|FG000|Overall Study|Other|5|||
146233932|NCT00312208|527374121|FG001|Overall Study|Other|7|||
146233933|NCT05018143|527374144|FG000|Overall Study|Lost to Follow-up|5|||
146233934|NCT05018143|527374145|FG001|Overall Study|Lost to Follow-up|4|||
146233935|NCT05018143|527374144|FG000|Overall Study|Withdrawal by Subject|0|||
146233936|NCT05018143|527374145|FG001|Overall Study|Withdrawal by Subject|1|||
146233937|NCT05601882|527374146|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
146233938|NCT05601882|527374147|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146233939|NCT05601882|527374148|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146233940|NCT05601882|527374149|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
146233941|NCT05601882|527374146|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
146233942|NCT05601882|527374147|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
146233943|NCT05601882|527374148|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
146233944|NCT05601882|527374149|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
146233945|NCT05601882|527374146|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
146293853|NCT00146328|527591953|FG000|Overall Study|Withdrawal by Subject|16|||
146293854|NCT00146328|527591954|FG001|Overall Study|Withdrawal by Subject|16|||
146293855|NCT00146328|527591955|FG002|Overall Study|Withdrawal by Subject|22|||
146293856|NCT00146328|527591953|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
145890352|NCT00949988|526105790|FG000|Overall Study|Withdrawal by Subject|3|||
145890353|NCT01929395|526105791|FG000|Overall Study|Did not complete - non-related toxicity|1|||
145890354|NCT01929395|526105792|FG001|Overall Study|Did not complete - non-related toxicity|0|||
145890355|NCT01929395|526105793|FG002|Overall Study|Did not complete - non-related toxicity|0|||
146233946|NCT05601882|527374147|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
146233947|NCT05601882|527374148|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
146233948|NCT05601882|527374149|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
146233949|NCT05601882|527374146|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
146233950|NCT05601882|527374147|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
146233951|NCT05601882|527374148|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
146233952|NCT05601882|527374149|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
146233953|NCT05601882|527374146|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
146233954|NCT05601882|527374147|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
146233955|NCT05601882|527374148|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
146233956|NCT05601882|527374149|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
146233957|NCT05601882|527374146|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
146233958|NCT05601882|527374147|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
146233959|NCT05601882|527374148|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
146233960|NCT05601882|527374149|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
146233961|NCT03593226|527374150|FG000|Overall Study|Disease progression|6|||
146233962|NCT03593226|527374151|FG001|Overall Study|Disease progression|13|||
146233963|NCT03593226|527374152|FG002|Overall Study|Disease progression|5|||
146233964|NCT03593226|527374153|FG003|Overall Study|Disease progression|6|||
146233965|NCT03593226|527374150|FG000|Overall Study|Adverse Event|0|||
146233966|NCT03593226|527374151|FG001|Overall Study|Adverse Event|1|||
146233967|NCT03593226|527374152|FG002|Overall Study|Adverse Event|0|||
146233968|NCT03593226|527374153|FG003|Overall Study|Adverse Event|0|||
146233969|NCT03593226|527374150|FG000|Overall Study|Withdrawal by Subject|0|||
146233970|NCT03593226|527374151|FG001|Overall Study|Withdrawal by Subject|4|||
146233971|NCT03593226|527374152|FG002|Overall Study|Withdrawal by Subject|1|||
146233972|NCT03593226|527374153|FG003|Overall Study|Withdrawal by Subject|0|||
146233973|NCT03593226|527374150|FG000|Overall Study|Physician Decision|0|||
146233974|NCT03593226|527374151|FG001|Overall Study|Physician Decision|1|||
146233975|NCT03593226|527374152|FG002|Overall Study|Physician Decision|0|||
146233976|NCT03593226|527374153|FG003|Overall Study|Physician Decision|0|||
146233977|NCT03593226|527374150|FG000|Overall Study|Clinical disease progression|0|||
146233978|NCT03593226|527374151|FG001|Overall Study|Clinical disease progression|0|||
146233979|NCT03593226|527374152|FG002|Overall Study|Clinical disease progression|1|||
146233980|NCT03593226|527374153|FG003|Overall Study|Clinical disease progression|0|||
146233981|NCT03891758|527374154|FG000|Overall Study|Adverse Event|2|||
146233982|NCT03891758|527374155|FG001|Overall Study|Adverse Event|0|||
146233983|NCT03891758|527374154|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146233984|NCT03891758|527374155|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146233985|NCT03789110|527374156|FG000|Overall Study|Adverse Event|2|||
146233986|NCT03789110|527374156|FG000|Overall Study|Physician Decision|1|||
146233987|NCT03789110|527374156|FG000|Overall Study|Withdrawal by Subject|2|||
146233988|NCT03789110|527374156|FG000|Overall Study|Lack of Efficacy|22|||
146233989|NCT03789110|527374156|FG000|Overall Study|still on treatment|3|||
146233990|NCT05464732|527374166|FG000|Overall Study|Lost to Follow-up|0|||
146233991|NCT05464732|527374167|FG001|Overall Study|Lost to Follow-up|1|||
146233992|NCT05464732|527374166|FG000|Overall Study|Adverse Event|1|||
146233993|NCT05464732|527374167|FG001|Overall Study|Adverse Event|0|||
146233994|NCT03959423|527374172|FG000|Overall Study|Withdrawal by Subject|2|||
146233995|NCT03959423|527374173|FG001|Overall Study|Withdrawal by Subject|3|||
146233996|NCT03959423|527374172|FG000|Overall Study|Physician Decision|0|||
146233997|NCT03959423|527374173|FG001|Overall Study|Physician Decision|1|||
146233998|NCT03959423|527374172|FG000|Overall Study|Lost to Follow-up|1|||
146233999|NCT03959423|527374173|FG001|Overall Study|Lost to Follow-up|0|||
146234000|NCT03959423|527374172|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
146234001|NCT03959423|527374173|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146234002|NCT00536120|527375019|FG000|Overall Study|Lost to Follow-up|1|||
146234003|NCT00536120|527375020|FG001|Overall Study|Lost to Follow-up|0|||
146234004|NCT00536120|527375019|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
146234005|NCT00536120|527375020|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
146234006|NCT00536120|527375019|FG000|Overall Study|Non-compliance|1|||
146234007|NCT00536120|527375020|FG001|Overall Study|Non-compliance|0|||
146234008|NCT00536120|527375019|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
146234009|NCT00536120|527375020|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
146234010|NCT00536120|527375019|FG000|Overall Study|Steroid Use|0|||
146234011|NCT00536120|527375020|FG001|Overall Study|Steroid Use|2|||
146234012|NCT00536120|527375019|FG000|Overall Study|Missed Study Visit|0|||
146234013|NCT00536120|527375020|FG001|Overall Study|Missed Study Visit|1|||
146234014|NCT02722434|527375021|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
146234015|NCT02722434|527375022|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
146234016|NCT02722434|527375021|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
146234017|NCT02722434|527375022|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
146234018|NCT04559698|527375023|FG000|Overall Study|Lost to Follow-up|14|||
146234019|NCT04559698|527375024|FG001|Overall Study|Lost to Follow-up|15|||
146234020|NCT04559698|527375023|FG000|Overall Study|Withdrawal by Subject|0|||
146234021|NCT04559698|527375024|FG001|Overall Study|Withdrawal by Subject|1|||
146234022|NCT03437733|527375026|FG000|Overall Study|Eligibility criteria not met|0|||
146234023|NCT03437733|527375027|FG001|Overall Study|Eligibility criteria not met|3|||
146234024|NCT01982682|527375028|FG000|Overall Study|Physician Decision|1|||
146234025|NCT00146172|527375029|FG000|Overall Study|Adverse Event|0|||
146234026|NCT00146172|527375030|FG001|Overall Study|Adverse Event|0|||
146234027|NCT00146172|527375031|FG002|Overall Study|Adverse Event|1|||
146234028|NCT00146172|527375032|FG003|Overall Study|Adverse Event|1|||
146234029|NCT00146172|527375033|FG004|Overall Study|Adverse Event|0|||
146234030|NCT00146172|527375034|FG005|Overall Study|Adverse Event|2|||
146234031|NCT00146172|527375035|FG006|Overall Study|Adverse Event|3|||
146234032|NCT00146172|527375036|FG007|Overall Study|Adverse Event|10|||
146234033|NCT00146172|527375029|FG000|Overall Study|Lost to Follow-up|0|||
146234034|NCT00146172|527375030|FG001|Overall Study|Lost to Follow-up|0|||
146234035|NCT00146172|527375031|FG002|Overall Study|Lost to Follow-up|0|||
146234036|NCT00146172|527375032|FG003|Overall Study|Lost to Follow-up|0|||
146234037|NCT00146172|527375033|FG004|Overall Study|Lost to Follow-up|0|||
146234038|NCT00146172|527375034|FG005|Overall Study|Lost to Follow-up|0|||
146234039|NCT00146172|527375035|FG006|Overall Study|Lost to Follow-up|0|||
146234040|NCT00146172|527375036|FG007|Overall Study|Lost to Follow-up|1|||
146234041|NCT00146172|527375029|FG000|Overall Study|Disease Progression|2|||
146234042|NCT00146172|527375030|FG001|Overall Study|Disease Progression|4|||
146234043|NCT00146172|527375031|FG002|Overall Study|Disease Progression|2|||
146234044|NCT00146172|527375032|FG003|Overall Study|Disease Progression|5|||
146234045|NCT00146172|527375033|FG004|Overall Study|Disease Progression|2|||
146234046|NCT00146172|527375034|FG005|Overall Study|Disease Progression|2|||
146234047|NCT00146172|527375035|FG006|Overall Study|Disease Progression|1|||
146234048|NCT00146172|527375036|FG007|Overall Study|Disease Progression|22|||
146234049|NCT00146172|527375029|FG000|Overall Study|Death|0|||
146234050|NCT00146172|527375030|FG001|Overall Study|Death|0|||
146234051|NCT00146172|527375031|FG002|Overall Study|Death|0|||
145890356|NCT01929395|526105791|FG000|Overall Study|Withdrawal by Subject|0|||
145890357|NCT01929395|526105792|FG001|Overall Study|Withdrawal by Subject|1|||
145890358|NCT01929395|526105793|FG002|Overall Study|Withdrawal by Subject|0|||
145890359|NCT01929395|526105791|FG000|Overall Study|Screen Fail|0|||
145890360|NCT01929395|526105792|FG001|Overall Study|Screen Fail|0|||
145890361|NCT01929395|526105793|FG002|Overall Study|Screen Fail|1|||
145890362|NCT02547766|526105794|FG000|Overall Study|Withdrawal by Subject|1|||
145890363|NCT00484419|526105798|FG000|Overall Study|Adverse Event|3|||
145890364|NCT00484419|526105799|FG001|Overall Study|Adverse Event|0|||
145890365|NCT00484419|526105800|FG002|Overall Study|Adverse Event|0|||
145890366|NCT00484419|526105798|FG000|Overall Study|Lost to Follow-up|1|||
145890367|NCT00484419|526105799|FG001|Overall Study|Lost to Follow-up|0|||
145890368|NCT00484419|526105800|FG002|Overall Study|Lost to Follow-up|2|||
145890369|NCT00484419|526105798|FG000|Overall Study|Withdrawal by Subject|3|||
145890370|NCT00484419|526105799|FG001|Overall Study|Withdrawal by Subject|1|||
145890371|NCT00484419|526105800|FG002|Overall Study|Withdrawal by Subject|1|||
145890372|NCT00484419|526105798|FG000|Overall Study|subject met discontinuation criteria|2|||
145890373|NCT00484419|526105799|FG001|Overall Study|subject met discontinuation criteria|2|||
145890374|NCT00484419|526105800|FG002|Overall Study|subject met discontinuation criteria|4|||
145890375|NCT00484419|526105798|FG000|Overall Study|required restricted medication|1|||
145890376|NCT00484419|526105799|FG001|Overall Study|required restricted medication|0|||
145890377|NCT00484419|526105800|FG002|Overall Study|required restricted medication|1|||
145890378|NCT00484419|526105798|FG000|Overall Study|Physician Decision|1|||
145890379|NCT00484419|526105799|FG001|Overall Study|Physician Decision|1|||
146234052|NCT00146172|527375032|FG003|Overall Study|Death|0|||
146234053|NCT00146172|527375033|FG004|Overall Study|Death|0|||
146234054|NCT00146172|527375034|FG005|Overall Study|Death|0|||
146234055|NCT00146172|527375035|FG006|Overall Study|Death|1|||
146234056|NCT00146172|527375036|FG007|Overall Study|Death|0|||
146234057|NCT00146172|527375029|FG000|Overall Study|Physician Decision|0|||
146234058|NCT00146172|527375030|FG001|Overall Study|Physician Decision|0|||
146234059|NCT00146172|527375031|FG002|Overall Study|Physician Decision|0|||
146234060|NCT00146172|527375032|FG003|Overall Study|Physician Decision|0|||
146234061|NCT00146172|527375033|FG004|Overall Study|Physician Decision|0|||
145890380|NCT00484419|526105800|FG002|Overall Study|Physician Decision|1|||
145890381|NCT00484419|526105798|FG000|Overall Study|subject unable to receive medication|1|||
145890382|NCT00484419|526105799|FG001|Overall Study|subject unable to receive medication|0|||
145890383|NCT00484419|526105800|FG002|Overall Study|subject unable to receive medication|0|||
146234062|NCT00146172|527375034|FG005|Overall Study|Physician Decision|0|||
145890384|NCT00484419|526105798|FG000|Overall Study|subject relocated|0|||
145890385|NCT00484419|526105799|FG001|Overall Study|subject relocated|1|||
145890386|NCT00484419|526105800|FG002|Overall Study|subject relocated|0|||
145890387|NCT00484419|526105798|FG000|Overall Study|sponsor decision, randomized in error|0|||
145890388|NCT00484419|526105799|FG001|Overall Study|sponsor decision, randomized in error|0|||
145890389|NCT00484419|526105800|FG002|Overall Study|sponsor decision, randomized in error|2|||
145890390|NCT03604341|526105801|FG000|Overall Study|Withdrawal by Subject|1|||
145890391|NCT03604341|526105802|FG001|Overall Study|Withdrawal by Subject|1|||
145890392|NCT03604341|526105801|FG000|Overall Study|Adverse Event|1|||
145890393|NCT03604341|526105802|FG001|Overall Study|Adverse Event|0|||
145890394|NCT03604341|526105801|FG000|Overall Study|Protocol Violation|0|||
145890395|NCT03604341|526105802|FG001|Overall Study|Protocol Violation|1|||
145890396|NCT01829113|526105804|FG000|Overall Study|Disease Progression|37|||
145890397|NCT01829113|526105805|FG001|Overall Study|Disease Progression|48|||
145890398|NCT01829113|526105804|FG000|Overall Study|Adverse Event|14|||
145890399|NCT01829113|526105805|FG001|Overall Study|Adverse Event|10|||
145890400|NCT01829113|526105804|FG000|Overall Study|Withdrawal by Subject|17|||
145890401|NCT01829113|526105805|FG001|Overall Study|Withdrawal by Subject|10|||
145890402|NCT01829113|526105804|FG000|Overall Study|Death|4|||
145890403|NCT01829113|526105805|FG001|Overall Study|Death|6|||
145890404|NCT01829113|526105804|FG000|Overall Study|Sponsor Decision|1|||
145890405|NCT01829113|526105805|FG001|Overall Study|Sponsor Decision|1|||
145890406|NCT01829113|526105804|FG000|Overall Study|No Study Treatment Received|3|||
145890407|NCT01829113|526105805|FG001|Overall Study|No Study Treatment Received|2|||
145890408|NCT01829113|526105804|FG000|Overall Study|Physician Decision|1|||
145890409|NCT01829113|526105805|FG001|Overall Study|Physician Decision|1|||
145890410|NCT00355472|526105806|FG000|Overall Study|Physician Decision|1|||
145890411|NCT00351351|526105813|FG000|Overall Study|surgical access pbs; device issues|9|||
145890412|NCT00351351|526105814|FG001|Overall Study|surgical access pbs; device issues|4|||
145890413|NCT01341587|526105815|FG000|Overall Study|Lost to Follow-up|2|||
145890414|NCT01341587|526105816|FG001|Overall Study|Lost to Follow-up|0|||
145890415|NCT01341587|526105815|FG000|Overall Study|stopped using the meters|2|||
145890416|NCT01341587|526105816|FG001|Overall Study|stopped using the meters|10|||
145890417|NCT03176784|526105817|FG000|Overall Study|Lost to Follow-up|77|||
145890418|NCT03176784|526105818|FG001|Overall Study|Lost to Follow-up|79|||
145890419|NCT03176784|526105819|FG002|Overall Study|Lost to Follow-up|79|||
145890420|NCT03176784|526105820|FG003|Overall Study|Lost to Follow-up|49|||
145890421|NCT03176784|526105817|FG000|Overall Study|Withdrawal by Subject|28|||
145890422|NCT03176784|526105818|FG001|Overall Study|Withdrawal by Subject|34|||
145890423|NCT03176784|526105819|FG002|Overall Study|Withdrawal by Subject|34|||
145890424|NCT03176784|526105820|FG003|Overall Study|Withdrawal by Subject|21|||
145890425|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
145890426|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
145890427|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
145890428|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
145890429|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
145890430|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
145890431|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
145890432|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
145890433|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
145890434|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
145890435|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
145970706|NCT00903968|526407246|FG003|Overall Study|Withdrawal by Subject|0|||
146234063|NCT00146172|527375035|FG006|Overall Study|Physician Decision|0|||
146234064|NCT00146172|527375036|FG007|Overall Study|Physician Decision|1|||
146234065|NCT00146172|527375029|FG000|Overall Study|Withdrawal by Subject|0|||
146234066|NCT00146172|527375030|FG001|Overall Study|Withdrawal by Subject|0|||
146234067|NCT00146172|527375031|FG002|Overall Study|Withdrawal by Subject|0|||
146234068|NCT00146172|527375032|FG003|Overall Study|Withdrawal by Subject|0|||
146234069|NCT00146172|527375033|FG004|Overall Study|Withdrawal by Subject|0|||
146234070|NCT00146172|527375034|FG005|Overall Study|Withdrawal by Subject|1|||
145890436|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
145890437|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890438|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890439|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
146234071|NCT00146172|527375035|FG006|Overall Study|Withdrawal by Subject|1|||
145890440|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
146234072|NCT00146172|527375036|FG007|Overall Study|Withdrawal by Subject|4|||
145890441|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
145890442|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
145890443|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
145890444|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
145890445|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
145890446|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
145890447|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
145890448|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
145890449|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
145890450|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
145890451|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
145890452|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
145890453|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Death|0|||
145890454|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Death|1|||
145890455|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Death|0|||
145890456|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Death|0|||
145890457|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145890458|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
145890459|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145890460|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145890461|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
145890462|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
145890463|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
145890464|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
145890465|NCT02990806|526105821|FG000|Stage 1 (22 Weeks)|Other|1|||
145890466|NCT02990806|526105822|FG001|Stage 1 (22 Weeks)|Other|3|||
145890467|NCT02990806|526105823|FG002|Stage 1 (22 Weeks)|Other|0|||
145890468|NCT02990806|526105824|FG003|Stage 1 (22 Weeks)|Other|0|||
145890469|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
145890470|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
145890471|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
145890472|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
145890473|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Death|1|||
145890474|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Death|0|||
145890475|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Death|0|||
145890476|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Death|0|||
145890477|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
145890478|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
145890479|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
145890480|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
145890481|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
145890482|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
145890483|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
145890484|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
145890485|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145890486|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
145890487|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145890488|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145890489|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
145890490|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
145890491|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
145890492|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
145890493|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890494|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145890495|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
145890496|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
145890497|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
145890498|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
145890499|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
145890500|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
145890501|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
145890502|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
145890503|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
145890504|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
145890505|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
145890506|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
145890507|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
145890508|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
145890509|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
145890510|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
146293857|NCT00146328|527591954|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
145890511|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
145890512|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
145890513|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Other|3|||
145890514|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Other|0|||
145890515|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Other|4|||
145890516|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Other|1|||
145890517|NCT02990806|526105821|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
146293858|NCT00146328|527591955|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
145970707|NCT00903968|526407247|FG004|Overall Study|Withdrawal by Subject|1|||
145970708|NCT00903968|526407248|FG005|Overall Study|Withdrawal by Subject|1|||
145970709|NCT00903968|526407249|FG006|Overall Study|Withdrawal by Subject|0|||
145970710|NCT00903968|526407250|FG007|Overall Study|Withdrawal by Subject|4|||
145970711|NCT00903968|526407243|FG000|Overall Study|Non-Compliance|0|||
145970712|NCT00903968|526407244|FG001|Overall Study|Non-Compliance|0|||
145970713|NCT00903968|526407245|FG002|Overall Study|Non-Compliance|0|||
145970714|NCT00903968|526407246|FG003|Overall Study|Non-Compliance|0|||
145970715|NCT00903968|526407247|FG004|Overall Study|Non-Compliance|0|||
145970716|NCT00903968|526407248|FG005|Overall Study|Non-Compliance|1|||
145970717|NCT00903968|526407249|FG006|Overall Study|Non-Compliance|0|||
145970718|NCT00903968|526407250|FG007|Overall Study|Non-Compliance|0|||
145970719|NCT00903968|526407243|FG000|Overall Study|Physician Decision|0|||
145970720|NCT00903968|526407244|FG001|Overall Study|Physician Decision|0|||
145970721|NCT00903968|526407245|FG002|Overall Study|Physician Decision|0|||
146234073|NCT00146172|527375029|FG000|Overall Study|Symptomatic Deterioration|1|||
146234074|NCT00146172|527375030|FG001|Overall Study|Symptomatic Deterioration|0|||
146234075|NCT00146172|527375031|FG002|Overall Study|Symptomatic Deterioration|1|||
146234076|NCT00146172|527375032|FG003|Overall Study|Symptomatic Deterioration|0|||
146234077|NCT00146172|527375033|FG004|Overall Study|Symptomatic Deterioration|1|||
146234078|NCT00146172|527375034|FG005|Overall Study|Symptomatic Deterioration|2|||
146234079|NCT00146172|527375035|FG006|Overall Study|Symptomatic Deterioration|0|||
146234080|NCT00146172|527375036|FG007|Overall Study|Symptomatic Deterioration|2|||
146234081|NCT00786864|527375037|FG000|Overall Study|Lost to Follow-up|0|||
145970722|NCT00903968|526407246|FG003|Overall Study|Physician Decision|0|||
145970723|NCT00903968|526407247|FG004|Overall Study|Physician Decision|0|||
145970724|NCT00903968|526407248|FG005|Overall Study|Physician Decision|1|||
145970725|NCT00903968|526407249|FG006|Overall Study|Physician Decision|0|||
145970726|NCT00903968|526407250|FG007|Overall Study|Physician Decision|0|||
145970727|NCT00903968|526407243|FG000|Overall Study|Progressive Disease|2|||
145890518|NCT02990806|526105822|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
145890519|NCT02990806|526105823|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
146234082|NCT00786864|527375038|FG001|Overall Study|Lost to Follow-up|1|||
146234083|NCT00786864|527375037|FG000|Overall Study|Sustained serious back injury|1|||
146234084|NCT00786864|527375038|FG001|Overall Study|Sustained serious back injury|0|||
146234085|NCT01184326|527375042|FG000|Overall Study|Adverse Event|1|||
146234086|NCT01184326|527375043|FG001|Overall Study|Adverse Event|2|||
146234087|NCT01184326|527375044|FG002|Overall Study|Adverse Event|0|||
145890520|NCT02990806|526105824|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
145890521|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
145890522|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
145890523|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
145890524|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
145890525|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145890526|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
145890527|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145890528|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145890529|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890530|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145890531|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890532|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145890533|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
145890534|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
145890535|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
145890536|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
145890537|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
145890538|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
145890539|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
145890540|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
145890541|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145890542|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145890543|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
145890544|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145890545|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145890546|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145890547|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145890548|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
145890549|NCT02990806|526105821|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145890550|NCT02990806|526105822|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145970728|NCT00903968|526407244|FG001|Overall Study|Progressive Disease|3|||
145970729|NCT00903968|526407245|FG002|Overall Study|Progressive Disease|2|||
145970730|NCT00903968|526407246|FG003|Overall Study|Progressive Disease|3|||
145970731|NCT00903968|526407247|FG004|Overall Study|Progressive Disease|3|||
145970732|NCT00903968|526407248|FG005|Overall Study|Progressive Disease|3|||
145970733|NCT00903968|526407249|FG006|Overall Study|Progressive Disease|0|||
145970734|NCT00903968|526407250|FG007|Overall Study|Progressive Disease|18|||
145970735|NCT00903968|526407243|FG000|Overall Study|Lack of Efficacy|0|||
146234088|NCT01184326|527375042|FG000|Overall Study|Death|0|||
146234089|NCT01184326|527375043|FG001|Overall Study|Death|0|||
146234090|NCT01184326|527375044|FG002|Overall Study|Death|1|||
146234091|NCT01184326|527375042|FG000|Overall Study|Withdrawal by Subject|0|||
146234092|NCT01184326|527375043|FG001|Overall Study|Withdrawal by Subject|0|||
146234093|NCT01184326|527375044|FG002|Overall Study|Withdrawal by Subject|1|||
145890551|NCT02990806|526105823|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
145890552|NCT02990806|526105824|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145890553|NCT01010750|526105825|FG000|Second Intervention|Adverse Event|0|||
145890554|NCT01010750|526105826|FG001|Second Intervention|Adverse Event|1|||
145890555|NCT01010750|526105827|FG002|Second Intervention|Adverse Event|0|||
145890556|NCT01010750|526105828|FG003|Second Intervention|Adverse Event|0|||
145890557|NCT01010750|526105829|FG004|Second Intervention|Adverse Event|0|||
145890558|NCT01010750|526105830|FG005|Second Intervention|Adverse Event|0|||
145970736|NCT00903968|526407244|FG001|Overall Study|Lack of Efficacy|0|||
145970737|NCT00903968|526407245|FG002|Overall Study|Lack of Efficacy|0|||
145970738|NCT00903968|526407246|FG003|Overall Study|Lack of Efficacy|0|||
146087649|NCT04393298|526841819|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146234094|NCT01184326|527375042|FG000|Overall Study|Physician Decision|1|||
146234095|NCT01184326|527375043|FG001|Overall Study|Physician Decision|1|||
146234096|NCT01184326|527375044|FG002|Overall Study|Physician Decision|0|||
146234097|NCT01184326|527375042|FG000|Overall Study|Disease Progression|1|||
146087650|NCT04393298|526841820|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087651|NCT04393298|526841821|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087652|NCT04393298|526841822|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087653|NCT04393298|526841823|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
146087654|NCT04393298|526841824|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
146087655|NCT04393298|526841810|FG000|Overall Study|Death|0|||
146087656|NCT04393298|526841811|FG001|Overall Study|Death|0|||
146087657|NCT04393298|526841812|FG002|Overall Study|Death|0|||
146087658|NCT04393298|526841813|FG003|Overall Study|Death|0|||
146087659|NCT04393298|526841814|FG004|Overall Study|Death|0|||
146087660|NCT04393298|526841815|FG005|Overall Study|Death|1|||
146087661|NCT04393298|526841816|FG006|Overall Study|Death|1|||
146087662|NCT04393298|526841817|FG007|Overall Study|Death|0|||
146087663|NCT04393298|526841818|FG008|Overall Study|Death|1|||
146087664|NCT04393298|526841819|FG009|Overall Study|Death|1|||
146087665|NCT04393298|526841820|FG010|Overall Study|Death|0|||
146087666|NCT04393298|526841821|FG011|Overall Study|Death|1|||
146087667|NCT04393298|526841822|FG012|Overall Study|Death|1|||
146087668|NCT04393298|526841823|FG013|Overall Study|Death|0|||
146087669|NCT04393298|526841824|FG014|Overall Study|Death|1|||
146087670|NCT04393298|526841810|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087671|NCT04393298|526841811|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087672|NCT04393298|526841812|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087673|NCT04393298|526841813|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087674|NCT04393298|526841814|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087675|NCT04393298|526841815|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
146087676|NCT04393298|526841816|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087677|NCT04393298|526841817|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087678|NCT04393298|526841818|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087679|NCT04393298|526841819|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087680|NCT04393298|526841820|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087681|NCT04393298|526841821|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087682|NCT04393298|526841822|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087683|NCT04393298|526841823|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087684|NCT04393298|526841824|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
146087685|NCT04393298|526841810|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
146087686|NCT04393298|526841811|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
146087687|NCT04393298|526841812|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
146087688|NCT04393298|526841813|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
146087689|NCT04393298|526841814|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
146087690|NCT04393298|526841815|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
146087691|NCT04393298|526841816|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
146087692|NCT04393298|526841817|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
146087693|NCT04393298|526841818|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
146087694|NCT04393298|526841819|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
145890559|NCT02654587|526105831|FG000|Overall Study|patient alive at end of study|22|||
145890560|NCT02654587|526105832|FG001|Overall Study|patient alive at end of study|8|||
145890561|NCT02654587|526105831|FG000|Overall Study|Withdrawal by Subject|1|||
145890562|NCT02654587|526105832|FG001|Overall Study|Withdrawal by Subject|7|||
145890563|NCT01825837|526105833|FG000|PART I|Withdrawal by Subject|0|||
145890564|NCT01825837|526105834|FG001|PART I|Withdrawal by Subject|0|||
145890565|NCT01825837|526105835|FG002|PART I|Withdrawal by Subject|0|||
145890566|NCT01825837|526105836|FG003|PART I|Withdrawal by Subject|6|||
145890567|NCT01825837|526105833|FG000|PART I|Patient non-compliance|0|||
145890568|NCT01825837|526105834|FG001|PART I|Patient non-compliance|0|||
145890569|NCT01825837|526105835|FG002|PART I|Patient non-compliance|0|||
145890570|NCT01825837|526105836|FG003|PART I|Patient non-compliance|1|||
145890571|NCT01825837|526105833|FG000|PART I|Treatment failure|0|||
145890572|NCT01825837|526105834|FG001|PART I|Treatment failure|0|||
145890573|NCT01825837|526105835|FG002|PART I|Treatment failure|0|||
145890574|NCT01825837|526105836|FG003|PART I|Treatment failure|7|||
145890575|NCT01825837|526105833|FG000|PART I|reason unspecified|0|||
145890576|NCT01825837|526105834|FG001|PART I|reason unspecified|0|||
145890577|NCT01825837|526105835|FG002|PART I|reason unspecified|0|||
145890578|NCT01825837|526105836|FG003|PART I|reason unspecified|3|||
145890579|NCT01825837|526105833|FG000|PART II|Withdrawal by Subject|3|||
145890580|NCT01825837|526105834|FG001|PART II|Withdrawal by Subject|3|||
145890581|NCT01825837|526105835|FG002|PART II|Withdrawal by Subject|7|||
145890582|NCT01825837|526105836|FG003|PART II|Withdrawal by Subject|0|||
145890583|NCT01825837|526105833|FG000|PART II|Patient non-compliance|5|||
145890584|NCT01825837|526105834|FG001|PART II|Patient non-compliance|2|||
145890585|NCT01825837|526105835|FG002|PART II|Patient non-compliance|4|||
145890586|NCT01825837|526105836|FG003|PART II|Patient non-compliance|0|||
145890587|NCT01825837|526105833|FG000|PART II|Adverse Event|3|||
145890588|NCT01825837|526105834|FG001|PART II|Adverse Event|3|||
145890589|NCT01825837|526105835|FG002|PART II|Adverse Event|1|||
145890590|NCT01825837|526105836|FG003|PART II|Adverse Event|0|||
145890591|NCT01825837|526105833|FG000|PART II|Treatment failure|6|||
145890592|NCT01825837|526105834|FG001|PART II|Treatment failure|4|||
145890593|NCT01825837|526105835|FG002|PART II|Treatment failure|5|||
145890594|NCT01825837|526105836|FG003|PART II|Treatment failure|0|||
145890595|NCT01825837|526105833|FG000|PART II|reason unspecified|2|||
145890596|NCT01825837|526105834|FG001|PART II|reason unspecified|2|||
145890597|NCT01825837|526105835|FG002|PART II|reason unspecified|2|||
145890598|NCT01825837|526105836|FG003|PART II|reason unspecified|0|||
145890599|NCT00904748|526105839|FG000|Overall Study|Withdrawal by Subject|1|||
145890600|NCT00904748|526105840|FG001|Overall Study|Withdrawal by Subject|1|||
145890601|NCT00904748|526105841|FG002|Overall Study|Withdrawal by Subject|1|||
145890602|NCT00904748|526105842|FG003|Overall Study|Withdrawal by Subject|2|||
145890603|NCT00904748|526105843|FG004|Overall Study|Withdrawal by Subject|0|||
145890604|NCT00904748|526105844|FG005|Overall Study|Withdrawal by Subject|0|||
145890605|NCT00904748|526105839|FG000|Overall Study|Adverse Event|0|||
145890606|NCT00904748|526105840|FG001|Overall Study|Adverse Event|0|||
145890607|NCT00904748|526105841|FG002|Overall Study|Adverse Event|0|||
145890608|NCT00904748|526105842|FG003|Overall Study|Adverse Event|0|||
145890609|NCT00904748|526105843|FG004|Overall Study|Adverse Event|1|||
145890610|NCT00904748|526105844|FG005|Overall Study|Adverse Event|0|||
145890611|NCT00873119|526105849|FG000|Overall Study|Patient request|4|||
145890612|NCT00873119|526105850|FG001|Overall Study|Patient request|2|||
145890613|NCT00873119|526105849|FG000|Overall Study|Adverse Event|8|||
145890614|NCT00873119|526105850|FG001|Overall Study|Adverse Event|0|||
145890615|NCT00873119|526105849|FG000|Overall Study|Progressive disease|26|||
145970739|NCT00903968|526407247|FG004|Overall Study|Lack of Efficacy|0|||
145970740|NCT00903968|526407248|FG005|Overall Study|Lack of Efficacy|0|||
145970741|NCT00903968|526407249|FG006|Overall Study|Lack of Efficacy|0|||
145970742|NCT00903968|526407250|FG007|Overall Study|Lack of Efficacy|3|||
145970743|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
145970744|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
145970745|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
145970746|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
145970747|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
145890616|NCT00873119|526105850|FG001|Overall Study|Progressive disease|18|||
145890617|NCT00873119|526105849|FG000|Overall Study|Death|2|||
145890618|NCT00873119|526105850|FG001|Overall Study|Death|1|||
145890619|NCT00873119|526105849|FG000|Overall Study|Other|2|||
145890620|NCT00873119|526105850|FG001|Overall Study|Other|5|||
145890621|NCT00873119|526105849|FG000|Overall Study|Not treated|2|||
145890622|NCT00873119|526105850|FG001|Overall Study|Not treated|0|||
145890623|NCT03648879|526105851|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
145890624|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
145890625|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
145890626|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
145890627|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
145970748|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
146234098|NCT01184326|527375043|FG001|Overall Study|Disease Progression|3|||
146234099|NCT01184326|527375044|FG002|Overall Study|Disease Progression|12|||
146234100|NCT01500200|527375053|FG000|Stage 1|Adverse Event|1|||
146234101|NCT01500200|527375054|FG001|Stage 1|Adverse Event|4|||
146234102|NCT01500200|527375055|FG002|Stage 1|Adverse Event|5|||
146234103|NCT01500200|527375056|FG003|Stage 1|Adverse Event|0|||
146234104|NCT01500200|527375057|FG004|Stage 1|Adverse Event|0|||
146234105|NCT01500200|527375058|FG005|Stage 1|Adverse Event|0|||
146234106|NCT01500200|527375053|FG000|Stage 1|Lost to Follow-up|2|||
146234107|NCT01500200|527375054|FG001|Stage 1|Lost to Follow-up|2|||
146234108|NCT01500200|527375055|FG002|Stage 1|Lost to Follow-up|1|||
146234109|NCT01500200|527375056|FG003|Stage 1|Lost to Follow-up|0|||
146234110|NCT01500200|527375057|FG004|Stage 1|Lost to Follow-up|0|||
146234111|NCT01500200|527375058|FG005|Stage 1|Lost to Follow-up|0|||
146234112|NCT01500200|527375053|FG000|Stage 1|Withdrawal by Subject|3|||
146234113|NCT01500200|527375054|FG001|Stage 1|Withdrawal by Subject|0|||
146234114|NCT01500200|527375055|FG002|Stage 1|Withdrawal by Subject|0|||
146234115|NCT01500200|527375056|FG003|Stage 1|Withdrawal by Subject|0|||
146234116|NCT01500200|527375057|FG004|Stage 1|Withdrawal by Subject|0|||
146234117|NCT01500200|527375058|FG005|Stage 1|Withdrawal by Subject|0|||
146234118|NCT01500200|527375053|FG000|Stage 1|Noncompliance with Study Drug|1|||
146234119|NCT01500200|527375054|FG001|Stage 1|Noncompliance with Study Drug|0|||
146234120|NCT01500200|527375055|FG002|Stage 1|Noncompliance with Study Drug|0|||
146234121|NCT01500200|527375056|FG003|Stage 1|Noncompliance with Study Drug|0|||
146234122|NCT01500200|527375057|FG004|Stage 1|Noncompliance with Study Drug|0|||
146234123|NCT01500200|527375058|FG005|Stage 1|Noncompliance with Study Drug|0|||
146234124|NCT01500200|527375053|FG000|Stage 1|Physician Decision|1|||
146234125|NCT01500200|527375054|FG001|Stage 1|Physician Decision|0|||
146234126|NCT01500200|527375055|FG002|Stage 1|Physician Decision|0|||
146234127|NCT01500200|527375056|FG003|Stage 1|Physician Decision|0|||
146234128|NCT01500200|527375057|FG004|Stage 1|Physician Decision|0|||
146234129|NCT01500200|527375058|FG005|Stage 1|Physician Decision|0|||
146234130|NCT01500200|527375053|FG000|Stage 2|Adverse Event|0|||
146234131|NCT01500200|527375054|FG001|Stage 2|Adverse Event|0|||
146234132|NCT01500200|527375055|FG002|Stage 2|Adverse Event|0|||
146234133|NCT01500200|527375056|FG003|Stage 2|Adverse Event|0|||
146234134|NCT01500200|527375057|FG004|Stage 2|Adverse Event|5|||
146234135|NCT01500200|527375058|FG005|Stage 2|Adverse Event|4|||
146234136|NCT00623194|527375059|FG000|Overall Study|Lack of Efficacy|1|||
146234137|NCT00623194|527375059|FG000|Overall Study|Protocol Violation|3|||
146234138|NCT00623194|527375059|FG000|Overall Study|Unclassified|1|||
146234139|NCT01952366|527375060|FG000|Overall Study|Death|22|||
146234140|NCT01952366|527375060|FG000|Overall Study|Withdrawal by Subject|9|||
146234141|NCT04860505|527375061|FG000|Overall Study|Lost to Follow-up|2|||
146234142|NCT00857766|527375062|FG000|Overall Study|Adverse Event|13|||
146234143|NCT00857766|527375063|FG001|Overall Study|Adverse Event|12|||
146234144|NCT00857766|527375062|FG000|Overall Study|Protocol Violation|11|||
146234145|NCT00857766|527375063|FG001|Overall Study|Protocol Violation|11|||
146234146|NCT00857766|527375062|FG000|Overall Study|Lost to Follow-up|1|||
146234147|NCT00857766|527375063|FG001|Overall Study|Lost to Follow-up|0|||
146234148|NCT00857766|527375062|FG000|Overall Study|Investigator Discretion|2|||
146234149|NCT00857766|527375063|FG001|Overall Study|Investigator Discretion|3|||
146234150|NCT00857766|527375062|FG000|Overall Study|Participant Withdrew Consent|4|||
146234151|NCT00857766|527375063|FG001|Overall Study|Participant Withdrew Consent|4|||
146234152|NCT01961609|527375064|FG000|Initiation|Missing|3|||
146234153|NCT01961609|527375065|FG001|Initiation|Missing|2|||
146234154|NCT01961609|527375066|FG002|Initiation|Missing|0|||
146234155|NCT01961609|527375067|FG003|Initiation|Missing|0|||
146234156|NCT01961609|527375064|FG000|Initiation|Protocol deviation|1|||
146234157|NCT01961609|527375065|FG001|Initiation|Protocol deviation|0|||
146234158|NCT01961609|527375066|FG002|Initiation|Protocol deviation|0|||
145890628|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
145890629|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
145890630|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
146234159|NCT01961609|527375067|FG003|Initiation|Protocol deviation|0|||
146234160|NCT01961609|527375064|FG000|Initiation|Death|0|||
146234161|NCT01961609|527375065|FG001|Initiation|Death|1|||
146234162|NCT01961609|527375066|FG002|Initiation|Death|0|||
146234163|NCT01961609|527375067|FG003|Initiation|Death|0|||
146234164|NCT01961609|527375064|FG000|Initiation|Administrative problems|1|||
146234165|NCT01961609|527375065|FG001|Initiation|Administrative problems|0|||
146234166|NCT01961609|527375066|FG002|Initiation|Administrative problems|0|||
146234167|NCT01961609|527375067|FG003|Initiation|Administrative problems|0|||
146234168|NCT01961609|527375064|FG000|Initiation|Withdrawal by Subject|1|||
146234169|NCT01961609|527375065|FG001|Initiation|Withdrawal by Subject|2|||
146234170|NCT01961609|527375066|FG002|Initiation|Withdrawal by Subject|0|||
146234171|NCT01961609|527375067|FG003|Initiation|Withdrawal by Subject|0|||
146234172|NCT01961609|527375064|FG000|Initiation|Lack of Efficacy|2|||
146234173|NCT01961609|527375065|FG001|Initiation|Lack of Efficacy|1|||
146234174|NCT01961609|527375066|FG002|Initiation|Lack of Efficacy|0|||
146234175|NCT01961609|527375067|FG003|Initiation|Lack of Efficacy|0|||
146234176|NCT01961609|527375064|FG000|Initiation|Abnormal lab values|0|||
146234177|NCT01961609|527375065|FG001|Initiation|Abnormal lab values|1|||
146234178|NCT01961609|527375066|FG002|Initiation|Abnormal lab values|0|||
146234179|NCT01961609|527375067|FG003|Initiation|Abnormal lab values|0|||
146234180|NCT01961609|527375064|FG000|Initiation|Adverse Event|3|||
146234181|NCT01961609|527375065|FG001|Initiation|Adverse Event|5|||
146234182|NCT01961609|527375066|FG002|Initiation|Adverse Event|0|||
146234183|NCT01961609|527375067|FG003|Initiation|Adverse Event|0|||
146234184|NCT01961609|527375064|FG000|Initiation|Randomized but not treated|1|||
146234185|NCT01961609|527375065|FG001|Initiation|Randomized but not treated|1|||
145890631|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
145890632|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
145890633|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
145890634|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
145890635|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
145890636|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
145890637|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
145890638|NCT04740931|526105852|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
145890639|NCT04740931|526105853|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
145890640|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
145890641|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
145890642|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
145890643|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
145890644|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
145890645|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
145890646|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
145890647|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
145890648|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
145890649|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
145890650|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
145890651|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
145890652|NCT04740931|526105852|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
145890653|NCT04740931|526105853|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
145890654|NCT04403763|526105854|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
145890655|NCT04403763|526105855|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
145890656|NCT04403763|526105856|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
145890657|NCT04403763|526105857|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
145890658|NCT04403763|526105858|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
145890659|NCT04403763|526105859|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
146234186|NCT01961609|527375066|FG002|Initiation|Randomized but not treated|0|||
145890660|NCT04403763|526105860|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
145970749|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
146234187|NCT01961609|527375067|FG003|Initiation|Randomized but not treated|0|||
146234188|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
146234189|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
146234190|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
145890661|NCT04403763|526105854|FG000|Stage 1|Early termination due to PK tube failure|0|||
145890662|NCT04403763|526105855|FG001|Stage 1|Early termination due to PK tube failure|0|||
145890663|NCT04403763|526105856|FG002|Stage 1|Early termination due to PK tube failure|1|||
145890664|NCT04403763|526105857|FG003|Stage 1|Early termination due to PK tube failure|0|||
145890665|NCT04403763|526105858|FG004|Stage 1|Early termination due to PK tube failure|0|||
145890666|NCT04403763|526105859|FG005|Stage 1|Early termination due to PK tube failure|0|||
146234191|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
146234192|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
146234193|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
146234194|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
146234195|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
146234196|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
145890667|NCT04403763|526105860|FG006|Stage 1|Early termination due to PK tube failure|0|||
145890668|NCT04403763|526105854|FG000|Stage 2A|Adverse Event|0|||
145890669|NCT04403763|526105855|FG001|Stage 2A|Adverse Event|0|||
145890670|NCT04403763|526105856|FG002|Stage 2A|Adverse Event|0|||
145890671|NCT04403763|526105857|FG003|Stage 2A|Adverse Event|0|||
145890672|NCT04403763|526105858|FG004|Stage 2A|Adverse Event|0|||
145890673|NCT04403763|526105859|FG005|Stage 2A|Adverse Event|0|||
145890674|NCT04403763|526105860|FG006|Stage 2A|Adverse Event|1|||
145890675|NCT01376310|526105861|FG000|Overall Study|Study closed/terminated|1|||
145890676|NCT01376310|526105862|FG001|Overall Study|Study closed/terminated|2|||
145890677|NCT01376310|526105861|FG000|Overall Study|Withdrawal by Subject|8|||
145890678|NCT01376310|526105862|FG001|Overall Study|Withdrawal by Subject|2|||
145890679|NCT01376310|526105861|FG000|Overall Study|Physician Decision|26|||
145890680|NCT01376310|526105862|FG001|Overall Study|Physician Decision|7|||
145890681|NCT01376310|526105861|FG000|Overall Study|Lost to Follow-up|1|||
145890682|NCT01376310|526105862|FG001|Overall Study|Lost to Follow-up|0|||
145890683|NCT02339740|526105863|FG000|Overall Study|Death|1|||
145890684|NCT02339740|526105864|FG001|Overall Study|Death|0|||
145890685|NCT02339740|526105863|FG000|Overall Study|Physician Decision|0|||
145890686|NCT02339740|526105864|FG001|Overall Study|Physician Decision|2|||
145890687|NCT02339740|526105863|FG000|Overall Study|Withdrawal by Subject|5|||
145890688|NCT02339740|526105864|FG001|Overall Study|Withdrawal by Subject|1|||
145890689|NCT02339740|526105863|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
145890690|NCT02339740|526105864|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
145890691|NCT01807117|526105865|FG000|Overall Study|Physician Decision|2|||
145890692|NCT01807117|526105865|FG000|Overall Study|Disease diagnosis not a study disease|1|||
145890693|NCT01534637|526105866|FG000|Overall Study|Physician Decision|3|||
145890694|NCT01534637|526105866|FG000|Overall Study|Lack of Efficacy|3|||
145890695|NCT01534637|526105866|FG000|Overall Study|Withdrawal by Subject|1|||
145890696|NCT01534637|526105866|FG000|Overall Study|Adverse Event|1|||
145890697|NCT01534637|526105866|FG000|Overall Study|Liver Mets before treatment|1|||
145890698|NCT01020799|526105872|FG000|Overall Study|Adverse Event|4|||
145890699|NCT01020799|526105873|FG001|Overall Study|Adverse Event|3|||
145890700|NCT01020799|526105874|FG002|Overall Study|Adverse Event|2|||
145890701|NCT01020799|526105872|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
145890702|NCT01020799|526105873|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
145890703|NCT01020799|526105874|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
145890704|NCT01020799|526105872|FG000|Overall Study|Protocol Violation|3|||
145890705|NCT01020799|526105873|FG001|Overall Study|Protocol Violation|2|||
145890706|NCT01020799|526105874|FG002|Overall Study|Protocol Violation|0|||
145890707|NCT01020799|526105872|FG000|Overall Study|Withdrawal by Subject|2|||
145890708|NCT01020799|526105873|FG001|Overall Study|Withdrawal by Subject|2|||
145890709|NCT01020799|526105874|FG002|Overall Study|Withdrawal by Subject|3|||
145890710|NCT01020799|526105872|FG000|Overall Study|Lost to Follow-up|6|||
145890711|NCT01020799|526105873|FG001|Overall Study|Lost to Follow-up|4|||
145890712|NCT01020799|526105874|FG002|Overall Study|Lost to Follow-up|2|||
145970750|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
145970751|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
145970752|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
145970753|NCT03979313|526407251|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
145970754|NCT03979313|526407252|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
145970755|NCT03979313|526407251|FG000|All Subjects|Any Other Reason|16|||
145970756|NCT03979313|526407252|FG001|All Subjects|Any Other Reason|23|||
145970757|NCT03979313|526407251|FG000|All Subjects|Covid-19|1|||
145970758|NCT03979313|526407252|FG001|All Subjects|Covid-19|3|||
145970759|NCT03979313|526407251|FG000|All Subjects|Withdrawal by Subject|35|||
145970760|NCT03979313|526407252|FG001|All Subjects|Withdrawal by Subject|44|||
145970761|NCT03979313|526407251|FG000|All Subjects|Death|0|||
145970762|NCT03979313|526407252|FG001|All Subjects|Death|5|||
146234197|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
145890713|NCT04179019|526105875|FG000|Overall Study|Lost to Follow-up|2|||
145890714|NCT04179019|526105875|FG000|Overall Study|Physician Decision|2|||
145890715|NCT04179019|526105875|FG000|Overall Study|Withdrawal by Subject|5|||
145970763|NCT03979313|526407251|FG000|All Subjects|Lost to Follow-up|28|||
145890716|NCT04179019|526105875|FG000|Overall Study|Adverse Event|4|||
145890717|NCT02149121|526105881|FG000|Main Study Period|Lack of Efficacy|2|||
145890718|NCT02149121|526105882|FG001|Main Study Period|Lack of Efficacy|2|||
145890719|NCT02149121|526105883|FG002|Main Study Period|Lack of Efficacy|1|||
145890720|NCT02149121|526105884|FG003|Main Study Period|Lack of Efficacy|0|||
145890721|NCT02149121|526105885|FG004|Main Study Period|Lack of Efficacy|0|||
145890722|NCT02149121|526105886|FG005|Main Study Period|Lack of Efficacy|0|||
145890723|NCT02149121|526105887|FG006|Main Study Period|Lack of Efficacy|0|||
145890724|NCT02149121|526105881|FG000|Main Study Period|Withdrawal by Subject|9|||
145890725|NCT02149121|526105882|FG001|Main Study Period|Withdrawal by Subject|5|||
145890726|NCT02149121|526105883|FG002|Main Study Period|Withdrawal by Subject|1|||
145890727|NCT02149121|526105884|FG003|Main Study Period|Withdrawal by Subject|0|||
145890728|NCT02149121|526105885|FG004|Main Study Period|Withdrawal by Subject|0|||
145890729|NCT02149121|526105886|FG005|Main Study Period|Withdrawal by Subject|0|||
145890730|NCT02149121|526105887|FG006|Main Study Period|Withdrawal by Subject|0|||
145890731|NCT02149121|526105881|FG000|Main Study Period|Adverse Event|2|||
145890732|NCT02149121|526105882|FG001|Main Study Period|Adverse Event|5|||
145890733|NCT02149121|526105883|FG002|Main Study Period|Adverse Event|1|||
145890734|NCT02149121|526105884|FG003|Main Study Period|Adverse Event|0|||
145890735|NCT02149121|526105885|FG004|Main Study Period|Adverse Event|0|||
145890736|NCT02149121|526105886|FG005|Main Study Period|Adverse Event|0|||
145890737|NCT02149121|526105887|FG006|Main Study Period|Adverse Event|0|||
145890738|NCT02149121|526105881|FG000|Main Study Period|Protocol Violation|2|||
145890739|NCT02149121|526105882|FG001|Main Study Period|Protocol Violation|0|||
145890740|NCT02149121|526105883|FG002|Main Study Period|Protocol Violation|0|||
145890741|NCT02149121|526105884|FG003|Main Study Period|Protocol Violation|0|||
145890742|NCT02149121|526105885|FG004|Main Study Period|Protocol Violation|0|||
145890743|NCT02149121|526105886|FG005|Main Study Period|Protocol Violation|0|||
145890744|NCT02149121|526105887|FG006|Main Study Period|Protocol Violation|0|||
145890745|NCT02149121|526105881|FG000|Main Study Period|Lost to Follow-up|2|||
145890746|NCT02149121|526105882|FG001|Main Study Period|Lost to Follow-up|1|||
145890747|NCT02149121|526105883|FG002|Main Study Period|Lost to Follow-up|0|||
145890748|NCT02149121|526105884|FG003|Main Study Period|Lost to Follow-up|0|||
145890749|NCT02149121|526105885|FG004|Main Study Period|Lost to Follow-up|0|||
145890750|NCT02149121|526105886|FG005|Main Study Period|Lost to Follow-up|0|||
145890751|NCT02149121|526105887|FG006|Main Study Period|Lost to Follow-up|0|||
145890752|NCT02149121|526105881|FG000|Main Study Period|Death|1|||
145890753|NCT02149121|526105882|FG001|Main Study Period|Death|0|||
145890754|NCT02149121|526105883|FG002|Main Study Period|Death|0|||
145890755|NCT02149121|526105884|FG003|Main Study Period|Death|0|||
145890756|NCT02149121|526105885|FG004|Main Study Period|Death|0|||
145890757|NCT02149121|526105886|FG005|Main Study Period|Death|0|||
145890758|NCT02149121|526105887|FG006|Main Study Period|Death|0|||
145890759|NCT02149121|526105881|FG000|Main Study Period|Physician Decision|1|||
145890760|NCT02149121|526105882|FG001|Main Study Period|Physician Decision|0|||
145890761|NCT02149121|526105883|FG002|Main Study Period|Physician Decision|0|||
145890762|NCT02149121|526105884|FG003|Main Study Period|Physician Decision|0|||
145890763|NCT02149121|526105885|FG004|Main Study Period|Physician Decision|0|||
145890764|NCT02149121|526105886|FG005|Main Study Period|Physician Decision|0|||
145890765|NCT02149121|526105887|FG006|Main Study Period|Physician Decision|0|||
145890766|NCT02149121|526105881|FG000|Main Study Period|Developed any malignancy|0|||
145890767|NCT02149121|526105882|FG001|Main Study Period|Developed any malignancy|1|||
145890768|NCT02149121|526105883|FG002|Main Study Period|Developed any malignancy|1|||
145890769|NCT02149121|526105884|FG003|Main Study Period|Developed any malignancy|0|||
145890770|NCT02149121|526105885|FG004|Main Study Period|Developed any malignancy|0|||
145890771|NCT02149121|526105886|FG005|Main Study Period|Developed any malignancy|0|||
145890772|NCT02149121|526105887|FG006|Main Study Period|Developed any malignancy|0|||
145890773|NCT02149121|526105881|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
145890774|NCT02149121|526105882|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
145890775|NCT02149121|526105883|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
145890776|NCT02149121|526105884|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
145890777|NCT02149121|526105885|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
145890778|NCT02149121|526105886|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
145890779|NCT02149121|526105887|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
145890780|NCT02149121|526105881|FG000|Main Study Period|Disease progression|0|||
145890781|NCT02149121|526105882|FG001|Main Study Period|Disease progression|1|||
145890782|NCT02149121|526105883|FG002|Main Study Period|Disease progression|0|||
145890783|NCT02149121|526105884|FG003|Main Study Period|Disease progression|0|||
145890784|NCT02149121|526105885|FG004|Main Study Period|Disease progression|0|||
145890785|NCT02149121|526105886|FG005|Main Study Period|Disease progression|0|||
145890786|NCT02149121|526105887|FG006|Main Study Period|Disease progression|0|||
145890787|NCT02149121|526105881|FG000|Extension Study Period|Withdrawal by Subject|0|||
145890788|NCT02149121|526105882|FG001|Extension Study Period|Withdrawal by Subject|0|||
145890789|NCT02149121|526105883|FG002|Extension Study Period|Withdrawal by Subject|0|||
145890790|NCT02149121|526105884|FG003|Extension Study Period|Withdrawal by Subject|1|||
146234198|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
146234199|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
146234200|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
146234201|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
146234202|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
146234203|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
146234204|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
146234205|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
146234206|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
146234207|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
145890791|NCT02149121|526105885|FG004|Extension Study Period|Withdrawal by Subject|0|||
145890792|NCT02149121|526105886|FG005|Extension Study Period|Withdrawal by Subject|2|||
145890793|NCT02149121|526105887|FG006|Extension Study Period|Withdrawal by Subject|0|||
145890794|NCT03166124|526105888|FG000|Treatment Period 1|Adverse Event|0|||
145890795|NCT03166124|526105889|FG001|Treatment Period 1|Adverse Event|0|||
145890796|NCT03166124|526105890|FG002|Treatment Period 1|Adverse Event|1|||
145890797|NCT03166124|526105891|FG003|Treatment Period 1|Adverse Event|0|||
145890798|NCT03166124|526105888|FG000|Wash-out Period|Withdrawal by Subject|0|||
145890799|NCT03166124|526105889|FG001|Wash-out Period|Withdrawal by Subject|1|||
146234208|NCT01961609|527375064|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146234209|NCT01961609|527375065|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146234210|NCT01961609|527375066|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
146234211|NCT01961609|527375067|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
146234212|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
146234213|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
146234214|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
146234215|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
146234216|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
146234217|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
145890800|NCT03166124|526105890|FG002|Wash-out Period|Withdrawal by Subject|0|||
146234218|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
146234219|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
146234220|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
146234221|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
146234222|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
146234223|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
145970764|NCT03979313|526407252|FG001|All Subjects|Lost to Follow-up|61|||
146234224|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146293859|NCT00146328|527591953|FG000|Overall Study|Trial ended/site closed|8|||
146293860|NCT00146328|527591954|FG001|Overall Study|Trial ended/site closed|2|||
146293861|NCT00146328|527591955|FG002|Overall Study|Trial ended/site closed|19|||
146293862|NCT00146328|527591953|FG000|Overall Study|Patient decision to end|0|||
146293863|NCT00146328|527591954|FG001|Overall Study|Patient decision to end|1|||
146293864|NCT00146328|527591955|FG002|Overall Study|Patient decision to end|6|||
146293865|NCT00146328|527591953|FG000|Overall Study|Enroll into other trial|2|||
146293866|NCT00146328|527591954|FG001|Overall Study|Enroll into other trial|4|||
146293867|NCT00146328|527591955|FG002|Overall Study|Enroll into other trial|2|||
146293868|NCT00146328|527591953|FG000|Overall Study|Death|0|||
146293869|NCT00146328|527591954|FG001|Overall Study|Death|1|||
146293870|NCT00146328|527591955|FG002|Overall Study|Death|1|||
146293871|NCT00146328|527591953|FG000|Overall Study|Moved|2|||
146293872|NCT00146328|527591954|FG001|Overall Study|Moved|0|||
146293873|NCT00146328|527591955|FG002|Overall Study|Moved|0|||
146293874|NCT00146328|527591953|FG000|Overall Study|Interaction with other medication|2|||
146293875|NCT00146328|527591954|FG001|Overall Study|Interaction with other medication|0|||
146293876|NCT00146328|527591955|FG002|Overall Study|Interaction with other medication|1|||
146293877|NCT00792805|527591956|FG000|Overall Study|Adverse Event|12|||
146293878|NCT00792805|527591957|FG001|Overall Study|Adverse Event|10|||
146293879|NCT00792805|527591958|FG002|Overall Study|Adverse Event|10|||
146293880|NCT00792805|527591956|FG000|Overall Study|Subject withdrew consent|5|||
146293881|NCT00792805|527591957|FG001|Overall Study|Subject withdrew consent|6|||
146234225|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
146293882|NCT00792805|527591958|FG002|Overall Study|Subject withdrew consent|5|||
146293883|NCT00792805|527591956|FG000|Overall Study|Administrative problems|2|||
146293884|NCT00792805|527591957|FG001|Overall Study|Administrative problems|0|||
145890801|NCT03166124|526105891|FG003|Wash-out Period|Withdrawal by Subject|1|||
145890802|NCT03166124|526105888|FG000|Wash-out Period|Adverse Event|0|||
145890803|NCT03166124|526105889|FG001|Wash-out Period|Adverse Event|1|||
145890804|NCT03166124|526105890|FG002|Wash-out Period|Adverse Event|1|||
145890805|NCT03166124|526105891|FG003|Wash-out Period|Adverse Event|0|||
146234226|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146234227|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
146234228|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
146234229|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
146234230|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
146234231|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
146234232|NCT01961609|527375064|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
146234233|NCT01961609|527375065|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
146234234|NCT01961609|527375066|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
146234235|NCT01961609|527375067|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
146234236|NCT01988402|527375068|FG000|Overall Study|Adverse Event|1|||
146234237|NCT01988402|527375069|FG001|Overall Study|Adverse Event|2|||
146234238|NCT01988402|527375068|FG000|Overall Study|Withdrawal by Subject|1|||
146234239|NCT01988402|527375069|FG001|Overall Study|Withdrawal by Subject|0|||
146234240|NCT01212744|527375072|FG000|Overall Study|Withdrawal by Subject|1|||
146234241|NCT02167451|527375074|FG000|Overall Study|Withdrawal by Subject|1|||
146234242|NCT00571649|527375075|FG000|Treatment Period|Adverse Event|438|||
146234243|NCT00571649|527375076|FG001|Treatment Period|Adverse Event|385|||
146234244|NCT00571649|527375075|FG000|Treatment Period|Clinical endpoint reached|50|||
146234245|NCT00571649|527375076|FG001|Treatment Period|Clinical endpoint reached|56|||
146234246|NCT00571649|527375075|FG000|Treatment Period|Withdrawal by Subject|285|||
146234247|NCT00571649|527375076|FG001|Treatment Period|Withdrawal by Subject|255|||
146234248|NCT00571649|527375075|FG000|Treatment Period|Death|76|||
146234249|NCT00571649|527375076|FG001|Treatment Period|Death|59|||
146234250|NCT00571649|527375075|FG000|Treatment Period|Physician Decision|8|||
146234251|NCT00571649|527375076|FG001|Treatment Period|Physician Decision|9|||
146234252|NCT00571649|527375075|FG000|Treatment Period|Lost to Follow-up|43|||
146234253|NCT00571649|527375076|FG001|Treatment Period|Lost to Follow-up|41|||
146234254|NCT00571649|527375075|FG000|Treatment Period|Non-compliant with study medication|88|||
146234255|NCT00571649|527375076|FG001|Treatment Period|Non-compliant with study medication|89|||
146234256|NCT00571649|527375075|FG000|Treatment Period|Patient convenience|11|||
146234257|NCT00571649|527375076|FG001|Treatment Period|Patient convenience|13|||
146234258|NCT00571649|527375075|FG000|Treatment Period|Protocol Violation|90|||
146234259|NCT00571649|527375076|FG001|Treatment Period|Protocol Violation|92|||
146234260|NCT00571649|527375075|FG000|Treatment Period|Technical problems|3|||
146234261|NCT00571649|527375076|FG001|Treatment Period|Technical problems|5|||
146234262|NCT00571649|527375075|FG000|Follow-up Period|Adverse Event|46|||
146234263|NCT00571649|527375076|FG001|Follow-up Period|Adverse Event|40|||
146234264|NCT00571649|527375075|FG000|Follow-up Period|Clinical endpoint reached|5|||
146234265|NCT00571649|527375076|FG001|Follow-up Period|Clinical endpoint reached|2|||
146234266|NCT00571649|527375075|FG000|Follow-up Period|Withdrawal by Subject|119|||
146234267|NCT00571649|527375076|FG001|Follow-up Period|Withdrawal by Subject|115|||
146234268|NCT00571649|527375075|FG000|Follow-up Period|Death|132|||
146234269|NCT00571649|527375076|FG001|Follow-up Period|Death|133|||
146234270|NCT00571649|527375075|FG000|Follow-up Period|Physician Decision|7|||
146234271|NCT00571649|527375076|FG001|Follow-up Period|Physician Decision|13|||
146234272|NCT00571649|527375075|FG000|Follow-up Period|Lost to Follow-up|95|||
146234273|NCT00571649|527375076|FG001|Follow-up Period|Lost to Follow-up|92|||
146234274|NCT00571649|527375075|FG000|Follow-up Period|Patient convenience|136|||
146234275|NCT00571649|527375076|FG001|Follow-up Period|Patient convenience|121|||
146234276|NCT00571649|527375075|FG000|Follow-up Period|Protocol Violation|5|||
146234277|NCT00571649|527375076|FG001|Follow-up Period|Protocol Violation|12|||
146234278|NCT01218659|527375077|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
146234279|NCT01218659|527375078|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
146234280|NCT01218659|527375079|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
146234281|NCT01218659|527375077|FG000|18-Month Randomized Period|Did not receive study drug|0|||
146234282|NCT01218659|527375078|FG001|18-Month Randomized Period|Did not receive study drug|3|||
146234283|NCT01218659|527375079|FG002|18-Month Randomized Period|Did not receive study drug|0|||
146234284|NCT01218659|527375077|FG000|12-Month OLE|Withdrawal by Subject|0|||
146234285|NCT01218659|527375078|FG001|12-Month OLE|Withdrawal by Subject|0|||
146234286|NCT01218659|527375079|FG002|12-Month OLE|Withdrawal by Subject|2|||
146234287|NCT01218659|527375077|FG000|12-Month OLE|Physician Decision|0|||
146234288|NCT01218659|527375078|FG001|12-Month OLE|Physician Decision|0|||
146234289|NCT01218659|527375079|FG002|12-Month OLE|Physician Decision|1|||
146234290|NCT01218659|527375077|FG000|12-Month OLE|Lost to Follow-up|0|||
146234291|NCT01218659|527375078|FG001|12-Month OLE|Lost to Follow-up|0|||
146234292|NCT01218659|527375079|FG002|12-Month OLE|Lost to Follow-up|1|||
146234293|NCT01218659|527375077|FG000|12-Month OLE|Pregnancy|0|||
146234294|NCT01218659|527375078|FG001|12-Month OLE|Pregnancy|0|||
145890806|NCT00788593|526105894|FG000|Placebo Run-in Phase|Adverse Event|2|||
145890807|NCT00788593|526105895|FG001|Placebo Run-in Phase|Adverse Event|0|||
145890808|NCT00788593|526105896|FG002|Placebo Run-in Phase|Adverse Event|0|||
145890809|NCT00788593|526105894|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
146234295|NCT01218659|527375079|FG002|12-Month OLE|Pregnancy|1|||
146234296|NCT01218659|527375077|FG000|12-Month OLE|Lack of Efficacy|0|||
146234297|NCT01218659|527375078|FG001|12-Month OLE|Lack of Efficacy|0|||
146234298|NCT01218659|527375079|FG002|12-Month OLE|Lack of Efficacy|1|||
146234299|NCT01218659|527375077|FG000|12-Month OLE|Declined to participate in the OLE|0|||
146234300|NCT01218659|527375078|FG001|12-Month OLE|Declined to participate in the OLE|0|||
146234301|NCT01218659|527375079|FG002|12-Month OLE|Declined to participate in the OLE|4|||
146234302|NCT00811941|527375080|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
146234303|NCT00811941|527375081|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
146234304|NCT00811941|527375080|FG000|All Treated Patients|Adverse Event|2|||
146234305|NCT00811941|527375081|FG001|All Treated Patients|Adverse Event|43|||
146234306|NCT00811941|527375080|FG000|All Treated Patients|Lack of Efficacy|2|||
146234307|NCT00811941|527375081|FG001|All Treated Patients|Lack of Efficacy|3|||
146234308|NCT00811941|527375080|FG000|All Treated Patients|Non-compliance|1|||
146234309|NCT00811941|527375081|FG001|All Treated Patients|Non-compliance|8|||
146234310|NCT00811941|527375080|FG000|All Treated Patients|Protocol Violation|5|||
146234311|NCT00811941|527375081|FG001|All Treated Patients|Protocol Violation|17|||
146234312|NCT00811941|527375080|FG000|All Treated Patients|Withdrawal by Subject|35|||
146234313|NCT00811941|527375081|FG001|All Treated Patients|Withdrawal by Subject|94|||
146234314|NCT00811941|527375080|FG000|All Treated Patients|Lost to Follow-up|3|||
146234315|NCT00811941|527375081|FG001|All Treated Patients|Lost to Follow-up|12|||
146234316|NCT00811941|527375080|FG000|All Treated Patients|Other Reason|4|||
146234317|NCT00811941|527375081|FG001|All Treated Patients|Other Reason|14|||
146234318|NCT03885232|527375082|FG000|Overall Study|Lost to Follow-up|74|||
146234319|NCT03885232|527375083|FG001|Overall Study|Lost to Follow-up|32|||
146234320|NCT03885232|527375082|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
146234321|NCT03885232|527375083|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
146234322|NCT02397096|527375084|FG000|Day 1 to Week 24|Adverse Event|7|||
146234323|NCT02397096|527375085|FG001|Day 1 to Week 24|Adverse Event|1|||
146234324|NCT02397096|527375084|FG000|Day 1 to Week 24|Death|1|||
146234325|NCT02397096|527375085|FG001|Day 1 to Week 24|Death|0|||
146234326|NCT02397096|527375084|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
146234327|NCT02397096|527375085|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
146234328|NCT02397096|527375084|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
146234329|NCT02397096|527375085|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
146234330|NCT02397096|527375084|FG000|Day 1 to Week 24|Physician Decision|2|||
146234331|NCT02397096|527375085|FG001|Day 1 to Week 24|Physician Decision|3|||
146234332|NCT02397096|527375084|FG000|Day 1 to Week 24|Protocol Violation|1|||
146234333|NCT02397096|527375085|FG001|Day 1 to Week 24|Protocol Violation|4|||
146234334|NCT02397096|527375084|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
146234335|NCT02397096|527375085|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
146234336|NCT02397096|527375084|FG000|Day 1 to Week 24|Randomized, not treated|3|||
146234337|NCT02397096|527375085|FG001|Day 1 to Week 24|Randomized, not treated|0|||
146234338|NCT02397096|527375084|FG000|Week 24 to Week 48|Adverse Event|6|||
146234339|NCT02397096|527375085|FG001|Week 24 to Week 48|Adverse Event|2|||
146234340|NCT02397096|527375084|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
146234341|NCT02397096|527375085|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
146234342|NCT02397096|527375084|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
146234343|NCT02397096|527375085|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
146234344|NCT02397096|527375084|FG000|Week 24 to Week 48|Physician Decision|2|||
146234345|NCT02397096|527375085|FG001|Week 24 to Week 48|Physician Decision|1|||
146234346|NCT02397096|527375084|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
146234347|NCT02397096|527375085|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
146234348|NCT02397096|527375084|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
146234349|NCT02397096|527375085|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
146234350|NCT02397096|527375084|FG000|Study Extension 1|Adverse Event|7|||
146234351|NCT02397096|527375085|FG001|Study Extension 1|Adverse Event|5|||
146234352|NCT02397096|527375084|FG000|Study Extension 1|Death|1|||
146234353|NCT02397096|527375085|FG001|Study Extension 1|Death|0|||
146234354|NCT02397096|527375084|FG000|Study Extension 1|Lack of Efficacy|2|||
146234355|NCT02397096|527375085|FG001|Study Extension 1|Lack of Efficacy|5|||
146234356|NCT02397096|527375084|FG000|Study Extension 1|Lost to Follow-up|2|||
146234357|NCT02397096|527375085|FG001|Study Extension 1|Lost to Follow-up|3|||
146234358|NCT02397096|527375084|FG000|Study Extension 1|Non-compliance with study drug|3|||
146234359|NCT02397096|527375085|FG001|Study Extension 1|Non-compliance with study drug|0|||
146234360|NCT02397096|527375084|FG000|Study Extension 1|Physician Decision|4|||
146234361|NCT02397096|527375085|FG001|Study Extension 1|Physician Decision|2|||
146234362|NCT02397096|527375084|FG000|Study Extension 1|Pregnancy|1|||
146234363|NCT02397096|527375085|FG001|Study Extension 1|Pregnancy|0|||
146234364|NCT02397096|527375084|FG000|Study Extension 1|Protocol Violation|0|||
146234365|NCT02397096|527375085|FG001|Study Extension 1|Protocol Violation|1|||
146234366|NCT02397096|527375084|FG000|Study Extension 1|Withdrawal by Subject|21|||
146234367|NCT02397096|527375085|FG001|Study Extension 1|Withdrawal by Subject|7|||
146293885|NCT00792805|527591958|FG002|Overall Study|Administrative problems|4|||
146293886|NCT00792805|527591956|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146293887|NCT00792805|527591957|FG001|Overall Study|Abnormal test procedure result(s)|2|||
146293888|NCT00792805|527591958|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146293889|NCT00792805|527591956|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146293890|NCT00792805|527591957|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146293891|NCT00792805|527591958|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146293892|NCT00792805|527591956|FG000|Overall Study|Lost to Follow-up|1|||
146293893|NCT00792805|527591957|FG001|Overall Study|Lost to Follow-up|1|||
146293894|NCT00792805|527591958|FG002|Overall Study|Lost to Follow-up|6|||
146293895|NCT00792805|527591956|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146293896|NCT00792805|527591957|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146293897|NCT00792805|527591958|FG002|Overall Study|Abnormal laboratory value(s)|1|||
146293898|NCT00792805|527591956|FG000|Overall Study|Protocol deviation|0|||
146293899|NCT00792805|527591957|FG001|Overall Study|Protocol deviation|1|||
146293900|NCT00792805|527591958|FG002|Overall Study|Protocol deviation|1|||
146293901|NCT02952001|527591964|FG000|Overall Study|Adverse Event|3|||
146293902|NCT02952001|527591965|FG001|Overall Study|Adverse Event|0|||
146293903|NCT02952001|527591964|FG000|Overall Study|Prohibited therapy|10|||
146293904|NCT02952001|527591965|FG001|Overall Study|Prohibited therapy|3|||
146293905|NCT02952001|527591964|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
146293906|NCT02952001|527591965|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
146293907|NCT02276872|527591968|FG000|Overall Study|Adverse Event|1|||
146293908|NCT02276872|527591969|FG001|Overall Study|Adverse Event|0|||
146293909|NCT02276872|527591970|FG002|Overall Study|Adverse Event|0|||
146293910|NCT04356183|527591972|FG000|Overall Study|Lost to Follow-up|1|||
146293911|NCT04356183|527591973|FG001|Overall Study|Lost to Follow-up|0|||
146293912|NCT04356183|527591972|FG000|Overall Study|Withdrawal by Subject|1|||
146293913|NCT04356183|527591973|FG001|Overall Study|Withdrawal by Subject|1|||
146293914|NCT00402363|527591974|FG000|Overall Study|Adverse Event|9|||
146293915|NCT00402363|527591975|FG001|Overall Study|Adverse Event|14|||
146293916|NCT00402363|527591976|FG002|Overall Study|Adverse Event|2|||
146293917|NCT00402363|527591977|FG003|Overall Study|Adverse Event|2|||
146293918|NCT00402363|527591974|FG000|Overall Study|Withdrew Consent|10|||
146293919|NCT00402363|527591975|FG001|Overall Study|Withdrew Consent|5|||
146293920|NCT00402363|527591976|FG002|Overall Study|Withdrew Consent|2|||
146293921|NCT00402363|527591977|FG003|Overall Study|Withdrew Consent|1|||
146293922|NCT00402363|527591974|FG000|Overall Study|Protocol Violation|3|||
146293923|NCT00402363|527591975|FG001|Overall Study|Protocol Violation|5|||
146293924|NCT00402363|527591976|FG002|Overall Study|Protocol Violation|0|||
146293925|NCT00402363|527591977|FG003|Overall Study|Protocol Violation|3|||
146293926|NCT00402363|527591974|FG000|Overall Study|Lost to Follow-up|5|||
146293927|NCT00402363|527591975|FG001|Overall Study|Lost to Follow-up|4|||
146293928|NCT00402363|527591976|FG002|Overall Study|Lost to Follow-up|0|||
146293929|NCT00402363|527591977|FG003|Overall Study|Lost to Follow-up|2|||
146293930|NCT00402363|527591974|FG000|Overall Study|"Captured as Other"|6|||
146293931|NCT00402363|527591975|FG001|Overall Study|"Captured as Other"|2|||
146293932|NCT00402363|527591976|FG002|Overall Study|"Captured as Other"|2|||
146293933|NCT00402363|527591977|FG003|Overall Study|"Captured as Other"|2|||
146293934|NCT00667355|527591987|FG000|Overall Study|Adverse Event|5|||
146293935|NCT00667355|527591987|FG000|Overall Study|Lost to Follow-up|1|||
146293936|NCT00667355|527591987|FG000|Overall Study|Other reason was not specified|5|||
146293937|NCT02175004|527591988|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
146293938|NCT02175004|527591989|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
146293939|NCT02175004|527591988|FG000|Overall Study|Investigator Judgment|1|||
146293940|NCT02175004|527591989|FG001|Overall Study|Investigator Judgment|4|||
146293941|NCT02175004|527591988|FG000|Overall Study|Voluntary Withdrawal|6|||
146293942|NCT02175004|527591989|FG001|Overall Study|Voluntary Withdrawal|19|||
146293943|NCT02175004|527591988|FG000|Overall Study|Liver Transplant|1|||
146293944|NCT02175004|527591989|FG001|Overall Study|Liver Transplant|0|||
146293945|NCT02175004|527591988|FG000|Overall Study|Disease Progression|1|||
146293946|NCT02175004|527591989|FG001|Overall Study|Disease Progression|0|||
146293947|NCT02175004|527591988|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
146293948|NCT02175004|527591989|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
146293949|NCT00162032|527591990|FG000|Overall Study|Lost to Follow-up|4|||
146293950|NCT00162032|527591991|FG001|Overall Study|Lost to Follow-up|2|||
146293951|NCT00162032|527591990|FG000|Overall Study|Reason not specified|1|||
146293952|NCT00162032|527591991|FG001|Overall Study|Reason not specified|0|||
146293953|NCT04263909|527591992|FG000|Overall Study|Physician Decision|1|||
146293954|NCT04263909|527591993|FG001|Overall Study|Physician Decision|0|||
146293955|NCT04263909|527591994|FG002|Overall Study|Physician Decision|0|||
146293956|NCT04263909|527591992|FG000|Overall Study|Adverse Event|3|||
146293957|NCT04263909|527591993|FG001|Overall Study|Adverse Event|0|||
146293958|NCT04263909|527591994|FG002|Overall Study|Adverse Event|0|||
146293959|NCT04263909|527591992|FG000|Overall Study|Protocol Violation|5|||
146293960|NCT04263909|527591993|FG001|Overall Study|Protocol Violation|0|||
146293961|NCT04263909|527591994|FG002|Overall Study|Protocol Violation|0|||
146293962|NCT05193500|527591995|FG000|Overall Study|Withdrawal by Subject|7|||
146293963|NCT05193500|527591996|FG001|Overall Study|Withdrawal by Subject|4|||
146293964|NCT05193500|527591997|FG002|Overall Study|Withdrawal by Subject|3|||
146293965|NCT05193500|527591998|FG003|Overall Study|Withdrawal by Subject|5|||
145890810|NCT00788593|526105895|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
145890811|NCT00788593|526105896|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
145890812|NCT00788593|526105894|FG000|Placebo Run-in Phase|Protocol Violation|2|||
145890813|NCT00788593|526105895|FG001|Placebo Run-in Phase|Protocol Violation|0|||
145890814|NCT00788593|526105896|FG002|Placebo Run-in Phase|Protocol Violation|0|||
145890815|NCT00788593|526105894|FG000|First Intervention Period|Adverse Event|0|||
145890816|NCT00788593|526105895|FG001|First Intervention Period|Adverse Event|1|||
145890817|NCT00788593|526105896|FG002|First Intervention Period|Adverse Event|0|||
145890818|NCT00788593|526105894|FG000|Second Intervention Period|Lost to Follow-up|0|||
145890819|NCT00788593|526105895|FG001|Second Intervention Period|Lost to Follow-up|1|||
145890820|NCT00788593|526105896|FG002|Second Intervention Period|Lost to Follow-up|0|||
145890821|NCT00788593|526105894|FG000|Second Intervention Period|Other|0|||
145890822|NCT00788593|526105895|FG001|Second Intervention Period|Other|0|||
145890823|NCT00788593|526105896|FG002|Second Intervention Period|Other|1|||
145890824|NCT00515034|526105897|FG000|Overall Study|Adverse Event|2|||
145890825|NCT00515034|526105898|FG001|Overall Study|Adverse Event|0|||
146087695|NCT04393298|526841820|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
146293966|NCT00744523|527591999|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
146293967|NCT00744523|527592000|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
146293968|NCT01139021|527592001|FG000|Overall Study|Adverse Event|0|||
146293969|NCT01139021|527592002|FG001|Overall Study|Adverse Event|0|||
146293970|NCT01139021|527592003|FG002|Overall Study|Adverse Event|0|||
146293971|NCT01139021|527592004|FG003|Overall Study|Adverse Event|0|||
146293972|NCT01139021|527592005|FG004|Overall Study|Adverse Event|1|||
146293973|NCT01139021|527592006|FG005|Overall Study|Adverse Event|0|||
146293974|NCT01139021|527592001|FG000|Overall Study|Lost to Follow-up|0|||
146293975|NCT01139021|527592002|FG001|Overall Study|Lost to Follow-up|0|||
146293976|NCT01139021|527592003|FG002|Overall Study|Lost to Follow-up|0|||
146293977|NCT01139021|527592004|FG003|Overall Study|Lost to Follow-up|0|||
146293978|NCT01139021|527592005|FG004|Overall Study|Lost to Follow-up|2|||
146293979|NCT01139021|527592006|FG005|Overall Study|Lost to Follow-up|0|||
146293980|NCT01139021|527592001|FG000|Overall Study|Protocol Violation|1|||
146293981|NCT01139021|527592002|FG001|Overall Study|Protocol Violation|0|||
146293982|NCT01139021|527592003|FG002|Overall Study|Protocol Violation|0|||
146293983|NCT01139021|527592004|FG003|Overall Study|Protocol Violation|0|||
146293984|NCT01139021|527592005|FG004|Overall Study|Protocol Violation|2|||
146293985|NCT01139021|527592006|FG005|Overall Study|Protocol Violation|0|||
146293986|NCT01139021|527592001|FG000|Overall Study|Withdrawal by Subject|0|||
146293987|NCT01139021|527592002|FG001|Overall Study|Withdrawal by Subject|0|||
146293988|NCT01139021|527592003|FG002|Overall Study|Withdrawal by Subject|0|||
146293989|NCT01139021|527592004|FG003|Overall Study|Withdrawal by Subject|1|||
146293990|NCT01139021|527592005|FG004|Overall Study|Withdrawal by Subject|4|||
146293991|NCT01139021|527592006|FG005|Overall Study|Withdrawal by Subject|0|||
146293992|NCT03588728|527592010|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
146293993|NCT03588728|527592011|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
146293994|NCT03588728|527592012|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
146293995|NCT03588728|527592013|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
146293996|NCT03588728|527592010|FG000|Overall Study|Lab shut down due to COVID-19|0|||
146293997|NCT03588728|527592011|FG001|Overall Study|Lab shut down due to COVID-19|0|||
146293998|NCT03588728|527592012|FG002|Overall Study|Lab shut down due to COVID-19|0|||
146293999|NCT03588728|527592013|FG003|Overall Study|Lab shut down due to COVID-19|1|||
146294000|NCT03588728|527592010|FG000|Overall Study|multiple technical issues|1|||
146294001|NCT03588728|527592011|FG001|Overall Study|multiple technical issues|0|||
146294002|NCT03588728|527592012|FG002|Overall Study|multiple technical issues|0|||
146294003|NCT03588728|527592013|FG003|Overall Study|multiple technical issues|0|||
146294004|NCT03588728|527592010|FG000|Overall Study|Hospitalized for COVID|1|||
146294005|NCT03588728|527592011|FG001|Overall Study|Hospitalized for COVID|0|||
146294006|NCT03588728|527592012|FG002|Overall Study|Hospitalized for COVID|0|||
146294007|NCT03588728|527592013|FG003|Overall Study|Hospitalized for COVID|0|||
146294008|NCT03588728|527592010|FG000|Overall Study|Schedule change unable to attend sessions|1|||
146294009|NCT03588728|527592011|FG001|Overall Study|Schedule change unable to attend sessions|0|||
145890826|NCT00515034|526105899|FG002|Overall Study|Adverse Event|1|||
145890827|NCT00515034|526105900|FG003|Overall Study|Adverse Event|0|||
145890828|NCT00515034|526105897|FG000|Overall Study|Death|4|||
145890829|NCT00515034|526105898|FG001|Overall Study|Death|2|||
146294010|NCT03588728|527592012|FG002|Overall Study|Schedule change unable to attend sessions|0|||
146294011|NCT03588728|527592013|FG003|Overall Study|Schedule change unable to attend sessions|0|||
146294012|NCT02027701|527592014|FG000|Overall Study|Adverse Event|3|||
146294013|NCT02027701|527592014|FG000|Overall Study|Lack of Efficacy|8|||
146294014|NCT02027701|527592014|FG000|Overall Study|Physician Decision|2|||
146294015|NCT02027701|527592014|FG000|Overall Study|Withdrawal by Subject|3|||
146294016|NCT00756470|527592015|FG000|Overall Study|Withdrawal by Subject|1|||
146234368|NCT02397096|527375084|FG000|Study Extension 2|Adverse Event|3|||
146234369|NCT02397096|527375085|FG001|Study Extension 2|Adverse Event|3|||
146234370|NCT02397096|527375084|FG000|Study Extension 2|Availability of study medication locally|152|||
146234371|NCT02397096|527375085|FG001|Study Extension 2|Availability of study medication locally|64|||
146234372|NCT02397096|527375084|FG000|Study Extension 2|Death|2|||
146234373|NCT02397096|527375085|FG001|Study Extension 2|Death|0|||
146234374|NCT02397096|527375084|FG000|Study Extension 2|Lack of Efficacy|1|||
146234375|NCT02397096|527375085|FG001|Study Extension 2|Lack of Efficacy|0|||
146234376|NCT02397096|527375084|FG000|Study Extension 2|Lost to Follow-up|2|||
146234377|NCT02397096|527375085|FG001|Study Extension 2|Lost to Follow-up|1|||
146234378|NCT02397096|527375084|FG000|Study Extension 2|Non-compliance with study drug|1|||
146234379|NCT02397096|527375085|FG001|Study Extension 2|Non-compliance with study drug|0|||
146234380|NCT02397096|527375084|FG000|Study Extension 2|Physician Decision|2|||
146234381|NCT02397096|527375085|FG001|Study Extension 2|Physician Decision|5|||
146234382|NCT02397096|527375084|FG000|Study Extension 2|Pregnancy|1|||
146234383|NCT02397096|527375085|FG001|Study Extension 2|Pregnancy|0|||
146234384|NCT02397096|527375084|FG000|Study Extension 2|Withdrawal by Subject|10|||
146234385|NCT02397096|527375085|FG001|Study Extension 2|Withdrawal by Subject|3|||
146234386|NCT02397096|527375084|FG000|Study Extension 3|Adverse Event|1|||
146234387|NCT02397096|527375085|FG001|Study Extension 3|Adverse Event|0|||
146234388|NCT02397096|527375084|FG000|Study Extension 3|Availability of study medication locally|11|||
146294017|NCT00756470|527592015|FG000|Overall Study|Adverse Event|4|||
146294018|NCT00820027|527592016|FG000|Overall Study|Adverse Event|15|||
146294019|NCT00820027|527592017|FG001|Overall Study|Adverse Event|8|||
146294020|NCT00820027|527592018|FG002|Overall Study|Adverse Event|10|||
146294021|NCT00820027|527592019|FG003|Overall Study|Adverse Event|5|||
146294022|NCT00820027|527592016|FG000|Overall Study|Lack of Efficacy|2|||
146294023|NCT00820027|527592017|FG001|Overall Study|Lack of Efficacy|1|||
146294024|NCT00820027|527592018|FG002|Overall Study|Lack of Efficacy|2|||
146294025|NCT00820027|527592019|FG003|Overall Study|Lack of Efficacy|2|||
146294026|NCT00820027|527592016|FG000|Overall Study|Physician Decision|0|||
146294027|NCT00820027|527592017|FG001|Overall Study|Physician Decision|1|||
146294028|NCT00820027|527592018|FG002|Overall Study|Physician Decision|1|||
146294029|NCT00820027|527592019|FG003|Overall Study|Physician Decision|0|||
146294030|NCT00820027|527592016|FG000|Overall Study|Protocol Violation|3|||
146294031|NCT00820027|527592017|FG001|Overall Study|Protocol Violation|0|||
146294032|NCT00820027|527592018|FG002|Overall Study|Protocol Violation|4|||
146294033|NCT00820027|527592019|FG003|Overall Study|Protocol Violation|0|||
146294034|NCT00820027|527592016|FG000|Overall Study|Withdrawal by Subject|6|||
146294035|NCT00820027|527592017|FG001|Overall Study|Withdrawal by Subject|4|||
146294036|NCT00820027|527592018|FG002|Overall Study|Withdrawal by Subject|4|||
146294037|NCT00820027|527592019|FG003|Overall Study|Withdrawal by Subject|6|||
146294038|NCT01978262|527592020|FG000|Overall Study|Withdrawal by Subject|9|||
146294039|NCT01978262|527592020|FG000|Overall Study|Lost to Follow-up|2|||
146294040|NCT03285178|527592021|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
145890830|NCT00515034|526105899|FG002|Overall Study|Death|1|||
145890831|NCT00515034|526105900|FG003|Overall Study|Death|3|||
145890832|NCT00515034|526105897|FG000|Overall Study|Withdrawal by Subject|1|||
145890833|NCT00515034|526105898|FG001|Overall Study|Withdrawal by Subject|0|||
145890834|NCT00515034|526105899|FG002|Overall Study|Withdrawal by Subject|3|||
145890835|NCT00515034|526105900|FG003|Overall Study|Withdrawal by Subject|0|||
145890836|NCT00515034|526105897|FG000|Overall Study|Physician Decision|0|||
145890837|NCT00515034|526105898|FG001|Overall Study|Physician Decision|0|||
145890838|NCT00515034|526105899|FG002|Overall Study|Physician Decision|1|||
145970765|NCT00089648|526407253|FG000|Overall Study|Adverse Event|7|||
145890839|NCT00515034|526105900|FG003|Overall Study|Physician Decision|1|||
145890840|NCT00515034|526105897|FG000|Overall Study|Other|1|||
145890841|NCT00515034|526105898|FG001|Overall Study|Other|0|||
145970766|NCT00089648|526407253|FG000|Overall Study|Withdrawal by Subject|1|||
146294041|NCT03285178|527592022|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146294042|NCT03285178|527592023|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146294043|NCT03285178|527592024|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146294044|NCT03285178|527592025|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146294045|NCT03285178|527592026|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145890842|NCT00515034|526105899|FG002|Overall Study|Other|2|||
146234389|NCT02397096|527375085|FG001|Study Extension 3|Availability of study medication locally|3|||
146234390|NCT02397096|527375084|FG000|Study Extension 3|Lost to Follow-up|1|||
146234391|NCT02397096|527375085|FG001|Study Extension 3|Lost to Follow-up|0|||
146234392|NCT02397096|527375084|FG000|Study Extension 3|Withdrawal by Subject|2|||
146234393|NCT02397096|527375085|FG001|Study Extension 3|Withdrawal by Subject|1|||
146234394|NCT03840902|527375086|FG000|Overall Study|Randomized but not treated|1|||
146234395|NCT03840902|527375087|FG001|Overall Study|Randomized but not treated|1|||
146234396|NCT06688357|527375091|FG000|Overall Study|Adverse Event|0|||
146234397|NCT06688357|527375092|FG001|Overall Study|Adverse Event|1|||
146234398|NCT03222609|527375095|FG000|Overall Study|Withdrew consent|2|||
146234399|NCT03222609|527375096|FG001|Overall Study|Withdrew consent|3|||
146234400|NCT03222609|527375097|FG002|Overall Study|Withdrew consent|4|||
146234401|NCT03222609|527375098|FG003|Overall Study|Withdrew consent|2|||
146234402|NCT03222609|527375095|FG000|Overall Study|Lost to Follow-up|1|||
146234403|NCT03222609|527375096|FG001|Overall Study|Lost to Follow-up|0|||
146234404|NCT03222609|527375097|FG002|Overall Study|Lost to Follow-up|0|||
146234405|NCT03222609|527375098|FG003|Overall Study|Lost to Follow-up|0|||
146234406|NCT03222609|527375095|FG000|Overall Study|Death|16|||
146234407|NCT03222609|527375096|FG001|Overall Study|Death|13|||
146234408|NCT03222609|527375097|FG002|Overall Study|Death|9|||
146234409|NCT03222609|527375098|FG003|Overall Study|Death|6|||
146234410|NCT03222609|527375095|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
146234411|NCT03222609|527375096|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
146234412|NCT03222609|527375097|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
146234413|NCT03222609|527375098|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
146234414|NCT05139992|527375099|FG000|Overall Study|Withdrawal by Subject|12|||
146234415|NCT05139992|527375099|FG000|Overall Study|Lost to Follow-up|6|||
146234416|NCT03834740|527375100|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
146234417|NCT03834740|527375101|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
146234418|NCT03834740|527375102|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
146234419|NCT01208974|527375103|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
146234420|NCT01208974|527375104|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146234421|NCT01208974|527375105|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146234422|NCT01208974|527375106|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
146234423|NCT01208974|527375103|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
146234424|NCT01208974|527375104|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
145890843|NCT00515034|526105900|FG003|Overall Study|Other|1|||
145890844|NCT02858726|526105901|FG000|Overall Study|Adverse Event|4|||
145890845|NCT02858726|526105902|FG001|Overall Study|Adverse Event|4|||
145890846|NCT02858726|526105903|FG002|Overall Study|Adverse Event|9|||
145890847|NCT02858726|526105904|FG003|Overall Study|Adverse Event|1|||
145890848|NCT02858726|526105901|FG000|Overall Study|Physician Decision|0|||
145890849|NCT02858726|526105902|FG001|Overall Study|Physician Decision|0|||
146234425|NCT01208974|527375105|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
145890850|NCT02858726|526105903|FG002|Overall Study|Physician Decision|1|||
145890851|NCT02858726|526105904|FG003|Overall Study|Physician Decision|0|||
146234426|NCT01208974|527375106|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
146234427|NCT01208974|527375103|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
146234428|NCT01208974|527375104|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146234429|NCT01208974|527375105|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146234430|NCT01208974|527375106|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
146234431|NCT03777657|527375107|FG000|Overall Study|Death|397|||
146234432|NCT03777657|527375108|FG001|Overall Study|Death|431|||
146234433|NCT03777657|527375107|FG000|Overall Study|Study Closed by Sponsor|77|||
146234434|NCT03777657|527375108|FG001|Overall Study|Study Closed by Sponsor|38|||
146234435|NCT03777657|527375107|FG000|Overall Study|Withdrawal by Subject|20|||
146234436|NCT03777657|527375108|FG001|Overall Study|Withdrawal by Subject|17|||
146234437|NCT03777657|527375107|FG000|Overall Study|Lost to Follow-up|6|||
146234438|NCT03777657|527375108|FG001|Overall Study|Lost to Follow-up|10|||
146234439|NCT03691493|527375109|FG000|Overall Study|Withdrawal by Subject|1|||
146234440|NCT02678689|527375110|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
146234441|NCT02678689|527375111|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
146234442|NCT02549352|527375112|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
146234443|NCT02549352|527375113|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
146234444|NCT02549352|527375112|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
146234445|NCT02549352|527375113|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
146234446|NCT02549352|527375112|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
146234447|NCT02549352|527375113|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
146234448|NCT02549352|527375112|FG000|12-month Follow-up|Withdrawal by Subject|4|||
146234449|NCT02549352|527375113|FG001|12-month Follow-up|Withdrawal by Subject|5|||
146234450|NCT02549352|527375112|FG000|12-month Follow-up|Lost to Follow-up|3|||
146234451|NCT02549352|527375113|FG001|12-month Follow-up|Lost to Follow-up|2|||
146234452|NCT02549352|527375112|FG000|12-month Follow-up|Death|0|||
146234453|NCT02549352|527375113|FG001|12-month Follow-up|Death|1|||
146234454|NCT02549352|527375112|FG000|12-month Follow-up|Protocol Violation|0|||
146234455|NCT02549352|527375113|FG001|12-month Follow-up|Protocol Violation|1|||
146234456|NCT02549352|527375112|FG000|12-month Follow-up|Other|1|||
146234457|NCT02549352|527375113|FG001|12-month Follow-up|Other|3|||
146234458|NCT05704725|527375114|FG000|Overall Study|Lost to Follow-up|0|||
146234459|NCT05704725|527375115|FG001|Overall Study|Lost to Follow-up|1|||
146234460|NCT05704725|527375114|FG000|Overall Study|Withdrawal by Subject|1|||
146234461|NCT05704725|527375115|FG001|Overall Study|Withdrawal by Subject|0|||
146234462|NCT01470144|527375116|FG000|Overall Study|Adverse Event|2|||
146234463|NCT01470144|527375116|FG000|Overall Study|Death|1|||
146234464|NCT01470144|527375116|FG000|Overall Study|Lung transplant|6|||
146234465|NCT01470144|527375116|FG000|Overall Study|Patient's and investigator's decision|1|||
146234466|NCT00593840|527375117|FG000|Overall Study|Withdrawal by Subject|1|||
146234467|NCT03459196|527376311|FG000|Overall Study|Subject didn't receive study catheter|2|||
146234468|NCT04503681|527376314|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
146234469|NCT04503681|527376315|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
146234470|NCT03752684|527376316|FG000|Overall Study|Lost to Follow-up|4|||
146234471|NCT03352713|527376319|FG000|Overall Study|Lost to Follow-up|8|||
146234472|NCT03352713|527376319|FG000|Overall Study|Withdrawn by investigator|5|||
146234473|NCT03352713|527376319|FG000|Overall Study|Completed 0 EMAs|8|||
146234474|NCT03352713|527376319|FG000|Overall Study|Device incompatible/stolen|5|||
146234475|NCT01812759|527376320|FG000|Overall Study|Physician Decision|0|||
146234476|NCT01812759|527376321|FG001|Overall Study|Physician Decision|0|||
146234477|NCT01812759|527376322|FG002|Overall Study|Physician Decision|1|||
146234478|NCT02760654|527376323|FG000|Overall Study|Lost to Follow-up|3|||
146234479|NCT02760654|527376324|FG001|Overall Study|Lost to Follow-up|3|||
146234480|NCT02760654|527376323|FG000|Overall Study|Withdrawal by Subject|4|||
146234481|NCT02760654|527376324|FG001|Overall Study|Withdrawal by Subject|3|||
146234482|NCT01084694|527376325|FG000|Overall Study|Withdrawal by Subject|2|||
146234483|NCT01084694|527376326|FG001|Overall Study|Withdrawal by Subject|1|||
146234484|NCT01084694|527376325|FG000|Overall Study|Death|2|||
146234485|NCT01084694|527376326|FG001|Overall Study|Death|12|||
146234486|NCT01084694|527376325|FG000|Overall Study|eligibility not maintained|2|||
146234487|NCT01084694|527376326|FG001|Overall Study|eligibility not maintained|7|||
146234488|NCT01128595|527376329|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146234489|NCT01128595|527376330|FG001|Treatment Period 3|Withdrawal by Subject|1|||
146234490|NCT01128595|527376331|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146234491|NCT01128595|527376332|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146234492|NCT00605306|527376333|FG000|Overall Study|Adverse Event|0|||
146234493|NCT00605306|527376334|FG001|Overall Study|Adverse Event|1|||
146234494|NCT00372775|527376335|FG000|Overall Study|Adverse Event|8|||
146234495|NCT00372775|527376335|FG000|Overall Study|Death|15|||
146234496|NCT00372775|527376335|FG000|Overall Study|Objective progression or relapse|30|||
146234497|NCT00372775|527376335|FG000|Overall Study|Global deterioration of health status|6|||
146234498|NCT00372775|527376335|FG000|Overall Study|Withdrawal by Subject|1|||
146234499|NCT00372775|527376335|FG000|Overall Study|Other|1|||
146234500|NCT00372775|527376335|FG000|Overall Study|Not Treated|2|||
146234501|NCT01750684|527376336|FG000|Overall Study|Death|1|||
146234502|NCT01750684|527376337|FG001|Overall Study|Death|0|||
146234503|NCT01750684|527376336|FG000|Overall Study|Non-compliance with Study Drug|0|||
146234504|NCT01750684|527376337|FG001|Overall Study|Non-compliance with Study Drug|1|||
146234505|NCT01750684|527376336|FG000|Overall Study|Withdrawn by Sponsor|0|||
146234506|NCT01750684|527376337|FG001|Overall Study|Withdrawn by Sponsor|1|||
146234507|NCT01750684|527376336|FG000|Overall Study|Protocol Violation|1|||
146234508|NCT01750684|527376337|FG001|Overall Study|Protocol Violation|0|||
146234509|NCT02185794|527376340|FG000|Overall Study|Enrolled but Never Dosed|1|||
146234510|NCT02185794|527376341|FG001|Overall Study|Enrolled but Never Dosed|6|||
146234511|NCT02185794|527376342|FG002|Overall Study|Enrolled but Never Dosed|3|||
146234512|NCT02185794|527376343|FG003|Overall Study|Enrolled but Never Dosed|1|||
146234513|NCT02185794|527376344|FG004|Overall Study|Enrolled but Never Dosed|1|||
146234514|NCT02185794|527376345|FG005|Overall Study|Enrolled but Never Dosed|0|||
146234515|NCT02185794|527376340|FG000|Overall Study|Investigator's Discretion|1|||
146234516|NCT02185794|527376341|FG001|Overall Study|Investigator's Discretion|0|||
146234517|NCT02185794|527376342|FG002|Overall Study|Investigator's Discretion|1|||
146234518|NCT02185794|527376343|FG003|Overall Study|Investigator's Discretion|2|||
146234519|NCT02185794|527376344|FG004|Overall Study|Investigator's Discretion|2|||
146234520|NCT02185794|527376345|FG005|Overall Study|Investigator's Discretion|15|||
146234521|NCT02185794|527376340|FG000|Overall Study|Withdrew Consent|2|||
146234522|NCT02185794|527376341|FG001|Overall Study|Withdrew Consent|5|||
146234523|NCT02185794|527376342|FG002|Overall Study|Withdrew Consent|10|||
146234524|NCT02185794|527376343|FG003|Overall Study|Withdrew Consent|2|||
146234525|NCT02185794|527376344|FG004|Overall Study|Withdrew Consent|0|||
146234526|NCT02185794|527376345|FG005|Overall Study|Withdrew Consent|0|||
146234527|NCT02185794|527376340|FG000|Overall Study|Lost to Follow-up|1|||
146234528|NCT02185794|527376341|FG001|Overall Study|Lost to Follow-up|2|||
146234529|NCT02185794|527376342|FG002|Overall Study|Lost to Follow-up|2|||
146234530|NCT02185794|527376343|FG003|Overall Study|Lost to Follow-up|3|||
146234531|NCT02185794|527376344|FG004|Overall Study|Lost to Follow-up|0|||
146234532|NCT02185794|527376345|FG005|Overall Study|Lost to Follow-up|1|||
146234533|NCT00336505|527376346|FG000|Overall Study|Adverse Event|10|||
146234534|NCT00336505|527376347|FG001|Overall Study|Adverse Event|9|||
146234535|NCT00336505|527376346|FG000|Overall Study|Lack of Efficacy|8|||
146234536|NCT00336505|527376347|FG001|Overall Study|Lack of Efficacy|4|||
146234537|NCT00336505|527376346|FG000|Overall Study|Lost to Follow-up|7|||
146234538|NCT00336505|527376347|FG001|Overall Study|Lost to Follow-up|4|||
146234539|NCT00336505|527376346|FG000|Overall Study|Withdrawal by Subject|5|||
146234540|NCT00336505|527376347|FG001|Overall Study|Withdrawal by Subject|3|||
146234541|NCT00336505|527376346|FG000|Overall Study|Other|7|||
146234542|NCT00336505|527376347|FG001|Overall Study|Other|7|||
146294046|NCT03285178|527592027|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
146294047|NCT03285178|527592021|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
146294048|NCT03285178|527592022|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294049|NCT03285178|527592023|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294050|NCT03285178|527592024|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294051|NCT03285178|527592025|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294052|NCT03285178|527592026|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294053|NCT03285178|527592027|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
146294054|NCT03285178|527592021|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
146294055|NCT03285178|527592022|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
146294056|NCT03285178|527592023|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
146294057|NCT03285178|527592024|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
146294058|NCT03285178|527592025|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
146294059|NCT03285178|527592026|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
146294060|NCT03285178|527592027|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
146294061|NCT03285178|527592021|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
146294062|NCT03285178|527592022|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294063|NCT03285178|527592023|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294064|NCT03285178|527592024|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294065|NCT03285178|527592025|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294066|NCT03285178|527592026|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294067|NCT03285178|527592027|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
146294068|NCT03285178|527592021|FG000|Single-Blind Run-In Period|Physician Decision|2|||
146294069|NCT03285178|527592022|FG001|Single-Blind Run-In Period|Physician Decision|0|||
146294070|NCT03285178|527592023|FG002|Single-Blind Run-In Period|Physician Decision|0|||
146294071|NCT03285178|527592024|FG003|Single-Blind Run-In Period|Physician Decision|0|||
146294072|NCT03285178|527592025|FG004|Single-Blind Run-In Period|Physician Decision|0|||
146294073|NCT03285178|527592026|FG005|Single-Blind Run-In Period|Physician Decision|0|||
146294074|NCT03285178|527592027|FG006|Single-Blind Run-In Period|Physician Decision|0|||
146294075|NCT03285178|527592021|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146294076|NCT03285178|527592022|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
146294077|NCT03285178|527592023|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
146294078|NCT03285178|527592024|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146294079|NCT03285178|527592025|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146294080|NCT03285178|527592026|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146294081|NCT03285178|527592027|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
146294082|NCT03285178|527592021|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146294083|NCT03285178|527592022|FG001|Double-Blind Treatment Period|Adverse Event|0|||
146294084|NCT03285178|527592023|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146294085|NCT03285178|527592024|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146294086|NCT03285178|527592025|FG004|Double-Blind Treatment Period|Adverse Event|0|||
146294087|NCT03285178|527592026|FG005|Double-Blind Treatment Period|Adverse Event|0|||
146294088|NCT03285178|527592027|FG006|Double-Blind Treatment Period|Adverse Event|2|||
146294089|NCT03285178|527592021|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146294090|NCT03285178|527592022|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146294091|NCT03285178|527592023|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146294092|NCT03285178|527592024|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
146294093|NCT03285178|527592025|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
146294094|NCT03285178|527592026|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
146294095|NCT03285178|527592027|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
146294096|NCT03285178|527592021|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146294097|NCT03285178|527592022|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146294098|NCT03285178|527592023|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146294099|NCT03285178|527592024|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146294100|NCT03285178|527592025|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146294101|NCT03285178|527592026|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146294102|NCT03285178|527592027|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146294103|NCT03285178|527592021|FG000|Double-Blind Treatment Period|COVID-19|0|||
146294104|NCT03285178|527592022|FG001|Double-Blind Treatment Period|COVID-19|0|||
146294105|NCT03285178|527592023|FG002|Double-Blind Treatment Period|COVID-19|1|||
146294106|NCT03285178|527592024|FG003|Double-Blind Treatment Period|COVID-19|0|||
146294107|NCT03285178|527592025|FG004|Double-Blind Treatment Period|COVID-19|0|||
146294108|NCT03285178|527592026|FG005|Double-Blind Treatment Period|COVID-19|0|||
146294109|NCT03285178|527592027|FG006|Double-Blind Treatment Period|COVID-19|0|||
146294110|NCT01388790|527592028|FG000|Overall Study|Ongoing at data cut-off date|8|||
146294111|NCT01128894|527592029|FG000|Overall Study|Adverse Event|31|||
146294112|NCT01128894|527592030|FG001|Overall Study|Adverse Event|41|||
146294113|NCT01128894|527592029|FG000|Overall Study|Protocol Violation|2|||
146294114|NCT01128894|527592030|FG001|Overall Study|Protocol Violation|1|||
146294115|NCT01128894|527592029|FG000|Overall Study|Noncompliance|4|||
146294116|NCT01128894|527592030|FG001|Overall Study|Noncompliance|5|||
146294117|NCT01128894|527592029|FG000|Overall Study|Lost to Follow-up|8|||
146294118|NCT01128894|527592030|FG001|Overall Study|Lost to Follow-up|8|||
146294119|NCT01128894|527592029|FG000|Overall Study|Withdrawal by Subject|10|||
146294120|NCT01128894|527592030|FG001|Overall Study|Withdrawal by Subject|12|||
145890852|NCT02858726|526105901|FG000|Overall Study|Protocol Violation|0|||
145890853|NCT02858726|526105902|FG001|Overall Study|Protocol Violation|0|||
145890854|NCT02858726|526105903|FG002|Overall Study|Protocol Violation|0|||
145890855|NCT02858726|526105904|FG003|Overall Study|Protocol Violation|1|||
146294121|NCT01128894|527592029|FG000|Overall Study|Physician Decision|2|||
146294122|NCT01128894|527592030|FG001|Overall Study|Physician Decision|1|||
146294123|NCT01128894|527592029|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
146294124|NCT01128894|527592030|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
146294125|NCT00195507|527592031|FG000|Overall Study|Adverse Event|24|||
146294126|NCT00195507|527592032|FG001|Overall Study|Adverse Event|13|||
146294127|NCT00195507|527592031|FG000|Overall Study|Death|0|||
146294128|NCT00195507|527592032|FG001|Overall Study|Death|1|||
146294129|NCT00195507|527592031|FG000|Overall Study|Failed to Return|4|||
146294130|NCT00195507|527592032|FG001|Overall Study|Failed to Return|3|||
146294131|NCT00195507|527592031|FG000|Overall Study|Physician Decision|1|||
146294132|NCT00195507|527592032|FG001|Overall Study|Physician Decision|2|||
146294133|NCT00195507|527592031|FG000|Overall Study|Lost to Follow-up|3|||
146294134|NCT00195507|527592032|FG001|Overall Study|Lost to Follow-up|2|||
146294135|NCT00195507|527592031|FG000|Overall Study|Protocol Violation|5|||
146294136|NCT00195507|527592032|FG001|Overall Study|Protocol Violation|4|||
146294137|NCT00195507|527592031|FG000|Overall Study|Lack of Efficacy|40|||
146294138|NCT00195507|527592032|FG001|Overall Study|Lack of Efficacy|67|||
146294139|NCT00195507|527592031|FG000|Overall Study|Withdrawal by Subject|16|||
146294140|NCT00195507|527592032|FG001|Overall Study|Withdrawal by Subject|23|||
146294141|NCT00195507|527592031|FG000|Overall Study|Protocol Deviation|6|||
146294142|NCT00195507|527592032|FG001|Overall Study|Protocol Deviation|3|||
146294143|NCT02202551|527592033|FG000|Overall Study|Adverse Event|8|||
146294144|NCT02202551|527592034|FG001|Overall Study|Adverse Event|19|||
146294145|NCT02202551|527592035|FG002|Overall Study|Adverse Event|5|||
146294146|NCT02202551|527592036|FG003|Overall Study|Adverse Event|9|||
146294147|NCT02202551|527592033|FG000|Overall Study|Death|3|||
146294148|NCT02202551|527592034|FG001|Overall Study|Death|2|||
145890856|NCT02858726|526105901|FG000|Overall Study|Study Terminated by Sponsor|0|||
145890857|NCT02858726|526105902|FG001|Overall Study|Study Terminated by Sponsor|0|||
145890858|NCT02858726|526105903|FG002|Overall Study|Study Terminated by Sponsor|0|||
145890859|NCT02858726|526105904|FG003|Overall Study|Study Terminated by Sponsor|1|||
145890860|NCT02858726|526105901|FG000|Overall Study|Withdrawal by Subject|1|||
145890861|NCT02858726|526105902|FG001|Overall Study|Withdrawal by Subject|2|||
145890862|NCT02858726|526105903|FG002|Overall Study|Withdrawal by Subject|1|||
145890863|NCT02858726|526105904|FG003|Overall Study|Withdrawal by Subject|0|||
145890864|NCT02858726|526105901|FG000|Overall Study|Noncompliance|0|||
145890865|NCT02858726|526105902|FG001|Overall Study|Noncompliance|1|||
145890866|NCT02858726|526105903|FG002|Overall Study|Noncompliance|0|||
145890867|NCT02858726|526105904|FG003|Overall Study|Noncompliance|0|||
145890868|NCT00233987|526105911|FG000|Overall Study|Withdrawal by Subject|1|||
145890869|NCT00233987|526105911|FG000|Overall Study|Lack of Efficacy|2|||
145890870|NCT00233987|526105911|FG000|Overall Study|Reason Under Review|1|||
145890871|NCT00233987|526105911|FG000|Overall Study|Other - Not Protocol Specified|5|||
145890872|NCT00233987|526105911|FG000|Overall Study|Eligible but No Treatment Received|2|||
145890873|NCT00233987|526105911|FG000|Overall Study|Ineligible|4|||
145890874|NCT01688726|526105914|FG000|Overall Study|Adverse Event|1|||
145890875|NCT01688726|526105915|FG001|Overall Study|Adverse Event|0|||
145890876|NCT01688726|526105914|FG000|Overall Study|Relocated abroad|0|||
145890877|NCT01688726|526105915|FG001|Overall Study|Relocated abroad|1|||
145890878|NCT01481324|526105916|FG000|Overall Study|Missing Data|0|||
146294149|NCT02202551|527592035|FG002|Overall Study|Death|1|||
146294150|NCT02202551|527592036|FG003|Overall Study|Death|1|||
145890879|NCT01481324|526105917|FG001|Overall Study|Missing Data|2|||
145890880|NCT01481324|526105918|FG002|Overall Study|Missing Data|2|||
146294151|NCT02202551|527592033|FG000|Overall Study|Lost to Follow-up|0|||
146294152|NCT02202551|527592034|FG001|Overall Study|Lost to Follow-up|1|||
146294153|NCT02202551|527592035|FG002|Overall Study|Lost to Follow-up|0|||
146294154|NCT02202551|527592036|FG003|Overall Study|Lost to Follow-up|1|||
146294155|NCT02202551|527592033|FG000|Overall Study|Needed to take excluded medication|0|||
146294156|NCT02202551|527592034|FG001|Overall Study|Needed to take excluded medication|2|||
146294157|NCT02202551|527592035|FG002|Overall Study|Needed to take excluded medication|0|||
145970767|NCT00089648|526407253|FG000|Overall Study|Lack of Efficacy|33|||
145970768|NCT00423605|526407254|FG000|Overall Study|Adverse Event|129|||
145970769|NCT00423605|526407254|FG000|Overall Study|Withdrawal by Subject|36|||
145970770|NCT00423605|526407254|FG000|Overall Study|Lost to Follow-up|15|||
146234543|NCT01092416|527376348|FG000|Enrollment|Atherectomy device not inserted|3|||
146234544|NCT01092416|527376348|FG000|30-Day Follow-up|Death|2|||
146234545|NCT01092416|527376348|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
146234546|NCT01092416|527376348|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
146234547|NCT01092416|527376348|FG000|12-Month Follow-up|Death|16|||
146234548|NCT01092416|527376348|FG000|12-Month Follow-up|Lost to Follow-up|4|||
146234549|NCT01092416|527376348|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
146234550|NCT01092416|527376348|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
146234551|NCT01092416|527376348|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
146234552|NCT00366249|527376349|FG000|Overall Study|Adverse Event|53|||
146234553|NCT00366249|527376350|FG001|Overall Study|Adverse Event|28|||
146234554|NCT00366249|527376349|FG000|Overall Study|Death|0|||
146234555|NCT00366249|527376350|FG001|Overall Study|Death|1|||
146234556|NCT00366249|527376349|FG000|Overall Study|Physician Decision|5|||
146234557|NCT00366249|527376350|FG001|Overall Study|Physician Decision|2|||
146234558|NCT00366249|527376349|FG000|Overall Study|Lost to Follow-up|2|||
146234559|NCT00366249|527376350|FG001|Overall Study|Lost to Follow-up|0|||
146234560|NCT00366249|527376349|FG000|Overall Study|Protocol Violation|1|||
146234561|NCT00366249|527376350|FG001|Overall Study|Protocol Violation|2|||
146294158|NCT02202551|527592036|FG003|Overall Study|Needed to take excluded medication|1|||
146294159|NCT02202551|527592033|FG000|Overall Study|Subject moved away|0|||
146294160|NCT02202551|527592034|FG001|Overall Study|Subject moved away|1|||
146294161|NCT02202551|527592035|FG002|Overall Study|Subject moved away|0|||
146294162|NCT02202551|527592036|FG003|Overall Study|Subject moved away|0|||
146294163|NCT02202551|527592033|FG000|Overall Study|DBS surgery|3|||
146294164|NCT02202551|527592034|FG001|Overall Study|DBS surgery|0|||
146294165|NCT02202551|527592035|FG002|Overall Study|DBS surgery|0|||
146294166|NCT02202551|527592036|FG003|Overall Study|DBS surgery|0|||
146234562|NCT00366249|527376349|FG000|Overall Study|Withdrawal by Subject|18|||
146234563|NCT00366249|527376350|FG001|Overall Study|Withdrawal by Subject|4|||
146234564|NCT00366249|527376349|FG000|Overall Study|Lack of Efficacy|21|||
146234565|NCT00366249|527376350|FG001|Overall Study|Lack of Efficacy|21|||
146234566|NCT00366249|527376349|FG000|Overall Study|Most due to osteomylitis status|31|||
146234567|NCT00366249|527376350|FG001|Overall Study|Most due to osteomylitis status|20|||
146234568|NCT01561300|527376351|FG000|Run in on Placebo|Adverse Event|1|||
146234569|NCT01561300|527376352|FG001|Run in on Placebo|Adverse Event|0|||
146234570|NCT00777049|527376353|FG000|Overall Study|Withdrawal by Subject|1|||
146234571|NCT00777049|527376354|FG001|Overall Study|Withdrawal by Subject|0|||
146234572|NCT00777049|527376353|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
146234573|NCT00777049|527376354|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
146234574|NCT00246805|527376355|FG000|Phase 1|Lost to Follow-up|1|||
146234575|NCT00246805|527376356|FG001|Phase 1|Lost to Follow-up|0|||
146234576|NCT03478969|527376357|FG000|Overall Study|Withdrawal by Subject|4|||
146234577|NCT03478969|527376358|FG001|Overall Study|Withdrawal by Subject|7|||
146234578|NCT03478969|527376359|FG002|Overall Study|Withdrawal by Subject|6|||
146234579|NCT03478969|527376357|FG000|Overall Study|Adverse Event|2|||
146234580|NCT03478969|527376358|FG001|Overall Study|Adverse Event|0|||
146234581|NCT03478969|527376359|FG002|Overall Study|Adverse Event|1|||
146234582|NCT03478969|527376357|FG000|Overall Study|Pregnancy|1|||
146234583|NCT03478969|527376358|FG001|Overall Study|Pregnancy|0|||
146234584|NCT03478969|527376359|FG002|Overall Study|Pregnancy|0|||
146234585|NCT03478969|527376357|FG000|Overall Study|Personal Reasons|1|||
146234586|NCT03478969|527376358|FG001|Overall Study|Personal Reasons|0|||
146234587|NCT03478969|527376359|FG002|Overall Study|Personal Reasons|1|||
146234588|NCT03478969|527376357|FG000|Overall Study|Covid-19|1|||
146234589|NCT03478969|527376358|FG001|Overall Study|Covid-19|4|||
146234590|NCT03478969|527376359|FG002|Overall Study|Covid-19|3|||
146294167|NCT02202551|527592033|FG000|Overall Study|Dyskinesia upon taper|1|||
146294168|NCT02202551|527592034|FG001|Overall Study|Dyskinesia upon taper|0|||
146294169|NCT02202551|527592035|FG002|Overall Study|Dyskinesia upon taper|0|||
146234591|NCT03478969|527376357|FG000|Overall Study|Multiple Reasons|0|||
146294170|NCT02202551|527592036|FG003|Overall Study|Dyskinesia upon taper|0|||
146234592|NCT03478969|527376358|FG001|Overall Study|Multiple Reasons|1|||
146294171|NCT02202551|527592033|FG000|Overall Study|Lack of Efficacy|0|||
146234593|NCT03478969|527376359|FG002|Overall Study|Multiple Reasons|1|||
146294172|NCT02202551|527592034|FG001|Overall Study|Lack of Efficacy|1|||
145970771|NCT00423605|526407254|FG000|Overall Study|Lack of Efficacy|38|||
146234594|NCT03478969|527376357|FG000|Overall Study|Eligibility Criteria|0|||
146234595|NCT03478969|527376358|FG001|Overall Study|Eligibility Criteria|0|||
146234596|NCT03478969|527376359|FG002|Overall Study|Eligibility Criteria|5|||
146234597|NCT03478969|527376357|FG000|Overall Study|Lost to Follow-up|0|||
146234598|NCT03478969|527376358|FG001|Overall Study|Lost to Follow-up|0|||
146234599|NCT03478969|527376359|FG002|Overall Study|Lost to Follow-up|1|||
146234600|NCT01185600|527376360|FG000|Overall Study|Adverse Event|1|||
146234601|NCT01185600|527376361|FG001|Overall Study|Adverse Event|1|||
146234602|NCT01185600|527376360|FG000|Overall Study|Death|0|||
146294173|NCT02202551|527592035|FG002|Overall Study|Lack of Efficacy|0|||
146294174|NCT02202551|527592036|FG003|Overall Study|Lack of Efficacy|0|||
146294175|NCT02202551|527592033|FG000|Overall Study|Physician Decision|1|||
146294176|NCT02202551|527592034|FG001|Overall Study|Physician Decision|0|||
146294177|NCT02202551|527592035|FG002|Overall Study|Physician Decision|0|||
146294178|NCT02202551|527592036|FG003|Overall Study|Physician Decision|0|||
146294179|NCT02202551|527592033|FG000|Overall Study|Site closure|3|||
146294180|NCT02202551|527592034|FG001|Overall Study|Site closure|0|||
146294181|NCT02202551|527592035|FG002|Overall Study|Site closure|0|||
146294182|NCT02202551|527592036|FG003|Overall Study|Site closure|1|||
146294183|NCT02202551|527592033|FG000|Overall Study|Unable to complete visits per protocol|1|||
146294184|NCT02202551|527592034|FG001|Overall Study|Unable to complete visits per protocol|0|||
146294185|NCT02202551|527592035|FG002|Overall Study|Unable to complete visits per protocol|0|||
146294186|NCT02202551|527592036|FG003|Overall Study|Unable to complete visits per protocol|0|||
146294187|NCT02202551|527592033|FG000|Overall Study|Worsening Dyskinesia|0|||
146294188|NCT02202551|527592034|FG001|Overall Study|Worsening Dyskinesia|0|||
146294189|NCT02202551|527592035|FG002|Overall Study|Worsening Dyskinesia|0|||
146294190|NCT02202551|527592036|FG003|Overall Study|Worsening Dyskinesia|1|||
146294191|NCT02202551|527592033|FG000|Overall Study|Protocol Violation|0|||
146294192|NCT02202551|527592034|FG001|Overall Study|Protocol Violation|1|||
146294193|NCT02202551|527592035|FG002|Overall Study|Protocol Violation|0|||
146294194|NCT02202551|527592036|FG003|Overall Study|Protocol Violation|0|||
146294195|NCT02202551|527592033|FG000|Overall Study|Sponsor's decision|2|||
146294196|NCT02202551|527592034|FG001|Overall Study|Sponsor's decision|0|||
146294197|NCT02202551|527592035|FG002|Overall Study|Sponsor's decision|0|||
146294198|NCT02202551|527592036|FG003|Overall Study|Sponsor's decision|0|||
146294199|NCT02202551|527592033|FG000|Overall Study|Subject unwilling to proceed|1|||
146294200|NCT02202551|527592034|FG001|Overall Study|Subject unwilling to proceed|5|||
146294201|NCT02202551|527592035|FG002|Overall Study|Subject unwilling to proceed|3|||
146294202|NCT02202551|527592036|FG003|Overall Study|Subject unwilling to proceed|5|||
146294203|NCT02202551|527592033|FG000|Overall Study|Subject consent withdrawn|0|||
146294204|NCT02202551|527592034|FG001|Overall Study|Subject consent withdrawn|3|||
146294205|NCT02202551|527592035|FG002|Overall Study|Subject consent withdrawn|1|||
146294206|NCT02202551|527592036|FG003|Overall Study|Subject consent withdrawn|2|||
146294207|NCT02202551|527592033|FG000|Overall Study|eGFR<50mL/min/m2|2|||
146294208|NCT02202551|527592034|FG001|Overall Study|eGFR<50mL/min/m2|2|||
146294209|NCT02202551|527592035|FG002|Overall Study|eGFR<50mL/min/m2|0|||
146294210|NCT02202551|527592036|FG003|Overall Study|eGFR<50mL/min/m2|1|||
146294211|NCT02349451|527592037|FG000|Overall Study|Withdrawal by Subject|0|||
146294212|NCT02349451|527592038|FG001|Overall Study|Withdrawal by Subject|1|||
146294213|NCT02349451|527592039|FG002|Overall Study|Withdrawal by Subject|2|||
146294214|NCT02349451|527592040|FG003|Overall Study|Withdrawal by Subject|1|||
146294215|NCT01176773|527592049|FG000|Overall Study|Screen Failure|2|||
146294216|NCT01176773|527592049|FG000|Overall Study|Withdrew consent|1|||
146294217|NCT02446886|527592052|FG000|Overall Study|Adverse Event|1|||
146294218|NCT02446886|527592053|FG001|Overall Study|Adverse Event|3|||
146294219|NCT02446886|527592052|FG000|Overall Study|Withdrawal by Subject|1|||
146294220|NCT02446886|527592053|FG001|Overall Study|Withdrawal by Subject|1|||
146294221|NCT00412971|527592066|FG000|Overall Study|Lost to Follow-up|17|||
146294222|NCT00412971|527592067|FG001|Overall Study|Lost to Follow-up|9|||
146294223|NCT00412971|527592066|FG000|Overall Study|Protocol Violation|13|||
146294224|NCT00412971|527592067|FG001|Overall Study|Protocol Violation|1|||
146294225|NCT01106404|527592068|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
146294226|NCT01106404|527592069|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
146294227|NCT01106404|527592068|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
146294228|NCT01106404|527592069|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
146294229|NCT01106404|527592068|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
146294230|NCT01106404|527592069|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
146294231|NCT01106404|527592068|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
146294232|NCT01106404|527592069|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
146294233|NCT00775450|527592070|FG000|Overall Study|Serious Adverse Event|2|||
146294234|NCT00775450|527592071|FG001|Overall Study|Serious Adverse Event|0|||
146294235|NCT00775450|527592072|FG002|Overall Study|Serious Adverse Event|0|||
146294236|NCT00775450|527592073|FG003|Overall Study|Serious Adverse Event|0|||
146294237|NCT00775450|527592074|FG004|Overall Study|Serious Adverse Event|0|||
146294238|NCT00775450|527592070|FG000|Overall Study|Protocol Violation|0|||
146294239|NCT00775450|527592071|FG001|Overall Study|Protocol Violation|0|||
146294240|NCT00775450|527592072|FG002|Overall Study|Protocol Violation|0|||
146294241|NCT00775450|527592073|FG003|Overall Study|Protocol Violation|0|||
146294242|NCT00775450|527592074|FG004|Overall Study|Protocol Violation|1|||
146294243|NCT00775450|527592070|FG000|Overall Study|Withdrawal by Subject|1|||
146294244|NCT00775450|527592071|FG001|Overall Study|Withdrawal by Subject|0|||
146294245|NCT00775450|527592072|FG002|Overall Study|Withdrawal by Subject|0|||
146294246|NCT00775450|527592073|FG003|Overall Study|Withdrawal by Subject|0|||
146294247|NCT00775450|527592074|FG004|Overall Study|Withdrawal by Subject|1|||
146294248|NCT01749540|527592075|FG000|Overall Study|Protocol Violation|0|||
146294249|NCT01749540|527592076|FG001|Overall Study|Protocol Violation|0|||
146294250|NCT01749540|527592077|FG002|Overall Study|Protocol Violation|0|||
146294251|NCT01749540|527592078|FG003|Overall Study|Protocol Violation|0|||
146294252|NCT01749540|527592079|FG004|Overall Study|Protocol Violation|0|||
146294253|NCT01749540|527592080|FG005|Overall Study|Protocol Violation|1|||
146294254|NCT01749540|527592081|FG006|Overall Study|Protocol Violation|1|||
146294255|NCT01749540|527592075|FG000|Overall Study|Withdrawal by Subject|0|||
146294256|NCT01749540|527592076|FG001|Overall Study|Withdrawal by Subject|0|||
146294257|NCT01749540|527592077|FG002|Overall Study|Withdrawal by Subject|0|||
146294258|NCT01749540|527592078|FG003|Overall Study|Withdrawal by Subject|1|||
146294259|NCT01749540|527592079|FG004|Overall Study|Withdrawal by Subject|0|||
146294260|NCT01749540|527592080|FG005|Overall Study|Withdrawal by Subject|0|||
146294261|NCT01749540|527592081|FG006|Overall Study|Withdrawal by Subject|0|||
146294262|NCT01749540|527592075|FG000|Overall Study|Initiated into extension study A536-06|0|||
146294263|NCT01749540|527592076|FG001|Overall Study|Initiated into extension study A536-06|0|||
146294264|NCT01749540|527592077|FG002|Overall Study|Initiated into extension study A536-06|0|||
146294265|NCT01749540|527592078|FG003|Overall Study|Initiated into extension study A536-06|0|||
146294266|NCT01749540|527592079|FG004|Overall Study|Initiated into extension study A536-06|0|||
146294267|NCT01749540|527592080|FG005|Overall Study|Initiated into extension study A536-06|2|||
146294268|NCT01749540|527592081|FG006|Overall Study|Initiated into extension study A536-06|24|||
146294269|NCT00752622|527592082|FG000|Induction Phase|Adverse Event|3|||
146294270|NCT00752622|527592082|FG000|Induction Phase|Other|3|||
146294271|NCT00752622|527592082|FG000|Induction Phase|Non-responder|14|||
146294272|NCT00752622|527592082|FG000|Induction Phase|Withdrawal by Subject|1|||
146294273|NCT00752622|527592082|FG000|Induction Phase|Premature study termination|14|||
146294274|NCT00752622|527592082|FG000|Observational Phase|Premature Study Termination|36|||
146294275|NCT00752622|527592082|FG000|Observational Phase|Non-responder|2|||
146294276|NCT00752622|527592082|FG000|Observational Phase|Withdrawal by Subject|2|||
146294277|NCT00752622|527592082|FG000|Observational Phase|Adverse Event|1|||
146294278|NCT00752622|527592082|FG000|Observational Phase|Other|2|||
146294279|NCT00752622|527592082|FG000|Interventional Phase|Non-responder|2|||
146294280|NCT00752622|527592082|FG000|Interventional Phase|Physician Decision|1|||
146294281|NCT00752622|527592082|FG000|Interventional Phase|Premature Study Termination|5|||
146294282|NCT00576836|527592083|FG000|Overall Study|Death|0|||
146294283|NCT00576836|527592084|FG001|Overall Study|Death|1|||
146294284|NCT00576836|527592083|FG000|Overall Study|Physician Decision|0|||
146294285|NCT00576836|527592084|FG001|Overall Study|Physician Decision|1|||
146294286|NCT00894686|527592085|FG000|Overall Study|Withdrawal by Subject|50|||
146294287|NCT00894686|527592085|FG000|Overall Study|Physician Decision|1|||
146294288|NCT00894686|527592085|FG000|Overall Study|Other|5|||
146294289|NCT00564018|527592086|FG000|Overall Study|Withdrawal by Subject|2|||
146294290|NCT00564018|527592087|FG001|Overall Study|Withdrawal by Subject|3|||
146294291|NCT00564018|527592088|FG002|Overall Study|Withdrawal by Subject|1|||
146294292|NCT03267940|527592091|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
146294293|NCT03267940|527592092|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
146294294|NCT03267940|527592093|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146294295|NCT03267940|527592094|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146294296|NCT03267940|527592095|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146294297|NCT03267940|527592096|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
146294298|NCT03267940|527592091|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146294299|NCT03267940|527592092|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
146294300|NCT03267940|527592093|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146294301|NCT03267940|527592094|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146294302|NCT03267940|527592095|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146294303|NCT03267940|527592096|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
146294304|NCT03267940|527592091|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146294305|NCT03267940|527592092|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
146294306|NCT03267940|527592093|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146294307|NCT03267940|527592094|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146294308|NCT03267940|527592095|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146087696|NCT04393298|526841821|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
146234603|NCT01185600|527376361|FG001|Overall Study|Death|1|||
146234604|NCT01185600|527376360|FG000|Overall Study|Lost to Follow-up|0|||
146234605|NCT01185600|527376361|FG001|Overall Study|Lost to Follow-up|5|||
146234606|NCT01185600|527376360|FG000|Overall Study|Physician Decision|29|||
146234607|NCT01185600|527376361|FG001|Overall Study|Physician Decision|35|||
146234608|NCT01185600|527376360|FG000|Overall Study|Withdrawal by Subject|1|||
146234609|NCT01185600|527376361|FG001|Overall Study|Withdrawal by Subject|1|||
146234610|NCT01185600|527376360|FG000|Overall Study|Hold by DSMB|1|||
146234611|NCT01185600|527376361|FG001|Overall Study|Hold by DSMB|2|||
146234612|NCT00724126|527376363|FG000|Overall Study|Adverse Event|2|||
146234613|NCT00724126|527376364|FG001|Overall Study|Adverse Event|0|||
146234614|NCT00724126|527376363|FG000|Overall Study|Withdrawal by Subject|8|||
146234615|NCT00724126|527376364|FG001|Overall Study|Withdrawal by Subject|6|||
146234616|NCT00724126|527376363|FG000|Overall Study|Lost to Follow-up|6|||
146234617|NCT00724126|527376364|FG001|Overall Study|Lost to Follow-up|6|||
146234618|NCT00724126|527376363|FG000|Overall Study|Noncompliance|2|||
146234619|NCT00724126|527376364|FG001|Overall Study|Noncompliance|1|||
146234620|NCT00724126|527376363|FG000|Overall Study|Subject randomized although ineligible|1|||
146234621|NCT00724126|527376364|FG001|Overall Study|Subject randomized although ineligible|1|||
146234622|NCT00724126|527376363|FG000|Overall Study|Subject had to leave vicinity of site|0|||
146234623|NCT00724126|527376364|FG001|Overall Study|Subject had to leave vicinity of site|1|||
146234624|NCT00739934|527376365|FG000|Voriconazole IV|Adverse Event|6|||
146234625|NCT00739934|527376365|FG000|Voriconazole Oral|Other|3|||
146234626|NCT01579318|527376368|FG000|Overall Study|Disease Progression|1|||
146234627|NCT03066609|527376375|FG000|INDUCTION|Pregnancy|0|||
146234628|NCT03066609|527376376|FG001|INDUCTION|Pregnancy|0|||
146234629|NCT03066609|527376377|FG002|INDUCTION|Pregnancy|1|||
146234630|NCT03066609|527376378|FG003|INDUCTION|Pregnancy|0|||
146234631|NCT03066609|527376375|FG000|INDUCTION|Lack of Efficacy|0|||
146234632|NCT03066609|527376376|FG001|INDUCTION|Lack of Efficacy|0|||
146234633|NCT03066609|527376377|FG002|INDUCTION|Lack of Efficacy|1|||
146234634|NCT03066609|527376378|FG003|INDUCTION|Lack of Efficacy|0|||
146234635|NCT03066609|527376375|FG000|INDUCTION|Adverse Event|2|||
146234636|NCT03066609|527376376|FG001|INDUCTION|Adverse Event|2|||
146234637|NCT03066609|527376377|FG002|INDUCTION|Adverse Event|0|||
146234638|NCT03066609|527376378|FG003|INDUCTION|Adverse Event|0|||
146234639|NCT03066609|527376375|FG000|MAINTENANCE|Adverse Event|0|||
146234640|NCT03066609|527376376|FG001|MAINTENANCE|Adverse Event|0|||
146234641|NCT03066609|527376377|FG002|MAINTENANCE|Adverse Event|0|||
146234642|NCT03066609|527376378|FG003|MAINTENANCE|Adverse Event|1|||
146234643|NCT03066609|527376375|FG000|MAINTENANCE|Withdrawal by Subject|4|||
146234644|NCT03066609|527376376|FG001|MAINTENANCE|Withdrawal by Subject|2|||
146234645|NCT03066609|527376377|FG002|MAINTENANCE|Withdrawal by Subject|1|||
146234646|NCT03066609|527376378|FG003|MAINTENANCE|Withdrawal by Subject|1|||
146234647|NCT03066609|527376375|FG000|MAINTENANCE|Lost to Follow-up|0|||
146234648|NCT03066609|527376376|FG001|MAINTENANCE|Lost to Follow-up|1|||
146234649|NCT03066609|527376377|FG002|MAINTENANCE|Lost to Follow-up|1|||
146234650|NCT03066609|527376378|FG003|MAINTENANCE|Lost to Follow-up|0|||
146234651|NCT03066609|527376375|FG000|MAINTENANCE|Pregnancy|1|||
146234652|NCT03066609|527376376|FG001|MAINTENANCE|Pregnancy|0|||
146234653|NCT03066609|527376377|FG002|MAINTENANCE|Pregnancy|0|||
146234654|NCT03066609|527376378|FG003|MAINTENANCE|Pregnancy|0|||
146234655|NCT03066609|527376375|FG000|MAINTENANCE|Lack of Efficacy|2|||
146234656|NCT03066609|527376376|FG001|MAINTENANCE|Lack of Efficacy|1|||
146234657|NCT03066609|527376377|FG002|MAINTENANCE|Lack of Efficacy|0|||
146234658|NCT03066609|527376378|FG003|MAINTENANCE|Lack of Efficacy|1|||
146234659|NCT03066609|527376375|FG000|OVERALL STUDY|Adverse Event|2|||
146234660|NCT03066609|527376376|FG001|OVERALL STUDY|Adverse Event|2|||
146234661|NCT03066609|527376377|FG002|OVERALL STUDY|Adverse Event|0|||
146234662|NCT03066609|527376378|FG003|OVERALL STUDY|Adverse Event|1|||
146234663|NCT03066609|527376375|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
146234664|NCT03066609|527376376|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
146234665|NCT03066609|527376377|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
146234666|NCT03066609|527376378|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
146234667|NCT03066609|527376375|FG000|OVERALL STUDY|Lost to Follow-up|1|||
146234668|NCT03066609|527376376|FG001|OVERALL STUDY|Lost to Follow-up|1|||
146234669|NCT03066609|527376377|FG002|OVERALL STUDY|Lost to Follow-up|1|||
146234670|NCT03066609|527376378|FG003|OVERALL STUDY|Lost to Follow-up|1|||
146234671|NCT03066609|527376375|FG000|OVERALL STUDY|Pregnancy|1|||
146234672|NCT03066609|527376376|FG001|OVERALL STUDY|Pregnancy|0|||
146234673|NCT03066609|527376377|FG002|OVERALL STUDY|Pregnancy|1|||
146234674|NCT03066609|527376378|FG003|OVERALL STUDY|Pregnancy|0|||
146234675|NCT03066609|527376375|FG000|OVERALL STUDY|Lack of Efficacy|2|||
146234676|NCT03066609|527376376|FG001|OVERALL STUDY|Lack of Efficacy|1|||
146234677|NCT03066609|527376377|FG002|OVERALL STUDY|Lack of Efficacy|1|||
146234678|NCT03066609|527376378|FG003|OVERALL STUDY|Lack of Efficacy|1|||
146234679|NCT03066609|527376375|FG000|OVERALL STUDY|discontinued follow up|0|||
146234680|NCT03066609|527376376|FG001|OVERALL STUDY|discontinued follow up|2|||
146234681|NCT03066609|527376377|FG002|OVERALL STUDY|discontinued follow up|0|||
146234682|NCT03066609|527376378|FG003|OVERALL STUDY|discontinued follow up|0|||
146234683|NCT03355573|527376379|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
146234684|NCT03355573|527376379|FG000|Overall Study|Sponsor's decision|1|||
146234685|NCT03355573|527376379|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
146234686|NCT03355573|527376379|FG000|Overall Study|PI's decision|2|||
146234687|NCT03355573|527376379|FG000|Overall Study|Withdrawal by Subject|23|||
146234688|NCT03355573|527376379|FG000|Overall Study|Lost to Follow-up|4|||
146234689|NCT03355573|527376379|FG000|Overall Study|Lack of Efficacy|2|||
146234690|NCT03355573|527376379|FG000|Overall Study|Adverse Event, non-fatal|17|||
146234691|NCT03355573|527376379|FG000|Overall Study|Adverse Event, serious fatal|2|||
146234692|NCT01566890|527376380|FG000|Overall Study|Adverse Event|1|||
146234693|NCT01566890|527376381|FG001|Overall Study|Adverse Event|0|||
146234694|NCT01566890|527376382|FG002|Overall Study|Adverse Event|0|||
146234695|NCT01566890|527376383|FG003|Overall Study|Adverse Event|0|||
146234696|NCT01566890|527376384|FG004|Overall Study|Adverse Event|0|||
146234697|NCT01566890|527376380|FG000|Overall Study|Withdrawal by Subject|3|||
146234698|NCT01566890|527376381|FG001|Overall Study|Withdrawal by Subject|1|||
146234699|NCT01566890|527376382|FG002|Overall Study|Withdrawal by Subject|1|||
146234700|NCT01566890|527376383|FG003|Overall Study|Withdrawal by Subject|1|||
146234701|NCT01566890|527376384|FG004|Overall Study|Withdrawal by Subject|0|||
146234702|NCT01566890|527376380|FG000|Overall Study|Screen failure|6|||
146234703|NCT01566890|527376381|FG001|Overall Study|Screen failure|0|||
146294309|NCT03267940|527592096|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
146294310|NCT03267940|527592091|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
146294311|NCT03267940|527592092|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
146294312|NCT03267940|527592093|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146294313|NCT03267940|527592094|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146294314|NCT03267940|527592095|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146294315|NCT03267940|527592096|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
146294316|NCT03267940|527592091|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146294317|NCT03267940|527592092|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146294318|NCT03267940|527592093|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146294319|NCT03267940|527592094|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
146294320|NCT03267940|527592095|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
146294321|NCT03267940|527592096|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
146294322|NCT03267940|527592091|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146294323|NCT03267940|527592092|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146294324|NCT03267940|527592093|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
146294325|NCT03267940|527592094|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
146294326|NCT03267940|527592095|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
146294327|NCT03267940|527592096|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
146294328|NCT03267940|527592091|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
146294329|NCT03267940|527592092|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
146294330|NCT03267940|527592093|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
146294331|NCT03267940|527592094|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146294332|NCT03267940|527592095|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146294333|NCT03267940|527592096|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
146294334|NCT03267940|527592091|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
146294335|NCT03267940|527592092|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
146294336|NCT03267940|527592093|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
146294337|NCT03267940|527592094|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
146294338|NCT03267940|527592095|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
146294339|NCT03267940|527592096|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
146294340|NCT03267940|527592091|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146294341|NCT03267940|527592092|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146294342|NCT03267940|527592093|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
146294343|NCT03267940|527592094|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
146234704|NCT01566890|527376382|FG002|Overall Study|Screen failure|1|||
146234705|NCT01566890|527376383|FG003|Overall Study|Screen failure|1|||
146234706|NCT01566890|527376384|FG004|Overall Study|Screen failure|0|||
146234707|NCT01566890|527376380|FG000|Overall Study|Incomplete CEU data|1|||
146234708|NCT01566890|527376381|FG001|Overall Study|Incomplete CEU data|3|||
146234709|NCT01566890|527376382|FG002|Overall Study|Incomplete CEU data|5|||
146234710|NCT01566890|527376383|FG003|Overall Study|Incomplete CEU data|8|||
146234711|NCT01566890|527376384|FG004|Overall Study|Incomplete CEU data|0|||
146234712|NCT01566890|527376380|FG000|Overall Study|Lost to Follow-up|0|||
146234713|NCT01566890|527376381|FG001|Overall Study|Lost to Follow-up|0|||
146234714|NCT01566890|527376382|FG002|Overall Study|Lost to Follow-up|4|||
146234715|NCT01566890|527376383|FG003|Overall Study|Lost to Follow-up|4|||
146234716|NCT01566890|527376384|FG004|Overall Study|Lost to Follow-up|0|||
146234717|NCT01566890|527376380|FG000|Overall Study|Other|0|||
146234718|NCT01566890|527376381|FG001|Overall Study|Other|0|||
146234719|NCT01566890|527376382|FG002|Overall Study|Other|0|||
146234720|NCT01566890|527376383|FG003|Overall Study|Other|0|||
146294344|NCT03267940|527592095|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
146294345|NCT03267940|527592096|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
146294346|NCT00388154|527592097|FG000|Overall Study|Withdrawal by Subject|1|||
146234721|NCT01566890|527376384|FG004|Overall Study|Other|7|||
146234722|NCT00523419|527376395|FG000|Overall Study|Adverse Event|1|||
146234723|NCT00523419|527376395|FG000|Overall Study|Withdrawal by Subject|1|||
146234724|NCT00523419|527376395|FG000|Overall Study|Physician Decision|2|||
146294347|NCT01074216|527592104|FG000|Overall Study|Physician Decision|1|||
146234725|NCT00523419|527376395|FG000|Overall Study|Progressive Disease|22|||
146234726|NCT00523419|527376395|FG000|Overall Study|Death due to Study Disease|4|||
146234727|NCT00523419|527376395|FG000|Overall Study|Death due to Adverse Event|2|||
146234728|NCT01211184|527376396|FG000|Overall Study|Withdrawal by Subject|0|||
146234729|NCT01211184|527376397|FG001|Overall Study|Withdrawal by Subject|2|||
146234730|NCT01211184|527376398|FG002|Overall Study|Withdrawal by Subject|1|||
146234731|NCT01421667|527376399|FG000|Overall Study|Withdrawal by Subject|0|||
146234732|NCT01421667|527376400|FG001|Overall Study|Withdrawal by Subject|1|||
146234733|NCT01421667|527376401|FG002|Overall Study|Withdrawal by Subject|2|||
146234734|NCT01421667|527376402|FG003|Overall Study|Withdrawal by Subject|1|||
146234735|NCT01421667|527376399|FG000|Overall Study|Lost to Follow-up|0|||
146234736|NCT01421667|527376400|FG001|Overall Study|Lost to Follow-up|1|||
145970772|NCT00423605|526407254|FG000|Overall Study|Sponsor Decision|3|||
146234737|NCT01421667|527376401|FG002|Overall Study|Lost to Follow-up|0|||
146234738|NCT01421667|527376402|FG003|Overall Study|Lost to Follow-up|0|||
146234739|NCT00822120|527376403|FG000|Initial Registration|Adverse Event|1|||
146234740|NCT00822120|527376404|FG001|Initial Registration|Adverse Event|0|||
146234741|NCT00822120|527376405|FG002|Initial Registration|Adverse Event|0|||
146234742|NCT00822120|527376406|FG003|Initial Registration|Adverse Event|0|||
146234743|NCT00822120|527376407|FG004|Initial Registration|Adverse Event|0|||
146234744|NCT00822120|527376408|FG005|Initial Registration|Adverse Event|0|||
146234745|NCT00822120|527376403|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
146234746|NCT00822120|527376404|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146234747|NCT00822120|527376405|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146234748|NCT00822120|527376406|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146234749|NCT00822120|527376407|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146234750|NCT00822120|527376408|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146234751|NCT00822120|527376403|FG000|Initial Registration|Reasons not Protocol Specified|2|||
146234752|NCT00822120|527376404|FG001|Initial Registration|Reasons not Protocol Specified|0|||
146234753|NCT00822120|527376405|FG002|Initial Registration|Reasons not Protocol Specified|0|||
146234754|NCT00822120|527376406|FG003|Initial Registration|Reasons not Protocol Specified|0|||
146234755|NCT00822120|527376407|FG004|Initial Registration|Reasons not Protocol Specified|0|||
146234756|NCT00822120|527376408|FG005|Initial Registration|Reasons not Protocol Specified|0|||
146234757|NCT00822120|527376403|FG000|Initial Registration|Ineligible|22|||
146234758|NCT00822120|527376404|FG001|Initial Registration|Ineligible|1|||
146234759|NCT00822120|527376405|FG002|Initial Registration|Ineligible|0|||
146234760|NCT00822120|527376406|FG003|Initial Registration|Ineligible|0|||
146234761|NCT00822120|527376407|FG004|Initial Registration|Ineligible|0|||
146234762|NCT00822120|527376408|FG005|Initial Registration|Ineligible|0|||
146234763|NCT00822120|527376403|FG000|PET-directed Therapy|Adverse Event|0|||
146234764|NCT00822120|527376404|FG001|PET-directed Therapy|Adverse Event|0|||
146234765|NCT00822120|527376405|FG002|PET-directed Therapy|Adverse Event|0|||
146234766|NCT00822120|527376406|FG003|PET-directed Therapy|Adverse Event|1|||
146234767|NCT00822120|527376407|FG004|PET-directed Therapy|Adverse Event|0|||
146234768|NCT00822120|527376408|FG005|PET-directed Therapy|Adverse Event|0|||
146234769|NCT00822120|527376403|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146234770|NCT00822120|527376404|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146234771|NCT00822120|527376405|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146234772|NCT00822120|527376406|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
146234773|NCT00822120|527376407|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146234774|NCT00822120|527376408|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
146234775|NCT00822120|527376403|FG000|PET-directed Therapy|Death|0|||
146234776|NCT00822120|527376404|FG001|PET-directed Therapy|Death|0|||
146234777|NCT00822120|527376405|FG002|PET-directed Therapy|Death|0|||
146234778|NCT00822120|527376406|FG003|PET-directed Therapy|Death|2|||
146234779|NCT00822120|527376407|FG004|PET-directed Therapy|Death|0|||
146234780|NCT00822120|527376408|FG005|PET-directed Therapy|Death|0|||
146234781|NCT00822120|527376403|FG000|PET-directed Therapy|Protocol Violation|0|||
146234782|NCT00822120|527376404|FG001|PET-directed Therapy|Protocol Violation|0|||
146234783|NCT00822120|527376405|FG002|PET-directed Therapy|Protocol Violation|0|||
146234784|NCT00822120|527376406|FG003|PET-directed Therapy|Protocol Violation|6|||
146234785|NCT00822120|527376407|FG004|PET-directed Therapy|Protocol Violation|0|||
146234786|NCT00822120|527376408|FG005|PET-directed Therapy|Protocol Violation|0|||
146234787|NCT04060212|527376410|FG000|Overall Study|Withdrawal by Subject|7|||
146234788|NCT03802994|527376414|FG000|Overall Study|Lost to Follow-up|0|||
146234789|NCT03802994|527376415|FG001|Overall Study|Lost to Follow-up|2|||
146234790|NCT03802994|527376416|FG002|Overall Study|Lost to Follow-up|3|||
146234791|NCT03802994|527376417|FG003|Overall Study|Lost to Follow-up|2|||
146234792|NCT03802994|527376418|FG004|Overall Study|Lost to Follow-up|2|||
146234793|NCT02646618|527376419|FG000|Overall Study|Lost to Follow-up|10|||
146234794|NCT02646618|527376420|FG001|Overall Study|Lost to Follow-up|14|||
146234795|NCT00918203|527376422|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
146234796|NCT00918203|527376423|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
146234797|NCT00918203|527376424|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
146234798|NCT00918203|527376422|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
146234799|NCT00918203|527376423|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
145970773|NCT00423605|526407254|FG000|Overall Study|Physician Decision|8|||
146294348|NCT01074216|527592104|FG000|Overall Study|Not Treated|12|||
146294349|NCT04751656|527594046|FG000|Overall Study|Lost to Follow-up|1|||
146294350|NCT03566810|527594047|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146294351|NCT03566810|527594048|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
146294352|NCT03566810|527594049|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146294353|NCT03566810|527594050|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
146294354|NCT01103245|527594051|FG000|Overall Study|Withdrawal by Subject|1|||
146294355|NCT01103245|527594052|FG001|Overall Study|Withdrawal by Subject|0|||
146294356|NCT01103245|527594053|FG002|Overall Study|Withdrawal by Subject|3|||
146294357|NCT01103245|527594054|FG003|Overall Study|Withdrawal by Subject|0|||
146294358|NCT01103245|527594051|FG000|Overall Study|Inadequate IV access|1|||
146294359|NCT01103245|527594052|FG001|Overall Study|Inadequate IV access|0|||
146294360|NCT01103245|527594053|FG002|Overall Study|Inadequate IV access|0|||
146294361|NCT01103245|527594054|FG003|Overall Study|Inadequate IV access|0|||
146294362|NCT01103245|527594051|FG000|Overall Study|Adverse Event|0|||
146294363|NCT01103245|527594052|FG001|Overall Study|Adverse Event|2|||
146294364|NCT01103245|527594053|FG002|Overall Study|Adverse Event|1|||
146294365|NCT01103245|527594054|FG003|Overall Study|Adverse Event|0|||
146294366|NCT01103245|527594051|FG000|Overall Study|Physician Decision|1|||
146294367|NCT01103245|527594052|FG001|Overall Study|Physician Decision|0|||
146294368|NCT01103245|527594053|FG002|Overall Study|Physician Decision|0|||
146294369|NCT01103245|527594054|FG003|Overall Study|Physician Decision|0|||
146294370|NCT01195545|527594055|FG000|Overall Study|Protocol Violation|4|||
146294371|NCT02425644|527594058|FG000|Overall Study|Lost to Follow-up|2|||
146294372|NCT02425644|527594059|FG001|Overall Study|Lost to Follow-up|3|||
145970774|NCT00423605|526407254|FG000|Overall Study|Protocol Violation|7|||
145970775|NCT00423605|526407254|FG000|Overall Study|Not one of the pre-specified options|5|||
146234800|NCT00918203|527376424|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
146234801|NCT00918203|527376422|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
146234802|NCT00918203|527376423|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
146234803|NCT00918203|527376424|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
146234804|NCT00918203|527376422|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
146234805|NCT00918203|527376423|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
146234806|NCT00918203|527376424|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
146234807|NCT00701701|527376427|FG000|Overall Study|Withdrawal by Subject|0|||
146234808|NCT00701701|527376428|FG001|Overall Study|Withdrawal by Subject|1|||
146234809|NCT00701701|527376427|FG000|Overall Study|Adverse Event|0|||
146234810|NCT00701701|527376428|FG001|Overall Study|Adverse Event|1|||
146234811|NCT00589875|527376429|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
146234812|NCT00589875|527376429|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
146234813|NCT03357952|527376432|FG000|Overall Study|Withdrawal by Subject|0|||
146234814|NCT03357952|527376433|FG001|Overall Study|Withdrawal by Subject|1|||
146234815|NCT03357952|527376432|FG000|Overall Study|Sponsor Decision|9|||
146234816|NCT03357952|527376433|FG001|Overall Study|Sponsor Decision|0|||
146234817|NCT02016872|527376434|FG000|Overall Study|Withdrawal by Subject|10|||
146234818|NCT02016872|527376434|FG000|Overall Study|Death Progression|2|||
146234819|NCT02016872|527376434|FG000|Overall Study|No FMISO scan|1|||
146234820|NCT02016872|527376434|FG000|Overall Study|Ineligible|2|||
146234821|NCT04517435|527376451|FG000|Overall Study|Withdrawal by Subject|0|||
146234822|NCT04517435|527376452|FG001|Overall Study|Withdrawal by Subject|0|||
146234823|NCT04517435|527376453|FG002|Overall Study|Withdrawal by Subject|1|||
146234824|NCT04517435|527376451|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
146234825|NCT04517435|527376452|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
146234826|NCT04517435|527376453|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
146234827|NCT06191679|527376454|FG000|Baseline|Lost to Follow-up|1|||
146234828|NCT06191679|527376455|FG001|Baseline|Lost to Follow-up|0|||
146234829|NCT06191679|527376456|FG002|Baseline|Lost to Follow-up|1|||
146234830|NCT06191679|527376457|FG003|Baseline|Lost to Follow-up|0|||
146234831|NCT06191679|527376454|FG000|Allocation to Group|Withdrawal by Subject|0|||
146234832|NCT06191679|527376455|FG001|Allocation to Group|Withdrawal by Subject|1|||
146234833|NCT06191679|527376456|FG002|Allocation to Group|Withdrawal by Subject|2|||
146234834|NCT06191679|527376457|FG003|Allocation to Group|Withdrawal by Subject|0|||
146234835|NCT06191679|527376454|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
146234836|NCT06191679|527376455|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
146234837|NCT06191679|527376456|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
146234838|NCT06191679|527376457|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
146234839|NCT06191679|527376454|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
146234840|NCT06191679|527376455|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
146234841|NCT06191679|527376456|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
146294373|NCT02425644|527594058|FG000|Overall Study|Withdrawal by Subject|41|||
146294374|NCT02425644|527594059|FG001|Overall Study|Withdrawal by Subject|36|||
146294375|NCT02425644|527594058|FG000|Overall Study|Lack of Efficacy|3|||
146294376|NCT02425644|527594059|FG001|Overall Study|Lack of Efficacy|10|||
146294377|NCT02425644|527594058|FG000|Overall Study|Adverse Event|13|||
146294378|NCT02425644|527594059|FG001|Overall Study|Adverse Event|3|||
146294379|NCT02425644|527594058|FG000|Overall Study|Death|0|||
146294380|NCT02425644|527594059|FG001|Overall Study|Death|2|||
146294381|NCT02425644|527594058|FG000|Overall Study|Other|18|||
146294382|NCT02425644|527594059|FG001|Overall Study|Other|17|||
146294383|NCT02720536|527594060|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
146294384|NCT02720536|527594060|FG000|Overall Study|PR - pregnancy|2|||
146294385|NCT02720536|527594060|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
146234842|NCT06191679|527376457|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
146234843|NCT06191679|527376454|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146234844|NCT06191679|527376455|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146234845|NCT06191679|527376456|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
146234846|NCT06191679|527376457|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
146234847|NCT02415127|527376458|FG000|Overall Study|Adverse Event|1|||
146234848|NCT02415127|527376459|FG001|Overall Study|Adverse Event|0|||
146234849|NCT00545545|527376460|FG000|Overall Study|Progressive Neoplastic Disease|1|||
146234850|NCT00545545|527376461|FG001|Overall Study|Progressive Neoplastic Disease|5|||
146234851|NCT00545545|527376462|FG002|Overall Study|Progressive Neoplastic Disease|0|||
146234852|NCT00545545|527376463|FG003|Overall Study|Progressive Neoplastic Disease|4|||
146234853|NCT00545545|527376464|FG004|Overall Study|Progressive Neoplastic Disease|8|||
146234854|NCT00545545|527376465|FG005|Overall Study|Progressive Neoplastic Disease|7|||
146234855|NCT00545545|527376460|FG000|Overall Study|Withdrawal by Subject|0|||
146234856|NCT00545545|527376461|FG001|Overall Study|Withdrawal by Subject|1|||
146234857|NCT00545545|527376462|FG002|Overall Study|Withdrawal by Subject|0|||
146234858|NCT00545545|527376463|FG003|Overall Study|Withdrawal by Subject|0|||
146234859|NCT00545545|527376464|FG004|Overall Study|Withdrawal by Subject|0|||
146234860|NCT00545545|527376465|FG005|Overall Study|Withdrawal by Subject|0|||
146234861|NCT00545545|527376460|FG000|Overall Study|Physician Decision|1|||
146234862|NCT00545545|527376461|FG001|Overall Study|Physician Decision|0|||
146234863|NCT00545545|527376462|FG002|Overall Study|Physician Decision|0|||
146234864|NCT00545545|527376463|FG003|Overall Study|Physician Decision|0|||
146234865|NCT00545545|527376464|FG004|Overall Study|Physician Decision|0|||
146234866|NCT00545545|527376465|FG005|Overall Study|Physician Decision|1|||
146234867|NCT00545545|527376460|FG000|Overall Study|Irinotecan intolerance|1|||
146234868|NCT00545545|527376461|FG001|Overall Study|Irinotecan intolerance|1|||
146234869|NCT00545545|527376462|FG002|Overall Study|Irinotecan intolerance|0|||
146234870|NCT00545545|527376463|FG003|Overall Study|Irinotecan intolerance|0|||
146234871|NCT00545545|527376464|FG004|Overall Study|Irinotecan intolerance|0|||
146234872|NCT00545545|527376465|FG005|Overall Study|Irinotecan intolerance|0|||
146234873|NCT00545545|527376460|FG000|Overall Study|No target lesions to track post surgery|0|||
146234874|NCT00545545|527376461|FG001|Overall Study|No target lesions to track post surgery|0|||
146234875|NCT00545545|527376462|FG002|Overall Study|No target lesions to track post surgery|0|||
146234876|NCT00545545|527376463|FG003|Overall Study|No target lesions to track post surgery|0|||
146234877|NCT00545545|527376464|FG004|Overall Study|No target lesions to track post surgery|1|||
146234878|NCT00545545|527376465|FG005|Overall Study|No target lesions to track post surgery|1|||
146234879|NCT02702843|527378388|FG000|Overall Study|Insufficient data to analyze|15|||
146234880|NCT02702843|527378389|FG001|Overall Study|Insufficient data to analyze|23|||
146234881|NCT04989816|527378391|FG000|Overall Study|Death|77|||
146234882|NCT04989816|527378391|FG000|Overall Study|Lost to Follow-up|3|||
146234883|NCT04213807|527378397|FG000|Overall Study|Physician Decision|0|||
146234884|NCT04213807|527378398|FG001|Overall Study|Physician Decision|0|||
146234885|NCT04213807|527378399|FG002|Overall Study|Physician Decision|1|||
146234886|NCT03801148|527378400|FG000|Period 1 (2 Days)|Adverse Event|1|||
146234887|NCT03801148|527378401|FG001|Period 1 (2 Days)|Adverse Event|1|||
146234888|NCT03801148|527378402|FG002|Period 1 (2 Days)|Adverse Event|0|||
146234889|NCT03801148|527378403|FG003|Period 1 (2 Days)|Adverse Event|0|||
146234890|NCT03801148|527378400|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146234891|NCT03801148|527378401|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146234892|NCT03801148|527378402|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
146234893|NCT03801148|527378403|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
146294386|NCT02720536|527594060|FG000|Overall Study|PR - death|1|||
146294387|NCT02720536|527594060|FG000|Overall Study|PR - adverse event|1|||
146294388|NCT02720536|527594060|FG000|Overall Study|PR - abnormal lab value(s)|1|||
146294389|NCT02720536|527594060|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
146294390|NCT00300781|527594061|FG000|Overall Study|Disease Progression|55|||
146294391|NCT00300781|527594062|FG001|Overall Study|Disease Progression|52|||
146234894|NCT03801148|527378400|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146234895|NCT03801148|527378401|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146234896|NCT03801148|527378402|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
146234897|NCT03801148|527378403|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
146234898|NCT03801148|527378400|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
146294422|NCT03236246|527594063|FG000|24-Week Dose Titration Period|Captured as Other|1|||
146294423|NCT03236246|527594064|FG001|24-Week Dose Titration Period|Captured as Other|2|||
146294424|NCT03236246|527594063|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
146294425|NCT03236246|527594064|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
146294426|NCT03236246|527594063|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
146294427|NCT03236246|527594064|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
146294428|NCT03236246|527594063|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
146294429|NCT03236246|527594064|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
146294430|NCT03236246|527594063|FG000|24-Week Dose Maintenance Period|Death|0|||
146294431|NCT03236246|527594064|FG001|24-Week Dose Maintenance Period|Death|1|||
146294432|NCT03236246|527594063|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
146294433|NCT03236246|527594064|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
146294434|NCT01794520|527594065|FG000|Overall Study|Adverse events- related to progression|0|||
146294435|NCT01794520|527594066|FG001|Overall Study|Adverse events- related to progression|0|||
146294436|NCT01794520|527594067|FG002|Overall Study|Adverse events- related to progression|1|||
146294437|NCT01794520|527594068|FG003|Overall Study|Adverse events- related to progression|2|||
146294438|NCT01794520|527594069|FG004|Overall Study|Adverse events- related to progression|0|||
146294439|NCT01794520|527594070|FG005|Overall Study|Adverse events- related to progression|1|||
146294440|NCT01794520|527594071|FG006|Overall Study|Adverse events- related to progression|0|||
146294441|NCT01794520|527594065|FG000|Overall Study|Adverse event- not related to progression|1|||
146294442|NCT01794520|527594066|FG001|Overall Study|Adverse event- not related to progression|1|||
146294443|NCT01794520|527594067|FG002|Overall Study|Adverse event- not related to progression|0|||
146294444|NCT01794520|527594068|FG003|Overall Study|Adverse event- not related to progression|0|||
146294445|NCT01794520|527594069|FG004|Overall Study|Adverse event- not related to progression|2|||
146294446|NCT01794520|527594070|FG005|Overall Study|Adverse event- not related to progression|0|||
146294447|NCT01794520|527594071|FG006|Overall Study|Adverse event- not related to progression|0|||
146294448|NCT01794520|527594065|FG000|Overall Study|Progressive disease|5|||
146294449|NCT01794520|527594066|FG001|Overall Study|Progressive disease|6|||
146294450|NCT01794520|527594067|FG002|Overall Study|Progressive disease|2|||
146294451|NCT01794520|527594068|FG003|Overall Study|Progressive disease|5|||
146294452|NCT01794520|527594069|FG004|Overall Study|Progressive disease|27|||
146294453|NCT01794520|527594070|FG005|Overall Study|Progressive disease|18|||
146294454|NCT01794520|527594071|FG006|Overall Study|Progressive disease|0|||
146294455|NCT01794520|527594065|FG000|Overall Study|Withdrew consent|0|||
146294456|NCT01794520|527594066|FG001|Overall Study|Withdrew consent|0|||
146294457|NCT01794520|527594067|FG002|Overall Study|Withdrew consent|1|||
146294458|NCT01794520|527594068|FG003|Overall Study|Withdrew consent|1|||
146294459|NCT01794520|527594069|FG004|Overall Study|Withdrew consent|0|||
146294460|NCT01794520|527594070|FG005|Overall Study|Withdrew consent|0|||
146294461|NCT01794520|527594071|FG006|Overall Study|Withdrew consent|0|||
146294462|NCT01794520|527594065|FG000|Overall Study|Lost to Follow-up|0|||
146294463|NCT01794520|527594066|FG001|Overall Study|Lost to Follow-up|0|||
146294464|NCT01794520|527594067|FG002|Overall Study|Lost to Follow-up|0|||
146294465|NCT01794520|527594068|FG003|Overall Study|Lost to Follow-up|0|||
146294466|NCT01794520|527594069|FG004|Overall Study|Lost to Follow-up|1|||
146294467|NCT01794520|527594070|FG005|Overall Study|Lost to Follow-up|0|||
146294468|NCT01794520|527594071|FG006|Overall Study|Lost to Follow-up|0|||
146294469|NCT01794520|527594065|FG000|Overall Study|Toxicity|0|||
146294470|NCT01794520|527594066|FG001|Overall Study|Toxicity|2|||
146294471|NCT01794520|527594067|FG002|Overall Study|Toxicity|0|||
146294472|NCT01794520|527594068|FG003|Overall Study|Toxicity|0|||
146294473|NCT01794520|527594069|FG004|Overall Study|Toxicity|0|||
146294474|NCT01794520|527594070|FG005|Overall Study|Toxicity|0|||
146294475|NCT01794520|527594071|FG006|Overall Study|Toxicity|0|||
146294476|NCT01794520|527594065|FG000|Overall Study|Study terminated by sponsor|0|||
146294477|NCT01794520|527594066|FG001|Overall Study|Study terminated by sponsor|0|||
146294478|NCT01794520|527594067|FG002|Overall Study|Study terminated by sponsor|1|||
146294479|NCT01794520|527594068|FG003|Overall Study|Study terminated by sponsor|0|||
146294480|NCT01794520|527594069|FG004|Overall Study|Study terminated by sponsor|1|||
146294481|NCT01794520|527594070|FG005|Overall Study|Study terminated by sponsor|0|||
146294482|NCT01794520|527594071|FG006|Overall Study|Study terminated by sponsor|7|||
146294483|NCT01794520|527594065|FG000|Overall Study|Death|0|||
146294484|NCT01794520|527594066|FG001|Overall Study|Death|0|||
146294485|NCT01794520|527594067|FG002|Overall Study|Death|0|||
146294486|NCT01794520|527594068|FG003|Overall Study|Death|0|||
146294487|NCT01794520|527594069|FG004|Overall Study|Death|1|||
146294488|NCT01794520|527594070|FG005|Overall Study|Death|0|||
146294489|NCT01794520|527594071|FG006|Overall Study|Death|22|||
146294490|NCT01794520|527594065|FG000|Overall Study|Other, not specified|0|||
146294491|NCT01794520|527594066|FG001|Overall Study|Other, not specified|0|||
146294492|NCT01794520|527594067|FG002|Overall Study|Other, not specified|1|||
146294493|NCT01794520|527594068|FG003|Overall Study|Other, not specified|1|||
146294494|NCT01794520|527594069|FG004|Overall Study|Other, not specified|4|||
146294495|NCT01794520|527594070|FG005|Overall Study|Other, not specified|1|||
146294496|NCT01794520|527594071|FG006|Overall Study|Other, not specified|2|||
146294497|NCT03291587|527594077|FG000|Overall Study|Lost to Follow-up|62|||
146294498|NCT03291587|527594078|FG001|Overall Study|Lost to Follow-up|43|||
146294499|NCT03291587|527594077|FG000|Overall Study|Refused to Answer|5|||
146294500|NCT03291587|527594078|FG001|Overall Study|Refused to Answer|2|||
146294501|NCT03291587|527594077|FG000|Overall Study|Death|2|||
146294502|NCT03291587|527594078|FG001|Overall Study|Death|4|||
146294503|NCT03291587|527594077|FG000|Overall Study|Not interested in participating|8|||
146294504|NCT03291587|527594078|FG001|Overall Study|Not interested in participating|6|||
146294505|NCT03291587|527594077|FG000|Overall Study|Too busy to participate|4|||
146294506|NCT03291587|527594078|FG001|Overall Study|Too busy to participate|2|||
146294507|NCT00796120|527594079|FG000|Overall Study|Death|3|||
146294508|NCT00796120|527594080|FG001|Overall Study|Death|0|||
146294509|NCT00796120|527594079|FG000|Overall Study|Adverse Event|11|||
146294510|NCT00796120|527594080|FG001|Overall Study|Adverse Event|6|||
146294511|NCT00796120|527594079|FG000|Overall Study|Progressive disease|22|||
146294512|NCT00796120|527594080|FG001|Overall Study|Progressive disease|13|||
146294513|NCT00796120|527594079|FG000|Overall Study|Participant refusal|3|||
146294514|NCT00796120|527594080|FG001|Overall Study|Participant refusal|4|||
146294515|NCT00796120|527594079|FG000|Overall Study|Other|6|||
146294516|NCT00796120|527594080|FG001|Overall Study|Other|17|||
146294517|NCT00796120|527594079|FG000|Overall Study|Physician Decision|16|||
146294518|NCT00796120|527594080|FG001|Overall Study|Physician Decision|17|||
146294519|NCT00796120|527594079|FG000|Overall Study|Randomized but not treated|0|||
146294520|NCT00796120|527594080|FG001|Overall Study|Randomized but not treated|3|||
146294521|NCT03737474|527594084|FG000|Overall Study|Adverse Event|18|||
146294522|NCT03737474|527594085|FG001|Overall Study|Adverse Event|48|||
146294523|NCT03737474|527594084|FG000|Overall Study|Lack of Efficacy|1|||
146294524|NCT03737474|527594085|FG001|Overall Study|Lack of Efficacy|3|||
146294525|NCT03737474|527594084|FG000|Overall Study|Protocol Violation|0|||
146294526|NCT03737474|527594085|FG001|Overall Study|Protocol Violation|8|||
146294527|NCT03737474|527594084|FG000|Overall Study|Withdrawal by Subject|5|||
146294528|NCT03737474|527594085|FG001|Overall Study|Withdrawal by Subject|20|||
146294529|NCT03737474|527594084|FG000|Overall Study|Non-compliance With Study Drug|0|||
146294530|NCT03737474|527594085|FG001|Overall Study|Non-compliance With Study Drug|1|||
146294531|NCT03737474|527594084|FG000|Overall Study|Physician Decision|1|||
146294532|NCT03737474|527594085|FG001|Overall Study|Physician Decision|4|||
146294533|NCT02513745|527594088|FG000|Overall Study|Criteria at time of surgery not met.|3|||
146294534|NCT02513745|527594089|FG001|Overall Study|Criteria at time of surgery not met.|3|||
146294535|NCT01209143|527594090|FG000|Overall Study|Adverse Event|2|||
146294536|NCT01209143|527594091|FG001|Overall Study|Adverse Event|1|||
146294537|NCT01209143|527594090|FG000|Overall Study|Death|0|||
146294538|NCT01209143|527594091|FG001|Overall Study|Death|1|||
146294539|NCT01209143|527594090|FG000|Overall Study|Physician Decision|3|||
146294540|NCT01209143|527594091|FG001|Overall Study|Physician Decision|1|||
146294541|NCT01209143|527594090|FG000|Overall Study|Lost to Follow-up|1|||
146294542|NCT01209143|527594091|FG001|Overall Study|Lost to Follow-up|0|||
146294543|NCT01209143|527594090|FG000|Overall Study|Withdrawal by Subject|2|||
146294544|NCT01209143|527594091|FG001|Overall Study|Withdrawal by Subject|1|||
146294545|NCT01209143|527594090|FG000|Overall Study|Disease progression|11|||
146294546|NCT01209143|527594091|FG001|Overall Study|Disease progression|16|||
146294547|NCT00381303|527594094|FG000|Overall Study|Lost to Follow-up|25|||
146294548|NCT00381303|527594095|FG001|Overall Study|Lost to Follow-up|9|||
146294549|NCT00381303|527594094|FG000|Overall Study|AE/HIV-related event|22|||
146294550|NCT00381303|527594095|FG001|Overall Study|AE/HIV-related event|6|||
146087793|NCT04626310|526841847|FG000|Overall Study|4-miss from treatment|6|||
146087794|NCT04626310|526841848|FG001|Overall Study|4-miss from treatment|5|||
146087795|NCT04626310|526841849|FG002|Overall Study|4-miss from treatment|5|||
146087796|NCT04626310|526841847|FG000|Overall Study|Withdrawal by Subject|1|||
146087797|NCT04626310|526841848|FG001|Overall Study|Withdrawal by Subject|0|||
146087798|NCT04626310|526841849|FG002|Overall Study|Withdrawal by Subject|3|||
146087799|NCT02278341|526841850|FG000|Overall Study|Randomized but never received study drug|1|||
146087800|NCT02278341|526841851|FG001|Overall Study|Randomized but never received study drug|1|||
146087801|NCT02278341|526841850|FG000|Overall Study|Adverse Event|3|||
146087802|NCT02278341|526841851|FG001|Overall Study|Adverse Event|0|||
146087803|NCT02278341|526841850|FG000|Overall Study|Death|68|||
146087804|NCT02278341|526841851|FG001|Overall Study|Death|56|||
146087805|NCT02278341|526841850|FG000|Overall Study|Withdrawal by Subject|30|||
146087806|NCT02278341|526841851|FG001|Overall Study|Withdrawal by Subject|19|||
146087807|NCT02278341|526841850|FG000|Overall Study|Lost to Follow-up|0|||
146087808|NCT02278341|526841851|FG001|Overall Study|Lost to Follow-up|1|||
146087809|NCT02278341|526841850|FG000|Overall Study|Physician Decision|1|||
146294551|NCT00381303|527594094|FG000|Overall Study|Non-Adherence|13|||
146294552|NCT00381303|527594095|FG001|Overall Study|Non-Adherence|6|||
146294553|NCT00381303|527594094|FG000|Overall Study|Withdrawal by Subject|13|||
146294554|NCT00381303|527594095|FG001|Overall Study|Withdrawal by Subject|6|||
146294555|NCT00381303|527594094|FG000|Overall Study|Virologic failure|6|||
146294556|NCT00381303|527594095|FG001|Overall Study|Virologic failure|4|||
146294557|NCT00381303|527594094|FG000|Overall Study|Ineligible to continue the trial|2|||
146294558|NCT00381303|527594095|FG001|Overall Study|Ineligible to continue the trial|1|||
146294559|NCT00381303|527594094|FG000|Overall Study|Pregnancy|2|||
146294560|NCT00381303|527594095|FG001|Overall Study|Pregnancy|0|||
146294561|NCT00381303|527594094|FG000|Overall Study|Physician Decision|1|||
146294562|NCT00381303|527594095|FG001|Overall Study|Physician Decision|0|||
146294563|NCT00381303|527594094|FG000|Overall Study|Physician's decision to close the site|3|||
146294564|NCT00381303|527594095|FG001|Overall Study|Physician's decision to close the site|1|||
146294565|NCT00381303|527594094|FG000|Overall Study|Subject moved out of state|2|||
146294566|NCT00381303|527594095|FG001|Overall Study|Subject moved out of state|0|||
146294567|NCT00381303|527594094|FG000|Overall Study|Subject taking too many different meds|1|||
146294568|NCT00381303|527594095|FG001|Overall Study|Subject taking too many different meds|0|||
146294569|NCT00381303|527594094|FG000|Overall Study|No virologic response by week 12|1|||
146294570|NCT00381303|527594095|FG001|Overall Study|No virologic response by week 12|0|||
146294571|NCT00381303|527594094|FG000|Overall Study|Subject was too busy for appointments|1|||
146294572|NCT00381303|527594095|FG001|Overall Study|Subject was too busy for appointments|0|||
146294573|NCT00381303|527594094|FG000|Overall Study|Subject did not continue visits|1|||
146294574|NCT00381303|527594095|FG001|Overall Study|Subject did not continue visits|0|||
146294575|NCT00381303|527594094|FG000|Overall Study|Subject primary physician's decision|1|||
146294576|NCT00381303|527594095|FG001|Overall Study|Subject primary physician's decision|0|||
146294577|NCT01211522|527594096|FG000|Overall Study|Withdrawal by Subject|3|||
146294578|NCT01211522|527594097|FG001|Overall Study|Withdrawal by Subject|7|||
146294579|NCT01211522|527594098|FG002|Overall Study|Withdrawal by Subject|5|||
146294580|NCT01145755|527594100|FG000|Overall Study|Adverse Event|2|||
146294581|NCT01145755|527594101|FG001|Overall Study|Adverse Event|4|||
146294582|NCT01145755|527594102|FG002|Overall Study|Adverse Event|2|||
146294583|NCT01145755|527594100|FG000|Overall Study|Withdrawal by Subject|2|||
146294584|NCT01145755|527594101|FG001|Overall Study|Withdrawal by Subject|2|||
146294585|NCT01145755|527594102|FG002|Overall Study|Withdrawal by Subject|2|||
146294586|NCT01145755|527594100|FG000|Overall Study|Lost to Follow-up|2|||
146294587|NCT01145755|527594101|FG001|Overall Study|Lost to Follow-up|3|||
146294588|NCT01145755|527594102|FG002|Overall Study|Lost to Follow-up|1|||
146294589|NCT01145755|527594100|FG000|Overall Study|Protocol Violation|0|||
146294590|NCT01145755|527594101|FG001|Overall Study|Protocol Violation|3|||
146294591|NCT01145755|527594102|FG002|Overall Study|Protocol Violation|1|||
146294592|NCT01145755|527594100|FG000|Overall Study|Study Closure|14|||
146294593|NCT01145755|527594101|FG001|Overall Study|Study Closure|14|||
146294594|NCT01145755|527594102|FG002|Overall Study|Study Closure|17|||
146294595|NCT01145755|527594100|FG000|Overall Study|Lack of Efficacy|0|||
146294596|NCT01145755|527594101|FG001|Overall Study|Lack of Efficacy|1|||
146294597|NCT01145755|527594102|FG002|Overall Study|Lack of Efficacy|0|||
146294598|NCT01145755|527594100|FG000|Overall Study|Patient could not swollow medication|0|||
146294599|NCT01145755|527594101|FG001|Overall Study|Patient could not swollow medication|0|||
146294600|NCT01145755|527594102|FG002|Overall Study|Patient could not swollow medication|1|||
146294601|NCT01145755|527594100|FG000|Overall Study|Withdrawal by Subject|0|||
146294602|NCT01145755|527594101|FG001|Overall Study|Withdrawal by Subject|0|||
146294603|NCT01145755|527594102|FG002|Overall Study|Withdrawal by Subject|1|||
146294604|NCT01145755|527594100|FG000|Overall Study|Positive urine ethanol|0|||
146294605|NCT01145755|527594101|FG001|Overall Study|Positive urine ethanol|1|||
146294606|NCT01145755|527594102|FG002|Overall Study|Positive urine ethanol|0|||
146294607|NCT01116882|527594108|FG000|30-day|Lost to Follow-up|50|||
146294608|NCT01116882|527594109|FG001|30-day|Lost to Follow-up|21|||
146294609|NCT01116882|527594108|FG000|30-day|Withdrawal by Subject|2|||
146294610|NCT01116882|527594109|FG001|30-day|Withdrawal by Subject|4|||
146294611|NCT01116882|527594108|FG000|30-day|Other Reasons|16|||
146294612|NCT01116882|527594109|FG001|30-day|Other Reasons|6|||
146294613|NCT01116882|527594108|FG000|12-month|Lost to Follow-up|111|||
146294614|NCT01116882|527594109|FG001|12-month|Lost to Follow-up|42|||
146294615|NCT01116882|527594108|FG000|12-month|Other Reasons|151|||
146294616|NCT01116882|527594109|FG001|12-month|Other Reasons|49|||
146294617|NCT01116882|527594108|FG000|12-month|Withdrawal by Subject|5|||
146294618|NCT01116882|527594109|FG001|12-month|Withdrawal by Subject|8|||
146294619|NCT00547365|527594110|FG000|Overall Study|Physician Decision|1|||
146294620|NCT00547365|527594110|FG000|Overall Study|Lost to Follow-up|1|||
146294621|NCT00547365|527594110|FG000|Overall Study|Protocol Violation|2|||
146294622|NCT00547365|527594110|FG000|Overall Study|death (not related to study)|4|||
146294623|NCT01777269|527594113|FG000|Overall Study|Adverse Event|24|||
146294624|NCT01777269|527594114|FG001|Overall Study|Adverse Event|33|||
146294625|NCT01777269|527594113|FG000|Overall Study|Lack of Efficacy|8|||
146294626|NCT01777269|527594114|FG001|Overall Study|Lack of Efficacy|10|||
146294627|NCT01777269|527594113|FG000|Overall Study|Protocol Violation|4|||
146294628|NCT01777269|527594114|FG001|Overall Study|Protocol Violation|4|||
146294629|NCT01777269|527594113|FG000|Overall Study|Participants reached stopping criteria|1|||
146294630|NCT01777269|527594114|FG001|Overall Study|Participants reached stopping criteria|1|||
146294631|NCT01777269|527594113|FG000|Overall Study|Lost to Follow-up|4|||
146294632|NCT01777269|527594114|FG001|Overall Study|Lost to Follow-up|0|||
146294633|NCT01777269|527594113|FG000|Overall Study|Physician Decision|5|||
146294634|NCT01777269|527594114|FG001|Overall Study|Physician Decision|2|||
146294635|NCT01777269|527594113|FG000|Overall Study|Withdrawal by Subject|9|||
146294636|NCT01777269|527594114|FG001|Overall Study|Withdrawal by Subject|9|||
146294637|NCT00504881|527594115|FG000|Overall Study|Lack of Efficacy|1|||
146294638|NCT00504881|527594116|FG001|Overall Study|Lack of Efficacy|5|||
146294639|NCT00504881|527594115|FG000|Overall Study|Lost to Follow-up|0|||
146294640|NCT00504881|527594116|FG001|Overall Study|Lost to Follow-up|2|||
146294641|NCT00504881|527594115|FG000|Overall Study|Withdrawal by Subject|1|||
146294642|NCT00504881|527594116|FG001|Overall Study|Withdrawal by Subject|4|||
146294643|NCT00504881|527594115|FG000|Overall Study|Non-Compliance|1|||
146294644|NCT00504881|527594116|FG001|Overall Study|Non-Compliance|0|||
146294645|NCT00504881|527594115|FG000|Overall Study|No Birth Control|0|||
146294646|NCT00504881|527594116|FG001|Overall Study|No Birth Control|1|||
146294647|NCT00504881|527594115|FG000|Overall Study|Safety Visit not performed|0|||
146294648|NCT00504881|527594116|FG001|Overall Study|Safety Visit not performed|1|||
146294649|NCT00504881|527594115|FG000|Overall Study|AE, serious fatal|0|||
146294650|NCT00504881|527594116|FG001|Overall Study|AE, serious fatal|1|||
146294651|NCT00504881|527594115|FG000|Overall Study|SAE, non-fatal|2|||
146294652|NCT00504881|527594116|FG001|Overall Study|SAE, non-fatal|6|||
146294653|NCT00504881|527594115|FG000|Overall Study|AE, non-serious non-fatal|4|||
146294654|NCT00504881|527594116|FG001|Overall Study|AE, non-serious non-fatal|14|||
146294655|NCT00504881|527594115|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146294656|NCT00504881|527594116|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
146294657|NCT00504881|527594115|FG000|Overall Study|AE of unknown type|1|||
146294658|NCT00504881|527594116|FG001|Overall Study|AE of unknown type|0|||
146294659|NCT00753272|527594124|FG000|Overall Study|Adverse Event|878|||
146294660|NCT00753272|527594125|FG001|Overall Study|Adverse Event|869|||
146294661|NCT00753272|527594124|FG000|Overall Study|Protocol Violation|28|||
146294662|NCT00753272|527594125|FG001|Overall Study|Protocol Violation|46|||
146294663|NCT00753272|527594124|FG000|Overall Study|Withdrawal by Subject|2481|||
146294664|NCT00753272|527594125|FG001|Overall Study|Withdrawal by Subject|2407|||
146294665|NCT00753272|527594124|FG000|Overall Study|Lost to Follow-up|491|||
146294666|NCT00753272|527594125|FG001|Overall Study|Lost to Follow-up|497|||
146294667|NCT00753272|527594124|FG000|Overall Study|Other|1104|||
146294668|NCT00753272|527594125|FG001|Overall Study|Other|1088|||
146294669|NCT00971243|527594126|FG000|Double Blind Period|Adverse Event|2|||
146294670|NCT00971243|527594127|FG001|Double Blind Period|Adverse Event|3|||
146294671|NCT00971243|527594128|FG002|Double Blind Period|Adverse Event|2|||
146294672|NCT00971243|527594129|FG003|Double Blind Period|Adverse Event|2|||
146294673|NCT00971243|527594130|FG004|Double Blind Period|Adverse Event|3|||
146294674|NCT00971243|527594126|FG000|Double Blind Period|Lost to Follow-up|0|||
146294675|NCT00971243|527594127|FG001|Double Blind Period|Lost to Follow-up|1|||
146294676|NCT00971243|527594128|FG002|Double Blind Period|Lost to Follow-up|1|||
146294677|NCT00971243|527594129|FG003|Double Blind Period|Lost to Follow-up|0|||
146294678|NCT00971243|527594130|FG004|Double Blind Period|Lost to Follow-up|1|||
146294679|NCT00971243|527594126|FG000|Double Blind Period|Physician Decision|10|||
146294680|NCT00971243|527594127|FG001|Double Blind Period|Physician Decision|6|||
146294681|NCT00971243|527594128|FG002|Double Blind Period|Physician Decision|7|||
146294682|NCT00971243|527594129|FG003|Double Blind Period|Physician Decision|6|||
146294683|NCT00971243|527594130|FG004|Double Blind Period|Physician Decision|7|||
146294684|NCT00971243|527594126|FG000|Double Blind Period|Protocol Violation|2|||
146294685|NCT00971243|527594127|FG001|Double Blind Period|Protocol Violation|0|||
146294686|NCT00971243|527594128|FG002|Double Blind Period|Protocol Violation|3|||
146294687|NCT00971243|527594129|FG003|Double Blind Period|Protocol Violation|2|||
146294688|NCT00971243|527594130|FG004|Double Blind Period|Protocol Violation|2|||
146294689|NCT00971243|527594126|FG000|Double Blind Period|Withdrawal by Subject|4|||
146294690|NCT00971243|527594127|FG001|Double Blind Period|Withdrawal by Subject|1|||
146294691|NCT00971243|527594128|FG002|Double Blind Period|Withdrawal by Subject|4|||
146294692|NCT00971243|527594129|FG003|Double Blind Period|Withdrawal by Subject|4|||
146294693|NCT00971243|527594130|FG004|Double Blind Period|Withdrawal by Subject|4|||
146294694|NCT00971243|527594126|FG000|Double Blind Period|Other reasons|1|||
146294695|NCT00971243|527594127|FG001|Double Blind Period|Other reasons|0|||
146294696|NCT00971243|527594128|FG002|Double Blind Period|Other reasons|2|||
146294697|NCT00971243|527594129|FG003|Double Blind Period|Other reasons|0|||
146294698|NCT00971243|527594130|FG004|Double Blind Period|Other reasons|1|||
146294699|NCT00971243|527594126|FG000|Open-label Period|Adverse Event|1|||
146294700|NCT00971243|527594127|FG001|Open-label Period|Adverse Event|0|||
146294701|NCT00971243|527594128|FG002|Open-label Period|Adverse Event|1|||
146294702|NCT00971243|527594129|FG003|Open-label Period|Adverse Event|1|||
145890990|NCT01287039|526107589|FG000|Overall Study|Change of location/residence|0|||
145890991|NCT01287039|526107590|FG001|Overall Study|Change of location/residence|3|||
146294703|NCT00971243|527594130|FG004|Open-label Period|Adverse Event|0|||
146294704|NCT00971243|527594126|FG000|Open-label Period|Physician Decision|5|||
146087810|NCT02278341|526841851|FG001|Overall Study|Physician Decision|1|||
146294705|NCT00971243|527594127|FG001|Open-label Period|Physician Decision|9|||
146294706|NCT00971243|527594128|FG002|Open-label Period|Physician Decision|3|||
146294707|NCT00971243|527594129|FG003|Open-label Period|Physician Decision|7|||
146294708|NCT00971243|527594130|FG004|Open-label Period|Physician Decision|2|||
146294709|NCT00971243|527594126|FG000|Open-label Period|Protocol Violation|1|||
146294710|NCT00971243|527594127|FG001|Open-label Period|Protocol Violation|1|||
146294711|NCT00971243|527594128|FG002|Open-label Period|Protocol Violation|1|||
145890992|NCT01287039|526107589|FG000|Overall Study|Elective surgery|0|||
145890993|NCT01287039|526107590|FG001|Overall Study|Elective surgery|1|||
145890994|NCT01287039|526107589|FG000|Overall Study|Protocol Violation|2|||
145890995|NCT01287039|526107590|FG001|Overall Study|Protocol Violation|3|||
145890996|NCT01287039|526107589|FG000|Overall Study|Excluded medication taken|1|||
145890997|NCT01287039|526107590|FG001|Overall Study|Excluded medication taken|0|||
145890998|NCT01287039|526107589|FG000|Overall Study|Noncompliance with study medication|0|||
145890999|NCT01287039|526107590|FG001|Overall Study|Noncompliance with study medication|1|||
145891000|NCT01287039|526107589|FG000|Overall Study|Problem with travel|0|||
145891001|NCT01287039|526107590|FG001|Overall Study|Problem with travel|1|||
145891002|NCT01287039|526107589|FG000|Overall Study|Death|1|||
145891003|NCT01287039|526107590|FG001|Overall Study|Death|0|||
145891004|NCT01287039|526107589|FG000|Overall Study|Change of residence|1|||
145970796|NCT01983930|526407273|FG000|Overall Study|Withdrawal by Subject|9|||
145970797|NCT01983930|526407274|FG001|Overall Study|Withdrawal by Subject|8|||
145970798|NCT01983930|526407273|FG000|Overall Study|Adverse Event|0|||
145970799|NCT01983930|526407274|FG001|Overall Study|Adverse Event|1|||
145970800|NCT00656617|526407275|FG000|Overall Study|Adverse Event|1|||
145970801|NCT00656617|526407275|FG000|Overall Study|Death|2|||
145970802|NCT00656617|526407275|FG000|Overall Study|Insurance Issues|2|||
145970803|NCT00656617|526407275|FG000|Overall Study|Move to different clinical trial|2|||
145970804|NCT00091819|526407276|FG000|Overall Study|Adverse Event|1|||
145970805|NCT00091819|526407277|FG001|Overall Study|Adverse Event|1|||
145970806|NCT00091819|526407276|FG000|Overall Study|Death|4|||
145970807|NCT00091819|526407277|FG001|Overall Study|Death|5|||
145970808|NCT00091819|526407276|FG000|Overall Study|Lost to Follow-up|26|||
145970809|NCT00091819|526407277|FG001|Overall Study|Lost to Follow-up|23|||
145970810|NCT00091819|526407276|FG000|Overall Study|Withdrawal by Subject|5|||
145970811|NCT00091819|526407277|FG001|Overall Study|Withdrawal by Subject|8|||
145970812|NCT00091819|526407276|FG000|Overall Study|Protocol Violation|1|||
145970813|NCT00091819|526407277|FG001|Overall Study|Protocol Violation|2|||
145970814|NCT00091819|526407276|FG000|Overall Study|Other|2|||
145970815|NCT00091819|526407277|FG001|Overall Study|Other|3|||
145970816|NCT00091819|526407276|FG000|Overall Study|Never received study treatment|3|||
145970817|NCT00091819|526407277|FG001|Overall Study|Never received study treatment|4|||
145970818|NCT05001620|526407278|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
145970819|NCT05001620|526407279|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
145970820|NCT02736617|526407280|FG000|Treatment|Adverse Event|1|||
145970821|NCT02736617|526407280|FG000|Treatment|Lack of Efficacy|1|||
146235081|NCT00622700|527378450|FG003|Extension Treatment Period|Protocol Violation|0|||
146235082|NCT00622700|527378451|FG004|Extension Treatment Period|Protocol Violation|0|||
146235083|NCT00622700|527378452|FG005|Extension Treatment Period|Protocol Violation|2|||
146235084|NCT00622700|527378453|FG006|Extension Treatment Period|Protocol Violation|0|||
146235085|NCT00622700|527378447|FG000|Extension Treatment Period|Lost to Follow-up|0|||
146235086|NCT00622700|527378448|FG001|Extension Treatment Period|Lost to Follow-up|0|||
146235087|NCT00622700|527378449|FG002|Extension Treatment Period|Lost to Follow-up|0|||
146235088|NCT00622700|527378450|FG003|Extension Treatment Period|Lost to Follow-up|0|||
146235089|NCT00622700|527378451|FG004|Extension Treatment Period|Lost to Follow-up|1|||
146235090|NCT00622700|527378452|FG005|Extension Treatment Period|Lost to Follow-up|0|||
146235091|NCT00622700|527378453|FG006|Extension Treatment Period|Lost to Follow-up|0|||
146235092|NCT00622700|527378447|FG000|Extension Treatment Period|Progressive Disease|0|||
146235093|NCT00622700|527378448|FG001|Extension Treatment Period|Progressive Disease|0|||
146235094|NCT00622700|527378449|FG002|Extension Treatment Period|Progressive Disease|0|||
146235095|NCT00622700|527378450|FG003|Extension Treatment Period|Progressive Disease|1|||
146235096|NCT00622700|527378451|FG004|Extension Treatment Period|Progressive Disease|2|||
146235097|NCT00622700|527378452|FG005|Extension Treatment Period|Progressive Disease|0|||
146235098|NCT00622700|527378453|FG006|Extension Treatment Period|Progressive Disease|2|||
146235099|NCT00622700|527378447|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146235100|NCT00622700|527378448|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146235101|NCT00622700|527378449|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146235102|NCT00622700|527378450|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
146235103|NCT00622700|527378451|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
146235104|NCT00622700|527378452|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
145970822|NCT02736617|526407280|FG000|Treatment|Withdrawal by Subject|1|||
145970823|NCT02736617|526407280|FG000|Maintenance|Lack of Efficacy|4|||
145891005|NCT01287039|526107590|FG001|Overall Study|Change of residence|0|||
145891006|NCT01287039|526107589|FG000|Overall Study|Adverse Event|7|||
145891007|NCT01287039|526107590|FG001|Overall Study|Adverse Event|4|||
145970824|NCT02736617|526407280|FG000|Maintenance|Physician Decision|1|||
145970825|NCT00481676|526407283|FG000|Overall Study|Adverse Event|0|||
145970826|NCT00481676|526407284|FG001|Overall Study|Adverse Event|1|||
145970827|NCT00481676|526407283|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145970828|NCT00481676|526407284|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146235105|NCT00622700|527378453|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
146235106|NCT00622700|527378447|FG000|Extension Treatment Period|Missing|0|||
146294712|NCT00971243|527594129|FG003|Open-label Period|Protocol Violation|0|||
146294713|NCT00971243|527594130|FG004|Open-label Period|Protocol Violation|1|||
146294714|NCT00971243|527594126|FG000|Open-label Period|Withdrawal by Subject|1|||
146294715|NCT00971243|527594127|FG001|Open-label Period|Withdrawal by Subject|0|||
146294716|NCT00971243|527594128|FG002|Open-label Period|Withdrawal by Subject|0|||
146294717|NCT00971243|527594129|FG003|Open-label Period|Withdrawal by Subject|2|||
146294718|NCT00971243|527594130|FG004|Open-label Period|Withdrawal by Subject|1|||
146294719|NCT00971243|527594126|FG000|Open-label Period|Other reason|0|||
146294720|NCT00971243|527594127|FG001|Open-label Period|Other reason|0|||
146294721|NCT00971243|527594128|FG002|Open-label Period|Other reason|0|||
146294722|NCT00971243|527594129|FG003|Open-label Period|Other reason|0|||
146294723|NCT00971243|527594130|FG004|Open-label Period|Other reason|2|||
146294724|NCT00803270|527594131|FG000|Overall Study|Lost to Follow-up|1|||
146294725|NCT00803270|527594132|FG001|Overall Study|Lost to Follow-up|2|||
146294726|NCT01966471|527594135|FG000|Overall Study|Death|44|||
145891008|NCT01287039|526107589|FG000|Overall Study|Withdrawal by Subject|14|||
145891009|NCT01287039|526107590|FG001|Overall Study|Withdrawal by Subject|11|||
145891010|NCT01287039|526107589|FG000|Overall Study|Lost to Follow-up|3|||
145891011|NCT01287039|526107590|FG001|Overall Study|Lost to Follow-up|2|||
145891012|NCT04109313|526107591|FG000|Overall Study|Pregnancy|1|||
145891013|NCT04109313|526107591|FG000|Overall Study|Adverse Event|11|||
145891014|NCT04109313|526107591|FG000|Overall Study|Lack of Efficacy|11|||
145891015|NCT04109313|526107591|FG000|Overall Study|Lost to Follow-up|1|||
145891016|NCT04109313|526107591|FG000|Overall Study|Physician Decision|2|||
145891017|NCT04109313|526107591|FG000|Overall Study|Subject Decision|13|||
146294727|NCT01966471|527594136|FG001|Overall Study|Death|56|||
146294728|NCT01966471|527594135|FG000|Overall Study|Lost to Follow-up|46|||
146294729|NCT01966471|527594136|FG001|Overall Study|Lost to Follow-up|39|||
145891018|NCT04109313|526107591|FG000|Overall Study|Covid-19 situation|2|||
145891019|NCT01272921|526107592|FG000|Overall Study|Protocol Violation|2|||
145891020|NCT01272921|526107593|FG001|Overall Study|Protocol Violation|1|||
145891021|NCT01132664|526107594|FG000|Phase lb|Adverse Event|0|||
146294730|NCT01966471|527594135|FG000|Overall Study|Various reasons|4|||
145891022|NCT01132664|526107595|FG001|Phase lb|Adverse Event|1|||
145891023|NCT01132664|526107596|FG002|Phase lb|Adverse Event|0|||
145891024|NCT01132664|526107597|FG003|Phase lb|Adverse Event|0|||
145891025|NCT01132664|526107598|FG004|Phase lb|Adverse Event|0|||
145891026|NCT01132664|526107594|FG000|Phase lb|Withdrawal by Subject|1|||
145891027|NCT01132664|526107595|FG001|Phase lb|Withdrawal by Subject|2|||
145891028|NCT01132664|526107596|FG002|Phase lb|Withdrawal by Subject|0|||
145891029|NCT01132664|526107597|FG003|Phase lb|Withdrawal by Subject|0|||
145891030|NCT01132664|526107598|FG004|Phase lb|Withdrawal by Subject|0|||
145891031|NCT01132664|526107594|FG000|Phase lb|Disease Progression|4|||
145891032|NCT01132664|526107595|FG001|Phase lb|Disease Progression|9|||
145891033|NCT01132664|526107596|FG002|Phase lb|Disease Progression|0|||
145891034|NCT01132664|526107597|FG003|Phase lb|Disease Progression|0|||
145891035|NCT01132664|526107598|FG004|Phase lb|Disease Progression|0|||
145891036|NCT01132664|526107594|FG000|Phase ll|Death|0|||
145891037|NCT01132664|526107595|FG001|Phase ll|Death|0|||
145891038|NCT01132664|526107596|FG002|Phase ll|Death|2|||
145891039|NCT01132664|526107597|FG003|Phase ll|Death|0|||
145891040|NCT01132664|526107598|FG004|Phase ll|Death|0|||
145891041|NCT01132664|526107594|FG000|Phase ll|Adverse Event|0|||
145891042|NCT01132664|526107595|FG001|Phase ll|Adverse Event|0|||
145891043|NCT01132664|526107596|FG002|Phase ll|Adverse Event|10|||
145891044|NCT01132664|526107597|FG003|Phase ll|Adverse Event|0|||
145891045|NCT01132664|526107598|FG004|Phase ll|Adverse Event|0|||
145891046|NCT01132664|526107594|FG000|Phase ll|Withdrawal by Subject|0|||
145891047|NCT01132664|526107595|FG001|Phase ll|Withdrawal by Subject|0|||
145891048|NCT01132664|526107596|FG002|Phase ll|Withdrawal by Subject|3|||
145891049|NCT01132664|526107597|FG003|Phase ll|Withdrawal by Subject|0|||
145891050|NCT01132664|526107598|FG004|Phase ll|Withdrawal by Subject|0|||
145891051|NCT01132664|526107594|FG000|Phase ll|Disease progression|0|||
145891052|NCT01132664|526107595|FG001|Phase ll|Disease progression|0|||
145891053|NCT01132664|526107596|FG002|Phase ll|Disease progression|35|||
145891054|NCT01132664|526107597|FG003|Phase ll|Disease progression|0|||
145891055|NCT01132664|526107598|FG004|Phase ll|Disease progression|0|||
145891056|NCT01132664|526107594|FG000|BM Cohort|Disease progression|0|||
145891057|NCT01132664|526107595|FG001|BM Cohort|Disease progression|0|||
145891058|NCT01132664|526107596|FG002|BM Cohort|Disease progression|0|||
145891059|NCT01132664|526107597|FG003|BM Cohort|Disease progression|3|||
146087811|NCT02278341|526841850|FG000|Overall Study|Miscellaneous|15|||
145891060|NCT01132664|526107598|FG004|BM Cohort|Disease progression|4|||
145891061|NCT01132664|526107594|FG000|BM Cohort|Adverse Event|0|||
145891062|NCT01132664|526107595|FG001|BM Cohort|Adverse Event|0|||
145891063|NCT01132664|526107596|FG002|BM Cohort|Adverse Event|0|||
145891064|NCT01132664|526107597|FG003|BM Cohort|Adverse Event|0|||
145891065|NCT01132664|526107598|FG004|BM Cohort|Adverse Event|1|||
145891066|NCT01132664|526107594|FG000|BM Cohort|Withdrawal by Subject|0|||
145891067|NCT01132664|526107595|FG001|BM Cohort|Withdrawal by Subject|0|||
145891068|NCT01132664|526107596|FG002|BM Cohort|Withdrawal by Subject|0|||
145891069|NCT01132664|526107597|FG003|BM Cohort|Withdrawal by Subject|0|||
146294731|NCT01966471|527594136|FG001|Overall Study|Various reasons|4|||
146294732|NCT01966471|527594135|FG000|Overall Study|Physician Decision|7|||
146294733|NCT01966471|527594136|FG001|Overall Study|Physician Decision|5|||
146294734|NCT01966471|527594135|FG000|Overall Study|Study Terminated By Sponsor|758|||
146294735|NCT01966471|527594136|FG001|Overall Study|Study Terminated By Sponsor|773|||
146294736|NCT01966471|527594135|FG000|Overall Study|Withdrawal by Subject|59|||
146294737|NCT01966471|527594136|FG001|Overall Study|Withdrawal by Subject|51|||
146294738|NCT02092220|527594138|FG000|Period 1|Unrelated Illness|0|||
146294739|NCT02092220|527594139|FG001|Period 1|Unrelated Illness|2|||
146294740|NCT02092220|527594138|FG000|Period 2|Severe Hypoglycaemia|1|||
146294741|NCT02092220|527594139|FG001|Period 2|Severe Hypoglycaemia|0|||
146294742|NCT02092220|527594138|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
146294743|NCT02092220|527594139|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
146294744|NCT00960531|527594140|FG000|Overall Study|Lack of Efficacy|1|||
146294745|NCT00960531|527594141|FG001|Overall Study|Lack of Efficacy|0|||
146294746|NCT00960531|527594142|FG002|Overall Study|Lack of Efficacy|0|||
146294747|NCT00960531|527594143|FG003|Overall Study|Lack of Efficacy|0|||
146294748|NCT00960531|527594144|FG004|Overall Study|Lack of Efficacy|0|||
146294749|NCT00960531|527594145|FG005|Overall Study|Lack of Efficacy|0|||
146294750|NCT00960531|527594146|FG006|Overall Study|Lack of Efficacy|0|||
146294751|NCT00960531|527594147|FG007|Overall Study|Lack of Efficacy|0|||
146294752|NCT00960531|527594148|FG008|Overall Study|Lack of Efficacy|0|||
146294753|NCT00960531|527594149|FG009|Overall Study|Lack of Efficacy|0|||
146294754|NCT00960531|527594140|FG000|Overall Study|Withdrawal by Subject|1|||
146294755|NCT00960531|527594141|FG001|Overall Study|Withdrawal by Subject|0|||
146294756|NCT00960531|527594142|FG002|Overall Study|Withdrawal by Subject|5|||
146294757|NCT00960531|527594143|FG003|Overall Study|Withdrawal by Subject|2|||
146294758|NCT00960531|527594144|FG004|Overall Study|Withdrawal by Subject|0|||
146294759|NCT00960531|527594145|FG005|Overall Study|Withdrawal by Subject|0|||
146294760|NCT00960531|527594146|FG006|Overall Study|Withdrawal by Subject|2|||
146294761|NCT00960531|527594147|FG007|Overall Study|Withdrawal by Subject|0|||
146294762|NCT00960531|527594148|FG008|Overall Study|Withdrawal by Subject|1|||
146294763|NCT00960531|527594149|FG009|Overall Study|Withdrawal by Subject|0|||
146294764|NCT00960531|527594140|FG000|Overall Study|Caregiver Request|2|||
146294765|NCT00960531|527594141|FG001|Overall Study|Caregiver Request|0|||
146294766|NCT00960531|527594142|FG002|Overall Study|Caregiver Request|6|||
146294767|NCT00960531|527594143|FG003|Overall Study|Caregiver Request|5|||
146294768|NCT00960531|527594144|FG004|Overall Study|Caregiver Request|0|||
146294769|NCT00960531|527594145|FG005|Overall Study|Caregiver Request|2|||
146294770|NCT00960531|527594146|FG006|Overall Study|Caregiver Request|3|||
146294771|NCT00960531|527594147|FG007|Overall Study|Caregiver Request|1|||
146294772|NCT00960531|527594148|FG008|Overall Study|Caregiver Request|3|||
146294773|NCT00960531|527594149|FG009|Overall Study|Caregiver Request|0|||
146294774|NCT00960531|527594140|FG000|Overall Study|Investigator Request|0|||
146294775|NCT00960531|527594141|FG001|Overall Study|Investigator Request|0|||
146294776|NCT00960531|527594142|FG002|Overall Study|Investigator Request|1|||
146294777|NCT00960531|527594143|FG003|Overall Study|Investigator Request|0|||
146294778|NCT00960531|527594144|FG004|Overall Study|Investigator Request|0|||
146294779|NCT00960531|527594145|FG005|Overall Study|Investigator Request|0|||
146294780|NCT00960531|527594146|FG006|Overall Study|Investigator Request|0|||
146294781|NCT00960531|527594147|FG007|Overall Study|Investigator Request|0|||
146294782|NCT00960531|527594148|FG008|Overall Study|Investigator Request|0|||
146294783|NCT00960531|527594149|FG009|Overall Study|Investigator Request|0|||
146294784|NCT00960531|527594140|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
146294785|NCT00960531|527594141|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146294786|NCT00960531|527594142|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
146294787|NCT00960531|527594143|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
146294788|NCT00960531|527594144|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
146294789|NCT00960531|527594145|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
146294790|NCT00960531|527594146|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
146087812|NCT02278341|526841851|FG001|Overall Study|Miscellaneous|14|||
146087813|NCT04902326|526841852|FG000|Overall Study|Withdrawal by Subject|1|||
146087814|NCT04902326|526841853|FG001|Overall Study|Withdrawal by Subject|3|||
146087815|NCT04902326|526841854|FG002|Overall Study|Withdrawal by Subject|0|||
146087816|NCT04902326|526841855|FG003|Overall Study|Withdrawal by Subject|1|||
146087817|NCT04902326|526841852|FG000|Overall Study|Lost to Follow-up|14|||
146087818|NCT04902326|526841853|FG001|Overall Study|Lost to Follow-up|14|||
146087819|NCT04902326|526841854|FG002|Overall Study|Lost to Follow-up|14|||
146087820|NCT04902326|526841855|FG003|Overall Study|Lost to Follow-up|6|||
146087821|NCT02604017|526841857|FG000|Overall Study|Withdrew Consent|0|||
146087822|NCT02604017|526841858|FG001|Overall Study|Withdrew Consent|2|||
146087823|NCT02604017|526841857|FG000|Overall Study|Lost to Follow-up|5|||
146087824|NCT02604017|526841858|FG001|Overall Study|Lost to Follow-up|6|||
146294791|NCT00960531|527594147|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
146294792|NCT00960531|527594148|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
146294793|NCT00960531|527594149|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
146294794|NCT00960531|527594140|FG000|Overall Study|Lost to Follow-up|0|||
146294795|NCT00960531|527594141|FG001|Overall Study|Lost to Follow-up|0|||
146294796|NCT00960531|527594142|FG002|Overall Study|Lost to Follow-up|1|||
146294797|NCT00960531|527594143|FG003|Overall Study|Lost to Follow-up|0|||
146294798|NCT00960531|527594144|FG004|Overall Study|Lost to Follow-up|0|||
146294799|NCT00960531|527594145|FG005|Overall Study|Lost to Follow-up|0|||
146294800|NCT00960531|527594146|FG006|Overall Study|Lost to Follow-up|1|||
146294801|NCT00960531|527594147|FG007|Overall Study|Lost to Follow-up|0|||
146294802|NCT00960531|527594148|FG008|Overall Study|Lost to Follow-up|0|||
146294803|NCT00960531|527594149|FG009|Overall Study|Lost to Follow-up|0|||
146294804|NCT00960531|527594140|FG000|Overall Study|Failed to Return|2|||
146294805|NCT00960531|527594141|FG001|Overall Study|Failed to Return|0|||
146294806|NCT00960531|527594142|FG002|Overall Study|Failed to Return|0|||
146294807|NCT00960531|527594143|FG003|Overall Study|Failed to Return|0|||
146294808|NCT00960531|527594144|FG004|Overall Study|Failed to Return|0|||
146294809|NCT00960531|527594145|FG005|Overall Study|Failed to Return|0|||
146294810|NCT00960531|527594146|FG006|Overall Study|Failed to Return|0|||
146294811|NCT00960531|527594147|FG007|Overall Study|Failed to Return|2|||
146294812|NCT00960531|527594148|FG008|Overall Study|Failed to Return|0|||
146294813|NCT00960531|527594149|FG009|Overall Study|Failed to Return|0|||
146294814|NCT00960531|527594140|FG000|Overall Study|Adverse Event (AE)|2|||
146294815|NCT00960531|527594141|FG001|Overall Study|Adverse Event (AE)|0|||
146294816|NCT00960531|527594142|FG002|Overall Study|Adverse Event (AE)|0|||
146294817|NCT00960531|527594143|FG003|Overall Study|Adverse Event (AE)|0|||
146294818|NCT00960531|527594144|FG004|Overall Study|Adverse Event (AE)|0|||
146294819|NCT00960531|527594145|FG005|Overall Study|Adverse Event (AE)|1|||
146294820|NCT00960531|527594146|FG006|Overall Study|Adverse Event (AE)|2|||
146294821|NCT00960531|527594147|FG007|Overall Study|Adverse Event (AE)|0|||
146294822|NCT00960531|527594148|FG008|Overall Study|Adverse Event (AE)|2|||
146294823|NCT00960531|527594149|FG009|Overall Study|Adverse Event (AE)|0|||
146294824|NCT00960531|527594140|FG000|Overall Study|Reason not Specified|2|||
146294825|NCT00960531|527594141|FG001|Overall Study|Reason not Specified|1|||
146294826|NCT00960531|527594142|FG002|Overall Study|Reason not Specified|13|||
146294827|NCT00960531|527594143|FG003|Overall Study|Reason not Specified|1|||
146294828|NCT00960531|527594144|FG004|Overall Study|Reason not Specified|2|||
146294829|NCT00960531|527594145|FG005|Overall Study|Reason not Specified|0|||
146294830|NCT00960531|527594146|FG006|Overall Study|Reason not Specified|16|||
146294831|NCT00960531|527594147|FG007|Overall Study|Reason not Specified|0|||
146294832|NCT00960531|527594148|FG008|Overall Study|Reason not Specified|8|||
146294833|NCT00960531|527594149|FG009|Overall Study|Reason not Specified|1|||
146294834|NCT00593957|527594150|FG000|Overall Study|Physician Decision|0|||
146294835|NCT00593957|527594151|FG001|Overall Study|Physician Decision|1|||
146294836|NCT00593957|527594152|FG002|Overall Study|Physician Decision|2|||
146294837|NCT02411578|527594153|FG000|Crossover Trial Phase|Pregnancy|0|||
146294838|NCT02411578|527594154|FG001|Crossover Trial Phase|Pregnancy|1|||
146294839|NCT01193920|527594155|FG000|Overall Study|Withdrawal by Subject|1|||
146294840|NCT01193920|527594156|FG001|Overall Study|Withdrawal by Subject|0|||
146294841|NCT01193920|527594157|FG002|Overall Study|Withdrawal by Subject|5|||
146294842|NCT01193920|527594158|FG003|Overall Study|Withdrawal by Subject|1|||
146294843|NCT01193920|527594159|FG004|Overall Study|Withdrawal by Subject|3|||
146294844|NCT01193920|527594160|FG005|Overall Study|Withdrawal by Subject|1|||
146294845|NCT01193920|527594161|FG006|Overall Study|Withdrawal by Subject|3|||
146294846|NCT01193920|527594162|FG007|Overall Study|Withdrawal by Subject|0|||
146294847|NCT01193920|527594163|FG008|Overall Study|Withdrawal by Subject|1|||
146294848|NCT01193920|527594164|FG009|Overall Study|Withdrawal by Subject|0|||
146294849|NCT01193920|527594155|FG000|Overall Study|Lost to Follow-up|1|||
146294850|NCT01193920|527594156|FG001|Overall Study|Lost to Follow-up|0|||
146294851|NCT01193920|527594157|FG002|Overall Study|Lost to Follow-up|1|||
146294852|NCT01193920|527594158|FG003|Overall Study|Lost to Follow-up|1|||
146294853|NCT01193920|527594159|FG004|Overall Study|Lost to Follow-up|3|||
146294854|NCT01193920|527594160|FG005|Overall Study|Lost to Follow-up|3|||
146294855|NCT01193920|527594161|FG006|Overall Study|Lost to Follow-up|1|||
146294856|NCT01193920|527594162|FG007|Overall Study|Lost to Follow-up|0|||
146294857|NCT01193920|527594163|FG008|Overall Study|Lost to Follow-up|2|||
146294858|NCT01193920|527594164|FG009|Overall Study|Lost to Follow-up|3|||
146294859|NCT01193920|527594155|FG000|Overall Study|Protocol Violation|1|||
146294860|NCT01193920|527594156|FG001|Overall Study|Protocol Violation|0|||
146294861|NCT01193920|527594157|FG002|Overall Study|Protocol Violation|0|||
146294862|NCT01193920|527594158|FG003|Overall Study|Protocol Violation|0|||
146294863|NCT01193920|527594159|FG004|Overall Study|Protocol Violation|0|||
146294864|NCT01193920|527594160|FG005|Overall Study|Protocol Violation|0|||
146294865|NCT01193920|527594161|FG006|Overall Study|Protocol Violation|0|||
146294866|NCT01193920|527594162|FG007|Overall Study|Protocol Violation|0|||
146294867|NCT01193920|527594163|FG008|Overall Study|Protocol Violation|0|||
146294868|NCT01193920|527594164|FG009|Overall Study|Protocol Violation|0|||
146294869|NCT01193920|527594155|FG000|Overall Study|Death|0|||
146294870|NCT01193920|527594156|FG001|Overall Study|Death|0|||
146294871|NCT01193920|527594157|FG002|Overall Study|Death|0|||
146294872|NCT01193920|527594158|FG003|Overall Study|Death|1|||
146294873|NCT01193920|527594159|FG004|Overall Study|Death|0|||
146294874|NCT01193920|527594160|FG005|Overall Study|Death|0|||
146294875|NCT01193920|527594161|FG006|Overall Study|Death|2|||
146294876|NCT01193920|527594162|FG007|Overall Study|Death|3|||
146294877|NCT01193920|527594163|FG008|Overall Study|Death|2|||
146294878|NCT01193920|527594164|FG009|Overall Study|Death|4|||
146294879|NCT01193920|527594155|FG000|Overall Study|Unable to classify|0|||
146294880|NCT01193920|527594156|FG001|Overall Study|Unable to classify|0|||
146294881|NCT01193920|527594157|FG002|Overall Study|Unable to classify|0|||
146294882|NCT01193920|527594158|FG003|Overall Study|Unable to classify|1|||
146294883|NCT01193920|527594159|FG004|Overall Study|Unable to classify|0|||
146294884|NCT01193920|527594160|FG005|Overall Study|Unable to classify|0|||
146294885|NCT01193920|527594161|FG006|Overall Study|Unable to classify|0|||
146294886|NCT01193920|527594162|FG007|Overall Study|Unable to classify|1|||
146294887|NCT01193920|527594163|FG008|Overall Study|Unable to classify|0|||
146294888|NCT01193920|527594164|FG009|Overall Study|Unable to classify|0|||
146294889|NCT00494481|527594165|FG000|Overall Study|Condition under investigation worsened|11|||
146294890|NCT00494481|527594166|FG001|Overall Study|Condition under investigation worsened|13|||
146294891|NCT00494481|527594165|FG000|Overall Study|Adverse Event|15|||
146294892|NCT00494481|527594166|FG001|Overall Study|Adverse Event|11|||
146294893|NCT00494481|527594165|FG000|Overall Study|Other|1|||
146294894|NCT00494481|527594166|FG001|Overall Study|Other|0|||
146294895|NCT00494481|527594165|FG000|Overall Study|Never received IP|2|||
146294896|NCT00494481|527594166|FG001|Overall Study|Never received IP|0|||
146294897|NCT01030198|527594167|FG000|Overall Study|Could not measure efficacy accurately|0|||
146294898|NCT01030198|527594168|FG001|Overall Study|Could not measure efficacy accurately|7|||
146294899|NCT00332189|527594169|FG000|Overall Study|Adverse Event|3|||
146294900|NCT00332189|527594169|FG000|Overall Study|Uncooperative/Noncompliant|3|||
146294901|NCT00332189|527594169|FG000|Overall Study|Withdrawal by Subject|9|||
146294902|NCT00332189|527594169|FG000|Overall Study|Lack of Efficacy|4|||
146294903|NCT00332189|527594169|FG000|Overall Study|Moved out of country|2|||
146294904|NCT02370043|527594170|FG000|Overall Study|Withdrawal by Subject|0|||
146294905|NCT02370043|527594171|FG001|Overall Study|Withdrawal by Subject|0|||
146294906|NCT02370043|527594172|FG002|Overall Study|Withdrawal by Subject|0|||
146294907|NCT02370043|527594173|FG003|Overall Study|Withdrawal by Subject|0|||
146294908|NCT02370043|527594174|FG004|Overall Study|Withdrawal by Subject|1|||
146294909|NCT02370043|527594175|FG005|Overall Study|Withdrawal by Subject|1|||
146294910|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
146294911|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
146294912|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
146294913|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
146294914|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
146294915|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
146294916|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
146294917|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
146294918|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
146294919|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
146294920|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
146294921|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
146294922|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
146294923|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
146294924|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
146294925|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
146294926|NCT01231516|527594176|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
146294927|NCT01231516|527594177|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
146294928|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
146294929|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
146294930|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
146294931|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
146294932|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
146294933|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
145970829|NCT00481676|526407283|FG000|Overall Study|Administrative problem|1|||
145970830|NCT00481676|526407284|FG001|Overall Study|Administrative problem|0|||
145970831|NCT02911116|526407285|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145970832|NCT02911116|526407286|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145970833|NCT02911116|526407285|FG000|Overall Study|Lost to Follow-up|0|||
145970834|NCT02911116|526407286|FG001|Overall Study|Lost to Follow-up|1|||
145970835|NCT00819039|526407287|FG000|Overall Study|Physician Decision|1|||
146294934|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
146294935|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
146294936|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
146294937|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
146294938|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
145970836|NCT00819039|526407288|FG001|Overall Study|Physician Decision|0|||
145970837|NCT00819039|526407289|FG002|Overall Study|Physician Decision|1|||
145970838|NCT00819039|526407287|FG000|Overall Study|Protocol Violation|1|||
145970839|NCT00819039|526407288|FG001|Overall Study|Protocol Violation|0|||
145970840|NCT00819039|526407289|FG002|Overall Study|Protocol Violation|0|||
145970841|NCT04796415|526407290|FG000|Overall Study|not interested|12|||
145970842|NCT04796415|526407290|FG000|Overall Study|health issue|8|||
145970843|NCT04796415|526407290|FG000|Overall Study|Other|4|||
145970844|NCT04796415|526407290|FG000|Overall Study|discharged from home health service|3|||
145970845|NCT04796415|526407290|FG000|Overall Study|re-hospitalization|2|||
145970846|NCT04796415|526407290|FG000|Overall Study|moving to nursing home|1|||
145970847|NCT04796415|526407290|FG000|Overall Study|lost contact|1|||
145970848|NCT01240694|526407291|FG000|Overall Study|Adverse Event|9|||
146087825|NCT02604017|526841857|FG000|Overall Study|Other|1|||
146087826|NCT02604017|526841858|FG001|Overall Study|Other|0|||
146087827|NCT01041495|526841859|FG000|Overall Study|Withdrawal by Subject|2|||
146087828|NCT01041495|526841860|FG001|Overall Study|Withdrawal by Subject|5|||
146087829|NCT01041495|526841859|FG000|Overall Study|Adverse Event|2|||
146087830|NCT01041495|526841860|FG001|Overall Study|Adverse Event|1|||
146087831|NCT01041495|526841859|FG000|Overall Study|Lost to Follow-up|0|||
146087832|NCT01041495|526841860|FG001|Overall Study|Lost to Follow-up|1|||
146087833|NCT01479985|526841864|FG000|Overall Study|Tablet malfunction, no data saved|1|||
146087834|NCT01479985|526841865|FG001|Overall Study|Tablet malfunction, no data saved|1|||
146087835|NCT01479985|526841864|FG000|Overall Study|No decisional conflict scale responses|0|||
146087836|NCT01479985|526841865|FG001|Overall Study|No decisional conflict scale responses|2|||
146087837|NCT01479985|526841864|FG000|Overall Study|No post-visit survey|5|||
146087838|NCT01479985|526841865|FG001|Overall Study|No post-visit survey|3|||
146087839|NCT01653782|526841866|FG000|Overall Study|Withdrawal by Subject|9|||
146087840|NCT01653782|526841867|FG001|Overall Study|Withdrawal by Subject|15|||
146087841|NCT01653782|526841868|FG002|Overall Study|Withdrawal by Subject|4|||
146087842|NCT01653782|526841866|FG000|Overall Study|Lost to Follow-up|7|||
146087843|NCT01653782|526841867|FG001|Overall Study|Lost to Follow-up|3|||
146087844|NCT01653782|526841868|FG002|Overall Study|Lost to Follow-up|2|||
146087845|NCT01850602|526841874|FG000|Overall Study|Adverse Event|7|||
146087846|NCT01850602|526841875|FG001|Overall Study|Adverse Event|10|||
146087847|NCT01850602|526841874|FG000|Overall Study|Physician Decision|2|||
146087848|NCT01850602|526841875|FG001|Overall Study|Physician Decision|1|||
146087849|NCT01850602|526841874|FG000|Overall Study|Withdrawal by Subject|2|||
146087850|NCT01850602|526841875|FG001|Overall Study|Withdrawal by Subject|4|||
146087851|NCT01850602|526841874|FG000|Overall Study|Decrease in serum calcium|2|||
146087852|NCT01850602|526841875|FG001|Overall Study|Decrease in serum calcium|3|||
146087853|NCT01850602|526841874|FG000|Overall Study|Increase in serum ferritin|1|||
146087854|NCT01850602|526841875|FG001|Overall Study|Increase in serum ferritin|0|||
146087855|NCT00367770|526841876|FG000|Overall Study|Adverse Event|1|||
146087856|NCT00367770|526841876|FG000|Overall Study|Withdrawal by Subject|1|||
146087857|NCT01634178|526841880|FG000|Treatment Period 1|Adverse Event|0|||
146087858|NCT01634178|526841881|FG001|Treatment Period 1|Adverse Event|1|||
146087859|NCT01634178|526841880|FG000|Treatment Period 2|Adverse Event|1|||
146087860|NCT01634178|526841881|FG001|Treatment Period 2|Adverse Event|0|||
146087861|NCT00287079|526841882|FG000|Overall Study|Qualifying relapse|12|||
146087862|NCT00287079|526841883|FG001|Overall Study|Qualifying relapse|1|||
146087863|NCT00287079|526841882|FG000|Overall Study|Non-qualifying relapse|1|||
146087864|NCT00287079|526841883|FG001|Overall Study|Non-qualifying relapse|0|||
146087865|NCT00287079|526841882|FG000|Overall Study|Adverse Event|5|||
146087866|NCT00287079|526841883|FG001|Overall Study|Adverse Event|0|||
146087867|NCT00287079|526841882|FG000|Overall Study|Protocol Violation|1|||
146087868|NCT00287079|526841883|FG001|Overall Study|Protocol Violation|0|||
146087869|NCT00287079|526841882|FG000|Overall Study|Other|3|||
146235107|NCT00622700|527378448|FG001|Extension Treatment Period|Missing|0|||
146235108|NCT00622700|527378449|FG002|Extension Treatment Period|Missing|0|||
146235109|NCT00622700|527378450|FG003|Extension Treatment Period|Missing|2|||
146235110|NCT00622700|527378451|FG004|Extension Treatment Period|Missing|3|||
146235111|NCT00622700|527378452|FG005|Extension Treatment Period|Missing|1|||
146235112|NCT00622700|527378453|FG006|Extension Treatment Period|Missing|0|||
146235113|NCT00622700|527378447|FG000|Extension Treatment Period|Other than specified above|0|||
146235114|NCT00622700|527378448|FG001|Extension Treatment Period|Other than specified above|0|||
145970849|NCT01240694|526407291|FG000|Overall Study|Lack of Efficacy|6|||
146087870|NCT00287079|526841883|FG001|Overall Study|Other|0|||
146087871|NCT01721577|526841884|FG000|Overall Study|Lack of Efficacy|1|||
146087872|NCT01721577|526841885|FG001|Overall Study|Lack of Efficacy|0|||
146087873|NCT01721577|526841884|FG000|Overall Study|Death|1|||
145970850|NCT01240694|526407291|FG000|Overall Study|Withdrawal by Subject|6|||
146087874|NCT01721577|526841885|FG001|Overall Study|Death|0|||
146087875|NCT01721577|526841884|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
146087876|NCT01721577|526841885|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
146087877|NCT01721577|526841884|FG000|Overall Study|Adverse Event|0|||
146235115|NCT00622700|527378449|FG002|Extension Treatment Period|Other than specified above|0|||
146294939|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
146294940|NCT01231516|527594176|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
146294941|NCT01231516|527594177|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
146294942|NCT05266586|527594178|FG000|Overall Study|Adverse Event|2|||
146294943|NCT05266586|527594179|FG001|Overall Study|Adverse Event|2|||
146294944|NCT05266586|527594180|FG002|Overall Study|Adverse Event|1|||
146294945|NCT05266586|527594178|FG000|Overall Study|Withdrawal by Subject|1|||
146294946|NCT05266586|527594179|FG001|Overall Study|Withdrawal by Subject|0|||
146294947|NCT05266586|527594180|FG002|Overall Study|Withdrawal by Subject|1|||
146294948|NCT05266586|527594178|FG000|Overall Study|Non-compliance with study drug|0|||
146294949|NCT05266586|527594179|FG001|Overall Study|Non-compliance with study drug|1|||
146294950|NCT05266586|527594180|FG002|Overall Study|Non-compliance with study drug|0|||
146294951|NCT05266586|527594178|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
146294952|NCT05266586|527594179|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
146294953|NCT05266586|527594180|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
146294954|NCT03707925|527594181|FG000|Overall Study|Inevaluable|1|||
146294955|NCT02876835|527594184|FG000|Treatment Period (51.1 Month)|Other|1|||
146294956|NCT02876835|527594185|FG001|Treatment Period (51.1 Month)|Other|0|||
146294957|NCT02876835|527594184|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
146294958|NCT02876835|527594185|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
146294959|NCT02876835|527594184|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
146294960|NCT02876835|527594185|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
146294961|NCT02876835|527594184|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
146294962|NCT02876835|527594185|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
146294963|NCT01117857|527594186|FG000|Overall Study|Lost to Follow-up|4|||
146294964|NCT01117857|527594186|FG000|Overall Study|Withdrawal by Subject|4|||
146087878|NCT01721577|526841885|FG001|Overall Study|Adverse Event|2|||
146087879|NCT01282203|526841888|FG000|Overall Study|Adverse Event|1|||
146294965|NCT01117857|527594186|FG000|Overall Study|Physician Decision|1|||
146294966|NCT05245097|527594187|FG000|Overall Study|Adverse Event|13|||
146294967|NCT05245097|527594188|FG001|Overall Study|Adverse Event|2|||
146294968|NCT05245097|527594187|FG000|Overall Study|Protocol Violation|8|||
146294969|NCT05245097|527594188|FG001|Overall Study|Protocol Violation|6|||
146294970|NCT05245097|527594187|FG000|Overall Study|Withdrawal by Subject|18|||
146294971|NCT05245097|527594188|FG001|Overall Study|Withdrawal by Subject|0|||
146294972|NCT05245097|527594187|FG000|Overall Study|Death|6|||
146294973|NCT05245097|527594188|FG001|Overall Study|Death|7|||
146294974|NCT05245097|527594187|FG000|Overall Study|Physician Decision|6|||
146294975|NCT05245097|527594188|FG001|Overall Study|Physician Decision|0|||
146294976|NCT05245097|527594187|FG000|Overall Study|Relocation|4|||
146294977|NCT05245097|527594188|FG001|Overall Study|Relocation|3|||
146294978|NCT04683731|527594193|FG000|Overall Study|Withdrawal by Subject|1|||
146087880|NCT00740051|526841891|FG000|Overall Study|Lack of Efficacy|2|||
146087881|NCT00740051|526841892|FG001|Overall Study|Lack of Efficacy|5|||
146087882|NCT00740051|526841891|FG000|Overall Study|Adverse Event|1|||
146087883|NCT00740051|526841892|FG001|Overall Study|Adverse Event|4|||
146087884|NCT00740051|526841891|FG000|Overall Study|Protocol Violation|2|||
146087885|NCT00740051|526841892|FG001|Overall Study|Protocol Violation|6|||
146087886|NCT00740051|526841891|FG000|Overall Study|Lost to Follow-up|3|||
146087887|NCT00740051|526841892|FG001|Overall Study|Lost to Follow-up|8|||
146087888|NCT00740051|526841891|FG000|Overall Study|Withdrawal by Subject|6|||
146087889|NCT00740051|526841892|FG001|Overall Study|Withdrawal by Subject|8|||
146087890|NCT00740051|526841891|FG000|Overall Study|Other reason (not specified)|4|||
146087891|NCT00740051|526841892|FG001|Overall Study|Other reason (not specified)|1|||
146087892|NCT00930982|526841893|FG000|Overall Study|Adverse Event|19|||
146087893|NCT00930982|526841894|FG001|Overall Study|Adverse Event|23|||
146087894|NCT00930982|526841893|FG000|Overall Study|Protocol Violation|1|||
146087895|NCT00930982|526841894|FG001|Overall Study|Protocol Violation|5|||
146087896|NCT00930982|526841893|FG000|Overall Study|Withdrawal by Subject|1|||
146294979|NCT04683731|527594194|FG001|Overall Study|Withdrawal by Subject|0|||
146294980|NCT04683731|527594195|FG002|Overall Study|Withdrawal by Subject|3|||
146294981|NCT04683731|527594196|FG003|Overall Study|Withdrawal by Subject|2|||
146294982|NCT04683731|527594193|FG000|Overall Study|Determined patient was not eligible|3|||
146294983|NCT04683731|527594194|FG001|Overall Study|Determined patient was not eligible|3|||
146294984|NCT04683731|527594195|FG002|Overall Study|Determined patient was not eligible|12|||
146294985|NCT04683731|527594196|FG003|Overall Study|Determined patient was not eligible|3|||
146294986|NCT00883051|527594198|FG000|Overall Study|Lost to Follow-up|0|||
146087897|NCT00930982|526841894|FG001|Overall Study|Withdrawal by Subject|1|||
146087898|NCT00991952|526841895|FG000|Overall Study|Adverse Event|0|||
146087899|NCT00991952|526841896|FG001|Overall Study|Adverse Event|1|||
146087900|NCT02483533|526841897|FG000|Overall Study|Lack of Efficacy|50|||
146087901|NCT02483533|526841898|FG001|Overall Study|Lack of Efficacy|50|||
146087902|NCT04365257|526841899|FG000|Overall Study|Physician Decision|1|||
146087903|NCT04365257|526841900|FG001|Overall Study|Physician Decision|0|||
146087904|NCT04365257|526841899|FG000|Overall Study|Patient Noncompliance|1|||
145970851|NCT01240694|526407291|FG000|Overall Study|Protocol Violation|2|||
145970852|NCT01240694|526407291|FG000|Overall Study|Lost to Follow-up|2|||
145970853|NCT01240694|526407291|FG000|Overall Study|Other than specified|3|||
145970854|NCT01240694|526407291|FG000|Overall Study|Withdrawn due to early study termination|107|||
145970855|NCT01513590|526407292|FG000|Overall Study|Adverse Event|2|||
145970856|NCT01513590|526407293|FG001|Overall Study|Adverse Event|3|||
145970857|NCT01513590|526407292|FG000|Overall Study|Withdrawal Criteria|3|||
145970858|NCT01513590|526407293|FG001|Overall Study|Withdrawal Criteria|0|||
146235116|NCT00622700|527378450|FG003|Extension Treatment Period|Other than specified above|0|||
146235117|NCT00622700|527378451|FG004|Extension Treatment Period|Other than specified above|0|||
146235118|NCT00622700|527378452|FG005|Extension Treatment Period|Other than specified above|1|||
146235119|NCT00622700|527378453|FG006|Extension Treatment Period|Other than specified above|1|||
146235120|NCT00942266|527378454|FG000|Overall Study|Withdrawal by Subject|1|||
146235121|NCT00942266|527378455|FG001|Overall Study|Withdrawal by Subject|0|||
146235122|NCT00942266|527378454|FG000|Overall Study|Adverse Event|2|||
146235123|NCT00942266|527378455|FG001|Overall Study|Adverse Event|1|||
146235124|NCT00942266|527378454|FG000|Overall Study|Disease Progression|38|||
146235125|NCT00942266|527378455|FG001|Overall Study|Disease Progression|11|||
146235126|NCT00942266|527378454|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
146235127|NCT00942266|527378455|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
146235128|NCT00942266|527378454|FG000|Overall Study|Intercurrent illness|0|||
146235129|NCT00942266|527378455|FG001|Overall Study|Intercurrent illness|1|||
146235130|NCT00942266|527378454|FG000|Overall Study|Physician Decision|2|||
146235131|NCT00942266|527378455|FG001|Overall Study|Physician Decision|0|||
146235132|NCT00942266|527378454|FG000|Overall Study|medical deterioration (pneumonia)|0|||
146235133|NCT00942266|527378455|FG001|Overall Study|medical deterioration (pneumonia)|1|||
146235134|NCT03611556|527378456|FG000|Overall Study|Death|7|||
146235135|NCT03611556|527378457|FG001|Overall Study|Death|7|||
146235136|NCT03611556|527378458|FG002|Overall Study|Death|3|||
146235137|NCT03611556|527378459|FG003|Overall Study|Death|8|||
146235138|NCT03611556|527378460|FG004|Overall Study|Death|47|||
146235139|NCT03611556|527378461|FG005|Overall Study|Death|32|||
146235140|NCT03611556|527378462|FG006|Overall Study|Death|53|||
146235141|NCT03611556|527378456|FG000|Overall Study|Withdrawal by Subject|0|||
146235142|NCT03611556|527378457|FG001|Overall Study|Withdrawal by Subject|0|||
146235143|NCT03611556|527378458|FG002|Overall Study|Withdrawal by Subject|0|||
146235144|NCT03611556|527378459|FG003|Overall Study|Withdrawal by Subject|0|||
146235145|NCT03611556|527378460|FG004|Overall Study|Withdrawal by Subject|4|||
146235146|NCT03611556|527378461|FG005|Overall Study|Withdrawal by Subject|2|||
146235147|NCT03611556|527378462|FG006|Overall Study|Withdrawal by Subject|4|||
146235148|NCT03611556|527378456|FG000|Overall Study|Sponsor decision|0|||
146235149|NCT03611556|527378457|FG001|Overall Study|Sponsor decision|0|||
146235150|NCT03611556|527378458|FG002|Overall Study|Sponsor decision|0|||
146235151|NCT03611556|527378459|FG003|Overall Study|Sponsor decision|0|||
146235152|NCT03611556|527378460|FG004|Overall Study|Sponsor decision|9|||
146235153|NCT03611556|527378461|FG005|Overall Study|Sponsor decision|4|||
146235154|NCT03611556|527378462|FG006|Overall Study|Sponsor decision|12|||
146235155|NCT03611556|527378456|FG000|Overall Study|Reasons|0|||
146235156|NCT03611556|527378457|FG001|Overall Study|Reasons|0|||
146235157|NCT03611556|527378458|FG002|Overall Study|Reasons|0|||
146235158|NCT03611556|527378459|FG003|Overall Study|Reasons|0|||
146235159|NCT03611556|527378460|FG004|Overall Study|Reasons|2|||
146235160|NCT03611556|527378461|FG005|Overall Study|Reasons|0|||
146235161|NCT03611556|527378462|FG006|Overall Study|Reasons|1|||
146235162|NCT02844439|527378468|FG000|Overall Study|Withdrawal by Subject|1|||
146235163|NCT02844439|527378468|FG000|Overall Study|Lost to Follow-up|2|||
146235164|NCT02844439|527378468|FG000|Overall Study|Termination by Sponsor|4|||
146235165|NCT02844439|527378468|FG000|Overall Study|Death|28|||
146235166|NCT02844439|527378468|FG000|Overall Study|Other|5|||
146235167|NCT05580003|527378474|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235168|NCT05580003|527378475|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235169|NCT05580003|527378476|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235170|NCT05580003|527378477|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235171|NCT05580003|527378478|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235172|NCT05580003|527378479|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235173|NCT05580003|527378480|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146235174|NCT05580003|527378481|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235175|NCT05580003|527378482|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235176|NCT05580003|527378483|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145970859|NCT01513590|526407292|FG000|Overall Study|Unclassified|5|||
146235177|NCT05580003|527378484|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145970860|NCT01513590|526407293|FG001|Overall Study|Unclassified|10|||
145970861|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
146235178|NCT05580003|527378485|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235179|NCT05580003|527378486|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146294987|NCT00883051|527594199|FG001|Overall Study|Lost to Follow-up|0|||
146294988|NCT00883051|527594200|FG002|Overall Study|Lost to Follow-up|0|||
146294989|NCT00883051|527594201|FG003|Overall Study|Lost to Follow-up|0|||
146294990|NCT00883051|527594202|FG004|Overall Study|Lost to Follow-up|1|||
146294991|NCT00883051|527594198|FG000|Overall Study|Did not use study medication|24|||
146294992|NCT00883051|527594199|FG001|Overall Study|Did not use study medication|22|||
146294993|NCT00883051|527594200|FG002|Overall Study|Did not use study medication|29|||
146294994|NCT00883051|527594201|FG003|Overall Study|Did not use study medication|29|||
146294995|NCT00883051|527594202|FG004|Overall Study|Did not use study medication|17|||
146294996|NCT01411839|527594205|FG000|Overall Study|Lost to Follow-up|4|||
146294997|NCT01411839|527594206|FG001|Overall Study|Lost to Follow-up|3|||
146294998|NCT03282240|527594207|FG000|Overall Study|Adverse Event|2|||
146294999|NCT03282240|527594208|FG001|Overall Study|Adverse Event|2|||
146295000|NCT03282240|527594209|FG002|Overall Study|Adverse Event|0|||
146295001|NCT03282240|527594207|FG000|Overall Study|Lost to Follow-up|3|||
146295002|NCT03282240|527594208|FG001|Overall Study|Lost to Follow-up|0|||
146295003|NCT03282240|527594209|FG002|Overall Study|Lost to Follow-up|0|||
146295004|NCT03282240|527594207|FG000|Overall Study|Protocol Deviation|4|||
146295005|NCT03282240|527594208|FG001|Overall Study|Protocol Deviation|1|||
146295006|NCT03282240|527594209|FG002|Overall Study|Protocol Deviation|2|||
146295007|NCT03282240|527594207|FG000|Overall Study|Withdrawal by Subject|1|||
146295008|NCT03282240|527594208|FG001|Overall Study|Withdrawal by Subject|0|||
146295009|NCT03282240|527594209|FG002|Overall Study|Withdrawal by Subject|1|||
146295010|NCT01675479|527594210|FG000|Overall Study|Lost to Follow-up|11|||
146295011|NCT03254485|527594211|FG000|Overall Study|Adverse Event|3|||
146295012|NCT03254485|527594212|FG001|Overall Study|Adverse Event|0|||
146295013|NCT03254485|527594213|FG002|Overall Study|Adverse Event|0|||
146295014|NCT03254485|527594214|FG003|Overall Study|Adverse Event|6|||
146295015|NCT03254485|527594211|FG000|Overall Study|Protocol Violation|6|||
146295016|NCT03254485|527594212|FG001|Overall Study|Protocol Violation|0|||
146295017|NCT03254485|527594213|FG002|Overall Study|Protocol Violation|0|||
146295018|NCT03254485|527594214|FG003|Overall Study|Protocol Violation|2|||
146295019|NCT03254485|527594211|FG000|Overall Study|Withdrawal by Subject|1|||
146295020|NCT03254485|527594212|FG001|Overall Study|Withdrawal by Subject|0|||
146295021|NCT03254485|527594213|FG002|Overall Study|Withdrawal by Subject|0|||
146295022|NCT03254485|527594214|FG003|Overall Study|Withdrawal by Subject|4|||
146295023|NCT03254485|527594211|FG000|Overall Study|Death|0|||
146295024|NCT03254485|527594212|FG001|Overall Study|Death|0|||
146295025|NCT03254485|527594213|FG002|Overall Study|Death|0|||
146295026|NCT03254485|527594214|FG003|Overall Study|Death|1|||
146295027|NCT03254485|527594211|FG000|Overall Study|Lost to Follow-up|1|||
146295028|NCT03254485|527594212|FG001|Overall Study|Lost to Follow-up|0|||
146295029|NCT03254485|527594213|FG002|Overall Study|Lost to Follow-up|0|||
146295030|NCT03254485|527594214|FG003|Overall Study|Lost to Follow-up|0|||
146295031|NCT03254485|527594211|FG000|Overall Study|Other|1|||
146295032|NCT03254485|527594212|FG001|Overall Study|Other|0|||
146295033|NCT03254485|527594213|FG002|Overall Study|Other|0|||
146295034|NCT03254485|527594214|FG003|Overall Study|Other|2|||
146295035|NCT01572922|527594216|FG000|Overall Study|Adverse Event|1|||
146295036|NCT01572922|527594216|FG000|Overall Study|Protocol Violation|1|||
146295037|NCT01572922|527594216|FG000|Overall Study|Death|1|||
146295038|NCT01335009|527594217|FG000|Overall Study|Too ill to travel to study sites|1|||
146295039|NCT01335009|527594218|FG001|Overall Study|Too ill to travel to study sites|0|||
146295040|NCT01335009|527594217|FG000|Overall Study|Death|28|||
146295041|NCT01335009|527594218|FG001|Overall Study|Death|32|||
146295042|NCT01335009|527594217|FG000|Overall Study|Withdrawal by Subject|1|||
146295043|NCT01335009|527594218|FG001|Overall Study|Withdrawal by Subject|1|||
146295044|NCT01335009|527594217|FG000|Overall Study|Lost to Follow-up|1|||
146295045|NCT01335009|527594218|FG001|Overall Study|Lost to Follow-up|0|||
146295046|NCT02818920|527594219|FG000|Overall Study|Unresectable|4|||
146295047|NCT02818920|527594219|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
146295048|NCT02818920|527594219|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
146295049|NCT02818920|527594219|FG000|Overall Study|Adverse Event|3|||
146295050|NCT02818920|527594219|FG000|Overall Study|Developed Other Disease|1|||
146295051|NCT02818920|527594219|FG000|Overall Study|Refused Further Treatment|1|||
146295052|NCT04821869|527594220|FG000|Overall Study|Adverse Event|4|||
146295053|NCT04821869|527594220|FG000|Overall Study|Withdrawal by Subject|2|||
146295054|NCT04821869|527594220|FG000|Overall Study|Did not meet FEV1 criteria|1|||
146295055|NCT01485354|527595910|FG000|Overall Study|Withdrawal by Subject|5|||
146295056|NCT00826111|527595911|FG000|Overall Study|Lost to Follow-up|0|||
146295057|NCT00826111|527595912|FG001|Overall Study|Lost to Follow-up|1|||
146295058|NCT00826111|527595911|FG000|Overall Study|Protocol Violation|1|||
146295059|NCT00826111|527595912|FG001|Overall Study|Protocol Violation|0|||
146295060|NCT00826111|527595911|FG000|Overall Study|Withdrawal by Subject|5|||
146295061|NCT00826111|527595912|FG001|Overall Study|Withdrawal by Subject|0|||
146295062|NCT00826111|527595911|FG000|Overall Study|Physician Decision|1|||
145891070|NCT01132664|526107598|FG004|BM Cohort|Withdrawal by Subject|1|||
146295063|NCT00826111|527595912|FG001|Overall Study|Physician Decision|1|||
146295064|NCT02805725|527595913|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
145970862|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
145970863|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
145970864|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
145970865|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
145970866|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
145970867|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
146295065|NCT02805725|527595914|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
146295066|NCT02805725|527595915|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
146295067|NCT02805725|527595916|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
146295068|NCT02805725|527595917|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
146295069|NCT02805725|527595913|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
146295070|NCT02805725|527595914|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
146295071|NCT02805725|527595915|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
146295072|NCT02805725|527595916|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
146295073|NCT02805725|527595917|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
146295074|NCT02805725|527595913|FG000|Phase II|Protocol Violation|0|||
146295075|NCT02805725|527595914|FG001|Phase II|Protocol Violation|0|||
146295076|NCT02805725|527595915|FG002|Phase II|Protocol Violation|0|||
146295077|NCT02805725|527595916|FG003|Phase II|Protocol Violation|0|||
146295078|NCT02805725|527595917|FG004|Phase II|Protocol Violation|6|||
146295079|NCT03511053|527595920|FG000|Overall Study|Withdrawal by Subject|1|||
146295080|NCT01028222|527595923|FG000|Overall Study|Protocol deviation|1|||
146295081|NCT01028222|527595924|FG001|Overall Study|Protocol deviation|0|||
146295082|NCT01028222|527595923|FG000|Overall Study|Disease progression|33|||
146295083|NCT01028222|527595924|FG001|Overall Study|Disease progression|9|||
146295084|NCT01028222|527595923|FG000|Overall Study|Administrative problems|1|||
146295085|NCT01028222|527595924|FG001|Overall Study|Administrative problems|1|||
146295086|NCT01028222|527595923|FG000|Overall Study|Lost to Follow-up|0|||
146295087|NCT01028222|527595924|FG001|Overall Study|Lost to Follow-up|1|||
146295088|NCT01028222|527595923|FG000|Overall Study|Withdrawal by Subject|1|||
146295089|NCT01028222|527595924|FG001|Overall Study|Withdrawal by Subject|0|||
146295090|NCT01028222|527595923|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
146295091|NCT01028222|527595924|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
146295092|NCT01028222|527595923|FG000|Overall Study|Adverse Event|2|||
146295093|NCT01028222|527595924|FG001|Overall Study|Adverse Event|0|||
146295094|NCT00567268|527595925|FG000|Overall Study|Protocol Violation|7|||
146295095|NCT00567268|527595925|FG000|Overall Study|Lost to Follow-up|36|||
145891071|NCT01996332|526107600|FG000|Overall Study|Adverse Event|117|||
145891072|NCT01996332|526107600|FG000|Overall Study|Lack of Efficacy|1245|||
145891073|NCT01996332|526107600|FG000|Overall Study|Death|264|||
145891074|NCT01996332|526107600|FG000|Overall Study|Protocol Violation|9|||
145891075|NCT01996332|526107600|FG000|Overall Study|Withdrawal by Subject|71|||
145891076|NCT01996332|526107600|FG000|Overall Study|Other|20|||
145891077|NCT01996332|526107600|FG000|Overall Study|Clinical Deterioration|28|||
145891078|NCT01996332|526107600|FG000|Overall Study|Physician Decision|17|||
145891079|NCT01996332|526107600|FG000|Overall Study|Lost to Follow-up|34|||
145891080|NCT02113189|526107601|FG000|Overall Study|Lost to follow up|2|||
145891081|NCT02113189|526107602|FG001|Overall Study|Lost to follow up|1|||
145891082|NCT02113189|526107603|FG002|Overall Study|Lost to follow up|3|||
145891083|NCT05016622|526107604|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
145891084|NCT05016622|526107604|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
145891085|NCT01304693|526107605|FG000|Overall Study|Adverse Event|0|||
145891086|NCT01304693|526107606|FG001|Overall Study|Adverse Event|0|||
145891087|NCT01304693|526107607|FG002|Overall Study|Adverse Event|0|||
145891088|NCT01304693|526107608|FG003|Overall Study|Adverse Event|0|||
145891089|NCT01304693|526107609|FG004|Overall Study|Adverse Event|1|||
145891090|NCT01304693|526107605|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
145891091|NCT01304693|526107606|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
145891092|NCT01304693|526107607|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
145891093|NCT01304693|526107608|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
145970868|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
146295096|NCT00567268|527595925|FG000|Overall Study|No Visit After First Day of Treatment|2|||
146295097|NCT00567268|527595925|FG000|Overall Study|No Drug Administration|4|||
146295098|NCT00567268|527595925|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
146295099|NCT02598557|527595926|FG000|Overall Study|Withdrawal by Subject|1|||
146295100|NCT02598557|527595927|FG001|Overall Study|Withdrawal by Subject|0|||
146295101|NCT02598557|527595928|FG002|Overall Study|Withdrawal by Subject|1|||
146295102|NCT02598557|527595926|FG000|Overall Study|Participant did not start treatment|2|||
146295103|NCT02598557|527595927|FG001|Overall Study|Participant did not start treatment|1|||
145891094|NCT01304693|526107609|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
145891095|NCT02954159|526107610|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
145891096|NCT02954159|526107611|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
145891097|NCT02954159|526107610|FG000|Overall Study|Withdrawal by Subject|0|||
145970869|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
146235180|NCT05580003|527378487|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235181|NCT05580003|527378488|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235182|NCT05580003|527378489|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145891098|NCT02954159|526107611|FG001|Overall Study|Withdrawal by Subject|1|||
145891099|NCT02581163|526107613|FG000|Overall Study|Failure to return|15|||
145891100|NCT02581163|526107613|FG000|Overall Study|Insufficient virological response|3|||
145891101|NCT02581163|526107613|FG000|Overall Study|Withdrew consent|1|||
145891102|NCT02581163|526107613|FG000|Overall Study|Death|1|||
146087905|NCT04365257|526841900|FG001|Overall Study|Patient Noncompliance|0|||
146295104|NCT02598557|527595928|FG002|Overall Study|Participant did not start treatment|1|||
146295105|NCT02598557|527595926|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
146295106|NCT02598557|527595927|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
146295107|NCT02598557|527595928|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
146295108|NCT02598557|527595926|FG000|Overall Study|Adverse Event|1|||
146235183|NCT05580003|527378490|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146295109|NCT02598557|527595927|FG001|Overall Study|Adverse Event|1|||
146295110|NCT02598557|527595928|FG002|Overall Study|Adverse Event|0|||
146295111|NCT02072434|527595929|FG000|Overall Study|Protocol Violation|10|||
146295112|NCT02072434|527595930|FG001|Overall Study|Protocol Violation|9|||
146295113|NCT02072434|527595929|FG000|Overall Study|Physician Decision|5|||
146295114|NCT02072434|527595930|FG001|Overall Study|Physician Decision|10|||
146295115|NCT02072434|527595929|FG000|Overall Study|Adverse event, serious fatal|1|||
146295116|NCT02072434|527595930|FG001|Overall Study|Adverse event, serious fatal|6|||
146295117|NCT02072434|527595929|FG000|Overall Study|Adverse Event|7|||
146295118|NCT02072434|527595930|FG001|Overall Study|Adverse Event|6|||
146295119|NCT02072434|527595929|FG000|Overall Study|Withdrawal by Subject|17|||
146295120|NCT02072434|527595930|FG001|Overall Study|Withdrawal by Subject|29|||
146295121|NCT02072434|527595929|FG000|Overall Study|Other|14|||
146295122|NCT02072434|527595930|FG001|Overall Study|Other|29|||
146295123|NCT02072434|527595929|FG000|Overall Study|Lost to Follow-up|0|||
146295124|NCT02072434|527595930|FG001|Overall Study|Lost to Follow-up|1|||
146295125|NCT00888433|527595935|FG000|Overall Study|Withdrawal by Subject|1|||
146295126|NCT00888433|527595936|FG001|Overall Study|Withdrawal by Subject|2|||
146295127|NCT00888433|527595935|FG000|Overall Study|Missed Visit|2|||
146295128|NCT00888433|527595936|FG001|Overall Study|Missed Visit|1|||
146295129|NCT04175808|527595937|FG000|Part A|Miscellaneous|2|||
146295130|NCT04175808|527595938|FG001|Part A|Miscellaneous|0|||
146295131|NCT04175808|527595939|FG002|Part A|Miscellaneous|0|||
146295132|NCT04175808|527595940|FG003|Part A|Miscellaneous|0|||
146295133|NCT04175808|527595941|FG004|Part A|Miscellaneous|0|||
146295134|NCT04175808|527595942|FG005|Part A|Miscellaneous|0|||
146295135|NCT04175808|527595943|FG006|Part A|Miscellaneous|0|||
146295136|NCT02021292|527595945|FG000|Overall Study|Physician Decision|0|||
146295137|NCT02021292|527595946|FG001|Overall Study|Physician Decision|1|||
146295138|NCT02021292|527595945|FG000|Overall Study|Lost to Follow-up|0|||
146295139|NCT02021292|527595946|FG001|Overall Study|Lost to Follow-up|1|||
146295140|NCT02021292|527595945|FG000|Overall Study|Death|0|||
146295141|NCT02021292|527595946|FG001|Overall Study|Death|1|||
146295142|NCT00823901|527595947|FG000|Overall Study|Adverse Event|1|||
146295143|NCT00823901|527595948|FG001|Overall Study|Adverse Event|1|||
146295144|NCT00823901|527595947|FG000|Overall Study|Lack of Efficacy|1|||
146295145|NCT00823901|527595948|FG001|Overall Study|Lack of Efficacy|0|||
146295146|NCT00823901|527595947|FG000|Overall Study|Lost to Follow-up|2|||
146295147|NCT00823901|527595948|FG001|Overall Study|Lost to Follow-up|1|||
146295148|NCT01369511|527595949|FG000|Overall Study|Adverse Event|1|||
146087906|NCT04365257|526841899|FG000|Overall Study|Withdrawal by Subject|0|||
146235184|NCT05580003|527378491|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235185|NCT05580003|527378492|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235186|NCT05580003|527378493|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235187|NCT05580003|527378494|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146295149|NCT01369511|527595950|FG001|Overall Study|Adverse Event|1|||
146295150|NCT01369511|527595951|FG002|Overall Study|Adverse Event|5|||
146295151|NCT01369511|527595952|FG003|Overall Study|Adverse Event|0|||
146295152|NCT01369511|527595949|FG000|Overall Study|Entry criteria not met|2|||
146295153|NCT01369511|527595950|FG001|Overall Study|Entry criteria not met|0|||
146295154|NCT01369511|527595951|FG002|Overall Study|Entry criteria not met|0|||
145891103|NCT02581163|526107613|FG000|Overall Study|Other, not specified|9|||
146295155|NCT01369511|527595952|FG003|Overall Study|Entry criteria not met|1|||
146087907|NCT04365257|526841900|FG001|Overall Study|Withdrawal by Subject|1|||
146295156|NCT01369511|527595949|FG000|Overall Study|Lost to Follow-up|0|||
146295157|NCT01369511|527595950|FG001|Overall Study|Lost to Follow-up|1|||
146295158|NCT01369511|527595951|FG002|Overall Study|Lost to Follow-up|1|||
145891104|NCT00262041|526107614|FG000|Overall Study|Withdrawal by Subject|0|||
146295159|NCT01369511|527595952|FG003|Overall Study|Lost to Follow-up|2|||
146295160|NCT01369511|527595949|FG000|Overall Study|Protocol Violation|0|||
146295161|NCT01369511|527595950|FG001|Overall Study|Protocol Violation|1|||
146295162|NCT01369511|527595951|FG002|Overall Study|Protocol Violation|0|||
146087908|NCT00509262|526841903|FG000|Overall Study|Adverse Event|16|||
146087909|NCT00509262|526841904|FG001|Overall Study|Adverse Event|18|||
146087910|NCT00509262|526841903|FG000|Overall Study|Other|2|||
146087911|NCT00509262|526841904|FG001|Overall Study|Other|2|||
146087912|NCT00509262|526841903|FG000|Overall Study|Lack of Efficacy|1|||
146087913|NCT00509262|526841904|FG001|Overall Study|Lack of Efficacy|0|||
146087914|NCT00509262|526841903|FG000|Overall Study|Lost to Follow-up|1|||
146087915|NCT00509262|526841904|FG001|Overall Study|Lost to Follow-up|6|||
146087916|NCT00509262|526841903|FG000|Overall Study|Physician Decision|1|||
146087917|NCT00509262|526841904|FG001|Overall Study|Physician Decision|3|||
146087918|NCT00509262|526841903|FG000|Overall Study|Protocol Violation|2|||
146087919|NCT00509262|526841904|FG001|Overall Study|Protocol Violation|2|||
146087920|NCT00509262|526841903|FG000|Overall Study|Withdrawal by Subject|24|||
146087921|NCT00509262|526841904|FG001|Overall Study|Withdrawal by Subject|11|||
146087922|NCT01715129|526841905|FG000|Overall Study|Adverse Event, fatal|1|||
146087923|NCT01715129|526841905|FG000|Overall Study|Lack of Efficacy|3|||
146087924|NCT01715129|526841905|FG000|Overall Study|Protocol Violation|1|||
146087925|NCT01715129|526841905|FG000|Overall Study|Consent Withdrawn|2|||
146087926|NCT01715129|526841905|FG000|Overall Study|Lost to Follow-up|1|||
146087927|NCT01715129|526841905|FG000|Overall Study|Other|1|||
146087928|NCT01146860|526841906|FG000|Overall Study|Withdrawal by Subject|0|||
146087929|NCT01146860|526841907|FG001|Overall Study|Withdrawal by Subject|1|||
146087930|NCT01423604|526841909|FG000|Safety Run-In|Adverse Event|3|||
146087931|NCT01423604|526841910|FG001|Safety Run-In|Adverse Event|0|||
146087932|NCT01423604|526841909|FG000|Safety Run-In|Death|1|||
146087933|NCT01423604|526841910|FG001|Safety Run-In|Death|0|||
146087934|NCT01423604|526841909|FG000|Safety Run-In|Physician Decision|1|||
146087935|NCT01423604|526841910|FG001|Safety Run-In|Physician Decision|0|||
146087936|NCT01423604|526841909|FG000|Safety Run-In|Disease progression|3|||
146087937|NCT01423604|526841910|FG001|Safety Run-In|Disease progression|0|||
146087938|NCT01423604|526841909|FG000|Safety Run-In|Patient decision|1|||
146087939|NCT01423604|526841910|FG001|Safety Run-In|Patient decision|0|||
146087940|NCT01423604|526841909|FG000|Randomized|Adverse Event|4|||
146087941|NCT01423604|526841910|FG001|Randomized|Adverse Event|10|||
146087942|NCT01423604|526841909|FG000|Randomized|Death|1|||
146087943|NCT01423604|526841910|FG001|Randomized|Death|0|||
146087944|NCT01423604|526841909|FG000|Randomized|Physician Decision|16|||
146087945|NCT01423604|526841910|FG001|Randomized|Physician Decision|13|||
146087946|NCT01423604|526841909|FG000|Randomized|Other - unspecified|37|||
146087947|NCT01423604|526841910|FG001|Randomized|Other - unspecified|31|||
146087948|NCT01423604|526841909|FG000|Randomized|Patient decision|5|||
146087949|NCT01423604|526841910|FG001|Randomized|Patient decision|9|||
146087950|NCT00378079|526841911|FG000|Overall Study|Lost to Follow-up|6|||
146087951|NCT00378079|526841912|FG001|Overall Study|Lost to Follow-up|1|||
146087952|NCT00378079|526841913|FG002|Overall Study|Lost to Follow-up|0|||
146087953|NCT02581943|526841914|FG000|Overall Study|Death|5|||
146087954|NCT02581943|526841915|FG001|Overall Study|Death|2|||
146087955|NCT02581943|526841914|FG000|Overall Study|Disease Progression|12|||
146087956|NCT02581943|526841915|FG001|Overall Study|Disease Progression|15|||
146087957|NCT02581943|526841914|FG000|Overall Study|Withdrawal by Subject|1|||
146087958|NCT02581943|526841915|FG001|Overall Study|Withdrawal by Subject|2|||
146087959|NCT01233687|526841916|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
146087960|NCT01233687|526841916|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
146087961|NCT01233687|526841916|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
146087962|NCT02290431|526841917|FG000|Overall Study|Adverse Event|20|||
146087963|NCT02290431|526841917|FG000|Overall Study|Progressive disease|4|||
146087964|NCT02290431|526841917|FG000|Overall Study|Study terminated by Sponsor|1|||
146087965|NCT02290431|526841917|FG000|Overall Study|Physician Decision|2|||
146087966|NCT02274038|526841922|FG000|Overall Study|Death|1|||
146087967|NCT03783702|526841923|FG000|Overall Study|Lost to Follow-up|6|||
146087968|NCT03783702|526841924|FG001|Overall Study|Lost to Follow-up|8|||
146087969|NCT03783702|526841923|FG000|Overall Study|Protocol Violation|1|||
146087970|NCT03783702|526841924|FG001|Overall Study|Protocol Violation|3|||
146087971|NCT04473482|526841925|FG000|Overall Study|Death|0|||
146087972|NCT04473482|526841926|FG001|Overall Study|Death|3|||
146087973|NCT04473482|526841925|FG000|Overall Study|Lost to Follow-up|9|||
146087974|NCT04473482|526841926|FG001|Overall Study|Lost to Follow-up|7|||
146087975|NCT04473482|526841925|FG000|Overall Study|Withdrawal by Subject|2|||
146087976|NCT04473482|526841926|FG001|Overall Study|Withdrawal by Subject|1|||
146087977|NCT00745615|526841933|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
146087978|NCT00745615|526841934|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
146087979|NCT00745615|526841935|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146087980|NCT00745615|526841936|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
146087981|NCT00745615|526841937|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146087982|NCT00745615|526841938|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
146087983|NCT00745615|526841933|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146087984|NCT00745615|526841934|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
146087985|NCT00745615|526841935|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146087986|NCT00745615|526841936|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146235188|NCT05580003|527378495|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235189|NCT05580003|527378496|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145891105|NCT00262041|526107615|FG001|Overall Study|Withdrawal by Subject|3|||
145891106|NCT00262041|526107616|FG002|Overall Study|Withdrawal by Subject|1|||
145891107|NCT00262041|526107614|FG000|Overall Study|Lost to Follow-up|1|||
145891108|NCT00262041|526107615|FG001|Overall Study|Lost to Follow-up|1|||
145891109|NCT00262041|526107616|FG002|Overall Study|Lost to Follow-up|5|||
145891110|NCT00262041|526107614|FG000|Overall Study|Unable to classify|1|||
145891111|NCT00262041|526107615|FG001|Overall Study|Unable to classify|0|||
145891112|NCT00262041|526107616|FG002|Overall Study|Unable to classify|0|||
145891113|NCT03578237|526107619|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
145891114|NCT03578237|526107620|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
145891115|NCT01173471|526107621|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145891116|NCT01173471|526107622|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146235190|NCT05580003|527378497|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235191|NCT05580003|527378498|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235192|NCT05580003|527378499|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235193|NCT05580003|527378500|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235194|NCT05580003|527378501|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146235195|NCT05580003|527378474|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235196|NCT05580003|527378475|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235197|NCT05580003|527378476|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235198|NCT05580003|527378477|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235199|NCT05580003|527378478|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235200|NCT05580003|527378479|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
146235201|NCT05580003|527378480|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235202|NCT05580003|527378481|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235203|NCT05580003|527378482|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235204|NCT05580003|527378483|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235205|NCT05580003|527378484|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235206|NCT05580003|527378485|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235207|NCT05580003|527378486|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235208|NCT05580003|527378487|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235209|NCT05580003|527378488|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235210|NCT05580003|527378489|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235211|NCT05580003|527378490|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235212|NCT05580003|527378491|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235213|NCT05580003|527378492|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235214|NCT05580003|527378493|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235215|NCT05580003|527378494|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235216|NCT05580003|527378495|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235217|NCT05580003|527378496|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235218|NCT05580003|527378497|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235219|NCT05580003|527378498|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235220|NCT05580003|527378499|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235221|NCT05580003|527378500|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235222|NCT05580003|527378501|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
146235223|NCT05580003|527378474|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235224|NCT05580003|527378475|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235225|NCT05580003|527378476|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235226|NCT05580003|527378477|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
146235227|NCT05580003|527378478|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235228|NCT05580003|527378479|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235229|NCT05580003|527378480|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235230|NCT05580003|527378481|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235231|NCT05580003|527378482|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235232|NCT05580003|527378483|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235233|NCT05580003|527378484|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235234|NCT05580003|527378485|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235235|NCT05580003|527378486|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235236|NCT05580003|527378487|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235237|NCT05580003|527378488|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235238|NCT05580003|527378489|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235239|NCT05580003|527378490|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235240|NCT05580003|527378491|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235241|NCT05580003|527378492|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235242|NCT05580003|527378493|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235243|NCT05580003|527378494|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235244|NCT05580003|527378495|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235245|NCT05580003|527378496|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235246|NCT05580003|527378497|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235247|NCT05580003|527378498|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235248|NCT05580003|527378499|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235249|NCT05580003|527378500|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235250|NCT05580003|527378501|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
146235251|NCT05580003|527378474|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235252|NCT05580003|527378475|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
146235253|NCT05580003|527378476|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235254|NCT05580003|527378477|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235255|NCT05580003|527378478|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235256|NCT05580003|527378479|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235257|NCT05580003|527378480|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235258|NCT05580003|527378481|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235259|NCT05580003|527378482|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235260|NCT05580003|527378483|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235261|NCT05580003|527378484|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235262|NCT05580003|527378485|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235263|NCT05580003|527378486|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235264|NCT05580003|527378487|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235265|NCT05580003|527378488|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235266|NCT05580003|527378489|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235267|NCT05580003|527378490|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235268|NCT05580003|527378491|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235269|NCT05580003|527378492|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235270|NCT05580003|527378493|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235271|NCT05580003|527378494|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235272|NCT05580003|527378495|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235273|NCT05580003|527378496|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235274|NCT05580003|527378497|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235275|NCT05580003|527378498|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235276|NCT05580003|527378499|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235277|NCT05580003|527378500|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235278|NCT05580003|527378501|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
146235279|NCT05580003|527378474|FG000|Part 2 (up to 10 Days)|Other|0|||
146235280|NCT05580003|527378475|FG001|Part 2 (up to 10 Days)|Other|0|||
146235281|NCT05580003|527378476|FG002|Part 2 (up to 10 Days)|Other|0|||
146235282|NCT05580003|527378477|FG003|Part 2 (up to 10 Days)|Other|0|||
146235283|NCT05580003|527378478|FG004|Part 2 (up to 10 Days)|Other|0|||
146235284|NCT05580003|527378479|FG005|Part 2 (up to 10 Days)|Other|0|||
146235285|NCT05580003|527378480|FG006|Part 2 (up to 10 Days)|Other|0|||
146235286|NCT05580003|527378481|FG007|Part 2 (up to 10 Days)|Other|0|||
146235287|NCT05580003|527378482|FG008|Part 2 (up to 10 Days)|Other|0|||
146235288|NCT05580003|527378483|FG009|Part 2 (up to 10 Days)|Other|1|||
146235289|NCT05580003|527378484|FG010|Part 2 (up to 10 Days)|Other|0|||
146235290|NCT05580003|527378485|FG011|Part 2 (up to 10 Days)|Other|0|||
146235291|NCT05580003|527378486|FG012|Part 2 (up to 10 Days)|Other|0|||
146235292|NCT05580003|527378487|FG013|Part 2 (up to 10 Days)|Other|0|||
146235293|NCT05580003|527378488|FG014|Part 2 (up to 10 Days)|Other|0|||
146235294|NCT05580003|527378489|FG015|Part 2 (up to 10 Days)|Other|0|||
146235295|NCT05580003|527378490|FG016|Part 2 (up to 10 Days)|Other|0|||
146235296|NCT05580003|527378491|FG017|Part 2 (up to 10 Days)|Other|0|||
146235297|NCT05580003|527378492|FG018|Part 2 (up to 10 Days)|Other|0|||
146235298|NCT05580003|527378493|FG019|Part 2 (up to 10 Days)|Other|0|||
146235299|NCT05580003|527378494|FG020|Part 2 (up to 10 Days)|Other|0|||
146235300|NCT05580003|527378495|FG021|Part 2 (up to 10 Days)|Other|0|||
146235301|NCT05580003|527378496|FG022|Part 2 (up to 10 Days)|Other|0|||
146235302|NCT05580003|527378497|FG023|Part 2 (up to 10 Days)|Other|0|||
146235303|NCT05580003|527378498|FG024|Part 2 (up to 10 Days)|Other|0|||
146235304|NCT05580003|527378499|FG025|Part 2 (up to 10 Days)|Other|0|||
146235305|NCT05580003|527378500|FG026|Part 2 (up to 10 Days)|Other|0|||
146235306|NCT05580003|527378501|FG027|Part 2 (up to 10 Days)|Other|0|||
146235307|NCT05580003|527378474|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235308|NCT05580003|527378475|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235309|NCT05580003|527378476|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235310|NCT05580003|527378477|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235311|NCT05580003|527378478|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235312|NCT05580003|527378479|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235313|NCT05580003|527378480|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235314|NCT05580003|527378481|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235315|NCT05580003|527378482|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235316|NCT05580003|527378483|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146295163|NCT01369511|527595952|FG003|Overall Study|Protocol Violation|2|||
146295164|NCT01369511|527595949|FG000|Overall Study|Physician Decision|3|||
146295165|NCT01369511|527595950|FG001|Overall Study|Physician Decision|4|||
146295166|NCT01369511|527595951|FG002|Overall Study|Physician Decision|0|||
146295167|NCT01369511|527595952|FG003|Overall Study|Physician Decision|0|||
146295168|NCT01369511|527595949|FG000|Overall Study|Sponsor decision|2|||
146295169|NCT01369511|527595950|FG001|Overall Study|Sponsor decision|0|||
146295170|NCT01369511|527595951|FG002|Overall Study|Sponsor decision|1|||
146295171|NCT01369511|527595952|FG003|Overall Study|Sponsor decision|0|||
146295172|NCT01369511|527595949|FG000|Overall Study|Withdrawal by Subject|5|||
146295173|NCT01369511|527595950|FG001|Overall Study|Withdrawal by Subject|6|||
146295174|NCT01369511|527595951|FG002|Overall Study|Withdrawal by Subject|4|||
146295175|NCT01369511|527595952|FG003|Overall Study|Withdrawal by Subject|6|||
146295176|NCT01180998|527595954|FG000|Overall Study|Poor Vision|0|||
146295177|NCT01180998|527595955|FG001|Overall Study|Poor Vision|2|||
146295178|NCT01180998|527595956|FG002|Overall Study|Poor Vision|2|||
146295179|NCT01180998|527595954|FG000|Overall Study|Lost to Follow-up|0|||
146295180|NCT01180998|527595955|FG001|Overall Study|Lost to Follow-up|0|||
146295181|NCT01180998|527595956|FG002|Overall Study|Lost to Follow-up|1|||
146295182|NCT01180998|527595954|FG000|Overall Study|Protocol Violation|1|||
146295183|NCT01180998|527595955|FG001|Overall Study|Protocol Violation|2|||
146295184|NCT01180998|527595956|FG002|Overall Study|Protocol Violation|0|||
146295185|NCT01180998|527595954|FG000|Overall Study|Withdrawal by Subject|0|||
146295186|NCT01180998|527595955|FG001|Overall Study|Withdrawal by Subject|0|||
146295187|NCT01180998|527595956|FG002|Overall Study|Withdrawal by Subject|1|||
146295188|NCT01180998|527595954|FG000|Overall Study|Poor comfort|3|||
146295189|NCT01180998|527595955|FG001|Overall Study|Poor comfort|0|||
146295190|NCT01180998|527595956|FG002|Overall Study|Poor comfort|4|||
146295191|NCT01180998|527595954|FG000|Overall Study|Poor lens handling|0|||
146295192|NCT01180998|527595955|FG001|Overall Study|Poor lens handling|0|||
146295193|NCT01180998|527595956|FG002|Overall Study|Poor lens handling|2|||
146295194|NCT01376349|527595957|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
146295195|NCT01376349|527595958|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
146295196|NCT01376349|527595959|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
146295197|NCT01376349|527595957|FG000|Raondomized Treatment|Adverse Event|13|||
146295198|NCT01376349|527595958|FG001|Raondomized Treatment|Adverse Event|17|||
146295199|NCT01376349|527595959|FG002|Raondomized Treatment|Adverse Event|14|||
146295200|NCT01376349|527595957|FG000|Raondomized Treatment|Unkown|1|||
146295201|NCT01376349|527595958|FG001|Raondomized Treatment|Unkown|2|||
146295202|NCT01376349|527595959|FG002|Raondomized Treatment|Unkown|1|||
146295203|NCT01376349|527595957|FG000|Raondomized Treatment|Alternative Treatment|0|||
146295204|NCT01376349|527595958|FG001|Raondomized Treatment|Alternative Treatment|0|||
146295205|NCT01376349|527595959|FG002|Raondomized Treatment|Alternative Treatment|1|||
146295206|NCT00068588|527595962|FG000|Overall Study|Adverse Event|0|||
146295207|NCT00068588|527595963|FG001|Overall Study|Adverse Event|0|||
146295208|NCT00068588|527595964|FG002|Overall Study|Adverse Event|2|||
146295209|NCT00068588|527595962|FG000|Overall Study|Withdrawal by Subject|0|||
146295210|NCT00068588|527595963|FG001|Overall Study|Withdrawal by Subject|0|||
146295211|NCT00068588|527595964|FG002|Overall Study|Withdrawal by Subject|1|||
146295212|NCT00068588|527595962|FG000|Overall Study|Poor KPS|0|||
145891117|NCT01173471|526107623|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145891118|NCT01173471|526107624|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145891119|NCT01173471|526107621|FG000|Overall Study|Condition under investigation worsened|2|||
145891120|NCT01173471|526107622|FG001|Overall Study|Condition under investigation worsened|0|||
145891121|NCT01173471|526107623|FG002|Overall Study|Condition under investigation worsened|0|||
145891122|NCT01173471|526107624|FG003|Overall Study|Condition under investigation worsened|0|||
146235317|NCT05580003|527378484|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235318|NCT05580003|527378485|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235319|NCT05580003|527378486|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235320|NCT05580003|527378487|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235321|NCT05580003|527378488|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235322|NCT05580003|527378489|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235323|NCT05580003|527378490|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235324|NCT05580003|527378491|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146295213|NCT00068588|527595963|FG001|Overall Study|Poor KPS|0|||
146295214|NCT00068588|527595964|FG002|Overall Study|Poor KPS|1|||
146295215|NCT04098068|527595965|FG000|Overall Study|Disease Progression|7|||
146295216|NCT04098068|527595965|FG000|Overall Study|Withdrawal by Subject|2|||
146295217|NCT04098068|527595965|FG000|Overall Study|New Cancer Diagnosis|1|||
146295218|NCT02465463|527595967|FG000|Overall Study|Lost to Follow-up|2|||
145891123|NCT01173471|526107621|FG000|Overall Study|Lost to Follow-up|0|||
146295219|NCT02465463|527595968|FG001|Overall Study|Lost to Follow-up|1|||
146295220|NCT02465463|527595967|FG000|Overall Study|Death|1|||
146295221|NCT02465463|527595968|FG001|Overall Study|Death|0|||
146295222|NCT02465463|527595967|FG000|Overall Study|Protocol Violation|1|||
146295223|NCT02465463|527595968|FG001|Overall Study|Protocol Violation|0|||
146295224|NCT01139658|527595973|FG000|Overall Study|Adverse Event|10|||
146295225|NCT01139658|527595974|FG001|Overall Study|Adverse Event|27|||
146235325|NCT05580003|527378492|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235326|NCT05580003|527378493|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
146235327|NCT05580003|527378494|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235328|NCT05580003|527378495|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235329|NCT05580003|527378496|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235330|NCT05580003|527378497|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235331|NCT05580003|527378498|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235332|NCT05580003|527378499|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235333|NCT05580003|527378500|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235334|NCT05580003|527378501|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
146235335|NCT05580003|527378474|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235336|NCT05580003|527378475|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235337|NCT05580003|527378476|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235338|NCT05580003|527378477|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235339|NCT05580003|527378478|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235340|NCT05580003|527378479|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235341|NCT05580003|527378480|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235342|NCT05580003|527378481|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235343|NCT05580003|527378482|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235344|NCT05580003|527378483|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235345|NCT05580003|527378484|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235346|NCT05580003|527378485|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235347|NCT05580003|527378486|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235348|NCT05580003|527378487|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235349|NCT05580003|527378488|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235350|NCT05580003|527378489|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235351|NCT05580003|527378490|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235352|NCT05580003|527378491|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145891124|NCT01173471|526107622|FG001|Overall Study|Lost to Follow-up|0|||
145970870|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
145970871|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Death|3|||
145970872|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Death|1|||
145970873|NCT01056276|526407294|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
145970874|NCT01056276|526407295|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
145970875|NCT01056276|526407294|FG000|Maintenance Therapy|Toxicity|0|||
145970876|NCT01056276|526407295|FG001|Maintenance Therapy|Toxicity|2|||
145970877|NCT01056276|526407294|FG000|Maintenance Therapy|Progressive Disease|0|||
145970878|NCT01056276|526407295|FG001|Maintenance Therapy|Progressive Disease|9|||
145970879|NCT01056276|526407294|FG000|Maintenance Therapy|Physician Decision|0|||
145970880|NCT01056276|526407295|FG001|Maintenance Therapy|Physician Decision|1|||
146087987|NCT00745615|526841937|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146087988|NCT00745615|526841938|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
146087989|NCT00745615|526841933|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
146087990|NCT00745615|526841934|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
146087991|NCT00745615|526841935|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
146087992|NCT00745615|526841936|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
146087993|NCT00745615|526841937|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
146087994|NCT00745615|526841938|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
146087995|NCT00745615|526841933|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145891125|NCT01173471|526107623|FG002|Overall Study|Lost to Follow-up|1|||
145891126|NCT01173471|526107624|FG003|Overall Study|Lost to Follow-up|0|||
145891127|NCT01173471|526107621|FG000|Overall Study|Reason given as Other|0|||
145891128|NCT01173471|526107622|FG001|Overall Study|Reason given as Other|0|||
145891129|NCT01173471|526107623|FG002|Overall Study|Reason given as Other|1|||
145891130|NCT01173471|526107624|FG003|Overall Study|Reason given as Other|0|||
145891131|NCT04132336|526107625|FG000|Overall Study|Investigator Decision|0|||
145891132|NCT04132336|526107626|FG001|Overall Study|Investigator Decision|1|||
145891133|NCT04132336|526107627|FG002|Overall Study|Investigator Decision|0|||
145891134|NCT04132336|526107628|FG003|Overall Study|Investigator Decision|0|||
145891135|NCT04132336|526107629|FG004|Overall Study|Investigator Decision|0|||
145891136|NCT04132336|526107630|FG005|Overall Study|Investigator Decision|0|||
145891137|NCT04132336|526107631|FG006|Overall Study|Investigator Decision|0|||
145891138|NCT02488330|526107633|FG000|Overall Study|Adverse Event|1|||
145891139|NCT02488330|526107633|FG000|Overall Study|Physician Decision|2|||
145891140|NCT02488330|526107633|FG000|Overall Study|Death|2|||
145891141|NCT02488330|526107633|FG000|Overall Study|Disease Progression|3|||
145891142|NCT02488330|526107633|FG000|Overall Study|Study Termination by Sponsor|4|||
145891143|NCT00584844|526107634|FG000|Overall Study|Withdrawal by Subject|59|||
145891144|NCT00584844|526107634|FG000|Overall Study|Screen Failure|20|||
145970881|NCT01056276|526407294|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
145970882|NCT01056276|526407295|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
145970883|NCT01056276|526407294|FG000|Maintenance Therapy|Intercurrent Illness|0|||
145891145|NCT01206816|526107637|FG000|Overall Study|Protocol Violation|0|||
145891146|NCT01206816|526107638|FG001|Overall Study|Protocol Violation|0|||
145891147|NCT01206816|526107639|FG002|Overall Study|Protocol Violation|1|||
145891148|NCT01206816|526107640|FG003|Overall Study|Protocol Violation|0|||
145891149|NCT01206816|526107641|FG004|Overall Study|Protocol Violation|0|||
145891150|NCT01206816|526107642|FG005|Overall Study|Protocol Violation|0|||
145891151|NCT01206816|526107643|FG006|Overall Study|Protocol Violation|0|||
145891152|NCT01206816|526107637|FG000|Overall Study|Withdrawal by Subject|0|||
145891153|NCT01206816|526107638|FG001|Overall Study|Withdrawal by Subject|0|||
145891154|NCT01206816|526107639|FG002|Overall Study|Withdrawal by Subject|1|||
145891155|NCT01206816|526107640|FG003|Overall Study|Withdrawal by Subject|0|||
145891156|NCT01206816|526107641|FG004|Overall Study|Withdrawal by Subject|0|||
145891157|NCT01206816|526107642|FG005|Overall Study|Withdrawal by Subject|0|||
145891158|NCT01206816|526107643|FG006|Overall Study|Withdrawal by Subject|0|||
145891159|NCT01206816|526107637|FG000|Overall Study|Progressive disease|3|||
145970884|NCT01056276|526407295|FG001|Maintenance Therapy|Intercurrent Illness|1|||
145970885|NCT01056276|526407294|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
145970886|NCT01056276|526407295|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
145970887|NCT01881425|526407296|FG000|Overall Study|Death|5|||
145970888|NCT01881425|526407297|FG001|Overall Study|Death|1|||
145970889|NCT01881425|526407296|FG000|Overall Study|Withdrawal by Subject|8|||
145970890|NCT01881425|526407297|FG001|Overall Study|Withdrawal by Subject|3|||
145970891|NCT01881425|526407296|FG000|Overall Study|Physician Decision|2|||
145970892|NCT01881425|526407297|FG001|Overall Study|Physician Decision|1|||
145970893|NCT01881425|526407296|FG000|Overall Study|Adverse Event|3|||
145970894|NCT01881425|526407297|FG001|Overall Study|Adverse Event|0|||
145970895|NCT01881425|526407296|FG000|Overall Study|General Anesthesia panic attack|0|||
145970896|NCT01881425|526407297|FG001|Overall Study|General Anesthesia panic attack|1|||
145970897|NCT01881425|526407296|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
145970898|NCT01881425|526407297|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
145970899|NCT01881425|526407296|FG000|Overall Study|Lost to Follow-up|7|||
145970900|NCT01881425|526407297|FG001|Overall Study|Lost to Follow-up|2|||
145970901|NCT00071981|526407298|FG000|Overall Study|Lack of Efficacy|37|||
145970902|NCT00071981|526407299|FG001|Overall Study|Lack of Efficacy|29|||
146087996|NCT00745615|526841934|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
146087997|NCT00745615|526841935|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146087998|NCT00745615|526841936|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146087999|NCT00745615|526841937|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146088000|NCT00745615|526841938|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
146088001|NCT00745615|526841933|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146088002|NCT00745615|526841934|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
146088003|NCT00745615|526841935|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146088004|NCT00745615|526841936|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146088005|NCT00745615|526841937|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146088006|NCT00745615|526841938|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
146088007|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146088008|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146088009|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146088010|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
146088011|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
146088012|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
146088013|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146088014|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146088015|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146088016|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
146088017|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
146088018|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
146088019|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146088020|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146088021|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146088022|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
146088023|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
146088024|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
146088025|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146088026|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
145970903|NCT00071981|526407300|FG002|Overall Study|Lack of Efficacy|30|||
145970904|NCT00071981|526407301|FG003|Overall Study|Lack of Efficacy|43|||
146168101|NCT05267600|527128073|FG001|Overall Study|Lost to Follow-up|0|||
145891160|NCT01206816|526107638|FG001|Overall Study|Progressive disease|3|||
145891161|NCT01206816|526107639|FG002|Overall Study|Progressive disease|13|||
145891162|NCT01206816|526107640|FG003|Overall Study|Progressive disease|3|||
146295226|NCT01139658|527595973|FG000|Overall Study|Lack of Efficacy|15|||
146295227|NCT01139658|527595974|FG001|Overall Study|Lack of Efficacy|7|||
146295228|NCT01139658|527595973|FG000|Overall Study|Withdrawal by Subject|2|||
146295229|NCT01139658|527595974|FG001|Overall Study|Withdrawal by Subject|4|||
146295230|NCT01139658|527595973|FG000|Overall Study|No documentation of treatment|1|||
146295231|NCT01139658|527595974|FG001|Overall Study|No documentation of treatment|0|||
146295232|NCT01139658|527595973|FG000|Overall Study|Other|28|||
146295233|NCT01139658|527595974|FG001|Overall Study|Other|75|||
146295234|NCT01119001|527595976|FG000|Overall Study|Withdrawal by Subject|2|||
146295235|NCT04343248|527595977|FG000|Overall Study|Withdrawal by Subject|5|||
146295236|NCT04343248|527595978|FG001|Overall Study|Withdrawal by Subject|6|||
146295237|NCT04343248|527595977|FG000|Overall Study|Death|1|||
146295238|NCT04343248|527595978|FG001|Overall Study|Death|2|||
145891163|NCT01206816|526107641|FG004|Overall Study|Progressive disease|3|||
145891164|NCT01206816|526107642|FG005|Overall Study|Progressive disease|16|||
146295239|NCT04343248|527595977|FG000|Overall Study|Lost to Follow-up|9|||
146295240|NCT04343248|527595978|FG001|Overall Study|Lost to Follow-up|6|||
146295241|NCT04343248|527595977|FG000|Overall Study|Physician Decision|0|||
146295242|NCT04343248|527595978|FG001|Overall Study|Physician Decision|1|||
146295243|NCT04343248|527595977|FG000|Overall Study|Adverse Event|1|||
146295244|NCT04343248|527595978|FG001|Overall Study|Adverse Event|0|||
146295245|NCT03604523|527595979|FG000|Overall Study|Physician Decision|1|||
146295246|NCT03604523|527595980|FG001|Overall Study|Physician Decision|0|||
146295247|NCT00810394|527595987|FG000|Overall Study|Withdrawal by Subject|3|||
146295248|NCT00467285|527595988|FG000|Overall Study|Lost to Follow-up|4|||
146295249|NCT00467285|527595989|FG001|Overall Study|Lost to Follow-up|4|||
146295250|NCT03891524|527595990|FG000|Overall Study|Death|0|||
146295251|NCT03891524|527595991|FG001|Overall Study|Death|0|||
146295252|NCT03891524|527595992|FG002|Overall Study|Death|0|||
146295253|NCT03891524|527595993|FG003|Overall Study|Death|0|||
146295254|NCT03891524|527595994|FG004|Overall Study|Death|0|||
146295255|NCT03891524|527595995|FG005|Overall Study|Death|0|||
146295256|NCT03891524|527595996|FG006|Overall Study|Death|0|||
146295257|NCT03891524|527595997|FG007|Overall Study|Death|1|||
146295258|NCT03891524|527595990|FG000|Overall Study|Withdrawal by Subject|0|||
146295259|NCT03891524|527595991|FG001|Overall Study|Withdrawal by Subject|1|||
146295260|NCT03891524|527595992|FG002|Overall Study|Withdrawal by Subject|2|||
146295261|NCT03891524|527595993|FG003|Overall Study|Withdrawal by Subject|1|||
146295262|NCT03891524|527595994|FG004|Overall Study|Withdrawal by Subject|2|||
146295263|NCT03891524|527595995|FG005|Overall Study|Withdrawal by Subject|2|||
146295264|NCT03891524|527595996|FG006|Overall Study|Withdrawal by Subject|2|||
145891165|NCT01206816|526107643|FG006|Overall Study|Progressive disease|3|||
145891166|NCT01206816|526107637|FG000|Overall Study|Other AE|0|||
145891167|NCT01206816|526107638|FG001|Overall Study|Other AE|0|||
145891168|NCT01206816|526107639|FG002|Overall Study|Other AE|4|||
145891169|NCT01206816|526107640|FG003|Overall Study|Other AE|0|||
145891170|NCT01206816|526107641|FG004|Overall Study|Other AE|0|||
145891171|NCT01206816|526107642|FG005|Overall Study|Other AE|3|||
145891172|NCT01206816|526107643|FG006|Overall Study|Other AE|2|||
145891173|NCT01206816|526107637|FG000|Overall Study|other than stated above|0|||
145891174|NCT01206816|526107638|FG001|Overall Study|other than stated above|0|||
145891175|NCT01206816|526107639|FG002|Overall Study|other than stated above|1|||
145891176|NCT01206816|526107640|FG003|Overall Study|other than stated above|0|||
145891177|NCT01206816|526107641|FG004|Overall Study|other than stated above|0|||
145891178|NCT01206816|526107642|FG005|Overall Study|other than stated above|0|||
145891179|NCT01206816|526107643|FG006|Overall Study|other than stated above|1|||
146088027|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146295265|NCT03891524|527595997|FG007|Overall Study|Withdrawal by Subject|1|||
146295266|NCT00475033|527596000|FG000|Infant Series|Failed to return|3|||
146295267|NCT00475033|527596001|FG001|Infant Series|Failed to return|4|||
146295268|NCT00475033|527596000|FG000|Infant Series|Parent or legal guardian request|1|||
146295269|NCT00475033|527596001|FG001|Infant Series|Parent or legal guardian request|5|||
146295270|NCT00475033|527596000|FG000|Infant Series|Protocol Violation|1|||
146295271|NCT00475033|527596001|FG001|Infant Series|Protocol Violation|2|||
146295272|NCT00475033|527596000|FG000|Infant Series|Lost to Follow-up|2|||
146295273|NCT00475033|527596001|FG001|Infant Series|Lost to Follow-up|0|||
146295274|NCT00475033|527596000|FG000|Infant Series|Adverse Event|0|||
146295275|NCT00475033|527596001|FG001|Infant Series|Adverse Event|2|||
146295276|NCT00475033|527596000|FG000|After the Infant Series|Adverse Event|0|||
146295277|NCT00475033|527596001|FG001|After the Infant Series|Adverse Event|4|||
146295278|NCT00475033|527596000|FG000|After the Infant Series|Parent or legal guardian request|2|||
146295279|NCT00475033|527596001|FG001|After the Infant Series|Parent or legal guardian request|2|||
146295280|NCT00475033|527596000|FG000|After the Infant Series|Failed to return|2|||
146295281|NCT00475033|527596001|FG001|After the Infant Series|Failed to return|1|||
145891180|NCT01939496|526107644|FG000|Overall Study|Adverse Event|2|||
145891181|NCT01939496|526107645|FG001|Overall Study|Adverse Event|0|||
145891182|NCT01939496|526107646|FG002|Overall Study|Adverse Event|0|||
146295282|NCT00475033|527596000|FG000|After the Infant Series|Protocol Violation|1|||
146295283|NCT00475033|527596001|FG001|After the Infant Series|Protocol Violation|0|||
145891183|NCT01939496|526107644|FG000|Overall Study|Lost to Follow-up|1|||
145891184|NCT01939496|526107645|FG001|Overall Study|Lost to Follow-up|1|||
145891185|NCT01939496|526107646|FG002|Overall Study|Lost to Follow-up|0|||
145891186|NCT01939496|526107644|FG000|Overall Study|Physician Decision|1|||
145891187|NCT01939496|526107645|FG001|Overall Study|Physician Decision|0|||
145891188|NCT01939496|526107646|FG002|Overall Study|Physician Decision|0|||
145891189|NCT01939496|526107644|FG000|Overall Study|Protocol Violation|3|||
145891190|NCT01939496|526107645|FG001|Overall Study|Protocol Violation|0|||
145891191|NCT01939496|526107646|FG002|Overall Study|Protocol Violation|0|||
145891192|NCT01939496|526107644|FG000|Overall Study|Withdrawal by Subject|0|||
145891193|NCT01939496|526107645|FG001|Overall Study|Withdrawal by Subject|1|||
145891194|NCT01939496|526107646|FG002|Overall Study|Withdrawal by Subject|1|||
146088028|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
146295284|NCT00475033|527596000|FG000|After the Infant Series|Lost to Follow-up|1|||
146295285|NCT00475033|527596001|FG001|After the Infant Series|Lost to Follow-up|0|||
146295286|NCT00475033|527596000|FG000|After the Infant Series|Other|0|||
146295287|NCT00475033|527596001|FG001|After the Infant Series|Other|1|||
146295288|NCT00475033|527596000|FG000|Toddler Dose|Parent or legal guardian request|2|||
146295289|NCT00475033|527596001|FG001|Toddler Dose|Parent or legal guardian request|0|||
146295290|NCT00475033|527596000|FG000|Toddler Dose|Failed to return|1|||
146295291|NCT00475033|527596001|FG001|Toddler Dose|Failed to return|0|||
146295292|NCT00475033|527596000|FG000|Toddler Dose|Lost to Follow-up|1|||
146295293|NCT00475033|527596001|FG001|Toddler Dose|Lost to Follow-up|0|||
146295294|NCT03231943|527596002|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295295|NCT03231943|527596003|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
146295296|NCT03231943|527596004|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
146295297|NCT03231943|527596005|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295298|NCT03231943|527596006|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295299|NCT03231943|527596007|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295300|NCT03231943|527596008|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295301|NCT03231943|527596009|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295302|NCT03231943|527596010|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295303|NCT03231943|527596011|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295304|NCT03231943|527596012|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295305|NCT03231943|527596013|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295306|NCT03231943|527596014|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
146295307|NCT03231943|527596002|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295308|NCT03231943|527596003|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
146295309|NCT03231943|527596004|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295310|NCT03231943|527596005|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295311|NCT03231943|527596006|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295312|NCT03231943|527596007|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295313|NCT03231943|527596008|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295314|NCT03231943|527596009|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295315|NCT03231943|527596010|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295316|NCT03231943|527596011|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295317|NCT03231943|527596012|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295318|NCT03231943|527596013|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295319|NCT03231943|527596014|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
146295320|NCT03231943|527596002|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
146295321|NCT03231943|527596003|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295322|NCT03231943|527596004|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295323|NCT03231943|527596005|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295324|NCT03231943|527596006|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295325|NCT03231943|527596007|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295326|NCT03231943|527596008|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295327|NCT03231943|527596009|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295328|NCT03231943|527596010|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295329|NCT03231943|527596011|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295330|NCT03231943|527596012|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295331|NCT03231943|527596013|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295332|NCT03231943|527596014|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
146295333|NCT03231943|527596002|FG000|Part 2|Adverse Event|0|||
146295334|NCT03231943|527596003|FG001|Part 2|Adverse Event|0|||
146295335|NCT03231943|527596004|FG002|Part 2|Adverse Event|0|||
146295336|NCT03231943|527596005|FG003|Part 2|Adverse Event|0|||
146295337|NCT03231943|527596006|FG004|Part 2|Adverse Event|0|||
146295338|NCT03231943|527596007|FG005|Part 2|Adverse Event|0|||
146295339|NCT03231943|527596008|FG006|Part 2|Adverse Event|0|||
145891195|NCT01939496|526107644|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
145891196|NCT01939496|526107645|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
145891197|NCT01939496|526107646|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
145891198|NCT01939496|526107644|FG000|Overall Study|Other|2|||
146295340|NCT03231943|527596009|FG007|Part 2|Adverse Event|0|||
146295341|NCT03231943|527596010|FG008|Part 2|Adverse Event|0|||
146295342|NCT03231943|527596011|FG009|Part 2|Adverse Event|0|||
146295343|NCT03231943|527596012|FG010|Part 2|Adverse Event|1|||
146295344|NCT03231943|527596013|FG011|Part 2|Adverse Event|0|||
146295345|NCT03231943|527596014|FG012|Part 2|Adverse Event|0|||
146295346|NCT03231943|527596002|FG000|Part 2|Withdrawal by Subject|0|||
146295347|NCT03231943|527596003|FG001|Part 2|Withdrawal by Subject|0|||
146295348|NCT03231943|527596004|FG002|Part 2|Withdrawal by Subject|0|||
146295349|NCT03231943|527596005|FG003|Part 2|Withdrawal by Subject|0|||
146295350|NCT03231943|527596006|FG004|Part 2|Withdrawal by Subject|0|||
146295351|NCT03231943|527596007|FG005|Part 2|Withdrawal by Subject|0|||
146295352|NCT03231943|527596008|FG006|Part 2|Withdrawal by Subject|0|||
146295353|NCT03231943|527596009|FG007|Part 2|Withdrawal by Subject|0|||
146295354|NCT03231943|527596010|FG008|Part 2|Withdrawal by Subject|0|||
146295355|NCT03231943|527596011|FG009|Part 2|Withdrawal by Subject|0|||
146295356|NCT03231943|527596012|FG010|Part 2|Withdrawal by Subject|0|||
146295357|NCT03231943|527596013|FG011|Part 2|Withdrawal by Subject|1|||
146295358|NCT03231943|527596014|FG012|Part 2|Withdrawal by Subject|0|||
146295359|NCT00445068|527596015|FG000|Overall Study|Disease progression|26|||
146295360|NCT00445068|527596015|FG000|Overall Study|Adverse Event|5|||
146295361|NCT00445068|527596015|FG000|Overall Study|Abnormal laboratory value|2|||
146295362|NCT00445068|527596015|FG000|Overall Study|Withdrawal by Subject|2|||
146295363|NCT00445068|527596015|FG000|Overall Study|Death|1|||
146295364|NCT04824521|527596016|FG000|Overall Study|Lost to Follow-up|1|||
146295365|NCT03444324|527596017|FG000|Overall Study|Withdrawal by Subject|0|||
146295366|NCT03444324|527596018|FG001|Overall Study|Withdrawal by Subject|1|||
146295367|NCT03444324|527596017|FG000|Overall Study|Lost to Follow-up|4|||
146295368|NCT03444324|527596018|FG001|Overall Study|Lost to Follow-up|2|||
146295369|NCT03444324|527596017|FG000|Overall Study|Protocol Violation|0|||
146295370|NCT03444324|527596018|FG001|Overall Study|Protocol Violation|1|||
146295371|NCT03444324|527596017|FG000|Overall Study|Lack of Trial Compliance|1|||
146295372|NCT03444324|527596018|FG001|Overall Study|Lack of Trial Compliance|1|||
146295373|NCT03444324|527596017|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
146295374|NCT03444324|527596018|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
146295375|NCT01598311|527596019|FG000|Overall Study|Physician Decision|4|||
146295376|NCT01598311|527596020|FG001|Overall Study|Physician Decision|5|||
146295377|NCT01598311|527596019|FG000|Overall Study|Adverse Event|9|||
146295378|NCT01598311|527596020|FG001|Overall Study|Adverse Event|13|||
146295379|NCT01598311|527596019|FG000|Overall Study|Lost to Follow-up|7|||
146295380|NCT01598311|527596020|FG001|Overall Study|Lost to Follow-up|12|||
146295381|NCT01598311|527596019|FG000|Overall Study|Withdrawal by Subject|9|||
146295382|NCT01598311|527596020|FG001|Overall Study|Withdrawal by Subject|13|||
146295383|NCT01598311|527596019|FG000|Overall Study|No reason provided.|0|||
146295384|NCT01598311|527596020|FG001|Overall Study|No reason provided.|5|||
146295385|NCT01598311|527596019|FG000|Overall Study|Randomized but never treated|8|||
146295386|NCT01598311|527596020|FG001|Overall Study|Randomized but never treated|5|||
146295387|NCT01598311|527596019|FG000|Overall Study|Treated but no confirmed CDAD|9|||
146295388|NCT01598311|527596020|FG001|Overall Study|Treated but no confirmed CDAD|8|||
146295389|NCT01598311|527596019|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
146295390|NCT01598311|527596020|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
146295391|NCT00658684|527596021|FG000|Overall Study|Adverse Event|10|||
146295392|NCT00658684|527596022|FG001|Overall Study|Adverse Event|8|||
145970905|NCT00071981|526407298|FG000|Overall Study|Adverse Event|4|||
145970906|NCT00071981|526407299|FG001|Overall Study|Adverse Event|4|||
145970907|NCT00071981|526407300|FG002|Overall Study|Adverse Event|3|||
145970908|NCT00071981|526407301|FG003|Overall Study|Adverse Event|1|||
145970909|NCT00071981|526407298|FG000|Overall Study|Death|0|||
145970910|NCT00071981|526407299|FG001|Overall Study|Death|0|||
145970911|NCT00071981|526407300|FG002|Overall Study|Death|1|||
145970912|NCT00071981|526407301|FG003|Overall Study|Death|1|||
145970913|NCT00071981|526407298|FG000|Overall Study|Withdrawal by Subject|3|||
145970914|NCT00071981|526407299|FG001|Overall Study|Withdrawal by Subject|1|||
146088029|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
146295393|NCT00658684|527596023|FG002|Overall Study|Adverse Event|2|||
146295394|NCT00658684|527596024|FG003|Overall Study|Adverse Event|0|||
146295395|NCT00658684|527596021|FG000|Overall Study|Withdrawal by Subject|6|||
146295396|NCT00658684|527596022|FG001|Overall Study|Withdrawal by Subject|4|||
146295397|NCT00658684|527596023|FG002|Overall Study|Withdrawal by Subject|1|||
146295398|NCT00658684|527596024|FG003|Overall Study|Withdrawal by Subject|1|||
146295399|NCT00658684|527596021|FG000|Overall Study|Lack of Efficacy|1|||
146295400|NCT00658684|527596022|FG001|Overall Study|Lack of Efficacy|1|||
146295401|NCT00658684|527596023|FG002|Overall Study|Lack of Efficacy|0|||
146295402|NCT00658684|527596024|FG003|Overall Study|Lack of Efficacy|0|||
146295403|NCT00658684|527596021|FG000|Overall Study|Protocol Violation|1|||
145970915|NCT00071981|526407300|FG002|Overall Study|Withdrawal by Subject|0|||
145970916|NCT00071981|526407301|FG003|Overall Study|Withdrawal by Subject|0|||
146295404|NCT00658684|527596022|FG001|Overall Study|Protocol Violation|1|||
146235353|NCT05580003|527378492|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235354|NCT05580003|527378493|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235355|NCT05580003|527378494|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
146235356|NCT05580003|527378495|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235357|NCT05580003|527378496|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235358|NCT05580003|527378497|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235359|NCT05580003|527378498|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235360|NCT05580003|527378499|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235361|NCT05580003|527378500|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235362|NCT05580003|527378501|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
146235363|NCT05580003|527378474|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146295405|NCT00658684|527596023|FG002|Overall Study|Protocol Violation|0|||
146295406|NCT00658684|527596024|FG003|Overall Study|Protocol Violation|0|||
146295407|NCT00658684|527596021|FG000|Overall Study|Pregnancy|1|||
146295408|NCT00658684|527596022|FG001|Overall Study|Pregnancy|1|||
146295409|NCT00658684|527596023|FG002|Overall Study|Pregnancy|0|||
146295410|NCT00658684|527596024|FG003|Overall Study|Pregnancy|0|||
146295411|NCT00688103|527596025|FG000|Overall Study|Adverse Event|4|||
146295412|NCT00688103|527596026|FG001|Overall Study|Adverse Event|1|||
146295413|NCT00688103|527596025|FG000|Overall Study|Lack of Efficacy|11|||
146295414|NCT00688103|527596026|FG001|Overall Study|Lack of Efficacy|1|||
146295415|NCT00688103|527596025|FG000|Overall Study|Withdrawal by Subject|4|||
146295416|NCT00688103|527596026|FG001|Overall Study|Withdrawal by Subject|2|||
145891199|NCT01939496|526107645|FG001|Overall Study|Other|0|||
145891200|NCT01939496|526107646|FG002|Overall Study|Other|1|||
145891201|NCT01642914|526107647|FG000|Overall Study|Adverse Event|11|||
145891202|NCT01642914|526107648|FG001|Overall Study|Adverse Event|7|||
145891203|NCT01642914|526107649|FG002|Overall Study|Adverse Event|15|||
145891204|NCT01642914|526107647|FG000|Overall Study|Lack of Efficacy|9|||
145891205|NCT01642914|526107648|FG001|Overall Study|Lack of Efficacy|4|||
145891206|NCT01642914|526107649|FG002|Overall Study|Lack of Efficacy|2|||
145891207|NCT01642914|526107647|FG000|Overall Study|Protocol Violation|15|||
145891208|NCT01642914|526107648|FG001|Overall Study|Protocol Violation|13|||
145891209|NCT01642914|526107649|FG002|Overall Study|Protocol Violation|6|||
145891210|NCT01642914|526107647|FG000|Overall Study|Withdrawal by Subject|5|||
145891211|NCT01642914|526107648|FG001|Overall Study|Withdrawal by Subject|5|||
145891212|NCT01642914|526107649|FG002|Overall Study|Withdrawal by Subject|10|||
145891213|NCT01642914|526107647|FG000|Overall Study|Lost to Follow-up|5|||
145891214|NCT01642914|526107648|FG001|Overall Study|Lost to Follow-up|3|||
145891215|NCT01642914|526107649|FG002|Overall Study|Lost to Follow-up|7|||
145891216|NCT01642914|526107647|FG000|Overall Study|Other Reason|1|||
145891217|NCT01642914|526107648|FG001|Overall Study|Other Reason|0|||
145891218|NCT01642914|526107649|FG002|Overall Study|Other Reason|0|||
145891219|NCT03028740|526107650|FG000|Overall Study|Did not Receive Study Drug|4|||
145891220|NCT03028740|526107651|FG001|Overall Study|Did not Receive Study Drug|5|||
145891221|NCT03028740|526107650|FG000|Overall Study|Adverse Event|8|||
145891222|NCT03028740|526107651|FG001|Overall Study|Adverse Event|26|||
145891223|NCT03028740|526107650|FG000|Overall Study|Lack of Efficacy|0|||
145891224|NCT03028740|526107651|FG001|Overall Study|Lack of Efficacy|1|||
145891225|NCT03028740|526107650|FG000|Overall Study|Withdrawal by Subject|48|||
145891226|NCT03028740|526107651|FG001|Overall Study|Withdrawal by Subject|101|||
145891227|NCT03028740|526107650|FG000|Overall Study|Lost to Follow-up|30|||
145891228|NCT03028740|526107651|FG001|Overall Study|Lost to Follow-up|54|||
145891229|NCT03028740|526107650|FG000|Overall Study|Physician Decision|4|||
145891230|NCT03028740|526107651|FG001|Overall Study|Physician Decision|11|||
145891231|NCT03028740|526107650|FG000|Overall Study|Protocol Violation|4|||
145891232|NCT03028740|526107651|FG001|Overall Study|Protocol Violation|8|||
145891233|NCT03028740|526107650|FG000|Overall Study|Non-compliance with Study Drug|0|||
145891234|NCT03028740|526107651|FG001|Overall Study|Non-compliance with Study Drug|2|||
145891235|NCT03028740|526107650|FG000|Overall Study|Study Terminated by Sponsor|467|||
145891236|NCT03028740|526107651|FG001|Overall Study|Study Terminated by Sponsor|917|||
145891237|NCT03028740|526107650|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
145891238|NCT03028740|526107651|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
146295417|NCT00688103|527596025|FG000|Overall Study|complex reasons|11|||
146295418|NCT00688103|527596026|FG001|Overall Study|complex reasons|9|||
146332885|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145891239|NCT03028740|526107650|FG000|Overall Study|Reason not Specified|1|||
145891240|NCT03028740|526107651|FG001|Overall Study|Reason not Specified|5|||
145891241|NCT00171301|526107652|FG000|Overall Study|Death|1|||
145891242|NCT00171301|526107653|FG001|Overall Study|Death|2|||
145891243|NCT00171301|526107652|FG000|Overall Study|Adverse Event|1|||
145891244|NCT00171301|526107653|FG001|Overall Study|Adverse Event|2|||
145891245|NCT00171301|526107652|FG000|Overall Study|Lost to Follow-up|6|||
145891246|NCT00171301|526107653|FG001|Overall Study|Lost to Follow-up|2|||
145891247|NCT00171301|526107652|FG000|Overall Study|Protocol Violation|0|||
145891248|NCT00171301|526107653|FG001|Overall Study|Protocol Violation|2|||
145891249|NCT00171301|526107652|FG000|Overall Study|Withdrawal by Subject|0|||
145891250|NCT00171301|526107653|FG001|Overall Study|Withdrawal by Subject|1|||
145891251|NCT04319159|526107655|FG000|Overall Study|Screening failure|13|||
145891252|NCT04319159|526107655|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
145891253|NCT04319159|526107655|FG000|Overall Study|Withdrawal by Subject|1|||
145891254|NCT02100319|526107658|FG000|Overall Study|Case Report Forms Uncollected|11|||
145891255|NCT02100319|526107658|FG000|Overall Study|Protocol Deviation|5|||
145891256|NCT02370914|526107659|FG000|Overall Study|Protocol Violation|2|||
145891257|NCT02589522|526107662|FG000|Overall Study|Physician Decision|1|||
145891258|NCT02589522|526107663|FG001|Overall Study|Physician Decision|2|||
145891259|NCT02589522|526107664|FG002|Overall Study|Physician Decision|0|||
145891260|NCT02589522|526107662|FG000|Overall Study|Did not start treatment|1|||
145891261|NCT02589522|526107663|FG001|Overall Study|Did not start treatment|0|||
145891262|NCT02589522|526107664|FG002|Overall Study|Did not start treatment|0|||
145891263|NCT01478828|526107665|FG000|Overall Study|Adverse Event|1|||
145891264|NCT02025010|526107666|FG000|Overall Study|Symptomatic or radiographic progression|36|||
145891265|NCT02025010|526107666|FG000|Overall Study|Adverse Event|6|||
145891266|NCT02025010|526107666|FG000|Overall Study|Physician Decision|7|||
145891267|NCT02025010|526107666|FG000|Overall Study|Withdrawal by Subject|3|||
145891268|NCT02025010|526107666|FG000|Overall Study|Intercurrent illness|3|||
145891269|NCT02025010|526107666|FG000|Overall Study|Patients still on treatment|3|||
145891270|NCT02025010|526107666|FG000|Overall Study|Never initiate the treatment|2|||
145891271|NCT00296491|526107668|FG000|Overall Study|Low Pollen Counts|18|||
146235364|NCT05580003|527378475|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235365|NCT05580003|527378476|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235366|NCT05580003|527378477|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145891272|NCT00296491|526107669|FG001|Overall Study|Low Pollen Counts|26|||
146235367|NCT05580003|527378478|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235368|NCT05580003|527378479|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235369|NCT05580003|527378480|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235370|NCT05580003|527378481|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235371|NCT05580003|527378482|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235372|NCT05580003|527378483|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235373|NCT05580003|527378484|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235374|NCT05580003|527378485|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235375|NCT05580003|527378486|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235376|NCT05580003|527378487|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235377|NCT05580003|527378488|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235378|NCT05580003|527378489|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235379|NCT05580003|527378490|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235380|NCT05580003|527378491|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235381|NCT05580003|527378492|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235382|NCT05580003|527378493|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235383|NCT05580003|527378494|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235384|NCT05580003|527378495|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
146235385|NCT05580003|527378496|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235386|NCT05580003|527378497|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235387|NCT05580003|527378498|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235388|NCT05580003|527378499|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235389|NCT05580003|527378500|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235390|NCT05580003|527378501|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
146235391|NCT05580003|527378474|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235392|NCT05580003|527378475|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235393|NCT05580003|527378476|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235394|NCT05580003|527378477|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235395|NCT05580003|527378478|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235396|NCT05580003|527378479|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235397|NCT05580003|527378480|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235398|NCT05580003|527378481|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235399|NCT05580003|527378482|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235400|NCT05580003|527378483|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235401|NCT05580003|527378484|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235402|NCT05580003|527378485|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235403|NCT05580003|527378486|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235404|NCT05580003|527378487|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235405|NCT05580003|527378488|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235406|NCT05580003|527378489|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145891273|NCT00296491|526107670|FG002|Overall Study|Low Pollen Counts|25|||
145891274|NCT00296491|526107671|FG003|Overall Study|Low Pollen Counts|16|||
145891275|NCT00296491|526107668|FG000|Overall Study|Protocol Violation|4|||
145891276|NCT00296491|526107669|FG001|Overall Study|Protocol Violation|6|||
145891277|NCT00296491|526107670|FG002|Overall Study|Protocol Violation|2|||
145891278|NCT00296491|526107671|FG003|Overall Study|Protocol Violation|3|||
145891279|NCT00296491|526107668|FG000|Overall Study|Adverse Event|1|||
145891280|NCT00296491|526107669|FG001|Overall Study|Adverse Event|3|||
145891281|NCT00296491|526107670|FG002|Overall Study|Adverse Event|1|||
145891282|NCT00296491|526107671|FG003|Overall Study|Adverse Event|4|||
145891283|NCT00296491|526107668|FG000|Overall Study|Withdrawn due to Asthma|0|||
145891284|NCT00296491|526107669|FG001|Overall Study|Withdrawn due to Asthma|0|||
145891285|NCT00296491|526107670|FG002|Overall Study|Withdrawn due to Asthma|0|||
145891286|NCT00296491|526107671|FG003|Overall Study|Withdrawn due to Asthma|4|||
145891287|NCT00296491|526107668|FG000|Overall Study|Withdrawal by Subject|7|||
145891288|NCT00296491|526107669|FG001|Overall Study|Withdrawal by Subject|3|||
145891289|NCT00296491|526107670|FG002|Overall Study|Withdrawal by Subject|3|||
145891290|NCT00296491|526107671|FG003|Overall Study|Withdrawal by Subject|2|||
145891291|NCT00296491|526107668|FG000|Overall Study|Non-Compliance|12|||
145891292|NCT00296491|526107669|FG001|Overall Study|Non-Compliance|13|||
145891293|NCT00296491|526107670|FG002|Overall Study|Non-Compliance|10|||
145891294|NCT00296491|526107671|FG003|Overall Study|Non-Compliance|14|||
145891295|NCT00296491|526107668|FG000|Overall Study|Lost to Follow-up|0|||
145891296|NCT00296491|526107669|FG001|Overall Study|Lost to Follow-up|2|||
145891297|NCT00296491|526107670|FG002|Overall Study|Lost to Follow-up|2|||
145891298|NCT00296491|526107671|FG003|Overall Study|Lost to Follow-up|0|||
145891299|NCT01300052|526107674|FG000|Overall Study|Adverse Event|3|||
145891300|NCT01300052|526107675|FG001|Overall Study|Adverse Event|0|||
145891301|NCT01300052|526107674|FG000|Overall Study|Withdrawal by Subject|2|||
145891302|NCT01300052|526107675|FG001|Overall Study|Withdrawal by Subject|2|||
145891303|NCT01300052|526107674|FG000|Overall Study|Protocol Violation|1|||
145891304|NCT01300052|526107675|FG001|Overall Study|Protocol Violation|1|||
145891305|NCT01661881|526107676|FG000|Overall Study|Disease Progression|1|||
145891306|NCT05444543|526107677|FG000|Overall Study|Withdrawal by Subject|1|||
145891307|NCT05444543|526107678|FG001|Overall Study|Withdrawal by Subject|0|||
145891308|NCT05444543|526107677|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
145891309|NCT05444543|526107678|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
145891310|NCT05444543|526107677|FG000|Overall Study|Adverse Event|0|||
145891311|NCT05444543|526107678|FG001|Overall Study|Adverse Event|1|||
145891312|NCT05444543|526107677|FG000|Overall Study|Family relocating at a distance from study site|0|||
145891313|NCT05444543|526107678|FG001|Overall Study|Family relocating at a distance from study site|1|||
145891314|NCT03847194|526107679|FG000|Overall Study|Lost to Follow-up|2|||
145891315|NCT03847194|526107680|FG001|Overall Study|Lost to Follow-up|5|||
145891316|NCT03847194|526107679|FG000|Overall Study|Withdrawal by Subject|1|||
145891317|NCT03847194|526107680|FG001|Overall Study|Withdrawal by Subject|2|||
145891318|NCT03847194|526107679|FG000|Overall Study|Death|0|||
145891319|NCT03847194|526107680|FG001|Overall Study|Death|1|||
145891320|NCT01144403|526107682|FG000|Overall Study|Lost to Follow-up|3|||
145891321|NCT01144403|526107682|FG000|Overall Study|Death|1|||
145891322|NCT01144403|526107682|FG000|Overall Study|Adverse Event|1|||
145891323|NCT03891329|526107683|FG000|Overall Study|Death|5|||
145891324|NCT03891329|526107683|FG000|Overall Study|Lost to Follow-up|4|||
145891325|NCT03891329|526107683|FG000|Overall Study|Physician Decision|4|||
145891326|NCT03891329|526107683|FG000|Overall Study|Device explanted|3|||
145891327|NCT03891329|526107683|FG000|Overall Study|No study device implanted|3|||
145891328|NCT02096588|526107684|FG000|Overall Study|Lack of Efficacy|2|||
145891329|NCT02096588|526107685|FG001|Overall Study|Lack of Efficacy|0|||
145891330|NCT02096588|526107684|FG000|Overall Study|Withdrawal by Subject|0|||
145891331|NCT02096588|526107685|FG001|Overall Study|Withdrawal by Subject|1|||
145891332|NCT01258101|526107687|FG000|Overall Study|Adverse Event|5|||
145891333|NCT01258101|526107688|FG001|Overall Study|Adverse Event|6|||
145891334|NCT01258101|526107689|FG002|Overall Study|Adverse Event|0|||
145891335|NCT01258101|526107690|FG003|Overall Study|Adverse Event|0|||
145891336|NCT01258101|526107687|FG000|Overall Study|Extra exclusion criterion amended|2|||
145891337|NCT01258101|526107688|FG001|Overall Study|Extra exclusion criterion amended|1|||
145891338|NCT01258101|526107689|FG002|Overall Study|Extra exclusion criterion amended|1|||
145891339|NCT01258101|526107690|FG003|Overall Study|Extra exclusion criterion amended|1|||
145891340|NCT01258101|526107687|FG000|Overall Study|Informed consent has been withdrawn|2|||
145891341|NCT01258101|526107688|FG001|Overall Study|Informed consent has been withdrawn|2|||
145891342|NCT01258101|526107689|FG002|Overall Study|Informed consent has been withdrawn|1|||
145891343|NCT01258101|526107690|FG003|Overall Study|Informed consent has been withdrawn|1|||
145970917|NCT00071981|526407298|FG000|Overall Study|No protocol therapy|2|||
145970918|NCT00071981|526407299|FG001|Overall Study|No protocol therapy|5|||
145970919|NCT00071981|526407300|FG002|Overall Study|No protocol therapy|1|||
145970920|NCT00071981|526407301|FG003|Overall Study|No protocol therapy|0|||
145970921|NCT00071981|526407298|FG000|Overall Study|others (not specified in the study)|0|||
145970922|NCT00071981|526407299|FG001|Overall Study|others (not specified in the study)|2|||
145970923|NCT00071981|526407300|FG002|Overall Study|others (not specified in the study)|2|||
145970924|NCT00071981|526407301|FG003|Overall Study|others (not specified in the study)|0|||
145970925|NCT01933594|526407303|FG000|Overall Study|Lost to Follow-up|1|||
145970926|NCT01933594|526407304|FG001|Overall Study|Lost to Follow-up|0|||
145970927|NCT01933594|526407305|FG002|Overall Study|Lost to Follow-up|0|||
145970928|NCT01933594|526407306|FG003|Overall Study|Lost to Follow-up|0|||
145970929|NCT01933594|526407307|FG004|Overall Study|Lost to Follow-up|1|||
145970930|NCT01933594|526407308|FG005|Overall Study|Lost to Follow-up|0|||
145970931|NCT01933594|526407303|FG000|Overall Study|Ineligible for subsequent study step|0|||
145970932|NCT01933594|526407304|FG001|Overall Study|Ineligible for subsequent study step|0|||
145970933|NCT01933594|526407305|FG002|Overall Study|Ineligible for subsequent study step|0|||
145970934|NCT01933594|526407306|FG003|Overall Study|Ineligible for subsequent study step|0|||
145970935|NCT01933594|526407307|FG004|Overall Study|Ineligible for subsequent study step|1|||
145970936|NCT01933594|526407308|FG005|Overall Study|Ineligible for subsequent study step|0|||
145970937|NCT04513366|526407309|FG000|Treatment Phase|Withdrawal by Subject|6|||
145970938|NCT04513366|526407310|FG001|Treatment Phase|Withdrawal by Subject|8|||
145970939|NCT04513366|526407311|FG002|Treatment Phase|Withdrawal by Subject|3|||
145970940|NCT04513366|526407309|FG000|Treatment Phase|Lost to Follow-up|1|||
145970941|NCT04513366|526407310|FG001|Treatment Phase|Lost to Follow-up|2|||
145970942|NCT04513366|526407311|FG002|Treatment Phase|Lost to Follow-up|5|||
145970943|NCT04513366|526407309|FG000|Treatment Phase|Other than Specified|1|||
145970944|NCT04513366|526407310|FG001|Treatment Phase|Other than Specified|0|||
145970945|NCT04513366|526407311|FG002|Treatment Phase|Other than Specified|2|||
145970946|NCT04513366|526407309|FG000|Treatment Phase|Physician Decision|2|||
145970947|NCT04513366|526407310|FG001|Treatment Phase|Physician Decision|0|||
145970948|NCT04513366|526407311|FG002|Treatment Phase|Physician Decision|0|||
145970949|NCT04513366|526407309|FG000|Treatment Phase|Adverse Event|0|||
145970950|NCT04513366|526407310|FG001|Treatment Phase|Adverse Event|1|||
145970951|NCT04513366|526407311|FG002|Treatment Phase|Adverse Event|1|||
145970952|NCT04513366|526407309|FG000|Extension Phase|Withdrawal by Subject|3|||
145970953|NCT04513366|526407310|FG001|Extension Phase|Withdrawal by Subject|1|||
145970954|NCT04513366|526407311|FG002|Extension Phase|Withdrawal by Subject|1|||
145970955|NCT04513366|526407309|FG000|Extension Phase|Other than Specified|4|||
145970956|NCT04513366|526407310|FG001|Extension Phase|Other than Specified|0|||
145970957|NCT04513366|526407311|FG002|Extension Phase|Other than Specified|1|||
145970958|NCT04513366|526407309|FG000|Extension Phase|Lost to Follow-up|1|||
145970959|NCT04513366|526407310|FG001|Extension Phase|Lost to Follow-up|1|||
145970960|NCT04513366|526407311|FG002|Extension Phase|Lost to Follow-up|1|||
145970961|NCT04513366|526407309|FG000|Extension Phase|Sponsor Decision|0|||
145970962|NCT04513366|526407310|FG001|Extension Phase|Sponsor Decision|1|||
145970963|NCT04513366|526407311|FG002|Extension Phase|Sponsor Decision|0|||
145970964|NCT04513366|526407309|FG000|Extension Phase|Death|0|||
145970965|NCT04513366|526407310|FG001|Extension Phase|Death|1|||
145970966|NCT04513366|526407311|FG002|Extension Phase|Death|0|||
145970967|NCT04513366|526407309|FG000|Extension Phase|Adverse Event|0|||
145970968|NCT04513366|526407310|FG001|Extension Phase|Adverse Event|0|||
145970969|NCT04513366|526407311|FG002|Extension Phase|Adverse Event|1|||
145970970|NCT01316575|526407315|FG000|Overall Study|Withdrawal by Subject|2|||
145970971|NCT01316575|526407316|FG001|Overall Study|Withdrawal by Subject|0|||
145970972|NCT01316575|526407315|FG000|Overall Study|Required alternate treatment|0|||
145970973|NCT01316575|526407316|FG001|Overall Study|Required alternate treatment|1|||
145970974|NCT02966834|526407317|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145970975|NCT02966834|526407318|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145970976|NCT02966834|526407319|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145970977|NCT02966834|526407320|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145970978|NCT02966834|526407321|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
145970979|NCT02966834|526407322|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145970980|NCT02966834|526407317|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
145970981|NCT02966834|526407318|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145970982|NCT02966834|526407319|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145970983|NCT02966834|526407320|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145970984|NCT02966834|526407321|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145970985|NCT02966834|526407322|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145970986|NCT02966834|526407317|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145970987|NCT02966834|526407318|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145970988|NCT02966834|526407319|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
145970989|NCT02966834|526407320|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
146056113|NCT00117637|526721099|FG000|Second Intervention (Period 2)|Adverse Event|0|||
145970990|NCT02966834|526407321|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145970991|NCT02966834|526407322|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
145970992|NCT02966834|526407317|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145970993|NCT02966834|526407318|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145970994|NCT02966834|526407319|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
145970995|NCT02966834|526407320|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
145970996|NCT02966834|526407321|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145970997|NCT02966834|526407322|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
145970998|NCT02966834|526407317|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145970999|NCT02966834|526407318|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146235407|NCT05580003|527378490|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235408|NCT05580003|527378491|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235409|NCT05580003|527378492|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235410|NCT05580003|527378493|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235411|NCT05580003|527378494|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235412|NCT05580003|527378495|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235413|NCT05580003|527378496|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235414|NCT05580003|527378497|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235415|NCT05580003|527378498|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235416|NCT05580003|527378499|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235417|NCT05580003|527378500|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
146235418|NCT05580003|527378501|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
146235419|NCT05580003|527378474|FG000|Part 6 Period 2 (Day 1)|Other|0|||
146235420|NCT05580003|527378475|FG001|Part 6 Period 2 (Day 1)|Other|0|||
146235421|NCT05580003|527378476|FG002|Part 6 Period 2 (Day 1)|Other|0|||
146235422|NCT05580003|527378477|FG003|Part 6 Period 2 (Day 1)|Other|0|||
146235423|NCT05580003|527378478|FG004|Part 6 Period 2 (Day 1)|Other|0|||
146235424|NCT05580003|527378479|FG005|Part 6 Period 2 (Day 1)|Other|0|||
146235425|NCT05580003|527378480|FG006|Part 6 Period 2 (Day 1)|Other|0|||
146235426|NCT05580003|527378481|FG007|Part 6 Period 2 (Day 1)|Other|0|||
146235427|NCT05580003|527378482|FG008|Part 6 Period 2 (Day 1)|Other|0|||
146235428|NCT05580003|527378483|FG009|Part 6 Period 2 (Day 1)|Other|0|||
146235429|NCT05580003|527378484|FG010|Part 6 Period 2 (Day 1)|Other|0|||
146235430|NCT05580003|527378485|FG011|Part 6 Period 2 (Day 1)|Other|0|||
146235431|NCT05580003|527378486|FG012|Part 6 Period 2 (Day 1)|Other|0|||
146235432|NCT05580003|527378487|FG013|Part 6 Period 2 (Day 1)|Other|0|||
146235433|NCT05580003|527378488|FG014|Part 6 Period 2 (Day 1)|Other|0|||
146235434|NCT05580003|527378489|FG015|Part 6 Period 2 (Day 1)|Other|0|||
146235435|NCT05580003|527378490|FG016|Part 6 Period 2 (Day 1)|Other|0|||
146235436|NCT05580003|527378491|FG017|Part 6 Period 2 (Day 1)|Other|0|||
146235437|NCT05580003|527378492|FG018|Part 6 Period 2 (Day 1)|Other|0|||
146235438|NCT05580003|527378493|FG019|Part 6 Period 2 (Day 1)|Other|0|||
146235439|NCT05580003|527378494|FG020|Part 6 Period 2 (Day 1)|Other|0|||
146235440|NCT05580003|527378495|FG021|Part 6 Period 2 (Day 1)|Other|0|||
146235441|NCT05580003|527378496|FG022|Part 6 Period 2 (Day 1)|Other|0|||
146235442|NCT05580003|527378497|FG023|Part 6 Period 2 (Day 1)|Other|0|||
146235443|NCT05580003|527378498|FG024|Part 6 Period 2 (Day 1)|Other|1|||
146235444|NCT05580003|527378499|FG025|Part 6 Period 2 (Day 1)|Other|0|||
146235445|NCT05580003|527378500|FG026|Part 6 Period 2 (Day 1)|Other|0|||
146235446|NCT05580003|527378501|FG027|Part 6 Period 2 (Day 1)|Other|0|||
146235447|NCT03500549|527378502|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
146235448|NCT03500549|527378503|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
146235449|NCT03500549|527378502|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
146235450|NCT03500549|527378503|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
146235451|NCT04337931|527378507|FG000|Overall Study|Death|4|||
146235452|NCT04337931|527378508|FG001|Overall Study|Death|1|||
146235453|NCT04337931|527378509|FG002|Overall Study|Death|7|||
146235454|NCT04337931|527378507|FG000|Overall Study|Withdrawal by Subject|0|||
146235455|NCT04337931|527378508|FG001|Overall Study|Withdrawal by Subject|1|||
146235456|NCT04337931|527378509|FG002|Overall Study|Withdrawal by Subject|0|||
146235457|NCT04337931|527378507|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
146235458|NCT04337931|527378508|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
146235459|NCT04337931|527378509|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
146235460|NCT04337931|527378507|FG000|Overall Study|Study terminated by sponsor|3|||
146235461|NCT04337931|527378508|FG001|Overall Study|Study terminated by sponsor|6|||
146235462|NCT04337931|527378509|FG002|Overall Study|Study terminated by sponsor|2|||
146235463|NCT04337931|527378507|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
146235464|NCT04337931|527378508|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
145971000|NCT02966834|526407319|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145971001|NCT02966834|526407320|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
145971002|NCT02966834|526407321|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145971003|NCT02966834|526407322|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145971004|NCT02966834|526407317|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145971005|NCT02966834|526407318|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145971006|NCT02966834|526407319|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145891344|NCT01258101|526107687|FG000|Overall Study|Patient is not able to attend visits|8|||
145891345|NCT01258101|526107688|FG001|Overall Study|Patient is not able to attend visits|9|||
145891346|NCT01258101|526107689|FG002|Overall Study|Patient is not able to attend visits|7|||
145891347|NCT01258101|526107690|FG003|Overall Study|Patient is not able to attend visits|6|||
145891348|NCT01258101|526107687|FG000|Overall Study|Patient´s compliance|4|||
145891349|NCT01258101|526107688|FG001|Overall Study|Patient´s compliance|3|||
145891350|NCT01258101|526107689|FG002|Overall Study|Patient´s compliance|1|||
145891351|NCT01258101|526107690|FG003|Overall Study|Patient´s compliance|2|||
145891352|NCT01258101|526107687|FG000|Overall Study|Lost to Follow-up|5|||
145891353|NCT01258101|526107688|FG001|Overall Study|Lost to Follow-up|5|||
145891354|NCT01258101|526107689|FG002|Overall Study|Lost to Follow-up|0|||
145891355|NCT01258101|526107690|FG003|Overall Study|Lost to Follow-up|6|||
145891356|NCT01258101|526107687|FG000|Overall Study|PCR positive at week 24|0|||
145891357|NCT01258101|526107688|FG001|Overall Study|PCR positive at week 24|0|||
145891358|NCT01258101|526107689|FG002|Overall Study|PCR positive at week 24|0|||
145891359|NCT01258101|526107690|FG003|Overall Study|PCR positive at week 24|1|||
145891360|NCT01258101|526107687|FG000|Overall Study|Other reason|7|||
145891361|NCT01258101|526107688|FG001|Overall Study|Other reason|8|||
145891362|NCT01258101|526107689|FG002|Overall Study|Other reason|1|||
145891363|NCT01258101|526107690|FG003|Overall Study|Other reason|8|||
145891364|NCT00063882|526107691|FG000|Overall Study|Protocol Violation|3|||
145891365|NCT00063882|526107692|FG001|Overall Study|Protocol Violation|3|||
145891366|NCT00063882|526107691|FG000|Overall Study|Withdrawal by Subject|2|||
145891367|NCT00063882|526107692|FG001|Overall Study|Withdrawal by Subject|1|||
145891368|NCT03438227|526107698|FG000|Overall Study|Withdrawal by Subject|10|||
145891369|NCT03438227|526107699|FG001|Overall Study|Withdrawal by Subject|5|||
145891370|NCT00293202|526107704|FG000|Overall Study|Withdrawal by Subject|1|||
145891371|NCT00293202|526107705|FG001|Overall Study|Withdrawal by Subject|2|||
145891372|NCT00293202|526107704|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
145891373|NCT00293202|526107705|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
145891374|NCT00293202|526107704|FG000|Overall Study|on-hold due to fistula maturation time|1|||
145891375|NCT00293202|526107705|FG001|Overall Study|on-hold due to fistula maturation time|0|||
146088030|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
146088031|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146088032|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146088033|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146088034|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
146088035|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
146088036|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
146088037|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146088038|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146088039|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146088040|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
146088041|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
146088042|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
146088043|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146088044|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146088045|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146088046|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146088047|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
146088048|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
146088049|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
146088050|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
146088051|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
146088052|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
146088053|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
146088054|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
146088055|NCT00745615|526841933|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146088056|NCT00745615|526841934|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146235465|NCT04337931|527378509|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
146235466|NCT04337931|527378507|FG000|Overall Study|Colorectal cancer treatment|1|||
146235467|NCT04337931|527378508|FG001|Overall Study|Colorectal cancer treatment|0|||
146235468|NCT04337931|527378509|FG002|Overall Study|Colorectal cancer treatment|0|||
146235469|NCT04337931|527378507|FG000|Overall Study|Participant decision|0|||
146235470|NCT04337931|527378508|FG001|Overall Study|Participant decision|1|||
145891376|NCT01560507|526107708|FG000|Overall Study|Lost to Follow-up|3|||
145891377|NCT01560507|526107709|FG001|Overall Study|Lost to Follow-up|1|||
145891378|NCT01560507|526107710|FG002|Overall Study|Lost to Follow-up|2|||
145891379|NCT01560507|526107708|FG000|Overall Study|Withdrawal by Subject|1|||
145891380|NCT01560507|526107709|FG001|Overall Study|Withdrawal by Subject|1|||
145891381|NCT01560507|526107710|FG002|Overall Study|Withdrawal by Subject|0|||
145891382|NCT01138111|526107711|FG000|Overall Study|Withdrawal by Subject|5|||
145891383|NCT01138111|526107711|FG000|Overall Study|Adverse Event|1|||
145891384|NCT01138111|526107711|FG000|Overall Study|Death|1|||
146295419|NCT03144804|527596028|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
146295420|NCT03769181|527597586|FG000|Overall Study|Adverse Event|1|||
146295421|NCT03769181|527597587|FG001|Overall Study|Adverse Event|0|||
146295422|NCT03769181|527597588|FG002|Overall Study|Adverse Event|2|||
145891385|NCT01138111|526107711|FG000|Overall Study|Lost to Follow-up|2|||
145891386|NCT00560937|526107712|FG000|Overall Study|Withdrawal by Subject|0|||
145891387|NCT00560937|526107713|FG001|Overall Study|Withdrawal by Subject|1|||
145891388|NCT00560937|526107712|FG000|Overall Study|Physician Decision|1|||
145891389|NCT00560937|526107713|FG001|Overall Study|Physician Decision|1|||
145891390|NCT01118117|526107714|FG000|Overall Study|Death|8|||
145891391|NCT01118117|526107715|FG001|Overall Study|Death|0|||
145891392|NCT01118117|526107714|FG000|Overall Study|Lost to Follow-up|6|||
145891393|NCT01118117|526107715|FG001|Overall Study|Lost to Follow-up|0|||
145891394|NCT01118117|526107714|FG000|Overall Study|Missed 12 Month Visit|7|||
145891395|NCT01118117|526107715|FG001|Overall Study|Missed 12 Month Visit|0|||
145891396|NCT03821272|526109942|FG000|Overall Study|Death|1|||
145891397|NCT03821272|526109943|FG001|Overall Study|Death|0|||
145891398|NCT03821272|526109942|FG000|Overall Study|Physician Decision|1|||
145891399|NCT03821272|526109943|FG001|Overall Study|Physician Decision|0|||
145891400|NCT03821272|526109942|FG000|Overall Study|Withdrawal by Subject|1|||
145891401|NCT03821272|526109943|FG001|Overall Study|Withdrawal by Subject|0|||
145891402|NCT05904769|526109944|FG000|Overall Study|Physician Decision|0|||
145891403|NCT05904769|526109945|FG001|Overall Study|Physician Decision|6|||
146295423|NCT03769181|527597589|FG003|Overall Study|Adverse Event|4|||
145891404|NCT05626803|526109946|FG000|Overall Study|Lost to Follow-up|0|||
145891405|NCT05626803|526109947|FG001|Overall Study|Lost to Follow-up|1|||
145891406|NCT05626803|526109948|FG002|Overall Study|Lost to Follow-up|0|||
145891407|NCT05626803|526109949|FG003|Overall Study|Lost to Follow-up|0|||
145891408|NCT00493246|526109954|FG000|Overall Study|Withdrawal by Subject|0|||
145891409|NCT00493246|526109955|FG001|Overall Study|Withdrawal by Subject|0|||
145891410|NCT00493246|526109956|FG002|Overall Study|Withdrawal by Subject|0|||
145891411|NCT00493246|526109957|FG003|Overall Study|Withdrawal by Subject|0|||
145891412|NCT00493246|526109958|FG004|Overall Study|Withdrawal by Subject|1|||
145891413|NCT00493246|526109959|FG005|Overall Study|Withdrawal by Subject|0|||
145891414|NCT00493246|526109960|FG006|Overall Study|Withdrawal by Subject|0|||
145891415|NCT00493246|526109961|FG007|Overall Study|Withdrawal by Subject|0|||
145891416|NCT00493246|526109954|FG000|Overall Study|No access to draw blood|0|||
145891417|NCT00493246|526109955|FG001|Overall Study|No access to draw blood|0|||
145891418|NCT00493246|526109956|FG002|Overall Study|No access to draw blood|0|||
145891419|NCT00493246|526109957|FG003|Overall Study|No access to draw blood|0|||
145891420|NCT00493246|526109958|FG004|Overall Study|No access to draw blood|0|||
145891421|NCT00493246|526109959|FG005|Overall Study|No access to draw blood|1|||
145891422|NCT00493246|526109960|FG006|Overall Study|No access to draw blood|0|||
145891423|NCT00493246|526109961|FG007|Overall Study|No access to draw blood|0|||
145891424|NCT00493246|526109954|FG000|Overall Study|Lost to Follow-up|0|||
145891425|NCT00493246|526109955|FG001|Overall Study|Lost to Follow-up|0|||
145891426|NCT00493246|526109956|FG002|Overall Study|Lost to Follow-up|0|||
145891427|NCT00493246|526109957|FG003|Overall Study|Lost to Follow-up|0|||
145891428|NCT00493246|526109958|FG004|Overall Study|Lost to Follow-up|0|||
145891429|NCT00493246|526109959|FG005|Overall Study|Lost to Follow-up|0|||
145891430|NCT00493246|526109960|FG006|Overall Study|Lost to Follow-up|1|||
145891431|NCT00493246|526109961|FG007|Overall Study|Lost to Follow-up|0|||
145891432|NCT00380692|526109967|FG000|Study Period II - Double Blind|Adverse Event|1|||
145891433|NCT00380692|526109968|FG001|Study Period II - Double Blind|Adverse Event|0|||
146295424|NCT03769181|527597586|FG000|Overall Study|Withdrawal by Subject|1|||
146295425|NCT03769181|527597587|FG001|Overall Study|Withdrawal by Subject|0|||
146295426|NCT03769181|527597588|FG002|Overall Study|Withdrawal by Subject|2|||
145891434|NCT00380692|526109967|FG000|Study Period II - Double Blind|Protocol Violation|2|||
145891435|NCT00380692|526109968|FG001|Study Period II - Double Blind|Protocol Violation|2|||
145891436|NCT00380692|526109967|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
145891437|NCT00380692|526109968|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
145891438|NCT00380692|526109967|FG000|Study Period II - Double Blind|Physician Decision|0|||
145891439|NCT00380692|526109968|FG001|Study Period II - Double Blind|Physician Decision|1|||
145891440|NCT00380692|526109967|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
145891441|NCT00380692|526109968|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
145891442|NCT00380692|526109967|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
145891443|NCT00380692|526109968|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
145891444|NCT00380692|526109967|FG000|Study Period III - Open Label|Adverse Event|5|||
145891445|NCT00380692|526109968|FG001|Study Period III - Open Label|Adverse Event|3|||
145891446|NCT00380692|526109967|FG000|Study Period III - Open Label|Protocol Violation|0|||
146295427|NCT03769181|527597589|FG003|Overall Study|Withdrawal by Subject|1|||
145891447|NCT00380692|526109968|FG001|Study Period III - Open Label|Protocol Violation|0|||
146295428|NCT03769181|527597586|FG000|Overall Study|Progressive disease|9|||
145891448|NCT00380692|526109967|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
145891449|NCT00380692|526109968|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
145891450|NCT00380692|526109967|FG000|Study Period III - Open Label|Physician Decision|0|||
145891451|NCT00380692|526109968|FG001|Study Period III - Open Label|Physician Decision|3|||
145891452|NCT00380692|526109967|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
145891453|NCT00380692|526109968|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
145891454|NCT00380692|526109967|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
145891455|NCT00380692|526109968|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
145891456|NCT02698865|526109971|FG000|Overall Study|Other|11|||
145891457|NCT02698865|526109972|FG001|Overall Study|Other|11|||
145891458|NCT02698865|526109971|FG000|Overall Study|Withdrawal by Subject|20|||
145891459|NCT02698865|526109972|FG001|Overall Study|Withdrawal by Subject|16|||
145891460|NCT02698865|526109971|FG000|Overall Study|Physician Decision|0|||
145891461|NCT02698865|526109972|FG001|Overall Study|Physician Decision|4|||
146088057|NCT00745615|526841935|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146088058|NCT00745615|526841936|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
146088059|NCT00745615|526841937|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
146088060|NCT00745615|526841938|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
146088061|NCT00570232|526841939|FG000|Overall Study|Adverse Event|10|||
146235471|NCT04337931|527378509|FG002|Overall Study|Participant decision|0|||
145891462|NCT02698865|526109971|FG000|Overall Study|Lost to Follow-up|4|||
145891463|NCT02698865|526109972|FG001|Overall Study|Lost to Follow-up|2|||
145891464|NCT03861481|526109973|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
145891465|NCT03861481|526109974|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
145891466|NCT03861481|526109973|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
145891467|NCT03861481|526109974|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
145891468|NCT03861481|526109973|FG000|Overall Study|Relapse|1|||
145891469|NCT03861481|526109974|FG001|Overall Study|Relapse|0|||
145891470|NCT03861481|526109973|FG000|Overall Study|Withdrawal by Subject|0|||
145891471|NCT03861481|526109974|FG001|Overall Study|Withdrawal by Subject|1|||
145891472|NCT03861481|526109973|FG000|Overall Study|Lack of Efficacy|4|||
145891473|NCT03861481|526109974|FG001|Overall Study|Lack of Efficacy|5|||
145891474|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
145891475|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
145891476|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
145891477|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
145891478|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
145891479|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
145891480|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
145891481|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
145891482|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
145891483|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
145891484|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
145891485|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
145891486|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
145891487|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
145891488|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
145891489|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
145891490|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145891491|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145891492|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
145891493|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145891494|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145891495|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145891496|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145891497|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145891498|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
145891499|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145891500|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145891501|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
145891502|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145891503|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
146235472|NCT01738438|527378510|FG000|Overall Study|Disease Progression|32|||
145891504|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
145891505|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
145891506|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
145891507|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
146088062|NCT00570232|526841939|FG000|Overall Study|discontinued due to medical condition|3|||
145891508|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
145891509|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
145891510|NCT00773734|526109975|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145891511|NCT00773734|526109976|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145891512|NCT00773734|526109977|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145891513|NCT00773734|526109978|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145971007|NCT02966834|526407320|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
145971008|NCT02966834|526407321|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145971009|NCT02966834|526407322|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145971010|NCT02814526|526407323|FG000|Overall Study|Adverse Event|4|||
145971011|NCT02814526|526407324|FG001|Overall Study|Adverse Event|3|||
146235473|NCT01738438|527378510|FG000|Overall Study|Adverse Event|3|||
146235474|NCT04436289|527378511|FG000|Overall Study|Death prior to hospital discharge|8|||
146235475|NCT04436289|527378512|FG001|Overall Study|Death prior to hospital discharge|5|||
146235476|NCT04436289|527378513|FG002|Overall Study|Death prior to hospital discharge|0|||
146235477|NCT04436289|527378514|FG003|Overall Study|Death prior to hospital discharge|1|||
146235478|NCT04436289|527378511|FG000|Overall Study|Withdrawal by Subject|0|||
146235479|NCT04436289|527378512|FG001|Overall Study|Withdrawal by Subject|1|||
146235480|NCT04436289|527378513|FG002|Overall Study|Withdrawal by Subject|4|||
146235481|NCT04436289|527378514|FG003|Overall Study|Withdrawal by Subject|0|||
146235482|NCT04436289|527378511|FG000|Overall Study|Extended hospital stay|0|||
146235483|NCT04436289|527378512|FG001|Overall Study|Extended hospital stay|1|||
146235484|NCT04436289|527378513|FG002|Overall Study|Extended hospital stay|0|||
146235485|NCT04436289|527378514|FG003|Overall Study|Extended hospital stay|0|||
145891514|NCT00773734|526109979|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
145971012|NCT02814526|526407323|FG000|Overall Study|Death|1|||
145971013|NCT02814526|526407324|FG001|Overall Study|Death|1|||
145971014|NCT02814526|526407323|FG000|Overall Study|Lost to Follow-up|3|||
145971015|NCT02814526|526407324|FG001|Overall Study|Lost to Follow-up|4|||
145971016|NCT02814526|526407323|FG000|Overall Study|non site physician decision|1|||
146168102|NCT05267600|527128072|FG000|Overall Study|Physician Decision|4|||
146168103|NCT05267600|527128073|FG001|Overall Study|Physician Decision|0|||
146168104|NCT05267600|527128072|FG000|Overall Study|Treatment Unblinded|0|||
146168105|NCT05267600|527128073|FG001|Overall Study|Treatment Unblinded|1|||
146168106|NCT05267600|527128072|FG000|Overall Study|Withdrawal by Subject|5|||
146168107|NCT05267600|527128073|FG001|Overall Study|Withdrawal by Subject|4|||
146168108|NCT04067401|527128074|FG000|Overall Study|Withdrawal by Subject|7|||
146168109|NCT04067401|527128075|FG001|Overall Study|Withdrawal by Subject|0|||
146168110|NCT04067401|527128074|FG000|Overall Study|no data provided|1|||
146168111|NCT04067401|527128075|FG001|Overall Study|no data provided|0|||
146168112|NCT01889186|527128077|FG000|Overall Study|Adverse event- not related to progression|18|||
146168113|NCT01889186|527128078|FG001|Overall Study|Adverse event- not related to progression|5|||
146168114|NCT01889186|527128077|FG000|Overall Study|Adverse event- related to progression|7|||
146168115|NCT01889186|527128078|FG001|Overall Study|Adverse event- related to progression|2|||
146168116|NCT01889186|527128077|FG000|Overall Study|COVID-19 logistical restrictions|1|||
146168117|NCT01889186|527128078|FG001|Overall Study|COVID-19 logistical restrictions|0|||
146168118|NCT01889186|527128077|FG000|Overall Study|Investigator request|1|||
146168119|NCT01889186|527128078|FG001|Overall Study|Investigator request|1|||
146168120|NCT01889186|527128077|FG000|Overall Study|Progressive disease- Richter's|12|||
146168121|NCT01889186|527128078|FG001|Overall Study|Progressive disease- Richter's|7|||
146168122|NCT01889186|527128077|FG000|Overall Study|Progressive disease per protocol|46|||
146168123|NCT01889186|527128078|FG001|Overall Study|Progressive disease per protocol|17|||
146168124|NCT01889186|527128077|FG000|Overall Study|Stem cell transplant|2|||
146168125|NCT01889186|527128078|FG001|Overall Study|Stem cell transplant|1|||
146168126|NCT01889186|527128077|FG000|Overall Study|Withdrew consent|2|||
146168127|NCT01889186|527128078|FG001|Overall Study|Withdrew consent|3|||
146168128|NCT01889186|527128077|FG000|Overall Study|Other, not specified|18|||
146168129|NCT01889186|527128078|FG001|Overall Study|Other, not specified|15|||
146168130|NCT02110901|527128079|FG000|Overall Study|Death|6|||
146168131|NCT02110901|527128080|FG001|Overall Study|Death|3|||
146168132|NCT02110901|527128079|FG000|Overall Study|Lost to Follow-up|12|||
146168133|NCT02110901|527128080|FG001|Overall Study|Lost to Follow-up|8|||
146168134|NCT02110901|527128079|FG000|Overall Study|Withdrawal by Subject|7|||
146168135|NCT02110901|527128080|FG001|Overall Study|Withdrawal by Subject|3|||
146168136|NCT02110901|527128079|FG000|Overall Study|received a kidney transplant|5|||
146168137|NCT02110901|527128080|FG001|Overall Study|received a kidney transplant|0|||
146168138|NCT01058304|527128083|FG000|Overall Study|Withdrawal by Subject|8|||
146168139|NCT01058304|527128084|FG001|Overall Study|Withdrawal by Subject|5|||
146168140|NCT01058304|527128083|FG000|Overall Study|Lost to Follow-up|13|||
146168141|NCT01058304|527128084|FG001|Overall Study|Lost to Follow-up|16|||
146168142|NCT01058304|527128083|FG000|Overall Study|Developed exclusion criterion|6|||
146168143|NCT01058304|527128084|FG001|Overall Study|Developed exclusion criterion|12|||
146168144|NCT02496767|527128085|FG000|Open-label Lead-in Phase|Adverse Event|176|||
145891515|NCT00773734|526109980|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
145891516|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145891517|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
145891518|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145891519|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145891520|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
146088063|NCT00570232|526841939|FG000|Overall Study|discontinued due to recurrence|8|||
146088064|NCT00570232|526841939|FG000|Overall Study|discontinued due to noncompliance|2|||
146088065|NCT01076075|526841940|FG000|Overall Study|Adverse Event|3|||
146088066|NCT01076075|526841941|FG001|Overall Study|Adverse Event|9|||
146088067|NCT01076075|526841940|FG000|Overall Study|Lack of Efficacy|5|||
146088068|NCT01076075|526841941|FG001|Overall Study|Lack of Efficacy|4|||
146088069|NCT01076075|526841940|FG000|Overall Study|Lost to Follow-up|6|||
146088070|NCT01076075|526841941|FG001|Overall Study|Lost to Follow-up|5|||
146088071|NCT01076075|526841940|FG000|Overall Study|other|19|||
146088072|NCT01076075|526841941|FG001|Overall Study|other|9|||
146088073|NCT01076075|526841940|FG000|Overall Study|Protocol Violation|0|||
145891521|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
145891522|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145891523|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
145891524|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
145891525|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
145891526|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145891527|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145891528|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145891529|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
145891530|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
145891531|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145891532|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145891533|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
145891534|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145891535|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
145891536|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
145891537|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145891538|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145891539|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145891540|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
145891541|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
146088074|NCT01076075|526841941|FG001|Overall Study|Protocol Violation|1|||
146088075|NCT01076075|526841940|FG000|Overall Study|Withdrawal by Subject|8|||
146088076|NCT01076075|526841941|FG001|Overall Study|Withdrawal by Subject|19|||
146088077|NCT01445886|526841947|FG000|Overall Study|Lost to Follow-up|2|||
146088078|NCT01445886|526841947|FG000|Overall Study|Protocol Violation|3|||
146088079|NCT00586664|526841948|FG000|Overall Study|Withdrawal by Subject|3|||
146088080|NCT00586664|526841949|FG001|Overall Study|Withdrawal by Subject|7|||
146088081|NCT00586664|526841950|FG002|Overall Study|Withdrawal by Subject|1|||
146088082|NCT00586664|526841948|FG000|Overall Study|Exclusion criteria met|2|||
146088083|NCT00586664|526841949|FG001|Overall Study|Exclusion criteria met|0|||
146088084|NCT00586664|526841950|FG002|Overall Study|Exclusion criteria met|0|||
146088085|NCT03473548|526841954|FG000|Overall Study|Did not attempt HST testing|3|||
146088086|NCT03473548|526841955|FG001|Overall Study|Did not attempt HST testing|0|||
146088087|NCT01585584|526841958|FG000|Overall Study|Lack of Efficacy|1|||
146088088|NCT01585584|526841958|FG000|Overall Study|Withdrawal by Subject|1|||
146088089|NCT01585584|526841958|FG000|Overall Study|Physician Decision|2|||
146295429|NCT03769181|527597587|FG001|Overall Study|Progressive disease|7|||
145891542|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145891543|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145891544|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
145891545|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145891546|NCT00773734|526109975|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
145891547|NCT00773734|526109976|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
145891548|NCT00773734|526109977|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
145891549|NCT00773734|526109978|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
146088090|NCT01986933|526841959|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
146088091|NCT01986933|526841960|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
146088092|NCT01986933|526841961|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
146088093|NCT01986933|526841962|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
146088094|NCT01986933|526841963|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
146088095|NCT01986933|526841959|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
146088096|NCT01986933|526841960|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146235486|NCT04436289|527378511|FG000|Overall Study|Lost to Follow-up|0|||
146235487|NCT04436289|527378512|FG001|Overall Study|Lost to Follow-up|4|||
146235488|NCT04436289|527378513|FG002|Overall Study|Lost to Follow-up|1|||
146235489|NCT04436289|527378514|FG003|Overall Study|Lost to Follow-up|3|||
146235490|NCT01532999|527378515|FG000|Overall Study|Lost to Follow-up|14|||
146235491|NCT01532999|527378516|FG001|Overall Study|Lost to Follow-up|8|||
146235492|NCT01532999|527378515|FG000|Overall Study|Physician Decision|1|||
146235493|NCT01532999|527378516|FG001|Overall Study|Physician Decision|2|||
146235494|NCT01532999|527378515|FG000|Overall Study|Withdrawal by Subject|5|||
146235495|NCT01532999|527378516|FG001|Overall Study|Withdrawal by Subject|0|||
146235496|NCT01532999|527378515|FG000|Overall Study|Relocated|2|||
146235497|NCT01532999|527378516|FG001|Overall Study|Relocated|0|||
146235498|NCT01532999|527378515|FG000|Overall Study|should not have been randomized|1|||
146235499|NCT01532999|527378516|FG001|Overall Study|should not have been randomized|0|||
146235500|NCT01532999|527378515|FG000|Overall Study|substantial noncompliance|2|||
146235501|NCT01532999|527378516|FG001|Overall Study|substantial noncompliance|0|||
146235502|NCT01532999|527378515|FG000|Overall Study|no show for week 9 assessments|6|||
146235503|NCT01532999|527378516|FG001|Overall Study|no show for week 9 assessments|4|||
146235504|NCT01532999|527378515|FG000|Overall Study|Adverse Event|0|||
146235505|NCT01532999|527378516|FG001|Overall Study|Adverse Event|1|||
146235506|NCT01532999|527378515|FG000|Overall Study|incarcerated|0|||
146235507|NCT01532999|527378516|FG001|Overall Study|incarcerated|1|||
146235508|NCT01532999|527378515|FG000|Overall Study|New job|0|||
146235509|NCT01532999|527378516|FG001|Overall Study|New job|2|||
146235510|NCT02928172|527378517|FG000|Overall Study|Device did not record data|1|||
146235511|NCT03280030|527378518|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
146235512|NCT03280030|527378519|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
146235513|NCT03280030|527378520|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
146235514|NCT03280030|527378518|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
146235515|NCT03280030|527378519|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
146235516|NCT03280030|527378520|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
146235517|NCT03280030|527378518|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
146235518|NCT03280030|527378519|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
146235519|NCT03280030|527378520|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
146235520|NCT03280030|527378518|FG000|Part 2 - Efficacy|Adverse Event|0|||
146235521|NCT03280030|527378519|FG001|Part 2 - Efficacy|Adverse Event|4|||
146235522|NCT03280030|527378520|FG002|Part 2 - Efficacy|Adverse Event|6|||
146235523|NCT03280030|527378518|FG000|Part 2 - Efficacy|Death|0|||
146235524|NCT03280030|527378519|FG001|Part 2 - Efficacy|Death|3|||
146235525|NCT03280030|527378520|FG002|Part 2 - Efficacy|Death|0|||
146235526|NCT03280030|527378518|FG000|Part 2 - Efficacy|Physician Decision|0|||
146235527|NCT03280030|527378519|FG001|Part 2 - Efficacy|Physician Decision|10|||
146235528|NCT03280030|527378520|FG002|Part 2 - Efficacy|Physician Decision|16|||
146235529|NCT03280030|527378518|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
146235530|NCT03280030|527378519|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
146235531|NCT03280030|527378520|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
146235532|NCT03280030|527378518|FG000|Part 2 - Efficacy|Progressive disease|0|||
146235533|NCT03280030|527378519|FG001|Part 2 - Efficacy|Progressive disease|7|||
146235534|NCT03280030|527378520|FG002|Part 2 - Efficacy|Progressive disease|5|||
146235535|NCT03211247|527378521|FG000|Overall Study|Adverse Event|8|||
146235536|NCT03211247|527378522|FG001|Overall Study|Adverse Event|0|||
146235537|NCT03211247|527378523|FG002|Overall Study|Adverse Event|1|||
146235538|NCT03211247|527378524|FG003|Overall Study|Adverse Event|0|||
146235539|NCT03211247|527378525|FG004|Overall Study|Adverse Event|0|||
146235540|NCT03211247|527378521|FG000|Overall Study|Lost to Follow-up|2|||
146235541|NCT03211247|527378522|FG001|Overall Study|Lost to Follow-up|1|||
146235542|NCT03211247|527378523|FG002|Overall Study|Lost to Follow-up|0|||
146235543|NCT03211247|527378524|FG003|Overall Study|Lost to Follow-up|0|||
146235544|NCT03211247|527378525|FG004|Overall Study|Lost to Follow-up|0|||
146235545|NCT03211247|527378521|FG000|Overall Study|Physician Decision|1|||
146235546|NCT03211247|527378522|FG001|Overall Study|Physician Decision|2|||
146235547|NCT03211247|527378523|FG002|Overall Study|Physician Decision|0|||
146235548|NCT03211247|527378524|FG003|Overall Study|Physician Decision|0|||
146235549|NCT03211247|527378525|FG004|Overall Study|Physician Decision|0|||
146235550|NCT03211247|527378521|FG000|Overall Study|Non-compliance with study drug|2|||
146235551|NCT03211247|527378522|FG001|Overall Study|Non-compliance with study drug|0|||
146235552|NCT03211247|527378523|FG002|Overall Study|Non-compliance with study drug|0|||
146235553|NCT03211247|527378524|FG003|Overall Study|Non-compliance with study drug|0|||
146235554|NCT03211247|527378525|FG004|Overall Study|Non-compliance with study drug|0|||
146235555|NCT03211247|527378521|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
146235556|NCT03211247|527378522|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
146235557|NCT03211247|527378523|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
146235558|NCT03211247|527378524|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
146235559|NCT03211247|527378525|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
146235560|NCT03211247|527378521|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
146235561|NCT03211247|527378522|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
146235562|NCT03211247|527378523|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
146235563|NCT03211247|527378524|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
146235564|NCT03211247|527378525|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
146235565|NCT03211247|527378521|FG000|Overall Study|Protocol Violation|0|||
146235566|NCT03211247|527378522|FG001|Overall Study|Protocol Violation|1|||
146235567|NCT03211247|527378523|FG002|Overall Study|Protocol Violation|0|||
146235568|NCT03211247|527378524|FG003|Overall Study|Protocol Violation|0|||
146235569|NCT03211247|527378525|FG004|Overall Study|Protocol Violation|0|||
146235570|NCT02761187|527378526|FG000|Overall Study|Too ill to Participate|13|||
146235571|NCT02761187|527378527|FG001|Overall Study|Too ill to Participate|8|||
146235572|NCT02761187|527378526|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
145971017|NCT02814526|526407324|FG001|Overall Study|non site physician decision|0|||
146295430|NCT03769181|527597588|FG002|Overall Study|Progressive disease|13|||
145891550|NCT00773734|526109979|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
145891551|NCT00773734|526109980|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
145891552|NCT00773734|526109975|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145891553|NCT00773734|526109976|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145891554|NCT00773734|526109977|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145891555|NCT00773734|526109978|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145891556|NCT00773734|526109979|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
145891557|NCT00773734|526109980|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
146295431|NCT03769181|527597589|FG003|Overall Study|Progressive disease|6|||
146295432|NCT03769181|527597586|FG000|Overall Study|Other - Unspecified|2|||
146295433|NCT03769181|527597587|FG001|Overall Study|Other - Unspecified|1|||
146295434|NCT03769181|527597588|FG002|Overall Study|Other - Unspecified|0|||
146295435|NCT03769181|527597589|FG003|Overall Study|Other - Unspecified|0|||
146295436|NCT03971422|527597590|FG000|Overall Study|Lost to Follow-up|0|||
146295437|NCT03971422|527597591|FG001|Overall Study|Lost to Follow-up|1|||
146295438|NCT03971422|527597592|FG002|Overall Study|Lost to Follow-up|0|||
146295439|NCT03971422|527597590|FG000|Overall Study|Lack of Efficacy|5|||
146295440|NCT03971422|527597591|FG001|Overall Study|Lack of Efficacy|1|||
146295441|NCT03971422|527597592|FG002|Overall Study|Lack of Efficacy|1|||
146295442|NCT03971422|527597590|FG000|Overall Study|Adverse event, not fatal|2|||
146295443|NCT03971422|527597591|FG001|Overall Study|Adverse event, not fatal|2|||
146295444|NCT03971422|527597592|FG002|Overall Study|Adverse event, not fatal|5|||
145891558|NCT00773734|526109975|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
145891559|NCT00773734|526109976|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
145891560|NCT00773734|526109977|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
146295445|NCT03971422|527597590|FG000|Overall Study|Worsening of MG Symptoms|1|||
146295446|NCT03971422|527597591|FG001|Overall Study|Worsening of MG Symptoms|4|||
146295447|NCT03971422|527597592|FG002|Overall Study|Worsening of MG Symptoms|2|||
146295448|NCT03971422|527597590|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
146295449|NCT03971422|527597591|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
146295450|NCT03971422|527597592|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
146295451|NCT03971422|527597590|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
146295452|NCT03971422|527597591|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
146295453|NCT03971422|527597592|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
146295454|NCT03971422|527597590|FG000|Overall Study|Due to COVID-19 pandemic|0|||
146295455|NCT03971422|527597591|FG001|Overall Study|Due to COVID-19 pandemic|1|||
146295456|NCT03971422|527597592|FG002|Overall Study|Due to COVID-19 pandemic|1|||
146295457|NCT01128361|527597594|FG000|Overall Study|Lost to Follow-up|0|||
146295458|NCT01128361|527597595|FG001|Overall Study|Lost to Follow-up|1|||
146295459|NCT01128361|527597594|FG000|Overall Study|Withdrawal by Subject|5|||
145891561|NCT00773734|526109978|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
145891562|NCT00773734|526109979|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
145891563|NCT00773734|526109980|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
145891564|NCT00773734|526109975|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
145891565|NCT00773734|526109976|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
145891566|NCT00773734|526109977|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
145891567|NCT00773734|526109978|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
145891568|NCT00773734|526109979|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
145891569|NCT00773734|526109980|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
145891570|NCT00773734|526109975|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
145891571|NCT00773734|526109976|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
145891572|NCT00773734|526109977|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
145891573|NCT00773734|526109978|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
145891574|NCT00773734|526109979|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
145891575|NCT00773734|526109980|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
145891576|NCT00773734|526109975|FG000|Extension: Active Treatment Week 24-52|Other|0|||
145891577|NCT00773734|526109976|FG001|Extension: Active Treatment Week 24-52|Other|0|||
145891578|NCT00773734|526109977|FG002|Extension: Active Treatment Week 24-52|Other|1|||
145891579|NCT00773734|526109978|FG003|Extension: Active Treatment Week 24-52|Other|2|||
145891580|NCT00773734|526109979|FG004|Extension: Active Treatment Week 24-52|Other|0|||
145891581|NCT00773734|526109980|FG005|Extension: Active Treatment Week 24-52|Other|1|||
145891582|NCT00773734|526109975|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145891583|NCT00773734|526109976|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145891584|NCT00773734|526109977|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
146295460|NCT01128361|527597595|FG001|Overall Study|Withdrawal by Subject|2|||
146295461|NCT01929980|527597596|FG000|Overall Study|Physician Decision|1|||
145891585|NCT00773734|526109978|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
146295462|NCT04082429|527597597|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
146295463|NCT04082429|527597598|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146295464|NCT04082429|527597599|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
145891586|NCT00773734|526109979|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145891587|NCT00773734|526109980|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145891588|NCT00773734|526109975|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145891589|NCT00773734|526109976|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145891590|NCT00773734|526109977|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
145891591|NCT00773734|526109978|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
145891592|NCT00773734|526109979|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145891593|NCT00773734|526109980|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145891594|NCT00773734|526109975|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145891595|NCT00773734|526109976|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145891596|NCT00773734|526109977|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
145971018|NCT02814526|526407323|FG000|Overall Study|participant noncompliance|1|||
145971019|NCT02814526|526407324|FG001|Overall Study|participant noncompliance|1|||
146235573|NCT02761187|527378527|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
146235574|NCT02761187|527378526|FG000|Overall Study|Patient withdrew consent|64|||
146235575|NCT02761187|527378527|FG001|Overall Study|Patient withdrew consent|58|||
146235576|NCT02761187|527378526|FG000|Overall Study|Physician discretion|4|||
146235577|NCT02761187|527378527|FG001|Overall Study|Physician discretion|8|||
146235578|NCT02761187|527378526|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
146235579|NCT02761187|527378527|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
146235580|NCT02761187|527378526|FG000|Overall Study|On Hospice|20|||
146235581|NCT02761187|527378527|FG001|Overall Study|On Hospice|26|||
146235582|NCT02761187|527378526|FG000|Overall Study|Deceased|474|||
146235583|NCT02761187|527378527|FG001|Overall Study|Deceased|642|||
146235584|NCT02761187|527378526|FG000|Overall Study|Lost to Follow-up|73|||
146235585|NCT02761187|527378527|FG001|Overall Study|Lost to Follow-up|63|||
146235586|NCT02761187|527378526|FG000|Overall Study|Due to study discontinued at site|100|||
146235587|NCT02761187|527378527|FG001|Overall Study|Due to study discontinued at site|85|||
146235588|NCT02761187|527378526|FG000|Overall Study|Reason not Specified|1484|||
146235589|NCT02761187|527378527|FG001|Overall Study|Reason not Specified|937|||
146235590|NCT04153890|527378528|FG000|Overall Study|Lost to Follow-up|9|||
146235591|NCT04153890|527378529|FG001|Overall Study|Lost to Follow-up|0|||
146235592|NCT04153890|527378530|FG002|Overall Study|Lost to Follow-up|9|||
146235593|NCT04153890|527378531|FG003|Overall Study|Lost to Follow-up|0|||
146235594|NCT04153890|527378528|FG000|Overall Study|Death|0|||
146235595|NCT04153890|527378529|FG001|Overall Study|Death|2|||
146235596|NCT04153890|527378530|FG002|Overall Study|Death|0|||
146235597|NCT04153890|527378531|FG003|Overall Study|Death|0|||
146235598|NCT04153890|527378528|FG000|Overall Study|Withdrawal by Subject|0|||
146235599|NCT04153890|527378529|FG001|Overall Study|Withdrawal by Subject|0|||
146235600|NCT04153890|527378530|FG002|Overall Study|Withdrawal by Subject|0|||
146235601|NCT04153890|527378531|FG003|Overall Study|Withdrawal by Subject|2|||
146235602|NCT03997474|527378534|FG000|Overall Study|Death|6|||
146235603|NCT03997474|527378535|FG001|Overall Study|Death|2|||
146235604|NCT03997474|527378536|FG002|Overall Study|Death|1|||
146235605|NCT03997474|527378534|FG000|Overall Study|Physician Decision|2|||
146235606|NCT03997474|527378535|FG001|Overall Study|Physician Decision|0|||
146235607|NCT03997474|527378536|FG002|Overall Study|Physician Decision|0|||
146235608|NCT03997474|527378534|FG000|Overall Study|study terminated by sponsor|1|||
146235609|NCT03997474|527378535|FG001|Overall Study|study terminated by sponsor|0|||
146235610|NCT03997474|527378536|FG002|Overall Study|study terminated by sponsor|1|||
146235611|NCT05786612|527378538|FG000|Overall Study|Adverse Event|1|||
146235612|NCT05786612|527378539|FG001|Overall Study|Adverse Event|2|||
146235613|NCT05786612|527378538|FG000|Overall Study|one screening failure|0|||
146235614|NCT05786612|527378539|FG001|Overall Study|one screening failure|2|||
146235615|NCT05630833|527378542|FG000|Overall Study|Adverse Event|3|||
146235616|NCT05630833|527378543|FG001|Overall Study|Adverse Event|0|||
146235617|NCT05630833|527378542|FG000|Overall Study|Lack of Efficacy|0|||
146235618|NCT05630833|527378543|FG001|Overall Study|Lack of Efficacy|1|||
146235619|NCT05630833|527378542|FG000|Overall Study|Lost to Follow-up|1|||
146235620|NCT05630833|527378543|FG001|Overall Study|Lost to Follow-up|0|||
146235621|NCT05630833|527378542|FG000|Overall Study|Withdrawal by Subject|3|||
145891597|NCT00773734|526109978|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
145971020|NCT02814526|526407323|FG000|Overall Study|Withdrawal by Subject|20|||
145971021|NCT02814526|526407324|FG001|Overall Study|Withdrawal by Subject|14|||
146235622|NCT05630833|527378543|FG001|Overall Study|Withdrawal by Subject|1|||
146235623|NCT03277989|527378545|FG000|Overall Study|Lost to Follow-up|6|||
145971022|NCT02814526|526407323|FG000|Overall Study|safety risk|2|||
146235624|NCT03277989|527378545|FG000|Overall Study|Adverse Event|6|||
146235625|NCT03277989|527378545|FG000|Overall Study|Withdrawal by Subject|3|||
146235626|NCT03277989|527378545|FG000|Overall Study|Didn't Receive Study Device|7|||
146235627|NCT03277989|527378545|FG000|Overall Study|Site Closure|26|||
146235628|NCT03277989|527378545|FG000|Overall Study|Sponsor Closure|107|||
146235629|NCT02798471|527378548|FG000|Overall Study|Adverse Event|7|||
146235630|NCT02798471|527378549|FG001|Overall Study|Adverse Event|2|||
145971023|NCT02814526|526407324|FG001|Overall Study|safety risk|1|||
145891598|NCT00773734|526109979|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145891599|NCT00773734|526109980|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145891600|NCT00773734|526109975|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145891601|NCT00773734|526109976|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145891602|NCT00773734|526109977|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
146235631|NCT02798471|527378548|FG000|Overall Study|Physician Decision|3|||
146235632|NCT02798471|527378549|FG001|Overall Study|Physician Decision|7|||
146235633|NCT02798471|527378548|FG000|Overall Study|Death|2|||
146235634|NCT02798471|527378549|FG001|Overall Study|Death|3|||
146235635|NCT02798471|527378548|FG000|Overall Study|Lost to Follow-up|0|||
146235636|NCT02798471|527378549|FG001|Overall Study|Lost to Follow-up|1|||
146235637|NCT02798471|527378548|FG000|Overall Study|Other|5|||
146235638|NCT02798471|527378549|FG001|Overall Study|Other|3|||
146235639|NCT02798471|527378548|FG000|Overall Study|Subject withdrew consent|0|||
146235640|NCT02798471|527378549|FG001|Overall Study|Subject withdrew consent|6|||
146235641|NCT02798471|527378548|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
146235642|NCT02798471|527378549|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
146235643|NCT02798471|527378548|FG000|Overall Study|Randomized, but not treated|0|||
146235644|NCT02798471|527378549|FG001|Overall Study|Randomized, but not treated|2|||
146235645|NCT03083366|527379902|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
146235646|NCT03083366|527379903|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
146235647|NCT03083366|527379902|FG000|Enrollment Period|Lack of Efficacy|1|||
146235648|NCT03083366|527379903|FG001|Enrollment Period|Lack of Efficacy|0|||
146235649|NCT06056310|527379908|FG000|Overall Study|Other Reasons|2|||
145891603|NCT00773734|526109978|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
145891604|NCT00773734|526109979|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145891605|NCT00773734|526109980|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145891606|NCT01220297|526109987|FG000|Overall Study|Death|2|||
145891607|NCT01220297|526109987|FG000|Overall Study|Lost to Follow-up|1|||
145891608|NCT02119286|526109989|FG000|Overall Study|Adverse Event|9|||
145891609|NCT02119286|526109990|FG001|Overall Study|Adverse Event|7|||
145891610|NCT02119286|526109991|FG002|Overall Study|Adverse Event|2|||
145891611|NCT02119286|526109989|FG000|Overall Study|Lack of Efficacy|11|||
145891612|NCT02119286|526109990|FG001|Overall Study|Lack of Efficacy|3|||
145891613|NCT02119286|526109991|FG002|Overall Study|Lack of Efficacy|4|||
145891614|NCT02119286|526109989|FG000|Overall Study|Lost to Follow-up|2|||
145891615|NCT02119286|526109990|FG001|Overall Study|Lost to Follow-up|0|||
145891616|NCT02119286|526109991|FG002|Overall Study|Lost to Follow-up|1|||
145891617|NCT02119286|526109989|FG000|Overall Study|Withdrawal by Subject|4|||
145891618|NCT02119286|526109990|FG001|Overall Study|Withdrawal by Subject|1|||
145891619|NCT02119286|526109991|FG002|Overall Study|Withdrawal by Subject|0|||
145891620|NCT03438396|526109993|FG000|Overall Study|Reason Not Specified|9|||
145891621|NCT03438396|526109993|FG000|Overall Study|Withdrawal by Subject|5|||
145891622|NCT03438396|526109993|FG000|Overall Study|Lost to Follow-up|2|||
145891623|NCT03438396|526109993|FG000|Overall Study|Death|85|||
145891624|NCT03438396|526109993|FG000|Overall Study|Not treated|1|||
145891625|NCT01744093|526109997|FG000|Overall Study|Withdrawal by Subject|6|||
145891626|NCT01744093|526109998|FG001|Overall Study|Withdrawal by Subject|1|||
145891627|NCT02006628|526109999|FG000|Overall Study|Adverse Event|1|||
145891628|NCT02006628|526110000|FG001|Overall Study|Adverse Event|1|||
145891629|NCT02006628|526109999|FG000|Overall Study|Withdrawal by Subject|2|||
145891630|NCT02006628|526110000|FG001|Overall Study|Withdrawal by Subject|1|||
145891631|NCT02384941|526110003|FG000|Overall Study|Adverse Event|11|||
145891632|NCT02384941|526110004|FG001|Overall Study|Adverse Event|13|||
145891633|NCT02384941|526110005|FG002|Overall Study|Adverse Event|17|||
145891634|NCT02384941|526110003|FG000|Overall Study|Lost to Follow-up|3|||
145891635|NCT02384941|526110004|FG001|Overall Study|Lost to Follow-up|2|||
145891636|NCT02384941|526110005|FG002|Overall Study|Lost to Follow-up|1|||
146235650|NCT06056310|527379908|FG000|Overall Study|Sponsor Request|16|||
146235651|NCT00065182|527379912|FG000|Overall Study|Adverse Event|24|||
146235652|NCT00065182|527379913|FG001|Overall Study|Adverse Event|17|||
146088097|NCT01986933|526841961|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146235653|NCT00065182|527379912|FG000|Overall Study|Lost to Follow-up|0|||
146235654|NCT00065182|527379913|FG001|Overall Study|Lost to Follow-up|4|||
145891637|NCT02384941|526110003|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145891638|NCT02384941|526110004|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145891639|NCT02384941|526110005|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145891640|NCT02384941|526110003|FG000|Overall Study|Physician Decision|1|||
145891641|NCT02384941|526110004|FG001|Overall Study|Physician Decision|1|||
145891642|NCT02384941|526110005|FG002|Overall Study|Physician Decision|0|||
145891643|NCT02384941|526110003|FG000|Overall Study|Protocol Violation|3|||
145891644|NCT02384941|526110004|FG001|Overall Study|Protocol Violation|0|||
145891645|NCT02384941|526110005|FG002|Overall Study|Protocol Violation|0|||
146088098|NCT01986933|526841962|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
146235655|NCT00065182|527379912|FG000|Overall Study|Protocol Violation|3|||
146235656|NCT00065182|527379913|FG001|Overall Study|Protocol Violation|4|||
146235657|NCT00065182|527379912|FG000|Overall Study|Serious adverse events (SAE)|1|||
146235658|NCT00065182|527379913|FG001|Overall Study|Serious adverse events (SAE)|0|||
146235659|NCT00065182|527379912|FG000|Overall Study|Sponsor Decision|11|||
146235660|NCT00065182|527379913|FG001|Overall Study|Sponsor Decision|7|||
146235661|NCT00065182|527379912|FG000|Overall Study|Withdrawal by Subject|8|||
146235662|NCT00065182|527379913|FG001|Overall Study|Withdrawal by Subject|3|||
146235663|NCT00065182|527379912|FG000|Overall Study|No clinical benefit|1|||
146235664|NCT00065182|527379913|FG001|Overall Study|No clinical benefit|0|||
146235665|NCT00065182|527379912|FG000|Overall Study|Death|0|||
146235666|NCT00065182|527379913|FG001|Overall Study|Death|1|||
146235667|NCT00065182|527379912|FG000|Overall Study|Decline in Status|0|||
146235668|NCT00065182|527379913|FG001|Overall Study|Decline in Status|1|||
146235669|NCT02633215|527379914|FG000|Overall Study|Lost to Follow-up|2|||
146235670|NCT02633215|527379915|FG001|Overall Study|Lost to Follow-up|3|||
146235671|NCT00754325|527379916|FG000|Initial Treatment|Continuing Active Treatment|4|||
146235672|NCT00754325|527379917|FG001|Initial Treatment|Continuing Active Treatment|5|||
146235673|NCT00754325|527379916|FG000|Initial Treatment|Adverse Event|7|||
146235674|NCT00754325|527379917|FG001|Initial Treatment|Adverse Event|6|||
146235675|NCT00754325|527379916|FG000|Initial Treatment|Withdrawal by Subject|2|||
146235676|NCT00754325|527379917|FG001|Initial Treatment|Withdrawal by Subject|2|||
146235677|NCT00754325|527379916|FG000|Initial Treatment|Physician Decision|2|||
146235678|NCT00754325|527379917|FG001|Initial Treatment|Physician Decision|0|||
146235679|NCT00754325|527379916|FG000|Initial Treatment|Sponsor Request|0|||
146235680|NCT00754325|527379917|FG001|Initial Treatment|Sponsor Request|1|||
146235681|NCT00754325|527379916|FG000|Initial Treatment|Disease Progression|35|||
146235682|NCT00754325|527379917|FG001|Initial Treatment|Disease Progression|35|||
146235683|NCT03442777|527379918|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
146235684|NCT03442777|527379919|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
146235685|NCT03442777|527379920|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
146235686|NCT01627561|527379921|FG000|Overall Study|Lost to Follow-up|1|||
146235687|NCT01627561|527379922|FG001|Overall Study|Lost to Follow-up|0|||
146235688|NCT01627561|527379921|FG000|Overall Study|Withdrawal by Subject|0|||
146235689|NCT01627561|527379922|FG001|Overall Study|Withdrawal by Subject|1|||
146235690|NCT01627561|527379921|FG000|Overall Study|Migrated/moved from study area|0|||
146235691|NCT01627561|527379922|FG001|Overall Study|Migrated/moved from study area|2|||
146235692|NCT00713596|527379924|FG000|Overall Study|Study was terminated|2|||
146235693|NCT00713596|527379925|FG001|Overall Study|Study was terminated|3|||
146235694|NCT00713596|527379926|FG002|Overall Study|Study was terminated|2|||
146235695|NCT04545619|527379927|FG000|Overall Study|due to equipment challenges|1|||
146235696|NCT00754065|527379932|FG000|Overall Study|Never received treatment|12|||
146235697|NCT00754065|527379933|FG001|Overall Study|Never received treatment|2|||
146235698|NCT00754065|527379932|FG000|Overall Study|Adverse Event|19|||
146235699|NCT00754065|527379933|FG001|Overall Study|Adverse Event|25|||
146235700|NCT00754065|527379932|FG000|Overall Study|Lost to Follow-up|7|||
146235701|NCT00754065|527379933|FG001|Overall Study|Lost to Follow-up|11|||
146235702|NCT00754065|527379932|FG000|Overall Study|Protocol Violation|12|||
146235703|NCT00754065|527379933|FG001|Overall Study|Protocol Violation|10|||
146235704|NCT00754065|527379932|FG000|Overall Study|Withdrawal by Subject|4|||
146235705|NCT00754065|527379933|FG001|Overall Study|Withdrawal by Subject|5|||
146235706|NCT00754065|527379932|FG000|Overall Study|Pregnancy|6|||
146235707|NCT00754065|527379933|FG001|Overall Study|Pregnancy|0|||
146235708|NCT00754065|527379932|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
146235709|NCT00754065|527379933|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
146235710|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
146235711|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
146235712|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235713|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235714|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235715|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
146235716|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
146235717|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235718|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235719|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235720|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235721|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235722|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235723|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
146235724|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235725|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235726|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235727|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235728|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235729|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
146235730|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
146235731|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235732|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235733|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235734|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235735|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235736|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235737|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
146235738|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
146235739|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235740|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235741|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235742|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235743|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235744|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
146235745|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235746|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235747|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235748|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235749|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235750|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235751|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
146235752|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235753|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235754|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235755|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235756|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235757|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
146235758|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
146235759|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235760|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235761|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235762|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235763|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235764|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235765|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
146235766|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235767|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235768|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235769|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235770|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235771|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235772|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
146235773|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235774|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235775|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235776|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235777|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235778|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235779|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
146235780|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146235781|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146235782|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
146235783|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235784|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235785|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
146235786|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
146235787|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235788|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235789|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235790|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146295465|NCT04082429|527597600|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
146295466|NCT04082429|527597601|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
146295467|NCT04082429|527597602|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146295468|NCT04082429|527597603|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146295469|NCT04082429|527597604|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146295470|NCT04082429|527597605|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
146295471|NCT04082429|527597597|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295472|NCT04082429|527597598|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295473|NCT04082429|527597599|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295474|NCT04082429|527597600|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295475|NCT04082429|527597601|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
146295476|NCT04082429|527597602|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295477|NCT04082429|527597603|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295478|NCT04082429|527597604|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295479|NCT04082429|527597605|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
146295480|NCT04082429|527597597|FG000|Main Part (After the Treatment Pause)|Death|0|||
146295481|NCT04082429|527597598|FG001|Main Part (After the Treatment Pause)|Death|0|||
146295482|NCT04082429|527597599|FG002|Main Part (After the Treatment Pause)|Death|0|||
146295483|NCT04082429|527597600|FG003|Main Part (After the Treatment Pause)|Death|0|||
146295484|NCT04082429|527597601|FG004|Main Part (After the Treatment Pause)|Death|1|||
146295485|NCT04082429|527597602|FG005|Main Part (After the Treatment Pause)|Death|0|||
146295486|NCT04082429|527597603|FG006|Main Part (After the Treatment Pause)|Death|0|||
146295487|NCT04082429|527597604|FG007|Main Part (After the Treatment Pause)|Death|0|||
146295488|NCT04082429|527597605|FG008|Main Part (After the Treatment Pause)|Death|0|||
146295489|NCT04082429|527597597|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295490|NCT04082429|527597598|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295491|NCT04082429|527597599|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295492|NCT04082429|527597600|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
146295493|NCT04082429|527597601|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295494|NCT04082429|527597602|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
146295495|NCT04082429|527597603|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295496|NCT04082429|527597604|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295497|NCT04082429|527597605|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
146295498|NCT04082429|527597597|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146295499|NCT04082429|527597598|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146295500|NCT04082429|527597599|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
146295501|NCT04082429|527597600|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
146295502|NCT04082429|527597601|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146295503|NCT04082429|527597602|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
146295504|NCT04082429|527597603|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145971024|NCT02814526|526407323|FG000|Overall Study|early termination-study terminated|1|||
145971025|NCT02814526|526407324|FG001|Overall Study|early termination-study terminated|2|||
146235791|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235792|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235793|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
146235794|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235795|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
146235796|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235797|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235798|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235799|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
146235800|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235801|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235802|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235803|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235804|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235805|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235806|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235807|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
146235808|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
146235809|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235810|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146295505|NCT04082429|527597604|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
145971026|NCT02814526|526407323|FG000|Overall Study|Other|0|||
146295506|NCT04082429|527597605|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
146295507|NCT04082429|527597597|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
146295508|NCT04082429|527597598|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145891646|NCT02384941|526110003|FG000|Overall Study|Withdrawal by Subject|26|||
145891647|NCT02384941|526110004|FG001|Overall Study|Withdrawal by Subject|19|||
145891648|NCT02384941|526110005|FG002|Overall Study|Withdrawal by Subject|20|||
145891649|NCT02384941|526110003|FG000|Overall Study|Pregnancy|0|||
145891650|NCT02384941|526110004|FG001|Overall Study|Pregnancy|0|||
145891651|NCT02384941|526110005|FG002|Overall Study|Pregnancy|1|||
145891652|NCT02384941|526110003|FG000|Overall Study|Other than specified above|4|||
145891653|NCT02384941|526110004|FG001|Overall Study|Other than specified above|0|||
145891654|NCT02384941|526110005|FG002|Overall Study|Other than specified above|1|||
145891655|NCT02493777|526110006|FG000|Overall Study|Lost to Follow-up|0|||
145891656|NCT02493777|526110007|FG001|Overall Study|Lost to Follow-up|1|||
145891657|NCT00468728|526110008|FG000|Treatment|criteria for mITT population|4|||
145891658|NCT00468728|526110009|FG001|Treatment|criteria for mITT population|11|||
145891659|NCT00468728|526110008|FG000|Follow-up|mITT failure|34|||
145891660|NCT00468728|526110009|FG001|Follow-up|mITT failure|31|||
145891661|NCT01705236|526110010|FG000|Overall Study|Lost to Follow-up|1|||
145891662|NCT01705236|526110010|FG000|Overall Study|Administrative problems|2|||
145891663|NCT01705236|526110010|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145891664|NCT01705236|526110010|FG000|Overall Study|Protocol Violation|3|||
145891665|NCT01705236|526110010|FG000|Overall Study|Abnormal test procedure result(s)|4|||
145891666|NCT01705236|526110010|FG000|Overall Study|Abnormal laboratory value(s)|4|||
145891667|NCT01705236|526110010|FG000|Overall Study|Withdrawal by Subject|5|||
145891668|NCT01705236|526110010|FG000|Overall Study|Adverse Event|5|||
145891669|NCT04572243|526110011|FG000|Core Study: 14 Weeks|Adverse Event|1|||
145891670|NCT04572243|526110012|FG001|Core Study: 14 Weeks|Adverse Event|2|||
145891671|NCT04572243|526110013|FG002|Core Study: 14 Weeks|Adverse Event|0|||
145891672|NCT04572243|526110014|FG003|Core Study: 14 Weeks|Adverse Event|0|||
145891673|NCT04572243|526110011|FG000|Core Study: 14 Weeks|Subject choice|0|||
145891674|NCT04572243|526110012|FG001|Core Study: 14 Weeks|Subject choice|2|||
145891675|NCT04572243|526110013|FG002|Core Study: 14 Weeks|Subject choice|0|||
145891676|NCT04572243|526110014|FG003|Core Study: 14 Weeks|Subject choice|0|||
145891677|NCT04572243|526110011|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
145891678|NCT04572243|526110012|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
145891679|NCT04572243|526110013|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
145891680|NCT04572243|526110014|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
145891681|NCT04572243|526110011|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
145891682|NCT04572243|526110012|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
145891683|NCT04572243|526110013|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
145891684|NCT04572243|526110014|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
145891685|NCT01231373|526110015|FG000|Overall Study|Withdrew consent prior to randomization|2|||
145891686|NCT01231373|526110016|FG001|Overall Study|Withdrew consent prior to randomization|1|||
145891687|NCT01231373|526110017|FG002|Overall Study|Withdrew consent prior to randomization|0|||
145891688|NCT01231373|526110018|FG003|Overall Study|Withdrew consent prior to randomization|0|||
145891689|NCT01231373|526110015|FG000|Overall Study|Lost to Follow-up|0|||
145891690|NCT01231373|526110016|FG001|Overall Study|Lost to Follow-up|0|||
145891691|NCT01231373|526110017|FG002|Overall Study|Lost to Follow-up|0|||
145891692|NCT01231373|526110018|FG003|Overall Study|Lost to Follow-up|1|||
145891693|NCT01231373|526110015|FG000|Overall Study|Withdrew Consent|1|||
145891694|NCT01231373|526110016|FG001|Overall Study|Withdrew Consent|0|||
145891695|NCT01231373|526110017|FG002|Overall Study|Withdrew Consent|0|||
145891696|NCT01231373|526110018|FG003|Overall Study|Withdrew Consent|0|||
145891697|NCT00775606|526110023|FG000|Overall Study|Study sponsor terminated funding|3|||
145891698|NCT00775606|526110024|FG001|Overall Study|Study sponsor terminated funding|0|||
145891699|NCT00767520|526110025|FG000|Overall Study|Participants still on treatment|11|||
145891700|NCT00767520|526110026|FG001|Overall Study|Participants still on treatment|15|||
145891701|NCT00767520|526110025|FG000|Overall Study|Randomized in error and Never treated|0|||
145971027|NCT02814526|526407324|FG001|Overall Study|Other|4|||
145971028|NCT01416571|526407325|FG000|Overall Study|Lost to Follow-up|2|||
145971029|NCT03454555|526408734|FG000|Overall Study|Death|6|||
145971030|NCT03454555|526408735|FG001|Overall Study|Death|6|||
145971031|NCT03454555|526408734|FG000|Overall Study|Lost to Follow-up|31|||
145971032|NCT03454555|526408735|FG001|Overall Study|Lost to Follow-up|12|||
145971033|NCT03454555|526408734|FG000|Overall Study|Physician Decision|2|||
146295509|NCT04082429|527597599|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145891702|NCT00767520|526110026|FG001|Overall Study|Randomized in error and Never treated|2|||
145891703|NCT01338987|526110027|FG000|Overall Study|enrolled on new protocol|0|||
145891704|NCT01338987|526110028|FG001|Overall Study|enrolled on new protocol|0|||
145891705|NCT01338987|526110029|FG002|Overall Study|enrolled on new protocol|1|||
145891706|NCT01338987|526110030|FG003|Overall Study|enrolled on new protocol|0|||
145891707|NCT01338987|526110031|FG004|Overall Study|enrolled on new protocol|0|||
145971034|NCT03454555|526408735|FG001|Overall Study|Physician Decision|6|||
145971035|NCT03454555|526408734|FG000|Overall Study|Withdrawal by Subject|34|||
146235811|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235812|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235813|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
146235814|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235815|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235816|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235817|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235818|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235819|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235820|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235821|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
146235822|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235823|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235824|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235825|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
146235826|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
146235827|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235828|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235829|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
146235830|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
146235831|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235832|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235833|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235834|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235835|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
146235836|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235837|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235838|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235839|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235840|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235841|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235842|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235843|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
146235844|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
146235845|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235846|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235847|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235848|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235849|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
146235850|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235851|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235852|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235853|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235854|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235855|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235856|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235857|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235858|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
146235859|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235860|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235861|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235862|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235863|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
146235864|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235865|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235866|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235867|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
146235868|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235869|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235870|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235871|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235872|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235873|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235874|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235875|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145971036|NCT03454555|526408735|FG001|Overall Study|Withdrawal by Subject|5|||
145971037|NCT03454555|526408734|FG000|Overall Study|Ineligible|1|||
145971038|NCT03454555|526408735|FG001|Overall Study|Ineligible|5|||
145971039|NCT01288430|526408739|FG000|Part 1|Progressive disease|2|||
145971040|NCT01288430|526408740|FG001|Part 1|Progressive disease|1|||
145971041|NCT01288430|526408741|FG002|Part 1|Progressive disease|1|||
145971042|NCT01288430|526408742|FG003|Part 1|Progressive disease|6|||
145971043|NCT01288430|526408743|FG004|Part 1|Progressive disease|2|||
145971044|NCT01288430|526408744|FG005|Part 1|Progressive disease|4|||
145971045|NCT01288430|526408745|FG006|Part 1|Progressive disease|2|||
145971046|NCT01288430|526408746|FG007|Part 1|Progressive disease|0|||
145971047|NCT01288430|526408747|FG008|Part 1|Progressive disease|0|||
145971048|NCT01288430|526408748|FG009|Part 1|Progressive disease|0|||
145971049|NCT01288430|526408739|FG000|Part 1|Clinical disease progression|0|||
145971050|NCT01288430|526408740|FG001|Part 1|Clinical disease progression|0|||
145971051|NCT01288430|526408741|FG002|Part 1|Clinical disease progression|1|||
145971052|NCT01288430|526408742|FG003|Part 1|Clinical disease progression|0|||
145971053|NCT01288430|526408743|FG004|Part 1|Clinical disease progression|0|||
145971054|NCT01288430|526408744|FG005|Part 1|Clinical disease progression|2|||
145971055|NCT01288430|526408745|FG006|Part 1|Clinical disease progression|2|||
145971056|NCT01288430|526408746|FG007|Part 1|Clinical disease progression|0|||
145971057|NCT01288430|526408747|FG008|Part 1|Clinical disease progression|0|||
145971058|NCT01288430|526408748|FG009|Part 1|Clinical disease progression|0|||
145971059|NCT01288430|526408739|FG000|Part 1|Death due to disease progression|0|||
145971060|NCT01288430|526408740|FG001|Part 1|Death due to disease progression|0|||
145971061|NCT01288430|526408741|FG002|Part 1|Death due to disease progression|0|||
145971062|NCT01288430|526408742|FG003|Part 1|Death due to disease progression|0|||
145971063|NCT01288430|526408743|FG004|Part 1|Death due to disease progression|1|||
145971064|NCT01288430|526408744|FG005|Part 1|Death due to disease progression|0|||
145971065|NCT01288430|526408745|FG006|Part 1|Death due to disease progression|0|||
146088099|NCT01986933|526841963|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
146235876|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235877|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
146235878|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235879|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235880|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235881|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235882|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235883|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235884|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235885|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
146235886|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
146235887|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235888|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235889|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235890|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235891|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
146235892|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235893|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235894|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235895|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235896|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235897|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235898|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235899|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
146235900|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235901|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235902|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235903|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145891708|NCT01338987|526110027|FG000|Overall Study|Disease progression on study|2|||
145891709|NCT01338987|526110028|FG001|Overall Study|Disease progression on study|1|||
145891710|NCT01338987|526110029|FG002|Overall Study|Disease progression on study|1|||
145891711|NCT01338987|526110030|FG003|Overall Study|Disease progression on study|0|||
146235904|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145891712|NCT01338987|526110031|FG004|Overall Study|Disease progression on study|0|||
145891713|NCT00958126|526110033|FG000|Overall Study|Serious Adverse Event|0|||
146235905|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
146235906|NCT04033445|527379934|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235907|NCT04033445|527379935|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235908|NCT04033445|527379936|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235909|NCT04033445|527379937|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235910|NCT04033445|527379938|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235911|NCT04033445|527379939|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235912|NCT04033445|527379940|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235913|NCT04033445|527379941|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
146235914|NCT04033445|527379942|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235915|NCT04033445|527379943|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235916|NCT04033445|527379944|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235917|NCT04033445|527379945|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235918|NCT04033445|527379946|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235919|NCT04033445|527379947|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
146235920|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235921|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235922|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235923|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145891714|NCT00958126|526110034|FG001|Overall Study|Serious Adverse Event|2|||
145891715|NCT00958126|526110035|FG002|Overall Study|Serious Adverse Event|0|||
145891716|NCT00958126|526110036|FG003|Overall Study|Serious Adverse Event|0|||
145891717|NCT00958126|526110037|FG004|Overall Study|Serious Adverse Event|0|||
145891718|NCT00958126|526110038|FG005|Overall Study|Serious Adverse Event|0|||
145891719|NCT00958126|526110039|FG006|Overall Study|Serious Adverse Event|1|||
145891720|NCT00958126|526110040|FG007|Overall Study|Serious Adverse Event|0|||
145891721|NCT00958126|526110033|FG000|Overall Study|Withdrawal by Subject|0|||
145891722|NCT00958126|526110034|FG001|Overall Study|Withdrawal by Subject|2|||
145891723|NCT00958126|526110035|FG002|Overall Study|Withdrawal by Subject|0|||
145891724|NCT00958126|526110036|FG003|Overall Study|Withdrawal by Subject|0|||
145971066|NCT01288430|526408746|FG007|Part 1|Death due to disease progression|0|||
145971067|NCT01288430|526408747|FG008|Part 1|Death due to disease progression|0|||
145971068|NCT01288430|526408748|FG009|Part 1|Death due to disease progression|0|||
145971069|NCT01288430|526408739|FG000|Part 1|Adverse Event|0|||
145971070|NCT01288430|526408740|FG001|Part 1|Adverse Event|0|||
145971071|NCT01288430|526408741|FG002|Part 1|Adverse Event|3|||
145971072|NCT01288430|526408742|FG003|Part 1|Adverse Event|1|||
145971073|NCT01288430|526408743|FG004|Part 1|Adverse Event|0|||
145971074|NCT01288430|526408744|FG005|Part 1|Adverse Event|0|||
145971075|NCT01288430|526408745|FG006|Part 1|Adverse Event|2|||
145971076|NCT01288430|526408746|FG007|Part 1|Adverse Event|0|||
145971077|NCT01288430|526408747|FG008|Part 1|Adverse Event|0|||
145971078|NCT01288430|526408748|FG009|Part 1|Adverse Event|0|||
146088100|NCT01986933|526841959|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
146088101|NCT01986933|526841960|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
146088102|NCT01986933|526841961|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
146088103|NCT01986933|526841962|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
146088104|NCT01986933|526841963|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
146088105|NCT01986933|526841959|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146088106|NCT01986933|526841960|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
146088107|NCT01986933|526841961|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146088108|NCT01986933|526841962|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
146088109|NCT01986933|526841963|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
146088110|NCT01986933|526841959|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146088111|NCT01986933|526841960|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146088112|NCT01986933|526841961|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146088113|NCT01986933|526841962|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
146088114|NCT01986933|526841963|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
146088115|NCT01986933|526841959|FG000|Active-to-active (Part B)|Adverse Event|0|||
146088116|NCT01986933|526841960|FG001|Active-to-active (Part B)|Adverse Event|2|||
146088117|NCT01986933|526841961|FG002|Active-to-active (Part B)|Adverse Event|0|||
146088118|NCT01986933|526841962|FG003|Active-to-active (Part B)|Adverse Event|1|||
146088119|NCT01986933|526841963|FG004|Active-to-active (Part B)|Adverse Event|3|||
146088120|NCT01986933|526841959|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
146088121|NCT01986933|526841960|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
146088122|NCT01986933|526841961|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
146088123|NCT01986933|526841962|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
146088124|NCT01986933|526841963|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
146088125|NCT01986933|526841959|FG000|Active-to-active (Part B)|Pregnancy|0|||
146088126|NCT01986933|526841960|FG001|Active-to-active (Part B)|Pregnancy|0|||
146088127|NCT01986933|526841961|FG002|Active-to-active (Part B)|Pregnancy|0|||
146088128|NCT01986933|526841962|FG003|Active-to-active (Part B)|Pregnancy|0|||
146088129|NCT01986933|526841963|FG004|Active-to-active (Part B)|Pregnancy|1|||
146088130|NCT01986933|526841959|FG000|Active-to-active (Part B)|Physician Decision|0|||
146088131|NCT01986933|526841960|FG001|Active-to-active (Part B)|Physician Decision|0|||
146088132|NCT01986933|526841961|FG002|Active-to-active (Part B)|Physician Decision|1|||
146088133|NCT01986933|526841962|FG003|Active-to-active (Part B)|Physician Decision|1|||
145971079|NCT01288430|526408739|FG000|Part 1|Other|0|||
145971080|NCT01288430|526408740|FG001|Part 1|Other|2|||
145971081|NCT01288430|526408741|FG002|Part 1|Other|0|||
145971082|NCT01288430|526408742|FG003|Part 1|Other|0|||
145891725|NCT00958126|526110037|FG004|Overall Study|Withdrawal by Subject|0|||
145891726|NCT00958126|526110038|FG005|Overall Study|Withdrawal by Subject|0|||
145891727|NCT00958126|526110039|FG006|Overall Study|Withdrawal by Subject|0|||
146235924|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235925|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235926|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235927|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235928|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
146235929|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
146235930|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
146235931|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
146235932|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
146235933|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
146235934|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235935|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235936|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235937|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235938|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235939|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235940|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235941|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235942|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
146235943|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
146235944|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
146235945|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
146235946|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
146235947|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
146235948|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235949|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235950|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235951|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235952|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235953|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235954|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235955|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235956|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235957|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235958|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
146235959|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
145891728|NCT00958126|526110040|FG007|Overall Study|Withdrawal by Subject|0|||
145891729|NCT00958126|526110033|FG000|Overall Study|Moved away from study area|0|||
145891730|NCT00958126|526110034|FG001|Overall Study|Moved away from study area|0|||
145891731|NCT00958126|526110035|FG002|Overall Study|Moved away from study area|1|||
145891732|NCT00958126|526110036|FG003|Overall Study|Moved away from study area|1|||
145891733|NCT00958126|526110037|FG004|Overall Study|Moved away from study area|0|||
145891734|NCT00958126|526110038|FG005|Overall Study|Moved away from study area|0|||
145891735|NCT00958126|526110039|FG006|Overall Study|Moved away from study area|0|||
145891736|NCT00958126|526110040|FG007|Overall Study|Moved away from study area|0|||
145891737|NCT00958126|526110033|FG000|Overall Study|Lost to Follow-up|1|||
145891738|NCT00958126|526110034|FG001|Overall Study|Lost to Follow-up|5|||
145891739|NCT00958126|526110035|FG002|Overall Study|Lost to Follow-up|9|||
145891740|NCT00958126|526110036|FG003|Overall Study|Lost to Follow-up|8|||
145891741|NCT00958126|526110037|FG004|Overall Study|Lost to Follow-up|0|||
145891742|NCT00958126|526110038|FG005|Overall Study|Lost to Follow-up|0|||
145891743|NCT00958126|526110039|FG006|Overall Study|Lost to Follow-up|0|||
145891744|NCT00958126|526110040|FG007|Overall Study|Lost to Follow-up|0|||
145891745|NCT00958126|526110033|FG000|Overall Study|Sponsor/Investigator decision|0|||
145891746|NCT00958126|526110034|FG001|Overall Study|Sponsor/Investigator decision|0|||
145891747|NCT00958126|526110035|FG002|Overall Study|Sponsor/Investigator decision|0|||
145891748|NCT00958126|526110036|FG003|Overall Study|Sponsor/Investigator decision|1|||
145891749|NCT00958126|526110037|FG004|Overall Study|Sponsor/Investigator decision|0|||
145891750|NCT00958126|526110038|FG005|Overall Study|Sponsor/Investigator decision|0|||
145891751|NCT00958126|526110039|FG006|Overall Study|Sponsor/Investigator decision|0|||
145971083|NCT01288430|526408743|FG004|Part 1|Other|0|||
145971084|NCT01288430|526408744|FG005|Part 1|Other|0|||
145891752|NCT00958126|526110040|FG007|Overall Study|Sponsor/Investigator decision|0|||
145891753|NCT00958126|526110033|FG000|Overall Study|Other Reason|0|||
145891754|NCT00958126|526110034|FG001|Overall Study|Other Reason|0|||
145891755|NCT00958126|526110035|FG002|Overall Study|Other Reason|0|||
145891756|NCT00958126|526110036|FG003|Overall Study|Other Reason|1|||
146235960|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
146235961|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
146235962|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235963|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235964|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235965|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235966|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235967|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235968|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235969|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235970|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235971|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
146235972|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
146235973|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
146235974|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
146235975|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
146235976|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235977|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235978|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235979|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235980|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235981|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235982|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235983|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235984|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
146235985|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
146235986|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
146235987|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
146235988|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
146235989|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
146235990|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235991|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235992|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235993|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235994|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235995|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235996|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146295510|NCT04082429|527597600|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146235997|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235998|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146235999|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146236000|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146236001|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146236002|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
146236003|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
146236004|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236005|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236006|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236007|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236008|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236009|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236010|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236011|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236012|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
146236013|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
146236014|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
146236015|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
146236016|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
146236017|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
146236018|NCT04033445|527379934|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236019|NCT04033445|527379935|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236020|NCT04033445|527379936|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236021|NCT04033445|527379937|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236022|NCT04033445|527379938|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236023|NCT04033445|527379939|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236024|NCT04033445|527379940|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236025|NCT04033445|527379941|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236026|NCT04033445|527379942|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236027|NCT04033445|527379943|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146236028|NCT04033445|527379944|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236029|NCT04033445|527379945|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146236030|NCT04033445|527379946|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
146236031|NCT04033445|527379947|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
146236032|NCT04353492|527379950|FG000|Overall Study|Subject decision|24|||
146236033|NCT04353492|527379950|FG000|Overall Study|Physician Decision|5|||
146236034|NCT04353492|527379950|FG000|Overall Study|Adverse Event|3|||
146236035|NCT04353492|527379950|FG000|Overall Study|Pregnancy|3|||
146236036|NCT04353492|527379950|FG000|Overall Study|Lost to Follow-up|2|||
146236037|NCT04353492|527379950|FG000|Overall Study|Protocol deviation|1|||
146236038|NCT04353492|527379950|FG000|Overall Study|Technical problems|1|||
146236039|NCT00776009|527379951|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
145891757|NCT00958126|526110037|FG004|Overall Study|Other Reason|0|||
145891758|NCT00958126|526110038|FG005|Overall Study|Other Reason|1|||
145891759|NCT00958126|526110039|FG006|Overall Study|Other Reason|0|||
145891760|NCT00958126|526110040|FG007|Overall Study|Other Reason|0|||
145891761|NCT00720226|526110041|FG000|Overall Study|Withdrawal by Subject|7|||
145891762|NCT00720226|526110042|FG001|Overall Study|Withdrawal by Subject|4|||
145891763|NCT00733369|526110043|FG000|Overall Study|Lost to Follow-up|2|||
145891764|NCT00733369|526110044|FG001|Overall Study|Lost to Follow-up|1|||
145891765|NCT00733369|526110043|FG000|Overall Study|Adverse Event|4|||
145891766|NCT00733369|526110044|FG001|Overall Study|Adverse Event|4|||
145891767|NCT00733369|526110043|FG000|Overall Study|Protocol Violation|4|||
145891768|NCT00733369|526110044|FG001|Overall Study|Protocol Violation|4|||
145891769|NCT03401073|526110045|FG000|Overall Study|Lost to Follow-up|1|||
145891770|NCT03401073|526110046|FG001|Overall Study|Lost to Follow-up|2|||
145891771|NCT01470612|526110050|FG000|Overall Study|Adverse Event|20|||
145891772|NCT01470612|526110051|FG001|Overall Study|Adverse Event|80|||
145891773|NCT01470612|526110050|FG000|Overall Study|Death|0|||
146236040|NCT00776009|527379952|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
146236041|NCT00776009|527379953|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
146236042|NCT00776009|527379954|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
146236043|NCT00776009|527379955|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
146295511|NCT04082429|527597601|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145891774|NCT01470612|526110051|FG001|Overall Study|Death|1|||
145891775|NCT01470612|526110050|FG000|Overall Study|Lack of Efficacy|20|||
145891776|NCT01470612|526110051|FG001|Overall Study|Lack of Efficacy|326|||
145891777|NCT01470612|526110050|FG000|Overall Study|Lost to Follow-up|2|||
145891778|NCT01470612|526110051|FG001|Overall Study|Lost to Follow-up|5|||
146236044|NCT00776009|527379956|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
146236045|NCT00776009|527379951|FG000|Period 1: First Intervention|Protocol Violation|0|||
146236046|NCT00776009|527379952|FG001|Period 1: First Intervention|Protocol Violation|1|||
146236047|NCT00776009|527379953|FG002|Period 1: First Intervention|Protocol Violation|0|||
146236048|NCT00776009|527379954|FG003|Period 1: First Intervention|Protocol Violation|0|||
146236049|NCT00776009|527379955|FG004|Period 1: First Intervention|Protocol Violation|1|||
146236050|NCT00776009|527379956|FG005|Period 1: First Intervention|Protocol Violation|0|||
146236051|NCT00776009|527379951|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
146236052|NCT00776009|527379952|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
146236053|NCT00776009|527379953|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
146236054|NCT00776009|527379954|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
146236055|NCT00776009|527379955|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
146236056|NCT00776009|527379956|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
146236057|NCT00776009|527379951|FG000|Period 2: Second Intervention|Protocol Violation|1|||
146236058|NCT00776009|527379952|FG001|Period 2: Second Intervention|Protocol Violation|0|||
146236059|NCT00776009|527379953|FG002|Period 2: Second Intervention|Protocol Violation|1|||
146236060|NCT00776009|527379954|FG003|Period 2: Second Intervention|Protocol Violation|0|||
146236061|NCT00776009|527379955|FG004|Period 2: Second Intervention|Protocol Violation|0|||
146236062|NCT00776009|527379956|FG005|Period 2: Second Intervention|Protocol Violation|0|||
146236063|NCT00776009|527379951|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
146236064|NCT00776009|527379952|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
146236065|NCT00776009|527379953|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
146236066|NCT00776009|527379954|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
146236067|NCT00776009|527379955|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
146236068|NCT00776009|527379956|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
146236069|NCT00582972|527379957|FG000|Overall Study|Protocol Violation|2|||
146236070|NCT02101775|527379963|FG000|Overall Study|Adverse Event|4|||
146236071|NCT02101775|527379964|FG001|Overall Study|Adverse Event|0|||
146236072|NCT02101775|527379965|FG002|Overall Study|Adverse Event|0|||
146236073|NCT02101775|527379963|FG000|Overall Study|Admission to Hospital|0|||
146236074|NCT02101775|527379964|FG001|Overall Study|Admission to Hospital|1|||
146236075|NCT02101775|527379965|FG002|Overall Study|Admission to Hospital|0|||
146236076|NCT00293397|527379966|FG000|Overall Study|Death|2|||
146236077|NCT00503906|527379969|FG000|Overall Study|Withdrawal by Subject|1|||
146236078|NCT04035447|527379970|FG000|Treatment Period|Lost to Follow-up|6|||
146236079|NCT04035447|527379971|FG001|Treatment Period|Lost to Follow-up|5|||
146236080|NCT04035447|527379970|FG000|Treatment Period|Physician Decision|0|||
146236081|NCT04035447|527379971|FG001|Treatment Period|Physician Decision|2|||
146236082|NCT03304587|527379972|FG000|Overall Study|Headache after intervention|0|||
146236083|NCT03304587|527379973|FG001|Overall Study|Headache after intervention|1|||
146236084|NCT03304587|527379972|FG000|Overall Study|Withdrawal by Subject|1|||
146236085|NCT03304587|527379973|FG001|Overall Study|Withdrawal by Subject|0|||
146236086|NCT01753999|527379974|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
146236087|NCT01753999|527379975|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
146236088|NCT01753999|527379974|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
146236089|NCT01753999|527379975|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
146236090|NCT01753999|527379974|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
146236091|NCT01753999|527379975|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
146236092|NCT01753999|527379974|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
146236093|NCT01753999|527379975|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
146295512|NCT04082429|527597602|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
145891779|NCT01470612|526110050|FG000|Overall Study|Did not meet entrance criteria|0|||
145891780|NCT01470612|526110051|FG001|Overall Study|Did not meet entrance criteria|1|||
145891781|NCT01470612|526110050|FG000|Overall Study|Pregnancy|2|||
145891782|NCT01470612|526110051|FG001|Overall Study|Pregnancy|10|||
145891783|NCT01470612|526110050|FG000|Overall Study|Protocol Violation|2|||
145891784|NCT01470612|526110051|FG001|Overall Study|Protocol Violation|7|||
145891785|NCT01470612|526110050|FG000|Overall Study|Withdrawal by Subject|24|||
145891786|NCT01470612|526110051|FG001|Overall Study|Withdrawal by Subject|79|||
145891787|NCT01470612|526110050|FG000|Overall Study|Other|14|||
145891788|NCT01470612|526110051|FG001|Overall Study|Other|156|||
145891789|NCT03078582|526110062|FG000|Overall Study|Adverse Event|0|||
146236094|NCT01753999|527379974|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
146236095|NCT01753999|527379975|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
146236096|NCT01753999|527379974|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
146295513|NCT04082429|527597603|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146236097|NCT01753999|527379975|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
146236098|NCT02029235|527379976|FG000|Overall Study|Non-compliance with study meds or diary|4|||
146236099|NCT02029235|527379977|FG001|Overall Study|Non-compliance with study meds or diary|1|||
145891790|NCT03078582|526110063|FG001|Overall Study|Adverse Event|8|||
145891791|NCT02972502|526110066|FG000|Overall Study|Lost to Follow-up|3|||
145891792|NCT02972502|526110067|FG001|Overall Study|Lost to Follow-up|1|||
145891793|NCT02972502|526110066|FG000|Overall Study|Withdrawal by Subject|1|||
145891794|NCT02972502|526110067|FG001|Overall Study|Withdrawal by Subject|1|||
145891795|NCT00430950|526110068|FG000|Overall Study|Adverse Event|7|||
145891796|NCT00430950|526110069|FG001|Overall Study|Adverse Event|6|||
145891797|NCT00430950|526110068|FG000|Overall Study|Withdrawal by Subject|1|||
145891798|NCT00430950|526110069|FG001|Overall Study|Withdrawal by Subject|0|||
145891799|NCT00430950|526110068|FG000|Overall Study|concomitant medication,etc.|5|||
145891800|NCT00430950|526110069|FG001|Overall Study|concomitant medication,etc.|7|||
145891801|NCT02442271|526110070|FG000|Overall Study|Adverse Event|1|||
145891802|NCT02442271|526110070|FG000|Overall Study|Withdrew Consent|1|||
145891803|NCT02442271|526110070|FG000|Overall Study|Lost to Follow-up|1|||
145891804|NCT02442271|526110070|FG000|Overall Study|Other|1|||
145891805|NCT00831623|526110077|FG000|Overall Study|Withdrawal by Subject|9|||
145891806|NCT00831623|526110077|FG000|Overall Study|Lost to Follow-up|1|||
145891807|NCT00831623|526110077|FG000|Overall Study|Not 2 years post-treatment|12|||
145891808|NCT01564459|526110079|FG000|Run-In|Adverse Event|7|||
145891809|NCT01564459|526110080|FG001|Run-In|Adverse Event|0|||
145891810|NCT01564459|526110081|FG002|Run-In|Adverse Event|0|||
145891811|NCT01564459|526110079|FG000|Run-In|Lost to Follow-up|1|||
145971085|NCT01288430|526408745|FG006|Part 1|Other|1|||
145971086|NCT01288430|526408746|FG007|Part 1|Other|0|||
145971087|NCT01288430|526408747|FG008|Part 1|Other|0|||
145971088|NCT01288430|526408748|FG009|Part 1|Other|0|||
145971089|NCT01288430|526408739|FG000|Part 2|Progressive disease|0|||
145971090|NCT01288430|526408740|FG001|Part 2|Progressive disease|0|||
145971091|NCT01288430|526408741|FG002|Part 2|Progressive disease|0|||
145971092|NCT01288430|526408742|FG003|Part 2|Progressive disease|0|||
145971093|NCT01288430|526408743|FG004|Part 2|Progressive disease|0|||
145971094|NCT01288430|526408744|FG005|Part 2|Progressive disease|0|||
145971095|NCT01288430|526408745|FG006|Part 2|Progressive disease|0|||
145971096|NCT01288430|526408746|FG007|Part 2|Progressive disease|8|||
145971097|NCT01288430|526408747|FG008|Part 2|Progressive disease|7|||
145971098|NCT01288430|526408748|FG009|Part 2|Progressive disease|2|||
145971099|NCT01288430|526408739|FG000|Part 2|Clinical disease progression|0|||
145971100|NCT01288430|526408740|FG001|Part 2|Clinical disease progression|0|||
145971101|NCT01288430|526408741|FG002|Part 2|Clinical disease progression|0|||
145971102|NCT01288430|526408742|FG003|Part 2|Clinical disease progression|0|||
145971103|NCT01288430|526408743|FG004|Part 2|Clinical disease progression|0|||
145971104|NCT01288430|526408744|FG005|Part 2|Clinical disease progression|0|||
145971105|NCT01288430|526408745|FG006|Part 2|Clinical disease progression|0|||
145971106|NCT01288430|526408746|FG007|Part 2|Clinical disease progression|2|||
145971107|NCT01288430|526408747|FG008|Part 2|Clinical disease progression|0|||
145971108|NCT01288430|526408748|FG009|Part 2|Clinical disease progression|0|||
145971109|NCT01288430|526408739|FG000|Part 2|Withdrawal by Subject|0|||
145971110|NCT01288430|526408740|FG001|Part 2|Withdrawal by Subject|0|||
145971111|NCT01288430|526408741|FG002|Part 2|Withdrawal by Subject|0|||
145971112|NCT01288430|526408742|FG003|Part 2|Withdrawal by Subject|0|||
145971113|NCT01288430|526408743|FG004|Part 2|Withdrawal by Subject|0|||
145971114|NCT01288430|526408744|FG005|Part 2|Withdrawal by Subject|0|||
145971115|NCT01288430|526408745|FG006|Part 2|Withdrawal by Subject|0|||
145971116|NCT01288430|526408746|FG007|Part 2|Withdrawal by Subject|1|||
145971117|NCT01288430|526408747|FG008|Part 2|Withdrawal by Subject|4|||
145971118|NCT01288430|526408748|FG009|Part 2|Withdrawal by Subject|0|||
145971119|NCT01288430|526408739|FG000|Part 2|Adverse Event|0|||
145971120|NCT01288430|526408740|FG001|Part 2|Adverse Event|0|||
145971121|NCT01288430|526408741|FG002|Part 2|Adverse Event|0|||
145971122|NCT01288430|526408742|FG003|Part 2|Adverse Event|0|||
145971123|NCT01288430|526408743|FG004|Part 2|Adverse Event|0|||
145971124|NCT01288430|526408744|FG005|Part 2|Adverse Event|0|||
145971125|NCT01288430|526408745|FG006|Part 2|Adverse Event|0|||
145971126|NCT01288430|526408746|FG007|Part 2|Adverse Event|1|||
145971127|NCT01288430|526408747|FG008|Part 2|Adverse Event|1|||
145971128|NCT01288430|526408748|FG009|Part 2|Adverse Event|0|||
145971129|NCT01288430|526408739|FG000|Part 2|Other|0|||
145971130|NCT01288430|526408740|FG001|Part 2|Other|0|||
145971131|NCT01288430|526408741|FG002|Part 2|Other|0|||
145971132|NCT01288430|526408742|FG003|Part 2|Other|0|||
145971133|NCT01288430|526408743|FG004|Part 2|Other|0|||
145971134|NCT01288430|526408744|FG005|Part 2|Other|0|||
145971135|NCT01288430|526408745|FG006|Part 2|Other|0|||
145971136|NCT01288430|526408746|FG007|Part 2|Other|0|||
145971137|NCT01288430|526408747|FG008|Part 2|Other|0|||
145971138|NCT01288430|526408748|FG009|Part 2|Other|1|||
145971139|NCT05172609|526408749|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
145971140|NCT05172609|526408750|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
145971141|NCT05172609|526408749|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
145891812|NCT01564459|526110080|FG001|Run-In|Lost to Follow-up|0|||
145891813|NCT01564459|526110081|FG002|Run-In|Lost to Follow-up|0|||
145891814|NCT01564459|526110079|FG000|Run-In|Non-compliance with study drug|2|||
145891815|NCT01564459|526110080|FG001|Run-In|Non-compliance with study drug|0|||
145971142|NCT05172609|526408750|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
145891816|NCT01564459|526110081|FG002|Run-In|Non-compliance with study drug|0|||
145891817|NCT01564459|526110079|FG000|Run-In|Protocol Violation|1|||
145891818|NCT01564459|526110080|FG001|Run-In|Protocol Violation|0|||
145891819|NCT01564459|526110081|FG002|Run-In|Protocol Violation|0|||
145891820|NCT01564459|526110079|FG000|Run-In|Withdrawal by Subject|1|||
145891821|NCT01564459|526110080|FG001|Run-In|Withdrawal by Subject|0|||
145891822|NCT01564459|526110081|FG002|Run-In|Withdrawal by Subject|0|||
145891823|NCT01564459|526110079|FG000|Double-blind Treatment|Adverse Event|0|||
145891824|NCT01564459|526110080|FG001|Double-blind Treatment|Adverse Event|0|||
145891825|NCT01564459|526110081|FG002|Double-blind Treatment|Adverse Event|1|||
145891826|NCT02080832|526110089|FG000|Overall Study|Excluded from analysis by MRI|9|||
145891827|NCT02080832|526110090|FG001|Overall Study|Excluded from analysis by MRI|10|||
145891828|NCT02080832|526110091|FG002|Overall Study|Excluded from analysis by MRI|14|||
145891829|NCT02080832|526110089|FG000|Overall Study|Lost to Follow-up|0|||
145891830|NCT02080832|526110090|FG001|Overall Study|Lost to Follow-up|2|||
145891831|NCT02080832|526110091|FG002|Overall Study|Lost to Follow-up|2|||
145891832|NCT01660022|526110092|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
145891833|NCT01660022|526110093|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
145891834|NCT01660022|526110094|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
145891835|NCT01660022|526110095|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
145891836|NCT01660022|526110096|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
145891837|NCT01660022|526110097|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
145891838|NCT01660022|526110092|FG000|First Sequence (7 Days)|Adverse Event|0|||
145891839|NCT01660022|526110093|FG001|First Sequence (7 Days)|Adverse Event|0|||
145891840|NCT01660022|526110094|FG002|First Sequence (7 Days)|Adverse Event|0|||
145891841|NCT01660022|526110095|FG003|First Sequence (7 Days)|Adverse Event|0|||
145891842|NCT01660022|526110096|FG004|First Sequence (7 Days)|Adverse Event|1|||
145891843|NCT01660022|526110097|FG005|First Sequence (7 Days)|Adverse Event|3|||
145891844|NCT01660022|526110092|FG000|First Sequence (7 Days)|Protocol Violation|0|||
145891845|NCT01660022|526110093|FG001|First Sequence (7 Days)|Protocol Violation|0|||
146236100|NCT02107261|527379978|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
146236101|NCT02107261|527379979|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
145891846|NCT01660022|526110094|FG002|First Sequence (7 Days)|Protocol Violation|0|||
145891847|NCT01660022|526110095|FG003|First Sequence (7 Days)|Protocol Violation|0|||
146236102|NCT02107261|527379978|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
146236103|NCT02107261|527379979|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
146236104|NCT02408887|527379982|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
146236105|NCT02408887|527379983|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
146236106|NCT02408887|527379982|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
146236107|NCT02408887|527379983|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
146236108|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146236109|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
146236110|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
146236111|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146236112|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
146236113|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
146236114|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
146236115|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
146236116|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
146236117|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
146236118|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
146236119|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
146236120|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
146236121|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
146236122|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
145891848|NCT01660022|526110096|FG004|First Sequence (7 Days)|Protocol Violation|0|||
145891849|NCT01660022|526110097|FG005|First Sequence (7 Days)|Protocol Violation|1|||
145891850|NCT00706992|526110099|FG000|Overall Study|Study termination|5|||
145891851|NCT00706992|526110100|FG001|Overall Study|Study termination|5|||
145891852|NCT00706992|526110101|FG002|Overall Study|Study termination|6|||
145891853|NCT00706992|526110102|FG003|Overall Study|Study termination|2|||
146236123|NCT03333109|527379984|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
146295514|NCT04082429|527597604|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
146295515|NCT04082429|527597605|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145891854|NCT00706992|526110103|FG004|Overall Study|Study termination|3|||
145891855|NCT00706992|526110104|FG005|Overall Study|Study termination|2|||
145891856|NCT00706992|526110105|FG006|Overall Study|Study termination|3|||
145891857|NCT00706992|526110099|FG000|Overall Study|Disease progression before treatment|0|||
145891858|NCT00706992|526110100|FG001|Overall Study|Disease progression before treatment|0|||
145891859|NCT00706992|526110101|FG002|Overall Study|Disease progression before treatment|0|||
145891860|NCT00706992|526110102|FG003|Overall Study|Disease progression before treatment|0|||
145891861|NCT00706992|526110103|FG004|Overall Study|Disease progression before treatment|1|||
145891862|NCT00706992|526110104|FG005|Overall Study|Disease progression before treatment|0|||
145891863|NCT00706992|526110105|FG006|Overall Study|Disease progression before treatment|0|||
145891864|NCT01277718|526110106|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
145891865|NCT01277718|526110107|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
145891866|NCT01277718|526110106|FG000|Period 2 - Second Intervention|Physician Decision|0|||
145891867|NCT01277718|526110107|FG001|Period 2 - Second Intervention|Physician Decision|2|||
145891868|NCT02746627|526110109|FG000|Overall Study|Withdrawal by Subject|1|||
145891869|NCT02746627|526110110|FG001|Overall Study|Withdrawal by Subject|1|||
145891870|NCT02746627|526110111|FG002|Overall Study|Withdrawal by Subject|1|||
145891871|NCT00766831|526110120|FG000|Overall Study|Withdrawal by Subject|4|||
145891872|NCT00766831|526110120|FG000|Overall Study|Lost to Follow-up|3|||
145891873|NCT00766831|526110120|FG000|Overall Study|Adverse Event|20|||
145891874|NCT00766831|526110120|FG000|Overall Study|Protocol Violation|15|||
145891875|NCT00766831|526110120|FG000|Overall Study|Physician Decision|5|||
145891876|NCT00766831|526110120|FG000|Overall Study|Withdrawal of consent|26|||
145891877|NCT00766831|526110120|FG000|Overall Study|Non cooperation by participants|14|||
145891878|NCT00766831|526110120|FG000|Overall Study|Other|28|||
145891879|NCT01392326|526110121|FG000|Overall Study|Death|2|||
145891880|NCT01392326|526110122|FG001|Overall Study|Death|0|||
145891881|NCT01392326|526110123|FG002|Overall Study|Death|0|||
145891882|NCT01392326|526110121|FG000|Overall Study|Withdrawal by Subject|12|||
145891883|NCT01392326|526110122|FG001|Overall Study|Withdrawal by Subject|11|||
145891884|NCT01392326|526110123|FG002|Overall Study|Withdrawal by Subject|15|||
145891885|NCT01392326|526110121|FG000|Overall Study|Protocol Violation|2|||
145891886|NCT01392326|526110122|FG001|Overall Study|Protocol Violation|0|||
145891887|NCT01392326|526110123|FG002|Overall Study|Protocol Violation|0|||
145891888|NCT01392326|526110121|FG000|Overall Study|Pregnancy|0|||
145891889|NCT01392326|526110122|FG001|Overall Study|Pregnancy|0|||
145891890|NCT01392326|526110123|FG002|Overall Study|Pregnancy|1|||
145891891|NCT01392326|526110121|FG000|Overall Study|Physician Decision|7|||
145891892|NCT01392326|526110122|FG001|Overall Study|Physician Decision|5|||
145891893|NCT01392326|526110123|FG002|Overall Study|Physician Decision|2|||
145891894|NCT01392326|526110121|FG000|Overall Study|Lost to Follow-up|1|||
145891895|NCT01392326|526110122|FG001|Overall Study|Lost to Follow-up|3|||
145891896|NCT01392326|526110123|FG002|Overall Study|Lost to Follow-up|4|||
145891897|NCT01392326|526110121|FG000|Overall Study|Lack of Efficacy|14|||
145891898|NCT01392326|526110122|FG001|Overall Study|Lack of Efficacy|10|||
145891899|NCT01392326|526110123|FG002|Overall Study|Lack of Efficacy|15|||
145891900|NCT01392326|526110121|FG000|Overall Study|Adverse Event|9|||
145891901|NCT01392326|526110122|FG001|Overall Study|Adverse Event|6|||
145891902|NCT01392326|526110123|FG002|Overall Study|Adverse Event|11|||
145891903|NCT00094094|526110126|FG000|Overall Study|Death|2|||
145891904|NCT00094094|526110126|FG000|Overall Study|Lack of Efficacy|23|||
145891905|NCT00094094|526110126|FG000|Overall Study|Adverse Event|7|||
145891906|NCT04459715|526110130|FG000|Overall Study|Adverse Event|3|||
145891907|NCT04459715|526110131|FG001|Overall Study|Adverse Event|3|||
145891908|NCT04459715|526110130|FG000|Overall Study|Death|111|||
145891909|NCT04459715|526110131|FG001|Overall Study|Death|93|||
145891910|NCT04459715|526110130|FG000|Overall Study|Lost to Follow-up|10|||
145891911|NCT04459715|526110131|FG001|Overall Study|Lost to Follow-up|9|||
145891912|NCT04459715|526110130|FG000|Overall Study|Other Reasons|4|||
145891913|NCT04459715|526110131|FG001|Overall Study|Other Reasons|5|||
145891914|NCT04459715|526110130|FG000|Overall Study|PROTOCOL DEVIATION|0|||
145891915|NCT04459715|526110131|FG001|Overall Study|PROTOCOL DEVIATION|1|||
145891916|NCT04459715|526110130|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
145891917|NCT04459715|526110131|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
145891918|NCT04459715|526110130|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
145891919|NCT04459715|526110131|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
145891920|NCT04459715|526110130|FG000|Overall Study|Withdrawal by Subject|22|||
145891921|NCT04459715|526110131|FG001|Overall Study|Withdrawal by Subject|22|||
145891922|NCT06029959|526111895|FG000|Overall Study|Physician Decision|6|||
145891923|NCT00003138|526111896|FG000|Step 1|Reasons off treatment not documented|60|||
145891924|NCT00003138|526111897|FG001|Step 1|Reasons off treatment not documented|57|||
146236124|NCT03333109|527379985|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
146236125|NCT03333109|527379986|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
145891925|NCT00003138|526111896|FG000|Step 1|Never started treatment|1|||
145891926|NCT00003138|526111897|FG001|Step 1|Never started treatment|0|||
145891927|NCT00003138|526111896|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
145891928|NCT00003138|526111897|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
145891929|NCT00003138|526111896|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
145891930|NCT00003138|526111897|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
145891931|NCT00003138|526111896|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
145891932|NCT00003138|526111897|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
145891933|NCT00003138|526111896|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
146236126|NCT03333109|527379984|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
145891934|NCT00003138|526111897|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
145891935|NCT04495283|526111898|FG000|Overall Study|Physician Decision|0|||
145891936|NCT04495283|526111899|FG001|Overall Study|Physician Decision|0|||
145891937|NCT04495283|526111900|FG002|Overall Study|Physician Decision|1|||
145891938|NCT04495283|526111898|FG000|Overall Study|Withdrawal by Subject|0|||
145891939|NCT04495283|526111899|FG001|Overall Study|Withdrawal by Subject|1|||
145891940|NCT04495283|526111900|FG002|Overall Study|Withdrawal by Subject|1|||
145891941|NCT04495283|526111898|FG000|Overall Study|Other|1|||
145891942|NCT04495283|526111899|FG001|Overall Study|Other|0|||
145891943|NCT04495283|526111900|FG002|Overall Study|Other|1|||
145891944|NCT02091141|526111901|FG000|Overall Study|Death|280|||
145891945|NCT02091141|526111902|FG001|Overall Study|Death|118|||
145891946|NCT02091141|526111903|FG002|Overall Study|Death|46|||
145891947|NCT02091141|526111904|FG003|Overall Study|Death|13|||
145891948|NCT02091141|526111905|FG004|Overall Study|Death|31|||
145971143|NCT05172609|526408749|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
145971144|NCT05172609|526408750|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
145971145|NCT00300053|526408759|FG000|Overall Study|Patient/Caregiver Preference|2|||
145971146|NCT00300053|526408760|FG001|Overall Study|Patient/Caregiver Preference|2|||
145971147|NCT00300053|526408761|FG002|Overall Study|Patient/Caregiver Preference|3|||
145971148|NCT00300053|526408759|FG000|Overall Study|Death|0|||
145971149|NCT00300053|526408760|FG001|Overall Study|Death|0|||
145971150|NCT00300053|526408761|FG002|Overall Study|Death|3|||
145971151|NCT00300053|526408759|FG000|Overall Study|Lost to Follow-up|0|||
145971152|NCT00300053|526408760|FG001|Overall Study|Lost to Follow-up|1|||
145971153|NCT00300053|526408761|FG002|Overall Study|Lost to Follow-up|0|||
145971154|NCT01963611|526408762|FG000|Overall Study|Adverse Event|1|||
145971155|NCT01963611|526408763|FG001|Overall Study|Adverse Event|1|||
145971156|NCT01963611|526408764|FG002|Overall Study|Adverse Event|3|||
145971157|NCT01963611|526408765|FG003|Overall Study|Adverse Event|4|||
145971158|NCT01963611|526408766|FG004|Overall Study|Adverse Event|3|||
145971159|NCT01963611|526408762|FG000|Overall Study|Protocol Violation|0|||
145971160|NCT01963611|526408763|FG001|Overall Study|Protocol Violation|0|||
146088134|NCT01986933|526841963|FG004|Active-to-active (Part B)|Physician Decision|0|||
146088135|NCT01986933|526841959|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
146088136|NCT01986933|526841960|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
145891949|NCT02091141|526111906|FG005|Overall Study|Death|16|||
145891950|NCT02091141|526111907|FG006|Overall Study|Death|12|||
145891951|NCT02091141|526111901|FG000|Overall Study|Withdrawal by Subject|21|||
145891952|NCT02091141|526111902|FG001|Overall Study|Withdrawal by Subject|13|||
145891953|NCT02091141|526111903|FG002|Overall Study|Withdrawal by Subject|3|||
145891954|NCT02091141|526111904|FG003|Overall Study|Withdrawal by Subject|2|||
145891955|NCT02091141|526111905|FG004|Overall Study|Withdrawal by Subject|2|||
145891956|NCT02091141|526111906|FG005|Overall Study|Withdrawal by Subject|3|||
145891957|NCT02091141|526111907|FG006|Overall Study|Withdrawal by Subject|0|||
145891958|NCT02091141|526111901|FG000|Overall Study|Lost to Follow-up|21|||
145891959|NCT02091141|526111902|FG001|Overall Study|Lost to Follow-up|5|||
145891960|NCT02091141|526111903|FG002|Overall Study|Lost to Follow-up|1|||
145891961|NCT02091141|526111904|FG003|Overall Study|Lost to Follow-up|0|||
145891962|NCT02091141|526111905|FG004|Overall Study|Lost to Follow-up|1|||
145891963|NCT02091141|526111906|FG005|Overall Study|Lost to Follow-up|2|||
145891964|NCT02091141|526111907|FG006|Overall Study|Lost to Follow-up|0|||
145891965|NCT02091141|526111901|FG000|Overall Study|Reason Not Specified|6|||
145891966|NCT02091141|526111902|FG001|Overall Study|Reason Not Specified|5|||
145891967|NCT02091141|526111903|FG002|Overall Study|Reason Not Specified|2|||
145891968|NCT02091141|526111904|FG003|Overall Study|Reason Not Specified|0|||
145891969|NCT02091141|526111905|FG004|Overall Study|Reason Not Specified|0|||
145891970|NCT02091141|526111906|FG005|Overall Study|Reason Not Specified|0|||
145891971|NCT02091141|526111907|FG006|Overall Study|Reason Not Specified|1|||
145891972|NCT02091141|526111901|FG000|Overall Study|Study Ended by Sponsor|1|||
145891973|NCT02091141|526111902|FG001|Overall Study|Study Ended by Sponsor|9|||
145891974|NCT02091141|526111903|FG002|Overall Study|Study Ended by Sponsor|0|||
145891975|NCT02091141|526111904|FG003|Overall Study|Study Ended by Sponsor|0|||
145891976|NCT02091141|526111905|FG004|Overall Study|Study Ended by Sponsor|0|||
145891977|NCT02091141|526111906|FG005|Overall Study|Study Ended by Sponsor|0|||
145891978|NCT02091141|526111907|FG006|Overall Study|Study Ended by Sponsor|0|||
145971161|NCT01963611|526408764|FG002|Overall Study|Protocol Violation|0|||
145971162|NCT01963611|526408765|FG003|Overall Study|Protocol Violation|1|||
145971163|NCT01963611|526408766|FG004|Overall Study|Protocol Violation|0|||
145891979|NCT02091141|526111901|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
145891980|NCT02091141|526111902|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
145891981|NCT02091141|526111903|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
145891982|NCT02091141|526111904|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
145971164|NCT01963611|526408762|FG000|Overall Study|Lack of Efficacy|0|||
145971165|NCT01963611|526408763|FG001|Overall Study|Lack of Efficacy|0|||
145971166|NCT01963611|526408764|FG002|Overall Study|Lack of Efficacy|0|||
146088137|NCT01986933|526841961|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
146236127|NCT03333109|527379985|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
146236128|NCT03333109|527379986|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
146236129|NCT03333109|527379984|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
146236130|NCT03333109|527379985|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
146236131|NCT03333109|527379986|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
146236132|NCT04088227|527379987|FG000|Overall Study|Withdrawal by Subject|1|||
146236133|NCT04088227|527379988|FG001|Overall Study|Withdrawal by Subject|0|||
145891983|NCT02091141|526111905|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
145891984|NCT02091141|526111906|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
145891985|NCT02091141|526111907|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
145891986|NCT02712333|526111912|FG000|First Period|Withdrawal by Subject|3|||
145891987|NCT02712333|526111913|FG001|First Period|Withdrawal by Subject|2|||
145891988|NCT02278718|526111914|FG000|Overall Study|Adverse Event|1|||
145891989|NCT02278718|526111915|FG001|Overall Study|Adverse Event|0|||
145891990|NCT02278718|526111914|FG000|Overall Study|Lost to Follow-up|2|||
145891991|NCT02278718|526111915|FG001|Overall Study|Lost to Follow-up|4|||
145891992|NCT02278718|526111914|FG000|Overall Study|Withdrawal by Subject|1|||
145891993|NCT02278718|526111915|FG001|Overall Study|Withdrawal by Subject|4|||
145891994|NCT02278718|526111914|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
145891995|NCT02278718|526111915|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
145891996|NCT02278718|526111914|FG000|Overall Study|Missing|0|||
145891997|NCT02278718|526111915|FG001|Overall Study|Missing|1|||
145891998|NCT03212794|526111916|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
145891999|NCT03212794|526111917|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
145892000|NCT03212794|526111916|FG000|Overall Study|Lost to Follow-up|5|||
145892001|NCT03212794|526111917|FG001|Overall Study|Lost to Follow-up|6|||
145892002|NCT03212794|526111916|FG000|Overall Study|Incarcerated; unable to participate|2|||
145892003|NCT03212794|526111917|FG001|Overall Study|Incarcerated; unable to participate|0|||
145892004|NCT03212794|526111916|FG000|Overall Study|Withdrawal by Subject|1|||
145892005|NCT03212794|526111917|FG001|Overall Study|Withdrawal by Subject|0|||
145892006|NCT03212794|526111916|FG000|Overall Study|Death|0|||
145892007|NCT03212794|526111917|FG001|Overall Study|Death|1|||
145892008|NCT03212794|526111916|FG000|Overall Study|Found to be ineligible after allocation|0|||
145892009|NCT03212794|526111917|FG001|Overall Study|Found to be ineligible after allocation|1|||
145892010|NCT03212794|526111916|FG000|Overall Study|Relocated out of area|2|||
145892011|NCT03212794|526111917|FG001|Overall Study|Relocated out of area|0|||
145892012|NCT01763918|526111918|FG000|Overall Study|Withdrawal by Subject|2|||
145892013|NCT01763918|526111919|FG001|Overall Study|Withdrawal by Subject|1|||
145892014|NCT01763918|526111920|FG002|Overall Study|Withdrawal by Subject|1|||
145892015|NCT01763918|526111921|FG003|Overall Study|Withdrawal by Subject|2|||
145892016|NCT01763918|526111918|FG000|Overall Study|Sponsor Decision|4|||
145892017|NCT01763918|526111919|FG001|Overall Study|Sponsor Decision|0|||
145892018|NCT01763918|526111920|FG002|Overall Study|Sponsor Decision|9|||
145892019|NCT01763918|526111921|FG003|Overall Study|Sponsor Decision|0|||
145892020|NCT00897949|526111922|FG000|Overall Study|Adverse Event|1|||
145892021|NCT00897949|526111923|FG001|Overall Study|Adverse Event|1|||
145892022|NCT00897949|526111924|FG002|Overall Study|Adverse Event|0|||
145892023|NCT00897949|526111922|FG000|Overall Study|Lost to Follow-up|0|||
145892024|NCT00897949|526111923|FG001|Overall Study|Lost to Follow-up|2|||
145892025|NCT00897949|526111924|FG002|Overall Study|Lost to Follow-up|1|||
145892026|NCT00897949|526111922|FG000|Overall Study|Protocol Violation|6|||
145892027|NCT00897949|526111923|FG001|Overall Study|Protocol Violation|3|||
145892028|NCT00897949|526111924|FG002|Overall Study|Protocol Violation|1|||
145892029|NCT00897949|526111922|FG000|Overall Study|Withdrawal by Subject|1|||
145892030|NCT00897949|526111923|FG001|Overall Study|Withdrawal by Subject|2|||
145892031|NCT00897949|526111924|FG002|Overall Study|Withdrawal by Subject|0|||
145892032|NCT00897949|526111922|FG000|Overall Study|Patient Uncoorperative|0|||
145892033|NCT00897949|526111923|FG001|Overall Study|Patient Uncoorperative|2|||
145971167|NCT01963611|526408765|FG003|Overall Study|Lack of Efficacy|1|||
146236134|NCT04088227|527379987|FG000|Overall Study|Surgery postponed >5weeks|1|||
146236135|NCT04088227|527379988|FG001|Overall Study|Surgery postponed >5weeks|0|||
146236136|NCT03160885|527379991|FG000|Initial Treatment Period|Not dosed|2|||
146236137|NCT03160885|527379992|FG001|Initial Treatment Period|Not dosed|0|||
145892034|NCT00897949|526111924|FG002|Overall Study|Patient Uncoorperative|1|||
145892035|NCT00897949|526111922|FG000|Overall Study|Lost to Follow-up|30|||
145892036|NCT00897949|526111923|FG001|Overall Study|Lost to Follow-up|23|||
145892037|NCT00897949|526111924|FG002|Overall Study|Lost to Follow-up|17|||
145892038|NCT00897949|526111922|FG000|Overall Study|Withdrawal by Subject|24|||
145892039|NCT00897949|526111923|FG001|Overall Study|Withdrawal by Subject|31|||
145892040|NCT00897949|526111924|FG002|Overall Study|Withdrawal by Subject|17|||
145892041|NCT00897949|526111922|FG000|Overall Study|Abnormal Prestudy Labs|2|||
146236138|NCT03160885|527379993|FG002|Initial Treatment Period|Not dosed|0|||
146236139|NCT03160885|527379994|FG003|Initial Treatment Period|Not dosed|0|||
146236140|NCT03160885|527379995|FG004|Initial Treatment Period|Not dosed|0|||
145892042|NCT00897949|526111923|FG001|Overall Study|Abnormal Prestudy Labs|3|||
145892043|NCT00897949|526111924|FG002|Overall Study|Abnormal Prestudy Labs|4|||
145892044|NCT00897949|526111922|FG000|Overall Study|Abnormal Baseline ECG|2|||
145892045|NCT00897949|526111923|FG001|Overall Study|Abnormal Baseline ECG|2|||
145892046|NCT00897949|526111924|FG002|Overall Study|Abnormal Baseline ECG|4|||
145892047|NCT00897949|526111922|FG000|Overall Study|Need for Concom. Med.|0|||
146236141|NCT03160885|527379996|FG005|Initial Treatment Period|Not dosed|0|||
146236142|NCT03160885|527379997|FG006|Initial Treatment Period|Not dosed|0|||
146236143|NCT03160885|527379991|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
146236144|NCT03160885|527379992|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
146236145|NCT03160885|527379993|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146236146|NCT03160885|527379994|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146236147|NCT03160885|527379995|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146236148|NCT03160885|527379996|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146236149|NCT03160885|527379997|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
146236150|NCT03160885|527379991|FG000|Open-label Treatment|Not dosed|0|||
146236151|NCT03160885|527379992|FG001|Open-label Treatment|Not dosed|0|||
146236152|NCT03160885|527379993|FG002|Open-label Treatment|Not dosed|0|||
146236153|NCT03160885|527379994|FG003|Open-label Treatment|Not dosed|0|||
146236154|NCT03160885|527379995|FG004|Open-label Treatment|Not dosed|0|||
146236155|NCT03160885|527379996|FG005|Open-label Treatment|Not dosed|0|||
146236156|NCT03160885|527379997|FG006|Open-label Treatment|Not dosed|2|||
146236157|NCT03160885|527379991|FG000|Open-label Treatment|Discontinued IMP|0|||
146236158|NCT03160885|527379992|FG001|Open-label Treatment|Discontinued IMP|0|||
146236159|NCT03160885|527379993|FG002|Open-label Treatment|Discontinued IMP|0|||
146236160|NCT03160885|527379994|FG003|Open-label Treatment|Discontinued IMP|0|||
146236161|NCT03160885|527379995|FG004|Open-label Treatment|Discontinued IMP|0|||
146236162|NCT03160885|527379996|FG005|Open-label Treatment|Discontinued IMP|0|||
146236163|NCT03160885|527379997|FG006|Open-label Treatment|Discontinued IMP|131|||
146236164|NCT03160885|527379991|FG000|Open-label Treatment|Completed Week 50|0|||
146236165|NCT03160885|527379992|FG001|Open-label Treatment|Completed Week 50|0|||
146236166|NCT03160885|527379993|FG002|Open-label Treatment|Completed Week 50|0|||
146236167|NCT03160885|527379994|FG003|Open-label Treatment|Completed Week 50|0|||
146236168|NCT03160885|527379995|FG004|Open-label Treatment|Completed Week 50|0|||
146236169|NCT03160885|527379996|FG005|Open-label Treatment|Completed Week 50|0|||
146236170|NCT03160885|527379997|FG006|Open-label Treatment|Completed Week 50|4|||
146236171|NCT03160885|527379991|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146236172|NCT03160885|527379992|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146236173|NCT03160885|527379993|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146236174|NCT03160885|527379994|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
146236175|NCT03160885|527379995|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146295516|NCT04082429|527597597|FG000|Extension Part|Ongoing|0|||
145892048|NCT00897949|526111923|FG001|Overall Study|Need for Concom. Med.|1|||
145892049|NCT00897949|526111924|FG002|Overall Study|Need for Concom. Med.|1|||
145892050|NCT00897949|526111922|FG000|Overall Study|Lack of Migraine Attack|29|||
145892051|NCT00897949|526111923|FG001|Overall Study|Lack of Migraine Attack|30|||
145892052|NCT00897949|526111924|FG002|Overall Study|Lack of Migraine Attack|19|||
145892053|NCT00897949|526111922|FG000|Overall Study|Did not take study drug|9|||
145892054|NCT00897949|526111923|FG001|Overall Study|Did not take study drug|3|||
145892055|NCT00897949|526111924|FG002|Overall Study|Did not take study drug|4|||
145892056|NCT01553747|526111925|FG000|Overall Study|Protocol Violation|0|||
145892057|NCT01553747|526111926|FG001|Overall Study|Protocol Violation|2|||
145892058|NCT01553747|526111927|FG002|Overall Study|Protocol Violation|0|||
145892059|NCT01553747|526111925|FG000|Overall Study|Voluntarily withdrew|70|||
145892060|NCT01553747|526111926|FG001|Overall Study|Voluntarily withdrew|66|||
145892061|NCT01553747|526111927|FG002|Overall Study|Voluntarily withdrew|74|||
145892062|NCT01553747|526111925|FG000|Overall Study|Adverse event or SAE|32|||
145892063|NCT01553747|526111926|FG001|Overall Study|Adverse event or SAE|28|||
145892064|NCT01553747|526111927|FG002|Overall Study|Adverse event or SAE|19|||
145892065|NCT01553747|526111925|FG000|Overall Study|Physician decision: other|10|||
145892066|NCT01553747|526111926|FG001|Overall Study|Physician decision: other|8|||
146236176|NCT03160885|527379996|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146236177|NCT03160885|527379997|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
146236178|NCT03160885|527379991|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
146295517|NCT04082429|527597598|FG001|Extension Part|Ongoing|7|||
146295518|NCT04082429|527597599|FG002|Extension Part|Ongoing|17|||
145892067|NCT01553747|526111927|FG002|Overall Study|Physician decision: other|7|||
145892068|NCT01553747|526111925|FG000|Overall Study|Lost to Follow-up|11|||
145892069|NCT01553747|526111926|FG001|Overall Study|Lost to Follow-up|5|||
145892070|NCT01553747|526111927|FG002|Overall Study|Lost to Follow-up|6|||
145892071|NCT01553747|526111925|FG000|Overall Study|Sponsor decision, specify|7|||
145892072|NCT01553747|526111926|FG001|Overall Study|Sponsor decision, specify|5|||
145892073|NCT01553747|526111927|FG002|Overall Study|Sponsor decision, specify|0|||
145892074|NCT01553747|526111925|FG000|Overall Study|Physician decision: lack of efficacy|1|||
145892075|NCT01553747|526111926|FG001|Overall Study|Physician decision: lack of efficacy|5|||
145892076|NCT01553747|526111927|FG002|Overall Study|Physician decision: lack of efficacy|3|||
145892077|NCT00102687|526111928|FG000|Initial Period|Withdrawal by Subject|6|||
145892078|NCT00102687|526111929|FG001|Initial Period|Withdrawal by Subject|3|||
145892079|NCT00102687|526111930|FG002|Initial Period|Withdrawal by Subject|5|||
145892080|NCT00102687|526111931|FG003|Initial Period|Withdrawal by Subject|0|||
145892081|NCT00102687|526111932|FG004|Initial Period|Withdrawal by Subject|0|||
145892082|NCT00102687|526111928|FG000|Initial Period|Adverse Event|4|||
145892083|NCT00102687|526111929|FG001|Initial Period|Adverse Event|7|||
145892084|NCT00102687|526111930|FG002|Initial Period|Adverse Event|9|||
145892085|NCT00102687|526111931|FG003|Initial Period|Adverse Event|0|||
145892086|NCT00102687|526111932|FG004|Initial Period|Adverse Event|0|||
145892087|NCT00102687|526111928|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
145892088|NCT00102687|526111929|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
145892089|NCT00102687|526111930|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
145892090|NCT00102687|526111931|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
145892091|NCT00102687|526111932|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
145892092|NCT00102687|526111928|FG000|Initial Period|Protocol Violation|0|||
145892093|NCT00102687|526111929|FG001|Initial Period|Protocol Violation|0|||
145892094|NCT00102687|526111930|FG002|Initial Period|Protocol Violation|2|||
146236179|NCT03160885|527379992|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
146236180|NCT03160885|527379993|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
146236181|NCT03160885|527379994|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
146236182|NCT03160885|527379995|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
146236183|NCT03160885|527379996|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
146236184|NCT03160885|527379997|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
146236185|NCT03160885|527379991|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146236186|NCT03160885|527379992|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146236187|NCT03160885|527379993|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
146236188|NCT03160885|527379994|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
146236189|NCT03160885|527379995|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
146236190|NCT03160885|527379996|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
146236191|NCT03160885|527379997|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
146236192|NCT03160885|527379991|FG000|Maintenance Treatment Period|Completed Week 50|0|||
146236193|NCT03160885|527379992|FG001|Maintenance Treatment Period|Completed Week 50|0|||
146236194|NCT03160885|527379993|FG002|Maintenance Treatment Period|Completed Week 50|1|||
146236195|NCT03160885|527379994|FG003|Maintenance Treatment Period|Completed Week 50|0|||
146236196|NCT03160885|527379995|FG004|Maintenance Treatment Period|Completed Week 50|0|||
146236197|NCT03160885|527379996|FG005|Maintenance Treatment Period|Completed Week 50|0|||
146236198|NCT03160885|527379997|FG006|Maintenance Treatment Period|Completed Week 50|0|||
146236199|NCT05485805|527380000|FG000|Overall Study|Withdrawal by Subject|1|||
146236200|NCT05485805|527380001|FG001|Overall Study|Withdrawal by Subject|2|||
146236201|NCT05485805|527380002|FG002|Overall Study|Withdrawal by Subject|2|||
146236202|NCT05485805|527380003|FG003|Overall Study|Withdrawal by Subject|0|||
146236203|NCT05485805|527380004|FG004|Overall Study|Withdrawal by Subject|2|||
146236204|NCT05485805|527380000|FG000|Overall Study|Adverse Event|0|||
146236205|NCT05485805|527380001|FG001|Overall Study|Adverse Event|1|||
146236206|NCT05485805|527380002|FG002|Overall Study|Adverse Event|0|||
146236207|NCT05485805|527380003|FG003|Overall Study|Adverse Event|0|||
146236208|NCT05485805|527380004|FG004|Overall Study|Adverse Event|0|||
146236209|NCT05485805|527380000|FG000|Overall Study|Lost to Follow-up|1|||
146236210|NCT05485805|527380001|FG001|Overall Study|Lost to Follow-up|1|||
146236211|NCT05485805|527380002|FG002|Overall Study|Lost to Follow-up|3|||
146236212|NCT05485805|527380003|FG003|Overall Study|Lost to Follow-up|1|||
146236213|NCT05485805|527380004|FG004|Overall Study|Lost to Follow-up|0|||
146236214|NCT00490139|527380005|FG000|Overall Study|Lost to Follow-up|249|||
146236215|NCT00490139|527380006|FG001|Overall Study|Lost to Follow-up|216|||
146236216|NCT00490139|527380007|FG002|Overall Study|Lost to Follow-up|205|||
146295519|NCT04082429|527597600|FG003|Extension Part|Ongoing|6|||
145892095|NCT00102687|526111931|FG003|Initial Period|Protocol Violation|0|||
145892096|NCT00102687|526111932|FG004|Initial Period|Protocol Violation|0|||
145892097|NCT00102687|526111928|FG000|Initial Period|Physician Decision|2|||
145892098|NCT00102687|526111929|FG001|Initial Period|Physician Decision|9|||
145892099|NCT00102687|526111930|FG002|Initial Period|Physician Decision|6|||
145892100|NCT00102687|526111931|FG003|Initial Period|Physician Decision|0|||
146236217|NCT00490139|527380008|FG003|Overall Study|Lost to Follow-up|229|||
146236218|NCT00490139|527380005|FG000|Overall Study|Withdrawal by Subject|333|||
145892101|NCT00102687|526111932|FG004|Initial Period|Physician Decision|0|||
145892102|NCT00102687|526111928|FG000|Initial Period|Sponsor's decision|0|||
145892103|NCT00102687|526111929|FG001|Initial Period|Sponsor's decision|1|||
145892104|NCT00102687|526111930|FG002|Initial Period|Sponsor's decision|1|||
145892105|NCT00102687|526111931|FG003|Initial Period|Sponsor's decision|0|||
145892106|NCT00102687|526111932|FG004|Initial Period|Sponsor's decision|0|||
145892107|NCT00102687|526111928|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
146236219|NCT00490139|527380006|FG001|Overall Study|Withdrawal by Subject|322|||
146236220|NCT00490139|527380007|FG002|Overall Study|Withdrawal by Subject|396|||
146236221|NCT00490139|527380008|FG003|Overall Study|Withdrawal by Subject|295|||
146236222|NCT00490139|527380005|FG000|Overall Study|Patient did not sign ICF 12|169|||
146236223|NCT00490139|527380006|FG001|Overall Study|Patient did not sign ICF 12|176|||
146236224|NCT00490139|527380007|FG002|Overall Study|Patient did not sign ICF 12|139|||
146236225|NCT00490139|527380008|FG003|Overall Study|Patient did not sign ICF 12|167|||
146236226|NCT00490139|527380005|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
146236227|NCT00490139|527380006|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
146236228|NCT00490139|527380007|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
146236229|NCT00490139|527380008|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
146236230|NCT00490139|527380005|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
146236231|NCT00490139|527380006|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
146236232|NCT00490139|527380007|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
146236233|NCT00490139|527380008|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
146236234|NCT00490139|527380005|FG000|Overall Study|Other reasons as defined per protocol|98|||
146236235|NCT00490139|527380006|FG001|Overall Study|Other reasons as defined per protocol|84|||
146236236|NCT00490139|527380007|FG002|Overall Study|Other reasons as defined per protocol|82|||
146236237|NCT00490139|527380008|FG003|Overall Study|Other reasons as defined per protocol|105|||
146236238|NCT03664804|527380010|FG000|Overall Study|Withdrawal by Subject|7|||
146236239|NCT05529992|527380011|FG000|Overall Study|Withdrawal by Subject|1|||
146236240|NCT06140290|527380012|FG000|Period 1|Adverse Event|1|||
146236241|NCT06140290|527380013|FG001|Period 1|Adverse Event|0|||
146236242|NCT06140290|527380012|FG000|Period 2|Assigned but not treated|0|||
146236243|NCT06140290|527380013|FG001|Period 2|Assigned but not treated|1|||
146236244|NCT06140290|527380012|FG000|Period 2|Withdrawal by Subject|0|||
146236245|NCT06140290|527380013|FG001|Period 2|Withdrawal by Subject|1|||
146236246|NCT05250115|527381012|FG000|Overall Study|Premature study end|40|||
146236247|NCT05250115|527381012|FG000|Overall Study|Adverse Event|8|||
146236248|NCT05250115|527381012|FG000|Overall Study|Lost to Follow-up|7|||
146236249|NCT05250115|527381012|FG000|Overall Study|Withdrawal by Subject|6|||
146236250|NCT05250115|527381012|FG000|Overall Study|Withdrawal of informed consent|1|||
146236251|NCT05250115|527381012|FG000|Overall Study|Other|7|||
146236252|NCT03758638|527381013|FG000|Overall Study|Pregnancy|17|||
146236253|NCT03758638|527381014|FG001|Overall Study|Pregnancy|25|||
146236254|NCT03758638|527381013|FG000|Overall Study|Lost to Follow-up|60|||
146236255|NCT03758638|527381014|FG001|Overall Study|Lost to Follow-up|54|||
146236256|NCT03758638|527381013|FG000|Overall Study|Protocol Violation|2|||
146236257|NCT03758638|527381014|FG001|Overall Study|Protocol Violation|0|||
146236258|NCT03758638|527381013|FG000|Overall Study|Withdrawal by Subject|8|||
146236259|NCT03758638|527381014|FG001|Overall Study|Withdrawal by Subject|2|||
146236260|NCT03758638|527381013|FG000|Overall Study|Providers not included in the primary outcome.|183|||
146236261|NCT03758638|527381014|FG001|Overall Study|Providers not included in the primary outcome.|128|||
146236262|NCT01314118|527381015|FG000|Overall Study|Adverse Event|9|||
146236263|NCT01314118|527381015|FG000|Overall Study|Progressive disease|27|||
146236264|NCT01314118|527381015|FG000|Overall Study|Physician Decision|11|||
146236265|NCT01314118|527381015|FG000|Overall Study|Death|4|||
146236266|NCT01314118|527381015|FG000|Overall Study|Protocol Violation|5|||
146236267|NCT01314118|527381015|FG000|Overall Study|Withdrawal by Subject|11|||
146236268|NCT01314118|527381015|FG000|Overall Study|Other|2|||
146236269|NCT01314118|527381015|FG000|Overall Study|Ongoing|62|||
146236270|NCT00790569|527381019|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
146236271|NCT00790569|527381020|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
146236272|NCT00790569|527381021|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
146236273|NCT00790569|527381019|FG000|End of Treatment (6 Month Interview)|Death|0|||
146236274|NCT00790569|527381020|FG001|End of Treatment (6 Month Interview)|Death|2|||
146236275|NCT00790569|527381021|FG002|End of Treatment (6 Month Interview)|Death|1|||
146236276|NCT00790569|527381019|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
146236277|NCT00790569|527381020|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
146236278|NCT00790569|527381021|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
146236279|NCT00790569|527381019|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
146236280|NCT00790569|527381020|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
146236281|NCT00790569|527381021|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
146236282|NCT00790569|527381019|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
146236283|NCT00790569|527381020|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
146236284|NCT00790569|527381021|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
146236285|NCT00790569|527381019|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
145892108|NCT00102687|526111929|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
145892109|NCT00102687|526111930|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
145892110|NCT00102687|526111931|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
145892111|NCT00102687|526111932|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
145892112|NCT00102687|526111928|FG000|Initial Period|Death|1|||
145892113|NCT00102687|526111929|FG001|Initial Period|Death|1|||
145892114|NCT00102687|526111930|FG002|Initial Period|Death|1|||
145892115|NCT00102687|526111931|FG003|Initial Period|Death|0|||
145892116|NCT00102687|526111932|FG004|Initial Period|Death|0|||
145892117|NCT00102687|526111928|FG000|Maintenance Period|Withdrawal by Subject|4|||
145892118|NCT00102687|526111929|FG001|Maintenance Period|Withdrawal by Subject|0|||
145892119|NCT00102687|526111930|FG002|Maintenance Period|Withdrawal by Subject|2|||
145892120|NCT00102687|526111931|FG003|Maintenance Period|Withdrawal by Subject|3|||
145892121|NCT00102687|526111932|FG004|Maintenance Period|Withdrawal by Subject|1|||
145892122|NCT00102687|526111928|FG000|Maintenance Period|Adverse Event|1|||
145892123|NCT00102687|526111929|FG001|Maintenance Period|Adverse Event|0|||
145892124|NCT00102687|526111930|FG002|Maintenance Period|Adverse Event|0|||
145892125|NCT00102687|526111931|FG003|Maintenance Period|Adverse Event|1|||
145892126|NCT00102687|526111932|FG004|Maintenance Period|Adverse Event|3|||
145892127|NCT00102687|526111928|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145892128|NCT00102687|526111929|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
145892129|NCT00102687|526111930|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145892130|NCT00102687|526111931|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
145892131|NCT00102687|526111932|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145892132|NCT00102687|526111928|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145892133|NCT00102687|526111929|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145892134|NCT00102687|526111930|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145892135|NCT00102687|526111931|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
145892136|NCT00102687|526111932|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
145892137|NCT00102687|526111928|FG000|Maintenance Period|Death|0|||
145892138|NCT00102687|526111929|FG001|Maintenance Period|Death|0|||
145892139|NCT00102687|526111930|FG002|Maintenance Period|Death|0|||
145892140|NCT00102687|526111931|FG003|Maintenance Period|Death|1|||
145892141|NCT00102687|526111932|FG004|Maintenance Period|Death|1|||
145892142|NCT00102687|526111928|FG000|Maintenance Period|Physician Decision|1|||
145892143|NCT00102687|526111929|FG001|Maintenance Period|Physician Decision|2|||
145892144|NCT00102687|526111930|FG002|Maintenance Period|Physician Decision|3|||
145892145|NCT00102687|526111931|FG003|Maintenance Period|Physician Decision|0|||
145892146|NCT00102687|526111932|FG004|Maintenance Period|Physician Decision|4|||
145892147|NCT02408120|526111938|FG000|Overall Study|Withdrawal by Subject|0|||
145892148|NCT02408120|526111939|FG001|Overall Study|Withdrawal by Subject|1|||
145892149|NCT02408120|526111938|FG000|Overall Study|Treatment Refusal|1|||
145892150|NCT02408120|526111939|FG001|Overall Study|Treatment Refusal|0|||
145892151|NCT02408120|526111938|FG000|Overall Study|Received Steroids|1|||
145892152|NCT02408120|526111939|FG001|Overall Study|Received Steroids|1|||
145892153|NCT02408120|526111938|FG000|Overall Study|Discharged same day|1|||
145892154|NCT02408120|526111939|FG001|Overall Study|Discharged same day|1|||
145892155|NCT02408120|526111938|FG000|Overall Study|Did not receive insulin|1|||
145892156|NCT02408120|526111939|FG001|Overall Study|Did not receive insulin|2|||
145892157|NCT01134627|526111940|FG000|Overall Study|Adverse Event|47|||
145892158|NCT01134627|526111941|FG001|Overall Study|Adverse Event|31|||
145892159|NCT01134627|526111940|FG000|Overall Study|Lost to Follow-up|1|||
145892160|NCT01134627|526111941|FG001|Overall Study|Lost to Follow-up|2|||
145892161|NCT01134627|526111940|FG000|Overall Study|Protocol Violation|3|||
145971168|NCT01963611|526408766|FG004|Overall Study|Lack of Efficacy|0|||
145971169|NCT01963611|526408762|FG000|Overall Study|Withdrawal by Subject|3|||
145971170|NCT01963611|526408763|FG001|Overall Study|Withdrawal by Subject|2|||
145971171|NCT01963611|526408764|FG002|Overall Study|Withdrawal by Subject|1|||
145971172|NCT01963611|526408765|FG003|Overall Study|Withdrawal by Subject|1|||
145971173|NCT01963611|526408766|FG004|Overall Study|Withdrawal by Subject|3|||
146295520|NCT04082429|527597601|FG004|Extension Part|Ongoing|45|||
145892162|NCT01134627|526111941|FG001|Overall Study|Protocol Violation|5|||
145892163|NCT01134627|526111940|FG000|Overall Study|Lack of Efficacy|2|||
145892164|NCT01134627|526111941|FG001|Overall Study|Lack of Efficacy|12|||
145892165|NCT01134627|526111940|FG000|Overall Study|Withdrawal by Subject|4|||
145892166|NCT01134627|526111941|FG001|Overall Study|Withdrawal by Subject|3|||
145892167|NCT01134627|526111940|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
145892168|NCT01134627|526111941|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
145892169|NCT01134627|526111940|FG000|Overall Study|Other|11|||
145971174|NCT01963611|526408762|FG000|Overall Study|Other|47|||
145971175|NCT01963611|526408763|FG001|Overall Study|Other|46|||
145971176|NCT01963611|526408764|FG002|Overall Study|Other|48|||
145971177|NCT01963611|526408765|FG003|Overall Study|Other|45|||
145971178|NCT01963611|526408766|FG004|Overall Study|Other|45|||
145892170|NCT01134627|526111941|FG001|Overall Study|Other|14|||
145892171|NCT00977431|526111947|FG000|Overall Study|Other than listed|1|||
145971179|NCT03801252|526408767|FG000|Overall Study|Protocol Violation|1|||
146236286|NCT00790569|527381020|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
145892172|NCT00977431|526111948|FG001|Overall Study|Other than listed|0|||
145892173|NCT00977431|526111949|FG002|Overall Study|Other than listed|0|||
145892174|NCT00977431|526111950|FG003|Overall Study|Other than listed|0|||
145892175|NCT00977431|526111951|FG004|Overall Study|Other than listed|2|||
145892176|NCT00977431|526111947|FG000|Overall Study|Protocol Violation|0|||
145892177|NCT00977431|526111948|FG001|Overall Study|Protocol Violation|0|||
145892178|NCT00977431|526111949|FG002|Overall Study|Protocol Violation|1|||
145892179|NCT00977431|526111950|FG003|Overall Study|Protocol Violation|0|||
145892180|NCT00977431|526111951|FG004|Overall Study|Protocol Violation|0|||
145892181|NCT00977431|526111947|FG000|Overall Study|Adverse Event|3|||
145892182|NCT00977431|526111948|FG001|Overall Study|Adverse Event|0|||
145892183|NCT00977431|526111949|FG002|Overall Study|Adverse Event|4|||
145892184|NCT00977431|526111950|FG003|Overall Study|Adverse Event|0|||
145892185|NCT00977431|526111951|FG004|Overall Study|Adverse Event|6|||
145892186|NCT00977431|526111947|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
145892187|NCT00977431|526111948|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
145892188|NCT00977431|526111949|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
145892189|NCT00977431|526111950|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
145892190|NCT00977431|526111951|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
145892191|NCT00977431|526111947|FG000|Overall Study|Progressive disease|2|||
145892192|NCT00977431|526111948|FG001|Overall Study|Progressive disease|6|||
145892193|NCT00977431|526111949|FG002|Overall Study|Progressive disease|1|||
145892194|NCT00977431|526111950|FG003|Overall Study|Progressive disease|3|||
145892195|NCT00977431|526111951|FG004|Overall Study|Progressive disease|5|||
145892196|NCT03739138|526111958|FG000|Overall Study|Death|0|||
145892197|NCT03739138|526111959|FG001|Overall Study|Death|7|||
145892198|NCT03739138|526111960|FG002|Overall Study|Death|4|||
145892199|NCT03739138|526111961|FG003|Overall Study|Death|13|||
145892200|NCT03739138|526111962|FG004|Overall Study|Death|0|||
145892201|NCT03739138|526111958|FG000|Overall Study|Lost to Follow-up|0|||
145892202|NCT03739138|526111959|FG001|Overall Study|Lost to Follow-up|0|||
145892203|NCT03739138|526111960|FG002|Overall Study|Lost to Follow-up|1|||
145892204|NCT03739138|526111961|FG003|Overall Study|Lost to Follow-up|0|||
145892205|NCT03739138|526111962|FG004|Overall Study|Lost to Follow-up|0|||
145892206|NCT03739138|526111958|FG000|Overall Study|Study Terminated By Sponsor|0|||
145892207|NCT03739138|526111959|FG001|Overall Study|Study Terminated By Sponsor|0|||
145892208|NCT03739138|526111960|FG002|Overall Study|Study Terminated By Sponsor|0|||
145892209|NCT03739138|526111961|FG003|Overall Study|Study Terminated By Sponsor|4|||
145892210|NCT03739138|526111962|FG004|Overall Study|Study Terminated By Sponsor|0|||
145892211|NCT03739138|526111958|FG000|Overall Study|Withdrawal by Subject|0|||
145892212|NCT03739138|526111959|FG001|Overall Study|Withdrawal by Subject|0|||
145892213|NCT03739138|526111960|FG002|Overall Study|Withdrawal by Subject|0|||
145892214|NCT03739138|526111961|FG003|Overall Study|Withdrawal by Subject|1|||
145892215|NCT03739138|526111962|FG004|Overall Study|Withdrawal by Subject|0|||
145892216|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
145892217|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
145892218|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
145892219|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
145892220|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
145892221|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
145892222|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
145892223|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
145892224|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
145892225|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
145892226|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Subject decision|1|||
145892227|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Subject decision|1|||
146236287|NCT00790569|527381021|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
146236288|NCT03244800|527381022|FG000|Overall Study|Adverse Event|0|||
145892228|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
145892229|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
145892230|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
145892231|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
145892232|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
146236289|NCT03244800|527381023|FG001|Overall Study|Adverse Event|1|||
146236290|NCT03244800|527381024|FG002|Overall Study|Adverse Event|0|||
145892233|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
145892234|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
145892235|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
145892236|NCT00518882|526111965|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
145892237|NCT00518882|526111966|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
145892238|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
145892239|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
145892240|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
145892241|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
145892242|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
145892243|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
145892244|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
146236291|NCT03244800|527381025|FG003|Overall Study|Adverse Event|1|||
146236292|NCT03244800|527381022|FG000|Overall Study|Withdrew treatment|0|||
146236293|NCT03244800|527381023|FG001|Overall Study|Withdrew treatment|0|||
146236294|NCT03244800|527381024|FG002|Overall Study|Withdrew treatment|0|||
146236295|NCT03244800|527381025|FG003|Overall Study|Withdrew treatment|1|||
145892245|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
145892246|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
145892247|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
145892248|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
145892249|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
145892250|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
145892251|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
145892252|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
145892253|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
145892254|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
145892255|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
145892256|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
145892257|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
145892258|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
145892259|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
145892260|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
145892261|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
145892262|NCT00518882|526111965|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
145892263|NCT00518882|526111966|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
145892264|NCT02696031|526111968|FG000|Up to Week 24|Adverse Event|2|||
145892265|NCT02696031|526111969|FG001|Up to Week 24|Adverse Event|4|||
145892266|NCT02696031|526111970|FG002|Up to Week 24|Adverse Event|2|||
145892267|NCT02696031|526111971|FG003|Up to Week 24|Adverse Event|0|||
145892268|NCT02696031|526111972|FG004|Up to Week 24|Adverse Event|0|||
145892269|NCT02696031|526111973|FG005|Up to Week 24|Adverse Event|0|||
145892270|NCT02696031|526111968|FG000|Up to Week 24|Lack of Efficacy|2|||
145892271|NCT02696031|526111969|FG001|Up to Week 24|Lack of Efficacy|1|||
145892272|NCT02696031|526111970|FG002|Up to Week 24|Lack of Efficacy|2|||
145892273|NCT02696031|526111971|FG003|Up to Week 24|Lack of Efficacy|0|||
145892274|NCT02696031|526111972|FG004|Up to Week 24|Lack of Efficacy|0|||
145892275|NCT02696031|526111973|FG005|Up to Week 24|Lack of Efficacy|0|||
145892276|NCT02696031|526111968|FG000|Up to Week 24|Lost to Follow-up|0|||
145892277|NCT02696031|526111969|FG001|Up to Week 24|Lost to Follow-up|1|||
145892278|NCT02696031|526111970|FG002|Up to Week 24|Lost to Follow-up|1|||
145892279|NCT02696031|526111971|FG003|Up to Week 24|Lost to Follow-up|0|||
145892280|NCT02696031|526111972|FG004|Up to Week 24|Lost to Follow-up|0|||
145892281|NCT02696031|526111973|FG005|Up to Week 24|Lost to Follow-up|0|||
145892282|NCT02696031|526111968|FG000|Up to Week 24|Physician Decision|1|||
145892283|NCT02696031|526111969|FG001|Up to Week 24|Physician Decision|0|||
145892284|NCT02696031|526111970|FG002|Up to Week 24|Physician Decision|1|||
146236296|NCT02941549|527381026|FG000|Overall Study|Adverse Event|1|||
146236297|NCT02941549|527381027|FG001|Overall Study|Adverse Event|0|||
146236298|NCT02941549|527381028|FG002|Overall Study|Adverse Event|0|||
146236299|NCT02941549|527381026|FG000|Overall Study|Withdrawal by Subject|2|||
146236300|NCT02941549|527381027|FG001|Overall Study|Withdrawal by Subject|1|||
146236301|NCT02941549|527381028|FG002|Overall Study|Withdrawal by Subject|2|||
145892285|NCT02696031|526111971|FG003|Up to Week 24|Physician Decision|0|||
145892286|NCT02696031|526111972|FG004|Up to Week 24|Physician Decision|0|||
145892287|NCT02696031|526111973|FG005|Up to Week 24|Physician Decision|0|||
145892288|NCT02696031|526111968|FG000|Up to Week 24|Protocol Violation|1|||
145892289|NCT02696031|526111969|FG001|Up to Week 24|Protocol Violation|0|||
145971180|NCT03801252|526408768|FG001|Overall Study|Protocol Violation|2|||
145971181|NCT02471183|526408769|FG000|Main Treatment Period|Adverse Event|1|||
145892290|NCT02696031|526111970|FG002|Up to Week 24|Protocol Violation|0|||
145892291|NCT02696031|526111971|FG003|Up to Week 24|Protocol Violation|0|||
146236302|NCT03451422|527381032|FG000|Overall Study|Lost to Follow-up|0|||
145892292|NCT02696031|526111972|FG004|Up to Week 24|Protocol Violation|0|||
145892293|NCT02696031|526111973|FG005|Up to Week 24|Protocol Violation|0|||
145892294|NCT02696031|526111968|FG000|Up to Week 24|Withdrawal by Subject|4|||
145971182|NCT02471183|526408769|FG000|Main Treatment Period|Withdrawal by Subject|1|||
145892295|NCT02696031|526111969|FG001|Up to Week 24|Withdrawal by Subject|1|||
145892296|NCT02696031|526111970|FG002|Up to Week 24|Withdrawal by Subject|5|||
145892297|NCT02696031|526111971|FG003|Up to Week 24|Withdrawal by Subject|0|||
145892298|NCT02696031|526111972|FG004|Up to Week 24|Withdrawal by Subject|0|||
145892299|NCT02696031|526111973|FG005|Up to Week 24|Withdrawal by Subject|0|||
146236303|NCT03451422|527381033|FG001|Overall Study|Lost to Follow-up|0|||
146236304|NCT03451422|527381034|FG002|Overall Study|Lost to Follow-up|0|||
146236305|NCT03451422|527381035|FG003|Overall Study|Lost to Follow-up|0|||
146295521|NCT04082429|527597602|FG005|Extension Part|Ongoing|0|||
146295522|NCT04082429|527597603|FG006|Extension Part|Ongoing|10|||
146295523|NCT04082429|527597604|FG007|Extension Part|Ongoing|23|||
146295524|NCT04082429|527597605|FG008|Extension Part|Ongoing|25|||
146295525|NCT04796896|527597606|FG000|Overall Study|Adverse Event|1|||
146295526|NCT04796896|527597607|FG001|Overall Study|Adverse Event|0|||
146295527|NCT04796896|527597608|FG002|Overall Study|Adverse Event|0|||
146295528|NCT04796896|527597609|FG003|Overall Study|Adverse Event|0|||
146295529|NCT04796896|527597610|FG004|Overall Study|Adverse Event|0|||
146295530|NCT04796896|527597611|FG005|Overall Study|Adverse Event|1|||
146295531|NCT04796896|527597612|FG006|Overall Study|Adverse Event|1|||
146295532|NCT04796896|527597613|FG007|Overall Study|Adverse Event|0|||
146295533|NCT04796896|527597614|FG008|Overall Study|Adverse Event|1|||
146295534|NCT04796896|527597615|FG009|Overall Study|Adverse Event|1|||
146295535|NCT04796896|527597616|FG010|Overall Study|Adverse Event|1|||
146295536|NCT04796896|527597617|FG011|Overall Study|Adverse Event|0|||
146295537|NCT04796896|527597606|FG000|Overall Study|Lost to Follow-up|24|||
146295538|NCT04796896|527597607|FG001|Overall Study|Lost to Follow-up|15|||
146295539|NCT04796896|527597608|FG002|Overall Study|Lost to Follow-up|6|||
146295540|NCT04796896|527597609|FG003|Overall Study|Lost to Follow-up|4|||
146295541|NCT04796896|527597610|FG004|Overall Study|Lost to Follow-up|21|||
146295542|NCT04796896|527597611|FG005|Overall Study|Lost to Follow-up|55|||
146295543|NCT04796896|527597612|FG006|Overall Study|Lost to Follow-up|237|||
146295544|NCT04796896|527597613|FG007|Overall Study|Lost to Follow-up|52|||
146295545|NCT04796896|527597614|FG008|Overall Study|Lost to Follow-up|221|||
146295546|NCT04796896|527597615|FG009|Overall Study|Lost to Follow-up|43|||
146295547|NCT04796896|527597616|FG010|Overall Study|Lost to Follow-up|142|||
145971183|NCT02471183|526408769|FG000|Extended Treatment Period|Lack of Efficacy|1|||
145971184|NCT00614393|526408774|FG000|Overall Study|Adverse Event|20|||
145971185|NCT00614393|526408775|FG001|Overall Study|Adverse Event|2|||
145971186|NCT00614393|526408776|FG002|Overall Study|Adverse Event|3|||
145971187|NCT00614393|526408777|FG003|Overall Study|Adverse Event|13|||
145971188|NCT00614393|526408778|FG004|Overall Study|Adverse Event|21|||
145971189|NCT00614393|526408774|FG000|Overall Study|Lost to Follow-up|0|||
145971190|NCT00614393|526408775|FG001|Overall Study|Lost to Follow-up|0|||
145971191|NCT00614393|526408776|FG002|Overall Study|Lost to Follow-up|0|||
145971192|NCT00614393|526408777|FG003|Overall Study|Lost to Follow-up|1|||
145971193|NCT00614393|526408778|FG004|Overall Study|Lost to Follow-up|2|||
145971194|NCT00614393|526408774|FG000|Overall Study|Physician Decision|17|||
145971195|NCT00614393|526408775|FG001|Overall Study|Physician Decision|0|||
145971196|NCT00614393|526408776|FG002|Overall Study|Physician Decision|1|||
145971197|NCT00614393|526408777|FG003|Overall Study|Physician Decision|8|||
145971198|NCT00614393|526408778|FG004|Overall Study|Physician Decision|9|||
145971199|NCT00614393|526408774|FG000|Overall Study|Progressive Disease|118|||
145971200|NCT00614393|526408775|FG001|Overall Study|Progressive Disease|5|||
145892300|NCT02696031|526111968|FG000|Up to Week 52|Adverse Event|4|||
145892301|NCT02696031|526111969|FG001|Up to Week 52|Adverse Event|5|||
145892302|NCT02696031|526111970|FG002|Up to Week 52|Adverse Event|3|||
145892303|NCT02696031|526111971|FG003|Up to Week 52|Adverse Event|0|||
145892304|NCT02696031|526111972|FG004|Up to Week 52|Adverse Event|0|||
145892305|NCT02696031|526111973|FG005|Up to Week 52|Adverse Event|0|||
145892306|NCT02696031|526111968|FG000|Up to Week 52|Lack of Efficacy|10|||
145892307|NCT02696031|526111969|FG001|Up to Week 52|Lack of Efficacy|7|||
145892308|NCT02696031|526111970|FG002|Up to Week 52|Lack of Efficacy|11|||
145892309|NCT02696031|526111971|FG003|Up to Week 52|Lack of Efficacy|0|||
145892310|NCT02696031|526111972|FG004|Up to Week 52|Lack of Efficacy|0|||
145892311|NCT02696031|526111973|FG005|Up to Week 52|Lack of Efficacy|0|||
145892312|NCT02696031|526111968|FG000|Up to Week 52|Lost to Follow-up|1|||
145892313|NCT02696031|526111969|FG001|Up to Week 52|Lost to Follow-up|1|||
145892314|NCT02696031|526111970|FG002|Up to Week 52|Lost to Follow-up|1|||
145892315|NCT02696031|526111971|FG003|Up to Week 52|Lost to Follow-up|0|||
145892316|NCT02696031|526111972|FG004|Up to Week 52|Lost to Follow-up|0|||
145892317|NCT02696031|526111973|FG005|Up to Week 52|Lost to Follow-up|0|||
145892318|NCT02696031|526111968|FG000|Up to Week 52|Physician Decision|1|||
145892319|NCT02696031|526111969|FG001|Up to Week 52|Physician Decision|1|||
145892320|NCT02696031|526111970|FG002|Up to Week 52|Physician Decision|2|||
145892321|NCT02696031|526111971|FG003|Up to Week 52|Physician Decision|0|||
145892322|NCT02696031|526111972|FG004|Up to Week 52|Physician Decision|0|||
145892323|NCT02696031|526111973|FG005|Up to Week 52|Physician Decision|0|||
145971201|NCT00614393|526408776|FG002|Overall Study|Progressive Disease|5|||
145971202|NCT00614393|526408777|FG003|Overall Study|Progressive Disease|138|||
145971203|NCT00614393|526408778|FG004|Overall Study|Progressive Disease|130|||
145971204|NCT00614393|526408774|FG000|Overall Study|Protocol Violation|1|||
145971205|NCT00614393|526408775|FG001|Overall Study|Protocol Violation|0|||
145971206|NCT00614393|526408776|FG002|Overall Study|Protocol Violation|0|||
145971207|NCT00614393|526408777|FG003|Overall Study|Protocol Violation|0|||
145971208|NCT00614393|526408778|FG004|Overall Study|Protocol Violation|0|||
145971209|NCT00614393|526408774|FG000|Overall Study|Terminated by Sponsor|0|||
145971210|NCT00614393|526408775|FG001|Overall Study|Terminated by Sponsor|0|||
145971211|NCT00614393|526408776|FG002|Overall Study|Terminated by Sponsor|0|||
145971212|NCT00614393|526408777|FG003|Overall Study|Terminated by Sponsor|0|||
145971213|NCT00614393|526408778|FG004|Overall Study|Terminated by Sponsor|1|||
145971214|NCT00614393|526408774|FG000|Overall Study|Withdrawal by Subject|20|||
145971215|NCT00614393|526408775|FG001|Overall Study|Withdrawal by Subject|1|||
145971216|NCT00614393|526408776|FG002|Overall Study|Withdrawal by Subject|1|||
145971217|NCT00614393|526408777|FG003|Overall Study|Withdrawal by Subject|16|||
145971218|NCT00614393|526408778|FG004|Overall Study|Withdrawal by Subject|13|||
145971219|NCT00614393|526408774|FG000|Overall Study|Other|4|||
145971220|NCT00614393|526408775|FG001|Overall Study|Other|0|||
145971221|NCT00614393|526408776|FG002|Overall Study|Other|0|||
145971222|NCT00614393|526408777|FG003|Overall Study|Other|4|||
145971223|NCT00614393|526408778|FG004|Overall Study|Other|2|||
145971224|NCT00614393|526408774|FG000|Overall Study|Not Treated|0|||
145971225|NCT00614393|526408775|FG001|Overall Study|Not Treated|0|||
145971226|NCT00614393|526408776|FG002|Overall Study|Not Treated|0|||
145971227|NCT00614393|526408777|FG003|Overall Study|Not Treated|0|||
145971228|NCT00614393|526408778|FG004|Overall Study|Not Treated|2|||
145971229|NCT02328105|526408779|FG000|Overall Study|Death|6|||
145971230|NCT02328105|526408779|FG000|Overall Study|Withdrawal by Subject|1|||
145971231|NCT02328105|526408779|FG000|Overall Study|Still On Study in Follow-Up|4|||
145971232|NCT00855582|526408780|FG000|Overall Study|Adverse Event|2|||
145892324|NCT02696031|526111968|FG000|Up to Week 52|Pregnancy|0|||
145892325|NCT02696031|526111969|FG001|Up to Week 52|Pregnancy|2|||
145892326|NCT02696031|526111970|FG002|Up to Week 52|Pregnancy|0|||
145892327|NCT02696031|526111971|FG003|Up to Week 52|Pregnancy|0|||
145892328|NCT02696031|526111972|FG004|Up to Week 52|Pregnancy|0|||
145892329|NCT02696031|526111973|FG005|Up to Week 52|Pregnancy|0|||
145892330|NCT02696031|526111968|FG000|Up to Week 52|Protocol Violation|1|||
145892331|NCT02696031|526111969|FG001|Up to Week 52|Protocol Violation|0|||
145892332|NCT02696031|526111970|FG002|Up to Week 52|Protocol Violation|0|||
145892333|NCT02696031|526111971|FG003|Up to Week 52|Protocol Violation|0|||
145892334|NCT02696031|526111972|FG004|Up to Week 52|Protocol Violation|0|||
145892335|NCT02696031|526111973|FG005|Up to Week 52|Protocol Violation|0|||
145892336|NCT02696031|526111968|FG000|Up to Week 52|Withdrawal by Subject|12|||
145892337|NCT02696031|526111969|FG001|Up to Week 52|Withdrawal by Subject|3|||
145892338|NCT02696031|526111970|FG002|Up to Week 52|Withdrawal by Subject|9|||
145892339|NCT02696031|526111971|FG003|Up to Week 52|Withdrawal by Subject|0|||
145892340|NCT02696031|526111972|FG004|Up to Week 52|Withdrawal by Subject|0|||
145892341|NCT02696031|526111973|FG005|Up to Week 52|Withdrawal by Subject|0|||
145892342|NCT02696031|526111968|FG000|Up to Week 104|Pregnancy|0|||
145892343|NCT02696031|526111969|FG001|Up to Week 104|Pregnancy|2|||
145892344|NCT02696031|526111970|FG002|Up to Week 104|Pregnancy|1|||
145892345|NCT02696031|526111971|FG003|Up to Week 104|Pregnancy|0|||
145892346|NCT02696031|526111972|FG004|Up to Week 104|Pregnancy|0|||
145892347|NCT02696031|526111973|FG005|Up to Week 104|Pregnancy|0|||
145892348|NCT02696031|526111968|FG000|Up to Week 104|Withdrawal by Subject|15|||
145892349|NCT02696031|526111969|FG001|Up to Week 104|Withdrawal by Subject|10|||
145892350|NCT02696031|526111970|FG002|Up to Week 104|Withdrawal by Subject|16|||
145892351|NCT02696031|526111971|FG003|Up to Week 104|Withdrawal by Subject|0|||
145892352|NCT02696031|526111972|FG004|Up to Week 104|Withdrawal by Subject|0|||
145892353|NCT02696031|526111973|FG005|Up to Week 104|Withdrawal by Subject|0|||
145892354|NCT02696031|526111968|FG000|Up to Week 104|Protocol Violation|1|||
145892355|NCT02696031|526111969|FG001|Up to Week 104|Protocol Violation|0|||
145892356|NCT02696031|526111970|FG002|Up to Week 104|Protocol Violation|0|||
145892357|NCT02696031|526111971|FG003|Up to Week 104|Protocol Violation|0|||
145892358|NCT02696031|526111972|FG004|Up to Week 104|Protocol Violation|0|||
145892359|NCT02696031|526111973|FG005|Up to Week 104|Protocol Violation|0|||
145892360|NCT02696031|526111968|FG000|Up to Week 104|Physician Decision|1|||
145892361|NCT02696031|526111969|FG001|Up to Week 104|Physician Decision|2|||
145892362|NCT02696031|526111970|FG002|Up to Week 104|Physician Decision|3|||
145892363|NCT02696031|526111971|FG003|Up to Week 104|Physician Decision|0|||
145892364|NCT02696031|526111972|FG004|Up to Week 104|Physician Decision|0|||
145892365|NCT02696031|526111973|FG005|Up to Week 104|Physician Decision|0|||
145892366|NCT02696031|526111968|FG000|Up to Week 104|Lost to Follow-up|2|||
145892367|NCT02696031|526111969|FG001|Up to Week 104|Lost to Follow-up|3|||
145892368|NCT02696031|526111970|FG002|Up to Week 104|Lost to Follow-up|1|||
145892369|NCT02696031|526111971|FG003|Up to Week 104|Lost to Follow-up|0|||
145892370|NCT02696031|526111972|FG004|Up to Week 104|Lost to Follow-up|0|||
145892371|NCT02696031|526111973|FG005|Up to Week 104|Lost to Follow-up|0|||
145892372|NCT02696031|526111968|FG000|Up to Week 104|Lack of Efficacy|13|||
145892373|NCT02696031|526111969|FG001|Up to Week 104|Lack of Efficacy|12|||
145892374|NCT02696031|526111970|FG002|Up to Week 104|Lack of Efficacy|11|||
145892375|NCT02696031|526111971|FG003|Up to Week 104|Lack of Efficacy|0|||
145892376|NCT02696031|526111972|FG004|Up to Week 104|Lack of Efficacy|0|||
145892377|NCT02696031|526111973|FG005|Up to Week 104|Lack of Efficacy|0|||
145892378|NCT02696031|526111968|FG000|Up to Week 104|Adverse Event|7|||
145892379|NCT02696031|526111969|FG001|Up to Week 104|Adverse Event|11|||
145892380|NCT02696031|526111970|FG002|Up to Week 104|Adverse Event|5|||
145892381|NCT02696031|526111971|FG003|Up to Week 104|Adverse Event|0|||
145892382|NCT02696031|526111972|FG004|Up to Week 104|Adverse Event|0|||
145892383|NCT02696031|526111973|FG005|Up to Week 104|Adverse Event|0|||
145892384|NCT02696031|526111968|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145892385|NCT02696031|526111969|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
145892386|NCT02696031|526111970|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145892387|NCT02696031|526111971|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145892388|NCT02696031|526111972|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145892389|NCT02696031|526111973|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145892390|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145892391|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145892392|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145892393|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
145892394|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
145892395|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
145892396|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145892397|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145892398|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145892399|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
145892400|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
145892401|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145892402|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145892403|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145892404|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145892405|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
145892406|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145892407|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145892408|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145892409|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145892410|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145892411|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145892412|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
145892413|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145892414|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145892415|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145892416|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145892417|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
145892418|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
145892419|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
145892420|NCT02696031|526111968|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145892421|NCT02696031|526111969|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145892422|NCT02696031|526111970|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145892423|NCT02696031|526111971|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
145892424|NCT02696031|526111972|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
145892425|NCT02696031|526111973|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
145892426|NCT00597116|526111974|FG000|Overall Study|Adverse Event|2|||
145892427|NCT00597116|526111975|FG001|Overall Study|Adverse Event|1|||
145892428|NCT00597116|526111974|FG000|Overall Study|Withdrawal by Subject|0|||
145892429|NCT00597116|526111975|FG001|Overall Study|Withdrawal by Subject|2|||
145892430|NCT00597116|526111974|FG000|Overall Study|Physician Decision|0|||
145892431|NCT00597116|526111975|FG001|Overall Study|Physician Decision|1|||
145892432|NCT00597116|526111974|FG000|Overall Study|Death|0|||
145892433|NCT00597116|526111975|FG001|Overall Study|Death|1|||
145892434|NCT00597116|526111974|FG000|Overall Study|Lost to Follow-up|1|||
145892435|NCT00597116|526111975|FG001|Overall Study|Lost to Follow-up|0|||
145892436|NCT00597116|526111974|FG000|Overall Study|Progressive disease|11|||
145892437|NCT00597116|526111975|FG001|Overall Study|Progressive disease|6|||
145892438|NCT02903238|526111979|FG000|Overall Study|Lost to Follow-up|4|||
145892439|NCT00700817|526111984|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
145892440|NCT00700817|526111985|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
145892441|NCT00700817|526111986|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
145892442|NCT00700817|526111987|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
145892443|NCT00700817|526111988|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
145892444|NCT00700817|526111984|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
145892445|NCT00700817|526111985|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145892446|NCT00700817|526111986|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
145892447|NCT00700817|526111987|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145892448|NCT00700817|526111988|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145892449|NCT00700817|526111984|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
145892450|NCT00700817|526111985|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
145892451|NCT00700817|526111986|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
145892452|NCT00700817|526111987|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
145892453|NCT00700817|526111988|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
145892454|NCT00700817|526111984|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
145892455|NCT00700817|526111985|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
145892456|NCT00700817|526111986|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
145892457|NCT00700817|526111987|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
145892458|NCT00700817|526111988|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
145892459|NCT00700817|526111984|FG000|Week 0-26 (Main Period)|Unclassified|14|||
145892460|NCT00700817|526111985|FG001|Week 0-26 (Main Period)|Unclassified|4|||
145892461|NCT00700817|526111986|FG002|Week 0-26 (Main Period)|Unclassified|8|||
145892462|NCT00700817|526111987|FG003|Week 0-26 (Main Period)|Unclassified|0|||
145892463|NCT00700817|526111988|FG004|Week 0-26 (Main Period)|Unclassified|0|||
145892464|NCT00700817|526111984|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
145892465|NCT00700817|526111985|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
145892466|NCT00700817|526111986|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
145892467|NCT00700817|526111987|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
145892468|NCT00700817|526111988|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
145892469|NCT00700817|526111984|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
145892470|NCT00700817|526111985|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
145892471|NCT00700817|526111986|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
146295548|NCT04796896|527597617|FG011|Overall Study|Lost to Follow-up|18|||
145892472|NCT00700817|526111987|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
145892473|NCT00700817|526111988|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
145892474|NCT00700817|526111984|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
146295549|NCT04796896|527597606|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
146295550|NCT04796896|527597607|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
146295551|NCT04796896|527597608|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
146295552|NCT04796896|527597609|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
146295553|NCT04796896|527597610|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
146295554|NCT04796896|527597611|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
146295555|NCT04796896|527597612|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
146295556|NCT04796896|527597613|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
146295557|NCT04796896|527597614|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
146295558|NCT04796896|527597615|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
146295559|NCT04796896|527597616|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
146295560|NCT04796896|527597617|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
146295561|NCT04796896|527597606|FG000|Overall Study|Physician Decision|1|||
146295562|NCT04796896|527597607|FG001|Overall Study|Physician Decision|0|||
146295563|NCT04796896|527597608|FG002|Overall Study|Physician Decision|0|||
146295564|NCT04796896|527597609|FG003|Overall Study|Physician Decision|0|||
146295565|NCT04796896|527597610|FG004|Overall Study|Physician Decision|0|||
146295566|NCT04796896|527597611|FG005|Overall Study|Physician Decision|3|||
146295567|NCT04796896|527597612|FG006|Overall Study|Physician Decision|18|||
146295568|NCT04796896|527597613|FG007|Overall Study|Physician Decision|1|||
146295569|NCT04796896|527597614|FG008|Overall Study|Physician Decision|7|||
146295570|NCT04796896|527597615|FG009|Overall Study|Physician Decision|0|||
146295571|NCT04796896|527597616|FG010|Overall Study|Physician Decision|5|||
146295572|NCT04796896|527597617|FG011|Overall Study|Physician Decision|0|||
146295573|NCT04796896|527597606|FG000|Overall Study|Withdrawal by Subject|36|||
146295574|NCT04796896|527597607|FG001|Overall Study|Withdrawal by Subject|31|||
146295575|NCT04796896|527597608|FG002|Overall Study|Withdrawal by Subject|11|||
146295576|NCT04796896|527597609|FG003|Overall Study|Withdrawal by Subject|8|||
146295577|NCT04796896|527597610|FG004|Overall Study|Withdrawal by Subject|16|||
146295578|NCT04796896|527597611|FG005|Overall Study|Withdrawal by Subject|162|||
146295579|NCT04796896|527597612|FG006|Overall Study|Withdrawal by Subject|299|||
146295580|NCT04796896|527597613|FG007|Overall Study|Withdrawal by Subject|149|||
146295581|NCT04796896|527597614|FG008|Overall Study|Withdrawal by Subject|303|||
146295582|NCT04796896|527597615|FG009|Overall Study|Withdrawal by Subject|94|||
146295583|NCT04796896|527597616|FG010|Overall Study|Withdrawal by Subject|192|||
146295584|NCT04796896|527597617|FG011|Overall Study|Withdrawal by Subject|16|||
146295585|NCT04796896|527597606|FG000|Overall Study|Other Than Specified|6|||
146295586|NCT04796896|527597607|FG001|Overall Study|Other Than Specified|5|||
146295587|NCT04796896|527597608|FG002|Overall Study|Other Than Specified|3|||
146295588|NCT04796896|527597609|FG003|Overall Study|Other Than Specified|2|||
146295589|NCT04796896|527597610|FG004|Overall Study|Other Than Specified|6|||
146295590|NCT04796896|527597611|FG005|Overall Study|Other Than Specified|31|||
146295591|NCT04796896|527597612|FG006|Overall Study|Other Than Specified|86|||
146295592|NCT04796896|527597613|FG007|Overall Study|Other Than Specified|66|||
146295593|NCT04796896|527597614|FG008|Overall Study|Other Than Specified|388|||
146295594|NCT04796896|527597615|FG009|Overall Study|Other Than Specified|48|||
145892475|NCT00700817|526111985|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
145892476|NCT00700817|526111986|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
145892477|NCT00700817|526111987|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
145892478|NCT00700817|526111988|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
145892479|NCT00700817|526111984|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
145892480|NCT00700817|526111985|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
146295595|NCT04796896|527597616|FG010|Overall Study|Other Than Specified|258|||
146295596|NCT04796896|527597617|FG011|Overall Study|Other Than Specified|4|||
145892481|NCT00700817|526111986|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
145892482|NCT00700817|526111987|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
145892483|NCT00700817|526111988|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
145892484|NCT00700817|526111984|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
145971233|NCT00855582|526408781|FG001|Overall Study|Adverse Event|6|||
145971234|NCT00855582|526408782|FG002|Overall Study|Adverse Event|3|||
145971235|NCT00855582|526408780|FG000|Overall Study|Death|1|||
145971236|NCT00855582|526408781|FG001|Overall Study|Death|0|||
145971237|NCT00855582|526408782|FG002|Overall Study|Death|0|||
145971238|NCT00855582|526408780|FG000|Overall Study|Lack of Efficacy|1|||
145971239|NCT00855582|526408781|FG001|Overall Study|Lack of Efficacy|3|||
145971240|NCT00855582|526408782|FG002|Overall Study|Lack of Efficacy|8|||
146088138|NCT01986933|526841962|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
146295597|NCT04796896|527597606|FG000|Overall Study|Protocol Deviation|0|||
145971241|NCT00855582|526408780|FG000|Overall Study|Lost to Follow-up|1|||
146088139|NCT01986933|526841963|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
145971242|NCT00855582|526408781|FG001|Overall Study|Lost to Follow-up|3|||
145971243|NCT00855582|526408782|FG002|Overall Study|Lost to Follow-up|1|||
145971244|NCT00855582|526408780|FG000|Overall Study|Physician Decision|0|||
145892485|NCT00700817|526111985|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
145892486|NCT00700817|526111986|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
145892487|NCT00700817|526111987|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
145892488|NCT00700817|526111988|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
145892489|NCT00700817|526111984|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145892490|NCT00700817|526111985|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
145892491|NCT00700817|526111986|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145892492|NCT00700817|526111987|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
145892493|NCT00700817|526111988|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145892494|NCT00700817|526111984|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145892495|NCT00700817|526111985|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
145892496|NCT00700817|526111986|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
145892497|NCT00700817|526111987|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145892498|NCT00700817|526111988|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145892499|NCT00700817|526111984|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
145892500|NCT00700817|526111985|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
145892501|NCT00700817|526111986|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145892502|NCT00700817|526111987|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145892503|NCT00700817|526111988|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145892504|NCT00700817|526111984|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
145892505|NCT00700817|526111985|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
145892506|NCT00700817|526111986|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
145892507|NCT00700817|526111987|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
145892508|NCT00700817|526111988|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
145892509|NCT00700817|526111984|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
145892510|NCT00700817|526111985|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
145892511|NCT00700817|526111986|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
145892512|NCT00700817|526111987|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
145892513|NCT00700817|526111988|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
145892514|NCT02777918|526111991|FG000|Overall Study|Medical reasons|1|||
145892515|NCT02777918|526111992|FG001|Overall Study|Medical reasons|2|||
145892516|NCT02777918|526111991|FG000|Overall Study|Too busy / stressed|1|||
145892517|NCT02777918|526111992|FG001|Overall Study|Too busy / stressed|1|||
145892518|NCT02777918|526111991|FG000|Overall Study|Withdrawal by Subject|1|||
145892519|NCT02777918|526111992|FG001|Overall Study|Withdrawal by Subject|1|||
145892520|NCT00757848|526111993|FG000|Overall Study|Voluntary discontinuation|1|||
145892521|NCT00757848|526111994|FG001|Overall Study|Voluntary discontinuation|0|||
146236306|NCT03451422|527381036|FG004|Overall Study|Lost to Follow-up|0|||
146236307|NCT03451422|527381037|FG005|Overall Study|Lost to Follow-up|1|||
146236308|NCT03451422|527381032|FG000|Overall Study|Decision by sponsor|1|||
146236309|NCT03451422|527381033|FG001|Overall Study|Decision by sponsor|0|||
146236310|NCT03451422|527381034|FG002|Overall Study|Decision by sponsor|1|||
146236311|NCT03451422|527381035|FG003|Overall Study|Decision by sponsor|0|||
146236312|NCT03451422|527381036|FG004|Overall Study|Decision by sponsor|0|||
146236313|NCT03451422|527381037|FG005|Overall Study|Decision by sponsor|0|||
146236314|NCT03451422|527381032|FG000|Overall Study|Withdrawal by Subject|0|||
146236315|NCT03451422|527381033|FG001|Overall Study|Withdrawal by Subject|0|||
146236316|NCT03451422|527381034|FG002|Overall Study|Withdrawal by Subject|2|||
146236317|NCT03451422|527381035|FG003|Overall Study|Withdrawal by Subject|3|||
146295598|NCT04796896|527597607|FG001|Overall Study|Protocol Deviation|0|||
145971245|NCT00855582|526408781|FG001|Overall Study|Physician Decision|0|||
145971246|NCT00855582|526408782|FG002|Overall Study|Physician Decision|1|||
145971247|NCT00855582|526408780|FG000|Overall Study|Protocol Violation|6|||
145971248|NCT00855582|526408781|FG001|Overall Study|Protocol Violation|2|||
145971249|NCT00855582|526408782|FG002|Overall Study|Protocol Violation|6|||
145971250|NCT00855582|526408780|FG000|Overall Study|Entry Criteria Not Met|8|||
145971251|NCT00855582|526408781|FG001|Overall Study|Entry Criteria Not Met|6|||
145971252|NCT00855582|526408782|FG002|Overall Study|Entry Criteria Not Met|3|||
145971253|NCT00855582|526408780|FG000|Overall Study|Withdrawal by Subject|7|||
146088140|NCT01986933|526841959|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
145971254|NCT00855582|526408781|FG001|Overall Study|Withdrawal by Subject|4|||
145971255|NCT00855582|526408782|FG002|Overall Study|Withdrawal by Subject|8|||
145971256|NCT03286504|526408791|FG000|Overall Study|Lost to Follow-up|19|||
145971257|NCT03286504|526408792|FG001|Overall Study|Lost to Follow-up|16|||
145971258|NCT02030600|526408793|FG000|Treatment Period 1|Adverse Event|5|||
146088141|NCT01986933|526841960|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
145892522|NCT00757848|526111993|FG000|Overall Study|Adverse Event|1|||
145892523|NCT00757848|526111994|FG001|Overall Study|Adverse Event|2|||
145971259|NCT02030600|526408794|FG001|Treatment Period 1|Adverse Event|7|||
145971260|NCT02030600|526408793|FG000|Treatment Period 1|Lack of Efficacy|0|||
145971261|NCT02030600|526408794|FG001|Treatment Period 1|Lack of Efficacy|1|||
145971262|NCT02030600|526408793|FG000|Treatment Period 1|Lost to Follow-up|11|||
146236318|NCT03451422|527381036|FG004|Overall Study|Withdrawal by Subject|2|||
146236319|NCT03451422|527381037|FG005|Overall Study|Withdrawal by Subject|1|||
146236320|NCT00918333|527381038|FG000|Overall Study|Drug not taken per protocol|1|||
146236321|NCT00918333|527381039|FG001|Overall Study|Drug not taken per protocol|0|||
146236322|NCT00918333|527381038|FG000|Overall Study|Inadequate amount of drugs provided|1|||
146236323|NCT00918333|527381039|FG001|Overall Study|Inadequate amount of drugs provided|4|||
146236324|NCT00918333|527381038|FG000|Overall Study|Ineligible|1|||
146236325|NCT00918333|527381039|FG001|Overall Study|Ineligible|0|||
146236326|NCT00918333|527381038|FG000|Overall Study|Withdrawal by Subject|0|||
146236327|NCT00918333|527381039|FG001|Overall Study|Withdrawal by Subject|1|||
146236328|NCT00263757|527381040|FG000|Overall Study|Withdrawal by Subject|5|||
146236329|NCT00263757|527381041|FG001|Overall Study|Withdrawal by Subject|4|||
146236330|NCT00263757|527381040|FG000|Overall Study|Screen failure|0|||
146236331|NCT00263757|527381041|FG001|Overall Study|Screen failure|1|||
146236332|NCT00263757|527381040|FG000|Overall Study|Adverse Event|3|||
146236333|NCT00263757|527381041|FG001|Overall Study|Adverse Event|3|||
146236334|NCT04384172|527381042|FG000|Overall Study|Lost to Follow-up|0|||
146236335|NCT04384172|527381043|FG001|Overall Study|Lost to Follow-up|2|||
146236336|NCT04384172|527381042|FG000|Overall Study|Pregnancy|1|||
146236337|NCT04384172|527381043|FG001|Overall Study|Pregnancy|0|||
146236338|NCT04384172|527381042|FG000|Overall Study|Withdrawal by Subject|0|||
146236339|NCT04384172|527381043|FG001|Overall Study|Withdrawal by Subject|1|||
146236340|NCT01759862|527381044|FG000|Overall Study|Physician Decision|3|||
146236341|NCT01759862|527381045|FG001|Overall Study|Physician Decision|1|||
146236342|NCT01759862|527381044|FG000|Overall Study|Adverse Event|0|||
146236343|NCT01759862|527381045|FG001|Overall Study|Adverse Event|1|||
146236344|NCT03631407|527381046|FG000|Overall Study|Withdrawal by Subject|3|||
146236345|NCT03631407|527381047|FG001|Overall Study|Withdrawal by Subject|2|||
146236346|NCT03631407|527381046|FG000|Overall Study|Sponsor Decision|0|||
146236347|NCT03631407|527381047|FG001|Overall Study|Sponsor Decision|2|||
146236348|NCT03631407|527381046|FG000|Overall Study|Death|16|||
146236349|NCT03631407|527381047|FG001|Overall Study|Death|16|||
146236350|NCT03631407|527381046|FG000|Overall Study|Randomized by mistake without study treatment|1|||
146236351|NCT03631407|527381047|FG001|Overall Study|Randomized by mistake without study treatment|0|||
146236352|NCT01437319|527381048|FG000|Phase I|Lost to Follow-up|2|||
146236353|NCT01437319|527381049|FG001|Phase I|Lost to Follow-up|0|||
146236354|NCT01437319|527381050|FG002|Phase I|Lost to Follow-up|0|||
146236355|NCT01437319|527381048|FG000|Phase I|Protocol Violation|1|||
146236356|NCT01437319|527381049|FG001|Phase I|Protocol Violation|0|||
146236357|NCT01437319|527381050|FG002|Phase I|Protocol Violation|0|||
146236358|NCT01437319|527381048|FG000|Phase I|Study related symptoms/complaints|27|||
146236359|NCT01437319|527381049|FG001|Phase I|Study related symptoms/complaints|0|||
146236360|NCT01437319|527381050|FG002|Phase I|Study related symptoms/complaints|0|||
146236361|NCT01437319|527381048|FG000|Phase I|Withdrawal by Subject|25|||
146236362|NCT01437319|527381049|FG001|Phase I|Withdrawal by Subject|0|||
146236363|NCT01437319|527381050|FG002|Phase I|Withdrawal by Subject|0|||
146236364|NCT01437319|527381048|FG000|Phase II|Withdrawal by Subject|0|||
146236365|NCT01437319|527381049|FG001|Phase II|Withdrawal by Subject|8|||
146236366|NCT01437319|527381050|FG002|Phase II|Withdrawal by Subject|16|||
146236367|NCT01437319|527381048|FG000|Phase II|Lost to Follow-up|0|||
146236368|NCT01437319|527381049|FG001|Phase II|Lost to Follow-up|7|||
146236369|NCT01437319|527381050|FG002|Phase II|Lost to Follow-up|2|||
146236370|NCT01437319|527381048|FG000|Phase II|Study related symptoms/complaints|0|||
146236371|NCT01437319|527381049|FG001|Phase II|Study related symptoms/complaints|28|||
146236372|NCT01437319|527381050|FG002|Phase II|Study related symptoms/complaints|19|||
146236373|NCT01437319|527381048|FG000|Phase II|Protocol Violation|0|||
146236374|NCT01437319|527381049|FG001|Phase II|Protocol Violation|1|||
146295599|NCT04796896|527597608|FG002|Overall Study|Protocol Deviation|0|||
146295600|NCT04796896|527597609|FG003|Overall Study|Protocol Deviation|1|||
146295601|NCT04796896|527597610|FG004|Overall Study|Protocol Deviation|1|||
145892524|NCT00757848|526111993|FG000|Overall Study|Incorrect enrolment|1|||
145892525|NCT00757848|526111994|FG001|Overall Study|Incorrect enrolment|0|||
145892526|NCT00058214|526111997|FG000|Overall Study|Adverse Event|1|||
145892527|NCT01949116|526112004|FG000|Overall Study|Death|2|||
145892528|NCT01949116|526112005|FG001|Overall Study|Death|0|||
145892529|NCT01949116|526112004|FG000|Overall Study|Lost to Follow-up|1|||
145892530|NCT01949116|526112005|FG001|Overall Study|Lost to Follow-up|3|||
145892531|NCT01949116|526112004|FG000|Overall Study|Withdrawal by Subject|5|||
145892532|NCT01949116|526112005|FG001|Overall Study|Withdrawal by Subject|3|||
145892533|NCT02556307|526112006|FG000|Overall Study|Premature treatment interruption|11|||
146236375|NCT01437319|527381050|FG002|Phase II|Protocol Violation|0|||
146236376|NCT00983294|527381051|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
146236377|NCT00983294|527381051|FG000|Colchicine With Azithromycin|Adverse Event|1|||
146236378|NCT03473743|527381052|FG000|Overall Study|Withdrawal by Subject|0|||
146295602|NCT04796896|527597611|FG005|Overall Study|Protocol Deviation|2|||
146295603|NCT04796896|527597612|FG006|Overall Study|Protocol Deviation|2|||
146236379|NCT03473743|527381053|FG001|Overall Study|Withdrawal by Subject|0|||
146236380|NCT03473743|527381054|FG002|Overall Study|Withdrawal by Subject|0|||
146236381|NCT03473743|527381055|FG003|Overall Study|Withdrawal by Subject|0|||
146236382|NCT03473743|527381056|FG004|Overall Study|Withdrawal by Subject|0|||
146295604|NCT04796896|527597613|FG007|Overall Study|Protocol Deviation|2|||
145892534|NCT02556307|526112006|FG000|Overall Study|Lost to Follow-up|36|||
145892535|NCT02556307|526112006|FG000|Overall Study|Change to triple therapy|4|||
145892536|NCT02556307|526112006|FG000|Overall Study|Enrolled but not treated|2|||
145892537|NCT02039414|526112015|FG000|Overall Study|Delivered|1|||
145892538|NCT02039414|526112016|FG001|Overall Study|Delivered|1|||
145892539|NCT02039414|526112015|FG000|Overall Study|Lost to Follow-up|2|||
145892540|NCT02039414|526112016|FG001|Overall Study|Lost to Follow-up|0|||
145892541|NCT02039414|526112015|FG000|Overall Study|Protocol Violation|3|||
145892542|NCT02039414|526112016|FG001|Overall Study|Protocol Violation|1|||
145892543|NCT04440449|526113387|FG000|Overall Study|Lost to Follow-up|2|||
145892544|NCT04440449|526113388|FG001|Overall Study|Lost to Follow-up|0|||
145892545|NCT05420012|526113392|FG000|Overall Study|Lost to Follow-up|0|||
145892546|NCT05420012|526113393|FG001|Overall Study|Lost to Follow-up|1|||
145892547|NCT03253744|526113395|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
145892548|NCT03253744|526113396|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
145892549|NCT03253744|526113397|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
145892550|NCT03253744|526113398|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
145892551|NCT03856593|526113401|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
145892552|NCT03856593|526113402|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
145892553|NCT01901874|526113403|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
145892554|NCT01901874|526113403|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
145892555|NCT01901874|526113403|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
145892556|NCT01901874|526113403|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
145892557|NCT01901874|526113403|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
145892558|NCT01901874|526113403|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
145892559|NCT03832738|526113410|FG000|Overall Study|Withdrawal by Subject|6|||
145892560|NCT03832738|526113411|FG001|Overall Study|Withdrawal by Subject|7|||
145892561|NCT03832738|526113412|FG002|Overall Study|Withdrawal by Subject|16|||
145892562|NCT03832738|526113410|FG000|Overall Study|Physician Decision|0|||
145892563|NCT03832738|526113411|FG001|Overall Study|Physician Decision|1|||
145892564|NCT03832738|526113412|FG002|Overall Study|Physician Decision|2|||
145892565|NCT03832738|526113410|FG000|Overall Study|Adverse Event|2|||
145892566|NCT03832738|526113411|FG001|Overall Study|Adverse Event|3|||
145892567|NCT03832738|526113412|FG002|Overall Study|Adverse Event|1|||
145892568|NCT03832738|526113410|FG000|Overall Study|Pregnancy|0|||
145892569|NCT03832738|526113411|FG001|Overall Study|Pregnancy|1|||
145892570|NCT03832738|526113412|FG002|Overall Study|Pregnancy|0|||
145892571|NCT03852459|526113415|FG000|Overall Study|Adverse Event|2|||
145892572|NCT03852459|526113416|FG001|Overall Study|Adverse Event|2|||
145892573|NCT03852459|526113415|FG000|Overall Study|Withdrawal by Subject|1|||
145892574|NCT03852459|526113416|FG001|Overall Study|Withdrawal by Subject|1|||
145892575|NCT00049842|526113417|FG000|Treatment Phase|Adverse Event|47|||
145892576|NCT00049842|526113418|FG001|Treatment Phase|Adverse Event|12|||
145892577|NCT00049842|526113417|FG000|Treatment Phase|Withdrawal by Subject|35|||
145892578|NCT00049842|526113418|FG001|Treatment Phase|Withdrawal by Subject|46|||
145892579|NCT00049842|526113417|FG000|Treatment Phase|Non-compliance with protocol|7|||
145892580|NCT00049842|526113418|FG001|Treatment Phase|Non-compliance with protocol|8|||
145892581|NCT00049842|526113417|FG000|Treatment Phase|Lost to Follow-up|4|||
145892582|NCT00049842|526113418|FG001|Treatment Phase|Lost to Follow-up|8|||
145892583|NCT00049842|526113417|FG000|Treatment Phase|Administrative|0|||
145892584|NCT00049842|526113418|FG001|Treatment Phase|Administrative|3|||
145892585|NCT00049842|526113417|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
145892586|NCT00049842|526113418|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
145892587|NCT00049842|526113417|FG000|Follow-up Phase|Adverse Event|6|||
145892588|NCT00049842|526113418|FG001|Follow-up Phase|Adverse Event|1|||
145892589|NCT00049842|526113417|FG000|Follow-up Phase|Other|1|||
145892590|NCT00049842|526113418|FG001|Follow-up Phase|Other|4|||
145892591|NCT03977701|526113419|FG000|Overall Study|COVID-19 pandemic|0|||
145892592|NCT03977701|526113420|FG001|Overall Study|COVID-19 pandemic|0|||
145892593|NCT03977701|526113421|FG002|Overall Study|COVID-19 pandemic|0|||
145892594|NCT03977701|526113422|FG003|Overall Study|COVID-19 pandemic|0|||
145892595|NCT03977701|526113423|FG004|Overall Study|COVID-19 pandemic|0|||
145892596|NCT03977701|526113424|FG005|Overall Study|COVID-19 pandemic|1|||
145892597|NCT03977701|526113425|FG006|Overall Study|COVID-19 pandemic|0|||
145892598|NCT03977701|526113426|FG007|Overall Study|COVID-19 pandemic|1|||
145892599|NCT03977701|526113427|FG008|Overall Study|COVID-19 pandemic|0|||
145892600|NCT03977701|526113428|FG009|Overall Study|COVID-19 pandemic|0|||
145892601|NCT01347866|526113429|FG000|Overall Study|Death|0|||
145892602|NCT01347866|526113430|FG001|Overall Study|Death|0|||
145892603|NCT01347866|526113431|FG002|Overall Study|Death|0|||
145892604|NCT01347866|526113432|FG003|Overall Study|Death|1|||
145892605|NCT01347866|526113433|FG004|Overall Study|Death|2|||
145892606|NCT01347866|526113434|FG005|Overall Study|Death|2|||
145892607|NCT01347866|526113435|FG006|Overall Study|Death|1|||
145892608|NCT01347866|526113436|FG007|Overall Study|Death|0|||
145892609|NCT01347866|526113437|FG008|Overall Study|Death|4|||
145892610|NCT01347866|526113438|FG009|Overall Study|Death|1|||
145892611|NCT01347866|526113439|FG010|Overall Study|Death|3|||
145892612|NCT01347866|526113440|FG011|Overall Study|Death|1|||
145892613|NCT01347866|526113441|FG012|Overall Study|Death|2|||
145892614|NCT01347866|526113442|FG013|Overall Study|Death|0|||
145892615|NCT01347866|526113443|FG014|Overall Study|Death|0|||
145892616|NCT01347866|526113444|FG015|Overall Study|Death|1|||
145892617|NCT01347866|526113445|FG016|Overall Study|Death|0|||
145892618|NCT01347866|526113429|FG000|Overall Study|Lost to Follow-up|0|||
145892619|NCT01347866|526113430|FG001|Overall Study|Lost to Follow-up|0|||
145892620|NCT01347866|526113431|FG002|Overall Study|Lost to Follow-up|0|||
145892621|NCT01347866|526113432|FG003|Overall Study|Lost to Follow-up|0|||
145892622|NCT01347866|526113433|FG004|Overall Study|Lost to Follow-up|0|||
145892623|NCT01347866|526113434|FG005|Overall Study|Lost to Follow-up|0|||
145892624|NCT01347866|526113435|FG006|Overall Study|Lost to Follow-up|0|||
145892625|NCT01347866|526113436|FG007|Overall Study|Lost to Follow-up|1|||
145892626|NCT01347866|526113437|FG008|Overall Study|Lost to Follow-up|1|||
145892627|NCT01347866|526113438|FG009|Overall Study|Lost to Follow-up|0|||
145892628|NCT01347866|526113439|FG010|Overall Study|Lost to Follow-up|0|||
145892629|NCT01347866|526113440|FG011|Overall Study|Lost to Follow-up|0|||
145892630|NCT01347866|526113441|FG012|Overall Study|Lost to Follow-up|0|||
145892631|NCT01347866|526113442|FG013|Overall Study|Lost to Follow-up|0|||
145892632|NCT01347866|526113443|FG014|Overall Study|Lost to Follow-up|0|||
145892633|NCT01347866|526113444|FG015|Overall Study|Lost to Follow-up|0|||
145892634|NCT01347866|526113445|FG016|Overall Study|Lost to Follow-up|0|||
145892635|NCT01347866|526113429|FG000|Overall Study|Other|3|||
145892636|NCT01347866|526113430|FG001|Overall Study|Other|1|||
145892637|NCT01347866|526113431|FG002|Overall Study|Other|1|||
145892638|NCT01347866|526113432|FG003|Overall Study|Other|4|||
145892639|NCT01347866|526113433|FG004|Overall Study|Other|5|||
145892640|NCT01347866|526113434|FG005|Overall Study|Other|0|||
145892641|NCT01347866|526113435|FG006|Overall Study|Other|5|||
145892642|NCT01347866|526113436|FG007|Overall Study|Other|3|||
145892643|NCT01347866|526113437|FG008|Overall Study|Other|22|||
145892644|NCT01347866|526113438|FG009|Overall Study|Other|5|||
145892645|NCT01347866|526113439|FG010|Overall Study|Other|0|||
145892646|NCT01347866|526113440|FG011|Overall Study|Other|3|||
145892647|NCT01347866|526113441|FG012|Overall Study|Other|4|||
145892648|NCT01347866|526113442|FG013|Overall Study|Other|4|||
145892649|NCT01347866|526113443|FG014|Overall Study|Other|2|||
145892650|NCT01347866|526113444|FG015|Overall Study|Other|3|||
145892651|NCT01347866|526113445|FG016|Overall Study|Other|0|||
145892652|NCT01347866|526113429|FG000|Overall Study|Subject refused further follow-up|2|||
145892653|NCT01347866|526113430|FG001|Overall Study|Subject refused further follow-up|0|||
145892654|NCT01347866|526113431|FG002|Overall Study|Subject refused further follow-up|0|||
145892655|NCT01347866|526113432|FG003|Overall Study|Subject refused further follow-up|2|||
145892656|NCT01347866|526113433|FG004|Overall Study|Subject refused further follow-up|0|||
145892657|NCT01347866|526113434|FG005|Overall Study|Subject refused further follow-up|1|||
145892658|NCT01347866|526113435|FG006|Overall Study|Subject refused further follow-up|0|||
145892659|NCT01347866|526113436|FG007|Overall Study|Subject refused further follow-up|0|||
145892660|NCT01347866|526113437|FG008|Overall Study|Subject refused further follow-up|4|||
145892661|NCT01347866|526113438|FG009|Overall Study|Subject refused further follow-up|1|||
145892662|NCT01347866|526113439|FG010|Overall Study|Subject refused further follow-up|0|||
145892663|NCT01347866|526113440|FG011|Overall Study|Subject refused further follow-up|0|||
145892664|NCT01347866|526113441|FG012|Overall Study|Subject refused further follow-up|1|||
145892665|NCT01347866|526113442|FG013|Overall Study|Subject refused further follow-up|3|||
145892666|NCT01347866|526113443|FG014|Overall Study|Subject refused further follow-up|1|||
145892667|NCT01347866|526113444|FG015|Overall Study|Subject refused further follow-up|0|||
145892668|NCT01347866|526113445|FG016|Overall Study|Subject refused further follow-up|2|||
145971263|NCT02030600|526408794|FG001|Treatment Period 1|Lost to Follow-up|3|||
145971264|NCT02030600|526408793|FG000|Treatment Period 1|Protocol Violation|22|||
145971265|NCT02030600|526408794|FG001|Treatment Period 1|Protocol Violation|17|||
145971266|NCT02030600|526408793|FG000|Treatment Period 1|Withdrawal by Subject|13|||
145971267|NCT02030600|526408794|FG001|Treatment Period 1|Withdrawal by Subject|17|||
145971268|NCT02030600|526408793|FG000|Treatment Period 1|Casebook Unsigned|1|||
145892669|NCT02429934|526113446|FG000|Overall Study|Withdrawal by Subject|0|||
145892670|NCT02429934|526113447|FG001|Overall Study|Withdrawal by Subject|2|||
145892671|NCT02429934|526113446|FG000|Overall Study|Adverse Event|2|||
145892672|NCT02429934|526113447|FG001|Overall Study|Adverse Event|0|||
145892673|NCT02429934|526113446|FG000|Overall Study|Lost to Follow-up|1|||
145892674|NCT02429934|526113447|FG001|Overall Study|Lost to Follow-up|1|||
145892675|NCT02429934|526113446|FG000|Overall Study|Physician Decision|1|||
145892676|NCT02429934|526113447|FG001|Overall Study|Physician Decision|0|||
145892677|NCT00869024|526113448|FG000|Overall Study|Death|2|||
145892678|NCT00869024|526113449|FG001|Overall Study|Death|3|||
145892679|NCT00869024|526113448|FG000|Overall Study|Lost to Follow-up|0|||
145892680|NCT00869024|526113449|FG001|Overall Study|Lost to Follow-up|1|||
145971269|NCT02030600|526408794|FG001|Treatment Period 1|Casebook Unsigned|0|||
145971270|NCT02030600|526408793|FG000|Treatment Period 1|Unclassified|1|||
145971271|NCT02030600|526408794|FG001|Treatment Period 1|Unclassified|0|||
145892681|NCT00869024|526113448|FG000|Overall Study|Protocol Violation|0|||
145892682|NCT00869024|526113449|FG001|Overall Study|Protocol Violation|1|||
145892683|NCT03545191|526113457|FG000|Overall Study|Death|1|||
145892684|NCT03545191|526113458|FG001|Overall Study|Death|0|||
145892685|NCT03545191|526113459|FG002|Overall Study|Death|0|||
145892686|NCT03545191|526113457|FG000|Overall Study|Adverse Event|4|||
145892687|NCT03545191|526113458|FG001|Overall Study|Adverse Event|2|||
145892688|NCT03545191|526113459|FG002|Overall Study|Adverse Event|7|||
145892689|NCT03545191|526113457|FG000|Overall Study|Other reasons|3|||
145892690|NCT03545191|526113458|FG001|Overall Study|Other reasons|11|||
145892691|NCT03545191|526113459|FG002|Overall Study|Other reasons|8|||
145892692|NCT03545191|526113457|FG000|Overall Study|Withdrawal by Subject|13|||
145892693|NCT03545191|526113458|FG001|Overall Study|Withdrawal by Subject|10|||
145892694|NCT03545191|526113459|FG002|Overall Study|Withdrawal by Subject|12|||
145892695|NCT03545191|526113457|FG000|Overall Study|Lost to Follow-up|1|||
145892696|NCT03545191|526113458|FG001|Overall Study|Lost to Follow-up|2|||
145892697|NCT03545191|526113459|FG002|Overall Study|Lost to Follow-up|3|||
145892698|NCT02025751|526113463|FG000|Overall Study|Lost to Follow-up|1|||
145892699|NCT02025751|526113464|FG001|Overall Study|Lost to Follow-up|0|||
145892700|NCT02025751|526113463|FG000|Overall Study|Adverse Event|0|||
145892701|NCT02025751|526113464|FG001|Overall Study|Adverse Event|1|||
145892702|NCT02025751|526113463|FG000|Overall Study|Physician Decision|0|||
145892703|NCT02025751|526113464|FG001|Overall Study|Physician Decision|1|||
145892704|NCT02025751|526113463|FG000|Overall Study|Withdrawal by Subject|0|||
145892705|NCT02025751|526113464|FG001|Overall Study|Withdrawal by Subject|1|||
145892706|NCT00653991|526113465|FG000|3 Month Follow-up|Participant would not respond|150|||
145892707|NCT00653991|526113466|FG001|3 Month Follow-up|Participant would not respond|157|||
145892708|NCT00653991|526113465|FG000|6 Month Follow-up|Participant would not respond|133|||
145892709|NCT00653991|526113466|FG001|6 Month Follow-up|Participant would not respond|141|||
145892710|NCT02181296|526113467|FG000|Overall Study|Lost to Follow-up|7|||
145892711|NCT02181296|526113468|FG001|Overall Study|Lost to Follow-up|6|||
145892712|NCT02939014|526113469|FG000|Overall Study|Lost to Follow-up|1|||
145892713|NCT02939014|526113470|FG001|Overall Study|Lost to Follow-up|0|||
145892714|NCT02939014|526113469|FG000|Overall Study|Death|4|||
145892715|NCT02939014|526113470|FG001|Overall Study|Death|3|||
145892716|NCT01244061|526113473|FG000|Overall Study|Death|1|||
145892717|NCT01244061|526113474|FG001|Overall Study|Death|0|||
145892718|NCT01244061|526113473|FG000|Overall Study|Did not meet entrance criteria|1|||
145892719|NCT01244061|526113474|FG001|Overall Study|Did not meet entrance criteria|0|||
145892720|NCT01244061|526113473|FG000|Overall Study|Lack of Efficacy|1|||
145892721|NCT01244061|526113474|FG001|Overall Study|Lack of Efficacy|3|||
145892722|NCT01244061|526113473|FG000|Overall Study|Lost to Follow-up|34|||
145892723|NCT01244061|526113474|FG001|Overall Study|Lost to Follow-up|30|||
145892724|NCT01244061|526113473|FG000|Overall Study|Withdrawal by Subject|29|||
145892725|NCT01244061|526113474|FG001|Overall Study|Withdrawal by Subject|46|||
145892726|NCT01244061|526113473|FG000|Overall Study|Other|8|||
145892727|NCT01244061|526113474|FG001|Overall Study|Other|19|||
145892728|NCT01244061|526113473|FG000|Overall Study|Protocol Violation|1|||
145892729|NCT01244061|526113474|FG001|Overall Study|Protocol Violation|1|||
145892730|NCT01244061|526113473|FG000|Overall Study|Adverse Event|5|||
145892731|NCT01244061|526113474|FG001|Overall Study|Adverse Event|2|||
145892732|NCT01244061|526113473|FG000|Overall Study|Randomized but not treated|2|||
145892733|NCT01244061|526113474|FG001|Overall Study|Randomized but not treated|2|||
145892734|NCT03351231|526113477|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
145892735|NCT03351231|526113477|FG000|Combination Therapy Period|Disease progression|2|||
145892736|NCT03351231|526113477|FG000|Combination Therapy Period|Study drug toxicity|1|||
145892737|NCT03351231|526113477|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
145892738|NCT03351231|526113477|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
145892739|NCT03351231|526113477|FG000|Safety Follow-Up Period|Other reason|2|||
145892740|NCT02340221|526113482|FG000|Overall Study|Death|100|||
145892741|NCT02340221|526113483|FG001|Overall Study|Death|197|||
145892742|NCT02340221|526113482|FG000|Overall Study|Withdrawal by Participant|24|||
145892743|NCT02340221|526113483|FG001|Overall Study|Withdrawal by Participant|37|||
145892744|NCT02340221|526113482|FG000|Overall Study|Lost to Follow-up|4|||
145892745|NCT02340221|526113483|FG001|Overall Study|Lost to Follow-up|15|||
145892746|NCT02340221|526113482|FG000|Overall Study|Reason Not Specified|85|||
145892747|NCT02340221|526113483|FG001|Overall Study|Reason Not Specified|165|||
145892748|NCT02340221|526113482|FG000|Overall Study|Study Terminated by Sponsor|1|||
145892749|NCT02340221|526113483|FG001|Overall Study|Study Terminated by Sponsor|3|||
145892750|NCT00518622|526113484|FG000|Overall Study|Lost to Follow-up|0|||
145892751|NCT00518622|526113485|FG001|Overall Study|Lost to Follow-up|0|||
145892752|NCT00518622|526113486|FG002|Overall Study|Lost to Follow-up|1|||
146236383|NCT03473743|527381057|FG005|Overall Study|Withdrawal by Subject|0|||
145892753|NCT00518622|526113487|FG003|Overall Study|Lost to Follow-up|0|||
145892754|NCT00518622|526113488|FG004|Overall Study|Lost to Follow-up|0|||
145892755|NCT00518622|526113489|FG005|Overall Study|Lost to Follow-up|0|||
145892756|NCT00518622|526113490|FG006|Overall Study|Lost to Follow-up|0|||
145892757|NCT00518622|526113491|FG007|Overall Study|Lost to Follow-up|0|||
145892758|NCT00518622|526113484|FG000|Overall Study|Study medication taken incorrectly|0|||
145892759|NCT00518622|526113485|FG001|Overall Study|Study medication taken incorrectly|1|||
146236384|NCT03473743|527381058|FG006|Overall Study|Withdrawal by Subject|0|||
146236385|NCT03473743|527381059|FG007|Overall Study|Withdrawal by Subject|3|||
146236386|NCT03473743|527381052|FG000|Overall Study|Other|0|||
145892760|NCT00518622|526113486|FG002|Overall Study|Study medication taken incorrectly|0|||
145892761|NCT00518622|526113487|FG003|Overall Study|Study medication taken incorrectly|0|||
145892762|NCT00518622|526113488|FG004|Overall Study|Study medication taken incorrectly|0|||
145892763|NCT00518622|526113489|FG005|Overall Study|Study medication taken incorrectly|0|||
145892764|NCT00518622|526113490|FG006|Overall Study|Study medication taken incorrectly|0|||
145892765|NCT00518622|526113491|FG007|Overall Study|Study medication taken incorrectly|0|||
145892766|NCT03487848|526113492|FG000|Overall Study|Lost to Follow-up|1|||
145892767|NCT03499119|526113493|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
145892768|NCT03499119|526113494|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
145892769|NCT03499119|526113495|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
145892770|NCT03499119|526113496|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
145892771|NCT03499119|526113493|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
145892772|NCT03499119|526113494|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
145892773|NCT03499119|526113495|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
145892774|NCT03499119|526113496|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
145892775|NCT03499119|526113493|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
145892776|NCT03499119|526113494|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
145892777|NCT03499119|526113495|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
145892778|NCT03499119|526113496|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
145892779|NCT03499119|526113493|FG000|Optional Extension Phase|Lost to Follow-up|0|||
145892780|NCT03499119|526113494|FG001|Optional Extension Phase|Lost to Follow-up|0|||
145892781|NCT03499119|526113495|FG002|Optional Extension Phase|Lost to Follow-up|0|||
145892782|NCT03499119|526113496|FG003|Optional Extension Phase|Lost to Follow-up|1|||
145892783|NCT03499119|526113493|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
145892784|NCT03499119|526113494|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
145892785|NCT03499119|526113495|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
145892786|NCT03499119|526113496|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
145892787|NCT03499119|526113493|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
145892788|NCT03499119|526113494|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
145892789|NCT03499119|526113495|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
145892790|NCT03499119|526113496|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
145892791|NCT02333487|526113497|FG000|Overall Study|Adverse Event|0|||
145892792|NCT02333487|526113498|FG001|Overall Study|Adverse Event|2|||
145892793|NCT02333487|526113499|FG002|Overall Study|Adverse Event|0|||
145892794|NCT00123955|526113500|FG000|Overall Study|Adverse Event|1|||
145892795|NCT00123955|526113501|FG001|Overall Study|Adverse Event|0|||
145892796|NCT00123955|526113500|FG000|Overall Study|Withdrawal by Subject|4|||
145892797|NCT00123955|526113501|FG001|Overall Study|Withdrawal by Subject|3|||
145892798|NCT00123955|526113500|FG000|Overall Study|Death|0|||
145892799|NCT00123955|526113501|FG001|Overall Study|Death|1|||
145892800|NCT01558297|526113502|FG000|Overall Study|Withdrawal by Subject|2|||
145892801|NCT01558297|526113503|FG001|Overall Study|Withdrawal by Subject|2|||
145892802|NCT01558297|526113504|FG002|Overall Study|Withdrawal by Subject|1|||
145892803|NCT02655016|526113507|FG000|Overall Study|Disease progression|6|||
145892804|NCT02655016|526113508|FG001|Overall Study|Disease progression|4|||
145892805|NCT02655016|526113507|FG000|Overall Study|Site closed|0|||
145892806|NCT02655016|526113508|FG001|Overall Study|Site closed|1|||
145892807|NCT02655016|526113507|FG000|Overall Study|Death|30|||
145892808|NCT02655016|526113508|FG001|Overall Study|Death|48|||
145892809|NCT02655016|526113507|FG000|Overall Study|Lost to Follow-up|1|||
145892810|NCT02655016|526113508|FG001|Overall Study|Lost to Follow-up|1|||
145892811|NCT02655016|526113507|FG000|Overall Study|Withdrawal by Subject|18|||
145892812|NCT02655016|526113508|FG001|Overall Study|Withdrawal by Subject|36|||
145892813|NCT02631876|526115170|FG000|Overall Study|Death|96|||
145892814|NCT02631876|526115171|FG001|Overall Study|Death|50|||
145892815|NCT02631876|526115170|FG000|Overall Study|Investigator's discretion|1|||
145892816|NCT02631876|526115171|FG001|Overall Study|Investigator's discretion|0|||
145892817|NCT02631876|526115170|FG000|Overall Study|Lost to Follow-up|2|||
145892818|NCT02631876|526115171|FG001|Overall Study|Lost to Follow-up|0|||
145892819|NCT02631876|526115170|FG000|Overall Study|Withdrawal by Subject|16|||
145892820|NCT02631876|526115171|FG001|Overall Study|Withdrawal by Subject|9|||
145892821|NCT02631876|526115170|FG000|Overall Study|Other than specified|4|||
145892822|NCT02631876|526115171|FG001|Overall Study|Other than specified|4|||
146236387|NCT03473743|527381053|FG001|Overall Study|Other|0|||
145892823|NCT01013649|526115174|FG000|First Step|Withdrawal by Subject|36|||
145892824|NCT01013649|526115175|FG001|First Step|Withdrawal by Subject|19|||
145892825|NCT01013649|526115176|FG002|First Step|Withdrawal by Subject|0|||
145892826|NCT01013649|526115177|FG003|First Step|Withdrawal by Subject|0|||
146236388|NCT03473743|527381054|FG002|Overall Study|Other|0|||
145892827|NCT01013649|526115174|FG000|First Step|Progression|58|||
145892828|NCT01013649|526115175|FG001|First Step|Progression|23|||
145892829|NCT01013649|526115176|FG002|First Step|Progression|0|||
145892830|NCT01013649|526115177|FG003|First Step|Progression|0|||
145892831|NCT01013649|526115174|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
146236389|NCT03473743|527381055|FG003|Overall Study|Other|1|||
146236390|NCT03473743|527381056|FG004|Overall Study|Other|0|||
145892832|NCT01013649|526115175|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
145892833|NCT01013649|526115176|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
145892834|NCT01013649|526115177|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
145892835|NCT01013649|526115174|FG000|First Step|Death|3|||
145892836|NCT01013649|526115175|FG001|First Step|Death|4|||
145892837|NCT01013649|526115176|FG002|First Step|Death|0|||
145892838|NCT01013649|526115177|FG003|First Step|Death|0|||
145892839|NCT01013649|526115174|FG000|First Step|Adverse Event|9|||
145892840|NCT01013649|526115175|FG001|First Step|Adverse Event|5|||
145892841|NCT01013649|526115176|FG002|First Step|Adverse Event|0|||
145892842|NCT01013649|526115177|FG003|First Step|Adverse Event|0|||
145892843|NCT01013649|526115174|FG000|First Step|Other|4|||
145892844|NCT01013649|526115175|FG001|First Step|Other|6|||
145892845|NCT01013649|526115176|FG002|First Step|Other|0|||
145892846|NCT01013649|526115177|FG003|First Step|Other|0|||
145892847|NCT04285567|526115178|FG000|Overall Study|Death|3|||
145892848|NCT04285567|526115179|FG001|Overall Study|Death|3|||
145892849|NCT04285567|526115178|FG000|Overall Study|Lost to Follow-up|1|||
145892850|NCT04285567|526115179|FG001|Overall Study|Lost to Follow-up|1|||
145892851|NCT04285567|526115178|FG000|Overall Study|Reason Not Specified|1|||
145892852|NCT04285567|526115179|FG001|Overall Study|Reason Not Specified|1|||
145892853|NCT04285567|526115178|FG000|Overall Study|Physician Decision|2|||
145892854|NCT04285567|526115179|FG001|Overall Study|Physician Decision|1|||
145892855|NCT04285567|526115178|FG000|Overall Study|Withdrawal by Subject|2|||
145892856|NCT04285567|526115179|FG001|Overall Study|Withdrawal by Subject|6|||
145892857|NCT04285567|526115178|FG000|Overall Study|Adverse Event|1|||
145892858|NCT04285567|526115179|FG001|Overall Study|Adverse Event|0|||
145892859|NCT04285567|526115178|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
145892860|NCT04285567|526115179|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
145892861|NCT01408563|526115180|FG000|Overall Study|Ineligible after consent/ registration|2|||
145892862|NCT02246439|526115186|FG000|Overall Study|Adverse Event|3|||
145892863|NCT02246439|526115187|FG001|Overall Study|Adverse Event|0|||
145892864|NCT02246439|526115186|FG000|Overall Study|Lost to Follow-up|7|||
145892865|NCT02246439|526115187|FG001|Overall Study|Lost to Follow-up|5|||
145892866|NCT02246439|526115186|FG000|Overall Study|Protocol Violation|0|||
145892867|NCT02246439|526115187|FG001|Overall Study|Protocol Violation|2|||
145892868|NCT02246439|526115186|FG000|Overall Study|Physician Decision|0|||
145892869|NCT02246439|526115187|FG001|Overall Study|Physician Decision|1|||
145892870|NCT02246439|526115186|FG000|Overall Study|Unkonwn|1|||
145892871|NCT02246439|526115187|FG001|Overall Study|Unkonwn|3|||
145892872|NCT02246439|526115186|FG000|Overall Study|Withdrawal by Subject|1|||
145892873|NCT02246439|526115187|FG001|Overall Study|Withdrawal by Subject|0|||
145892874|NCT03439852|526115188|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
145892875|NCT03439852|526115189|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
145892876|NCT03439852|526115188|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
145892877|NCT03439852|526115189|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
145892878|NCT03439852|526115188|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
145892879|NCT03439852|526115189|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
145892880|NCT02177136|526115194|FG000|DB Phase|Withdrawal by Subject|2|||
145892881|NCT02177136|526115195|FG001|DB Phase|Withdrawal by Subject|0|||
145892882|NCT02177136|526115196|FG002|DB Phase|Withdrawal by Subject|0|||
145892883|NCT02177136|526115197|FG003|DB Phase|Withdrawal by Subject|0|||
145892884|NCT02177136|526115194|FG000|DB Phase|Discontinued Due to Pruritus|1|||
145892885|NCT02177136|526115195|FG001|DB Phase|Discontinued Due to Pruritus|3|||
145892886|NCT02177136|526115196|FG002|DB Phase|Discontinued Due to Pruritus|0|||
145971272|NCT02030600|526408793|FG000|Treatment Period 2|Adverse Event|4|||
145971273|NCT02030600|526408794|FG001|Treatment Period 2|Adverse Event|4|||
145971274|NCT02030600|526408793|FG000|Treatment Period 2|Lack of Efficacy|2|||
145971275|NCT02030600|526408794|FG001|Treatment Period 2|Lack of Efficacy|1|||
145971276|NCT02030600|526408793|FG000|Treatment Period 2|Lost to Follow-up|4|||
145971277|NCT02030600|526408794|FG001|Treatment Period 2|Lost to Follow-up|2|||
145971278|NCT02030600|526408793|FG000|Treatment Period 2|Protocol Violation|1|||
145971279|NCT02030600|526408794|FG001|Treatment Period 2|Protocol Violation|2|||
146088142|NCT01986933|526841961|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
146088143|NCT01986933|526841962|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
146088144|NCT01986933|526841963|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
146088145|NCT01986933|526841959|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
146088146|NCT01986933|526841960|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
145892887|NCT02177136|526115197|FG003|DB Phase|Discontinued Due to Pruritus|0|||
145892888|NCT02177136|526115194|FG000|DB Phase|Adverse Event|3|||
145892889|NCT02177136|526115195|FG001|DB Phase|Adverse Event|2|||
145892890|NCT02177136|526115196|FG002|DB Phase|Adverse Event|3|||
145892891|NCT02177136|526115197|FG003|DB Phase|Adverse Event|0|||
145892892|NCT02177136|526115194|FG000|DB Phase|Protocol Violation|0|||
145892893|NCT02177136|526115195|FG001|DB Phase|Protocol Violation|0|||
145892894|NCT02177136|526115196|FG002|DB Phase|Protocol Violation|1|||
145892895|NCT02177136|526115197|FG003|DB Phase|Protocol Violation|0|||
145971280|NCT02030600|526408793|FG000|Treatment Period 2|Withdrawal by Subject|13|||
145892896|NCT02177136|526115194|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
145892897|NCT02177136|526115195|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
145892898|NCT02177136|526115196|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
145892899|NCT02177136|526115197|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
145892900|NCT02177136|526115194|FG000|LTSE Phase|Withdrawal by Subject|0|||
145892901|NCT02177136|526115195|FG001|LTSE Phase|Withdrawal by Subject|0|||
145892902|NCT02177136|526115196|FG002|LTSE Phase|Withdrawal by Subject|0|||
145892903|NCT02177136|526115197|FG003|LTSE Phase|Withdrawal by Subject|6|||
145892904|NCT02177136|526115194|FG000|LTSE Phase|Adverse Event|0|||
145892905|NCT02177136|526115195|FG001|LTSE Phase|Adverse Event|0|||
145892906|NCT02177136|526115196|FG002|LTSE Phase|Adverse Event|0|||
145892907|NCT02177136|526115197|FG003|LTSE Phase|Adverse Event|10|||
145892908|NCT02177136|526115194|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
145892909|NCT02177136|526115195|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
145892910|NCT02177136|526115196|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
145892911|NCT02177136|526115197|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
145892912|NCT02177136|526115194|FG000|LTSE Phase|Physician Decision|0|||
145892913|NCT02177136|526115195|FG001|LTSE Phase|Physician Decision|0|||
145892914|NCT02177136|526115196|FG002|LTSE Phase|Physician Decision|0|||
145892915|NCT02177136|526115197|FG003|LTSE Phase|Physician Decision|2|||
145892916|NCT02177136|526115194|FG000|LTSE Phase|Lost to Follow-up|0|||
145892917|NCT02177136|526115195|FG001|LTSE Phase|Lost to Follow-up|0|||
145892918|NCT02177136|526115196|FG002|LTSE Phase|Lost to Follow-up|0|||
145892919|NCT02177136|526115197|FG003|LTSE Phase|Lost to Follow-up|1|||
145892920|NCT02177136|526115194|FG000|LTSE Phase|Participant Moved|0|||
145892921|NCT02177136|526115195|FG001|LTSE Phase|Participant Moved|0|||
145892922|NCT02177136|526115196|FG002|LTSE Phase|Participant Moved|0|||
145892923|NCT02177136|526115197|FG003|LTSE Phase|Participant Moved|1|||
145892924|NCT02054130|526115198|FG000|Overall Study|Withdrawal by Subject|4|||
145892925|NCT02054130|526115199|FG001|Overall Study|Withdrawal by Subject|4|||
145892926|NCT02054130|526115200|FG002|Overall Study|Withdrawal by Subject|7|||
145971281|NCT02030600|526408794|FG001|Treatment Period 2|Withdrawal by Subject|9|||
145971282|NCT02030600|526408793|FG000|Treatment Period 2|Unclassified|1|||
145892927|NCT02054130|526115201|FG003|Overall Study|Withdrawal by Subject|10|||
145892928|NCT02054130|526115198|FG000|Overall Study|Death|0|||
145892929|NCT02054130|526115199|FG001|Overall Study|Death|1|||
145892930|NCT02054130|526115200|FG002|Overall Study|Death|0|||
145892931|NCT02054130|526115201|FG003|Overall Study|Death|0|||
145892932|NCT02054130|526115198|FG000|Overall Study|Lost to Follow-up|0|||
146295605|NCT04796896|527597614|FG008|Overall Study|Protocol Deviation|2|||
145892933|NCT02054130|526115199|FG001|Overall Study|Lost to Follow-up|0|||
145892934|NCT02054130|526115200|FG002|Overall Study|Lost to Follow-up|1|||
145892935|NCT02054130|526115201|FG003|Overall Study|Lost to Follow-up|2|||
145892936|NCT02054130|526115198|FG000|Overall Study|Missed dose|4|||
145892937|NCT02054130|526115199|FG001|Overall Study|Missed dose|6|||
145892938|NCT02054130|526115200|FG002|Overall Study|Missed dose|7|||
145892939|NCT02054130|526115201|FG003|Overall Study|Missed dose|10|||
145892940|NCT01386684|526115202|FG000|Overall Study|Lost to Follow-up|51|||
145892941|NCT01386684|526115202|FG000|Overall Study|Other|51|||
145892942|NCT01386684|526115202|FG000|Overall Study|Death|47|||
145892943|NCT01386684|526115202|FG000|Overall Study|Withdrawal of Consent|44|||
145892944|NCT01386684|526115202|FG000|Overall Study|Alternative Therapy Required|37|||
145892945|NCT01386684|526115202|FG000|Overall Study|Disease Progression|28|||
145892946|NCT01386684|526115202|FG000|Overall Study|Adverse Event|20|||
145892947|NCT01386684|526115202|FG000|Overall Study|Noncompliance|8|||
145892948|NCT01386684|526115202|FG000|Overall Study|Protocol Violation|4|||
145892949|NCT01386684|526115202|FG000|Overall Study|Missing|3|||
145892950|NCT00094458|526115203|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
145892951|NCT00094458|526115204|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
145892952|NCT00094458|526115205|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
145892953|NCT00094458|526115206|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
145892954|NCT00094458|526115207|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
145892955|NCT00094458|526115208|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
145892956|NCT00094458|526115203|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
145892957|NCT00094458|526115204|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
145892958|NCT00094458|526115205|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
145892959|NCT00094458|526115206|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
145892960|NCT00094458|526115207|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
145892961|NCT00094458|526115208|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
145892962|NCT00094458|526115203|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
145892963|NCT00094458|526115204|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
145892964|NCT00094458|526115205|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
145892965|NCT00094458|526115206|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
145892966|NCT00094458|526115207|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
145892967|NCT00094458|526115208|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
145892968|NCT00094458|526115203|FG000|Main Study: Through Week 30|Adverse Event|38|||
145892969|NCT00094458|526115204|FG001|Main Study: Through Week 30|Adverse Event|20|||
145892970|NCT00094458|526115205|FG002|Main Study: Through Week 30|Adverse Event|28|||
145892971|NCT00094458|526115206|FG003|Main Study: Through Week 30|Adverse Event|0|||
145892972|NCT00094458|526115207|FG004|Main Study: Through Week 30|Adverse Event|0|||
145892973|NCT00094458|526115208|FG005|Main Study: Through Week 30|Adverse Event|0|||
145892974|NCT00094458|526115203|FG000|Main Study: Through Week 30|Death|1|||
145892975|NCT00094458|526115204|FG001|Main Study: Through Week 30|Death|0|||
145892976|NCT00094458|526115205|FG002|Main Study: Through Week 30|Death|0|||
145892977|NCT00094458|526115206|FG003|Main Study: Through Week 30|Death|0|||
145892978|NCT00094458|526115207|FG004|Main Study: Through Week 30|Death|0|||
145892979|NCT00094458|526115208|FG005|Main Study: Through Week 30|Death|0|||
145892980|NCT00094458|526115203|FG000|Main Study: Through Week 30|Other|19|||
145892981|NCT00094458|526115204|FG001|Main Study: Through Week 30|Other|16|||
145892982|NCT00094458|526115205|FG002|Main Study: Through Week 30|Other|9|||
145892983|NCT00094458|526115206|FG003|Main Study: Through Week 30|Other|0|||
145892984|NCT00094458|526115207|FG004|Main Study: Through Week 30|Other|0|||
145892985|NCT00094458|526115208|FG005|Main Study: Through Week 30|Other|0|||
145892986|NCT00094458|526115203|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
145892987|NCT00094458|526115204|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
145892988|NCT00094458|526115205|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
145892989|NCT00094458|526115206|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145892990|NCT00094458|526115207|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145892991|NCT00094458|526115208|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145892992|NCT00094458|526115203|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
145971283|NCT02030600|526408794|FG001|Treatment Period 2|Unclassified|0|||
145971284|NCT00634504|526408799|FG000|Overall Study|Protocol Violation|1|||
146295606|NCT04796896|527597615|FG009|Overall Study|Protocol Deviation|1|||
145892993|NCT00094458|526115204|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145892994|NCT00094458|526115205|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
145892995|NCT00094458|526115206|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145892996|NCT00094458|526115207|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145892997|NCT00094458|526115208|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145892998|NCT00094458|526115203|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
145892999|NCT00094458|526115204|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
146295607|NCT04796896|527597616|FG010|Overall Study|Protocol Deviation|0|||
145893000|NCT00094458|526115205|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
145893001|NCT00094458|526115206|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145893002|NCT00094458|526115207|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145893003|NCT00094458|526115208|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145893004|NCT00094458|526115203|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
145893005|NCT00094458|526115204|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
145893006|NCT00094458|526115205|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
145893007|NCT00094458|526115206|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
145893008|NCT00094458|526115207|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
145893009|NCT00094458|526115208|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
145893010|NCT00094458|526115203|FG000|OLE: Open-Label Extension|Adverse Event|0|||
145893011|NCT00094458|526115204|FG001|OLE: Open-Label Extension|Adverse Event|0|||
145893012|NCT00094458|526115205|FG002|OLE: Open-Label Extension|Adverse Event|0|||
146236391|NCT03473743|527381057|FG005|Overall Study|Other|0|||
146236392|NCT03473743|527381058|FG006|Overall Study|Other|0|||
145893013|NCT00094458|526115206|FG003|OLE: Open-Label Extension|Adverse Event|0|||
145893014|NCT00094458|526115207|FG004|OLE: Open-Label Extension|Adverse Event|3|||
145893015|NCT00094458|526115208|FG005|OLE: Open-Label Extension|Adverse Event|4|||
145893016|NCT00094458|526115203|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145893017|NCT00094458|526115204|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145893018|NCT00094458|526115205|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145893019|NCT00094458|526115206|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
145893020|NCT00094458|526115207|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
145893021|NCT00094458|526115208|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145893022|NCT00094458|526115203|FG000|OLE: Open-Label Extension|Patient decision|0|||
145893023|NCT00094458|526115204|FG001|OLE: Open-Label Extension|Patient decision|0|||
145893024|NCT00094458|526115205|FG002|OLE: Open-Label Extension|Patient decision|0|||
145893025|NCT00094458|526115206|FG003|OLE: Open-Label Extension|Patient decision|0|||
145893026|NCT00094458|526115207|FG004|OLE: Open-Label Extension|Patient decision|1|||
145893027|NCT00094458|526115208|FG005|OLE: Open-Label Extension|Patient decision|0|||
145893028|NCT03247517|526115215|FG000|Overall Study|Adverse Event|0|||
145893029|NCT03247517|526115216|FG001|Overall Study|Adverse Event|4|||
145893030|NCT03247517|526115217|FG002|Overall Study|Adverse Event|2|||
145893031|NCT03247517|526115215|FG000|Overall Study|Lost to Follow-up|2|||
145893032|NCT03247517|526115216|FG001|Overall Study|Lost to Follow-up|6|||
145893033|NCT03247517|526115217|FG002|Overall Study|Lost to Follow-up|4|||
145893034|NCT03247517|526115215|FG000|Overall Study|Consent withdrawn by caregiver|1|||
145893035|NCT03247517|526115216|FG001|Overall Study|Consent withdrawn by caregiver|4|||
145893036|NCT03247517|526115217|FG002|Overall Study|Consent withdrawn by caregiver|7|||
145893037|NCT03247517|526115215|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
145893038|NCT03247517|526115216|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
145893039|NCT03247517|526115217|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
145893040|NCT03247517|526115215|FG000|Overall Study|Protocol Violation|0|||
145893041|NCT03247517|526115216|FG001|Overall Study|Protocol Violation|2|||
145893042|NCT03247517|526115217|FG002|Overall Study|Protocol Violation|0|||
145893043|NCT03247517|526115215|FG000|Overall Study|Multiple reasons|3|||
145893044|NCT03247517|526115216|FG001|Overall Study|Multiple reasons|1|||
145893045|NCT03247517|526115217|FG002|Overall Study|Multiple reasons|0|||
145893046|NCT03623386|526115218|FG000|Overall Study|Protocol Violation|3|||
145893047|NCT03623386|526115219|FG001|Overall Study|Protocol Violation|2|||
145893048|NCT03623386|526115220|FG002|Overall Study|Protocol Violation|0|||
145893049|NCT03623386|526115218|FG000|Overall Study|Physician Decision|1|||
145893050|NCT03623386|526115219|FG001|Overall Study|Physician Decision|1|||
145893051|NCT03623386|526115220|FG002|Overall Study|Physician Decision|0|||
145893052|NCT03623386|526115218|FG000|Overall Study|Lost to Follow-up|0|||
145893053|NCT03623386|526115219|FG001|Overall Study|Lost to Follow-up|2|||
145893054|NCT03623386|526115220|FG002|Overall Study|Lost to Follow-up|0|||
145893055|NCT03623386|526115218|FG000|Overall Study|COVID-19|0|||
145893056|NCT03623386|526115219|FG001|Overall Study|COVID-19|1|||
145893057|NCT03623386|526115220|FG002|Overall Study|COVID-19|0|||
145893058|NCT04271735|526115223|FG000|Overall Study|Physician Decision|2|||
145893059|NCT04271735|526115224|FG001|Overall Study|Physician Decision|0|||
145893060|NCT04268316|526115225|FG000|Overall Study|Withdrawal by Subject|2|||
145971285|NCT00634504|526408800|FG001|Overall Study|Protocol Violation|0|||
145971286|NCT02110693|526408801|FG000|Overall Study|Withdrawal by Subject|6|||
145971287|NCT02110693|526408802|FG001|Overall Study|Withdrawal by Subject|7|||
145971288|NCT02110693|526408801|FG000|Overall Study|skipped assessment|15|||
145893061|NCT04268316|526115226|FG001|Overall Study|Withdrawal by Subject|1|||
145893062|NCT04268316|526115227|FG002|Overall Study|Withdrawal by Subject|0|||
145893063|NCT00515541|526115228|FG000|Overall Study|Physician Decision|0|||
145893064|NCT00515541|526115229|FG001|Overall Study|Physician Decision|2|||
145893065|NCT00515541|526115230|FG002|Overall Study|Physician Decision|0|||
145893066|NCT00515541|526115231|FG003|Overall Study|Physician Decision|1|||
145893067|NCT00515541|526115228|FG000|Overall Study|No show for appointments|0|||
145893068|NCT00515541|526115229|FG001|Overall Study|No show for appointments|1|||
145893069|NCT00515541|526115230|FG002|Overall Study|No show for appointments|0|||
146236393|NCT03473743|527381059|FG007|Overall Study|Other|0|||
145893070|NCT00515541|526115231|FG003|Overall Study|No show for appointments|2|||
145893071|NCT00515541|526115228|FG000|Overall Study|Withdrawal by Subject|0|||
145893072|NCT00515541|526115229|FG001|Overall Study|Withdrawal by Subject|2|||
146236394|NCT03473743|527381052|FG000|Overall Study|Ongoing|0|||
145893073|NCT00515541|526115230|FG002|Overall Study|Withdrawal by Subject|0|||
145893074|NCT00515541|526115231|FG003|Overall Study|Withdrawal by Subject|2|||
145893075|NCT02132637|526115233|FG000|Study Period 1|Withdrawal by Subject|0|||
145893076|NCT02132637|526115234|FG001|Study Period 1|Withdrawal by Subject|4|||
145893077|NCT02132637|526115233|FG000|Study Period 1|Physician Decision|1|||
145893078|NCT02132637|526115234|FG001|Study Period 1|Physician Decision|0|||
145893079|NCT02132637|526115233|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
145893080|NCT02132637|526115234|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
145893081|NCT02132637|526115233|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
145893082|NCT02132637|526115234|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
145893083|NCT03197558|526115237|FG000|Overall Study|Tubes not placed|1|||
145893084|NCT00931268|526115249|FG000|Overall Study|Lost to Follow-up|6|||
145893085|NCT02072148|526115251|FG000|Overall Study|withdrew prior to surgery|23|||
145893086|NCT02072148|526115252|FG001|Overall Study|withdrew prior to surgery|0|||
145893087|NCT02072148|526115253|FG002|Overall Study|withdrew prior to surgery|0|||
145893088|NCT02072148|526115251|FG000|Overall Study|Death|0|||
145893089|NCT02072148|526115252|FG001|Overall Study|Death|0|||
145893090|NCT02072148|526115253|FG002|Overall Study|Death|1|||
145893091|NCT02072148|526115251|FG000|Overall Study|Withdrawal by Subject|0|||
145893092|NCT02072148|526115252|FG001|Overall Study|Withdrawal by Subject|13|||
145893093|NCT02072148|526115253|FG002|Overall Study|Withdrawal by Subject|12|||
145893094|NCT00430495|526115254|FG000|Overall Study|Adverse Event|2|||
145893095|NCT00430495|526115255|FG001|Overall Study|Adverse Event|3|||
145893096|NCT00430495|526115256|FG002|Overall Study|Adverse Event|2|||
145893097|NCT00430495|526115257|FG003|Overall Study|Adverse Event|0|||
145893098|NCT00430495|526115254|FG000|Overall Study|Death|0|||
145893099|NCT00430495|526115255|FG001|Overall Study|Death|0|||
145893100|NCT00430495|526115256|FG002|Overall Study|Death|1|||
145893101|NCT00430495|526115257|FG003|Overall Study|Death|0|||
145893102|NCT00430495|526115254|FG000|Overall Study|Lost to Follow-up|0|||
145893103|NCT00430495|526115255|FG001|Overall Study|Lost to Follow-up|1|||
145893104|NCT00430495|526115256|FG002|Overall Study|Lost to Follow-up|4|||
145893105|NCT00430495|526115257|FG003|Overall Study|Lost to Follow-up|0|||
145893106|NCT00430495|526115254|FG000|Overall Study|Protocol Violation|1|||
145893107|NCT00430495|526115255|FG001|Overall Study|Protocol Violation|0|||
145893108|NCT00430495|526115256|FG002|Overall Study|Protocol Violation|1|||
145893109|NCT00430495|526115257|FG003|Overall Study|Protocol Violation|0|||
145893110|NCT00430495|526115254|FG000|Overall Study|Disease Progression|1|||
145893111|NCT00430495|526115255|FG001|Overall Study|Disease Progression|1|||
145893112|NCT00430495|526115256|FG002|Overall Study|Disease Progression|0|||
145893113|NCT00430495|526115257|FG003|Overall Study|Disease Progression|0|||
145893114|NCT00430495|526115254|FG000|Overall Study|Other|8|||
145893115|NCT00430495|526115255|FG001|Overall Study|Other|2|||
145893116|NCT00430495|526115256|FG002|Overall Study|Other|5|||
145893117|NCT00430495|526115257|FG003|Overall Study|Other|4|||
145893118|NCT00430495|526115254|FG000|Overall Study|Randomized but not Treated|2|||
145893119|NCT00430495|526115255|FG001|Overall Study|Randomized but not Treated|0|||
145893120|NCT00430495|526115256|FG002|Overall Study|Randomized but not Treated|0|||
146236395|NCT03473743|527381053|FG001|Overall Study|Ongoing|0|||
146236396|NCT03473743|527381054|FG002|Overall Study|Ongoing|6|||
146236397|NCT03473743|527381055|FG003|Overall Study|Ongoing|8|||
146236398|NCT03473743|527381056|FG004|Overall Study|Ongoing|1|||
146236399|NCT03473743|527381057|FG005|Overall Study|Ongoing|1|||
146236400|NCT03473743|527381058|FG006|Overall Study|Ongoing|22|||
145893121|NCT00430495|526115257|FG003|Overall Study|Randomized but not Treated|0|||
145893122|NCT02400671|526115258|FG000|Overall Study|Death|5|||
145893123|NCT02400671|526115259|FG001|Overall Study|Death|3|||
145893124|NCT02400671|526115260|FG002|Overall Study|Death|4|||
146236401|NCT03473743|527381059|FG007|Overall Study|Ongoing|24|||
146236402|NCT03473743|527381052|FG000|Overall Study|Randomized but not treated|0|||
146236403|NCT03473743|527381053|FG001|Overall Study|Randomized but not treated|0|||
146236404|NCT03473743|527381054|FG002|Overall Study|Randomized but not treated|0|||
146236405|NCT03473743|527381055|FG003|Overall Study|Randomized but not treated|0|||
145893125|NCT02400671|526115258|FG000|Overall Study|Lost to Follow-up|20|||
146236406|NCT03473743|527381056|FG004|Overall Study|Randomized but not treated|0|||
146236407|NCT03473743|527381057|FG005|Overall Study|Randomized but not treated|0|||
145893126|NCT02400671|526115259|FG001|Overall Study|Lost to Follow-up|27|||
145893127|NCT02400671|526115260|FG002|Overall Study|Lost to Follow-up|24|||
146236408|NCT03473743|527381058|FG006|Overall Study|Randomized but not treated|1|||
146236409|NCT03473743|527381059|FG007|Overall Study|Randomized but not treated|1|||
146236410|NCT00980954|527381060|FG000|Overall Study|Protocol Violation|9|||
145893128|NCT02400671|526115258|FG000|Overall Study|Withdrawal by Subject|2|||
145893129|NCT02400671|526115259|FG001|Overall Study|Withdrawal by Subject|2|||
145893130|NCT02400671|526115260|FG002|Overall Study|Withdrawal by Subject|0|||
145893131|NCT00158756|526115261|FG000|Overall Study|Withdrawal by Subject|5|||
145893132|NCT00158756|526115262|FG001|Overall Study|Withdrawal by Subject|0|||
146236411|NCT00980954|527381061|FG001|Overall Study|Protocol Violation|15|||
146236412|NCT01458366|527381067|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
145893133|NCT00158756|526115263|FG002|Overall Study|Withdrawal by Subject|6|||
145893134|NCT00158756|526115264|FG003|Overall Study|Withdrawal by Subject|1|||
145893135|NCT00158756|526115265|FG004|Overall Study|Withdrawal by Subject|3|||
145893136|NCT00158756|526115261|FG000|Overall Study|Adverse Event|0|||
145893137|NCT00158756|526115262|FG001|Overall Study|Adverse Event|0|||
145893138|NCT00158756|526115263|FG002|Overall Study|Adverse Event|1|||
145893139|NCT00158756|526115264|FG003|Overall Study|Adverse Event|0|||
145893140|NCT00158756|526115265|FG004|Overall Study|Adverse Event|0|||
145893141|NCT00158756|526115261|FG000|Overall Study|Serious adverse event|0|||
145893142|NCT00158756|526115262|FG001|Overall Study|Serious adverse event|0|||
145893143|NCT00158756|526115263|FG002|Overall Study|Serious adverse event|1|||
145893144|NCT00158756|526115264|FG003|Overall Study|Serious adverse event|0|||
145893145|NCT00158756|526115265|FG004|Overall Study|Serious adverse event|0|||
145893146|NCT02145026|526115269|FG000|Overall Study|Adverse Event|2|||
145893147|NCT02145026|526115269|FG000|Overall Study|Death|4|||
145893148|NCT02145026|526115269|FG000|Overall Study|Withdrawal by Subject|2|||
145893149|NCT02145026|526115269|FG000|Overall Study|Physician Decision|4|||
145893150|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
145893151|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
145893152|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
145893153|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
145893154|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
145893155|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
145893156|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
145893157|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
145893158|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
145893159|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
145893160|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
145893161|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
145893162|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
145893163|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
145893164|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
145893165|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
145893166|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
145893167|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
145893168|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
145893169|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
145893170|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
145893171|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
145893172|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
145893173|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
145893174|NCT01421342|526115270|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
145893175|NCT01421342|526115271|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
145893176|NCT01421342|526115272|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
145893177|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
145893178|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
145893179|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
145893180|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
145893181|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
145893182|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
145893183|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
145893184|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
145893185|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
145893186|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
145893187|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
145893188|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
145893189|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
145893190|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
145893191|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
145893192|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
146088147|NCT01986933|526841961|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
146236413|NCT01458366|527381068|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
146236414|NCT01458366|527381069|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
146236415|NCT01458366|527381070|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
146236416|NCT01458366|527381071|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
146236417|NCT01458366|527381067|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146236418|NCT01458366|527381068|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146295608|NCT04796896|527597617|FG011|Overall Study|Protocol Deviation|0|||
145971289|NCT02110693|526408802|FG001|Overall Study|skipped assessment|18|||
145971290|NCT02110693|526408801|FG000|Overall Study|technical difficulties|6|||
145971291|NCT02110693|526408802|FG001|Overall Study|technical difficulties|4|||
145971292|NCT02110693|526408801|FG000|Overall Study|Other|1|||
146295609|NCT04796896|527597606|FG000|Overall Study|Missing|0|||
146295610|NCT04796896|527597607|FG001|Overall Study|Missing|0|||
145893193|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
145893194|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
145893195|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
145893196|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
145893197|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
145893198|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
145893199|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
145893200|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
145893201|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
145893202|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
145893203|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
145893204|NCT01421342|526115270|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
145893205|NCT01421342|526115271|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
145893206|NCT01421342|526115272|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
145893207|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
145893208|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
145893209|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
145893210|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
145893211|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
145893212|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
145893213|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
145893214|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
145893215|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
145893216|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
145893217|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
145893218|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
145893219|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
145893220|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
145893221|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
145893222|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
145893223|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
145893224|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
145893225|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
145893226|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
145893227|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
145893228|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145893229|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145893230|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145893231|NCT01421342|526115270|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
145893232|NCT01421342|526115271|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
145893233|NCT01421342|526115272|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
145893234|NCT03656874|526115275|FG000|Overall Study|Lost to Follow-up|3|||
145893235|NCT03656874|526115276|FG001|Overall Study|Lost to Follow-up|17|||
145893236|NCT03052322|526115278|FG000|Overall Study|Other un-specified|1|||
145893237|NCT03052322|526115279|FG001|Overall Study|Other un-specified|2|||
145893238|NCT03052322|526115278|FG000|Overall Study|Withdrawal by Subject|10|||
145893239|NCT03052322|526115279|FG001|Overall Study|Withdrawal by Subject|9|||
145893240|NCT03052322|526115278|FG000|Overall Study|Death|0|||
145893241|NCT03052322|526115279|FG001|Overall Study|Death|2|||
145893242|NCT03052322|526115278|FG000|Overall Study|Lack of Efficacy|1|||
145893243|NCT03052322|526115279|FG001|Overall Study|Lack of Efficacy|2|||
145893244|NCT03052322|526115278|FG000|Overall Study|Protocol Violation|1|||
145893245|NCT03052322|526115279|FG001|Overall Study|Protocol Violation|0|||
145893246|NCT03052322|526115278|FG000|Overall Study|Lost to Follow-up|2|||
145893247|NCT03052322|526115279|FG001|Overall Study|Lost to Follow-up|4|||
145893248|NCT03052322|526115278|FG000|Overall Study|Adverse Event|6|||
145893249|NCT03052322|526115279|FG001|Overall Study|Adverse Event|13|||
145893250|NCT04920916|526115280|FG000|Phase IIa 60 Day Study|Death|2|||
145893251|NCT04920916|526115281|FG001|Phase IIa 60 Day Study|Death|5|||
145893252|NCT04920916|526115280|FG000|1 Year Follow up (Phone Call)|Death|1|||
145893253|NCT04920916|526115281|FG001|1 Year Follow up (Phone Call)|Death|3|||
146295611|NCT04796896|527597608|FG002|Overall Study|Missing|0|||
146295612|NCT04796896|527597609|FG003|Overall Study|Missing|0|||
146088148|NCT01986933|526841962|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
146088149|NCT01986933|526841963|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
146088150|NCT01986933|526841959|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
146236419|NCT01458366|527381069|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146295613|NCT04796896|527597610|FG004|Overall Study|Missing|0|||
146236420|NCT01458366|527381070|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
146236421|NCT01458366|527381071|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
146236422|NCT04647487|527381072|FG000|Overall Study|Protocol Deviation|0|||
146236423|NCT04647487|527381073|FG001|Overall Study|Protocol Deviation|0|||
146236424|NCT04647487|527381074|FG002|Overall Study|Protocol Deviation|1|||
146236425|NCT04647487|527381072|FG000|Overall Study|Withdrawal by Subject|1|||
146236426|NCT04647487|527381073|FG001|Overall Study|Withdrawal by Subject|0|||
146236427|NCT04647487|527381074|FG002|Overall Study|Withdrawal by Subject|2|||
146236428|NCT03375320|527381075|FG000|Overall Study|Adverse Event|34|||
146236429|NCT03375320|527381076|FG001|Overall Study|Adverse Event|9|||
146236430|NCT03375320|527381077|FG002|Overall Study|Adverse Event|10|||
146236431|NCT03375320|527381078|FG003|Overall Study|Adverse Event|0|||
146236432|NCT03375320|527381075|FG000|Overall Study|Death|6|||
146236433|NCT03375320|527381076|FG001|Overall Study|Death|3|||
146236434|NCT03375320|527381077|FG002|Overall Study|Death|0|||
146236435|NCT03375320|527381078|FG003|Overall Study|Death|0|||
146236436|NCT03375320|527381075|FG000|Overall Study|Withdrawal by Subject|7|||
146236437|NCT03375320|527381076|FG001|Overall Study|Withdrawal by Subject|4|||
146236438|NCT03375320|527381077|FG002|Overall Study|Withdrawal by Subject|5|||
146236439|NCT03375320|527381078|FG003|Overall Study|Withdrawal by Subject|4|||
146236440|NCT03375320|527381075|FG000|Overall Study|Progressive disease|55|||
146236441|NCT03375320|527381076|FG001|Overall Study|Progressive disease|41|||
146236442|NCT03375320|527381077|FG002|Overall Study|Progressive disease|29|||
146236443|NCT03375320|527381078|FG003|Overall Study|Progressive disease|24|||
146295614|NCT04796896|527597611|FG005|Overall Study|Missing|0|||
146295615|NCT04796896|527597612|FG006|Overall Study|Missing|2|||
146295616|NCT04796896|527597613|FG007|Overall Study|Missing|1|||
146236444|NCT03375320|527381075|FG000|Overall Study|Alternative treatment|6|||
146295617|NCT04796896|527597614|FG008|Overall Study|Missing|2|||
146236445|NCT03375320|527381076|FG001|Overall Study|Alternative treatment|1|||
145893254|NCT04920916|526115280|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
145893255|NCT04920916|526115281|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
145893256|NCT00973765|526115282|FG000|Overall Study|Lost to Follow-up|8|||
145893257|NCT00973765|526115283|FG001|Overall Study|Lost to Follow-up|14|||
145893258|NCT01892657|526115284|FG000|Overall Study|Withdrawal by Subject|6|||
145893259|NCT01892657|526115284|FG000|Overall Study|Protocol Violation|12|||
145893260|NCT00076804|526115285|FG000|Overall Study|Death|9|||
145893261|NCT00076804|526115286|FG001|Overall Study|Death|20|||
146236446|NCT03375320|527381077|FG002|Overall Study|Alternative treatment|1|||
146236447|NCT03375320|527381078|FG003|Overall Study|Alternative treatment|0|||
145893262|NCT00076804|526115285|FG000|Overall Study|Lost to Follow-up|9|||
145893263|NCT00076804|526115286|FG001|Overall Study|Lost to Follow-up|9|||
145893264|NCT00076804|526115285|FG000|Overall Study|Withdrawal by Subject|10|||
145893265|NCT00076804|526115286|FG001|Overall Study|Withdrawal by Subject|8|||
145893266|NCT00076804|526115285|FG000|Overall Study|Early study Closure|32|||
145893267|NCT00076804|526115286|FG001|Overall Study|Early study Closure|32|||
145893268|NCT00354341|526115287|FG000|Overall Study|Adverse Event|1|||
145893269|NCT00354341|526115288|FG001|Overall Study|Adverse Event|0|||
145893270|NCT00354341|526115287|FG000|Overall Study|Death|0|||
145893271|NCT00354341|526115288|FG001|Overall Study|Death|2|||
145893272|NCT00354341|526115287|FG000|Overall Study|Refused treatment|1|||
145893273|NCT00354341|526115288|FG001|Overall Study|Refused treatment|2|||
145893274|NCT00354341|526115287|FG000|Overall Study|Failure to return|0|||
145893275|NCT00354341|526115288|FG001|Overall Study|Failure to return|1|||
145893276|NCT00354341|526115287|FG000|Overall Study|Other|1|||
145893277|NCT00354341|526115288|FG001|Overall Study|Other|2|||
145893278|NCT04295135|526115289|FG000|Overall Study|Withdrawal by Subject|2|||
145893279|NCT04295135|526115290|FG001|Overall Study|Withdrawal by Subject|1|||
145893280|NCT04295135|526115289|FG000|Overall Study|Subject left organization|8|||
145893281|NCT04295135|526115290|FG001|Overall Study|Subject left organization|4|||
145893282|NCT03463993|526115293|FG000|Overall Study|Lost to Follow-up|7|||
145893283|NCT03463993|526115294|FG001|Overall Study|Lost to Follow-up|8|||
145893284|NCT03463993|526115293|FG000|Overall Study|Withdrawal by Subject|2|||
145893285|NCT03463993|526115294|FG001|Overall Study|Withdrawal by Subject|0|||
145893286|NCT03463993|526115293|FG000|Overall Study|Protocol Violation|4|||
145893287|NCT03463993|526115294|FG001|Overall Study|Protocol Violation|1|||
145893288|NCT03463993|526115293|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
145893289|NCT03463993|526115294|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
145893290|NCT03463993|526115293|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
145893291|NCT03463993|526115294|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
145893292|NCT02566993|526115295|FG000|Overall Study|Randomized but not treated|5|||
145893293|NCT02566993|526115296|FG001|Overall Study|Randomized but not treated|16|||
145893294|NCT02566993|526115295|FG000|Overall Study|Progressive disease|213|||
145893295|NCT02566993|526115296|FG001|Overall Study|Progressive disease|152|||
145893296|NCT02566993|526115295|FG000|Overall Study|Withdrawal by Subject|12|||
145893297|NCT02566993|526115296|FG001|Overall Study|Withdrawal by Subject|28|||
145893298|NCT02566993|526115295|FG000|Overall Study|Death|17|||
145893299|NCT02566993|526115296|FG001|Overall Study|Death|23|||
145893300|NCT02566993|526115295|FG000|Overall Study|Physician Decision|10|||
145893301|NCT02566993|526115296|FG001|Overall Study|Physician Decision|17|||
145893302|NCT02566993|526115295|FG000|Overall Study|Study drug-related adverse event|20|||
145893303|NCT02566993|526115296|FG001|Overall Study|Study drug-related adverse event|41|||
145893304|NCT02566993|526115295|FG000|Overall Study|Non study drug-related adverse event|9|||
145893305|NCT02566993|526115296|FG001|Overall Study|Non study drug-related adverse event|9|||
145893306|NCT02566993|526115295|FG000|Overall Study|Symptomatic deterioration|9|||
145893307|NCT02566993|526115296|FG001|Overall Study|Symptomatic deterioration|16|||
145893308|NCT02566993|526115295|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
145893309|NCT02566993|526115296|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
145893310|NCT02566993|526115295|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
145893311|NCT02566993|526115296|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
145893312|NCT02566993|526115295|FG000|Overall Study|Screening failure|2|||
145893313|NCT02566993|526115296|FG001|Overall Study|Screening failure|0|||
145893314|NCT02566993|526115295|FG000|Overall Study|Lost to Follow-up|0|||
145893315|NCT02566993|526115296|FG001|Overall Study|Lost to Follow-up|1|||
145893316|NCT02566993|526115295|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
145893317|NCT02566993|526115296|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
145893318|NCT01546649|526115299|FG000|Overall Study|Adverse Event|4|||
145893319|NCT01546649|526115300|FG001|Overall Study|Adverse Event|5|||
146236448|NCT03375320|527381075|FG000|Overall Study|Other disease|1|||
146236449|NCT03375320|527381076|FG001|Overall Study|Other disease|1|||
145893320|NCT01546649|526115299|FG000|Overall Study|Protocol Violation|1|||
145893321|NCT01546649|526115300|FG001|Overall Study|Protocol Violation|0|||
145893322|NCT01546649|526115299|FG000|Overall Study|Lack of Efficacy|1|||
145893323|NCT01546649|526115300|FG001|Overall Study|Lack of Efficacy|0|||
145893324|NCT01546649|526115299|FG000|Overall Study|Recurrence|1|||
145893325|NCT01546649|526115300|FG001|Overall Study|Recurrence|1|||
145893326|NCT01546649|526115299|FG000|Overall Study|Discovery of secondary cancer|0|||
145893327|NCT01546649|526115300|FG001|Overall Study|Discovery of secondary cancer|1|||
145893328|NCT01546649|526115299|FG000|Overall Study|Withdrawal by Subject|1|||
145893329|NCT01546649|526115300|FG001|Overall Study|Withdrawal by Subject|2|||
145893330|NCT01621191|526115302|FG000|Overall Study|Adverse Event|9|||
145893331|NCT01621191|526115302|FG000|Overall Study|Withdrawal by Subject|8|||
145893332|NCT01621191|526115302|FG000|Overall Study|Lack of Efficacy|6|||
145893333|NCT01621191|526115302|FG000|Overall Study|Lost to Follow-up|1|||
145893334|NCT01621191|526115302|FG000|Overall Study|Site Removed From Study|1|||
145893335|NCT02143583|526115306|FG000|Overall Study|Withdrawal by Subject|1|||
145893336|NCT02143583|526115307|FG001|Overall Study|Withdrawal by Subject|0|||
145893337|NCT02143583|526115308|FG002|Overall Study|Withdrawal by Subject|1|||
145893338|NCT02143583|526115306|FG000|Overall Study|husband illness|0|||
145893339|NCT02143583|526115307|FG001|Overall Study|husband illness|0|||
145893340|NCT02143583|526115308|FG002|Overall Study|husband illness|1|||
145893341|NCT01641133|526115309|FG000|Overall Study|Protocol Violation|0|||
145893342|NCT01641133|526115310|FG001|Overall Study|Protocol Violation|1|||
145893343|NCT01641133|526115311|FG002|Overall Study|Protocol Violation|1|||
145893344|NCT01641133|526115309|FG000|Overall Study|Migrated/moved from study area|5|||
145893345|NCT01641133|526115310|FG001|Overall Study|Migrated/moved from study area|3|||
145893346|NCT01641133|526115311|FG002|Overall Study|Migrated/moved from study area|1|||
145893347|NCT01641133|526115309|FG000|Overall Study|Adverse Event|0|||
145893348|NCT01641133|526115310|FG001|Overall Study|Adverse Event|0|||
145893349|NCT01641133|526115311|FG002|Overall Study|Adverse Event|1|||
145893350|NCT01641133|526115309|FG000|Overall Study|Withdrawal by Subject|5|||
145893351|NCT01641133|526115310|FG001|Overall Study|Withdrawal by Subject|3|||
145893352|NCT01641133|526115311|FG002|Overall Study|Withdrawal by Subject|3|||
145893353|NCT01641133|526115309|FG000|Overall Study|Lost to Follow-up|0|||
145893354|NCT01641133|526115310|FG001|Overall Study|Lost to Follow-up|2|||
145893355|NCT01641133|526115311|FG002|Overall Study|Lost to Follow-up|2|||
145893356|NCT01393730|526115312|FG000|Overall Study|Withdrawal by Subject|3|||
145893357|NCT01393730|526115312|FG000|Overall Study|Other|2|||
145893358|NCT01393730|526115312|FG000|Overall Study|Adverse Event|1|||
145893359|NCT00103402|526115313|FG000|Overall Study|Adverse Event|3|||
145893360|NCT00103402|526115314|FG001|Overall Study|Adverse Event|4|||
145893361|NCT00103402|526115313|FG000|Overall Study|Lost to Follow-up|8|||
145893362|NCT00103402|526115314|FG001|Overall Study|Lost to Follow-up|7|||
145893363|NCT00103402|526115313|FG000|Overall Study|Dissatisfied/No longer interested|6|||
145893364|NCT00103402|526115314|FG001|Overall Study|Dissatisfied/No longer interested|6|||
145893365|NCT00103402|526115313|FG000|Overall Study|Personal constraints/Other|5|||
145893366|NCT00103402|526115314|FG001|Overall Study|Personal constraints/Other|0|||
145893367|NCT02674061|526115315|FG000|Overall Study|Death|229|||
145893368|NCT02674061|526115316|FG001|Overall Study|Death|77|||
145893369|NCT02674061|526115315|FG000|Overall Study|Lost to Follow-up|3|||
145893370|NCT02674061|526115316|FG001|Overall Study|Lost to Follow-up|3|||
145893371|NCT02674061|526115315|FG000|Overall Study|Withdrawal by Subject|9|||
145893372|NCT02674061|526115316|FG001|Overall Study|Withdrawal by Subject|1|||
145893373|NCT02674061|526115315|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
145971293|NCT02110693|526408802|FG001|Overall Study|Other|0|||
145971294|NCT04154956|526408805|FG000|Overall Study|Death|109|||
145971295|NCT04154956|526408806|FG001|Overall Study|Death|110|||
145971296|NCT04154956|526408805|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
145971297|NCT04154956|526408806|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
146236450|NCT03375320|527381077|FG002|Overall Study|Other disease|3|||
146236451|NCT03375320|527381078|FG003|Overall Study|Other disease|0|||
146236452|NCT03375320|527381075|FG000|Overall Study|Withdrawal prior to initiation|2|||
146236453|NCT03375320|527381076|FG001|Overall Study|Withdrawal prior to initiation|2|||
145893374|NCT02674061|526115316|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
145893375|NCT03334721|526115319|FG000|Overall Study|Withdrawal by Subject|1|||
145893376|NCT03334721|526115320|FG001|Overall Study|Withdrawal by Subject|0|||
145893377|NCT03334721|526115319|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
145893378|NCT03334721|526115320|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
145893379|NCT04189445|526117177|FG000|Overall Study|Withdrawal of consent|8|||
145893380|NCT04189445|526117178|FG001|Overall Study|Withdrawal of consent|1|||
145893381|NCT04189445|526117179|FG002|Overall Study|Withdrawal of consent|0|||
145893382|NCT04189445|526117177|FG000|Overall Study|Study Terminated by Sponsor|25|||
145893383|NCT04189445|526117178|FG001|Overall Study|Study Terminated by Sponsor|3|||
145893384|NCT04189445|526117179|FG002|Overall Study|Study Terminated by Sponsor|0|||
145893385|NCT04189445|526117177|FG000|Overall Study|Death|54|||
145893386|NCT04189445|526117178|FG001|Overall Study|Death|24|||
145893387|NCT04189445|526117179|FG002|Overall Study|Death|0|||
145893388|NCT02960893|526117181|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
145893389|NCT02960893|526117182|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
145971298|NCT04154956|526408805|FG000|Overall Study|Withdrawal by Subject|1|||
146236454|NCT03375320|527381077|FG002|Overall Study|Withdrawal prior to initiation|1|||
146236455|NCT03375320|527381078|FG003|Overall Study|Withdrawal prior to initiation|0|||
146236456|NCT03375320|527381075|FG000|Overall Study|Physician Decision|1|||
146236457|NCT03375320|527381076|FG001|Overall Study|Physician Decision|1|||
146236458|NCT03375320|527381077|FG002|Overall Study|Physician Decision|1|||
146236459|NCT03375320|527381078|FG003|Overall Study|Physician Decision|1|||
146236460|NCT03375320|527381075|FG000|Overall Study|Non-compliance|1|||
146236461|NCT03375320|527381076|FG001|Overall Study|Non-compliance|0|||
146236462|NCT03375320|527381077|FG002|Overall Study|Non-compliance|0|||
146236463|NCT03375320|527381078|FG003|Overall Study|Non-compliance|0|||
146236464|NCT02787005|527381079|FG000|Overall Study|Adverse Event|24|||
146236465|NCT02787005|527381080|FG001|Overall Study|Adverse Event|9|||
146236466|NCT02787005|527381081|FG002|Overall Study|Adverse Event|9|||
146236467|NCT02787005|527381082|FG003|Overall Study|Adverse Event|7|||
146236468|NCT02787005|527381083|FG004|Overall Study|Adverse Event|2|||
146236469|NCT02787005|527381079|FG000|Overall Study|Death|100|||
146236470|NCT02787005|527381080|FG001|Overall Study|Death|53|||
146236471|NCT02787005|527381081|FG002|Overall Study|Death|48|||
146236472|NCT02787005|527381082|FG003|Overall Study|Death|69|||
146236473|NCT02787005|527381083|FG004|Overall Study|Death|38|||
146236474|NCT02787005|527381079|FG000|Overall Study|Sponsor Decision|7|||
146236475|NCT02787005|527381080|FG001|Overall Study|Sponsor Decision|4|||
146236476|NCT02787005|527381081|FG002|Overall Study|Sponsor Decision|0|||
146236477|NCT02787005|527381082|FG003|Overall Study|Sponsor Decision|4|||
146236478|NCT02787005|527381083|FG004|Overall Study|Sponsor Decision|5|||
146236479|NCT02787005|527381079|FG000|Overall Study|Withdrawal by Subject|2|||
146236480|NCT02787005|527381080|FG001|Overall Study|Withdrawal by Subject|1|||
146236481|NCT02787005|527381081|FG002|Overall Study|Withdrawal by Subject|1|||
146236482|NCT02787005|527381082|FG003|Overall Study|Withdrawal by Subject|0|||
146236483|NCT02787005|527381083|FG004|Overall Study|Withdrawal by Subject|1|||
146236484|NCT02787005|527381079|FG000|Overall Study|Screen Failure|0|||
146236485|NCT02787005|527381080|FG001|Overall Study|Screen Failure|2|||
146236486|NCT02787005|527381081|FG002|Overall Study|Screen Failure|0|||
146236487|NCT02787005|527381082|FG003|Overall Study|Screen Failure|0|||
146236488|NCT02787005|527381083|FG004|Overall Study|Screen Failure|1|||
146236489|NCT02787005|527381079|FG000|Overall Study|Lost to Follow-up|0|||
146236490|NCT02787005|527381080|FG001|Overall Study|Lost to Follow-up|0|||
146236491|NCT02787005|527381081|FG002|Overall Study|Lost to Follow-up|0|||
146236492|NCT02787005|527381082|FG003|Overall Study|Lost to Follow-up|1|||
146236493|NCT02787005|527381083|FG004|Overall Study|Lost to Follow-up|0|||
146236494|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146236495|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
146236496|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146236497|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
146236498|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146236499|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
146236500|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146236501|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146236502|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146236503|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146236504|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
146236505|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
146236506|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146236507|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146236508|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146236509|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146236510|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
146236511|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
146236512|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
146236513|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146236514|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146236515|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
146236516|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146236517|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
146236518|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146236519|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146236520|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146236521|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146236522|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
146236523|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
146236524|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
146236525|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
146236526|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
146236527|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
146236528|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
146088151|NCT01986933|526841960|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
146236529|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
146236530|NCT02392234|527381084|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146236531|NCT02392234|527381085|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146236532|NCT02392234|527381086|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
146236533|NCT02392234|527381087|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146236534|NCT02392234|527381088|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
146236535|NCT02392234|527381089|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
146236536|NCT02392234|527381084|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
146236537|NCT02392234|527381085|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146236538|NCT02392234|527381086|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146236539|NCT02392234|527381087|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146236540|NCT02392234|527381088|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146236541|NCT02392234|527381089|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
146236542|NCT01387516|527381090|FG000|Overall Study|Lost to Follow-up|4|||
146236543|NCT01387516|527381091|FG001|Overall Study|Lost to Follow-up|4|||
146236544|NCT01387516|527381092|FG002|Overall Study|Lost to Follow-up|2|||
146236545|NCT01387516|527381093|FG003|Overall Study|Lost to Follow-up|3|||
146236546|NCT01387516|527381090|FG000|Overall Study|Withdrawal by Subject|1|||
146236547|NCT01387516|527381091|FG001|Overall Study|Withdrawal by Subject|1|||
146236548|NCT01387516|527381092|FG002|Overall Study|Withdrawal by Subject|2|||
146236549|NCT01387516|527381093|FG003|Overall Study|Withdrawal by Subject|0|||
146236550|NCT01387516|527381090|FG000|Overall Study|Death|0|||
146236551|NCT01387516|527381091|FG001|Overall Study|Death|0|||
146236552|NCT01387516|527381092|FG002|Overall Study|Death|0|||
146236553|NCT01387516|527381093|FG003|Overall Study|Death|1|||
146236554|NCT03170648|527381096|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
146236555|NCT03170648|527381096|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
146236556|NCT02052440|527381097|FG000|Overall Study|Withdrawal by Subject|0|||
146236557|NCT02052440|527381098|FG001|Overall Study|Withdrawal by Subject|1|||
146236558|NCT03509909|527381099|FG000|Overall Study|Withdrawal by Subject|16|||
146236559|NCT03509909|527381100|FG001|Overall Study|Withdrawal by Subject|9|||
146236560|NCT03509909|527381099|FG000|Overall Study|Lost to Follow-up|3|||
146236561|NCT03509909|527381100|FG001|Overall Study|Lost to Follow-up|4|||
146236562|NCT03509909|527381099|FG000|Overall Study|Adverse Event|2|||
146236563|NCT03509909|527381100|FG001|Overall Study|Adverse Event|0|||
146236564|NCT04325828|527381101|FG000|Overall Study|Ongoing|26|||
146236565|NCT05509816|527381102|FG000|Overall Study|Lost to Follow-up|1|||
146236566|NCT02130557|527381103|FG000|Overall Study|Withdrawal by Subject|12|||
146236567|NCT02130557|527381104|FG001|Overall Study|Withdrawal by Subject|12|||
146236568|NCT02130557|527381103|FG000|Overall Study|Investigator Request|0|||
146236569|NCT02130557|527381104|FG001|Overall Study|Investigator Request|2|||
146236570|NCT02130557|527381103|FG000|Overall Study|Deceased|14|||
146236571|NCT02130557|527381104|FG001|Overall Study|Deceased|14|||
146236572|NCT02130557|527381103|FG000|Overall Study|Lost to Follow-up|6|||
146236573|NCT02130557|527381104|FG001|Overall Study|Lost to Follow-up|7|||
146236574|NCT02130557|527381103|FG000|Overall Study|Other|2|||
146236575|NCT02130557|527381104|FG001|Overall Study|Other|1|||
146236576|NCT02130557|527381103|FG000|Overall Study|Missing|2|||
146236577|NCT02130557|527381104|FG001|Overall Study|Missing|1|||
146236578|NCT04066075|527381105|FG000|Overall Study|Lost to Follow-up|3|||
146236579|NCT04066075|527381106|FG001|Overall Study|Lost to Follow-up|3|||
146236580|NCT04066075|527381105|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
146236581|NCT04066075|527381106|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
146236582|NCT04066075|527381105|FG000|Overall Study|Withdrawal by Subject|2|||
146236583|NCT04066075|527381106|FG001|Overall Study|Withdrawal by Subject|2|||
146236584|NCT00309166|527381107|FG000|Overall Study|Adverse event, non-fatal|1|||
146236585|NCT00309166|527381108|FG001|Overall Study|Adverse event, non-fatal|0|||
146236586|NCT00309166|527381107|FG000|Overall Study|Withdrawal by Subject|4|||
146236587|NCT00309166|527381108|FG001|Overall Study|Withdrawal by Subject|3|||
146236588|NCT04801420|527381113|FG000|Overall Study|Other|1|||
146236589|NCT04801420|527381114|FG001|Overall Study|Other|2|||
146236590|NCT04801420|527381115|FG002|Overall Study|Other|1|||
146236591|NCT04801420|527381113|FG000|Overall Study|Lost to Follow-up|7|||
145971299|NCT04154956|526408806|FG001|Overall Study|Withdrawal by Subject|7|||
145971300|NCT04154956|526408805|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
146236592|NCT04801420|527381114|FG001|Overall Study|Lost to Follow-up|9|||
146236593|NCT04801420|527381115|FG002|Overall Study|Lost to Follow-up|10|||
146236594|NCT04801420|527381113|FG000|Overall Study|Moved from study area|0|||
146236595|NCT04801420|527381114|FG001|Overall Study|Moved from study area|1|||
146236596|NCT04801420|527381115|FG002|Overall Study|Moved from study area|1|||
146295618|NCT04796896|527597615|FG009|Overall Study|Missing|1|||
146236597|NCT04801420|527381113|FG000|Overall Study|Withdrawal by Subject|5|||
146236598|NCT04801420|527381114|FG001|Overall Study|Withdrawal by Subject|1|||
146236599|NCT04801420|527381115|FG002|Overall Study|Withdrawal by Subject|4|||
146236600|NCT04801420|527381113|FG000|Overall Study|Individual stopping criteria reached|0|||
146236601|NCT04801420|527381114|FG001|Overall Study|Individual stopping criteria reached|1|||
145971301|NCT04154956|526408806|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
145971302|NCT00147238|526408807|FG000|Overall Study|Inevaluable|8|||
145971303|NCT04424901|526408808|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
145971304|NCT04424901|526408809|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
145971305|NCT01348269|526408810|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
145971306|NCT01348269|526408811|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
145971307|NCT01348269|526408810|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
145971308|NCT01348269|526408811|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
145971309|NCT01348269|526408810|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
145971310|NCT01348269|526408811|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
146236602|NCT04801420|527381115|FG002|Overall Study|Individual stopping criteria reached|0|||
146236603|NCT04801420|527381113|FG000|Overall Study|Ongoing in the study|195|||
146236604|NCT04801420|527381114|FG001|Overall Study|Ongoing in the study|195|||
146236605|NCT04801420|527381115|FG002|Overall Study|Ongoing in the study|192|||
146236606|NCT03907488|527381116|FG000|Overall Study|Adverse Event|20|||
146236607|NCT03907488|527381117|FG001|Overall Study|Adverse Event|20|||
146236608|NCT03907488|527381116|FG000|Overall Study|Withdrawal by Subject|9|||
146236609|NCT03907488|527381117|FG001|Overall Study|Withdrawal by Subject|13|||
146236610|NCT03907488|527381116|FG000|Overall Study|Lack of Efficacy|0|||
146236611|NCT03907488|527381117|FG001|Overall Study|Lack of Efficacy|9|||
146236612|NCT03907488|527381116|FG000|Overall Study|Death|3|||
146236613|NCT03907488|527381117|FG001|Overall Study|Death|8|||
146236614|NCT03907488|527381116|FG000|Overall Study|not protocol specified|5|||
146236615|NCT03907488|527381117|FG001|Overall Study|not protocol specified|8|||
146236616|NCT03907488|527381116|FG000|Overall Study|Ineligible|9|||
146236617|NCT03907488|527381117|FG001|Overall Study|Ineligible|15|||
146236618|NCT01675492|527381118|FG000|Overall Study|study completed early - product approval|42|||
146236619|NCT04218357|527381119|FG000|1st Allocation|Withdrawal by Subject|1|||
146236620|NCT04218357|527381120|FG001|1st Allocation|Withdrawal by Subject|0|||
146236621|NCT05349838|527381121|FG000|Overall Study|Virological Failure|1|||
146236622|NCT05349838|527381122|FG001|Overall Study|Virological Failure|2|||
146236623|NCT05349838|527381121|FG000|Overall Study|Withdrawal by Subject|2|||
146236624|NCT05349838|527381122|FG001|Overall Study|Withdrawal by Subject|3|||
146236625|NCT05349838|527381121|FG000|Overall Study|Adverse Event|3|||
146236626|NCT05349838|527381122|FG001|Overall Study|Adverse Event|1|||
146236627|NCT05349838|527381121|FG000|Overall Study|Lost to Follow-up|1|||
146236628|NCT05349838|527381122|FG001|Overall Study|Lost to Follow-up|2|||
146236629|NCT05349838|527381121|FG000|Overall Study|Other reasons|5|||
146236630|NCT05349838|527381122|FG001|Overall Study|Other reasons|1|||
146236631|NCT04484623|527381124|FG000|Overall Study|Lost to Follow-up|0|||
146236632|NCT04484623|527381125|FG001|Overall Study|Lost to Follow-up|1|||
146236633|NCT04484623|527381124|FG000|Overall Study|Protocol Deviation|1|||
146236634|NCT04484623|527381125|FG001|Overall Study|Protocol Deviation|0|||
146236635|NCT04484623|527381124|FG000|Overall Study|Physician Decision|1|||
146236636|NCT04484623|527381125|FG001|Overall Study|Physician Decision|0|||
146236637|NCT04484623|527381124|FG000|Overall Study|Withdrawal by Subject|11|||
146236638|NCT04484623|527381125|FG001|Overall Study|Withdrawal by Subject|8|||
146236639|NCT04484623|527381124|FG000|Overall Study|Ongoing|94|||
146236640|NCT04484623|527381125|FG001|Overall Study|Ongoing|84|||
146236641|NCT00092534|527382655|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
146236642|NCT00092534|527382656|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
146236643|NCT00092534|527382657|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146236644|NCT00092534|527382658|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146236645|NCT00092534|527382659|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
146236646|NCT00092534|527382655|FG000|Base Study Vaccination Period|Adverse Event|3|||
146236647|NCT00092534|527382656|FG001|Base Study Vaccination Period|Adverse Event|1|||
146236648|NCT00092534|527382657|FG002|Base Study Vaccination Period|Adverse Event|0|||
146236649|NCT00092534|527382658|FG003|Base Study Vaccination Period|Adverse Event|0|||
146236650|NCT00092534|527382659|FG004|Base Study Vaccination Period|Adverse Event|0|||
146236651|NCT00092534|527382655|FG000|Base Study Vaccination Period|Death|5|||
146236652|NCT00092534|527382656|FG001|Base Study Vaccination Period|Death|4|||
146236653|NCT00092534|527382657|FG002|Base Study Vaccination Period|Death|0|||
146236654|NCT00092534|527382658|FG003|Base Study Vaccination Period|Death|0|||
146236655|NCT00092534|527382659|FG004|Base Study Vaccination Period|Death|0|||
146236656|NCT00092534|527382655|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
146236657|NCT00092534|527382656|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
146236658|NCT00092534|527382657|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
146236659|NCT00092534|527382658|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
146236660|NCT00092534|527382659|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146236661|NCT00092534|527382655|FG000|Base Study Vaccination Period|Physician Decision|1|||
145971311|NCT00805532|526408812|FG000|Overall Study|invalid data|0|||
145971312|NCT00805532|526408813|FG001|Overall Study|invalid data|1|||
146236662|NCT00092534|527382656|FG001|Base Study Vaccination Period|Physician Decision|0|||
146236663|NCT00092534|527382657|FG002|Base Study Vaccination Period|Physician Decision|0|||
146236664|NCT00092534|527382658|FG003|Base Study Vaccination Period|Physician Decision|0|||
146236665|NCT00092534|527382659|FG004|Base Study Vaccination Period|Physician Decision|0|||
146236666|NCT00092534|527382655|FG000|Base Study Vaccination Period|Pregnancy|9|||
146236667|NCT00092534|527382656|FG001|Base Study Vaccination Period|Pregnancy|7|||
146236668|NCT00092534|527382657|FG002|Base Study Vaccination Period|Pregnancy|0|||
146236669|NCT00092534|527382658|FG003|Base Study Vaccination Period|Pregnancy|0|||
145971313|NCT01859741|526408814|FG000|Overall Study|Death|3|||
146236670|NCT00092534|527382659|FG004|Base Study Vaccination Period|Pregnancy|0|||
146236671|NCT00092534|527382655|FG000|Base Study Vaccination Period|Protocol Violation|2|||
146295619|NCT04796896|527597616|FG010|Overall Study|Missing|1|||
146295620|NCT04796896|527597617|FG011|Overall Study|Missing|0|||
146295621|NCT04796896|527597606|FG000|Overall Study|Death|0|||
146295622|NCT04796896|527597607|FG001|Overall Study|Death|0|||
146295623|NCT04796896|527597608|FG002|Overall Study|Death|0|||
146295624|NCT04796896|527597609|FG003|Overall Study|Death|0|||
146295625|NCT04796896|527597610|FG004|Overall Study|Death|0|||
146295626|NCT04796896|527597611|FG005|Overall Study|Death|0|||
146295627|NCT04796896|527597612|FG006|Overall Study|Death|0|||
146295628|NCT04796896|527597613|FG007|Overall Study|Death|0|||
146295629|NCT04796896|527597614|FG008|Overall Study|Death|1|||
146295630|NCT04796896|527597615|FG009|Overall Study|Death|0|||
146295631|NCT04796896|527597616|FG010|Overall Study|Death|0|||
146295632|NCT04796896|527597617|FG011|Overall Study|Death|0|||
146295633|NCT05972733|527597620|FG000|Overall Study|Lost to Follow-up|2|||
146295634|NCT05972733|527597620|FG000|Overall Study|Withdrawal by Subject|1|||
146295635|NCT01177787|527597623|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
146295636|NCT01177787|527597623|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
146295637|NCT01177787|527597623|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
146295638|NCT02824263|527597630|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
146295639|NCT02824263|527597631|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
146295640|NCT02824263|527597630|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
146295641|NCT02824263|527597631|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
146295642|NCT00568321|527597632|FG000|Overall Study|Adverse Event|1|||
146295643|NCT00568321|527597633|FG001|Overall Study|Adverse Event|0|||
146295644|NCT00568321|527597634|FG002|Overall Study|Adverse Event|0|||
146295645|NCT00568321|527597632|FG000|Overall Study|Lack of Efficacy|8|||
146295646|NCT00568321|527597633|FG001|Overall Study|Lack of Efficacy|5|||
146295647|NCT00568321|527597634|FG002|Overall Study|Lack of Efficacy|6|||
146295648|NCT00568321|527597632|FG000|Overall Study|Lost to Follow-up|0|||
146295649|NCT00568321|527597633|FG001|Overall Study|Lost to Follow-up|0|||
146295650|NCT00568321|527597634|FG002|Overall Study|Lost to Follow-up|1|||
146295651|NCT00568321|527597632|FG000|Overall Study|Withdrawal by Subject|2|||
146295652|NCT00568321|527597633|FG001|Overall Study|Withdrawal by Subject|0|||
146295653|NCT00568321|527597634|FG002|Overall Study|Withdrawal by Subject|0|||
146295654|NCT00568321|527597632|FG000|Overall Study|Protocol Violation|0|||
146295655|NCT00568321|527597633|FG001|Overall Study|Protocol Violation|0|||
146295656|NCT00568321|527597634|FG002|Overall Study|Protocol Violation|1|||
146295657|NCT00568321|527597632|FG000|Overall Study|Randomized, not treated|2|||
146295658|NCT00568321|527597633|FG001|Overall Study|Randomized, not treated|0|||
146295659|NCT00568321|527597634|FG002|Overall Study|Randomized, not treated|1|||
146295660|NCT01676909|527597636|FG000|Overall Study|Withdrawal by Subject|3|||
146295661|NCT01676909|527597637|FG001|Overall Study|Withdrawal by Subject|5|||
146295662|NCT01676909|527597636|FG000|Overall Study|Lost to Follow-up|15|||
146295663|NCT01676909|527597637|FG001|Overall Study|Lost to Follow-up|9|||
146295664|NCT02076113|527597638|FG000|Overall Study|Lost to Follow-up|4|||
146295665|NCT02076113|527597639|FG001|Overall Study|Lost to Follow-up|1|||
146295666|NCT02076113|527597638|FG000|Overall Study|Withdrawal by Subject|2|||
146295667|NCT02076113|527597639|FG001|Overall Study|Withdrawal by Subject|3|||
146295668|NCT02076113|527597638|FG000|Overall Study|Death|1|||
146236672|NCT00092534|527382656|FG001|Base Study Vaccination Period|Protocol Violation|1|||
146236673|NCT00092534|527382657|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146236674|NCT00092534|527382658|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146236675|NCT00092534|527382659|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146236676|NCT00092534|527382655|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
146236677|NCT00092534|527382656|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
146236678|NCT00092534|527382657|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
146236679|NCT00092534|527382658|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
145971314|NCT01859741|526408815|FG001|Overall Study|Death|2|||
146236680|NCT00092534|527382659|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146236681|NCT00092534|527382655|FG000|Base Study Vaccination Period|Moved|14|||
146236682|NCT00092534|527382656|FG001|Base Study Vaccination Period|Moved|12|||
146236683|NCT00092534|527382657|FG002|Base Study Vaccination Period|Moved|0|||
146236684|NCT00092534|527382658|FG003|Base Study Vaccination Period|Moved|0|||
146236685|NCT00092534|527382659|FG004|Base Study Vaccination Period|Moved|0|||
146295669|NCT02076113|527597639|FG001|Overall Study|Death|3|||
146295670|NCT01176968|527597643|FG000|Overall Study|Adverse Event|10|||
146295671|NCT01176968|527597644|FG001|Overall Study|Adverse Event|11|||
146295672|NCT01176968|527597643|FG000|Overall Study|Death|2|||
146236686|NCT00092534|527382655|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
146295673|NCT01176968|527597644|FG001|Overall Study|Death|3|||
146295674|NCT01176968|527597643|FG000|Overall Study|Lack of Efficacy|0|||
146295675|NCT01176968|527597644|FG001|Overall Study|Lack of Efficacy|1|||
146295676|NCT01176968|527597643|FG000|Overall Study|Lost to Follow-up|16|||
146295677|NCT01176968|527597644|FG001|Overall Study|Lost to Follow-up|14|||
146295678|NCT01176968|527597643|FG000|Overall Study|Withdrawal by Subject|48|||
146295679|NCT01176968|527597644|FG001|Overall Study|Withdrawal by Subject|48|||
146295680|NCT01176968|527597643|FG000|Overall Study|Protocol Violation|2|||
146236687|NCT00092534|527382656|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146236688|NCT00092534|527382657|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146236689|NCT00092534|527382658|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146236690|NCT00092534|527382659|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
146236691|NCT00092534|527382655|FG000|Base Study Vaccination Period|Travel|1|||
146236692|NCT00092534|527382656|FG001|Base Study Vaccination Period|Travel|0|||
146236693|NCT00092534|527382657|FG002|Base Study Vaccination Period|Travel|0|||
146236694|NCT00092534|527382658|FG003|Base Study Vaccination Period|Travel|0|||
146236695|NCT00092534|527382659|FG004|Base Study Vaccination Period|Travel|0|||
146236696|NCT00092534|527382655|FG000|Base Study Vaccination Period|Site Closed|0|||
146236697|NCT00092534|527382656|FG001|Base Study Vaccination Period|Site Closed|1|||
146236698|NCT00092534|527382657|FG002|Base Study Vaccination Period|Site Closed|0|||
146236699|NCT00092534|527382658|FG003|Base Study Vaccination Period|Site Closed|0|||
146236700|NCT00092534|527382659|FG004|Base Study Vaccination Period|Site Closed|0|||
146236701|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Adverse Event|2|||
146236702|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Adverse Event|4|||
146236703|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Adverse Event|0|||
146236704|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Adverse Event|0|||
146236705|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Adverse Event|0|||
146236706|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Death|2|||
146236707|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Death|1|||
146236708|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Death|0|||
146236709|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Death|0|||
146236710|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Death|0|||
146236711|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
146236712|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
146236713|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
146236714|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
146236715|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
146236716|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Pregnancy|6|||
146236717|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Pregnancy|10|||
146236718|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Pregnancy|0|||
146236719|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Pregnancy|0|||
146236720|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Pregnancy|0|||
146236721|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
146236722|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
146236723|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
146236724|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
146236725|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
146236726|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
146236727|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
146236728|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146236729|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146236730|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
146236731|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Moved|62|||
146236732|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Moved|58|||
146236733|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Moved|0|||
146236734|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Moved|0|||
146236735|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Moved|0|||
146236736|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Travel|10|||
146236737|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Travel|7|||
146236738|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Travel|0|||
146236739|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Travel|0|||
146236740|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Travel|0|||
146236741|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Site Closed|0|||
146236742|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Site Closed|2|||
146236743|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Site Closed|0|||
146236744|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Site Closed|0|||
146236745|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Site Closed|0|||
146236746|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
146236747|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
146236748|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
146236749|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
146236750|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
146236751|NCT00092534|527382655|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
146236752|NCT00092534|527382656|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
146236753|NCT00092534|527382657|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
146236754|NCT00092534|527382658|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
146236755|NCT00092534|527382659|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
146236756|NCT00092534|527382655|FG000|Base Study EXT|Lost to Follow-up|0|||
146236757|NCT00092534|527382656|FG001|Base Study EXT|Lost to Follow-up|0|||
146236758|NCT00092534|527382657|FG002|Base Study EXT|Lost to Follow-up|41|||
146236759|NCT00092534|527382658|FG003|Base Study EXT|Lost to Follow-up|0|||
146236760|NCT00092534|527382659|FG004|Base Study EXT|Lost to Follow-up|0|||
146236761|NCT00092534|527382655|FG000|Base Study EXT|Physician Decision|0|||
146236762|NCT00092534|527382656|FG001|Base Study EXT|Physician Decision|0|||
146236763|NCT00092534|527382657|FG002|Base Study EXT|Physician Decision|1|||
146236764|NCT00092534|527382658|FG003|Base Study EXT|Physician Decision|0|||
146236765|NCT00092534|527382659|FG004|Base Study EXT|Physician Decision|0|||
146236766|NCT00092534|527382655|FG000|Base Study EXT|Pregnancy|0|||
146236767|NCT00092534|527382656|FG001|Base Study EXT|Pregnancy|0|||
146236768|NCT00092534|527382657|FG002|Base Study EXT|Pregnancy|12|||
146236769|NCT00092534|527382658|FG003|Base Study EXT|Pregnancy|0|||
146236770|NCT00092534|527382659|FG004|Base Study EXT|Pregnancy|0|||
146236771|NCT00092534|527382655|FG000|Base Study EXT|Withdrawal by Subject|0|||
146236772|NCT00092534|527382656|FG001|Base Study EXT|Withdrawal by Subject|0|||
146236773|NCT00092534|527382657|FG002|Base Study EXT|Withdrawal by Subject|18|||
146236774|NCT00092534|527382658|FG003|Base Study EXT|Withdrawal by Subject|0|||
146236775|NCT00092534|527382659|FG004|Base Study EXT|Withdrawal by Subject|0|||
146236776|NCT00092534|527382655|FG000|Base Study EXT|Participant moved|0|||
146236777|NCT00092534|527382656|FG001|Base Study EXT|Participant moved|0|||
146236778|NCT00092534|527382657|FG002|Base Study EXT|Participant moved|6|||
146236779|NCT00092534|527382658|FG003|Base Study EXT|Participant moved|0|||
146236780|NCT00092534|527382659|FG004|Base Study EXT|Participant moved|0|||
146236781|NCT00092534|527382655|FG000|Base Study EXT|Travel|0|||
146236782|NCT00092534|527382656|FG001|Base Study EXT|Travel|0|||
146236783|NCT00092534|527382657|FG002|Base Study EXT|Travel|2|||
146236784|NCT00092534|527382658|FG003|Base Study EXT|Travel|0|||
146236785|NCT00092534|527382659|FG004|Base Study EXT|Travel|0|||
146236786|NCT00092534|527382655|FG000|Base Study EXT|Site closed|0|||
146236787|NCT00092534|527382656|FG001|Base Study EXT|Site closed|0|||
146236788|NCT00092534|527382657|FG002|Base Study EXT|Site closed|21|||
146236789|NCT00092534|527382658|FG003|Base Study EXT|Site closed|0|||
146236790|NCT00092534|527382659|FG004|Base Study EXT|Site closed|0|||
146236791|NCT00092534|527382655|FG000|Base Study EXT|Study ended|0|||
146236792|NCT00092534|527382656|FG001|Base Study EXT|Study ended|0|||
146236793|NCT00092534|527382657|FG002|Base Study EXT|Study ended|29|||
146236794|NCT00092534|527382658|FG003|Base Study EXT|Study ended|0|||
146236795|NCT00092534|527382659|FG004|Base Study EXT|Study ended|0|||
146236796|NCT00092534|527382655|FG000|Base Study EXT|Protocol Violation|0|||
146236797|NCT00092534|527382656|FG001|Base Study EXT|Protocol Violation|0|||
146236798|NCT00092534|527382657|FG002|Base Study EXT|Protocol Violation|15|||
146236799|NCT00092534|527382658|FG003|Base Study EXT|Protocol Violation|0|||
146236800|NCT00092534|527382659|FG004|Base Study EXT|Protocol Violation|0|||
146236801|NCT00092534|527382655|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146236802|NCT00092534|527382656|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146236803|NCT00092534|527382657|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146236804|NCT00092534|527382658|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
146236805|NCT00092534|527382659|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
146236806|NCT03595124|527382660|FG000|Overall Study|Physician Decision|1|||
146236807|NCT03595124|527382661|FG001|Overall Study|Physician Decision|1|||
146236808|NCT03595124|527382662|FG002|Overall Study|Physician Decision|1|||
146236809|NCT03595124|527382660|FG000|Overall Study|Ineligible|1|||
146236810|NCT03595124|527382661|FG001|Overall Study|Ineligible|1|||
146236811|NCT03595124|527382662|FG002|Overall Study|Ineligible|0|||
146236812|NCT03595124|527382660|FG000|Overall Study|Disease Progression|4|||
146236813|NCT03595124|527382661|FG001|Overall Study|Disease Progression|1|||
146236814|NCT03595124|527382662|FG002|Overall Study|Disease Progression|4|||
146236815|NCT02036970|527382664|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146236816|NCT02036970|527382665|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146295681|NCT01176968|527597644|FG001|Overall Study|Protocol Violation|1|||
146295682|NCT01176968|527597643|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145893390|NCT02960893|526117183|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
145893391|NCT02960893|526117184|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
145893392|NCT02960893|526117181|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
145893393|NCT02960893|526117182|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
145893394|NCT02960893|526117183|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
145893395|NCT02960893|526117184|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
145893396|NCT02960893|526117181|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
145893397|NCT02960893|526117182|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
145893398|NCT02960893|526117183|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
145893399|NCT02960893|526117184|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
146088152|NCT01986933|526841961|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
146236817|NCT02036970|527382666|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
146236818|NCT02036970|527382667|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
146236819|NCT02036970|527382668|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146236820|NCT02036970|527382669|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146236821|NCT02036970|527382670|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
146236822|NCT02036970|527382671|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146236823|NCT02036970|527382672|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
146295683|NCT01176968|527597644|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
145971315|NCT01859741|526408816|FG002|Overall Study|Death|4|||
145971316|NCT01859741|526408817|FG003|Overall Study|Death|3|||
145971317|NCT01859741|526408818|FG004|Overall Study|Death|5|||
145971318|NCT01859741|526408819|FG005|Overall Study|Death|4|||
145971319|NCT01859741|526408820|FG006|Overall Study|Death|51|||
145971320|NCT01859741|526408821|FG007|Overall Study|Death|51|||
145971321|NCT01859741|526408814|FG000|Overall Study|Lost to Follow-up|0|||
145971322|NCT01859741|526408815|FG001|Overall Study|Lost to Follow-up|0|||
145971323|NCT01859741|526408816|FG002|Overall Study|Lost to Follow-up|0|||
145971324|NCT01859741|526408817|FG003|Overall Study|Lost to Follow-up|0|||
145971325|NCT01859741|526408818|FG004|Overall Study|Lost to Follow-up|0|||
145971326|NCT01859741|526408819|FG005|Overall Study|Lost to Follow-up|1|||
145971327|NCT01859741|526408820|FG006|Overall Study|Lost to Follow-up|0|||
145971328|NCT01859741|526408821|FG007|Overall Study|Lost to Follow-up|4|||
145971329|NCT01859741|526408814|FG000|Overall Study|Withdrawal by Subject|0|||
145971330|NCT01859741|526408815|FG001|Overall Study|Withdrawal by Subject|1|||
145971331|NCT01859741|526408816|FG002|Overall Study|Withdrawal by Subject|2|||
145971332|NCT01859741|526408817|FG003|Overall Study|Withdrawal by Subject|0|||
145971333|NCT01859741|526408818|FG004|Overall Study|Withdrawal by Subject|0|||
145971334|NCT01859741|526408819|FG005|Overall Study|Withdrawal by Subject|1|||
145971335|NCT01859741|526408820|FG006|Overall Study|Withdrawal by Subject|1|||
145971336|NCT01859741|526408821|FG007|Overall Study|Withdrawal by Subject|1|||
145971337|NCT01859741|526408814|FG000|Overall Study|Study Terminated by Sponsor|0|||
145971338|NCT01859741|526408815|FG001|Overall Study|Study Terminated by Sponsor|0|||
145971339|NCT01859741|526408816|FG002|Overall Study|Study Terminated by Sponsor|0|||
145971340|NCT01859741|526408817|FG003|Overall Study|Study Terminated by Sponsor|0|||
145971341|NCT01859741|526408818|FG004|Overall Study|Study Terminated by Sponsor|1|||
145971342|NCT01859741|526408819|FG005|Overall Study|Study Terminated by Sponsor|0|||
145971343|NCT01859741|526408820|FG006|Overall Study|Study Terminated by Sponsor|16|||
145971344|NCT01859741|526408821|FG007|Overall Study|Study Terminated by Sponsor|14|||
145971345|NCT01859741|526408814|FG000|Overall Study|Other|0|||
145971346|NCT01859741|526408815|FG001|Overall Study|Other|0|||
145971347|NCT01859741|526408816|FG002|Overall Study|Other|0|||
145971348|NCT01859741|526408817|FG003|Overall Study|Other|0|||
145971349|NCT01859741|526408818|FG004|Overall Study|Other|0|||
145971350|NCT01859741|526408819|FG005|Overall Study|Other|0|||
145971351|NCT01859741|526408820|FG006|Overall Study|Other|2|||
145971352|NCT01859741|526408821|FG007|Overall Study|Other|0|||
145971353|NCT02606253|526408825|FG000|Overall Study|Adverse Event|2|||
145971354|NCT02606253|526408826|FG001|Overall Study|Adverse Event|0|||
145971355|NCT02606253|526408827|FG002|Overall Study|Adverse Event|0|||
145971356|NCT02606253|526408825|FG000|Overall Study|Protocol Violation|2|||
145971357|NCT02606253|526408826|FG001|Overall Study|Protocol Violation|1|||
145971358|NCT02606253|526408827|FG002|Overall Study|Protocol Violation|0|||
145971359|NCT02606253|526408825|FG000|Overall Study|Physician Decision|1|||
145971360|NCT02606253|526408826|FG001|Overall Study|Physician Decision|1|||
145971361|NCT02606253|526408827|FG002|Overall Study|Physician Decision|0|||
145971362|NCT02765165|526408830|FG000|Treatment Period|Progressive disease|3|||
145971363|NCT02765165|526408831|FG001|Treatment Period|Progressive disease|2|||
145971364|NCT02765165|526408832|FG002|Treatment Period|Progressive disease|3|||
145971365|NCT02765165|526408833|FG003|Treatment Period|Progressive disease|3|||
145971366|NCT02765165|526408834|FG004|Treatment Period|Progressive disease|4|||
145971367|NCT02765165|526408835|FG005|Treatment Period|Progressive disease|2|||
145971368|NCT02765165|526408836|FG006|Treatment Period|Progressive disease|2|||
145971369|NCT02765165|526408830|FG000|Treatment Period|Physician Decision|0|||
145971370|NCT02765165|526408831|FG001|Treatment Period|Physician Decision|1|||
145971371|NCT02765165|526408832|FG002|Treatment Period|Physician Decision|0|||
145971372|NCT02765165|526408833|FG003|Treatment Period|Physician Decision|0|||
145971373|NCT02765165|526408834|FG004|Treatment Period|Physician Decision|0|||
145971374|NCT02765165|526408835|FG005|Treatment Period|Physician Decision|0|||
145971375|NCT02765165|526408836|FG006|Treatment Period|Physician Decision|0|||
145971376|NCT02765165|526408830|FG000|Treatment Period|Adverse Event|0|||
145971377|NCT02765165|526408831|FG001|Treatment Period|Adverse Event|1|||
145971378|NCT02765165|526408832|FG002|Treatment Period|Adverse Event|0|||
145971379|NCT02765165|526408833|FG003|Treatment Period|Adverse Event|0|||
145971380|NCT02765165|526408834|FG004|Treatment Period|Adverse Event|0|||
145971381|NCT02765165|526408835|FG005|Treatment Period|Adverse Event|0|||
145971382|NCT02765165|526408836|FG006|Treatment Period|Adverse Event|0|||
145971383|NCT02765165|526408830|FG000|Treatment Period|Withdrawal by Subject|0|||
145971384|NCT02765165|526408831|FG001|Treatment Period|Withdrawal by Subject|0|||
145971385|NCT02765165|526408832|FG002|Treatment Period|Withdrawal by Subject|0|||
145971386|NCT02765165|526408833|FG003|Treatment Period|Withdrawal by Subject|0|||
145971387|NCT02765165|526408834|FG004|Treatment Period|Withdrawal by Subject|2|||
145971388|NCT02765165|526408835|FG005|Treatment Period|Withdrawal by Subject|0|||
145971389|NCT02765165|526408836|FG006|Treatment Period|Withdrawal by Subject|0|||
145971390|NCT02765165|526408830|FG000|Treatment Period|Study terminated|0|||
145971391|NCT02765165|526408831|FG001|Treatment Period|Study terminated|0|||
145971392|NCT02765165|526408832|FG002|Treatment Period|Study terminated|0|||
145971393|NCT02765165|526408833|FG003|Treatment Period|Study terminated|0|||
146295684|NCT01176968|527597643|FG000|Overall Study|Study terminated by sponsor|0|||
146295685|NCT01176968|527597644|FG001|Overall Study|Study terminated by sponsor|1|||
146295686|NCT01176968|527597643|FG000|Overall Study|Reason not defined|5|||
146295687|NCT01176968|527597644|FG001|Overall Study|Reason not defined|3|||
146295688|NCT00718640|527597645|FG000|Overall Study|Adverse Event|4|||
146295689|NCT00718640|527597645|FG000|Overall Study|Death|1|||
146295690|NCT00718640|527597645|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
146295691|NCT03871829|527597648|FG000|Overall Study|Lost to Follow-up|0|||
146295692|NCT03871829|527597649|FG001|Overall Study|Lost to Follow-up|1|||
146295693|NCT03871829|527597648|FG000|Overall Study|Withdrawal by Subject|1|||
146295694|NCT03871829|527597649|FG001|Overall Study|Withdrawal by Subject|1|||
146295695|NCT03871829|527597648|FG000|Overall Study|Death|12|||
146295696|NCT03871829|527597649|FG001|Overall Study|Death|8|||
146295697|NCT03871829|527597648|FG000|Overall Study|Study terminated by sponsor|31|||
146295698|NCT03871829|527597649|FG001|Overall Study|Study terminated by sponsor|34|||
146295699|NCT02993523|527597650|FG000|Overall Study|Withdrew Consent|0|||
146295700|NCT02993523|527597651|FG001|Overall Study|Withdrew Consent|0|||
146295701|NCT02993523|527597652|FG002|Overall Study|Withdrew Consent|2|||
146295702|NCT02993523|527597653|FG003|Overall Study|Withdrew Consent|9|||
146295703|NCT02993523|527597654|FG004|Overall Study|Withdrew Consent|0|||
146295704|NCT02993523|527597650|FG000|Overall Study|Lost to Follow-up|0|||
146295705|NCT02993523|527597651|FG001|Overall Study|Lost to Follow-up|0|||
146295706|NCT02993523|527597652|FG002|Overall Study|Lost to Follow-up|3|||
146295707|NCT02993523|527597653|FG003|Overall Study|Lost to Follow-up|6|||
146295708|NCT02993523|527597654|FG004|Overall Study|Lost to Follow-up|0|||
146295709|NCT02993523|527597650|FG000|Overall Study|Death|1|||
146295710|NCT02993523|527597651|FG001|Overall Study|Death|1|||
146295711|NCT02993523|527597652|FG002|Overall Study|Death|138|||
146295712|NCT02993523|527597653|FG003|Overall Study|Death|222|||
146295713|NCT02993523|527597654|FG004|Overall Study|Death|6|||
146295714|NCT02993523|527597650|FG000|Overall Study|Reason not Specified|0|||
146295715|NCT02993523|527597651|FG001|Overall Study|Reason not Specified|0|||
146295716|NCT02993523|527597652|FG002|Overall Study|Reason not Specified|1|||
146295717|NCT02993523|527597653|FG003|Overall Study|Reason not Specified|1|||
146295718|NCT02993523|527597654|FG004|Overall Study|Reason not Specified|0|||
146295719|NCT03694418|527597655|FG000|Overall Study|Lost to Follow-up|115|||
146295720|NCT03694418|527597656|FG001|Overall Study|Lost to Follow-up|23|||
146295721|NCT03694418|527597657|FG002|Overall Study|Lost to Follow-up|12|||
146295722|NCT03694418|527597658|FG003|Overall Study|Lost to Follow-up|12|||
146295723|NCT03694418|527597659|FG004|Overall Study|Lost to Follow-up|13|||
146295724|NCT04288778|527597660|FG000|Overall Study|Withdrawal by Subject|2|||
146295725|NCT04288778|527597660|FG000|Overall Study|Adverse Event|5|||
146295726|NCT04288778|527597660|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146295727|NCT04288778|527597660|FG000|Overall Study|Other|1|||
146295728|NCT04288778|527597660|FG000|Overall Study|Started but not treated|2|||
146295729|NCT04485104|527597661|FG000|Overall Study|Physician Decision|2|||
146295730|NCT04485104|527597662|FG001|Overall Study|Physician Decision|0|||
146295731|NCT04485104|527597661|FG000|Overall Study|Decision by sponsor|0|||
146295732|NCT04485104|527597662|FG001|Overall Study|Decision by sponsor|1|||
146295733|NCT05057247|527597667|FG000|Overall Study|Death|4|||
146295734|NCT05057247|527597667|FG000|Overall Study|Physician Decision|3|||
146295735|NCT05057247|527597667|FG000|Overall Study|Progressive Disease|7|||
146295736|NCT05057247|527597667|FG000|Overall Study|Withdrawal by Subject|3|||
146295737|NCT05057247|527597667|FG000|Overall Study|Adverse Event|6|||
146295738|NCT05057247|527597667|FG000|Overall Study|Subject Non-Compliance|1|||
146295739|NCT05057247|527597667|FG000|Overall Study|On treatment|2|||
146295740|NCT05458479|527597668|FG000|Overall Study|Lost to Follow-up|1|||
146295741|NCT01386658|527597672|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
146295742|NCT01386658|527597673|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
146295743|NCT01386658|527597672|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
146295744|NCT01386658|527597673|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
145893400|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
146088153|NCT01986933|526841962|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
146295745|NCT01067326|527597680|FG000|Overall Study|Adverse Event|0|||
146295746|NCT01067326|527597681|FG001|Overall Study|Adverse Event|2|||
146295747|NCT01067326|527597680|FG000|Overall Study|Withdrawal by Subject|1|||
146295748|NCT01067326|527597681|FG001|Overall Study|Withdrawal by Subject|0|||
146295749|NCT01067326|527597680|FG000|Overall Study|Early Study Termination|1|||
146295750|NCT01067326|527597681|FG001|Overall Study|Early Study Termination|1|||
146295751|NCT00769860|527597682|FG000|Overall Study|Withdrawal by Subject|2|||
146295752|NCT00769860|527597683|FG001|Overall Study|Withdrawal by Subject|0|||
146295753|NCT03170154|527597687|FG000|Overall Study|Lost to Follow-up|4|||
146295754|NCT03170154|527597687|FG000|Overall Study|Death|2|||
146295755|NCT03170154|527597687|FG000|Overall Study|Withdrawal by Subject|2|||
146295756|NCT02279862|527597688|FG000|Overall Study|Study drug toxicity|3|||
146295757|NCT02279862|527597689|FG001|Overall Study|Study drug toxicity|6|||
146295758|NCT02279862|527597688|FG000|Overall Study|No longer meets criteria|0|||
146295759|NCT02279862|527597689|FG001|Overall Study|No longer meets criteria|1|||
145971394|NCT02765165|526408834|FG004|Treatment Period|Study terminated|0|||
145971395|NCT02765165|526408835|FG005|Treatment Period|Study terminated|1|||
145971396|NCT02765165|526408836|FG006|Treatment Period|Study terminated|2|||
145971397|NCT02765165|526408830|FG000|Post-treatment Follow-up|Death|1|||
145971398|NCT02765165|526408831|FG001|Post-treatment Follow-up|Death|2|||
145971399|NCT02765165|526408832|FG002|Post-treatment Follow-up|Death|1|||
145971400|NCT02765165|526408833|FG003|Post-treatment Follow-up|Death|1|||
145971401|NCT02765165|526408834|FG004|Post-treatment Follow-up|Death|1|||
145971402|NCT02765165|526408835|FG005|Post-treatment Follow-up|Death|1|||
145971403|NCT02765165|526408836|FG006|Post-treatment Follow-up|Death|0|||
145971404|NCT02765165|526408830|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
145971405|NCT02765165|526408831|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
145971406|NCT02765165|526408832|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
145971407|NCT02765165|526408833|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
145971408|NCT02765165|526408834|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
145971409|NCT02765165|526408835|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
145971410|NCT02765165|526408836|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
145971411|NCT02765165|526408830|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971412|NCT02765165|526408831|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971413|NCT02765165|526408832|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
145971414|NCT02765165|526408833|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971415|NCT02765165|526408834|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971416|NCT02765165|526408835|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971417|NCT02765165|526408836|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
145971418|NCT02765165|526408830|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145971419|NCT02765165|526408831|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145971420|NCT02765165|526408832|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
145971421|NCT02765165|526408833|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
145971422|NCT02765165|526408834|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145971423|NCT02765165|526408835|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145971424|NCT02765165|526408836|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145971425|NCT02765165|526408830|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971426|NCT02765165|526408831|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
145971427|NCT02765165|526408832|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971428|NCT02765165|526408833|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971429|NCT02765165|526408834|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971430|NCT02765165|526408835|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971431|NCT02765165|526408836|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
145971432|NCT02765165|526408830|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145971433|NCT02765165|526408831|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145971434|NCT02765165|526408832|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145971435|NCT02765165|526408833|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145971436|NCT02765165|526408834|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
145971437|NCT02765165|526408835|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
145971438|NCT02765165|526408836|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
145971439|NCT01186770|526408837|FG000|Overall Study|Ineligibility|0|||
145971440|NCT01186770|526408838|FG001|Overall Study|Ineligibility|0|||
145971441|NCT01186770|526408839|FG002|Overall Study|Ineligibility|2|||
145971442|NCT01186770|526408840|FG003|Overall Study|Ineligibility|0|||
145971443|NCT01186770|526408837|FG000|Overall Study|Protocol Violation|7|||
145971444|NCT01186770|526408838|FG001|Overall Study|Protocol Violation|9|||
145971445|NCT01186770|526408839|FG002|Overall Study|Protocol Violation|12|||
145971446|NCT01186770|526408840|FG003|Overall Study|Protocol Violation|14|||
145971447|NCT01186770|526408837|FG000|Overall Study|Adverse Event|2|||
145971448|NCT01186770|526408838|FG001|Overall Study|Adverse Event|9|||
145971449|NCT01186770|526408839|FG002|Overall Study|Adverse Event|7|||
145971450|NCT01186770|526408840|FG003|Overall Study|Adverse Event|9|||
145971451|NCT01186770|526408837|FG000|Overall Study|Withdrawal by Subject|15|||
145971452|NCT01186770|526408838|FG001|Overall Study|Withdrawal by Subject|13|||
146236824|NCT02036970|527382673|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
146236825|NCT02036970|527382664|FG000|Part 1: Day 1 Through Week 16|Death|0|||
146236826|NCT02036970|527382665|FG001|Part 1: Day 1 Through Week 16|Death|0|||
146236827|NCT02036970|527382666|FG002|Part 1: Day 1 Through Week 16|Death|0|||
146236828|NCT02036970|527382667|FG003|Part 1: Day 1 Through Week 16|Death|0|||
146236829|NCT02036970|527382668|FG004|Part 1: Day 1 Through Week 16|Death|0|||
146236830|NCT02036970|527382669|FG005|Part 1: Day 1 Through Week 16|Death|0|||
146236831|NCT02036970|527382670|FG006|Part 1: Day 1 Through Week 16|Death|0|||
146236832|NCT02036970|527382671|FG007|Part 1: Day 1 Through Week 16|Death|0|||
145971453|NCT01186770|526408839|FG002|Overall Study|Withdrawal by Subject|11|||
145971454|NCT01186770|526408840|FG003|Overall Study|Withdrawal by Subject|17|||
145971455|NCT01186770|526408837|FG000|Overall Study|Lost to Follow-up|10|||
146295760|NCT02279862|527597688|FG000|Overall Study|Administrative reason by sponsor|0|||
146295761|NCT02279862|527597689|FG001|Overall Study|Administrative reason by sponsor|1|||
146295762|NCT02279862|527597688|FG000|Overall Study|Disease progression|5|||
146295763|NCT02279862|527597689|FG001|Overall Study|Disease progression|2|||
146295764|NCT02279862|527597688|FG000|Overall Study|Study closed by sponsor|16|||
146295765|NCT02279862|527597689|FG001|Overall Study|Study closed by sponsor|13|||
146295766|NCT02279862|527597688|FG000|Overall Study|Other|1|||
146295767|NCT02279862|527597689|FG001|Overall Study|Other|2|||
146295768|NCT02279862|527597688|FG000|Overall Study|Withdrawal by Subject|1|||
146295769|NCT02279862|527597689|FG001|Overall Study|Withdrawal by Subject|0|||
146295770|NCT03431857|527597692|FG000|Overall Study|Death|6|||
146295771|NCT03431857|527597692|FG000|Overall Study|Lost to Follow-up|41|||
146295772|NCT03431857|527597692|FG000|Overall Study|Adverse Event|6|||
146295773|NCT03431857|527597692|FG000|Overall Study|Withdrawal by Subject|1|||
146295774|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
146295775|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
146295776|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
146295777|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
146295778|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
146295779|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
146295780|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
146295781|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
146295782|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
146295783|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
146295784|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
146295785|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
146295786|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
146295787|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
146295788|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
146295789|NCT01323621|527597693|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
146295790|NCT01323621|527597694|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
146295791|NCT01323621|527597695|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
146295792|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
146295793|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
146295794|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
146295795|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146295796|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
146295797|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
146295798|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
146295799|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
146295800|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
146295801|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146295802|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146295803|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146295804|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
146295805|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
146295806|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
146295807|NCT01323621|527597693|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146295808|NCT01323621|527597694|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
146295809|NCT01323621|527597695|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
146295810|NCT00651157|527597696|FG000|Overall Study|Death|1|||
146295811|NCT00651157|527597696|FG000|Overall Study|Protocol Violation|1|||
146295812|NCT01163721|527597701|FG000|Overall Study|Adverse Event|5|||
146295813|NCT01163721|527597702|FG001|Overall Study|Adverse Event|6|||
146295814|NCT01163721|527597701|FG000|Overall Study|Withdrawal by Subject|3|||
146295815|NCT01163721|527597702|FG001|Overall Study|Withdrawal by Subject|4|||
146295816|NCT01163721|527597701|FG000|Overall Study|Lost to Follow-up|0|||
146295817|NCT01163721|527597702|FG001|Overall Study|Lost to Follow-up|1|||
146295818|NCT01163721|527597701|FG000|Overall Study|Physician Decision|0|||
146295819|NCT01163721|527597702|FG001|Overall Study|Physician Decision|1|||
146295820|NCT00688181|527597703|FG000|Overall Study|Lost to Follow-up|17|||
146088154|NCT01986933|526841963|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
146088155|NCT01986933|526841959|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146295821|NCT00688181|527597703|FG000|Overall Study|Unknown Reason|4|||
146295822|NCT00688181|527597703|FG000|Overall Study|Non-clinical Reason|2|||
146295823|NCT01050205|527597704|FG000|Overall Study|Lost to Follow-up|7|||
146295824|NCT01050205|527597705|FG001|Overall Study|Lost to Follow-up|1|||
146295825|NCT01050205|527597704|FG000|Overall Study|Withdrawal by Subject|1|||
146295826|NCT01050205|527597705|FG001|Overall Study|Withdrawal by Subject|1|||
146088156|NCT01986933|526841960|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146295827|NCT01050205|527597704|FG000|Overall Study|Relocated from area|1|||
146295828|NCT01050205|527597705|FG001|Overall Study|Relocated from area|2|||
146295829|NCT01050205|527597704|FG000|Overall Study|Discontinued Intervention|2|||
146295830|NCT01050205|527597705|FG001|Overall Study|Discontinued Intervention|0|||
146295831|NCT01295281|527597708|FG000|First Intervention (7 Days)|Death|0|||
146295832|NCT01295281|527597709|FG001|First Intervention (7 Days)|Death|1|||
146295833|NCT00292461|527597710|FG000|Overall Study|Adverse Event|4|||
146295834|NCT00292461|527597711|FG001|Overall Study|Adverse Event|2|||
146295835|NCT00292461|527597710|FG000|Overall Study|Lack of Efficacy|1|||
146295836|NCT00292461|527597711|FG001|Overall Study|Lack of Efficacy|0|||
146295837|NCT00292461|527597710|FG000|Overall Study|Withdrawal by Subject|0|||
146295838|NCT00292461|527597711|FG001|Overall Study|Withdrawal by Subject|1|||
146295839|NCT00292461|527597710|FG000|Overall Study|Protocol Violation|4|||
146295840|NCT00292461|527597711|FG001|Overall Study|Protocol Violation|3|||
146295841|NCT00292461|527597710|FG000|Overall Study|Lost to Follow-up|1|||
146295842|NCT00292461|527597711|FG001|Overall Study|Lost to Follow-up|0|||
146295843|NCT00954421|527597712|FG000|Screening|screen failures|3|||
146295844|NCT00954421|527597712|FG000|6 Months of DBS|Withdrawal by Subject|1|||
146295845|NCT00954421|527597712|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
146295846|NCT01891721|527597713|FG000|Overall Study|Lost to Follow-up|10|||
146295847|NCT01891721|527597714|FG001|Overall Study|Lost to Follow-up|5|||
146295848|NCT01891721|527597715|FG002|Overall Study|Lost to Follow-up|1|||
146295849|NCT00633061|527597716|FG000|Overall Study|Study closed|86|||
146295850|NCT00633061|527597717|FG001|Overall Study|Study closed|0|||
146295851|NCT02708095|527597720|FG000|Overall Study|Adverse Event|4|||
146295852|NCT02708095|527597721|FG001|Overall Study|Adverse Event|10|||
146295853|NCT02708095|527597722|FG002|Overall Study|Adverse Event|11|||
146295854|NCT02708095|527597720|FG000|Overall Study|Lack of Efficacy|9|||
146295855|NCT02708095|527597721|FG001|Overall Study|Lack of Efficacy|3|||
146295856|NCT02708095|527597722|FG002|Overall Study|Lack of Efficacy|0|||
146295857|NCT02708095|527597720|FG000|Overall Study|Lost to Follow-up|2|||
146295858|NCT02708095|527597721|FG001|Overall Study|Lost to Follow-up|0|||
146295859|NCT02708095|527597722|FG002|Overall Study|Lost to Follow-up|0|||
146295860|NCT02708095|527597720|FG000|Overall Study|Physician Decision|2|||
146295861|NCT02708095|527597721|FG001|Overall Study|Physician Decision|3|||
146295862|NCT02708095|527597722|FG002|Overall Study|Physician Decision|2|||
146295863|NCT02708095|527597720|FG000|Overall Study|Protocol Violation|0|||
146295864|NCT02708095|527597721|FG001|Overall Study|Protocol Violation|0|||
146295865|NCT02708095|527597722|FG002|Overall Study|Protocol Violation|1|||
146295866|NCT02708095|527597720|FG000|Overall Study|Withdrawal by Subject|5|||
146295867|NCT02708095|527597721|FG001|Overall Study|Withdrawal by Subject|3|||
146295868|NCT02708095|527597722|FG002|Overall Study|Withdrawal by Subject|4|||
146295869|NCT05066724|527597735|FG000|Overall Study|Adverse Event|1|||
146295870|NCT05066724|527597735|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146295871|NCT05066724|527597735|FG000|Overall Study|Withdrawal by Subject|6|||
146295872|NCT05066724|527597735|FG000|Overall Study|Physician Decision|2|||
146295873|NCT01696942|527597750|FG000|Overall Study|Withdrawal by Subject|1|||
146295874|NCT01696942|527597751|FG001|Overall Study|Withdrawal by Subject|0|||
146295875|NCT01696942|527597750|FG000|Overall Study|Protocol Violation|1|||
146295876|NCT01696942|527597751|FG001|Overall Study|Protocol Violation|2|||
146295877|NCT01696942|527597750|FG000|Overall Study|screen failure|0|||
146295878|NCT01696942|527597751|FG001|Overall Study|screen failure|1|||
146295879|NCT01444651|527599053|FG000|Overall Study|Adverse Event|3|||
146295880|NCT01444651|527599054|FG001|Overall Study|Adverse Event|2|||
146295881|NCT01444651|527599053|FG000|Overall Study|Lost to Follow-up|5|||
146295882|NCT01444651|527599054|FG001|Overall Study|Lost to Follow-up|5|||
146295883|NCT01444651|527599053|FG000|Overall Study|Non-fasting|2|||
146295884|NCT01444651|527599054|FG001|Overall Study|Non-fasting|1|||
146295885|NCT01444651|527599053|FG000|Overall Study|Missing data|1|||
146295886|NCT01444651|527599054|FG001|Overall Study|Missing data|1|||
146295887|NCT01955122|527599055|FG000|Overall Study|Physician Decision|5|||
146295888|NCT01955122|527599056|FG001|Overall Study|Physician Decision|5|||
146295889|NCT01672788|527599057|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
146295890|NCT01672788|527599058|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
146295891|NCT01672788|527599059|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
146295892|NCT01672788|527599060|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
146295893|NCT03338192|527599061|FG000|Year One to Year Two|High Blood Pressure|7|||
146295894|NCT03338192|527599062|FG001|Year One to Year Two|High Blood Pressure|1|||
146295895|NCT03338192|527599061|FG000|Year One to Year Two|HIV +|1|||
146295896|NCT03338192|527599062|FG001|Year One to Year Two|HIV +|0|||
146295897|NCT03338192|527599061|FG000|Year Two to Year Four|High Blood Pressure|1|||
146295898|NCT03338192|527599062|FG001|Year Two to Year Four|High Blood Pressure|0|||
146295899|NCT03338192|527599061|FG000|Year Two to Year Four|HIV +|2|||
146295900|NCT03338192|527599062|FG001|Year Two to Year Four|HIV +|0|||
146295901|NCT03338192|527599061|FG000|Year Four to Year Six|High Blood Pressure|2|||
146295902|NCT03338192|527599062|FG001|Year Four to Year Six|High Blood Pressure|1|||
146295903|NCT03329196|527599063|FG000|Overall Study|Adverse Event|10|||
146295904|NCT03329196|527599064|FG001|Overall Study|Adverse Event|5|||
146295905|NCT03329196|527599063|FG000|Overall Study|Physician Decision|2|||
146295906|NCT03329196|527599064|FG001|Overall Study|Physician Decision|2|||
145971456|NCT01186770|526408838|FG001|Overall Study|Lost to Follow-up|6|||
145971457|NCT01186770|526408839|FG002|Overall Study|Lost to Follow-up|14|||
146236833|NCT02036970|527382672|FG008|Part 1: Day 1 Through Week 16|Death|1|||
146236834|NCT02036970|527382673|FG009|Part 1: Day 1 Through Week 16|Death|0|||
146236835|NCT02036970|527382664|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
146236836|NCT02036970|527382665|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236837|NCT02036970|527382666|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
146236838|NCT02036970|527382667|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236839|NCT02036970|527382668|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236840|NCT02036970|527382669|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236841|NCT02036970|527382670|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236842|NCT02036970|527382671|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236843|NCT02036970|527382672|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
146236844|NCT02036970|527382673|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
146236845|NCT02036970|527382664|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236846|NCT02036970|527382665|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236847|NCT02036970|527382666|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236848|NCT02036970|527382667|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236849|NCT02036970|527382668|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
146236850|NCT02036970|527382669|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236851|NCT02036970|527382670|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236852|NCT02036970|527382671|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
146236853|NCT02036970|527382672|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
146236854|NCT02036970|527382673|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
146236855|NCT02036970|527382664|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236856|NCT02036970|527382665|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236857|NCT02036970|527382666|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236858|NCT02036970|527382667|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
146236859|NCT02036970|527382668|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236860|NCT02036970|527382669|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236861|NCT02036970|527382670|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236862|NCT02036970|527382671|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236863|NCT02036970|527382672|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236864|NCT02036970|527382673|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
146236865|NCT02036970|527382664|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
146236866|NCT02036970|527382665|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
146236867|NCT02036970|527382666|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
146236868|NCT02036970|527382667|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
146236869|NCT02036970|527382668|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
146236870|NCT02036970|527382669|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
146236871|NCT02036970|527382670|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
146236872|NCT02036970|527382671|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
146236873|NCT02036970|527382672|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
146236874|NCT02036970|527382673|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
146236875|NCT02036970|527382664|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236876|NCT02036970|527382665|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236877|NCT02036970|527382666|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236878|NCT02036970|527382667|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236879|NCT02036970|527382668|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236880|NCT02036970|527382669|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236881|NCT02036970|527382670|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
146295907|NCT03329196|527599063|FG000|Overall Study|Withdrawal by Subject|11|||
146295908|NCT03329196|527599064|FG001|Overall Study|Withdrawal by Subject|3|||
145893401|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
145893402|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
145893403|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
145893404|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
145893405|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
145893406|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
145893407|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
145893408|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
145893409|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
145893410|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
145893411|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
145893412|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
145893413|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
145893414|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
145893415|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
145971458|NCT01186770|526408840|FG003|Overall Study|Lost to Follow-up|9|||
146295909|NCT03329196|527599063|FG000|Overall Study|Hepatic function abnormalities|0|||
146295910|NCT03329196|527599064|FG001|Overall Study|Hepatic function abnormalities|1|||
146295911|NCT03329196|527599063|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
146295912|NCT03329196|527599064|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
146295913|NCT03329196|527599063|FG000|Overall Study|Difficult to control Hb|2|||
146295914|NCT03329196|527599064|FG001|Overall Study|Difficult to control Hb|3|||
146295915|NCT03329196|527599063|FG000|Overall Study|Dialysis or renal transplant|13|||
146295916|NCT03329196|527599064|FG001|Overall Study|Dialysis or renal transplant|15|||
146295917|NCT02464228|527599067|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
146295918|NCT02464228|527599068|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
146295919|NCT02464228|527599069|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
146295920|NCT02464228|527599070|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
146295921|NCT02464228|527599067|FG000|Overall Study|Physician Decision|2|||
146295922|NCT02464228|527599068|FG001|Overall Study|Physician Decision|0|||
146295923|NCT02464228|527599069|FG002|Overall Study|Physician Decision|1|||
146295924|NCT02464228|527599070|FG003|Overall Study|Physician Decision|0|||
146295925|NCT02464228|527599067|FG000|Overall Study|Miscellaneous|1|||
146295926|NCT02464228|527599068|FG001|Overall Study|Miscellaneous|0|||
146295927|NCT02464228|527599069|FG002|Overall Study|Miscellaneous|1|||
146295928|NCT02464228|527599070|FG003|Overall Study|Miscellaneous|0|||
146295929|NCT02464228|527599067|FG000|Overall Study|Adverse Event|9|||
146295930|NCT02464228|527599068|FG001|Overall Study|Adverse Event|0|||
146295931|NCT02464228|527599069|FG002|Overall Study|Adverse Event|3|||
146295932|NCT02464228|527599070|FG003|Overall Study|Adverse Event|0|||
146295933|NCT02464228|527599067|FG000|Overall Study|Withdrawal by Subject|1|||
146295934|NCT02464228|527599068|FG001|Overall Study|Withdrawal by Subject|1|||
146295935|NCT02464228|527599069|FG002|Overall Study|Withdrawal by Subject|1|||
146295936|NCT02464228|527599070|FG003|Overall Study|Withdrawal by Subject|0|||
146295937|NCT02464228|527599067|FG000|Overall Study|Disease Progression|22|||
146295938|NCT02464228|527599068|FG001|Overall Study|Disease Progression|12|||
146295939|NCT02464228|527599069|FG002|Overall Study|Disease Progression|5|||
146295940|NCT02464228|527599070|FG003|Overall Study|Disease Progression|2|||
146295941|NCT01117454|527599073|FG000|Overall Study|Pregnancy|0|||
146295942|NCT01117454|527599074|FG001|Overall Study|Pregnancy|1|||
146295943|NCT01637623|527599083|FG000|Overall Study|Lost to Follow-up|0|||
146295944|NCT01637623|527599084|FG001|Overall Study|Lost to Follow-up|0|||
146295945|NCT01637623|527599085|FG002|Overall Study|Lost to Follow-up|2|||
146295946|NCT01637623|527599083|FG000|Overall Study|Physician Decision|1|||
146295947|NCT01637623|527599084|FG001|Overall Study|Physician Decision|0|||
146295948|NCT01637623|527599085|FG002|Overall Study|Physician Decision|1|||
146295949|NCT00784693|527599103|FG000|Overall Study|Lost to Follow-up|0|||
146295950|NCT00784693|527599104|FG001|Overall Study|Lost to Follow-up|1|||
146295951|NCT00784693|527599103|FG000|Overall Study|Lack of Efficacy|1|||
146295952|NCT00784693|527599104|FG001|Overall Study|Lack of Efficacy|1|||
145971459|NCT01186770|526408837|FG000|Overall Study|Insufficient response to treatment|7|||
145971460|NCT01186770|526408838|FG001|Overall Study|Insufficient response to treatment|8|||
145971461|NCT01186770|526408839|FG002|Overall Study|Insufficient response to treatment|5|||
145971462|NCT01186770|526408840|FG003|Overall Study|Insufficient response to treatment|7|||
145971463|NCT01186770|526408837|FG000|Overall Study|Other than specified|0|||
145971464|NCT01186770|526408838|FG001|Overall Study|Other than specified|1|||
145971465|NCT01186770|526408839|FG002|Overall Study|Other than specified|1|||
145971466|NCT01186770|526408840|FG003|Overall Study|Other than specified|2|||
146236882|NCT02036970|527382671|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
146236883|NCT02036970|527382672|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236884|NCT02036970|527382673|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
146236885|NCT02036970|527382664|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236886|NCT02036970|527382665|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
146236887|NCT02036970|527382666|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
146236888|NCT02036970|527382667|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146295953|NCT00784693|527599103|FG000|Overall Study|Withdrawal by Subject|0|||
146295954|NCT00784693|527599104|FG001|Overall Study|Withdrawal by Subject|4|||
145971467|NCT02567188|526408841|FG000|Overall Study|Death|10|||
145971468|NCT02567188|526408841|FG000|Overall Study|Terminated Mircera Treatment|9|||
146088157|NCT01986933|526841961|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146088158|NCT01986933|526841962|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
146088159|NCT01986933|526841963|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
146295955|NCT00784693|527599103|FG000|Overall Study|Randomized but not Treated|1|||
146295956|NCT00784693|527599104|FG001|Overall Study|Randomized but not Treated|0|||
146295957|NCT00784693|527599103|FG000|Overall Study|Other|1|||
146295958|NCT00784693|527599104|FG001|Overall Study|Other|0|||
146088160|NCT01986933|526841959|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
146295959|NCT00528866|527599105|FG000|Overall Study|Protocol Violation|6|||
146295960|NCT00993915|527599106|FG000|Overall Study|Insufficient clinical response|3|||
146295961|NCT00993915|527599106|FG000|Overall Study|Withdrawal by Subject|2|||
146295962|NCT00993915|527599106|FG000|Overall Study|Other|1|||
146295963|NCT00993915|527599106|FG000|Overall Study|Ongoing|3|||
146295964|NCT02430051|527599107|FG000|Overall Study|Withdrawal by Subject|6|||
146295965|NCT02430051|527599108|FG001|Overall Study|Withdrawal by Subject|3|||
146295966|NCT02430051|527599107|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
146295967|NCT02430051|527599108|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
146295968|NCT02430051|527599107|FG000|Overall Study|Protocol Violation|1|||
146295969|NCT02430051|527599108|FG001|Overall Study|Protocol Violation|0|||
146295970|NCT02030405|527599113|FG000|Overall Study|Withdrawal by Subject|1|||
146295971|NCT02030405|527599113|FG000|Overall Study|Lost to Follow-up|1|||
146295972|NCT00132496|527599114|FG000|Overall Study|Withdrawal by Subject|1|||
146295973|NCT00132496|527599115|FG001|Overall Study|Withdrawal by Subject|2|||
146295974|NCT00132496|527599114|FG000|Overall Study|Physician Decision|1|||
146295975|NCT00132496|527599115|FG001|Overall Study|Physician Decision|0|||
146295976|NCT04526197|527599116|FG000|Period 1|Adverse Event|0|||
146295977|NCT04526197|527599117|FG001|Period 1|Adverse Event|1|||
146295978|NCT04526197|527599116|FG000|Period 1|Withdrawal by Subject|1|||
146295979|NCT04526197|527599117|FG001|Period 1|Withdrawal by Subject|0|||
146295980|NCT04526197|527599116|FG000|Period 2|Adverse Event|0|||
146295981|NCT04526197|527599117|FG001|Period 2|Adverse Event|1|||
146295982|NCT04526197|527599116|FG000|Period 2|Withdrawal by Subject|0|||
146295983|NCT04526197|527599117|FG001|Period 2|Withdrawal by Subject|1|||
146295984|NCT01136811|527599118|FG000|Overall Study|Physician Decision|11|||
146295985|NCT00372385|527599119|FG000|Overall Study|Adverse Event|6|||
146295986|NCT00372385|527599120|FG001|Overall Study|Adverse Event|11|||
146295987|NCT00372385|527599121|FG002|Overall Study|Adverse Event|9|||
146295988|NCT00372385|527599122|FG003|Overall Study|Adverse Event|7|||
146295989|NCT00372385|527599119|FG000|Overall Study|Noncompliance|0|||
146295990|NCT00372385|527599120|FG001|Overall Study|Noncompliance|1|||
145971469|NCT02567188|526408841|FG000|Overall Study|Lost to Follow-up|5|||
145971470|NCT02567188|526408841|FG000|Overall Study|Adverse Event|1|||
145971471|NCT02567188|526408841|FG000|Overall Study|Withdrawal by Subject|1|||
145971472|NCT02567188|526408841|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
145971473|NCT02567188|526408841|FG000|Overall Study|Moved and Changed Clinic|1|||
145971474|NCT02567188|526408841|FG000|Overall Study|Started Hemodialysis|2|||
145971475|NCT02567188|526408841|FG000|Overall Study|Protocol Violation|5|||
145971476|NCT01189266|526408846|FG000|Overall Study|Adverse Event|1|||
145971477|NCT01189266|526408847|FG001|Overall Study|Adverse Event|0|||
145971478|NCT01189266|526408848|FG002|Overall Study|Adverse Event|5|||
145971479|NCT01189266|526408846|FG000|Overall Study|Death|0|||
145971480|NCT01189266|526408847|FG001|Overall Study|Death|0|||
145971481|NCT01189266|526408848|FG002|Overall Study|Death|5|||
145971482|NCT01189266|526408846|FG000|Overall Study|Lack of Efficacy|4|||
145971483|NCT01189266|526408847|FG001|Overall Study|Lack of Efficacy|5|||
145971484|NCT01189266|526408848|FG002|Overall Study|Lack of Efficacy|44|||
145971485|NCT01189266|526408846|FG000|Overall Study|Physician Decision|0|||
145971486|NCT01189266|526408847|FG001|Overall Study|Physician Decision|0|||
145971487|NCT01189266|526408848|FG002|Overall Study|Physician Decision|1|||
145971488|NCT01189266|526408846|FG000|Overall Study|Protocol Violation|0|||
145971489|NCT01189266|526408847|FG001|Overall Study|Protocol Violation|1|||
145971490|NCT01189266|526408848|FG002|Overall Study|Protocol Violation|1|||
145971491|NCT01189266|526408846|FG000|Overall Study|Withdrawal by Subject|0|||
145971492|NCT01189266|526408847|FG001|Overall Study|Withdrawal by Subject|0|||
145971493|NCT01189266|526408848|FG002|Overall Study|Withdrawal by Subject|1|||
145971494|NCT01189266|526408846|FG000|Overall Study|Patient refuses further therapy|1|||
145971495|NCT01189266|526408847|FG001|Overall Study|Patient refuses further therapy|0|||
145971496|NCT01189266|526408848|FG002|Overall Study|Patient refuses further therapy|7|||
145971497|NCT01189266|526408846|FG000|Overall Study|No treatment|0|||
145971498|NCT01189266|526408847|FG001|Overall Study|No treatment|0|||
145971499|NCT01189266|526408848|FG002|Overall Study|No treatment|1|||
145971500|NCT00537277|526408849|FG000|Overall Study|Adverse Event|1|||
145971501|NCT00537277|526408849|FG000|Overall Study|Lack of Efficacy|2|||
145971502|NCT00537277|526408849|FG000|Overall Study|Lost to Follow-up|12|||
145971503|NCT00537277|526408849|FG000|Overall Study|Protocol Violation|11|||
145971504|NCT00537277|526408849|FG000|Overall Study|Unclassified|4|||
145971505|NCT00537277|526408849|FG000|Overall Study|Inability to tolerate trial medication|4|||
145971506|NCT00537277|526408849|FG000|Overall Study|Non-compliance with trial procedures|15|||
145971507|NCT03620162|526408850|FG000|Overall Study|Physician Decision|4|||
145971508|NCT03620162|526408851|FG001|Overall Study|Physician Decision|0|||
146295991|NCT00372385|527599121|FG002|Overall Study|Noncompliance|1|||
146295992|NCT00372385|527599122|FG003|Overall Study|Noncompliance|1|||
146295993|NCT00372385|527599119|FG000|Overall Study|Physician Decision|1|||
146295994|NCT00372385|527599120|FG001|Overall Study|Physician Decision|0|||
146295995|NCT00372385|527599121|FG002|Overall Study|Physician Decision|0|||
146295996|NCT00372385|527599122|FG003|Overall Study|Physician Decision|0|||
145971509|NCT03620162|526408852|FG002|Overall Study|Physician Decision|1|||
145971510|NCT03620162|526408853|FG003|Overall Study|Physician Decision|0|||
145971511|NCT03620162|526408854|FG004|Overall Study|Physician Decision|2|||
146295997|NCT00372385|527599119|FG000|Overall Study|Lost to Follow-up|2|||
146295998|NCT00372385|527599120|FG001|Overall Study|Lost to Follow-up|0|||
146295999|NCT00372385|527599121|FG002|Overall Study|Lost to Follow-up|0|||
145971512|NCT03620162|526408850|FG000|Overall Study|Lost to Follow-up|2|||
145971513|NCT03620162|526408851|FG001|Overall Study|Lost to Follow-up|6|||
145971514|NCT03620162|526408852|FG002|Overall Study|Lost to Follow-up|7|||
145971515|NCT03620162|526408853|FG003|Overall Study|Lost to Follow-up|3|||
145971516|NCT03620162|526408854|FG004|Overall Study|Lost to Follow-up|2|||
145971517|NCT03620162|526408850|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
145971518|NCT03620162|526408851|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
145971519|NCT03620162|526408852|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
145971520|NCT03620162|526408853|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
145971521|NCT03620162|526408854|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
145971522|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
145971523|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
145971524|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
145971525|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
145971526|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
145971527|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
145971528|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
145971529|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
145971530|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
145971531|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
145971532|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
145971533|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
145971534|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
145971535|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
145971536|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
145971537|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
145971538|NCT00410163|526408857|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
145971539|NCT00410163|526408858|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
145971540|NCT00410163|526408857|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
145971541|NCT00410163|526408858|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
145971542|NCT00410163|526408857|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
145971543|NCT00410163|526408858|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
145971544|NCT00410163|526408857|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
145971545|NCT00410163|526408858|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
145971546|NCT00410163|526408857|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
145971547|NCT00410163|526408858|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
145971548|NCT00410163|526408857|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
145971549|NCT00410163|526408858|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
145971550|NCT04009837|526408860|FG000|Overall Study|Withdrawal by Subject|5|||
145971551|NCT04009837|526408861|FG001|Overall Study|Withdrawal by Subject|4|||
145971552|NCT04009837|526408860|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
145971553|NCT04009837|526408861|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
145971554|NCT01394276|526408863|FG000|Overall Study|Related Adverse event (AEs)|15|||
145971555|NCT01394276|526408863|FG000|Overall Study|Not related AEs|9|||
145971556|NCT01394276|526408863|FG000|Overall Study|Remission of disease|2|||
145971557|NCT01394276|526408863|FG000|Overall Study|Insufficient therapeutic effect|17|||
145971558|NCT01394276|526408863|FG000|Overall Study|Insufficient compliance|9|||
145971559|NCT01394276|526408863|FG000|Overall Study|Lost to Follow-up|5|||
145971560|NCT01394276|526408863|FG000|Overall Study|Participant moved to another site|1|||
146236889|NCT02036970|527382668|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236890|NCT02036970|527382669|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236891|NCT02036970|527382670|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236892|NCT02036970|527382671|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236893|NCT02036970|527382672|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
146236894|NCT02036970|527382673|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
146236895|NCT02036970|527382664|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
146236896|NCT02036970|527382665|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
146236897|NCT02036970|527382666|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
146236898|NCT02036970|527382667|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
146236899|NCT02036970|527382668|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
146236900|NCT02036970|527382669|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
146236901|NCT02036970|527382670|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
146236902|NCT02036970|527382671|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
146236903|NCT02036970|527382672|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
146296000|NCT00372385|527599122|FG003|Overall Study|Lost to Follow-up|0|||
145971561|NCT01394276|526408863|FG000|Overall Study|Pregnancy|1|||
145971562|NCT01394276|526408863|FG000|Overall Study|unavailability of drug at the Hospital|2|||
146236904|NCT02036970|527382673|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
146236905|NCT01171898|527382678|FG000|Overall Study|Death|0|||
146236906|NCT01171898|527382679|FG001|Overall Study|Death|0|||
146236907|NCT01171898|527382680|FG002|Overall Study|Death|2|||
146236908|NCT01171898|527382681|FG003|Overall Study|Death|0|||
146236909|NCT01171898|527382678|FG000|Overall Study|Lost to Follow-up|0|||
146236910|NCT01171898|527382679|FG001|Overall Study|Lost to Follow-up|1|||
146236911|NCT01171898|527382680|FG002|Overall Study|Lost to Follow-up|1|||
146236912|NCT01171898|527382681|FG003|Overall Study|Lost to Follow-up|1|||
146236913|NCT01171898|527382678|FG000|Overall Study|Withdrawal by Subject|1|||
146236914|NCT01171898|527382679|FG001|Overall Study|Withdrawal by Subject|4|||
146236915|NCT01171898|527382680|FG002|Overall Study|Withdrawal by Subject|6|||
146236916|NCT01171898|527382681|FG003|Overall Study|Withdrawal by Subject|3|||
146236917|NCT01171898|527382678|FG000|Overall Study|Terminated by Sponsor|1|||
146236918|NCT01171898|527382679|FG001|Overall Study|Terminated by Sponsor|0|||
146236919|NCT01171898|527382680|FG002|Overall Study|Terminated by Sponsor|0|||
146236920|NCT01171898|527382681|FG003|Overall Study|Terminated by Sponsor|0|||
146236921|NCT01171898|527382678|FG000|Overall Study|Ongoing|1|||
146236922|NCT01171898|527382679|FG001|Overall Study|Ongoing|9|||
146236923|NCT01171898|527382680|FG002|Overall Study|Ongoing|3|||
146236924|NCT01171898|527382681|FG003|Overall Study|Ongoing|0|||
146236925|NCT01171898|527382678|FG000|Overall Study|Other|1|||
146236926|NCT01171898|527382679|FG001|Overall Study|Other|5|||
146236927|NCT01171898|527382680|FG002|Overall Study|Other|0|||
146236928|NCT01171898|527382681|FG003|Overall Study|Other|2|||
146236929|NCT05802173|527382682|FG000|Overall Study|Withdrawal by Subject|2|||
146236930|NCT05802173|527382683|FG001|Overall Study|Withdrawal by Subject|0|||
146236931|NCT05802173|527382684|FG002|Overall Study|Withdrawal by Subject|0|||
146236932|NCT05802173|527382682|FG000|Overall Study|Protocol Violation|1|||
146236933|NCT05802173|527382683|FG001|Overall Study|Protocol Violation|0|||
146236934|NCT05802173|527382684|FG002|Overall Study|Protocol Violation|0|||
146236935|NCT05802173|527382682|FG000|Overall Study|Lost to Follow-up|0|||
146236936|NCT05802173|527382683|FG001|Overall Study|Lost to Follow-up|6|||
146236937|NCT05802173|527382684|FG002|Overall Study|Lost to Follow-up|4|||
146236938|NCT05802173|527382682|FG000|Overall Study|non-compliance|0|||
146236939|NCT05802173|527382683|FG001|Overall Study|non-compliance|1|||
146236940|NCT05802173|527382684|FG002|Overall Study|non-compliance|0|||
146236941|NCT02932410|527382685|FG000|Overall Study|Death|7|||
146236942|NCT02932410|527382686|FG001|Overall Study|Death|6|||
146236943|NCT02932410|527382687|FG002|Overall Study|Death|0|||
146236944|NCT02932410|527382688|FG003|Overall Study|Death|0|||
146236945|NCT02932410|527382685|FG000|Overall Study|Lost to Follow-up|1|||
146236946|NCT02932410|527382686|FG001|Overall Study|Lost to Follow-up|2|||
146236947|NCT02932410|527382687|FG002|Overall Study|Lost to Follow-up|0|||
146236948|NCT02932410|527382688|FG003|Overall Study|Lost to Follow-up|0|||
146236949|NCT02932410|527382685|FG000|Overall Study|Parent/Subjects decision|6|||
146236950|NCT02932410|527382686|FG001|Overall Study|Parent/Subjects decision|6|||
146236951|NCT02932410|527382687|FG002|Overall Study|Parent/Subjects decision|1|||
146236952|NCT02932410|527382688|FG003|Overall Study|Parent/Subjects decision|0|||
146236953|NCT02932410|527382685|FG000|Overall Study|Physician Decision|0|||
146236954|NCT02932410|527382686|FG001|Overall Study|Physician Decision|1|||
146236955|NCT02932410|527382687|FG002|Overall Study|Physician Decision|0|||
146236956|NCT02932410|527382688|FG003|Overall Study|Physician Decision|0|||
146236957|NCT00360269|527382689|FG000|Overall Study|Lost to Follow-up|7|||
146236958|NCT00360269|527382690|FG001|Overall Study|Lost to Follow-up|9|||
146236959|NCT00360269|527382689|FG000|Overall Study|Physician Decision|1|||
146236960|NCT00360269|527382690|FG001|Overall Study|Physician Decision|2|||
146236961|NCT00360269|527382689|FG000|Overall Study|Adverse Event|1|||
146236962|NCT00360269|527382690|FG001|Overall Study|Adverse Event|0|||
146236963|NCT00360269|527382689|FG000|Overall Study|Withdrawal by Subject|1|||
146236964|NCT00360269|527382690|FG001|Overall Study|Withdrawal by Subject|1|||
146236965|NCT00048932|527382693|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
146236966|NCT00048932|527382694|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
146236967|NCT00048932|527382695|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
146236968|NCT00048932|527382693|FG000|Double Blind Period (DB)|Adverse Event|51|||
146236969|NCT00048932|527382694|FG001|Double Blind Period (DB)|Adverse Event|19|||
146236970|NCT00048932|527382695|FG002|Double Blind Period (DB)|Adverse Event|0|||
146236971|NCT00048932|527382693|FG000|Double Blind Period (DB)|Death|5|||
146236972|NCT00048932|527382694|FG001|Double Blind Period (DB)|Death|3|||
146088161|NCT01986933|526841960|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
146236973|NCT00048932|527382695|FG002|Double Blind Period (DB)|Death|0|||
146236974|NCT00048932|527382693|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
146236975|NCT00048932|527382694|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
146236976|NCT00048932|527382695|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
146236977|NCT00048932|527382693|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
146236978|NCT00048932|527382694|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
146236979|NCT00048932|527382695|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
146236980|NCT00048932|527382693|FG000|Double Blind Period (DB)|Relocation|1|||
146236981|NCT00048932|527382694|FG001|Double Blind Period (DB)|Relocation|0|||
146296001|NCT00372385|527599119|FG000|Overall Study|Withdrawal by Subject|2|||
146296002|NCT00372385|527599120|FG001|Overall Study|Withdrawal by Subject|1|||
146296003|NCT00372385|527599121|FG002|Overall Study|Withdrawal by Subject|0|||
146296004|NCT00372385|527599122|FG003|Overall Study|Withdrawal by Subject|0|||
146296005|NCT00372385|527599119|FG000|Overall Study|Refusal of Treatment|3|||
146296006|NCT00372385|527599120|FG001|Overall Study|Refusal of Treatment|6|||
146296007|NCT00372385|527599121|FG002|Overall Study|Refusal of Treatment|0|||
146296008|NCT00372385|527599122|FG003|Overall Study|Refusal of Treatment|0|||
146296009|NCT00372385|527599119|FG000|Overall Study|No Response|1|||
146296010|NCT00372385|527599120|FG001|Overall Study|No Response|1|||
146296011|NCT00372385|527599121|FG002|Overall Study|No Response|0|||
146296012|NCT00372385|527599122|FG003|Overall Study|No Response|0|||
146296013|NCT00372385|527599119|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
146296014|NCT00372385|527599120|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146296015|NCT00372385|527599121|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146296016|NCT00372385|527599122|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
146296017|NCT00372385|527599119|FG000|Overall Study|Virologic Stopping Rule|17|||
146296018|NCT00372385|527599120|FG001|Overall Study|Virologic Stopping Rule|0|||
146296019|NCT00372385|527599121|FG002|Overall Study|Virologic Stopping Rule|0|||
146296020|NCT00372385|527599122|FG003|Overall Study|Virologic Stopping Rule|0|||
146296021|NCT02973048|527599124|FG000|Overall Study|Epidural catheter insertion failure|1|||
146296022|NCT02973048|527599125|FG001|Overall Study|Epidural catheter insertion failure|0|||
146296023|NCT02973048|527599124|FG000|Overall Study|Withdrawal by Subject|0|||
146296024|NCT02973048|527599125|FG001|Overall Study|Withdrawal by Subject|3|||
146296025|NCT01906346|527599129|FG000|Overall Study|AEs|1|||
146296026|NCT00364156|527599132|FG000|Overall Study|Withdrawal by Subject|73|||
146296027|NCT00364156|527599133|FG001|Overall Study|Withdrawal by Subject|80|||
146296028|NCT00364156|527599132|FG000|Overall Study|Protocol Violation|6|||
146296029|NCT00364156|527599133|FG001|Overall Study|Protocol Violation|1|||
146296030|NCT02511678|527599134|FG000|Overall Study|Withdrawal by Subject|2|||
146296031|NCT02511678|527599134|FG000|Overall Study|Lost to Follow-up|4|||
146296032|NCT02511678|527599134|FG000|Overall Study|Death|19|||
146296033|NCT02511678|527599134|FG000|Overall Study|Adverse Event|1|||
146296034|NCT02511678|527599134|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
146296035|NCT02511678|527599134|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
146296036|NCT02511678|527599134|FG000|Overall Study|Required Radiofrequency Ablation|1|||
146296037|NCT02511678|527599134|FG000|Overall Study|Biopsy was Negative|1|||
146296038|NCT02511678|527599134|FG000|Overall Study|Protocol Violation|1|||
146296039|NCT02511678|527599134|FG000|Overall Study|Received Radiation Treatment|1|||
146296040|NCT05125679|527599140|FG000|Overall Study|Study Terminated by Sponsor|2|||
146296041|NCT05125679|527599141|FG001|Overall Study|Study Terminated by Sponsor|5|||
146296042|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
146296043|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
146296044|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
146296045|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
146296046|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
146296047|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
146296048|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
146296049|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
146296050|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
146296051|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
146296052|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
146296053|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
146296054|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
146296055|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
146296056|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
146296057|NCT04908189|527599146|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
146296058|NCT04908189|527599147|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
146296059|NCT04908189|527599148|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
146296060|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
146296061|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
146296062|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
146296063|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
146296064|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
146296065|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
146296066|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
146296067|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
146296068|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
146296069|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
145971563|NCT01394276|526408863|FG000|Overall Study|Symptoms of concurrent diseases|1|||
145971564|NCT00655889|526408864|FG000|Overall Study|Inadequate cell growth|1|||
145971565|NCT00655889|526408864|FG000|Overall Study|Protocol Violation|1|||
145971566|NCT04585893|526408865|FG000|Overall Study|Death|1|||
145971567|NCT04585893|526408866|FG001|Overall Study|Death|0|||
145971568|NCT03573297|526408867|FG000|Open Label Treatment Period|Adverse Event|67|||
145971569|NCT03573297|526408868|FG001|Open Label Treatment Period|Adverse Event|0|||
145971570|NCT03573297|526408869|FG002|Open Label Treatment Period|Adverse Event|0|||
145971571|NCT03573297|526408870|FG003|Open Label Treatment Period|Adverse Event|0|||
145971572|NCT03573297|526408867|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
145971573|NCT03573297|526408868|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
145971574|NCT03573297|526408869|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
145971575|NCT03573297|526408870|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
145971576|NCT03573297|526408867|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
145971577|NCT03573297|526408868|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
145971578|NCT03573297|526408869|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
146088162|NCT01986933|526841961|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
146088163|NCT01986933|526841962|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
146088164|NCT01986933|526841963|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
146088165|NCT01986933|526841959|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
146088166|NCT01986933|526841960|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
146088167|NCT01986933|526841961|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
146088168|NCT01986933|526841962|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
146088169|NCT01986933|526841963|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
146236982|NCT00048932|527382695|FG002|Double Blind Period (DB)|Relocation|0|||
146236983|NCT00048932|527382693|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
146236984|NCT00048932|527382694|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
146236985|NCT00048932|527382695|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
146236986|NCT00048932|527382693|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
146236987|NCT00048932|527382694|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
146236988|NCT00048932|527382695|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
146236989|NCT00048932|527382693|FG000|Double Blind Period (DB)|Pregnancy|1|||
146236990|NCT00048932|527382694|FG001|Double Blind Period (DB)|Pregnancy|0|||
146236991|NCT00048932|527382695|FG002|Double Blind Period (DB)|Pregnancy|0|||
146236992|NCT00048932|527382693|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
146236993|NCT00048932|527382694|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
146236994|NCT00048932|527382695|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
146236995|NCT00048932|527382693|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
146236996|NCT00048932|527382694|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
146236997|NCT00048932|527382695|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
146236998|NCT00048932|527382693|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
146236999|NCT00048932|527382694|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
146237000|NCT00048932|527382695|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
146237001|NCT00048932|527382693|FG000|Open Label Period (OL)|Death|0|||
146237002|NCT00048932|527382694|FG001|Open Label Period (OL)|Death|0|||
146237003|NCT00048932|527382695|FG002|Open Label Period (OL)|Death|25|||
146237004|NCT00048932|527382693|FG000|Open Label Period (OL)|Adverse Event|0|||
146237005|NCT00048932|527382694|FG001|Open Label Period (OL)|Adverse Event|0|||
146237006|NCT00048932|527382695|FG002|Open Label Period (OL)|Adverse Event|103|||
146237007|NCT00048932|527382693|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
146237008|NCT00048932|527382694|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
146237009|NCT00048932|527382695|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
146237010|NCT00048932|527382693|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
146237011|NCT00048932|527382694|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
146237012|NCT00048932|527382695|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
146237013|NCT00048932|527382693|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
146237014|NCT00048932|527382694|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
146237015|NCT00048932|527382695|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
146237016|NCT00048932|527382693|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
146237017|NCT00048932|527382694|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
146237018|NCT00048932|527382695|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
146237019|NCT00048932|527382693|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
146237020|NCT00048932|527382694|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
146237021|NCT00048932|527382695|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
146237022|NCT00048932|527382693|FG000|Open Label Period (OL)|Pregnancy|0|||
146237023|NCT00048932|527382694|FG001|Open Label Period (OL)|Pregnancy|0|||
146237024|NCT00048932|527382695|FG002|Open Label Period (OL)|Pregnancy|6|||
145971579|NCT03573297|526408870|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
145971580|NCT03573297|526408867|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
145971581|NCT03573297|526408868|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
146237025|NCT00048932|527382693|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
145971582|NCT03573297|526408869|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
145971583|NCT03573297|526408870|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
145971584|NCT03573297|526408867|FG000|Open Label Treatment Period|Pregnancy|1|||
145971585|NCT03573297|526408868|FG001|Open Label Treatment Period|Pregnancy|0|||
145971586|NCT03573297|526408869|FG002|Open Label Treatment Period|Pregnancy|0|||
145971587|NCT03573297|526408870|FG003|Open Label Treatment Period|Pregnancy|0|||
145971588|NCT03573297|526408867|FG000|Open Label Treatment Period|Protocol Violation|17|||
145971589|NCT03573297|526408868|FG001|Open Label Treatment Period|Protocol Violation|0|||
145971590|NCT03573297|526408869|FG002|Open Label Treatment Period|Protocol Violation|0|||
145971591|NCT03573297|526408870|FG003|Open Label Treatment Period|Protocol Violation|0|||
145971592|NCT03573297|526408867|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
145971593|NCT03573297|526408868|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145971594|NCT03573297|526408869|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145971595|NCT03573297|526408870|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145971596|NCT03573297|526408867|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
145971597|NCT03573297|526408868|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145971598|NCT03573297|526408869|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145971599|NCT03573297|526408870|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145971600|NCT03573297|526408867|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
145971601|NCT03573297|526408868|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145971602|NCT03573297|526408869|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145971603|NCT03573297|526408870|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145971604|NCT03573297|526408867|FG000|Open Label Treatment Period|Other, Not Specified|7|||
145971605|NCT03573297|526408868|FG001|Open Label Treatment Period|Other, Not Specified|0|||
145971606|NCT03573297|526408869|FG002|Open Label Treatment Period|Other, Not Specified|0|||
145971607|NCT03573297|526408870|FG003|Open Label Treatment Period|Other, Not Specified|0|||
145971608|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
145971609|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
145971610|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
145971611|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
145971612|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145971613|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145971614|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Adverse Event|5|||
145971615|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Adverse Event|1|||
145971616|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145971617|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
145971618|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
145971619|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
145971620|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145971621|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
145971622|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
145971623|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
145971624|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145971625|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
145971626|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
145971627|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
145971628|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145971629|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
145971630|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
145971631|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
145971632|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
145971633|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
145971634|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
145971635|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
145971636|NCT03573297|526408867|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
145971637|NCT03573297|526408868|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
145971638|NCT03573297|526408869|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
146237026|NCT00048932|527382694|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
146237027|NCT00048932|527382695|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
146237028|NCT00048932|527382693|FG000|Open Label Period (OL)|Investigator Retiring|0|||
146237029|NCT00048932|527382694|FG001|Open Label Period (OL)|Investigator Retiring|0|||
146237030|NCT00048932|527382695|FG002|Open Label Period (OL)|Investigator Retiring|2|||
146237031|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
146237032|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
146088170|NCT01986933|526841959|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146237033|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
146296070|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
146296071|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
146296072|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
146296073|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
146296074|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
146296075|NCT04908189|527599146|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146296076|NCT04908189|527599147|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146296077|NCT04908189|527599148|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
146296078|NCT00607022|527599150|FG000|Overall Study|Withdrawal by Subject|1|||
146296079|NCT00607022|527599151|FG001|Overall Study|Withdrawal by Subject|0|||
146296080|NCT00607022|527599152|FG002|Overall Study|Withdrawal by Subject|0|||
146296081|NCT00458341|527599153|FG000|Cycle 1|Adverse Event|1|||
146296082|NCT00458341|527599154|FG001|Cycle 1|Adverse Event|0|||
146296083|NCT04540133|527599155|FG000|Overall Study|Lost to Follow-up|1|||
146296084|NCT04540133|527599156|FG001|Overall Study|Lost to Follow-up|0|||
146296085|NCT05461794|527599157|FG000|Overall Study|Withdrawal by Subject|1|||
146296086|NCT05461794|527599158|FG001|Overall Study|Withdrawal by Subject|1|||
146296087|NCT05461794|527599159|FG002|Overall Study|Withdrawal by Subject|3|||
146296088|NCT05461794|527599157|FG000|Overall Study|Study Terminated By Sponsor|18|||
145971639|NCT03573297|526408870|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
145971640|NCT01366092|526408873|FG000|Overall Study|Progressive cGVHD|2|||
145971641|NCT01366092|526408873|FG000|Overall Study|Physician Decision|1|||
146237034|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Relocated|0|||
146237035|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Relocated|0|||
146237036|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Relocated|6|||
146237037|NCT00048932|527382693|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
146237038|NCT00048932|527382694|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
146237039|NCT00048932|527382695|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
146237040|NCT00048932|527382693|FG000|Open Label Period (OL)|Site Closure|0|||
146237041|NCT00048932|527382694|FG001|Open Label Period (OL)|Site Closure|0|||
146237042|NCT00048932|527382695|FG002|Open Label Period (OL)|Site Closure|3|||
146237043|NCT00048932|527382693|FG000|Open Label Period (OL)|Trial Terminated|0|||
146237044|NCT00048932|527382694|FG001|Open Label Period (OL)|Trial Terminated|0|||
146237045|NCT00048932|527382695|FG002|Open Label Period (OL)|Trial Terminated|1|||
146237046|NCT00048932|527382693|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
146237047|NCT00048932|527382694|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
146237048|NCT00048932|527382695|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
146237049|NCT00048932|527382693|FG000|Open Label Period (OL)|Patient Decision|0|||
146237050|NCT00048932|527382694|FG001|Open Label Period (OL)|Patient Decision|0|||
146237051|NCT00048932|527382695|FG002|Open Label Period (OL)|Patient Decision|4|||
146237052|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
146237053|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
146237054|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
146237055|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
146237056|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
146237057|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
146237058|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
146237059|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
146237060|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
146237061|NCT00048932|527382693|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
146237062|NCT00048932|527382694|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
146237063|NCT00048932|527382695|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
146237064|NCT00048932|527382693|FG000|Open Label Period (OL)|Investigator Decision|0|||
146237065|NCT00048932|527382694|FG001|Open Label Period (OL)|Investigator Decision|0|||
146237066|NCT00048932|527382695|FG002|Open Label Period (OL)|Investigator Decision|4|||
146237067|NCT00048932|527382693|FG000|Open Label Period (OL)|Site Staff Issues|0|||
146237068|NCT00048932|527382694|FG001|Open Label Period (OL)|Site Staff Issues|0|||
146237069|NCT00048932|527382695|FG002|Open Label Period (OL)|Site Staff Issues|2|||
146237070|NCT00048932|527382693|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
146237071|NCT00048932|527382694|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
146237072|NCT00048932|527382695|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
146237073|NCT00048932|527382693|FG000|Open Label Period (OL)|Participant Surgery|0|||
146237074|NCT00048932|527382694|FG001|Open Label Period (OL)|Participant Surgery|0|||
146237075|NCT00048932|527382695|FG002|Open Label Period (OL)|Participant Surgery|1|||
146237076|NCT02232737|527382696|FG000|Overall Study|Lost to Follow-up|18|||
146237077|NCT02232737|527382697|FG001|Overall Study|Lost to Follow-up|28|||
146237078|NCT02232737|527382698|FG002|Overall Study|Lost to Follow-up|33|||
146237079|NCT02232737|527382696|FG000|Overall Study|Personal reasons|7|||
146237080|NCT02232737|527382697|FG001|Overall Study|Personal reasons|8|||
145971642|NCT01366092|526408873|FG000|Overall Study|Withdrawal by Subject|1|||
146296089|NCT05461794|527599158|FG001|Overall Study|Study Terminated By Sponsor|13|||
146296090|NCT05461794|527599159|FG002|Overall Study|Study Terminated By Sponsor|16|||
146296091|NCT05461794|527599157|FG000|Overall Study|Death|20|||
146296092|NCT05461794|527599158|FG001|Overall Study|Death|5|||
146296093|NCT05461794|527599159|FG002|Overall Study|Death|19|||
146296094|NCT02730598|527599164|FG000|Overall Study|Withdrawal by Subject|3|||
146296095|NCT02730598|527599165|FG001|Overall Study|Withdrawal by Subject|3|||
146296096|NCT02730598|527599164|FG000|Overall Study|Protocol Violation|0|||
146296097|NCT02730598|527599165|FG001|Overall Study|Protocol Violation|1|||
146296098|NCT02730598|527599164|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
146296099|NCT02730598|527599165|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
146296100|NCT02958267|527599171|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
146296101|NCT02958267|527599172|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
146296102|NCT02958267|527599171|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
146296103|NCT02958267|527599172|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
146296104|NCT02958267|527599171|FG000|Follow-up Visits|Additional treatment pursued|2|||
146296105|NCT02958267|527599172|FG001|Follow-up Visits|Additional treatment pursued|1|||
146296106|NCT01210118|527599173|FG000|Overall Study|Lost to Follow-up|1|||
146296107|NCT01210118|527599174|FG001|Overall Study|Lost to Follow-up|1|||
146296108|NCT01210118|527599173|FG000|Overall Study|Protocol Violation|1|||
146296109|NCT01210118|527599174|FG001|Overall Study|Protocol Violation|1|||
146296110|NCT01210118|527599173|FG000|Overall Study|Spontaneous abortion|1|||
146296111|NCT01210118|527599174|FG001|Overall Study|Spontaneous abortion|3|||
146296112|NCT00777946|527599175|FG000|Overall Study|Adverse Event|11|||
146296113|NCT00777946|527599176|FG001|Overall Study|Adverse Event|1|||
146296114|NCT00777946|527599177|FG002|Overall Study|Adverse Event|3|||
146296115|NCT00777946|527599175|FG000|Overall Study|Lack of Efficacy|0|||
146296116|NCT00777946|527599176|FG001|Overall Study|Lack of Efficacy|0|||
146296117|NCT00777946|527599177|FG002|Overall Study|Lack of Efficacy|9|||
146296118|NCT00777946|527599175|FG000|Overall Study|Condition no longer required study drug|1|||
146296119|NCT00777946|527599176|FG001|Overall Study|Condition no longer required study drug|0|||
146296120|NCT00777946|527599177|FG002|Overall Study|Condition no longer required study drug|0|||
146296121|NCT00777946|527599175|FG000|Overall Study|Patient withdrew consent|3|||
146296122|NCT00777946|527599176|FG001|Overall Study|Patient withdrew consent|2|||
146296123|NCT00777946|527599177|FG002|Overall Study|Patient withdrew consent|3|||
146296124|NCT00777946|527599175|FG000|Overall Study|Lost to Follow-up|3|||
146296125|NCT00777946|527599176|FG001|Overall Study|Lost to Follow-up|1|||
146296126|NCT00777946|527599177|FG002|Overall Study|Lost to Follow-up|0|||
146296127|NCT00777946|527599175|FG000|Overall Study|Protocol deviation|2|||
146296128|NCT00777946|527599176|FG001|Overall Study|Protocol deviation|1|||
146296129|NCT00777946|527599177|FG002|Overall Study|Protocol deviation|1|||
146296130|NCT00777946|527599175|FG000|Overall Study|Randomized in error|1|||
146296131|NCT00777946|527599176|FG001|Overall Study|Randomized in error|1|||
146296132|NCT00777946|527599177|FG002|Overall Study|Randomized in error|0|||
146296133|NCT02673619|527599181|FG000|Overall Study|Lost to Follow-up|1|||
146296134|NCT02673619|527599182|FG001|Overall Study|Lost to Follow-up|0|||
146296135|NCT02673619|527599183|FG002|Overall Study|Lost to Follow-up|0|||
146296136|NCT02673619|527599184|FG003|Overall Study|Lost to Follow-up|0|||
146296137|NCT02673619|527599181|FG000|Overall Study|Withdrawal by Subject|1|||
146296138|NCT02673619|527599182|FG001|Overall Study|Withdrawal by Subject|1|||
146296139|NCT02673619|527599183|FG002|Overall Study|Withdrawal by Subject|1|||
146296140|NCT02673619|527599184|FG003|Overall Study|Withdrawal by Subject|0|||
146296141|NCT02673619|527599181|FG000|Overall Study|Adverse Event|0|||
146296142|NCT02673619|527599182|FG001|Overall Study|Adverse Event|0|||
146296143|NCT02673619|527599183|FG002|Overall Study|Adverse Event|1|||
146296144|NCT02673619|527599184|FG003|Overall Study|Adverse Event|0|||
146296145|NCT02673619|527599181|FG000|Overall Study|Lack of Efficacy|0|||
146296146|NCT02673619|527599182|FG001|Overall Study|Lack of Efficacy|0|||
146296147|NCT02673619|527599183|FG002|Overall Study|Lack of Efficacy|1|||
146296148|NCT02673619|527599184|FG003|Overall Study|Lack of Efficacy|0|||
146296149|NCT01313117|527599186|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
146296150|NCT01313117|527599186|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
146296151|NCT03602261|527599191|FG000|Overall Study|Adverse Event|5|||
146296152|NCT03602261|527599192|FG001|Overall Study|Adverse Event|1|||
146296153|NCT03602261|527599191|FG000|Overall Study|Physician Decision|1|||
146296154|NCT03602261|527599192|FG001|Overall Study|Physician Decision|0|||
146296155|NCT03602261|527599191|FG000|Overall Study|Withdrawal by Subject|1|||
146296156|NCT03602261|527599192|FG001|Overall Study|Withdrawal by Subject|1|||
146296157|NCT03602261|527599191|FG000|Overall Study|Lack of Efficacy|0|||
146296158|NCT03602261|527599192|FG001|Overall Study|Lack of Efficacy|1|||
146296159|NCT03602261|527599191|FG000|Overall Study|Subject moving out of state|1|||
146296160|NCT03602261|527599192|FG001|Overall Study|Subject moving out of state|0|||
146296161|NCT03078907|527600553|FG000|Overall Study|Adverse Event|2|||
146296162|NCT03078907|527600554|FG001|Overall Study|Adverse Event|0|||
146296163|NCT03078907|527600553|FG000|Overall Study|Other|1|||
146296164|NCT03078907|527600554|FG001|Overall Study|Other|0|||
146296165|NCT03078907|527600553|FG000|Overall Study|Protocol Violation|0|||
146237081|NCT02232737|527382698|FG002|Overall Study|Personal reasons|14|||
146237082|NCT02232737|527382696|FG000|Overall Study|Adverse Event|6|||
146237083|NCT02232737|527382697|FG001|Overall Study|Adverse Event|3|||
146237084|NCT02232737|527382698|FG002|Overall Study|Adverse Event|8|||
146237085|NCT02232737|527382696|FG000|Overall Study|Incarcerated|2|||
146237086|NCT02232737|527382697|FG001|Overall Study|Incarcerated|1|||
146237087|NCT02232737|527382698|FG002|Overall Study|Incarcerated|2|||
146237088|NCT02232737|527382696|FG000|Overall Study|Withdrawal by Subject|0|||
146237089|NCT02232737|527382697|FG001|Overall Study|Withdrawal by Subject|1|||
146237090|NCT02232737|527382698|FG002|Overall Study|Withdrawal by Subject|2|||
146237091|NCT02232737|527382696|FG000|Overall Study|Death|0|||
146237092|NCT02232737|527382697|FG001|Overall Study|Death|1|||
146237093|NCT02232737|527382698|FG002|Overall Study|Death|1|||
146237094|NCT02232737|527382696|FG000|Overall Study|Physician Decision|1|||
146237095|NCT02232737|527382697|FG001|Overall Study|Physician Decision|3|||
146237096|NCT02232737|527382698|FG002|Overall Study|Physician Decision|1|||
146237097|NCT02232737|527382696|FG000|Overall Study|Protocol Violation|1|||
146237098|NCT02232737|527382697|FG001|Overall Study|Protocol Violation|0|||
146237099|NCT02232737|527382698|FG002|Overall Study|Protocol Violation|1|||
146237100|NCT02232737|527382696|FG000|Overall Study|Reason unknown|1|||
146237101|NCT02232737|527382697|FG001|Overall Study|Reason unknown|0|||
146237102|NCT02232737|527382698|FG002|Overall Study|Reason unknown|0|||
146237103|NCT02200705|527382701|FG000|Overall Study|Excluded|12|||
146237104|NCT02200705|527382701|FG000|Overall Study|Death|21|||
146237105|NCT02200705|527382701|FG000|Overall Study|Withdrawal by Subject|22|||
146237106|NCT02200705|527382701|FG000|Overall Study|Lost to Follow-up|13|||
146237107|NCT02200705|527382701|FG000|Overall Study|Physician Decision|5|||
146237108|NCT02200705|527382701|FG000|Overall Study|Adverse Event|2|||
146237109|NCT03738228|527382703|FG000|Overall Study|Never received study treatment|2|||
146237110|NCT03738228|527382704|FG001|Overall Study|Never received study treatment|2|||
146237111|NCT02866942|527382705|FG000|Overall Study|Invalid consent|1|||
146237112|NCT06212752|527382706|FG000|Overall Study|Death|5|||
146237113|NCT06212752|527382707|FG001|Overall Study|Death|3|||
146237114|NCT06212752|527382706|FG000|Overall Study|Participants ongoing|23|||
146237115|NCT06212752|527382707|FG001|Overall Study|Participants ongoing|8|||
146237116|NCT04162210|527382708|FG000|Overall Study|Lost to Follow-up|4|||
146237117|NCT04162210|527382709|FG001|Overall Study|Lost to Follow-up|1|||
146237118|NCT04162210|527382708|FG000|Overall Study|Withdrawal by Subject|17|||
146237119|NCT04162210|527382709|FG001|Overall Study|Withdrawal by Subject|9|||
146237120|NCT04162210|527382708|FG000|Overall Study|Ongoing|113|||
146237121|NCT04162210|527382709|FG001|Overall Study|Ongoing|59|||
146237122|NCT02568215|527382710|FG000|Overall Study|Death|1|||
146237123|NCT02568215|527382711|FG001|Overall Study|Death|2|||
146237124|NCT02568215|527382712|FG002|Overall Study|Death|0|||
146237125|NCT02568215|527382710|FG000|Overall Study|Physician Decision|2|||
146237126|NCT02568215|527382711|FG001|Overall Study|Physician Decision|2|||
146237127|NCT02568215|527382712|FG002|Overall Study|Physician Decision|2|||
146237128|NCT02568215|527382710|FG000|Overall Study|Lost to Follow-up|29|||
146237129|NCT02568215|527382711|FG001|Overall Study|Lost to Follow-up|32|||
146237130|NCT02568215|527382712|FG002|Overall Study|Lost to Follow-up|41|||
146237131|NCT02568215|527382710|FG000|Overall Study|Withdrawal by Subject|21|||
146237132|NCT02568215|527382711|FG001|Overall Study|Withdrawal by Subject|19|||
146237133|NCT02568215|527382712|FG002|Overall Study|Withdrawal by Subject|22|||
146237134|NCT02568215|527382710|FG000|Overall Study|Protocol Violation|1|||
146237135|NCT02568215|527382711|FG001|Overall Study|Protocol Violation|1|||
146237136|NCT02568215|527382712|FG002|Overall Study|Protocol Violation|0|||
146237137|NCT02568215|527382710|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
146237138|NCT02568215|527382711|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
146237139|NCT02568215|527382712|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
146237140|NCT02568215|527382710|FG000|Overall Study|Other|0|||
146237141|NCT02568215|527382711|FG001|Overall Study|Other|1|||
146237142|NCT02568215|527382712|FG002|Overall Study|Other|4|||
146237143|NCT01641900|527382713|FG000|Overall Study|Withdrawal by Subject|2|||
146237144|NCT01641900|527382714|FG001|Overall Study|Withdrawal by Subject|2|||
146237145|NCT00371345|527382715|FG000|Overall Study|Disease Progression|21|||
146237146|NCT00371345|527382716|FG001|Overall Study|Disease Progression|35|||
146237147|NCT00371345|527382715|FG000|Overall Study|Study Drug Toxicity|1|||
146237148|NCT00371345|527382716|FG001|Overall Study|Study Drug Toxicity|7|||
146237149|NCT00371345|527382715|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
146237150|NCT00371345|527382716|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
146237151|NCT00371345|527382715|FG000|Overall Study|Participant Request|1|||
146237152|NCT00371345|527382716|FG001|Overall Study|Participant Request|1|||
146237153|NCT00371345|527382715|FG000|Overall Study|Participant Withdrew Consent|0|||
146237154|NCT00371345|527382716|FG001|Overall Study|Participant Withdrew Consent|1|||
146237155|NCT02463448|527382722|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
146237156|NCT02463448|527382722|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
146237157|NCT02463448|527382722|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
146237158|NCT02463448|527382722|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
146237159|NCT01640951|527382723|FG000|Overall Study|Adverse Event|8|||
145971643|NCT02273167|526408875|FG000|Overall Study|Adverse Event|1|||
145971644|NCT02273167|526408876|FG001|Overall Study|Adverse Event|0|||
145971645|NCT02273167|526408877|FG002|Overall Study|Adverse Event|0|||
145971646|NCT02273167|526408875|FG000|Overall Study|Protocol Violation|3|||
145971647|NCT02273167|526408876|FG001|Overall Study|Protocol Violation|1|||
145971648|NCT02273167|526408877|FG002|Overall Study|Protocol Violation|1|||
145971649|NCT02273167|526408875|FG000|Overall Study|Lost to Follow-up|0|||
145971650|NCT02273167|526408876|FG001|Overall Study|Lost to Follow-up|1|||
145971651|NCT02273167|526408877|FG002|Overall Study|Lost to Follow-up|1|||
145971652|NCT02273167|526408875|FG000|Overall Study|Withdrawal by Subject|10|||
145971653|NCT02273167|526408876|FG001|Overall Study|Withdrawal by Subject|12|||
145971654|NCT02273167|526408877|FG002|Overall Study|Withdrawal by Subject|11|||
145971655|NCT02273167|526408875|FG000|Overall Study|Various|10|||
145971656|NCT02273167|526408876|FG001|Overall Study|Various|9|||
146296166|NCT03078907|527600554|FG001|Overall Study|Protocol Violation|1|||
146296167|NCT00985166|527600555|FG000|Overall Study|Lost to Follow-up|3|||
146296168|NCT00985166|527600556|FG001|Overall Study|Lost to Follow-up|2|||
146296169|NCT00985166|527600557|FG002|Overall Study|Lost to Follow-up|2|||
146296170|NCT00985166|527600555|FG000|Overall Study|Withdrawal by Subject|3|||
146296171|NCT00985166|527600556|FG001|Overall Study|Withdrawal by Subject|2|||
145971657|NCT02273167|526408877|FG002|Overall Study|Various|8|||
145971658|NCT01093846|526408878|FG000|Overall Study|Adverse Event|0|||
145971659|NCT01093846|526408879|FG001|Overall Study|Adverse Event|0|||
145971660|NCT01093846|526408880|FG002|Overall Study|Adverse Event|1|||
145971661|NCT01093846|526408878|FG000|Overall Study|Lack of Efficacy|0|||
145971662|NCT01093846|526408879|FG001|Overall Study|Lack of Efficacy|0|||
145971663|NCT01093846|526408880|FG002|Overall Study|Lack of Efficacy|4|||
145971664|NCT01093846|526408878|FG000|Overall Study|Condition no longer required study drug|1|||
145971665|NCT01093846|526408879|FG001|Overall Study|Condition no longer required study drug|1|||
145971666|NCT01093846|526408880|FG002|Overall Study|Condition no longer required study drug|1|||
145971667|NCT01093846|526408878|FG000|Overall Study|Administrative Problems|18|||
146296172|NCT00985166|527600557|FG002|Overall Study|Withdrawal by Subject|0|||
146296173|NCT00985166|527600555|FG000|Overall Study|Test not done|2|||
146296174|NCT00985166|527600556|FG001|Overall Study|Test not done|0|||
146296175|NCT00985166|527600557|FG002|Overall Study|Test not done|4|||
146296176|NCT00985166|527600555|FG000|Overall Study|Other|1|||
146296177|NCT00985166|527600556|FG001|Overall Study|Other|0|||
146296178|NCT00985166|527600557|FG002|Overall Study|Other|1|||
146296179|NCT00909792|527600564|FG000|Period 1|Did not meet inclusion criteria|0|||
146296180|NCT00909792|527600565|FG001|Period 1|Did not meet inclusion criteria|1|||
146296181|NCT00909792|527600564|FG000|Period 2|Biomicroscopy|1|||
146296182|NCT00909792|527600565|FG001|Period 2|Biomicroscopy|0|||
146296183|NCT00909792|527600564|FG000|Period 2|Lost to Follow-up|0|||
146296184|NCT00909792|527600565|FG001|Period 2|Lost to Follow-up|1|||
146296185|NCT03434353|527600566|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
146296186|NCT03434353|527600567|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
146296187|NCT03434353|527600568|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
146296188|NCT03434353|527600569|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
146296189|NCT03434353|527600570|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
146296190|NCT03434353|527600566|FG000|Overall Study|Withdrew consent|1|||
146296191|NCT03434353|527600567|FG001|Overall Study|Withdrew consent|0|||
146296192|NCT03434353|527600568|FG002|Overall Study|Withdrew consent|3|||
146296193|NCT03434353|527600569|FG003|Overall Study|Withdrew consent|0|||
146296194|NCT03434353|527600570|FG004|Overall Study|Withdrew consent|0|||
146296195|NCT03434353|527600566|FG000|Overall Study|Adverse Event|1|||
146296196|NCT03434353|527600567|FG001|Overall Study|Adverse Event|0|||
146296197|NCT03434353|527600568|FG002|Overall Study|Adverse Event|0|||
146296198|NCT03434353|527600569|FG003|Overall Study|Adverse Event|0|||
146296199|NCT03434353|527600570|FG004|Overall Study|Adverse Event|1|||
146296200|NCT03434353|527600566|FG000|Overall Study|Lost to Follow-up|2|||
145971668|NCT01093846|526408879|FG001|Overall Study|Administrative Problems|17|||
145971669|NCT01093846|526408880|FG002|Overall Study|Administrative Problems|15|||
145971670|NCT06125964|526410430|FG000|Overall Study|Lost to Follow-up|0|||
145971671|NCT06125964|526410431|FG001|Overall Study|Lost to Follow-up|1|||
145971672|NCT06125964|526410432|FG002|Overall Study|Lost to Follow-up|0|||
145971673|NCT06125964|526410433|FG003|Overall Study|Lost to Follow-up|0|||
145971674|NCT03405870|526410434|FG000|Overall Study|Withdrawal|1|||
145971675|NCT03405870|526410435|FG001|Overall Study|Withdrawal|0|||
146296201|NCT03434353|527600567|FG001|Overall Study|Lost to Follow-up|0|||
146296202|NCT03434353|527600568|FG002|Overall Study|Lost to Follow-up|0|||
146296203|NCT03434353|527600569|FG003|Overall Study|Lost to Follow-up|0|||
146296204|NCT03434353|527600570|FG004|Overall Study|Lost to Follow-up|0|||
145971676|NCT03405870|526410436|FG002|Overall Study|Withdrawal|1|||
145971677|NCT03405870|526410437|FG003|Overall Study|Withdrawal|0|||
145971678|NCT03405870|526410438|FG004|Overall Study|Withdrawal|0|||
146296205|NCT01990534|527600571|FG000|Overall Study|Death|22|||
146296206|NCT01990534|527600571|FG000|Overall Study|Progressive disease|3|||
145971679|NCT03405870|526410439|FG005|Overall Study|Withdrawal|0|||
145971680|NCT03405870|526410440|FG006|Overall Study|Withdrawal|1|||
145971681|NCT03405870|526410441|FG007|Overall Study|Withdrawal|0|||
145971682|NCT03737994|526410442|FG000|Overall Study|Withdrawal by Subject|0|||
145971683|NCT03737994|526410443|FG001|Overall Study|Withdrawal by Subject|0|||
145971684|NCT03737994|526410444|FG002|Overall Study|Withdrawal by Subject|0|||
145971685|NCT03737994|526410445|FG003|Overall Study|Withdrawal by Subject|0|||
145971686|NCT03737994|526410446|FG004|Overall Study|Withdrawal by Subject|0|||
145971687|NCT03737994|526410447|FG005|Overall Study|Withdrawal by Subject|0|||
145971688|NCT03737994|526410448|FG006|Overall Study|Withdrawal by Subject|1|||
145971689|NCT04761822|526410453|FG000|Overall Study|Adverse Event|3|||
145971690|NCT04761822|526410454|FG001|Overall Study|Adverse Event|1|||
145971691|NCT04761822|526410455|FG002|Overall Study|Adverse Event|1|||
145971692|NCT04761822|526410456|FG003|Overall Study|Adverse Event|3|||
145971693|NCT04761822|526410453|FG000|Overall Study|Lost to Follow-up|1|||
145971694|NCT04761822|526410454|FG001|Overall Study|Lost to Follow-up|0|||
145971695|NCT04761822|526410455|FG002|Overall Study|Lost to Follow-up|2|||
145971696|NCT04761822|526410456|FG003|Overall Study|Lost to Follow-up|3|||
145971697|NCT04761822|526410453|FG000|Overall Study|Physician Decision|0|||
145971698|NCT04761822|526410454|FG001|Overall Study|Physician Decision|1|||
145971699|NCT04761822|526410455|FG002|Overall Study|Physician Decision|0|||
145971700|NCT04761822|526410456|FG003|Overall Study|Physician Decision|0|||
145971701|NCT04761822|526410453|FG000|Overall Study|Withdrawal by Subject|3|||
145971702|NCT04761822|526410454|FG001|Overall Study|Withdrawal by Subject|8|||
145971703|NCT04761822|526410455|FG002|Overall Study|Withdrawal by Subject|1|||
145971704|NCT04761822|526410456|FG003|Overall Study|Withdrawal by Subject|11|||
145971705|NCT04761822|526410453|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
145971706|NCT04761822|526410454|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145971707|NCT04761822|526410455|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145971708|NCT04761822|526410456|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145971709|NCT04761822|526410453|FG000|Overall Study|Participant requested unblinding|0|||
145971710|NCT04761822|526410454|FG001|Overall Study|Participant requested unblinding|0|||
145971711|NCT04761822|526410455|FG002|Overall Study|Participant requested unblinding|0|||
145971712|NCT04761822|526410456|FG003|Overall Study|Participant requested unblinding|1|||
146237160|NCT01640951|527382724|FG001|Overall Study|Adverse Event|3|||
146237161|NCT01640951|527382725|FG002|Overall Study|Adverse Event|10|||
146237162|NCT01640951|527382726|FG003|Overall Study|Adverse Event|6|||
146237163|NCT01640951|527382727|FG004|Overall Study|Adverse Event|1|||
146237164|NCT01640951|527382728|FG005|Overall Study|Adverse Event|11|||
146237165|NCT01640951|527382729|FG006|Overall Study|Adverse Event|1|||
146237166|NCT01640951|527382730|FG007|Overall Study|Adverse Event|3|||
146237167|NCT01640951|527382723|FG000|Overall Study|Lack of Efficacy|20|||
146237168|NCT01640951|527382724|FG001|Overall Study|Lack of Efficacy|1|||
146237169|NCT01640951|527382725|FG002|Overall Study|Lack of Efficacy|7|||
146237170|NCT01640951|527382726|FG003|Overall Study|Lack of Efficacy|14|||
146237171|NCT01640951|527382727|FG004|Overall Study|Lack of Efficacy|0|||
146237172|NCT01640951|527382728|FG005|Overall Study|Lack of Efficacy|6|||
146237173|NCT01640951|527382729|FG006|Overall Study|Lack of Efficacy|5|||
146237174|NCT01640951|527382730|FG007|Overall Study|Lack of Efficacy|6|||
146237175|NCT01640951|527382723|FG000|Overall Study|Lost to Follow-up|1|||
146237176|NCT01640951|527382724|FG001|Overall Study|Lost to Follow-up|0|||
146237177|NCT01640951|527382725|FG002|Overall Study|Lost to Follow-up|6|||
146237178|NCT01640951|527382726|FG003|Overall Study|Lost to Follow-up|2|||
146237179|NCT01640951|527382727|FG004|Overall Study|Lost to Follow-up|2|||
146237180|NCT01640951|527382728|FG005|Overall Study|Lost to Follow-up|3|||
146237181|NCT01640951|527382729|FG006|Overall Study|Lost to Follow-up|1|||
146237182|NCT01640951|527382730|FG007|Overall Study|Lost to Follow-up|1|||
146237183|NCT01640951|527382723|FG000|Overall Study|Non-compliance with study treatment|0|||
146237184|NCT01640951|527382724|FG001|Overall Study|Non-compliance with study treatment|0|||
146237185|NCT01640951|527382725|FG002|Overall Study|Non-compliance with study treatment|1|||
146237186|NCT01640951|527382726|FG003|Overall Study|Non-compliance with study treatment|1|||
146237187|NCT01640951|527382727|FG004|Overall Study|Non-compliance with study treatment|1|||
146237188|NCT01640951|527382728|FG005|Overall Study|Non-compliance with study treatment|4|||
146237189|NCT01640951|527382729|FG006|Overall Study|Non-compliance with study treatment|1|||
146237190|NCT01640951|527382730|FG007|Overall Study|Non-compliance with study treatment|0|||
146237191|NCT01640951|527382723|FG000|Overall Study|Physician Decision|2|||
146237192|NCT01640951|527382724|FG001|Overall Study|Physician Decision|5|||
146237193|NCT01640951|527382725|FG002|Overall Study|Physician Decision|2|||
145971713|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
145971714|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
145971715|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Death|1|||
146088171|NCT01986933|526841960|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
146088172|NCT01986933|526841961|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146237194|NCT01640951|527382726|FG003|Overall Study|Physician Decision|2|||
146237195|NCT01640951|527382727|FG004|Overall Study|Physician Decision|2|||
146237196|NCT01640951|527382728|FG005|Overall Study|Physician Decision|3|||
146237197|NCT01640951|527382729|FG006|Overall Study|Physician Decision|3|||
146237198|NCT01640951|527382730|FG007|Overall Study|Physician Decision|0|||
146237199|NCT01640951|527382723|FG000|Overall Study|Pregnancy|3|||
146237200|NCT01640951|527382724|FG001|Overall Study|Pregnancy|0|||
145971716|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Death|3|||
145971717|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
145971718|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
145971719|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
145971720|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
145971721|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
145971722|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
145971723|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
145971724|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
145971725|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
145971726|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
145971727|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
145971728|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
145971729|NCT00362232|526410457|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
145971730|NCT00362232|526410458|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
145971731|NCT00362232|526410457|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
145971732|NCT00362232|526410458|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
145971733|NCT00362232|526410457|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
146237201|NCT01640951|527382725|FG002|Overall Study|Pregnancy|0|||
146237202|NCT01640951|527382726|FG003|Overall Study|Pregnancy|4|||
146237203|NCT01640951|527382727|FG004|Overall Study|Pregnancy|0|||
146237204|NCT01640951|527382728|FG005|Overall Study|Pregnancy|0|||
146237205|NCT01640951|527382729|FG006|Overall Study|Pregnancy|2|||
146237206|NCT01640951|527382730|FG007|Overall Study|Pregnancy|0|||
146237207|NCT01640951|527382723|FG000|Overall Study|Protocol Deviation|0|||
146237208|NCT01640951|527382724|FG001|Overall Study|Protocol Deviation|1|||
146237209|NCT01640951|527382725|FG002|Overall Study|Protocol Deviation|2|||
146237210|NCT01640951|527382726|FG003|Overall Study|Protocol Deviation|1|||
146237211|NCT01640951|527382727|FG004|Overall Study|Protocol Deviation|0|||
146237212|NCT01640951|527382728|FG005|Overall Study|Protocol Deviation|1|||
146237213|NCT01640951|527382729|FG006|Overall Study|Protocol Deviation|0|||
146237214|NCT01640951|527382730|FG007|Overall Study|Protocol Deviation|0|||
146237215|NCT01640951|527382723|FG000|Overall Study|Subject/Guardian decision|12|||
146237216|NCT01640951|527382724|FG001|Overall Study|Subject/Guardian decision|4|||
146237217|NCT01640951|527382725|FG002|Overall Study|Subject/Guardian decision|13|||
146237218|NCT01640951|527382726|FG003|Overall Study|Subject/Guardian decision|15|||
146237219|NCT01640951|527382727|FG004|Overall Study|Subject/Guardian decision|7|||
146237220|NCT01640951|527382728|FG005|Overall Study|Subject/Guardian decision|19|||
146237221|NCT01640951|527382729|FG006|Overall Study|Subject/Guardian decision|5|||
146237222|NCT01640951|527382730|FG007|Overall Study|Subject/Guardian decision|4|||
146237223|NCT01640951|527382723|FG000|Overall Study|Death|0|||
146237224|NCT01640951|527382724|FG001|Overall Study|Death|1|||
146237225|NCT01640951|527382725|FG002|Overall Study|Death|1|||
146237226|NCT01640951|527382726|FG003|Overall Study|Death|0|||
146237227|NCT01640951|527382727|FG004|Overall Study|Death|0|||
146237228|NCT01640951|527382728|FG005|Overall Study|Death|0|||
146237229|NCT01640951|527382729|FG006|Overall Study|Death|0|||
146237230|NCT01640951|527382730|FG007|Overall Study|Death|2|||
146237231|NCT04949542|527382731|FG000|Overall Study|Lost to Follow-up|4|||
146237232|NCT04949542|527382732|FG001|Overall Study|Lost to Follow-up|1|||
146237233|NCT01536093|527382733|FG000|Overall Study|Death|1|||
146237234|NCT01536093|527382734|FG001|Overall Study|Death|2|||
146237235|NCT01536093|527382733|FG000|Overall Study|absence of maternal colostrum|2|||
146237236|NCT01536093|527382734|FG001|Overall Study|absence of maternal colostrum|0|||
146237237|NCT01536093|527382733|FG000|Overall Study|Withdrawal by Subject|0|||
146237238|NCT01536093|527382734|FG001|Overall Study|Withdrawal by Subject|1|||
146237239|NCT02365597|527382735|FG000|Overall Study|Lost to Follow-up|0|||
146237240|NCT02365597|527382736|FG001|Overall Study|Lost to Follow-up|1|||
146237241|NCT02365597|527382737|FG002|Overall Study|Lost to Follow-up|0|||
146237242|NCT02365597|527382738|FG003|Overall Study|Lost to Follow-up|1|||
146237243|NCT02365597|527382735|FG000|Overall Study|Withdrawal by Subject|1|||
146237244|NCT02365597|527382736|FG001|Overall Study|Withdrawal by Subject|8|||
146237245|NCT02365597|527382737|FG002|Overall Study|Withdrawal by Subject|5|||
146237246|NCT02365597|527382738|FG003|Overall Study|Withdrawal by Subject|1|||
146237247|NCT02365597|527382735|FG000|Overall Study|Sponsor's decision|1|||
146237248|NCT02365597|527382736|FG001|Overall Study|Sponsor's decision|3|||
146237249|NCT02365597|527382737|FG002|Overall Study|Sponsor's decision|13|||
146237250|NCT02365597|527382738|FG003|Overall Study|Sponsor's decision|0|||
146237251|NCT02365597|527382735|FG000|Overall Study|Other|0|||
146237252|NCT02365597|527382736|FG001|Overall Study|Other|4|||
146237253|NCT02365597|527382737|FG002|Overall Study|Other|0|||
146237254|NCT02365597|527382738|FG003|Overall Study|Other|0|||
146237255|NCT02365597|527382735|FG000|Overall Study|Enrolled but not treated|0|||
146237256|NCT02365597|527382736|FG001|Overall Study|Enrolled but not treated|1|||
146237257|NCT02365597|527382737|FG002|Overall Study|Enrolled but not treated|1|||
146296207|NCT01990534|527600571|FG000|Overall Study|Protocol Violation|1|||
146237258|NCT02365597|527382738|FG003|Overall Study|Enrolled but not treated|0|||
146237259|NCT02365597|527382735|FG000|Overall Study|Ongoing|0|||
146296208|NCT01990534|527600571|FG000|Overall Study|Withdrawal of Informed Consent|2|||
146237260|NCT02365597|527382736|FG001|Overall Study|Ongoing|0|||
146237261|NCT02365597|527382737|FG002|Overall Study|Ongoing|0|||
146237262|NCT02365597|527382738|FG003|Overall Study|Ongoing|17|||
146237263|NCT02275611|527382739|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
146237264|NCT02275611|527382740|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
146237265|NCT02275611|527382741|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
146237266|NCT02275611|527382742|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
146237267|NCT00390884|527382750|FG000|Overall Study|Withdrawal by Subject|2|||
146237268|NCT00390884|527382751|FG001|Overall Study|Withdrawal by Subject|2|||
146237269|NCT04622332|527382752|FG000|Overall Study|Withdrawal by Subject|4|||
146237270|NCT04622332|527382753|FG001|Overall Study|Withdrawal by Subject|2|||
146237271|NCT04622332|527382752|FG000|Overall Study|Physician Decision|1|||
146237272|NCT04622332|527382753|FG001|Overall Study|Physician Decision|1|||
146237273|NCT04622332|527382752|FG000|Overall Study|Adverse Event|0|||
146237274|NCT04622332|527382753|FG001|Overall Study|Adverse Event|2|||
146237275|NCT04622332|527382752|FG000|Overall Study|Protocol Violation|0|||
146237276|NCT04622332|527382753|FG001|Overall Study|Protocol Violation|1|||
146237277|NCT05966155|527382754|FG000|Overall Study|Death|1|||
146237278|NCT05966155|527382755|FG001|Overall Study|Death|2|||
146237279|NCT05966155|527382754|FG000|Overall Study|Lost to Follow-up|63|||
146237280|NCT05966155|527382755|FG001|Overall Study|Lost to Follow-up|67|||
146237281|NCT05966155|527382754|FG000|Overall Study|Protocol Violation|1|||
146237282|NCT05966155|527382755|FG001|Overall Study|Protocol Violation|0|||
146237283|NCT05966155|527382754|FG000|Overall Study|Withdrawal by Subject|8|||
146237284|NCT05966155|527382755|FG001|Overall Study|Withdrawal by Subject|9|||
146237285|NCT05966155|527382754|FG000|Overall Study|Enrolled Erroneously|0|||
146237286|NCT05966155|527382755|FG001|Overall Study|Enrolled Erroneously|1|||
146237287|NCT05966155|527382754|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
146237288|NCT05966155|527382755|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
146237289|NCT05036278|527382758|FG000|Overall Study|Withdrawal by Subject|1|||
146237290|NCT05036278|527382758|FG000|Overall Study|Adverse Event|1|||
146237291|NCT03348631|527382763|FG000|Overall Study|Not Eligible, No treatment|0|||
146237292|NCT03348631|527382764|FG001|Overall Study|Not Eligible, No treatment|1|||
146237293|NCT03348631|527382763|FG000|Overall Study|Not Eligible, Treated|2|||
146237294|NCT03348631|527382764|FG001|Overall Study|Not Eligible, Treated|0|||
146237295|NCT03348631|527382763|FG000|Overall Study|Eligible, No Treatment|1|||
146237296|NCT03348631|527382764|FG001|Overall Study|Eligible, No Treatment|0|||
146237297|NCT01946204|527382765|FG000|Overall Study|Death|38|||
146237298|NCT01946204|527382766|FG001|Overall Study|Death|59|||
146237299|NCT01946204|527382765|FG000|Overall Study|Withdrawal by Subject|37|||
146237300|NCT01946204|527382766|FG001|Overall Study|Withdrawal by Subject|50|||
146237301|NCT01946204|527382765|FG000|Overall Study|Lost to Follow-up|3|||
146237302|NCT01946204|527382766|FG001|Overall Study|Lost to Follow-up|7|||
146237303|NCT01946204|527382765|FG000|Overall Study|Ongoing|316|||
146237304|NCT01946204|527382766|FG001|Overall Study|Ongoing|687|||
146237305|NCT01946204|527382765|FG000|Overall Study|Other|7|||
146237306|NCT01946204|527382766|FG001|Overall Study|Other|3|||
146237307|NCT03466411|527382767|FG000|Overall Study|Lost to Follow-up|0|||
146237308|NCT03466411|527382768|FG001|Overall Study|Lost to Follow-up|1|||
146237309|NCT03466411|527382769|FG002|Overall Study|Lost to Follow-up|1|||
146237310|NCT03466411|527382770|FG003|Overall Study|Lost to Follow-up|0|||
146237311|NCT03466411|527382771|FG004|Overall Study|Lost to Follow-up|0|||
146237312|NCT03466411|527382772|FG005|Overall Study|Lost to Follow-up|0|||
146237313|NCT03466411|527382773|FG006|Overall Study|Lost to Follow-up|1|||
146237314|NCT03466411|527382774|FG007|Overall Study|Lost to Follow-up|1|||
146237315|NCT03466411|527382775|FG008|Overall Study|Lost to Follow-up|0|||
146237316|NCT03466411|527382776|FG009|Overall Study|Lost to Follow-up|1|||
146237317|NCT03466411|527382777|FG010|Overall Study|Lost to Follow-up|1|||
146237318|NCT03466411|527382778|FG011|Overall Study|Lost to Follow-up|1|||
146237319|NCT03466411|527382779|FG012|Overall Study|Lost to Follow-up|0|||
146237320|NCT03466411|527382767|FG000|Overall Study|Withdrawal by Subject|14|||
146237321|NCT03466411|527382768|FG001|Overall Study|Withdrawal by Subject|7|||
146237322|NCT03466411|527382769|FG002|Overall Study|Withdrawal by Subject|8|||
146237323|NCT03466411|527382770|FG003|Overall Study|Withdrawal by Subject|4|||
146237324|NCT03466411|527382771|FG004|Overall Study|Withdrawal by Subject|6|||
146237325|NCT03466411|527382772|FG005|Overall Study|Withdrawal by Subject|3|||
146237326|NCT03466411|527382773|FG006|Overall Study|Withdrawal by Subject|6|||
146237327|NCT03466411|527382774|FG007|Overall Study|Withdrawal by Subject|9|||
146237328|NCT03466411|527382775|FG008|Overall Study|Withdrawal by Subject|6|||
146237329|NCT03466411|527382776|FG009|Overall Study|Withdrawal by Subject|11|||
146237330|NCT03466411|527382777|FG010|Overall Study|Withdrawal by Subject|14|||
146237331|NCT03466411|527382778|FG011|Overall Study|Withdrawal by Subject|12|||
146237332|NCT03466411|527382779|FG012|Overall Study|Withdrawal by Subject|7|||
146237333|NCT03466411|527382767|FG000|Overall Study|Other|1|||
146237334|NCT03466411|527382768|FG001|Overall Study|Other|1|||
146237335|NCT03466411|527382769|FG002|Overall Study|Other|0|||
146237336|NCT03466411|527382770|FG003|Overall Study|Other|1|||
146237337|NCT03466411|527382771|FG004|Overall Study|Other|2|||
145971734|NCT00362232|526410458|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
145971735|NCT00362232|526410457|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
145971736|NCT00362232|526410458|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
145971737|NCT00362232|526410457|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
145971738|NCT00362232|526410458|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
145971739|NCT05020015|526410465|FG000|Overall Study|Ongoing on study|1|||
145971740|NCT05020015|526410466|FG001|Overall Study|Ongoing on study|3|||
145971741|NCT05020015|526410467|FG002|Overall Study|Ongoing on study|4|||
145971742|NCT05020015|526410468|FG003|Overall Study|Ongoing on study|7|||
145971743|NCT05020015|526410465|FG000|Overall Study|Death|2|||
145971744|NCT05020015|526410466|FG001|Overall Study|Death|3|||
145971745|NCT05020015|526410467|FG002|Overall Study|Death|4|||
145971746|NCT05020015|526410468|FG003|Overall Study|Death|0|||
145971747|NCT05020015|526410465|FG000|Overall Study|Withdrawal by Subject|0|||
145971748|NCT05020015|526410466|FG001|Overall Study|Withdrawal by Subject|0|||
145971749|NCT05020015|526410467|FG002|Overall Study|Withdrawal by Subject|1|||
145971750|NCT05020015|526410468|FG003|Overall Study|Withdrawal by Subject|0|||
145971751|NCT05020015|526410465|FG000|Overall Study|Reason Not Specified|0|||
145971752|NCT05020015|526410466|FG001|Overall Study|Reason Not Specified|0|||
145971753|NCT05020015|526410467|FG002|Overall Study|Reason Not Specified|2|||
145971754|NCT05020015|526410468|FG003|Overall Study|Reason Not Specified|0|||
145971755|NCT02233413|526410469|FG000|Overall Study|Lost to Follow-up|7|||
145971756|NCT02233413|526410470|FG001|Overall Study|Lost to Follow-up|9|||
145971757|NCT02233413|526410469|FG000|Overall Study|Withdrawal by Subject|4|||
145971758|NCT02233413|526410470|FG001|Overall Study|Withdrawal by Subject|5|||
145971759|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
145971760|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
145971761|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
145971762|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
145971763|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
145971764|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
145971765|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
145971766|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
146237338|NCT03466411|527382772|FG005|Overall Study|Other|0|||
146237339|NCT03466411|527382773|FG006|Overall Study|Other|0|||
146237340|NCT03466411|527382774|FG007|Overall Study|Other|0|||
146237341|NCT03466411|527382775|FG008|Overall Study|Other|0|||
146237342|NCT03466411|527382776|FG009|Overall Study|Other|1|||
146237343|NCT03466411|527382777|FG010|Overall Study|Other|2|||
146237344|NCT03466411|527382778|FG011|Overall Study|Other|0|||
146237345|NCT03466411|527382779|FG012|Overall Study|Other|0|||
146237346|NCT03466411|527382767|FG000|Overall Study|Randomized but not Treated|0|||
146237347|NCT03466411|527382768|FG001|Overall Study|Randomized but not Treated|0|||
146237348|NCT03466411|527382769|FG002|Overall Study|Randomized but not Treated|0|||
146237349|NCT03466411|527382770|FG003|Overall Study|Randomized but not Treated|0|||
146237350|NCT03466411|527382771|FG004|Overall Study|Randomized but not Treated|0|||
146237351|NCT03466411|527382772|FG005|Overall Study|Randomized but not Treated|0|||
146237352|NCT03466411|527382773|FG006|Overall Study|Randomized but not Treated|1|||
146237353|NCT03466411|527382774|FG007|Overall Study|Randomized but not Treated|0|||
146237354|NCT03466411|527382775|FG008|Overall Study|Randomized but not Treated|0|||
146237355|NCT03466411|527382776|FG009|Overall Study|Randomized but not Treated|0|||
146237356|NCT03466411|527382777|FG010|Overall Study|Randomized but not Treated|0|||
146237357|NCT03466411|527382778|FG011|Overall Study|Randomized but not Treated|0|||
146237358|NCT03466411|527382779|FG012|Overall Study|Randomized but not Treated|0|||
146237359|NCT00274261|527382792|FG000|Overall Study|Adverse Event|19|||
146237360|NCT00274261|527382793|FG001|Overall Study|Adverse Event|11|||
146237361|NCT00274261|527382792|FG000|Overall Study|Pregnancy|114|||
146237362|NCT00274261|527382793|FG001|Overall Study|Pregnancy|83|||
146237363|NCT00274261|527382792|FG000|Overall Study|Withdrawal by Subject|179|||
146237364|NCT00274261|527382793|FG001|Overall Study|Withdrawal by Subject|126|||
146237365|NCT00274261|527382792|FG000|Overall Study|Protocol Violation|71|||
146237366|NCT00274261|527382793|FG001|Overall Study|Protocol Violation|42|||
146237367|NCT00274261|527382792|FG000|Overall Study|Lost to Follow-up|106|||
146237368|NCT00274261|527382793|FG001|Overall Study|Lost to Follow-up|75|||
146237369|NCT03582475|527382794|FG000|Treatment Period|Withdrawal by Subject|0|||
146237370|NCT03582475|527382795|FG001|Treatment Period|Withdrawal by Subject|1|||
146237371|NCT03582475|527382794|FG000|Follow-up Period|Withdrawal by Subject|0|||
146237372|NCT03582475|527382795|FG001|Follow-up Period|Withdrawal by Subject|1|||
146237373|NCT02257736|527382796|FG000|Overall Study|Progressive disease|365|||
146237374|NCT02257736|527382797|FG001|Overall Study|Progressive disease|327|||
146237375|NCT02257736|527382796|FG000|Overall Study|Adverse Event|45|||
146237376|NCT02257736|527382797|FG001|Overall Study|Adverse Event|56|||
146237377|NCT02257736|527382796|FG000|Overall Study|Withdrawal by Subject|21|||
146237378|NCT02257736|527382797|FG001|Overall Study|Withdrawal by Subject|38|||
146237379|NCT02257736|527382796|FG000|Overall Study|Death|11|||
146237380|NCT02257736|527382797|FG001|Overall Study|Death|6|||
145971767|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
145971768|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
145971769|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
145971770|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
145971771|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
145971772|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
145971773|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
145971774|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
145971775|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
145971776|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
145971777|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
145971778|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
145971779|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
145971780|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
145971781|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
145971782|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
145971783|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
145971784|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
145971785|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
145971786|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
145971787|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
145971788|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
145971789|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
145971790|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
145971791|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
145971792|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
145971793|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
146088173|NCT01986933|526841962|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146088174|NCT01986933|526841963|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
146237381|NCT02257736|527382796|FG000|Overall Study|Physician Decision|5|||
146237382|NCT02257736|527382797|FG001|Overall Study|Physician Decision|9|||
146237383|NCT02257736|527382796|FG000|Overall Study|Non-Compliance with study drug|1|||
146237384|NCT02257736|527382797|FG001|Overall Study|Non-Compliance with study drug|2|||
146237385|NCT02257736|527382796|FG000|Overall Study|Protocol Violation|1|||
146237386|NCT02257736|527382797|FG001|Overall Study|Protocol Violation|0|||
146237387|NCT02257736|527382796|FG000|Overall Study|Other|1|||
146237388|NCT02257736|527382797|FG001|Overall Study|Other|7|||
146237389|NCT02257736|527382796|FG000|Overall Study|Randomized, not treated|1|||
146237390|NCT02257736|527382797|FG001|Overall Study|Randomized, not treated|2|||
146237391|NCT03431350|527382798|FG000|Overall Study|ONGOING|0|||
146237392|NCT03431350|527382799|FG001|Overall Study|ONGOING|0|||
146237393|NCT03431350|527382800|FG002|Overall Study|ONGOING|2|||
146237394|NCT03431350|527382801|FG003|Overall Study|ONGOING|0|||
146237395|NCT03431350|527382802|FG004|Overall Study|ONGOING|1|||
146237396|NCT03431350|527382803|FG005|Overall Study|ONGOING|3|||
146237397|NCT03431350|527382804|FG006|Overall Study|ONGOING|0|||
146237398|NCT03431350|527382805|FG007|Overall Study|ONGOING|1|||
146237399|NCT03431350|527382806|FG008|Overall Study|ONGOING|3|||
146237400|NCT03431350|527382807|FG009|Overall Study|ONGOING|4|||
146237401|NCT03431350|527382808|FG010|Overall Study|ONGOING|2|||
146237402|NCT03431350|527382809|FG011|Overall Study|ONGOING|1|||
146237403|NCT03431350|527382798|FG000|Overall Study|Death|6|||
146237404|NCT03431350|527382799|FG001|Overall Study|Death|5|||
146237405|NCT03431350|527382800|FG002|Overall Study|Death|18|||
146237406|NCT03431350|527382801|FG003|Overall Study|Death|7|||
146237407|NCT03431350|527382802|FG004|Overall Study|Death|4|||
146237408|NCT03431350|527382803|FG005|Overall Study|Death|3|||
146237409|NCT03431350|527382804|FG006|Overall Study|Death|2|||
146237410|NCT03431350|527382805|FG007|Overall Study|Death|0|||
146237411|NCT03431350|527382806|FG008|Overall Study|Death|0|||
146237412|NCT03431350|527382807|FG009|Overall Study|Death|0|||
146237413|NCT03431350|527382808|FG010|Overall Study|Death|4|||
146237414|NCT03431350|527382809|FG011|Overall Study|Death|0|||
146237415|NCT03431350|527382798|FG000|Overall Study|Lost to Follow-up|0|||
146237416|NCT03431350|527382799|FG001|Overall Study|Lost to Follow-up|1|||
146237417|NCT03431350|527382800|FG002|Overall Study|Lost to Follow-up|0|||
146296209|NCT01990534|527600571|FG000|Overall Study|Symptomatic Deterioration|1|||
146237418|NCT03431350|527382801|FG003|Overall Study|Lost to Follow-up|0|||
146237419|NCT03431350|527382802|FG004|Overall Study|Lost to Follow-up|0|||
146237420|NCT03431350|527382803|FG005|Overall Study|Lost to Follow-up|0|||
146237421|NCT03431350|527382804|FG006|Overall Study|Lost to Follow-up|0|||
146237422|NCT03431350|527382805|FG007|Overall Study|Lost to Follow-up|0|||
146296210|NCT01990534|527600571|FG000|Overall Study|Withdrawal by Subject|3|||
146296211|NCT01990534|527600571|FG000|Overall Study|Reason not Specified|2|||
146296212|NCT01990534|527600571|FG000|Overall Study|Lost to Follow-up|1|||
146296213|NCT00234494|527600572|FG000|Overall Study|Protocol Violation|2|||
146296214|NCT01831544|527600575|FG000|Overall Study|Death|1|||
146296215|NCT01831544|527600575|FG000|Overall Study|Still on original MVAD device|2|||
146296216|NCT01681628|527600578|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
146296217|NCT01681628|527600579|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
146296218|NCT01681628|527600578|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
146296219|NCT01681628|527600579|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
146296220|NCT01681628|527600578|FG000|19 Months Follow-up|Death|1|||
146296221|NCT01681628|527600579|FG001|19 Months Follow-up|Death|0|||
146296222|NCT01681628|527600578|FG000|19 Months Follow-up|Lost to Follow-up|61|||
146296223|NCT01681628|527600579|FG001|19 Months Follow-up|Lost to Follow-up|43|||
146296224|NCT01521897|527600580|FG000|Overall Study|Protocol Violation|18|||
146296225|NCT01521897|527600580|FG000|Overall Study|Lost to Follow-up|5|||
146296226|NCT02194062|527600582|FG000|Overall Study|Lost to Follow-up|2|||
146296227|NCT02194062|527600583|FG001|Overall Study|Lost to Follow-up|2|||
146296228|NCT02194062|527600584|FG002|Overall Study|Lost to Follow-up|5|||
146296229|NCT04615247|527600585|FG000|Overall Study|Adverse Event|0|||
146296230|NCT04615247|527600586|FG001|Overall Study|Adverse Event|2|||
146296231|NCT04615247|527600585|FG000|Overall Study|Withdrawal by Subject|1|||
146296232|NCT04615247|527600586|FG001|Overall Study|Withdrawal by Subject|1|||
146296233|NCT04658186|527600589|FG000|Overall Study|Adverse Event|4|||
146296234|NCT04658186|527600590|FG001|Overall Study|Adverse Event|18|||
146296235|NCT04658186|527600591|FG002|Overall Study|Adverse Event|15|||
146296236|NCT04658186|527600589|FG000|Overall Study|Lack of Efficacy|1|||
146296237|NCT04658186|527600590|FG001|Overall Study|Lack of Efficacy|1|||
146296238|NCT04658186|527600591|FG002|Overall Study|Lack of Efficacy|0|||
146296239|NCT04658186|527600589|FG000|Overall Study|Protocol Violation|0|||
146296240|NCT04658186|527600590|FG001|Overall Study|Protocol Violation|0|||
146296241|NCT04658186|527600591|FG002|Overall Study|Protocol Violation|1|||
146296242|NCT04658186|527600589|FG000|Overall Study|Lost to Follow-up|0|||
146296243|NCT04658186|527600590|FG001|Overall Study|Lost to Follow-up|0|||
146296244|NCT04658186|527600591|FG002|Overall Study|Lost to Follow-up|2|||
146296245|NCT04658186|527600589|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
146296246|NCT04658186|527600590|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
146296247|NCT04658186|527600591|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
146296248|NCT04658186|527600589|FG000|Overall Study|Participant is Moving in Another Province|0|||
146296249|NCT04658186|527600590|FG001|Overall Study|Participant is Moving in Another Province|1|||
146296250|NCT04658186|527600591|FG002|Overall Study|Participant is Moving in Another Province|0|||
146296251|NCT04658186|527600589|FG000|Overall Study|Non-Compliance|0|||
146296252|NCT04658186|527600590|FG001|Overall Study|Non-Compliance|1|||
146296253|NCT04658186|527600591|FG002|Overall Study|Non-Compliance|1|||
146296254|NCT04658186|527600589|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
146296255|NCT04658186|527600590|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
146296256|NCT04658186|527600591|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
146296257|NCT04658186|527600589|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
146296258|NCT04658186|527600590|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
146296259|NCT04658186|527600591|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
146296260|NCT04658186|527600589|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
146296261|NCT04658186|527600590|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
145893416|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
145893417|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
145893418|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
145893419|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
145893420|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
145893421|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
145893422|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
145893423|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
145893424|NCT02960893|526117181|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
145893425|NCT02960893|526117182|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
145893426|NCT02960893|526117183|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
145893427|NCT02960893|526117184|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
145893428|NCT01995266|526117190|FG000|Overall Study|Death|1|||
146296262|NCT04658186|527600591|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
146296263|NCT04658186|527600589|FG000|Overall Study|PI Decision due to Participant Safety|0|||
146296264|NCT04658186|527600590|FG001|Overall Study|PI Decision due to Participant Safety|0|||
146296265|NCT04658186|527600591|FG002|Overall Study|PI Decision due to Participant Safety|1|||
146296266|NCT04658186|527600589|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
146296267|NCT04658186|527600590|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
146296268|NCT04658186|527600591|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
146296269|NCT00954174|527600592|FG000|Overall Study|Adverse Event|28|||
146296270|NCT00954174|527600593|FG001|Overall Study|Adverse Event|23|||
146296271|NCT00954174|527600594|FG002|Overall Study|Adverse Event|4|||
146296272|NCT00954174|527600595|FG003|Overall Study|Adverse Event|9|||
146296273|NCT00954174|527600592|FG000|Overall Study|Death|4|||
146296274|NCT00954174|527600593|FG001|Overall Study|Death|2|||
146296275|NCT00954174|527600594|FG002|Overall Study|Death|0|||
146296276|NCT00954174|527600595|FG003|Overall Study|Death|0|||
146296277|NCT00954174|527600592|FG000|Overall Study|Lack of Efficacy|32|||
146296278|NCT00954174|527600593|FG001|Overall Study|Lack of Efficacy|22|||
146296279|NCT00954174|527600594|FG002|Overall Study|Lack of Efficacy|8|||
146296280|NCT00954174|527600595|FG003|Overall Study|Lack of Efficacy|6|||
146296281|NCT00954174|527600592|FG000|Overall Study|Withdrawal by Subject|14|||
146296282|NCT00954174|527600593|FG001|Overall Study|Withdrawal by Subject|10|||
146296283|NCT00954174|527600594|FG002|Overall Study|Withdrawal by Subject|4|||
146296284|NCT00954174|527600595|FG003|Overall Study|Withdrawal by Subject|3|||
146296285|NCT00954174|527600592|FG000|Overall Study|Medical Reason|4|||
146296286|NCT00954174|527600593|FG001|Overall Study|Medical Reason|2|||
146296287|NCT00954174|527600594|FG002|Overall Study|Medical Reason|1|||
146296288|NCT00954174|527600595|FG003|Overall Study|Medical Reason|0|||
146296289|NCT00954174|527600592|FG000|Overall Study|Ineligible|40|||
146296290|NCT00954174|527600593|FG001|Overall Study|Ineligible|47|||
146296291|NCT00954174|527600594|FG002|Overall Study|Ineligible|7|||
146296292|NCT00954174|527600595|FG003|Overall Study|Ineligible|4|||
146296293|NCT00954174|527600592|FG000|Overall Study|Never Treated|4|||
146296294|NCT00954174|527600593|FG001|Overall Study|Never Treated|17|||
146296295|NCT00954174|527600594|FG002|Overall Study|Never Treated|0|||
146296296|NCT00954174|527600595|FG003|Overall Study|Never Treated|3|||
146296297|NCT02234323|527600596|FG000|All Enrolled|Not Treated: Completed study in database|2|||
146296298|NCT02234323|527600596|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
146296299|NCT02234323|527600596|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
146296300|NCT02234323|527600596|FG000|All Treated|Death|1|||
146296301|NCT02234323|527600596|FG000|All Treated|Physician Decision|5|||
146296302|NCT02234323|527600596|FG000|All Treated|Lack of Efficacy|3|||
146296303|NCT02234323|527600596|FG000|All Treated|Exceeded lab value limit|2|||
146296304|NCT02234323|527600596|FG000|All Treated|Other|7|||
146296305|NCT02249767|527600597|FG000|Overall Study|Did not use medication|8|||
146296306|NCT02249767|527600598|FG001|Overall Study|Did not use medication|9|||
146296307|NCT02249767|527600599|FG002|Overall Study|Did not use medication|8|||
146296308|NCT04585646|527600600|FG000|First Intervention|Physician Decision|1|||
146296309|NCT04585646|527600601|FG001|First Intervention|Physician Decision|0|||
146296310|NCT04585646|527600600|FG000|First Intervention|Lost to Follow-up|0|||
146296311|NCT04585646|527600601|FG001|First Intervention|Lost to Follow-up|3|||
146296312|NCT04585646|527600600|FG000|First Intervention|Withdrawal by Subject|0|||
146296313|NCT04585646|527600601|FG001|First Intervention|Withdrawal by Subject|1|||
146296314|NCT00867113|527600602|FG000|Treatment Period|Adverse Event|15|||
146296315|NCT00867113|527600602|FG000|Treatment Period|Death|2|||
146296316|NCT00867113|527600602|FG000|Treatment Period|Withdrawal by Subject|19|||
146237423|NCT03431350|527382806|FG008|Overall Study|Lost to Follow-up|0|||
146237424|NCT03431350|527382807|FG009|Overall Study|Lost to Follow-up|0|||
146237425|NCT03431350|527382808|FG010|Overall Study|Lost to Follow-up|0|||
146237426|NCT03431350|527382809|FG011|Overall Study|Lost to Follow-up|0|||
146237427|NCT03431350|527382798|FG000|Overall Study|Withdrawal by Subject|0|||
146237428|NCT03431350|527382799|FG001|Overall Study|Withdrawal by Subject|0|||
146237429|NCT03431350|527382800|FG002|Overall Study|Withdrawal by Subject|0|||
146237430|NCT03431350|527382801|FG003|Overall Study|Withdrawal by Subject|1|||
146237431|NCT03431350|527382802|FG004|Overall Study|Withdrawal by Subject|1|||
146237432|NCT03431350|527382803|FG005|Overall Study|Withdrawal by Subject|1|||
146237433|NCT03431350|527382804|FG006|Overall Study|Withdrawal by Subject|0|||
146237434|NCT03431350|527382805|FG007|Overall Study|Withdrawal by Subject|0|||
146237435|NCT03431350|527382806|FG008|Overall Study|Withdrawal by Subject|0|||
146296317|NCT00867113|527600602|FG000|Treatment Period|Lost to Follow-up|3|||
146296318|NCT00867113|527600602|FG000|Treatment Period|Administrative problems|1|||
146296319|NCT00867113|527600602|FG000|Treatment Period|Disease progression/relapse|1|||
146296320|NCT00867113|527600602|FG000|Treatment Period|Protocol Violation|4|||
146296321|NCT00867113|527600602|FG000|Post Treatment After Survival Follow-up|Death|1|||
146296322|NCT00867113|527600602|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
146296323|NCT00867113|527600602|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
146296324|NCT00867113|527600602|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
146088175|NCT00686998|526841964|FG000|Overall Study|Adverse Event|3|||
146237436|NCT03431350|527382807|FG009|Overall Study|Withdrawal by Subject|2|||
146296325|NCT01886313|527600603|FG000|Overall Study|Adverse Event|1|||
146296326|NCT01886313|527600604|FG001|Overall Study|Adverse Event|1|||
146296327|NCT04614662|527600605|FG000|Overall Study|Withdrawal by Subject|0|||
146237437|NCT03431350|527382808|FG010|Overall Study|Withdrawal by Subject|0|||
146237438|NCT03431350|527382809|FG011|Overall Study|Withdrawal by Subject|1|||
146237439|NCT03431350|527382798|FG000|Overall Study|Other|0|||
146237440|NCT03431350|527382799|FG001|Overall Study|Other|0|||
146237441|NCT03431350|527382800|FG002|Overall Study|Other|1|||
146237442|NCT03431350|527382801|FG003|Overall Study|Other|3|||
146237443|NCT03431350|527382802|FG004|Overall Study|Other|2|||
146237444|NCT03431350|527382803|FG005|Overall Study|Other|2|||
146237445|NCT03431350|527382804|FG006|Overall Study|Other|4|||
145971794|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
145971795|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
145971796|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
145971797|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
145971798|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
145971799|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
145971800|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
145971801|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
145971802|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
145971803|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
146237446|NCT03431350|527382805|FG007|Overall Study|Other|0|||
145971804|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
145971805|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
145971806|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
145971807|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
145971808|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
145971809|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
145971810|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
145971811|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
145971812|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
145971813|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
145971814|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
145971815|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
145971816|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
145971817|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
145971818|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
145971819|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
145971820|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
145971821|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
145971822|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
145971823|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
145971824|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
145971825|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
145971826|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
145971827|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
146088176|NCT00686998|526841965|FG001|Overall Study|Adverse Event|2|||
146237447|NCT03431350|527382806|FG008|Overall Study|Other|14|||
146237448|NCT03431350|527382807|FG009|Overall Study|Other|11|||
146237449|NCT03431350|527382808|FG010|Overall Study|Other|11|||
146237450|NCT03431350|527382809|FG011|Overall Study|Other|15|||
146237451|NCT03414684|527382810|FG000|First-course Treatment|Complete response|0|||
146237452|NCT03414684|527382811|FG001|First-course Treatment|Complete response|1|||
146237453|NCT03414684|527382810|FG000|First-course Treatment|Intercurrent illness|1|||
146237454|NCT03414684|527382811|FG001|First-course Treatment|Intercurrent illness|0|||
146237455|NCT03414684|527382810|FG000|First-course Treatment|Progressive Disease|31|||
146237456|NCT03414684|527382811|FG001|First-course Treatment|Progressive Disease|32|||
146237457|NCT03414684|527382810|FG000|First-course Treatment|Adverse Event|1|||
146237458|NCT03414684|527382811|FG001|First-course Treatment|Adverse Event|2|||
146237459|NCT03414684|527382810|FG000|First-course Treatment|Physician Decision|0|||
146237460|NCT03414684|527382811|FG001|First-course Treatment|Physician Decision|1|||
146237461|NCT03414684|527382810|FG000|First-course Treatment|Withdrawal by Subject|0|||
146237462|NCT03414684|527382811|FG001|First-course Treatment|Withdrawal by Subject|1|||
146237463|NCT03414684|527382810|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
146237464|NCT03414684|527382811|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
146237465|NCT03414684|527382810|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
146237466|NCT03414684|527382811|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
146237467|NCT03414684|527382810|FG000|First-course Treatment|Still on treatment|3|||
146237468|NCT03414684|527382811|FG001|First-course Treatment|Still on treatment|0|||
146237469|NCT03414684|527382810|FG000|First-course Treatment|Never started protocol therapy|2|||
146237470|NCT03414684|527382811|FG001|First-course Treatment|Never started protocol therapy|1|||
146237471|NCT03414684|527382810|FG000|Crossover Treatment|Progressive disease|0|||
145893429|NCT01995266|526117190|FG000|Overall Study|Lack of Efficacy|6|||
145893430|NCT01995266|526117190|FG000|Overall Study|Adverse Event|2|||
145893431|NCT03310411|526117191|FG000|Period 1|Adverse Event|0|||
145893432|NCT03310411|526117192|FG001|Period 1|Adverse Event|0|||
145893433|NCT03310411|526117193|FG002|Period 1|Adverse Event|0|||
145893434|NCT03310411|526117194|FG003|Period 1|Adverse Event|1|||
145893435|NCT00619112|526117195|FG000|Overall Study|Adverse Event|1|||
145893436|NCT00619112|526117196|FG001|Overall Study|Adverse Event|2|||
145893437|NCT03573505|526117201|FG000|Overall Study|Adverse Event|1|||
145893438|NCT03573505|526117202|FG001|Overall Study|Adverse Event|1|||
145893439|NCT03573505|526117201|FG000|Overall Study|Consent withdrawn|0|||
145893440|NCT03573505|526117202|FG001|Overall Study|Consent withdrawn|1|||
145893441|NCT03573505|526117201|FG000|Overall Study|Disease progression|0|||
145893442|NCT03573505|526117202|FG001|Overall Study|Disease progression|1|||
145893443|NCT03573505|526117201|FG000|Overall Study|Site Terminated by Sponsor|1|||
145893444|NCT03573505|526117202|FG001|Overall Study|Site Terminated by Sponsor|1|||
145893445|NCT03573505|526117201|FG000|Overall Study|Study terminated by sponsor|50|||
145893446|NCT03573505|526117202|FG001|Overall Study|Study terminated by sponsor|45|||
145893447|NCT03573505|526117201|FG000|Overall Study|Reason not specified|0|||
145893448|NCT03573505|526117202|FG001|Overall Study|Reason not specified|1|||
145893449|NCT03573505|526117201|FG000|Overall Study|Death|0|||
145893450|NCT03573505|526117202|FG001|Overall Study|Death|4|||
145893451|NCT02040779|526117203|FG000|Overall Study|Adverse Event|1|||
145893452|NCT02040779|526117204|FG001|Overall Study|Adverse Event|0|||
145893453|NCT02040779|526117205|FG002|Overall Study|Adverse Event|0|||
145893454|NCT02040779|526117203|FG000|Overall Study|Withdrawal by Subject|4|||
145893455|NCT02040779|526117204|FG001|Overall Study|Withdrawal by Subject|1|||
145893456|NCT02040779|526117205|FG002|Overall Study|Withdrawal by Subject|3|||
145893457|NCT02040779|526117203|FG000|Overall Study|Non-compliance|0|||
145893458|NCT02040779|526117204|FG001|Overall Study|Non-compliance|1|||
145893459|NCT02040779|526117205|FG002|Overall Study|Non-compliance|0|||
145893460|NCT02040779|526117203|FG000|Overall Study|Protocol Violation|2|||
145893461|NCT02040779|526117204|FG001|Overall Study|Protocol Violation|1|||
145893462|NCT02040779|526117205|FG002|Overall Study|Protocol Violation|0|||
145893463|NCT02040779|526117203|FG000|Overall Study|Lost to Follow-up|1|||
145893464|NCT02040779|526117204|FG001|Overall Study|Lost to Follow-up|2|||
145893465|NCT02040779|526117205|FG002|Overall Study|Lost to Follow-up|1|||
145893466|NCT02040779|526117203|FG000|Overall Study|Lack of Efficacy|4|||
145893467|NCT02040779|526117204|FG001|Overall Study|Lack of Efficacy|2|||
145893468|NCT02040779|526117205|FG002|Overall Study|Lack of Efficacy|0|||
145893469|NCT00922272|526117206|FG000|Open-label Phase|Adverse Event|5|||
145893470|NCT00922272|526117207|FG001|Open-label Phase|Adverse Event|0|||
145893471|NCT00922272|526117206|FG000|Open-label Phase|Protocol Violation|1|||
145893472|NCT00922272|526117207|FG001|Open-label Phase|Protocol Violation|0|||
145893473|NCT00922272|526117206|FG000|Open-label Phase|Withdrawal by Subject|11|||
145893474|NCT00922272|526117207|FG001|Open-label Phase|Withdrawal by Subject|0|||
145893475|NCT00922272|526117206|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
145893476|NCT00922272|526117207|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
146237472|NCT03414684|527382811|FG001|Crossover Treatment|Progressive disease|12|||
146237473|NCT03414684|527382810|FG000|Crossover Treatment|Adverse Event|0|||
146237474|NCT03414684|527382811|FG001|Crossover Treatment|Adverse Event|3|||
146237475|NCT03414684|527382810|FG000|Crossover Treatment|Physician Decision|0|||
146237476|NCT03414684|527382811|FG001|Crossover Treatment|Physician Decision|1|||
146237477|NCT03414684|527382810|FG000|Crossover Treatment|Still on treatment|0|||
146237478|NCT03414684|527382811|FG001|Crossover Treatment|Still on treatment|2|||
146237479|NCT02078648|527382812|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
146237480|NCT02078648|527382813|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
146237481|NCT02078648|527382812|FG000|Overall Study|Adverse Event|0|||
145893477|NCT00922272|526117206|FG000|Open-label Phase|Withdrawal criteria met|5|||
145893478|NCT00922272|526117207|FG001|Open-label Phase|Withdrawal criteria met|0|||
145893479|NCT00922272|526117206|FG000|Double-blind Phase|Adverse Event|1|||
145893480|NCT00922272|526117207|FG001|Double-blind Phase|Adverse Event|1|||
145893481|NCT00922272|526117206|FG000|Double-blind Phase|Withdrawal by Subject|1|||
145893482|NCT00922272|526117207|FG001|Double-blind Phase|Withdrawal by Subject|1|||
145893483|NCT00922272|526117206|FG000|Double-blind Phase|Lost to Follow-up|2|||
145893484|NCT00922272|526117207|FG001|Double-blind Phase|Lost to Follow-up|1|||
145971828|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
145893485|NCT00922272|526117206|FG000|Double-blind Phase|Withdrawal criteria met|1|||
145893486|NCT00922272|526117207|FG001|Double-blind Phase|Withdrawal criteria met|1|||
146237482|NCT02078648|527382813|FG001|Overall Study|Adverse Event|1|||
146237483|NCT02078648|527382812|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
146282340|NCT01879722|527546475|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
145893487|NCT00922272|526117206|FG000|Double-blind Phase|Noncompliance|1|||
145893488|NCT00922272|526117207|FG001|Double-blind Phase|Noncompliance|1|||
145893489|NCT00922272|526117206|FG000|Double-blind Phase|Positive urine drug screen|1|||
145893490|NCT00922272|526117207|FG001|Double-blind Phase|Positive urine drug screen|1|||
145893491|NCT02588950|526117214|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
145893492|NCT02588950|526117215|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
145893493|NCT02588950|526117216|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
145893494|NCT02588950|526117217|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
145893495|NCT02588950|526117214|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
145893496|NCT02588950|526117215|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
145893497|NCT02588950|526117216|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
145893498|NCT02588950|526117217|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
145893499|NCT00866658|526117218|FG000|Overall Study|Adverse Event|5|||
145893500|NCT00866658|526117219|FG001|Overall Study|Adverse Event|14|||
145893501|NCT00866658|526117218|FG000|Overall Study|Lack of Efficacy|2|||
145971829|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
145971830|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
145971831|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
145971832|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
145971833|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
145971834|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
145971835|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
145971836|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
145971837|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
145971838|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
145971839|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
145971840|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
145971841|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
145971842|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
145971843|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
145971844|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
145971845|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
145971846|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
145971847|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
145971848|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
145971849|NCT00090103|526410471|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
145971850|NCT00090103|526410472|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
145971851|NCT00090103|526410473|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
145971852|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
145971853|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
145971854|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
145971855|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
145971856|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
145971857|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
145971858|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
145971859|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
145971860|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
145971861|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
145971862|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
145971863|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
145971864|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
145971865|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
145971866|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
145971867|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
145971868|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
145971869|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
145971870|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
145971871|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
145971872|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
145971873|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
145971874|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
145971875|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
145971876|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
145893502|NCT00866658|526117219|FG001|Overall Study|Lack of Efficacy|1|||
145971877|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
146088177|NCT00686998|526841966|FG002|Overall Study|Adverse Event|1|||
146237484|NCT02078648|527382813|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
146237485|NCT02078648|527382812|FG000|Overall Study|Withdrawal by Subject|3|||
146237486|NCT02078648|527382813|FG001|Overall Study|Withdrawal by Subject|1|||
145893503|NCT00866658|526117218|FG000|Overall Study|Withdrawal by Subject|1|||
145893504|NCT00866658|526117219|FG001|Overall Study|Withdrawal by Subject|0|||
145893505|NCT00866658|526117218|FG000|Overall Study|Protocol Violation|1|||
145893506|NCT00866658|526117219|FG001|Overall Study|Protocol Violation|1|||
145893507|NCT00866658|526117218|FG000|Overall Study|Familial and Personal Reasons|4|||
145893508|NCT00866658|526117219|FG001|Overall Study|Familial and Personal Reasons|5|||
145893509|NCT00652028|526117220|FG000|Overall Study|Adverse Event|1|||
145893510|NCT00652028|526117221|FG001|Overall Study|Adverse Event|0|||
145893511|NCT00652028|526117222|FG002|Overall Study|Adverse Event|0|||
145893512|NCT00652028|526117223|FG003|Overall Study|Adverse Event|0|||
145893513|NCT00652028|526117220|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
145893514|NCT00652028|526117221|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
145893515|NCT00652028|526117222|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
145893516|NCT00652028|526117223|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
145893517|NCT00652028|526117220|FG000|Overall Study|Physician Decision|0|||
145893518|NCT00652028|526117221|FG001|Overall Study|Physician Decision|0|||
145893519|NCT00652028|526117222|FG002|Overall Study|Physician Decision|1|||
145893520|NCT00652028|526117223|FG003|Overall Study|Physician Decision|0|||
145893521|NCT02072824|526117224|FG000|Overall Study|Insufficient clinical response|1|||
145893522|NCT02072824|526117225|FG001|Overall Study|Insufficient clinical response|0|||
145893523|NCT02072824|526117226|FG002|Overall Study|Insufficient clinical response|1|||
145893524|NCT02072824|526117224|FG000|Overall Study|No longer willing to participate|1|||
145893525|NCT02072824|526117225|FG001|Overall Study|No longer willing to participate|0|||
145893526|NCT02072824|526117226|FG002|Overall Study|No longer willing to participate|1|||
145893527|NCT02072824|526117224|FG000|Overall Study|Medication error|0|||
145893528|NCT02072824|526117225|FG001|Overall Study|Medication error|1|||
145893529|NCT02072824|526117226|FG002|Overall Study|Medication error|0|||
145893530|NCT02072824|526117224|FG000|Overall Study|Adverse Event|0|||
145893531|NCT02072824|526117225|FG001|Overall Study|Adverse Event|0|||
145893532|NCT02072824|526117226|FG002|Overall Study|Adverse Event|1|||
145893533|NCT02751359|526117227|FG000|Overall Study|Lost to Follow-up|1|||
145893534|NCT02011113|526117228|FG000|Overall Study|Adverse Event|4|||
145893535|NCT02011113|526117228|FG000|Overall Study|Disease Progression (DP)|16|||
145893536|NCT02011113|526117228|FG000|Overall Study|Death|1|||
145893537|NCT02011113|526117228|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
145893538|NCT02011113|526117228|FG000|Overall Study|Investigator's judgement- DP|3|||
145893539|NCT02011113|526117228|FG000|Overall Study|Study terminated by sponsor|11|||
145893540|NCT02669940|526117231|FG000|Overall Study|Failure to return|0|||
145893541|NCT02669940|526117232|FG001|Overall Study|Failure to return|3|||
145893542|NCT02669940|526117231|FG000|Overall Study|Insufficient follow-up data|1|||
145893543|NCT02669940|526117232|FG001|Overall Study|Insufficient follow-up data|0|||
145893544|NCT05065983|526117241|FG000|Overall Study|Lost to Follow-up|2|||
145893545|NCT01765582|526117242|FG000|Overall Study|Other|3|||
145893546|NCT01765582|526117243|FG001|Overall Study|Other|6|||
145893547|NCT01765582|526117244|FG002|Overall Study|Other|9|||
145893548|NCT01765582|526117242|FG000|Overall Study|Lost to Follow-up|2|||
145893549|NCT01765582|526117243|FG001|Overall Study|Lost to Follow-up|2|||
145893550|NCT01765582|526117244|FG002|Overall Study|Lost to Follow-up|1|||
145893551|NCT01765582|526117242|FG000|Overall Study|Death|31|||
145893552|NCT01765582|526117243|FG001|Overall Study|Death|36|||
145893553|NCT01765582|526117244|FG002|Overall Study|Death|33|||
145893554|NCT01765582|526117242|FG000|Overall Study|Sponsor Decision|46|||
145893555|NCT01765582|526117243|FG001|Overall Study|Sponsor Decision|42|||
145893556|NCT01765582|526117244|FG002|Overall Study|Sponsor Decision|42|||
145893557|NCT01765582|526117242|FG000|Overall Study|Withdrawal of Consent|11|||
145893558|NCT01765582|526117243|FG001|Overall Study|Withdrawal of Consent|6|||
145893559|NCT01765582|526117244|FG002|Overall Study|Withdrawal of Consent|10|||
145893560|NCT00986180|526117245|FG000|Overall Study|Adverse Event|21|||
145893561|NCT00986180|526117246|FG001|Overall Study|Adverse Event|23|||
145893562|NCT00986180|526117245|FG000|Overall Study|Lack of Efficacy|4|||
145893563|NCT00986180|526117246|FG001|Overall Study|Lack of Efficacy|3|||
145893564|NCT00986180|526117245|FG000|Overall Study|Lost to Follow-up|5|||
145893565|NCT00986180|526117246|FG001|Overall Study|Lost to Follow-up|7|||
145893566|NCT00986180|526117245|FG000|Overall Study|Physician Decision|1|||
145893567|NCT00986180|526117246|FG001|Overall Study|Physician Decision|3|||
145893568|NCT00986180|526117245|FG000|Overall Study|Protocol Violation|2|||
145893569|NCT00986180|526117246|FG001|Overall Study|Protocol Violation|0|||
145893570|NCT00986180|526117245|FG000|Overall Study|Withdrawal by Subject|1|||
145893571|NCT00986180|526117246|FG001|Overall Study|Withdrawal by Subject|9|||
145893572|NCT00986180|526117245|FG000|Overall Study|Miscellanies|10|||
145893573|NCT00986180|526117246|FG001|Overall Study|Miscellanies|11|||
145893574|NCT03251963|526117251|FG000|Overall Study|inappropriate Xa level timing|6|||
145893575|NCT03251963|526117252|FG001|Overall Study|inappropriate Xa level timing|3|||
145893576|NCT03251963|526117251|FG000|Overall Study|no peak Xa level drawn|2|||
145893577|NCT03251963|526117252|FG001|Overall Study|no peak Xa level drawn|0|||
145893578|NCT03251963|526117251|FG000|Overall Study|bled prior to Xa level|1|||
145893579|NCT03251963|526117252|FG001|Overall Study|bled prior to Xa level|2|||
145893580|NCT00616941|526117253|FG000|Overall Study|Progressive Disease|1|||
145893581|NCT00616941|526117254|FG001|Overall Study|Progressive Disease|2|||
145893582|NCT00616941|526117255|FG002|Overall Study|Progressive Disease|1|||
146237487|NCT02078648|527382812|FG000|Overall Study|Investigator Decision|5|||
145893583|NCT00616941|526117253|FG000|Overall Study|Adverse Event|0|||
145893584|NCT00616941|526117254|FG001|Overall Study|Adverse Event|1|||
145893585|NCT00616941|526117255|FG002|Overall Study|Adverse Event|1|||
145893586|NCT00616941|526117253|FG000|Overall Study|Subject Non-compliance|0|||
145893587|NCT00616941|526117254|FG001|Overall Study|Subject Non-compliance|0|||
145893588|NCT00616941|526117255|FG002|Overall Study|Subject Non-compliance|1|||
145893589|NCT00616941|526117253|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
145893590|NCT00616941|526117254|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
145893591|NCT00616941|526117255|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
145893592|NCT00616941|526117253|FG000|Overall Study|Vaccination Suspended|0|||
145893593|NCT00616941|526117254|FG001|Overall Study|Vaccination Suspended|0|||
145893594|NCT00616941|526117255|FG002|Overall Study|Vaccination Suspended|3|||
145893595|NCT00706381|526117256|FG000|Overall Study|Lost to Follow-up|0|||
145893596|NCT00706381|526117257|FG001|Overall Study|Lost to Follow-up|1|||
145893597|NCT00706381|526117258|FG002|Overall Study|Lost to Follow-up|1|||
145893598|NCT00706381|526117259|FG003|Overall Study|Lost to Follow-up|0|||
145893599|NCT04355663|526117260|FG000|Overall Study|Physician Decision|2|||
145893600|NCT04355663|526117261|FG001|Overall Study|Physician Decision|7|||
145893601|NCT04355663|526117262|FG002|Overall Study|Physician Decision|0|||
145893602|NCT04355663|526117260|FG000|Overall Study|Adverse Event|0|||
145893603|NCT04355663|526117261|FG001|Overall Study|Adverse Event|0|||
145893604|NCT04355663|526117262|FG002|Overall Study|Adverse Event|1|||
145893605|NCT04355663|526117260|FG000|Overall Study|Withdrawal by Subject|0|||
145893606|NCT04355663|526117261|FG001|Overall Study|Withdrawal by Subject|8|||
145893607|NCT04355663|526117262|FG002|Overall Study|Withdrawal by Subject|3|||
145893608|NCT00038649|526117270|FG000|Overall Study|Adverse Event|9|||
145893609|NCT00942331|526117271|FG000|Overall Study|Did not start treatment|15|||
145893610|NCT00942331|526117272|FG001|Overall Study|Did not start treatment|22|||
145893611|NCT00567476|526117274|FG000|Overall Study|Adverse Event|2|||
145893612|NCT00567476|526117275|FG001|Overall Study|Adverse Event|0|||
145893613|NCT00567476|526117274|FG000|Overall Study|Pregnancy|1|||
145893614|NCT00567476|526117275|FG001|Overall Study|Pregnancy|0|||
145893615|NCT00567476|526117274|FG000|Overall Study|Protocol Violation|4|||
145893616|NCT00567476|526117275|FG001|Overall Study|Protocol Violation|1|||
145893617|NCT00567476|526117274|FG000|Overall Study|Lost to Follow-up|0|||
145893618|NCT00567476|526117275|FG001|Overall Study|Lost to Follow-up|1|||
145893619|NCT00567476|526117274|FG000|Overall Study|Administrative issues|1|||
145893620|NCT00567476|526117275|FG001|Overall Study|Administrative issues|0|||
145893621|NCT00567476|526117274|FG000|Overall Study|Medical Decision|0|||
145893622|NCT00567476|526117275|FG001|Overall Study|Medical Decision|1|||
145893623|NCT00567476|526117274|FG000|Overall Study|Non-adherence to protocol|0|||
145893624|NCT00567476|526117275|FG001|Overall Study|Non-adherence to protocol|1|||
145893625|NCT01491035|526117281|FG000|Overall Study|Lost to Follow-up|0|||
145893626|NCT01491035|526117282|FG001|Overall Study|Lost to Follow-up|0|||
145893627|NCT01491035|526117283|FG002|Overall Study|Lost to Follow-up|0|||
145893628|NCT01491035|526117284|FG003|Overall Study|Lost to Follow-up|0|||
145893629|NCT01491035|526117285|FG004|Overall Study|Lost to Follow-up|1|||
145893630|NCT01491035|526117286|FG005|Overall Study|Lost to Follow-up|0|||
145893631|NCT01491035|526117287|FG006|Overall Study|Lost to Follow-up|0|||
145893632|NCT01491035|526117288|FG007|Overall Study|Lost to Follow-up|0|||
145893633|NCT02999477|526117291|FG000|Overall Study|found ineligible after first dose|0|||
145893634|NCT02999477|526117292|FG001|Overall Study|found ineligible after first dose|1|||
145971878|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
145971879|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
145971880|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
145971881|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
145971882|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
145893635|NCT02999477|526117291|FG000|Overall Study|Withdrawal by Subject|1|||
145893636|NCT02999477|526117292|FG001|Overall Study|Withdrawal by Subject|1|||
145893637|NCT00891839|526117294|FG000|Overall Study|Adverse Event|2|||
145893638|NCT00891839|526117294|FG000|Overall Study|Withdrawal by Subject|2|||
145893639|NCT00891839|526117294|FG000|Overall Study|Disease progression|3|||
145971883|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
145893640|NCT00851643|526117298|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
145893641|NCT00851643|526117299|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145893642|NCT00851643|526117300|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145893643|NCT00851643|526117301|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145893644|NCT00851643|526117302|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145893645|NCT00851643|526117303|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145893646|NCT00851643|526117298|FG000|Base Study (Up to 12 Months)|Other|0|||
145893647|NCT00851643|526117299|FG001|Base Study (Up to 12 Months)|Other|0|||
145893648|NCT00851643|526117300|FG002|Base Study (Up to 12 Months)|Other|0|||
145893649|NCT00851643|526117301|FG003|Base Study (Up to 12 Months)|Other|0|||
145893650|NCT00851643|526117302|FG004|Base Study (Up to 12 Months)|Other|0|||
145893651|NCT00851643|526117303|FG005|Base Study (Up to 12 Months)|Other|1|||
145971884|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
145971885|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
145971886|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
145971887|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
145971888|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
145971889|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
145971890|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
145971891|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
145971892|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
145971893|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
145971894|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
145971895|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
145971896|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
145971897|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
145971898|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
145971899|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
145971900|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Death|1|||
145971901|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Death|0|||
145971902|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Death|1|||
145971903|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
145893652|NCT00851643|526117298|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
145893653|NCT00851643|526117299|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
146237488|NCT02078648|527382813|FG001|Overall Study|Investigator Decision|7|||
145893654|NCT00851643|526117300|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
145893655|NCT00851643|526117301|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
145893656|NCT00851643|526117302|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
145893657|NCT00851643|526117303|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
145893658|NCT00851643|526117298|FG000|Extension Study (Up to 36 Months)|Moved|0|||
145893659|NCT00851643|526117299|FG001|Extension Study (Up to 36 Months)|Moved|2|||
145893660|NCT00851643|526117300|FG002|Extension Study (Up to 36 Months)|Moved|1|||
145893661|NCT00851643|526117301|FG003|Extension Study (Up to 36 Months)|Moved|1|||
145893662|NCT00851643|526117302|FG004|Extension Study (Up to 36 Months)|Moved|0|||
145893663|NCT00851643|526117303|FG005|Extension Study (Up to 36 Months)|Moved|1|||
145893664|NCT01568866|526117304|FG000|Overall Study|Disease Progression|208|||
145893665|NCT01568866|526117305|FG001|Overall Study|Disease Progression|183|||
145893666|NCT01568866|526117304|FG000|Overall Study|Adverse Event|94|||
145893667|NCT01568866|526117305|FG001|Overall Study|Adverse Event|96|||
145893668|NCT01568866|526117304|FG000|Overall Study|Patient Request|55|||
145893669|NCT01568866|526117305|FG001|Overall Study|Patient Request|71|||
145893670|NCT01568866|526117304|FG000|Overall Study|Physician Decision|40|||
145893671|NCT01568866|526117305|FG001|Overall Study|Physician Decision|32|||
145893672|NCT01568866|526117304|FG000|Overall Study|Withdrawal by Subject|19|||
145893673|NCT01568866|526117305|FG001|Overall Study|Withdrawal by Subject|11|||
145893674|NCT01568866|526117304|FG000|Overall Study|Death|10|||
145893675|NCT01568866|526117305|FG001|Overall Study|Death|18|||
145893676|NCT01568866|526117304|FG000|Overall Study|Protocol Non-compliance|2|||
145893677|NCT01568866|526117305|FG001|Overall Study|Protocol Non-compliance|4|||
145893678|NCT01568866|526117304|FG000|Overall Study|Lost to Follow-up|1|||
145893679|NCT01568866|526117305|FG001|Overall Study|Lost to Follow-up|0|||
145893680|NCT01568866|526117304|FG000|Overall Study|Randomized but Not Dosed|9|||
145893681|NCT01568866|526117305|FG001|Overall Study|Randomized but Not Dosed|1|||
145893682|NCT03864042|526117306|FG000|DDI Phase|Adverse Event|2|||
145971904|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
145971905|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
145971906|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
145971907|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
145971908|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
145893683|NCT03864042|526117307|FG001|DDI Phase|Adverse Event|0|||
145893684|NCT03864042|526117308|FG002|DDI Phase|Adverse Event|0|||
145893685|NCT03864042|526117306|FG000|DDI Phase|Physician Decision|1|||
145893686|NCT03864042|526117307|FG001|DDI Phase|Physician Decision|0|||
145893687|NCT03864042|526117308|FG002|DDI Phase|Physician Decision|0|||
145893688|NCT03864042|526117306|FG000|DDI Phase|Progressive Disease|1|||
145893689|NCT03864042|526117307|FG001|DDI Phase|Progressive Disease|0|||
145893690|NCT03864042|526117308|FG002|DDI Phase|Progressive Disease|0|||
145893691|NCT03864042|526117306|FG000|Post-DDI Phase|Adverse Event|5|||
145893692|NCT03864042|526117307|FG001|Post-DDI Phase|Adverse Event|3|||
145893693|NCT03864042|526117308|FG002|Post-DDI Phase|Adverse Event|2|||
145893694|NCT03864042|526117306|FG000|Post-DDI Phase|Progressive Disease|11|||
145971909|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
145971910|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
146237489|NCT02078648|527382812|FG000|Overall Study|Death|1|||
146237490|NCT02078648|527382813|FG001|Overall Study|Death|1|||
146237491|NCT02078648|527382812|FG000|Overall Study|Undefined|0|||
146237492|NCT02078648|527382813|FG001|Overall Study|Undefined|1|||
146237493|NCT05379270|527382814|FG000|Overall Study|Withdrawal by Subject|1|||
146237494|NCT05379270|527382815|FG001|Overall Study|Withdrawal by Subject|1|||
146237495|NCT04306367|527382821|FG000|Overall Study|Progression of Disease|9|||
145893695|NCT03864042|526117307|FG001|Post-DDI Phase|Progressive Disease|6|||
145893696|NCT03864042|526117308|FG002|Post-DDI Phase|Progressive Disease|13|||
145893697|NCT03864042|526117306|FG000|Post-DDI Phase|Discretion of investigator|1|||
145893698|NCT03864042|526117307|FG001|Post-DDI Phase|Discretion of investigator|1|||
145893699|NCT03864042|526117308|FG002|Post-DDI Phase|Discretion of investigator|0|||
145893700|NCT03864042|526117306|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
145893701|NCT03864042|526117307|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
145893702|NCT03864042|526117308|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
145893703|NCT03864042|526117306|FG000|Post-DDI Phase|Withdrawal of consent|1|||
145893704|NCT03864042|526117307|FG001|Post-DDI Phase|Withdrawal of consent|2|||
145893705|NCT03864042|526117308|FG002|Post-DDI Phase|Withdrawal of consent|0|||
145893706|NCT01698775|526117309|FG000|Phase A|Adverse Event|2|||
145893707|NCT01698775|526117310|FG001|Phase A|Adverse Event|1|||
145893708|NCT01698775|526117309|FG000|Phase A|Death|1|||
145893709|NCT01698775|526117310|FG001|Phase A|Death|1|||
145893710|NCT01698775|526117309|FG000|Phase A|Lack of Efficacy|1|||
145893711|NCT01698775|526117310|FG001|Phase A|Lack of Efficacy|0|||
145893712|NCT01698775|526117309|FG000|Phase A|Lost to Follow-up|1|||
145893713|NCT01698775|526117310|FG001|Phase A|Lost to Follow-up|2|||
145893714|NCT01698775|526117309|FG000|Phase A|Protocol Violation|1|||
145893715|NCT01698775|526117310|FG001|Phase A|Protocol Violation|0|||
145893716|NCT01698775|526117309|FG000|Phase A|Withdrawal by Subject|3|||
145893717|NCT01698775|526117310|FG001|Phase A|Withdrawal by Subject|4|||
145893718|NCT01698775|526117309|FG000|Phase A|Kidney [transplant]|0|||
145893719|NCT01698775|526117310|FG001|Phase A|Kidney [transplant]|1|||
145893720|NCT01698775|526117309|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
145893721|NCT01698775|526117310|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
145893722|NCT01698775|526117309|FG000|Phase B|Adverse Event|6|||
145893723|NCT01698775|526117310|FG001|Phase B|Adverse Event|3|||
145893724|NCT01698775|526117309|FG000|Phase B|Death|0|||
145893725|NCT01698775|526117310|FG001|Phase B|Death|1|||
145893726|NCT01698775|526117309|FG000|Phase B|Lack of Efficacy|0|||
145893727|NCT01698775|526117310|FG001|Phase B|Lack of Efficacy|1|||
145893728|NCT01698775|526117309|FG000|Phase B|Lost to Follow-up|0|||
145893729|NCT01698775|526117310|FG001|Phase B|Lost to Follow-up|1|||
145893730|NCT01698775|526117309|FG000|Phase B|Physician Decision|1|||
145893731|NCT01698775|526117310|FG001|Phase B|Physician Decision|1|||
145893732|NCT01698775|526117309|FG000|Phase B|Protocol Violation|1|||
145893733|NCT01698775|526117310|FG001|Phase B|Protocol Violation|1|||
145893734|NCT01698775|526117309|FG000|Phase B|Withdrawal by Subject|6|||
145893735|NCT01698775|526117310|FG001|Phase B|Withdrawal by Subject|2|||
145893736|NCT00359788|526117311|FG000|Overall Study|Adverse Event|11|||
145893737|NCT00359788|526117312|FG001|Overall Study|Adverse Event|10|||
145893738|NCT00359788|526117311|FG000|Overall Study|Lack of Efficacy|1|||
145893739|NCT00359788|526117312|FG001|Overall Study|Lack of Efficacy|2|||
145893740|NCT00359788|526117311|FG000|Overall Study|Lost to Follow-up|3|||
145893741|NCT00359788|526117312|FG001|Overall Study|Lost to Follow-up|2|||
145893742|NCT00359788|526117311|FG000|Overall Study|Withdrawal by Subject|4|||
145893743|NCT00359788|526117312|FG001|Overall Study|Withdrawal by Subject|1|||
145893744|NCT00359788|526117311|FG000|Overall Study|Protocol Violation|4|||
145893745|NCT00359788|526117312|FG001|Overall Study|Protocol Violation|2|||
145893746|NCT01232491|526117315|FG000|Overall Study|Adverse Event|13|||
145893747|NCT01232491|526117316|FG001|Overall Study|Adverse Event|8|||
145893748|NCT01232491|526117315|FG000|Overall Study|Lack of Efficacy|1|||
145893749|NCT01232491|526117316|FG001|Overall Study|Lack of Efficacy|5|||
145893750|NCT01232491|526117315|FG000|Overall Study|Protocol Violation|13|||
145893751|NCT01232491|526117316|FG001|Overall Study|Protocol Violation|11|||
145893752|NCT01232491|526117315|FG000|Overall Study|Withdrawal Criteria|12|||
145893753|NCT01232491|526117316|FG001|Overall Study|Withdrawal Criteria|21|||
145893754|NCT01232491|526117315|FG000|Overall Study|Other|21|||
145893755|NCT01232491|526117316|FG001|Overall Study|Other|18|||
145893756|NCT02932228|526117319|FG000|Overall Study|Death|8|||
146237496|NCT04306367|527382821|FG000|Overall Study|Adverse Event|3|||
146237497|NCT04306367|527382821|FG000|Overall Study|Withdrawal by Subject|1|||
145893757|NCT02932228|526117320|FG001|Overall Study|Death|23|||
145893758|NCT02932228|526117319|FG000|Overall Study|not eligible upon chart review|2|||
145893759|NCT02932228|526117320|FG001|Overall Study|not eligible upon chart review|5|||
145893760|NCT06204887|526118749|FG000|Overall Study|Lost to Follow-up|3|||
145893761|NCT06204887|526118750|FG001|Overall Study|Lost to Follow-up|4|||
145893762|NCT06204887|526118751|FG002|Overall Study|Lost to Follow-up|1|||
145893763|NCT06204887|526118752|FG003|Overall Study|Lost to Follow-up|6|||
145893764|NCT02522403|526118753|FG000|Overall Study|Lost to Follow-up|2|||
145893765|NCT02522403|526118754|FG001|Overall Study|Lost to Follow-up|2|||
145893766|NCT02522403|526118753|FG000|Overall Study|Withdrawal by Subject|2|||
145893767|NCT02522403|526118754|FG001|Overall Study|Withdrawal by Subject|4|||
145893768|NCT05142566|526118755|FG000|Overall Study|Protocol Violation|1|||
145893769|NCT04718194|526118758|FG000|Overall Study|Withdrawal by Subject|3|||
145893770|NCT04718194|526118759|FG001|Overall Study|Withdrawal by Subject|0|||
145893771|NCT04718194|526118758|FG000|Overall Study|Lost to Follow-up|3|||
145893772|NCT04718194|526118759|FG001|Overall Study|Lost to Follow-up|0|||
145893773|NCT00856973|526118760|FG000|Overall Study|Adverse Event|5|||
145893774|NCT00856973|526118761|FG001|Overall Study|Adverse Event|5|||
145893775|NCT00856973|526118762|FG002|Overall Study|Adverse Event|3|||
145893776|NCT00856973|526118760|FG000|Overall Study|Lost to Follow-up|6|||
145893777|NCT00856973|526118761|FG001|Overall Study|Lost to Follow-up|3|||
145893778|NCT00856973|526118762|FG002|Overall Study|Lost to Follow-up|5|||
145893779|NCT00856973|526118760|FG000|Overall Study|Physician Decision|0|||
145893780|NCT00856973|526118761|FG001|Overall Study|Physician Decision|3|||
145893781|NCT00856973|526118762|FG002|Overall Study|Physician Decision|1|||
145893782|NCT00856973|526118760|FG000|Overall Study|Protocol Violation|1|||
145893783|NCT00856973|526118761|FG001|Overall Study|Protocol Violation|2|||
145893784|NCT00856973|526118762|FG002|Overall Study|Protocol Violation|1|||
145893785|NCT00856973|526118760|FG000|Overall Study|Withdrawal by Subject|13|||
145893786|NCT00856973|526118761|FG001|Overall Study|Withdrawal by Subject|16|||
145893787|NCT00856973|526118762|FG002|Overall Study|Withdrawal by Subject|15|||
145893788|NCT00856973|526118760|FG000|Overall Study|Other|11|||
145893789|NCT00856973|526118761|FG001|Overall Study|Other|12|||
145893790|NCT00856973|526118762|FG002|Overall Study|Other|13|||
145893791|NCT04556552|526118767|FG000|Overall Study|Lost to Follow-up|1|||
145893792|NCT04556552|526118768|FG001|Overall Study|Lost to Follow-up|0|||
145893793|NCT04556552|526118767|FG000|Overall Study|Claustrophobia|0|||
145893794|NCT04556552|526118768|FG001|Overall Study|Claustrophobia|1|||
145893795|NCT04556552|526118767|FG000|Overall Study|Inability to continue|0|||
145893796|NCT04556552|526118768|FG001|Overall Study|Inability to continue|1|||
145893797|NCT04551911|526118769|FG000|Overall Study|Lost to Follow-up|2|||
145893798|NCT04551911|526118770|FG001|Overall Study|Lost to Follow-up|1|||
145893799|NCT04551911|526118769|FG000|Overall Study|Withdrawal by Subject|10|||
145893800|NCT04551911|526118770|FG001|Overall Study|Withdrawal by Subject|10|||
145893801|NCT04551911|526118769|FG000|Overall Study|Did not receive the study drug|3|||
145893802|NCT04551911|526118770|FG001|Overall Study|Did not receive the study drug|4|||
145893803|NCT01215513|526118771|FG000|Overall Study|Not completed CS42|9|||
145893804|NCT01215513|526118771|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
145893805|NCT01215513|526118771|FG000|Overall Study|Adverse event (CS42A)|2|||
145893806|NCT01215513|526118771|FG000|Overall Study|Physician decision (CS42A)|6|||
145893807|NCT01215513|526118771|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
145893808|NCT01215513|526118771|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
145893809|NCT01553279|526118772|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
145893810|NCT01553279|526118773|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
145893811|NCT01553279|526118772|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
145893812|NCT01553279|526118773|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
145893813|NCT01553279|526118772|FG000|Interim Period|Withdrawal by Subject|2|||
145893814|NCT01553279|526118773|FG001|Interim Period|Withdrawal by Subject|2|||
145893815|NCT01553279|526118772|FG000|Interim Period|Lost to Follow-up|1|||
145893816|NCT01553279|526118773|FG001|Interim Period|Lost to Follow-up|0|||
145893817|NCT01553279|526118772|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
145893818|NCT01553279|526118773|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
145893819|NCT01553279|526118772|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
145893820|NCT01553279|526118773|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
145893821|NCT00605865|526118775|FG000|Overall Study|Protocol Violation|115|||
145893822|NCT03955471|526118776|FG000|Overall Study|Death|22|||
145893823|NCT03955471|526118776|FG000|Overall Study|Lost to Follow-up|1|||
145893824|NCT03955471|526118776|FG000|Overall Study|Withdrawal by Subject|6|||
145893825|NCT03955471|526118776|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
145893826|NCT01030341|526118779|FG000|Overall Study|Withdrawal by Subject|1|||
145893827|NCT01030341|526118779|FG000|Overall Study|Lost to Follow-up|2|||
145893828|NCT00821873|526118780|FG000|Overall Study|Lost to Follow-up|4|||
145893829|NCT01884311|526118783|FG000|Overall Study|Withdrawal by Subject|3|||
145893830|NCT01884311|526118783|FG000|Overall Study|withdrew consent due to AEs|1|||
145893831|NCT01884311|526118783|FG000|Overall Study|Precautionary measure|1|||
145893832|NCT02856880|526118786|FG000|Overall Study|Withdrawal of consent|1|||
145893833|NCT00793780|526118787|FG000|Overall Study|Withdrawal by Subject|2|||
145893834|NCT00793780|526118788|FG001|Overall Study|Withdrawal by Subject|1|||
145971911|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
145893835|NCT02858492|526118789|FG000|Overall Study|Withdrawal by Subject|0|||
145893836|NCT02858492|526118790|FG001|Overall Study|Withdrawal by Subject|1|||
145893837|NCT02858492|526118791|FG002|Overall Study|Withdrawal by Subject|0|||
145893838|NCT02858492|526118792|FG003|Overall Study|Withdrawal by Subject|1|||
145893839|NCT02858492|526118789|FG000|Overall Study|Adverse Event|0|||
145893840|NCT02858492|526118790|FG001|Overall Study|Adverse Event|0|||
145893841|NCT02858492|526118791|FG002|Overall Study|Adverse Event|0|||
145893842|NCT02858492|526118792|FG003|Overall Study|Adverse Event|3|||
145893843|NCT02858492|526118789|FG000|Overall Study|Lack of Efficacy|0|||
145971912|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
145971913|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
145971914|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
145971915|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
145971916|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
145971917|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
145971918|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
145971919|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
145971920|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
145971921|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
145971922|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
145971923|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
145971924|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Depression|0|||
145971925|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Depression|1|||
145971926|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Depression|0|||
145971927|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
145971928|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
145971929|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
145971930|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Jailed|0|||
145971931|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Jailed|1|||
145971932|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Jailed|0|||
145971933|NCT00090103|526410471|FG000|16-Week Safety Follow-up Period|Other|0|||
145971934|NCT00090103|526410472|FG001|16-Week Safety Follow-up Period|Other|1|||
145971935|NCT00090103|526410473|FG002|16-Week Safety Follow-up Period|Other|0|||
145971936|NCT03345004|526410476|FG000|Overall Study|Physician Decision|1|||
145971937|NCT03345004|526410477|FG001|Overall Study|Physician Decision|0|||
145971938|NCT03345004|526410476|FG000|Overall Study|Withdrawal by Subject|0|||
145971939|NCT03345004|526410477|FG001|Overall Study|Withdrawal by Subject|1|||
145971940|NCT01013753|526410480|FG000|Overall Study|Adverse Event|8|||
145971941|NCT01013753|526410480|FG000|Overall Study|Protocol Violation|3|||
145893844|NCT02858492|526118790|FG001|Overall Study|Lack of Efficacy|0|||
145893845|NCT02858492|526118791|FG002|Overall Study|Lack of Efficacy|0|||
145893846|NCT02858492|526118792|FG003|Overall Study|Lack of Efficacy|1|||
145893847|NCT02858492|526118789|FG000|Overall Study|Protocol defined stopping criteria|0|||
145893848|NCT02858492|526118790|FG001|Overall Study|Protocol defined stopping criteria|0|||
145893849|NCT02858492|526118791|FG002|Overall Study|Protocol defined stopping criteria|0|||
145893850|NCT02858492|526118792|FG003|Overall Study|Protocol defined stopping criteria|1|||
145893851|NCT00573157|526118793|FG000|Overall Study|Adverse Event|3|||
145893852|NCT00573157|526118794|FG001|Overall Study|Adverse Event|1|||
145893853|NCT00573157|526118793|FG000|Overall Study|Other|1|||
145893854|NCT00573157|526118794|FG001|Overall Study|Other|1|||
145893855|NCT01032018|526118797|FG000|Overall Study|Lost to Follow-up|6|||
145893856|NCT01032018|526118798|FG001|Overall Study|Lost to Follow-up|5|||
145893857|NCT01032018|526118797|FG000|Overall Study|Death|0|||
145893858|NCT01032018|526118798|FG001|Overall Study|Death|1|||
145893859|NCT00729248|526118802|FG000|Overall Study|Physician Decision|2|||
145893860|NCT00714493|526118810|FG000|Overall Study|Adverse Event|11|||
145893861|NCT00714493|526118810|FG000|Overall Study|Death|3|||
145893862|NCT00714493|526118810|FG000|Overall Study|Lack of Efficacy|10|||
145893863|NCT00714493|526118810|FG000|Overall Study|Lost to Follow-up|3|||
145893864|NCT00714493|526118810|FG000|Overall Study|Protocol Violation|12|||
145893865|NCT00714493|526118810|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
145893866|NCT00714493|526118810|FG000|Overall Study|OTHER|2|||
145893867|NCT01732874|526118811|FG000|Overall Study|Withdrawal by Subject|5|||
145893868|NCT01732874|526118812|FG001|Overall Study|Withdrawal by Subject|1|||
145971942|NCT01013753|526410480|FG000|Overall Study|Lost to Follow-up|1|||
145971943|NCT01013753|526410480|FG000|Overall Study|Withdrawal by Subject|2|||
145971944|NCT01013753|526410480|FG000|Overall Study|Other|2|||
145971945|NCT04757636|526410481|FG000|Overall Study|Adverse Event|25|||
145971946|NCT04757636|526410482|FG001|Overall Study|Adverse Event|8|||
145971947|NCT04757636|526410483|FG002|Overall Study|Adverse Event|11|||
145893869|NCT01732874|526118811|FG000|Overall Study|Death of Infant|3|||
145893870|NCT01732874|526118812|FG001|Overall Study|Death of Infant|2|||
145893871|NCT00688376|526118813|FG000|Double-Blind Phase|Adverse Event|4|||
145971948|NCT04757636|526410481|FG000|Overall Study|Death|9|||
145971949|NCT04757636|526410482|FG001|Overall Study|Death|12|||
145971950|NCT04757636|526410483|FG002|Overall Study|Death|6|||
145971951|NCT04757636|526410481|FG000|Overall Study|Lack of Efficacy|2|||
145971952|NCT04757636|526410482|FG001|Overall Study|Lack of Efficacy|0|||
145971953|NCT04757636|526410483|FG002|Overall Study|Lack of Efficacy|0|||
145971954|NCT04757636|526410481|FG000|Overall Study|Lost to Follow-up|1|||
145893872|NCT00688376|526118814|FG001|Double-Blind Phase|Adverse Event|4|||
145893873|NCT00688376|526118813|FG000|Double-Blind Phase|Protocol Violation|1|||
145893874|NCT00688376|526118814|FG001|Double-Blind Phase|Protocol Violation|2|||
145893875|NCT00688376|526118813|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
145971955|NCT04757636|526410482|FG001|Overall Study|Lost to Follow-up|6|||
145971956|NCT04757636|526410483|FG002|Overall Study|Lost to Follow-up|7|||
145971957|NCT04757636|526410481|FG000|Overall Study|Physician Decision|1|||
145971958|NCT04757636|526410482|FG001|Overall Study|Physician Decision|3|||
145971959|NCT04757636|526410483|FG002|Overall Study|Physician Decision|4|||
145971960|NCT04757636|526410481|FG000|Overall Study|Withdrawal by Subject|20|||
145971961|NCT04757636|526410482|FG001|Overall Study|Withdrawal by Subject|23|||
145971962|NCT04757636|526410483|FG002|Overall Study|Withdrawal by Subject|18|||
145971963|NCT04757636|526410481|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
145971964|NCT04757636|526410482|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
145971965|NCT04757636|526410483|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
145971966|NCT04757636|526410481|FG000|Overall Study|Study Terminated by Sponsor|103|||
145971967|NCT04757636|526410482|FG001|Overall Study|Study Terminated by Sponsor|104|||
145971968|NCT04757636|526410483|FG002|Overall Study|Study Terminated by Sponsor|114|||
145971969|NCT04757636|526410481|FG000|Overall Study|Sponsor Decision|0|||
145971970|NCT04757636|526410482|FG001|Overall Study|Sponsor Decision|0|||
145971971|NCT04757636|526410483|FG002|Overall Study|Sponsor Decision|1|||
145971972|NCT04757636|526410481|FG000|Overall Study|Randomized in Error|0|||
145971973|NCT04757636|526410482|FG001|Overall Study|Randomized in Error|0|||
145971974|NCT04757636|526410483|FG002|Overall Study|Randomized in Error|2|||
145971975|NCT02349386|526410486|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
145971976|NCT02349386|526410487|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
145971977|NCT02349386|526410488|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
145971978|NCT02349386|526410489|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
145893876|NCT00688376|526118814|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
145971979|NCT02349386|526410486|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
145971980|NCT02349386|526410487|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
145971981|NCT02349386|526410488|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
145971982|NCT02349386|526410489|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
145971983|NCT02349386|526410486|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145971984|NCT02349386|526410487|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145971985|NCT02349386|526410488|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
145971986|NCT02349386|526410489|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145971987|NCT02349386|526410486|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145971988|NCT02349386|526410487|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145971989|NCT02349386|526410488|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
145971990|NCT02349386|526410489|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145971991|NCT02349386|526410486|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
145971992|NCT02349386|526410487|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
145971993|NCT02349386|526410488|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
145893877|NCT00688376|526118813|FG000|Double-Blind Phase|Not treated|0|||
145893878|NCT00688376|526118814|FG001|Double-Blind Phase|Not treated|1|||
145893879|NCT00688376|526118813|FG000|Blinded Extension Phase|Adverse Event|3|||
145893880|NCT00688376|526118814|FG001|Blinded Extension Phase|Adverse Event|4|||
145893881|NCT00688376|526118813|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
145893882|NCT00688376|526118814|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
145893883|NCT00688376|526118813|FG000|Blinded Extension Phase|Physician Decision|1|||
145893884|NCT00688376|526118814|FG001|Blinded Extension Phase|Physician Decision|0|||
145893885|NCT00688376|526118813|FG000|Blinded Extension Phase|Other|1|||
145893886|NCT00688376|526118814|FG001|Blinded Extension Phase|Other|0|||
145893887|NCT00557076|526118815|FG000|Overall Study|Unblinding|0|||
145893888|NCT00557076|526118816|FG001|Overall Study|Unblinding|1|||
145893889|NCT04392583|526118818|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
145893890|NCT03484117|526118819|FG000|Overall Study|Lost to Follow-up|1|||
145893891|NCT03484117|526118820|FG001|Overall Study|Lost to Follow-up|3|||
145893892|NCT03484117|526118819|FG000|Overall Study|Declined participation in exit assess|1|||
145893893|NCT03484117|526118820|FG001|Overall Study|Declined participation in exit assess|1|||
145893894|NCT02303041|526118821|FG000|Overall Study|Adverse Event|1|||
145893895|NCT02303041|526118822|FG001|Overall Study|Adverse Event|2|||
145971994|NCT02349386|526410489|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
145971995|NCT02349386|526410486|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
146237498|NCT02401815|527382822|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237499|NCT02401815|527382823|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237500|NCT02401815|527382824|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145893896|NCT01070771|526118823|FG000|Overall Study|Adverse Event|2|||
145893897|NCT01070771|526118823|FG000|Overall Study|Protocol Violation|1|||
145971996|NCT02349386|526410487|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
145971997|NCT02349386|526410488|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
145971998|NCT02349386|526410489|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
145971999|NCT00984867|526410490|FG000|Overall Study|Adverse Event|3|||
146237501|NCT02401815|527382825|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
145893898|NCT00289874|526118824|FG000|Overall Study|Adverse Event|1|||
145893899|NCT00289874|526118825|FG001|Overall Study|Adverse Event|5|||
145893900|NCT00289874|526118824|FG000|Overall Study|Lost to Follow-up|1|||
145893901|NCT00289874|526118825|FG001|Overall Study|Lost to Follow-up|1|||
145893902|NCT00289874|526118824|FG000|Overall Study|Protocol Violation|3|||
145893903|NCT00289874|526118825|FG001|Overall Study|Protocol Violation|2|||
145893904|NCT00289874|526118824|FG000|Overall Study|Did not meet eligibility|1|||
146296328|NCT04614662|527600606|FG001|Overall Study|Withdrawal by Subject|1|||
146296329|NCT01230788|527600609|FG000|Overall Study|Prescribed exclusion drug|1|||
145893905|NCT00289874|526118825|FG001|Overall Study|Did not meet eligibility|0|||
145893906|NCT00136318|526118826|FG000|Overall Study|Adverse Event|5|||
145893907|NCT00136318|526118827|FG001|Overall Study|Adverse Event|5|||
145893908|NCT00136318|526118826|FG000|Overall Study|Withdrawal by Subject|2|||
145893909|NCT00136318|526118827|FG001|Overall Study|Withdrawal by Subject|2|||
145893910|NCT03835325|526118828|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
145893911|NCT03835325|526118828|FG000|Overall Study|Selection failure|1|||
145893912|NCT01370213|526118829|FG000|Overall Study|Early Death|1|||
145893913|NCT01370213|526118830|FG001|Overall Study|Early Death|0|||
145893914|NCT01370213|526118831|FG002|Overall Study|Early Death|0|||
145893915|NCT01370213|526118829|FG000|Overall Study|Not evaluable|0|||
145893916|NCT01370213|526118830|FG001|Overall Study|Not evaluable|2|||
145893917|NCT01370213|526118831|FG002|Overall Study|Not evaluable|0|||
145893918|NCT01550744|526118834|FG000|Open-Label|Lost to Follow-up|7|||
145893919|NCT01550744|526118835|FG001|Open-Label|Lost to Follow-up|0|||
145893920|NCT01550744|526118836|FG002|Open-Label|Lost to Follow-up|0|||
145893921|NCT01550744|526118834|FG000|Open-Label|Withdrawal by Subject|13|||
145893922|NCT01550744|526118835|FG001|Open-Label|Withdrawal by Subject|0|||
145893923|NCT01550744|526118836|FG002|Open-Label|Withdrawal by Subject|0|||
145893924|NCT01550744|526118834|FG000|Open-Label|Adverse Event|11|||
145893925|NCT01550744|526118835|FG001|Open-Label|Adverse Event|0|||
145893926|NCT01550744|526118836|FG002|Open-Label|Adverse Event|0|||
145893927|NCT01550744|526118834|FG000|Open-Label|Lack of Efficacy|4|||
145893928|NCT01550744|526118835|FG001|Open-Label|Lack of Efficacy|0|||
145893929|NCT01550744|526118836|FG002|Open-Label|Lack of Efficacy|0|||
145893930|NCT01550744|526118834|FG000|Open-Label|Protocol Violation|4|||
145893931|NCT01550744|526118835|FG001|Open-Label|Protocol Violation|0|||
145893932|NCT01550744|526118836|FG002|Open-Label|Protocol Violation|0|||
145893933|NCT01550744|526118834|FG000|Open-Label|Not all 3 study drug injections received|2|||
145893934|NCT01550744|526118835|FG001|Open-Label|Not all 3 study drug injections received|0|||
145893935|NCT01550744|526118836|FG002|Open-Label|Not all 3 study drug injections received|0|||
145893936|NCT01550744|526118834|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
145893937|NCT01550744|526118835|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
145893938|NCT01550744|526118836|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
145893939|NCT01550744|526118834|FG000|Open-Label|Other|1|||
145893940|NCT01550744|526118835|FG001|Open-Label|Other|0|||
145893941|NCT01550744|526118836|FG002|Open-Label|Other|0|||
145893942|NCT01550744|526118834|FG000|Double-Blind|Lost to Follow-up|0|||
145893943|NCT01550744|526118835|FG001|Double-Blind|Lost to Follow-up|6|||
145893944|NCT01550744|526118836|FG002|Double-Blind|Lost to Follow-up|12|||
145893945|NCT01550744|526118834|FG000|Double-Blind|Withdrawal by Subject|0|||
145893946|NCT01550744|526118835|FG001|Double-Blind|Withdrawal by Subject|2|||
145893947|NCT01550744|526118836|FG002|Double-Blind|Withdrawal by Subject|15|||
145893948|NCT01550744|526118834|FG000|Double-Blind|Adverse Event|0|||
145893949|NCT01550744|526118835|FG001|Double-Blind|Adverse Event|4|||
145893950|NCT01550744|526118836|FG002|Double-Blind|Adverse Event|15|||
145893951|NCT01550744|526118834|FG000|Double-Blind|Death|0|||
145893952|NCT01550744|526118835|FG001|Double-Blind|Death|1|||
145893953|NCT01550744|526118836|FG002|Double-Blind|Death|0|||
145893954|NCT01550744|526118834|FG000|Double-Blind|Lack of Efficacy|0|||
145893955|NCT01550744|526118835|FG001|Double-Blind|Lack of Efficacy|2|||
145893956|NCT01550744|526118836|FG002|Double-Blind|Lack of Efficacy|8|||
145893957|NCT01550744|526118834|FG000|Double-Blind|Protocol Violation|0|||
145893958|NCT01550744|526118835|FG001|Double-Blind|Protocol Violation|0|||
145893959|NCT01550744|526118836|FG002|Double-Blind|Protocol Violation|4|||
145893960|NCT01550744|526118834|FG000|Double-Blind|Pregnancy|0|||
145893961|NCT01550744|526118835|FG001|Double-Blind|Pregnancy|0|||
145972000|NCT00984867|526410491|FG001|Overall Study|Adverse Event|7|||
145972001|NCT00984867|526410490|FG000|Overall Study|Death|1|||
145972002|NCT00984867|526410491|FG001|Overall Study|Death|0|||
145972003|NCT00984867|526410490|FG000|Overall Study|Withdrawal by Subject|13|||
146088178|NCT00686998|526841964|FG000|Overall Study|Withdrawal by Subject|2|||
145893962|NCT01550744|526118836|FG002|Double-Blind|Pregnancy|3|||
145893963|NCT01550744|526118834|FG000|Double-Blind|Other|0|||
145893964|NCT01550744|526118835|FG001|Double-Blind|Other|2|||
145893965|NCT01550744|526118836|FG002|Double-Blind|Other|10|||
145893966|NCT03395639|526118838|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
145893967|NCT03395639|526118839|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
145893968|NCT03395639|526118840|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
145893969|NCT03395639|526118838|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
146296330|NCT01774084|527600611|FG000|Overall Study|Personal reasons|1|||
146296331|NCT01774084|527600612|FG001|Overall Study|Personal reasons|0|||
146296332|NCT04226833|527600613|FG000|Overall Study|Death|0|||
146296333|NCT04226833|527600614|FG001|Overall Study|Death|0|||
146296334|NCT04226833|527600615|FG002|Overall Study|Death|1|||
146296335|NCT04226833|527600616|FG003|Overall Study|Death|0|||
146296336|NCT01472380|527600617|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
145893970|NCT03395639|526118839|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
145893971|NCT03395639|526118840|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
145893972|NCT03395639|526118838|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
145893973|NCT03395639|526118839|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
145893974|NCT03395639|526118840|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
145893975|NCT03395639|526118838|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
145893976|NCT03395639|526118839|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
145893977|NCT03395639|526118840|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
145893978|NCT03395639|526118838|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
145893979|NCT03395639|526118839|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
145893980|NCT03395639|526118840|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
145893981|NCT00995085|526118844|FG000|Overall Study|Withdrawal by Subject|5|||
145893982|NCT02595008|526118848|FG000|Overall Study|Enrolled In Error|1|||
145893983|NCT02595008|526118849|FG001|Overall Study|Enrolled In Error|0|||
145893984|NCT03407118|526118850|FG000|Period 2|Withdrawal by Subject|1|||
145893985|NCT03407118|526118851|FG001|Period 2|Withdrawal by Subject|0|||
145893986|NCT01846273|526118852|FG000|Overall Study|Adverse Event|9|||
145893987|NCT01846273|526118853|FG001|Overall Study|Adverse Event|7|||
145893988|NCT01846273|526118854|FG002|Overall Study|Adverse Event|0|||
145893989|NCT01846273|526118852|FG000|Overall Study|Subject withdrew consent|5|||
145893990|NCT01846273|526118853|FG001|Overall Study|Subject withdrew consent|8|||
145893991|NCT01846273|526118854|FG002|Overall Study|Subject withdrew consent|0|||
145893992|NCT01846273|526118852|FG000|Overall Study|Lost to Follow-up|2|||
145893993|NCT01846273|526118853|FG001|Overall Study|Lost to Follow-up|1|||
145893994|NCT01846273|526118854|FG002|Overall Study|Lost to Follow-up|0|||
145893995|NCT01846273|526118852|FG000|Overall Study|Administrative problems|1|||
145893996|NCT01846273|526118853|FG001|Overall Study|Administrative problems|0|||
145893997|NCT01846273|526118854|FG002|Overall Study|Administrative problems|0|||
145893998|NCT01846273|526118852|FG000|Overall Study|Death|2|||
145893999|NCT01846273|526118853|FG001|Overall Study|Death|1|||
145894000|NCT01846273|526118854|FG002|Overall Study|Death|0|||
145894001|NCT01846273|526118852|FG000|Overall Study|Disease Progression|0|||
145894002|NCT01846273|526118853|FG001|Overall Study|Disease Progression|4|||
145894003|NCT01846273|526118854|FG002|Overall Study|Disease Progression|0|||
145894004|NCT01846273|526118852|FG000|Overall Study|Protocol Deviation|2|||
145894005|NCT01846273|526118853|FG001|Overall Study|Protocol Deviation|3|||
145894006|NCT01846273|526118854|FG002|Overall Study|Protocol Deviation|0|||
145894007|NCT01846273|526118852|FG000|Overall Study|Physician Decision|1|||
145894008|NCT01846273|526118853|FG001|Overall Study|Physician Decision|2|||
145894009|NCT01846273|526118854|FG002|Overall Study|Physician Decision|0|||
145894010|NCT02037165|526118855|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145894011|NCT02037165|526118856|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145894012|NCT02037165|526118857|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145894013|NCT02037165|526118858|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145894014|NCT02037165|526118859|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
145894015|NCT02220725|526118862|FG000|Overall Study|Lost to Follow-up|0|||
145894016|NCT02220725|526118863|FG001|Overall Study|Lost to Follow-up|0|||
145894017|NCT02220725|526118864|FG002|Overall Study|Lost to Follow-up|0|||
145894018|NCT02220725|526118865|FG003|Overall Study|Lost to Follow-up|1|||
145894019|NCT02220725|526118862|FG000|Overall Study|Withdrawal by Subject|0|||
145894020|NCT02220725|526118863|FG001|Overall Study|Withdrawal by Subject|0|||
145894021|NCT02220725|526118864|FG002|Overall Study|Withdrawal by Subject|0|||
145894022|NCT02220725|526118865|FG003|Overall Study|Withdrawal by Subject|1|||
145894023|NCT01673698|526118866|FG000|Overall Study|Lost to Follow-up|51|||
145894024|NCT01673698|526118867|FG001|Overall Study|Lost to Follow-up|13|||
145894025|NCT01297322|526118868|FG000|Overall Study|Lost to Follow-up|1|||
145894026|NCT01297322|526118869|FG001|Overall Study|Lost to Follow-up|0|||
145894027|NCT01297322|526118868|FG000|Overall Study|Withdrawal by Subject|0|||
145894028|NCT01297322|526118869|FG001|Overall Study|Withdrawal by Subject|1|||
145894029|NCT01297322|526118868|FG000|Overall Study|Protocol Violation|0|||
145894030|NCT01297322|526118869|FG001|Overall Study|Protocol Violation|3|||
145894031|NCT01583218|526118870|FG000|Overall Study|Withdrawal by Subject|43|||
145894032|NCT01583218|526118871|FG001|Overall Study|Withdrawal by Subject|29|||
145894033|NCT01583218|526118870|FG000|Overall Study|Death|206|||
145894034|NCT01583218|526118871|FG001|Overall Study|Death|211|||
146088179|NCT00686998|526841965|FG001|Overall Study|Withdrawal by Subject|1|||
146296337|NCT01472380|527600617|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
146296338|NCT03049735|527600618|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
146237502|NCT02401815|527382826|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237503|NCT02401815|527382827|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237504|NCT02401815|527382828|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237505|NCT02401815|527382829|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237506|NCT02401815|527382830|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237507|NCT02401815|527382831|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
146237508|NCT02401815|527382822|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
145894035|NCT01583218|526118870|FG000|Overall Study|Lost to Follow-up|11|||
145894036|NCT01583218|526118871|FG001|Overall Study|Lost to Follow-up|17|||
145894037|NCT01583218|526118870|FG000|Overall Study|Adverse event or serious adverse event|3|||
145894038|NCT01583218|526118871|FG001|Overall Study|Adverse event or serious adverse event|3|||
145894039|NCT01583218|526118870|FG000|Overall Study|Patient /Family decision|3|||
145894040|NCT01583218|526118871|FG001|Overall Study|Patient /Family decision|0|||
145894041|NCT01583218|526118870|FG000|Overall Study|Cannot contact patient directly|1|||
145894042|NCT01583218|526118871|FG001|Overall Study|Cannot contact patient directly|2|||
145894043|NCT01583218|526118870|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
145894044|NCT01583218|526118871|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
145894045|NCT01583218|526118870|FG000|Overall Study|Patient did not wish to attend visits|0|||
145894046|NCT01583218|526118871|FG001|Overall Study|Patient did not wish to attend visits|1|||
145894047|NCT01583218|526118870|FG000|Overall Study|Patient randomized but not dosed|17|||
145894048|NCT01583218|526118871|FG001|Overall Study|Patient randomized but not dosed|16|||
145894049|NCT01583218|526118870|FG000|Overall Study|Patient was assessed via phone in person|1|||
145894050|NCT01583218|526118871|FG001|Overall Study|Patient was assessed via phone in person|0|||
145894051|NCT01583218|526118870|FG000|Overall Study|Patient deemed ineligible after random|2|||
145894052|NCT01583218|526118871|FG001|Overall Study|Patient deemed ineligible after random|0|||
145894053|NCT01583218|526118870|FG000|Overall Study|Patient was early terminated from study|0|||
145894054|NCT01583218|526118871|FG001|Overall Study|Patient was early terminated from study|1|||
145894055|NCT01583218|526118870|FG000|Overall Study|Patient was randomized due to mistake|1|||
145894056|NCT01583218|526118871|FG001|Overall Study|Patient was randomized due to mistake|0|||
145894057|NCT01583218|526118870|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
145894058|NCT01583218|526118871|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
145894059|NCT01583218|526118870|FG000|Overall Study|Withdraw of consent on day of random|1|||
145894060|NCT01583218|526118871|FG001|Overall Study|Withdraw of consent on day of random|0|||
145894061|NCT02013375|526118874|FG000|Overall Study|Did not engraft|1|||
145894062|NCT02013375|526118874|FG000|Overall Study|Did not engraft|1|||
145894063|NCT00712985|526118875|FG000|Overall Study|1 withdrew prior to start of drug|1|||
145894064|NCT00712985|526118875|FG000|Overall Study|1 patient moved out of state|1|||
145894065|NCT00712985|526118875|FG000|Overall Study|Lack of Efficacy|3|||
145894066|NCT01663727|526118878|FG000|Overall Study|Death|161|||
145894067|NCT01663727|526118879|FG001|Overall Study|Death|155|||
145894068|NCT01663727|526118878|FG000|Overall Study|Lost to Follow-up|10|||
145894069|NCT01663727|526118879|FG001|Overall Study|Lost to Follow-up|8|||
145894070|NCT01663727|526118878|FG000|Overall Study|Withdrawal by Subject|18|||
145894071|NCT01663727|526118879|FG001|Overall Study|Withdrawal by Subject|25|||
145894072|NCT01663727|526118878|FG000|Overall Study|Study Terminated|51|||
145894073|NCT01663727|526118879|FG001|Overall Study|Study Terminated|50|||
145894074|NCT01663727|526118878|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
145894075|NCT01663727|526118879|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
145894076|NCT01663727|526118878|FG000|Overall Study|Withdrawal prior to dosing.|1|||
145894077|NCT01663727|526118879|FG001|Overall Study|Withdrawal prior to dosing.|0|||
145894078|NCT01902628|526118880|FG000|Overall Study|Withdrawal of participant's consent|7|||
145894079|NCT01902628|526118880|FG000|Overall Study|Adverse Event|41|||
145894080|NCT01902628|526118880|FG000|Overall Study|Lost to Follow-up|35|||
145894081|NCT00321828|526120339|FG000|Overall Study|Ineligible|3|||
145894082|NCT00321828|526120339|FG000|Overall Study|No follow up data|1|||
145894083|NCT02307266|526120340|FG000|Overall Study|Adverse Event|3|||
145894084|NCT02307266|526120341|FG001|Overall Study|Adverse Event|1|||
145894085|NCT02307266|526120342|FG002|Overall Study|Adverse Event|5|||
145894086|NCT02307266|526120340|FG000|Overall Study|Withdrawal by Subject|2|||
145894087|NCT02307266|526120341|FG001|Overall Study|Withdrawal by Subject|0|||
145894088|NCT02307266|526120342|FG002|Overall Study|Withdrawal by Subject|1|||
145894089|NCT02307266|526120340|FG000|Overall Study|Lost to Follow-up|3|||
145894090|NCT02307266|526120341|FG001|Overall Study|Lost to Follow-up|0|||
145894091|NCT02307266|526120342|FG002|Overall Study|Lost to Follow-up|0|||
145894092|NCT00858143|526120346|FG000|Overall Study|Adverse Event|16|||
145894093|NCT00858143|526120346|FG000|Overall Study|Lack of Efficacy|4|||
145894094|NCT00858143|526120346|FG000|Overall Study|Death|7|||
145894095|NCT00858143|526120346|FG000|Overall Study|Other|23|||
145894096|NCT03853148|526120348|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
146088180|NCT00686998|526841966|FG002|Overall Study|Withdrawal by Subject|2|||
145894097|NCT03853148|526120349|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
146088181|NCT00686998|526841964|FG000|Overall Study|Lack of Efficacy|7|||
146237509|NCT02401815|527382823|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237510|NCT02401815|527382824|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237511|NCT02401815|527382825|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
146237512|NCT02401815|527382826|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237513|NCT02401815|527382827|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237514|NCT02401815|527382828|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237515|NCT02401815|527382829|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145894098|NCT03853148|526120350|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
145894099|NCT03853148|526120351|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
145894100|NCT00059787|526120352|FG000|Overall Study|Adverse Event|13|||
145894101|NCT00059787|526120352|FG000|Overall Study|disease progression|2|||
145894102|NCT00059787|526120352|FG000|Overall Study|ineligible|1|||
145894103|NCT00059787|526120352|FG000|Overall Study|Other|4|||
145894104|NCT01248013|526120355|FG000|Overall Study|Withdrawal by Subject|14|||
145894105|NCT01388166|526120358|FG000|Overall Study|Adverse Event|16|||
145894106|NCT01388166|526120358|FG000|Overall Study|Lost to Follow-up|30|||
145894107|NCT01388166|526120358|FG000|Overall Study|Others than specified above|13|||
145894108|NCT00841906|526120359|FG000|Overall Study|Withdrawal by Subject|2|||
145894109|NCT00841906|526120360|FG001|Overall Study|Withdrawal by Subject|0|||
145894110|NCT01196078|526120365|FG000|Overall Study|Withdrawal by Subject|3|||
145894111|NCT01196078|526120366|FG001|Overall Study|Withdrawal by Subject|5|||
145894112|NCT01196078|526120365|FG000|Overall Study|Adverse Event|4|||
145894113|NCT01196078|526120366|FG001|Overall Study|Adverse Event|4|||
145894114|NCT01196078|526120365|FG000|Overall Study|Protocol Violation|2|||
145894115|NCT01196078|526120366|FG001|Overall Study|Protocol Violation|1|||
145894116|NCT01196078|526120365|FG000|Overall Study|Lack of Efficacy|17|||
145894117|NCT01196078|526120366|FG001|Overall Study|Lack of Efficacy|23|||
145894118|NCT01196078|526120365|FG000|Overall Study|Lost to Follow-up|1|||
145894119|NCT01196078|526120366|FG001|Overall Study|Lost to Follow-up|0|||
145894120|NCT01196078|526120365|FG000|Overall Study|Death|6|||
145894121|NCT01196078|526120366|FG001|Overall Study|Death|4|||
145894122|NCT02667288|526120367|FG000|Overall Study|Protocol Violation|5|||
145894123|NCT02667288|526120367|FG000|Overall Study|Lost to Follow-up|3|||
145894124|NCT02667288|526120367|FG000|Overall Study|Withdrawal by Subject|5|||
145894125|NCT00127036|526120368|FG000|Overall Study|Insufficient Data for Analysis|6|||
145894126|NCT00127036|526120369|FG001|Overall Study|Insufficient Data for Analysis|11|||
145894127|NCT00127036|526120368|FG000|Overall Study|Screen Failure|2|||
145894128|NCT00127036|526120369|FG001|Overall Study|Screen Failure|0|||
145894129|NCT04397445|526120372|FG000|Overall Study|Withdrawal by Subject|1|||
145894130|NCT04397445|526120373|FG001|Overall Study|Withdrawal by Subject|0|||
145894131|NCT04397445|526120374|FG002|Overall Study|Withdrawal by Subject|0|||
145894132|NCT04397445|526120375|FG003|Overall Study|Withdrawal by Subject|0|||
145894133|NCT01429051|526120376|FG000|Titration Phase|Death|1|||
145894134|NCT01429051|526120376|FG000|Titration Phase|Withdrawal by Subject|7|||
145894135|NCT01429051|526120376|FG000|Titration Phase|Physician Decision|1|||
145894136|NCT01429051|526120376|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
145894137|NCT01429051|526120376|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
145894138|NCT01429051|526120376|FG000|Efficacy Phase|Adverse Event|1|||
145894139|NCT01429051|526120376|FG000|Efficacy Phase|Death|1|||
145894140|NCT01429051|526120376|FG000|Tolerability Phase|Death|5|||
145894141|NCT01429051|526120376|FG000|Tolerability Phase|Adverse Event|2|||
145894142|NCT01429051|526120376|FG000|Tolerability Phase|Withdrawal by Subject|5|||
145894143|NCT01429051|526120376|FG000|Tolerability Phase|Physician Decision|1|||
145894144|NCT01429051|526120376|FG000|Tolerability Phase|Other|2|||
145894145|NCT03921151|526120377|FG000|Overall Study|Withdrawal by Subject|11|||
145894146|NCT03921151|526120378|FG001|Overall Study|Withdrawal by Subject|16|||
145894147|NCT00857792|526120380|FG000|Overall Study|inadequate image quality for analysis|12|||
145894148|NCT01797835|526120389|FG000|Overall Study|Lost to Follow-up|31|||
145894149|NCT01797835|526120390|FG001|Overall Study|Lost to Follow-up|27|||
145894150|NCT03001219|526120391|FG000|Proof of Concept|Study Termination by Sponsor|0|||
145894151|NCT03001219|526120392|FG001|Proof of Concept|Study Termination by Sponsor|1|||
145894152|NCT03001219|526120391|FG000|Proof of Concept|Withdrawal by Subject|0|||
145894153|NCT03001219|526120392|FG001|Proof of Concept|Withdrawal by Subject|4|||
145894154|NCT03001219|526120391|FG000|Proof of Concept|Protocol Deviation|0|||
145894155|NCT03001219|526120392|FG001|Proof of Concept|Protocol Deviation|1|||
145894156|NCT03001219|526120391|FG000|Proof of Concept|Adverse Event|1|||
145894157|NCT03001219|526120392|FG001|Proof of Concept|Adverse Event|1|||
145894158|NCT03001219|526120391|FG000|Proof of Concept|Physician Decision|1|||
145894159|NCT03001219|526120392|FG001|Proof of Concept|Physician Decision|0|||
145894160|NCT03001219|526120391|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
145894161|NCT03001219|526120392|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
145894162|NCT03001219|526120391|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
145894163|NCT03001219|526120392|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
145894164|NCT03001219|526120391|FG000|Extension Period Analysis|Physician Decision|0|||
145894165|NCT03001219|526120392|FG001|Extension Period Analysis|Physician Decision|1|||
145894166|NCT03001219|526120391|FG000|Extension Period Analysis|Adverse Event|1|||
145894167|NCT03001219|526120392|FG001|Extension Period Analysis|Adverse Event|1|||
145894168|NCT03001219|526120391|FG000|Extension Period Analysis|Protocol Deviation|0|||
145894169|NCT03001219|526120392|FG001|Extension Period Analysis|Protocol Deviation|1|||
145894170|NCT03001219|526120391|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
145894171|NCT03001219|526120392|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
145894172|NCT01403064|526120393|FG000|Overall Study|Death|0|||
145894173|NCT01403064|526120394|FG001|Overall Study|Death|0|||
145894174|NCT01403064|526120395|FG002|Overall Study|Death|1|||
145894175|NCT01403064|526120396|FG003|Overall Study|Death|1|||
145894176|NCT01403064|526120393|FG000|Overall Study|Withdrawal by Subject|0|||
146237516|NCT02401815|527382830|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237517|NCT02401815|527382831|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
146237518|NCT02401815|527382822|FG000|Dose Escalation (up to 670 Days)|Death|1|||
146237519|NCT02401815|527382823|FG001|Dose Escalation (up to 670 Days)|Death|2|||
145894177|NCT01403064|526120394|FG001|Overall Study|Withdrawal by Subject|0|||
145894178|NCT01403064|526120395|FG002|Overall Study|Withdrawal by Subject|1|||
145894179|NCT01403064|526120396|FG003|Overall Study|Withdrawal by Subject|1|||
145894180|NCT01403064|526120393|FG000|Overall Study|Other|1|||
145894181|NCT01403064|526120394|FG001|Overall Study|Other|0|||
145894182|NCT01403064|526120395|FG002|Overall Study|Other|2|||
145894183|NCT01403064|526120396|FG003|Overall Study|Other|1|||
145894184|NCT02528123|526120397|FG000|Overall Study|Lost to Follow-up|1|||
146237520|NCT02401815|527382824|FG002|Dose Escalation (up to 670 Days)|Death|3|||
145894185|NCT03760250|526120398|FG000|Overall Study|Withdrawal by Subject|1|||
145894186|NCT03760250|526120398|FG000|Overall Study|Physician Decision|1|||
145894187|NCT03733210|526120399|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
145894188|NCT03733210|526120400|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
145894189|NCT04421586|526120410|FG000|Overall Study|Death|0|||
145894190|NCT04421586|526120411|FG001|Overall Study|Death|1|||
145894191|NCT04421586|526120410|FG000|Overall Study|Lost to Follow-up|2|||
145894192|NCT04421586|526120411|FG001|Overall Study|Lost to Follow-up|2|||
145894193|NCT04421586|526120410|FG000|Overall Study|Withdrawn by PI|1|||
145894194|NCT04421586|526120411|FG001|Overall Study|Withdrawn by PI|0|||
145894195|NCT04421586|526120410|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
145894196|NCT04421586|526120411|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
145894197|NCT02963441|526120412|FG000|Overall Study|Protocol violation or withdrawn|8|||
145894198|NCT02963441|526120412|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
145894199|NCT02963441|526120412|FG000|Overall Study|IDx-DR insufficient quality|33|||
145894200|NCT04688931|526120413|FG000|Overall Study|Adverse Event|4|||
145894201|NCT04688931|526120414|FG001|Overall Study|Adverse Event|1|||
145894202|NCT04688931|526120413|FG000|Overall Study|Withdrawal by Subject|5|||
145894203|NCT04688931|526120414|FG001|Overall Study|Withdrawal by Subject|16|||
145894204|NCT04688931|526120413|FG000|Overall Study|Physician Decision|3|||
145894205|NCT04688931|526120414|FG001|Overall Study|Physician Decision|5|||
145894206|NCT04688931|526120413|FG000|Overall Study|Noncompliance|0|||
145894207|NCT04688931|526120414|FG001|Overall Study|Noncompliance|1|||
145894208|NCT04688931|526120413|FG000|Overall Study|Lost to Follow-up|1|||
145894209|NCT04688931|526120414|FG001|Overall Study|Lost to Follow-up|3|||
145894210|NCT04688931|526120413|FG000|Overall Study|Randomization Error|3|||
145894211|NCT04688931|526120414|FG001|Overall Study|Randomization Error|0|||
145894212|NCT04688931|526120413|FG000|Overall Study|Not Eligible|1|||
145894213|NCT04688931|526120414|FG001|Overall Study|Not Eligible|3|||
145894214|NCT04688931|526120413|FG000|Overall Study|Disease Progression|0|||
145894215|NCT04688931|526120414|FG001|Overall Study|Disease Progression|2|||
145894216|NCT04688931|526120413|FG000|Overall Study|Sponsor Requirement|1|||
146237521|NCT02401815|527382825|FG003|Dose Escalation (up to 670 Days)|Death|5|||
146237522|NCT02401815|527382826|FG004|Dose Escalation (up to 670 Days)|Death|4|||
146237523|NCT02401815|527382827|FG005|Dose Escalation (up to 670 Days)|Death|0|||
145894217|NCT04688931|526120414|FG001|Overall Study|Sponsor Requirement|1|||
146237524|NCT02401815|527382828|FG006|Dose Escalation (up to 670 Days)|Death|0|||
145894218|NCT04688931|526120413|FG000|Overall Study|Other Reason|1|||
145894219|NCT04688931|526120414|FG001|Overall Study|Other Reason|2|||
145894220|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Adverse Event|9|||
145894221|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Adverse Event|4|||
145894222|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Adverse Event|5|||
145894223|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Adverse Event|9|||
145894224|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Adverse Event|8|||
145894225|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Adverse Event|0|||
145894226|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Adverse Event|0|||
145894227|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
145894228|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
145894229|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
145894230|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
145894231|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
145894232|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
145894233|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
145894234|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Death|1|||
145894235|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Death|1|||
145894236|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Death|1|||
145894237|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Death|1|||
145894238|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Death|0|||
145894239|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Death|0|||
145894240|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Death|0|||
145894241|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
145894242|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
145894243|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
145894244|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
146237525|NCT02401815|527382829|FG007|Dose Escalation (up to 670 Days)|Death|0|||
145894245|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
146237526|NCT02401815|527382830|FG008|Dose Escalation (up to 670 Days)|Death|0|||
145894246|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
145894247|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
145894248|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145894249|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
146088182|NCT00686998|526841965|FG001|Overall Study|Lack of Efficacy|5|||
145894250|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
145894251|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
146088183|NCT00686998|526841966|FG002|Overall Study|Lack of Efficacy|0|||
145894252|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145894253|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145894254|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145894255|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
145894256|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
145894257|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
145894258|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
145894259|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
145894260|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
145894261|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
145894262|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Other|2|||
145894263|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Other|9|||
145894264|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Other|9|||
145894265|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Other|3|||
145894266|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Other|2|||
145894267|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Other|0|||
145894268|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Other|0|||
145894269|NCT00361335|526120415|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
145894270|NCT00361335|526120416|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
145894271|NCT00361335|526120417|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
145894272|NCT00361335|526120418|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
145894273|NCT00361335|526120419|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
145894274|NCT00361335|526120420|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
145894275|NCT00361335|526120421|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
145894276|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
145894277|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
145894278|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
145894279|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
145894280|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
145894281|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
145894282|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
145894283|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145894284|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145894285|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145894286|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145894287|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145894288|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145894289|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145894290|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Death|0|||
145894291|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Death|0|||
145894292|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Death|0|||
145894293|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Death|0|||
145894294|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Death|0|||
145894295|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Death|0|||
145894296|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Death|1|||
145894297|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145894298|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145894299|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145894300|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145894301|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145894302|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145894303|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145894304|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Other|1|||
145894305|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Other|0|||
145894306|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Other|0|||
145894307|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Other|1|||
145894308|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Other|0|||
145894309|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Other|1|||
145894310|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Other|2|||
145894311|NCT00361335|526120415|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145894312|NCT00361335|526120416|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145894313|NCT00361335|526120417|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
145894314|NCT00361335|526120418|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145894315|NCT00361335|526120419|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145894316|NCT00361335|526120420|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145894317|NCT00361335|526120421|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
145894318|NCT04505293|526120422|FG000|Overall Study|Lost to Follow-up|2|||
145894319|NCT04505293|526120422|FG000|Overall Study|Withdrawal by Subject|6|||
145894320|NCT04505293|526120422|FG000|Overall Study|CT scan unreadable|277|||
145894321|NCT00506129|526120423|FG000|Overall Study|Disease Progression/Relapse|15|||
145894322|NCT00506129|526120423|FG000|Overall Study|Death|7|||
145894323|NCT01968694|526120424|FG000|Washout (1 Month)|Lost to Follow-up|0|||
145894324|NCT01968694|526120425|FG001|Washout (1 Month)|Lost to Follow-up|1|||
145894325|NCT01400919|526120429|FG000|Overall Study|Withdrawal by Subject|4|||
145894326|NCT01400919|526120429|FG000|Overall Study|Lost to Follow-up|2|||
145894327|NCT01400919|526120429|FG000|Overall Study|Missed visit|2|||
145894328|NCT00251719|526120430|FG000|Overall Study|Adverse Event|14|||
145894329|NCT00251719|526120431|FG001|Overall Study|Adverse Event|8|||
145894330|NCT00251719|526120432|FG002|Overall Study|Adverse Event|7|||
145894331|NCT00251719|526120430|FG000|Overall Study|Protocol Violation|1|||
145894332|NCT00251719|526120431|FG001|Overall Study|Protocol Violation|1|||
145894333|NCT00251719|526120432|FG002|Overall Study|Protocol Violation|1|||
145894334|NCT00251719|526120430|FG000|Overall Study|Lost to Follow-up|5|||
145894335|NCT00251719|526120431|FG001|Overall Study|Lost to Follow-up|11|||
145894336|NCT00251719|526120432|FG002|Overall Study|Lost to Follow-up|8|||
145894337|NCT00251719|526120430|FG000|Overall Study|Withdrawal by Subject|14|||
145894338|NCT00251719|526120431|FG001|Overall Study|Withdrawal by Subject|12|||
145894339|NCT00251719|526120432|FG002|Overall Study|Withdrawal by Subject|11|||
145894340|NCT00251719|526120430|FG000|Overall Study|Lack of Efficacy|2|||
145894341|NCT00251719|526120431|FG001|Overall Study|Lack of Efficacy|1|||
145894342|NCT00251719|526120432|FG002|Overall Study|Lack of Efficacy|0|||
145894343|NCT00251719|526120430|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
145894344|NCT00251719|526120431|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
145894345|NCT00251719|526120432|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
145894346|NCT00251719|526120430|FG000|Overall Study|Investigator decision|1|||
145894347|NCT00251719|526120431|FG001|Overall Study|Investigator decision|1|||
145894348|NCT00251719|526120432|FG002|Overall Study|Investigator decision|0|||
145894349|NCT00251719|526120430|FG000|Overall Study|Noncompliance|2|||
145894350|NCT00251719|526120431|FG001|Overall Study|Noncompliance|3|||
145894351|NCT00251719|526120432|FG002|Overall Study|Noncompliance|1|||
145894352|NCT00251719|526120430|FG000|Overall Study|Barrett's esophagus|2|||
145894353|NCT00251719|526120431|FG001|Overall Study|Barrett's esophagus|2|||
145894354|NCT00251719|526120432|FG002|Overall Study|Barrett's esophagus|0|||
145894355|NCT02923674|526120435|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
146237527|NCT02401815|527382831|FG009|Dose Escalation (up to 670 Days)|Death|0|||
146237528|NCT02401815|527382822|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237529|NCT02401815|527382823|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
146237530|NCT02401815|527382824|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237531|NCT02401815|527382825|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145894356|NCT02923674|526120436|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
145894357|NCT02923674|526120437|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
145894358|NCT02923674|526120435|FG000|Overall Study|Lost to Follow-up|7|||
145894359|NCT02923674|526120436|FG001|Overall Study|Lost to Follow-up|12|||
145894360|NCT02923674|526120437|FG002|Overall Study|Lost to Follow-up|7|||
145894361|NCT02923674|526120435|FG000|Overall Study|Problem with intervention|2|||
145894362|NCT02923674|526120436|FG001|Overall Study|Problem with intervention|2|||
145894363|NCT02923674|526120437|FG002|Overall Study|Problem with intervention|1|||
145972004|NCT00984867|526410491|FG001|Overall Study|Withdrawal by Subject|4|||
145972005|NCT00984867|526410490|FG000|Overall Study|Lost to Follow-up|3|||
145972006|NCT00984867|526410491|FG001|Overall Study|Lost to Follow-up|4|||
145972007|NCT00984867|526410490|FG000|Overall Study|Poor/non-compliance|0|||
145972008|NCT00984867|526410491|FG001|Overall Study|Poor/non-compliance|1|||
145972009|NCT00984867|526410490|FG000|Overall Study|Subject no longer meets study criteria|1|||
145972010|NCT00984867|526410491|FG001|Overall Study|Subject no longer meets study criteria|1|||
145972011|NCT00984867|526410490|FG000|Overall Study|site closing|1|||
145972012|NCT00984867|526410491|FG001|Overall Study|site closing|0|||
145972013|NCT00984867|526410490|FG000|Overall Study|lack of efficacy and subject compliance|1|||
145972014|NCT00984867|526410491|FG001|Overall Study|lack of efficacy and subject compliance|0|||
145972015|NCT06057064|526410492|FG000|Overall Study|Death|2|||
145972016|NCT06057064|526410493|FG001|Overall Study|Death|0|||
145972017|NCT06057064|526410492|FG000|Overall Study|Physician Decision|1|||
145972018|NCT06057064|526410493|FG001|Overall Study|Physician Decision|0|||
145972019|NCT06057064|526410492|FG000|Overall Study|Withdrawal by Subject|1|||
146237532|NCT02401815|527382826|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
145972020|NCT06057064|526410493|FG001|Overall Study|Withdrawal by Subject|1|||
145972021|NCT01155141|526410501|FG000|Overall Study|Withdrawal by Subject|1|||
145972022|NCT01155141|526410501|FG000|Overall Study|Screen Failure|1|||
145972023|NCT00785629|526410503|FG000|Overall Study|Adverse Event|2|||
145972024|NCT00785629|526410504|FG001|Overall Study|Adverse Event|1|||
146088184|NCT00686998|526841964|FG000|Overall Study|Other|0|||
145894364|NCT02923674|526120435|FG000|Overall Study|Adverse Event|3|||
145894365|NCT02923674|526120436|FG001|Overall Study|Adverse Event|1|||
145894366|NCT02923674|526120437|FG002|Overall Study|Adverse Event|1|||
145894367|NCT02923674|526120435|FG000|Overall Study|Withdrawal by Subject|2|||
145894368|NCT02923674|526120436|FG001|Overall Study|Withdrawal by Subject|2|||
145894369|NCT02923674|526120437|FG002|Overall Study|Withdrawal by Subject|2|||
145972025|NCT00785629|526410505|FG002|Overall Study|Adverse Event|1|||
145972026|NCT00785629|526410506|FG003|Overall Study|Adverse Event|5|||
146088185|NCT00686998|526841965|FG001|Overall Study|Other|0|||
145972027|NCT00785629|526410503|FG000|Overall Study|Protocol Violation|1|||
145972028|NCT00785629|526410504|FG001|Overall Study|Protocol Violation|2|||
145972029|NCT00785629|526410505|FG002|Overall Study|Protocol Violation|4|||
145972030|NCT00785629|526410506|FG003|Overall Study|Protocol Violation|5|||
145972031|NCT00785629|526410503|FG000|Overall Study|administrative decision|5|||
145972032|NCT00785629|526410504|FG001|Overall Study|administrative decision|1|||
145972033|NCT00785629|526410505|FG002|Overall Study|administrative decision|3|||
145972034|NCT00785629|526410506|FG003|Overall Study|administrative decision|4|||
145972035|NCT00785629|526410503|FG000|Overall Study|Withdrawal by Subject|0|||
145972036|NCT00785629|526410504|FG001|Overall Study|Withdrawal by Subject|1|||
145972037|NCT00785629|526410505|FG002|Overall Study|Withdrawal by Subject|2|||
145972038|NCT00785629|526410506|FG003|Overall Study|Withdrawal by Subject|2|||
145972039|NCT00851591|526410508|FG000|Overall Study|Withdrawal by Subject|2|||
145972040|NCT00851591|526410509|FG001|Overall Study|Withdrawal by Subject|0|||
145972041|NCT01898130|526410512|FG000|Treatment|Withdrawal by Subject|2|||
145972042|NCT01898130|526410512|FG000|Treatment|Progressive Disease|4|||
145972043|NCT01898130|526410512|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
145972044|NCT00920816|526410513|FG000|Overall Study|Death|116|||
145972045|NCT00920816|526410514|FG001|Overall Study|Death|63|||
145972046|NCT00920816|526410515|FG002|Overall Study|Death|8|||
145972047|NCT00920816|526410516|FG003|Overall Study|Death|3|||
145972048|NCT00920816|526410513|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
145972049|NCT00920816|526410514|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
145972050|NCT00920816|526410515|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
145972051|NCT00920816|526410516|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
145972052|NCT00920816|526410513|FG000|Overall Study|Global deterioration of health status|2|||
145972053|NCT00920816|526410514|FG001|Overall Study|Global deterioration of health status|0|||
145972054|NCT00920816|526410515|FG002|Overall Study|Global deterioration of health status|0|||
145972055|NCT00920816|526410516|FG003|Overall Study|Global deterioration of health status|0|||
145972056|NCT00920816|526410513|FG000|Overall Study|Objective progression or relapse|6|||
145972057|NCT00920816|526410514|FG001|Overall Study|Objective progression or relapse|2|||
145972058|NCT00920816|526410515|FG002|Overall Study|Objective progression or relapse|0|||
145972059|NCT00920816|526410516|FG003|Overall Study|Objective progression or relapse|0|||
145972060|NCT00920816|526410513|FG000|Overall Study|Other|26|||
145972061|NCT00920816|526410514|FG001|Overall Study|Other|15|||
145972062|NCT00920816|526410515|FG002|Overall Study|Other|1|||
146088186|NCT00686998|526841966|FG002|Overall Study|Other|1|||
146088187|NCT00686998|526841964|FG000|Overall Study|Safety Reasons|1|||
145972063|NCT00920816|526410516|FG003|Overall Study|Other|2|||
145972064|NCT00920816|526410513|FG000|Overall Study|Lost to Follow-up|11|||
145972065|NCT00920816|526410514|FG001|Overall Study|Lost to Follow-up|2|||
145972066|NCT00920816|526410515|FG002|Overall Study|Lost to Follow-up|0|||
145894370|NCT00846521|526120440|FG000|Overall Study|Withdrawal by Subject|5|||
145894371|NCT00846521|526120440|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
145894372|NCT00846521|526120440|FG000|Overall Study|Protocol Violation|1|||
145894373|NCT02792959|526120441|FG000|Overall Study|Protocol Violation|1|||
145894374|NCT02408068|526120442|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
145894375|NCT02408068|526120443|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
145894376|NCT02408068|526120444|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
145894377|NCT02408068|526120445|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
145894378|NCT02408068|526120446|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
145894379|NCT02408068|526120447|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
145894380|NCT00003875|526120451|FG000|Overall Study|Screen Failed|1|||
145894381|NCT00886288|526120452|FG000|Overall Study|no respect of the 12 weeks period|657|||
145894382|NCT00886288|526120453|FG001|Overall Study|no respect of the 12 weeks period|227|||
145894383|NCT00886288|526120452|FG000|Overall Study|Lost to Follow-up|86|||
145894384|NCT00886288|526120453|FG001|Overall Study|Lost to Follow-up|0|||
145894385|NCT02335983|526120454|FG000|Overall Study|Sponsor Decision|0|||
145894386|NCT02335983|526120455|FG001|Overall Study|Sponsor Decision|0|||
145894387|NCT02335983|526120456|FG002|Overall Study|Sponsor Decision|1|||
145894388|NCT02335983|526120457|FG003|Overall Study|Sponsor Decision|1|||
145894389|NCT02335983|526120458|FG004|Overall Study|Sponsor Decision|0|||
145894390|NCT02335983|526120459|FG005|Overall Study|Sponsor Decision|1|||
146237533|NCT02401815|527382827|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237534|NCT02401815|527382828|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237535|NCT02401815|527382829|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237536|NCT02401815|527382830|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237537|NCT02401815|527382831|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
146237538|NCT02401815|527382822|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
145894391|NCT02335983|526120454|FG000|Overall Study|Withdrawal by Subject|3|||
145894392|NCT02335983|526120455|FG001|Overall Study|Withdrawal by Subject|2|||
145894393|NCT02335983|526120456|FG002|Overall Study|Withdrawal by Subject|2|||
145894394|NCT02335983|526120457|FG003|Overall Study|Withdrawal by Subject|1|||
145894395|NCT02335983|526120458|FG004|Overall Study|Withdrawal by Subject|3|||
145894396|NCT02335983|526120459|FG005|Overall Study|Withdrawal by Subject|9|||
145894397|NCT02335983|526120454|FG000|Overall Study|Death|0|||
145894398|NCT02335983|526120455|FG001|Overall Study|Death|0|||
145894399|NCT02335983|526120456|FG002|Overall Study|Death|2|||
145894400|NCT02335983|526120457|FG003|Overall Study|Death|0|||
145894401|NCT02335983|526120458|FG004|Overall Study|Death|0|||
145894402|NCT02335983|526120459|FG005|Overall Study|Death|0|||
145894403|NCT02335983|526120454|FG000|Overall Study|Lost to Follow-up|0|||
145894404|NCT02335983|526120455|FG001|Overall Study|Lost to Follow-up|0|||
145894405|NCT02335983|526120456|FG002|Overall Study|Lost to Follow-up|0|||
145894406|NCT02335983|526120457|FG003|Overall Study|Lost to Follow-up|0|||
145894407|NCT02335983|526120458|FG004|Overall Study|Lost to Follow-up|0|||
145894408|NCT02335983|526120459|FG005|Overall Study|Lost to Follow-up|1|||
145894409|NCT02335983|526120454|FG000|Overall Study|Protocol Specified Criteria|5|||
145894410|NCT02335983|526120455|FG001|Overall Study|Protocol Specified Criteria|7|||
145894411|NCT02335983|526120456|FG002|Overall Study|Protocol Specified Criteria|27|||
145894412|NCT02335983|526120457|FG003|Overall Study|Protocol Specified Criteria|7|||
145894413|NCT02335983|526120458|FG004|Overall Study|Protocol Specified Criteria|5|||
145894414|NCT02335983|526120459|FG005|Overall Study|Protocol Specified Criteria|21|||
145894415|NCT03127644|526120460|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145894416|NCT03127644|526120461|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145894417|NCT03127644|526120462|FG002|Overall Study|Study-specific withdrawal criteria|2|||
145894418|NCT04700280|526120467|FG000|Overall Study|Adverse Event|4|||
145894419|NCT04700280|526120468|FG001|Overall Study|Adverse Event|0|||
145894420|NCT04700280|526120467|FG000|Overall Study|Lack of Efficacy|1|||
145894421|NCT04700280|526120468|FG001|Overall Study|Lack of Efficacy|0|||
145894422|NCT04700280|526120467|FG000|Overall Study|Study terminated by sponsor|5|||
145894423|NCT04700280|526120468|FG001|Overall Study|Study terminated by sponsor|3|||
145894424|NCT04700280|526120467|FG000|Overall Study|Other than specified|1|||
145894425|NCT04700280|526120468|FG001|Overall Study|Other than specified|0|||
145894426|NCT02093221|526120471|FG000|Overall Study|Adverse Event|1|||
145894427|NCT02093221|526120472|FG001|Overall Study|Adverse Event|0|||
145894428|NCT02093221|526120473|FG002|Overall Study|Adverse Event|0|||
145894429|NCT02093221|526120474|FG003|Overall Study|Adverse Event|0|||
145894430|NCT02093221|526120475|FG004|Overall Study|Adverse Event|0|||
146237539|NCT02401815|527382823|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146237540|NCT02401815|527382824|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145894431|NCT02093221|526120471|FG000|Overall Study|Withdrawal by Subject|1|||
145894432|NCT02093221|526120472|FG001|Overall Study|Withdrawal by Subject|1|||
145894433|NCT02093221|526120473|FG002|Overall Study|Withdrawal by Subject|4|||
145894434|NCT02093221|526120474|FG003|Overall Study|Withdrawal by Subject|1|||
145894435|NCT02093221|526120475|FG004|Overall Study|Withdrawal by Subject|1|||
145894436|NCT02093221|526120471|FG000|Overall Study|Lost to Follow-up|2|||
145894437|NCT02093221|526120472|FG001|Overall Study|Lost to Follow-up|0|||
146237541|NCT02401815|527382825|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146237542|NCT02401815|527382826|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
146237543|NCT02401815|527382827|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145894438|NCT02093221|526120473|FG002|Overall Study|Lost to Follow-up|1|||
145894439|NCT02093221|526120474|FG003|Overall Study|Lost to Follow-up|1|||
145894440|NCT02093221|526120475|FG004|Overall Study|Lost to Follow-up|0|||
145894441|NCT02093221|526120471|FG000|Overall Study|Death|0|||
145894442|NCT02093221|526120472|FG001|Overall Study|Death|1|||
145894443|NCT02093221|526120473|FG002|Overall Study|Death|0|||
145894444|NCT02093221|526120474|FG003|Overall Study|Death|0|||
145894445|NCT02093221|526120475|FG004|Overall Study|Death|0|||
145894446|NCT02093221|526120471|FG000|Overall Study|Protocol Violation|0|||
145894447|NCT02093221|526120472|FG001|Overall Study|Protocol Violation|1|||
145894448|NCT02093221|526120473|FG002|Overall Study|Protocol Violation|0|||
145894449|NCT02093221|526120474|FG003|Overall Study|Protocol Violation|0|||
145894450|NCT02093221|526120475|FG004|Overall Study|Protocol Violation|0|||
145894451|NCT02093221|526120471|FG000|Overall Study|Study termination|6|||
145894452|NCT02093221|526120472|FG001|Overall Study|Study termination|5|||
145894453|NCT02093221|526120473|FG002|Overall Study|Study termination|4|||
145894454|NCT02093221|526120474|FG003|Overall Study|Study termination|6|||
145894455|NCT02093221|526120475|FG004|Overall Study|Study termination|7|||
145894456|NCT00257920|526120476|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
145894457|NCT00257920|526120477|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
145894458|NCT00257920|526120476|FG000|Period: Second Intervention|Other|2|||
145894459|NCT00257920|526120477|FG001|Period: Second Intervention|Other|1|||
145894460|NCT00770692|526120478|FG000|Overall Study|Withdrawal by Subject|7|||
145894461|NCT00770692|526120479|FG001|Overall Study|Withdrawal by Subject|9|||
145894462|NCT00770692|526120480|FG002|Overall Study|Withdrawal by Subject|9|||
145894463|NCT00770692|526120481|FG003|Overall Study|Withdrawal by Subject|6|||
145894464|NCT00770692|526120478|FG000|Overall Study|Adverse Event|3|||
145894465|NCT00770692|526120479|FG001|Overall Study|Adverse Event|0|||
145894466|NCT00770692|526120480|FG002|Overall Study|Adverse Event|4|||
145894467|NCT00770692|526120481|FG003|Overall Study|Adverse Event|4|||
145894468|NCT00770692|526120478|FG000|Overall Study|Investigator judgment|2|||
145894469|NCT00770692|526120479|FG001|Overall Study|Investigator judgment|0|||
145894470|NCT00770692|526120480|FG002|Overall Study|Investigator judgment|1|||
145894471|NCT00770692|526120481|FG003|Overall Study|Investigator judgment|1|||
145894472|NCT03629028|526120482|FG000|Overall Study|Lost to Follow-up|26|||
145894473|NCT03629028|526120483|FG001|Overall Study|Lost to Follow-up|23|||
145894474|NCT03629028|526120482|FG000|Overall Study|Pregnancy|4|||
145894475|NCT03629028|526120483|FG001|Overall Study|Pregnancy|2|||
145894476|NCT03629028|526120482|FG000|Overall Study|intolerance to examination|2|||
145894477|NCT03629028|526120483|FG001|Overall Study|intolerance to examination|0|||
145894478|NCT02687360|526120484|FG000|Overall Study|Withdrawal by Subject|3|||
145894479|NCT02687360|526120485|FG001|Overall Study|Withdrawal by Subject|0|||
145894480|NCT04932941|526120486|FG000|Overall Study|Lost to Follow-up|3|||
145894481|NCT04932941|526120487|FG001|Overall Study|Lost to Follow-up|1|||
145894482|NCT04932941|526120486|FG000|Overall Study|Withdrawal by Subject|7|||
145894483|NCT04932941|526120487|FG001|Overall Study|Withdrawal by Subject|4|||
145894484|NCT04932941|526120486|FG000|Overall Study|Other|4|||
146237544|NCT02401815|527382828|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145894485|NCT04932941|526120487|FG001|Overall Study|Other|2|||
145894486|NCT05069155|526120488|FG000|Overall Study|Withdrawal by Subject|1|||
145894487|NCT05069155|526120489|FG001|Overall Study|Withdrawal by Subject|3|||
145894488|NCT01366443|526120490|FG000|Overall Study|Lost to Follow-up|2|||
145894489|NCT01366443|526120490|FG000|Overall Study|Under 18 yo|1|||
145894490|NCT00731549|526120491|FG000|Overall Study|Lost to Follow-up|19|||
145894491|NCT00731549|526120491|FG000|Overall Study|Met withdrawal criteria|24|||
145894492|NCT00731549|526120491|FG000|Overall Study|Physician Decision|16|||
145894493|NCT00731549|526120491|FG000|Overall Study|Withdrawal by Subject|89|||
145894494|NCT00731549|526120491|FG000|Overall Study|Protocol deviation|1|||
145894495|NCT00731549|526120491|FG000|Overall Study|Adverse Event|31|||
145894496|NCT00731549|526120491|FG000|Overall Study|Lack of efficacy with AE|37|||
145894497|NCT00731549|526120491|FG000|Overall Study|Lack of efficacy without AE|6|||
145894498|NCT00588640|526120492|FG000|Overall Study|Physician Decision|1|||
145894499|NCT00588640|526120492|FG000|Overall Study|Ineligible Patient|1|||
145894500|NCT01111019|526120493|FG000|Overall Study|Withdrew Prematurely|2|||
145894501|NCT01111019|526120493|FG000|Overall Study|Other|1|||
145894502|NCT01293539|526121648|FG000|Overall Study|Physician Decision|1|||
145894503|NCT00891371|526121649|FG000|Pre-assignment|Inclusion/exclusion|5|||
145894504|NCT00891371|526121649|FG000|Pre-assignment|Consent withdrawal|1|||
145894505|NCT00891371|526121649|FG000|Treatment|Lack of Efficacy|5|||
145894506|NCT00891371|526121649|FG000|Treatment|Adverse Event|2|||
145894507|NCT00891371|526121649|FG000|Treatment|Death|1|||
145894508|NCT00891371|526121649|FG000|Treatment|Lost to Follow-up|1|||
145894509|NCT02836496|526121650|FG000|Overall Study|Adverse Event|2|||
145894510|NCT02836496|526121651|FG001|Overall Study|Adverse Event|1|||
145894511|NCT02836496|526121650|FG000|Overall Study|Withdrawal by Subject|0|||
145894512|NCT02836496|526121651|FG001|Overall Study|Withdrawal by Subject|1|||
145894513|NCT03914950|526121652|FG000|Overall Study|Physician Decision|54|||
145894514|NCT03201250|526121659|FG000|Overall Study|screen failures|3|||
145894515|NCT03201250|526121660|FG001|Overall Study|screen failures|0|||
145894516|NCT03201250|526121661|FG002|Overall Study|screen failures|0|||
145894517|NCT01780987|526121662|FG000|Overall Study|Adverse Event|0|||
145894518|NCT01780987|526121663|FG001|Overall Study|Adverse Event|4|||
145894519|NCT01780987|526121662|FG000|Overall Study|Withdrawal by Subject|2|||
145894520|NCT01780987|526121663|FG001|Overall Study|Withdrawal by Subject|0|||
145894521|NCT01780987|526121662|FG000|Overall Study|Request of Changing Hospital|0|||
145894522|NCT01780987|526121663|FG001|Overall Study|Request of Changing Hospital|1|||
145894523|NCT01780987|526121662|FG000|Overall Study|Changing Residence|1|||
145894524|NCT01780987|526121663|FG001|Overall Study|Changing Residence|0|||
145894525|NCT01780987|526121662|FG000|Overall Study|Not Receiving any Study Medication|0|||
145894526|NCT01780987|526121663|FG001|Overall Study|Not Receiving any Study Medication|1|||
145894527|NCT04168190|526121664|FG000|Overall Study|Lost to Follow-up|0|||
145894528|NCT04168190|526121665|FG001|Overall Study|Lost to Follow-up|1|||
145894529|NCT04168190|526121666|FG002|Overall Study|Lost to Follow-up|0|||
145894530|NCT04168190|526121667|FG003|Overall Study|Lost to Follow-up|7|||
145894531|NCT04168190|526121668|FG004|Overall Study|Lost to Follow-up|5|||
145894532|NCT04168190|526121664|FG000|Overall Study|Withdrawal by Subject|1|||
145894533|NCT04168190|526121665|FG001|Overall Study|Withdrawal by Subject|0|||
145894534|NCT04168190|526121666|FG002|Overall Study|Withdrawal by Subject|0|||
145894535|NCT04168190|526121667|FG003|Overall Study|Withdrawal by Subject|2|||
145894536|NCT04168190|526121668|FG004|Overall Study|Withdrawal by Subject|4|||
145894537|NCT04168190|526121664|FG000|Overall Study|Death|0|||
145894538|NCT04168190|526121665|FG001|Overall Study|Death|0|||
145894539|NCT04168190|526121666|FG002|Overall Study|Death|0|||
145894540|NCT04168190|526121667|FG003|Overall Study|Death|1|||
145894541|NCT04168190|526121668|FG004|Overall Study|Death|0|||
145894542|NCT00629265|526121669|FG000|Overall Study|Lost to Follow-up|4|||
145894543|NCT00629265|526121670|FG001|Overall Study|Lost to Follow-up|5|||
145894544|NCT00629265|526121669|FG000|Overall Study|Withdrawal by Subject|11|||
145894545|NCT00629265|526121670|FG001|Overall Study|Withdrawal by Subject|8|||
145894546|NCT00629265|526121669|FG000|Overall Study|Death|1|||
145894547|NCT00629265|526121670|FG001|Overall Study|Death|0|||
145894548|NCT00629265|526121669|FG000|Overall Study|Adverse Event|2|||
145894549|NCT00629265|526121670|FG001|Overall Study|Adverse Event|0|||
145894550|NCT00629265|526121669|FG000|Overall Study|HNC Recurrence|4|||
145894551|NCT00629265|526121670|FG001|Overall Study|HNC Recurrence|0|||
145894552|NCT00629265|526121669|FG000|Overall Study|Other CA Requiring Treatment|1|||
145894553|NCT00629265|526121670|FG001|Overall Study|Other CA Requiring Treatment|3|||
145894554|NCT00629265|526121669|FG000|Overall Study|Needed Esophageal Dilation|4|||
145894555|NCT00629265|526121670|FG001|Overall Study|Needed Esophageal Dilation|1|||
145894556|NCT00629265|526121669|FG000|Overall Study|Unrelated Medical Complications|3|||
145894557|NCT00629265|526121670|FG001|Overall Study|Unrelated Medical Complications|1|||
145894558|NCT00629265|526121669|FG000|Overall Study|Unknown Reason|2|||
145894559|NCT00629265|526121670|FG001|Overall Study|Unknown Reason|2|||
145894560|NCT01782482|526121677|FG000|Overall Study|Adverse Event|2|||
145894561|NCT01782482|526121678|FG001|Overall Study|Adverse Event|1|||
145894562|NCT01782482|526121677|FG000|Overall Study|Lost to Follow-up|2|||
145894563|NCT01782482|526121678|FG001|Overall Study|Lost to Follow-up|3|||
145894564|NCT01782482|526121677|FG000|Overall Study|Physician Decision|1|||
145894565|NCT01782482|526121678|FG001|Overall Study|Physician Decision|0|||
145894566|NCT01782482|526121677|FG000|Overall Study|Protocol Violation|1|||
145894567|NCT01782482|526121678|FG001|Overall Study|Protocol Violation|0|||
145894568|NCT01782482|526121677|FG000|Overall Study|Withdrawal by Subject|2|||
145894569|NCT01782482|526121678|FG001|Overall Study|Withdrawal by Subject|3|||
145894570|NCT01782482|526121677|FG000|Overall Study|Randomized in Error|2|||
145894571|NCT01782482|526121678|FG001|Overall Study|Randomized in Error|2|||
145894572|NCT01782482|526121677|FG000|Overall Study|Habitually wearing toric lens OS|0|||
146088188|NCT00686998|526841965|FG001|Overall Study|Safety Reasons|0|||
146237545|NCT02401815|527382829|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146237546|NCT02401815|527382830|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146237547|NCT02401815|527382831|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
146237548|NCT02401815|527382822|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237549|NCT02401815|527382823|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145894573|NCT01782482|526121678|FG001|Overall Study|Habitually wearing toric lens OS|1|||
145894574|NCT01194973|526121684|FG000|Screening Period|Screen Failure|3|||
145894575|NCT01194973|526121684|FG000|26 Week Treatment Period|Adverse Event|1|||
145894576|NCT01194973|526121684|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
145894577|NCT01194973|526121684|FG000|26 Week Treatment Period|Pregnancy|1|||
145894578|NCT01640873|526121685|FG000|Overall Study|Protocol Violation|2|||
145894579|NCT01640873|526121686|FG001|Overall Study|Protocol Violation|1|||
145894580|NCT01875471|526121689|FG000|Overall Study|Adverse Event|0|||
145894581|NCT01875471|526121690|FG001|Overall Study|Adverse Event|1|||
145894582|NCT01875471|526121689|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
145894583|NCT01875471|526121690|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
145894584|NCT01321008|526121693|FG000|Overall Study|Early Study Termination|1|||
145894585|NCT03978091|526121694|FG000|Overall Study|Lost to Follow-up|0|||
145894586|NCT03978091|526121695|FG001|Overall Study|Lost to Follow-up|0|||
145894587|NCT03978091|526121696|FG002|Overall Study|Lost to Follow-up|1|||
145894588|NCT03978091|526121697|FG003|Overall Study|Lost to Follow-up|0|||
145894589|NCT03978091|526121698|FG004|Overall Study|Lost to Follow-up|0|||
145894590|NCT03978091|526121699|FG005|Overall Study|Lost to Follow-up|0|||
145894591|NCT03978091|526121694|FG000|Overall Study|Withdrawal by Subject|0|||
145894592|NCT03978091|526121695|FG001|Overall Study|Withdrawal by Subject|0|||
145894593|NCT03978091|526121696|FG002|Overall Study|Withdrawal by Subject|0|||
145894594|NCT03978091|526121697|FG003|Overall Study|Withdrawal by Subject|1|||
145894595|NCT03978091|526121698|FG004|Overall Study|Withdrawal by Subject|1|||
145894596|NCT03978091|526121699|FG005|Overall Study|Withdrawal by Subject|0|||
146237550|NCT02401815|527382824|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237551|NCT02401815|527382825|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237552|NCT02401815|527382826|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237553|NCT02401815|527382827|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
145894597|NCT02749292|526121700|FG000|Overall Study|Physician Decision|1|||
145894598|NCT02749292|526121701|FG001|Overall Study|Physician Decision|0|||
145894599|NCT02749292|526121700|FG000|Overall Study|Withdrawal by Subject|5|||
145894600|NCT02749292|526121701|FG001|Overall Study|Withdrawal by Subject|7|||
145894601|NCT02749292|526121700|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
145894602|NCT02749292|526121701|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
145894603|NCT02749292|526121700|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
145894604|NCT02749292|526121701|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
145894605|NCT02749292|526121700|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
145894606|NCT02749292|526121701|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
145894607|NCT02749292|526121700|FG000|Overall Study|Adverse Event|4|||
145894608|NCT02749292|526121701|FG001|Overall Study|Adverse Event|1|||
145972067|NCT00920816|526410516|FG003|Overall Study|Lost to Follow-up|0|||
145972068|NCT00920816|526410513|FG000|Overall Study|Adverse Event|1|||
145972069|NCT00920816|526410514|FG001|Overall Study|Adverse Event|1|||
145972070|NCT00920816|526410515|FG002|Overall Study|Adverse Event|1|||
145972071|NCT00920816|526410516|FG003|Overall Study|Adverse Event|0|||
145972072|NCT00920816|526410513|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
146237554|NCT02401815|527382828|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237555|NCT02401815|527382829|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145972073|NCT00920816|526410514|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
145972074|NCT00920816|526410515|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
145972075|NCT00920816|526410516|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
145972076|NCT00920816|526410513|FG000|Overall Study|Randomized but not treated|3|||
146237556|NCT02401815|527382830|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
146237557|NCT02401815|527382831|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145972077|NCT00920816|526410514|FG001|Overall Study|Randomized but not treated|0|||
145972078|NCT00920816|526410515|FG002|Overall Study|Randomized but not treated|0|||
145972079|NCT00920816|526410516|FG003|Overall Study|Randomized but not treated|0|||
145972080|NCT01572792|526410519|FG000|Lead-in Study|Lost to Follow-up|5|||
145972081|NCT01572792|526410520|FG001|Lead-in Study|Lost to Follow-up|9|||
146237558|NCT02401815|527382822|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237559|NCT02401815|527382823|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237560|NCT02401815|527382824|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237561|NCT02401815|527382825|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237562|NCT02401815|527382826|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145894609|NCT02749292|526121700|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
145894610|NCT02749292|526121701|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
145894611|NCT02749292|526121700|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
145894612|NCT02749292|526121701|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
145894613|NCT02749292|526121700|FG000|Overall Study|Requiring glucocorticoids|0|||
145894614|NCT02749292|526121701|FG001|Overall Study|Requiring glucocorticoids|3|||
145894615|NCT02749292|526121700|FG000|Overall Study|Cancer|1|||
145894616|NCT02749292|526121701|FG001|Overall Study|Cancer|0|||
145894617|NCT01843348|526121702|FG000|Overall Study|Withdrawal by Subject|4|||
145894618|NCT01843348|526121703|FG001|Overall Study|Withdrawal by Subject|16|||
145894619|NCT01843348|526121704|FG002|Overall Study|Withdrawal by Subject|18|||
145894620|NCT01843348|526121702|FG000|Overall Study|Lost to Follow-up|5|||
145894621|NCT01843348|526121703|FG001|Overall Study|Lost to Follow-up|4|||
145894622|NCT01843348|526121704|FG002|Overall Study|Lost to Follow-up|2|||
145894623|NCT01843348|526121702|FG000|Overall Study|Death|5|||
145894624|NCT01843348|526121703|FG001|Overall Study|Death|3|||
145894625|NCT01843348|526121704|FG002|Overall Study|Death|4|||
145894626|NCT01843348|526121702|FG000|Overall Study|Graft loss/retransplantation|5|||
145894627|NCT01843348|526121703|FG001|Overall Study|Graft loss/retransplantation|8|||
145894628|NCT01843348|526121704|FG002|Overall Study|Graft loss/retransplantation|11|||
145894629|NCT01843348|526121702|FG000|Overall Study|Various reasons|4|||
145894630|NCT01843348|526121703|FG001|Overall Study|Various reasons|9|||
145894631|NCT01843348|526121704|FG002|Overall Study|Various reasons|6|||
145894632|NCT00679913|526121705|FG000|Overall Study|Protocol Violation|18|||
145894633|NCT00679913|526121706|FG001|Overall Study|Protocol Violation|13|||
145894634|NCT00062751|526121707|FG000|Overall Study|Disease progression|24|||
145894635|NCT00062751|526121708|FG001|Overall Study|Disease progression|17|||
145894636|NCT00062751|526121709|FG002|Overall Study|Disease progression|24|||
145894637|NCT00062751|526121710|FG003|Overall Study|Disease progression|2|||
145894638|NCT00062751|526121711|FG004|Overall Study|Disease progression|2|||
145894639|NCT00062751|526121707|FG000|Overall Study|Adverse Event|4|||
145894640|NCT00062751|526121708|FG001|Overall Study|Adverse Event|7|||
145894641|NCT00062751|526121709|FG002|Overall Study|Adverse Event|2|||
145894642|NCT00062751|526121710|FG003|Overall Study|Adverse Event|2|||
145894643|NCT00062751|526121711|FG004|Overall Study|Adverse Event|2|||
145894644|NCT00062751|526121707|FG000|Overall Study|Other|2|||
145894645|NCT00062751|526121708|FG001|Overall Study|Other|3|||
145894646|NCT00062751|526121709|FG002|Overall Study|Other|1|||
145894647|NCT00062751|526121710|FG003|Overall Study|Other|0|||
145894648|NCT00062751|526121711|FG004|Overall Study|Other|1|||
145894649|NCT00062751|526121707|FG000|Overall Study|Withdrawal by Subject|1|||
145894650|NCT00062751|526121708|FG001|Overall Study|Withdrawal by Subject|2|||
145894651|NCT00062751|526121709|FG002|Overall Study|Withdrawal by Subject|2|||
145894652|NCT00062751|526121710|FG003|Overall Study|Withdrawal by Subject|1|||
145894653|NCT00062751|526121711|FG004|Overall Study|Withdrawal by Subject|0|||
145972082|NCT01572792|526410521|FG002|Lead-in Study|Lost to Follow-up|4|||
146296339|NCT03049735|527600619|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
146296340|NCT03049735|527600620|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
146296341|NCT03049735|527600618|FG000|Overall Study|Other|5|||
145894654|NCT00062751|526121707|FG000|Overall Study|Symptomatic deterioration|1|||
145894655|NCT00062751|526121708|FG001|Overall Study|Symptomatic deterioration|1|||
146296342|NCT03049735|527600619|FG001|Overall Study|Other|3|||
145894656|NCT00062751|526121709|FG002|Overall Study|Symptomatic deterioration|0|||
145894657|NCT00062751|526121710|FG003|Overall Study|Symptomatic deterioration|0|||
145894658|NCT00062751|526121711|FG004|Overall Study|Symptomatic deterioration|1|||
145894659|NCT00062751|526121707|FG000|Overall Study|Death|1|||
145894660|NCT00062751|526121708|FG001|Overall Study|Death|0|||
145894661|NCT00062751|526121709|FG002|Overall Study|Death|1|||
145894662|NCT00062751|526121710|FG003|Overall Study|Death|0|||
145894663|NCT00062751|526121711|FG004|Overall Study|Death|0|||
145972083|NCT01572792|526410522|FG003|Lead-in Study|Lost to Follow-up|2|||
145972084|NCT01572792|526410523|FG004|Lead-in Study|Lost to Follow-up|4|||
145972085|NCT01572792|526410519|FG000|Lead-in Study|Withdrawal by Subject|22|||
145972086|NCT01572792|526410520|FG001|Lead-in Study|Withdrawal by Subject|11|||
145972087|NCT01572792|526410521|FG002|Lead-in Study|Withdrawal by Subject|12|||
145972088|NCT01572792|526410522|FG003|Lead-in Study|Withdrawal by Subject|24|||
145972089|NCT01572792|526410523|FG004|Lead-in Study|Withdrawal by Subject|11|||
145972090|NCT01572792|526410519|FG000|Lead-in Study|Protocol Violation|19|||
145972091|NCT01572792|526410520|FG001|Lead-in Study|Protocol Violation|10|||
145972092|NCT01572792|526410521|FG002|Lead-in Study|Protocol Violation|12|||
145972093|NCT01572792|526410522|FG003|Lead-in Study|Protocol Violation|13|||
145972094|NCT01572792|526410523|FG004|Lead-in Study|Protocol Violation|21|||
145972095|NCT01572792|526410519|FG000|Lead-in Study|Lack of Efficacy|20|||
145972096|NCT01572792|526410520|FG001|Lead-in Study|Lack of Efficacy|5|||
145972097|NCT01572792|526410521|FG002|Lead-in Study|Lack of Efficacy|4|||
145972098|NCT01572792|526410522|FG003|Lead-in Study|Lack of Efficacy|8|||
145972099|NCT01572792|526410523|FG004|Lead-in Study|Lack of Efficacy|10|||
145894664|NCT03097588|526121718|FG000|Overall Study|Adverse Event|1|||
145894665|NCT03828448|526121723|FG000|Overall Study|Sponsor's Discretion|34|||
145894666|NCT00456495|526121724|FG000|Overall Study|Physician Decision|2|||
145894667|NCT02192164|526121725|FG000|Overall Study|Other|8|||
145894668|NCT02192164|526121725|FG000|Overall Study|Withdrawal by Subject|1|||
145894669|NCT02192164|526121725|FG000|Overall Study|Physician Decision|4|||
145894670|NCT02192164|526121725|FG000|Overall Study|Did not meet the exclusion criteria|1|||
145894671|NCT00673933|526121726|FG000|Overall Study|Withdrawal by Subject|2|||
145894672|NCT00673933|526121726|FG000|Overall Study|Lost to Follow-up|1|||
145894673|NCT02206620|526121727|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145894674|NCT02206620|526121728|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145894675|NCT02206620|526121727|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
145894676|NCT02206620|526121728|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
145894677|NCT01346774|526121729|FG000|Overall Study|Did not take a single dose|6|||
145894678|NCT01346774|526121730|FG001|Overall Study|Did not take a single dose|4|||
145894679|NCT01346774|526121729|FG000|Overall Study|Lost to Follow-up|3|||
145894680|NCT01346774|526121730|FG001|Overall Study|Lost to Follow-up|4|||
145894681|NCT01346774|526121729|FG000|Overall Study|Withdrawal by Subject|1|||
145894682|NCT01346774|526121730|FG001|Overall Study|Withdrawal by Subject|4|||
145894683|NCT01346774|526121729|FG000|Overall Study|Protocol Violation|2|||
145894684|NCT01346774|526121730|FG001|Overall Study|Protocol Violation|3|||
145894685|NCT01346774|526121729|FG000|Overall Study|Adverse Event|1|||
145894686|NCT01346774|526121730|FG001|Overall Study|Adverse Event|2|||
145894687|NCT01929031|526121733|FG000|Overall Study|Adverse Event|3|||
145894688|NCT01929031|526121734|FG001|Overall Study|Adverse Event|1|||
145894689|NCT01929031|526121735|FG002|Overall Study|Adverse Event|1|||
145894690|NCT01929031|526121736|FG003|Overall Study|Adverse Event|0|||
145894691|NCT01929031|526121737|FG004|Overall Study|Adverse Event|0|||
145894692|NCT01929031|526121738|FG005|Overall Study|Adverse Event|0|||
145894693|NCT01929031|526121733|FG000|Overall Study|Protocol Violation|1|||
145894694|NCT01929031|526121734|FG001|Overall Study|Protocol Violation|0|||
145894695|NCT01929031|526121735|FG002|Overall Study|Protocol Violation|0|||
145894696|NCT01929031|526121736|FG003|Overall Study|Protocol Violation|0|||
145894697|NCT01929031|526121737|FG004|Overall Study|Protocol Violation|0|||
145894698|NCT01929031|526121738|FG005|Overall Study|Protocol Violation|1|||
145894699|NCT01929031|526121733|FG000|Overall Study|Reason other than specified above|0|||
145894700|NCT01929031|526121734|FG001|Overall Study|Reason other than specified above|1|||
145894701|NCT01929031|526121735|FG002|Overall Study|Reason other than specified above|0|||
145894702|NCT01929031|526121736|FG003|Overall Study|Reason other than specified above|0|||
145894703|NCT01929031|526121737|FG004|Overall Study|Reason other than specified above|1|||
145894704|NCT01929031|526121738|FG005|Overall Study|Reason other than specified above|0|||
145894705|NCT05816200|526121739|FG000|Overall Study|Lost to Follow-up|2|||
145894706|NCT05816200|526121740|FG001|Overall Study|Lost to Follow-up|1|||
145894707|NCT02394730|526121746|FG000|Overall Study|Lost to Follow-up|1|||
145894708|NCT02394730|526121747|FG001|Overall Study|Lost to Follow-up|0|||
145894709|NCT02394730|526121746|FG000|Overall Study|Withdrawal by Subject|0|||
145894710|NCT02394730|526121747|FG001|Overall Study|Withdrawal by Subject|1|||
145894711|NCT02384850|526121748|FG000|Overall Study|Withdrawal by Subject|2|||
145894712|NCT02384850|526121749|FG001|Overall Study|Withdrawal by Subject|2|||
145894713|NCT00507546|526121750|FG000|Overall Study|Withdrawal by Subject|1|||
145894714|NCT00507546|526121751|FG001|Overall Study|Withdrawal by Subject|0|||
145972100|NCT01572792|526410519|FG000|Lead-in Study|Adverse Event|21|||
146237563|NCT02401815|527382827|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237564|NCT02401815|527382828|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
146296343|NCT03049735|527600620|FG002|Overall Study|Other|1|||
145894715|NCT00507546|526121750|FG000|Overall Study|Protocol Violation|1|||
145894716|NCT00507546|526121751|FG001|Overall Study|Protocol Violation|0|||
145894717|NCT00507546|526121750|FG000|Overall Study|Physician Decision|0|||
145972101|NCT01572792|526410520|FG001|Lead-in Study|Adverse Event|21|||
145972102|NCT01572792|526410521|FG002|Lead-in Study|Adverse Event|22|||
145972103|NCT01572792|526410522|FG003|Lead-in Study|Adverse Event|16|||
145972104|NCT01572792|526410523|FG004|Lead-in Study|Adverse Event|14|||
145894718|NCT00507546|526121751|FG001|Overall Study|Physician Decision|1|||
145894719|NCT00609466|526121755|FG000|Overall Study|Withdrawal by Subject|0|||
145894720|NCT00609466|526121756|FG001|Overall Study|Withdrawal by Subject|1|||
145894721|NCT00609466|526121757|FG002|Overall Study|Withdrawal by Subject|1|||
145894722|NCT00609466|526121755|FG000|Overall Study|Adverse Event|2|||
145894723|NCT00609466|526121756|FG001|Overall Study|Adverse Event|3|||
145894724|NCT00609466|526121757|FG002|Overall Study|Adverse Event|1|||
145894725|NCT00609466|526121755|FG000|Overall Study|Lack of Efficacy|0|||
145894726|NCT00609466|526121756|FG001|Overall Study|Lack of Efficacy|2|||
145894727|NCT00609466|526121757|FG002|Overall Study|Lack of Efficacy|2|||
145894728|NCT03512262|526121758|FG000|Overall Study|Adverse Event|8|||
145894729|NCT03512262|526121759|FG001|Overall Study|Adverse Event|3|||
145894730|NCT03512262|526121758|FG000|Overall Study|Death (non-treatment emergent)|1|||
145894731|NCT03512262|526121759|FG001|Overall Study|Death (non-treatment emergent)|0|||
145894732|NCT03512262|526121758|FG000|Overall Study|Withdrawal by Subject|17|||
145894733|NCT03512262|526121759|FG001|Overall Study|Withdrawal by Subject|9|||
145894734|NCT03512262|526121758|FG000|Overall Study|Lost to Follow-up|7|||
145894735|NCT03512262|526121759|FG001|Overall Study|Lost to Follow-up|1|||
145894736|NCT03512262|526121758|FG000|Overall Study|Other than Specified|2|||
145894737|NCT03512262|526121759|FG001|Overall Study|Other than Specified|2|||
145894738|NCT01299805|526121760|FG000|Overall Study|Adverse Event|2|||
145894739|NCT01299805|526121761|FG001|Overall Study|Adverse Event|0|||
145894740|NCT03510182|526121762|FG000|Overall Study|Withdrawal by Subject|2|||
145894741|NCT01334710|526121769|FG000|Overall Study|Trial was terminated|3|||
145894742|NCT00375492|526121770|FG000|Overall Study|Adverse Event|4|||
145894743|NCT00375492|526121771|FG001|Overall Study|Adverse Event|5|||
145894744|NCT00375492|526121770|FG000|Overall Study|Entry Criteria Not Met|0|||
145894745|NCT00375492|526121771|FG001|Overall Study|Entry Criteria Not Met|1|||
145894746|NCT00375492|526121770|FG000|Overall Study|Loss of Glucose Control|0|||
145894747|NCT00375492|526121771|FG001|Overall Study|Loss of Glucose Control|1|||
145894748|NCT00375492|526121770|FG000|Overall Study|Lost to Follow-up|10|||
145894749|NCT00375492|526121771|FG001|Overall Study|Lost to Follow-up|5|||
145894750|NCT00375492|526121770|FG000|Overall Study|Physician Decision|0|||
145894751|NCT00375492|526121771|FG001|Overall Study|Physician Decision|4|||
145894752|NCT00375492|526121770|FG000|Overall Study|Protocol Violation|6|||
145894753|NCT00375492|526121771|FG001|Overall Study|Protocol Violation|3|||
145894754|NCT00375492|526121770|FG000|Overall Study|Sponsor Decision|0|||
145894755|NCT00375492|526121771|FG001|Overall Study|Sponsor Decision|1|||
145894756|NCT00375492|526121770|FG000|Overall Study|Withdrawal by Subject|6|||
145894757|NCT00375492|526121771|FG001|Overall Study|Withdrawal by Subject|6|||
145894758|NCT04062448|526123527|FG000|Overall Study|Lost to Follow-up|1|||
145894759|NCT04062448|526123527|FG000|Overall Study|Withdrawal by Subject|2|||
146237565|NCT02401815|527382829|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237566|NCT02401815|527382830|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237567|NCT02401815|527382831|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145894760|NCT04319718|526123528|FG000|Overall Study|Adverse Event|0|||
145894761|NCT04319718|526123529|FG001|Overall Study|Adverse Event|2|||
145894762|NCT04319718|526123528|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
145894763|NCT04319718|526123529|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
145894764|NCT01045421|526123530|FG000|Phase 1|Progressive Disease|0|||
145894765|NCT01045421|526123531|FG001|Phase 1|Progressive Disease|0|||
145894766|NCT01045421|526123532|FG002|Phase 1|Progressive Disease|0|||
145894767|NCT01045421|526123533|FG003|Phase 1|Progressive Disease|0|||
145894768|NCT01045421|526123534|FG004|Phase 1|Progressive Disease|1|||
145894769|NCT01045421|526123535|FG005|Phase 1|Progressive Disease|0|||
145894770|NCT01045421|526123536|FG006|Phase 1|Progressive Disease|0|||
145894771|NCT01045421|526123537|FG007|Phase 1|Progressive Disease|0|||
145894772|NCT01045421|526123538|FG008|Phase 1|Progressive Disease|0|||
145894773|NCT01045421|526123539|FG009|Phase 1|Progressive Disease|0|||
145894774|NCT01045421|526123540|FG010|Phase 1|Progressive Disease|0|||
145894775|NCT01045421|526123530|FG000|Phase 1|Withdrawal by Subject|0|||
145894776|NCT01045421|526123531|FG001|Phase 1|Withdrawal by Subject|0|||
145894777|NCT01045421|526123532|FG002|Phase 1|Withdrawal by Subject|0|||
145972105|NCT01572792|526410519|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
145972106|NCT01572792|526410520|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
145972107|NCT01572792|526410521|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
145894778|NCT01045421|526123533|FG003|Phase 1|Withdrawal by Subject|1|||
145972108|NCT01572792|526410522|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
145894779|NCT01045421|526123534|FG004|Phase 1|Withdrawal by Subject|0|||
145894780|NCT01045421|526123535|FG005|Phase 1|Withdrawal by Subject|0|||
145894781|NCT01045421|526123536|FG006|Phase 1|Withdrawal by Subject|0|||
146088189|NCT00686998|526841966|FG002|Overall Study|Safety Reasons|0|||
145894782|NCT01045421|526123537|FG007|Phase 1|Withdrawal by Subject|0|||
145894783|NCT01045421|526123538|FG008|Phase 1|Withdrawal by Subject|0|||
145894784|NCT01045421|526123539|FG009|Phase 1|Withdrawal by Subject|0|||
145894785|NCT01045421|526123540|FG010|Phase 1|Withdrawal by Subject|0|||
145894786|NCT01045421|526123530|FG000|Phase 2|Progressive Disease|0|||
145894787|NCT01045421|526123531|FG001|Phase 2|Progressive Disease|0|||
145894788|NCT01045421|526123532|FG002|Phase 2|Progressive Disease|0|||
145894789|NCT01045421|526123533|FG003|Phase 2|Progressive Disease|0|||
145894790|NCT01045421|526123534|FG004|Phase 2|Progressive Disease|0|||
145894791|NCT01045421|526123535|FG005|Phase 2|Progressive Disease|0|||
145894792|NCT01045421|526123536|FG006|Phase 2|Progressive Disease|0|||
145894793|NCT01045421|526123537|FG007|Phase 2|Progressive Disease|1|||
145894794|NCT01045421|526123538|FG008|Phase 2|Progressive Disease|1|||
145894795|NCT01045421|526123539|FG009|Phase 2|Progressive Disease|1|||
145894796|NCT01045421|526123540|FG010|Phase 2|Progressive Disease|1|||
145894797|NCT01045421|526123530|FG000|Phase 2|Death|0|||
145894798|NCT01045421|526123531|FG001|Phase 2|Death|0|||
145894799|NCT01045421|526123532|FG002|Phase 2|Death|0|||
145894800|NCT01045421|526123533|FG003|Phase 2|Death|0|||
145894801|NCT01045421|526123534|FG004|Phase 2|Death|0|||
145894802|NCT01045421|526123535|FG005|Phase 2|Death|0|||
145894803|NCT01045421|526123536|FG006|Phase 2|Death|0|||
145894804|NCT01045421|526123537|FG007|Phase 2|Death|1|||
145894805|NCT01045421|526123538|FG008|Phase 2|Death|1|||
145894806|NCT01045421|526123539|FG009|Phase 2|Death|2|||
145894807|NCT01045421|526123540|FG010|Phase 2|Death|0|||
145894808|NCT01045421|526123530|FG000|Phase 2|Other|0|||
145894809|NCT01045421|526123531|FG001|Phase 2|Other|0|||
145894810|NCT01045421|526123532|FG002|Phase 2|Other|0|||
145894811|NCT01045421|526123533|FG003|Phase 2|Other|0|||
145894812|NCT01045421|526123534|FG004|Phase 2|Other|0|||
145894813|NCT01045421|526123535|FG005|Phase 2|Other|0|||
145894814|NCT01045421|526123536|FG006|Phase 2|Other|0|||
145894815|NCT01045421|526123537|FG007|Phase 2|Other|3|||
145894816|NCT01045421|526123538|FG008|Phase 2|Other|0|||
145894817|NCT01045421|526123539|FG009|Phase 2|Other|0|||
145894818|NCT01045421|526123540|FG010|Phase 2|Other|1|||
145894819|NCT00599521|526123541|FG000|Overall Study|Lack of Efficacy|4|||
145894820|NCT00599521|526123542|FG001|Overall Study|Lack of Efficacy|8|||
145894821|NCT00599521|526123541|FG000|Overall Study|Adverse Event|4|||
145894822|NCT00599521|526123542|FG001|Overall Study|Adverse Event|1|||
145894823|NCT00599521|526123541|FG000|Overall Study|Withdrawal by Subject|28|||
145894824|NCT00599521|526123542|FG001|Overall Study|Withdrawal by Subject|34|||
145894825|NCT00599521|526123541|FG000|Overall Study|Protocol Violation|1|||
145894826|NCT00599521|526123542|FG001|Overall Study|Protocol Violation|1|||
145894827|NCT00599521|526123541|FG000|Overall Study|Lost to Follow-up|23|||
145894828|NCT00599521|526123542|FG001|Overall Study|Lost to Follow-up|23|||
145894829|NCT00599521|526123541|FG000|Overall Study|Pregnancy|0|||
145894830|NCT00599521|526123542|FG001|Overall Study|Pregnancy|2|||
145894831|NCT00912093|526123543|FG000|The Controlled Phase|Death|0|||
145894832|NCT00912093|526123544|FG001|The Controlled Phase|Death|1|||
145894833|NCT00912093|526123545|FG002|The Controlled Phase|Death|0|||
145894834|NCT00912093|526123546|FG003|The Controlled Phase|Death|0|||
145894835|NCT00912093|526123547|FG004|The Controlled Phase|Death|0|||
145894836|NCT00912093|526123543|FG000|The Controlled Phase|Medical Condition|0|||
145894837|NCT00912093|526123544|FG001|The Controlled Phase|Medical Condition|1|||
145894838|NCT00912093|526123545|FG002|The Controlled Phase|Medical Condition|0|||
145894839|NCT00912093|526123546|FG003|The Controlled Phase|Medical Condition|0|||
145894840|NCT00912093|526123547|FG004|The Controlled Phase|Medical Condition|0|||
145894841|NCT00912093|526123543|FG000|The Controlled Phase|Lost to Follow-up|0|||
145894842|NCT00912093|526123544|FG001|The Controlled Phase|Lost to Follow-up|0|||
145894843|NCT00912093|526123545|FG002|The Controlled Phase|Lost to Follow-up|0|||
145894844|NCT00912093|526123546|FG003|The Controlled Phase|Lost to Follow-up|0|||
145894845|NCT00912093|526123547|FG004|The Controlled Phase|Lost to Follow-up|1|||
145894846|NCT00307034|526123554|FG000|Overall Study|Adverse Event|1|||
145894847|NCT00307034|526123555|FG001|Overall Study|Adverse Event|2|||
145894848|NCT00307034|526123554|FG000|Overall Study|Withdrawal by Subject|1|||
145894849|NCT00307034|526123555|FG001|Overall Study|Withdrawal by Subject|2|||
145894850|NCT00307034|526123554|FG000|Overall Study|Lost to Follow-up|0|||
145894851|NCT00307034|526123555|FG001|Overall Study|Lost to Follow-up|3|||
145894852|NCT00450619|526123561|FG000|Overall Study|refused treatment after randomization|2|||
146088190|NCT05985980|526841967|FG000|Overall Study|Withdrawal by Subject|1|||
145894853|NCT00450619|526123562|FG001|Overall Study|refused treatment after randomization|0|||
145894854|NCT00450619|526123561|FG000|Overall Study|did not progress; refused further trmt|1|||
145894855|NCT00450619|526123562|FG001|Overall Study|did not progress; refused further trmt|1|||
146088191|NCT05985980|526841967|FG000|Overall Study|Withdrawal by Subject|1|||
146088192|NCT05985980|526841967|FG000|Overall Study|Withdrawal by Subject|1|||
145894856|NCT00450619|526123561|FG000|Overall Study|Adverse Event|1|||
145894857|NCT00450619|526123562|FG001|Overall Study|Adverse Event|0|||
145894858|NCT02034058|526123563|FG000|Overall Study|Death|3|||
145894859|NCT03254602|526123564|FG000|Overall Study|Lost to Follow-up|4|||
145894860|NCT02963311|526123567|FG000|Overall Study|Withdrawal by Subject|1|||
145894861|NCT02963311|526123567|FG000|Overall Study|Screen Failure|4|||
145894862|NCT01691820|526123568|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
145894863|NCT01691820|526123569|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
145894864|NCT01691820|526123568|FG000|Overall Study|Migrated/moved from study area|7|||
146237568|NCT02401815|527382822|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237569|NCT02401815|527382823|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237570|NCT02401815|527382824|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145894865|NCT01691820|526123569|FG001|Overall Study|Migrated/moved from study area|4|||
145894866|NCT01691820|526123568|FG000|Overall Study|Lost to Follow-up|6|||
145894867|NCT01691820|526123569|FG001|Overall Study|Lost to Follow-up|17|||
145894868|NCT01691820|526123568|FG000|Overall Study|Other (unspecified)|4|||
145894869|NCT01691820|526123569|FG001|Overall Study|Other (unspecified)|1|||
145894870|NCT04442490|526123571|FG000|Overall Study|Withdrawal by Subject|18|||
145894871|NCT04442490|526123572|FG001|Overall Study|Withdrawal by Subject|10|||
145894872|NCT04442490|526123571|FG000|Overall Study|Lost to Follow-up|7|||
145894873|NCT04442490|526123572|FG001|Overall Study|Lost to Follow-up|7|||
145894874|NCT04442490|526123571|FG000|Overall Study|Adverse Event|2|||
145894875|NCT04442490|526123572|FG001|Overall Study|Adverse Event|6|||
145894876|NCT04442490|526123571|FG000|Overall Study|Noncompliance|3|||
145894877|NCT04442490|526123572|FG001|Overall Study|Noncompliance|1|||
145894878|NCT04442490|526123571|FG000|Overall Study|Physician Decision|2|||
145894879|NCT04442490|526123572|FG001|Overall Study|Physician Decision|1|||
145894880|NCT04442490|526123571|FG000|Overall Study|Reason not Specified|2|||
145894881|NCT04442490|526123572|FG001|Overall Study|Reason not Specified|1|||
145894882|NCT04442490|526123571|FG000|Overall Study|Randomized but not Treated|3|||
145894883|NCT04442490|526123572|FG001|Overall Study|Randomized but not Treated|3|||
145894884|NCT02372071|526123584|FG000|Overall Study|Protocol Violation|18|||
145894885|NCT01449279|526123585|FG000|Overall Study|Lack of Efficacy|5|||
145894886|NCT01449279|526123585|FG000|Overall Study|Toxicity|2|||
145894887|NCT02618408|526123586|FG000|Overall Study|Withdrawal by Subject|1|||
145894888|NCT02618408|526123587|FG001|Overall Study|Withdrawal by Subject|0|||
145894889|NCT02618408|526123588|FG002|Overall Study|Withdrawal by Subject|4|||
145894890|NCT02618408|526123586|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
145894891|NCT02618408|526123587|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
146237571|NCT02401815|527382825|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237572|NCT02401815|527382826|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237573|NCT02401815|527382827|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
146237574|NCT02401815|527382828|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
146237575|NCT02401815|527382829|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237576|NCT02401815|527382830|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237577|NCT02401815|527382831|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
146237578|NCT02401815|527382822|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146296344|NCT03049735|527600618|FG000|Overall Study|Lack of Efficacy|4|||
146296345|NCT03049735|527600619|FG001|Overall Study|Lack of Efficacy|0|||
146296346|NCT03049735|527600620|FG002|Overall Study|Lack of Efficacy|3|||
146296347|NCT03049735|527600618|FG000|Overall Study|Protocol deviation|1|||
146296348|NCT03049735|527600619|FG001|Overall Study|Protocol deviation|0|||
146296349|NCT03049735|527600620|FG002|Overall Study|Protocol deviation|0|||
146296350|NCT03049735|527600618|FG000|Overall Study|Pregnancy|0|||
146296351|NCT03049735|527600619|FG001|Overall Study|Pregnancy|0|||
146296352|NCT03049735|527600620|FG002|Overall Study|Pregnancy|1|||
145894892|NCT02618408|526123588|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
145894893|NCT02618408|526123586|FG000|Overall Study|Lost to Follow-up|4|||
146237579|NCT02401815|527382823|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237580|NCT02401815|527382824|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237581|NCT02401815|527382825|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237582|NCT02401815|527382826|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237583|NCT02401815|527382827|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
146237584|NCT02401815|527382828|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237585|NCT02401815|527382829|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237586|NCT02401815|527382830|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145894894|NCT02618408|526123587|FG001|Overall Study|Lost to Follow-up|2|||
145894895|NCT02618408|526123588|FG002|Overall Study|Lost to Follow-up|6|||
145894896|NCT02618408|526123586|FG000|Overall Study|Adverse Event|4|||
145894897|NCT02618408|526123587|FG001|Overall Study|Adverse Event|0|||
145894898|NCT02618408|526123588|FG002|Overall Study|Adverse Event|10|||
145894899|NCT02618408|526123586|FG000|Overall Study|Physician Decision|1|||
145894900|NCT02618408|526123587|FG001|Overall Study|Physician Decision|1|||
146296353|NCT03049735|527600618|FG000|Overall Study|Adverse Event|7|||
146296354|NCT03049735|527600619|FG001|Overall Study|Adverse Event|18|||
146296355|NCT03049735|527600620|FG002|Overall Study|Adverse Event|5|||
146296356|NCT03049735|527600618|FG000|Overall Study|Withdrawal by Subject|10|||
146296357|NCT03049735|527600619|FG001|Overall Study|Withdrawal by Subject|3|||
146296358|NCT03049735|527600620|FG002|Overall Study|Withdrawal by Subject|7|||
146296359|NCT03049735|527600618|FG000|Overall Study|Lost to Follow-up|1|||
146296360|NCT03049735|527600619|FG001|Overall Study|Lost to Follow-up|5|||
145894901|NCT02618408|526123588|FG002|Overall Study|Physician Decision|2|||
145894902|NCT02618408|526123586|FG000|Overall Study|Protocol Violation|1|||
145894903|NCT02618408|526123587|FG001|Overall Study|Protocol Violation|1|||
145894904|NCT02618408|526123588|FG002|Overall Study|Protocol Violation|2|||
145894905|NCT02618408|526123586|FG000|Overall Study|Other, Multiple Categories|0|||
145894906|NCT02618408|526123587|FG001|Overall Study|Other, Multiple Categories|0|||
145894907|NCT02618408|526123588|FG002|Overall Study|Other, Multiple Categories|4|||
145894908|NCT03052959|526123602|FG000|Overall Study|Lost to Follow-up|4|||
145894909|NCT03052959|526123603|FG001|Overall Study|Lost to Follow-up|5|||
145894910|NCT01524679|526123604|FG000|Overall Study|Lost to Follow-up|1|||
145894911|NCT01524679|526123605|FG001|Overall Study|Lost to Follow-up|4|||
145894912|NCT01524679|526123604|FG000|Overall Study|Withdrawal by Subject|4|||
145894913|NCT01524679|526123605|FG001|Overall Study|Withdrawal by Subject|4|||
145894914|NCT01524679|526123604|FG000|Overall Study|Adverse Event|9|||
145894915|NCT01524679|526123605|FG001|Overall Study|Adverse Event|0|||
145894916|NCT01524679|526123604|FG000|Overall Study|Protocol Violation|1|||
145894917|NCT01524679|526123605|FG001|Overall Study|Protocol Violation|0|||
145894918|NCT01524679|526123604|FG000|Overall Study|Lack of Efficacy|2|||
145894919|NCT01524679|526123605|FG001|Overall Study|Lack of Efficacy|0|||
145894920|NCT01524679|526123604|FG000|Overall Study|e.g.wish for children, relocation|6|||
145894921|NCT01524679|526123605|FG001|Overall Study|e.g.wish for children, relocation|1|||
145894922|NCT03321630|526123608|FG000|Overall Study|Adverse Event|1|||
145894923|NCT03321630|526123608|FG000|Overall Study|Investigator Discretion|2|||
145894924|NCT03321630|526123608|FG000|Overall Study|Withdrawal by Subject|1|||
145894925|NCT00140426|526123609|FG000|Overall Study|Withdrawal by Subject|0|||
145894926|NCT00140426|526123610|FG001|Overall Study|Withdrawal by Subject|3|||
145894927|NCT04765384|526123611|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
145894928|NCT04765384|526123612|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
145894929|NCT04765384|526123613|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
145894930|NCT04765384|526123614|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
145894931|NCT04765384|526123615|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
145894932|NCT04765384|526123616|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
145894933|NCT04765384|526123611|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
145894934|NCT04765384|526123612|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
145894935|NCT04765384|526123613|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
145894936|NCT04765384|526123614|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
145894937|NCT04765384|526123615|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
145894938|NCT04765384|526123616|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
145894939|NCT04765384|526123611|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145894940|NCT04765384|526123612|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145894941|NCT04765384|526123613|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145894942|NCT04765384|526123614|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
146296361|NCT03049735|527600620|FG002|Overall Study|Lost to Follow-up|5|||
145894943|NCT04765384|526123615|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145894944|NCT04765384|526123616|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
145894945|NCT04765384|526123611|FG000|Post-natal: Neonates and Infants|Death|0|||
145894946|NCT04765384|526123612|FG001|Post-natal: Neonates and Infants|Death|0|||
145894947|NCT04765384|526123613|FG002|Post-natal: Neonates and Infants|Death|0|||
145894948|NCT04765384|526123614|FG003|Post-natal: Neonates and Infants|Death|1|||
145894949|NCT04765384|526123615|FG004|Post-natal: Neonates and Infants|Death|0|||
145894950|NCT04765384|526123616|FG005|Post-natal: Neonates and Infants|Death|0|||
145894951|NCT04765384|526123611|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145894952|NCT04765384|526123612|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145894953|NCT04765384|526123613|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145894954|NCT04765384|526123614|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145894955|NCT04765384|526123615|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145894956|NCT04765384|526123616|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
145894957|NCT01169532|526123621|FG000|Overall Study|Withdrawal by Subject|1|||
145894958|NCT02032706|526123625|FG000|Overall Study|Did not qualify|5|||
145894959|NCT02032706|526123625|FG000|Overall Study|Protocol Violation|1|||
145894960|NCT05070546|526123630|FG000|Overall Study|Death|0|||
145894961|NCT05070546|526123631|FG001|Overall Study|Death|0|||
145894962|NCT05070546|526123632|FG002|Overall Study|Death|0|||
145894963|NCT05070546|526123633|FG003|Overall Study|Death|0|||
145894964|NCT05070546|526123634|FG004|Overall Study|Death|0|||
145894965|NCT05070546|526123635|FG005|Overall Study|Death|1|||
145894966|NCT05070546|526123630|FG000|Overall Study|Lost to Follow-up|8|||
145894967|NCT05070546|526123631|FG001|Overall Study|Lost to Follow-up|2|||
145894968|NCT05070546|526123632|FG002|Overall Study|Lost to Follow-up|7|||
145894969|NCT05070546|526123633|FG003|Overall Study|Lost to Follow-up|1|||
145894970|NCT05070546|526123634|FG004|Overall Study|Lost to Follow-up|2|||
145972109|NCT01572792|526410523|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
145972110|NCT01572792|526410519|FG000|Extension Study|Lost to Follow-up|6|||
146296362|NCT02146326|527600621|FG000|Overall Study|Lost to Follow-up|3|||
146296363|NCT02146326|527600622|FG001|Overall Study|Lost to Follow-up|3|||
145894971|NCT05070546|526123635|FG005|Overall Study|Lost to Follow-up|0|||
145894972|NCT05070546|526123630|FG000|Overall Study|Withdrawal by Subject|1|||
145894973|NCT05070546|526123631|FG001|Overall Study|Withdrawal by Subject|1|||
145894974|NCT05070546|526123632|FG002|Overall Study|Withdrawal by Subject|3|||
145894975|NCT05070546|526123633|FG003|Overall Study|Withdrawal by Subject|0|||
145894976|NCT05070546|526123634|FG004|Overall Study|Withdrawal by Subject|0|||
145894977|NCT05070546|526123635|FG005|Overall Study|Withdrawal by Subject|0|||
145894978|NCT05070546|526123630|FG000|Overall Study|Other|0|||
145894979|NCT05070546|526123631|FG001|Overall Study|Other|0|||
145894980|NCT05070546|526123632|FG002|Overall Study|Other|0|||
145894981|NCT05070546|526123633|FG003|Overall Study|Other|0|||
145894982|NCT05070546|526123634|FG004|Overall Study|Other|3|||
145894983|NCT05070546|526123635|FG005|Overall Study|Other|0|||
145894984|NCT05070546|526123630|FG000|Overall Study|Randomized but not vaccinated|1|||
145894985|NCT05070546|526123631|FG001|Overall Study|Randomized but not vaccinated|0|||
145894986|NCT05070546|526123632|FG002|Overall Study|Randomized but not vaccinated|1|||
145894987|NCT05070546|526123633|FG003|Overall Study|Randomized but not vaccinated|1|||
145894988|NCT05070546|526123634|FG004|Overall Study|Randomized but not vaccinated|3|||
145894989|NCT05070546|526123635|FG005|Overall Study|Randomized but not vaccinated|0|||
145894990|NCT00160641|526123636|FG000|Overall Study|Adverse Event|102|||
145894991|NCT00160641|526123636|FG000|Overall Study|Withdrawal by Subject|87|||
145894992|NCT00160641|526123636|FG000|Overall Study|Lost to Follow-up|8|||
145894993|NCT00160641|526123636|FG000|Overall Study|Lack of Efficacy|12|||
145894994|NCT00160641|526123636|FG000|Overall Study|Protocol Violation|3|||
145894995|NCT00160641|526123636|FG000|Overall Study|Other|9|||
145894996|NCT02787408|526123637|FG000|Overall Study|Death|16|||
145894997|NCT02787408|526123637|FG000|Overall Study|Withdrawal by Subject|1|||
145894998|NCT02787408|526123637|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
145894999|NCT00985712|526123639|FG000|Overall Study|Adverse Event|0|||
145895000|NCT00985712|526123640|FG001|Overall Study|Adverse Event|1|||
145895001|NCT00985712|526123639|FG000|Overall Study|Lost to Follow-up|2|||
145895002|NCT00985712|526123640|FG001|Overall Study|Lost to Follow-up|2|||
145895003|NCT00985712|526123639|FG000|Overall Study|Protocol Violation|0|||
146237587|NCT02401815|527382831|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
146237588|NCT02401815|527382822|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146237589|NCT02401815|527382823|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145895004|NCT00985712|526123640|FG001|Overall Study|Protocol Violation|1|||
145895005|NCT00985712|526123639|FG000|Overall Study|Withdrawal by Subject|4|||
145895006|NCT00985712|526123640|FG001|Overall Study|Withdrawal by Subject|1|||
145972111|NCT01572792|526410520|FG001|Extension Study|Lost to Follow-up|2|||
145972112|NCT01572792|526410521|FG002|Extension Study|Lost to Follow-up|0|||
145972113|NCT01572792|526410522|FG003|Extension Study|Lost to Follow-up|3|||
145972114|NCT01572792|526410523|FG004|Extension Study|Lost to Follow-up|3|||
145972115|NCT01572792|526410519|FG000|Extension Study|Withdrawal by Subject|7|||
145972116|NCT01572792|526410520|FG001|Extension Study|Withdrawal by Subject|6|||
145972117|NCT01572792|526410521|FG002|Extension Study|Withdrawal by Subject|11|||
145972118|NCT01572792|526410522|FG003|Extension Study|Withdrawal by Subject|8|||
145972119|NCT01572792|526410523|FG004|Extension Study|Withdrawal by Subject|14|||
145972120|NCT01572792|526410519|FG000|Extension Study|Protocol Violation|0|||
145972121|NCT01572792|526410520|FG001|Extension Study|Protocol Violation|4|||
145972122|NCT01572792|526410521|FG002|Extension Study|Protocol Violation|3|||
145972123|NCT01572792|526410522|FG003|Extension Study|Protocol Violation|4|||
145972124|NCT01572792|526410523|FG004|Extension Study|Protocol Violation|3|||
145972125|NCT01572792|526410519|FG000|Extension Study|Lack of Efficacy|2|||
145972126|NCT01572792|526410520|FG001|Extension Study|Lack of Efficacy|3|||
145972127|NCT01572792|526410521|FG002|Extension Study|Lack of Efficacy|3|||
145972128|NCT01572792|526410522|FG003|Extension Study|Lack of Efficacy|2|||
145972129|NCT01572792|526410523|FG004|Extension Study|Lack of Efficacy|2|||
146088193|NCT05985980|526841967|FG000|Overall Study|Withdrawal by Subject|1|||
146088194|NCT03576274|526841969|FG000|Overall Study|Lost to Follow-up|3|||
146088195|NCT03576274|526841970|FG001|Overall Study|Lost to Follow-up|2|||
146237590|NCT02401815|527382824|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146088196|NCT03576274|526841971|FG002|Overall Study|Lost to Follow-up|3|||
146088197|NCT03576274|526841972|FG003|Overall Study|Lost to Follow-up|1|||
146088198|NCT03576274|526841973|FG004|Overall Study|Lost to Follow-up|3|||
146088199|NCT03576274|526841969|FG000|Overall Study|Withdrawal by Subject|5|||
145895007|NCT00985712|526123639|FG000|Overall Study|Sponsor decision|0|||
145895008|NCT00985712|526123640|FG001|Overall Study|Sponsor decision|2|||
145895009|NCT03096847|526123641|FG000|Overall Study|Other|2|||
146088200|NCT03576274|526841970|FG001|Overall Study|Withdrawal by Subject|3|||
146237591|NCT02401815|527382825|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146237592|NCT02401815|527382826|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146296364|NCT02146326|527600623|FG002|Overall Study|Lost to Follow-up|11|||
145895010|NCT03096847|526123642|FG001|Overall Study|Other|1|||
145895011|NCT03096847|526123643|FG002|Overall Study|Other|2|||
145895012|NCT03096847|526123641|FG000|Overall Study|Lost to Follow-up|1|||
145972130|NCT01572792|526410519|FG000|Extension Study|Adverse Event|7|||
145972131|NCT01572792|526410520|FG001|Extension Study|Adverse Event|6|||
145972132|NCT01572792|526410521|FG002|Extension Study|Adverse Event|5|||
145972133|NCT01572792|526410522|FG003|Extension Study|Adverse Event|6|||
146237593|NCT02401815|527382827|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146237594|NCT02401815|527382828|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
146237595|NCT02401815|527382829|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
146237596|NCT02401815|527382830|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
146237597|NCT02401815|527382831|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
146237598|NCT02401815|527382822|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237599|NCT02401815|527382823|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237600|NCT02401815|527382824|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237601|NCT02401815|527382825|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237602|NCT02401815|527382826|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237603|NCT02401815|527382827|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237604|NCT02401815|527382828|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237605|NCT02401815|527382829|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
146237606|NCT02401815|527382830|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
146237607|NCT02401815|527382831|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
146237608|NCT02401815|527382822|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237609|NCT02401815|527382823|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237610|NCT02401815|527382824|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237611|NCT02401815|527382825|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237612|NCT02401815|527382826|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237613|NCT02401815|527382827|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237614|NCT02401815|527382828|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237615|NCT02401815|527382829|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237616|NCT02401815|527382830|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
146237617|NCT02401815|527382831|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
146237618|NCT02401815|527382822|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237619|NCT02401815|527382823|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237620|NCT02401815|527382824|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237621|NCT02401815|527382825|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237622|NCT02401815|527382826|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237623|NCT02401815|527382827|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237624|NCT02401815|527382828|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237625|NCT02401815|527382829|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237626|NCT02401815|527382830|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
146237627|NCT02401815|527382831|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
146237628|NCT02401815|527382822|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237629|NCT02401815|527382823|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237630|NCT02401815|527382824|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237631|NCT02401815|527382825|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237632|NCT02401815|527382826|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237633|NCT02401815|527382827|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237634|NCT02401815|527382828|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
146237635|NCT02401815|527382829|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
146237636|NCT02401815|527382830|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145895013|NCT03096847|526123642|FG001|Overall Study|Lost to Follow-up|0|||
145895014|NCT03096847|526123643|FG002|Overall Study|Lost to Follow-up|1|||
145895015|NCT03096847|526123641|FG000|Overall Study|Death|6|||
145895016|NCT03096847|526123642|FG001|Overall Study|Death|0|||
145895017|NCT03096847|526123643|FG002|Overall Study|Death|2|||
145895018|NCT03096847|526123641|FG000|Overall Study|Protocol Violation|3|||
145895019|NCT03096847|526123642|FG001|Overall Study|Protocol Violation|0|||
145895020|NCT03096847|526123643|FG002|Overall Study|Protocol Violation|6|||
145895021|NCT03096847|526123641|FG000|Overall Study|Physician Decision|12|||
145895022|NCT03096847|526123642|FG001|Overall Study|Physician Decision|2|||
145895023|NCT03096847|526123643|FG002|Overall Study|Physician Decision|8|||
145895024|NCT03096847|526123641|FG000|Overall Study|Withdrawal by Subject|24|||
145895025|NCT03096847|526123642|FG001|Overall Study|Withdrawal by Subject|1|||
145895026|NCT03096847|526123643|FG002|Overall Study|Withdrawal by Subject|12|||
145895027|NCT03096847|526123641|FG000|Overall Study|Adverse Event|72|||
145895028|NCT03096847|526123642|FG001|Overall Study|Adverse Event|6|||
145895029|NCT03096847|526123643|FG002|Overall Study|Adverse Event|28|||
145895030|NCT03096847|526123641|FG000|Overall Study|Progressive disease|97|||
145895031|NCT03096847|526123642|FG001|Overall Study|Progressive disease|10|||
145895032|NCT03096847|526123643|FG002|Overall Study|Progressive disease|78|||
145895033|NCT03096847|526123641|FG000|Overall Study|Non-compliance with study medication|1|||
145895034|NCT03096847|526123642|FG001|Overall Study|Non-compliance with study medication|0|||
145972134|NCT01572792|526410523|FG004|Extension Study|Adverse Event|4|||
145972135|NCT01572792|526410519|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
145972136|NCT01572792|526410520|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
145972137|NCT01572792|526410521|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
145972138|NCT01572792|526410522|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
145972139|NCT01572792|526410523|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
145972140|NCT02472353|526410524|FG000|Overall Study|Lost to Follow-up|1|||
145972141|NCT02472353|526410525|FG001|Overall Study|Lost to Follow-up|1|||
145972142|NCT02472353|526410524|FG000|Overall Study|Withdrawal by Subject|2|||
145972143|NCT02472353|526410525|FG001|Overall Study|Withdrawal by Subject|1|||
145972144|NCT02472353|526410524|FG000|Overall Study|Study Termination|1|||
145972145|NCT02472353|526410525|FG001|Overall Study|Study Termination|4|||
145972146|NCT00797563|526410526|FG000|Overall Study|Adverse Event|1|||
145972147|NCT03416179|526410527|FG000|Overall Study|Death|90|||
145972148|NCT03416179|526410528|FG001|Overall Study|Death|87|||
145972149|NCT03416179|526410529|FG002|Overall Study|Death|117|||
145972150|NCT03416179|526410530|FG003|Overall Study|Death|113|||
145972151|NCT03416179|526410527|FG000|Overall Study|Withdrawal by Subject|15|||
145972152|NCT03416179|526410528|FG001|Overall Study|Withdrawal by Subject|20|||
145972153|NCT03416179|526410529|FG002|Overall Study|Withdrawal by Subject|6|||
145972154|NCT03416179|526410530|FG003|Overall Study|Withdrawal by Subject|9|||
145972155|NCT03416179|526410527|FG000|Overall Study|Lost to Follow-up|1|||
145972156|NCT03416179|526410528|FG001|Overall Study|Lost to Follow-up|1|||
145972157|NCT03416179|526410529|FG002|Overall Study|Lost to Follow-up|0|||
145972158|NCT03416179|526410530|FG003|Overall Study|Lost to Follow-up|3|||
145972159|NCT03416179|526410527|FG000|Overall Study|Study participation terminated by Sponsor|93|||
145972160|NCT03416179|526410528|FG001|Overall Study|Study participation terminated by Sponsor|91|||
145972161|NCT03416179|526410529|FG002|Overall Study|Study participation terminated by Sponsor|26|||
145972162|NCT03416179|526410530|FG003|Overall Study|Study participation terminated by Sponsor|31|||
145972163|NCT03416179|526410527|FG000|Overall Study|Other|2|||
145972164|NCT03416179|526410528|FG001|Overall Study|Other|3|||
145972165|NCT03416179|526410529|FG002|Overall Study|Other|1|||
145972166|NCT03416179|526410530|FG003|Overall Study|Other|0|||
145972167|NCT00688597|526410532|FG000|Overall Study|Adverse Event|2|||
145895035|NCT03096847|526123643|FG002|Overall Study|Non-compliance with study medication|0|||
145895036|NCT03096847|526123641|FG000|Overall Study|New therapy for study indication|1|||
145895037|NCT03096847|526123642|FG001|Overall Study|New therapy for study indication|0|||
145895038|NCT03096847|526123643|FG002|Overall Study|New therapy for study indication|1|||
145895039|NCT00359632|526123644|FG000|Overall Study|Death|2|||
145895040|NCT00359632|526123645|FG001|Overall Study|Death|0|||
145895041|NCT00359632|526123644|FG000|Overall Study|Adverse Event|1|||
145895042|NCT00359632|526123645|FG001|Overall Study|Adverse Event|0|||
145895043|NCT00359632|526123644|FG000|Overall Study|Non-compliance with visit schedule|1|||
145895044|NCT00359632|526123645|FG001|Overall Study|Non-compliance with visit schedule|0|||
145895045|NCT02458092|526123651|FG000|Overall Study|Withdrawal by Subject|1|||
145895046|NCT02458092|526123652|FG001|Overall Study|Withdrawal by Subject|0|||
145895047|NCT00251641|526123653|FG000|Overall Study|Adverse Event|80|||
145895048|NCT00251641|526123654|FG001|Overall Study|Adverse Event|8|||
145895049|NCT00251641|526123653|FG000|Overall Study|Lack of Efficacy|2|||
145895050|NCT00251641|526123654|FG001|Overall Study|Lack of Efficacy|1|||
145895051|NCT00251641|526123653|FG000|Overall Study|Progression of Disease|0|||
145895052|NCT00251641|526123654|FG001|Overall Study|Progression of Disease|2|||
145895053|NCT00251641|526123653|FG000|Overall Study|Lost to Follow-up|3|||
145895054|NCT00251641|526123654|FG001|Overall Study|Lost to Follow-up|3|||
145895055|NCT00251641|526123653|FG000|Overall Study|Withdrawal by Subject|6|||
145895056|NCT00251641|526123654|FG001|Overall Study|Withdrawal by Subject|8|||
145895057|NCT00251641|526123653|FG000|Overall Study|Protocol Violation|10|||
145895058|NCT00251641|526123654|FG001|Overall Study|Protocol Violation|2|||
145895059|NCT00251641|526123653|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
145895060|NCT00251641|526123654|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
145895061|NCT00251641|526123653|FG000|Overall Study|Switched Treatment|9|||
145895062|NCT00251641|526123654|FG001|Overall Study|Switched Treatment|63|||
145895063|NCT00876018|526123655|FG000|Overall Study|Lost to Follow-up|0|||
145895064|NCT00876018|526123656|FG001|Overall Study|Lost to Follow-up|1|||
145895065|NCT00876018|526123657|FG002|Overall Study|Lost to Follow-up|1|||
145972168|NCT00688597|526410533|FG001|Overall Study|Adverse Event|0|||
145972169|NCT00688597|526410534|FG002|Overall Study|Adverse Event|0|||
145972170|NCT00688597|526410532|FG000|Overall Study|Physician Decision|1|||
145972171|NCT00688597|526410533|FG001|Overall Study|Physician Decision|0|||
145972172|NCT00688597|526410534|FG002|Overall Study|Physician Decision|0|||
145972173|NCT06438601|526410535|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
145972174|NCT06438601|526410536|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
145972175|NCT06438601|526410535|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
146056114|NCT00117637|526721100|FG001|Second Intervention (Period 2)|Adverse Event|9|||
146056115|NCT00117637|526721099|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
145895066|NCT00876018|526123655|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
145895067|NCT00876018|526123656|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
145972176|NCT06438601|526410536|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
145972177|NCT05233761|526410539|FG000|Treatment Period A|Withdrawal by Subject|12|||
145972178|NCT05233761|526410540|FG001|Treatment Period A|Withdrawal by Subject|10|||
145972179|NCT05233761|526410539|FG000|Treatment Period A|Lost to Follow-up|6|||
145972180|NCT05233761|526410540|FG001|Treatment Period A|Lost to Follow-up|12|||
145972181|NCT05233761|526410539|FG000|Treatment Period A|Protocol Violation|8|||
145972182|NCT05233761|526410540|FG001|Treatment Period A|Protocol Violation|15|||
145972183|NCT04058717|526410545|FG000|Randomization Period|Lost to Follow-up|2|||
145972184|NCT04058717|526410546|FG001|Randomization Period|Lost to Follow-up|3|||
145972185|NCT04058717|526410547|FG002|Randomization Period|Lost to Follow-up|4|||
145972186|NCT04058717|526410548|FG003|Randomization Period|Lost to Follow-up|4|||
145972187|NCT04058717|526410545|FG000|Randomization Period|Withdrawal by Subject|1|||
145972188|NCT04058717|526410546|FG001|Randomization Period|Withdrawal by Subject|3|||
145972189|NCT04058717|526410547|FG002|Randomization Period|Withdrawal by Subject|3|||
145972190|NCT04058717|526410548|FG003|Randomization Period|Withdrawal by Subject|3|||
145972191|NCT04058717|526410545|FG000|Randomization Period|PI decision|0|||
145972192|NCT04058717|526410546|FG001|Randomization Period|PI decision|1|||
145972193|NCT04058717|526410547|FG002|Randomization Period|PI decision|0|||
145972194|NCT04058717|526410548|FG003|Randomization Period|PI decision|0|||
145972195|NCT01925417|526410549|FG000|Overall Study|Withdrawal by Subject|2|||
145972196|NCT01925417|526410549|FG000|Overall Study|Death|1|||
145972197|NCT01047319|526410550|FG000|Overall Study|Teva requested participant withdrawal|3|||
145972198|NCT01047319|526410551|FG001|Overall Study|Teva requested participant withdrawal|0|||
145972199|NCT01047319|526410552|FG002|Overall Study|Teva requested participant withdrawal|1|||
145972200|NCT01047319|526410550|FG000|Overall Study|Protocol Violation|3|||
145972201|NCT01047319|526410551|FG001|Overall Study|Protocol Violation|2|||
145972202|NCT01047319|526410552|FG002|Overall Study|Protocol Violation|4|||
145972203|NCT01047319|526410550|FG000|Overall Study|Lack of Efficacy|4|||
145972204|NCT01047319|526410551|FG001|Overall Study|Lack of Efficacy|3|||
145972205|NCT01047319|526410552|FG002|Overall Study|Lack of Efficacy|3|||
145972206|NCT01047319|526410550|FG000|Overall Study|Death|5|||
145972207|NCT01047319|526410551|FG001|Overall Study|Death|1|||
145972208|NCT01047319|526410552|FG002|Overall Study|Death|5|||
145972209|NCT01047319|526410550|FG000|Overall Study|Pregnancy|13|||
145972210|NCT01047319|526410551|FG001|Overall Study|Pregnancy|8|||
145972211|NCT01047319|526410552|FG002|Overall Study|Pregnancy|8|||
145972212|NCT01047319|526410550|FG000|Overall Study|Physician Decision|12|||
145972213|NCT01047319|526410551|FG001|Overall Study|Physician Decision|9|||
145972214|NCT01047319|526410552|FG002|Overall Study|Physician Decision|10|||
145972215|NCT01047319|526410550|FG000|Overall Study|Lost to Follow-up|14|||
145972216|NCT01047319|526410551|FG001|Overall Study|Lost to Follow-up|10|||
145972217|NCT01047319|526410552|FG002|Overall Study|Lost to Follow-up|10|||
145972218|NCT01047319|526410550|FG000|Overall Study|Adverse Event|16|||
145972219|NCT01047319|526410551|FG001|Overall Study|Adverse Event|27|||
145972220|NCT01047319|526410552|FG002|Overall Study|Adverse Event|21|||
145972221|NCT01047319|526410550|FG000|Overall Study|Withdrawal by Subject|77|||
145972222|NCT01047319|526410551|FG001|Overall Study|Withdrawal by Subject|75|||
145972223|NCT01047319|526410552|FG002|Overall Study|Withdrawal by Subject|87|||
145972224|NCT01047319|526410550|FG000|Overall Study|Study terminated by Sponsor|198|||
145972225|NCT01047319|526410551|FG001|Overall Study|Study terminated by Sponsor|215|||
145972226|NCT01047319|526410552|FG002|Overall Study|Study terminated by Sponsor|203|||
146088201|NCT03576274|526841971|FG002|Overall Study|Withdrawal by Subject|2|||
146088202|NCT03576274|526841972|FG003|Overall Study|Withdrawal by Subject|8|||
145895068|NCT00876018|526123657|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
145895069|NCT01230892|526123658|FG000|Overall Study|Withdrawal by Subject|1|||
145895070|NCT01230892|526123659|FG001|Overall Study|Withdrawal by Subject|1|||
145895071|NCT01230892|526123658|FG000|Overall Study|Lost to Follow-up|2|||
145895072|NCT01230892|526123659|FG001|Overall Study|Lost to Follow-up|0|||
145895073|NCT00725621|526123662|FG000|Overall Study|Adverse Event|25|||
145895074|NCT00725621|526123662|FG000|Overall Study|Lack of Efficacy|46|||
145895075|NCT00725621|526123662|FG000|Overall Study|Withdrawal by Subject|57|||
145895076|NCT00725621|526123662|FG000|Overall Study|Physician Decision|19|||
145895077|NCT00725621|526123662|FG000|Overall Study|Lost to Follow-up|52|||
145972227|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
145972228|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
145972229|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
145972230|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Death|0|||
145895078|NCT00725621|526123662|FG000|Overall Study|Non-compliance|8|||
145895079|NCT00725621|526123662|FG000|Overall Study|Continued treatment by other physician|6|||
145895080|NCT00725621|526123662|FG000|Overall Study|Switched to other study|1|||
145972231|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Death|0|||
145972232|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Death|1|||
145972233|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
145972234|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
145972235|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
145972236|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
146237637|NCT02401815|527382831|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
146237638|NCT00748709|527382832|FG000|Overall Study|Progressive disease|15|||
145895081|NCT00725621|526123662|FG000|Overall Study|Switched to other drug|1|||
145895082|NCT00725621|526123662|FG000|Overall Study|Prepared for elective surgery|1|||
145895083|NCT00725621|526123662|FG000|Overall Study|Reason not specified|55|||
145895084|NCT01189500|526123663|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
145895085|NCT01189500|526123663|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
145895086|NCT01000493|526123664|FG000|Overall Study|Adverse Event|3|||
145895087|NCT01000493|526123665|FG001|Overall Study|Adverse Event|6|||
145895088|NCT01000493|526123664|FG000|Overall Study|Lack of Efficacy|1|||
145895089|NCT01000493|526123665|FG001|Overall Study|Lack of Efficacy|1|||
145895090|NCT01000493|526123664|FG000|Overall Study|Protocol Violation|1|||
145895091|NCT01000493|526123665|FG001|Overall Study|Protocol Violation|8|||
145895092|NCT01000493|526123664|FG000|Overall Study|Study closed/terminated|25|||
145895093|NCT01000493|526123665|FG001|Overall Study|Study closed/terminated|23|||
145895094|NCT01000493|526123664|FG000|Overall Study|Lost to Follow-up|5|||
145895095|NCT01000493|526123665|FG001|Overall Study|Lost to Follow-up|9|||
145895096|NCT01000493|526123664|FG000|Overall Study|Physician Decision|1|||
145895097|NCT01000493|526123665|FG001|Overall Study|Physician Decision|1|||
145895098|NCT01000493|526123664|FG000|Overall Study|Withdrawal by Subject|3|||
145895099|NCT01000493|526123665|FG001|Overall Study|Withdrawal by Subject|7|||
145895100|NCT01144364|526123671|FG000|Induction Phase|Disease progression|14|||
145895101|NCT01144364|526123672|FG001|Induction Phase|Disease progression|0|||
145895102|NCT01144364|526123673|FG002|Induction Phase|Disease progression|0|||
145895103|NCT01144364|526123671|FG000|Induction Phase|Adverse Event|9|||
145895104|NCT01144364|526123672|FG001|Induction Phase|Adverse Event|0|||
145895105|NCT01144364|526123673|FG002|Induction Phase|Adverse Event|0|||
145895106|NCT01144364|526123671|FG000|Induction Phase|Death|1|||
145972237|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
145972238|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
145972239|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
145972240|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
145972241|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
145972242|NCT02696798|526410554|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
145972243|NCT02696798|526410555|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
145972244|NCT02696798|526410556|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
145972245|NCT02696798|526410554|FG000|Extended Treatment Period|Adverse Event|1|||
145972246|NCT02696798|526410555|FG001|Extended Treatment Period|Adverse Event|4|||
145972247|NCT02696798|526410556|FG002|Extended Treatment Period|Adverse Event|5|||
145972248|NCT02696798|526410554|FG000|Extended Treatment Period|Lack of Efficacy|7|||
145972249|NCT02696798|526410555|FG001|Extended Treatment Period|Lack of Efficacy|2|||
145972250|NCT02696798|526410556|FG002|Extended Treatment Period|Lack of Efficacy|2|||
145972251|NCT02696798|526410554|FG000|Extended Treatment Period|Lost to Follow-up|1|||
145972252|NCT02696798|526410555|FG001|Extended Treatment Period|Lost to Follow-up|0|||
145972253|NCT02696798|526410556|FG002|Extended Treatment Period|Lost to Follow-up|0|||
145972254|NCT02696798|526410554|FG000|Extended Treatment Period|Physician Decision|0|||
145972255|NCT02696798|526410555|FG001|Extended Treatment Period|Physician Decision|1|||
145972256|NCT02696798|526410556|FG002|Extended Treatment Period|Physician Decision|0|||
145972257|NCT02696798|526410554|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
145972258|NCT02696798|526410555|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
145972259|NCT02696798|526410556|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
145972260|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
145972261|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
145972262|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
145972263|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
145972264|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
145972265|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
145972266|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
145972267|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
145972268|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
145972269|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
145972270|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
145972271|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
145972272|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
145972273|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
145972274|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
145972275|NCT02696798|526410554|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
145972276|NCT02696798|526410555|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
146237639|NCT00748709|527382832|FG000|Overall Study|Drug reducing Toxity|2|||
146237640|NCT00748709|527382832|FG000|Overall Study|Other Adverse Event|1|||
145895107|NCT01144364|526123672|FG001|Induction Phase|Death|0|||
146237641|NCT00748709|527382832|FG000|Overall Study|Withdrawal by Subject|1|||
145895108|NCT01144364|526123673|FG002|Induction Phase|Death|0|||
145895109|NCT01144364|526123671|FG000|Induction Phase|Withdrawal by Subject|1|||
145895110|NCT01144364|526123672|FG001|Induction Phase|Withdrawal by Subject|0|||
145895111|NCT01144364|526123673|FG002|Induction Phase|Withdrawal by Subject|0|||
145895112|NCT01144364|526123671|FG000|Induction Phase|Lost to Follow-up|2|||
145895113|NCT01144364|526123672|FG001|Induction Phase|Lost to Follow-up|0|||
145895114|NCT01144364|526123673|FG002|Induction Phase|Lost to Follow-up|0|||
145895115|NCT01144364|526123671|FG000|Induction Phase|Physician Decision|1|||
145895116|NCT01144364|526123672|FG001|Induction Phase|Physician Decision|0|||
145895117|NCT01144364|526123673|FG002|Induction Phase|Physician Decision|0|||
145895118|NCT01144364|526123671|FG000|Induction Phase|Stable disease|2|||
145895119|NCT01144364|526123672|FG001|Induction Phase|Stable disease|0|||
145895120|NCT01144364|526123673|FG002|Induction Phase|Stable disease|0|||
145895121|NCT01144364|526123671|FG000|Induction Phase|Secondary neoplasia|1|||
145895122|NCT01144364|526123672|FG001|Induction Phase|Secondary neoplasia|0|||
145895123|NCT01144364|526123673|FG002|Induction Phase|Secondary neoplasia|0|||
145895124|NCT01144364|526123671|FG000|Induction Phase|Protocol Violation|1|||
145895125|NCT01144364|526123672|FG001|Induction Phase|Protocol Violation|0|||
145895126|NCT01144364|526123673|FG002|Induction Phase|Protocol Violation|0|||
145895127|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
145895128|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
145895129|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
145895130|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
145895131|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
145895132|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
145895133|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Death|0|||
145895134|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Death|2|||
145895135|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Death|0|||
145895136|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
145895137|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
145895138|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
145895139|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
145895140|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
145895141|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
145895142|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
145895143|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
145895144|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
145895145|NCT01144364|526123671|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
145895146|NCT01144364|526123672|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
145895147|NCT01144364|526123673|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
145895148|NCT02989168|526123674|FG000|Overall Study|Withdrawal by Subject|2|||
145895149|NCT02989168|526123675|FG001|Overall Study|Withdrawal by Subject|0|||
145895150|NCT02989168|526123674|FG000|Overall Study|Physician Decision|0|||
145895151|NCT02989168|526123675|FG001|Overall Study|Physician Decision|1|||
145895152|NCT02989168|526123674|FG000|Overall Study|Adverse Event|1|||
145895153|NCT02989168|526123675|FG001|Overall Study|Adverse Event|2|||
145895154|NCT02989168|526123674|FG000|Overall Study|Sponsor stopped study.|1|||
145895155|NCT02989168|526123675|FG001|Overall Study|Sponsor stopped study.|0|||
145895156|NCT03456960|526123676|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145895157|NCT03456960|526123677|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145895158|NCT03456960|526123678|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
145895159|NCT03456960|526123679|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
145895160|NCT03456960|526123680|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145895161|NCT03456960|526123681|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145895162|NCT03456960|526123676|FG000|Period 2 (1 Day)|Adverse Event|1|||
145895163|NCT03456960|526123677|FG001|Period 2 (1 Day)|Adverse Event|0|||
145895164|NCT03456960|526123678|FG002|Period 2 (1 Day)|Adverse Event|0|||
145895165|NCT03456960|526123679|FG003|Period 2 (1 Day)|Adverse Event|1|||
145895166|NCT03456960|526123680|FG004|Period 2 (1 Day)|Adverse Event|0|||
145895167|NCT03456960|526123681|FG005|Period 2 (1 Day)|Adverse Event|0|||
145895168|NCT00532935|526123682|FG000|Overall Study|Adverse Event|11|||
145895169|NCT00532935|526123683|FG001|Overall Study|Adverse Event|12|||
145895170|NCT00532935|526123682|FG000|Overall Study|Lack of Efficacy|0|||
145895171|NCT00532935|526123683|FG001|Overall Study|Lack of Efficacy|3|||
145895172|NCT00532935|526123682|FG000|Overall Study|Lost to Follow-up|10|||
145895173|NCT00532935|526123683|FG001|Overall Study|Lost to Follow-up|6|||
145972277|NCT02696798|526410556|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
145972278|NCT01277861|526410557|FG000|Overall Study|Physician Decision|2|||
145972279|NCT01277861|526410558|FG001|Overall Study|Physician Decision|2|||
146237642|NCT00748709|527382832|FG000|Overall Study|Other Reasons|1|||
145895174|NCT00532935|526123682|FG000|Overall Study|Physician Decision|4|||
145895175|NCT00532935|526123683|FG001|Overall Study|Physician Decision|5|||
145895176|NCT00532935|526123682|FG000|Overall Study|Pregnancy|1|||
145895177|NCT00532935|526123683|FG001|Overall Study|Pregnancy|0|||
145895178|NCT00532935|526123682|FG000|Overall Study|Protocol Violation|4|||
145972280|NCT01157845|526410559|FG000|Overall Study|Lost to Follow-up|5|||
145895179|NCT00532935|526123683|FG001|Overall Study|Protocol Violation|2|||
145895180|NCT00532935|526123682|FG000|Overall Study|Withdrawal by Subject|10|||
145895181|NCT00532935|526123683|FG001|Overall Study|Withdrawal by Subject|9|||
145895182|NCT00532935|526123682|FG000|Overall Study|Protocol Specific Criteria|11|||
145895183|NCT00532935|526123683|FG001|Overall Study|Protocol Specific Criteria|15|||
145895184|NCT01301508|526123684|FG000|Overall Study|Withdrawal by Subject|1|||
145895185|NCT01301508|526123685|FG001|Overall Study|Withdrawal by Subject|2|||
145895186|NCT01301508|526123684|FG000|Overall Study|Lost to Follow-up|0|||
146088203|NCT03576274|526841973|FG004|Overall Study|Withdrawal by Subject|6|||
146088204|NCT04854642|526843763|FG000|Overall Study|Adverse Event|1|||
146088205|NCT04854642|526843764|FG001|Overall Study|Adverse Event|2|||
146088206|NCT04854642|526843763|FG000|Overall Study|Withdrawal by Subject|0|||
146088207|NCT04854642|526843764|FG001|Overall Study|Withdrawal by Subject|1|||
146088208|NCT03387150|526843769|FG000|Overall Study|Withdrawal by Subject|3|||
146088209|NCT03387150|526843770|FG001|Overall Study|Withdrawal by Subject|0|||
146088210|NCT03387150|526843771|FG002|Overall Study|Withdrawal by Subject|3|||
145895187|NCT01301508|526123685|FG001|Overall Study|Lost to Follow-up|1|||
145895188|NCT01300923|526123686|FG000|Overall Study|Physician Decision|0|||
145895189|NCT01300923|526123687|FG001|Overall Study|Physician Decision|2|||
145895190|NCT01940497|526123690|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
145895191|NCT01940497|526123691|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
145895192|NCT01940497|526123690|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
145895193|NCT01940497|526123691|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
145895194|NCT01940497|526123690|FG000|Overall Study|Violation of Entry Criteria|1|||
145895195|NCT01940497|526123691|FG001|Overall Study|Violation of Entry Criteria|1|||
145895196|NCT01940497|526123690|FG000|Overall Study|Refused Treatment|1|||
145895197|NCT01940497|526123691|FG001|Overall Study|Refused Treatment|3|||
145895198|NCT01940497|526123690|FG000|Overall Study|Withdrew Consent|6|||
145895199|NCT01940497|526123691|FG001|Overall Study|Withdrew Consent|2|||
145895200|NCT01940497|526123690|FG000|Overall Study|Administrative/Other|1|||
145895201|NCT01940497|526123691|FG001|Overall Study|Administrative/Other|1|||
145895202|NCT02707861|526123692|FG000|Overall Study|Went onto commercial drug|30|||
145895203|NCT02707861|526123693|FG001|Overall Study|Went onto commercial drug|23|||
145895204|NCT02707861|526123692|FG000|Overall Study|Adverse Event|2|||
145895205|NCT02707861|526123693|FG001|Overall Study|Adverse Event|3|||
145895206|NCT02707861|526123692|FG000|Overall Study|Death|5|||
145895207|NCT02707861|526123693|FG001|Overall Study|Death|2|||
145895208|NCT02707861|526123692|FG000|Overall Study|Lack of Efficacy|0|||
145895209|NCT02707861|526123693|FG001|Overall Study|Lack of Efficacy|2|||
145895210|NCT02707861|526123692|FG000|Overall Study|Physician Decision|1|||
145895211|NCT02707861|526123693|FG001|Overall Study|Physician Decision|4|||
145895212|NCT02707861|526123692|FG000|Overall Study|Withdrawal by Subject|2|||
145895213|NCT02707861|526123693|FG001|Overall Study|Withdrawal by Subject|1|||
145895214|NCT02707861|526123692|FG000|Overall Study|Lost to Follow-up|1|||
145895215|NCT02707861|526123693|FG001|Overall Study|Lost to Follow-up|3|||
145895216|NCT03123861|526123694|FG000|Overall Study|Protocol Violation|1|||
145895217|NCT03123861|526123695|FG001|Overall Study|Protocol Violation|1|||
145895218|NCT03123861|526123694|FG000|Overall Study|Withdrawal by Subject|2|||
145895219|NCT03123861|526123695|FG001|Overall Study|Withdrawal by Subject|2|||
145895220|NCT00448136|526123698|FG000|Overall Study|Death|3|||
145895221|NCT00448136|526123699|FG001|Overall Study|Death|8|||
145895222|NCT00448136|526123698|FG000|Overall Study|Investigator's decision (progression)|1|||
145895223|NCT00448136|526123699|FG001|Overall Study|Investigator's decision (progression)|0|||
145895224|NCT03407430|526123702|FG000|Washout|Protocol Violation|1|||
145895225|NCT03407430|526123703|FG001|Washout|Protocol Violation|0|||
145895226|NCT00922987|526123705|FG000|Overall Study|Insufficient clinical response|1|||
145895227|NCT00922987|526123705|FG000|Overall Study|Protocol Violation|2|||
145895228|NCT00922987|526123705|FG000|Overall Study|Adverse Event|1|||
146088211|NCT03387150|526843772|FG003|Overall Study|Withdrawal by Subject|4|||
146088212|NCT03387150|526843773|FG004|Overall Study|Withdrawal by Subject|1|||
146088213|NCT03387150|526843774|FG005|Overall Study|Withdrawal by Subject|2|||
146237643|NCT02751528|527382837|FG000|Overall Study|Withdrawal by Subject|1|||
146088214|NCT03387150|526843775|FG006|Overall Study|Withdrawal by Subject|0|||
146237644|NCT02751528|527382837|FG000|Overall Study|Adverse Event|1|||
146237645|NCT05199571|527384281|FG000|Treatment Period|Participant decision|3|||
145895229|NCT04969861|526123706|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
145895230|NCT04969861|526123707|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
145895231|NCT00290251|526123708|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145895232|NCT00290251|526123709|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145895233|NCT00290251|526123710|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145895234|NCT00290251|526123711|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145895235|NCT00290251|526123712|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145895236|NCT00290251|526123713|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
145895237|NCT00290251|526123708|FG000|Treatment 1 (Months 2-4)|headache|0|||
145895238|NCT00290251|526123709|FG001|Treatment 1 (Months 2-4)|headache|0|||
145895239|NCT00290251|526123710|FG002|Treatment 1 (Months 2-4)|headache|0|||
145972281|NCT01157845|526410559|FG000|Overall Study|Withdrawal by Subject|12|||
145972282|NCT01157845|526410559|FG000|Overall Study|Physician Decision|3|||
145972283|NCT01157845|526410559|FG000|Overall Study|Protocol Violation|13|||
145972284|NCT01157845|526410559|FG000|Overall Study|Study was ended|1|||
145972285|NCT01157845|526410559|FG000|Overall Study|Device malfunction|1|||
145972286|NCT03311555|526410560|FG000|Overall Study|Adverse Event|1|||
145972287|NCT05493111|526412612|FG000|Overall Study|Adverse Event|3|||
145972288|NCT05493111|526412613|FG001|Overall Study|Adverse Event|4|||
145972289|NCT05493111|526412612|FG000|Overall Study|Withdrawal of Consent|19|||
145972290|NCT05493111|526412613|FG001|Overall Study|Withdrawal of Consent|10|||
146296365|NCT02146326|527600624|FG003|Overall Study|Lost to Follow-up|19|||
145972291|NCT05493111|526412612|FG000|Overall Study|Non-compliance|1|||
145972292|NCT05493111|526412613|FG001|Overall Study|Non-compliance|1|||
145972293|NCT05493111|526412612|FG000|Overall Study|Lost to Follow-up|8|||
145972294|NCT05493111|526412613|FG001|Overall Study|Lost to Follow-up|1|||
145972295|NCT05493111|526412612|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
145972296|NCT05493111|526412613|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
146088215|NCT03387150|526843769|FG000|Overall Study|Lost to Follow-up|3|||
146237646|NCT05199571|527384281|FG000|Treatment Period|Physician Decision|1|||
146237647|NCT05199571|527384281|FG000|Post-treatment Follow up Period|Participant decision|3|||
146237648|NCT03367156|527384282|FG000|Overall Study|Lack of interest|3|||
146237649|NCT03367156|527384283|FG001|Overall Study|Lack of interest|1|||
145895240|NCT00290251|526123711|FG003|Treatment 1 (Months 2-4)|headache|0|||
145895241|NCT00290251|526123712|FG004|Treatment 1 (Months 2-4)|headache|1|||
145895242|NCT00290251|526123713|FG005|Treatment 1 (Months 2-4)|headache|0|||
145895243|NCT00290251|526123708|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
145895244|NCT00290251|526123709|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
145895245|NCT00290251|526123710|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
145895246|NCT00290251|526123711|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
145895247|NCT00290251|526123712|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
145895248|NCT00290251|526123713|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
145895249|NCT03303625|526125358|FG000|Overall Study|Withdrawal by Subject|2|||
145895250|NCT03303625|526125359|FG001|Overall Study|Withdrawal by Subject|0|||
145895251|NCT03303625|526125360|FG002|Overall Study|Withdrawal by Subject|0|||
145895252|NCT03303625|526125361|FG003|Overall Study|Withdrawal by Subject|0|||
145895253|NCT01288053|526125362|FG000|Overall Study|Death|1|||
145895254|NCT03188666|526125363|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
146237650|NCT03367156|527384282|FG000|Overall Study|Death|2|||
145895255|NCT03188666|526125364|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
145895256|NCT03188666|526125365|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
145895257|NCT03188666|526125366|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
145895258|NCT03188666|526125363|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
145895259|NCT03188666|526125364|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
145895260|NCT03188666|526125365|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
146237651|NCT03367156|527384283|FG001|Overall Study|Death|0|||
146237652|NCT03367156|527384282|FG000|Overall Study|Lost to Follow-up|2|||
146237653|NCT03367156|527384283|FG001|Overall Study|Lost to Follow-up|1|||
146237654|NCT03367156|527384282|FG000|Overall Study|Became ineligible|1|||
145895261|NCT03188666|526125366|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
145895262|NCT03188666|526125363|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145895263|NCT03188666|526125364|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145895264|NCT03188666|526125365|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
145895265|NCT03188666|526125366|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145895266|NCT03188666|526125363|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
145895267|NCT03188666|526125364|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
145895268|NCT03188666|526125365|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
145895269|NCT03188666|526125366|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
145895270|NCT00144781|526125367|FG000|Overall Study|Adverse Event|0|||
145895271|NCT00144781|526125368|FG001|Overall Study|Adverse Event|1|||
145895272|NCT00144781|526125369|FG002|Overall Study|Adverse Event|0|||
145895273|NCT00144781|526125370|FG003|Overall Study|Adverse Event|0|||
145895274|NCT00144781|526125367|FG000|Overall Study|Non-compliant|0|||
145895275|NCT00144781|526125368|FG001|Overall Study|Non-compliant|1|||
145895276|NCT00144781|526125369|FG002|Overall Study|Non-compliant|0|||
145895277|NCT00144781|526125370|FG003|Overall Study|Non-compliant|0|||
145895278|NCT02068092|526125371|FG000|Overall Study|Physician Decision|2|||
145895279|NCT02068092|526125371|FG000|Overall Study|Adverse Event|2|||
145895280|NCT02068092|526125371|FG000|Overall Study|Lost to Follow-up|4|||
145895281|NCT02068092|526125371|FG000|Overall Study|Withdrawal by Subject|2|||
145895282|NCT03502707|526125372|FG000|Overall Study|Adverse Event|0|||
145895283|NCT03502707|526125373|FG001|Overall Study|Adverse Event|0|||
145895284|NCT03502707|526125374|FG002|Overall Study|Adverse Event|0|||
145895285|NCT03502707|526125375|FG003|Overall Study|Adverse Event|0|||
145895286|NCT03502707|526125376|FG004|Overall Study|Adverse Event|0|||
145895287|NCT03502707|526125377|FG005|Overall Study|Adverse Event|0|||
145895288|NCT03502707|526125378|FG006|Overall Study|Adverse Event|0|||
145895289|NCT03502707|526125379|FG007|Overall Study|Adverse Event|0|||
145895290|NCT03502707|526125380|FG008|Overall Study|Adverse Event|0|||
145895291|NCT03502707|526125381|FG009|Overall Study|Adverse Event|0|||
145895292|NCT03502707|526125382|FG010|Overall Study|Adverse Event|0|||
145895293|NCT03502707|526125383|FG011|Overall Study|Adverse Event|0|||
145895294|NCT03502707|526125384|FG012|Overall Study|Adverse Event|0|||
145895295|NCT03502707|526125385|FG013|Overall Study|Adverse Event|0|||
145895296|NCT03502707|526125386|FG014|Overall Study|Adverse Event|0|||
145895297|NCT03502707|526125387|FG015|Overall Study|Adverse Event|1|||
145895298|NCT03502707|526125388|FG016|Overall Study|Adverse Event|5|||
145895299|NCT03502707|526125389|FG017|Overall Study|Adverse Event|0|||
145895300|NCT03502707|526125372|FG000|Overall Study|Death|0|||
145895301|NCT03502707|526125373|FG001|Overall Study|Death|0|||
145895302|NCT03502707|526125374|FG002|Overall Study|Death|0|||
145895303|NCT03502707|526125375|FG003|Overall Study|Death|1|||
145895304|NCT03502707|526125376|FG004|Overall Study|Death|0|||
145895305|NCT03502707|526125377|FG005|Overall Study|Death|0|||
145895306|NCT03502707|526125378|FG006|Overall Study|Death|0|||
145895307|NCT03502707|526125379|FG007|Overall Study|Death|0|||
145895308|NCT03502707|526125380|FG008|Overall Study|Death|1|||
145895309|NCT03502707|526125381|FG009|Overall Study|Death|1|||
145895310|NCT03502707|526125382|FG010|Overall Study|Death|0|||
145895311|NCT03502707|526125383|FG011|Overall Study|Death|0|||
145895312|NCT03502707|526125384|FG012|Overall Study|Death|1|||
145895313|NCT03502707|526125385|FG013|Overall Study|Death|0|||
145895314|NCT03502707|526125386|FG014|Overall Study|Death|0|||
145895315|NCT03502707|526125387|FG015|Overall Study|Death|1|||
145895316|NCT03502707|526125388|FG016|Overall Study|Death|0|||
145895317|NCT03502707|526125389|FG017|Overall Study|Death|0|||
145895318|NCT03502707|526125372|FG000|Overall Study|Lost to Follow-up|0|||
146237655|NCT03367156|527384283|FG001|Overall Study|Became ineligible|2|||
146237656|NCT03367156|527384282|FG000|Overall Study|Hospitalization|1|||
145895319|NCT03502707|526125373|FG001|Overall Study|Lost to Follow-up|0|||
145895320|NCT03502707|526125374|FG002|Overall Study|Lost to Follow-up|0|||
145895321|NCT03502707|526125375|FG003|Overall Study|Lost to Follow-up|0|||
145895322|NCT03502707|526125376|FG004|Overall Study|Lost to Follow-up|0|||
145895323|NCT03502707|526125377|FG005|Overall Study|Lost to Follow-up|0|||
145895324|NCT03502707|526125378|FG006|Overall Study|Lost to Follow-up|0|||
145895325|NCT03502707|526125379|FG007|Overall Study|Lost to Follow-up|5|||
145895326|NCT03502707|526125380|FG008|Overall Study|Lost to Follow-up|0|||
145895327|NCT03502707|526125381|FG009|Overall Study|Lost to Follow-up|2|||
145895328|NCT03502707|526125382|FG010|Overall Study|Lost to Follow-up|1|||
145895329|NCT03502707|526125383|FG011|Overall Study|Lost to Follow-up|2|||
145895330|NCT03502707|526125384|FG012|Overall Study|Lost to Follow-up|1|||
145895331|NCT03502707|526125385|FG013|Overall Study|Lost to Follow-up|1|||
146237657|NCT03367156|527384283|FG001|Overall Study|Hospitalization|0|||
145895332|NCT03502707|526125386|FG014|Overall Study|Lost to Follow-up|0|||
145895333|NCT03502707|526125387|FG015|Overall Study|Lost to Follow-up|4|||
145895334|NCT03502707|526125388|FG016|Overall Study|Lost to Follow-up|9|||
145895335|NCT03502707|526125389|FG017|Overall Study|Lost to Follow-up|2|||
145895336|NCT03502707|526125372|FG000|Overall Study|Physician Decision|0|||
145895337|NCT03502707|526125373|FG001|Overall Study|Physician Decision|0|||
145895338|NCT03502707|526125374|FG002|Overall Study|Physician Decision|0|||
145895339|NCT03502707|526125375|FG003|Overall Study|Physician Decision|0|||
145895340|NCT03502707|526125376|FG004|Overall Study|Physician Decision|0|||
145895341|NCT03502707|526125377|FG005|Overall Study|Physician Decision|0|||
145895342|NCT03502707|526125378|FG006|Overall Study|Physician Decision|0|||
145895343|NCT03502707|526125379|FG007|Overall Study|Physician Decision|0|||
145895344|NCT03502707|526125380|FG008|Overall Study|Physician Decision|2|||
145895345|NCT03502707|526125381|FG009|Overall Study|Physician Decision|1|||
145895346|NCT03502707|526125382|FG010|Overall Study|Physician Decision|0|||
145895347|NCT03502707|526125383|FG011|Overall Study|Physician Decision|0|||
145895348|NCT03502707|526125384|FG012|Overall Study|Physician Decision|0|||
145895349|NCT03502707|526125385|FG013|Overall Study|Physician Decision|0|||
145895350|NCT03502707|526125386|FG014|Overall Study|Physician Decision|1|||
145895351|NCT03502707|526125387|FG015|Overall Study|Physician Decision|3|||
145895352|NCT03502707|526125388|FG016|Overall Study|Physician Decision|0|||
145895353|NCT03502707|526125389|FG017|Overall Study|Physician Decision|0|||
145895354|NCT03502707|526125372|FG000|Overall Study|Protocol Violation|0|||
145895355|NCT03502707|526125373|FG001|Overall Study|Protocol Violation|0|||
145895356|NCT03502707|526125374|FG002|Overall Study|Protocol Violation|0|||
145895357|NCT03502707|526125375|FG003|Overall Study|Protocol Violation|0|||
145895358|NCT03502707|526125376|FG004|Overall Study|Protocol Violation|0|||
145895359|NCT03502707|526125377|FG005|Overall Study|Protocol Violation|0|||
145895360|NCT03502707|526125378|FG006|Overall Study|Protocol Violation|0|||
145895361|NCT03502707|526125379|FG007|Overall Study|Protocol Violation|0|||
145895362|NCT03502707|526125380|FG008|Overall Study|Protocol Violation|0|||
145895363|NCT03502707|526125381|FG009|Overall Study|Protocol Violation|0|||
145895364|NCT03502707|526125382|FG010|Overall Study|Protocol Violation|0|||
145895365|NCT03502707|526125383|FG011|Overall Study|Protocol Violation|0|||
145895366|NCT03502707|526125384|FG012|Overall Study|Protocol Violation|0|||
145895367|NCT03502707|526125385|FG013|Overall Study|Protocol Violation|0|||
145895368|NCT03502707|526125386|FG014|Overall Study|Protocol Violation|0|||
145895369|NCT03502707|526125387|FG015|Overall Study|Protocol Violation|1|||
145895370|NCT03502707|526125388|FG016|Overall Study|Protocol Violation|0|||
145895371|NCT03502707|526125389|FG017|Overall Study|Protocol Violation|0|||
145895372|NCT03502707|526125372|FG000|Overall Study|Withdrawal by Subject|1|||
145895373|NCT03502707|526125373|FG001|Overall Study|Withdrawal by Subject|1|||
145895374|NCT03502707|526125374|FG002|Overall Study|Withdrawal by Subject|0|||
145895375|NCT03502707|526125375|FG003|Overall Study|Withdrawal by Subject|0|||
145895376|NCT03502707|526125376|FG004|Overall Study|Withdrawal by Subject|0|||
145895377|NCT03502707|526125377|FG005|Overall Study|Withdrawal by Subject|2|||
145895378|NCT03502707|526125378|FG006|Overall Study|Withdrawal by Subject|0|||
145895379|NCT03502707|526125379|FG007|Overall Study|Withdrawal by Subject|3|||
145895380|NCT03502707|526125380|FG008|Overall Study|Withdrawal by Subject|1|||
145895381|NCT03502707|526125381|FG009|Overall Study|Withdrawal by Subject|2|||
145895382|NCT03502707|526125382|FG010|Overall Study|Withdrawal by Subject|12|||
145895383|NCT03502707|526125383|FG011|Overall Study|Withdrawal by Subject|23|||
145895384|NCT03502707|526125384|FG012|Overall Study|Withdrawal by Subject|5|||
145895385|NCT03502707|526125385|FG013|Overall Study|Withdrawal by Subject|3|||
145895386|NCT03502707|526125386|FG014|Overall Study|Withdrawal by Subject|3|||
145895387|NCT03502707|526125387|FG015|Overall Study|Withdrawal by Subject|43|||
145895388|NCT03502707|526125388|FG016|Overall Study|Withdrawal by Subject|44|||
145895389|NCT03502707|526125389|FG017|Overall Study|Withdrawal by Subject|18|||
145895390|NCT03502707|526125372|FG000|Overall Study|Sponsor's Decision|1|||
145895391|NCT03502707|526125373|FG001|Overall Study|Sponsor's Decision|0|||
145895392|NCT03502707|526125374|FG002|Overall Study|Sponsor's Decision|0|||
145895393|NCT03502707|526125375|FG003|Overall Study|Sponsor's Decision|0|||
145895394|NCT03502707|526125376|FG004|Overall Study|Sponsor's Decision|0|||
145895395|NCT03502707|526125377|FG005|Overall Study|Sponsor's Decision|0|||
145895396|NCT03502707|526125378|FG006|Overall Study|Sponsor's Decision|0|||
145895397|NCT03502707|526125379|FG007|Overall Study|Sponsor's Decision|0|||
145895398|NCT03502707|526125380|FG008|Overall Study|Sponsor's Decision|0|||
145895399|NCT03502707|526125381|FG009|Overall Study|Sponsor's Decision|1|||
145895400|NCT03502707|526125382|FG010|Overall Study|Sponsor's Decision|0|||
145895401|NCT03502707|526125383|FG011|Overall Study|Sponsor's Decision|0|||
145895402|NCT03502707|526125384|FG012|Overall Study|Sponsor's Decision|0|||
145895403|NCT03502707|526125385|FG013|Overall Study|Sponsor's Decision|0|||
145895404|NCT03502707|526125386|FG014|Overall Study|Sponsor's Decision|0|||
145895405|NCT03502707|526125387|FG015|Overall Study|Sponsor's Decision|2|||
145895406|NCT03502707|526125388|FG016|Overall Study|Sponsor's Decision|1|||
145895407|NCT03502707|526125389|FG017|Overall Study|Sponsor's Decision|0|||
145895408|NCT03502707|526125372|FG000|Overall Study|Initiated Prohibited Medication|0|||
145895409|NCT03502707|526125373|FG001|Overall Study|Initiated Prohibited Medication|0|||
145895410|NCT03502707|526125374|FG002|Overall Study|Initiated Prohibited Medication|0|||
145972297|NCT05493111|526412612|FG000|Overall Study|Withdrawal by Subject|1|||
145972298|NCT05493111|526412613|FG001|Overall Study|Withdrawal by Subject|1|||
145972299|NCT03836053|526412614|FG000|Overall Study|Protocol-specified criteria|0|||
145972300|NCT03836053|526412615|FG001|Overall Study|Protocol-specified criteria|2|||
145972301|NCT03836053|526412616|FG002|Overall Study|Protocol-specified criteria|1|||
145972302|NCT03836053|526412614|FG000|Overall Study|Death|1|||
145972303|NCT03836053|526412615|FG001|Overall Study|Death|6|||
145972304|NCT03836053|526412616|FG002|Overall Study|Death|4|||
145972305|NCT03836053|526412614|FG000|Overall Study|Withdrawal of consent from study|0|||
145972306|NCT03836053|526412615|FG001|Overall Study|Withdrawal of consent from study|0|||
145972307|NCT03836053|526412616|FG002|Overall Study|Withdrawal of consent from study|1|||
145972308|NCT03836053|526412614|FG000|Overall Study|Decision by sponsor|0|||
145972309|NCT03836053|526412615|FG001|Overall Study|Decision by sponsor|2|||
145972310|NCT03836053|526412616|FG002|Overall Study|Decision by sponsor|4|||
145972311|NCT00788671|526412617|FG000|Overall Study|Death|2|||
145972312|NCT00788671|526412617|FG000|Overall Study|Unable to biopsy|1|||
145972313|NCT00788671|526412617|FG000|Overall Study|Withdrawal by Subject|4|||
145972314|NCT00788671|526412617|FG000|Overall Study|IUD expulsed|1|||
145972315|NCT00788671|526412617|FG000|Overall Study|Lost to follow up|2|||
145972316|NCT04486716|526412618|FG000|Core Phase|Subject decision|6|||
145972317|NCT04486716|526412618|FG000|Core Phase|Adverse Event|5|||
145972318|NCT04486716|526412618|FG000|Core Phase|Lost to Follow-up|1|||
145972319|NCT04486716|526412618|FG000|Core Phase|Physician Decision|1|||
145972320|NCT04486716|526412618|FG000|Core Phase|Enrolled subjects not treated|9|||
145972321|NCT03846479|526412619|FG000|Overall Study|Death|8|||
145972322|NCT03846479|526412619|FG000|Overall Study|Lost to Follow-up|1|||
145972323|NCT02332707|526412620|FG000|Overall Study|Adverse Event|0|||
145972324|NCT02332707|526412621|FG001|Overall Study|Adverse Event|0|||
145972325|NCT02332707|526412622|FG002|Overall Study|Adverse Event|0|||
145972326|NCT02332707|526412623|FG003|Overall Study|Adverse Event|0|||
145972327|NCT02332707|526412624|FG004|Overall Study|Adverse Event|0|||
145972328|NCT02332707|526412625|FG005|Overall Study|Adverse Event|0|||
145972329|NCT02332707|526412626|FG006|Overall Study|Adverse Event|0|||
145972330|NCT02332707|526412627|FG007|Overall Study|Adverse Event|0|||
145972331|NCT02332707|526412628|FG008|Overall Study|Adverse Event|0|||
145972332|NCT02332707|526412629|FG009|Overall Study|Adverse Event|0|||
145972333|NCT02332707|526412630|FG010|Overall Study|Adverse Event|0|||
145972334|NCT02332707|526412631|FG011|Overall Study|Adverse Event|0|||
146237658|NCT03367156|527384282|FG000|Overall Study|Concerned about Treatment|11|||
146237659|NCT03367156|527384283|FG001|Overall Study|Concerned about Treatment|3|||
146237660|NCT03367156|527384282|FG000|Overall Study|Started new treatment|4|||
145972335|NCT02332707|526412632|FG012|Overall Study|Adverse Event|1|||
145972336|NCT02332707|526412633|FG013|Overall Study|Adverse Event|0|||
145972337|NCT02332707|526412634|FG014|Overall Study|Adverse Event|0|||
145972338|NCT02332707|526412635|FG015|Overall Study|Adverse Event|0|||
145972339|NCT02332707|526412636|FG016|Overall Study|Adverse Event|0|||
145972340|NCT02332707|526412637|FG017|Overall Study|Adverse Event|0|||
145972341|NCT02332707|526412620|FG000|Overall Study|Lost to Follow-up|0|||
145972342|NCT02332707|526412621|FG001|Overall Study|Lost to Follow-up|0|||
145972343|NCT02332707|526412622|FG002|Overall Study|Lost to Follow-up|0|||
145972344|NCT02332707|526412623|FG003|Overall Study|Lost to Follow-up|0|||
145972345|NCT02332707|526412624|FG004|Overall Study|Lost to Follow-up|0|||
145972346|NCT02332707|526412625|FG005|Overall Study|Lost to Follow-up|1|||
145972347|NCT02332707|526412626|FG006|Overall Study|Lost to Follow-up|0|||
145972348|NCT02332707|526412627|FG007|Overall Study|Lost to Follow-up|0|||
145972349|NCT02332707|526412628|FG008|Overall Study|Lost to Follow-up|0|||
145895411|NCT03502707|526125375|FG003|Overall Study|Initiated Prohibited Medication|0|||
145895412|NCT03502707|526125376|FG004|Overall Study|Initiated Prohibited Medication|0|||
146237661|NCT03367156|527384283|FG001|Overall Study|Started new treatment|1|||
146237662|NCT03762850|527384284|FG000|Overall Study|Death|0|||
146237663|NCT03762850|527384285|FG001|Overall Study|Death|1|||
146237664|NCT03762850|527384284|FG000|Overall Study|Lost to Follow-up|0|||
146237665|NCT03762850|527384285|FG001|Overall Study|Lost to Follow-up|1|||
146237666|NCT03762850|527384284|FG000|Overall Study|Physician Decision|0|||
146237667|NCT03762850|527384285|FG001|Overall Study|Physician Decision|1|||
145895413|NCT03502707|526125377|FG005|Overall Study|Initiated Prohibited Medication|0|||
145895414|NCT03502707|526125378|FG006|Overall Study|Initiated Prohibited Medication|0|||
145895415|NCT03502707|526125379|FG007|Overall Study|Initiated Prohibited Medication|0|||
145895416|NCT03502707|526125380|FG008|Overall Study|Initiated Prohibited Medication|0|||
145895417|NCT03502707|526125381|FG009|Overall Study|Initiated Prohibited Medication|0|||
145895418|NCT03502707|526125382|FG010|Overall Study|Initiated Prohibited Medication|0|||
145895419|NCT03502707|526125383|FG011|Overall Study|Initiated Prohibited Medication|0|||
145895420|NCT03502707|526125384|FG012|Overall Study|Initiated Prohibited Medication|0|||
145895421|NCT03502707|526125385|FG013|Overall Study|Initiated Prohibited Medication|0|||
145895422|NCT03502707|526125386|FG014|Overall Study|Initiated Prohibited Medication|0|||
145895423|NCT03502707|526125387|FG015|Overall Study|Initiated Prohibited Medication|0|||
145895424|NCT03502707|526125388|FG016|Overall Study|Initiated Prohibited Medication|1|||
145895425|NCT03502707|526125389|FG017|Overall Study|Initiated Prohibited Medication|0|||
145895426|NCT03502707|526125372|FG000|Overall Study|Other|0|||
145895427|NCT03502707|526125373|FG001|Overall Study|Other|0|||
145895428|NCT03502707|526125374|FG002|Overall Study|Other|0|||
145895429|NCT03502707|526125375|FG003|Overall Study|Other|0|||
145895430|NCT03502707|526125376|FG004|Overall Study|Other|0|||
145895431|NCT03502707|526125377|FG005|Overall Study|Other|0|||
145895432|NCT03502707|526125378|FG006|Overall Study|Other|0|||
145895433|NCT03502707|526125379|FG007|Overall Study|Other|0|||
145895434|NCT03502707|526125380|FG008|Overall Study|Other|1|||
145895435|NCT03502707|526125381|FG009|Overall Study|Other|1|||
145895436|NCT03502707|526125382|FG010|Overall Study|Other|2|||
145895437|NCT03502707|526125383|FG011|Overall Study|Other|0|||
145895438|NCT03502707|526125384|FG012|Overall Study|Other|0|||
145895439|NCT03502707|526125385|FG013|Overall Study|Other|0|||
145895440|NCT03502707|526125386|FG014|Overall Study|Other|0|||
145895441|NCT03502707|526125387|FG015|Overall Study|Other|4|||
145895442|NCT03502707|526125388|FG016|Overall Study|Other|1|||
145895443|NCT03502707|526125389|FG017|Overall Study|Other|0|||
145895444|NCT03502707|526125372|FG000|Overall Study|Randomized but not vaccinated|0|||
145895445|NCT03502707|526125373|FG001|Overall Study|Randomized but not vaccinated|0|||
145895446|NCT03502707|526125374|FG002|Overall Study|Randomized but not vaccinated|0|||
145895447|NCT03502707|526125375|FG003|Overall Study|Randomized but not vaccinated|0|||
145895448|NCT03502707|526125376|FG004|Overall Study|Randomized but not vaccinated|0|||
145895449|NCT03502707|526125377|FG005|Overall Study|Randomized but not vaccinated|0|||
145895450|NCT03502707|526125378|FG006|Overall Study|Randomized but not vaccinated|0|||
145895451|NCT03502707|526125379|FG007|Overall Study|Randomized but not vaccinated|0|||
145895452|NCT03502707|526125380|FG008|Overall Study|Randomized but not vaccinated|0|||
145895453|NCT03502707|526125381|FG009|Overall Study|Randomized but not vaccinated|0|||
145895454|NCT03502707|526125382|FG010|Overall Study|Randomized but not vaccinated|0|||
145895455|NCT03502707|526125383|FG011|Overall Study|Randomized but not vaccinated|1|||
145895456|NCT03502707|526125384|FG012|Overall Study|Randomized but not vaccinated|0|||
145895457|NCT03502707|526125385|FG013|Overall Study|Randomized but not vaccinated|0|||
145895458|NCT03502707|526125386|FG014|Overall Study|Randomized but not vaccinated|0|||
145895459|NCT03502707|526125387|FG015|Overall Study|Randomized but not vaccinated|0|||
145895460|NCT03502707|526125388|FG016|Overall Study|Randomized but not vaccinated|0|||
145895461|NCT03502707|526125389|FG017|Overall Study|Randomized but not vaccinated|1|||
145895462|NCT03340064|526125391|FG000|First Period|Adverse Event, non-fatal|2|||
145895463|NCT03340064|526125392|FG001|First Period|Adverse Event, non-fatal|0|||
145895464|NCT03340064|526125391|FG000|First Period|Lack of Efficacy|3|||
145895465|NCT03340064|526125392|FG001|First Period|Lack of Efficacy|0|||
145895466|NCT03340064|526125391|FG000|Second Period|Adverse Event, non-fatal|1|||
145895467|NCT03340064|526125392|FG001|Second Period|Adverse Event, non-fatal|1|||
146237668|NCT03762850|527384284|FG000|Overall Study|Withdrawal by Subject|4|||
146237669|NCT03762850|527384285|FG001|Overall Study|Withdrawal by Subject|9|||
145895468|NCT03340064|526125391|FG000|Second Period|Lack of Efficacy|11|||
145895469|NCT03340064|526125392|FG001|Second Period|Lack of Efficacy|0|||
145895470|NCT03340064|526125391|FG000|Second Period|Physician Decision|3|||
145895471|NCT03340064|526125392|FG001|Second Period|Physician Decision|0|||
145895472|NCT03340064|526125391|FG000|Second Period|Withdrawal by Subject|2|||
145895473|NCT03340064|526125392|FG001|Second Period|Withdrawal by Subject|1|||
145895474|NCT03340064|526125391|FG000|Second Period|Approved Drug Available For Indication|1|||
145895475|NCT03340064|526125392|FG001|Second Period|Approved Drug Available For Indication|0|||
145895476|NCT03340064|526125391|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
146237670|NCT03002194|527384290|FG000|Overall Study|Lost to Follow-up|6|||
145972350|NCT02332707|526412629|FG009|Overall Study|Lost to Follow-up|0|||
145972351|NCT02332707|526412630|FG010|Overall Study|Lost to Follow-up|2|||
145895477|NCT03340064|526125392|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
145895478|NCT02221037|526125393|FG000|Overall Study|Physician Decision|0|||
145895479|NCT02221037|526125394|FG001|Overall Study|Physician Decision|0|||
145895480|NCT02221037|526125395|FG002|Overall Study|Physician Decision|1|||
145895481|NCT02221037|526125396|FG003|Overall Study|Physician Decision|0|||
145895482|NCT00062010|526125399|FG000|Overall Study|Ineligible|3|||
145972352|NCT02332707|526412631|FG011|Overall Study|Lost to Follow-up|0|||
145972353|NCT02332707|526412632|FG012|Overall Study|Lost to Follow-up|3|||
145895483|NCT02944383|526125400|FG000|Overall Study|Lost to Follow-up|0|||
145895484|NCT02944383|526125401|FG001|Overall Study|Lost to Follow-up|0|||
145895485|NCT02944383|526125402|FG002|Overall Study|Lost to Follow-up|1|||
145895486|NCT02944383|526125400|FG000|Overall Study|Withdrawal by Subject|1|||
145895487|NCT02944383|526125401|FG001|Overall Study|Withdrawal by Subject|0|||
145895488|NCT02944383|526125402|FG002|Overall Study|Withdrawal by Subject|0|||
145895489|NCT00852969|526125407|FG000|Overall Study|Adverse Event|0|||
145895490|NCT00852969|526125408|FG001|Overall Study|Adverse Event|1|||
145895491|NCT00852969|526125407|FG000|Overall Study|Lost to Follow-up|0|||
145895492|NCT00852969|526125408|FG001|Overall Study|Lost to Follow-up|1|||
145895493|NCT02358343|526125411|FG000|Screening Intervention|Death|0|||
145895494|NCT02358343|526125412|FG001|Screening Intervention|Death|2|||
145895495|NCT02358343|526125413|FG002|Screening Intervention|Death|0|||
145895496|NCT02358343|526125414|FG003|Screening Intervention|Death|0|||
145895497|NCT02358343|526125415|FG004|Screening Intervention|Death|0|||
145895498|NCT02358343|526125411|FG000|Screening Intervention|Withdrawal by Subject|1|||
145895499|NCT02358343|526125412|FG001|Screening Intervention|Withdrawal by Subject|0|||
145895500|NCT02358343|526125413|FG002|Screening Intervention|Withdrawal by Subject|0|||
145895501|NCT02358343|526125414|FG003|Screening Intervention|Withdrawal by Subject|0|||
145895502|NCT02358343|526125415|FG004|Screening Intervention|Withdrawal by Subject|0|||
145895503|NCT02358343|526125411|FG000|Screening Intervention|Determined Ineligible|5|||
145895504|NCT02358343|526125412|FG001|Screening Intervention|Determined Ineligible|6|||
145895505|NCT02358343|526125413|FG002|Screening Intervention|Determined Ineligible|0|||
145895506|NCT02358343|526125414|FG003|Screening Intervention|Determined Ineligible|0|||
145895507|NCT02358343|526125415|FG004|Screening Intervention|Determined Ineligible|0|||
145895508|NCT02358343|526125411|FG000|Comparative Efficacy Trial / Observation|Death|0|||
145895509|NCT02358343|526125412|FG001|Comparative Efficacy Trial / Observation|Death|0|||
145972354|NCT02332707|526412633|FG013|Overall Study|Lost to Follow-up|0|||
145895510|NCT02358343|526125413|FG002|Comparative Efficacy Trial / Observation|Death|2|||
145972355|NCT02332707|526412634|FG014|Overall Study|Lost to Follow-up|0|||
145972356|NCT02332707|526412635|FG015|Overall Study|Lost to Follow-up|0|||
145972357|NCT02332707|526412636|FG016|Overall Study|Lost to Follow-up|0|||
145895511|NCT02358343|526125414|FG003|Comparative Efficacy Trial / Observation|Death|0|||
145895512|NCT02358343|526125415|FG004|Comparative Efficacy Trial / Observation|Death|0|||
145895513|NCT02358343|526125411|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
145895514|NCT02358343|526125412|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
145895515|NCT02358343|526125413|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145895516|NCT02358343|526125414|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145895517|NCT02358343|526125415|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145895518|NCT02358343|526125411|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145895519|NCT02358343|526125412|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145895520|NCT02358343|526125413|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
145895521|NCT02358343|526125414|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145895522|NCT02358343|526125415|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145895523|NCT00090610|526125418|FG000|Overall Study|Withdrawal by Subject|1|||
145895524|NCT00090610|526125419|FG001|Overall Study|Withdrawal by Subject|1|||
145895525|NCT00609518|526125424|FG000|Overall Study|Death from Study Disease|32|||
145895526|NCT00609518|526125425|FG001|Overall Study|Death from Study Disease|32|||
145895527|NCT00609518|526125424|FG000|Overall Study|Withdrawal by Subject|5|||
145895528|NCT00609518|526125425|FG001|Overall Study|Withdrawal by Subject|3|||
145895529|NCT00609518|526125424|FG000|Overall Study|Lost to Follow-up|3|||
145895530|NCT00609518|526125425|FG001|Overall Study|Lost to Follow-up|0|||
145895531|NCT00609518|526125424|FG000|Overall Study|Physician Decision|1|||
145895532|NCT00609518|526125425|FG001|Overall Study|Physician Decision|3|||
145895533|NCT00609518|526125424|FG000|Overall Study|Death from Adverse Event|2|||
145895534|NCT00609518|526125425|FG001|Overall Study|Death from Adverse Event|2|||
145895535|NCT01687478|526125426|FG000|Overall Study|Adverse Event|3|||
145895536|NCT01687478|526125427|FG001|Overall Study|Adverse Event|10|||
145895537|NCT01687478|526125426|FG000|Overall Study|Lost to Follow-up|1|||
145895538|NCT01687478|526125427|FG001|Overall Study|Lost to Follow-up|3|||
145895539|NCT01687478|526125426|FG000|Overall Study|Protocol Violation|0|||
145895540|NCT01687478|526125427|FG001|Overall Study|Protocol Violation|2|||
145895541|NCT01687478|526125426|FG000|Overall Study|Withdrawal by Subject|21|||
145895542|NCT01687478|526125427|FG001|Overall Study|Withdrawal by Subject|19|||
145895543|NCT01687478|526125426|FG000|Overall Study|Physician Decision|1|||
145895544|NCT01687478|526125427|FG001|Overall Study|Physician Decision|3|||
145895545|NCT01687478|526125426|FG000|Overall Study|Entry Criteria Not Met|6|||
145895546|NCT01687478|526125427|FG001|Overall Study|Entry Criteria Not Met|2|||
145895547|NCT05855616|526125428|FG000|Overall Study|Lost to Follow-up|1|||
145895548|NCT05855616|526125429|FG001|Overall Study|Lost to Follow-up|2|||
145895549|NCT04032158|526125430|FG000|Overall Study|Study Termination|2|||
145895550|NCT04032158|526125431|FG001|Overall Study|Study Termination|1|||
145895551|NCT00292188|526125432|FG000|Single-Blind|Adverse Event|14|||
145895552|NCT00292188|526125433|FG001|Single-Blind|Adverse Event|0|||
145895553|NCT00292188|526125434|FG002|Single-Blind|Adverse Event|0|||
145895554|NCT00292188|526125432|FG000|Single-Blind|Lack of Efficacy|2|||
145895555|NCT00292188|526125433|FG001|Single-Blind|Lack of Efficacy|0|||
145895556|NCT00292188|526125434|FG002|Single-Blind|Lack of Efficacy|0|||
145895557|NCT00292188|526125432|FG000|Single-Blind|Laboratory Abnormality|5|||
145895558|NCT00292188|526125433|FG001|Single-Blind|Laboratory Abnormality|0|||
145895559|NCT00292188|526125434|FG002|Single-Blind|Laboratory Abnormality|0|||
145895560|NCT00292188|526125432|FG000|Single-Blind|Lost to Follow-up|3|||
145895561|NCT00292188|526125433|FG001|Single-Blind|Lost to Follow-up|0|||
145895562|NCT00292188|526125434|FG002|Single-Blind|Lost to Follow-up|0|||
145895563|NCT00292188|526125432|FG000|Single-Blind|Other|77|||
145895564|NCT00292188|526125433|FG001|Single-Blind|Other|0|||
145895565|NCT00292188|526125434|FG002|Single-Blind|Other|0|||
145895566|NCT00292188|526125432|FG000|Single-Blind|Withdrawal by Subject|12|||
145895567|NCT00292188|526125433|FG001|Single-Blind|Withdrawal by Subject|0|||
145895568|NCT00292188|526125434|FG002|Single-Blind|Withdrawal by Subject|0|||
145895569|NCT00292188|526125432|FG000|Single-Blind|Did not receive treatment|1|||
145895570|NCT00292188|526125433|FG001|Single-Blind|Did not receive treatment|0|||
145895571|NCT00292188|526125434|FG002|Single-Blind|Did not receive treatment|0|||
145895572|NCT00292188|526125432|FG000|Double-Blind|Adverse Event|0|||
145895573|NCT00292188|526125433|FG001|Double-Blind|Adverse Event|25|||
145895574|NCT00292188|526125434|FG002|Double-Blind|Adverse Event|9|||
145895575|NCT00292188|526125432|FG000|Double-Blind|Lack of Efficacy|0|||
145895576|NCT00292188|526125433|FG001|Double-Blind|Lack of Efficacy|2|||
145895577|NCT00292188|526125434|FG002|Double-Blind|Lack of Efficacy|12|||
145895578|NCT00292188|526125432|FG000|Double-Blind|Lost to Follow-up|0|||
145895579|NCT00292188|526125433|FG001|Double-Blind|Lost to Follow-up|1|||
145895580|NCT00292188|526125434|FG002|Double-Blind|Lost to Follow-up|0|||
145895581|NCT00292188|526125432|FG000|Double-Blind|Other|0|||
145895582|NCT00292188|526125433|FG001|Double-Blind|Other|3|||
145895583|NCT00292188|526125434|FG002|Double-Blind|Other|4|||
145895584|NCT00292188|526125432|FG000|Double-Blind|Withdrawal by Subject|0|||
145895585|NCT00292188|526125433|FG001|Double-Blind|Withdrawal by Subject|0|||
145895586|NCT00292188|526125434|FG002|Double-Blind|Withdrawal by Subject|3|||
145895587|NCT00292188|526125432|FG000|Double-Blind|Laboratory Abnormality|0|||
145895588|NCT00292188|526125433|FG001|Double-Blind|Laboratory Abnormality|0|||
145895589|NCT00292188|526125434|FG002|Double-Blind|Laboratory Abnormality|1|||
145895590|NCT04322149|526125435|FG000|Overall Study|Adverse Event|1|||
145895591|NCT04322149|526125436|FG001|Overall Study|Adverse Event|1|||
145895592|NCT04322149|526125437|FG002|Overall Study|Adverse Event|0|||
145895593|NCT04322149|526125438|FG003|Overall Study|Adverse Event|0|||
145895594|NCT04322149|526125435|FG000|Overall Study|Withdrawal by Subject|0|||
145895595|NCT04322149|526125436|FG001|Overall Study|Withdrawal by Subject|0|||
145895596|NCT04322149|526125437|FG002|Overall Study|Withdrawal by Subject|0|||
145895597|NCT04322149|526125438|FG003|Overall Study|Withdrawal by Subject|2|||
145895598|NCT04322149|526125435|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145895599|NCT04322149|526125436|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
145895600|NCT04322149|526125437|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145895601|NCT04322149|526125438|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145895602|NCT01700049|526125445|FG000|Overall Study|Withdrawal by Subject|1|||
145895603|NCT03084367|526125448|FG000|Overall Study|Lost to Follow-up|32|||
145895604|NCT03084367|526125448|FG000|Overall Study|Withdrawal by Subject|4|||
145895605|NCT03084367|526125448|FG000|Overall Study|Other|1|||
145895606|NCT01206101|526125449|FG000|Overall Study|Adverse Event|1|||
145895607|NCT01206101|526125450|FG001|Overall Study|Adverse Event|0|||
145895608|NCT01206101|526125449|FG000|Overall Study|Physician Decision|0|||
145895609|NCT01206101|526125450|FG001|Overall Study|Physician Decision|1|||
145895610|NCT01206101|526125449|FG000|Overall Study|Unclassified|1|||
145895611|NCT01206101|526125450|FG001|Overall Study|Unclassified|0|||
145895612|NCT04709835|526125453|FG000|Overall Study|Withdrawal by Subject|0|||
145895613|NCT04709835|526125454|FG001|Overall Study|Withdrawal by Subject|1|||
145895614|NCT04709835|526125455|FG002|Overall Study|Withdrawal by Subject|0|||
145895615|NCT01859130|526125456|FG000|Overall Study|Death|4|||
145895616|NCT01859130|526125456|FG000|Overall Study|Lost to Follow-up|16|||
145895617|NCT01859130|526125456|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
145895618|NCT01859130|526125456|FG000|Overall Study|Physician Decision|6|||
145895619|NCT01859130|526125456|FG000|Overall Study|Withdrawal by Subject|17|||
145895620|NCT01859130|526125456|FG000|Overall Study|Adverse Event|11|||
145895621|NCT04325204|526125457|FG000|Overall Study|Death|0|||
145895622|NCT04325204|526125458|FG001|Overall Study|Death|1|||
145895623|NCT04325204|526125457|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
145895624|NCT04325204|526125458|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
145895625|NCT04325204|526125457|FG000|Overall Study|Lost to Follow-up|8|||
145895626|NCT04325204|526125458|FG001|Overall Study|Lost to Follow-up|8|||
145895627|NCT04325204|526125457|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
145895628|NCT04325204|526125458|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
145895629|NCT04710979|526125461|FG000|Overall Study|Lost to Follow-up|2|||
145895630|NCT04710979|526125462|FG001|Overall Study|Lost to Follow-up|4|||
145895631|NCT04710979|526125461|FG000|Overall Study|Withdrawal by Subject|1|||
145895632|NCT04710979|526125462|FG001|Overall Study|Withdrawal by Subject|0|||
145895633|NCT00103311|526125468|FG000|Overall Study|Lost to Follow-up|1|||
145895634|NCT00103311|526125469|FG001|Overall Study|Lost to Follow-up|0|||
146237671|NCT03002194|527384290|FG000|Overall Study|Adverse Event|1|||
145895635|NCT00103311|526125468|FG000|Overall Study|Withdrawal by Subject|2|||
145895636|NCT00103311|526125469|FG001|Overall Study|Withdrawal by Subject|1|||
145895637|NCT00103311|526125468|FG000|Overall Study|Adverse Event|1|||
145895638|NCT00103311|526125469|FG001|Overall Study|Adverse Event|0|||
145895639|NCT03827564|526125470|FG000|Overall Study|Discontinued due to Study Termination|1|||
145895640|NCT03827564|526125471|FG001|Overall Study|Discontinued due to Study Termination|0|||
145895641|NCT00270257|526125472|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
145895642|NCT00270257|526125473|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
145895643|NCT01195103|526125474|FG000|Overall Study|Withdrawal by Subject|1|||
145895644|NCT01195103|526125475|FG001|Overall Study|Withdrawal by Subject|0|||
145895645|NCT01195103|526125476|FG002|Overall Study|Withdrawal by Subject|0|||
146237672|NCT03002194|527384290|FG000|Overall Study|Lack of Efficacy|1|||
145895646|NCT02621034|526125477|FG000|Overall Study|Lost to Follow-up|3|||
145895647|NCT02621034|526125478|FG001|Overall Study|Lost to Follow-up|2|||
145895648|NCT02621034|526125479|FG002|Overall Study|Lost to Follow-up|5|||
145895649|NCT00974974|526125489|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
145895650|NCT00974974|526125490|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
145895651|NCT00974974|526125489|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
145895652|NCT00974974|526125490|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
145895653|NCT00974974|526125489|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
145895654|NCT00974974|526125490|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
146237673|NCT03002194|527384290|FG000|Overall Study|Withdrawal by Subject|2|||
146237674|NCT03021993|527384291|FG000|Overall Study|Withdrawal by Subject|4|||
146237675|NCT03021993|527384291|FG000|Overall Study|Physician Decision|1|||
146237676|NCT03021993|527384291|FG000|Overall Study|enrolled but were not treated|1|||
146237677|NCT03021993|527384291|FG000|Overall Study|Death|3|||
146237678|NCT00756574|527384292|FG000|Overall Study|Withdrawal by Subject|9|||
146237679|NCT00756574|527384293|FG001|Overall Study|Withdrawal by Subject|7|||
146237680|NCT00756574|527384292|FG000|Overall Study|Lost to Follow-up|4|||
146237681|NCT00756574|527384293|FG001|Overall Study|Lost to Follow-up|4|||
146237682|NCT03516812|527384296|FG000|Overall Study|Adverse Event|4|||
146237683|NCT03516812|527384296|FG000|Overall Study|Lack of Efficacy|2|||
146237684|NCT04795167|527384297|FG000|Overall Study|Death|1|||
145895655|NCT00974974|526125489|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
145895656|NCT00974974|526125490|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
145895657|NCT00974974|526125489|FG000|IR CD-LD Dose Adjustment|Various|0|||
145895658|NCT00974974|526125490|FG001|IR CD-LD Dose Adjustment|Various|9|||
145895659|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Adverse Event|23|||
145895660|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Adverse Event|0|||
145895661|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Death|2|||
145895662|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Death|0|||
145895663|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
145895664|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
145895665|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
145895666|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
145895667|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Various|3|||
145895668|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Various|0|||
145895669|NCT00974974|526125489|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
145895670|NCT00974974|526125490|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
145895671|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
145895672|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
145895673|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
145895674|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
145895675|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
145895676|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
145895677|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
145895678|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
145895679|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
145895680|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
145895681|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
145895682|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
145895683|NCT00974974|526125489|FG000|Maintenance - Double Blind Treatment|Various|4|||
145895684|NCT00974974|526125490|FG001|Maintenance - Double Blind Treatment|Various|0|||
145895685|NCT01959035|526125491|FG000|Overall Study|Adverse Event|5|||
145895686|NCT01959035|526125491|FG000|Overall Study|Withdrawal by Subject|4|||
145895687|NCT01959035|526125491|FG000|Overall Study|Lost to Follow-up|1|||
145895688|NCT01959035|526125491|FG000|Overall Study|Other (no primary reason given)|1|||
145895689|NCT01936623|526125493|FG000|Overall Study|Lost to Follow-up|0|||
145895690|NCT01936623|526125494|FG001|Overall Study|Lost to Follow-up|5|||
146237685|NCT04795167|527384298|FG001|Overall Study|Death|18|||
146237686|NCT04795167|527384299|FG002|Overall Study|Death|1|||
145895691|NCT02575911|526125495|FG000|Overall Study|Lost to Follow-up|1|||
145895692|NCT03579966|526125496|FG000|Overall Study|Adverse Event|6|||
145895693|NCT03579966|526125496|FG000|Overall Study|Lost to Follow-up|4|||
145895694|NCT03579966|526125496|FG000|Overall Study|Physician Decision|10|||
145895695|NCT03579966|526125496|FG000|Overall Study|Pregnancy|1|||
145895696|NCT03579966|526125496|FG000|Overall Study|Withdrawal by Subject|16|||
145895697|NCT03579966|526125496|FG000|Overall Study|Study terminated by Sponsor|22|||
145895698|NCT03579966|526125496|FG000|Overall Study|Protocol Violation|1|||
145895699|NCT01249365|526125497|FG000|Overall Study|Lost to Follow-up|1|||
145895700|NCT01340768|526125498|FG000|Overall Study|Lost to Follow-up|10|||
145895701|NCT01340768|526125499|FG001|Overall Study|Lost to Follow-up|4|||
145895702|NCT01340768|526125498|FG000|Overall Study|Withdrawal by Subject|5|||
146237687|NCT04795167|527384297|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
146237688|NCT04795167|527384298|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
145895703|NCT01340768|526125499|FG001|Overall Study|Withdrawal by Subject|1|||
145895704|NCT01340768|526125498|FG000|Overall Study|Other|2|||
145895705|NCT01340768|526125499|FG001|Overall Study|Other|0|||
145895706|NCT03551496|526125500|FG000|Overall Study|Death|11|||
145895707|NCT03551496|526125501|FG001|Overall Study|Death|7|||
145895708|NCT03551496|526125500|FG000|Overall Study|Withdrawal by Subject|4|||
145895709|NCT03551496|526125501|FG001|Overall Study|Withdrawal by Subject|3|||
145895710|NCT03551496|526125500|FG000|Overall Study|Other Reasons|1|||
145895711|NCT03551496|526125501|FG001|Overall Study|Other Reasons|0|||
145895712|NCT00801099|526125502|FG000|Overall Study|Lost to Follow-up|101|||
145895713|NCT00950963|526125503|FG000|Overall Study|Lost to Follow-up|29|||
145895714|NCT00950963|526125504|FG001|Overall Study|Lost to Follow-up|24|||
145895715|NCT01675661|526125505|FG000|Overall Study|Lost to Follow-up|22|||
145895716|NCT01675661|526125506|FG001|Overall Study|Lost to Follow-up|23|||
145895717|NCT01675661|526125505|FG000|Overall Study|Practical problems|9|||
145895718|NCT01675661|526125506|FG001|Overall Study|Practical problems|5|||
145895719|NCT01675661|526125505|FG000|Overall Study|Moved away|5|||
145895720|NCT01675661|526125506|FG001|Overall Study|Moved away|6|||
145895721|NCT01675661|526125505|FG000|Overall Study|Withdrawal by Subject|3|||
145895722|NCT01675661|526125506|FG001|Overall Study|Withdrawal by Subject|7|||
145895723|NCT01675661|526125505|FG000|Overall Study|Physician Decision|0|||
145895724|NCT01675661|526125506|FG001|Overall Study|Physician Decision|2|||
145895725|NCT01675661|526125505|FG000|Overall Study|Death|0|||
145895726|NCT01675661|526125506|FG001|Overall Study|Death|1|||
145895727|NCT01675661|526125505|FG000|Overall Study|Other reason|1|||
145895728|NCT01675661|526125506|FG001|Overall Study|Other reason|2|||
146237689|NCT04795167|527384299|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
146237690|NCT03683576|527384305|FG000|Overall Study|Withdrawal by Subject|2|||
146237691|NCT03683576|527384306|FG001|Overall Study|Withdrawal by Subject|0|||
145895729|NCT01006135|526125509|FG000|Overall Study|Adverse Event|22|||
145895730|NCT01006135|526125509|FG000|Overall Study|Protocol Violation|14|||
145895731|NCT01006135|526125509|FG000|Overall Study|Lost to Follow-up|32|||
145895732|NCT01006135|526125509|FG000|Overall Study|Other|72|||
145895733|NCT01732484|526125511|FG000|Overall Study|Death|7|||
145895734|NCT01732484|526125511|FG000|Overall Study|Lost to Follow-up|14|||
145895735|NCT01732484|526125511|FG000|Overall Study|chronical illness|5|||
145895736|NCT00928707|526125519|FG000|Overall Study|Protocol Violation|1|||
145895737|NCT00928707|526125520|FG001|Overall Study|Protocol Violation|0|||
145895738|NCT00132028|526125521|FG000|Overall Study|Adverse Event|7|||
145895739|NCT00132028|526125521|FG000|Overall Study|Death|2|||
145895740|NCT00132028|526125521|FG000|Overall Study|Lack of Efficacy|11|||
145895741|NCT00132028|526125521|FG000|Overall Study|Withdrawal by Subject|2|||
145895742|NCT00132028|526125521|FG000|Overall Study|not eligible|2|||
145895743|NCT00132028|526125521|FG000|Overall Study|Physician Decision|3|||
145895744|NCT02140411|526125522|FG000|Overall Study|Adverse Event|1|||
145895745|NCT03176459|526125526|FG000|Overall Study|Lost to Follow-up|5|||
145895746|NCT03176459|526125527|FG001|Overall Study|Lost to Follow-up|7|||
145895747|NCT06077487|526128232|FG000|Overall Study|Withdrawal by Subject|0|||
145895748|NCT06077487|526128233|FG001|Overall Study|Withdrawal by Subject|1|||
145895749|NCT04905290|526128234|FG000|Overall Study|Adverse Event|4|||
145895750|NCT04905290|526128234|FG000|Overall Study|Death|2|||
145895751|NCT04905290|526128234|FG000|Overall Study|Withdrawal by Subject|4|||
145895752|NCT04905290|526128234|FG000|Overall Study|Physician Decision|2|||
145895753|NCT04905290|526128234|FG000|Overall Study|Lost to Follow-up|2|||
145895754|NCT04905290|526128234|FG000|Overall Study|Screen Failure|2|||
145895755|NCT04905290|526128234|FG000|Overall Study|Unsuccessful Procedure|2|||
145895756|NCT05101486|526128235|FG000|Overall Study|Death|1|||
145895757|NCT05101486|526128236|FG001|Overall Study|Death|0|||
145895758|NCT05101486|526128237|FG002|Overall Study|Death|1|||
145895759|NCT05101486|526128235|FG000|Overall Study|Lost to Follow-up|12|||
146237692|NCT03683576|527384307|FG002|Overall Study|Withdrawal by Subject|8|||
146237693|NCT03683576|527384308|FG003|Overall Study|Withdrawal by Subject|3|||
146237694|NCT03683576|527384305|FG000|Overall Study|Adverse Event|3|||
145895760|NCT05101486|526128236|FG001|Overall Study|Lost to Follow-up|8|||
145895761|NCT05101486|526128237|FG002|Overall Study|Lost to Follow-up|17|||
145895762|NCT05101486|526128235|FG000|Overall Study|Physician Decision|1|||
145895763|NCT05101486|526128236|FG001|Overall Study|Physician Decision|0|||
145972358|NCT02332707|526412637|FG017|Overall Study|Lost to Follow-up|0|||
145895764|NCT05101486|526128237|FG002|Overall Study|Physician Decision|0|||
145895765|NCT05101486|526128235|FG000|Overall Study|Protocol Violation|0|||
145895766|NCT05101486|526128236|FG001|Overall Study|Protocol Violation|0|||
145895767|NCT05101486|526128237|FG002|Overall Study|Protocol Violation|1|||
145895768|NCT05101486|526128235|FG000|Overall Study|Withdrawal by Subject|5|||
145895769|NCT05101486|526128236|FG001|Overall Study|Withdrawal by Subject|2|||
145895770|NCT05101486|526128237|FG002|Overall Study|Withdrawal by Subject|4|||
145895771|NCT05101486|526128235|FG000|Overall Study|Randomized but not vaccinated|1|||
145895772|NCT05101486|526128236|FG001|Overall Study|Randomized but not vaccinated|1|||
145895773|NCT05101486|526128237|FG002|Overall Study|Randomized but not vaccinated|1|||
145895774|NCT03295318|526128238|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
146237695|NCT03683576|527384306|FG001|Overall Study|Adverse Event|0|||
145895775|NCT03295318|526128239|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
145895776|NCT03295318|526128240|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
145895777|NCT03295318|526128238|FG000|Overall Study|Death|1|||
145895778|NCT03295318|526128239|FG001|Overall Study|Death|1|||
145895779|NCT03295318|526128240|FG002|Overall Study|Death|1|||
145895780|NCT03295318|526128238|FG000|Overall Study|Protocol Violation|4|||
145895781|NCT03295318|526128239|FG001|Overall Study|Protocol Violation|3|||
145895782|NCT03295318|526128240|FG002|Overall Study|Protocol Violation|3|||
145895783|NCT03295318|526128238|FG000|Overall Study|Withdrawal by Subject|0|||
145895784|NCT03295318|526128239|FG001|Overall Study|Withdrawal by Subject|0|||
145895785|NCT03295318|526128240|FG002|Overall Study|Withdrawal by Subject|1|||
145895786|NCT03295318|526128238|FG000|Overall Study|Subject discontinued due to travel|0|||
145895787|NCT03295318|526128239|FG001|Overall Study|Subject discontinued due to travel|1|||
145895788|NCT03295318|526128240|FG002|Overall Study|Subject discontinued due to travel|0|||
145895789|NCT03747601|526128241|FG000|Overall Study|COVID halt to visits|4|||
145895790|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
145895791|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
145895792|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
145895793|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
145895794|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
145895795|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
145895796|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
145895797|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
145895798|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
145895799|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
145895800|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
145895801|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
145895802|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
145895803|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
145895804|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
145895805|NCT02788045|526128242|FG000|Main Study (Up to Week 72)|Other|3|||
145895806|NCT02788045|526128243|FG001|Main Study (Up to Week 72)|Other|0|||
145895807|NCT02788045|526128244|FG002|Main Study (Up to Week 72)|Other|0|||
145895808|NCT02788045|526128242|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
145895809|NCT02788045|526128243|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
145895810|NCT02788045|526128244|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
145895811|NCT02788045|526128242|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
145895812|NCT02788045|526128243|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
145895813|NCT02788045|526128244|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
145895814|NCT02788045|526128242|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
145895815|NCT02788045|526128243|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
145895816|NCT02788045|526128244|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
145895817|NCT01183221|526128245|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
145895818|NCT01183221|526128246|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
145895819|NCT00678041|526128250|FG000|Overall Study|Physician Decision|5|||
145895820|NCT00678041|526128251|FG001|Overall Study|Physician Decision|5|||
145895821|NCT00807248|526128253|FG000|Overall Study|Adverse Event|1|||
145895822|NCT00807248|526128254|FG001|Overall Study|Adverse Event|2|||
145895823|NCT00807248|526128255|FG002|Overall Study|Adverse Event|2|||
145895824|NCT00807248|526128256|FG003|Overall Study|Adverse Event|6|||
145895825|NCT00807248|526128253|FG000|Overall Study|Lack of Efficacy|14|||
145895826|NCT00807248|526128254|FG001|Overall Study|Lack of Efficacy|4|||
145895827|NCT00807248|526128255|FG002|Overall Study|Lack of Efficacy|8|||
145895828|NCT00807248|526128256|FG003|Overall Study|Lack of Efficacy|3|||
145895829|NCT00807248|526128253|FG000|Overall Study|Protocol Violation|0|||
145895830|NCT00807248|526128254|FG001|Overall Study|Protocol Violation|1|||
145895831|NCT00807248|526128255|FG002|Overall Study|Protocol Violation|1|||
145895832|NCT00807248|526128256|FG003|Overall Study|Protocol Violation|0|||
145895833|NCT00807248|526128253|FG000|Overall Study|Withdrawal of Consent|5|||
145895834|NCT00807248|526128254|FG001|Overall Study|Withdrawal of Consent|5|||
145895835|NCT00807248|526128255|FG002|Overall Study|Withdrawal of Consent|5|||
145895836|NCT00807248|526128256|FG003|Overall Study|Withdrawal of Consent|5|||
145895837|NCT00807248|526128253|FG000|Overall Study|Lost to Follow-up|1|||
145895838|NCT00807248|526128254|FG001|Overall Study|Lost to Follow-up|0|||
145895839|NCT00807248|526128255|FG002|Overall Study|Lost to Follow-up|0|||
145895840|NCT00807248|526128256|FG003|Overall Study|Lost to Follow-up|0|||
145895841|NCT00807248|526128253|FG000|Overall Study|Other Reason|0|||
145895842|NCT00807248|526128254|FG001|Overall Study|Other Reason|0|||
145895843|NCT00807248|526128255|FG002|Overall Study|Other Reason|2|||
145895844|NCT00807248|526128256|FG003|Overall Study|Other Reason|0|||
145895845|NCT02444793|526128257|FG000|Overall Study|Lost to Follow-up|2|||
145895846|NCT02444793|526128258|FG001|Overall Study|Lost to Follow-up|2|||
145895847|NCT02444793|526128259|FG002|Overall Study|Lost to Follow-up|0|||
145895848|NCT02444793|526128260|FG003|Overall Study|Lost to Follow-up|0|||
145895849|NCT02444793|526128257|FG000|Overall Study|Death|0|||
145895850|NCT02444793|526128258|FG001|Overall Study|Death|3|||
146237696|NCT03683576|527384307|FG002|Overall Study|Adverse Event|0|||
146237697|NCT03683576|527384308|FG003|Overall Study|Adverse Event|4|||
146237698|NCT03683576|527384305|FG000|Overall Study|Lack of Efficacy|1|||
146237699|NCT03683576|527384306|FG001|Overall Study|Lack of Efficacy|0|||
146237700|NCT03683576|527384307|FG002|Overall Study|Lack of Efficacy|1|||
146237701|NCT03683576|527384308|FG003|Overall Study|Lack of Efficacy|1|||
146237702|NCT03683576|527384305|FG000|Overall Study|Lost to Follow-up|0|||
146237703|NCT03683576|527384306|FG001|Overall Study|Lost to Follow-up|1|||
146237704|NCT03683576|527384307|FG002|Overall Study|Lost to Follow-up|2|||
146296366|NCT02146326|527600621|FG000|Overall Study|Withdrawal by Subject|2|||
146296367|NCT02146326|527600622|FG001|Overall Study|Withdrawal by Subject|1|||
146296368|NCT02146326|527600623|FG002|Overall Study|Withdrawal by Subject|15|||
146296369|NCT02146326|527600624|FG003|Overall Study|Withdrawal by Subject|11|||
146296370|NCT02146326|527600621|FG000|Overall Study|Separated from mental health center|23|||
146296371|NCT02146326|527600622|FG001|Overall Study|Separated from mental health center|33|||
146296372|NCT02146326|527600623|FG002|Overall Study|Separated from mental health center|0|||
146296373|NCT02146326|527600624|FG003|Overall Study|Separated from mental health center|0|||
146296374|NCT02146326|527600621|FG000|Overall Study|Incarcerated|0|||
146296375|NCT02146326|527600622|FG001|Overall Study|Incarcerated|0|||
146296376|NCT02146326|527600623|FG002|Overall Study|Incarcerated|3|||
146296377|NCT02146326|527600624|FG003|Overall Study|Incarcerated|8|||
146296378|NCT02146326|527600621|FG000|Overall Study|Death|0|||
146296379|NCT02146326|527600622|FG001|Overall Study|Death|0|||
146296380|NCT02146326|527600623|FG002|Overall Study|Death|4|||
145895851|NCT02444793|526128259|FG002|Overall Study|Death|0|||
146296381|NCT02146326|527600624|FG003|Overall Study|Death|4|||
146237705|NCT03683576|527384308|FG003|Overall Study|Lost to Follow-up|0|||
146237706|NCT03683576|527384305|FG000|Overall Study|Other, Not Specified|0|||
146237707|NCT03683576|527384306|FG001|Overall Study|Other, Not Specified|2|||
146237708|NCT03683576|527384307|FG002|Overall Study|Other, Not Specified|0|||
146237709|NCT03683576|527384308|FG003|Overall Study|Other, Not Specified|0|||
146237710|NCT03683576|527384305|FG000|Overall Study|Protocol Violation|0|||
146237711|NCT03683576|527384306|FG001|Overall Study|Protocol Violation|1|||
146296382|NCT02146326|527600621|FG000|Overall Study|Unable to complete interview|0|||
146296383|NCT02146326|527600622|FG001|Overall Study|Unable to complete interview|0|||
146296384|NCT02146326|527600623|FG002|Overall Study|Unable to complete interview|10|||
146296385|NCT02146326|527600624|FG003|Overall Study|Unable to complete interview|6|||
146296386|NCT03153111|527600625|FG000|Overall Study|Death|2|||
146296387|NCT03153111|527600626|FG001|Overall Study|Death|5|||
146296388|NCT03153111|527600625|FG000|Overall Study|Lost to Follow-up|1|||
146296389|NCT03153111|527600626|FG001|Overall Study|Lost to Follow-up|0|||
146296390|NCT03153111|527600625|FG000|Overall Study|Physician Decision|5|||
146296391|NCT03153111|527600626|FG001|Overall Study|Physician Decision|1|||
146296392|NCT03153111|527600625|FG000|Overall Study|Withdrawal by Subject|3|||
146296393|NCT03153111|527600626|FG001|Overall Study|Withdrawal by Subject|3|||
146296394|NCT01079130|527600629|FG000|Overall Study|Adverse Event|1|||
146296395|NCT01079130|527600630|FG001|Overall Study|Adverse Event|1|||
146296396|NCT01079130|527600631|FG002|Overall Study|Adverse Event|0|||
146296397|NCT01079130|527600632|FG003|Overall Study|Adverse Event|1|||
146296398|NCT01079130|527600633|FG004|Overall Study|Adverse Event|5|||
146296399|NCT01079130|527600634|FG005|Overall Study|Adverse Event|1|||
146296400|NCT01079130|527600629|FG000|Overall Study|Administrative problems|1|||
146296401|NCT01079130|527600630|FG001|Overall Study|Administrative problems|3|||
146296402|NCT01079130|527600631|FG002|Overall Study|Administrative problems|0|||
146296403|NCT01079130|527600632|FG003|Overall Study|Administrative problems|0|||
146296404|NCT01079130|527600633|FG004|Overall Study|Administrative problems|0|||
146296405|NCT01079130|527600634|FG005|Overall Study|Administrative problems|1|||
146296406|NCT01079130|527600629|FG000|Overall Study|Withdrawal by Subject|0|||
146296407|NCT01079130|527600630|FG001|Overall Study|Withdrawal by Subject|1|||
146296408|NCT01079130|527600631|FG002|Overall Study|Withdrawal by Subject|0|||
146296409|NCT01079130|527600632|FG003|Overall Study|Withdrawal by Subject|0|||
146296410|NCT01079130|527600633|FG004|Overall Study|Withdrawal by Subject|1|||
146296411|NCT01079130|527600634|FG005|Overall Study|Withdrawal by Subject|3|||
146296412|NCT01079130|527600629|FG000|Overall Study|Protocol deviation|0|||
146296413|NCT01079130|527600630|FG001|Overall Study|Protocol deviation|2|||
146296414|NCT01079130|527600631|FG002|Overall Study|Protocol deviation|1|||
146088216|NCT03387150|526843770|FG001|Overall Study|Lost to Follow-up|2|||
146237712|NCT03683576|527384307|FG002|Overall Study|Protocol Violation|1|||
146237713|NCT03683576|527384308|FG003|Overall Study|Protocol Violation|0|||
146237714|NCT02628626|527384310|FG000|Overall Study|Withdrawal by Subject|2|||
146237715|NCT02628626|527384311|FG001|Overall Study|Withdrawal by Subject|2|||
146296415|NCT01079130|527600632|FG003|Overall Study|Protocol deviation|2|||
146296416|NCT01079130|527600633|FG004|Overall Study|Protocol deviation|0|||
146296417|NCT01079130|527600634|FG005|Overall Study|Protocol deviation|0|||
146296418|NCT01079130|527600629|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146296419|NCT01079130|527600630|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146296420|NCT01079130|527600631|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146296421|NCT01079130|527600632|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146296422|NCT01079130|527600633|FG004|Overall Study|Abnormal test procedure result(s)|1|||
146296423|NCT01079130|527600634|FG005|Overall Study|Abnormal test procedure result(s)|0|||
146296424|NCT01079130|527600629|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146296425|NCT01079130|527600630|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146296426|NCT01079130|527600631|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146296427|NCT01079130|527600632|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146296428|NCT01079130|527600633|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
146296429|NCT01079130|527600634|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
146296430|NCT01079130|527600629|FG000|Overall Study|Lost to Follow-up|0|||
146296431|NCT01079130|527600630|FG001|Overall Study|Lost to Follow-up|0|||
146296432|NCT01079130|527600631|FG002|Overall Study|Lost to Follow-up|0|||
146296433|NCT01079130|527600632|FG003|Overall Study|Lost to Follow-up|0|||
146296434|NCT01079130|527600633|FG004|Overall Study|Lost to Follow-up|1|||
146296435|NCT01079130|527600634|FG005|Overall Study|Lost to Follow-up|0|||
146296436|NCT01853982|527600635|FG000|Overall Study|Withdrawal by Subject|1|||
146296437|NCT01853982|527600636|FG001|Overall Study|Withdrawal by Subject|0|||
146296438|NCT01853982|527600635|FG000|Overall Study|Death|1|||
146296439|NCT01853982|527600636|FG001|Overall Study|Death|0|||
146296440|NCT01853982|527600635|FG000|Overall Study|Lost to Follow-up|0|||
146296441|NCT01853982|527600636|FG001|Overall Study|Lost to Follow-up|1|||
146296442|NCT00390910|527600637|FG000|Overall Study|Adverse Event|1|||
146296443|NCT00390910|527600638|FG001|Overall Study|Adverse Event|0|||
146296444|NCT00390910|527600639|FG002|Overall Study|Adverse Event|0|||
146296445|NCT00390910|527600637|FG000|Overall Study|Lost to Follow-up|0|||
146296446|NCT00390910|527600638|FG001|Overall Study|Lost to Follow-up|1|||
146296447|NCT00390910|527600639|FG002|Overall Study|Lost to Follow-up|5|||
146296448|NCT00390910|527600637|FG000|Overall Study|Withdrawal by Subject|1|||
146296449|NCT00390910|527600638|FG001|Overall Study|Withdrawal by Subject|3|||
146296450|NCT00390910|527600639|FG002|Overall Study|Withdrawal by Subject|2|||
146296451|NCT00390910|527600637|FG000|Overall Study|Migrated/moved from study area|0|||
146296452|NCT00390910|527600638|FG001|Overall Study|Migrated/moved from study area|0|||
146296453|NCT00390910|527600639|FG002|Overall Study|Migrated/moved from study area|3|||
146296454|NCT01839487|527600640|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
146296455|NCT01839487|527600641|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146296456|NCT01839487|527600642|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146296457|NCT01839487|527600643|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146296458|NCT01839487|527600644|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146296459|NCT01839487|527600645|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
146296460|NCT01839487|527600640|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
146296461|NCT01839487|527600641|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
146296462|NCT01839487|527600642|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146296463|NCT01839487|527600643|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146296464|NCT01839487|527600644|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146296465|NCT01839487|527600645|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
146296466|NCT01839487|527600640|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146296467|NCT01839487|527600641|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
146296468|NCT01839487|527600642|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146296469|NCT01839487|527600643|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146296470|NCT01839487|527600644|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146296471|NCT01839487|527600645|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
146296472|NCT01839487|527600640|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
146296473|NCT01839487|527600641|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146296474|NCT01839487|527600642|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146296475|NCT01839487|527600643|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146296476|NCT01839487|527600644|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146296477|NCT01839487|527600645|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
146296478|NCT01839487|527600640|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
146296479|NCT01839487|527600641|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
146296480|NCT01839487|527600642|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
146296481|NCT01839487|527600643|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
146296482|NCT01839487|527600644|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
146296483|NCT01839487|527600645|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
146296484|NCT01839487|527600640|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
146296485|NCT01839487|527600641|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
146296486|NCT01839487|527600642|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
146296487|NCT01839487|527600643|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
146296488|NCT01839487|527600644|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
146296489|NCT01839487|527600645|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
146296490|NCT01839487|527600640|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146296491|NCT01839487|527600641|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146296492|NCT01839487|527600642|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
145895852|NCT02444793|526128260|FG003|Overall Study|Death|0|||
145895853|NCT02444793|526128257|FG000|Overall Study|Other|0|||
145895854|NCT02444793|526128258|FG001|Overall Study|Other|0|||
145895855|NCT02444793|526128259|FG002|Overall Study|Other|2|||
145895856|NCT02444793|526128260|FG003|Overall Study|Other|0|||
145895857|NCT02444793|526128257|FG000|Overall Study|Objective progression or relapse|9|||
146237716|NCT02744066|527384312|FG000|Overall Study|Withdrawal by parent|0|||
146237717|NCT02744066|527384313|FG001|Overall Study|Withdrawal by parent|1|||
146237718|NCT02744066|527384312|FG000|Overall Study|Discharged from NICU prior to completion|0|||
146237719|NCT02744066|527384313|FG001|Overall Study|Discharged from NICU prior to completion|4|||
146237720|NCT05628103|527384314|FG000|Overall Study|Adverse Event|7|||
146237721|NCT05628103|527384314|FG000|Overall Study|Withdrawal by Subject|3|||
146237722|NCT05628103|527384314|FG000|Overall Study|Lost to Follow-up|3|||
146237723|NCT05628103|527384314|FG000|Overall Study|Lack of Efficacy|1|||
146237724|NCT05628103|527384314|FG000|Overall Study|Non-Compliance With Study Drug|4|||
146237725|NCT03492177|527384316|FG000|Overall Study|Adverse Event|1|||
146237726|NCT03492177|527384317|FG001|Overall Study|Adverse Event|0|||
146237727|NCT03492177|527384318|FG002|Overall Study|Adverse Event|0|||
146237728|NCT03492177|527384316|FG000|Overall Study|Death|3|||
146237729|NCT03492177|527384317|FG001|Overall Study|Death|0|||
146237730|NCT03492177|527384318|FG002|Overall Study|Death|3|||
146237731|NCT03492177|527384316|FG000|Overall Study|Lack of Efficacy|1|||
146237732|NCT03492177|527384317|FG001|Overall Study|Lack of Efficacy|2|||
146237733|NCT03492177|527384318|FG002|Overall Study|Lack of Efficacy|0|||
146237734|NCT03492177|527384316|FG000|Overall Study|Other|1|||
146237735|NCT03492177|527384317|FG001|Overall Study|Other|0|||
146237736|NCT03492177|527384318|FG002|Overall Study|Other|0|||
146237737|NCT03492177|527384316|FG000|Overall Study|Ongoing|16|||
146237738|NCT03492177|527384317|FG001|Overall Study|Ongoing|19|||
146237739|NCT03492177|527384318|FG002|Overall Study|Ongoing|17|||
146237740|NCT02499328|527384319|FG000|Overall Study|Withdrawal by Subject|1|||
146237741|NCT02499328|527384320|FG001|Overall Study|Withdrawal by Subject|1|||
146237742|NCT02499328|527384321|FG002|Overall Study|Withdrawal by Subject|5|||
146237743|NCT02499328|527384322|FG003|Overall Study|Withdrawal by Subject|3|||
146237744|NCT02499328|527384323|FG004|Overall Study|Withdrawal by Subject|5|||
146237745|NCT02499328|527384324|FG005|Overall Study|Withdrawal by Subject|0|||
146237746|NCT02499328|527384325|FG006|Overall Study|Withdrawal by Subject|0|||
146237747|NCT02499328|527384326|FG007|Overall Study|Withdrawal by Subject|0|||
146237748|NCT02499328|527384327|FG008|Overall Study|Withdrawal by Subject|2|||
146237749|NCT02499328|527384328|FG009|Overall Study|Withdrawal by Subject|2|||
146237750|NCT02499328|527384329|FG010|Overall Study|Withdrawal by Subject|0|||
146237751|NCT02499328|527384330|FG011|Overall Study|Withdrawal by Subject|3|||
146237752|NCT02499328|527384331|FG012|Overall Study|Withdrawal by Subject|7|||
146237753|NCT02499328|527384332|FG013|Overall Study|Withdrawal by Subject|3|||
146237754|NCT02499328|527384333|FG014|Overall Study|Withdrawal by Subject|1|||
146237755|NCT02499328|527384334|FG015|Overall Study|Withdrawal by Subject|0|||
146237756|NCT02499328|527384335|FG016|Overall Study|Withdrawal by Subject|0|||
146237757|NCT02499328|527384336|FG017|Overall Study|Withdrawal by Subject|3|||
146237758|NCT02499328|527384337|FG018|Overall Study|Withdrawal by Subject|0|||
146237759|NCT02499328|527384319|FG000|Overall Study|Lost to Follow-up|0|||
146237760|NCT02499328|527384320|FG001|Overall Study|Lost to Follow-up|1|||
146237761|NCT02499328|527384321|FG002|Overall Study|Lost to Follow-up|1|||
146237762|NCT02499328|527384322|FG003|Overall Study|Lost to Follow-up|2|||
146237763|NCT02499328|527384323|FG004|Overall Study|Lost to Follow-up|0|||
146237764|NCT02499328|527384324|FG005|Overall Study|Lost to Follow-up|0|||
146237765|NCT02499328|527384325|FG006|Overall Study|Lost to Follow-up|0|||
146237766|NCT02499328|527384326|FG007|Overall Study|Lost to Follow-up|2|||
146237767|NCT02499328|527384327|FG008|Overall Study|Lost to Follow-up|3|||
146237768|NCT02499328|527384328|FG009|Overall Study|Lost to Follow-up|0|||
146237769|NCT02499328|527384329|FG010|Overall Study|Lost to Follow-up|0|||
146237770|NCT02499328|527384330|FG011|Overall Study|Lost to Follow-up|0|||
146237771|NCT02499328|527384331|FG012|Overall Study|Lost to Follow-up|0|||
146237772|NCT02499328|527384332|FG013|Overall Study|Lost to Follow-up|0|||
146237773|NCT02499328|527384333|FG014|Overall Study|Lost to Follow-up|0|||
146237774|NCT02499328|527384334|FG015|Overall Study|Lost to Follow-up|0|||
146237775|NCT02499328|527384335|FG016|Overall Study|Lost to Follow-up|0|||
146237776|NCT02499328|527384336|FG017|Overall Study|Lost to Follow-up|0|||
146237777|NCT02499328|527384337|FG018|Overall Study|Lost to Follow-up|1|||
146237778|NCT02499328|527384319|FG000|Overall Study|Death|0|||
146237779|NCT02499328|527384320|FG001|Overall Study|Death|3|||
146237780|NCT02499328|527384321|FG002|Overall Study|Death|3|||
146237781|NCT02499328|527384322|FG003|Overall Study|Death|2|||
145895858|NCT02444793|526128258|FG001|Overall Study|Objective progression or relapse|1|||
145895859|NCT02444793|526128259|FG002|Overall Study|Objective progression or relapse|2|||
146237782|NCT02499328|527384323|FG004|Overall Study|Death|4|||
146237783|NCT02499328|527384324|FG005|Overall Study|Death|7|||
146237784|NCT02499328|527384325|FG006|Overall Study|Death|3|||
146237785|NCT02499328|527384326|FG007|Overall Study|Death|0|||
146237786|NCT02499328|527384327|FG008|Overall Study|Death|2|||
146237787|NCT02499328|527384328|FG009|Overall Study|Death|6|||
146237788|NCT02499328|527384329|FG010|Overall Study|Death|6|||
146237789|NCT02499328|527384330|FG011|Overall Study|Death|20|||
146237790|NCT02499328|527384331|FG012|Overall Study|Death|9|||
146237791|NCT02499328|527384332|FG013|Overall Study|Death|7|||
146237792|NCT02499328|527384333|FG014|Overall Study|Death|3|||
146237793|NCT02499328|527384334|FG015|Overall Study|Death|1|||
146237794|NCT02499328|527384335|FG016|Overall Study|Death|1|||
145895860|NCT02444793|526128260|FG003|Overall Study|Objective progression or relapse|3|||
145895861|NCT02504671|526128265|FG000|Overall Study|Withdrawal by Subject|1|||
145895862|NCT02504671|526128266|FG001|Overall Study|Withdrawal by Subject|5|||
145895863|NCT02504671|526128267|FG002|Overall Study|Withdrawal by Subject|4|||
145895864|NCT02504671|526128268|FG003|Overall Study|Withdrawal by Subject|4|||
145895865|NCT02504671|526128269|FG004|Overall Study|Withdrawal by Subject|5|||
145895866|NCT02504671|526128270|FG005|Overall Study|Withdrawal by Subject|3|||
145895867|NCT02504671|526128265|FG000|Overall Study|Lack of Efficacy|1|||
145895868|NCT02504671|526128266|FG001|Overall Study|Lack of Efficacy|3|||
145895869|NCT02504671|526128267|FG002|Overall Study|Lack of Efficacy|1|||
145895870|NCT02504671|526128268|FG003|Overall Study|Lack of Efficacy|0|||
145895871|NCT02504671|526128269|FG004|Overall Study|Lack of Efficacy|4|||
145895872|NCT02504671|526128270|FG005|Overall Study|Lack of Efficacy|4|||
146237795|NCT02499328|527384336|FG017|Overall Study|Death|16|||
145895873|NCT02504671|526128265|FG000|Overall Study|Adverse Event|1|||
145895874|NCT02504671|526128266|FG001|Overall Study|Adverse Event|1|||
145895875|NCT02504671|526128267|FG002|Overall Study|Adverse Event|0|||
145895876|NCT02504671|526128268|FG003|Overall Study|Adverse Event|1|||
145895877|NCT02504671|526128269|FG004|Overall Study|Adverse Event|0|||
145895878|NCT02504671|526128270|FG005|Overall Study|Adverse Event|2|||
145895879|NCT02504671|526128265|FG000|Overall Study|Protocol Violation|2|||
145895880|NCT02504671|526128266|FG001|Overall Study|Protocol Violation|1|||
145895881|NCT02504671|526128267|FG002|Overall Study|Protocol Violation|0|||
145895882|NCT02504671|526128268|FG003|Overall Study|Protocol Violation|0|||
145895883|NCT02504671|526128269|FG004|Overall Study|Protocol Violation|0|||
145895884|NCT02504671|526128270|FG005|Overall Study|Protocol Violation|1|||
145895885|NCT02504671|526128265|FG000|Overall Study|Lost to Follow-up|0|||
145895886|NCT02504671|526128266|FG001|Overall Study|Lost to Follow-up|0|||
145895887|NCT02504671|526128267|FG002|Overall Study|Lost to Follow-up|2|||
145895888|NCT02504671|526128268|FG003|Overall Study|Lost to Follow-up|0|||
145895889|NCT02504671|526128269|FG004|Overall Study|Lost to Follow-up|0|||
145895890|NCT02504671|526128270|FG005|Overall Study|Lost to Follow-up|1|||
145895891|NCT02504671|526128265|FG000|Overall Study|Protocol defined stopping criteria|7|||
145895892|NCT02504671|526128266|FG001|Overall Study|Protocol defined stopping criteria|4|||
145895893|NCT02504671|526128267|FG002|Overall Study|Protocol defined stopping criteria|3|||
145895894|NCT02504671|526128268|FG003|Overall Study|Protocol defined stopping criteria|5|||
145895895|NCT02504671|526128269|FG004|Overall Study|Protocol defined stopping criteria|3|||
145895896|NCT02504671|526128270|FG005|Overall Study|Protocol defined stopping criteria|3|||
145895897|NCT00210249|526128271|FG000|Overall Study|Lost to Follow-up|5|||
145895898|NCT00210249|526128271|FG000|Overall Study|Protocol Violation|11|||
146237796|NCT02499328|527384337|FG018|Overall Study|Death|5|||
146237797|NCT02499328|527384319|FG000|Overall Study|"Other"|2|||
146237798|NCT02499328|527384320|FG001|Overall Study|"Other"|2|||
146237799|NCT02499328|527384321|FG002|Overall Study|"Other"|1|||
146237800|NCT02499328|527384322|FG003|Overall Study|"Other"|3|||
146237801|NCT02499328|527384323|FG004|Overall Study|"Other"|6|||
146237802|NCT02499328|527384324|FG005|Overall Study|"Other"|2|||
146237803|NCT02499328|527384325|FG006|Overall Study|"Other"|3|||
146237804|NCT02499328|527384326|FG007|Overall Study|"Other"|4|||
146237805|NCT02499328|527384327|FG008|Overall Study|"Other"|6|||
146237806|NCT02499328|527384328|FG009|Overall Study|"Other"|16|||
146237807|NCT02499328|527384329|FG010|Overall Study|"Other"|13|||
146237808|NCT02499328|527384330|FG011|Overall Study|"Other"|31|||
146237809|NCT02499328|527384331|FG012|Overall Study|"Other"|8|||
146237810|NCT02499328|527384332|FG013|Overall Study|"Other"|7|||
146237811|NCT02499328|527384333|FG014|Overall Study|"Other"|6|||
146237812|NCT02499328|527384334|FG015|Overall Study|"Other"|0|||
146237813|NCT02499328|527384335|FG016|Overall Study|"Other"|0|||
146237814|NCT02499328|527384336|FG017|Overall Study|"Other"|34|||
146237815|NCT02499328|527384337|FG018|Overall Study|"Other"|43|||
146237816|NCT02499328|527384319|FG000|Overall Study|Disease Progression|0|||
146237817|NCT02499328|527384320|FG001|Overall Study|Disease Progression|0|||
146237818|NCT02499328|527384321|FG002|Overall Study|Disease Progression|0|||
146237819|NCT02499328|527384322|FG003|Overall Study|Disease Progression|0|||
146237820|NCT02499328|527384323|FG004|Overall Study|Disease Progression|0|||
146237821|NCT02499328|527384324|FG005|Overall Study|Disease Progression|0|||
145895899|NCT04280705|526128272|FG000|Overall Study|Enrolled but not treated|4|||
145895900|NCT04280705|526128273|FG001|Overall Study|Enrolled but not treated|10|||
145895901|NCT04280705|526128272|FG000|Overall Study|Physician Decision|1|||
145895902|NCT04280705|526128273|FG001|Overall Study|Physician Decision|0|||
145895903|NCT04280705|526128272|FG000|Overall Study|Withdrawal by Subject|7|||
145895904|NCT04280705|526128273|FG001|Overall Study|Withdrawal by Subject|9|||
146296493|NCT01839487|527600643|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
145895905|NCT04280705|526128272|FG000|Overall Study|Adverse Event|0|||
146237822|NCT02499328|527384325|FG006|Overall Study|Disease Progression|1|||
146237823|NCT02499328|527384326|FG007|Overall Study|Disease Progression|0|||
146237824|NCT02499328|527384327|FG008|Overall Study|Disease Progression|1|||
146237825|NCT02499328|527384328|FG009|Overall Study|Disease Progression|0|||
146237826|NCT02499328|527384329|FG010|Overall Study|Disease Progression|1|||
146237827|NCT02499328|527384330|FG011|Overall Study|Disease Progression|0|||
145895906|NCT04280705|526128273|FG001|Overall Study|Adverse Event|4|||
145895907|NCT04280705|526128272|FG000|Overall Study|Transferred to another hospital|1|||
146237828|NCT02499328|527384331|FG012|Overall Study|Disease Progression|0|||
146237829|NCT02499328|527384332|FG013|Overall Study|Disease Progression|0|||
146237830|NCT02499328|527384333|FG014|Overall Study|Disease Progression|0|||
146237831|NCT02499328|527384334|FG015|Overall Study|Disease Progression|0|||
146237832|NCT02499328|527384335|FG016|Overall Study|Disease Progression|0|||
146237833|NCT02499328|527384336|FG017|Overall Study|Disease Progression|2|||
145895908|NCT04280705|526128273|FG001|Overall Study|Transferred to another hospital|1|||
145895909|NCT03222583|526128274|FG000|Overall Study|Withdrawal by Subject|3|||
146237834|NCT02499328|527384337|FG018|Overall Study|Disease Progression|0|||
145895910|NCT03222583|526128275|FG001|Overall Study|Withdrawal by Subject|3|||
145895911|NCT03222583|526128274|FG000|Overall Study|Lost to Follow-up|1|||
145895912|NCT03222583|526128275|FG001|Overall Study|Lost to Follow-up|0|||
145895913|NCT03222583|526128274|FG000|Overall Study|Other|1|||
145895914|NCT03222583|526128275|FG001|Overall Study|Other|3|||
145895915|NCT02518919|526128278|FG000|Overall Study|Protocol Violation|1|||
145895916|NCT02518919|526128279|FG001|Overall Study|Protocol Violation|1|||
146237835|NCT02499328|527384319|FG000|Overall Study|Adverse Event|1|||
146237836|NCT02499328|527384320|FG001|Overall Study|Adverse Event|0|||
146237837|NCT02499328|527384321|FG002|Overall Study|Adverse Event|0|||
146237838|NCT02499328|527384322|FG003|Overall Study|Adverse Event|1|||
146237839|NCT02499328|527384323|FG004|Overall Study|Adverse Event|0|||
146237840|NCT02499328|527384324|FG005|Overall Study|Adverse Event|0|||
145895917|NCT02518919|526128280|FG002|Overall Study|Protocol Violation|2|||
145895918|NCT04498403|526128281|FG000|Overall Study|Adverse Event|1|||
145895919|NCT04498403|526128282|FG001|Overall Study|Adverse Event|0|||
145895920|NCT04498403|526128281|FG000|Overall Study|Study Terminated By Sponsor|29|||
145895921|NCT04498403|526128282|FG001|Overall Study|Study Terminated By Sponsor|10|||
145895922|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Death|89|||
145895923|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Death|193|||
145895924|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Death|198|||
145895925|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
145895926|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
145895927|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
145895928|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
145895929|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
145895930|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
145895931|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
145895932|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
145895933|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
145895934|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
145895935|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
145895936|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
145895937|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
145895938|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
145895939|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
145895940|NCT02031458|526128283|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
145895941|NCT02031458|526128284|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
145895942|NCT02031458|526128285|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
146237841|NCT02499328|527384325|FG006|Overall Study|Adverse Event|0|||
146237842|NCT02499328|527384326|FG007|Overall Study|Adverse Event|0|||
146237843|NCT02499328|527384327|FG008|Overall Study|Adverse Event|0|||
146237844|NCT02499328|527384328|FG009|Overall Study|Adverse Event|0|||
146237845|NCT02499328|527384329|FG010|Overall Study|Adverse Event|0|||
146237846|NCT02499328|527384330|FG011|Overall Study|Adverse Event|0|||
146237847|NCT02499328|527384331|FG012|Overall Study|Adverse Event|1|||
146237848|NCT02499328|527384332|FG013|Overall Study|Adverse Event|0|||
146237849|NCT02499328|527384333|FG014|Overall Study|Adverse Event|0|||
146237850|NCT02499328|527384334|FG015|Overall Study|Adverse Event|0|||
146237851|NCT02499328|527384335|FG016|Overall Study|Adverse Event|0|||
146237852|NCT02499328|527384336|FG017|Overall Study|Adverse Event|0|||
146237853|NCT02499328|527384337|FG018|Overall Study|Adverse Event|0|||
146237854|NCT01400958|527384340|FG000|Overall Study|Physician Decision|0|||
146237855|NCT01400958|527384341|FG001|Overall Study|Physician Decision|1|||
146237856|NCT01400958|527384340|FG000|Overall Study|Withdrawal by Subject|0|||
146237857|NCT01400958|527384341|FG001|Overall Study|Withdrawal by Subject|1|||
146237858|NCT01400958|527384340|FG000|Overall Study|Adverse Event|1|||
146237859|NCT01400958|527384341|FG001|Overall Study|Adverse Event|0|||
146237860|NCT03102034|527384344|FG000|Overall Study|Withdrawal by Subject|1|||
146237861|NCT03102034|527384345|FG001|Overall Study|Withdrawal by Subject|0|||
146237862|NCT05663866|527384350|FG000|Overall Study|Adverse Event|0|||
146237863|NCT05663866|527384351|FG001|Overall Study|Adverse Event|0|||
146237864|NCT05663866|527384352|FG002|Overall Study|Adverse Event|1|||
146237865|NCT05663866|527384353|FG003|Overall Study|Adverse Event|0|||
146237866|NCT05663866|527384350|FG000|Overall Study|Physician Decision|0|||
146237867|NCT05663866|527384351|FG001|Overall Study|Physician Decision|0|||
146237868|NCT05663866|527384352|FG002|Overall Study|Physician Decision|0|||
146237869|NCT05663866|527384353|FG003|Overall Study|Physician Decision|1|||
146237870|NCT05663866|527384350|FG000|Overall Study|Withdrawal by Subject|0|||
146237871|NCT05663866|527384351|FG001|Overall Study|Withdrawal by Subject|2|||
146237872|NCT05663866|527384352|FG002|Overall Study|Withdrawal by Subject|1|||
146237873|NCT05663866|527384353|FG003|Overall Study|Withdrawal by Subject|2|||
146237874|NCT05663866|527384350|FG000|Overall Study|Progressive disease|4|||
146237875|NCT05663866|527384351|FG001|Overall Study|Progressive disease|8|||
146237876|NCT05663866|527384352|FG002|Overall Study|Progressive disease|5|||
146237877|NCT05663866|527384353|FG003|Overall Study|Progressive disease|2|||
146237878|NCT05663866|527384350|FG000|Overall Study|Other|1|||
146237879|NCT05663866|527384351|FG001|Overall Study|Other|0|||
146237880|NCT05663866|527384352|FG002|Overall Study|Other|0|||
146237881|NCT05663866|527384353|FG003|Overall Study|Other|0|||
146237882|NCT05663866|527384350|FG000|Overall Study|Ongoing|1|||
146237883|NCT05663866|527384351|FG001|Overall Study|Ongoing|27|||
146237884|NCT05663866|527384352|FG002|Overall Study|Ongoing|6|||
146237885|NCT05663866|527384353|FG003|Overall Study|Ongoing|1|||
146237886|NCT03598907|527384358|FG000|Overall Study|Physician Decision|14|||
145895943|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Death|36|||
145895944|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Death|87|||
145895945|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Death|100|||
145895946|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
145895947|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
145895948|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
145895949|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Physician Decision|0|||
145895950|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Physician Decision|1|||
145895951|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Physician Decision|0|||
145895952|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
145895953|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
145895954|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
145895955|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
145895956|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
145895957|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
145895958|NCT02031458|526128283|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
145895959|NCT02031458|526128284|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
145895960|NCT02031458|526128285|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
145895961|NCT02031458|526128283|FG000|Baseline to May 8, 2015|On Treatment|43|||
146237887|NCT03598907|527384359|FG001|Overall Study|Physician Decision|19|||
146237888|NCT05741528|527384360|FG000|Overall Study|Withdrawal by Subject|11|||
146237889|NCT05741528|527384360|FG000|Overall Study|Lost to Follow-up|3|||
146237890|NCT05741528|527384360|FG000|Overall Study|Adverse Event|2|||
146237891|NCT05741528|527384360|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146237892|NCT05741528|527384360|FG000|Overall Study|Reason Not Specified|1|||
146237893|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
146237894|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
146237895|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
146237896|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
146237897|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
146237898|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
146237899|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
146237900|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
146237901|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146237902|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146237903|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
146237904|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
146237905|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
146237906|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
146237907|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
146237908|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
146237909|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
146237910|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
146237911|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
146237912|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
146237913|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
145895962|NCT02031458|526128284|FG001|Baseline to May 8, 2015|On Treatment|81|||
145895963|NCT02031458|526128285|FG002|Baseline to May 8, 2015|On Treatment|73|||
145895964|NCT02031458|526128283|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
145895965|NCT02031458|526128284|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
145895966|NCT02031458|526128285|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
146088217|NCT03387150|526843771|FG002|Overall Study|Lost to Follow-up|2|||
146088218|NCT03387150|526843772|FG003|Overall Study|Lost to Follow-up|3|||
146088219|NCT03387150|526843773|FG004|Overall Study|Lost to Follow-up|3|||
146237914|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146237915|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146237916|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146237917|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146237918|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
146237919|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
146237920|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
146237921|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
146237922|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146237923|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146237924|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146237925|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146237926|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
146237927|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
146237928|NCT03656718|527384363|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146237929|NCT03656718|527384364|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146237930|NCT03656718|527384365|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146237931|NCT03656718|527384366|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146237932|NCT03656718|527384367|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
146237933|NCT03656718|527384368|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
146237934|NCT03656718|527384369|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
146237935|NCT03656718|527384363|FG000|Treatment Period Part C|Disease progression|0|||
146237936|NCT03656718|527384364|FG001|Treatment Period Part C|Disease progression|0|||
146237937|NCT03656718|527384365|FG002|Treatment Period Part C|Disease progression|0|||
146237938|NCT03656718|527384366|FG003|Treatment Period Part C|Disease progression|0|||
145895967|NCT03188718|526128288|FG000|Overall Study|Participant noncompliance|4|||
146088220|NCT03387150|526843774|FG005|Overall Study|Lost to Follow-up|3|||
146296494|NCT01839487|527600644|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
146296495|NCT01839487|527600645|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
146296496|NCT01839487|527600640|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146296497|NCT01839487|527600641|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146296498|NCT01839487|527600642|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
146296499|NCT01839487|527600643|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
146296500|NCT01839487|527600644|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
146296501|NCT01839487|527600645|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
146296502|NCT01839487|527600640|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
146296503|NCT01839487|527600641|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
146296504|NCT01839487|527600642|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
146296505|NCT01839487|527600643|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
146296506|NCT01839487|527600644|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
146296507|NCT01839487|527600645|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
146296508|NCT01658826|527600651|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
146296509|NCT01658826|527600652|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
146296510|NCT01658826|527600651|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
146296511|NCT01658826|527600652|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
146296512|NCT01658826|527600651|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
146296513|NCT01658826|527600652|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
146296514|NCT01658826|527600651|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
146296515|NCT01658826|527600652|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
146296516|NCT01658826|527600651|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
145972359|NCT02332707|526412620|FG000|Overall Study|Physician Decision|0|||
146296517|NCT01658826|527600652|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
146296518|NCT01658826|527600651|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
146296519|NCT01658826|527600652|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
146296520|NCT01658826|527600651|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
146296521|NCT01658826|527600652|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
146296522|NCT01658826|527600651|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
146296523|NCT01658826|527600652|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
146296524|NCT01658826|527600651|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
146296525|NCT01658826|527600652|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
146296526|NCT01422850|527600656|FG000|Overall Study|Physician Decision|3|||
146296527|NCT04484831|527600657|FG000|Overall Study|Withdrawal by Subject|1|||
146296528|NCT04484831|527600658|FG001|Overall Study|Withdrawal by Subject|0|||
146296529|NCT02244996|527600659|FG000|Overall Study|Lack of Efficacy|2|||
146296530|NCT02244996|527600660|FG001|Overall Study|Lack of Efficacy|6|||
146296531|NCT00174265|527600661|FG000|Overall Study|Adverse Event|7|||
146296532|NCT00174265|527600662|FG001|Overall Study|Adverse Event|4|||
146296533|NCT00174265|527600661|FG000|Overall Study|Lack of Efficacy|2|||
146296534|NCT00174265|527600662|FG001|Overall Study|Lack of Efficacy|2|||
146296535|NCT00174265|527600661|FG000|Overall Study|Withdrawal by Subject|3|||
146296536|NCT00174265|527600662|FG001|Overall Study|Withdrawal by Subject|5|||
146296537|NCT00174265|527600661|FG000|Overall Study|Lost to Follow-up|1|||
146296538|NCT00174265|527600662|FG001|Overall Study|Lost to Follow-up|0|||
146296539|NCT00174265|527600661|FG000|Overall Study|Other (Not specified)|16|||
146296540|NCT00174265|527600662|FG001|Overall Study|Other (Not specified)|10|||
146296541|NCT00047320|527600664|FG000|Overall Study|Lack of Efficacy|8|||
146296542|NCT00047320|527600664|FG000|Overall Study|Lost to Follow-up|1|||
146296543|NCT00047320|527600664|FG000|Overall Study|Physician Decision|8|||
146296544|NCT00047320|527600664|FG000|Overall Study|Withdrawal by Subject|9|||
146296545|NCT00047320|527600664|FG000|Overall Study|Ineligible|2|||
146296546|NCT03471871|527600665|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146296547|NCT03471871|527600666|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146296548|NCT03471871|527600667|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
146296549|NCT03471871|527600668|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146296550|NCT03471871|527600669|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
146296551|NCT03471871|527600665|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146296552|NCT03471871|527600666|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146296553|NCT03471871|527600667|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
146296554|NCT03471871|527600668|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
146296555|NCT03471871|527600669|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
146296556|NCT03471871|527600665|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146296557|NCT03471871|527600666|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146296558|NCT03471871|527600667|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146296559|NCT03471871|527600668|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
146296560|NCT03471871|527600669|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
146296561|NCT03471871|527600665|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146296562|NCT03471871|527600666|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145895968|NCT03188718|526128288|FG000|Overall Study|Withdrawal by Subject|1|||
145895969|NCT03188718|526128288|FG000|Overall Study|Device failure|3|||
145895970|NCT02049450|526128289|FG000|Overall Study|Adverse Event|2|||
145895971|NCT02049450|526128289|FG000|Overall Study|Withdrawal by Subject|1|||
145895972|NCT02049450|526128289|FG000|Overall Study|Patients/guardian decision|1|||
146296563|NCT03471871|527600667|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145895973|NCT00577395|526128293|FG000|Overall Study|Study was terminated early by Sponsor|7|||
145895974|NCT00577395|526128294|FG001|Overall Study|Study was terminated early by Sponsor|6|||
145895975|NCT00394524|526128296|FG000|Overall Study|Protocol Violation|2|||
145895976|NCT00394524|526128297|FG001|Overall Study|Protocol Violation|3|||
145895977|NCT00394524|526128296|FG000|Overall Study|Death|1|||
145895978|NCT00394524|526128297|FG001|Overall Study|Death|0|||
145895979|NCT00394524|526128296|FG000|Overall Study|Withdrawal by Subject|0|||
145895980|NCT00394524|526128297|FG001|Overall Study|Withdrawal by Subject|1|||
145895981|NCT01462318|526128298|FG000|Main Study / TP-DI Study|Other|2|||
145895982|NCT01462318|526128299|FG001|Main Study / TP-DI Study|Other|0|||
146296564|NCT03471871|527600668|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
146296565|NCT03471871|527600669|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
146296566|NCT03471871|527600665|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146296567|NCT03471871|527600666|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146296568|NCT03471871|527600667|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146296569|NCT03471871|527600668|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
146296570|NCT03471871|527600669|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
146296571|NCT03040622|527600671|FG000|Overall Study|unable to implant device|3|||
146296572|NCT06071754|527600674|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
146237939|NCT03656718|527384367|FG004|Treatment Period Part C|Disease progression|12|||
146237940|NCT03656718|527384368|FG005|Treatment Period Part C|Disease progression|0|||
146237941|NCT03656718|527384369|FG006|Treatment Period Part C|Disease progression|0|||
146237942|NCT03656718|527384363|FG000|Treatment Period Part C|Death|0|||
146237943|NCT03656718|527384364|FG001|Treatment Period Part C|Death|0|||
146237944|NCT03656718|527384365|FG002|Treatment Period Part C|Death|0|||
146237945|NCT03656718|527384366|FG003|Treatment Period Part C|Death|0|||
146237946|NCT03656718|527384367|FG004|Treatment Period Part C|Death|1|||
146237947|NCT03656718|527384368|FG005|Treatment Period Part C|Death|0|||
145895983|NCT01462318|526128300|FG002|Main Study / TP-DI Study|Other|0|||
145895984|NCT01462318|526128298|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
145895985|NCT01462318|526128299|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
145895986|NCT01462318|526128300|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
145895987|NCT01462318|526128298|FG000|Main Study / TP-DI Study|Adverse Event|4|||
145895988|NCT01462318|526128299|FG001|Main Study / TP-DI Study|Adverse Event|0|||
145895989|NCT01462318|526128300|FG002|Main Study / TP-DI Study|Adverse Event|0|||
145895990|NCT01462318|526128298|FG000|Extension Phase|Lost to Follow-up|0|||
145895991|NCT01462318|526128299|FG001|Extension Phase|Lost to Follow-up|0|||
145895992|NCT01462318|526128300|FG002|Extension Phase|Lost to Follow-up|1|||
145895993|NCT01462318|526128298|FG000|Extension Phase|Other|0|||
145895994|NCT01462318|526128299|FG001|Extension Phase|Other|0|||
145895995|NCT01462318|526128300|FG002|Extension Phase|Other|1|||
145895996|NCT01462318|526128298|FG000|Extension Phase|Disease Progression|0|||
145895997|NCT01462318|526128299|FG001|Extension Phase|Disease Progression|0|||
145895998|NCT01462318|526128300|FG002|Extension Phase|Disease Progression|1|||
145895999|NCT01462318|526128298|FG000|Extension Phase|Withdrawal by Subject|0|||
146237948|NCT03656718|527384369|FG006|Treatment Period Part C|Death|0|||
146237949|NCT03656718|527384363|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146237950|NCT03656718|527384364|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146296601|NCT03422172|527602535|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
145896000|NCT01462318|526128299|FG001|Extension Phase|Withdrawal by Subject|0|||
146296602|NCT03422172|527602535|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
146296603|NCT03422172|527602535|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
146296604|NCT05736211|527602537|FG000|Overall Study|Lost to Follow-up|6|||
146296605|NCT05736211|527602538|FG001|Overall Study|Lost to Follow-up|0|||
146296606|NCT00293722|527602539|FG000|Overall Study|Other|427|||
145896001|NCT01462318|526128300|FG002|Extension Phase|Withdrawal by Subject|15|||
145896002|NCT01462318|526128298|FG000|Extension Phase|Investigator Decision|0|||
145896003|NCT01462318|526128299|FG001|Extension Phase|Investigator Decision|0|||
145896004|NCT01462318|526128300|FG002|Extension Phase|Investigator Decision|5|||
145896005|NCT01462318|526128298|FG000|Extension Phase|Adverse Event|0|||
145896006|NCT01462318|526128299|FG001|Extension Phase|Adverse Event|0|||
145896007|NCT01462318|526128300|FG002|Extension Phase|Adverse Event|22|||
145896008|NCT02227147|526128302|FG000|Controlled Treatment Period|Adverse Event|4|||
145896009|NCT02227147|526128303|FG001|Controlled Treatment Period|Adverse Event|3|||
145896010|NCT02227147|526128302|FG000|Controlled Treatment Period|Other|2|||
145896011|NCT02227147|526128303|FG001|Controlled Treatment Period|Other|0|||
145896012|NCT02227147|526128302|FG000|Follow-up Period|Other|3|||
145896013|NCT02227147|526128303|FG001|Follow-up Period|Other|5|||
145896014|NCT03347422|526128306|FG000|Part A (26 Weeks)|Adverse Event|3|||
145896015|NCT03347422|526128307|FG001|Part A (26 Weeks)|Adverse Event|0|||
145896016|NCT03347422|526128306|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
145896017|NCT03347422|526128307|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
145896018|NCT03347422|526128306|FG000|Part B (149 Weeks)|Adverse Event|0|||
145896019|NCT03347422|526128307|FG001|Part B (149 Weeks)|Adverse Event|1|||
145896020|NCT03347422|526128306|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
145896021|NCT03347422|526128307|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
145896022|NCT03347422|526128306|FG000|Part B (149 Weeks)|Other|1|||
145896023|NCT03347422|526128307|FG001|Part B (149 Weeks)|Other|0|||
145896024|NCT03709823|526128308|FG000|Overall Study|Adverse Event|0|||
145896025|NCT03709823|526128309|FG001|Overall Study|Adverse Event|0|||
145896026|NCT03709823|526128310|FG002|Overall Study|Adverse Event|1|||
145896027|NCT03709823|526128311|FG003|Overall Study|Adverse Event|0|||
145896028|NCT03709823|526128312|FG004|Overall Study|Adverse Event|0|||
145896029|NCT03709823|526128313|FG005|Overall Study|Adverse Event|0|||
145896030|NCT03709823|526128308|FG000|Overall Study|Lost to Follow-up|2|||
145896031|NCT03709823|526128309|FG001|Overall Study|Lost to Follow-up|2|||
145896032|NCT03709823|526128310|FG002|Overall Study|Lost to Follow-up|2|||
145896033|NCT03709823|526128311|FG003|Overall Study|Lost to Follow-up|1|||
145896034|NCT03709823|526128312|FG004|Overall Study|Lost to Follow-up|1|||
145896035|NCT03709823|526128313|FG005|Overall Study|Lost to Follow-up|0|||
145896036|NCT03709823|526128308|FG000|Overall Study|Withdrawal by Subject|1|||
145896037|NCT03709823|526128309|FG001|Overall Study|Withdrawal by Subject|3|||
145896038|NCT03709823|526128310|FG002|Overall Study|Withdrawal by Subject|0|||
145896039|NCT03709823|526128311|FG003|Overall Study|Withdrawal by Subject|0|||
145896040|NCT03709823|526128312|FG004|Overall Study|Withdrawal by Subject|0|||
145896041|NCT03709823|526128313|FG005|Overall Study|Withdrawal by Subject|0|||
145896042|NCT03709823|526128308|FG000|Overall Study|Other, Not Specified|0|||
145896043|NCT03709823|526128309|FG001|Overall Study|Other, Not Specified|0|||
145896044|NCT03709823|526128310|FG002|Overall Study|Other, Not Specified|0|||
145896045|NCT03709823|526128311|FG003|Overall Study|Other, Not Specified|1|||
145896046|NCT03709823|526128312|FG004|Overall Study|Other, Not Specified|0|||
145896047|NCT03709823|526128313|FG005|Overall Study|Other, Not Specified|0|||
145896048|NCT00158600|526128316|FG000|Overall Study|unable to commit time to study|0|||
145896049|NCT00158600|526128317|FG001|Overall Study|unable to commit time to study|1|||
145896050|NCT00158600|526128316|FG000|Overall Study|Adverse Event|2|||
145896051|NCT00158600|526128317|FG001|Overall Study|Adverse Event|1|||
145896052|NCT00158600|526128316|FG000|Overall Study|Death|1|||
145896053|NCT00158600|526128317|FG001|Overall Study|Death|0|||
145896054|NCT00158600|526128316|FG000|Overall Study|Withdrawal by Subject|2|||
145896055|NCT00158600|526128317|FG001|Overall Study|Withdrawal by Subject|2|||
145896056|NCT02038907|526128318|FG000|Overall Study|Protocol Violation|0|||
145896057|NCT02038907|526128319|FG001|Overall Study|Protocol Violation|0|||
146088221|NCT03387150|526843775|FG006|Overall Study|Lost to Follow-up|0|||
146088222|NCT03387150|526843769|FG000|Overall Study|Participant unable to adhere to visit|0|||
146237951|NCT03656718|527384365|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146237952|NCT03656718|527384366|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146237953|NCT03656718|527384367|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
146237954|NCT03656718|527384368|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146237955|NCT03656718|527384369|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
146237956|NCT03656718|527384363|FG000|Treatment Period Part C|Other reasons|0|||
146237957|NCT03656718|527384364|FG001|Treatment Period Part C|Other reasons|0|||
146237958|NCT03656718|527384365|FG002|Treatment Period Part C|Other reasons|0|||
146237959|NCT03656718|527384366|FG003|Treatment Period Part C|Other reasons|0|||
146237960|NCT03656718|527384367|FG004|Treatment Period Part C|Other reasons|1|||
146237961|NCT03656718|527384368|FG005|Treatment Period Part C|Other reasons|0|||
146237962|NCT03656718|527384369|FG006|Treatment Period Part C|Other reasons|0|||
146237963|NCT03656718|527384363|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
146237964|NCT03656718|527384364|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
146237965|NCT03656718|527384365|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
146237966|NCT03656718|527384366|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
145896058|NCT02038907|526128320|FG002|Overall Study|Protocol Violation|0|||
145896059|NCT02038907|526128321|FG003|Overall Study|Protocol Violation|0|||
145896060|NCT02038907|526128322|FG004|Overall Study|Protocol Violation|0|||
145896061|NCT02038907|526128323|FG005|Overall Study|Protocol Violation|0|||
145896062|NCT02038907|526128324|FG006|Overall Study|Protocol Violation|0|||
145896063|NCT02038907|526128325|FG007|Overall Study|Protocol Violation|0|||
145896064|NCT02038907|526128326|FG008|Overall Study|Protocol Violation|0|||
145896065|NCT02038907|526128327|FG009|Overall Study|Protocol Violation|0|||
145896066|NCT02038907|526128328|FG010|Overall Study|Protocol Violation|1|||
145896067|NCT02038907|526128329|FG011|Overall Study|Protocol Violation|0|||
145896068|NCT02038907|526128330|FG012|Overall Study|Protocol Violation|0|||
145896069|NCT02038907|526128331|FG013|Overall Study|Protocol Violation|0|||
145896070|NCT02038907|526128318|FG000|Overall Study|Withdrawal by Subject|0|||
145896071|NCT02038907|526128319|FG001|Overall Study|Withdrawal by Subject|0|||
145896072|NCT02038907|526128320|FG002|Overall Study|Withdrawal by Subject|0|||
145896073|NCT02038907|526128321|FG003|Overall Study|Withdrawal by Subject|0|||
145896074|NCT02038907|526128322|FG004|Overall Study|Withdrawal by Subject|0|||
145896075|NCT02038907|526128323|FG005|Overall Study|Withdrawal by Subject|0|||
145896076|NCT02038907|526128324|FG006|Overall Study|Withdrawal by Subject|0|||
145896077|NCT02038907|526128325|FG007|Overall Study|Withdrawal by Subject|0|||
145896078|NCT02038907|526128326|FG008|Overall Study|Withdrawal by Subject|0|||
145896079|NCT02038907|526128327|FG009|Overall Study|Withdrawal by Subject|0|||
145896080|NCT02038907|526128328|FG010|Overall Study|Withdrawal by Subject|1|||
145896081|NCT02038907|526128329|FG011|Overall Study|Withdrawal by Subject|0|||
145896082|NCT02038907|526128330|FG012|Overall Study|Withdrawal by Subject|0|||
145896083|NCT02038907|526128331|FG013|Overall Study|Withdrawal by Subject|0|||
145896084|NCT01246011|526128338|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
145896085|NCT01246011|526128339|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
145896086|NCT01246011|526128340|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
145896087|NCT01246011|526128338|FG000|Overall Study|Withdrawal by Subject|0|||
145896088|NCT01246011|526128339|FG001|Overall Study|Withdrawal by Subject|0|||
145896089|NCT01246011|526128340|FG002|Overall Study|Withdrawal by Subject|1|||
145896090|NCT04049617|526128341|FG000|Overall Study|Adverse Event|0|||
145896091|NCT04049617|526128342|FG001|Overall Study|Adverse Event|0|||
145896092|NCT04049617|526128343|FG002|Overall Study|Adverse Event|0|||
145896093|NCT04049617|526128344|FG003|Overall Study|Adverse Event|1|||
145896094|NCT04049617|526128345|FG004|Overall Study|Adverse Event|0|||
145896095|NCT04049617|526128346|FG005|Overall Study|Adverse Event|0|||
145896096|NCT04049617|526128341|FG000|Overall Study|Death|0|||
145896097|NCT04049617|526128342|FG001|Overall Study|Death|0|||
145896098|NCT04049617|526128343|FG002|Overall Study|Death|0|||
145896099|NCT04049617|526128344|FG003|Overall Study|Death|0|||
145896100|NCT04049617|526128345|FG004|Overall Study|Death|0|||
145896101|NCT04049617|526128346|FG005|Overall Study|Death|1|||
145896102|NCT04049617|526128341|FG000|Overall Study|Lost to Follow-up|0|||
145896103|NCT04049617|526128342|FG001|Overall Study|Lost to Follow-up|0|||
145896104|NCT04049617|526128343|FG002|Overall Study|Lost to Follow-up|0|||
145896105|NCT04049617|526128344|FG003|Overall Study|Lost to Follow-up|1|||
145896106|NCT04049617|526128345|FG004|Overall Study|Lost to Follow-up|0|||
146237967|NCT03656718|527384367|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
146237968|NCT03656718|527384368|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
146237969|NCT03656718|527384369|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
145896107|NCT04049617|526128346|FG005|Overall Study|Lost to Follow-up|0|||
145896108|NCT04049617|526128341|FG000|Overall Study|Withdrew consent|0|||
145896109|NCT04049617|526128342|FG001|Overall Study|Withdrew consent|0|||
145896110|NCT04049617|526128343|FG002|Overall Study|Withdrew consent|1|||
145896111|NCT04049617|526128344|FG003|Overall Study|Withdrew consent|0|||
145896112|NCT04049617|526128345|FG004|Overall Study|Withdrew consent|0|||
145896113|NCT04049617|526128346|FG005|Overall Study|Withdrew consent|0|||
145896114|NCT00987389|526128349|FG000|Overall Study|Ineligible|0|||
145896115|NCT00987389|526128350|FG001|Overall Study|Ineligible|3|||
145896116|NCT00987389|526128351|FG002|Overall Study|Ineligible|0|||
145896117|NCT00987389|526128352|FG003|Overall Study|Ineligible|0|||
145896118|NCT00987389|526128349|FG000|Overall Study|Lost to Follow-up|4|||
145896119|NCT00987389|526128350|FG001|Overall Study|Lost to Follow-up|1|||
145896120|NCT00987389|526128351|FG002|Overall Study|Lost to Follow-up|3|||
145896121|NCT00987389|526128352|FG003|Overall Study|Lost to Follow-up|1|||
145896122|NCT00987389|526128349|FG000|Overall Study|Withdrawal by Subject|4|||
145896123|NCT00987389|526128350|FG001|Overall Study|Withdrawal by Subject|3|||
145896124|NCT00987389|526128351|FG002|Overall Study|Withdrawal by Subject|2|||
145896125|NCT00987389|526128352|FG003|Overall Study|Withdrawal by Subject|1|||
145896126|NCT00987389|526128349|FG000|Overall Study|Withdrawn from Treatment|0|||
145896127|NCT00987389|526128350|FG001|Overall Study|Withdrawn from Treatment|1|||
145896128|NCT00987389|526128351|FG002|Overall Study|Withdrawn from Treatment|0|||
145896129|NCT00987389|526128352|FG003|Overall Study|Withdrawn from Treatment|0|||
145896130|NCT00987389|526128349|FG000|Overall Study|Multiple different reasons|1|||
145896131|NCT00987389|526128350|FG001|Overall Study|Multiple different reasons|0|||
145896132|NCT00987389|526128351|FG002|Overall Study|Multiple different reasons|3|||
145896133|NCT00987389|526128352|FG003|Overall Study|Multiple different reasons|1|||
145896134|NCT02992418|526128353|FG000|Overall Study|Withdrawal by Subject|11|||
145896135|NCT02992418|526128354|FG001|Overall Study|Withdrawal by Subject|12|||
145896136|NCT02992418|526128353|FG000|Overall Study|Non-compliance with the protocol|308|||
145896137|NCT02992418|526128354|FG001|Overall Study|Non-compliance with the protocol|308|||
145896138|NCT02992418|526128353|FG000|Overall Study|Lost to Follow-up|27|||
145896139|NCT02992418|526128354|FG001|Overall Study|Lost to Follow-up|22|||
145896140|NCT04465630|526128355|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
145896141|NCT04465630|526128355|FG000|Overall Study|Screen failure|8|||
145896142|NCT04465630|526128355|FG000|Overall Study|Baseline failure|16|||
145896143|NCT01087489|526128356|FG000|Overall Study|enrolled in another VA study|0|||
145896144|NCT01087489|526128357|FG001|Overall Study|enrolled in another VA study|1|||
145896145|NCT01087489|526128356|FG000|Overall Study|Death|0|||
145896146|NCT01087489|526128357|FG001|Overall Study|Death|1|||
145896147|NCT01087489|526128356|FG000|Overall Study|unable to survey by telephone|0|||
145896148|NCT01087489|526128357|FG001|Overall Study|unable to survey by telephone|1|||
145896149|NCT02005887|526128372|FG000|Overall Study|Protocol Violation|0|||
145896150|NCT02005887|526128373|FG001|Overall Study|Protocol Violation|2|||
145896151|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
145896152|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
145896153|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
145896154|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
145896155|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
145896156|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
145896157|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
145896158|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
145896159|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
145896160|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
145896161|NCT04771403|526128374|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
145896162|NCT04771403|526128375|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
145896163|NCT04771403|526128374|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
145896164|NCT04771403|526128375|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
145896165|NCT04771403|526128374|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
145896166|NCT04771403|526128375|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
145896167|NCT01615263|526128376|FG000|Overall Study|Post-randomization exclusion|0|||
145896168|NCT01615263|526128377|FG001|Overall Study|Post-randomization exclusion|2|||
145896169|NCT00857259|526128378|FG000|Overall Study|Protocol Violation|1|||
145896170|NCT00857259|526128379|FG001|Overall Study|Protocol Violation|0|||
145896171|NCT00857259|526128380|FG002|Overall Study|Protocol Violation|1|||
145896172|NCT02701413|526128381|FG000|Overall Study|Withdrawal by Subject|7|||
145896173|NCT02701413|526128382|FG001|Overall Study|Withdrawal by Subject|11|||
145896174|NCT02138136|526128383|FG000|Overall Study|Protocol Violation|4|||
145896175|NCT02138136|526128383|FG000|Overall Study|Physician Decision|7|||
145896176|NCT02138136|526128383|FG000|Overall Study|Lack of Efficacy|35|||
145896177|NCT02138136|526128383|FG000|Overall Study|Pregnancy|2|||
145896178|NCT02138136|526128383|FG000|Overall Study|Adverse Event|18|||
145896179|NCT02138136|526128383|FG000|Overall Study|Withdrawal by Subject|36|||
145896180|NCT02138136|526128383|FG000|Overall Study|Lost to Follow-up|32|||
145896181|NCT02138136|526128383|FG000|Overall Study|Withdrawn by Sponsor|5|||
145896182|NCT01359644|526128388|FG000|Treatment Period|Lack of Efficacy|0|||
145896183|NCT01359644|526128389|FG001|Treatment Period|Lack of Efficacy|1|||
145896184|NCT01359644|526128390|FG002|Treatment Period|Lack of Efficacy|0|||
145896185|NCT01359644|526128391|FG003|Treatment Period|Lack of Efficacy|0|||
145896186|NCT01359644|526128392|FG004|Treatment Period|Lack of Efficacy|0|||
145896187|NCT01359644|526128393|FG005|Treatment Period|Lack of Efficacy|0|||
145896188|NCT01359644|526128394|FG006|Treatment Period|Lack of Efficacy|0|||
145896189|NCT01359644|526128395|FG007|Treatment Period|Lack of Efficacy|0|||
145896190|NCT01359644|526128396|FG008|Treatment Period|Lack of Efficacy|0|||
145896191|NCT01359644|526128397|FG009|Treatment Period|Lack of Efficacy|0|||
145896192|NCT01359644|526128388|FG000|Treatment Period|Adverse Event|0|||
145896193|NCT01359644|526128389|FG001|Treatment Period|Adverse Event|0|||
145896194|NCT01359644|526128390|FG002|Treatment Period|Adverse Event|1|||
145896195|NCT01359644|526128391|FG003|Treatment Period|Adverse Event|0|||
145972360|NCT02332707|526412621|FG001|Overall Study|Physician Decision|0|||
146237970|NCT00489307|527384372|FG000|Overall Study|Death|1|||
145896196|NCT01359644|526128392|FG004|Treatment Period|Adverse Event|0|||
145896197|NCT01359644|526128393|FG005|Treatment Period|Adverse Event|1|||
145896198|NCT01359644|526128394|FG006|Treatment Period|Adverse Event|0|||
145896199|NCT01359644|526128395|FG007|Treatment Period|Adverse Event|0|||
145896200|NCT01359644|526128396|FG008|Treatment Period|Adverse Event|0|||
145896201|NCT01359644|526128397|FG009|Treatment Period|Adverse Event|0|||
145896202|NCT01359644|526128388|FG000|Treatment Period|Lost to Follow-up|0|||
145896203|NCT01359644|526128389|FG001|Treatment Period|Lost to Follow-up|0|||
145896204|NCT01359644|526128390|FG002|Treatment Period|Lost to Follow-up|0|||
145896205|NCT01359644|526128391|FG003|Treatment Period|Lost to Follow-up|0|||
145896206|NCT01359644|526128392|FG004|Treatment Period|Lost to Follow-up|0|||
145896207|NCT01359644|526128393|FG005|Treatment Period|Lost to Follow-up|1|||
145896208|NCT01359644|526128394|FG006|Treatment Period|Lost to Follow-up|0|||
145896209|NCT01359644|526128395|FG007|Treatment Period|Lost to Follow-up|0|||
145896210|NCT01359644|526128396|FG008|Treatment Period|Lost to Follow-up|0|||
145896211|NCT01359644|526128397|FG009|Treatment Period|Lost to Follow-up|0|||
145896212|NCT01359644|526128388|FG000|Follow-up Period|Withdrawal by Subject|0|||
145896213|NCT01359644|526128389|FG001|Follow-up Period|Withdrawal by Subject|0|||
145896214|NCT01359644|526128390|FG002|Follow-up Period|Withdrawal by Subject|0|||
145896215|NCT01359644|526128391|FG003|Follow-up Period|Withdrawal by Subject|0|||
145896216|NCT01359644|526128392|FG004|Follow-up Period|Withdrawal by Subject|0|||
145896217|NCT01359644|526128393|FG005|Follow-up Period|Withdrawal by Subject|1|||
145896218|NCT01359644|526128394|FG006|Follow-up Period|Withdrawal by Subject|0|||
145896219|NCT01359644|526128395|FG007|Follow-up Period|Withdrawal by Subject|0|||
145896220|NCT01359644|526128396|FG008|Follow-up Period|Withdrawal by Subject|0|||
145896221|NCT01359644|526128397|FG009|Follow-up Period|Withdrawal by Subject|0|||
145896222|NCT01359644|526128388|FG000|Follow-up Period|Lost to Follow-up|0|||
145896223|NCT01359644|526128389|FG001|Follow-up Period|Lost to Follow-up|0|||
145896224|NCT01359644|526128390|FG002|Follow-up Period|Lost to Follow-up|0|||
145896225|NCT01359644|526128391|FG003|Follow-up Period|Lost to Follow-up|0|||
145896226|NCT01359644|526128392|FG004|Follow-up Period|Lost to Follow-up|0|||
145896227|NCT01359644|526128393|FG005|Follow-up Period|Lost to Follow-up|0|||
145896228|NCT01359644|526128394|FG006|Follow-up Period|Lost to Follow-up|1|||
145896229|NCT01359644|526128395|FG007|Follow-up Period|Lost to Follow-up|2|||
145896230|NCT01359644|526128396|FG008|Follow-up Period|Lost to Follow-up|0|||
145896231|NCT01359644|526128397|FG009|Follow-up Period|Lost to Follow-up|0|||
145896232|NCT01660334|526128399|FG000|Overall Study|Lost to Follow-up|1|||
145896233|NCT00311311|526128400|FG000|Overall Study|Adverse Event|3|||
145896234|NCT00311311|526128401|FG001|Overall Study|Adverse Event|2|||
145896235|NCT00311311|526128400|FG000|Overall Study|Withdrawal by Subject|1|||
145896236|NCT00311311|526128401|FG001|Overall Study|Withdrawal by Subject|1|||
145896237|NCT00311311|526128400|FG000|Overall Study|Noncompliance|0|||
145896238|NCT00311311|526128401|FG001|Overall Study|Noncompliance|1|||
145896239|NCT00311311|526128400|FG000|Overall Study|Study Termination by Sponsor|3|||
145896240|NCT00311311|526128401|FG001|Overall Study|Study Termination by Sponsor|4|||
145896241|NCT00311311|526128400|FG000|Overall Study|Death|1|||
145896242|NCT00311311|526128401|FG001|Overall Study|Death|0|||
145896243|NCT00311311|526128400|FG000|Overall Study|Lack of ancillary assistance|0|||
145896244|NCT00311311|526128401|FG001|Overall Study|Lack of ancillary assistance|1|||
145896245|NCT00546572|526128402|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
145896246|NCT00546572|526128403|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
145896247|NCT00546572|526128402|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
145896248|NCT00546572|526128403|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
145896249|NCT00546572|526128402|FG000|Vax 1 / Year 0|Protocol Violation|3|||
145896250|NCT00546572|526128403|FG001|Vax 1 / Year 0|Protocol Violation|4|||
145896251|NCT00546572|526128402|FG000|Vax 1 / Year 0|Death|2|||
145896252|NCT00546572|526128403|FG001|Vax 1 / Year 0|Death|2|||
145896253|NCT00546572|526128402|FG000|Vax 1 / Year 0|Adverse Event|0|||
145896254|NCT00546572|526128403|FG001|Vax 1 / Year 0|Adverse Event|1|||
145896255|NCT00546572|526128402|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
145896256|NCT00546572|526128403|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
145896257|NCT00546572|526128402|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
145896258|NCT00546572|526128403|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
145896259|NCT00546572|526128402|FG000|Vax 2 / Year 1|Other|1|||
145896260|NCT00546572|526128403|FG001|Vax 2 / Year 1|Other|1|||
145896261|NCT00546572|526128402|FG000|Vax 2 / Year 1|Adverse Event|1|||
145896262|NCT00546572|526128403|FG001|Vax 2 / Year 1|Adverse Event|0|||
145896263|NCT00546572|526128402|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
145896264|NCT00546572|526128403|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
145896265|NCT02685202|526128404|FG000|Overall Study|Lost to Follow-up|9|||
145896266|NCT01229735|526128405|FG000|Overall Study|Lack of Efficacy|8|||
145896267|NCT01229735|526128406|FG001|Overall Study|Lack of Efficacy|8|||
145896268|NCT01229735|526128405|FG000|Overall Study|Protocol Violation|13|||
145896269|NCT01229735|526128406|FG001|Overall Study|Protocol Violation|8|||
145896270|NCT01229735|526128405|FG000|Overall Study|Lost to Follow-up|0|||
145896271|NCT01229735|526128406|FG001|Overall Study|Lost to Follow-up|2|||
145896272|NCT01229735|526128405|FG000|Overall Study|Withdrawal by Subject|18|||
145896273|NCT01229735|526128406|FG001|Overall Study|Withdrawal by Subject|17|||
145896274|NCT01229735|526128405|FG000|Overall Study|Other Reason|13|||
145896275|NCT01229735|526128406|FG001|Overall Study|Other Reason|10|||
145896276|NCT01229735|526128405|FG000|Overall Study|SAE, non-fatal|0|||
145896277|NCT01229735|526128406|FG001|Overall Study|SAE, non-fatal|4|||
145896278|NCT01229735|526128405|FG000|Overall Study|AE, non-serious non-fatal|13|||
145896279|NCT01229735|526128406|FG001|Overall Study|AE, non-serious non-fatal|17|||
145896280|NCT01229735|526128405|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145896281|NCT01229735|526128406|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145896282|NCT02130882|526128407|FG000|Overall Study|Withdrawal by Subject|0|||
145896283|NCT02130882|526128408|FG001|Overall Study|Withdrawal by Subject|1|||
145896284|NCT02615171|526128417|FG000|Overall Study|Lost to Follow-up|2|||
145896285|NCT02615171|526128418|FG001|Overall Study|Lost to Follow-up|1|||
145896286|NCT00741936|526128431|FG000|Overall Study|Lost to Follow-up|1|||
145896287|NCT00741936|526128432|FG001|Overall Study|Lost to Follow-up|1|||
145896288|NCT00741936|526128431|FG000|Overall Study|Adverse Event|3|||
145896289|NCT00741936|526128432|FG001|Overall Study|Adverse Event|4|||
145896290|NCT00741936|526128431|FG000|Overall Study|Pregnancy|0|||
145896291|NCT00741936|526128432|FG001|Overall Study|Pregnancy|1|||
145896292|NCT00741936|526128431|FG000|Overall Study|Protocol Violation|2|||
145896293|NCT00741936|526128432|FG001|Overall Study|Protocol Violation|0|||
145896294|NCT00741936|526128431|FG000|Overall Study|Lack of Efficacy|0|||
145896295|NCT00741936|526128432|FG001|Overall Study|Lack of Efficacy|2|||
145896296|NCT00741936|526128431|FG000|Overall Study|Low compliance|3|||
145896297|NCT00741936|526128432|FG001|Overall Study|Low compliance|0|||
145896298|NCT00369382|526128433|FG000|Overall Study|Death|0|||
145896299|NCT00369382|526128434|FG001|Overall Study|Death|2|||
145896300|NCT00369382|526128433|FG000|Overall Study|Physician Decision|2|||
145896301|NCT00369382|526128434|FG001|Overall Study|Physician Decision|1|||
145896302|NCT00369382|526128433|FG000|Overall Study|Withdrawal by Subject|5|||
145896303|NCT00369382|526128434|FG001|Overall Study|Withdrawal by Subject|0|||
145896304|NCT00369382|526128433|FG000|Overall Study|Randomized, not treated|2|||
145896305|NCT00369382|526128434|FG001|Overall Study|Randomized, not treated|0|||
145896306|NCT00369382|526128433|FG000|Overall Study|Other|1|||
145896307|NCT00369382|526128434|FG001|Overall Study|Other|0|||
145896308|NCT00446199|526128438|FG000|Overall Study|Adverse Event|7|||
145896309|NCT00446199|526128439|FG001|Overall Study|Adverse Event|4|||
145896310|NCT00446199|526128440|FG002|Overall Study|Adverse Event|6|||
145896311|NCT00446199|526128441|FG003|Overall Study|Adverse Event|4|||
145896312|NCT00446199|526128438|FG000|Overall Study|Lost to Follow-up|4|||
145896313|NCT00446199|526128439|FG001|Overall Study|Lost to Follow-up|5|||
145896314|NCT00446199|526128440|FG002|Overall Study|Lost to Follow-up|2|||
145896315|NCT00446199|526128441|FG003|Overall Study|Lost to Follow-up|6|||
145896316|NCT00446199|526128438|FG000|Overall Study|Protocol Violation|1|||
145896317|NCT00446199|526128439|FG001|Overall Study|Protocol Violation|2|||
145896318|NCT00446199|526128440|FG002|Overall Study|Protocol Violation|1|||
145896319|NCT00446199|526128441|FG003|Overall Study|Protocol Violation|3|||
145896320|NCT00446199|526128438|FG000|Overall Study|Withdrawal by Subject|2|||
145896321|NCT00446199|526128439|FG001|Overall Study|Withdrawal by Subject|5|||
145896322|NCT00446199|526128440|FG002|Overall Study|Withdrawal by Subject|9|||
145896323|NCT00446199|526128441|FG003|Overall Study|Withdrawal by Subject|10|||
145896324|NCT00446199|526128438|FG000|Overall Study|Site termination|2|||
145896325|NCT00446199|526128439|FG001|Overall Study|Site termination|0|||
145896326|NCT00446199|526128440|FG002|Overall Study|Site termination|0|||
145896327|NCT00446199|526128441|FG003|Overall Study|Site termination|1|||
145896328|NCT00446199|526128438|FG000|Overall Study|Randomization in Error|2|||
145896329|NCT00446199|526128439|FG001|Overall Study|Randomization in Error|0|||
145896330|NCT00446199|526128440|FG002|Overall Study|Randomization in Error|1|||
145896331|NCT00446199|526128441|FG003|Overall Study|Randomization in Error|1|||
145896332|NCT00446199|526128438|FG000|Overall Study|Lack of Efficacy|1|||
145896333|NCT00446199|526128439|FG001|Overall Study|Lack of Efficacy|0|||
145896334|NCT00446199|526128440|FG002|Overall Study|Lack of Efficacy|0|||
145896335|NCT00446199|526128441|FG003|Overall Study|Lack of Efficacy|1|||
145896336|NCT00446199|526128438|FG000|Overall Study|Non-compliant with study drug|1|||
145896337|NCT00446199|526128439|FG001|Overall Study|Non-compliant with study drug|0|||
145896338|NCT00446199|526128440|FG002|Overall Study|Non-compliant with study drug|5|||
145896339|NCT00446199|526128441|FG003|Overall Study|Non-compliant with study drug|0|||
145896340|NCT00446199|526128438|FG000|Overall Study|Non-compliant with visit schedule|1|||
145896341|NCT00446199|526128439|FG001|Overall Study|Non-compliant with visit schedule|1|||
145896342|NCT00446199|526128440|FG002|Overall Study|Non-compliant with visit schedule|1|||
145896343|NCT00446199|526128441|FG003|Overall Study|Non-compliant with visit schedule|2|||
145896344|NCT00446199|526128438|FG000|Overall Study|Hormone fear|0|||
145896345|NCT00446199|526128439|FG001|Overall Study|Hormone fear|0|||
145896346|NCT00446199|526128440|FG002|Overall Study|Hormone fear|0|||
145896347|NCT00446199|526128441|FG003|Overall Study|Hormone fear|1|||
145896348|NCT00446199|526128438|FG000|Overall Study|Lost interest in study participation|0|||
145896349|NCT00446199|526128439|FG001|Overall Study|Lost interest in study participation|1|||
145896350|NCT00446199|526128440|FG002|Overall Study|Lost interest in study participation|0|||
145896351|NCT00446199|526128441|FG003|Overall Study|Lost interest in study participation|0|||
145896352|NCT00446199|526128438|FG000|Overall Study|In-/Exclusion criterion violated|2|||
145972361|NCT02332707|526412622|FG002|Overall Study|Physician Decision|0|||
145896353|NCT00446199|526128439|FG001|Overall Study|In-/Exclusion criterion violated|1|||
145896354|NCT00446199|526128440|FG002|Overall Study|In-/Exclusion criterion violated|2|||
145896355|NCT00446199|526128441|FG003|Overall Study|In-/Exclusion criterion violated|1|||
145896356|NCT00446199|526128438|FG000|Overall Study|Move|0|||
145896357|NCT00446199|526128439|FG001|Overall Study|Move|1|||
145896358|NCT00446199|526128440|FG002|Overall Study|Move|0|||
145896359|NCT00446199|526128441|FG003|Overall Study|Move|0|||
145896360|NCT03696953|526130317|FG000|Overall Study|Withdrawal by Subject|6|||
145896361|NCT03696953|526130318|FG001|Overall Study|Withdrawal by Subject|1|||
145896362|NCT03696953|526130317|FG000|Overall Study|missed GBS swabs|2|||
145896363|NCT03696953|526130318|FG001|Overall Study|missed GBS swabs|2|||
145896364|NCT03696953|526130317|FG000|Overall Study|lost study bottle containing capsules|2|||
145896365|NCT03696953|526130318|FG001|Overall Study|lost study bottle containing capsules|0|||
145896366|NCT03696953|526130317|FG000|Overall Study|Premature birth|1|||
145896367|NCT03696953|526130318|FG001|Overall Study|Premature birth|4|||
145896368|NCT03696953|526130317|FG000|Overall Study|Gestational hypertension|1|||
145896369|NCT03696953|526130318|FG001|Overall Study|Gestational hypertension|1|||
145896370|NCT03696953|526130317|FG000|Overall Study|Gestational diabetes|2|||
145896371|NCT03696953|526130318|FG001|Overall Study|Gestational diabetes|1|||
145896372|NCT03696953|526130317|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
145896373|NCT03696953|526130318|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
145896374|NCT03696953|526130317|FG000|Overall Study|Changed prenatal provider|1|||
145896375|NCT03696953|526130318|FG001|Overall Study|Changed prenatal provider|1|||
145896376|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
145896377|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145896378|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145896379|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145896380|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145896381|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
145896382|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
145896383|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
145896384|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
145896385|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
145896386|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145896387|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
145896388|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145896389|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145896390|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145896391|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
145896392|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
145896393|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
145896394|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
145896395|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
146237971|NCT00489307|527384373|FG001|Overall Study|Death|1|||
146237972|NCT00489307|527384372|FG000|Overall Study|Lost to Follow-up|2|||
145896396|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
145896397|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
145896398|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
145896399|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
145896400|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
145896401|NCT02935686|526130320|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145896402|NCT02935686|526130321|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
145896403|NCT02935686|526130322|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145896404|NCT02935686|526130323|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145896405|NCT02935686|526130324|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145896406|NCT02935686|526130320|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
145896407|NCT02935686|526130321|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
145896408|NCT02935686|526130322|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
145896409|NCT02935686|526130323|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
146237973|NCT00489307|527384373|FG001|Overall Study|Lost to Follow-up|2|||
146237974|NCT00489307|527384372|FG000|Overall Study|Physician Decision|1|||
146237975|NCT00489307|527384373|FG001|Overall Study|Physician Decision|0|||
146237976|NCT00489307|527384372|FG000|Overall Study|Withdrawal by Subject|2|||
145896410|NCT02935686|526130324|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
145896411|NCT02935686|526130320|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145896412|NCT02935686|526130321|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
145896413|NCT02935686|526130322|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145896414|NCT02935686|526130323|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145896415|NCT02935686|526130324|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
146237977|NCT00489307|527384373|FG001|Overall Study|Withdrawal by Subject|4|||
146237978|NCT00489307|527384372|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
145896416|NCT02935686|526130320|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145896417|NCT02935686|526130321|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
145896418|NCT02935686|526130322|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145896419|NCT02935686|526130323|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145896420|NCT02935686|526130324|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145896421|NCT02935686|526130320|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145896422|NCT02935686|526130321|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145896423|NCT02935686|526130322|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145896424|NCT02935686|526130323|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145896425|NCT02935686|526130324|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
145896426|NCT02935686|526130320|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
146296607|NCT02634346|527602545|FG000|Overall Study|Withdrawal by Subject|8|||
146296608|NCT02634346|527602546|FG001|Overall Study|Withdrawal by Subject|9|||
146296609|NCT02634346|527602547|FG002|Overall Study|Withdrawal by Subject|8|||
146296610|NCT02634346|527602545|FG000|Overall Study|Adverse Event|2|||
146296611|NCT02634346|527602546|FG001|Overall Study|Adverse Event|2|||
145896427|NCT02935686|526130321|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
145896428|NCT02935686|526130322|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
145896429|NCT02935686|526130323|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
145896430|NCT02935686|526130324|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
145896431|NCT00759902|526130325|FG000|Overall Study|Adverse Event|0|||
145896432|NCT00759902|526130326|FG001|Overall Study|Adverse Event|1|||
145896433|NCT02128217|526130331|FG000|Overall Study|Lost to Follow-up|0|||
146296612|NCT02634346|527602547|FG002|Overall Study|Adverse Event|7|||
146296613|NCT02634346|527602545|FG000|Overall Study|Lack of Efficacy|1|||
146296614|NCT02634346|527602546|FG001|Overall Study|Lack of Efficacy|2|||
146296615|NCT02634346|527602547|FG002|Overall Study|Lack of Efficacy|8|||
146296616|NCT02634346|527602545|FG000|Overall Study|Lost to Follow-up|1|||
146296617|NCT02634346|527602546|FG001|Overall Study|Lost to Follow-up|0|||
146296618|NCT02634346|527602547|FG002|Overall Study|Lost to Follow-up|0|||
145896434|NCT02128217|526130332|FG001|Overall Study|Lost to Follow-up|1|||
145896435|NCT05071313|526130333|FG000|Overall Study|Lost to Follow-up|17|||
145896436|NCT05071313|526130334|FG001|Overall Study|Lost to Follow-up|10|||
145896437|NCT05071313|526130333|FG000|Overall Study|Physician Decision|1|||
145896438|NCT05071313|526130334|FG001|Overall Study|Physician Decision|6|||
145896439|NCT05071313|526130333|FG000|Overall Study|Death|1|||
145896440|NCT05071313|526130334|FG001|Overall Study|Death|0|||
145896441|NCT05071313|526130333|FG000|Overall Study|Withdrawal by Subject|10|||
145896442|NCT05071313|526130334|FG001|Overall Study|Withdrawal by Subject|15|||
145896443|NCT05071313|526130333|FG000|Overall Study|Other|1|||
145896444|NCT05071313|526130334|FG001|Overall Study|Other|0|||
145896445|NCT05071313|526130333|FG000|Overall Study|Randomized but not vaccinated|4|||
145896446|NCT05071313|526130334|FG001|Overall Study|Randomized but not vaccinated|2|||
145896447|NCT00541970|526130335|FG000|Month 7|Protocol Violation|9|||
145896448|NCT00541970|526130336|FG001|Month 7|Protocol Violation|13|||
145896449|NCT00541970|526130337|FG002|Month 7|Protocol Violation|11|||
145896450|NCT00541970|526130338|FG003|Month 7|Protocol Violation|5|||
145896451|NCT00541970|526130335|FG000|Month 12|Adverse Event|0|||
145896452|NCT00541970|526130336|FG001|Month 12|Adverse Event|1|||
145896453|NCT00541970|526130337|FG002|Month 12|Adverse Event|1|||
145896454|NCT00541970|526130338|FG003|Month 12|Adverse Event|1|||
145896455|NCT00541970|526130335|FG000|Month 12|Protocol Violation|12|||
145896456|NCT00541970|526130336|FG001|Month 12|Protocol Violation|21|||
145896457|NCT00541970|526130337|FG002|Month 12|Protocol Violation|20|||
145896458|NCT00541970|526130338|FG003|Month 12|Protocol Violation|15|||
145896459|NCT00541970|526130335|FG000|Month 18|Adverse Event|0|||
145896460|NCT00541970|526130336|FG001|Month 18|Adverse Event|1|||
145896461|NCT00541970|526130337|FG002|Month 18|Adverse Event|1|||
145896462|NCT00541970|526130338|FG003|Month 18|Adverse Event|1|||
145896463|NCT00541970|526130335|FG000|Month 18|Protocol Violation|14|||
145896464|NCT00541970|526130336|FG001|Month 18|Protocol Violation|23|||
145896465|NCT00541970|526130337|FG002|Month 18|Protocol Violation|24|||
145896466|NCT00541970|526130338|FG003|Month 18|Protocol Violation|16|||
145896467|NCT00541970|526130335|FG000|Month 24|Adverse Event|0|||
145896468|NCT00541970|526130336|FG001|Month 24|Adverse Event|1|||
145896469|NCT00541970|526130337|FG002|Month 24|Adverse Event|1|||
146296619|NCT02634346|527602545|FG000|Overall Study|Protocol Violation|0|||
146296620|NCT02634346|527602546|FG001|Overall Study|Protocol Violation|1|||
146296621|NCT02634346|527602547|FG002|Overall Study|Protocol Violation|0|||
146296622|NCT00992511|527602549|FG000|Overall Study|Migrated/moved from study area|1|||
146296623|NCT00992511|527602550|FG001|Overall Study|Migrated/moved from study area|0|||
145896470|NCT00541970|526130338|FG003|Month 24|Adverse Event|1|||
145896471|NCT00541970|526130335|FG000|Month 24|Protocol Violation|29|||
145896472|NCT00541970|526130336|FG001|Month 24|Protocol Violation|31|||
145896473|NCT00541970|526130337|FG002|Month 24|Protocol Violation|31|||
145896474|NCT00541970|526130338|FG003|Month 24|Protocol Violation|21|||
145896475|NCT00541970|526130335|FG000|Month 36|Protocol Violation|61|||
145896476|NCT00541970|526130336|FG001|Month 36|Protocol Violation|66|||
145896477|NCT00541970|526130337|FG002|Month 36|Protocol Violation|66|||
145896478|NCT00541970|526130338|FG003|Month 36|Protocol Violation|60|||
145896479|NCT00541970|526130335|FG000|Month 48|Withdrawal by Subject|2|||
145896480|NCT00541970|526130336|FG001|Month 48|Withdrawal by Subject|4|||
145896481|NCT00541970|526130337|FG002|Month 48|Withdrawal by Subject|4|||
145896482|NCT00541970|526130338|FG003|Month 48|Withdrawal by Subject|2|||
145896483|NCT00541970|526130335|FG000|Month 48|Other|3|||
145896484|NCT00541970|526130336|FG001|Month 48|Other|1|||
145896485|NCT00541970|526130337|FG002|Month 48|Other|1|||
145896486|NCT00541970|526130338|FG003|Month 48|Other|0|||
145896487|NCT00541970|526130335|FG000|Month 48|Lost to Follow-up|66|||
145896488|NCT00541970|526130336|FG001|Month 48|Lost to Follow-up|68|||
145896489|NCT00541970|526130337|FG002|Month 48|Lost to Follow-up|68|||
145896490|NCT00541970|526130338|FG003|Month 48|Lost to Follow-up|73|||
145896491|NCT00541970|526130335|FG000|Month 60|Protocol Violation|78|||
145896492|NCT00541970|526130336|FG001|Month 60|Protocol Violation|77|||
145896493|NCT00541970|526130337|FG002|Month 60|Protocol Violation|82|||
145896494|NCT00541970|526130338|FG003|Month 60|Protocol Violation|72|||
145896495|NCT03107026|526130339|FG000|Overall Study|Adverse Event|2|||
145896496|NCT03107026|526130340|FG001|Overall Study|Adverse Event|14|||
146237979|NCT00489307|527384373|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
146237980|NCT00489307|527384372|FG000|Overall Study|Surgery after assignment|1|||
145896497|NCT03107026|526130341|FG002|Overall Study|Adverse Event|23|||
145896498|NCT03107026|526130339|FG000|Overall Study|Lost to Follow-up|12|||
145896499|NCT03107026|526130340|FG001|Overall Study|Lost to Follow-up|12|||
145896500|NCT03107026|526130341|FG002|Overall Study|Lost to Follow-up|13|||
145896501|NCT03107026|526130339|FG000|Overall Study|Protocol Violation|1|||
145896502|NCT03107026|526130340|FG001|Overall Study|Protocol Violation|2|||
145896503|NCT03107026|526130341|FG002|Overall Study|Protocol Violation|0|||
145896504|NCT03107026|526130339|FG000|Overall Study|Pregnancy|1|||
145896505|NCT03107026|526130340|FG001|Overall Study|Pregnancy|0|||
145896506|NCT03107026|526130341|FG002|Overall Study|Pregnancy|0|||
145896507|NCT03107026|526130339|FG000|Overall Study|Withdrawal by Subject|13|||
145896508|NCT03107026|526130340|FG001|Overall Study|Withdrawal by Subject|5|||
146237981|NCT00489307|527384373|FG001|Overall Study|Surgery after assignment|0|||
146237982|NCT00489307|527384372|FG000|Overall Study|Did not fill up the forms|2|||
146237983|NCT00489307|527384373|FG001|Overall Study|Did not fill up the forms|1|||
146237984|NCT00489307|527384372|FG000|Overall Study|Patient or family refusal|5|||
145896509|NCT03107026|526130341|FG002|Overall Study|Withdrawal by Subject|17|||
145896510|NCT03107026|526130339|FG000|Overall Study|non compliance with study visits|1|||
145896511|NCT03107026|526130340|FG001|Overall Study|non compliance with study visits|2|||
145896512|NCT03107026|526130341|FG002|Overall Study|non compliance with study visits|0|||
145896513|NCT03107026|526130339|FG000|Overall Study|non-compliance with study drug|2|||
145896514|NCT03107026|526130340|FG001|Overall Study|non-compliance with study drug|2|||
145896515|NCT03107026|526130341|FG002|Overall Study|non-compliance with study drug|3|||
145896516|NCT03107026|526130339|FG000|Overall Study|Physician Decision|0|||
145896517|NCT03107026|526130340|FG001|Overall Study|Physician Decision|1|||
145896518|NCT03107026|526130341|FG002|Overall Study|Physician Decision|0|||
145896519|NCT03596151|526130344|FG000|Overall Study|Withdrawal by Subject|1|||
145896520|NCT00824616|526130346|FG000|Overall Study|Adverse Event|2|||
145896521|NCT00824616|526130347|FG001|Overall Study|Adverse Event|1|||
145896522|NCT00824616|526130346|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
145896523|NCT00824616|526130347|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
145896524|NCT00824616|526130346|FG000|Overall Study|Hyperglycemia|1|||
145896525|NCT00824616|526130347|FG001|Overall Study|Hyperglycemia|1|||
145896526|NCT00824616|526130346|FG000|Overall Study|Lack of Efficacy|2|||
146237985|NCT00489307|527384373|FG001|Overall Study|Patient or family refusal|9|||
145896527|NCT00824616|526130347|FG001|Overall Study|Lack of Efficacy|1|||
145896528|NCT00824616|526130346|FG000|Overall Study|Lost to Follow-up|0|||
145896529|NCT00824616|526130347|FG001|Overall Study|Lost to Follow-up|1|||
145896530|NCT00824616|526130346|FG000|Overall Study|Withdrawal by Subject|1|||
145896531|NCT00824616|526130347|FG001|Overall Study|Withdrawal by Subject|1|||
145896532|NCT04711902|526130348|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
145896533|NCT04711902|526130349|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
145896534|NCT04711902|526130350|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
145896535|NCT04711902|526130351|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
145896536|NCT04711902|526130352|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
145896537|NCT04711902|526130353|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
145896538|NCT01155024|526130358|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
145896539|NCT01155024|526130359|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
145896540|NCT01155024|526130358|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
145896541|NCT01155024|526130359|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
145896542|NCT01155024|526130358|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
145896543|NCT01155024|526130359|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
145896544|NCT03412396|526130360|FG000|Overall Study|Withdrawal by Subject|2|||
146237986|NCT02307682|527384374|FG000|Overall Study|Adverse Event|9|||
146237987|NCT02307682|527384375|FG001|Overall Study|Adverse Event|8|||
146237988|NCT02307682|527384376|FG002|Overall Study|Adverse Event|12|||
146237989|NCT02307682|527384374|FG000|Overall Study|Lack of Efficacy|1|||
146237990|NCT02307682|527384375|FG001|Overall Study|Lack of Efficacy|0|||
145896545|NCT03412396|526130360|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
145896546|NCT03412396|526130360|FG000|Overall Study|Did not undergo RP|2|||
145896547|NCT01593696|526130361|FG000|Dose Escalation|Progressive Disease|2|||
145896548|NCT01593696|526130362|FG001|Dose Escalation|Progressive Disease|0|||
145896549|NCT01593696|526130363|FG002|Dose Escalation|Progressive Disease|0|||
145896550|NCT01593696|526130364|FG003|Dose Escalation|Progressive Disease|0|||
145896551|NCT01593696|526130361|FG000|Dose Expansion|Fungal infection|0|||
145896552|NCT01593696|526130362|FG001|Dose Expansion|Fungal infection|0|||
145896553|NCT01593696|526130363|FG002|Dose Expansion|Fungal infection|1|||
145896554|NCT01593696|526130364|FG003|Dose Expansion|Fungal infection|0|||
145896555|NCT01383135|526130365|FG000|Overall Study|Not Scanned / Imaged|1|||
145896556|NCT01383135|526130366|FG001|Overall Study|Not Scanned / Imaged|0|||
145896557|NCT01383135|526130367|FG002|Overall Study|Not Scanned / Imaged|1|||
145896558|NCT01383135|526130368|FG003|Overall Study|Not Scanned / Imaged|0|||
145896559|NCT03167723|526130372|FG000|Overall Study|Protocol Violation|4|||
145896560|NCT03167723|526130373|FG001|Overall Study|Protocol Violation|6|||
145896561|NCT02397408|526130374|FG000|Overall Study|Physician Decision|4|||
145896562|NCT02397408|526130374|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
145896563|NCT03397771|526130375|FG000|Overall Study|2 erroneously randomized, never treated|3|||
145896564|NCT03397771|526130376|FG001|Overall Study|2 erroneously randomized, never treated|1|||
145896565|NCT03397771|526130375|FG000|Overall Study|Withdrawal by Subject|1|||
145896566|NCT03397771|526130376|FG001|Overall Study|Withdrawal by Subject|3|||
145896567|NCT03397771|526130375|FG000|Overall Study|Protocol Violation|2|||
145896568|NCT03397771|526130376|FG001|Overall Study|Protocol Violation|2|||
145896569|NCT03397771|526130375|FG000|Overall Study|Adverse Event|2|||
145896570|NCT03397771|526130376|FG001|Overall Study|Adverse Event|1|||
145896571|NCT04078126|526130379|FG000|Washout|Study put on hold due to COVID-19|0|||
145896572|NCT04078126|526130380|FG001|Washout|Study put on hold due to COVID-19|2|||
145896573|NCT04078126|526130379|FG000|Period 2|Study put on hold due to COVID-19|1|||
145896574|NCT04078126|526130380|FG001|Period 2|Study put on hold due to COVID-19|1|||
145896575|NCT02669758|526130383|FG000|Overall Study|Withdrawal by Subject|43|||
145896576|NCT02669758|526130383|FG000|Overall Study|Lost to Follow-up|19|||
145896577|NCT02669758|526130383|FG000|Overall Study|Adverse Event|16|||
145896578|NCT02669758|526130383|FG000|Overall Study|Non-Compliance with Study Drug|8|||
145896579|NCT02669758|526130383|FG000|Overall Study|Lack of Efficacy|5|||
145896580|NCT02669758|526130383|FG000|Overall Study|Pregnancy|1|||
145896581|NCT02669758|526130383|FG000|Overall Study|Study noncompliance|1|||
145896582|NCT02669758|526130383|FG000|Overall Study|Protocol Violation|1|||
145896583|NCT02149108|526130384|FG000|Overall Study|Not treated|1|||
145896584|NCT02149108|526130385|FG001|Overall Study|Not treated|2|||
145896585|NCT02149108|526130384|FG000|Overall Study|Progressive Disease (PD)|324|||
145896586|NCT02149108|526130385|FG001|Overall Study|Progressive Disease (PD)|318|||
145896587|NCT02149108|526130384|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
145896588|NCT02149108|526130385|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
145896589|NCT02149108|526130384|FG000|Overall Study|Other Adverse Event (AE)|8|||
145896590|NCT02149108|526130385|FG001|Overall Study|Other Adverse Event (AE)|18|||
145896591|NCT02149108|526130384|FG000|Overall Study|Other not defined above|0|||
145896592|NCT02149108|526130385|FG001|Overall Study|Other not defined above|2|||
145896593|NCT02149108|526130384|FG000|Overall Study|Refusal to continue trial medication|15|||
145896594|NCT02149108|526130385|FG001|Overall Study|Refusal to continue trial medication|11|||
145896595|NCT02149108|526130384|FG000|Overall Study|Lost to Follow-up|1|||
145896596|NCT02149108|526130385|FG001|Overall Study|Lost to Follow-up|0|||
145896597|NCT02455050|526130386|FG000|Treatment Period 1|Lost to Follow-up|1|||
145896598|NCT02455050|526130387|FG001|Treatment Period 1|Lost to Follow-up|1|||
145896599|NCT02455050|526130388|FG002|Treatment Period 1|Lost to Follow-up|1|||
145896600|NCT02455050|526130389|FG003|Treatment Period 1|Lost to Follow-up|2|||
145896601|NCT02455050|526130386|FG000|Treatment Period 2|Lost to Follow-up|1|||
145896602|NCT02455050|526130387|FG001|Treatment Period 2|Lost to Follow-up|0|||
145896603|NCT02455050|526130388|FG002|Treatment Period 2|Lost to Follow-up|2|||
145896604|NCT02455050|526130389|FG003|Treatment Period 2|Lost to Follow-up|1|||
145896605|NCT03402750|526130390|FG000|Overall Study|Lost to Follow-up|2|||
145896606|NCT03402750|526130391|FG001|Overall Study|Lost to Follow-up|1|||
145896607|NCT02981303|526130392|FG000|Overall Study|Progressive Disease|17|||
145896608|NCT02981303|526130393|FG001|Overall Study|Progressive Disease|37|||
145896609|NCT02981303|526130392|FG000|Overall Study|Adverse Event|1|||
145896610|NCT02981303|526130393|FG001|Overall Study|Adverse Event|4|||
145896611|NCT02981303|526130392|FG000|Overall Study|Withdrawal by Subject|0|||
145896612|NCT02981303|526130393|FG001|Overall Study|Withdrawal by Subject|1|||
145896613|NCT02325518|526130394|FG000|Overall Study|Adverse Event|4|||
145896614|NCT02325518|526130395|FG001|Overall Study|Adverse Event|1|||
145896615|NCT02325518|526130394|FG000|Overall Study|Physician Decision|0|||
145896616|NCT02325518|526130395|FG001|Overall Study|Physician Decision|1|||
145972362|NCT02332707|526412623|FG003|Overall Study|Physician Decision|1|||
145896617|NCT02325518|526130394|FG000|Overall Study|Withdrawal by Subject|0|||
145896618|NCT02325518|526130395|FG001|Overall Study|Withdrawal by Subject|1|||
145896619|NCT01259115|526130398|FG000|Period 1|Adverse Event|1|||
145896620|NCT01259115|526130399|FG001|Period 1|Adverse Event|0|||
145896621|NCT01259115|526130398|FG000|Period 1|Protocol Violation|2|||
145896622|NCT01259115|526130399|FG001|Period 1|Protocol Violation|0|||
145896623|NCT01259115|526130398|FG000|Period 1|Lost to Follow-up|0|||
145896624|NCT01259115|526130399|FG001|Period 1|Lost to Follow-up|1|||
145896625|NCT01259115|526130398|FG000|Period 2|Adverse Event|1|||
145896626|NCT01259115|526130399|FG001|Period 2|Adverse Event|0|||
145896627|NCT00848107|526130400|FG000|Overall Study|Lost to Follow-up|2|||
145896628|NCT00848107|526130400|FG000|Overall Study|Withdrawal by Subject|8|||
145896629|NCT00848107|526130400|FG000|Overall Study|Adverse Event|9|||
145896630|NCT00848107|526130400|FG000|Overall Study|Death|1|||
146296624|NCT00992511|527602551|FG002|Overall Study|Migrated/moved from study area|1|||
146296625|NCT00992511|527602552|FG003|Overall Study|Migrated/moved from study area|2|||
146296626|NCT00992511|527602549|FG000|Overall Study|Lost to Follow-up|1|||
146296627|NCT00992511|527602550|FG001|Overall Study|Lost to Follow-up|0|||
146296628|NCT00992511|527602551|FG002|Overall Study|Lost to Follow-up|0|||
146296629|NCT00992511|527602552|FG003|Overall Study|Lost to Follow-up|2|||
146296630|NCT00992511|527602549|FG000|Overall Study|Withdrawal by Subject|0|||
146296631|NCT00992511|527602550|FG001|Overall Study|Withdrawal by Subject|0|||
146296632|NCT00992511|527602551|FG002|Overall Study|Withdrawal by Subject|1|||
146296633|NCT00992511|527602552|FG003|Overall Study|Withdrawal by Subject|1|||
146296634|NCT04498169|527602553|FG000|Study Completion|Adverse Event|1|||
146296635|NCT04498169|527602554|FG001|Study Completion|Adverse Event|1|||
146296636|NCT02960854|527602557|FG000|Overall Study|Not Disclosed|2|||
146296637|NCT02960854|527602558|FG001|Overall Study|Not Disclosed|2|||
146296638|NCT02960854|527602557|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
146296639|NCT02960854|527602558|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
146296640|NCT02960854|527602557|FG000|Overall Study|Subject Withdrew Consent|0|||
146296641|NCT02960854|527602558|FG001|Overall Study|Subject Withdrew Consent|1|||
146296642|NCT02960854|527602557|FG000|Overall Study|Death|4|||
146296643|NCT02960854|527602558|FG001|Overall Study|Death|6|||
146296644|NCT00221195|527602559|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
146296645|NCT00221195|527602560|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
146296646|NCT00221195|527602559|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
146296647|NCT00221195|527602560|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
146296648|NCT00221195|527602559|FG000|Washout Period (Months 7-9)|Death|0|||
146296649|NCT00221195|527602560|FG001|Washout Period (Months 7-9)|Death|1|||
146296650|NCT00221195|527602559|FG000|Therapy 2 (Months 10-15)|Death|1|||
146296651|NCT00221195|527602560|FG001|Therapy 2 (Months 10-15)|Death|0|||
146296652|NCT00221195|527602559|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
146296653|NCT00221195|527602560|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
146296654|NCT00833911|527602562|FG000|Titration|Adverse Event|18|||
146296655|NCT00833911|527602562|FG000|Titration|Withdrawal by Subject|3|||
146296656|NCT00833911|527602562|FG000|Maintenance Phase I|Adverse Event|73|||
145896631|NCT00848107|526130400|FG000|Overall Study|Pregnancy|1|||
145896632|NCT01831765|526130401|FG000|Overall Study|Lack of Efficacy|1|||
145896633|NCT01831765|526130402|FG001|Overall Study|Lack of Efficacy|0|||
145896634|NCT01831765|526130403|FG002|Overall Study|Lack of Efficacy|0|||
145896635|NCT01831765|526130401|FG000|Overall Study|Other, sponsor withdrew subject|0|||
145896636|NCT01831765|526130402|FG001|Overall Study|Other, sponsor withdrew subject|1|||
145896637|NCT01831765|526130403|FG002|Overall Study|Other, sponsor withdrew subject|0|||
145896638|NCT01831765|526130401|FG000|Overall Study|Pregnancy|1|||
145896639|NCT01831765|526130402|FG001|Overall Study|Pregnancy|1|||
145896640|NCT01831765|526130403|FG002|Overall Study|Pregnancy|2|||
145896641|NCT01831765|526130401|FG000|Overall Study|Death|0|||
145896642|NCT01831765|526130402|FG001|Overall Study|Death|1|||
145896643|NCT01831765|526130403|FG002|Overall Study|Death|1|||
145896644|NCT01831765|526130401|FG000|Overall Study|Other, site closed|1|||
145896645|NCT01831765|526130402|FG001|Overall Study|Other, site closed|1|||
145896646|NCT01831765|526130403|FG002|Overall Study|Other, site closed|0|||
145896647|NCT01831765|526130401|FG000|Overall Study|Adverse Event|5|||
145896648|NCT01831765|526130402|FG001|Overall Study|Adverse Event|3|||
145896649|NCT01831765|526130403|FG002|Overall Study|Adverse Event|3|||
145896650|NCT01831765|526130401|FG000|Overall Study|Withdrawal by Subject|22|||
145896651|NCT01831765|526130402|FG001|Overall Study|Withdrawal by Subject|7|||
146296657|NCT00833911|527602562|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
146296658|NCT00833911|527602562|FG000|Maintenance Phase I|Physician Decision|10|||
146296659|NCT00833911|527602562|FG000|Maintenance Phase I|Lack of Efficacy|4|||
146296660|NCT00833911|527602562|FG000|Maintenance Phase II|Adverse Event|6|||
146296661|NCT00833911|527602562|FG000|Maintenance Phase II|Physician Decision|2|||
146296662|NCT00833911|527602562|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
145896652|NCT01831765|526130403|FG002|Overall Study|Withdrawal by Subject|17|||
145896653|NCT01831765|526130401|FG000|Overall Study|Withdrawal criteria|12|||
146296663|NCT00833911|527602562|FG000|Maintenance Phase II|Lack of Efficacy|1|||
146296664|NCT01383161|527602563|FG000|Overall Study|Adverse Event|5|||
146296665|NCT01383161|527602564|FG001|Overall Study|Adverse Event|1|||
146296666|NCT01383161|527602563|FG000|Overall Study|Withdrawal by Subject|0|||
146296667|NCT01383161|527602564|FG001|Overall Study|Withdrawal by Subject|2|||
146296668|NCT01383161|527602563|FG000|Overall Study|Lack of Efficacy|0|||
146296669|NCT01383161|527602564|FG001|Overall Study|Lack of Efficacy|1|||
146296670|NCT03942406|527602565|FG000|Overall Study|Lost to Follow-up|4|||
145896654|NCT01831765|526130402|FG001|Overall Study|Withdrawal criteria|10|||
145896655|NCT01831765|526130403|FG002|Overall Study|Withdrawal criteria|16|||
145896656|NCT01831765|526130401|FG000|Overall Study|Lost to Follow-up|2|||
145896657|NCT01831765|526130402|FG001|Overall Study|Lost to Follow-up|3|||
145896658|NCT01831765|526130403|FG002|Overall Study|Lost to Follow-up|3|||
145896659|NCT00507130|526130404|FG000|Overall Study|Lost to Follow-up|0|||
145896660|NCT00507130|526130405|FG001|Overall Study|Lost to Follow-up|0|||
145896661|NCT00507130|526130406|FG002|Overall Study|Lost to Follow-up|1|||
145896662|NCT00507130|526130407|FG003|Overall Study|Lost to Follow-up|1|||
145896663|NCT00507130|526130404|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
145896664|NCT00507130|526130405|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145896665|NCT00507130|526130406|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145896666|NCT00507130|526130407|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145896667|NCT00859586|526130408|FG000|Overall Study|Donors|4|||
145896668|NCT02524730|526130409|FG000|Overall Study|Lost to Follow-up|5|||
145896669|NCT02524730|526130409|FG000|Overall Study|Withdrawal by Subject|18|||
145896670|NCT02524730|526130409|FG000|Overall Study|Death|10|||
145896671|NCT02524730|526130409|FG000|Overall Study|Adverse Event|8|||
145896672|NCT02524730|526130409|FG000|Overall Study|Protocol Violation|1|||
145896673|NCT02524730|526130409|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
145896674|NCT00080938|526130414|FG000|Overall Study|Adverse Event|3|||
145896675|NCT00080938|526130414|FG000|Overall Study|Withdrawal by Subject|6|||
145896676|NCT00080938|526130414|FG000|Overall Study|Death|2|||
145896677|NCT00080938|526130414|FG000|Overall Study|Lack of Efficacy|7|||
145896678|NCT00080938|526130414|FG000|Overall Study|other disease|1|||
145896679|NCT00080938|526130414|FG000|Overall Study|Not started protocol therapy|1|||
145896680|NCT00080938|526130414|FG000|Overall Study|Ineligible|4|||
145896681|NCT00706511|526130421|FG000|Overall Study|Withdrawal by Subject|1|||
145896682|NCT00706511|526130422|FG001|Overall Study|Withdrawal by Subject|0|||
145896683|NCT00706511|526130423|FG002|Overall Study|Withdrawal by Subject|0|||
145896684|NCT00706511|526130424|FG003|Overall Study|Withdrawal by Subject|0|||
145896685|NCT02605993|526130426|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145896686|NCT02605993|526130427|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145896687|NCT02605993|526130428|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
145896688|NCT02605993|526130429|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145896689|NCT03493386|526130433|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145896690|NCT03493386|526130434|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
145896691|NCT03493386|526130435|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145896692|NCT03493386|526130436|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145896693|NCT04645966|526130437|FG000|Vaccination Phase|Adverse Event|1|||
145896694|NCT04645966|526130438|FG001|Vaccination Phase|Adverse Event|0|||
145896695|NCT04645966|526130439|FG002|Vaccination Phase|Adverse Event|0|||
145896696|NCT04645966|526130440|FG003|Vaccination Phase|Adverse Event|0|||
145896697|NCT04645966|526130441|FG004|Vaccination Phase|Adverse Event|0|||
145896698|NCT04645966|526130442|FG005|Vaccination Phase|Adverse Event|0|||
145896699|NCT04645966|526130443|FG006|Vaccination Phase|Adverse Event|1|||
145896700|NCT04645966|526130444|FG007|Vaccination Phase|Adverse Event|0|||
145896701|NCT04645966|526130445|FG008|Vaccination Phase|Adverse Event|0|||
145896702|NCT04645966|526130437|FG000|Vaccination Phase|Death|0|||
145896703|NCT04645966|526130438|FG001|Vaccination Phase|Death|0|||
145896704|NCT04645966|526130439|FG002|Vaccination Phase|Death|0|||
145896705|NCT04645966|526130440|FG003|Vaccination Phase|Death|0|||
145896706|NCT04645966|526130441|FG004|Vaccination Phase|Death|0|||
145896707|NCT04645966|526130442|FG005|Vaccination Phase|Death|1|||
145896708|NCT04645966|526130443|FG006|Vaccination Phase|Death|0|||
145896709|NCT04645966|526130444|FG007|Vaccination Phase|Death|0|||
145896710|NCT04645966|526130445|FG008|Vaccination Phase|Death|0|||
145896711|NCT04645966|526130437|FG000|Vaccination Phase|Protocol Violation|0|||
145896712|NCT04645966|526130438|FG001|Vaccination Phase|Protocol Violation|0|||
145896713|NCT04645966|526130439|FG002|Vaccination Phase|Protocol Violation|0|||
145896714|NCT04645966|526130440|FG003|Vaccination Phase|Protocol Violation|0|||
145896715|NCT04645966|526130441|FG004|Vaccination Phase|Protocol Violation|1|||
145896716|NCT04645966|526130442|FG005|Vaccination Phase|Protocol Violation|0|||
145896717|NCT04645966|526130443|FG006|Vaccination Phase|Protocol Violation|0|||
145896718|NCT04645966|526130444|FG007|Vaccination Phase|Protocol Violation|0|||
145896719|NCT04645966|526130445|FG008|Vaccination Phase|Protocol Violation|0|||
145896720|NCT04645966|526130437|FG000|Vaccination Phase|Study terminated by sponsor|0|||
145896721|NCT04645966|526130438|FG001|Vaccination Phase|Study terminated by sponsor|0|||
146296671|NCT03942406|527602566|FG001|Overall Study|Lost to Follow-up|5|||
146296672|NCT03942406|527602567|FG002|Overall Study|Lost to Follow-up|3|||
145896722|NCT04645966|526130439|FG002|Vaccination Phase|Study terminated by sponsor|14|||
145896723|NCT04645966|526130440|FG003|Vaccination Phase|Study terminated by sponsor|15|||
145896724|NCT04645966|526130441|FG004|Vaccination Phase|Study terminated by sponsor|47|||
145896725|NCT04645966|526130442|FG005|Vaccination Phase|Study terminated by sponsor|43|||
145896726|NCT04645966|526130443|FG006|Vaccination Phase|Study terminated by sponsor|29|||
145896727|NCT04645966|526130444|FG007|Vaccination Phase|Study terminated by sponsor|29|||
145896728|NCT04645966|526130445|FG008|Vaccination Phase|Study terminated by sponsor|12|||
145896729|NCT04645966|526130437|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
145896730|NCT04645966|526130438|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
145896731|NCT04645966|526130439|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
145896732|NCT04645966|526130440|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
145896733|NCT04645966|526130441|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
145896734|NCT04645966|526130442|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
145896735|NCT04645966|526130443|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
145896736|NCT04645966|526130444|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
145896737|NCT04645966|526130445|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
145896738|NCT04645966|526130437|FG000|Vaccination Phase|Other|0|||
145896739|NCT04645966|526130438|FG001|Vaccination Phase|Other|0|||
145896740|NCT04645966|526130439|FG002|Vaccination Phase|Other|0|||
145896741|NCT04645966|526130440|FG003|Vaccination Phase|Other|0|||
145896742|NCT04645966|526130441|FG004|Vaccination Phase|Other|0|||
145896743|NCT04645966|526130442|FG005|Vaccination Phase|Other|2|||
145896744|NCT04645966|526130443|FG006|Vaccination Phase|Other|0|||
145896745|NCT04645966|526130444|FG007|Vaccination Phase|Other|0|||
145896746|NCT04645966|526130445|FG008|Vaccination Phase|Other|0|||
145896747|NCT04645966|526130437|FG000|Vaccination Phase|Lost to Follow-up|0|||
145896748|NCT04645966|526130438|FG001|Vaccination Phase|Lost to Follow-up|0|||
145896749|NCT04645966|526130439|FG002|Vaccination Phase|Lost to Follow-up|0|||
145896750|NCT04645966|526130440|FG003|Vaccination Phase|Lost to Follow-up|0|||
145896751|NCT04645966|526130441|FG004|Vaccination Phase|Lost to Follow-up|0|||
145896752|NCT04645966|526130442|FG005|Vaccination Phase|Lost to Follow-up|0|||
145896753|NCT04645966|526130443|FG006|Vaccination Phase|Lost to Follow-up|0|||
145896754|NCT04645966|526130444|FG007|Vaccination Phase|Lost to Follow-up|1|||
145896755|NCT04645966|526130445|FG008|Vaccination Phase|Lost to Follow-up|0|||
145896756|NCT04645966|526130437|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
145896757|NCT04645966|526130438|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
145896758|NCT04645966|526130439|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
146237991|NCT02307682|527384376|FG002|Overall Study|Lack of Efficacy|1|||
146237992|NCT02307682|527384374|FG000|Overall Study|Physician Decision|2|||
146237993|NCT02307682|527384375|FG001|Overall Study|Physician Decision|2|||
146237994|NCT02307682|527384376|FG002|Overall Study|Physician Decision|8|||
146237995|NCT02307682|527384374|FG000|Overall Study|Progressive Disease|1|||
146237996|NCT02307682|527384375|FG001|Overall Study|Progressive Disease|0|||
146237997|NCT02307682|527384376|FG002|Overall Study|Progressive Disease|0|||
146237998|NCT02307682|527384374|FG000|Overall Study|Withdrawal by Subject|26|||
146237999|NCT02307682|527384375|FG001|Overall Study|Withdrawal by Subject|34|||
146238000|NCT02307682|527384376|FG002|Overall Study|Withdrawal by Subject|23|||
146238001|NCT02307682|527384374|FG000|Overall Study|Death|9|||
146238002|NCT02307682|527384375|FG001|Overall Study|Death|7|||
146238003|NCT02307682|527384376|FG002|Overall Study|Death|12|||
146238004|NCT02307682|527384374|FG000|Overall Study|Lost to Follow-up|1|||
146238005|NCT02307682|527384375|FG001|Overall Study|Lost to Follow-up|5|||
146238006|NCT02307682|527384376|FG002|Overall Study|Lost to Follow-up|6|||
146238007|NCT02307682|527384374|FG000|Overall Study|Protocol Deviation|0|||
146238008|NCT02307682|527384375|FG001|Overall Study|Protocol Deviation|0|||
146238009|NCT02307682|527384376|FG002|Overall Study|Protocol Deviation|2|||
146238010|NCT02307682|527384374|FG000|Overall Study|Other|1|||
146238011|NCT02307682|527384375|FG001|Overall Study|Other|1|||
146238012|NCT02307682|527384376|FG002|Overall Study|Other|0|||
146238013|NCT02517268|527384379|FG000|Overall Study|Withdrawal by Subject|1|||
146238014|NCT02517268|527384380|FG001|Overall Study|Withdrawal by Subject|0|||
146238015|NCT04686266|527384381|FG000|Overall Study|Withdrawal by Subject|0|||
146238016|NCT04686266|527384382|FG001|Overall Study|Withdrawal by Subject|1|||
146238017|NCT03227861|527384385|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
146238018|NCT03227861|527384385|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
146238019|NCT03227861|527384385|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
146238020|NCT03227861|527384385|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
146238021|NCT03227861|527384385|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
146238022|NCT03227861|527384385|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
146238023|NCT03227861|527384385|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
145896759|NCT04645966|526130440|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
145896760|NCT04645966|526130441|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
145896761|NCT04645966|526130442|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
145896762|NCT04645966|526130443|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
145896763|NCT04645966|526130444|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
145896764|NCT04645966|526130445|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
145896765|NCT04645966|526130437|FG000|Follow-up Phase|Lost to Follow-up|0|||
145896766|NCT04645966|526130438|FG001|Follow-up Phase|Lost to Follow-up|0|||
145896767|NCT04645966|526130439|FG002|Follow-up Phase|Lost to Follow-up|0|||
145896768|NCT04645966|526130440|FG003|Follow-up Phase|Lost to Follow-up|0|||
145896769|NCT04645966|526130441|FG004|Follow-up Phase|Lost to Follow-up|0|||
145896770|NCT04645966|526130442|FG005|Follow-up Phase|Lost to Follow-up|0|||
145896771|NCT04645966|526130443|FG006|Follow-up Phase|Lost to Follow-up|0|||
145896772|NCT04645966|526130444|FG007|Follow-up Phase|Lost to Follow-up|1|||
145896773|NCT04645966|526130445|FG008|Follow-up Phase|Lost to Follow-up|0|||
145896774|NCT00289536|526130446|FG000|Period 3|Lost to Follow-up|0|||
145896775|NCT00289536|526130447|FG001|Period 3|Lost to Follow-up|0|||
145896776|NCT00289536|526130448|FG002|Period 3|Lost to Follow-up|1|||
145896777|NCT03246126|526130449|FG000|Overall Study|Withdrawal by Subject|0|||
145896778|NCT03246126|526130450|FG001|Overall Study|Withdrawal by Subject|1|||
145896779|NCT01460901|526130451|FG000|Overall Study|Withdrawal by Subject|2|||
145896780|NCT00893737|526130452|FG000|Overall Study|Adverse Event|4|||
145896781|NCT00893737|526130452|FG000|Overall Study|Withdrawal by Subject|2|||
145896782|NCT00893737|526130452|FG000|Overall Study|Lost to Follow-up|6|||
145896783|NCT01156142|526130453|FG000|Overall Study|Withdrawal by Subject|8|||
145896784|NCT01156142|526130454|FG001|Overall Study|Withdrawal by Subject|6|||
145896785|NCT01156142|526130453|FG000|Overall Study|Ineligible|0|||
145896786|NCT01156142|526130454|FG001|Overall Study|Ineligible|1|||
145896787|NCT03981419|526130455|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
145896788|NCT03981419|526130456|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
145896789|NCT01330459|526130457|FG000|Overall Study|Physician Decision|0|||
145896790|NCT01330459|526130458|FG001|Overall Study|Physician Decision|2|||
146296673|NCT03942406|527602568|FG003|Overall Study|Lost to Follow-up|7|||
145896791|NCT00895947|526130460|FG000|Overall Study|Adverse Event|3|||
145896792|NCT00895947|526130461|FG001|Overall Study|Adverse Event|4|||
145896793|NCT00895947|526130460|FG000|Overall Study|Lost to Follow-up|3|||
145896794|NCT00895947|526130461|FG001|Overall Study|Lost to Follow-up|4|||
146296674|NCT03942406|527602569|FG004|Overall Study|Lost to Follow-up|1|||
146296675|NCT03942406|527602570|FG005|Overall Study|Lost to Follow-up|0|||
146296676|NCT03942406|527602571|FG006|Overall Study|Lost to Follow-up|0|||
146296677|NCT03942406|527602565|FG000|Overall Study|Withdrawal by Subject|3|||
146296678|NCT03942406|527602566|FG001|Overall Study|Withdrawal by Subject|1|||
146296679|NCT03942406|527602567|FG002|Overall Study|Withdrawal by Subject|1|||
146296680|NCT03942406|527602568|FG003|Overall Study|Withdrawal by Subject|3|||
146296681|NCT03942406|527602569|FG004|Overall Study|Withdrawal by Subject|0|||
146296682|NCT03942406|527602570|FG005|Overall Study|Withdrawal by Subject|0|||
146296683|NCT03942406|527602571|FG006|Overall Study|Withdrawal by Subject|0|||
146296684|NCT03942406|527602565|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
146296685|NCT03942406|527602566|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
146296686|NCT03942406|527602567|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
146296687|NCT03942406|527602568|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
146296688|NCT03942406|527602569|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
146296689|NCT03942406|527602570|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
146296690|NCT03942406|527602571|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
146296691|NCT01207596|527602572|FG000|Overall Study|Physician Decision|4|||
145896795|NCT00895947|526130460|FG000|Overall Study|Protocol Violation|4|||
145896796|NCT00895947|526130461|FG001|Overall Study|Protocol Violation|2|||
145896797|NCT00895947|526130460|FG000|Overall Study|Withdrawal by Subject|2|||
145896798|NCT00895947|526130461|FG001|Overall Study|Withdrawal by Subject|0|||
145896799|NCT02272634|526130464|FG000|Overall Study|Adverse Event|1|||
145896800|NCT02272634|526130465|FG001|Overall Study|Adverse Event|0|||
145896801|NCT02272634|526130466|FG002|Overall Study|Adverse Event|0|||
145896802|NCT02272634|526130464|FG000|Overall Study|Protocol Violation|0|||
145896803|NCT02272634|526130465|FG001|Overall Study|Protocol Violation|0|||
145896804|NCT02272634|526130466|FG002|Overall Study|Protocol Violation|1|||
145896805|NCT02272634|526130464|FG000|Overall Study|Withdrawal by Subject|0|||
145896806|NCT02272634|526130465|FG001|Overall Study|Withdrawal by Subject|1|||
145896807|NCT02272634|526130466|FG002|Overall Study|Withdrawal by Subject|0|||
145896808|NCT04620135|526130467|FG000|Study Completion|Adverse Event|2|||
145896809|NCT04620135|526130468|FG001|Study Completion|Adverse Event|3|||
145896810|NCT04620135|526130467|FG000|Study Completion|Withdrawal by Subject|2|||
145896811|NCT04620135|526130468|FG001|Study Completion|Withdrawal by Subject|0|||
145896812|NCT01437943|526130469|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
145896813|NCT01437943|526130470|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
145896814|NCT01437943|526130469|FG000|Overall Study|Subject expressed pregnancy plans|1|||
145896815|NCT01437943|526130470|FG001|Overall Study|Subject expressed pregnancy plans|0|||
145896816|NCT01437943|526130469|FG000|Overall Study|Adverse Event|2|||
146296692|NCT01207596|527602572|FG000|Overall Study|Lack of Efficacy|1|||
145896817|NCT01437943|526130470|FG001|Overall Study|Adverse Event|0|||
146296693|NCT01207596|527602572|FG000|Overall Study|Adverse Event|3|||
146296694|NCT01207596|527602572|FG000|Overall Study|Withdrawal by Subject|1|||
146296695|NCT00216203|527602573|FG000|Overall Study|Withdrawal by Subject|2|||
146296696|NCT02596620|527602576|FG000|Overall Study|Lost to Follow-up|1|||
145896818|NCT04647721|526130471|FG000|Overall Study|Withdrawal by Subject|0|||
145896819|NCT04647721|526130472|FG001|Overall Study|Withdrawal by Subject|2|||
145896820|NCT04647721|526130471|FG000|Overall Study|Lost to Follow-up|2|||
145896821|NCT04647721|526130472|FG001|Overall Study|Lost to Follow-up|0|||
145896822|NCT00502801|526130479|FG000|Treatment Period|Withdrawal by Subject|3|||
145896823|NCT00502801|526130479|FG000|Treatment Period|Adverse Event|7|||
145896824|NCT00502801|526130479|FG000|Treatment Period|Death|14|||
145896825|NCT00502801|526130479|FG000|Treatment Period|OTHER|30|||
145896826|NCT00502801|526130479|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
145896827|NCT00502801|526130479|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
145896828|NCT00502801|526130479|FG000|End of Therapy to Test of Cure|Death|3|||
145896829|NCT00502801|526130479|FG000|End of Therapy to Test of Cure|OTHER|2|||
145896830|NCT05011123|526132220|FG000|Overall Study|Withdrawal by Subject|4|||
145896831|NCT05011123|526132221|FG001|Overall Study|Withdrawal by Subject|2|||
145896832|NCT05011123|526132220|FG000|Overall Study|Lost to Follow-up|7|||
145896833|NCT05011123|526132221|FG001|Overall Study|Lost to Follow-up|6|||
145896834|NCT05011123|526132220|FG000|Overall Study|Ongoing at the time of DBL date|36|||
145896835|NCT05011123|526132221|FG001|Overall Study|Ongoing at the time of DBL date|10|||
145896836|NCT05011123|526132220|FG000|Overall Study|Randomized but did not receive vaccination|1|||
145896837|NCT05011123|526132221|FG001|Overall Study|Randomized but did not receive vaccination|0|||
145896838|NCT04221789|526132223|FG000|Overall Study|deviation from protoco|22|||
145896839|NCT04221789|526132224|FG001|Overall Study|deviation from protoco|8|||
145896840|NCT03845296|526132227|FG000|Overall Study|On Treatment|2|||
145896841|NCT03845296|526132228|FG001|Overall Study|On Treatment|1|||
145896842|NCT03845296|526132227|FG000|Overall Study|Adverse Event|4|||
145896843|NCT03845296|526132228|FG001|Overall Study|Adverse Event|11|||
145896844|NCT03845296|526132227|FG000|Overall Study|Refusal unrelated to adverse event|0|||
145896845|NCT03845296|526132228|FG001|Overall Study|Refusal unrelated to adverse event|1|||
145896846|NCT03845296|526132227|FG000|Overall Study|Progression/relapse|14|||
145896847|NCT03845296|526132228|FG001|Overall Study|Progression/relapse|18|||
145896848|NCT03845296|526132227|FG000|Overall Study|Death|4|||
145896849|NCT03845296|526132228|FG001|Overall Study|Death|0|||
145896850|NCT03845296|526132227|FG000|Overall Study|Other - not protocol specified|1|||
145896851|NCT03845296|526132228|FG001|Overall Study|Other - not protocol specified|3|||
146296697|NCT02596620|527602577|FG001|Overall Study|Lost to Follow-up|1|||
146296698|NCT01054144|527602578|FG000|Overall Study|Death|2|||
146296699|NCT02748018|527602579|FG000|Study Period|Adverse Event|1|||
145896852|NCT06218823|526132231|FG000|Overall Study|Death|3|||
145896853|NCT06218823|526132232|FG001|Overall Study|Death|0|||
145896854|NCT06218823|526132231|FG000|Overall Study|Lost to Follow-up|0|||
145896855|NCT06218823|526132232|FG001|Overall Study|Lost to Follow-up|2|||
145896856|NCT04732221|526132233|FG000|Base Period|Death|2|||
145896857|NCT04732221|526132234|FG001|Base Period|Death|0|||
145896858|NCT04732221|526132235|FG002|Base Period|Death|0|||
145896859|NCT04732221|526132236|FG003|Base Period|Death|0|||
145896860|NCT04732221|526132237|FG004|Base Period|Death|0|||
145896861|NCT04732221|526132238|FG005|Base Period|Death|0|||
145896862|NCT04732221|526132239|FG006|Base Period|Death|0|||
145896863|NCT04732221|526132233|FG000|Base Period|Withdrawal by Subject|0|||
145896864|NCT04732221|526132234|FG001|Base Period|Withdrawal by Subject|1|||
145896865|NCT04732221|526132235|FG002|Base Period|Withdrawal by Subject|1|||
145896866|NCT04732221|526132236|FG003|Base Period|Withdrawal by Subject|0|||
145896867|NCT04732221|526132237|FG004|Base Period|Withdrawal by Subject|0|||
145896868|NCT04732221|526132238|FG005|Base Period|Withdrawal by Subject|0|||
145896869|NCT04732221|526132239|FG006|Base Period|Withdrawal by Subject|0|||
145896870|NCT04732221|526132233|FG000|Extension Period|Adverse Event|0|||
145896871|NCT04732221|526132234|FG001|Extension Period|Adverse Event|0|||
145896872|NCT04732221|526132235|FG002|Extension Period|Adverse Event|0|||
145896873|NCT04732221|526132236|FG003|Extension Period|Adverse Event|0|||
145896874|NCT04732221|526132237|FG004|Extension Period|Adverse Event|0|||
145896875|NCT04732221|526132238|FG005|Extension Period|Adverse Event|1|||
146296700|NCT02748018|527602580|FG001|Study Period|Adverse Event|3|||
146296701|NCT02748018|527602581|FG002|Study Period|Adverse Event|4|||
145896876|NCT04732221|526132239|FG006|Extension Period|Adverse Event|0|||
145896877|NCT04732221|526132233|FG000|Extension Period|Death|0|||
145896878|NCT04732221|526132234|FG001|Extension Period|Death|0|||
145896879|NCT04732221|526132235|FG002|Extension Period|Death|0|||
145896880|NCT04732221|526132236|FG003|Extension Period|Death|0|||
145896881|NCT04732221|526132237|FG004|Extension Period|Death|1|||
145896882|NCT04732221|526132238|FG005|Extension Period|Death|0|||
145896883|NCT04732221|526132239|FG006|Extension Period|Death|2|||
145896884|NCT04732221|526132233|FG000|Extension Period|Pregnancy|0|||
145896885|NCT04732221|526132234|FG001|Extension Period|Pregnancy|0|||
146296702|NCT02748018|527602582|FG003|Study Period|Adverse Event|0|||
145896886|NCT04732221|526132235|FG002|Extension Period|Pregnancy|0|||
145896887|NCT04732221|526132236|FG003|Extension Period|Pregnancy|0|||
145896888|NCT04732221|526132237|FG004|Extension Period|Pregnancy|1|||
145896889|NCT04732221|526132238|FG005|Extension Period|Pregnancy|0|||
146296703|NCT02748018|527602583|FG004|Study Period|Adverse Event|3|||
145896890|NCT04732221|526132239|FG006|Extension Period|Pregnancy|0|||
145896891|NCT04732221|526132233|FG000|Extension Period|Sponsors Decision|0|||
145896892|NCT04732221|526132234|FG001|Extension Period|Sponsors Decision|0|||
145896893|NCT04732221|526132235|FG002|Extension Period|Sponsors Decision|0|||
145896894|NCT04732221|526132236|FG003|Extension Period|Sponsors Decision|0|||
145896895|NCT04732221|526132237|FG004|Extension Period|Sponsors Decision|41|||
145896896|NCT04732221|526132238|FG005|Extension Period|Sponsors Decision|40|||
145896897|NCT04732221|526132239|FG006|Extension Period|Sponsors Decision|40|||
145896898|NCT04732221|526132233|FG000|Extension Period|Withdrawal by Subject|0|||
145896899|NCT04732221|526132234|FG001|Extension Period|Withdrawal by Subject|0|||
145896900|NCT04732221|526132235|FG002|Extension Period|Withdrawal by Subject|0|||
145896901|NCT04732221|526132236|FG003|Extension Period|Withdrawal by Subject|0|||
145896902|NCT04732221|526132237|FG004|Extension Period|Withdrawal by Subject|1|||
145896903|NCT04732221|526132238|FG005|Extension Period|Withdrawal by Subject|5|||
145896904|NCT04732221|526132239|FG006|Extension Period|Withdrawal by Subject|2|||
145896905|NCT04385277|526132240|FG000|Overall Study|Physician Decision|2|||
145896906|NCT04385277|526132240|FG000|Overall Study|Ineligible|1|||
145896907|NCT04385277|526132240|FG000|Overall Study|Patient/Parent Refusal|2|||
145896908|NCT00461253|526132244|FG000|Overall Study|Death|985|||
145896909|NCT00461253|526132245|FG001|Overall Study|Death|0|||
145896910|NCT00461253|526132244|FG000|Overall Study|Protocol Violation|613|||
145896911|NCT00461253|526132245|FG001|Overall Study|Protocol Violation|236|||
145896912|NCT00461253|526132244|FG000|Overall Study|no response|2609|||
145896913|NCT00461253|526132245|FG001|Overall Study|no response|11789|||
145896914|NCT00461253|526132244|FG000|Overall Study|administrative|773|||
145896915|NCT00461253|526132245|FG001|Overall Study|administrative|7773|||
145896916|NCT02799095|526132246|FG000|Part A|Adverse Event|1|||
145896917|NCT02799095|526132247|FG001|Part A|Adverse Event|0|||
145896918|NCT02799095|526132248|FG002|Part A|Adverse Event|1|||
145896919|NCT02799095|526132249|FG003|Part A|Adverse Event|4|||
145896920|NCT02799095|526132250|FG004|Part A|Adverse Event|1|||
145896921|NCT02799095|526132251|FG005|Part A|Adverse Event|0|||
145896922|NCT02799095|526132252|FG006|Part A|Adverse Event|0|||
145896923|NCT02799095|526132253|FG007|Part A|Adverse Event|0|||
145896924|NCT02799095|526132254|FG008|Part A|Adverse Event|0|||
145896925|NCT02799095|526132255|FG009|Part A|Adverse Event|0|||
145896926|NCT02799095|526132256|FG010|Part A|Adverse Event|0|||
145896927|NCT02799095|526132257|FG011|Part A|Adverse Event|0|||
145896928|NCT02799095|526132258|FG012|Part A|Adverse Event|0|||
145896929|NCT02799095|526132259|FG013|Part A|Adverse Event|0|||
145896930|NCT02799095|526132260|FG014|Part A|Adverse Event|0|||
145896931|NCT02799095|526132261|FG015|Part A|Adverse Event|0|||
145896932|NCT02799095|526132262|FG016|Part A|Adverse Event|0|||
145896933|NCT02799095|526132246|FG000|Part A|Death|0|||
145896934|NCT02799095|526132247|FG001|Part A|Death|0|||
145896935|NCT02799095|526132248|FG002|Part A|Death|0|||
145896936|NCT02799095|526132249|FG003|Part A|Death|0|||
145896937|NCT02799095|526132250|FG004|Part A|Death|0|||
145896938|NCT02799095|526132251|FG005|Part A|Death|0|||
145896939|NCT02799095|526132252|FG006|Part A|Death|3|||
145896940|NCT02799095|526132253|FG007|Part A|Death|0|||
145896941|NCT02799095|526132254|FG008|Part A|Death|0|||
145896942|NCT02799095|526132255|FG009|Part A|Death|0|||
145896943|NCT02799095|526132256|FG010|Part A|Death|0|||
145896944|NCT02799095|526132257|FG011|Part A|Death|0|||
145896945|NCT02799095|526132258|FG012|Part A|Death|0|||
145896946|NCT02799095|526132259|FG013|Part A|Death|0|||
145896947|NCT02799095|526132260|FG014|Part A|Death|0|||
145896948|NCT02799095|526132261|FG015|Part A|Death|0|||
145896949|NCT02799095|526132262|FG016|Part A|Death|0|||
145896950|NCT02799095|526132246|FG000|Part A|Lost to Follow-up|0|||
145896951|NCT02799095|526132247|FG001|Part A|Lost to Follow-up|1|||
145896952|NCT02799095|526132248|FG002|Part A|Lost to Follow-up|0|||
145896953|NCT02799095|526132249|FG003|Part A|Lost to Follow-up|0|||
145896954|NCT02799095|526132250|FG004|Part A|Lost to Follow-up|0|||
145896955|NCT02799095|526132251|FG005|Part A|Lost to Follow-up|0|||
145896956|NCT02799095|526132252|FG006|Part A|Lost to Follow-up|1|||
145896957|NCT02799095|526132253|FG007|Part A|Lost to Follow-up|0|||
145896958|NCT02799095|526132254|FG008|Part A|Lost to Follow-up|0|||
145896959|NCT02799095|526132255|FG009|Part A|Lost to Follow-up|0|||
145896960|NCT02799095|526132256|FG010|Part A|Lost to Follow-up|0|||
145896961|NCT02799095|526132257|FG011|Part A|Lost to Follow-up|0|||
145896962|NCT02799095|526132258|FG012|Part A|Lost to Follow-up|0|||
145896963|NCT02799095|526132259|FG013|Part A|Lost to Follow-up|0|||
145896964|NCT02799095|526132260|FG014|Part A|Lost to Follow-up|0|||
145896965|NCT02799095|526132261|FG015|Part A|Lost to Follow-up|0|||
145896966|NCT02799095|526132262|FG016|Part A|Lost to Follow-up|0|||
145896967|NCT02799095|526132246|FG000|Part A|Progressive Disease|3|||
145896968|NCT02799095|526132247|FG001|Part A|Progressive Disease|3|||
145896969|NCT02799095|526132248|FG002|Part A|Progressive Disease|3|||
145896970|NCT02799095|526132249|FG003|Part A|Progressive Disease|2|||
145896971|NCT02799095|526132250|FG004|Part A|Progressive Disease|2|||
145896972|NCT02799095|526132251|FG005|Part A|Progressive Disease|0|||
145896973|NCT02799095|526132252|FG006|Part A|Progressive Disease|0|||
145896974|NCT02799095|526132253|FG007|Part A|Progressive Disease|0|||
145896975|NCT02799095|526132254|FG008|Part A|Progressive Disease|0|||
145896976|NCT02799095|526132255|FG009|Part A|Progressive Disease|0|||
145896977|NCT02799095|526132256|FG010|Part A|Progressive Disease|0|||
145896978|NCT02799095|526132257|FG011|Part A|Progressive Disease|0|||
145896979|NCT02799095|526132258|FG012|Part A|Progressive Disease|0|||
145896980|NCT02799095|526132259|FG013|Part A|Progressive Disease|0|||
145896981|NCT02799095|526132260|FG014|Part A|Progressive Disease|0|||
145896982|NCT02799095|526132261|FG015|Part A|Progressive Disease|0|||
145896983|NCT02799095|526132262|FG016|Part A|Progressive Disease|0|||
145896984|NCT02799095|526132246|FG000|Part A|Clinical Progression|1|||
145896985|NCT02799095|526132247|FG001|Part A|Clinical Progression|0|||
145896986|NCT02799095|526132248|FG002|Part A|Clinical Progression|2|||
145896987|NCT02799095|526132249|FG003|Part A|Clinical Progression|1|||
145896988|NCT02799095|526132250|FG004|Part A|Clinical Progression|5|||
145896989|NCT02799095|526132251|FG005|Part A|Clinical Progression|0|||
146296704|NCT02748018|527602584|FG005|Study Period|Adverse Event|3|||
145896990|NCT02799095|526132252|FG006|Part A|Clinical Progression|0|||
145896991|NCT02799095|526132253|FG007|Part A|Clinical Progression|0|||
145896992|NCT02799095|526132254|FG008|Part A|Clinical Progression|0|||
145896993|NCT02799095|526132255|FG009|Part A|Clinical Progression|0|||
145896994|NCT02799095|526132256|FG010|Part A|Clinical Progression|0|||
145972363|NCT02332707|526412624|FG004|Overall Study|Physician Decision|0|||
145972364|NCT02332707|526412625|FG005|Overall Study|Physician Decision|0|||
145972365|NCT02332707|526412626|FG006|Overall Study|Physician Decision|0|||
145972366|NCT02332707|526412627|FG007|Overall Study|Physician Decision|0|||
145972367|NCT02332707|526412628|FG008|Overall Study|Physician Decision|0|||
145972368|NCT02332707|526412629|FG009|Overall Study|Physician Decision|0|||
145972369|NCT02332707|526412630|FG010|Overall Study|Physician Decision|0|||
145972370|NCT02332707|526412631|FG011|Overall Study|Physician Decision|0|||
145972371|NCT02332707|526412632|FG012|Overall Study|Physician Decision|1|||
146296705|NCT02748018|527602579|FG000|Study Period|Withdrawal by Subject|7|||
145896995|NCT02799095|526132257|FG011|Part A|Clinical Progression|0|||
145896996|NCT02799095|526132258|FG012|Part A|Clinical Progression|0|||
145896997|NCT02799095|526132259|FG013|Part A|Clinical Progression|0|||
145896998|NCT02799095|526132260|FG014|Part A|Clinical Progression|0|||
145896999|NCT02799095|526132261|FG015|Part A|Clinical Progression|0|||
145897000|NCT02799095|526132262|FG016|Part A|Clinical Progression|0|||
145897001|NCT02799095|526132246|FG000|Part A|Protocol Deviation|0|||
145897002|NCT02799095|526132247|FG001|Part A|Protocol Deviation|0|||
145897003|NCT02799095|526132248|FG002|Part A|Protocol Deviation|1|||
145897004|NCT02799095|526132249|FG003|Part A|Protocol Deviation|0|||
145972372|NCT02332707|526412633|FG013|Overall Study|Physician Decision|0|||
146296706|NCT02748018|527602580|FG001|Study Period|Withdrawal by Subject|4|||
146296707|NCT02748018|527602581|FG002|Study Period|Withdrawal by Subject|4|||
146296708|NCT02748018|527602582|FG003|Study Period|Withdrawal by Subject|11|||
146296709|NCT02748018|527602583|FG004|Study Period|Withdrawal by Subject|12|||
146296710|NCT02748018|527602584|FG005|Study Period|Withdrawal by Subject|10|||
146296711|NCT02748018|527602579|FG000|Study Period|Pregnancy|0|||
146296712|NCT02748018|527602580|FG001|Study Period|Pregnancy|1|||
146296713|NCT02748018|527602581|FG002|Study Period|Pregnancy|0|||
146296714|NCT02748018|527602582|FG003|Study Period|Pregnancy|0|||
146296715|NCT02748018|527602583|FG004|Study Period|Pregnancy|1|||
146296716|NCT02748018|527602584|FG005|Study Period|Pregnancy|0|||
146296717|NCT02748018|527602579|FG000|Study Period|Physician Decision|2|||
146296718|NCT02748018|527602580|FG001|Study Period|Physician Decision|2|||
146296719|NCT02748018|527602581|FG002|Study Period|Physician Decision|1|||
146296720|NCT02748018|527602582|FG003|Study Period|Physician Decision|0|||
146296721|NCT02748018|527602583|FG004|Study Period|Physician Decision|2|||
146296722|NCT02748018|527602584|FG005|Study Period|Physician Decision|0|||
146296723|NCT02748018|527602579|FG000|Study Period|Lost to Follow-up|0|||
146296724|NCT02748018|527602580|FG001|Study Period|Lost to Follow-up|0|||
146296725|NCT02748018|527602581|FG002|Study Period|Lost to Follow-up|0|||
146296726|NCT02748018|527602582|FG003|Study Period|Lost to Follow-up|2|||
145897005|NCT02799095|526132250|FG004|Part A|Protocol Deviation|0|||
145897006|NCT02799095|526132251|FG005|Part A|Protocol Deviation|0|||
145897007|NCT02799095|526132252|FG006|Part A|Protocol Deviation|0|||
145972373|NCT02332707|526412634|FG014|Overall Study|Physician Decision|0|||
145972374|NCT02332707|526412635|FG015|Overall Study|Physician Decision|0|||
145972375|NCT02332707|526412636|FG016|Overall Study|Physician Decision|0|||
145897008|NCT02799095|526132253|FG007|Part A|Protocol Deviation|0|||
145897009|NCT02799095|526132254|FG008|Part A|Protocol Deviation|0|||
145897010|NCT02799095|526132255|FG009|Part A|Protocol Deviation|0|||
145897011|NCT02799095|526132256|FG010|Part A|Protocol Deviation|0|||
145897012|NCT02799095|526132257|FG011|Part A|Protocol Deviation|0|||
145897013|NCT02799095|526132258|FG012|Part A|Protocol Deviation|0|||
145972376|NCT02332707|526412637|FG017|Overall Study|Physician Decision|0|||
146296727|NCT02748018|527602583|FG004|Study Period|Lost to Follow-up|0|||
146296728|NCT02748018|527602584|FG005|Study Period|Lost to Follow-up|1|||
146296729|NCT02748018|527602579|FG000|Continuation Period|Adverse Event|2|||
146296730|NCT02748018|527602580|FG001|Continuation Period|Adverse Event|0|||
146296731|NCT02748018|527602581|FG002|Continuation Period|Adverse Event|1|||
146296732|NCT02748018|527602582|FG003|Continuation Period|Adverse Event|1|||
146296733|NCT02748018|527602583|FG004|Continuation Period|Adverse Event|1|||
145897014|NCT02799095|526132259|FG013|Part A|Protocol Deviation|0|||
145897015|NCT02799095|526132260|FG014|Part A|Protocol Deviation|0|||
145897016|NCT02799095|526132261|FG015|Part A|Protocol Deviation|0|||
145897017|NCT02799095|526132262|FG016|Part A|Protocol Deviation|0|||
145897018|NCT02799095|526132246|FG000|Part A|Withdrawal by Subject|0|||
145897019|NCT02799095|526132247|FG001|Part A|Withdrawal by Subject|0|||
145897020|NCT02799095|526132248|FG002|Part A|Withdrawal by Subject|0|||
145897021|NCT02799095|526132249|FG003|Part A|Withdrawal by Subject|1|||
145897022|NCT02799095|526132250|FG004|Part A|Withdrawal by Subject|3|||
146238024|NCT03227861|527384385|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
146238025|NCT03227861|527384385|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
146238026|NCT03227861|527384385|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
146238027|NCT05071430|527384389|FG000|Overall Study|Adverse Event|1|||
146238028|NCT05071430|527384390|FG001|Overall Study|Adverse Event|2|||
145897023|NCT02799095|526132251|FG005|Part A|Withdrawal by Subject|1|||
145897024|NCT02799095|526132252|FG006|Part A|Withdrawal by Subject|1|||
145897025|NCT02799095|526132253|FG007|Part A|Withdrawal by Subject|0|||
146238029|NCT05071430|527384389|FG000|Overall Study|Lost to Follow-up|4|||
146238030|NCT05071430|527384390|FG001|Overall Study|Lost to Follow-up|4|||
146238031|NCT05071430|527384389|FG000|Overall Study|Protocol Violation|1|||
146238032|NCT05071430|527384390|FG001|Overall Study|Protocol Violation|0|||
146238033|NCT05071430|527384389|FG000|Overall Study|Withdrawal by Subject|3|||
146238034|NCT05071430|527384390|FG001|Overall Study|Withdrawal by Subject|2|||
146238035|NCT05071430|527384389|FG000|Overall Study|Other|1|||
146238036|NCT05071430|527384390|FG001|Overall Study|Other|1|||
146238037|NCT01958021|527384391|FG000|Treatment|Progressive disease|206|||
146238038|NCT01958021|527384392|FG001|Treatment|Progressive disease|265|||
146238039|NCT01958021|527384391|FG000|Treatment|Adverse Event|38|||
146238040|NCT01958021|527384392|FG001|Treatment|Adverse Event|10|||
146238041|NCT01958021|527384391|FG000|Treatment|Subject/guardian decision|29|||
146238042|NCT01958021|527384392|FG001|Treatment|Subject/guardian decision|25|||
146238043|NCT01958021|527384391|FG000|Treatment|Physician Decision|28|||
146238044|NCT01958021|527384392|FG001|Treatment|Physician Decision|21|||
146238045|NCT01958021|527384391|FG000|Treatment|Death|6|||
146238046|NCT01958021|527384392|FG001|Treatment|Death|1|||
146238047|NCT01958021|527384391|FG000|Treatment|Protocol deviation|3|||
146238048|NCT01958021|527384392|FG001|Treatment|Protocol deviation|1|||
146238049|NCT01958021|527384391|FG000|Treatment|Sponsor decision|24|||
146238050|NCT01958021|527384392|FG001|Treatment|Sponsor decision|11|||
146238051|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146238052|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146238053|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Death|1|||
146238054|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Death|0|||
146238055|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
146238056|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146238057|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146238058|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146238059|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
146238060|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146238061|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
146238062|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
146238063|NCT01958021|527384391|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
146238064|NCT01958021|527384392|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
146238065|NCT05810285|527384393|FG000|Overall Study|Death|4|||
146238066|NCT05810285|527384394|FG001|Overall Study|Death|21|||
146238067|NCT05810285|527384393|FG000|Overall Study|Adverse Event|18|||
146238068|NCT05810285|527384394|FG001|Overall Study|Adverse Event|16|||
146238069|NCT04649047|527384395|FG000|Overall Study|Withdrawal by Subject|3|||
146238070|NCT05886777|527384396|FG000|Overall Study|Lost to Follow-up|1|||
146238071|NCT05886777|527384397|FG001|Overall Study|Lost to Follow-up|0|||
146238072|NCT05886777|527384398|FG002|Overall Study|Lost to Follow-up|2|||
146238073|NCT05886777|527384399|FG003|Overall Study|Lost to Follow-up|1|||
146238074|NCT05886777|527384400|FG004|Overall Study|Lost to Follow-up|0|||
146238075|NCT05886777|527384401|FG005|Overall Study|Lost to Follow-up|2|||
146238076|NCT05886777|527384402|FG006|Overall Study|Lost to Follow-up|0|||
146238077|NCT05886777|527384396|FG000|Overall Study|Other|0|||
146238078|NCT05886777|527384397|FG001|Overall Study|Other|2|||
146238079|NCT05886777|527384398|FG002|Overall Study|Other|1|||
146238080|NCT05886777|527384399|FG003|Overall Study|Other|0|||
146238081|NCT05886777|527384400|FG004|Overall Study|Other|0|||
146238082|NCT05886777|527384401|FG005|Overall Study|Other|0|||
146238083|NCT05886777|527384402|FG006|Overall Study|Other|0|||
146238084|NCT05886777|527384396|FG000|Overall Study|Withdrawal by Subject|1|||
146238085|NCT05886777|527384397|FG001|Overall Study|Withdrawal by Subject|0|||
145897026|NCT02799095|526132254|FG008|Part A|Withdrawal by Subject|0|||
145897027|NCT02799095|526132255|FG009|Part A|Withdrawal by Subject|0|||
145897028|NCT02799095|526132256|FG010|Part A|Withdrawal by Subject|0|||
146238086|NCT05886777|527384398|FG002|Overall Study|Withdrawal by Subject|1|||
146296734|NCT02748018|527602584|FG005|Continuation Period|Adverse Event|4|||
145897029|NCT02799095|526132257|FG011|Part A|Withdrawal by Subject|0|||
145897030|NCT02799095|526132258|FG012|Part A|Withdrawal by Subject|0|||
145897031|NCT02799095|526132259|FG013|Part A|Withdrawal by Subject|0|||
145897032|NCT02799095|526132260|FG014|Part A|Withdrawal by Subject|0|||
145897033|NCT02799095|526132261|FG015|Part A|Withdrawal by Subject|0|||
145897034|NCT02799095|526132262|FG016|Part A|Withdrawal by Subject|0|||
145897035|NCT02799095|526132246|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
145897036|NCT02799095|526132247|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
145897037|NCT02799095|526132248|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
145897038|NCT02799095|526132249|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
145897039|NCT02799095|526132250|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
145897040|NCT02799095|526132251|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
145897041|NCT02799095|526132252|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
145897042|NCT02799095|526132253|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
145897043|NCT02799095|526132254|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
145897044|NCT02799095|526132255|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
145897045|NCT02799095|526132256|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
145897046|NCT02799095|526132257|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
145897047|NCT02799095|526132258|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
145897048|NCT02799095|526132259|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
145897049|NCT02799095|526132260|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
145897050|NCT02799095|526132261|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
145897051|NCT02799095|526132262|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
145897052|NCT02799095|526132246|FG000|Part B|Death|0|||
145897053|NCT02799095|526132247|FG001|Part B|Death|0|||
145897054|NCT02799095|526132248|FG002|Part B|Death|0|||
145897055|NCT02799095|526132249|FG003|Part B|Death|0|||
145897056|NCT02799095|526132250|FG004|Part B|Death|0|||
145897057|NCT02799095|526132251|FG005|Part B|Death|0|||
145897058|NCT02799095|526132252|FG006|Part B|Death|0|||
145897059|NCT02799095|526132253|FG007|Part B|Death|7|||
145897060|NCT02799095|526132254|FG008|Part B|Death|7|||
145897061|NCT02799095|526132255|FG009|Part B|Death|0|||
145897062|NCT02799095|526132256|FG010|Part B|Death|0|||
145897063|NCT02799095|526132257|FG011|Part B|Death|0|||
145897064|NCT02799095|526132258|FG012|Part B|Death|0|||
145897065|NCT02799095|526132259|FG013|Part B|Death|0|||
145897066|NCT02799095|526132260|FG014|Part B|Death|0|||
145897067|NCT02799095|526132261|FG015|Part B|Death|0|||
145897068|NCT02799095|526132262|FG016|Part B|Death|0|||
145897069|NCT02799095|526132246|FG000|Part B|Progressive Disease|0|||
145897070|NCT02799095|526132247|FG001|Part B|Progressive Disease|0|||
145897071|NCT02799095|526132248|FG002|Part B|Progressive Disease|0|||
145897072|NCT02799095|526132249|FG003|Part B|Progressive Disease|0|||
145897073|NCT02799095|526132250|FG004|Part B|Progressive Disease|0|||
145897074|NCT02799095|526132251|FG005|Part B|Progressive Disease|0|||
145897075|NCT02799095|526132252|FG006|Part B|Progressive Disease|0|||
145897076|NCT02799095|526132253|FG007|Part B|Progressive Disease|1|||
145897077|NCT02799095|526132254|FG008|Part B|Progressive Disease|0|||
145897078|NCT02799095|526132255|FG009|Part B|Progressive Disease|0|||
145897079|NCT02799095|526132256|FG010|Part B|Progressive Disease|0|||
145972377|NCT02332707|526412620|FG000|Overall Study|Withdrawal by Subject|0|||
145972378|NCT02332707|526412621|FG001|Overall Study|Withdrawal by Subject|0|||
146238087|NCT05886777|527384399|FG003|Overall Study|Withdrawal by Subject|4|||
146238088|NCT05886777|527384400|FG004|Overall Study|Withdrawal by Subject|3|||
146238089|NCT05886777|527384401|FG005|Overall Study|Withdrawal by Subject|1|||
146238090|NCT05886777|527384402|FG006|Overall Study|Withdrawal by Subject|1|||
146238091|NCT05886777|527384396|FG000|Overall Study|Protocol Violation|0|||
146238092|NCT05886777|527384397|FG001|Overall Study|Protocol Violation|0|||
146238093|NCT05886777|527384398|FG002|Overall Study|Protocol Violation|1|||
146238094|NCT05886777|527384399|FG003|Overall Study|Protocol Violation|0|||
146238095|NCT05886777|527384400|FG004|Overall Study|Protocol Violation|0|||
146238096|NCT05886777|527384401|FG005|Overall Study|Protocol Violation|0|||
146238097|NCT05886777|527384402|FG006|Overall Study|Protocol Violation|0|||
146238098|NCT05886777|527384396|FG000|Overall Study|No longer met eligibility criteria|0|||
146238099|NCT05886777|527384397|FG001|Overall Study|No longer met eligibility criteria|1|||
146238100|NCT05886777|527384398|FG002|Overall Study|No longer met eligibility criteria|0|||
146238101|NCT05886777|527384399|FG003|Overall Study|No longer met eligibility criteria|0|||
146238102|NCT05886777|527384400|FG004|Overall Study|No longer met eligibility criteria|0|||
146238103|NCT05886777|527384401|FG005|Overall Study|No longer met eligibility criteria|0|||
146238104|NCT05886777|527384402|FG006|Overall Study|No longer met eligibility criteria|0|||
146238105|NCT03773107|527384403|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
146238106|NCT03773107|527384404|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
146238107|NCT03773107|527384405|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
146238108|NCT03773107|527384406|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
146238109|NCT07204444|527384409|FG000|Overall Study|Medical/Hospitalization|6|||
145897080|NCT02799095|526132257|FG011|Part B|Progressive Disease|0|||
145897081|NCT02799095|526132258|FG012|Part B|Progressive Disease|0|||
145897082|NCT02799095|526132259|FG013|Part B|Progressive Disease|0|||
146296735|NCT02748018|527602579|FG000|Continuation Period|Withdrawal by Subject|3|||
146296736|NCT02748018|527602580|FG001|Continuation Period|Withdrawal by Subject|5|||
146296737|NCT02748018|527602581|FG002|Continuation Period|Withdrawal by Subject|3|||
146296738|NCT02748018|527602582|FG003|Continuation Period|Withdrawal by Subject|9|||
146296739|NCT02748018|527602583|FG004|Continuation Period|Withdrawal by Subject|11|||
146296740|NCT02748018|527602584|FG005|Continuation Period|Withdrawal by Subject|1|||
146296741|NCT02748018|527602579|FG000|Continuation Period|Lost to Follow-up|0|||
146296742|NCT02748018|527602580|FG001|Continuation Period|Lost to Follow-up|2|||
146296743|NCT02748018|527602581|FG002|Continuation Period|Lost to Follow-up|1|||
146296744|NCT02748018|527602582|FG003|Continuation Period|Lost to Follow-up|0|||
146296745|NCT02748018|527602583|FG004|Continuation Period|Lost to Follow-up|1|||
146296746|NCT02748018|527602584|FG005|Continuation Period|Lost to Follow-up|0|||
146296747|NCT02748018|527602579|FG000|Continuation Period|Pregnancy|1|||
146296748|NCT02748018|527602580|FG001|Continuation Period|Pregnancy|2|||
146296749|NCT02748018|527602581|FG002|Continuation Period|Pregnancy|0|||
146296750|NCT02748018|527602582|FG003|Continuation Period|Pregnancy|0|||
146296751|NCT02748018|527602583|FG004|Continuation Period|Pregnancy|0|||
146296752|NCT02748018|527602584|FG005|Continuation Period|Pregnancy|0|||
146296753|NCT02748018|527602579|FG000|Continuation Period|Physician Decision|0|||
146296754|NCT02748018|527602580|FG001|Continuation Period|Physician Decision|1|||
146296755|NCT02748018|527602581|FG002|Continuation Period|Physician Decision|2|||
146296756|NCT02748018|527602582|FG003|Continuation Period|Physician Decision|0|||
146296757|NCT02748018|527602583|FG004|Continuation Period|Physician Decision|2|||
146296758|NCT02748018|527602584|FG005|Continuation Period|Physician Decision|1|||
146296759|NCT02748018|527602579|FG000|Continuation Period|Protocol Violation|0|||
146296760|NCT02748018|527602580|FG001|Continuation Period|Protocol Violation|1|||
146296761|NCT02748018|527602581|FG002|Continuation Period|Protocol Violation|0|||
146296762|NCT02748018|527602582|FG003|Continuation Period|Protocol Violation|0|||
146296763|NCT02748018|527602583|FG004|Continuation Period|Protocol Violation|0|||
146296764|NCT02748018|527602584|FG005|Continuation Period|Protocol Violation|0|||
146296765|NCT05628285|527602585|FG000|Overall Study|Lost to Follow-up|1|||
146296766|NCT02856893|527602586|FG000|Overall Study|Lack of Efficacy|27|||
146296767|NCT02856893|527602587|FG001|Overall Study|Lack of Efficacy|15|||
146296768|NCT02856893|527602588|FG002|Overall Study|Lack of Efficacy|19|||
146296769|NCT02856893|527602586|FG000|Overall Study|Death|1|||
146296770|NCT02856893|527602587|FG001|Overall Study|Death|0|||
146296771|NCT02856893|527602588|FG002|Overall Study|Death|0|||
146296772|NCT02856893|527602586|FG000|Overall Study|Adverse Event|2|||
146296773|NCT02856893|527602587|FG001|Overall Study|Adverse Event|0|||
146296774|NCT02856893|527602588|FG002|Overall Study|Adverse Event|0|||
146296775|NCT02856893|527602586|FG000|Overall Study|Physician Decision|0|||
146296776|NCT02856893|527602587|FG001|Overall Study|Physician Decision|2|||
146296777|NCT02856893|527602588|FG002|Overall Study|Physician Decision|3|||
146296778|NCT02856893|527602586|FG000|Overall Study|Withdrawal by Subject|1|||
146296779|NCT02856893|527602587|FG001|Overall Study|Withdrawal by Subject|1|||
146296780|NCT02856893|527602588|FG002|Overall Study|Withdrawal by Subject|0|||
146296781|NCT02856893|527602586|FG000|Overall Study|Other reasons|2|||
146296782|NCT02856893|527602587|FG001|Overall Study|Other reasons|1|||
146296783|NCT02856893|527602588|FG002|Overall Study|Other reasons|2|||
146296784|NCT03801902|527602589|FG000|Overall Study|Did not receive protocol treatment.|1|||
146296785|NCT03801902|527602590|FG001|Overall Study|Did not receive protocol treatment.|0|||
146296786|NCT03801902|527602591|FG002|Overall Study|Did not receive protocol treatment.|0|||
146296787|NCT03801902|527602592|FG003|Overall Study|Did not receive protocol treatment.|0|||
146296788|NCT03118674|527602593|FG000|Overall Study|Lost to Follow-up|2|||
146296789|NCT03118674|527602593|FG000|Overall Study|Screen Faliure|8|||
146296790|NCT03118674|527602593|FG000|Overall Study|Withdrawal by Subject|5|||
146296791|NCT01324323|527602594|FG000|Overall Study|Withdrawal by Subject|1|||
145972379|NCT02332707|526412622|FG002|Overall Study|Withdrawal by Subject|1|||
145972380|NCT02332707|526412623|FG003|Overall Study|Withdrawal by Subject|0|||
145972381|NCT02332707|526412624|FG004|Overall Study|Withdrawal by Subject|0|||
146296792|NCT00908232|527602595|FG000|Cycle 1 to 4|Death|5|||
146296793|NCT00908232|527602596|FG001|Cycle 1 to 4|Death|0|||
146296794|NCT00908232|527602597|FG002|Cycle 1 to 4|Death|0|||
146296795|NCT00908232|527602598|FG003|Cycle 1 to 4|Death|0|||
146296796|NCT00908232|527602595|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
146296797|NCT00908232|527602596|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
146296798|NCT00908232|527602597|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
146296799|NCT00908232|527602598|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
146296800|NCT00908232|527602595|FG000|Cycle 1 to 4|Progressive Disease|6|||
146296801|NCT00908232|527602596|FG001|Cycle 1 to 4|Progressive Disease|0|||
146296802|NCT00908232|527602597|FG002|Cycle 1 to 4|Progressive Disease|0|||
146296803|NCT00908232|527602598|FG003|Cycle 1 to 4|Progressive Disease|0|||
146296804|NCT00908232|527602595|FG000|Cycle 1 to 4|Adverse Event|12|||
146296805|NCT00908232|527602596|FG001|Cycle 1 to 4|Adverse Event|0|||
146296806|NCT00908232|527602597|FG002|Cycle 1 to 4|Adverse Event|0|||
146296807|NCT00908232|527602598|FG003|Cycle 1 to 4|Adverse Event|0|||
146296808|NCT00908232|527602595|FG000|Cycle 1 to 4|Other|1|||
146296809|NCT00908232|527602596|FG001|Cycle 1 to 4|Other|0|||
145897083|NCT02799095|526132260|FG014|Part B|Progressive Disease|0|||
145897084|NCT02799095|526132261|FG015|Part B|Progressive Disease|0|||
145897085|NCT02799095|526132262|FG016|Part B|Progressive Disease|0|||
145897086|NCT02799095|526132246|FG000|Part B|Withdrawal by Subject|0|||
145897087|NCT02799095|526132247|FG001|Part B|Withdrawal by Subject|0|||
145897088|NCT02799095|526132248|FG002|Part B|Withdrawal by Subject|0|||
145897089|NCT02799095|526132249|FG003|Part B|Withdrawal by Subject|0|||
145897090|NCT02799095|526132250|FG004|Part B|Withdrawal by Subject|0|||
145897091|NCT02799095|526132251|FG005|Part B|Withdrawal by Subject|0|||
145897092|NCT02799095|526132252|FG006|Part B|Withdrawal by Subject|0|||
145897093|NCT02799095|526132253|FG007|Part B|Withdrawal by Subject|10|||
145897094|NCT02799095|526132254|FG008|Part B|Withdrawal by Subject|7|||
145897095|NCT02799095|526132255|FG009|Part B|Withdrawal by Subject|0|||
145897096|NCT02799095|526132256|FG010|Part B|Withdrawal by Subject|0|||
145897097|NCT02799095|526132257|FG011|Part B|Withdrawal by Subject|0|||
145897098|NCT02799095|526132258|FG012|Part B|Withdrawal by Subject|0|||
145897099|NCT02799095|526132259|FG013|Part B|Withdrawal by Subject|0|||
145897100|NCT02799095|526132260|FG014|Part B|Withdrawal by Subject|0|||
145897101|NCT02799095|526132261|FG015|Part B|Withdrawal by Subject|0|||
145897102|NCT02799095|526132262|FG016|Part B|Withdrawal by Subject|0|||
145897103|NCT02799095|526132246|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
145897104|NCT02799095|526132247|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
145897105|NCT02799095|526132248|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
145897106|NCT02799095|526132249|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
145897107|NCT02799095|526132250|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
145897108|NCT02799095|526132251|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
145897109|NCT02799095|526132252|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
145897110|NCT02799095|526132253|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
145897111|NCT02799095|526132254|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
145897112|NCT02799095|526132255|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
145897113|NCT02799095|526132256|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
145897114|NCT02799095|526132257|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
145897115|NCT02799095|526132258|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
145897116|NCT02799095|526132259|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
145972382|NCT02332707|526412625|FG005|Overall Study|Withdrawal by Subject|0|||
145972383|NCT02332707|526412626|FG006|Overall Study|Withdrawal by Subject|0|||
145972384|NCT02332707|526412627|FG007|Overall Study|Withdrawal by Subject|0|||
145972385|NCT02332707|526412628|FG008|Overall Study|Withdrawal by Subject|0|||
145972386|NCT02332707|526412629|FG009|Overall Study|Withdrawal by Subject|3|||
145972387|NCT02332707|526412630|FG010|Overall Study|Withdrawal by Subject|0|||
145972388|NCT02332707|526412631|FG011|Overall Study|Withdrawal by Subject|0|||
145972389|NCT02332707|526412632|FG012|Overall Study|Withdrawal by Subject|0|||
145972390|NCT02332707|526412633|FG013|Overall Study|Withdrawal by Subject|0|||
145972391|NCT02332707|526412634|FG014|Overall Study|Withdrawal by Subject|0|||
145972392|NCT02332707|526412635|FG015|Overall Study|Withdrawal by Subject|0|||
146238110|NCT07204444|527384410|FG001|Overall Study|Medical/Hospitalization|9|||
146238111|NCT07204444|527384411|FG002|Overall Study|Medical/Hospitalization|6|||
146238112|NCT07204444|527384409|FG000|Overall Study|Treatment Provider Issue|1|||
146238113|NCT07204444|527384410|FG001|Overall Study|Treatment Provider Issue|3|||
146238114|NCT07204444|527384411|FG002|Overall Study|Treatment Provider Issue|0|||
146238115|NCT07204444|527384409|FG000|Overall Study|Withdrawal by Subject|11|||
146238116|NCT07204444|527384410|FG001|Overall Study|Withdrawal by Subject|5|||
146238117|NCT07204444|527384411|FG002|Overall Study|Withdrawal by Subject|5|||
146238118|NCT07204444|527384409|FG000|Overall Study|Death|3|||
146238119|NCT07204444|527384410|FG001|Overall Study|Death|6|||
146238120|NCT07204444|527384411|FG002|Overall Study|Death|1|||
146238121|NCT07204444|527384409|FG000|Overall Study|Unable To Reach|29|||
146238122|NCT07204444|527384410|FG001|Overall Study|Unable To Reach|26|||
146238123|NCT07204444|527384411|FG002|Overall Study|Unable To Reach|17|||
146238124|NCT07204444|527384409|FG000|Overall Study|Protocol Deviation|3|||
146238125|NCT07204444|527384410|FG001|Overall Study|Protocol Deviation|2|||
146238126|NCT07204444|527384411|FG002|Overall Study|Protocol Deviation|0|||
146238127|NCT04083976|527385528|FG000|Overall Study|Lost to Follow-up|3|||
146238128|NCT04083976|527385529|FG001|Overall Study|Lost to Follow-up|0|||
146238129|NCT04083976|527385530|FG002|Overall Study|Lost to Follow-up|0|||
146238130|NCT04083976|527385531|FG003|Overall Study|Lost to Follow-up|1|||
146238131|NCT04083976|527385528|FG000|Overall Study|Withdrawal by Subject|16|||
146238132|NCT04083976|527385529|FG001|Overall Study|Withdrawal by Subject|1|||
146238133|NCT04083976|527385530|FG002|Overall Study|Withdrawal by Subject|9|||
146238134|NCT04083976|527385531|FG003|Overall Study|Withdrawal by Subject|0|||
145897117|NCT02799095|526132260|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
145897118|NCT02799095|526132261|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
146238135|NCT04083976|527385528|FG000|Overall Study|Sponsor Decision|14|||
145897119|NCT02799095|526132262|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
145897120|NCT02799095|526132246|FG000|Part C|Adverse Event|0|||
145897121|NCT02799095|526132247|FG001|Part C|Adverse Event|0|||
146296810|NCT00908232|527602597|FG002|Cycle 1 to 4|Other|0|||
146238136|NCT04083976|527385529|FG001|Overall Study|Sponsor Decision|0|||
146296811|NCT00908232|527602598|FG003|Cycle 1 to 4|Other|0|||
146238137|NCT04083976|527385530|FG002|Overall Study|Sponsor Decision|0|||
146238138|NCT04083976|527385531|FG003|Overall Study|Sponsor Decision|7|||
146238139|NCT04083976|527385528|FG000|Overall Study|Other|1|||
146238140|NCT04083976|527385529|FG001|Overall Study|Other|0|||
146238141|NCT04083976|527385530|FG002|Overall Study|Other|1|||
146238142|NCT04083976|527385531|FG003|Overall Study|Other|0|||
146238143|NCT00512252|527385537|FG000|Overall Study|Lost to Follow-up|0|||
146238144|NCT00512252|527385538|FG001|Overall Study|Lost to Follow-up|0|||
145897122|NCT02799095|526132248|FG002|Part C|Adverse Event|0|||
145897123|NCT02799095|526132249|FG003|Part C|Adverse Event|0|||
145897124|NCT02799095|526132250|FG004|Part C|Adverse Event|0|||
145897125|NCT02799095|526132251|FG005|Part C|Adverse Event|0|||
145897126|NCT02799095|526132252|FG006|Part C|Adverse Event|0|||
146238145|NCT00512252|527385539|FG002|Overall Study|Lost to Follow-up|1|||
146238146|NCT00512252|527385537|FG000|Overall Study|Protocol Violation|0|||
146238147|NCT00512252|527385538|FG001|Overall Study|Protocol Violation|0|||
146238148|NCT00512252|527385539|FG002|Overall Study|Protocol Violation|1|||
146238149|NCT00512252|527385537|FG000|Overall Study|Death|0|||
146238150|NCT00512252|527385538|FG001|Overall Study|Death|0|||
146238151|NCT00512252|527385539|FG002|Overall Study|Death|1|||
146238152|NCT00705406|527385540|FG000|Overall Study|Lost to Follow-up|3|||
146238153|NCT00705406|527385541|FG001|Overall Study|Lost to Follow-up|3|||
146238154|NCT00705406|527385540|FG000|Overall Study|Did not receive study drug|1|||
146238155|NCT00705406|527385541|FG001|Overall Study|Did not receive study drug|2|||
146238156|NCT02357966|527385542|FG000|Overall Study|Death|0|||
146238157|NCT02357966|527385543|FG001|Overall Study|Death|0|||
146238158|NCT02357966|527385544|FG002|Overall Study|Death|1|||
146238159|NCT02357966|527385545|FG003|Overall Study|Death|0|||
146238160|NCT02357966|527385546|FG004|Overall Study|Death|2|||
146238161|NCT02357966|527385547|FG005|Overall Study|Death|0|||
146238162|NCT02357966|527385542|FG000|Overall Study|Physician Decision|1|||
146238163|NCT02357966|527385543|FG001|Overall Study|Physician Decision|0|||
146238164|NCT02357966|527385544|FG002|Overall Study|Physician Decision|0|||
146238165|NCT02357966|527385545|FG003|Overall Study|Physician Decision|0|||
146238166|NCT02357966|527385546|FG004|Overall Study|Physician Decision|1|||
146238167|NCT02357966|527385547|FG005|Overall Study|Physician Decision|0|||
146238168|NCT01779700|527385548|FG000|Overall Study|Adverse Event|4|||
146238169|NCT01779700|527385549|FG001|Overall Study|Adverse Event|3|||
146238170|NCT01779700|527385548|FG000|Overall Study|Withdrawal by Subject|0|||
146238171|NCT01779700|527385549|FG001|Overall Study|Withdrawal by Subject|2|||
146238172|NCT00442104|527385552|FG000|Overall Study|Adverse Event|5|||
146238173|NCT00442104|527385552|FG000|Overall Study|Death|2|||
146238174|NCT00442104|527385552|FG000|Overall Study|Lost to Follow-up|3|||
146238175|NCT00442104|527385552|FG000|Overall Study|Withdrawal by Subject|5|||
146238176|NCT00442104|527385552|FG000|Overall Study|Insufficient Clinical Response|10|||
146238177|NCT00442104|527385552|FG000|Overall Study|Other|21|||
146238178|NCT00442104|527385552|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
146238179|NCT04608409|527385553|FG000|Overall Study|Physician Decision|1|||
146238180|NCT04608409|527385554|FG001|Overall Study|Physician Decision|1|||
146238181|NCT04608409|527385555|FG002|Overall Study|Physician Decision|2|||
146238182|NCT04497415|527385556|FG000|Overall Study|Lost to Follow-up|43|||
146238183|NCT04497415|527385557|FG001|Overall Study|Lost to Follow-up|27|||
146238184|NCT00683800|527385559|FG000|Overall Study|Adverse Event|195|||
146238185|NCT00683800|527385560|FG001|Overall Study|Adverse Event|102|||
146238186|NCT00683800|527385559|FG000|Overall Study|Death|0|||
146238187|NCT00683800|527385560|FG001|Overall Study|Death|1|||
146238188|NCT00683800|527385559|FG000|Overall Study|Lost to Follow-up|57|||
146238189|NCT00683800|527385560|FG001|Overall Study|Lost to Follow-up|44|||
146238190|NCT00683800|527385559|FG000|Overall Study|Other|5|||
146238191|NCT00683800|527385560|FG001|Overall Study|Other|2|||
146238192|NCT00683800|527385559|FG000|Overall Study|Protocol Violation|13|||
146238193|NCT00683800|527385560|FG001|Overall Study|Protocol Violation|16|||
146238194|NCT00683800|527385559|FG000|Overall Study|Withdrawal by Subject|66|||
146238195|NCT00683800|527385560|FG001|Overall Study|Withdrawal by Subject|64|||
146238196|NCT00683800|527385559|FG000|Overall Study|Lack of Efficacy|61|||
146238197|NCT00683800|527385560|FG001|Overall Study|Lack of Efficacy|104|||
146238198|NCT00683800|527385559|FG000|Overall Study|Randomized, not treated|35|||
146238199|NCT00683800|527385560|FG001|Overall Study|Randomized, not treated|33|||
146238200|NCT03041233|527385563|FG000|Overall Study|Death|5|||
146238201|NCT03041233|527385563|FG000|Overall Study|Physician Decision|1|||
145897127|NCT02799095|526132253|FG007|Part C|Adverse Event|0|||
145897128|NCT02799095|526132254|FG008|Part C|Adverse Event|0|||
145897129|NCT02799095|526132255|FG009|Part C|Adverse Event|0|||
145897130|NCT02799095|526132256|FG010|Part C|Adverse Event|3|||
145897131|NCT02799095|526132257|FG011|Part C|Adverse Event|1|||
145897132|NCT02799095|526132258|FG012|Part C|Adverse Event|0|||
145897133|NCT02799095|526132259|FG013|Part C|Adverse Event|1|||
145897134|NCT02799095|526132260|FG014|Part C|Adverse Event|0|||
145897135|NCT02799095|526132261|FG015|Part C|Adverse Event|0|||
145897136|NCT02799095|526132262|FG016|Part C|Adverse Event|0|||
145897137|NCT02799095|526132246|FG000|Part C|Death|0|||
145897138|NCT02799095|526132247|FG001|Part C|Death|0|||
146238202|NCT03041233|527385563|FG000|Overall Study|Lost to Follow-up|16|||
145897139|NCT02799095|526132248|FG002|Part C|Death|0|||
145897140|NCT02799095|526132249|FG003|Part C|Death|0|||
145897141|NCT02799095|526132250|FG004|Part C|Death|0|||
145897142|NCT02799095|526132251|FG005|Part C|Death|0|||
145897143|NCT02799095|526132252|FG006|Part C|Death|0|||
145897144|NCT02799095|526132253|FG007|Part C|Death|0|||
145897145|NCT02799095|526132254|FG008|Part C|Death|0|||
145897146|NCT02799095|526132255|FG009|Part C|Death|0|||
145897147|NCT02799095|526132256|FG010|Part C|Death|7|||
145897148|NCT02799095|526132257|FG011|Part C|Death|5|||
145897149|NCT02799095|526132258|FG012|Part C|Death|6|||
145897150|NCT02799095|526132259|FG013|Part C|Death|8|||
145897151|NCT02799095|526132260|FG014|Part C|Death|1|||
145897152|NCT02799095|526132261|FG015|Part C|Death|8|||
145897153|NCT02799095|526132262|FG016|Part C|Death|1|||
145897154|NCT02799095|526132246|FG000|Part C|Lost to Follow-up|0|||
145897155|NCT02799095|526132247|FG001|Part C|Lost to Follow-up|0|||
145897156|NCT02799095|526132248|FG002|Part C|Lost to Follow-up|0|||
145897157|NCT02799095|526132249|FG003|Part C|Lost to Follow-up|0|||
145897158|NCT02799095|526132250|FG004|Part C|Lost to Follow-up|0|||
145897159|NCT02799095|526132251|FG005|Part C|Lost to Follow-up|0|||
145897160|NCT02799095|526132252|FG006|Part C|Lost to Follow-up|0|||
145897161|NCT02799095|526132253|FG007|Part C|Lost to Follow-up|0|||
145897162|NCT02799095|526132254|FG008|Part C|Lost to Follow-up|0|||
145897163|NCT02799095|526132255|FG009|Part C|Lost to Follow-up|0|||
145897164|NCT02799095|526132256|FG010|Part C|Lost to Follow-up|1|||
145897165|NCT02799095|526132257|FG011|Part C|Lost to Follow-up|1|||
145897166|NCT02799095|526132258|FG012|Part C|Lost to Follow-up|1|||
145897167|NCT02799095|526132259|FG013|Part C|Lost to Follow-up|3|||
145897168|NCT02799095|526132260|FG014|Part C|Lost to Follow-up|0|||
145897169|NCT02799095|526132261|FG015|Part C|Lost to Follow-up|0|||
145897170|NCT02799095|526132262|FG016|Part C|Lost to Follow-up|0|||
145897171|NCT02799095|526132246|FG000|Part C|Progressive Disease|0|||
145897172|NCT02799095|526132247|FG001|Part C|Progressive Disease|0|||
145897173|NCT02799095|526132248|FG002|Part C|Progressive Disease|0|||
145897174|NCT02799095|526132249|FG003|Part C|Progressive Disease|0|||
145897175|NCT02799095|526132250|FG004|Part C|Progressive Disease|0|||
145897176|NCT02799095|526132251|FG005|Part C|Progressive Disease|0|||
145897177|NCT02799095|526132252|FG006|Part C|Progressive Disease|0|||
145897178|NCT02799095|526132253|FG007|Part C|Progressive Disease|0|||
145897179|NCT02799095|526132254|FG008|Part C|Progressive Disease|0|||
145897180|NCT02799095|526132255|FG009|Part C|Progressive Disease|2|||
145897181|NCT02799095|526132256|FG010|Part C|Progressive Disease|13|||
145897182|NCT02799095|526132257|FG011|Part C|Progressive Disease|2|||
145897183|NCT02799095|526132258|FG012|Part C|Progressive Disease|0|||
145897184|NCT02799095|526132259|FG013|Part C|Progressive Disease|1|||
145897185|NCT02799095|526132260|FG014|Part C|Progressive Disease|0|||
145897186|NCT02799095|526132261|FG015|Part C|Progressive Disease|0|||
145897187|NCT02799095|526132262|FG016|Part C|Progressive Disease|0|||
145897188|NCT02799095|526132246|FG000|Part C|Clinical Progression|0|||
145897189|NCT02799095|526132247|FG001|Part C|Clinical Progression|0|||
145897190|NCT02799095|526132248|FG002|Part C|Clinical Progression|0|||
145897191|NCT02799095|526132249|FG003|Part C|Clinical Progression|0|||
145897192|NCT02799095|526132250|FG004|Part C|Clinical Progression|0|||
145897193|NCT02799095|526132251|FG005|Part C|Clinical Progression|0|||
145897194|NCT02799095|526132252|FG006|Part C|Clinical Progression|0|||
145897195|NCT02799095|526132253|FG007|Part C|Clinical Progression|0|||
145897196|NCT02799095|526132254|FG008|Part C|Clinical Progression|0|||
145897197|NCT02799095|526132255|FG009|Part C|Clinical Progression|1|||
145897198|NCT02799095|526132256|FG010|Part C|Clinical Progression|3|||
145897199|NCT02799095|526132257|FG011|Part C|Clinical Progression|0|||
145897200|NCT02799095|526132258|FG012|Part C|Clinical Progression|0|||
145897201|NCT02799095|526132259|FG013|Part C|Clinical Progression|1|||
145897202|NCT02799095|526132260|FG014|Part C|Clinical Progression|0|||
145897203|NCT02799095|526132261|FG015|Part C|Clinical Progression|0|||
145897204|NCT02799095|526132262|FG016|Part C|Clinical Progression|0|||
145897205|NCT02799095|526132246|FG000|Part C|Withdrawal by Subject|0|||
145897206|NCT02799095|526132247|FG001|Part C|Withdrawal by Subject|0|||
145897207|NCT02799095|526132248|FG002|Part C|Withdrawal by Subject|0|||
145897208|NCT02799095|526132249|FG003|Part C|Withdrawal by Subject|0|||
145897209|NCT02799095|526132250|FG004|Part C|Withdrawal by Subject|0|||
145897210|NCT02799095|526132251|FG005|Part C|Withdrawal by Subject|0|||
145897211|NCT02799095|526132252|FG006|Part C|Withdrawal by Subject|0|||
145897212|NCT02799095|526132253|FG007|Part C|Withdrawal by Subject|0|||
145897213|NCT02799095|526132254|FG008|Part C|Withdrawal by Subject|0|||
145897214|NCT02799095|526132255|FG009|Part C|Withdrawal by Subject|0|||
145897215|NCT02799095|526132256|FG010|Part C|Withdrawal by Subject|13|||
145897216|NCT02799095|526132257|FG011|Part C|Withdrawal by Subject|15|||
145897217|NCT02799095|526132258|FG012|Part C|Withdrawal by Subject|13|||
145897218|NCT02799095|526132259|FG013|Part C|Withdrawal by Subject|21|||
145897219|NCT02799095|526132260|FG014|Part C|Withdrawal by Subject|0|||
145897220|NCT02799095|526132261|FG015|Part C|Withdrawal by Subject|12|||
145897221|NCT02799095|526132262|FG016|Part C|Withdrawal by Subject|1|||
145897222|NCT02799095|526132246|FG000|Part C|Physician Decision|0|||
145897223|NCT02799095|526132247|FG001|Part C|Physician Decision|0|||
146238203|NCT03041233|527385563|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
146238204|NCT03041233|527385563|FG000|Overall Study|Sponsor Request|1|||
146238205|NCT03041233|527385563|FG000|Overall Study|Duplicate subject|1|||
146238206|NCT03041233|527385563|FG000|Overall Study|Re-ablation|1|||
146238207|NCT01588951|527385576|FG000|Overall Study|Ineligible in retrospect|0|||
145897224|NCT02799095|526132248|FG002|Part C|Physician Decision|0|||
145897225|NCT02799095|526132249|FG003|Part C|Physician Decision|0|||
145897226|NCT02799095|526132250|FG004|Part C|Physician Decision|0|||
145897227|NCT02799095|526132251|FG005|Part C|Physician Decision|0|||
145897228|NCT02799095|526132252|FG006|Part C|Physician Decision|0|||
145897229|NCT02799095|526132253|FG007|Part C|Physician Decision|0|||
145897230|NCT02799095|526132254|FG008|Part C|Physician Decision|0|||
145897231|NCT02799095|526132255|FG009|Part C|Physician Decision|0|||
145897232|NCT02799095|526132256|FG010|Part C|Physician Decision|1|||
145897233|NCT02799095|526132257|FG011|Part C|Physician Decision|0|||
145897234|NCT02799095|526132258|FG012|Part C|Physician Decision|0|||
145897235|NCT02799095|526132259|FG013|Part C|Physician Decision|0|||
145897236|NCT02799095|526132260|FG014|Part C|Physician Decision|0|||
145897237|NCT02799095|526132261|FG015|Part C|Physician Decision|0|||
145897238|NCT02799095|526132262|FG016|Part C|Physician Decision|0|||
145897239|NCT02799095|526132246|FG000|Part C|Other|0|||
145897240|NCT02799095|526132247|FG001|Part C|Other|0|||
146296812|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
146296813|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146238208|NCT01588951|527385577|FG001|Overall Study|Ineligible in retrospect|0|||
146238209|NCT01588951|527385578|FG002|Overall Study|Ineligible in retrospect|1|||
146238210|NCT01593020|527385579|FG000|Overall Study|Adverse Event|1|||
146238211|NCT01593020|527385580|FG001|Overall Study|Adverse Event|1|||
146238212|NCT01593020|527385579|FG000|Overall Study|Death|0|||
146238213|NCT01593020|527385580|FG001|Overall Study|Death|1|||
146238214|NCT01593020|527385579|FG000|Overall Study|Ineligible|1|||
146238215|NCT01593020|527385580|FG001|Overall Study|Ineligible|0|||
146296814|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146296815|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
146296816|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
146296817|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146296818|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146296819|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
146296820|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
146296821|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
146296822|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
146296823|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
146296824|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
146296825|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
146296826|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
146296827|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
146296828|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
146296829|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
146296830|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
146296831|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
146296832|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
146296833|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146296834|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146296835|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
146296836|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
146296837|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
146296838|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
146296839|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
145897241|NCT02799095|526132248|FG002|Part C|Other|0|||
145897242|NCT02799095|526132249|FG003|Part C|Other|0|||
145897243|NCT02799095|526132250|FG004|Part C|Other|0|||
145897244|NCT02799095|526132251|FG005|Part C|Other|0|||
145897245|NCT02799095|526132252|FG006|Part C|Other|0|||
145897246|NCT02799095|526132253|FG007|Part C|Other|0|||
145897247|NCT02799095|526132254|FG008|Part C|Other|0|||
145897248|NCT02799095|526132255|FG009|Part C|Other|0|||
145897249|NCT02799095|526132256|FG010|Part C|Other|0|||
145897250|NCT02799095|526132257|FG011|Part C|Other|2|||
145897251|NCT02799095|526132258|FG012|Part C|Other|2|||
145972393|NCT02332707|526412636|FG016|Overall Study|Withdrawal by Subject|0|||
146296840|NCT00908232|527602595|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
145897252|NCT02799095|526132259|FG013|Part C|Other|0|||
145897253|NCT02799095|526132260|FG014|Part C|Other|0|||
145897254|NCT02799095|526132261|FG015|Part C|Other|0|||
145897255|NCT02799095|526132262|FG016|Part C|Other|0|||
145897256|NCT01933113|526132263|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
145897257|NCT02297438|526132264|FG000|Overall Study|Death|79|||
145897258|NCT02297438|526132265|FG001|Overall Study|Death|86|||
146238216|NCT02350634|527385581|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
146238217|NCT02063659|527385595|FG000|Double-Blind Treatment Period|Adverse Event|1|||
146238218|NCT02063659|527385596|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146238219|NCT02063659|527385597|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146238220|NCT02063659|527385598|FG003|Double-Blind Treatment Period|Adverse Event|0|||
145897259|NCT02297438|526132264|FG000|Overall Study|Lost to Follow-up|9|||
145897260|NCT02297438|526132265|FG001|Overall Study|Lost to Follow-up|7|||
145897261|NCT02297438|526132264|FG000|Overall Study|Withdrawal by Subject|7|||
145897262|NCT02297438|526132265|FG001|Overall Study|Withdrawal by Subject|0|||
145897263|NCT02297438|526132264|FG000|Overall Study|Other|9|||
145897264|NCT02297438|526132265|FG001|Overall Study|Other|5|||
145897265|NCT02297438|526132264|FG000|Overall Study|Ongoing|65|||
145897266|NCT02297438|526132265|FG001|Overall Study|Ongoing|73|||
145897267|NCT04092894|526132268|FG000|Overall Study|Withdrawal by Subject|2|||
145897268|NCT04092894|526132269|FG001|Overall Study|Withdrawal by Subject|4|||
145897269|NCT04092894|526132268|FG000|Overall Study|Discontinued EEG after randomization|10|||
145897270|NCT04092894|526132269|FG001|Overall Study|Discontinued EEG after randomization|6|||
145897271|NCT01951885|526132270|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
145897272|NCT01951885|526132271|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
145897273|NCT01951885|526132270|FG000|Overall Study|Adverse Event|1|||
145897274|NCT01951885|526132271|FG001|Overall Study|Adverse Event|0|||
145897275|NCT01951885|526132270|FG000|Overall Study|Withdrawal by Subject|0|||
145897276|NCT01951885|526132271|FG001|Overall Study|Withdrawal by Subject|1|||
145897277|NCT01951885|526132270|FG000|Overall Study|ineligible due to a change in donor|0|||
145897278|NCT01951885|526132271|FG001|Overall Study|ineligible due to a change in donor|1|||
145897279|NCT01951885|526132270|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
145897280|NCT01951885|526132271|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
145897281|NCT00368979|526132275|FG000|Overall Study|Adverse Event|9|||
145897282|NCT00368979|526132276|FG001|Overall Study|Adverse Event|16|||
145897283|NCT00368979|526132275|FG000|Overall Study|Lack of Efficacy|5|||
145897284|NCT00368979|526132276|FG001|Overall Study|Lack of Efficacy|3|||
145897285|NCT00368979|526132275|FG000|Overall Study|Other|3|||
145897286|NCT00368979|526132276|FG001|Overall Study|Other|1|||
145897287|NCT00368979|526132275|FG000|Overall Study|Lost to Follow-up|1|||
145897288|NCT00368979|526132276|FG001|Overall Study|Lost to Follow-up|0|||
145897289|NCT00368979|526132275|FG000|Overall Study|Protocol Violation|2|||
145897290|NCT00368979|526132276|FG001|Overall Study|Protocol Violation|1|||
145897291|NCT00368979|526132275|FG000|Overall Study|Withdrawal by Subject|5|||
145897292|NCT00368979|526132276|FG001|Overall Study|Withdrawal by Subject|9|||
145897293|NCT02238626|526132277|FG000|Overall Study|Adverse Event|3|||
145897294|NCT02238626|526132278|FG001|Overall Study|Adverse Event|5|||
145897295|NCT02238626|526132279|FG002|Overall Study|Adverse Event|0|||
145897296|NCT02238626|526132280|FG003|Overall Study|Adverse Event|3|||
145897297|NCT02238626|526132277|FG000|Overall Study|Lost to Follow-up|2|||
145897298|NCT02238626|526132278|FG001|Overall Study|Lost to Follow-up|4|||
145897299|NCT02238626|526132279|FG002|Overall Study|Lost to Follow-up|2|||
145897300|NCT02238626|526132280|FG003|Overall Study|Lost to Follow-up|2|||
145897301|NCT02238626|526132277|FG000|Overall Study|Withdrawal by Subject|0|||
145897302|NCT02238626|526132278|FG001|Overall Study|Withdrawal by Subject|3|||
146238221|NCT02063659|527385595|FG000|Double-Blind Treatment Period|Physician Decision|1|||
146238222|NCT02063659|527385596|FG001|Double-Blind Treatment Period|Physician Decision|0|||
146238223|NCT02063659|527385597|FG002|Double-Blind Treatment Period|Physician Decision|0|||
146238224|NCT02063659|527385598|FG003|Double-Blind Treatment Period|Physician Decision|0|||
146238225|NCT02063659|527385595|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
145897303|NCT02238626|526132279|FG002|Overall Study|Withdrawal by Subject|0|||
145897304|NCT02238626|526132280|FG003|Overall Study|Withdrawal by Subject|1|||
145897305|NCT02238626|526132277|FG000|Overall Study|Death|0|||
146238226|NCT02063659|527385596|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
146238227|NCT02063659|527385597|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
146238228|NCT02063659|527385598|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
146238229|NCT02063659|527385595|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
146238230|NCT02063659|527385596|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
146238231|NCT02063659|527385597|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
146238232|NCT02063659|527385598|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
146238233|NCT02063659|527385595|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145897306|NCT02238626|526132278|FG001|Overall Study|Death|0|||
145897307|NCT02238626|526132279|FG002|Overall Study|Death|1|||
145897308|NCT02238626|526132280|FG003|Overall Study|Death|1|||
145897309|NCT02238626|526132277|FG000|Overall Study|Other|0|||
145897310|NCT02238626|526132278|FG001|Overall Study|Other|2|||
145897311|NCT02238626|526132279|FG002|Overall Study|Other|0|||
145897312|NCT02238626|526132280|FG003|Overall Study|Other|0|||
145897313|NCT00369655|526132281|FG000|Overall Study|Refusal of further treatment|2|||
145897314|NCT01683838|526132282|FG000|Overall Study|Adverse Event|12|||
145897315|NCT01683838|526132283|FG001|Overall Study|Adverse Event|2|||
145897316|NCT01683838|526132282|FG000|Overall Study|Protocol Violation|3|||
145897317|NCT01683838|526132283|FG001|Overall Study|Protocol Violation|1|||
145897318|NCT01683838|526132282|FG000|Overall Study|Withdrawal by Subject|6|||
145897319|NCT01683838|526132283|FG001|Overall Study|Withdrawal by Subject|5|||
145897320|NCT01683838|526132282|FG000|Overall Study|Lost to Follow-up|1|||
145897321|NCT01683838|526132283|FG001|Overall Study|Lost to Follow-up|1|||
145897322|NCT01683838|526132282|FG000|Overall Study|Other|4|||
145897323|NCT01683838|526132283|FG001|Overall Study|Other|3|||
145897324|NCT01646138|526132284|FG000|Overall Study|Lost to Follow-up|0|||
145897325|NCT01646138|526132285|FG001|Overall Study|Lost to Follow-up|0|||
145897326|NCT01646138|526132286|FG002|Overall Study|Lost to Follow-up|0|||
145897327|NCT01646138|526132287|FG003|Overall Study|Lost to Follow-up|0|||
145897328|NCT01646138|526132288|FG004|Overall Study|Lost to Follow-up|2|||
145897329|NCT03393806|526132290|FG000|Overall Study|Physician Decision|1|||
145897330|NCT03393806|526132291|FG001|Overall Study|Physician Decision|0|||
145897331|NCT01971970|526132292|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
145897332|NCT01971970|526132293|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
145897333|NCT01971970|526132292|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
145897334|NCT01971970|526132293|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
145897335|NCT01971970|526132292|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
145897336|NCT01971970|526132293|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
145897337|NCT01971970|526132292|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
145897338|NCT01971970|526132293|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
145897339|NCT01971970|526132292|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
145897340|NCT01971970|526132293|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
146238234|NCT02063659|527385596|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146238235|NCT02063659|527385597|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
146238236|NCT02063659|527385598|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
146238237|NCT02063659|527385595|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146238238|NCT02063659|527385596|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146238239|NCT02063659|527385597|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
146238240|NCT02063659|527385598|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
146238241|NCT02063659|527385595|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
146238242|NCT02063659|527385596|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
146238243|NCT02063659|527385597|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
146238244|NCT02063659|527385598|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
146238245|NCT02063659|527385595|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146238246|NCT02063659|527385596|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146238247|NCT02063659|527385597|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
146238248|NCT02063659|527385598|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
146238249|NCT02972359|527385599|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
146238250|NCT02972359|527385599|FG000|Overall Study|Lack of Efficacy|1|||
146238251|NCT02972359|527385599|FG000|Overall Study|Adverse Event|4|||
146238252|NCT02972359|527385599|FG000|Overall Study|Death|1|||
146238253|NCT02972359|527385599|FG000|Overall Study|Withdrawal by Subject|30|||
146238254|NCT02972359|527385599|FG000|Overall Study|Protocol Violation|1|||
146238255|NCT02972359|527385599|FG000|Overall Study|Lost to Follow-up|26|||
146238256|NCT02972359|527385599|FG000|Overall Study|Other reasons|5|||
146238257|NCT02972359|527385599|FG000|Overall Study|Missing|1|||
146238258|NCT00914966|527385600|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
146238259|NCT00914966|527385600|FG000|Step 1: 1500 Units|Physician Decision|1|||
146238260|NCT00914966|527385600|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
146238261|NCT03488719|527385601|FG000|Overall Study|Adverse Event|0|||
146238262|NCT03488719|527385602|FG001|Overall Study|Adverse Event|4|||
146238263|NCT03488719|527385603|FG002|Overall Study|Adverse Event|2|||
146238264|NCT03488719|527385601|FG000|Overall Study|Other|0|||
146238265|NCT03488719|527385602|FG001|Overall Study|Other|0|||
146238266|NCT03488719|527385603|FG002|Overall Study|Other|5|||
146238267|NCT03477175|527385604|FG000|Overall Study|Unable to travel due to COVID-19|0|||
146238268|NCT03477175|527385605|FG001|Overall Study|Unable to travel due to COVID-19|1|||
146238269|NCT03477175|527385604|FG000|Overall Study|Physician Decision|1|||
146238270|NCT03477175|527385605|FG001|Overall Study|Physician Decision|0|||
146238271|NCT03477175|527385604|FG000|Overall Study|Transitioned to commercial drug|6|||
146238272|NCT03477175|527385605|FG001|Overall Study|Transitioned to commercial drug|6|||
146238273|NCT03477175|527385604|FG000|Overall Study|Lost to Follow-up|1|||
146238274|NCT03477175|527385605|FG001|Overall Study|Lost to Follow-up|1|||
146238275|NCT03477175|527385604|FG000|Overall Study|Withdrawal by Subject|3|||
146238276|NCT03477175|527385605|FG001|Overall Study|Withdrawal by Subject|1|||
146238277|NCT03477175|527385604|FG000|Overall Study|Adverse Event|1|||
146238278|NCT03477175|527385605|FG001|Overall Study|Adverse Event|5|||
146238279|NCT03477175|527385604|FG000|Overall Study|Disease Progression|7|||
146238280|NCT03477175|527385605|FG001|Overall Study|Disease Progression|7|||
145943242|NCT02326298|526300464|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943243|NCT02326298|526300465|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146238281|NCT03371017|527385606|FG000|Overall Study|Physician Decision|0|||
146238282|NCT03371017|527385607|FG001|Overall Study|Physician Decision|1|||
145897341|NCT01971970|526132292|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
145897342|NCT01971970|526132293|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
145897343|NCT01971970|526132292|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
145897344|NCT01971970|526132293|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
145897345|NCT05297578|526132307|FG000|Overall Study|Lost to Follow-up|1|||
145897346|NCT05297578|526132308|FG001|Overall Study|Lost to Follow-up|1|||
145897347|NCT05297578|526132309|FG002|Overall Study|Lost to Follow-up|2|||
145897348|NCT05297578|526132310|FG003|Overall Study|Lost to Follow-up|1|||
145897349|NCT05297578|526132307|FG000|Overall Study|Death|0|||
145897350|NCT05297578|526132308|FG001|Overall Study|Death|1|||
145897351|NCT05297578|526132309|FG002|Overall Study|Death|0|||
145897352|NCT05297578|526132310|FG003|Overall Study|Death|0|||
145897353|NCT05297578|526132307|FG000|Overall Study|Withdrawal by Subject|0|||
145897354|NCT05297578|526132308|FG001|Overall Study|Withdrawal by Subject|0|||
145897355|NCT05297578|526132309|FG002|Overall Study|Withdrawal by Subject|1|||
145897356|NCT05297578|526132310|FG003|Overall Study|Withdrawal by Subject|0|||
145897357|NCT00117325|526132311|FG000|Overall Study|Adverse Event|3|||
145897358|NCT00117325|526132312|FG001|Overall Study|Adverse Event|3|||
145897359|NCT00117325|526132311|FG000|Overall Study|Lost to Follow-up|1|||
145897360|NCT00117325|526132312|FG001|Overall Study|Lost to Follow-up|1|||
145897361|NCT00117325|526132311|FG000|Overall Study|Protocol Violation|2|||
145897362|NCT00117325|526132312|FG001|Overall Study|Protocol Violation|3|||
145897363|NCT00117325|526132311|FG000|Overall Study|Withdrawal by Subject|3|||
145897364|NCT00117325|526132312|FG001|Overall Study|Withdrawal by Subject|2|||
145897365|NCT00117325|526132311|FG000|Overall Study|Lack of Efficacy|1|||
145897366|NCT00117325|526132312|FG001|Overall Study|Lack of Efficacy|0|||
146238283|NCT03371017|527385606|FG000|Overall Study|Reason not Specified|0|||
145897367|NCT00117325|526132311|FG000|Overall Study|Use of prohibited medicine|1|||
145897368|NCT00117325|526132312|FG001|Overall Study|Use of prohibited medicine|2|||
145897369|NCT00117325|526132311|FG000|Overall Study|Early termination|1|||
145897370|NCT00117325|526132312|FG001|Overall Study|Early termination|1|||
145897371|NCT00117325|526132311|FG000|Overall Study|Admisnitrative|1|||
145897372|NCT00117325|526132312|FG001|Overall Study|Admisnitrative|0|||
145897373|NCT01974440|526132315|FG000|Overall Study|Lost to Follow-up|7|||
145897374|NCT01974440|526132316|FG001|Overall Study|Lost to Follow-up|7|||
145897375|NCT01974440|526132315|FG000|Overall Study|Withdrawal by Subject|24|||
145897376|NCT01974440|526132316|FG001|Overall Study|Withdrawal by Subject|20|||
145897377|NCT01974440|526132315|FG000|Overall Study|Sponsor decision|109|||
145897378|NCT01974440|526132316|FG001|Overall Study|Sponsor decision|110|||
145897379|NCT00762437|526132317|FG000|Overall Study|Lost to Follow-up|7|||
145897380|NCT00762437|526132317|FG000|Overall Study|Missed final study visit|11|||
145897381|NCT00762437|526132317|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
145897382|NCT03979820|526132318|FG000|Overall Study|Protocol Violation|1|||
145897383|NCT03979820|526132319|FG001|Overall Study|Protocol Violation|0|||
145897384|NCT03979820|526132320|FG002|Overall Study|Protocol Violation|0|||
146238284|NCT03371017|527385607|FG001|Overall Study|Reason not Specified|1|||
146238285|NCT03371017|527385606|FG000|Overall Study|Lost to Follow-up|13|||
146238286|NCT03371017|527385607|FG001|Overall Study|Lost to Follow-up|16|||
146238287|NCT03371017|527385606|FG000|Overall Study|Death|228|||
146238288|NCT03371017|527385607|FG001|Overall Study|Death|215|||
146238289|NCT03371017|527385606|FG000|Overall Study|Withdrawal by Subject|20|||
146238290|NCT03371017|527385607|FG001|Overall Study|Withdrawal by Subject|25|||
146238291|NCT03371017|527385606|FG000|Overall Study|Study Ended by Sponsor|37|||
146238292|NCT03371017|527385607|FG001|Overall Study|Study Ended by Sponsor|38|||
146238293|NCT03371017|527385606|FG000|Overall Study|Protocol Deviation|0|||
146238294|NCT03371017|527385607|FG001|Overall Study|Protocol Deviation|1|||
146238295|NCT01855750|527385608|FG000|Overall Study|Death|78|||
146238296|NCT01855750|527385609|FG001|Overall Study|Death|78|||
146238297|NCT01855750|527385608|FG000|Overall Study|Lost to Follow-up|9|||
146238298|NCT01855750|527385609|FG001|Overall Study|Lost to Follow-up|23|||
146238299|NCT01855750|527385608|FG000|Overall Study|Withdrawal by Subject|35|||
146238300|NCT01855750|527385609|FG001|Overall Study|Withdrawal by Subject|28|||
146238301|NCT01855750|527385608|FG000|Overall Study|Sponsor ends the study|297|||
146238302|NCT01855750|527385609|FG001|Overall Study|Sponsor ends the study|290|||
146238303|NCT04300023|527385610|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
146238304|NCT04300023|527385611|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
146238305|NCT05525572|527385612|FG000|Overall Study|Lost to Follow-up|2|||
146238306|NCT05025384|527385619|FG000|Overall Study|Physician Decision|5|||
146238307|NCT05025384|527385620|FG001|Overall Study|Physician Decision|6|||
146238308|NCT05251363|527385621|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
146238309|NCT05251363|527385621|FG000|Overall Study After Implant Period|Death|9|||
145897385|NCT03979820|526132321|FG003|Overall Study|Protocol Violation|0|||
145897386|NCT03979820|526132318|FG000|Overall Study|Withdrawal by Subject|0|||
145897387|NCT03979820|526132319|FG001|Overall Study|Withdrawal by Subject|0|||
145897388|NCT03979820|526132320|FG002|Overall Study|Withdrawal by Subject|1|||
146296841|NCT00908232|527602596|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146296842|NCT00908232|527602597|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146296843|NCT00908232|527602598|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
146296844|NCT00537485|527602599|FG000|Overall Study|Adverse Event|10|||
146296845|NCT00537485|527602600|FG001|Overall Study|Adverse Event|5|||
146296846|NCT00537485|527602599|FG000|Overall Study|Withdrawal by Subject|3|||
146296847|NCT00537485|527602600|FG001|Overall Study|Withdrawal by Subject|2|||
146296848|NCT00537485|527602599|FG000|Overall Study|Withdrawal by Subject|1|||
146296849|NCT00537485|527602600|FG001|Overall Study|Withdrawal by Subject|3|||
146296850|NCT00537485|527602599|FG000|Overall Study|Physician Decision|1|||
146296851|NCT00537485|527602600|FG001|Overall Study|Physician Decision|0|||
146296852|NCT03153137|527602601|FG000|Overall Study|Lost to Follow-up|1|||
146296853|NCT03153137|527602602|FG001|Overall Study|Lost to Follow-up|0|||
146296854|NCT03153137|527602601|FG000|Overall Study|Withdrawal by Subject|2|||
146296855|NCT03153137|527602602|FG001|Overall Study|Withdrawal by Subject|1|||
146296856|NCT03153137|527602601|FG000|Overall Study|Physician Decision|0|||
146296857|NCT03153137|527602602|FG001|Overall Study|Physician Decision|3|||
146296858|NCT02260882|527602606|FG000|Overall Study|Protocol Violation|0|||
146296859|NCT02260882|527602607|FG001|Overall Study|Protocol Violation|1|||
146296860|NCT02119325|527602608|FG000|Washout Period 1|Adverse Event|0|||
146296861|NCT02119325|527602609|FG001|Washout Period 1|Adverse Event|1|||
146296862|NCT01601847|527602610|FG000|Overall Study|Death|1|||
146296863|NCT01601847|527602611|FG001|Overall Study|Death|0|||
146296864|NCT01601847|527602610|FG000|Overall Study|Withdrawal by Subject|11|||
146296865|NCT01601847|527602611|FG001|Overall Study|Withdrawal by Subject|7|||
146296866|NCT01601847|527602610|FG000|Overall Study|Lost to Follow-up|1|||
146296867|NCT01601847|527602611|FG001|Overall Study|Lost to Follow-up|3|||
146296868|NCT04209621|527602621|FG000|Overall Study|Death|1|||
146296869|NCT04209621|527602621|FG000|Overall Study|Study Terminated Early|2|||
146296870|NCT01372410|527602622|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146296871|NCT01372410|527602623|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146296872|NCT01372410|527602624|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146296873|NCT01372410|527602625|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146296874|NCT01372410|527602626|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
146296875|NCT01372410|527602627|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146296876|NCT01372410|527602628|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146296877|NCT01372410|527602629|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
146296878|NCT01372410|527602622|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296879|NCT01372410|527602623|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
146296880|NCT01372410|527602624|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296881|NCT01372410|527602625|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296882|NCT01372410|527602626|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296883|NCT01372410|527602627|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296884|NCT01372410|527602628|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
146296885|NCT01372410|527602629|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
146296886|NCT01372410|527602622|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296887|NCT01372410|527602623|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296888|NCT01372410|527602624|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296889|NCT01372410|527602625|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296890|NCT01372410|527602626|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
146238310|NCT05251363|527385621|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
146238311|NCT05251363|527385621|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
146238312|NCT05251363|527385621|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
146238313|NCT05251363|527385621|FG000|Overall Study After Implant Period|Physician Decision|1|||
146238314|NCT05251363|527385621|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
146238315|NCT03425682|527385622|FG000|Overall Study|Lost to Follow-up|2|||
146238316|NCT03425682|527385623|FG001|Overall Study|Lost to Follow-up|4|||
146238317|NCT03425682|527385622|FG000|Overall Study|Withdrawal by Subject|0|||
146238318|NCT03425682|527385623|FG001|Overall Study|Withdrawal by Subject|3|||
146238319|NCT03425682|527385622|FG000|Overall Study|Subject did not meet I/E|4|||
146238320|NCT03425682|527385623|FG001|Overall Study|Subject did not meet I/E|10|||
146238321|NCT03610581|527385624|FG000|Overall Study|Study terminated by sponsor|2|||
146238322|NCT03610581|527385625|FG001|Overall Study|Study terminated by sponsor|0|||
146238323|NCT03610581|527385624|FG000|Overall Study|Other|0|||
146296891|NCT01372410|527602627|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296892|NCT01372410|527602628|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296893|NCT01372410|527602629|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146296894|NCT01372410|527602622|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296895|NCT01372410|527602623|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296896|NCT01372410|527602624|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296897|NCT01372410|527602625|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296898|NCT01372410|527602626|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296899|NCT01372410|527602627|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296900|NCT01372410|527602628|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
146296901|NCT01372410|527602629|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
146296902|NCT01372410|527602622|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
146296903|NCT01372410|527602623|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296904|NCT01372410|527602624|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296905|NCT01372410|527602625|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296906|NCT01372410|527602626|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296907|NCT01372410|527602627|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296908|NCT01372410|527602628|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
146296909|NCT01372410|527602629|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
146296910|NCT01372410|527602622|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296911|NCT01372410|527602623|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296912|NCT01372410|527602624|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296913|NCT01372410|527602625|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296914|NCT01372410|527602626|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
146296915|NCT01372410|527602627|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296916|NCT01372410|527602628|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296917|NCT01372410|527602629|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
146296918|NCT01372410|527602622|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146296919|NCT01372410|527602623|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146296920|NCT01372410|527602624|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146296921|NCT01372410|527602625|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146296922|NCT01372410|527602626|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146296923|NCT01372410|527602627|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
146296924|NCT01372410|527602628|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146296925|NCT01372410|527602629|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
146296926|NCT01372410|527602622|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296927|NCT01372410|527602623|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296928|NCT01372410|527602624|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296929|NCT01372410|527602625|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296930|NCT01372410|527602626|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296931|NCT01372410|527602627|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296932|NCT01372410|527602628|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
146296933|NCT01372410|527602629|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
146296934|NCT01372410|527602622|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296935|NCT01372410|527602623|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296936|NCT01372410|527602624|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
146296937|NCT01372410|527602625|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296938|NCT01372410|527602626|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296939|NCT01372410|527602627|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296940|NCT01372410|527602628|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296941|NCT01372410|527602629|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
146296942|NCT01372410|527602622|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296943|NCT01372410|527602623|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296944|NCT01372410|527602624|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296945|NCT01372410|527602625|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296946|NCT01372410|527602626|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296947|NCT01372410|527602627|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
146296948|NCT01372410|527602628|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296949|NCT01372410|527602629|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
146296950|NCT01717768|527602636|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296951|NCT01717768|527602637|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
146296952|NCT01717768|527602638|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296953|NCT01717768|527602639|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296954|NCT01717768|527602640|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296955|NCT01717768|527602641|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296956|NCT01717768|527602642|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296957|NCT01717768|527602643|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296958|NCT01717768|527602644|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296959|NCT01717768|527602645|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296960|NCT01717768|527602646|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296961|NCT01717768|527602647|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
146296962|NCT01717768|527602636|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296963|NCT01717768|527602637|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296964|NCT01717768|527602638|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296965|NCT01717768|527602639|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296966|NCT01717768|527602640|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146238324|NCT03610581|527385625|FG001|Overall Study|Other|1|||
146296967|NCT01717768|527602641|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296968|NCT01717768|527602642|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296969|NCT01717768|527602643|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296970|NCT01717768|527602644|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296971|NCT01717768|527602645|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296972|NCT01717768|527602646|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
146296973|NCT01717768|527602647|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
146296974|NCT01717768|527602636|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296975|NCT01717768|527602637|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296976|NCT01717768|527602638|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145897389|NCT03979820|526132321|FG003|Overall Study|Withdrawal by Subject|0|||
146238325|NCT03610581|527385624|FG000|Overall Study|Withdrawal by Subject|1|||
146238326|NCT03610581|527385625|FG001|Overall Study|Withdrawal by Subject|0|||
146238327|NCT05470114|527385629|FG000|Overall Study|Withdrawal by Subject|1|||
146238328|NCT05470114|527385630|FG001|Overall Study|Withdrawal by Subject|0|||
146238329|NCT05470114|527385629|FG000|Overall Study|Lost to Follow-up|1|||
146238330|NCT05470114|527385630|FG001|Overall Study|Lost to Follow-up|0|||
146238331|NCT02488408|527385631|FG000|Part A|Adverse Event|2|||
146238332|NCT02488408|527385632|FG001|Part A|Adverse Event|0|||
146238333|NCT02488408|527385633|FG002|Part A|Adverse Event|0|||
146238334|NCT02488408|527385634|FG003|Part A|Adverse Event|0|||
146238335|NCT02488408|527385635|FG004|Part A|Adverse Event|0|||
146238336|NCT02488408|527385636|FG005|Part A|Adverse Event|0|||
146238337|NCT02488408|527385637|FG006|Part A|Adverse Event|0|||
146238338|NCT02488408|527385638|FG007|Part A|Adverse Event|0|||
146238339|NCT02488408|527385639|FG008|Part A|Adverse Event|0|||
146238340|NCT02488408|527385640|FG009|Part A|Adverse Event|0|||
146238341|NCT02488408|527385631|FG000|Part A|Death|1|||
146238342|NCT02488408|527385632|FG001|Part A|Death|5|||
146238343|NCT02488408|527385633|FG002|Part A|Death|0|||
146238344|NCT02488408|527385634|FG003|Part A|Death|0|||
146238345|NCT02488408|527385635|FG004|Part A|Death|3|||
146238346|NCT02488408|527385636|FG005|Part A|Death|0|||
146238347|NCT02488408|527385637|FG006|Part A|Death|0|||
146238348|NCT02488408|527385638|FG007|Part A|Death|0|||
146238349|NCT02488408|527385639|FG008|Part A|Death|0|||
146238350|NCT02488408|527385640|FG009|Part A|Death|0|||
146238351|NCT02488408|527385631|FG000|Part A|Disease Progression|2|||
146238352|NCT02488408|527385632|FG001|Part A|Disease Progression|8|||
146238353|NCT02488408|527385633|FG002|Part A|Disease Progression|2|||
146238354|NCT02488408|527385634|FG003|Part A|Disease Progression|3|||
146238355|NCT02488408|527385635|FG004|Part A|Disease Progression|4|||
146238356|NCT02488408|527385636|FG005|Part A|Disease Progression|0|||
146238357|NCT02488408|527385637|FG006|Part A|Disease Progression|0|||
145897390|NCT03979820|526132318|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
145897391|NCT03979820|526132319|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
145897392|NCT03979820|526132320|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
145897393|NCT03979820|526132321|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
145897394|NCT00988065|526132322|FG000|Overall Study|Adverse Event|4|||
145897395|NCT00988065|526132323|FG001|Overall Study|Adverse Event|10|||
145897396|NCT00988065|526132324|FG002|Overall Study|Adverse Event|2|||
145897397|NCT00988065|526132322|FG000|Overall Study|Lost to Follow-up|1|||
145897398|NCT00988065|526132323|FG001|Overall Study|Lost to Follow-up|2|||
145897399|NCT00988065|526132324|FG002|Overall Study|Lost to Follow-up|2|||
145897400|NCT00988065|526132322|FG000|Overall Study|Subject withdrew consent|3|||
145897401|NCT00988065|526132323|FG001|Overall Study|Subject withdrew consent|5|||
145897402|NCT00988065|526132324|FG002|Overall Study|Subject withdrew consent|2|||
145897403|NCT00988065|526132322|FG000|Overall Study|Noncompliance with protocol|5|||
145897404|NCT00988065|526132323|FG001|Overall Study|Noncompliance with protocol|6|||
145897405|NCT00988065|526132324|FG002|Overall Study|Noncompliance with protocol|9|||
145897406|NCT01355159|526132336|FG000|Overall Study|Withdrew consent|39|||
146238358|NCT02488408|527385638|FG007|Part A|Disease Progression|0|||
146238359|NCT02488408|527385639|FG008|Part A|Disease Progression|0|||
146238360|NCT02488408|527385640|FG009|Part A|Disease Progression|0|||
146238361|NCT02488408|527385631|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
145897407|NCT01355159|526132337|FG001|Overall Study|Withdrew consent|47|||
146238362|NCT02488408|527385632|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
146238363|NCT02488408|527385633|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
146238364|NCT02488408|527385634|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
145897408|NCT01355159|526132336|FG000|Overall Study|No primary outcome data|17|||
145897409|NCT01355159|526132337|FG001|Overall Study|No primary outcome data|11|||
146238365|NCT02488408|527385635|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
146238366|NCT02488408|527385636|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
146238367|NCT02488408|527385637|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
146238368|NCT02488408|527385638|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
146238369|NCT02488408|527385639|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
146238370|NCT02488408|527385640|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
146238371|NCT02488408|527385631|FG000|Part A|Investigator Decision|0|||
146238372|NCT02488408|527385632|FG001|Part A|Investigator Decision|1|||
146238373|NCT02488408|527385633|FG002|Part A|Investigator Decision|1|||
146238374|NCT02488408|527385634|FG003|Part A|Investigator Decision|0|||
146238375|NCT02488408|527385635|FG004|Part A|Investigator Decision|0|||
146238376|NCT02488408|527385636|FG005|Part A|Investigator Decision|0|||
146238377|NCT02488408|527385637|FG006|Part A|Investigator Decision|0|||
146238378|NCT02488408|527385638|FG007|Part A|Investigator Decision|0|||
146238379|NCT02488408|527385639|FG008|Part A|Investigator Decision|0|||
146238380|NCT02488408|527385640|FG009|Part A|Investigator Decision|0|||
146238381|NCT02488408|527385631|FG000|Part A|Withdrawal by Subject|0|||
146238382|NCT02488408|527385632|FG001|Part A|Withdrawal by Subject|0|||
146238383|NCT02488408|527385633|FG002|Part A|Withdrawal by Subject|2|||
146296977|NCT01717768|527602639|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296978|NCT01717768|527602640|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296979|NCT01717768|527602641|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296980|NCT01717768|527602642|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296981|NCT01717768|527602643|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
146296982|NCT01717768|527602644|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296983|NCT01717768|527602645|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296984|NCT01717768|527602646|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296985|NCT01717768|527602647|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
146296986|NCT01717768|527602636|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296987|NCT01717768|527602637|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296988|NCT01717768|527602638|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296989|NCT01717768|527602639|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296990|NCT01717768|527602640|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296991|NCT01717768|527602641|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296992|NCT01717768|527602642|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296993|NCT01717768|527602643|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296994|NCT01717768|527602644|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296995|NCT01717768|527602645|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
146296996|NCT01717768|527602646|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296997|NCT01717768|527602647|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
146296998|NCT01699789|527602650|FG000|Overall Study|Withdrawal by Subject|18|||
146296999|NCT01699789|527602651|FG001|Overall Study|Withdrawal by Subject|23|||
146297000|NCT01699789|527602650|FG000|Overall Study|Death|1|||
146297001|NCT01699789|527602651|FG001|Overall Study|Death|2|||
146297002|NCT01699789|527602650|FG000|Overall Study|Lost to Follow-up|83|||
146297003|NCT01699789|527602651|FG001|Overall Study|Lost to Follow-up|101|||
146297004|NCT02554903|527602652|FG000|Overall Study|Death|1|||
146297005|NCT02554903|527602653|FG001|Overall Study|Death|1|||
146297006|NCT02554903|527602652|FG000|Overall Study|Physician Decision|2|||
146297007|NCT02554903|527602653|FG001|Overall Study|Physician Decision|2|||
146297008|NCT02554903|527602652|FG000|Overall Study|Heart Transplant|1|||
146297009|NCT02554903|527602653|FG001|Overall Study|Heart Transplant|2|||
146297010|NCT00639223|527602658|FG000|Overall Study|Lost to Follow-up|0|||
146297011|NCT00639223|527602659|FG001|Overall Study|Lost to Follow-up|2|||
146297012|NCT02540538|527602662|FG000|Overall Study|Pregnancy|0|||
146297013|NCT02540538|527602663|FG001|Overall Study|Pregnancy|1|||
146297014|NCT02540538|527602664|FG002|Overall Study|Pregnancy|0|||
146297015|NCT01557348|527602668|FG000|Overall Study|Adverse Event|6|||
146297016|NCT01557348|527602669|FG001|Overall Study|Adverse Event|16|||
146297017|NCT01557348|527602668|FG000|Overall Study|Infusion reaction event|5|||
146297018|NCT01557348|527602669|FG001|Overall Study|Infusion reaction event|5|||
146297019|NCT01557348|527602668|FG000|Overall Study|Death|7|||
146297020|NCT01557348|527602669|FG001|Overall Study|Death|4|||
146297021|NCT01557348|527602668|FG000|Overall Study|Insufficient Therapeutic Response|13|||
146297022|NCT01557348|527602669|FG001|Overall Study|Insufficient Therapeutic Response|28|||
146297023|NCT01557348|527602668|FG000|Overall Study|Withdrawal by Subject|5|||
146297024|NCT01557348|527602669|FG001|Overall Study|Withdrawal by Subject|4|||
146297025|NCT01557348|527602668|FG000|Overall Study|Lost to Follow-up|26|||
146297026|NCT01557348|527602669|FG001|Overall Study|Lost to Follow-up|22|||
146297027|NCT01557348|527602668|FG000|Overall Study|Administrative|18|||
146297028|NCT01557348|527602669|FG001|Overall Study|Administrative|11|||
146297029|NCT00403754|527602670|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
146297030|NCT00403754|527602671|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
146238384|NCT02488408|527385634|FG003|Part A|Withdrawal by Subject|0|||
146238385|NCT02488408|527385635|FG004|Part A|Withdrawal by Subject|0|||
146238386|NCT02488408|527385636|FG005|Part A|Withdrawal by Subject|0|||
146238387|NCT02488408|527385637|FG006|Part A|Withdrawal by Subject|0|||
146297031|NCT00403754|527602672|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
146297032|NCT00403754|527602673|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
146297033|NCT00403754|527602670|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
146297034|NCT00403754|527602671|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
146297035|NCT00403754|527602672|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
146297036|NCT00403754|527602673|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
146297037|NCT02000427|527602674|FG000|Overall Study|Death|22|||
146297038|NCT03829319|527602675|FG000|Overall Study|Sponsor's Decision|4|||
146297039|NCT03829319|527602676|FG001|Overall Study|Sponsor's Decision|90|||
146297040|NCT03829319|527602677|FG002|Overall Study|Sponsor's Decision|102|||
146297041|NCT03829319|527602675|FG000|Overall Study|Withdrawal by Subject|1|||
146297042|NCT03829319|527602676|FG001|Overall Study|Withdrawal by Subject|5|||
146297043|NCT03829319|527602677|FG002|Overall Study|Withdrawal by Subject|4|||
146297044|NCT03829319|527602675|FG000|Overall Study|Physician Decision|0|||
146297045|NCT03829319|527602676|FG001|Overall Study|Physician Decision|3|||
146297046|NCT03829319|527602677|FG002|Overall Study|Physician Decision|0|||
146297047|NCT03829319|527602675|FG000|Overall Study|Lost to Follow-up|0|||
146297048|NCT03829319|527602676|FG001|Overall Study|Lost to Follow-up|0|||
146297049|NCT03829319|527602677|FG002|Overall Study|Lost to Follow-up|1|||
146297050|NCT03829319|527602675|FG000|Overall Study|Death|8|||
146297051|NCT03829319|527602676|FG001|Overall Study|Death|277|||
146297052|NCT03829319|527602677|FG002|Overall Study|Death|266|||
146297053|NCT02846532|527602678|FG000|Overall Study|Lost to Follow-up|0|||
146297054|NCT02846532|527602679|FG001|Overall Study|Lost to Follow-up|1|||
146297055|NCT02846532|527602680|FG002|Overall Study|Lost to Follow-up|1|||
146297056|NCT02846532|527602678|FG000|Overall Study|Withdrawal by Subject|1|||
146297057|NCT02846532|527602679|FG001|Overall Study|Withdrawal by Subject|2|||
146297058|NCT02846532|527602680|FG002|Overall Study|Withdrawal by Subject|0|||
146297059|NCT04484259|527602681|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146297060|NCT04484259|527602682|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146297061|NCT04484259|527602683|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146297062|NCT04484259|527602684|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
146297063|NCT04484259|527602685|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
146297064|NCT04484259|527602681|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146297065|NCT04484259|527602682|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146297066|NCT04484259|527602683|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146297067|NCT04484259|527602684|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
146297068|NCT04484259|527602685|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
146297069|NCT04484259|527602681|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146297070|NCT04484259|527602682|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146297071|NCT04484259|527602683|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146297072|NCT04484259|527602684|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
146297073|NCT04484259|527602685|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
146297074|NCT04484259|527602681|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146297075|NCT04484259|527602682|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146297076|NCT04484259|527602683|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146297077|NCT04484259|527602684|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
146297078|NCT04484259|527602685|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
146297079|NCT04484259|527602681|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146297080|NCT04484259|527602682|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146297081|NCT04484259|527602683|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146297082|NCT04484259|527602684|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
146297083|NCT04484259|527602685|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
146297084|NCT04484259|527602681|FG000|Randomized Treatment|Withdrawal by Subject|1|||
146297085|NCT04484259|527602682|FG001|Randomized Treatment|Withdrawal by Subject|0|||
146297086|NCT04484259|527602683|FG002|Randomized Treatment|Withdrawal by Subject|0|||
146297087|NCT04484259|527602684|FG003|Randomized Treatment|Withdrawal by Subject|0|||
146297088|NCT04484259|527602685|FG004|Randomized Treatment|Withdrawal by Subject|0|||
146297089|NCT03951220|527602686|FG000|Overall Study|Withdrawal by Subject|9|||
146297090|NCT03951220|527602687|FG001|Overall Study|Withdrawal by Subject|2|||
146297091|NCT03951220|527602688|FG002|Overall Study|Withdrawal by Subject|0|||
146297092|NCT04498832|527602689|FG000|Overall Study|Adverse Event|1|||
146297093|NCT04498832|527602690|FG001|Overall Study|Adverse Event|3|||
146297094|NCT04498832|527602689|FG000|Overall Study|Withdrawal by Subject|0|||
146297095|NCT04498832|527602690|FG001|Overall Study|Withdrawal by Subject|1|||
146297096|NCT05359003|527602691|FG000|Overall Study|Withdrawal by Subject|1|||
146297097|NCT05359003|527602692|FG001|Overall Study|Withdrawal by Subject|3|||
145897410|NCT01355159|526132336|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
145897411|NCT01355159|526132337|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
145897412|NCT01355159|526132336|FG000|Overall Study|Early intrauterine fetal death|6|||
146297098|NCT06268288|527602695|FG000|Overall Study|Withdrawal by Subject|1|||
146238388|NCT02488408|527385638|FG007|Part A|Withdrawal by Subject|0|||
146238389|NCT02488408|527385639|FG008|Part A|Withdrawal by Subject|0|||
146238390|NCT02488408|527385640|FG009|Part A|Withdrawal by Subject|0|||
146238391|NCT02488408|527385631|FG000|Part A|Other|1|||
146238392|NCT02488408|527385632|FG001|Part A|Other|0|||
146238393|NCT02488408|527385633|FG002|Part A|Other|0|||
146238394|NCT02488408|527385634|FG003|Part A|Other|0|||
146238395|NCT02488408|527385635|FG004|Part A|Other|0|||
146238396|NCT02488408|527385636|FG005|Part A|Other|0|||
146238397|NCT02488408|527385637|FG006|Part A|Other|0|||
146238398|NCT02488408|527385638|FG007|Part A|Other|0|||
146238399|NCT02488408|527385639|FG008|Part A|Other|0|||
146238400|NCT02488408|527385640|FG009|Part A|Other|0|||
146238401|NCT02488408|527385631|FG000|Part B|Adverse Event|0|||
146238402|NCT02488408|527385632|FG001|Part B|Adverse Event|0|||
146238403|NCT02488408|527385633|FG002|Part B|Adverse Event|0|||
146238404|NCT02488408|527385634|FG003|Part B|Adverse Event|0|||
146238405|NCT02488408|527385635|FG004|Part B|Adverse Event|0|||
146238406|NCT02488408|527385636|FG005|Part B|Adverse Event|2|||
146238407|NCT02488408|527385637|FG006|Part B|Adverse Event|2|||
146238408|NCT02488408|527385638|FG007|Part B|Adverse Event|7|||
146238409|NCT02488408|527385639|FG008|Part B|Adverse Event|2|||
146238410|NCT02488408|527385640|FG009|Part B|Adverse Event|2|||
146238411|NCT02488408|527385631|FG000|Part B|Death|0|||
146238412|NCT02488408|527385632|FG001|Part B|Death|0|||
146238413|NCT02488408|527385633|FG002|Part B|Death|0|||
146238414|NCT02488408|527385634|FG003|Part B|Death|0|||
146238415|NCT02488408|527385635|FG004|Part B|Death|0|||
146238416|NCT02488408|527385636|FG005|Part B|Death|3|||
146238417|NCT02488408|527385637|FG006|Part B|Death|1|||
146238418|NCT02488408|527385638|FG007|Part B|Death|2|||
146238419|NCT02488408|527385639|FG008|Part B|Death|2|||
146238420|NCT02488408|527385640|FG009|Part B|Death|2|||
146238421|NCT02488408|527385631|FG000|Part B|Death due to Disease Progression|0|||
146238422|NCT02488408|527385632|FG001|Part B|Death due to Disease Progression|0|||
146238423|NCT02488408|527385633|FG002|Part B|Death due to Disease Progression|0|||
146238424|NCT02488408|527385634|FG003|Part B|Death due to Disease Progression|0|||
146238425|NCT02488408|527385635|FG004|Part B|Death due to Disease Progression|0|||
146238426|NCT02488408|527385636|FG005|Part B|Death due to Disease Progression|2|||
146238427|NCT02488408|527385637|FG006|Part B|Death due to Disease Progression|2|||
146238428|NCT02488408|527385638|FG007|Part B|Death due to Disease Progression|1|||
146238429|NCT02488408|527385639|FG008|Part B|Death due to Disease Progression|1|||
146238430|NCT02488408|527385640|FG009|Part B|Death due to Disease Progression|1|||
146238431|NCT02488408|527385631|FG000|Part B|Disease Progression|0|||
146238432|NCT02488408|527385632|FG001|Part B|Disease Progression|0|||
146238433|NCT02488408|527385633|FG002|Part B|Disease Progression|0|||
146238434|NCT02488408|527385634|FG003|Part B|Disease Progression|0|||
146238435|NCT02488408|527385635|FG004|Part B|Disease Progression|0|||
146238436|NCT02488408|527385636|FG005|Part B|Disease Progression|6|||
146238437|NCT02488408|527385637|FG006|Part B|Disease Progression|9|||
146238438|NCT02488408|527385638|FG007|Part B|Disease Progression|7|||
146238439|NCT02488408|527385639|FG008|Part B|Disease Progression|9|||
146238440|NCT02488408|527385640|FG009|Part B|Disease Progression|11|||
146238441|NCT02488408|527385631|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
146238442|NCT02488408|527385632|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
146238443|NCT02488408|527385633|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
146238444|NCT02488408|527385634|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
146238445|NCT02488408|527385635|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
146238446|NCT02488408|527385636|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
146238447|NCT02488408|527385637|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
146238448|NCT02488408|527385638|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
146238449|NCT02488408|527385639|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
146238450|NCT02488408|527385640|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
146238451|NCT02488408|527385631|FG000|Part B|Investigator Decision|0|||
146238452|NCT02488408|527385632|FG001|Part B|Investigator Decision|0|||
146238453|NCT02488408|527385633|FG002|Part B|Investigator Decision|0|||
146238454|NCT02488408|527385634|FG003|Part B|Investigator Decision|0|||
146238455|NCT02488408|527385635|FG004|Part B|Investigator Decision|0|||
146238456|NCT02488408|527385636|FG005|Part B|Investigator Decision|0|||
146238457|NCT02488408|527385637|FG006|Part B|Investigator Decision|1|||
146238458|NCT02488408|527385638|FG007|Part B|Investigator Decision|0|||
146238459|NCT02488408|527385639|FG008|Part B|Investigator Decision|2|||
146297099|NCT06268288|527602696|FG001|Overall Study|Withdrawal by Subject|2|||
146238460|NCT02488408|527385640|FG009|Part B|Investigator Decision|1|||
146238461|NCT00719888|527385641|FG000|Overall Study|Death|24|||
146238462|NCT00719888|527385642|FG001|Overall Study|Death|9|||
146238463|NCT00719888|527385641|FG000|Overall Study|Relapse|8|||
146238464|NCT00719888|527385642|FG001|Overall Study|Relapse|3|||
146238465|NCT00719888|527385641|FG000|Overall Study|Physician Decision|1|||
146238466|NCT00719888|527385642|FG001|Overall Study|Physician Decision|0|||
146238467|NCT00719888|527385641|FG000|Overall Study|Withdrawal by Subject|1|||
146238468|NCT00719888|527385642|FG001|Overall Study|Withdrawal by Subject|0|||
146238469|NCT05037513|527385643|FG000|Intervention Period|Lost to Follow-up|1|||
145897413|NCT01355159|526132337|FG001|Overall Study|Early intrauterine fetal death|6|||
145897414|NCT01941940|526132338|FG000|Overall Study|Adverse Event|11|||
145897415|NCT01941940|526132338|FG000|Overall Study|Lost to Follow-up|2|||
145897416|NCT01941940|526132338|FG000|Overall Study|Physician Decision|2|||
145897417|NCT01941940|526132338|FG000|Overall Study|Withdrawal by Subject|15|||
145897418|NCT01941940|526132338|FG000|Overall Study|Death|1|||
145897419|NCT01941940|526132338|FG000|Overall Study|Other|1|||
145897420|NCT01941940|526132338|FG000|Overall Study|Other|1|||
145897421|NCT03212521|526132342|FG000|Overall Study|Adverse Event|1|||
145897422|NCT03212521|526132342|FG000|Overall Study|Lost to Follow-up|4|||
145897423|NCT03212521|526132342|FG000|Overall Study|Withdrawal by Subject|1|||
145897424|NCT03212521|526132342|FG000|Overall Study|Other|1|||
145897425|NCT00444457|526132343|FG000|Infant Series|Other|0|||
145897426|NCT00444457|526132344|FG001|Infant Series|Other|1|||
145897427|NCT00444457|526132345|FG002|Infant Series|Other|0|||
145897428|NCT00444457|526132346|FG003|Infant Series|Other|0|||
145897429|NCT00444457|526132343|FG000|Infant Series|Parent or legal guardian request|18|||
145897430|NCT00444457|526132344|FG001|Infant Series|Parent or legal guardian request|29|||
145897431|NCT00444457|526132345|FG002|Infant Series|Parent or legal guardian request|34|||
145897432|NCT00444457|526132346|FG003|Infant Series|Parent or legal guardian request|14|||
145897433|NCT00444457|526132343|FG000|Infant Series|Lost to Follow-up|10|||
145897434|NCT00444457|526132344|FG001|Infant Series|Lost to Follow-up|11|||
145897435|NCT00444457|526132345|FG002|Infant Series|Lost to Follow-up|7|||
145897436|NCT00444457|526132346|FG003|Infant Series|Lost to Follow-up|6|||
145897437|NCT00444457|526132343|FG000|Infant Series|Protocol Violation|16|||
145897438|NCT00444457|526132344|FG001|Infant Series|Protocol Violation|8|||
145897439|NCT00444457|526132345|FG002|Infant Series|Protocol Violation|6|||
145897440|NCT00444457|526132346|FG003|Infant Series|Protocol Violation|3|||
145897441|NCT00444457|526132343|FG000|Infant Series|Failed to return|5|||
145897442|NCT00444457|526132344|FG001|Infant Series|Failed to return|4|||
145897443|NCT00444457|526132345|FG002|Infant Series|Failed to return|4|||
145897444|NCT00444457|526132346|FG003|Infant Series|Failed to return|2|||
145897445|NCT00444457|526132343|FG000|Infant Series|Investigator request|4|||
145897446|NCT00444457|526132344|FG001|Infant Series|Investigator request|3|||
145897447|NCT00444457|526132345|FG002|Infant Series|Investigator request|3|||
145897448|NCT00444457|526132346|FG003|Infant Series|Investigator request|2|||
145897449|NCT00444457|526132343|FG000|Infant Series|Other|0|||
145897450|NCT00444457|526132344|FG001|Infant Series|Other|2|||
145897451|NCT00444457|526132345|FG002|Infant Series|Other|4|||
145897452|NCT00444457|526132346|FG003|Infant Series|Other|0|||
145897453|NCT00444457|526132343|FG000|Infant Series|Adverse Event|1|||
145897454|NCT00444457|526132344|FG001|Infant Series|Adverse Event|2|||
145897455|NCT00444457|526132345|FG002|Infant Series|Adverse Event|2|||
145897456|NCT00444457|526132346|FG003|Infant Series|Adverse Event|0|||
145897457|NCT00444457|526132343|FG000|Infant Series|Death|0|||
145897458|NCT00444457|526132344|FG001|Infant Series|Death|1|||
145897459|NCT00444457|526132345|FG002|Infant Series|Death|1|||
145897460|NCT00444457|526132346|FG003|Infant Series|Death|1|||
145897461|NCT00444457|526132343|FG000|After Infant Series|Other|0|||
145897462|NCT00444457|526132344|FG001|After Infant Series|Other|1|||
145897463|NCT00444457|526132345|FG002|After Infant Series|Other|1|||
145897464|NCT00444457|526132346|FG003|After Infant Series|Other|1|||
145897465|NCT00444457|526132343|FG000|After Infant Series|Parent or legal guardian request|4|||
145897466|NCT00444457|526132344|FG001|After Infant Series|Parent or legal guardian request|11|||
145897467|NCT00444457|526132345|FG002|After Infant Series|Parent or legal guardian request|6|||
145897468|NCT00444457|526132346|FG003|After Infant Series|Parent or legal guardian request|3|||
145897469|NCT00444457|526132343|FG000|After Infant Series|Failed to return|7|||
145897470|NCT00444457|526132344|FG001|After Infant Series|Failed to return|6|||
145897471|NCT00444457|526132345|FG002|After Infant Series|Failed to return|5|||
145897472|NCT00444457|526132346|FG003|After Infant Series|Failed to return|1|||
145897473|NCT00444457|526132343|FG000|After Infant Series|Lost to Follow-up|5|||
145897474|NCT00444457|526132344|FG001|After Infant Series|Lost to Follow-up|5|||
145897475|NCT00444457|526132345|FG002|After Infant Series|Lost to Follow-up|5|||
145897476|NCT00444457|526132346|FG003|After Infant Series|Lost to Follow-up|2|||
145897477|NCT00444457|526132343|FG000|After Infant Series|Protocol Violation|2|||
145897478|NCT00444457|526132344|FG001|After Infant Series|Protocol Violation|4|||
145897479|NCT00444457|526132345|FG002|After Infant Series|Protocol Violation|2|||
145897480|NCT00444457|526132346|FG003|After Infant Series|Protocol Violation|2|||
145897481|NCT00444457|526132343|FG000|After Infant Series|Adverse Event|2|||
145897482|NCT00444457|526132344|FG001|After Infant Series|Adverse Event|2|||
145897483|NCT00444457|526132345|FG002|After Infant Series|Adverse Event|0|||
145897484|NCT00444457|526132346|FG003|After Infant Series|Adverse Event|0|||
145897485|NCT00444457|526132343|FG000|After Infant Series|Investigator request|0|||
145897486|NCT00444457|526132344|FG001|After Infant Series|Investigator request|0|||
145897487|NCT00444457|526132345|FG002|After Infant Series|Investigator request|0|||
145897488|NCT00444457|526132346|FG003|After Infant Series|Investigator request|1|||
145897489|NCT00444457|526132343|FG000|After Infant Series|Other|0|||
145897490|NCT00444457|526132344|FG001|After Infant Series|Other|1|||
145897491|NCT00444457|526132345|FG002|After Infant Series|Other|0|||
145897492|NCT00444457|526132346|FG003|After Infant Series|Other|0|||
145897493|NCT00444457|526132343|FG000|Toddler Dose|Lost to Follow-up|4|||
145897494|NCT00444457|526132344|FG001|Toddler Dose|Lost to Follow-up|1|||
145897495|NCT00444457|526132345|FG002|Toddler Dose|Lost to Follow-up|1|||
145897496|NCT00444457|526132346|FG003|Toddler Dose|Lost to Follow-up|3|||
145897497|NCT00444457|526132343|FG000|Toddler Dose|Failed to return|2|||
145897498|NCT00444457|526132344|FG001|Toddler Dose|Failed to return|2|||
145897499|NCT00444457|526132345|FG002|Toddler Dose|Failed to return|1|||
145897500|NCT00444457|526132346|FG003|Toddler Dose|Failed to return|3|||
145897501|NCT00444457|526132343|FG000|Toddler Dose|Parent or legal guardian request|0|||
145897502|NCT00444457|526132344|FG001|Toddler Dose|Parent or legal guardian request|3|||
145897503|NCT00444457|526132345|FG002|Toddler Dose|Parent or legal guardian request|2|||
145897504|NCT00444457|526132346|FG003|Toddler Dose|Parent or legal guardian request|1|||
145897505|NCT00444457|526132343|FG000|Toddler Dose|Protocol Violation|1|||
145897506|NCT00444457|526132344|FG001|Toddler Dose|Protocol Violation|0|||
145897507|NCT00444457|526132345|FG002|Toddler Dose|Protocol Violation|0|||
145897508|NCT00444457|526132346|FG003|Toddler Dose|Protocol Violation|1|||
145897509|NCT00914459|526132349|FG000|Overall Study|Protocol Violation|0|||
145897510|NCT00914459|526132350|FG001|Overall Study|Protocol Violation|1|||
145897511|NCT00914459|526132349|FG000|Overall Study|Parent/Legal guardian request|1|||
145897512|NCT00914459|526132350|FG001|Overall Study|Parent/Legal guardian request|0|||
145897513|NCT01661179|526132351|FG000|Overall Study|Death|1|||
145897514|NCT01661179|526132351|FG000|Overall Study|Withdrawal by Subject|1|||
145897515|NCT01661179|526132351|FG000|Overall Study|Other Eligibility criteria|4|||
145897516|NCT01602965|526132352|FG000|Overall Study|Lost to Follow-up|4|||
145897517|NCT01602965|526132353|FG001|Overall Study|Lost to Follow-up|2|||
145897518|NCT03118570|526132354|FG000|Overall Study|Adverse Event|2|||
146238470|NCT05037513|527385644|FG001|Intervention Period|Lost to Follow-up|2|||
146238471|NCT05037513|527385643|FG000|Follow Up Period|Lost to Follow-up|16|||
146238472|NCT05037513|527385644|FG001|Follow Up Period|Lost to Follow-up|21|||
146238473|NCT05037513|527385643|FG000|Follow Up Period|Death|0|||
146238474|NCT05037513|527385644|FG001|Follow Up Period|Death|1|||
146238475|NCT05037513|527385643|FG000|Follow Up Period|Incarcerated|4|||
146238476|NCT05037513|527385644|FG001|Follow Up Period|Incarcerated|2|||
146238477|NCT04577651|527385645|FG000|Overall Study|Screen Failure|7|||
146238478|NCT04577651|527385645|FG000|Overall Study|Adverse Event|1|||
146238479|NCT04577651|527385645|FG000|Overall Study|Death|1|||
146238480|NCT04577651|527385645|FG000|Overall Study|Physician Decision|1|||
146238481|NCT04577651|527385645|FG000|Overall Study|Withdrawal by Subject|3|||
146238482|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
146238483|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
146238484|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
145897519|NCT03118570|526132355|FG001|Overall Study|Adverse Event|0|||
145897520|NCT03118570|526132356|FG002|Overall Study|Adverse Event|0|||
145897521|NCT03118570|526132357|FG003|Overall Study|Adverse Event|0|||
146238485|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
146238486|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
146238487|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
146238488|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
146238489|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
145897522|NCT03118570|526132358|FG004|Overall Study|Adverse Event|3|||
145897523|NCT03118570|526132354|FG000|Overall Study|Withdrawal by Subject|0|||
145897524|NCT03118570|526132355|FG001|Overall Study|Withdrawal by Subject|1|||
145897525|NCT03118570|526132356|FG002|Overall Study|Withdrawal by Subject|4|||
145897526|NCT03118570|526132357|FG003|Overall Study|Withdrawal by Subject|0|||
145897527|NCT03118570|526132358|FG004|Overall Study|Withdrawal by Subject|1|||
145897528|NCT03118570|526132354|FG000|Overall Study|Lost to Follow-up|2|||
145897529|NCT03118570|526132355|FG001|Overall Study|Lost to Follow-up|3|||
145897530|NCT03118570|526132356|FG002|Overall Study|Lost to Follow-up|1|||
145897531|NCT03118570|526132357|FG003|Overall Study|Lost to Follow-up|0|||
145897532|NCT03118570|526132358|FG004|Overall Study|Lost to Follow-up|1|||
145897533|NCT03118570|526132354|FG000|Overall Study|Other, Not Specified|1|||
145897534|NCT03118570|526132355|FG001|Overall Study|Other, Not Specified|3|||
145897535|NCT03118570|526132356|FG002|Overall Study|Other, Not Specified|0|||
145897536|NCT03118570|526132357|FG003|Overall Study|Other, Not Specified|0|||
145897537|NCT03118570|526132358|FG004|Overall Study|Other, Not Specified|0|||
145897538|NCT03071094|526132362|FG000|Overall Study|Death|1|||
145897539|NCT03071094|526132363|FG001|Overall Study|Death|1|||
145897540|NCT03071094|526132362|FG000|Overall Study|Adverse Event|1|||
145897541|NCT03071094|526132363|FG001|Overall Study|Adverse Event|0|||
145897542|NCT02312063|526132364|FG000|Overall Study|Withdrawal by Subject|0|||
145897543|NCT02312063|526132365|FG001|Overall Study|Withdrawal by Subject|1|||
145897544|NCT00321737|526132371|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
146238490|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
145897545|NCT00321737|526132372|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
146238491|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
146238492|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
146238493|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
145897546|NCT00321737|526132373|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
145897547|NCT00321737|526132371|FG000|Overall Study|Adverse Event|11|||
145897548|NCT00321737|526132372|FG001|Overall Study|Adverse Event|3|||
145897549|NCT00321737|526132373|FG002|Overall Study|Adverse Event|6|||
145897550|NCT00321737|526132371|FG000|Overall Study|Lost to Follow-up|5|||
145897551|NCT00321737|526132372|FG001|Overall Study|Lost to Follow-up|5|||
145897552|NCT00321737|526132373|FG002|Overall Study|Lost to Follow-up|6|||
145897553|NCT00321737|526132371|FG000|Overall Study|Withdrawal by Subject|19|||
145897554|NCT00321737|526132372|FG001|Overall Study|Withdrawal by Subject|12|||
145897555|NCT00321737|526132373|FG002|Overall Study|Withdrawal by Subject|17|||
145897556|NCT00321737|526132371|FG000|Overall Study|Protocol Violation|0|||
145897557|NCT00321737|526132372|FG001|Overall Study|Protocol Violation|0|||
145897558|NCT00321737|526132373|FG002|Overall Study|Protocol Violation|1|||
145897559|NCT00321737|526132371|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
145897560|NCT00321737|526132372|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145897561|NCT00321737|526132373|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145897562|NCT00321737|526132371|FG000|Overall Study|Possible Barrett's Esophagus|2|||
145897563|NCT00321737|526132372|FG001|Overall Study|Possible Barrett's Esophagus|1|||
145897564|NCT00321737|526132373|FG002|Overall Study|Possible Barrett's Esophagus|1|||
145897565|NCT00321737|526132371|FG000|Overall Study|Therapeutic Failure|6|||
145897566|NCT00321737|526132372|FG001|Overall Study|Therapeutic Failure|0|||
145897567|NCT00321737|526132373|FG002|Overall Study|Therapeutic Failure|2|||
145897568|NCT00321737|526132371|FG000|Overall Study|Pregnancy|0|||
146238494|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146238495|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146238496|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
146238497|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146238498|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
145897569|NCT00321737|526132372|FG001|Overall Study|Pregnancy|2|||
145897570|NCT00321737|526132373|FG002|Overall Study|Pregnancy|0|||
145897571|NCT00321737|526132371|FG000|Overall Study|Noncompliance|2|||
145897572|NCT00321737|526132372|FG001|Overall Study|Noncompliance|0|||
145897573|NCT00321737|526132373|FG002|Overall Study|Noncompliance|0|||
145897574|NCT00321737|526132371|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
145897575|NCT00321737|526132372|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
145897576|NCT00321737|526132373|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
145897577|NCT01079832|526132374|FG000|Overall Study|Withdrawal by Subject|1|||
145897578|NCT02283294|526132375|FG000|Overall Study|Lost to Follow-up|1|||
146238499|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146297100|NCT02684357|527602697|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
146297101|NCT02684357|527602698|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
145897579|NCT02283294|526132376|FG001|Overall Study|Lost to Follow-up|1|||
145897580|NCT02283294|526132375|FG000|Overall Study|Withdrawal by Subject|1|||
145897581|NCT02283294|526132376|FG001|Overall Study|Withdrawal by Subject|6|||
146238500|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146297102|NCT02684357|527602699|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
146238501|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
146238502|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
146297103|NCT02684357|527602700|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
145897582|NCT02283294|526132375|FG000|Overall Study|Protocol Violation|1|||
145897583|NCT02283294|526132376|FG001|Overall Study|Protocol Violation|0|||
146238503|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
146238504|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146238505|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146238506|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
146238507|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Other|1|||
146238508|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Other|0|||
146238509|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Other|0|||
146238510|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Other|0|||
146238511|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Other|0|||
146297104|NCT02684357|527602701|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
146297105|NCT02684357|527602702|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
146297106|NCT02684357|527602697|FG000|Part A|Lost to Follow-up|0|||
145897584|NCT02283294|526132375|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
145897585|NCT02283294|526132376|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
145897586|NCT00594646|526132377|FG000|Overall Study|Withdrawal by Subject|1|||
145897587|NCT00594646|526132377|FG000|Overall Study|Lost to Follow-up|15|||
145897588|NCT01195272|526132378|FG000|Overall Study|Adverse Event|1|||
145897589|NCT01195272|526132378|FG000|Overall Study|Lack of Efficacy|3|||
146238512|NCT02386098|527386756|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
146297107|NCT02684357|527602698|FG001|Part A|Lost to Follow-up|2|||
145897590|NCT01769339|526132379|FG000|Overall Study|Lost to Follow-up|42|||
145897591|NCT01769339|526132379|FG000|Overall Study|Adverse Event|1|||
146238513|NCT02386098|527386757|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
146297108|NCT02684357|527602699|FG002|Part A|Lost to Follow-up|2|||
145897592|NCT03548064|526134969|FG000|Overall Study|Withdrawal by Subject|0|||
146297109|NCT02684357|527602700|FG003|Part A|Lost to Follow-up|0|||
146297110|NCT02684357|527602701|FG004|Part A|Lost to Follow-up|0|||
146297111|NCT02684357|527602702|FG005|Part A|Lost to Follow-up|0|||
146297112|NCT02684357|527602697|FG000|Part A|Withdrawal by Subject|3|||
146297113|NCT02684357|527602698|FG001|Part A|Withdrawal by Subject|0|||
146297114|NCT02684357|527602699|FG002|Part A|Withdrawal by Subject|0|||
146297115|NCT02684357|527602700|FG003|Part A|Withdrawal by Subject|0|||
146297116|NCT02684357|527602701|FG004|Part A|Withdrawal by Subject|0|||
146297117|NCT02684357|527602702|FG005|Part A|Withdrawal by Subject|0|||
146297118|NCT02684357|527602697|FG000|Part A|Other|0|||
146297119|NCT02684357|527602698|FG001|Part A|Other|1|||
146297120|NCT02684357|527602699|FG002|Part A|Other|0|||
145897593|NCT03548064|526134970|FG001|Overall Study|Withdrawal by Subject|0|||
145897594|NCT03548064|526134971|FG002|Overall Study|Withdrawal by Subject|0|||
145897595|NCT03548064|526134972|FG003|Overall Study|Withdrawal by Subject|1|||
145897596|NCT03548064|526134973|FG004|Overall Study|Withdrawal by Subject|0|||
145897597|NCT03548064|526134974|FG005|Overall Study|Withdrawal by Subject|0|||
145897598|NCT03548064|526134975|FG006|Overall Study|Withdrawal by Subject|0|||
146297121|NCT02684357|527602700|FG003|Part A|Other|0|||
146297122|NCT02684357|527602701|FG004|Part A|Other|0|||
146297123|NCT02684357|527602702|FG005|Part A|Other|0|||
146297124|NCT02684357|527602697|FG000|Part B|Adverse Event (Other)|0|||
146297125|NCT02684357|527602698|FG001|Part B|Adverse Event (Other)|0|||
146297126|NCT02684357|527602699|FG002|Part B|Adverse Event (Other)|0|||
146297127|NCT02684357|527602700|FG003|Part B|Adverse Event (Other)|1|||
146297128|NCT02684357|527602701|FG004|Part B|Adverse Event (Other)|1|||
146297129|NCT02684357|527602702|FG005|Part B|Adverse Event (Other)|1|||
146297130|NCT02684357|527602697|FG000|Part B|Lost to Follow-up|0|||
146297131|NCT02684357|527602698|FG001|Part B|Lost to Follow-up|0|||
146297132|NCT02684357|527602699|FG002|Part B|Lost to Follow-up|0|||
145897599|NCT03548064|526134976|FG007|Overall Study|Withdrawal by Subject|0|||
145897600|NCT03548064|526134969|FG000|Overall Study|Lost to Follow-up|0|||
145897601|NCT03548064|526134970|FG001|Overall Study|Lost to Follow-up|0|||
145897602|NCT03548064|526134971|FG002|Overall Study|Lost to Follow-up|0|||
145897603|NCT03548064|526134972|FG003|Overall Study|Lost to Follow-up|0|||
145897604|NCT03548064|526134973|FG004|Overall Study|Lost to Follow-up|2|||
145897605|NCT03548064|526134974|FG005|Overall Study|Lost to Follow-up|0|||
145897606|NCT03548064|526134975|FG006|Overall Study|Lost to Follow-up|0|||
145897607|NCT03548064|526134976|FG007|Overall Study|Lost to Follow-up|0|||
145897608|NCT03548064|526134969|FG000|Overall Study|Covid-19 Pandemic|0|||
145897609|NCT03548064|526134970|FG001|Overall Study|Covid-19 Pandemic|0|||
145897610|NCT03548064|526134971|FG002|Overall Study|Covid-19 Pandemic|0|||
145897611|NCT03548064|526134972|FG003|Overall Study|Covid-19 Pandemic|0|||
145897612|NCT03548064|526134973|FG004|Overall Study|Covid-19 Pandemic|10|||
145897613|NCT03548064|526134974|FG005|Overall Study|Covid-19 Pandemic|3|||
146297133|NCT02684357|527602700|FG003|Part B|Lost to Follow-up|1|||
146297134|NCT02684357|527602701|FG004|Part B|Lost to Follow-up|1|||
146297135|NCT02684357|527602702|FG005|Part B|Lost to Follow-up|7|||
146297136|NCT02684357|527602697|FG000|Part B|Withdrawal by Subject|0|||
145897614|NCT03548064|526134975|FG006|Overall Study|Covid-19 Pandemic|0|||
145897615|NCT03548064|526134976|FG007|Overall Study|Covid-19 Pandemic|0|||
145897616|NCT04941729|526134977|FG000|Overall Study|Death|0|||
145897617|NCT04941729|526134978|FG001|Overall Study|Death|1|||
145897618|NCT04941729|526134977|FG000|Overall Study|Study terminated by sponsor|11|||
145897619|NCT04941729|526134978|FG001|Overall Study|Study terminated by sponsor|10|||
145897620|NCT05327816|526134989|FG000|Overall Study|Lost to Follow-up|1|||
145897621|NCT05327816|526134990|FG001|Overall Study|Lost to Follow-up|0|||
145897622|NCT05327816|526134991|FG002|Overall Study|Lost to Follow-up|0|||
145897623|NCT05327816|526134992|FG003|Overall Study|Lost to Follow-up|0|||
145897624|NCT05327816|526134993|FG004|Overall Study|Lost to Follow-up|0|||
145897625|NCT05327816|526134994|FG005|Overall Study|Lost to Follow-up|0|||
145897626|NCT05327816|526134995|FG006|Overall Study|Lost to Follow-up|0|||
145897627|NCT05327816|526134996|FG007|Overall Study|Lost to Follow-up|0|||
145897628|NCT05327816|526134997|FG008|Overall Study|Lost to Follow-up|0|||
145897629|NCT05327816|526134998|FG009|Overall Study|Lost to Follow-up|1|||
145897630|NCT05327816|526134999|FG010|Overall Study|Lost to Follow-up|0|||
145897631|NCT05327816|526134989|FG000|Overall Study|Withdrawal by Subject|0|||
145897632|NCT05327816|526134990|FG001|Overall Study|Withdrawal by Subject|0|||
146297137|NCT02684357|527602698|FG001|Part B|Withdrawal by Subject|0|||
146297138|NCT02684357|527602699|FG002|Part B|Withdrawal by Subject|0|||
146297139|NCT02684357|527602700|FG003|Part B|Withdrawal by Subject|0|||
146297140|NCT02684357|527602701|FG004|Part B|Withdrawal by Subject|2|||
145897633|NCT05327816|526134991|FG002|Overall Study|Withdrawal by Subject|0|||
145897634|NCT05327816|526134992|FG003|Overall Study|Withdrawal by Subject|0|||
145897635|NCT05327816|526134993|FG004|Overall Study|Withdrawal by Subject|1|||
145897636|NCT05327816|526134994|FG005|Overall Study|Withdrawal by Subject|1|||
146297141|NCT02684357|527602702|FG005|Part B|Withdrawal by Subject|4|||
146297142|NCT02684357|527602697|FG000|Part B|Other|0|||
146297143|NCT02684357|527602698|FG001|Part B|Other|0|||
146297144|NCT02684357|527602699|FG002|Part B|Other|0|||
146297145|NCT02684357|527602700|FG003|Part B|Other|1|||
146297146|NCT02684357|527602701|FG004|Part B|Other|0|||
145897637|NCT05327816|526134995|FG006|Overall Study|Withdrawal by Subject|0|||
145897638|NCT05327816|526134996|FG007|Overall Study|Withdrawal by Subject|0|||
145897639|NCT05327816|526134997|FG008|Overall Study|Withdrawal by Subject|0|||
145897640|NCT05327816|526134998|FG009|Overall Study|Withdrawal by Subject|0|||
145897641|NCT05327816|526134999|FG010|Overall Study|Withdrawal by Subject|0|||
145897642|NCT05327816|526134989|FG000|Overall Study|Study Terminated by Sponsor|11|||
145897643|NCT05327816|526134990|FG001|Overall Study|Study Terminated by Sponsor|12|||
145897644|NCT05327816|526134991|FG002|Overall Study|Study Terminated by Sponsor|12|||
145897645|NCT05327816|526134992|FG003|Overall Study|Study Terminated by Sponsor|12|||
145897646|NCT05327816|526134993|FG004|Overall Study|Study Terminated by Sponsor|11|||
145897647|NCT05327816|526134994|FG005|Overall Study|Study Terminated by Sponsor|11|||
145897648|NCT05327816|526134995|FG006|Overall Study|Study Terminated by Sponsor|11|||
145897649|NCT05327816|526134996|FG007|Overall Study|Study Terminated by Sponsor|11|||
145897650|NCT05327816|526134997|FG008|Overall Study|Study Terminated by Sponsor|11|||
145897651|NCT05327816|526134998|FG009|Overall Study|Study Terminated by Sponsor|11|||
145897652|NCT05327816|526134999|FG010|Overall Study|Study Terminated by Sponsor|12|||
145897653|NCT05327816|526134989|FG000|Overall Study|Randomized but not treated|0|||
145897654|NCT05327816|526134990|FG001|Overall Study|Randomized but not treated|0|||
145897655|NCT05327816|526134991|FG002|Overall Study|Randomized but not treated|0|||
145897656|NCT05327816|526134992|FG003|Overall Study|Randomized but not treated|0|||
145897657|NCT05327816|526134993|FG004|Overall Study|Randomized but not treated|0|||
145897658|NCT05327816|526134994|FG005|Overall Study|Randomized but not treated|0|||
145897659|NCT05327816|526134995|FG006|Overall Study|Randomized but not treated|1|||
145897660|NCT05327816|526134996|FG007|Overall Study|Randomized but not treated|1|||
145897661|NCT05327816|526134997|FG008|Overall Study|Randomized but not treated|1|||
145897662|NCT05327816|526134998|FG009|Overall Study|Randomized but not treated|0|||
145897663|NCT05327816|526134999|FG010|Overall Study|Randomized but not treated|0|||
145897664|NCT01106014|526135000|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
145897665|NCT01106014|526135001|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
145897666|NCT01106014|526135000|FG000|Overall Study|Adverse Event|78|||
145897667|NCT01106014|526135001|FG001|Overall Study|Adverse Event|42|||
145897668|NCT01106014|526135000|FG000|Overall Study|Withdrawal by Subject|43|||
145897669|NCT01106014|526135001|FG001|Overall Study|Withdrawal by Subject|37|||
145897670|NCT01106014|526135000|FG000|Overall Study|Administrative reason|7|||
145897671|NCT01106014|526135001|FG001|Overall Study|Administrative reason|6|||
145897672|NCT01106014|526135000|FG000|Overall Study|Lost to Follow-up|2|||
145897673|NCT01106014|526135001|FG001|Overall Study|Lost to Follow-up|3|||
145897674|NCT00658658|526135008|FG000|Overall Study|Withdrawal by Subject|0|||
145897675|NCT00658658|526135009|FG001|Overall Study|Withdrawal by Subject|1|||
145897676|NCT00658658|526135010|FG002|Overall Study|Withdrawal by Subject|0|||
145897677|NCT00658658|526135011|FG003|Overall Study|Withdrawal by Subject|0|||
145897678|NCT00658658|526135012|FG004|Overall Study|Withdrawal by Subject|0|||
145897679|NCT00658658|526135008|FG000|Overall Study|Death|4|||
145897680|NCT00658658|526135009|FG001|Overall Study|Death|0|||
145897681|NCT00658658|526135010|FG002|Overall Study|Death|0|||
145897682|NCT00658658|526135011|FG003|Overall Study|Death|1|||
145897683|NCT00658658|526135012|FG004|Overall Study|Death|1|||
145897684|NCT00658658|526135008|FG000|Overall Study|Disease Progression|0|||
145897685|NCT00658658|526135009|FG001|Overall Study|Disease Progression|1|||
145897686|NCT00658658|526135010|FG002|Overall Study|Disease Progression|0|||
145897687|NCT00658658|526135011|FG003|Overall Study|Disease Progression|1|||
145897688|NCT00658658|526135012|FG004|Overall Study|Disease Progression|3|||
145897689|NCT00658658|526135008|FG000|Overall Study|Protocol-specified Criteria|1|||
145897690|NCT00658658|526135009|FG001|Overall Study|Protocol-specified Criteria|0|||
145897691|NCT00658658|526135010|FG002|Overall Study|Protocol-specified Criteria|0|||
145897692|NCT00658658|526135011|FG003|Overall Study|Protocol-specified Criteria|0|||
145897693|NCT00658658|526135012|FG004|Overall Study|Protocol-specified Criteria|0|||
145897694|NCT00658658|526135008|FG000|Overall Study|Other|0|||
145897695|NCT00658658|526135009|FG001|Overall Study|Other|0|||
145897696|NCT00658658|526135010|FG002|Overall Study|Other|0|||
145897697|NCT00658658|526135011|FG003|Overall Study|Other|0|||
145897698|NCT00658658|526135012|FG004|Overall Study|Other|1|||
145897699|NCT03986138|526135013|FG000|First MRI Examination|Physician Decision|0|||
145897700|NCT03986138|526135014|FG001|First MRI Examination|Physician Decision|1|||
145897701|NCT03986138|526135013|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
145897702|NCT03986138|526135014|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
145897703|NCT03986138|526135013|FG000|Washout|Withdrawal by Subject|4|||
145897704|NCT03986138|526135014|FG001|Washout|Withdrawal by Subject|5|||
145897705|NCT03986138|526135013|FG000|Washout|Lost to Follow-up|0|||
145897706|NCT03986138|526135014|FG001|Washout|Lost to Follow-up|2|||
145897707|NCT03986138|526135013|FG000|Washout|Adverse Event|1|||
145897708|NCT03986138|526135014|FG001|Washout|Adverse Event|1|||
145897709|NCT03986138|526135013|FG000|Washout|Other reason|5|||
145897710|NCT03986138|526135014|FG001|Washout|Other reason|5|||
145897711|NCT03986138|526135013|FG000|Second MRI Examination|Withdrawal by Subject|0|||
145897712|NCT03986138|526135014|FG001|Second MRI Examination|Withdrawal by Subject|2|||
145897713|NCT04305587|526135016|FG000|Overall Study|Withdrawal by Subject|0|||
146088223|NCT03387150|526843770|FG001|Overall Study|Participant unable to adhere to visit|1|||
146088224|NCT03387150|526843771|FG002|Overall Study|Participant unable to adhere to visit|0|||
146088225|NCT03387150|526843772|FG003|Overall Study|Participant unable to adhere to visit|0|||
146088226|NCT03387150|526843773|FG004|Overall Study|Participant unable to adhere to visit|2|||
146088227|NCT03387150|526843774|FG005|Overall Study|Participant unable to adhere to visit|2|||
146088228|NCT03387150|526843775|FG006|Overall Study|Participant unable to adhere to visit|0|||
146088229|NCT04078178|526843776|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
146088230|NCT04078178|526843777|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
146088231|NCT04078178|526843776|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
146088232|NCT04078178|526843777|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
146088233|NCT04078178|526843776|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
146088234|NCT04078178|526843777|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
146088235|NCT04078178|526843776|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
145897714|NCT04305587|526135017|FG001|Overall Study|Withdrawal by Subject|0|||
146238514|NCT02386098|527386758|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146238515|NCT02386098|527386759|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146238516|NCT02386098|527386760|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
146238517|NCT03861052|527386761|FG000|Overall Study|Adverse Event|1|||
145897715|NCT04305587|526135018|FG002|Overall Study|Withdrawal by Subject|0|||
145897716|NCT04305587|526135019|FG003|Overall Study|Withdrawal by Subject|1|||
145897717|NCT04305587|526135020|FG004|Overall Study|Withdrawal by Subject|0|||
145897718|NCT04305587|526135021|FG005|Overall Study|Withdrawal by Subject|0|||
145897719|NCT04305587|526135022|FG006|Overall Study|Withdrawal by Subject|0|||
145897720|NCT04305587|526135023|FG007|Overall Study|Withdrawal by Subject|0|||
145897721|NCT04305587|526135024|FG008|Overall Study|Withdrawal by Subject|0|||
145897722|NCT01523457|526135025|FG000|Overall Study|Withdrawal by Subject|7|||
145897723|NCT01523457|526135026|FG001|Overall Study|Withdrawal by Subject|2|||
145897724|NCT02622113|526135029|FG000|Overall Study|Adverse Event|4|||
145897725|NCT02622113|526135030|FG001|Overall Study|Adverse Event|4|||
145897726|NCT02622113|526135029|FG000|Overall Study|Physician Decision|0|||
145897727|NCT02622113|526135030|FG001|Overall Study|Physician Decision|1|||
145897728|NCT02622113|526135029|FG000|Overall Study|Withdrawal by Subject|0|||
145897729|NCT02622113|526135030|FG001|Overall Study|Withdrawal by Subject|2|||
145897730|NCT02622113|526135029|FG000|Overall Study|Stopping Criteria|1|||
145897731|NCT02622113|526135030|FG001|Overall Study|Stopping Criteria|3|||
145897732|NCT00667810|526135031|FG000|Overall Study|Adverse Event|13|||
145897733|NCT00667810|526135032|FG001|Overall Study|Adverse Event|14|||
145897734|NCT00667810|526135033|FG002|Overall Study|Adverse Event|19|||
145897735|NCT00667810|526135034|FG003|Overall Study|Adverse Event|1|||
145897736|NCT00667810|526135031|FG000|Overall Study|Death|1|||
145897737|NCT00667810|526135032|FG001|Overall Study|Death|1|||
145897738|NCT00667810|526135033|FG002|Overall Study|Death|3|||
145897739|NCT00667810|526135034|FG003|Overall Study|Death|0|||
145897740|NCT00667810|526135031|FG000|Overall Study|Lack of Efficacy|1|||
145897741|NCT00667810|526135032|FG001|Overall Study|Lack of Efficacy|0|||
145897742|NCT00667810|526135033|FG002|Overall Study|Lack of Efficacy|2|||
145897743|NCT00667810|526135034|FG003|Overall Study|Lack of Efficacy|0|||
145897744|NCT00667810|526135031|FG000|Overall Study|Lost to Follow-up|1|||
145897745|NCT00667810|526135032|FG001|Overall Study|Lost to Follow-up|4|||
145897746|NCT00667810|526135033|FG002|Overall Study|Lost to Follow-up|2|||
145897747|NCT00667810|526135034|FG003|Overall Study|Lost to Follow-up|0|||
145897748|NCT00667810|526135031|FG000|Overall Study|Physician Decision|1|||
145897749|NCT00667810|526135032|FG001|Overall Study|Physician Decision|1|||
145897750|NCT00667810|526135033|FG002|Overall Study|Physician Decision|2|||
145897751|NCT00667810|526135034|FG003|Overall Study|Physician Decision|0|||
145897752|NCT00667810|526135031|FG000|Overall Study|Protocol Violation|0|||
145897753|NCT00667810|526135032|FG001|Overall Study|Protocol Violation|2|||
145897754|NCT00667810|526135033|FG002|Overall Study|Protocol Violation|0|||
145897755|NCT00667810|526135034|FG003|Overall Study|Protocol Violation|0|||
145897756|NCT00667810|526135031|FG000|Overall Study|Withdrawal by Subject|14|||
145897757|NCT00667810|526135032|FG001|Overall Study|Withdrawal by Subject|20|||
145897758|NCT00667810|526135033|FG002|Overall Study|Withdrawal by Subject|29|||
145897759|NCT00667810|526135034|FG003|Overall Study|Withdrawal by Subject|1|||
145897760|NCT00667810|526135031|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
145897761|NCT00667810|526135032|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
145897762|NCT00667810|526135033|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
145897763|NCT00667810|526135034|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145897764|NCT00667810|526135031|FG000|Overall Study|Failed to Return|0|||
145897765|NCT00667810|526135032|FG001|Overall Study|Failed to Return|0|||
145897766|NCT00667810|526135033|FG002|Overall Study|Failed to Return|2|||
146088236|NCT04078178|526843777|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
146088237|NCT04078178|526843776|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
146088238|NCT04078178|526843777|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
146238518|NCT03861052|527386762|FG001|Overall Study|Adverse Event|1|||
146238519|NCT03861052|527386763|FG002|Overall Study|Adverse Event|2|||
146238520|NCT03861052|527386764|FG003|Overall Study|Adverse Event|4|||
146238521|NCT03861052|527386761|FG000|Overall Study|Lost to Follow-up|0|||
146238522|NCT03861052|527386762|FG001|Overall Study|Lost to Follow-up|0|||
146238523|NCT03861052|527386763|FG002|Overall Study|Lost to Follow-up|0|||
145897767|NCT00667810|526135034|FG003|Overall Study|Failed to Return|0|||
145897768|NCT00667810|526135031|FG000|Overall Study|Loss of Caregiver|0|||
145897769|NCT00667810|526135032|FG001|Overall Study|Loss of Caregiver|1|||
145897770|NCT00667810|526135033|FG002|Overall Study|Loss of Caregiver|3|||
145897771|NCT00667810|526135034|FG003|Overall Study|Loss of Caregiver|0|||
145897772|NCT00667810|526135031|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
145897773|NCT00667810|526135032|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
145897774|NCT00667810|526135033|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
145897775|NCT00667810|526135034|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
145897776|NCT00667810|526135031|FG000|Overall Study|Other|6|||
145897777|NCT00667810|526135032|FG001|Overall Study|Other|6|||
145897778|NCT00667810|526135033|FG002|Overall Study|Other|5|||
145897779|NCT00667810|526135034|FG003|Overall Study|Other|0|||
145897780|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
145897781|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
145897782|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
145897783|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
145897784|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
145897785|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
145897786|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
145897787|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
145897788|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
145897789|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
145897790|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
145897791|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
145897792|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
145897793|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
145897794|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
145897795|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
145897796|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
145897797|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
145897798|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
145897799|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
145897800|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
145897801|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145897802|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145897803|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145897804|NCT03514641|526135044|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145897805|NCT03514641|526135045|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
145897806|NCT03514641|526135046|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145897807|NCT03514641|526135047|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145897808|NCT03514641|526135044|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
145897809|NCT03514641|526135045|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
145897810|NCT03514641|526135046|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
145897811|NCT03514641|526135047|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
145897812|NCT03514641|526135044|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
145897813|NCT03514641|526135045|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
145897814|NCT03514641|526135046|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
145897815|NCT03514641|526135047|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
145897816|NCT03514641|526135044|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
145897817|NCT03514641|526135045|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
145897818|NCT03514641|526135046|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
145897819|NCT03514641|526135047|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
145897820|NCT03514641|526135044|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
145897821|NCT03514641|526135045|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
145897822|NCT03514641|526135046|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
145897823|NCT03514641|526135047|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
145897824|NCT03514641|526135044|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
145897825|NCT03514641|526135045|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
145897826|NCT03514641|526135046|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
145897827|NCT03514641|526135047|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
145897828|NCT00505375|526135048|FG000|Overall Study|Death|1|||
145897829|NCT00505375|526135049|FG001|Overall Study|Death|0|||
145897830|NCT00505375|526135048|FG000|Overall Study|Withdrawal by Subject|2|||
145897831|NCT00505375|526135049|FG001|Overall Study|Withdrawal by Subject|2|||
145897832|NCT00505375|526135048|FG000|Overall Study|Lost to Follow-up|0|||
145897833|NCT00505375|526135049|FG001|Overall Study|Lost to Follow-up|2|||
146238524|NCT03861052|527386764|FG003|Overall Study|Lost to Follow-up|1|||
146297147|NCT02684357|527602702|FG005|Part B|Other|1|||
146297148|NCT04567615|527602703|FG000|Randomization|Participant withdrew consent|1|||
146297149|NCT04567615|527602704|FG001|Randomization|Participant withdrew consent|0|||
146297150|NCT04567615|527602705|FG002|Randomization|Participant withdrew consent|0|||
145897834|NCT00505375|526135048|FG000|Overall Study|Pregnancy|1|||
145897835|NCT00505375|526135049|FG001|Overall Study|Pregnancy|0|||
145897836|NCT00505375|526135048|FG000|Overall Study|Travel issues|0|||
145897837|NCT00505375|526135049|FG001|Overall Study|Travel issues|1|||
145897838|NCT01561430|526135050|FG000|Overall Study|Adverse Event|0|||
145897839|NCT01561430|526135051|FG001|Overall Study|Adverse Event|0|||
145897840|NCT01561430|526135052|FG002|Overall Study|Adverse Event|3|||
145897841|NCT01561430|526135053|FG003|Overall Study|Adverse Event|1|||
145897842|NCT01561430|526135050|FG000|Overall Study|Withdrawal by Subject|0|||
145897843|NCT01561430|526135051|FG001|Overall Study|Withdrawal by Subject|0|||
145897844|NCT01561430|526135052|FG002|Overall Study|Withdrawal by Subject|1|||
145897845|NCT01561430|526135053|FG003|Overall Study|Withdrawal by Subject|0|||
145897846|NCT01561430|526135050|FG000|Overall Study|Physician Decision|0|||
146088239|NCT04006119|526843778|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
145897847|NCT01561430|526135051|FG001|Overall Study|Physician Decision|1|||
145897848|NCT01561430|526135052|FG002|Overall Study|Physician Decision|0|||
145897849|NCT01561430|526135053|FG003|Overall Study|Physician Decision|0|||
145897850|NCT01561430|526135050|FG000|Overall Study|Sponsor Decision|1|||
145897851|NCT01561430|526135051|FG001|Overall Study|Sponsor Decision|14|||
145897852|NCT01561430|526135052|FG002|Overall Study|Sponsor Decision|13|||
145897853|NCT01561430|526135053|FG003|Overall Study|Sponsor Decision|12|||
145897854|NCT04234984|526135061|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
145897855|NCT04234984|526135061|FG000|Follow-up at the Second Time Point|Death|1|||
145897856|NCT04234984|526135061|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
145897857|NCT01055132|526135062|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
145897858|NCT01055132|526135063|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
145897859|NCT01055132|526135062|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
145897860|NCT01055132|526135063|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
145897861|NCT02570113|526135064|FG000|Overall Study|Withdrawal by Subject|3|||
146297151|NCT04567615|527602703|FG000|Randomization|Adverse event unrelated to study drug|0|||
146297152|NCT04567615|527602704|FG001|Randomization|Adverse event unrelated to study drug|1|||
146297153|NCT04567615|527602705|FG002|Randomization|Adverse event unrelated to study drug|0|||
145897862|NCT02564211|526135065|FG000|Overall Study|Adverse Event|4|||
145897863|NCT05183217|526135069|FG000|Overall Study|Withdrawal by Subject|1|||
145897864|NCT05183217|526135070|FG001|Overall Study|Withdrawal by Subject|1|||
145897865|NCT00415194|526135081|FG000|Overall Study|Adverse Event|37|||
145897866|NCT00415194|526135082|FG001|Overall Study|Adverse Event|32|||
145897867|NCT00415194|526135081|FG000|Overall Study|Entry Criteria Not Met|4|||
146088240|NCT04006119|526843778|FG000|End of Treatment Veledimex|Adverse Event|2|||
145897868|NCT00415194|526135082|FG001|Overall Study|Entry Criteria Not Met|8|||
145897869|NCT00415194|526135081|FG000|Overall Study|Lost to Follow-up|1|||
145897870|NCT00415194|526135082|FG001|Overall Study|Lost to Follow-up|0|||
145897871|NCT00415194|526135081|FG000|Overall Study|Physician Decision|10|||
145897872|NCT00415194|526135082|FG001|Overall Study|Physician Decision|16|||
145897873|NCT00415194|526135081|FG000|Overall Study|Progressive Disease|180|||
145897874|NCT00415194|526135082|FG001|Overall Study|Progressive Disease|217|||
145897875|NCT00415194|526135081|FG000|Overall Study|Protocol Violation|4|||
145897876|NCT00415194|526135082|FG001|Overall Study|Protocol Violation|2|||
145897877|NCT00415194|526135081|FG000|Overall Study|Withdrawal by Subject|28|||
145897878|NCT00415194|526135082|FG001|Overall Study|Withdrawal by Subject|21|||
145897879|NCT00415194|526135081|FG000|Overall Study|Death Due to Study Disease|26|||
145897880|NCT00415194|526135082|FG001|Overall Study|Death Due to Study Disease|29|||
145897881|NCT00415194|526135081|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
145897882|NCT00415194|526135082|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
145897883|NCT00415194|526135081|FG000|Overall Study|Death Due to Procedural Related AE|0|||
145897884|NCT00415194|526135082|FG001|Overall Study|Death Due to Procedural Related AE|1|||
145897885|NCT00415194|526135081|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
145897886|NCT00415194|526135082|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
146088241|NCT04006119|526843778|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
146088242|NCT04006119|526843778|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
146088243|NCT04006119|526843778|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
146088244|NCT04006119|526843778|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
146297154|NCT04567615|527602703|FG000|Treatment Period|Participant Withdrew Consent|2|||
145897887|NCT01297465|526135083|FG000|Overall Study|Lack of Ovarian Response|1|||
145897888|NCT01297465|526135084|FG001|Overall Study|Lack of Ovarian Response|1|||
145897889|NCT01297465|526135083|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
145897890|NCT01297465|526135084|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145897891|NCT01297465|526135083|FG000|Overall Study|No Oocytes Retrieved|1|||
145897892|NCT01297465|526135084|FG001|Overall Study|No Oocytes Retrieved|1|||
145897893|NCT01297465|526135083|FG000|Overall Study|Poor oocyte quality|0|||
145897894|NCT01297465|526135084|FG001|Overall Study|Poor oocyte quality|1|||
145897895|NCT01297465|526135083|FG000|Overall Study|No Fertilization|6|||
145897896|NCT01297465|526135084|FG001|Overall Study|No Fertilization|4|||
145897897|NCT01297465|526135083|FG000|Overall Study|All Embryos Discarded|0|||
145897898|NCT01297465|526135084|FG001|Overall Study|All Embryos Discarded|1|||
145897899|NCT01297465|526135083|FG000|Overall Study|Intention to Freeze all Embryos|0|||
145897900|NCT01297465|526135084|FG001|Overall Study|Intention to Freeze all Embryos|1|||
145897901|NCT00969540|526135085|FG000|Overall Study|Lost to Follow-up|1|||
145897902|NCT00969540|526135086|FG001|Overall Study|Lost to Follow-up|1|||
145897903|NCT02116608|526135092|FG000|Overall Study|Lost to Follow-up|0|||
145897904|NCT02116608|526135093|FG001|Overall Study|Lost to Follow-up|0|||
145897905|NCT02116608|526135094|FG002|Overall Study|Lost to Follow-up|1|||
145897906|NCT02116608|526135092|FG000|Overall Study|Physician Decision|0|||
145897907|NCT02116608|526135093|FG001|Overall Study|Physician Decision|1|||
145897908|NCT02116608|526135094|FG002|Overall Study|Physician Decision|0|||
145897909|NCT02116608|526135092|FG000|Overall Study|Death|0|||
145897910|NCT02116608|526135093|FG001|Overall Study|Death|1|||
145897911|NCT02116608|526135094|FG002|Overall Study|Death|0|||
145897912|NCT00988442|526135096|FG000|Overall Study|Death|1|||
145897913|NCT00988442|526135097|FG001|Overall Study|Death|2|||
145897914|NCT00988442|526135096|FG000|Overall Study|Lost to Follow-up|0|||
145897915|NCT00988442|526135097|FG001|Overall Study|Lost to Follow-up|1|||
145897916|NCT00988442|526135096|FG000|Overall Study|Early Study Closure|29|||
145897917|NCT00988442|526135097|FG001|Overall Study|Early Study Closure|25|||
145897918|NCT02731326|526135102|FG000|Overall Study|Withdrawal by Subject|4|||
145897919|NCT02731326|526135103|FG001|Overall Study|Withdrawal by Subject|1|||
145897920|NCT02731326|526135102|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
145897921|NCT02731326|526135103|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
145897922|NCT02731326|526135102|FG000|Overall Study|Discharged without AliveCor|10|||
145897923|NCT02731326|526135103|FG001|Overall Study|Discharged without AliveCor|0|||
145897924|NCT02731326|526135102|FG000|Overall Study|Duplicate Participant|1|||
145897925|NCT02731326|526135103|FG001|Overall Study|Duplicate Participant|1|||
145897926|NCT00302081|526135105|FG000|Overall Study|Adverse Event|6|||
145897927|NCT00302081|526135106|FG001|Overall Study|Adverse Event|5|||
145897928|NCT00302081|526135107|FG002|Overall Study|Adverse Event|4|||
145897929|NCT00302081|526135105|FG000|Overall Study|Lost to Follow-up|21|||
145897930|NCT00302081|526135106|FG001|Overall Study|Lost to Follow-up|18|||
146238525|NCT03861052|527386761|FG000|Overall Study|Physician Decision|0|||
146238526|NCT03861052|527386762|FG001|Overall Study|Physician Decision|1|||
146238527|NCT03861052|527386763|FG002|Overall Study|Physician Decision|0|||
145897931|NCT00302081|526135107|FG002|Overall Study|Lost to Follow-up|28|||
145897932|NCT00302081|526135105|FG000|Overall Study|Withdrawal by Subject|8|||
145897933|NCT00302081|526135106|FG001|Overall Study|Withdrawal by Subject|12|||
145897934|NCT00302081|526135107|FG002|Overall Study|Withdrawal by Subject|8|||
145897935|NCT00302081|526135105|FG000|Overall Study|Protocol Violation|5|||
145897936|NCT00302081|526135106|FG001|Overall Study|Protocol Violation|1|||
145897937|NCT00302081|526135107|FG002|Overall Study|Protocol Violation|2|||
145897938|NCT00302081|526135105|FG000|Overall Study|Lack of Efficacy|1|||
145897939|NCT00302081|526135106|FG001|Overall Study|Lack of Efficacy|0|||
145897940|NCT00302081|526135107|FG002|Overall Study|Lack of Efficacy|5|||
145897941|NCT00302081|526135105|FG000|Overall Study|Death|2|||
145897942|NCT00302081|526135106|FG001|Overall Study|Death|1|||
145897943|NCT00302081|526135107|FG002|Overall Study|Death|0|||
145897944|NCT00302081|526135105|FG000|Overall Study|Other|13|||
145897945|NCT00302081|526135106|FG001|Overall Study|Other|6|||
145897946|NCT00302081|526135107|FG002|Overall Study|Other|5|||
145897947|NCT04480710|526135108|FG000|Overall Study|Adverse Event|0|||
145897948|NCT04480710|526135109|FG001|Overall Study|Adverse Event|2|||
145897949|NCT04480710|526135110|FG002|Overall Study|Adverse Event|0|||
145897950|NCT04480710|526135111|FG003|Overall Study|Adverse Event|0|||
146088245|NCT04617795|526843779|FG000|Main Study|Lost to Follow-up|1|||
146088246|NCT04617795|526843780|FG001|Main Study|Lost to Follow-up|0|||
146088247|NCT00472459|526843781|FG000|Overall Study|Adverse Event|13|||
146238528|NCT03861052|527386764|FG003|Overall Study|Physician Decision|0|||
146238529|NCT03861052|527386761|FG000|Overall Study|Withdrawal by Subject|2|||
145897951|NCT04480710|526135108|FG000|Overall Study|Withdrawal by Subject|0|||
145897952|NCT04480710|526135109|FG001|Overall Study|Withdrawal by Subject|1|||
145897953|NCT04480710|526135110|FG002|Overall Study|Withdrawal by Subject|0|||
145897954|NCT04480710|526135111|FG003|Overall Study|Withdrawal by Subject|0|||
145897955|NCT04480710|526135108|FG000|Overall Study|Physician Decision|0|||
145897956|NCT04480710|526135109|FG001|Overall Study|Physician Decision|0|||
145897957|NCT04480710|526135110|FG002|Overall Study|Physician Decision|1|||
145897958|NCT04480710|526135111|FG003|Overall Study|Physician Decision|0|||
145897959|NCT05084963|526135113|FG000|Overall Study|Withdrawal by Subject|0|||
145897960|NCT05084963|526135114|FG001|Overall Study|Withdrawal by Subject|0|||
145897961|NCT05084963|526135115|FG002|Overall Study|Withdrawal by Subject|1|||
145897962|NCT03569228|526135116|FG000|Overall Study|Withdrawal by PI|0|||
145897963|NCT03569228|526135117|FG001|Overall Study|Withdrawal by PI|0|||
145897964|NCT03569228|526135118|FG002|Overall Study|Withdrawal by PI|2|||
146088248|NCT00472459|526843782|FG001|Overall Study|Adverse Event|13|||
145897965|NCT03569228|526135119|FG003|Overall Study|Withdrawal by PI|2|||
145897966|NCT03569228|526135120|FG004|Overall Study|Withdrawal by PI|1|||
145897967|NCT03569228|526135121|FG005|Overall Study|Withdrawal by PI|0|||
145897968|NCT03569228|526135122|FG006|Overall Study|Withdrawal by PI|0|||
145897969|NCT03569228|526135123|FG007|Overall Study|Withdrawal by PI|0|||
145897970|NCT03569228|526135124|FG008|Overall Study|Withdrawal by PI|0|||
146297155|NCT04567615|527602704|FG001|Treatment Period|Participant Withdrew Consent|5|||
146297156|NCT04567615|527602705|FG002|Treatment Period|Participant Withdrew Consent|1|||
146297157|NCT04567615|527602703|FG000|Treatment Period|Death|1|||
146297158|NCT04567615|527602704|FG001|Treatment Period|Death|2|||
145897971|NCT03569228|526135116|FG000|Overall Study|Lost to Follow-up|0|||
145897972|NCT03569228|526135117|FG001|Overall Study|Lost to Follow-up|0|||
146297159|NCT04567615|527602705|FG002|Treatment Period|Death|0|||
146297160|NCT04567615|527602703|FG000|Treatment Period|Lost to Follow-up|0|||
146297161|NCT04567615|527602704|FG001|Treatment Period|Lost to Follow-up|1|||
146297162|NCT04567615|527602705|FG002|Treatment Period|Lost to Follow-up|0|||
146297163|NCT04567615|527602703|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
146297164|NCT04567615|527602704|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
146297165|NCT04567615|527602705|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
146297166|NCT04567615|527602703|FG000|Treatment Period|Disease Progression|85|||
146297167|NCT04567615|527602704|FG001|Treatment Period|Disease Progression|63|||
146297168|NCT04567615|527602705|FG002|Treatment Period|Disease Progression|16|||
146297169|NCT04567615|527602703|FG000|Treatment Period|Study Drug Toxicity|3|||
146297170|NCT04567615|527602704|FG001|Treatment Period|Study Drug Toxicity|10|||
146297171|NCT04567615|527602705|FG002|Treatment Period|Study Drug Toxicity|4|||
146297172|NCT04567615|527602703|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
146297173|NCT04567615|527602704|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
146297174|NCT04567615|527602705|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
146297175|NCT04567615|527602703|FG000|Treatment Period|Other Reasons|1|||
146297176|NCT04567615|527602704|FG001|Treatment Period|Other Reasons|2|||
146297177|NCT04567615|527602705|FG002|Treatment Period|Other Reasons|0|||
146297178|NCT04567615|527602703|FG000|Treatment Period|Still On-going Treatment|21|||
145897973|NCT03569228|526135118|FG002|Overall Study|Lost to Follow-up|0|||
145897974|NCT03569228|526135119|FG003|Overall Study|Lost to Follow-up|0|||
145897975|NCT03569228|526135120|FG004|Overall Study|Lost to Follow-up|0|||
145897976|NCT03569228|526135121|FG005|Overall Study|Lost to Follow-up|0|||
145897977|NCT03569228|526135122|FG006|Overall Study|Lost to Follow-up|0|||
145897978|NCT03569228|526135123|FG007|Overall Study|Lost to Follow-up|0|||
145897979|NCT03569228|526135124|FG008|Overall Study|Lost to Follow-up|1|||
145897980|NCT03569228|526135116|FG000|Overall Study|Screen Fail|2|||
145897981|NCT03569228|526135117|FG001|Overall Study|Screen Fail|2|||
145897982|NCT03569228|526135118|FG002|Overall Study|Screen Fail|1|||
145897983|NCT03569228|526135119|FG003|Overall Study|Screen Fail|1|||
145897984|NCT03569228|526135120|FG004|Overall Study|Screen Fail|1|||
145897985|NCT03569228|526135121|FG005|Overall Study|Screen Fail|3|||
145897986|NCT03569228|526135122|FG006|Overall Study|Screen Fail|1|||
145897987|NCT03569228|526135123|FG007|Overall Study|Screen Fail|5|||
145897988|NCT03569228|526135124|FG008|Overall Study|Screen Fail|2|||
145897989|NCT05442866|526135125|FG000|Overall Study|Death|1|||
145897990|NCT05442866|526135125|FG000|Overall Study|Lost to Follow-up|9|||
145897991|NCT05442866|526135125|FG000|Overall Study|Protocol Violation|1|||
145897992|NCT03819049|526135126|FG000|Overall Study|Lost to Follow-up|1|||
145897993|NCT03819049|526135127|FG001|Overall Study|Lost to Follow-up|2|||
145897994|NCT03819049|526135128|FG002|Overall Study|Lost to Follow-up|9|||
145897995|NCT03819049|526135129|FG003|Overall Study|Lost to Follow-up|0|||
145897996|NCT03819049|526135130|FG004|Overall Study|Lost to Follow-up|3|||
145897997|NCT03819049|526135131|FG005|Overall Study|Lost to Follow-up|1|||
145897998|NCT03819049|526135132|FG006|Overall Study|Lost to Follow-up|0|||
145897999|NCT03819049|526135126|FG000|Overall Study|Withdrawal by Subject|0|||
145898000|NCT03819049|526135127|FG001|Overall Study|Withdrawal by Subject|0|||
145898001|NCT03819049|526135128|FG002|Overall Study|Withdrawal by Subject|18|||
145898002|NCT03819049|526135129|FG003|Overall Study|Withdrawal by Subject|0|||
145898003|NCT03819049|526135130|FG004|Overall Study|Withdrawal by Subject|10|||
145898004|NCT03819049|526135131|FG005|Overall Study|Withdrawal by Subject|9|||
145898005|NCT03819049|526135132|FG006|Overall Study|Withdrawal by Subject|1|||
145898006|NCT03819049|526135126|FG000|Overall Study|Ongoing|0|||
145898007|NCT03819049|526135127|FG001|Overall Study|Ongoing|0|||
145898008|NCT03819049|526135128|FG002|Overall Study|Ongoing|75|||
145898009|NCT03819049|526135129|FG003|Overall Study|Ongoing|0|||
145898010|NCT03819049|526135130|FG004|Overall Study|Ongoing|41|||
146297179|NCT04567615|527602704|FG001|Treatment Period|Still On-going Treatment|22|||
146297180|NCT04567615|527602705|FG002|Treatment Period|Still On-going Treatment|2|||
145898011|NCT03819049|526135131|FG005|Overall Study|Ongoing|0|||
145898012|NCT03819049|526135132|FG006|Overall Study|Ongoing|0|||
145898013|NCT03819049|526135126|FG000|Overall Study|Other|0|||
145898014|NCT03819049|526135127|FG001|Overall Study|Other|0|||
145898015|NCT03819049|526135128|FG002|Overall Study|Other|2|||
145898016|NCT03819049|526135129|FG003|Overall Study|Other|0|||
145898017|NCT03819049|526135130|FG004|Overall Study|Other|0|||
146297181|NCT05028517|527602706|FG000|Overall Study|Lost to Follow-up|13|||
146238530|NCT03861052|527386762|FG001|Overall Study|Withdrawal by Subject|5|||
146238531|NCT03861052|527386763|FG002|Overall Study|Withdrawal by Subject|3|||
146238532|NCT03861052|527386764|FG003|Overall Study|Withdrawal by Subject|0|||
146238533|NCT03861052|527386761|FG000|Overall Study|Relocation to other city|1|||
146238534|NCT03861052|527386762|FG001|Overall Study|Relocation to other city|0|||
146238535|NCT03861052|527386763|FG002|Overall Study|Relocation to other city|0|||
146238536|NCT03861052|527386764|FG003|Overall Study|Relocation to other city|0|||
146238537|NCT03712371|527386771|FG000|Overall Study|Lack of Efficacy|0|||
146238538|NCT03712371|527386772|FG001|Overall Study|Lack of Efficacy|0|||
146238539|NCT03712371|527386773|FG002|Overall Study|Lack of Efficacy|0|||
146238540|NCT03712371|527386774|FG003|Overall Study|Lack of Efficacy|1|||
146238541|NCT02362035|527386777|FG000|Overall Study|Death|67|||
145898018|NCT03819049|526135131|FG005|Overall Study|Other|0|||
145898019|NCT03819049|526135132|FG006|Overall Study|Other|0|||
145898020|NCT03819049|526135126|FG000|Overall Study|Randomized but not vaccinated|0|||
145898021|NCT03819049|526135127|FG001|Overall Study|Randomized but not vaccinated|0|||
146297182|NCT05028517|527602707|FG001|Overall Study|Lost to Follow-up|20|||
146297183|NCT05028517|527602708|FG002|Overall Study|Lost to Follow-up|12|||
146297184|NCT05028517|527602706|FG000|Overall Study|Withdrawal by Subject|0|||
146297185|NCT05028517|527602707|FG001|Overall Study|Withdrawal by Subject|0|||
146297186|NCT05028517|527602708|FG002|Overall Study|Withdrawal by Subject|1|||
146297187|NCT04982588|527604618|FG000|Overall Study|Withdrawal by Subject|2|||
146297188|NCT02170389|527604619|FG000|Overall Study|Study terminated prior to start of treat|1|||
146297189|NCT01008696|527604620|FG000|Overall Study|Participant's evasion of hospital visit|5|||
146297190|NCT01008696|527604621|FG001|Overall Study|Participant's evasion of hospital visit|4|||
146297191|NCT01008696|527604620|FG000|Overall Study|Withdrawal by Subject|2|||
146297192|NCT01008696|527604621|FG001|Overall Study|Withdrawal by Subject|4|||
146297193|NCT01008696|527604620|FG000|Overall Study|Physician Decision|5|||
146297194|NCT01008696|527604621|FG001|Overall Study|Physician Decision|1|||
146297195|NCT01008696|527604620|FG000|Overall Study|Adverse Event|1|||
146297196|NCT01008696|527604621|FG001|Overall Study|Adverse Event|0|||
146297197|NCT01008696|527604620|FG000|Overall Study|Participants' non-cooperation|2|||
146297198|NCT01008696|527604621|FG001|Overall Study|Participants' non-cooperation|3|||
146297199|NCT01008696|527604620|FG000|Overall Study|Other|2|||
146297200|NCT01008696|527604621|FG001|Overall Study|Other|3|||
146297201|NCT01008696|527604620|FG000|Overall Study|Other|0|||
146297202|NCT01008696|527604621|FG001|Overall Study|Other|2|||
146297203|NCT02366728|527604622|FG000|Overall Study|Death|0|||
146297204|NCT02366728|527604623|FG001|Overall Study|Death|0|||
146297205|NCT02366728|527604624|FG002|Overall Study|Death|1|||
146297206|NCT02366728|527604622|FG000|Overall Study|Adverse Event|1|||
146297207|NCT02366728|527604623|FG001|Overall Study|Adverse Event|0|||
146297208|NCT02366728|527604624|FG002|Overall Study|Adverse Event|0|||
146297209|NCT02366728|527604622|FG000|Overall Study|Screen Failure|2|||
145898022|NCT03819049|526135128|FG002|Overall Study|Randomized but not vaccinated|0|||
145898023|NCT03819049|526135129|FG003|Overall Study|Randomized but not vaccinated|1|||
145898024|NCT03819049|526135130|FG004|Overall Study|Randomized but not vaccinated|0|||
145898025|NCT03819049|526135131|FG005|Overall Study|Randomized but not vaccinated|2|||
145898026|NCT03819049|526135132|FG006|Overall Study|Randomized but not vaccinated|1|||
145898027|NCT03819049|526135126|FG000|Overall Study|Physician Decision|0|||
145898028|NCT03819049|526135127|FG001|Overall Study|Physician Decision|0|||
145898029|NCT03819049|526135128|FG002|Overall Study|Physician Decision|0|||
145898030|NCT03819049|526135129|FG003|Overall Study|Physician Decision|0|||
145898031|NCT03819049|526135130|FG004|Overall Study|Physician Decision|0|||
145898032|NCT03819049|526135131|FG005|Overall Study|Physician Decision|0|||
145898033|NCT03819049|526135132|FG006|Overall Study|Physician Decision|1|||
146238542|NCT02362035|527386777|FG000|Overall Study|Lost to Follow-up|3|||
146297210|NCT02366728|527604623|FG001|Overall Study|Screen Failure|1|||
146297211|NCT02366728|527604624|FG002|Overall Study|Screen Failure|0|||
146297212|NCT02366728|527604622|FG000|Overall Study|Only yielded 2 vaccines|1|||
146297213|NCT02366728|527604623|FG001|Overall Study|Only yielded 2 vaccines|0|||
146297214|NCT02366728|527604624|FG002|Overall Study|Only yielded 2 vaccines|0|||
146297215|NCT06069778|527604633|FG000|Overall Study|Withdrawal by Subject|1|||
146297216|NCT02310672|527604634|FG000|Overall Study|Death|1|||
146297217|NCT02310672|527604634|FG000|Overall Study|Lost to Follow-up|1|||
146297218|NCT02310672|527604634|FG000|Overall Study|Withdrawal by Subject|1|||
146297219|NCT02310672|527604634|FG000|Overall Study|Sponsor's decision|12|||
146297220|NCT04704336|527604638|FG000|Overall Study|Death|2|||
146297221|NCT04704336|527604639|FG001|Overall Study|Death|2|||
146297222|NCT04704336|527604638|FG000|Overall Study|Lost to Follow-up|33|||
145898034|NCT01616953|526135133|FG000|Overall Study|Lost to Follow-up|1|||
146238543|NCT02362035|527386777|FG000|Overall Study|Adverse Event|1|||
145898035|NCT01616953|526135134|FG001|Overall Study|Lost to Follow-up|0|||
146238544|NCT02362035|527386777|FG000|Overall Study|Physician Decision|1|||
146297223|NCT04704336|527604639|FG001|Overall Study|Lost to Follow-up|40|||
146297224|NCT01284062|527604649|FG000|Overall Study|Adverse Event|4|||
146297225|NCT01284062|527604650|FG001|Overall Study|Adverse Event|5|||
146297226|NCT01284062|527604651|FG002|Overall Study|Adverse Event|0|||
146297227|NCT01284062|527604652|FG003|Overall Study|Adverse Event|5|||
146297228|NCT01284062|527604649|FG000|Overall Study|Lack of Efficacy|3|||
146297229|NCT01284062|527604650|FG001|Overall Study|Lack of Efficacy|2|||
146297230|NCT01284062|527604651|FG002|Overall Study|Lack of Efficacy|2|||
146297231|NCT01284062|527604652|FG003|Overall Study|Lack of Efficacy|1|||
146297232|NCT01284062|527604649|FG000|Overall Study|Medication error without adverse event|0|||
146297233|NCT01284062|527604650|FG001|Overall Study|Medication error without adverse event|0|||
146297234|NCT01284062|527604651|FG002|Overall Study|Medication error without adverse event|1|||
146297235|NCT01284062|527604652|FG003|Overall Study|Medication error without adverse event|0|||
146297236|NCT01284062|527604649|FG000|Overall Study|Protocol Violation|1|||
146297237|NCT01284062|527604650|FG001|Overall Study|Protocol Violation|0|||
146297238|NCT01284062|527604651|FG002|Overall Study|Protocol Violation|0|||
146297239|NCT01284062|527604652|FG003|Overall Study|Protocol Violation|2|||
146297240|NCT01284062|527604649|FG000|Overall Study|Withdrawal by Subject|3|||
146297241|NCT01284062|527604650|FG001|Overall Study|Withdrawal by Subject|1|||
146297242|NCT01284062|527604651|FG002|Overall Study|Withdrawal by Subject|2|||
146297243|NCT01284062|527604652|FG003|Overall Study|Withdrawal by Subject|5|||
146297244|NCT01284062|527604649|FG000|Overall Study|Other|0|||
146297245|NCT01284062|527604650|FG001|Overall Study|Other|0|||
146297246|NCT01284062|527604651|FG002|Overall Study|Other|0|||
146297247|NCT01284062|527604652|FG003|Overall Study|Other|1|||
146297248|NCT01284062|527604649|FG000|Overall Study|Site Closed|0|||
146297249|NCT01284062|527604650|FG001|Overall Study|Site Closed|0|||
146297250|NCT01284062|527604651|FG002|Overall Study|Site Closed|1|||
146297251|NCT01284062|527604652|FG003|Overall Study|Site Closed|0|||
146297252|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
146297253|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
146297254|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
146297255|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
146297256|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
146297257|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
146297258|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
146297259|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
146297260|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Death|1|||
146297261|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Death|1|||
146297262|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
146297263|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
146297264|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
145898036|NCT01616953|526135133|FG000|Overall Study|lack of bone and soft tissue|1|||
145898037|NCT01616953|526135134|FG001|Overall Study|lack of bone and soft tissue|0|||
145898038|NCT01568320|526135135|FG000|Overall Study|Death|20|||
145898039|NCT01568320|526135135|FG000|Overall Study|Lost to Follow-up|9|||
145898040|NCT01568320|526135135|FG000|Overall Study|Withdrawal by Subject|10|||
145898041|NCT01568320|526135135|FG000|Overall Study|Conversion to open repair|1|||
145898042|NCT01568320|526135135|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
145898043|NCT00816361|526135137|FG000|Overall Study|Withdrawal by Subject|0|||
145898044|NCT00816361|526135138|FG001|Overall Study|Withdrawal by Subject|0|||
145898045|NCT00816361|526135139|FG002|Overall Study|Withdrawal by Subject|0|||
145898046|NCT00816361|526135140|FG003|Overall Study|Withdrawal by Subject|0|||
145898047|NCT00816361|526135141|FG004|Overall Study|Withdrawal by Subject|1|||
145898048|NCT00816361|526135142|FG005|Overall Study|Withdrawal by Subject|2|||
145898049|NCT00816361|526135143|FG006|Overall Study|Withdrawal by Subject|0|||
145898050|NCT00816361|526135144|FG007|Overall Study|Withdrawal by Subject|2|||
145898051|NCT00816361|526135145|FG008|Overall Study|Withdrawal by Subject|1|||
146297265|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
146297266|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
146297267|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
146297268|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
146297269|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
146297270|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
146297271|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
146297272|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
146297273|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
146297274|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
146297275|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
146297276|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
146297277|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
146297278|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
146297279|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
146297280|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
146297281|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
146297282|NCT00559585|527604655|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
146297283|NCT00559585|527604656|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
146297284|NCT00559585|527604655|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
146297285|NCT00559585|527604656|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
146297286|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
146297287|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
146297288|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
146297289|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
146297290|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
146297291|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
146297292|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
146297293|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
146297294|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
146297295|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
146297296|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
146297297|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
146297298|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
146297299|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
146297300|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
146297301|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
145972394|NCT02332707|526412637|FG017|Overall Study|Withdrawal by Subject|0|||
145972395|NCT01473134|526412638|FG000|Overall Study|Lost to Follow-up|21|||
145972396|NCT01473134|526412639|FG001|Overall Study|Lost to Follow-up|13|||
145972397|NCT01473134|526412638|FG000|Overall Study|Protocol Violation|32|||
145972398|NCT01473134|526412639|FG001|Overall Study|Protocol Violation|19|||
145972399|NCT01473134|526412638|FG000|Overall Study|Withdrawal by Subject|1|||
145972400|NCT01473134|526412639|FG001|Overall Study|Withdrawal by Subject|2|||
145972401|NCT01473134|526412638|FG000|Overall Study|Death|0|||
145972402|NCT01473134|526412639|FG001|Overall Study|Death|1|||
145972403|NCT01473134|526412638|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
145972404|NCT01473134|526412639|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
145972405|NCT01799889|526412642|FG000|Overall Study|Adverse Event|4|||
145972406|NCT01799889|526412643|FG001|Overall Study|Adverse Event|4|||
145972407|NCT01799889|526412644|FG002|Overall Study|Adverse Event|5|||
145972408|NCT01799889|526412645|FG003|Overall Study|Adverse Event|1|||
145972409|NCT01799889|526412646|FG004|Overall Study|Adverse Event|11|||
145972410|NCT01799889|526412647|FG005|Overall Study|Adverse Event|1|||
145972411|NCT01799889|526412648|FG006|Overall Study|Adverse Event|5|||
145972412|NCT01799889|526412649|FG007|Overall Study|Adverse Event|2|||
145972413|NCT01799889|526412650|FG008|Overall Study|Adverse Event|3|||
145972414|NCT01799889|526412651|FG009|Overall Study|Adverse Event|1|||
145972415|NCT01799889|526412652|FG010|Overall Study|Adverse Event|1|||
145972416|NCT01799889|526412653|FG011|Overall Study|Adverse Event|0|||
145972417|NCT01799889|526412642|FG000|Overall Study|Death|1|||
145972418|NCT01799889|526412643|FG001|Overall Study|Death|0|||
145972419|NCT01799889|526412644|FG002|Overall Study|Death|5|||
145972420|NCT01799889|526412645|FG003|Overall Study|Death|3|||
145972421|NCT01799889|526412646|FG004|Overall Study|Death|1|||
145972422|NCT01799889|526412647|FG005|Overall Study|Death|0|||
145972423|NCT01799889|526412648|FG006|Overall Study|Death|0|||
145972424|NCT01799889|526412649|FG007|Overall Study|Death|0|||
145972425|NCT01799889|526412650|FG008|Overall Study|Death|1|||
145972426|NCT01799889|526412651|FG009|Overall Study|Death|0|||
145972427|NCT01799889|526412652|FG010|Overall Study|Death|1|||
145972428|NCT01799889|526412653|FG011|Overall Study|Death|0|||
145972429|NCT01799889|526412642|FG000|Overall Study|Lack of Efficacy|1|||
145972430|NCT01799889|526412643|FG001|Overall Study|Lack of Efficacy|1|||
145972431|NCT01799889|526412644|FG002|Overall Study|Lack of Efficacy|0|||
145972432|NCT01799889|526412645|FG003|Overall Study|Lack of Efficacy|1|||
145972433|NCT01799889|526412646|FG004|Overall Study|Lack of Efficacy|2|||
145972434|NCT01799889|526412647|FG005|Overall Study|Lack of Efficacy|2|||
145972435|NCT01799889|526412648|FG006|Overall Study|Lack of Efficacy|0|||
145972436|NCT01799889|526412649|FG007|Overall Study|Lack of Efficacy|0|||
145972437|NCT01799889|526412650|FG008|Overall Study|Lack of Efficacy|2|||
146297302|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
145972438|NCT01799889|526412651|FG009|Overall Study|Lack of Efficacy|0|||
145972439|NCT01799889|526412652|FG010|Overall Study|Lack of Efficacy|1|||
145972440|NCT01799889|526412653|FG011|Overall Study|Lack of Efficacy|0|||
145972441|NCT01799889|526412642|FG000|Overall Study|Lost to Follow-up|0|||
145972442|NCT01799889|526412643|FG001|Overall Study|Lost to Follow-up|1|||
145972443|NCT01799889|526412644|FG002|Overall Study|Lost to Follow-up|0|||
145972444|NCT01799889|526412645|FG003|Overall Study|Lost to Follow-up|0|||
145972445|NCT01799889|526412646|FG004|Overall Study|Lost to Follow-up|0|||
145972446|NCT01799889|526412647|FG005|Overall Study|Lost to Follow-up|0|||
145972447|NCT01799889|526412648|FG006|Overall Study|Lost to Follow-up|0|||
145972448|NCT01799889|526412649|FG007|Overall Study|Lost to Follow-up|0|||
145972449|NCT01799889|526412650|FG008|Overall Study|Lost to Follow-up|0|||
145898052|NCT00816361|526135137|FG000|Overall Study|Death|4|||
145898053|NCT00816361|526135138|FG001|Overall Study|Death|3|||
145898054|NCT00816361|526135139|FG002|Overall Study|Death|3|||
145898055|NCT00816361|526135140|FG003|Overall Study|Death|3|||
145898056|NCT00816361|526135141|FG004|Overall Study|Death|1|||
145898057|NCT00816361|526135142|FG005|Overall Study|Death|1|||
145898058|NCT00816361|526135143|FG006|Overall Study|Death|3|||
145898059|NCT00816361|526135144|FG007|Overall Study|Death|7|||
145898060|NCT00816361|526135145|FG008|Overall Study|Death|8|||
145898061|NCT00816361|526135137|FG000|Overall Study|Other|0|||
145898062|NCT00816361|526135138|FG001|Overall Study|Other|0|||
145898063|NCT00816361|526135139|FG002|Overall Study|Other|0|||
145898064|NCT00816361|526135140|FG003|Overall Study|Other|0|||
145898065|NCT00816361|526135141|FG004|Overall Study|Other|0|||
145898066|NCT00816361|526135142|FG005|Overall Study|Other|0|||
145898067|NCT00816361|526135143|FG006|Overall Study|Other|0|||
145898068|NCT00816361|526135144|FG007|Overall Study|Other|0|||
145898069|NCT00816361|526135145|FG008|Overall Study|Other|1|||
145898070|NCT01394952|526135146|FG000|Overall Study|Lost to Follow-up|0|||
145898071|NCT01394952|526135147|FG001|Overall Study|Lost to Follow-up|5|||
145898072|NCT01394952|526135146|FG000|Overall Study|Withdrawal by Subject|10|||
145898073|NCT01394952|526135147|FG001|Overall Study|Withdrawal by Subject|5|||
145898074|NCT01394952|526135146|FG000|Overall Study|Physician Decision|2|||
145898075|NCT01394952|526135147|FG001|Overall Study|Physician Decision|0|||
145898076|NCT01394952|526135146|FG000|Overall Study|Sponsor Decision|5|||
145898077|NCT01394952|526135147|FG001|Overall Study|Sponsor Decision|7|||
145898078|NCT01986010|526135148|FG000|Overall Study|Adverse Event|0|||
145898079|NCT01986010|526135149|FG001|Overall Study|Adverse Event|1|||
145898080|NCT01986010|526135150|FG002|Overall Study|Adverse Event|0|||
145898081|NCT01986010|526135151|FG003|Overall Study|Adverse Event|0|||
145898082|NCT01986010|526135152|FG004|Overall Study|Adverse Event|0|||
145898083|NCT01986010|526135153|FG005|Overall Study|Adverse Event|0|||
145898084|NCT01986010|526135154|FG006|Overall Study|Adverse Event|0|||
145898085|NCT01986010|526135155|FG007|Overall Study|Adverse Event|0|||
145898086|NCT01986010|526135156|FG008|Overall Study|Adverse Event|0|||
145898087|NCT01986010|526135157|FG009|Overall Study|Adverse Event|0|||
145898088|NCT01986010|526135158|FG010|Overall Study|Adverse Event|0|||
145898089|NCT01986010|526135159|FG011|Overall Study|Adverse Event|0|||
145898090|NCT01986010|526135160|FG012|Overall Study|Adverse Event|0|||
145898091|NCT01986010|526135161|FG013|Overall Study|Adverse Event|0|||
145898092|NCT01986010|526135162|FG014|Overall Study|Adverse Event|0|||
145898093|NCT01986010|526135163|FG015|Overall Study|Adverse Event|1|||
145898094|NCT01986010|526135164|FG016|Overall Study|Adverse Event|0|||
145898095|NCT01986010|526135148|FG000|Overall Study|Lost to Follow-up|2|||
145898096|NCT01986010|526135149|FG001|Overall Study|Lost to Follow-up|1|||
145898097|NCT01986010|526135150|FG002|Overall Study|Lost to Follow-up|2|||
145898098|NCT01986010|526135151|FG003|Overall Study|Lost to Follow-up|2|||
145898099|NCT01986010|526135152|FG004|Overall Study|Lost to Follow-up|2|||
145898100|NCT01986010|526135153|FG005|Overall Study|Lost to Follow-up|2|||
145898101|NCT01986010|526135154|FG006|Overall Study|Lost to Follow-up|0|||
145898102|NCT01986010|526135155|FG007|Overall Study|Lost to Follow-up|0|||
145898103|NCT01986010|526135156|FG008|Overall Study|Lost to Follow-up|4|||
145898104|NCT01986010|526135157|FG009|Overall Study|Lost to Follow-up|2|||
145898105|NCT01986010|526135158|FG010|Overall Study|Lost to Follow-up|0|||
145898106|NCT01986010|526135159|FG011|Overall Study|Lost to Follow-up|1|||
145898107|NCT01986010|526135160|FG012|Overall Study|Lost to Follow-up|1|||
145898108|NCT01986010|526135161|FG013|Overall Study|Lost to Follow-up|1|||
145898109|NCT01986010|526135162|FG014|Overall Study|Lost to Follow-up|2|||
145898110|NCT01986010|526135163|FG015|Overall Study|Lost to Follow-up|0|||
146238545|NCT02362035|527386777|FG000|Overall Study|Subject started another cancer therapy|10|||
145898111|NCT01986010|526135164|FG016|Overall Study|Lost to Follow-up|0|||
145898112|NCT01986010|526135148|FG000|Overall Study|Physician Decision|0|||
145898113|NCT01986010|526135149|FG001|Overall Study|Physician Decision|0|||
145898114|NCT01986010|526135150|FG002|Overall Study|Physician Decision|0|||
145898115|NCT01986010|526135151|FG003|Overall Study|Physician Decision|0|||
145898116|NCT01986010|526135152|FG004|Overall Study|Physician Decision|0|||
145898117|NCT01986010|526135153|FG005|Overall Study|Physician Decision|0|||
145898118|NCT01986010|526135154|FG006|Overall Study|Physician Decision|0|||
145898119|NCT01986010|526135155|FG007|Overall Study|Physician Decision|0|||
146238546|NCT02362035|527386777|FG000|Overall Study|Study terminated by sponsor|45|||
145898120|NCT01986010|526135156|FG008|Overall Study|Physician Decision|0|||
145898121|NCT01986010|526135157|FG009|Overall Study|Physician Decision|0|||
145898122|NCT01986010|526135158|FG010|Overall Study|Physician Decision|0|||
145898123|NCT01986010|526135159|FG011|Overall Study|Physician Decision|0|||
145898124|NCT01986010|526135160|FG012|Overall Study|Physician Decision|0|||
145898125|NCT01986010|526135161|FG013|Overall Study|Physician Decision|0|||
145898126|NCT01986010|526135162|FG014|Overall Study|Physician Decision|1|||
145898127|NCT01986010|526135163|FG015|Overall Study|Physician Decision|0|||
145898128|NCT01986010|526135164|FG016|Overall Study|Physician Decision|0|||
145898129|NCT01986010|526135148|FG000|Overall Study|Withdrawal by Subject|2|||
145898130|NCT01986010|526135149|FG001|Overall Study|Withdrawal by Subject|2|||
146238547|NCT02362035|527386777|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
145898131|NCT01986010|526135150|FG002|Overall Study|Withdrawal by Subject|3|||
145898132|NCT01986010|526135151|FG003|Overall Study|Withdrawal by Subject|0|||
145898133|NCT01986010|526135152|FG004|Overall Study|Withdrawal by Subject|2|||
145898134|NCT01986010|526135153|FG005|Overall Study|Withdrawal by Subject|4|||
145898135|NCT01986010|526135154|FG006|Overall Study|Withdrawal by Subject|0|||
145898136|NCT01986010|526135155|FG007|Overall Study|Withdrawal by Subject|0|||
145898137|NCT01986010|526135156|FG008|Overall Study|Withdrawal by Subject|0|||
145898138|NCT01986010|526135157|FG009|Overall Study|Withdrawal by Subject|0|||
145898139|NCT01986010|526135158|FG010|Overall Study|Withdrawal by Subject|0|||
145898140|NCT01986010|526135159|FG011|Overall Study|Withdrawal by Subject|2|||
145898141|NCT01986010|526135160|FG012|Overall Study|Withdrawal by Subject|0|||
145898142|NCT01986010|526135161|FG013|Overall Study|Withdrawal by Subject|1|||
145898143|NCT01986010|526135162|FG014|Overall Study|Withdrawal by Subject|2|||
145898144|NCT01986010|526135163|FG015|Overall Study|Withdrawal by Subject|0|||
145898145|NCT01986010|526135164|FG016|Overall Study|Withdrawal by Subject|0|||
145898146|NCT01986010|526135148|FG000|Overall Study|Status Not Recorded|2|||
145898147|NCT01986010|526135149|FG001|Overall Study|Status Not Recorded|4|||
145898148|NCT01986010|526135150|FG002|Overall Study|Status Not Recorded|2|||
145898149|NCT01986010|526135151|FG003|Overall Study|Status Not Recorded|0|||
145898150|NCT01986010|526135152|FG004|Overall Study|Status Not Recorded|1|||
145898151|NCT01986010|526135153|FG005|Overall Study|Status Not Recorded|2|||
145898152|NCT01986010|526135154|FG006|Overall Study|Status Not Recorded|0|||
145898153|NCT01986010|526135155|FG007|Overall Study|Status Not Recorded|0|||
145898154|NCT01986010|526135156|FG008|Overall Study|Status Not Recorded|2|||
145898155|NCT01986010|526135157|FG009|Overall Study|Status Not Recorded|1|||
145898156|NCT01986010|526135158|FG010|Overall Study|Status Not Recorded|7|||
145898157|NCT01986010|526135159|FG011|Overall Study|Status Not Recorded|7|||
145898158|NCT01986010|526135160|FG012|Overall Study|Status Not Recorded|9|||
145898159|NCT01986010|526135161|FG013|Overall Study|Status Not Recorded|9|||
145898160|NCT01986010|526135162|FG014|Overall Study|Status Not Recorded|5|||
145898161|NCT01986010|526135163|FG015|Overall Study|Status Not Recorded|10|||
145898162|NCT01986010|526135164|FG016|Overall Study|Status Not Recorded|4|||
145898163|NCT01335997|526135165|FG000|Period I and II|Adverse Event|63|||
145898164|NCT01335997|526135166|FG001|Period I and II|Adverse Event|43|||
145898165|NCT01335997|526135165|FG000|Period I and II|Noncompliance with Study Drug|1|||
145898166|NCT01335997|526135166|FG001|Period I and II|Noncompliance with Study Drug|1|||
145898167|NCT01335997|526135165|FG000|Period I and II|Lost to Follow-up|3|||
145898168|NCT01335997|526135166|FG001|Period I and II|Lost to Follow-up|5|||
145898169|NCT01335997|526135165|FG000|Period I and II|Withdrawal by Subject|9|||
145898170|NCT01335997|526135166|FG001|Period I and II|Withdrawal by Subject|4|||
145898171|NCT01335997|526135165|FG000|Period I and II|Study Terminated by Sponsor|406|||
145898172|NCT01335997|526135166|FG001|Period I and II|Study Terminated by Sponsor|415|||
146088249|NCT00472459|526843781|FG000|Overall Study|Withdrawal by Subject|5|||
146088250|NCT00472459|526843782|FG001|Overall Study|Withdrawal by Subject|5|||
146088251|NCT00472459|526843781|FG000|Overall Study|Protocol Violation|3|||
146088252|NCT00472459|526843782|FG001|Overall Study|Protocol Violation|3|||
146088253|NCT00472459|526843781|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
146088254|NCT00472459|526843782|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
146088255|NCT00472459|526843781|FG000|Overall Study|Lost to Follow-up|1|||
146088256|NCT00472459|526843782|FG001|Overall Study|Lost to Follow-up|1|||
145898173|NCT01335997|526135165|FG000|Period I and II|Protocol Violation|9|||
145898174|NCT01335997|526135166|FG001|Period I and II|Protocol Violation|10|||
145898175|NCT01335997|526135165|FG000|Period I and II|Physician Decision|2|||
145898176|NCT01335997|526135166|FG001|Period I and II|Physician Decision|1|||
145898177|NCT01335997|526135165|FG000|Period III|Adverse Event|0|||
145898178|NCT01335997|526135166|FG001|Period III|Adverse Event|2|||
145898179|NCT01335997|526135165|FG000|Period III|Study Terminated by Sponsor|77|||
145898180|NCT01335997|526135166|FG001|Period III|Study Terminated by Sponsor|76|||
145898181|NCT01335997|526135165|FG000|Period III|Protocol Violation|0|||
145898182|NCT01335997|526135166|FG001|Period III|Protocol Violation|1|||
145898183|NCT01335997|526135165|FG000|Period III|Lost to Follow-up|1|||
145898184|NCT01335997|526135166|FG001|Period III|Lost to Follow-up|0|||
145898185|NCT02440568|526135169|FG000|Overall Study|Death|1|||
146088257|NCT04850313|526843783|FG000|Overall Study|Withdrawal by Subject|0|||
145898186|NCT02440568|526135170|FG001|Overall Study|Death|3|||
145898187|NCT02440568|526135171|FG002|Overall Study|Death|4|||
145898188|NCT02440568|526135172|FG003|Overall Study|Death|2|||
145898189|NCT02440568|526135169|FG000|Overall Study|Lack of Efficacy|2|||
145898190|NCT02440568|526135170|FG001|Overall Study|Lack of Efficacy|0|||
145898191|NCT02440568|526135171|FG002|Overall Study|Lack of Efficacy|1|||
145898192|NCT02440568|526135172|FG003|Overall Study|Lack of Efficacy|0|||
145898193|NCT02440568|526135169|FG000|Overall Study|Lost to Follow-up|1|||
145898194|NCT02440568|526135170|FG001|Overall Study|Lost to Follow-up|0|||
145898195|NCT02440568|526135171|FG002|Overall Study|Lost to Follow-up|0|||
145898196|NCT02440568|526135172|FG003|Overall Study|Lost to Follow-up|0|||
145898197|NCT00536263|526135173|FG000|Overall Study|Adverse Event|5|||
145898198|NCT00536263|526135174|FG001|Overall Study|Adverse Event|5|||
145898199|NCT00536263|526135175|FG002|Overall Study|Adverse Event|7|||
145972450|NCT01799889|526412651|FG009|Overall Study|Lost to Follow-up|0|||
145972451|NCT01799889|526412652|FG010|Overall Study|Lost to Follow-up|0|||
145972452|NCT01799889|526412653|FG011|Overall Study|Lost to Follow-up|0|||
145972453|NCT01799889|526412642|FG000|Overall Study|Physician Decision|3|||
145898200|NCT00536263|526135173|FG000|Overall Study|Lost to Follow-up|3|||
145898201|NCT00536263|526135174|FG001|Overall Study|Lost to Follow-up|4|||
145898202|NCT00536263|526135175|FG002|Overall Study|Lost to Follow-up|4|||
145898203|NCT00536263|526135173|FG000|Overall Study|Subject withdrew - not treatment related|2|||
145898204|NCT00536263|526135174|FG001|Overall Study|Subject withdrew - not treatment related|0|||
145898205|NCT00536263|526135175|FG002|Overall Study|Subject withdrew - not treatment related|5|||
145898206|NCT00536263|526135173|FG000|Overall Study|Subject withdrew - treatment related|0|||
145898207|NCT00536263|526135174|FG001|Overall Study|Subject withdrew - treatment related|3|||
145898208|NCT00536263|526135175|FG002|Overall Study|Subject withdrew - treatment related|2|||
145898209|NCT00536263|526135173|FG000|Overall Study|Noncompliance with protocol|0|||
145898210|NCT00536263|526135174|FG001|Overall Study|Noncompliance with protocol|0|||
145898211|NCT00536263|526135175|FG002|Overall Study|Noncompliance with protocol|1|||
145898212|NCT00536263|526135173|FG000|Overall Study|Did not meet protocol eligibility|1|||
145898213|NCT00536263|526135174|FG001|Overall Study|Did not meet protocol eligibility|2|||
145898214|NCT00536263|526135175|FG002|Overall Study|Did not meet protocol eligibility|2|||
145898215|NCT00826449|526135176|FG000|Overall Study|Disease Progression|4|||
145898216|NCT00826449|526135176|FG000|Overall Study|Withdrawal by Subject|1|||
145898217|NCT01103466|526135177|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
145898218|NCT01103466|526135178|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
145898219|NCT01103466|526135179|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
145898220|NCT01103466|526135177|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
145898221|NCT01103466|526135178|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
145898222|NCT01103466|526135179|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
145898223|NCT01103466|526135177|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145898224|NCT01103466|526135178|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145898225|NCT01103466|526135179|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145898226|NCT01103466|526135177|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
145898227|NCT01103466|526135178|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
145898228|NCT01103466|526135179|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
145898229|NCT01103466|526135177|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145898230|NCT01103466|526135178|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145898231|NCT01103466|526135179|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145898232|NCT01103466|526135177|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
145898233|NCT01103466|526135178|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
145898234|NCT01103466|526135179|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
145898235|NCT02994940|526135180|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
145898236|NCT02994940|526135181|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
145898237|NCT02994940|526135180|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
145898238|NCT02994940|526135181|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
145898239|NCT02994940|526135180|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
145898240|NCT02994940|526135181|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
145898241|NCT00975286|526135188|FG000|Overall Study|Adverse Event|9|||
145898242|NCT00975286|526135189|FG001|Overall Study|Adverse Event|19|||
145898243|NCT00975286|526135188|FG000|Overall Study|Protocol Violation|1|||
145898244|NCT00975286|526135189|FG001|Overall Study|Protocol Violation|2|||
145898245|NCT00975286|526135188|FG000|Overall Study|Withdrawal by Subject|0|||
145898246|NCT00975286|526135189|FG001|Overall Study|Withdrawal by Subject|2|||
145898247|NCT00975286|526135188|FG000|Overall Study|Familial and Personal Reasons|2|||
145898248|NCT00975286|526135189|FG001|Overall Study|Familial and Personal Reasons|2|||
145972454|NCT01799889|526412643|FG001|Overall Study|Physician Decision|2|||
145972455|NCT01799889|526412644|FG002|Overall Study|Physician Decision|4|||
145972456|NCT01799889|526412645|FG003|Overall Study|Physician Decision|4|||
145972457|NCT01799889|526412646|FG004|Overall Study|Physician Decision|5|||
145972458|NCT01799889|526412647|FG005|Overall Study|Physician Decision|5|||
145972459|NCT01799889|526412648|FG006|Overall Study|Physician Decision|5|||
146088258|NCT04850313|526843784|FG001|Overall Study|Withdrawal by Subject|1|||
146088259|NCT03269552|526843785|FG000|Overall Study|Adverse Event|2|||
146238548|NCT02362035|527386777|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
146238549|NCT02362035|527386777|FG000|Overall Study|Disease progression|11|||
146238550|NCT02362035|527386777|FG000|Overall Study|Withdrawal by Subject|20|||
145898249|NCT00975286|526135188|FG000|Overall Study|Poor Compliance to Protocol|0|||
145898250|NCT00975286|526135189|FG001|Overall Study|Poor Compliance to Protocol|2|||
145898251|NCT00975286|526135188|FG000|Overall Study|Sponsor Decision|0|||
145898252|NCT00975286|526135189|FG001|Overall Study|Sponsor Decision|2|||
145898253|NCT02357342|526135190|FG000|First 6 Months|Death|2|||
145898254|NCT02357342|526135191|FG001|First 6 Months|Death|0|||
145898255|NCT01674647|526135192|FG000|Treatment Period|Death|4|||
145972460|NCT01799889|526412649|FG007|Overall Study|Physician Decision|2|||
145898256|NCT01674647|526135193|FG001|Treatment Period|Death|1|||
145898257|NCT01674647|526135192|FG000|Treatment Period|Efficacy outcome reached|0|||
145898258|NCT01674647|526135193|FG001|Treatment Period|Efficacy outcome reached|1|||
145898259|NCT01674647|526135192|FG000|Treatment Period|Physician Decision|3|||
145898260|NCT01674647|526135193|FG001|Treatment Period|Physician Decision|1|||
145898261|NCT01674647|526135192|FG000|Treatment Period|Adverse Event|60|||
145898262|NCT01674647|526135193|FG001|Treatment Period|Adverse Event|22|||
145898263|NCT01674647|526135192|FG000|Treatment Period|Non-compliance with study drug|3|||
145898264|NCT01674647|526135193|FG001|Treatment Period|Non-compliance with study drug|0|||
145898265|NCT01674647|526135192|FG000|Treatment Period|Lost to Follow-up|1|||
145898266|NCT01674647|526135193|FG001|Treatment Period|Lost to Follow-up|1|||
145898267|NCT01674647|526135192|FG000|Treatment Period|Withdrawal by Subject|19|||
145898268|NCT01674647|526135193|FG001|Treatment Period|Withdrawal by Subject|16|||
145898269|NCT01674647|526135192|FG000|Treatment Period|Switching to other therapy|5|||
145898270|NCT01674647|526135193|FG001|Treatment Period|Switching to other therapy|2|||
145898271|NCT01674647|526135192|FG000|Treatment Period|Logistical difficulties|5|||
145898272|NCT01674647|526135193|FG001|Treatment Period|Logistical difficulties|8|||
145898273|NCT01674647|526135192|FG000|Treatment Period|Treatment failure|0|||
145898274|NCT01674647|526135193|FG001|Treatment Period|Treatment failure|14|||
145898275|NCT01674647|526135192|FG000|Treatment Period|Protocol Violation|56|||
145898276|NCT01674647|526135193|FG001|Treatment Period|Protocol Violation|36|||
145898277|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Death|3|||
145898278|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Death|2|||
145898279|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
145898280|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
145898281|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
145898282|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
145898283|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
145898284|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
145898285|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
145898286|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
145898287|NCT01674647|526135192|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
145898288|NCT01674647|526135193|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
145898289|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
145898290|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
145898291|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
145898292|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
145898293|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
145898294|NCT01490866|526135195|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
145898295|NCT01490866|526135195|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
145898296|NCT01490866|526135195|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
145898297|NCT01490866|526135195|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
145898298|NCT01490866|526135195|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
145898299|NCT01490866|526135195|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
145898300|NCT03201211|526135196|FG000|Overall Study|Adverse Event|1|||
145898301|NCT03201211|526135197|FG001|Overall Study|Adverse Event|0|||
145898302|NCT03201211|526135198|FG002|Overall Study|Adverse Event|0|||
145898303|NCT03201211|526135196|FG000|Overall Study|Protocol Violation|1|||
145898304|NCT03201211|526135197|FG001|Overall Study|Protocol Violation|0|||
145898305|NCT03201211|526135198|FG002|Overall Study|Protocol Violation|0|||
145898306|NCT03201211|526135196|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145898307|NCT03201211|526135197|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145898308|NCT03201211|526135198|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145898309|NCT03201211|526135196|FG000|Overall Study|OTHER unknown reasons|0|||
145898310|NCT03201211|526135197|FG001|Overall Study|OTHER unknown reasons|1|||
145898311|NCT03201211|526135198|FG002|Overall Study|OTHER unknown reasons|0|||
145898312|NCT01970865|526135199|FG000|Overall Study|Death|3|||
145898313|NCT01970865|526135200|FG001|Overall Study|Death|2|||
145898314|NCT01970865|526135201|FG002|Overall Study|Death|3|||
145898315|NCT01970865|526135202|FG003|Overall Study|Death|6|||
145898316|NCT01970865|526135203|FG004|Overall Study|Death|9|||
145898317|NCT01970865|526135204|FG005|Overall Study|Death|3|||
145898318|NCT01970865|526135205|FG006|Overall Study|Death|2|||
145898319|NCT01970865|526135206|FG007|Overall Study|Death|3|||
145898320|NCT01970865|526135207|FG008|Overall Study|Death|2|||
145898321|NCT01970865|526135208|FG009|Overall Study|Death|2|||
145898322|NCT01970865|526135209|FG010|Overall Study|Death|8|||
145898323|NCT01970865|526135210|FG011|Overall Study|Death|13|||
145898324|NCT01970865|526135211|FG012|Overall Study|Death|25|||
145898325|NCT01970865|526135212|FG013|Overall Study|Death|46|||
145898326|NCT01970865|526135213|FG014|Overall Study|Death|37|||
145972461|NCT01799889|526412650|FG008|Overall Study|Physician Decision|6|||
145898327|NCT01970865|526135214|FG015|Overall Study|Death|22|||
145898328|NCT01970865|526135215|FG016|Overall Study|Death|1|||
145898329|NCT01970865|526135216|FG017|Overall Study|Death|17|||
145898330|NCT01970865|526135199|FG000|Overall Study|Lost to Follow-up|0|||
145898331|NCT01970865|526135200|FG001|Overall Study|Lost to Follow-up|0|||
145898332|NCT01970865|526135201|FG002|Overall Study|Lost to Follow-up|0|||
145898333|NCT01970865|526135202|FG003|Overall Study|Lost to Follow-up|1|||
145898334|NCT01970865|526135203|FG004|Overall Study|Lost to Follow-up|1|||
145898335|NCT01970865|526135204|FG005|Overall Study|Lost to Follow-up|0|||
145898336|NCT01970865|526135205|FG006|Overall Study|Lost to Follow-up|0|||
145898337|NCT01970865|526135206|FG007|Overall Study|Lost to Follow-up|0|||
145898338|NCT01970865|526135207|FG008|Overall Study|Lost to Follow-up|0|||
145898339|NCT01970865|526135208|FG009|Overall Study|Lost to Follow-up|0|||
145898340|NCT01970865|526135209|FG010|Overall Study|Lost to Follow-up|1|||
145898341|NCT01970865|526135210|FG011|Overall Study|Lost to Follow-up|0|||
145898342|NCT01970865|526135211|FG012|Overall Study|Lost to Follow-up|2|||
145898343|NCT01970865|526135212|FG013|Overall Study|Lost to Follow-up|0|||
145898344|NCT01970865|526135213|FG014|Overall Study|Lost to Follow-up|1|||
145898345|NCT01970865|526135214|FG015|Overall Study|Lost to Follow-up|4|||
145898346|NCT01970865|526135215|FG016|Overall Study|Lost to Follow-up|0|||
145898347|NCT01970865|526135216|FG017|Overall Study|Lost to Follow-up|1|||
145898348|NCT01970865|526135199|FG000|Overall Study|Other|0|||
145898349|NCT01970865|526135200|FG001|Overall Study|Other|1|||
145898350|NCT01970865|526135201|FG002|Overall Study|Other|0|||
145898351|NCT01970865|526135202|FG003|Overall Study|Other|1|||
145898352|NCT01970865|526135203|FG004|Overall Study|Other|1|||
145898353|NCT01970865|526135204|FG005|Overall Study|Other|0|||
145898354|NCT01970865|526135205|FG006|Overall Study|Other|1|||
145898355|NCT01970865|526135206|FG007|Overall Study|Other|0|||
145898356|NCT01970865|526135207|FG008|Overall Study|Other|0|||
145898357|NCT01970865|526135208|FG009|Overall Study|Other|0|||
145898358|NCT01970865|526135209|FG010|Overall Study|Other|2|||
145898359|NCT01970865|526135210|FG011|Overall Study|Other|3|||
145898360|NCT01970865|526135211|FG012|Overall Study|Other|8|||
145898361|NCT01970865|526135212|FG013|Overall Study|Other|3|||
145898362|NCT01970865|526135213|FG014|Overall Study|Other|2|||
145898363|NCT01970865|526135214|FG015|Overall Study|Other|3|||
145898364|NCT01970865|526135215|FG016|Overall Study|Other|0|||
145898365|NCT01970865|526135216|FG017|Overall Study|Other|2|||
145898366|NCT01970865|526135199|FG000|Overall Study|Participant refused further follow-up|0|||
145898367|NCT01970865|526135200|FG001|Overall Study|Participant refused further follow-up|0|||
145898368|NCT01970865|526135201|FG002|Overall Study|Participant refused further follow-up|0|||
145898369|NCT01970865|526135202|FG003|Overall Study|Participant refused further follow-up|2|||
145898370|NCT01970865|526135203|FG004|Overall Study|Participant refused further follow-up|3|||
145898371|NCT01970865|526135204|FG005|Overall Study|Participant refused further follow-up|0|||
145898372|NCT01970865|526135205|FG006|Overall Study|Participant refused further follow-up|0|||
145898373|NCT01970865|526135206|FG007|Overall Study|Participant refused further follow-up|0|||
145898374|NCT01970865|526135207|FG008|Overall Study|Participant refused further follow-up|0|||
145898375|NCT01970865|526135208|FG009|Overall Study|Participant refused further follow-up|0|||
145898376|NCT01970865|526135209|FG010|Overall Study|Participant refused further follow-up|1|||
145898377|NCT01970865|526135210|FG011|Overall Study|Participant refused further follow-up|4|||
145898378|NCT01970865|526135211|FG012|Overall Study|Participant refused further follow-up|7|||
145898379|NCT01970865|526135212|FG013|Overall Study|Participant refused further follow-up|8|||
145898380|NCT01970865|526135213|FG014|Overall Study|Participant refused further follow-up|3|||
145898381|NCT01970865|526135214|FG015|Overall Study|Participant refused further follow-up|11|||
145898382|NCT01970865|526135215|FG016|Overall Study|Participant refused further follow-up|0|||
145898383|NCT01970865|526135216|FG017|Overall Study|Participant refused further follow-up|6|||
145898384|NCT01946191|526135217|FG000|Allocation|Did not complete orientation|1|||
145898385|NCT01946191|526135218|FG001|Allocation|Did not complete orientation|1|||
145898386|NCT01946191|526135217|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
145898387|NCT01946191|526135218|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
145898388|NCT01946191|526135217|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
145898389|NCT01946191|526135218|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
145898390|NCT01946191|526135217|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
145898391|NCT01946191|526135218|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
145898392|NCT02041091|526135219|FG000|Treatment|Adverse Event|3|||
145898393|NCT02041091|526135220|FG001|Treatment|Adverse Event|3|||
145898394|NCT02041091|526135219|FG000|Treatment|Withdrawal by Subject|2|||
146238551|NCT00229658|527386787|FG000|Overall Study|Administrative|2|||
146238552|NCT00229658|527386788|FG001|Overall Study|Administrative|1|||
146238553|NCT00229658|527386787|FG000|Overall Study|Investigator decision|13|||
146238554|NCT00229658|527386788|FG001|Overall Study|Investigator decision|10|||
146238555|NCT00229658|527386787|FG000|Overall Study|Other|80|||
146238556|NCT00229658|527386788|FG001|Overall Study|Other|60|||
145898395|NCT02041091|526135220|FG001|Treatment|Withdrawal by Subject|4|||
145898396|NCT02041091|526135219|FG000|Treatment|Physician Decision|1|||
145898397|NCT02041091|526135220|FG001|Treatment|Physician Decision|0|||
145898398|NCT02041091|526135219|FG000|Treatment|Sponsor Decision|15|||
145898399|NCT02041091|526135220|FG001|Treatment|Sponsor Decision|16|||
145972462|NCT01799889|526412651|FG009|Overall Study|Physician Decision|0|||
145898400|NCT02041091|526135219|FG000|Treatment|Lost to Follow-up|1|||
145898401|NCT02041091|526135220|FG001|Treatment|Lost to Follow-up|0|||
145898402|NCT02041091|526135219|FG000|Optional Safety Extension Period|Adverse Event|4|||
145898403|NCT02041091|526135220|FG001|Optional Safety Extension Period|Adverse Event|2|||
145898404|NCT02041091|526135219|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
145898405|NCT02041091|526135220|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
145898406|NCT02041091|526135219|FG000|Optional Safety Extension Period|Protocol Violation|2|||
145898407|NCT02041091|526135220|FG001|Optional Safety Extension Period|Protocol Violation|0|||
145898408|NCT02041091|526135219|FG000|Optional Safety Extension Period|Physician Decision|2|||
145898409|NCT02041091|526135220|FG001|Optional Safety Extension Period|Physician Decision|1|||
145898410|NCT02041091|526135219|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
145898411|NCT02041091|526135220|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
145898412|NCT02041091|526135219|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
145898413|NCT02041091|526135220|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
145898414|NCT01855074|526135221|FG000|Overall Study|Adverse Event|1|||
145898415|NCT01855074|526135221|FG000|Overall Study|Lost to Follow-up|4|||
145898416|NCT01855074|526135221|FG000|Overall Study|Withdrawal by Subject|8|||
145898417|NCT01855074|526135221|FG000|Overall Study|Started but not treated|1|||
145898418|NCT01150890|526135222|FG000|Overall Study|Other|0|||
145898419|NCT01150890|526135223|FG001|Overall Study|Other|1|||
145898420|NCT01150890|526135224|FG002|Overall Study|Other|0|||
145898421|NCT01150890|526135225|FG003|Overall Study|Other|2|||
145898422|NCT01150890|526135222|FG000|Overall Study|Pregnancy|0|||
145898423|NCT01150890|526135223|FG001|Overall Study|Pregnancy|0|||
145898424|NCT01150890|526135224|FG002|Overall Study|Pregnancy|0|||
145898425|NCT01150890|526135225|FG003|Overall Study|Pregnancy|1|||
145898426|NCT01150890|526135222|FG000|Overall Study|Administrative Decision|4|||
145898427|NCT01150890|526135223|FG001|Overall Study|Administrative Decision|4|||
145898428|NCT01150890|526135224|FG002|Overall Study|Administrative Decision|5|||
145898429|NCT01150890|526135225|FG003|Overall Study|Administrative Decision|6|||
145898430|NCT01150890|526135222|FG000|Overall Study|Ineligibility determined|0|||
145898431|NCT01150890|526135223|FG001|Overall Study|Ineligibility determined|1|||
145898432|NCT01150890|526135224|FG002|Overall Study|Ineligibility determined|0|||
145898433|NCT01150890|526135225|FG003|Overall Study|Ineligibility determined|0|||
145898434|NCT01150890|526135222|FG000|Overall Study|Adverse Event|0|||
145898435|NCT01150890|526135223|FG001|Overall Study|Adverse Event|0|||
145898436|NCT01150890|526135224|FG002|Overall Study|Adverse Event|2|||
145898437|NCT01150890|526135225|FG003|Overall Study|Adverse Event|0|||
145898438|NCT01150890|526135222|FG000|Overall Study|Withdrawal by Subject|0|||
145898439|NCT01150890|526135223|FG001|Overall Study|Withdrawal by Subject|0|||
145898440|NCT01150890|526135224|FG002|Overall Study|Withdrawal by Subject|2|||
145898441|NCT01150890|526135225|FG003|Overall Study|Withdrawal by Subject|1|||
145898442|NCT01150890|526135222|FG000|Overall Study|Disease progression|0|||
145898443|NCT01150890|526135223|FG001|Overall Study|Disease progression|7|||
145898444|NCT01150890|526135224|FG002|Overall Study|Disease progression|3|||
145898445|NCT01150890|526135225|FG003|Overall Study|Disease progression|7|||
145898446|NCT00006721|526137738|FG000|Overall Study|Adverse Event|0|||
145898447|NCT00006721|526137739|FG001|Overall Study|Adverse Event|4|||
145898448|NCT00006721|526137740|FG002|Overall Study|Adverse Event|4|||
145898449|NCT00006721|526137738|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145898450|NCT00006721|526137739|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
145898451|NCT00006721|526137740|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
145898452|NCT00006721|526137738|FG000|Overall Study|Progression/Relapse|0|||
145898453|NCT00006721|526137739|FG001|Overall Study|Progression/Relapse|1|||
145898454|NCT00006721|526137740|FG002|Overall Study|Progression/Relapse|2|||
145898455|NCT00006721|526137738|FG000|Overall Study|Death|0|||
145898456|NCT00006721|526137739|FG001|Overall Study|Death|1|||
145898457|NCT00006721|526137740|FG002|Overall Study|Death|2|||
145898458|NCT00006721|526137738|FG000|Overall Study|Other - Not Protocol Specified|0|||
145898459|NCT00006721|526137739|FG001|Overall Study|Other - Not Protocol Specified|7|||
145898460|NCT00006721|526137740|FG002|Overall Study|Other - Not Protocol Specified|7|||
145898461|NCT00006721|526137738|FG000|Overall Study|Ineligible|2|||
145898462|NCT00006721|526137739|FG001|Overall Study|Ineligible|12|||
145898463|NCT00006721|526137740|FG002|Overall Study|Ineligible|10|||
145898464|NCT00006721|526137738|FG000|Overall Study|Eligible but no Treatment Received|1|||
145898465|NCT00006721|526137739|FG001|Overall Study|Eligible but no Treatment Received|0|||
145898466|NCT00006721|526137740|FG002|Overall Study|Eligible but no Treatment Received|0|||
145898467|NCT05424042|526137741|FG000|Overall Study|Withdrawal by Subject|2|||
145898468|NCT05424042|526137742|FG001|Overall Study|Withdrawal by Subject|0|||
145898469|NCT05424042|526137743|FG002|Overall Study|Withdrawal by Subject|4|||
145898470|NCT05424042|526137741|FG000|Overall Study|Lost to Follow-up|0|||
145898471|NCT05424042|526137742|FG001|Overall Study|Lost to Follow-up|0|||
145898472|NCT05424042|526137743|FG002|Overall Study|Lost to Follow-up|1|||
145898473|NCT05091307|526137744|FG000|Overall Study|Death|0|||
145898474|NCT05091307|526137745|FG001|Overall Study|Death|0|||
145898475|NCT05091307|526137746|FG002|Overall Study|Death|1|||
145898476|NCT05091307|526137747|FG003|Overall Study|Death|0|||
145898477|NCT05091307|526137744|FG000|Overall Study|Lost to Follow-up|33|||
146088260|NCT02186301|526843786|FG000|Overall Study|Progressive Disease|7|||
146088261|NCT02186301|526843787|FG001|Overall Study|Progressive Disease|22|||
146088262|NCT02186301|526843788|FG002|Overall Study|Progressive Disease|27|||
146088263|NCT02186301|526843786|FG000|Overall Study|Adverse Event|5|||
145898478|NCT05091307|526137745|FG001|Overall Study|Lost to Follow-up|33|||
145898479|NCT05091307|526137746|FG002|Overall Study|Lost to Follow-up|2|||
145898480|NCT05091307|526137747|FG003|Overall Study|Lost to Follow-up|0|||
145898481|NCT05091307|526137744|FG000|Overall Study|Physician Decision|1|||
145898482|NCT05091307|526137745|FG001|Overall Study|Physician Decision|0|||
145898483|NCT05091307|526137746|FG002|Overall Study|Physician Decision|0|||
145898484|NCT05091307|526137747|FG003|Overall Study|Physician Decision|0|||
145898485|NCT05091307|526137744|FG000|Overall Study|Protocol Violation|1|||
145898486|NCT05091307|526137745|FG001|Overall Study|Protocol Violation|0|||
145898487|NCT05091307|526137746|FG002|Overall Study|Protocol Violation|0|||
145898488|NCT05091307|526137747|FG003|Overall Study|Protocol Violation|0|||
145898489|NCT05091307|526137744|FG000|Overall Study|Withdrawal by Subject|16|||
145898490|NCT05091307|526137745|FG001|Overall Study|Withdrawal by Subject|16|||
145898491|NCT05091307|526137746|FG002|Overall Study|Withdrawal by Subject|0|||
145898492|NCT05091307|526137747|FG003|Overall Study|Withdrawal by Subject|1|||
145898493|NCT05091307|526137744|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
145898494|NCT05091307|526137745|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
145898495|NCT05091307|526137746|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
145898496|NCT05091307|526137747|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
145898497|NCT05091307|526137744|FG000|Overall Study|Initiated Prohibited Medication|1|||
145898498|NCT05091307|526137745|FG001|Overall Study|Initiated Prohibited Medication|0|||
145898499|NCT05091307|526137746|FG002|Overall Study|Initiated Prohibited Medication|0|||
145898500|NCT05091307|526137747|FG003|Overall Study|Initiated Prohibited Medication|0|||
145898501|NCT05091307|526137744|FG000|Overall Study|Other|4|||
145898502|NCT05091307|526137745|FG001|Overall Study|Other|4|||
145898503|NCT05091307|526137746|FG002|Overall Study|Other|0|||
145898504|NCT05091307|526137747|FG003|Overall Study|Other|0|||
145898505|NCT05091307|526137744|FG000|Overall Study|Randomized but not vaccinated|0|||
145898506|NCT05091307|526137745|FG001|Overall Study|Randomized but not vaccinated|2|||
145898507|NCT05091307|526137746|FG002|Overall Study|Randomized but not vaccinated|0|||
145898508|NCT05091307|526137747|FG003|Overall Study|Randomized but not vaccinated|0|||
145898509|NCT03611543|526137748|FG000|Overall Study|Withdrawal by Subject|4|||
145898510|NCT03611543|526137749|FG001|Overall Study|Withdrawal by Subject|4|||
145898511|NCT03611543|526137748|FG000|Overall Study|Physician Decision|1|||
145898512|NCT03611543|526137749|FG001|Overall Study|Physician Decision|1|||
145898513|NCT03611543|526137748|FG000|Overall Study|Protocol Violation|2|||
145898514|NCT03611543|526137749|FG001|Overall Study|Protocol Violation|2|||
145898515|NCT03611543|526137748|FG000|Overall Study|Device failure|2|||
145898516|NCT03611543|526137749|FG001|Overall Study|Device failure|2|||
145898517|NCT03611543|526137748|FG000|Overall Study|Missing information|5|||
145898518|NCT03611543|526137749|FG001|Overall Study|Missing information|5|||
145898519|NCT04394351|526137750|FG000|Part A (16 Weeks)|Adverse Event|1|||
145898520|NCT04394351|526137751|FG001|Part A (16 Weeks)|Adverse Event|0|||
145898521|NCT04394351|526137752|FG002|Part A (16 Weeks)|Adverse Event|0|||
145898522|NCT04394351|526137753|FG003|Part A (16 Weeks)|Adverse Event|0|||
145898523|NCT04394351|526137754|FG004|Part A (16 Weeks)|Adverse Event|0|||
145898524|NCT04394351|526137755|FG005|Part A (16 Weeks)|Adverse Event|0|||
145898525|NCT04394351|526137756|FG006|Part A (16 Weeks)|Adverse Event|0|||
145898526|NCT04394351|526137757|FG007|Part A (16 Weeks)|Adverse Event|0|||
145898527|NCT04394351|526137750|FG000|Part A (16 Weeks)|Physician Decision|0|||
145898528|NCT04394351|526137751|FG001|Part A (16 Weeks)|Physician Decision|1|||
145898529|NCT04394351|526137752|FG002|Part A (16 Weeks)|Physician Decision|0|||
145898530|NCT04394351|526137753|FG003|Part A (16 Weeks)|Physician Decision|0|||
145898531|NCT04394351|526137754|FG004|Part A (16 Weeks)|Physician Decision|0|||
145898532|NCT04394351|526137755|FG005|Part A (16 Weeks)|Physician Decision|0|||
145898533|NCT04394351|526137756|FG006|Part A (16 Weeks)|Physician Decision|0|||
145898534|NCT04394351|526137757|FG007|Part A (16 Weeks)|Physician Decision|0|||
145898535|NCT04394351|526137750|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
146088264|NCT02186301|526843787|FG001|Overall Study|Adverse Event|5|||
146238557|NCT00229658|527386787|FG000|Overall Study|Lost to Follow-up|82|||
146238558|NCT00229658|527386788|FG001|Overall Study|Lost to Follow-up|55|||
145898536|NCT04394351|526137751|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
145898537|NCT04394351|526137752|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
145898538|NCT04394351|526137753|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
146238559|NCT00229658|527386787|FG000|Overall Study|Serious Adverse Event|2|||
145898539|NCT04394351|526137754|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
145898540|NCT04394351|526137755|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
145898541|NCT04394351|526137756|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
145898542|NCT04394351|526137757|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
146088265|NCT02186301|526843788|FG002|Overall Study|Adverse Event|5|||
146238560|NCT00229658|527386788|FG001|Overall Study|Serious Adverse Event|2|||
145898543|NCT04394351|526137750|FG000|Part B (36 Weeks)|Adverse Event|0|||
145898544|NCT04394351|526137751|FG001|Part B (36 Weeks)|Adverse Event|0|||
145898545|NCT04394351|526137752|FG002|Part B (36 Weeks)|Adverse Event|0|||
146238561|NCT00229658|527386787|FG000|Overall Study|Withdrawal of consent|46|||
146238562|NCT00229658|527386788|FG001|Overall Study|Withdrawal of consent|39|||
146238563|NCT02157116|527386789|FG000|Overall Study|Withdrawal by Subject|4|||
146238564|NCT02157116|527386789|FG000|Overall Study|Physician Decision|3|||
145898546|NCT04394351|526137753|FG003|Part B (36 Weeks)|Adverse Event|0|||
145898547|NCT04394351|526137754|FG004|Part B (36 Weeks)|Adverse Event|0|||
145898548|NCT04394351|526137755|FG005|Part B (36 Weeks)|Adverse Event|0|||
145898549|NCT04394351|526137756|FG006|Part B (36 Weeks)|Adverse Event|1|||
145898550|NCT04394351|526137757|FG007|Part B (36 Weeks)|Adverse Event|0|||
145898551|NCT04394351|526137750|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898552|NCT04394351|526137751|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898553|NCT04394351|526137752|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898554|NCT04394351|526137753|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898555|NCT04394351|526137754|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898556|NCT04394351|526137755|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
146238565|NCT02157116|527386789|FG000|Overall Study|Failed Screening|2|||
145898557|NCT04394351|526137756|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145898558|NCT04394351|526137757|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
145898559|NCT04394351|526137750|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898560|NCT04394351|526137751|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898561|NCT04394351|526137752|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898562|NCT04394351|526137753|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898563|NCT04394351|526137754|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898564|NCT04394351|526137755|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898565|NCT04394351|526137756|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145898566|NCT04394351|526137757|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
145898567|NCT04394351|526137750|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898568|NCT04394351|526137751|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898569|NCT04394351|526137752|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898570|NCT04394351|526137753|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898571|NCT04394351|526137754|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898572|NCT04394351|526137755|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898573|NCT04394351|526137756|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145898574|NCT04394351|526137757|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
145898575|NCT04394351|526137750|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898576|NCT04394351|526137751|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898577|NCT04394351|526137752|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898578|NCT04394351|526137753|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898579|NCT04394351|526137754|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898580|NCT04394351|526137755|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898581|NCT04394351|526137756|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145898582|NCT04394351|526137757|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
145898583|NCT03653507|526137758|FG000|Overall Study|Miscellaneous|28|||
145898584|NCT03653507|526137759|FG001|Overall Study|Miscellaneous|19|||
145898585|NCT03653507|526137758|FG000|Overall Study|Withdrawal by Subject|37|||
145898586|NCT03653507|526137759|FG001|Overall Study|Withdrawal by Subject|22|||
145898587|NCT03653507|526137758|FG000|Overall Study|Protocol Deviation|2|||
145898588|NCT03653507|526137759|FG001|Overall Study|Protocol Deviation|1|||
145898589|NCT03653507|526137758|FG000|Overall Study|Progressive disease|117|||
145898590|NCT03653507|526137759|FG001|Overall Study|Progressive disease|168|||
145898591|NCT03653507|526137758|FG000|Overall Study|Lost to Follow-up|1|||
145898592|NCT03653507|526137759|FG001|Overall Study|Lost to Follow-up|1|||
145898593|NCT03653507|526137758|FG000|Overall Study|Death|25|||
145898594|NCT03653507|526137759|FG001|Overall Study|Death|22|||
145898595|NCT03653507|526137758|FG000|Overall Study|Adverse Event|35|||
145898596|NCT03653507|526137759|FG001|Overall Study|Adverse Event|14|||
146238566|NCT00975585|527386790|FG000|Overall Study|Adverse Event|0|||
145898597|NCT03047473|526137770|FG000|Overall Study|Lost to Follow-up|2|||
145898598|NCT01367665|526137771|FG000|Overall Study|Death|102|||
146088266|NCT02186301|526843786|FG000|Overall Study|Death|1|||
146238567|NCT00975585|527386791|FG001|Overall Study|Adverse Event|4|||
146297303|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
146088267|NCT02186301|526843787|FG001|Overall Study|Death|0|||
146238568|NCT00975585|527386790|FG000|Overall Study|Lost to Follow-up|3|||
145898599|NCT01367665|526137772|FG001|Overall Study|Death|19|||
145898600|NCT01367665|526137771|FG000|Overall Study|Lost to Follow-up|222|||
145898601|NCT01367665|526137772|FG001|Overall Study|Lost to Follow-up|22|||
145898602|NCT01367665|526137771|FG000|Overall Study|Not Done|118|||
145898603|NCT01367665|526137772|FG001|Overall Study|Not Done|14|||
145898604|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
145898605|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
146238569|NCT00975585|527386791|FG001|Overall Study|Lost to Follow-up|5|||
146238570|NCT00975585|527386790|FG000|Overall Study|Withdrawal by Subject|2|||
145898606|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
145898607|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
145898608|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
145898609|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
145898610|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
145898611|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
145898612|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
145898613|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
145898614|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
145898615|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
145898616|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
145898617|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
145898618|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
145898619|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
145898620|NCT03182244|526137773|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
145898621|NCT03182244|526137774|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
145898622|NCT03182244|526137773|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
145898623|NCT03182244|526137774|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
145898624|NCT03182244|526137773|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
145898625|NCT03182244|526137774|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
145898626|NCT03182244|526137773|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
145898627|NCT03182244|526137774|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
145898628|NCT03182244|526137773|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
145898629|NCT03182244|526137774|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
145898630|NCT02752906|526137775|FG000|Overall Study|Protocol Violation|2|||
145898631|NCT02752906|526137776|FG001|Overall Study|Protocol Violation|1|||
145898632|NCT02752906|526137775|FG000|Overall Study|Withdrawal by Subject|2|||
145898633|NCT02752906|526137776|FG001|Overall Study|Withdrawal by Subject|2|||
145898634|NCT02752906|526137775|FG000|Overall Study|Lost to Follow-up|3|||
145898635|NCT02752906|526137776|FG001|Overall Study|Lost to Follow-up|2|||
145898636|NCT02492880|526137777|FG000|Overall Study|Lost to Follow-up|1|||
145898637|NCT02492880|526137777|FG000|Overall Study|Protocol Violation|1|||
145898638|NCT01200992|526137778|FG000|Overall Study|Study terminated early|35|||
145898639|NCT01200992|526137779|FG001|Overall Study|Study terminated early|41|||
145898640|NCT01200992|526137778|FG000|Overall Study|Randomized but not treated|2|||
145898641|NCT01200992|526137779|FG001|Overall Study|Randomized but not treated|0|||
145898642|NCT03186781|526137780|FG000|Overall Study|Lost to Follow-up|0|||
145898643|NCT03186781|526137781|FG001|Overall Study|Lost to Follow-up|0|||
145898644|NCT03186781|526137782|FG002|Overall Study|Lost to Follow-up|1|||
145898645|NCT03186781|526137783|FG003|Overall Study|Lost to Follow-up|0|||
145898646|NCT03186781|526137784|FG004|Overall Study|Lost to Follow-up|1|||
145898647|NCT03186781|526137785|FG005|Overall Study|Lost to Follow-up|0|||
145898648|NCT03186781|526137780|FG000|Overall Study|Moved from Area|0|||
145898649|NCT03186781|526137781|FG001|Overall Study|Moved from Area|0|||
145898650|NCT03186781|526137782|FG002|Overall Study|Moved from Area|0|||
145898651|NCT03186781|526137783|FG003|Overall Study|Moved from Area|0|||
145898652|NCT03186781|526137784|FG004|Overall Study|Moved from Area|1|||
145898653|NCT03186781|526137785|FG005|Overall Study|Moved from Area|0|||
145898654|NCT03186781|526137780|FG000|Overall Study|Withdrawal by Subject|0|||
145898655|NCT03186781|526137781|FG001|Overall Study|Withdrawal by Subject|0|||
145898656|NCT03186781|526137782|FG002|Overall Study|Withdrawal by Subject|0|||
145898657|NCT03186781|526137783|FG003|Overall Study|Withdrawal by Subject|0|||
145898658|NCT03186781|526137784|FG004|Overall Study|Withdrawal by Subject|1|||
145898659|NCT03186781|526137785|FG005|Overall Study|Withdrawal by Subject|0|||
145898660|NCT00792935|526137786|FG000|Overall Study|Adverse Event|2|||
145898661|NCT00792935|526137787|FG001|Overall Study|Adverse Event|1|||
145898662|NCT00792935|526137786|FG000|Overall Study|Lost to Follow-up|0|||
145898663|NCT00792935|526137787|FG001|Overall Study|Lost to Follow-up|1|||
145898664|NCT00792935|526137786|FG000|Overall Study|Protocol Violation|2|||
145898665|NCT00792935|526137787|FG001|Overall Study|Protocol Violation|0|||
145898666|NCT00792935|526137786|FG000|Overall Study|Withdrawal by Subject|0|||
145898667|NCT00792935|526137787|FG001|Overall Study|Withdrawal by Subject|1|||
145898668|NCT01345175|526137792|FG000|Overall Study|Physician Decision|0|||
146297304|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
146297305|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
145898669|NCT01345175|526137793|FG001|Overall Study|Physician Decision|1|||
145898670|NCT01345175|526137792|FG000|Overall Study|Withdrawal by Subject|1|||
145898671|NCT01345175|526137793|FG001|Overall Study|Withdrawal by Subject|1|||
145898672|NCT01345175|526137792|FG000|Overall Study|Failed to complete BFI|3|||
145898673|NCT01345175|526137793|FG001|Overall Study|Failed to complete BFI|2|||
145898674|NCT01345175|526137792|FG000|Overall Study|Stopped taking medication|2|||
145898675|NCT01345175|526137793|FG001|Overall Study|Stopped taking medication|2|||
145898676|NCT04112173|526137794|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
145898677|NCT02746471|526137795|FG000|Overall Study|Death|43|||
145898678|NCT02746471|526137795|FG000|Overall Study|Exited before 36 months|1119|||
145898679|NCT04492020|526137797|FG000|Overall Study|Adverse Event|1|||
145898680|NCT04492020|526137798|FG001|Overall Study|Adverse Event|3|||
145898681|NCT04492020|526137797|FG000|Overall Study|Withdrawal by Subject|4|||
145898682|NCT04492020|526137798|FG001|Overall Study|Withdrawal by Subject|3|||
145898683|NCT04492020|526137797|FG000|Overall Study|Lost to Follow-up|4|||
145898684|NCT04492020|526137798|FG001|Overall Study|Lost to Follow-up|3|||
145898685|NCT04492020|526137797|FG000|Overall Study|Protocol Violation|5|||
145898686|NCT04492020|526137798|FG001|Overall Study|Protocol Violation|2|||
145898687|NCT04492020|526137797|FG000|Overall Study|Lack of Qualifying Event|25|||
145898688|NCT04492020|526137798|FG001|Overall Study|Lack of Qualifying Event|27|||
145898689|NCT04492020|526137797|FG000|Overall Study|Non-compliance with Study Drug|2|||
145898690|NCT04492020|526137798|FG001|Overall Study|Non-compliance with Study Drug|1|||
145898691|NCT04594707|526137799|FG000|Overall Study|Adverse Event|0|||
145898692|NCT04594707|526137800|FG001|Overall Study|Adverse Event|0|||
145898693|NCT04594707|526137801|FG002|Overall Study|Adverse Event|1|||
145898694|NCT04594707|526137799|FG000|Overall Study|Death|0|||
145898695|NCT04594707|526137800|FG001|Overall Study|Death|2|||
145898696|NCT04594707|526137801|FG002|Overall Study|Death|2|||
145898697|NCT04594707|526137799|FG000|Overall Study|Lung Transplant|0|||
145898698|NCT04594707|526137800|FG001|Overall Study|Lung Transplant|0|||
145898699|NCT04594707|526137801|FG002|Overall Study|Lung Transplant|1|||
145898700|NCT04594707|526137799|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
145898701|NCT04594707|526137800|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
145898702|NCT04594707|526137801|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
145898703|NCT04594707|526137799|FG000|Overall Study|Study Terminated By Sponsor|19|||
145898704|NCT04594707|526137800|FG001|Overall Study|Study Terminated By Sponsor|47|||
145898705|NCT04594707|526137801|FG002|Overall Study|Study Terminated By Sponsor|41|||
145898706|NCT04594707|526137799|FG000|Overall Study|Withdrawal by Subject|1|||
145898707|NCT04594707|526137800|FG001|Overall Study|Withdrawal by Subject|0|||
145898708|NCT04594707|526137801|FG002|Overall Study|Withdrawal by Subject|2|||
145898709|NCT04585789|526137802|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
145898710|NCT04585789|526137803|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
145898711|NCT04585789|526137804|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
145898712|NCT04585789|526137802|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
145898713|NCT04585789|526137803|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
145898714|NCT04585789|526137804|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
145898715|NCT01175811|526137805|FG000|Overall Study|Adverse Event|1|||
145898716|NCT01175811|526137806|FG001|Overall Study|Adverse Event|1|||
145898717|NCT01175811|526137805|FG000|Overall Study|Entry criteria not met|3|||
145898718|NCT01175811|526137806|FG001|Overall Study|Entry criteria not met|1|||
145898719|NCT01175811|526137805|FG000|Overall Study|Lack of Efficacy|1|||
145898720|NCT01175811|526137806|FG001|Overall Study|Lack of Efficacy|0|||
145898721|NCT01175811|526137805|FG000|Overall Study|Lost to Follow-up|3|||
145898722|NCT01175811|526137806|FG001|Overall Study|Lost to Follow-up|2|||
145898723|NCT01175811|526137805|FG000|Overall Study|Physician Decision|1|||
145898724|NCT01175811|526137806|FG001|Overall Study|Physician Decision|1|||
145898725|NCT01175811|526137805|FG000|Overall Study|Protocol Violation|1|||
145898726|NCT01175811|526137806|FG001|Overall Study|Protocol Violation|2|||
145898727|NCT01175811|526137805|FG000|Overall Study|Withdrawal by Subject|6|||
145898728|NCT01175811|526137806|FG001|Overall Study|Withdrawal by Subject|7|||
145898729|NCT02628743|526137808|FG000|Overall Study|Other|3|||
145898730|NCT02628743|526137808|FG000|Overall Study|Withdrawal by Subject|50|||
145898731|NCT02628743|526137808|FG000|Overall Study|Study Terminated by Sponsor|76|||
145898732|NCT02628743|526137808|FG000|Overall Study|Physician Decision|2|||
145898733|NCT02534844|526137809|FG000|Part B|Withdrawal by Subject|0|||
145898734|NCT02534844|526137810|FG001|Part B|Withdrawal by Subject|0|||
145898735|NCT02534844|526137811|FG002|Part B|Withdrawal by Subject|0|||
145898736|NCT02534844|526137812|FG003|Part B|Withdrawal by Subject|0|||
145898737|NCT02534844|526137813|FG004|Part B|Withdrawal by Subject|2|||
145898738|NCT02534844|526137814|FG005|Part B|Withdrawal by Subject|1|||
145898739|NCT00655876|526137815|FG000|Overall Study|Protocol Violation|9|||
145898740|NCT00655876|526137816|FG001|Overall Study|Protocol Violation|7|||
145898741|NCT00326963|526137817|FG000|Overall Study|Adverse Event|2|||
145898742|NCT00326963|526137817|FG000|Overall Study|Injection site reaction|1|||
145898743|NCT00326963|526137817|FG000|Overall Study|Death|1|||
145898744|NCT00326963|526137817|FG000|Overall Study|Failure to return|10|||
145898745|NCT00326963|526137817|FG000|Overall Study|Withdrawal by Subject|10|||
145898746|NCT00326963|526137817|FG000|Overall Study|Refused treatment / did not cooperate|5|||
145898747|NCT00326963|526137817|FG000|Overall Study|Violation of selection criteria at entry|2|||
145898748|NCT00326963|526137817|FG000|Overall Study|Other protocol violation|1|||
145898749|NCT00326963|526137817|FG000|Overall Study|Administrative / other|1|||
145898750|NCT01468818|526137823|FG000|Overall Study|Death during treatment|2|||
145898751|NCT00338455|526137826|FG000|Overall Study|Death|2|||
145898752|NCT00338455|526137827|FG001|Overall Study|Death|1|||
145972463|NCT01799889|526412652|FG010|Overall Study|Physician Decision|0|||
145898753|NCT00338455|526137826|FG000|Overall Study|Physician Decision|1|||
145898754|NCT00338455|526137827|FG001|Overall Study|Physician Decision|0|||
145898755|NCT02266134|526137830|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
145898756|NCT02266134|526137831|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
145898757|NCT02266134|526137832|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
145898758|NCT02266134|526137833|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
145898759|NCT02266134|526137830|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
145898760|NCT02266134|526137831|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
145898761|NCT02266134|526137832|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
145898762|NCT02266134|526137833|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
145898763|NCT02266134|526137830|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
145898764|NCT02266134|526137831|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
145898765|NCT02266134|526137832|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
145898766|NCT02266134|526137833|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
145898767|NCT02266134|526137830|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
145898768|NCT02266134|526137831|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145898769|NCT02266134|526137832|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145898770|NCT02266134|526137833|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145898771|NCT02266134|526137830|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
145898772|NCT02266134|526137831|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
145898773|NCT02266134|526137832|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
145898774|NCT02266134|526137833|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
145898775|NCT02266134|526137830|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
145898776|NCT02266134|526137831|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145898777|NCT02266134|526137832|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145898778|NCT02266134|526137833|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145898779|NCT02331368|526137834|FG000|Overall Study|Withdrawal by Subject|3|||
145898780|NCT01763684|526137836|FG000|Overall Study|Study terminated early due to low enrollment|126|||
145898781|NCT01763684|526137837|FG001|Overall Study|Study terminated early due to low enrollment|127|||
145898782|NCT01763684|526137836|FG000|Overall Study|Study surgery not performed|7|||
145898783|NCT01763684|526137837|FG001|Overall Study|Study surgery not performed|6|||
145898784|NCT02987959|526137838|FG000|Overall Study|Grantor stopped supply of drugs|6|||
145898785|NCT02302859|526137840|FG000|Overall Study|Lost Phone|1|||
145898786|NCT02302859|526137841|FG001|Overall Study|Lost Phone|1|||
145898787|NCT02302859|526137840|FG000|Overall Study|Withdrawal by Subject|0|||
145898788|NCT02302859|526137841|FG001|Overall Study|Withdrawal by Subject|1|||
145898789|NCT00643565|526137843|FG000|Overall Study|Death|12|||
145898790|NCT00643565|526137844|FG001|Overall Study|Death|11|||
145898791|NCT00643565|526137843|FG000|Overall Study|Withdrawal by Subject|4|||
145898792|NCT00643565|526137844|FG001|Overall Study|Withdrawal by Subject|1|||
145898793|NCT00643565|526137843|FG000|Overall Study|Lost to Follow-up|0|||
146088268|NCT02186301|526843788|FG002|Overall Study|Death|0|||
146088269|NCT02186301|526843786|FG000|Overall Study|Withdrawal by Subject|5|||
146088270|NCT02186301|526843787|FG001|Overall Study|Withdrawal by Subject|1|||
145898794|NCT00643565|526137844|FG001|Overall Study|Lost to Follow-up|6|||
145898795|NCT00643565|526137843|FG000|Overall Study|Other|7|||
145898796|NCT00643565|526137844|FG001|Overall Study|Other|8|||
145898797|NCT00643565|526137843|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
145898798|NCT00643565|526137844|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
145898799|NCT00643565|526137843|FG000|Overall Study|Recurrence of Disease|2|||
145898800|NCT00643565|526137844|FG001|Overall Study|Recurrence of Disease|1|||
145898801|NCT00643565|526137843|FG000|Overall Study|Progression of Disease|18|||
145898802|NCT00643565|526137844|FG001|Overall Study|Progression of Disease|14|||
145898803|NCT00643565|526137843|FG000|Overall Study|Protocol Violation|3|||
145898804|NCT00643565|526137844|FG001|Overall Study|Protocol Violation|0|||
145898805|NCT00643565|526137843|FG000|Overall Study|Did Not Cooperate|0|||
146088271|NCT02186301|526843788|FG002|Overall Study|Withdrawal by Subject|3|||
146088272|NCT02186301|526843786|FG000|Overall Study|Physician Decision|1|||
145898806|NCT00643565|526137844|FG001|Overall Study|Did Not Cooperate|1|||
145898807|NCT00643565|526137843|FG000|Overall Study|Administrative|22|||
145898808|NCT00643565|526137844|FG001|Overall Study|Administrative|16|||
145898809|NCT00643565|526137843|FG000|Overall Study|Adverse Event|5|||
145898810|NCT00643565|526137844|FG001|Overall Study|Adverse Event|8|||
145898811|NCT04305496|526137849|FG000|Global Cohort|Withdrawal by Subject|13|||
145898812|NCT04305496|526137850|FG001|Global Cohort|Withdrawal by Subject|6|||
145898813|NCT04305496|526137849|FG000|Global Cohort|Physician Decision|1|||
145898814|NCT04305496|526137850|FG001|Global Cohort|Physician Decision|1|||
145898815|NCT04305496|526137849|FG000|Global Cohort|Subjective disease progression|16|||
145898816|NCT04305496|526137850|FG001|Global Cohort|Subjective disease progression|17|||
145898817|NCT04305496|526137849|FG000|Global Cohort|Condition under investigation worsened|209|||
146088273|NCT02186301|526843787|FG001|Overall Study|Physician Decision|0|||
146088274|NCT02186301|526843788|FG002|Overall Study|Physician Decision|1|||
146088275|NCT02186301|526843786|FG000|Overall Study|Study Terminated by Sponsor|1|||
145898818|NCT04305496|526137850|FG001|Global Cohort|Condition under investigation worsened|273|||
145898819|NCT04305496|526137849|FG000|Global Cohort|Protocol Violation|2|||
145898820|NCT04305496|526137850|FG001|Global Cohort|Protocol Violation|0|||
145898821|NCT04305496|526137849|FG000|Global Cohort|Adverse Event|44|||
145898822|NCT04305496|526137850|FG001|Global Cohort|Adverse Event|6|||
145898823|NCT04305496|526137849|FG000|Global Cohort|Death|3|||
145898824|NCT04305496|526137850|FG001|Global Cohort|Death|2|||
145898825|NCT04305496|526137849|FG000|Global Cohort|Any reason not specifically recorded|4|||
145898826|NCT04305496|526137850|FG001|Global Cohort|Any reason not specifically recorded|5|||
145898827|NCT04305496|526137849|FG000|China Cohort|Any reason not specifically recorded|1|||
145898828|NCT04305496|526137850|FG001|China Cohort|Any reason not specifically recorded|1|||
145898829|NCT04305496|526137849|FG000|China Cohort|Adverse Event|8|||
145898830|NCT04305496|526137850|FG001|China Cohort|Adverse Event|2|||
145898831|NCT04305496|526137849|FG000|China Cohort|Condition under investigation worsened|40|||
145898832|NCT04305496|526137850|FG001|China Cohort|Condition under investigation worsened|47|||
145898833|NCT04305496|526137849|FG000|China Cohort|Subjective disease progression|2|||
145898834|NCT04305496|526137850|FG001|China Cohort|Subjective disease progression|2|||
145898835|NCT04305496|526137849|FG000|China Cohort|Withdrawal by Subject|2|||
145898836|NCT04305496|526137850|FG001|China Cohort|Withdrawal by Subject|1|||
145898837|NCT01157897|526137851|FG000|Overall Study|Lost to Follow-up|2|||
145898838|NCT01157897|526137852|FG001|Overall Study|Lost to Follow-up|0|||
145898839|NCT01157897|526137853|FG002|Overall Study|Lost to Follow-up|0|||
145898840|NCT01157897|526137854|FG003|Overall Study|Lost to Follow-up|1|||
145898841|NCT01157897|526137851|FG000|Overall Study|Relocated|0|||
145898842|NCT01157897|526137852|FG001|Overall Study|Relocated|2|||
145898843|NCT01157897|526137853|FG002|Overall Study|Relocated|0|||
145898844|NCT01157897|526137854|FG003|Overall Study|Relocated|0|||
145898845|NCT00681590|526137855|FG000|Overall Study|Withdrawal by Subject|2|||
145898846|NCT00681590|526137856|FG001|Overall Study|Withdrawal by Subject|12|||
145898847|NCT02912650|526137857|FG000|Overall Study|Withdrawal by Subject|1|||
145898848|NCT02912650|526137858|FG001|Overall Study|Withdrawal by Subject|0|||
145898849|NCT02912650|526137859|FG002|Overall Study|Withdrawal by Subject|1|||
145898850|NCT02912650|526137860|FG003|Overall Study|Withdrawal by Subject|5|||
145898851|NCT02912650|526137857|FG000|Overall Study|Adverse Event|0|||
145898852|NCT02912650|526137858|FG001|Overall Study|Adverse Event|0|||
145898853|NCT02912650|526137859|FG002|Overall Study|Adverse Event|1|||
145898854|NCT02912650|526137860|FG003|Overall Study|Adverse Event|0|||
145898855|NCT01791153|526137862|FG000|Part 1: Blinded Period|Adverse Event|7|||
145898856|NCT01791153|526137863|FG001|Part 1: Blinded Period|Adverse Event|3|||
145898857|NCT01791153|526137864|FG002|Part 1: Blinded Period|Adverse Event|2|||
145898858|NCT01791153|526137865|FG003|Part 1: Blinded Period|Adverse Event|0|||
145898859|NCT01791153|526137866|FG004|Part 1: Blinded Period|Adverse Event|0|||
145898860|NCT01791153|526137867|FG005|Part 1: Blinded Period|Adverse Event|0|||
145898861|NCT01791153|526137868|FG006|Part 1: Blinded Period|Adverse Event|0|||
145898862|NCT01791153|526137869|FG007|Part 1: Blinded Period|Adverse Event|0|||
145898863|NCT01791153|526137862|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
145898864|NCT01791153|526137863|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
145898865|NCT01791153|526137864|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
145898866|NCT01791153|526137865|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
145898867|NCT01791153|526137866|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
145898868|NCT01791153|526137867|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
145898869|NCT01791153|526137868|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
145898870|NCT01791153|526137869|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
145898871|NCT01791153|526137862|FG000|Part 1: Blinded Period|Non-Compliance|1|||
145898872|NCT01791153|526137863|FG001|Part 1: Blinded Period|Non-Compliance|0|||
145898873|NCT01791153|526137864|FG002|Part 1: Blinded Period|Non-Compliance|0|||
145898874|NCT01791153|526137865|FG003|Part 1: Blinded Period|Non-Compliance|0|||
145898875|NCT01791153|526137866|FG004|Part 1: Blinded Period|Non-Compliance|0|||
145898876|NCT01791153|526137867|FG005|Part 1: Blinded Period|Non-Compliance|0|||
145898877|NCT01791153|526137868|FG006|Part 1: Blinded Period|Non-Compliance|0|||
145898878|NCT01791153|526137869|FG007|Part 1: Blinded Period|Non-Compliance|0|||
145898879|NCT01791153|526137862|FG000|Part 1: Blinded Period|Physician Decision|0|||
145898880|NCT01791153|526137863|FG001|Part 1: Blinded Period|Physician Decision|0|||
145898881|NCT01791153|526137864|FG002|Part 1: Blinded Period|Physician Decision|0|||
145898882|NCT01791153|526137865|FG003|Part 1: Blinded Period|Physician Decision|1|||
145898883|NCT01791153|526137866|FG004|Part 1: Blinded Period|Physician Decision|0|||
145898884|NCT01791153|526137867|FG005|Part 1: Blinded Period|Physician Decision|0|||
145898885|NCT01791153|526137868|FG006|Part 1: Blinded Period|Physician Decision|0|||
145898886|NCT01791153|526137869|FG007|Part 1: Blinded Period|Physician Decision|0|||
145898887|NCT01791153|526137862|FG000|Part 1: Blinded Period|Protocol Violation|0|||
145898888|NCT01791153|526137863|FG001|Part 1: Blinded Period|Protocol Violation|0|||
145898889|NCT01791153|526137864|FG002|Part 1: Blinded Period|Protocol Violation|0|||
145898890|NCT01791153|526137865|FG003|Part 1: Blinded Period|Protocol Violation|1|||
145898891|NCT01791153|526137866|FG004|Part 1: Blinded Period|Protocol Violation|0|||
145898892|NCT01791153|526137867|FG005|Part 1: Blinded Period|Protocol Violation|0|||
145898893|NCT01791153|526137868|FG006|Part 1: Blinded Period|Protocol Violation|0|||
146297306|NCT00559585|527604655|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
146297307|NCT00559585|527604656|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
145898894|NCT01791153|526137869|FG007|Part 1: Blinded Period|Protocol Violation|0|||
145898895|NCT01791153|526137862|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
145898896|NCT01791153|526137863|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
145898897|NCT01791153|526137864|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
145898898|NCT01791153|526137865|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
145898899|NCT01791153|526137866|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
145898900|NCT01791153|526137867|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
145898901|NCT01791153|526137868|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
145898902|NCT01791153|526137869|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
145898903|NCT01791153|526137862|FG000|Part 2: Open-label Period|Adverse Event|0|||
145898904|NCT01791153|526137863|FG001|Part 2: Open-label Period|Adverse Event|0|||
145898905|NCT01791153|526137864|FG002|Part 2: Open-label Period|Adverse Event|0|||
145898906|NCT01791153|526137865|FG003|Part 2: Open-label Period|Adverse Event|0|||
145898907|NCT01791153|526137866|FG004|Part 2: Open-label Period|Adverse Event|0|||
145898908|NCT01791153|526137867|FG005|Part 2: Open-label Period|Adverse Event|1|||
145898909|NCT01791153|526137868|FG006|Part 2: Open-label Period|Adverse Event|1|||
145898910|NCT01791153|526137869|FG007|Part 2: Open-label Period|Adverse Event|2|||
145898911|NCT01791153|526137862|FG000|Part 2: Open-label Period|Death|0|||
145898912|NCT01791153|526137863|FG001|Part 2: Open-label Period|Death|0|||
145898913|NCT01791153|526137864|FG002|Part 2: Open-label Period|Death|0|||
145898914|NCT01791153|526137865|FG003|Part 2: Open-label Period|Death|0|||
145898915|NCT01791153|526137866|FG004|Part 2: Open-label Period|Death|0|||
145898916|NCT01791153|526137867|FG005|Part 2: Open-label Period|Death|1|||
145898917|NCT01791153|526137868|FG006|Part 2: Open-label Period|Death|1|||
145898918|NCT01791153|526137869|FG007|Part 2: Open-label Period|Death|1|||
145898919|NCT01791153|526137862|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
145898920|NCT01791153|526137863|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
145898921|NCT01791153|526137864|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
145898922|NCT01791153|526137865|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
145898923|NCT01791153|526137866|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
145898924|NCT01791153|526137867|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
145898925|NCT01791153|526137868|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
145898926|NCT01791153|526137869|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
145898927|NCT01791153|526137862|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
145898928|NCT01791153|526137863|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
145898929|NCT01791153|526137864|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
145898930|NCT01791153|526137865|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
145898931|NCT01791153|526137866|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
145898932|NCT01791153|526137867|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
145898933|NCT01791153|526137868|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
145898934|NCT01791153|526137869|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
145898935|NCT01791153|526137862|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
145898936|NCT01791153|526137863|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
145898937|NCT01791153|526137864|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
145898938|NCT01791153|526137865|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
145898939|NCT01791153|526137866|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
145898940|NCT01791153|526137867|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
145898941|NCT01791153|526137868|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
145898942|NCT01791153|526137869|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
145898943|NCT01791153|526137862|FG000|Part 2: Open-label Period|Physician Decision|0|||
145898944|NCT01791153|526137863|FG001|Part 2: Open-label Period|Physician Decision|0|||
145898945|NCT01791153|526137864|FG002|Part 2: Open-label Period|Physician Decision|0|||
145898946|NCT01791153|526137865|FG003|Part 2: Open-label Period|Physician Decision|0|||
145898947|NCT01791153|526137866|FG004|Part 2: Open-label Period|Physician Decision|1|||
145898948|NCT01791153|526137867|FG005|Part 2: Open-label Period|Physician Decision|1|||
145898949|NCT01791153|526137868|FG006|Part 2: Open-label Period|Physician Decision|0|||
145898950|NCT01791153|526137869|FG007|Part 2: Open-label Period|Physician Decision|0|||
145898951|NCT02562482|526137870|FG000|Overall Study|Enrolled, but did not receive product|4|||
145898952|NCT02562482|526137871|FG001|Overall Study|Enrolled, but did not receive product|0|||
146297308|NCT02644941|527604657|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
146297309|NCT02644941|527604658|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
145898953|NCT02562482|526137870|FG000|Overall Study|Lost to Follow-up|9|||
145898954|NCT02562482|526137871|FG001|Overall Study|Lost to Follow-up|6|||
145898955|NCT02562482|526137870|FG000|Overall Study|Moved from area|2|||
145898956|NCT02562482|526137871|FG001|Overall Study|Moved from area|3|||
145898957|NCT02562482|526137870|FG000|Overall Study|Withdrawal by Subject|5|||
145898958|NCT02562482|526137871|FG001|Overall Study|Withdrawal by Subject|3|||
145898959|NCT02562482|526137870|FG000|Overall Study|Physician Decision|1|||
145898960|NCT02562482|526137871|FG001|Overall Study|Physician Decision|3|||
145898961|NCT02562482|526137870|FG000|Overall Study|Illness/Injury unrelated to product|0|||
145898962|NCT02562482|526137871|FG001|Overall Study|Illness/Injury unrelated to product|1|||
145898963|NCT04135196|526137882|FG000|Overall Study|Lost to Follow-up|8|||
145898964|NCT04135196|526137883|FG001|Overall Study|Lost to Follow-up|7|||
145898965|NCT04135196|526137884|FG002|Overall Study|Lost to Follow-up|8|||
145898966|NCT04135196|526137885|FG003|Overall Study|Lost to Follow-up|9|||
145898967|NCT04135196|526137886|FG004|Overall Study|Lost to Follow-up|1|||
145898968|NCT04135196|526137882|FG000|Overall Study|Pregnancy|0|||
145898969|NCT04135196|526137883|FG001|Overall Study|Pregnancy|0|||
145898970|NCT04135196|526137884|FG002|Overall Study|Pregnancy|1|||
145898971|NCT04135196|526137885|FG003|Overall Study|Pregnancy|0|||
145898972|NCT04135196|526137886|FG004|Overall Study|Pregnancy|0|||
145898973|NCT04135196|526137882|FG000|Overall Study|Withdrawal by Subject|0|||
145898974|NCT04135196|526137883|FG001|Overall Study|Withdrawal by Subject|0|||
145898975|NCT04135196|526137884|FG002|Overall Study|Withdrawal by Subject|0|||
145898976|NCT04135196|526137885|FG003|Overall Study|Withdrawal by Subject|0|||
145898977|NCT04135196|526137886|FG004|Overall Study|Withdrawal by Subject|1|||
145898978|NCT01121666|526137887|FG000|Overall Study|Protocol Violation|29|||
145898979|NCT01121666|526137888|FG001|Overall Study|Protocol Violation|10|||
145898980|NCT01083810|526137891|FG000|Overall Study|Lost to Follow-up|23|||
145898981|NCT01083810|526137892|FG001|Overall Study|Lost to Follow-up|11|||
145898982|NCT01083810|526137893|FG002|Overall Study|Lost to Follow-up|4|||
145898983|NCT01083810|526137891|FG000|Overall Study|Adverse Event|15|||
145898984|NCT01083810|526137892|FG001|Overall Study|Adverse Event|11|||
145898985|NCT01083810|526137893|FG002|Overall Study|Adverse Event|4|||
145898986|NCT01083810|526137891|FG000|Overall Study|Withdrawal by Subject|7|||
145898987|NCT01083810|526137892|FG001|Overall Study|Withdrawal by Subject|2|||
145898988|NCT01083810|526137893|FG002|Overall Study|Withdrawal by Subject|4|||
145898989|NCT01083810|526137891|FG000|Overall Study|Reason not reported|6|||
145898990|NCT01083810|526137892|FG001|Overall Study|Reason not reported|1|||
145898991|NCT01083810|526137893|FG002|Overall Study|Reason not reported|1|||
145898992|NCT01083810|526137891|FG000|Overall Study|Non-compliance|4|||
145898993|NCT01083810|526137892|FG001|Overall Study|Non-compliance|7|||
145898994|NCT01083810|526137893|FG002|Overall Study|Non-compliance|2|||
145898995|NCT01083810|526137891|FG000|Overall Study|Simplification|4|||
145898996|NCT01083810|526137892|FG001|Overall Study|Simplification|1|||
145898997|NCT01083810|526137893|FG002|Overall Study|Simplification|0|||
145898998|NCT01083810|526137891|FG000|Overall Study|Death|2|||
145898999|NCT01083810|526137892|FG001|Overall Study|Death|2|||
145899000|NCT01083810|526137893|FG002|Overall Study|Death|3|||
145899001|NCT01083810|526137891|FG000|Overall Study|Co-morbidities|1|||
145899002|NCT01083810|526137892|FG001|Overall Study|Co-morbidities|0|||
145899003|NCT01083810|526137893|FG002|Overall Study|Co-morbidities|0|||
145899004|NCT01083810|526137891|FG000|Overall Study|Participation in study|1|||
145899005|NCT01083810|526137892|FG001|Overall Study|Participation in study|0|||
145899006|NCT01083810|526137893|FG002|Overall Study|Participation in study|0|||
145899007|NCT01083810|526137891|FG000|Overall Study|Therapy break|1|||
145899008|NCT01083810|526137892|FG001|Overall Study|Therapy break|2|||
145899009|NCT01083810|526137893|FG002|Overall Study|Therapy break|2|||
145899010|NCT01083810|526137891|FG000|Overall Study|Virologic failure|1|||
145899011|NCT01083810|526137892|FG001|Overall Study|Virologic failure|8|||
145899012|NCT01083810|526137893|FG002|Overall Study|Virologic failure|0|||
145899013|NCT02132754|526137894|FG000|Overall Study|Adverse Event|0|||
145899014|NCT02132754|526137895|FG001|Overall Study|Adverse Event|0|||
145899015|NCT02132754|526137896|FG002|Overall Study|Adverse Event|0|||
145899016|NCT02132754|526137897|FG003|Overall Study|Adverse Event|0|||
145899017|NCT02132754|526137898|FG004|Overall Study|Adverse Event|0|||
145899018|NCT02132754|526137899|FG005|Overall Study|Adverse Event|0|||
145899019|NCT02132754|526137900|FG006|Overall Study|Adverse Event|0|||
145899020|NCT02132754|526137901|FG007|Overall Study|Adverse Event|0|||
145899021|NCT02132754|526137902|FG008|Overall Study|Adverse Event|0|||
145899022|NCT02132754|526137903|FG009|Overall Study|Adverse Event|0|||
145899023|NCT02132754|526137904|FG010|Overall Study|Adverse Event|0|||
145899024|NCT02132754|526137905|FG011|Overall Study|Adverse Event|0|||
145899025|NCT02132754|526137906|FG012|Overall Study|Adverse Event|0|||
145899026|NCT02132754|526137907|FG013|Overall Study|Adverse Event|0|||
145899027|NCT02132754|526137908|FG014|Overall Study|Adverse Event|0|||
145899028|NCT02132754|526137909|FG015|Overall Study|Adverse Event|0|||
145899029|NCT02132754|526137910|FG016|Overall Study|Adverse Event|0|||
145899030|NCT02132754|526137911|FG017|Overall Study|Adverse Event|1|||
145899031|NCT02132754|526137912|FG018|Overall Study|Adverse Event|0|||
145899032|NCT02132754|526137913|FG019|Overall Study|Adverse Event|0|||
145899033|NCT02132754|526137914|FG020|Overall Study|Adverse Event|0|||
145899034|NCT02132754|526137915|FG021|Overall Study|Adverse Event|0|||
145972464|NCT01799889|526412653|FG011|Overall Study|Physician Decision|1|||
145899035|NCT02132754|526137916|FG022|Overall Study|Adverse Event|0|||
145899036|NCT02132754|526137917|FG023|Overall Study|Adverse Event|0|||
145899037|NCT02132754|526137918|FG024|Overall Study|Adverse Event|0|||
145899038|NCT02132754|526137919|FG025|Overall Study|Adverse Event|1|||
145899039|NCT02132754|526137920|FG026|Overall Study|Adverse Event|1|||
145899040|NCT02132754|526137921|FG027|Overall Study|Adverse Event|0|||
145899041|NCT02132754|526137922|FG028|Overall Study|Adverse Event|0|||
145899042|NCT02132754|526137923|FG029|Overall Study|Adverse Event|0|||
145899043|NCT02132754|526137924|FG030|Overall Study|Adverse Event|1|||
145899044|NCT02132754|526137925|FG031|Overall Study|Adverse Event|0|||
145899045|NCT02132754|526137926|FG032|Overall Study|Adverse Event|1|||
145899046|NCT02132754|526137927|FG033|Overall Study|Adverse Event|1|||
145899047|NCT02132754|526137894|FG000|Overall Study|Clinical Progression|0|||
145899048|NCT02132754|526137895|FG001|Overall Study|Clinical Progression|0|||
145899049|NCT02132754|526137896|FG002|Overall Study|Clinical Progression|0|||
145899050|NCT02132754|526137897|FG003|Overall Study|Clinical Progression|0|||
145899051|NCT02132754|526137898|FG004|Overall Study|Clinical Progression|0|||
145899052|NCT02132754|526137899|FG005|Overall Study|Clinical Progression|0|||
145899053|NCT02132754|526137900|FG006|Overall Study|Clinical Progression|0|||
145899054|NCT02132754|526137901|FG007|Overall Study|Clinical Progression|0|||
145899055|NCT02132754|526137902|FG008|Overall Study|Clinical Progression|0|||
145899056|NCT02132754|526137903|FG009|Overall Study|Clinical Progression|1|||
145899057|NCT02132754|526137904|FG010|Overall Study|Clinical Progression|0|||
145899058|NCT02132754|526137905|FG011|Overall Study|Clinical Progression|0|||
145899059|NCT02132754|526137906|FG012|Overall Study|Clinical Progression|0|||
145899060|NCT02132754|526137907|FG013|Overall Study|Clinical Progression|0|||
145899061|NCT02132754|526137908|FG014|Overall Study|Clinical Progression|0|||
145899062|NCT02132754|526137909|FG015|Overall Study|Clinical Progression|0|||
145899063|NCT02132754|526137910|FG016|Overall Study|Clinical Progression|1|||
145899064|NCT02132754|526137911|FG017|Overall Study|Clinical Progression|1|||
145899065|NCT02132754|526137912|FG018|Overall Study|Clinical Progression|0|||
145899066|NCT02132754|526137913|FG019|Overall Study|Clinical Progression|1|||
145899067|NCT02132754|526137914|FG020|Overall Study|Clinical Progression|0|||
145899068|NCT02132754|526137915|FG021|Overall Study|Clinical Progression|0|||
145899069|NCT02132754|526137916|FG022|Overall Study|Clinical Progression|1|||
145899070|NCT02132754|526137917|FG023|Overall Study|Clinical Progression|0|||
145899071|NCT02132754|526137918|FG024|Overall Study|Clinical Progression|1|||
145899072|NCT02132754|526137919|FG025|Overall Study|Clinical Progression|1|||
145899073|NCT02132754|526137920|FG026|Overall Study|Clinical Progression|0|||
145899074|NCT02132754|526137921|FG027|Overall Study|Clinical Progression|1|||
145899075|NCT02132754|526137922|FG028|Overall Study|Clinical Progression|1|||
145899076|NCT02132754|526137923|FG029|Overall Study|Clinical Progression|0|||
145899077|NCT02132754|526137924|FG030|Overall Study|Clinical Progression|1|||
145899078|NCT02132754|526137925|FG031|Overall Study|Clinical Progression|0|||
145899079|NCT02132754|526137926|FG032|Overall Study|Clinical Progression|0|||
145899080|NCT02132754|526137927|FG033|Overall Study|Clinical Progression|2|||
145899081|NCT02132754|526137894|FG000|Overall Study|Death|0|||
145899082|NCT02132754|526137895|FG001|Overall Study|Death|0|||
145899083|NCT02132754|526137896|FG002|Overall Study|Death|0|||
145899084|NCT02132754|526137897|FG003|Overall Study|Death|0|||
145899085|NCT02132754|526137898|FG004|Overall Study|Death|0|||
145899086|NCT02132754|526137899|FG005|Overall Study|Death|0|||
145899087|NCT02132754|526137900|FG006|Overall Study|Death|0|||
145899088|NCT02132754|526137901|FG007|Overall Study|Death|0|||
145899089|NCT02132754|526137902|FG008|Overall Study|Death|0|||
145899090|NCT02132754|526137903|FG009|Overall Study|Death|0|||
145899091|NCT02132754|526137904|FG010|Overall Study|Death|0|||
145899092|NCT02132754|526137905|FG011|Overall Study|Death|0|||
145899093|NCT02132754|526137906|FG012|Overall Study|Death|0|||
145899094|NCT02132754|526137907|FG013|Overall Study|Death|0|||
145899095|NCT02132754|526137908|FG014|Overall Study|Death|0|||
145899096|NCT02132754|526137909|FG015|Overall Study|Death|1|||
145899097|NCT02132754|526137910|FG016|Overall Study|Death|0|||
145899098|NCT02132754|526137911|FG017|Overall Study|Death|0|||
145899099|NCT02132754|526137912|FG018|Overall Study|Death|0|||
145899100|NCT02132754|526137913|FG019|Overall Study|Death|1|||
145899101|NCT02132754|526137914|FG020|Overall Study|Death|0|||
146088276|NCT02186301|526843787|FG001|Overall Study|Study Terminated by Sponsor|0|||
146088277|NCT02186301|526843788|FG002|Overall Study|Study Terminated by Sponsor|11|||
145899102|NCT02132754|526137915|FG021|Overall Study|Death|1|||
145899103|NCT02132754|526137916|FG022|Overall Study|Death|0|||
146088278|NCT02186301|526843786|FG000|Overall Study|Protocol Deviation|0|||
145899104|NCT02132754|526137917|FG023|Overall Study|Death|0|||
145899105|NCT02132754|526137918|FG024|Overall Study|Death|0|||
145899106|NCT02132754|526137919|FG025|Overall Study|Death|0|||
145899107|NCT02132754|526137920|FG026|Overall Study|Death|1|||
145899108|NCT02132754|526137921|FG027|Overall Study|Death|0|||
145899109|NCT02132754|526137922|FG028|Overall Study|Death|0|||
145899110|NCT02132754|526137923|FG029|Overall Study|Death|0|||
145899111|NCT02132754|526137924|FG030|Overall Study|Death|0|||
145899112|NCT02132754|526137925|FG031|Overall Study|Death|0|||
145899113|NCT02132754|526137926|FG032|Overall Study|Death|0|||
145899114|NCT02132754|526137927|FG033|Overall Study|Death|2|||
145899115|NCT02132754|526137894|FG000|Overall Study|Excluded Medication|0|||
145899116|NCT02132754|526137895|FG001|Overall Study|Excluded Medication|0|||
145899117|NCT02132754|526137896|FG002|Overall Study|Excluded Medication|0|||
146088279|NCT02186301|526843787|FG001|Overall Study|Protocol Deviation|2|||
146088280|NCT02186301|526843788|FG002|Overall Study|Protocol Deviation|0|||
146238571|NCT00975585|527386791|FG001|Overall Study|Withdrawal by Subject|1|||
145899118|NCT02132754|526137897|FG003|Overall Study|Excluded Medication|0|||
145899119|NCT02132754|526137898|FG004|Overall Study|Excluded Medication|0|||
145899120|NCT02132754|526137899|FG005|Overall Study|Excluded Medication|0|||
145899121|NCT02132754|526137900|FG006|Overall Study|Excluded Medication|0|||
145899122|NCT02132754|526137901|FG007|Overall Study|Excluded Medication|0|||
145899123|NCT02132754|526137902|FG008|Overall Study|Excluded Medication|0|||
145899124|NCT02132754|526137903|FG009|Overall Study|Excluded Medication|0|||
145899125|NCT02132754|526137904|FG010|Overall Study|Excluded Medication|0|||
145899126|NCT02132754|526137905|FG011|Overall Study|Excluded Medication|0|||
145899127|NCT02132754|526137906|FG012|Overall Study|Excluded Medication|0|||
145899128|NCT02132754|526137907|FG013|Overall Study|Excluded Medication|0|||
145899129|NCT02132754|526137908|FG014|Overall Study|Excluded Medication|0|||
145899130|NCT02132754|526137909|FG015|Overall Study|Excluded Medication|0|||
145899131|NCT02132754|526137910|FG016|Overall Study|Excluded Medication|0|||
145899132|NCT02132754|526137911|FG017|Overall Study|Excluded Medication|0|||
145899133|NCT02132754|526137912|FG018|Overall Study|Excluded Medication|0|||
145899134|NCT02132754|526137913|FG019|Overall Study|Excluded Medication|0|||
145899135|NCT02132754|526137914|FG020|Overall Study|Excluded Medication|1|||
145899136|NCT02132754|526137915|FG021|Overall Study|Excluded Medication|0|||
145899137|NCT02132754|526137916|FG022|Overall Study|Excluded Medication|0|||
145899138|NCT02132754|526137917|FG023|Overall Study|Excluded Medication|0|||
145899139|NCT02132754|526137918|FG024|Overall Study|Excluded Medication|0|||
145899140|NCT02132754|526137919|FG025|Overall Study|Excluded Medication|0|||
145899141|NCT02132754|526137920|FG026|Overall Study|Excluded Medication|0|||
145899142|NCT02132754|526137921|FG027|Overall Study|Excluded Medication|0|||
145899143|NCT02132754|526137922|FG028|Overall Study|Excluded Medication|0|||
145899144|NCT02132754|526137923|FG029|Overall Study|Excluded Medication|0|||
146238572|NCT00975585|527386790|FG000|Overall Study|Lens issue|2|||
145899145|NCT02132754|526137924|FG030|Overall Study|Excluded Medication|0|||
145899146|NCT02132754|526137925|FG031|Overall Study|Excluded Medication|0|||
145899147|NCT02132754|526137926|FG032|Overall Study|Excluded Medication|0|||
146088281|NCT02186301|526843786|FG000|Overall Study|Missing|0|||
145899148|NCT02132754|526137927|FG033|Overall Study|Excluded Medication|1|||
145899149|NCT02132754|526137894|FG000|Overall Study|Physician Decision|0|||
145899150|NCT02132754|526137895|FG001|Overall Study|Physician Decision|0|||
145899151|NCT02132754|526137896|FG002|Overall Study|Physician Decision|0|||
145899152|NCT02132754|526137897|FG003|Overall Study|Physician Decision|0|||
145899153|NCT02132754|526137898|FG004|Overall Study|Physician Decision|0|||
145899154|NCT02132754|526137899|FG005|Overall Study|Physician Decision|0|||
145899155|NCT02132754|526137900|FG006|Overall Study|Physician Decision|0|||
145899156|NCT02132754|526137901|FG007|Overall Study|Physician Decision|0|||
145899157|NCT02132754|526137902|FG008|Overall Study|Physician Decision|0|||
145899158|NCT02132754|526137903|FG009|Overall Study|Physician Decision|1|||
145899159|NCT02132754|526137904|FG010|Overall Study|Physician Decision|0|||
145899160|NCT02132754|526137905|FG011|Overall Study|Physician Decision|1|||
145899161|NCT02132754|526137906|FG012|Overall Study|Physician Decision|1|||
145899162|NCT02132754|526137907|FG013|Overall Study|Physician Decision|0|||
145899163|NCT02132754|526137908|FG014|Overall Study|Physician Decision|0|||
145899164|NCT02132754|526137909|FG015|Overall Study|Physician Decision|1|||
145899165|NCT02132754|526137910|FG016|Overall Study|Physician Decision|0|||
145899166|NCT02132754|526137911|FG017|Overall Study|Physician Decision|0|||
145899167|NCT02132754|526137912|FG018|Overall Study|Physician Decision|0|||
145899168|NCT02132754|526137913|FG019|Overall Study|Physician Decision|0|||
145899169|NCT02132754|526137914|FG020|Overall Study|Physician Decision|0|||
145899170|NCT02132754|526137915|FG021|Overall Study|Physician Decision|0|||
145899171|NCT02132754|526137916|FG022|Overall Study|Physician Decision|0|||
145899172|NCT02132754|526137917|FG023|Overall Study|Physician Decision|0|||
145899173|NCT02132754|526137918|FG024|Overall Study|Physician Decision|1|||
146238573|NCT00975585|527386791|FG001|Overall Study|Lens issue|2|||
146238574|NCT01953224|527386792|FG000|Overall Study|Lost to Follow-up|1|||
146238575|NCT01953224|527386793|FG001|Overall Study|Lost to Follow-up|1|||
145899174|NCT02132754|526137919|FG025|Overall Study|Physician Decision|0|||
145899175|NCT02132754|526137920|FG026|Overall Study|Physician Decision|0|||
145899176|NCT02132754|526137921|FG027|Overall Study|Physician Decision|0|||
145899177|NCT02132754|526137922|FG028|Overall Study|Physician Decision|0|||
145899178|NCT02132754|526137923|FG029|Overall Study|Physician Decision|0|||
145899179|NCT02132754|526137924|FG030|Overall Study|Physician Decision|0|||
145899180|NCT02132754|526137925|FG031|Overall Study|Physician Decision|1|||
145899181|NCT02132754|526137926|FG032|Overall Study|Physician Decision|0|||
145899182|NCT02132754|526137927|FG033|Overall Study|Physician Decision|3|||
145899183|NCT02132754|526137894|FG000|Overall Study|Progressive Disease|1|||
145899184|NCT02132754|526137895|FG001|Overall Study|Progressive Disease|1|||
145899185|NCT02132754|526137896|FG002|Overall Study|Progressive Disease|1|||
145899186|NCT02132754|526137897|FG003|Overall Study|Progressive Disease|1|||
145899187|NCT02132754|526137898|FG004|Overall Study|Progressive Disease|1|||
145899188|NCT02132754|526137899|FG005|Overall Study|Progressive Disease|1|||
145899189|NCT02132754|526137900|FG006|Overall Study|Progressive Disease|1|||
145899190|NCT02132754|526137901|FG007|Overall Study|Progressive Disease|1|||
145899191|NCT02132754|526137902|FG008|Overall Study|Progressive Disease|1|||
145899192|NCT02132754|526137903|FG009|Overall Study|Progressive Disease|3|||
146238576|NCT01953224|527386792|FG000|Overall Study|Withdrawal by Subject|1|||
145899193|NCT02132754|526137904|FG010|Overall Study|Progressive Disease|3|||
145899194|NCT02132754|526137905|FG011|Overall Study|Progressive Disease|2|||
145899195|NCT02132754|526137906|FG012|Overall Study|Progressive Disease|2|||
146238577|NCT01953224|527386793|FG001|Overall Study|Withdrawal by Subject|2|||
146238578|NCT00205179|527386796|FG000|Overall Study|Death|0|||
145899196|NCT02132754|526137907|FG013|Overall Study|Progressive Disease|3|||
145899197|NCT02132754|526137908|FG014|Overall Study|Progressive Disease|2|||
145899198|NCT02132754|526137909|FG015|Overall Study|Progressive Disease|1|||
145899199|NCT02132754|526137910|FG016|Overall Study|Progressive Disease|2|||
145899200|NCT02132754|526137911|FG017|Overall Study|Progressive Disease|1|||
145899201|NCT02132754|526137912|FG018|Overall Study|Progressive Disease|3|||
145899202|NCT02132754|526137913|FG019|Overall Study|Progressive Disease|1|||
145899203|NCT02132754|526137914|FG020|Overall Study|Progressive Disease|1|||
145899204|NCT02132754|526137915|FG021|Overall Study|Progressive Disease|3|||
145899205|NCT02132754|526137916|FG022|Overall Study|Progressive Disease|2|||
145899206|NCT02132754|526137917|FG023|Overall Study|Progressive Disease|3|||
145899207|NCT02132754|526137918|FG024|Overall Study|Progressive Disease|0|||
145899208|NCT02132754|526137919|FG025|Overall Study|Progressive Disease|1|||
145899209|NCT02132754|526137920|FG026|Overall Study|Progressive Disease|2|||
145899210|NCT02132754|526137921|FG027|Overall Study|Progressive Disease|1|||
145899211|NCT02132754|526137922|FG028|Overall Study|Progressive Disease|2|||
145899212|NCT02132754|526137923|FG029|Overall Study|Progressive Disease|3|||
145899213|NCT02132754|526137924|FG030|Overall Study|Progressive Disease|1|||
145899214|NCT02132754|526137925|FG031|Overall Study|Progressive Disease|1|||
145899215|NCT02132754|526137926|FG032|Overall Study|Progressive Disease|3|||
145899216|NCT02132754|526137927|FG033|Overall Study|Progressive Disease|6|||
145899217|NCT02132754|526137894|FG000|Overall Study|Screen Failure|0|||
145899218|NCT02132754|526137895|FG001|Overall Study|Screen Failure|0|||
145899219|NCT02132754|526137896|FG002|Overall Study|Screen Failure|0|||
145899220|NCT02132754|526137897|FG003|Overall Study|Screen Failure|0|||
145899221|NCT02132754|526137898|FG004|Overall Study|Screen Failure|0|||
145899222|NCT02132754|526137899|FG005|Overall Study|Screen Failure|0|||
145899223|NCT02132754|526137900|FG006|Overall Study|Screen Failure|0|||
145899224|NCT02132754|526137901|FG007|Overall Study|Screen Failure|0|||
145899225|NCT02132754|526137902|FG008|Overall Study|Screen Failure|0|||
145899226|NCT02132754|526137903|FG009|Overall Study|Screen Failure|0|||
145899227|NCT02132754|526137904|FG010|Overall Study|Screen Failure|0|||
145899228|NCT02132754|526137905|FG011|Overall Study|Screen Failure|0|||
145899229|NCT02132754|526137906|FG012|Overall Study|Screen Failure|0|||
145899230|NCT02132754|526137907|FG013|Overall Study|Screen Failure|0|||
145899231|NCT02132754|526137908|FG014|Overall Study|Screen Failure|0|||
145899232|NCT02132754|526137909|FG015|Overall Study|Screen Failure|0|||
145899233|NCT02132754|526137910|FG016|Overall Study|Screen Failure|0|||
145899234|NCT02132754|526137911|FG017|Overall Study|Screen Failure|0|||
145899235|NCT02132754|526137912|FG018|Overall Study|Screen Failure|0|||
145899236|NCT02132754|526137913|FG019|Overall Study|Screen Failure|1|||
145899237|NCT02132754|526137914|FG020|Overall Study|Screen Failure|0|||
145899238|NCT02132754|526137915|FG021|Overall Study|Screen Failure|1|||
145899239|NCT02132754|526137916|FG022|Overall Study|Screen Failure|0|||
145899240|NCT02132754|526137917|FG023|Overall Study|Screen Failure|0|||
145899241|NCT02132754|526137918|FG024|Overall Study|Screen Failure|0|||
145899242|NCT02132754|526137919|FG025|Overall Study|Screen Failure|0|||
145899243|NCT02132754|526137920|FG026|Overall Study|Screen Failure|0|||
145899244|NCT02132754|526137921|FG027|Overall Study|Screen Failure|0|||
145899245|NCT02132754|526137922|FG028|Overall Study|Screen Failure|0|||
145899246|NCT02132754|526137923|FG029|Overall Study|Screen Failure|0|||
145899247|NCT02132754|526137924|FG030|Overall Study|Screen Failure|0|||
145899248|NCT02132754|526137925|FG031|Overall Study|Screen Failure|0|||
145899249|NCT02132754|526137926|FG032|Overall Study|Screen Failure|0|||
145899250|NCT02132754|526137927|FG033|Overall Study|Screen Failure|0|||
145899251|NCT02132754|526137894|FG000|Overall Study|Transferred to Extension Study|0|||
145899252|NCT02132754|526137895|FG001|Overall Study|Transferred to Extension Study|0|||
145899253|NCT02132754|526137896|FG002|Overall Study|Transferred to Extension Study|0|||
145899254|NCT02132754|526137897|FG003|Overall Study|Transferred to Extension Study|0|||
145899255|NCT02132754|526137898|FG004|Overall Study|Transferred to Extension Study|0|||
145899256|NCT02132754|526137899|FG005|Overall Study|Transferred to Extension Study|0|||
145899257|NCT02132754|526137900|FG006|Overall Study|Transferred to Extension Study|0|||
145899258|NCT02132754|526137901|FG007|Overall Study|Transferred to Extension Study|0|||
146238579|NCT00205179|527386797|FG001|Overall Study|Death|2|||
145899259|NCT02132754|526137902|FG008|Overall Study|Transferred to Extension Study|0|||
145899260|NCT02132754|526137903|FG009|Overall Study|Transferred to Extension Study|0|||
145899261|NCT02132754|526137904|FG010|Overall Study|Transferred to Extension Study|0|||
145899262|NCT02132754|526137905|FG011|Overall Study|Transferred to Extension Study|0|||
145899263|NCT02132754|526137906|FG012|Overall Study|Transferred to Extension Study|0|||
145899264|NCT02132754|526137907|FG013|Overall Study|Transferred to Extension Study|0|||
145899265|NCT02132754|526137908|FG014|Overall Study|Transferred to Extension Study|0|||
145899266|NCT02132754|526137909|FG015|Overall Study|Transferred to Extension Study|0|||
145972465|NCT01799889|526412642|FG000|Overall Study|Progressive Disease|30|||
145899267|NCT02132754|526137910|FG016|Overall Study|Transferred to Extension Study|0|||
146088282|NCT02186301|526843787|FG001|Overall Study|Missing|0|||
146088283|NCT02186301|526843788|FG002|Overall Study|Missing|2|||
146088284|NCT02186301|526843786|FG000|Overall Study|Other|0|||
146088285|NCT02186301|526843787|FG001|Overall Study|Other|0|||
146238580|NCT00205179|527386796|FG000|Overall Study|Physician Decision|1|||
145899268|NCT02132754|526137911|FG017|Overall Study|Transferred to Extension Study|0|||
145899269|NCT02132754|526137912|FG018|Overall Study|Transferred to Extension Study|0|||
145899270|NCT02132754|526137913|FG019|Overall Study|Transferred to Extension Study|0|||
145899271|NCT02132754|526137914|FG020|Overall Study|Transferred to Extension Study|0|||
145899272|NCT02132754|526137915|FG021|Overall Study|Transferred to Extension Study|0|||
145899273|NCT02132754|526137916|FG022|Overall Study|Transferred to Extension Study|0|||
145899274|NCT02132754|526137917|FG023|Overall Study|Transferred to Extension Study|0|||
145899275|NCT02132754|526137918|FG024|Overall Study|Transferred to Extension Study|0|||
145899276|NCT02132754|526137919|FG025|Overall Study|Transferred to Extension Study|0|||
145899277|NCT02132754|526137920|FG026|Overall Study|Transferred to Extension Study|0|||
145899278|NCT02132754|526137921|FG027|Overall Study|Transferred to Extension Study|0|||
145899279|NCT02132754|526137922|FG028|Overall Study|Transferred to Extension Study|0|||
145899280|NCT02132754|526137923|FG029|Overall Study|Transferred to Extension Study|0|||
145899281|NCT02132754|526137924|FG030|Overall Study|Transferred to Extension Study|0|||
145899282|NCT02132754|526137925|FG031|Overall Study|Transferred to Extension Study|0|||
145899283|NCT02132754|526137926|FG032|Overall Study|Transferred to Extension Study|0|||
145899284|NCT02132754|526137927|FG033|Overall Study|Transferred to Extension Study|6|||
145899285|NCT02132754|526137894|FG000|Overall Study|Withdrawal by Subject|0|||
145899286|NCT02132754|526137895|FG001|Overall Study|Withdrawal by Subject|0|||
145899287|NCT02132754|526137896|FG002|Overall Study|Withdrawal by Subject|0|||
145899288|NCT02132754|526137897|FG003|Overall Study|Withdrawal by Subject|0|||
145899289|NCT02132754|526137898|FG004|Overall Study|Withdrawal by Subject|0|||
145899290|NCT02132754|526137899|FG005|Overall Study|Withdrawal by Subject|0|||
145899291|NCT02132754|526137900|FG006|Overall Study|Withdrawal by Subject|0|||
145899292|NCT02132754|526137901|FG007|Overall Study|Withdrawal by Subject|0|||
145899293|NCT02132754|526137902|FG008|Overall Study|Withdrawal by Subject|0|||
145899294|NCT02132754|526137903|FG009|Overall Study|Withdrawal by Subject|1|||
145899295|NCT02132754|526137904|FG010|Overall Study|Withdrawal by Subject|0|||
145899296|NCT02132754|526137905|FG011|Overall Study|Withdrawal by Subject|0|||
145899297|NCT02132754|526137906|FG012|Overall Study|Withdrawal by Subject|1|||
145899298|NCT02132754|526137907|FG013|Overall Study|Withdrawal by Subject|0|||
145899299|NCT02132754|526137908|FG014|Overall Study|Withdrawal by Subject|1|||
145899300|NCT02132754|526137909|FG015|Overall Study|Withdrawal by Subject|2|||
145899301|NCT02132754|526137910|FG016|Overall Study|Withdrawal by Subject|1|||
145899302|NCT02132754|526137911|FG017|Overall Study|Withdrawal by Subject|0|||
145899303|NCT02132754|526137912|FG018|Overall Study|Withdrawal by Subject|0|||
145899304|NCT02132754|526137913|FG019|Overall Study|Withdrawal by Subject|0|||
145899305|NCT02132754|526137914|FG020|Overall Study|Withdrawal by Subject|1|||
145899306|NCT02132754|526137915|FG021|Overall Study|Withdrawal by Subject|0|||
145899307|NCT02132754|526137916|FG022|Overall Study|Withdrawal by Subject|0|||
145899308|NCT02132754|526137917|FG023|Overall Study|Withdrawal by Subject|0|||
145899309|NCT02132754|526137918|FG024|Overall Study|Withdrawal by Subject|1|||
145899310|NCT02132754|526137919|FG025|Overall Study|Withdrawal by Subject|0|||
145899311|NCT02132754|526137920|FG026|Overall Study|Withdrawal by Subject|0|||
145899312|NCT02132754|526137921|FG027|Overall Study|Withdrawal by Subject|1|||
145899313|NCT02132754|526137922|FG028|Overall Study|Withdrawal by Subject|0|||
145899314|NCT02132754|526137923|FG029|Overall Study|Withdrawal by Subject|0|||
145899315|NCT02132754|526137924|FG030|Overall Study|Withdrawal by Subject|0|||
145899316|NCT02132754|526137925|FG031|Overall Study|Withdrawal by Subject|1|||
145899317|NCT02132754|526137926|FG032|Overall Study|Withdrawal by Subject|0|||
145899318|NCT02132754|526137927|FG033|Overall Study|Withdrawal by Subject|2|||
145899319|NCT01167257|526140658|FG000|Overall Study|Lost to Follow-up|2|||
145899320|NCT01167257|526140659|FG001|Overall Study|Lost to Follow-up|2|||
145899321|NCT01167257|526140658|FG000|Overall Study|Withdrew consent|1|||
145899322|NCT01167257|526140659|FG001|Overall Study|Withdrew consent|1|||
145899323|NCT03283319|526140661|FG000|Overall Study|Lost to Follow-up|5|||
145899324|NCT03283319|526140662|FG001|Overall Study|Lost to Follow-up|4|||
145899325|NCT03283319|526140663|FG002|Overall Study|Lost to Follow-up|5|||
145899326|NCT03283319|526140664|FG003|Overall Study|Lost to Follow-up|5|||
145899327|NCT03283319|526140665|FG004|Overall Study|Lost to Follow-up|4|||
145899328|NCT03283319|526140666|FG005|Overall Study|Lost to Follow-up|3|||
145899329|NCT03283319|526140661|FG000|Overall Study|Withdrawal by Subject|2|||
145899330|NCT03283319|526140662|FG001|Overall Study|Withdrawal by Subject|2|||
145899331|NCT03283319|526140663|FG002|Overall Study|Withdrawal by Subject|2|||
145899332|NCT03283319|526140664|FG003|Overall Study|Withdrawal by Subject|1|||
145899333|NCT03283319|526140665|FG004|Overall Study|Withdrawal by Subject|0|||
145899334|NCT03283319|526140666|FG005|Overall Study|Withdrawal by Subject|1|||
145899335|NCT03283319|526140661|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
145899336|NCT03283319|526140662|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
146238581|NCT00205179|527386797|FG001|Overall Study|Physician Decision|1|||
145899337|NCT03283319|526140663|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
145899338|NCT03283319|526140664|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
145899339|NCT03283319|526140665|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
145899340|NCT03283319|526140666|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
145899341|NCT00721630|526140667|FG000|Overall Study|Participant found to be ineligible|1|||
145899342|NCT02213510|526140669|FG000|Overall Study|Death|0|||
145899343|NCT02213510|526140670|FG001|Overall Study|Death|1|||
145899344|NCT02213510|526140669|FG000|Overall Study|Lost to Follow-up|1|||
145899345|NCT02213510|526140670|FG001|Overall Study|Lost to Follow-up|0|||
145899346|NCT03954834|526140671|FG000|Overall Study|Adverse Event|1|||
145899347|NCT03954834|526140672|FG001|Overall Study|Adverse Event|3|||
145899348|NCT03954834|526140673|FG002|Overall Study|Adverse Event|1|||
145899349|NCT03954834|526140674|FG003|Overall Study|Adverse Event|1|||
145899350|NCT03954834|526140671|FG000|Overall Study|Death|0|||
145899351|NCT03954834|526140672|FG001|Overall Study|Death|0|||
145899352|NCT03954834|526140673|FG002|Overall Study|Death|0|||
145899353|NCT03954834|526140674|FG003|Overall Study|Death|1|||
145899354|NCT03954834|526140671|FG000|Overall Study|Physician Decision|0|||
145899355|NCT03954834|526140672|FG001|Overall Study|Physician Decision|1|||
145899356|NCT03954834|526140673|FG002|Overall Study|Physician Decision|0|||
145899357|NCT03954834|526140674|FG003|Overall Study|Physician Decision|2|||
145899358|NCT03954834|526140671|FG000|Overall Study|Protocol Violation|1|||
145899359|NCT03954834|526140672|FG001|Overall Study|Protocol Violation|0|||
145899360|NCT03954834|526140673|FG002|Overall Study|Protocol Violation|0|||
145899361|NCT03954834|526140674|FG003|Overall Study|Protocol Violation|1|||
145899362|NCT03954834|526140671|FG000|Overall Study|Withdrawal by Subject|2|||
145899363|NCT03954834|526140672|FG001|Overall Study|Withdrawal by Subject|3|||
145899364|NCT03954834|526140673|FG002|Overall Study|Withdrawal by Subject|13|||
145899365|NCT03954834|526140674|FG003|Overall Study|Withdrawal by Subject|6|||
145899366|NCT03954834|526140671|FG000|Overall Study|Participant left the country|0|||
145899367|NCT03954834|526140672|FG001|Overall Study|Participant left the country|0|||
145899368|NCT03954834|526140673|FG002|Overall Study|Participant left the country|1|||
145899369|NCT03954834|526140674|FG003|Overall Study|Participant left the country|0|||
145899370|NCT03954834|526140671|FG000|Overall Study|Lost to Follow-up|3|||
145899371|NCT03954834|526140672|FG001|Overall Study|Lost to Follow-up|2|||
145899372|NCT03954834|526140673|FG002|Overall Study|Lost to Follow-up|3|||
145899373|NCT03954834|526140674|FG003|Overall Study|Lost to Follow-up|5|||
145899374|NCT00372411|526140677|FG000|Overall Study|Withdrawal by Subject|3|||
145899375|NCT00372411|526140678|FG001|Overall Study|Withdrawal by Subject|4|||
145899376|NCT00372411|526140679|FG002|Overall Study|Withdrawal by Subject|1|||
145899377|NCT00372411|526140677|FG000|Overall Study|Death|0|||
145899378|NCT00372411|526140678|FG001|Overall Study|Death|2|||
145899379|NCT00372411|526140679|FG002|Overall Study|Death|1|||
145899380|NCT00372411|526140677|FG000|Overall Study|Lost to Follow-up|1|||
145899381|NCT00372411|526140678|FG001|Overall Study|Lost to Follow-up|1|||
145899382|NCT00372411|526140679|FG002|Overall Study|Lost to Follow-up|1|||
145899383|NCT00372411|526140677|FG000|Overall Study|Adverse Event|1|||
145899384|NCT00372411|526140678|FG001|Overall Study|Adverse Event|1|||
145899385|NCT00372411|526140679|FG002|Overall Study|Adverse Event|0|||
145899386|NCT01059344|526140680|FG000|Overall Study|Adverse Event|12|||
145899387|NCT01059344|526140681|FG001|Overall Study|Adverse Event|30|||
145899388|NCT01059344|526140680|FG000|Overall Study|Withdrawal by Subject|6|||
145899389|NCT01059344|526140681|FG001|Overall Study|Withdrawal by Subject|9|||
145899390|NCT01059344|526140680|FG000|Overall Study|Lost to Follow-up|1|||
145899391|NCT01059344|526140681|FG001|Overall Study|Lost to Follow-up|1|||
145899392|NCT01059344|526140680|FG000|Overall Study|Other|3|||
145899393|NCT01059344|526140681|FG001|Overall Study|Other|6|||
145899394|NCT01739348|526140682|FG000|Part I (Base Study)|Adverse Event|41|||
145899395|NCT01739348|526140683|FG001|Part I (Base Study)|Adverse Event|52|||
145899396|NCT01739348|526140684|FG002|Part I (Base Study)|Adverse Event|8|||
145899397|NCT01739348|526140685|FG003|Part I (Base Study)|Adverse Event|33|||
145899398|NCT01739348|526140682|FG000|Part I (Base Study)|Death|10|||
145899399|NCT01739348|526140683|FG001|Part I (Base Study)|Death|7|||
145899400|NCT01739348|526140684|FG002|Part I (Base Study)|Death|2|||
145899401|NCT01739348|526140685|FG003|Part I (Base Study)|Death|8|||
145899402|NCT01739348|526140682|FG000|Part I (Base Study)|Lack of Efficacy|3|||
145899403|NCT01739348|526140683|FG001|Part I (Base Study)|Lack of Efficacy|8|||
145899404|NCT01739348|526140684|FG002|Part I (Base Study)|Lack of Efficacy|0|||
145899405|NCT01739348|526140685|FG003|Part I (Base Study)|Lack of Efficacy|7|||
145899406|NCT01739348|526140682|FG000|Part I (Base Study)|Lost to Follow-up|4|||
145899407|NCT01739348|526140683|FG001|Part I (Base Study)|Lost to Follow-up|2|||
145899408|NCT01739348|526140684|FG002|Part I (Base Study)|Lost to Follow-up|4|||
145899409|NCT01739348|526140685|FG003|Part I (Base Study)|Lost to Follow-up|4|||
145899410|NCT01739348|526140682|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
145899411|NCT01739348|526140683|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
145899412|NCT01739348|526140684|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
145899413|NCT01739348|526140685|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
146238582|NCT00205179|527386796|FG000|Overall Study|Adverse Event|1|||
146238583|NCT00205179|527386797|FG001|Overall Study|Adverse Event|1|||
145899414|NCT01739348|526140682|FG000|Part I (Base Study)|Physician Decision|10|||
145899415|NCT01739348|526140683|FG001|Part I (Base Study)|Physician Decision|7|||
145899416|NCT01739348|526140684|FG002|Part I (Base Study)|Physician Decision|1|||
145899417|NCT01739348|526140685|FG003|Part I (Base Study)|Physician Decision|4|||
145899418|NCT01739348|526140682|FG000|Part I (Base Study)|Protocol Violation|2|||
145899419|NCT01739348|526140683|FG001|Part I (Base Study)|Protocol Violation|0|||
145899420|NCT01739348|526140684|FG002|Part I (Base Study)|Protocol Violation|1|||
145899421|NCT01739348|526140685|FG003|Part I (Base Study)|Protocol Violation|2|||
145899422|NCT01739348|526140682|FG000|Part I (Base Study)|Screen Failure|2|||
145899423|NCT01739348|526140683|FG001|Part I (Base Study)|Screen Failure|0|||
145899424|NCT01739348|526140684|FG002|Part I (Base Study)|Screen Failure|0|||
145899425|NCT01739348|526140685|FG003|Part I (Base Study)|Screen Failure|0|||
145899426|NCT01739348|526140682|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
145899427|NCT01739348|526140683|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
145899428|NCT01739348|526140684|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
145899429|NCT01739348|526140685|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
145899430|NCT01739348|526140682|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
145899431|NCT01739348|526140683|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
145899432|NCT01739348|526140684|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
145899433|NCT01739348|526140685|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
145899434|NCT01739348|526140682|FG000|Part I (Base Study)|Participant Moved|4|||
145899435|NCT01739348|526140683|FG001|Part I (Base Study)|Participant Moved|3|||
145899436|NCT01739348|526140684|FG002|Part I (Base Study)|Participant Moved|1|||
145899437|NCT01739348|526140685|FG003|Part I (Base Study)|Participant Moved|7|||
145899438|NCT01739348|526140682|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
145899439|NCT01739348|526140683|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
145899440|NCT01739348|526140684|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
145899441|NCT01739348|526140685|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
145899442|NCT01739348|526140682|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
145899443|NCT01739348|526140683|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
145899444|NCT01739348|526140684|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
145899445|NCT01739348|526140685|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
145899446|NCT01739348|526140682|FG000|Part II (Extension Study)|Adverse Event|10|||
145899447|NCT01739348|526140683|FG001|Part II (Extension Study)|Adverse Event|11|||
145899448|NCT01739348|526140684|FG002|Part II (Extension Study)|Adverse Event|7|||
145899449|NCT01739348|526140685|FG003|Part II (Extension Study)|Adverse Event|26|||
145899450|NCT01739348|526140682|FG000|Part II (Extension Study)|Death|3|||
145899451|NCT01739348|526140683|FG001|Part II (Extension Study)|Death|3|||
145899452|NCT01739348|526140684|FG002|Part II (Extension Study)|Death|2|||
145899453|NCT01739348|526140685|FG003|Part II (Extension Study)|Death|6|||
145899454|NCT01739348|526140682|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
145899455|NCT01739348|526140683|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
145899456|NCT01739348|526140684|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
145899457|NCT01739348|526140685|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
145899458|NCT01739348|526140682|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
145899459|NCT01739348|526140683|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
145899460|NCT01739348|526140684|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
145899461|NCT01739348|526140685|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
145899462|NCT01739348|526140682|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145899463|NCT01739348|526140683|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145899464|NCT01739348|526140684|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145899465|NCT01739348|526140685|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
145899466|NCT01739348|526140682|FG000|Part II (Extension Study)|Physician Decision|7|||
145899467|NCT01739348|526140683|FG001|Part II (Extension Study)|Physician Decision|11|||
145899468|NCT01739348|526140684|FG002|Part II (Extension Study)|Physician Decision|6|||
145899469|NCT01739348|526140685|FG003|Part II (Extension Study)|Physician Decision|12|||
145899470|NCT01739348|526140682|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
145899471|NCT01739348|526140683|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
145899472|NCT01739348|526140684|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
145899473|NCT01739348|526140685|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
145899474|NCT01739348|526140682|FG000|Part II (Extension Study)|Participant Moved|3|||
145899475|NCT01739348|526140683|FG001|Part II (Extension Study)|Participant Moved|3|||
145899476|NCT01739348|526140684|FG002|Part II (Extension Study)|Participant Moved|0|||
145899477|NCT01739348|526140685|FG003|Part II (Extension Study)|Participant Moved|3|||
145899478|NCT01739348|526140682|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
145899479|NCT01739348|526140683|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
145972466|NCT01799889|526412643|FG001|Overall Study|Progressive Disease|26|||
146238584|NCT00463229|527386798|FG000|Overall Study|Lost to Follow-up|5|||
146238585|NCT00463229|527386799|FG001|Overall Study|Lost to Follow-up|7|||
145899480|NCT01739348|526140684|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
145899481|NCT01739348|526140685|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
145899482|NCT01739348|526140682|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
145899483|NCT01739348|526140683|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
145899484|NCT01739348|526140684|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
145899485|NCT01739348|526140685|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
145899486|NCT01447420|526140688|FG000|Overall Study|Adverse Event|2|||
145899487|NCT01447420|526140689|FG001|Overall Study|Adverse Event|4|||
145899488|NCT01447420|526140690|FG002|Overall Study|Adverse Event|2|||
145899489|NCT01447420|526140688|FG000|Overall Study|Protocol Violation|3|||
145899490|NCT01447420|526140689|FG001|Overall Study|Protocol Violation|3|||
145899491|NCT01447420|526140690|FG002|Overall Study|Protocol Violation|0|||
145899492|NCT01447420|526140688|FG000|Overall Study|Withdrawal by Subject|4|||
145899493|NCT01447420|526140689|FG001|Overall Study|Withdrawal by Subject|1|||
145899494|NCT01447420|526140690|FG002|Overall Study|Withdrawal by Subject|0|||
145899495|NCT01447420|526140688|FG000|Overall Study|Lack of Efficacy|1|||
145899496|NCT01447420|526140689|FG001|Overall Study|Lack of Efficacy|19|||
145899497|NCT01447420|526140690|FG002|Overall Study|Lack of Efficacy|8|||
145899498|NCT04562155|526140692|FG000|Overall Study|COVID-19 pandemic|0|||
146238586|NCT00463229|527386798|FG000|Overall Study|Death|4|||
146238587|NCT00463229|527386799|FG001|Overall Study|Death|3|||
146238588|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
146238589|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
146238590|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
146238591|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
145899499|NCT04562155|526140693|FG001|Overall Study|COVID-19 pandemic|0|||
145899500|NCT04562155|526140694|FG002|Overall Study|COVID-19 pandemic|0|||
145899501|NCT04562155|526140695|FG003|Overall Study|COVID-19 pandemic|1|||
145899502|NCT04562155|526140692|FG000|Overall Study|Adverse Event|7|||
145899503|NCT04562155|526140693|FG001|Overall Study|Adverse Event|3|||
145899504|NCT04562155|526140694|FG002|Overall Study|Adverse Event|8|||
145899505|NCT04562155|526140695|FG003|Overall Study|Adverse Event|1|||
145899506|NCT04562155|526140692|FG000|Overall Study|Withdrawal by Subject|3|||
145899507|NCT04562155|526140693|FG001|Overall Study|Withdrawal by Subject|6|||
145899508|NCT04562155|526140694|FG002|Overall Study|Withdrawal by Subject|3|||
145899509|NCT04562155|526140695|FG003|Overall Study|Withdrawal by Subject|3|||
145899510|NCT04562155|526140692|FG000|Overall Study|Participant personal reason|1|||
145899511|NCT04562155|526140693|FG001|Overall Study|Participant personal reason|0|||
145899512|NCT04562155|526140694|FG002|Overall Study|Participant personal reason|2|||
145899513|NCT04562155|526140695|FG003|Overall Study|Participant personal reason|1|||
145899514|NCT01085201|526140696|FG000|Overall Study|Scheduling conflict|1|||
145899515|NCT01085201|526140697|FG001|Overall Study|Scheduling conflict|0|||
145899516|NCT01085201|526140698|FG002|Overall Study|Scheduling conflict|1|||
145899517|NCT01085201|526140699|FG003|Overall Study|Scheduling conflict|0|||
145899518|NCT01085201|526140700|FG004|Overall Study|Scheduling conflict|0|||
145899519|NCT01085201|526140696|FG000|Overall Study|Unknown- no study drug|2|||
145899520|NCT01085201|526140697|FG001|Overall Study|Unknown- no study drug|0|||
145899521|NCT01085201|526140698|FG002|Overall Study|Unknown- no study drug|0|||
145899522|NCT01085201|526140699|FG003|Overall Study|Unknown- no study drug|0|||
145899523|NCT01085201|526140700|FG004|Overall Study|Unknown- no study drug|0|||
145899524|NCT01085201|526140696|FG000|Overall Study|Fond ineligible after consent|0|||
145899525|NCT01085201|526140697|FG001|Overall Study|Fond ineligible after consent|1|||
145899526|NCT01085201|526140698|FG002|Overall Study|Fond ineligible after consent|1|||
145899527|NCT01085201|526140699|FG003|Overall Study|Fond ineligible after consent|0|||
145899528|NCT01085201|526140700|FG004|Overall Study|Fond ineligible after consent|0|||
145899529|NCT00528411|526140702|FG000|Overall Study|Adverse Event|4|||
145899530|NCT00528411|526140703|FG001|Overall Study|Adverse Event|0|||
145899531|NCT00528411|526140704|FG002|Overall Study|Adverse Event|1|||
145899532|NCT00528411|526140702|FG000|Overall Study|Incorrect Enrolment|1|||
145899533|NCT00528411|526140703|FG001|Overall Study|Incorrect Enrolment|1|||
145899534|NCT00528411|526140704|FG002|Overall Study|Incorrect Enrolment|0|||
145899535|NCT00528411|526140702|FG000|Overall Study|Severe non-compliance to protocol|0|||
145899536|NCT00528411|526140703|FG001|Overall Study|Severe non-compliance to protocol|1|||
145899537|NCT00528411|526140704|FG002|Overall Study|Severe non-compliance to protocol|0|||
145899538|NCT00528411|526140702|FG000|Overall Study|Prior commitment medication|0|||
145899539|NCT00528411|526140703|FG001|Overall Study|Prior commitment medication|1|||
145899540|NCT00528411|526140704|FG002|Overall Study|Prior commitment medication|0|||
145899541|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
145899542|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
145899543|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
145899544|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
145899545|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
145899546|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
145899547|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
146238592|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
145899548|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
145899549|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
145899550|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899551|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
145899552|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899553|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899554|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899555|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899556|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899557|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899558|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145899559|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899560|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
145899561|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899562|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
145899563|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899564|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899565|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899566|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899567|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899568|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899569|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
145899570|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899571|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
145899572|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899573|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899574|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899575|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899576|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145899577|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
145899578|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
145899579|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
145899580|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899581|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
145899582|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899583|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899584|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899585|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899586|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899587|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
145899588|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899589|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899590|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899591|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899592|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899593|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899594|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145899595|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899596|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899597|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899598|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
145899599|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899600|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899601|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899602|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899603|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899604|NCT03893565|526140705|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145899605|NCT03893565|526140706|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
145899606|NCT03893565|526140707|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
145899607|NCT03893565|526140708|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
145899608|NCT03893565|526140709|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145899609|NCT03893565|526140710|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145899610|NCT03893565|526140711|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
146238593|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
146238594|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
146238595|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
146238596|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
145899611|NCT03893565|526140712|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145899612|NCT03893565|526140713|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145899613|NCT03893565|526140705|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
145899614|NCT03893565|526140706|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
145899615|NCT03893565|526140707|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
145899616|NCT03893565|526140708|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
145899617|NCT03893565|526140709|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
145899618|NCT03893565|526140710|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
145899619|NCT03893565|526140711|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
145899620|NCT03893565|526140712|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
145899621|NCT03893565|526140713|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
145899622|NCT03893565|526140705|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899623|NCT03893565|526140706|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899624|NCT03893565|526140707|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899625|NCT03893565|526140708|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899626|NCT03893565|526140709|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899627|NCT03893565|526140710|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899628|NCT03893565|526140711|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
145899629|NCT03893565|526140712|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899630|NCT03893565|526140713|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145899631|NCT03893565|526140705|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899632|NCT03893565|526140706|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899633|NCT03893565|526140707|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899634|NCT03893565|526140708|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899635|NCT03893565|526140709|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899636|NCT03893565|526140710|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
145899637|NCT03893565|526140711|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
145899638|NCT03893565|526140712|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899639|NCT03893565|526140713|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145899640|NCT03893565|526140705|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
145899641|NCT03893565|526140706|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
145899642|NCT03893565|526140707|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
145899643|NCT03893565|526140708|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
145899644|NCT03893565|526140709|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
145899645|NCT03893565|526140710|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
145899646|NCT03893565|526140711|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
145899647|NCT03893565|526140712|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
145899648|NCT03893565|526140713|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
145899649|NCT03893565|526140705|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899650|NCT03893565|526140706|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899651|NCT03893565|526140707|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899652|NCT03893565|526140708|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899653|NCT03893565|526140709|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899654|NCT03893565|526140710|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899655|NCT03893565|526140711|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899656|NCT03893565|526140712|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
145899657|NCT03893565|526140713|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145899658|NCT03893565|526140705|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899659|NCT03893565|526140706|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899660|NCT03893565|526140707|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899661|NCT03893565|526140708|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899662|NCT03893565|526140709|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899663|NCT03893565|526140710|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899664|NCT03893565|526140711|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899665|NCT03893565|526140712|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
145899666|NCT03893565|526140713|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145899667|NCT03893565|526140705|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
146238597|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
145899668|NCT03893565|526140706|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899669|NCT03893565|526140707|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899670|NCT03893565|526140708|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899671|NCT03893565|526140709|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899672|NCT03893565|526140710|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899673|NCT03893565|526140711|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899674|NCT03893565|526140712|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
145899675|NCT03893565|526140713|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145899676|NCT03893565|526140705|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899677|NCT03893565|526140706|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899678|NCT03893565|526140707|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899679|NCT03893565|526140708|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899680|NCT03893565|526140709|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899681|NCT03893565|526140710|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899682|NCT03893565|526140711|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899683|NCT03893565|526140712|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145899684|NCT03893565|526140713|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
145899685|NCT00851318|526140714|FG000|Overall Study|Withdrawal by Subject|7|||
145899686|NCT00851318|526140715|FG001|Overall Study|Withdrawal by Subject|1|||
145899687|NCT00851318|526140716|FG002|Overall Study|Withdrawal by Subject|5|||
145899688|NCT00851318|526140717|FG003|Overall Study|Withdrawal by Subject|3|||
145899689|NCT00851318|526140714|FG000|Overall Study|Adverse Event|13|||
145899690|NCT00851318|526140715|FG001|Overall Study|Adverse Event|2|||
145899691|NCT00851318|526140716|FG002|Overall Study|Adverse Event|9|||
145899692|NCT00851318|526140717|FG003|Overall Study|Adverse Event|12|||
145899693|NCT00851318|526140714|FG000|Overall Study|Pregnancy|0|||
145899694|NCT00851318|526140715|FG001|Overall Study|Pregnancy|0|||
145899695|NCT00851318|526140716|FG002|Overall Study|Pregnancy|1|||
145899696|NCT00851318|526140717|FG003|Overall Study|Pregnancy|1|||
145899697|NCT00851318|526140714|FG000|Overall Study|Lack of Efficacy|8|||
145899698|NCT00851318|526140715|FG001|Overall Study|Lack of Efficacy|2|||
145899699|NCT00851318|526140716|FG002|Overall Study|Lack of Efficacy|4|||
145899700|NCT00851318|526140717|FG003|Overall Study|Lack of Efficacy|2|||
145899701|NCT00851318|526140714|FG000|Overall Study|Non-compliance with Study Procedures|2|||
145899702|NCT00851318|526140715|FG001|Overall Study|Non-compliance with Study Procedures|0|||
145899703|NCT00851318|526140716|FG002|Overall Study|Non-compliance with Study Procedures|1|||
145899704|NCT00851318|526140717|FG003|Overall Study|Non-compliance with Study Procedures|0|||
145899705|NCT00851318|526140714|FG000|Overall Study|Physician Decision|0|||
145899706|NCT00851318|526140715|FG001|Overall Study|Physician Decision|0|||
145899707|NCT00851318|526140716|FG002|Overall Study|Physician Decision|1|||
145899708|NCT00851318|526140717|FG003|Overall Study|Physician Decision|1|||
145899709|NCT01442688|526140718|FG000|First Intervention|Withdrawal by Subject|1|||
145899710|NCT01442688|526140719|FG001|First Intervention|Withdrawal by Subject|0|||
145899711|NCT01442688|526140718|FG000|First Intervention|subject incarcerated|1|||
145899712|NCT01442688|526140719|FG001|First Intervention|subject incarcerated|0|||
145899713|NCT01442688|526140718|FG000|Second Intervention|Adverse Event|1|||
145899714|NCT01442688|526140719|FG001|Second Intervention|Adverse Event|0|||
145899715|NCT02643355|526140720|FG000|Overall Study|Withdrawal by Subject|1|||
145899716|NCT02643355|526140721|FG001|Overall Study|Withdrawal by Subject|3|||
145899717|NCT02643355|526140720|FG000|Overall Study|Protocol Violation|0|||
145899718|NCT02643355|526140721|FG001|Overall Study|Protocol Violation|2|||
145899719|NCT01715571|526140722|FG000|Overall Study|Lost to Follow-up|8|||
145899720|NCT04658095|526140727|FG000|Overall Study|Study terminated|5|||
145899721|NCT04658095|526140728|FG001|Overall Study|Study terminated|1|||
145899722|NCT04658095|526140729|FG002|Overall Study|Study terminated|4|||
145899723|NCT05961215|526140730|FG000|Overall Study|Withdrawal by Subject|1|||
145899724|NCT05187013|526140731|FG000|Overall Study|Withdrawal by Subject|1|||
145899725|NCT05187013|526140732|FG001|Overall Study|Withdrawal by Subject|1|||
145899726|NCT05187013|526140733|FG002|Overall Study|Withdrawal by Subject|0|||
145899727|NCT05187013|526140731|FG000|Overall Study|Death|0|||
145899728|NCT05187013|526140732|FG001|Overall Study|Death|1|||
145899729|NCT05187013|526140733|FG002|Overall Study|Death|0|||
145899730|NCT05187013|526140731|FG000|Overall Study|Lost to Follow-up|20|||
145899731|NCT05187013|526140732|FG001|Overall Study|Lost to Follow-up|17|||
146238598|NCT01767467|527386806|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
145899732|NCT05187013|526140733|FG002|Overall Study|Lost to Follow-up|0|||
145899733|NCT05187013|526140731|FG000|Overall Study|Ongoing Participants|3|||
145899734|NCT05187013|526140732|FG001|Overall Study|Ongoing Participants|5|||
145899735|NCT05187013|526140733|FG002|Overall Study|Ongoing Participants|0|||
145899736|NCT02387983|526140734|FG000|Overall Study|Adverse Event|4|||
145899737|NCT02387983|526140734|FG000|Overall Study|Protocol Violation|1|||
145899738|NCT02387983|526140734|FG000|Overall Study|Withdrawal by Subject|2|||
146238599|NCT01767467|527386807|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
145899739|NCT00077857|526140735|FG000|Overall Study|Adverse Event|30|||
145899740|NCT00077857|526140736|FG001|Overall Study|Adverse Event|32|||
145899741|NCT00077857|526140735|FG000|Overall Study|Death|7|||
145899742|NCT00077857|526140736|FG001|Overall Study|Death|3|||
145899743|NCT00077857|526140735|FG000|Overall Study|Insufficient therapeutic response|112|||
145899744|NCT00077857|526140736|FG001|Overall Study|Insufficient therapeutic response|128|||
145899745|NCT00077857|526140735|FG000|Overall Study|Violation of selection criteria at entry|3|||
145899746|NCT00077857|526140736|FG001|Overall Study|Violation of selection criteria at entry|1|||
145899747|NCT00077857|526140735|FG000|Overall Study|Other protocol violation|0|||
145899748|NCT00077857|526140736|FG001|Overall Study|Other protocol violation|1|||
145899749|NCT00077857|526140735|FG000|Overall Study|Refused treatment|29|||
145899750|NCT00077857|526140736|FG001|Overall Study|Refused treatment|21|||
145899751|NCT00077857|526140735|FG000|Overall Study|Failure to return|5|||
145899752|NCT00077857|526140736|FG001|Overall Study|Failure to return|5|||
145899753|NCT00077857|526140735|FG000|Overall Study|Other|15|||
145899754|NCT00077857|526140736|FG001|Overall Study|Other|13|||
145899755|NCT04480021|526140737|FG000|Overall Study|Lost to Follow-up|3|||
145899756|NCT04480021|526140738|FG001|Overall Study|Lost to Follow-up|4|||
145899757|NCT01096368|526140741|FG000|Overall Study|Death|0|||
145899758|NCT01096368|526140742|FG001|Overall Study|Death|1|||
145899759|NCT01096368|526140743|FG002|Overall Study|Death|0|||
145899760|NCT01096368|526140744|FG003|Overall Study|Death|0|||
145899761|NCT01096368|526140745|FG004|Overall Study|Death|0|||
145899762|NCT01096368|526140741|FG000|Overall Study|Physician Decision|0|||
145899763|NCT01096368|526140742|FG001|Overall Study|Physician Decision|13|||
145899764|NCT01096368|526140743|FG002|Overall Study|Physician Decision|2|||
145899765|NCT01096368|526140744|FG003|Overall Study|Physician Decision|4|||
145899766|NCT01096368|526140745|FG004|Overall Study|Physician Decision|6|||
145899767|NCT01096368|526140741|FG000|Overall Study|Withdrawal by Subject|0|||
145899768|NCT01096368|526140742|FG001|Overall Study|Withdrawal by Subject|52|||
145899769|NCT01096368|526140743|FG002|Overall Study|Withdrawal by Subject|0|||
145899770|NCT01096368|526140744|FG003|Overall Study|Withdrawal by Subject|10|||
145899771|NCT01096368|526140745|FG004|Overall Study|Withdrawal by Subject|14|||
145899772|NCT01096368|526140741|FG000|Overall Study|Ineligible|0|||
145899773|NCT01096368|526140742|FG001|Overall Study|Ineligible|3|||
145899774|NCT01096368|526140743|FG002|Overall Study|Ineligible|2|||
145899775|NCT01096368|526140744|FG003|Overall Study|Ineligible|0|||
145899776|NCT01096368|526140745|FG004|Overall Study|Ineligible|25|||
145899777|NCT01096368|526140741|FG000|Overall Study|Did not start treatment|0|||
145899778|NCT01096368|526140742|FG001|Overall Study|Did not start treatment|4|||
145899779|NCT01096368|526140743|FG002|Overall Study|Did not start treatment|4|||
145899780|NCT01096368|526140744|FG003|Overall Study|Did not start treatment|0|||
145899781|NCT01096368|526140745|FG004|Overall Study|Did not start treatment|0|||
145899782|NCT01096368|526140741|FG000|Overall Study|Progressive disease|0|||
145899783|NCT01096368|526140742|FG001|Overall Study|Progressive disease|6|||
145899784|NCT01096368|526140743|FG002|Overall Study|Progressive disease|0|||
145899785|NCT01096368|526140744|FG003|Overall Study|Progressive disease|10|||
145899786|NCT01096368|526140745|FG004|Overall Study|Progressive disease|3|||
145899787|NCT01096368|526140741|FG000|Overall Study|Other|0|||
145899788|NCT01096368|526140742|FG001|Overall Study|Other|0|||
145899789|NCT01096368|526140743|FG002|Overall Study|Other|1|||
145899790|NCT01096368|526140744|FG003|Overall Study|Other|0|||
145899791|NCT01096368|526140745|FG004|Overall Study|Other|0|||
145899792|NCT01096368|526140741|FG000|Overall Study|Treated with institutional review|0|||
145899793|NCT01096368|526140742|FG001|Overall Study|Treated with institutional review|0|||
145899794|NCT01096368|526140743|FG002|Overall Study|Treated with institutional review|0|||
145899795|NCT01096368|526140744|FG003|Overall Study|Treated with institutional review|0|||
145899796|NCT01096368|526140745|FG004|Overall Study|Treated with institutional review|1|||
145899797|NCT06187909|526140746|FG000|Overall Study|Withdrawal by Subject|2|||
145899798|NCT06187909|526140747|FG001|Overall Study|Withdrawal by Subject|2|||
145899799|NCT06354998|526140748|FG000|Overall Study|Withdrawal by Subject|3|||
145899800|NCT06354998|526140749|FG001|Overall Study|Withdrawal by Subject|0|||
145899801|NCT04740814|526140751|FG000|Overall Study|Adverse Event|3|||
145899802|NCT04740814|526140751|FG000|Overall Study|Protocol Violation|2|||
145899803|NCT04740814|526140751|FG000|Overall Study|Lost to Follow-up|2|||
145899804|NCT04740814|526140751|FG000|Overall Study|Withdrawal by Subject|3|||
145899805|NCT00085423|526140752|FG000|Overall Study|Withdrawal by Subject|1|||
146238600|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
145899806|NCT00085423|526140752|FG000|Overall Study|screen failure|1|||
145972467|NCT01799889|526412644|FG002|Overall Study|Progressive Disease|25|||
146238601|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
145899807|NCT02500641|526140755|FG000|Overall Study|Adverse Event|0|||
145899808|NCT02500641|526140756|FG001|Overall Study|Adverse Event|2|||
145899809|NCT02500641|526140755|FG000|Overall Study|Withdrawal by Subject|4|||
145899810|NCT02500641|526140756|FG001|Overall Study|Withdrawal by Subject|5|||
145899811|NCT02500641|526140755|FG000|Overall Study|Unable to follow study procedures|3|||
145899812|NCT02500641|526140756|FG001|Overall Study|Unable to follow study procedures|2|||
145899813|NCT02500641|526140755|FG000|Overall Study|Protocol Violation|1|||
145899814|NCT02500641|526140756|FG001|Overall Study|Protocol Violation|2|||
145899815|NCT02500641|526140755|FG000|Overall Study|Lost to Follow-up|1|||
145899816|NCT02500641|526140756|FG001|Overall Study|Lost to Follow-up|0|||
145899817|NCT02500641|526140755|FG000|Overall Study|Sponsor decision|1|||
145899818|NCT02500641|526140756|FG001|Overall Study|Sponsor decision|0|||
145899819|NCT02500641|526140755|FG000|Overall Study|Non compliance to study drug|0|||
145899820|NCT02500641|526140756|FG001|Overall Study|Non compliance to study drug|1|||
145899821|NCT02317614|526140764|FG000|Overall Study|Lost to Follow-up|1|||
145899822|NCT02317614|526140765|FG001|Overall Study|Lost to Follow-up|1|||
145899823|NCT02317614|526140764|FG000|Overall Study|Withdrawal by Subject|1|||
145899824|NCT02317614|526140765|FG001|Overall Study|Withdrawal by Subject|0|||
145899825|NCT02317614|526140764|FG000|Overall Study|Death|1|||
145899826|NCT02317614|526140765|FG001|Overall Study|Death|1|||
145899827|NCT03285308|526140770|FG000|Overall Study|Adverse Event|3|||
145899828|NCT03285308|526140771|FG001|Overall Study|Adverse Event|7|||
145899829|NCT03285308|526140770|FG000|Overall Study|Withdrawal by Subject|8|||
145899830|NCT03285308|526140771|FG001|Overall Study|Withdrawal by Subject|9|||
145899831|NCT03285308|526140770|FG000|Overall Study|Lost to Follow-up|3|||
145899832|NCT03285308|526140771|FG001|Overall Study|Lost to Follow-up|1|||
145899833|NCT03285308|526140770|FG000|Overall Study|Protocol Deviation|6|||
145899834|NCT03285308|526140771|FG001|Overall Study|Protocol Deviation|5|||
145899835|NCT03285308|526140770|FG000|Overall Study|Reason not Specified|0|||
145899836|NCT03285308|526140771|FG001|Overall Study|Reason not Specified|1|||
145899837|NCT02283983|526140772|FG000|Overall Study|Inclusion criteria not met|0|||
145899838|NCT02283983|526140773|FG001|Overall Study|Inclusion criteria not met|1|||
145899839|NCT02283983|526140772|FG000|Overall Study|Withdrawal by Subject|4|||
145899840|NCT02283983|526140773|FG001|Overall Study|Withdrawal by Subject|2|||
145899841|NCT02283983|526140772|FG000|Overall Study|Protocol Violation|0|||
145899842|NCT02283983|526140773|FG001|Overall Study|Protocol Violation|4|||
145899843|NCT02283983|526140772|FG000|Overall Study|Physician Decision|2|||
145899844|NCT02283983|526140773|FG001|Overall Study|Physician Decision|4|||
145899845|NCT02283983|526140772|FG000|Overall Study|Death|1|||
145899846|NCT02283983|526140773|FG001|Overall Study|Death|0|||
145899847|NCT02283983|526140772|FG000|Overall Study|Adverse Event|1|||
145899848|NCT02283983|526140773|FG001|Overall Study|Adverse Event|0|||
145899849|NCT02283983|526140772|FG000|Overall Study|Lost to Follow-up|9|||
145899850|NCT02283983|526140773|FG001|Overall Study|Lost to Follow-up|8|||
145899851|NCT02283983|526140772|FG000|Overall Study|Relapse|1|||
145899852|NCT02283983|526140773|FG001|Overall Study|Relapse|0|||
145899853|NCT03283761|526140774|FG000|Study Treatment|Patient Non-Compliance|1|||
145899854|NCT03283761|526140774|FG000|Study Treatment|Alternative Cancer Therapy|7|||
145899855|NCT03283761|526140774|FG000|Study Treatment|Disease progression|21|||
145899856|NCT03283761|526140774|FG000|Study Treatment|Adverse Event|3|||
145899857|NCT03283761|526140774|FG000|Study Treatment|Withdrawal by Subject|4|||
145899858|NCT03283761|526140774|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
145899859|NCT03283761|526140774|FG000|Study Treatment|Symptomatic Deterioration|1|||
145899860|NCT03283761|526140774|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
145899861|NCT03283761|526140774|FG000|Follow up|Lost to Follow-up|1|||
145899862|NCT03283761|526140774|FG000|Follow up|Symptomatic Deterioration|1|||
145899863|NCT03283761|526140774|FG000|Follow up|Death|29|||
145899864|NCT03283761|526140774|FG000|Follow up|study terminated|4|||
145899865|NCT03283761|526140774|FG000|Follow up|Primary Investigator Withdrawal|1|||
145899866|NCT03283761|526140774|FG000|Follow up|Switched to alternative therapy|1|||
145899867|NCT03283761|526140774|FG000|Follow up|Subject is now in Hospice|1|||
145899868|NCT04453202|526140780|FG000|Overall Study|Adverse Event|0|||
146297310|NCT01145495|527604659|FG000|Overall Study|Adverse Event|6|||
145899869|NCT04453202|526140781|FG001|Overall Study|Adverse Event|0|||
145899870|NCT04453202|526140782|FG002|Overall Study|Adverse Event|0|||
145899871|NCT04453202|526140783|FG003|Overall Study|Adverse Event|0|||
145899872|NCT04453202|526140784|FG004|Overall Study|Adverse Event|0|||
145899873|NCT04453202|526140785|FG005|Overall Study|Adverse Event|0|||
145899874|NCT04453202|526140786|FG006|Overall Study|Adverse Event|1|||
145899875|NCT04453202|526140787|FG007|Overall Study|Adverse Event|0|||
145899876|NCT04453202|526140788|FG008|Overall Study|Adverse Event|0|||
145899877|NCT04453202|526140789|FG009|Overall Study|Adverse Event|0|||
145899878|NCT04453202|526140790|FG010|Overall Study|Adverse Event|0|||
145899879|NCT04453202|526140780|FG000|Overall Study|Death|0|||
145899880|NCT04453202|526140781|FG001|Overall Study|Death|0|||
145899881|NCT04453202|526140782|FG002|Overall Study|Death|0|||
145899882|NCT04453202|526140783|FG003|Overall Study|Death|0|||
145899883|NCT04453202|526140784|FG004|Overall Study|Death|0|||
145899884|NCT04453202|526140785|FG005|Overall Study|Death|0|||
145899885|NCT04453202|526140786|FG006|Overall Study|Death|0|||
145899886|NCT04453202|526140787|FG007|Overall Study|Death|0|||
145899887|NCT04453202|526140788|FG008|Overall Study|Death|0|||
145899888|NCT04453202|526140789|FG009|Overall Study|Death|1|||
145899889|NCT04453202|526140790|FG010|Overall Study|Death|0|||
145899890|NCT04453202|526140780|FG000|Overall Study|Lost to Follow-up|0|||
145972468|NCT01799889|526412645|FG003|Overall Study|Progressive Disease|30|||
145899891|NCT04453202|526140781|FG001|Overall Study|Lost to Follow-up|1|||
145899892|NCT04453202|526140782|FG002|Overall Study|Lost to Follow-up|0|||
145899893|NCT04453202|526140783|FG003|Overall Study|Lost to Follow-up|1|||
145899894|NCT04453202|526140784|FG004|Overall Study|Lost to Follow-up|0|||
145899895|NCT04453202|526140785|FG005|Overall Study|Lost to Follow-up|0|||
145899896|NCT04453202|526140786|FG006|Overall Study|Lost to Follow-up|0|||
145899897|NCT04453202|526140787|FG007|Overall Study|Lost to Follow-up|0|||
145899898|NCT04453202|526140788|FG008|Overall Study|Lost to Follow-up|0|||
145899899|NCT04453202|526140789|FG009|Overall Study|Lost to Follow-up|1|||
145899900|NCT04453202|526140790|FG010|Overall Study|Lost to Follow-up|1|||
145899901|NCT04453202|526140780|FG000|Overall Study|Withdrawal by Subject|1|||
145899902|NCT04453202|526140781|FG001|Overall Study|Withdrawal by Subject|2|||
145899903|NCT04453202|526140782|FG002|Overall Study|Withdrawal by Subject|1|||
145899904|NCT04453202|526140783|FG003|Overall Study|Withdrawal by Subject|2|||
145899905|NCT04453202|526140784|FG004|Overall Study|Withdrawal by Subject|1|||
145899906|NCT04453202|526140785|FG005|Overall Study|Withdrawal by Subject|1|||
145899907|NCT04453202|526140786|FG006|Overall Study|Withdrawal by Subject|0|||
145899908|NCT04453202|526140787|FG007|Overall Study|Withdrawal by Subject|0|||
145899909|NCT04453202|526140788|FG008|Overall Study|Withdrawal by Subject|0|||
145899910|NCT04453202|526140789|FG009|Overall Study|Withdrawal by Subject|1|||
145899911|NCT04453202|526140790|FG010|Overall Study|Withdrawal by Subject|0|||
145899912|NCT04453202|526140780|FG000|Overall Study|Adverse Event|0|||
145899913|NCT04453202|526140781|FG001|Overall Study|Adverse Event|0|||
145899914|NCT04453202|526140782|FG002|Overall Study|Adverse Event|0|||
145899915|NCT04453202|526140783|FG003|Overall Study|Adverse Event|0|||
145899916|NCT04453202|526140784|FG004|Overall Study|Adverse Event|0|||
145899917|NCT04453202|526140785|FG005|Overall Study|Adverse Event|1|||
145899918|NCT04453202|526140786|FG006|Overall Study|Adverse Event|0|||
145899919|NCT04453202|526140787|FG007|Overall Study|Adverse Event|0|||
145899920|NCT04453202|526140788|FG008|Overall Study|Adverse Event|0|||
145899921|NCT04453202|526140789|FG009|Overall Study|Adverse Event|0|||
145899922|NCT04453202|526140790|FG010|Overall Study|Adverse Event|0|||
145899923|NCT00669071|526140794|FG000|Overall Study|Lost to Follow-up|3|||
145899924|NCT00669071|526140794|FG000|Overall Study|Final visit 40 days out of window|1|||
145899925|NCT03276221|526140795|FG000|Overall Study|Lost to Follow-up|6|||
146088286|NCT02186301|526843788|FG002|Overall Study|Other|1|||
146088287|NCT03560739|526843790|FG000|Overall Study|Adverse Event|0|||
146088288|NCT03560739|526843791|FG001|Overall Study|Adverse Event|1|||
146088289|NCT03560739|526843792|FG002|Overall Study|Adverse Event|0|||
145899926|NCT03276221|526140796|FG001|Overall Study|Lost to Follow-up|2|||
145899927|NCT03276221|526140797|FG002|Overall Study|Lost to Follow-up|0|||
146088290|NCT03560739|526843793|FG003|Overall Study|Adverse Event|0|||
146088291|NCT01741012|526843797|FG000|Overall Study|Lost to Follow-up|1|||
146088292|NCT01741012|526843797|FG000|Overall Study|Withdrawal by Subject|2|||
146088293|NCT00095238|526843798|FG000|Overall Study|Lack of Efficacy|9|||
146088294|NCT00095238|526843799|FG001|Overall Study|Lack of Efficacy|9|||
146088295|NCT00095238|526843798|FG000|Overall Study|Adverse Event|331|||
146088296|NCT00095238|526843799|FG001|Overall Study|Adverse Event|287|||
146088297|NCT00095238|526843798|FG000|Overall Study|Subject Withdrew Consent|208|||
146088298|NCT00095238|526843799|FG001|Overall Study|Subject Withdrew Consent|223|||
146088299|NCT00095238|526843798|FG000|Overall Study|Death|154|||
146088300|NCT00095238|526843799|FG001|Overall Study|Death|170|||
146088301|NCT00095238|526843798|FG000|Overall Study|Lost to Follow-up|19|||
146088302|NCT00095238|526843799|FG001|Overall Study|Lost to Follow-up|24|||
146088303|NCT00095238|526843798|FG000|Overall Study|Noncompliance|44|||
145899928|NCT03276221|526140795|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
145899929|NCT03276221|526140796|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
145899930|NCT03276221|526140797|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
145899931|NCT00424775|526140798|FG000|Overall Study|Adverse Event|2|||
145899932|NCT00424775|526140799|FG001|Overall Study|Adverse Event|0|||
145899933|NCT00424775|526140798|FG000|Overall Study|Lack of Efficacy|1|||
145899934|NCT00424775|526140799|FG001|Overall Study|Lack of Efficacy|0|||
145899935|NCT02900976|526140801|FG000|Overall Study|Adverse Event|0|||
145899936|NCT02900976|526140802|FG001|Overall Study|Adverse Event|1|||
145899937|NCT02900976|526140801|FG000|Overall Study|Physician Decision|0|||
146088304|NCT00095238|526843799|FG001|Overall Study|Noncompliance|45|||
145899938|NCT02900976|526140802|FG001|Overall Study|Physician Decision|2|||
146088305|NCT00095238|526843798|FG000|Overall Study|No longer met study criteria|4|||
145899939|NCT02900976|526140801|FG000|Overall Study|Progressive disease|0|||
145899940|NCT02900976|526140802|FG001|Overall Study|Progressive disease|6|||
146088306|NCT00095238|526843799|FG001|Overall Study|No longer met study criteria|5|||
145899941|NCT01408628|526140803|FG000|Consented|Withdrawal by Subject|12|||
145899942|NCT01408628|526140803|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
146088307|NCT00095238|526843798|FG000|Overall Study|Study terminated by sponsor|0|||
146088308|NCT00095238|526843799|FG001|Overall Study|Study terminated by sponsor|1|||
146088309|NCT00095238|526843798|FG000|Overall Study|Missing|1|||
146088310|NCT00095238|526843799|FG001|Overall Study|Missing|0|||
146088311|NCT00095238|526843798|FG000|Overall Study|Other Reasons|87|||
145899943|NCT01408628|526140803|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
145899944|NCT01408628|526140803|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
145972469|NCT01799889|526412646|FG004|Overall Study|Progressive Disease|23|||
145972470|NCT01799889|526412647|FG005|Overall Study|Progressive Disease|9|||
146238602|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
145899945|NCT01181271|526140804|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
145899946|NCT01181271|526140804|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
145899947|NCT01181271|526140804|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
145899948|NCT01181271|526140804|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
145899949|NCT00750308|526140805|FG000|First Treatment|Adverse Event|0|||
145899950|NCT00750308|526140806|FG001|First Treatment|Adverse Event|1|||
145899951|NCT00750308|526140807|FG002|First Treatment|Adverse Event|0|||
145899952|NCT00750308|526140808|FG003|First Treatment|Adverse Event|0|||
146238603|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
146238604|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
146238605|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
146238606|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
146238607|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
145899953|NCT00750308|526140809|FG004|First Treatment|Adverse Event|0|||
145899954|NCT00750308|526140810|FG005|First Treatment|Adverse Event|0|||
145899955|NCT00750308|526140811|FG006|First Treatment|Adverse Event|0|||
145899956|NCT00750308|526140812|FG007|First Treatment|Adverse Event|0|||
145899957|NCT00750308|526140813|FG008|First Treatment|Adverse Event|0|||
145899958|NCT00750308|526140814|FG009|First Treatment|Adverse Event|0|||
145899959|NCT00750308|526140815|FG010|First Treatment|Adverse Event|1|||
145899960|NCT00750308|526140816|FG011|First Treatment|Adverse Event|1|||
145899961|NCT00750308|526140805|FG000|First Treatment|Withdrawal by Subject|0|||
145899962|NCT00750308|526140806|FG001|First Treatment|Withdrawal by Subject|0|||
145899963|NCT00750308|526140807|FG002|First Treatment|Withdrawal by Subject|0|||
145899964|NCT00750308|526140808|FG003|First Treatment|Withdrawal by Subject|1|||
145899965|NCT00750308|526140809|FG004|First Treatment|Withdrawal by Subject|0|||
145899966|NCT00750308|526140810|FG005|First Treatment|Withdrawal by Subject|0|||
145899967|NCT00750308|526140811|FG006|First Treatment|Withdrawal by Subject|0|||
145899968|NCT00750308|526140812|FG007|First Treatment|Withdrawal by Subject|1|||
145899969|NCT00750308|526140813|FG008|First Treatment|Withdrawal by Subject|0|||
145899970|NCT00750308|526140814|FG009|First Treatment|Withdrawal by Subject|0|||
145899971|NCT00750308|526140815|FG010|First Treatment|Withdrawal by Subject|0|||
145899972|NCT00750308|526140816|FG011|First Treatment|Withdrawal by Subject|0|||
145899973|NCT00750308|526140805|FG000|Second Treatment|Adverse Event|0|||
145899974|NCT00750308|526140806|FG001|Second Treatment|Adverse Event|0|||
145899975|NCT00750308|526140807|FG002|Second Treatment|Adverse Event|0|||
145899976|NCT00750308|526140808|FG003|Second Treatment|Adverse Event|0|||
145899977|NCT00750308|526140809|FG004|Second Treatment|Adverse Event|0|||
145899978|NCT00750308|526140810|FG005|Second Treatment|Adverse Event|1|||
145899979|NCT00750308|526140811|FG006|Second Treatment|Adverse Event|0|||
145899980|NCT00750308|526140812|FG007|Second Treatment|Adverse Event|0|||
145899981|NCT00750308|526140813|FG008|Second Treatment|Adverse Event|1|||
145899982|NCT00750308|526140814|FG009|Second Treatment|Adverse Event|0|||
145899983|NCT00750308|526140815|FG010|Second Treatment|Adverse Event|0|||
145899984|NCT00750308|526140816|FG011|Second Treatment|Adverse Event|0|||
145899985|NCT00750308|526140805|FG000|Second Treatment|Withdrawal by Subject|0|||
145899986|NCT00750308|526140806|FG001|Second Treatment|Withdrawal by Subject|0|||
145899987|NCT00750308|526140807|FG002|Second Treatment|Withdrawal by Subject|0|||
145899988|NCT00750308|526140808|FG003|Second Treatment|Withdrawal by Subject|0|||
145899989|NCT00750308|526140809|FG004|Second Treatment|Withdrawal by Subject|1|||
145899990|NCT00750308|526140810|FG005|Second Treatment|Withdrawal by Subject|0|||
145899991|NCT00750308|526140811|FG006|Second Treatment|Withdrawal by Subject|0|||
145899992|NCT00750308|526140812|FG007|Second Treatment|Withdrawal by Subject|0|||
145899993|NCT00750308|526140813|FG008|Second Treatment|Withdrawal by Subject|0|||
145899994|NCT00750308|526140814|FG009|Second Treatment|Withdrawal by Subject|0|||
145899995|NCT00750308|526140815|FG010|Second Treatment|Withdrawal by Subject|0|||
145899996|NCT00750308|526140816|FG011|Second Treatment|Withdrawal by Subject|0|||
145899997|NCT00750308|526140805|FG000|Third Treatment|Withdrawal by Subject|0|||
145899998|NCT00750308|526140806|FG001|Third Treatment|Withdrawal by Subject|1|||
145899999|NCT00750308|526140807|FG002|Third Treatment|Withdrawal by Subject|0|||
145900000|NCT00750308|526140808|FG003|Third Treatment|Withdrawal by Subject|0|||
145900001|NCT00750308|526140809|FG004|Third Treatment|Withdrawal by Subject|0|||
145900002|NCT00750308|526140810|FG005|Third Treatment|Withdrawal by Subject|0|||
145900003|NCT00750308|526140811|FG006|Third Treatment|Withdrawal by Subject|0|||
145900004|NCT00750308|526140812|FG007|Third Treatment|Withdrawal by Subject|0|||
145900005|NCT00750308|526140813|FG008|Third Treatment|Withdrawal by Subject|0|||
145900006|NCT00750308|526140814|FG009|Third Treatment|Withdrawal by Subject|0|||
145972471|NCT01799889|526412648|FG006|Overall Study|Progressive Disease|8|||
145900007|NCT00750308|526140815|FG010|Third Treatment|Withdrawal by Subject|0|||
145900008|NCT00750308|526140816|FG011|Third Treatment|Withdrawal by Subject|0|||
145900009|NCT00513682|526140817|FG000|Washout Phase|Adverse Event|2|||
146238608|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
146297311|NCT01145495|527604659|FG000|Overall Study|Withdrawal by Subject|6|||
145900010|NCT04156620|526140818|FG000|Overall Study|Adverse event - TP 1|5|||
145900011|NCT04156620|526140819|FG001|Overall Study|Adverse event - TP 1|2|||
145900012|NCT04156620|526140818|FG000|Overall Study|Lost to follow-up TP 1|1|||
145900013|NCT04156620|526140819|FG001|Overall Study|Lost to follow-up TP 1|1|||
145900014|NCT04156620|526140818|FG000|Overall Study|Progressive disease - TP 1|0|||
145900015|NCT04156620|526140819|FG001|Overall Study|Progressive disease - TP 1|1|||
145900016|NCT04156620|526140818|FG000|Overall Study|Subject decision - TP 1|3|||
145900017|NCT04156620|526140819|FG001|Overall Study|Subject decision - TP 1|5|||
145900018|NCT04156620|526140818|FG000|Overall Study|Adverse event - TP 2|5|||
145900019|NCT04156620|526140819|FG001|Overall Study|Adverse event - TP 2|6|||
145900020|NCT04156620|526140818|FG000|Overall Study|Death - TP 2|1|||
145900021|NCT04156620|526140819|FG001|Overall Study|Death - TP 2|0|||
145900022|NCT04156620|526140818|FG000|Overall Study|Lost to follow-up - TP 2|5|||
145900023|NCT04156620|526140819|FG001|Overall Study|Lost to follow-up - TP 2|2|||
145900024|NCT04156620|526140818|FG000|Overall Study|Physician decision - TP 2|4|||
145900025|NCT04156620|526140819|FG001|Overall Study|Physician decision - TP 2|2|||
145900026|NCT04156620|526140818|FG000|Overall Study|Pregnancy - TP 2|1|||
145900027|NCT04156620|526140819|FG001|Overall Study|Pregnancy - TP 2|1|||
145900028|NCT04156620|526140818|FG000|Overall Study|Subject decision - TP 2|11|||
145900029|NCT04156620|526140819|FG001|Overall Study|Subject decision - TP 2|9|||
145900030|NCT04156620|526140818|FG000|Overall Study|New therapy for study indication - TP 2|1|||
145900031|NCT04156620|526140819|FG001|Overall Study|New therapy for study indication - TP 2|0|||
145900032|NCT02980874|526140820|FG000|Overall Study|Adverse Event|2|||
145900033|NCT02980874|526140821|FG001|Overall Study|Adverse Event|7|||
145900034|NCT02980874|526140820|FG000|Overall Study|Withdrawal by Subject|7|||
145900035|NCT02980874|526140821|FG001|Overall Study|Withdrawal by Subject|2|||
145900036|NCT02980874|526140820|FG000|Overall Study|Lost to Follow-up|5|||
145900037|NCT02980874|526140821|FG001|Overall Study|Lost to Follow-up|5|||
145900038|NCT02980874|526140820|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
145900039|NCT02980874|526140821|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
145900040|NCT02980874|526140820|FG000|Overall Study|Unknown study completion status|1|||
145900041|NCT02980874|526140821|FG001|Overall Study|Unknown study completion status|0|||
145900042|NCT02450526|526140822|FG000|DB Period (Cycle 1)|Adverse Event|0|||
145900043|NCT02450526|526140823|FG001|DB Period (Cycle 1)|Adverse Event|0|||
145900044|NCT02450526|526140824|FG002|DB Period (Cycle 1)|Adverse Event|2|||
145900045|NCT02450526|526140825|FG003|DB Period (Cycle 1)|Adverse Event|0|||
145900046|NCT02450526|526140826|FG004|DB Period (Cycle 1)|Adverse Event|0|||
145900047|NCT02450526|526140822|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
145900048|NCT02450526|526140823|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
145900049|NCT02450526|526140824|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
145900050|NCT02450526|526140825|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
145900051|NCT02450526|526140826|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
145900052|NCT02450526|526140822|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
145900053|NCT02450526|526140823|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
145900054|NCT02450526|526140824|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
145900055|NCT02450526|526140825|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
145900056|NCT02450526|526140826|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
145900057|NCT02450526|526140822|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
145900058|NCT02450526|526140823|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
145900059|NCT02450526|526140824|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
145900060|NCT02450526|526140825|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
145900061|NCT02450526|526140826|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
145900062|NCT02450526|526140822|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
145900063|NCT02450526|526140823|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
145900064|NCT02450526|526140824|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
145900065|NCT02450526|526140825|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
145900066|NCT02450526|526140826|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
145900067|NCT02450526|526140822|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145900068|NCT02450526|526140823|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145900069|NCT02450526|526140824|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145900070|NCT02450526|526140825|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145900071|NCT02450526|526140826|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
145900072|NCT02450526|526140822|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145900073|NCT02450526|526140823|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145900074|NCT02450526|526140824|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145900075|NCT02450526|526140825|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145900076|NCT02450526|526140826|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
145900077|NCT02450526|526140822|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
145900078|NCT02450526|526140823|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
145900079|NCT02450526|526140824|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
145900080|NCT02450526|526140825|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
145900081|NCT02450526|526140826|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
146297312|NCT01145495|527604659|FG000|Overall Study|Disease progression after respone|2|||
145900082|NCT01753336|526140827|FG000|Overall Study|Patient decision|12|||
145900083|NCT01753336|526140827|FG000|Overall Study|Lost to Follow-up|3|||
145900084|NCT01753336|526140827|FG000|Overall Study|Physician Decision|2|||
145900085|NCT01753336|526140827|FG000|Overall Study|Sponsor's decision|2|||
145900086|NCT01753336|526140827|FG000|Overall Study|Withdrawal by Subject|1|||
145900087|NCT02435836|526140828|FG000|Overall Study|Lost to Follow-up|21|||
145900088|NCT02435836|526140828|FG000|Overall Study|Lack of Efficacy|1|||
145900089|NCT02435836|526140828|FG000|Overall Study|Withdrawal by Subject|236|||
145900090|NCT02435836|526140828|FG000|Overall Study|Insufficient Clinical Response|26|||
145900091|NCT02435836|526140828|FG000|Overall Study|Adverse Event|44|||
145900092|NCT02435836|526140828|FG000|Overall Study|Sponsor discontinued trial|167|||
145900093|NCT02435836|526140828|FG000|Overall Study|Noncompliance|27|||
145900094|NCT02435836|526140828|FG000|Overall Study|Protocol Violation|6|||
145900095|NCT02435836|526140828|FG000|Overall Study|Met Withdrawal Criteria|7|||
145900096|NCT02435836|526140828|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
145900097|NCT01629966|526140829|FG000|Overall Study|Pregnancy|0|||
145900098|NCT01629966|526140830|FG001|Overall Study|Pregnancy|1|||
145900099|NCT01629966|526140831|FG002|Overall Study|Pregnancy|0|||
145900100|NCT01629966|526140829|FG000|Overall Study|Lost to Follow-up|10|||
145900101|NCT01629966|526140830|FG001|Overall Study|Lost to Follow-up|13|||
145900102|NCT01629966|526140831|FG002|Overall Study|Lost to Follow-up|9|||
145900103|NCT01629966|526140829|FG000|Overall Study|Withdrawal by Subject|8|||
145900104|NCT01629966|526140830|FG001|Overall Study|Withdrawal by Subject|9|||
145900105|NCT01629966|526140831|FG002|Overall Study|Withdrawal by Subject|16|||
145900106|NCT01629966|526140829|FG000|Overall Study|Protocol Violation|7|||
145900107|NCT01629966|526140830|FG001|Overall Study|Protocol Violation|9|||
145900108|NCT01629966|526140831|FG002|Overall Study|Protocol Violation|7|||
145900109|NCT01629966|526140829|FG000|Overall Study|Lack of Efficacy|5|||
145900110|NCT01629966|526140830|FG001|Overall Study|Lack of Efficacy|2|||
145900111|NCT01629966|526140831|FG002|Overall Study|Lack of Efficacy|4|||
145900112|NCT01629966|526140829|FG000|Overall Study|Adverse Event|11|||
145900113|NCT01629966|526140830|FG001|Overall Study|Adverse Event|18|||
145900114|NCT01629966|526140831|FG002|Overall Study|Adverse Event|30|||
145900115|NCT02991430|526140834|FG000|Treatment Period 1|Adverse Event|1|||
145900116|NCT02991430|526140835|FG001|Treatment Period 1|Adverse Event|0|||
145900117|NCT02991430|526140836|FG002|Treatment Period 1|Adverse Event|2|||
145900118|NCT02991430|526140834|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145900119|NCT02991430|526140835|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145900120|NCT02991430|526140836|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145900121|NCT02991430|526140834|FG000|Treatment Period 2|Study Termination|6|||
145900122|NCT02991430|526140835|FG001|Treatment Period 2|Study Termination|3|||
145900123|NCT02991430|526140836|FG002|Treatment Period 2|Study Termination|3|||
145900124|NCT02991430|526140834|FG000|Treatment Period 2|Lost to Follow-up|0|||
145900125|NCT02991430|526140835|FG001|Treatment Period 2|Lost to Follow-up|0|||
145900126|NCT02991430|526140836|FG002|Treatment Period 2|Lost to Follow-up|1|||
145900127|NCT02991430|526140834|FG000|Post-treatment Observation Period|Study Termination|3|||
145900128|NCT02991430|526140835|FG001|Post-treatment Observation Period|Study Termination|6|||
145900129|NCT02991430|526140836|FG002|Post-treatment Observation Period|Study Termination|5|||
145900130|NCT03970837|526140837|FG000|Overall Study|Adverse Event|23|||
145900131|NCT03970837|526140838|FG001|Overall Study|Adverse Event|20|||
145900132|NCT03970837|526140839|FG002|Overall Study|Adverse Event|16|||
145900133|NCT03970837|526140840|FG003|Overall Study|Adverse Event|6|||
145900134|NCT03970837|526140841|FG004|Overall Study|Adverse Event|4|||
145900135|NCT03970837|526140842|FG005|Overall Study|Adverse Event|5|||
145900136|NCT03970837|526140843|FG006|Overall Study|Adverse Event|1|||
145900137|NCT03970837|526140844|FG007|Overall Study|Adverse Event|5|||
145900138|NCT03970837|526140845|FG008|Overall Study|Adverse Event|0|||
145900139|NCT03970837|526140846|FG009|Overall Study|Adverse Event|0|||
145900140|NCT03970837|526140847|FG010|Overall Study|Adverse Event|1|||
145900141|NCT03970837|526140848|FG011|Overall Study|Adverse Event|1|||
145900142|NCT03970837|526140837|FG000|Overall Study|Lack of Efficacy|14|||
145900143|NCT03970837|526140838|FG001|Overall Study|Lack of Efficacy|12|||
145900144|NCT03970837|526140839|FG002|Overall Study|Lack of Efficacy|1|||
145900145|NCT03970837|526140840|FG003|Overall Study|Lack of Efficacy|2|||
145900146|NCT03970837|526140841|FG004|Overall Study|Lack of Efficacy|3|||
145900147|NCT03970837|526140842|FG005|Overall Study|Lack of Efficacy|4|||
145900148|NCT03970837|526140843|FG006|Overall Study|Lack of Efficacy|6|||
145900149|NCT03970837|526140844|FG007|Overall Study|Lack of Efficacy|1|||
145900150|NCT03970837|526140845|FG008|Overall Study|Lack of Efficacy|1|||
145900151|NCT03970837|526140846|FG009|Overall Study|Lack of Efficacy|0|||
145900152|NCT03970837|526140847|FG010|Overall Study|Lack of Efficacy|0|||
145900153|NCT03970837|526140848|FG011|Overall Study|Lack of Efficacy|0|||
145900154|NCT03970837|526140837|FG000|Overall Study|Lost to Follow-up|6|||
145900155|NCT03970837|526140838|FG001|Overall Study|Lost to Follow-up|5|||
145900156|NCT03970837|526140839|FG002|Overall Study|Lost to Follow-up|5|||
145900157|NCT03970837|526140840|FG003|Overall Study|Lost to Follow-up|1|||
145900158|NCT03970837|526140841|FG004|Overall Study|Lost to Follow-up|0|||
145900159|NCT03970837|526140842|FG005|Overall Study|Lost to Follow-up|2|||
145900160|NCT03970837|526140843|FG006|Overall Study|Lost to Follow-up|0|||
145900161|NCT03970837|526140844|FG007|Overall Study|Lost to Follow-up|0|||
145900162|NCT03970837|526140845|FG008|Overall Study|Lost to Follow-up|0|||
145900163|NCT03970837|526140846|FG009|Overall Study|Lost to Follow-up|0|||
145900164|NCT03970837|526140847|FG010|Overall Study|Lost to Follow-up|0|||
145900165|NCT03970837|526140848|FG011|Overall Study|Lost to Follow-up|0|||
145900166|NCT03970837|526140837|FG000|Overall Study|Protocol Violation|1|||
145900167|NCT03970837|526140838|FG001|Overall Study|Protocol Violation|0|||
145900168|NCT03970837|526140839|FG002|Overall Study|Protocol Violation|0|||
145900169|NCT03970837|526140840|FG003|Overall Study|Protocol Violation|0|||
145900170|NCT03970837|526140841|FG004|Overall Study|Protocol Violation|0|||
145900171|NCT03970837|526140842|FG005|Overall Study|Protocol Violation|0|||
145900172|NCT03970837|526140843|FG006|Overall Study|Protocol Violation|0|||
145900173|NCT03970837|526140844|FG007|Overall Study|Protocol Violation|0|||
145900174|NCT03970837|526140845|FG008|Overall Study|Protocol Violation|0|||
145900175|NCT03970837|526140846|FG009|Overall Study|Protocol Violation|0|||
145900176|NCT03970837|526140847|FG010|Overall Study|Protocol Violation|0|||
145900177|NCT03970837|526140848|FG011|Overall Study|Protocol Violation|0|||
145900178|NCT03970837|526140837|FG000|Overall Study|Physician Decision|5|||
145900179|NCT03970837|526140838|FG001|Overall Study|Physician Decision|8|||
145900180|NCT03970837|526140839|FG002|Overall Study|Physician Decision|4|||
145900181|NCT03970837|526140840|FG003|Overall Study|Physician Decision|1|||
145900182|NCT03970837|526140841|FG004|Overall Study|Physician Decision|5|||
145900183|NCT03970837|526140842|FG005|Overall Study|Physician Decision|2|||
145900184|NCT03970837|526140843|FG006|Overall Study|Physician Decision|4|||
145900185|NCT03970837|526140844|FG007|Overall Study|Physician Decision|5|||
145900186|NCT03970837|526140845|FG008|Overall Study|Physician Decision|0|||
145900187|NCT03970837|526140846|FG009|Overall Study|Physician Decision|1|||
145900188|NCT03970837|526140847|FG010|Overall Study|Physician Decision|0|||
145900189|NCT03970837|526140848|FG011|Overall Study|Physician Decision|0|||
145900190|NCT03970837|526140837|FG000|Overall Study|Withdrawal by Subject|32|||
145900191|NCT03970837|526140838|FG001|Overall Study|Withdrawal by Subject|35|||
145900192|NCT03970837|526140839|FG002|Overall Study|Withdrawal by Subject|12|||
145900193|NCT03970837|526140840|FG003|Overall Study|Withdrawal by Subject|8|||
145900194|NCT03970837|526140841|FG004|Overall Study|Withdrawal by Subject|6|||
145900195|NCT03970837|526140842|FG005|Overall Study|Withdrawal by Subject|8|||
145900196|NCT03970837|526140843|FG006|Overall Study|Withdrawal by Subject|2|||
145900197|NCT03970837|526140844|FG007|Overall Study|Withdrawal by Subject|3|||
145900198|NCT03970837|526140845|FG008|Overall Study|Withdrawal by Subject|0|||
145900199|NCT03970837|526140846|FG009|Overall Study|Withdrawal by Subject|0|||
145900200|NCT03970837|526140847|FG010|Overall Study|Withdrawal by Subject|0|||
145900201|NCT03970837|526140848|FG011|Overall Study|Withdrawal by Subject|1|||
145900202|NCT03970837|526140837|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
145900203|NCT03970837|526140838|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
145900204|NCT03970837|526140839|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
145900205|NCT03970837|526140840|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145900206|NCT03970837|526140841|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
145900207|NCT03970837|526140842|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145900208|NCT03970837|526140843|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145900209|NCT03970837|526140844|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145900210|NCT03970837|526140845|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145900211|NCT03970837|526140846|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145900212|NCT03970837|526140847|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145900213|NCT03970837|526140848|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145900214|NCT03970837|526140837|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900215|NCT03970837|526140838|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900216|NCT03970837|526140839|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900217|NCT03970837|526140840|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900218|NCT03970837|526140841|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900219|NCT03970837|526140842|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145900220|NCT03970837|526140843|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
145900221|NCT03970837|526140844|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
145900222|NCT03970837|526140845|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
145900223|NCT03970837|526140846|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
145900224|NCT03970837|526140847|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
145900225|NCT03970837|526140848|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
145900226|NCT04568031|526140851|FG000|Overall Study|Lost to Follow-up|1|||
145900227|NCT04568031|526140852|FG001|Overall Study|Lost to Follow-up|0|||
145900228|NCT04568031|526140853|FG002|Overall Study|Lost to Follow-up|0|||
145900229|NCT04568031|526140854|FG003|Overall Study|Lost to Follow-up|0|||
145900230|NCT04568031|526140851|FG000|Overall Study|Physician Decision|1|||
145900231|NCT04568031|526140852|FG001|Overall Study|Physician Decision|0|||
145900232|NCT04568031|526140853|FG002|Overall Study|Physician Decision|1|||
145900233|NCT04568031|526140854|FG003|Overall Study|Physician Decision|0|||
145900234|NCT04568031|526140851|FG000|Overall Study|Withdrawal by Subject|1|||
145900235|NCT04568031|526140852|FG001|Overall Study|Withdrawal by Subject|0|||
145900236|NCT04568031|526140853|FG002|Overall Study|Withdrawal by Subject|4|||
145900237|NCT04568031|526140854|FG003|Overall Study|Withdrawal by Subject|1|||
146238609|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
146238610|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
146238611|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
146238612|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
145900238|NCT00228423|526140857|FG000|Overall Study|Adverse Event|2|||
145900239|NCT00228423|526140858|FG001|Overall Study|Adverse Event|5|||
145900240|NCT00228423|526140857|FG000|Overall Study|Withdrawal by Subject|7|||
145900241|NCT00228423|526140858|FG001|Overall Study|Withdrawal by Subject|3|||
145900242|NCT00228423|526140857|FG000|Overall Study|Protocol Violation|1|||
145900243|NCT00228423|526140858|FG001|Overall Study|Protocol Violation|3|||
145900244|NCT00228423|526140857|FG000|Overall Study|Physician Decision|0|||
145900245|NCT00228423|526140858|FG001|Overall Study|Physician Decision|1|||
145900246|NCT03870477|526140867|FG000|Overall Study|Early Study Termination|1|||
145900247|NCT04555720|526140872|FG000|Overall Study|Lost to Follow-up|2|||
145900248|NCT04555720|526140873|FG001|Overall Study|Lost to Follow-up|0|||
145900249|NCT04555720|526140874|FG002|Overall Study|Lost to Follow-up|0|||
145900250|NCT04555720|526140875|FG003|Overall Study|Lost to Follow-up|0|||
145900251|NCT04555720|526140872|FG000|Overall Study|Withdrawal by Subject|4|||
145900252|NCT04555720|526140873|FG001|Overall Study|Withdrawal by Subject|6|||
145900253|NCT04555720|526140874|FG002|Overall Study|Withdrawal by Subject|0|||
145900254|NCT04555720|526140875|FG003|Overall Study|Withdrawal by Subject|0|||
145900255|NCT00719849|526140876|FG000|Overall Study|Death|0|||
145900256|NCT00719849|526140877|FG001|Overall Study|Death|1|||
145900257|NCT02201290|526140879|FG000|Overall Study|Withdrawal by Subject|2|||
145900258|NCT02201290|526140879|FG000|Overall Study|Lack of Efficacy|2|||
145900259|NCT02201290|526140879|FG000|Overall Study|Adverse Event|1|||
145900260|NCT03907462|526140880|FG000|Overall Study|Physician Decision|1|||
145900261|NCT03907462|526140881|FG001|Overall Study|Physician Decision|3|||
145900262|NCT03907462|526140882|FG002|Overall Study|Physician Decision|1|||
145900263|NCT03907462|526140880|FG000|Overall Study|Withdrawal by Subject|6|||
145900264|NCT03907462|526140881|FG001|Overall Study|Withdrawal by Subject|3|||
146297313|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
146297314|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
146297315|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Death|0|||
146297316|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Death|1|||
146297317|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
146297318|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
146297319|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
145900265|NCT03907462|526140882|FG002|Overall Study|Withdrawal by Subject|3|||
145900266|NCT03907462|526140880|FG000|Overall Study|Pregnancy|4|||
145900267|NCT03907462|526140881|FG001|Overall Study|Pregnancy|2|||
145900268|NCT03907462|526140882|FG002|Overall Study|Pregnancy|6|||
145900269|NCT03907462|526140880|FG000|Overall Study|Lost to Follow-up|16|||
145900270|NCT03907462|526140881|FG001|Overall Study|Lost to Follow-up|18|||
145900271|NCT03907462|526140882|FG002|Overall Study|Lost to Follow-up|22|||
145900272|NCT02370329|526143127|FG000|Overall Study|Alternate treatment|1|||
145900273|NCT02370329|526143127|FG000|Overall Study|Adverse Event|1|||
145900274|NCT02370329|526143127|FG000|Overall Study|Disease progression|3|||
145900275|NCT02370329|526143127|FG000|Overall Study|Physician Decision|2|||
145900276|NCT02370329|526143127|FG000|Overall Study|Study closure|4|||
145900277|NCT03786718|526143139|FG000|Overall Study|Lost to Follow-up|3|||
145900278|NCT03786718|526143139|FG000|Overall Study|Withdrawal by Subject|1|||
145900279|NCT03786718|526143139|FG000|Overall Study|Did not use the intervention|2|||
145900280|NCT03786718|526143139|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
145900281|NCT00699283|526143149|FG000|Overall Study|Lack of Efficacy|15|||
145900282|NCT00699283|526143150|FG001|Overall Study|Lack of Efficacy|5|||
145900283|NCT00699283|526143149|FG000|Overall Study|Lost to Follow-up|2|||
145900284|NCT00699283|526143150|FG001|Overall Study|Lost to Follow-up|0|||
145900285|NCT00699283|526143149|FG000|Overall Study|Withdrawal by Subject|1|||
146238613|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
146238614|NCT01767467|527386806|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
145900286|NCT00699283|526143150|FG001|Overall Study|Withdrawal by Subject|0|||
146238615|NCT01767467|527386807|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
146238616|NCT01359150|527386808|FG000|Overall Study|Lack of Efficacy|1|||
146238617|NCT01359150|527386809|FG001|Overall Study|Lack of Efficacy|1|||
146297320|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
145900287|NCT00699283|526143149|FG000|Overall Study|Other Reason|5|||
145900288|NCT00699283|526143150|FG001|Overall Study|Other Reason|1|||
145900289|NCT00699283|526143149|FG000|Overall Study|SAE, non-fatal|1|||
145900290|NCT00699283|526143150|FG001|Overall Study|SAE, non-fatal|1|||
145900291|NCT00699283|526143149|FG000|Overall Study|AE, non-serious non-fatal|8|||
145900292|NCT00699283|526143150|FG001|Overall Study|AE, non-serious non-fatal|1|||
145900293|NCT00699283|526143149|FG000|Overall Study|AE of unknown type|1|||
145900294|NCT00699283|526143150|FG001|Overall Study|AE of unknown type|0|||
145900295|NCT01398514|526143151|FG000|Overall Study|Adverse Event|1|||
145900296|NCT01398514|526143152|FG001|Overall Study|Adverse Event|0|||
145900297|NCT01398514|526143151|FG000|Overall Study|Non-compliance with study procedures|2|||
145900298|NCT01398514|526143152|FG001|Overall Study|Non-compliance with study procedures|0|||
145900299|NCT01398514|526143151|FG000|Overall Study|Physiologic non-responsiveness|1|||
145900300|NCT01398514|526143152|FG001|Overall Study|Physiologic non-responsiveness|3|||
145900301|NCT01398514|526143151|FG000|Overall Study|Failure to show a conditioned response|4|||
145900302|NCT01398514|526143152|FG001|Overall Study|Failure to show a conditioned response|3|||
145900303|NCT01570686|526143156|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145900304|NCT01570686|526143157|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145900305|NCT01570686|526143156|FG000|Overall Study|Administrative problems|0|||
145900306|NCT01570686|526143157|FG001|Overall Study|Administrative problems|1|||
145900307|NCT01570686|526143156|FG000|Overall Study|Adverse Event|8|||
145900308|NCT01570686|526143157|FG001|Overall Study|Adverse Event|6|||
145900309|NCT01570686|526143156|FG000|Overall Study|Lost to Follow-up|4|||
145900310|NCT01570686|526143157|FG001|Overall Study|Lost to Follow-up|3|||
145900311|NCT01570686|526143156|FG000|Overall Study|Protocol Deviation|3|||
145900312|NCT01570686|526143157|FG001|Overall Study|Protocol Deviation|0|||
145900313|NCT01570686|526143156|FG000|Overall Study|Withdrawal by Subject|4|||
145900314|NCT01570686|526143157|FG001|Overall Study|Withdrawal by Subject|4|||
145900315|NCT01570686|526143156|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145900316|NCT01570686|526143157|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145900317|NCT00754650|526143158|FG000|Overall Study|Disease Progression|2|||
145900318|NCT00805675|526143159|FG000|Overall Study|Adverse Event|0|||
145900319|NCT00805675|526143160|FG001|Overall Study|Adverse Event|0|||
145900320|NCT00805675|526143161|FG002|Overall Study|Adverse Event|1|||
145900321|NCT02771795|526143162|FG000|Overall Study|Withdrawal by Subject|47|||
145900322|NCT02771795|526143163|FG001|Overall Study|Withdrawal by Subject|37|||
145900323|NCT02771795|526143162|FG000|Overall Study|Termination by premature discontinuation of study|168|||
145900324|NCT02771795|526143163|FG001|Overall Study|Termination by premature discontinuation of study|185|||
145900325|NCT02906930|526143167|FG000|Overall Study|Withdrawal by Subject|0|||
145900326|NCT02906930|526143168|FG001|Overall Study|Withdrawal by Subject|5|||
145900327|NCT02906930|526143169|FG002|Overall Study|Withdrawal by Subject|5|||
145900328|NCT02906930|526143170|FG003|Overall Study|Withdrawal by Subject|4|||
145900329|NCT02906930|526143167|FG000|Overall Study|Lost to Follow-up|5|||
145900330|NCT02906930|526143168|FG001|Overall Study|Lost to Follow-up|7|||
145900331|NCT02906930|526143169|FG002|Overall Study|Lost to Follow-up|5|||
145900332|NCT02906930|526143170|FG003|Overall Study|Lost to Follow-up|2|||
145900333|NCT02906930|526143167|FG000|Overall Study|Death|0|||
145900334|NCT02906930|526143168|FG001|Overall Study|Death|0|||
145900335|NCT02906930|526143169|FG002|Overall Study|Death|1|||
145900336|NCT02906930|526143170|FG003|Overall Study|Death|0|||
145900337|NCT02906930|526143167|FG000|Overall Study|Other|1|||
145900338|NCT02906930|526143168|FG001|Overall Study|Other|2|||
145900339|NCT02906930|526143169|FG002|Overall Study|Other|1|||
145972472|NCT01799889|526412649|FG007|Overall Study|Progressive Disease|13|||
145972473|NCT01799889|526412650|FG008|Overall Study|Progressive Disease|18|||
145972474|NCT01799889|526412651|FG009|Overall Study|Progressive Disease|5|||
145972475|NCT01799889|526412652|FG010|Overall Study|Progressive Disease|3|||
145972476|NCT01799889|526412653|FG011|Overall Study|Progressive Disease|1|||
145900340|NCT02906930|526143170|FG003|Overall Study|Other|2|||
145900341|NCT00910091|526143173|FG000|Pre-assignment|Withdrawal by Subject|0|||
145900342|NCT00910091|526143174|FG001|Pre-assignment|Withdrawal by Subject|2|||
145900343|NCT00910091|526143173|FG000|Treatment and Survival|Withdrawal by Subject|3|||
145900344|NCT00910091|526143174|FG001|Treatment and Survival|Withdrawal by Subject|4|||
145900345|NCT00910091|526143173|FG000|Treatment and Survival|Adverse Event|1|||
145900346|NCT00910091|526143174|FG001|Treatment and Survival|Adverse Event|0|||
145900347|NCT00622466|526143175|FG000|Overall Study|Death|1|||
145900348|NCT00622466|526143175|FG000|Overall Study|Adverse Event|1|||
145900349|NCT00622466|526143175|FG000|Overall Study|Withdrawal by Subject|2|||
145972477|NCT01799889|526412642|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
145900350|NCT01908816|526143176|FG000|Overall Study|Subject's no longer requires study drug|0|||
145900351|NCT01908816|526143177|FG001|Overall Study|Subject's no longer requires study drug|0|||
145900352|NCT01908816|526143178|FG002|Overall Study|Subject's no longer requires study drug|0|||
145900353|NCT01908816|526143179|FG003|Overall Study|Subject's no longer requires study drug|1|||
145900354|NCT01908816|526143176|FG000|Overall Study|Protocol deviation|1|||
145900355|NCT01908816|526143177|FG001|Overall Study|Protocol deviation|2|||
145900356|NCT01908816|526143178|FG002|Overall Study|Protocol deviation|1|||
145900357|NCT01908816|526143179|FG003|Overall Study|Protocol deviation|1|||
145900358|NCT01908816|526143176|FG000|Overall Study|Withdrawal by Subject|0|||
145900359|NCT01908816|526143177|FG001|Overall Study|Withdrawal by Subject|4|||
145900360|NCT01908816|526143178|FG002|Overall Study|Withdrawal by Subject|2|||
145972478|NCT01799889|526412643|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
145900361|NCT01908816|526143179|FG003|Overall Study|Withdrawal by Subject|2|||
145900362|NCT01908816|526143176|FG000|Overall Study|Lost to Follow-up|3|||
145900363|NCT01908816|526143177|FG001|Overall Study|Lost to Follow-up|5|||
145900364|NCT01908816|526143178|FG002|Overall Study|Lost to Follow-up|4|||
145900365|NCT01908816|526143179|FG003|Overall Study|Lost to Follow-up|2|||
145972479|NCT01799889|526412644|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
145972480|NCT01799889|526412645|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
145972481|NCT01799889|526412646|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
145972482|NCT01799889|526412647|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
145972483|NCT01799889|526412648|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
145972484|NCT01799889|526412649|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
145972485|NCT01799889|526412650|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
145972486|NCT01799889|526412651|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
145972487|NCT01799889|526412652|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
145972488|NCT01799889|526412653|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
145972489|NCT01799889|526412642|FG000|Overall Study|Study Terminated By Sponsor|1|||
145972490|NCT01799889|526412643|FG001|Overall Study|Study Terminated By Sponsor|0|||
146238618|NCT01359150|527386808|FG000|Overall Study|Withdrawal by Subject|1|||
146238619|NCT01359150|527386809|FG001|Overall Study|Withdrawal by Subject|1|||
146238620|NCT01359150|527386808|FG000|Overall Study|Adverse Event|4|||
146238621|NCT01359150|527386809|FG001|Overall Study|Adverse Event|3|||
146238622|NCT01359150|527386808|FG000|Overall Study|Other|1|||
146238623|NCT01359150|527386809|FG001|Overall Study|Other|0|||
146238624|NCT01787032|527386812|FG000|Overall Study|Protocol Violation|0|||
146238625|NCT01787032|527386813|FG001|Overall Study|Protocol Violation|0|||
146238626|NCT01787032|527386814|FG002|Overall Study|Protocol Violation|0|||
146238627|NCT01787032|527386815|FG003|Overall Study|Protocol Violation|0|||
146238628|NCT01787032|527386816|FG004|Overall Study|Protocol Violation|1|||
146238629|NCT01787032|527386817|FG005|Overall Study|Protocol Violation|1|||
145900366|NCT01908816|526143176|FG000|Overall Study|Death|1|||
145900367|NCT01908816|526143177|FG001|Overall Study|Death|0|||
145900368|NCT01908816|526143178|FG002|Overall Study|Death|7|||
145900369|NCT01908816|526143179|FG003|Overall Study|Death|1|||
145900370|NCT01908816|526143176|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145900371|NCT01908816|526143177|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145900372|NCT01908816|526143178|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
145900373|NCT01908816|526143179|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145900374|NCT01908816|526143176|FG000|Overall Study|Early termination|87|||
145900375|NCT01908816|526143177|FG001|Overall Study|Early termination|60|||
145900376|NCT01908816|526143178|FG002|Overall Study|Early termination|43|||
145900377|NCT01908816|526143179|FG003|Overall Study|Early termination|28|||
145900378|NCT01007942|526143180|FG000|Overall Study|Adverse Event|29|||
145900379|NCT01007942|526143181|FG001|Overall Study|Adverse Event|14|||
145900380|NCT01007942|526143180|FG000|Overall Study|Abnormal test procedure|0|||
145900381|NCT01007942|526143181|FG001|Overall Study|Abnormal test procedure|1|||
145900382|NCT01007942|526143180|FG000|Overall Study|Disease progression|217|||
145900383|NCT01007942|526143181|FG001|Overall Study|Disease progression|242|||
145900384|NCT01007942|526143180|FG000|Overall Study|New cancer therapy|5|||
145900385|NCT01007942|526143181|FG001|Overall Study|New cancer therapy|1|||
145900386|NCT01007942|526143180|FG000|Overall Study|Protocol Violation|1|||
145900387|NCT01007942|526143181|FG001|Overall Study|Protocol Violation|1|||
145900388|NCT01007942|526143180|FG000|Overall Study|Withdrawal by Subject|19|||
145900389|NCT01007942|526143181|FG001|Overall Study|Withdrawal by Subject|14|||
145900390|NCT01007942|526143180|FG000|Overall Study|Lost to Follow-up|1|||
145900391|NCT01007942|526143181|FG001|Overall Study|Lost to Follow-up|0|||
145900392|NCT01007942|526143180|FG000|Overall Study|Administrative problems|2|||
145900393|NCT01007942|526143181|FG001|Overall Study|Administrative problems|0|||
145900394|NCT01007942|526143180|FG000|Overall Study|Death|3|||
145900395|NCT01007942|526143181|FG001|Overall Study|Death|2|||
145900396|NCT01007942|526143180|FG000|Overall Study|Patients untreated|4|||
145900397|NCT01007942|526143181|FG001|Overall Study|Patients untreated|3|||
145900398|NCT03929757|526143182|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
145900399|NCT03929757|526143183|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
145900400|NCT03929757|526143184|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
145900401|NCT03929757|526143182|FG000|Main Study: Up to Day 365|Other|1|||
145972491|NCT01799889|526412644|FG002|Overall Study|Study Terminated By Sponsor|0|||
146238630|NCT02040870|527386818|FG000|Overall Study|Completed treatment phase|6|||
146238631|NCT02040870|527386818|FG000|Overall Study|Adverse Event|7|||
146238632|NCT02040870|527386818|FG000|Overall Study|Progressive disease|58|||
146238633|NCT02040870|527386818|FG000|Overall Study|Physician Decision|6|||
145900402|NCT03929757|526143183|FG001|Main Study: Up to Day 365|Other|0|||
146238634|NCT02040870|527386818|FG000|Overall Study|Subject/guardian decision|10|||
146238635|NCT02040870|527386818|FG000|Overall Study|Lost to Follow-up|3|||
146238636|NCT02040870|527386818|FG000|Overall Study|Death|13|||
146238637|NCT00853593|527386822|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
145900403|NCT03929757|526143184|FG002|Main Study: Up to Day 365|Other|0|||
145900404|NCT03929757|526143182|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
145900405|NCT03929757|526143183|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
145900406|NCT03929757|526143184|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
145900407|NCT00114166|526143185|FG000|Overall Study|Wrong primary|0|||
145900408|NCT00114166|526143186|FG001|Overall Study|Wrong primary|1|||
145900409|NCT01154816|526143187|FG000|Overall Study|Withdrawal by Subject|1|||
145900410|NCT01154816|526143188|FG001|Overall Study|Withdrawal by Subject|0|||
145900411|NCT01154816|526143189|FG002|Overall Study|Withdrawal by Subject|0|||
145900412|NCT01154816|526143190|FG003|Overall Study|Withdrawal by Subject|1|||
145900413|NCT01154816|526143191|FG004|Overall Study|Withdrawal by Subject|0|||
145900414|NCT01154816|526143192|FG005|Overall Study|Withdrawal by Subject|0|||
145900415|NCT01154816|526143193|FG006|Overall Study|Withdrawal by Subject|0|||
145900416|NCT01154816|526143194|FG007|Overall Study|Withdrawal by Subject|0|||
145900417|NCT01154816|526143195|FG008|Overall Study|Withdrawal by Subject|1|||
145900418|NCT01154816|526143196|FG009|Overall Study|Withdrawal by Subject|3|||
145900419|NCT01154816|526143197|FG010|Overall Study|Withdrawal by Subject|0|||
145900420|NCT01154816|526143198|FG011|Overall Study|Withdrawal by Subject|0|||
145972492|NCT01799889|526412645|FG003|Overall Study|Study Terminated By Sponsor|0|||
146238638|NCT00853593|527386822|FG000|Overall Study|Model 4396 lead not attempted|29|||
146238639|NCT00853593|527386822|FG000|Overall Study|Implant not attempted|4|||
145900421|NCT01154816|526143187|FG000|Overall Study|Progressive Disease|13|||
145900422|NCT01154816|526143188|FG001|Overall Study|Progressive Disease|8|||
145900423|NCT01154816|526143189|FG002|Overall Study|Progressive Disease|9|||
145900424|NCT01154816|526143190|FG003|Overall Study|Progressive Disease|9|||
145900425|NCT01154816|526143191|FG004|Overall Study|Progressive Disease|8|||
145900426|NCT01154816|526143192|FG005|Overall Study|Progressive Disease|8|||
145900427|NCT01154816|526143193|FG006|Overall Study|Progressive Disease|5|||
145900428|NCT01154816|526143194|FG007|Overall Study|Progressive Disease|6|||
145900429|NCT01154816|526143195|FG008|Overall Study|Progressive Disease|8|||
145900430|NCT01154816|526143196|FG009|Overall Study|Progressive Disease|6|||
145900431|NCT01154816|526143197|FG010|Overall Study|Progressive Disease|10|||
145900432|NCT01154816|526143198|FG011|Overall Study|Progressive Disease|3|||
145900433|NCT01154816|526143187|FG000|Overall Study|Physician Decision|1|||
145900434|NCT01154816|526143188|FG001|Overall Study|Physician Decision|0|||
145900435|NCT01154816|526143189|FG002|Overall Study|Physician Decision|1|||
145900436|NCT01154816|526143190|FG003|Overall Study|Physician Decision|0|||
145900437|NCT01154816|526143191|FG004|Overall Study|Physician Decision|2|||
145900438|NCT01154816|526143192|FG005|Overall Study|Physician Decision|0|||
145900439|NCT01154816|526143193|FG006|Overall Study|Physician Decision|0|||
145900440|NCT01154816|526143194|FG007|Overall Study|Physician Decision|0|||
145900441|NCT01154816|526143195|FG008|Overall Study|Physician Decision|0|||
145900442|NCT01154816|526143196|FG009|Overall Study|Physician Decision|1|||
145900443|NCT01154816|526143197|FG010|Overall Study|Physician Decision|1|||
145900444|NCT01154816|526143198|FG011|Overall Study|Physician Decision|1|||
145900445|NCT01154816|526143187|FG000|Overall Study|Adverse Event|5|||
145900446|NCT01154816|526143188|FG001|Overall Study|Adverse Event|2|||
145900447|NCT01154816|526143189|FG002|Overall Study|Adverse Event|0|||
145900448|NCT01154816|526143190|FG003|Overall Study|Adverse Event|0|||
145900449|NCT01154816|526143191|FG004|Overall Study|Adverse Event|0|||
145900450|NCT01154816|526143192|FG005|Overall Study|Adverse Event|0|||
145900451|NCT01154816|526143193|FG006|Overall Study|Adverse Event|1|||
145900452|NCT01154816|526143194|FG007|Overall Study|Adverse Event|1|||
145900453|NCT01154816|526143195|FG008|Overall Study|Adverse Event|0|||
145900454|NCT01154816|526143196|FG009|Overall Study|Adverse Event|0|||
145900455|NCT01154816|526143197|FG010|Overall Study|Adverse Event|0|||
145900456|NCT01154816|526143198|FG011|Overall Study|Adverse Event|0|||
145900457|NCT04715932|526143199|FG000|Overall Study|Lost to Follow-up|1|||
145900458|NCT04715932|526143200|FG001|Overall Study|Lost to Follow-up|0|||
145900459|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900460|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145900461|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900462|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900463|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900464|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145900465|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145900466|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900467|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145972493|NCT01799889|526412646|FG004|Overall Study|Study Terminated By Sponsor|2|||
145972494|NCT01799889|526412647|FG005|Overall Study|Study Terminated By Sponsor|1|||
145972495|NCT01799889|526412648|FG006|Overall Study|Study Terminated By Sponsor|0|||
145972496|NCT01799889|526412649|FG007|Overall Study|Study Terminated By Sponsor|2|||
145900468|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900469|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900470|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900471|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900472|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900473|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900474|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900475|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900476|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900477|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145972497|NCT01799889|526412650|FG008|Overall Study|Study Terminated By Sponsor|1|||
145972498|NCT01799889|526412651|FG009|Overall Study|Study Terminated By Sponsor|1|||
145972499|NCT01799889|526412652|FG010|Overall Study|Study Terminated By Sponsor|0|||
145972500|NCT01799889|526412653|FG011|Overall Study|Study Terminated By Sponsor|0|||
145972501|NCT01799889|526412642|FG000|Overall Study|Withdrawal by Subject|1|||
145972502|NCT01799889|526412643|FG001|Overall Study|Withdrawal by Subject|6|||
145972503|NCT01799889|526412644|FG002|Overall Study|Withdrawal by Subject|4|||
145972504|NCT01799889|526412645|FG003|Overall Study|Withdrawal by Subject|0|||
145972505|NCT01799889|526412646|FG004|Overall Study|Withdrawal by Subject|5|||
145972506|NCT01799889|526412647|FG005|Overall Study|Withdrawal by Subject|1|||
145972507|NCT01799889|526412648|FG006|Overall Study|Withdrawal by Subject|3|||
146238640|NCT03890289|527386823|FG000|Overall Study|Adverse Event|1|||
146238641|NCT03890289|527386823|FG000|Overall Study|Physician Decision|1|||
146238642|NCT03890289|527386823|FG000|Overall Study|Lack of Efficacy|2|||
146238643|NCT02816398|527386824|FG000|Overall Study|Death|5|||
146238644|NCT02816398|527386824|FG000|Overall Study|Lack of Efficacy|8|||
146238645|NCT02816398|527386824|FG000|Overall Study|Lost to Follow-up|1|||
146238646|NCT03362190|527386825|FG000|Overall Study|Adverse Event|0|||
146238647|NCT03362190|527386826|FG001|Overall Study|Adverse Event|0|||
146238648|NCT03362190|527386827|FG002|Overall Study|Adverse Event|0|||
146238649|NCT03362190|527386828|FG003|Overall Study|Adverse Event|1|||
146238650|NCT03362190|527386825|FG000|Overall Study|Withdrawal by Subject|0|||
146238651|NCT03362190|527386826|FG001|Overall Study|Withdrawal by Subject|0|||
146238652|NCT03362190|527386827|FG002|Overall Study|Withdrawal by Subject|0|||
146238653|NCT03362190|527386828|FG003|Overall Study|Withdrawal by Subject|1|||
146238654|NCT00687219|527386829|FG000|Overall Study|Adverse Event|8|||
146238655|NCT00687219|527386829|FG000|Overall Study|Discontinuance criteria met|7|||
146238656|NCT00687219|527386829|FG000|Overall Study|HCV-RNA positive conversion|34|||
146238657|NCT00687219|527386829|FG000|Overall Study|Withdrawal by Subject|1|||
145900478|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900479|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900480|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900481|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900482|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900483|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145900484|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900485|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
145900486|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900487|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900488|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900489|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900490|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900491|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900492|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900493|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900494|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900495|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900496|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900497|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900498|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900499|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900500|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900501|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900502|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900503|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900504|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900505|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900506|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900507|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900508|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145900509|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
145972508|NCT01799889|526412649|FG007|Overall Study|Withdrawal by Subject|1|||
145972509|NCT01799889|526412650|FG008|Overall Study|Withdrawal by Subject|2|||
145972510|NCT01799889|526412651|FG009|Overall Study|Withdrawal by Subject|1|||
145972511|NCT01799889|526412652|FG010|Overall Study|Withdrawal by Subject|1|||
145900510|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
146238658|NCT00687219|527386829|FG000|Overall Study|Lack of Efficacy|1|||
146238659|NCT01367236|527386837|FG000|Overall Study|Withdrawal by Subject|3|||
146238660|NCT01367236|527386838|FG001|Overall Study|Withdrawal by Subject|1|||
146238661|NCT02235298|527386839|FG000|Overall Study|Lost to Follow-up|6|||
146238662|NCT02235298|527386840|FG001|Overall Study|Lost to Follow-up|5|||
146238663|NCT02235298|527386839|FG000|Overall Study|Adverse Event|2|||
145900511|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
145900512|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
145900513|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
145900514|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
145900515|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
145900516|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
145900517|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
145900518|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
145900519|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
145900520|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
145900521|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
145900522|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
145900523|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
145900524|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
145900525|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
145900526|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
145900527|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
145900528|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
145900529|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
145900530|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
145900531|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
145900532|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
145900533|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
145900534|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
145900535|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900536|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900537|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900538|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900539|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900540|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900541|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900542|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900543|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900544|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900545|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900546|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900547|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900548|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900549|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900550|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900551|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900552|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900553|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900554|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900555|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
146238664|NCT02235298|527386840|FG001|Overall Study|Adverse Event|2|||
146238665|NCT02235298|527386839|FG000|Overall Study|Withdrawal by Subject|0|||
146238666|NCT02235298|527386840|FG001|Overall Study|Withdrawal by Subject|1|||
146238667|NCT04038580|527386853|FG000|Washout 1|Death|0|||
146238668|NCT04038580|527386854|FG001|Washout 1|Death|0|||
146238669|NCT04038580|527386855|FG002|Washout 1|Death|0|||
146238670|NCT04038580|527386856|FG003|Washout 1|Death|1|||
146238671|NCT04038580|527386857|FG004|Washout 1|Death|0|||
146238672|NCT04038580|527386858|FG005|Washout 1|Death|0|||
146238673|NCT04038580|527386853|FG000|Washout 1|Withdrawal by Subject|0|||
146238674|NCT04038580|527386854|FG001|Washout 1|Withdrawal by Subject|0|||
146238675|NCT04038580|527386855|FG002|Washout 1|Withdrawal by Subject|0|||
145900556|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900557|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900558|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145900559|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900560|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
146238676|NCT04038580|527386856|FG003|Washout 1|Withdrawal by Subject|0|||
146238677|NCT04038580|527386857|FG004|Washout 1|Withdrawal by Subject|1|||
145900561|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900562|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900563|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145972512|NCT01799889|526412653|FG011|Overall Study|Withdrawal by Subject|1|||
145972513|NCT01799889|526412642|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146238678|NCT04038580|527386858|FG005|Washout 1|Withdrawal by Subject|0|||
146238679|NCT04038580|527386853|FG000|Wash-out 2|Withdrawal by Subject|1|||
146238680|NCT04038580|527386854|FG001|Wash-out 2|Withdrawal by Subject|0|||
145900564|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
145900565|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
145900566|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900567|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900568|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
145900569|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900570|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900571|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900572|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900573|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900574|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900575|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900576|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900577|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900578|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900579|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900580|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900581|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900582|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900583|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145900584|NCT02393248|526143201|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900585|NCT02393248|526143202|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900586|NCT02393248|526143203|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900587|NCT02393248|526143204|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900588|NCT02393248|526143205|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900589|NCT02393248|526143206|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900590|NCT02393248|526143207|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
145900591|NCT02393248|526143208|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900592|NCT02393248|526143209|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
146297321|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
145900593|NCT02393248|526143210|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900594|NCT02393248|526143211|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900595|NCT02393248|526143212|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900596|NCT02393248|526143213|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900597|NCT02393248|526143214|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900598|NCT02393248|526143215|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900599|NCT02393248|526143216|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900600|NCT02393248|526143217|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900601|NCT02393248|526143218|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900602|NCT02393248|526143219|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900603|NCT02393248|526143220|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900604|NCT02393248|526143221|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900605|NCT02393248|526143222|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900606|NCT02393248|526143223|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900607|NCT02393248|526143224|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900608|NCT02393248|526143225|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145900609|NCT02393248|526143201|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900610|NCT02393248|526143202|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900611|NCT02393248|526143203|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900612|NCT02393248|526143204|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900613|NCT02393248|526143205|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900614|NCT02393248|526143206|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900615|NCT02393248|526143207|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900616|NCT02393248|526143208|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900617|NCT02393248|526143209|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900618|NCT02393248|526143210|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
146297322|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
146297323|NCT00323297|527604666|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
146088312|NCT00095238|526843799|FG001|Overall Study|Other Reasons|88|||
145900619|NCT02393248|526143211|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900620|NCT02393248|526143212|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
145900621|NCT02393248|526143213|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
145900622|NCT02393248|526143214|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
145900623|NCT02393248|526143215|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
145900624|NCT02393248|526143216|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
146297324|NCT00323297|527604667|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
146297325|NCT00323297|527604666|FG000|Part B (Open-label)|Death|0|||
146297326|NCT00323297|527604667|FG001|Part B (Open-label)|Death|1|||
146297327|NCT00323297|527604666|FG000|Part B (Open-label)|Reason unspecified|0|||
146297328|NCT00323297|527604667|FG001|Part B (Open-label)|Reason unspecified|1|||
146297329|NCT00323297|527604666|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
146297330|NCT00323297|527604667|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
146297331|NCT00323297|527604666|FG000|Part B (Open-label)|Lack of Efficacy|3|||
146297332|NCT00323297|527604667|FG001|Part B (Open-label)|Lack of Efficacy|1|||
146297333|NCT00323297|527604666|FG000|Part B (Open-label)|Adverse Event|5|||
146297334|NCT00323297|527604667|FG001|Part B (Open-label)|Adverse Event|5|||
145900625|NCT02393248|526143217|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900626|NCT02393248|526143218|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900627|NCT02393248|526143219|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900628|NCT02393248|526143220|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900629|NCT02393248|526143221|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900630|NCT02393248|526143222|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900631|NCT02393248|526143223|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900632|NCT02393248|526143224|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900633|NCT02393248|526143225|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145900634|NCT02393248|526143201|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900635|NCT02393248|526143202|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900636|NCT02393248|526143203|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900637|NCT02393248|526143204|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900638|NCT02393248|526143205|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900639|NCT02393248|526143206|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900640|NCT02393248|526143207|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900641|NCT02393248|526143208|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900642|NCT02393248|526143209|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900643|NCT02393248|526143210|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900644|NCT02393248|526143211|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
145900645|NCT02393248|526143212|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
145900646|NCT02393248|526143213|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900647|NCT02393248|526143214|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900648|NCT02393248|526143215|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900649|NCT02393248|526143216|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900650|NCT02393248|526143217|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900651|NCT02393248|526143218|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900652|NCT02393248|526143219|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900653|NCT02393248|526143220|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900654|NCT02393248|526143221|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
146238681|NCT04038580|527386855|FG002|Wash-out 2|Withdrawal by Subject|0|||
146238682|NCT04038580|527386856|FG003|Wash-out 2|Withdrawal by Subject|2|||
146238683|NCT04038580|527386857|FG004|Wash-out 2|Withdrawal by Subject|0|||
146238684|NCT04038580|527386858|FG005|Wash-out 2|Withdrawal by Subject|1|||
146238685|NCT04038580|527386853|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
146238686|NCT04038580|527386854|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
146238687|NCT04038580|527386855|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
146238688|NCT04038580|527386856|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
146238689|NCT04038580|527386857|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
146238690|NCT04038580|527386858|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
145900655|NCT02393248|526143222|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900656|NCT02393248|526143223|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900657|NCT02393248|526143224|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
146297335|NCT00323297|527604666|FG000|Part B (Open-label)|Protocol Violation|0|||
146297336|NCT00323297|527604667|FG001|Part B (Open-label)|Protocol Violation|1|||
146297337|NCT01603082|527604669|FG000|Overall Study|Adverse Event|0|||
145900658|NCT02393248|526143225|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145900659|NCT02393248|526143201|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
146238691|NCT04038580|527386853|FG000|Wash-out 3|Withdrawal by Subject|1|||
146238692|NCT04038580|527386854|FG001|Wash-out 3|Withdrawal by Subject|0|||
146238693|NCT04038580|527386855|FG002|Wash-out 3|Withdrawal by Subject|2|||
146297338|NCT01603082|527604670|FG001|Overall Study|Adverse Event|1|||
146297339|NCT01603082|527604669|FG000|Overall Study|Withdrawal by Subject|1|||
146088313|NCT03505671|526843800|FG000|Overall Study|Withdrawal by Subject|2|||
146238694|NCT04038580|527386856|FG003|Wash-out 3|Withdrawal by Subject|0|||
146238695|NCT04038580|527386857|FG004|Wash-out 3|Withdrawal by Subject|0|||
146238696|NCT04038580|527386858|FG005|Wash-out 3|Withdrawal by Subject|0|||
146238697|NCT00093496|527388004|FG000|Overall Study|Protocol Violation|1|||
146238698|NCT00093496|527388005|FG001|Overall Study|Protocol Violation|3|||
145900660|NCT02393248|526143202|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
145900661|NCT02393248|526143203|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
145900662|NCT02393248|526143204|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
145900663|NCT02393248|526143205|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
145900664|NCT02393248|526143206|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
145900665|NCT02393248|526143207|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
145900666|NCT02393248|526143208|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
145900667|NCT02393248|526143209|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
145900668|NCT02393248|526143210|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
145900669|NCT02393248|526143211|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
145900670|NCT02393248|526143212|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
145900671|NCT02393248|526143213|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
145900672|NCT02393248|526143214|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
145900673|NCT02393248|526143215|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
145900674|NCT02393248|526143216|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
145900675|NCT02393248|526143217|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
145900676|NCT02393248|526143218|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
145900677|NCT02393248|526143219|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
145900678|NCT02393248|526143220|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
145900679|NCT02393248|526143221|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
145900680|NCT02393248|526143222|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
145900681|NCT02393248|526143223|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
145900682|NCT02393248|526143224|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
145900683|NCT02393248|526143225|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
145900684|NCT02393248|526143201|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900685|NCT02393248|526143202|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900686|NCT02393248|526143203|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900687|NCT02393248|526143204|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900688|NCT02393248|526143205|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900689|NCT02393248|526143206|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900690|NCT02393248|526143207|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900691|NCT02393248|526143208|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900692|NCT02393248|526143209|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900693|NCT02393248|526143210|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900694|NCT02393248|526143211|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900695|NCT02393248|526143212|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
145900696|NCT02393248|526143213|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900697|NCT02393248|526143214|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
145900698|NCT02393248|526143215|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900699|NCT02393248|526143216|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900700|NCT02393248|526143217|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900701|NCT02393248|526143218|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900702|NCT02393248|526143219|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900703|NCT02393248|526143220|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900704|NCT02393248|526143221|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900705|NCT02393248|526143222|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900706|NCT02393248|526143223|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900707|NCT02393248|526143224|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900708|NCT02393248|526143225|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145900709|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900710|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900711|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900712|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900713|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900714|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900715|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900716|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900717|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900718|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
146088314|NCT03505671|526843801|FG001|Overall Study|Withdrawal by Subject|1|||
146088315|NCT03505671|526843800|FG000|Overall Study|Lost to Follow-up|1|||
146238699|NCT01932970|527388006|FG000|Overall Study|Withdrawal by Subject|5|||
146238700|NCT01932970|527388006|FG000|Overall Study|Death|1|||
146238701|NCT01932970|527388006|FG000|Overall Study|Lost to Follow-up|2|||
146088316|NCT03505671|526843801|FG001|Overall Study|Lost to Follow-up|0|||
146088317|NCT03410823|526843804|FG000|Overall Study|Death|1|||
146088318|NCT03410823|526843804|FG000|Overall Study|Withdrawal by Subject|2|||
146238702|NCT01932970|527388006|FG000|Overall Study|Protocol Specified Criteria|10|||
146238703|NCT00853580|527388007|FG000|Overall Study|Lost to Follow-up|3|||
146238704|NCT00853580|527388008|FG001|Overall Study|Lost to Follow-up|5|||
146238705|NCT00853580|527388007|FG000|Overall Study|Protocol Violation|2|||
146238706|NCT00853580|527388008|FG001|Overall Study|Protocol Violation|1|||
145900719|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900720|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900721|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900722|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900723|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900724|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900725|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900726|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900727|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145900728|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900729|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
145900730|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145900731|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900732|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145900733|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145900734|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Death|0|||
145900735|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Death|0|||
145900736|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Death|0|||
145900737|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Death|0|||
145900738|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Death|0|||
145900739|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Death|0|||
145900740|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Death|0|||
145900741|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Death|0|||
145900742|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Death|0|||
145900743|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Death|0|||
145900744|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Death|0|||
145900745|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Death|0|||
145900746|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Death|0|||
145900747|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Death|0|||
145900748|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Death|0|||
145900749|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Death|1|||
145900750|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Death|7|||
145900751|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Death|5|||
145900752|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Death|5|||
145900753|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Death|3|||
145900754|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Death|7|||
145900755|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Death|5|||
145900756|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Death|6|||
146088319|NCT03410823|526843804|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
146088320|NCT06460493|526843808|FG000|Overall Study|Withdrawal by Subject|2|||
146088321|NCT03707184|526843811|FG000|Overall Study|Withdrawal by Subject|2|||
145900757|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Death|3|||
145900758|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Death|0|||
145900759|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900760|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900761|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900762|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900763|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900764|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900765|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900766|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900767|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900768|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900769|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900770|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900771|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900772|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900773|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900774|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
146088322|NCT04704154|526843812|FG000|Overall Study|Adverse Event|3|||
145900775|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145900776|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900777|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900778|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
146088323|NCT04704154|526843813|FG001|Overall Study|Adverse Event|2|||
145900779|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900780|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900781|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900782|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
145900783|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145900784|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Disease Progression|0|||
145900785|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Disease Progression|0|||
145900786|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Disease Progression|0|||
145900787|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Disease Progression|0|||
145900788|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Disease Progression|0|||
145900789|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Disease Progression|0|||
145900790|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Disease Progression|0|||
145900791|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Disease Progression|0|||
145900792|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Disease Progression|0|||
145900793|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Disease Progression|0|||
145900794|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Disease Progression|0|||
145900795|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Disease Progression|0|||
145900796|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Disease Progression|0|||
145900797|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Disease Progression|0|||
145900798|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Disease Progression|0|||
145900799|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Disease Progression|0|||
145900800|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Disease Progression|0|||
145900801|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Disease Progression|0|||
145900802|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Disease Progression|0|||
145900803|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Disease Progression|0|||
145900804|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Disease Progression|2|||
145972514|NCT01799889|526412643|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145900805|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Disease Progression|1|||
145900806|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Disease Progression|0|||
145900807|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Disease Progression|0|||
145900808|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Disease Progression|0|||
145900809|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900810|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900811|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900812|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900813|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900814|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900815|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900816|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900817|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900818|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900819|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900820|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900821|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900822|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900823|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900824|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900825|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900826|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900827|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900828|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900829|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
145900830|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
145900831|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900832|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900833|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
145900834|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900835|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900836|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900837|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900838|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900839|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900840|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145972515|NCT01799889|526412644|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145900841|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145972516|NCT01799889|526412645|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145900842|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900843|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900844|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900845|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900846|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900847|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900848|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900849|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900850|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900851|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900852|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900853|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900854|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
145900855|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900856|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900857|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900858|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145900859|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Adverse Event|0|||
145900860|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Adverse Event|0|||
145900861|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Adverse Event|0|||
145900862|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Adverse Event|0|||
145900863|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Adverse Event|0|||
145900864|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Adverse Event|0|||
145900865|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Adverse Event|0|||
145900866|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Adverse Event|0|||
145900867|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Adverse Event|0|||
145900868|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Adverse Event|0|||
145900869|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Adverse Event|0|||
145900870|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Adverse Event|0|||
145900871|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Adverse Event|0|||
145900872|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Adverse Event|0|||
145900873|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Adverse Event|0|||
145900874|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Adverse Event|0|||
145900875|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Adverse Event|0|||
145900876|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Adverse Event|0|||
145900877|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Adverse Event|0|||
145900878|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Adverse Event|0|||
145900879|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Adverse Event|0|||
145900880|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Adverse Event|0|||
145900881|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Adverse Event|0|||
145900882|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Adverse Event|1|||
145900883|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Adverse Event|0|||
145900884|NCT02393248|526143201|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900885|NCT02393248|526143202|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900886|NCT02393248|526143203|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900887|NCT02393248|526143204|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900888|NCT02393248|526143205|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900889|NCT02393248|526143206|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900890|NCT02393248|526143207|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900891|NCT02393248|526143208|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900892|NCT02393248|526143209|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900893|NCT02393248|526143210|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900894|NCT02393248|526143211|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900895|NCT02393248|526143212|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900896|NCT02393248|526143213|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900897|NCT02393248|526143214|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900898|NCT02393248|526143215|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900899|NCT02393248|526143216|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900900|NCT02393248|526143217|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
146088324|NCT04704154|526843814|FG002|Overall Study|Adverse Event|4|||
146088325|NCT04704154|526843815|FG003|Overall Study|Adverse Event|2|||
146088326|NCT04704154|526843816|FG004|Overall Study|Adverse Event|3|||
145900901|NCT02393248|526143218|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900902|NCT02393248|526143219|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900903|NCT02393248|526143220|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900904|NCT02393248|526143221|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900905|NCT02393248|526143222|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900906|NCT02393248|526143223|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900907|NCT02393248|526143224|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
145900908|NCT02393248|526143225|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145900909|NCT03560986|526143226|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
145900910|NCT03560986|526143227|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
145900911|NCT03560986|526143226|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
145900912|NCT03560986|526143227|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
145900913|NCT03560986|526143226|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
145900914|NCT03560986|526143227|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
145900915|NCT03560986|526143226|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
145900916|NCT03560986|526143227|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
145900917|NCT03560986|526143226|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
145900918|NCT03560986|526143227|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
145900919|NCT03560986|526143226|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
145900920|NCT03560986|526143227|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
145900921|NCT03560986|526143226|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
145900922|NCT03560986|526143227|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
145900923|NCT01783548|526143240|FG000|Overall Study|Adverse Event|8|||
145900924|NCT01783548|526143241|FG001|Overall Study|Adverse Event|4|||
145900925|NCT01783548|526143240|FG000|Overall Study|Withdrawal by Subject|11|||
145900926|NCT01783548|526143241|FG001|Overall Study|Withdrawal by Subject|8|||
145900927|NCT01783548|526143240|FG000|Overall Study|Non-compliance|4|||
145900928|NCT01783548|526143241|FG001|Overall Study|Non-compliance|0|||
145900929|NCT01783548|526143240|FG000|Overall Study|Protocol Violation|2|||
145900930|NCT01783548|526143241|FG001|Overall Study|Protocol Violation|2|||
145900931|NCT01783548|526143240|FG000|Overall Study|Lost to Follow-up|8|||
145900932|NCT01783548|526143241|FG001|Overall Study|Lost to Follow-up|3|||
145900933|NCT01783548|526143240|FG000|Overall Study|Lack of Efficacy|1|||
145900934|NCT01783548|526143241|FG001|Overall Study|Lack of Efficacy|1|||
145900935|NCT03825341|526143242|FG000|Overall Study|Withdrawal by Subject|0|||
145900936|NCT03825341|526143243|FG001|Overall Study|Withdrawal by Subject|1|||
145900937|NCT04053465|526143247|FG000|Overall Study|Withdrawal by Subject|4|||
145900938|NCT04053465|526143248|FG001|Overall Study|Withdrawal by Subject|4|||
145900939|NCT04091659|526143252|FG000|Overall Study|Protocol Violation|3|||
145900940|NCT04091659|526143253|FG001|Overall Study|Protocol Violation|0|||
145900941|NCT04091659|526143252|FG000|Overall Study|Lost to Follow-up|0|||
145900942|NCT04091659|526143253|FG001|Overall Study|Lost to Follow-up|1|||
145900943|NCT03678285|526143264|FG000|Overall Study|Adverse Event|2|||
145900944|NCT03678285|526143264|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
145900945|NCT03678285|526143264|FG000|Overall Study|Dehydrated prior to start of workout|1|||
145900946|NCT00123474|526143265|FG000|Randomized to Treatment|Randomized, never treated|1|||
145900947|NCT00123474|526143266|FG001|Randomized to Treatment|Randomized, never treated|4|||
145900948|NCT00123474|526143267|FG002|Randomized to Treatment|Randomized, never treated|2|||
145900949|NCT00123474|526143268|FG003|Randomized to Treatment|Randomized, never treated|1|||
145900950|NCT00123474|526143265|FG000|As Treated at Study Closure|not reported when site closed|1|||
145900951|NCT00123474|526143266|FG001|As Treated at Study Closure|not reported when site closed|0|||
145900952|NCT00123474|526143267|FG002|As Treated at Study Closure|not reported when site closed|1|||
145900953|NCT00123474|526143268|FG003|As Treated at Study Closure|not reported when site closed|0|||
145900954|NCT00123474|526143265|FG000|As Treated at Study Closure|Adverse Event|10|||
145900955|NCT00123474|526143266|FG001|As Treated at Study Closure|Adverse Event|4|||
145900956|NCT00123474|526143267|FG002|As Treated at Study Closure|Adverse Event|10|||
145900957|NCT00123474|526143268|FG003|As Treated at Study Closure|Adverse Event|8|||
145900958|NCT00123474|526143265|FG000|As Treated at Study Closure|Disease Progression|35|||
145900959|NCT00123474|526143266|FG001|As Treated at Study Closure|Disease Progression|42|||
145900960|NCT00123474|526143267|FG002|As Treated at Study Closure|Disease Progression|29|||
145900961|NCT00123474|526143268|FG003|As Treated at Study Closure|Disease Progression|27|||
146238707|NCT00853580|527388007|FG000|Overall Study|Withdrawal by Subject|2|||
146238708|NCT00853580|527388008|FG001|Overall Study|Withdrawal by Subject|8|||
145900962|NCT00123474|526143265|FG000|As Treated at Study Closure|Investigator Request|12|||
145900963|NCT00123474|526143266|FG001|As Treated at Study Closure|Investigator Request|6|||
145900964|NCT00123474|526143267|FG002|As Treated at Study Closure|Investigator Request|7|||
145900965|NCT00123474|526143268|FG003|As Treated at Study Closure|Investigator Request|5|||
146238709|NCT00853580|527388007|FG000|Overall Study|Commenced contraindicated therapy|0|||
146238710|NCT00853580|527388008|FG001|Overall Study|Commenced contraindicated therapy|2|||
146238711|NCT01700205|527388009|FG000|Overall Study|Withdrawal by Subject|13|||
145900966|NCT00123474|526143265|FG000|As Treated at Study Closure|non-specified|54|||
145900967|NCT00123474|526143266|FG001|As Treated at Study Closure|non-specified|47|||
145900968|NCT00123474|526143267|FG002|As Treated at Study Closure|non-specified|57|||
145900969|NCT00123474|526143268|FG003|As Treated at Study Closure|non-specified|60|||
145900970|NCT00123474|526143265|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
145900971|NCT00123474|526143266|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
145900972|NCT00123474|526143267|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
145900973|NCT00123474|526143268|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
145900974|NCT00123474|526143265|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
145900975|NCT00123474|526143266|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
145900976|NCT00123474|526143267|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
145900977|NCT00123474|526143268|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
145900978|NCT00616629|526143269|FG000|Overall Study|Protocol Violation|1|||
145900979|NCT00616629|526143270|FG001|Overall Study|Protocol Violation|2|||
145900980|NCT00616629|526143271|FG002|Overall Study|Protocol Violation|1|||
145900981|NCT00616629|526143272|FG003|Overall Study|Protocol Violation|0|||
145900982|NCT00616629|526143273|FG004|Overall Study|Protocol Violation|0|||
145900983|NCT00616629|526143269|FG000|Overall Study|AV-block|1|||
145900984|NCT00616629|526143270|FG001|Overall Study|AV-block|0|||
145900985|NCT00616629|526143271|FG002|Overall Study|AV-block|0|||
145900986|NCT00616629|526143272|FG003|Overall Study|AV-block|0|||
145900987|NCT00616629|526143273|FG004|Overall Study|AV-block|0|||
145900988|NCT00660400|526143277|FG000|Overall Study|Lack of insurance approval|1|||
145900989|NCT00660400|526143277|FG000|Overall Study|Suboptimal organ function|1|||
145900990|NCT00660400|526143277|FG000|Overall Study|Intracranial hemorrhage|1|||
145900991|NCT00660400|526143277|FG000|Overall Study|Withdrawal by Subject|1|||
145900992|NCT04005352|526143280|FG000|Overall Study|Adverse Event|4|||
145900993|NCT04005352|526143281|FG001|Overall Study|Adverse Event|5|||
145900994|NCT04005352|526143280|FG000|Overall Study|Death|4|||
145900995|NCT04005352|526143281|FG001|Overall Study|Death|2|||
145900996|NCT04005352|526143280|FG000|Overall Study|Lost to Follow-up|6|||
145900997|NCT04005352|526143281|FG001|Overall Study|Lost to Follow-up|2|||
145900998|NCT04005352|526143280|FG000|Overall Study|Physician Decision|7|||
145900999|NCT04005352|526143281|FG001|Overall Study|Physician Decision|13|||
145901000|NCT04005352|526143280|FG000|Overall Study|Protocol Violation|0|||
145901001|NCT04005352|526143281|FG001|Overall Study|Protocol Violation|1|||
145901002|NCT04005352|526143280|FG000|Overall Study|Withdrawal by Subject|28|||
145901003|NCT04005352|526143281|FG001|Overall Study|Withdrawal by Subject|38|||
145901004|NCT05788289|526143295|FG000|Overall Study|Death|3|||
145901005|NCT02970318|526143298|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
145901006|NCT02970318|526143299|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
145901007|NCT02970318|526143300|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
145901008|NCT02970318|526143301|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
145901009|NCT02970318|526143298|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
145901010|NCT02970318|526143299|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
145901011|NCT02970318|526143300|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
145901012|NCT02970318|526143301|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
145901013|NCT02970318|526143298|FG000|Overall for Arm A & Main for Arm B|Death|41|||
145901014|NCT02970318|526143299|FG001|Overall for Arm A & Main for Arm B|Death|33|||
145901015|NCT02970318|526143300|FG002|Overall for Arm A & Main for Arm B|Death|0|||
145901016|NCT02970318|526143301|FG003|Overall for Arm A & Main for Arm B|Death|0|||
145901017|NCT02970318|526143298|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145901018|NCT02970318|526143299|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
145901019|NCT02970318|526143300|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145901020|NCT02970318|526143301|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145901021|NCT02970318|526143298|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145901022|NCT02970318|526143299|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145901023|NCT02970318|526143300|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
145901024|NCT02970318|526143301|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145901025|NCT02970318|526143298|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
145901026|NCT02970318|526143299|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
145901027|NCT02970318|526143300|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
145901028|NCT02970318|526143301|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
145901029|NCT02970318|526143298|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
145901030|NCT02970318|526143299|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
145901031|NCT02970318|526143300|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
145901032|NCT02970318|526143301|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
146238712|NCT01700205|527388010|FG001|Overall Study|Withdrawal by Subject|13|||
146238713|NCT01700205|527388009|FG000|Overall Study|Protocol Violation|2|||
145901033|NCT00809159|526143303|FG000|Part 1|Adverse Event|1|||
146238714|NCT01700205|527388010|FG001|Overall Study|Protocol Violation|2|||
146088327|NCT04704154|526843817|FG005|Overall Study|Adverse Event|0|||
146088328|NCT04704154|526843812|FG000|Overall Study|Death|3|||
146088329|NCT04704154|526843813|FG001|Overall Study|Death|0|||
146088330|NCT04704154|526843814|FG002|Overall Study|Death|0|||
146088331|NCT04704154|526843815|FG003|Overall Study|Death|0|||
146088332|NCT04704154|526843816|FG004|Overall Study|Death|3|||
146088333|NCT04704154|526843817|FG005|Overall Study|Death|0|||
146088334|NCT04704154|526843812|FG000|Overall Study|Physician Decision|1|||
146088335|NCT04704154|526843813|FG001|Overall Study|Physician Decision|0|||
146088336|NCT04704154|526843814|FG002|Overall Study|Physician Decision|1|||
146088337|NCT04704154|526843815|FG003|Overall Study|Physician Decision|0|||
146088338|NCT04704154|526843816|FG004|Overall Study|Physician Decision|2|||
146088339|NCT04704154|526843817|FG005|Overall Study|Physician Decision|0|||
146088340|NCT04704154|526843812|FG000|Overall Study|Participant Decision|1|||
146088341|NCT04704154|526843813|FG001|Overall Study|Participant Decision|1|||
146088342|NCT04704154|526843814|FG002|Overall Study|Participant Decision|0|||
146088343|NCT04704154|526843815|FG003|Overall Study|Participant Decision|0|||
146088344|NCT04704154|526843816|FG004|Overall Study|Participant Decision|0|||
146088345|NCT04704154|526843817|FG005|Overall Study|Participant Decision|0|||
146088346|NCT04704154|526843812|FG000|Overall Study|Progressive Disease|19|||
146088347|NCT04704154|526843813|FG001|Overall Study|Progressive Disease|17|||
146088348|NCT04704154|526843814|FG002|Overall Study|Progressive Disease|20|||
146088349|NCT04704154|526843815|FG003|Overall Study|Progressive Disease|18|||
146088350|NCT04704154|526843816|FG004|Overall Study|Progressive Disease|36|||
146088351|NCT04704154|526843817|FG005|Overall Study|Progressive Disease|30|||
146088352|NCT04704154|526843812|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
145901034|NCT00809159|526143304|FG001|Part 1|Adverse Event|1|||
145901035|NCT00809159|526143305|FG002|Part 1|Adverse Event|0|||
145901036|NCT00809159|526143306|FG003|Part 1|Adverse Event|0|||
145901037|NCT00809159|526143307|FG004|Part 1|Adverse Event|0|||
145901038|NCT00809159|526143308|FG005|Part 1|Adverse Event|0|||
145901039|NCT00809159|526143303|FG000|Part 1|Lost to Follow-up|1|||
145901040|NCT00809159|526143304|FG001|Part 1|Lost to Follow-up|0|||
145901041|NCT00809159|526143305|FG002|Part 1|Lost to Follow-up|0|||
145901042|NCT00809159|526143306|FG003|Part 1|Lost to Follow-up|0|||
145901043|NCT00809159|526143307|FG004|Part 1|Lost to Follow-up|0|||
145901044|NCT00809159|526143308|FG005|Part 1|Lost to Follow-up|0|||
145901045|NCT00809159|526143303|FG000|Part 1|Withdrawal by Subject|3|||
145901046|NCT00809159|526143304|FG001|Part 1|Withdrawal by Subject|1|||
145901047|NCT00809159|526143305|FG002|Part 1|Withdrawal by Subject|0|||
145901048|NCT00809159|526143306|FG003|Part 1|Withdrawal by Subject|0|||
145901049|NCT00809159|526143307|FG004|Part 1|Withdrawal by Subject|0|||
145901050|NCT00809159|526143308|FG005|Part 1|Withdrawal by Subject|0|||
145901051|NCT00809159|526143303|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
145901052|NCT00809159|526143304|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
145901053|NCT00809159|526143305|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
145901054|NCT00809159|526143306|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
145901055|NCT00809159|526143307|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
145901056|NCT00809159|526143308|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
145901057|NCT00809159|526143303|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
145901058|NCT00809159|526143304|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
146088353|NCT04704154|526843813|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146088354|NCT04704154|526843814|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
146088355|NCT04704154|526843815|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146088356|NCT04704154|526843816|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
146088357|NCT04704154|526843817|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
146088358|NCT04704154|526843812|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
146088359|NCT04704154|526843813|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
146088360|NCT04704154|526843814|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
146088361|NCT04704154|526843815|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
146088362|NCT04704154|526843816|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
146088363|NCT04704154|526843817|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
146088364|NCT04950608|526843818|FG000|Overall Study|Withdrawal by Subject|2|||
146088365|NCT04950608|526843818|FG000|Overall Study|Physician Decision|3|||
146088366|NCT03220438|526843819|FG000|Overall Study|Lost to Follow-up|0|||
146088367|NCT03220438|526843820|FG001|Overall Study|Lost to Follow-up|0|||
146088368|NCT03220438|526843821|FG002|Overall Study|Lost to Follow-up|1|||
145901059|NCT00809159|526143305|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
145901060|NCT00809159|526143306|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
145901061|NCT00809159|526143307|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
145901062|NCT00809159|526143308|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
145901063|NCT00809159|526143303|FG000|Part 1 and 2|Administrative problems|0|||
145901064|NCT00809159|526143304|FG001|Part 1 and 2|Administrative problems|0|||
146238715|NCT01728324|527388011|FG000|Termination of DBV|Adverse Event|14|||
146238716|NCT01728324|527388012|FG001|Termination of DBV|Adverse Event|13|||
146238717|NCT01728324|527388013|FG002|Termination of DBV|Adverse Event|4|||
146238718|NCT01728324|527388011|FG000|Termination of DBV|Lack of Efficacy|14|||
146238719|NCT01728324|527388012|FG001|Termination of DBV|Lack of Efficacy|12|||
146238720|NCT01728324|527388013|FG002|Termination of DBV|Lack of Efficacy|8|||
145901065|NCT00809159|526143305|FG002|Part 1 and 2|Administrative problems|0|||
145901066|NCT00809159|526143306|FG003|Part 1 and 2|Administrative problems|1|||
145901067|NCT00809159|526143307|FG004|Part 1 and 2|Administrative problems|0|||
145901068|NCT00809159|526143308|FG005|Part 1 and 2|Administrative problems|0|||
145901069|NCT00809159|526143303|FG000|Part 1 and 2|Adverse Event|0|||
145901070|NCT00809159|526143304|FG001|Part 1 and 2|Adverse Event|0|||
145901071|NCT00809159|526143305|FG002|Part 1 and 2|Adverse Event|1|||
145901072|NCT00809159|526143306|FG003|Part 1 and 2|Adverse Event|0|||
145901073|NCT00809159|526143307|FG004|Part 1 and 2|Adverse Event|1|||
145901074|NCT00809159|526143308|FG005|Part 1 and 2|Adverse Event|1|||
145901075|NCT00809159|526143303|FG000|Part 1 and 2|Lost to Follow-up|0|||
145901076|NCT00809159|526143304|FG001|Part 1 and 2|Lost to Follow-up|0|||
145901077|NCT00809159|526143305|FG002|Part 1 and 2|Lost to Follow-up|1|||
145901078|NCT00809159|526143306|FG003|Part 1 and 2|Lost to Follow-up|1|||
145901079|NCT00809159|526143307|FG004|Part 1 and 2|Lost to Follow-up|0|||
145901080|NCT00809159|526143308|FG005|Part 1 and 2|Lost to Follow-up|0|||
145901081|NCT00809159|526143303|FG000|Part 1 and 2|Withdrawal by Subject|0|||
145901082|NCT00809159|526143304|FG001|Part 1 and 2|Withdrawal by Subject|0|||
145901083|NCT00809159|526143305|FG002|Part 1 and 2|Withdrawal by Subject|4|||
145901084|NCT00809159|526143306|FG003|Part 1 and 2|Withdrawal by Subject|0|||
145901085|NCT00809159|526143307|FG004|Part 1 and 2|Withdrawal by Subject|0|||
145901086|NCT00809159|526143308|FG005|Part 1 and 2|Withdrawal by Subject|1|||
145901087|NCT04188301|526143309|FG000|Month 3|Lost to Follow-up|0|||
145901088|NCT04188301|526143310|FG001|Month 3|Lost to Follow-up|0|||
145901089|NCT04188301|526143311|FG002|Month 3|Lost to Follow-up|1|||
145901090|NCT04188301|526143309|FG000|Month 12|Lost to Follow-up|0|||
145901091|NCT04188301|526143310|FG001|Month 12|Lost to Follow-up|0|||
145901092|NCT04188301|526143311|FG002|Month 12|Lost to Follow-up|2|||
145901093|NCT04188301|526143309|FG000|Month 12|Death|1|||
145901094|NCT04188301|526143310|FG001|Month 12|Death|1|||
145901095|NCT04188301|526143311|FG002|Month 12|Death|0|||
145901096|NCT04188301|526143309|FG000|Month 18|Lost to Follow-up|6|||
145901097|NCT04188301|526143310|FG001|Month 18|Lost to Follow-up|0|||
145901098|NCT04188301|526143311|FG002|Month 18|Lost to Follow-up|0|||
145901099|NCT01770392|526143312|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
145901100|NCT03401450|526143313|FG000|Overall Study|Lost to Follow-up|4|||
145901101|NCT03401450|526143314|FG001|Overall Study|Lost to Follow-up|6|||
145901102|NCT03401450|526143313|FG000|Overall Study|Anesthesia plan changed|2|||
145901103|NCT03401450|526143314|FG001|Overall Study|Anesthesia plan changed|2|||
145901104|NCT03401450|526143313|FG000|Overall Study|Did not complete medication diary|4|||
145901105|NCT03401450|526143314|FG001|Overall Study|Did not complete medication diary|2|||
145901106|NCT03401450|526143313|FG000|Overall Study|post surgery medication change|2|||
145901107|NCT03401450|526143314|FG001|Overall Study|post surgery medication change|1|||
145901108|NCT03401450|526143313|FG000|Overall Study|Cancelled surgery|0|||
145901109|NCT03401450|526143314|FG001|Overall Study|Cancelled surgery|2|||
145901110|NCT02352779|526143321|FG000|Overall Study|Personal Issues|1|||
145901111|NCT02352779|526143322|FG001|Overall Study|Personal Issues|1|||
145901112|NCT02352779|526143323|FG002|Overall Study|Personal Issues|0|||
145901113|NCT02352779|526143321|FG000|Overall Study|Too Many Forms|2|||
145901114|NCT02352779|526143322|FG001|Overall Study|Too Many Forms|0|||
145901115|NCT02352779|526143323|FG002|Overall Study|Too Many Forms|0|||
145901116|NCT02352779|526143321|FG000|Overall Study|Feeling Overwhelmed|1|||
146238721|NCT01728324|527388011|FG000|Termination of DBV|Withdrawal by Subject|9|||
146238722|NCT01728324|527388012|FG001|Termination of DBV|Withdrawal by Subject|6|||
146238723|NCT01728324|527388013|FG002|Termination of DBV|Withdrawal by Subject|2|||
145901117|NCT02352779|526143322|FG001|Overall Study|Feeling Overwhelmed|0|||
145901118|NCT02352779|526143323|FG002|Overall Study|Feeling Overwhelmed|0|||
145901119|NCT02352779|526143321|FG000|Overall Study|Disliked Intervention|1|||
145901120|NCT02352779|526143322|FG001|Overall Study|Disliked Intervention|0|||
146238724|NCT01728324|527388011|FG000|Termination of DBV|Other than stated|1|||
145901121|NCT02352779|526143323|FG002|Overall Study|Disliked Intervention|0|||
145901122|NCT02352779|526143321|FG000|Overall Study|Changed Mind|1|||
145901123|NCT02352779|526143322|FG001|Overall Study|Changed Mind|0|||
145901124|NCT02352779|526143323|FG002|Overall Study|Changed Mind|0|||
145901125|NCT02352779|526143321|FG000|Overall Study|Study Related Symptoms|1|||
145901126|NCT02352779|526143322|FG001|Overall Study|Study Related Symptoms|0|||
145901127|NCT02352779|526143323|FG002|Overall Study|Study Related Symptoms|0|||
145901128|NCT02352779|526143321|FG000|Overall Study|Absence of Symptoms|1|||
145901129|NCT02352779|526143322|FG001|Overall Study|Absence of Symptoms|0|||
145901130|NCT02352779|526143323|FG002|Overall Study|Absence of Symptoms|0|||
146238725|NCT01728324|527388012|FG001|Termination of DBV|Other than stated|3|||
145901131|NCT02352779|526143321|FG000|Overall Study|Other Medical Reason|0|||
145901132|NCT02352779|526143322|FG001|Overall Study|Other Medical Reason|0|||
145901133|NCT02352779|526143323|FG002|Overall Study|Other Medical Reason|1|||
145901134|NCT02352779|526143321|FG000|Overall Study|No Reason|0|||
146238726|NCT01728324|527388013|FG002|Termination of DBV|Other than stated|0|||
146238727|NCT01728324|527388011|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
146238728|NCT01728324|527388012|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
146238729|NCT01728324|527388013|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
146238730|NCT01728324|527388011|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
146238731|NCT01728324|527388012|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
146238732|NCT01728324|527388013|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
145901135|NCT02352779|526143322|FG001|Overall Study|No Reason|0|||
145901136|NCT02352779|526143323|FG002|Overall Study|No Reason|1|||
145901137|NCT00968799|526143326|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
145901138|NCT03753763|526143331|FG000|Overall Study|Adverse Event|2|||
145901139|NCT03753763|526143332|FG001|Overall Study|Adverse Event|0|||
145901140|NCT03753763|526143331|FG000|Overall Study|Withdrawal by Subject|3|||
145901141|NCT03753763|526143332|FG001|Overall Study|Withdrawal by Subject|1|||
145901142|NCT03753763|526143331|FG000|Overall Study|clinical deterioration|1|||
145901143|NCT03753763|526143332|FG001|Overall Study|clinical deterioration|0|||
145901144|NCT01104779|526143333|FG000|Overall Study|Protocol Violation|1|||
145901145|NCT01104779|526143334|FG001|Overall Study|Protocol Violation|2|||
145901146|NCT01104779|526143335|FG002|Overall Study|Protocol Violation|2|||
145901147|NCT01104779|526143333|FG000|Overall Study|Lack of Efficacy|26|||
145901148|NCT01104779|526143334|FG001|Overall Study|Lack of Efficacy|12|||
145901149|NCT01104779|526143335|FG002|Overall Study|Lack of Efficacy|13|||
145901150|NCT01104779|526143333|FG000|Overall Study|Adverse Event|13|||
145901151|NCT01104779|526143334|FG001|Overall Study|Adverse Event|14|||
145901152|NCT01104779|526143335|FG002|Overall Study|Adverse Event|13|||
145901153|NCT01104779|526143333|FG000|Overall Study|Did not meet inc/exc criteria|1|||
145901154|NCT01104779|526143334|FG001|Overall Study|Did not meet inc/exc criteria|1|||
145901155|NCT01104779|526143335|FG002|Overall Study|Did not meet inc/exc criteria|1|||
145901156|NCT01104779|526143333|FG000|Overall Study|Other reasons|0|||
145901157|NCT01104779|526143334|FG001|Overall Study|Other reasons|1|||
145901158|NCT01104779|526143335|FG002|Overall Study|Other reasons|0|||
145901159|NCT01104779|526143333|FG000|Overall Study|Lost to Follow-up|2|||
145901160|NCT01104779|526143334|FG001|Overall Study|Lost to Follow-up|0|||
145901161|NCT01104779|526143335|FG002|Overall Study|Lost to Follow-up|1|||
145901162|NCT01104779|526143333|FG000|Overall Study|Withdrawal by Subject|16|||
146088369|NCT03220438|526843822|FG003|Overall Study|Lost to Follow-up|0|||
145901163|NCT01104779|526143334|FG001|Overall Study|Withdrawal by Subject|25|||
145901164|NCT01104779|526143335|FG002|Overall Study|Withdrawal by Subject|32|||
145901165|NCT01372774|526143338|FG000|Overall Study|Withdrawal prior to treatment|4|||
145901166|NCT01372774|526143339|FG001|Overall Study|Withdrawal prior to treatment|5|||
145901167|NCT00389831|526143340|FG000|Overall Study|Lack of Efficacy|0|||
145901168|NCT00389831|526143341|FG001|Overall Study|Lack of Efficacy|2|||
145901169|NCT00389831|526143340|FG000|Overall Study|Did not receive treatment.|0|||
145901170|NCT00389831|526143341|FG001|Overall Study|Did not receive treatment.|2|||
145901171|NCT00389831|526143340|FG000|Overall Study|Other reasons|0|||
145901172|NCT00389831|526143341|FG001|Overall Study|Other reasons|2|||
145901173|NCT00389831|526143340|FG000|Overall Study|Lost to Follow-up|0|||
145901174|NCT00389831|526143341|FG001|Overall Study|Lost to Follow-up|1|||
145901175|NCT04639713|526143346|FG000|Overall Study|Protocol Noncompliance|2|||
145901176|NCT04639713|526143346|FG000|Overall Study|Withdrawal by Subject|1|||
145901177|NCT00977379|526145724|FG000|Overall Study|Withdrawal by Subject|1|||
145901178|NCT00977379|526145725|FG001|Overall Study|Withdrawal by Subject|1|||
145901179|NCT00977379|526145724|FG000|Overall Study|Death|7|||
145901180|NCT00977379|526145725|FG001|Overall Study|Death|9|||
145901181|NCT00977379|526145724|FG000|Overall Study|Premature Study Termination|4|||
145901182|NCT00977379|526145725|FG001|Overall Study|Premature Study Termination|0|||
145901183|NCT00977379|526145724|FG000|Overall Study|Participant Moving House|0|||
145901184|NCT00977379|526145725|FG001|Overall Study|Participant Moving House|1|||
145901185|NCT00977379|526145724|FG000|Overall Study|Randomization Error|0|||
145901186|NCT00977379|526145725|FG001|Overall Study|Randomization Error|1|||
145901187|NCT02603393|526145726|FG000|Overall Study|Patient/guardian decision|32|||
145901188|NCT02603393|526145727|FG001|Overall Study|Patient/guardian decision|18|||
145901189|NCT02603393|526145726|FG000|Overall Study|Adverse Event|17|||
146088370|NCT04565236|526843823|FG000|Overall Study|Patient/Guardian Decision|0|||
145901190|NCT02603393|526145727|FG001|Overall Study|Adverse Event|15|||
145901191|NCT02603393|526145726|FG000|Overall Study|Technical problems|4|||
145901192|NCT02603393|526145727|FG001|Overall Study|Technical problems|7|||
146238733|NCT01728324|527388011|FG000|Termination of FDV|Adverse Event|14|||
145901193|NCT02603393|526145726|FG000|Overall Study|Lack of Efficacy|7|||
145901194|NCT02603393|526145727|FG001|Overall Study|Lack of Efficacy|2|||
145901195|NCT02603393|526145726|FG000|Overall Study|Death|3|||
145901196|NCT02603393|526145727|FG001|Overall Study|Death|4|||
145901197|NCT02603393|526145726|FG000|Overall Study|Physician Decision|3|||
145901198|NCT02603393|526145727|FG001|Overall Study|Physician Decision|3|||
145901199|NCT02603393|526145726|FG000|Overall Study|Protocol deviation|2|||
145901200|NCT02603393|526145727|FG001|Overall Study|Protocol deviation|3|||
145901201|NCT02603393|526145726|FG000|Overall Study|Lost to Follow-up|1|||
145901202|NCT02603393|526145727|FG001|Overall Study|Lost to Follow-up|2|||
145901203|NCT02603393|526145726|FG000|Overall Study|Non-compliance with study treatment|1|||
145901204|NCT02603393|526145727|FG001|Overall Study|Non-compliance with study treatment|0|||
145901205|NCT02603393|526145726|FG000|Overall Study|Sponsor decision|1|||
145901206|NCT02603393|526145727|FG001|Overall Study|Sponsor decision|0|||
145901207|NCT00699374|526145728|FG000|Overall Study|Death|93|||
145901208|NCT00699374|526145729|FG001|Overall Study|Death|83|||
145901209|NCT00699374|526145728|FG000|Overall Study|Adverse Event|70|||
145901210|NCT00699374|526145729|FG001|Overall Study|Adverse Event|67|||
145901211|NCT00699374|526145728|FG000|Overall Study|Global deterioration of health status|7|||
145901212|NCT00699374|526145729|FG001|Overall Study|Global deterioration of health status|8|||
145901213|NCT00699374|526145728|FG000|Overall Study|Lost to Follow-up|3|||
145901214|NCT00699374|526145729|FG001|Overall Study|Lost to Follow-up|5|||
145901215|NCT00699374|526145728|FG000|Overall Study|Withdrawal by Subject|34|||
145901216|NCT00699374|526145729|FG001|Overall Study|Withdrawal by Subject|44|||
145901217|NCT00699374|526145728|FG000|Overall Study|Objective progression or relapse|281|||
145901218|NCT00699374|526145729|FG001|Overall Study|Objective progression or relapse|277|||
145901219|NCT00699374|526145728|FG000|Overall Study|Other|18|||
145901220|NCT00699374|526145729|FG001|Overall Study|Other|15|||
145901221|NCT00699374|526145728|FG000|Overall Study|Protocol Violation|2|||
145901222|NCT00699374|526145729|FG001|Overall Study|Protocol Violation|6|||
145901223|NCT00699374|526145728|FG000|Overall Study|Study terminated by sponsor|13|||
145901224|NCT00699374|526145729|FG001|Overall Study|Study terminated by sponsor|28|||
145901225|NCT00699374|526145728|FG000|Overall Study|Randomized but not treated|4|||
145901226|NCT00699374|526145729|FG001|Overall Study|Randomized but not treated|2|||
145901227|NCT00699374|526145728|FG000|Overall Study|Died 28 days after last dose|5|||
145901228|NCT00699374|526145729|FG001|Overall Study|Died 28 days after last dose|9|||
145901229|NCT01359969|526145733|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
145901230|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
145901231|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
145901232|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
145901233|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
145901234|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145901235|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145901236|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145901237|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
145901238|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145901239|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145901240|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145901241|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
145901242|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
145901243|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
145901244|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
145901245|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
145901246|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145901247|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145901248|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145901249|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
145901250|NCT00593736|526145737|FG000|Screening Period and Placebo Run-in|Various|0|||
145901251|NCT00593736|526145738|FG001|Screening Period and Placebo Run-in|Various|0|||
145901252|NCT00593736|526145739|FG002|Screening Period and Placebo Run-in|Various|0|||
145901253|NCT00593736|526145740|FG003|Screening Period and Placebo Run-in|Various|25|||
145901254|NCT00593736|526145737|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
145901255|NCT00593736|526145738|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
145901256|NCT00593736|526145739|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
145901257|NCT00593736|526145740|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
145901258|NCT00593736|526145737|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
145901259|NCT00593736|526145738|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
145901260|NCT00593736|526145739|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
146238734|NCT01728324|527388012|FG001|Termination of FDV|Adverse Event|13|||
146238735|NCT01728324|527388013|FG002|Termination of FDV|Adverse Event|4|||
146238736|NCT01728324|527388011|FG000|Termination of FDV|Lack of Efficacy|14|||
145901261|NCT00593736|526145740|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
145901262|NCT00593736|526145737|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
145901263|NCT00593736|526145738|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
145901264|NCT00593736|526145739|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
145901265|NCT00593736|526145740|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
145901266|NCT00593736|526145737|FG000|Treatment Period and Placebo Run-out|Various|1|||
145901267|NCT00593736|526145738|FG001|Treatment Period and Placebo Run-out|Various|1|||
145901268|NCT00593736|526145739|FG002|Treatment Period and Placebo Run-out|Various|1|||
145901269|NCT00593736|526145740|FG003|Treatment Period and Placebo Run-out|Various|0|||
145901270|NCT01868893|526145741|FG000|Overall Study|Adverse Event|2|||
145901271|NCT01868893|526145741|FG000|Overall Study|Commercial availability of study drug|17|||
145901272|NCT01868893|526145741|FG000|Overall Study|Neutropenia|1|||
145901273|NCT01857271|526145742|FG000|Overall Study|Lost to Follow-up|1|||
145901274|NCT04283500|526145747|FG000|Overall Study|Lost to Follow-up|8|||
145901275|NCT04283500|526145747|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
145901276|NCT02006693|526145751|FG000|Overall Study|No Reason Specified|6|||
145901277|NCT02006693|526145752|FG001|Overall Study|No Reason Specified|8|||
145901278|NCT02006693|526145751|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
145901279|NCT02006693|526145752|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
145901280|NCT02006693|526145751|FG000|Overall Study|XEN Implant Explantation|0|||
145901281|NCT02006693|526145752|FG001|Overall Study|XEN Implant Explantation|1|||
145901282|NCT02006693|526145751|FG000|Overall Study|Death|2|||
145901283|NCT02006693|526145752|FG001|Overall Study|Death|2|||
145901284|NCT02006693|526145751|FG000|Overall Study|Lost to Follow-up|4|||
145901285|NCT02006693|526145752|FG001|Overall Study|Lost to Follow-up|1|||
145901286|NCT02006693|526145751|FG000|Overall Study|Patient Decision|4|||
145901287|NCT02006693|526145752|FG001|Overall Study|Patient Decision|0|||
145901288|NCT01119508|526145755|FG000|Overall Study|Adverse Event|56|||
145901289|NCT01119508|526145755|FG000|Overall Study|Withdrawal by Subject|2|||
145901290|NCT01119508|526145755|FG000|Overall Study|Died before tumor response evaluation|1|||
145901291|NCT00265395|526145756|FG000|Overall Study|Adverse Event|3|||
145901292|NCT00265395|526145757|FG001|Overall Study|Adverse Event|6|||
145901293|NCT00265395|526145756|FG000|Overall Study|Lost to Follow-up|2|||
145901294|NCT00265395|526145757|FG001|Overall Study|Lost to Follow-up|1|||
145901295|NCT00265395|526145756|FG000|Overall Study|Withdrawal by Subject|1|||
145901296|NCT00265395|526145757|FG001|Overall Study|Withdrawal by Subject|6|||
145901297|NCT00265395|526145756|FG000|Overall Study|Protocol Violation|2|||
145901298|NCT00265395|526145757|FG001|Overall Study|Protocol Violation|2|||
145901299|NCT00265395|526145756|FG000|Overall Study|Lack of Efficacy|0|||
145901300|NCT00265395|526145757|FG001|Overall Study|Lack of Efficacy|1|||
145901301|NCT00265395|526145756|FG000|Overall Study|Administrative|0|||
145901302|NCT00265395|526145757|FG001|Overall Study|Administrative|1|||
145901303|NCT00552578|526145765|FG000|Overall Study|Lost to Follow-up|1|||
145901304|NCT00552578|526145766|FG001|Overall Study|Lost to Follow-up|1|||
145901305|NCT00470067|526145767|FG000|Overall Study|Death|1|||
145901306|NCT00470067|526145767|FG000|Overall Study|Disease Progression|6|||
145901307|NCT02563106|526145768|FG000|Overall Study|Withdrawal by Subject|7|||
145901308|NCT02563106|526145769|FG001|Overall Study|Withdrawal by Subject|8|||
145901309|NCT02563106|526145768|FG000|Overall Study|Adverse Event|17|||
145901310|NCT02563106|526145769|FG001|Overall Study|Adverse Event|15|||
145901311|NCT02563106|526145768|FG000|Overall Study|Protocol Violation|1|||
145901312|NCT02563106|526145769|FG001|Overall Study|Protocol Violation|0|||
145901313|NCT02563106|526145768|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
145901314|NCT02563106|526145769|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
145901315|NCT02563106|526145768|FG000|Overall Study|Lost to Follow-up|3|||
145901316|NCT02563106|526145769|FG001|Overall Study|Lost to Follow-up|2|||
145901317|NCT02563106|526145768|FG000|Overall Study|Physician Decision|3|||
145901318|NCT02563106|526145769|FG001|Overall Study|Physician Decision|1|||
145901319|NCT02563106|526145768|FG000|Overall Study|Other reason - not specified|2|||
145901320|NCT02563106|526145769|FG001|Overall Study|Other reason - not specified|1|||
145901321|NCT04729309|526145770|FG000|Period 1|Subject unable to return for Period 2|3|||
145901322|NCT04729309|526145771|FG001|Period 1|Subject unable to return for Period 2|0|||
145901323|NCT04729309|526145770|FG000|Period 1|Lost to Follow-up|1|||
145901324|NCT04729309|526145771|FG001|Period 1|Lost to Follow-up|0|||
145901325|NCT01059539|526145772|FG000|Overall Study|Adverse Event|66|||
145901326|NCT01059539|526145772|FG000|Overall Study|Insufficient Therapeutic Response|26|||
145901327|NCT01059539|526145772|FG000|Overall Study|Protocol Violation|55|||
145901328|NCT01059539|526145772|FG000|Overall Study|Withdrawal of Consent|80|||
145901329|NCT01059539|526145772|FG000|Overall Study|Lost to Follow-up|42|||
145901330|NCT01059539|526145772|FG000|Overall Study|Reason Not Specified|2|||
145901331|NCT02085135|526145773|FG000|Overall Study|Adverse Event|4|||
145901332|NCT02085135|526145774|FG001|Overall Study|Adverse Event|7|||
145901333|NCT02085135|526145773|FG000|Overall Study|Lost to Follow-up|2|||
145901334|NCT02085135|526145774|FG001|Overall Study|Lost to Follow-up|2|||
145901335|NCT02085135|526145773|FG000|Overall Study|Withdrawal by Subject|3|||
145901336|NCT02085135|526145774|FG001|Overall Study|Withdrawal by Subject|0|||
145901337|NCT02085135|526145773|FG000|Overall Study|Lack of Efficacy|2|||
145901338|NCT02085135|526145774|FG001|Overall Study|Lack of Efficacy|0|||
145901339|NCT01212588|526145775|FG000|Overall Study|Physician Decision|0|||
145901340|NCT01212588|526145776|FG001|Overall Study|Physician Decision|1|||
145901341|NCT01212588|526145775|FG000|Overall Study|Protocol Violation|1|||
145901342|NCT01212588|526145776|FG001|Overall Study|Protocol Violation|1|||
145901343|NCT03317834|526145777|FG000|Overall Study|Death|2|||
145901344|NCT03317834|526145777|FG000|Overall Study|Device Revision|5|||
145901345|NCT03317834|526145777|FG000|Overall Study|Withdrawal by Subject|13|||
145901346|NCT03317834|526145777|FG000|Overall Study|Lost to Follow-up|13|||
145901347|NCT01517373|526145782|FG000|Run-in Period|Death|1|||
145901348|NCT01517373|526145783|FG001|Run-in Period|Death|0|||
145901349|NCT01517373|526145784|FG002|Run-in Period|Death|0|||
145901350|NCT01517373|526145785|FG003|Run-in Period|Death|0|||
145901351|NCT01517373|526145786|FG004|Run-in Period|Death|0|||
145901352|NCT01517373|526145787|FG005|Run-in Period|Death|0|||
145901353|NCT01517373|526145782|FG000|Run-in Period|Adverse Event|5|||
145901354|NCT01517373|526145783|FG001|Run-in Period|Adverse Event|0|||
145901355|NCT01517373|526145784|FG002|Run-in Period|Adverse Event|0|||
145901356|NCT01517373|526145785|FG003|Run-in Period|Adverse Event|0|||
145901357|NCT01517373|526145786|FG004|Run-in Period|Adverse Event|0|||
145901358|NCT01517373|526145787|FG005|Run-in Period|Adverse Event|0|||
145901359|NCT01517373|526145782|FG000|Run-in Period|Did not meet eligibility criteria|34|||
145901360|NCT01517373|526145783|FG001|Run-in Period|Did not meet eligibility criteria|0|||
145901361|NCT01517373|526145784|FG002|Run-in Period|Did not meet eligibility criteria|0|||
145901362|NCT01517373|526145785|FG003|Run-in Period|Did not meet eligibility criteria|0|||
145901363|NCT01517373|526145786|FG004|Run-in Period|Did not meet eligibility criteria|0|||
145901364|NCT01517373|526145787|FG005|Run-in Period|Did not meet eligibility criteria|0|||
145901365|NCT01517373|526145782|FG000|Run-in Period|Lost to Follow-up|1|||
145901366|NCT01517373|526145783|FG001|Run-in Period|Lost to Follow-up|0|||
145901367|NCT01517373|526145784|FG002|Run-in Period|Lost to Follow-up|0|||
145901368|NCT01517373|526145785|FG003|Run-in Period|Lost to Follow-up|0|||
145901369|NCT01517373|526145786|FG004|Run-in Period|Lost to Follow-up|0|||
145901370|NCT01517373|526145787|FG005|Run-in Period|Lost to Follow-up|0|||
145901371|NCT01517373|526145782|FG000|Run-in Period|Withdrawal by Subject|12|||
145901372|NCT01517373|526145783|FG001|Run-in Period|Withdrawal by Subject|0|||
145901373|NCT01517373|526145784|FG002|Run-in Period|Withdrawal by Subject|0|||
145901374|NCT01517373|526145785|FG003|Run-in Period|Withdrawal by Subject|0|||
145901375|NCT01517373|526145786|FG004|Run-in Period|Withdrawal by Subject|0|||
145901376|NCT01517373|526145787|FG005|Run-in Period|Withdrawal by Subject|0|||
145901377|NCT01517373|526145782|FG000|Run-in Period|Sponsor Decision|3|||
145901378|NCT01517373|526145783|FG001|Run-in Period|Sponsor Decision|0|||
145901379|NCT01517373|526145784|FG002|Run-in Period|Sponsor Decision|0|||
145901380|NCT01517373|526145785|FG003|Run-in Period|Sponsor Decision|0|||
145901381|NCT01517373|526145786|FG004|Run-in Period|Sponsor Decision|0|||
145901382|NCT01517373|526145787|FG005|Run-in Period|Sponsor Decision|0|||
145901383|NCT01517373|526145782|FG000|Run-in Period|Other|1|||
145901384|NCT01517373|526145783|FG001|Run-in Period|Other|0|||
145901385|NCT01517373|526145784|FG002|Run-in Period|Other|0|||
145901386|NCT01517373|526145785|FG003|Run-in Period|Other|0|||
145901387|NCT01517373|526145786|FG004|Run-in Period|Other|0|||
145901388|NCT01517373|526145787|FG005|Run-in Period|Other|0|||
145901389|NCT01517373|526145782|FG000|Treatment Period|Adverse Event|0|||
145901390|NCT01517373|526145783|FG001|Treatment Period|Adverse Event|0|||
145901391|NCT01517373|526145784|FG002|Treatment Period|Adverse Event|0|||
145901392|NCT01517373|526145785|FG003|Treatment Period|Adverse Event|0|||
146088371|NCT04565236|526843824|FG001|Overall Study|Patient/Guardian Decision|0|||
146088372|NCT04565236|526843825|FG002|Overall Study|Patient/Guardian Decision|1|||
146088373|NCT04565236|526843826|FG003|Overall Study|Patient/Guardian Decision|0|||
146088374|NCT01117051|526843830|FG000|Overall Study|Withdrawal by Subject|5|||
145901393|NCT01517373|526145786|FG004|Treatment Period|Adverse Event|0|||
145901394|NCT01517373|526145787|FG005|Treatment Period|Adverse Event|2|||
145901395|NCT01517373|526145782|FG000|Treatment Period|Lost to Follow-up|0|||
145901396|NCT01517373|526145783|FG001|Treatment Period|Lost to Follow-up|0|||
145901397|NCT01517373|526145784|FG002|Treatment Period|Lost to Follow-up|1|||
146088375|NCT01117051|526843831|FG001|Overall Study|Withdrawal by Subject|3|||
146088376|NCT01117051|526843830|FG000|Overall Study|Adverse Event|4|||
146088377|NCT01117051|526843831|FG001|Overall Study|Adverse Event|3|||
146088378|NCT01117051|526843830|FG000|Overall Study|Lost to Follow-up|0|||
146088379|NCT01117051|526843831|FG001|Overall Study|Lost to Follow-up|1|||
145901398|NCT01517373|526145785|FG003|Treatment Period|Lost to Follow-up|1|||
145901399|NCT01517373|526145786|FG004|Treatment Period|Lost to Follow-up|0|||
145901400|NCT01517373|526145787|FG005|Treatment Period|Lost to Follow-up|0|||
145901401|NCT01517373|526145782|FG000|Treatment Period|Withdrawal by Subject|0|||
145901402|NCT01517373|526145783|FG001|Treatment Period|Withdrawal by Subject|3|||
145901403|NCT01517373|526145784|FG002|Treatment Period|Withdrawal by Subject|2|||
145901404|NCT01517373|526145785|FG003|Treatment Period|Withdrawal by Subject|2|||
145901405|NCT01517373|526145786|FG004|Treatment Period|Withdrawal by Subject|2|||
145901406|NCT01517373|526145787|FG005|Treatment Period|Withdrawal by Subject|3|||
145901407|NCT01517373|526145782|FG000|Treatment Period|Other|0|||
145901408|NCT01517373|526145783|FG001|Treatment Period|Other|0|||
145901409|NCT01517373|526145784|FG002|Treatment Period|Other|0|||
145901410|NCT01517373|526145785|FG003|Treatment Period|Other|0|||
145901411|NCT01517373|526145786|FG004|Treatment Period|Other|1|||
145901412|NCT01517373|526145787|FG005|Treatment Period|Other|0|||
145901413|NCT01517373|526145782|FG000|Treatment Period|Protocol Violation|0|||
145901414|NCT01517373|526145783|FG001|Treatment Period|Protocol Violation|0|||
146238737|NCT01728324|527388012|FG001|Termination of FDV|Lack of Efficacy|12|||
146238738|NCT01728324|527388013|FG002|Termination of FDV|Lack of Efficacy|8|||
146238739|NCT01728324|527388011|FG000|Termination of FDV|Withdrawal by Subject|9|||
146238740|NCT01728324|527388012|FG001|Termination of FDV|Withdrawal by Subject|6|||
146238741|NCT01728324|527388013|FG002|Termination of FDV|Withdrawal by Subject|2|||
146238742|NCT01728324|527388011|FG000|Termination of FDV|Other than stated|1|||
146238743|NCT01728324|527388012|FG001|Termination of FDV|Other than stated|3|||
146238744|NCT01728324|527388013|FG002|Termination of FDV|Other than stated|0|||
145901415|NCT01517373|526145784|FG002|Treatment Period|Protocol Violation|0|||
145901416|NCT01517373|526145785|FG003|Treatment Period|Protocol Violation|0|||
145901417|NCT01517373|526145786|FG004|Treatment Period|Protocol Violation|1|||
145901418|NCT01517373|526145787|FG005|Treatment Period|Protocol Violation|0|||
145901419|NCT01517373|526145782|FG000|Treatment Period|Lack of Efficacy|0|||
145901420|NCT01517373|526145783|FG001|Treatment Period|Lack of Efficacy|1|||
145901421|NCT01517373|526145784|FG002|Treatment Period|Lack of Efficacy|1|||
145901422|NCT01517373|526145785|FG003|Treatment Period|Lack of Efficacy|3|||
145901423|NCT01517373|526145786|FG004|Treatment Period|Lack of Efficacy|2|||
145901424|NCT01517373|526145787|FG005|Treatment Period|Lack of Efficacy|0|||
145901425|NCT01517373|526145782|FG000|Treatment Period|Medication error without AEs|0|||
145901426|NCT01517373|526145783|FG001|Treatment Period|Medication error without AEs|0|||
145901427|NCT01517373|526145784|FG002|Treatment Period|Medication error without AEs|2|||
145901428|NCT01517373|526145785|FG003|Treatment Period|Medication error without AEs|1|||
145901429|NCT01517373|526145786|FG004|Treatment Period|Medication error without AEs|0|||
145901430|NCT01517373|526145787|FG005|Treatment Period|Medication error without AEs|2|||
145901431|NCT01085734|526145792|FG000|Overall Study|Adverse Event|0|||
145901432|NCT01085734|526145793|FG001|Overall Study|Adverse Event|2|||
145901433|NCT01085734|526145792|FG000|Overall Study|Death|1|||
145901434|NCT01085734|526145793|FG001|Overall Study|Death|0|||
145901435|NCT01085734|526145792|FG000|Overall Study|Lost to Follow-up|0|||
145901436|NCT01085734|526145793|FG001|Overall Study|Lost to Follow-up|1|||
145901437|NCT01085734|526145792|FG000|Overall Study|Withdrawal by Subject|0|||
145901438|NCT01085734|526145793|FG001|Overall Study|Withdrawal by Subject|1|||
145901439|NCT02695537|526145795|FG000|Overall Study|Adverse Event|3|||
145901440|NCT02695537|526145795|FG000|Overall Study|Lack of Efficacy|28|||
145901441|NCT02695537|526145795|FG000|Overall Study|Withdrawal by Subject|4|||
145901442|NCT02695537|526145795|FG000|Overall Study|Protocol Violation|3|||
145901443|NCT02792699|526145796|FG000|Overall Study|Adverse Event|1|||
145901444|NCT02792699|526145797|FG001|Overall Study|Adverse Event|2|||
145901445|NCT02792699|526145798|FG002|Overall Study|Adverse Event|4|||
145901446|NCT02792699|526145796|FG000|Overall Study|Withdrawal by Subject|4|||
145901447|NCT02792699|526145797|FG001|Overall Study|Withdrawal by Subject|4|||
145901448|NCT02792699|526145798|FG002|Overall Study|Withdrawal by Subject|3|||
145901449|NCT02792699|526145796|FG000|Overall Study|Lost to Follow-up|0|||
145901450|NCT02792699|526145797|FG001|Overall Study|Lost to Follow-up|1|||
145901451|NCT02792699|526145798|FG002|Overall Study|Lost to Follow-up|2|||
145901452|NCT02792699|526145796|FG000|Overall Study|Physician Decision|2|||
145901453|NCT02792699|526145797|FG001|Overall Study|Physician Decision|0|||
145901454|NCT02792699|526145798|FG002|Overall Study|Physician Decision|0|||
145901455|NCT02792699|526145796|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
145901456|NCT02792699|526145797|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
145901457|NCT02792699|526145798|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
145901458|NCT02792699|526145796|FG000|Overall Study|Other|1|||
145901459|NCT02792699|526145797|FG001|Overall Study|Other|0|||
145901460|NCT02792699|526145798|FG002|Overall Study|Other|0|||
145901461|NCT04524364|526145799|FG000|Overall Study|Physician Decision|3|||
145901462|NCT04524364|526145800|FG001|Overall Study|Physician Decision|6|||
145901463|NCT04524364|526145799|FG000|Overall Study|Adverse Event|0|||
145901464|NCT04524364|526145800|FG001|Overall Study|Adverse Event|1|||
145901465|NCT04524364|526145799|FG000|Overall Study|Investigational device deficiency|0|||
146238745|NCT01728324|527388011|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
146238746|NCT01728324|527388012|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
146238747|NCT01728324|527388013|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
146238748|NCT01728324|527388011|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
146238749|NCT01728324|527388012|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
145901466|NCT04524364|526145800|FG001|Overall Study|Investigational device deficiency|1|||
145901467|NCT04524364|526145799|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
145901468|NCT04524364|526145800|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
145901469|NCT04524364|526145799|FG000|Overall Study|Device unavailability|0|||
145901470|NCT04524364|526145800|FG001|Overall Study|Device unavailability|2|||
145901471|NCT04524364|526145799|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
145901472|NCT04524364|526145800|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
145901473|NCT04524364|526145799|FG000|Overall Study|Low International normalized ratio (INR)|1|||
145901474|NCT04524364|526145800|FG001|Overall Study|Low International normalized ratio (INR)|0|||
145901475|NCT03233230|526145806|FG000|Overall Study|Adverse Event|6|||
145901476|NCT03233230|526145807|FG001|Overall Study|Adverse Event|3|||
145901477|NCT03233230|526145808|FG002|Overall Study|Adverse Event|6|||
146238750|NCT01728324|527388013|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
146238751|NCT01728324|527388011|FG000|Termination of RBV|Adverse Event|15|||
146238752|NCT01728324|527388012|FG001|Termination of RBV|Adverse Event|16|||
146238753|NCT01728324|527388013|FG002|Termination of RBV|Adverse Event|5|||
146238754|NCT01728324|527388011|FG000|Termination of RBV|Lack of Efficacy|14|||
146238755|NCT01728324|527388012|FG001|Termination of RBV|Lack of Efficacy|11|||
146238756|NCT01728324|527388013|FG002|Termination of RBV|Lack of Efficacy|7|||
146238757|NCT01728324|527388011|FG000|Termination of RBV|Withdrawal by Subject|9|||
146238758|NCT01728324|527388012|FG001|Termination of RBV|Withdrawal by Subject|5|||
146238759|NCT01728324|527388013|FG002|Termination of RBV|Withdrawal by Subject|2|||
146238760|NCT01728324|527388011|FG000|Termination of RBV|Other than stated|1|||
146238761|NCT01728324|527388012|FG001|Termination of RBV|Other than stated|3|||
146238762|NCT01728324|527388013|FG002|Termination of RBV|Other than stated|1|||
146238763|NCT01728324|527388011|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
145901478|NCT03233230|526145809|FG003|Overall Study|Adverse Event|3|||
145901479|NCT03233230|526145806|FG000|Overall Study|Protocol Violation|1|||
145901480|NCT03233230|526145807|FG001|Overall Study|Protocol Violation|2|||
145901481|NCT03233230|526145808|FG002|Overall Study|Protocol Violation|1|||
145901482|NCT03233230|526145809|FG003|Overall Study|Protocol Violation|1|||
145901483|NCT03233230|526145806|FG000|Overall Study|Lack of Efficacy|1|||
145901484|NCT03233230|526145807|FG001|Overall Study|Lack of Efficacy|0|||
145901485|NCT03233230|526145808|FG002|Overall Study|Lack of Efficacy|0|||
145901486|NCT03233230|526145809|FG003|Overall Study|Lack of Efficacy|0|||
145901487|NCT03233230|526145806|FG000|Overall Study|Other|5|||
145901488|NCT03233230|526145807|FG001|Overall Study|Other|5|||
145901489|NCT03233230|526145808|FG002|Overall Study|Other|5|||
145901490|NCT03233230|526145809|FG003|Overall Study|Other|3|||
145901491|NCT03233230|526145806|FG000|Overall Study|Withdrawal by Subject|2|||
145901492|NCT03233230|526145807|FG001|Overall Study|Withdrawal by Subject|2|||
145901493|NCT03233230|526145808|FG002|Overall Study|Withdrawal by Subject|0|||
145901494|NCT03233230|526145809|FG003|Overall Study|Withdrawal by Subject|1|||
145901495|NCT03233230|526145806|FG000|Overall Study|Lost to Follow-up|0|||
145901496|NCT03233230|526145807|FG001|Overall Study|Lost to Follow-up|3|||
145901497|NCT03233230|526145808|FG002|Overall Study|Lost to Follow-up|0|||
145901498|NCT03233230|526145809|FG003|Overall Study|Lost to Follow-up|0|||
145901499|NCT01584843|526145810|FG000|First Treatment Period|Adverse Event|0|||
145901500|NCT01584843|526145811|FG001|First Treatment Period|Adverse Event|0|||
145901501|NCT01584843|526145812|FG002|First Treatment Period|Adverse Event|1|||
145901502|NCT01584843|526145813|FG003|First Treatment Period|Adverse Event|0|||
145901503|NCT01584843|526145814|FG004|First Treatment Period|Adverse Event|0|||
145901504|NCT01584843|526145815|FG005|First Treatment Period|Adverse Event|0|||
145901505|NCT01584843|526145810|FG000|First Treatment Period|Protocol Violation|0|||
145901506|NCT01584843|526145811|FG001|First Treatment Period|Protocol Violation|0|||
145901507|NCT01584843|526145812|FG002|First Treatment Period|Protocol Violation|0|||
145901508|NCT01584843|526145813|FG003|First Treatment Period|Protocol Violation|0|||
145901509|NCT01584843|526145814|FG004|First Treatment Period|Protocol Violation|0|||
145901510|NCT01584843|526145815|FG005|First Treatment Period|Protocol Violation|1|||
145901511|NCT01584843|526145810|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145901512|NCT01584843|526145811|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145901513|NCT01584843|526145812|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145901514|NCT01584843|526145813|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145901515|NCT01584843|526145814|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145901516|NCT01584843|526145815|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
145901517|NCT01584843|526145810|FG000|Second Treatment Period|Withdrawal by Subject|0|||
145901518|NCT01584843|526145811|FG001|Second Treatment Period|Withdrawal by Subject|0|||
145901519|NCT01584843|526145812|FG002|Second Treatment Period|Withdrawal by Subject|0|||
145901520|NCT01584843|526145813|FG003|Second Treatment Period|Withdrawal by Subject|0|||
145901521|NCT01584843|526145814|FG004|Second Treatment Period|Withdrawal by Subject|0|||
145901522|NCT01584843|526145815|FG005|Second Treatment Period|Withdrawal by Subject|1|||
145901523|NCT04126213|526145818|FG000|Overall Study|Lost to Follow-up|9|||
145901524|NCT04126213|526145819|FG001|Overall Study|Lost to Follow-up|1|||
146238764|NCT01728324|527388012|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
146238765|NCT01728324|527388013|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
146238766|NCT01728324|527388011|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
146238767|NCT01728324|527388012|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
146238768|NCT01728324|527388013|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
146238769|NCT03113409|527388016|FG000|Overall Study|Withdrawal by Subject|5|||
146238770|NCT03113409|527388017|FG001|Overall Study|Withdrawal by Subject|0|||
145901525|NCT04126213|526145820|FG002|Overall Study|Lost to Follow-up|5|||
145901526|NCT04126213|526145821|FG003|Overall Study|Lost to Follow-up|10|||
145901527|NCT04126213|526145822|FG004|Overall Study|Lost to Follow-up|4|||
145901528|NCT04126213|526145823|FG005|Overall Study|Lost to Follow-up|7|||
145901529|NCT04126213|526145818|FG000|Overall Study|Withdrawal by Subject|3|||
145901530|NCT04126213|526145819|FG001|Overall Study|Withdrawal by Subject|2|||
145901531|NCT04126213|526145820|FG002|Overall Study|Withdrawal by Subject|1|||
145901532|NCT04126213|526145821|FG003|Overall Study|Withdrawal by Subject|1|||
145901533|NCT04126213|526145822|FG004|Overall Study|Withdrawal by Subject|1|||
145901534|NCT04126213|526145823|FG005|Overall Study|Withdrawal by Subject|1|||
145901535|NCT04126213|526145818|FG000|Overall Study|Other|0|||
145901536|NCT04126213|526145819|FG001|Overall Study|Other|0|||
145901537|NCT04126213|526145820|FG002|Overall Study|Other|2|||
145901538|NCT04126213|526145821|FG003|Overall Study|Other|2|||
145901539|NCT04126213|526145822|FG004|Overall Study|Other|0|||
145901540|NCT04126213|526145823|FG005|Overall Study|Other|1|||
145901541|NCT04126213|526145818|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145901542|NCT04126213|526145819|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145901543|NCT04126213|526145820|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145901544|NCT04126213|526145821|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145901545|NCT04126213|526145822|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145901546|NCT04126213|526145823|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145901547|NCT02853370|526145824|FG000|Overall Study|Physician Decision|1|||
145901548|NCT02853370|526145824|FG000|Overall Study|Lack of Efficacy|2|||
145901549|NCT02853370|526145824|FG000|Overall Study|Death|1|||
145901550|NCT02853370|526145824|FG000|Overall Study|Adverse Event|4|||
145901551|NCT02853370|526145824|FG000|Overall Study|Withdrawal by Subject|3|||
145901552|NCT02196701|526145825|FG000|Overall Study|Adverse Event|1|||
145901553|NCT02196701|526145825|FG000|Overall Study|Lost to Follow-up|1|||
145901554|NCT02196701|526145825|FG000|Overall Study|Non-adherence to Protocol|1|||
145901555|NCT03275064|526145826|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145901556|NCT03275064|526145827|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145901557|NCT03275064|526145828|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145901558|NCT03275064|526145829|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
145901559|NCT03275064|526145830|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145901560|NCT03275064|526145826|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
145901561|NCT03275064|526145827|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145901562|NCT03275064|526145828|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145901563|NCT03275064|526145829|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145901564|NCT03275064|526145830|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145901565|NCT03275064|526145826|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
145901566|NCT03275064|526145827|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
145901567|NCT03275064|526145828|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
145901568|NCT03275064|526145829|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
145901569|NCT03275064|526145830|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
145901570|NCT03275064|526145826|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145901571|NCT03275064|526145827|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145901572|NCT03275064|526145828|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
146238771|NCT03113409|527388018|FG002|Overall Study|Withdrawal by Subject|0|||
145901573|NCT03275064|526145829|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
145901574|NCT03275064|526145830|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145901575|NCT03275064|526145826|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
145901576|NCT03275064|526145827|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145901577|NCT03275064|526145828|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
145901578|NCT03275064|526145829|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145901579|NCT03275064|526145830|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145901580|NCT00827632|526145831|FG000|Overall Study|Lost to Follow-up|8|||
145901581|NCT00827632|526145832|FG001|Overall Study|Lost to Follow-up|12|||
145901582|NCT00827632|526145831|FG000|Overall Study|Early withdrawal|14|||
146238772|NCT03335488|527388023|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
146238773|NCT03335488|527388024|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
146238774|NCT03335488|527388023|FG000|Safety Extension Period|Adverse Event|1|||
146238775|NCT03335488|527388024|FG001|Safety Extension Period|Adverse Event|0|||
146238776|NCT03335488|527388023|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
146238777|NCT03335488|527388024|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
146238778|NCT00388726|527388025|FG000|Overall Study|Adverse Event|50|||
146238779|NCT00388726|527388026|FG001|Overall Study|Adverse Event|24|||
146238780|NCT00388726|527388025|FG000|Overall Study|Progressive Disease|336|||
146238781|NCT00388726|527388026|FG001|Overall Study|Progressive Disease|153|||
146238782|NCT00388726|527388025|FG000|Overall Study|Clinical Progression|61|||
145972517|NCT01799889|526412646|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146238783|NCT00388726|527388026|FG001|Overall Study|Clinical Progression|36|||
146238784|NCT00388726|527388025|FG000|Overall Study|Withdrawal by Subject|10|||
146238785|NCT00388726|527388026|FG001|Overall Study|Withdrawal by Subject|7|||
146238786|NCT00388726|527388025|FG000|Overall Study|Administrative|6|||
146238787|NCT00388726|527388026|FG001|Overall Study|Administrative|9|||
146238788|NCT00388726|527388025|FG000|Overall Study|Physician Decision|18|||
145901583|NCT00827632|526145832|FG001|Overall Study|Early withdrawal|11|||
145901584|NCT03734666|526145834|FG000|Overall Study|Other|7|||
145901585|NCT03734666|526145835|FG001|Overall Study|Other|4|||
145901586|NCT03734666|526145834|FG000|Overall Study|Lost to Follow-up|12|||
145901587|NCT03734666|526145835|FG001|Overall Study|Lost to Follow-up|12|||
145901588|NCT01910389|526145837|FG000|Overall Study|Withdrawal by Subject|2|||
145901589|NCT01910389|526145838|FG001|Overall Study|Withdrawal by Subject|0|||
145901590|NCT01910389|526145837|FG000|Overall Study|Study Closed|13|||
145901591|NCT01910389|526145838|FG001|Overall Study|Study Closed|8|||
145901592|NCT01898650|526145841|FG000|Overall Study|the subject would not lie still for imaging|1|||
145901593|NCT05896202|526145842|FG000|Overall Study|Lost to Follow-up|2|||
145901594|NCT05896202|526145843|FG001|Overall Study|Lost to Follow-up|2|||
145901595|NCT03923530|526145844|FG000|Overall Study|Withdrawal by Subject|1|||
145901596|NCT03923530|526145844|FG000|Overall Study|screen failure|3|||
145901597|NCT00407758|526145845|FG000|Overall Study|ineligible -improper prior treatment|1|||
145901598|NCT04669691|526145856|FG000|Overall Study|Death|0|||
145901599|NCT04669691|526145857|FG001|Overall Study|Death|1|||
145901600|NCT04669691|526145858|FG002|Overall Study|Death|0|||
145901601|NCT04669691|526145859|FG003|Overall Study|Death|0|||
145901602|NCT04669691|526145860|FG004|Overall Study|Death|0|||
145901603|NCT04669691|526145861|FG005|Overall Study|Death|0|||
145901604|NCT02722148|526145862|FG000|Overall Study|Lost to Follow-up|2|||
145901605|NCT02722148|526145862|FG000|Overall Study|Non compliant with treatment regimen|3|||
145901606|NCT00855803|526145863|FG000|Overall Study|Death|2|||
145901607|NCT00855803|526145863|FG000|Overall Study|Lost to Follow-up|2|||
145901608|NCT00855803|526145863|FG000|Overall Study|Technical inability to undergo procedure|2|||
145901609|NCT00855803|526145863|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
145901610|NCT00855803|526145863|FG000|Overall Study|Withdrawal by Subject|3|||
145901611|NCT00855803|526145863|FG000|Overall Study|Physician Decision|3|||
145901612|NCT04430855|526145870|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
145901613|NCT04430855|526145871|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
145901614|NCT04430855|526145870|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
145901615|NCT04430855|526145871|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
145901616|NCT04430855|526145870|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
145901617|NCT04430855|526145871|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
145901618|NCT04430855|526145870|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
145901619|NCT04430855|526145871|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
145901620|NCT04430855|526145870|FG000|Period 1 (Weeks 1-12)|Other|0|||
145901621|NCT04430855|526145871|FG001|Period 1 (Weeks 1-12)|Other|1|||
145901622|NCT04430855|526145870|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
145901623|NCT04430855|526145871|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
145901624|NCT04430855|526145870|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
145901625|NCT04430855|526145871|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
145901626|NCT04430855|526145870|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
145901627|NCT04430855|526145871|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
145901628|NCT01425723|526145872|FG000|Overall Study|Lack of Efficacy|0|||
145901629|NCT01425723|526145873|FG001|Overall Study|Lack of Efficacy|1|||
145901630|NCT01425723|526145872|FG000|Overall Study|Withdrawal by Subject|1|||
145901631|NCT01425723|526145873|FG001|Overall Study|Withdrawal by Subject|4|||
145901632|NCT01425723|526145872|FG000|Overall Study|Lost to Follow-up|0|||
145901633|NCT01425723|526145873|FG001|Overall Study|Lost to Follow-up|3|||
145901634|NCT01425723|526145872|FG000|Overall Study|Physician Decision|2|||
145901635|NCT01425723|526145873|FG001|Overall Study|Physician Decision|0|||
145901636|NCT01425723|526145872|FG000|Overall Study|Other|1|||
145901637|NCT01425723|526145873|FG001|Overall Study|Other|10|||
145901638|NCT04874636|526145874|FG000|Overall Study|Adverse Event|17|||
145901639|NCT04874636|526145875|FG001|Overall Study|Adverse Event|7|||
145901640|NCT04874636|526145874|FG000|Overall Study|Lost to Follow-up|1|||
145901641|NCT04874636|526145875|FG001|Overall Study|Lost to Follow-up|0|||
146238789|NCT00388726|527388026|FG001|Overall Study|Physician Decision|13|||
146238790|NCT00388726|527388025|FG000|Overall Study|Death|3|||
145901642|NCT04874636|526145874|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145901643|NCT04874636|526145875|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145901644|NCT04874636|526145874|FG000|Overall Study|Physician Decision|1|||
145901645|NCT04874636|526145875|FG001|Overall Study|Physician Decision|0|||
145901646|NCT04874636|526145874|FG000|Overall Study|Withdrawal by Subject|6|||
145901647|NCT04874636|526145875|FG001|Overall Study|Withdrawal by Subject|5|||
145901648|NCT02582866|526145887|FG000|Overall Study|Death|1|||
145901649|NCT02582866|526145887|FG000|Overall Study|Lack of Efficacy|2|||
145901650|NCT02582866|526145887|FG000|Overall Study|Lost to Follow-up|2|||
145901651|NCT02582866|526145887|FG000|Overall Study|Withdrawal by Subject|7|||
145901652|NCT02582866|526145887|FG000|Overall Study|Investigator decision|5|||
145901653|NCT02582866|526145887|FG000|Overall Study|Participant wants to get pregnant|1|||
145901654|NCT02582866|526145887|FG000|Overall Study|Pregnancy|2|||
145901655|NCT02582866|526145887|FG000|Overall Study|Sponsor decision|1|||
146238791|NCT00388726|527388026|FG001|Overall Study|Death|2|||
146238792|NCT04971733|527388027|FG000|Overall Study|Adverse Event|1|||
146238793|NCT04971733|527388028|FG001|Overall Study|Adverse Event|1|||
146238794|NCT04971733|527388027|FG000|Overall Study|Subject choice|2|||
146238795|NCT04971733|527388028|FG001|Overall Study|Subject choice|0|||
146238796|NCT04971733|527388027|FG000|Overall Study|Withdrawal by Subject|1|||
146238797|NCT04971733|527388028|FG001|Overall Study|Withdrawal by Subject|0|||
146238798|NCT04971733|527388027|FG000|Overall Study|Other|1|||
146238799|NCT04971733|527388028|FG001|Overall Study|Other|0|||
146238800|NCT02406092|527388037|FG000|Overall Study|Screen failure|10|||
146238801|NCT02406092|527388038|FG001|Overall Study|Screen failure|7|||
146238802|NCT02406092|527388037|FG000|Overall Study|Death|22|||
146238803|NCT02406092|527388038|FG001|Overall Study|Death|5|||
146238804|NCT02406092|527388037|FG000|Overall Study|Lost to Follow-up|4|||
146238805|NCT02406092|527388038|FG001|Overall Study|Lost to Follow-up|1|||
146238806|NCT02406092|527388037|FG000|Overall Study|Adverse Event|1|||
146238807|NCT02406092|527388038|FG001|Overall Study|Adverse Event|0|||
146238808|NCT02406092|527388037|FG000|Overall Study|Withdrawal by Subject|1|||
146238809|NCT02406092|527388038|FG001|Overall Study|Withdrawal by Subject|0|||
146238810|NCT00600353|527388040|FG000|Overall Study|history of malignancy within 5 years|1|||
146238811|NCT00600353|527388041|FG001|Overall Study|history of malignancy within 5 years|0|||
146238812|NCT00600353|527388040|FG000|Overall Study|History of prepartive regimen|0|||
146238813|NCT00600353|527388041|FG001|Overall Study|History of prepartive regimen|1|||
146238814|NCT04941482|527388042|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
146238815|NCT04941482|527388043|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
146238816|NCT03229408|527388044|FG000|Overall Study|Withdrawal by Subject|4|||
146238817|NCT03229408|527388045|FG001|Overall Study|Withdrawal by Subject|1|||
145901656|NCT02582866|526145887|FG000|Overall Study|Withdrawal due to personal reasons|1|||
145901657|NCT03567382|526145890|FG000|Overall Study|Lost to Follow-up|1|||
145901658|NCT03567382|526145891|FG001|Overall Study|Lost to Follow-up|21|||
145901659|NCT03567382|526145892|FG002|Overall Study|Lost to Follow-up|1|||
145901660|NCT03567382|526145893|FG003|Overall Study|Lost to Follow-up|21|||
145901661|NCT03567382|526145890|FG000|Overall Study|Withdrawal by Subject|2|||
145901662|NCT03567382|526145891|FG001|Overall Study|Withdrawal by Subject|14|||
145901663|NCT03567382|526145892|FG002|Overall Study|Withdrawal by Subject|1|||
145901664|NCT03567382|526145893|FG003|Overall Study|Withdrawal by Subject|12|||
145901665|NCT02011386|526145894|FG000|Overall Study|Non-compliance|2|||
145901666|NCT02011386|526145894|FG000|Overall Study|Lack of Efficacy|3|||
145901667|NCT01709838|526145895|FG000|Overall Study|Withdrawal by Subject|21|||
145901668|NCT01709838|526145895|FG000|Overall Study|Lost to Follow-up|16|||
145901669|NCT01709838|526145895|FG000|Overall Study|Pregnancy|10|||
145901670|NCT01709838|526145895|FG000|Overall Study|Subject/guardian decision|8|||
145901671|NCT01709838|526145895|FG000|Overall Study|Adverse Event|4|||
145901672|NCT01709838|526145895|FG000|Overall Study|Physician Decision|4|||
145901673|NCT01709838|526145895|FG000|Overall Study|Death|3|||
145901674|NCT01709838|526145895|FG000|Overall Study|Protocol Violation|1|||
145901675|NCT00620659|526145896|FG000|Treatment Period 1|Adverse Event|1|||
145901676|NCT00620659|526145897|FG001|Treatment Period 1|Adverse Event|0|||
145901677|NCT00620659|526145898|FG002|Treatment Period 1|Adverse Event|0|||
145901678|NCT00620659|526145899|FG003|Treatment Period 1|Adverse Event|3|||
145901679|NCT00620659|526145900|FG004|Treatment Period 1|Adverse Event|0|||
145901680|NCT00620659|526145901|FG005|Treatment Period 1|Adverse Event|0|||
145901681|NCT00620659|526145896|FG000|Treatment Period 1|Protocol Violation|1|||
145901682|NCT00620659|526145897|FG001|Treatment Period 1|Protocol Violation|0|||
145901683|NCT00620659|526145898|FG002|Treatment Period 1|Protocol Violation|0|||
145901684|NCT00620659|526145899|FG003|Treatment Period 1|Protocol Violation|0|||
145901685|NCT00620659|526145900|FG004|Treatment Period 1|Protocol Violation|0|||
145901686|NCT00620659|526145901|FG005|Treatment Period 1|Protocol Violation|0|||
145901687|NCT00620659|526145896|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145901688|NCT00620659|526145897|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145901689|NCT00620659|526145898|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145901690|NCT00620659|526145899|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145901691|NCT00620659|526145900|FG004|Treatment Period 1|Withdrawal by Subject|1|||
145901692|NCT00620659|526145901|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145901693|NCT00620659|526145896|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
145901694|NCT00620659|526145897|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
145901695|NCT00620659|526145898|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
145901696|NCT00620659|526145899|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
145972518|NCT01799889|526412647|FG005|Overall Study|Non-Compliance With Study Drug|1|||
146238818|NCT03229408|527388044|FG000|Overall Study|Adverse Event|2|||
146238819|NCT03229408|527388045|FG001|Overall Study|Adverse Event|0|||
146238820|NCT03229408|527388044|FG000|Overall Study|Pregnancy|0|||
146238821|NCT03229408|527388045|FG001|Overall Study|Pregnancy|1|||
146282341|NCT01879722|527546476|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
145901697|NCT00620659|526145900|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
145901698|NCT00620659|526145901|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
145901699|NCT00620659|526145896|FG000|Treatment Period 2|Adverse Event|0|||
145901700|NCT00620659|526145897|FG001|Treatment Period 2|Adverse Event|3|||
145901701|NCT00620659|526145898|FG002|Treatment Period 2|Adverse Event|0|||
145901702|NCT00620659|526145899|FG003|Treatment Period 2|Adverse Event|0|||
145901703|NCT00620659|526145900|FG004|Treatment Period 2|Adverse Event|2|||
145901704|NCT00620659|526145901|FG005|Treatment Period 2|Adverse Event|0|||
145901705|NCT00620659|526145896|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145901706|NCT00620659|526145897|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145901707|NCT00620659|526145898|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145901708|NCT00620659|526145899|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145901709|NCT00620659|526145900|FG004|Treatment Period 2|Withdrawal by Subject|3|||
145901710|NCT00620659|526145901|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145901711|NCT00620659|526145896|FG000|Placebo Washout Period 2|Adverse Event|2|||
145901712|NCT00620659|526145897|FG001|Placebo Washout Period 2|Adverse Event|0|||
145901713|NCT00620659|526145898|FG002|Placebo Washout Period 2|Adverse Event|0|||
145901714|NCT00620659|526145899|FG003|Placebo Washout Period 2|Adverse Event|0|||
145901715|NCT00620659|526145900|FG004|Placebo Washout Period 2|Adverse Event|0|||
145901716|NCT00620659|526145901|FG005|Placebo Washout Period 2|Adverse Event|0|||
145901717|NCT00620659|526145896|FG000|Treatment Period 3|Adverse Event|0|||
145901718|NCT00620659|526145897|FG001|Treatment Period 3|Adverse Event|2|||
145901719|NCT00620659|526145898|FG002|Treatment Period 3|Adverse Event|0|||
145901720|NCT00620659|526145899|FG003|Treatment Period 3|Adverse Event|0|||
145901721|NCT00620659|526145900|FG004|Treatment Period 3|Adverse Event|0|||
145901722|NCT00620659|526145901|FG005|Treatment Period 3|Adverse Event|0|||
145901723|NCT00620659|526145896|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145901724|NCT00620659|526145897|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145901725|NCT00620659|526145898|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145901726|NCT00620659|526145899|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146238822|NCT03229408|527388044|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
146238823|NCT03229408|527388045|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
146238824|NCT04200664|527388046|FG000|Overall Study|Withdrawal by Subject|1|||
146238825|NCT04200664|527388047|FG001|Overall Study|Withdrawal by Subject|0|||
146238826|NCT04200664|527388048|FG002|Overall Study|Withdrawal by Subject|0|||
146238827|NCT03745313|527388053|FG000|At 30 Days Follow-up|Death|2|||
146238828|NCT03745313|527388053|FG000|At 6 Months Follow-up|Death|1|||
146238829|NCT03745313|527388053|FG000|At 6 Months Follow-up|Missed Visit|1|||
146238830|NCT03745313|527388053|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
146238831|NCT03745313|527388053|FG000|At 1 Year Follow-up|Death|2|||
146238832|NCT03745313|527388053|FG000|At 1 Year Follow-up|Missed Visit|2|||
146238833|NCT03745313|527388053|FG000|At 2 Year Follow-up|Missed Visit|1|||
146238834|NCT03611075|527388055|FG000|Overall Study|Physician Decision|0|||
146238835|NCT03611075|527388056|FG001|Overall Study|Physician Decision|1|||
146238836|NCT03611075|527388057|FG002|Overall Study|Physician Decision|1|||
146238837|NCT03611075|527388058|FG003|Overall Study|Physician Decision|0|||
146238838|NCT03611075|527388059|FG004|Overall Study|Physician Decision|0|||
146238839|NCT03611075|527388060|FG005|Overall Study|Physician Decision|0|||
146238840|NCT03611075|527388061|FG006|Overall Study|Physician Decision|0|||
146238841|NCT03611075|527388062|FG007|Overall Study|Physician Decision|0|||
146238842|NCT03611075|527388063|FG008|Overall Study|Physician Decision|0|||
146238843|NCT03611075|527388055|FG000|Overall Study|Lost to Follow-up|1|||
146238844|NCT03611075|527388056|FG001|Overall Study|Lost to Follow-up|0|||
146238845|NCT03611075|527388057|FG002|Overall Study|Lost to Follow-up|0|||
146238846|NCT03611075|527388058|FG003|Overall Study|Lost to Follow-up|2|||
145901727|NCT00620659|526145900|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145901728|NCT00620659|526145901|FG005|Treatment Period 3|Withdrawal by Subject|0|||
145901729|NCT01193127|526145902|FG000|Randomized|Surgery Cancelled|0|||
145901730|NCT01193127|526145903|FG001|Randomized|Surgery Cancelled|0|||
145901731|NCT01193127|526145904|FG002|Randomized|Surgery Cancelled|0|||
145901732|NCT01193127|526145905|FG003|Randomized|Surgery Cancelled|1|||
145901733|NCT01193127|526145902|FG000|Treated|Withdrawal by Subject|0|||
145901734|NCT01193127|526145903|FG001|Treated|Withdrawal by Subject|0|||
145901735|NCT01193127|526145904|FG002|Treated|Withdrawal by Subject|0|||
145901736|NCT01193127|526145905|FG003|Treated|Withdrawal by Subject|1|||
145901737|NCT03246646|526145908|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
145901738|NCT03246646|526145909|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
145901739|NCT03246646|526145908|FG000|Overall Study|Withdrawal by Subject|3|||
145901740|NCT03246646|526145909|FG001|Overall Study|Withdrawal by Subject|0|||
145901741|NCT03246646|526145908|FG000|Overall Study|Lost to Follow-up|7|||
145901742|NCT03246646|526145909|FG001|Overall Study|Lost to Follow-up|0|||
145901743|NCT03190330|526147986|FG000|Overall Study|Adverse Event|2|||
145901744|NCT03190330|526147986|FG000|Overall Study|Death|10|||
146238847|NCT03611075|527388059|FG004|Overall Study|Lost to Follow-up|0|||
146238848|NCT03611075|527388060|FG005|Overall Study|Lost to Follow-up|0|||
145901745|NCT03190330|526147986|FG000|Overall Study|Lost to Follow-up|1|||
146238849|NCT03611075|527388061|FG006|Overall Study|Lost to Follow-up|0|||
146238850|NCT03611075|527388062|FG007|Overall Study|Lost to Follow-up|0|||
146238851|NCT03611075|527388063|FG008|Overall Study|Lost to Follow-up|0|||
146238852|NCT03611075|527388055|FG000|Overall Study|Withdrawal by Subject|0|||
145901746|NCT03190330|526147986|FG000|Overall Study|Withdrawal by Subject|6|||
145901747|NCT03190330|526147986|FG000|Overall Study|Progressive Disease|1|||
145901748|NCT02081209|526147987|FG000|Overall Study|Withdrawal by Subject|1|||
145901749|NCT00633243|526147991|FG000|Overall Study|Withdrawal by Subject|0|||
145901750|NCT00633243|526147992|FG001|Overall Study|Withdrawal by Subject|1|||
145901751|NCT00633243|526147991|FG000|Overall Study|incarceration|0|||
145901752|NCT00633243|526147992|FG001|Overall Study|incarceration|2|||
145901753|NCT00633243|526147991|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
145901754|NCT00633243|526147992|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
145901755|NCT00633243|526147991|FG000|Overall Study|Not comfortable with self-injecting|0|||
145901756|NCT00633243|526147992|FG001|Overall Study|Not comfortable with self-injecting|1|||
145901757|NCT00633243|526147991|FG000|Overall Study|Mental Health--Depression|0|||
145901758|NCT00633243|526147992|FG001|Overall Study|Mental Health--Depression|1|||
145901759|NCT00633243|526147991|FG000|Overall Study|Couldn't tolerate side-effects|1|||
145901760|NCT00633243|526147992|FG001|Overall Study|Couldn't tolerate side-effects|1|||
145901761|NCT02022748|526147993|FG000|Overall Study|Adverse Event|1|||
145901762|NCT02022748|526147994|FG001|Overall Study|Adverse Event|1|||
145901763|NCT02022748|526147995|FG002|Overall Study|Adverse Event|0|||
145901764|NCT02022748|526147993|FG000|Overall Study|Withdrawal by Subject|0|||
145901765|NCT02022748|526147994|FG001|Overall Study|Withdrawal by Subject|1|||
145901766|NCT02022748|526147995|FG002|Overall Study|Withdrawal by Subject|0|||
145901767|NCT00554190|526147999|FG000|Overall Study|Termination forms not completed|10|||
145901768|NCT01502410|526148000|FG000|Overall Study|Adverse Event|1|||
145901769|NCT01502410|526148001|FG001|Overall Study|Adverse Event|2|||
145901770|NCT01502410|526148002|FG002|Overall Study|Adverse Event|0|||
145901771|NCT01502410|526148003|FG003|Overall Study|Adverse Event|0|||
145901772|NCT01502410|526148000|FG000|Overall Study|Lack of Efficacy|7|||
145901773|NCT01502410|526148001|FG001|Overall Study|Lack of Efficacy|7|||
145901774|NCT01502410|526148002|FG002|Overall Study|Lack of Efficacy|0|||
145901775|NCT01502410|526148003|FG003|Overall Study|Lack of Efficacy|0|||
145901776|NCT01502410|526148000|FG000|Overall Study|Physician Decision|0|||
145901777|NCT01502410|526148001|FG001|Overall Study|Physician Decision|1|||
145901778|NCT01502410|526148002|FG002|Overall Study|Physician Decision|0|||
145901779|NCT01502410|526148003|FG003|Overall Study|Physician Decision|0|||
145901780|NCT01502410|526148000|FG000|Overall Study|Withdrawal by Subject|2|||
145901781|NCT01502410|526148001|FG001|Overall Study|Withdrawal by Subject|0|||
145901782|NCT01502410|526148002|FG002|Overall Study|Withdrawal by Subject|0|||
145901783|NCT01502410|526148003|FG003|Overall Study|Withdrawal by Subject|0|||
145901784|NCT04345601|526148004|FG000|Overall Study|Death|0|||
145901785|NCT04345601|526148005|FG001|Overall Study|Death|3|||
145901786|NCT04345601|526148006|FG002|Overall Study|Death|2|||
145901787|NCT04345601|526148004|FG000|Overall Study|Lost to Follow-up|0|||
145901788|NCT04345601|526148005|FG001|Overall Study|Lost to Follow-up|0|||
145901789|NCT04345601|526148006|FG002|Overall Study|Lost to Follow-up|2|||
145901790|NCT03700385|526148007|FG000|Overall Study|Lost to Follow-up|1|||
145901791|NCT03537599|526148008|FG000|Overall Study|Disease Progression|2|||
145901792|NCT03537599|526148009|FG001|Overall Study|Disease Progression|1|||
145901793|NCT03537599|526148008|FG000|Overall Study|Death|0|||
145901794|NCT03537599|526148009|FG001|Overall Study|Death|1|||
145901795|NCT02585934|526148010|FG000|Overall Study|Lost to Follow-up|2|||
145901796|NCT02585934|526148011|FG001|Overall Study|Lost to Follow-up|2|||
145901797|NCT02585934|526148010|FG000|Overall Study|Protocol Violation|14|||
145901798|NCT02585934|526148011|FG001|Overall Study|Protocol Violation|11|||
145901799|NCT02585934|526148010|FG000|Overall Study|Adverse Event|21|||
145901800|NCT02585934|526148011|FG001|Overall Study|Adverse Event|22|||
145901801|NCT02585934|526148010|FG000|Overall Study|Physician Decision|3|||
145901802|NCT02585934|526148011|FG001|Overall Study|Physician Decision|2|||
145972519|NCT01799889|526412648|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145972520|NCT01799889|526412649|FG007|Overall Study|Non-Compliance With Study Drug|0|||
145972521|NCT01799889|526412650|FG008|Overall Study|Non-Compliance With Study Drug|0|||
145972522|NCT01799889|526412651|FG009|Overall Study|Non-Compliance With Study Drug|0|||
145901803|NCT02585934|526148010|FG000|Overall Study|Withdrawal by Subject|7|||
145901804|NCT02585934|526148011|FG001|Overall Study|Withdrawal by Subject|21|||
145901805|NCT02585934|526148010|FG000|Overall Study|Lack of Efficacy|2|||
145901806|NCT02585934|526148011|FG001|Overall Study|Lack of Efficacy|1|||
145901807|NCT02585934|526148010|FG000|Overall Study|Death|2|||
145901808|NCT02585934|526148011|FG001|Overall Study|Death|0|||
145901809|NCT02585934|526148010|FG000|Overall Study|Caregiver Withdrew Consent|7|||
145901810|NCT02585934|526148011|FG001|Overall Study|Caregiver Withdrew Consent|7|||
145901811|NCT02585934|526148010|FG000|Overall Study|Sponsor Termination|1|||
145901812|NCT02585934|526148011|FG001|Overall Study|Sponsor Termination|2|||
145901813|NCT02585934|526148010|FG000|Overall Study|Another Reason|10|||
145901814|NCT02585934|526148011|FG001|Overall Study|Another Reason|5|||
145972523|NCT01799889|526412652|FG010|Overall Study|Non-Compliance With Study Drug|0|||
145972524|NCT01799889|526412653|FG011|Overall Study|Non-Compliance With Study Drug|0|||
145901815|NCT02338193|526148012|FG000|Overall Study|Withdrawal by Subject|0|||
145901816|NCT02338193|526148013|FG001|Overall Study|Withdrawal by Subject|0|||
145901817|NCT02338193|526148014|FG002|Overall Study|Withdrawal by Subject|2|||
145901818|NCT02338193|526148012|FG000|Overall Study|Pregnancy|0|||
145901819|NCT02338193|526148013|FG001|Overall Study|Pregnancy|1|||
145901820|NCT02338193|526148014|FG002|Overall Study|Pregnancy|1|||
145901821|NCT02338193|526148012|FG000|Overall Study|Noncompliant with visits|2|||
145901822|NCT02338193|526148013|FG001|Overall Study|Noncompliant with visits|2|||
145901823|NCT02338193|526148014|FG002|Overall Study|Noncompliant with visits|7|||
145901824|NCT02338193|526148012|FG000|Overall Study|moved out of state|0|||
145901825|NCT02338193|526148013|FG001|Overall Study|moved out of state|1|||
145901826|NCT02338193|526148014|FG002|Overall Study|moved out of state|0|||
145901827|NCT02338193|526148012|FG000|Overall Study|intolerant of side effects|1|||
145901828|NCT02338193|526148013|FG001|Overall Study|intolerant of side effects|0|||
145901829|NCT02338193|526148014|FG002|Overall Study|intolerant of side effects|0|||
145901830|NCT01136967|526148016|FG000|Overall Study|Adverse Event|9|||
145901831|NCT01136967|526148017|FG001|Overall Study|Adverse Event|12|||
145901832|NCT01136967|526148016|FG000|Overall Study|Participant Choice|8|||
145901833|NCT01136967|526148017|FG001|Overall Study|Participant Choice|3|||
145901834|NCT01136967|526148016|FG000|Overall Study|Lost to Follow-up|0|||
145901835|NCT01136967|526148017|FG001|Overall Study|Lost to Follow-up|1|||
145901836|NCT01136967|526148016|FG000|Overall Study|Withdrawal by Subject|1|||
145901837|NCT01136967|526148017|FG001|Overall Study|Withdrawal by Subject|2|||
145901838|NCT01136967|526148016|FG000|Overall Study|Clinical Progression|3|||
145901839|NCT01136967|526148017|FG001|Overall Study|Clinical Progression|5|||
145901840|NCT01136967|526148016|FG000|Overall Study|Radiation|1|||
145901841|NCT01136967|526148017|FG001|Overall Study|Radiation|0|||
145901842|NCT01136967|526148016|FG000|Overall Study|Non-compliance|1|||
145901843|NCT01136967|526148017|FG001|Overall Study|Non-compliance|0|||
145901844|NCT01136967|526148016|FG000|Overall Study|Investigator's Choice|1|||
145901845|NCT01136967|526148017|FG001|Overall Study|Investigator's Choice|1|||
145901846|NCT01136967|526148016|FG000|Overall Study|Increase in Lesion Size|0|||
145901847|NCT01136967|526148017|FG001|Overall Study|Increase in Lesion Size|2|||
145901848|NCT01136967|526148016|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
145901849|NCT01136967|526148017|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
145901850|NCT01735955|526148021|FG000|Overall Study|Administrative problems|1|||
145901851|NCT01735955|526148021|FG000|Overall Study|Patient/guardian decision|1|||
145901852|NCT01735955|526148021|FG000|Overall Study|Patient withdrew consent|2|||
145901853|NCT01735955|526148021|FG000|Overall Study|Physician Decision|4|||
145901854|NCT01735955|526148021|FG000|Overall Study|Disease progression|24|||
145901855|NCT01735955|526148021|FG000|Overall Study|Adverse Event|5|||
145901856|NCT02885181|526148022|FG000|Overall Study|Investigator's Discretion|0|||
145901857|NCT02885181|526148023|FG001|Overall Study|Investigator's Discretion|1|||
145901858|NCT02885181|526148024|FG002|Overall Study|Investigator's Discretion|0|||
145901859|NCT02885181|526148025|FG003|Overall Study|Investigator's Discretion|1|||
145901860|NCT02885181|526148022|FG000|Overall Study|Adverse Event|0|||
145901861|NCT02885181|526148023|FG001|Overall Study|Adverse Event|0|||
145901862|NCT02885181|526148024|FG002|Overall Study|Adverse Event|0|||
145901863|NCT02885181|526148025|FG003|Overall Study|Adverse Event|1|||
145901864|NCT02885181|526148022|FG000|Overall Study|Withdrawal by Subject|0|||
145901865|NCT02885181|526148023|FG001|Overall Study|Withdrawal by Subject|0|||
145901866|NCT02885181|526148024|FG002|Overall Study|Withdrawal by Subject|0|||
145901867|NCT02885181|526148025|FG003|Overall Study|Withdrawal by Subject|1|||
145901868|NCT01716715|526148026|FG000|Overall Study|Never Treated|2|||
145901869|NCT01716715|526148027|FG001|Overall Study|Never Treated|4|||
145901870|NCT04228783|526148028|FG000|Overall Study|Adverse Event|1|||
145901871|NCT04228783|526148029|FG001|Overall Study|Adverse Event|0|||
145901872|NCT04228783|526148030|FG002|Overall Study|Adverse Event|2|||
145901873|NCT04228783|526148031|FG003|Overall Study|Adverse Event|0|||
145901874|NCT04228783|526148032|FG004|Overall Study|Adverse Event|0|||
145901875|NCT04228783|526148033|FG005|Overall Study|Adverse Event|1|||
145901876|NCT04228783|526148028|FG000|Overall Study|Death|0|||
145901877|NCT04228783|526148029|FG001|Overall Study|Death|0|||
145972525|NCT04476043|526412654|FG000|Overall Study|Withdrawal by Subject|1|||
145972526|NCT04476043|526412655|FG001|Overall Study|Withdrawal by Subject|3|||
145972527|NCT04476043|526412656|FG002|Overall Study|Withdrawal by Subject|4|||
145972528|NCT04476043|526412657|FG003|Overall Study|Withdrawal by Subject|1|||
145972529|NCT04476043|526412654|FG000|Overall Study|Lost to Follow-up|1|||
145972530|NCT04476043|526412655|FG001|Overall Study|Lost to Follow-up|1|||
145972531|NCT04476043|526412656|FG002|Overall Study|Lost to Follow-up|2|||
145972532|NCT04476043|526412657|FG003|Overall Study|Lost to Follow-up|1|||
145972533|NCT04476043|526412654|FG000|Overall Study|Adverse Event|2|||
146238853|NCT03611075|527388056|FG001|Overall Study|Withdrawal by Subject|1|||
145901878|NCT04228783|526148030|FG002|Overall Study|Death|0|||
145901879|NCT04228783|526148031|FG003|Overall Study|Death|0|||
145901880|NCT04228783|526148032|FG004|Overall Study|Death|1|||
145901881|NCT04228783|526148033|FG005|Overall Study|Death|0|||
145972534|NCT04476043|526412655|FG001|Overall Study|Adverse Event|0|||
145901882|NCT04228783|526148028|FG000|Overall Study|Lost to Follow-up|36|||
145901883|NCT04228783|526148029|FG001|Overall Study|Lost to Follow-up|36|||
145901884|NCT04228783|526148030|FG002|Overall Study|Lost to Follow-up|28|||
145901885|NCT04228783|526148031|FG003|Overall Study|Lost to Follow-up|6|||
145972535|NCT04476043|526412656|FG002|Overall Study|Adverse Event|1|||
145972536|NCT04476043|526412657|FG003|Overall Study|Adverse Event|0|||
145972537|NCT04476043|526412654|FG000|Overall Study|Protocol Violation|0|||
145972538|NCT04476043|526412655|FG001|Overall Study|Protocol Violation|1|||
145972539|NCT04476043|526412656|FG002|Overall Study|Protocol Violation|0|||
145972540|NCT04476043|526412657|FG003|Overall Study|Protocol Violation|0|||
145972541|NCT06217380|526412658|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
145901886|NCT04228783|526148032|FG004|Overall Study|Lost to Follow-up|14|||
145901887|NCT04228783|526148033|FG005|Overall Study|Lost to Follow-up|3|||
145901888|NCT04228783|526148028|FG000|Overall Study|Physician Decision|1|||
145901889|NCT04228783|526148029|FG001|Overall Study|Physician Decision|2|||
145901890|NCT04228783|526148030|FG002|Overall Study|Physician Decision|0|||
145901891|NCT04228783|526148031|FG003|Overall Study|Physician Decision|0|||
145901892|NCT04228783|526148032|FG004|Overall Study|Physician Decision|0|||
145901893|NCT04228783|526148033|FG005|Overall Study|Physician Decision|0|||
145901894|NCT04228783|526148028|FG000|Overall Study|Protocol Violation|0|||
145901895|NCT04228783|526148029|FG001|Overall Study|Protocol Violation|0|||
145901896|NCT04228783|526148030|FG002|Overall Study|Protocol Violation|0|||
145901897|NCT04228783|526148031|FG003|Overall Study|Protocol Violation|1|||
145901898|NCT04228783|526148032|FG004|Overall Study|Protocol Violation|0|||
145901899|NCT04228783|526148033|FG005|Overall Study|Protocol Violation|0|||
145901900|NCT04228783|526148028|FG000|Overall Study|Withdrawal by Subject|6|||
145901901|NCT04228783|526148029|FG001|Overall Study|Withdrawal by Subject|10|||
146238854|NCT03611075|527388057|FG002|Overall Study|Withdrawal by Subject|1|||
146238855|NCT03611075|527388058|FG003|Overall Study|Withdrawal by Subject|1|||
146238856|NCT03611075|527388059|FG004|Overall Study|Withdrawal by Subject|0|||
146238857|NCT03611075|527388060|FG005|Overall Study|Withdrawal by Subject|0|||
146238858|NCT03611075|527388061|FG006|Overall Study|Withdrawal by Subject|1|||
146238859|NCT03611075|527388062|FG007|Overall Study|Withdrawal by Subject|0|||
146238860|NCT03611075|527388063|FG008|Overall Study|Withdrawal by Subject|0|||
146238861|NCT03611075|527388055|FG000|Overall Study|Reason unknown|0|||
146238862|NCT03611075|527388056|FG001|Overall Study|Reason unknown|0|||
146238863|NCT03611075|527388057|FG002|Overall Study|Reason unknown|0|||
146238864|NCT03611075|527388058|FG003|Overall Study|Reason unknown|1|||
146238865|NCT03611075|527388059|FG004|Overall Study|Reason unknown|0|||
146238866|NCT03611075|527388060|FG005|Overall Study|Reason unknown|0|||
146238867|NCT03611075|527388061|FG006|Overall Study|Reason unknown|1|||
146238868|NCT03611075|527388062|FG007|Overall Study|Reason unknown|0|||
146238869|NCT03611075|527388063|FG008|Overall Study|Reason unknown|0|||
146238870|NCT01701401|527388064|FG000|Overall Study|Randomized But Not Treated|3|||
146297340|NCT01603082|527604670|FG001|Overall Study|Withdrawal by Subject|0|||
145901902|NCT04228783|526148030|FG002|Overall Study|Withdrawal by Subject|19|||
145901903|NCT04228783|526148031|FG003|Overall Study|Withdrawal by Subject|1|||
145901904|NCT04228783|526148032|FG004|Overall Study|Withdrawal by Subject|2|||
145901905|NCT04228783|526148033|FG005|Overall Study|Withdrawal by Subject|0|||
145901906|NCT04228783|526148028|FG000|Overall Study|Other|4|||
145901907|NCT04228783|526148029|FG001|Overall Study|Other|3|||
145901908|NCT04228783|526148030|FG002|Overall Study|Other|2|||
145901909|NCT04228783|526148031|FG003|Overall Study|Other|1|||
145901910|NCT04228783|526148032|FG004|Overall Study|Other|0|||
145901911|NCT04228783|526148033|FG005|Overall Study|Other|0|||
145901912|NCT00626392|526148034|FG000|Run-in Period|Adverse Event|0|||
145901913|NCT00626392|526148035|FG001|Run-in Period|Adverse Event|0|||
145901914|NCT00626392|526148036|FG002|Run-in Period|Adverse Event|1|||
145901915|NCT00626392|526148037|FG003|Run-in Period|Adverse Event|0|||
145901916|NCT00626392|526148038|FG004|Run-in Period|Adverse Event|1|||
145901917|NCT00626392|526148039|FG005|Run-in Period|Adverse Event|0|||
145901918|NCT00626392|526148034|FG000|Run-in Period|Withdrawal by Subject|0|||
145901919|NCT00626392|526148035|FG001|Run-in Period|Withdrawal by Subject|1|||
145901920|NCT00626392|526148036|FG002|Run-in Period|Withdrawal by Subject|1|||
145972542|NCT06217380|526412658|FG000|Overall Study|Physician Decision|1|||
145972543|NCT06217380|526412658|FG000|Overall Study|Withdrawal by Subject|2|||
145972544|NCT06633965|526412659|FG000|Overall Study|Withdrawal by Subject|0|||
145901921|NCT00626392|526148037|FG003|Run-in Period|Withdrawal by Subject|1|||
145901922|NCT00626392|526148038|FG004|Run-in Period|Withdrawal by Subject|3|||
145972545|NCT06633965|526412660|FG001|Overall Study|Withdrawal by Subject|1|||
146238871|NCT01701401|527388065|FG001|Overall Study|Randomized But Not Treated|1|||
145901923|NCT00626392|526148039|FG005|Run-in Period|Withdrawal by Subject|1|||
145901924|NCT00626392|526148034|FG000|Run-in Period|Noncompliance|1|||
145901925|NCT00626392|526148035|FG001|Run-in Period|Noncompliance|0|||
145972546|NCT02469233|526412661|FG000|Overall Study|Death|1|||
145901926|NCT00626392|526148036|FG002|Run-in Period|Noncompliance|1|||
145901927|NCT00626392|526148037|FG003|Run-in Period|Noncompliance|0|||
145972547|NCT02469233|526412662|FG001|Overall Study|Death|1|||
146238872|NCT01701401|527388066|FG002|Overall Study|Randomized But Not Treated|0|||
146238873|NCT01701401|527388067|FG003|Overall Study|Randomized But Not Treated|1|||
146238874|NCT01701401|527388064|FG000|Overall Study|Lost to Follow-up|5|||
145901928|NCT00626392|526148038|FG004|Run-in Period|Noncompliance|0|||
145901929|NCT00626392|526148039|FG005|Run-in Period|Noncompliance|0|||
145901930|NCT00626392|526148034|FG000|Coadministration Period|Adverse Event|3|||
145901931|NCT00626392|526148035|FG001|Coadministration Period|Adverse Event|1|||
145901932|NCT00626392|526148036|FG002|Coadministration Period|Adverse Event|7|||
145901933|NCT00626392|526148037|FG003|Coadministration Period|Adverse Event|4|||
145901934|NCT00626392|526148038|FG004|Coadministration Period|Adverse Event|3|||
145901935|NCT00626392|526148039|FG005|Coadministration Period|Adverse Event|4|||
145901936|NCT00626392|526148034|FG000|Coadministration Period|Withdrawal by Subject|1|||
145901937|NCT00626392|526148035|FG001|Coadministration Period|Withdrawal by Subject|1|||
145901938|NCT00626392|526148036|FG002|Coadministration Period|Withdrawal by Subject|0|||
145901939|NCT00626392|526148037|FG003|Coadministration Period|Withdrawal by Subject|1|||
145901940|NCT00626392|526148038|FG004|Coadministration Period|Withdrawal by Subject|0|||
145901941|NCT00626392|526148039|FG005|Coadministration Period|Withdrawal by Subject|1|||
145901942|NCT00626392|526148034|FG000|Coadministration Period|Protocol Violation|0|||
145901943|NCT00626392|526148035|FG001|Coadministration Period|Protocol Violation|1|||
145901944|NCT00626392|526148036|FG002|Coadministration Period|Protocol Violation|0|||
145901945|NCT00626392|526148037|FG003|Coadministration Period|Protocol Violation|1|||
145901946|NCT00626392|526148038|FG004|Coadministration Period|Protocol Violation|1|||
145901947|NCT00626392|526148039|FG005|Coadministration Period|Protocol Violation|0|||
145901948|NCT00626392|526148034|FG000|Coadministration Period|Other|0|||
145901949|NCT00626392|526148035|FG001|Coadministration Period|Other|2|||
145901950|NCT00626392|526148036|FG002|Coadministration Period|Other|3|||
145901951|NCT00626392|526148037|FG003|Coadministration Period|Other|1|||
145901952|NCT00626392|526148038|FG004|Coadministration Period|Other|1|||
145901953|NCT00626392|526148039|FG005|Coadministration Period|Other|1|||
145901954|NCT03151811|526148040|FG000|Overall Study|Randomized But Not Treated|18|||
145901955|NCT03151811|526148041|FG001|Overall Study|Randomized But Not Treated|3|||
145901956|NCT03151811|526148040|FG000|Overall Study|Progressive Disease|130|||
145901957|NCT03151811|526148041|FG001|Overall Study|Progressive Disease|170|||
145901958|NCT03151811|526148040|FG000|Overall Study|Adverse Event|49|||
145901959|NCT03151811|526148041|FG001|Overall Study|Adverse Event|40|||
145901960|NCT03151811|526148040|FG000|Overall Study|Lack of Efficacy|6|||
145901961|NCT03151811|526148041|FG001|Overall Study|Lack of Efficacy|8|||
145901962|NCT03151811|526148040|FG000|Overall Study|Physician Decision|21|||
145901963|NCT03151811|526148041|FG001|Overall Study|Physician Decision|9|||
145901964|NCT03151811|526148040|FG000|Overall Study|Withdrawal by Subject|17|||
145901965|NCT03151811|526148041|FG001|Overall Study|Withdrawal by Subject|7|||
145901966|NCT03151811|526148040|FG000|Overall Study|Lost to Follow-up|0|||
145901967|NCT03151811|526148041|FG001|Overall Study|Lost to Follow-up|1|||
145901968|NCT03151811|526148040|FG000|Overall Study|Study Terminated by Sponsor|5|||
145901969|NCT03151811|526148041|FG001|Overall Study|Study Terminated by Sponsor|11|||
145901970|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
145901971|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
145901972|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
145901973|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
145901974|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
145901975|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
145901976|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
145901977|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
145901978|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
145901979|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
145901980|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Death|1|||
145901981|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Death|0|||
145901982|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Death|0|||
145901983|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Death|0|||
145901984|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Death|0|||
145901985|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
145901986|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
145901987|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
145901988|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
145901989|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
145901990|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
145901991|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
145901992|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
145901993|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
145901994|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
145901995|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
145972548|NCT02469233|526412661|FG000|Overall Study|Lost to post or 6 month follow up|7|||
145901996|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145901997|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
145972549|NCT02469233|526412662|FG001|Overall Study|Lost to post or 6 month follow up|2|||
145901998|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145901999|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
145902000|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
145902001|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
145902002|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
145902003|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
145902004|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145902005|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
145902006|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145902007|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145902008|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145902009|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145902010|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Other|4|||
145902011|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Other|4|||
145902012|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Other|3|||
145902013|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Other|1|||
145902014|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Other|0|||
145902015|NCT01081834|526148044|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
145902016|NCT01081834|526148045|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
145902017|NCT01081834|526148046|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145902018|NCT01081834|526148047|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145902019|NCT01081834|526148048|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145902020|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145902021|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145902022|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145902023|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145902024|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145902025|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Death|1|||
145902026|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Death|0|||
145902027|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145902028|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Death|0|||
145902029|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Death|0|||
145902030|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
145902031|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
145902032|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145902033|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145902034|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145902035|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145902036|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145902037|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145902038|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145902039|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145902040|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145902041|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
145902042|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145902043|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145902044|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145902045|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145902046|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145902047|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145902048|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145902049|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145902050|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
145902051|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
145902052|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145902053|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145902054|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145902055|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Other|4|||
145902056|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Other|5|||
145902057|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Other|4|||
145902058|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Other|0|||
145902059|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Other|0|||
145902060|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
145902061|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
145902062|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145902063|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145902064|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145902065|NCT01081834|526148044|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145902066|NCT01081834|526148045|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
145902067|NCT01081834|526148046|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145902068|NCT01081834|526148047|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145902069|NCT01081834|526148048|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145902070|NCT00742924|526148049|FG000|Overall Study|Adverse Event|0|||
145902071|NCT00742924|526148050|FG001|Overall Study|Adverse Event|0|||
145902072|NCT00742924|526148051|FG002|Overall Study|Adverse Event|1|||
145902073|NCT00742924|526148052|FG003|Overall Study|Adverse Event|1|||
145902074|NCT00742924|526148049|FG000|Overall Study|Lack of Efficacy|5|||
145902075|NCT00742924|526148050|FG001|Overall Study|Lack of Efficacy|1|||
145902076|NCT00742924|526148051|FG002|Overall Study|Lack of Efficacy|2|||
145902077|NCT00742924|526148052|FG003|Overall Study|Lack of Efficacy|4|||
145902078|NCT00742924|526148049|FG000|Overall Study|Physician Decision|0|||
145902079|NCT00742924|526148050|FG001|Overall Study|Physician Decision|0|||
145902080|NCT00742924|526148051|FG002|Overall Study|Physician Decision|0|||
145902081|NCT00742924|526148052|FG003|Overall Study|Physician Decision|1|||
145902082|NCT00742924|526148049|FG000|Overall Study|Withdrawal by Subject|0|||
145902083|NCT00742924|526148050|FG001|Overall Study|Withdrawal by Subject|1|||
145902084|NCT00742924|526148051|FG002|Overall Study|Withdrawal by Subject|1|||
145902085|NCT00742924|526148052|FG003|Overall Study|Withdrawal by Subject|0|||
145902086|NCT01777620|526148053|FG000|Overall Study|Subject Withdrawal|1|||
145902087|NCT01777620|526148054|FG001|Overall Study|Subject Withdrawal|0|||
145902088|NCT00936897|526148076|FG000|Overall Study|Withdrawal by Subject|9|||
145902089|NCT00936897|526148077|FG001|Overall Study|Withdrawal by Subject|19|||
145902090|NCT00936897|526148076|FG000|Overall Study|Adverse Event|4|||
145902091|NCT00936897|526148077|FG001|Overall Study|Adverse Event|13|||
145902092|NCT00936897|526148076|FG000|Overall Study|Other|3|||
145902093|NCT00936897|526148077|FG001|Overall Study|Other|9|||
145902094|NCT00936897|526148076|FG000|Overall Study|Lost to Follow-up|1|||
145902095|NCT00936897|526148077|FG001|Overall Study|Lost to Follow-up|10|||
145902096|NCT00936897|526148076|FG000|Overall Study|Administrative Decision|1|||
145902097|NCT00936897|526148077|FG001|Overall Study|Administrative Decision|2|||
145902098|NCT00936897|526148076|FG000|Overall Study|Protocol Violation|1|||
145902099|NCT00936897|526148077|FG001|Overall Study|Protocol Violation|1|||
145902100|NCT00936897|526148076|FG000|Overall Study|Ineligibility Determined|0|||
145902101|NCT00936897|526148077|FG001|Overall Study|Ineligibility Determined|3|||
145902102|NCT00936897|526148076|FG000|Overall Study|Noncompliance|0|||
145902103|NCT00936897|526148077|FG001|Overall Study|Noncompliance|2|||
145902104|NCT00936897|526148076|FG000|Overall Study|Death|0|||
145902105|NCT00936897|526148077|FG001|Overall Study|Death|1|||
145902106|NCT04058067|526148078|FG000|Overall Study|Adverse Event|2|||
145902107|NCT04058067|526148079|FG001|Overall Study|Adverse Event|0|||
145902108|NCT04058067|526148078|FG000|Overall Study|Death|0|||
145902109|NCT04058067|526148079|FG001|Overall Study|Death|1|||
145902110|NCT04058067|526148078|FG000|Overall Study|Physician Decision|3|||
145902111|NCT04058067|526148079|FG001|Overall Study|Physician Decision|1|||
145902112|NCT04058067|526148078|FG000|Overall Study|Protocol Violation|0|||
145902113|NCT04058067|526148079|FG001|Overall Study|Protocol Violation|1|||
145902114|NCT04058067|526148078|FG000|Overall Study|Withdrawal by Subject|7|||
145902115|NCT04058067|526148079|FG001|Overall Study|Withdrawal by Subject|8|||
145902116|NCT00417170|526148080|FG000|Overall Study|Adverse Event|1|||
145902117|NCT00417170|526148081|FG001|Overall Study|Adverse Event|1|||
145902118|NCT00417170|526148080|FG000|Overall Study|Withdrawal by Subject|1|||
145902119|NCT00417170|526148081|FG001|Overall Study|Withdrawal by Subject|1|||
145902120|NCT00417170|526148080|FG000|Overall Study|Lost to Follow-up|0|||
145902121|NCT00417170|526148081|FG001|Overall Study|Lost to Follow-up|1|||
145902122|NCT05005312|526148082|FG000|Overall Study|Enrolled, but not treated|0|||
145902123|NCT05005312|526148083|FG001|Overall Study|Enrolled, but not treated|1|||
145902124|NCT01283035|526148084|FG000|Overall Study|Subject later found ineligible|1|||
145902125|NCT03597529|526148089|FG000|Overall Study|Lost to Follow-up|10|||
145902126|NCT03597529|526148090|FG001|Overall Study|Lost to Follow-up|12|||
145902127|NCT03597529|526148089|FG000|Overall Study|Physician Decision|3|||
145902128|NCT03597529|526148090|FG001|Overall Study|Physician Decision|1|||
145902129|NCT03597529|526148089|FG000|Overall Study|Withdrawal by Subject|6|||
145902130|NCT03597529|526148090|FG001|Overall Study|Withdrawal by Subject|3|||
145902131|NCT03597529|526148089|FG000|Overall Study|Non-compliant with study activities|1|||
145902132|NCT03597529|526148090|FG001|Overall Study|Non-compliant with study activities|2|||
145902133|NCT03464630|526148093|FG000|Overall Study|Lost to Follow-up|62|||
145902134|NCT03464630|526148094|FG001|Overall Study|Lost to Follow-up|52|||
146088380|NCT01117051|526843830|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
145902135|NCT03464630|526148093|FG000|Overall Study|Withdrawal by Subject|16|||
145902136|NCT03464630|526148094|FG001|Overall Study|Withdrawal by Subject|10|||
145902137|NCT03464630|526148093|FG000|Overall Study|Passive Disengagement|8|||
145902138|NCT03464630|526148094|FG001|Overall Study|Passive Disengagement|4|||
145902139|NCT02256436|526148099|FG000|Overall Study|Adverse Event|9|||
145902140|NCT02256436|526148100|FG001|Overall Study|Adverse Event|14|||
145902141|NCT02256436|526148099|FG000|Overall Study|Death|216|||
145902142|NCT02256436|526148100|FG001|Overall Study|Death|208|||
145902143|NCT02256436|526148099|FG000|Overall Study|Lost to Follow-up|1|||
145902144|NCT02256436|526148100|FG001|Overall Study|Lost to Follow-up|2|||
145902145|NCT02256436|526148099|FG000|Overall Study|Physician Decision|1|||
145902146|NCT02256436|526148100|FG001|Overall Study|Physician Decision|0|||
145902147|NCT02256436|526148099|FG000|Overall Study|Protocol Violation|0|||
145902148|NCT02256436|526148100|FG001|Overall Study|Protocol Violation|1|||
145902149|NCT02256436|526148099|FG000|Overall Study|Withdrawal by Subject|26|||
145902150|NCT02256436|526148100|FG001|Overall Study|Withdrawal by Subject|10|||
145902151|NCT02256436|526148099|FG000|Overall Study|Transferred to Extension Study|11|||
145902152|NCT02256436|526148100|FG001|Overall Study|Transferred to Extension Study|23|||
145902153|NCT02256436|526148099|FG000|Overall Study|Did Not Continue on Extension Study|8|||
145902154|NCT02256436|526148100|FG001|Overall Study|Did Not Continue on Extension Study|12|||
145902155|NCT06077149|526148101|FG000|Overall Study|Death|1|||
145902156|NCT06077149|526148102|FG001|Overall Study|Death|0|||
145902157|NCT06077149|526148101|FG000|Overall Study|Withdrawal by Subject|2|||
145902158|NCT06077149|526148102|FG001|Overall Study|Withdrawal by Subject|0|||
145902159|NCT06077149|526148101|FG000|Overall Study|RSV infection before vaccination|3|||
145902160|NCT06077149|526148102|FG001|Overall Study|RSV infection before vaccination|0|||
145902161|NCT04154631|526148103|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
145902162|NCT04154631|526148104|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
145902163|NCT02238795|526148105|FG000|Overall Study|Patient without purpura fulminans|1|||
145902164|NCT03384654|526148108|FG000|Overall Study|Withdrawal by Subject|0|||
145902165|NCT03384654|526148109|FG001|Overall Study|Withdrawal by Subject|0|||
145902166|NCT03384654|526148110|FG002|Overall Study|Withdrawal by Subject|1|||
145902167|NCT03384654|526148111|FG003|Overall Study|Withdrawal by Subject|0|||
145902168|NCT04159935|526148114|FG000|Overall Study|Study terminated due to COVID-19|1|||
145902169|NCT04159935|526148115|FG001|Overall Study|Study terminated due to COVID-19|3|||
145902170|NCT01341782|526148116|FG000|Overall Study|Adverse Event|1|||
145902171|NCT01341782|526148117|FG001|Overall Study|Adverse Event|1|||
145902172|NCT01341782|526148116|FG000|Overall Study|Withdrawal by Subject|6|||
145902173|NCT01341782|526148117|FG001|Overall Study|Withdrawal by Subject|5|||
145902174|NCT01341782|526148116|FG000|Overall Study|Missed 3 consecutive doses|0|||
145902175|NCT01341782|526148117|FG001|Overall Study|Missed 3 consecutive doses|4|||
145902176|NCT01341782|526148116|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
145902177|NCT01341782|526148117|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
145902178|NCT01341782|526148116|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
145902179|NCT01341782|526148117|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
145902180|NCT01341782|526148116|FG000|Overall Study|Other|5|||
145902181|NCT01341782|526148117|FG001|Overall Study|Other|0|||
145902182|NCT00620555|526148119|FG000|Overall Study|Adverse Event|4|||
145902183|NCT00620555|526148119|FG000|Overall Study|Protocol Violation|2|||
145902184|NCT00620555|526148119|FG000|Overall Study|Lack of Efficacy|12|||
145902185|NCT00620555|526148119|FG000|Overall Study|Withdrawal by Subject|1|||
145902186|NCT00620555|526148119|FG000|Overall Study|Choice of other treatment|1|||
145902187|NCT00620555|526148119|FG000|Overall Study|Visit failure against planned|1|||
145902188|NCT02036775|526148120|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145902189|NCT02036775|526148121|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145902190|NCT02036775|526148122|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145902191|NCT02036775|526148123|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145902192|NCT02036775|526148124|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145902193|NCT02036775|526148125|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
145902194|NCT03796039|526148126|FG000|Overall Study|Death|2|||
145902195|NCT03796039|526148127|FG001|Overall Study|Death|1|||
145902196|NCT03796039|526148126|FG000|Overall Study|Withdrawal by Subject|7|||
145902197|NCT03796039|526148127|FG001|Overall Study|Withdrawal by Subject|4|||
145902198|NCT01140503|526148128|FG000|Overall Study|Withdrawal by Subject|1|||
145902199|NCT00587990|526148129|FG000|Overall Study|Death|0|||
145902200|NCT00587990|526148130|FG001|Overall Study|Death|0|||
145902201|NCT00587990|526148131|FG002|Overall Study|Death|1|||
145902202|NCT00206323|526148134|FG000|Overall Study|Lack of Efficacy|4|||
145902203|NCT00206323|526148135|FG001|Overall Study|Lack of Efficacy|1|||
145902204|NCT00206323|526148134|FG000|Overall Study|Adverse Event|1|||
145902205|NCT00206323|526148135|FG001|Overall Study|Adverse Event|1|||
145902206|NCT00206323|526148134|FG000|Overall Study|Lost to Follow-up|1|||
145902207|NCT00206323|526148135|FG001|Overall Study|Lost to Follow-up|1|||
145902208|NCT03334617|526148136|FG000|Overall Study|Adverse Event|0|||
146088381|NCT01117051|526843831|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
145902209|NCT03334617|526148137|FG001|Overall Study|Adverse Event|0|||
146088382|NCT01117051|526843830|FG000|Overall Study|Sponsor's decision|3|||
145902210|NCT03334617|526148138|FG002|Overall Study|Adverse Event|0|||
145902211|NCT03334617|526148139|FG003|Overall Study|Adverse Event|0|||
145902212|NCT03334617|526148140|FG004|Overall Study|Adverse Event|0|||
145902213|NCT03334617|526148141|FG005|Overall Study|Adverse Event|0|||
145902214|NCT03334617|526148142|FG006|Overall Study|Adverse Event|0|||
145902215|NCT03334617|526148143|FG007|Overall Study|Adverse Event|0|||
145902216|NCT03334617|526148144|FG008|Overall Study|Adverse Event|1|||
145902217|NCT03334617|526148145|FG009|Overall Study|Adverse Event|0|||
145902218|NCT03334617|526148146|FG010|Overall Study|Adverse Event|0|||
145902219|NCT03334617|526148147|FG011|Overall Study|Adverse Event|0|||
145902220|NCT03334617|526148148|FG012|Overall Study|Adverse Event|1|||
145902221|NCT03334617|526148149|FG013|Overall Study|Adverse Event|0|||
145902222|NCT03334617|526148150|FG014|Overall Study|Adverse Event|0|||
145902223|NCT03334617|526148151|FG015|Overall Study|Adverse Event|0|||
145902224|NCT03334617|526148152|FG016|Overall Study|Adverse Event|0|||
145902225|NCT03334617|526148153|FG017|Overall Study|Adverse Event|0|||
145902226|NCT03334617|526148154|FG018|Overall Study|Adverse Event|0|||
145902227|NCT03334617|526148155|FG019|Overall Study|Adverse Event|0|||
145902228|NCT03334617|526148156|FG020|Overall Study|Adverse Event|0|||
145902229|NCT03334617|526148157|FG021|Overall Study|Adverse Event|0|||
145902230|NCT03334617|526148136|FG000|Overall Study|Death|18|||
145902231|NCT03334617|526148137|FG001|Overall Study|Death|18|||
145902232|NCT03334617|526148138|FG002|Overall Study|Death|20|||
145902233|NCT03334617|526148139|FG003|Overall Study|Death|21|||
145902234|NCT03334617|526148140|FG004|Overall Study|Death|20|||
145902235|NCT03334617|526148141|FG005|Overall Study|Death|16|||
145902236|NCT03334617|526148142|FG006|Overall Study|Death|28|||
145902237|NCT03334617|526148143|FG007|Overall Study|Death|35|||
145902238|NCT03334617|526148144|FG008|Overall Study|Death|47|||
145902239|NCT03334617|526148145|FG009|Overall Study|Death|0|||
145902240|NCT03334617|526148146|FG010|Overall Study|Death|19|||
145902241|NCT03334617|526148147|FG011|Overall Study|Death|6|||
145902242|NCT03334617|526148148|FG012|Overall Study|Death|20|||
145902243|NCT03334617|526148149|FG013|Overall Study|Death|22|||
145902244|NCT03334617|526148150|FG014|Overall Study|Death|17|||
145902245|NCT03334617|526148151|FG015|Overall Study|Death|18|||
145902246|NCT03334617|526148152|FG016|Overall Study|Death|12|||
145902247|NCT03334617|526148153|FG017|Overall Study|Death|15|||
145902248|NCT03334617|526148154|FG018|Overall Study|Death|16|||
145902249|NCT03334617|526148155|FG019|Overall Study|Death|27|||
145902250|NCT03334617|526148156|FG020|Overall Study|Death|14|||
145902251|NCT03334617|526148157|FG021|Overall Study|Death|27|||
145902252|NCT03334617|526148136|FG000|Overall Study|Lost to Follow-up|0|||
145902253|NCT03334617|526148137|FG001|Overall Study|Lost to Follow-up|0|||
145902254|NCT03334617|526148138|FG002|Overall Study|Lost to Follow-up|0|||
145902255|NCT03334617|526148139|FG003|Overall Study|Lost to Follow-up|1|||
145902256|NCT03334617|526148140|FG004|Overall Study|Lost to Follow-up|0|||
145902257|NCT03334617|526148141|FG005|Overall Study|Lost to Follow-up|1|||
145902258|NCT03334617|526148142|FG006|Overall Study|Lost to Follow-up|0|||
145902259|NCT03334617|526148143|FG007|Overall Study|Lost to Follow-up|0|||
145902260|NCT03334617|526148144|FG008|Overall Study|Lost to Follow-up|1|||
145902261|NCT03334617|526148145|FG009|Overall Study|Lost to Follow-up|0|||
145902262|NCT03334617|526148146|FG010|Overall Study|Lost to Follow-up|0|||
145902263|NCT03334617|526148147|FG011|Overall Study|Lost to Follow-up|0|||
145902264|NCT03334617|526148148|FG012|Overall Study|Lost to Follow-up|0|||
145902265|NCT03334617|526148149|FG013|Overall Study|Lost to Follow-up|0|||
145902266|NCT03334617|526148150|FG014|Overall Study|Lost to Follow-up|0|||
145902267|NCT03334617|526148151|FG015|Overall Study|Lost to Follow-up|0|||
145902268|NCT03334617|526148152|FG016|Overall Study|Lost to Follow-up|0|||
146238875|NCT01701401|527388065|FG001|Overall Study|Lost to Follow-up|5|||
145902269|NCT03334617|526148153|FG017|Overall Study|Lost to Follow-up|0|||
146238876|NCT01701401|527388066|FG002|Overall Study|Lost to Follow-up|1|||
145902270|NCT03334617|526148154|FG018|Overall Study|Lost to Follow-up|0|||
145902271|NCT03334617|526148155|FG019|Overall Study|Lost to Follow-up|0|||
145902272|NCT03334617|526148156|FG020|Overall Study|Lost to Follow-up|0|||
145902273|NCT03334617|526148157|FG021|Overall Study|Lost to Follow-up|0|||
145902274|NCT03334617|526148136|FG000|Overall Study|Withdrawal by Subject|0|||
145972550|NCT00947544|526412663|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
145972551|NCT00947544|526412664|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
145902275|NCT03334617|526148137|FG001|Overall Study|Withdrawal by Subject|1|||
145902276|NCT03334617|526148138|FG002|Overall Study|Withdrawal by Subject|0|||
145902277|NCT03334617|526148139|FG003|Overall Study|Withdrawal by Subject|0|||
145902278|NCT03334617|526148140|FG004|Overall Study|Withdrawal by Subject|1|||
145902279|NCT03334617|526148141|FG005|Overall Study|Withdrawal by Subject|1|||
145902280|NCT03334617|526148142|FG006|Overall Study|Withdrawal by Subject|1|||
145902281|NCT03334617|526148143|FG007|Overall Study|Withdrawal by Subject|2|||
145902282|NCT03334617|526148144|FG008|Overall Study|Withdrawal by Subject|0|||
145902283|NCT03334617|526148145|FG009|Overall Study|Withdrawal by Subject|0|||
145902284|NCT03334617|526148146|FG010|Overall Study|Withdrawal by Subject|0|||
145902285|NCT03334617|526148147|FG011|Overall Study|Withdrawal by Subject|1|||
145902286|NCT03334617|526148148|FG012|Overall Study|Withdrawal by Subject|1|||
145902287|NCT03334617|526148149|FG013|Overall Study|Withdrawal by Subject|0|||
145902288|NCT03334617|526148150|FG014|Overall Study|Withdrawal by Subject|2|||
145902289|NCT03334617|526148151|FG015|Overall Study|Withdrawal by Subject|1|||
146238877|NCT01701401|527388067|FG003|Overall Study|Lost to Follow-up|3|||
146088383|NCT01117051|526843831|FG001|Overall Study|Sponsor's decision|1|||
145902290|NCT03334617|526148152|FG016|Overall Study|Withdrawal by Subject|0|||
145902291|NCT03334617|526148153|FG017|Overall Study|Withdrawal by Subject|1|||
145902292|NCT03334617|526148154|FG018|Overall Study|Withdrawal by Subject|1|||
145902293|NCT03334617|526148155|FG019|Overall Study|Withdrawal by Subject|1|||
145902294|NCT03334617|526148156|FG020|Overall Study|Withdrawal by Subject|0|||
145902295|NCT03334617|526148157|FG021|Overall Study|Withdrawal by Subject|1|||
145902296|NCT03334617|526148136|FG000|Overall Study|Other|1|||
145902297|NCT03334617|526148137|FG001|Overall Study|Other|2|||
145902298|NCT03334617|526148138|FG002|Overall Study|Other|0|||
145902299|NCT03334617|526148139|FG003|Overall Study|Other|1|||
145902300|NCT03334617|526148140|FG004|Overall Study|Other|1|||
145902301|NCT03334617|526148141|FG005|Overall Study|Other|0|||
145902302|NCT03334617|526148142|FG006|Overall Study|Other|2|||
145902303|NCT03334617|526148143|FG007|Overall Study|Other|1|||
145902304|NCT03334617|526148144|FG008|Overall Study|Other|8|||
145902305|NCT03334617|526148145|FG009|Overall Study|Other|0|||
145902306|NCT03334617|526148146|FG010|Overall Study|Other|3|||
145902307|NCT03334617|526148147|FG011|Overall Study|Other|1|||
145902308|NCT03334617|526148148|FG012|Overall Study|Other|3|||
145902309|NCT03334617|526148149|FG013|Overall Study|Other|1|||
145902310|NCT03334617|526148150|FG014|Overall Study|Other|1|||
145902311|NCT03334617|526148151|FG015|Overall Study|Other|3|||
145902312|NCT03334617|526148152|FG016|Overall Study|Other|3|||
145902313|NCT03334617|526148153|FG017|Overall Study|Other|3|||
145902314|NCT03334617|526148154|FG018|Overall Study|Other|7|||
145902315|NCT03334617|526148155|FG019|Overall Study|Other|4|||
145902316|NCT03334617|526148156|FG020|Overall Study|Other|1|||
145902317|NCT03334617|526148157|FG021|Overall Study|Other|4|||
145902318|NCT03334617|526148136|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
145902319|NCT03334617|526148137|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
145902320|NCT03334617|526148138|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
145902321|NCT03334617|526148139|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
145902322|NCT03334617|526148140|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
145902323|NCT03334617|526148141|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
145902324|NCT03334617|526148142|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
145902325|NCT03334617|526148143|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
145902326|NCT03334617|526148144|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
145902327|NCT03334617|526148145|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
145902328|NCT03334617|526148146|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
145902329|NCT03334617|526148147|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
145902330|NCT03334617|526148148|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
145902331|NCT03334617|526148149|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
145902332|NCT03334617|526148150|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
145902333|NCT03334617|526148151|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
145902334|NCT03334617|526148152|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
145902335|NCT03334617|526148153|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
145902336|NCT03334617|526148154|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
145902337|NCT03334617|526148155|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
145902338|NCT03334617|526148156|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
145902339|NCT03334617|526148157|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
145902340|NCT03657342|526148158|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
145902341|NCT03657342|526148159|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
145902342|NCT03657342|526148158|FG000|Overall Study|Withdrawal by Subject|4|||
145902343|NCT03657342|526148159|FG001|Overall Study|Withdrawal by Subject|4|||
145902344|NCT03657342|526148158|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
145902345|NCT03657342|526148159|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
145902346|NCT03657342|526148158|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
145902347|NCT03657342|526148159|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
145902348|NCT01822275|526148160|FG000|Overall Study|Withdrawal by Subject|3|||
145902349|NCT01822275|526148160|FG000|Overall Study|Adverse Event|3|||
145902350|NCT01822275|526148160|FG000|Overall Study|Progression|14|||
145902351|NCT01822275|526148160|FG000|Overall Study|Physician Decision|2|||
145902352|NCT00911807|526148161|FG000|Overall Study|Adverse Event|2|||
145902353|NCT00911807|526148162|FG001|Overall Study|Adverse Event|1|||
145902354|NCT00911807|526148163|FG002|Overall Study|Adverse Event|5|||
145902355|NCT00911807|526148161|FG000|Overall Study|Death|0|||
145902356|NCT00911807|526148162|FG001|Overall Study|Death|0|||
145902357|NCT00911807|526148163|FG002|Overall Study|Death|1|||
145902358|NCT00911807|526148161|FG000|Overall Study|Protocol Violation|6|||
145902359|NCT00911807|526148162|FG001|Overall Study|Protocol Violation|4|||
145902360|NCT00911807|526148163|FG002|Overall Study|Protocol Violation|9|||
145902361|NCT00911807|526148161|FG000|Overall Study|Withdrawal by Subject|8|||
145902362|NCT00911807|526148162|FG001|Overall Study|Withdrawal by Subject|10|||
145902363|NCT00911807|526148163|FG002|Overall Study|Withdrawal by Subject|7|||
145902364|NCT00911807|526148161|FG000|Overall Study|Organizational reasons|1|||
145902365|NCT00911807|526148162|FG001|Overall Study|Organizational reasons|3|||
145902366|NCT00911807|526148163|FG002|Overall Study|Organizational reasons|1|||
145902367|NCT01672970|526148164|FG000|Overall Study|Lack of Efficacy|12|||
145902368|NCT01672970|526148164|FG000|Overall Study|Adverse Event|18|||
145902369|NCT01672970|526148164|FG000|Overall Study|Withdrawal by Subject|2|||
145902370|NCT01672970|526148164|FG000|Overall Study|Lost to Follow-up|5|||
145902371|NCT01672970|526148164|FG000|Overall Study|Other|9|||
145902372|NCT01672970|526148164|FG000|Overall Study|Enrolled but not treated|1|||
145902373|NCT00186043|526148167|FG000|Overall Study|Lack of Efficacy|1|||
145902374|NCT00186043|526148168|FG001|Overall Study|Lack of Efficacy|3|||
145902375|NCT00186043|526148167|FG000|Overall Study|Lost to Follow-up|4|||
145902376|NCT00186043|526148168|FG001|Overall Study|Lost to Follow-up|6|||
145902377|NCT00186043|526148167|FG000|Overall Study|Withdrawal by Subject|1|||
145902378|NCT00186043|526148168|FG001|Overall Study|Withdrawal by Subject|0|||
145902379|NCT00186043|526148167|FG000|Overall Study|Adverse Event|7|||
145902380|NCT00186043|526148168|FG001|Overall Study|Adverse Event|3|||
145902381|NCT00186043|526148167|FG000|Overall Study|Protocol Violation|2|||
145902382|NCT00186043|526148168|FG001|Overall Study|Protocol Violation|1|||
145902383|NCT03258853|526148169|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
145902384|NCT03258853|526148170|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
145902385|NCT00871741|526148175|FG000|Overall Study|Premature study termination|9|||
145902386|NCT00871741|526148176|FG001|Overall Study|Premature study termination|7|||
145902387|NCT01565850|526148177|FG000|Overall Study|Adverse Event|0|||
145902388|NCT01565850|526148178|FG001|Overall Study|Adverse Event|1|||
145902389|NCT01565850|526148177|FG000|Overall Study|Lost to Follow-up|12|||
145902390|NCT01565850|526148178|FG001|Overall Study|Lost to Follow-up|4|||
145902391|NCT01565850|526148177|FG000|Overall Study|Investigator's Discretion|2|||
145902392|NCT01565850|526148178|FG001|Overall Study|Investigator's Discretion|1|||
145902393|NCT01565850|526148177|FG000|Overall Study|Participant noncompliance|2|||
145902394|NCT01565850|526148178|FG001|Overall Study|Participant noncompliance|0|||
145902395|NCT01565850|526148177|FG000|Overall Study|Withdrew Consent|4|||
145902396|NCT01565850|526148178|FG001|Overall Study|Withdrew Consent|2|||
145902397|NCT05323123|526148179|FG000|Overall Study|Withdrawal by Subject|2|||
145902398|NCT05323123|526148180|FG001|Overall Study|Withdrawal by Subject|1|||
145902399|NCT05323123|526148179|FG000|Overall Study|Lost to Follow-up|4|||
145902400|NCT05323123|526148180|FG001|Overall Study|Lost to Follow-up|2|||
145902401|NCT05323123|526148179|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
145902402|NCT05323123|526148180|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
145902403|NCT05529472|526148181|FG000|Overall Study|Withdrawal by Subject|1|||
145902404|NCT05529472|526148182|FG001|Overall Study|Withdrawal by Subject|1|||
145902405|NCT00379340|526150417|FG000|Overall Study|Death|0|||
145902406|NCT00379340|526150418|FG001|Overall Study|Death|0|||
145902407|NCT00379340|526150419|FG002|Overall Study|Death|0|||
145902408|NCT00379340|526150420|FG003|Overall Study|Death|2|||
145902409|NCT00379340|526150421|FG004|Overall Study|Death|0|||
145902410|NCT00379340|526150417|FG000|Overall Study|Lack of Efficacy|6|||
145902411|NCT00379340|526150418|FG001|Overall Study|Lack of Efficacy|1|||
145902412|NCT00379340|526150419|FG002|Overall Study|Lack of Efficacy|0|||
145902413|NCT00379340|526150420|FG003|Overall Study|Lack of Efficacy|4|||
145902414|NCT00379340|526150421|FG004|Overall Study|Lack of Efficacy|3|||
145902415|NCT00379340|526150417|FG000|Overall Study|Physician Decision|6|||
145902416|NCT00379340|526150418|FG001|Overall Study|Physician Decision|2|||
145902417|NCT00379340|526150419|FG002|Overall Study|Physician Decision|1|||
145902418|NCT00379340|526150420|FG003|Overall Study|Physician Decision|2|||
145902419|NCT00379340|526150421|FG004|Overall Study|Physician Decision|3|||
145902420|NCT00379340|526150417|FG000|Overall Study|Withdrawal by Subject|0|||
145902421|NCT00379340|526150418|FG001|Overall Study|Withdrawal by Subject|0|||
145902422|NCT00379340|526150419|FG002|Overall Study|Withdrawal by Subject|0|||
145902423|NCT00379340|526150420|FG003|Overall Study|Withdrawal by Subject|1|||
145902424|NCT00379340|526150421|FG004|Overall Study|Withdrawal by Subject|0|||
145902425|NCT00379340|526150417|FG000|Overall Study|Refusal of further protocol therapy|1|||
145902426|NCT00379340|526150418|FG001|Overall Study|Refusal of further protocol therapy|0|||
145902427|NCT00379340|526150419|FG002|Overall Study|Refusal of further protocol therapy|1|||
145902428|NCT00379340|526150420|FG003|Overall Study|Refusal of further protocol therapy|1|||
145902429|NCT00379340|526150421|FG004|Overall Study|Refusal of further protocol therapy|7|||
145902430|NCT00379340|526150417|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
145972552|NCT02566005|526412670|FG000|Overall Study|vaginal bleeding|0|||
145972553|NCT02566005|526412671|FG001|Overall Study|vaginal bleeding|1|||
145972554|NCT02566005|526412670|FG000|Overall Study|received foley|8|||
145902431|NCT00379340|526150418|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
145902432|NCT00379340|526150419|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
145902433|NCT00379340|526150420|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
145972555|NCT02566005|526412671|FG001|Overall Study|received foley|0|||
145902434|NCT00379340|526150421|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
145902435|NCT00379340|526150417|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
145902436|NCT00379340|526150418|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
145902437|NCT00379340|526150419|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
145902438|NCT00379340|526150420|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
145902439|NCT00379340|526150421|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
145902440|NCT04347122|526150422|FG000|Overall Study|Physician Decision|0|||
145902441|NCT04347122|526150423|FG001|Overall Study|Physician Decision|3|||
145902442|NCT04347122|526150424|FG002|Overall Study|Physician Decision|3|||
145902443|NCT04347122|526150425|FG003|Overall Study|Physician Decision|6|||
145902444|NCT04994483|526150426|FG000|Overall Study|Adverse Event|26|||
145902445|NCT04994483|526150427|FG001|Overall Study|Adverse Event|17|||
145902446|NCT04994483|526150426|FG000|Overall Study|Lost to Follow-up|6|||
145902447|NCT04994483|526150427|FG001|Overall Study|Lost to Follow-up|10|||
145902448|NCT04994483|526150426|FG000|Overall Study|Noncompliance with study drug|8|||
145902449|NCT04994483|526150427|FG001|Overall Study|Noncompliance with study drug|5|||
145902450|NCT04994483|526150426|FG000|Overall Study|Physician Decision|5|||
145902451|NCT04994483|526150427|FG001|Overall Study|Physician Decision|0|||
145902452|NCT04994483|526150426|FG000|Overall Study|Withdrawal by Subject|41|||
145902453|NCT04994483|526150427|FG001|Overall Study|Withdrawal by Subject|38|||
145902454|NCT04994483|526150426|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
145902455|NCT04994483|526150427|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
145902456|NCT04994483|526150426|FG000|Overall Study|Met stopping criteria|1|||
145902457|NCT04994483|526150427|FG001|Overall Study|Met stopping criteria|0|||
145902458|NCT04994483|526150426|FG000|Overall Study|Randomized in error, not treated|4|||
145902459|NCT04994483|526150427|FG001|Overall Study|Randomized in error, not treated|3|||
145902460|NCT04994483|526150426|FG000|Overall Study|Lack of a reliable study partner|0|||
145902461|NCT04994483|526150427|FG001|Overall Study|Lack of a reliable study partner|1|||
145902462|NCT04994483|526150426|FG000|Overall Study|Met MRI exclusion criteria|0|||
145902463|NCT04994483|526150427|FG001|Overall Study|Met MRI exclusion criteria|1|||
145902464|NCT00112866|526150428|FG000|Overall Study|Protocol Violation|1|||
145902465|NCT00112866|526150429|FG001|Overall Study|Protocol Violation|0|||
145902466|NCT00112866|526150428|FG000|Overall Study|did not start treatment post-op|1|||
145902467|NCT00112866|526150429|FG001|Overall Study|did not start treatment post-op|2|||
145902468|NCT02903030|526150430|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145902469|NCT02903030|526150431|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145902470|NCT01555671|526150433|FG000|Overall Study|Physician Decision|20|||
145902471|NCT01555671|526150434|FG001|Overall Study|Physician Decision|25|||
145902472|NCT04590040|526150435|FG000|Treatment Period|Lost to Follow-up|2|||
145902473|NCT04590040|526150436|FG001|Treatment Period|Lost to Follow-up|5|||
145902474|NCT04590040|526150437|FG002|Treatment Period|Lost to Follow-up|0|||
145902475|NCT04590040|526150435|FG000|Treatment Period|Physician Decision|0|||
145902476|NCT04590040|526150436|FG001|Treatment Period|Physician Decision|0|||
145902477|NCT04590040|526150437|FG002|Treatment Period|Physician Decision|2|||
145902478|NCT00631657|526150445|FG000|6-Month Treatment Period|Adverse Event|47|||
145902479|NCT00631657|526150446|FG001|6-Month Treatment Period|Adverse Event|0|||
145902480|NCT00631657|526150447|FG002|6-Month Treatment Period|Adverse Event|7|||
145902481|NCT00631657|526150445|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
145902482|NCT00631657|526150446|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
145902483|NCT00631657|526150447|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
145902484|NCT00631657|526150445|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
145902485|NCT00631657|526150446|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
145902486|NCT00631657|526150447|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
145902487|NCT00631657|526150445|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
145902488|NCT00631657|526150446|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
145902489|NCT00631657|526150447|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
145902490|NCT00631657|526150445|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
145902491|NCT00631657|526150446|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
145902492|NCT00631657|526150447|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
145902493|NCT00631657|526150445|FG000|6-Month Treatment Period|Other|16|||
145902494|NCT00631657|526150446|FG001|6-Month Treatment Period|Other|0|||
145902495|NCT00631657|526150447|FG002|6-Month Treatment Period|Other|4|||
145902496|NCT00631657|526150445|FG000|6-Month Treatment Period|Not Treated|2|||
145902497|NCT00631657|526150446|FG001|6-Month Treatment Period|Not Treated|0|||
145902498|NCT00631657|526150447|FG002|6-Month Treatment Period|Not Treated|1|||
145902499|NCT00631657|526150445|FG000|7-Day Discontinuation Period|Not Treated|1|||
145902500|NCT00631657|526150446|FG001|7-Day Discontinuation Period|Not Treated|1|||
145902501|NCT00631657|526150447|FG002|7-Day Discontinuation Period|Not Treated|1|||
145902502|NCT00631657|526150445|FG000|7-Day Discontinuation Period|Other|1|||
145902503|NCT00631657|526150446|FG001|7-Day Discontinuation Period|Other|0|||
145902504|NCT00631657|526150447|FG002|7-Day Discontinuation Period|Other|0|||
145902505|NCT01284361|526150452|FG000|Overall Study|Withdrawal by Subject|1|||
145902506|NCT01284361|526150452|FG000|Overall Study|Protocol Violation|5|||
146088384|NCT01117051|526843830|FG000|Overall Study|Surgical procedure|0|||
145902507|NCT01284361|526150452|FG000|Overall Study|Adverse Event|1|||
145902508|NCT01284361|526150452|FG000|Overall Study|Lost to Follow-up|2|||
145902509|NCT01957397|526150459|FG000|Test Period 1|sudden leakage/small bag|1|||
145902510|NCT01957397|526150460|FG001|Test Period 1|sudden leakage/small bag|1|||
145902511|NCT01957397|526150459|FG000|Test Period 1|Withdrawal by Subject|1|||
145902512|NCT01957397|526150460|FG001|Test Period 1|Withdrawal by Subject|0|||
145902513|NCT01957397|526150459|FG000|Test Period 2|Adverse Event|0|||
145902514|NCT01957397|526150460|FG001|Test Period 2|Adverse Event|1|||
145902515|NCT01957397|526150459|FG000|Test Period 3|Adverse Event|1|||
145902516|NCT01957397|526150460|FG001|Test Period 3|Adverse Event|2|||
145902517|NCT01957397|526150459|FG000|Test Period 3|the adhesive did not work|1|||
145902518|NCT01957397|526150460|FG001|Test Period 3|the adhesive did not work|0|||
145902519|NCT00540293|526150461|FG000|Overall Study|Adverse event related to study drug|10|||
145902520|NCT00540293|526150461|FG000|Overall Study|Adverse event not related to study drug|7|||
145902521|NCT00540293|526150461|FG000|Overall Study|Withdrawal by Subject|6|||
145902522|NCT00540293|526150461|FG000|Overall Study|Protocol violation, & subject schedule|12|||
145902523|NCT00325195|526150464|FG000|Randomized|Not dosed|5|||
145902524|NCT00325195|526150465|FG001|Randomized|Not dosed|5|||
145902525|NCT00325195|526150466|FG002|Randomized|Not dosed|3|||
145902526|NCT00325195|526150464|FG000|Received Intervention: ITT Population|Adverse Event|15|||
145902527|NCT00325195|526150465|FG001|Received Intervention: ITT Population|Adverse Event|17|||
145902528|NCT00325195|526150466|FG002|Received Intervention: ITT Population|Adverse Event|1|||
145902529|NCT00325195|526150464|FG000|Received Intervention: ITT Population|Death|3|||
145902530|NCT00325195|526150465|FG001|Received Intervention: ITT Population|Death|1|||
145902531|NCT00325195|526150466|FG002|Received Intervention: ITT Population|Death|0|||
145902532|NCT00325195|526150464|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
145902533|NCT00325195|526150465|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
145902534|NCT00325195|526150466|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
145902535|NCT00325195|526150464|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
145902536|NCT00325195|526150465|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
145902537|NCT00325195|526150466|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
145902538|NCT00325195|526150464|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
145902539|NCT00325195|526150465|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
145902540|NCT00325195|526150466|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
145902541|NCT05083585|526150467|FG000|Overall Study|Death|1|||
145902542|NCT05083585|526150468|FG001|Overall Study|Death|1|||
145902543|NCT05083585|526150467|FG000|Overall Study|Lost to Follow-up|1|||
145902544|NCT05083585|526150468|FG001|Overall Study|Lost to Follow-up|1|||
145902545|NCT05083585|526150467|FG000|Overall Study|Withdrawal by Subject|2|||
145902546|NCT05083585|526150468|FG001|Overall Study|Withdrawal by Subject|0|||
145902547|NCT05083585|526150467|FG000|Overall Study|Randomized but not vaccinated|2|||
145902548|NCT05083585|526150468|FG001|Overall Study|Randomized but not vaccinated|0|||
145902549|NCT00806286|526150469|FG000|Overall Study|Adverse Event|5|||
145902550|NCT00806286|526150470|FG001|Overall Study|Adverse Event|2|||
145902551|NCT00806286|526150471|FG002|Overall Study|Adverse Event|0|||
145902552|NCT00806286|526150469|FG000|Overall Study|Disease progression|31|||
145902553|NCT00806286|526150470|FG001|Overall Study|Disease progression|38|||
145902554|NCT00806286|526150471|FG002|Overall Study|Disease progression|1|||
145902555|NCT00806286|526150469|FG000|Overall Study|Death|1|||
145902556|NCT00806286|526150470|FG001|Overall Study|Death|6|||
145902557|NCT00806286|526150471|FG002|Overall Study|Death|0|||
145902558|NCT00806286|526150469|FG000|Overall Study|Lost to Follow-up|0|||
145902559|NCT00806286|526150470|FG001|Overall Study|Lost to Follow-up|1|||
145902560|NCT00806286|526150471|FG002|Overall Study|Lost to Follow-up|0|||
145902561|NCT00806286|526150469|FG000|Overall Study|Withdrawal by Subject|8|||
145902562|NCT00806286|526150470|FG001|Overall Study|Withdrawal by Subject|3|||
145902563|NCT00806286|526150471|FG002|Overall Study|Withdrawal by Subject|1|||
145902564|NCT00806286|526150469|FG000|Overall Study|Physician Decision|2|||
145902565|NCT00806286|526150470|FG001|Overall Study|Physician Decision|2|||
145902566|NCT00806286|526150471|FG002|Overall Study|Physician Decision|0|||
145902567|NCT00806286|526150469|FG000|Overall Study|Due to a variety of reasons|7|||
145902568|NCT00806286|526150470|FG001|Overall Study|Due to a variety of reasons|2|||
145902569|NCT00806286|526150471|FG002|Overall Study|Due to a variety of reasons|1|||
145902570|NCT03469336|526150472|FG000|Overall Study|Adverse Event|1|||
145972556|NCT02566005|526412670|FG000|Overall Study|did not receive foley|0|||
145972557|NCT02566005|526412671|FG001|Overall Study|did not receive foley|1|||
145972558|NCT02566005|526412670|FG000|Overall Study|labor after randomization|0|||
145902571|NCT00686075|526150474|FG000|Overall Study|Withdrawal by Subject|4|||
145902572|NCT00686075|526150475|FG001|Overall Study|Withdrawal by Subject|3|||
145902573|NCT00686075|526150476|FG002|Overall Study|Withdrawal by Subject|3|||
145902574|NCT00686075|526150477|FG003|Overall Study|Withdrawal by Subject|7|||
145902575|NCT00686075|526150478|FG004|Overall Study|Withdrawal by Subject|1|||
145902576|NCT00686075|526150479|FG005|Overall Study|Withdrawal by Subject|0|||
145902577|NCT00686075|526150480|FG006|Overall Study|Withdrawal by Subject|0|||
145902578|NCT00686075|526150481|FG007|Overall Study|Withdrawal by Subject|2|||
145902579|NCT00686075|526150482|FG008|Overall Study|Withdrawal by Subject|4|||
145902580|NCT00686075|526150483|FG009|Overall Study|Withdrawal by Subject|6|||
145902581|NCT00686075|526150474|FG000|Overall Study|Lost to Follow-up|3|||
145902582|NCT00686075|526150475|FG001|Overall Study|Lost to Follow-up|6|||
145902583|NCT00686075|526150476|FG002|Overall Study|Lost to Follow-up|3|||
145902584|NCT00686075|526150477|FG003|Overall Study|Lost to Follow-up|2|||
145902585|NCT00686075|526150478|FG004|Overall Study|Lost to Follow-up|3|||
145902586|NCT00686075|526150479|FG005|Overall Study|Lost to Follow-up|3|||
145902587|NCT00686075|526150480|FG006|Overall Study|Lost to Follow-up|0|||
145902588|NCT00686075|526150481|FG007|Overall Study|Lost to Follow-up|0|||
145902589|NCT00686075|526150482|FG008|Overall Study|Lost to Follow-up|2|||
145902590|NCT00686075|526150483|FG009|Overall Study|Lost to Follow-up|3|||
145902591|NCT00686075|526150474|FG000|Overall Study|Other|1|||
145902592|NCT00686075|526150475|FG001|Overall Study|Other|1|||
145902593|NCT00686075|526150476|FG002|Overall Study|Other|0|||
145902594|NCT00686075|526150477|FG003|Overall Study|Other|0|||
145902595|NCT00686075|526150478|FG004|Overall Study|Other|0|||
145902596|NCT00686075|526150479|FG005|Overall Study|Other|0|||
145902597|NCT00686075|526150480|FG006|Overall Study|Other|0|||
145902598|NCT00686075|526150481|FG007|Overall Study|Other|0|||
145902599|NCT00686075|526150482|FG008|Overall Study|Other|0|||
145902600|NCT00686075|526150483|FG009|Overall Study|Other|1|||
145902601|NCT02740699|526150484|FG000|Overall Study|Lost to Follow-up|5|||
145902602|NCT02740699|526150484|FG000|Overall Study|Withdrawal by Subject|14|||
145902603|NCT02740699|526150484|FG000|Overall Study|Physician Decision|5|||
145902604|NCT04713553|526150486|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
145902605|NCT04713553|526150487|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
145902606|NCT04713553|526150488|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
145902607|NCT04713553|526150489|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
145902608|NCT04713553|526150490|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
145902609|NCT04713553|526150491|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
145902610|NCT04713553|526150492|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
145902611|NCT04713553|526150486|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902612|NCT04713553|526150487|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902613|NCT04713553|526150488|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902614|NCT04713553|526150489|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
145902615|NCT04713553|526150490|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902616|NCT04713553|526150491|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902617|NCT04713553|526150492|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145902618|NCT04713553|526150486|FG000|Primary Study (2 Months)|Other|1|||
145902619|NCT04713553|526150487|FG001|Primary Study (2 Months)|Other|2|||
145902620|NCT04713553|526150488|FG002|Primary Study (2 Months)|Other|0|||
145902621|NCT04713553|526150489|FG003|Primary Study (2 Months)|Other|0|||
145902622|NCT04713553|526150490|FG004|Primary Study (2 Months)|Other|1|||
145902623|NCT04713553|526150491|FG005|Primary Study (2 Months)|Other|0|||
145902624|NCT04713553|526150492|FG006|Primary Study (2 Months)|Other|0|||
145902625|NCT04713553|526150486|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
145902626|NCT04713553|526150487|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
145902627|NCT04713553|526150488|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
145902628|NCT04713553|526150489|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
145902629|NCT04713553|526150490|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
145902630|NCT04713553|526150491|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
145902631|NCT04713553|526150492|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
145902632|NCT04713553|526150486|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902633|NCT04713553|526150487|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902634|NCT04713553|526150488|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
145902635|NCT04713553|526150489|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902636|NCT04713553|526150490|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902637|NCT04713553|526150491|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902638|NCT04713553|526150492|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
145902639|NCT03783039|526150494|FG000|Overall Study|Death|2|||
145902640|NCT03783039|526150495|FG001|Overall Study|Death|1|||
145902641|NCT00918138|526150496|FG000|Overall Study|Subject withdrew consent|1|||
145902642|NCT00918138|526150497|FG001|Overall Study|Subject withdrew consent|1|||
145902643|NCT00918138|526150496|FG000|Overall Study|Death|1|||
145902644|NCT00918138|526150497|FG001|Overall Study|Death|0|||
145902645|NCT02315196|526150498|FG000|Overall Study|Withdrew consent|9|||
145902646|NCT03400943|526150499|FG000|Treatment Period 1|Adverse Event|0|||
145902647|NCT03400943|526150500|FG001|Treatment Period 1|Adverse Event|0|||
145902648|NCT03400943|526150501|FG002|Treatment Period 1|Adverse Event|0|||
145902649|NCT03400943|526150502|FG003|Treatment Period 1|Adverse Event|1|||
145902650|NCT03400943|526150499|FG000|Treatment Period 1|Lost to Follow-up|1|||
145902651|NCT03400943|526150500|FG001|Treatment Period 1|Lost to Follow-up|0|||
145902652|NCT03400943|526150501|FG002|Treatment Period 1|Lost to Follow-up|0|||
145902653|NCT03400943|526150502|FG003|Treatment Period 1|Lost to Follow-up|0|||
145902654|NCT03400943|526150499|FG000|Treatment Period 1|Protocol Violation|0|||
145902655|NCT03400943|526150500|FG001|Treatment Period 1|Protocol Violation|1|||
145902656|NCT03400943|526150501|FG002|Treatment Period 1|Protocol Violation|1|||
145902657|NCT03400943|526150502|FG003|Treatment Period 1|Protocol Violation|0|||
145902658|NCT03400943|526150499|FG000|Treatment Period 1|Study terminated by sponsor|2|||
145902659|NCT03400943|526150500|FG001|Treatment Period 1|Study terminated by sponsor|0|||
145902660|NCT03400943|526150501|FG002|Treatment Period 1|Study terminated by sponsor|0|||
145902661|NCT03400943|526150502|FG003|Treatment Period 1|Study terminated by sponsor|1|||
145902662|NCT03400943|526150499|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145902663|NCT03400943|526150500|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145902664|NCT03400943|526150501|FG002|Treatment Period 1|Withdrawal by Subject|3|||
145902665|NCT03400943|526150502|FG003|Treatment Period 1|Withdrawal by Subject|1|||
145902666|NCT03400943|526150499|FG000|Treatment Period 1|Other|2|||
145902667|NCT03400943|526150500|FG001|Treatment Period 1|Other|1|||
145902668|NCT03400943|526150501|FG002|Treatment Period 1|Other|2|||
145902669|NCT03400943|526150502|FG003|Treatment Period 1|Other|2|||
145902670|NCT03400943|526150499|FG000|Post-treatment Period 1|Adverse Event|2|||
145902671|NCT03400943|526150500|FG001|Post-treatment Period 1|Adverse Event|0|||
145902672|NCT03400943|526150501|FG002|Post-treatment Period 1|Adverse Event|0|||
145902673|NCT03400943|526150502|FG003|Post-treatment Period 1|Adverse Event|0|||
145902674|NCT03400943|526150499|FG000|Post-treatment Period 1|Protocol Violation|1|||
145902675|NCT03400943|526150500|FG001|Post-treatment Period 1|Protocol Violation|0|||
145902676|NCT03400943|526150501|FG002|Post-treatment Period 1|Protocol Violation|0|||
145902677|NCT03400943|526150502|FG003|Post-treatment Period 1|Protocol Violation|0|||
145902678|NCT03400943|526150499|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
145902679|NCT03400943|526150500|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
145902680|NCT03400943|526150501|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
145902681|NCT03400943|526150502|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
145902682|NCT03400943|526150499|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
145902683|NCT03400943|526150500|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
145902684|NCT03400943|526150501|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
145902685|NCT03400943|526150502|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
145902686|NCT03400943|526150499|FG000|Post-treatment Period 1|Other|2|||
145902687|NCT03400943|526150500|FG001|Post-treatment Period 1|Other|0|||
145902688|NCT03400943|526150501|FG002|Post-treatment Period 1|Other|4|||
145902689|NCT03400943|526150502|FG003|Post-treatment Period 1|Other|5|||
145902690|NCT03400943|526150499|FG000|Treatment Period 2|Study terminated by sponsor|0|||
145902691|NCT03400943|526150500|FG001|Treatment Period 2|Study terminated by sponsor|1|||
145902692|NCT03400943|526150501|FG002|Treatment Period 2|Study terminated by sponsor|0|||
145902693|NCT03400943|526150502|FG003|Treatment Period 2|Study terminated by sponsor|0|||
145902694|NCT03400943|526150499|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145902695|NCT03400943|526150500|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145902696|NCT03400943|526150501|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145902697|NCT03400943|526150502|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145902698|NCT03400943|526150499|FG000|Treatment Period 2|Other|1|||
145902699|NCT03400943|526150500|FG001|Treatment Period 2|Other|6|||
145902700|NCT03400943|526150501|FG002|Treatment Period 2|Other|0|||
145902701|NCT03400943|526150502|FG003|Treatment Period 2|Other|0|||
145902702|NCT03400943|526150499|FG000|Follow-up Period|Withdrawal by Subject|1|||
145902703|NCT03400943|526150500|FG001|Follow-up Period|Withdrawal by Subject|0|||
145902704|NCT03400943|526150501|FG002|Follow-up Period|Withdrawal by Subject|0|||
145902705|NCT03400943|526150502|FG003|Follow-up Period|Withdrawal by Subject|0|||
145902706|NCT03839823|526150503|FG000|Overall Study|Adverse Event|8|||
145902707|NCT03839823|526150504|FG001|Overall Study|Adverse Event|4|||
145902708|NCT03839823|526150503|FG000|Overall Study|Death|1|||
145902709|NCT03839823|526150504|FG001|Overall Study|Death|0|||
145902710|NCT03839823|526150503|FG000|Overall Study|Physician Decision|1|||
145902711|NCT03839823|526150504|FG001|Overall Study|Physician Decision|5|||
145902712|NCT03839823|526150503|FG000|Overall Study|Progressive Disease (PD)|65|||
145902713|NCT03839823|526150504|FG001|Overall Study|Progressive Disease (PD)|65|||
145902714|NCT03839823|526150503|FG000|Overall Study|Subject Decision|2|||
145902715|NCT03839823|526150504|FG001|Overall Study|Subject Decision|9|||
145902716|NCT03839823|526150503|FG000|Overall Study|Not Treated|0|||
145902717|NCT03839823|526150504|FG001|Overall Study|Not Treated|10|||
145902718|NCT03327792|526150505|FG000|Overall Study|Adverse Event|4|||
145902719|NCT03327792|526150506|FG001|Overall Study|Adverse Event|0|||
145902720|NCT03327792|526150505|FG000|Overall Study|Family/Personal issues|3|||
146088385|NCT01117051|526843831|FG001|Overall Study|Surgical procedure|1|||
145902721|NCT03327792|526150506|FG001|Overall Study|Family/Personal issues|2|||
145902722|NCT03327792|526150505|FG000|Overall Study|Lost to Follow-up|0|||
145902723|NCT03327792|526150506|FG001|Overall Study|Lost to Follow-up|1|||
145902724|NCT01475097|526150511|FG000|Overall Study|Protocol Violation|1|||
145902725|NCT01475097|526150512|FG001|Overall Study|Protocol Violation|1|||
145902726|NCT04516759|526150514|FG000|Overall Study|Withdrawal by Subject|1|||
145902727|NCT04516759|526150515|FG001|Overall Study|Withdrawal by Subject|1|||
145902728|NCT04516759|526150514|FG000|Overall Study|Other|0|||
145902729|NCT04516759|526150515|FG001|Overall Study|Other|1|||
145902730|NCT01001988|526150516|FG000|Overall Study|Protocol Violation|84|||
145902731|NCT01001988|526150516|FG000|Overall Study|Withdrawal by Subject|18|||
145902732|NCT01001988|526150516|FG000|Overall Study|Lost to Follow-up|15|||
145902733|NCT01221363|526150519|FG000|Overall Study|Pregnancy|1|||
145902734|NCT01221363|526150520|FG001|Overall Study|Pregnancy|0|||
145902735|NCT01221363|526150519|FG000|Overall Study|Withdrawal by Subject|11|||
145902736|NCT01221363|526150520|FG001|Overall Study|Withdrawal by Subject|5|||
145902737|NCT01329549|526150523|FG000|Overall Study|Withdrawal by Subject|1|||
145902738|NCT01329549|526150523|FG000|Overall Study|Adverse Event|1|||
145902739|NCT01756079|526150526|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
145902740|NCT01756079|526150526|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
145902741|NCT01756079|526150526|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
145902742|NCT01756079|526150526|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
145902743|NCT01756079|526150526|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
145902744|NCT04015908|526150527|FG000|Overall Study|Lost to Follow-up|0|||
145902745|NCT04015908|526150528|FG001|Overall Study|Lost to Follow-up|1|||
145902746|NCT01775189|526150529|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902747|NCT01775189|526150530|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
145902748|NCT01775189|526150531|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902749|NCT01775189|526150532|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902750|NCT01775189|526150533|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902751|NCT01775189|526150534|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902752|NCT01775189|526150535|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145902753|NCT01775189|526150529|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902754|NCT01775189|526150530|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
145902755|NCT01775189|526150531|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902756|NCT01775189|526150532|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902757|NCT01775189|526150533|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902758|NCT01775189|526150534|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902759|NCT01775189|526150535|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145902760|NCT01775189|526150529|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145902761|NCT01775189|526150530|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
145902762|NCT01775189|526150531|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
145902763|NCT01775189|526150532|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145902764|NCT01775189|526150533|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145902765|NCT01775189|526150534|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145902766|NCT01775189|526150535|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145902767|NCT01775189|526150529|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902768|NCT01775189|526150530|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902769|NCT01775189|526150531|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902770|NCT01775189|526150532|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902771|NCT01775189|526150533|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902772|NCT01775189|526150534|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
145902773|NCT01775189|526150535|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145902774|NCT01775189|526150529|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902775|NCT01775189|526150530|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902776|NCT01775189|526150531|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902777|NCT01775189|526150532|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
145902778|NCT01775189|526150533|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902779|NCT01775189|526150534|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902780|NCT01775189|526150535|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145902781|NCT01775189|526150529|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145902782|NCT01775189|526150530|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145902783|NCT01775189|526150531|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145902784|NCT01775189|526150532|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
145902785|NCT01775189|526150533|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145902786|NCT01775189|526150534|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145902787|NCT01775189|526150535|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
145902788|NCT01755767|526150536|FG000|Overall Study|Progressive Disease|8|||
145902789|NCT01755767|526150537|FG001|Overall Study|Progressive Disease|7|||
145902790|NCT01755767|526150538|FG002|Overall Study|Progressive Disease|91|||
145902791|NCT01755767|526150539|FG003|Overall Study|Progressive Disease|43|||
145902792|NCT01755767|526150536|FG000|Overall Study|Clinical Disease Progression|4|||
145902793|NCT01755767|526150537|FG001|Overall Study|Clinical Disease Progression|2|||
145902794|NCT01755767|526150538|FG002|Overall Study|Clinical Disease Progression|29|||
145902795|NCT01755767|526150539|FG003|Overall Study|Clinical Disease Progression|20|||
145902796|NCT01755767|526150536|FG000|Overall Study|Radiographic Disease Progression|9|||
145902797|NCT01755767|526150537|FG001|Overall Study|Radiographic Disease Progression|4|||
146297341|NCT01603082|527604669|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
145902798|NCT01755767|526150538|FG002|Overall Study|Radiographic Disease Progression|44|||
145902799|NCT01755767|526150539|FG003|Overall Study|Radiographic Disease Progression|27|||
145902800|NCT01755767|526150536|FG000|Overall Study|Adverse Event|6|||
145902801|NCT01755767|526150537|FG001|Overall Study|Adverse Event|0|||
145902802|NCT01755767|526150538|FG002|Overall Study|Adverse Event|28|||
145902803|NCT01755767|526150539|FG003|Overall Study|Adverse Event|11|||
145902804|NCT01755767|526150536|FG000|Overall Study|Death|1|||
145902805|NCT01755767|526150537|FG001|Overall Study|Death|2|||
145902806|NCT01755767|526150538|FG002|Overall Study|Death|15|||
145902807|NCT01755767|526150539|FG003|Overall Study|Death|4|||
145902808|NCT01755767|526150536|FG000|Overall Study|Subject Decision|0|||
145902809|NCT01755767|526150537|FG001|Overall Study|Subject Decision|0|||
145902810|NCT01755767|526150538|FG002|Overall Study|Subject Decision|10|||
145902811|NCT01755767|526150539|FG003|Overall Study|Subject Decision|3|||
145902812|NCT01755767|526150536|FG000|Overall Study|Withdrawal by Subject|0|||
145902813|NCT01755767|526150537|FG001|Overall Study|Withdrawal by Subject|0|||
145902814|NCT01755767|526150538|FG002|Overall Study|Withdrawal by Subject|2|||
145902815|NCT01755767|526150539|FG003|Overall Study|Withdrawal by Subject|1|||
145902816|NCT01755767|526150536|FG000|Overall Study|Other|0|||
145902817|NCT01755767|526150537|FG001|Overall Study|Other|0|||
145902818|NCT01755767|526150538|FG002|Overall Study|Other|2|||
145902819|NCT01755767|526150539|FG003|Overall Study|Other|3|||
145902820|NCT01755767|526150536|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
145902821|NCT01755767|526150537|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
145902822|NCT01755767|526150538|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
145902823|NCT01755767|526150539|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
145902824|NCT04623086|526150540|FG000|Overall Study|Withdrawal by Subject|0|||
145902825|NCT04623086|526150541|FG001|Overall Study|Withdrawal by Subject|0|||
145902826|NCT04623086|526150542|FG002|Overall Study|Withdrawal by Subject|10|||
145902827|NCT00191165|526150543|FG000|Overall Study|Adverse Event|2|||
145902828|NCT00191165|526150544|FG001|Overall Study|Adverse Event|0|||
145902829|NCT00191165|526150543|FG000|Overall Study|Protocol Violation|0|||
145902830|NCT00191165|526150544|FG001|Overall Study|Protocol Violation|1|||
145902831|NCT00191165|526150543|FG000|Overall Study|Participant Moved Away|0|||
145902832|NCT00191165|526150544|FG001|Overall Study|Participant Moved Away|1|||
145902833|NCT00715624|526150545|FG000|Overall Study|Adverse Event|12|||
145902834|NCT00715624|526150546|FG001|Overall Study|Adverse Event|37|||
145902835|NCT00715624|526150545|FG000|Overall Study|Lack of Efficacy|11|||
145902836|NCT00715624|526150546|FG001|Overall Study|Lack of Efficacy|11|||
145902837|NCT00715624|526150545|FG000|Overall Study|Lost to Follow-up|1|||
145902838|NCT00715624|526150546|FG001|Overall Study|Lost to Follow-up|2|||
145902839|NCT00715624|526150545|FG000|Overall Study|Protocol Violation|1|||
145902840|NCT00715624|526150546|FG001|Overall Study|Protocol Violation|0|||
145902841|NCT00715624|526150545|FG000|Overall Study|Withdrawal by Subject|11|||
145902842|NCT00715624|526150546|FG001|Overall Study|Withdrawal by Subject|25|||
145902843|NCT00715624|526150545|FG000|Overall Study|Familial and personal reasons|10|||
145902844|NCT00715624|526150546|FG001|Overall Study|Familial and personal reasons|22|||
145902845|NCT00715624|526150545|FG000|Overall Study|Poor compliance|6|||
145902846|NCT00715624|526150546|FG001|Overall Study|Poor compliance|13|||
145902847|NCT00715624|526150545|FG000|Overall Study|Sponsor decision|0|||
145902848|NCT00715624|526150546|FG001|Overall Study|Sponsor decision|4|||
145902849|NCT00715624|526150545|FG000|Overall Study|Incorrect randomization (not treated)|0|||
145902850|NCT00715624|526150546|FG001|Overall Study|Incorrect randomization (not treated)|1|||
145902851|NCT00715624|526150545|FG000|Overall Study|Other|0|||
145902852|NCT00715624|526150546|FG001|Overall Study|Other|1|||
145902853|NCT03200912|526150547|FG000|Overall Study|Adverse Event|3|||
145902854|NCT03200912|526150548|FG001|Overall Study|Adverse Event|0|||
145902855|NCT03200912|526150549|FG002|Overall Study|Adverse Event|0|||
145902856|NCT03200912|526150547|FG000|Overall Study|Withdrawal by Subject|1|||
145902857|NCT03200912|526150548|FG001|Overall Study|Withdrawal by Subject|2|||
145902858|NCT03200912|526150549|FG002|Overall Study|Withdrawal by Subject|4|||
145902859|NCT03200912|526150547|FG000|Overall Study|Non-compliance with study drug|0|||
145902860|NCT03200912|526150548|FG001|Overall Study|Non-compliance with study drug|1|||
145902861|NCT03200912|526150549|FG002|Overall Study|Non-compliance with study drug|0|||
145902862|NCT03196635|526150551|FG000|Overall Study|Withdrawal by Subject|1|||
145902863|NCT00998309|526150555|FG000|Overall Study|Protocol Violation|4|||
145902864|NCT00735397|526150557|FG000|Overall Study|Adverse Event|194|||
145902865|NCT00735397|526150557|FG000|Overall Study|Lost to Follow-up|33|||
145902866|NCT00735397|526150557|FG000|Overall Study|Participant choice|252|||
145902867|NCT00735397|526150557|FG000|Overall Study|Inadequate therapeutic effect|202|||
145902868|NCT00735397|526150557|FG000|Overall Study|Administrative/Other|502|||
145902869|NCT02865460|526150560|FG000|Overall Study|Adverse Event|1|||
145902870|NCT02865460|526150561|FG001|Overall Study|Adverse Event|0|||
145902871|NCT02865460|526150560|FG000|Overall Study|Withdrawal by Subject|1|||
145902872|NCT02865460|526150561|FG001|Overall Study|Withdrawal by Subject|1|||
145902873|NCT02865460|526150560|FG000|Overall Study|Lost to Follow-up|7|||
145902874|NCT02865460|526150561|FG001|Overall Study|Lost to Follow-up|4|||
145902875|NCT02865460|526150560|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
145902876|NCT02865460|526150561|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
145902877|NCT00380744|526150562|FG000|Overall Study|Death|0|||
145902878|NCT00380744|526150563|FG001|Overall Study|Death|0|||
145902879|NCT00380744|526150564|FG002|Overall Study|Death|0|||
145902880|NCT00380744|526150565|FG003|Overall Study|Death|0|||
145902881|NCT00380744|526150566|FG004|Overall Study|Death|0|||
145902882|NCT00380744|526150567|FG005|Overall Study|Death|0|||
145902883|NCT00380744|526150568|FG006|Overall Study|Death|1|||
145902884|NCT00380744|526150562|FG000|Overall Study|Withdrawal by Subject|1|||
145902885|NCT00380744|526150563|FG001|Overall Study|Withdrawal by Subject|0|||
145902886|NCT00380744|526150564|FG002|Overall Study|Withdrawal by Subject|0|||
145902887|NCT00380744|526150565|FG003|Overall Study|Withdrawal by Subject|0|||
145902888|NCT00380744|526150566|FG004|Overall Study|Withdrawal by Subject|0|||
145902889|NCT00380744|526150567|FG005|Overall Study|Withdrawal by Subject|0|||
145902890|NCT00380744|526150568|FG006|Overall Study|Withdrawal by Subject|0|||
145902891|NCT01696279|526150569|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
145902892|NCT01696279|526150570|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145902893|NCT01696279|526150571|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145902894|NCT01696279|526150572|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145902895|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145902896|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
145902897|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145902898|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145902899|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145902900|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
145902901|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145902902|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145902903|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145902904|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
145902905|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145902906|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145902907|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145902908|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
145902909|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145902910|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145902911|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145902912|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
145902913|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145902914|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145902915|NCT01696279|526150569|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145902916|NCT01696279|526150570|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
145902917|NCT01696279|526150571|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145902918|NCT01696279|526150572|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145902919|NCT01696279|526150569|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145902920|NCT01696279|526150570|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145902921|NCT01696279|526150571|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
145902922|NCT01696279|526150572|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145902923|NCT01696279|526150569|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145902924|NCT01696279|526150570|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145902925|NCT01696279|526150571|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145902926|NCT01696279|526150572|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
145902927|NCT01696279|526150569|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145902928|NCT01696279|526150570|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145902929|NCT01696279|526150571|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145902930|NCT01696279|526150572|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
145902931|NCT01696279|526150569|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145902932|NCT01696279|526150570|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145902933|NCT01696279|526150571|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145902934|NCT01696279|526150572|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
145902935|NCT01441947|526150574|FG000|Overall Study|Withdrawal by Subject|3|||
145902936|NCT01441947|526150575|FG001|Overall Study|Withdrawal by Subject|0|||
145902937|NCT02927366|526150576|FG000|Overall Study|Adverse Event|1|||
145902938|NCT02927366|526150577|FG001|Overall Study|Adverse Event|0|||
145902939|NCT02927366|526150576|FG000|Overall Study|Patient schedule|1|||
145902940|NCT02927366|526150577|FG001|Overall Study|Patient schedule|0|||
145902941|NCT00724048|526150578|FG000|Overall Study|Adverse Event|1|||
145902942|NCT00724048|526150579|FG001|Overall Study|Adverse Event|1|||
146297342|NCT01603082|527604670|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
145902943|NCT00724048|526150580|FG002|Overall Study|Adverse Event|1|||
145902944|NCT00724048|526150581|FG003|Overall Study|Adverse Event|0|||
145902945|NCT00724048|526150578|FG000|Overall Study|Lost to Follow-up|0|||
145902946|NCT00724048|526150579|FG001|Overall Study|Lost to Follow-up|1|||
145902947|NCT00724048|526150580|FG002|Overall Study|Lost to Follow-up|0|||
145902948|NCT00724048|526150581|FG003|Overall Study|Lost to Follow-up|0|||
145902949|NCT00724048|526150578|FG000|Overall Study|Withdrawal by Subject|1|||
145902950|NCT00724048|526150579|FG001|Overall Study|Withdrawal by Subject|2|||
145902951|NCT00724048|526150580|FG002|Overall Study|Withdrawal by Subject|1|||
145902952|NCT00724048|526150581|FG003|Overall Study|Withdrawal by Subject|2|||
145902953|NCT00724048|526150578|FG000|Overall Study|Investigator decision|0|||
145902954|NCT00724048|526150579|FG001|Overall Study|Investigator decision|0|||
145902955|NCT00724048|526150580|FG002|Overall Study|Investigator decision|1|||
145902956|NCT00724048|526150581|FG003|Overall Study|Investigator decision|0|||
145902957|NCT00724048|526150578|FG000|Overall Study|Did not tolerate study drug|0|||
145902958|NCT00724048|526150579|FG001|Overall Study|Did not tolerate study drug|0|||
145902959|NCT00724048|526150580|FG002|Overall Study|Did not tolerate study drug|0|||
145902960|NCT00724048|526150581|FG003|Overall Study|Did not tolerate study drug|1|||
145902961|NCT00724048|526150578|FG000|Overall Study|Other than specified|1|||
145902962|NCT00724048|526150579|FG001|Overall Study|Other than specified|1|||
145902963|NCT00724048|526150580|FG002|Overall Study|Other than specified|0|||
145902964|NCT00724048|526150581|FG003|Overall Study|Other than specified|0|||
145902965|NCT02329847|526150582|FG000|Overall Study|Death|4|||
145902966|NCT02329847|526150583|FG001|Overall Study|Death|4|||
145902967|NCT02329847|526150584|FG002|Overall Study|Death|22|||
145902968|NCT02329847|526150585|FG003|Overall Study|Death|12|||
145902969|NCT02329847|526150586|FG004|Overall Study|Death|20|||
145902970|NCT02329847|526150587|FG005|Overall Study|Death|13|||
145902971|NCT02329847|526150582|FG000|Overall Study|Lost to Follow-up|0|||
145902972|NCT02329847|526150583|FG001|Overall Study|Lost to Follow-up|0|||
145902973|NCT02329847|526150584|FG002|Overall Study|Lost to Follow-up|2|||
145902974|NCT02329847|526150585|FG003|Overall Study|Lost to Follow-up|3|||
145902975|NCT02329847|526150586|FG004|Overall Study|Lost to Follow-up|0|||
145902976|NCT02329847|526150587|FG005|Overall Study|Lost to Follow-up|1|||
145902977|NCT02329847|526150582|FG000|Overall Study|Physician Decision|0|||
145902978|NCT02329847|526150583|FG001|Overall Study|Physician Decision|0|||
145902979|NCT02329847|526150584|FG002|Overall Study|Physician Decision|0|||
145902980|NCT02329847|526150585|FG003|Overall Study|Physician Decision|0|||
145902981|NCT02329847|526150586|FG004|Overall Study|Physician Decision|1|||
145902982|NCT02329847|526150587|FG005|Overall Study|Physician Decision|0|||
145902983|NCT02329847|526150582|FG000|Overall Study|Withdrawal by Subject|2|||
145902984|NCT02329847|526150583|FG001|Overall Study|Withdrawal by Subject|1|||
145902985|NCT02329847|526150584|FG002|Overall Study|Withdrawal by Subject|5|||
145902986|NCT02329847|526150585|FG003|Overall Study|Withdrawal by Subject|7|||
145902987|NCT02329847|526150586|FG004|Overall Study|Withdrawal by Subject|8|||
145902988|NCT02329847|526150587|FG005|Overall Study|Withdrawal by Subject|3|||
145902989|NCT02329847|526150582|FG000|Overall Study|Other|1|||
145902990|NCT02329847|526150583|FG001|Overall Study|Other|2|||
145902991|NCT02329847|526150584|FG002|Overall Study|Other|6|||
145902992|NCT02329847|526150585|FG003|Overall Study|Other|13|||
145902993|NCT02329847|526150586|FG004|Overall Study|Other|10|||
145902994|NCT02329847|526150587|FG005|Overall Study|Other|3|||
145902995|NCT03918109|526150589|FG000|Overall Study|Withdrawal by Subject|0|||
145902996|NCT03918109|526150590|FG001|Overall Study|Withdrawal by Subject|0|||
145902997|NCT03918109|526150591|FG002|Overall Study|Withdrawal by Subject|2|||
145902998|NCT03918109|526150592|FG003|Overall Study|Withdrawal by Subject|1|||
145902999|NCT03918109|526150589|FG000|Overall Study|Lost to Follow-up|0|||
145903000|NCT03918109|526150590|FG001|Overall Study|Lost to Follow-up|0|||
145903001|NCT03918109|526150591|FG002|Overall Study|Lost to Follow-up|0|||
145903002|NCT03918109|526150592|FG003|Overall Study|Lost to Follow-up|1|||
145903003|NCT03276780|526150593|FG000|Overall Study|Withdrawal by Subject|5|||
145903004|NCT03276780|526150594|FG001|Overall Study|Withdrawal by Subject|3|||
145903005|NCT03276780|526150593|FG000|Overall Study|Lost to Follow-up|3|||
145903006|NCT03276780|526150594|FG001|Overall Study|Lost to Follow-up|5|||
145903007|NCT03276780|526150593|FG000|Overall Study|Moved out of state|1|||
145903008|NCT03276780|526150594|FG001|Overall Study|Moved out of state|1|||
145903009|NCT03276780|526150593|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
145903010|NCT03276780|526150594|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
145903011|NCT03276780|526150593|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
145903012|NCT03276780|526150594|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
145903013|NCT02304458|526150595|FG000|Overall Study|Adverse Event|0|||
145903014|NCT02304458|526150596|FG001|Overall Study|Adverse Event|0|||
145903015|NCT02304458|526150597|FG002|Overall Study|Adverse Event|7|||
145903016|NCT02304458|526150598|FG003|Overall Study|Adverse Event|0|||
145903017|NCT02304458|526150599|FG004|Overall Study|Adverse Event|0|||
145903018|NCT02304458|526150600|FG005|Overall Study|Adverse Event|0|||
145903019|NCT02304458|526150601|FG006|Overall Study|Adverse Event|3|||
145903020|NCT02304458|526150602|FG007|Overall Study|Adverse Event|4|||
145903021|NCT02304458|526150595|FG000|Overall Study|Death|0|||
145903022|NCT02304458|526150596|FG001|Overall Study|Death|0|||
145903023|NCT02304458|526150597|FG002|Overall Study|Death|2|||
145903024|NCT02304458|526150598|FG003|Overall Study|Death|0|||
145903025|NCT02304458|526150599|FG004|Overall Study|Death|0|||
145903026|NCT02304458|526150600|FG005|Overall Study|Death|0|||
145903027|NCT02304458|526150601|FG006|Overall Study|Death|1|||
145903028|NCT02304458|526150602|FG007|Overall Study|Death|0|||
145903029|NCT02304458|526150595|FG000|Overall Study|Lack of Efficacy|4|||
145903030|NCT02304458|526150596|FG001|Overall Study|Lack of Efficacy|6|||
145903031|NCT02304458|526150597|FG002|Overall Study|Lack of Efficacy|38|||
145903032|NCT02304458|526150598|FG003|Overall Study|Lack of Efficacy|5|||
145903033|NCT02304458|526150599|FG004|Overall Study|Lack of Efficacy|6|||
145903034|NCT02304458|526150600|FG005|Overall Study|Lack of Efficacy|6|||
145903035|NCT02304458|526150601|FG006|Overall Study|Lack of Efficacy|21|||
145903036|NCT02304458|526150602|FG007|Overall Study|Lack of Efficacy|4|||
145903037|NCT02304458|526150595|FG000|Overall Study|Physician Decision|2|||
145903038|NCT02304458|526150596|FG001|Overall Study|Physician Decision|0|||
145903039|NCT02304458|526150597|FG002|Overall Study|Physician Decision|16|||
145903040|NCT02304458|526150598|FG003|Overall Study|Physician Decision|1|||
145903041|NCT02304458|526150599|FG004|Overall Study|Physician Decision|0|||
145903042|NCT02304458|526150600|FG005|Overall Study|Physician Decision|0|||
145903043|NCT02304458|526150601|FG006|Overall Study|Physician Decision|3|||
145903044|NCT02304458|526150602|FG007|Overall Study|Physician Decision|0|||
145903045|NCT02304458|526150595|FG000|Overall Study|Protocol Violation|0|||
145903046|NCT02304458|526150596|FG001|Overall Study|Protocol Violation|0|||
145903047|NCT02304458|526150597|FG002|Overall Study|Protocol Violation|1|||
145903048|NCT02304458|526150598|FG003|Overall Study|Protocol Violation|0|||
145903049|NCT02304458|526150599|FG004|Overall Study|Protocol Violation|0|||
145903050|NCT02304458|526150600|FG005|Overall Study|Protocol Violation|0|||
145903051|NCT02304458|526150601|FG006|Overall Study|Protocol Violation|0|||
145903052|NCT02304458|526150602|FG007|Overall Study|Protocol Violation|0|||
145903053|NCT02304458|526150595|FG000|Overall Study|Withdrawal by Subject|1|||
145903054|NCT02304458|526150596|FG001|Overall Study|Withdrawal by Subject|0|||
145903055|NCT02304458|526150597|FG002|Overall Study|Withdrawal by Subject|7|||
145903056|NCT02304458|526150598|FG003|Overall Study|Withdrawal by Subject|0|||
145903057|NCT02304458|526150599|FG004|Overall Study|Withdrawal by Subject|0|||
145903058|NCT02304458|526150600|FG005|Overall Study|Withdrawal by Subject|0|||
145903059|NCT02304458|526150601|FG006|Overall Study|Withdrawal by Subject|1|||
145903060|NCT02304458|526150602|FG007|Overall Study|Withdrawal by Subject|0|||
145903061|NCT00390221|526150603|FG000|Overall Study|Lost to Follow-up|0|||
145903062|NCT00390221|526150604|FG001|Overall Study|Lost to Follow-up|3|||
145903063|NCT00390221|526150605|FG002|Overall Study|Lost to Follow-up|0|||
145903064|NCT00390221|526150603|FG000|Overall Study|Adverse Event|1|||
145903065|NCT00390221|526150604|FG001|Overall Study|Adverse Event|4|||
145903066|NCT00390221|526150605|FG002|Overall Study|Adverse Event|3|||
145903067|NCT00390221|526150603|FG000|Overall Study|Investigator Decision|0|||
145903068|NCT00390221|526150604|FG001|Overall Study|Investigator Decision|0|||
145903069|NCT00390221|526150605|FG002|Overall Study|Investigator Decision|1|||
145903070|NCT00390221|526150603|FG000|Overall Study|Withdrawal by Subject|13|||
145903071|NCT00390221|526150604|FG001|Overall Study|Withdrawal by Subject|9|||
145903072|NCT00390221|526150605|FG002|Overall Study|Withdrawal by Subject|7|||
145903073|NCT00390221|526150603|FG000|Overall Study|Subject Non-compliance|1|||
145903074|NCT00390221|526150604|FG001|Overall Study|Subject Non-compliance|0|||
145903075|NCT00390221|526150605|FG002|Overall Study|Subject Non-compliance|2|||
145903076|NCT00390221|526150603|FG000|Overall Study|Other|3|||
145903077|NCT00390221|526150604|FG001|Overall Study|Other|4|||
145903078|NCT00390221|526150605|FG002|Overall Study|Other|2|||
145903079|NCT02013674|526150610|FG000|Overall Study|Death|0|||
145903080|NCT02013674|526150611|FG001|Overall Study|Death|1|||
145903081|NCT02013674|526150610|FG000|Overall Study|Lost to Follow-up|1|||
145903082|NCT02013674|526150611|FG001|Overall Study|Lost to Follow-up|0|||
145903083|NCT03433755|526150615|FG000|Overall Study|Lost to Follow-up|1|||
145903084|NCT03433755|526150616|FG001|Overall Study|Lost to Follow-up|0|||
145903085|NCT03433755|526150617|FG002|Overall Study|Lost to Follow-up|0|||
145903086|NCT03433755|526150618|FG003|Overall Study|Lost to Follow-up|0|||
145903087|NCT03433755|526150615|FG000|Overall Study|Decision by Sponsor|1|||
145903088|NCT03433755|526150616|FG001|Overall Study|Decision by Sponsor|0|||
145903089|NCT03433755|526150617|FG002|Overall Study|Decision by Sponsor|0|||
145903090|NCT03433755|526150618|FG003|Overall Study|Decision by Sponsor|0|||
145903091|NCT05065567|526150622|FG000|Overall Study|Lost to Follow-up|10|||
145903092|NCT05065567|526150623|FG001|Overall Study|Lost to Follow-up|9|||
145903093|NCT05065567|526150624|FG002|Overall Study|Lost to Follow-up|6|||
145903094|NCT03589768|526152680|FG000|Overall Study|Death|1|||
145903095|NCT03589768|526152681|FG001|Overall Study|Death|0|||
145903096|NCT03589768|526152682|FG002|Overall Study|Death|8|||
145903097|NCT03589768|526152683|FG003|Overall Study|Death|3|||
145903098|NCT03589768|526152680|FG000|Overall Study|Withdrawal by Subject|2|||
145903099|NCT03589768|526152681|FG001|Overall Study|Withdrawal by Subject|0|||
145903100|NCT03589768|526152682|FG002|Overall Study|Withdrawal by Subject|0|||
145903101|NCT03589768|526152683|FG003|Overall Study|Withdrawal by Subject|0|||
146238878|NCT01701401|527388064|FG000|Overall Study|Withdrew Consent|0|||
145903102|NCT03589768|526152680|FG000|Overall Study|Protocol Violation|1|||
145903103|NCT03589768|526152681|FG001|Overall Study|Protocol Violation|0|||
145903104|NCT03589768|526152682|FG002|Overall Study|Protocol Violation|0|||
145903105|NCT03589768|526152683|FG003|Overall Study|Protocol Violation|0|||
145903106|NCT04663295|526152684|FG000|Run-in Period|Withdrawal by Subject|3|||
145903107|NCT04663295|526152684|FG000|Overall Study Period|Pregnancy|1|||
145903108|NCT04663295|526152684|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
145903109|NCT03972163|526152697|FG000|Overall Study|Death|0|||
145903110|NCT03972163|526152698|FG001|Overall Study|Death|1|||
145903111|NCT00537303|526152699|FG000|Overall Study|Adverse Event|1|||
145903112|NCT00537303|526152700|FG001|Overall Study|Adverse Event|4|||
145903113|NCT00537303|526152699|FG000|Overall Study|Lack of Efficacy|6|||
145903114|NCT00537303|526152700|FG001|Overall Study|Lack of Efficacy|7|||
145903115|NCT00537303|526152699|FG000|Overall Study|Protocol Violation|8|||
145903116|NCT00537303|526152700|FG001|Overall Study|Protocol Violation|4|||
145903117|NCT00537303|526152699|FG000|Overall Study|Withdrawal criteria|3|||
145903118|NCT00537303|526152700|FG001|Overall Study|Withdrawal criteria|3|||
145903119|NCT00537303|526152699|FG000|Overall Study|Unclassified|8|||
145903120|NCT00537303|526152700|FG001|Overall Study|Unclassified|7|||
145903121|NCT03511326|526152702|FG000|Overall Study|Withdrawal by Subject|1|||
145903122|NCT00849186|526152703|FG000|Overall Study|Adverse Event|2|||
145903123|NCT00849186|526152703|FG000|Overall Study|Withdrawal by Subject|1|||
145903124|NCT00849186|526152703|FG000|Overall Study|not treated|6|||
145903125|NCT00849186|526152703|FG000|Overall Study|Other|1|||
145903126|NCT00867503|526152706|FG000|Overall Study|Withdrawal by Subject|1|||
145903127|NCT02704403|526152707|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
145903128|NCT02704403|526152708|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
145903129|NCT02704403|526152707|FG000|Overall Study|Administrative reasons by sponsor|1251|||
145903130|NCT02704403|526152708|FG001|Overall Study|Administrative reasons by sponsor|616|||
145903131|NCT02704403|526152707|FG000|Overall Study|Death|4|||
145903132|NCT02704403|526152708|FG001|Overall Study|Death|3|||
145903133|NCT02704403|526152707|FG000|Overall Study|Endpoint event|52|||
145903134|NCT02704403|526152708|FG001|Overall Study|Endpoint event|24|||
145903135|NCT02704403|526152707|FG000|Overall Study|Lost to Follow-up|22|||
145903136|NCT02704403|526152708|FG001|Overall Study|Lost to Follow-up|11|||
145903137|NCT02704403|526152707|FG000|Overall Study|Protocol Violation|15|||
145903138|NCT02704403|526152708|FG001|Overall Study|Protocol Violation|15|||
145903139|NCT02704403|526152707|FG000|Overall Study|Adverse Event|2|||
145903140|NCT02704403|526152708|FG001|Overall Study|Adverse Event|0|||
145903141|NCT02704403|526152707|FG000|Overall Study|Withdrawal by Subject|85|||
145903142|NCT02704403|526152708|FG001|Overall Study|Withdrawal by Subject|45|||
145903143|NCT02704403|526152707|FG000|Overall Study|Investigator decision|1|||
145903144|NCT02704403|526152708|FG001|Overall Study|Investigator decision|1|||
145903145|NCT02704403|526152707|FG000|Overall Study|Follow-up not possible|1|||
145903146|NCT02704403|526152708|FG001|Overall Study|Follow-up not possible|2|||
145903147|NCT01844856|526152711|FG000|Overall Study|Lost to Follow-up|15|||
145903148|NCT01844856|526152712|FG001|Overall Study|Lost to Follow-up|3|||
145903149|NCT01844856|526152711|FG000|Overall Study|Adverse Event|3|||
145903150|NCT01844856|526152712|FG001|Overall Study|Adverse Event|6|||
145903151|NCT01844856|526152711|FG000|Overall Study|Withdrawal by Subject|3|||
145903152|NCT01844856|526152712|FG001|Overall Study|Withdrawal by Subject|2|||
145903153|NCT01844856|526152711|FG000|Overall Study|Noncompliance|2|||
145903154|NCT01844856|526152712|FG001|Overall Study|Noncompliance|3|||
145903155|NCT01844856|526152711|FG000|Overall Study|Enterococcus Resistant|0|||
145903156|NCT01844856|526152712|FG001|Overall Study|Enterococcus Resistant|1|||
145903157|NCT01844856|526152711|FG000|Overall Study|Inadvertently Not Scheduled|1|||
145903158|NCT01844856|526152712|FG001|Overall Study|Inadvertently Not Scheduled|0|||
145903159|NCT01844856|526152711|FG000|Overall Study|Randomized but was a Screen Failure|0|||
145903160|NCT01844856|526152712|FG001|Overall Study|Randomized but was a Screen Failure|1|||
145903161|NCT00927394|526152713|FG000|Overall Study|Adverse Event|14|||
145903162|NCT00927394|526152714|FG001|Overall Study|Adverse Event|9|||
145903163|NCT00927394|526152713|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
145903164|NCT00927394|526152714|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
145903165|NCT00927394|526152713|FG000|Overall Study|Withdrawal by Subject|20|||
145903166|NCT00927394|526152714|FG001|Overall Study|Withdrawal by Subject|24|||
145903167|NCT00927394|526152713|FG000|Overall Study|Lost to Follow-up|8|||
145903168|NCT00927394|526152714|FG001|Overall Study|Lost to Follow-up|14|||
145903169|NCT00927394|526152713|FG000|Overall Study|Administrative Problem|1|||
145903170|NCT00927394|526152714|FG001|Overall Study|Administrative Problem|0|||
145903171|NCT00927394|526152713|FG000|Overall Study|Death|1|||
145903172|NCT00927394|526152714|FG001|Overall Study|Death|1|||
145903173|NCT00927394|526152713|FG000|Overall Study|Protocol deviation|16|||
145903174|NCT00927394|526152714|FG001|Overall Study|Protocol deviation|13|||
145903175|NCT00927394|526152713|FG000|Overall Study|Randomized in error|0|||
145903176|NCT00927394|526152714|FG001|Overall Study|Randomized in error|1|||
145903177|NCT00229723|526152716|FG000|Concomitant Phase|Adverse Event|4|||
145903178|NCT00229723|526152717|FG001|Concomitant Phase|Adverse Event|2|||
145903179|NCT00229723|526152718|FG002|Concomitant Phase|Adverse Event|5|||
145903180|NCT00229723|526152719|FG003|Concomitant Phase|Adverse Event|2|||
145903181|NCT00229723|526152720|FG004|Concomitant Phase|Adverse Event|0|||
145903182|NCT00229723|526152721|FG005|Concomitant Phase|Adverse Event|1|||
145903183|NCT00229723|526152722|FG006|Concomitant Phase|Adverse Event|2|||
145903184|NCT00229723|526152716|FG000|Concomitant Phase|Objective disease progression|0|||
145903185|NCT00229723|526152717|FG001|Concomitant Phase|Objective disease progression|0|||
145903186|NCT00229723|526152718|FG002|Concomitant Phase|Objective disease progression|0|||
145903187|NCT00229723|526152719|FG003|Concomitant Phase|Objective disease progression|0|||
145903188|NCT00229723|526152720|FG004|Concomitant Phase|Objective disease progression|0|||
145903189|NCT00229723|526152721|FG005|Concomitant Phase|Objective disease progression|0|||
145903190|NCT00229723|526152722|FG006|Concomitant Phase|Objective disease progression|0|||
145903191|NCT00229723|526152716|FG000|Concomitant Phase|Clinical progression|0|||
145903192|NCT00229723|526152717|FG001|Concomitant Phase|Clinical progression|0|||
145903193|NCT00229723|526152718|FG002|Concomitant Phase|Clinical progression|0|||
145903194|NCT00229723|526152719|FG003|Concomitant Phase|Clinical progression|0|||
145903195|NCT00229723|526152720|FG004|Concomitant Phase|Clinical progression|0|||
145903196|NCT00229723|526152721|FG005|Concomitant Phase|Clinical progression|0|||
145903197|NCT00229723|526152722|FG006|Concomitant Phase|Clinical progression|1|||
145903198|NCT00229723|526152716|FG000|Concomitant Phase|Lost to Follow-up|0|||
145903199|NCT00229723|526152717|FG001|Concomitant Phase|Lost to Follow-up|0|||
145903200|NCT00229723|526152718|FG002|Concomitant Phase|Lost to Follow-up|0|||
145903201|NCT00229723|526152719|FG003|Concomitant Phase|Lost to Follow-up|0|||
145903202|NCT00229723|526152720|FG004|Concomitant Phase|Lost to Follow-up|1|||
145903203|NCT00229723|526152721|FG005|Concomitant Phase|Lost to Follow-up|0|||
145903204|NCT00229723|526152722|FG006|Concomitant Phase|Lost to Follow-up|0|||
145903205|NCT00229723|526152716|FG000|Concomitant Phase|Informed consent withdrawn|3|||
145903206|NCT00229723|526152717|FG001|Concomitant Phase|Informed consent withdrawn|2|||
145903207|NCT00229723|526152718|FG002|Concomitant Phase|Informed consent withdrawn|0|||
145903208|NCT00229723|526152719|FG003|Concomitant Phase|Informed consent withdrawn|2|||
145903209|NCT00229723|526152720|FG004|Concomitant Phase|Informed consent withdrawn|0|||
145903210|NCT00229723|526152721|FG005|Concomitant Phase|Informed consent withdrawn|0|||
145903211|NCT00229723|526152722|FG006|Concomitant Phase|Informed consent withdrawn|0|||
145903212|NCT00229723|526152716|FG000|Concomitant Phase|Severe non-compliance|0|||
145903213|NCT00229723|526152717|FG001|Concomitant Phase|Severe non-compliance|1|||
145903214|NCT00229723|526152718|FG002|Concomitant Phase|Severe non-compliance|0|||
145903215|NCT00229723|526152719|FG003|Concomitant Phase|Severe non-compliance|0|||
145903216|NCT00229723|526152720|FG004|Concomitant Phase|Severe non-compliance|1|||
145903217|NCT00229723|526152721|FG005|Concomitant Phase|Severe non-compliance|0|||
145903218|NCT00229723|526152722|FG006|Concomitant Phase|Severe non-compliance|0|||
145903219|NCT00229723|526152716|FG000|Concomitant Phase|Other|3|||
145903220|NCT00229723|526152717|FG001|Concomitant Phase|Other|0|||
145903221|NCT00229723|526152718|FG002|Concomitant Phase|Other|1|||
145903222|NCT00229723|526152719|FG003|Concomitant Phase|Other|1|||
145903223|NCT00229723|526152720|FG004|Concomitant Phase|Other|0|||
145903224|NCT00229723|526152721|FG005|Concomitant Phase|Other|2|||
145903225|NCT00229723|526152722|FG006|Concomitant Phase|Other|0|||
145903226|NCT00229723|526152716|FG000|Maintenance Phase|Adverse Event|7|||
145903227|NCT00229723|526152717|FG001|Maintenance Phase|Adverse Event|2|||
145903228|NCT00229723|526152718|FG002|Maintenance Phase|Adverse Event|1|||
145903229|NCT00229723|526152719|FG003|Maintenance Phase|Adverse Event|4|||
145903230|NCT00229723|526152720|FG004|Maintenance Phase|Adverse Event|7|||
145903231|NCT00229723|526152721|FG005|Maintenance Phase|Adverse Event|5|||
145903232|NCT00229723|526152722|FG006|Maintenance Phase|Adverse Event|2|||
145903233|NCT00229723|526152716|FG000|Maintenance Phase|Objective disease progression|5|||
145903234|NCT00229723|526152717|FG001|Maintenance Phase|Objective disease progression|5|||
145903235|NCT00229723|526152718|FG002|Maintenance Phase|Objective disease progression|3|||
145903236|NCT00229723|526152719|FG003|Maintenance Phase|Objective disease progression|6|||
145903237|NCT00229723|526152720|FG004|Maintenance Phase|Objective disease progression|2|||
145903238|NCT00229723|526152721|FG005|Maintenance Phase|Objective disease progression|9|||
145903239|NCT00229723|526152722|FG006|Maintenance Phase|Objective disease progression|5|||
145903240|NCT00229723|526152716|FG000|Maintenance Phase|Clinical progression|4|||
145903241|NCT00229723|526152717|FG001|Maintenance Phase|Clinical progression|1|||
145903242|NCT00229723|526152718|FG002|Maintenance Phase|Clinical progression|2|||
145903243|NCT00229723|526152719|FG003|Maintenance Phase|Clinical progression|2|||
145903244|NCT00229723|526152720|FG004|Maintenance Phase|Clinical progression|1|||
145903245|NCT00229723|526152721|FG005|Maintenance Phase|Clinical progression|1|||
145903246|NCT00229723|526152722|FG006|Maintenance Phase|Clinical progression|1|||
145903247|NCT00229723|526152716|FG000|Maintenance Phase|Lost to Follow-up|0|||
145903248|NCT00229723|526152717|FG001|Maintenance Phase|Lost to Follow-up|1|||
145903249|NCT00229723|526152718|FG002|Maintenance Phase|Lost to Follow-up|2|||
145903250|NCT00229723|526152719|FG003|Maintenance Phase|Lost to Follow-up|2|||
145903251|NCT00229723|526152720|FG004|Maintenance Phase|Lost to Follow-up|0|||
145903252|NCT00229723|526152721|FG005|Maintenance Phase|Lost to Follow-up|0|||
145903253|NCT00229723|526152722|FG006|Maintenance Phase|Lost to Follow-up|1|||
146238879|NCT01701401|527388065|FG001|Overall Study|Withdrew Consent|3|||
145903254|NCT00229723|526152716|FG000|Maintenance Phase|Informed consent withdrawn|1|||
145903255|NCT00229723|526152717|FG001|Maintenance Phase|Informed consent withdrawn|0|||
145903256|NCT00229723|526152718|FG002|Maintenance Phase|Informed consent withdrawn|0|||
145903257|NCT00229723|526152719|FG003|Maintenance Phase|Informed consent withdrawn|1|||
145903258|NCT00229723|526152720|FG004|Maintenance Phase|Informed consent withdrawn|1|||
145903259|NCT00229723|526152721|FG005|Maintenance Phase|Informed consent withdrawn|1|||
145903260|NCT00229723|526152722|FG006|Maintenance Phase|Informed consent withdrawn|0|||
145903261|NCT00229723|526152716|FG000|Maintenance Phase|Severe non-compliance|3|||
145903262|NCT00229723|526152717|FG001|Maintenance Phase|Severe non-compliance|1|||
145903263|NCT00229723|526152718|FG002|Maintenance Phase|Severe non-compliance|0|||
145903264|NCT00229723|526152719|FG003|Maintenance Phase|Severe non-compliance|0|||
145903265|NCT00229723|526152720|FG004|Maintenance Phase|Severe non-compliance|1|||
145903266|NCT00229723|526152721|FG005|Maintenance Phase|Severe non-compliance|0|||
145903267|NCT00229723|526152722|FG006|Maintenance Phase|Severe non-compliance|0|||
145903268|NCT00229723|526152716|FG000|Maintenance Phase|Other|5|||
145903269|NCT00229723|526152717|FG001|Maintenance Phase|Other|4|||
145903270|NCT00229723|526152718|FG002|Maintenance Phase|Other|1|||
145903271|NCT00229723|526152719|FG003|Maintenance Phase|Other|2|||
145903272|NCT00229723|526152720|FG004|Maintenance Phase|Other|3|||
145903273|NCT00229723|526152721|FG005|Maintenance Phase|Other|3|||
145903274|NCT00229723|526152722|FG006|Maintenance Phase|Other|1|||
145903275|NCT02309138|526152723|FG000|Overall Study|Withdrawal by Subject|44|||
145903276|NCT02309138|526152724|FG001|Overall Study|Withdrawal by Subject|15|||
145903277|NCT02309138|526152723|FG000|Overall Study|Protocol Violation|4|||
145903278|NCT02309138|526152724|FG001|Overall Study|Protocol Violation|2|||
145903279|NCT02309138|526152723|FG000|Overall Study|delivered before visit 2|0|||
145903280|NCT02309138|526152724|FG001|Overall Study|delivered before visit 2|1|||
145903281|NCT03421730|526152728|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903282|NCT03421730|526152729|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
145903283|NCT03421730|526152730|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903284|NCT03421730|526152731|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903285|NCT03421730|526152732|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903286|NCT03421730|526152733|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903287|NCT03421730|526152734|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903288|NCT03421730|526152735|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903289|NCT03421730|526152736|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903290|NCT03421730|526152737|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903291|NCT03421730|526152738|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903292|NCT03421730|526152739|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145903293|NCT03421730|526152728|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903294|NCT03421730|526152729|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903295|NCT03421730|526152730|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903296|NCT03421730|526152731|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903297|NCT03421730|526152732|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
145903298|NCT03421730|526152733|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903299|NCT03421730|526152734|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903300|NCT03421730|526152735|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903301|NCT03421730|526152736|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903302|NCT03421730|526152737|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903303|NCT03421730|526152738|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903304|NCT03421730|526152739|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145903305|NCT01338870|526152742|FG000|Overall Study|Lost to Follow-up|0|||
145903306|NCT01338870|526152743|FG001|Overall Study|Lost to Follow-up|0|||
145903307|NCT01338870|526152744|FG002|Overall Study|Lost to Follow-up|1|||
145903308|NCT01338870|526152745|FG003|Overall Study|Lost to Follow-up|0|||
145903309|NCT01338870|526152746|FG004|Overall Study|Lost to Follow-up|1|||
145903310|NCT01338870|526152747|FG005|Overall Study|Lost to Follow-up|0|||
145903311|NCT01338870|526152742|FG000|Overall Study|Withdrawal by Subject|2|||
145903312|NCT01338870|526152743|FG001|Overall Study|Withdrawal by Subject|3|||
145903313|NCT01338870|526152744|FG002|Overall Study|Withdrawal by Subject|4|||
145903314|NCT01338870|526152745|FG003|Overall Study|Withdrawal by Subject|0|||
145903315|NCT01338870|526152746|FG004|Overall Study|Withdrawal by Subject|0|||
145903316|NCT01338870|526152747|FG005|Overall Study|Withdrawal by Subject|2|||
145903317|NCT01338870|526152742|FG000|Overall Study|Other|3|||
145903318|NCT01338870|526152743|FG001|Overall Study|Other|3|||
145903319|NCT01338870|526152744|FG002|Overall Study|Other|3|||
145903320|NCT01338870|526152745|FG003|Overall Study|Other|2|||
145903321|NCT01338870|526152746|FG004|Overall Study|Other|0|||
145903322|NCT01338870|526152747|FG005|Overall Study|Other|2|||
145903323|NCT01338870|526152742|FG000|Overall Study|Protocol Violation|0|||
145903324|NCT01338870|526152743|FG001|Overall Study|Protocol Violation|2|||
145903325|NCT01338870|526152744|FG002|Overall Study|Protocol Violation|2|||
145903326|NCT01338870|526152745|FG003|Overall Study|Protocol Violation|2|||
145903327|NCT01338870|526152746|FG004|Overall Study|Protocol Violation|1|||
145903328|NCT01338870|526152747|FG005|Overall Study|Protocol Violation|1|||
145903329|NCT01338870|526152742|FG000|Overall Study|Adverse Event|4|||
145903330|NCT01338870|526152743|FG001|Overall Study|Adverse Event|4|||
145903331|NCT01338870|526152744|FG002|Overall Study|Adverse Event|1|||
145903332|NCT01338870|526152745|FG003|Overall Study|Adverse Event|5|||
145903333|NCT01338870|526152746|FG004|Overall Study|Adverse Event|4|||
145903334|NCT01338870|526152747|FG005|Overall Study|Adverse Event|1|||
145903335|NCT01955083|526152748|FG000|Overall Study|Lost to Follow-up|1|||
145903336|NCT01955083|526152749|FG001|Overall Study|Lost to Follow-up|1|||
145903337|NCT00901576|526152758|FG000|Second Intervention|Withdrawal by Subject|0|||
145903338|NCT00901576|526152759|FG001|Second Intervention|Withdrawal by Subject|0|||
145903339|NCT00901576|526152760|FG002|Second Intervention|Withdrawal by Subject|0|||
145903340|NCT00901576|526152761|FG003|Second Intervention|Withdrawal by Subject|1|||
145903341|NCT00901576|526152762|FG004|Second Intervention|Withdrawal by Subject|0|||
145903342|NCT00901576|526152763|FG005|Second Intervention|Withdrawal by Subject|1|||
145903343|NCT00901576|526152758|FG000|Second Intervention|Physician Decision|1|||
145903344|NCT00901576|526152759|FG001|Second Intervention|Physician Decision|0|||
145903345|NCT00901576|526152760|FG002|Second Intervention|Physician Decision|0|||
145903346|NCT00901576|526152761|FG003|Second Intervention|Physician Decision|0|||
145903347|NCT00901576|526152762|FG004|Second Intervention|Physician Decision|0|||
145903348|NCT00901576|526152763|FG005|Second Intervention|Physician Decision|0|||
145903349|NCT01559389|526152764|FG000|Overall Study|Withdrawal by Subject|20|||
145903350|NCT01559389|526152765|FG001|Overall Study|Withdrawal by Subject|20|||
145903351|NCT02871492|526152766|FG000|Overall Study|Lost to Follow-up|6|||
145903352|NCT02871492|526152767|FG001|Overall Study|Lost to Follow-up|3|||
145903353|NCT02871492|526152768|FG002|Overall Study|Lost to Follow-up|5|||
145903354|NCT02871492|526152766|FG000|Overall Study|Withdrawal by Subject|0|||
145903355|NCT02871492|526152767|FG001|Overall Study|Withdrawal by Subject|0|||
145903356|NCT02871492|526152768|FG002|Overall Study|Withdrawal by Subject|1|||
145903357|NCT04546724|526152769|FG000|Overall Study|Withdrawal by Subject|145|||
145903358|NCT04546724|526152770|FG001|Overall Study|Withdrawal by Subject|41|||
145903359|NCT04546724|526152769|FG000|Overall Study|Adverse Event|1|||
145903360|NCT04546724|526152770|FG001|Overall Study|Adverse Event|1|||
145903361|NCT04546724|526152769|FG000|Overall Study|Lost to Follow-up|186|||
145903362|NCT04546724|526152770|FG001|Overall Study|Lost to Follow-up|63|||
145903363|NCT04546724|526152769|FG000|Overall Study|Physician Decision|8|||
145903364|NCT04546724|526152770|FG001|Overall Study|Physician Decision|2|||
145903365|NCT04546724|526152769|FG000|Overall Study|Death|2|||
145903366|NCT04546724|526152770|FG001|Overall Study|Death|1|||
145903367|NCT04546724|526152769|FG000|Overall Study|subject has been out of town|1|||
145903368|NCT04546724|526152770|FG001|Overall Study|subject has been out of town|0|||
145903369|NCT04546724|526152769|FG000|Overall Study|subject is incarcerated|2|||
145903370|NCT04546724|526152770|FG001|Overall Study|subject is incarcerated|0|||
145903371|NCT04546724|526152769|FG000|Overall Study|subject is relocating|12|||
145903372|NCT04546724|526152770|FG001|Overall Study|subject is relocating|4|||
145903373|NCT04546724|526152769|FG000|Overall Study|Subject in another study|1|||
145903374|NCT04546724|526152770|FG001|Overall Study|Subject in another study|1|||
145903375|NCT03583086|526152773|FG000|Overall Study|Death|2|||
145903376|NCT03583086|526152774|FG001|Overall Study|Death|6|||
145903377|NCT03583086|526152775|FG002|Overall Study|Death|12|||
145903378|NCT03583086|526152776|FG003|Overall Study|Death|10|||
145903379|NCT03583086|526152777|FG004|Overall Study|Death|14|||
145903380|NCT03583086|526152778|FG005|Overall Study|Death|14|||
145903381|NCT03583086|526152779|FG006|Overall Study|Death|4|||
145903382|NCT03583086|526152773|FG000|Overall Study|Withdrawal by Subject|0|||
145903383|NCT03583086|526152774|FG001|Overall Study|Withdrawal by Subject|0|||
145903384|NCT03583086|526152775|FG002|Overall Study|Withdrawal by Subject|1|||
145903385|NCT03583086|526152776|FG003|Overall Study|Withdrawal by Subject|0|||
145903386|NCT03583086|526152777|FG004|Overall Study|Withdrawal by Subject|0|||
145903387|NCT03583086|526152778|FG005|Overall Study|Withdrawal by Subject|0|||
145903388|NCT03583086|526152779|FG006|Overall Study|Withdrawal by Subject|1|||
145903389|NCT03583086|526152773|FG000|Overall Study|Refused follow-up|0|||
145903390|NCT03583086|526152774|FG001|Overall Study|Refused follow-up|0|||
145903391|NCT03583086|526152775|FG002|Overall Study|Refused follow-up|1|||
145903392|NCT03583086|526152776|FG003|Overall Study|Refused follow-up|0|||
145972559|NCT02566005|526412671|FG001|Overall Study|labor after randomization|4|||
145903393|NCT03583086|526152777|FG004|Overall Study|Refused follow-up|1|||
145903394|NCT03583086|526152778|FG005|Overall Study|Refused follow-up|0|||
145903395|NCT03583086|526152779|FG006|Overall Study|Refused follow-up|0|||
145972560|NCT01294514|526412674|FG000|Overall Study|Excluded due to Arrhythmia|1|||
145903396|NCT03583086|526152773|FG000|Overall Study|Declining Performance Status|0|||
145903397|NCT03583086|526152774|FG001|Overall Study|Declining Performance Status|0|||
145903398|NCT03583086|526152775|FG002|Overall Study|Declining Performance Status|1|||
145903399|NCT03583086|526152776|FG003|Overall Study|Declining Performance Status|0|||
145903400|NCT03583086|526152777|FG004|Overall Study|Declining Performance Status|0|||
145903401|NCT03583086|526152778|FG005|Overall Study|Declining Performance Status|0|||
145903402|NCT03583086|526152779|FG006|Overall Study|Declining Performance Status|0|||
145903403|NCT03583086|526152773|FG000|Overall Study|Still on study|0|||
145903404|NCT03583086|526152774|FG001|Overall Study|Still on study|0|||
145903405|NCT03583086|526152775|FG002|Overall Study|Still on study|0|||
145903406|NCT03583086|526152776|FG003|Overall Study|Still on study|1|||
145903407|NCT03583086|526152777|FG004|Overall Study|Still on study|0|||
145903408|NCT03583086|526152778|FG005|Overall Study|Still on study|0|||
145903409|NCT03583086|526152779|FG006|Overall Study|Still on study|1|||
145903410|NCT03583086|526152773|FG000|Overall Study|Disease progression|0|||
145903411|NCT03583086|526152774|FG001|Overall Study|Disease progression|0|||
145903412|NCT03583086|526152775|FG002|Overall Study|Disease progression|0|||
145903413|NCT03583086|526152776|FG003|Overall Study|Disease progression|0|||
145903414|NCT03583086|526152777|FG004|Overall Study|Disease progression|0|||
145903415|NCT03583086|526152778|FG005|Overall Study|Disease progression|0|||
145903416|NCT03583086|526152779|FG006|Overall Study|Disease progression|1|||
145903417|NCT03583086|526152773|FG000|Overall Study|Undergoing radiation therapy|0|||
145903418|NCT03583086|526152774|FG001|Overall Study|Undergoing radiation therapy|0|||
145903419|NCT03583086|526152775|FG002|Overall Study|Undergoing radiation therapy|0|||
145903420|NCT03583086|526152776|FG003|Overall Study|Undergoing radiation therapy|0|||
145903421|NCT03583086|526152777|FG004|Overall Study|Undergoing radiation therapy|0|||
146088386|NCT01117051|526843830|FG000|Overall Study|Randomized by mistake|0|||
146088387|NCT01117051|526843831|FG001|Overall Study|Randomized by mistake|1|||
146088388|NCT01117051|526843830|FG000|Overall Study|Convenience issue|1|||
146088389|NCT01117051|526843831|FG001|Overall Study|Convenience issue|0|||
146088390|NCT03584373|526843832|FG000|Overall Study|Lost to Follow-up|7|||
146088391|NCT03584373|526843833|FG001|Overall Study|Lost to Follow-up|8|||
146088392|NCT01487577|526843834|FG000|Overall Study|Became ineligible after signing consent|1|||
146088393|NCT03780400|526843835|FG000|Overall Study|Lost to Follow-up|5|||
146088394|NCT03780400|526843835|FG000|Overall Study|Withdrawal by Subject|2|||
146088395|NCT01315236|526843836|FG000|Double-blind Phase|Death|1|||
146088396|NCT01315236|526843837|FG001|Double-blind Phase|Death|0|||
146088397|NCT01315236|526843836|FG000|Double-blind Phase|Adverse Event|1|||
146088398|NCT01315236|526843837|FG001|Double-blind Phase|Adverse Event|0|||
146088399|NCT01315236|526843836|FG000|Double-blind Phase|Withdrawal of Consent|1|||
146088400|NCT01315236|526843837|FG001|Double-blind Phase|Withdrawal of Consent|0|||
146088401|NCT01315236|526843836|FG000|Double-blind Phase|Lost to Follow-up|1|||
146088402|NCT01315236|526843837|FG001|Double-blind Phase|Lost to Follow-up|0|||
146088403|NCT01315236|526843836|FG000|Open-label Phase|Death|1|||
146088404|NCT01315236|526843837|FG001|Open-label Phase|Death|0|||
146088405|NCT01315236|526843836|FG000|Open-label Phase|Adverse Event|0|||
146088406|NCT01315236|526843837|FG001|Open-label Phase|Adverse Event|1|||
146088407|NCT01315236|526843836|FG000|Open-label Phase|Other|0|||
146088408|NCT01315236|526843837|FG001|Open-label Phase|Other|1|||
146088409|NCT01315236|526843836|FG000|12-Month Follow-up Period|Death|0|||
146088410|NCT01315236|526843837|FG001|12-Month Follow-up Period|Death|1|||
146088411|NCT01315236|526843836|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
146088412|NCT01315236|526843837|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
145903422|NCT03583086|526152778|FG005|Overall Study|Undergoing radiation therapy|0|||
145903423|NCT03583086|526152779|FG006|Overall Study|Undergoing radiation therapy|1|||
145903424|NCT03583086|526152773|FG000|Overall Study|Lost to Follow-up|0|||
145903425|NCT03583086|526152774|FG001|Overall Study|Lost to Follow-up|0|||
145903426|NCT03583086|526152775|FG002|Overall Study|Lost to Follow-up|0|||
145903427|NCT03583086|526152776|FG003|Overall Study|Lost to Follow-up|0|||
145903428|NCT03583086|526152777|FG004|Overall Study|Lost to Follow-up|0|||
145903429|NCT03583086|526152778|FG005|Overall Study|Lost to Follow-up|1|||
145903430|NCT03583086|526152779|FG006|Overall Study|Lost to Follow-up|0|||
145903431|NCT03583086|526152773|FG000|Overall Study|Adverse Event|0|||
145903432|NCT03583086|526152774|FG001|Overall Study|Adverse Event|0|||
146088413|NCT00470184|526843841|FG000|Overall Study|Not Treated(became ineligible)|4|||
146088414|NCT00470184|526843841|FG000|Overall Study|Not treated (other)|1|||
146088415|NCT00470184|526843841|FG000|Overall Study|disease Progression|4|||
146088416|NCT00470184|526843841|FG000|Overall Study|Adverse Event|3|||
146088417|NCT00470184|526843841|FG000|Overall Study|Withdrawal by Subject|4|||
146088418|NCT00470184|526843841|FG000|Overall Study|other|5|||
145903433|NCT03583086|526152775|FG002|Overall Study|Adverse Event|0|||
145903434|NCT03583086|526152776|FG003|Overall Study|Adverse Event|0|||
146088419|NCT00470184|526843841|FG000|Overall Study|recurrence|1|||
146088420|NCT03282565|526843842|FG000|Overall Study|COVID-19 Research Shutdown|0|||
146088421|NCT03282565|526843843|FG001|Overall Study|COVID-19 Research Shutdown|2|||
146088422|NCT03282565|526843844|FG002|Overall Study|COVID-19 Research Shutdown|2|||
146088423|NCT02011893|526843845|FG000|Enrollment to Randomization|Adverse Event|2|||
146088424|NCT02011893|526843846|FG001|Enrollment to Randomization|Adverse Event|0|||
146088425|NCT02011893|526843847|FG002|Enrollment to Randomization|Adverse Event|0|||
146088426|NCT02011893|526843845|FG000|Enrollment to Randomization|Physician Decision|10|||
145903435|NCT03583086|526152777|FG004|Overall Study|Adverse Event|0|||
145903436|NCT03583086|526152778|FG005|Overall Study|Adverse Event|1|||
145903437|NCT03583086|526152779|FG006|Overall Study|Adverse Event|0|||
145903438|NCT00171951|526152781|FG000|Overall Study|Adverse Event|1|||
145903439|NCT00171951|526152781|FG000|Overall Study|Abnormal Laboratory Values|2|||
145903440|NCT00171951|526152781|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145903441|NCT00171951|526152781|FG000|Overall Study|Participants Withdrew Consent|3|||
145903442|NCT00171951|526152781|FG000|Overall Study|New Cancer Therapy|5|||
145903443|NCT00171951|526152781|FG000|Overall Study|Reason not Specified|2|||
145903444|NCT00396812|526152782|FG000|Overall Study|Physician Decision|1|||
145903445|NCT03201445|526152786|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
145903446|NCT03201445|526152787|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
145903447|NCT03201445|526152786|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
145903448|NCT03201445|526152787|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
145903449|NCT03201445|526152786|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
145903450|NCT03201445|526152787|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
145903451|NCT03201445|526152786|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
145903452|NCT03201445|526152787|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
145903453|NCT03201445|526152786|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
145903454|NCT03201445|526152787|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
145903455|NCT03201445|526152786|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
145903456|NCT03201445|526152787|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
145903457|NCT03201445|526152786|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
145903458|NCT03201445|526152787|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
145903459|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
145903460|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
145903461|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
145903462|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
145903463|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
145903464|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
145903465|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
145903466|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
145903467|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
145903468|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
145903469|NCT03201445|526152786|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
145903470|NCT03201445|526152787|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
145903471|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
145903472|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
145903473|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
145903474|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
145903475|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
145903476|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
145903477|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
145903478|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
145903479|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
145903480|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
145903481|NCT03201445|526152786|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
145903482|NCT03201445|526152787|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
145903483|NCT03201445|526152786|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
145903484|NCT03201445|526152787|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
145903485|NCT03201445|526152786|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
145903486|NCT03201445|526152787|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
145903487|NCT01346293|526152790|FG000|Overall Study|Protocol Violation|30|||
145903488|NCT01346293|526152791|FG001|Overall Study|Protocol Violation|9|||
145903489|NCT01346293|526152790|FG000|Overall Study|Lost to Follow-up|21|||
145903490|NCT01346293|526152791|FG001|Overall Study|Lost to Follow-up|8|||
145903491|NCT01346293|526152790|FG000|Overall Study|Withdrawal by Subject|15|||
145903492|NCT01346293|526152791|FG001|Overall Study|Withdrawal by Subject|4|||
145903493|NCT01346293|526152790|FG000|Overall Study|Other|1|||
145903494|NCT01346293|526152791|FG001|Overall Study|Other|0|||
145903495|NCT01844505|526152794|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
145903496|NCT01844505|526152795|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
145903497|NCT01844505|526152796|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
145903498|NCT01844505|526152794|FG000|Treatment Period|Other Reasons|120|||
145903499|NCT01844505|526152795|FG001|Treatment Period|Other Reasons|136|||
145903500|NCT01844505|526152796|FG002|Treatment Period|Other Reasons|58|||
145903501|NCT01844505|526152794|FG000|Treatment Period|Lost to Follow-up|9|||
145903502|NCT01844505|526152795|FG001|Treatment Period|Lost to Follow-up|11|||
145903503|NCT01844505|526152796|FG002|Treatment Period|Lost to Follow-up|6|||
145972561|NCT00141921|526412676|FG000|Overall Study|Remain on Study|28|||
145972562|NCT00141921|526412676|FG000|Overall Study|Withdrawal by Subject|42|||
145903504|NCT01844505|526152794|FG000|Treatment Period|Death|175|||
145903505|NCT01844505|526152795|FG001|Treatment Period|Death|154|||
145903506|NCT01844505|526152796|FG002|Treatment Period|Death|228|||
145903507|NCT00128830|526152797|FG000|Overall Study|Adverse Event|10|||
145903508|NCT00128830|526152797|FG000|Overall Study|Withdrawal by Subject|14|||
145903509|NCT00128830|526152797|FG000|Overall Study|Lost to Follow-up|4|||
145903510|NCT00128830|526152797|FG000|Overall Study|Reached a virologic endpoint|29|||
145903511|NCT00128830|526152797|FG000|Overall Study|Non-compliant|4|||
145903512|NCT00128830|526152797|FG000|Overall Study|Discontinued or ineligible for study|2|||
145903513|NCT00128830|526152797|FG000|Overall Study|Other|9|||
145903514|NCT02730351|526152798|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
145903515|NCT02730351|526152799|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
145903516|NCT02730351|526152798|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
146238880|NCT01701401|527388066|FG002|Overall Study|Withdrew Consent|1|||
146238881|NCT01701401|527388067|FG003|Overall Study|Withdrew Consent|2|||
146238882|NCT01701401|527388064|FG000|Overall Study|Lack of Efficacy|1|||
146238883|NCT01701401|527388065|FG001|Overall Study|Lack of Efficacy|0|||
146238884|NCT01701401|527388066|FG002|Overall Study|Lack of Efficacy|2|||
145903517|NCT02730351|526152799|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
145903518|NCT02730351|526152798|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
145903519|NCT02730351|526152799|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
145903520|NCT02730351|526152798|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
145903521|NCT02730351|526152799|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
145903522|NCT02730351|526152798|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
145903523|NCT02730351|526152799|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
145903524|NCT00311402|526152800|FG000|Overall Study|Adverse Event|118|||
145903525|NCT00311402|526152801|FG001|Overall Study|Adverse Event|105|||
145903526|NCT00311402|526152800|FG000|Overall Study|Lost to Follow-up|0|||
145903527|NCT00311402|526152801|FG001|Overall Study|Lost to Follow-up|3|||
145903528|NCT00311402|526152800|FG000|Overall Study|Withdrawal by Subject|17|||
145903529|NCT00311402|526152801|FG001|Overall Study|Withdrawal by Subject|18|||
145903530|NCT00311402|526152800|FG000|Overall Study|Lack of Efficacy|58|||
145903531|NCT00311402|526152801|FG001|Overall Study|Lack of Efficacy|42|||
145903532|NCT00311402|526152800|FG000|Overall Study|Protocol Violation|7|||
145903533|NCT00311402|526152801|FG001|Overall Study|Protocol Violation|6|||
145903534|NCT00311402|526152800|FG000|Overall Study|IRB's rejection etc.|10|||
145903535|NCT00311402|526152801|FG001|Overall Study|IRB's rejection etc.|3|||
145903536|NCT00838435|526152802|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
145903537|NCT00838435|526152802|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
145903538|NCT00838435|526152802|FG000|Part 2 (7 Years)|Adverse Event|2|||
145903539|NCT00838435|526152802|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
145903540|NCT00838435|526152802|FG000|Part 2 (7 Years)|Physician Decision|1|||
145903541|NCT00838435|526152802|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
145903542|NCT00838435|526152802|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
145903543|NCT02754856|526152808|FG000|Overall Study|Withdrawal by Subject|1|||
145903544|NCT04874155|526152811|FG000|Overall Study|Lost to Follow-up|1|||
145903545|NCT04874155|526152812|FG001|Overall Study|Lost to Follow-up|1|||
145903546|NCT04874155|526152811|FG000|Overall Study|Withdrawal by Subject|2|||
145903547|NCT04874155|526152812|FG001|Overall Study|Withdrawal by Subject|2|||
145903548|NCT00530218|526152813|FG000|Overall Study|CMV Not Detected|13|||
145903549|NCT00530218|526152813|FG000|Overall Study|Death|12|||
145903550|NCT00678886|526152816|FG000|Overall Study|Withdrawal by Subject|0|||
145903551|NCT00678886|526152817|FG001|Overall Study|Withdrawal by Subject|0|||
145903552|NCT00678886|526152818|FG002|Overall Study|Withdrawal by Subject|4|||
145903553|NCT00678886|526152819|FG003|Overall Study|Withdrawal by Subject|6|||
145903554|NCT00678886|526152816|FG000|Overall Study|Physician Decision|0|||
145903555|NCT00678886|526152817|FG001|Overall Study|Physician Decision|0|||
145903556|NCT00678886|526152818|FG002|Overall Study|Physician Decision|1|||
145903557|NCT00678886|526152819|FG003|Overall Study|Physician Decision|1|||
145903558|NCT00678886|526152816|FG000|Overall Study|Lost to Follow-up|0|||
145903559|NCT00678886|526152817|FG001|Overall Study|Lost to Follow-up|0|||
145903560|NCT00678886|526152818|FG002|Overall Study|Lost to Follow-up|3|||
146238885|NCT01701401|527388067|FG003|Overall Study|Lack of Efficacy|0|||
145903561|NCT00678886|526152819|FG003|Overall Study|Lost to Follow-up|2|||
145903562|NCT00678886|526152816|FG000|Overall Study|Other|0|||
145903563|NCT00678886|526152817|FG001|Overall Study|Other|0|||
145903564|NCT00678886|526152818|FG002|Overall Study|Other|1|||
145903565|NCT00678886|526152819|FG003|Overall Study|Other|0|||
145903566|NCT03477903|526152820|FG000|Overall Study|Study Terminated by Sponsor|1|||
145903567|NCT01147107|526152821|FG000|Overall Study|Lack of Efficacy|5|||
145903568|NCT01147107|526152822|FG001|Overall Study|Lack of Efficacy|0|||
145903569|NCT01147107|526152821|FG000|Overall Study|Withdrawal by Subject|1|||
145903570|NCT01147107|526152822|FG001|Overall Study|Withdrawal by Subject|1|||
145903571|NCT03496610|526152823|FG000|Overall Study|Lost to Follow-up|3|||
145903572|NCT03496610|526152824|FG001|Overall Study|Lost to Follow-up|2|||
146088427|NCT02011893|526843846|FG001|Enrollment to Randomization|Physician Decision|0|||
146238886|NCT01701401|527388064|FG000|Overall Study|Adverse Event|1|||
146238887|NCT01701401|527388065|FG001|Overall Study|Adverse Event|0|||
145903573|NCT03496610|526152823|FG000|Overall Study|Physician Decision|1|||
145903574|NCT03496610|526152824|FG001|Overall Study|Physician Decision|0|||
145903575|NCT03496610|526152823|FG000|Overall Study|Withdrawal by Subject|1|||
145903576|NCT03496610|526152824|FG001|Overall Study|Withdrawal by Subject|0|||
145903577|NCT05330468|526152825|FG000|Overall Study|Death|6|||
145903578|NCT05330468|526152825|FG000|Overall Study|Withdrawal by Subject|4|||
145903579|NCT05330468|526152825|FG000|Overall Study|Lost to Follow-up|4|||
145903580|NCT00477295|526152829|FG000|Overall Study|Adverse Event|31|||
145903581|NCT00477295|526152830|FG001|Overall Study|Adverse Event|35|||
145903582|NCT00477295|526152829|FG000|Overall Study|Withdrawal by Subject|35|||
145903583|NCT00477295|526152830|FG001|Overall Study|Withdrawal by Subject|24|||
145903584|NCT00477295|526152829|FG000|Overall Study|Lack of Efficacy|23|||
145903585|NCT00477295|526152830|FG001|Overall Study|Lack of Efficacy|23|||
145903586|NCT00477295|526152829|FG000|Overall Study|Protocol Violation|3|||
145903587|NCT00477295|526152830|FG001|Overall Study|Protocol Violation|8|||
145903588|NCT00477295|526152829|FG000|Overall Study|Physician Decision|4|||
145903589|NCT00477295|526152830|FG001|Overall Study|Physician Decision|5|||
145903590|NCT00477295|526152829|FG000|Overall Study|Lost to Follow-up|21|||
145903591|NCT00477295|526152830|FG001|Overall Study|Lost to Follow-up|11|||
145903592|NCT00477295|526152829|FG000|Overall Study|Other|4|||
145903593|NCT00477295|526152830|FG001|Overall Study|Other|3|||
145903594|NCT03835221|526152833|FG000|Methafilcon A|Withdrawal by Subject|1|||
145903595|NCT01197755|526152839|FG000|Overall Study|Adverse Event|8|||
145903596|NCT01197755|526152840|FG001|Overall Study|Adverse Event|10|||
145903597|NCT01197755|526152841|FG002|Overall Study|Adverse Event|10|||
146238888|NCT01701401|527388066|FG002|Overall Study|Adverse Event|0|||
146238889|NCT01701401|527388067|FG003|Overall Study|Adverse Event|0|||
146238890|NCT01701401|527388064|FG000|Overall Study|Protocol Violation|0|||
145903598|NCT01197755|526152839|FG000|Overall Study|Study-specific discontinuation criteria|2|||
145903599|NCT01197755|526152840|FG001|Overall Study|Study-specific discontinuation criteria|1|||
145903600|NCT01197755|526152841|FG002|Overall Study|Study-specific discontinuation criteria|0|||
145903601|NCT01197755|526152839|FG000|Overall Study|Entered the long-term extension study|18|||
145903602|NCT01197755|526152840|FG001|Overall Study|Entered the long-term extension study|21|||
145903603|NCT01197755|526152841|FG002|Overall Study|Entered the long-term extension study|35|||
145903604|NCT01197755|526152839|FG000|Overall Study|Lack of therapeutic response|0|||
145903605|NCT01197755|526152840|FG001|Overall Study|Lack of therapeutic response|7|||
145903606|NCT01197755|526152841|FG002|Overall Study|Lack of therapeutic response|4|||
145903607|NCT01197755|526152839|FG000|Overall Study|Severe non-compliance to the protocol|2|||
145903608|NCT01197755|526152840|FG001|Overall Study|Severe non-compliance to the protocol|1|||
145903609|NCT01197755|526152841|FG002|Overall Study|Severe non-compliance to the protocol|2|||
145903610|NCT01197755|526152839|FG000|Overall Study|Withdrawal by Subject|1|||
145903611|NCT01197755|526152840|FG001|Overall Study|Withdrawal by Subject|0|||
145903612|NCT01197755|526152841|FG002|Overall Study|Withdrawal by Subject|0|||
145903613|NCT01197755|526152839|FG000|Overall Study|Lost to Follow-up|0|||
145903614|NCT01197755|526152840|FG001|Overall Study|Lost to Follow-up|0|||
145903615|NCT01197755|526152841|FG002|Overall Study|Lost to Follow-up|1|||
145903616|NCT01197755|526152839|FG000|Overall Study|eg, change in circumstances|7|||
145903617|NCT01197755|526152840|FG001|Overall Study|eg, change in circumstances|3|||
145903618|NCT01197755|526152841|FG002|Overall Study|eg, change in circumstances|2|||
145903619|NCT03365011|526152842|FG000|Overall Study|Withdrawal by Subject|1|||
145903620|NCT03365011|526152843|FG001|Overall Study|Withdrawal by Subject|2|||
145903621|NCT00499174|526152844|FG000|Overall Study|Physician Decision|78|||
145903622|NCT00499174|526152845|FG001|Overall Study|Physician Decision|9|||
145903623|NCT03582826|526152846|FG000|Overall Study|Lost to Follow-up|39|||
145903624|NCT03582826|526152847|FG001|Overall Study|Lost to Follow-up|0|||
145903625|NCT03582826|526152846|FG000|Overall Study|Withdrawal by Subject|2|||
145903626|NCT03582826|526152847|FG001|Overall Study|Withdrawal by Subject|0|||
145903627|NCT01214915|526152848|FG000|Overall Study|Adverse Event|8|||
145903628|NCT01214915|526152848|FG000|Overall Study|Lack of Efficacy|3|||
145903629|NCT04730349|526152849|FG000|Overall Study|Participant withdrew consent|1|||
145903630|NCT04730349|526152850|FG001|Overall Study|Participant withdrew consent|0|||
145903631|NCT04730349|526152849|FG000|Overall Study|Disease progression|6|||
145903632|NCT04730349|526152850|FG001|Overall Study|Disease progression|4|||
145903633|NCT04730349|526152849|FG000|Overall Study|Study drug toxicity|0|||
145903634|NCT04730349|526152850|FG001|Overall Study|Study drug toxicity|1|||
145903635|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
145903636|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
145903637|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903638|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903639|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903640|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
146088428|NCT02011893|526843847|FG002|Enrollment to Randomization|Physician Decision|0|||
145903641|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903642|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
146238891|NCT01701401|527388065|FG001|Overall Study|Protocol Violation|0|||
145903643|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903644|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903645|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903646|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903647|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903648|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145903649|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
145903650|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
145903651|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903652|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903653|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903654|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903655|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903656|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903657|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903658|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903659|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903660|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903661|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903662|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145903663|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
145903664|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
145903665|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903666|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903667|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903668|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903669|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903670|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903671|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903672|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903673|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903674|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903675|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903676|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145903677|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
145903678|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
145903679|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903680|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903681|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903682|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903683|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903684|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903685|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903686|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903687|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903688|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903689|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903690|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145903691|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
145903692|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
145903693|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903694|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903695|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903696|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903697|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903698|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903699|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903700|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903701|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903702|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903703|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903704|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145903705|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
145903706|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
145903707|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903708|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903709|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903710|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903711|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903712|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903713|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903714|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903715|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903716|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903717|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903718|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145903719|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
145903720|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
145903721|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903722|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903723|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903724|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903725|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903726|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903727|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903728|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903729|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903730|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903731|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903732|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145903733|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
145903734|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
145903735|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903736|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903737|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903738|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903739|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903740|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903741|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903742|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903743|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903744|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903745|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903746|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145903747|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
145903748|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
145903749|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903750|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903751|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903752|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903753|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903754|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903755|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903756|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903757|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903758|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903759|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903760|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145903761|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
145903762|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
145903763|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903764|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903765|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903766|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903767|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903768|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903769|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903770|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903771|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903772|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903773|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903774|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145903775|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
145903776|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
145903777|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903778|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903779|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903780|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903781|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903782|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903783|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903784|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903785|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903786|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903787|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903788|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145903789|NCT03982199|526152858|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
145903790|NCT03982199|526152859|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
145903791|NCT03982199|526152860|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903792|NCT03982199|526152861|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903793|NCT03982199|526152862|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903794|NCT03982199|526152863|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903795|NCT03982199|526152864|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903796|NCT03982199|526152865|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903797|NCT03982199|526152866|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903798|NCT03982199|526152867|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903799|NCT03982199|526152868|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903800|NCT03982199|526152869|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903801|NCT03982199|526152870|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903802|NCT03982199|526152871|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145903803|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903804|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903805|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903806|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
145903807|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903808|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903809|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903810|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903811|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903812|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903813|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903814|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903815|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903816|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145903817|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903818|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903819|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
145903820|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903821|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903822|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903823|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903824|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903825|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903826|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903827|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903828|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903829|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903830|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145903831|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903832|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903833|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
145903834|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903835|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903836|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
146297343|NCT00634010|527604676|FG000|Overall Study|Adverse Event|2|||
146297344|NCT00634010|527604677|FG001|Overall Study|Adverse Event|5|||
145972563|NCT00141921|526412676|FG000|Overall Study|Lost to Follow-up|19|||
145903837|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903838|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903839|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903840|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903841|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903842|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903843|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903844|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145903845|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903846|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903847|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
145903848|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
145903849|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903850|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903851|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903852|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903853|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903854|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903855|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903856|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903857|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903858|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145903859|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903860|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903861|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903862|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
145903863|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903864|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903865|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903866|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903867|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903868|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903869|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903870|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903871|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903872|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145903873|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903874|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903875|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
145903876|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
145903877|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903878|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903879|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903880|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903881|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903882|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903883|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903884|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903885|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903886|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145903887|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903888|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903889|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903890|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903891|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903892|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903893|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903894|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903895|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
145903896|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903897|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903898|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903899|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903900|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145903901|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903902|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903903|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903904|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903905|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903906|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903907|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903908|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903909|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
145903910|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903911|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903912|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903913|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903914|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145903915|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903916|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903917|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903918|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903919|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903920|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903921|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903922|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903923|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
145903924|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903925|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903926|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903927|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903928|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145903929|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903930|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903931|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903932|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903933|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903934|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903935|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903936|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903937|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
145903938|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903939|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903940|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903941|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903942|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145903943|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903944|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903945|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903946|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903947|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903948|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903949|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903950|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903951|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
145903952|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903953|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903954|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903955|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903956|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145903957|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903958|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903959|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903960|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903961|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903962|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
146088429|NCT02011893|526843845|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
146088430|NCT02011893|526843846|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
145903963|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903964|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
145903965|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
145903966|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903967|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903968|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903969|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903970|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145903971|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903972|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903973|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903974|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903975|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903976|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903977|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903978|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903979|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
145903980|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903981|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903982|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903983|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903984|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145903985|NCT03982199|526152858|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903986|NCT03982199|526152859|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903987|NCT03982199|526152860|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903988|NCT03982199|526152861|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903989|NCT03982199|526152862|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903990|NCT03982199|526152863|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
145903991|NCT03982199|526152864|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903992|NCT03982199|526152865|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
145903993|NCT03982199|526152866|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
145903994|NCT03982199|526152867|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903995|NCT03982199|526152868|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903996|NCT03982199|526152869|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903997|NCT03982199|526152870|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903998|NCT03982199|526152871|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145903999|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904000|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904001|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904002|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904003|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904004|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904005|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904006|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145972564|NCT00141921|526412676|FG000|Overall Study|Noncompliance|17|||
146297345|NCT00634010|527604676|FG000|Overall Study|Withdrawal by Subject|5|||
146297346|NCT00634010|527604677|FG001|Overall Study|Withdrawal by Subject|6|||
146297347|NCT00634010|527604676|FG000|Overall Study|Physician Decision|1|||
146297348|NCT00634010|527604677|FG001|Overall Study|Physician Decision|1|||
146297349|NCT00634010|527604676|FG000|Overall Study|Disease Progression|1|||
146297350|NCT00634010|527604677|FG001|Overall Study|Disease Progression|1|||
146297351|NCT00634010|527604676|FG000|Overall Study|Non-Compliant|1|||
146297352|NCT00634010|527604677|FG001|Overall Study|Non-Compliant|1|||
146297353|NCT01026142|527604678|FG000|Overall Study|Death|136|||
146297354|NCT01026142|527604679|FG001|Overall Study|Death|134|||
146297355|NCT01026142|527604678|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
146297356|NCT01026142|527604679|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
146297357|NCT01862640|527604683|FG000|Overall Study|Adverse Event|4|||
146297358|NCT01862640|527604684|FG001|Overall Study|Adverse Event|10|||
146297359|NCT01862640|527604685|FG002|Overall Study|Adverse Event|6|||
146297360|NCT01862640|527604686|FG003|Overall Study|Adverse Event|8|||
146297361|NCT01862640|527604683|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146297362|NCT01862640|527604684|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146297363|NCT01862640|527604685|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
146297364|NCT01862640|527604686|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
145904007|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145904008|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
145904009|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
145904010|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
145904011|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
145904012|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
145904013|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904014|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904015|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904016|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904017|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904018|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904019|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904020|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904021|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904022|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
145904023|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904024|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904025|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904026|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145904027|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904028|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904029|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904030|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904031|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904032|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904033|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904034|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904035|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904036|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904037|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904038|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904039|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145904040|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
145904041|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904042|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904043|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904044|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904045|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904046|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904047|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904048|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904049|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904050|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904051|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
145904052|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
145904053|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
145904054|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145904055|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904056|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904057|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904058|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904059|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904060|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904061|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904062|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904063|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904064|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
146088431|NCT02011893|526843847|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
146088432|NCT02011893|526843845|FG000|Enrollment to Randomization|Screening Failure|29|||
146088433|NCT02011893|526843846|FG001|Enrollment to Randomization|Screening Failure|0|||
146088434|NCT02011893|526843847|FG002|Enrollment to Randomization|Screening Failure|0|||
146238892|NCT01701401|527388066|FG002|Overall Study|Protocol Violation|1|||
145904065|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904066|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904067|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145904068|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
145904069|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904070|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904071|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904072|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904073|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904074|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904075|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904076|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904077|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904078|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904079|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904080|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145904081|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
145904082|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
145904083|NCT03982199|526152858|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904084|NCT03982199|526152859|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904085|NCT03982199|526152860|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904086|NCT03982199|526152861|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904087|NCT03982199|526152862|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904088|NCT03982199|526152863|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904089|NCT03982199|526152864|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904090|NCT03982199|526152865|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904091|NCT03982199|526152866|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904092|NCT03982199|526152867|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904093|NCT03982199|526152868|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904094|NCT03982199|526152869|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904095|NCT03982199|526152870|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
145904096|NCT03982199|526152871|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145904097|NCT03510598|526154403|FG000|Overall Study|Withdrawal by Subject|1|||
145904098|NCT04240392|526154404|FG000|Overall Study|Withdrawal by Subject|13|||
145904099|NCT04240392|526154405|FG001|Overall Study|Withdrawal by Subject|4|||
145904100|NCT04240392|526154404|FG000|Overall Study|Lost to Follow-up|11|||
145904101|NCT04240392|526154405|FG001|Overall Study|Lost to Follow-up|12|||
145904102|NCT03665441|526154413|FG000|Overall Study|survival follow up ongoing|23|||
145904103|NCT03665441|526154414|FG001|Overall Study|survival follow up ongoing|0|||
145904104|NCT03665441|526154413|FG000|Overall Study|Patients ongoing on treatment|9|||
145904105|NCT03665441|526154414|FG001|Overall Study|Patients ongoing on treatment|6|||
145904106|NCT03665441|526154413|FG000|Overall Study|Randomized but not treated|7|||
145904107|NCT03665441|526154414|FG001|Overall Study|Randomized but not treated|11|||
145904108|NCT00191113|526154415|FG000|Core Study|Withdrawal by Subject|25|||
145904109|NCT00191113|526154416|FG001|Core Study|Withdrawal by Subject|9|||
145904110|NCT00191113|526154415|FG000|Core Study|Protocol Violation|6|||
145904111|NCT00191113|526154416|FG001|Core Study|Protocol Violation|2|||
145904112|NCT00191113|526154415|FG000|Core Study|Lost to Follow-up|3|||
145904113|NCT00191113|526154416|FG001|Core Study|Lost to Follow-up|0|||
145904114|NCT00191113|526154415|FG000|Core Study|Adverse Event|0|||
145904115|NCT00191113|526154416|FG001|Core Study|Adverse Event|2|||
145904116|NCT00191113|526154415|FG000|Core Study|Lack of Efficacy|0|||
145904117|NCT00191113|526154416|FG001|Core Study|Lack of Efficacy|2|||
145904118|NCT00191113|526154415|FG000|Core Study|Death|1|||
145904119|NCT00191113|526154416|FG001|Core Study|Death|0|||
145904120|NCT05307510|526154417|FG000|Overall Study|Lost to Follow-up|3|||
145904121|NCT05307510|526154418|FG001|Overall Study|Lost to Follow-up|6|||
145904122|NCT05307510|526154417|FG000|Overall Study|Withdrawal by Subject|0|||
145904123|NCT05307510|526154418|FG001|Overall Study|Withdrawal by Subject|1|||
145904124|NCT03610516|526154419|FG000|Treatment Epoch|Adverse Event|3|||
145904125|NCT03610516|526154420|FG001|Treatment Epoch|Adverse Event|1|||
145904126|NCT03610516|526154419|FG000|Treatment Epoch|Death|1|||
145904127|NCT03610516|526154420|FG001|Treatment Epoch|Death|0|||
145904128|NCT03610516|526154419|FG000|Treatment Epoch|Lack of Efficacy|0|||
145904129|NCT03610516|526154420|FG001|Treatment Epoch|Lack of Efficacy|1|||
145904130|NCT03610516|526154419|FG000|Treatment Epoch|No longer requires treatment|1|||
145904131|NCT03610516|526154420|FG001|Treatment Epoch|No longer requires treatment|0|||
145972565|NCT00141921|526412676|FG000|Overall Study|Disease Progression|7|||
145904132|NCT03610516|526154419|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
145904133|NCT03610516|526154420|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
145904134|NCT03610516|526154419|FG000|Treatment Epoch|Physician Decision|8|||
145904135|NCT03610516|526154420|FG001|Treatment Epoch|Physician Decision|5|||
145904136|NCT03610516|526154419|FG000|Treatment Epoch|Protocol Deviation|1|||
145904137|NCT03610516|526154420|FG001|Treatment Epoch|Protocol Deviation|0|||
145904138|NCT03610516|526154419|FG000|Treatment Epoch|Withdrawal by Subject|3|||
145904139|NCT03610516|526154420|FG001|Treatment Epoch|Withdrawal by Subject|1|||
145904140|NCT03610516|526154419|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
145904141|NCT03610516|526154420|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
145904142|NCT03610516|526154419|FG000|Post-Treatment Follow-up|Death|1|||
145904143|NCT03610516|526154420|FG001|Post-Treatment Follow-up|Death|0|||
145904144|NCT04241315|526154423|FG000|Overall Study|Withdrawal by Subject|0|||
145904145|NCT04241315|526154424|FG001|Overall Study|Withdrawal by Subject|1|||
145904146|NCT03047330|526154425|FG000|Sleep Block 1|Withdrawal by Subject|3|||
145904147|NCT00000378|526154426|FG000|Overall Study|Lack of Efficacy|16|||
145904148|NCT00000378|526154427|FG001|Overall Study|Lack of Efficacy|14|||
145904149|NCT00663026|526154442|FG000|Overall Study|Lost to Follow-up|1|||
145904150|NCT00663026|526154443|FG001|Overall Study|Lost to Follow-up|0|||
145904151|NCT00663026|526154444|FG002|Overall Study|Lost to Follow-up|0|||
145904152|NCT00663026|526154442|FG000|Overall Study|Other|1|||
145904153|NCT00663026|526154443|FG001|Overall Study|Other|2|||
145904154|NCT00663026|526154444|FG002|Overall Study|Other|0|||
145904155|NCT00663026|526154442|FG000|Overall Study|Adverse Event|0|||
145904156|NCT00663026|526154443|FG001|Overall Study|Adverse Event|2|||
145904157|NCT00663026|526154444|FG002|Overall Study|Adverse Event|3|||
145904158|NCT00663026|526154442|FG000|Overall Study|Caregiver Request|0|||
145904159|NCT00663026|526154443|FG001|Overall Study|Caregiver Request|2|||
145904160|NCT00663026|526154444|FG002|Overall Study|Caregiver Request|0|||
145904161|NCT00663026|526154442|FG000|Overall Study|Withdrawal by Subject|0|||
145904162|NCT00663026|526154443|FG001|Overall Study|Withdrawal by Subject|0|||
145904163|NCT00663026|526154444|FG002|Overall Study|Withdrawal by Subject|1|||
145904164|NCT04003896|526154448|FG000|Overall Study|Withdrawal by Subject|3|||
145904165|NCT04003896|526154448|FG000|Overall Study|Physician Decision|1|||
145904166|NCT01682863|526154449|FG000|Overall Study|Subject/guardian decision|19|||
145904167|NCT01682863|526154450|FG001|Overall Study|Subject/guardian decision|12|||
145904168|NCT01682863|526154451|FG002|Overall Study|Subject/guardian decision|10|||
145904169|NCT01682863|526154449|FG000|Overall Study|Lost to Follow-up|5|||
145904170|NCT01682863|526154450|FG001|Overall Study|Lost to Follow-up|1|||
145904171|NCT01682863|526154451|FG002|Overall Study|Lost to Follow-up|6|||
145904172|NCT01682863|526154449|FG000|Overall Study|Death|1|||
145904173|NCT01682863|526154450|FG001|Overall Study|Death|3|||
145904174|NCT01682863|526154451|FG002|Overall Study|Death|4|||
145904175|NCT01682863|526154449|FG000|Overall Study|Protocol deviation|1|||
145904176|NCT01682863|526154450|FG001|Overall Study|Protocol deviation|0|||
146297365|NCT01862640|527604683|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
145904177|NCT01682863|526154451|FG002|Overall Study|Protocol deviation|1|||
145904178|NCT01682863|526154449|FG000|Overall Study|Technical problems|1|||
145904179|NCT01682863|526154450|FG001|Overall Study|Technical problems|0|||
145904180|NCT01682863|526154451|FG002|Overall Study|Technical problems|0|||
145904181|NCT01682863|526154449|FG000|Overall Study|Adverse Event|0|||
145904182|NCT01682863|526154450|FG001|Overall Study|Adverse Event|1|||
145904183|NCT01682863|526154451|FG002|Overall Study|Adverse Event|2|||
145904184|NCT01682863|526154449|FG000|Overall Study|Physician Decision|0|||
145904185|NCT01682863|526154450|FG001|Overall Study|Physician Decision|0|||
145904186|NCT01682863|526154451|FG002|Overall Study|Physician Decision|1|||
145904187|NCT00837473|526154452|FG000|Overall Study|Lost to Follow-up|1|||
145904188|NCT00837473|526154452|FG000|Overall Study|Withdrawal by Subject|2|||
146297366|NCT01862640|527604684|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
146297367|NCT01862640|527604685|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
145904189|NCT04576923|526154453|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
145904190|NCT01161407|526154454|FG000|Overall Study|Protocol Violation|3|||
145904191|NCT01161407|526154455|FG001|Overall Study|Protocol Violation|1|||
145904192|NCT01635283|526154456|FG000|Overall Study|Tumor Progression|3|||
145904193|NCT01635283|526154456|FG000|Overall Study|Lost to Follow-up|1|||
145904194|NCT01305044|526154461|FG000|Overall Study|Withdrawal by Subject|3|||
145904195|NCT01305044|526154462|FG001|Overall Study|Withdrawal by Subject|6|||
145904196|NCT00492024|526154465|FG000|Treatment|Adverse Event|3|||
145904197|NCT00492024|526154466|FG001|Treatment|Adverse Event|1|||
145904198|NCT00492024|526154465|FG000|Treatment|Lack of Efficacy|21|||
145904199|NCT00492024|526154466|FG001|Treatment|Lack of Efficacy|20|||
145904200|NCT00492024|526154465|FG000|Treatment|Lost to Follow-up|3|||
145904201|NCT00492024|526154466|FG001|Treatment|Lost to Follow-up|1|||
145904202|NCT00492024|526154465|FG000|Treatment|Withdrawal by Subject|2|||
145904203|NCT00492024|526154466|FG001|Treatment|Withdrawal by Subject|0|||
145904204|NCT00492024|526154465|FG000|Follow up|Lack of Efficacy|0|||
145904205|NCT00492024|526154466|FG001|Follow up|Lack of Efficacy|1|||
145904206|NCT00492024|526154465|FG000|Follow up|Lost to Follow-up|1|||
145904207|NCT00492024|526154466|FG001|Follow up|Lost to Follow-up|1|||
145904208|NCT02677714|526154479|FG000|Overall Study|Withdrawal by Subject|2|||
145904209|NCT02677714|526154480|FG001|Overall Study|Withdrawal by Subject|0|||
145904210|NCT04628793|526154481|FG000|Overall Study|Study terminated by sponsor|0|||
146297368|NCT01862640|527604686|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
145904211|NCT04628793|526154482|FG001|Overall Study|Study terminated by sponsor|0|||
145904212|NCT04628793|526154483|FG002|Overall Study|Study terminated by sponsor|8|||
145904213|NCT04628793|526154481|FG000|Overall Study|Withdrawal by Subject|2|||
145904214|NCT04628793|526154482|FG001|Overall Study|Withdrawal by Subject|3|||
145904215|NCT04628793|526154483|FG002|Overall Study|Withdrawal by Subject|0|||
145904216|NCT04628793|526154481|FG000|Overall Study|Lost to Follow-up|0|||
145904217|NCT04628793|526154482|FG001|Overall Study|Lost to Follow-up|1|||
145904218|NCT04628793|526154483|FG002|Overall Study|Lost to Follow-up|0|||
145904219|NCT02278055|526154486|FG000|Overall Study|Adverse Event|1|||
145904220|NCT02278055|526154486|FG000|Overall Study|Lost to Follow-up|1|||
145904221|NCT02278055|526154486|FG000|Overall Study|Withdrawal by Subject|2|||
145904222|NCT02278055|526154486|FG000|Overall Study|Progressive Disease|4|||
145904223|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
145904224|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
145904225|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
145904226|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
145904227|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
145904228|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
145904229|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
145904230|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
145904231|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
145904232|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
145904233|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
145904234|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
145904235|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
145904236|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
145904237|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
145904238|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
145904239|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
145904240|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
145904241|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
145904242|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
145904243|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
145904244|NCT04040192|526154487|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
145904245|NCT04040192|526154488|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
145904246|NCT04040192|526154489|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
145904247|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
145904248|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
145904249|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
145904250|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
145904251|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
145904252|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
145904253|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
145904254|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
145904255|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
145904256|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
145904257|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
145904258|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
145904259|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145904260|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
145904261|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
145904262|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
145904263|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
145904264|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
145904265|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
145904266|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
145904267|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
145904268|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
145904269|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
145904270|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
145904271|NCT04040192|526154487|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
145904272|NCT04040192|526154488|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
145904273|NCT04040192|526154489|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
145904274|NCT00469144|526154490|FG000|Overall Study|Death|0|||
146297369|NCT01862640|527604683|FG000|Overall Study|Withdrawal by Subject|2|||
146238893|NCT01701401|527388067|FG003|Overall Study|Protocol Violation|0|||
146238894|NCT04827732|527388071|FG000|Overall Study|Did not start treatment|0|||
146238895|NCT04827732|527388072|FG001|Overall Study|Did not start treatment|1|||
146238896|NCT04827732|527388073|FG002|Overall Study|Did not start treatment|0|||
146238897|NCT04827732|527388074|FG003|Overall Study|Did not start treatment|1|||
146238898|NCT04021862|527388075|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146238899|NCT04021862|527388076|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
146238900|NCT04021862|527388077|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146238901|NCT04021862|527388078|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
146297370|NCT01862640|527604684|FG001|Overall Study|Withdrawal by Subject|4|||
146297371|NCT01862640|527604685|FG002|Overall Study|Withdrawal by Subject|8|||
146297372|NCT01862640|527604686|FG003|Overall Study|Withdrawal by Subject|5|||
145904275|NCT00469144|526154491|FG001|Overall Study|Death|1|||
145904276|NCT00469144|526154490|FG000|Overall Study|No Response|5|||
145904277|NCT00469144|526154491|FG001|Overall Study|No Response|5|||
145904278|NCT00469144|526154490|FG000|Overall Study|Progressive Disease|1|||
145904279|NCT00469144|526154491|FG001|Overall Study|Progressive Disease|0|||
145904280|NCT01994291|526154492|FG000|Overall Study|Adverse Event|4|||
145904281|NCT01994291|526154493|FG001|Overall Study|Adverse Event|1|||
145904282|NCT01994291|526154494|FG002|Overall Study|Adverse Event|3|||
145904283|NCT01994291|526154492|FG000|Overall Study|Lost to Follow-up|1|||
145904284|NCT01994291|526154493|FG001|Overall Study|Lost to Follow-up|1|||
145904285|NCT01994291|526154494|FG002|Overall Study|Lost to Follow-up|0|||
145904286|NCT01994291|526154492|FG000|Overall Study|Does not meet entrance criteria|1|||
145904287|NCT01994291|526154493|FG001|Overall Study|Does not meet entrance criteria|0|||
145904288|NCT01994291|526154494|FG002|Overall Study|Does not meet entrance criteria|0|||
145904289|NCT01994291|526154492|FG000|Overall Study|Medication error without associated AE|1|||
145904290|NCT01994291|526154493|FG001|Overall Study|Medication error without associated AE|0|||
145904291|NCT01994291|526154494|FG002|Overall Study|Medication error without associated AE|1|||
145904292|NCT01994291|526154492|FG000|Overall Study|Protocol Violation|1|||
145904293|NCT01994291|526154493|FG001|Overall Study|Protocol Violation|0|||
145904294|NCT01994291|526154494|FG002|Overall Study|Protocol Violation|0|||
145904295|NCT01994291|526154492|FG000|Overall Study|Withdrawal by Subject|6|||
145904296|NCT01994291|526154493|FG001|Overall Study|Withdrawal by Subject|3|||
145904297|NCT01994291|526154494|FG002|Overall Study|Withdrawal by Subject|5|||
145904298|NCT01994291|526154492|FG000|Overall Study|Other|1|||
145904299|NCT01994291|526154493|FG001|Overall Study|Other|2|||
145904300|NCT01994291|526154494|FG002|Overall Study|Other|0|||
145904301|NCT00856375|526154495|FG000|Overall Study|Other|0|||
145904302|NCT00856375|526154496|FG001|Overall Study|Other|1|||
145904303|NCT00856375|526154495|FG000|Overall Study|Death|32|||
145904304|NCT00856375|526154496|FG001|Overall Study|Death|30|||
145904305|NCT00856375|526154495|FG000|Overall Study|Sponsor Terminated Study|7|||
145904306|NCT00856375|526154496|FG001|Overall Study|Sponsor Terminated Study|7|||
145904307|NCT00856375|526154495|FG000|Overall Study|Withdrawal by Subject|2|||
145904308|NCT00856375|526154496|FG001|Overall Study|Withdrawal by Subject|1|||
145904309|NCT00856375|526154495|FG000|Overall Study|Lost to Follow-up|1|||
145904310|NCT00856375|526154496|FG001|Overall Study|Lost to Follow-up|2|||
145904311|NCT02227446|526154497|FG000|Overall Study|not eligible post randomization|18|||
145904312|NCT02227446|526154498|FG001|Overall Study|not eligible post randomization|29|||
145904313|NCT02227446|526154497|FG000|Overall Study|Withdrawal by Subject|4|||
145904314|NCT02227446|526154498|FG001|Overall Study|Withdrawal by Subject|5|||
145904315|NCT02121392|526154499|FG000|Prior to Intervention|Protocol Violation|40|||
145904316|NCT02121392|526154500|FG001|Prior to Intervention|Protocol Violation|35|||
145904317|NCT02121392|526154499|FG000|Prior to Intervention|Withdrawal by Subject|8|||
145904318|NCT02121392|526154500|FG001|Prior to Intervention|Withdrawal by Subject|6|||
145904319|NCT02121392|526154499|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
145904320|NCT02121392|526154500|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
145904321|NCT02121392|526154499|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
145904322|NCT02121392|526154500|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
145904323|NCT01352416|526154501|FG000|Overall Study|Physician Decision|1|||
145904324|NCT01352416|526154502|FG001|Overall Study|Physician Decision|2|||
145904325|NCT01352416|526154503|FG002|Overall Study|Physician Decision|2|||
145904326|NCT01352416|526154504|FG003|Overall Study|Physician Decision|1|||
145904327|NCT03016975|526154513|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
146238902|NCT04021862|527388079|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145904328|NCT03016975|526154514|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
145904329|NCT03016975|526154515|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
145904330|NCT03016975|526154513|FG000|At 6 Months Follow-up|Death|2|||
145904331|NCT03016975|526154514|FG001|At 6 Months Follow-up|Death|0|||
145904332|NCT03016975|526154515|FG002|At 6 Months Follow-up|Death|0|||
146088435|NCT02011893|526843845|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
146297373|NCT01862640|527604683|FG000|Overall Study|Protocol Deviation|0|||
145904333|NCT03016975|526154513|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
146238903|NCT04021862|527388080|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145904334|NCT03016975|526154514|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
145904335|NCT03016975|526154515|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
145904336|NCT03016975|526154513|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
145904337|NCT03016975|526154514|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
145904338|NCT03016975|526154515|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
145904339|NCT03016975|526154513|FG000|At 6 Months Follow-up|Aborted implant|1|||
145904340|NCT03016975|526154514|FG001|At 6 Months Follow-up|Aborted implant|0|||
145904341|NCT03016975|526154515|FG002|At 6 Months Follow-up|Aborted implant|0|||
145904342|NCT03016975|526154513|FG000|At 2 Year Follow-up|Death|1|||
145904343|NCT03016975|526154514|FG001|At 2 Year Follow-up|Death|0|||
145904344|NCT03016975|526154515|FG002|At 2 Year Follow-up|Death|0|||
145904345|NCT03016975|526154513|FG000|At 3 Year Follow-up|Death|1|||
145904346|NCT03016975|526154514|FG001|At 3 Year Follow-up|Death|0|||
145904347|NCT03016975|526154515|FG002|At 3 Year Follow-up|Death|0|||
145904348|NCT03016975|526154513|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
145904349|NCT03016975|526154514|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
145904350|NCT03016975|526154515|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
145904351|NCT03016975|526154513|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
145904352|NCT03016975|526154514|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
145904353|NCT03016975|526154515|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
145904354|NCT02901548|526154516|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
145904355|NCT01228019|526154528|FG000|Overall Study|Dose Violation|70|||
145904356|NCT01228019|526154528|FG000|Overall Study|Duplicate enrollment|1|||
145904357|NCT01228019|526154528|FG000|Overall Study|Missing pre-treatment data|72|||
145904358|NCT01228019|526154528|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
145904359|NCT01228019|526154528|FG000|Overall Study|Violation of Entry Criterion|9|||
145904360|NCT02640053|526154530|FG000|Overall Study|Withdrawal by Subject|2|||
145904361|NCT02640053|526154531|FG001|Overall Study|Withdrawal by Subject|1|||
145904362|NCT02640053|526154530|FG000|Overall Study|Adverse Event|1|||
145904363|NCT02640053|526154531|FG001|Overall Study|Adverse Event|1|||
145904364|NCT02640053|526154530|FG000|Overall Study|Alternative Therapy|1|||
145904365|NCT02640053|526154531|FG001|Overall Study|Alternative Therapy|1|||
145904366|NCT02640053|526154530|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
145904367|NCT02640053|526154531|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
145904368|NCT02348723|526154533|FG000|Overall Study|No ablation|21|||
145904369|NCT02348723|526154534|FG001|Overall Study|No ablation|20|||
145904370|NCT02348723|526154533|FG000|Overall Study|Non-compliant with Protocol|1|||
145904371|NCT02348723|526154534|FG001|Overall Study|Non-compliant with Protocol|0|||
145904372|NCT02348723|526154533|FG000|Overall Study|Lost to Follow-up|1|||
145904373|NCT02348723|526154534|FG001|Overall Study|Lost to Follow-up|1|||
145904374|NCT02348723|526154533|FG000|Overall Study|Consent withdrawn|1|||
145904375|NCT02348723|526154534|FG001|Overall Study|Consent withdrawn|3|||
145904376|NCT02348723|526154533|FG000|Overall Study|Reason other than specified|1|||
145904377|NCT02348723|526154534|FG001|Overall Study|Reason other than specified|1|||
145904378|NCT02348723|526154533|FG000|Overall Study|Adverse Event|3|||
145904379|NCT02348723|526154534|FG001|Overall Study|Adverse Event|1|||
146238904|NCT04021862|527388075|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
146238905|NCT04021862|527388076|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146238906|NCT04021862|527388077|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145904380|NCT01268501|526154535|FG000|Overall Study|Lost to Follow-up|1|||
145904381|NCT01268501|526154535|FG000|Overall Study|Withdrawal by Subject|3|||
145904382|NCT01268501|526154535|FG000|Overall Study|Unacceptable Subjective Vision|3|||
145904383|NCT01268501|526154535|FG000|Overall Study|Handling Difficulties|2|||
145904384|NCT01458106|526154538|FG000|Overall Study|Withdrawal by Subject|2|||
145904385|NCT01458106|526154539|FG001|Overall Study|Withdrawal by Subject|0|||
145904386|NCT01458106|526154538|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
145904387|NCT01458106|526154539|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
145904388|NCT01458106|526154538|FG000|Overall Study|Withdrawn Per Protocol|0|||
145904389|NCT01458106|526154539|FG001|Overall Study|Withdrawn Per Protocol|1|||
146238907|NCT04021862|527388078|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145904390|NCT00073021|526154540|FG000|Overall Study|Protocol Violation|2|||
145904391|NCT00073021|526154541|FG001|Overall Study|Protocol Violation|1|||
145972566|NCT00141921|526412676|FG000|Overall Study|Protocol Deviation|7|||
145972567|NCT00141921|526412676|FG000|Overall Study|Adverse Event|5|||
145972568|NCT00141921|526412676|FG000|Overall Study|Administrative Decision|2|||
145972569|NCT00141921|526412676|FG000|Overall Study|Pregnancy|4|||
146238908|NCT04021862|527388079|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145904392|NCT00073021|526154540|FG000|Overall Study|Adverse Event|4|||
145904393|NCT00073021|526154541|FG001|Overall Study|Adverse Event|4|||
145904394|NCT00073021|526154540|FG000|Overall Study|Withdrawal by Subject|6|||
145904395|NCT00073021|526154541|FG001|Overall Study|Withdrawal by Subject|5|||
145904396|NCT00073021|526154540|FG000|Overall Study|Physician Decision|3|||
145904397|NCT00073021|526154541|FG001|Overall Study|Physician Decision|1|||
145904398|NCT00073021|526154540|FG000|Overall Study|Lack of Efficacy|11|||
145972570|NCT00141921|526412676|FG000|Overall Study|Ineligibility Determined|2|||
145972571|NCT00141921|526412676|FG000|Overall Study|Other|8|||
145904399|NCT00073021|526154541|FG001|Overall Study|Lack of Efficacy|5|||
145904400|NCT03050060|526154542|FG000|Overall Study|Adverse Event|7|||
145904401|NCT03050060|526154542|FG000|Overall Study|Withdrawal by Subject|1|||
145904402|NCT03050060|526154542|FG000|Overall Study|Progression|7|||
145904403|NCT00761865|526154545|FG000|Overall Study|Lost to Follow-up|8|||
145904404|NCT00761865|526154546|FG001|Overall Study|Lost to Follow-up|7|||
145904405|NCT01094886|526154547|FG000|Overall Study|Adverse Event|2|||
145904406|NCT01094886|526154547|FG000|Overall Study|Withdrawal by Subject|5|||
145904407|NCT03866902|526154549|FG000|Overall Study|Lost to Follow-up|98|||
145904408|NCT03866902|526154550|FG001|Overall Study|Lost to Follow-up|82|||
145904409|NCT03866902|526154549|FG000|Overall Study|Pregnancy|18|||
145904410|NCT03866902|526154550|FG001|Overall Study|Pregnancy|24|||
145904411|NCT03155945|526154551|FG000|Overall Study|Lost to Follow-up|0|||
145904412|NCT03155945|526154552|FG001|Overall Study|Lost to Follow-up|1|||
145904413|NCT03155945|526154551|FG000|Overall Study|Withdrawal by Subject|0|||
145904414|NCT03155945|526154552|FG001|Overall Study|Withdrawal by Subject|1|||
145904415|NCT03155945|526154551|FG000|Overall Study|Other Reason|0|||
145904416|NCT03155945|526154552|FG001|Overall Study|Other Reason|1|||
145904417|NCT02886624|526155889|FG000|12-week Post Treatment Follow-up|Death|1|||
145904418|NCT02886624|526155889|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
145904419|NCT00402116|526155890|FG000|Overall Study|Jaw infection after surgery-other|1|||
145904420|NCT00402116|526155891|FG001|Overall Study|Jaw infection after surgery-other|0|||
145904421|NCT00402116|526155892|FG002|Overall Study|Jaw infection after surgery-other|0|||
145904422|NCT00402116|526155890|FG000|Overall Study|Withdrawal by Subject|1|||
145904423|NCT00402116|526155891|FG001|Overall Study|Withdrawal by Subject|0|||
145904424|NCT00402116|526155892|FG002|Overall Study|Withdrawal by Subject|5|||
145904425|NCT00402116|526155890|FG000|Overall Study|Treatment completed per protocol|1|||
145904426|NCT00402116|526155891|FG001|Overall Study|Treatment completed per protocol|1|||
145904427|NCT00402116|526155892|FG002|Overall Study|Treatment completed per protocol|2|||
145904428|NCT00402116|526155890|FG000|Overall Study|other complicating disease|0|||
145904429|NCT00402116|526155891|FG001|Overall Study|other complicating disease|0|||
145904430|NCT00402116|526155892|FG002|Overall Study|other complicating disease|2|||
145904431|NCT00402116|526155890|FG000|Overall Study|Disease Progression|0|||
145904432|NCT00402116|526155891|FG001|Overall Study|Disease Progression|4|||
145904433|NCT00402116|526155892|FG002|Overall Study|Disease Progression|38|||
145904434|NCT00402116|526155890|FG000|Overall Study|mistaken thrombocytopenia|0|||
145904435|NCT00402116|526155891|FG001|Overall Study|mistaken thrombocytopenia|0|||
145904436|NCT00402116|526155892|FG002|Overall Study|mistaken thrombocytopenia|1|||
145904437|NCT00402116|526155890|FG000|Overall Study|decline related hyponatremia/tumor|0|||
145904438|NCT00402116|526155891|FG001|Overall Study|decline related hyponatremia/tumor|0|||
145904439|NCT00402116|526155892|FG002|Overall Study|decline related hyponatremia/tumor|1|||
145904440|NCT00402116|526155890|FG000|Overall Study|Adverse Event|0|||
145904441|NCT00402116|526155891|FG001|Overall Study|Adverse Event|1|||
145904442|NCT00402116|526155892|FG002|Overall Study|Adverse Event|6|||
145904443|NCT05048329|526155893|FG000|Overall Study|Withdrawal by Subject|1|||
145904444|NCT05048329|526155893|FG000|Overall Study|Screenfail|1|||
145904445|NCT00324649|526155894|FG000|Overall Study|Adverse Event|1|||
145904446|NCT00324649|526155895|FG001|Overall Study|Adverse Event|4|||
146238909|NCT04021862|527388080|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
146238910|NCT04021862|527388075|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146238911|NCT04021862|527388076|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146238912|NCT04021862|527388077|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
145904447|NCT00324649|526155894|FG000|Overall Study|Withdrawal by Subject|0|||
145904448|NCT00324649|526155895|FG001|Overall Study|Withdrawal by Subject|1|||
145904449|NCT00324649|526155894|FG000|Overall Study|Noncompliance|1|||
145904450|NCT00324649|526155895|FG001|Overall Study|Noncompliance|0|||
145904451|NCT02065700|526155896|FG000|Overall Study|Adverse Event|165|||
145904452|NCT02065700|526155897|FG001|Overall Study|Adverse Event|101|||
145904453|NCT02065700|526155896|FG000|Overall Study|Withdrawal by Subject|90|||
145904454|NCT02065700|526155897|FG001|Overall Study|Withdrawal by Subject|29|||
145904455|NCT02065700|526155896|FG000|Overall Study|Lost to Follow-up|12|||
145904456|NCT02065700|526155897|FG001|Overall Study|Lost to Follow-up|9|||
145904457|NCT02065700|526155896|FG000|Overall Study|Physician Decision|2|||
146238913|NCT04021862|527388078|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146238914|NCT04021862|527388079|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
146238915|NCT04021862|527388080|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145904458|NCT02065700|526155897|FG001|Overall Study|Physician Decision|0|||
145904459|NCT02065700|526155896|FG000|Overall Study|Sponsor Request|38|||
145904460|NCT02065700|526155897|FG001|Overall Study|Sponsor Request|15|||
145904461|NCT02065700|526155896|FG000|Overall Study|Treatment Failure|3|||
145904462|NCT02065700|526155897|FG001|Overall Study|Treatment Failure|2|||
145904463|NCT02065700|526155896|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
145904464|NCT02065700|526155897|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
145904465|NCT02065700|526155896|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
145904466|NCT02065700|526155897|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
145904467|NCT02065700|526155896|FG000|Overall Study|Non-compliance with Study Procedures|2|||
145904468|NCT02065700|526155897|FG001|Overall Study|Non-compliance with Study Procedures|0|||
145904469|NCT02065700|526155896|FG000|Overall Study|Not Defined|21|||
145904470|NCT02065700|526155897|FG001|Overall Study|Not Defined|3|||
145904471|NCT01635218|526155898|FG000|Overall Study|Lost to Follow-up|3|||
145904472|NCT01635218|526155899|FG001|Overall Study|Lost to Follow-up|7|||
145904473|NCT01635218|526155900|FG002|Overall Study|Lost to Follow-up|6|||
145904474|NCT01724489|526155901|FG000|Overall Study|Adverse Event|8|||
145904475|NCT01724489|526155902|FG001|Overall Study|Adverse Event|3|||
145904476|NCT01724489|526155901|FG000|Overall Study|Surgery, medication|1|||
145904477|NCT01724489|526155902|FG001|Overall Study|Surgery, medication|1|||
145904478|NCT01724489|526155901|FG000|Overall Study|Lost to Follow-up|1|||
145904479|NCT01724489|526155902|FG001|Overall Study|Lost to Follow-up|2|||
145904480|NCT01724489|526155901|FG000|Overall Study|Withdrawal by Subject|6|||
145904481|NCT01724489|526155902|FG001|Overall Study|Withdrawal by Subject|6|||
145904482|NCT01664130|526155905|FG000|Overall Study|competing secondary disease|2|||
145904483|NCT00554606|526155909|FG000|Overall Study|Adverse Event|3|||
145904484|NCT00554606|526155909|FG000|Overall Study|Abnormal laboratory values|1|||
145904485|NCT00554606|526155909|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
145904486|NCT00554606|526155909|FG000|Overall Study|Subject withdrew consent|2|||
145904487|NCT00554606|526155909|FG000|Overall Study|Lost to Follow-up|2|||
145904488|NCT00554606|526155909|FG000|Overall Study|Administrative problems|60|||
145904489|NCT00554606|526155909|FG000|Overall Study|Death|1|||
145904490|NCT00554606|526155909|FG000|Overall Study|Protocol deviation|2|||
145904491|NCT01439009|526155910|FG000|Overall Study|Physician Decision|5|||
145904492|NCT01439009|526155911|FG001|Overall Study|Physician Decision|3|||
145904493|NCT01439009|526155910|FG000|Overall Study|Protocol Violation|2|||
145904494|NCT01439009|526155911|FG001|Overall Study|Protocol Violation|0|||
145904495|NCT01439009|526155910|FG000|Overall Study|Deviation of exclusion criteria|1|||
145904496|NCT01439009|526155911|FG001|Overall Study|Deviation of exclusion criteria|0|||
145904497|NCT03257865|526155912|FG000|Overall Study|Adverse Event|4|||
145904498|NCT03257865|526155913|FG001|Overall Study|Adverse Event|8|||
145904499|NCT03257865|526155912|FG000|Overall Study|Lack of Efficacy|1|||
145904500|NCT03257865|526155913|FG001|Overall Study|Lack of Efficacy|2|||
145904501|NCT03257865|526155912|FG000|Overall Study|Non-compliance with Study Drug|0|||
145904502|NCT03257865|526155913|FG001|Overall Study|Non-compliance with Study Drug|2|||
145904503|NCT03257865|526155912|FG000|Overall Study|Withdrawal by Subject|23|||
145904504|NCT03257865|526155913|FG001|Overall Study|Withdrawal by Subject|17|||
145904505|NCT03257865|526155912|FG000|Overall Study|Physician Decision|3|||
145904506|NCT03257865|526155913|FG001|Overall Study|Physician Decision|1|||
145904507|NCT03257865|526155912|FG000|Overall Study|Other|0|||
145904508|NCT03257865|526155913|FG001|Overall Study|Other|1|||
145904509|NCT03257865|526155912|FG000|Overall Study|Lost to Follow-up|4|||
145904510|NCT03257865|526155913|FG001|Overall Study|Lost to Follow-up|4|||
145904511|NCT01292226|526155915|FG000|Overall Study|Adverse Event|5|||
145904512|NCT01292226|526155915|FG000|Overall Study|Death|1|||
145904513|NCT01292226|526155915|FG000|Overall Study|Graft loss|1|||
145904514|NCT01292226|526155915|FG000|Overall Study|Protocol Violation|3|||
145904515|NCT01292226|526155915|FG000|Overall Study|Withdrawal by Subject|1|||
145904516|NCT01292226|526155915|FG000|Overall Study|Other|2|||
145904517|NCT02910063|526155919|FG000|Phase 2|Withdrawal by Subject|3|||
145904518|NCT02910063|526155920|FG001|Phase 2|Withdrawal by Subject|0|||
145904519|NCT02910063|526155921|FG002|Phase 2|Withdrawal by Subject|0|||
145904520|NCT02910063|526155919|FG000|Phase 2|Lost to Follow-up|1|||
145904521|NCT02910063|526155920|FG001|Phase 2|Lost to Follow-up|0|||
145972572|NCT01208051|526412692|FG000|Total Enrollment|Withdrawal by Subject|0|||
145972573|NCT01208051|526412693|FG001|Total Enrollment|Withdrawal by Subject|1|||
145972574|NCT01208051|526412694|FG002|Total Enrollment|Withdrawal by Subject|0|||
145972575|NCT01208051|526412695|FG003|Total Enrollment|Withdrawal by Subject|0|||
145972576|NCT01208051|526412696|FG004|Total Enrollment|Withdrawal by Subject|2|||
145972577|NCT01208051|526412692|FG000|Total Enrollment|Brain metastases|0|||
145972578|NCT01208051|526412693|FG001|Total Enrollment|Brain metastases|0|||
145972579|NCT01208051|526412694|FG002|Total Enrollment|Brain metastases|1|||
145972580|NCT01208051|526412695|FG003|Total Enrollment|Brain metastases|0|||
145972581|NCT01208051|526412696|FG004|Total Enrollment|Brain metastases|0|||
145972582|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
145904522|NCT02910063|526155921|FG002|Phase 2|Lost to Follow-up|0|||
145904523|NCT02910063|526155919|FG000|Phase 2|Death|24|||
145972583|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
145904524|NCT02910063|526155920|FG001|Phase 2|Death|0|||
145904525|NCT02910063|526155921|FG002|Phase 2|Death|0|||
145904526|NCT04435184|526155922|FG000|Overall Study|follow-up blood draws missing|3|||
145904527|NCT04435184|526155923|FG001|Overall Study|follow-up blood draws missing|5|||
145904528|NCT04693416|526155924|FG000|Overall Study|Lost to Follow-up|13|||
145904529|NCT04693416|526155925|FG001|Overall Study|Lost to Follow-up|0|||
145972584|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
145972585|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
145904530|NCT00474266|526155926|FG000|Overall Study|Withdrawal by Subject|7|||
145904531|NCT00474266|526155927|FG001|Overall Study|Withdrawal by Subject|20|||
145904532|NCT00474266|526155928|FG002|Overall Study|Withdrawal by Subject|4|||
145904533|NCT00474266|526155929|FG003|Overall Study|Withdrawal by Subject|7|||
145904534|NCT02774642|526155933|FG000|Overall Study|Lost to Follow-up|9|||
145904535|NCT02774642|526155934|FG001|Overall Study|Lost to Follow-up|7|||
145904536|NCT02365558|526155938|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
145904537|NCT02365558|526155939|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
145904538|NCT02365558|526155938|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
145904539|NCT02365558|526155939|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
145904540|NCT00369317|526155940|FG000|Overall Study|Adverse Event|3|||
145904541|NCT00369317|526155940|FG000|Overall Study|Death|1|||
145904542|NCT00369317|526155940|FG000|Overall Study|Lack of Efficacy|5|||
145904543|NCT00369317|526155940|FG000|Overall Study|Physician Decision|2|||
145904544|NCT00369317|526155940|FG000|Overall Study|Withdrawal by Subject|8|||
145904545|NCT00369317|526155940|FG000|Overall Study|Ineligible|1|||
145904546|NCT00426361|526155947|FG000|Overall Study|Lost to Follow-up|3|||
145904547|NCT00426361|526155948|FG001|Overall Study|Lost to Follow-up|2|||
145904548|NCT00426361|526155949|FG002|Overall Study|Lost to Follow-up|5|||
145904549|NCT00426361|526155947|FG000|Overall Study|Withdrawal by Subject|1|||
145904550|NCT00426361|526155948|FG001|Overall Study|Withdrawal by Subject|3|||
145904551|NCT00426361|526155949|FG002|Overall Study|Withdrawal by Subject|0|||
145904552|NCT02828241|526155953|FG000|Overall Study|Adverse Event|7|||
145904553|NCT02828241|526155954|FG001|Overall Study|Adverse Event|2|||
145904554|NCT02828241|526155953|FG000|Overall Study|Protocol Violation|1|||
145904555|NCT02828241|526155954|FG001|Overall Study|Protocol Violation|0|||
145904556|NCT06281171|526155966|FG000|Timepoint 2|Lost to Follow-up|6|||
145904557|NCT06281171|526155967|FG001|Timepoint 2|Lost to Follow-up|4|||
145904558|NCT06281171|526155966|FG000|Timepoint 3|Lost to Follow-up|0|||
145904559|NCT06281171|526155967|FG001|Timepoint 3|Lost to Follow-up|5|||
145904560|NCT00510289|526155972|FG000|Overall Study|Withdrawal by Subject|7|||
145904561|NCT00510289|526155972|FG000|Overall Study|Refused bone marrow biopsy|2|||
145904562|NCT00510289|526155972|FG000|Overall Study|Lost to Follow-up|1|||
145904563|NCT00510289|526155972|FG000|Overall Study|Progressed prior to starting drug|2|||
145904564|NCT00861198|526155975|FG000|Overall Study|SpyGlass Failed|5|||
145904565|NCT02288182|526155976|FG000|Overall Study|Adverse Event|0|||
145904566|NCT02288182|526155977|FG001|Overall Study|Adverse Event|1|||
145904567|NCT02288182|526155976|FG000|Overall Study|Lost to Follow-up|0|||
145904568|NCT02288182|526155977|FG001|Overall Study|Lost to Follow-up|1|||
145904569|NCT02823652|526155978|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
145904570|NCT02823652|526155979|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
145904571|NCT02823652|526155980|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
145904572|NCT02823652|526155978|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
145904573|NCT02823652|526155979|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
145904574|NCT02823652|526155980|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
145904575|NCT02823652|526155978|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
145904576|NCT02823652|526155979|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
145904577|NCT02823652|526155980|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
145904578|NCT02823652|526155978|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
145904579|NCT02823652|526155979|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
145904580|NCT02823652|526155980|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
145904581|NCT00319982|526155983|FG000|Overall Study|Withdrawal by Subject|1|||
145904582|NCT00319982|526155984|FG001|Overall Study|Withdrawal by Subject|0|||
145904583|NCT02351960|526155985|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
145972586|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
145972587|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
145972588|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
145972589|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
145972590|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
146238916|NCT04021862|527388075|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
145904584|NCT02351960|526155986|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
145904585|NCT02351960|526155985|FG000|Overall Study|Voluntary Withdrawal|5|||
146238917|NCT04021862|527388076|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
145904586|NCT02351960|526155986|FG001|Overall Study|Voluntary Withdrawal|4|||
145904587|NCT02351960|526155985|FG000|Overall Study|Significant Protocol Deviation|0|||
145904588|NCT02351960|526155986|FG001|Overall Study|Significant Protocol Deviation|5|||
145904589|NCT03480386|526155987|FG000|Overall Study|Did not complete measures at 3-months|17|||
145972591|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
145972592|NCT00973973|526412698|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
145904590|NCT03480386|526155988|FG001|Overall Study|Did not complete measures at 3-months|14|||
145904591|NCT03480386|526155987|FG000|Overall Study|No baseline measures|11|||
145904592|NCT03480386|526155988|FG001|Overall Study|No baseline measures|14|||
145904593|NCT03480386|526155987|FG000|Overall Study|Death|0|||
145904594|NCT03480386|526155988|FG001|Overall Study|Death|5|||
145904595|NCT03480386|526155987|FG000|Overall Study|Withdrawal by Subject|12|||
145904596|NCT03480386|526155988|FG001|Overall Study|Withdrawal by Subject|8|||
145904597|NCT03480386|526155987|FG000|Overall Study|Lost to Follow-up|2|||
145904598|NCT03480386|526155988|FG001|Overall Study|Lost to Follow-up|1|||
145904599|NCT03480386|526155987|FG000|Overall Study|Complicating disease|0|||
145904600|NCT03480386|526155988|FG001|Overall Study|Complicating disease|1|||
145904601|NCT03480386|526155987|FG000|Overall Study|Disease progression|3|||
145904602|NCT03480386|526155988|FG001|Overall Study|Disease progression|0|||
145904603|NCT03480386|526155987|FG000|Overall Study|Became ineligible|0|||
145904604|NCT03480386|526155988|FG001|Overall Study|Became ineligible|2|||
145904605|NCT00574912|526155989|FG000|Overall Study|Could not place IV lines.|3|||
145904606|NCT00574912|526155989|FG000|Overall Study|scheduling conflicts|3|||
145904607|NCT00574912|526155989|FG000|Overall Study|Physician Decision|2|||
145904608|NCT00638027|526155999|FG000|Overall Study|Adverse Event|0|||
145904609|NCT00638027|526156000|FG001|Overall Study|Adverse Event|2|||
145904610|NCT00371397|526156002|FG000|Session 1|Withdrawal by Subject|1|||
145904611|NCT00371397|526156003|FG001|Session 1|Withdrawal by Subject|0|||
145904612|NCT00371397|526156004|FG002|Session 1|Withdrawal by Subject|0|||
145904613|NCT00371397|526156005|FG003|Session 1|Withdrawal by Subject|0|||
145904614|NCT00371397|526156006|FG004|Session 1|Withdrawal by Subject|0|||
145904615|NCT00371397|526156007|FG005|Session 1|Withdrawal by Subject|0|||
145904616|NCT00371397|526156008|FG006|Session 1|Withdrawal by Subject|0|||
145904617|NCT00371397|526156009|FG007|Session 1|Withdrawal by Subject|1|||
145904618|NCT00371397|526156010|FG008|Session 1|Withdrawal by Subject|0|||
145904619|NCT00371397|526156011|FG009|Session 1|Withdrawal by Subject|0|||
145904620|NCT00371397|526156012|FG010|Session 1|Withdrawal by Subject|0|||
145904621|NCT00371397|526156013|FG011|Session 1|Withdrawal by Subject|0|||
145904622|NCT03014180|526156014|FG000|Overall Study|Protocol Violation|2|||
145904623|NCT02377427|526156015|FG000|Part A (Up to Week 20)|Physician Decision|1|||
145904624|NCT02377427|526156016|FG001|Part A (Up to Week 20)|Physician Decision|0|||
145904625|NCT02377427|526156017|FG002|Part A (Up to Week 20)|Physician Decision|0|||
145904626|NCT02377427|526156018|FG003|Part A (Up to Week 20)|Physician Decision|0|||
145904627|NCT02377427|526156019|FG004|Part A (Up to Week 20)|Physician Decision|0|||
145904628|NCT02377427|526156015|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
145904629|NCT02377427|526156016|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145904630|NCT02377427|526156017|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145904631|NCT02377427|526156018|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145904632|NCT02377427|526156019|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145904633|NCT02377427|526156015|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
145904634|NCT02377427|526156016|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145904635|NCT02377427|526156017|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145904636|NCT02377427|526156018|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145904637|NCT02377427|526156019|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145904638|NCT02377427|526156015|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145904639|NCT02377427|526156016|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145904640|NCT02377427|526156017|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
145904641|NCT02377427|526156018|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145904642|NCT02377427|526156019|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145904643|NCT03395405|526157846|FG000|Overall Study|Death|0|||
145904644|NCT03395405|526157847|FG001|Overall Study|Death|2|||
145904645|NCT03395405|526157846|FG000|Overall Study|Lost to Follow-up|0|||
145904646|NCT03395405|526157847|FG001|Overall Study|Lost to Follow-up|1|||
145904647|NCT03395405|526157846|FG000|Overall Study|Protocol Violation|0|||
145904648|NCT03395405|526157847|FG001|Overall Study|Protocol Violation|1|||
145904649|NCT03395405|526157846|FG000|Overall Study|Withdrawal by Subject|3|||
145904650|NCT03395405|526157847|FG001|Overall Study|Withdrawal by Subject|1|||
145904651|NCT03395405|526157846|FG000|Overall Study|COVID-19 Pandemic|1|||
145904652|NCT03395405|526157847|FG001|Overall Study|COVID-19 Pandemic|0|||
145904653|NCT00213135|526157852|FG000|Overall Study|Adverse Event|9|||
145904654|NCT00213135|526157853|FG001|Overall Study|Adverse Event|5|||
145904655|NCT00213135|526157854|FG002|Overall Study|Adverse Event|5|||
145904656|NCT00213135|526157852|FG000|Overall Study|Lost to Follow-up|11|||
145904657|NCT00213135|526157853|FG001|Overall Study|Lost to Follow-up|8|||
145904658|NCT00213135|526157854|FG002|Overall Study|Lost to Follow-up|4|||
145904659|NCT00213135|526157852|FG000|Overall Study|Protocol Violation|4|||
145904660|NCT00213135|526157853|FG001|Overall Study|Protocol Violation|4|||
145972593|NCT00973973|526412699|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
145972594|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
145904661|NCT00213135|526157854|FG002|Overall Study|Protocol Violation|10|||
146297374|NCT01862640|527604684|FG001|Overall Study|Protocol Deviation|0|||
145904662|NCT00213135|526157852|FG000|Overall Study|Death|1|||
145904663|NCT00213135|526157853|FG001|Overall Study|Death|1|||
145904664|NCT00213135|526157854|FG002|Overall Study|Death|2|||
145904665|NCT00213135|526157852|FG000|Overall Study|Disease progression|4|||
145904666|NCT00213135|526157853|FG001|Overall Study|Disease progression|5|||
145904667|NCT00213135|526157854|FG002|Overall Study|Disease progression|21|||
145904668|NCT00213135|526157852|FG000|Overall Study|Other|21|||
145904669|NCT00213135|526157853|FG001|Overall Study|Other|12|||
145904670|NCT00213135|526157854|FG002|Overall Study|Other|15|||
145904671|NCT01908907|526157858|FG000|Overall Study|Physician Decision|1|||
145904672|NCT01908907|526157859|FG001|Overall Study|Physician Decision|0|||
145904673|NCT01908907|526157858|FG000|Overall Study|Protocol Violation|1|||
145904674|NCT01908907|526157859|FG001|Overall Study|Protocol Violation|0|||
145904675|NCT00660907|526157860|FG000|Overall Study|Incorrect Enrollment|1|||
145904676|NCT00660907|526157861|FG001|Overall Study|Incorrect Enrollment|1|||
145904677|NCT00660907|526157860|FG000|Overall Study|Adverse Event|33|||
145904678|NCT00660907|526157861|FG001|Overall Study|Adverse Event|19|||
145904679|NCT00660907|526157860|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
145904680|NCT00660907|526157861|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
145904681|NCT00660907|526157860|FG000|Overall Study|Withdrawal by Subject|23|||
145904682|NCT00660907|526157861|FG001|Overall Study|Withdrawal by Subject|32|||
145904683|NCT00660907|526157860|FG000|Overall Study|Lost to Follow-up|3|||
145904684|NCT00660907|526157861|FG001|Overall Study|Lost to Follow-up|3|||
145904685|NCT00660907|526157860|FG000|Overall Study|Poor/Non-Compliance|5|||
145904686|NCT00660907|526157861|FG001|Overall Study|Poor/Non-Compliance|1|||
145904687|NCT00660907|526157860|FG000|Overall Study|Safety|1|||
145904688|NCT00660907|526157861|FG001|Overall Study|Safety|0|||
145904689|NCT00660907|526157860|FG000|Overall Study|Death|1|||
145904690|NCT00660907|526157861|FG001|Overall Study|Death|3|||
145904691|NCT00660907|526157860|FG000|Overall Study|Various|11|||
145904692|NCT00660907|526157861|FG001|Overall Study|Various|8|||
145904693|NCT00359801|526157868|FG000|Overall Study|Lost to Follow-up|72|||
145904694|NCT00359801|526157869|FG001|Overall Study|Lost to Follow-up|58|||
145904695|NCT00359801|526157868|FG000|Overall Study|Withdrawal by Subject|143|||
145904696|NCT00359801|526157869|FG001|Overall Study|Withdrawal by Subject|96|||
145904697|NCT00359801|526157868|FG000|Overall Study|Other|66|||
145904698|NCT00359801|526157869|FG001|Overall Study|Other|46|||
145904699|NCT00359801|526157868|FG000|Overall Study|Final Status Unknown: missing data|7|||
145904700|NCT00359801|526157869|FG001|Overall Study|Final Status Unknown: missing data|4|||
145904701|NCT00359801|526157868|FG000|Overall Study|Sponsor Decision|17|||
145904702|NCT00359801|526157869|FG001|Overall Study|Sponsor Decision|16|||
145904703|NCT02929056|526157871|FG000|Overall Study|Lost to Follow-up|0|||
145904704|NCT02929056|526157872|FG001|Overall Study|Lost to Follow-up|1|||
145904705|NCT01056289|526157876|FG000|Open-label Phase|Adverse Event|29|||
145904706|NCT01056289|526157877|FG001|Open-label Phase|Adverse Event|0|||
145904707|NCT01056289|526157878|FG002|Open-label Phase|Adverse Event|0|||
145904708|NCT01056289|526157879|FG003|Open-label Phase|Adverse Event|0|||
145904709|NCT01056289|526157876|FG000|Open-label Phase|Lost to Follow-up|30|||
145904710|NCT01056289|526157877|FG001|Open-label Phase|Lost to Follow-up|0|||
145904711|NCT01056289|526157878|FG002|Open-label Phase|Lost to Follow-up|0|||
145904712|NCT01056289|526157879|FG003|Open-label Phase|Lost to Follow-up|0|||
145904713|NCT01056289|526157876|FG000|Open-label Phase|Other|9|||
145904714|NCT01056289|526157877|FG001|Open-label Phase|Other|0|||
145904715|NCT01056289|526157878|FG002|Open-label Phase|Other|0|||
145904716|NCT01056289|526157879|FG003|Open-label Phase|Other|0|||
145904717|NCT01056289|526157876|FG000|Open-label Phase|Protocol Violation|6|||
145904718|NCT01056289|526157877|FG001|Open-label Phase|Protocol Violation|0|||
145904719|NCT01056289|526157878|FG002|Open-label Phase|Protocol Violation|0|||
145904720|NCT01056289|526157879|FG003|Open-label Phase|Protocol Violation|0|||
145904721|NCT01056289|526157876|FG000|Open-label Phase|Withdrawal by Subject|26|||
145904722|NCT01056289|526157877|FG001|Open-label Phase|Withdrawal by Subject|0|||
145904723|NCT01056289|526157878|FG002|Open-label Phase|Withdrawal by Subject|0|||
145904724|NCT01056289|526157879|FG003|Open-label Phase|Withdrawal by Subject|0|||
145904725|NCT01056289|526157876|FG000|Open-label Phase|Lack of Efficacy|18|||
145904726|NCT01056289|526157877|FG001|Open-label Phase|Lack of Efficacy|0|||
145904727|NCT01056289|526157878|FG002|Open-label Phase|Lack of Efficacy|0|||
145904728|NCT01056289|526157879|FG003|Open-label Phase|Lack of Efficacy|0|||
145904729|NCT01056289|526157876|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
145904730|NCT01056289|526157877|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
145904731|NCT01056289|526157878|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
145904732|NCT01056289|526157879|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
145904733|NCT01056289|526157876|FG000|Double-blind Phase|Adverse Event|0|||
145904734|NCT01056289|526157877|FG001|Double-blind Phase|Adverse Event|1|||
145904735|NCT01056289|526157878|FG002|Double-blind Phase|Adverse Event|2|||
145904736|NCT01056289|526157879|FG003|Double-blind Phase|Adverse Event|1|||
145904737|NCT01056289|526157876|FG000|Double-blind Phase|Lost to Follow-up|0|||
145904738|NCT01056289|526157877|FG001|Double-blind Phase|Lost to Follow-up|2|||
145904739|NCT01056289|526157878|FG002|Double-blind Phase|Lost to Follow-up|2|||
145904740|NCT01056289|526157879|FG003|Double-blind Phase|Lost to Follow-up|2|||
145904741|NCT01056289|526157876|FG000|Double-blind Phase|Other|0|||
145904742|NCT01056289|526157877|FG001|Double-blind Phase|Other|0|||
145904743|NCT01056289|526157878|FG002|Double-blind Phase|Other|1|||
145904744|NCT01056289|526157879|FG003|Double-blind Phase|Other|2|||
145904745|NCT01056289|526157876|FG000|Double-blind Phase|Protocol Violation|0|||
145904746|NCT01056289|526157877|FG001|Double-blind Phase|Protocol Violation|0|||
145904747|NCT01056289|526157878|FG002|Double-blind Phase|Protocol Violation|1|||
145904748|NCT01056289|526157879|FG003|Double-blind Phase|Protocol Violation|1|||
145904749|NCT01056289|526157876|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145904750|NCT01056289|526157877|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145904751|NCT01056289|526157878|FG002|Double-blind Phase|Withdrawal by Subject|4|||
145904752|NCT01056289|526157879|FG003|Double-blind Phase|Withdrawal by Subject|2|||
145904753|NCT01056289|526157876|FG000|Double-blind Phase|Discontinuation symptom|0|||
145904754|NCT01056289|526157877|FG001|Double-blind Phase|Discontinuation symptom|1|||
145904755|NCT01056289|526157878|FG002|Double-blind Phase|Discontinuation symptom|2|||
145904756|NCT01056289|526157879|FG003|Double-blind Phase|Discontinuation symptom|2|||
145904757|NCT01056289|526157876|FG000|Double-blind Phase|Physician Decision|0|||
145904758|NCT01056289|526157877|FG001|Double-blind Phase|Physician Decision|0|||
145904759|NCT01056289|526157878|FG002|Double-blind Phase|Physician Decision|1|||
145904760|NCT01056289|526157879|FG003|Double-blind Phase|Physician Decision|0|||
145904761|NCT00450801|526157880|FG000|Overall Study|Death|1|||
145904762|NCT01396512|526157883|FG000|Overall Study|Withdrawal by Subject|0|||
145904763|NCT01396512|526157884|FG001|Overall Study|Withdrawal by Subject|1|||
145904764|NCT02856555|526157885|FG000|Overall Study|Adverse Event|1|||
145904765|NCT02856555|526157886|FG001|Overall Study|Adverse Event|0|||
145904766|NCT02856555|526157887|FG002|Overall Study|Adverse Event|0|||
145904767|NCT02856555|526157885|FG000|Overall Study|Lost to Follow-up|1|||
145904768|NCT02856555|526157886|FG001|Overall Study|Lost to Follow-up|3|||
145904769|NCT02856555|526157887|FG002|Overall Study|Lost to Follow-up|0|||
145904770|NCT02856555|526157885|FG000|Overall Study|Withdrawal by Subject|3|||
145904771|NCT02856555|526157886|FG001|Overall Study|Withdrawal by Subject|0|||
145904772|NCT02856555|526157887|FG002|Overall Study|Withdrawal by Subject|0|||
145904773|NCT02856555|526157885|FG000|Overall Study|Randomized but Never Treated|0|||
145904774|NCT02856555|526157886|FG001|Overall Study|Randomized but Never Treated|1|||
145904775|NCT02856555|526157887|FG002|Overall Study|Randomized but Never Treated|0|||
145904776|NCT01564537|526157891|FG000|Overall Study|Site Terminated by Sponsor|1|||
145904777|NCT01564537|526157892|FG001|Overall Study|Site Terminated by Sponsor|0|||
145904778|NCT01564537|526157891|FG000|Overall Study|Withdrawal by Subject|12|||
145904779|NCT01564537|526157892|FG001|Overall Study|Withdrawal by Subject|14|||
145904780|NCT01564537|526157891|FG000|Overall Study|Lost to Follow-up|7|||
145904781|NCT01564537|526157892|FG001|Overall Study|Lost to Follow-up|3|||
145904782|NCT01564537|526157891|FG000|Overall Study|Reason not specified|81|||
145904783|NCT01564537|526157892|FG001|Overall Study|Reason not specified|82|||
145904784|NCT05776862|526157893|FG000|Overall Study|Adverse Event|0|||
145904785|NCT05776862|526157894|FG001|Overall Study|Adverse Event|1|||
145904786|NCT05776862|526157893|FG000|Overall Study|non-compliance|1|||
145904787|NCT05776862|526157894|FG001|Overall Study|non-compliance|0|||
145904788|NCT02448706|526157895|FG000|Overall Study|Withdrawal by Subject|4|||
145904789|NCT02448706|526157896|FG001|Overall Study|Withdrawal by Subject|3|||
145904790|NCT02448706|526157895|FG000|Overall Study|Protocol Violation|1|||
145904791|NCT02448706|526157896|FG001|Overall Study|Protocol Violation|1|||
145904792|NCT01199471|526157897|FG000|Overall Study|Protocol Violation|4|||
145904793|NCT01199471|526157897|FG000|Overall Study|Withdrawal by Subject|1|||
145904794|NCT01199471|526157897|FG000|Overall Study|Physician Decision|1|||
145904795|NCT03151408|526157898|FG000|Overall Study|Adverse Event|24|||
145904796|NCT03151408|526157899|FG001|Overall Study|Adverse Event|23|||
145904797|NCT03151408|526157898|FG000|Overall Study|Death|46|||
145904798|NCT03151408|526157899|FG001|Overall Study|Death|26|||
145904799|NCT03151408|526157898|FG000|Overall Study|Physician Decision|13|||
145904800|NCT03151408|526157899|FG001|Overall Study|Physician Decision|19|||
145904801|NCT03151408|526157898|FG000|Overall Study|Withdrawal by Subject|16|||
145904802|NCT03151408|526157899|FG001|Overall Study|Withdrawal by Subject|20|||
145904803|NCT03151408|526157898|FG000|Overall Study|Progressive disease|45|||
145904804|NCT03151408|526157899|FG001|Overall Study|Progressive disease|61|||
145904805|NCT03151408|526157898|FG000|Overall Study|non-compliance by patient|1|||
145904806|NCT03151408|526157899|FG001|Overall Study|non-compliance by patient|0|||
145904807|NCT03151408|526157898|FG000|Overall Study|other reasons|56|||
145904808|NCT03151408|526157899|FG001|Overall Study|other reasons|52|||
145904809|NCT03151408|526157898|FG000|Overall Study|randomized and not treated|2|||
145904810|NCT03151408|526157899|FG001|Overall Study|randomized and not treated|2|||
145904811|NCT03262038|526157904|FG000|Overall Study|Withdrawal by Subject|0|||
145904812|NCT03262038|526157905|FG001|Overall Study|Withdrawal by Subject|1|||
146297375|NCT01862640|527604685|FG002|Overall Study|Protocol Deviation|1|||
145904813|NCT04933968|526157906|FG000|Overall Study|Adverse Event|0|||
145904814|NCT04933968|526157907|FG001|Overall Study|Adverse Event|0|||
145904815|NCT04933968|526157908|FG002|Overall Study|Adverse Event|1|||
145904816|NCT04933968|526157909|FG003|Overall Study|Adverse Event|1|||
145904817|NCT04933968|526157910|FG004|Overall Study|Adverse Event|0|||
145904818|NCT04933968|526157911|FG005|Overall Study|Adverse Event|0|||
145904819|NCT04933968|526157906|FG000|Overall Study|Lost to Follow-up|1|||
145904820|NCT04933968|526157907|FG001|Overall Study|Lost to Follow-up|0|||
145904821|NCT04933968|526157908|FG002|Overall Study|Lost to Follow-up|1|||
145904822|NCT04933968|526157909|FG003|Overall Study|Lost to Follow-up|0|||
145904823|NCT04933968|526157910|FG004|Overall Study|Lost to Follow-up|0|||
145904824|NCT04933968|526157911|FG005|Overall Study|Lost to Follow-up|0|||
145904825|NCT04933968|526157906|FG000|Overall Study|Randomized not treated|1|||
145904826|NCT04933968|526157907|FG001|Overall Study|Randomized not treated|0|||
145904827|NCT04933968|526157908|FG002|Overall Study|Randomized not treated|0|||
145904828|NCT04933968|526157909|FG003|Overall Study|Randomized not treated|0|||
145904829|NCT04933968|526157910|FG004|Overall Study|Randomized not treated|0|||
145904830|NCT04933968|526157911|FG005|Overall Study|Randomized not treated|0|||
145904831|NCT04933968|526157906|FG000|Overall Study|Sponsor terminated study|0|||
145904832|NCT04933968|526157907|FG001|Overall Study|Sponsor terminated study|0|||
145904833|NCT04933968|526157908|FG002|Overall Study|Sponsor terminated study|0|||
145904834|NCT04933968|526157909|FG003|Overall Study|Sponsor terminated study|1|||
145904835|NCT04933968|526157910|FG004|Overall Study|Sponsor terminated study|2|||
145904836|NCT04933968|526157911|FG005|Overall Study|Sponsor terminated study|0|||
145904837|NCT04933968|526157906|FG000|Overall Study|Other|0|||
145904838|NCT04933968|526157907|FG001|Overall Study|Other|0|||
145904839|NCT04933968|526157908|FG002|Overall Study|Other|0|||
145904840|NCT04933968|526157909|FG003|Overall Study|Other|1|||
145904841|NCT04933968|526157910|FG004|Overall Study|Other|0|||
145904842|NCT04933968|526157911|FG005|Overall Study|Other|0|||
145904843|NCT04933968|526157906|FG000|Overall Study|Missing|1|||
145904844|NCT04933968|526157907|FG001|Overall Study|Missing|3|||
145904845|NCT04933968|526157908|FG002|Overall Study|Missing|2|||
145904846|NCT04933968|526157909|FG003|Overall Study|Missing|1|||
145904847|NCT04933968|526157910|FG004|Overall Study|Missing|1|||
146238918|NCT04021862|527388077|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
146238919|NCT04021862|527388078|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
146238920|NCT04021862|527388079|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
146238921|NCT04021862|527388080|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
145904848|NCT04933968|526157911|FG005|Overall Study|Missing|0|||
145904849|NCT03323437|526157912|FG000|Overall Study|Withdrawal by Subject|0|||
145904850|NCT03323437|526157913|FG001|Overall Study|Withdrawal by Subject|4|||
145904851|NCT02119819|526157916|FG000|Overall Study|Adverse Event|3|||
145904852|NCT02119819|526157917|FG001|Overall Study|Adverse Event|1|||
145904853|NCT02119819|526157918|FG002|Overall Study|Adverse Event|2|||
145904854|NCT02119819|526157919|FG003|Overall Study|Adverse Event|3|||
145904855|NCT02119819|526157920|FG004|Overall Study|Adverse Event|0|||
145904856|NCT02119819|526157921|FG005|Overall Study|Adverse Event|1|||
145904857|NCT02119819|526157916|FG000|Overall Study|Lack of Efficacy|0|||
145904858|NCT02119819|526157917|FG001|Overall Study|Lack of Efficacy|0|||
145904859|NCT02119819|526157918|FG002|Overall Study|Lack of Efficacy|0|||
145904860|NCT02119819|526157919|FG003|Overall Study|Lack of Efficacy|0|||
145904861|NCT02119819|526157920|FG004|Overall Study|Lack of Efficacy|0|||
145904862|NCT02119819|526157921|FG005|Overall Study|Lack of Efficacy|1|||
145904863|NCT02119819|526157916|FG000|Overall Study|Lost to Follow-up|0|||
145904864|NCT02119819|526157917|FG001|Overall Study|Lost to Follow-up|0|||
145904865|NCT02119819|526157918|FG002|Overall Study|Lost to Follow-up|1|||
145904866|NCT02119819|526157919|FG003|Overall Study|Lost to Follow-up|2|||
145904867|NCT02119819|526157920|FG004|Overall Study|Lost to Follow-up|1|||
145904868|NCT02119819|526157921|FG005|Overall Study|Lost to Follow-up|2|||
145904869|NCT02119819|526157916|FG000|Overall Study|Physician Decision|1|||
145904870|NCT02119819|526157917|FG001|Overall Study|Physician Decision|1|||
145904871|NCT02119819|526157918|FG002|Overall Study|Physician Decision|0|||
145904872|NCT02119819|526157919|FG003|Overall Study|Physician Decision|0|||
145904873|NCT02119819|526157920|FG004|Overall Study|Physician Decision|0|||
145904874|NCT02119819|526157921|FG005|Overall Study|Physician Decision|1|||
145904875|NCT02119819|526157916|FG000|Overall Study|Withdrawal by Subject|5|||
145904876|NCT02119819|526157917|FG001|Overall Study|Withdrawal by Subject|3|||
145904877|NCT02119819|526157918|FG002|Overall Study|Withdrawal by Subject|0|||
145904878|NCT02119819|526157919|FG003|Overall Study|Withdrawal by Subject|0|||
145904879|NCT02119819|526157920|FG004|Overall Study|Withdrawal by Subject|6|||
145904880|NCT02119819|526157921|FG005|Overall Study|Withdrawal by Subject|10|||
145904881|NCT02119819|526157916|FG000|Overall Study|Jury Duty|0|||
145904882|NCT02119819|526157917|FG001|Overall Study|Jury Duty|0|||
145904883|NCT02119819|526157918|FG002|Overall Study|Jury Duty|1|||
145904884|NCT02119819|526157919|FG003|Overall Study|Jury Duty|0|||
145904885|NCT02119819|526157920|FG004|Overall Study|Jury Duty|0|||
145904886|NCT02119819|526157921|FG005|Overall Study|Jury Duty|0|||
145904887|NCT02119819|526157916|FG000|Overall Study|Protocol Violation|0|||
145904888|NCT02119819|526157917|FG001|Overall Study|Protocol Violation|0|||
145904889|NCT02119819|526157918|FG002|Overall Study|Protocol Violation|0|||
145904890|NCT02119819|526157919|FG003|Overall Study|Protocol Violation|1|||
145904891|NCT02119819|526157920|FG004|Overall Study|Protocol Violation|0|||
145904892|NCT02119819|526157921|FG005|Overall Study|Protocol Violation|0|||
145904893|NCT02119819|526157916|FG000|Overall Study|Left the city to get a job|0|||
145904894|NCT02119819|526157917|FG001|Overall Study|Left the city to get a job|0|||
145904895|NCT02119819|526157918|FG002|Overall Study|Left the city to get a job|0|||
145904896|NCT02119819|526157919|FG003|Overall Study|Left the city to get a job|1|||
145972595|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
145904897|NCT02119819|526157920|FG004|Overall Study|Left the city to get a job|0|||
145904898|NCT02119819|526157921|FG005|Overall Study|Left the city to get a job|0|||
145904899|NCT02045147|526157922|FG000|Overall Study|Withdrawal by Subject|2|||
146297376|NCT01862640|527604686|FG003|Overall Study|Protocol Deviation|0|||
145904900|NCT02045147|526157923|FG001|Overall Study|Withdrawal by Subject|0|||
145904901|NCT02045147|526157924|FG002|Overall Study|Withdrawal by Subject|0|||
145904902|NCT02045147|526157925|FG003|Overall Study|Withdrawal by Subject|0|||
145904903|NCT02045147|526157926|FG004|Overall Study|Withdrawal by Subject|0|||
145904904|NCT02045147|526157927|FG005|Overall Study|Withdrawal by Subject|0|||
145904905|NCT02045147|526157928|FG006|Overall Study|Withdrawal by Subject|0|||
145904906|NCT02045147|526157929|FG007|Overall Study|Withdrawal by Subject|1|||
145904907|NCT02045147|526157922|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
145904908|NCT02045147|526157923|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
145904909|NCT02045147|526157924|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
145904910|NCT02045147|526157925|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
145904911|NCT02045147|526157926|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
145904912|NCT02045147|526157927|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
145904913|NCT02045147|526157928|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
145904914|NCT02045147|526157929|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
145904915|NCT04839692|526157930|FG000|Overall Study|Withdrawal by Subject|0|||
145904916|NCT04839692|526157931|FG001|Overall Study|Withdrawal by Subject|3|||
145904917|NCT04839692|526157930|FG000|Overall Study|Physician Decision|1|||
145904918|NCT04839692|526157931|FG001|Overall Study|Physician Decision|0|||
145904919|NCT02383810|526157932|FG000|Overall Study|Physician Decision|1|||
145904920|NCT02383810|526157933|FG001|Overall Study|Physician Decision|1|||
145904921|NCT02383810|526157934|FG002|Overall Study|Physician Decision|0|||
145904922|NCT02383810|526157935|FG003|Overall Study|Physician Decision|0|||
145904923|NCT02383810|526157936|FG004|Overall Study|Physician Decision|0|||
145904924|NCT02383810|526157937|FG005|Overall Study|Physician Decision|0|||
145904925|NCT02383810|526157938|FG006|Overall Study|Physician Decision|0|||
145904926|NCT02383810|526157939|FG007|Overall Study|Physician Decision|0|||
145904927|NCT02383810|526157932|FG000|Overall Study|Withdrawal by Subject|2|||
145904928|NCT02383810|526157933|FG001|Overall Study|Withdrawal by Subject|3|||
145904929|NCT02383810|526157934|FG002|Overall Study|Withdrawal by Subject|3|||
145904930|NCT02383810|526157935|FG003|Overall Study|Withdrawal by Subject|3|||
145904931|NCT02383810|526157936|FG004|Overall Study|Withdrawal by Subject|0|||
145904932|NCT02383810|526157937|FG005|Overall Study|Withdrawal by Subject|0|||
145904933|NCT02383810|526157938|FG006|Overall Study|Withdrawal by Subject|0|||
145904934|NCT02383810|526157939|FG007|Overall Study|Withdrawal by Subject|0|||
145904935|NCT02383810|526157932|FG000|Overall Study|Adverse Event|0|||
145904936|NCT02383810|526157933|FG001|Overall Study|Adverse Event|2|||
145904937|NCT02383810|526157934|FG002|Overall Study|Adverse Event|4|||
145904938|NCT02383810|526157935|FG003|Overall Study|Adverse Event|5|||
145904939|NCT02383810|526157936|FG004|Overall Study|Adverse Event|0|||
145904940|NCT02383810|526157937|FG005|Overall Study|Adverse Event|1|||
145904941|NCT02383810|526157938|FG006|Overall Study|Adverse Event|1|||
145904942|NCT02383810|526157939|FG007|Overall Study|Adverse Event|0|||
145904943|NCT02383810|526157932|FG000|Overall Study|Lost to Follow-up|0|||
145904944|NCT02383810|526157933|FG001|Overall Study|Lost to Follow-up|1|||
145904945|NCT02383810|526157934|FG002|Overall Study|Lost to Follow-up|0|||
145904946|NCT02383810|526157935|FG003|Overall Study|Lost to Follow-up|1|||
145904947|NCT02383810|526157936|FG004|Overall Study|Lost to Follow-up|0|||
145904948|NCT02383810|526157937|FG005|Overall Study|Lost to Follow-up|0|||
145904949|NCT02383810|526157938|FG006|Overall Study|Lost to Follow-up|0|||
145904950|NCT02383810|526157939|FG007|Overall Study|Lost to Follow-up|0|||
145904951|NCT02383810|526157932|FG000|Overall Study|other|0|||
145904952|NCT02383810|526157933|FG001|Overall Study|other|0|||
145904953|NCT02383810|526157934|FG002|Overall Study|other|0|||
145904954|NCT02383810|526157935|FG003|Overall Study|other|2|||
145904955|NCT02383810|526157936|FG004|Overall Study|other|0|||
145904956|NCT02383810|526157937|FG005|Overall Study|other|0|||
145904957|NCT02383810|526157938|FG006|Overall Study|other|0|||
145904958|NCT02383810|526157939|FG007|Overall Study|other|0|||
145904959|NCT02383810|526157932|FG000|Overall Study|subject did not receive study treatment|0|||
145904960|NCT02383810|526157933|FG001|Overall Study|subject did not receive study treatment|1|||
145904961|NCT02383810|526157934|FG002|Overall Study|subject did not receive study treatment|0|||
145904962|NCT02383810|526157935|FG003|Overall Study|subject did not receive study treatment|0|||
145904963|NCT02383810|526157936|FG004|Overall Study|subject did not receive study treatment|0|||
145904964|NCT02383810|526157937|FG005|Overall Study|subject did not receive study treatment|0|||
145904965|NCT02383810|526157938|FG006|Overall Study|subject did not receive study treatment|0|||
145904966|NCT02383810|526157939|FG007|Overall Study|subject did not receive study treatment|0|||
145904967|NCT03247816|526157942|FG000|Overall Study|Adverse Event|12|||
145904968|NCT03247816|526157942|FG000|Overall Study|Physician Decision|3|||
145904969|NCT03247816|526157942|FG000|Overall Study|Lack of Efficacy|1|||
145972596|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
145904970|NCT03247816|526157942|FG000|Overall Study|Lost to Follow-up|10|||
145904971|NCT03247816|526157942|FG000|Overall Study|Missing Feraccru stop date|3|||
145904972|NCT02861014|526157944|FG000|Primary Analysis|Adverse Event|7|||
145904973|NCT02861014|526157944|FG000|Primary Analysis|Death|1|||
145904974|NCT02861014|526157944|FG000|Primary Analysis|Lack of Efficacy|3|||
145904975|NCT02861014|526157944|FG000|Primary Analysis|Physician Decision|2|||
145904976|NCT02861014|526157944|FG000|Primary Analysis|Pregnancy|4|||
145904977|NCT02861014|526157944|FG000|Primary Analysis|Protocol Violation|2|||
145904978|NCT02861014|526157944|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
145904979|NCT02861014|526157944|FG000|Primary Analysis|Withdrawal by Subject|14|||
145904980|NCT02861014|526157944|FG000|Primary Analysis|Commercial ocrelizumab|3|||
145904981|NCT02861014|526157944|FG000|Safety Follow-up|Adverse Event|1|||
145904982|NCT02861014|526157944|FG000|Safety Follow-up|Pregnancy|1|||
145904983|NCT02861014|526157944|FG000|Safety Follow-up|Withdrawal by Subject|9|||
145904984|NCT02861014|526157944|FG000|Safety Follow-up|Study terminated by sponsor|1|||
145904985|NCT02861014|526157944|FG000|Safety Follow-up|Physician Decision|1|||
145972597|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
145972598|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
145972599|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
145972600|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
145972601|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
145972602|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
145972603|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
145972604|NCT00973973|526412698|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
145972605|NCT00973973|526412699|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
145972606|NCT02471339|526412700|FG000|Overall Study|Did not provide follow-up data|2|||
145972607|NCT02471339|526412701|FG001|Overall Study|Did not provide follow-up data|0|||
145972608|NCT01541748|526412702|FG000|Overall Study|Lost to Follow-up|17|||
145972609|NCT01541748|526412702|FG000|Overall Study|Moved out of state|1|||
145972610|NCT01541748|526412702|FG000|Overall Study|Withdrawal by Subject|7|||
145972611|NCT01541748|526412702|FG000|Overall Study|Screen failure|5|||
145972612|NCT01541748|526412702|FG000|Overall Study|Did not receive study device|1|||
145972613|NCT00626639|526412703|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
145972614|NCT00626639|526412704|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
145972615|NCT01461551|526412705|FG000|Overall Study|Physician Decision|2|||
145972616|NCT01461551|526412706|FG001|Overall Study|Physician Decision|1|||
145972617|NCT01461551|526412707|FG002|Overall Study|Physician Decision|2|||
145972618|NCT03473197|526412708|FG000|Overall Study|Adverse Event|4|||
145972619|NCT03473197|526412708|FG000|Overall Study|Lost to Follow-up|1|||
145972620|NCT03473197|526412708|FG000|Overall Study|Withdrawal by Subject|5|||
145972621|NCT02326883|526412711|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
145972622|NCT02326883|526412712|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
145972623|NCT02326883|526412713|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
145972624|NCT02107898|526412714|FG000|Overall Study|Adverse Event|4|||
145972625|NCT02107898|526412715|FG001|Overall Study|Adverse Event|7|||
145972626|NCT02107898|526412714|FG000|Overall Study|Poor compliance to protocol|0|||
145972627|NCT02107898|526412715|FG001|Overall Study|Poor compliance to protocol|1|||
145972628|NCT02107898|526412714|FG000|Overall Study|Participant moved|0|||
145972629|NCT02107898|526412715|FG001|Overall Study|Participant moved|2|||
145972630|NCT02107898|526412714|FG000|Overall Study|Consent withdrawn by participant|2|||
145972631|NCT02107898|526412715|FG001|Overall Study|Consent withdrawn by participant|1|||
145972632|NCT02107898|526412714|FG000|Overall Study|Randomized but not treated|0|||
145972633|NCT02107898|526412715|FG001|Overall Study|Randomized but not treated|1|||
145972634|NCT03329989|526412716|FG000|Overall Study|Withdrawal by Subject|9|||
145972635|NCT03329989|526412716|FG000|Overall Study|Lost to Follow-up|8|||
145972636|NCT03329989|526412716|FG000|Overall Study|Adverse Event|5|||
145972637|NCT03329989|526412716|FG000|Overall Study|Protocol Violation|1|||
145972638|NCT01283386|526412717|FG000|Overall Study|Death|2|||
145972639|NCT01283386|526412718|FG001|Overall Study|Death|0|||
145972640|NCT01283386|526412717|FG000|Overall Study|Withdrawal by Subject|2|||
145972641|NCT01283386|526412718|FG001|Overall Study|Withdrawal by Subject|1|||
145972642|NCT01283386|526412717|FG000|Overall Study|Relapse of underlying disease|1|||
145972643|NCT01283386|526412718|FG001|Overall Study|Relapse of underlying disease|3|||
145972644|NCT01283386|526412717|FG000|Overall Study|Progression of underlying disease|2|||
145972645|NCT01283386|526412718|FG001|Overall Study|Progression of underlying disease|7|||
145972646|NCT01283386|526412717|FG000|Overall Study|Reason not specified|1|||
146238922|NCT04021862|527388075|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146238923|NCT04021862|527388076|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145972647|NCT01283386|526412718|FG001|Overall Study|Reason not specified|0|||
145972648|NCT01283386|526412717|FG000|Overall Study|Protocol Violation|0|||
145972649|NCT01283386|526412718|FG001|Overall Study|Protocol Violation|1|||
145972650|NCT02469857|526412719|FG000|Overall Study|Death|24|||
145972651|NCT02469857|526412720|FG001|Overall Study|Death|29|||
145972652|NCT02469857|526412719|FG000|Overall Study|Discontinuation|1|||
145972653|NCT02469857|526412720|FG001|Overall Study|Discontinuation|3|||
145904986|NCT02861014|526157944|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
145904987|NCT02861014|526157944|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
145972654|NCT03483103|526412721|FG000|Pre-Treatment Phase|Other reasons|1|||
145972655|NCT03483103|526412721|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
145972656|NCT03483103|526412721|FG000|Pre-Treatment Phase|Disease-related complications|1|||
145972657|NCT03483103|526412721|FG000|Pre-Treatment Phase|Death|5|||
145972658|NCT03483103|526412721|FG000|Treatment Phase|Withdrawal by Subject|7|||
145972659|NCT03483103|526412721|FG000|Treatment Phase|Other reasons|1|||
145972660|NCT03483103|526412721|FG000|Treatment Phase|Death|23|||
145972661|NCT03483103|526412721|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
145972662|NCT03483103|526412721|FG000|Treatment Phase|Received nonconforming product|1|||
145972663|NCT00297167|526412723|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
145972664|NCT00297167|526412724|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
145972665|NCT00297167|526412725|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
145904988|NCT00926783|526157945|FG000|Overall Study|Incomplete CFAE Procedures|3|||
145904989|NCT00926783|526157946|FG001|Overall Study|Incomplete CFAE Procedures|3|||
145904990|NCT01696058|526157949|FG000|Overall Study|Adverse Event|21|||
145904991|NCT01696058|526157950|FG001|Overall Study|Adverse Event|11|||
145904992|NCT01696058|526157949|FG000|Overall Study|Lack of Efficacy|2|||
145904993|NCT01696058|526157950|FG001|Overall Study|Lack of Efficacy|3|||
145904994|NCT01696058|526157949|FG000|Overall Study|Protocol Violation|9|||
145904995|NCT01696058|526157950|FG001|Overall Study|Protocol Violation|3|||
145904996|NCT01696058|526157949|FG000|Overall Study|Lost to Follow-up|2|||
145904997|NCT01696058|526157950|FG001|Overall Study|Lost to Follow-up|5|||
145904998|NCT01696058|526157949|FG000|Overall Study|Withdrawal by Subject|4|||
145904999|NCT01696058|526157950|FG001|Overall Study|Withdrawal by Subject|6|||
145905000|NCT01696058|526157949|FG000|Overall Study|Other reason prematurely discontinued|5|||
145905001|NCT01696058|526157950|FG001|Overall Study|Other reason prematurely discontinued|3|||
145905002|NCT01934335|526157951|FG000|Overall Study|Withdrawal by Subject|1|||
145905003|NCT01934335|526157952|FG001|Overall Study|Withdrawal by Subject|1|||
145905004|NCT01421511|526157953|FG000|Overall Study|Lost to Follow-up|11|||
145905005|NCT01421511|526157954|FG001|Overall Study|Lost to Follow-up|14|||
145905006|NCT01421511|526157953|FG000|Overall Study|Randomized but didn't receive study drug|1|||
145905007|NCT01421511|526157954|FG001|Overall Study|Randomized but didn't receive study drug|7|||
145905008|NCT01421511|526157953|FG000|Overall Study|Physician Decision|0|||
145905009|NCT01421511|526157954|FG001|Overall Study|Physician Decision|1|||
145905010|NCT01421511|526157953|FG000|Overall Study|Withdrawal by Subject|6|||
145905011|NCT01421511|526157954|FG001|Overall Study|Withdrawal by Subject|5|||
145905012|NCT01421511|526157953|FG000|Overall Study|Death|1|||
145905013|NCT01421511|526157954|FG001|Overall Study|Death|1|||
145905014|NCT01661062|526157957|FG000|Overall Study|Completed Treatment Off Study|3|||
145905015|NCT01661062|526157957|FG000|Overall Study|Withdrawal by Subject|2|||
145905016|NCT04106661|526157959|FG000|Overall Study|Protocol Violation|3|||
145905017|NCT04106661|526157960|FG001|Overall Study|Protocol Violation|0|||
145905018|NCT04106661|526157959|FG000|Overall Study|Scheduling difficulties|1|||
145905019|NCT04106661|526157960|FG001|Overall Study|Scheduling difficulties|1|||
145905020|NCT00233402|526157961|FG000|Overall Study|No pathology data|12|||
145905021|NCT00233402|526157962|FG001|Overall Study|No pathology data|9|||
145905022|NCT00233402|526157961|FG000|Overall Study|No Ta/T1|89|||
145905023|NCT00233402|526157962|FG001|Overall Study|No Ta/T1|94|||
145905024|NCT00233402|526157961|FG000|Overall Study|Lost to follow up etc|3|||
145905025|NCT00233402|526157962|FG001|Overall Study|Lost to follow up etc|21|||
145905026|NCT00423319|526157965|FG000|Overall Study|Death|2|||
145905027|NCT00423319|526157966|FG001|Overall Study|Death|0|||
145905028|NCT00423319|526157965|FG000|Overall Study|Adverse Event|93|||
145905029|NCT00423319|526157966|FG001|Overall Study|Adverse Event|112|||
145905030|NCT00423319|526157965|FG000|Overall Study|Withdrawal by Subject|86|||
145905031|NCT00423319|526157966|FG001|Overall Study|Withdrawal by Subject|99|||
145905032|NCT00423319|526157965|FG000|Overall Study|Lost to Follow-up|4|||
145905033|NCT00423319|526157966|FG001|Overall Study|Lost to Follow-up|3|||
145905034|NCT00423319|526157965|FG000|Overall Study|Poor compliance or noncompliance|1|||
145905035|NCT00423319|526157966|FG001|Overall Study|Poor compliance or noncompliance|1|||
145972666|NCT00297167|526412723|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
145972667|NCT00297167|526412724|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
145972668|NCT00297167|526412725|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
145972669|NCT04167462|526412728|FG000|Overall Study|Other reasons|3|||
145972670|NCT04167462|526412729|FG001|Overall Study|Other reasons|2|||
145972671|NCT04167462|526412728|FG000|Overall Study|Withdrawal by Subject|6|||
146297377|NCT01019317|527604687|FG000|Overall Study|Not Eligible|4|||
146297378|NCT02178553|527604688|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
146297379|NCT02178553|527604689|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
145905036|NCT00423319|526157965|FG000|Overall Study|No longer meets study criteria|15|||
145905037|NCT00423319|526157966|FG001|Overall Study|No longer meets study criteria|15|||
145905038|NCT00423319|526157965|FG000|Overall Study|Other|23|||
145905039|NCT00423319|526157966|FG001|Overall Study|Other|22|||
145905040|NCT02639052|526157967|FG000|Overall Study|Lost to Follow-up|1|||
145905041|NCT04572893|526157973|FG000|Part A|Adverse Event|1|||
145905042|NCT04572893|526157974|FG001|Part A|Adverse Event|0|||
145905043|NCT04572893|526157975|FG002|Part A|Adverse Event|0|||
145905044|NCT04572893|526157976|FG003|Part A|Adverse Event|0|||
145905045|NCT04572893|526157977|FG004|Part A|Adverse Event|0|||
145905046|NCT04572893|526157978|FG005|Part A|Adverse Event|0|||
145905047|NCT04572893|526157979|FG006|Part A|Adverse Event|0|||
145905048|NCT04572893|526157973|FG000|Part B|Withdrawal by Subject|0|||
145905049|NCT04572893|526157974|FG001|Part B|Withdrawal by Subject|0|||
145905050|NCT04572893|526157975|FG002|Part B|Withdrawal by Subject|0|||
145905051|NCT04572893|526157976|FG003|Part B|Withdrawal by Subject|0|||
145905052|NCT04572893|526157977|FG004|Part B|Withdrawal by Subject|0|||
145905053|NCT04572893|526157978|FG005|Part B|Withdrawal by Subject|1|||
145905054|NCT04572893|526157979|FG006|Part B|Withdrawal by Subject|0|||
145905055|NCT04572893|526157973|FG000|Part B|Study terminated by sponsor|0|||
145905056|NCT04572893|526157974|FG001|Part B|Study terminated by sponsor|0|||
145905057|NCT04572893|526157975|FG002|Part B|Study terminated by sponsor|0|||
145905058|NCT04572893|526157976|FG003|Part B|Study terminated by sponsor|0|||
145905059|NCT04572893|526157977|FG004|Part B|Study terminated by sponsor|7|||
145905060|NCT04572893|526157978|FG005|Part B|Study terminated by sponsor|5|||
145905061|NCT04572893|526157979|FG006|Part B|Study terminated by sponsor|3|||
145905062|NCT04572893|526157973|FG000|Part B|Lost to Follow-up|0|||
145905063|NCT04572893|526157974|FG001|Part B|Lost to Follow-up|0|||
145905064|NCT04572893|526157975|FG002|Part B|Lost to Follow-up|0|||
145905065|NCT04572893|526157976|FG003|Part B|Lost to Follow-up|0|||
146238924|NCT04021862|527388077|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145905066|NCT04572893|526157977|FG004|Part B|Lost to Follow-up|0|||
145905067|NCT04572893|526157978|FG005|Part B|Lost to Follow-up|0|||
145905068|NCT04572893|526157979|FG006|Part B|Lost to Follow-up|1|||
145905069|NCT04572893|526157973|FG000|Part B|Adverse Event|0|||
145905070|NCT04572893|526157974|FG001|Part B|Adverse Event|0|||
145905071|NCT04572893|526157975|FG002|Part B|Adverse Event|0|||
145905072|NCT04572893|526157976|FG003|Part B|Adverse Event|0|||
145905073|NCT04572893|526157977|FG004|Part B|Adverse Event|1|||
145905074|NCT04572893|526157978|FG005|Part B|Adverse Event|1|||
145905075|NCT04572893|526157979|FG006|Part B|Adverse Event|0|||
145905076|NCT05038800|526157980|FG000|Overall Study|Death|1|||
145905077|NCT05038800|526157981|FG001|Overall Study|Death|1|||
145905078|NCT05038800|526157982|FG002|Overall Study|Death|5|||
145905079|NCT05038800|526157983|FG003|Overall Study|Death|3|||
145905080|NCT05038800|526157984|FG004|Overall Study|Death|1|||
145905081|NCT05038800|526157980|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145905082|NCT05038800|526157981|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145905083|NCT05038800|526157982|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145905084|NCT05038800|526157983|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145905085|NCT05038800|526157984|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145905086|NCT05038800|526157980|FG000|Overall Study|Lack of Efficacy|0|||
145905087|NCT05038800|526157981|FG001|Overall Study|Lack of Efficacy|0|||
145905088|NCT05038800|526157982|FG002|Overall Study|Lack of Efficacy|0|||
145905089|NCT05038800|526157983|FG003|Overall Study|Lack of Efficacy|0|||
145905090|NCT05038800|526157984|FG004|Overall Study|Lack of Efficacy|1|||
145905091|NCT00121134|526157985|FG000|Overall Study|Progression of Disease|5|||
145905092|NCT00121134|526157986|FG001|Overall Study|Progression of Disease|3|||
145905093|NCT00121134|526157987|FG002|Overall Study|Progression of Disease|4|||
145905094|NCT00121134|526157988|FG003|Overall Study|Progression of Disease|2|||
145905095|NCT00121134|526157985|FG000|Overall Study|Toxicity|4|||
145905096|NCT00121134|526157986|FG001|Overall Study|Toxicity|7|||
145905097|NCT00121134|526157987|FG002|Overall Study|Toxicity|13|||
145905098|NCT00121134|526157988|FG003|Overall Study|Toxicity|5|||
145905099|NCT00121134|526157985|FG000|Overall Study|Physician Decision|6|||
145905100|NCT00121134|526157986|FG001|Overall Study|Physician Decision|4|||
146238925|NCT04021862|527388078|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
146238926|NCT04021862|527388079|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145972672|NCT04167462|526412729|FG001|Overall Study|Withdrawal by Subject|7|||
146238927|NCT04021862|527388080|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
146238928|NCT04057131|527388081|FG000|Overall Study|Protocol Violation|24|||
145972673|NCT04167462|526412728|FG000|Overall Study|Adverse Event|4|||
145905101|NCT00121134|526157987|FG002|Overall Study|Physician Decision|4|||
145905102|NCT00121134|526157988|FG003|Overall Study|Physician Decision|1|||
145905103|NCT00121134|526157985|FG000|Overall Study|Treatment Delay|1|||
145905104|NCT00121134|526157986|FG001|Overall Study|Treatment Delay|0|||
145905105|NCT00121134|526157987|FG002|Overall Study|Treatment Delay|0|||
145905106|NCT00121134|526157988|FG003|Overall Study|Treatment Delay|0|||
145905107|NCT00121134|526157985|FG000|Overall Study|Intercurrent Illness|0|||
145905108|NCT00121134|526157986|FG001|Overall Study|Intercurrent Illness|0|||
145905109|NCT00121134|526157987|FG002|Overall Study|Intercurrent Illness|0|||
145905110|NCT00121134|526157988|FG003|Overall Study|Intercurrent Illness|1|||
145905111|NCT00121134|526157985|FG000|Overall Study|Patient Personal Reasons|0|||
145972674|NCT04167462|526412729|FG001|Overall Study|Adverse Event|0|||
145905112|NCT00121134|526157986|FG001|Overall Study|Patient Personal Reasons|1|||
145905113|NCT00121134|526157987|FG002|Overall Study|Patient Personal Reasons|0|||
146238929|NCT03835754|527388082|FG000|Overall Study|Death|4|||
145905114|NCT00121134|526157988|FG003|Overall Study|Patient Personal Reasons|0|||
145905115|NCT02478320|526157991|FG000|Overall Study|Adverse Event|2|||
145905116|NCT02478320|526157992|FG001|Overall Study|Adverse Event|0|||
145905117|NCT02478320|526157991|FG000|Overall Study|Death|1|||
145905118|NCT02478320|526157992|FG001|Overall Study|Death|0|||
145905119|NCT02478320|526157991|FG000|Overall Study|Lack of Efficacy|4|||
146238930|NCT02830204|527388083|FG000|Overall Study|Death|9|||
146238931|NCT02830204|527388083|FG000|Overall Study|Withdrawal by Subject|1|||
146238932|NCT04445831|527388086|FG000|Overall Study|Withdrawal by Subject|2|||
146238933|NCT04445831|527388087|FG001|Overall Study|Withdrawal by Subject|1|||
146238934|NCT04445831|527388088|FG002|Overall Study|Withdrawal by Subject|1|||
146238935|NCT04445831|527388089|FG003|Overall Study|Withdrawal by Subject|0|||
146238936|NCT04445831|527388090|FG004|Overall Study|Withdrawal by Subject|0|||
146238937|NCT04445831|527388091|FG005|Overall Study|Withdrawal by Subject|0|||
146238938|NCT04445831|527388092|FG006|Overall Study|Withdrawal by Subject|0|||
146238939|NCT04445831|527388086|FG000|Overall Study|Subject withdrawal by caregiver|0|||
146238940|NCT04445831|527388087|FG001|Overall Study|Subject withdrawal by caregiver|1|||
146238941|NCT04445831|527388088|FG002|Overall Study|Subject withdrawal by caregiver|0|||
146238942|NCT04445831|527388089|FG003|Overall Study|Subject withdrawal by caregiver|0|||
146238943|NCT04445831|527388090|FG004|Overall Study|Subject withdrawal by caregiver|0|||
146238944|NCT04445831|527388091|FG005|Overall Study|Subject withdrawal by caregiver|0|||
146238945|NCT04445831|527388092|FG006|Overall Study|Subject withdrawal by caregiver|0|||
146238946|NCT05613907|527388096|FG000|Overall Study|Lost to Follow-up|5|||
146238947|NCT05613907|527388096|FG000|Overall Study|Death|3|||
146238948|NCT05613907|527388096|FG000|Overall Study|Withdrawal by Subject|2|||
146238949|NCT04701203|527388115|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
146238950|NCT04701203|527388116|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
146238951|NCT04701203|527388117|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
146238952|NCT04701203|527388115|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
146238953|NCT04701203|527388116|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
146238954|NCT04701203|527388117|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
146238955|NCT04701203|527388115|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
146238956|NCT04701203|527388116|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
146238957|NCT04701203|527388117|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
146238958|NCT04701203|527388115|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
146238959|NCT04701203|527388116|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
146238960|NCT04701203|527388117|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
146238961|NCT00491894|527388119|FG000|Overall Study|Adverse Event|14|||
146238962|NCT00491894|527388119|FG000|Overall Study|Withdrawal by Subject|5|||
146238963|NCT00491894|527388119|FG000|Overall Study|Death|3|||
146238964|NCT00491894|527388119|FG000|Overall Study|Lost to Follow-up|3|||
146238965|NCT00491894|527388119|FG000|Overall Study|Lack of Efficacy|2|||
146238966|NCT00491894|527388119|FG000|Overall Study|Other-Failed to meet any criteria|2|||
146238967|NCT00491894|527388119|FG000|Overall Study|Physician Decision|2|||
146238968|NCT00491894|527388119|FG000|Overall Study|Protocol Violation|2|||
146238969|NCT00491894|527388119|FG000|Overall Study|Other-Intake of prohibited medication|1|||
146238970|NCT01563185|527388120|FG000|Overall Study|Withdrawal by Subject|1|||
146238971|NCT01563185|527388120|FG000|Overall Study|Non-Compliance with study drug|1|||
145905120|NCT02478320|526157992|FG001|Overall Study|Lack of Efficacy|0|||
145905121|NCT02478320|526157991|FG000|Overall Study|Withdrawal by Subject|2|||
145905122|NCT02478320|526157992|FG001|Overall Study|Withdrawal by Subject|0|||
145905123|NCT02478320|526157991|FG000|Overall Study|Screen Failure|3|||
145905124|NCT02478320|526157992|FG001|Overall Study|Screen Failure|0|||
145972675|NCT04167462|526412728|FG000|Overall Study|Pregnancy|1|||
145972676|NCT04167462|526412729|FG001|Overall Study|Pregnancy|0|||
145972677|NCT04167462|526412728|FG000|Overall Study|Lack of Efficacy|0|||
145972678|NCT04167462|526412729|FG001|Overall Study|Lack of Efficacy|1|||
145972679|NCT01033136|526412730|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
145972680|NCT01033136|526412731|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
145972681|NCT00142415|526412732|FG000|Overall Study|Physician Decision|0|||
145972682|NCT00142415|526412733|FG001|Overall Study|Physician Decision|0|||
145972683|NCT00142415|526412734|FG002|Overall Study|Physician Decision|0|||
145972684|NCT00142415|526412735|FG003|Overall Study|Physician Decision|0|||
145972685|NCT00142415|526412736|FG004|Overall Study|Physician Decision|1|||
145972686|NCT00142415|526412737|FG005|Overall Study|Physician Decision|2|||
145972687|NCT03530696|526412739|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
145972688|NCT03530696|526412740|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
146088436|NCT02011893|526843846|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
145905125|NCT02533375|526157993|FG000|Overall Study|Lack of Efficacy|3|||
146238972|NCT05293717|527388122|FG000|Overall Study|Physician Decision|1|||
145905126|NCT02533375|526157993|FG000|Overall Study|Adverse Event|2|||
145972689|NCT01129128|526412741|FG000|Overall Study|Lost to Follow-up|2|||
146238973|NCT02328014|527389640|FG000|Overall Study|Adverse Event|1|||
146238974|NCT02328014|527389641|FG001|Overall Study|Adverse Event|0|||
146238975|NCT02328014|527389642|FG002|Overall Study|Adverse Event|0|||
145972690|NCT01129128|526412742|FG001|Overall Study|Lost to Follow-up|2|||
145972691|NCT01129128|526412743|FG002|Overall Study|Lost to Follow-up|1|||
145972692|NCT01129128|526412741|FG000|Overall Study|Protocol Violation|0|||
145972693|NCT01129128|526412742|FG001|Overall Study|Protocol Violation|1|||
145972694|NCT01129128|526412743|FG002|Overall Study|Protocol Violation|0|||
145972695|NCT01129128|526412741|FG000|Overall Study|Withdrawal by Subject|0|||
145972696|NCT01129128|526412742|FG001|Overall Study|Withdrawal by Subject|1|||
145972697|NCT01129128|526412743|FG002|Overall Study|Withdrawal by Subject|3|||
145972698|NCT01129128|526412741|FG000|Overall Study|Physician Decision|1|||
145972699|NCT01129128|526412742|FG001|Overall Study|Physician Decision|0|||
145972700|NCT01129128|526412743|FG002|Overall Study|Physician Decision|0|||
145972701|NCT00844519|526412744|FG000|Overall Study|Withdrawal by Subject|1|||
145972702|NCT00844519|526412745|FG001|Overall Study|Withdrawal by Subject|1|||
146238976|NCT02328014|527389643|FG003|Overall Study|Adverse Event|1|||
146238977|NCT02328014|527389640|FG000|Overall Study|Death|0|||
146238978|NCT02328014|527389641|FG001|Overall Study|Death|0|||
146238979|NCT02328014|527389642|FG002|Overall Study|Death|0|||
146238980|NCT02328014|527389643|FG003|Overall Study|Death|4|||
146238981|NCT02328014|527389640|FG000|Overall Study|Physician Decision|0|||
146238982|NCT02328014|527389641|FG001|Overall Study|Physician Decision|0|||
146238983|NCT02328014|527389642|FG002|Overall Study|Physician Decision|0|||
146238984|NCT02328014|527389643|FG003|Overall Study|Physician Decision|1|||
145905127|NCT00960115|526157994|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
145905128|NCT00960115|526157995|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
145905129|NCT04619992|526157996|FG000|Overall Study|Withdrawal by Subject|1|||
145905130|NCT04619992|526157997|FG001|Overall Study|Withdrawal by Subject|0|||
145905131|NCT04428333|526157998|FG000|Overall Study|Physician Decision|5|||
145905132|NCT04428333|526157999|FG001|Overall Study|Physician Decision|6|||
145905133|NCT04428333|526157998|FG000|Overall Study|Withdrawal by Subject|1|||
145905134|NCT04428333|526157999|FG001|Overall Study|Withdrawal by Subject|3|||
145905135|NCT04428333|526157998|FG000|Overall Study|Study Terminated By Sponsor|14|||
145905136|NCT04428333|526157999|FG001|Overall Study|Study Terminated By Sponsor|16|||
145905137|NCT04853992|526158000|FG000|Treatment Period A|Adverse Event|0|||
145905138|NCT04853992|526158001|FG001|Treatment Period A|Adverse Event|1|||
145905139|NCT04853992|526158000|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
145905140|NCT04853992|526158001|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
145905141|NCT02269163|526158002|FG000|Overall Study|Lost to Follow-up|1|||
145905142|NCT02269163|526158003|FG001|Overall Study|Lost to Follow-up|0|||
145905143|NCT02269163|526158002|FG000|Overall Study|Major protocol violation|0|||
145905144|NCT02269163|526158003|FG001|Overall Study|Major protocol violation|1|||
145905145|NCT02269163|526158002|FG000|Overall Study|Other|2|||
145905146|NCT02269163|526158003|FG001|Overall Study|Other|2|||
145905147|NCT02269163|526158002|FG000|Overall Study|Withdrawal by Subject|0|||
145905148|NCT02269163|526158003|FG001|Overall Study|Withdrawal by Subject|3|||
145905149|NCT02269163|526158002|FG000|Overall Study|Physician Decision|0|||
145905150|NCT02269163|526158003|FG001|Overall Study|Physician Decision|1|||
145905151|NCT00758680|526158004|FG000|Overall Study|Adverse Event|0|||
145905152|NCT00758680|526158005|FG001|Overall Study|Adverse Event|0|||
145905153|NCT00758680|526158006|FG002|Overall Study|Adverse Event|0|||
145905154|NCT00758680|526158007|FG003|Overall Study|Adverse Event|0|||
145905155|NCT00758680|526158008|FG004|Overall Study|Adverse Event|0|||
145905156|NCT00758680|526158009|FG005|Overall Study|Adverse Event|0|||
145905157|NCT00758680|526158010|FG006|Overall Study|Adverse Event|0|||
145905158|NCT00758680|526158011|FG007|Overall Study|Adverse Event|1|||
145972703|NCT00844519|526412744|FG000|Overall Study|Adverse Event|1|||
145972704|NCT00844519|526412745|FG001|Overall Study|Adverse Event|0|||
145972705|NCT01056536|526412746|FG000|Overall Study|Lost to Follow-up|202|||
145972706|NCT01056536|526412747|FG001|Overall Study|Lost to Follow-up|116|||
145972707|NCT01056536|526412748|FG002|Overall Study|Lost to Follow-up|248|||
145972708|NCT01551173|526412753|FG000|Overall Study|Withdrawal by Subject|11|||
146238985|NCT02328014|527389640|FG000|Overall Study|Disease Progression|1|||
146238986|NCT02328014|527389641|FG001|Overall Study|Disease Progression|0|||
146297380|NCT02178553|527604688|FG000|Overall Study|Physician Decision|0|||
146297381|NCT02178553|527604689|FG001|Overall Study|Physician Decision|4|||
146238987|NCT02328014|527389642|FG002|Overall Study|Disease Progression|1|||
145905159|NCT00758680|526158012|FG008|Overall Study|Adverse Event|0|||
145905160|NCT00758680|526158013|FG009|Overall Study|Adverse Event|1|||
145905161|NCT00758680|526158004|FG000|Overall Study|Laboratory Adverse Event|0|||
145905162|NCT00758680|526158005|FG001|Overall Study|Laboratory Adverse Event|0|||
145905163|NCT00758680|526158006|FG002|Overall Study|Laboratory Adverse Event|0|||
145905164|NCT00758680|526158007|FG003|Overall Study|Laboratory Adverse Event|0|||
145905165|NCT00758680|526158008|FG004|Overall Study|Laboratory Adverse Event|0|||
145972709|NCT01551173|526412754|FG001|Overall Study|Withdrawal by Subject|16|||
145972710|NCT01551173|526412753|FG000|Overall Study|Adverse Event|7|||
145972711|NCT01551173|526412754|FG001|Overall Study|Adverse Event|6|||
145972712|NCT01551173|526412753|FG000|Overall Study|Lost to Follow-up|5|||
146238988|NCT02328014|527389643|FG003|Overall Study|Disease Progression|3|||
146238989|NCT02328014|527389640|FG000|Overall Study|Study Terminated by Sponsor|4|||
146297382|NCT02178553|527604688|FG000|Overall Study|Technical problem with injection|1|||
145905166|NCT00758680|526158009|FG005|Overall Study|Laboratory Adverse Event|0|||
145905167|NCT00758680|526158010|FG006|Overall Study|Laboratory Adverse Event|0|||
145905168|NCT00758680|526158011|FG007|Overall Study|Laboratory Adverse Event|0|||
145905169|NCT00758680|526158012|FG008|Overall Study|Laboratory Adverse Event|1|||
145905170|NCT00758680|526158013|FG009|Overall Study|Laboratory Adverse Event|0|||
145905171|NCT00758680|526158004|FG000|Overall Study|Withdrawal by Subject|0|||
145905172|NCT00758680|526158005|FG001|Overall Study|Withdrawal by Subject|0|||
145905173|NCT00758680|526158006|FG002|Overall Study|Withdrawal by Subject|0|||
145905174|NCT00758680|526158007|FG003|Overall Study|Withdrawal by Subject|0|||
145905175|NCT00758680|526158008|FG004|Overall Study|Withdrawal by Subject|0|||
145905176|NCT00758680|526158009|FG005|Overall Study|Withdrawal by Subject|0|||
145905177|NCT00758680|526158010|FG006|Overall Study|Withdrawal by Subject|1|||
145905178|NCT00758680|526158011|FG007|Overall Study|Withdrawal by Subject|0|||
145905179|NCT00758680|526158012|FG008|Overall Study|Withdrawal by Subject|1|||
145905180|NCT00758680|526158013|FG009|Overall Study|Withdrawal by Subject|0|||
145905181|NCT01284621|526158014|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145905182|NCT01284621|526158015|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145905183|NCT01284621|526158016|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145905184|NCT01284621|526158017|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145905185|NCT01284621|526158018|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
145905186|NCT01284621|526158019|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145905187|NCT02099682|526158022|FG000|Overall Study|Data Not Available|51|||
145905188|NCT02099682|526158022|FG000|Overall Study|Lost to Follow-up|31|||
145905189|NCT02099682|526158022|FG000|Overall Study|Other|29|||
145905190|NCT02802631|526158023|FG000|Overall Study|Withdrawal by Subject|1|||
145905191|NCT02802631|526158024|FG001|Overall Study|Withdrawal by Subject|0|||
145905192|NCT02802631|526158025|FG002|Overall Study|Withdrawal by Subject|0|||
145905193|NCT02802631|526158026|FG003|Overall Study|Withdrawal by Subject|0|||
145905194|NCT02802631|526158027|FG004|Overall Study|Withdrawal by Subject|0|||
145905195|NCT02802631|526158028|FG005|Overall Study|Withdrawal by Subject|0|||
145905196|NCT02802631|526158029|FG006|Overall Study|Withdrawal by Subject|0|||
145905197|NCT02802631|526158030|FG007|Overall Study|Withdrawal by Subject|0|||
145905198|NCT02802631|526158023|FG000|Overall Study|Physician Decision|1|||
145905199|NCT02802631|526158024|FG001|Overall Study|Physician Decision|0|||
145905200|NCT02802631|526158025|FG002|Overall Study|Physician Decision|0|||
145905201|NCT02802631|526158026|FG003|Overall Study|Physician Decision|0|||
145905202|NCT02802631|526158027|FG004|Overall Study|Physician Decision|0|||
145905203|NCT02802631|526158028|FG005|Overall Study|Physician Decision|0|||
145905204|NCT02802631|526158029|FG006|Overall Study|Physician Decision|1|||
145905205|NCT02802631|526158030|FG007|Overall Study|Physician Decision|0|||
145972713|NCT01551173|526412754|FG001|Overall Study|Lost to Follow-up|7|||
145972714|NCT01551173|526412753|FG000|Overall Study|Other|5|||
145972715|NCT01551173|526412754|FG001|Overall Study|Other|3|||
146238990|NCT02328014|527389641|FG001|Overall Study|Study Terminated by Sponsor|1|||
146238991|NCT02328014|527389642|FG002|Overall Study|Study Terminated by Sponsor|1|||
146238992|NCT02328014|527389643|FG003|Overall Study|Study Terminated by Sponsor|0|||
146238993|NCT02328014|527389640|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
146238994|NCT02328014|527389641|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
146238995|NCT02328014|527389642|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
146238996|NCT02328014|527389643|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
146238997|NCT02328014|527389640|FG000|Overall Study|Withdrawal by Subject|0|||
146238998|NCT02328014|527389641|FG001|Overall Study|Withdrawal by Subject|0|||
146238999|NCT02328014|527389642|FG002|Overall Study|Withdrawal by Subject|0|||
146239000|NCT02328014|527389643|FG003|Overall Study|Withdrawal by Subject|1|||
146239001|NCT05422339|527389644|FG000|Overall Study|Withdrawal by Subject|17|||
146239002|NCT05422339|527389645|FG001|Overall Study|Withdrawal by Subject|15|||
146239003|NCT04172675|527389646|FG000|Overall Study|Withdrawal by Subject|7|||
146239004|NCT04172675|527389647|FG001|Overall Study|Withdrawal by Subject|5|||
146239005|NCT04172675|527389648|FG002|Overall Study|Withdrawal by Subject|1|||
146239006|NCT04172675|527389649|FG003|Overall Study|Withdrawal by Subject|4|||
146239007|NCT05029284|527389656|FG000|Overall Study|Lost to Follow-up|1|||
146239008|NCT03070392|527389657|FG000|Overall Study|Not Treated|7|||
145905206|NCT02802631|526158023|FG000|Overall Study|Adverse Event|0|||
145905207|NCT02802631|526158024|FG001|Overall Study|Adverse Event|2|||
145972716|NCT04530344|526412755|FG000|Overall Study|Lost to Follow-up|3|||
146297383|NCT02178553|527604689|FG001|Overall Study|Technical problem with injection|3|||
145905208|NCT02802631|526158025|FG002|Overall Study|Adverse Event|0|||
145905209|NCT02802631|526158026|FG003|Overall Study|Adverse Event|1|||
145905210|NCT02802631|526158027|FG004|Overall Study|Adverse Event|6|||
145905211|NCT02802631|526158028|FG005|Overall Study|Adverse Event|1|||
145905212|NCT02802631|526158029|FG006|Overall Study|Adverse Event|4|||
145905213|NCT02802631|526158030|FG007|Overall Study|Adverse Event|0|||
146239009|NCT03070392|527389658|FG001|Overall Study|Not Treated|0|||
146239010|NCT03070392|527389659|FG002|Overall Study|Not Treated|3|||
146239011|NCT03070392|527389660|FG003|Overall Study|Not Treated|12|||
146239012|NCT03070392|527389657|FG000|Overall Study|Death|3|||
145905214|NCT02802631|526158023|FG000|Overall Study|Sponsor Decision|0|||
145905215|NCT02802631|526158024|FG001|Overall Study|Sponsor Decision|0|||
145905216|NCT02802631|526158025|FG002|Overall Study|Sponsor Decision|6|||
145905217|NCT02802631|526158026|FG003|Overall Study|Sponsor Decision|0|||
145905218|NCT02802631|526158027|FG004|Overall Study|Sponsor Decision|2|||
145905219|NCT02802631|526158028|FG005|Overall Study|Sponsor Decision|0|||
145905220|NCT02802631|526158029|FG006|Overall Study|Sponsor Decision|0|||
145905221|NCT02802631|526158030|FG007|Overall Study|Sponsor Decision|4|||
145905222|NCT02342639|526158031|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
145905223|NCT02342639|526158032|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
145905224|NCT02342639|526158031|FG000|Overall Study|Protocol Violation|0|||
145905225|NCT02342639|526158032|FG001|Overall Study|Protocol Violation|2|||
145905226|NCT02293863|526158033|FG000|Overall Study|Death|4|||
145905227|NCT02293863|526158034|FG001|Overall Study|Death|6|||
145905228|NCT02293863|526158035|FG002|Overall Study|Death|4|||
145905229|NCT02293863|526158033|FG000|Overall Study|Lost to Follow-up|2|||
145905230|NCT02293863|526158034|FG001|Overall Study|Lost to Follow-up|2|||
145905231|NCT02293863|526158035|FG002|Overall Study|Lost to Follow-up|2|||
145905232|NCT02293863|526158033|FG000|Overall Study|Withdrawal by Subject|3|||
145905233|NCT02293863|526158034|FG001|Overall Study|Withdrawal by Subject|3|||
145905234|NCT02293863|526158035|FG002|Overall Study|Withdrawal by Subject|1|||
145905235|NCT02293863|526158033|FG000|Overall Study|Reason Not Specified|0|||
145905236|NCT02293863|526158034|FG001|Overall Study|Reason Not Specified|2|||
145905237|NCT02293863|526158035|FG002|Overall Study|Reason Not Specified|2|||
145905238|NCT02212379|526158036|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
145905239|NCT02212379|526158036|FG000|From Baseline to Week 48|Adverse Event|7|||
145905240|NCT02212379|526158036|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
145905241|NCT02212379|526158036|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
145905242|NCT02212379|526158036|FG000|From Week 48 to Week 96|Adverse Event|1|||
145905243|NCT02212379|526158036|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
145905244|NCT00416884|526158039|FG000|Overall Study|Study terminated due to low accrual|1|||
145905245|NCT00704730|526158040|FG000|Overall Study|Adverse Event|35|||
145905246|NCT00704730|526158041|FG001|Overall Study|Adverse Event|9|||
145905247|NCT00704730|526158040|FG000|Overall Study|Death|11|||
145905248|NCT00704730|526158041|FG001|Overall Study|Death|5|||
145905249|NCT00704730|526158040|FG000|Overall Study|Physician Decision|2|||
145905250|NCT00704730|526158041|FG001|Overall Study|Physician Decision|0|||
145905251|NCT00704730|526158040|FG000|Overall Study|Did not receive drug|5|||
145905252|NCT00704730|526158041|FG001|Overall Study|Did not receive drug|2|||
145905253|NCT00704730|526158040|FG000|Overall Study|Disease progression per PI|58|||
145905254|NCT00704730|526158041|FG001|Overall Study|Disease progression per PI|67|||
145905255|NCT00704730|526158040|FG000|Overall Study|data unavailable|1|||
145905256|NCT00704730|526158041|FG001|Overall Study|data unavailable|0|||
145905257|NCT00704730|526158040|FG000|Overall Study|Withdrawal by Subject|9|||
145905258|NCT00704730|526158041|FG001|Overall Study|Withdrawal by Subject|13|||
145905259|NCT04975191|526159844|FG000|Overall Study|Protocol Violation|1|||
145905260|NCT04975191|526159845|FG001|Overall Study|Protocol Violation|2|||
145905261|NCT04975191|526159846|FG002|Overall Study|Protocol Violation|2|||
145905262|NCT04975191|526159847|FG003|Overall Study|Protocol Violation|2|||
145905263|NCT04975191|526159844|FG000|Overall Study|Lost to Follow-up|13|||
145905264|NCT04975191|526159845|FG001|Overall Study|Lost to Follow-up|3|||
145905265|NCT04975191|526159846|FG002|Overall Study|Lost to Follow-up|8|||
145905266|NCT04975191|526159847|FG003|Overall Study|Lost to Follow-up|8|||
145905267|NCT00761657|526159848|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
145905268|NCT00761657|526159849|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
145905269|NCT00761657|526159850|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
145905270|NCT00761657|526159851|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
145905271|NCT00761657|526159852|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
145905272|NCT00761657|526159853|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
145905273|NCT00761657|526159854|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
145905274|NCT00761657|526159855|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
145905275|NCT00761657|526159856|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
145905276|NCT00761657|526159848|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905277|NCT00761657|526159849|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905278|NCT00761657|526159850|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
145905279|NCT00761657|526159851|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
146297384|NCT05085665|527604690|FG000|Overall Study|Physician Decision|2|||
145905280|NCT00761657|526159852|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905281|NCT00761657|526159853|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905282|NCT00761657|526159854|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905283|NCT00761657|526159855|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905284|NCT00761657|526159856|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145905285|NCT00761657|526159848|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
145905286|NCT00761657|526159849|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
145905287|NCT00761657|526159850|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
145905288|NCT00761657|526159851|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
145905289|NCT00761657|526159852|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
145905290|NCT00761657|526159853|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
145905291|NCT00761657|526159854|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
145905292|NCT00761657|526159855|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
145905293|NCT00761657|526159856|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
145905294|NCT00761657|526159848|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
145905295|NCT00761657|526159849|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
145905296|NCT00761657|526159850|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
145905297|NCT00761657|526159851|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
145905298|NCT00761657|526159852|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
145905299|NCT00761657|526159853|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
145905300|NCT00761657|526159854|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
145905301|NCT00761657|526159855|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
145905302|NCT00761657|526159856|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
145905303|NCT02245412|526159864|FG000|Treatment Period|Death|1|||
145905304|NCT02245412|526159865|FG001|Treatment Period|Death|1|||
145905305|NCT02245412|526159866|FG002|Treatment Period|Death|0|||
145905306|NCT02245412|526159864|FG000|Treatment Period|Physician Decision|1|||
145905307|NCT02245412|526159865|FG001|Treatment Period|Physician Decision|1|||
145905308|NCT02245412|526159866|FG002|Treatment Period|Physician Decision|0|||
145905309|NCT02245412|526159864|FG000|Treatment Period|Withdrawal by Subject|2|||
145905310|NCT02245412|526159865|FG001|Treatment Period|Withdrawal by Subject|1|||
145905311|NCT02245412|526159866|FG002|Treatment Period|Withdrawal by Subject|0|||
145905312|NCT02245412|526159864|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
145905313|NCT02245412|526159865|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
145905314|NCT02245412|526159866|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
145905315|NCT02245412|526159864|FG000|Follow-Up Period|Death|4|||
145905316|NCT02245412|526159865|FG001|Follow-Up Period|Death|2|||
145905317|NCT02245412|526159866|FG002|Follow-Up Period|Death|1|||
145905318|NCT02245412|526159864|FG000|Follow-Up Period|Physician Decision|1|||
145905319|NCT02245412|526159865|FG001|Follow-Up Period|Physician Decision|0|||
145905320|NCT02245412|526159866|FG002|Follow-Up Period|Physician Decision|0|||
145905321|NCT02245412|526159864|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
145905322|NCT02245412|526159865|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
145905323|NCT02245412|526159866|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
145905324|NCT02500043|526159873|FG000|Overall Study|Randomized, but not Treated|2|||
145905325|NCT02500043|526159874|FG001|Overall Study|Randomized, but not Treated|2|||
145905326|NCT02500043|526159873|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
145905327|NCT02500043|526159874|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
145905328|NCT02500043|526159873|FG000|Overall Study|Adverse Event|33|||
145905329|NCT02500043|526159874|FG001|Overall Study|Adverse Event|11|||
145905330|NCT02500043|526159873|FG000|Overall Study|Clinical Progression|54|||
145905331|NCT02500043|526159874|FG001|Overall Study|Clinical Progression|35|||
145905332|NCT02500043|526159873|FG000|Overall Study|Radiological Progression|192|||
145905333|NCT02500043|526159874|FG001|Overall Study|Radiological Progression|110|||
145972717|NCT04530344|526412756|FG001|Overall Study|Lost to Follow-up|3|||
145972718|NCT04530344|526412757|FG002|Overall Study|Lost to Follow-up|3|||
145972719|NCT04530344|526412758|FG003|Overall Study|Lost to Follow-up|10|||
145972720|NCT04530344|526412755|FG000|Overall Study|Withdrawal by Subject|14|||
145972721|NCT04530344|526412756|FG001|Overall Study|Withdrawal by Subject|5|||
145972722|NCT04530344|526412757|FG002|Overall Study|Withdrawal by Subject|18|||
145972723|NCT04530344|526412758|FG003|Overall Study|Withdrawal by Subject|33|||
145972724|NCT04530344|526412755|FG000|Overall Study|Adverse Event|0|||
145972725|NCT04530344|526412756|FG001|Overall Study|Adverse Event|0|||
145972726|NCT04530344|526412757|FG002|Overall Study|Adverse Event|0|||
145972727|NCT04530344|526412758|FG003|Overall Study|Adverse Event|1|||
145972728|NCT04530344|526412755|FG000|Overall Study|Lack of Efficacy|0|||
145972729|NCT04530344|526412756|FG001|Overall Study|Lack of Efficacy|0|||
145972730|NCT04530344|526412757|FG002|Overall Study|Lack of Efficacy|0|||
145972731|NCT04530344|526412758|FG003|Overall Study|Lack of Efficacy|1|||
145972732|NCT04530344|526412755|FG000|Overall Study|Physician Decision|0|||
145972733|NCT04530344|526412756|FG001|Overall Study|Physician Decision|0|||
145972734|NCT04530344|526412757|FG002|Overall Study|Physician Decision|1|||
146239013|NCT03070392|527389658|FG001|Overall Study|Death|0|||
145972735|NCT04530344|526412758|FG003|Overall Study|Physician Decision|1|||
145905334|NCT02500043|526159873|FG000|Overall Study|Physician's Decision|11|||
145905335|NCT02500043|526159874|FG001|Overall Study|Physician's Decision|3|||
145905336|NCT02500043|526159873|FG000|Overall Study|Withdrawal by Subject|14|||
145905337|NCT02500043|526159874|FG001|Overall Study|Withdrawal by Subject|4|||
145972736|NCT04530344|526412755|FG000|Overall Study|Pregnancy|0|||
145905338|NCT02500043|526159873|FG000|Overall Study|Death|11|||
145905339|NCT02500043|526159874|FG001|Overall Study|Death|2|||
145905340|NCT02500043|526159873|FG000|Overall Study|Protocol Deviation|1|||
145905341|NCT02500043|526159874|FG001|Overall Study|Protocol Deviation|0|||
145905342|NCT01371747|526159875|FG000|Overall Study|Adverse Event|4|||
145905343|NCT01371747|526159876|FG001|Overall Study|Adverse Event|2|||
145905344|NCT01371747|526159877|FG002|Overall Study|Adverse Event|7|||
145972737|NCT04530344|526412756|FG001|Overall Study|Pregnancy|0|||
145972738|NCT04530344|526412757|FG002|Overall Study|Pregnancy|2|||
146239014|NCT03070392|527389659|FG002|Overall Study|Death|0|||
146239015|NCT03070392|527389660|FG003|Overall Study|Death|1|||
146239016|NCT03070392|527389657|FG000|Overall Study|Withdrawal by Subject|7|||
146239017|NCT03070392|527389658|FG001|Overall Study|Withdrawal by Subject|0|||
146239018|NCT03070392|527389659|FG002|Overall Study|Withdrawal by Subject|0|||
146239019|NCT03070392|527389660|FG003|Overall Study|Withdrawal by Subject|3|||
146239020|NCT03070392|527389657|FG000|Overall Study|Physician Decision|1|||
146239021|NCT03070392|527389658|FG001|Overall Study|Physician Decision|0|||
146239022|NCT03070392|527389659|FG002|Overall Study|Physician Decision|0|||
146239023|NCT03070392|527389660|FG003|Overall Study|Physician Decision|2|||
145905345|NCT01371747|526159878|FG003|Overall Study|Adverse Event|2|||
145905346|NCT01371747|526159879|FG004|Overall Study|Adverse Event|2|||
145905347|NCT01371747|526159880|FG005|Overall Study|Adverse Event|2|||
145905348|NCT01371747|526159875|FG000|Overall Study|Death|1|||
145905349|NCT01371747|526159876|FG001|Overall Study|Death|0|||
145905350|NCT01371747|526159877|FG002|Overall Study|Death|4|||
145905351|NCT01371747|526159878|FG003|Overall Study|Death|1|||
145905352|NCT01371747|526159879|FG004|Overall Study|Death|2|||
145905353|NCT01371747|526159880|FG005|Overall Study|Death|0|||
145905354|NCT01371747|526159875|FG000|Overall Study|Abnormal Renal Function|0|||
145905355|NCT01371747|526159876|FG001|Overall Study|Abnormal Renal Function|2|||
145905356|NCT01371747|526159877|FG002|Overall Study|Abnormal Renal Function|0|||
145905357|NCT01371747|526159878|FG003|Overall Study|Abnormal Renal Function|1|||
145905358|NCT01371747|526159879|FG004|Overall Study|Abnormal Renal Function|0|||
145905359|NCT01371747|526159880|FG005|Overall Study|Abnormal Renal Function|1|||
145905360|NCT01371747|526159875|FG000|Overall Study|High Serum Potassium Results|1|||
145905361|NCT01371747|526159876|FG001|Overall Study|High Serum Potassium Results|1|||
145905362|NCT01371747|526159877|FG002|Overall Study|High Serum Potassium Results|1|||
145905363|NCT01371747|526159878|FG003|Overall Study|High Serum Potassium Results|2|||
145905364|NCT01371747|526159879|FG004|Overall Study|High Serum Potassium Results|0|||
145905365|NCT01371747|526159880|FG005|Overall Study|High Serum Potassium Results|2|||
145905366|NCT01371747|526159875|FG000|Overall Study|Low Serum Potassium Results|1|||
145905367|NCT01371747|526159876|FG001|Overall Study|Low Serum Potassium Results|1|||
145905368|NCT01371747|526159877|FG002|Overall Study|Low Serum Potassium Results|1|||
145905369|NCT01371747|526159878|FG003|Overall Study|Low Serum Potassium Results|1|||
145905370|NCT01371747|526159879|FG004|Overall Study|Low Serum Potassium Results|0|||
145905371|NCT01371747|526159880|FG005|Overall Study|Low Serum Potassium Results|3|||
145905372|NCT01371747|526159875|FG000|Overall Study|Protocol Violation|0|||
145905373|NCT01371747|526159876|FG001|Overall Study|Protocol Violation|0|||
145905374|NCT01371747|526159877|FG002|Overall Study|Protocol Violation|1|||
145905375|NCT01371747|526159878|FG003|Overall Study|Protocol Violation|0|||
145905376|NCT01371747|526159879|FG004|Overall Study|Protocol Violation|0|||
145905377|NCT01371747|526159880|FG005|Overall Study|Protocol Violation|0|||
145905378|NCT01371747|526159875|FG000|Overall Study|Non-Compliance|3|||
145905379|NCT01371747|526159876|FG001|Overall Study|Non-Compliance|4|||
145905380|NCT01371747|526159877|FG002|Overall Study|Non-Compliance|3|||
145905381|NCT01371747|526159878|FG003|Overall Study|Non-Compliance|0|||
145905382|NCT01371747|526159879|FG004|Overall Study|Non-Compliance|0|||
145905383|NCT01371747|526159880|FG005|Overall Study|Non-Compliance|1|||
145905384|NCT01371747|526159875|FG000|Overall Study|Physician Decision|0|||
145905385|NCT01371747|526159876|FG001|Overall Study|Physician Decision|0|||
145905386|NCT01371747|526159877|FG002|Overall Study|Physician Decision|0|||
145905387|NCT01371747|526159878|FG003|Overall Study|Physician Decision|0|||
145905388|NCT01371747|526159879|FG004|Overall Study|Physician Decision|1|||
145905389|NCT01371747|526159880|FG005|Overall Study|Physician Decision|0|||
145905390|NCT01371747|526159875|FG000|Overall Study|Withdrawal by Subject|6|||
145905391|NCT01371747|526159876|FG001|Overall Study|Withdrawal by Subject|12|||
145905392|NCT01371747|526159877|FG002|Overall Study|Withdrawal by Subject|5|||
145905393|NCT01371747|526159878|FG003|Overall Study|Withdrawal by Subject|2|||
145972739|NCT04530344|526412758|FG003|Overall Study|Pregnancy|1|||
145905394|NCT01371747|526159879|FG004|Overall Study|Withdrawal by Subject|2|||
145905395|NCT01371747|526159880|FG005|Overall Study|Withdrawal by Subject|4|||
145905396|NCT01371747|526159875|FG000|Overall Study|Other Reasons|2|||
145905397|NCT01371747|526159876|FG001|Overall Study|Other Reasons|1|||
145905398|NCT01371747|526159877|FG002|Overall Study|Other Reasons|2|||
146297385|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145905399|NCT01371747|526159878|FG003|Overall Study|Other Reasons|0|||
145905400|NCT01371747|526159879|FG004|Overall Study|Other Reasons|0|||
145972740|NCT04530344|526412755|FG000|Overall Study|Protocol Violation|0|||
145905401|NCT01371747|526159880|FG005|Overall Study|Other Reasons|1|||
146297386|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145972741|NCT04530344|526412756|FG001|Overall Study|Protocol Violation|0|||
146239024|NCT03070392|527389657|FG000|Overall Study|Progressive Disease|154|||
146239025|NCT03070392|527389658|FG001|Overall Study|Progressive Disease|6|||
145905402|NCT02094417|526159881|FG000|Overall Study|Adverse Event|0|||
145905403|NCT02094417|526159882|FG001|Overall Study|Adverse Event|0|||
145905404|NCT02094417|526159883|FG002|Overall Study|Adverse Event|0|||
145905405|NCT02094417|526159884|FG003|Overall Study|Adverse Event|1|||
145905406|NCT02094417|526159881|FG000|Overall Study|Eligibility criteria|0|||
145905407|NCT02094417|526159882|FG001|Overall Study|Eligibility criteria|1|||
145905408|NCT02094417|526159883|FG002|Overall Study|Eligibility criteria|0|||
145905409|NCT02094417|526159884|FG003|Overall Study|Eligibility criteria|0|||
145905410|NCT02094417|526159881|FG000|Overall Study|No responder|4|||
145905411|NCT02094417|526159882|FG001|Overall Study|No responder|4|||
145905412|NCT02094417|526159883|FG002|Overall Study|No responder|4|||
145905413|NCT02094417|526159884|FG003|Overall Study|No responder|3|||
145905414|NCT02094417|526159881|FG000|Overall Study|Unable to conduct observations or assess|0|||
145905415|NCT02094417|526159882|FG001|Overall Study|Unable to conduct observations or assess|1|||
145905416|NCT02094417|526159883|FG002|Overall Study|Unable to conduct observations or assess|0|||
145905417|NCT02094417|526159884|FG003|Overall Study|Unable to conduct observations or assess|0|||
145905418|NCT02094417|526159881|FG000|Overall Study|Withdrawal by Subject|1|||
145905419|NCT02094417|526159882|FG001|Overall Study|Withdrawal by Subject|2|||
145905420|NCT02094417|526159883|FG002|Overall Study|Withdrawal by Subject|1|||
145905421|NCT02094417|526159884|FG003|Overall Study|Withdrawal by Subject|3|||
145905422|NCT01473524|526159887|FG000|DB Phase|Adverse Event|4|||
145905423|NCT01473524|526159888|FG001|DB Phase|Adverse Event|8|||
145905424|NCT01473524|526159889|FG002|DB Phase|Adverse Event|2|||
145905425|NCT01473524|526159890|FG003|DB Phase|Adverse Event|0|||
145905426|NCT01473524|526159891|FG004|DB Phase|Adverse Event|0|||
145905427|NCT01473524|526159892|FG005|DB Phase|Adverse Event|0|||
145905428|NCT01473524|526159887|FG000|DB Phase|Death|1|||
145905429|NCT01473524|526159888|FG001|DB Phase|Death|0|||
145905430|NCT01473524|526159889|FG002|DB Phase|Death|0|||
145905431|NCT01473524|526159890|FG003|DB Phase|Death|0|||
145905432|NCT01473524|526159891|FG004|DB Phase|Death|0|||
145905433|NCT01473524|526159892|FG005|DB Phase|Death|0|||
145905434|NCT01473524|526159887|FG000|DB Phase|Withdrawal by Subject|2|||
145905435|NCT01473524|526159888|FG001|DB Phase|Withdrawal by Subject|1|||
145905436|NCT01473524|526159889|FG002|DB Phase|Withdrawal by Subject|1|||
145905437|NCT01473524|526159890|FG003|DB Phase|Withdrawal by Subject|0|||
145905438|NCT01473524|526159891|FG004|DB Phase|Withdrawal by Subject|0|||
145905439|NCT01473524|526159892|FG005|DB Phase|Withdrawal by Subject|0|||
145905440|NCT01473524|526159887|FG000|LTSE Phase|Withdrawal by Subject|0|||
145905441|NCT01473524|526159888|FG001|LTSE Phase|Withdrawal by Subject|0|||
145905442|NCT01473524|526159889|FG002|LTSE Phase|Withdrawal by Subject|0|||
145905443|NCT01473524|526159890|FG003|LTSE Phase|Withdrawal by Subject|3|||
145905444|NCT01473524|526159891|FG004|LTSE Phase|Withdrawal by Subject|3|||
145905445|NCT01473524|526159892|FG005|LTSE Phase|Withdrawal by Subject|6|||
145905446|NCT01473524|526159887|FG000|LTSE Phase|Death|0|||
145905447|NCT01473524|526159888|FG001|LTSE Phase|Death|0|||
145905448|NCT01473524|526159889|FG002|LTSE Phase|Death|0|||
145905449|NCT01473524|526159890|FG003|LTSE Phase|Death|0|||
145905450|NCT01473524|526159891|FG004|LTSE Phase|Death|1|||
145905451|NCT01473524|526159892|FG005|LTSE Phase|Death|0|||
145905452|NCT01473524|526159887|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
145905453|NCT01473524|526159888|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
145905454|NCT01473524|526159889|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
145905455|NCT01473524|526159890|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
145905456|NCT01473524|526159891|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
145905457|NCT01473524|526159892|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
145905458|NCT01473524|526159887|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
145905459|NCT01473524|526159888|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
146239026|NCT03070392|527389659|FG002|Overall Study|Progressive Disease|2|||
146239027|NCT03070392|527389660|FG003|Overall Study|Progressive Disease|70|||
146239028|NCT03070392|527389657|FG000|Overall Study|Adverse Event|6|||
146239029|NCT03070392|527389658|FG001|Overall Study|Adverse Event|1|||
146239030|NCT03070392|527389659|FG002|Overall Study|Adverse Event|1|||
146239031|NCT03070392|527389660|FG003|Overall Study|Adverse Event|3|||
146239032|NCT03070392|527389657|FG000|Overall Study|Alternate anticancer treatment|1|||
146239033|NCT03070392|527389658|FG001|Overall Study|Alternate anticancer treatment|0|||
146239034|NCT03070392|527389659|FG002|Overall Study|Alternate anticancer treatment|0|||
146297387|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
146297388|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145905460|NCT01473524|526159889|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
145905461|NCT01473524|526159890|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
145905462|NCT01473524|526159891|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
145905463|NCT01473524|526159892|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
145905464|NCT01473524|526159887|FG000|LTSE Phase|Lost to Follow-up|0|||
145905465|NCT01473524|526159888|FG001|LTSE Phase|Lost to Follow-up|0|||
146088437|NCT02011893|526843847|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
146239035|NCT03070392|527389660|FG003|Overall Study|Alternate anticancer treatment|1|||
146239036|NCT03070392|527389657|FG000|Overall Study|Ongoing|73|||
145905466|NCT01473524|526159889|FG002|LTSE Phase|Lost to Follow-up|0|||
145905467|NCT01473524|526159890|FG003|LTSE Phase|Lost to Follow-up|1|||
145905468|NCT01473524|526159891|FG004|LTSE Phase|Lost to Follow-up|3|||
145905469|NCT01473524|526159892|FG005|LTSE Phase|Lost to Follow-up|2|||
145905470|NCT01473524|526159887|FG000|LTSE Phase|Principal Investigator Decision|0|||
145905471|NCT01473524|526159888|FG001|LTSE Phase|Principal Investigator Decision|0|||
145905472|NCT01473524|526159889|FG002|LTSE Phase|Principal Investigator Decision|0|||
145905473|NCT01473524|526159890|FG003|LTSE Phase|Principal Investigator Decision|1|||
145905474|NCT01473524|526159891|FG004|LTSE Phase|Principal Investigator Decision|1|||
145905475|NCT01473524|526159892|FG005|LTSE Phase|Principal Investigator Decision|3|||
145905476|NCT01473524|526159887|FG000|LTSE Phase|Liver Transplantation|0|||
145905477|NCT01473524|526159888|FG001|LTSE Phase|Liver Transplantation|0|||
145905478|NCT01473524|526159889|FG002|LTSE Phase|Liver Transplantation|0|||
145905479|NCT01473524|526159890|FG003|LTSE Phase|Liver Transplantation|0|||
145905480|NCT01473524|526159891|FG004|LTSE Phase|Liver Transplantation|0|||
145905481|NCT01473524|526159892|FG005|LTSE Phase|Liver Transplantation|1|||
145905482|NCT01473524|526159887|FG000|LTSE Phase|Pregnancy|0|||
145905483|NCT01473524|526159888|FG001|LTSE Phase|Pregnancy|0|||
145905484|NCT01473524|526159889|FG002|LTSE Phase|Pregnancy|0|||
145905485|NCT01473524|526159890|FG003|LTSE Phase|Pregnancy|1|||
145905486|NCT01473524|526159891|FG004|LTSE Phase|Pregnancy|0|||
145905487|NCT01473524|526159892|FG005|LTSE Phase|Pregnancy|0|||
145905488|NCT01473524|526159887|FG000|LTSE Phase|Protocol Violation|0|||
145905489|NCT01473524|526159888|FG001|LTSE Phase|Protocol Violation|0|||
145905490|NCT01473524|526159889|FG002|LTSE Phase|Protocol Violation|0|||
145905491|NCT01473524|526159890|FG003|LTSE Phase|Protocol Violation|0|||
145905492|NCT01473524|526159891|FG004|LTSE Phase|Protocol Violation|0|||
145905493|NCT01473524|526159892|FG005|LTSE Phase|Protocol Violation|1|||
145905494|NCT01544179|526159894|FG000|Overall Study|Death|50|||
145905495|NCT01544179|526159895|FG001|Overall Study|Death|37|||
145905496|NCT01544179|526159894|FG000|Overall Study|Lost to Follow-up|0|||
145905497|NCT01544179|526159895|FG001|Overall Study|Lost to Follow-up|1|||
145905498|NCT01544179|526159894|FG000|Overall Study|Adverse Event|0|||
145905499|NCT01544179|526159895|FG001|Overall Study|Adverse Event|1|||
145905500|NCT01544179|526159894|FG000|Overall Study|Withdrawal by Subject|12|||
145905501|NCT01544179|526159895|FG001|Overall Study|Withdrawal by Subject|7|||
145905502|NCT01544179|526159894|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
145905503|NCT01544179|526159895|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145905504|NCT03146962|526159898|FG000|Overall Study|Lost to Follow-up|1|||
145905505|NCT03146962|526159899|FG001|Overall Study|Lost to Follow-up|1|||
145905506|NCT03146962|526159900|FG002|Overall Study|Lost to Follow-up|0|||
145905507|NCT03146962|526159901|FG003|Overall Study|Lost to Follow-up|0|||
145905508|NCT03146962|526159902|FG004|Overall Study|Lost to Follow-up|0|||
145905509|NCT03146962|526159903|FG005|Overall Study|Lost to Follow-up|0|||
145905510|NCT03146962|526159904|FG006|Overall Study|Lost to Follow-up|0|||
145905511|NCT03146962|526159905|FG007|Overall Study|Lost to Follow-up|0|||
145905512|NCT03146962|526159906|FG008|Overall Study|Lost to Follow-up|0|||
145905513|NCT03146962|526159907|FG009|Overall Study|Lost to Follow-up|0|||
145905514|NCT03146962|526159898|FG000|Overall Study|Adverse Event|0|||
145905515|NCT03146962|526159899|FG001|Overall Study|Adverse Event|3|||
145905516|NCT03146962|526159900|FG002|Overall Study|Adverse Event|0|||
145905517|NCT03146962|526159901|FG003|Overall Study|Adverse Event|0|||
145905518|NCT03146962|526159902|FG004|Overall Study|Adverse Event|0|||
145905519|NCT03146962|526159903|FG005|Overall Study|Adverse Event|0|||
145905520|NCT03146962|526159904|FG006|Overall Study|Adverse Event|0|||
145905521|NCT03146962|526159905|FG007|Overall Study|Adverse Event|1|||
145905522|NCT03146962|526159906|FG008|Overall Study|Adverse Event|0|||
145905523|NCT03146962|526159907|FG009|Overall Study|Adverse Event|0|||
145905524|NCT03146962|526159898|FG000|Overall Study|Withdrawal by Subject|0|||
145905525|NCT03146962|526159899|FG001|Overall Study|Withdrawal by Subject|0|||
145905526|NCT03146962|526159900|FG002|Overall Study|Withdrawal by Subject|0|||
145905527|NCT03146962|526159901|FG003|Overall Study|Withdrawal by Subject|0|||
145905528|NCT03146962|526159902|FG004|Overall Study|Withdrawal by Subject|1|||
145905529|NCT03146962|526159903|FG005|Overall Study|Withdrawal by Subject|0|||
145905530|NCT03146962|526159904|FG006|Overall Study|Withdrawal by Subject|0|||
145905531|NCT03146962|526159905|FG007|Overall Study|Withdrawal by Subject|0|||
145905532|NCT03146962|526159906|FG008|Overall Study|Withdrawal by Subject|0|||
145905533|NCT03146962|526159907|FG009|Overall Study|Withdrawal by Subject|0|||
145905534|NCT03146962|526159898|FG000|Overall Study|Death|0|||
145905535|NCT03146962|526159899|FG001|Overall Study|Death|1|||
145905536|NCT03146962|526159900|FG002|Overall Study|Death|0|||
145905537|NCT03146962|526159901|FG003|Overall Study|Death|0|||
145972742|NCT04530344|526412757|FG002|Overall Study|Protocol Violation|0|||
145972743|NCT04530344|526412758|FG003|Overall Study|Protocol Violation|1|||
145905538|NCT03146962|526159902|FG004|Overall Study|Death|0|||
145905539|NCT03146962|526159903|FG005|Overall Study|Death|0|||
145905540|NCT03146962|526159904|FG006|Overall Study|Death|0|||
145905541|NCT03146962|526159905|FG007|Overall Study|Death|0|||
145905542|NCT03146962|526159906|FG008|Overall Study|Death|0|||
145905543|NCT03146962|526159907|FG009|Overall Study|Death|0|||
145905544|NCT03146962|526159898|FG000|Overall Study|COVID Precautions|1|||
145905545|NCT03146962|526159899|FG001|Overall Study|COVID Precautions|0|||
145905546|NCT03146962|526159900|FG002|Overall Study|COVID Precautions|0|||
145905547|NCT03146962|526159901|FG003|Overall Study|COVID Precautions|0|||
145905548|NCT03146962|526159902|FG004|Overall Study|COVID Precautions|0|||
145905549|NCT03146962|526159903|FG005|Overall Study|COVID Precautions|0|||
145905550|NCT03146962|526159904|FG006|Overall Study|COVID Precautions|0|||
145905551|NCT03146962|526159905|FG007|Overall Study|COVID Precautions|0|||
145905552|NCT03146962|526159906|FG008|Overall Study|COVID Precautions|0|||
145905553|NCT03146962|526159907|FG009|Overall Study|COVID Precautions|0|||
145905554|NCT03146962|526159898|FG000|Overall Study|Physician Decision|0|||
145905555|NCT03146962|526159899|FG001|Overall Study|Physician Decision|0|||
145905556|NCT03146962|526159900|FG002|Overall Study|Physician Decision|0|||
145905557|NCT03146962|526159901|FG003|Overall Study|Physician Decision|0|||
145905558|NCT03146962|526159902|FG004|Overall Study|Physician Decision|0|||
145905559|NCT03146962|526159903|FG005|Overall Study|Physician Decision|0|||
145905560|NCT03146962|526159904|FG006|Overall Study|Physician Decision|0|||
145905561|NCT03146962|526159905|FG007|Overall Study|Physician Decision|0|||
145905562|NCT03146962|526159906|FG008|Overall Study|Physician Decision|0|||
145905563|NCT03146962|526159907|FG009|Overall Study|Physician Decision|1|||
145905564|NCT03146962|526159898|FG000|Overall Study|Started New Treatment|0|||
145905565|NCT03146962|526159899|FG001|Overall Study|Started New Treatment|1|||
145905566|NCT03146962|526159900|FG002|Overall Study|Started New Treatment|0|||
145905567|NCT03146962|526159901|FG003|Overall Study|Started New Treatment|0|||
145905568|NCT03146962|526159902|FG004|Overall Study|Started New Treatment|0|||
145905569|NCT03146962|526159903|FG005|Overall Study|Started New Treatment|0|||
145905570|NCT03146962|526159904|FG006|Overall Study|Started New Treatment|0|||
145905571|NCT03146962|526159905|FG007|Overall Study|Started New Treatment|0|||
145905572|NCT03146962|526159906|FG008|Overall Study|Started New Treatment|0|||
145905573|NCT03146962|526159907|FG009|Overall Study|Started New Treatment|0|||
145905574|NCT00049530|526159908|FG000|Overall Study|Lack of Efficacy|25|||
145905575|NCT00049530|526159908|FG000|Overall Study|Adverse Event|2|||
145905576|NCT00049530|526159908|FG000|Overall Study|Death|1|||
145905577|NCT00049530|526159908|FG000|Overall Study|symptomatic deterioration|1|||
145905578|NCT00049530|526159908|FG000|Overall Study|ineligible|3|||
145905579|NCT02549027|526159912|FG000|Washout After Period 4|Withdrawal by Subject|0|||
145905580|NCT02549027|526159913|FG001|Washout After Period 4|Withdrawal by Subject|1|||
145905581|NCT02549027|526159914|FG002|Washout After Period 4|Withdrawal by Subject|1|||
145905582|NCT02549027|526159915|FG003|Washout After Period 4|Withdrawal by Subject|1|||
145905583|NCT02549027|526159916|FG004|Washout After Period 4|Withdrawal by Subject|0|||
145905584|NCT02549027|526159917|FG005|Washout After Period 4|Withdrawal by Subject|0|||
145905585|NCT02549027|526159912|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145905586|NCT02549027|526159913|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145905587|NCT02549027|526159914|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145905588|NCT02549027|526159915|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145905589|NCT02549027|526159916|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
145905590|NCT02549027|526159917|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145905591|NCT02186834|526159918|FG000|Dose Escalation|Death|0|||
145905592|NCT02186834|526159919|FG001|Dose Escalation|Death|0|||
145905593|NCT02186834|526159920|FG002|Dose Escalation|Death|0|||
145905594|NCT02186834|526159921|FG003|Dose Escalation|Death|1|||
145905595|NCT02186834|526159922|FG004|Dose Escalation|Death|0|||
145905596|NCT02186834|526159923|FG005|Dose Escalation|Death|0|||
145905597|NCT02186834|526159918|FG000|Treatment at RP2D|Died prior to treatment|0|||
145905598|NCT02186834|526159919|FG001|Treatment at RP2D|Died prior to treatment|0|||
145905599|NCT02186834|526159920|FG002|Treatment at RP2D|Died prior to treatment|0|||
145905600|NCT02186834|526159921|FG003|Treatment at RP2D|Died prior to treatment|0|||
145905601|NCT02186834|526159922|FG004|Treatment at RP2D|Died prior to treatment|0|||
145905602|NCT02186834|526159923|FG005|Treatment at RP2D|Died prior to treatment|1|||
145905603|NCT05384171|526159927|FG000|Overall Study|Lost to Follow-up|9|||
145905604|NCT05384171|526159928|FG001|Overall Study|Lost to Follow-up|9|||
145905605|NCT05384171|526159927|FG000|Overall Study|Withdrawal by Subject|3|||
145905606|NCT05384171|526159928|FG001|Overall Study|Withdrawal by Subject|0|||
145905607|NCT00749892|526159929|FG000|Overall Study|Withdrawal by Subject|3|||
145905608|NCT04581369|526159930|FG000|Overall Study|Death|7|||
145905609|NCT04581369|526159931|FG001|Overall Study|Death|6|||
145905610|NCT04581369|526159932|FG002|Overall Study|Death|0|||
145905611|NCT04581369|526159930|FG000|Overall Study|Lost to Follow-up|7|||
145905612|NCT04581369|526159931|FG001|Overall Study|Lost to Follow-up|3|||
145905613|NCT04581369|526159932|FG002|Overall Study|Lost to Follow-up|0|||
145905614|NCT04581369|526159930|FG000|Overall Study|liver transplant|2|||
145905615|NCT04581369|526159931|FG001|Overall Study|liver transplant|2|||
145905616|NCT04581369|526159932|FG002|Overall Study|liver transplant|0|||
145905617|NCT04581369|526159930|FG000|Overall Study|transitioned to hospice care|0|||
145905618|NCT04581369|526159931|FG001|Overall Study|transitioned to hospice care|5|||
145905619|NCT04581369|526159932|FG002|Overall Study|transitioned to hospice care|0|||
145905620|NCT00780910|526159933|FG000|Overall Study|Adverse Event|2|||
145905621|NCT01111825|526159935|FG000|Overall Study|Withdrawal by Subject|0|||
145905622|NCT01111825|526159936|FG001|Overall Study|Withdrawal by Subject|0|||
145905623|NCT01111825|526159937|FG002|Overall Study|Withdrawal by Subject|1|||
146239037|NCT03070392|527389658|FG001|Overall Study|Ongoing|0|||
145905624|NCT01111825|526159938|FG003|Overall Study|Withdrawal by Subject|0|||
145905625|NCT01111825|526159935|FG000|Overall Study|Lost to Follow-up|0|||
145905626|NCT01111825|526159936|FG001|Overall Study|Lost to Follow-up|0|||
145905627|NCT01111825|526159937|FG002|Overall Study|Lost to Follow-up|3|||
145905628|NCT01111825|526159938|FG003|Overall Study|Lost to Follow-up|1|||
145905629|NCT01111825|526159935|FG000|Overall Study|Adverse Event|2|||
145905630|NCT01111825|526159936|FG001|Overall Study|Adverse Event|1|||
145905631|NCT01111825|526159937|FG002|Overall Study|Adverse Event|4|||
145905632|NCT01111825|526159938|FG003|Overall Study|Adverse Event|0|||
145905633|NCT01111825|526159935|FG000|Overall Study|Disease Progression|1|||
145905634|NCT01111825|526159936|FG001|Overall Study|Disease Progression|0|||
145905635|NCT01111825|526159937|FG002|Overall Study|Disease Progression|0|||
145905636|NCT01111825|526159938|FG003|Overall Study|Disease Progression|0|||
145905637|NCT01111825|526159935|FG000|Overall Study|Discontinuation by Sponsor|0|||
145905638|NCT01111825|526159936|FG001|Overall Study|Discontinuation by Sponsor|0|||
145905639|NCT01111825|526159937|FG002|Overall Study|Discontinuation by Sponsor|0|||
145905640|NCT01111825|526159938|FG003|Overall Study|Discontinuation by Sponsor|20|||
145905641|NCT00106964|526159939|FG000|Overall Study|Lost to Follow-up|8|||
145905642|NCT00106964|526159940|FG001|Overall Study|Lost to Follow-up|6|||
145905643|NCT00106964|526159941|FG002|Overall Study|Lost to Follow-up|2|||
145905644|NCT00106964|526159939|FG000|Overall Study|Pregnancy|2|||
145905645|NCT00106964|526159940|FG001|Overall Study|Pregnancy|3|||
145905646|NCT00106964|526159941|FG002|Overall Study|Pregnancy|2|||
145905647|NCT00106964|526159939|FG000|Overall Study|Death|1|||
145905648|NCT00106964|526159940|FG001|Overall Study|Death|1|||
145905649|NCT00106964|526159941|FG002|Overall Study|Death|0|||
145905650|NCT00106964|526159939|FG000|Overall Study|Incarceration|0|||
145905651|NCT00106964|526159940|FG001|Overall Study|Incarceration|1|||
145905652|NCT00106964|526159941|FG002|Overall Study|Incarceration|0|||
145905653|NCT00106964|526159939|FG000|Overall Study|Site Funding Terminated|0|||
145905654|NCT00106964|526159940|FG001|Overall Study|Site Funding Terminated|1|||
145905655|NCT00106964|526159941|FG002|Overall Study|Site Funding Terminated|1|||
145905656|NCT00106964|526159939|FG000|Overall Study|Failure to adhere|2|||
145905657|NCT00106964|526159940|FG001|Overall Study|Failure to adhere|0|||
145905658|NCT00106964|526159941|FG002|Overall Study|Failure to adhere|0|||
145905659|NCT00106964|526159939|FG000|Overall Study|Did not meet eligibility criteria|0|||
145905660|NCT00106964|526159940|FG001|Overall Study|Did not meet eligibility criteria|2|||
145905661|NCT00106964|526159941|FG002|Overall Study|Did not meet eligibility criteria|2|||
145905662|NCT00106964|526159939|FG000|Overall Study|Required disallowed medication|0|||
145905663|NCT00106964|526159940|FG001|Overall Study|Required disallowed medication|1|||
145905664|NCT00106964|526159941|FG002|Overall Study|Required disallowed medication|0|||
145905665|NCT04746794|526159942|FG000|Overall Study|Did not complete any study assessment|50303|||
145905666|NCT04746794|526159943|FG001|Overall Study|Did not complete any study assessment|44997|||
145905667|NCT01422187|526159948|FG000|Overall Study|Personal reason|1|||
145905668|NCT01422187|526159949|FG001|Overall Study|Personal reason|0|||
145905669|NCT01422187|526159950|FG002|Overall Study|Personal reason|0|||
145905670|NCT01422187|526159948|FG000|Overall Study|Lost to Follow-up|0|||
145905671|NCT01422187|526159949|FG001|Overall Study|Lost to Follow-up|1|||
145905672|NCT01422187|526159950|FG002|Overall Study|Lost to Follow-up|0|||
145905673|NCT00168818|526159951|FG000|Overall Study|Adverse Event|23|||
145905674|NCT00168818|526159952|FG001|Overall Study|Adverse Event|29|||
145905675|NCT00168818|526159953|FG002|Overall Study|Adverse Event|31|||
145905676|NCT00168818|526159951|FG000|Overall Study|Protocol Violation|16|||
145905677|NCT00168818|526159952|FG001|Overall Study|Protocol Violation|11|||
145905678|NCT00168818|526159953|FG002|Overall Study|Protocol Violation|11|||
145905679|NCT00168818|526159951|FG000|Overall Study|Lost to Follow-up|13|||
145905680|NCT00168818|526159952|FG001|Overall Study|Lost to Follow-up|4|||
145905681|NCT00168818|526159953|FG002|Overall Study|Lost to Follow-up|15|||
145905682|NCT00168818|526159951|FG000|Overall Study|Withdrawal by Subject|43|||
145905683|NCT00168818|526159952|FG001|Overall Study|Withdrawal by Subject|41|||
145905684|NCT00168818|526159953|FG002|Overall Study|Withdrawal by Subject|37|||
145905685|NCT00168818|526159951|FG000|Overall Study|Other|22|||
145905686|NCT00168818|526159952|FG001|Overall Study|Other|24|||
145972744|NCT04530344|526412755|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
145972745|NCT04530344|526412756|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
145972746|NCT04530344|526412757|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
145972747|NCT04530344|526412758|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
146297389|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
145905687|NCT00168818|526159953|FG002|Overall Study|Other|30|||
145905688|NCT00168818|526159951|FG000|Treatment|Adverse Event|77|||
145905689|NCT00168818|526159952|FG001|Treatment|Adverse Event|89|||
145905690|NCT00168818|526159953|FG002|Treatment|Adverse Event|68|||
145905691|NCT00168818|526159951|FG000|Treatment|Protocol Violation|8|||
145905692|NCT00168818|526159952|FG001|Treatment|Protocol Violation|11|||
145905693|NCT00168818|526159953|FG002|Treatment|Protocol Violation|11|||
145905694|NCT00168818|526159951|FG000|Treatment|Lost to Follow-up|0|||
145905695|NCT00168818|526159952|FG001|Treatment|Lost to Follow-up|2|||
145905696|NCT00168818|526159953|FG002|Treatment|Lost to Follow-up|1|||
145905697|NCT00168818|526159951|FG000|Treatment|Withdrawal by Subject|25|||
145905698|NCT00168818|526159952|FG001|Treatment|Withdrawal by Subject|20|||
145905699|NCT00168818|526159953|FG002|Treatment|Withdrawal by Subject|22|||
145905700|NCT00168818|526159951|FG000|Treatment|Other|23|||
145905701|NCT00168818|526159952|FG001|Treatment|Other|29|||
145905702|NCT00168818|526159953|FG002|Treatment|Other|31|||
145905703|NCT02538965|526159960|FG000|Treatment Period|Other = Death due to disease progression|1|||
145905704|NCT02538965|526159960|FG000|Treatment Period|Adverse Event|2|||
145905705|NCT02538965|526159960|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
145905706|NCT02538965|526159960|FG000|Treatment Period|Treatment Failure|9|||
145905707|NCT02538965|526159960|FG000|Treatment Period|Disease Progression|1|||
145905708|NCT02538965|526159960|FG000|Treatment Period|Physician Decision|2|||
145905709|NCT02538965|526159960|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
145905710|NCT02538965|526159960|FG000|Follow-Up Period|Withdrawal by Parent|4|||
145905711|NCT00875797|526159961|FG000|Overall Study|Protocol Violation|6|||
145905712|NCT00875797|526159962|FG001|Overall Study|Protocol Violation|3|||
145905713|NCT01590797|526159967|FG000|Overall Study|Adverse Event|4|||
145905714|NCT01590797|526159968|FG001|Overall Study|Adverse Event|3|||
145905715|NCT01590797|526159967|FG000|Overall Study|Lack of Efficacy|0|||
145905716|NCT01590797|526159968|FG001|Overall Study|Lack of Efficacy|2|||
145905717|NCT01590797|526159967|FG000|Overall Study|Lost to Follow-up|0|||
145905718|NCT01590797|526159968|FG001|Overall Study|Lost to Follow-up|1|||
145905719|NCT01590797|526159967|FG000|Overall Study|Protocol Violation|4|||
145905720|NCT01590797|526159968|FG001|Overall Study|Protocol Violation|1|||
145905721|NCT01590797|526159967|FG000|Overall Study|Withdrawal by Subject|7|||
145905722|NCT01590797|526159968|FG001|Overall Study|Withdrawal by Subject|5|||
145905723|NCT01590797|526159967|FG000|Overall Study|Other Protocol Specified Criteria|2|||
145905724|NCT01590797|526159968|FG001|Overall Study|Other Protocol Specified Criteria|4|||
145905725|NCT00195338|526159976|FG000|Overall Study|Lost to Follow-up|2|||
145905726|NCT00195338|526159976|FG000|Overall Study|Adverse Event|5|||
145905727|NCT00195338|526159976|FG000|Overall Study|Lack of Efficacy|1|||
145905728|NCT00195338|526159976|FG000|Overall Study|Early closure of the site|4|||
145905729|NCT00811928|526159977|FG000|Overall Study|AEs and SAEs Including Death|7|||
145905730|NCT00811928|526159978|FG001|Overall Study|AEs and SAEs Including Death|11|||
145905731|NCT00811928|526159977|FG000|Overall Study|Withdrawal by Subject|18|||
145905732|NCT00811928|526159978|FG001|Overall Study|Withdrawal by Subject|12|||
145905733|NCT00811928|526159977|FG000|Overall Study|Did Not Take Study Drug|3|||
145905734|NCT00811928|526159978|FG001|Overall Study|Did Not Take Study Drug|0|||
145905735|NCT00811928|526159977|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
146239038|NCT03070392|527389659|FG002|Overall Study|Ongoing|0|||
146239039|NCT03070392|527389660|FG003|Overall Study|Ongoing|11|||
146239040|NCT02972034|527389661|FG000|Overall Study|Death|11|||
146239041|NCT02972034|527389662|FG001|Overall Study|Death|1|||
146239042|NCT02972034|527389663|FG002|Overall Study|Death|3|||
146239043|NCT02972034|527389664|FG003|Overall Study|Death|3|||
146239044|NCT02972034|527389665|FG004|Overall Study|Death|2|||
146239045|NCT02972034|527389666|FG005|Overall Study|Death|2|||
146239046|NCT02972034|527389667|FG006|Overall Study|Death|3|||
146239047|NCT02972034|527389668|FG007|Overall Study|Death|4|||
146239048|NCT02972034|527389669|FG008|Overall Study|Death|8|||
146239049|NCT02972034|527389670|FG009|Overall Study|Death|11|||
146239050|NCT02972034|527389671|FG010|Overall Study|Death|3|||
146239051|NCT02972034|527389672|FG011|Overall Study|Death|2|||
146239052|NCT02972034|527389673|FG012|Overall Study|Death|11|||
146239053|NCT02972034|527389674|FG013|Overall Study|Death|10|||
146239054|NCT02972034|527389675|FG014|Overall Study|Death|9|||
146239055|NCT02972034|527389661|FG000|Overall Study|Lost to Follow-up|0|||
146239056|NCT02972034|527389662|FG001|Overall Study|Lost to Follow-up|0|||
146239057|NCT02972034|527389663|FG002|Overall Study|Lost to Follow-up|0|||
146239058|NCT02972034|527389664|FG003|Overall Study|Lost to Follow-up|0|||
146239059|NCT02972034|527389665|FG004|Overall Study|Lost to Follow-up|1|||
145905736|NCT00811928|526159978|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
145905737|NCT00811928|526159977|FG000|Overall Study|Investigator Decision|2|||
145905738|NCT00811928|526159978|FG001|Overall Study|Investigator Decision|1|||
145905739|NCT00811928|526159977|FG000|Overall Study|Poor Compliance|2|||
145905740|NCT00811928|526159978|FG001|Overall Study|Poor Compliance|5|||
145905741|NCT00314951|526159979|FG000|Treatment|Didn't meet criteria for mITT population|16|||
145972748|NCT04530344|526412755|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145972749|NCT04530344|526412756|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145972750|NCT04530344|526412757|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
146239060|NCT02972034|527389666|FG005|Overall Study|Lost to Follow-up|0|||
146239061|NCT02972034|527389667|FG006|Overall Study|Lost to Follow-up|0|||
145905742|NCT00314951|526159980|FG001|Treatment|Didn't meet criteria for mITT population|11|||
146239062|NCT02972034|527389668|FG007|Overall Study|Lost to Follow-up|1|||
145905743|NCT00314951|526159979|FG000|Follow-up|mITT failure|44|||
145905744|NCT00314951|526159980|FG001|Follow-up|mITT failure|34|||
145905745|NCT03503864|526159983|FG000|Overall Study|Protocol Violation|6|||
145905746|NCT03503864|526159983|FG000|Overall Study|Withdrawal by Subject|7|||
146239063|NCT02972034|527389669|FG008|Overall Study|Lost to Follow-up|0|||
146239064|NCT02972034|527389670|FG009|Overall Study|Lost to Follow-up|0|||
146239065|NCT02972034|527389671|FG010|Overall Study|Lost to Follow-up|0|||
146239066|NCT02972034|527389672|FG011|Overall Study|Lost to Follow-up|0|||
146239067|NCT02972034|527389673|FG012|Overall Study|Lost to Follow-up|0|||
145905747|NCT00468650|526159984|FG000|Overall Study|Lost to Follow-up|4|||
145905748|NCT00468650|526159984|FG000|Overall Study|Withdrawal by Subject|2|||
145905749|NCT00468650|526159984|FG000|Overall Study|Protocol Violation|1|||
145905750|NCT02087189|526159985|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
145905751|NCT00642278|526159988|FG000|Overall Study|Adverse Event|2|||
145905752|NCT00642278|526159989|FG001|Overall Study|Adverse Event|1|||
145905753|NCT00642278|526159990|FG002|Overall Study|Adverse Event|3|||
145905754|NCT00642278|526159991|FG003|Overall Study|Adverse Event|1|||
145905755|NCT00642278|526159992|FG004|Overall Study|Adverse Event|2|||
145905756|NCT00642278|526159993|FG005|Overall Study|Adverse Event|2|||
145905757|NCT00642278|526159994|FG006|Overall Study|Adverse Event|0|||
145905758|NCT00642278|526159988|FG000|Overall Study|Lack of Efficacy|0|||
145905759|NCT00642278|526159989|FG001|Overall Study|Lack of Efficacy|1|||
145905760|NCT00642278|526159990|FG002|Overall Study|Lack of Efficacy|0|||
145905761|NCT00642278|526159991|FG003|Overall Study|Lack of Efficacy|0|||
145905762|NCT00642278|526159992|FG004|Overall Study|Lack of Efficacy|0|||
145905763|NCT00642278|526159993|FG005|Overall Study|Lack of Efficacy|0|||
145905764|NCT00642278|526159994|FG006|Overall Study|Lack of Efficacy|0|||
145905765|NCT00642278|526159988|FG000|Overall Study|Lost to Follow-up|5|||
145905766|NCT00642278|526159989|FG001|Overall Study|Lost to Follow-up|1|||
145905767|NCT00642278|526159990|FG002|Overall Study|Lost to Follow-up|0|||
145905768|NCT00642278|526159991|FG003|Overall Study|Lost to Follow-up|1|||
145905769|NCT00642278|526159992|FG004|Overall Study|Lost to Follow-up|0|||
145905770|NCT00642278|526159993|FG005|Overall Study|Lost to Follow-up|1|||
145905771|NCT00642278|526159994|FG006|Overall Study|Lost to Follow-up|1|||
145905772|NCT00642278|526159988|FG000|Overall Study|Physician Decision|0|||
145905773|NCT00642278|526159989|FG001|Overall Study|Physician Decision|0|||
145905774|NCT00642278|526159990|FG002|Overall Study|Physician Decision|0|||
145905775|NCT00642278|526159991|FG003|Overall Study|Physician Decision|1|||
145905776|NCT00642278|526159992|FG004|Overall Study|Physician Decision|0|||
145905777|NCT00642278|526159993|FG005|Overall Study|Physician Decision|0|||
145905778|NCT00642278|526159994|FG006|Overall Study|Physician Decision|0|||
145905779|NCT00642278|526159988|FG000|Overall Study|Protocol Violation|0|||
145905780|NCT00642278|526159989|FG001|Overall Study|Protocol Violation|0|||
145905781|NCT00642278|526159990|FG002|Overall Study|Protocol Violation|1|||
145905782|NCT00642278|526159991|FG003|Overall Study|Protocol Violation|1|||
145905783|NCT00642278|526159992|FG004|Overall Study|Protocol Violation|0|||
145905784|NCT00642278|526159993|FG005|Overall Study|Protocol Violation|1|||
145905785|NCT00642278|526159994|FG006|Overall Study|Protocol Violation|2|||
145905786|NCT00642278|526159988|FG000|Overall Study|Withdrawal by Subject|1|||
145905787|NCT00642278|526159989|FG001|Overall Study|Withdrawal by Subject|1|||
145905788|NCT00642278|526159990|FG002|Overall Study|Withdrawal by Subject|1|||
145905789|NCT00642278|526159991|FG003|Overall Study|Withdrawal by Subject|3|||
145905790|NCT00642278|526159992|FG004|Overall Study|Withdrawal by Subject|6|||
145905791|NCT00642278|526159993|FG005|Overall Study|Withdrawal by Subject|2|||
145905792|NCT00642278|526159994|FG006|Overall Study|Withdrawal by Subject|2|||
145905793|NCT00642278|526159988|FG000|Overall Study|Noncompliance with study drug regimen|0|||
145905794|NCT00642278|526159989|FG001|Overall Study|Noncompliance with study drug regimen|0|||
145905795|NCT00642278|526159990|FG002|Overall Study|Noncompliance with study drug regimen|0|||
145905796|NCT00642278|526159991|FG003|Overall Study|Noncompliance with study drug regimen|1|||
145905797|NCT00642278|526159992|FG004|Overall Study|Noncompliance with study drug regimen|0|||
146239068|NCT02972034|527389674|FG013|Overall Study|Lost to Follow-up|0|||
146239069|NCT02972034|527389675|FG014|Overall Study|Lost to Follow-up|1|||
146239070|NCT02972034|527389661|FG000|Overall Study|Physician Decision|0|||
145905798|NCT00642278|526159993|FG005|Overall Study|Noncompliance with study drug regimen|0|||
145905799|NCT00642278|526159994|FG006|Overall Study|Noncompliance with study drug regimen|0|||
146239071|NCT02972034|527389662|FG001|Overall Study|Physician Decision|0|||
146239072|NCT02972034|527389663|FG002|Overall Study|Physician Decision|0|||
146239073|NCT02972034|527389664|FG003|Overall Study|Physician Decision|0|||
146239074|NCT02972034|527389665|FG004|Overall Study|Physician Decision|0|||
146239075|NCT02972034|527389666|FG005|Overall Study|Physician Decision|0|||
146239076|NCT02972034|527389667|FG006|Overall Study|Physician Decision|0|||
146239077|NCT02972034|527389668|FG007|Overall Study|Physician Decision|1|||
146239078|NCT02972034|527389669|FG008|Overall Study|Physician Decision|0|||
146239079|NCT02972034|527389670|FG009|Overall Study|Physician Decision|0|||
146297390|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
145905800|NCT00642278|526159988|FG000|Overall Study|Other|2|||
145905801|NCT00642278|526159989|FG001|Overall Study|Other|1|||
145905802|NCT00642278|526159990|FG002|Overall Study|Other|0|||
145905803|NCT00642278|526159991|FG003|Overall Study|Other|1|||
145905804|NCT00642278|526159992|FG004|Overall Study|Other|0|||
145905805|NCT00642278|526159993|FG005|Overall Study|Other|1|||
145905806|NCT00642278|526159994|FG006|Overall Study|Other|0|||
145905807|NCT00090363|526159995|FG000|Overall Study|Lost to Follow-up|1|||
145972751|NCT04530344|526412758|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145905808|NCT00090363|526159996|FG001|Overall Study|Lost to Follow-up|2|||
145905809|NCT00090363|526159997|FG002|Overall Study|Lost to Follow-up|1|||
146239080|NCT02972034|527389671|FG010|Overall Study|Physician Decision|1|||
146239081|NCT02972034|527389672|FG011|Overall Study|Physician Decision|0|||
145905810|NCT00090363|526159995|FG000|Overall Study|Withdrawal by Subject|7|||
145905811|NCT00090363|526159996|FG001|Overall Study|Withdrawal by Subject|7|||
145905812|NCT00090363|526159997|FG002|Overall Study|Withdrawal by Subject|6|||
145905813|NCT00090363|526159995|FG000|Overall Study|Study-specific discontinuation criteria|75|||
145905814|NCT00090363|526159996|FG001|Overall Study|Study-specific discontinuation criteria|74|||
145905815|NCT00090363|526159997|FG002|Overall Study|Study-specific discontinuation criteria|62|||
145905816|NCT00090363|526159995|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145905817|NCT00090363|526159996|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145905818|NCT00090363|526159997|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145905819|NCT00090363|526159995|FG000|Overall Study|Consent expired|7|||
145905820|NCT00090363|526159996|FG001|Overall Study|Consent expired|10|||
145905821|NCT00090363|526159997|FG002|Overall Study|Consent expired|9|||
145905822|NCT00090363|526159995|FG000|Overall Study|Reasons not specified|2|||
145905823|NCT00090363|526159996|FG001|Overall Study|Reasons not specified|1|||
145905824|NCT00090363|526159997|FG002|Overall Study|Reasons not specified|1|||
145905825|NCT00090363|526159995|FG000|Overall Study|Continuing on study off treatment|14|||
145905826|NCT00090363|526159996|FG001|Overall Study|Continuing on study off treatment|13|||
145905827|NCT00090363|526159997|FG002|Overall Study|Continuing on study off treatment|16|||
145905828|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145905829|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145905830|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
145905831|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145905832|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145905833|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
145905834|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145905835|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145905836|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145905837|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145905838|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145905839|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145905840|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145905841|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
145905842|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
145905843|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145905844|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145905845|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145905846|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145905847|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
146239082|NCT02972034|527389673|FG012|Overall Study|Physician Decision|0|||
146239083|NCT02972034|527389674|FG013|Overall Study|Physician Decision|0|||
146239084|NCT02972034|527389675|FG014|Overall Study|Physician Decision|0|||
146239085|NCT02972034|527389661|FG000|Overall Study|Sponsor Decision|0|||
146239086|NCT02972034|527389662|FG001|Overall Study|Sponsor Decision|0|||
146239087|NCT02972034|527389663|FG002|Overall Study|Sponsor Decision|0|||
146239088|NCT02972034|527389664|FG003|Overall Study|Sponsor Decision|1|||
146239089|NCT02972034|527389665|FG004|Overall Study|Sponsor Decision|0|||
146239090|NCT02972034|527389666|FG005|Overall Study|Sponsor Decision|0|||
146239091|NCT02972034|527389667|FG006|Overall Study|Sponsor Decision|1|||
146239092|NCT02972034|527389668|FG007|Overall Study|Sponsor Decision|1|||
146239093|NCT02972034|527389669|FG008|Overall Study|Sponsor Decision|1|||
146239094|NCT02972034|527389670|FG009|Overall Study|Sponsor Decision|2|||
146239095|NCT02972034|527389671|FG010|Overall Study|Sponsor Decision|2|||
146239096|NCT02972034|527389672|FG011|Overall Study|Sponsor Decision|0|||
146239097|NCT02972034|527389673|FG012|Overall Study|Sponsor Decision|1|||
146239098|NCT02972034|527389674|FG013|Overall Study|Sponsor Decision|0|||
146239099|NCT02972034|527389675|FG014|Overall Study|Sponsor Decision|1|||
146239100|NCT02972034|527389661|FG000|Overall Study|Withdrawal by Subject|3|||
146239101|NCT02972034|527389662|FG001|Overall Study|Withdrawal by Subject|0|||
146239102|NCT02972034|527389663|FG002|Overall Study|Withdrawal by Subject|0|||
145905848|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
145905849|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
145905850|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
145905851|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
146239103|NCT02972034|527389664|FG003|Overall Study|Withdrawal by Subject|0|||
146239104|NCT02972034|527389665|FG004|Overall Study|Withdrawal by Subject|1|||
146239105|NCT02972034|527389666|FG005|Overall Study|Withdrawal by Subject|1|||
146239106|NCT02972034|527389667|FG006|Overall Study|Withdrawal by Subject|0|||
146239107|NCT02972034|527389668|FG007|Overall Study|Withdrawal by Subject|0|||
146239108|NCT02972034|527389669|FG008|Overall Study|Withdrawal by Subject|1|||
146239109|NCT02972034|527389670|FG009|Overall Study|Withdrawal by Subject|1|||
146239110|NCT02972034|527389671|FG010|Overall Study|Withdrawal by Subject|2|||
146239111|NCT02972034|527389672|FG011|Overall Study|Withdrawal by Subject|1|||
145905852|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145905853|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145905854|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145905855|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
145905856|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145905857|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145905858|NCT03713619|526160000|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
145905859|NCT03713619|526160001|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
145905860|NCT03713619|526160002|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145905861|NCT03713619|526160003|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145905862|NCT03713619|526160004|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145905863|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
145905864|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
145905865|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
145905866|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
145905867|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
145905868|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145905869|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145905870|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145905871|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145905872|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145905873|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
145905874|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
145905875|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
145905876|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
145905877|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
145905878|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
145905879|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
145905880|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
145905881|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
145905882|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
145905883|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
145905884|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
145905885|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145905886|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
145905887|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
145905888|NCT03713619|526160000|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145905889|NCT03713619|526160001|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145905890|NCT03713619|526160002|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145905891|NCT03713619|526160003|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145905892|NCT03713619|526160004|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145905893|NCT04642365|526160006|FG000|Overall Study|Death|3|||
145905894|NCT04642365|526160007|FG001|Overall Study|Death|2|||
145905895|NCT04642365|526160008|FG002|Overall Study|Death|4|||
145905896|NCT04642365|526160009|FG003|Overall Study|Death|5|||
145905897|NCT04642365|526160010|FG004|Overall Study|Death|5|||
145905898|NCT04642365|526160011|FG005|Overall Study|Death|3|||
145905899|NCT04642365|526160012|FG006|Overall Study|Death|2|||
145905900|NCT04642365|526160013|FG007|Overall Study|Death|1|||
145905901|NCT04642365|526160006|FG000|Overall Study|Physician Decision|1|||
145905902|NCT04642365|526160007|FG001|Overall Study|Physician Decision|0|||
145905903|NCT04642365|526160008|FG002|Overall Study|Physician Decision|0|||
145905904|NCT04642365|526160009|FG003|Overall Study|Physician Decision|0|||
145905905|NCT04642365|526160010|FG004|Overall Study|Physician Decision|0|||
145905906|NCT04642365|526160011|FG005|Overall Study|Physician Decision|0|||
145905907|NCT04642365|526160012|FG006|Overall Study|Physician Decision|0|||
145905908|NCT04642365|526160013|FG007|Overall Study|Physician Decision|0|||
146239112|NCT02972034|527389673|FG012|Overall Study|Withdrawal by Subject|1|||
146239113|NCT02972034|527389674|FG013|Overall Study|Withdrawal by Subject|1|||
146239114|NCT02972034|527389675|FG014|Overall Study|Withdrawal by Subject|0|||
146239115|NCT02972034|527389661|FG000|Overall Study|Screen Failure|0|||
146239116|NCT02972034|527389662|FG001|Overall Study|Screen Failure|0|||
146239117|NCT02972034|527389663|FG002|Overall Study|Screen Failure|0|||
146239118|NCT02972034|527389664|FG003|Overall Study|Screen Failure|0|||
145905909|NCT04642365|526160006|FG000|Overall Study|Progressive Disease|1|||
145905910|NCT04642365|526160007|FG001|Overall Study|Progressive Disease|1|||
145972752|NCT04530344|526412755|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
145972753|NCT04530344|526412756|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
146239119|NCT02972034|527389665|FG004|Overall Study|Screen Failure|0|||
145905911|NCT04642365|526160008|FG002|Overall Study|Progressive Disease|1|||
146239120|NCT02972034|527389666|FG005|Overall Study|Screen Failure|0|||
146239121|NCT02972034|527389667|FG006|Overall Study|Screen Failure|0|||
146297391|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
145905912|NCT04642365|526160009|FG003|Overall Study|Progressive Disease|0|||
145905913|NCT04642365|526160010|FG004|Overall Study|Progressive Disease|0|||
145905914|NCT04642365|526160011|FG005|Overall Study|Progressive Disease|0|||
145905915|NCT04642365|526160012|FG006|Overall Study|Progressive Disease|1|||
145905916|NCT04642365|526160013|FG007|Overall Study|Progressive Disease|0|||
145905917|NCT04642365|526160006|FG000|Overall Study|Study Terminated By Sponsor|0|||
145905918|NCT04642365|526160007|FG001|Overall Study|Study Terminated By Sponsor|2|||
145905919|NCT04642365|526160008|FG002|Overall Study|Study Terminated By Sponsor|1|||
145905920|NCT04642365|526160009|FG003|Overall Study|Study Terminated By Sponsor|1|||
145905921|NCT04642365|526160010|FG004|Overall Study|Study Terminated By Sponsor|1|||
145905922|NCT04642365|526160011|FG005|Overall Study|Study Terminated By Sponsor|2|||
145905923|NCT04642365|526160012|FG006|Overall Study|Study Terminated By Sponsor|2|||
145905924|NCT04642365|526160013|FG007|Overall Study|Study Terminated By Sponsor|1|||
145905925|NCT04642365|526160006|FG000|Overall Study|Symptomatic Deterioration|1|||
145905926|NCT04642365|526160007|FG001|Overall Study|Symptomatic Deterioration|1|||
145905927|NCT04642365|526160008|FG002|Overall Study|Symptomatic Deterioration|0|||
145905928|NCT04642365|526160009|FG003|Overall Study|Symptomatic Deterioration|0|||
145905929|NCT04642365|526160010|FG004|Overall Study|Symptomatic Deterioration|0|||
145905930|NCT04642365|526160011|FG005|Overall Study|Symptomatic Deterioration|1|||
145905931|NCT04642365|526160012|FG006|Overall Study|Symptomatic Deterioration|0|||
145905932|NCT04642365|526160013|FG007|Overall Study|Symptomatic Deterioration|0|||
145905933|NCT04642365|526160006|FG000|Overall Study|Withdrawal by Subject|0|||
145905934|NCT04642365|526160007|FG001|Overall Study|Withdrawal by Subject|0|||
145905935|NCT04642365|526160008|FG002|Overall Study|Withdrawal by Subject|1|||
145905936|NCT04642365|526160009|FG003|Overall Study|Withdrawal by Subject|1|||
145905937|NCT04642365|526160010|FG004|Overall Study|Withdrawal by Subject|0|||
145905938|NCT04642365|526160011|FG005|Overall Study|Withdrawal by Subject|0|||
145905939|NCT04642365|526160012|FG006|Overall Study|Withdrawal by Subject|2|||
145905940|NCT04642365|526160013|FG007|Overall Study|Withdrawal by Subject|0|||
145905941|NCT04642365|526160006|FG000|Overall Study|Adverse Event|0|||
145905942|NCT04642365|526160007|FG001|Overall Study|Adverse Event|0|||
145905943|NCT04642365|526160008|FG002|Overall Study|Adverse Event|0|||
146088438|NCT02011893|526843845|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
146088439|NCT02011893|526843846|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
146088440|NCT02011893|526843847|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
146239122|NCT02972034|527389668|FG007|Overall Study|Screen Failure|0|||
145905944|NCT04642365|526160009|FG003|Overall Study|Adverse Event|0|||
145905945|NCT04642365|526160010|FG004|Overall Study|Adverse Event|0|||
145905946|NCT04642365|526160011|FG005|Overall Study|Adverse Event|0|||
145905947|NCT04642365|526160012|FG006|Overall Study|Adverse Event|0|||
145905948|NCT04642365|526160013|FG007|Overall Study|Adverse Event|1|||
145905949|NCT00673387|526160015|FG000|Overall Study|Withdrawal by Subject|15|||
145905950|NCT00673387|526160016|FG001|Overall Study|Withdrawal by Subject|16|||
145905951|NCT00673387|526160017|FG002|Overall Study|Withdrawal by Subject|20|||
145905952|NCT00673387|526160018|FG003|Overall Study|Withdrawal by Subject|16|||
145905953|NCT00673387|526160019|FG004|Overall Study|Withdrawal by Subject|18|||
145905954|NCT00673387|526160020|FG005|Overall Study|Withdrawal by Subject|21|||
145905955|NCT00673387|526160021|FG006|Overall Study|Withdrawal by Subject|15|||
145905956|NCT00673387|526160022|FG007|Overall Study|Withdrawal by Subject|21|||
145905957|NCT00673387|526160015|FG000|Overall Study|Adverse Event|3|||
145905958|NCT00673387|526160016|FG001|Overall Study|Adverse Event|1|||
145905959|NCT00673387|526160017|FG002|Overall Study|Adverse Event|5|||
145905960|NCT00673387|526160018|FG003|Overall Study|Adverse Event|2|||
145905961|NCT00673387|526160019|FG004|Overall Study|Adverse Event|6|||
145905962|NCT00673387|526160020|FG005|Overall Study|Adverse Event|2|||
145905963|NCT00673387|526160021|FG006|Overall Study|Adverse Event|5|||
145905964|NCT00673387|526160022|FG007|Overall Study|Adverse Event|5|||
145905965|NCT00673387|526160015|FG000|Overall Study|Physician Decision|0|||
145905966|NCT00673387|526160016|FG001|Overall Study|Physician Decision|0|||
145905967|NCT00673387|526160017|FG002|Overall Study|Physician Decision|0|||
145905968|NCT00673387|526160018|FG003|Overall Study|Physician Decision|0|||
145905969|NCT00673387|526160019|FG004|Overall Study|Physician Decision|0|||
145905970|NCT00673387|526160020|FG005|Overall Study|Physician Decision|5|||
145905971|NCT00673387|526160021|FG006|Overall Study|Physician Decision|1|||
145905972|NCT00673387|526160022|FG007|Overall Study|Physician Decision|1|||
145905973|NCT00673387|526160015|FG000|Overall Study|Protocol Violation|3|||
145905974|NCT00673387|526160016|FG001|Overall Study|Protocol Violation|0|||
145905975|NCT00673387|526160017|FG002|Overall Study|Protocol Violation|1|||
145905976|NCT00673387|526160018|FG003|Overall Study|Protocol Violation|2|||
145905977|NCT00673387|526160019|FG004|Overall Study|Protocol Violation|0|||
145905978|NCT00673387|526160020|FG005|Overall Study|Protocol Violation|1|||
145905979|NCT00673387|526160021|FG006|Overall Study|Protocol Violation|1|||
145905980|NCT00673387|526160022|FG007|Overall Study|Protocol Violation|3|||
146239123|NCT02972034|527389669|FG008|Overall Study|Screen Failure|0|||
145905981|NCT00673387|526160015|FG000|Overall Study|Lost to Follow-up|8|||
146239124|NCT02972034|527389670|FG009|Overall Study|Screen Failure|0|||
146239125|NCT02972034|527389671|FG010|Overall Study|Screen Failure|0|||
145905982|NCT00673387|526160016|FG001|Overall Study|Lost to Follow-up|6|||
145905983|NCT00673387|526160017|FG002|Overall Study|Lost to Follow-up|5|||
145905984|NCT00673387|526160018|FG003|Overall Study|Lost to Follow-up|6|||
145905985|NCT00673387|526160019|FG004|Overall Study|Lost to Follow-up|6|||
145905986|NCT00673387|526160020|FG005|Overall Study|Lost to Follow-up|5|||
145905987|NCT00673387|526160021|FG006|Overall Study|Lost to Follow-up|8|||
145905988|NCT00673387|526160022|FG007|Overall Study|Lost to Follow-up|5|||
145905989|NCT00418821|526160023|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
145905990|NCT00270855|526161455|FG000|Overall Study|Withdrawal by Subject|8|||
145905991|NCT00270855|526161456|FG001|Overall Study|Withdrawal by Subject|8|||
145905992|NCT02618759|526161461|FG000|Overall Study|Lost to Follow-up|0|||
145905993|NCT02618759|526161462|FG001|Overall Study|Lost to Follow-up|1|||
145905994|NCT02618759|526161461|FG000|Overall Study|Withdrawal by Subject|1|||
145905995|NCT02618759|526161462|FG001|Overall Study|Withdrawal by Subject|0|||
145905996|NCT02618759|526161461|FG000|Overall Study|Other Reasons|1|||
145905997|NCT02618759|526161462|FG001|Overall Study|Other Reasons|4|||
145905998|NCT02152605|526161463|FG000|Overall Study|Adverse Event|6|||
145905999|NCT02152605|526161464|FG001|Overall Study|Adverse Event|8|||
145906000|NCT02152605|526161463|FG000|Overall Study|Lack of Efficacy|7|||
145906001|NCT02152605|526161464|FG001|Overall Study|Lack of Efficacy|4|||
145906002|NCT02152605|526161463|FG000|Overall Study|Protocol deviation|1|||
145906003|NCT02152605|526161464|FG001|Overall Study|Protocol deviation|4|||
145906004|NCT02152605|526161463|FG000|Overall Study|Lost to Follow-up|1|||
145906005|NCT02152605|526161464|FG001|Overall Study|Lost to Follow-up|0|||
145906006|NCT02152605|526161463|FG000|Overall Study|Withdrew consent|4|||
145906007|NCT02152605|526161464|FG001|Overall Study|Withdrew consent|2|||
145906008|NCT03333941|526161467|FG000|Overall Study|Lost to Follow-up|10|||
145906009|NCT03333941|526161467|FG000|Overall Study|Death|2|||
145906010|NCT03333941|526161467|FG000|Overall Study|Adverse Event|1|||
145906011|NCT00580788|526161468|FG000|Overall Study|Adverse Event|0|||
145906012|NCT00580788|526161469|FG001|Overall Study|Adverse Event|0|||
145906013|NCT00580788|526161470|FG002|Overall Study|Adverse Event|0|||
145906014|NCT00580788|526161471|FG003|Overall Study|Adverse Event|1|||
145906015|NCT03301649|526161474|FG000|Overall Study|Need alternate therapy due to live lice|17|||
145906016|NCT03301649|526161475|FG001|Overall Study|Need alternate therapy due to live lice|25|||
145906017|NCT03301649|526161476|FG002|Overall Study|Need alternate therapy due to live lice|81|||
145906018|NCT03301649|526161474|FG000|Overall Study|Lost to Follow-up|11|||
145906019|NCT03301649|526161475|FG001|Overall Study|Lost to Follow-up|11|||
145906020|NCT03301649|526161476|FG002|Overall Study|Lost to Follow-up|3|||
145906021|NCT03301649|526161474|FG000|Overall Study|Protocol Violation|0|||
145906022|NCT03301649|526161475|FG001|Overall Study|Protocol Violation|1|||
145906023|NCT03301649|526161476|FG002|Overall Study|Protocol Violation|1|||
145906024|NCT03301649|526161474|FG000|Overall Study|Withdrawal by Subject|10|||
145906025|NCT03301649|526161475|FG001|Overall Study|Withdrawal by Subject|4|||
145906026|NCT03301649|526161476|FG002|Overall Study|Withdrawal by Subject|0|||
145906027|NCT03301649|526161474|FG000|Overall Study|Other than specified|5|||
145906028|NCT03301649|526161475|FG001|Overall Study|Other than specified|3|||
145906029|NCT03301649|526161476|FG002|Overall Study|Other than specified|0|||
145906030|NCT00887289|526161477|FG000|Overall Study|Lack of Efficacy|14|||
146239126|NCT02972034|527389672|FG011|Overall Study|Screen Failure|0|||
146239127|NCT02972034|527389673|FG012|Overall Study|Screen Failure|1|||
146239128|NCT02972034|527389674|FG013|Overall Study|Screen Failure|0|||
146239129|NCT02972034|527389675|FG014|Overall Study|Screen Failure|0|||
146239130|NCT03009344|527389676|FG000|Overall Study|Lack of Efficacy|5|||
146239131|NCT03009344|527389676|FG000|Overall Study|Withdrawal by Subject|1|||
146239132|NCT03009344|527389676|FG000|Overall Study|Adverse Event|1|||
146239133|NCT00378898|527389677|FG000|Overall Study|Withdrawal by Subject|10|||
146239134|NCT00378898|527389678|FG001|Overall Study|Withdrawal by Subject|5|||
146239135|NCT00378898|527389677|FG000|Overall Study|Protocol Violation|1|||
146239136|NCT00378898|527389678|FG001|Overall Study|Protocol Violation|1|||
146239137|NCT02534233|527389681|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
146239138|NCT01278030|527389688|FG000|Overall Study|Withdrawal by Subject|8|||
146239139|NCT01278030|527389689|FG001|Overall Study|Withdrawal by Subject|4|||
146239140|NCT00458783|527389691|FG000|Overall Study|Protocol Violation|1228|||
146239141|NCT00458783|527389692|FG001|Overall Study|Protocol Violation|1220|||
146239142|NCT01737398|527389693|FG000|Overall Study|Adverse event or SAE|16|||
145906031|NCT00887289|526161477|FG000|Overall Study|Adverse Event|27|||
145906032|NCT00887289|526161477|FG000|Overall Study|Withdrawal by Subject|26|||
145906033|NCT00887289|526161477|FG000|Overall Study|Lost to Follow-up|8|||
145906034|NCT00887289|526161477|FG000|Overall Study|Other|20|||
145906035|NCT02932306|526161478|FG000|Overall Study|Withdrawal by Subject|16|||
145906036|NCT02932306|526161479|FG001|Overall Study|Withdrawal by Subject|25|||
145906037|NCT02932306|526161478|FG000|Overall Study|Adverse Event|3|||
145906038|NCT02932306|526161479|FG001|Overall Study|Adverse Event|0|||
145906039|NCT02932306|526161478|FG000|Overall Study|Pregnancy|2|||
145906040|NCT02932306|526161479|FG001|Overall Study|Pregnancy|0|||
145906041|NCT02932306|526161478|FG000|Overall Study|Protocol Violation|1|||
146239143|NCT01737398|527389694|FG001|Overall Study|Adverse event or SAE|1|||
145906042|NCT02932306|526161479|FG001|Overall Study|Protocol Violation|1|||
146239144|NCT01737398|527389693|FG000|Overall Study|Stopping rule met|2|||
145906043|NCT02932306|526161478|FG000|Overall Study|Noncompliance with Study Drug|1|||
145906044|NCT02932306|526161479|FG001|Overall Study|Noncompliance with Study Drug|1|||
145906045|NCT02932306|526161478|FG000|Overall Study|Lost to Follow-up|36|||
145906046|NCT02932306|526161479|FG001|Overall Study|Lost to Follow-up|40|||
145906047|NCT02932306|526161478|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
145906048|NCT02932306|526161479|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
145906049|NCT02932306|526161478|FG000|Overall Study|Lack of Efficacy|0|||
145906050|NCT02932306|526161479|FG001|Overall Study|Lack of Efficacy|2|||
145906051|NCT02932306|526161478|FG000|Overall Study|Worsening condition|2|||
145906052|NCT02932306|526161479|FG001|Overall Study|Worsening condition|0|||
145906053|NCT02932306|526161478|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
145906054|NCT02932306|526161479|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
145906055|NCT00509366|526161480|FG000|Overall Study|Not Treated (Screen Failure)|1|||
145906056|NCT00509366|526161481|FG001|Overall Study|Not Treated (Screen Failure)|1|||
145906057|NCT00509366|526161482|FG002|Overall Study|Not Treated (Screen Failure)|1|||
145906058|NCT00509366|526161483|FG003|Overall Study|Not Treated (Screen Failure)|0|||
145906059|NCT00509366|526161484|FG004|Overall Study|Not Treated (Screen Failure)|0|||
145906060|NCT00282919|526161487|FG000|Overall Study|Lack of Efficacy|4|||
145906061|NCT00282919|526161487|FG000|Overall Study|Withdrawal by Subject|1|||
145906062|NCT00282919|526161487|FG000|Overall Study|Asymptomatic Parasitemia|2|||
145906063|NCT01438996|526161488|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
145906064|NCT01438996|526161489|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
145906065|NCT01438996|526161490|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
145906066|NCT04497948|526161493|FG000|Overall Study|Death|2|||
145906067|NCT00696787|526161494|FG000|Overall Study|Adverse Event|1|||
145906068|NCT00696787|526161495|FG001|Overall Study|Adverse Event|0|||
145906069|NCT00696787|526161496|FG002|Overall Study|Adverse Event|6|||
145906070|NCT00696787|526161494|FG000|Overall Study|Discontinuation by Sponsor|9|||
145906071|NCT00696787|526161495|FG001|Overall Study|Discontinuation by Sponsor|13|||
145906072|NCT00696787|526161496|FG002|Overall Study|Discontinuation by Sponsor|14|||
145906073|NCT00696787|526161494|FG000|Overall Study|Lack of Efficacy|0|||
145972754|NCT04530344|526412757|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
145972755|NCT04530344|526412758|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
145972756|NCT04530344|526412755|FG000|Overall Study|Personal Reasons|0|||
145972757|NCT04530344|526412756|FG001|Overall Study|Personal Reasons|0|||
145972758|NCT04530344|526412757|FG002|Overall Study|Personal Reasons|0|||
145972759|NCT04530344|526412758|FG003|Overall Study|Personal Reasons|1|||
145972760|NCT04530344|526412755|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145972761|NCT04530344|526412756|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145972762|NCT04530344|526412757|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145972763|NCT04530344|526412758|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
145972764|NCT01654276|526412767|FG000|Overall Study|Lack of Efficacy|1|||
145972765|NCT01654276|526412767|FG000|Overall Study|Lost to Follow-up|4|||
145972766|NCT01654276|526412767|FG000|Overall Study|Withdrawal by Subject|1|||
145972767|NCT01977846|526412770|FG000|Total Study - Prospective|Death|0|||
145972768|NCT01977846|526412771|FG001|Total Study - Prospective|Death|1|||
145972769|NCT01977846|526412770|FG000|Total Study - Prospective|Lost to Follow-up|0|||
145972770|NCT01977846|526412771|FG001|Total Study - Prospective|Lost to Follow-up|8|||
145972771|NCT01977846|526412770|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
145972772|NCT01977846|526412771|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
145972773|NCT01977846|526412770|FG000|Total Study - Prospective|Not available at time of visit|0|||
145972774|NCT01977846|526412771|FG001|Total Study - Prospective|Not available at time of visit|5|||
145972775|NCT01977846|526412770|FG000|Total Study - Prospective|No show|0|||
145972776|NCT01977846|526412771|FG001|Total Study - Prospective|No show|1|||
145972777|NCT01977846|526412770|FG000|Total Study - Prospective|Protocol Violation|0|||
145972778|NCT01977846|526412771|FG001|Total Study - Prospective|Protocol Violation|1|||
145972779|NCT00596635|526412772|FG000|Overall Study|Lost to Follow-up|0|||
145972780|NCT00596635|526412773|FG001|Overall Study|Lost to Follow-up|2|||
146239145|NCT01737398|527389694|FG001|Overall Study|Stopping rule met|1|||
146239146|NCT01737398|527389693|FG000|Overall Study|Voluntary withdrawal|2|||
145972781|NCT00596635|526412774|FG002|Overall Study|Lost to Follow-up|0|||
145972782|NCT00596635|526412772|FG000|Overall Study|Treatment for symptomatic UTI|4|||
145972783|NCT00596635|526412773|FG001|Overall Study|Treatment for symptomatic UTI|6|||
145972784|NCT00596635|526412774|FG002|Overall Study|Treatment for symptomatic UTI|3|||
145972785|NCT00596635|526412772|FG000|Overall Study|Hip fracture|2|||
145972786|NCT00596635|526412773|FG001|Overall Study|Hip fracture|3|||
146239147|NCT01737398|527389694|FG001|Overall Study|Voluntary withdrawal|3|||
145972787|NCT00596635|526412774|FG002|Overall Study|Hip fracture|3|||
145906074|NCT00696787|526161495|FG001|Overall Study|Lack of Efficacy|1|||
145906075|NCT00696787|526161496|FG002|Overall Study|Lack of Efficacy|0|||
145906076|NCT00696787|526161494|FG000|Overall Study|Lost to Follow-up|4|||
145906077|NCT00696787|526161495|FG001|Overall Study|Lost to Follow-up|0|||
145906078|NCT00696787|526161496|FG002|Overall Study|Lost to Follow-up|3|||
145906079|NCT00696787|526161494|FG000|Overall Study|Withdrawal by Subject|0|||
146239148|NCT01737398|527389693|FG000|Overall Study|Ineligibility|1|||
146239149|NCT01737398|527389694|FG001|Overall Study|Ineligibility|0|||
146239150|NCT01737398|527389693|FG000|Overall Study|Liver transplant|1|||
145906080|NCT00696787|526161495|FG001|Overall Study|Withdrawal by Subject|3|||
145906081|NCT00696787|526161496|FG002|Overall Study|Withdrawal by Subject|2|||
145906082|NCT00696787|526161494|FG000|Overall Study|Failed to return|1|||
145906083|NCT00696787|526161495|FG001|Overall Study|Failed to return|3|||
145906084|NCT00696787|526161496|FG002|Overall Study|Failed to return|1|||
145906085|NCT03207243|526161501|FG000|Overall Study|Adverse Event|2|||
145906086|NCT03207243|526161502|FG001|Overall Study|Adverse Event|2|||
145906087|NCT03207243|526161501|FG000|Overall Study|Loss of Asthma Control|47|||
145906088|NCT03207243|526161502|FG001|Overall Study|Loss of Asthma Control|31|||
145906089|NCT03207243|526161501|FG000|Overall Study|Withdrawal by Subject|2|||
145906090|NCT03207243|526161502|FG001|Overall Study|Withdrawal by Subject|4|||
145906091|NCT03207243|526161501|FG000|Overall Study|Physician Decision|1|||
145906092|NCT03207243|526161502|FG001|Overall Study|Physician Decision|1|||
145906093|NCT03207243|526161501|FG000|Overall Study|Lost to Follow-up|0|||
145906094|NCT03207243|526161502|FG001|Overall Study|Lost to Follow-up|1|||
145906095|NCT03207243|526161501|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
145906096|NCT03207243|526161502|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
145906097|NCT03207243|526161501|FG000|Overall Study|Protocol Violation|0|||
145906098|NCT03207243|526161502|FG001|Overall Study|Protocol Violation|3|||
145906099|NCT01377987|526161505|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
145906100|NCT01377987|526161506|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
145906101|NCT04893018|526161508|FG000|Overall Study|Lost to Follow-up|1|||
145906102|NCT04893018|526161509|FG001|Overall Study|Lost to Follow-up|0|||
145906103|NCT04893018|526161508|FG000|Overall Study|Withdrawal by Subject|2|||
145906104|NCT04893018|526161509|FG001|Overall Study|Withdrawal by Subject|0|||
145906105|NCT04893018|526161508|FG000|Overall Study|Study Terminated|1|||
145906106|NCT04893018|526161509|FG001|Overall Study|Study Terminated|2|||
145906107|NCT02842073|526161512|FG000|Overall Study|Withdrawal by Subject|1|||
145906108|NCT01333397|526161513|FG000|Overall Study|Lost to Follow-up|1|||
145906109|NCT01333397|526161514|FG001|Overall Study|Lost to Follow-up|0|||
145906110|NCT01333397|526161515|FG002|Overall Study|Lost to Follow-up|0|||
145906111|NCT01333397|526161516|FG003|Overall Study|Lost to Follow-up|1|||
145906112|NCT01333397|526161517|FG004|Overall Study|Lost to Follow-up|0|||
145906113|NCT01085357|526161518|FG000|Overall Study|Adverse Event|1|||
145906114|NCT01085357|526161519|FG001|Overall Study|Adverse Event|1|||
145906115|NCT01085357|526161518|FG000|Overall Study|Subject Decision|4|||
145906116|NCT01085357|526161519|FG001|Overall Study|Subject Decision|3|||
145906117|NCT01085357|526161518|FG000|Overall Study|Investigator Decision|1|||
145906118|NCT01085357|526161519|FG001|Overall Study|Investigator Decision|1|||
145906119|NCT01085357|526161518|FG000|Overall Study|Death|11|||
145906120|NCT01085357|526161519|FG001|Overall Study|Death|1|||
145906121|NCT01085357|526161518|FG000|Overall Study|Lost to Follow-up|2|||
145906122|NCT01085357|526161519|FG001|Overall Study|Lost to Follow-up|0|||
145906123|NCT05320887|526161522|FG000|Overall Study|Lost to Follow-up|0|||
145906124|NCT05320887|526161523|FG001|Overall Study|Lost to Follow-up|3|||
145906125|NCT05320887|526161524|FG002|Overall Study|Lost to Follow-up|0|||
145906126|NCT05320887|526161525|FG003|Overall Study|Lost to Follow-up|0|||
145906127|NCT00920790|526161526|FG000|Overall Study|aggravation of general condition|14|||
145906128|NCT04411914|526161527|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
145906129|NCT04411914|526161528|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
145906130|NCT02015065|526161529|FG000|Overall Study|Death on study|1|||
145906131|NCT02015065|526161530|FG001|Overall Study|Death on study|2|||
145906132|NCT02015065|526161531|FG002|Overall Study|Death on study|1|||
145906133|NCT01860677|526161532|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
145906134|NCT01860677|526161533|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
145906135|NCT01144715|526161534|FG000|Overall Study|Lost to Follow-up|2|||
145906136|NCT01144715|526161535|FG001|Overall Study|Lost to Follow-up|1|||
145906137|NCT01144715|526161534|FG000|Overall Study|Withdrawal by Subject|2|||
145906138|NCT01144715|526161535|FG001|Overall Study|Withdrawal by Subject|1|||
145906139|NCT01144715|526161534|FG000|Overall Study|Adverse Event|0|||
145906140|NCT01144715|526161535|FG001|Overall Study|Adverse Event|1|||
145906141|NCT03553576|526161536|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
145906142|NCT03553576|526161537|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
145906143|NCT03553576|526161536|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
145906144|NCT03553576|526161537|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
145906145|NCT03553576|526161536|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
145906146|NCT03553576|526161537|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
145906147|NCT03553576|526161536|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
145906148|NCT03553576|526161537|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
145906149|NCT03553576|526161536|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
145943244|NCT02326298|526300466|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
146239151|NCT01737398|527389694|FG001|Overall Study|Liver transplant|0|||
145906150|NCT03553576|526161537|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
145906151|NCT03553576|526161536|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
145906152|NCT03553576|526161537|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
145906153|NCT03553576|526161536|FG000|Overall Study|Physician Decision|2|||
145906154|NCT03553576|526161537|FG001|Overall Study|Physician Decision|5|||
145906155|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
145906156|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
145906157|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
145906158|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
145906159|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
145906160|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
145906161|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
145906162|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
145906163|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
145906164|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
145906165|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
145906166|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
145906167|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
145906168|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
145906169|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
145906170|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
145906171|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
145906172|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
145906173|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
145906174|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
145906175|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
145906176|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
145906177|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
145906178|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
145906179|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
145906180|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
145906181|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
145906182|NCT02552212|526161538|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
145906183|NCT02552212|526161539|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
145972788|NCT00596635|526412772|FG000|Overall Study|Could not provide urine specimen|1|||
145972789|NCT00596635|526412773|FG001|Overall Study|Could not provide urine specimen|2|||
145972790|NCT00596635|526412774|FG002|Overall Study|Could not provide urine specimen|2|||
145972791|NCT00127803|526412776|FG000|Overall Study|Adverse Event|2|||
145972792|NCT00127803|526412777|FG001|Overall Study|Adverse Event|0|||
145972793|NCT00127803|526412778|FG002|Overall Study|Adverse Event|0|||
145972794|NCT00127803|526412779|FG003|Overall Study|Adverse Event|0|||
145972795|NCT00127803|526412776|FG000|Overall Study|Withdrawal by Subject|1|||
145972796|NCT00127803|526412777|FG001|Overall Study|Withdrawal by Subject|0|||
145972797|NCT00127803|526412778|FG002|Overall Study|Withdrawal by Subject|0|||
146239152|NCT01737398|527389693|FG000|Overall Study|Disease progression|2|||
146239153|NCT01737398|527389694|FG001|Overall Study|Disease progression|3|||
146239154|NCT01737398|527389693|FG000|Overall Study|Sponsor's decision|2|||
145906184|NCT02552212|526161540|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
145906185|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
145906186|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
145906187|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
145906188|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
145906189|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
145906190|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
145906191|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
145906192|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
145906193|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
145972798|NCT00127803|526412779|FG003|Overall Study|Withdrawal by Subject|0|||
145972799|NCT00127803|526412776|FG000|Overall Study|Lost to Follow-up|0|||
145972800|NCT00127803|526412777|FG001|Overall Study|Lost to Follow-up|0|||
145972801|NCT00127803|526412778|FG002|Overall Study|Lost to Follow-up|0|||
146239155|NCT01737398|527389694|FG001|Overall Study|Sponsor's decision|0|||
145972802|NCT00127803|526412779|FG003|Overall Study|Lost to Follow-up|1|||
145972803|NCT01020123|526412782|FG000|Main Period|Withdrawal by Subject|6|||
145972804|NCT01020123|526412783|FG001|Main Period|Withdrawal by Subject|5|||
145972805|NCT01020123|526412784|FG002|Main Period|Withdrawal by Subject|3|||
145972806|NCT01020123|526412785|FG003|Main Period|Withdrawal by Subject|1|||
145972807|NCT01020123|526412786|FG004|Main Period|Withdrawal by Subject|6|||
146239156|NCT03220724|527389698|FG000|Overall Study|Lost to Follow-up|2|||
146239157|NCT03220724|527389699|FG001|Overall Study|Lost to Follow-up|2|||
145906194|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
145906195|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
145906196|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
145906197|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
145906198|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
145906199|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
145906200|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
145906201|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
145906202|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
145906203|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
145906204|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
145906205|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
145906206|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
145906207|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
145906208|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
145906209|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
145906210|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
145906211|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
145906212|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
145906213|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
145906214|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
145906215|NCT02552212|526161538|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
145906216|NCT02552212|526161539|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
145906217|NCT02552212|526161540|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
145906218|NCT02728843|526161541|FG000|Overall Study|Adverse Event|0|||
145906219|NCT02728843|526161542|FG001|Overall Study|Adverse Event|2|||
145906220|NCT02728843|526161543|FG002|Overall Study|Adverse Event|3|||
145906221|NCT02728843|526161544|FG003|Overall Study|Adverse Event|1|||
145906222|NCT02728843|526161545|FG004|Overall Study|Adverse Event|2|||
145906223|NCT02728843|526161541|FG000|Overall Study|Lack of Efficacy|0|||
145906224|NCT02728843|526161542|FG001|Overall Study|Lack of Efficacy|1|||
145906225|NCT02728843|526161543|FG002|Overall Study|Lack of Efficacy|1|||
145906226|NCT02728843|526161544|FG003|Overall Study|Lack of Efficacy|0|||
145906227|NCT02728843|526161545|FG004|Overall Study|Lack of Efficacy|0|||
145906228|NCT02728843|526161541|FG000|Overall Study|Protocol Violation|2|||
145906229|NCT02728843|526161542|FG001|Overall Study|Protocol Violation|0|||
145906230|NCT02728843|526161543|FG002|Overall Study|Protocol Violation|4|||
145906231|NCT02728843|526161544|FG003|Overall Study|Protocol Violation|2|||
145906232|NCT02728843|526161545|FG004|Overall Study|Protocol Violation|2|||
145906233|NCT02728843|526161541|FG000|Overall Study|Withdrawal by Subject|1|||
145906234|NCT02728843|526161542|FG001|Overall Study|Withdrawal by Subject|0|||
145906235|NCT02728843|526161543|FG002|Overall Study|Withdrawal by Subject|0|||
145906236|NCT02728843|526161544|FG003|Overall Study|Withdrawal by Subject|1|||
145906237|NCT02728843|526161545|FG004|Overall Study|Withdrawal by Subject|0|||
145906238|NCT02728843|526161541|FG000|Overall Study|Use of rescue medication|0|||
145906239|NCT02728843|526161542|FG001|Overall Study|Use of rescue medication|2|||
145906240|NCT02728843|526161543|FG002|Overall Study|Use of rescue medication|0|||
145906241|NCT02728843|526161544|FG003|Overall Study|Use of rescue medication|2|||
145906242|NCT02728843|526161545|FG004|Overall Study|Use of rescue medication|1|||
145906243|NCT01671332|526161546|FG000|Overall Study|Withdrawal by Subject|1|||
145906244|NCT01671332|526161547|FG001|Overall Study|Withdrawal by Subject|1|||
145906245|NCT02056392|526161558|FG000|Overall Study|Lost to Follow-up|0|||
145906246|NCT02056392|526161559|FG001|Overall Study|Lost to Follow-up|1|||
145906247|NCT02056392|526161560|FG002|Overall Study|Lost to Follow-up|2|||
145906248|NCT02056392|526161561|FG003|Overall Study|Lost to Follow-up|0|||
145906249|NCT02056392|526161562|FG004|Overall Study|Lost to Follow-up|0|||
146297392|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
146297393|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
145906250|NCT02056392|526161563|FG005|Overall Study|Lost to Follow-up|0|||
145906251|NCT02056392|526161558|FG000|Overall Study|Protocol Violation|1|||
145906252|NCT02056392|526161559|FG001|Overall Study|Protocol Violation|0|||
145906253|NCT02056392|526161560|FG002|Overall Study|Protocol Violation|1|||
145906254|NCT02056392|526161561|FG003|Overall Study|Protocol Violation|0|||
146297394|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
145906255|NCT02056392|526161562|FG004|Overall Study|Protocol Violation|0|||
145906256|NCT02056392|526161563|FG005|Overall Study|Protocol Violation|0|||
146297395|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
146297396|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
145906257|NCT02056392|526161558|FG000|Overall Study|Withdrawal by Subject|1|||
145906258|NCT02056392|526161559|FG001|Overall Study|Withdrawal by Subject|0|||
145906259|NCT02056392|526161560|FG002|Overall Study|Withdrawal by Subject|0|||
145906260|NCT02056392|526161561|FG003|Overall Study|Withdrawal by Subject|0|||
145906261|NCT02056392|526161562|FG004|Overall Study|Withdrawal by Subject|1|||
145906262|NCT02056392|526161563|FG005|Overall Study|Withdrawal by Subject|0|||
145906263|NCT01806506|526161564|FG000|Overall Study|Lost to Follow-up|2|||
145906264|NCT01806506|526161565|FG001|Overall Study|Lost to Follow-up|1|||
145906265|NCT02092467|526161568|FG000|Overall Study|Death|49|||
145906266|NCT02092467|526161569|FG001|Overall Study|Death|66|||
145906267|NCT02092467|526161570|FG002|Overall Study|Death|38|||
145906268|NCT02092467|526161568|FG000|Overall Study|Lost to Follow-up|38|||
145906269|NCT02092467|526161569|FG001|Overall Study|Lost to Follow-up|35|||
145906270|NCT02092467|526161570|FG002|Overall Study|Lost to Follow-up|40|||
145906271|NCT02092467|526161568|FG000|Overall Study|Global Deterioration of Health Status|1|||
145906272|NCT02092467|526161569|FG001|Overall Study|Global Deterioration of Health Status|0|||
145906273|NCT02092467|526161570|FG002|Overall Study|Global Deterioration of Health Status|0|||
145906274|NCT02092467|526161568|FG000|Overall Study|Other|32|||
145906275|NCT02092467|526161569|FG001|Overall Study|Other|30|||
145906276|NCT02092467|526161570|FG002|Overall Study|Other|24|||
145906277|NCT02092467|526161568|FG000|Overall Study|Withdrawal by Subject|282|||
145906278|NCT02092467|526161569|FG001|Overall Study|Withdrawal by Subject|327|||
145906279|NCT02092467|526161570|FG002|Overall Study|Withdrawal by Subject|289|||
145906280|NCT02092467|526161568|FG000|Overall Study|Randomized but not treated|2|||
145906281|NCT02092467|526161569|FG001|Overall Study|Randomized but not treated|1|||
145906282|NCT02092467|526161570|FG002|Overall Study|Randomized but not treated|7|||
145906283|NCT02952898|526161575|FG000|Overall Study|Withdrawal by Subject|10|||
145906284|NCT02952898|526161576|FG001|Overall Study|Withdrawal by Subject|8|||
145906285|NCT02952898|526161577|FG002|Overall Study|Withdrawal by Subject|8|||
145906286|NCT02952898|526161575|FG000|Overall Study|Adverse Event|8|||
145906287|NCT02952898|526161576|FG001|Overall Study|Adverse Event|8|||
145906288|NCT02952898|526161577|FG002|Overall Study|Adverse Event|3|||
145906289|NCT02952898|526161575|FG000|Overall Study|Lost to Follow-up|3|||
145906290|NCT02952898|526161576|FG001|Overall Study|Lost to Follow-up|2|||
145906291|NCT02952898|526161577|FG002|Overall Study|Lost to Follow-up|2|||
145906292|NCT02952898|526161575|FG000|Overall Study|Non-compliance with study drug|1|||
145906293|NCT02952898|526161576|FG001|Overall Study|Non-compliance with study drug|1|||
145906294|NCT02952898|526161577|FG002|Overall Study|Non-compliance with study drug|2|||
145906295|NCT04844762|526161580|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906296|NCT04844762|526161581|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906297|NCT04844762|526161582|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
145906298|NCT04844762|526161583|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906299|NCT04844762|526161584|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906300|NCT04844762|526161585|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906301|NCT04844762|526161580|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145906302|NCT04844762|526161581|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145906303|NCT04844762|526161582|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145906304|NCT04844762|526161583|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145906305|NCT04844762|526161584|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145906306|NCT04844762|526161585|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145906307|NCT04844762|526161580|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906308|NCT04844762|526161581|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906309|NCT04844762|526161582|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145906310|NCT04844762|526161583|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
145906311|NCT04844762|526161584|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906312|NCT04844762|526161585|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145906313|NCT04844762|526161580|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906314|NCT04844762|526161581|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906315|NCT04844762|526161582|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145906316|NCT04844762|526161583|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145906317|NCT04844762|526161584|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
145906318|NCT04844762|526161585|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906319|NCT04844762|526161580|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
145906320|NCT04844762|526161581|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
145906321|NCT04844762|526161582|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906322|NCT04844762|526161583|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906323|NCT04844762|526161584|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906324|NCT04844762|526161585|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906325|NCT04844762|526161580|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145906326|NCT04844762|526161581|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906327|NCT04844762|526161582|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906328|NCT04844762|526161583|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145972808|NCT01020123|526412787|FG005|Main Period|Withdrawal by Subject|3|||
145972809|NCT01020123|526412788|FG006|Main Period|Withdrawal by Subject|2|||
145906329|NCT04844762|526161584|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906330|NCT04844762|526161585|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906331|NCT04844762|526161580|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906332|NCT04844762|526161581|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906333|NCT04844762|526161582|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906334|NCT04844762|526161583|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906335|NCT04844762|526161584|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145906336|NCT04844762|526161585|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145906337|NCT04844762|526161580|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
145906338|NCT04844762|526161581|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906339|NCT04844762|526161582|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906340|NCT04844762|526161583|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906341|NCT04844762|526161584|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906342|NCT04844762|526161585|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145906343|NCT04844762|526161580|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145906344|NCT04844762|526161581|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906345|NCT04844762|526161582|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906346|NCT04844762|526161583|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906347|NCT04844762|526161584|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145906348|NCT04844762|526161585|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145906349|NCT04844762|526161580|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145906350|NCT04844762|526161581|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
145906351|NCT04844762|526161582|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145906352|NCT04844762|526161583|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145906353|NCT04844762|526161584|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145906354|NCT04844762|526161585|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145906355|NCT04844762|526161580|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145906356|NCT04844762|526161581|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145906357|NCT04844762|526161582|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145906358|NCT04844762|526161583|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
145906359|NCT04844762|526161584|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145906360|NCT04844762|526161585|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145906361|NCT04400682|526161586|FG000|Period 1|Withdrawal by Subject|1|||
145906362|NCT04400682|526161587|FG001|Period 1|Withdrawal by Subject|4|||
145906363|NCT02105974|526161588|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
145906364|NCT02105974|526161589|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
145906365|NCT02105974|526161590|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
145906366|NCT02105974|526161588|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
145906367|NCT02105974|526161589|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
145906368|NCT02105974|526161590|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
145906369|NCT02105974|526161588|FG000|2 Week Run-in Period|Adverse Event|6|||
145906370|NCT02105974|526161589|FG001|2 Week Run-in Period|Adverse Event|0|||
145906371|NCT02105974|526161590|FG002|2 Week Run-in Period|Adverse Event|0|||
145906372|NCT02105974|526161588|FG000|2 Week Run-in Period|Study closed/terminated|1|||
145906373|NCT02105974|526161589|FG001|2 Week Run-in Period|Study closed/terminated|0|||
145906374|NCT02105974|526161590|FG002|2 Week Run-in Period|Study closed/terminated|0|||
145906375|NCT02105974|526161588|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
145906376|NCT02105974|526161589|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
145906377|NCT02105974|526161590|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
145906378|NCT02105974|526161588|FG000|2 Week Run-in Period|Withdrew consent|23|||
145906379|NCT02105974|526161589|FG001|2 Week Run-in Period|Withdrew consent|0|||
145906380|NCT02105974|526161590|FG002|2 Week Run-in Period|Withdrew consent|0|||
145906381|NCT02105974|526161588|FG000|2 Week Run-in Period|Investigator discretion|8|||
145906382|NCT02105974|526161589|FG001|2 Week Run-in Period|Investigator discretion|0|||
145906383|NCT02105974|526161590|FG002|2 Week Run-in Period|Investigator discretion|0|||
145906384|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
145906385|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
145906386|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
145906387|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
145906388|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
145906389|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
145906390|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
146239158|NCT03220724|527389700|FG002|Overall Study|Lost to Follow-up|0|||
146239159|NCT03220724|527389701|FG003|Overall Study|Lost to Follow-up|3|||
146239160|NCT03220724|527389702|FG004|Overall Study|Lost to Follow-up|1|||
146239161|NCT03220724|527389703|FG005|Overall Study|Lost to Follow-up|0|||
146239162|NCT03220724|527389704|FG006|Overall Study|Lost to Follow-up|2|||
146239163|NCT03220724|527389705|FG007|Overall Study|Lost to Follow-up|1|||
146088441|NCT02011893|526843845|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
146088442|NCT02011893|526843846|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
146088443|NCT02011893|526843847|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
146088444|NCT02011893|526843845|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
146088445|NCT02011893|526843846|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
146088446|NCT02011893|526843847|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
146088447|NCT02011893|526843845|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
146088448|NCT02011893|526843846|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
146088449|NCT02011893|526843847|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
146088450|NCT00518973|526843848|FG000|Overall Study|Withdrawal by Subject|3|||
146088451|NCT00518973|526843849|FG001|Overall Study|Withdrawal by Subject|2|||
146088452|NCT03452527|526843850|FG000|Overall Study|Withdrawal by Subject|1|||
146088453|NCT03452527|526843851|FG001|Overall Study|Withdrawal by Subject|1|||
146088454|NCT03452527|526843850|FG000|Overall Study|Study Terminated|2|||
146088455|NCT03452527|526843851|FG001|Overall Study|Study Terminated|3|||
146088456|NCT00582816|526843852|FG000|Overall Study|Engraftment Failure|3|||
146088457|NCT02129777|526843855|FG000|Double-Blind Period|Adverse Event|0|||
146088458|NCT02129777|526843856|FG001|Double-Blind Period|Adverse Event|0|||
146088459|NCT02129777|526843857|FG002|Double-Blind Period|Adverse Event|0|||
146088460|NCT02129777|526843858|FG003|Double-Blind Period|Adverse Event|0|||
146239164|NCT03220724|527389706|FG008|Overall Study|Lost to Follow-up|0|||
146239165|NCT03220724|527389698|FG000|Overall Study|Withdrawal by Subject|1|||
146239166|NCT03220724|527389699|FG001|Overall Study|Withdrawal by Subject|0|||
146088461|NCT02129777|526843859|FG004|Double-Blind Period|Adverse Event|1|||
146088462|NCT02129777|526843860|FG005|Double-Blind Period|Adverse Event|0|||
146088463|NCT02129777|526843861|FG006|Double-Blind Period|Adverse Event|0|||
146088464|NCT02129777|526843855|FG000|Double-Blind Period|Lost to Follow-up|1|||
146088465|NCT02129777|526843856|FG001|Double-Blind Period|Lost to Follow-up|1|||
146088466|NCT02129777|526843857|FG002|Double-Blind Period|Lost to Follow-up|1|||
146088467|NCT02129777|526843858|FG003|Double-Blind Period|Lost to Follow-up|2|||
146088468|NCT02129777|526843859|FG004|Double-Blind Period|Lost to Follow-up|0|||
146239167|NCT03220724|527389700|FG002|Overall Study|Withdrawal by Subject|1|||
145906391|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
145906392|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
145906393|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
145906394|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
145906395|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
145906396|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
145906397|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
145906398|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
145906399|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
145906400|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
145906401|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
145906402|NCT02105974|526161588|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
145906403|NCT02105974|526161589|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
145906404|NCT02105974|526161590|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
145906405|NCT00477633|526161591|FG000|Overall Study|Did not receive treatment|23|||
145906406|NCT00477633|526161591|FG000|Overall Study|Adverse Event|143|||
145906407|NCT00477633|526161591|FG000|Overall Study|Pregnancy|23|||
145906408|NCT00477633|526161591|FG000|Overall Study|Lost to Follow-up|271|||
145906409|NCT00477633|526161591|FG000|Overall Study|Withdrawal by Subject|149|||
145906410|NCT00477633|526161591|FG000|Overall Study|Protocol Violation|25|||
145906411|NCT00477633|526161591|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
145906412|NCT02968849|526161592|FG000|Overall Study|Death|8|||
145906413|NCT02968849|526161593|FG001|Overall Study|Death|10|||
146239168|NCT03220724|527389701|FG003|Overall Study|Withdrawal by Subject|0|||
145906414|NCT02968849|526161592|FG000|Overall Study|Lost to Follow-up|31|||
145906415|NCT02968849|526161593|FG001|Overall Study|Lost to Follow-up|29|||
146088469|NCT02129777|526843860|FG005|Double-Blind Period|Lost to Follow-up|0|||
146088470|NCT02129777|526843861|FG006|Double-Blind Period|Lost to Follow-up|0|||
146088471|NCT02129777|526843855|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146088472|NCT02129777|526843856|FG001|Double-Blind Period|Withdrawal by Subject|4|||
146239169|NCT03220724|527389702|FG004|Overall Study|Withdrawal by Subject|0|||
146088473|NCT02129777|526843857|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146088474|NCT02129777|526843858|FG003|Double-Blind Period|Withdrawal by Subject|2|||
145906416|NCT02968849|526161592|FG000|Overall Study|Withdrawal by Subject|73|||
146088475|NCT02129777|526843859|FG004|Double-Blind Period|Withdrawal by Subject|3|||
146088476|NCT02129777|526843860|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146088477|NCT02129777|526843861|FG006|Double-Blind Period|Withdrawal by Subject|0|||
146088478|NCT02129777|526843855|FG000|Double-Blind Period|Pregnancy|0|||
145906417|NCT02968849|526161593|FG001|Overall Study|Withdrawal by Subject|64|||
145906418|NCT02968849|526161592|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
146239170|NCT03220724|527389703|FG005|Overall Study|Withdrawal by Subject|0|||
146239171|NCT03220724|527389704|FG006|Overall Study|Withdrawal by Subject|0|||
146239172|NCT03220724|527389705|FG007|Overall Study|Withdrawal by Subject|0|||
145906419|NCT02968849|526161593|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
145906420|NCT02968849|526161592|FG000|Overall Study|Physician Decision|6|||
145906421|NCT02968849|526161593|FG001|Overall Study|Physician Decision|9|||
145906422|NCT02968849|526161592|FG000|Overall Study|Other|16|||
145906423|NCT02968849|526161593|FG001|Overall Study|Other|10|||
145906424|NCT00805467|526163296|FG000|Overall Study|Lack of Efficacy|0|||
145906425|NCT00805467|526163297|FG001|Overall Study|Lack of Efficacy|8|||
145906426|NCT00805467|526163298|FG002|Overall Study|Lack of Efficacy|13|||
145906427|NCT00805467|526163299|FG003|Overall Study|Lack of Efficacy|86|||
145906428|NCT00805467|526163296|FG000|Overall Study|Lost to Follow-up|0|||
145906429|NCT00805467|526163297|FG001|Overall Study|Lost to Follow-up|1|||
145906430|NCT00805467|526163298|FG002|Overall Study|Lost to Follow-up|7|||
145906431|NCT00805467|526163299|FG003|Overall Study|Lost to Follow-up|21|||
145906432|NCT00805467|526163296|FG000|Overall Study|Withdrawal by Subject|0|||
145906433|NCT00805467|526163297|FG001|Overall Study|Withdrawal by Subject|6|||
145906434|NCT00805467|526163298|FG002|Overall Study|Withdrawal by Subject|45|||
145906435|NCT00805467|526163299|FG003|Overall Study|Withdrawal by Subject|50|||
145906436|NCT00805467|526163296|FG000|Overall Study|Protocol Violation|0|||
145906437|NCT00805467|526163297|FG001|Overall Study|Protocol Violation|3|||
145906438|NCT00805467|526163298|FG002|Overall Study|Protocol Violation|0|||
145906439|NCT00805467|526163299|FG003|Overall Study|Protocol Violation|5|||
145906440|NCT00805467|526163296|FG000|Overall Study|Adverse Event|0|||
145906441|NCT00805467|526163297|FG001|Overall Study|Adverse Event|13|||
145906442|NCT00805467|526163298|FG002|Overall Study|Adverse Event|26|||
145906443|NCT00805467|526163299|FG003|Overall Study|Adverse Event|57|||
145906444|NCT00805467|526163296|FG000|Overall Study|Death|0|||
145906445|NCT00805467|526163297|FG001|Overall Study|Death|2|||
145906446|NCT00805467|526163298|FG002|Overall Study|Death|7|||
145906447|NCT00805467|526163299|FG003|Overall Study|Death|5|||
145906448|NCT00805467|526163296|FG000|Overall Study|Physician Decision|0|||
145906449|NCT00805467|526163297|FG001|Overall Study|Physician Decision|1|||
145906450|NCT00805467|526163298|FG002|Overall Study|Physician Decision|2|||
145906451|NCT00805467|526163299|FG003|Overall Study|Physician Decision|6|||
145906452|NCT00805467|526163296|FG000|Overall Study|Not reported|0|||
145906453|NCT00805467|526163297|FG001|Overall Study|Not reported|0|||
145906454|NCT00805467|526163298|FG002|Overall Study|Not reported|3|||
145906455|NCT00805467|526163299|FG003|Overall Study|Not reported|7|||
145906456|NCT00478244|526163304|FG000|Overall Study|Did not receive transplant|1|||
145906457|NCT00459043|526163305|FG000|Overall Study|Withdrawal by Subject|1|||
145906458|NCT00459043|526163306|FG001|Overall Study|Withdrawal by Subject|0|||
145906459|NCT01392963|526163307|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
145906460|NCT01392963|526163308|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
145906461|NCT01392963|526163307|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
145906462|NCT01392963|526163308|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
145906463|NCT01392963|526163307|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
145906464|NCT01392963|526163308|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
145906465|NCT03156504|526163312|FG000|Overall Study|Withdrawal by Subject|1|||
145906466|NCT02755649|526163313|FG000|Overall Study|Transitioned into OLE study|99|||
145906467|NCT02755649|526163314|FG001|Overall Study|Transitioned into OLE study|98|||
145906468|NCT02755649|526163315|FG002|Overall Study|Transitioned into OLE study|100|||
145906469|NCT02755649|526163313|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
145906470|NCT02755649|526163314|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
145906471|NCT02755649|526163315|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
145906472|NCT02755649|526163313|FG000|Overall Study|Physician Decision|0|||
145906473|NCT02755649|526163314|FG001|Overall Study|Physician Decision|0|||
145906474|NCT02755649|526163315|FG002|Overall Study|Physician Decision|2|||
145906475|NCT02755649|526163313|FG000|Overall Study|Withdrawal by Subject|0|||
145906476|NCT02755649|526163314|FG001|Overall Study|Withdrawal by Subject|1|||
145906477|NCT02755649|526163315|FG002|Overall Study|Withdrawal by Subject|0|||
145972810|NCT01020123|526412782|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
145972811|NCT01020123|526412783|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
146239173|NCT03220724|527389706|FG008|Overall Study|Withdrawal by Subject|0|||
145906478|NCT02755649|526163313|FG000|Overall Study|Undecided|1|||
145906479|NCT02755649|526163314|FG001|Overall Study|Undecided|0|||
145906480|NCT02755649|526163315|FG002|Overall Study|Undecided|0|||
145906481|NCT01403051|526163319|FG000|Overall Study|Protocol Violation|2|||
145906482|NCT01403051|526163320|FG001|Overall Study|Protocol Violation|0|||
145906483|NCT01403051|526163319|FG000|Overall Study|Death|1|||
145906484|NCT01403051|526163320|FG001|Overall Study|Death|0|||
146239174|NCT00019604|527389707|FG000|Overall Study|Death|1|||
145906485|NCT01403051|526163319|FG000|Overall Study|Withdrawal by Subject|2|||
145906486|NCT01403051|526163320|FG001|Overall Study|Withdrawal by Subject|1|||
145906487|NCT01403051|526163319|FG000|Overall Study|Lost to Follow-up|5|||
145906488|NCT01403051|526163320|FG001|Overall Study|Lost to Follow-up|5|||
145906489|NCT03022084|526163321|FG000|Overall Study|Lost to Follow-up|2|||
145906490|NCT03022084|526163322|FG001|Overall Study|Lost to Follow-up|3|||
145906491|NCT03559400|526163330|FG000|Overall Study|Lost to Follow-up|9|||
145906492|NCT03559400|526163331|FG001|Overall Study|Lost to Follow-up|7|||
145906493|NCT03559400|526163330|FG000|Overall Study|Death|0|||
145906494|NCT03559400|526163331|FG001|Overall Study|Death|2|||
145906495|NCT01433549|526163332|FG000|Phase 2: Second Study Product|Adverse Event|0|||
145906496|NCT01433549|526163333|FG001|Phase 2: Second Study Product|Adverse Event|1|||
145906497|NCT00603837|526163336|FG000|Overall Study|Physician Decision|3|||
145906498|NCT00603837|526163337|FG001|Overall Study|Physician Decision|0|||
145906499|NCT00741286|526163340|FG000|Overall Study|Lost to Follow-up|15|||
145906500|NCT00741286|526163341|FG001|Overall Study|Lost to Follow-up|10|||
146297397|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
146297398|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
146297399|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
146297400|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
146297401|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
146297402|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
146297403|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
146297404|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
146297405|NCT01641809|527604692|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
146297406|NCT01641809|527604693|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
146297407|NCT01641809|527604694|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
145906501|NCT00741286|526163340|FG000|Overall Study|Adverse Event|1|||
145906502|NCT00741286|526163341|FG001|Overall Study|Adverse Event|6|||
145906503|NCT00741286|526163340|FG000|Overall Study|Protocol Violation|3|||
145906504|NCT00741286|526163341|FG001|Overall Study|Protocol Violation|2|||
145906505|NCT00741286|526163340|FG000|Overall Study|Primary Outcome|1|||
145906506|NCT00741286|526163341|FG001|Overall Study|Primary Outcome|1|||
145906507|NCT00425373|526163342|FG000|Overall Study|Adverse Event|2|||
145906508|NCT00425373|526163343|FG001|Overall Study|Adverse Event|2|||
145906509|NCT00425373|526163344|FG002|Overall Study|Adverse Event|0|||
145906510|NCT00425373|526163345|FG003|Overall Study|Adverse Event|1|||
145906511|NCT00425373|526163346|FG004|Overall Study|Adverse Event|4|||
145906512|NCT00425373|526163347|FG005|Overall Study|Adverse Event|6|||
145906513|NCT00425373|526163348|FG006|Overall Study|Adverse Event|2|||
145906514|NCT00425373|526163349|FG007|Overall Study|Adverse Event|3|||
145906515|NCT00425373|526163350|FG008|Overall Study|Adverse Event|8|||
145906516|NCT00425373|526163342|FG000|Overall Study|Lost to Follow-up|0|||
145906517|NCT00425373|526163343|FG001|Overall Study|Lost to Follow-up|1|||
145906518|NCT00425373|526163344|FG002|Overall Study|Lost to Follow-up|0|||
145906519|NCT00425373|526163345|FG003|Overall Study|Lost to Follow-up|0|||
145906520|NCT00425373|526163346|FG004|Overall Study|Lost to Follow-up|1|||
145906521|NCT00425373|526163347|FG005|Overall Study|Lost to Follow-up|0|||
145906522|NCT00425373|526163348|FG006|Overall Study|Lost to Follow-up|0|||
145906523|NCT00425373|526163349|FG007|Overall Study|Lost to Follow-up|0|||
145906524|NCT00425373|526163350|FG008|Overall Study|Lost to Follow-up|0|||
145906525|NCT00425373|526163342|FG000|Overall Study|Protocol Violation|1|||
145906526|NCT00425373|526163343|FG001|Overall Study|Protocol Violation|0|||
145906527|NCT00425373|526163344|FG002|Overall Study|Protocol Violation|1|||
145906528|NCT00425373|526163345|FG003|Overall Study|Protocol Violation|0|||
145906529|NCT00425373|526163346|FG004|Overall Study|Protocol Violation|0|||
145906530|NCT00425373|526163347|FG005|Overall Study|Protocol Violation|0|||
145906531|NCT00425373|526163348|FG006|Overall Study|Protocol Violation|0|||
145906532|NCT00425373|526163349|FG007|Overall Study|Protocol Violation|5|||
145906533|NCT00425373|526163350|FG008|Overall Study|Protocol Violation|3|||
145906534|NCT00425373|526163342|FG000|Overall Study|Withdrawal by Subject|2|||
145906535|NCT00425373|526163343|FG001|Overall Study|Withdrawal by Subject|0|||
145906536|NCT00425373|526163344|FG002|Overall Study|Withdrawal by Subject|2|||
145906537|NCT00425373|526163345|FG003|Overall Study|Withdrawal by Subject|1|||
145906538|NCT00425373|526163346|FG004|Overall Study|Withdrawal by Subject|4|||
145906539|NCT00425373|526163347|FG005|Overall Study|Withdrawal by Subject|0|||
146297408|NCT01641809|527604695|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
146297409|NCT01641809|527604692|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
146297410|NCT01641809|527604693|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
145906540|NCT00425373|526163348|FG006|Overall Study|Withdrawal by Subject|2|||
145906541|NCT00425373|526163349|FG007|Overall Study|Withdrawal by Subject|2|||
145906542|NCT00425373|526163350|FG008|Overall Study|Withdrawal by Subject|2|||
145906543|NCT00425373|526163342|FG000|Overall Study|Lack of Efficacy|0|||
145906544|NCT00425373|526163343|FG001|Overall Study|Lack of Efficacy|0|||
145906545|NCT00425373|526163344|FG002|Overall Study|Lack of Efficacy|0|||
145906546|NCT00425373|526163345|FG003|Overall Study|Lack of Efficacy|0|||
145906547|NCT00425373|526163346|FG004|Overall Study|Lack of Efficacy|1|||
145906548|NCT00425373|526163347|FG005|Overall Study|Lack of Efficacy|3|||
145906549|NCT00425373|526163348|FG006|Overall Study|Lack of Efficacy|3|||
145906550|NCT00425373|526163349|FG007|Overall Study|Lack of Efficacy|0|||
145906551|NCT00425373|526163350|FG008|Overall Study|Lack of Efficacy|5|||
145906552|NCT02960490|526163351|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
145906553|NCT02960490|526163352|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
145906554|NCT02960490|526163353|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906555|NCT02960490|526163354|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906556|NCT02960490|526163355|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906557|NCT02960490|526163356|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906558|NCT02960490|526163357|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906559|NCT02960490|526163358|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906560|NCT02960490|526163359|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906561|NCT02960490|526163360|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145906562|NCT02960490|526163351|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906563|NCT02960490|526163352|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
145906564|NCT02960490|526163353|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906565|NCT02960490|526163354|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906566|NCT02960490|526163355|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906567|NCT02960490|526163356|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906568|NCT02960490|526163357|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906569|NCT02960490|526163358|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906570|NCT02960490|526163359|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906571|NCT02960490|526163360|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145906572|NCT02960490|526163351|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
145906573|NCT02960490|526163352|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
145906574|NCT02960490|526163353|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906575|NCT02960490|526163354|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906576|NCT02960490|526163355|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906577|NCT02960490|526163356|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906578|NCT02960490|526163357|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906579|NCT02960490|526163358|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906580|NCT02960490|526163359|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906581|NCT02960490|526163360|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145906582|NCT02960490|526163351|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
145906583|NCT02960490|526163352|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
145906584|NCT02960490|526163353|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906585|NCT02960490|526163354|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906586|NCT02960490|526163355|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906587|NCT02960490|526163356|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906588|NCT02960490|526163357|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906589|NCT02960490|526163358|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906590|NCT02960490|526163359|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906591|NCT02960490|526163360|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145906592|NCT02960490|526163351|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906593|NCT02960490|526163352|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906594|NCT02960490|526163353|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
145906595|NCT02960490|526163354|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
145906596|NCT02960490|526163355|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906597|NCT02960490|526163356|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
145906598|NCT02960490|526163357|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906599|NCT02960490|526163358|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906600|NCT02960490|526163359|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906601|NCT02960490|526163360|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145906602|NCT02960490|526163351|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906603|NCT02960490|526163352|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906604|NCT02960490|526163353|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
145906605|NCT02960490|526163354|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906606|NCT02960490|526163355|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
145906607|NCT02960490|526163356|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906608|NCT02960490|526163357|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906609|NCT02960490|526163358|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906610|NCT02960490|526163359|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906611|NCT02960490|526163360|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145906612|NCT02960490|526163351|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
145906613|NCT02960490|526163352|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
145906614|NCT02960490|526163353|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
145906615|NCT02960490|526163354|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
145906616|NCT02960490|526163355|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
145906617|NCT02960490|526163356|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
145972812|NCT01020123|526412784|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
145906618|NCT02960490|526163357|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
145906619|NCT02960490|526163358|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
145906620|NCT02960490|526163359|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
145906621|NCT02960490|526163360|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
145906622|NCT02960490|526163351|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906623|NCT02960490|526163352|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906624|NCT02960490|526163353|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906625|NCT02960490|526163354|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906626|NCT02960490|526163355|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906627|NCT02960490|526163356|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906628|NCT02960490|526163357|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
145906629|NCT02960490|526163358|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
145906630|NCT02960490|526163359|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
145906631|NCT02960490|526163360|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145906632|NCT02960490|526163351|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906633|NCT02960490|526163352|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906634|NCT02960490|526163353|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906635|NCT02960490|526163354|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906636|NCT02960490|526163355|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906637|NCT02960490|526163356|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906638|NCT02960490|526163357|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906639|NCT02960490|526163358|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
145906640|NCT02960490|526163359|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906641|NCT02960490|526163360|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145906642|NCT02960490|526163351|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906643|NCT02960490|526163352|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906644|NCT02960490|526163353|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906645|NCT02960490|526163354|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906646|NCT02960490|526163355|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906647|NCT02960490|526163356|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145906648|NCT02960490|526163357|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
145906649|NCT02960490|526163358|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
145906650|NCT02960490|526163359|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
145906651|NCT02960490|526163360|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
145906652|NCT02960490|526163351|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906653|NCT02960490|526163352|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906654|NCT02960490|526163353|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906655|NCT02960490|526163354|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906656|NCT02960490|526163355|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906657|NCT02960490|526163356|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906658|NCT02960490|526163357|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
145906659|NCT02960490|526163358|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906660|NCT02960490|526163359|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906661|NCT02960490|526163360|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145906662|NCT02960490|526163351|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906663|NCT02960490|526163352|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906664|NCT02960490|526163353|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906665|NCT02960490|526163354|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906666|NCT02960490|526163355|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906667|NCT02960490|526163356|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906668|NCT02960490|526163357|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906669|NCT02960490|526163358|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
145906670|NCT02960490|526163359|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906671|NCT02960490|526163360|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
145906672|NCT02910011|526163370|FG000|Overall Study|Physician Decision|2|||
145906673|NCT02460679|526163373|FG000|Overall Study|Investigator Decision|1|||
145906674|NCT02460679|526163373|FG000|Overall Study|Withdrawal by Subject|4|||
145906675|NCT00339144|526163381|FG000|Overall Study|Disease progression|5|||
145906676|NCT00339144|526163382|FG001|Overall Study|Disease progression|2|||
145906677|NCT00339144|526163383|FG002|Overall Study|Disease progression|2|||
145906678|NCT00339144|526163381|FG000|Overall Study|Study drug toxicity|3|||
145906679|NCT00339144|526163382|FG001|Overall Study|Study drug toxicity|1|||
145906680|NCT00339144|526163383|FG002|Overall Study|Study drug toxicity|1|||
145906681|NCT00339144|526163381|FG000|Overall Study|Participant's request to discontinuation|1|||
145906682|NCT00339144|526163382|FG001|Overall Study|Participant's request to discontinuation|0|||
145972813|NCT01020123|526412785|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
146088479|NCT02129777|526843856|FG001|Double-Blind Period|Pregnancy|0|||
146088480|NCT02129777|526843857|FG002|Double-Blind Period|Pregnancy|0|||
145906683|NCT00339144|526163383|FG002|Overall Study|Participant's request to discontinuation|1|||
145906684|NCT00478426|526163385|FG000|Overall Study|Withdrawal by Subject|1|||
145906685|NCT00789737|526163390|FG000|Overall Study|Withdrawal by Subject|13|||
146297411|NCT01641809|527604694|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
145906686|NCT00789737|526163391|FG001|Overall Study|Withdrawal by Subject|22|||
145906687|NCT00789737|526163390|FG000|Overall Study|Lost to Follow-up|10|||
145906688|NCT00789737|526163391|FG001|Overall Study|Lost to Follow-up|14|||
145906689|NCT00789737|526163390|FG000|Overall Study|Adverse Event|8|||
145906690|NCT00789737|526163391|FG001|Overall Study|Adverse Event|8|||
145906691|NCT00789737|526163390|FG000|Overall Study|Protocol Violation|3|||
145906692|NCT00789737|526163391|FG001|Overall Study|Protocol Violation|0|||
145906693|NCT00789737|526163390|FG000|Overall Study|Lack of Efficacy|3|||
145906694|NCT00789737|526163391|FG001|Overall Study|Lack of Efficacy|0|||
145906695|NCT00789737|526163390|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
145906696|NCT00789737|526163391|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
145906697|NCT00789737|526163390|FG000|Overall Study|Other|11|||
145906698|NCT00789737|526163391|FG001|Overall Study|Other|7|||
145906699|NCT01189487|526163392|FG000|Overall Study|Lack of Efficacy|2|||
145906700|NCT01189487|526163392|FG000|Overall Study|Adverse Event|1|||
145906701|NCT04630158|526163393|FG000|Overall Study|Adverse Event|1|||
145906702|NCT04630158|526163394|FG001|Overall Study|Adverse Event|1|||
145906703|NCT04630158|526163395|FG002|Overall Study|Adverse Event|1|||
145906704|NCT04630158|526163393|FG000|Overall Study|Physician Decision|0|||
145906705|NCT04630158|526163394|FG001|Overall Study|Physician Decision|2|||
145906706|NCT04630158|526163395|FG002|Overall Study|Physician Decision|0|||
145906707|NCT04630158|526163393|FG000|Overall Study|Protocol Violation|1|||
145906708|NCT04630158|526163394|FG001|Overall Study|Protocol Violation|0|||
145906709|NCT04630158|526163395|FG002|Overall Study|Protocol Violation|1|||
145906710|NCT04630158|526163393|FG000|Overall Study|Withdrawal by Subject|2|||
145906711|NCT04630158|526163394|FG001|Overall Study|Withdrawal by Subject|1|||
145906712|NCT04630158|526163395|FG002|Overall Study|Withdrawal by Subject|2|||
145906713|NCT03485365|526163398|FG000|Overall Study|Protocol Violation|0|||
145906714|NCT03485365|526163399|FG001|Overall Study|Protocol Violation|0|||
145906715|NCT03485365|526163400|FG002|Overall Study|Protocol Violation|0|||
145906716|NCT03485365|526163401|FG003|Overall Study|Protocol Violation|1|||
145906717|NCT03485365|526163402|FG004|Overall Study|Protocol Violation|0|||
145906718|NCT03485365|526163403|FG005|Overall Study|Protocol Violation|0|||
145906719|NCT03485365|526163404|FG006|Overall Study|Protocol Violation|1|||
145906720|NCT03485365|526163405|FG007|Overall Study|Protocol Violation|0|||
145906721|NCT03485365|526163406|FG008|Overall Study|Protocol Violation|0|||
145906722|NCT03136965|526163408|FG000|Overall Study|Lost to Follow-up|0|||
145906723|NCT03136965|526163409|FG001|Overall Study|Lost to Follow-up|1|||
145906724|NCT03136965|526163410|FG002|Overall Study|Lost to Follow-up|0|||
145906725|NCT01210612|526163412|FG000|Overall Study|Withdrawal by Subject|0|||
145906726|NCT01210612|526163413|FG001|Overall Study|Withdrawal by Subject|2|||
145906727|NCT02290223|526163419|FG000|6 Months|Lost to Follow-up|9|||
145906728|NCT02290223|526163420|FG001|6 Months|Lost to Follow-up|6|||
145906729|NCT02290223|526163419|FG000|6 Months|Withdrawal by Subject|5|||
145906730|NCT02290223|526163420|FG001|6 Months|Withdrawal by Subject|0|||
145906731|NCT02290223|526163419|FG000|6 Months|deceased (not related to study)|2|||
145906732|NCT02290223|526163420|FG001|6 Months|deceased (not related to study)|0|||
145906733|NCT02290223|526163419|FG000|12 Months|Lost to Follow-up|16|||
145906734|NCT02290223|526163420|FG001|12 Months|Lost to Follow-up|10|||
145906735|NCT02290223|526163419|FG000|12 Months|Refusal|0|||
145906736|NCT02290223|526163420|FG001|12 Months|Refusal|1|||
145906737|NCT05293639|526163421|FG000|Overall Study|Withdrawal by Subject|1|||
145906738|NCT05293639|526163422|FG001|Overall Study|Withdrawal by Subject|1|||
145906739|NCT05293639|526163423|FG002|Overall Study|Withdrawal by Subject|2|||
145906740|NCT05293639|526163421|FG000|Overall Study|Death|0|||
145906741|NCT05293639|526163422|FG001|Overall Study|Death|1|||
145906742|NCT05293639|526163423|FG002|Overall Study|Death|0|||
145906743|NCT05293639|526163421|FG000|Overall Study|Lost to Follow-up|0|||
145906744|NCT05293639|526163422|FG001|Overall Study|Lost to Follow-up|0|||
145906745|NCT05293639|526163423|FG002|Overall Study|Lost to Follow-up|5|||
145906746|NCT05293639|526163421|FG000|Overall Study|Other|0|||
145906747|NCT05293639|526163422|FG001|Overall Study|Other|0|||
145906748|NCT05293639|526163423|FG002|Overall Study|Other|1|||
145906749|NCT00813800|526163429|FG000|Overall Study|Screen Failure after Consent|2|||
145906750|NCT00813800|526163429|FG000|Overall Study|Adverse Event|1|||
145906751|NCT00813800|526163429|FG000|Overall Study|Worsening of depression|2|||
145906752|NCT00813800|526163429|FG000|Overall Study|Physician Decision|1|||
145906753|NCT02785952|526163430|FG000|Overall Study|Adverse Event|31|||
145906754|NCT02785952|526163431|FG001|Overall Study|Adverse Event|19|||
145906755|NCT02785952|526163430|FG000|Overall Study|Refusal unrelated to adverse events|10|||
145906756|NCT02785952|526163431|FG001|Overall Study|Refusal unrelated to adverse events|5|||
145906757|NCT02785952|526163430|FG000|Overall Study|Disease progression/relapse|61|||
145906758|NCT02785952|526163431|FG001|Overall Study|Disease progression/relapse|89|||
145906759|NCT02785952|526163430|FG000|Overall Study|Death|11|||
145906760|NCT02785952|526163431|FG001|Overall Study|Death|7|||
146239175|NCT00019604|527389707|FG000|Overall Study|Progressive disease|23|||
146239176|NCT00019604|527389707|FG000|Overall Study|Refused treatment|1|||
145906761|NCT02785952|526163430|FG000|Overall Study|Other- not protocol specified|6|||
145906762|NCT02785952|526163431|FG001|Overall Study|Other- not protocol specified|4|||
145906763|NCT02785952|526163430|FG000|Overall Study|On protocol treatment|6|||
145906764|NCT02785952|526163431|FG001|Overall Study|On protocol treatment|3|||
145906765|NCT00351533|526163435|FG000|Overall Study|Extubated before first BAL|1|||
145906766|NCT00351533|526163436|FG001|Overall Study|Extubated before first BAL|0|||
145906767|NCT00351533|526163435|FG000|Overall Study|Lost to Follow-up|1|||
145906768|NCT00351533|526163436|FG001|Overall Study|Lost to Follow-up|3|||
145906769|NCT00351533|526163435|FG000|Overall Study|Physician Decision|0|||
145906770|NCT00351533|526163436|FG001|Overall Study|Physician Decision|1|||
145906771|NCT00351533|526163435|FG000|Overall Study|Withdrawal by Subject|0|||
145906772|NCT00351533|526163436|FG001|Overall Study|Withdrawal by Subject|1|||
145906773|NCT03185013|526163437|FG000|Overall Study|Withdrawal by Subject|5|||
145906774|NCT03185013|526163438|FG001|Overall Study|Withdrawal by Subject|3|||
145906775|NCT03185013|526163437|FG000|Overall Study|Adverse Event|1|||
145906776|NCT03185013|526163438|FG001|Overall Study|Adverse Event|0|||
145906777|NCT03185013|526163437|FG000|Overall Study|Progressive Disease|1|||
145906778|NCT03185013|526163438|FG001|Overall Study|Progressive Disease|0|||
145906779|NCT03185013|526163437|FG000|Overall Study|Lost to Follow-up|8|||
145906780|NCT03185013|526163438|FG001|Overall Study|Lost to Follow-up|2|||
145906781|NCT03185013|526163437|FG000|Overall Study|Physician Decision|1|||
145906782|NCT03185013|526163438|FG001|Overall Study|Physician Decision|0|||
145906783|NCT03185013|526163437|FG000|Overall Study|Protocol Deviation|2|||
145906784|NCT03185013|526163438|FG001|Overall Study|Protocol Deviation|0|||
145906785|NCT03185013|526163437|FG000|Overall Study|Reason not Specified|3|||
145906786|NCT03185013|526163438|FG001|Overall Study|Reason not Specified|2|||
145906787|NCT03185013|526163437|FG000|Overall Study|Death|1|||
145906788|NCT03185013|526163438|FG001|Overall Study|Death|0|||
145906789|NCT00197496|526163439|FG000|Baseline to Discharge|not interested|1|||
145906790|NCT00197496|526163440|FG001|Baseline to Discharge|not interested|0|||
145906791|NCT00197496|526163439|FG000|Baseline to Discharge|MRSA|1|||
145906792|NCT00197496|526163440|FG001|Baseline to Discharge|MRSA|0|||
145906793|NCT00197496|526163439|FG000|Baseline to Discharge|Physician Decision|0|||
145906794|NCT00197496|526163440|FG001|Baseline to Discharge|Physician Decision|1|||
145906795|NCT00197496|526163439|FG000|Baseline to Discharge|Protocol Violation|0|||
145906796|NCT00197496|526163440|FG001|Baseline to Discharge|Protocol Violation|1|||
145906797|NCT00197496|526163439|FG000|Follow-up|Lost to Follow-up|2|||
145906798|NCT00197496|526163440|FG001|Follow-up|Lost to Follow-up|1|||
145906799|NCT00857584|526163443|FG000|Overall Study|Lack of Efficacy|1|||
145906800|NCT00857584|526163444|FG001|Overall Study|Lack of Efficacy|2|||
145906801|NCT00857584|526163443|FG000|Overall Study|Adverse Event|2|||
145906802|NCT00857584|526163444|FG001|Overall Study|Adverse Event|2|||
145906803|NCT00857584|526163443|FG000|Overall Study|Physician Decision|1|||
145906804|NCT00857584|526163444|FG001|Overall Study|Physician Decision|1|||
145906805|NCT01102374|526163445|FG000|Overall Study|Death|9|||
145906806|NCT01102374|526163446|FG001|Overall Study|Death|13|||
145906807|NCT01102374|526163445|FG000|Overall Study|Lost to Follow-up|7|||
145906808|NCT01102374|526163446|FG001|Overall Study|Lost to Follow-up|6|||
145906809|NCT01104792|526163447|FG000|Overall Study|Adverse Event|77|||
145906810|NCT01104792|526163447|FG000|Overall Study|Insufficient Therapeutic Response|22|||
145906811|NCT01104792|526163447|FG000|Overall Study|Protocol Violation|45|||
145906812|NCT01104792|526163447|FG000|Overall Study|Withdrawal of Consent|179|||
145906813|NCT01104792|526163447|FG000|Overall Study|Lost to Follow-up|43|||
145906814|NCT01104792|526163447|FG000|Overall Study|Reasons Not Specified|27|||
145906815|NCT01104792|526163447|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
145906816|NCT02203331|526163452|FG000|Overall Study|Pregnancy|1|||
145906817|NCT02203331|526163453|FG001|Overall Study|Pregnancy|0|||
145906818|NCT02203331|526163454|FG002|Overall Study|Pregnancy|0|||
145906819|NCT02203331|526163455|FG003|Overall Study|Pregnancy|0|||
145906820|NCT02203331|526163456|FG004|Overall Study|Pregnancy|2|||
145906821|NCT02203331|526163457|FG005|Overall Study|Pregnancy|0|||
145906822|NCT02203331|526163452|FG000|Overall Study|Withdrawal by Subject|1|||
145906823|NCT02203331|526163453|FG001|Overall Study|Withdrawal by Subject|0|||
145906824|NCT02203331|526163454|FG002|Overall Study|Withdrawal by Subject|1|||
145906825|NCT02203331|526163455|FG003|Overall Study|Withdrawal by Subject|0|||
145906826|NCT02203331|526163456|FG004|Overall Study|Withdrawal by Subject|0|||
145906827|NCT02203331|526163457|FG005|Overall Study|Withdrawal by Subject|3|||
145906828|NCT02203331|526163452|FG000|Overall Study|Adverse Event|4|||
145906829|NCT02203331|526163453|FG001|Overall Study|Adverse Event|8|||
145906830|NCT02203331|526163454|FG002|Overall Study|Adverse Event|3|||
145906831|NCT02203331|526163455|FG003|Overall Study|Adverse Event|4|||
145906832|NCT02203331|526163456|FG004|Overall Study|Adverse Event|3|||
145906833|NCT02203331|526163457|FG005|Overall Study|Adverse Event|3|||
145906834|NCT02203331|526163452|FG000|Overall Study|Other Reasons|1|||
145906835|NCT02203331|526163453|FG001|Overall Study|Other Reasons|2|||
145906836|NCT02203331|526163454|FG002|Overall Study|Other Reasons|0|||
145906837|NCT02203331|526163455|FG003|Overall Study|Other Reasons|2|||
145906838|NCT02203331|526163456|FG004|Overall Study|Other Reasons|0|||
145906839|NCT02203331|526163457|FG005|Overall Study|Other Reasons|0|||
145906840|NCT02203331|526163452|FG000|Overall Study|Lack of Efficacy|0|||
145906841|NCT02203331|526163453|FG001|Overall Study|Lack of Efficacy|2|||
145906842|NCT02203331|526163454|FG002|Overall Study|Lack of Efficacy|1|||
145906843|NCT02203331|526163455|FG003|Overall Study|Lack of Efficacy|0|||
145906844|NCT02203331|526163456|FG004|Overall Study|Lack of Efficacy|0|||
145906845|NCT02203331|526163457|FG005|Overall Study|Lack of Efficacy|1|||
145906846|NCT02203331|526163452|FG000|Overall Study|Protocol Violation|0|||
145906847|NCT02203331|526163453|FG001|Overall Study|Protocol Violation|2|||
145906848|NCT02203331|526163454|FG002|Overall Study|Protocol Violation|0|||
145906849|NCT02203331|526163455|FG003|Overall Study|Protocol Violation|1|||
145906850|NCT02203331|526163456|FG004|Overall Study|Protocol Violation|1|||
145906851|NCT02203331|526163457|FG005|Overall Study|Protocol Violation|0|||
145906852|NCT02203331|526163452|FG000|Overall Study|Lost to Follow-up|0|||
145906853|NCT02203331|526163453|FG001|Overall Study|Lost to Follow-up|0|||
145906854|NCT02203331|526163454|FG002|Overall Study|Lost to Follow-up|0|||
145906855|NCT02203331|526163455|FG003|Overall Study|Lost to Follow-up|0|||
145906856|NCT02203331|526163456|FG004|Overall Study|Lost to Follow-up|1|||
145906857|NCT02203331|526163457|FG005|Overall Study|Lost to Follow-up|0|||
145906858|NCT03462459|526163463|FG000|Overall Study|Death|1|||
145906859|NCT03462459|526163464|FG001|Overall Study|Death|0|||
145906860|NCT03462459|526163463|FG000|Overall Study|Lack of Efficacy|2|||
145906861|NCT03462459|526163464|FG001|Overall Study|Lack of Efficacy|4|||
145906862|NCT03462459|526163463|FG000|Overall Study|Lost to Follow-up|1|||
145906863|NCT03462459|526163464|FG001|Overall Study|Lost to Follow-up|3|||
145906864|NCT03462459|526163463|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
145906865|NCT03462459|526163464|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
145906866|NCT03462459|526163463|FG000|Overall Study|Withdrawal by Subject|3|||
145906867|NCT03462459|526163464|FG001|Overall Study|Withdrawal by Subject|2|||
145906868|NCT03462459|526163463|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
145906869|NCT03462459|526163464|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
145906870|NCT02551666|526163466|FG000|Overall Study|Withdrawal by Subject|1|||
145906871|NCT02551666|526163467|FG001|Overall Study|Withdrawal by Subject|3|||
145906872|NCT01177059|526163468|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
145906873|NCT01177059|526163468|FG000|Overall Study|Withdrew consent|2|||
145906874|NCT01177059|526163468|FG000|Overall Study|Lost to Follow-up|18|||
145906875|NCT04051619|526163469|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
145906876|NCT04051619|526163470|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
145906877|NCT04051619|526163469|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
145906878|NCT04051619|526163470|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
145906879|NCT01200069|526165475|FG000|Overall Study|Withdrawal by Subject|0|||
145906880|NCT01200069|526165476|FG001|Overall Study|Withdrawal by Subject|1|||
145906881|NCT00070499|526165477|FG000|Overall Study|Adverse Event|6|||
145906882|NCT00070499|526165478|FG001|Overall Study|Adverse Event|6|||
145906883|NCT00070499|526165479|FG002|Overall Study|Adverse Event|19|||
145906884|NCT00070499|526165480|FG003|Overall Study|Adverse Event|15|||
145906885|NCT00070499|526165477|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
145906886|NCT00070499|526165478|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
145906887|NCT00070499|526165479|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
145906888|NCT00070499|526165480|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
145906889|NCT00070499|526165477|FG000|Overall Study|Progression/relapse|4|||
145906890|NCT00070499|526165478|FG001|Overall Study|Progression/relapse|2|||
145906891|NCT00070499|526165479|FG002|Overall Study|Progression/relapse|1|||
145906892|NCT00070499|526165480|FG003|Overall Study|Progression/relapse|4|||
145906893|NCT00070499|526165477|FG000|Overall Study|Death|1|||
145906894|NCT00070499|526165478|FG001|Overall Study|Death|1|||
145906895|NCT00070499|526165479|FG002|Overall Study|Death|1|||
145906896|NCT00070499|526165480|FG003|Overall Study|Death|2|||
145906897|NCT00070499|526165477|FG000|Overall Study|Other - not protocol specified|7|||
145906898|NCT00070499|526165478|FG001|Overall Study|Other - not protocol specified|3|||
145906899|NCT00070499|526165479|FG002|Overall Study|Other - not protocol specified|12|||
145906900|NCT00070499|526165480|FG003|Overall Study|Other - not protocol specified|20|||
145906901|NCT00070499|526165477|FG000|Overall Study|Still on protocol treatment|10|||
145906902|NCT00070499|526165478|FG001|Overall Study|Still on protocol treatment|4|||
145906903|NCT00070499|526165479|FG002|Overall Study|Still on protocol treatment|79|||
145906904|NCT00070499|526165480|FG003|Overall Study|Still on protocol treatment|57|||
145906905|NCT00070499|526165477|FG000|Overall Study|Did not start treatment|1|||
145906906|NCT00070499|526165478|FG001|Overall Study|Did not start treatment|0|||
145906907|NCT00070499|526165479|FG002|Overall Study|Did not start treatment|0|||
146297412|NCT01641809|527604695|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
145906908|NCT00070499|526165480|FG003|Overall Study|Did not start treatment|2|||
145906909|NCT00070499|526165477|FG000|Overall Study|Not eligible|2|||
145906910|NCT00070499|526165478|FG001|Overall Study|Not eligible|5|||
145906911|NCT00070499|526165479|FG002|Overall Study|Not eligible|3|||
145906912|NCT00070499|526165480|FG003|Overall Study|Not eligible|2|||
145906913|NCT01924754|526165481|FG000|Overall Study|Lost to Follow-up|1|||
145906914|NCT01924754|526165482|FG001|Overall Study|Lost to Follow-up|2|||
145906915|NCT01924754|526165483|FG002|Overall Study|Lost to Follow-up|1|||
145906916|NCT01924754|526165481|FG000|Overall Study|Pregnancy|0|||
145906917|NCT01924754|526165482|FG001|Overall Study|Pregnancy|1|||
145906918|NCT01924754|526165483|FG002|Overall Study|Pregnancy|2|||
145906919|NCT02899195|526165486|FG000|Concurrent Durvalumab|Adverse Event|4|||
145906920|NCT02899195|526165486|FG000|Concurrent Durvalumab|Physician Decision|1|||
145906921|NCT02899195|526165486|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
145906922|NCT02899195|526165486|FG000|Concurrent Durvalumab|Progressive Disease|5|||
145906923|NCT02899195|526165486|FG000|Maintenance Durvalumab|Adverse Event|1|||
145906924|NCT02899195|526165486|FG000|Maintenance Durvalumab|Physician Decision|1|||
145906925|NCT02899195|526165486|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
145906926|NCT02899195|526165486|FG000|Maintenance Durvalumab|Progressive Disease|31|||
145906927|NCT04778904|526165487|FG000|Overall Study|Protocol Violation|1|||
145906928|NCT04778904|526165488|FG001|Overall Study|Protocol Violation|0|||
145906929|NCT04778904|526165489|FG002|Overall Study|Protocol Violation|0|||
145906930|NCT04778904|526165490|FG003|Overall Study|Protocol Violation|0|||
145906931|NCT04778904|526165487|FG000|Overall Study|Withdrawal by Subject|0|||
145906932|NCT04778904|526165488|FG001|Overall Study|Withdrawal by Subject|0|||
145906933|NCT04778904|526165489|FG002|Overall Study|Withdrawal by Subject|1|||
145906934|NCT04778904|526165490|FG003|Overall Study|Withdrawal by Subject|0|||
145906935|NCT03452137|526165491|FG000|Overall Study|Death|67|||
145906936|NCT03452137|526165492|FG001|Overall Study|Death|70|||
145906937|NCT03452137|526165491|FG000|Overall Study|Lost to Follow-up|4|||
145906938|NCT03452137|526165492|FG001|Overall Study|Lost to Follow-up|2|||
145906939|NCT03452137|526165491|FG000|Overall Study|Physician Decision|0|||
145906940|NCT03452137|526165492|FG001|Overall Study|Physician Decision|1|||
145906941|NCT03452137|526165491|FG000|Overall Study|Study Terminated by Sponsor|120|||
145906942|NCT03452137|526165492|FG001|Overall Study|Study Terminated by Sponsor|121|||
145906943|NCT03452137|526165491|FG000|Overall Study|Withdrawal by Subject|12|||
145906944|NCT03452137|526165492|FG001|Overall Study|Withdrawal by Subject|9|||
145906945|NCT04138043|526165493|FG000|Overall Study|Withdrawal by Subject|0|||
145906946|NCT04138043|526165494|FG001|Overall Study|Withdrawal by Subject|1|||
145906947|NCT03772717|526165495|FG000|Overall Study|Withdrawal by Subject|2|||
145906948|NCT02856802|526165496|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
145906949|NCT02856802|526165497|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
145906950|NCT02856802|526165496|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
145906951|NCT02856802|526165497|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
145906952|NCT02856802|526165496|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
145906953|NCT02856802|526165497|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
145906954|NCT02856802|526165496|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
145906955|NCT02856802|526165497|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
145906956|NCT02856802|526165496|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
145906957|NCT02856802|526165497|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
145906958|NCT02856802|526165496|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
145906959|NCT02856802|526165497|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
145906960|NCT00587860|526165498|FG000|Overall Study|Lost to Follow-up|2|||
145906961|NCT00587860|526165499|FG001|Overall Study|Lost to Follow-up|2|||
145906962|NCT00587860|526165498|FG000|Overall Study|Withdrawal by Subject|3|||
145906963|NCT00587860|526165499|FG001|Overall Study|Withdrawal by Subject|3|||
145906964|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
145906965|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
145906966|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
145906967|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
145906968|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
145906969|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
145906970|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
145906971|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
146297413|NCT01641809|527604692|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
145906972|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
145906973|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
145906974|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
145972814|NCT01020123|526412786|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
145972815|NCT01020123|526412787|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
145906975|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
145906976|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
145906977|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
145906978|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
145906979|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
145906980|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
145972816|NCT01020123|526412788|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
145972817|NCT01020123|526412782|FG000|Main Period|Adverse Event|5|||
145972818|NCT01020123|526412783|FG001|Main Period|Adverse Event|2|||
145972819|NCT01020123|526412784|FG002|Main Period|Adverse Event|2|||
145972820|NCT01020123|526412785|FG003|Main Period|Adverse Event|1|||
145972821|NCT01020123|526412786|FG004|Main Period|Adverse Event|1|||
145972822|NCT01020123|526412787|FG005|Main Period|Adverse Event|2|||
145972823|NCT01020123|526412788|FG006|Main Period|Adverse Event|1|||
145972824|NCT01020123|526412782|FG000|Main Period|Protocol Violation|4|||
145972825|NCT01020123|526412783|FG001|Main Period|Protocol Violation|4|||
145972826|NCT01020123|526412784|FG002|Main Period|Protocol Violation|2|||
145972827|NCT01020123|526412785|FG003|Main Period|Protocol Violation|5|||
145972828|NCT01020123|526412786|FG004|Main Period|Protocol Violation|2|||
145972829|NCT01020123|526412787|FG005|Main Period|Protocol Violation|3|||
145972830|NCT01020123|526412788|FG006|Main Period|Protocol Violation|2|||
145972831|NCT01020123|526412782|FG000|Main Period|Lost to Follow-up|0|||
145972832|NCT01020123|526412783|FG001|Main Period|Lost to Follow-up|2|||
145972833|NCT01020123|526412784|FG002|Main Period|Lost to Follow-up|0|||
145972834|NCT01020123|526412785|FG003|Main Period|Lost to Follow-up|0|||
146088481|NCT02129777|526843858|FG003|Double-Blind Period|Pregnancy|0|||
145906981|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
145906982|NCT00261443|526165500|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
145906983|NCT00261443|526165501|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
145906984|NCT00261443|526165502|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
145906985|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
145906986|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
145906987|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
145906988|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
145906989|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
145906990|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
145906991|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
145906992|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
145906993|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
145906994|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
145906995|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
145906996|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
145906997|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
145906998|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
145906999|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
145907000|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
145907001|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
145907002|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
145907003|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
145907004|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
145907005|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
145907006|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
145907007|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
145907008|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
145907009|NCT00261443|526165500|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
145907010|NCT00261443|526165501|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
145907011|NCT00261443|526165502|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
145907012|NCT00261443|526165500|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
145907013|NCT00261443|526165501|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
145907014|NCT00261443|526165502|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
145907015|NCT00261443|526165500|FG000|3: Assessment of Relapse|Adverse Event|0|||
145907016|NCT00261443|526165501|FG001|3: Assessment of Relapse|Adverse Event|15|||
145907017|NCT00261443|526165502|FG002|3: Assessment of Relapse|Adverse Event|19|||
145907018|NCT00261443|526165500|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
145907019|NCT00261443|526165501|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
145907020|NCT00261443|526165502|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
145907021|NCT00261443|526165500|FG000|3: Assessment of Relapse|Death|0|||
145907022|NCT00261443|526165501|FG001|3: Assessment of Relapse|Death|0|||
145907023|NCT00261443|526165502|FG002|3: Assessment of Relapse|Death|1|||
145907024|NCT00261443|526165500|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
145907025|NCT00261443|526165501|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
145972835|NCT01020123|526412786|FG004|Main Period|Lost to Follow-up|0|||
145972836|NCT01020123|526412787|FG005|Main Period|Lost to Follow-up|0|||
145972837|NCT01020123|526412788|FG006|Main Period|Lost to Follow-up|0|||
145972838|NCT01020123|526412782|FG000|Main Period|Unclasified|2|||
145972839|NCT01020123|526412783|FG001|Main Period|Unclasified|0|||
145972840|NCT01020123|526412784|FG002|Main Period|Unclasified|1|||
145972841|NCT01020123|526412785|FG003|Main Period|Unclasified|0|||
145972842|NCT01020123|526412786|FG004|Main Period|Unclasified|1|||
145907026|NCT00261443|526165502|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
145907027|NCT00261443|526165500|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
145907028|NCT00261443|526165501|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
145907029|NCT00261443|526165502|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
145907030|NCT00261443|526165500|FG000|3: Assessment of Relapse|Pregnancy|0|||
145907031|NCT00261443|526165501|FG001|3: Assessment of Relapse|Pregnancy|2|||
145907032|NCT00261443|526165502|FG002|3: Assessment of Relapse|Pregnancy|1|||
145907033|NCT00261443|526165500|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
145907034|NCT00261443|526165501|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
145907035|NCT00261443|526165502|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
145907036|NCT00261443|526165500|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
145907037|NCT00261443|526165501|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
145907038|NCT00261443|526165502|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
145907039|NCT00261443|526165500|FG000|3: Assessment of Relapse|Other Reasons|0|||
145907040|NCT00261443|526165501|FG001|3: Assessment of Relapse|Other Reasons|4|||
145907041|NCT00261443|526165502|FG002|3: Assessment of Relapse|Other Reasons|3|||
145907042|NCT00261443|526165500|FG000|4: Extension Phase|Adverse Event|0|||
145907043|NCT00261443|526165501|FG001|4: Extension Phase|Adverse Event|1|||
145907044|NCT00261443|526165502|FG002|4: Extension Phase|Adverse Event|0|||
145907045|NCT00261443|526165500|FG000|4: Extension Phase|Withdrawal by Subject|0|||
145907046|NCT00261443|526165501|FG001|4: Extension Phase|Withdrawal by Subject|1|||
145907047|NCT00261443|526165502|FG002|4: Extension Phase|Withdrawal by Subject|2|||
145907048|NCT00261443|526165500|FG000|4: Extension Phase|Lost to Follow-up|0|||
145907049|NCT00261443|526165501|FG001|4: Extension Phase|Lost to Follow-up|1|||
145907050|NCT00261443|526165502|FG002|4: Extension Phase|Lost to Follow-up|0|||
145907051|NCT01286753|526165503|FG000|Overall Study|Adverse Event|7|||
145907052|NCT01286753|526165504|FG001|Overall Study|Adverse Event|6|||
145907053|NCT01286753|526165503|FG000|Overall Study|Progression|11|||
145907054|NCT01286753|526165504|FG001|Overall Study|Progression|13|||
145907055|NCT01286753|526165503|FG000|Overall Study|Refused Treatment|1|||
145907056|NCT01286753|526165504|FG001|Overall Study|Refused Treatment|0|||
145907057|NCT01286753|526165503|FG000|Overall Study|Withdrawal of Consent|0|||
145907058|NCT01286753|526165504|FG001|Overall Study|Withdrawal of Consent|2|||
145907059|NCT01286753|526165503|FG000|Overall Study|Discontinued to Join Extension Study|6|||
145907060|NCT01286753|526165504|FG001|Overall Study|Discontinued to Join Extension Study|4|||
145907061|NCT01286753|526165503|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
145907062|NCT01286753|526165504|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
145907063|NCT00923273|526165516|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145907064|NCT00923273|526165517|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145907065|NCT00923273|526165518|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145907066|NCT00923273|526165519|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
145907067|NCT00923273|526165520|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145907068|NCT00923273|526165516|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145907069|NCT00923273|526165517|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145907070|NCT00923273|526165518|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145907071|NCT00923273|526165519|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
145907072|NCT00923273|526165520|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145907073|NCT00605540|526165521|FG000|Overall Study|Death|15|||
145907074|NCT00605540|526165521|FG000|Overall Study|Lost to Follow-up|23|||
145907075|NCT02540850|526165522|FG000|Overall Study|Lost to Follow-up|69|||
145907076|NCT02540850|526165523|FG001|Overall Study|Lost to Follow-up|66|||
145907077|NCT02540850|526165524|FG002|Overall Study|Lost to Follow-up|34|||
145907078|NCT00264550|526165525|FG000|Overall Study|Death|0|||
145907079|NCT00264550|526165526|FG001|Overall Study|Death|3|||
145907080|NCT00264550|526165527|FG002|Overall Study|Death|0|||
145907081|NCT00264550|526165528|FG003|Overall Study|Death|0|||
146239177|NCT00019604|527389707|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
146239178|NCT00019604|527389707|FG000|Overall Study|Going to have liver transplant|1|||
146239179|NCT00019604|527389707|FG000|Overall Study|Move to a different study|1|||
146239180|NCT00019604|527389707|FG000|Overall Study|Non compliant on systemic CH|1|||
146239181|NCT00019604|527389707|FG000|Overall Study|Non compliant|1|||
146239182|NCT00019604|527389707|FG000|Overall Study|Resectable disease|1|||
145907082|NCT00264550|526165525|FG000|Overall Study|Lost to Follow-up|3|||
145907083|NCT00264550|526165526|FG001|Overall Study|Lost to Follow-up|1|||
145907084|NCT00264550|526165527|FG002|Overall Study|Lost to Follow-up|1|||
145907085|NCT00264550|526165528|FG003|Overall Study|Lost to Follow-up|1|||
145907086|NCT00264550|526165525|FG000|Overall Study|Adverse Event|23|||
145907087|NCT00264550|526165526|FG001|Overall Study|Adverse Event|18|||
145907088|NCT00264550|526165527|FG002|Overall Study|Adverse Event|9|||
145907089|NCT00264550|526165528|FG003|Overall Study|Adverse Event|14|||
146239183|NCT00019604|527389707|FG000|Overall Study|Started new chemo regimen|1|||
146239184|NCT00019604|527389707|FG000|Overall Study|Pt going to immunotherapy study|1|||
146239185|NCT00019604|527389707|FG000|Overall Study|Too much disease|1|||
145907090|NCT00264550|526165525|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145907091|NCT00264550|526165526|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
145907092|NCT00264550|526165527|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
145907093|NCT00264550|526165528|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
145907094|NCT00264550|526165525|FG000|Overall Study|Discontinued oral study agent|0|||
145907095|NCT00264550|526165526|FG001|Overall Study|Discontinued oral study agent|1|||
145907096|NCT00264550|526165527|FG002|Overall Study|Discontinued oral study agent|0|||
145907097|NCT00264550|526165528|FG003|Overall Study|Discontinued oral study agent|0|||
145907098|NCT00264550|526165525|FG000|Overall Study|Other|13|||
145907099|NCT00264550|526165526|FG001|Overall Study|Other|7|||
145907100|NCT00264550|526165527|FG002|Overall Study|Other|3|||
145907101|NCT00264550|526165528|FG003|Overall Study|Other|9|||
145907102|NCT02246114|526165531|FG000|Overall Study|miscarriage|1|||
145907103|NCT02246114|526165532|FG001|Overall Study|miscarriage|0|||
145907104|NCT00129389|526165538|FG000|Overall Study|Adverse Event|19|||
145907105|NCT00129389|526165539|FG001|Overall Study|Adverse Event|87|||
145907106|NCT00129389|526165538|FG000|Overall Study|Death|0|||
145907107|NCT00129389|526165539|FG001|Overall Study|Death|1|||
145907108|NCT00129389|526165538|FG000|Overall Study|Lost to Follow-up|2|||
145907109|NCT00129389|526165539|FG001|Overall Study|Lost to Follow-up|1|||
145907110|NCT00129389|526165538|FG000|Overall Study|Physician Decision|0|||
145907111|NCT00129389|526165539|FG001|Overall Study|Physician Decision|4|||
145907112|NCT00129389|526165538|FG000|Overall Study|Protocol Violation|0|||
145907113|NCT00129389|526165539|FG001|Overall Study|Protocol Violation|6|||
145907114|NCT00129389|526165538|FG000|Overall Study|Withdrawal by Subject|9|||
145907115|NCT00129389|526165539|FG001|Overall Study|Withdrawal by Subject|23|||
145907116|NCT00129389|526165538|FG000|Overall Study|Relapse|1|||
145907117|NCT00129389|526165539|FG001|Overall Study|Relapse|0|||
145907118|NCT00129389|526165538|FG000|Overall Study|Not eligible|1|||
145907119|NCT00129389|526165539|FG001|Overall Study|Not eligible|2|||
145907120|NCT00129389|526165538|FG000|Overall Study|Crossed to the other arm|1|||
145907121|NCT00129389|526165539|FG001|Overall Study|Crossed to the other arm|16|||
145907122|NCT02794246|526165541|FG000|Overall Study|Withdrawal by Subject|2|||
145907123|NCT02794246|526165541|FG000|Overall Study|Physician Decision|4|||
145907124|NCT04611529|526165542|FG000|2-day Follow up|Lost to Follow-up|5|||
145907125|NCT04611529|526165543|FG001|2-day Follow up|Lost to Follow-up|6|||
145907126|NCT04611529|526165544|FG002|2-day Follow up|Lost to Follow-up|3|||
145907127|NCT01831258|526165608|FG000|Overall Study|Withdrawal by Subject|2|||
145907128|NCT01831258|526165609|FG001|Overall Study|Withdrawal by Subject|1|||
145907129|NCT01831258|526165608|FG000|Overall Study|Lost to Follow-up|3|||
145907130|NCT01831258|526165609|FG001|Overall Study|Lost to Follow-up|2|||
145907131|NCT02564887|526165618|FG000|Overall Study|Lost to Follow-up|6|||
145907132|NCT02564887|526165619|FG001|Overall Study|Lost to Follow-up|0|||
145907133|NCT01199016|526165620|FG000|Overall Study|No longer meets eligibility criteria|4|||
145907134|NCT01199016|526165620|FG000|Overall Study|Entrance criteria|5|||
145907135|NCT01199016|526165620|FG000|Overall Study|Protocol Violation|9|||
145907136|NCT01199016|526165620|FG000|Overall Study|Other|13|||
145907137|NCT01199016|526165620|FG000|Overall Study|Withdrawal by Subject|21|||
145907138|NCT01199016|526165620|FG000|Overall Study|Lost to Follow-up|25|||
145907139|NCT02368314|526165629|FG000|Overall Study|Withdrawal by Subject|2|||
145907140|NCT02368314|526165630|FG001|Overall Study|Withdrawal by Subject|1|||
145907141|NCT02368314|526165629|FG000|Overall Study|Adverse Event|1|||
145907142|NCT02368314|526165630|FG001|Overall Study|Adverse Event|2|||
145907143|NCT02752087|526165631|FG000|Washout|Physician Decision|1|||
145907144|NCT02752087|526165632|FG001|Washout|Physician Decision|0|||
145907145|NCT02458287|526165633|FG000|Overall Study|Adverse Event|0|||
145907146|NCT02458287|526165634|FG001|Overall Study|Adverse Event|0|||
145907147|NCT02458287|526165635|FG002|Overall Study|Adverse Event|0|||
145907148|NCT02458287|526165636|FG003|Overall Study|Adverse Event|1|||
145907149|NCT02458287|526165633|FG000|Overall Study|Lost to Follow-up|0|||
145907150|NCT02458287|526165634|FG001|Overall Study|Lost to Follow-up|1|||
145907151|NCT02458287|526165635|FG002|Overall Study|Lost to Follow-up|1|||
145972843|NCT01020123|526412787|FG005|Main Period|Unclasified|3|||
145972844|NCT01020123|526412788|FG006|Main Period|Unclasified|6|||
145907152|NCT02458287|526165636|FG003|Overall Study|Lost to Follow-up|0|||
145907153|NCT02458287|526165633|FG000|Overall Study|Protocol Violation|0|||
145907154|NCT02458287|526165634|FG001|Overall Study|Protocol Violation|1|||
145907155|NCT02458287|526165635|FG002|Overall Study|Protocol Violation|0|||
145907156|NCT02458287|526165636|FG003|Overall Study|Protocol Violation|0|||
145907157|NCT02458287|526165633|FG000|Overall Study|Withdrawal by Subject|0|||
145907158|NCT02458287|526165634|FG001|Overall Study|Withdrawal by Subject|2|||
145907159|NCT02458287|526165635|FG002|Overall Study|Withdrawal by Subject|2|||
145907160|NCT02458287|526165636|FG003|Overall Study|Withdrawal by Subject|1|||
145907161|NCT02458287|526165633|FG000|Overall Study|Relocated Out of State|0|||
145907162|NCT02458287|526165634|FG001|Overall Study|Relocated Out of State|0|||
145907163|NCT02458287|526165635|FG002|Overall Study|Relocated Out of State|0|||
145907164|NCT02458287|526165636|FG003|Overall Study|Relocated Out of State|1|||
145907165|NCT00843635|526165637|FG000|Overall Study|Adverse Event|2|||
145907166|NCT00843635|526165638|FG001|Overall Study|Adverse Event|2|||
145907167|NCT00843635|526165639|FG002|Overall Study|Adverse Event|0|||
145907168|NCT00863772|526165643|FG000|Overall Study|Adverse Event|1|||
145907169|NCT00863772|526165644|FG001|Overall Study|Adverse Event|4|||
145907170|NCT00863772|526165645|FG002|Overall Study|Adverse Event|0|||
145907171|NCT00863772|526165643|FG000|Overall Study|Lack of Efficacy|4|||
145907172|NCT00863772|526165644|FG001|Overall Study|Lack of Efficacy|2|||
145907173|NCT00863772|526165645|FG002|Overall Study|Lack of Efficacy|4|||
145907174|NCT00863772|526165643|FG000|Overall Study|Lost to Follow-up|5|||
145907175|NCT00863772|526165644|FG001|Overall Study|Lost to Follow-up|1|||
145907176|NCT00863772|526165645|FG002|Overall Study|Lost to Follow-up|1|||
145907177|NCT00863772|526165643|FG000|Overall Study|Protocol Violation|2|||
145907178|NCT00863772|526165644|FG001|Overall Study|Protocol Violation|0|||
145907179|NCT00863772|526165645|FG002|Overall Study|Protocol Violation|2|||
145907180|NCT00863772|526165643|FG000|Overall Study|Withdrawal by Subject|4|||
145907181|NCT00863772|526165644|FG001|Overall Study|Withdrawal by Subject|7|||
145907182|NCT00863772|526165645|FG002|Overall Study|Withdrawal by Subject|5|||
145907183|NCT00863772|526165643|FG000|Overall Study|Study terminated by sponsor|44|||
145907184|NCT00863772|526165644|FG001|Overall Study|Study terminated by sponsor|45|||
145907185|NCT00863772|526165645|FG002|Overall Study|Study terminated by sponsor|36|||
145907186|NCT00863772|526165643|FG000|Overall Study|Entered extension study|6|||
145907187|NCT00863772|526165644|FG001|Overall Study|Entered extension study|4|||
145907188|NCT00863772|526165645|FG002|Overall Study|Entered extension study|9|||
145907189|NCT00863772|526165643|FG000|Overall Study|Other|1|||
145907190|NCT00863772|526165644|FG001|Overall Study|Other|2|||
145907191|NCT00863772|526165645|FG002|Overall Study|Other|4|||
145907192|NCT00863772|526165643|FG000|Overall Study|Randomized but not Treated|1|||
145907193|NCT00863772|526165644|FG001|Overall Study|Randomized but not Treated|0|||
145907194|NCT00863772|526165645|FG002|Overall Study|Randomized but not Treated|0|||
145907195|NCT00086281|526165646|FG000|Phase 1|Adverse Event|0|||
145907196|NCT00086281|526165647|FG001|Phase 1|Adverse Event|0|||
145907197|NCT00086281|526165648|FG002|Phase 1|Adverse Event|0|||
145907198|NCT00086281|526165649|FG003|Phase 1|Adverse Event|0|||
145907199|NCT00086281|526165650|FG004|Phase 1|Adverse Event|0|||
145907200|NCT00086281|526165651|FG005|Phase 1|Adverse Event|0|||
145907201|NCT00086281|526165652|FG006|Phase 1|Adverse Event|0|||
145907202|NCT00086281|526165653|FG007|Phase 1|Adverse Event|0|||
145907203|NCT00086281|526165654|FG008|Phase 1|Adverse Event|0|||
145907204|NCT00086281|526165655|FG009|Phase 1|Adverse Event|1|||
145907205|NCT00086281|526165656|FG010|Phase 1|Adverse Event|2|||
145907206|NCT00086281|526165657|FG011|Phase 1|Adverse Event|1|||
145907207|NCT00086281|526165658|FG012|Phase 1|Adverse Event|1|||
145907208|NCT00086281|526165659|FG013|Phase 1|Adverse Event|1|||
145907209|NCT00086281|526165660|FG014|Phase 1|Adverse Event|2|||
145907210|NCT00086281|526165646|FG000|Phase 1|Protocol Violation|0|||
145907211|NCT00086281|526165647|FG001|Phase 1|Protocol Violation|0|||
145907212|NCT00086281|526165648|FG002|Phase 1|Protocol Violation|0|||
145907213|NCT00086281|526165649|FG003|Phase 1|Protocol Violation|0|||
145907214|NCT00086281|526165650|FG004|Phase 1|Protocol Violation|0|||
145907215|NCT00086281|526165651|FG005|Phase 1|Protocol Violation|0|||
146239186|NCT00019604|527389707|FG000|Overall Study|Unable to evaluate|1|||
146239187|NCT00019604|527389707|FG000|Overall Study|Details for other not available|4|||
146239188|NCT00454194|527389722|FG000|Overall Study|Adverse Event|7|||
146239189|NCT00454194|527389723|FG001|Overall Study|Adverse Event|2|||
146239190|NCT00454194|527389722|FG000|Overall Study|Withdrawal by Subject|12|||
146239191|NCT00454194|527389723|FG001|Overall Study|Withdrawal by Subject|8|||
146239192|NCT00454194|527389722|FG000|Overall Study|Other Medical Problems|1|||
145907216|NCT00086281|526165652|FG006|Phase 1|Protocol Violation|0|||
145907217|NCT00086281|526165653|FG007|Phase 1|Protocol Violation|0|||
145907218|NCT00086281|526165654|FG008|Phase 1|Protocol Violation|0|||
145907219|NCT00086281|526165655|FG009|Phase 1|Protocol Violation|0|||
145907220|NCT00086281|526165656|FG010|Phase 1|Protocol Violation|1|||
145907221|NCT00086281|526165657|FG011|Phase 1|Protocol Violation|0|||
145907222|NCT00086281|526165658|FG012|Phase 1|Protocol Violation|0|||
145907223|NCT00086281|526165659|FG013|Phase 1|Protocol Violation|0|||
145972845|NCT01020123|526412782|FG000|Extention Period|Withdrawal by Subject|2|||
146239193|NCT00454194|527389723|FG001|Overall Study|Other Medical Problems|2|||
145907224|NCT00086281|526165660|FG014|Phase 1|Protocol Violation|0|||
145907225|NCT00086281|526165646|FG000|Phase 1|Serious Adverse Event|0|||
145907226|NCT00086281|526165647|FG001|Phase 1|Serious Adverse Event|0|||
145907227|NCT00086281|526165648|FG002|Phase 1|Serious Adverse Event|0|||
145907228|NCT00086281|526165649|FG003|Phase 1|Serious Adverse Event|0|||
145907229|NCT00086281|526165650|FG004|Phase 1|Serious Adverse Event|0|||
145907230|NCT00086281|526165651|FG005|Phase 1|Serious Adverse Event|0|||
145907231|NCT00086281|526165652|FG006|Phase 1|Serious Adverse Event|0|||
145907232|NCT00086281|526165653|FG007|Phase 1|Serious Adverse Event|0|||
145907233|NCT00086281|526165654|FG008|Phase 1|Serious Adverse Event|0|||
145907234|NCT00086281|526165655|FG009|Phase 1|Serious Adverse Event|0|||
145907235|NCT00086281|526165656|FG010|Phase 1|Serious Adverse Event|0|||
145907236|NCT00086281|526165657|FG011|Phase 1|Serious Adverse Event|0|||
145907237|NCT00086281|526165658|FG012|Phase 1|Serious Adverse Event|0|||
145907238|NCT00086281|526165659|FG013|Phase 1|Serious Adverse Event|0|||
145907239|NCT00086281|526165660|FG014|Phase 1|Serious Adverse Event|1|||
145907240|NCT00086281|526165646|FG000|Phase 2|Adverse Event|0|||
145907241|NCT00086281|526165647|FG001|Phase 2|Adverse Event|0|||
145907242|NCT00086281|526165648|FG002|Phase 2|Adverse Event|0|||
145907243|NCT00086281|526165649|FG003|Phase 2|Adverse Event|0|||
145907244|NCT00086281|526165650|FG004|Phase 2|Adverse Event|0|||
145907245|NCT00086281|526165651|FG005|Phase 2|Adverse Event|0|||
145907246|NCT00086281|526165652|FG006|Phase 2|Adverse Event|0|||
145907247|NCT00086281|526165653|FG007|Phase 2|Adverse Event|0|||
145907248|NCT00086281|526165654|FG008|Phase 2|Adverse Event|0|||
145907249|NCT00086281|526165655|FG009|Phase 2|Adverse Event|0|||
145907250|NCT00086281|526165656|FG010|Phase 2|Adverse Event|0|||
145907251|NCT00086281|526165657|FG011|Phase 2|Adverse Event|0|||
145907252|NCT00086281|526165658|FG012|Phase 2|Adverse Event|1|||
145907253|NCT00086281|526165659|FG013|Phase 2|Adverse Event|1|||
145907254|NCT00086281|526165660|FG014|Phase 2|Adverse Event|0|||
145907255|NCT03456453|526165663|FG000|Overall Study|Withdrawal by Subject|2|||
145907256|NCT03456453|526165664|FG001|Overall Study|Withdrawal by Subject|0|||
145907257|NCT03456453|526165663|FG000|Overall Study|Not released to community|1|||
145907258|NCT03456453|526165664|FG001|Overall Study|Not released to community|5|||
145907259|NCT03456453|526165663|FG000|Overall Study|Lost to Follow-up|0|||
145907260|NCT03456453|526165664|FG001|Overall Study|Lost to Follow-up|2|||
145907261|NCT00896480|526165665|FG000|Overall Study|Disease progression/recurrence|21|||
145907262|NCT00205803|526165667|FG000|Infant Series|Lost to Follow-up|10|||
145907263|NCT00205803|526165668|FG001|Infant Series|Lost to Follow-up|4|||
145907264|NCT00205803|526165667|FG000|Infant Series|Withdrawal by Subject|2|||
145907265|NCT00205803|526165668|FG001|Infant Series|Withdrawal by Subject|5|||
145907266|NCT00205803|526165667|FG000|Infant Series|Physician Decision|3|||
145907267|NCT00205803|526165668|FG001|Infant Series|Physician Decision|1|||
145907268|NCT00205803|526165667|FG000|Infant Series|Protocol Violation|1|||
145907269|NCT00205803|526165668|FG001|Infant Series|Protocol Violation|0|||
145907270|NCT00205803|526165667|FG000|Infant Series|Lost Kaiser coverage|0|||
145907271|NCT00205803|526165668|FG001|Infant Series|Lost Kaiser coverage|1|||
145907272|NCT00205803|526165667|FG000|Infant Series|Non-compliant|1|||
145972846|NCT01020123|526412783|FG001|Extention Period|Withdrawal by Subject|1|||
145972847|NCT01020123|526412784|FG002|Extention Period|Withdrawal by Subject|1|||
145972848|NCT01020123|526412785|FG003|Extention Period|Withdrawal by Subject|0|||
145972849|NCT01020123|526412786|FG004|Extention Period|Withdrawal by Subject|0|||
145972850|NCT01020123|526412787|FG005|Extention Period|Withdrawal by Subject|0|||
145972851|NCT01020123|526412788|FG006|Extention Period|Withdrawal by Subject|0|||
145972852|NCT01020123|526412782|FG000|Extention Period|Adverse Event|0|||
145907273|NCT00205803|526165668|FG001|Infant Series|Non-compliant|0|||
145907274|NCT00205803|526165667|FG000|Infant Series|Sponsor request|1|||
145907275|NCT00205803|526165668|FG001|Infant Series|Sponsor request|0|||
145907276|NCT00205803|526165667|FG000|After Infant Series|Adverse Event|1|||
145907277|NCT00205803|526165668|FG001|After Infant Series|Adverse Event|1|||
145907278|NCT00205803|526165667|FG000|After Infant Series|Protocol Violation|1|||
145907279|NCT00205803|526165668|FG001|After Infant Series|Protocol Violation|1|||
145907280|NCT00205803|526165667|FG000|After Infant Series|Lost to Follow-up|2|||
145907281|NCT00205803|526165668|FG001|After Infant Series|Lost to Follow-up|1|||
145907282|NCT00205803|526165667|FG000|After Infant Series|Physician Decision|3|||
145907283|NCT00205803|526165668|FG001|After Infant Series|Physician Decision|2|||
145907284|NCT00205803|526165667|FG000|After Infant Series|Withdrawal by Subject|1|||
145907285|NCT00205803|526165668|FG001|After Infant Series|Withdrawal by Subject|4|||
145907286|NCT00205803|526165667|FG000|After Infant Series|Other|10|||
145907287|NCT00205803|526165668|FG001|After Infant Series|Other|4|||
145907288|NCT00205803|526165667|FG000|Toddler Dose|Lost to Follow-up|2|||
145907289|NCT00205803|526165668|FG001|Toddler Dose|Lost to Follow-up|3|||
145907290|NCT03255655|526165672|FG000|Overall Study|Lost to Follow-up|7|||
145907291|NCT03255655|526165673|FG001|Overall Study|Lost to Follow-up|4|||
145907292|NCT00658021|526165674|FG000|28-Week Treatment Period|Adverse Event|3|||
145972853|NCT01020123|526412783|FG001|Extention Period|Adverse Event|0|||
145907293|NCT00658021|526165675|FG001|28-Week Treatment Period|Adverse Event|1|||
145907294|NCT00658021|526165676|FG002|28-Week Treatment Period|Adverse Event|0|||
145907295|NCT00658021|526165674|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
145907296|NCT00658021|526165675|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
145907297|NCT00658021|526165676|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
145907298|NCT00658021|526165674|FG000|28-Week Treatment Period|Protocol Violation|0|||
145907299|NCT00658021|526165675|FG001|28-Week Treatment Period|Protocol Violation|2|||
145907300|NCT00658021|526165676|FG002|28-Week Treatment Period|Protocol Violation|1|||
145907301|NCT00658021|526165674|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
145907302|NCT00658021|526165675|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
145907303|NCT00658021|526165676|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
145972854|NCT01020123|526412784|FG002|Extention Period|Adverse Event|0|||
145907304|NCT00658021|526165674|FG000|28-Week Treatment Period|Physician Decision|1|||
145907305|NCT00658021|526165675|FG001|28-Week Treatment Period|Physician Decision|2|||
145907306|NCT00658021|526165676|FG002|28-Week Treatment Period|Physician Decision|1|||
145907307|NCT00658021|526165674|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145907308|NCT00658021|526165675|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145907309|NCT00658021|526165676|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145907310|NCT00658021|526165674|FG000|28-Week Treatment Period|Loss of glucose control|1|||
145907311|NCT00658021|526165675|FG001|28-Week Treatment Period|Loss of glucose control|1|||
145907312|NCT00658021|526165676|FG002|28-Week Treatment Period|Loss of glucose control|10|||
145907313|NCT00658021|526165674|FG000|28-Week Treatment Period|Other|2|||
145907314|NCT00658021|526165675|FG001|28-Week Treatment Period|Other|3|||
145907315|NCT00658021|526165676|FG002|28-Week Treatment Period|Other|1|||
145907316|NCT00658021|526165674|FG000|28-Week Treatment Period|Did not receive treatment|2|||
145907317|NCT00658021|526165675|FG001|28-Week Treatment Period|Did not receive treatment|0|||
145907318|NCT00658021|526165676|FG002|28-Week Treatment Period|Did not receive treatment|0|||
145907319|NCT00658021|526165674|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
145907320|NCT00658021|526165675|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
145907321|NCT00658021|526165676|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
145907322|NCT00658021|526165674|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
145907323|NCT00658021|526165675|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
145907324|NCT00658021|526165676|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
145907325|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
145907326|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
145907327|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907328|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907329|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907330|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907331|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907332|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907333|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907334|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145907335|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
145907336|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
145907337|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907338|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907339|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907340|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907341|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907342|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907343|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907344|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145907345|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907346|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
145907347|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907348|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907349|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907350|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907351|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907352|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907353|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907354|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145907355|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
145907356|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907357|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907358|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907359|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907360|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
146088482|NCT02129777|526843859|FG004|Double-Blind Period|Pregnancy|1|||
146088483|NCT02129777|526843860|FG005|Double-Blind Period|Pregnancy|0|||
145907361|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907362|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907363|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907364|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145907365|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
145907366|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
145907367|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
146088484|NCT02129777|526843861|FG006|Double-Blind Period|Pregnancy|0|||
146088485|NCT02129777|526843855|FG000|Double-Blind Period|Lack of Efficacy|3|||
145907368|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907369|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907370|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907371|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907372|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907373|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907374|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145907375|NCT04784533|526165679|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
145907376|NCT04784533|526165680|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
145907377|NCT04784533|526165681|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907378|NCT04784533|526165682|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907379|NCT04784533|526165683|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907380|NCT04784533|526165684|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907381|NCT04784533|526165685|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907382|NCT04784533|526165686|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907383|NCT04784533|526165687|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907384|NCT04784533|526165688|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145907385|NCT04784533|526165679|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907386|NCT04784533|526165680|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907387|NCT04784533|526165681|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
145907388|NCT04784533|526165682|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907389|NCT04784533|526165683|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907390|NCT04784533|526165684|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907391|NCT04784533|526165685|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907392|NCT04784533|526165686|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907393|NCT04784533|526165687|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907394|NCT04784533|526165688|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145907395|NCT04784533|526165679|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907396|NCT04784533|526165680|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907397|NCT04784533|526165681|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907398|NCT04784533|526165682|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907399|NCT04784533|526165683|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907400|NCT04784533|526165684|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907401|NCT04784533|526165685|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907402|NCT04784533|526165686|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907403|NCT04784533|526165687|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
145907404|NCT04784533|526165688|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145907405|NCT04784533|526165679|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907406|NCT04784533|526165680|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907407|NCT04784533|526165681|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907408|NCT04784533|526165682|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907409|NCT04784533|526165683|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907410|NCT04784533|526165684|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907411|NCT04784533|526165685|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907412|NCT04784533|526165686|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145907413|NCT04784533|526165687|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
145907414|NCT04784533|526165688|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
145907415|NCT02542605|526165705|FG000|Part B: Challenge Phase|Sponsor decision|1|||
145907416|NCT02542605|526165706|FG001|Part B: Challenge Phase|Sponsor decision|0|||
145907417|NCT02542605|526165707|FG002|Part B: Challenge Phase|Sponsor decision|0|||
145907418|NCT02542605|526165705|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
145907419|NCT02542605|526165706|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
145907420|NCT02542605|526165707|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
145907421|NCT02682927|526165708|FG000|Overall Study|Adverse Event|0|||
145907422|NCT02682927|526165709|FG001|Overall Study|Adverse Event|0|||
145907423|NCT02682927|526165710|FG002|Overall Study|Adverse Event|5|||
145907424|NCT02682927|526165711|FG003|Overall Study|Adverse Event|1|||
145907425|NCT02682927|526165712|FG004|Overall Study|Adverse Event|0|||
145907426|NCT02682927|526165713|FG005|Overall Study|Adverse Event|2|||
145907427|NCT02682927|526165708|FG000|Overall Study|Death|0|||
145907428|NCT02682927|526165709|FG001|Overall Study|Death|0|||
145907429|NCT02682927|526165710|FG002|Overall Study|Death|0|||
145907430|NCT02682927|526165711|FG003|Overall Study|Death|1|||
145907431|NCT02682927|526165712|FG004|Overall Study|Death|0|||
145907432|NCT02682927|526165713|FG005|Overall Study|Death|0|||
145907433|NCT02682927|526165708|FG000|Overall Study|Lack of Efficacy|1|||
145907434|NCT02682927|526165709|FG001|Overall Study|Lack of Efficacy|0|||
145907435|NCT02682927|526165710|FG002|Overall Study|Lack of Efficacy|0|||
145907436|NCT02682927|526165711|FG003|Overall Study|Lack of Efficacy|1|||
145907437|NCT02682927|526165712|FG004|Overall Study|Lack of Efficacy|0|||
145907438|NCT02682927|526165713|FG005|Overall Study|Lack of Efficacy|0|||
145972855|NCT01020123|526412785|FG003|Extention Period|Adverse Event|1|||
145972856|NCT01020123|526412786|FG004|Extention Period|Adverse Event|0|||
145972857|NCT01020123|526412787|FG005|Extention Period|Adverse Event|0|||
145972858|NCT01020123|526412788|FG006|Extention Period|Adverse Event|0|||
145972859|NCT01020123|526412782|FG000|Extention Period|Protocol Violation|1|||
145972860|NCT01020123|526412783|FG001|Extention Period|Protocol Violation|1|||
145972861|NCT01020123|526412784|FG002|Extention Period|Protocol Violation|1|||
145972862|NCT01020123|526412785|FG003|Extention Period|Protocol Violation|0|||
145907439|NCT02682927|526165708|FG000|Overall Study|Other|0|||
145907440|NCT02682927|526165709|FG001|Overall Study|Other|0|||
145907441|NCT02682927|526165710|FG002|Overall Study|Other|0|||
145907442|NCT02682927|526165711|FG003|Overall Study|Other|2|||
145907443|NCT02682927|526165712|FG004|Overall Study|Other|0|||
145907444|NCT02682927|526165713|FG005|Overall Study|Other|0|||
145907445|NCT02682927|526165708|FG000|Overall Study|Withdrawal by Subject|2|||
145907446|NCT02682927|526165709|FG001|Overall Study|Withdrawal by Subject|0|||
145907447|NCT02682927|526165710|FG002|Overall Study|Withdrawal by Subject|1|||
145907448|NCT02682927|526165711|FG003|Overall Study|Withdrawal by Subject|0|||
145907449|NCT02682927|526165712|FG004|Overall Study|Withdrawal by Subject|1|||
145907450|NCT02682927|526165713|FG005|Overall Study|Withdrawal by Subject|1|||
145907451|NCT03408639|526167146|FG000|Overall Study|Death|5|||
145907452|NCT03408639|526167147|FG001|Overall Study|Death|5|||
145907453|NCT03408639|526167146|FG000|Overall Study|Lost to Follow-up|1|||
145907454|NCT03408639|526167147|FG001|Overall Study|Lost to Follow-up|4|||
145907455|NCT03408639|526167146|FG000|Overall Study|Withdrawal by Subject|2|||
145907456|NCT03408639|526167147|FG001|Overall Study|Withdrawal by Subject|7|||
145907457|NCT03408639|526167146|FG000|Overall Study|Physician Decision|3|||
145907458|NCT03408639|526167147|FG001|Overall Study|Physician Decision|6|||
145907459|NCT04998851|526167148|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
145907460|NCT04998851|526167149|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
145907461|NCT04998851|526167148|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
145907462|NCT04998851|526167149|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
145907463|NCT03132155|526167150|FG000|Overall Study|Lack of Efficacy|6|||
145907464|NCT03132155|526167150|FG000|Overall Study|Lost to Follow-up|1|||
145907465|NCT03132155|526167150|FG000|Overall Study|Withdrawal by Subject|1|||
145907466|NCT02925403|526167154|FG000|Overall Study|Lost to Follow-up|0|||
145907467|NCT02925403|526167155|FG001|Overall Study|Lost to Follow-up|1|||
145907468|NCT02126826|526167156|FG000|Overall Study|Withdrawal by Subject|0|||
145907469|NCT02126826|526167157|FG001|Overall Study|Withdrawal by Subject|0|||
145907470|NCT02126826|526167158|FG002|Overall Study|Withdrawal by Subject|0|||
145907471|NCT02126826|526167159|FG003|Overall Study|Withdrawal by Subject|1|||
145907472|NCT02126826|526167160|FG004|Overall Study|Withdrawal by Subject|0|||
145907473|NCT02126826|526167161|FG005|Overall Study|Withdrawal by Subject|0|||
145907474|NCT02126826|526167162|FG006|Overall Study|Withdrawal by Subject|0|||
145907475|NCT04971187|526167163|FG000|Overall Study|Screen failures|2|||
145907476|NCT00591773|526167164|FG000|Overall Study|Adverse Event|9|||
145907477|NCT00591773|526167165|FG001|Overall Study|Adverse Event|9|||
145907478|NCT00591773|526167166|FG002|Overall Study|Adverse Event|6|||
145907479|NCT00591773|526167164|FG000|Overall Study|Protocol Violation|2|||
145907480|NCT00591773|526167165|FG001|Overall Study|Protocol Violation|3|||
145907481|NCT00591773|526167166|FG002|Overall Study|Protocol Violation|0|||
145907482|NCT00591773|526167164|FG000|Overall Study|Lost to Follow-up|1|||
145907483|NCT00591773|526167165|FG001|Overall Study|Lost to Follow-up|4|||
145907484|NCT00591773|526167166|FG002|Overall Study|Lost to Follow-up|1|||
145907485|NCT00591773|526167164|FG000|Overall Study|Withdrawal by Subject|2|||
145907486|NCT00591773|526167165|FG001|Overall Study|Withdrawal by Subject|5|||
145907487|NCT00591773|526167166|FG002|Overall Study|Withdrawal by Subject|3|||
145907488|NCT00591773|526167164|FG000|Overall Study|Lack of Efficacy|1|||
145907489|NCT00591773|526167165|FG001|Overall Study|Lack of Efficacy|2|||
145907490|NCT00591773|526167166|FG002|Overall Study|Lack of Efficacy|2|||
145907491|NCT00591773|526167164|FG000|Overall Study|Other|1|||
145907492|NCT00591773|526167165|FG001|Overall Study|Other|1|||
145907493|NCT00591773|526167166|FG002|Overall Study|Other|4|||
145907494|NCT02135614|526167167|FG000|Overall Study|Randomized but Not Treated|2|||
145907495|NCT02135614|526167168|FG001|Overall Study|Randomized but Not Treated|1|||
145907496|NCT02135614|526167167|FG000|Overall Study|Adverse Event|0|||
145907497|NCT02135614|526167168|FG001|Overall Study|Adverse Event|1|||
145907498|NCT02135614|526167167|FG000|Overall Study|Death|1|||
145907499|NCT02135614|526167168|FG001|Overall Study|Death|0|||
145907500|NCT02135614|526167167|FG000|Overall Study|Investigator's Discretion|0|||
145907501|NCT02135614|526167168|FG001|Overall Study|Investigator's Discretion|1|||
145907502|NCT02135614|526167167|FG000|Overall Study|Withdrew Consent|2|||
145907503|NCT02135614|526167168|FG001|Overall Study|Withdrew Consent|2|||
145907504|NCT02135614|526167167|FG000|Overall Study|Lost to Follow-up|3|||
145907505|NCT02135614|526167168|FG001|Overall Study|Lost to Follow-up|0|||
145907506|NCT01207583|526167176|FG000|Overall Study|Withdrawal by Subject|0|||
145972863|NCT01020123|526412786|FG004|Extention Period|Protocol Violation|0|||
145907507|NCT01207583|526167177|FG001|Overall Study|Withdrawal by Subject|3|||
145907508|NCT01207583|526167178|FG002|Overall Study|Withdrawal by Subject|1|||
145907509|NCT01207583|526167176|FG000|Overall Study|Participant failed to return|1|||
145907510|NCT01207583|526167177|FG001|Overall Study|Participant failed to return|0|||
145907511|NCT01207583|526167178|FG002|Overall Study|Participant failed to return|0|||
145907512|NCT01207583|526167176|FG000|Overall Study|Lost to Follow-up|0|||
145907513|NCT01207583|526167177|FG001|Overall Study|Lost to Follow-up|2|||
145907514|NCT01207583|526167178|FG002|Overall Study|Lost to Follow-up|0|||
145907515|NCT03743415|526167179|FG000|Overall Study|Death|5|||
145907516|NCT03743415|526167180|FG001|Overall Study|Death|3|||
145907517|NCT03743415|526167181|FG002|Overall Study|Death|1|||
145907518|NCT03743415|526167182|FG003|Overall Study|Death|4|||
145907519|NCT03743415|526167183|FG004|Overall Study|Death|0|||
145907520|NCT03743415|526167184|FG005|Overall Study|Death|0|||
145907521|NCT03743415|526167185|FG006|Overall Study|Death|0|||
145907522|NCT03743415|526167186|FG007|Overall Study|Death|0|||
145907523|NCT03743415|526167187|FG008|Overall Study|Death|1|||
145907524|NCT03743415|526167188|FG009|Overall Study|Death|0|||
145907525|NCT03743415|526167179|FG000|Overall Study|Withdrawal by Subject|1|||
145907526|NCT03743415|526167180|FG001|Overall Study|Withdrawal by Subject|0|||
145907527|NCT03743415|526167181|FG002|Overall Study|Withdrawal by Subject|4|||
145907528|NCT03743415|526167182|FG003|Overall Study|Withdrawal by Subject|5|||
145907529|NCT03743415|526167183|FG004|Overall Study|Withdrawal by Subject|5|||
145907530|NCT03743415|526167184|FG005|Overall Study|Withdrawal by Subject|2|||
145907531|NCT03743415|526167185|FG006|Overall Study|Withdrawal by Subject|2|||
145907532|NCT03743415|526167186|FG007|Overall Study|Withdrawal by Subject|5|||
145907533|NCT03743415|526167187|FG008|Overall Study|Withdrawal by Subject|9|||
145907534|NCT03743415|526167188|FG009|Overall Study|Withdrawal by Subject|10|||
145907535|NCT03743415|526167179|FG000|Overall Study|Lost to Follow-up|2|||
145907536|NCT03743415|526167180|FG001|Overall Study|Lost to Follow-up|0|||
145907537|NCT03743415|526167181|FG002|Overall Study|Lost to Follow-up|2|||
145907538|NCT03743415|526167182|FG003|Overall Study|Lost to Follow-up|1|||
145907539|NCT03743415|526167183|FG004|Overall Study|Lost to Follow-up|1|||
145907540|NCT03743415|526167184|FG005|Overall Study|Lost to Follow-up|0|||
145907541|NCT03743415|526167185|FG006|Overall Study|Lost to Follow-up|1|||
145907542|NCT03743415|526167186|FG007|Overall Study|Lost to Follow-up|4|||
145907543|NCT03743415|526167187|FG008|Overall Study|Lost to Follow-up|13|||
145907544|NCT03743415|526167188|FG009|Overall Study|Lost to Follow-up|13|||
145907545|NCT02679235|526167189|FG000|Overall Study|Withdrawal by Subject|3|||
145907546|NCT02679235|526167189|FG000|Overall Study|Adverse Event|1|||
145907547|NCT00094861|526167190|FG000|Overall Study|Adverse Event|5|||
145907548|NCT00094861|526167191|FG001|Overall Study|Adverse Event|2|||
145907549|NCT00094861|526167190|FG000|Overall Study|Withdrawal by Subject|5|||
145907550|NCT00094861|526167191|FG001|Overall Study|Withdrawal by Subject|3|||
145907551|NCT00094861|526167190|FG000|Overall Study|Physician Decision|1|||
145907552|NCT00094861|526167191|FG001|Overall Study|Physician Decision|1|||
145907553|NCT00094861|526167190|FG000|Overall Study|Lost to Follow-up|0|||
145907554|NCT00094861|526167191|FG001|Overall Study|Lost to Follow-up|1|||
145907555|NCT00094861|526167190|FG000|Overall Study|Death|4|||
146239194|NCT00454194|527389722|FG000|Overall Study|Other Unspecified Reason|2|||
146239195|NCT00454194|527389723|FG001|Overall Study|Other Unspecified Reason|2|||
146239196|NCT00586313|527389731|FG000|Overall Study|Lack of Efficacy|2|||
146239197|NCT03205566|527389733|FG000|Phase 1|Protocol Violation|1|||
146239198|NCT03205566|527389734|FG001|Phase 1|Protocol Violation|1|||
146239199|NCT03184987|527389735|FG000|Overall Study|Withdrawal by Subject|0|||
145907556|NCT00094861|526167191|FG001|Overall Study|Death|2|||
145907557|NCT00094861|526167190|FG000|Overall Study|Other|3|||
145907558|NCT00094861|526167191|FG001|Overall Study|Other|0|||
145907559|NCT02473523|526167194|FG000|Overall Study|Death|1|||
145907560|NCT02473523|526167194|FG000|Overall Study|Lost to Follow-up|1|||
145907561|NCT01191944|526167195|FG000|Overall Study|Adverse Event|11|||
145907562|NCT01191944|526167196|FG001|Overall Study|Adverse Event|12|||
145907563|NCT01191944|526167195|FG000|Overall Study|Protocol Violation|1|||
145972864|NCT01020123|526412787|FG005|Extention Period|Protocol Violation|0|||
145907564|NCT01191944|526167196|FG001|Overall Study|Protocol Violation|2|||
145907565|NCT01191944|526167195|FG000|Overall Study|Withdrawal by Subject|4|||
145907566|NCT01191944|526167196|FG001|Overall Study|Withdrawal by Subject|2|||
145907567|NCT01191944|526167195|FG000|Overall Study|Other|1|||
145907568|NCT01191944|526167196|FG001|Overall Study|Other|3|||
145907569|NCT00253448|526167199|FG000|Overall Study|Withdrawal by Subject|1|||
145907570|NCT02052011|526167201|FG000|Overall Study|Lost to Follow-up|3|||
145907571|NCT02052011|526167202|FG001|Overall Study|Lost to Follow-up|0|||
145907572|NCT02052011|526167201|FG000|Overall Study|Withdrawal by Subject|1|||
145907573|NCT02052011|526167202|FG001|Overall Study|Withdrawal by Subject|2|||
145907574|NCT00000620|526167203|FG000|Overall Study|Death|86|||
145907575|NCT00000620|526167204|FG001|Overall Study|Death|67|||
145907576|NCT00000620|526167205|FG002|Overall Study|Death|112|||
145907577|NCT00000620|526167206|FG003|Overall Study|Death|126|||
145907578|NCT00000620|526167207|FG004|Overall Study|Death|64|||
145907579|NCT00000620|526167208|FG005|Overall Study|Death|77|||
145907580|NCT00000620|526167209|FG006|Overall Study|Death|91|||
146239200|NCT03184987|527389736|FG001|Overall Study|Withdrawal by Subject|1|||
145907581|NCT00000620|526167210|FG007|Overall Study|Death|95|||
145907582|NCT00000620|526167203|FG000|Overall Study|Lost to Follow-up|14|||
145907583|NCT00000620|526167204|FG001|Overall Study|Lost to Follow-up|14|||
145907584|NCT00000620|526167205|FG002|Overall Study|Lost to Follow-up|14|||
145907585|NCT00000620|526167206|FG003|Overall Study|Lost to Follow-up|14|||
145907586|NCT00000620|526167207|FG004|Overall Study|Lost to Follow-up|15|||
145907587|NCT00000620|526167208|FG005|Overall Study|Lost to Follow-up|15|||
145907588|NCT00000620|526167209|FG006|Overall Study|Lost to Follow-up|13|||
145907589|NCT00000620|526167210|FG007|Overall Study|Lost to Follow-up|14|||
145907590|NCT00000620|526167203|FG000|Overall Study|Withdrawal by Subject|40|||
145907591|NCT00000620|526167204|FG001|Overall Study|Withdrawal by Subject|27|||
145907592|NCT00000620|526167205|FG002|Overall Study|Withdrawal by Subject|28|||
145907593|NCT00000620|526167206|FG003|Overall Study|Withdrawal by Subject|27|||
145907594|NCT00000620|526167207|FG004|Overall Study|Withdrawal by Subject|30|||
145907595|NCT00000620|526167208|FG005|Overall Study|Withdrawal by Subject|32|||
145907596|NCT00000620|526167209|FG006|Overall Study|Withdrawal by Subject|32|||
145907597|NCT00000620|526167210|FG007|Overall Study|Withdrawal by Subject|21|||
145907598|NCT00000620|526167203|FG000|Overall Study|missed closeout visit|22|||
145907599|NCT00000620|526167204|FG001|Overall Study|missed closeout visit|28|||
145907600|NCT00000620|526167205|FG002|Overall Study|missed closeout visit|16|||
145907601|NCT00000620|526167206|FG003|Overall Study|missed closeout visit|11|||
145907602|NCT00000620|526167207|FG004|Overall Study|missed closeout visit|26|||
145907603|NCT00000620|526167208|FG005|Overall Study|missed closeout visit|28|||
145907604|NCT00000620|526167209|FG006|Overall Study|missed closeout visit|13|||
145907605|NCT00000620|526167210|FG007|Overall Study|missed closeout visit|16|||
145907606|NCT01851330|526167211|FG000|Overall Study|Lack of Efficacy|10|||
145907607|NCT01851330|526167212|FG001|Overall Study|Lack of Efficacy|9|||
145907608|NCT01851330|526167213|FG002|Overall Study|Lack of Efficacy|2|||
145907609|NCT01851330|526167211|FG000|Overall Study|Lost to Follow-up|1|||
145907610|NCT01851330|526167212|FG001|Overall Study|Lost to Follow-up|6|||
145907611|NCT01851330|526167213|FG002|Overall Study|Lost to Follow-up|9|||
145907612|NCT01851330|526167211|FG000|Overall Study|Withdrew Consent|2|||
145907613|NCT01851330|526167212|FG001|Overall Study|Withdrew Consent|1|||
145907614|NCT01851330|526167213|FG002|Overall Study|Withdrew Consent|0|||
145907615|NCT01851330|526167211|FG000|Overall Study|Investigator's Discretion|0|||
145907616|NCT01851330|526167212|FG001|Overall Study|Investigator's Discretion|0|||
145907617|NCT01851330|526167213|FG002|Overall Study|Investigator's Discretion|1|||
145907618|NCT02648932|526167214|FG000|Overall Study|No transplant|3|||
145907619|NCT02648932|526167215|FG001|Overall Study|No transplant|1|||
145907620|NCT01307111|526167218|FG000|IUD Insertion|Lost to Follow-up|2|||
145907621|NCT01307111|526167219|FG001|IUD Insertion|Lost to Follow-up|0|||
145907622|NCT01307111|526167218|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
145907623|NCT01307111|526167219|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
145907624|NCT01275729|526167223|FG000|Overall Study|Death|3|||
145907625|NCT01275729|526167223|FG000|Overall Study|Withdrawal by Subject|1|||
145907626|NCT02252406|526167224|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
145907627|NCT02252406|526167225|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
145907628|NCT02252406|526167224|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
145907629|NCT02252406|526167225|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
145907630|NCT02252406|526167224|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
145907631|NCT02252406|526167225|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
145907632|NCT02252406|526167224|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
145907633|NCT02252406|526167225|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
145907634|NCT02252406|526167224|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
145907635|NCT02252406|526167225|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
145907636|NCT01994850|526167227|FG000|Overall Study|Physician Decision|1|||
145907637|NCT01994850|526167227|FG000|Overall Study|Withdrawal by Subject|1|||
145907638|NCT00182325|526167231|FG000|Overall Study|Lost to Follow-up|7|||
145907639|NCT00182325|526167232|FG001|Overall Study|Lost to Follow-up|7|||
145907640|NCT00182325|526167231|FG000|Overall Study|Miscarriage|5|||
145907641|NCT00182325|526167232|FG001|Overall Study|Miscarriage|3|||
145907642|NCT00182325|526167231|FG000|Overall Study|Did not complete survey|22|||
145907643|NCT00182325|526167232|FG001|Overall Study|Did not complete survey|43|||
146088486|NCT02129777|526843856|FG001|Double-Blind Period|Lack of Efficacy|1|||
145907644|NCT01420965|526167235|FG000|Overall Study|Withdrawal by Subject|1|||
145907645|NCT01420965|526167236|FG001|Overall Study|Withdrawal by Subject|0|||
145907646|NCT01420965|526167237|FG002|Overall Study|Withdrawal by Subject|0|||
145907647|NCT01420965|526167235|FG000|Overall Study|Adverse Event|0|||
145907648|NCT01420965|526167236|FG001|Overall Study|Adverse Event|1|||
145907649|NCT01420965|526167237|FG002|Overall Study|Adverse Event|0|||
145907650|NCT01890434|526167274|FG000|Overall Study|Adverse Event|8|||
145907651|NCT01890434|526167274|FG000|Overall Study|PCI at external hospital|1|||
145907652|NCT01890434|526167274|FG000|Overall Study|Assessment discrepancy|1|||
145907653|NCT01890434|526167274|FG000|Overall Study|CRC didn't contact participant for FU|1|||
145907654|NCT01890434|526167274|FG000|Overall Study|Could not get whole set of images|1|||
145907655|NCT01890434|526167274|FG000|Overall Study|Decline to return for GSPECT|1|||
145907656|NCT01890434|526167274|FG000|Overall Study|GSPECT at rest was not done|1|||
145907657|NCT01890434|526167274|FG000|Overall Study|Participant didn't complete MRI|1|||
145907658|NCT01890434|526167274|FG000|Overall Study|Uncontactable by phone|1|||
145907659|NCT01890434|526167274|FG000|Overall Study|Moved out of position|1|||
145907660|NCT01890434|526167274|FG000|Overall Study|Unable to contact|1|||
145907661|NCT01890434|526167274|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
145907662|NCT03280381|526167275|FG000|Overall Study|Physician Decision|0|||
145907663|NCT03280381|526167276|FG001|Overall Study|Physician Decision|2|||
145907664|NCT01267994|526167279|FG000|Overall Study|Adverse Event|2|||
145907665|NCT02655666|526167280|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
145907666|NCT00895414|526167283|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
145907667|NCT00895414|526167284|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
145907668|NCT00895414|526167283|FG000|First Intervention (14 Days)|Physician Decision|0|||
145907669|NCT00895414|526167284|FG001|First Intervention (14 Days)|Physician Decision|1|||
145907670|NCT05199090|526167289|FG000|Overall Study|Adverse Event|1|||
145907671|NCT05199090|526167290|FG001|Overall Study|Adverse Event|4|||
145907672|NCT05199090|526167291|FG002|Overall Study|Adverse Event|0|||
145907673|NCT05199090|526167292|FG003|Overall Study|Adverse Event|0|||
145907674|NCT05199090|526167293|FG004|Overall Study|Adverse Event|0|||
145907675|NCT05199090|526167294|FG005|Overall Study|Adverse Event|0|||
145907676|NCT05199090|526167289|FG000|Overall Study|Lost to Follow-up|1|||
145907677|NCT05199090|526167290|FG001|Overall Study|Lost to Follow-up|0|||
145907678|NCT05199090|526167291|FG002|Overall Study|Lost to Follow-up|1|||
145907679|NCT05199090|526167292|FG003|Overall Study|Lost to Follow-up|4|||
145907680|NCT05199090|526167293|FG004|Overall Study|Lost to Follow-up|0|||
145907681|NCT05199090|526167294|FG005|Overall Study|Lost to Follow-up|5|||
145907682|NCT05199090|526167289|FG000|Overall Study|Physician Decision|0|||
145907683|NCT05199090|526167290|FG001|Overall Study|Physician Decision|0|||
145907684|NCT05199090|526167291|FG002|Overall Study|Physician Decision|0|||
145907685|NCT05199090|526167292|FG003|Overall Study|Physician Decision|0|||
145907686|NCT05199090|526167293|FG004|Overall Study|Physician Decision|0|||
145907687|NCT05199090|526167294|FG005|Overall Study|Physician Decision|1|||
145907688|NCT05199090|526167289|FG000|Overall Study|Study terminated by sponsor|0|||
145907689|NCT05199090|526167290|FG001|Overall Study|Study terminated by sponsor|6|||
145907690|NCT05199090|526167291|FG002|Overall Study|Study terminated by sponsor|0|||
145907691|NCT05199090|526167292|FG003|Overall Study|Study terminated by sponsor|0|||
145907692|NCT05199090|526167293|FG004|Overall Study|Study terminated by sponsor|0|||
145907693|NCT05199090|526167294|FG005|Overall Study|Study terminated by sponsor|5|||
145907694|NCT05199090|526167289|FG000|Overall Study|Subject decision|0|||
145907695|NCT05199090|526167290|FG001|Overall Study|Subject decision|4|||
145907696|NCT05199090|526167291|FG002|Overall Study|Subject decision|0|||
145907697|NCT05199090|526167292|FG003|Overall Study|Subject decision|2|||
145907698|NCT05199090|526167293|FG004|Overall Study|Subject decision|5|||
145907699|NCT05199090|526167294|FG005|Overall Study|Subject decision|2|||
145907700|NCT03489109|526167295|FG000|Overall Study|Lost to Follow-up|1|||
145907701|NCT03489109|526167296|FG001|Overall Study|Lost to Follow-up|2|||
145907702|NCT02181790|526167297|FG000|Overall Study|study terminated|2|||
145907703|NCT02181790|526167298|FG001|Overall Study|study terminated|0|||
145907704|NCT03276078|526167299|FG000|Overall Study|Adverse Event|1|||
145907705|NCT02552732|526167300|FG000|Overall Study|Lost to Follow-up|2|||
145907706|NCT02552732|526167300|FG000|Overall Study|Physician Decision|1|||
145907707|NCT02552732|526167300|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
145907708|NCT02552732|526167300|FG000|Overall Study|Withdrawal by Subject|6|||
145907709|NCT01275430|526167302|FG000|Overall Study|Adverse Event|1|||
145907710|NCT01275430|526167302|FG000|Overall Study|No Contrast Injection|6|||
145907711|NCT01275430|526167302|FG000|Overall Study|Device Malfunction|1|||
145907712|NCT01275430|526167302|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
145907713|NCT04988087|526167303|FG000|Overall Study|Adverse Event|4|||
145907714|NCT04988087|526167304|FG001|Overall Study|Adverse Event|0|||
146239201|NCT03184987|527389737|FG002|Overall Study|Withdrawal by Subject|2|||
146239202|NCT03184987|527389735|FG000|Overall Study|Physician Decision|0|||
145907715|NCT04988087|526167305|FG002|Overall Study|Adverse Event|0|||
145907716|NCT04988087|526167306|FG003|Overall Study|Adverse Event|0|||
145907717|NCT04988087|526167303|FG000|Overall Study|Withdrawal by Subject|1|||
145907718|NCT04988087|526167304|FG001|Overall Study|Withdrawal by Subject|1|||
145907719|NCT04988087|526167305|FG002|Overall Study|Withdrawal by Subject|0|||
145907720|NCT04988087|526167306|FG003|Overall Study|Withdrawal by Subject|0|||
145907721|NCT04988087|526167303|FG000|Overall Study|Technical problems|7|||
145907722|NCT04988087|526167304|FG001|Overall Study|Technical problems|9|||
145907723|NCT04988087|526167305|FG002|Overall Study|Technical problems|1|||
145907724|NCT04988087|526167306|FG003|Overall Study|Technical problems|2|||
145907725|NCT02613182|526167307|FG000|Overall Study|Death|6|||
145907726|NCT02613182|526167307|FG000|Overall Study|Physician Decision|1|||
145907727|NCT02613182|526167307|FG000|Overall Study|Study Terminated by Sponsor|21|||
145907728|NCT02613182|526167307|FG000|Overall Study|Withdrawal by Subject|6|||
145907729|NCT01547130|526167308|FG000|Overall Study|Lost to Follow-up|9|||
145907730|NCT01547130|526167309|FG001|Overall Study|Lost to Follow-up|5|||
146239203|NCT03184987|527389736|FG001|Overall Study|Physician Decision|0|||
145907731|NCT03968978|526167310|FG000|Overall Study|Adverse Event|1|||
145907732|NCT03968978|526167311|FG001|Overall Study|Adverse Event|0|||
145907733|NCT02714426|526167312|FG000|Overall Study|Withdrawal by Subject|2|||
145907734|NCT02714426|526167313|FG001|Overall Study|Withdrawal by Subject|2|||
145907735|NCT00025259|526167315|FG000|Overall Study|Death|1|||
145907736|NCT00025259|526167316|FG001|Overall Study|Death|3|||
145907737|NCT00025259|526167317|FG002|Overall Study|Death|0|||
145907738|NCT00025259|526167318|FG003|Overall Study|Death|3|||
145907739|NCT00025259|526167319|FG004|Overall Study|Death|0|||
145907740|NCT00025259|526167320|FG005|Overall Study|Death|1|||
145907741|NCT00025259|526167321|FG006|Overall Study|Death|2|||
145907742|NCT00025259|526167315|FG000|Overall Study|Lack of Efficacy|2|||
145907743|NCT00025259|526167316|FG001|Overall Study|Lack of Efficacy|46|||
146239204|NCT03184987|527389737|FG002|Overall Study|Physician Decision|1|||
146239205|NCT03184987|527389735|FG000|Overall Study|Adverse Event|1|||
145907744|NCT00025259|526167317|FG002|Overall Study|Lack of Efficacy|60|||
145907745|NCT00025259|526167318|FG003|Overall Study|Lack of Efficacy|78|||
145907746|NCT00025259|526167319|FG004|Overall Study|Lack of Efficacy|11|||
145907747|NCT00025259|526167320|FG005|Overall Study|Lack of Efficacy|30|||
145907748|NCT00025259|526167321|FG006|Overall Study|Lack of Efficacy|38|||
145907749|NCT00025259|526167315|FG000|Overall Study|Lost to Follow-up|2|||
145907750|NCT00025259|526167316|FG001|Overall Study|Lost to Follow-up|9|||
145907751|NCT00025259|526167317|FG002|Overall Study|Lost to Follow-up|13|||
145907752|NCT00025259|526167318|FG003|Overall Study|Lost to Follow-up|13|||
145907753|NCT00025259|526167319|FG004|Overall Study|Lost to Follow-up|1|||
145907754|NCT00025259|526167320|FG005|Overall Study|Lost to Follow-up|3|||
145907755|NCT00025259|526167321|FG006|Overall Study|Lost to Follow-up|1|||
145907756|NCT00025259|526167315|FG000|Overall Study|Physician Decision|12|||
145907757|NCT00025259|526167316|FG001|Overall Study|Physician Decision|1|||
145907758|NCT00025259|526167317|FG002|Overall Study|Physician Decision|0|||
145907759|NCT00025259|526167318|FG003|Overall Study|Physician Decision|5|||
145907760|NCT00025259|526167319|FG004|Overall Study|Physician Decision|4|||
145907761|NCT00025259|526167320|FG005|Overall Study|Physician Decision|2|||
145907762|NCT00025259|526167321|FG006|Overall Study|Physician Decision|1|||
145907763|NCT00025259|526167315|FG000|Overall Study|Protocol Violation|3|||
145907764|NCT00025259|526167316|FG001|Overall Study|Protocol Violation|2|||
145907765|NCT00025259|526167317|FG002|Overall Study|Protocol Violation|2|||
145907766|NCT00025259|526167318|FG003|Overall Study|Protocol Violation|1|||
145907767|NCT00025259|526167319|FG004|Overall Study|Protocol Violation|2|||
145907768|NCT00025259|526167320|FG005|Overall Study|Protocol Violation|1|||
145907769|NCT00025259|526167321|FG006|Overall Study|Protocol Violation|3|||
145907770|NCT00025259|526167315|FG000|Overall Study|Withdrawal by Subject|9|||
145907771|NCT00025259|526167316|FG001|Overall Study|Withdrawal by Subject|27|||
145907772|NCT00025259|526167317|FG002|Overall Study|Withdrawal by Subject|6|||
145907773|NCT00025259|526167318|FG003|Overall Study|Withdrawal by Subject|14|||
145907774|NCT00025259|526167319|FG004|Overall Study|Withdrawal by Subject|11|||
145907775|NCT00025259|526167320|FG005|Overall Study|Withdrawal by Subject|8|||
145907776|NCT00025259|526167321|FG006|Overall Study|Withdrawal by Subject|3|||
145907777|NCT00025259|526167315|FG000|Overall Study|Ineligible|14|||
145907778|NCT00025259|526167316|FG001|Overall Study|Ineligible|1|||
145907779|NCT00025259|526167317|FG002|Overall Study|Ineligible|0|||
145907780|NCT00025259|526167318|FG003|Overall Study|Ineligible|0|||
145907781|NCT00025259|526167319|FG004|Overall Study|Ineligible|6|||
145907782|NCT00025259|526167320|FG005|Overall Study|Ineligible|0|||
145907783|NCT00025259|526167321|FG006|Overall Study|Ineligible|1|||
145907784|NCT00025259|526167315|FG000|Overall Study|Randomization error|1|||
145907785|NCT00025259|526167316|FG001|Overall Study|Randomization error|0|||
145907786|NCT00025259|526167317|FG002|Overall Study|Randomization error|0|||
145907787|NCT00025259|526167318|FG003|Overall Study|Randomization error|0|||
145907788|NCT00025259|526167319|FG004|Overall Study|Randomization error|1|||
145972865|NCT01020123|526412788|FG006|Extention Period|Protocol Violation|1|||
146239206|NCT03184987|527389736|FG001|Overall Study|Adverse Event|0|||
146239207|NCT03184987|527389737|FG002|Overall Study|Adverse Event|1|||
146239208|NCT01619059|527389744|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
145907789|NCT00025259|526167320|FG005|Overall Study|Randomization error|7|||
145907790|NCT00025259|526167321|FG006|Overall Study|Randomization error|2|||
145907791|NCT00025259|526167315|FG000|Overall Study|Adverse Event|1|||
145907792|NCT00025259|526167316|FG001|Overall Study|Adverse Event|0|||
145907793|NCT00025259|526167317|FG002|Overall Study|Adverse Event|0|||
145907794|NCT00025259|526167318|FG003|Overall Study|Adverse Event|0|||
145907795|NCT00025259|526167319|FG004|Overall Study|Adverse Event|0|||
145907796|NCT00025259|526167320|FG005|Overall Study|Adverse Event|0|||
145907797|NCT00025259|526167321|FG006|Overall Study|Adverse Event|0|||
145907798|NCT00908310|526167324|FG000|Overall Study|Death|37|||
145907799|NCT00908310|526167324|FG000|Overall Study|Withdrawal by Subject|7|||
145907800|NCT00908310|526167324|FG000|Overall Study|Lost to Follow-up|7|||
145907801|NCT00908310|526167324|FG000|Overall Study|Screening failure|5|||
146239209|NCT01619059|527389745|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
146239210|NCT01619059|527389744|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
145907802|NCT00908310|526167324|FG000|Overall Study|Other reasons|4|||
145907803|NCT02071849|526167325|FG000|6-month Primary Endpoint|Did not receive device|4|||
145907804|NCT02071849|526167325|FG000|6-month Primary Endpoint|Adverse Event|1|||
145907805|NCT02071849|526167325|FG000|2-year Extended Follow-up|Adverse Event|1|||
145907806|NCT00725205|526167328|FG000|Overall Study|Adverse Event|22|||
145907807|NCT00725205|526167328|FG000|Overall Study|Investigator Discontinued|1|||
145907808|NCT00725205|526167328|FG000|Overall Study|Non-compliance With Protocol|14|||
145907809|NCT00725205|526167328|FG000|Overall Study|Other|8|||
145907810|NCT00725205|526167328|FG000|Overall Study|Protocol Defined Clinical Event|1|||
145907811|NCT00725205|526167328|FG000|Overall Study|Treatment Failure|41|||
145907812|NCT05819203|526167329|FG000|Overall Study|Protocol Violation|1|||
145907813|NCT05819203|526167330|FG001|Overall Study|Protocol Violation|2|||
145907814|NCT05819203|526167329|FG000|Overall Study|Withdrawal by Subject|1|||
145907815|NCT05819203|526167330|FG001|Overall Study|Withdrawal by Subject|0|||
145907816|NCT04123561|526167333|FG000|Overall Study|Lost to Follow-up|20|||
145907817|NCT04123561|526167334|FG001|Overall Study|Lost to Follow-up|12|||
145907818|NCT04123561|526167335|FG002|Overall Study|Lost to Follow-up|5|||
145907819|NCT04123561|526167333|FG000|Overall Study|Withdrawal by Subject|9|||
145907820|NCT04123561|526167334|FG001|Overall Study|Withdrawal by Subject|7|||
145907821|NCT04123561|526167335|FG002|Overall Study|Withdrawal by Subject|9|||
145907822|NCT04123561|526167333|FG000|Overall Study|Lack of Efficacy|7|||
145907823|NCT04123561|526167334|FG001|Overall Study|Lack of Efficacy|8|||
145907824|NCT04123561|526167335|FG002|Overall Study|Lack of Efficacy|6|||
145907825|NCT04123561|526167333|FG000|Overall Study|Adverse Event|5|||
145907826|NCT04123561|526167334|FG001|Overall Study|Adverse Event|2|||
146088487|NCT02129777|526843857|FG002|Double-Blind Period|Lack of Efficacy|0|||
146088488|NCT02129777|526843858|FG003|Double-Blind Period|Lack of Efficacy|3|||
146088489|NCT02129777|526843859|FG004|Double-Blind Period|Lack of Efficacy|2|||
146088490|NCT02129777|526843860|FG005|Double-Blind Period|Lack of Efficacy|0|||
146088491|NCT02129777|526843861|FG006|Double-Blind Period|Lack of Efficacy|0|||
146088492|NCT02129777|526843855|FG000|Double-Blind Period|Other|1|||
146088493|NCT02129777|526843856|FG001|Double-Blind Period|Other|2|||
146088494|NCT02129777|526843857|FG002|Double-Blind Period|Other|0|||
146088495|NCT02129777|526843858|FG003|Double-Blind Period|Other|0|||
146088496|NCT02129777|526843859|FG004|Double-Blind Period|Other|0|||
146088497|NCT02129777|526843860|FG005|Double-Blind Period|Other|0|||
146088498|NCT02129777|526843861|FG006|Double-Blind Period|Other|0|||
146088499|NCT02129777|526843855|FG000|Open-Label Period|Lack of Efficacy|0|||
146088500|NCT02129777|526843856|FG001|Open-Label Period|Lack of Efficacy|0|||
146088501|NCT02129777|526843857|FG002|Open-Label Period|Lack of Efficacy|0|||
146088502|NCT02129777|526843858|FG003|Open-Label Period|Lack of Efficacy|0|||
146088503|NCT02129777|526843859|FG004|Open-Label Period|Lack of Efficacy|0|||
146088504|NCT02129777|526843860|FG005|Open-Label Period|Lack of Efficacy|0|||
146088505|NCT02129777|526843861|FG006|Open-Label Period|Lack of Efficacy|5|||
146088506|NCT02129777|526843855|FG000|Open-Label Period|Lost to Follow-up|0|||
146088507|NCT02129777|526843856|FG001|Open-Label Period|Lost to Follow-up|0|||
146088508|NCT02129777|526843857|FG002|Open-Label Period|Lost to Follow-up|0|||
146088509|NCT02129777|526843858|FG003|Open-Label Period|Lost to Follow-up|0|||
146088510|NCT02129777|526843859|FG004|Open-Label Period|Lost to Follow-up|0|||
146088511|NCT02129777|526843860|FG005|Open-Label Period|Lost to Follow-up|1|||
146088512|NCT02129777|526843861|FG006|Open-Label Period|Lost to Follow-up|1|||
146088513|NCT02129777|526843855|FG000|Open-Label Period|Withdrawal by Subject|0|||
146088514|NCT02129777|526843856|FG001|Open-Label Period|Withdrawal by Subject|0|||
146088515|NCT02129777|526843857|FG002|Open-Label Period|Withdrawal by Subject|0|||
146088516|NCT02129777|526843858|FG003|Open-Label Period|Withdrawal by Subject|0|||
146088517|NCT02129777|526843859|FG004|Open-Label Period|Withdrawal by Subject|0|||
146088518|NCT02129777|526843860|FG005|Open-Label Period|Withdrawal by Subject|1|||
146088519|NCT02129777|526843861|FG006|Open-Label Period|Withdrawal by Subject|3|||
146088520|NCT02129777|526843855|FG000|Open-Label Period|Study Termination|0|||
146088521|NCT02129777|526843856|FG001|Open-Label Period|Study Termination|0|||
146088522|NCT02129777|526843857|FG002|Open-Label Period|Study Termination|0|||
146088523|NCT02129777|526843858|FG003|Open-Label Period|Study Termination|0|||
146088524|NCT02129777|526843859|FG004|Open-Label Period|Study Termination|0|||
146088525|NCT02129777|526843860|FG005|Open-Label Period|Study Termination|10|||
146088526|NCT02129777|526843861|FG006|Open-Label Period|Study Termination|39|||
146088527|NCT01565499|526843863|FG000|Overall Study|Physician Decision|1|||
146088528|NCT01565499|526843863|FG000|Overall Study|Adverse Event|5|||
146088529|NCT01565499|526843863|FG000|Overall Study|Withdrawal by Subject|2|||
146088530|NCT01923168|526843870|FG000|Overall Study|Protocol Violation|1|||
146088531|NCT01923168|526843871|FG001|Overall Study|Protocol Violation|1|||
146088532|NCT01923168|526843872|FG002|Overall Study|Protocol Violation|0|||
146088533|NCT01923168|526843870|FG000|Overall Study|Subject/guardian decision|14|||
146088534|NCT01923168|526843871|FG001|Overall Study|Subject/guardian decision|14|||
145907827|NCT04123561|526167335|FG002|Overall Study|Adverse Event|3|||
145907828|NCT04123561|526167333|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
145907829|NCT04123561|526167334|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
145907830|NCT04123561|526167335|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
145907831|NCT04123561|526167333|FG000|Overall Study|Death|0|||
145907832|NCT04123561|526167334|FG001|Overall Study|Death|0|||
145907833|NCT04123561|526167335|FG002|Overall Study|Death|1|||
146297414|NCT01641809|527604693|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
145907834|NCT04123561|526167333|FG000|Overall Study|Protocol Violation|0|||
145907835|NCT04123561|526167334|FG001|Overall Study|Protocol Violation|1|||
145907836|NCT04123561|526167335|FG002|Overall Study|Protocol Violation|0|||
145907837|NCT03654599|526167339|FG000|Overall Study|Lost to Follow-up|14|||
145907838|NCT03654599|526167340|FG001|Overall Study|Lost to Follow-up|12|||
145907839|NCT03654599|526167339|FG000|Overall Study|Death|8|||
145907840|NCT03654599|526167340|FG001|Overall Study|Death|6|||
145907841|NCT03654599|526167339|FG000|Overall Study|Withdrawal by Subject|6|||
145907842|NCT03654599|526167340|FG001|Overall Study|Withdrawal by Subject|4|||
145907843|NCT03092219|526168593|FG000|Overall Study|Protocol Violation|7|||
145907844|NCT03092219|526168594|FG001|Overall Study|Protocol Violation|4|||
145907845|NCT03278626|526168595|FG000|Overall Study|Death|2|||
145907846|NCT03278626|526168595|FG000|Overall Study|Toxicity|1|||
145907847|NCT03278626|526168595|FG000|Overall Study|Disease Progression|2|||
145907848|NCT05013008|526168597|FG000|Overall Study|Exclusion from mBFAS|5|||
145907849|NCT05013008|526168598|FG001|Overall Study|Exclusion from mBFAS|25|||
145907850|NCT01443728|526168599|FG000|Overall Study|Lost to Follow-up|2|||
145907851|NCT01443728|526168600|FG001|Overall Study|Lost to Follow-up|0|||
145907852|NCT01443728|526168599|FG000|Overall Study|Withdrawal by Subject|1|||
145907853|NCT01443728|526168600|FG001|Overall Study|Withdrawal by Subject|1|||
145907854|NCT01443728|526168599|FG000|Overall Study|Adverse Event|0|||
145907855|NCT01443728|526168600|FG001|Overall Study|Adverse Event|2|||
145907856|NCT04981717|526168601|FG000|Overall Study|Protocol Violation|0|||
145907857|NCT04981717|526168602|FG001|Overall Study|Protocol Violation|3|||
145907858|NCT04981717|526168601|FG000|Overall Study|Adverse Event|1|||
145907859|NCT04981717|526168602|FG001|Overall Study|Adverse Event|3|||
145907860|NCT04981717|526168601|FG000|Overall Study|Pregnancy|1|||
145907861|NCT04981717|526168602|FG001|Overall Study|Pregnancy|0|||
145907862|NCT04981717|526168601|FG000|Overall Study|Physician Decision|1|||
145907863|NCT04981717|526168602|FG001|Overall Study|Physician Decision|0|||
145907864|NCT04981717|526168601|FG000|Overall Study|Sponsor Request|157|||
145907865|NCT04981717|526168602|FG001|Overall Study|Sponsor Request|172|||
145907866|NCT04981717|526168601|FG000|Overall Study|Lost to Follow-up|4|||
145907867|NCT04981717|526168602|FG001|Overall Study|Lost to Follow-up|5|||
145907868|NCT04981717|526168601|FG000|Overall Study|Withdrawal by Subject|50|||
145907869|NCT04981717|526168602|FG001|Overall Study|Withdrawal by Subject|37|||
145907870|NCT02640482|526168603|FG000|Overall Study|Lost to Follow-up|3|||
145907871|NCT02640482|526168604|FG001|Overall Study|Lost to Follow-up|0|||
145907872|NCT02129608|526168607|FG000|Overall Study|Lost to Follow-up|0|||
145907873|NCT02129608|526168608|FG001|Overall Study|Lost to Follow-up|1|||
145907874|NCT02129608|526168609|FG002|Overall Study|Lost to Follow-up|1|||
145907875|NCT02129608|526168607|FG000|Overall Study|Withdrawal by Subject|0|||
145907876|NCT02129608|526168608|FG001|Overall Study|Withdrawal by Subject|0|||
145907877|NCT02129608|526168609|FG002|Overall Study|Withdrawal by Subject|2|||
145907878|NCT00451204|526168610|FG000|Overall Study|Adverse Event|4|||
145907879|NCT00451204|526168611|FG001|Overall Study|Adverse Event|6|||
145907880|NCT00451204|526168610|FG000|Overall Study|Lack of Efficacy|4|||
145907881|NCT00451204|526168611|FG001|Overall Study|Lack of Efficacy|4|||
145907882|NCT00451204|526168610|FG000|Overall Study|Lost to Follow-up|4|||
145907883|NCT00451204|526168611|FG001|Overall Study|Lost to Follow-up|4|||
145907884|NCT00451204|526168610|FG000|Overall Study|Protocol Violation|1|||
145907885|NCT00451204|526168611|FG001|Overall Study|Protocol Violation|0|||
145907886|NCT00451204|526168610|FG000|Overall Study|Patient refusal|8|||
145907887|NCT00451204|526168611|FG001|Overall Study|Patient refusal|4|||
145907888|NCT00451204|526168610|FG000|Overall Study|Other|1|||
145907889|NCT00451204|526168611|FG001|Overall Study|Other|2|||
145907890|NCT03760185|526168612|FG000|Overall Study|Lost to Follow-up|1|||
145907891|NCT03760185|526168613|FG001|Overall Study|Lost to Follow-up|1|||
145907892|NCT02242045|526168614|FG000|Overall Study|Investigator's Discretion|1|||
145907893|NCT02242045|526168614|FG000|Overall Study|Progressive Disease|2|||
146297415|NCT01641809|527604694|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
145907894|NCT02242045|526168614|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
145907895|NCT02242045|526168614|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
145907896|NCT00976911|526168620|FG000|Overall Study|Withdrawal by Subject|4|||
145907897|NCT00976911|526168621|FG001|Overall Study|Withdrawal by Subject|6|||
145907898|NCT00976911|526168620|FG000|Overall Study|Death|138|||
145907899|NCT00976911|526168621|FG001|Overall Study|Death|126|||
145907900|NCT00976911|526168620|FG000|Overall Study|Adverse Event|0|||
145907901|NCT00976911|526168621|FG001|Overall Study|Adverse Event|1|||
145907902|NCT00976911|526168620|FG000|Overall Study|Protocol Violation|2|||
145907903|NCT00976911|526168621|FG001|Overall Study|Protocol Violation|0|||
145907904|NCT00976911|526168620|FG000|Overall Study|Other|8|||
145907905|NCT00976911|526168621|FG001|Overall Study|Other|9|||
145907906|NCT00976911|526168620|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
145907907|NCT00976911|526168621|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
145907908|NCT02954991|526168622|FG000|Overall Study|Death|92|||
145907909|NCT02954991|526168623|FG001|Overall Study|Death|11|||
145907910|NCT02954991|526168624|FG002|Overall Study|Death|2|||
145907911|NCT02954991|526168622|FG000|Overall Study|Lost to Follow-up|3|||
145907912|NCT02954991|526168623|FG001|Overall Study|Lost to Follow-up|2|||
145907913|NCT02954991|526168624|FG002|Overall Study|Lost to Follow-up|0|||
145907914|NCT02954991|526168622|FG000|Overall Study|Withdrawal by Subject|9|||
145907915|NCT02954991|526168623|FG001|Overall Study|Withdrawal by Subject|8|||
145907916|NCT02954991|526168624|FG002|Overall Study|Withdrawal by Subject|1|||
145907917|NCT02954991|526168622|FG000|Overall Study|Study Terminated by Sponsor|18|||
145907918|NCT02954991|526168623|FG001|Overall Study|Study Terminated by Sponsor|10|||
145907919|NCT02954991|526168624|FG002|Overall Study|Study Terminated by Sponsor|1|||
145907920|NCT02954991|526168622|FG000|Overall Study|Miscellaneous|2|||
145907921|NCT02954991|526168623|FG001|Overall Study|Miscellaneous|1|||
145907922|NCT02954991|526168624|FG002|Overall Study|Miscellaneous|1|||
145907923|NCT00576316|526168625|FG000|Overall Study|Adverse Event|9|||
145907924|NCT00576316|526168625|FG000|Overall Study|Withdrawal by Subject|2|||
145907925|NCT00576316|526168625|FG000|Overall Study|Protocol Violation|9|||
145907926|NCT02552303|526168626|FG000|Allocation|Withdrawal by Subject|2|||
145907927|NCT02552303|526168627|FG001|Allocation|Withdrawal by Subject|1|||
145907928|NCT02552303|526168628|FG002|Allocation|Withdrawal by Subject|1|||
145907929|NCT02552303|526168629|FG003|Allocation|Withdrawal by Subject|1|||
145907930|NCT02552303|526168626|FG000|Allocation|ineligible|1|||
145907931|NCT02552303|526168627|FG001|Allocation|ineligible|1|||
145907932|NCT02552303|526168628|FG002|Allocation|ineligible|0|||
145907933|NCT02552303|526168629|FG003|Allocation|ineligible|0|||
145907934|NCT02552303|526168626|FG000|Follow-Up|Lost to Follow-up|0|||
145907935|NCT02552303|526168627|FG001|Follow-Up|Lost to Follow-up|0|||
145907936|NCT02552303|526168628|FG002|Follow-Up|Lost to Follow-up|1|||
145907937|NCT02552303|526168629|FG003|Follow-Up|Lost to Follow-up|0|||
145907938|NCT02552303|526168626|FG000|Follow-Up|ineligible|0|||
145907939|NCT02552303|526168627|FG001|Follow-Up|ineligible|2|||
145907940|NCT02552303|526168628|FG002|Follow-Up|ineligible|0|||
145907941|NCT02552303|526168629|FG003|Follow-Up|ineligible|0|||
145907942|NCT04602546|526168634|FG000|Overall Study|Training|2|||
145907943|NCT04602546|526168635|FG001|Overall Study|Training|2|||
145907944|NCT04602546|526168636|FG002|Overall Study|Training|1|||
145907945|NCT04602546|526168637|FG003|Overall Study|Training|2|||
145907946|NCT04602546|526168638|FG004|Overall Study|Training|0|||
145907947|NCT04602546|526168634|FG000|Overall Study|Randomized with disqualified data|2|||
145907948|NCT04602546|526168635|FG001|Overall Study|Randomized with disqualified data|0|||
145907949|NCT04602546|526168636|FG002|Overall Study|Randomized with disqualified data|2|||
145907950|NCT04602546|526168637|FG003|Overall Study|Randomized with disqualified data|5|||
145907951|NCT04602546|526168638|FG004|Overall Study|Randomized with disqualified data|3|||
145907952|NCT01266031|526168639|FG000|Overall Study|Not treated|0|||
145907953|NCT01266031|526168640|FG001|Overall Study|Not treated|3|||
145907954|NCT01266031|526168641|FG002|Overall Study|Not treated|2|||
145907955|NCT01174043|526168642|FG000|Overall Study|Disease progression|5|||
145907956|NCT01174043|526168642|FG000|Overall Study|Adverse Event|3|||
145907957|NCT01174043|526168642|FG000|Overall Study|Death|1|||
145907958|NCT01174043|526168642|FG000|Overall Study|Withdrawal by Subject|2|||
145907959|NCT02047734|526168643|FG000|Overall Study|Adverse Event|18|||
145907960|NCT02047734|526168644|FG001|Overall Study|Adverse Event|13|||
145907961|NCT02047734|526168645|FG002|Overall Study|Adverse Event|13|||
145907962|NCT02047734|526168643|FG000|Overall Study|Lack of Efficacy|4|||
145907963|NCT02047734|526168644|FG001|Overall Study|Lack of Efficacy|5|||
145907964|NCT02047734|526168645|FG002|Overall Study|Lack of Efficacy|1|||
145907965|NCT02047734|526168643|FG000|Overall Study|Protocol Violation|3|||
145907966|NCT02047734|526168644|FG001|Overall Study|Protocol Violation|1|||
145907967|NCT02047734|526168645|FG002|Overall Study|Protocol Violation|1|||
146239211|NCT01619059|527389745|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
146239212|NCT01619059|527389744|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
146239213|NCT01619059|527389745|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
146239214|NCT01619059|527389744|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
146239215|NCT01619059|527389745|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
146239216|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
146239217|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
146239218|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
146239219|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
145907968|NCT02047734|526168643|FG000|Overall Study|Lost to Follow-up|1|||
145907969|NCT02047734|526168644|FG001|Overall Study|Lost to Follow-up|4|||
145907970|NCT02047734|526168645|FG002|Overall Study|Lost to Follow-up|0|||
145907971|NCT02047734|526168643|FG000|Overall Study|Death|0|||
145907972|NCT02047734|526168644|FG001|Overall Study|Death|1|||
145907973|NCT02047734|526168645|FG002|Overall Study|Death|0|||
145907974|NCT02047734|526168643|FG000|Overall Study|Withdrawal by Subject|30|||
145907975|NCT02047734|526168644|FG001|Overall Study|Withdrawal by Subject|31|||
145907976|NCT02047734|526168645|FG002|Overall Study|Withdrawal by Subject|19|||
145907977|NCT02047734|526168643|FG000|Overall Study|Physician Decision|7|||
145907978|NCT02047734|526168644|FG001|Overall Study|Physician Decision|6|||
145907979|NCT02047734|526168645|FG002|Overall Study|Physician Decision|5|||
145907980|NCT02047734|526168643|FG000|Overall Study|Miscellaneous|2|||
145907981|NCT02047734|526168644|FG001|Overall Study|Miscellaneous|4|||
145907982|NCT02047734|526168645|FG002|Overall Study|Miscellaneous|6|||
145907983|NCT02047734|526168643|FG000|Overall Study|Did Not Receive Study Drug|2|||
145907984|NCT02047734|526168644|FG001|Overall Study|Did Not Receive Study Drug|4|||
145907985|NCT02047734|526168645|FG002|Overall Study|Did Not Receive Study Drug|1|||
145907986|NCT02289456|526168652|FG000|Induction Period|Death|2|||
145907987|NCT02289456|526168652|FG000|Induction Period|Adverse Event|11|||
145907988|NCT02289456|526168652|FG000|Induction Period|Progressive Disease (PD)|4|||
145907989|NCT02289456|526168652|FG000|Induction Period|Symptomatic Deterioration|4|||
145907990|NCT02289456|526168652|FG000|Induction Period|Withdrawal by Subject|2|||
145907991|NCT02289456|526168652|FG000|Induction Period|Miscellaneous|1|||
145907992|NCT02289456|526168652|FG000|Monotherapy Period|Death|1|||
145907993|NCT02289456|526168652|FG000|Monotherapy Period|Adverse Event|1|||
145907994|NCT02289456|526168652|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
145907995|NCT02289456|526168652|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
145907996|NCT02289456|526168652|FG000|Monotherapy Period|Withdrawal by Subject|2|||
145907997|NCT02289456|526168652|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
145907998|NCT02289456|526168652|FG000|Monotherapy Period|Miscellaneous|1|||
145907999|NCT02463357|526168653|FG000|Overall Study|Withdrawal by Subject|1|||
145908000|NCT02463357|526168654|FG001|Overall Study|Withdrawal by Subject|0|||
145908001|NCT02463357|526168655|FG002|Overall Study|Withdrawal by Subject|0|||
145908002|NCT02463357|526168656|FG003|Overall Study|Withdrawal by Subject|0|||
145908003|NCT02463357|526168657|FG004|Overall Study|Withdrawal by Subject|0|||
145908004|NCT02463357|526168653|FG000|Overall Study|Withdrawal by Subject|0|||
145908005|NCT02463357|526168654|FG001|Overall Study|Withdrawal by Subject|0|||
145908006|NCT02463357|526168655|FG002|Overall Study|Withdrawal by Subject|0|||
145908007|NCT02463357|526168656|FG003|Overall Study|Withdrawal by Subject|0|||
145908008|NCT02463357|526168657|FG004|Overall Study|Withdrawal by Subject|1|||
145908009|NCT01371539|526168660|FG000|Period One: One Week|Lost to Follow-up|0|||
145908010|NCT01371539|526168661|FG001|Period One: One Week|Lost to Follow-up|1|||
145908011|NCT01371539|526168660|FG000|Period Two: One Week|Lost to Follow-up|0|||
145908012|NCT01371539|526168661|FG001|Period Two: One Week|Lost to Follow-up|1|||
145908013|NCT01371539|526168660|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
145908014|NCT01371539|526168661|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
145908015|NCT01371539|526168660|FG000|Period Two: One Week|Time/job conflict|0|||
145908016|NCT01371539|526168661|FG001|Period Two: One Week|Time/job conflict|1|||
145908017|NCT01399658|526168662|FG000|Overall Study|Ineligible|1|||
145908018|NCT01399658|526168662|FG000|Overall Study|Machine Technical Issue|3|||
145908019|NCT01399658|526168662|FG000|Overall Study|Alternative therapy|1|||
145908020|NCT01399658|526168662|FG000|Overall Study|No reason given|1|||
145908021|NCT01721317|526168664|FG000|Overall Study|Study Closed / Terminated|2|||
145908022|NCT01721317|526168665|FG001|Overall Study|Study Closed / Terminated|2|||
145908023|NCT01721317|526168664|FG000|Overall Study|Physician Decision|0|||
145908024|NCT01721317|526168665|FG001|Overall Study|Physician Decision|1|||
145908025|NCT01721317|526168664|FG000|Overall Study|Withdrawal by Subject|0|||
145908026|NCT01721317|526168665|FG001|Overall Study|Withdrawal by Subject|1|||
145908027|NCT02806024|526168674|FG000|Overall Study|Night Delivery|1|||
145908028|NCT02806024|526168675|FG001|Overall Study|Night Delivery|1|||
145908029|NCT02806024|526168674|FG000|Overall Study|DVT during antepartum admission|0|||
145908030|NCT02806024|526168675|FG001|Overall Study|DVT during antepartum admission|1|||
145908031|NCT02892149|526168676|FG000|Overall Study|Death|262|||
145908032|NCT02892149|526168677|FG001|Overall Study|Death|278|||
145908033|NCT02892149|526168676|FG000|Overall Study|Withdrawal by Subject|53|||
145908034|NCT02892149|526168677|FG001|Overall Study|Withdrawal by Subject|47|||
145908035|NCT02892149|526168676|FG000|Overall Study|Lost to Follow-up|37|||
145908036|NCT02892149|526168677|FG001|Overall Study|Lost to Follow-up|31|||
145908037|NCT04868968|526168685|FG000|Overall Study|Lost to Follow-up|1|||
145908038|NCT02996487|526168686|FG000|Overall Study|Lost to Follow-up|1|||
145908039|NCT02996487|526168687|FG001|Overall Study|Lost to Follow-up|1|||
145908040|NCT02996487|526168688|FG002|Overall Study|Lost to Follow-up|0|||
145908041|NCT02996487|526168686|FG000|Overall Study|Death|0|||
145908042|NCT02996487|526168687|FG001|Overall Study|Death|1|||
146239220|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
146239221|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
146239222|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Death|1|||
146239223|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Death|0|||
146239224|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
146239225|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
145908043|NCT02996487|526168688|FG002|Overall Study|Death|0|||
145908044|NCT02996487|526168686|FG000|Overall Study|Withdrawal by Subject|2|||
145908045|NCT02996487|526168687|FG001|Overall Study|Withdrawal by Subject|3|||
145908046|NCT02996487|526168688|FG002|Overall Study|Withdrawal by Subject|0|||
145908047|NCT01004003|526168689|FG000|Overall Study|Progressive disease|2|||
145908048|NCT01004003|526168690|FG001|Overall Study|Progressive disease|1|||
145908049|NCT01004003|526168691|FG002|Overall Study|Progressive disease|1|||
145908050|NCT01004003|526168692|FG003|Overall Study|Progressive disease|0|||
145908051|NCT01004003|526168693|FG004|Overall Study|Progressive disease|2|||
146239226|NCT01619059|527389744|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
145908052|NCT01004003|526168694|FG005|Overall Study|Progressive disease|1|||
145908053|NCT01004003|526168695|FG006|Overall Study|Progressive disease|1|||
145908054|NCT01004003|526168696|FG007|Overall Study|Progressive disease|39|||
145908055|NCT01004003|526168697|FG008|Overall Study|Progressive disease|22|||
145908056|NCT01004003|526168689|FG000|Overall Study|Adverse Event|4|||
145908057|NCT01004003|526168690|FG001|Overall Study|Adverse Event|2|||
145908058|NCT01004003|526168691|FG002|Overall Study|Adverse Event|3|||
145908059|NCT01004003|526168692|FG003|Overall Study|Adverse Event|3|||
145908060|NCT01004003|526168693|FG004|Overall Study|Adverse Event|2|||
145908061|NCT01004003|526168694|FG005|Overall Study|Adverse Event|2|||
145908062|NCT01004003|526168695|FG006|Overall Study|Adverse Event|7|||
145908063|NCT01004003|526168696|FG007|Overall Study|Adverse Event|21|||
145908064|NCT01004003|526168697|FG008|Overall Study|Adverse Event|6|||
145908065|NCT01004003|526168689|FG000|Overall Study|Refused to continue taking trial med.|0|||
145908066|NCT01004003|526168690|FG001|Overall Study|Refused to continue taking trial med.|0|||
145908067|NCT01004003|526168691|FG002|Overall Study|Refused to continue taking trial med.|0|||
145908068|NCT01004003|526168692|FG003|Overall Study|Refused to continue taking trial med.|0|||
145908069|NCT01004003|526168693|FG004|Overall Study|Refused to continue taking trial med.|0|||
145908070|NCT01004003|526168694|FG005|Overall Study|Refused to continue taking trial med.|0|||
145908071|NCT01004003|526168695|FG006|Overall Study|Refused to continue taking trial med.|0|||
145908072|NCT01004003|526168696|FG007|Overall Study|Refused to continue taking trial med.|0|||
145908073|NCT01004003|526168697|FG008|Overall Study|Refused to continue taking trial med.|2|||
145908074|NCT01004003|526168689|FG000|Overall Study|Other|0|||
145908075|NCT01004003|526168690|FG001|Overall Study|Other|0|||
145908076|NCT01004003|526168691|FG002|Overall Study|Other|0|||
145908077|NCT01004003|526168692|FG003|Overall Study|Other|0|||
145908078|NCT01004003|526168693|FG004|Overall Study|Other|0|||
145908079|NCT01004003|526168694|FG005|Overall Study|Other|1|||
145908080|NCT01004003|526168695|FG006|Overall Study|Other|0|||
145908081|NCT01004003|526168696|FG007|Overall Study|Other|0|||
145908082|NCT01004003|526168697|FG008|Overall Study|Other|0|||
145908083|NCT00259272|526168702|FG000|Overall Study|Adverse Event|2|||
145908084|NCT00259272|526168703|FG001|Overall Study|Adverse Event|1|||
145908085|NCT00259272|526168704|FG002|Overall Study|Adverse Event|0|||
145908086|NCT00259272|526168705|FG003|Overall Study|Adverse Event|3|||
145908087|NCT00259272|526168702|FG000|Overall Study|Lack of Efficacy|5|||
145908088|NCT00259272|526168703|FG001|Overall Study|Lack of Efficacy|1|||
145908089|NCT00259272|526168704|FG002|Overall Study|Lack of Efficacy|2|||
145908090|NCT00259272|526168705|FG003|Overall Study|Lack of Efficacy|6|||
145908091|NCT00259272|526168702|FG000|Overall Study|Physician Decision|1|||
145908092|NCT00259272|526168703|FG001|Overall Study|Physician Decision|2|||
145908093|NCT00259272|526168704|FG002|Overall Study|Physician Decision|1|||
145908094|NCT00259272|526168705|FG003|Overall Study|Physician Decision|3|||
145908095|NCT00259272|526168702|FG000|Overall Study|Protocol Violation|2|||
145908096|NCT00259272|526168703|FG001|Overall Study|Protocol Violation|0|||
145908097|NCT00259272|526168704|FG002|Overall Study|Protocol Violation|0|||
145908098|NCT00259272|526168705|FG003|Overall Study|Protocol Violation|1|||
145908099|NCT00259272|526168702|FG000|Overall Study|Sponsor Decision|0|||
145908100|NCT00259272|526168703|FG001|Overall Study|Sponsor Decision|1|||
145908101|NCT00259272|526168704|FG002|Overall Study|Sponsor Decision|0|||
145908102|NCT00259272|526168705|FG003|Overall Study|Sponsor Decision|0|||
145908103|NCT00259272|526168702|FG000|Overall Study|Withdrawal by Subject|4|||
145908104|NCT00259272|526168703|FG001|Overall Study|Withdrawal by Subject|2|||
145908105|NCT00259272|526168704|FG002|Overall Study|Withdrawal by Subject|2|||
145908106|NCT00259272|526168705|FG003|Overall Study|Withdrawal by Subject|7|||
145908107|NCT00259272|526168702|FG000|Overall Study|Lost to Follow-up|1|||
145908108|NCT00259272|526168703|FG001|Overall Study|Lost to Follow-up|0|||
145908109|NCT00259272|526168704|FG002|Overall Study|Lost to Follow-up|0|||
145908110|NCT00259272|526168705|FG003|Overall Study|Lost to Follow-up|1|||
145908111|NCT00103610|526168706|FG000|Overall Study|Entered Rescue Procedure|10|||
145908112|NCT00103610|526168707|FG001|Overall Study|Entered Rescue Procedure|52|||
145908113|NCT00103610|526168706|FG000|Overall Study|Death|16|||
145908114|NCT00103610|526168707|FG001|Overall Study|Death|12|||
145908115|NCT00103610|526168706|FG000|Overall Study|Elective Withdrawal|4|||
145908116|NCT00103610|526168707|FG001|Overall Study|Elective Withdrawal|0|||
145908117|NCT00103610|526168706|FG000|Overall Study|Lost to Follow-up|3|||
145908118|NCT00103610|526168707|FG001|Overall Study|Lost to Follow-up|1|||
145908119|NCT00103610|526168706|FG000|Overall Study|Adverse Event|2|||
145908120|NCT00103610|526168707|FG001|Overall Study|Adverse Event|2|||
145908121|NCT00103610|526168706|FG000|Overall Study|Other|2|||
145908122|NCT00103610|526168707|FG001|Overall Study|Other|7|||
145908123|NCT00103610|526168706|FG000|Overall Study|Failed mobilization|1|||
145908124|NCT00103610|526168707|FG001|Overall Study|Failed mobilization|5|||
145908125|NCT00103610|526168706|FG000|Overall Study|Noncompliance|0|||
145908126|NCT00103610|526168707|FG001|Overall Study|Noncompliance|1|||
145908127|NCT00315731|526168710|FG000|Overall Study|Lost to Follow-up|1|||
145908128|NCT00315731|526168710|FG000|Overall Study|Death|5|||
145908129|NCT04614246|526168711|FG000|Overall Study|Adverse Event|0|||
145908130|NCT04614246|526168712|FG001|Overall Study|Adverse Event|1|||
146239227|NCT01619059|527389745|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
146239228|NCT01170208|527389748|FG000|Overall Study|Withdrawal by Subject|5|||
146239229|NCT01170208|527389749|FG001|Overall Study|Withdrawal by Subject|0|||
146239230|NCT01170208|527389750|FG002|Overall Study|Withdrawal by Subject|1|||
145908131|NCT04614246|526168713|FG002|Overall Study|Adverse Event|1|||
145972866|NCT01020123|526412782|FG000|Extention Period|Lost to Follow-up|0|||
145972867|NCT01020123|526412783|FG001|Extention Period|Lost to Follow-up|0|||
145972868|NCT01020123|526412784|FG002|Extention Period|Lost to Follow-up|0|||
145972869|NCT01020123|526412785|FG003|Extention Period|Lost to Follow-up|0|||
145972870|NCT01020123|526412786|FG004|Extention Period|Lost to Follow-up|0|||
145972871|NCT01020123|526412787|FG005|Extention Period|Lost to Follow-up|2|||
145972872|NCT01020123|526412788|FG006|Extention Period|Lost to Follow-up|0|||
145972873|NCT00846365|526412789|FG000|Overall Study|Adverse Event|20|||
145972874|NCT00846365|526412790|FG001|Overall Study|Adverse Event|30|||
145972875|NCT00846365|526412791|FG002|Overall Study|Adverse Event|11|||
145972876|NCT00846365|526412789|FG000|Overall Study|Protocol Violation|5|||
145972877|NCT00846365|526412790|FG001|Overall Study|Protocol Violation|4|||
145972878|NCT00846365|526412791|FG002|Overall Study|Protocol Violation|0|||
145972879|NCT00846365|526412789|FG000|Overall Study|Lost to Follow-up|8|||
145972880|NCT00846365|526412790|FG001|Overall Study|Lost to Follow-up|2|||
145972881|NCT00846365|526412791|FG002|Overall Study|Lost to Follow-up|5|||
145972882|NCT00846365|526412789|FG000|Overall Study|Withdrawal by Subject|11|||
145972883|NCT00846365|526412790|FG001|Overall Study|Withdrawal by Subject|11|||
145972884|NCT00846365|526412791|FG002|Overall Study|Withdrawal by Subject|9|||
145972885|NCT00846365|526412789|FG000|Overall Study|Pregnancy|1|||
145972886|NCT00846365|526412790|FG001|Overall Study|Pregnancy|0|||
145972887|NCT00846365|526412791|FG002|Overall Study|Pregnancy|0|||
145972888|NCT00846365|526412789|FG000|Overall Study|Lack of Efficacy|1|||
145972889|NCT00846365|526412790|FG001|Overall Study|Lack of Efficacy|1|||
145972890|NCT00846365|526412791|FG002|Overall Study|Lack of Efficacy|2|||
145972891|NCT00846365|526412789|FG000|Overall Study|Other|9|||
145972892|NCT00846365|526412790|FG001|Overall Study|Other|1|||
145972893|NCT00846365|526412791|FG002|Overall Study|Other|6|||
145972894|NCT03095287|526414113|FG000|Overall Study|Treatment Failure|1|||
145972895|NCT03095287|526414113|FG000|Overall Study|Adverse Event|1|||
145908132|NCT04614246|526168714|FG003|Overall Study|Adverse Event|2|||
145908133|NCT04614246|526168715|FG004|Overall Study|Adverse Event|1|||
145908134|NCT04614246|526168711|FG000|Overall Study|Lost to Follow-up|0|||
145908135|NCT04614246|526168712|FG001|Overall Study|Lost to Follow-up|1|||
145908136|NCT04614246|526168713|FG002|Overall Study|Lost to Follow-up|0|||
145908137|NCT04614246|526168714|FG003|Overall Study|Lost to Follow-up|1|||
145908138|NCT04614246|526168715|FG004|Overall Study|Lost to Follow-up|3|||
145908139|NCT04614246|526168711|FG000|Overall Study|Other reason|0|||
145908140|NCT04614246|526168712|FG001|Overall Study|Other reason|1|||
145908141|NCT04614246|526168713|FG002|Overall Study|Other reason|2|||
145908142|NCT04614246|526168714|FG003|Overall Study|Other reason|0|||
145908143|NCT04614246|526168715|FG004|Overall Study|Other reason|0|||
145908144|NCT04614246|526168711|FG000|Overall Study|Withdrawal by Subject|4|||
145908145|NCT04614246|526168712|FG001|Overall Study|Withdrawal by Subject|2|||
145908146|NCT04614246|526168713|FG002|Overall Study|Withdrawal by Subject|4|||
145908147|NCT04614246|526168714|FG003|Overall Study|Withdrawal by Subject|3|||
145908148|NCT04614246|526168715|FG004|Overall Study|Withdrawal by Subject|4|||
145908149|NCT04614246|526168711|FG000|Overall Study|Physician Decision|0|||
145908150|NCT04614246|526168712|FG001|Overall Study|Physician Decision|2|||
145908151|NCT04614246|526168713|FG002|Overall Study|Physician Decision|1|||
145908152|NCT04614246|526168714|FG003|Overall Study|Physician Decision|0|||
145908153|NCT04614246|526168715|FG004|Overall Study|Physician Decision|0|||
145908154|NCT04614246|526168711|FG000|Overall Study|Study terminated by sponsor|10|||
145908155|NCT04614246|526168712|FG001|Overall Study|Study terminated by sponsor|15|||
145908156|NCT04614246|526168713|FG002|Overall Study|Study terminated by sponsor|12|||
145908157|NCT04614246|526168714|FG003|Overall Study|Study terminated by sponsor|13|||
145908158|NCT04614246|526168715|FG004|Overall Study|Study terminated by sponsor|9|||
145908159|NCT04614246|526168711|FG000|Overall Study|Pregnancy|2|||
145972896|NCT02394275|526414114|FG000|Overall Study|Adverse Event|22|||
145972897|NCT02394275|526414114|FG000|Overall Study|Lost to Follow-up|7|||
145972898|NCT00782067|526414115|FG000|Overall Study|Adverse Event|35|||
145972899|NCT00782067|526414115|FG000|Overall Study|Subject withdrew consent|11|||
145972900|NCT00782067|526414115|FG000|Overall Study|Lost to Follow-up|2|||
145972901|NCT00782067|526414115|FG000|Overall Study|Administrative problems|14|||
146239231|NCT01170208|527389748|FG000|Overall Study|Protocol Violation|1|||
145908160|NCT04614246|526168712|FG001|Overall Study|Pregnancy|0|||
145908161|NCT04614246|526168713|FG002|Overall Study|Pregnancy|1|||
145908162|NCT04614246|526168714|FG003|Overall Study|Pregnancy|0|||
145908163|NCT04614246|526168715|FG004|Overall Study|Pregnancy|0|||
145908164|NCT01680497|526168717|FG000|Overall Study|Lost to Follow-up|2|||
145908165|NCT03597464|526168720|FG000|Overall Study|Withdrawal by Subject|4|||
145972902|NCT00782067|526414115|FG000|Overall Study|Death|9|||
145972903|NCT00782067|526414115|FG000|Overall Study|Disease progression|43|||
145972904|NCT00782067|526414115|FG000|Overall Study|Protocol deviation|2|||
145972905|NCT03813654|526414119|FG000|Overall Study|Protocol Violation|0|||
145908166|NCT03597464|526168721|FG001|Overall Study|Withdrawal by Subject|5|||
145908167|NCT03597464|526168720|FG000|Overall Study|Lost to Follow-up|3|||
145908168|NCT03597464|526168721|FG001|Overall Study|Lost to Follow-up|1|||
145908169|NCT03597464|526168720|FG000|Overall Study|Pregnancy|3|||
145908170|NCT03597464|526168721|FG001|Overall Study|Pregnancy|1|||
145908171|NCT03597464|526168720|FG000|Overall Study|Lack of Efficacy|2|||
145908172|NCT03597464|526168721|FG001|Overall Study|Lack of Efficacy|0|||
145908173|NCT03597464|526168720|FG000|Overall Study|Physician Decision|2|||
145908174|NCT03597464|526168721|FG001|Overall Study|Physician Decision|2|||
145908175|NCT03597464|526168720|FG000|Overall Study|Protocol Violation|1|||
145908176|NCT03597464|526168721|FG001|Overall Study|Protocol Violation|1|||
145908177|NCT03597464|526168720|FG000|Overall Study|Adverse Event|0|||
145908178|NCT03597464|526168721|FG001|Overall Study|Adverse Event|2|||
145908179|NCT03597464|526168720|FG000|Overall Study|Death|0|||
145908180|NCT03597464|526168721|FG001|Overall Study|Death|3|||
145908181|NCT00340678|526168728|FG000|Overall Study|Lost to Follow-up|1|||
145908182|NCT00340678|526168729|FG001|Overall Study|Lost to Follow-up|0|||
145908183|NCT00340678|526168730|FG002|Overall Study|Lost to Follow-up|0|||
145908184|NCT00340678|526168731|FG003|Overall Study|Lost to Follow-up|0|||
145972906|NCT03813654|526414120|FG001|Overall Study|Protocol Violation|1|||
145972907|NCT03813654|526414121|FG002|Overall Study|Protocol Violation|2|||
145908185|NCT00278889|526168732|FG000|Overall Study|Withdrawal by Subject|0|||
145908186|NCT00278889|526168733|FG001|Overall Study|Withdrawal by Subject|5|||
145908187|NCT00278889|526168734|FG002|Overall Study|Withdrawal by Subject|3|||
145908188|NCT00278889|526168732|FG000|Overall Study|Lost to Follow-up|1|||
145908189|NCT00278889|526168733|FG001|Overall Study|Lost to Follow-up|1|||
145908190|NCT00278889|526168734|FG002|Overall Study|Lost to Follow-up|0|||
145908191|NCT00278889|526168732|FG000|Overall Study|Death|24|||
145908192|NCT00278889|526168733|FG001|Overall Study|Death|21|||
145908193|NCT00278889|526168734|FG002|Overall Study|Death|17|||
145908194|NCT04042376|526168735|FG000|Overall Study|Withdrawal by Subject|1|||
145908195|NCT04042376|526168735|FG000|Overall Study|Death|3|||
145908196|NCT01243775|526168736|FG000|Overall Study|Withdrawal by Subject|2|||
145908197|NCT00287586|526171028|FG000|Overall Study|Withdrew Consent|19|||
145908198|NCT00287586|526171029|FG001|Overall Study|Withdrew Consent|30|||
145908199|NCT00287586|526171028|FG000|Overall Study|Lost to Follow-up|5|||
145908200|NCT00287586|526171029|FG001|Overall Study|Lost to Follow-up|4|||
145908201|NCT00287586|526171028|FG000|Overall Study|Death|2|||
145908202|NCT00287586|526171029|FG001|Overall Study|Death|3|||
145908203|NCT00287586|526171028|FG000|Overall Study|Elevated Hematocrit|3|||
145908204|NCT00287586|526171029|FG001|Overall Study|Elevated Hematocrit|0|||
145908205|NCT00287586|526171028|FG000|Overall Study|Rash|3|||
145908206|NCT00287586|526171029|FG001|Overall Study|Rash|0|||
145908207|NCT00287586|526171028|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
145908208|NCT00287586|526171029|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
145908209|NCT00287586|526171028|FG000|Overall Study|Stroke|2|||
145908210|NCT00287586|526171029|FG001|Overall Study|Stroke|0|||
145908211|NCT00287586|526171028|FG000|Overall Study|Myocardial Infarction|1|||
145908212|NCT00287586|526171029|FG001|Overall Study|Myocardial Infarction|0|||
145908213|NCT00287586|526171028|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
145908214|NCT00287586|526171029|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
145908215|NCT00287586|526171028|FG000|Overall Study|Cognitive Impairment|1|||
145908216|NCT00287586|526171029|FG001|Overall Study|Cognitive Impairment|0|||
145908217|NCT00287586|526171028|FG000|Overall Study|Pancreatic Cancer|1|||
145908218|NCT00287586|526171029|FG001|Overall Study|Pancreatic Cancer|3|||
145908219|NCT00287586|526171028|FG000|Overall Study|Sleep Apnea|1|||
145908220|NCT00287586|526171029|FG001|Overall Study|Sleep Apnea|0|||
145908221|NCT00287586|526171028|FG000|Overall Study|Shoulder Pain|1|||
145972908|NCT03813654|526414119|FG000|Overall Study|Withdrawal by Subject|1|||
145972909|NCT03813654|526414120|FG001|Overall Study|Withdrawal by Subject|0|||
145972910|NCT03813654|526414121|FG002|Overall Study|Withdrawal by Subject|0|||
145972911|NCT01732692|526414123|FG000|Overall Study|Adverse Event|0|||
145972912|NCT01732692|526414124|FG001|Overall Study|Adverse Event|1|||
145908222|NCT00287586|526171029|FG001|Overall Study|Shoulder Pain|0|||
145908223|NCT00287586|526171028|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
145908224|NCT00287586|526171029|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
145972913|NCT01155323|526414125|FG000|First Intervention|exclusion criteria|1|||
145908225|NCT00287586|526171028|FG000|Overall Study|Nonadherence|1|||
145908226|NCT00287586|526171029|FG001|Overall Study|Nonadherence|1|||
145908227|NCT00287586|526171028|FG000|Overall Study|Enrolled in Another Study|1|||
145908228|NCT00287586|526171029|FG001|Overall Study|Enrolled in Another Study|0|||
145908229|NCT00287586|526171028|FG000|Overall Study|Major Depression|0|||
145972914|NCT01155323|526414126|FG001|First Intervention|exclusion criteria|1|||
145972915|NCT01155323|526414125|FG000|Second Intervention|Lost to Follow-up|1|||
145908230|NCT00287586|526171029|FG001|Overall Study|Major Depression|2|||
145908231|NCT00287586|526171028|FG000|Overall Study|Lung Cancer|0|||
145908232|NCT00287586|526171029|FG001|Overall Study|Lung Cancer|2|||
145908233|NCT00287586|526171028|FG000|Overall Study|Elevated IPSS Score|0|||
145908234|NCT00287586|526171029|FG001|Overall Study|Elevated IPSS Score|1|||
145972916|NCT01155323|526414126|FG001|Second Intervention|Lost to Follow-up|1|||
145972917|NCT00671060|526414127|FG000|Overall Study|Protocol Violation|1|||
145972918|NCT00671060|526414128|FG001|Overall Study|Protocol Violation|0|||
145972919|NCT00671060|526414127|FG000|Overall Study|Physician Decision|0|||
145972920|NCT00671060|526414128|FG001|Overall Study|Physician Decision|1|||
145972921|NCT00303186|526414129|FG000|Overall Study|Other|52|||
145908235|NCT00287586|526171028|FG000|Overall Study|Retroperitoneal Cancer|0|||
145908236|NCT00287586|526171029|FG001|Overall Study|Retroperitoneal Cancer|1|||
145908237|NCT00287586|526171028|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
145908238|NCT00287586|526171029|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
145908239|NCT00287586|526171028|FG000|Overall Study|Mood Swings and Irritability|0|||
145908240|NCT00287586|526171029|FG001|Overall Study|Mood Swings and Irritability|1|||
145908241|NCT00287586|526171028|FG000|Overall Study|Bradycardia|0|||
145908242|NCT00287586|526171029|FG001|Overall Study|Bradycardia|1|||
145908243|NCT00287586|526171028|FG000|Overall Study|Itchy Swollen Eyes|0|||
145908244|NCT00287586|526171029|FG001|Overall Study|Itchy Swollen Eyes|1|||
145908245|NCT00287586|526171028|FG000|Overall Study|Recurrent Melanoma|0|||
145908246|NCT00287586|526171029|FG001|Overall Study|Recurrent Melanoma|1|||
145908247|NCT03106987|526171030|FG000|Overall Study|Death|37|||
145908248|NCT03106987|526171031|FG001|Overall Study|Death|22|||
145908249|NCT03106987|526171032|FG002|Overall Study|Death|12|||
145908250|NCT03106987|526171033|FG003|Overall Study|Death|8|||
145908251|NCT03106987|526171030|FG000|Overall Study|Lost to Follow-up|2|||
145908252|NCT03106987|526171031|FG001|Overall Study|Lost to Follow-up|0|||
145908253|NCT03106987|526171032|FG002|Overall Study|Lost to Follow-up|2|||
145908254|NCT03106987|526171033|FG003|Overall Study|Lost to Follow-up|2|||
145908255|NCT03106987|526171030|FG000|Overall Study|Withdrawal by Subject|5|||
145908256|NCT03106987|526171031|FG001|Overall Study|Withdrawal by Subject|1|||
145908257|NCT03106987|526171032|FG002|Overall Study|Withdrawal by Subject|4|||
145908258|NCT03106987|526171033|FG003|Overall Study|Withdrawal by Subject|1|||
145908259|NCT03336528|526171034|FG000|Overall Study|Protocol Violation|1|||
145908260|NCT03336528|526171035|FG001|Overall Study|Protocol Violation|1|||
145908261|NCT03336528|526171034|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
145908262|NCT03336528|526171035|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
145908263|NCT03336528|526171034|FG000|Overall Study|Did not receive study medication|1|||
145908264|NCT03336528|526171035|FG001|Overall Study|Did not receive study medication|2|||
145908265|NCT02114385|526171038|FG000|Overall Study|Withdrawal by Subject|3|||
145908266|NCT02114385|526171039|FG001|Overall Study|Withdrawal by Subject|2|||
145908267|NCT02114385|526171038|FG000|Overall Study|Lost to Follow-up|0|||
145908268|NCT02114385|526171039|FG001|Overall Study|Lost to Follow-up|6|||
145908269|NCT01753297|526171043|FG000|Overall Study|Lost to Follow-up|7|||
145908270|NCT01753297|526171044|FG001|Overall Study|Lost to Follow-up|2|||
145908271|NCT01753297|526171043|FG000|Overall Study|Withdrawal by Subject|26|||
145908272|NCT01753297|526171044|FG001|Overall Study|Withdrawal by Subject|23|||
145908273|NCT01753297|526171043|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
145908274|NCT01753297|526171044|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
145908275|NCT01753297|526171043|FG000|Overall Study|Death|0|||
145908276|NCT01753297|526171044|FG001|Overall Study|Death|2|||
145908277|NCT01753297|526171043|FG000|Overall Study|Did not attend end of study visit|7|||
145908278|NCT01753297|526171044|FG001|Overall Study|Did not attend end of study visit|8|||
145908279|NCT00230178|526171045|FG000|Overall Study|Adverse Event|1|||
145908280|NCT00230178|526171046|FG001|Overall Study|Adverse Event|5|||
145908281|NCT00230178|526171047|FG002|Overall Study|Adverse Event|2|||
145908282|NCT00230178|526171045|FG000|Overall Study|Withdrawal by Subject|0|||
145908283|NCT00230178|526171046|FG001|Overall Study|Withdrawal by Subject|0|||
145908284|NCT00230178|526171047|FG002|Overall Study|Withdrawal by Subject|1|||
145908285|NCT00230178|526171045|FG000|Overall Study|Various other reasons|3|||
145908286|NCT00230178|526171046|FG001|Overall Study|Various other reasons|2|||
145908287|NCT00230178|526171047|FG002|Overall Study|Various other reasons|4|||
145908288|NCT00447876|526171050|FG000|Overall Study|Withdrawal by Subject|1|||
145908289|NCT00447876|526171051|FG001|Overall Study|Withdrawal by Subject|4|||
145908290|NCT00447876|526171050|FG000|Overall Study|Lost to Follow-up|1|||
145908291|NCT00447876|526171051|FG001|Overall Study|Lost to Follow-up|0|||
145908292|NCT00447876|526171050|FG000|Overall Study|Deterioration of symptomology|1|||
145908293|NCT00447876|526171051|FG001|Overall Study|Deterioration of symptomology|0|||
145908294|NCT02533180|526171052|FG000|Overall Study|Death|0|||
145908295|NCT02533180|526171053|FG001|Overall Study|Death|2|||
145908296|NCT02533180|526171052|FG000|Overall Study|Lost to Follow-up|0|||
145908297|NCT02533180|526171053|FG001|Overall Study|Lost to Follow-up|1|||
145908298|NCT02533180|526171052|FG000|Overall Study|Physician Decision|0|||
145908299|NCT02533180|526171053|FG001|Overall Study|Physician Decision|1|||
145908300|NCT02533180|526171052|FG000|Overall Study|Withdrawal by Subject|2|||
145908301|NCT02533180|526171053|FG001|Overall Study|Withdrawal by Subject|5|||
145908302|NCT02533180|526171052|FG000|Overall Study|Screen Failure|37|||
145972922|NCT02020941|526414130|FG000|Overall Study|Adverse Event|1|||
145908303|NCT02533180|526171053|FG001|Overall Study|Screen Failure|0|||
145908304|NCT02533180|526171052|FG000|Overall Study|Protocol Deviation|0|||
145908305|NCT02533180|526171053|FG001|Overall Study|Protocol Deviation|1|||
145972923|NCT02020941|526414130|FG000|Overall Study|Physician Decision|2|||
145908306|NCT02533180|526171052|FG000|Overall Study|Non-compliance|0|||
145908307|NCT02533180|526171053|FG001|Overall Study|Non-compliance|1|||
145908308|NCT00005957|526171056|FG000|Overall Study|No treated|3|||
145908309|NCT00005957|526171057|FG001|Overall Study|No treated|9|||
145908310|NCT00005957|526171056|FG000|Overall Study|Crossover to the other arm|5|||
145908311|NCT00005957|526171057|FG001|Overall Study|Crossover to the other arm|19|||
145908312|NCT00582010|526171059|FG000|Overall Study|Death|0|||
145908313|NCT00582010|526171060|FG001|Overall Study|Death|1|||
145908314|NCT02620579|526171067|FG000|Overall Study|Physician Decision|0|||
145908315|NCT02620579|526171068|FG001|Overall Study|Physician Decision|0|||
145908316|NCT02620579|526171069|FG002|Overall Study|Physician Decision|0|||
145908317|NCT02620579|526171070|FG003|Overall Study|Physician Decision|1|||
145908318|NCT02620579|526171067|FG000|Overall Study|Withdrawal by Subject|0|||
145908319|NCT02620579|526171068|FG001|Overall Study|Withdrawal by Subject|1|||
145908320|NCT02620579|526171069|FG002|Overall Study|Withdrawal by Subject|1|||
145908321|NCT02620579|526171070|FG003|Overall Study|Withdrawal by Subject|0|||
145908322|NCT00796107|526171071|FG000|Overall Study|Lack of Efficacy|1|||
145908323|NCT00796107|526171071|FG000|Overall Study|Progressive Disease|5|||
145908324|NCT02681510|526171072|FG000|Overall Study|Withdrawal by Subject|1|||
145908325|NCT02681510|526171072|FG000|Overall Study|Lost to Follow-up|9|||
145908326|NCT00958893|526171077|FG000|Overall Study|Study prematurely terminated|4|||
145908327|NCT00378573|526171078|FG000|Treatment Period|Adverse Event|9|||
145908328|NCT00378573|526171078|FG000|Treatment Period|Physician Decision|1|||
145908329|NCT00378573|526171078|FG000|Treatment Period|Withdrawal by Subject|2|||
145908330|NCT00378573|526171078|FG000|Treatment Period|Disease Progression|4|||
145908331|NCT00378573|526171078|FG000|Treatment Period|Sponsor decision to close study|1|||
145908332|NCT00378573|526171078|FG000|Follow-up|Death|12|||
145908333|NCT00378573|526171078|FG000|Follow-up|Lost to Follow-up|1|||
145908334|NCT00378573|526171078|FG000|Follow-up|Withdrawal by Subject|1|||
145908335|NCT03682107|526171081|FG000|Overall Study|Withdrawal by Subject|0|||
145908336|NCT03682107|526171082|FG001|Overall Study|Withdrawal by Subject|1|||
145908337|NCT03682107|526171083|FG002|Overall Study|Withdrawal by Subject|0|||
145908338|NCT03682107|526171084|FG003|Overall Study|Withdrawal by Subject|0|||
145908339|NCT03682107|526171085|FG004|Overall Study|Withdrawal by Subject|0|||
145908340|NCT03837743|526171088|FG000|Overall Study|Adverse Event|1|||
145908341|NCT03837743|526171088|FG000|Overall Study|Withdrawal by Subject|2|||
145908342|NCT00252239|526171089|FG000|Overall Study|Withdrawal by Subject|1|||
145908343|NCT00252239|526171090|FG001|Overall Study|Withdrawal by Subject|0|||
145908344|NCT00252239|526171091|FG002|Overall Study|Withdrawal by Subject|0|||
145908345|NCT00252239|526171092|FG003|Overall Study|Withdrawal by Subject|1|||
145908346|NCT00252239|526171089|FG000|Overall Study|Lost to Follow-up|0|||
145908347|NCT00252239|526171090|FG001|Overall Study|Lost to Follow-up|0|||
145908348|NCT00252239|526171091|FG002|Overall Study|Lost to Follow-up|2|||
145908349|NCT00252239|526171092|FG003|Overall Study|Lost to Follow-up|0|||
145908350|NCT02257385|526171094|FG000|Overall Study|Adverse Event|12|||
145908351|NCT02257385|526171095|FG001|Overall Study|Adverse Event|8|||
145908352|NCT02257385|526171094|FG000|Overall Study|Lack of Efficacy|1|||
145908353|NCT02257385|526171095|FG001|Overall Study|Lack of Efficacy|2|||
145908354|NCT02257385|526171094|FG000|Overall Study|Protocol Violation|5|||
145908355|NCT02257385|526171095|FG001|Overall Study|Protocol Violation|7|||
145908356|NCT02257385|526171094|FG000|Overall Study|Lost to Follow-up|0|||
145908357|NCT02257385|526171095|FG001|Overall Study|Lost to Follow-up|1|||
145908358|NCT02257385|526171094|FG000|Overall Study|Withdrawal by Subject|4|||
145908359|NCT02257385|526171095|FG001|Overall Study|Withdrawal by Subject|4|||
145908360|NCT01822366|526171102|FG000|Overall Study|Lost to Follow-up|5|||
145908361|NCT01822366|526171103|FG001|Overall Study|Lost to Follow-up|1|||
145908362|NCT01822366|526171104|FG002|Overall Study|Lost to Follow-up|5|||
145908363|NCT01822366|526171105|FG003|Overall Study|Lost to Follow-up|1|||
145908364|NCT01822366|526171102|FG000|Overall Study|Withdrawal by Subject|0|||
145908365|NCT01822366|526171103|FG001|Overall Study|Withdrawal by Subject|6|||
145908366|NCT01822366|526171104|FG002|Overall Study|Withdrawal by Subject|0|||
145908367|NCT01822366|526171105|FG003|Overall Study|Withdrawal by Subject|6|||
145908368|NCT01822366|526171102|FG000|Overall Study|Partial Intervention Completion|0|||
145908369|NCT01822366|526171103|FG001|Overall Study|Partial Intervention Completion|15|||
145908370|NCT01822366|526171104|FG002|Overall Study|Partial Intervention Completion|0|||
145908371|NCT01822366|526171105|FG003|Overall Study|Partial Intervention Completion|15|||
145908372|NCT00384930|526171108|FG000|Overall Study|Adverse Event|5|||
145908373|NCT00384930|526171109|FG001|Overall Study|Adverse Event|4|||
145908374|NCT00384930|526171110|FG002|Overall Study|Adverse Event|12|||
145908375|NCT00384930|526171111|FG003|Overall Study|Adverse Event|11|||
145908376|NCT00384930|526171112|FG004|Overall Study|Adverse Event|14|||
145908377|NCT00384930|526171108|FG000|Overall Study|Entry Criteria Not Met|2|||
145908378|NCT00384930|526171109|FG001|Overall Study|Entry Criteria Not Met|6|||
145908379|NCT00384930|526171110|FG002|Overall Study|Entry Criteria Not Met|7|||
145908380|NCT00384930|526171111|FG003|Overall Study|Entry Criteria Not Met|8|||
145908381|NCT00384930|526171112|FG004|Overall Study|Entry Criteria Not Met|4|||
145908382|NCT00384930|526171108|FG000|Overall Study|Lack of Efficacy|1|||
145908383|NCT00384930|526171109|FG001|Overall Study|Lack of Efficacy|1|||
145908384|NCT00384930|526171110|FG002|Overall Study|Lack of Efficacy|2|||
145908385|NCT00384930|526171111|FG003|Overall Study|Lack of Efficacy|1|||
145908386|NCT00384930|526171112|FG004|Overall Study|Lack of Efficacy|2|||
145908387|NCT00384930|526171108|FG000|Overall Study|Lost to Follow-up|5|||
145908388|NCT00384930|526171109|FG001|Overall Study|Lost to Follow-up|3|||
145908389|NCT00384930|526171110|FG002|Overall Study|Lost to Follow-up|0|||
145908390|NCT00384930|526171111|FG003|Overall Study|Lost to Follow-up|4|||
145908391|NCT00384930|526171112|FG004|Overall Study|Lost to Follow-up|6|||
145908392|NCT00384930|526171108|FG000|Overall Study|Physician Decision|0|||
145908393|NCT00384930|526171109|FG001|Overall Study|Physician Decision|1|||
145908394|NCT00384930|526171110|FG002|Overall Study|Physician Decision|1|||
145908395|NCT00384930|526171111|FG003|Overall Study|Physician Decision|0|||
145908396|NCT00384930|526171112|FG004|Overall Study|Physician Decision|1|||
145908397|NCT00384930|526171108|FG000|Overall Study|Protocol Violation|1|||
145908398|NCT00384930|526171109|FG001|Overall Study|Protocol Violation|0|||
145908399|NCT00384930|526171110|FG002|Overall Study|Protocol Violation|1|||
145908400|NCT00384930|526171111|FG003|Overall Study|Protocol Violation|6|||
145908401|NCT00384930|526171112|FG004|Overall Study|Protocol Violation|4|||
145908402|NCT00384930|526171108|FG000|Overall Study|Sponsor Decision|3|||
145908403|NCT00384930|526171109|FG001|Overall Study|Sponsor Decision|4|||
145908404|NCT00384930|526171110|FG002|Overall Study|Sponsor Decision|0|||
145908405|NCT00384930|526171111|FG003|Overall Study|Sponsor Decision|5|||
145908406|NCT00384930|526171112|FG004|Overall Study|Sponsor Decision|0|||
145908407|NCT00384930|526171108|FG000|Overall Study|Withdrawal by Subject|9|||
145908408|NCT00384930|526171109|FG001|Overall Study|Withdrawal by Subject|7|||
145908409|NCT00384930|526171110|FG002|Overall Study|Withdrawal by Subject|7|||
145908410|NCT00384930|526171111|FG003|Overall Study|Withdrawal by Subject|6|||
145908411|NCT00384930|526171112|FG004|Overall Study|Withdrawal by Subject|16|||
145908412|NCT00384930|526171108|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
145908413|NCT00384930|526171109|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
145908414|NCT00384930|526171110|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145908415|NCT00384930|526171111|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145908416|NCT00384930|526171112|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145908417|NCT01449370|526171115|FG000|Overall Study|Disease Progression|5|||
145908418|NCT01449370|526171116|FG001|Overall Study|Disease Progression|4|||
145908419|NCT01449370|526171117|FG002|Overall Study|Disease Progression|8|||
145908420|NCT01449370|526171118|FG003|Overall Study|Disease Progression|3|||
145908421|NCT01449370|526171119|FG004|Overall Study|Disease Progression|3|||
145908422|NCT01449370|526171120|FG005|Overall Study|Disease Progression|3|||
145908423|NCT01449370|526171121|FG006|Overall Study|Disease Progression|3|||
145908424|NCT01449370|526171122|FG007|Overall Study|Disease Progression|2|||
145908425|NCT01449370|526171123|FG008|Overall Study|Disease Progression|9|||
145908426|NCT01449370|526171124|FG009|Overall Study|Disease Progression|1|||
145908427|NCT01449370|526171125|FG010|Overall Study|Disease Progression|3|||
145908428|NCT01449370|526171126|FG011|Overall Study|Disease Progression|3|||
145908429|NCT01449370|526171127|FG012|Overall Study|Disease Progression|2|||
145908430|NCT01449370|526171128|FG013|Overall Study|Disease Progression|8|||
145908431|NCT01449370|526171129|FG014|Overall Study|Disease Progression|3|||
145908432|NCT01449370|526171130|FG015|Overall Study|Disease Progression|1|||
145908433|NCT01449370|526171131|FG016|Overall Study|Disease Progression|4|||
145908434|NCT01449370|526171132|FG017|Overall Study|Disease Progression|3|||
145908435|NCT01449370|526171133|FG018|Overall Study|Disease Progression|1|||
145908436|NCT01449370|526171134|FG019|Overall Study|Disease Progression|2|||
145908437|NCT01449370|526171135|FG020|Overall Study|Disease Progression|5|||
145908438|NCT01449370|526171136|FG021|Overall Study|Disease Progression|2|||
145908439|NCT01449370|526171137|FG022|Overall Study|Disease Progression|3|||
145908440|NCT01449370|526171138|FG023|Overall Study|Disease Progression|7|||
145908441|NCT01449370|526171139|FG024|Overall Study|Disease Progression|3|||
145908442|NCT01449370|526171115|FG000|Overall Study|Adverse Event|1|||
145908443|NCT01449370|526171116|FG001|Overall Study|Adverse Event|2|||
145908444|NCT01449370|526171117|FG002|Overall Study|Adverse Event|0|||
145908445|NCT01449370|526171118|FG003|Overall Study|Adverse Event|1|||
145908446|NCT01449370|526171119|FG004|Overall Study|Adverse Event|0|||
145908447|NCT01449370|526171120|FG005|Overall Study|Adverse Event|0|||
145908448|NCT01449370|526171121|FG006|Overall Study|Adverse Event|0|||
145908449|NCT01449370|526171122|FG007|Overall Study|Adverse Event|0|||
145908450|NCT01449370|526171123|FG008|Overall Study|Adverse Event|1|||
145908451|NCT01449370|526171124|FG009|Overall Study|Adverse Event|1|||
145908452|NCT01449370|526171125|FG010|Overall Study|Adverse Event|0|||
145908453|NCT01449370|526171126|FG011|Overall Study|Adverse Event|0|||
145908454|NCT01449370|526171127|FG012|Overall Study|Adverse Event|0|||
145908455|NCT01449370|526171128|FG013|Overall Study|Adverse Event|2|||
145908456|NCT01449370|526171129|FG014|Overall Study|Adverse Event|0|||
145908457|NCT01449370|526171130|FG015|Overall Study|Adverse Event|1|||
145908458|NCT01449370|526171131|FG016|Overall Study|Adverse Event|0|||
145908459|NCT01449370|526171132|FG017|Overall Study|Adverse Event|0|||
146239232|NCT01170208|527389749|FG001|Overall Study|Protocol Violation|0|||
145908460|NCT01449370|526171133|FG018|Overall Study|Adverse Event|1|||
145908461|NCT01449370|526171134|FG019|Overall Study|Adverse Event|1|||
145908462|NCT01449370|526171135|FG020|Overall Study|Adverse Event|0|||
145972924|NCT02020941|526414130|FG000|Overall Study|Withdrawal by Subject|1|||
145972925|NCT02020941|526414130|FG000|Overall Study|Disease Progression|4|||
145972926|NCT02832037|526414131|FG000|Overall Study|Administrative reasons|0|||
145972927|NCT02832037|526414132|FG001|Overall Study|Administrative reasons|0|||
145972928|NCT02832037|526414133|FG002|Overall Study|Administrative reasons|1|||
145972929|NCT02832037|526414134|FG003|Overall Study|Administrative reasons|0|||
145972930|NCT02832037|526414135|FG004|Overall Study|Administrative reasons|0|||
145972931|NCT02832037|526414131|FG000|Overall Study|Protocol Violation|3|||
145972932|NCT02832037|526414132|FG001|Overall Study|Protocol Violation|0|||
145972933|NCT02832037|526414133|FG002|Overall Study|Protocol Violation|4|||
145908463|NCT01449370|526171136|FG021|Overall Study|Adverse Event|1|||
145908464|NCT01449370|526171137|FG022|Overall Study|Adverse Event|0|||
145908465|NCT01449370|526171138|FG023|Overall Study|Adverse Event|1|||
145908466|NCT01449370|526171139|FG024|Overall Study|Adverse Event|3|||
145908467|NCT01449370|526171115|FG000|Overall Study|Participant Decision|0|||
145908468|NCT01449370|526171116|FG001|Overall Study|Participant Decision|0|||
145908469|NCT01449370|526171117|FG002|Overall Study|Participant Decision|0|||
145908470|NCT01449370|526171118|FG003|Overall Study|Participant Decision|0|||
145908471|NCT01449370|526171119|FG004|Overall Study|Participant Decision|0|||
145908472|NCT01449370|526171120|FG005|Overall Study|Participant Decision|0|||
145908473|NCT01449370|526171121|FG006|Overall Study|Participant Decision|0|||
145908474|NCT01449370|526171122|FG007|Overall Study|Participant Decision|1|||
145908475|NCT01449370|526171123|FG008|Overall Study|Participant Decision|1|||
145908476|NCT01449370|526171124|FG009|Overall Study|Participant Decision|0|||
145908477|NCT01449370|526171125|FG010|Overall Study|Participant Decision|0|||
145908478|NCT01449370|526171126|FG011|Overall Study|Participant Decision|0|||
145908479|NCT01449370|526171127|FG012|Overall Study|Participant Decision|1|||
145908480|NCT01449370|526171128|FG013|Overall Study|Participant Decision|1|||
145908481|NCT01449370|526171129|FG014|Overall Study|Participant Decision|0|||
145908482|NCT01449370|526171130|FG015|Overall Study|Participant Decision|1|||
145908483|NCT01449370|526171131|FG016|Overall Study|Participant Decision|3|||
145908484|NCT01449370|526171132|FG017|Overall Study|Participant Decision|0|||
145908485|NCT01449370|526171133|FG018|Overall Study|Participant Decision|1|||
145908486|NCT01449370|526171134|FG019|Overall Study|Participant Decision|0|||
145908487|NCT01449370|526171135|FG020|Overall Study|Participant Decision|0|||
145908488|NCT01449370|526171136|FG021|Overall Study|Participant Decision|1|||
145908489|NCT01449370|526171137|FG022|Overall Study|Participant Decision|0|||
145908490|NCT01449370|526171138|FG023|Overall Study|Participant Decision|0|||
145908491|NCT01449370|526171139|FG024|Overall Study|Participant Decision|1|||
145908492|NCT01449370|526171115|FG000|Overall Study|Lost to Follow-up|0|||
145908493|NCT01449370|526171116|FG001|Overall Study|Lost to Follow-up|0|||
145908494|NCT01449370|526171117|FG002|Overall Study|Lost to Follow-up|0|||
145908495|NCT01449370|526171118|FG003|Overall Study|Lost to Follow-up|0|||
145908496|NCT01449370|526171119|FG004|Overall Study|Lost to Follow-up|0|||
145908497|NCT01449370|526171120|FG005|Overall Study|Lost to Follow-up|0|||
145908498|NCT01449370|526171121|FG006|Overall Study|Lost to Follow-up|0|||
145908499|NCT01449370|526171122|FG007|Overall Study|Lost to Follow-up|0|||
145908500|NCT01449370|526171123|FG008|Overall Study|Lost to Follow-up|0|||
145908501|NCT01449370|526171124|FG009|Overall Study|Lost to Follow-up|0|||
145908502|NCT01449370|526171125|FG010|Overall Study|Lost to Follow-up|0|||
145908503|NCT01449370|526171126|FG011|Overall Study|Lost to Follow-up|0|||
145908504|NCT01449370|526171127|FG012|Overall Study|Lost to Follow-up|0|||
145908505|NCT01449370|526171128|FG013|Overall Study|Lost to Follow-up|0|||
145908506|NCT01449370|526171129|FG014|Overall Study|Lost to Follow-up|0|||
145908507|NCT01449370|526171130|FG015|Overall Study|Lost to Follow-up|0|||
145908508|NCT01449370|526171131|FG016|Overall Study|Lost to Follow-up|0|||
145908509|NCT01449370|526171132|FG017|Overall Study|Lost to Follow-up|0|||
145908510|NCT01449370|526171133|FG018|Overall Study|Lost to Follow-up|0|||
145908511|NCT01449370|526171134|FG019|Overall Study|Lost to Follow-up|0|||
145908512|NCT01449370|526171135|FG020|Overall Study|Lost to Follow-up|1|||
145908513|NCT01449370|526171136|FG021|Overall Study|Lost to Follow-up|0|||
145908514|NCT01449370|526171137|FG022|Overall Study|Lost to Follow-up|0|||
145908515|NCT01449370|526171138|FG023|Overall Study|Lost to Follow-up|0|||
145908516|NCT01449370|526171139|FG024|Overall Study|Lost to Follow-up|0|||
145908517|NCT01449370|526171115|FG000|Overall Study|Other|0|||
145908518|NCT01449370|526171116|FG001|Overall Study|Other|0|||
145908519|NCT01449370|526171117|FG002|Overall Study|Other|0|||
145908520|NCT01449370|526171118|FG003|Overall Study|Other|0|||
145908521|NCT01449370|526171119|FG004|Overall Study|Other|0|||
145972934|NCT02832037|526414134|FG003|Overall Study|Protocol Violation|1|||
146088535|NCT01923168|526843872|FG002|Overall Study|Subject/guardian decision|4|||
146088536|NCT01923168|526843870|FG000|Overall Study|Adverse Event|12|||
145908522|NCT01449370|526171120|FG005|Overall Study|Other|0|||
145908523|NCT01449370|526171121|FG006|Overall Study|Other|0|||
145908524|NCT01449370|526171122|FG007|Overall Study|Other|0|||
145908525|NCT01449370|526171123|FG008|Overall Study|Other|1|||
145908526|NCT01449370|526171124|FG009|Overall Study|Other|1|||
145908527|NCT01449370|526171125|FG010|Overall Study|Other|0|||
145908528|NCT01449370|526171126|FG011|Overall Study|Other|0|||
145972935|NCT02832037|526414135|FG004|Overall Study|Protocol Violation|2|||
145908529|NCT01449370|526171127|FG012|Overall Study|Other|0|||
145908530|NCT01449370|526171128|FG013|Overall Study|Other|0|||
145908531|NCT01449370|526171129|FG014|Overall Study|Other|0|||
145908532|NCT01449370|526171130|FG015|Overall Study|Other|0|||
145908533|NCT01449370|526171131|FG016|Overall Study|Other|0|||
145908534|NCT01449370|526171132|FG017|Overall Study|Other|0|||
145908535|NCT01449370|526171133|FG018|Overall Study|Other|0|||
145908536|NCT01449370|526171134|FG019|Overall Study|Other|0|||
145908537|NCT01449370|526171135|FG020|Overall Study|Other|0|||
145908538|NCT01449370|526171136|FG021|Overall Study|Other|0|||
145908539|NCT01449370|526171137|FG022|Overall Study|Other|1|||
145908540|NCT01449370|526171138|FG023|Overall Study|Other|1|||
145908541|NCT01449370|526171139|FG024|Overall Study|Other|0|||
145908542|NCT01449370|526171115|FG000|Overall Study|Medication Prohibited by Protocol|0|||
145908543|NCT01449370|526171116|FG001|Overall Study|Medication Prohibited by Protocol|0|||
145908544|NCT01449370|526171117|FG002|Overall Study|Medication Prohibited by Protocol|0|||
145908545|NCT01449370|526171118|FG003|Overall Study|Medication Prohibited by Protocol|0|||
145908546|NCT01449370|526171119|FG004|Overall Study|Medication Prohibited by Protocol|0|||
145908547|NCT01449370|526171120|FG005|Overall Study|Medication Prohibited by Protocol|0|||
145908548|NCT01449370|526171121|FG006|Overall Study|Medication Prohibited by Protocol|0|||
145908549|NCT01449370|526171122|FG007|Overall Study|Medication Prohibited by Protocol|0|||
145908550|NCT01449370|526171123|FG008|Overall Study|Medication Prohibited by Protocol|0|||
145908551|NCT01449370|526171124|FG009|Overall Study|Medication Prohibited by Protocol|0|||
145908552|NCT01449370|526171125|FG010|Overall Study|Medication Prohibited by Protocol|0|||
145908553|NCT01449370|526171126|FG011|Overall Study|Medication Prohibited by Protocol|0|||
145908554|NCT01449370|526171127|FG012|Overall Study|Medication Prohibited by Protocol|0|||
145908555|NCT01449370|526171128|FG013|Overall Study|Medication Prohibited by Protocol|0|||
145908556|NCT01449370|526171129|FG014|Overall Study|Medication Prohibited by Protocol|0|||
145908557|NCT01449370|526171130|FG015|Overall Study|Medication Prohibited by Protocol|0|||
145908558|NCT01449370|526171131|FG016|Overall Study|Medication Prohibited by Protocol|0|||
145908559|NCT01449370|526171132|FG017|Overall Study|Medication Prohibited by Protocol|0|||
145908560|NCT01449370|526171133|FG018|Overall Study|Medication Prohibited by Protocol|0|||
145908561|NCT01449370|526171134|FG019|Overall Study|Medication Prohibited by Protocol|0|||
145908562|NCT01449370|526171135|FG020|Overall Study|Medication Prohibited by Protocol|0|||
145908563|NCT01449370|526171136|FG021|Overall Study|Medication Prohibited by Protocol|0|||
145908564|NCT01449370|526171137|FG022|Overall Study|Medication Prohibited by Protocol|0|||
145908565|NCT01449370|526171138|FG023|Overall Study|Medication Prohibited by Protocol|1|||
145908566|NCT01449370|526171139|FG024|Overall Study|Medication Prohibited by Protocol|0|||
145908567|NCT01449370|526171115|FG000|Overall Study|Death|0|||
145908568|NCT01449370|526171116|FG001|Overall Study|Death|0|||
145908569|NCT01449370|526171117|FG002|Overall Study|Death|0|||
145908570|NCT01449370|526171118|FG003|Overall Study|Death|0|||
145908571|NCT01449370|526171119|FG004|Overall Study|Death|0|||
145908572|NCT01449370|526171120|FG005|Overall Study|Death|0|||
145908573|NCT01449370|526171121|FG006|Overall Study|Death|0|||
145908574|NCT01449370|526171122|FG007|Overall Study|Death|0|||
145908575|NCT01449370|526171123|FG008|Overall Study|Death|0|||
145908576|NCT01449370|526171124|FG009|Overall Study|Death|0|||
145908577|NCT01449370|526171125|FG010|Overall Study|Death|0|||
145972936|NCT02832037|526414131|FG000|Overall Study|Lost to Follow-up|2|||
145908578|NCT01449370|526171126|FG011|Overall Study|Death|0|||
145908579|NCT01449370|526171127|FG012|Overall Study|Death|0|||
145972937|NCT02832037|526414132|FG001|Overall Study|Lost to Follow-up|0|||
145972938|NCT02832037|526414133|FG002|Overall Study|Lost to Follow-up|3|||
145972939|NCT02832037|526414134|FG003|Overall Study|Lost to Follow-up|0|||
145972940|NCT02832037|526414135|FG004|Overall Study|Lost to Follow-up|5|||
145972941|NCT02832037|526414131|FG000|Overall Study|Withdrawal by Subject|9|||
145972942|NCT02832037|526414132|FG001|Overall Study|Withdrawal by Subject|8|||
145972943|NCT02832037|526414133|FG002|Overall Study|Withdrawal by Subject|0|||
145908580|NCT01449370|526171128|FG013|Overall Study|Death|0|||
145908581|NCT01449370|526171129|FG014|Overall Study|Death|0|||
145908582|NCT01449370|526171130|FG015|Overall Study|Death|0|||
145908583|NCT01449370|526171131|FG016|Overall Study|Death|0|||
145908584|NCT01449370|526171132|FG017|Overall Study|Death|0|||
145908585|NCT01449370|526171133|FG018|Overall Study|Death|0|||
145908586|NCT01449370|526171134|FG019|Overall Study|Death|0|||
145908587|NCT01449370|526171135|FG020|Overall Study|Death|0|||
145908588|NCT01449370|526171136|FG021|Overall Study|Death|0|||
145908589|NCT01449370|526171137|FG022|Overall Study|Death|0|||
145908590|NCT01449370|526171138|FG023|Overall Study|Death|0|||
145908591|NCT01449370|526171139|FG024|Overall Study|Death|1|||
145908592|NCT00534404|526171140|FG000|Overall Study|Death|0|||
145972944|NCT02832037|526414134|FG003|Overall Study|Withdrawal by Subject|4|||
145908593|NCT00534404|526171141|FG001|Overall Study|Death|0|||
145908594|NCT00534404|526171142|FG002|Overall Study|Death|2|||
145908595|NCT00534404|526171140|FG000|Overall Study|Withdrawal by Subject|8|||
145908596|NCT00534404|526171141|FG001|Overall Study|Withdrawal by Subject|2|||
145908597|NCT00534404|526171142|FG002|Overall Study|Withdrawal by Subject|38|||
145972945|NCT02832037|526414135|FG004|Overall Study|Withdrawal by Subject|8|||
145972946|NCT02832037|526414131|FG000|Overall Study|Adverse Event|5|||
145908598|NCT00534404|526171140|FG000|Overall Study|Removed by study staff|2|||
145908599|NCT00534404|526171141|FG001|Overall Study|Removed by study staff|3|||
145908600|NCT00534404|526171142|FG002|Overall Study|Removed by study staff|1|||
145908601|NCT00534404|526171140|FG000|Overall Study|Lost to Follow-up|170|||
145908602|NCT00534404|526171141|FG001|Overall Study|Lost to Follow-up|138|||
145908603|NCT00534404|526171142|FG002|Overall Study|Lost to Follow-up|201|||
145972947|NCT02832037|526414132|FG001|Overall Study|Adverse Event|4|||
145972948|NCT02832037|526414133|FG002|Overall Study|Adverse Event|0|||
145972949|NCT02832037|526414134|FG003|Overall Study|Adverse Event|2|||
145972950|NCT02832037|526414135|FG004|Overall Study|Adverse Event|4|||
145908604|NCT02027428|526171143|FG000|Induction|Never treated|7|||
145908605|NCT02027428|526171144|FG001|Induction|Never treated|0|||
145908606|NCT02027428|526171145|FG002|Induction|Never treated|0|||
145908607|NCT02027428|526171143|FG000|Induction|Progressive disease|77|||
145908608|NCT02027428|526171144|FG001|Induction|Progressive disease|0|||
145908609|NCT02027428|526171145|FG002|Induction|Progressive disease|0|||
145908610|NCT02027428|526171143|FG000|Induction|Adverse Event|51|||
145908611|NCT02027428|526171144|FG001|Induction|Adverse Event|0|||
145908612|NCT02027428|526171145|FG002|Induction|Adverse Event|0|||
145972951|NCT00937950|526414143|FG000|Overall Study|Withdrawal by Subject|23|||
145972952|NCT00937950|526414143|FG000|Overall Study|Migrated/moved from study area|27|||
145972953|NCT00937950|526414143|FG000|Overall Study|Lost to Follow-up|144|||
145972954|NCT00937950|526414143|FG000|Overall Study|Missing confirmed|4|||
145972955|NCT00937950|526414143|FG000|Overall Study|Other|18|||
145972956|NCT01531153|526414146|FG000|Overall Study|Withdrawal by Subject|10|||
145972957|NCT01531153|526414147|FG001|Overall Study|Withdrawal by Subject|9|||
145972958|NCT01531153|526414148|FG002|Overall Study|Withdrawal by Subject|15|||
145972959|NCT00435942|526414149|FG000|Overall Study|Death|17|||
145972960|NCT00435942|526414150|FG001|Overall Study|Death|10|||
145972961|NCT00435942|526414149|FG000|Overall Study|Withdrawal by Subject|2|||
145972962|NCT00435942|526414150|FG001|Overall Study|Withdrawal by Subject|0|||
145972963|NCT00435942|526414149|FG000|Overall Study|Lost to Follow-up|0|||
145972964|NCT00435942|526414150|FG001|Overall Study|Lost to Follow-up|16|||
145972965|NCT00435942|526414149|FG000|Overall Study|Conversion to Open Repair|1|||
145972966|NCT00435942|526414150|FG001|Overall Study|Conversion to Open Repair|0|||
145972967|NCT00435942|526414149|FG000|Overall Study|Technical Failure|3|||
145972968|NCT00435942|526414150|FG001|Overall Study|Technical Failure|0|||
145972969|NCT00435942|526414149|FG000|Overall Study|Other|0|||
145972970|NCT00435942|526414150|FG001|Overall Study|Other|1|||
145972971|NCT02378181|526414151|FG000|Overall Study|Lost to Follow-up|2|||
145972972|NCT02378181|526414152|FG001|Overall Study|Lost to Follow-up|5|||
145972973|NCT02378181|526414151|FG000|Overall Study|Withdrawal by Subject|1|||
145972974|NCT02378181|526414152|FG001|Overall Study|Withdrawal by Subject|1|||
145972975|NCT02378181|526414151|FG000|Overall Study|Incarcerated|0|||
145972976|NCT02378181|526414152|FG001|Overall Study|Incarcerated|1|||
145972977|NCT01180777|526414153|FG000|Overall Study|Protocol Violation|6|||
145908613|NCT02027428|526171143|FG000|Induction|Withdrawal by Subject|22|||
145908614|NCT02027428|526171144|FG001|Induction|Withdrawal by Subject|0|||
145908615|NCT02027428|526171145|FG002|Induction|Withdrawal by Subject|0|||
145908616|NCT02027428|526171143|FG000|Induction|Death|21|||
145908617|NCT02027428|526171144|FG001|Induction|Death|0|||
145908618|NCT02027428|526171145|FG002|Induction|Death|0|||
145908619|NCT02027428|526171143|FG000|Induction|Symptomatic deterioration|16|||
145908620|NCT02027428|526171144|FG001|Induction|Symptomatic deterioration|0|||
145908621|NCT02027428|526171145|FG002|Induction|Symptomatic deterioration|0|||
145908622|NCT02027428|526171143|FG000|Induction|Study terminated by sponsor|12|||
145972978|NCT01180777|526414153|FG000|Overall Study|Poor lens fit|4|||
145908623|NCT02027428|526171144|FG001|Induction|Study terminated by sponsor|0|||
145908624|NCT02027428|526171145|FG002|Induction|Study terminated by sponsor|0|||
145908625|NCT02027428|526171143|FG000|Induction|Protocol Violation|1|||
145908626|NCT02027428|526171144|FG001|Induction|Protocol Violation|0|||
145972979|NCT01180777|526414153|FG000|Overall Study|Lost to Follow-up|1|||
145972980|NCT01180777|526414153|FG000|Overall Study|Adverse Event|1|||
145972981|NCT04491994|526414154|FG000|Overall Study|Withdrawal by Subject|10|||
145972982|NCT04491994|526414155|FG001|Overall Study|Withdrawal by Subject|5|||
145908627|NCT02027428|526171145|FG002|Induction|Protocol Violation|0|||
145908628|NCT02027428|526171143|FG000|Induction|Miscellaneous|14|||
145972983|NCT04491994|526414154|FG000|Overall Study|developed fever > 3 days|4|||
145972984|NCT04491994|526414155|FG001|Overall Study|developed fever > 3 days|1|||
145972985|NCT04491994|526414154|FG000|Overall Study|Protocol Violation|11|||
145972986|NCT04491994|526414155|FG001|Overall Study|Protocol Violation|2|||
145972987|NCT04491994|526414154|FG000|Overall Study|Lost to Follow-up|4|||
145972988|NCT04491994|526414155|FG001|Overall Study|Lost to Follow-up|3|||
145908629|NCT02027428|526171144|FG001|Induction|Miscellaneous|0|||
145908630|NCT02027428|526171145|FG002|Induction|Miscellaneous|0|||
145908631|NCT02027428|526171143|FG000|Induction|Induction Treatment Ongoing|4|||
145908632|NCT02027428|526171144|FG001|Induction|Induction Treatment Ongoing|0|||
145972989|NCT02320396|526414156|FG000|Overall Study|Adverse Event|2|||
145972990|NCT02320396|526414157|FG001|Overall Study|Adverse Event|2|||
145972991|NCT02320396|526414156|FG000|Overall Study|Pregnancy|0|||
145972992|NCT02320396|526414157|FG001|Overall Study|Pregnancy|1|||
145908633|NCT02027428|526171145|FG002|Induction|Induction Treatment Ongoing|0|||
145908634|NCT02027428|526171143|FG000|Maintenance|Death|0|||
145908635|NCT02027428|526171144|FG001|Maintenance|Death|3|||
145908636|NCT02027428|526171145|FG002|Maintenance|Death|2|||
145908637|NCT02027428|526171143|FG000|Maintenance|Adverse Event|0|||
145908638|NCT02027428|526171144|FG001|Maintenance|Adverse Event|21|||
145908639|NCT02027428|526171145|FG002|Maintenance|Adverse Event|1|||
145908640|NCT02027428|526171143|FG000|Maintenance|Progressive disease|0|||
145908641|NCT02027428|526171144|FG001|Maintenance|Progressive disease|84|||
145908642|NCT02027428|526171145|FG002|Maintenance|Progressive disease|47|||
145908643|NCT02027428|526171143|FG000|Maintenance|Symptomatic deterioration|0|||
145908644|NCT02027428|526171144|FG001|Maintenance|Symptomatic deterioration|4|||
145908645|NCT02027428|526171145|FG002|Maintenance|Symptomatic deterioration|1|||
145908646|NCT02027428|526171143|FG000|Maintenance|Withdrawal by Subject|0|||
145908647|NCT02027428|526171144|FG001|Maintenance|Withdrawal by Subject|6|||
145908648|NCT02027428|526171145|FG002|Maintenance|Withdrawal by Subject|5|||
145908649|NCT02027428|526171143|FG000|Maintenance|Protocol Violation|0|||
145908650|NCT02027428|526171144|FG001|Maintenance|Protocol Violation|0|||
145908651|NCT02027428|526171145|FG002|Maintenance|Protocol Violation|1|||
145908652|NCT02027428|526171143|FG000|Maintenance|Other|0|||
145908653|NCT02027428|526171144|FG001|Maintenance|Other|6|||
145908654|NCT02027428|526171145|FG002|Maintenance|Other|3|||
145908655|NCT02027428|526171143|FG000|Survival Follow-up|Death|0|||
145908656|NCT02027428|526171144|FG001|Survival Follow-up|Death|78|||
145908657|NCT02027428|526171145|FG002|Survival Follow-up|Death|45|||
145908658|NCT02027428|526171143|FG000|Survival Follow-up|Lost to Follow-up|0|||
145908659|NCT02027428|526171144|FG001|Survival Follow-up|Lost to Follow-up|1|||
145908660|NCT02027428|526171145|FG002|Survival Follow-up|Lost to Follow-up|1|||
145908661|NCT03097991|526171149|FG000|Overall Study|Didn't meet study criteria|8|||
145908662|NCT03097991|526171150|FG001|Overall Study|Didn't meet study criteria|0|||
145908663|NCT03097991|526171149|FG000|Overall Study|Withdrawal by Subject|12|||
145908664|NCT03097991|526171150|FG001|Overall Study|Withdrawal by Subject|6|||
145908665|NCT03097991|526171149|FG000|Overall Study|Death of Baby|3|||
145908666|NCT03097991|526171150|FG001|Overall Study|Death of Baby|1|||
145908667|NCT03097991|526171149|FG000|Overall Study|Lost to Follow-up|24|||
145908668|NCT03097991|526171150|FG001|Overall Study|Lost to Follow-up|38|||
145908669|NCT03097991|526171149|FG000|Overall Study|Adverse Event|3|||
145908670|NCT03097991|526171150|FG001|Overall Study|Adverse Event|5|||
145908671|NCT01098487|526171152|FG000|Overall Study|Adverse Event|22|||
145908672|NCT01098487|526171152|FG000|Overall Study|Lack of Efficacy|11|||
145908673|NCT01098487|526171152|FG000|Overall Study|Withdrawal by Subject|7|||
145908674|NCT01098487|526171152|FG000|Overall Study|Lost to Follow-up|3|||
145908675|NCT01098487|526171152|FG000|Overall Study|Physician Decision|1|||
145908676|NCT03301623|526171157|FG000|Overall Study|Death|3|||
145908677|NCT03301623|526171158|FG001|Overall Study|Death|1|||
145908678|NCT03301623|526171157|FG000|Overall Study|Withdrawal by Subject|11|||
145908679|NCT03301623|526171158|FG001|Overall Study|Withdrawal by Subject|13|||
145908680|NCT03301623|526171157|FG000|Overall Study|Lost to Follow-up|3|||
145908681|NCT03301623|526171158|FG001|Overall Study|Lost to Follow-up|1|||
145908682|NCT01374269|526171159|FG000|Overall Study|Withdrawal by Subject|4|||
145908683|NCT01374269|526171160|FG001|Overall Study|Withdrawal by Subject|0|||
145908684|NCT01374269|526171159|FG000|Overall Study|Lost to Follow-up|1|||
145908685|NCT01374269|526171160|FG001|Overall Study|Lost to Follow-up|3|||
145908686|NCT01374269|526171159|FG000|Overall Study|closed research|1|||
145908687|NCT01374269|526171160|FG001|Overall Study|closed research|2|||
145908688|NCT03316547|526171163|FG000|Overall Study|Death|3|||
145908689|NCT03316547|526171164|FG001|Overall Study|Death|1|||
145908690|NCT03316547|526171163|FG000|Overall Study|Lost to Follow-up|6|||
145908691|NCT03316547|526171164|FG001|Overall Study|Lost to Follow-up|6|||
145908692|NCT03316547|526171163|FG000|Overall Study|Withdrawal by Subject|3|||
145908693|NCT03316547|526171164|FG001|Overall Study|Withdrawal by Subject|2|||
145908694|NCT03316547|526171163|FG000|Overall Study|Transfer to another hospital|6|||
145908695|NCT03316547|526171164|FG001|Overall Study|Transfer to another hospital|4|||
145908696|NCT00996892|526171165|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
145908697|NCT00996892|526171166|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
145908698|NCT00996892|526171167|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
145908699|NCT00996892|526171168|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
145908700|NCT00996892|526171169|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
145908701|NCT00996892|526171170|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
145908702|NCT00996892|526171171|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
145908703|NCT00996892|526171172|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
145972993|NCT02320396|526414156|FG000|Overall Study|Protocol Violation|0|||
145908704|NCT00996892|526171173|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
145908705|NCT00996892|526171174|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
145908706|NCT00996892|526171175|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
145908707|NCT00996892|526171176|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
145972994|NCT02320396|526414157|FG001|Overall Study|Protocol Violation|1|||
145908708|NCT00996892|526171177|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
145908709|NCT00996892|526171178|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
145908710|NCT00996892|526171179|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
145972995|NCT02320396|526414156|FG000|Overall Study|Withdrawal by Subject|2|||
145908711|NCT00996892|526171180|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
145908712|NCT00996892|526171181|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
145908713|NCT00996892|526171182|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
145908714|NCT00996892|526171183|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
145908715|NCT00996892|526171184|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
145908716|NCT00996892|526171165|FG000|Dose-Escalation Stage 1|Death|1|||
145908717|NCT00996892|526171166|FG001|Dose-Escalation Stage 1|Death|0|||
145908718|NCT00996892|526171167|FG002|Dose-Escalation Stage 1|Death|0|||
145908719|NCT00996892|526171168|FG003|Dose-Escalation Stage 1|Death|0|||
145908720|NCT00996892|526171169|FG004|Dose-Escalation Stage 1|Death|0|||
145908721|NCT00996892|526171170|FG005|Dose-Escalation Stage 1|Death|1|||
145908722|NCT00996892|526171171|FG006|Dose-Escalation Stage 1|Death|0|||
145908723|NCT00996892|526171172|FG007|Dose-Escalation Stage 1|Death|0|||
145908724|NCT00996892|526171173|FG008|Dose-Escalation Stage 1|Death|0|||
145908725|NCT00996892|526171174|FG009|Dose-Escalation Stage 1|Death|0|||
145908726|NCT00996892|526171175|FG010|Dose-Escalation Stage 1|Death|0|||
145908727|NCT00996892|526171176|FG011|Dose-Escalation Stage 1|Death|0|||
145908728|NCT00996892|526171177|FG012|Dose-Escalation Stage 1|Death|0|||
145908729|NCT00996892|526171178|FG013|Dose-Escalation Stage 1|Death|0|||
145908730|NCT00996892|526171179|FG014|Dose-Escalation Stage 1|Death|0|||
145908731|NCT00996892|526171180|FG015|Dose-Escalation Stage 1|Death|0|||
145908732|NCT00996892|526171181|FG016|Dose-Escalation Stage 1|Death|0|||
145908733|NCT00996892|526171182|FG017|Dose-Escalation Stage 1|Death|0|||
145908734|NCT00996892|526171183|FG018|Dose-Escalation Stage 1|Death|0|||
145908735|NCT00996892|526171184|FG019|Dose-Escalation Stage 1|Death|0|||
145908736|NCT00996892|526171165|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
145908737|NCT00996892|526171166|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
145908738|NCT00996892|526171167|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
145908739|NCT00996892|526171168|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
145908740|NCT00996892|526171169|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
145908741|NCT00996892|526171170|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
145908742|NCT00996892|526171171|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
145908743|NCT00996892|526171172|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
145908744|NCT00996892|526171173|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
145908745|NCT00996892|526171174|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
145908746|NCT00996892|526171175|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
145908747|NCT00996892|526171176|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
145908748|NCT00996892|526171177|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
145908749|NCT00996892|526171178|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
145908750|NCT00996892|526171179|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
145908751|NCT00996892|526171180|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
145908752|NCT00996892|526171181|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
145908753|NCT00996892|526171182|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
145908754|NCT00996892|526171183|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
145908755|NCT00996892|526171184|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
145908756|NCT00996892|526171165|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908757|NCT00996892|526171166|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145908758|NCT00996892|526171167|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908759|NCT00996892|526171168|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
145908760|NCT00996892|526171169|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145908761|NCT00996892|526171170|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145908762|NCT00996892|526171171|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145908763|NCT00996892|526171172|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908764|NCT00996892|526171173|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908765|NCT00996892|526171174|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908766|NCT00996892|526171175|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908767|NCT00996892|526171176|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908768|NCT00996892|526171177|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908769|NCT00996892|526171178|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908770|NCT00996892|526171179|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908771|NCT00996892|526171180|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908772|NCT00996892|526171181|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908773|NCT00996892|526171182|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908774|NCT00996892|526171183|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908775|NCT00996892|526171184|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145908776|NCT00996892|526171165|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
145908777|NCT00996892|526171166|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
145908778|NCT00996892|526171167|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
145908779|NCT00996892|526171168|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
145972996|NCT02320396|526414157|FG001|Overall Study|Withdrawal by Subject|0|||
145972997|NCT03331562|526414158|FG000|Overall Study|Adverse Event|2|||
145908780|NCT00996892|526171169|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
145908781|NCT00996892|526171170|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
145908782|NCT00996892|526171171|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
145908783|NCT00996892|526171172|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
145908784|NCT00996892|526171173|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
145908785|NCT00996892|526171174|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
145908786|NCT00996892|526171175|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
145908787|NCT00996892|526171176|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
145908788|NCT00996892|526171177|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
145908789|NCT00996892|526171178|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
145908790|NCT00996892|526171179|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
145908791|NCT00996892|526171180|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
145908792|NCT00996892|526171181|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
145908793|NCT00996892|526171182|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
145908794|NCT00996892|526171183|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
145908795|NCT00996892|526171184|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
145908796|NCT00996892|526171165|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
145908797|NCT00996892|526171166|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
145908798|NCT00996892|526171167|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
145908799|NCT00996892|526171168|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
145908800|NCT00996892|526171169|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
145908801|NCT00996892|526171170|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
145908802|NCT00996892|526171171|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
145908803|NCT00996892|526171172|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
145908804|NCT00996892|526171173|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
145908805|NCT00996892|526171174|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
145908806|NCT00996892|526171175|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
145908807|NCT00996892|526171176|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
145908808|NCT00996892|526171177|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
145908809|NCT00996892|526171178|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
145908810|NCT00996892|526171179|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
145908811|NCT00996892|526171180|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
145908812|NCT00996892|526171181|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
145908813|NCT00996892|526171182|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
145908814|NCT00996892|526171183|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
145908815|NCT00996892|526171184|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
145908816|NCT00996892|526171165|FG000|Dose-Escalation Stage 1A|Death|0|||
145908817|NCT00996892|526171166|FG001|Dose-Escalation Stage 1A|Death|0|||
145908818|NCT00996892|526171167|FG002|Dose-Escalation Stage 1A|Death|0|||
145908819|NCT00996892|526171168|FG003|Dose-Escalation Stage 1A|Death|0|||
145908820|NCT00996892|526171169|FG004|Dose-Escalation Stage 1A|Death|0|||
145908821|NCT00996892|526171170|FG005|Dose-Escalation Stage 1A|Death|0|||
145908822|NCT00996892|526171171|FG006|Dose-Escalation Stage 1A|Death|0|||
145908823|NCT00996892|526171172|FG007|Dose-Escalation Stage 1A|Death|0|||
145908824|NCT00996892|526171173|FG008|Dose-Escalation Stage 1A|Death|0|||
145908825|NCT00996892|526171174|FG009|Dose-Escalation Stage 1A|Death|2|||
145908826|NCT00996892|526171175|FG010|Dose-Escalation Stage 1A|Death|0|||
145908827|NCT00996892|526171176|FG011|Dose-Escalation Stage 1A|Death|1|||
145908828|NCT00996892|526171177|FG012|Dose-Escalation Stage 1A|Death|1|||
145908829|NCT00996892|526171178|FG013|Dose-Escalation Stage 1A|Death|0|||
145908830|NCT00996892|526171179|FG014|Dose-Escalation Stage 1A|Death|0|||
145908831|NCT00996892|526171180|FG015|Dose-Escalation Stage 1A|Death|0|||
145908832|NCT00996892|526171181|FG016|Dose-Escalation Stage 1A|Death|0|||
145908833|NCT00996892|526171182|FG017|Dose-Escalation Stage 1A|Death|0|||
145908834|NCT00996892|526171183|FG018|Dose-Escalation Stage 1A|Death|0|||
145908835|NCT00996892|526171184|FG019|Dose-Escalation Stage 1A|Death|0|||
145908836|NCT00996892|526171165|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
145908837|NCT00996892|526171166|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
145908838|NCT00996892|526171167|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
145908839|NCT00996892|526171168|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
145908840|NCT00996892|526171169|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
145908841|NCT00996892|526171170|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
145908842|NCT00996892|526171171|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
145908843|NCT00996892|526171172|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
145908844|NCT00996892|526171173|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
145908845|NCT00996892|526171174|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
145908846|NCT00996892|526171175|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
145908847|NCT00996892|526171176|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
145908848|NCT00996892|526171177|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
145908849|NCT00996892|526171178|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
145908850|NCT00996892|526171179|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
145908851|NCT00996892|526171180|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
145908852|NCT00996892|526171181|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
145908853|NCT00996892|526171182|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
145908854|NCT00996892|526171183|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
145908855|NCT00996892|526171184|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
146297416|NCT01641809|527604695|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
146297417|NCT01641809|527604692|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
146297418|NCT01641809|527604693|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
146297419|NCT01641809|527604694|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
146297420|NCT01641809|527604695|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
145908856|NCT00996892|526171165|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908857|NCT00996892|526171166|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908858|NCT00996892|526171167|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908859|NCT00996892|526171168|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908860|NCT00996892|526171169|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908861|NCT00996892|526171170|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908862|NCT00996892|526171171|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908863|NCT00996892|526171172|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908864|NCT00996892|526171173|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908865|NCT00996892|526171174|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145908866|NCT00996892|526171175|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145908867|NCT00996892|526171176|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145908868|NCT00996892|526171177|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145908869|NCT00996892|526171178|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908870|NCT00996892|526171179|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908871|NCT00996892|526171180|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908872|NCT00996892|526171181|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908873|NCT00996892|526171182|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908874|NCT00996892|526171183|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908875|NCT00996892|526171184|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145908876|NCT00996892|526171165|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
145908877|NCT00996892|526171166|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
145908878|NCT00996892|526171167|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
145908879|NCT00996892|526171168|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
145908880|NCT00996892|526171169|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
145908881|NCT00996892|526171170|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
145908882|NCT00996892|526171171|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
145908883|NCT00996892|526171172|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
145908884|NCT00996892|526171173|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
145908885|NCT00996892|526171174|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
145908886|NCT00996892|526171175|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
145908887|NCT00996892|526171176|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
145908888|NCT00996892|526171177|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
145908889|NCT00996892|526171178|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
145908890|NCT00996892|526171179|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
145908891|NCT00996892|526171180|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
145908892|NCT00996892|526171181|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
145908893|NCT00996892|526171182|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
145908894|NCT00996892|526171183|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
145908895|NCT00996892|526171184|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
145908896|NCT00996892|526171165|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
145908897|NCT00996892|526171166|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
145908898|NCT00996892|526171167|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
145908899|NCT00996892|526171168|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
145908900|NCT00996892|526171169|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
145908901|NCT00996892|526171170|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
145908902|NCT00996892|526171171|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
145908903|NCT00996892|526171172|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
145908904|NCT00996892|526171173|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
145908905|NCT00996892|526171174|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
145908906|NCT00996892|526171175|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
145908907|NCT00996892|526171176|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
145908908|NCT00996892|526171177|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
145908909|NCT00996892|526171178|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
145908910|NCT00996892|526171179|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
145908911|NCT00996892|526171180|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
145908912|NCT00996892|526171181|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
145908913|NCT00996892|526171182|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
145908914|NCT00996892|526171183|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
145908915|NCT00996892|526171184|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
145908916|NCT00996892|526171165|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
145908917|NCT00996892|526171166|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
145908918|NCT00996892|526171167|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
145908919|NCT00996892|526171168|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
145908920|NCT00996892|526171169|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
145908921|NCT00996892|526171170|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
145908922|NCT00996892|526171171|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
145908923|NCT00996892|526171172|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
145908924|NCT00996892|526171173|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
145908925|NCT00996892|526171174|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
145908926|NCT00996892|526171175|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
145908927|NCT00996892|526171176|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
145908928|NCT00996892|526171177|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
145908929|NCT00996892|526171178|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
145908930|NCT00996892|526171179|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
145908931|NCT00996892|526171180|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
145908932|NCT00996892|526171181|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
145908933|NCT00996892|526171182|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
145908934|NCT00996892|526171183|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
145908935|NCT00996892|526171184|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
145908936|NCT00996892|526171165|FG000|Expansion Stage 2|Adverse Event|0|||
145908937|NCT00996892|526171166|FG001|Expansion Stage 2|Adverse Event|0|||
145908938|NCT00996892|526171167|FG002|Expansion Stage 2|Adverse Event|0|||
145908939|NCT00996892|526171168|FG003|Expansion Stage 2|Adverse Event|0|||
145908940|NCT00996892|526171169|FG004|Expansion Stage 2|Adverse Event|0|||
145908941|NCT00996892|526171170|FG005|Expansion Stage 2|Adverse Event|0|||
145908942|NCT00996892|526171171|FG006|Expansion Stage 2|Adverse Event|0|||
145908943|NCT00996892|526171172|FG007|Expansion Stage 2|Adverse Event|0|||
145908944|NCT00996892|526171173|FG008|Expansion Stage 2|Adverse Event|0|||
145908945|NCT00996892|526171174|FG009|Expansion Stage 2|Adverse Event|0|||
145908946|NCT00996892|526171175|FG010|Expansion Stage 2|Adverse Event|0|||
145908947|NCT00996892|526171176|FG011|Expansion Stage 2|Adverse Event|0|||
145908948|NCT00996892|526171177|FG012|Expansion Stage 2|Adverse Event|0|||
145908949|NCT00996892|526171178|FG013|Expansion Stage 2|Adverse Event|0|||
145908950|NCT00996892|526171179|FG014|Expansion Stage 2|Adverse Event|0|||
145908951|NCT00996892|526171180|FG015|Expansion Stage 2|Adverse Event|0|||
145908952|NCT00996892|526171181|FG016|Expansion Stage 2|Adverse Event|0|||
145908953|NCT00996892|526171182|FG017|Expansion Stage 2|Adverse Event|0|||
145908954|NCT00996892|526171183|FG018|Expansion Stage 2|Adverse Event|3|||
145908955|NCT00996892|526171184|FG019|Expansion Stage 2|Adverse Event|0|||
145908956|NCT00996892|526171165|FG000|Expansion Stage 2|Death|0|||
145908957|NCT00996892|526171166|FG001|Expansion Stage 2|Death|0|||
145908958|NCT00996892|526171167|FG002|Expansion Stage 2|Death|0|||
145908959|NCT00996892|526171168|FG003|Expansion Stage 2|Death|0|||
145908960|NCT00996892|526171169|FG004|Expansion Stage 2|Death|0|||
145908961|NCT00996892|526171170|FG005|Expansion Stage 2|Death|0|||
145908962|NCT00996892|526171171|FG006|Expansion Stage 2|Death|0|||
145908963|NCT00996892|526171172|FG007|Expansion Stage 2|Death|0|||
145908964|NCT00996892|526171173|FG008|Expansion Stage 2|Death|0|||
145908965|NCT00996892|526171174|FG009|Expansion Stage 2|Death|0|||
145908966|NCT00996892|526171175|FG010|Expansion Stage 2|Death|0|||
145908967|NCT00996892|526171176|FG011|Expansion Stage 2|Death|0|||
145908968|NCT00996892|526171177|FG012|Expansion Stage 2|Death|0|||
145908969|NCT00996892|526171178|FG013|Expansion Stage 2|Death|0|||
145908970|NCT00996892|526171179|FG014|Expansion Stage 2|Death|0|||
145908971|NCT00996892|526171180|FG015|Expansion Stage 2|Death|0|||
145908972|NCT00996892|526171181|FG016|Expansion Stage 2|Death|0|||
145908973|NCT00996892|526171182|FG017|Expansion Stage 2|Death|0|||
145908974|NCT00996892|526171183|FG018|Expansion Stage 2|Death|2|||
145908975|NCT00996892|526171184|FG019|Expansion Stage 2|Death|0|||
145908976|NCT00996892|526171165|FG000|Expansion Stage 2|Physician Decision|0|||
145908977|NCT00996892|526171166|FG001|Expansion Stage 2|Physician Decision|0|||
145908978|NCT00996892|526171167|FG002|Expansion Stage 2|Physician Decision|0|||
145908979|NCT00996892|526171168|FG003|Expansion Stage 2|Physician Decision|0|||
145908980|NCT00996892|526171169|FG004|Expansion Stage 2|Physician Decision|0|||
145908981|NCT00996892|526171170|FG005|Expansion Stage 2|Physician Decision|0|||
146297421|NCT01641809|527604692|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
145908982|NCT00996892|526171171|FG006|Expansion Stage 2|Physician Decision|0|||
145908983|NCT00996892|526171172|FG007|Expansion Stage 2|Physician Decision|0|||
145908984|NCT00996892|526171173|FG008|Expansion Stage 2|Physician Decision|0|||
145908985|NCT00996892|526171174|FG009|Expansion Stage 2|Physician Decision|0|||
145908986|NCT00996892|526171175|FG010|Expansion Stage 2|Physician Decision|0|||
145908987|NCT00996892|526171176|FG011|Expansion Stage 2|Physician Decision|0|||
145908988|NCT00996892|526171177|FG012|Expansion Stage 2|Physician Decision|0|||
145908989|NCT00996892|526171178|FG013|Expansion Stage 2|Physician Decision|0|||
145908990|NCT00996892|526171179|FG014|Expansion Stage 2|Physician Decision|0|||
145908991|NCT00996892|526171180|FG015|Expansion Stage 2|Physician Decision|0|||
145908992|NCT00996892|526171181|FG016|Expansion Stage 2|Physician Decision|0|||
145908993|NCT00996892|526171182|FG017|Expansion Stage 2|Physician Decision|0|||
145908994|NCT00996892|526171183|FG018|Expansion Stage 2|Physician Decision|1|||
145972998|NCT03331562|526414159|FG001|Overall Study|Adverse Event|0|||
145908995|NCT00996892|526171184|FG019|Expansion Stage 2|Physician Decision|0|||
145908996|NCT00996892|526171165|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
145908997|NCT00996892|526171166|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
145972999|NCT03331562|526414158|FG000|Overall Study|Death|1|||
145973000|NCT03331562|526414159|FG001|Overall Study|Death|0|||
145973001|NCT03718000|526414160|FG000|Overall Study|Relocation|2|||
145973002|NCT03718000|526414161|FG001|Overall Study|Relocation|4|||
145973003|NCT03718000|526414160|FG000|Overall Study|Pregnancy|0|||
145908998|NCT00996892|526171167|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
145908999|NCT00996892|526171168|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
145909000|NCT00996892|526171169|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
145909001|NCT00996892|526171170|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
145909002|NCT00996892|526171171|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
145909003|NCT00996892|526171172|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
145909004|NCT00996892|526171173|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
145909005|NCT00996892|526171174|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
145909006|NCT00996892|526171175|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
145909007|NCT00996892|526171176|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
145909008|NCT00996892|526171177|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
145909009|NCT00996892|526171178|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
145909010|NCT00996892|526171179|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
145909011|NCT00996892|526171180|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
145909012|NCT00996892|526171181|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
145909013|NCT00996892|526171182|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
145909014|NCT00996892|526171183|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
145909015|NCT00996892|526171184|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
145909016|NCT00996892|526171165|FG000|Expansion Stage 2|Disease Progression|0|||
145909017|NCT00996892|526171166|FG001|Expansion Stage 2|Disease Progression|0|||
145909018|NCT00996892|526171167|FG002|Expansion Stage 2|Disease Progression|0|||
145909019|NCT00996892|526171168|FG003|Expansion Stage 2|Disease Progression|0|||
145909020|NCT00996892|526171169|FG004|Expansion Stage 2|Disease Progression|0|||
145909021|NCT00996892|526171170|FG005|Expansion Stage 2|Disease Progression|0|||
145909022|NCT00996892|526171171|FG006|Expansion Stage 2|Disease Progression|0|||
145909023|NCT00996892|526171172|FG007|Expansion Stage 2|Disease Progression|0|||
145909024|NCT00996892|526171173|FG008|Expansion Stage 2|Disease Progression|0|||
145909025|NCT00996892|526171174|FG009|Expansion Stage 2|Disease Progression|0|||
145909026|NCT00996892|526171175|FG010|Expansion Stage 2|Disease Progression|0|||
145909027|NCT00996892|526171176|FG011|Expansion Stage 2|Disease Progression|0|||
145909028|NCT00996892|526171177|FG012|Expansion Stage 2|Disease Progression|0|||
145909029|NCT00996892|526171178|FG013|Expansion Stage 2|Disease Progression|0|||
145909030|NCT00996892|526171179|FG014|Expansion Stage 2|Disease Progression|0|||
145909031|NCT00996892|526171180|FG015|Expansion Stage 2|Disease Progression|0|||
145909032|NCT00996892|526171181|FG016|Expansion Stage 2|Disease Progression|0|||
145909033|NCT00996892|526171182|FG017|Expansion Stage 2|Disease Progression|0|||
145909034|NCT00996892|526171183|FG018|Expansion Stage 2|Disease Progression|28|||
145909035|NCT00996892|526171184|FG019|Expansion Stage 2|Disease Progression|0|||
145909036|NCT00996892|526171165|FG000|Expansion Stage 2A|Adverse Event|0|||
145909037|NCT00996892|526171166|FG001|Expansion Stage 2A|Adverse Event|0|||
145909038|NCT00996892|526171167|FG002|Expansion Stage 2A|Adverse Event|0|||
145909039|NCT00996892|526171168|FG003|Expansion Stage 2A|Adverse Event|0|||
145909040|NCT00996892|526171169|FG004|Expansion Stage 2A|Adverse Event|0|||
145909041|NCT00996892|526171170|FG005|Expansion Stage 2A|Adverse Event|0|||
145909042|NCT00996892|526171171|FG006|Expansion Stage 2A|Adverse Event|0|||
145909043|NCT00996892|526171172|FG007|Expansion Stage 2A|Adverse Event|0|||
145909044|NCT00996892|526171173|FG008|Expansion Stage 2A|Adverse Event|0|||
145909045|NCT00996892|526171174|FG009|Expansion Stage 2A|Adverse Event|0|||
145909046|NCT00996892|526171175|FG010|Expansion Stage 2A|Adverse Event|0|||
145909047|NCT00996892|526171176|FG011|Expansion Stage 2A|Adverse Event|0|||
145909048|NCT00996892|526171177|FG012|Expansion Stage 2A|Adverse Event|0|||
145909049|NCT00996892|526171178|FG013|Expansion Stage 2A|Adverse Event|0|||
145909050|NCT00996892|526171179|FG014|Expansion Stage 2A|Adverse Event|0|||
145909051|NCT00996892|526171180|FG015|Expansion Stage 2A|Adverse Event|0|||
145909052|NCT00996892|526171181|FG016|Expansion Stage 2A|Adverse Event|0|||
145973004|NCT03718000|526414161|FG001|Overall Study|Pregnancy|1|||
145909053|NCT00996892|526171182|FG017|Expansion Stage 2A|Adverse Event|0|||
145909054|NCT00996892|526171183|FG018|Expansion Stage 2A|Adverse Event|0|||
145909055|NCT00996892|526171184|FG019|Expansion Stage 2A|Adverse Event|8|||
145909056|NCT00996892|526171165|FG000|Expansion Stage 2A|Physician Decision|0|||
145909057|NCT00996892|526171166|FG001|Expansion Stage 2A|Physician Decision|0|||
145909058|NCT00996892|526171167|FG002|Expansion Stage 2A|Physician Decision|0|||
145909059|NCT00996892|526171168|FG003|Expansion Stage 2A|Physician Decision|0|||
145909060|NCT00996892|526171169|FG004|Expansion Stage 2A|Physician Decision|0|||
145909061|NCT00996892|526171170|FG005|Expansion Stage 2A|Physician Decision|0|||
145909062|NCT00996892|526171171|FG006|Expansion Stage 2A|Physician Decision|0|||
145909063|NCT00996892|526171172|FG007|Expansion Stage 2A|Physician Decision|0|||
145909064|NCT00996892|526171173|FG008|Expansion Stage 2A|Physician Decision|0|||
145973005|NCT02475213|526414164|FG000|Overall Study|Adverse Event|2|||
145973006|NCT02475213|526414165|FG001|Overall Study|Adverse Event|0|||
145909065|NCT00996892|526171174|FG009|Expansion Stage 2A|Physician Decision|0|||
145909066|NCT00996892|526171175|FG010|Expansion Stage 2A|Physician Decision|0|||
145909067|NCT00996892|526171176|FG011|Expansion Stage 2A|Physician Decision|0|||
145909068|NCT00996892|526171177|FG012|Expansion Stage 2A|Physician Decision|0|||
145909069|NCT00996892|526171178|FG013|Expansion Stage 2A|Physician Decision|0|||
145909070|NCT00996892|526171179|FG014|Expansion Stage 2A|Physician Decision|0|||
145909071|NCT00996892|526171180|FG015|Expansion Stage 2A|Physician Decision|0|||
145909072|NCT00996892|526171181|FG016|Expansion Stage 2A|Physician Decision|0|||
145909073|NCT00996892|526171182|FG017|Expansion Stage 2A|Physician Decision|0|||
145909074|NCT00996892|526171183|FG018|Expansion Stage 2A|Physician Decision|0|||
145909075|NCT00996892|526171184|FG019|Expansion Stage 2A|Physician Decision|2|||
145909076|NCT00996892|526171165|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
145909077|NCT00996892|526171166|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
145909078|NCT00996892|526171167|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
145909079|NCT00996892|526171168|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
145909080|NCT00996892|526171169|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
145909081|NCT00996892|526171170|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
145909082|NCT00996892|526171171|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
145909083|NCT00996892|526171172|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
145909084|NCT00996892|526171173|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
145909085|NCT00996892|526171174|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
145909086|NCT00996892|526171175|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
145909087|NCT00996892|526171176|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
145909088|NCT00996892|526171177|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
145909089|NCT00996892|526171178|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
145909090|NCT00996892|526171179|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
145909091|NCT00996892|526171180|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
145909092|NCT00996892|526171181|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
145909093|NCT00996892|526171182|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
145909094|NCT00996892|526171183|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
145909095|NCT00996892|526171184|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
145909096|NCT00996892|526171165|FG000|Expansion Stage 2A|Disease Progression|0|||
145909097|NCT00996892|526171166|FG001|Expansion Stage 2A|Disease Progression|0|||
145909098|NCT00996892|526171167|FG002|Expansion Stage 2A|Disease Progression|0|||
145909099|NCT00996892|526171168|FG003|Expansion Stage 2A|Disease Progression|0|||
145909100|NCT00996892|526171169|FG004|Expansion Stage 2A|Disease Progression|0|||
145909101|NCT00996892|526171170|FG005|Expansion Stage 2A|Disease Progression|0|||
145909102|NCT00996892|526171171|FG006|Expansion Stage 2A|Disease Progression|0|||
145909103|NCT00996892|526171172|FG007|Expansion Stage 2A|Disease Progression|0|||
145909104|NCT00996892|526171173|FG008|Expansion Stage 2A|Disease Progression|0|||
145909105|NCT00996892|526171174|FG009|Expansion Stage 2A|Disease Progression|0|||
145909106|NCT00996892|526171175|FG010|Expansion Stage 2A|Disease Progression|0|||
145909107|NCT00996892|526171176|FG011|Expansion Stage 2A|Disease Progression|0|||
145909108|NCT00996892|526171177|FG012|Expansion Stage 2A|Disease Progression|0|||
145909109|NCT00996892|526171178|FG013|Expansion Stage 2A|Disease Progression|0|||
145909110|NCT00996892|526171179|FG014|Expansion Stage 2A|Disease Progression|0|||
145909111|NCT00996892|526171180|FG015|Expansion Stage 2A|Disease Progression|0|||
145909112|NCT00996892|526171181|FG016|Expansion Stage 2A|Disease Progression|0|||
145909113|NCT00996892|526171182|FG017|Expansion Stage 2A|Disease Progression|0|||
145909114|NCT00996892|526171183|FG018|Expansion Stage 2A|Disease Progression|0|||
145909115|NCT00996892|526171184|FG019|Expansion Stage 2A|Disease Progression|31|||
145909116|NCT01653912|526171185|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145909117|NCT01653912|526171186|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
145909118|NCT01653912|526171187|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145909119|NCT01653912|526171188|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145909120|NCT01653912|526171189|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145909121|NCT01653912|526171190|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145909122|NCT01653912|526171185|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145909123|NCT01653912|526171186|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145909124|NCT01653912|526171187|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
145909125|NCT01653912|526171188|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145909126|NCT01653912|526171189|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145909127|NCT01653912|526171190|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145909128|NCT01653912|526171185|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145909129|NCT01653912|526171186|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145909130|NCT01653912|526171187|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145909131|NCT01653912|526171188|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
145909132|NCT01653912|526171189|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145909133|NCT01653912|526171190|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145909134|NCT01653912|526171185|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909135|NCT01653912|526171186|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909136|NCT01653912|526171187|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145973007|NCT02475213|526414166|FG002|Overall Study|Adverse Event|0|||
145909137|NCT01653912|526171188|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
145909138|NCT01653912|526171189|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909139|NCT01653912|526171190|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909140|NCT01653912|526171185|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145909141|NCT01653912|526171186|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145909142|NCT01653912|526171187|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145909143|NCT01653912|526171188|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
146239233|NCT01170208|527389750|FG002|Overall Study|Protocol Violation|1|||
146239234|NCT01160354|527389755|FG000|Overall Study|Death|0|||
145909144|NCT01653912|526171189|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145909145|NCT01653912|526171190|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
145909146|NCT01653912|526171185|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145909147|NCT01653912|526171186|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145909148|NCT01653912|526171187|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145909149|NCT01653912|526171188|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145909150|NCT01653912|526171189|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145909151|NCT01653912|526171190|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
145909152|NCT01653912|526171185|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909153|NCT01653912|526171186|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909154|NCT01653912|526171187|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909155|NCT01653912|526171188|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909156|NCT01653912|526171189|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145909157|NCT01653912|526171190|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
145909158|NCT00708227|526171191|FG000|Overall Study|Physician Decision|0|||
145909159|NCT00708227|526171192|FG001|Overall Study|Physician Decision|3|||
145909160|NCT00708227|526171193|FG002|Overall Study|Physician Decision|1|||
145909161|NCT00708227|526171194|FG003|Overall Study|Physician Decision|2|||
145909162|NCT00708227|526171191|FG000|Overall Study|Withdrawal by Subject|1|||
145909163|NCT00708227|526171192|FG001|Overall Study|Withdrawal by Subject|2|||
145909164|NCT00708227|526171193|FG002|Overall Study|Withdrawal by Subject|0|||
145909165|NCT00708227|526171194|FG003|Overall Study|Withdrawal by Subject|1|||
145909166|NCT04007991|526171195|FG000|Overall Study|Withdrawal by Subject|1|||
145909167|NCT04007991|526171196|FG001|Overall Study|Withdrawal by Subject|1|||
145909168|NCT04007991|526171195|FG000|Overall Study|Physician Decision|1|||
145909169|NCT04007991|526171196|FG001|Overall Study|Physician Decision|1|||
145909170|NCT04007991|526171195|FG000|Overall Study|Non-compliance with Study Drug|0|||
145909171|NCT04007991|526171196|FG001|Overall Study|Non-compliance with Study Drug|1|||
145909172|NCT04007991|526171195|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
145909173|NCT04007991|526171196|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
145909174|NCT04007991|526171195|FG000|Overall Study|Adverse event, non-fatal|5|||
145909175|NCT04007991|526171196|FG001|Overall Study|Adverse event, non-fatal|0|||
145909176|NCT04007991|526171195|FG000|Overall Study|Lost to Follow-up|2|||
145909177|NCT04007991|526171196|FG001|Overall Study|Lost to Follow-up|1|||
145909178|NCT01987479|526171197|FG000|Overall Study|Protocol Violation|1|||
145909179|NCT01987479|526171197|FG000|Overall Study|Physician Decision|2|||
145909180|NCT01987479|526171197|FG000|Overall Study|Participant/legal guardian decision|1|||
145909181|NCT01987479|526171197|FG000|Overall Study|Other|5|||
145909182|NCT01987479|526171197|FG000|Overall Study|Lost to Follow-up|1|||
145909183|NCT01987479|526171197|FG000|Overall Study|Adverse Event|7|||
145909184|NCT05314816|526171198|FG000|Overall Study|Lost to Follow-up|5|||
145909185|NCT05314816|526171199|FG001|Overall Study|Lost to Follow-up|0|||
145909186|NCT05314816|526171200|FG002|Overall Study|Lost to Follow-up|1|||
145909187|NCT05314816|526171198|FG000|Overall Study|Protocol Violation|13|||
145909188|NCT05314816|526171199|FG001|Overall Study|Protocol Violation|8|||
145909189|NCT05314816|526171200|FG002|Overall Study|Protocol Violation|0|||
145909190|NCT04324073|526173588|FG000|Overall Study|withdrew consent|0|||
145909191|NCT04324073|526173589|FG001|Overall Study|withdrew consent|4|||
145909192|NCT04324073|526173590|FG002|Overall Study|withdrew consent|2|||
145909193|NCT04324073|526173591|FG003|Overall Study|withdrew consent|8|||
145909194|NCT05833139|526173592|FG000|Study Period 2|Adverse Event|1|||
145909195|NCT02260570|526173597|FG000|Overall Study|Withdrawal by Subject|2|||
145909196|NCT02260570|526173598|FG001|Overall Study|Withdrawal by Subject|1|||
145909197|NCT02260570|526173597|FG000|Overall Study|Physician Decision|1|||
145909198|NCT02260570|526173598|FG001|Overall Study|Physician Decision|1|||
145909199|NCT03996447|526173599|FG000|First MRI Examination|Adverse Event|2|||
145909200|NCT03996447|526173600|FG001|First MRI Examination|Adverse Event|0|||
145909201|NCT03996447|526173599|FG000|First MRI Examination|Withdrawal by Subject|1|||
145909202|NCT03996447|526173600|FG001|First MRI Examination|Withdrawal by Subject|2|||
145909203|NCT03996447|526173599|FG000|First MRI Examination|Protocol Violation|0|||
145909204|NCT03996447|526173600|FG001|First MRI Examination|Protocol Violation|1|||
145909205|NCT03996447|526173599|FG000|Washout|Adverse Event|2|||
145909206|NCT03996447|526173600|FG001|Washout|Adverse Event|0|||
145909207|NCT03996447|526173599|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
145909208|NCT03996447|526173600|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
145909209|NCT03996447|526173599|FG000|Washout|Withdrawal by Subject|0|||
146239235|NCT01160354|527389756|FG001|Overall Study|Death|1|||
145909210|NCT03996447|526173600|FG001|Washout|Withdrawal by Subject|1|||
145909211|NCT03996447|526173599|FG000|Washout|Other reason|1|||
145909212|NCT03996447|526173600|FG001|Washout|Other reason|1|||
145909213|NCT00369486|526173603|FG000|4-Week Visit|Missed visit|2|||
145909214|NCT00369486|526173604|FG001|4-Week Visit|Missed visit|2|||
145909215|NCT00369486|526173605|FG002|4-Week Visit|Missed visit|0|||
145909216|NCT00369486|526173606|FG003|4-Week Visit|Missed visit|2|||
145909217|NCT00369486|526173607|FG004|4-Week Visit|Missed visit|1|||
145909218|NCT00369486|526173603|FG000|4-Week Visit|Dropped|0|||
145909219|NCT00369486|526173604|FG001|4-Week Visit|Dropped|0|||
145909220|NCT00369486|526173605|FG002|4-Week Visit|Dropped|1|||
145909221|NCT00369486|526173606|FG003|4-Week Visit|Dropped|0|||
145909222|NCT00369486|526173607|FG004|4-Week Visit|Dropped|0|||
145909223|NCT00369486|526173603|FG000|8-Week Visit|Missed visit|0|||
145909224|NCT00369486|526173604|FG001|8-Week Visit|Missed visit|1|||
145909225|NCT00369486|526173605|FG002|8-Week Visit|Missed visit|0|||
145909226|NCT00369486|526173606|FG003|8-Week Visit|Missed visit|0|||
145909227|NCT00369486|526173607|FG004|8-Week Visit|Missed visit|1|||
145909228|NCT00369486|526173603|FG000|8-Week Visit|Dropped|0|||
145909229|NCT00369486|526173604|FG001|8-Week Visit|Dropped|0|||
145909230|NCT00369486|526173605|FG002|8-Week Visit|Dropped|0|||
145909231|NCT00369486|526173606|FG003|8-Week Visit|Dropped|1|||
145909232|NCT00369486|526173607|FG004|8-Week Visit|Dropped|0|||
145909233|NCT00369486|526173603|FG000|17-Week Visit|Missed visit|0|||
145909234|NCT00369486|526173604|FG001|17-Week Visit|Missed visit|0|||
145909235|NCT00369486|526173605|FG002|17-Week Visit|Missed visit|1|||
145909236|NCT00369486|526173606|FG003|17-Week Visit|Missed visit|1|||
145909237|NCT00369486|526173607|FG004|17-Week Visit|Missed visit|1|||
145909238|NCT00369486|526173603|FG000|34-Week Visit|Dropped|0|||
145909239|NCT00369486|526173604|FG001|34-Week Visit|Dropped|1|||
145909240|NCT00369486|526173605|FG002|34-Week Visit|Dropped|1|||
145909241|NCT00369486|526173606|FG003|34-Week Visit|Dropped|3|||
145909242|NCT00369486|526173607|FG004|34-Week Visit|Dropped|3|||
145909243|NCT01810302|526173614|FG000|Overall Study|Death|1|||
145909244|NCT01810302|526173615|FG001|Overall Study|Death|0|||
145909245|NCT01810302|526173614|FG000|Overall Study|Physician Decision|0|||
145909246|NCT01810302|526173615|FG001|Overall Study|Physician Decision|1|||
145909247|NCT01659125|526173616|FG000|Overall Study|Withdrawal by Subject|2|||
145909248|NCT01659125|526173616|FG000|Overall Study|Lost to Follow-up|7|||
145909249|NCT01659125|526173616|FG000|Overall Study|Technical Problem|1|||
145909250|NCT01659125|526173616|FG000|Overall Study|Time Constraints|2|||
145909251|NCT01659125|526173616|FG000|Overall Study|Failed to Start Treatment|2|||
145909252|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #1|24|||
145909253|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #1|0|||
145909254|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
145909255|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
145909256|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909257|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909258|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
145909259|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
145909260|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
145909261|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
145909262|NCT03888066|526173617|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909263|NCT03888066|526173618|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909264|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909265|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909266|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
145909267|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
145909268|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909269|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909270|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
145909271|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909272|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #2|5|||
145909273|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #2|0|||
145909274|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
145909275|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
145909276|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
145909277|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
145909278|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
145909279|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
145909280|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #3|11|||
145973008|NCT02475213|526414167|FG003|Overall Study|Adverse Event|1|||
145973009|NCT02475213|526414168|FG004|Overall Study|Adverse Event|1|||
145973010|NCT02475213|526414169|FG005|Overall Study|Adverse Event|4|||
145973011|NCT02475213|526414170|FG006|Overall Study|Adverse Event|6|||
145973012|NCT02475213|526414171|FG007|Overall Study|Adverse Event|2|||
145973013|NCT02475213|526414164|FG000|Overall Study|Physician Decision|1|||
145909281|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #3|0|||
145909282|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
145909283|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
145909284|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
145909285|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145909286|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909287|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909288|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #4|3|||
145909289|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #4|0|||
145909290|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
145909291|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
145909292|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
145909293|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
145909294|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
145909295|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145909296|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
145909297|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
145909298|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
145909299|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909300|NCT03888066|526173617|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
145909301|NCT03888066|526173618|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145909302|NCT03888066|526173617|FG000|Run-in Phase|AE (Adverse Event)|17|||
145909303|NCT03888066|526173618|FG001|Run-in Phase|AE (Adverse Event)|0|||
145909304|NCT03888066|526173617|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
145909305|NCT03888066|526173618|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
145909306|NCT03888066|526173617|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909307|NCT03888066|526173618|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909308|NCT03888066|526173617|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145909309|NCT03888066|526173618|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909310|NCT03888066|526173617|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
145909311|NCT03888066|526173618|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145909312|NCT03888066|526173617|FG000|Run-in Phase|Withdrawal by Subject|43|||
145909313|NCT03888066|526173618|FG001|Run-in Phase|Withdrawal by Subject|0|||
145909314|NCT03888066|526173617|FG000|Run-in Phase|AE; Physician Decision|1|||
145909315|NCT03888066|526173618|FG001|Run-in Phase|AE; Physician Decision|0|||
145909316|NCT03888066|526173617|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
145909317|NCT03888066|526173618|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145909318|NCT03888066|526173617|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
145909319|NCT03888066|526173618|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
145909320|NCT03888066|526173617|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
145909321|NCT03888066|526173618|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145909322|NCT03888066|526173617|FG000|Run-in Phase|Death|1|||
145909323|NCT03888066|526173618|FG001|Run-in Phase|Death|0|||
145909324|NCT03888066|526173617|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
145909325|NCT03888066|526173618|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
145909326|NCT03888066|526173617|FG000|Run-in Phase|Physician Decision|1|||
145909327|NCT03888066|526173618|FG001|Run-in Phase|Physician Decision|0|||
145909328|NCT03888066|526173617|FG000|Run-in Phase|Protocol Violation|13|||
145909329|NCT03888066|526173618|FG001|Run-in Phase|Protocol Violation|0|||
145909330|NCT03888066|526173617|FG000|Run-in Phase|Sponsor Request|34|||
145909331|NCT03888066|526173618|FG001|Run-in Phase|Sponsor Request|0|||
145909332|NCT03888066|526173617|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
145909333|NCT03888066|526173618|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
145909334|NCT03888066|526173617|FG000|Run-in Phase|Withdrawal Of Consent|1|||
146239236|NCT01160354|527389757|FG002|Overall Study|Death|1|||
145909335|NCT03888066|526173618|FG001|Run-in Phase|Withdrawal Of Consent|0|||
145909336|NCT03888066|526173617|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
145909337|NCT03888066|526173618|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
145973014|NCT02475213|526414165|FG001|Overall Study|Physician Decision|1|||
145973015|NCT02475213|526414166|FG002|Overall Study|Physician Decision|1|||
145973016|NCT02475213|526414167|FG003|Overall Study|Physician Decision|0|||
145973017|NCT02475213|526414168|FG004|Overall Study|Physician Decision|0|||
145973018|NCT02475213|526414169|FG005|Overall Study|Physician Decision|1|||
145909338|NCT03888066|526173617|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
145909339|NCT03888066|526173618|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
145909340|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
145909341|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
145909342|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
145909343|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
145909344|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
145909345|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
145909346|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
145909347|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
145909348|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
145909349|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
145909350|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
145909351|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
145973019|NCT02475213|526414170|FG006|Overall Study|Physician Decision|4|||
145909352|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
145909353|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
145909354|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
145909355|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
145909356|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
145909357|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
145909358|NCT03888066|526173617|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
145909359|NCT03888066|526173618|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
145909360|NCT02207634|526173619|FG000|Overall Study|Withdrawal by Subject|21|||
145909361|NCT02207634|526173620|FG001|Overall Study|Withdrawal by Subject|31|||
145909362|NCT02207634|526173619|FG000|Overall Study|Lost to Follow-up|1|||
145909363|NCT02207634|526173620|FG001|Overall Study|Lost to Follow-up|0|||
145909364|NCT02077140|526173621|FG000|Overall Study|Lost to Follow-up|4|||
145909365|NCT02077140|526173622|FG001|Overall Study|Lost to Follow-up|1|||
145909366|NCT02077140|526173623|FG002|Overall Study|Lost to Follow-up|2|||
145909367|NCT02077140|526173624|FG003|Overall Study|Lost to Follow-up|2|||
145909368|NCT02077140|526173625|FG004|Overall Study|Lost to Follow-up|3|||
145909369|NCT02077140|526173621|FG000|Overall Study|Withdrawal by Subject|0|||
145909370|NCT02077140|526173622|FG001|Overall Study|Withdrawal by Subject|1|||
145909371|NCT02077140|526173623|FG002|Overall Study|Withdrawal by Subject|0|||
145909372|NCT02077140|526173624|FG003|Overall Study|Withdrawal by Subject|2|||
145909373|NCT02077140|526173625|FG004|Overall Study|Withdrawal by Subject|2|||
145909374|NCT00974922|526173626|FG000|Overall Study|study terminated|24|||
145909375|NCT00459355|526173627|FG000|Overall Study|Subject no longer met inc criteria|20|||
145909376|NCT00459355|526173628|FG001|Overall Study|Subject no longer met inc criteria|18|||
145909377|NCT01762800|526173631|FG000|Overall Study|Adverse Event|8|||
145909378|NCT01762800|526173632|FG001|Overall Study|Adverse Event|13|||
145909379|NCT01762800|526173631|FG000|Overall Study|Lack of Efficacy|3|||
145909380|NCT01762800|526173632|FG001|Overall Study|Lack of Efficacy|2|||
145909381|NCT01762800|526173631|FG000|Overall Study|Study Closed/Terminated|0|||
145909382|NCT01762800|526173632|FG001|Overall Study|Study Closed/Terminated|1|||
145909383|NCT01762800|526173631|FG000|Overall Study|Physician Decision|1|||
145909384|NCT01762800|526173632|FG001|Overall Study|Physician Decision|1|||
145909385|NCT01762800|526173631|FG000|Overall Study|Withdrawal by Subject|7|||
145909386|NCT01762800|526173632|FG001|Overall Study|Withdrawal by Subject|4|||
145909387|NCT01173120|526173634|FG000|Overall Study|Lack of Efficacy|2|||
145909388|NCT01173120|526173634|FG000|Overall Study|Lost to Follow-up|1|||
145909389|NCT01173120|526173634|FG000|Overall Study|Participant Decision|2|||
145909390|NCT01173120|526173634|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
145909391|NCT01173120|526173634|FG000|Overall Study|Switch-Participant Decision|12|||
145909392|NCT01173120|526173634|FG000|Overall Study|Switch-Difficulty With Device|12|||
145909393|NCT00113763|526173635|FG000|Overall Study|Adverse Event|5|||
145909394|NCT00113763|526173636|FG001|Overall Study|Adverse Event|2|||
145909395|NCT00113763|526173635|FG000|Overall Study|Disease Progression|28|||
145909396|NCT00113763|526173636|FG001|Overall Study|Disease Progression|14|||
145909397|NCT00113763|526173635|FG000|Overall Study|Lost to Follow-up|10|||
145909398|NCT00113763|526173636|FG001|Overall Study|Lost to Follow-up|0|||
145909399|NCT00113763|526173635|FG000|Overall Study|Withdrawal by Subject|1|||
145909400|NCT00113763|526173636|FG001|Overall Study|Withdrawal by Subject|4|||
145909401|NCT00113763|526173635|FG000|Overall Study|Other|27|||
145909402|NCT00113763|526173636|FG001|Overall Study|Other|6|||
145973020|NCT02475213|526414171|FG007|Overall Study|Physician Decision|0|||
145909403|NCT00113763|526173635|FG000|Overall Study|Non-compliance|1|||
145909404|NCT00113763|526173636|FG001|Overall Study|Non-compliance|0|||
145973021|NCT02475213|526414164|FG000|Overall Study|Progressive Disease|3|||
145973022|NCT02475213|526414165|FG001|Overall Study|Progressive Disease|2|||
145909405|NCT00113763|526173635|FG000|Overall Study|Ongoing|1|||
145909406|NCT00113763|526173636|FG001|Overall Study|Ongoing|0|||
145909407|NCT00517881|526173637|FG000|Overall Study|Protocol Violation|2|||
145909408|NCT00517881|526173637|FG000|Overall Study|Adverse Event|1|||
145909409|NCT00517881|526173637|FG000|Overall Study|Renal transplantation|2|||
145909410|NCT02847260|526173638|FG000|Overall Study|Adverse Event|3|||
145909411|NCT02847260|526173638|FG000|Overall Study|Withdrawal by Subject|2|||
145909412|NCT02847260|526173638|FG000|Overall Study|Clinical Deterioration|1|||
145909413|NCT02847260|526173638|FG000|Overall Study|Physician Decision|1|||
145909414|NCT02906358|526173641|FG000|Overall Study|Withdrawal by Subject|10|||
145909415|NCT02906358|526173642|FG001|Overall Study|Withdrawal by Subject|7|||
145909416|NCT02906358|526173641|FG000|Overall Study|Lost to Follow-up|12|||
145909417|NCT02906358|526173642|FG001|Overall Study|Lost to Follow-up|15|||
145909418|NCT02699684|526173643|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
145909419|NCT02699684|526173644|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
145909420|NCT01145508|526173645|FG000|Overall Study|Adverse Event|1|||
145909421|NCT01145508|526173646|FG001|Overall Study|Adverse Event|0|||
145909422|NCT01145508|526173645|FG000|Overall Study|Death|1|||
145909423|NCT01145508|526173646|FG001|Overall Study|Death|0|||
145909424|NCT01145508|526173645|FG000|Overall Study|Physician Decision|2|||
145909425|NCT01145508|526173646|FG001|Overall Study|Physician Decision|1|||
145909426|NCT01145508|526173645|FG000|Overall Study|Never started treatment|1|||
145909427|NCT01145508|526173646|FG001|Overall Study|Never started treatment|1|||
145909428|NCT02111603|526173655|FG000|Overall Study|Withdrawal by Subject|1|||
145909429|NCT00799825|526173658|FG000|Overall Study|Adverse Event|1|||
145909430|NCT00799825|526173658|FG000|Overall Study|Withdrawal by Subject|6|||
145909431|NCT00799825|526173658|FG000|Overall Study|Lost to Follow-up|38|||
145909432|NCT00799825|526173658|FG000|Overall Study|Pregnancy|3|||
145973023|NCT02475213|526414166|FG002|Overall Study|Progressive Disease|2|||
146297422|NCT01641809|527604693|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
145909433|NCT00789035|526173659|FG000|Overall Study|Adverse Event|0|||
145909434|NCT00789035|526173660|FG001|Overall Study|Adverse Event|2|||
145909435|NCT00789035|526173661|FG002|Overall Study|Adverse Event|0|||
145909436|NCT00789035|526173662|FG003|Overall Study|Adverse Event|1|||
145909437|NCT00789035|526173663|FG004|Overall Study|Adverse Event|3|||
145909438|NCT00789035|526173659|FG000|Overall Study|Lack of Efficacy|3|||
145909439|NCT00789035|526173660|FG001|Overall Study|Lack of Efficacy|0|||
145909440|NCT00789035|526173661|FG002|Overall Study|Lack of Efficacy|0|||
145909441|NCT00789035|526173662|FG003|Overall Study|Lack of Efficacy|0|||
145909442|NCT00789035|526173663|FG004|Overall Study|Lack of Efficacy|2|||
145909443|NCT00789035|526173659|FG000|Overall Study|Protocol Violation|1|||
145909444|NCT00789035|526173660|FG001|Overall Study|Protocol Violation|0|||
145909445|NCT00789035|526173661|FG002|Overall Study|Protocol Violation|0|||
145909446|NCT00789035|526173662|FG003|Overall Study|Protocol Violation|0|||
145909447|NCT00789035|526173663|FG004|Overall Study|Protocol Violation|0|||
145909448|NCT00789035|526173659|FG000|Overall Study|Withdrawal by Subject|0|||
145909449|NCT00789035|526173660|FG001|Overall Study|Withdrawal by Subject|2|||
145909450|NCT00789035|526173661|FG002|Overall Study|Withdrawal by Subject|0|||
145909451|NCT00789035|526173662|FG003|Overall Study|Withdrawal by Subject|0|||
145909452|NCT00789035|526173663|FG004|Overall Study|Withdrawal by Subject|0|||
145909453|NCT00789035|526173659|FG000|Overall Study|Other reason not defined above|2|||
145909454|NCT00789035|526173660|FG001|Overall Study|Other reason not defined above|3|||
145909455|NCT00789035|526173661|FG002|Overall Study|Other reason not defined above|1|||
145909456|NCT00789035|526173662|FG003|Overall Study|Other reason not defined above|0|||
145909457|NCT00789035|526173663|FG004|Overall Study|Other reason not defined above|1|||
145909458|NCT00362336|526173664|FG000|Overall Study|Serious Adverse Event|1|||
145909459|NCT00362336|526173665|FG001|Overall Study|Serious Adverse Event|0|||
145909460|NCT00362336|526173666|FG002|Overall Study|Serious Adverse Event|1|||
145909461|NCT00362336|526173664|FG000|Overall Study|Protocol Violation|0|||
145909462|NCT00362336|526173665|FG001|Overall Study|Protocol Violation|0|||
145909463|NCT00362336|526173666|FG002|Overall Study|Protocol Violation|1|||
145909464|NCT00362336|526173664|FG000|Overall Study|Lost to Follow-up|6|||
145909465|NCT00362336|526173665|FG001|Overall Study|Lost to Follow-up|4|||
145909466|NCT00362336|526173666|FG002|Overall Study|Lost to Follow-up|0|||
145909467|NCT00362336|526173664|FG000|Overall Study|Withdrawal by Subject|3|||
145909468|NCT00362336|526173665|FG001|Overall Study|Withdrawal by Subject|3|||
145909469|NCT00362336|526173666|FG002|Overall Study|Withdrawal by Subject|1|||
145909470|NCT04414618|526173667|FG000|Overall Study|Death|3|||
145909471|NCT04414618|526173668|FG001|Overall Study|Death|3|||
145909472|NCT04414618|526173667|FG000|Overall Study|Withdrawal by Subject|2|||
145909473|NCT04414618|526173668|FG001|Overall Study|Withdrawal by Subject|1|||
145909474|NCT04414618|526173667|FG000|Overall Study|Lost to Follow-up|2|||
145909475|NCT04414618|526173668|FG001|Overall Study|Lost to Follow-up|3|||
145909476|NCT04414618|526173667|FG000|Overall Study|Physician Decision|1|||
145973024|NCT02475213|526414167|FG003|Overall Study|Progressive Disease|13|||
145909477|NCT04414618|526173668|FG001|Overall Study|Physician Decision|0|||
145973025|NCT02475213|526414168|FG004|Overall Study|Progressive Disease|15|||
145909478|NCT00658879|526173669|FG000|Overall Study|Protocol Violation|1|||
145909479|NCT02640690|526173670|FG000|Overall Study|Lost to Follow-up|7|||
145909480|NCT02640690|526173671|FG001|Overall Study|Lost to Follow-up|7|||
145909481|NCT02640690|526173670|FG000|Overall Study|Withdrawal by Subject|16|||
145909482|NCT02640690|526173671|FG001|Overall Study|Withdrawal by Subject|20|||
145909483|NCT02640690|526173670|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
145909484|NCT02640690|526173671|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
145909485|NCT01520870|526173672|FG000|Overall Study|Withdrawal by Subject|2|||
145909486|NCT01118975|526173673|FG000|Overall Study|Adverse Event|0|||
145909487|NCT01118975|526173674|FG001|Overall Study|Adverse Event|1|||
145909488|NCT01645787|526173675|FG000|Washout (2 Weeks)|Adverse Event|1|||
145909489|NCT01645787|526173676|FG001|Washout (2 Weeks)|Adverse Event|0|||
145909490|NCT04315506|526173686|FG000|Overall Study|Lost to Follow-up|74|||
145909491|NCT04315506|526173687|FG001|Overall Study|Lost to Follow-up|82|||
145909492|NCT04315506|526173686|FG000|Overall Study|Withdrawal by Subject|8|||
145909493|NCT04315506|526173687|FG001|Overall Study|Withdrawal by Subject|8|||
145909494|NCT04315506|526173686|FG000|Overall Study|Physician Decision|0|||
145973026|NCT02475213|526414169|FG005|Overall Study|Progressive Disease|25|||
145973027|NCT02475213|526414170|FG006|Overall Study|Progressive Disease|30|||
145973028|NCT02475213|526414171|FG007|Overall Study|Progressive Disease|10|||
145909495|NCT04315506|526173687|FG001|Overall Study|Physician Decision|1|||
145909496|NCT02661217|526173688|FG000|Overall Study|Physician Decision|12|||
145909497|NCT02661217|526173689|FG001|Overall Study|Physician Decision|15|||
145909498|NCT02661217|526173688|FG000|Overall Study|Lost to Follow-up|1|||
145909499|NCT02661217|526173689|FG001|Overall Study|Lost to Follow-up|4|||
145909500|NCT02661217|526173688|FG000|Overall Study|Protocol Deviation|0|||
145909501|NCT02661217|526173689|FG001|Overall Study|Protocol Deviation|4|||
145909502|NCT02661217|526173688|FG000|Overall Study|Non-compliance with study treatment|5|||
145909503|NCT02661217|526173689|FG001|Overall Study|Non-compliance with study treatment|5|||
145909504|NCT02661217|526173688|FG000|Overall Study|Death|21|||
145909505|NCT02661217|526173689|FG001|Overall Study|Death|15|||
145909506|NCT02661217|526173688|FG000|Overall Study|Adverse Event|10|||
145909507|NCT02661217|526173689|FG001|Overall Study|Adverse Event|8|||
145909508|NCT02661217|526173688|FG000|Overall Study|Withdrawal by Subject|15|||
145909509|NCT02661217|526173689|FG001|Overall Study|Withdrawal by Subject|19|||
145909510|NCT02661217|526173688|FG000|Overall Study|Did not enter follow-up epoch|7|||
145909511|NCT02661217|526173689|FG001|Overall Study|Did not enter follow-up epoch|10|||
145909512|NCT02661217|526173688|FG000|Overall Study|Death - no study drug received|1|||
145909513|NCT02661217|526173689|FG001|Overall Study|Death - no study drug received|2|||
145909514|NCT02661217|526173688|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
145909515|NCT02661217|526173689|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
145909516|NCT01098474|526173707|FG000|Active Phase|Other|0|||
145909517|NCT01098474|526173708|FG001|Active Phase|Other|0|||
145909518|NCT01098474|526173709|FG002|Active Phase|Other|3|||
145909519|NCT01098474|526173710|FG003|Active Phase|Other|0|||
145909520|NCT01098474|526173711|FG004|Active Phase|Other|0|||
145909521|NCT01098474|526173712|FG005|Active Phase|Other|0|||
145909522|NCT01098474|526173707|FG000|Active Phase|Withdrawal by Subject|1|||
145909523|NCT01098474|526173708|FG001|Active Phase|Withdrawal by Subject|1|||
145909524|NCT01098474|526173709|FG002|Active Phase|Withdrawal by Subject|2|||
145909525|NCT01098474|526173710|FG003|Active Phase|Withdrawal by Subject|0|||
145909526|NCT01098474|526173711|FG004|Active Phase|Withdrawal by Subject|0|||
145909527|NCT01098474|526173712|FG005|Active Phase|Withdrawal by Subject|0|||
145909528|NCT01098474|526173707|FG000|Active Phase|Lost to Follow-up|1|||
145909529|NCT01098474|526173708|FG001|Active Phase|Lost to Follow-up|0|||
145909530|NCT01098474|526173709|FG002|Active Phase|Lost to Follow-up|0|||
145909531|NCT01098474|526173710|FG003|Active Phase|Lost to Follow-up|0|||
145909532|NCT01098474|526173711|FG004|Active Phase|Lost to Follow-up|0|||
145909533|NCT01098474|526173712|FG005|Active Phase|Lost to Follow-up|0|||
145909534|NCT01098474|526173707|FG000|Follow Up Phase|Travelled out of study area|0|||
145909535|NCT01098474|526173708|FG001|Follow Up Phase|Travelled out of study area|0|||
145909536|NCT01098474|526173709|FG002|Follow Up Phase|Travelled out of study area|0|||
145909537|NCT01098474|526173710|FG003|Follow Up Phase|Travelled out of study area|0|||
145909538|NCT01098474|526173711|FG004|Follow Up Phase|Travelled out of study area|1|||
145909539|NCT01098474|526173712|FG005|Follow Up Phase|Travelled out of study area|0|||
145909540|NCT01098474|526173707|FG000|Follow Up Phase|Other|0|||
145909541|NCT01098474|526173708|FG001|Follow Up Phase|Other|0|||
145909542|NCT01098474|526173709|FG002|Follow Up Phase|Other|0|||
145909543|NCT01098474|526173710|FG003|Follow Up Phase|Other|0|||
145909544|NCT01098474|526173711|FG004|Follow Up Phase|Other|0|||
145909545|NCT01098474|526173712|FG005|Follow Up Phase|Other|4|||
145909546|NCT01098474|526173707|FG000|Follow Up Phase|Withdrawal by Subject|0|||
145909547|NCT01098474|526173708|FG001|Follow Up Phase|Withdrawal by Subject|0|||
145909548|NCT01098474|526173709|FG002|Follow Up Phase|Withdrawal by Subject|0|||
145973029|NCT02475213|526414164|FG000|Overall Study|Death|0|||
145909549|NCT01098474|526173710|FG003|Follow Up Phase|Withdrawal by Subject|2|||
145909550|NCT01098474|526173711|FG004|Follow Up Phase|Withdrawal by Subject|0|||
145909551|NCT01098474|526173712|FG005|Follow Up Phase|Withdrawal by Subject|1|||
145909552|NCT01098474|526173707|FG000|Follow Up Phase|Lost to Follow-up|0|||
145909553|NCT01098474|526173708|FG001|Follow Up Phase|Lost to Follow-up|0|||
145909554|NCT01098474|526173709|FG002|Follow Up Phase|Lost to Follow-up|0|||
145909555|NCT01098474|526173710|FG003|Follow Up Phase|Lost to Follow-up|0|||
145909556|NCT01098474|526173711|FG004|Follow Up Phase|Lost to Follow-up|1|||
145909557|NCT01098474|526173712|FG005|Follow Up Phase|Lost to Follow-up|0|||
145909558|NCT00626561|526173715|FG000|Overall Study|Withdrawal by Subject|2|||
145909559|NCT00626561|526173715|FG000|Overall Study|Disease Progression|2|||
145909560|NCT03993379|526173716|FG000|Overall Study|The study was terminated early due to business decision.|0|||
145909561|NCT03993379|526173717|FG001|Overall Study|The study was terminated early due to business decision.|2|||
145909562|NCT03993379|526173718|FG002|Overall Study|The study was terminated early due to business decision.|0|||
145909563|NCT03993379|526173719|FG003|Overall Study|The study was terminated early due to business decision.|0|||
145909564|NCT03993379|526173716|FG000|Overall Study|Withdrawal by Subject|0|||
145909565|NCT03993379|526173717|FG001|Overall Study|Withdrawal by Subject|1|||
145909566|NCT03993379|526173718|FG002|Overall Study|Withdrawal by Subject|0|||
145909567|NCT03993379|526173719|FG003|Overall Study|Withdrawal by Subject|0|||
145909568|NCT02604407|526173720|FG000|Overall Study|Adverse Event|0|||
145909569|NCT02604407|526173721|FG001|Overall Study|Adverse Event|7|||
145909570|NCT02604407|526173722|FG002|Overall Study|Adverse Event|5|||
145909571|NCT02604407|526173720|FG000|Overall Study|Protocol Violation|2|||
145909572|NCT02604407|526173721|FG001|Overall Study|Protocol Violation|0|||
145909573|NCT02604407|526173722|FG002|Overall Study|Protocol Violation|0|||
145909574|NCT02604407|526173720|FG000|Overall Study|Withdrawal by Subject|3|||
145909575|NCT02604407|526173721|FG001|Overall Study|Withdrawal by Subject|3|||
145909576|NCT02604407|526173722|FG002|Overall Study|Withdrawal by Subject|5|||
145909577|NCT02604407|526173720|FG000|Overall Study|Lost to Follow-up|2|||
145973030|NCT02475213|526414165|FG001|Overall Study|Death|0|||
145973031|NCT02475213|526414166|FG002|Overall Study|Death|0|||
145973032|NCT02475213|526414167|FG003|Overall Study|Death|0|||
145973033|NCT02475213|526414168|FG004|Overall Study|Death|0|||
145973034|NCT02475213|526414169|FG005|Overall Study|Death|4|||
145973035|NCT02475213|526414170|FG006|Overall Study|Death|1|||
145973036|NCT02475213|526414171|FG007|Overall Study|Death|0|||
145973037|NCT02475213|526414164|FG000|Overall Study|Protocol Violation|0|||
145973038|NCT02475213|526414165|FG001|Overall Study|Protocol Violation|0|||
145973039|NCT02475213|526414166|FG002|Overall Study|Protocol Violation|0|||
145973040|NCT02475213|526414167|FG003|Overall Study|Protocol Violation|0|||
145973041|NCT02475213|526414168|FG004|Overall Study|Protocol Violation|1|||
145973042|NCT02475213|526414169|FG005|Overall Study|Protocol Violation|0|||
145973043|NCT02475213|526414170|FG006|Overall Study|Protocol Violation|0|||
145973044|NCT02475213|526414171|FG007|Overall Study|Protocol Violation|0|||
145973045|NCT02475213|526414164|FG000|Overall Study|Withdrawal by Subject|0|||
145973046|NCT02475213|526414165|FG001|Overall Study|Withdrawal by Subject|0|||
145973047|NCT02475213|526414166|FG002|Overall Study|Withdrawal by Subject|0|||
145973048|NCT02475213|526414167|FG003|Overall Study|Withdrawal by Subject|1|||
145973049|NCT02475213|526414168|FG004|Overall Study|Withdrawal by Subject|0|||
145973050|NCT02475213|526414169|FG005|Overall Study|Withdrawal by Subject|2|||
145973051|NCT02475213|526414170|FG006|Overall Study|Withdrawal by Subject|2|||
145973052|NCT02475213|526414171|FG007|Overall Study|Withdrawal by Subject|0|||
145973053|NCT02475213|526414164|FG000|Overall Study|Other|0|||
145973054|NCT02475213|526414165|FG001|Overall Study|Other|0|||
145973055|NCT02475213|526414166|FG002|Overall Study|Other|0|||
145973056|NCT02475213|526414167|FG003|Overall Study|Other|1|||
145973057|NCT02475213|526414168|FG004|Overall Study|Other|3|||
145973058|NCT02475213|526414169|FG005|Overall Study|Other|1|||
145973059|NCT02475213|526414170|FG006|Overall Study|Other|0|||
145973060|NCT02475213|526414171|FG007|Overall Study|Other|0|||
145973061|NCT00505921|526414172|FG000|Overall Study|Ineligible|1|||
145973062|NCT00505921|526414172|FG000|Overall Study|Failed to Mobilize|8|||
145973063|NCT02441283|526414173|FG000|Overall Study|Withdrew consent|15|||
145973064|NCT02441283|526414173|FG000|Overall Study|Lost to Follow-up|42|||
145973065|NCT02441283|526414173|FG000|Overall Study|Death|1|||
145973066|NCT02441283|526414173|FG000|Overall Study|Other, not specified|32|||
145973067|NCT00630292|526414174|FG000|Overall Study|Withdrawal by Subject|1|||
145973068|NCT02382939|526414175|FG000|Overall Study|Adverse Event|1|||
145973069|NCT02382939|526414176|FG001|Overall Study|Adverse Event|1|||
145973070|NCT02382939|526414175|FG000|Overall Study|Withdrawal by Subject|2|||
145973071|NCT02382939|526414176|FG001|Overall Study|Withdrawal by Subject|2|||
145973072|NCT05383209|526414179|FG000|Overall Study|Adverse Event: Non-ocular|0|||
145973073|NCT05383209|526414180|FG001|Overall Study|Adverse Event: Non-ocular|1|||
145973074|NCT05383209|526414181|FG002|Overall Study|Adverse Event: Non-ocular|0|||
145973075|NCT05383209|526414179|FG000|Overall Study|Lost to Follow-up|2|||
145973076|NCT05383209|526414180|FG001|Overall Study|Lost to Follow-up|1|||
145973077|NCT05383209|526414181|FG002|Overall Study|Lost to Follow-up|4|||
145973078|NCT05383209|526414179|FG000|Overall Study|Withdrawal by Subject|2|||
145973079|NCT05383209|526414180|FG001|Overall Study|Withdrawal by Subject|0|||
145973080|NCT05383209|526414181|FG002|Overall Study|Withdrawal by Subject|1|||
145973081|NCT05383209|526414179|FG000|Overall Study|Death|1|||
145973082|NCT05383209|526414180|FG001|Overall Study|Death|0|||
145973083|NCT05383209|526414181|FG002|Overall Study|Death|0|||
145973084|NCT05383209|526414179|FG000|Overall Study|Other|0|||
145909578|NCT02604407|526173721|FG001|Overall Study|Lost to Follow-up|1|||
145909579|NCT02604407|526173722|FG002|Overall Study|Lost to Follow-up|2|||
145909580|NCT02604407|526173720|FG000|Overall Study|Lack of Efficacy|1|||
145909581|NCT02604407|526173721|FG001|Overall Study|Lack of Efficacy|0|||
145909582|NCT02604407|526173722|FG002|Overall Study|Lack of Efficacy|0|||
145909583|NCT02604407|526173720|FG000|Overall Study|Other|3|||
145909584|NCT02604407|526173721|FG001|Overall Study|Other|1|||
145909585|NCT02604407|526173722|FG002|Overall Study|Other|4|||
145909586|NCT00606632|526173725|FG000|Overall Study|Withdrawal by Subject|13|||
145909587|NCT00606632|526173725|FG000|Overall Study|Miscellaneous reasons|9|||
145909588|NCT00711880|526173728|FG000|Overall Study|Adverse Event|11|||
145909589|NCT00711880|526173729|FG001|Overall Study|Adverse Event|2|||
145909590|NCT00711880|526173728|FG000|Overall Study|Patient non-compliance|1|||
145909591|NCT00711880|526173729|FG001|Overall Study|Patient non-compliance|0|||
145909592|NCT00711880|526173728|FG000|Overall Study|Lack of Efficacy|1|||
145909593|NCT00711880|526173729|FG001|Overall Study|Lack of Efficacy|5|||
145909594|NCT00704132|526173730|FG000|Overall Study|Clinical Adverse Experience|1|||
145909595|NCT00704132|526173731|FG001|Overall Study|Clinical Adverse Experience|0|||
145909596|NCT00704132|526173730|FG000|Overall Study|Lack of Efficacy|0|||
145909597|NCT00704132|526173731|FG001|Overall Study|Lack of Efficacy|1|||
145909598|NCT00704132|526173730|FG000|Overall Study|Withdrawal by Subject|0|||
145909599|NCT00704132|526173731|FG001|Overall Study|Withdrawal by Subject|1|||
145909600|NCT03348163|526173732|FG000|Overall Study|Withdrawal by Subject|2|||
145909601|NCT03348163|526173733|FG001|Overall Study|Withdrawal by Subject|0|||
145909602|NCT02756208|526173734|FG000|Overall Study|Withdrawal by Subject|1|||
145909603|NCT02756208|526173735|FG001|Overall Study|Withdrawal by Subject|0|||
145909604|NCT02756208|526173736|FG002|Overall Study|Withdrawal by Subject|1|||
145909605|NCT02756208|526173737|FG003|Overall Study|Withdrawal by Subject|3|||
145909606|NCT02756208|526173734|FG000|Overall Study|Lost to Follow-up|3|||
145909607|NCT02756208|526173735|FG001|Overall Study|Lost to Follow-up|1|||
145909608|NCT02756208|526173736|FG002|Overall Study|Lost to Follow-up|1|||
145909609|NCT02756208|526173737|FG003|Overall Study|Lost to Follow-up|1|||
145909610|NCT02756208|526173734|FG000|Overall Study|Physician Decision|1|||
145909611|NCT02756208|526173735|FG001|Overall Study|Physician Decision|0|||
145909612|NCT02756208|526173736|FG002|Overall Study|Physician Decision|0|||
145909613|NCT02756208|526173737|FG003|Overall Study|Physician Decision|0|||
145909614|NCT02756208|526173734|FG000|Overall Study|Protocol Violation|0|||
145909615|NCT02756208|526173735|FG001|Overall Study|Protocol Violation|1|||
145909616|NCT02756208|526173736|FG002|Overall Study|Protocol Violation|0|||
145909617|NCT02756208|526173737|FG003|Overall Study|Protocol Violation|0|||
145909618|NCT02585778|526173738|FG000|Overall Study|Adverse Event|17|||
145909619|NCT02585778|526173739|FG001|Overall Study|Adverse Event|4|||
145909620|NCT02585778|526173738|FG000|Overall Study|Participant did not wish to continue|9|||
145909621|NCT02585778|526173739|FG001|Overall Study|Participant did not wish to continue|4|||
145909622|NCT02585778|526173738|FG000|Overall Study|Poor compliance to study protocol|0|||
145909623|NCT02585778|526173739|FG001|Overall Study|Poor compliance to study protocol|2|||
145909624|NCT02585778|526173738|FG000|Overall Study|Death|0|||
145909625|NCT02585778|526173739|FG001|Overall Study|Death|1|||
145909626|NCT02585778|526173738|FG000|Overall Study|Randomized but not treated|1|||
145909627|NCT02585778|526173739|FG001|Overall Study|Randomized but not treated|2|||
145909628|NCT02585778|526173738|FG000|Overall Study|Other than specified above|6|||
145909629|NCT02585778|526173739|FG001|Overall Study|Other than specified above|2|||
145909630|NCT04841577|526173740|FG000|Overall Study|Adverse Event|5|||
145973085|NCT05383209|526414180|FG001|Overall Study|Other|1|||
146239237|NCT02743819|527389759|FG000|Overall Study|Lack of Efficacy|5|||
145909631|NCT04841577|526173741|FG001|Overall Study|Adverse Event|10|||
145909632|NCT04841577|526173740|FG000|Overall Study|Lost to Follow-up|8|||
145909633|NCT04841577|526173741|FG001|Overall Study|Lost to Follow-up|7|||
145909634|NCT04841577|526173740|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145909635|NCT04841577|526173741|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
145909636|NCT04841577|526173740|FG000|Overall Study|Other|0|||
145909637|NCT04841577|526173741|FG001|Overall Study|Other|1|||
145909638|NCT00356525|526173747|FG000|Overall Study|Progressive Disease|8|||
145909639|NCT00356525|526173748|FG001|Overall Study|Progressive Disease|5|||
145909640|NCT00356525|526173749|FG002|Overall Study|Progressive Disease|4|||
145909641|NCT00356525|526173750|FG003|Overall Study|Progressive Disease|2|||
145909642|NCT00356525|526173747|FG000|Overall Study|Adverse Event|1|||
145909643|NCT00356525|526173748|FG001|Overall Study|Adverse Event|3|||
145909644|NCT00356525|526173749|FG002|Overall Study|Adverse Event|1|||
145909645|NCT00356525|526173750|FG003|Overall Study|Adverse Event|1|||
145909646|NCT00356525|526173747|FG000|Overall Study|Lost to Follow-up|1|||
145909647|NCT00356525|526173748|FG001|Overall Study|Lost to Follow-up|0|||
146239238|NCT02743819|527389759|FG000|Overall Study|Death|2|||
145909648|NCT00356525|526173749|FG002|Overall Study|Lost to Follow-up|0|||
145909649|NCT00356525|526173750|FG003|Overall Study|Lost to Follow-up|0|||
145909650|NCT00356525|526173747|FG000|Overall Study|Physician Decision|2|||
145909651|NCT00356525|526173748|FG001|Overall Study|Physician Decision|2|||
145909652|NCT00356525|526173749|FG002|Overall Study|Physician Decision|2|||
145909653|NCT00356525|526173750|FG003|Overall Study|Physician Decision|1|||
145909654|NCT00356525|526173747|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
145909655|NCT00356525|526173748|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
145909656|NCT00356525|526173749|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
145909657|NCT00356525|526173750|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
145909658|NCT00356525|526173747|FG000|Overall Study|Withdrawal by Subject|1|||
145909659|NCT00356525|526173748|FG001|Overall Study|Withdrawal by Subject|1|||
145909660|NCT00356525|526173749|FG002|Overall Study|Withdrawal by Subject|0|||
145909661|NCT00356525|526173750|FG003|Overall Study|Withdrawal by Subject|3|||
145909662|NCT00356525|526173747|FG000|Overall Study|Death|0|||
145909663|NCT00356525|526173748|FG001|Overall Study|Death|0|||
145909664|NCT00356525|526173749|FG002|Overall Study|Death|0|||
145909665|NCT00356525|526173750|FG003|Overall Study|Death|1|||
145909666|NCT00356525|526173747|FG000|Overall Study|Sponsor Decision|0|||
145909667|NCT00356525|526173748|FG001|Overall Study|Sponsor Decision|0|||
145909668|NCT00356525|526173749|FG002|Overall Study|Sponsor Decision|0|||
145909669|NCT00356525|526173750|FG003|Overall Study|Sponsor Decision|1|||
145909670|NCT00652340|526173751|FG000|Overall Study|Had not progressed.|4|||
145909671|NCT00652340|526173752|FG001|Overall Study|Had not progressed.|3|||
145909672|NCT00214383|526173755|FG000|Overall Study|Lost to Follow-up|16|||
145909673|NCT00214383|526173756|FG001|Overall Study|Lost to Follow-up|26|||
145909674|NCT00879411|526173757|FG000|Overall Study|lost to follow-up (non-AE)|162|||
145909675|NCT01038297|526173758|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
145909676|NCT01038297|526173759|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
145909677|NCT01038297|526173760|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
145909678|NCT01589497|526173771|FG000|Overall Study|Withdrawal by Subject|0|||
145909679|NCT01589497|526173772|FG001|Overall Study|Withdrawal by Subject|1|||
145909680|NCT01589497|526173773|FG002|Overall Study|Withdrawal by Subject|0|||
145909681|NCT01589497|526173774|FG003|Overall Study|Withdrawal by Subject|1|||
145909682|NCT01589497|526173771|FG000|Overall Study|Death|1|||
145909683|NCT01589497|526173772|FG001|Overall Study|Death|0|||
145909684|NCT01589497|526173773|FG002|Overall Study|Death|0|||
145909685|NCT01589497|526173774|FG003|Overall Study|Death|0|||
145909686|NCT01589497|526173771|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145909687|NCT01589497|526173772|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145909688|NCT01589497|526173773|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
145909689|NCT01589497|526173774|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145909690|NCT02516553|526173775|FG000|Overall Study|Progressive disease|2|||
145909691|NCT02516553|526173776|FG001|Overall Study|Progressive disease|2|||
145909692|NCT02516553|526173777|FG002|Overall Study|Progressive disease|3|||
145909693|NCT02516553|526173778|FG003|Overall Study|Progressive disease|5|||
145909694|NCT02516553|526173779|FG004|Overall Study|Progressive disease|3|||
145909695|NCT02516553|526173780|FG005|Overall Study|Progressive disease|0|||
145909696|NCT02516553|526173781|FG006|Overall Study|Progressive disease|5|||
145909697|NCT02516553|526173782|FG007|Overall Study|Progressive disease|5|||
145909698|NCT02516553|526173783|FG008|Overall Study|Progressive disease|11|||
145909699|NCT02516553|526173784|FG009|Overall Study|Progressive disease|3|||
145909700|NCT02516553|526173785|FG010|Overall Study|Progressive disease|10|||
145909701|NCT02516553|526173786|FG011|Overall Study|Progressive disease|8|||
145909702|NCT02516553|526173787|FG012|Overall Study|Progressive disease|8|||
145909703|NCT02516553|526173788|FG013|Overall Study|Progressive disease|2|||
145909704|NCT02516553|526173789|FG014|Overall Study|Progressive disease|2|||
145909705|NCT02516553|526173790|FG015|Overall Study|Progressive disease|2|||
145909706|NCT02516553|526173791|FG016|Overall Study|Progressive disease|1|||
145909707|NCT02516553|526173792|FG017|Overall Study|Progressive disease|9|||
145909708|NCT02516553|526173793|FG018|Overall Study|Progressive disease|12|||
145909709|NCT02516553|526173794|FG019|Overall Study|Progressive disease|7|||
145909710|NCT02516553|526173795|FG020|Overall Study|Progressive disease|16|||
145909711|NCT02516553|526173796|FG021|Overall Study|Progressive disease|18|||
145909712|NCT02516553|526173775|FG000|Overall Study|Dose limiting toxicity|0|||
145909713|NCT02516553|526173776|FG001|Overall Study|Dose limiting toxicity|0|||
145909714|NCT02516553|526173777|FG002|Overall Study|Dose limiting toxicity|0|||
145909715|NCT02516553|526173778|FG003|Overall Study|Dose limiting toxicity|0|||
145909716|NCT02516553|526173779|FG004|Overall Study|Dose limiting toxicity|3|||
145909717|NCT02516553|526173780|FG005|Overall Study|Dose limiting toxicity|1|||
145909718|NCT02516553|526173781|FG006|Overall Study|Dose limiting toxicity|1|||
145909719|NCT02516553|526173782|FG007|Overall Study|Dose limiting toxicity|0|||
145909720|NCT02516553|526173783|FG008|Overall Study|Dose limiting toxicity|1|||
145909721|NCT02516553|526173784|FG009|Overall Study|Dose limiting toxicity|0|||
145909722|NCT02516553|526173785|FG010|Overall Study|Dose limiting toxicity|0|||
145909723|NCT02516553|526173786|FG011|Overall Study|Dose limiting toxicity|1|||
145909724|NCT02516553|526173787|FG012|Overall Study|Dose limiting toxicity|0|||
145909725|NCT02516553|526173788|FG013|Overall Study|Dose limiting toxicity|1|||
145909726|NCT02516553|526173789|FG014|Overall Study|Dose limiting toxicity|0|||
145909727|NCT02516553|526173790|FG015|Overall Study|Dose limiting toxicity|0|||
145909728|NCT02516553|526173791|FG016|Overall Study|Dose limiting toxicity|1|||
145909729|NCT02516553|526173792|FG017|Overall Study|Dose limiting toxicity|1|||
145909730|NCT02516553|526173793|FG018|Overall Study|Dose limiting toxicity|0|||
145909731|NCT02516553|526173794|FG019|Overall Study|Dose limiting toxicity|2|||
145909732|NCT02516553|526173795|FG020|Overall Study|Dose limiting toxicity|0|||
145909733|NCT02516553|526173796|FG021|Overall Study|Dose limiting toxicity|0|||
145909734|NCT02516553|526173775|FG000|Overall Study|Other Adverse Events|0|||
145909735|NCT02516553|526173776|FG001|Overall Study|Other Adverse Events|0|||
145909736|NCT02516553|526173777|FG002|Overall Study|Other Adverse Events|0|||
145909737|NCT02516553|526173778|FG003|Overall Study|Other Adverse Events|1|||
145909738|NCT02516553|526173779|FG004|Overall Study|Other Adverse Events|0|||
145909739|NCT02516553|526173780|FG005|Overall Study|Other Adverse Events|1|||
146088537|NCT01923168|526843871|FG001|Overall Study|Adverse Event|12|||
146088538|NCT01923168|526843872|FG002|Overall Study|Adverse Event|0|||
146088539|NCT01923168|526843870|FG000|Overall Study|Physician Decision|6|||
146088540|NCT01923168|526843871|FG001|Overall Study|Physician Decision|9|||
146088541|NCT01923168|526843872|FG002|Overall Study|Physician Decision|5|||
146088542|NCT01923168|526843870|FG000|Overall Study|Progressive disease|4|||
146088543|NCT01923168|526843871|FG001|Overall Study|Progressive disease|3|||
146088544|NCT01923168|526843872|FG002|Overall Study|Progressive disease|7|||
146088545|NCT01923168|526843870|FG000|Overall Study|Death|0|||
146088546|NCT01923168|526843871|FG001|Overall Study|Death|0|||
146088547|NCT01923168|526843872|FG002|Overall Study|Death|1|||
146088548|NCT03116347|526843873|FG000|Overall Study|Withdrawal by Subject|1|||
146088549|NCT03116347|526843874|FG001|Overall Study|Withdrawal by Subject|2|||
146297423|NCT01641809|527604694|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
145973086|NCT05383209|526414181|FG002|Overall Study|Other|0|||
145973087|NCT00321763|526414183|FG000|Overall Study|Adverse Event|1|||
145909740|NCT02516553|526173781|FG006|Overall Study|Other Adverse Events|0|||
145909741|NCT02516553|526173782|FG007|Overall Study|Other Adverse Events|0|||
145909742|NCT02516553|526173783|FG008|Overall Study|Other Adverse Events|0|||
145909743|NCT02516553|526173784|FG009|Overall Study|Other Adverse Events|1|||
145909744|NCT02516553|526173785|FG010|Overall Study|Other Adverse Events|3|||
145909745|NCT02516553|526173786|FG011|Overall Study|Other Adverse Events|2|||
145909746|NCT02516553|526173787|FG012|Overall Study|Other Adverse Events|0|||
145909747|NCT02516553|526173788|FG013|Overall Study|Other Adverse Events|1|||
145909748|NCT02516553|526173789|FG014|Overall Study|Other Adverse Events|0|||
145909749|NCT02516553|526173790|FG015|Overall Study|Other Adverse Events|0|||
145909750|NCT02516553|526173791|FG016|Overall Study|Other Adverse Events|0|||
145909751|NCT02516553|526173792|FG017|Overall Study|Other Adverse Events|2|||
145909752|NCT02516553|526173793|FG018|Overall Study|Other Adverse Events|1|||
145909753|NCT02516553|526173794|FG019|Overall Study|Other Adverse Events|2|||
145909754|NCT02516553|526173795|FG020|Overall Study|Other Adverse Events|2|||
145909755|NCT02516553|526173796|FG021|Overall Study|Other Adverse Events|1|||
145909756|NCT02516553|526173775|FG000|Overall Study|Refused to continue trial medication|0|||
145909757|NCT02516553|526173776|FG001|Overall Study|Refused to continue trial medication|0|||
145909758|NCT02516553|526173777|FG002|Overall Study|Refused to continue trial medication|0|||
145909759|NCT02516553|526173778|FG003|Overall Study|Refused to continue trial medication|0|||
145909760|NCT02516553|526173779|FG004|Overall Study|Refused to continue trial medication|0|||
145909761|NCT02516553|526173780|FG005|Overall Study|Refused to continue trial medication|0|||
145909762|NCT02516553|526173781|FG006|Overall Study|Refused to continue trial medication|0|||
145909763|NCT02516553|526173782|FG007|Overall Study|Refused to continue trial medication|0|||
145909764|NCT02516553|526173783|FG008|Overall Study|Refused to continue trial medication|0|||
145909765|NCT02516553|526173784|FG009|Overall Study|Refused to continue trial medication|0|||
145909766|NCT02516553|526173785|FG010|Overall Study|Refused to continue trial medication|1|||
145909767|NCT02516553|526173786|FG011|Overall Study|Refused to continue trial medication|0|||
145909768|NCT02516553|526173787|FG012|Overall Study|Refused to continue trial medication|0|||
145973088|NCT00321763|526414184|FG001|Overall Study|Adverse Event|1|||
145973089|NCT00321763|526414185|FG002|Overall Study|Adverse Event|0|||
145909769|NCT02516553|526173788|FG013|Overall Study|Refused to continue trial medication|0|||
145909770|NCT02516553|526173789|FG014|Overall Study|Refused to continue trial medication|0|||
145909771|NCT02516553|526173790|FG015|Overall Study|Refused to continue trial medication|0|||
145973090|NCT00321763|526414186|FG003|Overall Study|Adverse Event|1|||
145973091|NCT00321763|526414183|FG000|Overall Study|Withdrawal by Subject|2|||
145973092|NCT00321763|526414184|FG001|Overall Study|Withdrawal by Subject|0|||
145973093|NCT00321763|526414185|FG002|Overall Study|Withdrawal by Subject|1|||
146297424|NCT01641809|527604695|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
145909772|NCT02516553|526173791|FG016|Overall Study|Refused to continue trial medication|0|||
145909773|NCT02516553|526173792|FG017|Overall Study|Refused to continue trial medication|0|||
145909774|NCT02516553|526173793|FG018|Overall Study|Refused to continue trial medication|1|||
145909775|NCT02516553|526173794|FG019|Overall Study|Refused to continue trial medication|0|||
145909776|NCT02516553|526173795|FG020|Overall Study|Refused to continue trial medication|0|||
145909777|NCT02516553|526173796|FG021|Overall Study|Refused to continue trial medication|1|||
146088550|NCT01255787|526843875|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
146088551|NCT01255787|526843876|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
146088552|NCT01255787|526843877|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
145973094|NCT00321763|526414186|FG003|Overall Study|Withdrawal by Subject|0|||
145909778|NCT02516553|526173775|FG000|Overall Study|other reasons than listed|0|||
145909779|NCT02516553|526173776|FG001|Overall Study|other reasons than listed|0|||
145909780|NCT02516553|526173777|FG002|Overall Study|other reasons than listed|0|||
145909781|NCT02516553|526173778|FG003|Overall Study|other reasons than listed|0|||
145909782|NCT02516553|526173779|FG004|Overall Study|other reasons than listed|0|||
145909783|NCT02516553|526173780|FG005|Overall Study|other reasons than listed|0|||
145909784|NCT02516553|526173781|FG006|Overall Study|other reasons than listed|0|||
145909785|NCT02516553|526173782|FG007|Overall Study|other reasons than listed|1|||
145909786|NCT02516553|526173783|FG008|Overall Study|other reasons than listed|1|||
145909787|NCT02516553|526173784|FG009|Overall Study|other reasons than listed|0|||
145909788|NCT02516553|526173785|FG010|Overall Study|other reasons than listed|1|||
145909789|NCT02516553|526173786|FG011|Overall Study|other reasons than listed|1|||
145909790|NCT02516553|526173787|FG012|Overall Study|other reasons than listed|0|||
145909791|NCT02516553|526173788|FG013|Overall Study|other reasons than listed|0|||
145909792|NCT02516553|526173789|FG014|Overall Study|other reasons than listed|0|||
145909793|NCT02516553|526173790|FG015|Overall Study|other reasons than listed|0|||
145909794|NCT02516553|526173791|FG016|Overall Study|other reasons than listed|0|||
145909795|NCT02516553|526173792|FG017|Overall Study|other reasons than listed|0|||
145909796|NCT02516553|526173793|FG018|Overall Study|other reasons than listed|0|||
145909797|NCT02516553|526173794|FG019|Overall Study|other reasons than listed|0|||
145909798|NCT02516553|526173795|FG020|Overall Study|other reasons than listed|2|||
145909799|NCT02516553|526173796|FG021|Overall Study|other reasons than listed|2|||
145909800|NCT03052127|526173797|FG000|Overall Study|Withdrawal by Subject|0|||
145909801|NCT03052127|526173798|FG001|Overall Study|Withdrawal by Subject|0|||
145909802|NCT03052127|526173799|FG002|Overall Study|Withdrawal by Subject|0|||
145909803|NCT03052127|526173800|FG003|Overall Study|Withdrawal by Subject|0|||
145909804|NCT03052127|526173801|FG004|Overall Study|Withdrawal by Subject|0|||
145909805|NCT03052127|526173802|FG005|Overall Study|Withdrawal by Subject|0|||
145909806|NCT03052127|526173803|FG006|Overall Study|Withdrawal by Subject|0|||
145909807|NCT03052127|526173804|FG007|Overall Study|Withdrawal by Subject|1|||
145909808|NCT03052127|526173805|FG008|Overall Study|Withdrawal by Subject|1|||
145909809|NCT03052127|526173806|FG009|Overall Study|Withdrawal by Subject|1|||
145909810|NCT03052127|526173807|FG010|Overall Study|Withdrawal by Subject|0|||
145909811|NCT03052127|526173808|FG011|Overall Study|Withdrawal by Subject|0|||
145909812|NCT03052127|526173797|FG000|Overall Study|Discontinuation by Sponsor|0|||
145909813|NCT03052127|526173798|FG001|Overall Study|Discontinuation by Sponsor|0|||
145909814|NCT03052127|526173799|FG002|Overall Study|Discontinuation by Sponsor|0|||
145909815|NCT03052127|526173800|FG003|Overall Study|Discontinuation by Sponsor|0|||
145909816|NCT03052127|526173801|FG004|Overall Study|Discontinuation by Sponsor|0|||
145909817|NCT03052127|526173802|FG005|Overall Study|Discontinuation by Sponsor|0|||
145909818|NCT03052127|526173803|FG006|Overall Study|Discontinuation by Sponsor|0|||
145909819|NCT03052127|526173804|FG007|Overall Study|Discontinuation by Sponsor|0|||
145909820|NCT03052127|526173805|FG008|Overall Study|Discontinuation by Sponsor|4|||
145909821|NCT03052127|526173806|FG009|Overall Study|Discontinuation by Sponsor|2|||
145909822|NCT03052127|526173807|FG010|Overall Study|Discontinuation by Sponsor|5|||
145909823|NCT03052127|526173808|FG011|Overall Study|Discontinuation by Sponsor|13|||
145909824|NCT03052127|526173797|FG000|Overall Study|Inability to comply with trial requirements|0|||
145909825|NCT03052127|526173798|FG001|Overall Study|Inability to comply with trial requirements|0|||
145973095|NCT00321763|526414183|FG000|Overall Study|Lost to Follow-up|3|||
145973096|NCT00321763|526414184|FG001|Overall Study|Lost to Follow-up|1|||
145973097|NCT00321763|526414185|FG002|Overall Study|Lost to Follow-up|5|||
145973098|NCT00321763|526414186|FG003|Overall Study|Lost to Follow-up|4|||
145973099|NCT00717886|526414187|FG000|Overall Study|Withdrawal by Subject|3|||
145909826|NCT03052127|526173799|FG002|Overall Study|Inability to comply with trial requirements|1|||
145909827|NCT03052127|526173800|FG003|Overall Study|Inability to comply with trial requirements|0|||
145909828|NCT03052127|526173801|FG004|Overall Study|Inability to comply with trial requirements|0|||
145909829|NCT03052127|526173802|FG005|Overall Study|Inability to comply with trial requirements|0|||
145909830|NCT03052127|526173803|FG006|Overall Study|Inability to comply with trial requirements|0|||
145909831|NCT03052127|526173804|FG007|Overall Study|Inability to comply with trial requirements|0|||
145909832|NCT03052127|526173805|FG008|Overall Study|Inability to comply with trial requirements|0|||
145909833|NCT03052127|526173806|FG009|Overall Study|Inability to comply with trial requirements|0|||
145909834|NCT03052127|526173807|FG010|Overall Study|Inability to comply with trial requirements|0|||
145909835|NCT03052127|526173808|FG011|Overall Study|Inability to comply with trial requirements|0|||
145909836|NCT03052127|526173797|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145909837|NCT03052127|526173798|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909838|NCT03052127|526173799|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909839|NCT03052127|526173800|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909840|NCT03052127|526173801|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145909841|NCT03052127|526173802|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145909842|NCT03052127|526173803|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145973100|NCT00717886|526414187|FG000|Overall Study|Treatment Failure|1|||
145909843|NCT03052127|526173804|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909844|NCT03052127|526173805|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909845|NCT03052127|526173806|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909846|NCT03052127|526173807|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909847|NCT03052127|526173808|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145909848|NCT04458922|526175882|FG000|Overall Study|Withdrawal by Subject|1|||
145909849|NCT04458922|526175883|FG001|Overall Study|Withdrawal by Subject|0|||
145909850|NCT04458922|526175884|FG002|Overall Study|Withdrawal by Subject|2|||
145909851|NCT04458922|526175882|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
145909852|NCT04458922|526175883|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
145909853|NCT04458922|526175884|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
145909854|NCT04458922|526175882|FG000|Overall Study|Adverse Event|1|||
145909855|NCT04458922|526175883|FG001|Overall Study|Adverse Event|0|||
145909856|NCT04458922|526175884|FG002|Overall Study|Adverse Event|0|||
145909857|NCT04458922|526175882|FG000|Overall Study|Started new study|0|||
145909858|NCT04458922|526175883|FG001|Overall Study|Started new study|0|||
145909859|NCT04458922|526175884|FG002|Overall Study|Started new study|1|||
145909860|NCT04458922|526175882|FG000|Overall Study|Progressive disease|6|||
145909861|NCT04458922|526175883|FG001|Overall Study|Progressive disease|8|||
145909862|NCT04458922|526175884|FG002|Overall Study|Progressive disease|2|||
145909863|NCT04458922|526175882|FG000|Overall Study|Death|1|||
145909864|NCT04458922|526175883|FG001|Overall Study|Death|0|||
145909865|NCT04458922|526175884|FG002|Overall Study|Death|2|||
145909866|NCT04458922|526175882|FG000|Overall Study|Participant started chemotherapy|0|||
145909867|NCT04458922|526175883|FG001|Overall Study|Participant started chemotherapy|1|||
145909868|NCT04458922|526175884|FG002|Overall Study|Participant started chemotherapy|0|||
145909869|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
145909870|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
145909871|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
145909872|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
145909873|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
145909874|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
145909875|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
145909876|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
145909877|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
145909878|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
145909879|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
145909880|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
145909881|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
145909882|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
145909883|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
145909884|NCT04856930|526175888|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145909885|NCT04856930|526175889|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
145909886|NCT04856930|526175890|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
146088553|NCT01255787|526843878|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
146088554|NCT01255787|526843875|FG000|Overall Study|Major Protocol Deviation|1|||
146297425|NCT01641809|527604692|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
146297426|NCT01641809|527604693|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
145909887|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
145909888|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
145909889|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
145909890|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
145909891|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
145909892|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
145909893|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
145909894|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
145909895|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
145909896|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
145909897|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
145909898|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
145909899|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
145909900|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145909901|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145909902|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
145909903|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
145909904|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
145909905|NCT04856930|526175888|FG000|Extension Period (16 Weeks)|Other than specified|0|||
145909906|NCT04856930|526175889|FG001|Extension Period (16 Weeks)|Other than specified|0|||
145909907|NCT04856930|526175890|FG002|Extension Period (16 Weeks)|Other than specified|1|||
145909908|NCT04856930|526175888|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
145909909|NCT04856930|526175889|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
145909910|NCT04856930|526175890|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
145909911|NCT04856930|526175888|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
145909912|NCT04856930|526175889|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
145909913|NCT04856930|526175890|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
145909914|NCT04856930|526175888|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
145909915|NCT04856930|526175889|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
145909916|NCT04856930|526175890|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
145909917|NCT04856930|526175888|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
145909918|NCT04856930|526175889|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
145909919|NCT04856930|526175890|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
145909920|NCT01009814|526175893|FG000|Overall Study|No longer met study criteria|1|||
145909921|NCT01009814|526175894|FG001|Overall Study|No longer met study criteria|1|||
145909922|NCT01009814|526175895|FG002|Overall Study|No longer met study criteria|0|||
145909923|NCT01009814|526175896|FG003|Overall Study|No longer met study criteria|0|||
145909924|NCT01009814|526175897|FG004|Overall Study|No longer met study criteria|0|||
145909925|NCT00618371|526175898|FG000|Overall Study|Withdrawal by Subject|2|||
145909926|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
145909927|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
145909928|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
145909929|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
145909930|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
145909931|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
145909932|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
145909933|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
145909934|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
145909935|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
145909936|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
145909937|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
145909938|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
145909939|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
145909940|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
145909941|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145909942|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145909943|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145909944|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145909945|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145909946|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
145909947|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
145909948|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
145909949|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
145909950|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
145909951|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145909952|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145909953|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145909954|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145909955|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145909956|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
145909957|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
145909958|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
145909959|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
145909960|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
145909961|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145909962|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145909963|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145909964|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145909965|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145909966|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909967|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909968|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909969|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
145909970|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909971|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909972|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909973|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909974|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909975|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145909976|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
145909977|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
145909978|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
145909979|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
145909980|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
145909981|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
145909982|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
145909983|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
145909984|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
145909985|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
145909986|NCT03104400|526175899|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909987|NCT03104400|526175900|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909988|NCT03104400|526175901|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909989|NCT03104400|526175902|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
145909990|NCT03104400|526175903|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909991|NCT03104400|526175904|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909992|NCT03104400|526175905|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909993|NCT03104400|526175906|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909994|NCT03104400|526175907|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909995|NCT03104400|526175908|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145909996|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
145909997|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
145909998|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
145909999|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
145910000|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
145910001|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
145910002|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
145910003|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
145910004|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
145910005|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
145910006|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145910007|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145910008|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145910009|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145910010|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145910011|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
145910012|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
145910013|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
145910014|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
145973101|NCT01553851|526414188|FG000|Overall Study|Adverse Event|2|||
145973102|NCT01553851|526414188|FG000|Overall Study|constipation|1|||
145910015|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
145910016|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145910017|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145910018|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145910019|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145910020|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145910021|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
145973103|NCT02101294|526414189|FG000|Overall Study|Withdrawal by Subject|5|||
145973104|NCT02101294|526414189|FG000|Overall Study|Lost to Follow-up|6|||
145973105|NCT03822416|526414192|FG000|Overall Study|Lost to Follow-up|1|||
145973106|NCT03822416|526414193|FG001|Overall Study|Lost to Follow-up|0|||
145973107|NCT03822416|526414192|FG000|Overall Study|Withdrawal by Subject|0|||
145910022|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
145910023|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
145910024|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
145973108|NCT03822416|526414193|FG001|Overall Study|Withdrawal by Subject|1|||
145973109|NCT01303419|526414194|FG000|Overall Study|Discontinuation of study|60|||
145973110|NCT01303419|526414194|FG000|Overall Study|Did not complete both imaging methods|5|||
145973111|NCT01303419|526414194|FG000|Overall Study|Did not meet all I/E after screening|31|||
145910025|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
145910026|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145910027|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145910028|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145910029|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145910030|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145910031|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
145910032|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
145910033|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
145910034|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
145910035|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
145910036|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910037|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910038|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910039|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910040|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910041|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910042|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
145910043|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145910044|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
145910045|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
145910046|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910047|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910048|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910049|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910050|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910051|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910052|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910053|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
145910054|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
145910055|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145910056|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
145910057|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
145910058|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
145910059|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
145910060|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
145910061|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
145910062|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
145910063|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
145910064|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
145910065|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
145910066|NCT03104400|526175899|FG000|Period 2 Week 56 - 260)|Other|0|||
145910067|NCT03104400|526175900|FG001|Period 2 Week 56 - 260)|Other|0|||
145910068|NCT03104400|526175901|FG002|Period 2 Week 56 - 260)|Other|0|||
145910069|NCT03104400|526175902|FG003|Period 2 Week 56 - 260)|Other|0|||
145910070|NCT03104400|526175903|FG004|Period 2 Week 56 - 260)|Other|0|||
145910071|NCT03104400|526175904|FG005|Period 2 Week 56 - 260)|Other|0|||
145910072|NCT03104400|526175905|FG006|Period 2 Week 56 - 260)|Other|0|||
145910073|NCT03104400|526175906|FG007|Period 2 Week 56 - 260)|Other|0|||
145910074|NCT03104400|526175907|FG008|Period 2 Week 56 - 260)|Other|1|||
145910075|NCT03104400|526175908|FG009|Period 2 Week 56 - 260)|Other|1|||
145910076|NCT02013817|526175909|FG000|Overall Study|Adverse Event|12|||
145910077|NCT02013817|526175909|FG000|Overall Study|Withdrawal by Subject|4|||
145910078|NCT02013817|526175909|FG000|Overall Study|Death|2|||
145910079|NCT02013817|526175909|FG000|Overall Study|Other|9|||
145910080|NCT01582152|526175910|FG000|Overall Study|Disease Progression|4|||
145910081|NCT01582152|526175911|FG001|Overall Study|Disease Progression|5|||
145910082|NCT01582152|526175910|FG000|Overall Study|Adverse Event|2|||
145910083|NCT01582152|526175911|FG001|Overall Study|Adverse Event|1|||
145910084|NCT01434810|526175912|FG000|Overall Study|Did not receive treatment|11|||
145910085|NCT01434810|526175913|FG001|Overall Study|Did not receive treatment|3|||
145910086|NCT01434810|526175912|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
145910087|NCT01434810|526175913|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
145910088|NCT01609023|526175917|FG000|Overall Study|Lack of Efficacy|3|||
145973112|NCT02709369|526414195|FG000|Overall Study|Lost to Follow-up|15|||
145973113|NCT02709369|526414195|FG000|Overall Study|Withdrawal by Subject|10|||
145973114|NCT02709369|526414195|FG000|Overall Study|Did not received intervention|2|||
145973115|NCT01900314|526414196|FG000|Overall Study|Lost to Follow-up|1|||
145973116|NCT01900314|526414197|FG001|Overall Study|Lost to Follow-up|0|||
145910089|NCT01609023|526175917|FG000|Overall Study|Withdrawal by Subject|4|||
145910090|NCT01609023|526175917|FG000|Overall Study|Lost to Follow-up|8|||
145910091|NCT01609023|526175917|FG000|Overall Study|Toxicity|3|||
145910092|NCT01609023|526175917|FG000|Overall Study|Disease progression|10|||
145910093|NCT01609023|526175917|FG000|Overall Study|Physician Decision|2|||
145910094|NCT01609023|526175917|FG000|Overall Study|Death|2|||
145910095|NCT01609023|526175917|FG000|Overall Study|Personal reasons|1|||
145910096|NCT04172597|526175922|FG000|Overall Study|Disease Progression|0|||
145910097|NCT04172597|526175923|FG001|Overall Study|Disease Progression|0|||
145910098|NCT04172597|526175924|FG002|Overall Study|Disease Progression|0|||
145910099|NCT04172597|526175925|FG003|Overall Study|Disease Progression|0|||
145910100|NCT04172597|526175926|FG004|Overall Study|Disease Progression|1|||
145910101|NCT00794339|526175927|FG000|Overall Study|Withdrawal by Subject|3|||
145910102|NCT00794339|526175927|FG000|Overall Study|Ineligible|4|||
145910103|NCT00794339|526175927|FG000|Overall Study|Tx prior to ATSM|3|||
145910104|NCT00794339|526175927|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
145910105|NCT00794339|526175927|FG000|Overall Study|Tx not per protocol|1|||
145910106|NCT01611857|526175928|FG000|Overall Study|Withdrawal by Subject|0|||
145910107|NCT01611857|526175929|FG001|Overall Study|Withdrawal by Subject|2|||
145910108|NCT02439970|526175930|FG000|Overall Study|Study Terminated|2|||
145910109|NCT02439970|526175931|FG001|Overall Study|Study Terminated|3|||
145910110|NCT02952586|526175934|FG000|Lead-In Phase (7 Days)|Death|0|||
145910111|NCT02952586|526175935|FG001|Lead-In Phase (7 Days)|Death|1|||
145910112|NCT02952586|526175934|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
145910113|NCT02952586|526175935|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
145910114|NCT02952586|526175934|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
145910115|NCT02952586|526175935|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
145910116|NCT02952586|526175934|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
145910117|NCT02952586|526175935|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
145910118|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
145910119|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
145910120|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
145910121|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
145910122|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
145910123|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
145910124|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
145910125|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
145910126|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
145910127|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
145910128|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
145910129|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
145910130|NCT02952586|526175934|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
145910131|NCT02952586|526175935|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
145910132|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Death|3|||
145910133|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Death|8|||
145910134|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
145910135|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
145910136|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
145910137|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
145910138|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
145910139|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
145910140|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
145910141|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
145910142|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
145910143|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
145910144|NCT02952586|526175934|FG000|CRT for Cisplatin (63 Days)|Other|1|||
145910145|NCT02952586|526175935|FG001|CRT for Cisplatin (63 Days)|Other|1|||
145910146|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Death|5|||
145910147|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Death|8|||
145910148|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
145910149|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
145910150|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
145910151|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
145910152|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
145910153|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
145910154|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
145910155|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
145910156|NCT02952586|526175934|FG000|CRT for IMRT (63 Days)|Other|1|||
145910157|NCT02952586|526175935|FG001|CRT for IMRT (63 Days)|Other|0|||
145910158|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Death|17|||
145910159|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Death|11|||
145910160|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
145910161|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
145910162|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
145910163|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
145910164|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
145910165|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
145910166|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
145973117|NCT01900314|526414196|FG000|Overall Study|Protocol Violation|0|||
145973118|NCT01900314|526414197|FG001|Overall Study|Protocol Violation|1|||
145973119|NCT01900314|526414196|FG000|Overall Study|Withdrawal by Subject|3|||
145910167|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
145910168|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
145910169|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
145910170|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
145910171|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
145910172|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
145910173|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
145973120|NCT01900314|526414197|FG001|Overall Study|Withdrawal by Subject|3|||
145973121|NCT01104766|526414198|FG000|Overall Study|Did not meet inc/exc criteria|1|||
145973122|NCT01104766|526414199|FG001|Overall Study|Did not meet inc/exc criteria|0|||
145910174|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Other|2|||
145910175|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Other|1|||
145910176|NCT02952586|526175934|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
145910177|NCT02952586|526175935|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
145910178|NCT02952586|526175934|FG000|Follow-Up Phase (90 Days)|Death|12|||
145910179|NCT02952586|526175935|FG001|Follow-Up Phase (90 Days)|Death|10|||
145910180|NCT02952586|526175934|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
145910181|NCT02952586|526175935|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
145910182|NCT02952586|526175934|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
145910183|NCT02952586|526175935|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
145910184|NCT02952586|526175934|FG000|Follow-Up Phase (90 Days)|Other|7|||
145910185|NCT02952586|526175935|FG001|Follow-Up Phase (90 Days)|Other|5|||
145910186|NCT02952586|526175934|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
145910187|NCT02952586|526175935|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
145910188|NCT02952586|526175934|FG000|LT Follow-up (up to 45 Months)|Death|51|||
145910189|NCT02952586|526175935|FG001|LT Follow-up (up to 45 Months)|Death|31|||
145910190|NCT02952586|526175934|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
145910191|NCT02952586|526175935|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
145910192|NCT02952586|526175934|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
145910193|NCT02952586|526175935|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
145910194|NCT02952586|526175934|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
145910195|NCT02952586|526175935|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
145910196|NCT00492778|526175936|FG000|Overall Study|Ineligible by Pathology Review|8|||
145910197|NCT00492778|526175937|FG001|Overall Study|Ineligible by Pathology Review|1|||
145910198|NCT03717012|526175954|FG000|Overall Study|Due to trial termination|1|||
145910199|NCT03717012|526175955|FG001|Overall Study|Due to trial termination|2|||
145910200|NCT03717012|526175954|FG000|Overall Study|Protocol Violation|0|||
145910201|NCT03717012|526175955|FG001|Overall Study|Protocol Violation|2|||
145910202|NCT03717012|526175954|FG000|Overall Study|Adverse Event|0|||
145910203|NCT03717012|526175955|FG001|Overall Study|Adverse Event|1|||
145910204|NCT03717012|526175954|FG000|Overall Study|Lung transplant|0|||
145910205|NCT03717012|526175955|FG001|Overall Study|Lung transplant|1|||
145910206|NCT04974749|526175956|FG000|Overall Study|Withdrawal by Subject|2|||
145910207|NCT04974749|526175956|FG000|Overall Study|Gestation|1|||
145910208|NCT02075515|526175963|FG000|Overall Study|Serious Adverse Event|1|||
145910209|NCT02075515|526175964|FG001|Overall Study|Serious Adverse Event|1|||
145910210|NCT02075515|526175965|FG002|Overall Study|Serious Adverse Event|1|||
145910211|NCT02075515|526175963|FG000|Overall Study|Non-Serious Adverse Event|0|||
145910212|NCT02075515|526175964|FG001|Overall Study|Non-Serious Adverse Event|1|||
145910213|NCT02075515|526175965|FG002|Overall Study|Non-Serious Adverse Event|0|||
145910214|NCT02075515|526175963|FG000|Overall Study|Withdrawal by Subject|2|||
145910215|NCT02075515|526175964|FG001|Overall Study|Withdrawal by Subject|0|||
145910216|NCT02075515|526175965|FG002|Overall Study|Withdrawal by Subject|1|||
145910217|NCT02075515|526175963|FG000|Overall Study|Lost to Follow-up|1|||
145910218|NCT02075515|526175964|FG001|Overall Study|Lost to Follow-up|3|||
145910219|NCT02075515|526175965|FG002|Overall Study|Lost to Follow-up|6|||
145910220|NCT00741338|526175968|FG000|Overall Study|Adverse Event|0|||
145910221|NCT00741338|526175969|FG001|Overall Study|Adverse Event|1|||
145910222|NCT03593395|526175970|FG000|Overall Study|Lost to Follow-up|48|||
145910223|NCT03593395|526175971|FG001|Overall Study|Lost to Follow-up|3|||
145910224|NCT03593395|526175970|FG000|Overall Study|Withdrawal by Subject|5|||
145973123|NCT01104766|526414200|FG002|Overall Study|Did not meet inc/exc criteria|0|||
145910225|NCT03593395|526175971|FG001|Overall Study|Withdrawal by Subject|24|||
145910226|NCT03593395|526175970|FG000|Overall Study|Death|2|||
145910227|NCT03593395|526175971|FG001|Overall Study|Death|3|||
145910228|NCT03593395|526175970|FG000|Overall Study|Physician Decision|0|||
145910229|NCT03593395|526175971|FG001|Overall Study|Physician Decision|6|||
145910230|NCT03593395|526175970|FG000|Overall Study|Participant Relocated|19|||
145910231|NCT03593395|526175971|FG001|Overall Study|Participant Relocated|3|||
145910232|NCT03593395|526175970|FG000|Overall Study|No Information|1|||
145910233|NCT03593395|526175971|FG001|Overall Study|No Information|7|||
145973124|NCT01104766|526414201|FG003|Overall Study|Did not meet inc/exc criteria|0|||
145910234|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
145910235|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
145910236|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
145910237|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145910238|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145910239|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
145973125|NCT01104766|526414198|FG000|Overall Study|Adverse Event|17|||
145910240|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145910241|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145910242|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145910243|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145910244|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145910245|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145910246|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145910247|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145910248|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145910249|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
145910250|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145910251|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
145910252|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145910253|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145910254|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145910255|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145910256|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145910257|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145910258|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145910259|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145910260|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145910261|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
145910262|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145910263|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145910264|NCT03713632|526175972|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
145910265|NCT03713632|526175973|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145910266|NCT03713632|526175974|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145910267|NCT03713632|526175975|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145910268|NCT03713632|526175976|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145910269|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
145910270|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
145910271|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
145910272|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
145910273|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
145910274|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
145910275|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
145910276|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
145910277|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
145910278|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
145910279|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
145910280|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
145910281|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
145910282|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
145973126|NCT01104766|526414199|FG001|Overall Study|Adverse Event|15|||
145973127|NCT01104766|526414200|FG002|Overall Study|Adverse Event|20|||
145973128|NCT01104766|526414201|FG003|Overall Study|Adverse Event|14|||
145973129|NCT01104766|526414198|FG000|Overall Study|Lack of Efficacy|20|||
145973130|NCT01104766|526414199|FG001|Overall Study|Lack of Efficacy|15|||
145973131|NCT01104766|526414200|FG002|Overall Study|Lack of Efficacy|14|||
145973132|NCT01104766|526414201|FG003|Overall Study|Lack of Efficacy|8|||
145973133|NCT01104766|526414198|FG000|Overall Study|Protocol Violation|2|||
145973134|NCT01104766|526414199|FG001|Overall Study|Protocol Violation|0|||
145973135|NCT01104766|526414200|FG002|Overall Study|Protocol Violation|0|||
145973136|NCT01104766|526414201|FG003|Overall Study|Protocol Violation|0|||
145973137|NCT01104766|526414198|FG000|Overall Study|Withdrawal by Subject|17|||
145973138|NCT01104766|526414199|FG001|Overall Study|Withdrawal by Subject|19|||
145973139|NCT01104766|526414200|FG002|Overall Study|Withdrawal by Subject|25|||
145973140|NCT01104766|526414201|FG003|Overall Study|Withdrawal by Subject|15|||
145973141|NCT01104766|526414198|FG000|Overall Study|Lost to Follow-up|1|||
145973142|NCT01104766|526414199|FG001|Overall Study|Lost to Follow-up|2|||
145973143|NCT01104766|526414200|FG002|Overall Study|Lost to Follow-up|1|||
145973144|NCT01104766|526414201|FG003|Overall Study|Lost to Follow-up|1|||
145973145|NCT01136915|526414203|FG000|Overall Study|Lost to Follow-up|2|||
145973146|NCT01136915|526414204|FG001|Overall Study|Lost to Follow-up|0|||
145973147|NCT01136915|526414203|FG000|Overall Study|Exclusion criterion met|0|||
145973148|NCT01136915|526414204|FG001|Overall Study|Exclusion criterion met|1|||
145973149|NCT03282097|526414207|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
145973150|NCT03282097|526414208|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
145973151|NCT03282097|526414207|FG000|Intervention Visit Complete|Patient Death|13|||
145973152|NCT03282097|526414208|FG001|Intervention Visit Complete|Patient Death|15|||
145973153|NCT03282097|526414207|FG000|Intervention Visit Complete|Caregiver Death|0|||
145973154|NCT03282097|526414208|FG001|Intervention Visit Complete|Caregiver Death|3|||
145973155|NCT03282097|526414207|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
145973156|NCT03282097|526414208|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
145973157|NCT03282097|526414207|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
146239239|NCT02743819|527389759|FG000|Overall Study|Adverse Event|1|||
145910283|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
145910284|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
145910285|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
145910286|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145910287|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
145910288|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145910289|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145910290|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145910291|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145910292|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145910293|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145910294|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
145910295|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145910296|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145910297|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145910298|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145910299|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Death|0|||
145910300|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Death|1|||
145910301|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Death|0|||
145910302|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Death|0|||
145910303|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Death|0|||
145910304|NCT03713632|526175972|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145910305|NCT03713632|526175973|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145910306|NCT03713632|526175974|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145910307|NCT03713632|526175975|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145910308|NCT03713632|526175976|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145910309|NCT01524978|526175977|FG000|Overall Study|Other|16|||
145910310|NCT01524978|526175978|FG001|Overall Study|Other|2|||
145910311|NCT01524978|526175979|FG002|Overall Study|Other|1|||
145910312|NCT01524978|526175980|FG003|Overall Study|Other|2|||
145910313|NCT01524978|526175981|FG004|Overall Study|Other|1|||
145910314|NCT01524978|526175982|FG005|Overall Study|Other|3|||
145910315|NCT01524978|526175983|FG006|Overall Study|Other|17|||
145910316|NCT01524978|526175984|FG007|Overall Study|Other|1|||
145910317|NCT01524978|526175985|FG008|Overall Study|Other|2|||
145910318|NCT01524978|526175986|FG009|Overall Study|Other|2|||
145910319|NCT01524978|526175987|FG010|Overall Study|Other|5|||
145910320|NCT01524978|526175977|FG000|Overall Study|Withdrawal by Subject|12|||
145910321|NCT01524978|526175978|FG001|Overall Study|Withdrawal by Subject|0|||
145910322|NCT01524978|526175979|FG002|Overall Study|Withdrawal by Subject|1|||
145910323|NCT01524978|526175980|FG003|Overall Study|Withdrawal by Subject|1|||
145910324|NCT01524978|526175981|FG004|Overall Study|Withdrawal by Subject|3|||
145910325|NCT01524978|526175982|FG005|Overall Study|Withdrawal by Subject|1|||
145910326|NCT01524978|526175983|FG006|Overall Study|Withdrawal by Subject|6|||
145910327|NCT01524978|526175984|FG007|Overall Study|Withdrawal by Subject|2|||
145910328|NCT01524978|526175985|FG008|Overall Study|Withdrawal by Subject|4|||
145910329|NCT01524978|526175986|FG009|Overall Study|Withdrawal by Subject|0|||
145910330|NCT01524978|526175987|FG010|Overall Study|Withdrawal by Subject|5|||
145910331|NCT01524978|526175977|FG000|Overall Study|Lost to Follow-up|0|||
145910332|NCT01524978|526175978|FG001|Overall Study|Lost to Follow-up|0|||
145910333|NCT01524978|526175979|FG002|Overall Study|Lost to Follow-up|3|||
145910334|NCT01524978|526175980|FG003|Overall Study|Lost to Follow-up|0|||
145910335|NCT01524978|526175981|FG004|Overall Study|Lost to Follow-up|1|||
145910336|NCT01524978|526175982|FG005|Overall Study|Lost to Follow-up|1|||
145910337|NCT01524978|526175983|FG006|Overall Study|Lost to Follow-up|2|||
145910338|NCT01524978|526175984|FG007|Overall Study|Lost to Follow-up|0|||
145910339|NCT01524978|526175985|FG008|Overall Study|Lost to Follow-up|1|||
145910340|NCT01524978|526175986|FG009|Overall Study|Lost to Follow-up|1|||
145910341|NCT01524978|526175987|FG010|Overall Study|Lost to Follow-up|1|||
145910342|NCT01524978|526175977|FG000|Overall Study|Death|34|||
145910343|NCT01524978|526175978|FG001|Overall Study|Death|2|||
145910344|NCT01524978|526175979|FG002|Overall Study|Death|5|||
145910345|NCT01524978|526175980|FG003|Overall Study|Death|24|||
145910346|NCT01524978|526175981|FG004|Overall Study|Death|4|||
145910347|NCT01524978|526175982|FG005|Overall Study|Death|4|||
145910348|NCT01524978|526175983|FG006|Overall Study|Death|1|||
145910349|NCT01524978|526175984|FG007|Overall Study|Death|9|||
145910350|NCT01524978|526175985|FG008|Overall Study|Death|5|||
145910351|NCT01524978|526175986|FG009|Overall Study|Death|6|||
145910352|NCT01524978|526175987|FG010|Overall Study|Death|17|||
146239240|NCT03389802|527389760|FG000|Overall Study|Lack of Efficacy|3|||
145910353|NCT02165735|526175993|FG000|Overall Study|Lost to Follow-up|12|||
145910354|NCT02165735|526175994|FG001|Overall Study|Lost to Follow-up|10|||
145910355|NCT02165735|526175993|FG000|Overall Study|Withdrawal by Subject|3|||
145910356|NCT02165735|526175994|FG001|Overall Study|Withdrawal by Subject|0|||
145910357|NCT02165735|526175993|FG000|Overall Study|Participant indicated lack of time|1|||
145910358|NCT02165735|526175994|FG001|Overall Study|Participant indicated lack of time|3|||
145910359|NCT02165735|526175993|FG000|Overall Study|Protocol Violation|0|||
145910360|NCT02165735|526175994|FG001|Overall Study|Protocol Violation|1|||
145910361|NCT03066258|526175995|FG000|Overall Study|Death|1|||
145910362|NCT03066258|526175996|FG001|Overall Study|Death|0|||
145910363|NCT03066258|526175997|FG002|Overall Study|Death|0|||
145910364|NCT03066258|526175998|FG003|Overall Study|Death|0|||
145910365|NCT03066258|526175999|FG004|Overall Study|Death|1|||
145910366|NCT02784795|526176000|FG000|Overall Study|Progressive Disease|2|||
145910367|NCT02784795|526176001|FG001|Overall Study|Progressive Disease|1|||
145910368|NCT02784795|526176002|FG002|Overall Study|Progressive Disease|1|||
145910369|NCT02784795|526176003|FG003|Overall Study|Progressive Disease|0|||
145910370|NCT02784795|526176004|FG004|Overall Study|Progressive Disease|2|||
145910371|NCT02784795|526176005|FG005|Overall Study|Progressive Disease|0|||
145910372|NCT02784795|526176006|FG006|Overall Study|Progressive Disease|2|||
145910373|NCT02784795|526176007|FG007|Overall Study|Progressive Disease|0|||
145910374|NCT02784795|526176008|FG008|Overall Study|Progressive Disease|0|||
145910375|NCT02784795|526176009|FG009|Overall Study|Progressive Disease|0|||
145910376|NCT02784795|526176010|FG010|Overall Study|Progressive Disease|1|||
145910377|NCT02784795|526176011|FG011|Overall Study|Progressive Disease|0|||
145910378|NCT02784795|526176000|FG000|Overall Study|Adverse Event|1|||
145910379|NCT02784795|526176001|FG001|Overall Study|Adverse Event|0|||
145910380|NCT02784795|526176002|FG002|Overall Study|Adverse Event|0|||
145910381|NCT02784795|526176003|FG003|Overall Study|Adverse Event|1|||
145910382|NCT02784795|526176004|FG004|Overall Study|Adverse Event|0|||
145910383|NCT02784795|526176005|FG005|Overall Study|Adverse Event|0|||
145910384|NCT02784795|526176006|FG006|Overall Study|Adverse Event|1|||
145910385|NCT02784795|526176007|FG007|Overall Study|Adverse Event|0|||
145910386|NCT02784795|526176008|FG008|Overall Study|Adverse Event|0|||
145910387|NCT02784795|526176009|FG009|Overall Study|Adverse Event|0|||
145910388|NCT02784795|526176010|FG010|Overall Study|Adverse Event|0|||
145910389|NCT02784795|526176011|FG011|Overall Study|Adverse Event|2|||
145910390|NCT02784795|526176000|FG000|Overall Study|Withdrawal by Subject|1|||
145910391|NCT02784795|526176001|FG001|Overall Study|Withdrawal by Subject|0|||
145910392|NCT02784795|526176002|FG002|Overall Study|Withdrawal by Subject|2|||
145910393|NCT02784795|526176003|FG003|Overall Study|Withdrawal by Subject|1|||
145910394|NCT02784795|526176004|FG004|Overall Study|Withdrawal by Subject|3|||
145910395|NCT02784795|526176005|FG005|Overall Study|Withdrawal by Subject|0|||
145910396|NCT02784795|526176006|FG006|Overall Study|Withdrawal by Subject|0|||
145910397|NCT02784795|526176007|FG007|Overall Study|Withdrawal by Subject|1|||
145910398|NCT02784795|526176008|FG008|Overall Study|Withdrawal by Subject|0|||
145910399|NCT02784795|526176009|FG009|Overall Study|Withdrawal by Subject|0|||
145910400|NCT02784795|526176010|FG010|Overall Study|Withdrawal by Subject|0|||
145910401|NCT02784795|526176011|FG011|Overall Study|Withdrawal by Subject|2|||
145910402|NCT02784795|526176000|FG000|Overall Study|Death|0|||
145910403|NCT02784795|526176001|FG001|Overall Study|Death|0|||
145910404|NCT02784795|526176002|FG002|Overall Study|Death|0|||
145910405|NCT02784795|526176003|FG003|Overall Study|Death|0|||
145910406|NCT02784795|526176004|FG004|Overall Study|Death|1|||
145910407|NCT02784795|526176005|FG005|Overall Study|Death|0|||
145910408|NCT02784795|526176006|FG006|Overall Study|Death|0|||
145910409|NCT02784795|526176007|FG007|Overall Study|Death|0|||
145910410|NCT02784795|526176008|FG008|Overall Study|Death|0|||
145910411|NCT02784795|526176009|FG009|Overall Study|Death|0|||
145910412|NCT02784795|526176010|FG010|Overall Study|Death|0|||
145910413|NCT02784795|526176011|FG011|Overall Study|Death|0|||
145910414|NCT02784795|526176000|FG000|Overall Study|Physician Decision|0|||
145910415|NCT02784795|526176001|FG001|Overall Study|Physician Decision|0|||
145910416|NCT02784795|526176002|FG002|Overall Study|Physician Decision|0|||
145910417|NCT02784795|526176003|FG003|Overall Study|Physician Decision|0|||
145910418|NCT02784795|526176004|FG004|Overall Study|Physician Decision|0|||
145910419|NCT02784795|526176005|FG005|Overall Study|Physician Decision|0|||
145910420|NCT02784795|526176006|FG006|Overall Study|Physician Decision|1|||
145910421|NCT02784795|526176007|FG007|Overall Study|Physician Decision|0|||
145910422|NCT02784795|526176008|FG008|Overall Study|Physician Decision|0|||
145910423|NCT02784795|526176009|FG009|Overall Study|Physician Decision|0|||
145910424|NCT02784795|526176010|FG010|Overall Study|Physician Decision|0|||
145910425|NCT02784795|526176011|FG011|Overall Study|Physician Decision|0|||
145910426|NCT02540083|526176014|FG000|Overall Study|Withdrawal by Subject|16|||
145910427|NCT00101283|526176015|FG000|Overall Study|Withdrawal by Subject|0|||
145910428|NCT00101283|526176016|FG001|Overall Study|Withdrawal by Subject|1|||
145910429|NCT00101283|526176015|FG000|Overall Study|Insurance Refusal|0|||
145910430|NCT00101283|526176016|FG001|Overall Study|Insurance Refusal|1|||
145910431|NCT00101283|526176015|FG000|Overall Study|Prostate Cancer Recurrence|0|||
145910432|NCT00101283|526176016|FG001|Overall Study|Prostate Cancer Recurrence|1|||
145910433|NCT02797171|526176017|FG000|Overall Study|Lost to Follow-up|2|||
145910434|NCT02797171|526176018|FG001|Overall Study|Lost to Follow-up|0|||
145910435|NCT02797171|526176019|FG002|Overall Study|Lost to Follow-up|2|||
145910436|NCT02797171|526176020|FG003|Overall Study|Lost to Follow-up|1|||
145910437|NCT02797171|526176021|FG004|Overall Study|Lost to Follow-up|2|||
145910438|NCT02797171|526176022|FG005|Overall Study|Lost to Follow-up|0|||
145910439|NCT02797171|526176017|FG000|Overall Study|Withdrawal by Subject|1|||
145910440|NCT02797171|526176018|FG001|Overall Study|Withdrawal by Subject|1|||
145910441|NCT02797171|526176019|FG002|Overall Study|Withdrawal by Subject|0|||
145910442|NCT02797171|526176020|FG003|Overall Study|Withdrawal by Subject|0|||
145910443|NCT02797171|526176021|FG004|Overall Study|Withdrawal by Subject|0|||
145910444|NCT02797171|526176022|FG005|Overall Study|Withdrawal by Subject|0|||
145910445|NCT02797171|526176017|FG000|Overall Study|Protocol Violation|1|||
145910446|NCT02797171|526176018|FG001|Overall Study|Protocol Violation|0|||
145910447|NCT02797171|526176019|FG002|Overall Study|Protocol Violation|0|||
145910448|NCT02797171|526176020|FG003|Overall Study|Protocol Violation|0|||
145910449|NCT02797171|526176021|FG004|Overall Study|Protocol Violation|0|||
145910450|NCT02797171|526176022|FG005|Overall Study|Protocol Violation|0|||
145910451|NCT02797171|526176017|FG000|Overall Study|Participant unable to adhere|0|||
145910452|NCT02797171|526176018|FG001|Overall Study|Participant unable to adhere|1|||
145910453|NCT02797171|526176019|FG002|Overall Study|Participant unable to adhere|0|||
145910454|NCT02797171|526176020|FG003|Overall Study|Participant unable to adhere|0|||
145910455|NCT02797171|526176021|FG004|Overall Study|Participant unable to adhere|0|||
145910456|NCT02797171|526176022|FG005|Overall Study|Participant unable to adhere|0|||
145910457|NCT02797171|526176017|FG000|Overall Study|Not Randomized|0|||
145910458|NCT02797171|526176018|FG001|Overall Study|Not Randomized|0|||
145910459|NCT02797171|526176019|FG002|Overall Study|Not Randomized|0|||
145910460|NCT02797171|526176020|FG003|Overall Study|Not Randomized|0|||
145910461|NCT02797171|526176021|FG004|Overall Study|Not Randomized|0|||
145910462|NCT02797171|526176022|FG005|Overall Study|Not Randomized|1|||
145910463|NCT00595309|526176023|FG000|Overall Study|Lost to Follow-up|1|||
145910464|NCT00595309|526176023|FG000|Overall Study|planned vaccination against yellow fever|1|||
145910465|NCT00595309|526176023|FG000|Overall Study|acute infection after V0|1|||
145910466|NCT00595309|526176023|FG000|Overall Study|personal reason|1|||
145910467|NCT01372748|526176026|FG000|Overall Study|Lost to Follow-up|16|||
145910468|NCT01372748|526176027|FG001|Overall Study|Lost to Follow-up|34|||
145910469|NCT01372748|526176026|FG000|Overall Study|Withdrawal by Subject|7|||
145910470|NCT01372748|526176027|FG001|Overall Study|Withdrawal by Subject|5|||
145910471|NCT00134901|526176028|FG000|Overall Study|Lost to Follow-up|5|||
145910472|NCT00134901|526176029|FG001|Overall Study|Lost to Follow-up|5|||
145910473|NCT00134901|526176028|FG000|Overall Study|discontinued intervention|12|||
145910474|NCT00134901|526176029|FG001|Overall Study|discontinued intervention|10|||
145910475|NCT02301390|526176032|FG000|Overall Study|Withdrawal by Subject|3|||
145910476|NCT02301390|526176033|FG001|Overall Study|Withdrawal by Subject|5|||
145910477|NCT02301390|526176032|FG000|Overall Study|Protocol Violation|1|||
145910478|NCT02301390|526176033|FG001|Overall Study|Protocol Violation|0|||
145910479|NCT02301390|526176032|FG000|Overall Study|Physician Decision|1|||
145910480|NCT02301390|526176033|FG001|Overall Study|Physician Decision|0|||
145910481|NCT02301390|526176032|FG000|Overall Study|Lost to Follow-up|0|||
145910482|NCT02301390|526176033|FG001|Overall Study|Lost to Follow-up|1|||
145910483|NCT02301390|526176032|FG000|Overall Study|Death|2|||
145910484|NCT02301390|526176033|FG001|Overall Study|Death|2|||
145910485|NCT02301390|526176032|FG000|Overall Study|Procedure not completed|0|||
145910486|NCT02301390|526176033|FG001|Overall Study|Procedure not completed|4|||
145910487|NCT02301390|526176032|FG000|Overall Study|Missed multiple visits|1|||
145910488|NCT02301390|526176033|FG001|Overall Study|Missed multiple visits|1|||
145973158|NCT03282097|526414208|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
145973159|NCT03282097|526414207|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
145973160|NCT03282097|526414208|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
145910489|NCT02301390|526176032|FG000|Overall Study|study terminated|2|||
145910490|NCT02301390|526176033|FG001|Overall Study|study terminated|0|||
145910491|NCT00185588|526176034|FG000|Overall Study|Adverse Event|3|||
145910492|NCT00185588|526176035|FG001|Overall Study|Adverse Event|1|||
145910493|NCT00185588|526176036|FG002|Overall Study|Adverse Event|4|||
145910494|NCT00185588|526176037|FG003|Overall Study|Adverse Event|2|||
145910495|NCT00185588|526176034|FG000|Overall Study|Lost to Follow-up|0|||
145910496|NCT00185588|526176035|FG001|Overall Study|Lost to Follow-up|0|||
145910497|NCT00185588|526176036|FG002|Overall Study|Lost to Follow-up|1|||
145910498|NCT00185588|526176037|FG003|Overall Study|Lost to Follow-up|2|||
145910499|NCT00185588|526176034|FG000|Overall Study|Withdrawal by Subject|0|||
145910500|NCT00185588|526176035|FG001|Overall Study|Withdrawal by Subject|1|||
145910501|NCT00185588|526176036|FG002|Overall Study|Withdrawal by Subject|0|||
145910502|NCT00185588|526176037|FG003|Overall Study|Withdrawal by Subject|0|||
145910503|NCT00185588|526176034|FG000|Overall Study|Physician Decision|0|||
145973161|NCT03282097|526414207|FG000|Primary Outcome Data Collection Complete|Missing|2|||
145973162|NCT03282097|526414208|FG001|Primary Outcome Data Collection Complete|Missing|3|||
145973163|NCT03282097|526414207|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
145973164|NCT03282097|526414208|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
145910504|NCT00185588|526176035|FG001|Overall Study|Physician Decision|0|||
145910505|NCT00185588|526176036|FG002|Overall Study|Physician Decision|1|||
146239241|NCT03389802|527389761|FG001|Overall Study|Lack of Efficacy|3|||
145910506|NCT00185588|526176037|FG003|Overall Study|Physician Decision|0|||
145910507|NCT00398866|526176038|FG000|Overall Study|Adverse Event|1|||
145910508|NCT00398866|526176039|FG001|Overall Study|Adverse Event|0|||
145910509|NCT00398866|526176040|FG002|Overall Study|Adverse Event|0|||
145910510|NCT00398866|526176038|FG000|Overall Study|Lack of Efficacy|0|||
145910511|NCT00398866|526176039|FG001|Overall Study|Lack of Efficacy|0|||
145910512|NCT00398866|526176040|FG002|Overall Study|Lack of Efficacy|1|||
145910513|NCT00398866|526176038|FG000|Overall Study|Lost to Follow-up|7|||
145910514|NCT00398866|526176039|FG001|Overall Study|Lost to Follow-up|6|||
145910515|NCT00398866|526176040|FG002|Overall Study|Lost to Follow-up|4|||
145910516|NCT00398866|526176038|FG000|Overall Study|Withdrawal by Subject|5|||
145910517|NCT00398866|526176039|FG001|Overall Study|Withdrawal by Subject|1|||
145910518|NCT00398866|526176040|FG002|Overall Study|Withdrawal by Subject|2|||
145910519|NCT00398866|526176038|FG000|Overall Study|Unable to complete requirements of study|1|||
145910520|NCT00398866|526176039|FG001|Overall Study|Unable to complete requirements of study|1|||
145910521|NCT00398866|526176040|FG002|Overall Study|Unable to complete requirements of study|1|||
145910522|NCT02481869|526176041|FG000|Overall Study|Lost to Follow-up|3|||
145910523|NCT02481869|526176042|FG001|Overall Study|Lost to Follow-up|4|||
145910524|NCT02481869|526176041|FG000|Overall Study|Withdrawal by Subject|2|||
145910525|NCT02481869|526176042|FG001|Overall Study|Withdrawal by Subject|0|||
145910526|NCT03908437|526176045|FG000|Overall Study|Death|0|||
145910527|NCT03908437|526176046|FG001|Overall Study|Death|1|||
145910528|NCT03908437|526176045|FG000|Overall Study|Lost to Follow-up|31|||
145910529|NCT03908437|526176046|FG001|Overall Study|Lost to Follow-up|24|||
145910530|NCT00442962|526176047|FG000|Overall Study|Pregnancy|1|||
145910531|NCT00442962|526176047|FG000|Overall Study|Lost to Follow-up|7|||
145910532|NCT04238650|526176048|FG000|Overall Study|Withdrawal by Subject|0|||
145910533|NCT04238650|526176049|FG001|Overall Study|Withdrawal by Subject|1|||
145910534|NCT03633825|526176050|FG000|Enrollment|Did not post on network|5066|||
145910535|NCT03633825|526176051|FG001|Enrollment|Did not post on network|5080|||
145910536|NCT03633825|526176050|FG000|Enrollment|Post not classified as crisis|13967|||
145910537|NCT03633825|526176051|FG001|Enrollment|Post not classified as crisis|13757|||
145910538|NCT03633825|526176050|FG000|Follow up|Lost to Follow-up|478|||
145910539|NCT03633825|526176051|FG001|Follow up|Lost to Follow-up|450|||
145910540|NCT04759768|526176056|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
145910541|NCT04759768|526176057|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
145910542|NCT04759768|526176056|FG000|Washout (7 Days)|Physician Decision|0|||
145910543|NCT04759768|526176057|FG001|Washout (7 Days)|Physician Decision|1|||
145910544|NCT01128543|526176058|FG000|Overall Study|Withdrawal by Subject|3|||
145910545|NCT01128543|526176058|FG000|Overall Study|Protocol Violation|1|||
145910546|NCT02676765|526176059|FG000|Overall Study|Lost to Follow-up|0|||
145910547|NCT02676765|526176060|FG001|Overall Study|Lost to Follow-up|1|||
145910548|NCT02374346|526176061|FG000|Overall Study|operated or discharged during weekend|48|||
145910549|NCT04487067|526176071|FG000|Overall Study|Adverse Event|3|||
145910550|NCT04487067|526176071|FG000|Overall Study|Death Other Than Progressive Disease|60|||
145910551|NCT04487067|526176071|FG000|Overall Study|Death Due To Progressive Disease|40|||
145910552|NCT04487067|526176071|FG000|Overall Study|Lost to Follow-up|3|||
145910553|NCT04487067|526176071|FG000|Overall Study|Progressive Disease|1|||
145910554|NCT04487067|526176071|FG000|Overall Study|Protocol Violation|3|||
145910555|NCT04487067|526176071|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
145910556|NCT04487067|526176071|FG000|Overall Study|Withdrawal by Subject|15|||
145910557|NCT00246324|526176072|FG000|Overall Study|Withdrawal by Subject|1|||
145910558|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
145910559|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
145910560|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
145910561|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Death|1|||
145910562|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Death|3|||
146297427|NCT01641809|527604694|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
146297428|NCT01641809|527604695|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
146297429|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
146297430|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
145910563|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Death|1|||
145910564|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
145910565|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
145910566|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
145910567|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
145910568|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
145910569|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
145910570|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
145910571|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
145910572|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
145910573|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
145910574|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
145910575|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
145910576|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
145910577|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
145910578|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
145910579|NCT00299130|526176073|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
145910580|NCT00299130|526176074|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
145910581|NCT00299130|526176075|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
145910582|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
145910583|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
145910584|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
145910585|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
145910586|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
145910587|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
145910588|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
145910589|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
145910590|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
145910591|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
145910592|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
145910593|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
145910594|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
145910595|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
145910596|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
145910597|NCT00299130|526176073|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
145910598|NCT00299130|526176074|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
145910599|NCT00299130|526176075|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
145910600|NCT00299130|526176073|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
145910601|NCT00299130|526176074|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
145910602|NCT00299130|526176075|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
145910603|NCT00299130|526176073|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
145910604|NCT00299130|526176074|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
145910605|NCT00299130|526176075|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
145910606|NCT00299130|526176073|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
145910607|NCT00299130|526176074|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
145910608|NCT00299130|526176075|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
145910609|NCT00345631|526176078|FG000|Overall Study|Withdrawal by Subject|1|||
145910610|NCT00345631|526176079|FG001|Overall Study|Withdrawal by Subject|0|||
145910611|NCT00345631|526176080|FG002|Overall Study|Withdrawal by Subject|1|||
145910612|NCT00345631|526176078|FG000|Overall Study|Adverse Event|0|||
145910613|NCT00345631|526176079|FG001|Overall Study|Adverse Event|1|||
145910614|NCT00345631|526176080|FG002|Overall Study|Adverse Event|0|||
145910615|NCT00345631|526176078|FG000|Overall Study|Lost to Follow-up|3|||
145910616|NCT00345631|526176079|FG001|Overall Study|Lost to Follow-up|7|||
145910617|NCT00345631|526176080|FG002|Overall Study|Lost to Follow-up|4|||
145910618|NCT00345631|526176078|FG000|Overall Study|Other reasons|0|||
145910619|NCT00345631|526176079|FG001|Overall Study|Other reasons|0|||
145910620|NCT00345631|526176080|FG002|Overall Study|Other reasons|1|||
145910621|NCT01130597|526176088|FG000|Overall Study|Protocol-specified (High K+)|1|||
145910622|NCT01130597|526176088|FG000|Overall Study|Adverse Event|4|||
145910623|NCT01130597|526176088|FG000|Overall Study|Death|1|||
145910624|NCT01130597|526176088|FG000|Overall Study|Protocol Violation|1|||
145910625|NCT03371459|526176089|FG000|Washout|Lost to Follow-up|0|||
145910626|NCT03371459|526176090|FG001|Washout|Lost to Follow-up|1|||
145910627|NCT03922529|526178364|FG000|Overall Study|Withdrawal by Subject|13|||
145910628|NCT03922529|526178365|FG001|Overall Study|Withdrawal by Subject|12|||
145910629|NCT03922529|526178364|FG000|Overall Study|Death|7|||
145910630|NCT03922529|526178365|FG001|Overall Study|Death|12|||
145910631|NCT03922529|526178364|FG000|Overall Study|Lost to Follow-up|12|||
145910632|NCT03922529|526178365|FG001|Overall Study|Lost to Follow-up|19|||
145910633|NCT03922529|526178364|FG000|Overall Study|Adverse Event|1|||
145910634|NCT03922529|526178365|FG001|Overall Study|Adverse Event|0|||
145910635|NCT03922529|526178364|FG000|Overall Study|Death after withdrawal|1|||
145910636|NCT03922529|526178365|FG001|Overall Study|Death after withdrawal|0|||
145910637|NCT03922529|526178364|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
145910638|NCT03922529|526178365|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
145910639|NCT03922529|526178364|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
145910640|NCT03922529|526178365|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
145910641|NCT02017015|526178366|FG000|Overall Study|Adverse Event|9|||
145910642|NCT02017015|526178366|FG000|Overall Study|Withdrawal by Subject|21|||
145910643|NCT02017015|526178366|FG000|Overall Study|Death|4|||
145910644|NCT02017015|526178366|FG000|Overall Study|Progressive Disease|31|||
145910645|NCT02017015|526178366|FG000|Overall Study|Non-compliance with study drug|2|||
145973165|NCT03282097|526414207|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
145973166|NCT03282097|526414208|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
145973167|NCT03282097|526414207|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
145910646|NCT02017015|526178366|FG000|Overall Study|Physician Decision|2|||
145910647|NCT01277601|526178369|FG000|Overall Study|Adverse Event|5|||
145910648|NCT01277601|526178370|FG001|Overall Study|Adverse Event|3|||
145910649|NCT01277601|526178371|FG002|Overall Study|Adverse Event|0|||
145910650|NCT01277601|526178372|FG003|Overall Study|Adverse Event|7|||
145910651|NCT01277601|526178369|FG000|Overall Study|Withdrawal by Subject|18|||
145910652|NCT01277601|526178370|FG001|Overall Study|Withdrawal by Subject|21|||
145910653|NCT01277601|526178371|FG002|Overall Study|Withdrawal by Subject|8|||
145910654|NCT01277601|526178372|FG003|Overall Study|Withdrawal by Subject|17|||
145910655|NCT01277601|526178369|FG000|Overall Study|Lost to Follow-up|7|||
145910656|NCT01277601|526178370|FG001|Overall Study|Lost to Follow-up|9|||
145910657|NCT01277601|526178371|FG002|Overall Study|Lost to Follow-up|4|||
145910658|NCT01277601|526178372|FG003|Overall Study|Lost to Follow-up|2|||
145910659|NCT01277601|526178369|FG000|Overall Study|Physician Decision|3|||
145910660|NCT01277601|526178370|FG001|Overall Study|Physician Decision|5|||
145910661|NCT01277601|526178371|FG002|Overall Study|Physician Decision|1|||
145910662|NCT01277601|526178372|FG003|Overall Study|Physician Decision|6|||
145910663|NCT01277601|526178369|FG000|Overall Study|Pregnancy|2|||
145910664|NCT01277601|526178370|FG001|Overall Study|Pregnancy|2|||
145910665|NCT01277601|526178371|FG002|Overall Study|Pregnancy|4|||
145910666|NCT01277601|526178372|FG003|Overall Study|Pregnancy|1|||
145910667|NCT01277601|526178369|FG000|Overall Study|Noncompliance with Study Drug|1|||
145910668|NCT01277601|526178370|FG001|Overall Study|Noncompliance with Study Drug|3|||
145910669|NCT01277601|526178371|FG002|Overall Study|Noncompliance with Study Drug|2|||
145910670|NCT01277601|526178372|FG003|Overall Study|Noncompliance with Study Drug|0|||
145910671|NCT01277601|526178369|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
145910672|NCT01277601|526178370|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
145910673|NCT01277601|526178371|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
145910674|NCT01277601|526178372|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
145910675|NCT01277601|526178369|FG000|Overall Study|Protocol Violation|0|||
145910676|NCT01277601|526178370|FG001|Overall Study|Protocol Violation|2|||
145910677|NCT01277601|526178371|FG002|Overall Study|Protocol Violation|5|||
145910678|NCT01277601|526178372|FG003|Overall Study|Protocol Violation|0|||
145910679|NCT01277601|526178369|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
145910680|NCT01277601|526178370|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
145910681|NCT01277601|526178371|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
145910682|NCT01277601|526178372|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
145910683|NCT04034927|526178373|FG000|Overall Study|Adverse Event|4|||
145910684|NCT04034927|526178374|FG001|Overall Study|Adverse Event|9|||
145910685|NCT04034927|526178373|FG000|Overall Study|Death|0|||
145910686|NCT04034927|526178374|FG001|Overall Study|Death|1|||
145910687|NCT04034927|526178373|FG000|Overall Study|Withdrawal by Subject|0|||
145910688|NCT04034927|526178374|FG001|Overall Study|Withdrawal by Subject|3|||
145910689|NCT04034927|526178373|FG000|Overall Study|Still on Treatment|2|||
145910690|NCT04034927|526178374|FG001|Overall Study|Still on Treatment|1|||
145910691|NCT04034927|526178373|FG000|Overall Study|Other|1|||
145910692|NCT04034927|526178374|FG001|Overall Study|Other|1|||
145910693|NCT04158245|526178375|FG000|Overall Study|Lost to Follow-up|1|||
145910694|NCT02291510|526178376|FG000|Overall Study|Adverse Event|0|||
145910695|NCT02291510|526178377|FG001|Overall Study|Adverse Event|0|||
145910696|NCT02291510|526178378|FG002|Overall Study|Adverse Event|0|||
145910697|NCT02291510|526178379|FG003|Overall Study|Adverse Event|1|||
145910698|NCT01433055|526178383|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
145910699|NCT01433055|526178384|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
145910700|NCT01433055|526178383|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
145910701|NCT01433055|526178384|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
145910702|NCT00678210|526178389|FG000|Overall Study|Adverse Event|1|||
145910703|NCT00678210|526178390|FG001|Overall Study|Adverse Event|2|||
145910704|NCT00678210|526178391|FG002|Overall Study|Adverse Event|3|||
145910705|NCT00678210|526178392|FG003|Overall Study|Adverse Event|3|||
145910706|NCT00678210|526178389|FG000|Overall Study|Lack of Efficacy|2|||
145910707|NCT00678210|526178390|FG001|Overall Study|Lack of Efficacy|3|||
145910708|NCT00678210|526178391|FG002|Overall Study|Lack of Efficacy|1|||
145910709|NCT00678210|526178392|FG003|Overall Study|Lack of Efficacy|9|||
145910710|NCT00678210|526178389|FG000|Overall Study|Lost to Follow-up|4|||
145910711|NCT00678210|526178390|FG001|Overall Study|Lost to Follow-up|2|||
145910712|NCT00678210|526178391|FG002|Overall Study|Lost to Follow-up|0|||
145973168|NCT03282097|526414208|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
145973169|NCT02755090|526414212|FG000|Overall Study|equipment malfunction|1|||
145910713|NCT00678210|526178392|FG003|Overall Study|Lost to Follow-up|1|||
145910714|NCT00678210|526178389|FG000|Overall Study|Withdrawal by Subject|3|||
145910715|NCT00678210|526178390|FG001|Overall Study|Withdrawal by Subject|4|||
145910716|NCT00678210|526178391|FG002|Overall Study|Withdrawal by Subject|1|||
145910717|NCT00678210|526178392|FG003|Overall Study|Withdrawal by Subject|7|||
145910718|NCT00678210|526178389|FG000|Overall Study|Other|1|||
145910719|NCT00678210|526178390|FG001|Overall Study|Other|0|||
145910720|NCT00678210|526178391|FG002|Overall Study|Other|1|||
145910721|NCT00678210|526178392|FG003|Overall Study|Other|0|||
145910722|NCT04825912|526178393|FG000|Overall Study|Death|3|||
145910723|NCT04825912|526178393|FG000|Overall Study|Withdrawal by Subject|1|||
145910724|NCT00855894|526178394|FG000|Overall Study|Death|31|||
145910725|NCT00855894|526178394|FG000|Overall Study|Patient's decision|1|||
145910726|NCT00855894|526178394|FG000|Overall Study|Disease progression|1|||
145910727|NCT03055624|526178395|FG000|Overall Study|Study closed|9|||
145910728|NCT00191191|526178405|FG000|Overall Study|Entry Criteria Exclusion|2|||
145910729|NCT00191191|526178406|FG001|Overall Study|Entry Criteria Exclusion|0|||
145910730|NCT00191191|526178405|FG000|Overall Study|Treated with Another Systemic Agent|1|||
145910731|NCT00191191|526178406|FG001|Overall Study|Treated with Another Systemic Agent|1|||
145910732|NCT00191191|526178405|FG000|Overall Study|Adverse Event|11|||
145910733|NCT00191191|526178406|FG001|Overall Study|Adverse Event|21|||
145910734|NCT00191191|526178405|FG000|Overall Study|Progressive Disease|84|||
145910735|NCT00191191|526178406|FG001|Overall Study|Progressive Disease|72|||
145910736|NCT00191191|526178405|FG000|Overall Study|Toxicity After Dose Reduction|7|||
145910737|NCT00191191|526178406|FG001|Overall Study|Toxicity After Dose Reduction|8|||
145910738|NCT00191191|526178405|FG000|Overall Study|Family/Caregiver Decision|5|||
145910739|NCT00191191|526178406|FG001|Overall Study|Family/Caregiver Decision|7|||
145910740|NCT00191191|526178405|FG000|Overall Study|Lost to Follow-up|1|||
145910741|NCT00191191|526178406|FG001|Overall Study|Lost to Follow-up|0|||
145910742|NCT00191191|526178405|FG000|Overall Study|Physician Decision|3|||
145910743|NCT00191191|526178406|FG001|Overall Study|Physician Decision|2|||
145910744|NCT00191191|526178405|FG000|Overall Study|Good Clinical Practice Violation|0|||
145910745|NCT00191191|526178406|FG001|Overall Study|Good Clinical Practice Violation|1|||
145910746|NCT05246670|526178407|FG000|Overall Study|Withdrawal by Subject|2|||
145910747|NCT05246670|526178408|FG001|Overall Study|Withdrawal by Subject|3|||
145910748|NCT05246670|526178409|FG002|Overall Study|Withdrawal by Subject|0|||
145910749|NCT05246670|526178410|FG003|Overall Study|Withdrawal by Subject|1|||
145910750|NCT05246670|526178407|FG000|Overall Study|Adverse Event|0|||
145910751|NCT05246670|526178408|FG001|Overall Study|Adverse Event|0|||
145910752|NCT05246670|526178409|FG002|Overall Study|Adverse Event|1|||
145910753|NCT05246670|526178410|FG003|Overall Study|Adverse Event|0|||
145910754|NCT05246670|526178407|FG000|Overall Study|Physician Decision|1|||
145910755|NCT05246670|526178408|FG001|Overall Study|Physician Decision|0|||
145910756|NCT05246670|526178409|FG002|Overall Study|Physician Decision|0|||
145910757|NCT05246670|526178410|FG003|Overall Study|Physician Decision|0|||
145910758|NCT05246670|526178407|FG000|Overall Study|Protocol Violation|1|||
145910759|NCT05246670|526178408|FG001|Overall Study|Protocol Violation|0|||
145910760|NCT05246670|526178409|FG002|Overall Study|Protocol Violation|0|||
145910761|NCT05246670|526178410|FG003|Overall Study|Protocol Violation|0|||
145910762|NCT04152291|526178411|FG000|Overall Study|Covid-19 restrictions|27|||
145910763|NCT04152291|526178411|FG000|Overall Study|Withdrawal by Subject|3|||
145910764|NCT03597295|526178412|FG000|Overall Study|Death|70|||
145910765|NCT03597295|526178412|FG000|Overall Study|Lost to Follow-up|7|||
145910766|NCT05124691|526178413|FG000|Phase II|Eligibility criteria|0|||
145910767|NCT05124691|526178414|FG001|Phase II|Eligibility criteria|1|||
145910768|NCT05124691|526178415|FG002|Phase II|Eligibility criteria|0|||
145910769|NCT05124691|526178413|FG000|Phase II|Withdrawal by Subject|6|||
145910770|NCT05124691|526178414|FG001|Phase II|Withdrawal by Subject|2|||
145910771|NCT05124691|526178415|FG002|Phase II|Withdrawal by Subject|3|||
145910772|NCT05124691|526178413|FG000|Phase III|Withdrawal by Subject|6|||
145910773|NCT05124691|526178414|FG001|Phase III|Withdrawal by Subject|4|||
145910774|NCT05124691|526178415|FG002|Phase III|Withdrawal by Subject|4|||
145910775|NCT05124691|526178413|FG000|Phase III|Lost to Follow-up|1|||
145910776|NCT05124691|526178414|FG001|Phase III|Lost to Follow-up|0|||
145910777|NCT05124691|526178415|FG002|Phase III|Lost to Follow-up|0|||
145973170|NCT02755090|526414213|FG001|Overall Study|equipment malfunction|0|||
145973171|NCT01564407|526414215|FG000|Overall Study|Lost to Follow-up|0|||
145973172|NCT01564407|526414216|FG001|Overall Study|Lost to Follow-up|1|||
145973173|NCT01564407|526414217|FG002|Overall Study|Lost to Follow-up|0|||
145973174|NCT01564407|526414218|FG003|Overall Study|Lost to Follow-up|0|||
145973175|NCT01564407|526414219|FG004|Overall Study|Lost to Follow-up|0|||
145910778|NCT05211726|526178416|FG000|Overall Study|Withdrawal by Subject|2|||
145910779|NCT05211726|526178417|FG001|Overall Study|Withdrawal by Subject|3|||
145910780|NCT05211726|526178416|FG000|Overall Study|Protocol Violation|0|||
145910781|NCT05211726|526178417|FG001|Overall Study|Protocol Violation|1|||
145910782|NCT03509467|526178418|FG000|Overall Study|Withdrawal by Subject|5|||
145910783|NCT03509467|526178419|FG001|Overall Study|Withdrawal by Subject|1|||
145973176|NCT01564407|526414215|FG000|Overall Study|Withdrawal by Subject|0|||
145973177|NCT01564407|526414216|FG001|Overall Study|Withdrawal by Subject|1|||
145973178|NCT01564407|526414217|FG002|Overall Study|Withdrawal by Subject|0|||
145910784|NCT03509467|526178420|FG002|Overall Study|Withdrawal by Subject|6|||
145910785|NCT03509467|526178421|FG003|Overall Study|Withdrawal by Subject|7|||
145910786|NCT03509467|526178422|FG004|Overall Study|Withdrawal by Subject|10|||
145910787|NCT03509467|526178423|FG005|Overall Study|Withdrawal by Subject|10|||
145910788|NCT03509467|526178424|FG006|Overall Study|Withdrawal by Subject|10|||
145910789|NCT03509467|526178425|FG007|Overall Study|Withdrawal by Subject|10|||
145910790|NCT03509467|526178418|FG000|Overall Study|Death|0|||
145910791|NCT03509467|526178419|FG001|Overall Study|Death|0|||
145973179|NCT01564407|526414218|FG003|Overall Study|Withdrawal by Subject|0|||
145973180|NCT01564407|526414219|FG004|Overall Study|Withdrawal by Subject|0|||
145973181|NCT01564407|526414215|FG000|Overall Study|funding lost, study ended|0|||
145973182|NCT01564407|526414216|FG001|Overall Study|funding lost, study ended|0|||
145973183|NCT01564407|526414217|FG002|Overall Study|funding lost, study ended|0|||
145973184|NCT01564407|526414218|FG003|Overall Study|funding lost, study ended|1|||
145973185|NCT01564407|526414219|FG004|Overall Study|funding lost, study ended|0|||
145973186|NCT05049122|526414220|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
145973187|NCT05049122|526414220|FG000|Overall Study|Participant moved|1|||
145910792|NCT03509467|526178420|FG002|Overall Study|Death|2|||
146239242|NCT03389802|527389762|FG002|Overall Study|Lack of Efficacy|13|||
145910793|NCT03509467|526178421|FG003|Overall Study|Death|2|||
145910794|NCT03509467|526178422|FG004|Overall Study|Death|1|||
145910795|NCT03509467|526178423|FG005|Overall Study|Death|0|||
145910796|NCT03509467|526178424|FG006|Overall Study|Death|1|||
145910797|NCT03509467|526178425|FG007|Overall Study|Death|0|||
145910798|NCT03509467|526178418|FG000|Overall Study|Proxy Withdrawal|0|||
145910799|NCT03509467|526178419|FG001|Overall Study|Proxy Withdrawal|0|||
145910800|NCT03509467|526178420|FG002|Overall Study|Proxy Withdrawal|0|||
145910801|NCT03509467|526178421|FG003|Overall Study|Proxy Withdrawal|0|||
145910802|NCT03509467|526178422|FG004|Overall Study|Proxy Withdrawal|0|||
145910803|NCT03509467|526178423|FG005|Overall Study|Proxy Withdrawal|0|||
145910804|NCT03509467|526178424|FG006|Overall Study|Proxy Withdrawal|0|||
145910805|NCT03509467|526178425|FG007|Overall Study|Proxy Withdrawal|1|||
145910806|NCT00428116|526178426|FG000|Overall Study|Death|1|||
145910807|NCT00428116|526178427|FG001|Overall Study|Death|0|||
145910808|NCT00428116|526178426|FG000|Overall Study|Withdrawal by Subject|1|||
145910809|NCT00428116|526178427|FG001|Overall Study|Withdrawal by Subject|0|||
145910810|NCT00428116|526178426|FG000|Overall Study|Lost to Follow-up|1|||
145910811|NCT00428116|526178427|FG001|Overall Study|Lost to Follow-up|0|||
145910812|NCT01141205|526178428|FG000|Overall Study|Physician Decision|1|||
145910813|NCT01141205|526178429|FG001|Overall Study|Physician Decision|1|||
145910814|NCT01141205|526178428|FG000|Overall Study|Lost to Follow-up|1|||
145910815|NCT01141205|526178429|FG001|Overall Study|Lost to Follow-up|0|||
145910816|NCT01141205|526178428|FG000|Overall Study|Withdrawal by Subject|1|||
145910817|NCT01141205|526178429|FG001|Overall Study|Withdrawal by Subject|1|||
145910818|NCT01685840|526178432|FG000|Overall Study|Death|77|||
145910819|NCT01685840|526178433|FG001|Overall Study|Death|66|||
145910820|NCT01685840|526178432|FG000|Overall Study|Lost to Follow-up|27|||
145910821|NCT01685840|526178433|FG001|Overall Study|Lost to Follow-up|25|||
145910822|NCT01685840|526178432|FG000|Overall Study|Physician Decision|3|||
145910823|NCT01685840|526178433|FG001|Overall Study|Physician Decision|7|||
145910824|NCT01685840|526178432|FG000|Overall Study|Withdrawal by Subject|14|||
145910825|NCT01685840|526178433|FG001|Overall Study|Withdrawal by Subject|17|||
145910826|NCT01685840|526178432|FG000|Overall Study|Futility|197|||
145910827|NCT01685840|526178433|FG001|Overall Study|Futility|200|||
145910828|NCT01685840|526178432|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
145910829|NCT01685840|526178433|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
145910830|NCT00710866|526178434|FG000|Overall Study|Protocol Violation|5|||
145910831|NCT00710866|526178435|FG001|Overall Study|Protocol Violation|4|||
145910832|NCT00710866|526178434|FG000|Overall Study|Withdrawal by Subject|2|||
145910833|NCT00710866|526178435|FG001|Overall Study|Withdrawal by Subject|1|||
145910834|NCT00710866|526178434|FG000|Overall Study|Lost to Follow-up|1|||
145910835|NCT00710866|526178435|FG001|Overall Study|Lost to Follow-up|0|||
145910836|NCT00710866|526178434|FG000|Overall Study|Failed to meet eligibility|1|||
145910837|NCT00710866|526178435|FG001|Overall Study|Failed to meet eligibility|1|||
145910838|NCT03340974|526178440|FG000|Completion of Study -Long Term Follow up|Death|8|||
145910839|NCT03340974|526178441|FG001|Completion of Study -Long Term Follow up|Death|5|||
145910840|NCT03340974|526178442|FG002|Completion of Study -Long Term Follow up|Death|5|||
145973188|NCT05049122|526414220|FG000|Overall Study|At the direction of the doctor|1|||
145973189|NCT05722015|526414221|FG000|Overall Study|Death|57|||
145973190|NCT05722015|526414222|FG001|Overall Study|Death|37|||
145973191|NCT05722015|526414221|FG000|Overall Study|Lost to Follow-up|1|||
145973192|NCT05722015|526414222|FG001|Overall Study|Lost to Follow-up|0|||
145973193|NCT05722015|526414221|FG000|Overall Study|Withdrawal by Subject|5|||
146239243|NCT03389802|527389763|FG003|Overall Study|Lack of Efficacy|6|||
146239244|NCT03389802|527389764|FG004|Overall Study|Lack of Efficacy|1|||
146239245|NCT03389802|527389760|FG000|Overall Study|Adverse Event|0|||
146239246|NCT03389802|527389761|FG001|Overall Study|Adverse Event|0|||
146239247|NCT03389802|527389762|FG002|Overall Study|Adverse Event|1|||
146239248|NCT03389802|527389763|FG003|Overall Study|Adverse Event|0|||
146239249|NCT03389802|527389764|FG004|Overall Study|Adverse Event|4|||
146239250|NCT03389802|527389760|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
146297431|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
146297432|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
145910841|NCT03340974|526178443|FG003|Completion of Study -Long Term Follow up|Death|7|||
145910842|NCT03340974|526178440|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
145910843|NCT03340974|526178441|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
145910844|NCT03340974|526178442|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
145910845|NCT03340974|526178443|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
145910846|NCT03340974|526178440|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
145910847|NCT03340974|526178441|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
145910848|NCT03340974|526178442|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
145910849|NCT03340974|526178443|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
145910850|NCT03340974|526178440|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
145910851|NCT03340974|526178441|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
145910852|NCT03340974|526178442|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
145910853|NCT03340974|526178443|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
145910854|NCT00396565|526178444|FG000|Overall Study|Physician Decision|3|||
145910855|NCT00396565|526178445|FG001|Overall Study|Physician Decision|1|||
145910856|NCT00396565|526178446|FG002|Overall Study|Physician Decision|2|||
145910857|NCT00396565|526178444|FG000|Overall Study|Adverse Event|5|||
145910858|NCT00396565|526178445|FG001|Overall Study|Adverse Event|13|||
145910859|NCT00396565|526178446|FG002|Overall Study|Adverse Event|3|||
145910860|NCT00396565|526178444|FG000|Overall Study|Withdrawal by Subject|8|||
145910861|NCT00396565|526178445|FG001|Overall Study|Withdrawal by Subject|13|||
145910862|NCT00396565|526178446|FG002|Overall Study|Withdrawal by Subject|1|||
145910863|NCT00396565|526178444|FG000|Overall Study|Lack of Efficacy|32|||
145910864|NCT00396565|526178445|FG001|Overall Study|Lack of Efficacy|64|||
145910865|NCT00396565|526178446|FG002|Overall Study|Lack of Efficacy|11|||
145910866|NCT04324021|526178447|FG000|Overall Study|Adverse Event|1|||
145910867|NCT04324021|526178448|FG001|Overall Study|Adverse Event|0|||
145910868|NCT04324021|526178449|FG002|Overall Study|Adverse Event|0|||
145910869|NCT04324021|526178447|FG000|Overall Study|Lack of Efficacy|0|||
145910870|NCT04324021|526178448|FG001|Overall Study|Lack of Efficacy|0|||
145910871|NCT04324021|526178449|FG002|Overall Study|Lack of Efficacy|1|||
145910872|NCT04324021|526178447|FG000|Overall Study|Death|1|||
145910873|NCT04324021|526178448|FG001|Overall Study|Death|1|||
145910874|NCT04324021|526178449|FG002|Overall Study|Death|0|||
145910875|NCT04877457|526178450|FG000|Overall Study|Early termination of study due to low enrollment|2|||
145910876|NCT04877457|526178451|FG001|Overall Study|Early termination of study due to low enrollment|1|||
145910877|NCT02006732|526178452|FG000|Overall Study|Adverse Event|10|||
145910878|NCT02006732|526178453|FG001|Overall Study|Adverse Event|7|||
145910879|NCT02006732|526178454|FG002|Overall Study|Adverse Event|4|||
145910880|NCT02006732|526178455|FG003|Overall Study|Adverse Event|2|||
145910881|NCT02006732|526178452|FG000|Overall Study|Lack of Efficacy|6|||
145910882|NCT02006732|526178453|FG001|Overall Study|Lack of Efficacy|3|||
145910883|NCT02006732|526178454|FG002|Overall Study|Lack of Efficacy|1|||
145910884|NCT02006732|526178455|FG003|Overall Study|Lack of Efficacy|1|||
145910885|NCT02006732|526178452|FG000|Overall Study|Protocol Violation|1|||
145910886|NCT02006732|526178453|FG001|Overall Study|Protocol Violation|1|||
145910887|NCT02006732|526178454|FG002|Overall Study|Protocol Violation|0|||
145910888|NCT02006732|526178455|FG003|Overall Study|Protocol Violation|0|||
145910889|NCT02006732|526178452|FG000|Overall Study|Lost to Follow-up|0|||
145910890|NCT02006732|526178453|FG001|Overall Study|Lost to Follow-up|1|||
145910891|NCT02006732|526178454|FG002|Overall Study|Lost to Follow-up|0|||
145910892|NCT02006732|526178455|FG003|Overall Study|Lost to Follow-up|0|||
145910893|NCT02006732|526178452|FG000|Overall Study|Withdrawal by Subject|3|||
145910894|NCT02006732|526178453|FG001|Overall Study|Withdrawal by Subject|0|||
145910895|NCT02006732|526178454|FG002|Overall Study|Withdrawal by Subject|4|||
145910896|NCT02006732|526178455|FG003|Overall Study|Withdrawal by Subject|1|||
145910897|NCT02211417|526178456|FG000|Overall Study|Withdrawal by Subject|11|||
145910898|NCT02211417|526178457|FG001|Overall Study|Withdrawal by Subject|8|||
145910899|NCT02211417|526178456|FG000|Overall Study|Protocol Violation|1|||
145910900|NCT02211417|526178457|FG001|Overall Study|Protocol Violation|0|||
145910901|NCT02211417|526178456|FG000|Overall Study|Pregnancy|0|||
145910902|NCT02211417|526178457|FG001|Overall Study|Pregnancy|1|||
145910903|NCT02211417|526178456|FG000|Overall Study|Lost to Follow-up|2|||
145910904|NCT02211417|526178457|FG001|Overall Study|Lost to Follow-up|3|||
145910905|NCT02211417|526178456|FG000|Overall Study|Adverse Event|1|||
145910906|NCT02211417|526178457|FG001|Overall Study|Adverse Event|4|||
145910907|NCT01198132|526178458|FG000|Overall Study|Withdrawal by Subject|4|||
145910908|NCT01198132|526178459|FG001|Overall Study|Withdrawal by Subject|5|||
145910909|NCT01198132|526178458|FG000|Overall Study|Physician Decision|5|||
145910910|NCT01198132|526178459|FG001|Overall Study|Physician Decision|4|||
145910911|NCT01198132|526178458|FG000|Overall Study|Other Unspecified|3|||
145910912|NCT01198132|526178459|FG001|Overall Study|Other Unspecified|6|||
145910913|NCT01198132|526178458|FG000|Overall Study|Lack of Efficacy|2|||
145910914|NCT01198132|526178459|FG001|Overall Study|Lack of Efficacy|3|||
145910915|NCT01198132|526178458|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
145910916|NCT01198132|526178459|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
145910917|NCT01198132|526178458|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
145910918|NCT01198132|526178459|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
145910919|NCT01198132|526178458|FG000|Overall Study|Adverse Event|0|||
145910920|NCT01198132|526178459|FG001|Overall Study|Adverse Event|1|||
145910921|NCT01198132|526178458|FG000|Overall Study|Protocol Violation|1|||
145910922|NCT01198132|526178459|FG001|Overall Study|Protocol Violation|0|||
145910923|NCT01755091|526178460|FG000|Overall Study|Withdrawal by Subject|6|||
145910924|NCT01755091|526178461|FG001|Overall Study|Withdrawal by Subject|1|||
145910925|NCT01755091|526178462|FG002|Overall Study|Withdrawal by Subject|3|||
145910926|NCT01755091|526178460|FG000|Overall Study|Adverse Event|1|||
145910927|NCT01755091|526178461|FG001|Overall Study|Adverse Event|1|||
145910928|NCT01755091|526178462|FG002|Overall Study|Adverse Event|1|||
145910929|NCT01755091|526178460|FG000|Overall Study|Lost to Follow-up|1|||
145910930|NCT01755091|526178461|FG001|Overall Study|Lost to Follow-up|0|||
145910931|NCT01755091|526178462|FG002|Overall Study|Lost to Follow-up|1|||
145910932|NCT01755091|526178460|FG000|Overall Study|Physician Decision|1|||
145910933|NCT01755091|526178461|FG001|Overall Study|Physician Decision|1|||
145910934|NCT01755091|526178462|FG002|Overall Study|Physician Decision|2|||
145910935|NCT03516513|526178463|FG000|Overall Study|Withdrawal by Subject|2|||
145910936|NCT03516513|526178464|FG001|Overall Study|Withdrawal by Subject|2|||
145910937|NCT03516513|526178465|FG002|Overall Study|Withdrawal by Subject|0|||
145910938|NCT03516513|526178466|FG003|Overall Study|Withdrawal by Subject|0|||
145910939|NCT03071276|526178467|FG000|Overall Study|Adverse Event|1|||
145910940|NCT03071276|526178467|FG000|Overall Study|Lack of Efficacy|14|||
145910941|NCT01885195|526178468|FG000|Overall Study|Adverse Event|29|||
145910942|NCT01885195|526178468|FG000|Overall Study|Death|1|||
145910943|NCT01885195|526178468|FG000|Overall Study|Disease Progression|67|||
145910944|NCT01885195|526178468|FG000|Overall Study|Protocol Deviation|2|||
145910945|NCT01885195|526178468|FG000|Overall Study|Physician Decision|3|||
145910946|NCT01885195|526178468|FG000|Overall Study|Patient/guardian decision|8|||
145910947|NCT03390426|526178469|FG000|Overall Study|Protocol Violation|0|||
145910948|NCT03390426|526178470|FG001|Overall Study|Protocol Violation|1|||
145910949|NCT03694327|526178475|FG000|Overall Study|Lost to Follow-up|13|||
145910950|NCT03694327|526178476|FG001|Overall Study|Lost to Follow-up|23|||
145910951|NCT00307437|526178477|FG000|Controlled Period|Adverse Event|7|||
145910952|NCT00307437|526178478|FG001|Controlled Period|Adverse Event|2|||
145910953|NCT00307437|526178479|FG002|Controlled Period|Adverse Event|5|||
145910954|NCT00307437|526178480|FG003|Controlled Period|Adverse Event|0|||
145910955|NCT00307437|526178481|FG004|Controlled Period|Adverse Event|0|||
145910956|NCT00307437|526178482|FG005|Controlled Period|Adverse Event|0|||
145910957|NCT00307437|526178483|FG006|Controlled Period|Adverse Event|0|||
145910958|NCT00307437|526178477|FG000|Controlled Period|Death|0|||
145910959|NCT00307437|526178478|FG001|Controlled Period|Death|0|||
145910960|NCT00307437|526178479|FG002|Controlled Period|Death|1|||
145910961|NCT00307437|526178480|FG003|Controlled Period|Death|0|||
145910962|NCT00307437|526178481|FG004|Controlled Period|Death|0|||
145910963|NCT00307437|526178482|FG005|Controlled Period|Death|0|||
145973194|NCT05722015|526414222|FG001|Overall Study|Withdrawal by Subject|1|||
145973195|NCT05722015|526414221|FG000|Overall Study|Participants Ongoing|188|||
145973196|NCT05722015|526414222|FG001|Overall Study|Participants Ongoing|88|||
145973197|NCT02657551|526414223|FG000|Overall Study|Adverse Event|2|||
145973198|NCT02657551|526414223|FG000|Overall Study|Withdrawal by Subject|1|||
145973199|NCT02657551|526414223|FG000|Overall Study|Non-Compliance|1|||
146088555|NCT01255787|526843876|FG001|Overall Study|Major Protocol Deviation|1|||
146088556|NCT01255787|526843877|FG002|Overall Study|Major Protocol Deviation|0|||
145910964|NCT00307437|526178483|FG006|Controlled Period|Death|0|||
145910965|NCT00307437|526178477|FG000|Controlled Period|Lack of Efficacy|2|||
145910966|NCT00307437|526178478|FG001|Controlled Period|Lack of Efficacy|0|||
145910967|NCT00307437|526178479|FG002|Controlled Period|Lack of Efficacy|0|||
146088557|NCT01255787|526843878|FG003|Overall Study|Major Protocol Deviation|4|||
146088558|NCT01255787|526843875|FG000|Overall Study|Lost to Follow-up|1|||
146088559|NCT01255787|526843876|FG001|Overall Study|Lost to Follow-up|2|||
146088560|NCT01255787|526843877|FG002|Overall Study|Lost to Follow-up|4|||
146088561|NCT01255787|526843878|FG003|Overall Study|Lost to Follow-up|2|||
146088562|NCT01255787|526843875|FG000|Overall Study|Withdrawal of Consent|3|||
146088563|NCT01255787|526843876|FG001|Overall Study|Withdrawal of Consent|9|||
145910968|NCT00307437|526178480|FG003|Controlled Period|Lack of Efficacy|0|||
145910969|NCT00307437|526178481|FG004|Controlled Period|Lack of Efficacy|0|||
145910970|NCT00307437|526178482|FG005|Controlled Period|Lack of Efficacy|0|||
145910971|NCT00307437|526178483|FG006|Controlled Period|Lack of Efficacy|0|||
145910972|NCT00307437|526178477|FG000|Controlled Period|Lost to Follow-up|2|||
145973200|NCT02657551|526414223|FG000|Overall Study|Progression / Relapse|4|||
145973201|NCT04478266|526414224|FG000|Overall Study|Adverse Event|20|||
145973202|NCT04478266|526414225|FG001|Overall Study|Adverse Event|21|||
145910973|NCT00307437|526178478|FG001|Controlled Period|Lost to Follow-up|3|||
145910974|NCT00307437|526178479|FG002|Controlled Period|Lost to Follow-up|0|||
145910975|NCT00307437|526178480|FG003|Controlled Period|Lost to Follow-up|0|||
145910976|NCT00307437|526178481|FG004|Controlled Period|Lost to Follow-up|0|||
145910977|NCT00307437|526178482|FG005|Controlled Period|Lost to Follow-up|0|||
146088564|NCT01255787|526843877|FG002|Overall Study|Withdrawal of Consent|3|||
146088565|NCT01255787|526843878|FG003|Overall Study|Withdrawal of Consent|4|||
146088566|NCT01255787|526843875|FG000|Overall Study|Pregnancy|0|||
146088567|NCT01255787|526843876|FG001|Overall Study|Pregnancy|0|||
146088568|NCT01255787|526843877|FG002|Overall Study|Pregnancy|0|||
146088569|NCT01255787|526843878|FG003|Overall Study|Pregnancy|1|||
146088570|NCT01255787|526843875|FG000|Overall Study|Lack of Efficacy|2|||
146088571|NCT01255787|526843876|FG001|Overall Study|Lack of Efficacy|2|||
146088572|NCT01255787|526843877|FG002|Overall Study|Lack of Efficacy|2|||
146088573|NCT01255787|526843878|FG003|Overall Study|Lack of Efficacy|2|||
146088574|NCT01255787|526843875|FG000|Overall Study|Noncompliance with Study Drug|3|||
145973203|NCT04478266|526414224|FG000|Overall Study|Progressive disease|146|||
145973204|NCT04478266|526414225|FG001|Overall Study|Progressive disease|168|||
145973205|NCT04478266|526414224|FG000|Overall Study|Poor compliance to protocol|1|||
145973206|NCT04478266|526414225|FG001|Overall Study|Poor compliance to protocol|0|||
145973207|NCT04478266|526414224|FG000|Overall Study|Withdrawal by Subject|19|||
145973208|NCT04478266|526414225|FG001|Overall Study|Withdrawal by Subject|16|||
145973209|NCT04478266|526414224|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
145973210|NCT04478266|526414225|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
145973211|NCT04478266|526414224|FG000|Overall Study|Study terminated by sponsor|33|||
145973212|NCT04478266|526414225|FG001|Overall Study|Study terminated by sponsor|35|||
145910978|NCT00307437|526178483|FG006|Controlled Period|Lost to Follow-up|0|||
145910979|NCT00307437|526178477|FG000|Controlled Period|Other|5|||
145910980|NCT00307437|526178478|FG001|Controlled Period|Other|1|||
145910981|NCT00307437|526178479|FG002|Controlled Period|Other|3|||
145910982|NCT00307437|526178480|FG003|Controlled Period|Other|0|||
145910983|NCT00307437|526178481|FG004|Controlled Period|Other|0|||
145910984|NCT00307437|526178482|FG005|Controlled Period|Other|0|||
145910985|NCT00307437|526178483|FG006|Controlled Period|Other|0|||
145910986|NCT00307437|526178477|FG000|After Controlled Period|Adverse Event|0|||
145910987|NCT00307437|526178478|FG001|After Controlled Period|Adverse Event|0|||
145910988|NCT00307437|526178479|FG002|After Controlled Period|Adverse Event|0|||
145910989|NCT00307437|526178480|FG003|After Controlled Period|Adverse Event|18|||
145910990|NCT00307437|526178481|FG004|After Controlled Period|Adverse Event|16|||
145910991|NCT00307437|526178482|FG005|After Controlled Period|Adverse Event|31|||
145910992|NCT00307437|526178483|FG006|After Controlled Period|Adverse Event|40|||
145910993|NCT00307437|526178477|FG000|After Controlled Period|Death|0|||
145910994|NCT00307437|526178478|FG001|After Controlled Period|Death|0|||
145910995|NCT00307437|526178479|FG002|After Controlled Period|Death|0|||
145910996|NCT00307437|526178480|FG003|After Controlled Period|Death|3|||
145910997|NCT00307437|526178481|FG004|After Controlled Period|Death|1|||
145910998|NCT00307437|526178482|FG005|After Controlled Period|Death|1|||
145910999|NCT00307437|526178483|FG006|After Controlled Period|Death|3|||
145911000|NCT00307437|526178477|FG000|After Controlled Period|Lack of Efficacy|0|||
145911001|NCT00307437|526178478|FG001|After Controlled Period|Lack of Efficacy|0|||
145911002|NCT00307437|526178479|FG002|After Controlled Period|Lack of Efficacy|0|||
145911003|NCT00307437|526178480|FG003|After Controlled Period|Lack of Efficacy|15|||
145911004|NCT00307437|526178481|FG004|After Controlled Period|Lack of Efficacy|17|||
145911005|NCT00307437|526178482|FG005|After Controlled Period|Lack of Efficacy|37|||
145911006|NCT00307437|526178483|FG006|After Controlled Period|Lack of Efficacy|24|||
145911007|NCT00307437|526178477|FG000|After Controlled Period|Lost to Follow-up|0|||
145911008|NCT00307437|526178478|FG001|After Controlled Period|Lost to Follow-up|0|||
145911009|NCT00307437|526178479|FG002|After Controlled Period|Lost to Follow-up|0|||
145911010|NCT00307437|526178480|FG003|After Controlled Period|Lost to Follow-up|7|||
145911011|NCT00307437|526178481|FG004|After Controlled Period|Lost to Follow-up|12|||
145911012|NCT00307437|526178482|FG005|After Controlled Period|Lost to Follow-up|13|||
145911013|NCT00307437|526178483|FG006|After Controlled Period|Lost to Follow-up|18|||
145911014|NCT00307437|526178477|FG000|After Controlled Period|Other|0|||
145911015|NCT00307437|526178478|FG001|After Controlled Period|Other|0|||
145911016|NCT00307437|526178479|FG002|After Controlled Period|Other|0|||
145973213|NCT04478266|526414224|FG000|Overall Study|Other: unspecified|5|||
146088575|NCT01255787|526843876|FG001|Overall Study|Noncompliance with Study Drug|1|||
146088576|NCT01255787|526843877|FG002|Overall Study|Noncompliance with Study Drug|0|||
146088577|NCT01255787|526843878|FG003|Overall Study|Noncompliance with Study Drug|0|||
146088578|NCT00476047|526843879|FG000|Overall Study|Lost to Follow-up|1|||
145911017|NCT00307437|526178480|FG003|After Controlled Period|Other|15|||
145911018|NCT00307437|526178481|FG004|After Controlled Period|Other|9|||
145911019|NCT00307437|526178482|FG005|After Controlled Period|Other|40|||
145911020|NCT00307437|526178483|FG006|After Controlled Period|Other|28|||
145911021|NCT00509795|526178484|FG000|Overall Study|Adverse Event|4|||
145911022|NCT00509795|526178485|FG001|Overall Study|Adverse Event|3|||
145911023|NCT00509795|526178486|FG002|Overall Study|Adverse Event|5|||
145911024|NCT00509795|526178487|FG003|Overall Study|Adverse Event|4|||
145973214|NCT04478266|526414225|FG001|Overall Study|Other: unspecified|7|||
145973215|NCT04478266|526414224|FG000|Overall Study|Randomized but not treated|1|||
146088579|NCT03170232|526843880|FG000|Overall Study|Adverse Event|0|||
146088580|NCT03170232|526843881|FG001|Overall Study|Adverse Event|1|||
145911025|NCT00509795|526178484|FG000|Overall Study|Death|3|||
145911026|NCT00509795|526178485|FG001|Overall Study|Death|1|||
145911027|NCT00509795|526178486|FG002|Overall Study|Death|2|||
146088581|NCT03170232|526843880|FG000|Overall Study|Protocol Violation|0|||
145973216|NCT04478266|526414225|FG001|Overall Study|Randomized but not treated|1|||
145973217|NCT01101178|526414226|FG000|Period 1|Withdrawal by Subject|1|||
145973218|NCT01101178|526414227|FG001|Period 1|Withdrawal by Subject|2|||
145973219|NCT01101178|526414226|FG000|Period 1|Positive drug screen|1|||
145973220|NCT01101178|526414227|FG001|Period 1|Positive drug screen|1|||
145911028|NCT00509795|526178487|FG003|Overall Study|Death|7|||
145911029|NCT00509795|526178484|FG000|Overall Study|Lack of Efficacy|0|||
145911030|NCT00509795|526178485|FG001|Overall Study|Lack of Efficacy|0|||
145911031|NCT00509795|526178486|FG002|Overall Study|Lack of Efficacy|2|||
145911032|NCT00509795|526178487|FG003|Overall Study|Lack of Efficacy|2|||
145911033|NCT00509795|526178484|FG000|Overall Study|Lost to Follow-up|1|||
145911034|NCT00509795|526178485|FG001|Overall Study|Lost to Follow-up|2|||
145911035|NCT00509795|526178486|FG002|Overall Study|Lost to Follow-up|4|||
145973221|NCT01101178|526414226|FG000|Period 1|Adverse Event|2|||
145911036|NCT00509795|526178487|FG003|Overall Study|Lost to Follow-up|4|||
145911037|NCT00509795|526178484|FG000|Overall Study|OTHER|1|||
145911038|NCT00509795|526178485|FG001|Overall Study|OTHER|0|||
145911039|NCT00509795|526178486|FG002|Overall Study|OTHER|4|||
145911040|NCT00509795|526178487|FG003|Overall Study|OTHER|1|||
145911041|NCT00509795|526178484|FG000|Overall Study|Protocol Violation|3|||
145911042|NCT00509795|526178485|FG001|Overall Study|Protocol Violation|0|||
145911043|NCT00509795|526178486|FG002|Overall Study|Protocol Violation|3|||
145911044|NCT00509795|526178487|FG003|Overall Study|Protocol Violation|1|||
145911045|NCT00509795|526178484|FG000|Overall Study|Withdrawal by Subject|10|||
145911046|NCT00509795|526178485|FG001|Overall Study|Withdrawal by Subject|5|||
145911047|NCT00509795|526178486|FG002|Overall Study|Withdrawal by Subject|7|||
145911048|NCT00509795|526178487|FG003|Overall Study|Withdrawal by Subject|8|||
145911049|NCT02521376|526178488|FG000|Overall Study|Enrolled, But Not Treated|1|||
145911050|NCT02521376|526178489|FG001|Overall Study|Enrolled, But Not Treated|0|||
145911051|NCT02521376|526178490|FG002|Overall Study|Enrolled, But Not Treated|0|||
145911052|NCT02521376|526178491|FG003|Overall Study|Enrolled, But Not Treated|0|||
145911053|NCT00143247|526178498|FG000|Overall Study|Death|8|||
145911054|NCT00143247|526178498|FG000|Overall Study|Adverse Event|19|||
145911055|NCT00143247|526178498|FG000|Overall Study|Lack of Efficacy|3|||
145911056|NCT00143247|526178498|FG000|Overall Study|Withdrawal by Subject|55|||
145911057|NCT00143247|526178498|FG000|Overall Study|Study terminated by sponsor|31|||
145911058|NCT00143247|526178498|FG000|Overall Study|Protocol Violation|15|||
145911059|NCT00143247|526178498|FG000|Overall Study|Lost to Follow-up|12|||
145911060|NCT00143247|526178498|FG000|Overall Study|following inaccurate lab adverse event|1|||
145911061|NCT00143247|526178498|FG000|Overall Study|Other|12|||
145911062|NCT02933255|526178501|FG000|Overall Study|Discontinued due to study closure.|1|||
145911063|NCT02933255|526178502|FG001|Overall Study|Discontinued due to study closure.|0|||
145911064|NCT02766283|526178503|FG000|Overall Study|Lost to Follow-up|27|||
145911065|NCT04380961|526178504|FG000|Overall Study|Lost to Follow-up|17|||
145911066|NCT04380961|526178505|FG001|Overall Study|Lost to Follow-up|11|||
145911067|NCT04380961|526178504|FG000|Overall Study|Withdrawal by Subject|3|||
145911068|NCT04380961|526178505|FG001|Overall Study|Withdrawal by Subject|0|||
145911069|NCT04380961|526178504|FG000|Overall Study|Death|22|||
145911070|NCT04380961|526178505|FG001|Overall Study|Death|16|||
145911071|NCT04380961|526178504|FG000|Overall Study|Other|1|||
145911072|NCT04380961|526178505|FG001|Overall Study|Other|0|||
145911073|NCT04380961|526178504|FG000|Overall Study|Randomized but Not Treated|1|||
145911074|NCT04380961|526178505|FG001|Overall Study|Randomized but Not Treated|2|||
145911075|NCT00805961|526178506|FG000|Modality Therapy|Withdrawal by Subject|1|||
145911076|NCT00805961|526178506|FG000|Modality Therapy|Adverse Event|1|||
145911077|NCT00805961|526178506|FG000|Modality Therapy|Disease Progression|2|||
145911078|NCT00805961|526178506|FG000|Treatment-Free Interval|Adverse Event|3|||
145911079|NCT00805961|526178506|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
145911080|NCT00805961|526178506|FG000|Treatment-Free Interval|Physician Decision|1|||
145973222|NCT01101178|526414227|FG001|Period 1|Adverse Event|1|||
145973223|NCT01101178|526414226|FG000|Period 2|Withdrawal by Subject|0|||
145973224|NCT01101178|526414227|FG001|Period 2|Withdrawal by Subject|1|||
145973225|NCT01850641|526414228|FG000|Overall Study|Physician Decision|1|||
145911081|NCT00805961|526178506|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
145973226|NCT01850641|526414228|FG000|Overall Study|Decrease in serum phosphorus|1|||
145911082|NCT00805961|526178506|FG000|Maintenance Treatment|Lack of Efficacy|13|||
145911083|NCT00805961|526178506|FG000|Maintenance Treatment|Intercurrent Illness|7|||
145911084|NCT00805961|526178506|FG000|Maintenance Treatment|Adverse Event|6|||
145911085|NCT00805961|526178506|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
145911086|NCT00805961|526178506|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
145911087|NCT00805961|526178506|FG000|Maintenance Treatment|Withdrawn Consent|1|||
145911088|NCT04803305|526178507|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
145911089|NCT04803305|526178508|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
145911090|NCT04803305|526178507|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
145911091|NCT04803305|526178508|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
145911092|NCT04803305|526178507|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
145973227|NCT01850641|526414228|FG000|Overall Study|Decrease in serum calcium|2|||
145973228|NCT01850641|526414228|FG000|Overall Study|Increase in serum ferritin|1|||
145911093|NCT04803305|526178508|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
145911094|NCT04803305|526178507|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
145911095|NCT04803305|526178508|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
145911096|NCT04803305|526178507|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
145911097|NCT04803305|526178508|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
145911098|NCT04803305|526178507|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
145911099|NCT04803305|526178508|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
145911100|NCT04803305|526178507|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
145911101|NCT04803305|526178508|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
145911102|NCT04803305|526178507|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
145911103|NCT04803305|526178508|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
145911104|NCT00306995|526178515|FG000|Study Part I|Withdrawal by Subject|0|||
145911105|NCT00306995|526178516|FG001|Study Part I|Withdrawal by Subject|0|||
145911106|NCT00306995|526178517|FG002|Study Part I|Withdrawal by Subject|0|||
145911107|NCT00306995|526178518|FG003|Study Part I|Withdrawal by Subject|0|||
145911108|NCT00306995|526178519|FG004|Study Part I|Withdrawal by Subject|0|||
145911109|NCT00306995|526178520|FG005|Study Part I|Withdrawal by Subject|0|||
145911110|NCT00306995|526178521|FG006|Study Part I|Withdrawal by Subject|1|||
145911111|NCT00306995|526178515|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
145911112|NCT00306995|526178516|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
145911113|NCT00306995|526178517|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
145911114|NCT00306995|526178518|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
145911115|NCT00306995|526178519|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
145911116|NCT00306995|526178520|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
145911117|NCT00306995|526178521|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
145911118|NCT02465398|526179990|FG000|Overall Study|Death|7|||
145911119|NCT02465398|526179990|FG000|Overall Study|Revision|7|||
145911120|NCT02465398|526179990|FG000|Overall Study|did not receive study device|1|||
145911121|NCT02465398|526179990|FG000|Overall Study|Withdrawal by Subject|1|||
145911122|NCT02465398|526179990|FG000|Overall Study|Lost to Follow-up|14|||
145911123|NCT03965689|526179991|FG000|Overall Study|Too sick to get study intervention|2|||
145973229|NCT00720759|526414231|FG000|Overall Study|Lost to Follow-up|0|||
145973230|NCT00720759|526414232|FG001|Overall Study|Lost to Follow-up|1|||
145973231|NCT00720759|526414233|FG002|Overall Study|Lost to Follow-up|1|||
145973232|NCT00720759|526414234|FG003|Overall Study|Lost to Follow-up|0|||
145911124|NCT01383707|526180002|FG000|Overall Study|Consent withdrawal|6|||
145911125|NCT01383707|526180002|FG000|Overall Study|Death|19|||
145911126|NCT01383707|526180002|FG000|Overall Study|Other|8|||
145911127|NCT01383707|526180002|FG000|Overall Study|Sponsor's decision|2|||
145911128|NCT01383707|526180002|FG000|Overall Study|Adverse Event|14|||
145911129|NCT01383707|526180002|FG000|Overall Study|Progressive disease|23|||
145911130|NCT02437903|526180003|FG000|Overall Study|Adverse Event|1|||
145911131|NCT02437903|526180003|FG000|Overall Study|Withdrawal by Subject|1|||
145911132|NCT02437903|526180003|FG000|Overall Study|Lost to Follow-up|3|||
145911133|NCT01121562|526180006|FG000|Overall Study|Objective progression or relapse|8|||
145911134|NCT01121562|526180006|FG000|Overall Study|Withdrawal by Subject|1|||
145911135|NCT01121562|526180006|FG000|Overall Study|Adverse Event|1|||
145911136|NCT01121562|526180006|FG000|Overall Study|Sponsor Decision|1|||
145911137|NCT01121562|526180006|FG000|Overall Study|Met study discontinuation criteria|1|||
145911138|NCT00616421|526180007|FG000|Overall Study|Withdrawal by Subject|9|||
145911139|NCT00616421|526180008|FG001|Overall Study|Withdrawal by Subject|11|||
145911140|NCT00616421|526180009|FG002|Overall Study|Withdrawal by Subject|8|||
145911141|NCT00616421|526180007|FG000|Overall Study|Lost to Follow-up|12|||
145911142|NCT00616421|526180008|FG001|Overall Study|Lost to Follow-up|26|||
145911143|NCT00616421|526180009|FG002|Overall Study|Lost to Follow-up|30|||
145911144|NCT00616421|526180007|FG000|Overall Study|Inappropriate enrollment|3|||
145911145|NCT00616421|526180008|FG001|Overall Study|Inappropriate enrollment|0|||
145911146|NCT00616421|526180009|FG002|Overall Study|Inappropriate enrollment|1|||
145911147|NCT00616421|526180007|FG000|Overall Study|Administrative reason|1|||
145911148|NCT00616421|526180008|FG001|Overall Study|Administrative reason|0|||
145911149|NCT00616421|526180009|FG002|Overall Study|Administrative reason|0|||
145911150|NCT00616421|526180007|FG000|Overall Study|Protocol Violation|0|||
145973233|NCT05032196|526414238|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145973234|NCT05032196|526414239|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
145973235|NCT05032196|526414240|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145911151|NCT00616421|526180008|FG001|Overall Study|Protocol Violation|1|||
145911152|NCT00616421|526180009|FG002|Overall Study|Protocol Violation|2|||
146088582|NCT03170232|526843881|FG001|Overall Study|Protocol Violation|1|||
145911153|NCT00616421|526180007|FG000|Overall Study|Unable to classify|1|||
145911154|NCT00616421|526180008|FG001|Overall Study|Unable to classify|0|||
145911155|NCT00616421|526180009|FG002|Overall Study|Unable to classify|0|||
145911156|NCT01427608|526180010|FG000|Overall Study|Death|1|||
145911157|NCT01427608|526180011|FG001|Overall Study|Death|0|||
145911158|NCT01427608|526180010|FG000|Overall Study|Withdrawal by Subject|7|||
145911159|NCT01427608|526180011|FG001|Overall Study|Withdrawal by Subject|3|||
145911160|NCT01427608|526180010|FG000|Overall Study|Relapsed-all cause|13|||
145911161|NCT01427608|526180011|FG001|Overall Study|Relapsed-all cause|34|||
145911162|NCT01427608|526180010|FG000|Overall Study|Events not attributed to study meds|0|||
145911163|NCT01427608|526180011|FG001|Overall Study|Events not attributed to study meds|1|||
145911164|NCT04071405|526180012|FG000|Overall Study|Protocol Violation|3|||
145911165|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
145911166|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
145911167|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
145911168|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
145911169|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
145911170|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
145911171|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
145911172|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
145911173|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
145911174|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
145911175|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
145911176|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
145911177|NCT02422797|526180013|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
145911178|NCT02422797|526180014|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
145911179|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
145911180|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
145911181|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
145911182|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
145911183|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
145911184|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
145911185|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
145911186|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
145911187|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
145911188|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
145911189|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
145911190|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
145911191|NCT02422797|526180013|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
145911192|NCT02422797|526180014|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
145911193|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
145911194|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
145911195|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
145911196|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
145911197|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
145911198|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
145911199|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
145911200|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
145911201|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
145911202|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
145911203|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
145911204|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
145911205|NCT02422797|526180013|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
145911206|NCT02422797|526180014|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
145911207|NCT05445492|526180017|FG000|Overall Study|Physician Decision|1|||
145911208|NCT04289363|526180021|FG000|Overall Study|Lost to Follow-up|14|||
145911209|NCT04289363|526180022|FG001|Overall Study|Lost to Follow-up|0|||
145911210|NCT03790657|526180023|FG000|Overall Study|Adverse Event|1|||
145911211|NCT03790657|526180024|FG001|Overall Study|Adverse Event|1|||
145911212|NCT03790657|526180023|FG000|Overall Study|Withdrawal by Subject|1|||
145911213|NCT03790657|526180024|FG001|Overall Study|Withdrawal by Subject|1|||
145911214|NCT03126435|526180025|FG000|Overall Study|Death|90|||
145911215|NCT03126435|526180026|FG001|Overall Study|Death|84|||
145911216|NCT03126435|526180025|FG000|Overall Study|Lost to Follow-up|4|||
145911217|NCT03126435|526180026|FG001|Overall Study|Lost to Follow-up|3|||
145911218|NCT03126435|526180025|FG000|Overall Study|Physician Decision|0|||
145911219|NCT03126435|526180026|FG001|Overall Study|Physician Decision|1|||
145911220|NCT03126435|526180025|FG000|Overall Study|Withdrawal by Subject|6|||
145911221|NCT03126435|526180026|FG001|Overall Study|Withdrawal by Subject|12|||
145911222|NCT03126435|526180025|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
145911223|NCT03126435|526180026|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
145911224|NCT03971474|526180027|FG000|Overall Study|Adverse Event|11|||
145911225|NCT03971474|526180028|FG001|Overall Study|Adverse Event|7|||
145911226|NCT03971474|526180027|FG000|Overall Study|Refusal unrelated to adverse event|5|||
145911227|NCT03971474|526180028|FG001|Overall Study|Refusal unrelated to adverse event|1|||
145911228|NCT03971474|526180027|FG000|Overall Study|Progression/relapse|40|||
145911229|NCT03971474|526180028|FG001|Overall Study|Progression/relapse|47|||
145911230|NCT03971474|526180027|FG000|Overall Study|Death|6|||
145911231|NCT03971474|526180028|FG001|Overall Study|Death|3|||
145911232|NCT03971474|526180027|FG000|Overall Study|Other - not protocol specified|5|||
145911233|NCT03971474|526180028|FG001|Overall Study|Other - not protocol specified|4|||
145911234|NCT03971474|526180027|FG000|Overall Study|On treatment|0|||
145911235|NCT03971474|526180028|FG001|Overall Study|On treatment|7|||
145911236|NCT02370238|526180035|FG000|Overall Study|Death|42|||
145911237|NCT02370238|526180036|FG001|Overall Study|Death|35|||
145911238|NCT02370238|526180035|FG000|Overall Study|Lost to Follow-up|1|||
145911239|NCT02370238|526180036|FG001|Overall Study|Lost to Follow-up|3|||
145911240|NCT02370238|526180035|FG000|Overall Study|Withdrawal by Subject|2|||
145911241|NCT02370238|526180036|FG001|Overall Study|Withdrawal by Subject|6|||
145911242|NCT02370238|526180035|FG000|Overall Study|Other|2|||
145911243|NCT02370238|526180036|FG001|Overall Study|Other|1|||
145911244|NCT01807065|526180037|FG000|Overall Study|Receive no sip-T due to IV access|1|||
145911245|NCT01807065|526180038|FG001|Overall Study|Receive no sip-T due to IV access|1|||
145911246|NCT01153425|526180040|FG000|Overall Study|Withdrawal by Subject|3|||
145911247|NCT01153425|526180041|FG001|Overall Study|Withdrawal by Subject|3|||
145911248|NCT01937871|526180042|FG000|Overall Study|Adverse Event|6|||
145911249|NCT01937871|526180043|FG001|Overall Study|Adverse Event|6|||
145911250|NCT01937871|526180044|FG002|Overall Study|Adverse Event|2|||
145911251|NCT01937871|526180042|FG000|Overall Study|Lost to Follow-up|8|||
145911252|NCT01937871|526180043|FG001|Overall Study|Lost to Follow-up|2|||
145911253|NCT01937871|526180044|FG002|Overall Study|Lost to Follow-up|4|||
145911254|NCT01937871|526180042|FG000|Overall Study|Withdrawal by Subject|9|||
145911255|NCT01937871|526180043|FG001|Overall Study|Withdrawal by Subject|6|||
145911256|NCT01937871|526180044|FG002|Overall Study|Withdrawal by Subject|4|||
145911257|NCT01937871|526180042|FG000|Overall Study|Physician Decision|0|||
145911258|NCT01937871|526180043|FG001|Overall Study|Physician Decision|1|||
145911259|NCT01937871|526180044|FG002|Overall Study|Physician Decision|0|||
145911260|NCT01937871|526180042|FG000|Overall Study|Entry Criteria Not Met|1|||
145911261|NCT01937871|526180043|FG001|Overall Study|Entry Criteria Not Met|2|||
145911262|NCT01937871|526180044|FG002|Overall Study|Entry Criteria Not Met|1|||
145911263|NCT01482312|526180045|FG000|Period 1, 90 Minutes of Wear|Other|1|||
145911264|NCT01482312|526180046|FG001|Period 1, 90 Minutes of Wear|Other|0|||
145911265|NCT01482312|526180047|FG002|Period 1, 90 Minutes of Wear|Other|0|||
145911266|NCT01482312|526180045|FG000|Period 2, 90 Minutes of Wear|Other|1|||
145911267|NCT01482312|526180046|FG001|Period 2, 90 Minutes of Wear|Other|0|||
145911268|NCT01482312|526180047|FG002|Period 2, 90 Minutes of Wear|Other|0|||
145911269|NCT01699815|526180048|FG000|Overall Study|Protocol Violation|4|||
145911270|NCT01699815|526180049|FG001|Overall Study|Protocol Violation|7|||
145911271|NCT01699815|526180048|FG000|Overall Study|record could not be located|1|||
145911272|NCT01699815|526180049|FG001|Overall Study|record could not be located|0|||
145911273|NCT01699815|526180048|FG000|Overall Study|Adverse Event|0|||
145911274|NCT01699815|526180049|FG001|Overall Study|Adverse Event|1|||
145911275|NCT01295320|526180050|FG000|Overall Study|Adverse Event|2|||
145911276|NCT01295320|526180050|FG000|Overall Study|Lost to Follow-up|4|||
145911277|NCT01295320|526180050|FG000|Overall Study|Withdrawal by Subject|2|||
145911278|NCT01295320|526180050|FG000|Overall Study|Subject was bedridden|1|||
145911279|NCT01295320|526180050|FG000|Overall Study|Unable to travel|1|||
145911280|NCT00699816|526180051|FG000|Overall Study|Protocol Violation|1|||
145973236|NCT05032196|526414241|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145973237|NCT05032196|526414242|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145973238|NCT05032196|526414243|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145911281|NCT00699816|526180052|FG001|Overall Study|Protocol Violation|3|||
145911282|NCT01569295|526180053|FG000|Overall Study|Progressive Disease|75|||
145911283|NCT01569295|526180054|FG001|Overall Study|Progressive Disease|139|||
145911284|NCT01569295|526180053|FG000|Overall Study|Adverse Event|39|||
145911285|NCT01569295|526180054|FG001|Overall Study|Adverse Event|14|||
145911286|NCT01569295|526180053|FG000|Overall Study|Withdrawal by Subject|25|||
145911287|NCT01569295|526180054|FG001|Overall Study|Withdrawal by Subject|12|||
145911288|NCT01569295|526180053|FG000|Overall Study|Death|19|||
145911289|NCT01569295|526180054|FG001|Overall Study|Death|15|||
145911290|NCT01569295|526180053|FG000|Overall Study|Physician Decision|13|||
145911291|NCT01569295|526180054|FG001|Overall Study|Physician Decision|18|||
145911292|NCT01569295|526180053|FG000|Overall Study|Study Terminated by Sponsor|24|||
145911293|NCT01569295|526180054|FG001|Overall Study|Study Terminated by Sponsor|2|||
145911294|NCT01569295|526180053|FG000|Overall Study|Other Reason not Specified|3|||
145911295|NCT01569295|526180054|FG001|Overall Study|Other Reason not Specified|5|||
145911296|NCT01569295|526180053|FG000|Overall Study|Non-Compliance with Study Drug|6|||
145911297|NCT01569295|526180054|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146088583|NCT03170232|526843880|FG000|Overall Study|Lack of Efficacy|0|||
145911298|NCT01569295|526180053|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
145911299|NCT01569295|526180054|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
145911300|NCT01569295|526180053|FG000|Overall Study|Lost to Follow-up|1|||
145911301|NCT01569295|526180054|FG001|Overall Study|Lost to Follow-up|1|||
146088584|NCT03170232|526843881|FG001|Overall Study|Lack of Efficacy|1|||
146088585|NCT03170232|526843880|FG000|Overall Study|Study closed/terminated|26|||
146088586|NCT03170232|526843881|FG001|Overall Study|Study closed/terminated|23|||
146088587|NCT03170232|526843880|FG000|Overall Study|Lost to Follow-up|1|||
146088588|NCT03170232|526843881|FG001|Overall Study|Lost to Follow-up|0|||
146088589|NCT03170232|526843880|FG000|Overall Study|Withdrawal by Subject|0|||
146088590|NCT03170232|526843881|FG001|Overall Study|Withdrawal by Subject|1|||
146088591|NCT03882008|526843882|FG000|Overall Study|Withdrawal by Subject|1|||
146088592|NCT03882008|526843882|FG000|Overall Study|Lost to Follow-up|1|||
146088593|NCT00768469|526843884|FG000|Overall Study|Adverse Event|0|||
146088594|NCT00768469|526843885|FG001|Overall Study|Adverse Event|2|||
146088595|NCT00768469|526843884|FG000|Overall Study|Disease Progression|3|||
146088596|NCT00768469|526843885|FG001|Overall Study|Disease Progression|4|||
145911302|NCT02508935|526180055|FG000|Overall Study|Withdrawal by Subject|1|||
145911303|NCT02508935|526180055|FG000|Overall Study|Withdrawal by Caregiver|8|||
145911304|NCT02508935|526180055|FG000|Overall Study|Pain Score <4|1|||
145911305|NCT02508935|526180055|FG000|Overall Study|Emesis|3|||
145911306|NCT02508935|526180055|FG000|Overall Study|Adverse Event|3|||
145911307|NCT02508935|526180055|FG000|Overall Study|Protocol Violation|1|||
145911308|NCT02508935|526180055|FG000|Overall Study|Physician Decision|1|||
145911309|NCT02508935|526180055|FG000|Overall Study|Trial terminated by sponsor|5|||
145911310|NCT02125877|526180056|FG000|Overall Study|Physician Decision|1|||
145911311|NCT02125877|526180057|FG001|Overall Study|Physician Decision|0|||
145911312|NCT02125877|526180056|FG000|Overall Study|Death|0|||
145911313|NCT02125877|526180057|FG001|Overall Study|Death|1|||
145911314|NCT02125877|526180056|FG000|Overall Study|Administrative problems|0|||
145911315|NCT02125877|526180057|FG001|Overall Study|Administrative problems|1|||
145911316|NCT02125877|526180056|FG000|Overall Study|Participant/guardian decision|0|||
145911317|NCT02125877|526180057|FG001|Overall Study|Participant/guardian decision|2|||
145911318|NCT02125877|526180056|FG000|Overall Study|Withdrawal by Subject|2|||
146088597|NCT00768469|526843884|FG000|Overall Study|Withdrawal by Subject|0|||
145911319|NCT02125877|526180057|FG001|Overall Study|Withdrawal by Subject|1|||
145911320|NCT02125877|526180056|FG000|Overall Study|Protocol deviation|4|||
145911321|NCT02125877|526180057|FG001|Overall Study|Protocol deviation|1|||
145911322|NCT02125877|526180056|FG000|Overall Study|Adverse Event|6|||
145911323|NCT02125877|526180057|FG001|Overall Study|Adverse Event|4|||
145911324|NCT01973595|526180058|FG000|Washout|Withdrawal by Subject|1|||
145911325|NCT01973595|526180059|FG001|Washout|Withdrawal by Subject|0|||
145911326|NCT01973595|526180060|FG002|Washout|Withdrawal by Subject|1|||
145911327|NCT01973595|526180061|FG003|Washout|Withdrawal by Subject|0|||
145911328|NCT02800642|526180070|FG000|Overall Study|Death|3|||
145911329|NCT02800642|526180070|FG000|Overall Study|Other|10|||
145911330|NCT02800642|526180070|FG000|Overall Study|Physician Decision|2|||
145911331|NCT02800642|526180070|FG000|Overall Study|Adverse Event|6|||
145911332|NCT02800642|526180070|FG000|Overall Study|Withdrawal by Subject|3|||
145911333|NCT02800642|526180070|FG000|Overall Study|Lost to Follow-up|1|||
145911334|NCT04868500|526180071|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
145911335|NCT04868500|526180072|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
145911336|NCT04868500|526180071|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
145911337|NCT04868500|526180072|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
145911338|NCT01941498|526180076|FG000|Overall Study|Relocated out of state|1|||
145911339|NCT05299528|526180079|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911340|NCT05299528|526180080|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
145911341|NCT05299528|526180081|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911342|NCT05299528|526180082|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911343|NCT05299528|526180083|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911344|NCT05299528|526180084|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911345|NCT05299528|526180085|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145911346|NCT05299528|526180079|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911347|NCT05299528|526180080|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911348|NCT05299528|526180081|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911349|NCT05299528|526180082|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911350|NCT05299528|526180083|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911351|NCT05299528|526180084|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
145911352|NCT05299528|526180085|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145911353|NCT05299528|526180079|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
145911354|NCT05299528|526180080|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
146088598|NCT00768469|526843885|FG001|Overall Study|Withdrawal by Subject|1|||
146088599|NCT04966741|526843886|FG000|Overall Study|Lost to Follow-up|1|||
146088600|NCT04966741|526843887|FG001|Overall Study|Lost to Follow-up|0|||
146088601|NCT01582854|526843890|FG000|Overall Study|Death|8|||
146088602|NCT01582854|526843891|FG001|Overall Study|Death|5|||
146088603|NCT01582854|526843890|FG000|Overall Study|Adverse Event|2|||
146088604|NCT01582854|526843891|FG001|Overall Study|Adverse Event|3|||
146088605|NCT01582854|526843890|FG000|Overall Study|Withdrawal by Participant|8|||
146088606|NCT01582854|526843891|FG001|Overall Study|Withdrawal by Participant|11|||
146088607|NCT01582854|526843890|FG000|Overall Study|Lost to Follow-up|1|||
146088608|NCT01582854|526843891|FG001|Overall Study|Lost to Follow-up|2|||
146088609|NCT01582854|526843890|FG000|Overall Study|Physician Decision|0|||
146088610|NCT01582854|526843891|FG001|Overall Study|Physician Decision|1|||
146088611|NCT01582854|526843890|FG000|Overall Study|Recurrent Stroke|13|||
146088612|NCT01582854|526843891|FG001|Overall Study|Recurrent Stroke|8|||
146088613|NCT01582854|526843890|FG000|Overall Study|Disallowed Concomitant Medication|3|||
146088614|NCT01582854|526843891|FG001|Overall Study|Disallowed Concomitant Medication|2|||
146088615|NCT01582854|526843890|FG000|Overall Study|Carotid or Neurosurgery|0|||
146088616|NCT01582854|526843891|FG001|Overall Study|Carotid or Neurosurgery|1|||
146088617|NCT01582854|526843890|FG000|Overall Study|General Anaesthesia|0|||
146088618|NCT01582854|526843891|FG001|Overall Study|General Anaesthesia|1|||
146088619|NCT01582854|526843890|FG000|Overall Study|Other Miscellaneous Reason|1|||
146088620|NCT01582854|526843891|FG001|Overall Study|Other Miscellaneous Reason|0|||
146088621|NCT02953509|526843892|FG000|Overall Study|Death|1|||
146088622|NCT02953509|526843893|FG001|Overall Study|Death|3|||
146088623|NCT02953509|526843894|FG002|Overall Study|Death|3|||
146088624|NCT02953509|526843895|FG003|Overall Study|Death|4|||
146088625|NCT02953509|526843896|FG004|Overall Study|Death|12|||
146088626|NCT02953509|526843897|FG005|Overall Study|Death|3|||
146088627|NCT02953509|526843898|FG006|Overall Study|Death|25|||
146088628|NCT02953509|526843899|FG007|Overall Study|Death|10|||
146088629|NCT02953509|526843900|FG008|Overall Study|Death|21|||
146088630|NCT02953509|526843901|FG009|Overall Study|Death|20|||
146088631|NCT02953509|526843892|FG000|Overall Study|Reason Not Specified|0|||
146088632|NCT02953509|526843893|FG001|Overall Study|Reason Not Specified|2|||
146088633|NCT02953509|526843894|FG002|Overall Study|Reason Not Specified|8|||
146088634|NCT02953509|526843895|FG003|Overall Study|Reason Not Specified|2|||
146088635|NCT02953509|526843896|FG004|Overall Study|Reason Not Specified|11|||
146088636|NCT02953509|526843897|FG005|Overall Study|Reason Not Specified|4|||
146088637|NCT02953509|526843898|FG006|Overall Study|Reason Not Specified|12|||
146088638|NCT02953509|526843899|FG007|Overall Study|Reason Not Specified|2|||
146088639|NCT02953509|526843900|FG008|Overall Study|Reason Not Specified|7|||
146088640|NCT02953509|526843901|FG009|Overall Study|Reason Not Specified|2|||
146088641|NCT02953509|526843892|FG000|Overall Study|Consent Withdrawn|1|||
146088642|NCT02953509|526843893|FG001|Overall Study|Consent Withdrawn|1|||
146088643|NCT02953509|526843894|FG002|Overall Study|Consent Withdrawn|2|||
146088644|NCT02953509|526843895|FG003|Overall Study|Consent Withdrawn|1|||
146088645|NCT02953509|526843896|FG004|Overall Study|Consent Withdrawn|3|||
146088646|NCT02953509|526843897|FG005|Overall Study|Consent Withdrawn|0|||
146088647|NCT02953509|526843898|FG006|Overall Study|Consent Withdrawn|4|||
146088648|NCT02953509|526843899|FG007|Overall Study|Consent Withdrawn|1|||
146088649|NCT02953509|526843900|FG008|Overall Study|Consent Withdrawn|1|||
146088650|NCT02953509|526843901|FG009|Overall Study|Consent Withdrawn|4|||
146088651|NCT02953509|526843892|FG000|Overall Study|Lost to Follow-up|0|||
146088652|NCT02953509|526843893|FG001|Overall Study|Lost to Follow-up|0|||
146088653|NCT02953509|526843894|FG002|Overall Study|Lost to Follow-up|0|||
146088654|NCT02953509|526843895|FG003|Overall Study|Lost to Follow-up|0|||
146088655|NCT02953509|526843896|FG004|Overall Study|Lost to Follow-up|0|||
146088656|NCT02953509|526843897|FG005|Overall Study|Lost to Follow-up|0|||
146088657|NCT02953509|526843898|FG006|Overall Study|Lost to Follow-up|1|||
146088658|NCT02953509|526843899|FG007|Overall Study|Lost to Follow-up|1|||
146088659|NCT02953509|526843900|FG008|Overall Study|Lost to Follow-up|1|||
146088660|NCT02953509|526843901|FG009|Overall Study|Lost to Follow-up|1|||
146088661|NCT02953509|526843892|FG000|Overall Study|Study terminated by sponsor|1|||
146088662|NCT02953509|526843893|FG001|Overall Study|Study terminated by sponsor|0|||
146088663|NCT02953509|526843894|FG002|Overall Study|Study terminated by sponsor|0|||
146088664|NCT02953509|526843895|FG003|Overall Study|Study terminated by sponsor|0|||
146088665|NCT02953509|526843896|FG004|Overall Study|Study terminated by sponsor|0|||
146297433|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
146297434|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
145911355|NCT05299528|526180081|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
145911356|NCT05299528|526180082|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
146088666|NCT02953509|526843897|FG005|Overall Study|Study terminated by sponsor|0|||
146088667|NCT02953509|526843898|FG006|Overall Study|Study terminated by sponsor|1|||
146088668|NCT02953509|526843899|FG007|Overall Study|Study terminated by sponsor|0|||
146088669|NCT02953509|526843900|FG008|Overall Study|Study terminated by sponsor|1|||
146088670|NCT02953509|526843901|FG009|Overall Study|Study terminated by sponsor|1|||
146088671|NCT00484185|526843904|FG000|Overall Study|Lost to Follow-up|44|||
146088672|NCT00484185|526843904|FG000|Overall Study|Other|20|||
146088673|NCT00484185|526843904|FG000|Overall Study|Randomized but not treated|5|||
146088674|NCT00484185|526843904|FG000|Overall Study|Death|2|||
146088675|NCT00459056|526843905|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
145911357|NCT05299528|526180083|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
145911358|NCT05299528|526180084|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
145911359|NCT05299528|526180085|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
145911360|NCT00490841|526180086|FG000|Overall Study|Death|5|||
145911361|NCT00490841|526180086|FG000|Overall Study|Withdrawal by Subject|4|||
145911362|NCT00490841|526180086|FG000|Overall Study|Lost to Follow-up|1|||
145911363|NCT00490841|526180086|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
145911364|NCT04697069|526180087|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
145911365|NCT04697069|526180088|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
145911366|NCT04697069|526180087|FG000|Overall Study|Study termination|2|||
145911367|NCT04697069|526180088|FG001|Overall Study|Study termination|1|||
145911368|NCT02779855|526180089|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
145911369|NCT02779855|526180090|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
145911370|NCT02779855|526180091|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
145911371|NCT01301729|526180092|FG000|Overall Study|Withdrawal by Subject|2|||
145911372|NCT01301729|526180092|FG000|Overall Study|Participant did not Return for Treatment|1|||
145911373|NCT01301729|526180092|FG000|Overall Study|Violated Selection Criteria|1|||
145911374|NCT05794503|526180093|FG000|Overall Study|Operation Cancelled|2|||
145911375|NCT05794503|526180094|FG001|Overall Study|Operation Cancelled|0|||
145911376|NCT05794503|526180093|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
145911377|NCT05794503|526180094|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
145911378|NCT05794503|526180093|FG000|Overall Study|Protocol Violation|1|||
145911379|NCT05794503|526180094|FG001|Overall Study|Protocol Violation|0|||
145911380|NCT02185053|526180095|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
145911381|NCT02185053|526180096|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
145911382|NCT02185053|526180097|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
145911383|NCT02185053|526180095|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
145911384|NCT02185053|526180096|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145911385|NCT02185053|526180097|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145911386|NCT02185053|526180095|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
145911387|NCT02185053|526180096|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
145911388|NCT02185053|526180097|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
145911389|NCT02185053|526180095|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
145911390|NCT02185053|526180096|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
145911391|NCT02185053|526180097|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
145911392|NCT02185053|526180095|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145911393|NCT02185053|526180096|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
145911394|NCT02185053|526180097|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145911395|NCT02185053|526180095|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
145911396|NCT02185053|526180096|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
145911397|NCT02185053|526180097|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
145911398|NCT02185053|526180095|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
145911399|NCT02185053|526180096|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
145911400|NCT02185053|526180097|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
145911401|NCT02185053|526180095|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
145911402|NCT02185053|526180096|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
145911403|NCT02185053|526180097|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
145911404|NCT00338728|526180103|FG000|Overall Study|Screen Failure|14|||
145911405|NCT01862484|526180104|FG000|Overall Study|Lack of Efficacy|1|||
145911406|NCT01862484|526180105|FG001|Overall Study|Lack of Efficacy|1|||
145911407|NCT01862484|526180104|FG000|Overall Study|Lost to Follow-up|1|||
145911408|NCT01862484|526180105|FG001|Overall Study|Lost to Follow-up|2|||
145911409|NCT01862484|526180104|FG000|Overall Study|Protocol Violation|0|||
145911410|NCT01862484|526180105|FG001|Overall Study|Protocol Violation|2|||
145911411|NCT01862484|526180104|FG000|Overall Study|Withdrawal by Subject|0|||
145911412|NCT01862484|526180105|FG001|Overall Study|Withdrawal by Subject|3|||
146088676|NCT00459056|526843906|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
146088677|NCT01222403|526843909|FG000|Overall Study|Inappropriate enrollment|0|||
145911413|NCT00721227|526180106|FG000|Overall Study|Lost to Follow-up|3|||
145911414|NCT00721227|526180107|FG001|Overall Study|Lost to Follow-up|0|||
145911415|NCT00721227|526180106|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
145911416|NCT00721227|526180107|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
145911417|NCT02759692|526180108|FG000|Period 1|Test article no longer available|1|||
145911418|NCT02759692|526180109|FG001|Period 1|Test article no longer available|1|||
145911419|NCT02759692|526180108|FG000|Period 1|No longer meets eligibility criteria.|1|||
145911420|NCT02759692|526180109|FG001|Period 1|No longer meets eligibility criteria.|0|||
145911421|NCT02759692|526180108|FG000|Period 1|Miss-Randomized|1|||
145911422|NCT02759692|526180109|FG001|Period 1|Miss-Randomized|1|||
145911423|NCT02759692|526180108|FG000|Period 2|Lost to Follow-up|1|||
145911424|NCT02759692|526180109|FG001|Period 2|Lost to Follow-up|0|||
145911425|NCT02759692|526180108|FG000|Period 2|Test article no longer available|0|||
145973239|NCT05032196|526414238|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145973240|NCT05032196|526414239|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145973241|NCT05032196|526414240|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145911426|NCT02759692|526180109|FG001|Period 2|Test article no longer available|1|||
145911427|NCT01954745|526180110|FG000|Overall Study|Radiological Progression|11|||
145911428|NCT01954745|526180110|FG000|Overall Study|Clinical Progression|5|||
145911429|NCT01954745|526180110|FG000|Overall Study|Adverse Event|2|||
145911430|NCT01954745|526180110|FG000|Overall Study|Death|1|||
145911431|NCT03207867|526180113|FG000|Overall Study|Adverse Event|1|||
145911432|NCT03207867|526180114|FG001|Overall Study|Adverse Event|0|||
145911433|NCT03207867|526180115|FG002|Overall Study|Adverse Event|1|||
145911434|NCT03207867|526180116|FG003|Overall Study|Adverse Event|0|||
145911435|NCT03207867|526180117|FG004|Overall Study|Adverse Event|0|||
145911436|NCT03207867|526180118|FG005|Overall Study|Adverse Event|2|||
145911437|NCT03207867|526180119|FG006|Overall Study|Adverse Event|1|||
145911438|NCT03207867|526180120|FG007|Overall Study|Adverse Event|1|||
145911439|NCT03207867|526180121|FG008|Overall Study|Adverse Event|2|||
145911440|NCT03207867|526180122|FG009|Overall Study|Adverse Event|2|||
145911441|NCT03207867|526180123|FG010|Overall Study|Adverse Event|0|||
145911442|NCT03207867|526180124|FG011|Overall Study|Adverse Event|0|||
145911443|NCT03207867|526180125|FG012|Overall Study|Adverse Event|0|||
145911444|NCT03207867|526180126|FG013|Overall Study|Adverse Event|0|||
145911445|NCT03207867|526180127|FG014|Overall Study|Adverse Event|0|||
145911446|NCT03207867|526180128|FG015|Overall Study|Adverse Event|0|||
145911447|NCT03207867|526180129|FG016|Overall Study|Adverse Event|3|||
145911448|NCT03207867|526180130|FG017|Overall Study|Adverse Event|1|||
145911449|NCT03207867|526180131|FG018|Overall Study|Adverse Event|2|||
145911450|NCT03207867|526180132|FG019|Overall Study|Adverse Event|1|||
145911451|NCT03207867|526180133|FG020|Overall Study|Adverse Event|0|||
145911452|NCT03207867|526180134|FG021|Overall Study|Adverse Event|0|||
145911453|NCT03207867|526180135|FG022|Overall Study|Adverse Event|0|||
145911454|NCT03207867|526180136|FG023|Overall Study|Adverse Event|0|||
145911455|NCT03207867|526180113|FG000|Overall Study|Death|0|||
145911456|NCT03207867|526180114|FG001|Overall Study|Death|0|||
145911457|NCT03207867|526180115|FG002|Overall Study|Death|0|||
145911458|NCT03207867|526180116|FG003|Overall Study|Death|0|||
145911459|NCT03207867|526180117|FG004|Overall Study|Death|0|||
145911460|NCT03207867|526180118|FG005|Overall Study|Death|1|||
145911461|NCT03207867|526180119|FG006|Overall Study|Death|0|||
145911462|NCT03207867|526180120|FG007|Overall Study|Death|3|||
145911463|NCT03207867|526180121|FG008|Overall Study|Death|1|||
145973242|NCT05032196|526414241|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
146297435|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
146297436|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
146297437|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
146297438|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
146297439|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
146297440|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
146297441|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
146297442|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
146297443|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
146297444|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
146297445|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
146297446|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
146297447|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
146297448|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
146297449|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
146297450|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
146297451|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
146297452|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
145911464|NCT03207867|526180122|FG009|Overall Study|Death|2|||
145973243|NCT05032196|526414242|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145973244|NCT05032196|526414243|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145973245|NCT05032196|526414238|FG000|Period 2 (Multidose)|Physician Decision|0|||
145973246|NCT05032196|526414239|FG001|Period 2 (Multidose)|Physician Decision|0|||
145973247|NCT05032196|526414240|FG002|Period 2 (Multidose)|Physician Decision|0|||
146297453|NCT01641809|527604692|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
146297454|NCT01641809|527604693|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
145911465|NCT03207867|526180123|FG010|Overall Study|Death|0|||
146297455|NCT01641809|527604694|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
145911466|NCT03207867|526180124|FG011|Overall Study|Death|1|||
145911467|NCT03207867|526180125|FG012|Overall Study|Death|0|||
145911468|NCT03207867|526180126|FG013|Overall Study|Death|1|||
145911469|NCT03207867|526180127|FG014|Overall Study|Death|0|||
145911470|NCT03207867|526180128|FG015|Overall Study|Death|0|||
145911471|NCT03207867|526180129|FG016|Overall Study|Death|0|||
145911472|NCT03207867|526180130|FG017|Overall Study|Death|2|||
145911473|NCT03207867|526180131|FG018|Overall Study|Death|0|||
145911474|NCT03207867|526180132|FG019|Overall Study|Death|1|||
145911475|NCT03207867|526180133|FG020|Overall Study|Death|0|||
145911476|NCT03207867|526180134|FG021|Overall Study|Death|0|||
145911477|NCT03207867|526180135|FG022|Overall Study|Death|0|||
145911478|NCT03207867|526180136|FG023|Overall Study|Death|0|||
145911479|NCT03207867|526180113|FG000|Overall Study|Physician Decision|3|||
145911480|NCT03207867|526180114|FG001|Overall Study|Physician Decision|5|||
145911481|NCT03207867|526180115|FG002|Overall Study|Physician Decision|0|||
145911482|NCT03207867|526180116|FG003|Overall Study|Physician Decision|3|||
145911483|NCT03207867|526180117|FG004|Overall Study|Physician Decision|2|||
145911484|NCT03207867|526180118|FG005|Overall Study|Physician Decision|0|||
145911485|NCT03207867|526180119|FG006|Overall Study|Physician Decision|0|||
145911486|NCT03207867|526180120|FG007|Overall Study|Physician Decision|0|||
145911487|NCT03207867|526180121|FG008|Overall Study|Physician Decision|4|||
145911488|NCT03207867|526180122|FG009|Overall Study|Physician Decision|2|||
145911489|NCT03207867|526180123|FG010|Overall Study|Physician Decision|0|||
145911490|NCT03207867|526180124|FG011|Overall Study|Physician Decision|4|||
145911491|NCT03207867|526180125|FG012|Overall Study|Physician Decision|0|||
145911492|NCT03207867|526180126|FG013|Overall Study|Physician Decision|0|||
145911493|NCT03207867|526180127|FG014|Overall Study|Physician Decision|2|||
145911494|NCT03207867|526180128|FG015|Overall Study|Physician Decision|1|||
145911495|NCT03207867|526180129|FG016|Overall Study|Physician Decision|1|||
145911496|NCT03207867|526180130|FG017|Overall Study|Physician Decision|2|||
145911497|NCT03207867|526180131|FG018|Overall Study|Physician Decision|1|||
145911498|NCT03207867|526180132|FG019|Overall Study|Physician Decision|3|||
145911499|NCT03207867|526180133|FG020|Overall Study|Physician Decision|0|||
145911500|NCT03207867|526180134|FG021|Overall Study|Physician Decision|0|||
145911501|NCT03207867|526180135|FG022|Overall Study|Physician Decision|0|||
145911502|NCT03207867|526180136|FG023|Overall Study|Physician Decision|0|||
145911503|NCT03207867|526180113|FG000|Overall Study|Progressive Disease|7|||
145911504|NCT03207867|526180114|FG001|Overall Study|Progressive Disease|7|||
145911505|NCT03207867|526180115|FG002|Overall Study|Progressive Disease|9|||
145911506|NCT03207867|526180116|FG003|Overall Study|Progressive Disease|10|||
145911507|NCT03207867|526180117|FG004|Overall Study|Progressive Disease|11|||
145911508|NCT03207867|526180118|FG005|Overall Study|Progressive Disease|10|||
145911509|NCT03207867|526180119|FG006|Overall Study|Progressive Disease|9|||
145911510|NCT03207867|526180120|FG007|Overall Study|Progressive Disease|8|||
145911511|NCT03207867|526180121|FG008|Overall Study|Progressive Disease|19|||
145911512|NCT03207867|526180122|FG009|Overall Study|Progressive Disease|23|||
145911513|NCT03207867|526180123|FG010|Overall Study|Progressive Disease|2|||
145911514|NCT03207867|526180124|FG011|Overall Study|Progressive Disease|24|||
145911515|NCT03207867|526180125|FG012|Overall Study|Progressive Disease|3|||
145973248|NCT05032196|526414241|FG003|Period 2 (Multidose)|Physician Decision|0|||
145973249|NCT05032196|526414242|FG004|Period 2 (Multidose)|Physician Decision|1|||
145973250|NCT05032196|526414243|FG005|Period 2 (Multidose)|Physician Decision|0|||
145973251|NCT00857389|526414244|FG000|Overall Study|Did not proceed to transplant|2|||
145973252|NCT05260008|526414245|FG000|Overall Study|Physician Decision|0|||
145973253|NCT05260008|526414246|FG001|Overall Study|Physician Decision|1|||
145973254|NCT05260008|526414247|FG002|Overall Study|Physician Decision|0|||
145973255|NCT05260008|526414248|FG003|Overall Study|Physician Decision|0|||
146056116|NCT00117637|526721100|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
146056117|NCT00117637|526721099|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
146056118|NCT00117637|526721100|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
146056119|NCT00117637|526721099|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
146056120|NCT00117637|526721100|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
146056121|NCT00117637|526721099|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
146056122|NCT00117637|526721100|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
146056123|NCT00117637|526721099|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
146056124|NCT00117637|526721100|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
146056125|NCT00117637|526721099|FG000|Second Intervention (Period 2)|reason not reported|1|||
146056126|NCT00117637|526721100|FG001|Second Intervention (Period 2)|reason not reported|0|||
146056127|NCT01620060|526721102|FG000|Overall Study|Adverse Event|9|||
146056128|NCT01620060|526721102|FG000|Overall Study|Protocol Violation|1|||
146056129|NCT01620060|526721102|FG000|Overall Study|Withdrawal by Subject|1|||
146056130|NCT01620060|526721102|FG000|Overall Study|Did not comply with Study Produre|1|||
145911516|NCT03207867|526180126|FG013|Overall Study|Progressive Disease|11|||
145911517|NCT03207867|526180127|FG014|Overall Study|Progressive Disease|9|||
145911518|NCT03207867|526180128|FG015|Overall Study|Progressive Disease|5|||
145911519|NCT03207867|526180129|FG016|Overall Study|Progressive Disease|10|||
145911520|NCT03207867|526180130|FG017|Overall Study|Progressive Disease|14|||
145911521|NCT03207867|526180131|FG018|Overall Study|Progressive Disease|13|||
145911522|NCT03207867|526180132|FG019|Overall Study|Progressive Disease|14|||
146056131|NCT01620060|526721102|FG000|Overall Study|Family emergency|1|||
145911523|NCT03207867|526180133|FG020|Overall Study|Progressive Disease|6|||
145911524|NCT03207867|526180134|FG021|Overall Study|Progressive Disease|3|||
145911525|NCT03207867|526180135|FG022|Overall Study|Progressive Disease|3|||
145911526|NCT03207867|526180136|FG023|Overall Study|Progressive Disease|3|||
145911527|NCT03207867|526180113|FG000|Overall Study|Patient/guardian Decision|0|||
145911528|NCT03207867|526180114|FG001|Overall Study|Patient/guardian Decision|0|||
145911529|NCT03207867|526180115|FG002|Overall Study|Patient/guardian Decision|1|||
145911530|NCT03207867|526180116|FG003|Overall Study|Patient/guardian Decision|1|||
145911531|NCT03207867|526180117|FG004|Overall Study|Patient/guardian Decision|1|||
145911532|NCT03207867|526180118|FG005|Overall Study|Patient/guardian Decision|2|||
145911533|NCT03207867|526180119|FG006|Overall Study|Patient/guardian Decision|1|||
145911534|NCT03207867|526180120|FG007|Overall Study|Patient/guardian Decision|0|||
145911535|NCT03207867|526180121|FG008|Overall Study|Patient/guardian Decision|1|||
145911536|NCT03207867|526180122|FG009|Overall Study|Patient/guardian Decision|0|||
145911537|NCT03207867|526180123|FG010|Overall Study|Patient/guardian Decision|0|||
145911538|NCT03207867|526180124|FG011|Overall Study|Patient/guardian Decision|1|||
145911539|NCT03207867|526180125|FG012|Overall Study|Patient/guardian Decision|0|||
145911540|NCT03207867|526180126|FG013|Overall Study|Patient/guardian Decision|1|||
145911541|NCT03207867|526180127|FG014|Overall Study|Patient/guardian Decision|2|||
145911542|NCT03207867|526180128|FG015|Overall Study|Patient/guardian Decision|0|||
145911543|NCT03207867|526180129|FG016|Overall Study|Patient/guardian Decision|1|||
145911544|NCT03207867|526180130|FG017|Overall Study|Patient/guardian Decision|3|||
145911545|NCT03207867|526180131|FG018|Overall Study|Patient/guardian Decision|4|||
145911546|NCT03207867|526180132|FG019|Overall Study|Patient/guardian Decision|1|||
145911547|NCT03207867|526180133|FG020|Overall Study|Patient/guardian Decision|0|||
145911548|NCT03207867|526180134|FG021|Overall Study|Patient/guardian Decision|0|||
145911549|NCT03207867|526180135|FG022|Overall Study|Patient/guardian Decision|0|||
145911550|NCT03207867|526180136|FG023|Overall Study|Patient/guardian Decision|0|||
145911551|NCT05422625|526180137|FG000|Overall Study|Withdrawal by Subject|1|||
145911552|NCT05422625|526180138|FG001|Overall Study|Withdrawal by Subject|0|||
145911553|NCT02731638|526181879|FG000|Overall Study|Lost to Follow-up|6|||
145911554|NCT02731638|526181880|FG001|Overall Study|Lost to Follow-up|9|||
145911555|NCT02454608|526181881|FG000|Double-Blind Period|Lack of Efficacy|0|||
145911556|NCT02454608|526181882|FG001|Double-Blind Period|Lack of Efficacy|2|||
145911557|NCT02454608|526181883|FG002|Double-Blind Period|Lack of Efficacy|0|||
145911558|NCT02454608|526181881|FG000|Open Label Period|Lost to Follow-up|0|||
145911559|NCT02454608|526181882|FG001|Open Label Period|Lost to Follow-up|0|||
145911560|NCT02454608|526181883|FG002|Open Label Period|Lost to Follow-up|11|||
145911561|NCT02454608|526181881|FG000|Open Label Period|Withdrawal by Subject|0|||
145911562|NCT02454608|526181882|FG001|Open Label Period|Withdrawal by Subject|0|||
145911563|NCT02454608|526181883|FG002|Open Label Period|Withdrawal by Subject|8|||
145911564|NCT01769456|526181888|FG000|Overall Study|Lost to Follow-up|19|||
145911565|NCT01769456|526181888|FG000|Overall Study|Withdrawal by Subject|3|||
145911566|NCT01769456|526181888|FG000|Overall Study|Did not receive PCC intervention|6|||
145911567|NCT01769456|526181888|FG000|Overall Study|Moved out of the area|3|||
146239251|NCT03389802|527389761|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
145911568|NCT01769456|526181888|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
145911569|NCT01769456|526181888|FG000|Overall Study|Parental request to youth to withdraw|1|||
145911570|NCT05244122|526181895|FG000|Overall Study|Withdrawal by Subject|318|||
145911571|NCT02969382|526181900|FG000|Overall Study|Adverse Event|8|||
145911572|NCT02969382|526181901|FG001|Overall Study|Adverse Event|10|||
145911573|NCT02969382|526181900|FG000|Overall Study|Lack of Efficacy|4|||
146239252|NCT03389802|527389762|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
146239253|NCT03389802|527389763|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
146239254|NCT03389802|527389764|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
145911574|NCT02969382|526181901|FG001|Overall Study|Lack of Efficacy|5|||
145911575|NCT02969382|526181900|FG000|Overall Study|Death|0|||
145911576|NCT02969382|526181901|FG001|Overall Study|Death|1|||
145911577|NCT02969382|526181900|FG000|Overall Study|PROTOCOL DEVIATION|0|||
145911578|NCT02969382|526181901|FG001|Overall Study|PROTOCOL DEVIATION|1|||
145911579|NCT02969382|526181900|FG000|Overall Study|Withdrawal by Subject|14|||
145911580|NCT02969382|526181901|FG001|Overall Study|Withdrawal by Subject|9|||
145911581|NCT01214655|526181902|FG000|Part A|Progressive Disease|7|||
145911582|NCT01214655|526181903|FG001|Part A|Progressive Disease|0|||
145973256|NCT02472405|526416345|FG000|Overall Study|Lost to Follow-up|9|||
145973257|NCT02472405|526416345|FG000|Overall Study|Adverse Event|1|||
145973258|NCT01134042|526416346|FG000|Overall Study|Adverse Event|3|||
145973259|NCT01134042|526416347|FG001|Overall Study|Adverse Event|7|||
145973260|NCT01134042|526416348|FG002|Overall Study|Adverse Event|2|||
145973261|NCT01134042|526416346|FG000|Overall Study|Lack of Efficacy|21|||
145973262|NCT01134042|526416347|FG001|Overall Study|Lack of Efficacy|6|||
145973263|NCT01134042|526416348|FG002|Overall Study|Lack of Efficacy|18|||
145973264|NCT01134042|526416346|FG000|Overall Study|Protocol Violation|5|||
145973265|NCT01134042|526416347|FG001|Overall Study|Protocol Violation|3|||
145973266|NCT01134042|526416348|FG002|Overall Study|Protocol Violation|5|||
145973267|NCT01134042|526416346|FG000|Overall Study|Lost to Follow-up|2|||
145973268|NCT01134042|526416347|FG001|Overall Study|Lost to Follow-up|0|||
145973269|NCT01134042|526416348|FG002|Overall Study|Lost to Follow-up|1|||
145973270|NCT01134042|526416346|FG000|Overall Study|Physician Decision|4|||
145973271|NCT01134042|526416347|FG001|Overall Study|Physician Decision|8|||
145973272|NCT01134042|526416348|FG002|Overall Study|Physician Decision|1|||
145911583|NCT01214655|526181904|FG002|Part A|Progressive Disease|0|||
145911584|NCT01214655|526181902|FG000|Part A|Physician Decision|1|||
145911585|NCT01214655|526181903|FG001|Part A|Physician Decision|0|||
145911586|NCT01214655|526181904|FG002|Part A|Physician Decision|0|||
145911587|NCT01214655|526181902|FG000|Part B|Progressive disease|0|||
145911588|NCT01214655|526181903|FG001|Part B|Progressive disease|10|||
145911589|NCT01214655|526181904|FG002|Part B|Progressive disease|0|||
145911590|NCT01214655|526181902|FG000|Part B|Death|0|||
145911591|NCT01214655|526181903|FG001|Part B|Death|1|||
145911592|NCT01214655|526181904|FG002|Part B|Death|0|||
145911593|NCT01214655|526181902|FG000|Part B|Withdrawal by Subject|0|||
145911594|NCT01214655|526181903|FG001|Part B|Withdrawal by Subject|2|||
145911595|NCT01214655|526181904|FG002|Part B|Withdrawal by Subject|0|||
145911596|NCT01214655|526181902|FG000|Part C|Progressive Disease|0|||
145911597|NCT01214655|526181903|FG001|Part C|Progressive Disease|0|||
145911598|NCT01214655|526181904|FG002|Part C|Progressive Disease|5|||
145911599|NCT01214655|526181902|FG000|Part C|Death|0|||
145973273|NCT01134042|526416346|FG000|Overall Study|Withdrawal by Subject|13|||
145973274|NCT01134042|526416347|FG001|Overall Study|Withdrawal by Subject|4|||
145973275|NCT01134042|526416348|FG002|Overall Study|Withdrawal by Subject|7|||
145973276|NCT05350423|526416351|FG000|Overall Study|Lost to Follow-up|3|||
145973277|NCT05350423|526416352|FG001|Overall Study|Lost to Follow-up|3|||
145973278|NCT05350423|526416351|FG000|Overall Study|screen failure|5|||
145973279|NCT05350423|526416352|FG001|Overall Study|screen failure|6|||
145973280|NCT02097277|526416358|FG000|Overall Study|Subject no longer meets study criteria|0|||
145973281|NCT02097277|526416359|FG001|Overall Study|Subject no longer meets study criteria|1|||
145973282|NCT02097277|526416360|FG002|Overall Study|Subject no longer meets study criteria|0|||
145973283|NCT02097277|526416361|FG003|Overall Study|Subject no longer meets study criteria|1|||
145973284|NCT02097277|526416362|FG004|Overall Study|Subject no longer meets study criteria|0|||
145973285|NCT02097277|526416358|FG000|Overall Study|Subject request to discontinue treatment|0|||
145973286|NCT02097277|526416359|FG001|Overall Study|Subject request to discontinue treatment|0|||
145973287|NCT02097277|526416360|FG002|Overall Study|Subject request to discontinue treatment|0|||
145973288|NCT02097277|526416361|FG003|Overall Study|Subject request to discontinue treatment|0|||
145973289|NCT02097277|526416362|FG004|Overall Study|Subject request to discontinue treatment|1|||
145973290|NCT02097277|526416358|FG000|Overall Study|Lost to Follow-up|0|||
145973291|NCT02097277|526416359|FG001|Overall Study|Lost to Follow-up|1|||
145973292|NCT02097277|526416360|FG002|Overall Study|Lost to Follow-up|1|||
145973293|NCT02097277|526416361|FG003|Overall Study|Lost to Follow-up|0|||
145973294|NCT02097277|526416362|FG004|Overall Study|Lost to Follow-up|0|||
145973295|NCT02097277|526416358|FG000|Overall Study|Withdrawal by Subject|2|||
145973296|NCT02097277|526416359|FG001|Overall Study|Withdrawal by Subject|1|||
145973297|NCT02097277|526416360|FG002|Overall Study|Withdrawal by Subject|0|||
145973298|NCT02097277|526416361|FG003|Overall Study|Withdrawal by Subject|1|||
145973299|NCT02097277|526416362|FG004|Overall Study|Withdrawal by Subject|0|||
145973300|NCT02097277|526416358|FG000|Overall Study|Adverse Event|0|||
145973301|NCT02097277|526416359|FG001|Overall Study|Adverse Event|0|||
145973302|NCT02097277|526416360|FG002|Overall Study|Adverse Event|1|||
145973303|NCT02097277|526416361|FG003|Overall Study|Adverse Event|2|||
145973304|NCT02097277|526416362|FG004|Overall Study|Adverse Event|0|||
145973305|NCT01091259|526416365|FG000|Overall Study|Adverse Event|3|||
145973306|NCT01091259|526416365|FG000|Overall Study|Lack of Efficacy|2|||
145973307|NCT03320369|526416366|FG000|Overall Study|Adverse Event|1|||
145973308|NCT03320369|526416366|FG000|Overall Study|Withdrawal by Subject|2|||
145973309|NCT01137786|526416369|FG000|Overall Study|Lost to Follow-up|0|||
145973310|NCT01137786|526416370|FG001|Overall Study|Lost to Follow-up|2|||
145973311|NCT01137786|526416369|FG000|Overall Study|Withdrawal by Subject|1|||
145973312|NCT01137786|526416370|FG001|Overall Study|Withdrawal by Subject|1|||
145973313|NCT00770367|526416371|FG000|First Intervention|Withdrawal by Subject|0|||
145973314|NCT00770367|526416372|FG001|First Intervention|Withdrawal by Subject|2|||
145973315|NCT00770367|526416371|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
145973316|NCT00770367|526416372|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
145973317|NCT00770367|526416371|FG000|Second Intervention|Lost to Follow-up|2|||
145973318|NCT00770367|526416372|FG001|Second Intervention|Lost to Follow-up|0|||
145973319|NCT04727749|526416373|FG000|Overall Study|Lost to Follow-up|10|||
145973320|NCT04727749|526416374|FG001|Overall Study|Lost to Follow-up|3|||
145973321|NCT00716417|526416376|FG000|Overall Study|Adverse Event|0|||
145973322|NCT00716417|526416377|FG001|Overall Study|Adverse Event|0|||
145973323|NCT00716417|526416378|FG002|Overall Study|Adverse Event|2|||
145973324|NCT00716417|526416379|FG003|Overall Study|Adverse Event|1|||
145911600|NCT01214655|526181903|FG001|Part C|Death|0|||
145911601|NCT01214655|526181904|FG002|Part C|Death|1|||
146239255|NCT01706159|527389765|FG000|Overall Study|Withdrawal Criteria|2|||
145911602|NCT01214655|526181902|FG000|Part C|Physician Decision|0|||
145911603|NCT01214655|526181903|FG001|Part C|Physician Decision|0|||
145911604|NCT01214655|526181904|FG002|Part C|Physician Decision|1|||
145973325|NCT00716417|526416380|FG004|Overall Study|Adverse Event|0|||
145973326|NCT00716417|526416381|FG005|Overall Study|Adverse Event|0|||
145973327|NCT00716417|526416382|FG006|Overall Study|Adverse Event|3|||
145973328|NCT00716417|526416383|FG007|Overall Study|Adverse Event|1|||
146088678|NCT01222403|526843910|FG001|Overall Study|Inappropriate enrollment|2|||
146088679|NCT00725842|526843911|FG000|Overall Study|Lost to Follow-up|19|||
146088680|NCT00725842|526843911|FG000|Overall Study|Death|1|||
146088681|NCT00725842|526843911|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
146088682|NCT00725842|526843911|FG000|Overall Study|Consent date prior to study start date|5|||
146088683|NCT00725842|526843911|FG000|Overall Study|Inclusion criterion not met|1|||
146088684|NCT00725842|526843911|FG000|Overall Study|No Visit 1 data|1|||
146088685|NCT02793622|526843915|FG000|Overall Study|Lost to Follow-up|31|||
146088686|NCT02793622|526843916|FG001|Overall Study|Lost to Follow-up|19|||
146088687|NCT02793622|526843915|FG000|Overall Study|Withdrawal by Subject|21|||
146088688|NCT02793622|526843916|FG001|Overall Study|Withdrawal by Subject|17|||
146088689|NCT02793622|526843915|FG000|Overall Study|Adverse Event|0|||
146088690|NCT02793622|526843916|FG001|Overall Study|Adverse Event|1|||
146088691|NCT02793622|526843915|FG000|Overall Study|Protocol Violation|1|||
146088692|NCT02793622|526843916|FG001|Overall Study|Protocol Violation|5|||
146088693|NCT02068768|526843917|FG000|Overall Study|Lost to Follow-up|5|||
146088694|NCT02068768|526843917|FG000|Overall Study|Early Termination by Sponsor|2|||
146088695|NCT01683019|526845029|FG000|Overall Study|Withdrawal by Subject|2|||
146088696|NCT01683019|526845030|FG001|Overall Study|Withdrawal by Subject|1|||
146088697|NCT01683019|526845031|FG002|Overall Study|Withdrawal by Subject|4|||
146088698|NCT04050371|526845037|FG000|Overall Study|Withdrawal by Subject|1|||
146088699|NCT04050371|526845038|FG001|Overall Study|Withdrawal by Subject|0|||
146088700|NCT00597701|526845039|FG000|Overall Study|Withdrawal by Subject|5|||
146088701|NCT00597701|526845040|FG001|Overall Study|Withdrawal by Subject|5|||
146088702|NCT00597701|526845039|FG000|Overall Study|Death|0|||
146088703|NCT00597701|526845040|FG001|Overall Study|Death|1|||
146088704|NCT00597701|526845039|FG000|Overall Study|Physician Decision|2|||
146088705|NCT00597701|526845040|FG001|Overall Study|Physician Decision|0|||
146088706|NCT00597701|526845039|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
146088707|NCT00597701|526845040|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
146088708|NCT01107418|526845041|FG000|Overall Study|Disease Progression|45|||
146088709|NCT01107418|526845041|FG000|Overall Study|Adverse Event|3|||
146088710|NCT01107418|526845041|FG000|Overall Study|Withdrawal by Subject|1|||
146088711|NCT01107418|526845041|FG000|Overall Study|Study Closing|1|||
146088712|NCT01107418|526845041|FG000|Overall Study|Started Other Therapy|1|||
146088713|NCT01107418|526845041|FG000|Overall Study|Entered Extension Study|1|||
146088714|NCT01155219|526845045|FG000|Overall Study|Adverse Event|3|||
146088715|NCT01155219|526845046|FG001|Overall Study|Adverse Event|1|||
146088716|NCT01155219|526845045|FG000|Overall Study|non-medical reason|1|||
146088717|NCT01155219|526845046|FG001|Overall Study|non-medical reason|2|||
146088718|NCT01394718|526845047|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
146088719|NCT01394718|526845048|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
146088720|NCT01547780|526845049|FG000|Baseline PET Scan|Physician Decision|1|||
146088721|NCT01547780|526845050|FG001|Baseline PET Scan|Physician Decision|0|||
146088722|NCT01547780|526845051|FG002|Baseline PET Scan|Physician Decision|1|||
146088723|NCT01547780|526845052|FG003|Baseline PET Scan|Physician Decision|0|||
146088724|NCT01547780|526845049|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
146088725|NCT01547780|526845050|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
146088726|NCT01547780|526845051|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
146088727|NCT01547780|526845052|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
146088728|NCT01362595|526845056|FG000|Overall Study|Screen failure|10|||
146088729|NCT01362595|526845056|FG000|Overall Study|Withdrawal by Subject|2|||
146088730|NCT00959374|526845057|FG000|Overall Study|Withdrawal by Subject|2|||
146088731|NCT00959374|526845057|FG000|Overall Study|Lost to Follow-up|14|||
146088732|NCT00959374|526845057|FG000|Overall Study|Death|1|||
146088733|NCT00959374|526845057|FG000|Overall Study|Protocol Violation|1|||
146088734|NCT00959374|526845057|FG000|Overall Study|Implant Removed/Not Replaced|4|||
146088735|NCT00959374|526845057|FG000|Overall Study|Physician Decision|1|||
146088736|NCT02448680|526845058|FG000|Overall Study|Physician Decision|1|||
146088737|NCT02448680|526845059|FG001|Overall Study|Physician Decision|1|||
146088738|NCT02448680|526845058|FG000|Overall Study|Withdrawal by Subject|0|||
146088739|NCT02448680|526845059|FG001|Overall Study|Withdrawal by Subject|2|||
146088740|NCT01736657|526845060|FG000|Overall Study|insufficient vascular access|1|||
146088741|NCT00749580|526845069|FG000|Overall Study|Lost to Follow-up|4|||
146088742|NCT00749580|526845070|FG001|Overall Study|Lost to Follow-up|8|||
146088743|NCT00749580|526845069|FG000|Overall Study|Adverse Event|0|||
146088744|NCT00749580|526845070|FG001|Overall Study|Adverse Event|1|||
146088745|NCT00740246|526845076|FG000|Overall Study|Received Blood Transfusion|0|||
146088746|NCT00740246|526845077|FG001|Overall Study|Received Blood Transfusion|1|||
146088747|NCT00740246|526845076|FG000|Overall Study|Adverse Event|1|||
146088748|NCT00740246|526845077|FG001|Overall Study|Adverse Event|2|||
146088749|NCT00740246|526845076|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
145911605|NCT01977417|526181906|FG000|Overall Study|Adverse Event|1|||
145911606|NCT01977417|526181907|FG001|Overall Study|Adverse Event|0|||
146088750|NCT00740246|526845077|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
146088751|NCT00740246|526845076|FG000|Overall Study|Lost to Follow-up|2|||
146088752|NCT00740246|526845077|FG001|Overall Study|Lost to Follow-up|2|||
145911607|NCT01977417|526181906|FG000|Overall Study|Withdrawal by Subject|2|||
145911608|NCT01977417|526181907|FG001|Overall Study|Withdrawal by Subject|4|||
145911609|NCT01977417|526181906|FG000|Overall Study|Female enrollment goal met|0|||
145911610|NCT01977417|526181907|FG001|Overall Study|Female enrollment goal met|2|||
145911611|NCT01692626|526181908|FG000|Overall Study|Death|0|||
145911612|NCT01692626|526181909|FG001|Overall Study|Death|1|||
145911613|NCT01692626|526181908|FG000|Overall Study|Adverse Event|2|||
145911614|NCT01692626|526181909|FG001|Overall Study|Adverse Event|3|||
145911615|NCT01692626|526181908|FG000|Overall Study|Protocol Violation|1|||
145911616|NCT01692626|526181909|FG001|Overall Study|Protocol Violation|2|||
145911617|NCT01692626|526181908|FG000|Overall Study|Withdrawal by Subject|1|||
145911618|NCT01692626|526181909|FG001|Overall Study|Withdrawal by Subject|0|||
145911619|NCT02794870|526181917|FG000|Overall Study|Withdrawal by Subject|2|||
145911620|NCT02794870|526181918|FG001|Overall Study|Withdrawal by Subject|0|||
145911621|NCT01495702|526181919|FG000|Randomized Phase|Randomized But Not Treated|1|||
145911622|NCT01495702|526181920|FG001|Randomized Phase|Randomized But Not Treated|4|||
145911623|NCT01495702|526181919|FG000|Randomized Phase|Adverse Event|2|||
145911624|NCT01495702|526181920|FG001|Randomized Phase|Adverse Event|2|||
145911625|NCT01495702|526181919|FG000|Randomized Phase|Death|1|||
145911626|NCT01495702|526181920|FG001|Randomized Phase|Death|0|||
145911627|NCT01495702|526181919|FG000|Randomized Phase|Lack of Efficacy|2|||
145911628|NCT01495702|526181920|FG001|Randomized Phase|Lack of Efficacy|0|||
145911629|NCT01495702|526181919|FG000|Randomized Phase|Investigators Discretion|2|||
145911630|NCT01495702|526181920|FG001|Randomized Phase|Investigators Discretion|0|||
145911631|NCT01495702|526181919|FG000|Randomized Phase|Withdrew Consent|10|||
145911632|NCT01495702|526181920|FG001|Randomized Phase|Withdrew Consent|18|||
145911633|NCT01495702|526181919|FG000|Randomized Phase|Lost to Follow-up|4|||
145911634|NCT01495702|526181920|FG001|Randomized Phase|Lost to Follow-up|3|||
145911635|NCT01495702|526181919|FG000|Randomized Phase|Participant Noncompliance|1|||
145911636|NCT01495702|526181920|FG001|Randomized Phase|Participant Noncompliance|0|||
145911637|NCT01495702|526181919|FG000|Randomized Phase|Protocol Violation|3|||
145911638|NCT01495702|526181920|FG001|Randomized Phase|Protocol Violation|1|||
145911639|NCT04152863|526181921|FG000|Overall Study|Death|13|||
145911640|NCT04152863|526181922|FG001|Overall Study|Death|12|||
145911641|NCT04152863|526181923|FG002|Overall Study|Death|7|||
145911642|NCT04152863|526181921|FG000|Overall Study|Physician Decision|1|||
145911643|NCT04152863|526181922|FG001|Overall Study|Physician Decision|1|||
145911644|NCT04152863|526181923|FG002|Overall Study|Physician Decision|1|||
145911645|NCT04152863|526181921|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
145911646|NCT04152863|526181922|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
145911647|NCT04152863|526181923|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
145911648|NCT04152863|526181921|FG000|Overall Study|Withdrawal by Subject|2|||
145911649|NCT04152863|526181922|FG001|Overall Study|Withdrawal by Subject|1|||
145911650|NCT04152863|526181923|FG002|Overall Study|Withdrawal by Subject|3|||
145911651|NCT02276807|526181927|FG000|Overall Study|Withdrawal by Subject|8|||
145911652|NCT02276807|526181928|FG001|Overall Study|Withdrawal by Subject|7|||
145911653|NCT02276807|526181927|FG000|Overall Study|Lost to Follow-up|10|||
145911654|NCT02276807|526181928|FG001|Overall Study|Lost to Follow-up|10|||
145911655|NCT03154125|526181934|FG000|Overall Study|Lost to Follow-up|11|||
145911656|NCT03154125|526181935|FG001|Overall Study|Lost to Follow-up|11|||
145911657|NCT03154125|526181936|FG002|Overall Study|Lost to Follow-up|0|||
145911658|NCT03154125|526181934|FG000|Overall Study|Withdrawal by Subject|49|||
145911659|NCT03154125|526181935|FG001|Overall Study|Withdrawal by Subject|55|||
145911660|NCT03154125|526181936|FG002|Overall Study|Withdrawal by Subject|8|||
145911661|NCT03154125|526181934|FG000|Overall Study|Physician Decision|13|||
145911662|NCT03154125|526181935|FG001|Overall Study|Physician Decision|6|||
145911663|NCT03154125|526181936|FG002|Overall Study|Physician Decision|0|||
145911664|NCT03154125|526181934|FG000|Overall Study|Protocol Violation|3|||
145911665|NCT03154125|526181935|FG001|Overall Study|Protocol Violation|5|||
145911666|NCT03154125|526181936|FG002|Overall Study|Protocol Violation|0|||
145911667|NCT00799058|526181937|FG000|Overall Study|Withdrawal by Subject|2|||
145911668|NCT00799058|526181938|FG001|Overall Study|Withdrawal by Subject|2|||
145911669|NCT00799058|526181939|FG002|Overall Study|Withdrawal by Subject|2|||
145911670|NCT00799058|526181937|FG000|Overall Study|Lost to Follow-up|1|||
145911671|NCT00799058|526181938|FG001|Overall Study|Lost to Follow-up|2|||
145911672|NCT00799058|526181939|FG002|Overall Study|Lost to Follow-up|1|||
145911673|NCT00799058|526181937|FG000|Overall Study|Adverse Event|0|||
145911674|NCT00799058|526181938|FG001|Overall Study|Adverse Event|2|||
145911675|NCT00799058|526181939|FG002|Overall Study|Adverse Event|0|||
145911676|NCT00799058|526181937|FG000|Overall Study|Pregnancy|1|||
145911677|NCT00799058|526181938|FG001|Overall Study|Pregnancy|0|||
145911678|NCT00799058|526181939|FG002|Overall Study|Pregnancy|0|||
145911679|NCT00799058|526181937|FG000|Overall Study|Not adherent|3|||
145911680|NCT00799058|526181938|FG001|Overall Study|Not adherent|2|||
145911681|NCT00799058|526181939|FG002|Overall Study|Not adherent|1|||
145911682|NCT00799058|526181937|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
145911683|NCT00799058|526181938|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
145973329|NCT00716417|526416384|FG008|Overall Study|Adverse Event|0|||
145911684|NCT00799058|526181939|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
145911685|NCT00799058|526181937|FG000|Overall Study|IP dispensing error|1|||
145911686|NCT00799058|526181938|FG001|Overall Study|IP dispensing error|0|||
145911687|NCT00799058|526181939|FG002|Overall Study|IP dispensing error|0|||
145911688|NCT00799058|526181937|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
145911689|NCT00799058|526181938|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
145911690|NCT00799058|526181939|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
145911691|NCT00799058|526181937|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
145911692|NCT00799058|526181938|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
145911693|NCT00799058|526181939|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
145911694|NCT00799058|526181937|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
145911695|NCT00799058|526181938|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
145911696|NCT00799058|526181939|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
145911697|NCT00799058|526181937|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
145911698|NCT00799058|526181938|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
145911699|NCT00799058|526181939|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
145911700|NCT00810511|526181942|FG000|Overall Study|Protocol Violation|0|||
145911701|NCT00810511|526181943|FG001|Overall Study|Protocol Violation|1|||
145911702|NCT00810511|526181942|FG000|Overall Study|Lack of Efficacy|9|||
145911703|NCT00810511|526181943|FG001|Overall Study|Lack of Efficacy|1|||
145911704|NCT00810511|526181942|FG000|Overall Study|death in the family|0|||
145911705|NCT00810511|526181943|FG001|Overall Study|death in the family|1|||
145911706|NCT00810511|526181942|FG000|Overall Study|Lost to Follow-up|1|||
145911707|NCT00810511|526181943|FG001|Overall Study|Lost to Follow-up|0|||
145911708|NCT00810511|526181942|FG000|Overall Study|deposits on contact lens|0|||
145911709|NCT00810511|526181943|FG001|Overall Study|deposits on contact lens|1|||
145911710|NCT02088697|526181944|FG000|Period I|Physician Decision|1|||
145911711|NCT02088697|526181945|FG001|Period I|Physician Decision|4|||
145911712|NCT02088697|526181944|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
145911713|NCT02088697|526181945|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
145911714|NCT00462904|526181946|FG000|Overall Study|Lost to Follow-up|1|||
145911715|NCT02652949|526181947|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
145911716|NCT02652949|526181947|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
145911717|NCT02652949|526181947|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
145911718|NCT02652949|526181947|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
145911719|NCT02652949|526181947|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
145911720|NCT02652949|526181947|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
145911721|NCT02652949|526181947|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
145911722|NCT02652949|526181947|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
145911723|NCT02652949|526181947|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
145911724|NCT02652949|526181947|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
145911725|NCT02652949|526181947|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
145911726|NCT02652949|526181947|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
145973330|NCT00716417|526416385|FG009|Overall Study|Adverse Event|3|||
145973331|NCT00716417|526416376|FG000|Overall Study|Withdrawal by Subject|0|||
145973332|NCT00716417|526416377|FG001|Overall Study|Withdrawal by Subject|1|||
145973333|NCT00716417|526416378|FG002|Overall Study|Withdrawal by Subject|0|||
145973334|NCT00716417|526416379|FG003|Overall Study|Withdrawal by Subject|2|||
145973335|NCT00716417|526416380|FG004|Overall Study|Withdrawal by Subject|0|||
145973336|NCT00716417|526416381|FG005|Overall Study|Withdrawal by Subject|0|||
145973337|NCT00716417|526416382|FG006|Overall Study|Withdrawal by Subject|1|||
145973338|NCT00716417|526416383|FG007|Overall Study|Withdrawal by Subject|0|||
145973339|NCT00716417|526416384|FG008|Overall Study|Withdrawal by Subject|0|||
145973340|NCT00716417|526416385|FG009|Overall Study|Withdrawal by Subject|0|||
145973341|NCT00716417|526416376|FG000|Overall Study|Progressive disease|3|||
145973342|NCT00716417|526416377|FG001|Overall Study|Progressive disease|5|||
145973343|NCT00716417|526416378|FG002|Overall Study|Progressive disease|3|||
145973344|NCT00716417|526416379|FG003|Overall Study|Progressive disease|8|||
145973345|NCT00716417|526416380|FG004|Overall Study|Progressive disease|0|||
145973346|NCT00716417|526416381|FG005|Overall Study|Progressive disease|3|||
145973347|NCT00716417|526416382|FG006|Overall Study|Progressive disease|3|||
145973348|NCT00716417|526416383|FG007|Overall Study|Progressive disease|1|||
145973349|NCT00716417|526416384|FG008|Overall Study|Progressive disease|5|||
145973350|NCT00716417|526416385|FG009|Overall Study|Progressive disease|0|||
145973351|NCT00716417|526416376|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
145973352|NCT00716417|526416377|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
145973353|NCT00716417|526416378|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
145973354|NCT00716417|526416379|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
145911727|NCT02652949|526181947|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
145973355|NCT00716417|526416380|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
146239256|NCT01706159|527389766|FG001|Overall Study|Withdrawal Criteria|1|||
145911728|NCT02652949|526181947|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
145911729|NCT02652949|526181947|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145911730|NCT02652949|526181947|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
145911731|NCT02652949|526181947|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145911732|NCT04342819|526181948|FG000|Overall Study|Declined|4|||
145911733|NCT04342819|526181948|FG000|Overall Study|Not meeeting selection criteria|1|||
145911734|NCT02287922|526181949|FG000|Overall Study|Adverse Event|1|||
145911735|NCT02287922|526181950|FG001|Overall Study|Adverse Event|1|||
145911736|NCT02287922|526181951|FG002|Overall Study|Adverse Event|3|||
145911737|NCT02287922|526181952|FG003|Overall Study|Adverse Event|4|||
145911738|NCT02287922|526181949|FG000|Overall Study|Withdrawal by Subject|1|||
145911739|NCT02287922|526181950|FG001|Overall Study|Withdrawal by Subject|1|||
145911740|NCT02287922|526181951|FG002|Overall Study|Withdrawal by Subject|1|||
145911741|NCT02287922|526181952|FG003|Overall Study|Withdrawal by Subject|2|||
145911742|NCT02287922|526181949|FG000|Overall Study|Lost to Follow-up|0|||
145911743|NCT02287922|526181950|FG001|Overall Study|Lost to Follow-up|0|||
145911744|NCT02287922|526181951|FG002|Overall Study|Lost to Follow-up|1|||
145911745|NCT02287922|526181952|FG003|Overall Study|Lost to Follow-up|0|||
145911746|NCT02287922|526181949|FG000|Overall Study|Sponsor's decision|0|||
145911747|NCT02287922|526181950|FG001|Overall Study|Sponsor's decision|0|||
145911748|NCT02287922|526181951|FG002|Overall Study|Sponsor's decision|0|||
145911749|NCT02287922|526181952|FG003|Overall Study|Sponsor's decision|1|||
145911750|NCT02287922|526181949|FG000|Overall Study|Other|1|||
145911751|NCT02287922|526181950|FG001|Overall Study|Other|0|||
145911752|NCT02287922|526181951|FG002|Overall Study|Other|2|||
145911753|NCT02287922|526181952|FG003|Overall Study|Other|0|||
145911754|NCT03607487|526181962|FG000|Overall Study|Withdrawal by Subject|2|||
145911755|NCT03607487|526181963|FG001|Overall Study|Withdrawal by Subject|0|||
145911756|NCT03607487|526181964|FG002|Overall Study|Withdrawal by Subject|0|||
145911757|NCT03607487|526181965|FG003|Overall Study|Withdrawal by Subject|1|||
145911758|NCT01884337|526181966|FG000|Treatment|Adverse Event|2|||
145911759|NCT01884337|526181967|FG001|Treatment|Adverse Event|2|||
145911760|NCT01884337|526181966|FG000|Treatment|Subj. request to discont. treatment|2|||
145911761|NCT01884337|526181967|FG001|Treatment|Subj. request to discont. treatment|0|||
145911762|NCT01884337|526181966|FG000|Follow-up Period|Lost to Follow-up|1|||
145911763|NCT01884337|526181967|FG001|Follow-up Period|Lost to Follow-up|1|||
145911764|NCT02455518|526181968|FG000|Overall Study|Protocol Violation|0|||
145911765|NCT02455518|526181969|FG001|Overall Study|Protocol Violation|1|||
145911766|NCT02455518|526181970|FG002|Overall Study|Protocol Violation|1|||
145911767|NCT02455518|526181971|FG003|Overall Study|Protocol Violation|3|||
145911768|NCT04223752|526181977|FG000|Overall Study|Participant enrolled in error|0|||
145911769|NCT04223752|526181978|FG001|Overall Study|Participant enrolled in error|0|||
145911770|NCT04223752|526181979|FG002|Overall Study|Participant enrolled in error|0|||
145911771|NCT04223752|526181980|FG003|Overall Study|Participant enrolled in error|0|||
145911772|NCT04223752|526181981|FG004|Overall Study|Participant enrolled in error|1|||
145911773|NCT04223752|526181977|FG000|Overall Study|Death|0|||
145911774|NCT04223752|526181978|FG001|Overall Study|Death|0|||
145911775|NCT04223752|526181979|FG002|Overall Study|Death|0|||
145911776|NCT04223752|526181980|FG003|Overall Study|Death|2|||
145911777|NCT04223752|526181981|FG004|Overall Study|Death|1|||
145911778|NCT04759703|526181982|FG000|Overall Study|Withdrawal by Subject|4|||
145911779|NCT04759703|526181983|FG001|Overall Study|Withdrawal by Subject|9|||
145911780|NCT04759703|526181982|FG000|Overall Study|Adverse Event|1|||
145911781|NCT04759703|526181983|FG001|Overall Study|Adverse Event|0|||
145911782|NCT04759703|526181982|FG000|Overall Study|Lost to Follow-up|2|||
145911783|NCT04759703|526181983|FG001|Overall Study|Lost to Follow-up|0|||
145911784|NCT04186845|526181995|FG000|Overall Study|Death|2|||
145911785|NCT04186845|526181995|FG000|Overall Study|Lost to Follow-up|1|||
145911786|NCT04186845|526181995|FG000|Overall Study|Physician Decision|1|||
145911787|NCT04186845|526181995|FG000|Overall Study|Protocol Violation|1|||
145911788|NCT04186845|526181995|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
145911789|NCT04186845|526181995|FG000|Overall Study|Biopsy ordered but not done|1|||
145911790|NCT04186845|526181995|FG000|Overall Study|It was previously confirmed|1|||
145911791|NCT04186845|526181995|FG000|Overall Study|Patient cancelled scheduled scans|2|||
145911792|NCT04186845|526181995|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
145911793|NCT04186845|526181995|FG000|Overall Study|Subject refused confirmatory imaging|1|||
145911794|NCT04186845|526181995|FG000|Overall Study|Too small to biopsy|1|||
145973356|NCT00716417|526416381|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
145911795|NCT05061420|526181996|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
145911796|NCT05061420|526181997|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145911797|NCT05061420|526181998|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145911798|NCT05061420|526181996|FG000|Overall Study|Progressive disease|11|||
145911799|NCT05061420|526181997|FG001|Overall Study|Progressive disease|15|||
145911800|NCT05061420|526181998|FG002|Overall Study|Progressive disease|14|||
145911801|NCT05061420|526181996|FG000|Overall Study|Withdrawal by Subject|2|||
145911802|NCT05061420|526181997|FG001|Overall Study|Withdrawal by Subject|0|||
145973357|NCT00716417|526416382|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
145973358|NCT00716417|526416383|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
145973359|NCT00716417|526416384|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
145973360|NCT00716417|526416385|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
145973361|NCT00716417|526416376|FG000|Overall Study|On patient request due to toxicities|0|||
145973362|NCT00716417|526416377|FG001|Overall Study|On patient request due to toxicities|0|||
145911803|NCT05061420|526181998|FG002|Overall Study|Withdrawal by Subject|1|||
145911804|NCT05061420|526181996|FG000|Overall Study|Not related to COVID-19|2|||
145911805|NCT05061420|526181997|FG001|Overall Study|Not related to COVID-19|0|||
145911806|NCT05061420|526181998|FG002|Overall Study|Not related to COVID-19|0|||
145911807|NCT01814553|526181999|FG000|Overall Study|PD per clinical progression|6|||
145911808|NCT01814553|526182000|FG001|Overall Study|PD per clinical progression|8|||
145911809|NCT01814553|526181999|FG000|Overall Study|Other Adverse Event|4|||
145911810|NCT01814553|526182000|FG001|Overall Study|Other Adverse Event|5|||
145911811|NCT01814553|526181999|FG000|Overall Study|Withdrawal by Subject|1|||
145911812|NCT01814553|526182000|FG001|Overall Study|Withdrawal by Subject|1|||
145911813|NCT01814553|526181999|FG000|Overall Study|Other than stated|7|||
145911814|NCT01814553|526182000|FG001|Overall Study|Other than stated|8|||
145911815|NCT03138655|526182004|FG000|Overall Study|Adverse Event|2|||
145911816|NCT03138655|526182005|FG001|Overall Study|Adverse Event|1|||
145911817|NCT03138655|526182006|FG002|Overall Study|Adverse Event|2|||
145911818|NCT03138655|526182007|FG003|Overall Study|Adverse Event|1|||
145911819|NCT03138655|526182008|FG004|Overall Study|Adverse Event|1|||
145911820|NCT03138655|526182009|FG005|Overall Study|Adverse Event|4|||
145911821|NCT03138655|526182010|FG006|Overall Study|Adverse Event|2|||
145911822|NCT03138655|526182011|FG007|Overall Study|Adverse Event|2|||
145911823|NCT03138655|526182004|FG000|Overall Study|Withdrawal by Subject|0|||
145911824|NCT03138655|526182005|FG001|Overall Study|Withdrawal by Subject|1|||
145911825|NCT03138655|526182006|FG002|Overall Study|Withdrawal by Subject|0|||
145911826|NCT03138655|526182007|FG003|Overall Study|Withdrawal by Subject|0|||
145911827|NCT03138655|526182008|FG004|Overall Study|Withdrawal by Subject|0|||
145911828|NCT03138655|526182009|FG005|Overall Study|Withdrawal by Subject|0|||
145911829|NCT03138655|526182010|FG006|Overall Study|Withdrawal by Subject|1|||
145911830|NCT03138655|526182011|FG007|Overall Study|Withdrawal by Subject|0|||
145911831|NCT03138655|526182004|FG000|Overall Study|Reason not Specified|1|||
145911832|NCT03138655|526182005|FG001|Overall Study|Reason not Specified|0|||
145911833|NCT03138655|526182006|FG002|Overall Study|Reason not Specified|0|||
145911834|NCT03138655|526182007|FG003|Overall Study|Reason not Specified|2|||
145911835|NCT03138655|526182008|FG004|Overall Study|Reason not Specified|1|||
145911836|NCT03138655|526182009|FG005|Overall Study|Reason not Specified|1|||
145911837|NCT03138655|526182010|FG006|Overall Study|Reason not Specified|0|||
145911838|NCT03138655|526182011|FG007|Overall Study|Reason not Specified|0|||
145911839|NCT02859142|526182012|FG000|Overall Study|Adverse Event|1|||
145911840|NCT02859142|526182013|FG001|Overall Study|Adverse Event|2|||
145911841|NCT02859142|526182012|FG000|Overall Study|Lost to Follow-up|1|||
145911842|NCT02859142|526182013|FG001|Overall Study|Lost to Follow-up|4|||
145911843|NCT02859142|526182012|FG000|Overall Study|Withdrawal by Subject|2|||
145911844|NCT02859142|526182013|FG001|Overall Study|Withdrawal by Subject|0|||
145911845|NCT02859142|526182012|FG000|Overall Study|Scheduling difficulties|0|||
145911846|NCT02859142|526182013|FG001|Overall Study|Scheduling difficulties|3|||
145911847|NCT03290079|526182014|FG000|Overall Study|Death|2|||
145911848|NCT00447993|526182017|FG000|Overall Study|Lost to Follow-up|0|||
145911849|NCT00447993|526182018|FG001|Overall Study|Lost to Follow-up|0|||
145911850|NCT00447993|526182019|FG002|Overall Study|Lost to Follow-up|2|||
145911851|NCT00447993|526182020|FG003|Overall Study|Lost to Follow-up|2|||
145911852|NCT00447993|526182017|FG000|Overall Study|Withdrawal by Subject|0|||
145911853|NCT00447993|526182018|FG001|Overall Study|Withdrawal by Subject|0|||
145911854|NCT00447993|526182019|FG002|Overall Study|Withdrawal by Subject|2|||
145911855|NCT00447993|526182020|FG003|Overall Study|Withdrawal by Subject|2|||
145973363|NCT00716417|526416378|FG002|Overall Study|On patient request due to toxicities|0|||
145973364|NCT00716417|526416379|FG003|Overall Study|On patient request due to toxicities|0|||
145973365|NCT00716417|526416380|FG004|Overall Study|On patient request due to toxicities|0|||
145973366|NCT00716417|526416381|FG005|Overall Study|On patient request due to toxicities|0|||
145973367|NCT00716417|526416382|FG006|Overall Study|On patient request due to toxicities|0|||
145911856|NCT02503787|526182025|FG000|Enrollment|Withdrawal by Subject|6|||
145973368|NCT00716417|526416383|FG007|Overall Study|On patient request due to toxicities|1|||
145973369|NCT00716417|526416384|FG008|Overall Study|On patient request due to toxicities|0|||
145973370|NCT00716417|526416385|FG009|Overall Study|On patient request due to toxicities|0|||
145973371|NCT01138046|526416388|FG000|Overall Study|Withdrawal due to death|6|||
145973372|NCT03839641|526416390|FG000|Overall Study|Withdrawal by Subject|1|||
145973373|NCT03839641|526416391|FG001|Overall Study|Withdrawal by Subject|1|||
145973374|NCT03765073|526416392|FG000|Stage 1|Lost to Follow-up|1|||
145911857|NCT02503787|526182025|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
145911858|NCT02503787|526182025|FG000|Enrollment|Physician Decision|2|||
145911859|NCT02503787|526182025|FG000|Enrollment|Insurance issue|2|||
145911860|NCT02503787|526182025|FG000|Enrollment|Lost to Follow-up|1|||
145911861|NCT02503787|526182025|FG000|Enrollment|Study closure|1|||
145911862|NCT02503787|526182025|FG000|Enrollment|Adverse Event|1|||
145911863|NCT02503787|526182025|FG000|Enrollment|Protocol Violation|1|||
145911864|NCT02503787|526182025|FG000|Enrollment|Inability to implant system|1|||
145911865|NCT02503787|526182025|FG000|Enrollment|Unable to be programmed|1|||
145911866|NCT02503787|526182025|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
145911867|NCT02503787|526182025|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
145911868|NCT02503787|526182025|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
145911869|NCT02503787|526182025|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
145911870|NCT02503787|526182025|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
145911871|NCT02503787|526182025|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
145911872|NCT04700137|526182026|FG000|Overall Study|Lost to Follow-up|1|||
145911873|NCT04700137|526182027|FG001|Overall Study|Lost to Follow-up|6|||
145911874|NCT04700137|526182028|FG002|Overall Study|Lost to Follow-up|1|||
145911875|NCT04700137|526182029|FG003|Overall Study|Lost to Follow-up|1|||
145911876|NCT04700137|526182026|FG000|Overall Study|Withdrawal by Subject|0|||
145911877|NCT04700137|526182027|FG001|Overall Study|Withdrawal by Subject|0|||
145911878|NCT04700137|526182028|FG002|Overall Study|Withdrawal by Subject|1|||
145911879|NCT04700137|526182029|FG003|Overall Study|Withdrawal by Subject|0|||
145911880|NCT04700137|526182026|FG000|Overall Study|Death|0|||
145911881|NCT04700137|526182027|FG001|Overall Study|Death|0|||
145911882|NCT04700137|526182028|FG002|Overall Study|Death|1|||
145911883|NCT04700137|526182029|FG003|Overall Study|Death|0|||
145911884|NCT04787627|526182030|FG000|Overall Study|Withdrawal by Subject|3|||
145911885|NCT04787627|526182031|FG001|Overall Study|Withdrawal by Subject|0|||
145911886|NCT04787627|526182030|FG000|Overall Study|Physician Decision|2|||
145911887|NCT04787627|526182031|FG001|Overall Study|Physician Decision|0|||
145911888|NCT04787627|526182030|FG000|Overall Study|Excluded|0|||
145911889|NCT04787627|526182031|FG001|Overall Study|Excluded|1|||
145911890|NCT00548093|526182032|FG000|Overall Study|Death|33|||
145911891|NCT00548093|526182033|FG001|Overall Study|Death|13|||
145911892|NCT00548093|526182032|FG000|Overall Study|Lost to Follow-up|3|||
145911893|NCT00548093|526182033|FG001|Overall Study|Lost to Follow-up|1|||
145911894|NCT00548093|526182032|FG000|Overall Study|Objective progression or relapse|1|||
145911895|NCT00548093|526182033|FG001|Overall Study|Objective progression or relapse|1|||
145911896|NCT00548093|526182032|FG000|Overall Study|Other|11|||
145911897|NCT00548093|526182033|FG001|Overall Study|Other|1|||
145911898|NCT00548093|526182032|FG000|Overall Study|Withdrawal by Subject|1|||
145911899|NCT00548093|526182033|FG001|Overall Study|Withdrawal by Subject|0|||
145911900|NCT00548093|526182032|FG000|Overall Study|Completed post-treatment follow-up|1|||
145911901|NCT00548093|526182033|FG001|Overall Study|Completed post-treatment follow-up|0|||
145911902|NCT02924727|526182038|FG000|Overall Study|Withdrawal by Subject|2|||
145911903|NCT02924727|526182039|FG001|Overall Study|Withdrawal by Subject|4|||
145911904|NCT02924727|526182038|FG000|Overall Study|Lost to Follow-up|2|||
145911905|NCT02924727|526182039|FG001|Overall Study|Lost to Follow-up|5|||
145911906|NCT02924727|526182038|FG000|Overall Study|Death|221|||
145911907|NCT02924727|526182039|FG001|Overall Study|Death|247|||
145911908|NCT02924727|526182038|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
145911909|NCT02924727|526182039|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
145911910|NCT01464931|526182040|FG000|Overall Study|Withdrawal by Subject|1|||
145911911|NCT01464931|526182041|FG001|Overall Study|Withdrawal by Subject|0|||
145911912|NCT01982812|526182044|FG000|Overall Study|Death|1|||
145911913|NCT01982812|526182045|FG001|Overall Study|Death|5|||
145911914|NCT01982812|526182044|FG000|Overall Study|Adverse Event|0|||
145911915|NCT01982812|526182045|FG001|Overall Study|Adverse Event|5|||
145911916|NCT00174954|526182046|FG000|Overall Study|Adverse Event|2|||
145911917|NCT00174954|526182046|FG000|Overall Study|No tophi found in MRI|1|||
145911918|NCT00174954|526182046|FG000|Overall Study|Physician Decision|1|||
145911919|NCT00993421|526182047|FG000|Overall Study|Adverse Event|2|||
145911920|NCT00993421|526182048|FG001|Overall Study|Adverse Event|7|||
145911921|NCT00993421|526182049|FG002|Overall Study|Adverse Event|6|||
145911922|NCT00993421|526182050|FG003|Overall Study|Adverse Event|9|||
145911923|NCT00993421|526182051|FG004|Overall Study|Adverse Event|5|||
145911924|NCT00993421|526182052|FG005|Overall Study|Adverse Event|7|||
145911925|NCT00993421|526182053|FG006|Overall Study|Adverse Event|1|||
145973375|NCT03765073|526416393|FG001|Stage 1|Lost to Follow-up|0|||
145973376|NCT03765073|526416394|FG002|Stage 1|Lost to Follow-up|0|||
145911926|NCT00993421|526182047|FG000|Overall Study|Sponsor Decision|36|||
145911927|NCT00993421|526182048|FG001|Overall Study|Sponsor Decision|31|||
145911928|NCT00993421|526182049|FG002|Overall Study|Sponsor Decision|28|||
145911929|NCT00993421|526182050|FG003|Overall Study|Sponsor Decision|30|||
145911930|NCT00993421|526182051|FG004|Overall Study|Sponsor Decision|38|||
145911931|NCT00993421|526182052|FG005|Overall Study|Sponsor Decision|30|||
145911932|NCT00993421|526182053|FG006|Overall Study|Sponsor Decision|29|||
145911933|NCT00993421|526182047|FG000|Overall Study|Lost to Follow-up|3|||
145911934|NCT00993421|526182048|FG001|Overall Study|Lost to Follow-up|5|||
145911935|NCT00993421|526182049|FG002|Overall Study|Lost to Follow-up|5|||
145911936|NCT00993421|526182050|FG003|Overall Study|Lost to Follow-up|0|||
145911937|NCT00993421|526182051|FG004|Overall Study|Lost to Follow-up|0|||
145911938|NCT00993421|526182052|FG005|Overall Study|Lost to Follow-up|0|||
145911939|NCT00993421|526182053|FG006|Overall Study|Lost to Follow-up|6|||
145911940|NCT00993421|526182047|FG000|Overall Study|Withdrawal by Subject|3|||
145911941|NCT00993421|526182048|FG001|Overall Study|Withdrawal by Subject|2|||
145911942|NCT00993421|526182049|FG002|Overall Study|Withdrawal by Subject|3|||
145911943|NCT00993421|526182050|FG003|Overall Study|Withdrawal by Subject|3|||
145911944|NCT00993421|526182051|FG004|Overall Study|Withdrawal by Subject|3|||
145911945|NCT00993421|526182052|FG005|Overall Study|Withdrawal by Subject|5|||
145911946|NCT00993421|526182053|FG006|Overall Study|Withdrawal by Subject|3|||
145911947|NCT00993421|526182047|FG000|Overall Study|Death|0|||
145911948|NCT00993421|526182048|FG001|Overall Study|Death|0|||
145911949|NCT00993421|526182049|FG002|Overall Study|Death|0|||
145911950|NCT00993421|526182050|FG003|Overall Study|Death|0|||
145911951|NCT00993421|526182051|FG004|Overall Study|Death|0|||
145911952|NCT00993421|526182052|FG005|Overall Study|Death|0|||
145911953|NCT00993421|526182053|FG006|Overall Study|Death|1|||
145911954|NCT00993421|526182047|FG000|Overall Study|Entry Criteria Exclusion|0|||
145911955|NCT00993421|526182048|FG001|Overall Study|Entry Criteria Exclusion|0|||
145911956|NCT00993421|526182049|FG002|Overall Study|Entry Criteria Exclusion|1|||
145911957|NCT00993421|526182050|FG003|Overall Study|Entry Criteria Exclusion|3|||
145911958|NCT00993421|526182051|FG004|Overall Study|Entry Criteria Exclusion|0|||
145911959|NCT00993421|526182052|FG005|Overall Study|Entry Criteria Exclusion|1|||
145911960|NCT00993421|526182053|FG006|Overall Study|Entry Criteria Exclusion|0|||
145911961|NCT00993421|526182047|FG000|Overall Study|Physician Decision|0|||
145911962|NCT00993421|526182048|FG001|Overall Study|Physician Decision|0|||
145911963|NCT00993421|526182049|FG002|Overall Study|Physician Decision|0|||
145911964|NCT00993421|526182050|FG003|Overall Study|Physician Decision|0|||
145911965|NCT00993421|526182051|FG004|Overall Study|Physician Decision|0|||
145911966|NCT00993421|526182052|FG005|Overall Study|Physician Decision|1|||
145911967|NCT00993421|526182053|FG006|Overall Study|Physician Decision|1|||
145911968|NCT00993421|526182047|FG000|Overall Study|Protocol Violation|0|||
145911969|NCT00993421|526182048|FG001|Overall Study|Protocol Violation|0|||
145911970|NCT00993421|526182049|FG002|Overall Study|Protocol Violation|0|||
145911971|NCT00993421|526182050|FG003|Overall Study|Protocol Violation|0|||
145911972|NCT00993421|526182051|FG004|Overall Study|Protocol Violation|0|||
145911973|NCT00993421|526182052|FG005|Overall Study|Protocol Violation|2|||
145911974|NCT00993421|526182053|FG006|Overall Study|Protocol Violation|1|||
145911975|NCT03514017|526182054|FG000|Overall Study|Death|1|||
145911976|NCT03514017|526182054|FG000|Overall Study|Adverse Event|1|||
145911977|NCT02447744|526182058|FG000|Overall Study|Withdrawal by Subject|3|||
145911978|NCT02447744|526182059|FG001|Overall Study|Withdrawal by Subject|1|||
145911979|NCT02447744|526182058|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
145911980|NCT02447744|526182059|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
145911981|NCT00912912|526182060|FG000|Overall Study|Withdrawal by Subject|1|||
145911982|NCT00912912|526182060|FG000|Overall Study|Disease Progression|3|||
145911983|NCT01496976|526183654|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
145911984|NCT05938621|526183655|FG000|Overall Study|Lost to Follow-up|1|||
145911985|NCT05938621|526183656|FG001|Overall Study|Lost to Follow-up|5|||
145911986|NCT05938621|526183657|FG002|Overall Study|Lost to Follow-up|2|||
145911987|NCT05938621|526183658|FG003|Overall Study|Lost to Follow-up|2|||
145911988|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
145911989|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
145911990|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
145911991|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145911992|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145911993|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145911994|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
145911995|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
145911996|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
145911997|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
145911998|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
145911999|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
145912000|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145912001|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145912002|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145912003|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
145912004|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145912005|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145912006|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
145912007|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
145912008|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
145912009|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145912010|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145973377|NCT03765073|526416395|FG003|Stage 1|Lost to Follow-up|0|||
145912011|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145912012|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145912013|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145912014|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145912015|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
145912016|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
145912017|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
145912018|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912019|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912020|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912021|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912022|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912023|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145912024|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
145912025|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
145912026|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
145912027|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145912028|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145912029|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145912030|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
145912031|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145912032|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145912033|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
145912034|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912035|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912036|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912037|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912038|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912039|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912040|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912041|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145912042|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912043|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
145912044|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912045|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912046|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912047|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912048|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912049|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912050|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912051|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912052|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912053|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
145912054|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912055|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912056|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912057|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912058|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145973378|NCT03765073|526416396|FG004|Stage 1|Lost to Follow-up|0|||
146088753|NCT00740246|526845076|FG000|Overall Study|Withdrawal by Subject|4|||
146088754|NCT00740246|526845077|FG001|Overall Study|Withdrawal by Subject|3|||
145912059|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145912060|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
145912061|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145943245|NCT02326298|526300467|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943246|NCT02326298|526300468|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943247|NCT02326298|526300469|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943248|NCT02326298|526300470|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943249|NCT02326298|526300471|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943250|NCT02326298|526300472|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943251|NCT02326298|526300473|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943252|NCT02326298|526300474|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943253|NCT02326298|526300475|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943254|NCT02326298|526300476|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145943255|NCT02326298|526300477|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145912062|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912063|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912064|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912065|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912066|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912067|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912068|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145912069|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
145912070|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912071|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912072|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912073|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912074|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912075|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912076|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912077|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145912078|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
145912079|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912080|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912081|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912082|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912083|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912084|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912085|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912086|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145912087|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912088|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
145912089|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
145912090|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912091|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912092|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912093|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912094|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912095|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145912096|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
145912097|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
145912098|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912099|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912100|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912101|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912102|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912103|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912104|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145912105|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912106|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
145912107|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912108|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912109|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912110|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912111|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912112|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912113|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145912114|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912115|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
145912116|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912117|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912118|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912119|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912120|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912121|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912122|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145912123|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912124|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912125|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
145912126|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912127|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912128|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912129|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912130|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912131|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145912132|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912133|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912134|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
145912135|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912136|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912137|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912138|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912139|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912140|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145912141|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912142|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912143|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
145912144|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912145|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912146|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912147|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912148|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912149|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145912150|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912151|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912152|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912153|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912154|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912155|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912156|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
145912157|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912158|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145912159|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
145912160|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
145912161|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912162|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912163|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912164|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912165|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912166|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145912167|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145943256|NCT02326298|526300464|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
145943257|NCT02326298|526300465|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943258|NCT02326298|526300466|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943259|NCT02326298|526300467|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943260|NCT02326298|526300468|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943261|NCT02326298|526300469|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943262|NCT02326298|526300470|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943263|NCT02326298|526300471|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943264|NCT02326298|526300472|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943265|NCT02326298|526300473|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146297456|NCT01641809|527604695|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
146297457|NCT03294109|527604696|FG000|Overall Study|Withdrawal by Subject|6|||
146297458|NCT03294109|527604697|FG001|Overall Study|Withdrawal by Subject|5|||
146088755|NCT00740246|526845076|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
146088756|NCT00740246|526845077|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
145912168|NCT03598790|526183659|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912169|NCT03598790|526183660|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912170|NCT03598790|526183661|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
145912171|NCT03598790|526183662|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912172|NCT03598790|526183663|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912173|NCT03598790|526183664|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912174|NCT03598790|526183665|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912175|NCT03598790|526183666|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912176|NCT03598790|526183667|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145912177|NCT03598790|526183659|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912178|NCT03598790|526183660|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912179|NCT03598790|526183661|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912180|NCT03598790|526183662|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
145912181|NCT03598790|526183663|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
145912182|NCT03598790|526183664|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
145912183|NCT03598790|526183665|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912184|NCT03598790|526183666|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912185|NCT03598790|526183667|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145912186|NCT03598790|526183659|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912187|NCT03598790|526183660|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912188|NCT03598790|526183661|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912189|NCT03598790|526183662|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
145912190|NCT03598790|526183663|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912191|NCT03598790|526183664|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912192|NCT03598790|526183665|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912193|NCT03598790|526183666|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912194|NCT03598790|526183667|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145912195|NCT03598790|526183659|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912196|NCT03598790|526183660|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912197|NCT03598790|526183661|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912198|NCT03598790|526183662|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
145912199|NCT03598790|526183663|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912200|NCT03598790|526183664|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912201|NCT03598790|526183665|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912202|NCT03598790|526183666|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912203|NCT03598790|526183667|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145912204|NCT03598790|526183659|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912205|NCT03598790|526183660|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912206|NCT03598790|526183661|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912207|NCT03598790|526183662|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
145912208|NCT03598790|526183663|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
145912209|NCT03598790|526183664|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912210|NCT03598790|526183665|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912211|NCT03598790|526183666|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912212|NCT03598790|526183667|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145912213|NCT03598790|526183659|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912214|NCT03598790|526183660|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912215|NCT03598790|526183661|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912216|NCT03598790|526183662|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
145912217|NCT03598790|526183663|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912218|NCT03598790|526183664|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912219|NCT03598790|526183665|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
146088757|NCT00740246|526845076|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
146088758|NCT00740246|526845077|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
146088759|NCT00740246|526845076|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
146088760|NCT00740246|526845077|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
146088761|NCT00740246|526845076|FG000|Overall Study|Unable To Comply With Study Visits|2|||
146088762|NCT00740246|526845077|FG001|Overall Study|Unable To Comply With Study Visits|0|||
146088763|NCT00740246|526845076|FG000|Overall Study|Unable to Access Vein|0|||
146088764|NCT00740246|526845077|FG001|Overall Study|Unable to Access Vein|2|||
145912220|NCT03598790|526183666|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912221|NCT03598790|526183667|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145912222|NCT05292183|526183669|FG000|Overall Study|Adverse Event|1|||
145973379|NCT03765073|526416397|FG005|Stage 1|Lost to Follow-up|0|||
145973380|NCT03765073|526416398|FG006|Stage 1|Lost to Follow-up|0|||
145973381|NCT03765073|526416399|FG007|Stage 1|Lost to Follow-up|0|||
145973382|NCT03765073|526416400|FG008|Stage 1|Lost to Follow-up|0|||
145973383|NCT03765073|526416401|FG009|Stage 1|Lost to Follow-up|0|||
145973384|NCT03765073|526416402|FG010|Stage 1|Lost to Follow-up|0|||
145973385|NCT03765073|526416403|FG011|Stage 1|Lost to Follow-up|0|||
145973386|NCT03765073|526416404|FG012|Stage 1|Lost to Follow-up|0|||
145973387|NCT03765073|526416405|FG013|Stage 1|Lost to Follow-up|0|||
145973388|NCT03765073|526416406|FG014|Stage 1|Lost to Follow-up|0|||
145973389|NCT03765073|526416407|FG015|Stage 1|Lost to Follow-up|0|||
145973390|NCT03765073|526416408|FG016|Stage 1|Lost to Follow-up|0|||
145973391|NCT03765073|526416409|FG017|Stage 1|Lost to Follow-up|0|||
145973392|NCT03765073|526416410|FG018|Stage 1|Lost to Follow-up|0|||
145973393|NCT03765073|526416411|FG019|Stage 1|Lost to Follow-up|0|||
145973394|NCT03765073|526416412|FG020|Stage 1|Lost to Follow-up|0|||
145973395|NCT03765073|526416392|FG000|Stage 1|Withdrawal by participant|0|||
145973396|NCT03765073|526416393|FG001|Stage 1|Withdrawal by participant|1|||
145973397|NCT03765073|526416394|FG002|Stage 1|Withdrawal by participant|0|||
145973398|NCT03765073|526416395|FG003|Stage 1|Withdrawal by participant|0|||
145973399|NCT03765073|526416396|FG004|Stage 1|Withdrawal by participant|0|||
145973400|NCT03765073|526416397|FG005|Stage 1|Withdrawal by participant|0|||
145973401|NCT03765073|526416398|FG006|Stage 1|Withdrawal by participant|0|||
145973402|NCT03765073|526416399|FG007|Stage 1|Withdrawal by participant|0|||
145973403|NCT03765073|526416400|FG008|Stage 1|Withdrawal by participant|0|||
145973404|NCT03765073|526416401|FG009|Stage 1|Withdrawal by participant|0|||
145973405|NCT03765073|526416402|FG010|Stage 1|Withdrawal by participant|0|||
145912223|NCT01059786|526183670|FG000|Overall Study|Did not receive 6 cycles.|0|||
145912224|NCT01059786|526183671|FG001|Overall Study|Did not receive 6 cycles.|0|||
145912225|NCT01059786|526183672|FG002|Overall Study|Did not receive 6 cycles.|4|||
145912226|NCT01059786|526183673|FG003|Overall Study|Did not receive 6 cycles.|1|||
145912227|NCT01059786|526183674|FG004|Overall Study|Did not receive 6 cycles.|0|||
145912228|NCT04460885|526183675|FG000|Overall Study|Withdrawal by Subject|6|||
145912229|NCT04460885|526183676|FG001|Overall Study|Withdrawal by Subject|8|||
145912230|NCT04460885|526183675|FG000|Overall Study|Site closure|1|||
145912231|NCT04460885|526183676|FG001|Overall Study|Site closure|0|||
145912232|NCT04460885|526183675|FG000|Overall Study|Death|5|||
145912233|NCT04460885|526183676|FG001|Overall Study|Death|4|||
145912234|NCT04460885|526183675|FG000|Overall Study|Physician Decision|2|||
145912235|NCT04460885|526183676|FG001|Overall Study|Physician Decision|1|||
145912236|NCT04460885|526183675|FG000|Overall Study|Lost to Follow-up|4|||
145912237|NCT04460885|526183676|FG001|Overall Study|Lost to Follow-up|4|||
145912238|NCT04205812|526183677|FG000|Randomized Treatment Period|Ongoing|28|||
145912239|NCT04205812|526183678|FG001|Randomized Treatment Period|Ongoing|138|||
145912240|NCT04205812|526183677|FG000|Randomized Treatment Period|Death|94|||
145912241|NCT04205812|526183678|FG001|Randomized Treatment Period|Death|226|||
145912242|NCT04205812|526183677|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
145912243|NCT04205812|526183678|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
145912244|NCT04205812|526183677|FG000|Randomized Treatment Period|Physician Decision|1|||
145912245|NCT04205812|526183678|FG001|Randomized Treatment Period|Physician Decision|4|||
145912246|NCT04205812|526183677|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
145912247|NCT04205812|526183678|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
145912248|NCT04205812|526183677|FG000|Randomized Treatment Period|Progressive Disease|0|||
145912249|NCT04205812|526183678|FG001|Randomized Treatment Period|Progressive Disease|1|||
145912250|NCT04205812|526183677|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
145912251|NCT04205812|526183678|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
145912252|NCT04205812|526183677|FG000|Monotherapy Treatment Period|Ongoing|17|||
145912253|NCT04205812|526183678|FG001|Monotherapy Treatment Period|Ongoing|0|||
145973406|NCT03765073|526416403|FG011|Stage 1|Withdrawal by participant|0|||
145973407|NCT03765073|526416404|FG012|Stage 1|Withdrawal by participant|0|||
145973408|NCT03765073|526416405|FG013|Stage 1|Withdrawal by participant|0|||
145973409|NCT03765073|526416406|FG014|Stage 1|Withdrawal by participant|0|||
145912254|NCT04205812|526183677|FG000|Monotherapy Treatment Period|Death|39|||
145973410|NCT03765073|526416407|FG015|Stage 1|Withdrawal by participant|0|||
145973411|NCT03765073|526416408|FG016|Stage 1|Withdrawal by participant|0|||
145973412|NCT03765073|526416409|FG017|Stage 1|Withdrawal by participant|0|||
145912255|NCT04205812|526183678|FG001|Monotherapy Treatment Period|Death|0|||
145912256|NCT04205812|526183677|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
145912257|NCT04205812|526183678|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
145912258|NCT04205812|526183677|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
145912259|NCT04205812|526183678|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
145912260|NCT04559347|526183679|FG000|Overall Study|Death|1|||
145973413|NCT03765073|526416410|FG018|Stage 1|Withdrawal by participant|0|||
145973414|NCT03765073|526416411|FG019|Stage 1|Withdrawal by participant|0|||
145973415|NCT03765073|526416412|FG020|Stage 1|Withdrawal by participant|0|||
145912261|NCT04559347|526183680|FG001|Overall Study|Death|0|||
145912262|NCT04559347|526183679|FG000|Overall Study|Thoracotomy conversion|1|||
145912263|NCT04559347|526183680|FG001|Overall Study|Thoracotomy conversion|1|||
145912264|NCT04559347|526183679|FG000|Overall Study|Provider unavailable|2|||
145912265|NCT04559347|526183680|FG001|Overall Study|Provider unavailable|1|||
145912266|NCT04559347|526183679|FG000|Overall Study|Other|2|||
145912267|NCT04559347|526183680|FG001|Overall Study|Other|1|||
145912268|NCT00371033|526183682|FG000|Overall Study|Lost to Follow-up|3|||
145912269|NCT00371033|526183683|FG001|Overall Study|Lost to Follow-up|2|||
145912270|NCT00371033|526183682|FG000|Overall Study|No longer interested|2|||
145912271|NCT00371033|526183683|FG001|Overall Study|No longer interested|0|||
145912272|NCT00371033|526183682|FG000|Overall Study|Uknown|3|||
145912273|NCT00371033|526183683|FG001|Overall Study|Uknown|1|||
145912274|NCT05929651|526183690|FG000|Overall Study|Protocol Deviation|1|||
145912275|NCT05929651|526183690|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
145912276|NCT05026177|526183691|FG000|Overall Study|Adverse Event|33|||
145912277|NCT05026177|526183692|FG001|Overall Study|Adverse Event|33|||
145912278|NCT05026177|526183693|FG002|Overall Study|Adverse Event|17|||
145912279|NCT05026177|526183691|FG000|Overall Study|Lost to Follow-up|7|||
145912280|NCT05026177|526183692|FG001|Overall Study|Lost to Follow-up|6|||
145912281|NCT05026177|526183693|FG002|Overall Study|Lost to Follow-up|8|||
145912282|NCT05026177|526183691|FG000|Overall Study|Noncompliance with study drug|6|||
145912283|NCT05026177|526183692|FG001|Overall Study|Noncompliance with study drug|2|||
145912284|NCT05026177|526183693|FG002|Overall Study|Noncompliance with study drug|1|||
145912285|NCT05026177|526183691|FG000|Overall Study|Physician Decision|4|||
145912286|NCT05026177|526183692|FG001|Overall Study|Physician Decision|1|||
145912287|NCT05026177|526183693|FG002|Overall Study|Physician Decision|0|||
145912288|NCT05026177|526183691|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
145912289|NCT05026177|526183692|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
145912290|NCT05026177|526183693|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
145912291|NCT05026177|526183691|FG000|Overall Study|Withdrawal by Subject|53|||
145912292|NCT05026177|526183692|FG001|Overall Study|Withdrawal by Subject|51|||
145912293|NCT05026177|526183693|FG002|Overall Study|Withdrawal by Subject|55|||
145912294|NCT05026177|526183691|FG000|Overall Study|Protocol Violation|0|||
145912295|NCT05026177|526183692|FG001|Overall Study|Protocol Violation|1|||
145912296|NCT05026177|526183693|FG002|Overall Study|Protocol Violation|0|||
145912297|NCT05026177|526183691|FG000|Overall Study|Study terminated by sponsor|70|||
145912298|NCT05026177|526183692|FG001|Overall Study|Study terminated by sponsor|74|||
145912299|NCT05026177|526183693|FG002|Overall Study|Study terminated by sponsor|67|||
145912300|NCT05026177|526183691|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
145912301|NCT05026177|526183692|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
145912302|NCT05026177|526183693|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
145912303|NCT05026177|526183691|FG000|Overall Study|Starting alternative treatment|0|||
145912304|NCT05026177|526183692|FG001|Overall Study|Starting alternative treatment|1|||
145912305|NCT05026177|526183693|FG002|Overall Study|Starting alternative treatment|1|||
145912306|NCT05026177|526183691|FG000|Overall Study|Noncompliance with study procedures|0|||
145912307|NCT05026177|526183692|FG001|Overall Study|Noncompliance with study procedures|1|||
145912308|NCT05026177|526183693|FG002|Overall Study|Noncompliance with study procedures|1|||
145912309|NCT05026177|526183691|FG000|Overall Study|Met stopping criteria|0|||
145912310|NCT05026177|526183692|FG001|Overall Study|Met stopping criteria|0|||
145912311|NCT05026177|526183693|FG002|Overall Study|Met stopping criteria|1|||
145912312|NCT05026177|526183691|FG000|Overall Study|Health issues preventing continuation|0|||
145912313|NCT05026177|526183692|FG001|Overall Study|Health issues preventing continuation|0|||
145912314|NCT05026177|526183693|FG002|Overall Study|Health issues preventing continuation|1|||
145912315|NCT05026177|526183691|FG000|Overall Study|Randomized in error, not treated|0|||
145912316|NCT05026177|526183692|FG001|Overall Study|Randomized in error, not treated|0|||
145912317|NCT05026177|526183693|FG002|Overall Study|Randomized in error, not treated|2|||
145912318|NCT03816878|526183698|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
145912319|NCT03816878|526183699|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
145912320|NCT03816878|526183698|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
145912321|NCT03816878|526183699|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
145912322|NCT03355469|526183700|FG000|Overall Study|COVID-19|3|||
145912323|NCT03355469|526183701|FG001|Overall Study|COVID-19|2|||
145912324|NCT03355469|526183702|FG002|Overall Study|COVID-19|3|||
145912325|NCT03355469|526183703|FG003|Overall Study|COVID-19|3|||
145912326|NCT03355469|526183700|FG000|Overall Study|Lost to Follow-up|1|||
145912327|NCT03355469|526183701|FG001|Overall Study|Lost to Follow-up|0|||
145912328|NCT03355469|526183702|FG002|Overall Study|Lost to Follow-up|1|||
145912329|NCT03355469|526183703|FG003|Overall Study|Lost to Follow-up|0|||
145912330|NCT03355469|526183700|FG000|Overall Study|Withdrawal by Subject|2|||
145912331|NCT03355469|526183701|FG001|Overall Study|Withdrawal by Subject|1|||
145912332|NCT03355469|526183702|FG002|Overall Study|Withdrawal by Subject|0|||
145912333|NCT03355469|526183703|FG003|Overall Study|Withdrawal by Subject|3|||
146297459|NCT03690141|527604700|FG000|Overall Study|Adverse Event|5|||
145912334|NCT05626231|526183704|FG000|Provider Enrollment|Worked part-time|4|||
145912335|NCT05626231|526183704|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
145912336|NCT05626231|526183704|FG000|Provider Enrollment|Non-clinical employee|1|||
145912337|NCT05626231|526183704|FG000|Provider Enrollment|Provider does not see clients|3|||
145912338|NCT05626231|526183704|FG000|Provider Enrollment|Other|5|||
145912339|NCT03765788|526183706|FG000|Overall Study|Subject decision|2|||
145912340|NCT03765788|526183707|FG001|Overall Study|Subject decision|3|||
145912341|NCT03765788|526183706|FG000|Overall Study|Physician Decision|2|||
145912342|NCT03765788|526183707|FG001|Overall Study|Physician Decision|4|||
145912343|NCT03765788|526183706|FG000|Overall Study|Death|0|||
145912344|NCT03765788|526183707|FG001|Overall Study|Death|1|||
145912345|NCT03765788|526183706|FG000|Overall Study|Lost to Follow-up|1|||
145912346|NCT03765788|526183707|FG001|Overall Study|Lost to Follow-up|0|||
145912347|NCT03203850|526183708|FG000|Overall Study|Subject/guardian decision|4|||
145912348|NCT03203850|526183709|FG001|Overall Study|Subject/guardian decision|3|||
145912349|NCT03203850|526183708|FG000|Overall Study|Adverse Event|3|||
145912350|NCT03203850|526183709|FG001|Overall Study|Adverse Event|0|||
145912351|NCT03203850|526183708|FG000|Overall Study|Death|1|||
145912352|NCT03203850|526183709|FG001|Overall Study|Death|0|||
145912353|NCT02717455|526183710|FG000|Overall Study|Adverse Event|1|||
145912354|NCT02717455|526183711|FG001|Overall Study|Adverse Event|0|||
145912355|NCT02717455|526183712|FG002|Overall Study|Adverse Event|0|||
145912356|NCT02717455|526183713|FG003|Overall Study|Adverse Event|2|||
145912357|NCT02717455|526183714|FG004|Overall Study|Adverse Event|2|||
145912358|NCT02717455|526183715|FG005|Overall Study|Adverse Event|2|||
145912359|NCT02717455|526183710|FG000|Overall Study|Withdrawal by Subject|1|||
145912360|NCT02717455|526183711|FG001|Overall Study|Withdrawal by Subject|1|||
145912361|NCT02717455|526183712|FG002|Overall Study|Withdrawal by Subject|0|||
145912362|NCT02717455|526183713|FG003|Overall Study|Withdrawal by Subject|2|||
145912363|NCT02717455|526183714|FG004|Overall Study|Withdrawal by Subject|2|||
145912364|NCT02717455|526183715|FG005|Overall Study|Withdrawal by Subject|1|||
145912365|NCT02717455|526183710|FG000|Overall Study|Death|1|||
145912366|NCT02717455|526183711|FG001|Overall Study|Death|0|||
145912367|NCT02717455|526183712|FG002|Overall Study|Death|0|||
145912368|NCT02717455|526183713|FG003|Overall Study|Death|0|||
145912369|NCT02717455|526183714|FG004|Overall Study|Death|1|||
145912370|NCT02717455|526183715|FG005|Overall Study|Death|0|||
145912371|NCT02717455|526183710|FG000|Overall Study|Did not receive study drug|0|||
145912372|NCT02717455|526183711|FG001|Overall Study|Did not receive study drug|0|||
145912373|NCT02717455|526183712|FG002|Overall Study|Did not receive study drug|0|||
145912374|NCT02717455|526183713|FG003|Overall Study|Did not receive study drug|1|||
145912375|NCT02717455|526183714|FG004|Overall Study|Did not receive study drug|0|||
145912376|NCT02717455|526183715|FG005|Overall Study|Did not receive study drug|1|||
145912377|NCT02717455|526183710|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145912378|NCT02717455|526183711|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145912379|NCT02717455|526183712|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145912380|NCT02717455|526183713|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145912381|NCT02717455|526183714|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145912382|NCT02717455|526183715|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
145912383|NCT02717455|526183710|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
145912384|NCT02717455|526183711|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
145912385|NCT02717455|526183712|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
145912386|NCT02717455|526183713|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
145912387|NCT02717455|526183714|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
146297460|NCT03690141|527604700|FG000|Overall Study|Withdrawal by Subject|3|||
145912388|NCT02717455|526183715|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
145912389|NCT00733005|526183716|FG000|Overall Study|Adverse Event|0|||
145912390|NCT00733005|526183717|FG001|Overall Study|Adverse Event|1|||
145912391|NCT00733005|526183716|FG000|Overall Study|Treatment Failure|0|||
145912392|NCT00733005|526183717|FG001|Overall Study|Treatment Failure|1|||
145912393|NCT00733005|526183716|FG000|Overall Study|Withdrawal by Subject|0|||
145912394|NCT00733005|526183717|FG001|Overall Study|Withdrawal by Subject|1|||
145973416|NCT03765073|526416392|FG000|Stage 2|Death|0|||
145973417|NCT03765073|526416393|FG001|Stage 2|Death|0|||
145973418|NCT03765073|526416394|FG002|Stage 2|Death|0|||
145912395|NCT00733005|526183716|FG000|Overall Study|Protocol Violation|2|||
145912396|NCT00733005|526183717|FG001|Overall Study|Protocol Violation|0|||
145912397|NCT05256134|526183721|FG000|Overall Study|Study Terminated by Sponsor|11|||
145912398|NCT05256134|526183722|FG001|Overall Study|Study Terminated by Sponsor|10|||
145912399|NCT05256134|526183721|FG000|Overall Study|Withdrawal by Subject|1|||
145912400|NCT05256134|526183722|FG001|Overall Study|Withdrawal by Subject|3|||
145912401|NCT05223920|526183723|FG000|Overall Study|Adverse Event|6|||
145912402|NCT05223920|526183724|FG001|Overall Study|Adverse Event|3|||
145973419|NCT03765073|526416395|FG003|Stage 2|Death|0|||
145912403|NCT05223920|526183723|FG000|Overall Study|Death|2|||
145912404|NCT05223920|526183724|FG001|Overall Study|Death|0|||
145912405|NCT05223920|526183723|FG000|Overall Study|Disease Progression|1|||
145912406|NCT05223920|526183724|FG001|Overall Study|Disease Progression|2|||
145912407|NCT05223920|526183723|FG000|Overall Study|Physician Decision|1|||
146088765|NCT00740246|526845076|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
146088766|NCT00740246|526845077|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
146088767|NCT01001299|526845078|FG000|Overall Study|Insufficient Therapeutic Response|20|||
146088768|NCT01001299|526845078|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
146088769|NCT01001299|526845078|FG000|Overall Study|Death|1|||
146088770|NCT01001299|526845078|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
146088771|NCT01001299|526845078|FG000|Overall Study|Withdrew Consent|1|||
146088772|NCT01056380|526845079|FG000|Overall Study|Lost to Follow-up|2|||
146088773|NCT01056380|526845080|FG001|Overall Study|Lost to Follow-up|3|||
146088774|NCT04068896|526845081|FG000|Overall Study|Adverse Event|2|||
146088775|NCT04068896|526845082|FG001|Overall Study|Adverse Event|0|||
146088776|NCT04068896|526845083|FG002|Overall Study|Adverse Event|1|||
146088777|NCT04068896|526845084|FG003|Overall Study|Adverse Event|0|||
146088778|NCT04068896|526845085|FG004|Overall Study|Adverse Event|0|||
146088779|NCT04068896|526845086|FG005|Overall Study|Adverse Event|0|||
146088780|NCT04068896|526845081|FG000|Overall Study|Death|3|||
146088781|NCT04068896|526845082|FG001|Overall Study|Death|1|||
146088782|NCT04068896|526845083|FG002|Overall Study|Death|3|||
146088783|NCT04068896|526845084|FG003|Overall Study|Death|19|||
146088784|NCT04068896|526845085|FG004|Overall Study|Death|17|||
146088785|NCT04068896|526845086|FG005|Overall Study|Death|0|||
146088786|NCT04068896|526845081|FG000|Overall Study|Physician Decision|0|||
146088787|NCT04068896|526845082|FG001|Overall Study|Physician Decision|0|||
146088788|NCT04068896|526845083|FG002|Overall Study|Physician Decision|0|||
146088789|NCT04068896|526845084|FG003|Overall Study|Physician Decision|1|||
146088790|NCT04068896|526845085|FG004|Overall Study|Physician Decision|0|||
146088791|NCT04068896|526845086|FG005|Overall Study|Physician Decision|0|||
146088792|NCT04068896|526845081|FG000|Overall Study|progressive disease|3|||
146088793|NCT04068896|526845082|FG001|Overall Study|progressive disease|5|||
146088794|NCT04068896|526845083|FG002|Overall Study|progressive disease|3|||
146088795|NCT04068896|526845084|FG003|Overall Study|progressive disease|2|||
146088796|NCT04068896|526845085|FG004|Overall Study|progressive disease|1|||
146088797|NCT04068896|526845086|FG005|Overall Study|progressive disease|2|||
146088798|NCT04068896|526845081|FG000|Overall Study|Study terminated by sponsor|0|||
146088799|NCT04068896|526845082|FG001|Overall Study|Study terminated by sponsor|0|||
146088800|NCT04068896|526845083|FG002|Overall Study|Study terminated by sponsor|1|||
146088801|NCT04068896|526845084|FG003|Overall Study|Study terminated by sponsor|2|||
146088802|NCT04068896|526845085|FG004|Overall Study|Study terminated by sponsor|1|||
146088803|NCT04068896|526845086|FG005|Overall Study|Study terminated by sponsor|4|||
146088804|NCT04068896|526845081|FG000|Overall Study|Protocol Violation|0|||
146088805|NCT04068896|526845082|FG001|Overall Study|Protocol Violation|0|||
146088806|NCT04068896|526845083|FG002|Overall Study|Protocol Violation|0|||
146088807|NCT04068896|526845084|FG003|Overall Study|Protocol Violation|1|||
146088808|NCT04068896|526845085|FG004|Overall Study|Protocol Violation|0|||
146088809|NCT04068896|526845086|FG005|Overall Study|Protocol Violation|0|||
146088810|NCT04068896|526845081|FG000|Overall Study|Withdrawal by Subject|0|||
146088811|NCT04068896|526845082|FG001|Overall Study|Withdrawal by Subject|3|||
146088812|NCT04068896|526845083|FG002|Overall Study|Withdrawal by Subject|0|||
146088813|NCT04068896|526845084|FG003|Overall Study|Withdrawal by Subject|2|||
146088814|NCT04068896|526845085|FG004|Overall Study|Withdrawal by Subject|1|||
146088815|NCT04068896|526845086|FG005|Overall Study|Withdrawal by Subject|0|||
146088816|NCT04068896|526845081|FG000|Overall Study|Symptomatic deterioration|2|||
146088817|NCT04068896|526845082|FG001|Overall Study|Symptomatic deterioration|0|||
146088818|NCT04068896|526845083|FG002|Overall Study|Symptomatic deterioration|0|||
146088819|NCT04068896|526845084|FG003|Overall Study|Symptomatic deterioration|0|||
146088820|NCT04068896|526845085|FG004|Overall Study|Symptomatic deterioration|0|||
146088821|NCT04068896|526845086|FG005|Overall Study|Symptomatic deterioration|0|||
146088822|NCT02522871|526845087|FG000|Overall Study|Protocol Violation|1|||
146297461|NCT03690141|527604700|FG000|Overall Study|Physician Decision|4|||
146088823|NCT02522871|526845088|FG001|Overall Study|Protocol Violation|4|||
146088824|NCT02522871|526845087|FG000|Overall Study|Treated without randomization|1|||
146088825|NCT02522871|526845088|FG001|Overall Study|Treated without randomization|0|||
146088826|NCT02522871|526845087|FG000|Overall Study|Death|9|||
146088827|NCT02522871|526845088|FG001|Overall Study|Death|9|||
146088828|NCT02522871|526845087|FG000|Overall Study|Died in operating room prior to transplant|0|||
146088829|NCT02522871|526845088|FG001|Overall Study|Died in operating room prior to transplant|1|||
146088830|NCT01075191|526845090|FG000|Overall Study|Death|1|||
146088831|NCT01075191|526845090|FG000|Overall Study|Intensification|3|||
146088832|NCT01075191|526845090|FG000|Overall Study|Co-morbidities|1|||
145912408|NCT05223920|526183724|FG001|Overall Study|Physician Decision|2|||
146088833|NCT01075191|526845090|FG000|Overall Study|Adverse Event|4|||
146088834|NCT01075191|526845090|FG000|Overall Study|Noncompliance|3|||
146088835|NCT01075191|526845090|FG000|Overall Study|Therapy Break|3|||
146088836|NCT01075191|526845090|FG000|Overall Study|Patient's Wish|2|||
146088837|NCT01075191|526845090|FG000|Overall Study|Unknown Reasons|1|||
146088838|NCT00718237|526845095|FG000|Overall Study|Adverse Event|1|||
146088839|NCT00718237|526845096|FG001|Overall Study|Adverse Event|3|||
146088840|NCT00718237|526845095|FG000|Overall Study|Lost to Follow-up|2|||
146088841|NCT00718237|526845096|FG001|Overall Study|Lost to Follow-up|2|||
146088842|NCT00718237|526845095|FG000|Overall Study|Physician Decision|1|||
146088843|NCT00718237|526845096|FG001|Overall Study|Physician Decision|0|||
146088844|NCT00718237|526845095|FG000|Overall Study|Withdrawal by Subject|9|||
146088845|NCT00718237|526845096|FG001|Overall Study|Withdrawal by Subject|10|||
146088846|NCT00555425|526845097|FG000|Overall Study|Missed Medication > 1 wk|34|||
146088847|NCT00555425|526845098|FG001|Overall Study|Missed Medication > 1 wk|15|||
146088848|NCT00555425|526845097|FG000|Overall Study|Missed 3 physician management visits|1|||
146088849|NCT00555425|526845098|FG001|Overall Study|Missed 3 physician management visits|0|||
146088850|NCT00555425|526845097|FG000|Overall Study|Met criteria for protective transfer|16|||
146088851|NCT00555425|526845098|FG001|Overall Study|Met criteria for protective transfer|3|||
146088852|NCT00555425|526845097|FG000|Overall Study|Became pregnant and transferred care|0|||
146088853|NCT00555425|526845098|FG001|Overall Study|Became pregnant and transferred care|1|||
146088854|NCT01262352|526845099|FG000|Period 1|Illness after randomization|1|||
146088855|NCT01262352|526845100|FG001|Period 1|Illness after randomization|0|||
146088856|NCT01262352|526845099|FG000|Washout|Adverse Event|1|||
146088857|NCT01262352|526845100|FG001|Washout|Adverse Event|1|||
146088858|NCT01262352|526845099|FG000|Washout|Extended Washout|0|||
146088859|NCT01262352|526845100|FG001|Washout|Extended Washout|1|||
146088860|NCT01185834|526845101|FG000|Overall Study|Lost to Follow-up|2|||
146088861|NCT01185834|526845101|FG000|Overall Study|Discomfort|4|||
145912409|NCT05223920|526183723|FG000|Overall Study|Sponsor decision|11|||
145912410|NCT05223920|526183724|FG001|Overall Study|Sponsor decision|9|||
145912411|NCT05223920|526183723|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
145912412|NCT05223920|526183724|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
145912413|NCT05223920|526183723|FG000|Overall Study|Subject decision|1|||
145912414|NCT05223920|526183724|FG001|Overall Study|Subject decision|0|||
145912415|NCT05223920|526183723|FG000|Overall Study|Withdrawal by Subject|1|||
145912416|NCT05223920|526183724|FG001|Overall Study|Withdrawal by Subject|6|||
145912417|NCT00261950|526183725|FG000|Overall Study|Lost to Follow-up|2|||
145912418|NCT00261950|526183725|FG000|Overall Study|Death|6|||
145912419|NCT00261950|526183725|FG000|Overall Study|Withdrawal by Subject|5|||
145912420|NCT00261950|526183725|FG000|Overall Study|Other|1|||
145912421|NCT00261950|526183725|FG000|Overall Study|Physician Decision|1|||
145912422|NCT00261950|526183725|FG000|Overall Study|Protocol specified Criteria|11|||
145912423|NCT01023035|526183726|FG000|Treatment Period|Adverse Event|27|||
145912424|NCT01023035|526183727|FG001|Treatment Period|Adverse Event|32|||
145912425|NCT01023035|526183728|FG002|Treatment Period|Adverse Event|50|||
145912426|NCT01023035|526183726|FG000|Treatment Period|Non-Medical Reasons|19|||
145912427|NCT01023035|526183727|FG001|Treatment Period|Non-Medical Reasons|22|||
145912428|NCT01023035|526183728|FG002|Treatment Period|Non-Medical Reasons|44|||
145912429|NCT01023035|526183726|FG000|Treatment Period|Treatment Failure|26|||
145912430|NCT01023035|526183727|FG001|Treatment Period|Treatment Failure|31|||
145912431|NCT01023035|526183728|FG002|Treatment Period|Treatment Failure|24|||
145912432|NCT01023035|526183726|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
145912433|NCT01023035|526183727|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
145912434|NCT01023035|526183728|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
145912435|NCT01023035|526183726|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
145912436|NCT01023035|526183727|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
145912437|NCT01023035|526183728|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
145912438|NCT00445432|526183733|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
145912439|NCT00445432|526183734|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
145912440|NCT00445432|526183735|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
145912441|NCT00445432|526183736|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
145912442|NCT00445432|526183733|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145912443|NCT00445432|526183734|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145912444|NCT00445432|526183735|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
145912445|NCT00445432|526183736|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145912446|NCT00445432|526183733|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
145912447|NCT00445432|526183734|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
145912448|NCT00445432|526183735|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
146088862|NCT01185834|526845101|FG000|Overall Study|Biomicroscopy|4|||
146088863|NCT01185834|526845101|FG000|Overall Study|Time/Job Conflict|2|||
146088864|NCT01185834|526845101|FG000|Overall Study|Early exit - Site error|2|||
146088865|NCT03189381|526845102|FG000|Overall Study|Death|1|||
146088866|NCT03189381|526845103|FG001|Overall Study|Death|0|||
146088867|NCT01975831|526845104|FG000|Overall Study|Adverse Event|1|||
146088868|NCT01975831|526845105|FG001|Overall Study|Adverse Event|2|||
146088869|NCT01975831|526845106|FG002|Overall Study|Adverse Event|2|||
145973420|NCT03765073|526416396|FG004|Stage 2|Death|0|||
145912449|NCT00445432|526183736|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
145912450|NCT00445432|526183733|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
145912451|NCT00445432|526183734|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
145912452|NCT00445432|526183735|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
145912453|NCT00445432|526183736|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
145912454|NCT00445432|526183733|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145912455|NCT00445432|526183734|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145912456|NCT00445432|526183735|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145912457|NCT00445432|526183736|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
145912458|NCT00445432|526183733|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145912459|NCT00445432|526183734|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145912460|NCT00445432|526183735|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145912461|NCT00445432|526183736|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
145912462|NCT00445432|526183733|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
145912463|NCT00445432|526183734|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
145912464|NCT00445432|526183735|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
145912465|NCT00445432|526183736|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
145912466|NCT02789137|526183737|FG000|Overall Study|Dropped out/Died|58|||
145912467|NCT01090414|526183738|FG000|Study 101-99|Progressive Disease|28|||
145912468|NCT01090414|526183739|FG001|Study 101-99|Progressive Disease|48|||
145912469|NCT01090414|526183740|FG002|Study 101-99|Progressive Disease|10|||
145912470|NCT01090414|526183741|FG003|Study 101-99|Progressive Disease|4|||
145912471|NCT01090414|526183738|FG000|Study 101-99|Adverse Event|10|||
145912472|NCT01090414|526183739|FG001|Study 101-99|Adverse Event|28|||
145912473|NCT01090414|526183740|FG002|Study 101-99|Adverse Event|18|||
145912474|NCT01090414|526183741|FG003|Study 101-99|Adverse Event|0|||
145912475|NCT01090414|526183738|FG000|Study 101-99|Investigator Request|1|||
145912476|NCT01090414|526183739|FG001|Study 101-99|Investigator Request|11|||
145912477|NCT01090414|526183740|FG002|Study 101-99|Investigator Request|4|||
145912478|NCT01090414|526183741|FG003|Study 101-99|Investigator Request|0|||
145912479|NCT01090414|526183738|FG000|Study 101-99|Death|3|||
145912480|NCT01090414|526183739|FG001|Study 101-99|Death|8|||
145912481|NCT01090414|526183740|FG002|Study 101-99|Death|1|||
145912482|NCT01090414|526183741|FG003|Study 101-99|Death|0|||
145912483|NCT01090414|526183738|FG000|Study 101-99|Sponsor Discontinued Study|0|||
145912484|NCT01090414|526183739|FG001|Study 101-99|Sponsor Discontinued Study|7|||
145912485|NCT01090414|526183740|FG002|Study 101-99|Sponsor Discontinued Study|5|||
145912486|NCT01090414|526183741|FG003|Study 101-99|Sponsor Discontinued Study|0|||
145912487|NCT01090414|526183738|FG000|Study 101-99|Other (Unknown Reasons)|3|||
145912488|NCT01090414|526183739|FG001|Study 101-99|Other (Unknown Reasons)|3|||
145912489|NCT01090414|526183740|FG002|Study 101-99|Other (Unknown Reasons)|0|||
145912490|NCT01090414|526183741|FG003|Study 101-99|Other (Unknown Reasons)|0|||
145912491|NCT01090414|526183738|FG000|Study 101-99|Withdrew Consent|0|||
145912492|NCT01090414|526183739|FG001|Study 101-99|Withdrew Consent|2|||
145912493|NCT01090414|526183740|FG002|Study 101-99|Withdrew Consent|3|||
145912494|NCT01090414|526183741|FG003|Study 101-99|Withdrew Consent|1|||
145912495|NCT01090414|526183738|FG000|Study 101-99|Participant Request|3|||
145912496|NCT01090414|526183739|FG001|Study 101-99|Participant Request|1|||
145912497|NCT01090414|526183740|FG002|Study 101-99|Participant Request|0|||
145912498|NCT01090414|526183741|FG003|Study 101-99|Participant Request|0|||
145912499|NCT00247676|526183744|FG000|Overall Study|Death|5|||
145912500|NCT00247676|526183744|FG000|Overall Study|Adverse Event|11|||
145912501|NCT00247676|526183744|FG000|Overall Study|Lack of Efficacy|15|||
145912502|NCT00247676|526183744|FG000|Overall Study|Other|3|||
145912503|NCT00247676|526183744|FG000|Overall Study|Withdrawal by Subject|2|||
145912504|NCT00911300|526183745|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
145912505|NCT00911300|526183746|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
145973421|NCT03765073|526416397|FG005|Stage 2|Death|0|||
145973422|NCT03765073|526416398|FG006|Stage 2|Death|0|||
145973423|NCT03765073|526416399|FG007|Stage 2|Death|0|||
145973424|NCT03765073|526416400|FG008|Stage 2|Death|0|||
145912506|NCT00911300|526183745|FG000|Overall Study|Death|1|||
145912507|NCT00911300|526183746|FG001|Overall Study|Death|0|||
145912508|NCT00911300|526183745|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
145912509|NCT00911300|526183746|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
145912510|NCT00911300|526183745|FG000|Overall Study|Adverse Event|14|||
145912511|NCT00911300|526183746|FG001|Overall Study|Adverse Event|6|||
145912512|NCT00911300|526183745|FG000|Overall Study|Protocol Violation|3|||
145912513|NCT00911300|526183746|FG001|Overall Study|Protocol Violation|2|||
145912514|NCT00911300|526183745|FG000|Overall Study|Consent Withdrawn|4|||
145912515|NCT00911300|526183746|FG001|Overall Study|Consent Withdrawn|12|||
145912516|NCT00911300|526183745|FG000|Overall Study|Coronary Angiography Performed|1|||
145912517|NCT00911300|526183746|FG001|Overall Study|Coronary Angiography Performed|0|||
145912518|NCT00911300|526183745|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
145912519|NCT00911300|526183746|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
145973425|NCT03765073|526416401|FG009|Stage 2|Death|1|||
145973426|NCT03765073|526416402|FG010|Stage 2|Death|0|||
145973427|NCT03765073|526416403|FG011|Stage 2|Death|1|||
145973428|NCT03765073|526416404|FG012|Stage 2|Death|0|||
145973429|NCT03765073|526416405|FG013|Stage 2|Death|0|||
145973430|NCT03765073|526416406|FG014|Stage 2|Death|0|||
145973431|NCT03765073|526416407|FG015|Stage 2|Death|0|||
146239257|NCT01706159|527389765|FG000|Overall Study|Unclassified|6|||
146239258|NCT01706159|527389766|FG001|Overall Study|Unclassified|1|||
146239259|NCT02454959|527389768|FG000|Overall Study|Protocol-Specified Criteria|3|||
146239260|NCT02454959|527389768|FG000|Overall Study|Physician Decision|1|||
146239261|NCT02454959|527389768|FG000|Overall Study|Withdrawal by Subject|3|||
146239262|NCT02454959|527389768|FG000|Overall Study|Adverse Event|2|||
146239263|NCT00989196|527389769|FG000|Treatment Period|Lost to Follow-up|1|||
146239264|NCT00989196|527389770|FG001|Treatment Period|Lost to Follow-up|0|||
146239265|NCT02409680|527389771|FG000|Overall Study|Lost to Follow-up|15|||
146239266|NCT02409680|527389772|FG001|Overall Study|Lost to Follow-up|30|||
146239267|NCT03789656|527389773|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
146239268|NCT03789656|527389774|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146239269|NCT03789656|527389775|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146239270|NCT03789656|527389776|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
146239271|NCT03789656|527389777|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
146239272|NCT03789656|527389773|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146239273|NCT03789656|527389774|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146239274|NCT03789656|527389775|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
146239275|NCT03789656|527389776|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146239276|NCT03789656|527389777|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
146239277|NCT03789656|527389773|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
146239278|NCT03789656|527389774|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146239279|NCT03789656|527389775|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
145912520|NCT00911300|526183745|FG000|Overall Study|Received Commercial Treatment|1|||
145912521|NCT00911300|526183746|FG001|Overall Study|Received Commercial Treatment|0|||
145912522|NCT00911300|526183745|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
145912523|NCT00911300|526183746|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
145912524|NCT00911300|526183745|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
145912525|NCT00911300|526183746|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
145912526|NCT00911300|526183745|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
145912527|NCT00911300|526183746|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
145912528|NCT00911300|526183745|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
145912529|NCT00911300|526183746|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
145912530|NCT00911300|526183745|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
145912531|NCT00911300|526183746|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
145912532|NCT00911300|526183745|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
145912533|NCT00911300|526183746|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
145912534|NCT00911300|526183745|FG000|Overall Study|International Normalized Ratio Too High|0|||
145912535|NCT00911300|526183746|FG001|Overall Study|International Normalized Ratio Too High|1|||
145912536|NCT00911300|526183745|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
145912537|NCT00911300|526183746|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
145912538|NCT00911300|526183745|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
145912539|NCT00911300|526183746|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
145912540|NCT00911300|526183745|FG000|Overall Study|Physician Decision|0|||
146239280|NCT03789656|527389776|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146239281|NCT03789656|527389777|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
146239282|NCT03789656|527389773|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
146239283|NCT03789656|527389774|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146239284|NCT03789656|527389775|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146239285|NCT03789656|527389776|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146239286|NCT03789656|527389777|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
146239287|NCT05325294|527389782|FG000|Overall Study|Adverse Event|3|||
146239288|NCT05325294|527389783|FG001|Overall Study|Adverse Event|3|||
145912541|NCT00911300|526183746|FG001|Overall Study|Physician Decision|1|||
145912542|NCT00911300|526183745|FG000|Overall Study|Treatment Stopped by Mistake|0|||
145912543|NCT00911300|526183746|FG001|Overall Study|Treatment Stopped by Mistake|1|||
145973432|NCT03765073|526416408|FG016|Stage 2|Death|2|||
145973433|NCT03765073|526416409|FG017|Stage 2|Death|0|||
145973434|NCT03765073|526416410|FG018|Stage 2|Death|0|||
146239289|NCT05325294|527389782|FG000|Overall Study|Physician Decision|0|||
146239290|NCT05325294|527389783|FG001|Overall Study|Physician Decision|1|||
146239291|NCT05325294|527389782|FG000|Overall Study|Withdrawal by Subject|0|||
146239292|NCT05325294|527389783|FG001|Overall Study|Withdrawal by Subject|3|||
146239293|NCT05325294|527389782|FG000|Overall Study|Lost to Follow-up|1|||
146239294|NCT05325294|527389783|FG001|Overall Study|Lost to Follow-up|0|||
146239295|NCT05325294|527389782|FG000|Overall Study|Sponsor Request|0|||
146239296|NCT05325294|527389783|FG001|Overall Study|Sponsor Request|2|||
145973435|NCT03765073|526416411|FG019|Stage 2|Death|0|||
145973436|NCT03765073|526416412|FG020|Stage 2|Death|0|||
145912544|NCT00911300|526183745|FG000|Overall Study|Randomized; No Study Medication Received|0|||
145912545|NCT00911300|526183746|FG001|Overall Study|Randomized; No Study Medication Received|2|||
145912546|NCT00560391|526183751|FG000|Overall Study|Still on treatment|0|||
145912547|NCT00560391|526183752|FG001|Overall Study|Still on treatment|0|||
145912548|NCT00560391|526183753|FG002|Overall Study|Still on treatment|0|||
145912549|NCT00560391|526183754|FG003|Overall Study|Still on treatment|1|||
145912550|NCT00560391|526183755|FG004|Overall Study|Still on treatment|2|||
145912551|NCT03668808|526183756|FG000|First Intervention|Withdrawal by Subject|2|||
145912552|NCT03668808|526183757|FG001|First Intervention|Withdrawal by Subject|2|||
145912553|NCT00280735|526183758|FG000|Overall Study|Adverse Event|5|||
145912554|NCT00280735|526183758|FG000|Overall Study|Lack of Efficacy|3|||
145912555|NCT00280735|526183758|FG000|Overall Study|Withdrawal by Subject|8|||
145912556|NCT00280735|526183758|FG000|Overall Study|Intercurrent Illness|2|||
145912557|NCT04138823|526183759|FG000|Overall Study|Clinical disease progression|0|||
145912558|NCT04138823|526183760|FG001|Overall Study|Clinical disease progression|0|||
145912559|NCT04138823|526183761|FG002|Overall Study|Clinical disease progression|1|||
145912560|NCT04138823|526183759|FG000|Overall Study|Objective disease progression|3|||
145912561|NCT04138823|526183760|FG001|Overall Study|Objective disease progression|2|||
145912562|NCT04138823|526183761|FG002|Overall Study|Objective disease progression|5|||
145912563|NCT02466685|526183762|FG000|Overall Study|Adverse Event|5|||
145912564|NCT02466685|526183763|FG001|Overall Study|Adverse Event|2|||
145912565|NCT02466685|526183762|FG000|Overall Study|Lost to Follow-up|1|||
145912566|NCT02466685|526183763|FG001|Overall Study|Lost to Follow-up|1|||
145912567|NCT02466685|526183762|FG000|Overall Study|Withdrawal by Subject|1|||
145912568|NCT02466685|526183763|FG001|Overall Study|Withdrawal by Subject|0|||
145912569|NCT02466685|526183762|FG000|Overall Study|Physician Decision|1|||
145912570|NCT02466685|526183763|FG001|Overall Study|Physician Decision|1|||
145912571|NCT01277211|526183766|FG000|Overall Study|Adverse Event|60|||
145912572|NCT01277211|526183767|FG001|Overall Study|Adverse Event|22|||
145912573|NCT01277211|526183766|FG000|Overall Study|Pregnancy|9|||
145912574|NCT01277211|526183767|FG001|Overall Study|Pregnancy|4|||
145912575|NCT01277211|526183766|FG000|Overall Study|Lost to Follow-up|14|||
145912576|NCT01277211|526183767|FG001|Overall Study|Lost to Follow-up|9|||
145912577|NCT01277211|526183766|FG000|Overall Study|Did not wish to continue|17|||
145912578|NCT01277211|526183767|FG001|Overall Study|Did not wish to continue|0|||
145912579|NCT01277211|526183766|FG000|Overall Study|Withdrew Consent|9|||
145912580|NCT01277211|526183767|FG001|Overall Study|Withdrew Consent|9|||
145912581|NCT01277211|526183766|FG000|Overall Study|Non-compliance with protocol|13|||
145912582|NCT01277211|526183767|FG001|Overall Study|Non-compliance with protocol|4|||
145912583|NCT01277211|526183766|FG000|Overall Study|Did not meet protocol eligibility|1|||
145912584|NCT01277211|526183767|FG001|Overall Study|Did not meet protocol eligibility|0|||
145912585|NCT01277211|526183766|FG000|Overall Study|Administrative|3|||
145912586|NCT01277211|526183767|FG001|Overall Study|Administrative|0|||
145912587|NCT01277211|526183766|FG000|Overall Study|Pregnancy wish|0|||
145912588|NCT01277211|526183767|FG001|Overall Study|Pregnancy wish|2|||
145912589|NCT01277211|526183766|FG000|Overall Study|Discontinued prior to treatment|24|||
145912590|NCT01277211|526183767|FG001|Overall Study|Discontinued prior to treatment|13|||
145912591|NCT03452943|526183768|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
145912592|NCT03452943|526183769|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
145912593|NCT03452943|526183768|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
145912594|NCT03452943|526183769|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
145912595|NCT03452943|526183768|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
145912596|NCT03452943|526183769|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
145912597|NCT03452943|526183768|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
145912598|NCT03452943|526183769|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
145912599|NCT03452943|526183768|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
146239297|NCT02434328|527389785|FG000|Overall Study|Adverse Event|9|||
146239298|NCT02434328|527389786|FG001|Overall Study|Adverse Event|4|||
146239299|NCT02434328|527389785|FG000|Overall Study|Lack of Efficacy|0|||
145912600|NCT03452943|526183769|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
145912601|NCT03452943|526183768|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
145912602|NCT03452943|526183769|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
145912603|NCT03017612|526183774|FG000|Overall Study|Adverse Event|2|||
145912604|NCT04895982|526183775|FG000|Overall Study|Withdrawal by Subject|0|||
145912605|NCT04895982|526183776|FG001|Overall Study|Withdrawal by Subject|0|||
145912606|NCT04895982|526183777|FG002|Overall Study|Withdrawal by Subject|0|||
145912607|NCT04895982|526183778|FG003|Overall Study|Withdrawal by Subject|0|||
145912608|NCT04895982|526183779|FG004|Overall Study|Withdrawal by Subject|0|||
145973437|NCT03765073|526416392|FG000|Stage 2|Lost to Follow-up|0|||
145973438|NCT03765073|526416393|FG001|Stage 2|Lost to Follow-up|0|||
146239300|NCT02434328|527389786|FG001|Overall Study|Lack of Efficacy|2|||
145912609|NCT04895982|526183780|FG005|Overall Study|Withdrawal by Subject|1|||
145973439|NCT03765073|526416394|FG002|Stage 2|Lost to Follow-up|0|||
146239301|NCT02434328|527389785|FG000|Overall Study|Physician Decision|0|||
145912610|NCT04895982|526183781|FG006|Overall Study|Withdrawal by Subject|1|||
145973440|NCT03765073|526416395|FG003|Stage 2|Lost to Follow-up|5|||
145912611|NCT04895982|526183782|FG007|Overall Study|Withdrawal by Subject|0|||
145912612|NCT04895982|526183783|FG008|Overall Study|Withdrawal by Subject|0|||
145912613|NCT04895982|526183784|FG009|Overall Study|Withdrawal by Subject|1|||
145912614|NCT04895982|526183785|FG010|Overall Study|Withdrawal by Subject|0|||
145912615|NCT04895982|526183786|FG011|Overall Study|Withdrawal by Subject|1|||
145912616|NCT04895982|526183775|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145912617|NCT04895982|526183776|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145912618|NCT04895982|526183777|FG002|Overall Study|Withdrawal by parent/guardian|3|||
145912619|NCT04895982|526183778|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145912620|NCT04895982|526183779|FG004|Overall Study|Withdrawal by parent/guardian|3|||
145912621|NCT04895982|526183780|FG005|Overall Study|Withdrawal by parent/guardian|2|||
145912622|NCT04895982|526183781|FG006|Overall Study|Withdrawal by parent/guardian|1|||
145912623|NCT04895982|526183782|FG007|Overall Study|Withdrawal by parent/guardian|0|||
145912624|NCT04895982|526183783|FG008|Overall Study|Withdrawal by parent/guardian|3|||
145912625|NCT04895982|526183784|FG009|Overall Study|Withdrawal by parent/guardian|0|||
145912626|NCT04895982|526183785|FG010|Overall Study|Withdrawal by parent/guardian|0|||
145912627|NCT04895982|526183786|FG011|Overall Study|Withdrawal by parent/guardian|0|||
145912628|NCT04895982|526183775|FG000|Overall Study|Other|0|||
145912629|NCT04895982|526183776|FG001|Overall Study|Other|0|||
145912630|NCT04895982|526183777|FG002|Overall Study|Other|1|||
145912631|NCT04895982|526183778|FG003|Overall Study|Other|1|||
145912632|NCT04895982|526183779|FG004|Overall Study|Other|0|||
145912633|NCT04895982|526183780|FG005|Overall Study|Other|0|||
145912634|NCT04895982|526183781|FG006|Overall Study|Other|0|||
145912635|NCT04895982|526183782|FG007|Overall Study|Other|0|||
145912636|NCT04895982|526183783|FG008|Overall Study|Other|0|||
145912637|NCT04895982|526183784|FG009|Overall Study|Other|1|||
145912638|NCT04895982|526183785|FG010|Overall Study|Other|0|||
145912639|NCT04895982|526183786|FG011|Overall Study|Other|0|||
145912640|NCT04895982|526183775|FG000|Overall Study|Protocol Violation|0|||
145912641|NCT04895982|526183776|FG001|Overall Study|Protocol Violation|0|||
145912642|NCT04895982|526183777|FG002|Overall Study|Protocol Violation|1|||
145912643|NCT04895982|526183778|FG003|Overall Study|Protocol Violation|1|||
145912644|NCT04895982|526183779|FG004|Overall Study|Protocol Violation|1|||
145912645|NCT04895982|526183780|FG005|Overall Study|Protocol Violation|0|||
145912646|NCT04895982|526183781|FG006|Overall Study|Protocol Violation|0|||
145912647|NCT04895982|526183782|FG007|Overall Study|Protocol Violation|1|||
145912648|NCT04895982|526183783|FG008|Overall Study|Protocol Violation|0|||
145912649|NCT04895982|526183784|FG009|Overall Study|Protocol Violation|0|||
145912650|NCT04895982|526183785|FG010|Overall Study|Protocol Violation|0|||
145912651|NCT04895982|526183786|FG011|Overall Study|Protocol Violation|0|||
145912652|NCT04895982|526183775|FG000|Overall Study|Lost to Follow-up|0|||
145912653|NCT04895982|526183776|FG001|Overall Study|Lost to Follow-up|0|||
145912654|NCT04895982|526183777|FG002|Overall Study|Lost to Follow-up|1|||
145912655|NCT04895982|526183778|FG003|Overall Study|Lost to Follow-up|0|||
145912656|NCT04895982|526183779|FG004|Overall Study|Lost to Follow-up|0|||
145912657|NCT04895982|526183780|FG005|Overall Study|Lost to Follow-up|1|||
145912658|NCT04895982|526183781|FG006|Overall Study|Lost to Follow-up|0|||
145912659|NCT04895982|526183782|FG007|Overall Study|Lost to Follow-up|0|||
145912660|NCT04895982|526183783|FG008|Overall Study|Lost to Follow-up|1|||
145912661|NCT04895982|526183784|FG009|Overall Study|Lost to Follow-up|0|||
145912662|NCT04895982|526183785|FG010|Overall Study|Lost to Follow-up|0|||
145912663|NCT04895982|526183786|FG011|Overall Study|Lost to Follow-up|0|||
145912664|NCT04895982|526183775|FG000|Overall Study|Refused further study procedures|0|||
146239302|NCT02434328|527389786|FG001|Overall Study|Physician Decision|1|||
146239303|NCT02434328|527389785|FG000|Overall Study|Withdrawal by Subject|12|||
146239304|NCT02434328|527389786|FG001|Overall Study|Withdrawal by Subject|21|||
146239305|NCT02434328|527389785|FG000|Overall Study|Death|4|||
146239306|NCT02434328|527389786|FG001|Overall Study|Death|7|||
146239307|NCT02434328|527389785|FG000|Overall Study|Lost to Follow-up|1|||
145912665|NCT04895982|526183776|FG001|Overall Study|Refused further study procedures|0|||
145912666|NCT04895982|526183777|FG002|Overall Study|Refused further study procedures|1|||
145912667|NCT04895982|526183778|FG003|Overall Study|Refused further study procedures|0|||
145912668|NCT04895982|526183779|FG004|Overall Study|Refused further study procedures|0|||
146239308|NCT02434328|527389786|FG001|Overall Study|Lost to Follow-up|6|||
145912669|NCT04895982|526183780|FG005|Overall Study|Refused further study procedures|0|||
145912670|NCT04895982|526183781|FG006|Overall Study|Refused further study procedures|0|||
145912671|NCT04895982|526183782|FG007|Overall Study|Refused further study procedures|0|||
146239309|NCT02434328|527389785|FG000|Overall Study|Other|4|||
146239310|NCT02434328|527389786|FG001|Overall Study|Other|1|||
145912672|NCT04895982|526183783|FG008|Overall Study|Refused further study procedures|0|||
145912673|NCT04895982|526183784|FG009|Overall Study|Refused further study procedures|0|||
146239311|NCT03147287|527389787|FG000|Overall Study|Randomized Not Treated|2|||
145912674|NCT04895982|526183785|FG010|Overall Study|Refused further study procedures|0|||
145912675|NCT04895982|526183786|FG011|Overall Study|Refused further study procedures|0|||
145912676|NCT02215967|526183797|FG000|Overall Study|Patient became ineligible for treatment|0|||
145912677|NCT02215967|526183798|FG001|Overall Study|Patient became ineligible for treatment|0|||
146297462|NCT03690141|527604700|FG000|Overall Study|Disease progression|4|||
145912678|NCT02215967|526183799|FG002|Overall Study|Patient became ineligible for treatment|0|||
145912679|NCT02215967|526183800|FG003|Overall Study|Patient became ineligible for treatment|3|||
145912680|NCT02215967|526183797|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
145912681|NCT02215967|526183798|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
145912682|NCT02215967|526183799|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
145912683|NCT02215967|526183800|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
145912684|NCT00352417|526183801|FG000|Overall Study|Adverse Event|1|||
145912685|NCT00352417|526183802|FG001|Overall Study|Adverse Event|0|||
145912686|NCT00352417|526183801|FG000|Overall Study|Protocol Violation|0|||
145912687|NCT00352417|526183802|FG001|Overall Study|Protocol Violation|2|||
145912688|NCT00352417|526183801|FG000|Overall Study|Withdrawal by Subject|1|||
145912689|NCT00352417|526183802|FG001|Overall Study|Withdrawal by Subject|2|||
145912690|NCT00352417|526183801|FG000|Overall Study|Lost to Follow-up|1|||
145912691|NCT00352417|526183802|FG001|Overall Study|Lost to Follow-up|0|||
145912692|NCT00352417|526183801|FG000|Overall Study|Schedule Change|2|||
145912693|NCT00352417|526183802|FG001|Overall Study|Schedule Change|1|||
145912694|NCT02090725|526185354|FG000|Overall Study|Withdrawal by Subject|1|||
145912695|NCT02090725|526185354|FG000|Overall Study|participants moved from area|3|||
145912696|NCT01625988|526185371|FG000|Overall Study|Lost to Follow-up|5|||
145912697|NCT01625988|526185372|FG001|Overall Study|Lost to Follow-up|6|||
145912698|NCT01625988|526185371|FG000|Overall Study|Withdrawal by Subject|8|||
145912699|NCT01625988|526185372|FG001|Overall Study|Withdrawal by Subject|3|||
145912700|NCT01625988|526185371|FG000|Overall Study|Adverse Event|0|||
145912701|NCT01625988|526185372|FG001|Overall Study|Adverse Event|1|||
145912702|NCT01625988|526185371|FG000|Overall Study|Lack of Efficacy|0|||
145912703|NCT01625988|526185372|FG001|Overall Study|Lack of Efficacy|1|||
145912704|NCT01625988|526185371|FG000|Overall Study|Randomized Inappropriately|1|||
145912705|NCT01625988|526185372|FG001|Overall Study|Randomized Inappropriately|0|||
145912706|NCT01625988|526185371|FG000|Overall Study|Protocol Violation|0|||
145912707|NCT01625988|526185372|FG001|Overall Study|Protocol Violation|2|||
145912708|NCT01644617|526185373|FG000|Overall Study|Withdrawal by Subject|3|||
145912709|NCT01644617|526185374|FG001|Overall Study|Withdrawal by Subject|4|||
145912710|NCT01644617|526185375|FG002|Overall Study|Withdrawal by Subject|1|||
145912711|NCT01644617|526185373|FG000|Overall Study|Lost to Follow-up|0|||
145912712|NCT01644617|526185374|FG001|Overall Study|Lost to Follow-up|1|||
145912713|NCT01644617|526185375|FG002|Overall Study|Lost to Follow-up|0|||
145973441|NCT03765073|526416396|FG004|Stage 2|Lost to Follow-up|1|||
145973442|NCT03765073|526416397|FG005|Stage 2|Lost to Follow-up|0|||
145973443|NCT03765073|526416398|FG006|Stage 2|Lost to Follow-up|3|||
145973444|NCT03765073|526416399|FG007|Stage 2|Lost to Follow-up|3|||
145973445|NCT03765073|526416400|FG008|Stage 2|Lost to Follow-up|1|||
145973446|NCT03765073|526416401|FG009|Stage 2|Lost to Follow-up|6|||
145973447|NCT03765073|526416402|FG010|Stage 2|Lost to Follow-up|5|||
145973448|NCT03765073|526416403|FG011|Stage 2|Lost to Follow-up|1|||
145973449|NCT03765073|526416404|FG012|Stage 2|Lost to Follow-up|1|||
145973450|NCT03765073|526416405|FG013|Stage 2|Lost to Follow-up|3|||
145973451|NCT03765073|526416406|FG014|Stage 2|Lost to Follow-up|3|||
145973452|NCT03765073|526416407|FG015|Stage 2|Lost to Follow-up|1|||
145973453|NCT03765073|526416408|FG016|Stage 2|Lost to Follow-up|6|||
145973454|NCT03765073|526416409|FG017|Stage 2|Lost to Follow-up|0|||
145973455|NCT03765073|526416410|FG018|Stage 2|Lost to Follow-up|0|||
145973456|NCT03765073|526416411|FG019|Stage 2|Lost to Follow-up|0|||
145912714|NCT01644617|526185373|FG000|Overall Study|Adverse Event|3|||
145912715|NCT01644617|526185374|FG001|Overall Study|Adverse Event|0|||
145912716|NCT01644617|526185375|FG002|Overall Study|Adverse Event|6|||
145912717|NCT00196326|526185376|FG000|Overall Study|Did not meet protocol requirements|64|||
145912718|NCT00196326|526185376|FG000|Overall Study|Non-compliance with the protocol|81|||
145912719|NCT00196326|526185376|FG000|Overall Study|Physician Decision|3|||
145912720|NCT00196326|526185376|FG000|Overall Study|Withdrawal by Subject|225|||
145912721|NCT00196326|526185376|FG000|Overall Study|Adverse Event|253|||
145912722|NCT00196326|526185376|FG000|Overall Study|Pregnancy|34|||
145912723|NCT00196326|526185376|FG000|Overall Study|Lost to Follow-up|304|||
145912724|NCT00196326|526185376|FG000|Overall Study|Other|22|||
145912725|NCT02964312|526185377|FG000|Overall Study|Lost to Follow-up|28|||
145912726|NCT02964312|526185377|FG000|Overall Study|Withdrawal by Subject|11|||
145912727|NCT02964312|526185377|FG000|Overall Study|Lack of Efficacy|10|||
145973457|NCT03765073|526416412|FG020|Stage 2|Lost to Follow-up|0|||
145973458|NCT03765073|526416392|FG000|Stage 2|Other|0|||
145912728|NCT02964312|526185377|FG000|Overall Study|Did not consent to long-term FU|14|||
145912729|NCT02964312|526185377|FG000|Overall Study|Death|1|||
145912730|NCT03685344|526185380|FG000|Overall Study|Withdrawal by Subject|1|||
145912731|NCT03685344|526185381|FG001|Overall Study|Withdrawal by Subject|1|||
145973459|NCT03765073|526416393|FG001|Stage 2|Other|0|||
145973460|NCT03765073|526416394|FG002|Stage 2|Other|0|||
145973461|NCT03765073|526416395|FG003|Stage 2|Other|0|||
145973462|NCT03765073|526416396|FG004|Stage 2|Other|0|||
145973463|NCT03765073|526416397|FG005|Stage 2|Other|0|||
145973464|NCT03765073|526416398|FG006|Stage 2|Other|0|||
145973465|NCT03765073|526416399|FG007|Stage 2|Other|1|||
145973466|NCT03765073|526416400|FG008|Stage 2|Other|1|||
145973467|NCT03765073|526416401|FG009|Stage 2|Other|3|||
145912732|NCT03685344|526185382|FG002|Overall Study|Withdrawal by Subject|2|||
145912733|NCT03685344|526185383|FG003|Overall Study|Withdrawal by Subject|0|||
145912734|NCT03685344|526185380|FG000|Overall Study|Physician Decision|1|||
145912735|NCT03685344|526185381|FG001|Overall Study|Physician Decision|1|||
145912736|NCT03685344|526185382|FG002|Overall Study|Physician Decision|5|||
145912737|NCT03685344|526185383|FG003|Overall Study|Physician Decision|0|||
145912738|NCT03685344|526185380|FG000|Overall Study|Death|1|||
145912739|NCT03685344|526185381|FG001|Overall Study|Death|1|||
145912740|NCT03685344|526185382|FG002|Overall Study|Death|0|||
145912741|NCT03685344|526185383|FG003|Overall Study|Death|0|||
145912742|NCT02121652|526185386|FG000|Overall Study|Lost to Follow-up|2|||
145912743|NCT02121652|526185387|FG001|Overall Study|Lost to Follow-up|1|||
145912744|NCT02121652|526185386|FG000|Overall Study|Death|1|||
145912745|NCT02121652|526185387|FG001|Overall Study|Death|0|||
145912746|NCT02121652|526185386|FG000|Overall Study|Withdrawal by Subject|3|||
145912747|NCT02121652|526185387|FG001|Overall Study|Withdrawal by Subject|3|||
145912748|NCT03639779|526185394|FG000|Overall Study|Lost to Follow-up|1|||
145912749|NCT02413229|526185397|FG000|Overall Study|Adverse Event|0|||
145912750|NCT02413229|526185398|FG001|Overall Study|Adverse Event|0|||
145912751|NCT02413229|526185399|FG002|Overall Study|Adverse Event|0|||
145912752|NCT02413229|526185400|FG003|Overall Study|Adverse Event|1|||
145912753|NCT02413229|526185401|FG004|Overall Study|Adverse Event|0|||
145912754|NCT02413229|526185402|FG005|Overall Study|Adverse Event|0|||
145912755|NCT02413229|526185403|FG006|Overall Study|Adverse Event|0|||
145912756|NCT02413229|526185404|FG007|Overall Study|Adverse Event|1|||
145912757|NCT02413229|526185397|FG000|Overall Study|Lost to Follow-up|0|||
145912758|NCT02413229|526185398|FG001|Overall Study|Lost to Follow-up|0|||
145912759|NCT02413229|526185399|FG002|Overall Study|Lost to Follow-up|1|||
145912760|NCT02413229|526185400|FG003|Overall Study|Lost to Follow-up|0|||
145912761|NCT02413229|526185401|FG004|Overall Study|Lost to Follow-up|2|||
145912762|NCT02413229|526185402|FG005|Overall Study|Lost to Follow-up|0|||
145912763|NCT02413229|526185403|FG006|Overall Study|Lost to Follow-up|0|||
145912764|NCT02413229|526185404|FG007|Overall Study|Lost to Follow-up|0|||
145912765|NCT02413229|526185397|FG000|Overall Study|Withdrawal by Subject|1|||
145912766|NCT02413229|526185398|FG001|Overall Study|Withdrawal by Subject|1|||
145912767|NCT02413229|526185399|FG002|Overall Study|Withdrawal by Subject|0|||
145912768|NCT02413229|526185400|FG003|Overall Study|Withdrawal by Subject|0|||
145912769|NCT02413229|526185401|FG004|Overall Study|Withdrawal by Subject|1|||
145912770|NCT02413229|526185402|FG005|Overall Study|Withdrawal by Subject|0|||
145912771|NCT02413229|526185403|FG006|Overall Study|Withdrawal by Subject|0|||
145912772|NCT02413229|526185404|FG007|Overall Study|Withdrawal by Subject|2|||
145912773|NCT02413229|526185397|FG000|Overall Study|Progressive Disease|0|||
145912774|NCT02413229|526185398|FG001|Overall Study|Progressive Disease|0|||
145912775|NCT02413229|526185399|FG002|Overall Study|Progressive Disease|0|||
145912776|NCT02413229|526185400|FG003|Overall Study|Progressive Disease|0|||
145912777|NCT02413229|526185401|FG004|Overall Study|Progressive Disease|0|||
145912778|NCT02413229|526185402|FG005|Overall Study|Progressive Disease|0|||
145912779|NCT02413229|526185403|FG006|Overall Study|Progressive Disease|0|||
145912780|NCT02413229|526185404|FG007|Overall Study|Progressive Disease|1|||
145912781|NCT01232452|526185405|FG000|Overall Study|Adverse Event|17|||
145912782|NCT01232452|526185406|FG001|Overall Study|Adverse Event|15|||
145912783|NCT01232452|526185405|FG000|Overall Study|Withdrawal by Subject|11|||
145912784|NCT01232452|526185406|FG001|Overall Study|Withdrawal by Subject|8|||
145912785|NCT01232452|526185405|FG000|Overall Study|Physician Decision|8|||
145912786|NCT01232452|526185406|FG001|Overall Study|Physician Decision|12|||
145912787|NCT01232452|526185405|FG000|Overall Study|Protocol entry criterion not met|0|||
145912788|NCT01232452|526185406|FG001|Overall Study|Protocol entry criterion not met|2|||
145912789|NCT01232452|526185405|FG000|Overall Study|Sponsor Decision|3|||
145912790|NCT01232452|526185406|FG001|Overall Study|Sponsor Decision|1|||
145912791|NCT01232452|526185405|FG000|Overall Study|Protocol Violation|0|||
145912792|NCT01232452|526185406|FG001|Overall Study|Protocol Violation|1|||
145912793|NCT03594071|526185407|FG000|Overall Study|Re-operation|3|||
145912794|NCT03594071|526185407|FG000|Overall Study|Missed visit|2|||
145912795|NCT05219448|526185408|FG000|Overall Study|Lost to Follow-up|9|||
145912796|NCT05219448|526185409|FG001|Overall Study|Lost to Follow-up|0|||
145912797|NCT03022370|526185411|FG000|Overall Study|Death|6|||
145912798|NCT03022370|526185412|FG001|Overall Study|Death|12|||
145912799|NCT03022370|526185411|FG000|Overall Study|Lost to Follow-up|174|||
145912800|NCT03022370|526185412|FG001|Overall Study|Lost to Follow-up|109|||
145912801|NCT00668317|526185413|FG000|Overall Study|Adverse Event|2|||
145912802|NCT01526655|526185417|FG000|Overall Study|Withdrawal by Subject|0|||
145912803|NCT01526655|526185418|FG001|Overall Study|Withdrawal by Subject|1|||
145912804|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
145912805|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Death|1|||
145912806|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
145912807|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
145912808|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
145912809|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
145912810|NCT02001987|526185420|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
145912811|NCT02001987|526185420|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
145912812|NCT02001987|526185420|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
145912813|NCT02001987|526185420|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
145912814|NCT02001987|526185420|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
145912815|NCT02001987|526185420|FG000|LTE Period (52 Weeks)|Other|3|||
145912816|NCT01965860|526185421|FG000|Overall Study|Pregnancy|1|||
145912817|NCT01965860|526185422|FG001|Overall Study|Pregnancy|0|||
145912818|NCT01965860|526185423|FG002|Overall Study|Pregnancy|1|||
145912819|NCT01965860|526185421|FG000|Overall Study|Logistics|1|||
145912820|NCT01965860|526185422|FG001|Overall Study|Logistics|0|||
145912821|NCT01965860|526185423|FG002|Overall Study|Logistics|0|||
145912822|NCT02064296|526185427|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
145912823|NCT02064296|526185428|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
145912824|NCT02064296|526185429|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
145912825|NCT02064296|526185427|FG000|Intervention|Withdrawal by Subject|0|||
145912826|NCT02064296|526185428|FG001|Intervention|Withdrawal by Subject|1|||
145912827|NCT02064296|526185429|FG002|Intervention|Withdrawal by Subject|2|||
145912828|NCT02288325|526185435|FG000|Run-in Period|Adverse Event|48|||
145912829|NCT02288325|526185436|FG001|Run-in Period|Adverse Event|0|||
145912830|NCT02288325|526185437|FG002|Run-in Period|Adverse Event|0|||
145912831|NCT02288325|526185435|FG000|Run-in Period|Lack of Efficacy|16|||
145912832|NCT02288325|526185436|FG001|Run-in Period|Lack of Efficacy|0|||
145912833|NCT02288325|526185437|FG002|Run-in Period|Lack of Efficacy|0|||
145912834|NCT02288325|526185435|FG000|Run-in Period|Withdrawal of Consent|28|||
145912835|NCT02288325|526185436|FG001|Run-in Period|Withdrawal of Consent|0|||
145912836|NCT02288325|526185437|FG002|Run-in Period|Withdrawal of Consent|0|||
145912837|NCT02288325|526185435|FG000|Run-in Period|Lost to Follow-up|25|||
145912838|NCT02288325|526185436|FG001|Run-in Period|Lost to Follow-up|0|||
145912839|NCT02288325|526185437|FG002|Run-in Period|Lost to Follow-up|0|||
145912840|NCT02288325|526185435|FG000|Run-in Period|Protocol Violation|17|||
145912841|NCT02288325|526185436|FG001|Run-in Period|Protocol Violation|0|||
145912842|NCT02288325|526185437|FG002|Run-in Period|Protocol Violation|0|||
145912843|NCT02288325|526185435|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
145912844|NCT02288325|526185436|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
145912845|NCT02288325|526185437|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
145912846|NCT02288325|526185435|FG000|Run-in Period|Reason not Specified|8|||
145912847|NCT02288325|526185436|FG001|Run-in Period|Reason not Specified|0|||
145912848|NCT02288325|526185437|FG002|Run-in Period|Reason not Specified|0|||
145912849|NCT02288325|526185435|FG000|Stabilization Period|Adverse Event|13|||
145912850|NCT02288325|526185436|FG001|Stabilization Period|Adverse Event|0|||
145912851|NCT02288325|526185437|FG002|Stabilization Period|Adverse Event|0|||
145912852|NCT02288325|526185435|FG000|Stabilization Period|Lack of Efficacy|22|||
145912853|NCT02288325|526185436|FG001|Stabilization Period|Lack of Efficacy|0|||
145912854|NCT02288325|526185437|FG002|Stabilization Period|Lack of Efficacy|0|||
145912855|NCT02288325|526185435|FG000|Stabilization Period|Withdrawal of Consent|23|||
145912856|NCT02288325|526185436|FG001|Stabilization Period|Withdrawal of Consent|0|||
145912857|NCT02288325|526185437|FG002|Stabilization Period|Withdrawal of Consent|0|||
145912858|NCT02288325|526185435|FG000|Stabilization Period|Lost to Follow-up|12|||
145912859|NCT02288325|526185436|FG001|Stabilization Period|Lost to Follow-up|0|||
145912860|NCT02288325|526185437|FG002|Stabilization Period|Lost to Follow-up|0|||
145912861|NCT02288325|526185435|FG000|Stabilization Period|Protocol Violation|8|||
145912862|NCT02288325|526185436|FG001|Stabilization Period|Protocol Violation|0|||
145912863|NCT02288325|526185437|FG002|Stabilization Period|Protocol Violation|0|||
145912864|NCT02288325|526185435|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
145912865|NCT02288325|526185436|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
145912866|NCT02288325|526185437|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
145912867|NCT02288325|526185435|FG000|Stabilization Period|Reason not Specified|15|||
145912868|NCT02288325|526185436|FG001|Stabilization Period|Reason not Specified|0|||
145912869|NCT02288325|526185437|FG002|Stabilization Period|Reason not Specified|0|||
145912870|NCT02288325|526185435|FG000|Double-blind Treatment Period|Adverse Event|0|||
145912871|NCT02288325|526185436|FG001|Double-blind Treatment Period|Adverse Event|2|||
145912872|NCT02288325|526185437|FG002|Double-blind Treatment Period|Adverse Event|5|||
145912873|NCT02288325|526185435|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
145912874|NCT02288325|526185436|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
145912875|NCT02288325|526185437|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
145973468|NCT03765073|526416402|FG010|Stage 2|Other|0|||
145973469|NCT03765073|526416403|FG011|Stage 2|Other|0|||
145973470|NCT03765073|526416404|FG012|Stage 2|Other|0|||
145912876|NCT02288325|526185435|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145912877|NCT02288325|526185436|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
145912878|NCT02288325|526185437|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
145912879|NCT02288325|526185435|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145912880|NCT02288325|526185436|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145973471|NCT03765073|526416405|FG013|Stage 2|Other|0|||
145973472|NCT03765073|526416406|FG014|Stage 2|Other|0|||
146239312|NCT03147287|527389788|FG001|Overall Study|Randomized Not Treated|1|||
145912881|NCT02288325|526185437|FG002|Double-blind Treatment Period|Protocol Violation|2|||
145912882|NCT02288325|526185435|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
145912883|NCT02288325|526185436|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
145912884|NCT02288325|526185437|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
145912885|NCT02288325|526185435|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
145912886|NCT02288325|526185436|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
145912887|NCT02288325|526185437|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
145912888|NCT03735121|526185440|FG000|Overall Study|Death|3|||
145912889|NCT03735121|526185441|FG001|Overall Study|Death|6|||
145912890|NCT03735121|526185442|FG002|Overall Study|Death|8|||
145912891|NCT03735121|526185443|FG003|Overall Study|Death|37|||
145912892|NCT03735121|526185444|FG004|Overall Study|Death|86|||
145912893|NCT03735121|526185440|FG000|Overall Study|Withdrawal by Subject|1|||
145912894|NCT03735121|526185441|FG001|Overall Study|Withdrawal by Subject|1|||
145912895|NCT03735121|526185442|FG002|Overall Study|Withdrawal by Subject|3|||
145912896|NCT03735121|526185443|FG003|Overall Study|Withdrawal by Subject|4|||
145912897|NCT03735121|526185444|FG004|Overall Study|Withdrawal by Subject|2|||
145912898|NCT03735121|526185440|FG000|Overall Study|Progressive Disease|0|||
145912899|NCT03735121|526185441|FG001|Overall Study|Progressive Disease|0|||
145912900|NCT03735121|526185442|FG002|Overall Study|Progressive Disease|1|||
145912901|NCT03735121|526185443|FG003|Overall Study|Progressive Disease|0|||
145912902|NCT03735121|526185444|FG004|Overall Study|Progressive Disease|0|||
145912903|NCT03735121|526185440|FG000|Overall Study|Lost to Follow-up|0|||
145912904|NCT03735121|526185441|FG001|Overall Study|Lost to Follow-up|0|||
145912905|NCT03735121|526185442|FG002|Overall Study|Lost to Follow-up|0|||
145912906|NCT03735121|526185443|FG003|Overall Study|Lost to Follow-up|0|||
145973473|NCT03765073|526416407|FG015|Stage 2|Other|1|||
145973474|NCT03765073|526416408|FG016|Stage 2|Other|2|||
145973475|NCT03765073|526416409|FG017|Stage 2|Other|0|||
145973476|NCT03765073|526416410|FG018|Stage 2|Other|0|||
145973477|NCT03765073|526416411|FG019|Stage 2|Other|0|||
145973478|NCT03765073|526416412|FG020|Stage 2|Other|0|||
145973479|NCT03765073|526416392|FG000|Stage 2|Withdrawal by parent/guardian|0|||
145973480|NCT03765073|526416393|FG001|Stage 2|Withdrawal by parent/guardian|0|||
145973481|NCT03765073|526416394|FG002|Stage 2|Withdrawal by parent/guardian|0|||
145973482|NCT03765073|526416395|FG003|Stage 2|Withdrawal by parent/guardian|0|||
145973483|NCT03765073|526416396|FG004|Stage 2|Withdrawal by parent/guardian|0|||
145973484|NCT03765073|526416397|FG005|Stage 2|Withdrawal by parent/guardian|0|||
145973485|NCT03765073|526416398|FG006|Stage 2|Withdrawal by parent/guardian|0|||
145973486|NCT03765073|526416399|FG007|Stage 2|Withdrawal by parent/guardian|0|||
145973487|NCT03765073|526416400|FG008|Stage 2|Withdrawal by parent/guardian|0|||
145973488|NCT03765073|526416401|FG009|Stage 2|Withdrawal by parent/guardian|0|||
145973489|NCT03765073|526416402|FG010|Stage 2|Withdrawal by parent/guardian|3|||
145973490|NCT03765073|526416403|FG011|Stage 2|Withdrawal by parent/guardian|3|||
145973491|NCT03765073|526416404|FG012|Stage 2|Withdrawal by parent/guardian|3|||
145973492|NCT03765073|526416405|FG013|Stage 2|Withdrawal by parent/guardian|1|||
145973493|NCT03765073|526416406|FG014|Stage 2|Withdrawal by parent/guardian|1|||
145973494|NCT03765073|526416407|FG015|Stage 2|Withdrawal by parent/guardian|0|||
145973495|NCT03765073|526416408|FG016|Stage 2|Withdrawal by parent/guardian|3|||
145973496|NCT03765073|526416409|FG017|Stage 2|Withdrawal by parent/guardian|0|||
145973497|NCT03765073|526416410|FG018|Stage 2|Withdrawal by parent/guardian|0|||
145973498|NCT03765073|526416411|FG019|Stage 2|Withdrawal by parent/guardian|0|||
145973499|NCT03765073|526416412|FG020|Stage 2|Withdrawal by parent/guardian|0|||
145973500|NCT03765073|526416392|FG000|Stage 2|Withdrawal by Subject|0|||
145973501|NCT03765073|526416393|FG001|Stage 2|Withdrawal by Subject|0|||
145973502|NCT03765073|526416394|FG002|Stage 2|Withdrawal by Subject|0|||
145973503|NCT03765073|526416395|FG003|Stage 2|Withdrawal by Subject|3|||
145973504|NCT03765073|526416396|FG004|Stage 2|Withdrawal by Subject|3|||
145973505|NCT03765073|526416397|FG005|Stage 2|Withdrawal by Subject|3|||
145973506|NCT03765073|526416398|FG006|Stage 2|Withdrawal by Subject|0|||
145973507|NCT03765073|526416399|FG007|Stage 2|Withdrawal by Subject|1|||
146239313|NCT03147287|527389789|FG002|Overall Study|Randomized Not Treated|1|||
146239314|NCT03147287|527389787|FG000|Overall Study|Progressive Disease RECIST|31|||
145912907|NCT03735121|526185444|FG004|Overall Study|Lost to Follow-up|1|||
145912908|NCT03735121|526185440|FG000|Overall Study|Ongoing|3|||
145912909|NCT03735121|526185441|FG001|Overall Study|Ongoing|3|||
145912910|NCT03735121|526185442|FG002|Overall Study|Ongoing|26|||
145912911|NCT03735121|526185443|FG003|Overall Study|Ongoing|83|||
145912912|NCT03735121|526185444|FG004|Overall Study|Ongoing|158|||
145973508|NCT03765073|526416400|FG008|Stage 2|Withdrawal by Subject|0|||
145973509|NCT03765073|526416401|FG009|Stage 2|Withdrawal by Subject|5|||
145912913|NCT04036110|526185452|FG000|Overall Study|Lost to Follow-up|3|||
145973510|NCT03765073|526416402|FG010|Stage 2|Withdrawal by Subject|0|||
145973511|NCT03765073|526416403|FG011|Stage 2|Withdrawal by Subject|0|||
145973512|NCT03765073|526416404|FG012|Stage 2|Withdrawal by Subject|0|||
145973513|NCT03765073|526416405|FG013|Stage 2|Withdrawal by Subject|0|||
146239315|NCT03147287|527389788|FG001|Overall Study|Progressive Disease RECIST|72|||
146239316|NCT03147287|527389789|FG002|Overall Study|Progressive Disease RECIST|32|||
145912914|NCT04036110|526185453|FG001|Overall Study|Lost to Follow-up|2|||
145912915|NCT04036110|526185454|FG002|Overall Study|Lost to Follow-up|1|||
145912916|NCT04036110|526185452|FG000|Overall Study|Study Suspended|4|||
145912917|NCT04036110|526185453|FG001|Overall Study|Study Suspended|5|||
145912918|NCT04036110|526185454|FG002|Overall Study|Study Suspended|1|||
145912919|NCT01107197|526185455|FG000|Overall Study|Death|12|||
145912920|NCT01107197|526185456|FG001|Overall Study|Death|10|||
145912921|NCT01107197|526185455|FG000|Overall Study|Lost to Follow-up|5|||
145912922|NCT01107197|526185456|FG001|Overall Study|Lost to Follow-up|8|||
145912923|NCT01107197|526185455|FG000|Overall Study|Withdrawal by Subject|3|||
145912924|NCT01107197|526185456|FG001|Overall Study|Withdrawal by Subject|5|||
145912925|NCT05180227|526185457|FG000|Overall Study|Hypertension at screening|1|||
145912926|NCT05180227|526185457|FG000|Overall Study|Lost to Follow-up|1|||
145912927|NCT02593110|526185458|FG000|Overall Study|Withdrawal by Subject|0|||
145912928|NCT02593110|526185459|FG001|Overall Study|Withdrawal by Subject|3|||
145912929|NCT02593110|526185460|FG002|Overall Study|Withdrawal by Subject|3|||
145912930|NCT02593110|526185461|FG003|Overall Study|Withdrawal by Subject|2|||
145912931|NCT02593110|526185458|FG000|Overall Study|Death|0|||
145912932|NCT02593110|526185459|FG001|Overall Study|Death|0|||
145912933|NCT02593110|526185460|FG002|Overall Study|Death|1|||
145912934|NCT02593110|526185461|FG003|Overall Study|Death|0|||
145912935|NCT03548337|526185462|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
145912936|NCT03548337|526185463|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
145912937|NCT03548337|526185462|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
145912938|NCT03548337|526185463|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
145912939|NCT03548337|526185462|FG000|Infant Series|Lost to Follow-up|2|||
145912940|NCT03548337|526185463|FG001|Infant Series|Lost to Follow-up|1|||
145912941|NCT03548337|526185462|FG000|Infant Series|Adverse Event|0|||
145912942|NCT03548337|526185463|FG001|Infant Series|Adverse Event|2|||
145912943|NCT03548337|526185462|FG000|Infant Series|Randomized but Not Vaccinated|1|||
145912944|NCT03548337|526185463|FG001|Infant Series|Randomized but Not Vaccinated|0|||
145912945|NCT03548337|526185462|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
145912946|NCT03548337|526185463|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
145912947|NCT01911273|526185466|FG000|Overall Study|Progression of Disease|1|||
145912948|NCT01911273|526185467|FG001|Overall Study|Progression of Disease|0|||
145912949|NCT01911273|526185466|FG000|Overall Study|Withdrawal by Subject|0|||
145912950|NCT01911273|526185467|FG001|Overall Study|Withdrawal by Subject|2|||
145912951|NCT02359994|526185472|FG000|Overall Population Study|Adverse Event|1|||
145912952|NCT02359994|526185473|FG001|Overall Population Study|Adverse Event|1|||
145912953|NCT02359994|526185472|FG000|Overall Population Study|Death|1|||
145912954|NCT02359994|526185473|FG001|Overall Population Study|Death|5|||
145912955|NCT02359994|526185472|FG000|Overall Population Study|Lost to Follow-up|1|||
145912956|NCT02359994|526185473|FG001|Overall Population Study|Lost to Follow-up|1|||
145912957|NCT02359994|526185472|FG000|Overall Population Study|Withdrawal by Subject|1|||
145912958|NCT02359994|526185473|FG001|Overall Population Study|Withdrawal by Subject|0|||
145912959|NCT02359994|526185472|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
145912960|NCT02359994|526185473|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
145912961|NCT02359994|526185472|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
145912962|NCT02359994|526185473|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
145912963|NCT02359994|526185472|FG000|Extended Oncology 24-Month Survival|Death|19|||
145912964|NCT02359994|526185473|FG001|Extended Oncology 24-Month Survival|Death|21|||
145912965|NCT02359994|526185472|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
145912966|NCT02359994|526185473|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
145912967|NCT04597632|526185474|FG000|Overall Study|Withdrawal by Subject|10|||
145912968|NCT04597632|526185474|FG000|Overall Study|Lost to Follow-up|1|||
145912969|NCT04597632|526185474|FG000|Overall Study|Death|1|||
145912970|NCT04597632|526185474|FG000|Overall Study|Adverse Event|5|||
145912971|NCT00919854|526185479|FG000|Overall Study|Adverse Event|1|||
145912972|NCT00985491|526185480|FG000|Overall Study|Adverse Event|8|||
145912973|NCT00985491|526185480|FG000|Overall Study|device migration|7|||
145912974|NCT00985491|526185480|FG000|Overall Study|Withdrawal by Subject|1|||
145912975|NCT00985491|526185480|FG000|Overall Study|implant failure|3|||
145912976|NCT01893346|526185481|FG000|Overall Study|Lost to Follow-up|0|||
145912977|NCT01893346|526185482|FG001|Overall Study|Lost to Follow-up|1|||
145912978|NCT01893346|526185483|FG002|Overall Study|Lost to Follow-up|0|||
145912979|NCT01893346|526185484|FG003|Overall Study|Lost to Follow-up|0|||
145912980|NCT01893346|526185481|FG000|Overall Study|Protocol Violation|1|||
145912981|NCT01893346|526185482|FG001|Overall Study|Protocol Violation|0|||
145912982|NCT01893346|526185483|FG002|Overall Study|Protocol Violation|0|||
145912983|NCT01893346|526185484|FG003|Overall Study|Protocol Violation|0|||
145912984|NCT01893346|526185481|FG000|Overall Study|Withdrawal by Subject|2|||
145912985|NCT01893346|526185482|FG001|Overall Study|Withdrawal by Subject|0|||
145912986|NCT01893346|526185483|FG002|Overall Study|Withdrawal by Subject|0|||
145912987|NCT01893346|526185484|FG003|Overall Study|Withdrawal by Subject|0|||
145912988|NCT02296931|526185487|FG000|Overall Study|Protocol Violation|0|||
146088870|NCT01975831|526845107|FG003|Overall Study|Adverse Event|0|||
146088871|NCT01975831|526845108|FG004|Overall Study|Adverse Event|1|||
146088872|NCT01975831|526845109|FG005|Overall Study|Adverse Event|1|||
146088873|NCT01975831|526845110|FG006|Overall Study|Adverse Event|3|||
146088874|NCT01975831|526845111|FG007|Overall Study|Adverse Event|4|||
146088875|NCT01975831|526845112|FG008|Overall Study|Adverse Event|1|||
146088876|NCT01975831|526845104|FG000|Overall Study|Death|1|||
146088877|NCT01975831|526845105|FG001|Overall Study|Death|1|||
146088878|NCT01975831|526845106|FG002|Overall Study|Death|0|||
146088879|NCT01975831|526845107|FG003|Overall Study|Death|0|||
146088880|NCT01975831|526845108|FG004|Overall Study|Death|1|||
145912989|NCT02296931|526185488|FG001|Overall Study|Protocol Violation|2|||
145912990|NCT01590277|526185489|FG000|Overall Study|Withdrawal by Subject|3|||
145912991|NCT01590277|526185489|FG000|Overall Study|Withdrawal by Subject|2|||
145912992|NCT01590277|526185489|FG000|Overall Study|Withdrawal by Subject|1|||
145912993|NCT01590277|526185489|FG000|Overall Study|Withdrawal by Subject|1|||
145912994|NCT04386616|526185490|FG000|Overall Study|Death|22|||
145912995|NCT04386616|526185491|FG001|Overall Study|Death|22|||
145912996|NCT04386616|526185492|FG002|Overall Study|Death|21|||
145912997|NCT04386616|526185490|FG000|Overall Study|Lost to Follow-up|5|||
145912998|NCT04386616|526185491|FG001|Overall Study|Lost to Follow-up|8|||
145912999|NCT04386616|526185492|FG002|Overall Study|Lost to Follow-up|6|||
145913000|NCT04386616|526185490|FG000|Overall Study|Withdrawal by Subject|2|||
145913001|NCT04386616|526185491|FG001|Overall Study|Withdrawal by Subject|4|||
145913002|NCT04386616|526185492|FG002|Overall Study|Withdrawal by Subject|1|||
145913003|NCT04386616|526185490|FG000|Overall Study|Adverse Event|1|||
145913004|NCT04386616|526185491|FG001|Overall Study|Adverse Event|1|||
145913005|NCT04386616|526185492|FG002|Overall Study|Adverse Event|0|||
145913006|NCT01377012|526185493|FG000|Core Study|Study terminated by Sponsor|47|||
145913007|NCT01377012|526185494|FG001|Core Study|Study terminated by Sponsor|54|||
145913008|NCT01377012|526185495|FG002|Core Study|Study terminated by Sponsor|46|||
145913009|NCT01377012|526185493|FG000|Core Study|Technical problems|1|||
145913010|NCT01377012|526185494|FG001|Core Study|Technical problems|0|||
145913011|NCT01377012|526185495|FG002|Core Study|Technical problems|0|||
145913012|NCT01377012|526185493|FG000|Core Study|Withdrawal by Subject|15|||
145913013|NCT01377012|526185494|FG001|Core Study|Withdrawal by Subject|23|||
145913014|NCT01377012|526185495|FG002|Core Study|Withdrawal by Subject|18|||
145913015|NCT01377012|526185493|FG000|Core Study|Protocol Violation|7|||
145913016|NCT01377012|526185494|FG001|Core Study|Protocol Violation|3|||
145913017|NCT01377012|526185495|FG002|Core Study|Protocol Violation|2|||
145913018|NCT01377012|526185493|FG000|Core Study|Pregnancy|0|||
145913019|NCT01377012|526185494|FG001|Core Study|Pregnancy|0|||
145913020|NCT01377012|526185495|FG002|Core Study|Pregnancy|1|||
145913021|NCT01377012|526185493|FG000|Core Study|Physician Decision|5|||
145913022|NCT01377012|526185494|FG001|Core Study|Physician Decision|4|||
145913023|NCT01377012|526185495|FG002|Core Study|Physician Decision|10|||
145913024|NCT01377012|526185493|FG000|Core Study|Non-Compliant with study treatment|0|||
145913025|NCT01377012|526185494|FG001|Core Study|Non-Compliant with study treatment|0|||
145913026|NCT01377012|526185495|FG002|Core Study|Non-Compliant with study treatment|1|||
145913027|NCT01377012|526185493|FG000|Core Study|No Longer require treatment|0|||
145913028|NCT01377012|526185494|FG001|Core Study|No Longer require treatment|0|||
145913029|NCT01377012|526185495|FG002|Core Study|No Longer require treatment|1|||
145913030|NCT01377012|526185493|FG000|Core Study|Lost to Follow-up|7|||
145913031|NCT01377012|526185494|FG001|Core Study|Lost to Follow-up|5|||
145913032|NCT01377012|526185495|FG002|Core Study|Lost to Follow-up|4|||
145913033|NCT01377012|526185493|FG000|Core Study|Lack of Efficacy|41|||
145913034|NCT01377012|526185494|FG001|Core Study|Lack of Efficacy|28|||
145913035|NCT01377012|526185495|FG002|Core Study|Lack of Efficacy|37|||
145913036|NCT01377012|526185493|FG000|Core Study|Death|1|||
145913037|NCT01377012|526185494|FG001|Core Study|Death|1|||
145913038|NCT01377012|526185495|FG002|Core Study|Death|1|||
145913039|NCT01377012|526185493|FG000|Core Study|Adverse Event|10|||
145913040|NCT01377012|526185494|FG001|Core Study|Adverse Event|14|||
145913041|NCT01377012|526185495|FG002|Core Study|Adverse Event|13|||
146088881|NCT01975831|526845109|FG005|Overall Study|Death|0|||
145913042|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
145913043|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
145913044|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
145913045|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
145913046|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
145913047|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
145913048|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
145913049|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
145913050|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
145913051|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
145913052|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
146088882|NCT01975831|526845110|FG006|Overall Study|Death|1|||
146088883|NCT01975831|526845111|FG007|Overall Study|Death|0|||
146088884|NCT01975831|526845112|FG008|Overall Study|Death|0|||
145913053|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
145913054|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
145913055|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
145913056|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
145913057|NCT01377012|526185493|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
145913058|NCT01377012|526185494|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
145913059|NCT01377012|526185495|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
145913060|NCT01632280|526185513|FG000|Overall Study|Withdrawal by Subject|1|||
145913061|NCT01632280|526185514|FG001|Overall Study|Withdrawal by Subject|0|||
145913062|NCT03086551|526185522|FG000|First Intervention|Failure to meet inclusion criterion|1|||
145913063|NCT03086551|526185523|FG001|First Intervention|Failure to meet inclusion criterion|0|||
145913064|NCT03086551|526185522|FG000|First Intervention|Lost to Follow-up|0|||
145913065|NCT03086551|526185523|FG001|First Intervention|Lost to Follow-up|1|||
145913066|NCT03086551|526185522|FG000|Washout|Lost to Follow-up|1|||
145913067|NCT03086551|526185523|FG001|Washout|Lost to Follow-up|2|||
145913068|NCT03086551|526185522|FG000|Washout|Withdrawal by Subject|2|||
145913069|NCT03086551|526185523|FG001|Washout|Withdrawal by Subject|1|||
145913070|NCT03736031|526185524|FG000|Overall Study|Death|2|||
145913071|NCT03736031|526185525|FG001|Overall Study|Death|4|||
145913072|NCT03736031|526185524|FG000|Overall Study|Lost to Follow-up|21|||
145913073|NCT03736031|526185525|FG001|Overall Study|Lost to Follow-up|2|||
145913074|NCT03736031|526185524|FG000|Overall Study|Withdrawal by Subject|9|||
145913075|NCT03736031|526185525|FG001|Overall Study|Withdrawal by Subject|0|||
145913076|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
145913077|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
145913078|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
145913079|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
145913080|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
145913081|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
145913082|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
145913083|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
145913084|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
145913085|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
145913086|NCT00451178|526185526|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
145913087|NCT00451178|526185527|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
145913088|NCT00451178|526185526|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
145913089|NCT00451178|526185527|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
145913090|NCT00451178|526185526|FG000|Prior to Maintenance Therapy|PD|2|||
145913091|NCT00451178|526185527|FG001|Prior to Maintenance Therapy|PD|0|||
145913092|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
145913093|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
145913094|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
145913095|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
145913096|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
145913097|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
145913098|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
145913099|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
145913100|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
145913101|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
145913102|NCT00451178|526185526|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
145913103|NCT00451178|526185527|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
145913104|NCT00451178|526185526|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
145913105|NCT00451178|526185527|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
145913106|NCT01260701|526185528|FG000|Overall Study|Adverse Event|9|||
145913107|NCT01260701|526185528|FG000|Overall Study|Withdrawal by Subject|2|||
145913108|NCT01260701|526185528|FG000|Overall Study|Progression|53|||
145913109|NCT01260701|526185528|FG000|Overall Study|Death|2|||
145913110|NCT01260701|526185528|FG000|Overall Study|Not protocol specified|3|||
145913111|NCT01260701|526185528|FG000|Overall Study|Under review|1|||
145913112|NCT01260701|526185528|FG000|Overall Study|Ineligible|4|||
145913113|NCT01260701|526185528|FG000|Overall Study|Did not begin protocol therapy|1|||
145913114|NCT02498613|526187782|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
145913115|NCT02498613|526187783|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
146088885|NCT01975831|526845104|FG000|Overall Study|Progressive Disease|1|||
146088886|NCT01975831|526845105|FG001|Overall Study|Progressive Disease|3|||
146088887|NCT01975831|526845106|FG002|Overall Study|Progressive Disease|2|||
145913116|NCT02498613|526187784|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
146088888|NCT01975831|526845107|FG003|Overall Study|Progressive Disease|4|||
145913117|NCT02498613|526187785|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
145913118|NCT02498613|526187782|FG000|Overall Study|Withdrawal by Subject|3|||
145913119|NCT02498613|526187783|FG001|Overall Study|Withdrawal by Subject|1|||
145913120|NCT02498613|526187784|FG002|Overall Study|Withdrawal by Subject|0|||
145913121|NCT02498613|526187785|FG003|Overall Study|Withdrawal by Subject|0|||
145913122|NCT05109611|526187787|FG000|Overall Study|Adverse Event|13|||
145913123|NCT05109611|526187788|FG001|Overall Study|Adverse Event|10|||
145913124|NCT05109611|526187787|FG000|Overall Study|Withdrawal by Subject|1|||
145913125|NCT05109611|526187788|FG001|Overall Study|Withdrawal by Subject|0|||
145913126|NCT05109611|526187787|FG000|Overall Study|Lost to Follow-up|1|||
145913127|NCT05109611|526187788|FG001|Overall Study|Lost to Follow-up|2|||
145913128|NCT05109611|526187787|FG000|Overall Study|Protocol Violation|0|||
145913129|NCT05109611|526187788|FG001|Overall Study|Protocol Violation|4|||
145913130|NCT05109611|526187787|FG000|Overall Study|Information unavailable|1|||
145913131|NCT05109611|526187788|FG001|Overall Study|Information unavailable|1|||
146088889|NCT01975831|526845108|FG004|Overall Study|Progressive Disease|13|||
146088890|NCT01975831|526845109|FG005|Overall Study|Progressive Disease|9|||
146088891|NCT01975831|526845110|FG006|Overall Study|Progressive Disease|10|||
146088892|NCT01975831|526845111|FG007|Overall Study|Progressive Disease|8|||
146088893|NCT01975831|526845112|FG008|Overall Study|Progressive Disease|10|||
146088894|NCT01975831|526845104|FG000|Overall Study|Withdrawal by Subject|0|||
146088895|NCT01975831|526845105|FG001|Overall Study|Withdrawal by Subject|3|||
145913132|NCT00233948|526187791|FG000|Overall Study|Adverse Event|1|||
145913133|NCT00233948|526187792|FG001|Overall Study|Adverse Event|0|||
145913134|NCT00233948|526187793|FG002|Overall Study|Adverse Event|0|||
145913135|NCT00233948|526187794|FG003|Overall Study|Adverse Event|0|||
145913136|NCT00233948|526187795|FG004|Overall Study|Adverse Event|0|||
145913137|NCT00233948|526187796|FG005|Overall Study|Adverse Event|0|||
145913138|NCT03573830|526187797|FG000|Overall Study|Dropped without completing treatment|0|||
145913139|NCT03573830|526187798|FG001|Overall Study|Dropped without completing treatment|7|||
145913140|NCT03573830|526187797|FG000|Overall Study|Lost to Follow-up|4|||
145913141|NCT03573830|526187798|FG001|Overall Study|Lost to Follow-up|0|||
146088896|NCT01975831|526845106|FG002|Overall Study|Withdrawal by Subject|0|||
146088897|NCT01975831|526845107|FG003|Overall Study|Withdrawal by Subject|0|||
146088898|NCT01975831|526845108|FG004|Overall Study|Withdrawal by Subject|3|||
146088899|NCT01975831|526845109|FG005|Overall Study|Withdrawal by Subject|1|||
146088900|NCT01975831|526845110|FG006|Overall Study|Withdrawal by Subject|1|||
146088901|NCT01975831|526845111|FG007|Overall Study|Withdrawal by Subject|0|||
146088902|NCT01975831|526845112|FG008|Overall Study|Withdrawal by Subject|0|||
146088903|NCT01975831|526845104|FG000|Overall Study|Physician Decision|0|||
146088904|NCT01975831|526845105|FG001|Overall Study|Physician Decision|0|||
146088905|NCT01975831|526845106|FG002|Overall Study|Physician Decision|0|||
146088906|NCT01975831|526845107|FG003|Overall Study|Physician Decision|0|||
146088907|NCT01975831|526845108|FG004|Overall Study|Physician Decision|0|||
146088908|NCT01975831|526845109|FG005|Overall Study|Physician Decision|1|||
146088909|NCT01975831|526845110|FG006|Overall Study|Physician Decision|0|||
146088910|NCT01975831|526845111|FG007|Overall Study|Physician Decision|1|||
146088911|NCT01975831|526845112|FG008|Overall Study|Physician Decision|0|||
146088912|NCT01975831|526845104|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
146088913|NCT01975831|526845105|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
146088914|NCT01975831|526845106|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
146088915|NCT01975831|526845107|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
146088916|NCT01975831|526845108|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
146088917|NCT01975831|526845109|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
146088918|NCT01975831|526845110|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
146088919|NCT01975831|526845111|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
146088920|NCT01975831|526845112|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
146088921|NCT01975831|526845104|FG000|Overall Study|Entered Hospice|0|||
146088922|NCT01975831|526845105|FG001|Overall Study|Entered Hospice|0|||
146088923|NCT01975831|526845106|FG002|Overall Study|Entered Hospice|0|||
146088924|NCT01975831|526845107|FG003|Overall Study|Entered Hospice|0|||
146088925|NCT01975831|526845108|FG004|Overall Study|Entered Hospice|0|||
146088926|NCT01975831|526845109|FG005|Overall Study|Entered Hospice|1|||
146088927|NCT01975831|526845110|FG006|Overall Study|Entered Hospice|0|||
146088928|NCT01975831|526845111|FG007|Overall Study|Entered Hospice|0|||
146088929|NCT01975831|526845112|FG008|Overall Study|Entered Hospice|0|||
146088930|NCT01975831|526845104|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
146088931|NCT01975831|526845105|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
146297463|NCT04744285|527604701|FG000|Overall Study|Withdrawal by Subject|1|||
145913142|NCT03284723|526187799|FG000|Overall Study|Death|0|||
145913143|NCT03284723|526187800|FG001|Overall Study|Death|0|||
145913144|NCT03284723|526187801|FG002|Overall Study|Death|0|||
145913145|NCT03284723|526187802|FG003|Overall Study|Death|1|||
145913146|NCT03284723|526187803|FG004|Overall Study|Death|0|||
145913147|NCT03284723|526187804|FG005|Overall Study|Death|0|||
145913148|NCT03284723|526187805|FG006|Overall Study|Death|1|||
145913149|NCT03284723|526187806|FG007|Overall Study|Death|0|||
145913150|NCT03284723|526187807|FG008|Overall Study|Death|0|||
145913151|NCT03284723|526187808|FG009|Overall Study|Death|2|||
145913152|NCT03284723|526187809|FG010|Overall Study|Death|1|||
146088932|NCT01975831|526845106|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
146088933|NCT01975831|526845107|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
145913153|NCT03284723|526187810|FG011|Overall Study|Death|0|||
145913154|NCT03284723|526187799|FG000|Overall Study|Lost to Follow-up|0|||
145913155|NCT03284723|526187800|FG001|Overall Study|Lost to Follow-up|0|||
145913156|NCT03284723|526187801|FG002|Overall Study|Lost to Follow-up|0|||
145913157|NCT03284723|526187802|FG003|Overall Study|Lost to Follow-up|0|||
145913158|NCT03284723|526187803|FG004|Overall Study|Lost to Follow-up|0|||
145913159|NCT03284723|526187804|FG005|Overall Study|Lost to Follow-up|2|||
145913160|NCT03284723|526187805|FG006|Overall Study|Lost to Follow-up|1|||
145913161|NCT03284723|526187806|FG007|Overall Study|Lost to Follow-up|0|||
145913162|NCT03284723|526187807|FG008|Overall Study|Lost to Follow-up|0|||
145913163|NCT03284723|526187808|FG009|Overall Study|Lost to Follow-up|2|||
145913164|NCT03284723|526187809|FG010|Overall Study|Lost to Follow-up|0|||
145913165|NCT03284723|526187810|FG011|Overall Study|Lost to Follow-up|0|||
145913166|NCT03284723|526187799|FG000|Overall Study|Study Terminated By Sponsor|0|||
145913167|NCT03284723|526187800|FG001|Overall Study|Study Terminated By Sponsor|0|||
145913168|NCT03284723|526187801|FG002|Overall Study|Study Terminated By Sponsor|0|||
145913169|NCT03284723|526187802|FG003|Overall Study|Study Terminated By Sponsor|0|||
145913170|NCT03284723|526187803|FG004|Overall Study|Study Terminated By Sponsor|1|||
145913171|NCT03284723|526187804|FG005|Overall Study|Study Terminated By Sponsor|0|||
145913172|NCT03284723|526187805|FG006|Overall Study|Study Terminated By Sponsor|0|||
145913173|NCT03284723|526187806|FG007|Overall Study|Study Terminated By Sponsor|0|||
145913174|NCT03284723|526187807|FG008|Overall Study|Study Terminated By Sponsor|1|||
145913175|NCT03284723|526187808|FG009|Overall Study|Study Terminated By Sponsor|1|||
145913176|NCT03284723|526187809|FG010|Overall Study|Study Terminated By Sponsor|1|||
145913177|NCT03284723|526187810|FG011|Overall Study|Study Terminated By Sponsor|1|||
145913178|NCT03284723|526187799|FG000|Overall Study|Withdrawal by Subject|0|||
145913179|NCT03284723|526187800|FG001|Overall Study|Withdrawal by Subject|0|||
145913180|NCT03284723|526187801|FG002|Overall Study|Withdrawal by Subject|0|||
145913181|NCT03284723|526187802|FG003|Overall Study|Withdrawal by Subject|0|||
145913182|NCT03284723|526187803|FG004|Overall Study|Withdrawal by Subject|5|||
145913183|NCT03284723|526187804|FG005|Overall Study|Withdrawal by Subject|3|||
145913184|NCT03284723|526187805|FG006|Overall Study|Withdrawal by Subject|1|||
145913185|NCT03284723|526187806|FG007|Overall Study|Withdrawal by Subject|0|||
145913186|NCT03284723|526187807|FG008|Overall Study|Withdrawal by Subject|6|||
145913187|NCT03284723|526187808|FG009|Overall Study|Withdrawal by Subject|0|||
145913188|NCT03284723|526187809|FG010|Overall Study|Withdrawal by Subject|3|||
145913189|NCT03284723|526187810|FG011|Overall Study|Withdrawal by Subject|1|||
145913190|NCT03284723|526187799|FG000|Overall Study|Other|1|||
145913191|NCT03284723|526187800|FG001|Overall Study|Other|0|||
145913192|NCT03284723|526187801|FG002|Overall Study|Other|1|||
145913193|NCT03284723|526187802|FG003|Overall Study|Other|0|||
145913194|NCT03284723|526187803|FG004|Overall Study|Other|1|||
145913195|NCT03284723|526187804|FG005|Overall Study|Other|0|||
145913196|NCT03284723|526187805|FG006|Overall Study|Other|0|||
145913197|NCT03284723|526187806|FG007|Overall Study|Other|0|||
145913198|NCT03284723|526187807|FG008|Overall Study|Other|0|||
145913199|NCT03284723|526187808|FG009|Overall Study|Other|0|||
145913200|NCT03284723|526187809|FG010|Overall Study|Other|1|||
145913201|NCT03284723|526187810|FG011|Overall Study|Other|0|||
145913202|NCT03284723|526187799|FG000|Overall Study|Adverse Event|0|||
145913203|NCT03284723|526187800|FG001|Overall Study|Adverse Event|0|||
145913204|NCT03284723|526187801|FG002|Overall Study|Adverse Event|0|||
145913205|NCT03284723|526187802|FG003|Overall Study|Adverse Event|0|||
145913206|NCT03284723|526187803|FG004|Overall Study|Adverse Event|0|||
145913207|NCT03284723|526187804|FG005|Overall Study|Adverse Event|0|||
145913208|NCT03284723|526187805|FG006|Overall Study|Adverse Event|0|||
145913209|NCT03284723|526187806|FG007|Overall Study|Adverse Event|0|||
145913210|NCT03284723|526187807|FG008|Overall Study|Adverse Event|1|||
145913211|NCT03284723|526187808|FG009|Overall Study|Adverse Event|0|||
145913212|NCT03284723|526187809|FG010|Overall Study|Adverse Event|0|||
145913213|NCT03284723|526187810|FG011|Overall Study|Adverse Event|0|||
145913214|NCT00615199|526187811|FG000|Overall Study|Adverse Event|3|||
145913215|NCT00615199|526187812|FG001|Overall Study|Adverse Event|1|||
145913216|NCT00615199|526187813|FG002|Overall Study|Adverse Event|1|||
145913217|NCT00615199|526187814|FG003|Overall Study|Adverse Event|0|||
145913218|NCT00615199|526187811|FG000|Overall Study|Lack of Efficacy|2|||
145913219|NCT00615199|526187812|FG001|Overall Study|Lack of Efficacy|0|||
146088934|NCT01975831|526845108|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
145913220|NCT00615199|526187813|FG002|Overall Study|Lack of Efficacy|0|||
145913221|NCT00615199|526187814|FG003|Overall Study|Lack of Efficacy|1|||
145913222|NCT00615199|526187811|FG000|Overall Study|Lost to Follow-up|1|||
145913223|NCT00615199|526187812|FG001|Overall Study|Lost to Follow-up|0|||
145913224|NCT00615199|526187813|FG002|Overall Study|Lost to Follow-up|0|||
145913225|NCT00615199|526187814|FG003|Overall Study|Lost to Follow-up|0|||
145913226|NCT00615199|526187811|FG000|Overall Study|Other|0|||
145913227|NCT00615199|526187812|FG001|Overall Study|Other|0|||
145913228|NCT00615199|526187813|FG002|Overall Study|Other|0|||
145913229|NCT00615199|526187814|FG003|Overall Study|Other|1|||
145913230|NCT00615199|526187811|FG000|Overall Study|Withdrawal by Subject|2|||
145913231|NCT00615199|526187812|FG001|Overall Study|Withdrawal by Subject|1|||
146088935|NCT01975831|526845109|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
146088936|NCT01975831|526845110|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
146088937|NCT01975831|526845111|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
146088938|NCT01975831|526845112|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
146088939|NCT01401959|526845113|FG000|Enrolled|Withdrawal by Subject|1|||
146088940|NCT01401959|526845114|FG001|Enrolled|Withdrawal by Subject|0|||
146088941|NCT01401959|526845115|FG002|Enrolled|Withdrawal by Subject|0|||
146088942|NCT01401959|526845113|FG000|Treated|Disease Progression|2|||
146088943|NCT01401959|526845114|FG001|Treated|Disease Progression|2|||
146088944|NCT01401959|526845115|FG002|Treated|Disease Progression|1|||
146088945|NCT01401959|526845113|FG000|Treated|Adverse Event|4|||
146088946|NCT01401959|526845114|FG001|Treated|Adverse Event|3|||
146088947|NCT01401959|526845115|FG002|Treated|Adverse Event|2|||
146088948|NCT01401959|526845113|FG000|Treated|Withdrawal by Subject|1|||
146088949|NCT01401959|526845114|FG001|Treated|Withdrawal by Subject|2|||
146088950|NCT01401959|526845115|FG002|Treated|Withdrawal by Subject|2|||
146088951|NCT01401959|526845113|FG000|Treated|Protocol Violation|0|||
146088952|NCT01401959|526845114|FG001|Treated|Protocol Violation|1|||
146088953|NCT01401959|526845115|FG002|Treated|Protocol Violation|0|||
146088954|NCT00251004|526845116|FG000|Overall Study|Withdrawal by Subject|23|||
146088955|NCT00251004|526845117|FG001|Overall Study|Withdrawal by Subject|16|||
146088956|NCT00251004|526845118|FG002|Overall Study|Withdrawal by Subject|14|||
146088957|NCT00251004|526845116|FG000|Overall Study|Death|9|||
146088958|NCT00251004|526845117|FG001|Overall Study|Death|10|||
146088959|NCT00251004|526845118|FG002|Overall Study|Death|8|||
146088960|NCT00251004|526845116|FG000|Overall Study|Lost to Follow-up|1|||
146088961|NCT00251004|526845117|FG001|Overall Study|Lost to Follow-up|2|||
146088962|NCT00251004|526845118|FG002|Overall Study|Lost to Follow-up|1|||
146088963|NCT00251004|526845116|FG000|Overall Study|Graft Loss|12|||
146088964|NCT00251004|526845117|FG001|Overall Study|Graft Loss|13|||
146088965|NCT00251004|526845118|FG002|Overall Study|Graft Loss|8|||
146088966|NCT02694718|526845123|FG000|Overall Study|Death|1|||
146088967|NCT02694718|526845123|FG000|Overall Study|Withdrawal by Subject|1|||
146088968|NCT02925793|526845124|FG000|Overall Study|Adverse Event|3|||
146088969|NCT02925793|526845125|FG001|Overall Study|Adverse Event|3|||
146239317|NCT03147287|527389787|FG000|Overall Study|Progressive Disease not RECIST|13|||
146239318|NCT03147287|527389788|FG001|Overall Study|Progressive Disease not RECIST|21|||
146239319|NCT03147287|527389789|FG002|Overall Study|Progressive Disease not RECIST|13|||
146239320|NCT03147287|527389787|FG000|Overall Study|Physician Decision|1|||
146239321|NCT03147287|527389788|FG001|Overall Study|Physician Decision|2|||
146239322|NCT03147287|527389789|FG002|Overall Study|Physician Decision|1|||
146239323|NCT03147287|527389787|FG000|Overall Study|Intercurrent illness|0|||
146239324|NCT03147287|527389788|FG001|Overall Study|Intercurrent illness|1|||
145913232|NCT00615199|526187813|FG002|Overall Study|Withdrawal by Subject|0|||
145913233|NCT00615199|526187814|FG003|Overall Study|Withdrawal by Subject|0|||
145913234|NCT02653625|526187817|FG000|Overall Study|Adverse Event|1|||
145913235|NCT02653625|526187817|FG000|Overall Study|Non-compliance with Study Drug|1|||
145913236|NCT02653625|526187817|FG000|Overall Study|Protocol Violation|1|||
145913237|NCT02653625|526187817|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
145913238|NCT00064987|526187818|FG000|Overall Study|Physician Decision|3|||
145913239|NCT00064987|526187819|FG001|Overall Study|Physician Decision|0|||
145913240|NCT00764881|526187823|FG000|Overall Study|Adverse Event|5|||
145913241|NCT00764881|526187824|FG001|Overall Study|Adverse Event|1|||
145913242|NCT00764881|526187823|FG000|Overall Study|Withdrawal by Subject|1|||
145913243|NCT00764881|526187824|FG001|Overall Study|Withdrawal by Subject|3|||
145913244|NCT00764881|526187823|FG000|Overall Study|Protocol Violation|2|||
145913245|NCT00764881|526187824|FG001|Overall Study|Protocol Violation|2|||
145913246|NCT00764881|526187823|FG000|Overall Study|Lost to Follow-up|2|||
145913247|NCT00764881|526187824|FG001|Overall Study|Lost to Follow-up|0|||
145913248|NCT00764881|526187823|FG000|Overall Study|Noncompliant|1|||
145913249|NCT00764881|526187824|FG001|Overall Study|Noncompliant|0|||
145913250|NCT00764881|526187823|FG000|Overall Study|Accidentally discontinued study drug|1|||
146239325|NCT03147287|527389789|FG002|Overall Study|Intercurrent illness|0|||
146239326|NCT03147287|527389787|FG000|Overall Study|Withdrawal by Subject|2|||
146239327|NCT03147287|527389788|FG001|Overall Study|Withdrawal by Subject|3|||
146239328|NCT03147287|527389789|FG002|Overall Study|Withdrawal by Subject|2|||
145913251|NCT00764881|526187824|FG001|Overall Study|Accidentally discontinued study drug|0|||
145913252|NCT00764881|526187823|FG000|Overall Study|Wished to become pregnant|1|||
145913253|NCT00764881|526187824|FG001|Overall Study|Wished to become pregnant|0|||
145913254|NCT00764881|526187823|FG000|Overall Study|Carcinoma detected|1|||
145913255|NCT00764881|526187824|FG001|Overall Study|Carcinoma detected|0|||
146088970|NCT02925793|526845126|FG002|Overall Study|Adverse Event|6|||
146088971|NCT02925793|526845124|FG000|Overall Study|Withdrawal by Subject|16|||
146088972|NCT02925793|526845125|FG001|Overall Study|Withdrawal by Subject|15|||
146088973|NCT02925793|526845126|FG002|Overall Study|Withdrawal by Subject|13|||
146088974|NCT02925793|526845124|FG000|Overall Study|Investigator Discretion|0|||
146088975|NCT02925793|526845125|FG001|Overall Study|Investigator Discretion|1|||
146088976|NCT02925793|526845126|FG002|Overall Study|Investigator Discretion|1|||
146297464|NCT04744285|527604702|FG001|Overall Study|Withdrawal by Subject|1|||
145913256|NCT00764881|526187823|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
145913257|NCT00764881|526187824|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
145913258|NCT00764881|526187823|FG000|Overall Study|no treatment or no observation|2|||
145913259|NCT00764881|526187824|FG001|Overall Study|no treatment or no observation|2|||
145913260|NCT01567462|526187825|FG000|Overall Study|Withdrawal by Subject|4|||
145913261|NCT01567462|526187826|FG001|Overall Study|Withdrawal by Subject|7|||
145913262|NCT00886015|526187829|FG000|Overall Study|Death|0|||
145913263|NCT00886015|526187830|FG001|Overall Study|Death|2|||
145913264|NCT02548156|526187835|FG000|Washout Period 1|Lost to Follow-up|0|||
145913265|NCT02548156|526187836|FG001|Washout Period 1|Lost to Follow-up|0|||
145913266|NCT02548156|526187837|FG002|Washout Period 1|Lost to Follow-up|0|||
145913267|NCT02548156|526187838|FG003|Washout Period 1|Lost to Follow-up|0|||
145913268|NCT02548156|526187839|FG004|Washout Period 1|Lost to Follow-up|1|||
145913269|NCT02548156|526187840|FG005|Washout Period 1|Lost to Follow-up|0|||
145913270|NCT00444587|526187843|FG000|Overall Study|Death|2|||
145913271|NCT00444587|526187844|FG001|Overall Study|Death|1|||
145913272|NCT00444587|526187843|FG000|Overall Study|Progression of the disease|73|||
145913273|NCT00444587|526187844|FG001|Overall Study|Progression of the disease|8|||
145913274|NCT00444587|526187843|FG000|Overall Study|Refused treatment/did not cooperate|4|||
145913275|NCT00444587|526187844|FG001|Overall Study|Refused treatment/did not cooperate|1|||
145913276|NCT00444587|526187843|FG000|Overall Study|Investigator decision|3|||
145913277|NCT00444587|526187844|FG001|Overall Study|Investigator decision|0|||
145913278|NCT00444587|526187843|FG000|Overall Study|Protocol Violation|1|||
145913279|NCT00444587|526187844|FG001|Overall Study|Protocol Violation|0|||
145913280|NCT00444587|526187843|FG000|Overall Study|Missing|0|||
145913281|NCT00444587|526187844|FG001|Overall Study|Missing|5|||
145913282|NCT01473407|526187853|FG000|Overall Study|Physician Decision|1|||
145913283|NCT01473407|526187854|FG001|Overall Study|Physician Decision|4|||
145913284|NCT01473407|526187853|FG000|Overall Study|Lost to Follow-up|10|||
145913285|NCT01473407|526187854|FG001|Overall Study|Lost to Follow-up|4|||
145913286|NCT01473407|526187853|FG000|Overall Study|Adverse Event|8|||
145913287|NCT01473407|526187854|FG001|Overall Study|Adverse Event|8|||
145913288|NCT01473407|526187853|FG000|Overall Study|Randomization Error|3|||
145913289|NCT01473407|526187854|FG001|Overall Study|Randomization Error|1|||
145913290|NCT01473407|526187853|FG000|Overall Study|Withdrawal by Subject|4|||
145913291|NCT01473407|526187854|FG001|Overall Study|Withdrawal by Subject|7|||
145913292|NCT01473407|526187853|FG000|Overall Study|Kidney Transplant|7|||
145913293|NCT01473407|526187854|FG001|Overall Study|Kidney Transplant|6|||
145913294|NCT01473407|526187853|FG000|Overall Study|Vacation/Travel|1|||
145913295|NCT01473407|526187854|FG001|Overall Study|Vacation/Travel|1|||
145913296|NCT01473407|526187853|FG000|Overall Study|Elevated Hemoglobin|1|||
145913297|NCT01473407|526187854|FG001|Overall Study|Elevated Hemoglobin|0|||
145913298|NCT01473407|526187853|FG000|Overall Study|Patient Received Aranesp|1|||
145913299|NCT01473407|526187854|FG001|Overall Study|Patient Received Aranesp|0|||
145913300|NCT01473407|526187853|FG000|Overall Study|Patient Lost Green Card Status|1|||
145913301|NCT01473407|526187854|FG001|Overall Study|Patient Lost Green Card Status|0|||
145913302|NCT01473407|526187853|FG000|Overall Study|Temperature Excursion|2|||
145913303|NCT01473407|526187854|FG001|Overall Study|Temperature Excursion|3|||
145913304|NCT01473407|526187853|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
145913305|NCT01473407|526187854|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
145913306|NCT01473407|526187853|FG000|Overall Study|Sponsor's Decision|10|||
146297465|NCT04744285|527604703|FG002|Overall Study|Withdrawal by Subject|2|||
145913307|NCT01473407|526187854|FG001|Overall Study|Sponsor's Decision|10|||
145913308|NCT01473407|526187853|FG000|Overall Study|Site Closure|1|||
145913309|NCT01473407|526187854|FG001|Overall Study|Site Closure|0|||
145913310|NCT00369941|526187855|FG000|Overall Study|Never Treated|1|||
145913311|NCT00369941|526187856|FG001|Overall Study|Never Treated|2|||
145913312|NCT00369941|526187855|FG000|Overall Study|Adverse Event|14|||
145913313|NCT00369941|526187856|FG001|Overall Study|Adverse Event|28|||
145913314|NCT00369941|526187855|FG000|Overall Study|Lack of Efficacy|6|||
145913315|NCT00369941|526187856|FG001|Overall Study|Lack of Efficacy|10|||
145913316|NCT00369941|526187855|FG000|Overall Study|Lost to Follow-up|12|||
146297466|NCT04744285|527604704|FG003|Overall Study|Withdrawal by Subject|1|||
145913317|NCT00369941|526187856|FG001|Overall Study|Lost to Follow-up|22|||
145913318|NCT00369941|526187855|FG000|Overall Study|Protocol Violation|5|||
145913319|NCT00369941|526187856|FG001|Overall Study|Protocol Violation|3|||
146297467|NCT00448435|527604705|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
146297468|NCT00448435|527604706|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
145913320|NCT00369941|526187855|FG000|Overall Study|Withdrawal by Subject|5|||
145913321|NCT00369941|526187856|FG001|Overall Study|Withdrawal by Subject|18|||
145913322|NCT00369941|526187855|FG000|Overall Study|Pregnancy|4|||
145913323|NCT00369941|526187856|FG001|Overall Study|Pregnancy|2|||
145913324|NCT00369941|526187855|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
145913325|NCT00369941|526187856|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
145913326|NCT00369941|526187855|FG000|Overall Study|Moved|11|||
145913327|NCT00369941|526187856|FG001|Overall Study|Moved|5|||
145913328|NCT00369941|526187855|FG000|Overall Study|Treatment with Prohibited Medication|3|||
145913329|NCT00369941|526187856|FG001|Overall Study|Treatment with Prohibited Medication|1|||
145913330|NCT00369941|526187855|FG000|Overall Study|Employment Interfered with Study Visits|1|||
145913331|NCT00369941|526187856|FG001|Overall Study|Employment Interfered with Study Visits|0|||
145913332|NCT00369941|526187855|FG000|Overall Study|Study Site Terminated|2|||
145973514|NCT03765073|526416406|FG014|Stage 2|Withdrawal by Subject|0|||
145973515|NCT03765073|526416407|FG015|Stage 2|Withdrawal by Subject|0|||
145973516|NCT03765073|526416408|FG016|Stage 2|Withdrawal by Subject|0|||
145973517|NCT03765073|526416409|FG017|Stage 2|Withdrawal by Subject|0|||
145973518|NCT03765073|526416410|FG018|Stage 2|Withdrawal by Subject|0|||
145973519|NCT03765073|526416411|FG019|Stage 2|Withdrawal by Subject|0|||
145973520|NCT03765073|526416412|FG020|Stage 2|Withdrawal by Subject|0|||
145973521|NCT03765073|526416392|FG000|Stage 3|Adverse Event|0|||
145973522|NCT03765073|526416393|FG001|Stage 3|Adverse Event|0|||
145973523|NCT03765073|526416394|FG002|Stage 3|Adverse Event|0|||
145973524|NCT03765073|526416395|FG003|Stage 3|Adverse Event|0|||
145973525|NCT03765073|526416396|FG004|Stage 3|Adverse Event|0|||
145973526|NCT03765073|526416397|FG005|Stage 3|Adverse Event|0|||
145973527|NCT03765073|526416398|FG006|Stage 3|Adverse Event|0|||
145973528|NCT03765073|526416399|FG007|Stage 3|Adverse Event|0|||
145973529|NCT03765073|526416400|FG008|Stage 3|Adverse Event|0|||
146088977|NCT02925793|526845124|FG000|Overall Study|Lost to Follow-up|2|||
146088978|NCT02925793|526845125|FG001|Overall Study|Lost to Follow-up|3|||
145913333|NCT00369941|526187856|FG001|Overall Study|Study Site Terminated|0|||
145913334|NCT00369941|526187855|FG000|Overall Study|Miscellaneous|3|||
145913335|NCT00369941|526187856|FG001|Overall Study|Miscellaneous|3|||
145913336|NCT01027702|526187857|FG000|Overall Study|Received subsequent therapy|1|||
145913337|NCT01027702|526187858|FG001|Overall Study|Received subsequent therapy|2|||
145913338|NCT01027702|526187859|FG002|Overall Study|Received subsequent therapy|0|||
145913339|NCT01027702|526187860|FG003|Overall Study|Received subsequent therapy|4|||
145913340|NCT01027702|526187861|FG004|Overall Study|Received subsequent therapy|1|||
145913341|NCT01027702|526187862|FG005|Overall Study|Received subsequent therapy|0|||
145913342|NCT01027702|526187863|FG006|Overall Study|Received subsequent therapy|1|||
145913343|NCT01027702|526187857|FG000|Overall Study|Death|0|||
145913344|NCT01027702|526187858|FG001|Overall Study|Death|0|||
145913345|NCT01027702|526187859|FG002|Overall Study|Death|1|||
145913346|NCT01027702|526187860|FG003|Overall Study|Death|0|||
145913347|NCT01027702|526187861|FG004|Overall Study|Death|0|||
145913348|NCT01027702|526187862|FG005|Overall Study|Death|0|||
145913349|NCT01027702|526187863|FG006|Overall Study|Death|0|||
145913350|NCT00403585|526187864|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
145913351|NCT00403585|526187864|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
145913352|NCT00403585|526187864|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
145913353|NCT02862730|526187873|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913354|NCT02862730|526187874|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913355|NCT02862730|526187875|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
145913356|NCT02862730|526187876|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913357|NCT02862730|526187877|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913358|NCT02862730|526187878|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913359|NCT02862730|526187879|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145913360|NCT02862730|526187873|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
145913361|NCT02862730|526187874|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913362|NCT02862730|526187875|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913363|NCT02862730|526187876|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913364|NCT02862730|526187877|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913365|NCT02862730|526187878|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913366|NCT02862730|526187879|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145913367|NCT02862730|526187873|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145913368|NCT02862730|526187874|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145913369|NCT02862730|526187875|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
145913370|NCT02862730|526187876|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145913371|NCT02862730|526187877|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
145913372|NCT02862730|526187878|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145913373|NCT02862730|526187879|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145913374|NCT02862730|526187873|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145913375|NCT02862730|526187874|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145913376|NCT02862730|526187875|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145913377|NCT02862730|526187876|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
145913378|NCT02862730|526187877|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145973530|NCT03765073|526416401|FG009|Stage 3|Adverse Event|0|||
145973531|NCT03765073|526416402|FG010|Stage 3|Adverse Event|0|||
145973532|NCT03765073|526416403|FG011|Stage 3|Adverse Event|0|||
146088979|NCT02925793|526845126|FG002|Overall Study|Lost to Follow-up|1|||
145973533|NCT03765073|526416404|FG012|Stage 3|Adverse Event|0|||
145973534|NCT03765073|526416405|FG013|Stage 3|Adverse Event|0|||
146088980|NCT02925793|526845124|FG000|Overall Study|Lack of Efficacy|2|||
146239329|NCT03147287|527389787|FG000|Overall Study|Patient Non-Compliance|0|||
146239330|NCT03147287|527389788|FG001|Overall Study|Patient Non-Compliance|2|||
146239331|NCT03147287|527389789|FG002|Overall Study|Patient Non-Compliance|0|||
146239332|NCT03147287|527389787|FG000|Overall Study|Patient moved|0|||
146239333|NCT03147287|527389788|FG001|Overall Study|Patient moved|1|||
146239334|NCT03147287|527389789|FG002|Overall Study|Patient moved|0|||
145913379|NCT02862730|526187878|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145913380|NCT02862730|526187879|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145913381|NCT02738138|526187888|FG000|Overall Study|Adverse Event|0|||
145913382|NCT02738138|526187889|FG001|Overall Study|Adverse Event|1|||
145913383|NCT02738138|526187888|FG000|Overall Study|Lost to Follow-up|2|||
145913384|NCT02738138|526187889|FG001|Overall Study|Lost to Follow-up|0|||
145913385|NCT02738138|526187888|FG000|Overall Study|Other - not further specified|1|||
145913386|NCT02738138|526187889|FG001|Overall Study|Other - not further specified|0|||
145913387|NCT02932462|526187890|FG000|Overall Study|Adverse Event|1|||
145913388|NCT02932462|526187891|FG001|Overall Study|Adverse Event|2|||
145913389|NCT02932462|526187890|FG000|Overall Study|Lost to Follow-up|4|||
145913390|NCT02932462|526187891|FG001|Overall Study|Lost to Follow-up|1|||
145913391|NCT02932462|526187890|FG000|Overall Study|Protocol Violation|0|||
145913392|NCT02932462|526187891|FG001|Overall Study|Protocol Violation|5|||
145913393|NCT02932462|526187890|FG000|Overall Study|Withdrawal by Subject|1|||
145913394|NCT02932462|526187891|FG001|Overall Study|Withdrawal by Subject|4|||
145913395|NCT02932462|526187890|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145913396|NCT02932462|526187891|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145913397|NCT02932462|526187890|FG000|Overall Study|Progressive Disease|1|||
145913398|NCT02932462|526187891|FG001|Overall Study|Progressive Disease|0|||
145913399|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Other|34|||
145913400|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Other|0|||
145913401|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Other|0|||
145913402|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Other|0|||
145913403|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Death|14|||
145913404|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Death|0|||
145913405|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Death|0|||
145913406|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Death|0|||
145913407|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
145913408|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
145913409|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
145913410|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
145913411|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
145913412|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145913413|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145913414|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145913415|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
145913416|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
145913417|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
145913418|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
145913419|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
145913420|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145973535|NCT03765073|526416406|FG014|Stage 3|Adverse Event|0|||
145973536|NCT03765073|526416407|FG015|Stage 3|Adverse Event|0|||
145973537|NCT03765073|526416408|FG016|Stage 3|Adverse Event|0|||
145973538|NCT03765073|526416409|FG017|Stage 3|Adverse Event|0|||
145973539|NCT03765073|526416410|FG018|Stage 3|Adverse Event|1|||
145973540|NCT03765073|526416411|FG019|Stage 3|Adverse Event|0|||
145973541|NCT03765073|526416412|FG020|Stage 3|Adverse Event|0|||
145973542|NCT03765073|526416392|FG000|Stage 3|Death|0|||
145973543|NCT03765073|526416393|FG001|Stage 3|Death|0|||
145973544|NCT03765073|526416394|FG002|Stage 3|Death|0|||
145973545|NCT03765073|526416395|FG003|Stage 3|Death|0|||
145973546|NCT03765073|526416396|FG004|Stage 3|Death|0|||
145973547|NCT03765073|526416397|FG005|Stage 3|Death|0|||
145973548|NCT03765073|526416398|FG006|Stage 3|Death|0|||
145973549|NCT03765073|526416399|FG007|Stage 3|Death|0|||
145973550|NCT03765073|526416400|FG008|Stage 3|Death|0|||
145973551|NCT03765073|526416401|FG009|Stage 3|Death|0|||
146297469|NCT04195581|527604709|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
145913421|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145973552|NCT03765073|526416402|FG010|Stage 3|Death|0|||
145973553|NCT03765073|526416403|FG011|Stage 3|Death|0|||
145973554|NCT03765073|526416404|FG012|Stage 3|Death|0|||
145973555|NCT03765073|526416405|FG013|Stage 3|Death|0|||
145973556|NCT03765073|526416406|FG014|Stage 3|Death|0|||
145973557|NCT03765073|526416407|FG015|Stage 3|Death|0|||
145973558|NCT03765073|526416408|FG016|Stage 3|Death|0|||
145973559|NCT03765073|526416409|FG017|Stage 3|Death|0|||
146239335|NCT03147287|527389787|FG000|Overall Study|Arm A crossover without PD|1|||
146239336|NCT03147287|527389788|FG001|Overall Study|Arm A crossover without PD|0|||
145913422|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145913423|NCT01995513|526187892|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
145913424|NCT01995513|526187893|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145913425|NCT01995513|526187894|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145913426|NCT01995513|526187895|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145913427|NCT01995513|526187892|FG000|Period 1: Second Open Label Treatment|Other|0|||
145913428|NCT01995513|526187893|FG001|Period 1: Second Open Label Treatment|Other|2|||
145913429|NCT01995513|526187894|FG002|Period 1: Second Open Label Treatment|Other|0|||
145913430|NCT01995513|526187895|FG003|Period 1: Second Open Label Treatment|Other|0|||
145913431|NCT01995513|526187892|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
145913432|NCT01995513|526187893|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
145913433|NCT01995513|526187894|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
145913434|NCT01995513|526187895|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
145913435|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Death|0|||
145913436|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Death|0|||
145913437|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Death|0|||
145913438|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Death|1|||
145913439|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Other|0|||
145913440|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Other|0|||
145913441|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Other|3|||
145913442|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Other|3|||
145913443|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
146088981|NCT02925793|526845125|FG001|Overall Study|Lack of Efficacy|6|||
146088982|NCT02925793|526845126|FG002|Overall Study|Lack of Efficacy|4|||
145913444|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
145913445|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
145913446|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
145913447|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
145913448|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
145913449|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
145913450|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
145913451|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
145913452|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
145913453|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
145913454|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
145913455|NCT01995513|526187892|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145913456|NCT01995513|526187893|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145913457|NCT01995513|526187894|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145913458|NCT01995513|526187895|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
145913459|NCT01750190|526187896|FG000|Overall Study|Adverse Event|47|||
145913460|NCT01750190|526187897|FG001|Overall Study|Adverse Event|19|||
145913461|NCT01750190|526187896|FG000|Overall Study|Death|38|||
145913462|NCT01750190|526187897|FG001|Overall Study|Death|11|||
145913463|NCT01750190|526187896|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
145913464|NCT01750190|526187897|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
145913465|NCT01750190|526187896|FG000|Overall Study|Lost to Follow-up|28|||
145913466|NCT01750190|526187897|FG001|Overall Study|Lost to Follow-up|7|||
145913467|NCT01750190|526187896|FG000|Overall Study|Physician Decision|16|||
145913468|NCT01750190|526187897|FG001|Overall Study|Physician Decision|17|||
145913469|NCT01750190|526187896|FG000|Overall Study|Protocol Violation|6|||
145913470|NCT01750190|526187897|FG001|Overall Study|Protocol Violation|5|||
145913471|NCT01750190|526187896|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
145913472|NCT01750190|526187897|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
145913473|NCT01750190|526187896|FG000|Overall Study|Withdrawal by Subject|83|||
145913474|NCT01750190|526187897|FG001|Overall Study|Withdrawal by Subject|89|||
145913475|NCT01750190|526187896|FG000|Overall Study|Kidney Transplant|8|||
145913476|NCT01750190|526187897|FG001|Overall Study|Kidney Transplant|4|||
146088983|NCT02925793|526845124|FG000|Overall Study|Other:|2|||
146088984|NCT02925793|526845125|FG001|Overall Study|Other:|1|||
146088985|NCT02925793|526845126|FG002|Overall Study|Other:|3|||
146088986|NCT01244490|526845127|FG000|Overall Study|Lack of Efficacy|14|||
146088987|NCT01244490|526845128|FG001|Overall Study|Lack of Efficacy|5|||
145913477|NCT01750190|526187896|FG000|Overall Study|Dialysis|22|||
145913478|NCT01750190|526187897|FG001|Overall Study|Dialysis|8|||
145913479|NCT01750190|526187896|FG000|Overall Study|Other than Specified|13|||
145913480|NCT01750190|526187897|FG001|Overall Study|Other than Specified|4|||
145913481|NCT02955212|526187904|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
145913482|NCT02955212|526187905|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
145913483|NCT02955212|526187904|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
146088988|NCT01244490|526845129|FG002|Overall Study|Lack of Efficacy|5|||
146088989|NCT01244490|526845127|FG000|Overall Study|Withdrawal by Subject|4|||
146088990|NCT01244490|526845128|FG001|Overall Study|Withdrawal by Subject|4|||
145913484|NCT02955212|526187905|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
145913485|NCT02955212|526187904|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
145913486|NCT02955212|526187905|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
145913487|NCT02955212|526187904|FG000|Period 1: Double-blind Treatment Period|Other|3|||
145913488|NCT02955212|526187905|FG001|Period 1: Double-blind Treatment Period|Other|2|||
145913489|NCT02955212|526187904|FG000|Period 2: Open-label Extension|Adverse Event|11|||
145913490|NCT02955212|526187905|FG001|Period 2: Open-label Extension|Adverse Event|7|||
145913491|NCT02955212|526187904|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
145913492|NCT02955212|526187905|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
145913493|NCT02955212|526187904|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
145913494|NCT02955212|526187905|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
145913495|NCT02955212|526187904|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
145913496|NCT02955212|526187905|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
145913497|NCT02955212|526187904|FG000|Period 2: Open-label Extension|Other|2|||
145913498|NCT02955212|526187905|FG001|Period 2: Open-label Extension|Other|4|||
145913499|NCT02009722|526187906|FG000|Overall Study|Protocol Violation|1|||
145913500|NCT02009722|526187907|FG001|Overall Study|Protocol Violation|2|||
145913501|NCT02009722|526187906|FG000|Overall Study|Did not receive intervention|0|||
145913502|NCT02009722|526187907|FG001|Overall Study|Did not receive intervention|1|||
145913503|NCT02454933|526187916|FG000|Overall Study|Progressive disease|10|||
145913504|NCT02454933|526187917|FG001|Overall Study|Progressive disease|7|||
145913505|NCT02454933|526187916|FG000|Overall Study|Adverse Event|1|||
145913506|NCT02454933|526187917|FG001|Overall Study|Adverse Event|1|||
145913507|NCT02454933|526187916|FG000|Overall Study|Withdrawal by Subject|0|||
145913508|NCT02454933|526187917|FG001|Overall Study|Withdrawal by Subject|3|||
145913509|NCT02454933|526187916|FG000|Overall Study|Lost to Follow-up|1|||
145913510|NCT02454933|526187917|FG001|Overall Study|Lost to Follow-up|0|||
145913511|NCT02071225|526187923|FG000|Overall Study|Withdrawal of Consent|2|||
145913512|NCT02071225|526187923|FG000|Overall Study|Protocol Deviation|1|||
145913513|NCT02071225|526187923|FG000|Overall Study|Lost to Follow-up|2|||
145913514|NCT02071225|526187923|FG000|Overall Study|Death|25|||
145913515|NCT04753216|526187924|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
145913516|NCT04753216|526187924|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
145913517|NCT04753216|526187924|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
145913518|NCT01895777|526187925|FG000|Overall Study|Adverse Event|1|||
145913519|NCT01895777|526187926|FG001|Overall Study|Adverse Event|2|||
145913520|NCT01895777|526187925|FG000|Overall Study|Lost to Follow-up|2|||
145913521|NCT01895777|526187926|FG001|Overall Study|Lost to Follow-up|0|||
145913522|NCT01895777|526187925|FG000|Overall Study|Not treated|1|||
145913523|NCT01895777|526187926|FG001|Overall Study|Not treated|0|||
145913524|NCT01895777|526187925|FG000|Overall Study|Other reasons|3|||
145913525|NCT01895777|526187926|FG001|Overall Study|Other reasons|2|||
145913526|NCT01895777|526187925|FG000|Overall Study|Non-compliance with the CTP|2|||
145913527|NCT01895777|526187926|FG001|Overall Study|Non-compliance with the CTP|1|||
145913528|NCT01342081|526187927|FG000|Overall Study|Did not receive allocated intervention|0|||
145913529|NCT01342081|526187928|FG001|Overall Study|Did not receive allocated intervention|0|||
145913530|NCT01342081|526187929|FG002|Overall Study|Did not receive allocated intervention|1|||
145913531|NCT01342081|526187927|FG000|Overall Study|Adverse Event|1|||
145913532|NCT01342081|526187928|FG001|Overall Study|Adverse Event|0|||
145913533|NCT01342081|526187929|FG002|Overall Study|Adverse Event|0|||
145913534|NCT01342081|526187927|FG000|Overall Study|Physician Decision|0|||
145913535|NCT01342081|526187928|FG001|Overall Study|Physician Decision|1|||
145913536|NCT01342081|526187929|FG002|Overall Study|Physician Decision|0|||
145913537|NCT01342081|526187927|FG000|Overall Study|Withdrawal by Subject|1|||
145913538|NCT01342081|526187928|FG001|Overall Study|Withdrawal by Subject|1|||
145913539|NCT01342081|526187929|FG002|Overall Study|Withdrawal by Subject|0|||
145913540|NCT03571828|526187938|FG000|Overall Study|Withdrawal by Subject|1|||
145913541|NCT03571828|526187939|FG001|Overall Study|Withdrawal by Subject|0|||
145913542|NCT03571828|526187938|FG000|Overall Study|Decision by sponsor|5|||
145913543|NCT03571828|526187939|FG001|Overall Study|Decision by sponsor|1|||
145913544|NCT03571828|526187938|FG000|Overall Study|Death|2|||
145913545|NCT03571828|526187939|FG001|Overall Study|Death|0|||
145913546|NCT00666328|526187940|FG000|Overall Study|Death|2|||
145913547|NCT00666328|526187940|FG000|Overall Study|Lost to Follow-up|2|||
146088991|NCT01244490|526845129|FG002|Overall Study|Withdrawal by Subject|9|||
145913548|NCT00666328|526187940|FG000|Overall Study|No longer met eligibility criteria|1|||
145913549|NCT02829918|526187943|FG000|Overall Study|Death|2|||
145913550|NCT02829918|526187943|FG000|Overall Study|Withdrawal by Subject|4|||
145913551|NCT02829918|526187943|FG000|Overall Study|Adverse Event|1|||
145913552|NCT02829918|526187943|FG000|Overall Study|Progression|1|||
145913553|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
145913554|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Off-label use|283|||
145913555|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
145913556|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
146088992|NCT01244490|526845127|FG000|Overall Study|Adverse Event|1|||
146297470|NCT04195581|527604709|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
146297471|NCT04195581|527604709|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
146297472|NCT04195581|527604709|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
146297473|NCT04195581|527604709|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
146297474|NCT04195581|527604709|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
146297475|NCT00821431|527604710|FG000|Overall Study|Adverse Event|6|||
146297476|NCT00821431|527604711|FG001|Overall Study|Adverse Event|3|||
146297477|NCT00821431|527604710|FG000|Overall Study|Withdrawal by Subject|5|||
145913557|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
145913558|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
145913559|NCT01070953|526187945|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
145913560|NCT01070953|526187945|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
145913561|NCT01070953|526187945|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
145913562|NCT01070953|526187945|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
145913563|NCT01957176|526187946|FG000|Overall Study|Adverse Event|2|||
145913564|NCT01957176|526187947|FG001|Overall Study|Adverse Event|0|||
145913565|NCT01957176|526187946|FG000|Overall Study|Physician Decision|2|||
145913566|NCT01957176|526187947|FG001|Overall Study|Physician Decision|1|||
145913567|NCT01957176|526187946|FG000|Overall Study|Withdrawal by Subject|1|||
145913568|NCT01957176|526187947|FG001|Overall Study|Withdrawal by Subject|0|||
145913569|NCT00839254|526187948|FG000|Overall Study|Protocol Violation|0|||
145913570|NCT00839254|526187949|FG001|Overall Study|Protocol Violation|1|||
145913571|NCT00839254|526187950|FG002|Overall Study|Protocol Violation|1|||
145913572|NCT00839254|526187951|FG003|Overall Study|Protocol Violation|1|||
145913573|NCT00839254|526187952|FG004|Overall Study|Protocol Violation|0|||
145913574|NCT00839254|526187953|FG005|Overall Study|Protocol Violation|0|||
145913575|NCT00839254|526187954|FG006|Overall Study|Protocol Violation|1|||
145913576|NCT00839254|526187955|FG007|Overall Study|Protocol Violation|2|||
145913577|NCT00839254|526187948|FG000|Overall Study|Physician Decision|0|||
145913578|NCT00839254|526187949|FG001|Overall Study|Physician Decision|1|||
145913579|NCT00839254|526187950|FG002|Overall Study|Physician Decision|0|||
145913580|NCT00839254|526187951|FG003|Overall Study|Physician Decision|0|||
145913581|NCT00839254|526187952|FG004|Overall Study|Physician Decision|0|||
145913582|NCT00839254|526187953|FG005|Overall Study|Physician Decision|0|||
145913583|NCT00839254|526187954|FG006|Overall Study|Physician Decision|0|||
145913584|NCT00839254|526187955|FG007|Overall Study|Physician Decision|1|||
145913585|NCT00839254|526187948|FG000|Overall Study|Wrong treatment number allocation|0|||
145913586|NCT00839254|526187949|FG001|Overall Study|Wrong treatment number allocation|1|||
145913587|NCT00839254|526187950|FG002|Overall Study|Wrong treatment number allocation|0|||
145913588|NCT00839254|526187951|FG003|Overall Study|Wrong treatment number allocation|0|||
145913589|NCT00839254|526187952|FG004|Overall Study|Wrong treatment number allocation|0|||
145913590|NCT00839254|526187953|FG005|Overall Study|Wrong treatment number allocation|1|||
145913591|NCT00839254|526187954|FG006|Overall Study|Wrong treatment number allocation|0|||
145913592|NCT00839254|526187955|FG007|Overall Study|Wrong treatment number allocation|0|||
145913593|NCT00839254|526187948|FG000|Overall Study|Adverse Event|12|||
145913594|NCT00839254|526187949|FG001|Overall Study|Adverse Event|6|||
145913595|NCT00839254|526187950|FG002|Overall Study|Adverse Event|3|||
145913596|NCT00839254|526187951|FG003|Overall Study|Adverse Event|5|||
145913597|NCT00839254|526187952|FG004|Overall Study|Adverse Event|2|||
145913598|NCT00839254|526187953|FG005|Overall Study|Adverse Event|1|||
145913599|NCT00839254|526187954|FG006|Overall Study|Adverse Event|0|||
145913600|NCT00839254|526187955|FG007|Overall Study|Adverse Event|1|||
145913601|NCT00839254|526187948|FG000|Overall Study|Withdrawal by Subject|87|||
145913602|NCT00839254|526187949|FG001|Overall Study|Withdrawal by Subject|53|||
145913603|NCT00839254|526187950|FG002|Overall Study|Withdrawal by Subject|54|||
145913604|NCT00839254|526187951|FG003|Overall Study|Withdrawal by Subject|32|||
145913605|NCT00839254|526187952|FG004|Overall Study|Withdrawal by Subject|27|||
145913606|NCT00839254|526187953|FG005|Overall Study|Withdrawal by Subject|15|||
145913607|NCT00839254|526187954|FG006|Overall Study|Withdrawal by Subject|22|||
145913608|NCT00839254|526187955|FG007|Overall Study|Withdrawal by Subject|9|||
145913609|NCT00839254|526187948|FG000|Overall Study|Wrong group allocation|0|||
145913610|NCT00839254|526187949|FG001|Overall Study|Wrong group allocation|0|||
145913611|NCT00839254|526187950|FG002|Overall Study|Wrong group allocation|0|||
145913612|NCT00839254|526187951|FG003|Overall Study|Wrong group allocation|0|||
145913613|NCT00839254|526187952|FG004|Overall Study|Wrong group allocation|0|||
145913614|NCT00839254|526187953|FG005|Overall Study|Wrong group allocation|0|||
145913615|NCT00839254|526187954|FG006|Overall Study|Wrong group allocation|1|||
145913616|NCT00839254|526187955|FG007|Overall Study|Wrong group allocation|0|||
145913617|NCT00839254|526187948|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
145913618|NCT00839254|526187949|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
145913619|NCT00839254|526187950|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
145913620|NCT00839254|526187951|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
146297478|NCT00821431|527604711|FG001|Overall Study|Withdrawal by Subject|0|||
145973560|NCT03765073|526416410|FG018|Stage 3|Death|0|||
145913621|NCT00839254|526187952|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
145913622|NCT00839254|526187953|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
145913623|NCT00839254|526187954|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
145913624|NCT00839254|526187955|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
145913625|NCT00839254|526187948|FG000|Overall Study|Withdrawn due to non-compliance|2|||
145913626|NCT00839254|526187949|FG001|Overall Study|Withdrawn due to non-compliance|0|||
145913627|NCT00839254|526187950|FG002|Overall Study|Withdrawn due to non-compliance|0|||
145913628|NCT00839254|526187951|FG003|Overall Study|Withdrawn due to non-compliance|0|||
145913629|NCT00839254|526187952|FG004|Overall Study|Withdrawn due to non-compliance|0|||
145913630|NCT00839254|526187953|FG005|Overall Study|Withdrawn due to non-compliance|0|||
145913631|NCT00839254|526187954|FG006|Overall Study|Withdrawn due to non-compliance|0|||
145913632|NCT00839254|526187955|FG007|Overall Study|Withdrawn due to non-compliance|0|||
145913633|NCT00839254|526187948|FG000|Overall Study|Lost to Follow-up|51|||
145913634|NCT00839254|526187949|FG001|Overall Study|Lost to Follow-up|30|||
145913635|NCT00839254|526187950|FG002|Overall Study|Lost to Follow-up|32|||
145913636|NCT00839254|526187951|FG003|Overall Study|Lost to Follow-up|24|||
145913637|NCT00839254|526187952|FG004|Overall Study|Lost to Follow-up|8|||
145913638|NCT00839254|526187953|FG005|Overall Study|Lost to Follow-up|8|||
145913639|NCT00839254|526187954|FG006|Overall Study|Lost to Follow-up|4|||
145913640|NCT00839254|526187955|FG007|Overall Study|Lost to Follow-up|2|||
145913641|NCT01823835|526187956|FG000|Overall Study|Adverse Event|0|||
145913642|NCT01823835|526187957|FG001|Overall Study|Adverse Event|0|||
145913643|NCT01823835|526187958|FG002|Overall Study|Adverse Event|0|||
145913644|NCT01823835|526187959|FG003|Overall Study|Adverse Event|0|||
145913645|NCT01823835|526187960|FG004|Overall Study|Adverse Event|1|||
145913646|NCT01823835|526187961|FG005|Overall Study|Adverse Event|0|||
145913647|NCT01823835|526187962|FG006|Overall Study|Adverse Event|1|||
145913648|NCT01823835|526187963|FG007|Overall Study|Adverse Event|0|||
145913649|NCT01823835|526187964|FG008|Overall Study|Adverse Event|0|||
145913650|NCT01823835|526187965|FG009|Overall Study|Adverse Event|0|||
145913651|NCT01823835|526187966|FG010|Overall Study|Adverse Event|1|||
145913652|NCT01823835|526187967|FG011|Overall Study|Adverse Event|2|||
145913653|NCT01823835|526187968|FG012|Overall Study|Adverse Event|0|||
145913654|NCT01823835|526187969|FG013|Overall Study|Adverse Event|0|||
145913655|NCT01823835|526187970|FG014|Overall Study|Adverse Event|0|||
145913656|NCT01823835|526187956|FG000|Overall Study|Physician Decision|0|||
145913657|NCT01823835|526187957|FG001|Overall Study|Physician Decision|0|||
145913658|NCT01823835|526187958|FG002|Overall Study|Physician Decision|0|||
145913659|NCT01823835|526187959|FG003|Overall Study|Physician Decision|0|||
145913660|NCT01823835|526187960|FG004|Overall Study|Physician Decision|0|||
145913661|NCT01823835|526187961|FG005|Overall Study|Physician Decision|0|||
145913662|NCT01823835|526187962|FG006|Overall Study|Physician Decision|0|||
145913663|NCT01823835|526187963|FG007|Overall Study|Physician Decision|0|||
145913664|NCT01823835|526187964|FG008|Overall Study|Physician Decision|0|||
145913665|NCT01823835|526187965|FG009|Overall Study|Physician Decision|0|||
145913666|NCT01823835|526187966|FG010|Overall Study|Physician Decision|0|||
145913667|NCT01823835|526187967|FG011|Overall Study|Physician Decision|2|||
145913668|NCT01823835|526187968|FG012|Overall Study|Physician Decision|0|||
145913669|NCT01823835|526187969|FG013|Overall Study|Physician Decision|0|||
145913670|NCT01823835|526187970|FG014|Overall Study|Physician Decision|0|||
145913671|NCT01823835|526187956|FG000|Overall Study|Progressive Disease|3|||
145913672|NCT01823835|526187957|FG001|Overall Study|Progressive Disease|4|||
145913673|NCT01823835|526187958|FG002|Overall Study|Progressive Disease|3|||
145913674|NCT01823835|526187959|FG003|Overall Study|Progressive Disease|6|||
145913675|NCT01823835|526187960|FG004|Overall Study|Progressive Disease|4|||
145913676|NCT01823835|526187961|FG005|Overall Study|Progressive Disease|6|||
145913677|NCT01823835|526187962|FG006|Overall Study|Progressive Disease|5|||
145913678|NCT01823835|526187963|FG007|Overall Study|Progressive Disease|3|||
145913679|NCT01823835|526187964|FG008|Overall Study|Progressive Disease|3|||
145913680|NCT01823835|526187965|FG009|Overall Study|Progressive Disease|18|||
145913681|NCT01823835|526187966|FG010|Overall Study|Progressive Disease|8|||
145913682|NCT01823835|526187967|FG011|Overall Study|Progressive Disease|46|||
145913683|NCT01823835|526187968|FG012|Overall Study|Progressive Disease|18|||
145913684|NCT01823835|526187969|FG013|Overall Study|Progressive Disease|4|||
145913685|NCT01823835|526187970|FG014|Overall Study|Progressive Disease|6|||
145913686|NCT01823835|526187956|FG000|Overall Study|Study Termination|0|||
145913687|NCT01823835|526187957|FG001|Overall Study|Study Termination|0|||
145913688|NCT01823835|526187958|FG002|Overall Study|Study Termination|0|||
145913689|NCT01823835|526187959|FG003|Overall Study|Study Termination|0|||
145913690|NCT01823835|526187960|FG004|Overall Study|Study Termination|1|||
145913691|NCT01823835|526187961|FG005|Overall Study|Study Termination|0|||
145913692|NCT01823835|526187962|FG006|Overall Study|Study Termination|0|||
145913693|NCT01823835|526187963|FG007|Overall Study|Study Termination|0|||
145913694|NCT01823835|526187964|FG008|Overall Study|Study Termination|0|||
145913695|NCT01823835|526187965|FG009|Overall Study|Study Termination|0|||
145913696|NCT01823835|526187966|FG010|Overall Study|Study Termination|0|||
145913697|NCT01823835|526187967|FG011|Overall Study|Study Termination|1|||
145913698|NCT01823835|526187968|FG012|Overall Study|Study Termination|0|||
145913699|NCT01823835|526187969|FG013|Overall Study|Study Termination|0|||
145913700|NCT01823835|526187970|FG014|Overall Study|Study Termination|0|||
145913701|NCT01823835|526187956|FG000|Overall Study|Withdrawal by Subject|0|||
145913702|NCT01823835|526187957|FG001|Overall Study|Withdrawal by Subject|0|||
145913703|NCT01823835|526187958|FG002|Overall Study|Withdrawal by Subject|1|||
145913704|NCT01823835|526187959|FG003|Overall Study|Withdrawal by Subject|0|||
145913705|NCT01823835|526187960|FG004|Overall Study|Withdrawal by Subject|0|||
145913706|NCT01823835|526187961|FG005|Overall Study|Withdrawal by Subject|0|||
145913707|NCT01823835|526187962|FG006|Overall Study|Withdrawal by Subject|0|||
145913708|NCT01823835|526187963|FG007|Overall Study|Withdrawal by Subject|0|||
145913709|NCT01823835|526187964|FG008|Overall Study|Withdrawal by Subject|0|||
145913710|NCT01823835|526187965|FG009|Overall Study|Withdrawal by Subject|1|||
145913711|NCT01823835|526187966|FG010|Overall Study|Withdrawal by Subject|1|||
145913712|NCT01823835|526187967|FG011|Overall Study|Withdrawal by Subject|2|||
145913713|NCT01823835|526187968|FG012|Overall Study|Withdrawal by Subject|1|||
145913714|NCT01823835|526187969|FG013|Overall Study|Withdrawal by Subject|0|||
145913715|NCT01823835|526187970|FG014|Overall Study|Withdrawal by Subject|0|||
145913716|NCT01320150|526187971|FG000|Overall Study|Protocol Violation|15|||
145913717|NCT01320150|526187971|FG000|Overall Study|Withdrawal by Subject|5|||
145913718|NCT01320150|526187971|FG000|Overall Study|Death|2|||
145913719|NCT01320150|526187971|FG000|Overall Study|Lost to Follow-up|44|||
145913720|NCT01290302|526189738|FG000|Overall Study|Adverse Event|2|||
145913721|NCT01290302|526189739|FG001|Overall Study|Adverse Event|0|||
145913722|NCT01290302|526189738|FG000|Overall Study|Withdrawal by Subject|1|||
145913723|NCT01290302|526189739|FG001|Overall Study|Withdrawal by Subject|0|||
145913724|NCT01290302|526189738|FG000|Overall Study|Physician Decision|0|||
145913725|NCT01290302|526189739|FG001|Overall Study|Physician Decision|2|||
145913726|NCT01290302|526189738|FG000|Overall Study|Expiration of time for screening window|1|||
145913727|NCT01290302|526189739|FG001|Overall Study|Expiration of time for screening window|0|||
145913728|NCT04856917|526189742|FG000|Overall Study|Withdrawal by Subject|4|||
145913729|NCT04856917|526189743|FG001|Overall Study|Withdrawal by Subject|3|||
145913730|NCT04856917|526189744|FG002|Overall Study|Withdrawal by Subject|1|||
145913731|NCT04856917|526189742|FG000|Overall Study|Lost to Follow-up|3|||
145913732|NCT04856917|526189743|FG001|Overall Study|Lost to Follow-up|1|||
145913733|NCT04856917|526189744|FG002|Overall Study|Lost to Follow-up|1|||
145913734|NCT04856917|526189742|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
145913735|NCT04856917|526189743|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
145913736|NCT04856917|526189744|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
145913737|NCT04856917|526189742|FG000|Overall Study|Other|1|||
145913738|NCT04856917|526189743|FG001|Overall Study|Other|1|||
145913739|NCT04856917|526189744|FG002|Overall Study|Other|0|||
145913740|NCT06195930|526189745|FG000|Overall Study|Adverse Event|4|||
145913741|NCT03631199|526189746|FG000|Overall Study|Progressive disease|9|||
145913742|NCT03631199|526189747|FG001|Overall Study|Progressive disease|5|||
145913743|NCT03631199|526189748|FG002|Overall Study|Progressive disease|5|||
145913744|NCT03631199|526189749|FG003|Overall Study|Progressive disease|149|||
145913745|NCT03631199|526189750|FG004|Overall Study|Progressive disease|148|||
145913746|NCT03631199|526189746|FG000|Overall Study|Physician Decision|0|||
145913747|NCT03631199|526189747|FG001|Overall Study|Physician Decision|2|||
145913748|NCT03631199|526189748|FG002|Overall Study|Physician Decision|3|||
145913749|NCT03631199|526189749|FG003|Overall Study|Physician Decision|19|||
145913750|NCT03631199|526189750|FG004|Overall Study|Physician Decision|13|||
145913751|NCT03631199|526189746|FG000|Overall Study|Adverse Event|1|||
145913752|NCT03631199|526189747|FG001|Overall Study|Adverse Event|1|||
145913753|NCT03631199|526189748|FG002|Overall Study|Adverse Event|0|||
145913754|NCT03631199|526189749|FG003|Overall Study|Adverse Event|28|||
145913755|NCT03631199|526189750|FG004|Overall Study|Adverse Event|29|||
145913756|NCT03631199|526189746|FG000|Overall Study|Death|0|||
145913757|NCT03631199|526189747|FG001|Overall Study|Death|1|||
145913758|NCT03631199|526189748|FG002|Overall Study|Death|0|||
145913759|NCT03631199|526189749|FG003|Overall Study|Death|35|||
145913760|NCT03631199|526189750|FG004|Overall Study|Death|48|||
145913761|NCT03631199|526189746|FG000|Overall Study|Subject decision|0|||
145913762|NCT03631199|526189747|FG001|Overall Study|Subject decision|1|||
145913763|NCT03631199|526189748|FG002|Overall Study|Subject decision|0|||
145913764|NCT03631199|526189749|FG003|Overall Study|Subject decision|12|||
145913765|NCT03631199|526189750|FG004|Overall Study|Subject decision|12|||
145913766|NCT03631199|526189746|FG000|Overall Study|No treated|0|||
145913767|NCT03631199|526189747|FG001|Overall Study|No treated|0|||
145913768|NCT03631199|526189748|FG002|Overall Study|No treated|0|||
145973561|NCT03765073|526416411|FG019|Stage 3|Death|3|||
145913769|NCT03631199|526189749|FG003|Overall Study|No treated|0|||
145913770|NCT03631199|526189750|FG004|Overall Study|No treated|1|||
145913771|NCT03631199|526189746|FG000|Overall Study|Treatment ongoing|0|||
145913772|NCT03631199|526189747|FG001|Overall Study|Treatment ongoing|1|||
145913773|NCT03631199|526189748|FG002|Overall Study|Treatment ongoing|1|||
145913774|NCT03631199|526189749|FG003|Overall Study|Treatment ongoing|76|||
145913775|NCT03631199|526189750|FG004|Overall Study|Treatment ongoing|71|||
145913776|NCT03631199|526189746|FG000|Overall Study|Guardian decision|0|||
145913777|NCT03631199|526189747|FG001|Overall Study|Guardian decision|0|||
145973562|NCT03765073|526416412|FG020|Stage 3|Death|2|||
145913778|NCT03631199|526189748|FG002|Overall Study|Guardian decision|0|||
145913779|NCT03631199|526189749|FG003|Overall Study|Guardian decision|1|||
145913780|NCT03631199|526189750|FG004|Overall Study|Guardian decision|1|||
145913781|NCT03999996|526189751|FG000|Prior to Booster|Adverse Event|2|||
145913782|NCT03999996|526189752|FG001|Prior to Booster|Adverse Event|0|||
145913783|NCT03999996|526189753|FG002|Prior to Booster|Adverse Event|0|||
145913784|NCT03999996|526189754|FG003|Prior to Booster|Adverse Event|0|||
145913785|NCT03999996|526189751|FG000|Prior to Booster|Lost to Follow-up|17|||
145913786|NCT03999996|526189752|FG001|Prior to Booster|Lost to Follow-up|22|||
145913787|NCT03999996|526189753|FG002|Prior to Booster|Lost to Follow-up|0|||
145913788|NCT03999996|526189754|FG003|Prior to Booster|Lost to Follow-up|0|||
145913789|NCT03999996|526189751|FG000|Prior to Booster|Withdrawal of Consent|51|||
145913790|NCT03999996|526189752|FG001|Prior to Booster|Withdrawal of Consent|8|||
145913791|NCT03999996|526189753|FG002|Prior to Booster|Withdrawal of Consent|0|||
145913792|NCT03999996|526189754|FG003|Prior to Booster|Withdrawal of Consent|0|||
145913793|NCT03999996|526189751|FG000|Prior to Booster|Death|0|||
145913794|NCT03999996|526189752|FG001|Prior to Booster|Death|1|||
145913795|NCT03999996|526189753|FG002|Prior to Booster|Death|0|||
145913796|NCT03999996|526189754|FG003|Prior to Booster|Death|0|||
145913797|NCT03999996|526189751|FG000|Prior to Booster|Reason Not Specified|27|||
145913798|NCT03999996|526189752|FG001|Prior to Booster|Reason Not Specified|4|||
145913799|NCT03999996|526189753|FG002|Prior to Booster|Reason Not Specified|0|||
145913800|NCT03999996|526189754|FG003|Prior to Booster|Reason Not Specified|0|||
145913801|NCT03999996|526189751|FG000|Booster Phase|Lost to Follow-up|0|||
145913802|NCT03999996|526189752|FG001|Booster Phase|Lost to Follow-up|0|||
145913803|NCT03999996|526189753|FG002|Booster Phase|Lost to Follow-up|3|||
145913804|NCT03999996|526189754|FG003|Booster Phase|Lost to Follow-up|3|||
145913805|NCT03999996|526189751|FG000|Booster Phase|Withdrawal of Consent|0|||
145913806|NCT03999996|526189752|FG001|Booster Phase|Withdrawal of Consent|0|||
145913807|NCT03999996|526189753|FG002|Booster Phase|Withdrawal of Consent|0|||
145913808|NCT03999996|526189754|FG003|Booster Phase|Withdrawal of Consent|1|||
145913809|NCT03999996|526189751|FG000|Booster Phase|Reason Not Specified|0|||
145913810|NCT03999996|526189752|FG001|Booster Phase|Reason Not Specified|0|||
145913811|NCT03999996|526189753|FG002|Booster Phase|Reason Not Specified|0|||
145913812|NCT03999996|526189754|FG003|Booster Phase|Reason Not Specified|1|||
145913813|NCT03690388|526189755|FG000|Overall Study|Adverse Event|8|||
145913814|NCT03690388|526189756|FG001|Overall Study|Adverse Event|1|||
145913815|NCT03690388|526189755|FG000|Overall Study|Radiographic Progression|14|||
145913816|NCT03690388|526189756|FG001|Overall Study|Radiographic Progression|29|||
145913817|NCT03690388|526189755|FG000|Overall Study|Clinical deterioration|10|||
145913818|NCT03690388|526189756|FG001|Overall Study|Clinical deterioration|6|||
145913819|NCT03690388|526189755|FG000|Overall Study|Withdrawal by Subject|2|||
145913820|NCT03690388|526189756|FG001|Overall Study|Withdrawal by Subject|0|||
145913821|NCT03690388|526189755|FG000|Overall Study|Lack of Efficacy|1|||
145913822|NCT03690388|526189756|FG001|Overall Study|Lack of Efficacy|0|||
145913823|NCT03690388|526189755|FG000|Overall Study|Lost to Follow-up|1|||
145913824|NCT03690388|526189756|FG001|Overall Study|Lost to Follow-up|0|||
145913825|NCT00577863|526189765|FG000|Overall Study|Adverse Event|4|||
145913826|NCT00577863|526189766|FG001|Overall Study|Adverse Event|2|||
145913827|NCT00577863|526189765|FG000|Overall Study|Death|1|||
145913828|NCT00577863|526189766|FG001|Overall Study|Death|0|||
145913829|NCT00577863|526189765|FG000|Overall Study|Lost to Follow-up|2|||
145913830|NCT00577863|526189766|FG001|Overall Study|Lost to Follow-up|2|||
145913831|NCT00577863|526189765|FG000|Overall Study|Entry Criteria Exclusion|1|||
145913832|NCT00577863|526189766|FG001|Overall Study|Entry Criteria Exclusion|0|||
145913833|NCT00577863|526189765|FG000|Overall Study|Withdrawal by Subject|0|||
145913834|NCT00577863|526189766|FG001|Overall Study|Withdrawal by Subject|2|||
145913835|NCT00577863|526189765|FG000|Overall Study|Sponsor Decision|2|||
145913836|NCT00577863|526189766|FG001|Overall Study|Sponsor Decision|7|||
145913837|NCT00577863|526189765|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
145913838|NCT00577863|526189766|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
145913839|NCT03934541|526189777|FG000|Overall Study|Study Terminated by Sponsor|0|||
145913840|NCT03934541|526189778|FG001|Overall Study|Study Terminated by Sponsor|1|||
145913841|NCT03934541|526189779|FG002|Overall Study|Study Terminated by Sponsor|0|||
145913842|NCT03934541|526189780|FG003|Overall Study|Study Terminated by Sponsor|0|||
145913843|NCT02673775|526189786|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
145913844|NCT02673775|526189787|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
145913845|NCT02673775|526189786|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
145913846|NCT02673775|526189787|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
145913847|NCT02673775|526189786|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
145913848|NCT02673775|526189787|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
145913849|NCT02673775|526189786|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
145913850|NCT02673775|526189787|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
145913851|NCT02441686|526189788|FG000|Induction|Adverse Event|4|||
145913852|NCT02441686|526189788|FG000|Induction|Complicating disease|1|||
145913853|NCT02441686|526189788|FG000|Induction|Physician Decision|1|||
146239337|NCT03147287|527389789|FG002|Overall Study|Arm A crossover without PD|0|||
146239338|NCT03147287|527389787|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
145913854|NCT02441686|526189788|FG000|Induction|Withdrawal by Subject|1|||
145913855|NCT02441686|526189788|FG000|Induction|Did not receive treatment|1|||
145913856|NCT02441686|526189788|FG000|Maintenance|Remaining on Treatment|23|||
146239339|NCT03147287|527389788|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
146239340|NCT03147287|527389789|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
146239341|NCT00925548|527391286|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
146239342|NCT00925548|527391287|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
146239343|NCT02278796|527391288|FG000|Overall Study|Death|2|||
146239344|NCT02278796|527391289|FG001|Overall Study|Death|3|||
146239345|NCT03214081|527391290|FG000|Overall Study|Case Report Forms Uncollected|9|||
146239346|NCT03214081|527391290|FG000|Overall Study|Protocol Deviation|54|||
146239347|NCT02962284|527391291|FG000|Overall Study|Death|2|||
146239348|NCT02962284|527391292|FG001|Overall Study|Death|0|||
146239349|NCT02962284|527391291|FG000|Overall Study|Progressive disease|2|||
146239350|NCT02962284|527391292|FG001|Overall Study|Progressive disease|3|||
146239351|NCT02962284|527391291|FG000|Overall Study|Withdrawal by Subject|1|||
146239352|NCT02962284|527391292|FG001|Overall Study|Withdrawal by Subject|0|||
146239353|NCT02372799|527391295|FG000|Treatment Period|Adverse Event|3|||
146239354|NCT02372799|527391296|FG001|Treatment Period|Adverse Event|10|||
146239355|NCT02372799|527391297|FG002|Treatment Period|Adverse Event|6|||
146239356|NCT02372799|527391295|FG000|Treatment Period|Insufficient therapeutic response|2|||
146239357|NCT02372799|527391296|FG001|Treatment Period|Insufficient therapeutic response|2|||
146239358|NCT02372799|527391297|FG002|Treatment Period|Insufficient therapeutic response|0|||
146239359|NCT02372799|527391295|FG000|Treatment Period|Withdrawal by Subject|10|||
146239360|NCT02372799|527391296|FG001|Treatment Period|Withdrawal by Subject|10|||
146239361|NCT02372799|527391297|FG002|Treatment Period|Withdrawal by Subject|2|||
146239362|NCT02372799|527391295|FG000|Treatment Period|Lost to Follow-up|11|||
146239363|NCT02372799|527391296|FG001|Treatment Period|Lost to Follow-up|5|||
146239364|NCT02372799|527391297|FG002|Treatment Period|Lost to Follow-up|3|||
146239365|NCT02372799|527391295|FG000|Treatment Period|Protocol Violation|3|||
146239366|NCT02372799|527391296|FG001|Treatment Period|Protocol Violation|0|||
146239367|NCT02372799|527391297|FG002|Treatment Period|Protocol Violation|0|||
146239368|NCT02372799|527391295|FG000|Treatment Period|Non-compliance with study drug|4|||
145913857|NCT02441686|526189788|FG000|Maintenance|Physician Decision|1|||
145913858|NCT02441686|526189788|FG000|Maintenance|Adverse Event|3|||
145913859|NCT02441686|526189788|FG000|Maintenance|Progressive Disease|10|||
145913860|NCT02441686|526189788|FG000|Maintenance|Withdrawal by Subject|1|||
145913861|NCT03762239|526189789|FG000|Overall Study|Appointment to the doctor|1|||
145913862|NCT03762239|526189790|FG001|Overall Study|Appointment to the doctor|1|||
145913863|NCT04471428|526189791|FG000|Overall Study|Withdrawal by Subject|29|||
145913864|NCT04471428|526189792|FG001|Overall Study|Withdrawal by Subject|1|||
145913865|NCT04471428|526189791|FG000|Overall Study|Physician Decision|0|||
145913866|NCT04471428|526189792|FG001|Overall Study|Physician Decision|1|||
146088993|NCT01244490|526845128|FG001|Overall Study|Adverse Event|9|||
146088994|NCT01244490|526845129|FG002|Overall Study|Adverse Event|5|||
146088995|NCT01244490|526845127|FG000|Overall Study|Lost to Follow-up|0|||
146088996|NCT01244490|526845128|FG001|Overall Study|Lost to Follow-up|6|||
146088997|NCT01244490|526845129|FG002|Overall Study|Lost to Follow-up|3|||
145913867|NCT04471428|526189791|FG000|Overall Study|Reason Not Specified|0|||
145913868|NCT04471428|526189792|FG001|Overall Study|Reason Not Specified|2|||
145913869|NCT04471428|526189791|FG000|Overall Study|Death|106|||
145913870|NCT04471428|526189792|FG001|Overall Study|Death|114|||
145913871|NCT04471428|526189791|FG000|Overall Study|Ongoing in the study|45|||
145913872|NCT04471428|526189792|FG001|Overall Study|Ongoing in the study|68|||
145913873|NCT00535405|526189793|FG000|Overall Study|Adverse Event|6|||
145913874|NCT00535405|526189794|FG001|Overall Study|Adverse Event|8|||
145913875|NCT00535405|526189795|FG002|Overall Study|Adverse Event|3|||
145913876|NCT00535405|526189796|FG003|Overall Study|Adverse Event|8|||
145913877|NCT00535405|526189797|FG004|Overall Study|Adverse Event|6|||
145913878|NCT00535405|526189793|FG000|Overall Study|Lost to Follow-up|1|||
145913879|NCT00535405|526189794|FG001|Overall Study|Lost to Follow-up|3|||
145913880|NCT00535405|526189795|FG002|Overall Study|Lost to Follow-up|3|||
145913881|NCT00535405|526189796|FG003|Overall Study|Lost to Follow-up|2|||
145913882|NCT00535405|526189797|FG004|Overall Study|Lost to Follow-up|1|||
146239369|NCT02372799|527391296|FG001|Treatment Period|Non-compliance with study drug|4|||
146239370|NCT02372799|527391297|FG002|Treatment Period|Non-compliance with study drug|4|||
146239371|NCT02372799|527391295|FG000|Treatment Period|Miscellaneous Reasons|1|||
146239372|NCT02372799|527391296|FG001|Treatment Period|Miscellaneous Reasons|1|||
145913883|NCT00535405|526189793|FG000|Overall Study|Physician Decision|3|||
146239373|NCT02372799|527391297|FG002|Treatment Period|Miscellaneous Reasons|0|||
146239374|NCT02372799|527391295|FG000|Down-taper Period|Lost to Follow-up|1|||
145913884|NCT00535405|526189794|FG001|Overall Study|Physician Decision|2|||
146088998|NCT01244490|526845127|FG000|Overall Study|Other|0|||
146088999|NCT01244490|526845128|FG001|Overall Study|Other|0|||
146089000|NCT01244490|526845129|FG002|Overall Study|Other|1|||
146239375|NCT02372799|527391296|FG001|Down-taper Period|Lost to Follow-up|2|||
146239376|NCT02372799|527391297|FG002|Down-taper Period|Lost to Follow-up|2|||
146239377|NCT00089609|527391298|FG000|Overall Study|Withdrawal by Subject|3|||
146239378|NCT00089609|527391299|FG001|Overall Study|Withdrawal by Subject|1|||
146239379|NCT05815342|527391301|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
146239380|NCT05815342|527391301|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
146239381|NCT05815342|527391301|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
146239382|NCT05815342|527391301|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
146239383|NCT05815342|527391301|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
146239384|NCT03116464|527391302|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
146239385|NCT00747006|527391303|FG000|Overall Study|Adverse Event|1|||
146239386|NCT00747006|527391304|FG001|Overall Study|Adverse Event|0|||
146239387|NCT00747006|527391305|FG002|Overall Study|Adverse Event|0|||
146297479|NCT00821431|527604710|FG000|Overall Study|Lost to Follow-up|1|||
146297480|NCT00821431|527604711|FG001|Overall Study|Lost to Follow-up|0|||
145913885|NCT00535405|526189795|FG002|Overall Study|Physician Decision|0|||
145913886|NCT00535405|526189796|FG003|Overall Study|Physician Decision|1|||
145913887|NCT00535405|526189797|FG004|Overall Study|Physician Decision|1|||
145913888|NCT00535405|526189793|FG000|Overall Study|Protocol Violation|2|||
145913889|NCT00535405|526189794|FG001|Overall Study|Protocol Violation|2|||
145913890|NCT00535405|526189795|FG002|Overall Study|Protocol Violation|2|||
145913891|NCT00535405|526189796|FG003|Overall Study|Protocol Violation|1|||
145913892|NCT00535405|526189797|FG004|Overall Study|Protocol Violation|0|||
145913893|NCT00535405|526189793|FG000|Overall Study|Withdrawal by Subject|5|||
145913894|NCT00535405|526189794|FG001|Overall Study|Withdrawal by Subject|11|||
145913895|NCT00535405|526189795|FG002|Overall Study|Withdrawal by Subject|10|||
145913896|NCT00535405|526189796|FG003|Overall Study|Withdrawal by Subject|10|||
145913897|NCT00535405|526189797|FG004|Overall Study|Withdrawal by Subject|8|||
145913898|NCT03151304|526189798|FG000|Overall Study|Termination of study by Sponsor|23|||
145913899|NCT03151304|526189798|FG000|Overall Study|missing|3|||
145913900|NCT03151304|526189798|FG000|Overall Study|Withdrawal by Subject|8|||
145913901|NCT03151304|526189798|FG000|Overall Study|multiple reasons|30|||
145913902|NCT03519087|526189799|FG000|Clinic Evaluation|Physician Decision|15|||
145913903|NCT03519087|526189800|FG001|Clinic Evaluation|Physician Decision|18|||
145913904|NCT03519087|526189801|FG002|Clinic Evaluation|Physician Decision|0|||
145913905|NCT03519087|526189802|FG003|Clinic Evaluation|Physician Decision|0|||
145913906|NCT03519087|526189803|FG004|Clinic Evaluation|Physician Decision|0|||
145913907|NCT03519087|526189799|FG000|Clinic Evaluation|Protocol Violation|1|||
145913908|NCT03519087|526189800|FG001|Clinic Evaluation|Protocol Violation|0|||
145913909|NCT03519087|526189801|FG002|Clinic Evaluation|Protocol Violation|0|||
145913910|NCT03519087|526189802|FG003|Clinic Evaluation|Protocol Violation|0|||
145913911|NCT03519087|526189803|FG004|Clinic Evaluation|Protocol Violation|0|||
145913912|NCT03519087|526189799|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
145913913|NCT03519087|526189800|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
145913914|NCT03519087|526189801|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
145913915|NCT03519087|526189802|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
145913916|NCT03519087|526189803|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
145973563|NCT03765073|526416392|FG000|Stage 3|Lost to Follow-up|0|||
145973564|NCT03765073|526416393|FG001|Stage 3|Lost to Follow-up|0|||
145973565|NCT03765073|526416394|FG002|Stage 3|Lost to Follow-up|0|||
145973566|NCT03765073|526416395|FG003|Stage 3|Lost to Follow-up|0|||
145973567|NCT03765073|526416396|FG004|Stage 3|Lost to Follow-up|0|||
145973568|NCT03765073|526416397|FG005|Stage 3|Lost to Follow-up|0|||
145913917|NCT03519087|526189799|FG000|Re-randomization for Treatment|Not appropriate|2|||
145913918|NCT03519087|526189800|FG001|Re-randomization for Treatment|Not appropriate|3|||
145913919|NCT03519087|526189801|FG002|Re-randomization for Treatment|Not appropriate|0|||
145913920|NCT03519087|526189802|FG003|Re-randomization for Treatment|Not appropriate|0|||
145913921|NCT03519087|526189803|FG004|Re-randomization for Treatment|Not appropriate|0|||
145913922|NCT03519087|526189799|FG000|Laboratory Testing|Lost to Follow-up|0|||
145913923|NCT03519087|526189800|FG001|Laboratory Testing|Lost to Follow-up|0|||
145913924|NCT03519087|526189801|FG002|Laboratory Testing|Lost to Follow-up|2|||
145913925|NCT03519087|526189802|FG003|Laboratory Testing|Lost to Follow-up|3|||
145913926|NCT03519087|526189803|FG004|Laboratory Testing|Lost to Follow-up|6|||
145913927|NCT03519087|526189799|FG000|Laboratory Testing|Protocol Violation|0|||
145913928|NCT03519087|526189800|FG001|Laboratory Testing|Protocol Violation|0|||
145913929|NCT03519087|526189801|FG002|Laboratory Testing|Protocol Violation|0|||
145913930|NCT03519087|526189802|FG003|Laboratory Testing|Protocol Violation|1|||
145913931|NCT03519087|526189803|FG004|Laboratory Testing|Protocol Violation|0|||
145913932|NCT01137071|526189805|FG000|Overall Study|Disease Progression|11|||
145913933|NCT01137071|526189805|FG000|Overall Study|Withdrawal by Subject|2|||
146239388|NCT00747006|527391303|FG000|Overall Study|Lost to Follow-up|0|||
146239389|NCT00747006|527391304|FG001|Overall Study|Lost to Follow-up|1|||
145973569|NCT03765073|526416398|FG006|Stage 3|Lost to Follow-up|0|||
146239390|NCT00747006|527391305|FG002|Overall Study|Lost to Follow-up|0|||
146297481|NCT00821431|527604710|FG000|Overall Study|Protocol Violation|3|||
145913934|NCT01137071|526189805|FG000|Overall Study|Wrongly Included|1|||
145913935|NCT02565511|526189806|FG000|Overall Study|Study terminated by Sponsor|35|||
145913936|NCT02565511|526189807|FG001|Overall Study|Study terminated by Sponsor|22|||
145913937|NCT02565511|526189808|FG002|Overall Study|Study terminated by Sponsor|235|||
145913938|NCT02565511|526189809|FG003|Overall Study|Study terminated by Sponsor|156|||
145913939|NCT02565511|526189806|FG000|Overall Study|Withdrawal by Subject|3|||
145913940|NCT02565511|526189807|FG001|Overall Study|Withdrawal by Subject|0|||
145913941|NCT02565511|526189808|FG002|Overall Study|Withdrawal by Subject|12|||
145913942|NCT02565511|526189809|FG003|Overall Study|Withdrawal by Subject|5|||
145913943|NCT02565511|526189806|FG000|Overall Study|Adverse Event|0|||
145913944|NCT02565511|526189807|FG001|Overall Study|Adverse Event|0|||
145913945|NCT02565511|526189808|FG002|Overall Study|Adverse Event|1|||
145913946|NCT02565511|526189809|FG003|Overall Study|Adverse Event|1|||
145913947|NCT02565511|526189806|FG000|Overall Study|Lost to Follow-up|4|||
145913948|NCT02565511|526189807|FG001|Overall Study|Lost to Follow-up|1|||
145913949|NCT02565511|526189808|FG002|Overall Study|Lost to Follow-up|0|||
145913950|NCT02565511|526189809|FG003|Overall Study|Lost to Follow-up|1|||
145913951|NCT02565511|526189806|FG000|Overall Study|Physician Decision|0|||
145913952|NCT02565511|526189807|FG001|Overall Study|Physician Decision|0|||
145913953|NCT02565511|526189808|FG002|Overall Study|Physician Decision|0|||
145913954|NCT02565511|526189809|FG003|Overall Study|Physician Decision|1|||
145913955|NCT02565511|526189806|FG000|Overall Study|Protocol deviation|0|||
145913956|NCT02565511|526189807|FG001|Overall Study|Protocol deviation|0|||
145913957|NCT02565511|526189808|FG002|Overall Study|Protocol deviation|3|||
145913958|NCT02565511|526189809|FG003|Overall Study|Protocol deviation|0|||
145913959|NCT04807400|526189810|FG000|Overall Study|Adverse Event|2|||
145913960|NCT04807400|526189811|FG001|Overall Study|Adverse Event|3|||
145913961|NCT04807400|526189812|FG002|Overall Study|Adverse Event|3|||
145913962|NCT04807400|526189810|FG000|Overall Study|Death|2|||
145913963|NCT04807400|526189811|FG001|Overall Study|Death|0|||
145913964|NCT04807400|526189812|FG002|Overall Study|Death|0|||
145913965|NCT04807400|526189810|FG000|Overall Study|Lost to Follow-up|8|||
145913966|NCT04807400|526189811|FG001|Overall Study|Lost to Follow-up|6|||
145913967|NCT04807400|526189812|FG002|Overall Study|Lost to Follow-up|6|||
145913968|NCT04807400|526189810|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145913969|NCT04807400|526189811|FG001|Overall Study|Non-Compliance With Study Drug|4|||
145913970|NCT04807400|526189812|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145913971|NCT04807400|526189810|FG000|Overall Study|Participant Decision|20|||
145913972|NCT04807400|526189811|FG001|Overall Study|Participant Decision|19|||
145913973|NCT04807400|526189812|FG002|Overall Study|Participant Decision|26|||
145913974|NCT04807400|526189810|FG000|Overall Study|Physician Decision|0|||
145913975|NCT04807400|526189811|FG001|Overall Study|Physician Decision|1|||
145913976|NCT04807400|526189812|FG002|Overall Study|Physician Decision|0|||
145913977|NCT04807400|526189810|FG000|Overall Study|Protocol Violation|4|||
145913978|NCT04807400|526189811|FG001|Overall Study|Protocol Violation|3|||
145913979|NCT04807400|526189812|FG002|Overall Study|Protocol Violation|7|||
145913980|NCT04807400|526189810|FG000|Overall Study|Withdrawal by Subject|13|||
145913981|NCT04807400|526189811|FG001|Overall Study|Withdrawal by Subject|9|||
145913982|NCT04807400|526189812|FG002|Overall Study|Withdrawal by Subject|20|||
145913983|NCT04807400|526189810|FG000|Overall Study|Mis-randomized|1|||
145913984|NCT04807400|526189811|FG001|Overall Study|Mis-randomized|0|||
145913985|NCT04807400|526189812|FG002|Overall Study|Mis-randomized|0|||
145913986|NCT03656744|526189813|FG000|Overall Study|Adverse Event|1|||
145913987|NCT03656744|526189814|FG001|Overall Study|Adverse Event|4|||
145913988|NCT03656744|526189815|FG002|Overall Study|Adverse Event|1|||
145913989|NCT03656744|526189813|FG000|Overall Study|Protocol Violation|1|||
146239391|NCT00747006|527391303|FG000|Overall Study|Physician Decision|2|||
146239392|NCT00747006|527391304|FG001|Overall Study|Physician Decision|0|||
146239393|NCT00747006|527391305|FG002|Overall Study|Physician Decision|1|||
146239394|NCT00357994|527391306|FG000|Overall Study|Adverse Event|1|||
146239395|NCT00357994|527391307|FG001|Overall Study|Adverse Event|2|||
146239396|NCT00357994|527391306|FG000|Overall Study|Lack of Efficacy|0|||
146239397|NCT00357994|527391307|FG001|Overall Study|Lack of Efficacy|1|||
146239398|NCT00357994|527391306|FG000|Overall Study|Protocol Violation|1|||
145913990|NCT03656744|526189814|FG001|Overall Study|Protocol Violation|0|||
145913991|NCT03656744|526189815|FG002|Overall Study|Protocol Violation|0|||
145913992|NCT03656744|526189813|FG000|Overall Study|Lost to Follow-up|2|||
145913993|NCT03656744|526189814|FG001|Overall Study|Lost to Follow-up|2|||
145913994|NCT03656744|526189815|FG002|Overall Study|Lost to Follow-up|0|||
145913995|NCT03656744|526189813|FG000|Overall Study|Withdrawal by Subject|0|||
146239399|NCT00357994|527391307|FG001|Overall Study|Protocol Violation|0|||
145913996|NCT03656744|526189814|FG001|Overall Study|Withdrawal by Subject|1|||
145913997|NCT03656744|526189815|FG002|Overall Study|Withdrawal by Subject|0|||
145913998|NCT03656744|526189813|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
145913999|NCT03656744|526189814|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
145914000|NCT03656744|526189815|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
145914001|NCT01332292|526189819|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146239400|NCT00345046|527391310|FG000|Overall Study|Protocol Violation|1|||
146239401|NCT00345046|527391311|FG001|Overall Study|Protocol Violation|1|||
146089001|NCT00393042|526845130|FG000|First Intervention|Withdrawal by Subject|1|||
146089002|NCT00393042|526845131|FG001|First Intervention|Withdrawal by Subject|2|||
146089003|NCT00393042|526845130|FG000|First Intervention|Lost to Follow-up|3|||
146089004|NCT00393042|526845131|FG001|First Intervention|Lost to Follow-up|3|||
146089005|NCT00393042|526845130|FG000|First Intervention|Protocol Violation|1|||
146089006|NCT00393042|526845131|FG001|First Intervention|Protocol Violation|0|||
146089007|NCT00393042|526845130|FG000|First Intervention|Adverse Event|0|||
146089008|NCT00393042|526845131|FG001|First Intervention|Adverse Event|1|||
145914002|NCT01332292|526189820|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145914003|NCT01332292|526189819|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145914004|NCT01332292|526189820|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145914005|NCT01332292|526189819|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
145914006|NCT01332292|526189820|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
145914007|NCT03910673|526189822|FG000|Overall Study|Adverse Event|0|||
145914008|NCT03910673|526189823|FG001|Overall Study|Adverse Event|0|||
145914009|NCT03910673|526189824|FG002|Overall Study|Adverse Event|0|||
145914010|NCT03910673|526189825|FG003|Overall Study|Adverse Event|2|||
145914011|NCT03910673|526189826|FG004|Overall Study|Adverse Event|0|||
145914012|NCT00098774|526189827|FG000|Overall Study|Adverse Event|2|||
145914013|NCT00098774|526189827|FG000|Overall Study|Disease Progression|9|||
145914014|NCT00098774|526189827|FG000|Overall Study|Withdrawal by Subject|1|||
145914015|NCT00098774|526189827|FG000|Overall Study|Failed (to respond) during induction|4|||
145914016|NCT00098774|526189827|FG000|Overall Study|Physician Decision|2|||
145914017|NCT00796757|526189828|FG000|Overall Study|Withdrawal by Subject|14|||
145914018|NCT00796757|526189828|FG000|Overall Study|Death|61|||
145914019|NCT00796757|526189828|FG000|Overall Study|Protocol Violation|1|||
145914020|NCT00796757|526189828|FG000|Overall Study|Participant noncompliance|1|||
145914021|NCT00796757|526189828|FG000|Overall Study|Investigator's decision|2|||
145914022|NCT00796757|526189828|FG000|Overall Study|Other|7|||
145914023|NCT03142191|526189829|FG000|Placebo Controlled Period|Death|0|||
145914024|NCT03142191|526189830|FG001|Placebo Controlled Period|Death|1|||
145914025|NCT03142191|526189831|FG002|Placebo Controlled Period|Death|1|||
145914026|NCT03142191|526189832|FG003|Placebo Controlled Period|Death|0|||
145914027|NCT03142191|526189833|FG004|Placebo Controlled Period|Death|0|||
145914028|NCT03142191|526189829|FG000|Placebo Controlled Period|Adverse Event|4|||
145914029|NCT03142191|526189830|FG001|Placebo Controlled Period|Adverse Event|5|||
145914030|NCT03142191|526189831|FG002|Placebo Controlled Period|Adverse Event|1|||
145914031|NCT03142191|526189832|FG003|Placebo Controlled Period|Adverse Event|0|||
145914032|NCT03142191|526189833|FG004|Placebo Controlled Period|Adverse Event|0|||
145914033|NCT03142191|526189829|FG000|Placebo Controlled Period|Progressive Disease|1|||
146297482|NCT00821431|527604711|FG001|Overall Study|Protocol Violation|1|||
145914034|NCT03142191|526189830|FG001|Placebo Controlled Period|Progressive Disease|0|||
145914035|NCT03142191|526189831|FG002|Placebo Controlled Period|Progressive Disease|1|||
145914036|NCT03142191|526189832|FG003|Placebo Controlled Period|Progressive Disease|0|||
145914037|NCT03142191|526189833|FG004|Placebo Controlled Period|Progressive Disease|0|||
145914038|NCT03142191|526189829|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
145914039|NCT03142191|526189830|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
145914040|NCT03142191|526189831|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
145914041|NCT03142191|526189832|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
145914042|NCT03142191|526189833|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
145914043|NCT03142191|526189829|FG000|Placebo Controlled Period|Other Reasons|1|||
145914044|NCT03142191|526189830|FG001|Placebo Controlled Period|Other Reasons|0|||
145914045|NCT03142191|526189831|FG002|Placebo Controlled Period|Other Reasons|0|||
145914046|NCT03142191|526189832|FG003|Placebo Controlled Period|Other Reasons|0|||
145914047|NCT03142191|526189833|FG004|Placebo Controlled Period|Other Reasons|0|||
145914048|NCT03142191|526189829|FG000|Active Treatment Extension Period|Death|2|||
145914049|NCT03142191|526189830|FG001|Active Treatment Extension Period|Death|1|||
145914050|NCT03142191|526189831|FG002|Active Treatment Extension Period|Death|1|||
145914051|NCT03142191|526189832|FG003|Active Treatment Extension Period|Death|1|||
145914052|NCT03142191|526189833|FG004|Active Treatment Extension Period|Death|0|||
145914053|NCT03142191|526189829|FG000|Active Treatment Extension Period|Adverse Event|6|||
145914054|NCT03142191|526189830|FG001|Active Treatment Extension Period|Adverse Event|5|||
145914055|NCT03142191|526189831|FG002|Active Treatment Extension Period|Adverse Event|4|||
145914056|NCT03142191|526189832|FG003|Active Treatment Extension Period|Adverse Event|1|||
145914057|NCT03142191|526189833|FG004|Active Treatment Extension Period|Adverse Event|0|||
145914058|NCT03142191|526189829|FG000|Active Treatment Extension Period|Progressive Disease|10|||
145914059|NCT03142191|526189830|FG001|Active Treatment Extension Period|Progressive Disease|5|||
145914060|NCT03142191|526189831|FG002|Active Treatment Extension Period|Progressive Disease|4|||
145914061|NCT03142191|526189832|FG003|Active Treatment Extension Period|Progressive Disease|1|||
145914062|NCT03142191|526189833|FG004|Active Treatment Extension Period|Progressive Disease|2|||
146089009|NCT00393042|526845130|FG000|Second Intervetion|Adverse Event|0|||
146089010|NCT00393042|526845131|FG001|Second Intervetion|Adverse Event|3|||
146089011|NCT00393042|526845130|FG000|Second Intervetion|Withdrawal by Subject|0|||
146089012|NCT00393042|526845131|FG001|Second Intervetion|Withdrawal by Subject|2|||
145914063|NCT03142191|526189829|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
145914064|NCT03142191|526189830|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
145914065|NCT03142191|526189831|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
145914066|NCT03142191|526189832|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
145914067|NCT03142191|526189833|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
145914068|NCT03142191|526189829|FG000|Active Treatment Extension Period|Physician Decision|2|||
145914069|NCT03142191|526189830|FG001|Active Treatment Extension Period|Physician Decision|0|||
145914070|NCT03142191|526189831|FG002|Active Treatment Extension Period|Physician Decision|0|||
145914071|NCT03142191|526189832|FG003|Active Treatment Extension Period|Physician Decision|0|||
145914072|NCT03142191|526189833|FG004|Active Treatment Extension Period|Physician Decision|0|||
145914073|NCT03142191|526189829|FG000|Active Treatment Extension Period|Other Reasons|3|||
145914074|NCT03142191|526189830|FG001|Active Treatment Extension Period|Other Reasons|3|||
145914075|NCT03142191|526189831|FG002|Active Treatment Extension Period|Other Reasons|3|||
145914076|NCT03142191|526189832|FG003|Active Treatment Extension Period|Other Reasons|8|||
145914077|NCT03142191|526189833|FG004|Active Treatment Extension Period|Other Reasons|3|||
145914078|NCT03142191|526189829|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
145914079|NCT03142191|526189830|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
145914080|NCT03142191|526189831|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
145914081|NCT03142191|526189832|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
145914082|NCT03142191|526189833|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
145914083|NCT01130493|526189838|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
145914084|NCT01130493|526189839|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
145914085|NCT01130493|526189840|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
145914086|NCT01130493|526189838|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
145914087|NCT01130493|526189839|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
145914088|NCT01130493|526189840|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
145914089|NCT01130493|526189838|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
145914090|NCT01130493|526189839|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
145914091|NCT01130493|526189840|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
145914092|NCT01130493|526189838|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
145914093|NCT01130493|526189839|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
145914094|NCT01130493|526189840|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
145914095|NCT01130493|526189838|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
145914096|NCT01130493|526189839|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
145914097|NCT01130493|526189840|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
145914098|NCT01130493|526189838|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
145914099|NCT01130493|526189839|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
145914100|NCT01130493|526189840|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
145914101|NCT01130493|526189838|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
145914102|NCT01130493|526189839|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
145914103|NCT01130493|526189840|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
145914104|NCT01130493|526189838|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
145914105|NCT01130493|526189839|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
145914106|NCT01130493|526189840|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
145914107|NCT01130493|526189838|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
145914108|NCT01130493|526189839|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
145914109|NCT01130493|526189840|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
145914110|NCT01130493|526189838|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
145914111|NCT01130493|526189839|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
145914112|NCT01130493|526189840|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
145914113|NCT01130493|526189838|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
145914114|NCT01130493|526189839|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
145914115|NCT01130493|526189840|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
145914116|NCT01130493|526189838|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
145914117|NCT01130493|526189839|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
145914118|NCT01130493|526189840|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
145914119|NCT01130493|526189838|FG000|Part 2: OLE|Adverse Event|0|||
145914120|NCT01130493|526189839|FG001|Part 2: OLE|Adverse Event|2|||
145914121|NCT01130493|526189840|FG002|Part 2: OLE|Adverse Event|1|||
145914122|NCT01130493|526189838|FG000|Part 2: OLE|Withdrawal by Subject|0|||
145914123|NCT01130493|526189839|FG001|Part 2: OLE|Withdrawal by Subject|1|||
145914124|NCT01130493|526189840|FG002|Part 2: OLE|Withdrawal by Subject|4|||
145914125|NCT00879086|526189843|FG000|Overall Study|Adverse Event|3|||
145914126|NCT00879086|526189844|FG001|Overall Study|Adverse Event|15|||
145914127|NCT00879086|526189843|FG000|Overall Study|Participant choice|2|||
145914128|NCT00879086|526189844|FG001|Overall Study|Participant choice|2|||
146089013|NCT00393042|526845130|FG000|Second Intervetion|Lack of Efficacy|1|||
146239402|NCT00345046|527391312|FG002|Overall Study|Protocol Violation|2|||
145914129|NCT00879086|526189843|FG000|Overall Study|Progression of disease|40|||
145914130|NCT00879086|526189844|FG001|Overall Study|Progression of disease|26|||
145914131|NCT00879086|526189843|FG000|Overall Study|Withdrawal of consent|2|||
145914132|NCT00879086|526189844|FG001|Overall Study|Withdrawal of consent|1|||
145914133|NCT00879086|526189843|FG000|Overall Study|Other|4|||
145914134|NCT00879086|526189844|FG001|Overall Study|Other|6|||
145914135|NCT00879086|526189843|FG000|Overall Study|Death|1|||
145914136|NCT00879086|526189844|FG001|Overall Study|Death|2|||
145914137|NCT02969044|526189845|FG000|Overall Study|Withdrawal by Subject|2|||
145914138|NCT02969044|526189846|FG001|Overall Study|Withdrawal by Subject|6|||
146239403|NCT04652869|527391317|FG000|Overall Study|Withdrawal by Subject|0|||
146239404|NCT04652869|527391318|FG001|Overall Study|Withdrawal by Subject|2|||
146239405|NCT04652869|527391319|FG002|Overall Study|Withdrawal by Subject|0|||
146239406|NCT01372085|527391320|FG000|Washout Period 2|Physician Decision|0|||
145914139|NCT02969044|526189845|FG000|Overall Study|Adverse Event|3|||
146239407|NCT01372085|527391321|FG001|Washout Period 2|Physician Decision|0|||
146239408|NCT01372085|527391322|FG002|Washout Period 2|Physician Decision|0|||
146239409|NCT01372085|527391323|FG003|Washout Period 2|Physician Decision|0|||
146239410|NCT01372085|527391324|FG004|Washout Period 2|Physician Decision|1|||
146239411|NCT01372085|527391325|FG005|Washout Period 2|Physician Decision|0|||
146239412|NCT01372085|527391326|FG006|Washout Period 2|Physician Decision|0|||
146239413|NCT01372085|527391327|FG007|Washout Period 2|Physician Decision|0|||
146239414|NCT01372085|527391328|FG008|Washout Period 2|Physician Decision|0|||
146239415|NCT01372085|527391329|FG009|Washout Period 2|Physician Decision|0|||
146239416|NCT01372085|527391320|FG000|Washout Period 3|Withdrawal by Subject|0|||
146239417|NCT01372085|527391321|FG001|Washout Period 3|Withdrawal by Subject|0|||
146239418|NCT01372085|527391322|FG002|Washout Period 3|Withdrawal by Subject|0|||
146239419|NCT01372085|527391323|FG003|Washout Period 3|Withdrawal by Subject|0|||
146239420|NCT01372085|527391324|FG004|Washout Period 3|Withdrawal by Subject|0|||
146239421|NCT01372085|527391325|FG005|Washout Period 3|Withdrawal by Subject|2|||
146239422|NCT01372085|527391326|FG006|Washout Period 3|Withdrawal by Subject|0|||
146239423|NCT01372085|527391327|FG007|Washout Period 3|Withdrawal by Subject|0|||
146239424|NCT01372085|527391328|FG008|Washout Period 3|Withdrawal by Subject|0|||
146239425|NCT01372085|527391329|FG009|Washout Period 3|Withdrawal by Subject|0|||
146239426|NCT00562094|527391330|FG000|Overall Study|Lost to Follow-up|62|||
146239427|NCT03689946|527391331|FG000|Overall Study|Withdrawal by Subject|3|||
146239428|NCT03689946|527391331|FG000|Overall Study|Lost to Follow-up|3|||
146239429|NCT03689946|527391331|FG000|Overall Study|Data corruption|2|||
146239430|NCT01555138|527391332|FG000|Overall Study|Death|0|||
146239431|NCT01555138|527391333|FG001|Overall Study|Death|1|||
146239432|NCT01555138|527391332|FG000|Overall Study|Lost to Follow-up|1|||
146239433|NCT01555138|527391333|FG001|Overall Study|Lost to Follow-up|0|||
146239434|NCT01555138|527391332|FG000|Overall Study|Abnormal Lab reults|1|||
146239435|NCT01555138|527391333|FG001|Overall Study|Abnormal Lab reults|3|||
146239436|NCT01555138|527391332|FG000|Overall Study|Lack of Efficacy|2|||
146239437|NCT01555138|527391333|FG001|Overall Study|Lack of Efficacy|2|||
146239438|NCT01555138|527391332|FG000|Overall Study|Protocol Violation|5|||
146239439|NCT01555138|527391333|FG001|Overall Study|Protocol Violation|3|||
145914140|NCT02969044|526189846|FG001|Overall Study|Adverse Event|0|||
145914141|NCT04728802|526189847|FG000|Overall Study|Withdrawal by Subject|4|||
145914142|NCT04728802|526189848|FG001|Overall Study|Withdrawal by Subject|20|||
145914143|NCT04728802|526189847|FG000|Overall Study|Physician Decision|7|||
145914144|NCT04728802|526189848|FG001|Overall Study|Physician Decision|7|||
145914145|NCT04728802|526189847|FG000|Overall Study|Protocol Violation|10|||
145914146|NCT04728802|526189848|FG001|Overall Study|Protocol Violation|4|||
145914147|NCT04728802|526189847|FG000|Overall Study|Transfer|1|||
145914148|NCT04728802|526189848|FG001|Overall Study|Transfer|0|||
145914149|NCT04728802|526189847|FG000|Overall Study|Death|4|||
145914150|NCT04728802|526189848|FG001|Overall Study|Death|5|||
145914151|NCT04728802|526189847|FG000|Overall Study|Other|3|||
145914152|NCT04728802|526189848|FG001|Overall Study|Other|0|||
145914153|NCT04650204|526189849|FG000|Overall Study|Study was Terminated|2|||
146239440|NCT01555138|527391332|FG000|Overall Study|Administrative problems|8|||
146239441|NCT01555138|527391333|FG001|Overall Study|Administrative problems|0|||
146239442|NCT01555138|527391332|FG000|Overall Study|Withdrawal by Subject|16|||
145914154|NCT04650204|526189850|FG001|Overall Study|Study was Terminated|1|||
146089014|NCT00393042|526845131|FG001|Second Intervetion|Lack of Efficacy|0|||
146239443|NCT01555138|527391333|FG001|Overall Study|Withdrawal by Subject|15|||
146239444|NCT01555138|527391332|FG000|Overall Study|Adverse Event|14|||
146239445|NCT01555138|527391333|FG001|Overall Study|Adverse Event|14|||
146239446|NCT01613417|527391334|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
146239447|NCT01613417|527391335|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
146239448|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
145914155|NCT01330303|526189851|FG000|Period 1|Adverse Event|1|||
145914156|NCT01330303|526189852|FG001|Period 1|Adverse Event|0|||
145914157|NCT01330303|526189851|FG000|Period 1|Protocol Violation|0|||
146239449|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
145914158|NCT01330303|526189852|FG001|Period 1|Protocol Violation|1|||
145914159|NCT01330303|526189851|FG000|Period 1|Withdrawal by Subject|0|||
145914160|NCT01330303|526189852|FG001|Period 1|Withdrawal by Subject|1|||
145914161|NCT04388553|526189854|FG000|Overall Study|Protocol Violation|1|||
145914162|NCT04388553|526189855|FG001|Overall Study|Protocol Violation|0|||
145914163|NCT02123446|526189856|FG000|Washout Period (1 Day)|Physician Decision|1|||
145914164|NCT02123446|526189857|FG001|Washout Period (1 Day)|Physician Decision|0|||
145914165|NCT00489827|526189866|FG000|Overall Study|Intraoperative exclusion criteria|1|||
145914166|NCT00489827|526189867|FG001|Overall Study|Intraoperative exclusion criteria|1|||
145914167|NCT00489827|526189866|FG000|Overall Study|Intraoperative exclusion criteria|1|||
145914168|NCT00489827|526189867|FG001|Overall Study|Intraoperative exclusion criteria|1|||
145914169|NCT00625872|526189872|FG000|Overall Study|Withdrawal by Subject|1|||
145914170|NCT00625872|526189873|FG001|Overall Study|Withdrawal by Subject|0|||
145914171|NCT00625872|526189872|FG000|Overall Study|Does not meet inclusion criteria|1|||
145914172|NCT00625872|526189873|FG001|Overall Study|Does not meet inclusion criteria|0|||
145914173|NCT00625872|526189872|FG000|Overall Study|Terminated by sponsor|2|||
145914174|NCT00625872|526189873|FG001|Overall Study|Terminated by sponsor|5|||
145914175|NCT00625872|526189872|FG000|Overall Study|Randomized but not treated|0|||
145914176|NCT00625872|526189873|FG001|Overall Study|Randomized but not treated|1|||
145914177|NCT01512160|526189874|FG000|Overall Study|Lost to Follow-up|1|||
145914178|NCT01512160|526189875|FG001|Overall Study|Lost to Follow-up|0|||
145914179|NCT01512160|526189876|FG002|Overall Study|Lost to Follow-up|0|||
145914180|NCT01512160|526189877|FG003|Overall Study|Lost to Follow-up|0|||
145914181|NCT01512160|526189874|FG000|Overall Study|Withdrawal by Subject|1|||
145914182|NCT01512160|526189875|FG001|Overall Study|Withdrawal by Subject|0|||
145914183|NCT01512160|526189876|FG002|Overall Study|Withdrawal by Subject|0|||
145914184|NCT01512160|526189877|FG003|Overall Study|Withdrawal by Subject|1|||
145914185|NCT00265759|526191094|FG000|Overall Study|Withdrawal by Subject|0|||
145914186|NCT00265759|526191095|FG001|Overall Study|Withdrawal by Subject|1|||
145914187|NCT00265759|526191096|FG002|Overall Study|Withdrawal by Subject|2|||
145914188|NCT00265759|526191097|FG003|Overall Study|Withdrawal by Subject|2|||
145914189|NCT00265759|526191094|FG000|Overall Study|Cancel|0|||
145914190|NCT00265759|526191095|FG001|Overall Study|Cancel|0|||
145914191|NCT00265759|526191096|FG002|Overall Study|Cancel|0|||
145914192|NCT00265759|526191097|FG003|Overall Study|Cancel|3|||
145914193|NCT00265759|526191094|FG000|Overall Study|Ineligible|0|||
145914194|NCT00265759|526191095|FG001|Overall Study|Ineligible|0|||
145914195|NCT00265759|526191096|FG002|Overall Study|Ineligible|0|||
145914196|NCT00265759|526191097|FG003|Overall Study|Ineligible|1|||
145914197|NCT00265759|526191094|FG000|Overall Study|Bilateral disease|0|||
145914198|NCT00265759|526191095|FG001|Overall Study|Bilateral disease|0|||
145914199|NCT00265759|526191096|FG002|Overall Study|Bilateral disease|0|||
145914200|NCT00265759|526191097|FG003|Overall Study|Bilateral disease|2|||
145914201|NCT00265759|526191094|FG000|Overall Study|Discontinued due to intolerability|0|||
145914202|NCT00265759|526191095|FG001|Overall Study|Discontinued due to intolerability|0|||
145914203|NCT00265759|526191096|FG002|Overall Study|Discontinued due to intolerability|0|||
145914204|NCT00265759|526191097|FG003|Overall Study|Discontinued due to intolerability|1|||
145914205|NCT03729596|526191100|FG000|Overall Study|Death|3|||
145914206|NCT03729596|526191101|FG001|Overall Study|Death|5|||
145914207|NCT03729596|526191102|FG002|Overall Study|Death|4|||
145914208|NCT03729596|526191103|FG003|Overall Study|Death|1|||
145914209|NCT03729596|526191104|FG004|Overall Study|Death|0|||
145914210|NCT03729596|526191105|FG005|Overall Study|Death|34|||
145914211|NCT03729596|526191106|FG006|Overall Study|Death|18|||
145914212|NCT03729596|526191107|FG007|Overall Study|Death|14|||
145914213|NCT03729596|526191108|FG008|Overall Study|Death|19|||
145914214|NCT03729596|526191109|FG009|Overall Study|Death|9|||
145914215|NCT03729596|526191100|FG000|Overall Study|Lost to Follow-up|0|||
145914216|NCT03729596|526191101|FG001|Overall Study|Lost to Follow-up|0|||
145914217|NCT03729596|526191102|FG002|Overall Study|Lost to Follow-up|0|||
145914218|NCT03729596|526191103|FG003|Overall Study|Lost to Follow-up|0|||
145914219|NCT03729596|526191104|FG004|Overall Study|Lost to Follow-up|0|||
145914220|NCT03729596|526191105|FG005|Overall Study|Lost to Follow-up|0|||
145914221|NCT03729596|526191106|FG006|Overall Study|Lost to Follow-up|1|||
145914222|NCT03729596|526191107|FG007|Overall Study|Lost to Follow-up|0|||
145914223|NCT03729596|526191108|FG008|Overall Study|Lost to Follow-up|0|||
145914224|NCT03729596|526191109|FG009|Overall Study|Lost to Follow-up|1|||
145914225|NCT03729596|526191100|FG000|Overall Study|protocol amendment|0|||
145914226|NCT03729596|526191101|FG001|Overall Study|protocol amendment|1|||
145914227|NCT03729596|526191102|FG002|Overall Study|protocol amendment|3|||
145914228|NCT03729596|526191103|FG003|Overall Study|protocol amendment|6|||
145914229|NCT03729596|526191104|FG004|Overall Study|protocol amendment|5|||
145914230|NCT03729596|526191105|FG005|Overall Study|protocol amendment|0|||
145914231|NCT03729596|526191106|FG006|Overall Study|protocol amendment|0|||
145914232|NCT03729596|526191107|FG007|Overall Study|protocol amendment|0|||
145914233|NCT03729596|526191108|FG008|Overall Study|protocol amendment|0|||
145914234|NCT03729596|526191109|FG009|Overall Study|protocol amendment|0|||
145914235|NCT03729596|526191100|FG000|Overall Study|Withdrawal by Subject|0|||
145914236|NCT03729596|526191101|FG001|Overall Study|Withdrawal by Subject|0|||
145914237|NCT03729596|526191102|FG002|Overall Study|Withdrawal by Subject|0|||
145914238|NCT03729596|526191103|FG003|Overall Study|Withdrawal by Subject|0|||
145914239|NCT03729596|526191104|FG004|Overall Study|Withdrawal by Subject|0|||
145914240|NCT03729596|526191105|FG005|Overall Study|Withdrawal by Subject|4|||
145914241|NCT03729596|526191106|FG006|Overall Study|Withdrawal by Subject|2|||
145914242|NCT03729596|526191107|FG007|Overall Study|Withdrawal by Subject|3|||
145914243|NCT03729596|526191108|FG008|Overall Study|Withdrawal by Subject|2|||
145914244|NCT03729596|526191109|FG009|Overall Study|Withdrawal by Subject|3|||
145914245|NCT03729596|526191100|FG000|Overall Study|study terminated by sponsor|0|||
145914246|NCT03729596|526191101|FG001|Overall Study|study terminated by sponsor|0|||
145914247|NCT03729596|526191102|FG002|Overall Study|study terminated by sponsor|0|||
145914248|NCT03729596|526191103|FG003|Overall Study|study terminated by sponsor|0|||
145914249|NCT03729596|526191104|FG004|Overall Study|study terminated by sponsor|1|||
145914250|NCT03729596|526191105|FG005|Overall Study|study terminated by sponsor|3|||
145914251|NCT03729596|526191106|FG006|Overall Study|study terminated by sponsor|0|||
145914252|NCT03729596|526191107|FG007|Overall Study|study terminated by sponsor|1|||
145914253|NCT03729596|526191108|FG008|Overall Study|study terminated by sponsor|0|||
145914254|NCT03729596|526191109|FG009|Overall Study|study terminated by sponsor|0|||
145914255|NCT03713593|526191110|FG000|Overall Study|Sponsor Decision|73|||
145914256|NCT03713593|526191111|FG001|Overall Study|Sponsor Decision|41|||
145914257|NCT03713593|526191110|FG000|Overall Study|Lost to Follow-up|2|||
145914258|NCT03713593|526191111|FG001|Overall Study|Lost to Follow-up|1|||
145914259|NCT03713593|526191110|FG000|Overall Study|Death|314|||
145914260|NCT03713593|526191111|FG001|Overall Study|Death|349|||
145914261|NCT03713593|526191110|FG000|Overall Study|Withdrawal by Subject|6|||
145914262|NCT03713593|526191111|FG001|Overall Study|Withdrawal by Subject|8|||
145914263|NCT06419907|526191112|FG000|Overall Study|Protocol Violation|0|||
145914264|NCT06419907|526191113|FG001|Overall Study|Protocol Violation|3|||
145914265|NCT06419907|526191114|FG002|Overall Study|Protocol Violation|0|||
145914266|NCT06419907|526191115|FG003|Overall Study|Protocol Violation|1|||
145914267|NCT06419907|526191112|FG000|Overall Study|Lost to Follow-up|0|||
145914268|NCT06419907|526191113|FG001|Overall Study|Lost to Follow-up|0|||
145914269|NCT06419907|526191114|FG002|Overall Study|Lost to Follow-up|2|||
145914270|NCT06419907|526191115|FG003|Overall Study|Lost to Follow-up|1|||
145914271|NCT03130777|526191116|FG000|Overall Study|Death|0|||
145914272|NCT03130777|526191117|FG001|Overall Study|Death|1|||
145914273|NCT03130777|526191116|FG000|Overall Study|Did not meet eligibility criteria|1|||
145914274|NCT03130777|526191117|FG001|Overall Study|Did not meet eligibility criteria|0|||
145914275|NCT02586688|526191119|FG000|Overall Study|Lost to Follow-up|2|||
145914276|NCT02586688|526191120|FG001|Overall Study|Lost to Follow-up|1|||
145914277|NCT02586688|526191119|FG000|Overall Study|Withdrawal by Subject|1|||
145914278|NCT02586688|526191120|FG001|Overall Study|Withdrawal by Subject|1|||
145914279|NCT02586688|526191119|FG000|Overall Study|Adverse Event|3|||
145914280|NCT02586688|526191120|FG001|Overall Study|Adverse Event|1|||
145914281|NCT03560037|526191121|FG000|Overall Study|Protocol Violation|1|||
145914282|NCT03560037|526191122|FG001|Overall Study|Protocol Violation|0|||
145914283|NCT03560037|526191121|FG000|Overall Study|Physician Decision|0|||
145914284|NCT03560037|526191122|FG001|Overall Study|Physician Decision|1|||
145914285|NCT03620708|526191123|FG000|Overall Study|Lost to Follow-up|1|||
145914286|NCT03620708|526191124|FG001|Overall Study|Lost to Follow-up|1|||
145914287|NCT03620708|526191125|FG002|Overall Study|Lost to Follow-up|2|||
145914288|NCT03620708|526191123|FG000|Overall Study|Withdrawal by Subject|0|||
145914289|NCT03620708|526191124|FG001|Overall Study|Withdrawal by Subject|0|||
145914290|NCT03620708|526191125|FG002|Overall Study|Withdrawal by Subject|1|||
145914291|NCT00266630|526191136|FG000|Overall Study|Adverse Event|8|||
145914292|NCT00266630|526191137|FG001|Overall Study|Adverse Event|6|||
145914293|NCT00266630|526191136|FG000|Overall Study|Lack of Efficacy|1|||
145914294|NCT00266630|526191137|FG001|Overall Study|Lack of Efficacy|4|||
145914295|NCT00266630|526191136|FG000|Overall Study|Entry Criteria not met|1|||
145914296|NCT00266630|526191137|FG001|Overall Study|Entry Criteria not met|0|||
145914297|NCT00266630|526191136|FG000|Overall Study|Protocol Violation|1|||
145914298|NCT00266630|526191137|FG001|Overall Study|Protocol Violation|3|||
145914299|NCT00266630|526191136|FG000|Overall Study|Physician Decision|1|||
145914300|NCT00266630|526191137|FG001|Overall Study|Physician Decision|2|||
146239450|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
146239451|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
145914301|NCT00266630|526191136|FG000|Overall Study|Withdrawal by Subject|10|||
145914302|NCT00266630|526191137|FG001|Overall Study|Withdrawal by Subject|2|||
145914303|NCT00266630|526191136|FG000|Overall Study|Lost to Follow-up|1|||
145914304|NCT00266630|526191137|FG001|Overall Study|Lost to Follow-up|0|||
145914305|NCT00266630|526191136|FG000|Overall Study|Other|19|||
145914306|NCT00266630|526191137|FG001|Overall Study|Other|11|||
145914307|NCT05377749|526191138|FG000|3 Weeks|Lost to Follow-up|2|||
145914308|NCT05377749|526191139|FG001|3 Weeks|Lost to Follow-up|4|||
145914309|NCT05377749|526191138|FG000|3 Weeks|Withdrawal by Subject|1|||
145914310|NCT05377749|526191139|FG001|3 Weeks|Withdrawal by Subject|1|||
145914311|NCT01720225|526191142|FG000|Overall Study|Withdrawal by Subject|0|||
145914312|NCT01720225|526191143|FG001|Overall Study|Withdrawal by Subject|1|||
145914313|NCT01720225|526191142|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
145973570|NCT03765073|526416399|FG007|Stage 3|Lost to Follow-up|0|||
146239452|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
145914314|NCT01720225|526191143|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
145914315|NCT00661193|526191147|FG000|Overall Study|Adverse Event|2|||
145914316|NCT00661193|526191148|FG001|Overall Study|Adverse Event|1|||
145914317|NCT00661193|526191147|FG000|Overall Study|Withdrawal by Subject|3|||
145914318|NCT00661193|526191148|FG001|Overall Study|Withdrawal by Subject|1|||
145914319|NCT00661193|526191147|FG000|Overall Study|Progression|27|||
145914320|NCT00661193|526191148|FG001|Overall Study|Progression|24|||
145914321|NCT00661193|526191147|FG000|Overall Study|Not protocol specified|1|||
145914322|NCT00661193|526191148|FG001|Overall Study|Not protocol specified|0|||
145914323|NCT03280264|526191149|FG000|Overall Study|Adverse Event|1|||
145914324|NCT03280264|526191149|FG000|Overall Study|Physician Decision|1|||
145914325|NCT03280264|526191149|FG000|Overall Study|Withdrawal by Subject|1|||
145914326|NCT00524420|526191151|FG000|Overall Study|Lack of Efficacy|1|||
145914327|NCT00524420|526191152|FG001|Overall Study|Lack of Efficacy|0|||
145914328|NCT02096744|526191154|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
145914329|NCT02096744|526191155|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
145914330|NCT02096744|526191154|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
145914331|NCT02096744|526191155|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
145914332|NCT02096744|526191154|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
145914333|NCT02096744|526191155|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
145914334|NCT02445963|526191158|FG000|Overall Study|Lost to Follow-up|1|||
145914335|NCT02445963|526191159|FG001|Overall Study|Lost to Follow-up|0|||
145914336|NCT02445963|526191160|FG002|Overall Study|Lost to Follow-up|0|||
145914337|NCT02445963|526191161|FG003|Overall Study|Lost to Follow-up|0|||
145914338|NCT02445963|526191158|FG000|Overall Study|Change in employment|1|||
145914339|NCT02445963|526191159|FG001|Overall Study|Change in employment|0|||
145914340|NCT02445963|526191160|FG002|Overall Study|Change in employment|0|||
145914341|NCT02445963|526191161|FG003|Overall Study|Change in employment|0|||
145914342|NCT02445963|526191158|FG000|Overall Study|Symptoms post-vaccination|0|||
145914343|NCT02445963|526191159|FG001|Overall Study|Symptoms post-vaccination|0|||
145914344|NCT02445963|526191160|FG002|Overall Study|Symptoms post-vaccination|1|||
145914345|NCT02445963|526191161|FG003|Overall Study|Symptoms post-vaccination|0|||
145914346|NCT02517463|526191165|FG000|Overall Study|Lost to Follow-up|5|||
145914347|NCT02517463|526191166|FG001|Overall Study|Lost to Follow-up|2|||
145914348|NCT03449446|526191167|FG000|Overall Study|Randomized but Never Treated|0|||
145914349|NCT03449446|526191168|FG001|Overall Study|Randomized but Never Treated|0|||
145914350|NCT03449446|526191169|FG002|Overall Study|Randomized but Never Treated|1|||
145914351|NCT03449446|526191170|FG003|Overall Study|Randomized but Never Treated|1|||
145914352|NCT03449446|526191171|FG004|Overall Study|Randomized but Never Treated|1|||
145914353|NCT03449446|526191172|FG005|Overall Study|Randomized but Never Treated|0|||
145914354|NCT03449446|526191173|FG006|Overall Study|Randomized but Never Treated|0|||
145914355|NCT03449446|526191167|FG000|Overall Study|Unknown Reason|33|||
145914356|NCT03449446|526191168|FG001|Overall Study|Unknown Reason|1|||
145914357|NCT03449446|526191169|FG002|Overall Study|Unknown Reason|1|||
145914358|NCT03449446|526191170|FG003|Overall Study|Unknown Reason|1|||
145914359|NCT03449446|526191171|FG004|Overall Study|Unknown Reason|2|||
145914360|NCT03449446|526191172|FG005|Overall Study|Unknown Reason|2|||
145914361|NCT03449446|526191173|FG006|Overall Study|Unknown Reason|0|||
145914362|NCT03449446|526191167|FG000|Overall Study|Withdrew Consent|1|||
145914363|NCT03449446|526191168|FG001|Overall Study|Withdrew Consent|3|||
145914364|NCT03449446|526191169|FG002|Overall Study|Withdrew Consent|1|||
145914365|NCT03449446|526191170|FG003|Overall Study|Withdrew Consent|4|||
145914366|NCT03449446|526191171|FG004|Overall Study|Withdrew Consent|4|||
145914367|NCT03449446|526191172|FG005|Overall Study|Withdrew Consent|4|||
145914368|NCT03449446|526191173|FG006|Overall Study|Withdrew Consent|1|||
145914369|NCT03449446|526191167|FG000|Overall Study|Adverse Event|1|||
145914370|NCT03449446|526191168|FG001|Overall Study|Adverse Event|2|||
145914371|NCT03449446|526191169|FG002|Overall Study|Adverse Event|1|||
145914372|NCT03449446|526191170|FG003|Overall Study|Adverse Event|0|||
145914373|NCT03449446|526191171|FG004|Overall Study|Adverse Event|0|||
145914374|NCT03449446|526191172|FG005|Overall Study|Adverse Event|2|||
146239453|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
146297483|NCT00821431|527604710|FG000|Overall Study|Physician Decision|0|||
145914375|NCT03449446|526191173|FG006|Overall Study|Adverse Event|0|||
145914376|NCT03449446|526191167|FG000|Overall Study|Lost to Follow-up|0|||
145914377|NCT03449446|526191168|FG001|Overall Study|Lost to Follow-up|0|||
145914378|NCT03449446|526191169|FG002|Overall Study|Lost to Follow-up|2|||
145914379|NCT03449446|526191170|FG003|Overall Study|Lost to Follow-up|1|||
145914380|NCT03449446|526191171|FG004|Overall Study|Lost to Follow-up|3|||
145914381|NCT03449446|526191172|FG005|Overall Study|Lost to Follow-up|0|||
145914382|NCT03449446|526191173|FG006|Overall Study|Lost to Follow-up|0|||
145914383|NCT03449446|526191167|FG000|Overall Study|Investigator's Discretion|0|||
145914384|NCT03449446|526191168|FG001|Overall Study|Investigator's Discretion|1|||
145914385|NCT03449446|526191169|FG002|Overall Study|Investigator's Discretion|1|||
145914386|NCT03449446|526191170|FG003|Overall Study|Investigator's Discretion|2|||
145914387|NCT03449446|526191171|FG004|Overall Study|Investigator's Discretion|0|||
145914388|NCT03449446|526191172|FG005|Overall Study|Investigator's Discretion|0|||
145914389|NCT03449446|526191173|FG006|Overall Study|Investigator's Discretion|0|||
145914390|NCT03449446|526191167|FG000|Overall Study|Non Compliance with Study Drug|1|||
145914391|NCT03449446|526191168|FG001|Overall Study|Non Compliance with Study Drug|0|||
145914392|NCT03449446|526191169|FG002|Overall Study|Non Compliance with Study Drug|0|||
145914393|NCT03449446|526191170|FG003|Overall Study|Non Compliance with Study Drug|0|||
145914394|NCT03449446|526191171|FG004|Overall Study|Non Compliance with Study Drug|0|||
145914395|NCT03449446|526191172|FG005|Overall Study|Non Compliance with Study Drug|0|||
145914396|NCT03449446|526191173|FG006|Overall Study|Non Compliance with Study Drug|0|||
145914397|NCT03449446|526191167|FG000|Overall Study|Protocol Violation|0|||
145914398|NCT03449446|526191168|FG001|Overall Study|Protocol Violation|0|||
145914399|NCT03449446|526191169|FG002|Overall Study|Protocol Violation|0|||
145914400|NCT03449446|526191170|FG003|Overall Study|Protocol Violation|0|||
145914401|NCT03449446|526191171|FG004|Overall Study|Protocol Violation|1|||
145914402|NCT03449446|526191172|FG005|Overall Study|Protocol Violation|1|||
145914403|NCT03449446|526191173|FG006|Overall Study|Protocol Violation|0|||
145914404|NCT03449446|526191167|FG000|Overall Study|Death|0|||
145914405|NCT03449446|526191168|FG001|Overall Study|Death|0|||
145914406|NCT03449446|526191169|FG002|Overall Study|Death|0|||
145914407|NCT03449446|526191170|FG003|Overall Study|Death|0|||
145914408|NCT03449446|526191171|FG004|Overall Study|Death|1|||
145914409|NCT03449446|526191172|FG005|Overall Study|Death|0|||
145914410|NCT03449446|526191173|FG006|Overall Study|Death|0|||
145914411|NCT04208750|526191180|FG000|Overall Study|Lost to Follow-up|16|||
145914412|NCT04208750|526191181|FG001|Overall Study|Lost to Follow-up|15|||
145914413|NCT02201277|526191182|FG000|Overall Study|Death|3|||
146089015|NCT00393042|526845130|FG000|Second Intervetion|Lost to Follow-up|0|||
146089016|NCT00393042|526845131|FG001|Second Intervetion|Lost to Follow-up|2|||
146089017|NCT00393042|526845130|FG000|Second Intervetion|Protocol Violation|1|||
146089018|NCT00393042|526845131|FG001|Second Intervetion|Protocol Violation|1|||
146089019|NCT03324581|526845137|FG000|Overall Study|Adverse Event|18|||
146089020|NCT03324581|526845138|FG001|Overall Study|Adverse Event|11|||
146089021|NCT03324581|526845139|FG002|Overall Study|Adverse Event|7|||
146089022|NCT03324581|526845137|FG000|Overall Study|Lack of Efficacy|0|||
146089023|NCT03324581|526845138|FG001|Overall Study|Lack of Efficacy|1|||
146089024|NCT03324581|526845139|FG002|Overall Study|Lack of Efficacy|0|||
146089025|NCT03324581|526845137|FG000|Overall Study|Lost to Follow-up|5|||
146089026|NCT03324581|526845138|FG001|Overall Study|Lost to Follow-up|3|||
146089027|NCT03324581|526845139|FG002|Overall Study|Lost to Follow-up|6|||
146089028|NCT03324581|526845137|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
146089029|NCT03324581|526845138|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
146089030|NCT03324581|526845139|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
146089031|NCT03324581|526845137|FG000|Overall Study|Physician Decision|0|||
146089032|NCT03324581|526845138|FG001|Overall Study|Physician Decision|1|||
146089033|NCT03324581|526845139|FG002|Overall Study|Physician Decision|2|||
146089034|NCT03324581|526845137|FG000|Overall Study|Protocol Deviation|8|||
146089035|NCT03324581|526845138|FG001|Overall Study|Protocol Deviation|9|||
146239454|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
146239455|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146239456|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146297484|NCT00821431|527604711|FG001|Overall Study|Physician Decision|1|||
145914414|NCT02201277|526191183|FG001|Overall Study|Death|4|||
145914415|NCT02201277|526191182|FG000|Overall Study|Lost to Follow-up|2|||
145914416|NCT02201277|526191183|FG001|Overall Study|Lost to Follow-up|1|||
145914417|NCT02201277|526191182|FG000|Overall Study|Failed retrieval|1|||
145914418|NCT02201277|526191183|FG001|Overall Study|Failed retrieval|0|||
145914419|NCT02201277|526191182|FG000|Overall Study|Physician Decision|1|||
145914420|NCT02201277|526191183|FG001|Overall Study|Physician Decision|0|||
145914421|NCT05022212|526191186|FG000|Overall Study|Lost to Follow-up|0|||
145914422|NCT05022212|526191187|FG001|Overall Study|Lost to Follow-up|2|||
145914423|NCT02729909|526191188|FG000|Overall Study|Lost to Follow-up|0|||
145914424|NCT02729909|526191189|FG001|Overall Study|Lost to Follow-up|1|||
145914425|NCT02729909|526191188|FG000|Overall Study|Lack of Efficacy|0|||
145914426|NCT02729909|526191189|FG001|Overall Study|Lack of Efficacy|2|||
145914427|NCT02729909|526191188|FG000|Overall Study|Significant Protocol Deviation|0|||
145914428|NCT02729909|526191189|FG001|Overall Study|Significant Protocol Deviation|2|||
145914429|NCT02729909|526191188|FG000|Overall Study|Voluntary Withdrawal|1|||
146089036|NCT03324581|526845139|FG002|Overall Study|Protocol Deviation|4|||
146089037|NCT03324581|526845137|FG000|Overall Study|Withdrawal by Subject|6|||
146089038|NCT03324581|526845138|FG001|Overall Study|Withdrawal by Subject|8|||
146089039|NCT03324581|526845139|FG002|Overall Study|Withdrawal by Subject|6|||
146089040|NCT03324581|526845137|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
146089041|NCT03324581|526845138|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
146089042|NCT03324581|526845139|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
146089043|NCT00321893|526845141|FG000|Overall Study|Non-Compliance/Refusal|16|||
146089044|NCT00321893|526845142|FG001|Overall Study|Non-Compliance/Refusal|10|||
146089045|NCT00321893|526845141|FG000|Overall Study|Lost to Follow-up|2|||
146239457|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146239458|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
146239459|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
146239460|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146239461|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146239462|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
146239463|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
146239464|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
146239465|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
146239466|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
146239467|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
146239468|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
146239469|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
145914430|NCT02729909|526191189|FG001|Overall Study|Voluntary Withdrawal|0|||
145914431|NCT00866359|526191191|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
145914432|NCT00866359|526191192|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
145914433|NCT00866359|526191193|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
145914434|NCT00866359|526191194|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
145914435|NCT00866359|526191191|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
145914436|NCT00866359|526191192|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145914437|NCT00866359|526191193|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145914438|NCT00866359|526191194|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145914439|NCT00866359|526191191|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
145914440|NCT00866359|526191192|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145914441|NCT00866359|526191193|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145914442|NCT00866359|526191194|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145914443|NCT00866359|526191191|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
145914444|NCT00866359|526191192|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
145914445|NCT00866359|526191193|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
145914446|NCT00866359|526191194|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
145914447|NCT00866359|526191191|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
145914448|NCT00866359|526191192|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
145914449|NCT00866359|526191193|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
145914450|NCT00866359|526191194|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
145914451|NCT00866359|526191191|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
145914452|NCT00866359|526191192|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
145914453|NCT00866359|526191193|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
145914454|NCT00866359|526191194|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
145914455|NCT01625091|526191195|FG000|Intervention|Death|1|||
145914456|NCT01625091|526191196|FG001|Intervention|Death|1|||
145914457|NCT01625091|526191195|FG000|Intervention|Withdrawal by Subject|4|||
145914458|NCT01625091|526191196|FG001|Intervention|Withdrawal by Subject|1|||
145914459|NCT01625091|526191195|FG000|Intervention|Adverse Event|0|||
145914460|NCT01625091|526191196|FG001|Intervention|Adverse Event|2|||
145914461|NCT01625091|526191195|FG000|Intervention|Lost to Follow-up|4|||
145914462|NCT01625091|526191196|FG001|Intervention|Lost to Follow-up|4|||
145914463|NCT01625091|526191195|FG000|Intervention|Study termination|2|||
145914464|NCT01625091|526191196|FG001|Intervention|Study termination|3|||
145914465|NCT01625091|526191195|FG000|Post-intervention|Death|0|||
145914466|NCT01625091|526191196|FG001|Post-intervention|Death|1|||
145914467|NCT01625091|526191195|FG000|Post-intervention|Lost to Follow-up|2|||
145914468|NCT01625091|526191196|FG001|Post-intervention|Lost to Follow-up|0|||
145914469|NCT01625091|526191195|FG000|Post-intervention|Study termination|2|||
145914470|NCT01625091|526191196|FG001|Post-intervention|Study termination|1|||
145914471|NCT02163057|526191197|FG000|Overall Study|Participant Refusal to Continue|2|||
145914472|NCT02163057|526191198|FG001|Overall Study|Participant Refusal to Continue|2|||
146239470|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
146239471|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
146239472|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
146239473|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
146239474|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
146239475|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
146239476|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
146239477|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
146239478|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
145914473|NCT02163057|526191197|FG000|Overall Study|Participant Significant Noncompliance|0|||
145914474|NCT02163057|526191198|FG001|Overall Study|Participant Significant Noncompliance|1|||
145914475|NCT02163057|526191197|FG000|Overall Study|Progression of Disease|1|||
145914476|NCT02163057|526191198|FG001|Overall Study|Progression of Disease|2|||
145973571|NCT03765073|526416400|FG008|Stage 3|Lost to Follow-up|0|||
145914477|NCT00768248|526191202|FG000|Overall Study|Research coordinator didn't collect data|1|||
145914478|NCT00768248|526191203|FG001|Overall Study|Research coordinator didn't collect data|1|||
145914479|NCT01547390|526191207|FG000|Overall Study|Withdrawal by Subject|10|||
145914480|NCT01547390|526191208|FG001|Overall Study|Withdrawal by Subject|7|||
145973572|NCT03765073|526416401|FG009|Stage 3|Lost to Follow-up|0|||
145973573|NCT03765073|526416402|FG010|Stage 3|Lost to Follow-up|0|||
145973574|NCT03765073|526416403|FG011|Stage 3|Lost to Follow-up|0|||
145973575|NCT03765073|526416404|FG012|Stage 3|Lost to Follow-up|0|||
145973576|NCT03765073|526416405|FG013|Stage 3|Lost to Follow-up|0|||
145973577|NCT03765073|526416406|FG014|Stage 3|Lost to Follow-up|0|||
145973578|NCT03765073|526416407|FG015|Stage 3|Lost to Follow-up|0|||
145973579|NCT03765073|526416408|FG016|Stage 3|Lost to Follow-up|0|||
145973580|NCT03765073|526416409|FG017|Stage 3|Lost to Follow-up|8|||
145973581|NCT03765073|526416410|FG018|Stage 3|Lost to Follow-up|5|||
145973582|NCT03765073|526416411|FG019|Stage 3|Lost to Follow-up|7|||
145973583|NCT03765073|526416412|FG020|Stage 3|Lost to Follow-up|4|||
145973584|NCT03765073|526416392|FG000|Stage 3|No longer meets eligibility criteria|0|||
145973585|NCT03765073|526416393|FG001|Stage 3|No longer meets eligibility criteria|0|||
145973586|NCT03765073|526416394|FG002|Stage 3|No longer meets eligibility criteria|0|||
145973587|NCT03765073|526416395|FG003|Stage 3|No longer meets eligibility criteria|0|||
145973588|NCT03765073|526416396|FG004|Stage 3|No longer meets eligibility criteria|0|||
145973589|NCT03765073|526416397|FG005|Stage 3|No longer meets eligibility criteria|0|||
145973590|NCT03765073|526416398|FG006|Stage 3|No longer meets eligibility criteria|0|||
145973591|NCT03765073|526416399|FG007|Stage 3|No longer meets eligibility criteria|0|||
145973592|NCT03765073|526416400|FG008|Stage 3|No longer meets eligibility criteria|0|||
145973593|NCT03765073|526416401|FG009|Stage 3|No longer meets eligibility criteria|0|||
145973594|NCT03765073|526416402|FG010|Stage 3|No longer meets eligibility criteria|0|||
145973595|NCT03765073|526416403|FG011|Stage 3|No longer meets eligibility criteria|0|||
145973596|NCT03765073|526416404|FG012|Stage 3|No longer meets eligibility criteria|0|||
145973597|NCT03765073|526416405|FG013|Stage 3|No longer meets eligibility criteria|0|||
145973598|NCT03765073|526416406|FG014|Stage 3|No longer meets eligibility criteria|0|||
145973599|NCT03765073|526416407|FG015|Stage 3|No longer meets eligibility criteria|0|||
145973600|NCT03765073|526416408|FG016|Stage 3|No longer meets eligibility criteria|0|||
145973601|NCT03765073|526416409|FG017|Stage 3|No longer meets eligibility criteria|0|||
145973602|NCT03765073|526416410|FG018|Stage 3|No longer meets eligibility criteria|1|||
145973603|NCT03765073|526416411|FG019|Stage 3|No longer meets eligibility criteria|0|||
145973604|NCT03765073|526416412|FG020|Stage 3|No longer meets eligibility criteria|1|||
145973605|NCT03765073|526416392|FG000|Stage 3|Other|0|||
145973606|NCT03765073|526416393|FG001|Stage 3|Other|0|||
145973607|NCT03765073|526416394|FG002|Stage 3|Other|0|||
145973608|NCT03765073|526416395|FG003|Stage 3|Other|0|||
145973609|NCT03765073|526416396|FG004|Stage 3|Other|0|||
145973610|NCT03765073|526416397|FG005|Stage 3|Other|0|||
145973611|NCT03765073|526416398|FG006|Stage 3|Other|0|||
146089046|NCT00321893|526845142|FG001|Overall Study|Lost to Follow-up|1|||
146089047|NCT00321893|526845141|FG000|Overall Study|Adverse Event|6|||
146089048|NCT00321893|526845142|FG001|Overall Study|Adverse Event|3|||
146089049|NCT03455764|526845143|FG000|Overall Study|Adverse Event|1|||
146089050|NCT03455764|526845144|FG001|Overall Study|Adverse Event|0|||
146089051|NCT03455764|526845145|FG002|Overall Study|Adverse Event|0|||
146089052|NCT03455764|526845146|FG003|Overall Study|Adverse Event|0|||
145914481|NCT01547390|526191207|FG000|Overall Study|termination of pregnancy|0|||
145914482|NCT01547390|526191208|FG001|Overall Study|termination of pregnancy|1|||
145914483|NCT01547390|526191207|FG000|Overall Study|Lost to Follow-up|0|||
145914484|NCT01547390|526191208|FG001|Overall Study|Lost to Follow-up|2|||
145914485|NCT01547390|526191207|FG000|Overall Study|Adverse Event|3|||
145914486|NCT01547390|526191208|FG001|Overall Study|Adverse Event|0|||
145914487|NCT01959295|526191211|FG000|Overall Study|Adverse Event|2|||
145914488|NCT01959295|526191212|FG001|Overall Study|Adverse Event|0|||
145914489|NCT01959295|526191211|FG000|Overall Study|Lost to Follow-up|0|||
145914490|NCT01959295|526191212|FG001|Overall Study|Lost to Follow-up|2|||
145914491|NCT01959295|526191211|FG000|Overall Study|Physician Decision|2|||
145914492|NCT01959295|526191212|FG001|Overall Study|Physician Decision|3|||
145914493|NCT01959295|526191211|FG000|Overall Study|Protocol Violation|16|||
145914494|NCT01959295|526191212|FG001|Overall Study|Protocol Violation|5|||
145914495|NCT01959295|526191211|FG000|Overall Study|Withdrawal by Subject|3|||
145914496|NCT01959295|526191212|FG001|Overall Study|Withdrawal by Subject|1|||
145914497|NCT01959295|526191211|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
145914498|NCT01959295|526191212|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
145914499|NCT04917861|526191214|FG000|Main Study (196 Days)|Adverse Event|0|||
145973612|NCT03765073|526416399|FG007|Stage 3|Other|0|||
145973613|NCT03765073|526416400|FG008|Stage 3|Other|0|||
145973614|NCT03765073|526416401|FG009|Stage 3|Other|0|||
145973615|NCT03765073|526416402|FG010|Stage 3|Other|0|||
145973616|NCT03765073|526416403|FG011|Stage 3|Other|0|||
145973617|NCT03765073|526416404|FG012|Stage 3|Other|0|||
145973618|NCT03765073|526416405|FG013|Stage 3|Other|0|||
145973619|NCT03765073|526416406|FG014|Stage 3|Other|0|||
146089053|NCT03455764|526845147|FG004|Overall Study|Adverse Event|0|||
146089054|NCT03455764|526845143|FG000|Overall Study|Disease Progression|4|||
146089055|NCT03455764|526845144|FG001|Overall Study|Disease Progression|0|||
145914500|NCT04917861|526191215|FG001|Main Study (196 Days)|Adverse Event|1|||
145914501|NCT04917861|526191216|FG002|Main Study (196 Days)|Adverse Event|0|||
145914502|NCT04917861|526191217|FG003|Main Study (196 Days)|Adverse Event|0|||
145914503|NCT04917861|526191214|FG000|Main Study (196 Days)|Death|0|||
145914504|NCT04917861|526191215|FG001|Main Study (196 Days)|Death|0|||
145914505|NCT04917861|526191216|FG002|Main Study (196 Days)|Death|0|||
145914506|NCT04917861|526191217|FG003|Main Study (196 Days)|Death|1|||
145914507|NCT04917861|526191214|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
145914508|NCT04917861|526191215|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
145914509|NCT04917861|526191216|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
145914510|NCT04917861|526191217|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
145914511|NCT04917861|526191214|FG000|Main Study (196 Days)|Physician Decision|0|||
145914512|NCT04917861|526191215|FG001|Main Study (196 Days)|Physician Decision|0|||
145914513|NCT04917861|526191216|FG002|Main Study (196 Days)|Physician Decision|0|||
145914514|NCT04917861|526191217|FG003|Main Study (196 Days)|Physician Decision|1|||
145914515|NCT04917861|526191214|FG000|Main Study (196 Days)|Pregnancy|1|||
145914516|NCT04917861|526191215|FG001|Main Study (196 Days)|Pregnancy|1|||
145914517|NCT04917861|526191216|FG002|Main Study (196 Days)|Pregnancy|0|||
145914518|NCT04917861|526191217|FG003|Main Study (196 Days)|Pregnancy|0|||
145914519|NCT04917861|526191214|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
145914520|NCT04917861|526191215|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
145914521|NCT04917861|526191216|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
145914522|NCT04917861|526191217|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
145914523|NCT04917861|526191214|FG000|Main Study (196 Days)|Other Than Specified|1|||
145914524|NCT04917861|526191215|FG001|Main Study (196 Days)|Other Than Specified|0|||
145914525|NCT04917861|526191216|FG002|Main Study (196 Days)|Other Than Specified|1|||
145914526|NCT04917861|526191217|FG003|Main Study (196 Days)|Other Than Specified|2|||
145914527|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
145914528|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
145914529|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
145914530|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
145914531|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145914532|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
145914533|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145914534|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145914535|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145914536|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
145914537|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145914538|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145914539|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
145914540|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
145914541|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
145914542|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
145914543|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145914544|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
145914545|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145914546|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145914547|NCT04917861|526191214|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
145914548|NCT04917861|526191215|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
145914549|NCT04917861|526191216|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
145914550|NCT04917861|526191217|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
145914551|NCT01128179|526191218|FG000|Overall Study|Death|1|||
145914552|NCT01128179|526191219|FG001|Overall Study|Death|0|||
145914553|NCT01128179|526191218|FG000|Overall Study|Protocol Violation|1|||
146297485|NCT01387230|527604712|FG000|Overall Study|Adverse Event|0|||
146297486|NCT01387230|527604713|FG001|Overall Study|Adverse Event|1|||
146297487|NCT01387230|527604714|FG002|Overall Study|Adverse Event|3|||
146297488|NCT01387230|527604712|FG000|Overall Study|Lack of Efficacy|8|||
146297489|NCT01387230|527604713|FG001|Overall Study|Lack of Efficacy|5|||
146297490|NCT01387230|527604714|FG002|Overall Study|Lack of Efficacy|4|||
146297491|NCT01387230|527604712|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
146297492|NCT01387230|527604713|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146297493|NCT01387230|527604714|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
146297494|NCT01387230|527604712|FG000|Overall Study|Lost to Follow-up|0|||
146297495|NCT01387230|527604713|FG001|Overall Study|Lost to Follow-up|0|||
146297496|NCT01387230|527604714|FG002|Overall Study|Lost to Follow-up|1|||
145914554|NCT01128179|526191219|FG001|Overall Study|Protocol Violation|0|||
145914555|NCT02694328|526191220|FG000|Overall Study|Adverse Event|27|||
145914556|NCT02694328|526191221|FG001|Overall Study|Adverse Event|33|||
145914557|NCT02694328|526191220|FG000|Overall Study|Withdrawal by Subject|27|||
145914558|NCT02694328|526191221|FG001|Overall Study|Withdrawal by Subject|23|||
145914559|NCT02694328|526191220|FG000|Overall Study|Lost to Follow-up|26|||
146297497|NCT01387230|527604712|FG000|Overall Study|Withdrawal by Subject|4|||
145914560|NCT02694328|526191221|FG001|Overall Study|Lost to Follow-up|22|||
145914561|NCT02694328|526191220|FG000|Overall Study|Noncompliant with study drug|11|||
145914562|NCT02694328|526191221|FG001|Overall Study|Noncompliant with study drug|8|||
145914563|NCT02694328|526191220|FG000|Overall Study|Incarceration|1|||
145914564|NCT02694328|526191221|FG001|Overall Study|Incarceration|1|||
145914565|NCT02694328|526191220|FG000|Overall Study|Lack of Efficacy|1|||
145914566|NCT02694328|526191221|FG001|Overall Study|Lack of Efficacy|2|||
145914567|NCT02694328|526191220|FG000|Overall Study|Pregnancy|1|||
145914568|NCT02694328|526191221|FG001|Overall Study|Pregnancy|1|||
145914569|NCT02694328|526191220|FG000|Overall Study|Protocol Violation|6|||
145914570|NCT02694328|526191221|FG001|Overall Study|Protocol Violation|5|||
145914571|NCT02694328|526191220|FG000|Overall Study|Abnormal Laboratory Value|0|||
145914572|NCT02694328|526191221|FG001|Overall Study|Abnormal Laboratory Value|3|||
145914573|NCT00720382|526191225|FG000|Overall Study|Adverse Event|54|||
145914574|NCT00720382|526191226|FG001|Overall Study|Adverse Event|17|||
145914575|NCT00720382|526191225|FG000|Overall Study|Lack of Efficacy|18|||
145914576|NCT00720382|526191226|FG001|Overall Study|Lack of Efficacy|7|||
145914577|NCT00720382|526191225|FG000|Overall Study|Non-Compliance|15|||
145914578|NCT00720382|526191226|FG001|Overall Study|Non-Compliance|5|||
145914579|NCT00720382|526191225|FG000|Overall Study|Withdrawal by Subject|47|||
145914580|NCT00720382|526191226|FG001|Overall Study|Withdrawal by Subject|11|||
145914581|NCT00720382|526191225|FG000|Overall Study|Lost to Follow-up|28|||
145914582|NCT00720382|526191226|FG001|Overall Study|Lost to Follow-up|14|||
145914583|NCT00720382|526191225|FG000|Overall Study|administrative|14|||
145914584|NCT00720382|526191226|FG001|Overall Study|administrative|5|||
145914585|NCT05192889|526191227|FG000|Block 1: All Eligible Patients|Death|2|||
145914586|NCT05192889|526191228|FG001|Block 1: All Eligible Patients|Death|0|||
145914587|NCT05192889|526191229|FG002|Block 1: All Eligible Patients|Death|0|||
145914588|NCT05192889|526191227|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
145914589|NCT05192889|526191228|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
145914590|NCT05192889|526191229|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
145914591|NCT05192889|526191227|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
145914592|NCT05192889|526191228|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
145914593|NCT05192889|526191229|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
145914594|NCT05221320|526193820|FG000|Overall Study|Lack of Efficacy|3|||
145914595|NCT05221320|526193821|FG001|Overall Study|Lack of Efficacy|7|||
145914596|NCT05221320|526193822|FG002|Overall Study|Lack of Efficacy|10|||
145914597|NCT05221320|526193823|FG003|Overall Study|Lack of Efficacy|1|||
145914598|NCT05221320|526193824|FG004|Overall Study|Lack of Efficacy|0|||
145914599|NCT05221320|526193825|FG005|Overall Study|Lack of Efficacy|0|||
145914600|NCT05221320|526193820|FG000|Overall Study|Physician Decision|1|||
145914601|NCT05221320|526193821|FG001|Overall Study|Physician Decision|0|||
145914602|NCT05221320|526193822|FG002|Overall Study|Physician Decision|3|||
145914603|NCT05221320|526193823|FG003|Overall Study|Physician Decision|1|||
145914604|NCT05221320|526193824|FG004|Overall Study|Physician Decision|0|||
145914605|NCT05221320|526193825|FG005|Overall Study|Physician Decision|0|||
145914606|NCT05221320|526193820|FG000|Overall Study|Withdrawal by Subject|0|||
145914607|NCT05221320|526193821|FG001|Overall Study|Withdrawal by Subject|3|||
145914608|NCT05221320|526193822|FG002|Overall Study|Withdrawal by Subject|1|||
145914609|NCT05221320|526193823|FG003|Overall Study|Withdrawal by Subject|0|||
145914610|NCT05221320|526193824|FG004|Overall Study|Withdrawal by Subject|0|||
145914611|NCT05221320|526193825|FG005|Overall Study|Withdrawal by Subject|0|||
145914612|NCT05221320|526193820|FG000|Overall Study|Death|0|||
145914613|NCT05221320|526193821|FG001|Overall Study|Death|5|||
145914614|NCT05221320|526193822|FG002|Overall Study|Death|6|||
145914615|NCT05221320|526193823|FG003|Overall Study|Death|0|||
145914616|NCT05221320|526193824|FG004|Overall Study|Death|1|||
145973620|NCT03765073|526416407|FG015|Stage 3|Other|0|||
145973621|NCT03765073|526416408|FG016|Stage 3|Other|0|||
145973622|NCT03765073|526416409|FG017|Stage 3|Other|1|||
145973623|NCT03765073|526416410|FG018|Stage 3|Other|2|||
145973624|NCT03765073|526416411|FG019|Stage 3|Other|2|||
145914617|NCT05221320|526193825|FG005|Overall Study|Death|0|||
145914618|NCT06473519|526193826|FG000|Overall Study|Lost to Follow-up|2|||
145914619|NCT06473519|526193827|FG001|Overall Study|Lost to Follow-up|5|||
145914620|NCT06473519|526193826|FG000|Overall Study|Withdrawal by Subject|1|||
145914621|NCT06473519|526193827|FG001|Overall Study|Withdrawal by Subject|4|||
145914622|NCT06473519|526193826|FG000|Overall Study|Randomized but not vaccinated|1|||
145914623|NCT06473519|526193827|FG001|Overall Study|Randomized but not vaccinated|2|||
145914624|NCT02514447|526193828|FG000|Overall Study|Withdrawal by Subject|3|||
145914625|NCT02514447|526193829|FG001|Overall Study|Withdrawal by Subject|1|||
145914626|NCT02514447|526193830|FG002|Overall Study|Withdrawal by Subject|1|||
145914627|NCT02514447|526193831|FG003|Overall Study|Withdrawal by Subject|0|||
145914628|NCT02514447|526193832|FG004|Overall Study|Withdrawal by Subject|0|||
145914629|NCT02514447|526193833|FG005|Overall Study|Withdrawal by Subject|0|||
145914630|NCT02514447|526193834|FG006|Overall Study|Withdrawal by Subject|0|||
145914631|NCT02514447|526193835|FG007|Overall Study|Withdrawal by Subject|1|||
145973625|NCT03765073|526416412|FG020|Stage 3|Other|2|||
145973626|NCT03765073|526416392|FG000|Stage 3|Withdrawal by parent/guardian|0|||
145914632|NCT02514447|526193836|FG008|Overall Study|Withdrawal by Subject|1|||
145914633|NCT02514447|526193828|FG000|Overall Study|Death|24|||
145914634|NCT02514447|526193829|FG001|Overall Study|Death|28|||
145914635|NCT02514447|526193830|FG002|Overall Study|Death|29|||
145914636|NCT02514447|526193831|FG003|Overall Study|Death|0|||
145914637|NCT02514447|526193832|FG004|Overall Study|Death|3|||
145914638|NCT02514447|526193833|FG005|Overall Study|Death|4|||
145914639|NCT02514447|526193834|FG006|Overall Study|Death|8|||
145914640|NCT02514447|526193835|FG007|Overall Study|Death|6|||
145914641|NCT02514447|526193836|FG008|Overall Study|Death|5|||
145914642|NCT02514447|526193828|FG000|Overall Study|Lost to Follow-up|1|||
145914643|NCT02514447|526193829|FG001|Overall Study|Lost to Follow-up|0|||
145914644|NCT02514447|526193830|FG002|Overall Study|Lost to Follow-up|0|||
145914645|NCT02514447|526193831|FG003|Overall Study|Lost to Follow-up|0|||
145914646|NCT02514447|526193832|FG004|Overall Study|Lost to Follow-up|0|||
145914647|NCT02514447|526193833|FG005|Overall Study|Lost to Follow-up|0|||
145914648|NCT02514447|526193834|FG006|Overall Study|Lost to Follow-up|0|||
145914649|NCT02514447|526193835|FG007|Overall Study|Lost to Follow-up|0|||
145973627|NCT03765073|526416393|FG001|Stage 3|Withdrawal by parent/guardian|0|||
145973628|NCT03765073|526416394|FG002|Stage 3|Withdrawal by parent/guardian|0|||
145973629|NCT03765073|526416395|FG003|Stage 3|Withdrawal by parent/guardian|0|||
145973630|NCT03765073|526416396|FG004|Stage 3|Withdrawal by parent/guardian|0|||
145973631|NCT03765073|526416397|FG005|Stage 3|Withdrawal by parent/guardian|0|||
145973632|NCT03765073|526416398|FG006|Stage 3|Withdrawal by parent/guardian|0|||
145973633|NCT03765073|526416399|FG007|Stage 3|Withdrawal by parent/guardian|0|||
145973634|NCT03765073|526416400|FG008|Stage 3|Withdrawal by parent/guardian|0|||
145973635|NCT03765073|526416401|FG009|Stage 3|Withdrawal by parent/guardian|0|||
145973636|NCT03765073|526416402|FG010|Stage 3|Withdrawal by parent/guardian|0|||
145973637|NCT03765073|526416403|FG011|Stage 3|Withdrawal by parent/guardian|0|||
145973638|NCT03765073|526416404|FG012|Stage 3|Withdrawal by parent/guardian|0|||
145973639|NCT03765073|526416405|FG013|Stage 3|Withdrawal by parent/guardian|0|||
145973640|NCT03765073|526416406|FG014|Stage 3|Withdrawal by parent/guardian|0|||
145973641|NCT03765073|526416407|FG015|Stage 3|Withdrawal by parent/guardian|0|||
145973642|NCT03765073|526416408|FG016|Stage 3|Withdrawal by parent/guardian|0|||
145973643|NCT03765073|526416409|FG017|Stage 3|Withdrawal by parent/guardian|0|||
145973644|NCT03765073|526416410|FG018|Stage 3|Withdrawal by parent/guardian|0|||
145973645|NCT03765073|526416411|FG019|Stage 3|Withdrawal by parent/guardian|6|||
145973646|NCT03765073|526416412|FG020|Stage 3|Withdrawal by parent/guardian|9|||
145973647|NCT03765073|526416392|FG000|Stage 3|Withdrawal by Subject|0|||
145973648|NCT03765073|526416393|FG001|Stage 3|Withdrawal by Subject|0|||
145973649|NCT03765073|526416394|FG002|Stage 3|Withdrawal by Subject|0|||
145973650|NCT03765073|526416395|FG003|Stage 3|Withdrawal by Subject|0|||
145973651|NCT03765073|526416396|FG004|Stage 3|Withdrawal by Subject|0|||
145973652|NCT03765073|526416397|FG005|Stage 3|Withdrawal by Subject|0|||
145973653|NCT03765073|526416398|FG006|Stage 3|Withdrawal by Subject|0|||
145973654|NCT03765073|526416399|FG007|Stage 3|Withdrawal by Subject|0|||
145973655|NCT03765073|526416400|FG008|Stage 3|Withdrawal by Subject|0|||
145973656|NCT03765073|526416401|FG009|Stage 3|Withdrawal by Subject|0|||
145973657|NCT03765073|526416402|FG010|Stage 3|Withdrawal by Subject|0|||
145973658|NCT03765073|526416403|FG011|Stage 3|Withdrawal by Subject|0|||
145973659|NCT03765073|526416404|FG012|Stage 3|Withdrawal by Subject|0|||
145973660|NCT03765073|526416405|FG013|Stage 3|Withdrawal by Subject|0|||
145973661|NCT03765073|526416406|FG014|Stage 3|Withdrawal by Subject|0|||
145973662|NCT03765073|526416407|FG015|Stage 3|Withdrawal by Subject|0|||
145973663|NCT03765073|526416408|FG016|Stage 3|Withdrawal by Subject|0|||
145973664|NCT03765073|526416409|FG017|Stage 3|Withdrawal by Subject|8|||
145973665|NCT03765073|526416410|FG018|Stage 3|Withdrawal by Subject|11|||
146239479|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
146239480|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
146239481|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
145973666|NCT03765073|526416411|FG019|Stage 3|Withdrawal by Subject|0|||
145973667|NCT03765073|526416412|FG020|Stage 3|Withdrawal by Subject|0|||
145973668|NCT03188822|526416419|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
145973669|NCT03188822|526416419|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
145973670|NCT04537299|526416420|FG000|Overall Study|Withdrawal by Subject|2|||
145973671|NCT04537299|526416421|FG001|Overall Study|Withdrawal by Subject|0|||
145973672|NCT04537299|526416420|FG000|Overall Study|Protocol Violation|1|||
145973673|NCT04537299|526416421|FG001|Overall Study|Protocol Violation|1|||
145973674|NCT03034967|526416426|FG000|Overall Study|Withdrawal by Subject|9|||
145914650|NCT02514447|526193836|FG008|Overall Study|Lost to Follow-up|1|||
145914651|NCT02514447|526193828|FG000|Overall Study|Sponsor Termination of Study|0|||
145914652|NCT02514447|526193829|FG001|Overall Study|Sponsor Termination of Study|1|||
145914653|NCT02514447|526193830|FG002|Overall Study|Sponsor Termination of Study|1|||
145914654|NCT02514447|526193831|FG003|Overall Study|Sponsor Termination of Study|0|||
145973675|NCT03034967|526416427|FG001|Overall Study|Withdrawal by Subject|2|||
145973676|NCT03034967|526416428|FG002|Overall Study|Withdrawal by Subject|6|||
145973677|NCT03034967|526416429|FG003|Overall Study|Withdrawal by Subject|6|||
145914655|NCT02514447|526193832|FG004|Overall Study|Sponsor Termination of Study|0|||
145914656|NCT02514447|526193833|FG005|Overall Study|Sponsor Termination of Study|0|||
145914657|NCT02514447|526193834|FG006|Overall Study|Sponsor Termination of Study|0|||
145914658|NCT02514447|526193835|FG007|Overall Study|Sponsor Termination of Study|0|||
145914659|NCT02514447|526193836|FG008|Overall Study|Sponsor Termination of Study|0|||
145914660|NCT02514447|526193828|FG000|Overall Study|Study completion per Investigator|1|||
145914661|NCT02514447|526193829|FG001|Overall Study|Study completion per Investigator|0|||
145914662|NCT02514447|526193830|FG002|Overall Study|Study completion per Investigator|1|||
145914663|NCT02514447|526193831|FG003|Overall Study|Study completion per Investigator|2|||
145914664|NCT02514447|526193832|FG004|Overall Study|Study completion per Investigator|0|||
145914665|NCT02514447|526193833|FG005|Overall Study|Study completion per Investigator|0|||
145914666|NCT02514447|526193834|FG006|Overall Study|Study completion per Investigator|0|||
145914667|NCT02514447|526193835|FG007|Overall Study|Study completion per Investigator|0|||
145914668|NCT02514447|526193836|FG008|Overall Study|Study completion per Investigator|1|||
145914669|NCT03300817|526193838|FG000|Overall Study|Withdrawal by Subject|1|||
145914670|NCT03300817|526193838|FG000|Overall Study|Adverse Event|1|||
145914671|NCT03300817|526193838|FG000|Overall Study|Subject Found to be Ineligible|2|||
145914672|NCT05168202|526193839|FG000|Overall Study|Progressive Disease|4|||
145914673|NCT05168202|526193840|FG001|Overall Study|Progressive Disease|4|||
145914674|NCT05168202|526193841|FG002|Overall Study|Progressive Disease|2|||
145914675|NCT05168202|526193842|FG003|Overall Study|Progressive Disease|3|||
145914676|NCT05168202|526193843|FG004|Overall Study|Progressive Disease|2|||
145914677|NCT05168202|526193844|FG005|Overall Study|Progressive Disease|3|||
145914678|NCT05168202|526193845|FG006|Overall Study|Progressive Disease|2|||
145914679|NCT05168202|526193839|FG000|Overall Study|Adverse Event|2|||
145914680|NCT05168202|526193840|FG001|Overall Study|Adverse Event|1|||
145914681|NCT05168202|526193841|FG002|Overall Study|Adverse Event|4|||
145914682|NCT05168202|526193842|FG003|Overall Study|Adverse Event|4|||
145914683|NCT05168202|526193843|FG004|Overall Study|Adverse Event|3|||
145914684|NCT05168202|526193844|FG005|Overall Study|Adverse Event|2|||
145914685|NCT05168202|526193845|FG006|Overall Study|Adverse Event|0|||
145914686|NCT05168202|526193839|FG000|Overall Study|Lack of Efficacy|0|||
145914687|NCT05168202|526193840|FG001|Overall Study|Lack of Efficacy|1|||
145914688|NCT05168202|526193841|FG002|Overall Study|Lack of Efficacy|1|||
145914689|NCT05168202|526193842|FG003|Overall Study|Lack of Efficacy|0|||
145914690|NCT05168202|526193843|FG004|Overall Study|Lack of Efficacy|1|||
145914691|NCT05168202|526193844|FG005|Overall Study|Lack of Efficacy|2|||
145914692|NCT05168202|526193845|FG006|Overall Study|Lack of Efficacy|2|||
145914693|NCT05168202|526193839|FG000|Overall Study|Withdrawal by Subject|0|||
145914694|NCT05168202|526193840|FG001|Overall Study|Withdrawal by Subject|0|||
145914695|NCT05168202|526193841|FG002|Overall Study|Withdrawal by Subject|1|||
145914696|NCT05168202|526193842|FG003|Overall Study|Withdrawal by Subject|1|||
145914697|NCT05168202|526193843|FG004|Overall Study|Withdrawal by Subject|1|||
145914698|NCT05168202|526193844|FG005|Overall Study|Withdrawal by Subject|1|||
145914699|NCT05168202|526193845|FG006|Overall Study|Withdrawal by Subject|0|||
145914700|NCT05168202|526193839|FG000|Overall Study|Disease Relapse|0|||
145914701|NCT05168202|526193840|FG001|Overall Study|Disease Relapse|1|||
145914702|NCT05168202|526193841|FG002|Overall Study|Disease Relapse|0|||
145914703|NCT05168202|526193842|FG003|Overall Study|Disease Relapse|1|||
145914704|NCT05168202|526193843|FG004|Overall Study|Disease Relapse|1|||
145914705|NCT05168202|526193844|FG005|Overall Study|Disease Relapse|0|||
145914706|NCT05168202|526193845|FG006|Overall Study|Disease Relapse|0|||
145914707|NCT05168202|526193839|FG000|Overall Study|Other Reasons|0|||
145914708|NCT05168202|526193840|FG001|Overall Study|Other Reasons|0|||
145914709|NCT05168202|526193841|FG002|Overall Study|Other Reasons|0|||
145914710|NCT05168202|526193842|FG003|Overall Study|Other Reasons|0|||
145914711|NCT05168202|526193843|FG004|Overall Study|Other Reasons|0|||
145914712|NCT05168202|526193844|FG005|Overall Study|Other Reasons|2|||
145914713|NCT05168202|526193845|FG006|Overall Study|Other Reasons|1|||
145914714|NCT05168202|526193839|FG000|Overall Study|Physician Decision|0|||
145914715|NCT05168202|526193840|FG001|Overall Study|Physician Decision|1|||
145914716|NCT05168202|526193841|FG002|Overall Study|Physician Decision|1|||
145914717|NCT05168202|526193842|FG003|Overall Study|Physician Decision|0|||
145914718|NCT05168202|526193843|FG004|Overall Study|Physician Decision|0|||
145914719|NCT05168202|526193844|FG005|Overall Study|Physician Decision|0|||
145914720|NCT05168202|526193845|FG006|Overall Study|Physician Decision|0|||
145914721|NCT05168202|526193839|FG000|Overall Study|Study Terminated by Sponsor|0|||
145914722|NCT05168202|526193840|FG001|Overall Study|Study Terminated by Sponsor|0|||
145914723|NCT05168202|526193841|FG002|Overall Study|Study Terminated by Sponsor|0|||
145914724|NCT05168202|526193842|FG003|Overall Study|Study Terminated by Sponsor|1|||
145914725|NCT05168202|526193843|FG004|Overall Study|Study Terminated by Sponsor|0|||
145914726|NCT05168202|526193844|FG005|Overall Study|Study Terminated by Sponsor|0|||
145914727|NCT05168202|526193845|FG006|Overall Study|Study Terminated by Sponsor|0|||
145914728|NCT04011722|526193846|FG000|30 Days|Death|5|||
145914729|NCT04011722|526193847|FG001|30 Days|Death|1|||
145914730|NCT04011722|526193846|FG000|1 Year|Death|13|||
145914731|NCT04011722|526193847|FG001|1 Year|Death|5|||
145914732|NCT04011722|526193846|FG000|1 Year|Withdrawal by Subject|8|||
146239482|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
146239483|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146239484|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146239485|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146239486|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
146239487|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146239488|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146239489|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
146239490|NCT03732807|527391339|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239491|NCT03732807|527391340|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239492|NCT03732807|527391341|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239493|NCT03732807|527391342|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239494|NCT03732807|527391343|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239495|NCT03732807|527391344|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
146239496|NCT03732807|527391345|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146239497|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146239498|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146239499|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146239500|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
146239501|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146239502|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
146239503|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
146239504|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
146239505|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
146239506|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
146239507|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
145914733|NCT04011722|526193847|FG001|1 Year|Withdrawal by Subject|2|||
145914734|NCT04011722|526193846|FG000|1 Year|Missed Visit|6|||
145914735|NCT04011722|526193847|FG001|1 Year|Missed Visit|1|||
145914736|NCT04011722|526193846|FG000|1 Year|Pending Visit|0|||
145914737|NCT04011722|526193847|FG001|1 Year|Pending Visit|11|||
146239508|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
146239509|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
146239510|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
146239511|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146239512|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146239513|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
146239514|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
146239515|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
146239516|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
146239517|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
146239518|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146239519|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
146239520|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146239521|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146239522|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146239523|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
146239524|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145914738|NCT04011722|526193846|FG000|1 Year|Not Yet Due|0|||
146239525|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146239526|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146239527|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146239528|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146297498|NCT01387230|527604713|FG001|Overall Study|Withdrawal by Subject|1|||
146297499|NCT01387230|527604714|FG002|Overall Study|Withdrawal by Subject|0|||
146297500|NCT03026127|527604717|FG000|CRISP R61|Adverse Event|5|||
146297501|NCT03026127|527604718|FG001|CRISP R61|Adverse Event|0|||
146297502|NCT03026127|527604719|FG002|CRISP R61|Adverse Event|0|||
146297503|NCT03026127|527604717|FG000|CRISP R61|Lost to Follow-up|2|||
145914739|NCT04011722|526193847|FG001|1 Year|Not Yet Due|9|||
145914740|NCT04011722|526193846|FG000|2 Year|Death|16|||
145914741|NCT04011722|526193847|FG001|2 Year|Death|1|||
145914742|NCT04011722|526193846|FG000|2 Year|Withdrawal by Subject|10|||
145914743|NCT04011722|526193847|FG001|2 Year|Withdrawal by Subject|1|||
145914744|NCT04011722|526193846|FG000|2 Year|Missed Visit|9|||
145914745|NCT04011722|526193847|FG001|2 Year|Missed Visit|0|||
145914746|NCT04011722|526193846|FG000|2 Year|Visit Pending|1|||
145914747|NCT04011722|526193847|FG001|2 Year|Visit Pending|3|||
146297504|NCT03026127|527604718|FG001|CRISP R61|Lost to Follow-up|0|||
145914748|NCT04011722|526193846|FG000|2 Year|Not Yet Due|43|||
145914749|NCT04011722|526193847|FG001|2 Year|Not Yet Due|54|||
145914750|NCT04011722|526193846|FG000|3 Year|Death|10|||
145914751|NCT04011722|526193847|FG001|3 Year|Death|0|||
145914752|NCT04011722|526193846|FG000|3 Year|Withdrawal by Subject|2|||
145914753|NCT04011722|526193847|FG001|3 Year|Withdrawal by Subject|0|||
145914754|NCT04011722|526193846|FG000|3 Year|Missed Visit|2|||
145914755|NCT04011722|526193847|FG001|3 Year|Missed Visit|0|||
145914756|NCT04011722|526193846|FG000|3 Year|Pending Visit|34|||
145914757|NCT04011722|526193847|FG001|3 Year|Pending Visit|0|||
145914758|NCT04011722|526193846|FG000|3 Year|Not Yet Due|99|||
145914759|NCT04011722|526193847|FG001|3 Year|Not Yet Due|0|||
145914760|NCT05061134|526193848|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
145914761|NCT05061134|526193849|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
145914762|NCT05061134|526193850|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
145914763|NCT05061134|526193848|FG000|Overall Study|Subject not treated|0|||
145914764|NCT05061134|526193849|FG001|Overall Study|Subject not treated|0|||
145914765|NCT05061134|526193850|FG002|Overall Study|Subject not treated|2|||
145914766|NCT05061134|526193848|FG000|Overall Study|Other|0|||
145914767|NCT05061134|526193849|FG001|Overall Study|Other|0|||
145914768|NCT05061134|526193850|FG002|Overall Study|Other|9|||
145914769|NCT05061134|526193848|FG000|Overall Study|Withdrawal by Subject|9|||
145914770|NCT05061134|526193849|FG001|Overall Study|Withdrawal by Subject|8|||
145914771|NCT05061134|526193850|FG002|Overall Study|Withdrawal by Subject|5|||
145914772|NCT05061134|526193848|FG000|Overall Study|Study Terminated by Sponsor|22|||
145914773|NCT05061134|526193849|FG001|Overall Study|Study Terminated by Sponsor|14|||
145914774|NCT05061134|526193850|FG002|Overall Study|Study Terminated by Sponsor|7|||
145914775|NCT05061134|526193848|FG000|Overall Study|Progressive Disease|1|||
145914776|NCT05061134|526193849|FG001|Overall Study|Progressive Disease|2|||
145914777|NCT05061134|526193850|FG002|Overall Study|Progressive Disease|0|||
145914778|NCT05061134|526193848|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
145914779|NCT05061134|526193849|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
145914780|NCT05061134|526193850|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
145914781|NCT05061134|526193848|FG000|Overall Study|Lost to Follow-up|1|||
145914782|NCT05061134|526193849|FG001|Overall Study|Lost to Follow-up|0|||
145914783|NCT05061134|526193850|FG002|Overall Study|Lost to Follow-up|0|||
145914784|NCT05061134|526193848|FG000|Overall Study|Physician Decision|1|||
145914785|NCT05061134|526193849|FG001|Overall Study|Physician Decision|1|||
145914786|NCT05061134|526193850|FG002|Overall Study|Physician Decision|0|||
145914787|NCT05061134|526193848|FG000|Overall Study|Disease progression|1|||
145914788|NCT05061134|526193849|FG001|Overall Study|Disease progression|0|||
145914789|NCT05061134|526193850|FG002|Overall Study|Disease progression|0|||
145914790|NCT05061134|526193848|FG000|Overall Study|Death|43|||
145914791|NCT05061134|526193849|FG001|Overall Study|Death|23|||
145914792|NCT05061134|526193850|FG002|Overall Study|Death|14|||
145914793|NCT05061134|526193848|FG000|Overall Study|Database lock|2|||
145914794|NCT05061134|526193849|FG001|Overall Study|Database lock|0|||
145914795|NCT05061134|526193850|FG002|Overall Study|Database lock|0|||
145914796|NCT00001521|526193851|FG000|Overall Study|Withdrawal by Subject|3|||
145914797|NCT00001521|526193852|FG001|Overall Study|Withdrawal by Subject|3|||
145914798|NCT00001521|526193851|FG000|Overall Study|Physician Decision|1|||
145914799|NCT00001521|526193852|FG001|Overall Study|Physician Decision|1|||
145914800|NCT00001521|526193851|FG000|Overall Study|Noncompliant|6|||
145914801|NCT00001521|526193852|FG001|Overall Study|Noncompliant|3|||
145914802|NCT04848480|526193853|FG000|Main Phase (26 Weeks)|Death|1|||
145914803|NCT04848480|526193854|FG001|Main Phase (26 Weeks)|Death|0|||
145914804|NCT04848480|526193853|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
145914805|NCT04848480|526193854|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
145914806|NCT04848480|526193853|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
145914807|NCT04848480|526193854|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
145914808|NCT04848480|526193853|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
145914809|NCT04848480|526193854|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
145914810|NCT04848480|526193853|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
145914811|NCT04848480|526193854|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
145914812|NCT04848480|526193853|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
145914813|NCT04848480|526193854|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
145914814|NCT03176134|526193855|FG000|Overall Study|Lost to Follow-up|0|||
145914815|NCT03176134|526193856|FG001|Overall Study|Lost to Follow-up|2|||
145914816|NCT03176134|526193857|FG002|Overall Study|Lost to Follow-up|0|||
145973678|NCT03034967|526416430|FG004|Overall Study|Withdrawal by Subject|9|||
145973679|NCT03034967|526416431|FG005|Overall Study|Withdrawal by Subject|2|||
145914817|NCT03176134|526193858|FG003|Overall Study|Lost to Follow-up|0|||
145914818|NCT03176134|526193859|FG004|Overall Study|Lost to Follow-up|0|||
145914819|NCT03176134|526193860|FG005|Overall Study|Lost to Follow-up|0|||
145914820|NCT03176134|526193861|FG006|Overall Study|Lost to Follow-up|0|||
145914821|NCT03176134|526193862|FG007|Overall Study|Lost to Follow-up|0|||
145914822|NCT03176134|526193855|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145914823|NCT03176134|526193856|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145973680|NCT03034967|526416426|FG000|Overall Study|Physician Decision|1|||
145914824|NCT03176134|526193857|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145914825|NCT03176134|526193858|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146239529|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
146239530|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
146239531|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
145914826|NCT03176134|526193859|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145914827|NCT03176134|526193860|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145914828|NCT03176134|526193861|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
145914829|NCT03176134|526193862|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
145914830|NCT03410056|526193865|FG000|Overall Study|Decision by Sponsor|0|||
145914831|NCT03410056|526193866|FG001|Overall Study|Decision by Sponsor|0|||
145914832|NCT03410056|526193867|FG002|Overall Study|Decision by Sponsor|3|||
145914833|NCT03410056|526193868|FG003|Overall Study|Decision by Sponsor|0|||
145914834|NCT03410056|526193869|FG004|Overall Study|Decision by Sponsor|0|||
145914835|NCT03410056|526193870|FG005|Overall Study|Decision by Sponsor|0|||
145914836|NCT03410056|526193871|FG006|Overall Study|Decision by Sponsor|0|||
145914837|NCT03410056|526193865|FG000|Overall Study|Withdrawal by Subject|0|||
145914838|NCT03410056|526193866|FG001|Overall Study|Withdrawal by Subject|2|||
145914839|NCT03410056|526193867|FG002|Overall Study|Withdrawal by Subject|5|||
145914840|NCT03410056|526193868|FG003|Overall Study|Withdrawal by Subject|5|||
145914841|NCT03410056|526193869|FG004|Overall Study|Withdrawal by Subject|0|||
145914842|NCT03410056|526193870|FG005|Overall Study|Withdrawal by Subject|0|||
145914843|NCT03410056|526193871|FG006|Overall Study|Withdrawal by Subject|0|||
145914844|NCT01499095|526193876|FG000|Overall Study|Randomized But Not Treated|1|||
145914845|NCT01499095|526193877|FG001|Overall Study|Randomized But Not Treated|1|||
145914846|NCT01499095|526193876|FG000|Overall Study|Adverse Event|12|||
145914847|NCT01499095|526193877|FG001|Overall Study|Adverse Event|7|||
145914848|NCT01499095|526193876|FG000|Overall Study|Lack of Efficacy|2|||
145914849|NCT01499095|526193877|FG001|Overall Study|Lack of Efficacy|1|||
145914850|NCT01499095|526193876|FG000|Overall Study|Protocol Violation|6|||
145914851|NCT01499095|526193877|FG001|Overall Study|Protocol Violation|7|||
145914852|NCT01499095|526193876|FG000|Overall Study|Received Rescue Therapy|32|||
145914853|NCT01499095|526193877|FG001|Overall Study|Received Rescue Therapy|40|||
145914854|NCT01499095|526193876|FG000|Overall Study|Diverse Reasons|22|||
145914855|NCT01499095|526193877|FG001|Overall Study|Diverse Reasons|25|||
145914856|NCT01499095|526193876|FG000|Overall Study|Lost to Follow-up|6|||
145914857|NCT01499095|526193877|FG001|Overall Study|Lost to Follow-up|4|||
145914858|NCT01499095|526193876|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
145914859|NCT01499095|526193877|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
145914860|NCT01499095|526193876|FG000|Overall Study|Hypoglycemia|3|||
145914861|NCT01499095|526193877|FG001|Overall Study|Hypoglycemia|1|||
145914862|NCT01499095|526193876|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
145914863|NCT01499095|526193877|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
145914864|NCT01499095|526193876|FG000|Overall Study|Change in Injection Schedule|2|||
145914865|NCT01499095|526193877|FG001|Overall Study|Change in Injection Schedule|0|||
145914866|NCT01499095|526193876|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145914867|NCT01499095|526193877|FG001|Overall Study|Perceived Lack of Efficacy|1|||
145914868|NCT04358081|526193878|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
145914869|NCT04358081|526193879|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
145914870|NCT04358081|526193880|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
145914871|NCT04358081|526193878|FG000|Treatment Phase of Study|Adverse Event|1|||
145914872|NCT04358081|526193879|FG001|Treatment Phase of Study|Adverse Event|0|||
145914873|NCT04358081|526193880|FG002|Treatment Phase of Study|Adverse Event|1|||
145914874|NCT04358081|526193878|FG000|Treatment Phase of Study|Physician Decision|2|||
145914875|NCT04358081|526193879|FG001|Treatment Phase of Study|Physician Decision|0|||
145914876|NCT04358081|526193880|FG002|Treatment Phase of Study|Physician Decision|1|||
145914877|NCT04358081|526193878|FG000|Treatment Phase of Study|Protocol Violation|1|||
145914878|NCT04358081|526193879|FG001|Treatment Phase of Study|Protocol Violation|0|||
145914879|NCT04358081|526193880|FG002|Treatment Phase of Study|Protocol Violation|0|||
145914880|NCT04358081|526193878|FG000|Study Completion Phase|Death|0|||
145914881|NCT04358081|526193879|FG001|Study Completion Phase|Death|0|||
145914882|NCT04358081|526193880|FG002|Study Completion Phase|Death|1|||
145914883|NCT04358081|526193878|FG000|Study Completion Phase|Lost to Follow-up|1|||
146239532|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
146239533|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
145914884|NCT04358081|526193879|FG001|Study Completion Phase|Lost to Follow-up|0|||
145914885|NCT04358081|526193880|FG002|Study Completion Phase|Lost to Follow-up|1|||
145914886|NCT04909853|526193881|FG000|Part 1|Assigned but not treated|0|||
145914887|NCT04909853|526193882|FG001|Part 1|Assigned but not treated|0|||
145914888|NCT04909853|526193883|FG002|Part 1|Assigned but not treated|1|||
145914889|NCT04909853|526193884|FG003|Part 1|Assigned but not treated|0|||
145914890|NCT04909853|526193881|FG000|Part 2|Adverse Event|0|||
145914891|NCT04909853|526193882|FG001|Part 2|Adverse Event|0|||
145914892|NCT04909853|526193883|FG002|Part 2|Adverse Event|0|||
145914893|NCT04909853|526193884|FG003|Part 2|Adverse Event|1|||
145914894|NCT00077207|526193885|FG000|Overall Study|Adverse Event|5|||
145914895|NCT00077207|526193885|FG000|Overall Study|Lack of Efficacy|12|||
145914896|NCT00077207|526193885|FG000|Overall Study|Physician Decision|6|||
145914897|NCT00077207|526193885|FG000|Overall Study|Withdrawal by Subject|6|||
145914898|NCT00077207|526193885|FG000|Overall Study|Ineligible|1|||
145914899|NCT03288714|526193886|FG000|Overall Study|Lost to Follow-up|2|||
145914900|NCT03288714|526193887|FG001|Overall Study|Lost to Follow-up|1|||
145914901|NCT03288714|526193886|FG000|Overall Study|Non-compliance with study schedule|2|||
145914902|NCT03288714|526193887|FG001|Overall Study|Non-compliance with study schedule|0|||
145914903|NCT03288714|526193886|FG000|Overall Study|Withdrawal by Subject|3|||
145914904|NCT03288714|526193887|FG001|Overall Study|Withdrawal by Subject|1|||
145914905|NCT03288714|526193886|FG000|Overall Study|Clinical Worsening|2|||
145914906|NCT03288714|526193887|FG001|Overall Study|Clinical Worsening|1|||
145914907|NCT03288714|526193886|FG000|Overall Study|Adverse Event|1|||
145914908|NCT03288714|526193887|FG001|Overall Study|Adverse Event|0|||
145914909|NCT04882241|526193888|FG000|Overall Study|Ongoing in study|46|||
145914910|NCT04882241|526193889|FG001|Overall Study|Ongoing in study|48|||
145914911|NCT04882241|526193890|FG002|Overall Study|Ongoing in study|0|||
145914912|NCT04882241|526193891|FG003|Overall Study|Ongoing in study|0|||
145914913|NCT04882241|526193888|FG000|Overall Study|Death|13|||
145914914|NCT04882241|526193889|FG001|Overall Study|Death|13|||
145914915|NCT04882241|526193890|FG002|Overall Study|Death|0|||
145914916|NCT04882241|526193891|FG003|Overall Study|Death|0|||
145914917|NCT05024747|526193901|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
145914918|NCT05024747|526193902|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
145914919|NCT05024747|526193901|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
145914920|NCT05024747|526193902|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
145914921|NCT05024747|526193901|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
145914922|NCT05024747|526193902|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
145914923|NCT04428034|526193903|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
145914924|NCT02556801|526193904|FG000|Overall Study|Lost to Follow-up|1|||
145914925|NCT02556801|526193905|FG001|Overall Study|Lost to Follow-up|0|||
145914926|NCT02556801|526193906|FG002|Overall Study|Lost to Follow-up|2|||
146089056|NCT03455764|526845145|FG002|Overall Study|Disease Progression|0|||
146089057|NCT03455764|526845146|FG003|Overall Study|Disease Progression|0|||
145914927|NCT02556801|526193907|FG003|Overall Study|Lost to Follow-up|0|||
145914928|NCT02556801|526193904|FG000|Overall Study|Withdrawal by Subject|1|||
145914929|NCT02556801|526193905|FG001|Overall Study|Withdrawal by Subject|1|||
145914930|NCT02556801|526193906|FG002|Overall Study|Withdrawal by Subject|1|||
145914931|NCT02556801|526193907|FG003|Overall Study|Withdrawal by Subject|0|||
145914932|NCT02556801|526193904|FG000|Overall Study|Protocol Violation|0|||
145914933|NCT02556801|526193905|FG001|Overall Study|Protocol Violation|3|||
145914934|NCT02556801|526193906|FG002|Overall Study|Protocol Violation|1|||
145914935|NCT02556801|526193907|FG003|Overall Study|Protocol Violation|1|||
145914936|NCT02556801|526193904|FG000|Overall Study|Adverse Event|0|||
145914937|NCT02556801|526193905|FG001|Overall Study|Adverse Event|2|||
145914938|NCT02556801|526193906|FG002|Overall Study|Adverse Event|0|||
145914939|NCT02556801|526193907|FG003|Overall Study|Adverse Event|3|||
145914940|NCT02556801|526193904|FG000|Overall Study|Pregnancy|0|||
145914941|NCT02556801|526193905|FG001|Overall Study|Pregnancy|1|||
145914942|NCT02556801|526193906|FG002|Overall Study|Pregnancy|0|||
145914943|NCT02556801|526193907|FG003|Overall Study|Pregnancy|0|||
145914944|NCT02556801|526193904|FG000|Overall Study|Personal reasons patient|0|||
145914945|NCT02556801|526193905|FG001|Overall Study|Personal reasons patient|0|||
145914946|NCT02556801|526193906|FG002|Overall Study|Personal reasons patient|0|||
145914947|NCT02556801|526193907|FG003|Overall Study|Personal reasons patient|1|||
145914948|NCT01942993|526193908|FG000|Overall Study|Lost to Follow-up|1|||
145914949|NCT01942993|526193908|FG000|Overall Study|Physician Decision|1|||
145914950|NCT01350271|526193909|FG000|Overall Study|Lost to Follow-up|21|||
145914951|NCT01350271|526193910|FG001|Overall Study|Lost to Follow-up|17|||
146089058|NCT03455764|526845147|FG004|Overall Study|Disease Progression|0|||
145914952|NCT01350271|526193911|FG002|Overall Study|Lost to Follow-up|26|||
145914953|NCT02906670|526193915|FG000|Cohort 1, QW|Radiological Progression|1|||
145914954|NCT02906670|526193916|FG001|Cohort 1, QW|Radiological Progression|0|||
145914955|NCT02906670|526193917|FG002|Cohort 1, QW|Radiological Progression|0|||
145914956|NCT02906670|526193918|FG003|Cohort 1, QW|Radiological Progression|0|||
145914957|NCT02906670|526193919|FG004|Cohort 1, QW|Radiological Progression|0|||
145914958|NCT02906670|526193920|FG005|Cohort 1, QW|Radiological Progression|0|||
145914959|NCT02906670|526193921|FG006|Cohort 1, QW|Radiological Progression|0|||
145914960|NCT02906670|526193922|FG007|Cohort 1, QW|Radiological Progression|0|||
145914961|NCT02906670|526193923|FG008|Cohort 1, QW|Radiological Progression|0|||
145914962|NCT02906670|526193924|FG009|Cohort 1, QW|Radiological Progression|0|||
145914963|NCT02906670|526193915|FG000|Cohort 2, QW|Radiological Progression|0|||
145914964|NCT02906670|526193916|FG001|Cohort 2, QW|Radiological Progression|1|||
145914965|NCT02906670|526193917|FG002|Cohort 2, QW|Radiological Progression|0|||
145914966|NCT02906670|526193918|FG003|Cohort 2, QW|Radiological Progression|0|||
146089059|NCT03455764|526845143|FG000|Overall Study|On Treatment|1|||
146089060|NCT03455764|526845144|FG001|Overall Study|On Treatment|0|||
145914967|NCT02906670|526193919|FG004|Cohort 2, QW|Radiological Progression|0|||
145914968|NCT02906670|526193920|FG005|Cohort 2, QW|Radiological Progression|0|||
145914969|NCT02906670|526193921|FG006|Cohort 2, QW|Radiological Progression|0|||
145914970|NCT02906670|526193922|FG007|Cohort 2, QW|Radiological Progression|0|||
145914971|NCT02906670|526193923|FG008|Cohort 2, QW|Radiological Progression|0|||
145914972|NCT02906670|526193924|FG009|Cohort 2, QW|Radiological Progression|0|||
145914973|NCT02906670|526193915|FG000|Cohort 3, QW|Radiological Progression|0|||
145914974|NCT02906670|526193916|FG001|Cohort 3, QW|Radiological Progression|0|||
145914975|NCT02906670|526193917|FG002|Cohort 3, QW|Radiological Progression|2|||
145914976|NCT02906670|526193918|FG003|Cohort 3, QW|Radiological Progression|0|||
145914977|NCT02906670|526193919|FG004|Cohort 3, QW|Radiological Progression|0|||
145914978|NCT02906670|526193920|FG005|Cohort 3, QW|Radiological Progression|0|||
145914979|NCT02906670|526193921|FG006|Cohort 3, QW|Radiological Progression|0|||
145914980|NCT02906670|526193922|FG007|Cohort 3, QW|Radiological Progression|0|||
145914981|NCT02906670|526193923|FG008|Cohort 3, QW|Radiological Progression|0|||
145914982|NCT02906670|526193924|FG009|Cohort 3, QW|Radiological Progression|0|||
145914983|NCT02906670|526193915|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914984|NCT02906670|526193916|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914985|NCT02906670|526193917|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
145914986|NCT02906670|526193918|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914987|NCT02906670|526193919|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914988|NCT02906670|526193920|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914989|NCT02906670|526193921|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914990|NCT02906670|526193922|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914991|NCT02906670|526193923|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914992|NCT02906670|526193924|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
145914993|NCT02906670|526193915|FG000|Cohort 4, Q2W|Radiological Progression|0|||
145914994|NCT02906670|526193916|FG001|Cohort 4, Q2W|Radiological Progression|0|||
145914995|NCT02906670|526193917|FG002|Cohort 4, Q2W|Radiological Progression|0|||
145914996|NCT02906670|526193918|FG003|Cohort 4, Q2W|Radiological Progression|0|||
145914997|NCT02906670|526193919|FG004|Cohort 4, Q2W|Radiological Progression|0|||
145914998|NCT02906670|526193920|FG005|Cohort 4, Q2W|Radiological Progression|1|||
145914999|NCT02906670|526193921|FG006|Cohort 4, Q2W|Radiological Progression|0|||
145915000|NCT02906670|526193922|FG007|Cohort 4, Q2W|Radiological Progression|0|||
145915001|NCT02906670|526193923|FG008|Cohort 4, Q2W|Radiological Progression|0|||
145915002|NCT02906670|526193924|FG009|Cohort 4, Q2W|Radiological Progression|0|||
145915003|NCT02906670|526193915|FG000|Cohort 4, Q2W|Clinical Progression|0|||
145915004|NCT02906670|526193916|FG001|Cohort 4, Q2W|Clinical Progression|0|||
145915005|NCT02906670|526193917|FG002|Cohort 4, Q2W|Clinical Progression|0|||
145915006|NCT02906670|526193918|FG003|Cohort 4, Q2W|Clinical Progression|0|||
145915007|NCT02906670|526193919|FG004|Cohort 4, Q2W|Clinical Progression|0|||
145915008|NCT02906670|526193920|FG005|Cohort 4, Q2W|Clinical Progression|2|||
145915009|NCT02906670|526193921|FG006|Cohort 4, Q2W|Clinical Progression|0|||
145915010|NCT02906670|526193922|FG007|Cohort 4, Q2W|Clinical Progression|0|||
145973681|NCT03034967|526416427|FG001|Overall Study|Physician Decision|0|||
145973682|NCT03034967|526416428|FG002|Overall Study|Physician Decision|1|||
145973683|NCT03034967|526416429|FG003|Overall Study|Physician Decision|1|||
145973684|NCT03034967|526416430|FG004|Overall Study|Physician Decision|1|||
145973685|NCT03034967|526416431|FG005|Overall Study|Physician Decision|0|||
145973686|NCT03034967|526416426|FG000|Overall Study|Lost to Follow-up|0|||
145973687|NCT03034967|526416427|FG001|Overall Study|Lost to Follow-up|0|||
145973688|NCT03034967|526416428|FG002|Overall Study|Lost to Follow-up|0|||
145973689|NCT03034967|526416429|FG003|Overall Study|Lost to Follow-up|1|||
145973690|NCT03034967|526416430|FG004|Overall Study|Lost to Follow-up|0|||
145973691|NCT03034967|526416431|FG005|Overall Study|Lost to Follow-up|2|||
145973692|NCT03034967|526416426|FG000|Overall Study|Liver function test abnormality|0|||
145973693|NCT03034967|526416427|FG001|Overall Study|Liver function test abnormality|0|||
145973694|NCT03034967|526416428|FG002|Overall Study|Liver function test abnormality|1|||
145973695|NCT03034967|526416429|FG003|Overall Study|Liver function test abnormality|0|||
145973696|NCT03034967|526416430|FG004|Overall Study|Liver function test abnormality|0|||
145973697|NCT03034967|526416431|FG005|Overall Study|Liver function test abnormality|0|||
145973698|NCT03034967|526416426|FG000|Overall Study|Protocol Violation|1|||
145973699|NCT03034967|526416427|FG001|Overall Study|Protocol Violation|0|||
145973700|NCT03034967|526416428|FG002|Overall Study|Protocol Violation|0|||
145973701|NCT03034967|526416429|FG003|Overall Study|Protocol Violation|0|||
145973702|NCT03034967|526416430|FG004|Overall Study|Protocol Violation|0|||
145973703|NCT03034967|526416431|FG005|Overall Study|Protocol Violation|2|||
145973704|NCT03034967|526416426|FG000|Overall Study|Lack of Efficacy|0|||
145973705|NCT03034967|526416427|FG001|Overall Study|Lack of Efficacy|1|||
145973706|NCT03034967|526416428|FG002|Overall Study|Lack of Efficacy|2|||
145973707|NCT03034967|526416429|FG003|Overall Study|Lack of Efficacy|1|||
145973708|NCT03034967|526416430|FG004|Overall Study|Lack of Efficacy|1|||
145973709|NCT03034967|526416431|FG005|Overall Study|Lack of Efficacy|0|||
145973710|NCT03034967|526416426|FG000|Overall Study|Adverse Event, non-fatal|3|||
145973711|NCT03034967|526416427|FG001|Overall Study|Adverse Event, non-fatal|1|||
145973712|NCT03034967|526416428|FG002|Overall Study|Adverse Event, non-fatal|2|||
145915011|NCT02906670|526193923|FG008|Cohort 4, Q2W|Clinical Progression|0|||
145915012|NCT02906670|526193924|FG009|Cohort 4, Q2W|Clinical Progression|0|||
145915013|NCT02906670|526193915|FG000|Cohort 5, Q2W|Radiological Progression|0|||
145915014|NCT02906670|526193916|FG001|Cohort 5, Q2W|Radiological Progression|0|||
145915015|NCT02906670|526193917|FG002|Cohort 5, Q2W|Radiological Progression|0|||
145915016|NCT02906670|526193918|FG003|Cohort 5, Q2W|Radiological Progression|0|||
145915017|NCT02906670|526193919|FG004|Cohort 5, Q2W|Radiological Progression|0|||
145915018|NCT02906670|526193920|FG005|Cohort 5, Q2W|Radiological Progression|0|||
145915019|NCT02906670|526193921|FG006|Cohort 5, Q2W|Radiological Progression|4|||
145915020|NCT02906670|526193922|FG007|Cohort 5, Q2W|Radiological Progression|0|||
145915021|NCT02906670|526193923|FG008|Cohort 5, Q2W|Radiological Progression|0|||
145915022|NCT02906670|526193924|FG009|Cohort 5, Q2W|Radiological Progression|0|||
145915023|NCT02906670|526193915|FG000|Cohort 5, Q2W|Clinical Progression|0|||
145915024|NCT02906670|526193916|FG001|Cohort 5, Q2W|Clinical Progression|0|||
145915025|NCT02906670|526193917|FG002|Cohort 5, Q2W|Clinical Progression|0|||
145915026|NCT02906670|526193918|FG003|Cohort 5, Q2W|Clinical Progression|0|||
145915027|NCT02906670|526193919|FG004|Cohort 5, Q2W|Clinical Progression|0|||
145915028|NCT02906670|526193920|FG005|Cohort 5, Q2W|Clinical Progression|0|||
145915029|NCT02906670|526193921|FG006|Cohort 5, Q2W|Clinical Progression|1|||
145915030|NCT02906670|526193922|FG007|Cohort 5, Q2W|Clinical Progression|0|||
145915031|NCT02906670|526193923|FG008|Cohort 5, Q2W|Clinical Progression|0|||
145915032|NCT02906670|526193924|FG009|Cohort 5, Q2W|Clinical Progression|0|||
145915033|NCT02906670|526193915|FG000|Cohort 5, Q2W|Adverse Event|0|||
145915034|NCT02906670|526193916|FG001|Cohort 5, Q2W|Adverse Event|0|||
145915035|NCT02906670|526193917|FG002|Cohort 5, Q2W|Adverse Event|0|||
145915036|NCT02906670|526193918|FG003|Cohort 5, Q2W|Adverse Event|0|||
145915037|NCT02906670|526193919|FG004|Cohort 5, Q2W|Adverse Event|0|||
145915038|NCT02906670|526193920|FG005|Cohort 5, Q2W|Adverse Event|0|||
145915039|NCT02906670|526193921|FG006|Cohort 5, Q2W|Adverse Event|1|||
145915040|NCT02906670|526193922|FG007|Cohort 5, Q2W|Adverse Event|0|||
145973713|NCT03034967|526416429|FG003|Overall Study|Adverse Event, non-fatal|0|||
145973714|NCT03034967|526416430|FG004|Overall Study|Adverse Event, non-fatal|2|||
145973715|NCT03034967|526416431|FG005|Overall Study|Adverse Event, non-fatal|8|||
145973716|NCT03034967|526416426|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
145973717|NCT03034967|526416427|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
145973718|NCT03034967|526416428|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
145973719|NCT03034967|526416429|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
145973720|NCT03034967|526416430|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
145973721|NCT03034967|526416431|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
145973722|NCT03806296|526416432|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
145973723|NCT03806296|526416433|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
145973724|NCT03806296|526416434|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
145973725|NCT03806296|526416432|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
145973726|NCT03806296|526416433|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
145973727|NCT03806296|526416434|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
145973728|NCT03806296|526416432|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
145973729|NCT03806296|526416433|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
145973730|NCT03806296|526416434|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
145973731|NCT00790036|526416448|FG000|Overall Study|Abnormal lab values|3|||
145973732|NCT00790036|526416449|FG001|Overall Study|Abnormal lab values|2|||
145973733|NCT00790036|526416448|FG000|Overall Study|Administrative problems|5|||
145973734|NCT00790036|526416449|FG001|Overall Study|Administrative problems|9|||
145973735|NCT00790036|526416448|FG000|Overall Study|Adverse Event|113|||
145973736|NCT00790036|526416449|FG001|Overall Study|Adverse Event|44|||
145973737|NCT00790036|526416448|FG000|Overall Study|Death|1|||
145973738|NCT00790036|526416449|FG001|Overall Study|Death|0|||
145973739|NCT00790036|526416448|FG000|Overall Study|Disease progression|24|||
145973740|NCT00790036|526416449|FG001|Overall Study|Disease progression|48|||
145973741|NCT00790036|526416448|FG000|Overall Study|Lost to Follow-up|1|||
145973742|NCT00790036|526416449|FG001|Overall Study|Lost to Follow-up|2|||
145973743|NCT00790036|526416448|FG000|Overall Study|Protocol Violation|10|||
145973744|NCT00790036|526416449|FG001|Overall Study|Protocol Violation|2|||
145973745|NCT00790036|526416448|FG000|Overall Study|Withdrawal by Subject|18|||
145973746|NCT00790036|526416449|FG001|Overall Study|Withdrawal by Subject|7|||
145973747|NCT00790036|526416448|FG000|Overall Study|Subject/guardian decision|20|||
145915041|NCT02906670|526193923|FG008|Cohort 5, Q2W|Adverse Event|0|||
145915042|NCT02906670|526193924|FG009|Cohort 5, Q2W|Adverse Event|0|||
145915043|NCT02906670|526193915|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915044|NCT02906670|526193916|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145973748|NCT00790036|526416449|FG001|Overall Study|Subject/guardian decision|7|||
145973749|NCT05845619|526416452|FG000|Overall Study|duplicate enrollment|2|||
145973750|NCT05845619|526416453|FG001|Overall Study|duplicate enrollment|2|||
145973751|NCT05845619|526416454|FG002|Overall Study|duplicate enrollment|1|||
145973752|NCT03636477|526416458|FG000|Overall Study|Adverse Event|0|||
145915045|NCT02906670|526193917|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915046|NCT02906670|526193918|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915047|NCT02906670|526193919|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915048|NCT02906670|526193920|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915049|NCT02906670|526193921|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
145915050|NCT02906670|526193922|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915051|NCT02906670|526193923|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915052|NCT02906670|526193924|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145915053|NCT02906670|526193915|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
145915054|NCT02906670|526193916|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
145915055|NCT02906670|526193917|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
145915056|NCT02906670|526193918|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
145915057|NCT02906670|526193919|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
145915058|NCT02906670|526193920|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
145915059|NCT02906670|526193921|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
145915060|NCT02906670|526193922|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
145915061|NCT02906670|526193923|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
145915062|NCT02906670|526193924|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
145915063|NCT02906670|526193915|FG000|Cohort 5P, Q2W|Adverse Event|0|||
145915064|NCT02906670|526193916|FG001|Cohort 5P, Q2W|Adverse Event|0|||
145915065|NCT02906670|526193917|FG002|Cohort 5P, Q2W|Adverse Event|0|||
145915066|NCT02906670|526193918|FG003|Cohort 5P, Q2W|Adverse Event|0|||
145915067|NCT02906670|526193919|FG004|Cohort 5P, Q2W|Adverse Event|0|||
145915068|NCT02906670|526193920|FG005|Cohort 5P, Q2W|Adverse Event|0|||
145915069|NCT02906670|526193921|FG006|Cohort 5P, Q2W|Adverse Event|0|||
145915070|NCT02906670|526193922|FG007|Cohort 5P, Q2W|Adverse Event|1|||
145915071|NCT02906670|526193923|FG008|Cohort 5P, Q2W|Adverse Event|0|||
145915072|NCT02906670|526193924|FG009|Cohort 5P, Q2W|Adverse Event|0|||
145915073|NCT02906670|526193915|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
145915074|NCT02906670|526193916|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
145915075|NCT02906670|526193917|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
145915076|NCT02906670|526193918|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
145915077|NCT02906670|526193919|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
145915078|NCT02906670|526193920|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
145915079|NCT02906670|526193921|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
145915080|NCT02906670|526193922|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
145915081|NCT02906670|526193923|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
145915082|NCT02906670|526193924|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
145915083|NCT02906670|526193915|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
145915084|NCT02906670|526193916|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
145915085|NCT02906670|526193917|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
145915086|NCT02906670|526193918|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
145915087|NCT02906670|526193919|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
145915088|NCT02906670|526193920|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
145915089|NCT02906670|526193921|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
145915090|NCT02906670|526193922|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
145915091|NCT02906670|526193923|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
145915092|NCT02906670|526193924|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
145915093|NCT02906670|526193915|FG000|Cohort 4P, QW|Radiological Progression|0|||
145915094|NCT02906670|526193916|FG001|Cohort 4P, QW|Radiological Progression|0|||
145915095|NCT02906670|526193917|FG002|Cohort 4P, QW|Radiological Progression|0|||
145915096|NCT02906670|526193918|FG003|Cohort 4P, QW|Radiological Progression|3|||
145915097|NCT02906670|526193919|FG004|Cohort 4P, QW|Radiological Progression|0|||
145915098|NCT02906670|526193920|FG005|Cohort 4P, QW|Radiological Progression|0|||
145915099|NCT02906670|526193921|FG006|Cohort 4P, QW|Radiological Progression|0|||
145915100|NCT02906670|526193922|FG007|Cohort 4P, QW|Radiological Progression|0|||
145915101|NCT02906670|526193923|FG008|Cohort 4P, QW|Radiological Progression|0|||
145915102|NCT02906670|526193924|FG009|Cohort 4P, QW|Radiological Progression|0|||
145915103|NCT02906670|526193915|FG000|Cohort 7P, Q2W|Adverse Event|0|||
145915104|NCT02906670|526193916|FG001|Cohort 7P, Q2W|Adverse Event|0|||
145915105|NCT02906670|526193917|FG002|Cohort 7P, Q2W|Adverse Event|0|||
145915106|NCT02906670|526193918|FG003|Cohort 7P, Q2W|Adverse Event|0|||
145915107|NCT02906670|526193919|FG004|Cohort 7P, Q2W|Adverse Event|0|||
145915108|NCT02906670|526193920|FG005|Cohort 7P, Q2W|Adverse Event|0|||
145915109|NCT02906670|526193921|FG006|Cohort 7P, Q2W|Adverse Event|0|||
145915110|NCT02906670|526193922|FG007|Cohort 7P, Q2W|Adverse Event|0|||
145915111|NCT02906670|526193923|FG008|Cohort 7P, Q2W|Adverse Event|0|||
145915112|NCT02906670|526193924|FG009|Cohort 7P, Q2W|Adverse Event|1|||
145915113|NCT02906670|526193915|FG000|Cohort 7P, Q2W|Physician Decision|0|||
145915114|NCT02906670|526193916|FG001|Cohort 7P, Q2W|Physician Decision|0|||
145915115|NCT02906670|526193917|FG002|Cohort 7P, Q2W|Physician Decision|0|||
145915116|NCT02906670|526193918|FG003|Cohort 7P, Q2W|Physician Decision|0|||
145915117|NCT02906670|526193919|FG004|Cohort 7P, Q2W|Physician Decision|0|||
145915118|NCT02906670|526193920|FG005|Cohort 7P, Q2W|Physician Decision|0|||
145915119|NCT02906670|526193921|FG006|Cohort 7P, Q2W|Physician Decision|0|||
145915120|NCT02906670|526193922|FG007|Cohort 7P, Q2W|Physician Decision|0|||
145915121|NCT02906670|526193923|FG008|Cohort 7P, Q2W|Physician Decision|0|||
145915122|NCT02906670|526193924|FG009|Cohort 7P, Q2W|Physician Decision|1|||
145915123|NCT02906670|526193915|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915124|NCT02906670|526193916|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915125|NCT02906670|526193917|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915126|NCT02906670|526193918|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915127|NCT02906670|526193919|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915128|NCT02906670|526193920|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915129|NCT02906670|526193921|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915130|NCT02906670|526193922|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915131|NCT02906670|526193923|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145915132|NCT02906670|526193924|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
145915133|NCT02906670|526193915|FG000|Cohort 5P, QW|Radiological Progression|0|||
145915134|NCT02906670|526193916|FG001|Cohort 5P, QW|Radiological Progression|0|||
145915135|NCT02906670|526193917|FG002|Cohort 5P, QW|Radiological Progression|0|||
145915136|NCT02906670|526193918|FG003|Cohort 5P, QW|Radiological Progression|0|||
145915137|NCT02906670|526193919|FG004|Cohort 5P, QW|Radiological Progression|3|||
145915138|NCT02906670|526193920|FG005|Cohort 5P, QW|Radiological Progression|0|||
145915139|NCT02906670|526193921|FG006|Cohort 5P, QW|Radiological Progression|0|||
145915140|NCT02906670|526193922|FG007|Cohort 5P, QW|Radiological Progression|0|||
145915141|NCT02906670|526193923|FG008|Cohort 5P, QW|Radiological Progression|0|||
145915142|NCT02906670|526193924|FG009|Cohort 5P, QW|Radiological Progression|0|||
145915143|NCT01349192|526193925|FG000|Overall Study|Protocol Violation|0|||
145915144|NCT01349192|526193926|FG001|Overall Study|Protocol Violation|1|||
145915145|NCT01349192|526193925|FG000|Overall Study|Withdrawal by Subject|0|||
145915146|NCT01349192|526193926|FG001|Overall Study|Withdrawal by Subject|2|||
145915147|NCT01349192|526193925|FG000|Overall Study|Lost to Follow-up|1|||
145915148|NCT01349192|526193926|FG001|Overall Study|Lost to Follow-up|3|||
145915149|NCT01349192|526193925|FG000|Overall Study|Failure to adhere to Protocol|2|||
145915150|NCT01349192|526193926|FG001|Overall Study|Failure to adhere to Protocol|0|||
145915151|NCT01973439|526193927|FG000|Overall Study|Lost samples from one PK Day|2|||
145915152|NCT01973439|526193927|FG000|Overall Study|Vomiting after commencing once daily|1|||
145915153|NCT01973439|526193927|FG000|Overall Study|PK curve incomplete|2|||
145915154|NCT02038010|526193928|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145915155|NCT02038010|526193929|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
145915156|NCT02038010|526193930|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145915157|NCT02038010|526193931|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145915158|NCT02038010|526193928|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
145915159|NCT02038010|526193929|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145915160|NCT02038010|526193930|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145915161|NCT02038010|526193931|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145915162|NCT02038010|526193928|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145915163|NCT02038010|526193929|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
145915164|NCT02038010|526193930|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145915165|NCT02038010|526193931|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145915166|NCT02038010|526193928|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
145915167|NCT02038010|526193929|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
145915168|NCT02038010|526193930|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
145915169|NCT02038010|526193931|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
145915170|NCT02038010|526193928|FG000|Follow Up|Death|4|||
145915171|NCT02038010|526193929|FG001|Follow Up|Death|3|||
145915172|NCT02038010|526193930|FG002|Follow Up|Death|0|||
145915173|NCT02038010|526193931|FG003|Follow Up|Death|0|||
145915174|NCT02038010|526193928|FG000|Follow Up|Other|3|||
145915175|NCT02038010|526193929|FG001|Follow Up|Other|0|||
145973753|NCT03636477|526416459|FG001|Overall Study|Adverse Event|0|||
145973754|NCT03636477|526416460|FG002|Overall Study|Adverse Event|1|||
145973755|NCT05168800|526416461|FG000|Time 1 Survey|Did not start T1 survey|182|||
145973756|NCT05168800|526416462|FG001|Time 1 Survey|Did not start T1 survey|150|||
145973757|NCT05168800|526416463|FG002|Time 1 Survey|Did not start T1 survey|140|||
145915176|NCT02038010|526193930|FG002|Follow Up|Other|0|||
145915177|NCT02038010|526193931|FG003|Follow Up|Other|0|||
145915178|NCT02262325|526193936|FG000|Overall Study|Death|16|||
145915179|NCT02262325|526193936|FG000|Overall Study|Lost to Follow-up|1|||
145915180|NCT02815995|526193937|FG000|Overall Study|Disease Progression|3|||
145915181|NCT02815995|526193938|FG001|Overall Study|Disease Progression|7|||
145915182|NCT02815995|526193939|FG002|Overall Study|Disease Progression|2|||
145915183|NCT02815995|526193940|FG003|Overall Study|Disease Progression|4|||
145915184|NCT02815995|526193941|FG004|Overall Study|Disease Progression|3|||
145973758|NCT05168800|526416461|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
145973759|NCT05168800|526416462|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
145915185|NCT02815995|526193942|FG005|Overall Study|Disease Progression|9|||
145915186|NCT02815995|526193943|FG006|Overall Study|Disease Progression|3|||
145973760|NCT05168800|526416463|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
146089061|NCT03455764|526845145|FG002|Overall Study|On Treatment|0|||
146297505|NCT03026127|527604719|FG002|CRISP R61|Lost to Follow-up|0|||
145915187|NCT02815995|526193944|FG007|Overall Study|Disease Progression|1|||
145915188|NCT02815995|526193937|FG000|Overall Study|Adverse Event|1|||
145915189|NCT02815995|526193938|FG001|Overall Study|Adverse Event|2|||
146297506|NCT03026127|527604717|FG000|CRISP R61|Dropped before therapy|5|||
146297507|NCT03026127|527604718|FG001|CRISP R61|Dropped before therapy|0|||
146297508|NCT03026127|527604719|FG002|CRISP R61|Dropped before therapy|0|||
146297509|NCT03026127|527604717|FG000|CRISP R33|Lost to Follow-up|0|||
146297510|NCT03026127|527604718|FG001|CRISP R33|Lost to Follow-up|5|||
146297511|NCT03026127|527604719|FG002|CRISP R33|Lost to Follow-up|4|||
146297512|NCT03026127|527604717|FG000|CRISP R33|Adverse Event|0|||
146297513|NCT03026127|527604718|FG001|CRISP R33|Adverse Event|9|||
146297514|NCT03026127|527604719|FG002|CRISP R33|Adverse Event|5|||
146297515|NCT03026127|527604717|FG000|CRISP R33|Withdrawal by Subject|0|||
146297516|NCT03026127|527604718|FG001|CRISP R33|Withdrawal by Subject|9|||
146297517|NCT03026127|527604719|FG002|CRISP R33|Withdrawal by Subject|1|||
146297518|NCT03026127|527604717|FG000|CRISP R33|Lack of Efficacy|0|||
145915190|NCT02815995|526193939|FG002|Overall Study|Adverse Event|2|||
145915191|NCT02815995|526193940|FG003|Overall Study|Adverse Event|0|||
145915192|NCT02815995|526193941|FG004|Overall Study|Adverse Event|0|||
145915193|NCT02815995|526193942|FG005|Overall Study|Adverse Event|1|||
145915194|NCT02815995|526193943|FG006|Overall Study|Adverse Event|0|||
145915195|NCT02815995|526193944|FG007|Overall Study|Adverse Event|0|||
145915196|NCT02815995|526193937|FG000|Overall Study|Pregnancy|0|||
145915197|NCT02815995|526193938|FG001|Overall Study|Pregnancy|0|||
145915198|NCT02815995|526193939|FG002|Overall Study|Pregnancy|0|||
145915199|NCT02815995|526193940|FG003|Overall Study|Pregnancy|0|||
145915200|NCT02815995|526193941|FG004|Overall Study|Pregnancy|0|||
145915201|NCT02815995|526193942|FG005|Overall Study|Pregnancy|0|||
145915202|NCT02815995|526193943|FG006|Overall Study|Pregnancy|1|||
145915203|NCT02815995|526193944|FG007|Overall Study|Pregnancy|0|||
145915204|NCT01071915|526193945|FG000|Overall Study|Adverse Event|3|||
145915205|NCT01071915|526193945|FG000|Overall Study|Physician Decision|2|||
145915206|NCT01071915|526193945|FG000|Overall Study|Withdrawal by Subject|2|||
145915207|NCT01071915|526193945|FG000|Overall Study|Miscellaneous Reasons|2|||
145915208|NCT00114140|526193946|FG000|Overall Study|Protocol Violation|7|||
145915209|NCT00104572|526193947|FG000|Overall Study|Withdrawal by Subject|3|||
145973761|NCT05168800|526416461|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
145973762|NCT05168800|526416462|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
145973763|NCT05168800|526416463|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
145973764|NCT05168800|526416461|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
145973765|NCT05168800|526416462|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
145973766|NCT05168800|526416463|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
145973767|NCT05168800|526416461|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
145973768|NCT05168800|526416462|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
145973769|NCT05168800|526416463|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
145973770|NCT05168800|526416461|FG000|Time 1 Survey|Withdrawal by Subject|6|||
146089062|NCT03455764|526845146|FG003|Overall Study|On Treatment|0|||
146089063|NCT03455764|526845147|FG004|Overall Study|On Treatment|0|||
146089064|NCT03523000|526845148|FG000|Overall Study|Withdrawal by Subject|3|||
146239534|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146239535|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146239536|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
146239537|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146239538|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
146239539|NCT03732807|527391339|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
146239540|NCT03732807|527391340|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
146239541|NCT03732807|527391341|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
146239542|NCT03732807|527391342|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
146239543|NCT03732807|527391343|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
146239544|NCT03732807|527391344|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
146297519|NCT03026127|527604718|FG001|CRISP R33|Lack of Efficacy|3|||
146297520|NCT03026127|527604719|FG002|CRISP R33|Lack of Efficacy|2|||
145915210|NCT00104572|526193948|FG001|Overall Study|Withdrawal by Subject|3|||
146089065|NCT03523000|526845149|FG001|Overall Study|Withdrawal by Subject|0|||
146297521|NCT03026127|527604717|FG000|CRISP R33|Physician Decision|0|||
146297522|NCT03026127|527604718|FG001|CRISP R33|Physician Decision|3|||
146297523|NCT03026127|527604719|FG002|CRISP R33|Physician Decision|1|||
146297524|NCT03026127|527604717|FG000|CRISP R33|Transportation|0|||
145915211|NCT00104572|526193949|FG002|Overall Study|Withdrawal by Subject|0|||
145915212|NCT02290405|526193951|FG000|Overall Study|Withdrawal by Subject|1|||
145915213|NCT02290405|526193952|FG001|Overall Study|Withdrawal by Subject|0|||
145915214|NCT02016183|526193953|FG000|Overall Study|Case Report Forms Uncollected|13|||
145915215|NCT02016183|526193953|FG000|Overall Study|Protocol Violation|52|||
145915216|NCT00129545|526193965|FG000|Overall Study|Death|5|||
146089066|NCT03523000|526845148|FG000|Overall Study|Unsuccessful trial|2|||
146239545|NCT03732807|527391345|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
146239546|NCT00599196|527391346|FG000|Overall Study|Lack of Efficacy|22|||
146239547|NCT00599196|527391346|FG000|Overall Study|Adverse Event|93|||
146239548|NCT00599196|527391346|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
146239549|NCT00599196|527391346|FG000|Overall Study|Subject withdrew consent|43|||
146239550|NCT00599196|527391346|FG000|Overall Study|Study ended per sponsor|197|||
146239551|NCT00599196|527391346|FG000|Overall Study|Lost to Follow-up|17|||
146239552|NCT00599196|527391346|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
146239553|NCT00599196|527391346|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
146239554|NCT00599196|527391346|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
146239555|NCT00599196|527391346|FG000|Overall Study|Other: Pt Moved To Australia|1|||
146239556|NCT00599196|527391346|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
146239557|NCT00599196|527391346|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
146239558|NCT03274076|527391348|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
146239559|NCT03274076|527391349|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
146239560|NCT03274076|527391350|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
146239561|NCT03274076|527391351|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
146239562|NCT03274076|527391348|FG000|24 Weeks Open Label|Adverse Event|0|||
146239563|NCT03274076|527391349|FG001|24 Weeks Open Label|Adverse Event|0|||
146239564|NCT03274076|527391350|FG002|24 Weeks Open Label|Adverse Event|2|||
146239565|NCT03274076|527391351|FG003|24 Weeks Open Label|Adverse Event|0|||
145915217|NCT00129545|526193966|FG001|Overall Study|Death|60|||
145915218|NCT00129545|526193967|FG002|Overall Study|Death|44|||
145915219|NCT00129545|526193965|FG000|Overall Study|Withdrawal by Subject|3|||
145915220|NCT00129545|526193966|FG001|Overall Study|Withdrawal by Subject|18|||
145915221|NCT00129545|526193967|FG002|Overall Study|Withdrawal by Subject|44|||
145915222|NCT00129545|526193965|FG000|Overall Study|Lost to Follow-up|2|||
145915223|NCT00129545|526193966|FG001|Overall Study|Lost to Follow-up|22|||
145915224|NCT00129545|526193967|FG002|Overall Study|Lost to Follow-up|13|||
146239566|NCT03274076|527391348|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
146239567|NCT03274076|527391349|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
146239568|NCT03274076|527391350|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
146239569|NCT03274076|527391351|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
146239570|NCT00641537|527391375|FG000|96-week Period|Adverse Event|0|||
146239571|NCT00641537|527391376|FG001|96-week Period|Adverse Event|1|||
146239572|NCT00641537|527391377|FG002|96-week Period|Adverse Event|3|||
146239573|NCT00641537|527391378|FG003|96-week Period|Adverse Event|0|||
146239574|NCT00641537|527391379|FG004|96-week Period|Adverse Event|2|||
146239575|NCT00641537|527391380|FG005|96-week Period|Adverse Event|0|||
146239576|NCT00641537|527391381|FG006|96-week Period|Adverse Event|0|||
146239577|NCT00641537|527391382|FG007|96-week Period|Adverse Event|0|||
146239578|NCT00641537|527391375|FG000|96-week Period|Lost to Follow-up|3|||
146239579|NCT00641537|527391376|FG001|96-week Period|Lost to Follow-up|1|||
146239580|NCT00641537|527391377|FG002|96-week Period|Lost to Follow-up|2|||
146239581|NCT00641537|527391378|FG003|96-week Period|Lost to Follow-up|2|||
146239582|NCT00641537|527391379|FG004|96-week Period|Lost to Follow-up|4|||
145915225|NCT00129545|526193965|FG000|Overall Study|Physician Decision|0|||
145915226|NCT00129545|526193966|FG001|Overall Study|Physician Decision|3|||
145973771|NCT05168800|526416462|FG001|Time 1 Survey|Withdrawal by Subject|3|||
145973772|NCT05168800|526416463|FG002|Time 1 Survey|Withdrawal by Subject|2|||
145973773|NCT05168800|526416461|FG000|Time 2 Survey|Already excluded at Time 1|228|||
145973774|NCT05168800|526416462|FG001|Time 2 Survey|Already excluded at Time 1|202|||
145973775|NCT05168800|526416463|FG002|Time 2 Survey|Already excluded at Time 1|173|||
145973776|NCT05168800|526416461|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
145973777|NCT05168800|526416462|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
145973778|NCT05168800|526416463|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
145973779|NCT05168800|526416461|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
145973780|NCT05168800|526416462|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
145973781|NCT05168800|526416463|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
145973782|NCT05168800|526416461|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
145973783|NCT05168800|526416462|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
145973784|NCT05168800|526416463|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
145973785|NCT05168800|526416461|FG000|Time 2 Survey|Withdrawal by Subject|1|||
145973786|NCT05168800|526416462|FG001|Time 2 Survey|Withdrawal by Subject|0|||
145973787|NCT05168800|526416463|FG002|Time 2 Survey|Withdrawal by Subject|1|||
146239583|NCT00641537|527391380|FG005|96-week Period|Lost to Follow-up|0|||
146239584|NCT00641537|527391381|FG006|96-week Period|Lost to Follow-up|1|||
146239585|NCT00641537|527391382|FG007|96-week Period|Lost to Follow-up|0|||
145973788|NCT05168800|526416461|FG000|Time 3 Survey|Already excluded at Time 1|228|||
145915227|NCT00129545|526193967|FG002|Overall Study|Physician Decision|10|||
145915228|NCT00129545|526193965|FG000|Overall Study|Device not implanted|16|||
145973789|NCT05168800|526416462|FG001|Time 3 Survey|Already excluded at Time 1|200|||
146239586|NCT00641537|527391375|FG000|96-week Period|Protocol Violation|0|||
146239587|NCT00641537|527391376|FG001|96-week Period|Protocol Violation|1|||
146239588|NCT00641537|527391377|FG002|96-week Period|Protocol Violation|0|||
146239589|NCT00641537|527391378|FG003|96-week Period|Protocol Violation|1|||
145915229|NCT00129545|526193966|FG001|Overall Study|Device not implanted|61|||
145915230|NCT00129545|526193967|FG002|Overall Study|Device not implanted|0|||
145915231|NCT00770328|526193968|FG000|Overall Study|Adverse Event|11|||
145915232|NCT00770328|526193969|FG001|Overall Study|Adverse Event|2|||
145915233|NCT00770328|526193968|FG000|Overall Study|Lost to Follow-up|2|||
145915234|NCT00770328|526193969|FG001|Overall Study|Lost to Follow-up|2|||
145915235|NCT03541317|526193971|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
145915236|NCT03541317|526193972|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145915237|NCT03541317|526193973|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145915238|NCT03541317|526193974|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145915239|NCT03541317|526193975|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145915240|NCT03541317|526193976|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145915241|NCT02536846|526193981|FG000|Overall Study|Withdrawal by Subject|1|||
145915242|NCT03164616|526193982|FG000|Overall Study|Death|250|||
145915243|NCT03164616|526193983|FG001|Overall Study|Death|264|||
145915244|NCT03164616|526193984|FG002|Overall Study|Death|279|||
145915245|NCT03164616|526193982|FG000|Overall Study|Lost to Follow-up|2|||
145915246|NCT03164616|526193983|FG001|Overall Study|Lost to Follow-up|2|||
145915247|NCT03164616|526193984|FG002|Overall Study|Lost to Follow-up|2|||
145915248|NCT03164616|526193982|FG000|Overall Study|Withdrawal by Subject|6|||
145915249|NCT03164616|526193983|FG001|Overall Study|Withdrawal by Subject|7|||
145915250|NCT03164616|526193984|FG002|Overall Study|Withdrawal by Subject|16|||
145915251|NCT04604795|526193985|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
145915252|NCT04604795|526193986|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
145915253|NCT04604795|526193987|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915254|NCT04604795|526193988|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915255|NCT04604795|526193989|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915256|NCT04604795|526193990|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915257|NCT04604795|526193991|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915258|NCT04604795|526193992|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915259|NCT04604795|526193993|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915260|NCT04604795|526193994|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145915261|NCT04604795|526193985|FG000|Part B: Up to Day 14|Adverse Event|0|||
145915262|NCT04604795|526193986|FG001|Part B: Up to Day 14|Adverse Event|0|||
146239590|NCT00641537|527391379|FG004|96-week Period|Protocol Violation|0|||
146239591|NCT00641537|527391380|FG005|96-week Period|Protocol Violation|1|||
146239592|NCT00641537|527391381|FG006|96-week Period|Protocol Violation|0|||
146239593|NCT00641537|527391382|FG007|96-week Period|Protocol Violation|0|||
146239594|NCT00641537|527391375|FG000|96-week Period|Death|2|||
146239595|NCT00641537|527391376|FG001|96-week Period|Death|0|||
146239596|NCT00641537|527391377|FG002|96-week Period|Death|1|||
146239597|NCT00641537|527391378|FG003|96-week Period|Death|0|||
146239598|NCT00641537|527391379|FG004|96-week Period|Death|0|||
146239599|NCT00641537|527391380|FG005|96-week Period|Death|0|||
146239600|NCT00641537|527391381|FG006|96-week Period|Death|0|||
146239601|NCT00641537|527391382|FG007|96-week Period|Death|0|||
146239602|NCT00641537|527391375|FG000|96-week Period|Other|4|||
146239603|NCT00641537|527391376|FG001|96-week Period|Other|7|||
146239604|NCT00641537|527391377|FG002|96-week Period|Other|14|||
146239605|NCT00641537|527391378|FG003|96-week Period|Other|9|||
146239606|NCT00641537|527391379|FG004|96-week Period|Other|11|||
146239607|NCT00641537|527391380|FG005|96-week Period|Other|6|||
146239608|NCT00641537|527391381|FG006|96-week Period|Other|4|||
146239609|NCT00641537|527391382|FG007|96-week Period|Other|6|||
146239610|NCT00641537|527391375|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146239611|NCT00641537|527391376|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146239612|NCT00641537|527391377|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146239613|NCT00641537|527391378|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
146239614|NCT00641537|527391379|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
146239615|NCT00641537|527391380|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
146239616|NCT00641537|527391381|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146297525|NCT03026127|527604718|FG001|CRISP R33|Transportation|2|||
145915263|NCT04604795|526193987|FG002|Part B: Up to Day 14|Adverse Event|0|||
145915264|NCT04604795|526193988|FG003|Part B: Up to Day 14|Adverse Event|0|||
146239617|NCT00641537|527391382|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
146239618|NCT00641537|527391375|FG000|24-Week Supplemental Follow-up Period|Other|0|||
146239619|NCT00641537|527391376|FG001|24-Week Supplemental Follow-up Period|Other|2|||
146297526|NCT03026127|527604719|FG002|CRISP R33|Transportation|1|||
145915265|NCT04604795|526193989|FG004|Part B: Up to Day 14|Adverse Event|2|||
145915266|NCT04604795|526193990|FG005|Part B: Up to Day 14|Adverse Event|1|||
146239620|NCT00641537|527391377|FG002|24-Week Supplemental Follow-up Period|Other|2|||
146239621|NCT00641537|527391378|FG003|24-Week Supplemental Follow-up Period|Other|1|||
146239622|NCT00641537|527391379|FG004|24-Week Supplemental Follow-up Period|Other|3|||
146239623|NCT00641537|527391380|FG005|24-Week Supplemental Follow-up Period|Other|0|||
146239624|NCT00641537|527391381|FG006|24-Week Supplemental Follow-up Period|Other|1|||
145915267|NCT04604795|526193991|FG006|Part B: Up to Day 14|Adverse Event|0|||
146239625|NCT00641537|527391382|FG007|24-Week Supplemental Follow-up Period|Other|1|||
146239626|NCT01801007|527391383|FG000|Overall Study|Adverse Event|2|||
146239627|NCT01801007|527391383|FG000|Overall Study|Lost to Follow-up|4|||
146239628|NCT01801007|527391383|FG000|Overall Study|Withdrawal by Subject|5|||
146239629|NCT00665392|527391384|FG000|Overall Study|not treated|1|||
146239630|NCT02426138|527391385|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146239631|NCT02426138|527391386|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146239632|NCT00553332|527391392|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
146239633|NCT03924869|527391405|FG000|Overall Study|Death|66|||
146239634|NCT03924869|527391406|FG001|Overall Study|Death|53|||
146239635|NCT03924869|527391405|FG000|Overall Study|Lost to Follow-up|2|||
146239636|NCT03924869|527391406|FG001|Overall Study|Lost to Follow-up|0|||
146239637|NCT03924869|527391405|FG000|Overall Study|Physician Decision|0|||
146239638|NCT03924869|527391406|FG001|Overall Study|Physician Decision|3|||
146239639|NCT03924869|527391405|FG000|Overall Study|Withdrawal by Subject|5|||
146239640|NCT03924869|527391406|FG001|Overall Study|Withdrawal by Subject|1|||
146239641|NCT03924869|527391405|FG000|Overall Study|Participants Ongoing|154|||
146239642|NCT03924869|527391406|FG001|Overall Study|Participants Ongoing|164|||
146239643|NCT04762277|527391409|FG000|Overall Study|Withdrawal by Subject|0|||
146239644|NCT04762277|527391410|FG001|Overall Study|Withdrawal by Subject|2|||
146239645|NCT04762277|527391409|FG000|Overall Study|Protocol Violation|0|||
146239646|NCT04762277|527391410|FG001|Overall Study|Protocol Violation|1|||
146239647|NCT04762277|527391409|FG000|Overall Study|Adverse Event|1|||
146239648|NCT04762277|527391410|FG001|Overall Study|Adverse Event|0|||
146239649|NCT05824559|527391411|FG000|Overall Study|Adverse Event|2|||
146239650|NCT05824559|527391411|FG000|Overall Study|Physician Decision|2|||
146239651|NCT05824559|527391411|FG000|Overall Study|Progressive Disease|16|||
146239652|NCT05824559|527391411|FG000|Overall Study|Study Terminated by Sponsor|1|||
146239653|NCT05824559|527391411|FG000|Overall Study|Withdrawal by Subject|2|||
146239654|NCT05366751|527391412|FG000|Overall Study|Adverse Event|25|||
146239655|NCT05366751|527391412|FG000|Overall Study|Physician Decision|3|||
146239656|NCT05366751|527391412|FG000|Overall Study|Lost to Follow-up|2|||
146239657|NCT05366751|527391412|FG000|Overall Study|Withdrawal by Subject|14|||
146239658|NCT05366751|527391412|FG000|Overall Study|Study Terminated by Sponsor|50|||
146239659|NCT05366751|527391412|FG000|Overall Study|Site Terminated by Sponsor|3|||
146239660|NCT01690624|527391415|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
146239661|NCT01690624|527391416|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
146297527|NCT01182766|527604723|FG000|Overall Study|Lost to Follow-up|32|||
145915268|NCT04604795|526193992|FG007|Part B: Up to Day 14|Adverse Event|0|||
145915269|NCT04604795|526193993|FG008|Part B: Up to Day 14|Adverse Event|0|||
145915270|NCT04604795|526193994|FG009|Part B: Up to Day 14|Adverse Event|0|||
145915271|NCT04604795|526193985|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915272|NCT04604795|526193986|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915273|NCT04604795|526193987|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915274|NCT04604795|526193988|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915275|NCT04604795|526193989|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915276|NCT04604795|526193990|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915277|NCT04604795|526193991|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915278|NCT04604795|526193992|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915279|NCT04604795|526193993|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145915280|NCT04604795|526193994|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
145915281|NCT04604795|526193985|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915282|NCT04604795|526193986|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915283|NCT04604795|526193987|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915284|NCT04604795|526193988|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915285|NCT04604795|526193989|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915286|NCT04604795|526193990|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915287|NCT04604795|526193991|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915288|NCT04604795|526193992|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915289|NCT04604795|526193993|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
145915290|NCT04604795|526193994|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145915291|NCT04604795|526193985|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915292|NCT04604795|526193986|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915293|NCT04604795|526193987|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
146089067|NCT03523000|526845149|FG001|Overall Study|Unsuccessful trial|0|||
146239662|NCT01690624|527391417|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
146239663|NCT01690624|527391418|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
146239664|NCT01690624|527391415|FG000|Overall Study|Adverse event (other than DLT)|3|||
146239665|NCT01690624|527391416|FG001|Overall Study|Adverse event (other than DLT)|1|||
146239666|NCT01690624|527391417|FG002|Overall Study|Adverse event (other than DLT)|1|||
145973790|NCT05168800|526416463|FG002|Time 3 Survey|Already excluded at Time 1|173|||
145973791|NCT05168800|526416461|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
145973792|NCT05168800|526416462|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
145973793|NCT05168800|526416463|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
145973794|NCT05168800|526416461|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
145973795|NCT05168800|526416462|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
145973796|NCT05168800|526416463|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
145973797|NCT05168800|526416461|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
145973798|NCT05168800|526416462|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
145973799|NCT05168800|526416463|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
145973800|NCT05352399|526416471|FG000|Overall Study|Discontinued intervention|6|||
145973801|NCT02340949|526416472|FG000|Overall Study|Adverse Event|4|||
145973802|NCT02340949|526416473|FG001|Overall Study|Adverse Event|2|||
145973803|NCT02340949|526416472|FG000|Overall Study|Withdrawal by Subject|2|||
145973804|NCT02340949|526416473|FG001|Overall Study|Withdrawal by Subject|0|||
145973805|NCT02340949|526416472|FG000|Overall Study|Progression disease|6|||
145973806|NCT02340949|526416473|FG001|Overall Study|Progression disease|2|||
145973807|NCT02340949|526416472|FG000|Overall Study|Death|3|||
145973808|NCT02340949|526416473|FG001|Overall Study|Death|0|||
145973809|NCT02340949|526416472|FG000|Overall Study|Physician Decision|1|||
145973810|NCT02340949|526416473|FG001|Overall Study|Physician Decision|0|||
145973811|NCT00296517|526416474|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
145973812|NCT00296517|526416475|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
145973813|NCT00296517|526416474|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
145973814|NCT00296517|526416475|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
145973815|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
145973816|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
145973817|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
145973818|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
145973819|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
145973820|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
145973821|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
145973822|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
146239667|NCT01690624|527391418|FG003|Overall Study|Adverse event (other than DLT)|1|||
146239668|NCT01690624|527391415|FG000|Overall Study|Withdrawal by Subject|0|||
146239669|NCT01690624|527391416|FG001|Overall Study|Withdrawal by Subject|0|||
146239670|NCT01690624|527391417|FG002|Overall Study|Withdrawal by Subject|1|||
146239671|NCT01690624|527391418|FG003|Overall Study|Withdrawal by Subject|0|||
146239672|NCT01690624|527391415|FG000|Overall Study|Sponsor is ending trial|0|||
146239673|NCT01690624|527391416|FG001|Overall Study|Sponsor is ending trial|0|||
146239674|NCT01690624|527391417|FG002|Overall Study|Sponsor is ending trial|0|||
146239675|NCT01690624|527391418|FG003|Overall Study|Sponsor is ending trial|1|||
146239676|NCT01690624|527391415|FG000|Overall Study|Physician Decision|0|||
146239677|NCT01690624|527391416|FG001|Overall Study|Physician Decision|0|||
146239678|NCT01690624|527391417|FG002|Overall Study|Physician Decision|0|||
146239679|NCT01690624|527391418|FG003|Overall Study|Physician Decision|1|||
146239680|NCT01690624|527391415|FG000|Overall Study|Withdrawal by Subject|0|||
146239681|NCT01690624|527391416|FG001|Overall Study|Withdrawal by Subject|1|||
146239682|NCT01690624|527391417|FG002|Overall Study|Withdrawal by Subject|0|||
146239683|NCT01690624|527391418|FG003|Overall Study|Withdrawal by Subject|0|||
146239684|NCT01690624|527391415|FG000|Overall Study|Lack of Efficacy|1|||
146239685|NCT01690624|527391416|FG001|Overall Study|Lack of Efficacy|1|||
146239686|NCT01690624|527391417|FG002|Overall Study|Lack of Efficacy|3|||
146239687|NCT01690624|527391418|FG003|Overall Study|Lack of Efficacy|0|||
146239688|NCT04912856|527391422|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
146239689|NCT04912856|527391423|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
146239690|NCT04912856|527391422|FG000|Overall Study|Not reported in synoptic CSR.|0|||
146239691|NCT04912856|527391423|FG001|Overall Study|Not reported in synoptic CSR.|1|||
146239692|NCT00647387|527391426|FG000|Overall Study|Lost to Follow-up|6|||
146239693|NCT00647387|527391426|FG000|Overall Study|Unsuccessful implant|5|||
146239694|NCT00647387|527391426|FG000|Overall Study|Device explanted|3|||
146239695|NCT00647387|527391426|FG000|Overall Study|Other Reason|3|||
146239696|NCT00647387|527391426|FG000|Overall Study|Death|2|||
146239697|NCT03678688|527393037|FG000|Overall Study|Reason not Specified|0|||
146239698|NCT03678688|527393038|FG001|Overall Study|Reason not Specified|0|||
146239699|NCT03678688|527393039|FG002|Overall Study|Reason not Specified|3|||
146239700|NCT03678688|527393040|FG003|Overall Study|Reason not Specified|0|||
145973823|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
145973824|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
145973825|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
145973826|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
146239701|NCT03678688|527393041|FG004|Overall Study|Reason not Specified|1|||
146239702|NCT03678688|527393042|FG005|Overall Study|Reason not Specified|0|||
146239703|NCT03678688|527393043|FG006|Overall Study|Reason not Specified|0|||
145973827|NCT00296517|526416474|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
146239704|NCT03678688|527393044|FG007|Overall Study|Reason not Specified|0|||
146239705|NCT03678688|527393045|FG008|Overall Study|Reason not Specified|0|||
146239706|NCT03678688|527393037|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
146239707|NCT03678688|527393038|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
146239708|NCT03678688|527393039|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
146239709|NCT03678688|527393040|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
146239710|NCT03678688|527393041|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
146239711|NCT03678688|527393042|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
146239712|NCT03678688|527393043|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
146239713|NCT03678688|527393044|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
146239714|NCT03678688|527393045|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
146239715|NCT03678688|527393037|FG000|Overall Study|Covid Related Adverse Event|0|||
146239716|NCT03678688|527393038|FG001|Overall Study|Covid Related Adverse Event|0|||
146239717|NCT03678688|527393039|FG002|Overall Study|Covid Related Adverse Event|0|||
146239718|NCT03678688|527393040|FG003|Overall Study|Covid Related Adverse Event|0|||
146239719|NCT03678688|527393041|FG004|Overall Study|Covid Related Adverse Event|0|||
146239720|NCT03678688|527393042|FG005|Overall Study|Covid Related Adverse Event|3|||
146239721|NCT03678688|527393043|FG006|Overall Study|Covid Related Adverse Event|1|||
146239722|NCT03678688|527393044|FG007|Overall Study|Covid Related Adverse Event|1|||
146239723|NCT03678688|527393045|FG008|Overall Study|Covid Related Adverse Event|0|||
146239724|NCT03678688|527393037|FG000|Overall Study|Physician Decision|0|||
146239725|NCT03678688|527393038|FG001|Overall Study|Physician Decision|0|||
146239726|NCT03678688|527393039|FG002|Overall Study|Physician Decision|0|||
146239727|NCT03678688|527393040|FG003|Overall Study|Physician Decision|0|||
146239728|NCT03678688|527393041|FG004|Overall Study|Physician Decision|0|||
146239729|NCT03678688|527393042|FG005|Overall Study|Physician Decision|1|||
146239730|NCT03678688|527393043|FG006|Overall Study|Physician Decision|0|||
146239731|NCT03678688|527393044|FG007|Overall Study|Physician Decision|0|||
146239732|NCT03678688|527393045|FG008|Overall Study|Physician Decision|0|||
146239733|NCT03678688|527393037|FG000|Overall Study|Withdrawal by Subject|0|||
146239734|NCT03678688|527393038|FG001|Overall Study|Withdrawal by Subject|0|||
146239735|NCT03678688|527393039|FG002|Overall Study|Withdrawal by Subject|0|||
146239736|NCT03678688|527393040|FG003|Overall Study|Withdrawal by Subject|0|||
146239737|NCT03678688|527393041|FG004|Overall Study|Withdrawal by Subject|0|||
146239738|NCT03678688|527393042|FG005|Overall Study|Withdrawal by Subject|0|||
146239739|NCT03678688|527393043|FG006|Overall Study|Withdrawal by Subject|2|||
146297528|NCT01182766|527604724|FG001|Overall Study|Lost to Follow-up|36|||
146297529|NCT01182766|527604725|FG002|Overall Study|Lost to Follow-up|29|||
145973828|NCT00296517|526416475|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
145973829|NCT00964782|526416476|FG000|Overall Study|Lost to Follow-up|1|||
145973830|NCT00964782|526416477|FG001|Overall Study|Lost to Follow-up|0|||
145973831|NCT01143324|526416483|FG000|Overall Study|Lost to Follow-up|11|||
145973832|NCT01143324|526416483|FG000|Overall Study|Withdrawal by Subject|4|||
145973833|NCT01143324|526416483|FG000|Overall Study|Explant of the device|4|||
145973834|NCT02774889|526416488|FG000|Overall Study|Lost to Follow-up|2|||
145973835|NCT02774889|526416489|FG001|Overall Study|Lost to Follow-up|1|||
145973836|NCT03479905|526416509|FG000|Overall Study|Other airway method used|4|||
145973837|NCT03479905|526416510|FG001|Overall Study|Other airway method used|5|||
145973838|NCT03479905|526416511|FG002|Overall Study|Other airway method used|5|||
145973839|NCT00862992|526416512|FG000|Overall Study|Adverse Event|2|||
145973840|NCT00862992|526416513|FG001|Overall Study|Adverse Event|1|||
145973841|NCT00862992|526416514|FG002|Overall Study|Adverse Event|1|||
145973842|NCT00862992|526416512|FG000|Overall Study|Physician Decision|1|||
145973843|NCT00862992|526416513|FG001|Overall Study|Physician Decision|0|||
145973844|NCT00862992|526416514|FG002|Overall Study|Physician Decision|0|||
145973845|NCT00862992|526416512|FG000|Overall Study|Withdrawal by Subject|0|||
145973846|NCT00862992|526416513|FG001|Overall Study|Withdrawal by Subject|0|||
145973847|NCT00862992|526416514|FG002|Overall Study|Withdrawal by Subject|2|||
145973848|NCT02318940|526416515|FG000|Overall Study|lost the record|1|||
145973849|NCT02318940|526416516|FG001|Overall Study|lost the record|0|||
145973850|NCT04584788|526416527|FG000|Overall Study|Physician Decision|8|||
145973851|NCT04584788|526416527|FG000|Overall Study|Withdrawal by Subject|1|||
145973852|NCT04584788|526416527|FG000|Overall Study|Adverse Event|3|||
145973853|NCT04817410|526418663|FG000|Overall Study|Withdrawal by Subject|5|||
145973854|NCT04817410|526418663|FG000|Overall Study|Physician Decision|3|||
145973855|NCT01431976|526418664|FG000|Overall Study|Adverse Event|6|||
145973856|NCT01431976|526418664|FG000|Overall Study|Lack of Efficacy|2|||
146089068|NCT00495131|526845150|FG000|Overall Study|Adverse Event|6|||
146239740|NCT03678688|527393044|FG007|Overall Study|Withdrawal by Subject|1|||
146239741|NCT03678688|527393045|FG008|Overall Study|Withdrawal by Subject|0|||
146239742|NCT01583166|527393048|FG000|Overall Study|Withdrawal by Subject|4|||
146239743|NCT01583166|527393049|FG001|Overall Study|Withdrawal by Subject|6|||
146239744|NCT02000752|527393052|FG000|Overall Study|Dystocic delivery|19|||
146239745|NCT02000752|527393053|FG001|Overall Study|Dystocic delivery|8|||
146239746|NCT02000752|527393052|FG000|Overall Study|Shift Changes|12|||
146239747|NCT02000752|527393053|FG001|Overall Study|Shift Changes|5|||
146297530|NCT01182766|527604723|FG000|Overall Study|Withdrawal by Subject|14|||
145915294|NCT04604795|526193988|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915295|NCT04604795|526193989|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915296|NCT04604795|526193990|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915297|NCT04604795|526193991|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915298|NCT04604795|526193992|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915299|NCT04604795|526193993|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
145915300|NCT04604795|526193994|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145915301|NCT04604795|526193985|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915302|NCT04604795|526193986|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915303|NCT04604795|526193987|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915304|NCT04604795|526193988|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915305|NCT04604795|526193989|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915306|NCT04604795|526193990|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915307|NCT04604795|526193991|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915308|NCT04604795|526193992|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
145973857|NCT01431976|526418664|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
145973858|NCT01431976|526418664|FG000|Overall Study|Physician Decision|1|||
145973859|NCT01431976|526418664|FG000|Overall Study|Withdrawal by Subject|1|||
145973860|NCT00460798|526418666|FG000|Overall Study|Death|59|||
145973861|NCT00460798|526418666|FG000|Overall Study|Adverse Event|27|||
145973862|NCT00460798|526418666|FG000|Overall Study|Lost to Follow-up|19|||
145973863|NCT00460798|526418666|FG000|Overall Study|Progressive Disease|99|||
145973864|NCT00460798|526418666|FG000|Overall Study|Other|27|||
145973865|NCT00460798|526418666|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
145973866|NCT00460798|526418666|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
145973867|NCT04666298|526418674|FG000|Overall Study|Subject decision|1|||
145973868|NCT04666298|526418675|FG001|Overall Study|Subject decision|0|||
145973869|NCT04666298|526418676|FG002|Overall Study|Subject decision|0|||
145973870|NCT04666298|526418677|FG003|Overall Study|Subject decision|2|||
145973871|NCT04666298|526418674|FG000|Overall Study|Death|1|||
145973872|NCT04666298|526418675|FG001|Overall Study|Death|0|||
145973873|NCT04666298|526418676|FG002|Overall Study|Death|0|||
145973874|NCT04666298|526418677|FG003|Overall Study|Death|0|||
145973875|NCT04666298|526418674|FG000|Overall Study|Lost to Follow-up|0|||
145973876|NCT04666298|526418675|FG001|Overall Study|Lost to Follow-up|0|||
145973877|NCT04666298|526418676|FG002|Overall Study|Lost to Follow-up|0|||
145973878|NCT04666298|526418677|FG003|Overall Study|Lost to Follow-up|1|||
145973879|NCT04666298|526418674|FG000|Overall Study|Physician Decision|0|||
145973880|NCT04666298|526418675|FG001|Overall Study|Physician Decision|0|||
145973881|NCT04666298|526418676|FG002|Overall Study|Physician Decision|0|||
146239748|NCT01079806|527393056|FG000|Day 1 to Week 96|Adverse Event|0|||
146239749|NCT01079806|527393057|FG001|Day 1 to Week 96|Adverse Event|3|||
146239750|NCT01079806|527393056|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
145973882|NCT04666298|526418677|FG003|Overall Study|Physician Decision|1|||
146239751|NCT01079806|527393057|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
146239752|NCT01079806|527393056|FG000|Day 1 to Week 96|Pregnancy|0|||
146239753|NCT01079806|527393057|FG001|Day 1 to Week 96|Pregnancy|1|||
146239754|NCT01079806|527393056|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
146239755|NCT01079806|527393057|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
146239756|NCT01079806|527393056|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
146239757|NCT01079806|527393057|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
146239758|NCT01079806|527393056|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
146239759|NCT01079806|527393057|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
146239760|NCT01079806|527393056|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
146239761|NCT01079806|527393057|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
146239762|NCT01079806|527393056|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
146239763|NCT01079806|527393057|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
146239764|NCT01079806|527393056|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
146239765|NCT01079806|527393057|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
146239766|NCT01079806|527393056|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
146239767|NCT01079806|527393057|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
146239768|NCT00047385|527393061|FG000|Overall Study|Death before any screening|2|||
146239769|NCT00047385|527393062|FG001|Overall Study|Death before any screening|5|||
146239770|NCT00047385|527393061|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
146239771|NCT00047385|527393062|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
146239772|NCT00047385|527393061|FG000|Overall Study|Eligible for screening but had no screen|260|||
145915309|NCT04604795|526193993|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
145973883|NCT04666298|526418674|FG000|Overall Study|Protocol deviation|0|||
145973884|NCT04666298|526418675|FG001|Overall Study|Protocol deviation|0|||
146239773|NCT00047385|527393062|FG001|Overall Study|Eligible for screening but had no screen|492|||
146239774|NCT03865732|527393063|FG000|Overall Study|Adverse Event|0|||
145973885|NCT04666298|526418676|FG002|Overall Study|Protocol deviation|1|||
145973886|NCT04666298|526418677|FG003|Overall Study|Protocol deviation|0|||
145915310|NCT04604795|526193994|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
145915311|NCT04502212|526194000|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
145915312|NCT04502212|526194000|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
145915313|NCT00111241|526194001|FG000|Overall Study|Lost to Follow-up|1|||
145915314|NCT00111241|526194002|FG001|Overall Study|Lost to Follow-up|0|||
145915315|NCT00111241|526194001|FG000|Overall Study|Withdrawal by Subject|4|||
145915316|NCT00111241|526194002|FG001|Overall Study|Withdrawal by Subject|0|||
145915317|NCT00111241|526194001|FG000|Overall Study|Protocol Violation|9|||
145973887|NCT02178956|526418678|FG000|Overall Study|Lost to Follow-up|4|||
145973888|NCT02178956|526418679|FG001|Overall Study|Lost to Follow-up|4|||
145973889|NCT02178956|526418678|FG000|Overall Study|Sponsor terminated study|49|||
145973890|NCT02178956|526418679|FG001|Overall Study|Sponsor terminated study|58|||
145973891|NCT02178956|526418678|FG000|Overall Study|Withdrawal by Subject|15|||
145973892|NCT02178956|526418679|FG001|Overall Study|Withdrawal by Subject|11|||
145973893|NCT02178956|526418678|FG000|Overall Study|Various Reasons|3|||
146239775|NCT03865732|527393064|FG001|Overall Study|Adverse Event|1|||
146239776|NCT03392194|527393065|FG000|Overall Study|Withdrawal by Subject|1|||
146239777|NCT03392194|527393066|FG001|Overall Study|Withdrawal by Subject|2|||
146239778|NCT03392194|527393065|FG000|Overall Study|Conflicts with personal schedule|1|||
146239779|NCT03392194|527393066|FG001|Overall Study|Conflicts with personal schedule|0|||
146239780|NCT01009645|527393070|FG000|Overall Study|Lost to Follow-up|2|||
146239781|NCT01009645|527393071|FG001|Overall Study|Lost to Follow-up|8|||
146239782|NCT01009645|527393072|FG002|Overall Study|Lost to Follow-up|4|||
146239783|NCT01009645|527393073|FG003|Overall Study|Lost to Follow-up|5|||
146239784|NCT00620854|527393075|FG000|Washout 1|Withdrawal by Subject|0|||
146239785|NCT00620854|527393076|FG001|Washout 1|Withdrawal by Subject|0|||
146239786|NCT00620854|527393077|FG002|Washout 1|Withdrawal by Subject|1|||
146239787|NCT00620854|527393078|FG003|Washout 1|Withdrawal by Subject|1|||
146239788|NCT00620854|527393079|FG004|Washout 1|Withdrawal by Subject|0|||
146239789|NCT00620854|527393080|FG005|Washout 1|Withdrawal by Subject|0|||
146239790|NCT03345979|527393081|FG000|Overall Study|Withdrawal by Subject|20|||
146239791|NCT03345979|527393082|FG001|Overall Study|Withdrawal by Subject|31|||
146239792|NCT03345979|527393081|FG000|Overall Study|Adverse Event|10|||
146239793|NCT03345979|527393082|FG001|Overall Study|Adverse Event|11|||
146239794|NCT03345979|527393081|FG000|Overall Study|Lost to Follow-up|8|||
146239795|NCT03345979|527393082|FG001|Overall Study|Lost to Follow-up|9|||
146239796|NCT03345979|527393081|FG000|Overall Study|Lack of Efficacy|4|||
146239797|NCT03345979|527393082|FG001|Overall Study|Lack of Efficacy|2|||
146239798|NCT03345979|527393081|FG000|Overall Study|Protocol Violation|1|||
146239799|NCT03345979|527393082|FG001|Overall Study|Protocol Violation|3|||
146239800|NCT03345979|527393081|FG000|Overall Study|Physician Decision|0|||
146239801|NCT03345979|527393082|FG001|Overall Study|Physician Decision|2|||
146239802|NCT00734578|527393083|FG000|Overall Study|Adverse Event|4|||
146239803|NCT00734578|527393084|FG001|Overall Study|Adverse Event|6|||
146239804|NCT00734578|527393085|FG002|Overall Study|Adverse Event|1|||
146239805|NCT00734578|527393083|FG000|Overall Study|Protocol Violation|8|||
146239806|NCT00734578|527393084|FG001|Overall Study|Protocol Violation|6|||
145915318|NCT00111241|526194002|FG001|Overall Study|Protocol Violation|8|||
145915319|NCT00111241|526194001|FG000|Overall Study|Adverse Event|1|||
145915320|NCT00111241|526194002|FG001|Overall Study|Adverse Event|0|||
145915321|NCT01449812|526194013|FG000|Overall Study|Migrated/moved from study area|1|||
145915322|NCT01449812|526194014|FG001|Overall Study|Migrated/moved from study area|0|||
145915323|NCT01449812|526194015|FG002|Overall Study|Migrated/moved from study area|0|||
145915324|NCT01449812|526194013|FG000|Overall Study|Withdrawal by Subject|0|||
145915325|NCT01449812|526194014|FG001|Overall Study|Withdrawal by Subject|0|||
145915326|NCT01449812|526194015|FG002|Overall Study|Withdrawal by Subject|1|||
145915327|NCT01449812|526194013|FG000|Overall Study|Lost to Follow-up|1|||
145915328|NCT01449812|526194014|FG001|Overall Study|Lost to Follow-up|0|||
145915329|NCT01449812|526194015|FG002|Overall Study|Lost to Follow-up|0|||
146239807|NCT00734578|527393085|FG002|Overall Study|Protocol Violation|3|||
145915330|NCT01855828|526194016|FG000|Overall Study|Adverse Event|1|||
145915331|NCT01855828|526194016|FG000|Overall Study|Withdrawal by Subject|1|||
145915332|NCT01866098|526194017|FG000|Overall Study|Lost to Follow-up|11|||
145915333|NCT01866098|526194018|FG001|Overall Study|Lost to Follow-up|18|||
146239808|NCT00734578|527393083|FG000|Overall Study|Withdrawal by Subject|7|||
146239809|NCT00734578|527393084|FG001|Overall Study|Withdrawal by Subject|8|||
146239810|NCT00734578|527393085|FG002|Overall Study|Withdrawal by Subject|11|||
146239811|NCT00734578|527393083|FG000|Overall Study|Lost to Follow-up|9|||
146239812|NCT00734578|527393084|FG001|Overall Study|Lost to Follow-up|3|||
146239813|NCT00734578|527393085|FG002|Overall Study|Lost to Follow-up|5|||
145915334|NCT01866098|526194019|FG002|Overall Study|Lost to Follow-up|13|||
145973894|NCT02178956|526418679|FG001|Overall Study|Various Reasons|5|||
145973895|NCT01756235|526418680|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
146239814|NCT00734578|527393083|FG000|Overall Study|Lack of Efficacy|3|||
146239815|NCT00734578|527393084|FG001|Overall Study|Lack of Efficacy|2|||
146239816|NCT00734578|527393085|FG002|Overall Study|Lack of Efficacy|5|||
146239817|NCT00734578|527393083|FG000|Overall Study|Randomized in error|1|||
145915335|NCT01866098|526194017|FG000|Overall Study|Physician Decision|0|||
145915336|NCT01866098|526194018|FG001|Overall Study|Physician Decision|1|||
145915337|NCT01866098|526194019|FG002|Overall Study|Physician Decision|2|||
145915338|NCT01866098|526194017|FG000|Overall Study|Adverse Event|1|||
145915339|NCT01866098|526194018|FG001|Overall Study|Adverse Event|5|||
145915340|NCT01866098|526194019|FG002|Overall Study|Adverse Event|4|||
145915341|NCT01866098|526194017|FG000|Overall Study|Protocol Violation|1|||
145915342|NCT01866098|526194018|FG001|Overall Study|Protocol Violation|0|||
145915343|NCT01866098|526194019|FG002|Overall Study|Protocol Violation|0|||
145915344|NCT01866098|526194017|FG000|Overall Study|Withdrawal by Subject|1|||
145915345|NCT01866098|526194018|FG001|Overall Study|Withdrawal by Subject|2|||
145915346|NCT01866098|526194019|FG002|Overall Study|Withdrawal by Subject|0|||
145915347|NCT01866098|526194017|FG000|Overall Study|Unrelated Hospitalization|2|||
145915348|NCT01866098|526194018|FG001|Overall Study|Unrelated Hospitalization|0|||
145915349|NCT01866098|526194019|FG002|Overall Study|Unrelated Hospitalization|1|||
145915350|NCT01866098|526194017|FG000|Overall Study|Non-compliance|1|||
145915351|NCT01866098|526194018|FG001|Overall Study|Non-compliance|0|||
145915352|NCT01866098|526194019|FG002|Overall Study|Non-compliance|1|||
145915353|NCT01866098|526194017|FG000|Overall Study|Pregnancy|2|||
145915354|NCT01866098|526194018|FG001|Overall Study|Pregnancy|0|||
145915355|NCT01866098|526194019|FG002|Overall Study|Pregnancy|0|||
145915356|NCT01866098|526194017|FG000|Overall Study|Death|0|||
145915357|NCT01866098|526194018|FG001|Overall Study|Death|1|||
145915358|NCT01866098|526194019|FG002|Overall Study|Death|0|||
145915359|NCT04239027|526194024|FG000|Overall Study|Adverse Event|4|||
145915360|NCT04239027|526194024|FG000|Overall Study|Withdrawal by Subject|9|||
145915361|NCT04239027|526194024|FG000|Overall Study|Death|1|||
145915362|NCT04239027|526194024|FG000|Overall Study|Physician Decision|9|||
145915363|NCT04239027|526194024|FG000|Overall Study|Lost to Follow-up|2|||
145915364|NCT04239027|526194024|FG000|Overall Study|Lack of Efficacy|1|||
145915365|NCT03172494|526194031|FG000|Overall Study|Adverse Event|5|||
145915366|NCT03172494|526194032|FG001|Overall Study|Adverse Event|1|||
145915367|NCT03172494|526194033|FG002|Overall Study|Adverse Event|15|||
145915368|NCT03172494|526194031|FG000|Overall Study|Protocol Violation|3|||
145915369|NCT03172494|526194032|FG001|Overall Study|Protocol Violation|2|||
145915370|NCT03172494|526194033|FG002|Overall Study|Protocol Violation|1|||
145915371|NCT03172494|526194031|FG000|Overall Study|Lack of Efficacy|0|||
145915372|NCT03172494|526194032|FG001|Overall Study|Lack of Efficacy|0|||
145915373|NCT03172494|526194033|FG002|Overall Study|Lack of Efficacy|4|||
145915374|NCT03172494|526194031|FG000|Overall Study|Pregnancy|0|||
145915375|NCT03172494|526194032|FG001|Overall Study|Pregnancy|1|||
145915376|NCT03172494|526194033|FG002|Overall Study|Pregnancy|0|||
145915377|NCT03172494|526194031|FG000|Overall Study|Withdrawal by Subject|10|||
145915378|NCT03172494|526194032|FG001|Overall Study|Withdrawal by Subject|8|||
145915379|NCT03172494|526194033|FG002|Overall Study|Withdrawal by Subject|8|||
145915380|NCT03172494|526194031|FG000|Overall Study|Severe hypoglycaemic episode|0|||
145915381|NCT03172494|526194032|FG001|Overall Study|Severe hypoglycaemic episode|0|||
145915382|NCT03172494|526194033|FG002|Overall Study|Severe hypoglycaemic episode|1|||
145915383|NCT03172494|526194031|FG000|Overall Study|Non-compliance towards treatment|2|||
145915384|NCT03172494|526194032|FG001|Overall Study|Non-compliance towards treatment|0|||
145915385|NCT03172494|526194033|FG002|Overall Study|Non-compliance towards treatment|0|||
145915386|NCT00143390|526194034|FG000|Overall Study|Death|2|||
145915387|NCT00143390|526194035|FG001|Overall Study|Death|0|||
145915388|NCT00143390|526194034|FG000|Overall Study|Not meeting entry criteria|2|||
145915389|NCT00143390|526194035|FG001|Overall Study|Not meeting entry criteria|5|||
145915390|NCT00143390|526194034|FG000|Overall Study|Withdrawal by Subject|4|||
145915391|NCT00143390|526194035|FG001|Overall Study|Withdrawal by Subject|4|||
145915392|NCT00143390|526194034|FG000|Overall Study|Progressive disease|119|||
145915393|NCT00143390|526194035|FG001|Overall Study|Progressive disease|115|||
145915394|NCT00143390|526194034|FG000|Overall Study|Protocol Violation|2|||
145915395|NCT00143390|526194035|FG001|Overall Study|Protocol Violation|0|||
145915396|NCT00143390|526194034|FG000|Overall Study|Study termination|10|||
145915397|NCT00143390|526194035|FG001|Overall Study|Study termination|15|||
145915398|NCT00143390|526194034|FG000|Overall Study|Adverse Event|9|||
145915399|NCT00143390|526194035|FG001|Overall Study|Adverse Event|8|||
145915400|NCT00143390|526194034|FG000|Overall Study|Other|1|||
145915401|NCT00143390|526194035|FG001|Overall Study|Other|2|||
145915402|NCT02764151|526194038|FG000|Overall Study|Subject refused further follow-up|0|||
145915403|NCT02764151|526194039|FG001|Overall Study|Subject refused further follow-up|0|||
145915404|NCT02764151|526194040|FG002|Overall Study|Subject refused further follow-up|0|||
145915405|NCT02764151|526194041|FG003|Overall Study|Subject refused further follow-up|1|||
145973896|NCT02327078|526418681|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145915406|NCT02764151|526194038|FG000|Overall Study|Other|0|||
145915407|NCT02764151|526194039|FG001|Overall Study|Other|0|||
145915408|NCT02764151|526194040|FG002|Overall Study|Other|0|||
145915409|NCT02764151|526194041|FG003|Overall Study|Other|2|||
145915410|NCT01450683|526194042|FG000|Overall Study|Adverse Event|2|||
145915411|NCT02108912|526194044|FG000|Overall Study|Lost to Follow-up|1|||
145915412|NCT02108912|526194045|FG001|Overall Study|Lost to Follow-up|1|||
145973897|NCT02327078|526418682|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145973898|NCT02327078|526418683|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
145973899|NCT02327078|526418684|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145973900|NCT02327078|526418685|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145973901|NCT02327078|526418686|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145973902|NCT02327078|526418687|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145973903|NCT02327078|526418688|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
145973904|NCT02327078|526418689|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
145973905|NCT02327078|526418681|FG000|Overall Study|Death|2|||
145973906|NCT02327078|526418682|FG001|Overall Study|Death|4|||
145973907|NCT02327078|526418683|FG002|Overall Study|Death|10|||
145973908|NCT02327078|526418684|FG003|Overall Study|Death|6|||
146089069|NCT00495131|526845151|FG001|Overall Study|Adverse Event|2|||
146089070|NCT00495131|526845150|FG000|Overall Study|Lack of Efficacy|0|||
146239818|NCT00734578|527393084|FG001|Overall Study|Randomized in error|0|||
146239819|NCT00734578|527393085|FG002|Overall Study|Randomized in error|0|||
146239820|NCT00734578|527393083|FG000|Overall Study|Exclusion criteria|1|||
146239821|NCT00734578|527393084|FG001|Overall Study|Exclusion criteria|0|||
146239822|NCT00734578|527393085|FG002|Overall Study|Exclusion criteria|0|||
146239823|NCT00999596|527393086|FG000|Overall Study|Statistical population not required|101|||
146239824|NCT02095145|527393087|FG000|Overall Study|Withdrawal by Subject|1|||
146239825|NCT02095145|527393088|FG001|Overall Study|Withdrawal by Subject|0|||
146239826|NCT02085941|527393090|FG000|Overall Study|Lack of Efficacy|1|||
146239827|NCT02085941|527393091|FG001|Overall Study|Lack of Efficacy|0|||
146239828|NCT02085941|527393090|FG000|Overall Study|Death|6|||
146239829|NCT02085941|527393091|FG001|Overall Study|Death|1|||
146239830|NCT02085941|527393090|FG000|Overall Study|Lost to Follow-up|1|||
146239831|NCT02085941|527393091|FG001|Overall Study|Lost to Follow-up|0|||
146239832|NCT02085941|527393090|FG000|Overall Study|Physician Decision|0|||
146239833|NCT02085941|527393091|FG001|Overall Study|Physician Decision|2|||
146239834|NCT02788981|527393099|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
146239835|NCT02788981|527393100|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
146239836|NCT00249769|527393101|FG000|Overall Study|Withdrawal by Subject|1|||
146239837|NCT00249769|527393102|FG001|Overall Study|Withdrawal by Subject|10|||
146239838|NCT00249769|527393103|FG002|Overall Study|Withdrawal by Subject|6|||
146239839|NCT00249769|527393101|FG000|Overall Study|Migration from Study Area|1|||
146239840|NCT00249769|527393102|FG001|Overall Study|Migration from Study Area|3|||
146239841|NCT00249769|527393103|FG002|Overall Study|Migration from Study Area|14|||
146239842|NCT00249769|527393101|FG000|Overall Study|Miscellaneous|0|||
146239843|NCT00249769|527393102|FG001|Overall Study|Miscellaneous|2|||
146239844|NCT00249769|527393103|FG002|Overall Study|Miscellaneous|2|||
146239845|NCT00249769|527393101|FG000|Overall Study|Adverse Event|0|||
146239846|NCT00249769|527393102|FG001|Overall Study|Adverse Event|0|||
146239847|NCT00249769|527393103|FG002|Overall Study|Adverse Event|1|||
146239848|NCT00249769|527393101|FG000|Overall Study|Physician Decision|0|||
146239849|NCT00249769|527393102|FG001|Overall Study|Physician Decision|0|||
146239850|NCT00249769|527393103|FG002|Overall Study|Physician Decision|2|||
146239851|NCT00249769|527393101|FG000|Overall Study|Lost to Follow-up|0|||
146239852|NCT00249769|527393102|FG001|Overall Study|Lost to Follow-up|0|||
146239853|NCT00249769|527393103|FG002|Overall Study|Lost to Follow-up|3|||
146239854|NCT02022657|527393104|FG000|Overall Study|Withdrawal by Subject|2|||
146239855|NCT02022657|527393105|FG001|Overall Study|Withdrawal by Subject|0|||
146239856|NCT02022657|527393106|FG002|Overall Study|Withdrawal by Subject|1|||
146239857|NCT02022657|527393107|FG003|Overall Study|Withdrawal by Subject|0|||
145973909|NCT02327078|526418685|FG004|Overall Study|Death|4|||
145973910|NCT02327078|526418686|FG005|Overall Study|Death|3|||
145973911|NCT02327078|526418687|FG006|Overall Study|Death|2|||
145973912|NCT02327078|526418688|FG007|Overall Study|Death|51|||
145973913|NCT02327078|526418689|FG008|Overall Study|Death|97|||
145973914|NCT02327078|526418681|FG000|Overall Study|Lost to Follow-up|0|||
145973915|NCT02327078|526418682|FG001|Overall Study|Lost to Follow-up|1|||
145973916|NCT02327078|526418683|FG002|Overall Study|Lost to Follow-up|1|||
145973917|NCT02327078|526418684|FG003|Overall Study|Lost to Follow-up|0|||
146089071|NCT00495131|526845151|FG001|Overall Study|Lack of Efficacy|2|||
146089072|NCT00495131|526845150|FG000|Overall Study|Lost to Follow-up|0|||
146239858|NCT02022657|527393108|FG004|Overall Study|Withdrawal by Subject|0|||
146239859|NCT02022657|527393109|FG005|Overall Study|Withdrawal by Subject|0|||
146239860|NCT02022657|527393104|FG000|Overall Study|Physician Decision|0|||
146239861|NCT02022657|527393105|FG001|Overall Study|Physician Decision|0|||
146239862|NCT02022657|527393106|FG002|Overall Study|Physician Decision|0|||
146239863|NCT02022657|527393107|FG003|Overall Study|Physician Decision|0|||
146239864|NCT02022657|527393108|FG004|Overall Study|Physician Decision|0|||
146239865|NCT02022657|527393109|FG005|Overall Study|Physician Decision|1|||
145973918|NCT02327078|526418685|FG004|Overall Study|Lost to Follow-up|0|||
146089073|NCT00495131|526845151|FG001|Overall Study|Lost to Follow-up|2|||
146089074|NCT00495131|526845150|FG000|Overall Study|Withdrawal by Subject|1|||
145915413|NCT02108912|526194044|FG000|Overall Study|lack of transportation|1|||
145915414|NCT02108912|526194045|FG001|Overall Study|lack of transportation|0|||
145915415|NCT02108912|526194044|FG000|Overall Study|high blood pressure|1|||
145915416|NCT02108912|526194045|FG001|Overall Study|high blood pressure|0|||
145915417|NCT03180645|526194046|FG000|Overall Study|Adverse Event|0|||
145915418|NCT03180645|526194047|FG001|Overall Study|Adverse Event|1|||
145915419|NCT03180645|526194048|FG002|Overall Study|Adverse Event|2|||
145915420|NCT00852202|526194053|FG000|Overall Study|Adverse Event|2|||
145915421|NCT00852202|526194054|FG001|Overall Study|Adverse Event|3|||
145915422|NCT00852202|526194055|FG002|Overall Study|Adverse Event|7|||
145973919|NCT02327078|526418686|FG005|Overall Study|Lost to Follow-up|0|||
145973920|NCT02327078|526418687|FG006|Overall Study|Lost to Follow-up|0|||
145973921|NCT02327078|526418688|FG007|Overall Study|Lost to Follow-up|2|||
145973922|NCT02327078|526418689|FG008|Overall Study|Lost to Follow-up|5|||
145973923|NCT02327078|526418681|FG000|Overall Study|Site Terminated by Sponsor|1|||
145973924|NCT02327078|526418682|FG001|Overall Study|Site Terminated by Sponsor|0|||
145973925|NCT02327078|526418683|FG002|Overall Study|Site Terminated by Sponsor|1|||
145973926|NCT02327078|526418684|FG003|Overall Study|Site Terminated by Sponsor|4|||
145973927|NCT02327078|526418685|FG004|Overall Study|Site Terminated by Sponsor|0|||
145973928|NCT02327078|526418686|FG005|Overall Study|Site Terminated by Sponsor|0|||
145973929|NCT02327078|526418687|FG006|Overall Study|Site Terminated by Sponsor|0|||
145973930|NCT02327078|526418688|FG007|Overall Study|Site Terminated by Sponsor|11|||
145973931|NCT02327078|526418689|FG008|Overall Study|Site Terminated by Sponsor|25|||
145973932|NCT02327078|526418681|FG000|Overall Study|Physician Decision|0|||
145973933|NCT02327078|526418682|FG001|Overall Study|Physician Decision|0|||
145973934|NCT02327078|526418683|FG002|Overall Study|Physician Decision|0|||
145973935|NCT02327078|526418684|FG003|Overall Study|Physician Decision|1|||
145973936|NCT02327078|526418685|FG004|Overall Study|Physician Decision|0|||
145973937|NCT02327078|526418686|FG005|Overall Study|Physician Decision|0|||
145973938|NCT02327078|526418687|FG006|Overall Study|Physician Decision|0|||
145973939|NCT02327078|526418688|FG007|Overall Study|Physician Decision|0|||
145973940|NCT02327078|526418689|FG008|Overall Study|Physician Decision|1|||
145973941|NCT02327078|526418681|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145973942|NCT02327078|526418682|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145973943|NCT02327078|526418683|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145973944|NCT02327078|526418684|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145973945|NCT02327078|526418685|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145973946|NCT02327078|526418686|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145973947|NCT02327078|526418687|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145973948|NCT02327078|526418688|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
145973949|NCT02327078|526418689|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
145973950|NCT02327078|526418681|FG000|Overall Study|Reason not Specified|0|||
145973951|NCT02327078|526418682|FG001|Overall Study|Reason not Specified|0|||
145973952|NCT02327078|526418683|FG002|Overall Study|Reason not Specified|0|||
145973953|NCT02327078|526418684|FG003|Overall Study|Reason not Specified|0|||
145973954|NCT02327078|526418685|FG004|Overall Study|Reason not Specified|0|||
145973955|NCT02327078|526418686|FG005|Overall Study|Reason not Specified|0|||
145973956|NCT02327078|526418687|FG006|Overall Study|Reason not Specified|0|||
145973957|NCT02327078|526418688|FG007|Overall Study|Reason not Specified|5|||
145973958|NCT02327078|526418689|FG008|Overall Study|Reason not Specified|12|||
145973959|NCT04797169|526418692|FG000|Overall Study|Lost to Follow-up|84|||
145973960|NCT04797169|526418693|FG001|Overall Study|Lost to Follow-up|67|||
145973961|NCT04797169|526418692|FG000|Overall Study|Pregnancy|1|||
145973962|NCT04797169|526418693|FG001|Overall Study|Pregnancy|3|||
145973963|NCT04797169|526418692|FG000|Overall Study|Withdrawal by Subject|27|||
145973964|NCT04797169|526418693|FG001|Overall Study|Withdrawal by Subject|35|||
145973965|NCT02337829|526418696|FG000|Overall Study|Death|0|||
145973966|NCT02337829|526418697|FG001|Overall Study|Death|1|||
145973967|NCT02337829|526418698|FG002|Overall Study|Death|0|||
145973968|NCT02337829|526418699|FG003|Overall Study|Death|0|||
145973969|NCT02337829|526418696|FG000|Overall Study|Study terminated by sponsor|12|||
145973970|NCT02337829|526418697|FG001|Overall Study|Study terminated by sponsor|10|||
146239866|NCT03739866|527393116|FG000|Overall Study|Lost to Follow-up|0|||
146239867|NCT03739866|527393117|FG001|Overall Study|Lost to Follow-up|0|||
145915423|NCT00852202|526194053|FG000|Overall Study|Lack of Efficacy|4|||
145973971|NCT02337829|526418698|FG002|Overall Study|Study terminated by sponsor|5|||
145973972|NCT02337829|526418699|FG003|Overall Study|Study terminated by sponsor|6|||
145973973|NCT02337829|526418696|FG000|Overall Study|discontinued for other reasons|6|||
145973974|NCT02337829|526418697|FG001|Overall Study|discontinued for other reasons|3|||
145973975|NCT02337829|526418698|FG002|Overall Study|discontinued for other reasons|1|||
145915424|NCT00852202|526194054|FG001|Overall Study|Lack of Efficacy|1|||
145973976|NCT02337829|526418699|FG003|Overall Study|discontinued for other reasons|4|||
145915425|NCT00852202|526194055|FG002|Overall Study|Lack of Efficacy|2|||
145973977|NCT04221490|526418702|FG000|At 30 Days Follow-up|Death|7|||
145973978|NCT04221490|526418702|FG000|At 30 Days Follow-up|Missed Visit|4|||
145973979|NCT04221490|526418702|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
145973980|NCT04221490|526418702|FG000|At 6 Months Follow-up|Death|9|||
145915426|NCT00852202|526194053|FG000|Overall Study|Protocol Violation|2|||
145915427|NCT00852202|526194054|FG001|Overall Study|Protocol Violation|2|||
145915428|NCT00852202|526194055|FG002|Overall Study|Protocol Violation|7|||
145915429|NCT00852202|526194053|FG000|Overall Study|Withdrawal by Subject|3|||
145915430|NCT00852202|526194054|FG001|Overall Study|Withdrawal by Subject|1|||
145915431|NCT00852202|526194055|FG002|Overall Study|Withdrawal by Subject|2|||
145915432|NCT00852202|526194053|FG000|Overall Study|Lost to Follow-up|5|||
145915433|NCT00852202|526194054|FG001|Overall Study|Lost to Follow-up|5|||
145915434|NCT00852202|526194055|FG002|Overall Study|Lost to Follow-up|6|||
145915435|NCT00852202|526194053|FG000|Overall Study|pregnancy,moving away and surgery|1|||
145915436|NCT00852202|526194054|FG001|Overall Study|pregnancy,moving away and surgery|0|||
145915437|NCT00852202|526194055|FG002|Overall Study|pregnancy,moving away and surgery|2|||
145915438|NCT02905032|526194058|FG000|Overall Study|Withdrawal by Subject|2|||
145915439|NCT02905032|526194059|FG001|Overall Study|Withdrawal by Subject|0|||
145915440|NCT02905032|526194060|FG002|Overall Study|Withdrawal by Subject|0|||
145915441|NCT02905032|526194058|FG000|Overall Study|Protocol Violation|6|||
145915442|NCT02905032|526194059|FG001|Overall Study|Protocol Violation|12|||
145915443|NCT02905032|526194060|FG002|Overall Study|Protocol Violation|0|||
145915444|NCT00739063|526194061|FG000|Overall Study|Screen failures|8|||
146239868|NCT03739866|527393118|FG002|Overall Study|Lost to Follow-up|0|||
146239869|NCT03739866|527393119|FG003|Overall Study|Lost to Follow-up|1|||
146239870|NCT03739866|527393120|FG004|Overall Study|Lost to Follow-up|0|||
146239871|NCT03739866|527393121|FG005|Overall Study|Lost to Follow-up|0|||
146239872|NCT03739866|527393122|FG006|Overall Study|Lost to Follow-up|0|||
146239873|NCT03739866|527393123|FG007|Overall Study|Lost to Follow-up|0|||
146239874|NCT03739866|527393116|FG000|Overall Study|Enrolled but not treated|0|||
146239875|NCT03739866|527393117|FG001|Overall Study|Enrolled but not treated|0|||
146239876|NCT03739866|527393118|FG002|Overall Study|Enrolled but not treated|1|||
146239877|NCT03739866|527393119|FG003|Overall Study|Enrolled but not treated|0|||
146239878|NCT03739866|527393120|FG004|Overall Study|Enrolled but not treated|1|||
146239879|NCT03739866|527393121|FG005|Overall Study|Enrolled but not treated|0|||
146239880|NCT03739866|527393122|FG006|Overall Study|Enrolled but not treated|0|||
146239881|NCT03739866|527393123|FG007|Overall Study|Enrolled but not treated|0|||
146239882|NCT03057600|527393124|FG000|Overall Study|Adverse Event|0|||
146239883|NCT03057600|527393125|FG001|Overall Study|Adverse Event|0|||
146239884|NCT03057600|527393126|FG002|Overall Study|Adverse Event|4|||
146239885|NCT03057600|527393127|FG003|Overall Study|Adverse Event|0|||
146239886|NCT03057600|527393124|FG000|Overall Study|Radiologic Disease Progression|8|||
146239887|NCT03057600|527393125|FG001|Overall Study|Radiologic Disease Progression|7|||
146239888|NCT03057600|527393126|FG002|Overall Study|Radiologic Disease Progression|13|||
146239889|NCT03057600|527393127|FG003|Overall Study|Radiologic Disease Progression|10|||
146239890|NCT03057600|527393124|FG000|Overall Study|Symptomatic Deterioration|0|||
146239891|NCT03057600|527393125|FG001|Overall Study|Symptomatic Deterioration|1|||
146239892|NCT03057600|527393126|FG002|Overall Study|Symptomatic Deterioration|1|||
146239893|NCT03057600|527393127|FG003|Overall Study|Symptomatic Deterioration|0|||
146239894|NCT03057600|527393124|FG000|Overall Study|Investigator Decision|0|||
146239895|NCT03057600|527393125|FG001|Overall Study|Investigator Decision|0|||
146239896|NCT03057600|527393126|FG002|Overall Study|Investigator Decision|1|||
146239897|NCT03057600|527393127|FG003|Overall Study|Investigator Decision|0|||
146239898|NCT03057600|527393124|FG000|Overall Study|Study Termination by Sponsor|0|||
146239899|NCT03057600|527393125|FG001|Overall Study|Study Termination by Sponsor|0|||
146239900|NCT03057600|527393126|FG002|Overall Study|Study Termination by Sponsor|0|||
146239901|NCT03057600|527393127|FG003|Overall Study|Study Termination by Sponsor|2|||
146239902|NCT03057600|527393124|FG000|Overall Study|Withdrawal by Subject|0|||
146239903|NCT03057600|527393125|FG001|Overall Study|Withdrawal by Subject|1|||
146239904|NCT03057600|527393126|FG002|Overall Study|Withdrawal by Subject|0|||
146239905|NCT03057600|527393127|FG003|Overall Study|Withdrawal by Subject|0|||
146239906|NCT03057600|527393124|FG000|Overall Study|Other, Not Specified|1|||
146239907|NCT03057600|527393125|FG001|Overall Study|Other, Not Specified|1|||
146239908|NCT03057600|527393126|FG002|Overall Study|Other, Not Specified|1|||
146239909|NCT03057600|527393127|FG003|Overall Study|Other, Not Specified|1|||
146239910|NCT02203799|527393128|FG000|Overall Study|Withdrawal by Subject|3|||
146239911|NCT01953692|527393131|FG000|Overall Study|Adverse Event|5|||
146239912|NCT01953692|527393132|FG001|Overall Study|Adverse Event|2|||
146239913|NCT01953692|527393133|FG002|Overall Study|Adverse Event|4|||
146239914|NCT01953692|527393134|FG003|Overall Study|Adverse Event|2|||
146239915|NCT01953692|527393135|FG004|Overall Study|Adverse Event|1|||
146239916|NCT01953692|527393136|FG005|Overall Study|Adverse Event|2|||
146239917|NCT01953692|527393137|FG006|Overall Study|Adverse Event|0|||
146239918|NCT01953692|527393138|FG007|Overall Study|Adverse Event|0|||
146239919|NCT01953692|527393139|FG008|Overall Study|Adverse Event|0|||
146239920|NCT01953692|527393131|FG000|Overall Study|Clinical Progression|0|||
145915445|NCT06082843|526195834|FG000|Overall Study|Withdrawal by Subject|0|||
145915446|NCT06082843|526195835|FG001|Overall Study|Withdrawal by Subject|2|||
145915447|NCT06082843|526195834|FG000|Overall Study|Study terminated by sponsor|12|||
145915448|NCT06082843|526195835|FG001|Overall Study|Study terminated by sponsor|8|||
146297531|NCT01182766|527604724|FG001|Overall Study|Withdrawal by Subject|3|||
146297532|NCT01182766|527604725|FG002|Overall Study|Withdrawal by Subject|6|||
146297533|NCT01182766|527604723|FG000|Overall Study|Physician Decision|1|||
146297534|NCT01182766|527604724|FG001|Overall Study|Physician Decision|0|||
146297535|NCT01182766|527604725|FG002|Overall Study|Physician Decision|0|||
146297536|NCT01182766|527604723|FG000|Overall Study|Non-compliance|1|||
146297537|NCT01182766|527604724|FG001|Overall Study|Non-compliance|1|||
146297538|NCT01182766|527604725|FG002|Overall Study|Non-compliance|1|||
146297539|NCT03027557|527604726|FG000|Overall Study|Adverse Event|1|||
145973981|NCT04221490|526418702|FG000|At 6 Months Follow-up|Physician Decision|1|||
145973982|NCT04221490|526418702|FG000|At 6 Months Follow-up|Missed Visit|8|||
145973983|NCT04221490|526418702|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
145973984|NCT02763566|526418711|FG000|Overall Study|Lost to Follow-up|1|||
145973985|NCT02763566|526418712|FG001|Overall Study|Lost to Follow-up|4|||
145973986|NCT02763566|526418713|FG002|Overall Study|Lost to Follow-up|0|||
145973987|NCT02763566|526418714|FG003|Overall Study|Lost to Follow-up|1|||
145973988|NCT02763566|526418711|FG000|Overall Study|On study treatment at study conclusion|114|||
145973989|NCT02763566|526418712|FG001|Overall Study|On study treatment at study conclusion|34|||
145973990|NCT02763566|526418713|FG002|Overall Study|On study treatment at study conclusion|54|||
146239921|NCT01953692|527393132|FG001|Overall Study|Clinical Progression|15|||
146239922|NCT01953692|527393133|FG002|Overall Study|Clinical Progression|7|||
146239923|NCT01953692|527393134|FG003|Overall Study|Clinical Progression|5|||
146239924|NCT01953692|527393135|FG004|Overall Study|Clinical Progression|0|||
146239925|NCT01953692|527393136|FG005|Overall Study|Clinical Progression|7|||
146239926|NCT01953692|527393137|FG006|Overall Study|Clinical Progression|20|||
146239927|NCT01953692|527393138|FG007|Overall Study|Clinical Progression|3|||
146239928|NCT01953692|527393139|FG008|Overall Study|Clinical Progression|3|||
146239929|NCT01953692|527393131|FG000|Overall Study|Death|5|||
146239930|NCT01953692|527393132|FG001|Overall Study|Death|0|||
146239931|NCT01953692|527393133|FG002|Overall Study|Death|2|||
146239932|NCT01953692|527393134|FG003|Overall Study|Death|2|||
146239933|NCT01953692|527393135|FG004|Overall Study|Death|1|||
146239934|NCT01953692|527393136|FG005|Overall Study|Death|3|||
146239935|NCT01953692|527393137|FG006|Overall Study|Death|6|||
146239936|NCT01953692|527393138|FG007|Overall Study|Death|2|||
146239937|NCT01953692|527393139|FG008|Overall Study|Death|1|||
146239938|NCT01953692|527393131|FG000|Overall Study|Excluded Medication|1|||
146239939|NCT01953692|527393132|FG001|Overall Study|Excluded Medication|0|||
146239940|NCT01953692|527393133|FG002|Overall Study|Excluded Medication|0|||
146239941|NCT01953692|527393134|FG003|Overall Study|Excluded Medication|0|||
146239942|NCT01953692|527393135|FG004|Overall Study|Excluded Medication|0|||
146239943|NCT01953692|527393136|FG005|Overall Study|Excluded Medication|0|||
146239944|NCT01953692|527393137|FG006|Overall Study|Excluded Medication|0|||
146239945|NCT01953692|527393138|FG007|Overall Study|Excluded Medication|0|||
146239946|NCT01953692|527393139|FG008|Overall Study|Excluded Medication|0|||
146239947|NCT01953692|527393131|FG000|Overall Study|Lost to Follow-up|1|||
146239948|NCT01953692|527393132|FG001|Overall Study|Lost to Follow-up|0|||
146239949|NCT01953692|527393133|FG002|Overall Study|Lost to Follow-up|3|||
146239950|NCT01953692|527393134|FG003|Overall Study|Lost to Follow-up|1|||
146239951|NCT01953692|527393135|FG004|Overall Study|Lost to Follow-up|0|||
146239952|NCT01953692|527393136|FG005|Overall Study|Lost to Follow-up|1|||
146239953|NCT01953692|527393137|FG006|Overall Study|Lost to Follow-up|0|||
146239954|NCT01953692|527393138|FG007|Overall Study|Lost to Follow-up|0|||
146239955|NCT01953692|527393139|FG008|Overall Study|Lost to Follow-up|0|||
145973991|NCT02763566|526418714|FG003|Overall Study|On study treatment at study conclusion|13|||
145973992|NCT02763566|526418711|FG000|Overall Study|Withdrawal by Subject|3|||
145973993|NCT02763566|526418712|FG001|Overall Study|Withdrawal by Subject|1|||
145973994|NCT02763566|526418713|FG002|Overall Study|Withdrawal by Subject|0|||
145973995|NCT02763566|526418714|FG003|Overall Study|Withdrawal by Subject|0|||
145973996|NCT04896385|526418715|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
145973997|NCT04896385|526418716|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
145973998|NCT04896385|526418717|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
146239956|NCT01953692|527393131|FG000|Overall Study|Physician Decision|11|||
146239957|NCT01953692|527393132|FG001|Overall Study|Physician Decision|4|||
145973999|NCT04896385|526418718|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
145974000|NCT04896385|526418715|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
146239958|NCT01953692|527393133|FG002|Overall Study|Physician Decision|2|||
146239959|NCT01953692|527393134|FG003|Overall Study|Physician Decision|2|||
146239960|NCT01953692|527393135|FG004|Overall Study|Physician Decision|1|||
146239961|NCT01953692|527393136|FG005|Overall Study|Physician Decision|2|||
146297540|NCT03027557|527604727|FG001|Overall Study|Adverse Event|0|||
146239962|NCT01953692|527393137|FG006|Overall Study|Physician Decision|4|||
146239963|NCT01953692|527393138|FG007|Overall Study|Physician Decision|1|||
146239964|NCT01953692|527393139|FG008|Overall Study|Physician Decision|0|||
146239965|NCT01953692|527393131|FG000|Overall Study|Protocol Violation|0|||
146239966|NCT01953692|527393132|FG001|Overall Study|Protocol Violation|2|||
146239967|NCT01953692|527393133|FG002|Overall Study|Protocol Violation|1|||
146297541|NCT03027557|527604728|FG002|Overall Study|Adverse Event|0|||
146297542|NCT02510560|527604729|FG000|Overall Study|Discontinued from Treatment|27|||
146239968|NCT01953692|527393134|FG003|Overall Study|Protocol Violation|0|||
145915449|NCT01368497|526195836|FG000|Overall Study|Lost to Follow-up|2|||
145915450|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
145915451|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
145915452|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
145915453|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
145915454|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
145915455|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
145915456|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
145915457|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
145915458|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
145915459|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
145915460|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
145915461|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
145915462|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
145915463|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
145915464|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
145915465|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
145915466|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
145915467|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
145915468|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
145915469|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
145915470|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
145915471|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
145915472|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
145915473|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
145915474|NCT01130532|526195837|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
145915475|NCT01130532|526195838|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
145915476|NCT01130532|526195839|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
145915477|NCT01130532|526195840|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
145915478|NCT01130532|526195837|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
145915479|NCT01130532|526195838|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
145915480|NCT01130532|526195839|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
145915481|NCT01130532|526195840|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
145915482|NCT01130532|526195837|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145915483|NCT01130532|526195838|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145915484|NCT01130532|526195839|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145915485|NCT01130532|526195840|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
145915486|NCT01130532|526195837|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145915487|NCT01130532|526195838|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145915488|NCT01130532|526195839|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145915489|NCT01130532|526195840|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
145915490|NCT01130532|526195837|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145915491|NCT01130532|526195838|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145915492|NCT01130532|526195839|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145915493|NCT01130532|526195840|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
145915494|NCT02762929|526195841|FG000|Overall Study|Adverse Event|0|||
145915495|NCT02762929|526195842|FG001|Overall Study|Adverse Event|0|||
145915496|NCT02762929|526195843|FG002|Overall Study|Adverse Event|0|||
145915497|NCT02762929|526195844|FG003|Overall Study|Adverse Event|1|||
145915498|NCT02762929|526195845|FG004|Overall Study|Adverse Event|0|||
145915499|NCT02762929|526195846|FG005|Overall Study|Adverse Event|0|||
145915500|NCT02762929|526195841|FG000|Overall Study|Lost to Follow-up|1|||
145915501|NCT02762929|526195842|FG001|Overall Study|Lost to Follow-up|2|||
145915502|NCT02762929|526195843|FG002|Overall Study|Lost to Follow-up|0|||
145915503|NCT02762929|526195844|FG003|Overall Study|Lost to Follow-up|1|||
145915504|NCT02762929|526195845|FG004|Overall Study|Lost to Follow-up|0|||
145915505|NCT02762929|526195846|FG005|Overall Study|Lost to Follow-up|0|||
145915506|NCT02762929|526195841|FG000|Overall Study|Withdrawal by Subject|0|||
145915507|NCT02762929|526195842|FG001|Overall Study|Withdrawal by Subject|1|||
145915508|NCT02762929|526195843|FG002|Overall Study|Withdrawal by Subject|0|||
145915509|NCT02762929|526195844|FG003|Overall Study|Withdrawal by Subject|0|||
145915510|NCT02762929|526195845|FG004|Overall Study|Withdrawal by Subject|0|||
146239969|NCT01953692|527393135|FG004|Overall Study|Protocol Violation|0|||
145915511|NCT02762929|526195846|FG005|Overall Study|Withdrawal by Subject|0|||
145915512|NCT02762929|526195841|FG000|Overall Study|exclusionary medication disclosed late|0|||
145915513|NCT02762929|526195842|FG001|Overall Study|exclusionary medication disclosed late|0|||
145915514|NCT02762929|526195843|FG002|Overall Study|exclusionary medication disclosed late|0|||
145915515|NCT02762929|526195844|FG003|Overall Study|exclusionary medication disclosed late|1|||
145915516|NCT02762929|526195845|FG004|Overall Study|exclusionary medication disclosed late|0|||
145915517|NCT02762929|526195846|FG005|Overall Study|exclusionary medication disclosed late|0|||
145915518|NCT02656303|526195848|FG000|Overall Study|Adverse Event|3|||
145915519|NCT02656303|526195849|FG001|Overall Study|Adverse Event|2|||
146239970|NCT01953692|527393136|FG005|Overall Study|Protocol Violation|0|||
145915520|NCT02656303|526195850|FG002|Overall Study|Adverse Event|0|||
145915521|NCT02656303|526195848|FG000|Overall Study|Death|12|||
145915522|NCT02656303|526195849|FG001|Overall Study|Death|4|||
145915523|NCT02656303|526195850|FG002|Overall Study|Death|1|||
145915524|NCT02656303|526195848|FG000|Overall Study|Lack of Efficacy|1|||
145915525|NCT02656303|526195849|FG001|Overall Study|Lack of Efficacy|0|||
145915526|NCT02656303|526195850|FG002|Overall Study|Lack of Efficacy|0|||
145915527|NCT02656303|526195848|FG000|Overall Study|Non-Compliance with Study|1|||
145915528|NCT02656303|526195849|FG001|Overall Study|Non-Compliance with Study|1|||
145915529|NCT02656303|526195850|FG002|Overall Study|Non-Compliance with Study|0|||
145915530|NCT02656303|526195848|FG000|Overall Study|Investigator Decision|2|||
145915531|NCT02656303|526195849|FG001|Overall Study|Investigator Decision|1|||
145915532|NCT02656303|526195850|FG002|Overall Study|Investigator Decision|0|||
145915533|NCT02656303|526195848|FG000|Overall Study|Progressive Disease|25|||
145915534|NCT02656303|526195849|FG001|Overall Study|Progressive Disease|14|||
145915535|NCT02656303|526195850|FG002|Overall Study|Progressive Disease|10|||
145915536|NCT02656303|526195848|FG000|Overall Study|Study Terminated by Sponsor|20|||
145915537|NCT02656303|526195849|FG001|Overall Study|Study Terminated by Sponsor|7|||
145915538|NCT02656303|526195850|FG002|Overall Study|Study Terminated by Sponsor|5|||
145915539|NCT02656303|526195848|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
145915540|NCT02656303|526195849|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
145915541|NCT02656303|526195850|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
145915542|NCT02656303|526195848|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
145915543|NCT02656303|526195849|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
145915544|NCT02656303|526195850|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
145915545|NCT02656303|526195848|FG000|Overall Study|Reason not Specified|1|||
145915546|NCT02656303|526195849|FG001|Overall Study|Reason not Specified|1|||
145915547|NCT02656303|526195850|FG002|Overall Study|Reason not Specified|2|||
145915548|NCT03041311|526195853|FG000|Overall Study|Death|39|||
145915549|NCT03041311|526195854|FG001|Overall Study|Death|42|||
145915550|NCT03041311|526195853|FG000|Overall Study|Lost to Follow-up|0|||
145915551|NCT03041311|526195854|FG001|Overall Study|Lost to Follow-up|1|||
145915552|NCT03041311|526195853|FG000|Overall Study|Withdrawal by Subject|8|||
145915553|NCT03041311|526195854|FG001|Overall Study|Withdrawal by Subject|5|||
145915554|NCT03041311|526195853|FG000|Overall Study|Sponsor Terminated Study|2|||
145915555|NCT03041311|526195854|FG001|Overall Study|Sponsor Terminated Study|4|||
145915556|NCT03041311|526195853|FG000|Overall Study|Disease Progression|3|||
145915557|NCT03041311|526195854|FG001|Overall Study|Disease Progression|1|||
145915558|NCT03041311|526195853|FG000|Overall Study|Randomized in error, did not receive drug|2|||
145915559|NCT03041311|526195854|FG001|Overall Study|Randomized in error, did not receive drug|0|||
145915560|NCT00443729|526195855|FG000|Overall Study|Never Treated|0|||
145915561|NCT00443729|526195856|FG001|Overall Study|Never Treated|1|||
145915562|NCT00443729|526195855|FG000|Overall Study|Lack of Efficacy|4|||
145915563|NCT00443729|526195856|FG001|Overall Study|Lack of Efficacy|2|||
145915564|NCT00443729|526195855|FG000|Overall Study|Lost to Follow-up|0|||
145915565|NCT00443729|526195856|FG001|Overall Study|Lost to Follow-up|1|||
145915566|NCT00443729|526195855|FG000|Overall Study|Physician Decision|2|||
145915567|NCT00443729|526195856|FG001|Overall Study|Physician Decision|1|||
145915568|NCT00443729|526195855|FG000|Overall Study|Protocol Violation|1|||
145915569|NCT00443729|526195856|FG001|Overall Study|Protocol Violation|1|||
145915570|NCT00443729|526195855|FG000|Overall Study|Withdrawal by Subject|3|||
145915571|NCT00443729|526195856|FG001|Overall Study|Withdrawal by Subject|1|||
145915572|NCT01842438|526195857|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
145915573|NCT01842438|526195858|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
145915574|NCT01842438|526195857|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
145915575|NCT01842438|526195858|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
145915576|NCT01842438|526195857|FG000|T2: 6month Follow-up|Death|0|||
145915577|NCT01842438|526195858|FG001|T2: 6month Follow-up|Death|1|||
145915578|NCT00782626|526195862|FG000|Overall Study|Adverse Event|1|||
145915579|NCT00782626|526195862|FG000|Overall Study|Progressive Disease|5|||
145915580|NCT00782626|526195862|FG000|Overall Study|Other Complicating Disease|1|||
145915581|NCT04054765|526195863|FG000|Baseline|Withdrawal by Subject|5|||
145915582|NCT04054765|526195864|FG001|Baseline|Withdrawal by Subject|3|||
145915583|NCT04054765|526195863|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
145915584|NCT04054765|526195864|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
145915585|NCT04054765|526195863|FG000|3-month Follow up|Withdrawal by Subject|0|||
145915586|NCT04054765|526195864|FG001|3-month Follow up|Withdrawal by Subject|3|||
145915587|NCT04054765|526195863|FG000|6-month Follow up|Lost to Follow-up|32|||
145915588|NCT04054765|526195864|FG001|6-month Follow up|Lost to Follow-up|32|||
145915589|NCT02366689|526195867|FG000|Overall Study|Withdrawal by Subject|1|||
145915590|NCT02366689|526195868|FG001|Overall Study|Withdrawal by Subject|0|||
145915591|NCT02366689|526195869|FG002|Overall Study|Withdrawal by Subject|1|||
145915592|NCT02366689|526195867|FG000|Overall Study|Lost to Follow-up|3|||
145915593|NCT02366689|526195868|FG001|Overall Study|Lost to Follow-up|2|||
145915594|NCT02366689|526195869|FG002|Overall Study|Lost to Follow-up|0|||
145915595|NCT02366689|526195867|FG000|Overall Study|Pregnancy|0|||
145915596|NCT02366689|526195868|FG001|Overall Study|Pregnancy|1|||
145915597|NCT02366689|526195869|FG002|Overall Study|Pregnancy|1|||
145915598|NCT01290068|526195870|FG000|Overall Study|Adverse Event|1|||
145915599|NCT01290068|526195871|FG001|Overall Study|Adverse Event|3|||
145915600|NCT01290068|526195870|FG000|Overall Study|Lost to Follow-up|3|||
145915601|NCT01290068|526195871|FG001|Overall Study|Lost to Follow-up|0|||
145915602|NCT01290068|526195870|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
145915603|NCT01290068|526195871|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
145915604|NCT01290068|526195870|FG000|Overall Study|Other|3|||
145915605|NCT01290068|526195871|FG001|Overall Study|Other|1|||
146239971|NCT01953692|527393137|FG006|Overall Study|Protocol Violation|0|||
146239972|NCT01953692|527393138|FG007|Overall Study|Protocol Violation|1|||
146239973|NCT01953692|527393139|FG008|Overall Study|Protocol Violation|0|||
146239974|NCT01953692|527393131|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239975|NCT01953692|527393132|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239976|NCT01953692|527393133|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239977|NCT01953692|527393134|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145974001|NCT04896385|526418716|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
145974002|NCT04896385|526418717|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145974003|NCT04896385|526418718|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145974004|NCT04896385|526418715|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146239978|NCT01953692|527393135|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239979|NCT01953692|527393136|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145915606|NCT03283566|526195874|FG000|Overall Study|Lost to Follow-up|1|||
145915607|NCT03283566|526195875|FG001|Overall Study|Lost to Follow-up|2|||
145915608|NCT03718832|526195876|FG000|Analysis Sample|Withdrawal by Subject|18|||
145915609|NCT03718832|526195877|FG001|Analysis Sample|Withdrawal by Subject|15|||
145915610|NCT03718832|526195876|FG000|Analysis Sample|Legal hold on data|1|||
145915611|NCT03718832|526195877|FG001|Analysis Sample|Legal hold on data|0|||
145915612|NCT03718832|526195876|FG000|Analysis Sample|Participant from treated household|0|||
145915613|NCT03718832|526195877|FG001|Analysis Sample|Participant from treated household|1|||
145915614|NCT03718832|526195876|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
145974005|NCT04896385|526418716|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
145974006|NCT04896385|526418717|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
145974007|NCT04896385|526418718|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
145974008|NCT04896385|526418715|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145974009|NCT04896385|526418716|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145974010|NCT04896385|526418717|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
146089075|NCT00495131|526845151|FG001|Overall Study|Withdrawal by Subject|0|||
146089076|NCT00727532|526845152|FG000|Overall Study|Adverse Event|1|||
146089077|NCT00727532|526845152|FG000|Overall Study|Withdrawal by Subject|1|||
146089078|NCT00829933|526845153|FG000|Overall Study|Adverse Event|2|||
146089079|NCT00829933|526845154|FG001|Overall Study|Adverse Event|3|||
146089080|NCT00829933|526845155|FG002|Overall Study|Adverse Event|2|||
146089081|NCT00829933|526845156|FG003|Overall Study|Adverse Event|1|||
146089082|NCT00829933|526845153|FG000|Overall Study|Death|0|||
146089083|NCT00829933|526845154|FG001|Overall Study|Death|0|||
146089084|NCT00829933|526845155|FG002|Overall Study|Death|1|||
146089085|NCT00829933|526845156|FG003|Overall Study|Death|1|||
146089086|NCT00829933|526845153|FG000|Overall Study|Lack of Efficacy|0|||
146089087|NCT00829933|526845154|FG001|Overall Study|Lack of Efficacy|1|||
146089088|NCT00829933|526845155|FG002|Overall Study|Lack of Efficacy|0|||
146089089|NCT00829933|526845156|FG003|Overall Study|Lack of Efficacy|0|||
146089090|NCT00829933|526845153|FG000|Overall Study|Physician Decision|5|||
146089091|NCT00829933|526845154|FG001|Overall Study|Physician Decision|7|||
146089092|NCT00829933|526845155|FG002|Overall Study|Physician Decision|8|||
146089093|NCT00829933|526845156|FG003|Overall Study|Physician Decision|1|||
146089094|NCT00829933|526845153|FG000|Overall Study|Pregnancy|0|||
146089095|NCT00829933|526845154|FG001|Overall Study|Pregnancy|0|||
146089096|NCT00829933|526845155|FG002|Overall Study|Pregnancy|0|||
146089097|NCT00829933|526845156|FG003|Overall Study|Pregnancy|2|||
146089098|NCT00829933|526845153|FG000|Overall Study|Protocol Violation|2|||
146089099|NCT00829933|526845154|FG001|Overall Study|Protocol Violation|1|||
146239980|NCT01953692|527393137|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239981|NCT01953692|527393138|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
145915615|NCT03718832|526195877|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
145915616|NCT01996241|526195879|FG000|Overall Study|Lost to Follow-up|252|||
145915617|NCT01996241|526195880|FG001|Overall Study|Lost to Follow-up|235|||
146089100|NCT00829933|526845155|FG002|Overall Study|Protocol Violation|0|||
146089101|NCT00829933|526845156|FG003|Overall Study|Protocol Violation|0|||
146089102|NCT00829933|526845153|FG000|Overall Study|withdrew before treatment started|5|||
146089103|NCT00829933|526845154|FG001|Overall Study|withdrew before treatment started|1|||
146089104|NCT00829933|526845155|FG002|Overall Study|withdrew before treatment started|2|||
146089105|NCT00829933|526845156|FG003|Overall Study|withdrew before treatment started|9|||
146089106|NCT00523367|526845157|FG000|Overall Study|19 screen failures|19|||
145915618|NCT03052751|526195881|FG000|Dosing Period 1|Adverse Event|0|||
145915619|NCT03052751|526195882|FG001|Dosing Period 1|Adverse Event|1|||
145915620|NCT03052751|526195883|FG002|Dosing Period 1|Adverse Event|0|||
145915621|NCT03052751|526195884|FG003|Dosing Period 1|Adverse Event|0|||
145915622|NCT03052751|526195885|FG004|Dosing Period 1|Adverse Event|0|||
145915623|NCT03052751|526195886|FG005|Dosing Period 1|Adverse Event|0|||
145915624|NCT03052751|526195881|FG000|Dosing Period 2|Adverse Event|0|||
145915625|NCT03052751|526195882|FG001|Dosing Period 2|Adverse Event|0|||
145915626|NCT03052751|526195883|FG002|Dosing Period 2|Adverse Event|3|||
145915627|NCT03052751|526195884|FG003|Dosing Period 2|Adverse Event|0|||
145915628|NCT03052751|526195885|FG004|Dosing Period 2|Adverse Event|0|||
145915629|NCT03052751|526195886|FG005|Dosing Period 2|Adverse Event|0|||
145915630|NCT03052751|526195881|FG000|Observation Period|Adverse Event|0|||
145915631|NCT03052751|526195882|FG001|Observation Period|Adverse Event|0|||
145915632|NCT03052751|526195883|FG002|Observation Period|Adverse Event|0|||
145915633|NCT03052751|526195884|FG003|Observation Period|Adverse Event|0|||
145915634|NCT03052751|526195885|FG004|Observation Period|Adverse Event|1|||
145915635|NCT03052751|526195886|FG005|Observation Period|Adverse Event|0|||
145915636|NCT01068262|526195889|FG000|Overall Study|Adverse Event|2|||
145915637|NCT01068262|526195890|FG001|Overall Study|Adverse Event|0|||
145915638|NCT01068262|526195891|FG002|Overall Study|Adverse Event|1|||
145915639|NCT01068262|526195892|FG003|Overall Study|Adverse Event|0|||
145915640|NCT01068262|526195889|FG000|Overall Study|Protocol Violation|1|||
145915641|NCT01068262|526195890|FG001|Overall Study|Protocol Violation|0|||
145915642|NCT01068262|526195891|FG002|Overall Study|Protocol Violation|0|||
145915643|NCT01068262|526195892|FG003|Overall Study|Protocol Violation|0|||
145915644|NCT01068262|526195889|FG000|Overall Study|Withdrawal by Subject|0|||
145915645|NCT01068262|526195890|FG001|Overall Study|Withdrawal by Subject|1|||
145915646|NCT01068262|526195891|FG002|Overall Study|Withdrawal by Subject|0|||
145915647|NCT01068262|526195892|FG003|Overall Study|Withdrawal by Subject|0|||
145915648|NCT04182490|526195893|FG000|Overall Study|Withdrawal by Subject|3|||
145915649|NCT04182490|526195894|FG001|Overall Study|Withdrawal by Subject|3|||
145915650|NCT04182490|526195893|FG000|Overall Study|Lost to Follow-up|0|||
145915651|NCT04182490|526195894|FG001|Overall Study|Lost to Follow-up|1|||
145915652|NCT04182490|526195893|FG000|Overall Study|Physician Decision|0|||
145915653|NCT04182490|526195894|FG001|Overall Study|Physician Decision|1|||
145915654|NCT00853099|526195895|FG000|Double-blind Period|Adverse Event|7|||
145915655|NCT00853099|526195896|FG001|Double-blind Period|Adverse Event|9|||
145915656|NCT00853099|526195897|FG002|Double-blind Period|Adverse Event|13|||
145915657|NCT00853099|526195898|FG003|Double-blind Period|Adverse Event|0|||
145915658|NCT00853099|526195895|FG000|Double-blind Period|Withdrawal by Subject|2|||
145915659|NCT00853099|526195896|FG001|Double-blind Period|Withdrawal by Subject|3|||
145915660|NCT00853099|526195897|FG002|Double-blind Period|Withdrawal by Subject|0|||
145915661|NCT00853099|526195898|FG003|Double-blind Period|Withdrawal by Subject|0|||
145915662|NCT00853099|526195895|FG000|Double-blind Period|Lack of Efficacy|14|||
145915663|NCT00853099|526195896|FG001|Double-blind Period|Lack of Efficacy|17|||
145915664|NCT00853099|526195897|FG002|Double-blind Period|Lack of Efficacy|16|||
145915665|NCT00853099|526195898|FG003|Double-blind Period|Lack of Efficacy|0|||
145915666|NCT00853099|526195895|FG000|Double-blind Period|Other|0|||
145915667|NCT00853099|526195896|FG001|Double-blind Period|Other|0|||
145915668|NCT00853099|526195897|FG002|Double-blind Period|Other|1|||
145915669|NCT00853099|526195898|FG003|Double-blind Period|Other|0|||
145915670|NCT00853099|526195895|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
145915671|NCT00853099|526195896|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
145915672|NCT00853099|526195897|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
145915673|NCT00853099|526195898|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
145915674|NCT00853099|526195895|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145915675|NCT00853099|526195896|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145915676|NCT00853099|526195897|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145915677|NCT00853099|526195898|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
145915678|NCT00853099|526195895|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
145915679|NCT00853099|526195896|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
145915680|NCT00853099|526195897|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
145915681|NCT00853099|526195898|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
145915682|NCT00853099|526195895|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145915683|NCT00853099|526195896|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145915684|NCT00853099|526195897|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145915685|NCT00853099|526195898|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
145915686|NCT00853099|526195895|FG000|Double-blind + Open-label Periods|Other|0|||
145915687|NCT00853099|526195896|FG001|Double-blind + Open-label Periods|Other|0|||
145915688|NCT00853099|526195897|FG002|Double-blind + Open-label Periods|Other|0|||
145915689|NCT00853099|526195898|FG003|Double-blind + Open-label Periods|Other|6|||
145915690|NCT01811472|526195901|FG000|Overall Study|Adverse Event|1|||
145915691|NCT01811472|526195902|FG001|Overall Study|Adverse Event|0|||
145915692|NCT01811472|526195903|FG002|Overall Study|Adverse Event|4|||
145915693|NCT01811472|526195901|FG000|Overall Study|Lost to Follow-up|0|||
145915694|NCT01811472|526195902|FG001|Overall Study|Lost to Follow-up|0|||
145915695|NCT01811472|526195903|FG002|Overall Study|Lost to Follow-up|1|||
145915696|NCT01811472|526195901|FG000|Overall Study|Subject/guardian decision|1|||
145915697|NCT01811472|526195902|FG001|Overall Study|Subject/guardian decision|0|||
145915698|NCT01811472|526195903|FG002|Overall Study|Subject/guardian decision|0|||
145915699|NCT00124748|526195912|FG000|Overall Study|Adverse Event|8|||
145915700|NCT00124748|526195913|FG001|Overall Study|Adverse Event|39|||
145915701|NCT00124748|526195912|FG000|Overall Study|Abnormal laboratory Value|2|||
145915702|NCT00124748|526195913|FG001|Overall Study|Abnormal laboratory Value|2|||
145915703|NCT00124748|526195912|FG000|Overall Study|Abnormal Procedure|0|||
146239982|NCT01953692|527393139|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
146239983|NCT01953692|527393131|FG000|Overall Study|Withdrawal by Subject|4|||
146239984|NCT01953692|527393132|FG001|Overall Study|Withdrawal by Subject|2|||
146239985|NCT01953692|527393133|FG002|Overall Study|Withdrawal by Subject|1|||
146239986|NCT01953692|527393134|FG003|Overall Study|Withdrawal by Subject|2|||
146239987|NCT01953692|527393135|FG004|Overall Study|Withdrawal by Subject|0|||
146239988|NCT01953692|527393136|FG005|Overall Study|Withdrawal by Subject|3|||
146239989|NCT01953692|527393137|FG006|Overall Study|Withdrawal by Subject|2|||
146239990|NCT01953692|527393138|FG007|Overall Study|Withdrawal by Subject|1|||
146239991|NCT01953692|527393139|FG008|Overall Study|Withdrawal by Subject|1|||
146239992|NCT02022670|527393140|FG000|Overall Study|Adverse Event|1|||
146239993|NCT02022670|527393141|FG001|Overall Study|Adverse Event|0|||
146239994|NCT02022670|527393142|FG002|Overall Study|Adverse Event|1|||
146239995|NCT04677738|527393151|FG000|Overall Study|Withdrawal by Subject|4|||
146239996|NCT04677738|527393152|FG001|Overall Study|Withdrawal by Subject|2|||
146239997|NCT03697603|527393155|FG000|Overall Study|Adverse Event|3|||
146239998|NCT03697603|527393156|FG001|Overall Study|Adverse Event|18|||
146239999|NCT03697603|527393157|FG002|Overall Study|Adverse Event|3|||
146240000|NCT03697603|527393155|FG000|Overall Study|Physician Decision|1|||
146240001|NCT03697603|527393156|FG001|Overall Study|Physician Decision|0|||
146240002|NCT03697603|527393157|FG002|Overall Study|Physician Decision|2|||
146240003|NCT03697603|527393155|FG000|Overall Study|Protocol Violation|3|||
146240004|NCT03697603|527393156|FG001|Overall Study|Protocol Violation|8|||
146240005|NCT03697603|527393157|FG002|Overall Study|Protocol Violation|5|||
146240006|NCT03697603|527393155|FG000|Overall Study|Withdrawal by Subject|5|||
146240007|NCT03697603|527393156|FG001|Overall Study|Withdrawal by Subject|1|||
146240008|NCT03697603|527393157|FG002|Overall Study|Withdrawal by Subject|1|||
146240009|NCT03697603|527393155|FG000|Overall Study|Protocol Violation|0|||
146240010|NCT03697603|527393156|FG001|Overall Study|Protocol Violation|0|||
146240011|NCT03697603|527393157|FG002|Overall Study|Protocol Violation|1|||
146240012|NCT01683409|527393160|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146240013|NCT01683409|527393161|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146240014|NCT01683409|527393162|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
146240015|NCT01683409|527393163|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146240016|NCT01683409|527393164|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
146240017|NCT01683409|527393160|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
146240018|NCT01683409|527393161|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
146240019|NCT01683409|527393162|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
146240020|NCT01683409|527393163|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
146240021|NCT01683409|527393164|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
146240022|NCT01683409|527393160|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146240023|NCT01683409|527393161|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
146240024|NCT01683409|527393162|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146240025|NCT01683409|527393163|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146240026|NCT01683409|527393164|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
146240027|NCT01683409|527393160|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146240028|NCT01683409|527393161|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146240029|NCT01683409|527393162|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
146240030|NCT01683409|527393163|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
146240031|NCT01683409|527393164|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
146240032|NCT01683409|527393160|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146240033|NCT01683409|527393161|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146240034|NCT01683409|527393162|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
145915704|NCT00124748|526195913|FG001|Overall Study|Abnormal Procedure|1|||
145915705|NCT00124748|526195912|FG000|Overall Study|Lack of Efficacy|20|||
145915706|NCT00124748|526195913|FG001|Overall Study|Lack of Efficacy|41|||
146240035|NCT01683409|527393163|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146240036|NCT01683409|527393164|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
146240037|NCT01683409|527393160|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
146240038|NCT01683409|527393161|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146240039|NCT01683409|527393162|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146240040|NCT01683409|527393163|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
146240041|NCT01683409|527393164|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
146240042|NCT01683409|527393160|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
146240043|NCT01683409|527393161|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146240044|NCT01683409|527393162|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146240045|NCT01683409|527393163|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
146240046|NCT01683409|527393164|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
146240047|NCT01683409|527393160|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
146240048|NCT01683409|527393161|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146240049|NCT01683409|527393162|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146240050|NCT01683409|527393163|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146240051|NCT01683409|527393164|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
146240052|NCT01683409|527393160|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
146240053|NCT01683409|527393161|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
146240054|NCT01683409|527393162|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
146240055|NCT01683409|527393163|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
146240056|NCT01683409|527393164|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
146240057|NCT01683409|527393160|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146240058|NCT01683409|527393161|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146240059|NCT01683409|527393162|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146240060|NCT01683409|527393163|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
146240061|NCT01683409|527393164|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
146240062|NCT01683409|527393160|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146240063|NCT01683409|527393161|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146240064|NCT01683409|527393162|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
146240065|NCT01683409|527393163|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146240066|NCT01683409|527393164|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
146240067|NCT04218864|527393165|FG000|Overall Study|Lost to Follow-up|8|||
146240068|NCT04218864|527393166|FG001|Overall Study|Lost to Follow-up|4|||
146240069|NCT04218864|527393165|FG000|Overall Study|Withdrawal by Subject|1|||
146240070|NCT04218864|527393166|FG001|Overall Study|Withdrawal by Subject|3|||
146240071|NCT03520036|527393167|FG000|Overall Study|Adverse Event|1|||
146240072|NCT03520036|527393168|FG001|Overall Study|Adverse Event|2|||
146240073|NCT03520036|527393169|FG002|Overall Study|Adverse Event|0|||
146240074|NCT03520036|527393167|FG000|Overall Study|Protocol Violation|1|||
146240075|NCT03520036|527393168|FG001|Overall Study|Protocol Violation|0|||
146240076|NCT03520036|527393169|FG002|Overall Study|Protocol Violation|0|||
146240077|NCT03520036|527393167|FG000|Overall Study|Withdrawal by Subject|0|||
146240078|NCT03520036|527393168|FG001|Overall Study|Withdrawal by Subject|1|||
145915707|NCT00124748|526195912|FG000|Overall Study|No longer requires study drug|1|||
145915708|NCT00124748|526195913|FG001|Overall Study|No longer requires study drug|1|||
145915709|NCT00124748|526195912|FG000|Overall Study|Protocol Violation|3|||
145915710|NCT00124748|526195913|FG001|Overall Study|Protocol Violation|1|||
145915711|NCT00124748|526195912|FG000|Overall Study|Withdrawal by Subject|5|||
145915712|NCT00124748|526195913|FG001|Overall Study|Withdrawal by Subject|15|||
145915713|NCT00124748|526195912|FG000|Overall Study|Lost to Follow-up|2|||
145915714|NCT00124748|526195913|FG001|Overall Study|Lost to Follow-up|7|||
145915715|NCT00124748|526195912|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
145915716|NCT00124748|526195913|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
145915717|NCT00124748|526195912|FG000|Overall Study|Death|1|||
145915718|NCT00124748|526195913|FG001|Overall Study|Death|3|||
145915719|NCT00322712|526195914|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
145915720|NCT02790437|526195924|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
145915721|NCT02790437|526195925|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
145915722|NCT02790437|526195924|FG000|Overall Study|Adverse Event|1|||
145915723|NCT02790437|526195925|FG001|Overall Study|Adverse Event|0|||
145915724|NCT02790437|526195924|FG000|Overall Study|Withdrawal by Subject|1|||
145915725|NCT02790437|526195925|FG001|Overall Study|Withdrawal by Subject|0|||
145915726|NCT04688671|526195929|FG000|Overall Study|Adverse Event|3|||
145915727|NCT04688671|526195930|FG001|Overall Study|Adverse Event|1|||
145915728|NCT04688671|526195929|FG000|Overall Study|Withdrawal by Subject|3|||
145915729|NCT04688671|526195930|FG001|Overall Study|Withdrawal by Subject|1|||
145974011|NCT04896385|526418718|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
146240079|NCT03520036|527393169|FG002|Overall Study|Withdrawal by Subject|4|||
146240080|NCT03520036|527393167|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
145974012|NCT04896385|526418715|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
146240081|NCT03520036|527393168|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
146240082|NCT03520036|527393169|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
146240083|NCT00467272|527393170|FG000|Overall Study|Pneumonia|2|||
146240084|NCT00467272|527393170|FG000|Overall Study|Thrombophlebitis|1|||
146240085|NCT00145470|527393173|FG000|Overall Study|Adverse Event|19|||
146240086|NCT00145470|527393174|FG001|Overall Study|Adverse Event|25|||
145915730|NCT04688671|526195929|FG000|Overall Study|Lack of Efficacy|1|||
145915731|NCT04688671|526195930|FG001|Overall Study|Lack of Efficacy|1|||
145915732|NCT04688671|526195929|FG000|Overall Study|Protocol Violation|1|||
145915733|NCT04688671|526195930|FG001|Overall Study|Protocol Violation|0|||
146240087|NCT00145470|527393173|FG000|Overall Study|Lack of Efficacy|27|||
146240088|NCT00145470|527393174|FG001|Overall Study|Lack of Efficacy|13|||
146240089|NCT00145470|527393173|FG000|Overall Study|Withdrawal by Subject|36|||
146240090|NCT00145470|527393174|FG001|Overall Study|Withdrawal by Subject|34|||
146240091|NCT00145470|527393173|FG000|Overall Study|Lost to Follow-up|21|||
146240092|NCT00145470|527393174|FG001|Overall Study|Lost to Follow-up|17|||
146240093|NCT00145470|527393173|FG000|Overall Study|Reason Not Reported|9|||
146240094|NCT00145470|527393174|FG001|Overall Study|Reason Not Reported|9|||
146240095|NCT00676091|527393175|FG000|Infant Series|Parent or legal guardian request|10|||
146240096|NCT00676091|527393176|FG001|Infant Series|Parent or legal guardian request|8|||
146240097|NCT00676091|527393175|FG000|Infant Series|Protocol Violation|6|||
146240098|NCT00676091|527393176|FG001|Infant Series|Protocol Violation|3|||
146240099|NCT00676091|527393175|FG000|Infant Series|Adverse Event|2|||
146240100|NCT00676091|527393176|FG001|Infant Series|Adverse Event|3|||
146240101|NCT00676091|527393175|FG000|Infant Series|Failed to return|1|||
146240102|NCT00676091|527393176|FG001|Infant Series|Failed to return|3|||
145915734|NCT04688671|526195929|FG000|Overall Study|Lost to Follow-up|0|||
145915735|NCT04688671|526195930|FG001|Overall Study|Lost to Follow-up|1|||
145915736|NCT01626690|526195931|FG000|Overall Study|Protocol Violation|1|||
145915737|NCT01626690|526195932|FG001|Overall Study|Protocol Violation|0|||
145915738|NCT01626690|526195931|FG000|Overall Study|Adverse Event|1|||
145915739|NCT01626690|526195932|FG001|Overall Study|Adverse Event|0|||
145915740|NCT04720053|526195933|FG000|Overall Study|Lost to Follow-up|12|||
145915741|NCT01960257|526195934|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
145915742|NCT01960257|526195935|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
145915743|NCT01960257|526195936|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
145915744|NCT01960257|526195934|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
145915745|NCT01960257|526195935|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
145915746|NCT01960257|526195936|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
145915747|NCT01960257|526195934|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
145915748|NCT01960257|526195935|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
145915749|NCT01960257|526195936|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
145915750|NCT03908125|526195937|FG000|Overall Study|Withdrawal by Subject|92|||
145915751|NCT03908125|526195937|FG000|Overall Study|Lost to Follow-up|8|||
145915752|NCT01125189|526195938|FG000|Treatment Period|Lack of Efficacy|15|||
145915753|NCT01125189|526195939|FG001|Treatment Period|Lack of Efficacy|18|||
145915754|NCT01125189|526195940|FG002|Treatment Period|Lack of Efficacy|25|||
145915755|NCT01125189|526195938|FG000|Treatment Period|Adverse Event|7|||
145915756|NCT01125189|526195939|FG001|Treatment Period|Adverse Event|8|||
145915757|NCT01125189|526195940|FG002|Treatment Period|Adverse Event|8|||
145915758|NCT01125189|526195938|FG000|Treatment Period|Withdrawal by Subject|3|||
145915759|NCT01125189|526195939|FG001|Treatment Period|Withdrawal by Subject|1|||
145915760|NCT01125189|526195940|FG002|Treatment Period|Withdrawal by Subject|1|||
145915761|NCT01125189|526195938|FG000|Treatment Period|Death|1|||
145915762|NCT01125189|526195939|FG001|Treatment Period|Death|0|||
145915763|NCT01125189|526195940|FG002|Treatment Period|Death|0|||
145915764|NCT01125189|526195938|FG000|Treatment Period|Lost to Follow-up|1|||
145915765|NCT01125189|526195939|FG001|Treatment Period|Lost to Follow-up|2|||
145915766|NCT01125189|526195940|FG002|Treatment Period|Lost to Follow-up|1|||
145915767|NCT01125189|526195938|FG000|Treatment Period|Poor compliance/noncompliance|0|||
145915768|NCT01125189|526195939|FG001|Treatment Period|Poor compliance/noncompliance|1|||
145915769|NCT01125189|526195940|FG002|Treatment Period|Poor compliance/noncompliance|0|||
145915770|NCT01125189|526195938|FG000|Treatment Period|Participants requested to discontinue|1|||
145915771|NCT01125189|526195939|FG001|Treatment Period|Participants requested to discontinue|3|||
145915772|NCT01125189|526195940|FG002|Treatment Period|Participants requested to discontinue|4|||
145915773|NCT01125189|526195938|FG000|Treatment Period|Other reasons|1|||
145915774|NCT01125189|526195939|FG001|Treatment Period|Other reasons|1|||
145915775|NCT01125189|526195940|FG002|Treatment Period|Other reasons|0|||
145915776|NCT01125189|526195938|FG000|Treatment Period|Completed 24 week treatment period only|2|||
145915777|NCT01125189|526195939|FG001|Treatment Period|Completed 24 week treatment period only|1|||
145974013|NCT04896385|526418716|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
145974014|NCT04896385|526418717|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
145974015|NCT04896385|526418718|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
145974016|NCT04896385|526418715|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
145974017|NCT04896385|526418716|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
146240103|NCT00676091|527393175|FG000|Infant Series|Lost to Follow-up|1|||
146240104|NCT00676091|527393176|FG001|Infant Series|Lost to Follow-up|0|||
146240105|NCT00676091|527393175|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
145915778|NCT01125189|526195940|FG002|Treatment Period|Completed 24 week treatment period only|2|||
145915779|NCT01125189|526195938|FG000|Follow up Period|Withdrawal by Subject|3|||
145915780|NCT01125189|526195939|FG001|Follow up Period|Withdrawal by Subject|2|||
145915781|NCT01125189|526195940|FG002|Follow up Period|Withdrawal by Subject|5|||
145915782|NCT01125189|526195938|FG000|Follow up Period|Death|1|||
145915783|NCT01125189|526195939|FG001|Follow up Period|Death|0|||
145915784|NCT01125189|526195940|FG002|Follow up Period|Death|0|||
145915785|NCT01125189|526195938|FG000|Follow up Period|Lost to Follow-up|12|||
145915786|NCT01125189|526195939|FG001|Follow up Period|Lost to Follow-up|9|||
145915787|NCT01125189|526195940|FG002|Follow up Period|Lost to Follow-up|6|||
145915788|NCT01125189|526195938|FG000|Follow up Period|Other reasons|4|||
145915789|NCT01125189|526195939|FG001|Follow up Period|Other reasons|4|||
145915790|NCT01125189|526195940|FG002|Follow up Period|Other reasons|5|||
145915791|NCT00110396|526195941|FG000|Overall Study|Adverse Event|15|||
145915792|NCT00110396|526195941|FG000|Overall Study|Lost to Follow-up|1|||
145915793|NCT00110396|526195941|FG000|Overall Study|Administration of plasmapheresis|1|||
145915794|NCT00110396|526195941|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
145915795|NCT00110396|526195941|FG000|Overall Study|Lack of Efficacy|1|||
146240106|NCT00676091|527393176|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
146240107|NCT00676091|527393175|FG000|After Infant Series|Adverse Event|0|||
146240108|NCT00676091|527393176|FG001|After Infant Series|Adverse Event|1|||
146240109|NCT00676091|527393175|FG000|After Infant Series|Protocol Violation|0|||
146240110|NCT00676091|527393176|FG001|After Infant Series|Protocol Violation|1|||
146240111|NCT00676091|527393175|FG000|After Infant Series|Failed to return|1|||
146240112|NCT00676091|527393176|FG001|After Infant Series|Failed to return|1|||
146240113|NCT00676091|527393175|FG000|Toddler Dose|Failed to return|2|||
146240114|NCT00676091|527393176|FG001|Toddler Dose|Failed to return|0|||
146240115|NCT00676091|527393175|FG000|Toddler Dose|Parent or legal guardian request|1|||
146240116|NCT00676091|527393176|FG001|Toddler Dose|Parent or legal guardian request|0|||
146240117|NCT00933270|527393179|FG000|Overall Study|Withdrawal by Subject|26|||
146240118|NCT00933270|527393179|FG000|Overall Study|Insufficient Follow-up|10|||
146240119|NCT00933270|527393179|FG000|Overall Study|Lost to Follow-up|14|||
146240120|NCT00933270|527393179|FG000|Overall Study|Adverse Event|1|||
146240121|NCT00933270|527393179|FG000|Overall Study|Missed Visit|2|||
146240122|NCT00933270|527393179|FG000|Overall Study|Death|24|||
146240123|NCT00933270|527393179|FG000|Overall Study|Moved or would not return|10|||
146240124|NCT03343704|527393180|FG000|Overall Study|Refused to complete follow up|0|||
146240125|NCT03343704|527393181|FG001|Overall Study|Refused to complete follow up|1|||
146240126|NCT03343704|527393180|FG000|Overall Study|Death|0|||
146240127|NCT03343704|527393181|FG001|Overall Study|Death|1|||
146240128|NCT03343704|527393180|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
146240129|NCT03343704|527393181|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
146240130|NCT05349721|527394852|FG000|Part A (24 Weeks)|Adverse Event|9|||
146240131|NCT05349721|527394853|FG001|Part A (24 Weeks)|Adverse Event|2|||
146240132|NCT05349721|527394852|FG000|Part A (24 Weeks)|Death|8|||
146240133|NCT05349721|527394853|FG001|Part A (24 Weeks)|Death|3|||
146240134|NCT05349721|527394852|FG000|Part A (24 Weeks)|Disease Progression|1|||
146240135|NCT05349721|527394853|FG001|Part A (24 Weeks)|Disease Progression|1|||
146240136|NCT05349721|527394852|FG000|Part A (24 Weeks)|Screen Failure|2|||
146240137|NCT05349721|527394853|FG001|Part A (24 Weeks)|Screen Failure|0|||
146240138|NCT05349721|527394852|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
146240139|NCT05349721|527394853|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
146240140|NCT05349721|527394852|FG000|Part A (24 Weeks)|Other Than Specified|5|||
146240141|NCT05349721|527394853|FG001|Part A (24 Weeks)|Other Than Specified|1|||
146240142|NCT05349721|527394852|FG000|Part B (28 Weeks)|Adverse Event|3|||
146240143|NCT05349721|527394853|FG001|Part B (28 Weeks)|Adverse Event|0|||
146240144|NCT05349721|527394852|FG000|Part B (28 Weeks)|Death|21|||
146240145|NCT05349721|527394853|FG001|Part B (28 Weeks)|Death|11|||
146240146|NCT05349721|527394852|FG000|Part B (28 Weeks)|Disease Progression|2|||
146240147|NCT05349721|527394853|FG001|Part B (28 Weeks)|Disease Progression|1|||
146240148|NCT05349721|527394852|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
146240149|NCT05349721|527394853|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
146240150|NCT05349721|527394852|FG000|Part B (28 Weeks)|Physician Decision|1|||
146240151|NCT05349721|527394853|FG001|Part B (28 Weeks)|Physician Decision|0|||
146240152|NCT05349721|527394852|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
146240153|NCT05349721|527394853|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
146240154|NCT05349721|527394852|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
146240155|NCT05349721|527394853|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
146240156|NCT05349721|527394852|FG000|Part B (28 Weeks)|Other Than Specified|4|||
146240157|NCT05349721|527394853|FG001|Part B (28 Weeks)|Other Than Specified|2|||
146240158|NCT05349721|527394852|FG000|Part C (108 Weeks)|Death|0|||
146240159|NCT05349721|527394853|FG001|Part C (108 Weeks)|Death|1|||
145974018|NCT04896385|526418717|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
146240160|NCT05349721|527394852|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
146240161|NCT05349721|527394853|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
146240162|NCT05349721|527394852|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
145915796|NCT00110396|526195941|FG000|Overall Study|Decided not to continue treatment|1|||
145915797|NCT00110396|526195941|FG000|Overall Study|Patient non-compliance|1|||
146240163|NCT05349721|527394853|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
146240164|NCT05349721|527394852|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
146240165|NCT05349721|527394853|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
146240166|NCT03136159|527394855|FG000|Overall Study|chorioamnionitis|2|||
146240167|NCT03136159|527394856|FG001|Overall Study|chorioamnionitis|0|||
146240168|NCT03136159|527394855|FG000|Overall Study|vertical skin incision|1|||
145915798|NCT00110396|526195941|FG000|Overall Study|Patient refused to continue|1|||
146240169|NCT03136159|527394856|FG001|Overall Study|vertical skin incision|0|||
146240170|NCT03136159|527394855|FG000|Overall Study|additional dressing|1|||
146240171|NCT03136159|527394856|FG001|Overall Study|additional dressing|0|||
146240172|NCT03136159|527394855|FG000|Overall Study|never got dressing placed|1|||
146240173|NCT03136159|527394856|FG001|Overall Study|never got dressing placed|0|||
146240174|NCT03823703|527394857|FG000|Overall Study|Sponsor request|0|||
146240175|NCT03823703|527394858|FG001|Overall Study|Sponsor request|3|||
146240176|NCT03823703|527394859|FG002|Overall Study|Sponsor request|4|||
146240177|NCT03823703|527394857|FG000|Overall Study|Adverse Event|3|||
146240178|NCT03823703|527394858|FG001|Overall Study|Adverse Event|1|||
146240179|NCT03823703|527394859|FG002|Overall Study|Adverse Event|0|||
146240180|NCT03823703|527394857|FG000|Overall Study|Withdrawal by Subject|0|||
146240181|NCT03823703|527394858|FG001|Overall Study|Withdrawal by Subject|1|||
146240182|NCT03823703|527394859|FG002|Overall Study|Withdrawal by Subject|0|||
146240183|NCT03137459|527394860|FG000|2-month Assessment|Withdrawal by Subject|13|||
146240184|NCT03137459|527394861|FG001|2-month Assessment|Withdrawal by Subject|3|||
146240185|NCT03137459|527394860|FG000|2-month Assessment|Unable to reach|42|||
146240186|NCT03137459|527394861|FG001|2-month Assessment|Unable to reach|32|||
146240187|NCT03137459|527394860|FG000|2-month Assessment|Refused assessment|7|||
146240188|NCT03137459|527394861|FG001|2-month Assessment|Refused assessment|5|||
146240189|NCT03137459|527394860|FG000|2-month Assessment|Acutely ill|6|||
146240190|NCT03137459|527394861|FG001|2-month Assessment|Acutely ill|2|||
146240191|NCT03137459|527394860|FG000|4-month Assessment|Death|4|||
146240192|NCT03137459|527394861|FG001|4-month Assessment|Death|2|||
146240193|NCT03137459|527394860|FG000|4-month Assessment|Withdrawal by Subject|4|||
146240194|NCT03137459|527394861|FG001|4-month Assessment|Withdrawal by Subject|2|||
146240195|NCT03137459|527394860|FG000|4-month Assessment|Unable to reach|44|||
146240196|NCT03137459|527394861|FG001|4-month Assessment|Unable to reach|29|||
146240197|NCT03137459|527394860|FG000|4-month Assessment|Refused assessment|24|||
146240198|NCT03137459|527394861|FG001|4-month Assessment|Refused assessment|10|||
146240199|NCT03137459|527394860|FG000|4-month Assessment|Acutely ill|2|||
146240200|NCT03137459|527394861|FG001|4-month Assessment|Acutely ill|3|||
146240201|NCT03137459|527394860|FG000|6-months|Lost to Follow-up|14|||
146240202|NCT03137459|527394861|FG001|6-months|Lost to Follow-up|11|||
146240203|NCT03137459|527394860|FG000|6-months|Death|0|||
146240204|NCT03137459|527394861|FG001|6-months|Death|2|||
146240205|NCT03137459|527394860|FG000|6-months|Refused assessment|6|||
146240206|NCT03137459|527394861|FG001|6-months|Refused assessment|3|||
146240207|NCT03137459|527394860|FG000|6-months|Acutely ill|1|||
146240208|NCT03137459|527394861|FG001|6-months|Acutely ill|1|||
146240209|NCT00985088|527394862|FG000|Overall Study|Serious Adverse Event|1|||
146240210|NCT00985088|527394863|FG001|Overall Study|Serious Adverse Event|1|||
146240211|NCT00985088|527394864|FG002|Overall Study|Serious Adverse Event|0|||
146240212|NCT00985088|527394865|FG003|Overall Study|Serious Adverse Event|0|||
146240213|NCT00985088|527394866|FG004|Overall Study|Serious Adverse Event|0|||
146240214|NCT00985088|527394867|FG005|Overall Study|Serious Adverse Event|0|||
146240215|NCT00985088|527394868|FG006|Overall Study|Serious Adverse Event|0|||
146240216|NCT00985088|527394869|FG007|Overall Study|Serious Adverse Event|1|||
146240217|NCT00985088|527394862|FG000|Overall Study|Adverse Event|0|||
146240218|NCT00985088|527394863|FG001|Overall Study|Adverse Event|0|||
146240219|NCT00985088|527394864|FG002|Overall Study|Adverse Event|1|||
146240220|NCT00985088|527394865|FG003|Overall Study|Adverse Event|0|||
146240221|NCT00985088|527394866|FG004|Overall Study|Adverse Event|0|||
146240222|NCT00985088|527394867|FG005|Overall Study|Adverse Event|0|||
146240223|NCT00985088|527394868|FG006|Overall Study|Adverse Event|0|||
146240224|NCT00985088|527394869|FG007|Overall Study|Adverse Event|0|||
146240225|NCT00985088|527394862|FG000|Overall Study|Withdrawal by Subject|4|||
146240226|NCT00985088|527394863|FG001|Overall Study|Withdrawal by Subject|0|||
146240227|NCT00985088|527394864|FG002|Overall Study|Withdrawal by Subject|0|||
146240228|NCT00985088|527394865|FG003|Overall Study|Withdrawal by Subject|1|||
146240229|NCT00985088|527394866|FG004|Overall Study|Withdrawal by Subject|3|||
145915799|NCT00110396|526195941|FG000|Overall Study|Patient refused to participate|1|||
145915800|NCT00110396|526195941|FG000|Overall Study|Patient will|1|||
146240230|NCT00985088|527394867|FG005|Overall Study|Withdrawal by Subject|2|||
146240231|NCT00985088|527394868|FG006|Overall Study|Withdrawal by Subject|1|||
146240232|NCT00985088|527394869|FG007|Overall Study|Withdrawal by Subject|2|||
146240233|NCT00985088|527394862|FG000|Overall Study|Migrated/moved from study area|0|||
146240234|NCT00985088|527394863|FG001|Overall Study|Migrated/moved from study area|0|||
146240235|NCT00985088|527394864|FG002|Overall Study|Migrated/moved from study area|1|||
146240236|NCT00985088|527394865|FG003|Overall Study|Migrated/moved from study area|0|||
146240237|NCT00985088|527394866|FG004|Overall Study|Migrated/moved from study area|0|||
145915801|NCT00110396|526195941|FG000|Overall Study|Patient's decision|1|||
146240238|NCT00985088|527394867|FG005|Overall Study|Migrated/moved from study area|0|||
146240239|NCT00985088|527394868|FG006|Overall Study|Migrated/moved from study area|0|||
145915802|NCT00110396|526195941|FG000|Overall Study|Participation in MS vaccine study|1|||
146240240|NCT00985088|527394869|FG007|Overall Study|Migrated/moved from study area|1|||
145915803|NCT00110396|526195941|FG000|Overall Study|Pregnancy|1|||
145915804|NCT00110396|526195941|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
145974019|NCT04896385|526418718|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
145974020|NCT03197129|526418719|FG000|Overall Study|did not answer the VPT: shyness|4|||
145974021|NCT03197129|526418720|FG001|Overall Study|did not answer the VPT: shyness|5|||
145974022|NCT02442349|526418721|FG000|Overall Study|Death|95|||
145974023|NCT02442349|526418721|FG000|Overall Study|Withdrawal by Subject|27|||
145974024|NCT02442349|526418721|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
145974025|NCT02442349|526418721|FG000|Overall Study|Lost to Follow-up|1|||
145974026|NCT03126110|526418722|FG000|Phase 1|Death|2|||
145974027|NCT03126110|526418723|FG001|Phase 1|Death|2|||
145915805|NCT00110396|526195941|FG000|Overall Study|Protocol Violation|2|||
145915806|NCT00110396|526195941|FG000|Overall Study|Patient refused to come back|1|||
145915807|NCT00110396|526195941|FG000|Overall Study|The patient has refused|2|||
145915808|NCT00110396|526195941|FG000|Overall Study|The patient has refused to visit site|1|||
145915809|NCT00110396|526195941|FG000|Overall Study|Patient is to be administered copaxone|1|||
145915810|NCT02414958|526195944|FG000|Overall Study|Adverse Event|6|||
145915811|NCT02414958|526195945|FG001|Overall Study|Adverse Event|6|||
145915812|NCT02414958|526195946|FG002|Overall Study|Adverse Event|3|||
145915813|NCT02414958|526195944|FG000|Overall Study|Protocol Violation|10|||
145915814|NCT02414958|526195945|FG001|Overall Study|Protocol Violation|3|||
145915815|NCT02414958|526195946|FG002|Overall Study|Protocol Violation|1|||
145915816|NCT02414958|526195944|FG000|Overall Study|Lost to Follow-up|7|||
145974028|NCT03126110|526418724|FG002|Phase 1|Death|4|||
145974029|NCT03126110|526418725|FG003|Phase 1|Death|3|||
145974030|NCT03126110|526418726|FG004|Phase 1|Death|4|||
146089107|NCT00523367|526845157|FG000|Overall Study|4 Withdrawn by PI|4|||
146089108|NCT00543855|526847254|FG000|Overall Study|Adverse Event|3|||
146089109|NCT00543855|526847255|FG001|Overall Study|Adverse Event|1|||
146089110|NCT00543855|526847256|FG002|Overall Study|Adverse Event|3|||
146089111|NCT00543855|526847257|FG003|Overall Study|Adverse Event|4|||
146089112|NCT00543855|526847254|FG000|Overall Study|Lost to Follow-up|0|||
146089113|NCT00543855|526847255|FG001|Overall Study|Lost to Follow-up|0|||
146089114|NCT00543855|526847256|FG002|Overall Study|Lost to Follow-up|1|||
146089115|NCT00543855|526847257|FG003|Overall Study|Lost to Follow-up|0|||
146089116|NCT00543855|526847254|FG000|Overall Study|Withdrawal by Subject|0|||
146089117|NCT00543855|526847255|FG001|Overall Study|Withdrawal by Subject|1|||
146089118|NCT00543855|526847256|FG002|Overall Study|Withdrawal by Subject|2|||
146089119|NCT00543855|526847257|FG003|Overall Study|Withdrawal by Subject|0|||
146089120|NCT00543855|526847254|FG000|Overall Study|Protocol Violation|1|||
146089121|NCT00543855|526847255|FG001|Overall Study|Protocol Violation|0|||
146089122|NCT00543855|526847256|FG002|Overall Study|Protocol Violation|0|||
146089123|NCT00543855|526847257|FG003|Overall Study|Protocol Violation|0|||
146089124|NCT04285580|526847258|FG000|Overall Study|Protocol Violation|0|||
146089125|NCT04285580|526847259|FG001|Overall Study|Protocol Violation|1|||
146089126|NCT02582255|526847260|FG000|Overall Study|Protocol Violation|0|||
146089127|NCT02582255|526847261|FG001|Overall Study|Protocol Violation|3|||
146089128|NCT01709578|526847263|FG000|Overall Study|Rescued and entered in long term safety|63|||
146089129|NCT01709578|526847264|FG001|Overall Study|Rescued and entered in long term safety|25|||
146089130|NCT01709578|526847265|FG002|Overall Study|Rescued and entered in long term safety|26|||
146089131|NCT01709578|526847263|FG000|Overall Study|Adverse Event|9|||
146089132|NCT01709578|526847264|FG001|Overall Study|Adverse Event|18|||
146089133|NCT01709578|526847265|FG002|Overall Study|Adverse Event|17|||
146089134|NCT01709578|526847263|FG000|Overall Study|Lack of Efficacy|5|||
146089135|NCT01709578|526847264|FG001|Overall Study|Lack of Efficacy|4|||
146089136|NCT01709578|526847265|FG002|Overall Study|Lack of Efficacy|2|||
146089137|NCT01709578|526847263|FG000|Overall Study|Poor compliance to protocol|1|||
146089138|NCT01709578|526847264|FG001|Overall Study|Poor compliance to protocol|2|||
146089139|NCT01709578|526847265|FG002|Overall Study|Poor compliance to protocol|1|||
146089140|NCT01709578|526847263|FG000|Overall Study|Other, not related to safety or efficacy|2|||
146089141|NCT01709578|526847264|FG001|Overall Study|Other, not related to safety or efficacy|7|||
145915817|NCT02414958|526195945|FG001|Overall Study|Lost to Follow-up|4|||
145915818|NCT02414958|526195946|FG002|Overall Study|Lost to Follow-up|0|||
145915819|NCT02414958|526195944|FG000|Overall Study|Withdrawal by Subject|5|||
145915820|NCT02414958|526195945|FG001|Overall Study|Withdrawal by Subject|3|||
145974031|NCT03126110|526418727|FG005|Phase 1|Death|4|||
145974032|NCT03126110|526418728|FG006|Phase 1|Death|3|||
145974033|NCT03126110|526418729|FG007|Phase 1|Death|4|||
145974034|NCT03126110|526418730|FG008|Phase 1|Death|5|||
145974035|NCT03126110|526418731|FG009|Phase 1|Death|2|||
146089142|NCT01709578|526847265|FG002|Overall Study|Other, not related to safety or efficacy|5|||
146089143|NCT01314911|526847267|FG000|Overall Study|Lost to Follow-up|3|||
146089144|NCT01314911|526847268|FG001|Overall Study|Lost to Follow-up|2|||
146089145|NCT01314911|526847267|FG000|Overall Study|Withdrawal by Subject|1|||
146089146|NCT01314911|526847268|FG001|Overall Study|Withdrawal by Subject|3|||
146089147|NCT01314911|526847267|FG000|Overall Study|Received Non-randomized Study Drug|0|||
146089148|NCT01314911|526847268|FG001|Overall Study|Received Non-randomized Study Drug|1|||
146089149|NCT01314911|526847267|FG000|Overall Study|Never Started Treatment|1|||
145974036|NCT03126110|526418732|FG010|Phase 1|Death|6|||
145974037|NCT03126110|526418733|FG011|Phase 1|Death|0|||
145974038|NCT03126110|526418734|FG012|Phase 1|Death|0|||
145974039|NCT03126110|526418735|FG013|Phase 1|Death|0|||
145974040|NCT03126110|526418736|FG014|Phase 1|Death|0|||
145974041|NCT03126110|526418737|FG015|Phase 1|Death|0|||
145974042|NCT03126110|526418738|FG016|Phase 1|Death|0|||
145974043|NCT03126110|526418722|FG000|Phase 1|Lost to Follow-up|0|||
146240241|NCT00985088|527394862|FG000|Overall Study|Lost to Follow-up|6|||
146240242|NCT00985088|527394863|FG001|Overall Study|Lost to Follow-up|1|||
146240243|NCT00985088|527394864|FG002|Overall Study|Lost to Follow-up|2|||
146240244|NCT00985088|527394865|FG003|Overall Study|Lost to Follow-up|6|||
146240245|NCT00985088|527394866|FG004|Overall Study|Lost to Follow-up|6|||
146240246|NCT00985088|527394867|FG005|Overall Study|Lost to Follow-up|5|||
146240247|NCT00985088|527394868|FG006|Overall Study|Lost to Follow-up|3|||
146240248|NCT00985088|527394869|FG007|Overall Study|Lost to Follow-up|2|||
146240249|NCT01732757|527394870|FG000|Overall Study|Lost to Follow-up|1|||
146240250|NCT01732757|527394871|FG001|Overall Study|Lost to Follow-up|0|||
146240251|NCT01732757|527394872|FG002|Overall Study|Lost to Follow-up|0|||
146240252|NCT00491400|527394873|FG000|Overall Study|Withdrawal by Subject|5|||
146240253|NCT00491400|527394874|FG001|Overall Study|Withdrawal by Subject|4|||
146240254|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
146240255|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
145915821|NCT02414958|526195946|FG002|Overall Study|Withdrawal by Subject|5|||
145915822|NCT02414958|526195944|FG000|Overall Study|Other than specified|4|||
145915823|NCT02414958|526195945|FG001|Overall Study|Other than specified|4|||
145915824|NCT02414958|526195946|FG002|Overall Study|Other than specified|5|||
145915825|NCT00245466|526195951|FG000|Overall Study|Adverse Event|2|||
145915826|NCT00245466|526195952|FG001|Overall Study|Adverse Event|8|||
145915827|NCT00245466|526195953|FG002|Overall Study|Adverse Event|4|||
145915828|NCT00245466|526195951|FG000|Overall Study|Low prostate specific antigen suppr|16|||
145915829|NCT00245466|526195952|FG001|Overall Study|Low prostate specific antigen suppr|14|||
145915830|NCT00245466|526195953|FG002|Overall Study|Low prostate specific antigen suppr|5|||
145915831|NCT00245466|526195951|FG000|Overall Study|Insufficient testosterone suppr|12|||
145915832|NCT00245466|526195952|FG001|Overall Study|Insufficient testosterone suppr|12|||
145915833|NCT00245466|526195953|FG002|Overall Study|Insufficient testosterone suppr|21|||
145915834|NCT00245466|526195951|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
145915835|NCT00245466|526195952|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
145915836|NCT00245466|526195953|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
145915837|NCT00245466|526195951|FG000|Overall Study|Withdrawal by Subject|2|||
145915838|NCT00245466|526195952|FG001|Overall Study|Withdrawal by Subject|2|||
145915839|NCT00245466|526195953|FG002|Overall Study|Withdrawal by Subject|1|||
145915840|NCT00245466|526195951|FG000|Overall Study|Lost to Follow-up|3|||
145915841|NCT00245466|526195952|FG001|Overall Study|Lost to Follow-up|0|||
145915842|NCT00245466|526195953|FG002|Overall Study|Lost to Follow-up|0|||
145915843|NCT00245466|526195951|FG000|Overall Study|Disease progression|0|||
145915844|NCT00245466|526195952|FG001|Overall Study|Disease progression|3|||
145915845|NCT00245466|526195953|FG002|Overall Study|Disease progression|1|||
145915846|NCT00245466|526195951|FG000|Overall Study|Protocol Violation|1|||
145915847|NCT00245466|526195952|FG001|Overall Study|Protocol Violation|2|||
145915848|NCT00245466|526195953|FG002|Overall Study|Protocol Violation|2|||
145915849|NCT00245466|526195951|FG000|Overall Study|Death|0|||
145915850|NCT00245466|526195952|FG001|Overall Study|Death|2|||
145915851|NCT00245466|526195953|FG002|Overall Study|Death|0|||
145915852|NCT00245466|526195951|FG000|Overall Study|Administrative reasons|0|||
145915853|NCT00245466|526195952|FG001|Overall Study|Administrative reasons|1|||
145915854|NCT00245466|526195953|FG002|Overall Study|Administrative reasons|0|||
145915855|NCT05064397|526195954|FG000|Overall Study|Adverse Event|4|||
145915856|NCT05064397|526195954|FG000|Overall Study|Lack of Efficacy|12|||
145915857|NCT05064397|526195954|FG000|Overall Study|Withdrawal by Subject|3|||
145915858|NCT05064397|526195954|FG000|Overall Study|Lost to Follow-up|1|||
145915859|NCT05064397|526195954|FG000|Overall Study|Other reasons|3|||
145915860|NCT00769379|526195955|FG000|Overall Study|No follow up data mapped to Other.|3|||
145915861|NCT00769379|526195956|FG001|Overall Study|No follow up data mapped to Other.|13|||
145915862|NCT00344448|526195959|FG000|Screening|Withdrawal by Subject|0|||
145915863|NCT00344448|526195960|FG001|Screening|Withdrawal by Subject|1|||
145915864|NCT00344448|526195959|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
145915865|NCT00344448|526195960|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
145915866|NCT00344448|526195959|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
145915867|NCT00344448|526195960|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
145974044|NCT03126110|526418723|FG001|Phase 1|Lost to Follow-up|1|||
146240256|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
146240257|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
146240258|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
145915868|NCT00344448|526195959|FG000|Open Label|Withdrawal by Subject|1|||
145915869|NCT00344448|526195960|FG001|Open Label|Withdrawal by Subject|1|||
145974045|NCT03126110|526418724|FG002|Phase 1|Lost to Follow-up|0|||
145974046|NCT03126110|526418725|FG003|Phase 1|Lost to Follow-up|0|||
145915870|NCT00344448|526195959|FG000|Open Label|Study terminated|1|||
145915871|NCT00344448|526195960|FG001|Open Label|Study terminated|0|||
145915872|NCT04194645|526195965|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915873|NCT04194645|526195966|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915874|NCT04194645|526195967|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915875|NCT04194645|526195968|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915876|NCT04194645|526195969|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915877|NCT04194645|526195970|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915878|NCT04194645|526195971|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915879|NCT04194645|526195972|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915880|NCT04194645|526195973|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915881|NCT04194645|526195974|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
145915882|NCT04194645|526195975|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915883|NCT04194645|526195976|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915884|NCT04194645|526195977|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915885|NCT04194645|526195978|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915886|NCT04194645|526195979|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145915887|NCT03076775|526195980|FG000|Overall Study|Lost to Follow-up|1|||
145915888|NCT03076775|526195981|FG001|Overall Study|Lost to Follow-up|0|||
145915889|NCT01783886|526195982|FG000|Overall Study|Lost to Follow-up|0|||
145915890|NCT01783886|526195983|FG001|Overall Study|Lost to Follow-up|3|||
145915891|NCT01783886|526195984|FG002|Overall Study|Lost to Follow-up|0|||
145915892|NCT01783886|526195982|FG000|Overall Study|Protocol deviation|0|||
145915893|NCT01783886|526195983|FG001|Overall Study|Protocol deviation|0|||
145915894|NCT01783886|526195984|FG002|Overall Study|Protocol deviation|2|||
145915895|NCT01783886|526195982|FG000|Overall Study|Withdrawal of consent by participant|1|||
145915896|NCT01783886|526195983|FG001|Overall Study|Withdrawal of consent by participant|3|||
145915897|NCT01783886|526195984|FG002|Overall Study|Withdrawal of consent by participant|4|||
145915898|NCT01783886|526195982|FG000|Overall Study|Adverse Event|4|||
145915899|NCT01783886|526195983|FG001|Overall Study|Adverse Event|5|||
145915900|NCT01783886|526195984|FG002|Overall Study|Adverse Event|4|||
145915901|NCT04542057|526195985|FG000|Overall Study|Death|3|||
145915902|NCT04542057|526195986|FG001|Overall Study|Death|1|||
145915903|NCT04542057|526195985|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
145915904|NCT04542057|526195986|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
145915905|NCT04542057|526195985|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
145915906|NCT04542057|526195986|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
146240259|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
146240260|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
146240261|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
146240262|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
146240263|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
146240264|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
146240265|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
146240266|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Other|1|||
146240267|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Other|0|||
146240268|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Other|0|||
146240269|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
146240270|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
146240271|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
146240272|NCT00887224|527394877|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
146240273|NCT00887224|527394878|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
146240274|NCT00887224|527394879|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
146240275|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
146240276|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
146240277|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
146240278|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
146240279|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
146240280|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
146240281|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
145915907|NCT04542057|526195985|FG000|Overall Study|Adverse Event|15|||
145915908|NCT04542057|526195986|FG001|Overall Study|Adverse Event|6|||
146240282|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
146240283|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
146240284|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
145915909|NCT04542057|526195985|FG000|Overall Study|COVID-19 adverse event|6|||
145915910|NCT04542057|526195986|FG001|Overall Study|COVID-19 adverse event|4|||
145915911|NCT04542057|526195985|FG000|Overall Study|Lack of Efficacy|2|||
145915912|NCT04542057|526195986|FG001|Overall Study|Lack of Efficacy|5|||
145915913|NCT04542057|526195985|FG000|Overall Study|Study terminated by sponsor|1|||
145915914|NCT04542057|526195986|FG001|Overall Study|Study terminated by sponsor|0|||
145915915|NCT04542057|526195985|FG000|Overall Study|Investigator discretion|2|||
145974047|NCT03126110|526418726|FG004|Phase 1|Lost to Follow-up|0|||
145915916|NCT04542057|526195986|FG001|Overall Study|Investigator discretion|1|||
145915917|NCT04542057|526195985|FG000|Overall Study|Withdrawal by Subject|52|||
145915918|NCT04542057|526195986|FG001|Overall Study|Withdrawal by Subject|30|||
146240285|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
146240286|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
146240287|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Other|1|||
146240288|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Other|0|||
145915919|NCT04542057|526195985|FG000|Overall Study|Lost to Follow-up|8|||
145915920|NCT04542057|526195986|FG001|Overall Study|Lost to Follow-up|11|||
145915921|NCT04542057|526195985|FG000|Overall Study|Other|2|||
145915922|NCT04542057|526195986|FG001|Overall Study|Other|2|||
145915923|NCT00940316|526195989|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
145915924|NCT00940316|526195990|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
145915925|NCT00940316|526195991|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
145915926|NCT00940316|526195989|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
145915927|NCT00940316|526195990|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
145915928|NCT00940316|526195991|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
145915929|NCT00940316|526195989|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
145915930|NCT00940316|526195990|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
145915931|NCT00940316|526195991|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
145915932|NCT00940316|526195989|FG000|Treated After Cycle 5|Adverse Event|0|||
145915933|NCT00940316|526195990|FG001|Treated After Cycle 5|Adverse Event|0|||
145915934|NCT00940316|526195991|FG002|Treated After Cycle 5|Adverse Event|1|||
145915935|NCT00940316|526195989|FG000|Treated After Cycle 5|Progressive disease|0|||
145915936|NCT00940316|526195990|FG001|Treated After Cycle 5|Progressive disease|1|||
145915937|NCT00940316|526195991|FG002|Treated After Cycle 5|Progressive disease|0|||
145915938|NCT03404674|526195993|FG000|Overall Study|Inability to Attend Future Visits|0|||
145915939|NCT03404674|526195994|FG001|Overall Study|Inability to Attend Future Visits|1|||
145915940|NCT03404674|526195995|FG002|Overall Study|Inability to Attend Future Visits|1|||
145915941|NCT03404674|526195996|FG003|Overall Study|Inability to Attend Future Visits|0|||
145915942|NCT03404674|526195997|FG004|Overall Study|Inability to Attend Future Visits|0|||
145915943|NCT03404674|526195998|FG005|Overall Study|Inability to Attend Future Visits|0|||
145915944|NCT03404674|526195993|FG000|Overall Study|Behavioral Problems|0|||
145915945|NCT03404674|526195994|FG001|Overall Study|Behavioral Problems|0|||
145915946|NCT03404674|526195995|FG002|Overall Study|Behavioral Problems|1|||
145915947|NCT03404674|526195996|FG003|Overall Study|Behavioral Problems|0|||
145915948|NCT03404674|526195997|FG004|Overall Study|Behavioral Problems|0|||
145915949|NCT03404674|526195998|FG005|Overall Study|Behavioral Problems|0|||
145915950|NCT03404674|526195993|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
145915951|NCT03404674|526195994|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
145915952|NCT03404674|526195995|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
145915953|NCT03404674|526195996|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
145915954|NCT03404674|526195997|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
145915955|NCT03404674|526195998|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
145915956|NCT02324582|526195999|FG000|Overall Study|Screen Failures|0|||
145915957|NCT02324582|526196000|FG001|Overall Study|Screen Failures|5|||
145915958|NCT00996489|526196002|FG000|Overall Study|Device failure|45|||
145915959|NCT00996489|526196002|FG000|Overall Study|Discontinued|116|||
145915960|NCT00952731|526196011|FG000|Overall Study|Drug supply expired|1|||
145915961|NCT00952731|526196012|FG001|Overall Study|Drug supply expired|0|||
145915962|NCT01184079|526196013|FG000|Overall Study|Lost to Follow-up|14|||
145915963|NCT01184079|526196014|FG001|Overall Study|Lost to Follow-up|2|||
145915964|NCT04233073|526196015|FG000|Overall Study|Death|5|||
145915965|NCT02603146|526198058|FG000|Overall Study|Lost to Follow-up|5|||
145915966|NCT02603146|526198059|FG001|Overall Study|Lost to Follow-up|6|||
145915967|NCT02603146|526198058|FG000|Overall Study|Withdrawal by Subject|8|||
146240289|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Other|0|||
146240290|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
146240291|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
146240292|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
145915968|NCT02603146|526198059|FG001|Overall Study|Withdrawal by Subject|10|||
145915969|NCT02603146|526198058|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
145915970|NCT02603146|526198059|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
145915971|NCT02603146|526198058|FG000|Overall Study|Participant moved|2|||
145915972|NCT02603146|526198059|FG001|Overall Study|Participant moved|0|||
145915973|NCT02603146|526198058|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
145915974|NCT02603146|526198059|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
145915975|NCT00818766|526198064|FG000|Overall Study|Could not be Contacted on Day 28|11|||
145915976|NCT00818766|526198065|FG001|Overall Study|Could not be Contacted on Day 28|10|||
145915977|NCT00818766|526198064|FG000|Overall Study|Death|1|||
145915978|NCT00818766|526198065|FG001|Overall Study|Death|0|||
145915979|NCT00818766|526198064|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
145915980|NCT00818766|526198065|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
146240293|NCT00887224|527394877|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
146240294|NCT00887224|527394878|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
146240295|NCT00887224|527394879|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
146240296|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
146240297|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
146240298|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
146240299|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
146240300|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
146240301|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
146240302|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
146240303|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
146240304|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
146240305|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
146240306|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
146240307|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
146240308|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Other|30|||
146240309|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Other|0|||
146240310|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Other|0|||
146240311|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
146240312|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
146240313|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
146240314|NCT00887224|527394877|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
146240315|NCT00887224|527394878|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
146240316|NCT00887224|527394879|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
146240317|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Adverse Event|0|||
146240318|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Adverse Event|7|||
146240319|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Adverse Event|2|||
145915981|NCT02719184|526198070|FG000|Overall Study|Other than listed|1|||
145915982|NCT02719184|526198071|FG001|Overall Study|Other than listed|12|||
145915983|NCT02719184|526198072|FG002|Overall Study|Other than listed|13|||
145915984|NCT02719184|526198073|FG003|Overall Study|Other than listed|22|||
145915985|NCT02719184|526198074|FG004|Overall Study|Other than listed|9|||
145915986|NCT02719184|526198070|FG000|Overall Study|Withdrawal by Subject|5|||
145915987|NCT02719184|526198071|FG001|Overall Study|Withdrawal by Subject|3|||
145915988|NCT02719184|526198072|FG002|Overall Study|Withdrawal by Subject|6|||
145915989|NCT02719184|526198073|FG003|Overall Study|Withdrawal by Subject|6|||
145915990|NCT02719184|526198074|FG004|Overall Study|Withdrawal by Subject|0|||
145915991|NCT02719184|526198070|FG000|Overall Study|Lost to Follow-up|0|||
145915992|NCT02719184|526198071|FG001|Overall Study|Lost to Follow-up|4|||
145915993|NCT02719184|526198072|FG002|Overall Study|Lost to Follow-up|1|||
145915994|NCT02719184|526198073|FG003|Overall Study|Lost to Follow-up|3|||
145915995|NCT02719184|526198074|FG004|Overall Study|Lost to Follow-up|0|||
145915996|NCT02719184|526198070|FG000|Overall Study|Protocol Violation|0|||
145915997|NCT02719184|526198071|FG001|Overall Study|Protocol Violation|3|||
145915998|NCT02719184|526198072|FG002|Overall Study|Protocol Violation|0|||
145915999|NCT02719184|526198073|FG003|Overall Study|Protocol Violation|2|||
145916000|NCT02719184|526198074|FG004|Overall Study|Protocol Violation|0|||
145916001|NCT02719184|526198070|FG000|Overall Study|Adverse Event|0|||
145916002|NCT02719184|526198071|FG001|Overall Study|Adverse Event|0|||
145916003|NCT02719184|526198072|FG002|Overall Study|Adverse Event|0|||
145916004|NCT02719184|526198073|FG003|Overall Study|Adverse Event|3|||
145916005|NCT02719184|526198074|FG004|Overall Study|Adverse Event|0|||
145916006|NCT00470535|526198078|FG000|Overall Study|Disease Progression|13|||
145916007|NCT00470535|526198078|FG000|Overall Study|Withdrawal by Subject|1|||
145916008|NCT00470535|526198078|FG000|Overall Study|Adverse Event|1|||
145916009|NCT00470535|526198078|FG000|Overall Study|Death|1|||
145916010|NCT00470535|526198078|FG000|Overall Study|Other|2|||
145916011|NCT04108299|526198080|FG000|Overall Study|Not interested in participating|2|||
145916012|NCT04108299|526198081|FG001|Overall Study|Not interested in participating|1|||
145916013|NCT04108299|526198082|FG002|Overall Study|Not interested in participating|2|||
145916014|NCT04108299|526198083|FG003|Overall Study|Not interested in participating|1|||
145916015|NCT04123405|526198087|FG000|Overall Study|Adverse Event|1|||
145916016|NCT04123405|526198088|FG001|Overall Study|Adverse Event|2|||
145916017|NCT04123405|526198089|FG002|Overall Study|Adverse Event|3|||
145916018|NCT04123405|526198090|FG003|Overall Study|Adverse Event|3|||
145916019|NCT04123405|526198087|FG000|Overall Study|Exclusion criteria met|1|||
145974048|NCT03126110|526418727|FG005|Phase 1|Lost to Follow-up|0|||
146240320|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Failed to return|0|||
146240321|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Failed to return|2|||
145916020|NCT04123405|526198088|FG001|Overall Study|Exclusion criteria met|2|||
145916021|NCT04123405|526198089|FG002|Overall Study|Exclusion criteria met|0|||
145916022|NCT04123405|526198090|FG003|Overall Study|Exclusion criteria met|2|||
145916023|NCT04123405|526198087|FG000|Overall Study|Withdrawal by Subject|1|||
145916024|NCT04123405|526198088|FG001|Overall Study|Withdrawal by Subject|3|||
145916025|NCT04123405|526198089|FG002|Overall Study|Withdrawal by Subject|0|||
145916026|NCT04123405|526198090|FG003|Overall Study|Withdrawal by Subject|2|||
145916027|NCT04123405|526198087|FG000|Overall Study|Contact to subject lost|0|||
145916028|NCT04123405|526198088|FG001|Overall Study|Contact to subject lost|0|||
145916029|NCT04123405|526198089|FG002|Overall Study|Contact to subject lost|0|||
145916030|NCT04123405|526198090|FG003|Overall Study|Contact to subject lost|1|||
145916031|NCT04123405|526198087|FG000|Overall Study|screening failure|1|||
145916032|NCT04123405|526198088|FG001|Overall Study|screening failure|0|||
145916033|NCT04123405|526198089|FG002|Overall Study|screening failure|0|||
145916034|NCT04123405|526198090|FG003|Overall Study|screening failure|0|||
145916035|NCT00662649|526198092|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
145916036|NCT00662649|526198093|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
145916037|NCT00662649|526198094|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
145916038|NCT00662649|526198095|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
145916039|NCT00662649|526198096|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
145916040|NCT00662649|526198092|FG000|Core Study (24 Months)|Adverse Event|22|||
145916041|NCT00662649|526198093|FG001|Core Study (24 Months)|Adverse Event|13|||
145916042|NCT00662649|526198094|FG002|Core Study (24 Months)|Adverse Event|18|||
145916043|NCT00662649|526198095|FG003|Core Study (24 Months)|Adverse Event|0|||
145916044|NCT00662649|526198096|FG004|Core Study (24 Months)|Adverse Event|0|||
145916045|NCT00662649|526198092|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
145916046|NCT00662649|526198093|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
145916047|NCT00662649|526198094|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
145916048|NCT00662649|526198095|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
145916049|NCT00662649|526198096|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
145916050|NCT00662649|526198092|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
145916051|NCT00662649|526198093|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
145916052|NCT00662649|526198094|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
145916053|NCT00662649|526198095|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
145916054|NCT00662649|526198096|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
145916055|NCT00662649|526198092|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
145916056|NCT00662649|526198093|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
145916057|NCT00662649|526198094|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
145916058|NCT00662649|526198095|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
145916059|NCT00662649|526198096|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
145916060|NCT00662649|526198092|FG000|Core Study (24 Months)|Protocol Violation|5|||
145916061|NCT00662649|526198093|FG001|Core Study (24 Months)|Protocol Violation|5|||
145916062|NCT00662649|526198094|FG002|Core Study (24 Months)|Protocol Violation|4|||
145916063|NCT00662649|526198095|FG003|Core Study (24 Months)|Protocol Violation|0|||
145916064|NCT00662649|526198096|FG004|Core Study (24 Months)|Protocol Violation|0|||
145916065|NCT00662649|526198092|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
145916066|NCT00662649|526198093|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
145916067|NCT00662649|526198094|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
145916068|NCT00662649|526198095|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
145916069|NCT00662649|526198096|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
145916070|NCT00662649|526198092|FG000|Core Study (24 Months)|Death|1|||
145916071|NCT00662649|526198093|FG001|Core Study (24 Months)|Death|0|||
145916072|NCT00662649|526198094|FG002|Core Study (24 Months)|Death|2|||
145916073|NCT00662649|526198095|FG003|Core Study (24 Months)|Death|0|||
145916074|NCT00662649|526198096|FG004|Core Study (24 Months)|Death|0|||
145974049|NCT03126110|526418728|FG006|Phase 1|Lost to Follow-up|0|||
145974050|NCT03126110|526418729|FG007|Phase 1|Lost to Follow-up|0|||
145974051|NCT03126110|526418730|FG008|Phase 1|Lost to Follow-up|1|||
145974052|NCT03126110|526418731|FG009|Phase 1|Lost to Follow-up|0|||
145974053|NCT03126110|526418732|FG010|Phase 1|Lost to Follow-up|0|||
145974054|NCT03126110|526418733|FG011|Phase 1|Lost to Follow-up|0|||
145974055|NCT03126110|526418734|FG012|Phase 1|Lost to Follow-up|0|||
145974056|NCT03126110|526418735|FG013|Phase 1|Lost to Follow-up|0|||
145974057|NCT03126110|526418736|FG014|Phase 1|Lost to Follow-up|0|||
145974058|NCT03126110|526418737|FG015|Phase 1|Lost to Follow-up|0|||
145974059|NCT03126110|526418738|FG016|Phase 1|Lost to Follow-up|0|||
145974060|NCT03126110|526418722|FG000|Phase 1|Withdrawal by Subject|1|||
145974061|NCT03126110|526418723|FG001|Phase 1|Withdrawal by Subject|0|||
145974062|NCT03126110|526418724|FG002|Phase 1|Withdrawal by Subject|0|||
145974063|NCT03126110|526418725|FG003|Phase 1|Withdrawal by Subject|1|||
145916075|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
145916076|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
145916077|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
145916078|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
145974064|NCT03126110|526418726|FG004|Phase 1|Withdrawal by Subject|1|||
145974065|NCT03126110|526418727|FG005|Phase 1|Withdrawal by Subject|0|||
145974066|NCT03126110|526418728|FG006|Phase 1|Withdrawal by Subject|0|||
145974067|NCT03126110|526418729|FG007|Phase 1|Withdrawal by Subject|0|||
145974068|NCT03126110|526418730|FG008|Phase 1|Withdrawal by Subject|2|||
145974069|NCT03126110|526418731|FG009|Phase 1|Withdrawal by Subject|1|||
145974070|NCT03126110|526418732|FG010|Phase 1|Withdrawal by Subject|0|||
146240322|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Failed to return|2|||
146240323|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
146240324|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
146240325|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
146240326|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
146240327|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
146240328|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
145916079|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
145916080|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
145916081|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
145916082|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
145916083|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
145916084|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
145916085|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
145916086|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
145916087|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
145916088|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
145916089|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
145916090|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
145916091|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
145916092|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
145916093|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
145916094|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
145916095|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
145916096|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
145916097|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
145916098|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
145916099|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
145916100|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
145916101|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
145916102|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145916103|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145916104|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145916105|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
145916106|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
145916107|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
145916108|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
145916109|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
145916110|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145916111|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
145916112|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145916113|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145916114|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145916115|NCT00662649|526198092|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
145916116|NCT00662649|526198093|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
145916117|NCT00662649|526198094|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
145916118|NCT00662649|526198095|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
145916119|NCT00662649|526198096|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
145916120|NCT01026194|526198097|FG000|Period 1：Double Blind Period|Adverse Event|2|||
145916121|NCT01026194|526198098|FG001|Period 1：Double Blind Period|Adverse Event|1|||
145916122|NCT01026194|526198097|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
145916123|NCT01026194|526198098|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
145916124|NCT01026194|526198097|FG000|Period 1：Double Blind Period|Physician Decision|0|||
145916125|NCT01026194|526198098|FG001|Period 1：Double Blind Period|Physician Decision|4|||
145916126|NCT01026194|526198097|FG000|Period 2：Open-label Period|Adverse Event|4|||
145916127|NCT01026194|526198098|FG001|Period 2：Open-label Period|Adverse Event|5|||
145916128|NCT01026194|526198097|FG000|Period 2：Open-label Period|Physician Decision|3|||
145916129|NCT01026194|526198098|FG001|Period 2：Open-label Period|Physician Decision|1|||
145916130|NCT01026194|526198097|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
145916131|NCT01026194|526198098|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
145916132|NCT00545714|526198101|FG000|Induction Phase (6 Months)|Physician Decision|3|||
145974071|NCT03126110|526418733|FG011|Phase 1|Withdrawal by Subject|0|||
145974072|NCT03126110|526418734|FG012|Phase 1|Withdrawal by Subject|0|||
146240329|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Other|0|||
145974073|NCT03126110|526418735|FG013|Phase 1|Withdrawal by Subject|0|||
146240330|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Other|2|||
145916133|NCT00545714|526198101|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
145916134|NCT00545714|526198101|FG000|Induction Phase (6 Months)|Disease Progression|1|||
145916135|NCT00545714|526198101|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
145916136|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
145916137|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
145916138|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
145916139|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
145916140|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
145916141|NCT00545714|526198101|FG000|Maintenance Phase (36 Months)|Death|2|||
145916142|NCT02515331|526198104|FG000|Overall Study|Withdrawal by Subject|0|||
145916143|NCT02515331|526198105|FG001|Overall Study|Withdrawal by Subject|0|||
145916144|NCT02515331|526198106|FG002|Overall Study|Withdrawal by Subject|1|||
145916145|NCT02515331|526198104|FG000|Overall Study|Protocol deviation|0|||
145916146|NCT02515331|526198105|FG001|Overall Study|Protocol deviation|0|||
146089150|NCT01314911|526847268|FG001|Overall Study|Never Started Treatment|0|||
145916147|NCT02515331|526198106|FG002|Overall Study|Protocol deviation|3|||
145916148|NCT02515331|526198104|FG000|Overall Study|Adverse Event|2|||
145916149|NCT02515331|526198105|FG001|Overall Study|Adverse Event|0|||
145916150|NCT02515331|526198106|FG002|Overall Study|Adverse Event|0|||
145916151|NCT03889886|526198109|FG000|Overall Study|Other|0|||
145916152|NCT03889886|526198110|FG001|Overall Study|Other|1|||
145916153|NCT03889886|526198111|FG002|Overall Study|Other|0|||
145916154|NCT03889886|526198112|FG003|Overall Study|Other|1|||
145916155|NCT03889886|526198109|FG000|Overall Study|Withdrawal by Subject|0|||
145916156|NCT03889886|526198110|FG001|Overall Study|Withdrawal by Subject|0|||
145916157|NCT03889886|526198111|FG002|Overall Study|Withdrawal by Subject|1|||
145916158|NCT03889886|526198112|FG003|Overall Study|Withdrawal by Subject|0|||
145916159|NCT03889886|526198109|FG000|Overall Study|Adverse Event|0|||
145916160|NCT03889886|526198110|FG001|Overall Study|Adverse Event|0|||
145916161|NCT03889886|526198111|FG002|Overall Study|Adverse Event|0|||
145916162|NCT03889886|526198112|FG003|Overall Study|Adverse Event|6|||
145916163|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
145916164|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
145916165|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
145916166|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916167|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
145916168|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
145916169|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916170|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916171|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916172|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916173|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916174|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916175|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916176|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916177|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916178|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916179|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145916180|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145916181|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916182|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
145916183|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145916184|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
145916185|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145916186|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916187|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916188|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916189|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916190|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916191|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916192|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916193|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916194|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916195|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916196|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145916197|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
145916198|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145916199|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145916200|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
146240331|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Other|0|||
145916201|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
146089151|NCT03150485|526847269|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
145916202|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145916203|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916204|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916205|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916206|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916207|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916208|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916209|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916210|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916211|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916212|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916213|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145916214|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916215|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
145916216|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
145916217|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916218|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
145916219|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
145916220|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916221|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916222|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916223|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916224|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916225|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916226|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916227|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916228|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916229|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916230|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145916231|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916232|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916233|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
145916234|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
145916235|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916236|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916237|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916238|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916239|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916240|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916241|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916242|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916243|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916244|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916245|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916246|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916247|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145916248|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916249|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916250|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916251|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916252|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
145916253|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916254|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916255|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916256|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916257|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916258|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916259|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916260|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916261|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916262|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916263|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916264|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145916265|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916266|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
145916267|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916268|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916269|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916270|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916271|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916272|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916273|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916274|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916275|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916276|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916277|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916278|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916279|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916280|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916281|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145916282|NCT00758524|526198113|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916283|NCT00758524|526198114|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
145916284|NCT00758524|526198115|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916285|NCT00758524|526198116|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916286|NCT00758524|526198117|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916287|NCT00758524|526198118|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916288|NCT00758524|526198119|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916289|NCT00758524|526198120|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916290|NCT00758524|526198121|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916291|NCT00758524|526198122|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916292|NCT00758524|526198123|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916293|NCT00758524|526198124|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916294|NCT00758524|526198125|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916295|NCT00758524|526198126|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916296|NCT00758524|526198127|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916297|NCT00758524|526198128|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916298|NCT00758524|526198129|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145916299|NCT00758524|526198113|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916300|NCT00758524|526198114|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916301|NCT00758524|526198115|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916302|NCT00758524|526198116|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916303|NCT00758524|526198117|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916304|NCT00758524|526198118|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916305|NCT00758524|526198119|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916306|NCT00758524|526198120|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916307|NCT00758524|526198121|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
145916308|NCT00758524|526198122|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916309|NCT00758524|526198123|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916310|NCT00758524|526198124|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916311|NCT00758524|526198125|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916312|NCT00758524|526198126|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916313|NCT00758524|526198127|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916314|NCT00758524|526198128|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916315|NCT00758524|526198129|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145916316|NCT00758524|526198113|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916317|NCT00758524|526198114|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916318|NCT00758524|526198115|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916319|NCT00758524|526198116|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916320|NCT00758524|526198117|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145974074|NCT03126110|526418736|FG014|Phase 1|Withdrawal by Subject|0|||
145974075|NCT03126110|526418737|FG015|Phase 1|Withdrawal by Subject|0|||
145974076|NCT03126110|526418738|FG016|Phase 1|Withdrawal by Subject|0|||
145974077|NCT03126110|526418722|FG000|Phase 1|Safety follow-up no longer necessary|1|||
145974078|NCT03126110|526418723|FG001|Phase 1|Safety follow-up no longer necessary|0|||
146240332|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
145974079|NCT03126110|526418724|FG002|Phase 1|Safety follow-up no longer necessary|0|||
145974080|NCT03126110|526418725|FG003|Phase 1|Safety follow-up no longer necessary|0|||
145974081|NCT03126110|526418726|FG004|Phase 1|Safety follow-up no longer necessary|0|||
146240333|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
146240334|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
146240335|NCT00887224|527394877|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
145916321|NCT00758524|526198118|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916322|NCT00758524|526198119|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
145916323|NCT00758524|526198120|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916324|NCT00758524|526198121|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916325|NCT00758524|526198122|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916326|NCT00758524|526198123|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916327|NCT00758524|526198124|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916328|NCT00758524|526198125|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916329|NCT00758524|526198126|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916330|NCT00758524|526198127|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916331|NCT00758524|526198128|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916332|NCT00758524|526198129|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145916333|NCT04176250|526198130|FG000|Overall Study|Adverse Event|0|||
145916334|NCT04176250|526198131|FG001|Overall Study|Adverse Event|1|||
145916335|NCT04176250|526198132|FG002|Overall Study|Adverse Event|0|||
145916336|NCT04176250|526198133|FG003|Overall Study|Adverse Event|1|||
145916337|NCT04176250|526198134|FG004|Overall Study|Adverse Event|0|||
145916338|NCT04176250|526198135|FG005|Overall Study|Adverse Event|1|||
145916339|NCT04176250|526198130|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145916340|NCT04176250|526198131|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145916341|NCT04176250|526198132|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
145916342|NCT04176250|526198133|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
145916343|NCT04176250|526198134|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145916344|NCT04176250|526198135|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145916345|NCT04176250|526198130|FG000|Overall Study|Withdrawal by Subject|0|||
145916346|NCT04176250|526198131|FG001|Overall Study|Withdrawal by Subject|0|||
145916347|NCT04176250|526198132|FG002|Overall Study|Withdrawal by Subject|0|||
145916348|NCT04176250|526198133|FG003|Overall Study|Withdrawal by Subject|0|||
145916349|NCT04176250|526198134|FG004|Overall Study|Withdrawal by Subject|0|||
145916350|NCT04176250|526198135|FG005|Overall Study|Withdrawal by Subject|1|||
145916351|NCT04176250|526198130|FG000|Overall Study|Randomized in error|0|||
145916352|NCT04176250|526198131|FG001|Overall Study|Randomized in error|0|||
145916353|NCT04176250|526198132|FG002|Overall Study|Randomized in error|0|||
145916354|NCT04176250|526198133|FG003|Overall Study|Randomized in error|0|||
145916355|NCT04176250|526198134|FG004|Overall Study|Randomized in error|1|||
145916356|NCT04176250|526198135|FG005|Overall Study|Randomized in error|0|||
145974082|NCT03126110|526418727|FG005|Phase 1|Safety follow-up no longer necessary|0|||
145974083|NCT03126110|526418728|FG006|Phase 1|Safety follow-up no longer necessary|0|||
145974084|NCT03126110|526418729|FG007|Phase 1|Safety follow-up no longer necessary|0|||
145974085|NCT03126110|526418730|FG008|Phase 1|Safety follow-up no longer necessary|0|||
145974086|NCT03126110|526418731|FG009|Phase 1|Safety follow-up no longer necessary|0|||
145974087|NCT03126110|526418732|FG010|Phase 1|Safety follow-up no longer necessary|0|||
145974088|NCT03126110|526418733|FG011|Phase 1|Safety follow-up no longer necessary|0|||
145974089|NCT03126110|526418734|FG012|Phase 1|Safety follow-up no longer necessary|0|||
145974090|NCT03126110|526418735|FG013|Phase 1|Safety follow-up no longer necessary|0|||
145974091|NCT03126110|526418736|FG014|Phase 1|Safety follow-up no longer necessary|0|||
145974092|NCT03126110|526418737|FG015|Phase 1|Safety follow-up no longer necessary|0|||
145974093|NCT03126110|526418738|FG016|Phase 1|Safety follow-up no longer necessary|0|||
145974094|NCT03126110|526418722|FG000|Phase 1|Survival follow-up no longer necessary|0|||
145974095|NCT03126110|526418723|FG001|Phase 1|Survival follow-up no longer necessary|0|||
145974096|NCT03126110|526418724|FG002|Phase 1|Survival follow-up no longer necessary|1|||
145974097|NCT03126110|526418725|FG003|Phase 1|Survival follow-up no longer necessary|0|||
145974098|NCT03126110|526418726|FG004|Phase 1|Survival follow-up no longer necessary|0|||
145974099|NCT03126110|526418727|FG005|Phase 1|Survival follow-up no longer necessary|0|||
145974100|NCT03126110|526418728|FG006|Phase 1|Survival follow-up no longer necessary|0|||
145974101|NCT03126110|526418729|FG007|Phase 1|Survival follow-up no longer necessary|0|||
145974102|NCT03126110|526418730|FG008|Phase 1|Survival follow-up no longer necessary|0|||
145974103|NCT03126110|526418731|FG009|Phase 1|Survival follow-up no longer necessary|0|||
145974104|NCT03126110|526418732|FG010|Phase 1|Survival follow-up no longer necessary|0|||
145974105|NCT03126110|526418733|FG011|Phase 1|Survival follow-up no longer necessary|0|||
145974106|NCT03126110|526418734|FG012|Phase 1|Survival follow-up no longer necessary|0|||
145974107|NCT03126110|526418735|FG013|Phase 1|Survival follow-up no longer necessary|0|||
145974108|NCT03126110|526418736|FG014|Phase 1|Survival follow-up no longer necessary|0|||
145974109|NCT03126110|526418737|FG015|Phase 1|Survival follow-up no longer necessary|0|||
145974110|NCT03126110|526418738|FG016|Phase 1|Survival follow-up no longer necessary|0|||
145974111|NCT03126110|526418722|FG000|Phase 2|Study terminated by the sponsor|0|||
145974112|NCT03126110|526418723|FG001|Phase 2|Study terminated by the sponsor|0|||
145974113|NCT03126110|526418724|FG002|Phase 2|Study terminated by the sponsor|0|||
145916357|NCT00276484|526198136|FG000|Overall Study|Adverse Event|4|||
145916358|NCT00276484|526198137|FG001|Overall Study|Adverse Event|7|||
145916359|NCT00276484|526198136|FG000|Overall Study|Lost to Follow-up|1|||
145916360|NCT00276484|526198137|FG001|Overall Study|Lost to Follow-up|1|||
145916361|NCT00276484|526198136|FG000|Overall Study|Protocol Violation|0|||
145916362|NCT00276484|526198137|FG001|Overall Study|Protocol Violation|1|||
145916363|NCT00276484|526198136|FG000|Overall Study|Withdrawal by Subject|4|||
145916364|NCT00276484|526198137|FG001|Overall Study|Withdrawal by Subject|3|||
145916365|NCT00276484|526198136|FG000|Overall Study|Could not take time off work|0|||
145916366|NCT00276484|526198137|FG001|Overall Study|Could not take time off work|1|||
145916367|NCT01431079|526198147|FG000|Overall Study|Lost to Follow-up|35|||
145916368|NCT01431079|526198148|FG001|Overall Study|Lost to Follow-up|39|||
145916369|NCT01202175|526198149|FG000|Overall Study|Lost to Follow-up|2|||
145916370|NCT01202175|526198149|FG000|Overall Study|Withdrawal by Subject|1|||
145916371|NCT01202175|526198149|FG000|Overall Study|Adverse Event|2|||
145916372|NCT04747470|526198150|FG000|Overall Study|Death|0|||
145916373|NCT04747470|526198151|FG001|Overall Study|Death|3|||
145916374|NCT04747470|526198152|FG002|Overall Study|Death|2|||
145916375|NCT04747470|526198153|FG003|Overall Study|Death|2|||
145916376|NCT04747470|526198154|FG004|Overall Study|Death|2|||
145916377|NCT04747470|526198155|FG005|Overall Study|Death|0|||
145916378|NCT04747470|526198156|FG006|Overall Study|Death|0|||
145916379|NCT04747470|526198157|FG007|Overall Study|Death|0|||
145916380|NCT04747470|526198158|FG008|Overall Study|Death|0|||
145916381|NCT04747470|526198159|FG009|Overall Study|Death|0|||
145916382|NCT04747470|526198160|FG010|Overall Study|Death|0|||
145916383|NCT04747470|526198150|FG000|Overall Study|Withdrew Consent|0|||
145916384|NCT04747470|526198151|FG001|Overall Study|Withdrew Consent|0|||
145916385|NCT04747470|526198152|FG002|Overall Study|Withdrew Consent|0|||
145916386|NCT04747470|526198153|FG003|Overall Study|Withdrew Consent|1|||
145916387|NCT04747470|526198154|FG004|Overall Study|Withdrew Consent|0|||
145916388|NCT04747470|526198155|FG005|Overall Study|Withdrew Consent|0|||
145916389|NCT04747470|526198156|FG006|Overall Study|Withdrew Consent|0|||
145916390|NCT04747470|526198157|FG007|Overall Study|Withdrew Consent|0|||
145916391|NCT04747470|526198158|FG008|Overall Study|Withdrew Consent|0|||
145916392|NCT04747470|526198159|FG009|Overall Study|Withdrew Consent|0|||
145916393|NCT04747470|526198160|FG010|Overall Study|Withdrew Consent|0|||
145916394|NCT04747470|526198150|FG000|Overall Study|Study Terminated by Sponsor|0|||
145916395|NCT04747470|526198151|FG001|Overall Study|Study Terminated by Sponsor|0|||
145916396|NCT04747470|526198152|FG002|Overall Study|Study Terminated by Sponsor|1|||
145916397|NCT04747470|526198153|FG003|Overall Study|Study Terminated by Sponsor|0|||
145916398|NCT04747470|526198154|FG004|Overall Study|Study Terminated by Sponsor|2|||
145916399|NCT04747470|526198155|FG005|Overall Study|Study Terminated by Sponsor|0|||
145916400|NCT04747470|526198156|FG006|Overall Study|Study Terminated by Sponsor|0|||
145916401|NCT04747470|526198157|FG007|Overall Study|Study Terminated by Sponsor|0|||
145916402|NCT04747470|526198158|FG008|Overall Study|Study Terminated by Sponsor|0|||
145916403|NCT04747470|526198159|FG009|Overall Study|Study Terminated by Sponsor|0|||
145916404|NCT04747470|526198160|FG010|Overall Study|Study Terminated by Sponsor|0|||
145916405|NCT03885661|526198161|FG000|Overall Study|Withdrawal by Subject|0|||
145916406|NCT03885661|526198162|FG001|Overall Study|Withdrawal by Subject|1|||
145916407|NCT03885661|526198161|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
145916408|NCT03885661|526198162|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
145916409|NCT00856193|526198163|FG000|Period 2|Abnormal test procedure results|0|||
145916410|NCT00856193|526198164|FG001|Period 2|Abnormal test procedure results|1|||
145916411|NCT00856193|526198163|FG000|Period 2|Lost to Follow-up|0|||
145916412|NCT00856193|526198164|FG001|Period 2|Lost to Follow-up|1|||
145916413|NCT02232984|526198165|FG000|Overall Study|Withdrawal by Subject|5|||
145916414|NCT02232984|526198165|FG000|Overall Study|Death|1|||
145916415|NCT02232984|526198165|FG000|Overall Study|Investigator withdrawal|10|||
145916416|NCT02232984|526198165|FG000|Overall Study|Device implant unsuccessful|53|||
145916417|NCT02232984|526198165|FG000|Overall Study|not disclosed by site|7|||
145916418|NCT02232984|526198165|FG000|Overall Study|Protocol Violation|1|||
145916419|NCT02286843|526198170|FG000|Overall Study|Not Treated|4|||
145916420|NCT02286843|526198170|FG000|Overall Study|Protocol Violation|1|||
145916421|NCT02286843|526198170|FG000|Overall Study|Withdrawal by Subject|1|||
145916422|NCT00041132|526198177|FG000|Overall Study|Adverse Event|19|||
145916423|NCT00041132|526198177|FG000|Overall Study|Death|1|||
145916424|NCT00041132|526198177|FG000|Overall Study|Not Eligible|7|||
145916425|NCT00041132|526198177|FG000|Overall Study|Withdrawal by Subject|1|||
145916426|NCT00041132|526198177|FG000|Overall Study|Physician Decision|2|||
145916427|NCT00995774|526198182|FG000|Training Period 2|Withdrawal by Subject|2|||
145916428|NCT00995774|526198183|FG001|Training Period 2|Withdrawal by Subject|0|||
145974114|NCT03126110|526418725|FG003|Phase 2|Study terminated by the sponsor|0|||
145974115|NCT03126110|526418726|FG004|Phase 2|Study terminated by the sponsor|0|||
145974116|NCT03126110|526418727|FG005|Phase 2|Study terminated by the sponsor|0|||
145974117|NCT03126110|526418728|FG006|Phase 2|Study terminated by the sponsor|0|||
145974118|NCT03126110|526418729|FG007|Phase 2|Study terminated by the sponsor|0|||
145916429|NCT01808573|526198184|FG000|Overall Study|Death|212|||
145916430|NCT01808573|526198185|FG001|Overall Study|Death|240|||
146297543|NCT02510560|527604730|FG001|Overall Study|Discontinued from Treatment|18|||
146297544|NCT02510560|527604731|FG002|Overall Study|Discontinued from Treatment|19|||
146297545|NCT02510560|527604729|FG000|Overall Study|Other|4|||
146297546|NCT02510560|527604730|FG001|Overall Study|Other|4|||
146297547|NCT02510560|527604731|FG002|Overall Study|Other|3|||
146297548|NCT04427501|527604732|FG000|Overall Study|Death|0|||
146297549|NCT04427501|527604733|FG001|Overall Study|Death|0|||
146297550|NCT04427501|527604734|FG002|Overall Study|Death|0|||
146297551|NCT04427501|527604735|FG003|Overall Study|Death|0|||
146297552|NCT04427501|527604736|FG004|Overall Study|Death|0|||
146297553|NCT04427501|527604737|FG005|Overall Study|Death|15|||
146297554|NCT04427501|527604738|FG006|Overall Study|Death|0|||
146297555|NCT04427501|527604739|FG007|Overall Study|Death|0|||
146297556|NCT04427501|527604740|FG008|Overall Study|Death|0|||
146297557|NCT04427501|527604741|FG009|Overall Study|Death|0|||
146297558|NCT04427501|527604742|FG010|Overall Study|Death|0|||
146297559|NCT04427501|527604743|FG011|Overall Study|Death|0|||
146297560|NCT04427501|527604732|FG000|Overall Study|Lost to Follow-up|5|||
146297561|NCT04427501|527604733|FG001|Overall Study|Lost to Follow-up|1|||
146297562|NCT04427501|527604734|FG002|Overall Study|Lost to Follow-up|2|||
146297563|NCT04427501|527604735|FG003|Overall Study|Lost to Follow-up|0|||
146297564|NCT04427501|527604736|FG004|Overall Study|Lost to Follow-up|2|||
146297565|NCT04427501|527604737|FG005|Overall Study|Lost to Follow-up|11|||
146297566|NCT04427501|527604738|FG006|Overall Study|Lost to Follow-up|10|||
146297567|NCT04427501|527604739|FG007|Overall Study|Lost to Follow-up|10|||
146297568|NCT04427501|527604740|FG008|Overall Study|Lost to Follow-up|2|||
146297569|NCT04427501|527604741|FG009|Overall Study|Lost to Follow-up|5|||
145916431|NCT01808573|526198184|FG000|Overall Study|Withdrawal by Subject|12|||
145916432|NCT01808573|526198185|FG001|Overall Study|Withdrawal by Subject|10|||
145916433|NCT01808573|526198184|FG000|Overall Study|Lost to Follow-up|3|||
145916434|NCT01808573|526198185|FG001|Overall Study|Lost to Follow-up|0|||
145916435|NCT01808573|526198184|FG000|Overall Study|Discontinuation of study by sponsor|79|||
145916436|NCT01808573|526198185|FG001|Overall Study|Discontinuation of study by sponsor|64|||
145916437|NCT01808573|526198184|FG000|Overall Study|Randomized in Error|1|||
145916438|NCT01808573|526198185|FG001|Overall Study|Randomized in Error|0|||
145916439|NCT01523002|526198188|FG000|Period 1|Withdrawal by Subject|1|||
145916440|NCT01523002|526198189|FG001|Period 1|Withdrawal by Subject|3|||
145916441|NCT01523002|526198188|FG000|Period 1|Lost to Follow-up|1|||
145916442|NCT01523002|526198189|FG001|Period 1|Lost to Follow-up|0|||
145916443|NCT01523002|526198188|FG000|Period 1|Adverse Event|0|||
145916444|NCT01523002|526198189|FG001|Period 1|Adverse Event|8|||
145916445|NCT01523002|526198188|FG000|Period 2|Withdrawal by Subject|4|||
145916446|NCT01523002|526198189|FG001|Period 2|Withdrawal by Subject|1|||
145916447|NCT01523002|526198188|FG000|Period 2|Adverse Event|2|||
145916448|NCT01523002|526198189|FG001|Period 2|Adverse Event|5|||
145916449|NCT01523002|526198188|FG000|Period 3|Withdrawal by Subject|1|||
145916450|NCT01523002|526198189|FG001|Period 3|Withdrawal by Subject|0|||
145916451|NCT01523002|526198188|FG000|Period 3|Adverse Event|3|||
145916452|NCT01523002|526198189|FG001|Period 3|Adverse Event|0|||
145916453|NCT01256502|526198190|FG000|Overall Study|Had scaffold removed|4|||
145916454|NCT01256502|526198190|FG000|Overall Study|Personal reasons|5|||
145916455|NCT01256502|526198190|FG000|Overall Study|Protocol deviation|1|||
145916456|NCT00489255|526198191|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
145916457|NCT00489255|526198192|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
145916458|NCT00489255|526198191|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
145916459|NCT00489255|526198192|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
145916460|NCT00489255|526198191|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
145916461|NCT00489255|526198192|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
145916462|NCT00489255|526198191|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
145916463|NCT00489255|526198192|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
145916464|NCT00489255|526198191|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
145916465|NCT00489255|526198192|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
145916466|NCT00489255|526198191|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
145916467|NCT00489255|526198192|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
145916468|NCT00489255|526198191|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
145916469|NCT00489255|526198192|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
145974119|NCT03126110|526418730|FG008|Phase 2|Study terminated by the sponsor|0|||
145974120|NCT03126110|526418731|FG009|Phase 2|Study terminated by the sponsor|0|||
145974121|NCT03126110|526418732|FG010|Phase 2|Study terminated by the sponsor|0|||
145974122|NCT03126110|526418733|FG011|Phase 2|Study terminated by the sponsor|0|||
145974123|NCT03126110|526418734|FG012|Phase 2|Study terminated by the sponsor|0|||
145974124|NCT03126110|526418735|FG013|Phase 2|Study terminated by the sponsor|4|||
145974125|NCT03126110|526418736|FG014|Phase 2|Study terminated by the sponsor|0|||
145916470|NCT00489255|526198191|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
146297570|NCT04427501|527604742|FG010|Overall Study|Lost to Follow-up|2|||
146297571|NCT04427501|527604743|FG011|Overall Study|Lost to Follow-up|0|||
146297572|NCT04427501|527604732|FG000|Overall Study|Physician Decision|0|||
146297573|NCT04427501|527604733|FG001|Overall Study|Physician Decision|3|||
146297574|NCT04427501|527604734|FG002|Overall Study|Physician Decision|0|||
145916471|NCT00489255|526198192|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
145916472|NCT00489255|526198191|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
145916473|NCT00489255|526198192|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
145916474|NCT00489255|526198191|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
145916475|NCT00489255|526198192|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
145916476|NCT03953612|526198193|FG000|Overall Study|Randomized but did not start|1|||
145916477|NCT03953612|526198194|FG001|Overall Study|Randomized but did not start|1|||
145916478|NCT03953612|526198195|FG002|Overall Study|Randomized but did not start|1|||
145916479|NCT03953612|526198193|FG000|Overall Study|Withdrawal by Subject|2|||
145916480|NCT03953612|526198194|FG001|Overall Study|Withdrawal by Subject|1|||
145916481|NCT03953612|526198195|FG002|Overall Study|Withdrawal by Subject|0|||
145916482|NCT03485352|526198196|FG000|Overall Study|Lost to Follow-up|9|||
145916483|NCT04779879|526198212|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145916484|NCT04779879|526198213|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145916485|NCT04779879|526198214|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145916486|NCT04779879|526198215|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
145916487|NCT04779879|526198216|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145916488|NCT04779879|526198217|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145916489|NCT04779879|526198212|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
145916490|NCT04779879|526198213|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
145916491|NCT04779879|526198214|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
145916492|NCT04779879|526198215|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
145916493|NCT04779879|526198216|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
145916494|NCT04779879|526198217|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
145916495|NCT04779879|526198212|FG000|Part C: Up to Week 36|Death|0|||
145916496|NCT04779879|526198213|FG001|Part C: Up to Week 36|Death|0|||
145916497|NCT04779879|526198214|FG002|Part C: Up to Week 36|Death|0|||
145916498|NCT04779879|526198215|FG003|Part C: Up to Week 36|Death|0|||
145916499|NCT04779879|526198216|FG004|Part C: Up to Week 36|Death|0|||
145916500|NCT04779879|526198217|FG005|Part C: Up to Week 36|Death|1|||
145916501|NCT04779879|526198212|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
145916502|NCT04779879|526198213|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
145916503|NCT04779879|526198214|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
145916504|NCT04779879|526198215|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
145916505|NCT04779879|526198216|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
145916506|NCT04779879|526198217|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
145916507|NCT05101343|526198218|FG000|Overall Study|Withdrawal by Subject|2|||
145916508|NCT05101343|526198219|FG001|Overall Study|Withdrawal by Subject|1|||
145916509|NCT02854527|526198220|FG000|Overall Study|Adverse Event|0|||
145916510|NCT02854527|526198221|FG001|Overall Study|Adverse Event|0|||
145916511|NCT02854527|526198222|FG002|Overall Study|Adverse Event|0|||
145916512|NCT02854527|526198223|FG003|Overall Study|Adverse Event|0|||
145916513|NCT02854527|526198224|FG004|Overall Study|Adverse Event|1|||
145916514|NCT02854527|526198225|FG005|Overall Study|Adverse Event|0|||
145916515|NCT02854527|526198226|FG006|Overall Study|Adverse Event|0|||
145916516|NCT02854527|526198227|FG007|Overall Study|Adverse Event|0|||
145916517|NCT02854527|526198228|FG008|Overall Study|Adverse Event|0|||
145916518|NCT02854527|526198229|FG009|Overall Study|Adverse Event|0|||
145916519|NCT02854527|526198220|FG000|Overall Study|Lost to Follow-up|0|||
145916520|NCT02854527|526198221|FG001|Overall Study|Lost to Follow-up|0|||
145916521|NCT02854527|526198222|FG002|Overall Study|Lost to Follow-up|0|||
145916522|NCT02854527|526198223|FG003|Overall Study|Lost to Follow-up|1|||
145916523|NCT02854527|526198224|FG004|Overall Study|Lost to Follow-up|0|||
145916524|NCT02854527|526198225|FG005|Overall Study|Lost to Follow-up|0|||
145916525|NCT02854527|526198226|FG006|Overall Study|Lost to Follow-up|0|||
145916526|NCT02854527|526198227|FG007|Overall Study|Lost to Follow-up|0|||
145916527|NCT02854527|526198228|FG008|Overall Study|Lost to Follow-up|0|||
145916528|NCT02854527|526198229|FG009|Overall Study|Lost to Follow-up|0|||
145916529|NCT01682811|526198233|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916530|NCT01682811|526198234|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916531|NCT01682811|526198235|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916532|NCT01682811|526198236|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916533|NCT01682811|526198237|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
145916534|NCT01682811|526198238|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916535|NCT01682811|526198239|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145916536|NCT01682811|526198233|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
145916537|NCT01682811|526198234|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
145916538|NCT01682811|526198235|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
145916539|NCT01682811|526198236|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
145916540|NCT01682811|526198237|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
145916541|NCT01682811|526198238|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
145916542|NCT01682811|526198239|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
145974126|NCT03126110|526418737|FG015|Phase 2|Study terminated by the sponsor|0|||
145974127|NCT03126110|526418738|FG016|Phase 2|Study terminated by the sponsor|0|||
145974128|NCT03126110|526418722|FG000|Phase 2|Withdrawal by Subject|0|||
145916543|NCT01682811|526198233|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916544|NCT01682811|526198234|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916545|NCT01682811|526198235|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916546|NCT01682811|526198236|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916547|NCT01682811|526198237|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
145916548|NCT01682811|526198238|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916549|NCT01682811|526198239|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
145916550|NCT01682811|526198233|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916551|NCT01682811|526198234|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916552|NCT01682811|526198235|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916553|NCT01682811|526198236|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916554|NCT01682811|526198237|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916555|NCT01682811|526198238|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
145916556|NCT01682811|526198239|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
145916557|NCT04452669|526200551|FG000|Overall Study|Death|1|||
145916558|NCT04452669|526200552|FG001|Overall Study|Death|4|||
145916559|NCT05126693|526200553|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
145916560|NCT05126693|526200554|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
145916561|NCT05126693|526200553|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
145916562|NCT05126693|526200554|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
145916563|NCT05126693|526200553|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
145916564|NCT05126693|526200554|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
145916565|NCT05525520|526200555|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
145916566|NCT05525520|526200556|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
145916567|NCT05525520|526200555|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
145916568|NCT05525520|526200556|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
145916569|NCT05878093|526200557|FG000|Overall Study|Withdrawal by Subject|3|||
145916570|NCT05878093|526200558|FG001|Overall Study|Withdrawal by Subject|1|||
145916571|NCT02721732|526200559|FG000|Overall Study|Adverse Event|2|||
145916572|NCT02721732|526200560|FG001|Overall Study|Adverse Event|0|||
145916573|NCT02721732|526200561|FG002|Overall Study|Adverse Event|2|||
145916574|NCT02721732|526200562|FG003|Overall Study|Adverse Event|0|||
145916575|NCT02721732|526200563|FG004|Overall Study|Adverse Event|1|||
145916576|NCT02721732|526200564|FG005|Overall Study|Adverse Event|0|||
145916577|NCT02721732|526200565|FG006|Overall Study|Adverse Event|1|||
145916578|NCT02721732|526200566|FG007|Overall Study|Adverse Event|0|||
145916579|NCT02721732|526200567|FG008|Overall Study|Adverse Event|1|||
145916580|NCT02721732|526200568|FG009|Overall Study|Adverse Event|1|||
145916581|NCT02721732|526200559|FG000|Overall Study|Death|0|||
145916582|NCT02721732|526200560|FG001|Overall Study|Death|0|||
145916583|NCT02721732|526200561|FG002|Overall Study|Death|0|||
145916584|NCT02721732|526200562|FG003|Overall Study|Death|0|||
145916585|NCT02721732|526200563|FG004|Overall Study|Death|1|||
145916586|NCT02721732|526200564|FG005|Overall Study|Death|0|||
145916587|NCT02721732|526200565|FG006|Overall Study|Death|1|||
145916588|NCT02721732|526200566|FG007|Overall Study|Death|0|||
145916589|NCT02721732|526200567|FG008|Overall Study|Death|0|||
145916590|NCT02721732|526200568|FG009|Overall Study|Death|1|||
145916591|NCT02721732|526200559|FG000|Overall Study|Lack of Efficacy|12|||
145916592|NCT02721732|526200560|FG001|Overall Study|Lack of Efficacy|11|||
145916593|NCT02721732|526200561|FG002|Overall Study|Lack of Efficacy|18|||
145916594|NCT02721732|526200562|FG003|Overall Study|Lack of Efficacy|5|||
145916595|NCT02721732|526200563|FG004|Overall Study|Lack of Efficacy|21|||
145916596|NCT02721732|526200564|FG005|Overall Study|Lack of Efficacy|2|||
145916597|NCT02721732|526200565|FG006|Overall Study|Lack of Efficacy|8|||
145916598|NCT02721732|526200566|FG007|Overall Study|Lack of Efficacy|11|||
145916599|NCT02721732|526200567|FG008|Overall Study|Lack of Efficacy|10|||
145916600|NCT02721732|526200568|FG009|Overall Study|Lack of Efficacy|20|||
145916601|NCT02721732|526200559|FG000|Overall Study|Physician Decision|0|||
145916602|NCT02721732|526200560|FG001|Overall Study|Physician Decision|0|||
145916603|NCT02721732|526200561|FG002|Overall Study|Physician Decision|1|||
145916604|NCT02721732|526200562|FG003|Overall Study|Physician Decision|0|||
145916605|NCT02721732|526200563|FG004|Overall Study|Physician Decision|0|||
145916606|NCT02721732|526200564|FG005|Overall Study|Physician Decision|0|||
145916607|NCT02721732|526200565|FG006|Overall Study|Physician Decision|0|||
145916608|NCT02721732|526200566|FG007|Overall Study|Physician Decision|0|||
145974129|NCT03126110|526418723|FG001|Phase 2|Withdrawal by Subject|0|||
145916609|NCT02721732|526200567|FG008|Overall Study|Physician Decision|0|||
145916610|NCT02721732|526200568|FG009|Overall Study|Physician Decision|0|||
145916611|NCT02721732|526200559|FG000|Overall Study|Withdrawal by Subject|1|||
145916612|NCT02721732|526200560|FG001|Overall Study|Withdrawal by Subject|0|||
145916613|NCT02721732|526200561|FG002|Overall Study|Withdrawal by Subject|0|||
145916614|NCT02721732|526200562|FG003|Overall Study|Withdrawal by Subject|0|||
145916615|NCT02721732|526200563|FG004|Overall Study|Withdrawal by Subject|3|||
145916616|NCT02721732|526200564|FG005|Overall Study|Withdrawal by Subject|0|||
145916617|NCT02721732|526200565|FG006|Overall Study|Withdrawal by Subject|1|||
145916618|NCT02721732|526200566|FG007|Overall Study|Withdrawal by Subject|1|||
145916619|NCT02721732|526200567|FG008|Overall Study|Withdrawal by Subject|0|||
145916620|NCT02721732|526200568|FG009|Overall Study|Withdrawal by Subject|1|||
145916621|NCT02721732|526200559|FG000|Overall Study|Participant Choice|1|||
145916622|NCT02721732|526200560|FG001|Overall Study|Participant Choice|0|||
145916623|NCT02721732|526200561|FG002|Overall Study|Participant Choice|0|||
145916624|NCT02721732|526200562|FG003|Overall Study|Participant Choice|0|||
145916625|NCT02721732|526200563|FG004|Overall Study|Participant Choice|0|||
145916626|NCT02721732|526200564|FG005|Overall Study|Participant Choice|0|||
145916627|NCT02721732|526200565|FG006|Overall Study|Participant Choice|0|||
145916628|NCT02721732|526200566|FG007|Overall Study|Participant Choice|0|||
145916629|NCT02721732|526200567|FG008|Overall Study|Participant Choice|0|||
145916630|NCT02721732|526200568|FG009|Overall Study|Participant Choice|1|||
145916631|NCT02721732|526200559|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916632|NCT02721732|526200560|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916633|NCT02721732|526200561|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
145916634|NCT02721732|526200562|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916635|NCT02721732|526200563|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916636|NCT02721732|526200564|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916637|NCT02721732|526200565|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916638|NCT02721732|526200566|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916639|NCT02721732|526200567|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916640|NCT02721732|526200568|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145916641|NCT02721732|526200559|FG000|Overall Study|Progression and withdrew consent|1|||
145916642|NCT02721732|526200560|FG001|Overall Study|Progression and withdrew consent|1|||
145916643|NCT02721732|526200561|FG002|Overall Study|Progression and withdrew consent|0|||
145916644|NCT02721732|526200562|FG003|Overall Study|Progression and withdrew consent|0|||
145916645|NCT02721732|526200563|FG004|Overall Study|Progression and withdrew consent|0|||
145916646|NCT02721732|526200564|FG005|Overall Study|Progression and withdrew consent|0|||
145916647|NCT02721732|526200565|FG006|Overall Study|Progression and withdrew consent|0|||
145916648|NCT02721732|526200566|FG007|Overall Study|Progression and withdrew consent|0|||
145916649|NCT02721732|526200567|FG008|Overall Study|Progression and withdrew consent|0|||
145916650|NCT02721732|526200568|FG009|Overall Study|Progression and withdrew consent|1|||
145916651|NCT02721732|526200559|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
145916652|NCT02721732|526200560|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
145916653|NCT02721732|526200561|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
145916654|NCT02721732|526200562|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
145916655|NCT02721732|526200563|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
145916656|NCT02721732|526200564|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
145916657|NCT02721732|526200565|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
145916658|NCT02721732|526200566|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
145916659|NCT02721732|526200567|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
145916660|NCT02721732|526200568|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
145916661|NCT04100018|526200574|FG000|Pre-Treatment Period|Not Reported|0|||
145916662|NCT04100018|526200575|FG001|Pre-Treatment Period|Not Reported|4|||
145916663|NCT04100018|526200574|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
145916664|NCT04100018|526200575|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
145916665|NCT04100018|526200574|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
145916666|NCT04100018|526200575|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
145916667|NCT04100018|526200574|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
145916668|NCT04100018|526200575|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145916669|NCT04100018|526200574|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
145916670|NCT04100018|526200575|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
145916671|NCT04100018|526200574|FG000|Treatment Period|Ongoing Treatment|1|||
145916672|NCT04100018|526200575|FG001|Treatment Period|Ongoing Treatment|0|||
145916673|NCT04100018|526200574|FG000|Treatment Period|Other Reason|26|||
145916674|NCT04100018|526200575|FG001|Treatment Period|Other Reason|37|||
145916675|NCT04100018|526200574|FG000|Treatment Period|Completed treatment as per protocol|1|||
145916676|NCT04100018|526200575|FG001|Treatment Period|Completed treatment as per protocol|2|||
145916677|NCT04100018|526200574|FG000|Treatment Period|Maximum clinical benefit|3|||
145916678|NCT04100018|526200575|FG001|Treatment Period|Maximum clinical benefit|0|||
145916679|NCT04100018|526200574|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
145916680|NCT04100018|526200575|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
145916681|NCT04100018|526200574|FG000|Treatment Period|Study drug toxicity|67|||
145916682|NCT04100018|526200575|FG001|Treatment Period|Study drug toxicity|28|||
145916683|NCT04100018|526200574|FG000|Treatment Period|Disease Progression|284|||
145916684|NCT04100018|526200575|FG001|Treatment Period|Disease Progression|327|||
145916685|NCT04100018|526200574|FG000|Treatment Period|Administrative reasons by sponsor|16|||
145916686|NCT04100018|526200575|FG001|Treatment Period|Administrative reasons by sponsor|30|||
145916687|NCT04100018|526200574|FG000|Treatment Period|Poor/Non-Compliance|1|||
145974130|NCT03126110|526418724|FG002|Phase 2|Withdrawal by Subject|0|||
145974131|NCT03126110|526418725|FG003|Phase 2|Withdrawal by Subject|0|||
145974132|NCT03126110|526418726|FG004|Phase 2|Withdrawal by Subject|0|||
145974133|NCT03126110|526418727|FG005|Phase 2|Withdrawal by Subject|0|||
146240336|NCT00887224|527394878|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
146240337|NCT00887224|527394879|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
146240338|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
146240339|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
146240340|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
146240341|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
145916688|NCT04100018|526200575|FG001|Treatment Period|Poor/Non-Compliance|0|||
145916689|NCT04100018|526200574|FG000|Treatment Period|Lost to Follow-up|2|||
145916690|NCT04100018|526200575|FG001|Treatment Period|Lost to Follow-up|2|||
145916691|NCT04100018|526200574|FG000|Treatment Period|Death|16|||
145916692|NCT04100018|526200575|FG001|Treatment Period|Death|11|||
145916693|NCT04100018|526200574|FG000|Treatment Period|Participant withdrew consent|10|||
145916694|NCT04100018|526200575|FG001|Treatment Period|Participant withdrew consent|10|||
145916695|NCT04100018|526200574|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
145916696|NCT04100018|526200575|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
145916697|NCT04100018|526200574|FG000|Treatment Period|Adverse Event|14|||
145916698|NCT04100018|526200575|FG001|Treatment Period|Adverse Event|6|||
145916699|NCT04100018|526200574|FG000|Treatment Period|Lack of Efficacy|4|||
145916700|NCT04100018|526200575|FG001|Treatment Period|Lack of Efficacy|2|||
145916701|NCT02848001|526200576|FG000|Overall Study|other reasons|0|||
145916702|NCT02848001|526200577|FG001|Overall Study|other reasons|0|||
145916703|NCT02848001|526200578|FG002|Overall Study|other reasons|1|||
145916704|NCT02848001|526200579|FG003|Overall Study|other reasons|0|||
145916705|NCT02848001|526200580|FG004|Overall Study|other reasons|4|||
145916706|NCT02848001|526200581|FG005|Overall Study|other reasons|1|||
145916707|NCT02848001|526200582|FG006|Overall Study|other reasons|0|||
145916708|NCT02848001|526200583|FG007|Overall Study|other reasons|2|||
145916709|NCT02848001|526200584|FG008|Overall Study|other reasons|2|||
145916710|NCT02848001|526200585|FG009|Overall Study|other reasons|3|||
145916711|NCT02848001|526200586|FG010|Overall Study|other reasons|0|||
145916712|NCT02848001|526200587|FG011|Overall Study|other reasons|1|||
145916713|NCT02848001|526200588|FG012|Overall Study|other reasons|1|||
145916714|NCT02848001|526200589|FG013|Overall Study|other reasons|0|||
145916715|NCT02848001|526200590|FG014|Overall Study|other reasons|0|||
145916716|NCT02848001|526200591|FG015|Overall Study|other reasons|2|||
145916717|NCT02848001|526200592|FG016|Overall Study|other reasons|1|||
145916718|NCT02848001|526200576|FG000|Overall Study|Lack of Efficacy|0|||
145916719|NCT02848001|526200577|FG001|Overall Study|Lack of Efficacy|1|||
145916720|NCT02848001|526200578|FG002|Overall Study|Lack of Efficacy|1|||
145916721|NCT02848001|526200579|FG003|Overall Study|Lack of Efficacy|2|||
145916722|NCT02848001|526200580|FG004|Overall Study|Lack of Efficacy|3|||
145916723|NCT02848001|526200581|FG005|Overall Study|Lack of Efficacy|0|||
145916724|NCT02848001|526200582|FG006|Overall Study|Lack of Efficacy|1|||
145916725|NCT02848001|526200583|FG007|Overall Study|Lack of Efficacy|0|||
145916726|NCT02848001|526200584|FG008|Overall Study|Lack of Efficacy|0|||
145916727|NCT02848001|526200585|FG009|Overall Study|Lack of Efficacy|1|||
145916728|NCT02848001|526200586|FG010|Overall Study|Lack of Efficacy|0|||
145916729|NCT02848001|526200587|FG011|Overall Study|Lack of Efficacy|2|||
145916730|NCT02848001|526200588|FG012|Overall Study|Lack of Efficacy|0|||
145916731|NCT02848001|526200589|FG013|Overall Study|Lack of Efficacy|2|||
145916732|NCT02848001|526200590|FG014|Overall Study|Lack of Efficacy|2|||
145916733|NCT02848001|526200591|FG015|Overall Study|Lack of Efficacy|0|||
145916734|NCT02848001|526200592|FG016|Overall Study|Lack of Efficacy|0|||
145916735|NCT02848001|526200576|FG000|Overall Study|Progressive Disease|2|||
145916736|NCT02848001|526200577|FG001|Overall Study|Progressive Disease|1|||
145916737|NCT02848001|526200578|FG002|Overall Study|Progressive Disease|0|||
145916738|NCT02848001|526200579|FG003|Overall Study|Progressive Disease|4|||
145916739|NCT02848001|526200580|FG004|Overall Study|Progressive Disease|3|||
145916740|NCT02848001|526200581|FG005|Overall Study|Progressive Disease|0|||
145916741|NCT02848001|526200582|FG006|Overall Study|Progressive Disease|4|||
146240342|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
146240343|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
146240344|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
146240345|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
145916742|NCT02848001|526200583|FG007|Overall Study|Progressive Disease|1|||
145916743|NCT02848001|526200584|FG008|Overall Study|Progressive Disease|0|||
145916744|NCT02848001|526200585|FG009|Overall Study|Progressive Disease|2|||
146240346|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
145916745|NCT02848001|526200586|FG010|Overall Study|Progressive Disease|3|||
145916746|NCT02848001|526200587|FG011|Overall Study|Progressive Disease|2|||
145916747|NCT02848001|526200588|FG012|Overall Study|Progressive Disease|1|||
145916748|NCT02848001|526200589|FG013|Overall Study|Progressive Disease|0|||
145974134|NCT03126110|526418728|FG006|Phase 2|Withdrawal by Subject|0|||
145974135|NCT03126110|526418729|FG007|Phase 2|Withdrawal by Subject|0|||
145916749|NCT02848001|526200590|FG014|Overall Study|Progressive Disease|2|||
145916750|NCT02848001|526200591|FG015|Overall Study|Progressive Disease|4|||
145916751|NCT02848001|526200592|FG016|Overall Study|Progressive Disease|0|||
145916752|NCT02848001|526200576|FG000|Overall Study|Adverse Event|0|||
145916753|NCT02848001|526200577|FG001|Overall Study|Adverse Event|0|||
145916754|NCT02848001|526200578|FG002|Overall Study|Adverse Event|0|||
145916755|NCT02848001|526200579|FG003|Overall Study|Adverse Event|0|||
145916756|NCT02848001|526200580|FG004|Overall Study|Adverse Event|2|||
145916757|NCT02848001|526200581|FG005|Overall Study|Adverse Event|0|||
145916758|NCT02848001|526200582|FG006|Overall Study|Adverse Event|0|||
145916759|NCT02848001|526200583|FG007|Overall Study|Adverse Event|0|||
145916760|NCT02848001|526200584|FG008|Overall Study|Adverse Event|0|||
145916761|NCT02848001|526200585|FG009|Overall Study|Adverse Event|1|||
145916762|NCT02848001|526200586|FG010|Overall Study|Adverse Event|0|||
145916763|NCT02848001|526200587|FG011|Overall Study|Adverse Event|1|||
145916764|NCT02848001|526200588|FG012|Overall Study|Adverse Event|1|||
145916765|NCT02848001|526200589|FG013|Overall Study|Adverse Event|0|||
145916766|NCT02848001|526200590|FG014|Overall Study|Adverse Event|2|||
145916767|NCT02848001|526200591|FG015|Overall Study|Adverse Event|0|||
145916768|NCT02848001|526200592|FG016|Overall Study|Adverse Event|0|||
145916769|NCT02848001|526200576|FG000|Overall Study|Death|0|||
145916770|NCT02848001|526200577|FG001|Overall Study|Death|0|||
145974136|NCT03126110|526418730|FG008|Phase 2|Withdrawal by Subject|0|||
145974137|NCT03126110|526418731|FG009|Phase 2|Withdrawal by Subject|0|||
145974138|NCT03126110|526418732|FG010|Phase 2|Withdrawal by Subject|0|||
145974139|NCT03126110|526418733|FG011|Phase 2|Withdrawal by Subject|1|||
145974140|NCT03126110|526418734|FG012|Phase 2|Withdrawal by Subject|3|||
145974141|NCT03126110|526418735|FG013|Phase 2|Withdrawal by Subject|3|||
146297575|NCT04427501|527604735|FG003|Overall Study|Physician Decision|0|||
146297576|NCT04427501|527604736|FG004|Overall Study|Physician Decision|0|||
145974142|NCT03126110|526418736|FG014|Phase 2|Withdrawal by Subject|2|||
145974143|NCT03126110|526418737|FG015|Phase 2|Withdrawal by Subject|1|||
145974144|NCT03126110|526418738|FG016|Phase 2|Withdrawal by Subject|0|||
145974145|NCT03126110|526418722|FG000|Phase 2|Lost to Follow-up|0|||
145974146|NCT03126110|526418723|FG001|Phase 2|Lost to Follow-up|0|||
145974147|NCT03126110|526418724|FG002|Phase 2|Lost to Follow-up|0|||
146240347|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
146240348|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
146240349|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
146240350|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
146240351|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
146240352|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
146240353|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
146240354|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
146240355|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
146240356|NCT00887224|527394877|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
145974148|NCT03126110|526418725|FG003|Phase 2|Lost to Follow-up|0|||
145974149|NCT03126110|526418726|FG004|Phase 2|Lost to Follow-up|0|||
145974150|NCT03126110|526418727|FG005|Phase 2|Lost to Follow-up|0|||
145974151|NCT03126110|526418728|FG006|Phase 2|Lost to Follow-up|0|||
145974152|NCT03126110|526418729|FG007|Phase 2|Lost to Follow-up|0|||
145974153|NCT03126110|526418730|FG008|Phase 2|Lost to Follow-up|0|||
145974154|NCT03126110|526418731|FG009|Phase 2|Lost to Follow-up|0|||
145974155|NCT03126110|526418732|FG010|Phase 2|Lost to Follow-up|0|||
145974156|NCT03126110|526418733|FG011|Phase 2|Lost to Follow-up|1|||
145974157|NCT03126110|526418734|FG012|Phase 2|Lost to Follow-up|1|||
146240357|NCT00887224|527394878|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
145916771|NCT02848001|526200578|FG002|Overall Study|Death|0|||
145916772|NCT02848001|526200579|FG003|Overall Study|Death|1|||
146240358|NCT00887224|527394879|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
145916773|NCT02848001|526200580|FG004|Overall Study|Death|3|||
145916774|NCT02848001|526200581|FG005|Overall Study|Death|1|||
145916775|NCT02848001|526200582|FG006|Overall Study|Death|2|||
145916776|NCT02848001|526200583|FG007|Overall Study|Death|3|||
145916777|NCT02848001|526200584|FG008|Overall Study|Death|4|||
145916778|NCT02848001|526200585|FG009|Overall Study|Death|1|||
145916779|NCT02848001|526200586|FG010|Overall Study|Death|0|||
145974158|NCT03126110|526418735|FG013|Phase 2|Lost to Follow-up|1|||
145974159|NCT03126110|526418736|FG014|Phase 2|Lost to Follow-up|2|||
145974160|NCT03126110|526418737|FG015|Phase 2|Lost to Follow-up|0|||
145974161|NCT03126110|526418738|FG016|Phase 2|Lost to Follow-up|0|||
145974162|NCT03126110|526418722|FG000|Phase 2|Death|0|||
145974163|NCT03126110|526418723|FG001|Phase 2|Death|0|||
146297577|NCT04427501|527604737|FG005|Overall Study|Physician Decision|0|||
145916780|NCT02848001|526200587|FG011|Overall Study|Death|1|||
145916781|NCT02848001|526200588|FG012|Overall Study|Death|3|||
145916782|NCT02848001|526200589|FG013|Overall Study|Death|0|||
145916783|NCT02848001|526200590|FG014|Overall Study|Death|2|||
145974164|NCT03126110|526418724|FG002|Phase 2|Death|0|||
145974165|NCT03126110|526418725|FG003|Phase 2|Death|0|||
145974166|NCT03126110|526418726|FG004|Phase 2|Death|0|||
145974167|NCT03126110|526418727|FG005|Phase 2|Death|0|||
145916784|NCT02848001|526200591|FG015|Overall Study|Death|3|||
145916785|NCT02848001|526200592|FG016|Overall Study|Death|0|||
145916786|NCT02848001|526200576|FG000|Overall Study|Physician Decision|0|||
145916787|NCT02848001|526200577|FG001|Overall Study|Physician Decision|0|||
145916788|NCT02848001|526200578|FG002|Overall Study|Physician Decision|0|||
145916789|NCT02848001|526200579|FG003|Overall Study|Physician Decision|0|||
145916790|NCT02848001|526200580|FG004|Overall Study|Physician Decision|0|||
145916791|NCT02848001|526200581|FG005|Overall Study|Physician Decision|0|||
145916792|NCT02848001|526200582|FG006|Overall Study|Physician Decision|0|||
145916793|NCT02848001|526200583|FG007|Overall Study|Physician Decision|0|||
145916794|NCT02848001|526200584|FG008|Overall Study|Physician Decision|1|||
145916795|NCT02848001|526200585|FG009|Overall Study|Physician Decision|1|||
145916796|NCT02848001|526200586|FG010|Overall Study|Physician Decision|0|||
145916797|NCT02848001|526200587|FG011|Overall Study|Physician Decision|0|||
145916798|NCT02848001|526200588|FG012|Overall Study|Physician Decision|2|||
145916799|NCT02848001|526200589|FG013|Overall Study|Physician Decision|0|||
145916800|NCT02848001|526200590|FG014|Overall Study|Physician Decision|0|||
145916801|NCT02848001|526200591|FG015|Overall Study|Physician Decision|0|||
145916802|NCT02848001|526200592|FG016|Overall Study|Physician Decision|0|||
145916803|NCT02848001|526200576|FG000|Overall Study|Withdrawal by Subject|0|||
145916804|NCT02848001|526200577|FG001|Overall Study|Withdrawal by Subject|0|||
145916805|NCT02848001|526200578|FG002|Overall Study|Withdrawal by Subject|0|||
145916806|NCT02848001|526200579|FG003|Overall Study|Withdrawal by Subject|0|||
145916807|NCT02848001|526200580|FG004|Overall Study|Withdrawal by Subject|0|||
145916808|NCT02848001|526200581|FG005|Overall Study|Withdrawal by Subject|1|||
145916809|NCT02848001|526200582|FG006|Overall Study|Withdrawal by Subject|1|||
145916810|NCT02848001|526200583|FG007|Overall Study|Withdrawal by Subject|1|||
145916811|NCT02848001|526200584|FG008|Overall Study|Withdrawal by Subject|0|||
145916812|NCT02848001|526200585|FG009|Overall Study|Withdrawal by Subject|0|||
145916813|NCT02848001|526200586|FG010|Overall Study|Withdrawal by Subject|0|||
145916814|NCT02848001|526200587|FG011|Overall Study|Withdrawal by Subject|0|||
145916815|NCT02848001|526200588|FG012|Overall Study|Withdrawal by Subject|0|||
145916816|NCT02848001|526200589|FG013|Overall Study|Withdrawal by Subject|0|||
145916817|NCT02848001|526200590|FG014|Overall Study|Withdrawal by Subject|0|||
145916818|NCT02848001|526200591|FG015|Overall Study|Withdrawal by Subject|0|||
145916819|NCT02848001|526200592|FG016|Overall Study|Withdrawal by Subject|0|||
145916820|NCT00118157|526200596|FG000|Overall Study|Adverse Event|2|||
145916821|NCT00118157|526200596|FG000|Overall Study|Death|8|||
145916822|NCT00118157|526200596|FG000|Overall Study|Withdrawal by Subject|2|||
145916823|NCT05989672|526200597|FG000|Overall Study|Adverse Event|3|||
145916824|NCT05989672|526200598|FG001|Overall Study|Adverse Event|0|||
145916825|NCT05989672|526200599|FG002|Overall Study|Adverse Event|0|||
145916826|NCT00696423|526200600|FG000|Overall Study|Lost to Follow-up|0|||
145916827|NCT00696423|526200601|FG001|Overall Study|Lost to Follow-up|5|||
145916828|NCT03989102|526200602|FG000|Year 1|Withdrawal by Subject|6|||
145916829|NCT03989102|526200603|FG001|Year 1|Withdrawal by Subject|2|||
145916830|NCT03989102|526200604|FG002|Year 1|Withdrawal by Subject|7|||
145916831|NCT03989102|526200602|FG000|Year 1|Lost to Follow-up|5|||
145916832|NCT03989102|526200603|FG001|Year 1|Lost to Follow-up|2|||
145916833|NCT03989102|526200604|FG002|Year 1|Lost to Follow-up|5|||
145916834|NCT03989102|526200602|FG000|Year 1|Subject met withdrawal criteria|1|||
145916835|NCT03989102|526200603|FG001|Year 1|Subject met withdrawal criteria|0|||
145916836|NCT03989102|526200604|FG002|Year 1|Subject met withdrawal criteria|1|||
145916837|NCT03989102|526200602|FG000|Year 2|Lost to Follow-up|7|||
145916838|NCT03989102|526200603|FG001|Year 2|Lost to Follow-up|3|||
145916839|NCT03989102|526200604|FG002|Year 2|Lost to Follow-up|4|||
145916840|NCT03989102|526200602|FG000|Year 2|Withdrawal by Subject|3|||
145916841|NCT03989102|526200603|FG001|Year 2|Withdrawal by Subject|1|||
145916842|NCT03989102|526200604|FG002|Year 2|Withdrawal by Subject|2|||
145916843|NCT03989102|526200602|FG000|Year 2|Subject non-compliant|3|||
145916844|NCT03989102|526200603|FG001|Year 2|Subject non-compliant|2|||
145916845|NCT03989102|526200604|FG002|Year 2|Subject non-compliant|0|||
145916846|NCT03989102|526200602|FG000|Year 2|Travel|1|||
145916847|NCT03989102|526200603|FG001|Year 2|Travel|0|||
145974168|NCT03126110|526418728|FG006|Phase 2|Death|0|||
145916848|NCT03989102|526200604|FG002|Year 2|Travel|1|||
145916849|NCT03989102|526200602|FG000|Year 2|P16 missing|4|||
145916850|NCT03989102|526200603|FG001|Year 2|P16 missing|2|||
145916851|NCT03989102|526200604|FG002|Year 2|P16 missing|1|||
145916852|NCT03989102|526200602|FG000|Year 2|P11 missing|1|||
145916853|NCT03989102|526200603|FG001|Year 2|P11 missing|3|||
145916854|NCT03989102|526200604|FG002|Year 2|P11 missing|7|||
145916855|NCT03989102|526200602|FG000|Year 2|Definitive displacement outside the study site|0|||
145916856|NCT03989102|526200603|FG001|Year 2|Definitive displacement outside the study site|1|||
145916857|NCT03989102|526200604|FG002|Year 2|Definitive displacement outside the study site|0|||
145916858|NCT03989102|526200602|FG000|Year 2|Subject missed last study visit|0|||
145916859|NCT03989102|526200603|FG001|Year 2|Subject missed last study visit|1|||
145916860|NCT03989102|526200604|FG002|Year 2|Subject missed last study visit|0|||
145916861|NCT03989102|526200602|FG000|Year 2|Death|0|||
145916862|NCT03989102|526200603|FG001|Year 2|Death|1|||
145916863|NCT03989102|526200604|FG002|Year 2|Death|0|||
145916864|NCT03989102|526200602|FG000|Year 2|Subject not reachable|0|||
145916865|NCT03989102|526200603|FG001|Year 2|Subject not reachable|0|||
145916866|NCT03989102|526200604|FG002|Year 2|Subject not reachable|1|||
145916867|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
145916868|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
145916869|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
145916870|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145916871|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145916872|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145916873|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
145916874|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
145916875|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
145916876|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
145916877|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
145916878|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
145916879|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
145916880|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
145916881|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
145916882|NCT03989102|526200602|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
145916883|NCT03989102|526200603|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
145916884|NCT03989102|526200604|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
145916885|NCT04515147|526200613|FG000|Overall Study|Withdrawal by Subject|1|||
145916886|NCT04515147|526200614|FG001|Overall Study|Withdrawal by Subject|0|||
145916887|NCT04515147|526200615|FG002|Overall Study|Withdrawal by Subject|10|||
145916888|NCT04515147|526200616|FG003|Overall Study|Withdrawal by Subject|18|||
145916889|NCT04515147|526200617|FG004|Overall Study|Withdrawal by Subject|1|||
145916890|NCT04515147|526200618|FG005|Overall Study|Withdrawal by Subject|8|||
145916891|NCT04515147|526200613|FG000|Overall Study|Lost to Follow-up|0|||
145916892|NCT04515147|526200614|FG001|Overall Study|Lost to Follow-up|1|||
145916893|NCT04515147|526200615|FG002|Overall Study|Lost to Follow-up|5|||
145916894|NCT04515147|526200616|FG003|Overall Study|Lost to Follow-up|6|||
145916895|NCT04515147|526200617|FG004|Overall Study|Lost to Follow-up|2|||
145916896|NCT04515147|526200618|FG005|Overall Study|Lost to Follow-up|1|||
145916897|NCT04515147|526200613|FG000|Overall Study|Adverse Event|0|||
145916898|NCT04515147|526200614|FG001|Overall Study|Adverse Event|0|||
145916899|NCT04515147|526200615|FG002|Overall Study|Adverse Event|0|||
145916900|NCT04515147|526200616|FG003|Overall Study|Adverse Event|2|||
145916901|NCT04515147|526200617|FG004|Overall Study|Adverse Event|0|||
145916902|NCT04515147|526200618|FG005|Overall Study|Adverse Event|0|||
145916903|NCT04515147|526200613|FG000|Overall Study|Miscellaneous|0|||
145916904|NCT04515147|526200614|FG001|Overall Study|Miscellaneous|0|||
145916905|NCT04515147|526200615|FG002|Overall Study|Miscellaneous|0|||
145916906|NCT04515147|526200616|FG003|Overall Study|Miscellaneous|1|||
145916907|NCT04515147|526200617|FG004|Overall Study|Miscellaneous|0|||
145916908|NCT04515147|526200618|FG005|Overall Study|Miscellaneous|1|||
145916909|NCT02760004|526200621|FG000|Overall Study|Lost to Follow-up|13|||
145916910|NCT02760004|526200622|FG001|Overall Study|Lost to Follow-up|22|||
145916911|NCT00970593|526200625|FG000|Overall Study|Adverse Event|1|||
145916912|NCT00970593|526200626|FG001|Overall Study|Adverse Event|1|||
145916913|NCT00970593|526200627|FG002|Overall Study|Adverse Event|0|||
145916914|NCT00970593|526200628|FG003|Overall Study|Adverse Event|0|||
145916915|NCT00970593|526200629|FG004|Overall Study|Adverse Event|0|||
145916916|NCT00970593|526200630|FG005|Overall Study|Adverse Event|0|||
145916917|NCT00970593|526200631|FG006|Overall Study|Adverse Event|0|||
145916918|NCT00970593|526200625|FG000|Overall Study|Discontinuation of study by sponsor|0|||
145916919|NCT00970593|526200626|FG001|Overall Study|Discontinuation of study by sponsor|0|||
145916920|NCT00970593|526200627|FG002|Overall Study|Discontinuation of study by sponsor|5|||
145916921|NCT00970593|526200628|FG003|Overall Study|Discontinuation of study by sponsor|0|||
145916922|NCT00970593|526200629|FG004|Overall Study|Discontinuation of study by sponsor|0|||
146297578|NCT04427501|527604738|FG006|Overall Study|Physician Decision|2|||
145916923|NCT00970593|526200630|FG005|Overall Study|Discontinuation of study by sponsor|0|||
145916924|NCT00970593|526200631|FG006|Overall Study|Discontinuation of study by sponsor|2|||
145916925|NCT00970593|526200625|FG000|Overall Study|Withdrawal by Subject|0|||
145916926|NCT00970593|526200626|FG001|Overall Study|Withdrawal by Subject|0|||
145916927|NCT00970593|526200627|FG002|Overall Study|Withdrawal by Subject|1|||
145916928|NCT00970593|526200628|FG003|Overall Study|Withdrawal by Subject|0|||
145916929|NCT00970593|526200629|FG004|Overall Study|Withdrawal by Subject|0|||
145916930|NCT00970593|526200630|FG005|Overall Study|Withdrawal by Subject|0|||
145916931|NCT00970593|526200631|FG006|Overall Study|Withdrawal by Subject|0|||
145916932|NCT03749330|526200636|FG000|Overall Study|Clinicians left work in the CICU|0|||
145916933|NCT03749330|526200637|FG001|Overall Study|Clinicians left work in the CICU|2|||
145916934|NCT03749330|526200638|FG002|Overall Study|Clinicians left work in the CICU|0|||
145916935|NCT03749330|526200639|FG003|Overall Study|Clinicians left work in the CICU|0|||
145916936|NCT03749330|526200640|FG004|Overall Study|Clinicians left work in the CICU|0|||
145916937|NCT03749330|526200641|FG005|Overall Study|Clinicians left work in the CICU|0|||
145916938|NCT02676882|526200644|FG000|Overall Study|Adverse Event|1|||
145916939|NCT02676882|526200645|FG001|Overall Study|Adverse Event|0|||
145916940|NCT02676882|526200644|FG000|Overall Study|Lost to Follow-up|1|||
145916941|NCT02676882|526200645|FG001|Overall Study|Lost to Follow-up|0|||
145916942|NCT02676882|526200644|FG000|Overall Study|Withdrawal by Subject|1|||
145916943|NCT02676882|526200645|FG001|Overall Study|Withdrawal by Subject|2|||
145916944|NCT01518322|526200649|FG000|Overall Study|FeNO measurement was missing|13|||
145916945|NCT01269918|526200650|FG000|Overall Study|Did not receive study drug|0|||
145916946|NCT01269918|526200651|FG001|Overall Study|Did not receive study drug|3|||
145916947|NCT03624192|526200652|FG000|Overall Study|Lost to Follow-up|1|||
145916948|NCT03624192|526200653|FG001|Overall Study|Lost to Follow-up|1|||
145916949|NCT04660331|526200654|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
145916950|NCT04660331|526200655|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
145916951|NCT04660331|526200656|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
145916952|NCT01487525|526200659|FG000|Overall Study|Withdrawal by Subject|0|||
145916953|NCT01487525|526200660|FG001|Overall Study|Withdrawal by Subject|1|||
145916954|NCT01640249|526200661|FG000|Period 1|Withdrawal by Subject|1|||
145916955|NCT01640249|526200662|FG001|Period 1|Withdrawal by Subject|0|||
145916956|NCT01640249|526200663|FG002|Period 1|Withdrawal by Subject|0|||
145916957|NCT01640249|526200664|FG003|Period 1|Withdrawal by Subject|0|||
145916958|NCT01640249|526200665|FG004|Period 1|Withdrawal by Subject|0|||
145916959|NCT01640249|526200666|FG005|Period 1|Withdrawal by Subject|1|||
145916960|NCT01640249|526200667|FG006|Period 1|Withdrawal by Subject|0|||
145916961|NCT01870778|526200668|FG000|Overall Study|Withdrawal by Subject|8|||
145916962|NCT01870778|526200669|FG001|Overall Study|Withdrawal by Subject|7|||
145916963|NCT01870778|526200668|FG000|Overall Study|Lost to Follow-up|0|||
145916964|NCT01870778|526200669|FG001|Overall Study|Lost to Follow-up|2|||
145916965|NCT00065156|526200670|FG000|Overall Study|Adverse Event|37|||
145916966|NCT00065156|526200670|FG000|Overall Study|Lack of Efficacy|52|||
145916967|NCT00065156|526200670|FG000|Overall Study|Withdrawal by Subject|8|||
145916968|NCT00065156|526200670|FG000|Overall Study|Lost to Follow-up|1|||
145916969|NCT00065156|526200670|FG000|Overall Study|Death|11|||
145916970|NCT00065156|526200670|FG000|Overall Study|Study Closed by Sponsor|2|||
145916971|NCT00065156|526200670|FG000|Overall Study|Disease Progression|7|||
145916972|NCT00065156|526200670|FG000|Overall Study|Investigator Decision|2|||
145974169|NCT03126110|526418729|FG007|Phase 2|Death|0|||
145974170|NCT03126110|526418730|FG008|Phase 2|Death|0|||
145974171|NCT03126110|526418731|FG009|Phase 2|Death|0|||
145974172|NCT03126110|526418732|FG010|Phase 2|Death|0|||
145974173|NCT03126110|526418733|FG011|Phase 2|Death|6|||
146240359|NCT01698918|527394882|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
146240360|NCT01698918|527394882|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
146240361|NCT01698918|527394882|FG000|First Line Treatment (Core+Extension)|Death|2|||
146240362|NCT01698918|527394882|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
146240363|NCT01698918|527394882|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
146240364|NCT01698918|527394882|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
146240365|NCT01698918|527394882|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
145916973|NCT00065156|526200670|FG000|Overall Study|Non-Compliance|2|||
145916974|NCT00065156|526200670|FG000|Overall Study|Loss of Response|1|||
145916975|NCT00065156|526200670|FG000|Overall Study|Secondary Malign Disease|1|||
145974174|NCT03126110|526418734|FG012|Phase 2|Death|12|||
145974175|NCT03126110|526418735|FG013|Phase 2|Death|25|||
145974176|NCT03126110|526418736|FG014|Phase 2|Death|11|||
145974177|NCT03126110|526418737|FG015|Phase 2|Death|3|||
145974178|NCT03126110|526418738|FG016|Phase 2|Death|2|||
145974179|NCT03126110|526418722|FG000|Phase 2|Progressive Disease|0|||
145974180|NCT03126110|526418723|FG001|Phase 2|Progressive Disease|0|||
145974181|NCT03126110|526418724|FG002|Phase 2|Progressive Disease|0|||
145974182|NCT03126110|526418725|FG003|Phase 2|Progressive Disease|0|||
145974183|NCT03126110|526418726|FG004|Phase 2|Progressive Disease|0|||
146240366|NCT01698918|527394882|FG000|Second Line Treatment (Core+Extension)|Death|1|||
145916976|NCT00100828|526200671|FG000|Overall Study|Physician Decision|6|||
145916977|NCT01176513|526200672|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
145916978|NCT01215136|526200673|FG000|Overall Study|Adverse Event|2|||
145916979|NCT01215136|526200674|FG001|Overall Study|Adverse Event|9|||
145916980|NCT01215136|526200673|FG000|Overall Study|Disease Progression|3|||
145974184|NCT03126110|526418727|FG005|Phase 2|Progressive Disease|0|||
145974185|NCT03126110|526418728|FG006|Phase 2|Progressive Disease|0|||
145974186|NCT03126110|526418729|FG007|Phase 2|Progressive Disease|0|||
145974187|NCT03126110|526418730|FG008|Phase 2|Progressive Disease|0|||
145974188|NCT03126110|526418731|FG009|Phase 2|Progressive Disease|0|||
146240367|NCT01698918|527394882|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
146297579|NCT04427501|527604739|FG007|Overall Study|Physician Decision|0|||
145916981|NCT01215136|526200674|FG001|Overall Study|Disease Progression|14|||
145916982|NCT01215136|526200673|FG000|Overall Study|Symptomatic Deterioration|1|||
145916983|NCT01215136|526200674|FG001|Overall Study|Symptomatic Deterioration|1|||
145916984|NCT01215136|526200673|FG000|Overall Study|Death|0|||
145974189|NCT03126110|526418732|FG010|Phase 2|Progressive Disease|0|||
146240368|NCT01698918|527394882|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
146240369|NCT04693637|527394886|FG000|Overall Study|Death|4|||
146240370|NCT04693637|527394886|FG000|Overall Study|Withdrawal by Subject|3|||
145916985|NCT01215136|526200674|FG001|Overall Study|Death|2|||
145916986|NCT01215136|526200673|FG000|Overall Study|Withdrawal by Subject|0|||
145916987|NCT01215136|526200674|FG001|Overall Study|Withdrawal by Subject|1|||
145916988|NCT02308124|526200675|FG000|Overall Study|Lost to Follow-up|6|||
145916989|NCT02308124|526200676|FG001|Overall Study|Lost to Follow-up|6|||
145916990|NCT02308124|526200677|FG002|Overall Study|Lost to Follow-up|6|||
145916991|NCT02308124|526200675|FG000|Overall Study|Adverse Event|0|||
145916992|NCT02308124|526200676|FG001|Overall Study|Adverse Event|2|||
145916993|NCT02308124|526200677|FG002|Overall Study|Adverse Event|2|||
145916994|NCT01197911|526200682|FG000|Overall Study|Adverse Event|0|||
145916995|NCT01197911|526200683|FG001|Overall Study|Adverse Event|0|||
145916996|NCT01197911|526200684|FG002|Overall Study|Adverse Event|1|||
145916997|NCT01526057|526200687|FG000|Overall Study|Withdrawal by Subject|3|||
145916998|NCT01526057|526200688|FG001|Overall Study|Withdrawal by Subject|2|||
145916999|NCT01526057|526200689|FG002|Overall Study|Withdrawal by Subject|2|||
145917000|NCT01526057|526200687|FG000|Overall Study|Adverse Event|3|||
145917001|NCT01526057|526200688|FG001|Overall Study|Adverse Event|1|||
145917002|NCT01526057|526200689|FG002|Overall Study|Adverse Event|1|||
145917003|NCT01526057|526200687|FG000|Overall Study|Death|1|||
145917004|NCT01526057|526200688|FG001|Overall Study|Death|0|||
145917005|NCT01526057|526200689|FG002|Overall Study|Death|0|||
145917006|NCT01526057|526200687|FG000|Overall Study|Lost to Follow-up|1|||
145917007|NCT01526057|526200688|FG001|Overall Study|Lost to Follow-up|0|||
145917008|NCT01526057|526200689|FG002|Overall Study|Lost to Follow-up|1|||
145917009|NCT01526057|526200687|FG000|Overall Study|Other|1|||
145917010|NCT01526057|526200688|FG001|Overall Study|Other|0|||
145917011|NCT01526057|526200689|FG002|Overall Study|Other|1|||
145917012|NCT01526057|526200687|FG000|Overall Study|Protocol Violation|0|||
145917013|NCT01526057|526200688|FG001|Overall Study|Protocol Violation|0|||
145917014|NCT01526057|526200689|FG002|Overall Study|Protocol Violation|1|||
145917015|NCT02273388|526200696|FG000|Overall Study|Adverse Event|0|||
145917016|NCT02273388|526200697|FG001|Overall Study|Adverse Event|0|||
145917017|NCT02273388|526200698|FG002|Overall Study|Adverse Event|0|||
145917018|NCT02273388|526200699|FG003|Overall Study|Adverse Event|0|||
145917019|NCT02273388|526200700|FG004|Overall Study|Adverse Event|0|||
145917020|NCT02273388|526200701|FG005|Overall Study|Adverse Event|0|||
145917021|NCT02273388|526200702|FG006|Overall Study|Adverse Event|1|||
145917022|NCT02273388|526200703|FG007|Overall Study|Adverse Event|2|||
145917023|NCT02273388|526200704|FG008|Overall Study|Adverse Event|0|||
145917024|NCT02273388|526200705|FG009|Overall Study|Adverse Event|0|||
145917025|NCT02273388|526200706|FG010|Overall Study|Adverse Event|0|||
145917026|NCT02273388|526200707|FG011|Overall Study|Adverse Event|0|||
145917027|NCT02273388|526200696|FG000|Overall Study|Adverse Event study disease worse|4|||
145917028|NCT02273388|526200697|FG001|Overall Study|Adverse Event study disease worse|3|||
145917029|NCT02273388|526200698|FG002|Overall Study|Adverse Event study disease worse|3|||
145917030|NCT02273388|526200699|FG003|Overall Study|Adverse Event study disease worse|2|||
145917031|NCT02273388|526200700|FG004|Overall Study|Adverse Event study disease worse|4|||
145917032|NCT02273388|526200701|FG005|Overall Study|Adverse Event study disease worse|3|||
145917033|NCT02273388|526200702|FG006|Overall Study|Adverse Event study disease worse|14|||
145917034|NCT02273388|526200703|FG007|Overall Study|Adverse Event study disease worse|6|||
145917035|NCT02273388|526200704|FG008|Overall Study|Adverse Event study disease worse|6|||
145917036|NCT02273388|526200705|FG009|Overall Study|Adverse Event study disease worse|5|||
145917037|NCT02273388|526200706|FG010|Overall Study|Adverse Event study disease worse|10|||
145917038|NCT02273388|526200707|FG011|Overall Study|Adverse Event study disease worse|1|||
145917039|NCT02273388|526200696|FG000|Overall Study|Sponsor decision|0|||
145917040|NCT02273388|526200697|FG001|Overall Study|Sponsor decision|0|||
145917041|NCT02273388|526200698|FG002|Overall Study|Sponsor decision|0|||
146240371|NCT04693637|527394886|FG000|Overall Study|Physician Decision|2|||
146240372|NCT04693637|527394886|FG000|Overall Study|Lost to Follow-up|1|||
145917042|NCT02273388|526200699|FG003|Overall Study|Sponsor decision|0|||
145917043|NCT02273388|526200700|FG004|Overall Study|Sponsor decision|0|||
145917044|NCT02273388|526200701|FG005|Overall Study|Sponsor decision|0|||
145917045|NCT02273388|526200702|FG006|Overall Study|Sponsor decision|0|||
145917046|NCT02273388|526200703|FG007|Overall Study|Sponsor decision|0|||
146240373|NCT05553366|527394891|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
145917047|NCT02273388|526200704|FG008|Overall Study|Sponsor decision|0|||
145917048|NCT02273388|526200705|FG009|Overall Study|Sponsor decision|0|||
145917049|NCT02273388|526200706|FG010|Overall Study|Sponsor decision|0|||
145917050|NCT02273388|526200707|FG011|Overall Study|Sponsor decision|1|||
145917051|NCT01042093|526200708|FG000|Overall Study|Protocol Violation|2|||
145917052|NCT01042093|526200709|FG001|Overall Study|Protocol Violation|2|||
145917053|NCT01042093|526200710|FG002|Overall Study|Protocol Violation|2|||
145917054|NCT01042093|526200711|FG003|Overall Study|Protocol Violation|3|||
145917055|NCT01042093|526200708|FG000|Overall Study|Withdrawal by Subject|0|||
145917056|NCT01042093|526200709|FG001|Overall Study|Withdrawal by Subject|0|||
146240374|NCT05553366|527394892|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
145917057|NCT01042093|526200710|FG002|Overall Study|Withdrawal by Subject|0|||
145917058|NCT01042093|526200711|FG003|Overall Study|Withdrawal by Subject|1|||
145974190|NCT03126110|526418733|FG011|Phase 2|Progressive Disease|0|||
145974191|NCT03126110|526418734|FG012|Phase 2|Progressive Disease|0|||
145974192|NCT03126110|526418735|FG013|Phase 2|Progressive Disease|1|||
145974193|NCT03126110|526418736|FG014|Phase 2|Progressive Disease|0|||
145974194|NCT03126110|526418737|FG015|Phase 2|Progressive Disease|0|||
145974195|NCT03126110|526418738|FG016|Phase 2|Progressive Disease|0|||
145974196|NCT03126110|526418722|FG000|Phase 2|Started new treatment|0|||
145974197|NCT03126110|526418723|FG001|Phase 2|Started new treatment|0|||
145974198|NCT03126110|526418724|FG002|Phase 2|Started new treatment|0|||
145974199|NCT03126110|526418725|FG003|Phase 2|Started new treatment|0|||
145974200|NCT03126110|526418726|FG004|Phase 2|Started new treatment|0|||
145974201|NCT03126110|526418727|FG005|Phase 2|Started new treatment|0|||
145974202|NCT03126110|526418728|FG006|Phase 2|Started new treatment|0|||
145974203|NCT03126110|526418729|FG007|Phase 2|Started new treatment|0|||
145974204|NCT03126110|526418730|FG008|Phase 2|Started new treatment|0|||
145974205|NCT03126110|526418731|FG009|Phase 2|Started new treatment|0|||
145974206|NCT03126110|526418732|FG010|Phase 2|Started new treatment|0|||
145974207|NCT03126110|526418733|FG011|Phase 2|Started new treatment|0|||
145974208|NCT03126110|526418734|FG012|Phase 2|Started new treatment|0|||
145974209|NCT03126110|526418735|FG013|Phase 2|Started new treatment|0|||
145974210|NCT03126110|526418736|FG014|Phase 2|Started new treatment|1|||
145974211|NCT03126110|526418737|FG015|Phase 2|Started new treatment|0|||
145974212|NCT03126110|526418738|FG016|Phase 2|Started new treatment|0|||
145974213|NCT01285518|526418739|FG000|Overall Study|Lost to Follow-up|0|||
145974214|NCT01285518|526418740|FG001|Overall Study|Lost to Follow-up|0|||
145974215|NCT01285518|526418741|FG002|Overall Study|Lost to Follow-up|0|||
145974216|NCT01285518|526418742|FG003|Overall Study|Lost to Follow-up|0|||
145974217|NCT01285518|526418743|FG004|Overall Study|Lost to Follow-up|0|||
145917059|NCT04331808|526200712|FG000|Overall Study|Withdrew consent|1|||
145917060|NCT04331808|526200713|FG001|Overall Study|Withdrew consent|0|||
145917061|NCT04331808|526200714|FG002|Overall Study|Withdrew consent|2|||
145917062|NCT04331808|526200715|FG003|Overall Study|Withdrew consent|3|||
145917063|NCT01329900|526200719|FG000|Overall Study|Elevated creatinine/renal function|1|||
145917064|NCT03493685|526202073|FG000|Overall Study|Death|4|||
145917065|NCT03493685|526202074|FG001|Overall Study|Death|3|||
145917066|NCT03493685|526202073|FG000|Overall Study|Lost to Follow-up|3|||
145917067|NCT03493685|526202074|FG001|Overall Study|Lost to Follow-up|2|||
145917068|NCT03493685|526202073|FG000|Overall Study|Physician Decision|2|||
145917069|NCT03493685|526202074|FG001|Overall Study|Physician Decision|0|||
145917070|NCT03493685|526202073|FG000|Overall Study|Withdrawal by Subject|7|||
145917071|NCT03493685|526202074|FG001|Overall Study|Withdrawal by Subject|11|||
145917072|NCT04576507|526202075|FG000|Overall Study|Adverse Event|4|||
145917073|NCT04576507|526202075|FG000|Overall Study|Withdrawal by Subject|1|||
145917074|NCT04467840|526202076|FG000|Overall Study|Death|35|||
145917075|NCT04467840|526202077|FG001|Overall Study|Death|39|||
145917076|NCT04467840|526202076|FG000|Overall Study|Withdrawal by Subject|8|||
145917077|NCT04467840|526202077|FG001|Overall Study|Withdrawal by Subject|4|||
145917078|NCT04467840|526202076|FG000|Overall Study|Adverse Event|2|||
145917079|NCT04467840|526202077|FG001|Overall Study|Adverse Event|0|||
145917080|NCT04467840|526202076|FG000|Overall Study|Lost to Follow-up|1|||
145917081|NCT04467840|526202077|FG001|Overall Study|Lost to Follow-up|3|||
145917082|NCT04467840|526202076|FG000|Overall Study|Physician Decision|1|||
145917083|NCT04467840|526202077|FG001|Overall Study|Physician Decision|0|||
145917084|NCT04467840|526202076|FG000|Overall Study|Other|1|||
145917085|NCT04467840|526202077|FG001|Overall Study|Other|5|||
145917086|NCT04467840|526202076|FG000|Overall Study|Missing study completion status|3|||
145917087|NCT04467840|526202077|FG001|Overall Study|Missing study completion status|1|||
145917088|NCT05201794|526202082|FG000|Overall Study|Withdrawal by Subject|13|||
145974218|NCT01285518|526418744|FG005|Overall Study|Lost to Follow-up|1|||
145974219|NCT01285518|526418745|FG006|Overall Study|Lost to Follow-up|0|||
145974220|NCT01285518|526418746|FG007|Overall Study|Lost to Follow-up|0|||
145974221|NCT00879658|526418747|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145974222|NCT00879658|526418748|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145974223|NCT00879658|526418749|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145974224|NCT00879658|526418750|FG003|Overall Study|Abnormal laboratory value(s)|1|||
145974225|NCT00879658|526418751|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145974226|NCT00879658|526418752|FG005|Overall Study|Abnormal laboratory value(s)|0|||
145917089|NCT05201794|526202083|FG001|Overall Study|Withdrawal by Subject|12|||
145917090|NCT05201794|526202084|FG002|Overall Study|Withdrawal by Subject|14|||
145917091|NCT05201794|526202085|FG003|Overall Study|Withdrawal by Subject|0|||
145917092|NCT05201794|526202082|FG000|Overall Study|Adverse Event|5|||
145917093|NCT05201794|526202083|FG001|Overall Study|Adverse Event|5|||
145917094|NCT05201794|526202084|FG002|Overall Study|Adverse Event|4|||
145917095|NCT05201794|526202085|FG003|Overall Study|Adverse Event|0|||
145917096|NCT05201794|526202082|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
145917097|NCT05201794|526202083|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145974227|NCT00879658|526418753|FG006|Overall Study|Abnormal laboratory value(s)|0|||
145917098|NCT05201794|526202084|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
145917099|NCT05201794|526202085|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145917100|NCT05201794|526202082|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145917101|NCT05201794|526202083|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145917102|NCT05201794|526202084|FG002|Overall Study|Non-Compliance With Study Drug|3|||
145917103|NCT05201794|526202085|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145917104|NCT05201794|526202082|FG000|Overall Study|Physician Decision|1|||
145917105|NCT05201794|526202083|FG001|Overall Study|Physician Decision|3|||
145917106|NCT05201794|526202084|FG002|Overall Study|Physician Decision|2|||
145917107|NCT05201794|526202085|FG003|Overall Study|Physician Decision|0|||
145917108|NCT05201794|526202082|FG000|Overall Study|Lost to Follow-up|2|||
145917109|NCT05201794|526202083|FG001|Overall Study|Lost to Follow-up|2|||
145917110|NCT05201794|526202084|FG002|Overall Study|Lost to Follow-up|0|||
145917111|NCT05201794|526202085|FG003|Overall Study|Lost to Follow-up|0|||
145917112|NCT05201794|526202082|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
145917113|NCT05201794|526202083|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
145917114|NCT05201794|526202084|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
145917115|NCT05201794|526202085|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
145917116|NCT05201794|526202082|FG000|Overall Study|Protocol Violation|2|||
145917117|NCT05201794|526202083|FG001|Overall Study|Protocol Violation|0|||
145917118|NCT05201794|526202084|FG002|Overall Study|Protocol Violation|1|||
145917119|NCT05201794|526202085|FG003|Overall Study|Protocol Violation|0|||
145917120|NCT05201794|526202082|FG000|Overall Study|Death|1|||
145917121|NCT05201794|526202083|FG001|Overall Study|Death|0|||
145917122|NCT05201794|526202084|FG002|Overall Study|Death|0|||
145917123|NCT05201794|526202085|FG003|Overall Study|Death|0|||
145917124|NCT05201794|526202082|FG000|Overall Study|Site Terminated By Sponsor|0|||
145917125|NCT05201794|526202083|FG001|Overall Study|Site Terminated By Sponsor|1|||
145917126|NCT05201794|526202084|FG002|Overall Study|Site Terminated By Sponsor|0|||
145917127|NCT05201794|526202085|FG003|Overall Study|Site Terminated By Sponsor|0|||
145917128|NCT05201794|526202082|FG000|Overall Study|Other|3|||
145917129|NCT05201794|526202083|FG001|Overall Study|Other|3|||
145917130|NCT05201794|526202084|FG002|Overall Study|Other|3|||
145917131|NCT05201794|526202085|FG003|Overall Study|Other|0|||
145917132|NCT05201794|526202082|FG000|Overall Study|Randomized But Not Treated|1|||
145917133|NCT05201794|526202083|FG001|Overall Study|Randomized But Not Treated|2|||
145917134|NCT05201794|526202084|FG002|Overall Study|Randomized But Not Treated|1|||
145917135|NCT05201794|526202085|FG003|Overall Study|Randomized But Not Treated|0|||
145917136|NCT04653454|526202090|FG000|Overall Study|Withdrawal by Subject|1|||
145917137|NCT04653454|526202090|FG000|Overall Study|Physician Decision|40|||
145917138|NCT00711243|526202093|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
145917139|NCT00711243|526202094|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
145917140|NCT00711243|526202095|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
145917141|NCT00711243|526202096|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
145917142|NCT00711243|526202097|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
145917143|NCT00711243|526202098|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
145917144|NCT00711243|526202093|FG000|Reached First Response/4 Cycles|Death|0|||
145917145|NCT00711243|526202094|FG001|Reached First Response/4 Cycles|Death|0|||
145917146|NCT00711243|526202095|FG002|Reached First Response/4 Cycles|Death|0|||
145917147|NCT00711243|526202096|FG003|Reached First Response/4 Cycles|Death|0|||
145917148|NCT00711243|526202097|FG004|Reached First Response/4 Cycles|Death|0|||
145917149|NCT00711243|526202098|FG005|Reached First Response/4 Cycles|Death|2|||
145917150|NCT00711243|526202093|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
145917151|NCT00711243|526202094|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
145917152|NCT00711243|526202095|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
145917153|NCT00711243|526202096|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
145917154|NCT00711243|526202097|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
145917155|NCT00711243|526202098|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
145917156|NCT00711243|526202093|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
145917157|NCT00711243|526202094|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
145917158|NCT00711243|526202095|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
145917159|NCT00711243|526202096|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
145917160|NCT00711243|526202097|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
145917161|NCT00711243|526202098|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
145917162|NCT00711243|526202093|FG000|Treated Cycle 5 After First Response|Death|0|||
145917163|NCT00711243|526202094|FG001|Treated Cycle 5 After First Response|Death|0|||
145917164|NCT00711243|526202095|FG002|Treated Cycle 5 After First Response|Death|0|||
145917165|NCT00711243|526202096|FG003|Treated Cycle 5 After First Response|Death|0|||
146297580|NCT04427501|527604740|FG008|Overall Study|Physician Decision|0|||
145917166|NCT00711243|526202097|FG004|Treated Cycle 5 After First Response|Death|0|||
145917167|NCT00711243|526202098|FG005|Treated Cycle 5 After First Response|Death|2|||
145917168|NCT00711243|526202093|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
145917169|NCT00711243|526202094|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
146240375|NCT05553366|527394893|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
146240376|NCT05553366|527394891|FG000|Overall Study|Lost to Follow-up|3|||
146240377|NCT05553366|527394892|FG001|Overall Study|Lost to Follow-up|3|||
146240378|NCT05553366|527394893|FG002|Overall Study|Lost to Follow-up|3|||
146240379|NCT05553366|527394891|FG000|Overall Study|Other non-compliance|1|||
146240380|NCT05553366|527394892|FG001|Overall Study|Other non-compliance|1|||
145917170|NCT00711243|526202095|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
145917171|NCT00711243|526202096|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
145917172|NCT00711243|526202097|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
145917173|NCT00711243|526202098|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
145917174|NCT00711243|526202093|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145917175|NCT00711243|526202094|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145917176|NCT00711243|526202095|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145917177|NCT00711243|526202096|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145917178|NCT00711243|526202097|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145917179|NCT00711243|526202098|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
145917180|NCT01962103|526202102|FG000|Phase 1|Adverse Event|4|||
145917181|NCT01962103|526202103|FG001|Phase 1|Adverse Event|0|||
145917182|NCT01962103|526202104|FG002|Phase 1|Adverse Event|2|||
145917183|NCT01962103|526202105|FG003|Phase 1|Adverse Event|1|||
145917184|NCT01962103|526202106|FG004|Phase 1|Adverse Event|2|||
145917185|NCT01962103|526202107|FG005|Phase 1|Adverse Event|2|||
145917186|NCT01962103|526202108|FG006|Phase 1|Adverse Event|0|||
145917187|NCT01962103|526202109|FG007|Phase 1|Adverse Event|0|||
145917188|NCT01962103|526202110|FG008|Phase 1|Adverse Event|0|||
145917189|NCT01962103|526202102|FG000|Phase 1|Progressive Disease|8|||
145917190|NCT01962103|526202103|FG001|Phase 1|Progressive Disease|6|||
145917191|NCT01962103|526202104|FG002|Phase 1|Progressive Disease|8|||
145917192|NCT01962103|526202105|FG003|Phase 1|Progressive Disease|4|||
145917193|NCT01962103|526202106|FG004|Phase 1|Progressive Disease|5|||
145917194|NCT01962103|526202107|FG005|Phase 1|Progressive Disease|4|||
145917195|NCT01962103|526202108|FG006|Phase 1|Progressive Disease|0|||
145917196|NCT01962103|526202109|FG007|Phase 1|Progressive Disease|0|||
145917197|NCT01962103|526202110|FG008|Phase 1|Progressive Disease|0|||
145917198|NCT01962103|526202102|FG000|Phase 1|Withdrawal by Subject|0|||
145917199|NCT01962103|526202103|FG001|Phase 1|Withdrawal by Subject|0|||
145917200|NCT01962103|526202104|FG002|Phase 1|Withdrawal by Subject|0|||
145917201|NCT01962103|526202105|FG003|Phase 1|Withdrawal by Subject|2|||
145917202|NCT01962103|526202106|FG004|Phase 1|Withdrawal by Subject|0|||
145917203|NCT01962103|526202107|FG005|Phase 1|Withdrawal by Subject|0|||
145917204|NCT01962103|526202108|FG006|Phase 1|Withdrawal by Subject|0|||
145917205|NCT01962103|526202109|FG007|Phase 1|Withdrawal by Subject|0|||
145917206|NCT01962103|526202110|FG008|Phase 1|Withdrawal by Subject|0|||
145917207|NCT01962103|526202102|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
145917208|NCT01962103|526202103|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
145917209|NCT01962103|526202104|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
145917210|NCT01962103|526202105|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
145917211|NCT01962103|526202106|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
145917212|NCT01962103|526202107|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
145917213|NCT01962103|526202108|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
145917214|NCT01962103|526202109|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
145917215|NCT01962103|526202110|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
145917216|NCT01962103|526202102|FG000|Phase 1|Physician Decision|0|||
145917217|NCT01962103|526202103|FG001|Phase 1|Physician Decision|0|||
145917218|NCT01962103|526202104|FG002|Phase 1|Physician Decision|0|||
145917219|NCT01962103|526202105|FG003|Phase 1|Physician Decision|1|||
145917220|NCT01962103|526202106|FG004|Phase 1|Physician Decision|0|||
145917221|NCT01962103|526202107|FG005|Phase 1|Physician Decision|0|||
145917222|NCT01962103|526202108|FG006|Phase 1|Physician Decision|0|||
145974228|NCT00879658|526418747|FG000|Overall Study|Administrative problems|2|||
145974229|NCT00879658|526418748|FG001|Overall Study|Administrative problems|1|||
145974230|NCT00879658|526418749|FG002|Overall Study|Administrative problems|0|||
146240381|NCT05553366|527394893|FG002|Overall Study|Other non-compliance|0|||
145917223|NCT01962103|526202109|FG007|Phase 1|Physician Decision|0|||
145974231|NCT00879658|526418750|FG003|Overall Study|Administrative problems|1|||
145917224|NCT01962103|526202110|FG008|Phase 1|Physician Decision|0|||
145917225|NCT01962103|526202102|FG000|Phase 1|Symptomatic Deterioration|3|||
145917226|NCT01962103|526202103|FG001|Phase 1|Symptomatic Deterioration|2|||
145917227|NCT01962103|526202104|FG002|Phase 1|Symptomatic Deterioration|2|||
145917228|NCT01962103|526202105|FG003|Phase 1|Symptomatic Deterioration|2|||
145917229|NCT01962103|526202106|FG004|Phase 1|Symptomatic Deterioration|1|||
145917230|NCT01962103|526202107|FG005|Phase 1|Symptomatic Deterioration|1|||
145917231|NCT01962103|526202108|FG006|Phase 1|Symptomatic Deterioration|0|||
145917232|NCT01962103|526202109|FG007|Phase 1|Symptomatic Deterioration|0|||
145917233|NCT01962103|526202110|FG008|Phase 1|Symptomatic Deterioration|0|||
145974232|NCT00879658|526418751|FG004|Overall Study|Administrative problems|0|||
146240382|NCT05553366|527394891|FG000|Overall Study|Randomized but not dosed|0|||
145917234|NCT01962103|526202102|FG000|Phase 1|Miscellaneous|1|||
145917235|NCT01962103|526202103|FG001|Phase 1|Miscellaneous|0|||
145917236|NCT01962103|526202104|FG002|Phase 1|Miscellaneous|0|||
145917237|NCT01962103|526202105|FG003|Phase 1|Miscellaneous|0|||
145917238|NCT01962103|526202106|FG004|Phase 1|Miscellaneous|0|||
145917239|NCT01962103|526202107|FG005|Phase 1|Miscellaneous|0|||
145917240|NCT01962103|526202108|FG006|Phase 1|Miscellaneous|0|||
145917241|NCT01962103|526202109|FG007|Phase 1|Miscellaneous|0|||
145917242|NCT01962103|526202110|FG008|Phase 1|Miscellaneous|0|||
145917243|NCT01962103|526202102|FG000|Phase 2|Adverse Event|0|||
145917244|NCT01962103|526202103|FG001|Phase 2|Adverse Event|0|||
145917245|NCT01962103|526202104|FG002|Phase 2|Adverse Event|0|||
145917246|NCT01962103|526202105|FG003|Phase 2|Adverse Event|0|||
145917247|NCT01962103|526202106|FG004|Phase 2|Adverse Event|0|||
145917248|NCT01962103|526202107|FG005|Phase 2|Adverse Event|0|||
145917249|NCT01962103|526202108|FG006|Phase 2|Adverse Event|1|||
145917250|NCT01962103|526202109|FG007|Phase 2|Adverse Event|0|||
145917251|NCT01962103|526202110|FG008|Phase 2|Adverse Event|3|||
145917252|NCT01962103|526202102|FG000|Phase 2|Progressive Disease|0|||
145917253|NCT01962103|526202103|FG001|Phase 2|Progressive Disease|0|||
145917254|NCT01962103|526202104|FG002|Phase 2|Progressive Disease|0|||
145917255|NCT01962103|526202105|FG003|Phase 2|Progressive Disease|0|||
145917256|NCT01962103|526202106|FG004|Phase 2|Progressive Disease|0|||
145917257|NCT01962103|526202107|FG005|Phase 2|Progressive Disease|0|||
145917258|NCT01962103|526202108|FG006|Phase 2|Progressive Disease|11|||
145917259|NCT01962103|526202109|FG007|Phase 2|Progressive Disease|12|||
145917260|NCT01962103|526202110|FG008|Phase 2|Progressive Disease|11|||
145917261|NCT01962103|526202102|FG000|Phase 2|Symptomatic Deterioration|0|||
145917262|NCT01962103|526202103|FG001|Phase 2|Symptomatic Deterioration|0|||
145917263|NCT01962103|526202104|FG002|Phase 2|Symptomatic Deterioration|0|||
145917264|NCT01962103|526202105|FG003|Phase 2|Symptomatic Deterioration|0|||
145917265|NCT01962103|526202106|FG004|Phase 2|Symptomatic Deterioration|0|||
145917266|NCT01962103|526202107|FG005|Phase 2|Symptomatic Deterioration|0|||
145917267|NCT01962103|526202108|FG006|Phase 2|Symptomatic Deterioration|2|||
145917268|NCT01962103|526202109|FG007|Phase 2|Symptomatic Deterioration|2|||
145917269|NCT01962103|526202110|FG008|Phase 2|Symptomatic Deterioration|0|||
145917270|NCT01321749|526202111|FG000|Overall Study|Lost to Follow-up|4|||
145917271|NCT01321749|526202112|FG001|Overall Study|Lost to Follow-up|11|||
145917272|NCT01321749|526202111|FG000|Overall Study|Protocol Violation|4|||
145917273|NCT01321749|526202112|FG001|Overall Study|Protocol Violation|7|||
145917274|NCT01321749|526202111|FG000|Overall Study|Withdrawal by Subject|5|||
145917275|NCT01321749|526202112|FG001|Overall Study|Withdrawal by Subject|4|||
145917276|NCT02763046|526202120|FG000|Overall Study|Adverse Event|5|||
145917277|NCT02763046|526202121|FG001|Overall Study|Adverse Event|4|||
145917278|NCT02763046|526202122|FG002|Overall Study|Adverse Event|0|||
145917279|NCT02763046|526202120|FG000|Overall Study|Lack of Efficacy|1|||
145917280|NCT02763046|526202121|FG001|Overall Study|Lack of Efficacy|1|||
145917281|NCT02763046|526202122|FG002|Overall Study|Lack of Efficacy|3|||
145917282|NCT02763046|526202120|FG000|Overall Study|Physician Decision|1|||
145917283|NCT02763046|526202121|FG001|Overall Study|Physician Decision|0|||
145917284|NCT02763046|526202122|FG002|Overall Study|Physician Decision|1|||
145917285|NCT02763046|526202120|FG000|Overall Study|Subject/guardian decision|2|||
145917286|NCT02763046|526202121|FG001|Overall Study|Subject/guardian decision|0|||
145917287|NCT02763046|526202122|FG002|Overall Study|Subject/guardian decision|4|||
145917288|NCT02094300|526202133|FG000|Overall Study|Death|7|||
145917289|NCT02094300|526202133|FG000|Overall Study|Lost to Follow-up|10|||
145917290|NCT02094300|526202133|FG000|Overall Study|Still be eligible for follow-up|3|||
145917291|NCT00725491|526202136|FG000|Overall Study|Adverse Event|3|||
145917292|NCT00725491|526202137|FG001|Overall Study|Adverse Event|2|||
145917293|NCT00725491|526202136|FG000|Overall Study|Pregnancy|0|||
145917294|NCT00725491|526202137|FG001|Overall Study|Pregnancy|3|||
145974233|NCT00879658|526418752|FG005|Overall Study|Administrative problems|0|||
146297581|NCT04427501|527604741|FG009|Overall Study|Physician Decision|0|||
146297582|NCT04427501|527604742|FG010|Overall Study|Physician Decision|0|||
146297583|NCT04427501|527604743|FG011|Overall Study|Physician Decision|0|||
146297584|NCT04427501|527604732|FG000|Overall Study|Withdrawal by Subject|9|||
145917295|NCT00725491|526202136|FG000|Overall Study|Risk for hyperstimulation|2|||
145917296|NCT00725491|526202137|FG001|Overall Study|Risk for hyperstimulation|9|||
145917297|NCT00725491|526202136|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
145917298|NCT00725491|526202137|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
145917299|NCT00725491|526202136|FG000|Overall Study|Fertilization failure|0|||
145917300|NCT00725491|526202137|FG001|Overall Study|Fertilization failure|1|||
145917301|NCT00725491|526202136|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
145917302|NCT00725491|526202137|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
145917303|NCT01495000|526202140|FG000|Overall Study|Lost to Follow-up|2|||
145917304|NCT01495000|526202141|FG001|Overall Study|Lost to Follow-up|2|||
145917305|NCT01495000|526202140|FG000|Overall Study|Protocol Violation|1|||
145917306|NCT01495000|526202141|FG001|Overall Study|Protocol Violation|0|||
145917307|NCT01495000|526202140|FG000|Overall Study|Withdrawal by Subject|10|||
145917308|NCT01495000|526202141|FG001|Overall Study|Withdrawal by Subject|10|||
146297585|NCT04427501|527604733|FG001|Overall Study|Withdrawal by Subject|2|||
145917309|NCT02070965|526202142|FG000|Overall Study|Lost to Follow-up|0|||
145917310|NCT02070965|526202143|FG001|Overall Study|Lost to Follow-up|1|||
145917311|NCT02070965|526202144|FG002|Overall Study|Lost to Follow-up|0|||
145917312|NCT02070965|526202142|FG000|Overall Study|Withdrawal by Subject|1|||
145917313|NCT02070965|526202143|FG001|Overall Study|Withdrawal by Subject|1|||
145917314|NCT02070965|526202144|FG002|Overall Study|Withdrawal by Subject|1|||
145917315|NCT02070965|526202142|FG000|Overall Study|Subject moved|1|||
145917316|NCT02070965|526202143|FG001|Overall Study|Subject moved|0|||
145917317|NCT02070965|526202144|FG002|Overall Study|Subject moved|0|||
145917318|NCT00942357|526202147|FG000|Overall Study|Ineligible|37|||
145917319|NCT00942357|526202148|FG001|Overall Study|Ineligible|40|||
145917320|NCT00707239|526202159|FG000|Overall Study|Adverse Event|5|||
145917321|NCT00707239|526202160|FG001|Overall Study|Adverse Event|3|||
145917322|NCT00707239|526202161|FG002|Overall Study|Adverse Event|2|||
145917323|NCT00707239|526202159|FG000|Overall Study|Death|3|||
145917324|NCT00707239|526202160|FG001|Overall Study|Death|1|||
145917325|NCT00707239|526202161|FG002|Overall Study|Death|3|||
145917326|NCT00707239|526202159|FG000|Overall Study|Physician Decision|1|||
145917327|NCT00707239|526202160|FG001|Overall Study|Physician Decision|1|||
145917328|NCT00707239|526202161|FG002|Overall Study|Physician Decision|2|||
145917329|NCT00707239|526202159|FG000|Overall Study|Protocol Violation|0|||
145917330|NCT00707239|526202160|FG001|Overall Study|Protocol Violation|0|||
145917331|NCT00707239|526202161|FG002|Overall Study|Protocol Violation|1|||
145917332|NCT00707239|526202159|FG000|Overall Study|Lack of Efficacy|1|||
145917333|NCT00707239|526202160|FG001|Overall Study|Lack of Efficacy|2|||
145917334|NCT00707239|526202161|FG002|Overall Study|Lack of Efficacy|0|||
145917335|NCT00707239|526202159|FG000|Overall Study|Randomized, but not treated|1|||
145917336|NCT00707239|526202160|FG001|Overall Study|Randomized, but not treated|1|||
145917337|NCT00707239|526202161|FG002|Overall Study|Randomized, but not treated|1|||
145917338|NCT00707239|526202159|FG000|Overall Study|Other|8|||
145917339|NCT00707239|526202160|FG001|Overall Study|Other|3|||
145917340|NCT00707239|526202161|FG002|Overall Study|Other|5|||
145917341|NCT01778530|526202166|FG000|Overall Study|Progression on study|1|||
145917342|NCT01778530|526202166|FG000|Overall Study|Adverse event/side effect|1|||
145917343|NCT03472014|526202167|FG000|Overall Study|Lost to Follow-up|4|||
145917344|NCT00312338|526202172|FG000|Overall Study|Adverse Event|7|||
145917345|NCT00312338|526202173|FG001|Overall Study|Adverse Event|2|||
145917346|NCT00312338|526202172|FG000|Overall Study|Lost to Follow-up|9|||
145917347|NCT00312338|526202173|FG001|Overall Study|Lost to Follow-up|1|||
145917348|NCT00312338|526202172|FG000|Overall Study|Withdrawal by Subject|4|||
145917349|NCT00312338|526202173|FG001|Overall Study|Withdrawal by Subject|0|||
145917350|NCT00312338|526202172|FG000|Overall Study|Subsequent infection|2|||
145917351|NCT00312338|526202173|FG001|Overall Study|Subsequent infection|0|||
145917352|NCT00262028|526202174|FG000|Overall Study|Withdrawal by Subject|6|||
145917353|NCT00262028|526202175|FG001|Overall Study|Withdrawal by Subject|3|||
145917354|NCT00262028|526202176|FG002|Overall Study|Withdrawal by Subject|6|||
145917355|NCT00262028|526202177|FG003|Overall Study|Withdrawal by Subject|5|||
145917356|NCT00262028|526202178|FG004|Overall Study|Withdrawal by Subject|2|||
145917357|NCT00262028|526202179|FG005|Overall Study|Withdrawal by Subject|3|||
145917358|NCT00262028|526202180|FG006|Overall Study|Withdrawal by Subject|5|||
145917359|NCT00262028|526202181|FG007|Overall Study|Withdrawal by Subject|7|||
146240383|NCT05553366|527394892|FG001|Overall Study|Randomized but not dosed|0|||
146240384|NCT05553366|527394893|FG002|Overall Study|Randomized but not dosed|2|||
145917360|NCT00262028|526202182|FG008|Overall Study|Withdrawal by Subject|2|||
145917361|NCT00262028|526202174|FG000|Overall Study|Lost to Follow-up|7|||
145917362|NCT00262028|526202175|FG001|Overall Study|Lost to Follow-up|7|||
145917363|NCT00262028|526202176|FG002|Overall Study|Lost to Follow-up|5|||
145917364|NCT00262028|526202177|FG003|Overall Study|Lost to Follow-up|5|||
145917365|NCT00262028|526202178|FG004|Overall Study|Lost to Follow-up|4|||
146240385|NCT00795184|527394899|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
146240386|NCT00795184|527394900|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
146240387|NCT03781375|527394901|FG000|Double-blind Phase|Adverse Event|0|||
146240388|NCT03781375|527394902|FG001|Double-blind Phase|Adverse Event|1|||
145917366|NCT00262028|526202179|FG005|Overall Study|Lost to Follow-up|3|||
145917367|NCT00262028|526202180|FG006|Overall Study|Lost to Follow-up|3|||
145917368|NCT00262028|526202181|FG007|Overall Study|Lost to Follow-up|5|||
145917369|NCT00262028|526202182|FG008|Overall Study|Lost to Follow-up|6|||
145917370|NCT00262028|526202174|FG000|Overall Study|Administrative Reason|11|||
145917371|NCT00262028|526202175|FG001|Overall Study|Administrative Reason|14|||
145917372|NCT00262028|526202176|FG002|Overall Study|Administrative Reason|9|||
145917373|NCT00262028|526202177|FG003|Overall Study|Administrative Reason|12|||
145917374|NCT00262028|526202178|FG004|Overall Study|Administrative Reason|6|||
145917375|NCT00262028|526202179|FG005|Overall Study|Administrative Reason|7|||
145917376|NCT00262028|526202180|FG006|Overall Study|Administrative Reason|4|||
145917377|NCT00262028|526202181|FG007|Overall Study|Administrative Reason|6|||
145917378|NCT00262028|526202182|FG008|Overall Study|Administrative Reason|10|||
145917379|NCT00262028|526202174|FG000|Overall Study|Protocol Violation|0|||
145917380|NCT00262028|526202175|FG001|Overall Study|Protocol Violation|0|||
146240389|NCT03781375|527394901|FG000|Double-blind Phase|Lack of Response|6|||
145917381|NCT00262028|526202176|FG002|Overall Study|Protocol Violation|0|||
145917382|NCT00262028|526202177|FG003|Overall Study|Protocol Violation|1|||
145917383|NCT00262028|526202178|FG004|Overall Study|Protocol Violation|0|||
145917384|NCT00262028|526202179|FG005|Overall Study|Protocol Violation|0|||
145917385|NCT00262028|526202180|FG006|Overall Study|Protocol Violation|0|||
145917386|NCT00262028|526202181|FG007|Overall Study|Protocol Violation|0|||
145917387|NCT00262028|526202182|FG008|Overall Study|Protocol Violation|0|||
145917388|NCT00262028|526202174|FG000|Overall Study|Unable to classify|0|||
145917389|NCT00262028|526202175|FG001|Overall Study|Unable to classify|3|||
145917390|NCT00262028|526202176|FG002|Overall Study|Unable to classify|0|||
145917391|NCT00262028|526202177|FG003|Overall Study|Unable to classify|0|||
145917392|NCT00262028|526202178|FG004|Overall Study|Unable to classify|0|||
145917393|NCT00262028|526202179|FG005|Overall Study|Unable to classify|0|||
145917394|NCT00262028|526202180|FG006|Overall Study|Unable to classify|0|||
145917395|NCT00262028|526202181|FG007|Overall Study|Unable to classify|0|||
145917396|NCT00262028|526202182|FG008|Overall Study|Unable to classify|1|||
145917397|NCT04583735|526202183|FG000|Double-masked Treatment Period|Adverse Event|0|||
145917398|NCT04583735|526202184|FG001|Double-masked Treatment Period|Adverse Event|1|||
145917399|NCT04583735|526202183|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
145917400|NCT04583735|526202184|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
145917401|NCT04583735|526202183|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
145917402|NCT04583735|526202184|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
145917403|NCT04583735|526202183|FG000|Open-label Treatment Period|Adverse Event|1|||
145917404|NCT04583735|526202184|FG001|Open-label Treatment Period|Adverse Event|1|||
145917405|NCT04583735|526202183|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
145917406|NCT04583735|526202184|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145917407|NCT04583735|526202183|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145917408|NCT04583735|526202184|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
145917409|NCT00613171|526202185|FG000|Overall Study|Adverse Event|7|||
145917410|NCT00613171|526202185|FG000|Overall Study|Withdrawal by Subject|3|||
145917411|NCT00613171|526202185|FG000|Overall Study|Reason not Specified|4|||
145917412|NCT01169350|526202188|FG000|Overall Study|Physician Decision|3|||
145917413|NCT01169350|526202188|FG000|Overall Study|Lost to Follow-up|2|||
145917414|NCT04870710|526202191|FG000|Overall Study|Lost to Follow-up|3|||
145917415|NCT02553772|526202193|FG000|Overall Study|Adverse Event|2|||
145917416|NCT02553772|526202194|FG001|Overall Study|Adverse Event|3|||
145917417|NCT02553772|526202193|FG000|Overall Study|Lost to Follow-up|2|||
145917418|NCT02553772|526202194|FG001|Overall Study|Lost to Follow-up|1|||
145917419|NCT02553772|526202193|FG000|Overall Study|Withdrawal of Consent|1|||
145917420|NCT02553772|526202194|FG001|Overall Study|Withdrawal of Consent|1|||
145917421|NCT02553772|526202193|FG000|Overall Study|Lack of Efficacy|1|||
145917422|NCT02553772|526202194|FG001|Overall Study|Lack of Efficacy|0|||
145917423|NCT02553772|526202193|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145917424|NCT02553772|526202194|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145917425|NCT05724589|526202195|FG000|Overall Study|Lost to Follow-up|1|||
145917426|NCT00786409|526202196|FG000|Overall Study|Withdrawal by Subject|2|||
145917427|NCT00786409|526202196|FG000|Overall Study|Adverse Event|2|||
145917428|NCT00786409|526202196|FG000|Overall Study|Pregnancy|2|||
145917429|NCT00786409|526202196|FG000|Overall Study|Lost to Follow-up|1|||
145917430|NCT00610129|526202197|FG000|Overall Study|Not treated since patients ineligible|3|||
145917431|NCT00141778|526202200|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
145917432|NCT00141778|526202201|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
145917433|NCT00141778|526202202|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
145917434|NCT00141778|526202200|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
145917435|NCT00141778|526202201|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
145917436|NCT00141778|526202202|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
145917437|NCT00141778|526202200|FG000|Started Study Medication|Withdrawal by Subject|0|||
145917438|NCT00141778|526202201|FG001|Started Study Medication|Withdrawal by Subject|2|||
145917439|NCT00141778|526202202|FG002|Started Study Medication|Withdrawal by Subject|0|||
145917440|NCT00141778|526202200|FG000|Started Study Medication|Difficulty Swallowing|0|||
145917441|NCT00141778|526202201|FG001|Started Study Medication|Difficulty Swallowing|1|||
145917442|NCT00141778|526202202|FG002|Started Study Medication|Difficulty Swallowing|0|||
145917443|NCT00141778|526202200|FG000|Started Study Medication|Chest Discomfort|0|||
145917444|NCT00141778|526202201|FG001|Started Study Medication|Chest Discomfort|0|||
145917445|NCT00141778|526202202|FG002|Started Study Medication|Chest Discomfort|1|||
145917446|NCT01982955|526202203|FG000|Overall Study|Randomized but not treated|0|||
145917447|NCT01982955|526202204|FG001|Overall Study|Randomized but not treated|0|||
145917448|NCT01982955|526202205|FG002|Overall Study|Randomized but not treated|0|||
145917449|NCT01982955|526202206|FG003|Overall Study|Randomized but not treated|1|||
145917450|NCT01982955|526202207|FG004|Overall Study|Randomized but not treated|0|||
145943266|NCT02326298|526300474|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943267|NCT02326298|526300475|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943268|NCT02326298|526300476|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145943269|NCT02326298|526300477|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
146240390|NCT03781375|527394902|FG001|Double-blind Phase|Lack of Response|2|||
146240391|NCT03781375|527394901|FG000|Double-blind Phase|Other|1|||
146240392|NCT03781375|527394902|FG001|Double-blind Phase|Other|3|||
146240393|NCT03781375|527394901|FG000|Open-label Phase|Protocol Issues|0|||
145917451|NCT05655546|526203535|FG000|Overall Study|Withdrawal by Subject|2|||
145917452|NCT05655546|526203536|FG001|Overall Study|Withdrawal by Subject|4|||
145917453|NCT04179838|526203545|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
145917454|NCT04179838|526203546|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
145917455|NCT04179838|526203545|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
145917456|NCT04179838|526203546|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
145917457|NCT00086684|526203547|FG000|Overall Study|Adverse Event|12|||
145917458|NCT00086684|526203548|FG001|Overall Study|Adverse Event|17|||
145917459|NCT00086684|526203549|FG002|Overall Study|Adverse Event|14|||
145917460|NCT00086684|526203547|FG000|Overall Study|Lack of Efficacy|6|||
145917461|NCT00086684|526203548|FG001|Overall Study|Lack of Efficacy|6|||
145917462|NCT00086684|526203549|FG002|Overall Study|Lack of Efficacy|5|||
145917463|NCT00086684|526203547|FG000|Overall Study|Lost to Follow-up|15|||
145917464|NCT00086684|526203548|FG001|Overall Study|Lost to Follow-up|8|||
145917465|NCT00086684|526203549|FG002|Overall Study|Lost to Follow-up|10|||
145917466|NCT00086684|526203547|FG000|Overall Study|Protocol Violation|8|||
145917467|NCT00086684|526203548|FG001|Overall Study|Protocol Violation|3|||
145917468|NCT00086684|526203549|FG002|Overall Study|Protocol Violation|0|||
145917469|NCT00086684|526203547|FG000|Overall Study|Withdrawal by Subject|0|||
145917470|NCT00086684|526203548|FG001|Overall Study|Withdrawal by Subject|4|||
145917471|NCT00086684|526203549|FG002|Overall Study|Withdrawal by Subject|10|||
145917472|NCT00086684|526203547|FG000|Overall Study|NONCOMPLIANCE|5|||
145917473|NCT00086684|526203548|FG001|Overall Study|NONCOMPLIANCE|7|||
145917474|NCT00086684|526203549|FG002|Overall Study|NONCOMPLIANCE|6|||
145917475|NCT00086684|526203547|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145917476|NCT00086684|526203548|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
145917477|NCT00086684|526203549|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145917478|NCT00086684|526203547|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
145917479|NCT00086684|526203548|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
145917480|NCT00086684|526203549|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
145917481|NCT00086684|526203547|FG000|Overall Study|Other|4|||
145917482|NCT00086684|526203548|FG001|Overall Study|Other|2|||
145917483|NCT00086684|526203549|FG002|Overall Study|Other|3|||
145917484|NCT01067105|526203550|FG000|Overall Study|Adverse Event|14|||
145917485|NCT01067105|526203550|FG000|Overall Study|Protocol Violation|48|||
145917486|NCT01067105|526203550|FG000|Overall Study|Withdrawal by Subject|36|||
145917487|NCT01067105|526203550|FG000|Overall Study|Lost to Follow-up|6|||
145917488|NCT01067105|526203550|FG000|Overall Study|Physician Decision|6|||
145917489|NCT01067105|526203550|FG000|Overall Study|Other|31|||
145917490|NCT02203357|526203554|FG000|Overall Study|Lost to Follow-up|58|||
145917491|NCT02203357|526203555|FG001|Overall Study|Lost to Follow-up|66|||
145917492|NCT02203357|526203556|FG002|Overall Study|Lost to Follow-up|70|||
145917493|NCT02439216|526203557|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
145917494|NCT02439216|526203558|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917495|NCT02439216|526203559|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917496|NCT02439216|526203560|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917497|NCT02439216|526203561|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917498|NCT02439216|526203562|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917499|NCT02439216|526203563|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917500|NCT02439216|526203564|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917501|NCT02439216|526203565|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145917502|NCT02439216|526203557|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917503|NCT02439216|526203558|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917504|NCT02439216|526203559|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917505|NCT02439216|526203560|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917506|NCT02439216|526203561|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917507|NCT02439216|526203562|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917508|NCT02439216|526203563|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917509|NCT02439216|526203564|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
145917510|NCT02439216|526203565|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145917511|NCT02439216|526203557|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917512|NCT02439216|526203558|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917513|NCT02439216|526203559|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917514|NCT02439216|526203560|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917515|NCT02439216|526203561|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917516|NCT02439216|526203562|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917517|NCT02439216|526203563|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145917518|NCT02439216|526203564|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
146240394|NCT03781375|527394902|FG001|Open-label Phase|Protocol Issues|1|||
146297586|NCT04427501|527604734|FG002|Overall Study|Withdrawal by Subject|2|||
145917519|NCT02439216|526203565|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
145917520|NCT02439216|526203557|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917521|NCT02439216|526203558|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917522|NCT02439216|526203559|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917523|NCT02439216|526203560|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917524|NCT02439216|526203561|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917525|NCT02439216|526203562|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917526|NCT02439216|526203563|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917527|NCT02439216|526203564|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145917528|NCT02439216|526203565|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
145917529|NCT02439216|526203557|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917530|NCT02439216|526203558|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917531|NCT02439216|526203559|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917532|NCT02439216|526203560|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917533|NCT02439216|526203561|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917534|NCT02439216|526203562|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917535|NCT02439216|526203563|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145917536|NCT02439216|526203564|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
145917537|NCT02439216|526203565|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
145917538|NCT02493660|526203572|FG000|Overall Study|Physician Decision|0|||
145917539|NCT02493660|526203573|FG001|Overall Study|Physician Decision|1|||
145917540|NCT02493660|526203572|FG000|Overall Study|Adverse Event|4|||
145917541|NCT02493660|526203573|FG001|Overall Study|Adverse Event|2|||
145917542|NCT02493660|526203572|FG000|Overall Study|Withdrawal by Subject|2|||
145917543|NCT02493660|526203573|FG001|Overall Study|Withdrawal by Subject|3|||
145917544|NCT02493660|526203572|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
145917545|NCT02493660|526203573|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
145917546|NCT02493660|526203572|FG000|Overall Study|Protocol Violation|0|||
145917547|NCT02493660|526203573|FG001|Overall Study|Protocol Violation|1|||
145917548|NCT02493660|526203572|FG000|Overall Study|Death|0|||
145917549|NCT02493660|526203573|FG001|Overall Study|Death|1|||
145917550|NCT02493660|526203572|FG000|Overall Study|Lost to Follow-up|2|||
145917551|NCT02493660|526203573|FG001|Overall Study|Lost to Follow-up|4|||
145917552|NCT01050530|526203574|FG000|Overall Study|Adverse Event|6|||
145917553|NCT01050530|526203575|FG001|Overall Study|Adverse Event|3|||
145917554|NCT01050530|526203574|FG000|Overall Study|Lack of Efficacy|1|||
145917555|NCT01050530|526203575|FG001|Overall Study|Lack of Efficacy|4|||
145917556|NCT01050530|526203574|FG000|Overall Study|Withdrawal by Subject|0|||
145917557|NCT01050530|526203575|FG001|Overall Study|Withdrawal by Subject|3|||
145917558|NCT01050530|526203574|FG000|Overall Study|Protocol Violation|1|||
145917559|NCT01050530|526203575|FG001|Overall Study|Protocol Violation|0|||
145917560|NCT02288312|526203576|FG000|Overall Study|Pregnancy|1|||
145917561|NCT02288312|526203577|FG001|Overall Study|Pregnancy|0|||
145917562|NCT02288312|526203578|FG002|Overall Study|Pregnancy|0|||
145917563|NCT01276041|526203579|FG000|Overall Study|Adverse Event|2|||
145917564|NCT01276041|526203579|FG000|Overall Study|Protocol Violation|1|||
145917565|NCT03347110|526203586|FG000|Overall Study|Other (Participant is incarcerated)|1|||
145917566|NCT03347110|526203586|FG000|Overall Study|Withdrawal by Subject|9|||
145917567|NCT03347110|526203586|FG000|Overall Study|Lost to Follow-up|1|||
145917568|NCT03347110|526203586|FG000|Overall Study|Lack of Efficacy|2|||
145917569|NCT03347110|526203586|FG000|Overall Study|Adverse Event, non-fatal|9|||
145917570|NCT02105467|526203589|FG000|Period 1|Lost to Follow-up|1|||
145917571|NCT02105467|526203590|FG001|Period 1|Lost to Follow-up|0|||
145917572|NCT02105467|526203589|FG000|Period 1|Death|1|||
145917573|NCT02105467|526203590|FG001|Period 1|Death|0|||
145917574|NCT02105467|526203589|FG000|Period 2|Lost to Follow-up|1|||
145917575|NCT02105467|526203590|FG001|Period 2|Lost to Follow-up|0|||
145917576|NCT02105467|526203589|FG000|Period 2|Death|1|||
145917577|NCT02105467|526203590|FG001|Period 2|Death|0|||
145917578|NCT02105467|526203589|FG000|Period 2|Withdrawal by Subject|0|||
145917579|NCT02105467|526203590|FG001|Period 2|Withdrawal by Subject|2|||
145917580|NCT02105467|526203589|FG000|Period 3|Lost to Follow-up|0|||
145917581|NCT02105467|526203590|FG001|Period 3|Lost to Follow-up|1|||
145917582|NCT00958828|526203591|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
145917583|NCT00958828|526203592|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
145917584|NCT00958828|526203591|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
145917585|NCT00958828|526203592|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
145917586|NCT02687451|526203593|FG000|Overall Study|Withdrawal by Subject|1|||
145917587|NCT02687451|526203594|FG001|Overall Study|Withdrawal by Subject|0|||
145917588|NCT02687451|526203595|FG002|Overall Study|Withdrawal by Subject|0|||
145917589|NCT02687451|526203596|FG003|Overall Study|Withdrawal by Subject|0|||
145917590|NCT02687451|526203597|FG004|Overall Study|Withdrawal by Subject|0|||
145917591|NCT02687451|526203598|FG005|Overall Study|Withdrawal by Subject|1|||
145917592|NCT00811733|526203599|FG000|Overall Study|Investigator Discretion|10|||
145917593|NCT00811733|526203600|FG001|Overall Study|Investigator Discretion|8|||
145917594|NCT00811733|526203599|FG000|Overall Study|Withdrawal by Subject|1|||
145917595|NCT00811733|526203600|FG001|Overall Study|Withdrawal by Subject|2|||
145917596|NCT00793871|526203601|FG000|Overall Study|Death|50|||
145917597|NCT00793871|526203601|FG000|Overall Study|Lost to Follow-up|3|||
145917598|NCT00793871|526203601|FG000|Overall Study|Study terminated by the Sponsor|7|||
145917599|NCT02500589|526203602|FG000|Overall Study|Withdrawal by Subject|11|||
145917600|NCT02500589|526203603|FG001|Overall Study|Withdrawal by Subject|14|||
145917601|NCT02500589|526203602|FG000|Overall Study|Lost to Follow-up|10|||
145917602|NCT02500589|526203603|FG001|Overall Study|Lost to Follow-up|12|||
145917603|NCT02500589|526203602|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
145917604|NCT02500589|526203603|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
145917605|NCT02500589|526203602|FG000|Overall Study|Death|7|||
145917606|NCT02500589|526203603|FG001|Overall Study|Death|5|||
145917607|NCT00840749|526203604|FG000|Overall Study|Death|1|||
145917608|NCT00840749|526203605|FG001|Overall Study|Death|2|||
145917609|NCT00840749|526203604|FG000|Overall Study|not treated on study arm|11|||
145917610|NCT00840749|526203605|FG001|Overall Study|not treated on study arm|11|||
146240395|NCT03781375|527394901|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
146240396|NCT03781375|527394902|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
145917611|NCT00840749|526203604|FG000|Overall Study|study closed|19|||
145917612|NCT00840749|526203605|FG001|Overall Study|study closed|14|||
145917613|NCT01958437|526203606|FG000|Overall Study|Incidental MRI findings|0|||
145917614|NCT01958437|526203607|FG001|Overall Study|Incidental MRI findings|0|||
145917615|NCT01958437|526203608|FG002|Overall Study|Incidental MRI findings|1|||
145917616|NCT01958437|526203609|FG003|Overall Study|Incidental MRI findings|1|||
145917617|NCT03442751|526203610|FG000|Overall Study|Withdrawal by Subject|3|||
145917618|NCT03442751|526203611|FG001|Overall Study|Withdrawal by Subject|1|||
145917619|NCT03442751|526203610|FG000|Overall Study|Lost to Follow-up|3|||
145917620|NCT03442751|526203611|FG001|Overall Study|Lost to Follow-up|0|||
145917621|NCT01928472|526203613|FG000|Overall Study|Death|0|||
145917622|NCT01928472|526203614|FG001|Overall Study|Death|0|||
145917623|NCT01928472|526203615|FG002|Overall Study|Death|1|||
145917624|NCT01928472|526203616|FG003|Overall Study|Death|0|||
145974234|NCT00879658|526418753|FG006|Overall Study|Administrative problems|0|||
145974235|NCT00879658|526418747|FG000|Overall Study|Adverse Event|6|||
145974236|NCT00879658|526418748|FG001|Overall Study|Adverse Event|4|||
145974237|NCT00879658|526418749|FG002|Overall Study|Adverse Event|3|||
145974238|NCT00879658|526418750|FG003|Overall Study|Adverse Event|1|||
145974239|NCT00879658|526418751|FG004|Overall Study|Adverse Event|2|||
145974240|NCT00879658|526418752|FG005|Overall Study|Adverse Event|0|||
145974241|NCT00879658|526418753|FG006|Overall Study|Adverse Event|0|||
145974242|NCT00879658|526418747|FG000|Overall Study|Protocol Violation|1|||
145974243|NCT00879658|526418748|FG001|Overall Study|Protocol Violation|0|||
145974244|NCT00879658|526418749|FG002|Overall Study|Protocol Violation|0|||
145974245|NCT00879658|526418750|FG003|Overall Study|Protocol Violation|0|||
145974246|NCT00879658|526418751|FG004|Overall Study|Protocol Violation|0|||
145974247|NCT00879658|526418752|FG005|Overall Study|Protocol Violation|0|||
145974248|NCT00879658|526418753|FG006|Overall Study|Protocol Violation|0|||
145974249|NCT00879658|526418747|FG000|Overall Study|Withdrawal by Subject|3|||
145974250|NCT00879658|526418748|FG001|Overall Study|Withdrawal by Subject|0|||
145974251|NCT00879658|526418749|FG002|Overall Study|Withdrawal by Subject|2|||
145974252|NCT00879658|526418750|FG003|Overall Study|Withdrawal by Subject|0|||
145974253|NCT00879658|526418751|FG004|Overall Study|Withdrawal by Subject|0|||
145974254|NCT00879658|526418752|FG005|Overall Study|Withdrawal by Subject|1|||
145974255|NCT00879658|526418753|FG006|Overall Study|Withdrawal by Subject|0|||
145974256|NCT00879658|526418747|FG000|Overall Study|Lack of Efficacy|0|||
145974257|NCT00879658|526418748|FG001|Overall Study|Lack of Efficacy|0|||
145974258|NCT00879658|526418749|FG002|Overall Study|Lack of Efficacy|2|||
145974259|NCT00879658|526418750|FG003|Overall Study|Lack of Efficacy|0|||
145974260|NCT00879658|526418751|FG004|Overall Study|Lack of Efficacy|0|||
145974261|NCT00879658|526418752|FG005|Overall Study|Lack of Efficacy|0|||
145917625|NCT01928472|526203613|FG000|Overall Study|Withdrawal by Subject|4|||
145917626|NCT01928472|526203614|FG001|Overall Study|Withdrawal by Subject|4|||
145917627|NCT01928472|526203615|FG002|Overall Study|Withdrawal by Subject|1|||
145917628|NCT01928472|526203616|FG003|Overall Study|Withdrawal by Subject|2|||
145917629|NCT01928472|526203613|FG000|Overall Study|Lost to Follow-up|2|||
145974262|NCT00879658|526418753|FG006|Overall Study|Lack of Efficacy|0|||
145974263|NCT00879658|526418747|FG000|Overall Study|misrandomized (never received study med)|0|||
145974264|NCT00879658|526418748|FG001|Overall Study|misrandomized (never received study med)|0|||
145974265|NCT00879658|526418749|FG002|Overall Study|misrandomized (never received study med)|0|||
145974266|NCT00879658|526418750|FG003|Overall Study|misrandomized (never received study med)|1|||
145974267|NCT00879658|526418751|FG004|Overall Study|misrandomized (never received study med)|0|||
145974268|NCT00879658|526418752|FG005|Overall Study|misrandomized (never received study med)|0|||
145974269|NCT00879658|526418753|FG006|Overall Study|misrandomized (never received study med)|0|||
145917630|NCT01928472|526203614|FG001|Overall Study|Lost to Follow-up|3|||
145917631|NCT01928472|526203615|FG002|Overall Study|Lost to Follow-up|4|||
145917632|NCT01928472|526203616|FG003|Overall Study|Lost to Follow-up|0|||
145917633|NCT01928472|526203613|FG000|Overall Study|Administrative Reason|2|||
145917634|NCT01928472|526203614|FG001|Overall Study|Administrative Reason|1|||
145917635|NCT01928472|526203615|FG002|Overall Study|Administrative Reason|0|||
145917636|NCT01928472|526203616|FG003|Overall Study|Administrative Reason|0|||
145917637|NCT01928472|526203613|FG000|Overall Study|Unclassified|0|||
145917638|NCT01928472|526203614|FG001|Overall Study|Unclassified|0|||
145917639|NCT01928472|526203615|FG002|Overall Study|Unclassified|1|||
145917640|NCT01928472|526203616|FG003|Overall Study|Unclassified|0|||
145917641|NCT02603887|526203618|FG000|Stage 1|Adverse Event|4|||
145917642|NCT02603887|526203618|FG000|Stage 1|Disease progression|1|||
145917643|NCT02603887|526203618|FG000|Stage 2|FDA guidance|1|||
145917644|NCT01308424|526203621|FG000|Baseline Eligibility|Screen Failures|71|||
145917645|NCT01308424|526203622|FG001|Baseline Eligibility|Screen Failures|0|||
145917646|NCT01308424|526203623|FG002|Baseline Eligibility|Screen Failures|0|||
145917647|NCT01308424|526203621|FG000|Randomization|Adverse Event|0|||
146089152|NCT03150485|526847270|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146089153|NCT03150485|526847271|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
145917648|NCT01308424|526203622|FG001|Randomization|Adverse Event|1|||
145917649|NCT01308424|526203623|FG002|Randomization|Adverse Event|1|||
145917650|NCT01308424|526203621|FG000|Randomization|Lost to Follow-up|0|||
145917651|NCT01308424|526203622|FG001|Randomization|Lost to Follow-up|1|||
145917652|NCT01308424|526203623|FG002|Randomization|Lost to Follow-up|0|||
145917653|NCT01308424|526203621|FG000|Randomization|Physician Decision|0|||
145917654|NCT01308424|526203622|FG001|Randomization|Physician Decision|1|||
145917655|NCT01308424|526203623|FG002|Randomization|Physician Decision|1|||
145917656|NCT00948155|526203624|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
145917657|NCT00948155|526203625|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
145917658|NCT00948155|526203624|FG000|Washout 14 Days|Lost to Follow-up|1|||
145917659|NCT00948155|526203625|FG001|Washout 14 Days|Lost to Follow-up|2|||
145917660|NCT01841593|526203628|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
145917661|NCT01841593|526203629|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
145917662|NCT01841593|526203628|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
145917663|NCT01841593|526203629|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
145917664|NCT03125798|526203631|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
145917665|NCT03125798|526203632|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
145917666|NCT03125798|526203631|FG000|Overall Study|Conversion to thoracotomy|7|||
145917667|NCT03125798|526203632|FG001|Overall Study|Conversion to thoracotomy|7|||
145917668|NCT02635984|526203633|FG000|Overall Study|Lost to Follow-up|2|||
145917669|NCT02635984|526203634|FG001|Overall Study|Lost to Follow-up|4|||
145917670|NCT02635984|526203633|FG000|Overall Study|Study Arm Closed|1|||
145917671|NCT02635984|526203634|FG001|Overall Study|Study Arm Closed|0|||
145917672|NCT00307086|526203635|FG000|Overall Study|ineligible|5|||
145917673|NCT02189837|526203638|FG000|Overall Study|Withdrawal by Subject|2|||
145917674|NCT02189837|526203639|FG001|Overall Study|Withdrawal by Subject|1|||
145917675|NCT02189837|526203640|FG002|Overall Study|Withdrawal by Subject|3|||
145917676|NCT02189837|526203641|FG003|Overall Study|Withdrawal by Subject|1|||
145917677|NCT02189837|526203638|FG000|Overall Study|Sponsor Decision|0|||
145917678|NCT02189837|526203639|FG001|Overall Study|Sponsor Decision|0|||
145917679|NCT02189837|526203640|FG002|Overall Study|Sponsor Decision|0|||
145917680|NCT02189837|526203641|FG003|Overall Study|Sponsor Decision|1|||
145917681|NCT02198963|526203647|FG000|Overall Study|Adverse Event|1|||
145917682|NCT02198963|526203647|FG000|Overall Study|Withdrawal by Subject|6|||
145917683|NCT00243412|526203648|FG000|Overall Study|Death|0|||
145917684|NCT00243412|526203649|FG001|Overall Study|Death|1|||
145917685|NCT00243412|526203648|FG000|Overall Study|Adverse Event|4|||
145917686|NCT00243412|526203649|FG001|Overall Study|Adverse Event|2|||
145917687|NCT00243412|526203648|FG000|Overall Study|Lost to Follow-up|0|||
145917688|NCT00243412|526203649|FG001|Overall Study|Lost to Follow-up|1|||
145917689|NCT00243412|526203648|FG000|Overall Study|Physician Decision|1|||
145917690|NCT00243412|526203649|FG001|Overall Study|Physician Decision|1|||
145917691|NCT00243412|526203648|FG000|Overall Study|Withdrawal by Subject|4|||
145917692|NCT00243412|526203649|FG001|Overall Study|Withdrawal by Subject|5|||
145917693|NCT00243412|526203648|FG000|Overall Study|Other|1|||
145917694|NCT00243412|526203649|FG001|Overall Study|Other|1|||
146089154|NCT03150485|526847272|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
145917695|NCT03629184|526203654|FG000|Overall Study|Withdrawal by Subject|2|||
145917696|NCT03629184|526203655|FG001|Overall Study|Withdrawal by Subject|1|||
145917697|NCT03629184|526203654|FG000|Overall Study|Physician Decision|1|||
145917698|NCT03629184|526203655|FG001|Overall Study|Physician Decision|0|||
145917699|NCT03447743|526203656|FG000|Overall Study|Withdrawal by Subject|2|||
145917700|NCT03447743|526203656|FG000|Overall Study|Lost to Follow-up|3|||
145917701|NCT03447743|526203656|FG000|Overall Study|Adverse Event|1|||
145917702|NCT03447743|526203656|FG000|Overall Study|Did not meet criteria to continue|1|||
146089155|NCT03150485|526847273|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
146089156|NCT03150485|526847274|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
145917703|NCT02046603|526203657|FG000|Overall Study|Other|11|||
145917704|NCT02046603|526203658|FG001|Overall Study|Other|66|||
145917705|NCT02046603|526203657|FG000|Overall Study|Protocol Violation|0|||
145917706|NCT02046603|526203658|FG001|Overall Study|Protocol Violation|1|||
145917707|NCT02046603|526203657|FG000|Overall Study|Participant/legal guardian decision|1|||
145917708|NCT02046603|526203658|FG001|Overall Study|Participant/legal guardian decision|3|||
145917709|NCT02046603|526203657|FG000|Overall Study|Physician Decision|2|||
145917710|NCT02046603|526203658|FG001|Overall Study|Physician Decision|1|||
145917711|NCT02046603|526203657|FG000|Overall Study|Lost to Follow-up|1|||
145917712|NCT02046603|526203658|FG001|Overall Study|Lost to Follow-up|2|||
145917713|NCT02046603|526203657|FG000|Overall Study|Death|0|||
145917714|NCT02046603|526203658|FG001|Overall Study|Death|1|||
145917715|NCT02046603|526203657|FG000|Overall Study|Adverse Event|0|||
145917716|NCT02046603|526203658|FG001|Overall Study|Adverse Event|1|||
145917717|NCT05620082|526203663|FG000|Overall Study|Discharged before study end|1|||
145917718|NCT05620082|526203664|FG001|Overall Study|Discharged before study end|4|||
145917719|NCT05620082|526203665|FG002|Overall Study|Discharged before study end|0|||
145917720|NCT05620082|526203663|FG000|Overall Study|Moved to a different ward|1|||
145917721|NCT05620082|526203664|FG001|Overall Study|Moved to a different ward|0|||
145917722|NCT05620082|526203665|FG002|Overall Study|Moved to a different ward|0|||
145917723|NCT05620082|526203663|FG000|Overall Study|Feeling too unwell|1|||
145917724|NCT05620082|526203664|FG001|Overall Study|Feeling too unwell|0|||
145917725|NCT05620082|526203665|FG002|Overall Study|Feeling too unwell|0|||
145917726|NCT04075487|526205533|FG000|Overall Study|Withdrawal by Subject|1|||
145917727|NCT03411863|526205536|FG000|Overall Study|Withdrawal by Subject|3|||
145917728|NCT03411863|526205537|FG001|Overall Study|Withdrawal by Subject|1|||
145917729|NCT03411863|526205536|FG000|Overall Study|Physician Decision|0|||
145917730|NCT03411863|526205537|FG001|Overall Study|Physician Decision|1|||
145917731|NCT05767905|526205538|FG000|Overall Study|Adverse Event|0|||
145917732|NCT05767905|526205539|FG001|Overall Study|Adverse Event|0|||
145917733|NCT05767905|526205540|FG002|Overall Study|Adverse Event|1|||
145917734|NCT03535740|526205541|FG000|Overall Study|Death|44|||
145917735|NCT03535740|526205541|FG000|Overall Study|Lost to Follow-up|1|||
145917736|NCT03535740|526205541|FG000|Overall Study|Withdrawal by Subject|13|||
145917737|NCT03535740|526205541|FG000|Overall Study|Site terminated by Sponsor|45|||
145917738|NCT05198518|526205545|FG000|Screening Visit|Deemed unable to participate|58|||
145917739|NCT05198518|526205546|FG001|Screening Visit|Deemed unable to participate|0|||
145917740|NCT05198518|526205547|FG002|Screening Visit|Deemed unable to participate|0|||
145917741|NCT02766335|526205548|FG000|Initial Registration|Adverse Event|6|||
145917742|NCT02766335|526205549|FG001|Initial Registration|Adverse Event|3|||
145917743|NCT02766335|526205550|FG002|Initial Registration|Adverse Event|0|||
145917744|NCT02766335|526205548|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
145917745|NCT02766335|526205549|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
145917746|NCT02766335|526205550|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
145917747|NCT02766335|526205548|FG000|Initial Registration|Progression/relapse|49|||
145917748|NCT02766335|526205549|FG001|Initial Registration|Progression/relapse|15|||
145974270|NCT00639509|526418756|FG000|Overall Study|Death|1|||
145974271|NCT00294658|526418757|FG000|Overall Study|Death|0|||
145974272|NCT00294658|526418758|FG001|Overall Study|Death|1|||
145974273|NCT00294658|526418757|FG000|Overall Study|Lost to Follow-up|4|||
145974274|NCT00294658|526418758|FG001|Overall Study|Lost to Follow-up|0|||
145974275|NCT00294658|526418757|FG000|Overall Study|Physician Decision|1|||
145974276|NCT00294658|526418758|FG001|Overall Study|Physician Decision|2|||
145974277|NCT00294658|526418757|FG000|Overall Study|Pregnancy|0|||
145974278|NCT00294658|526418758|FG001|Overall Study|Pregnancy|1|||
145974279|NCT00294658|526418757|FG000|Overall Study|Withdrawal by Subject|0|||
145974280|NCT00294658|526418758|FG001|Overall Study|Withdrawal by Subject|4|||
145974281|NCT00294658|526418757|FG000|Overall Study|Found to have invasive thymoma|1|||
145974282|NCT00294658|526418758|FG001|Overall Study|Found to have invasive thymoma|0|||
145974283|NCT00294658|526418757|FG000|Overall Study|Patient and family were not satisfied|0|||
145974284|NCT00294658|526418758|FG001|Overall Study|Patient and family were not satisfied|1|||
145974285|NCT00580840|526418759|FG000|Run-in|Adverse Event|17|||
145974286|NCT00580840|526418760|FG001|Run-in|Adverse Event|0|||
145974287|NCT00580840|526418761|FG002|Run-in|Adverse Event|0|||
145974288|NCT00580840|526418762|FG003|Run-in|Adverse Event|0|||
145974289|NCT00580840|526418759|FG000|Run-in|Lack of Efficacy|93|||
145917749|NCT02766335|526205550|FG002|Initial Registration|Progression/relapse|0|||
145917750|NCT02766335|526205548|FG000|Initial Registration|Death|1|||
145917751|NCT02766335|526205549|FG001|Initial Registration|Death|3|||
145917752|NCT02766335|526205550|FG002|Initial Registration|Death|0|||
145917753|NCT02766335|526205548|FG000|Initial Registration|not protocol specified|1|||
145917754|NCT02766335|526205549|FG001|Initial Registration|not protocol specified|9|||
145974290|NCT00580840|526418760|FG001|Run-in|Lack of Efficacy|0|||
145974291|NCT00580840|526418761|FG002|Run-in|Lack of Efficacy|0|||
145974292|NCT00580840|526418762|FG003|Run-in|Lack of Efficacy|0|||
145974293|NCT00580840|526418759|FG000|Run-in|Loss of Efficacy|1|||
145974294|NCT00580840|526418760|FG001|Run-in|Loss of Efficacy|0|||
145974295|NCT00580840|526418761|FG002|Run-in|Loss of Efficacy|0|||
145974296|NCT00580840|526418762|FG003|Run-in|Loss of Efficacy|0|||
145917755|NCT02766335|526205550|FG002|Initial Registration|not protocol specified|0|||
145917756|NCT02766335|526205548|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
145917757|NCT02766335|526205549|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
145917758|NCT02766335|526205550|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
145917759|NCT02766335|526205548|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
145917760|NCT02766335|526205549|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
145917761|NCT02766335|526205550|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
145917762|NCT03645863|526205552|FG000|Overall Study|Withdrawal by Subject|1|||
145917763|NCT03645863|526205553|FG001|Overall Study|Withdrawal by Subject|0|||
145917764|NCT03645863|526205554|FG002|Overall Study|Withdrawal by Subject|0|||
145917765|NCT00124917|526205560|FG000|Overall Study|Physician Decision|3|||
145917766|NCT03518008|526205561|FG000|Period 2, Second Week of Wear|Family emergency|0|||
145917767|NCT03518008|526205562|FG001|Period 2, Second Week of Wear|Family emergency|1|||
145917768|NCT03164551|526205563|FG000|Overall Study|Imaging discontinued prior completion|8|||
145917769|NCT03164551|526205564|FG001|Overall Study|Imaging discontinued prior completion|0|||
145917770|NCT03164551|526205563|FG000|Overall Study|Participant was non-compliant|1|||
145917771|NCT03164551|526205564|FG001|Overall Study|Participant was non-compliant|0|||
145917772|NCT03164551|526205563|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
145917773|NCT03164551|526205564|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
145917774|NCT03164551|526205563|FG000|Overall Study|Other|8|||
145917775|NCT03164551|526205564|FG001|Overall Study|Other|2|||
145917776|NCT01515423|526205565|FG000|Open Label Phase|Adverse Event|57|||
145917777|NCT01515423|526205566|FG001|Open Label Phase|Adverse Event|0|||
145917778|NCT01515423|526205567|FG002|Open Label Phase|Adverse Event|0|||
145917779|NCT01515423|526205565|FG000|Open Label Phase|Death|2|||
145917780|NCT01515423|526205566|FG001|Open Label Phase|Death|0|||
145917781|NCT01515423|526205567|FG002|Open Label Phase|Death|0|||
145917782|NCT01515423|526205565|FG000|Open Label Phase|Lack of Efficacy|117|||
145917783|NCT01515423|526205566|FG001|Open Label Phase|Lack of Efficacy|0|||
145917784|NCT01515423|526205567|FG002|Open Label Phase|Lack of Efficacy|0|||
145917785|NCT01515423|526205565|FG000|Open Label Phase|Lost to Follow-up|21|||
145917786|NCT01515423|526205566|FG001|Open Label Phase|Lost to Follow-up|0|||
145917787|NCT01515423|526205567|FG002|Open Label Phase|Lost to Follow-up|0|||
145917788|NCT01515423|526205565|FG000|Open Label Phase|Withdrawal by Subject|118|||
145917789|NCT01515423|526205566|FG001|Open Label Phase|Withdrawal by Subject|0|||
145917790|NCT01515423|526205567|FG002|Open Label Phase|Withdrawal by Subject|0|||
145917791|NCT01515423|526205565|FG000|Open Label Phase|excluded from DB Phase|70|||
145917792|NCT01515423|526205566|FG001|Open Label Phase|excluded from DB Phase|0|||
145917793|NCT01515423|526205567|FG002|Open Label Phase|excluded from DB Phase|0|||
145917794|NCT01515423|526205565|FG000|Open Label Phase|Other|28|||
145917795|NCT01515423|526205566|FG001|Open Label Phase|Other|0|||
145917796|NCT01515423|526205567|FG002|Open Label Phase|Other|0|||
145917797|NCT01515423|526205565|FG000|DOUBLE BLIND|Adverse Event|0|||
145917798|NCT01515423|526205566|FG001|DOUBLE BLIND|Adverse Event|15|||
145917799|NCT01515423|526205567|FG002|DOUBLE BLIND|Adverse Event|13|||
145917800|NCT01515423|526205565|FG000|DOUBLE BLIND|Death|0|||
145917801|NCT01515423|526205566|FG001|DOUBLE BLIND|Death|1|||
145917802|NCT01515423|526205567|FG002|DOUBLE BLIND|Death|2|||
145917803|NCT01515423|526205565|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
145917804|NCT01515423|526205566|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
145917805|NCT01515423|526205567|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
145917806|NCT01515423|526205565|FG000|DOUBLE BLIND|Pregnancy|0|||
145917807|NCT01515423|526205566|FG001|DOUBLE BLIND|Pregnancy|2|||
145917808|NCT01515423|526205567|FG002|DOUBLE BLIND|Pregnancy|0|||
145917809|NCT01515423|526205565|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
145917810|NCT01515423|526205566|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
145917811|NCT01515423|526205567|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
145917812|NCT01515423|526205565|FG000|DOUBLE BLIND|Other|0|||
145917813|NCT01515423|526205566|FG001|DOUBLE BLIND|Other|6|||
145917814|NCT01515423|526205567|FG002|DOUBLE BLIND|Other|12|||
145917815|NCT01515423|526205565|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
145917816|NCT01515423|526205566|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
145917817|NCT01515423|526205567|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
145917818|NCT01125917|526205576|FG000|Overall Study|Adverse Event|43|||
145917819|NCT01125917|526205576|FG000|Overall Study|Lost to Follow-up|23|||
145917820|NCT01125917|526205576|FG000|Overall Study|Withdrawal by Subject|31|||
145917821|NCT01125917|526205576|FG000|Overall Study|Administrative|223|||
145917822|NCT01125917|526205576|FG000|Overall Study|Lack of Efficacy|19|||
145917823|NCT04421131|526205580|FG000|Overall Study|Lost to Follow-up|1|||
145917824|NCT04421131|526205580|FG000|Overall Study|Protocol Violation|2|||
145917825|NCT04421131|526205580|FG000|Overall Study|App crashed|5|||
145917826|NCT02501928|526205581|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145917827|NCT02501928|526205582|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145917828|NCT02501928|526205583|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
145917829|NCT02501928|526205584|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
145917830|NCT02501928|526205585|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
145917831|NCT02501928|526205586|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
145917832|NCT00951496|526205590|FG000|Overall Study|Did not initiate study treatment|10|||
145917833|NCT00951496|526205591|FG001|Overall Study|Did not initiate study treatment|8|||
145917834|NCT00951496|526205592|FG002|Overall Study|Did not initiate study treatment|13|||
145917835|NCT00838526|526205594|FG000|Overall Study|Adverse Event|3|||
145917836|NCT00838526|526205595|FG001|Overall Study|Adverse Event|12|||
145917837|NCT00838526|526205594|FG000|Overall Study|Lost to Follow-up|4|||
145917838|NCT00838526|526205595|FG001|Overall Study|Lost to Follow-up|12|||
145917839|NCT00838526|526205594|FG000|Overall Study|Withdrawal by Subject|4|||
145917840|NCT00838526|526205595|FG001|Overall Study|Withdrawal by Subject|5|||
145917841|NCT00838526|526205594|FG000|Overall Study|Lack of Efficacy|2|||
145917842|NCT00838526|526205595|FG001|Overall Study|Lack of Efficacy|3|||
145917843|NCT00838526|526205594|FG000|Overall Study|Other|11|||
145917844|NCT00838526|526205595|FG001|Overall Study|Other|7|||
145917845|NCT00476190|526205605|FG000|Overall Study|Ineligible|1|||
145917846|NCT00476190|526205606|FG001|Overall Study|Ineligible|1|||
145917847|NCT00476190|526205605|FG000|Overall Study|Induction Death|2|||
145917848|NCT00476190|526205606|FG001|Overall Study|Induction Death|0|||
145917849|NCT00476190|526205605|FG000|Overall Study|Induction Failure|2|||
145917850|NCT00476190|526205606|FG001|Overall Study|Induction Failure|4|||
145917851|NCT00476190|526205605|FG000|Overall Study|Lost to Follow-up|1|||
145917852|NCT00476190|526205606|FG001|Overall Study|Lost to Follow-up|0|||
145917853|NCT00476190|526205605|FG000|Overall Study|Relapse/Progression|5|||
145917854|NCT00476190|526205606|FG001|Overall Study|Relapse/Progression|2|||
145917855|NCT00476190|526205605|FG000|Overall Study|Remission Death|0|||
145917856|NCT00476190|526205606|FG001|Overall Study|Remission Death|1|||
145917857|NCT00476190|526205605|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
145917858|NCT00476190|526205606|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
145917859|NCT00476190|526205605|FG000|Overall Study|Withdrawal by Subject|6|||
145917860|NCT00476190|526205606|FG001|Overall Study|Withdrawal by Subject|2|||
145917861|NCT00476190|526205605|FG000|Overall Study|Other|9|||
145917862|NCT00476190|526205606|FG001|Overall Study|Other|10|||
145917863|NCT04782076|526205609|FG000|Overall Study|Family Emergency|1|||
145917864|NCT02860546|526205614|FG000|Overall Study|Clinical Progression|6|||
145917865|NCT02860546|526205614|FG000|Overall Study|Radiological Progression|12|||
145917866|NCT02466321|526205615|FG000|Overall Study|Death|26|||
145917867|NCT02466321|526205615|FG000|Overall Study|Revision|6|||
145917868|NCT02466321|526205615|FG000|Overall Study|Lost to Follow-up|60|||
145917869|NCT02466321|526205615|FG000|Overall Study|Did not receive study device|1|||
145917870|NCT00281957|526205617|FG000|Overall Study|Adverse Event|7|||
145917871|NCT00281957|526205618|FG001|Overall Study|Adverse Event|2|||
145917872|NCT00281957|526205617|FG000|Overall Study|Death|1|||
145917873|NCT00281957|526205618|FG001|Overall Study|Death|0|||
145917874|NCT00281957|526205617|FG000|Overall Study|Progression/relapse|47|||
145917875|NCT00281957|526205618|FG001|Overall Study|Progression/relapse|35|||
145917876|NCT00281957|526205617|FG000|Overall Study|Not protocol specified|8|||
145917877|NCT00281957|526205618|FG001|Overall Study|Not protocol specified|1|||
145917878|NCT00281957|526205617|FG000|Overall Study|Not eligible|1|||
145917879|NCT00281957|526205618|FG001|Overall Study|Not eligible|2|||
145917880|NCT00281957|526205617|FG000|Overall Study|Did not start treatment|3|||
145917881|NCT00281957|526205618|FG001|Overall Study|Did not start treatment|1|||
145917882|NCT00281957|526205617|FG000|Overall Study|Refusal unrelated to adverse events|0|||
145917883|NCT00281957|526205618|FG001|Overall Study|Refusal unrelated to adverse events|1|||
145917884|NCT01876446|526205619|FG000|Overall Study|Death|0|||
145917885|NCT01876446|526205620|FG001|Overall Study|Death|1|||
145917886|NCT01876446|526205619|FG000|Overall Study|Withdrawal by Subject|1|||
145917887|NCT01876446|526205620|FG001|Overall Study|Withdrawal by Subject|2|||
145917888|NCT01876446|526205619|FG000|Overall Study|Physician Decision|1|||
145917889|NCT01876446|526205620|FG001|Overall Study|Physician Decision|3|||
145917890|NCT00822692|526205630|FG000|Overall Study|Lost to Follow-up|17|||
145917891|NCT00822692|526205631|FG001|Overall Study|Lost to Follow-up|25|||
145917892|NCT03281876|526205633|FG000|Overall Study|Adverse Event|4|||
145917893|NCT03281876|526205634|FG001|Overall Study|Adverse Event|15|||
145917894|NCT03281876|526205633|FG000|Overall Study|Lost to Follow-up|1|||
145917895|NCT03281876|526205634|FG001|Overall Study|Lost to Follow-up|4|||
145917896|NCT03281876|526205633|FG000|Overall Study|Withdrawal by Subject|11|||
145917897|NCT03281876|526205634|FG001|Overall Study|Withdrawal by Subject|15|||
145917898|NCT03281876|526205633|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145917899|NCT03281876|526205634|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145917900|NCT03281876|526205633|FG000|Overall Study|OTHER|5|||
145917901|NCT03281876|526205634|FG001|Overall Study|OTHER|5|||
145917902|NCT02208089|526205635|FG000|Overall Study|Withdrawal by Subject|1|||
145917903|NCT02208089|526205636|FG001|Overall Study|Withdrawal by Subject|0|||
145917904|NCT02208089|526205635|FG000|Overall Study|Lost to Follow-up|6|||
145917905|NCT02208089|526205636|FG001|Overall Study|Lost to Follow-up|0|||
145917906|NCT02443740|526205637|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917907|NCT02443740|526205638|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917908|NCT02443740|526205639|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917909|NCT02443740|526205640|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917910|NCT02443740|526205641|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917911|NCT02443740|526205642|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
145917912|NCT02443740|526205643|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917913|NCT02443740|526205644|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917914|NCT02443740|526205645|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917915|NCT02443740|526205646|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917916|NCT02443740|526205647|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
145917917|NCT02443740|526205637|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
145917918|NCT02443740|526205638|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917919|NCT02443740|526205639|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917920|NCT02443740|526205640|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917921|NCT02443740|526205641|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917922|NCT02443740|526205642|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917923|NCT02443740|526205643|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
145917924|NCT02443740|526205644|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917925|NCT02443740|526205645|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917926|NCT02443740|526205646|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917927|NCT02443740|526205647|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145917928|NCT02443740|526205637|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917929|NCT02443740|526205638|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917930|NCT02443740|526205639|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917931|NCT02443740|526205640|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917932|NCT02443740|526205641|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917933|NCT02443740|526205642|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
145917934|NCT02443740|526205643|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917935|NCT02443740|526205644|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917936|NCT02443740|526205645|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917937|NCT02443740|526205646|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917938|NCT02443740|526205647|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145917939|NCT00456300|526205648|FG000|Overall Study|Adverse Event|1|||
145917940|NCT00456300|526205649|FG001|Overall Study|Adverse Event|0|||
145917941|NCT02452476|526205650|FG000|Overall Study|Death|4|||
145974297|NCT00580840|526418759|FG000|Run-in|Lost to Follow-up|4|||
145974298|NCT00580840|526418760|FG001|Run-in|Lost to Follow-up|0|||
145974299|NCT00580840|526418761|FG002|Run-in|Lost to Follow-up|0|||
145974300|NCT00580840|526418762|FG003|Run-in|Lost to Follow-up|0|||
145974301|NCT00580840|526418759|FG000|Run-in|Withdrawal by Subject|5|||
145974302|NCT00580840|526418760|FG001|Run-in|Withdrawal by Subject|0|||
145974303|NCT00580840|526418761|FG002|Run-in|Withdrawal by Subject|0|||
145974304|NCT00580840|526418762|FG003|Run-in|Withdrawal by Subject|0|||
145974305|NCT00580840|526418759|FG000|Run-in|Other: Per Sponsor Request|2|||
145974306|NCT00580840|526418760|FG001|Run-in|Other: Per Sponsor Request|0|||
145974307|NCT00580840|526418761|FG002|Run-in|Other: Per Sponsor Request|0|||
145974308|NCT00580840|526418762|FG003|Run-in|Other: Per Sponsor Request|0|||
145974309|NCT00580840|526418759|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
145974310|NCT00580840|526418760|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145974311|NCT00580840|526418761|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145974312|NCT00580840|526418762|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145974313|NCT00580840|526418759|FG000|Run-in|Other: Exclusionary Lab Value|1|||
145974314|NCT00580840|526418760|FG001|Run-in|Other: Exclusionary Lab Value|0|||
145974315|NCT00580840|526418761|FG002|Run-in|Other: Exclusionary Lab Value|0|||
145974316|NCT00580840|526418762|FG003|Run-in|Other: Exclusionary Lab Value|0|||
145974317|NCT00580840|526418759|FG000|Double-Blind|Adverse Event|0|||
145974318|NCT00580840|526418760|FG001|Double-Blind|Adverse Event|3|||
145974319|NCT00580840|526418761|FG002|Double-Blind|Adverse Event|4|||
145974320|NCT00580840|526418762|FG003|Double-Blind|Adverse Event|1|||
145974321|NCT00580840|526418759|FG000|Double-Blind|Loss of Efficacy|0|||
145974322|NCT00580840|526418760|FG001|Double-Blind|Loss of Efficacy|1|||
145974323|NCT00580840|526418761|FG002|Double-Blind|Loss of Efficacy|2|||
145974324|NCT00580840|526418762|FG003|Double-Blind|Loss of Efficacy|10|||
145974325|NCT00580840|526418759|FG000|Double-Blind|Lost to Follow-up|0|||
145974326|NCT00580840|526418760|FG001|Double-Blind|Lost to Follow-up|1|||
145917942|NCT02452476|526205651|FG001|Overall Study|Death|7|||
145917943|NCT02452476|526205650|FG000|Overall Study|Lost to Follow-up|1|||
145917944|NCT02452476|526205651|FG001|Overall Study|Lost to Follow-up|1|||
145917945|NCT02452476|526205650|FG000|Overall Study|Physician Decision|1|||
145974327|NCT00580840|526418761|FG002|Double-Blind|Lost to Follow-up|0|||
145974328|NCT00580840|526418762|FG003|Double-Blind|Lost to Follow-up|2|||
145974329|NCT00580840|526418759|FG000|Double-Blind|Withdrawal by Subject|0|||
145974330|NCT00580840|526418760|FG001|Double-Blind|Withdrawal by Subject|1|||
145974331|NCT00580840|526418761|FG002|Double-Blind|Withdrawal by Subject|2|||
145974332|NCT00580840|526418762|FG003|Double-Blind|Withdrawal by Subject|2|||
145974333|NCT00580840|526418759|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
145974334|NCT00580840|526418760|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
146089157|NCT05828095|526847276|FG000|Overall Study|Lost to Follow-up|1|||
145917946|NCT02452476|526205651|FG001|Overall Study|Physician Decision|1|||
145917947|NCT02452476|526205650|FG000|Overall Study|Not treated|5|||
145917948|NCT02452476|526205651|FG001|Overall Study|Not treated|1|||
145917949|NCT00683657|526205656|FG000|Overall Study|Adverse Event|0|||
145917950|NCT00683657|526205657|FG001|Overall Study|Adverse Event|1|||
145917951|NCT00683657|526205656|FG000|Overall Study|Subject Withdrew Consent|1|||
145917952|NCT00683657|526205657|FG001|Overall Study|Subject Withdrew Consent|0|||
145917953|NCT03200717|526205666|FG000|Overall Study|Progressive disease|24|||
145917954|NCT03200717|526205667|FG001|Overall Study|Progressive disease|5|||
145917955|NCT03200717|526205666|FG000|Overall Study|Adverse Event|11|||
145917956|NCT03200717|526205667|FG001|Overall Study|Adverse Event|8|||
145917957|NCT03200717|526205666|FG000|Overall Study|Physician Decision|3|||
145917958|NCT03200717|526205667|FG001|Overall Study|Physician Decision|2|||
145917959|NCT03200717|526205666|FG000|Overall Study|Death|2|||
146240397|NCT03781375|527394901|FG000|Open-label Phase|Other|2|||
145917960|NCT03200717|526205667|FG001|Overall Study|Death|0|||
145917961|NCT03200717|526205666|FG000|Overall Study|Subject/Guardian Decision|1|||
145917962|NCT03200717|526205667|FG001|Overall Study|Subject/Guardian Decision|0|||
145917963|NCT01461538|526205668|FG000|Overall Study|Death|15|||
145917964|NCT01461538|526205669|FG001|Overall Study|Death|6|||
145917965|NCT01461538|526205670|FG002|Overall Study|Death|2|||
145917966|NCT01461538|526205668|FG000|Overall Study|Study Stopped by Sponsor|2|||
145917967|NCT01461538|526205669|FG001|Overall Study|Study Stopped by Sponsor|1|||
145917968|NCT01461538|526205670|FG002|Overall Study|Study Stopped by Sponsor|0|||
145917969|NCT01461538|526205668|FG000|Overall Study|Withdrawal by Subject|1|||
145917970|NCT01461538|526205669|FG001|Overall Study|Withdrawal by Subject|1|||
145917971|NCT01461538|526205670|FG002|Overall Study|Withdrawal by Subject|0|||
145917972|NCT03552380|526205672|FG000|Study Treatment|Disease Progression|3|||
145917973|NCT03552380|526205673|FG001|Study Treatment|Disease Progression|4|||
145917974|NCT03552380|526205672|FG000|Study Treatment|Adverse Event|2|||
145917975|NCT03552380|526205673|FG001|Study Treatment|Adverse Event|2|||
145917976|NCT03552380|526205672|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
145917977|NCT03552380|526205673|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
145917978|NCT03552380|526205672|FG000|Follow up|Death|3|||
145917979|NCT03552380|526205673|FG001|Follow up|Death|4|||
145917980|NCT03552380|526205672|FG000|Follow up|Site IRB terminated|0|||
145974335|NCT00580840|526418761|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
145974336|NCT00580840|526418762|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
145974337|NCT00580840|526418759|FG000|Double-Blind|Other: Forbidden Medication|0|||
145974338|NCT00580840|526418760|FG001|Double-Blind|Other: Forbidden Medication|0|||
145974339|NCT00580840|526418761|FG002|Double-Blind|Other: Forbidden Medication|1|||
145974340|NCT00580840|526418762|FG003|Double-Blind|Other: Forbidden Medication|0|||
145974341|NCT01402700|526418764|FG000|Overall Study|Death|3|||
145974342|NCT01402700|526418764|FG000|Overall Study|Withdrawal by Subject|3|||
145974343|NCT01402700|526418764|FG000|Overall Study|Missed Visit|1|||
145974344|NCT03507790|526418765|FG000|Overall Study|Adverse Event|0|||
145974345|NCT03507790|526418766|FG001|Overall Study|Adverse Event|11|||
145974346|NCT03507790|526418767|FG002|Overall Study|Adverse Event|3|||
145974347|NCT03507790|526418765|FG000|Overall Study|Withdrawal by Subject|2|||
145974348|NCT03507790|526418766|FG001|Overall Study|Withdrawal by Subject|0|||
145974349|NCT03507790|526418767|FG002|Overall Study|Withdrawal by Subject|0|||
145974350|NCT03507790|526418765|FG000|Overall Study|Subject moved to another location|1|||
145974351|NCT03507790|526418766|FG001|Overall Study|Subject moved to another location|2|||
145974352|NCT03507790|526418767|FG002|Overall Study|Subject moved to another location|0|||
145974353|NCT03507790|526418765|FG000|Overall Study|Non-compliance with study drug|0|||
145974354|NCT03507790|526418766|FG001|Overall Study|Non-compliance with study drug|0|||
145974355|NCT03507790|526418767|FG002|Overall Study|Non-compliance with study drug|1|||
146240398|NCT03781375|527394902|FG001|Open-label Phase|Other|2|||
146240399|NCT02079649|527394903|FG000|Overall Study|Lost to Follow-up|0|||
145917981|NCT03552380|526205673|FG001|Follow up|Site IRB terminated|1|||
145917982|NCT02461160|526205674|FG000|Overall Study|Lost to Follow-up|0|||
145917983|NCT02461160|526205675|FG001|Overall Study|Lost to Follow-up|0|||
145917984|NCT02461160|526205676|FG002|Overall Study|Lost to Follow-up|0|||
145917985|NCT02461160|526205677|FG003|Overall Study|Lost to Follow-up|0|||
145974356|NCT03507790|526418765|FG000|Overall Study|COVID 19 Pandemic|0|||
145974357|NCT03507790|526418766|FG001|Overall Study|COVID 19 Pandemic|1|||
145974358|NCT03507790|526418767|FG002|Overall Study|COVID 19 Pandemic|0|||
145974359|NCT03507790|526418765|FG000|Overall Study|Lost to Follow-up|0|||
145974360|NCT03507790|526418766|FG001|Overall Study|Lost to Follow-up|1|||
145917986|NCT02461160|526205678|FG004|Overall Study|Lost to Follow-up|0|||
145917987|NCT02461160|526205679|FG005|Overall Study|Lost to Follow-up|0|||
145917988|NCT02461160|526205680|FG006|Overall Study|Lost to Follow-up|0|||
145917989|NCT02461160|526205681|FG007|Overall Study|Lost to Follow-up|1|||
145917990|NCT02461160|526205682|FG008|Overall Study|Lost to Follow-up|0|||
145917991|NCT02461160|526205683|FG009|Overall Study|Lost to Follow-up|0|||
145917992|NCT02461160|526205684|FG010|Overall Study|Lost to Follow-up|0|||
145974361|NCT03507790|526418767|FG002|Overall Study|Lost to Follow-up|0|||
146089158|NCT05828095|526847277|FG001|Overall Study|Lost to Follow-up|0|||
146240400|NCT02079649|527394904|FG001|Overall Study|Lost to Follow-up|0|||
145917993|NCT02461160|526205685|FG011|Overall Study|Lost to Follow-up|0|||
145917994|NCT02461160|526205686|FG012|Overall Study|Lost to Follow-up|0|||
145917995|NCT01112059|526205687|FG000|Overall Study|Withdrawal by Subject|1|||
145917996|NCT01112059|526205688|FG001|Overall Study|Withdrawal by Subject|0|||
145917997|NCT03567980|526205691|FG000|Overall Study|Adverse Event|1|||
145917998|NCT02633787|526205692|FG000|Overall Study|Withdrawal by Subject|1|||
145917999|NCT05373108|526205693|FG000|Overall Study|Withdrawal by Subject|2|||
145918000|NCT00349973|526205694|FG000|Overall Study|Adverse Event|3|||
145918001|NCT00349973|526205695|FG001|Overall Study|Adverse Event|3|||
145918002|NCT00349973|526205694|FG000|Overall Study|Withdrawal by Subject|1|||
145918003|NCT00349973|526205695|FG001|Overall Study|Withdrawal by Subject|0|||
145918004|NCT04871776|526205696|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
145918005|NCT04871776|526205697|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
145918006|NCT04871776|526205698|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
145918007|NCT04871776|526205696|FG000|Overall Study|Did not meet eligibility criteria|1|||
145918008|NCT04871776|526205697|FG001|Overall Study|Did not meet eligibility criteria|1|||
145918009|NCT04871776|526205698|FG002|Overall Study|Did not meet eligibility criteria|1|||
145918010|NCT06389487|526205704|FG000|Overall Study|Lost to Follow-up|9|||
145918011|NCT06389487|526205705|FG001|Overall Study|Lost to Follow-up|5|||
145918012|NCT06389487|526205706|FG002|Overall Study|Lost to Follow-up|13|||
145918013|NCT06389487|526205704|FG000|Overall Study|Protocol Violation|0|||
145918014|NCT06389487|526205705|FG001|Overall Study|Protocol Violation|0|||
145918015|NCT06389487|526205706|FG002|Overall Study|Protocol Violation|2|||
145918016|NCT06389487|526205704|FG000|Overall Study|Withdrawal by Subject|2|||
145918017|NCT06389487|526205705|FG001|Overall Study|Withdrawal by Subject|2|||
145918018|NCT06389487|526205706|FG002|Overall Study|Withdrawal by Subject|1|||
145918019|NCT06389487|526205704|FG000|Overall Study|Other|1|||
145918020|NCT06389487|526205705|FG001|Overall Study|Other|0|||
145918021|NCT06389487|526205706|FG002|Overall Study|Other|1|||
145918022|NCT05016960|526207353|FG000|Overall Study|Withdrawal by Subject|1|||
145918023|NCT05016960|526207354|FG001|Overall Study|Withdrawal by Subject|9|||
145918024|NCT00116779|526207357|FG000|Overall Study|Adverse Event|4|||
145918025|NCT00116779|526207358|FG001|Overall Study|Adverse Event|2|||
145918026|NCT00116779|526207357|FG000|Overall Study|Protocol Violation|1|||
145918027|NCT00116779|526207358|FG001|Overall Study|Protocol Violation|4|||
145918028|NCT00116779|526207357|FG000|Overall Study|Withdrawal by Subject|4|||
145918029|NCT00116779|526207358|FG001|Overall Study|Withdrawal by Subject|1|||
145918030|NCT00116779|526207357|FG000|Overall Study|Inadequate testosterone suppression|7|||
145918031|NCT00116779|526207358|FG001|Overall Study|Inadequate testosterone suppression|9|||
145974362|NCT03507790|526418765|FG000|Overall Study|Discontinuation of the trial at the site|1|||
145974363|NCT03507790|526418766|FG001|Overall Study|Discontinuation of the trial at the site|1|||
145974364|NCT03507790|526418767|FG002|Overall Study|Discontinuation of the trial at the site|0|||
145974365|NCT03507790|526418765|FG000|Overall Study|Randomized in error|0|||
145974366|NCT03507790|526418766|FG001|Overall Study|Randomized in error|0|||
145974367|NCT03507790|526418767|FG002|Overall Study|Randomized in error|1|||
145974368|NCT00157755|526418769|FG000|Overall Study|Death|2|||
145974369|NCT00157755|526418770|FG001|Overall Study|Death|3|||
145974370|NCT00157755|526418771|FG002|Overall Study|Death|3|||
145974371|NCT00157755|526418772|FG003|Overall Study|Death|2|||
145974372|NCT00157755|526418773|FG004|Overall Study|Death|0|||
145974373|NCT00157755|526418774|FG005|Overall Study|Death|0|||
145974374|NCT00157755|526418769|FG000|Overall Study|Lost to Follow-up|0|||
145974375|NCT00157755|526418770|FG001|Overall Study|Lost to Follow-up|0|||
145974376|NCT00157755|526418771|FG002|Overall Study|Lost to Follow-up|1|||
145974377|NCT00157755|526418772|FG003|Overall Study|Lost to Follow-up|0|||
145974378|NCT00157755|526418773|FG004|Overall Study|Lost to Follow-up|0|||
145974379|NCT00157755|526418774|FG005|Overall Study|Lost to Follow-up|0|||
145974380|NCT00157755|526418769|FG000|Overall Study|Withdrawal by Subject|0|||
145974381|NCT00157755|526418770|FG001|Overall Study|Withdrawal by Subject|0|||
145974382|NCT00157755|526418771|FG002|Overall Study|Withdrawal by Subject|1|||
145974383|NCT00157755|526418772|FG003|Overall Study|Withdrawal by Subject|1|||
145974384|NCT00157755|526418773|FG004|Overall Study|Withdrawal by Subject|1|||
145974385|NCT00157755|526418774|FG005|Overall Study|Withdrawal by Subject|2|||
145974386|NCT00157755|526418769|FG000|Overall Study|Explant due to infection|0|||
145974387|NCT00157755|526418770|FG001|Overall Study|Explant due to infection|0|||
146297587|NCT04427501|527604735|FG003|Overall Study|Withdrawal by Subject|3|||
146297588|NCT04427501|527604736|FG004|Overall Study|Withdrawal by Subject|7|||
145918032|NCT00116779|526207357|FG000|Overall Study|Physician Decision|3|||
145918033|NCT00116779|526207358|FG001|Overall Study|Physician Decision|1|||
145918034|NCT00116779|526207357|FG000|Overall Study|Elevated PSA levels|2|||
145918035|NCT00116779|526207358|FG001|Overall Study|Elevated PSA levels|2|||
145918036|NCT01321879|526207359|FG000|Overall Study|Lack of Efficacy|5|||
145918037|NCT01321879|526207359|FG000|Overall Study|Adverse Event|5|||
145918038|NCT01321879|526207359|FG000|Overall Study|Death|3|||
145918039|NCT01321879|526207359|FG000|Overall Study|Withdrawal by Subject|1|||
145918040|NCT03743051|526207360|FG000|Overall Study|Adverse Event|5|||
146297589|NCT04427501|527604737|FG005|Overall Study|Withdrawal by Subject|25|||
146240401|NCT02079649|527394905|FG002|Overall Study|Lost to Follow-up|0|||
146240402|NCT02079649|527394906|FG003|Overall Study|Lost to Follow-up|1|||
146240403|NCT02079649|527394903|FG000|Overall Study|Withdrawal by Subject|0|||
146240404|NCT02079649|527394904|FG001|Overall Study|Withdrawal by Subject|0|||
146240405|NCT02079649|527394905|FG002|Overall Study|Withdrawal by Subject|0|||
146240406|NCT02079649|527394906|FG003|Overall Study|Withdrawal by Subject|1|||
146240407|NCT02079649|527394903|FG000|Overall Study|Randomization error (prior to treatment)|1|||
146240408|NCT02079649|527394904|FG001|Overall Study|Randomization error (prior to treatment)|0|||
146240409|NCT02079649|527394905|FG002|Overall Study|Randomization error (prior to treatment)|1|||
146240410|NCT02079649|527394906|FG003|Overall Study|Randomization error (prior to treatment)|0|||
146240411|NCT01034306|527394907|FG000|Overall Study|Adverse Event|1|||
146240412|NCT01034306|527394908|FG001|Overall Study|Adverse Event|0|||
146240413|NCT01034306|527394907|FG000|Overall Study|Lost to Follow-up|0|||
146240414|NCT01034306|527394908|FG001|Overall Study|Lost to Follow-up|1|||
146240415|NCT01034306|527394907|FG000|Overall Study|Withdrawal by Subject|2|||
146240416|NCT01034306|527394908|FG001|Overall Study|Withdrawal by Subject|2|||
146240417|NCT01034306|527394907|FG000|Overall Study|hospitalized and decided to stop|1|||
146240418|NCT01034306|527394908|FG001|Overall Study|hospitalized and decided to stop|0|||
146240419|NCT01034306|527394907|FG000|Overall Study|Noncomplience|1|||
146240420|NCT01034306|527394908|FG001|Overall Study|Noncomplience|0|||
146240421|NCT00836498|527394909|FG000|Overall Study|Adverse Event|1|||
146240422|NCT00836498|527394910|FG001|Overall Study|Adverse Event|0|||
146240423|NCT00836498|527394909|FG000|Overall Study|Lost to Follow-up|1|||
146240424|NCT00836498|527394910|FG001|Overall Study|Lost to Follow-up|0|||
146240425|NCT00836498|527394909|FG000|Overall Study|Withdrawal by Subject|2|||
146240426|NCT00836498|527394910|FG001|Overall Study|Withdrawal by Subject|1|||
146240427|NCT01968967|527394911|FG000|Treatment Period|Other|22|||
146240428|NCT01968967|527394912|FG001|Treatment Period|Other|22|||
146240429|NCT01968967|527394913|FG002|Treatment Period|Other|0|||
146240430|NCT01968967|527394914|FG003|Treatment Period|Other|0|||
146240431|NCT01968967|527394915|FG004|Treatment Period|Other|0|||
146240432|NCT01968967|527394911|FG000|Treatment Period|Withdrawal by Subject|71|||
146240433|NCT01968967|527394912|FG001|Treatment Period|Withdrawal by Subject|61|||
146240434|NCT01968967|527394913|FG002|Treatment Period|Withdrawal by Subject|0|||
146240435|NCT01968967|527394914|FG003|Treatment Period|Withdrawal by Subject|0|||
146240436|NCT01968967|527394915|FG004|Treatment Period|Withdrawal by Subject|0|||
146240437|NCT01968967|527394911|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
146240438|NCT01968967|527394912|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
146240439|NCT01968967|527394913|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
146240440|NCT01968967|527394914|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
146240441|NCT01968967|527394915|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
145918041|NCT03743051|526207361|FG001|Overall Study|Adverse Event|9|||
145918042|NCT03743051|526207360|FG000|Overall Study|Death|27|||
145918043|NCT03743051|526207361|FG001|Overall Study|Death|26|||
145918044|NCT03743051|526207360|FG000|Overall Study|Lost to Follow-up|4|||
145918045|NCT03743051|526207361|FG001|Overall Study|Lost to Follow-up|8|||
145918046|NCT03743051|526207360|FG000|Overall Study|Withdrawal by Subject|32|||
145918047|NCT03743051|526207361|FG001|Overall Study|Withdrawal by Subject|19|||
145918048|NCT03743051|526207360|FG000|Overall Study|Physician Decision|10|||
145918049|NCT03743051|526207361|FG001|Overall Study|Physician Decision|15|||
145918050|NCT03743051|526207360|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
145918051|NCT03743051|526207361|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
145918052|NCT00711087|526207364|FG000|Overall Study|Lost to Follow-up|1|||
145918053|NCT00711087|526207365|FG001|Overall Study|Lost to Follow-up|0|||
145918054|NCT03652051|526207366|FG000|Stage 1|Adverse Event|0|||
145918055|NCT03652051|526207367|FG001|Stage 1|Adverse Event|5|||
145918056|NCT03652051|526207368|FG002|Stage 1|Adverse Event|7|||
146240442|NCT01968967|527394911|FG000|Treatment Period|Lost to Follow-up|26|||
146240443|NCT01968967|527394912|FG001|Treatment Period|Lost to Follow-up|31|||
146240444|NCT01968967|527394913|FG002|Treatment Period|Lost to Follow-up|0|||
146240445|NCT01968967|527394914|FG003|Treatment Period|Lost to Follow-up|0|||
145918057|NCT03652051|526207369|FG003|Stage 1|Adverse Event|1|||
146240446|NCT01968967|527394915|FG004|Treatment Period|Lost to Follow-up|0|||
146240447|NCT01968967|527394911|FG000|Treatment Period|Protocol Violation|1|||
146240448|NCT01968967|527394912|FG001|Treatment Period|Protocol Violation|2|||
146240449|NCT01968967|527394913|FG002|Treatment Period|Protocol Violation|0|||
146240450|NCT01968967|527394914|FG003|Treatment Period|Protocol Violation|0|||
146240451|NCT01968967|527394915|FG004|Treatment Period|Protocol Violation|0|||
146240452|NCT01968967|527394911|FG000|Treatment Period|Adverse Event|9|||
146240453|NCT01968967|527394912|FG001|Treatment Period|Adverse Event|8|||
145918058|NCT03652051|526207366|FG000|Stage 1|Withdrawal by Subject|0|||
145918059|NCT03652051|526207367|FG001|Stage 1|Withdrawal by Subject|0|||
145918060|NCT03652051|526207368|FG002|Stage 1|Withdrawal by Subject|1|||
145918061|NCT03652051|526207369|FG003|Stage 1|Withdrawal by Subject|0|||
145918062|NCT03652051|526207366|FG000|Stage 2|Adverse Event|0|||
145918063|NCT03652051|526207367|FG001|Stage 2|Adverse Event|2|||
146240454|NCT01968967|527394913|FG002|Treatment Period|Adverse Event|0|||
146240455|NCT01968967|527394914|FG003|Treatment Period|Adverse Event|0|||
145918064|NCT03652051|526207368|FG002|Stage 2|Adverse Event|1|||
145918065|NCT03652051|526207369|FG003|Stage 2|Adverse Event|0|||
146240456|NCT01968967|527394915|FG004|Treatment Period|Adverse Event|0|||
146240457|NCT01968967|527394911|FG000|Treatment Period|Death|9|||
146240458|NCT01968967|527394912|FG001|Treatment Period|Death|2|||
145918066|NCT03652051|526207366|FG000|Stage 2|Protocol Violation|0|||
145918067|NCT03652051|526207367|FG001|Stage 2|Protocol Violation|1|||
145918068|NCT03652051|526207368|FG002|Stage 2|Protocol Violation|6|||
145918069|NCT03652051|526207369|FG003|Stage 2|Protocol Violation|0|||
145918070|NCT03652051|526207366|FG000|Stage 2|Lost to Follow-up|0|||
145918071|NCT03652051|526207367|FG001|Stage 2|Lost to Follow-up|2|||
145918072|NCT03652051|526207368|FG002|Stage 2|Lost to Follow-up|0|||
145918073|NCT03652051|526207369|FG003|Stage 2|Lost to Follow-up|3|||
145918074|NCT03652051|526207366|FG000|Stage 2|Withdrawal by Subject|0|||
145918075|NCT03652051|526207367|FG001|Stage 2|Withdrawal by Subject|11|||
145918076|NCT03652051|526207368|FG002|Stage 2|Withdrawal by Subject|9|||
145918077|NCT03652051|526207369|FG003|Stage 2|Withdrawal by Subject|3|||
145918078|NCT01113892|526207376|FG000|Overall Study|Lost to Follow-up|2|||
145918079|NCT01113892|526207377|FG001|Overall Study|Lost to Follow-up|2|||
145918080|NCT01113892|526207376|FG000|Overall Study|Withdrawal by Subject|1|||
145918081|NCT01113892|526207377|FG001|Overall Study|Withdrawal by Subject|1|||
145918082|NCT01113892|526207376|FG000|Overall Study|Death|2|||
145918083|NCT01113892|526207377|FG001|Overall Study|Death|4|||
145918084|NCT01113892|526207376|FG000|Overall Study|Graft no longer evaluable|9|||
145918085|NCT01113892|526207377|FG001|Overall Study|Graft no longer evaluable|9|||
145918086|NCT02394600|526207378|FG000|Overall Study|Adverse Event|3|||
145918087|NCT02394600|526207379|FG001|Overall Study|Adverse Event|0|||
145918088|NCT02394600|526207378|FG000|Overall Study|Lost to Follow-up|0|||
145918089|NCT02394600|526207379|FG001|Overall Study|Lost to Follow-up|1|||
146240459|NCT01968967|527394913|FG002|Treatment Period|Death|0|||
146240460|NCT01968967|527394914|FG003|Treatment Period|Death|0|||
146240461|NCT01968967|527394915|FG004|Treatment Period|Death|0|||
146240462|NCT01968967|527394911|FG000|Treatment Period|Randomized Not Treated|6|||
146240463|NCT01968967|527394912|FG001|Treatment Period|Randomized Not Treated|5|||
145918090|NCT02394600|526207378|FG000|Overall Study|Withdrawal by Subject|0|||
145918091|NCT02394600|526207379|FG001|Overall Study|Withdrawal by Subject|1|||
145918092|NCT02394600|526207378|FG000|Overall Study|Protocol Violation|1|||
145918093|NCT02394600|526207379|FG001|Overall Study|Protocol Violation|0|||
145918094|NCT00428246|526207380|FG000|Overall Study|Withdrawal by Subject|0|||
145918095|NCT00428246|526207381|FG001|Overall Study|Withdrawal by Subject|0|||
145918096|NCT00428246|526207382|FG002|Overall Study|Withdrawal by Subject|1|||
145918097|NCT00428246|526207380|FG000|Overall Study|Adverse Event|1|||
145918098|NCT00428246|526207381|FG001|Overall Study|Adverse Event|0|||
145918099|NCT00428246|526207382|FG002|Overall Study|Adverse Event|0|||
145918100|NCT02569801|526207383|FG000|Overall Study|Withdrawal by Subject|9|||
145918101|NCT02569801|526207384|FG001|Overall Study|Withdrawal by Subject|9|||
145918102|NCT02569801|526207383|FG000|Overall Study|Sponsor Decision|13|||
145918103|NCT02569801|526207384|FG001|Overall Study|Sponsor Decision|14|||
145918104|NCT02569801|526207383|FG000|Overall Study|Progressive Disease|2|||
145918105|NCT02569801|526207384|FG001|Overall Study|Progressive Disease|7|||
145918106|NCT02569801|526207383|FG000|Overall Study|Lost to Follow-up|0|||
145918107|NCT02569801|526207384|FG001|Overall Study|Lost to Follow-up|1|||
145918108|NCT02569801|526207383|FG000|Overall Study|Death|12|||
145918109|NCT02569801|526207384|FG001|Overall Study|Death|4|||
146240464|NCT01968967|527394913|FG002|Treatment Period|Randomized Not Treated|0|||
145918110|NCT01960413|526207386|FG000|Overall Study|Withdrawal by Subject|1|||
145918111|NCT01960413|526207387|FG001|Overall Study|Withdrawal by Subject|1|||
145918112|NCT01960413|526207386|FG000|Overall Study|Physician Decision|1|||
145918113|NCT01960413|526207387|FG001|Overall Study|Physician Decision|0|||
145918114|NCT01960413|526207386|FG000|Overall Study|Lost to Follow-up|2|||
145918115|NCT01960413|526207387|FG001|Overall Study|Lost to Follow-up|0|||
146240465|NCT01968967|527394914|FG003|Treatment Period|Randomized Not Treated|0|||
146240466|NCT01968967|527394915|FG004|Treatment Period|Randomized Not Treated|0|||
146240467|NCT01968967|527394911|FG000|Extension Period|Withdrew Consent|0|||
146240468|NCT01968967|527394912|FG001|Extension Period|Withdrew Consent|0|||
146240469|NCT01968967|527394913|FG002|Extension Period|Withdrew Consent|2|||
145918116|NCT00791778|526207390|FG000|Double-blind Treatment|Adverse Event|49|||
145918117|NCT00791778|526207391|FG001|Double-blind Treatment|Adverse Event|9|||
145918118|NCT00791778|526207390|FG000|Double-blind Treatment|Physician Decision|6|||
145918119|NCT00791778|526207391|FG001|Double-blind Treatment|Physician Decision|26|||
145918120|NCT00791778|526207390|FG000|Double-blind Treatment|Protocol Violation|0|||
145918121|NCT00791778|526207391|FG001|Double-blind Treatment|Protocol Violation|4|||
146240470|NCT01968967|527394914|FG003|Extension Period|Withdrew Consent|0|||
145918122|NCT00791778|526207390|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
145918123|NCT00791778|526207391|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
145918124|NCT00791778|526207390|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
145918125|NCT00791778|526207391|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
145918126|NCT00791778|526207390|FG000|Follow-up|Withdrawal by Subject|3|||
145918127|NCT00791778|526207391|FG001|Follow-up|Withdrawal by Subject|0|||
146240471|NCT01968967|527394915|FG004|Extension Period|Withdrew Consent|5|||
145918128|NCT00791778|526207390|FG000|Follow-up|Lost to Follow-up|2|||
145918129|NCT00791778|526207391|FG001|Follow-up|Lost to Follow-up|1|||
145918130|NCT04886596|526207394|FG000|Overall Study|Adverse Event|442|||
145918131|NCT04886596|526207395|FG001|Overall Study|Adverse Event|441|||
145918132|NCT04886596|526207394|FG000|Overall Study|Lost to Follow-up|448|||
145918133|NCT04886596|526207395|FG001|Overall Study|Lost to Follow-up|465|||
145918134|NCT04886596|526207394|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
145918135|NCT04886596|526207395|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
145918136|NCT04886596|526207394|FG000|Overall Study|Migrated/moved from the study area|201|||
145918137|NCT04886596|526207395|FG001|Overall Study|Migrated/moved from the study area|184|||
145918138|NCT04886596|526207394|FG000|Overall Study|Other|298|||
145918139|NCT04886596|526207395|FG001|Overall Study|Other|326|||
145918140|NCT04620746|526207396|FG000|Overall Study|Adverse Event|2|||
145918141|NCT04620746|526207397|FG001|Overall Study|Adverse Event|0|||
145918142|NCT04620746|526207396|FG000|Overall Study|Uniterpretable skin test|1|||
145918143|NCT04620746|526207397|FG001|Overall Study|Uniterpretable skin test|0|||
145918144|NCT04620746|526207396|FG000|Overall Study|Withdrawal by Subject|0|||
145918145|NCT04620746|526207397|FG001|Overall Study|Withdrawal by Subject|1|||
145918146|NCT03473925|526207398|FG000|Overall Study|Death|48|||
145918147|NCT03473925|526207399|FG001|Overall Study|Death|44|||
145918148|NCT03473925|526207398|FG000|Overall Study|Sponsor Decision|2|||
145918149|NCT03473925|526207399|FG001|Overall Study|Sponsor Decision|7|||
145918150|NCT03473925|526207398|FG000|Overall Study|Withdrawal by Subject|1|||
145918151|NCT03473925|526207399|FG001|Overall Study|Withdrawal by Subject|3|||
145918152|NCT03473925|526207398|FG000|Overall Study|Not Treated|1|||
145918153|NCT03473925|526207399|FG001|Overall Study|Not Treated|1|||
145918154|NCT02756611|526207402|FG000|Overall Study|Death|70|||
145918155|NCT02756611|526207402|FG000|Overall Study|Withdrawal by Subject|2|||
145918156|NCT02756611|526207402|FG000|Overall Study|Lost to Follow-up|3|||
145918157|NCT02756611|526207402|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
145918158|NCT02756611|526207402|FG000|Overall Study|Other|10|||
145918159|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
145918160|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
145918161|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
145918162|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
145918163|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
145918164|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
145918165|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
145918166|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
145918167|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
145918168|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
145918169|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
145918170|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
145918171|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
145918172|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
145918173|NCT04338022|526207414|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
145918174|NCT04338022|526207415|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
145918175|NCT04338022|526207414|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
145918176|NCT04338022|526207415|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
145918177|NCT04338022|526207414|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
145918178|NCT04338022|526207415|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
145918179|NCT04338022|526207414|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
145918180|NCT04338022|526207415|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
145918181|NCT04338022|526207414|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
145918182|NCT04338022|526207415|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
145918183|NCT04338022|526207414|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
145918184|NCT04338022|526207415|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
146089159|NCT05828095|526847276|FG000|Overall Study|Reactogenicity symptom|0|||
146089160|NCT05828095|526847277|FG001|Overall Study|Reactogenicity symptom|1|||
146089161|NCT00096954|526847283|FG000|Overall Study|Adverse Event|3|||
146089162|NCT00096954|526847284|FG001|Overall Study|Adverse Event|1|||
146089163|NCT00096954|526847283|FG000|Overall Study|Withdrawal by Subject|9|||
145918185|NCT04338022|526207414|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
145918186|NCT04338022|526207415|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
145918187|NCT02348112|526207418|FG000|Overall Study|Withdrawal by Subject|32|||
145918188|NCT02348112|526207419|FG001|Overall Study|Withdrawal by Subject|29|||
145918189|NCT02348112|526207418|FG000|Overall Study|Lost to Follow-up|24|||
145918190|NCT02348112|526207419|FG001|Overall Study|Lost to Follow-up|20|||
146089164|NCT00096954|526847284|FG001|Overall Study|Withdrawal by Subject|8|||
146089165|NCT00096954|526847283|FG000|Overall Study|Physician Decision|1|||
146089166|NCT00096954|526847284|FG001|Overall Study|Physician Decision|1|||
146089167|NCT00096954|526847283|FG000|Overall Study|Sponsors Decision|1|||
145918191|NCT02348112|526207418|FG000|Overall Study|Physician Decision|17|||
145918192|NCT02348112|526207419|FG001|Overall Study|Physician Decision|15|||
145918193|NCT02348112|526207418|FG000|Overall Study|Site closed due to PI leaving|0|||
145918194|NCT02348112|526207419|FG001|Overall Study|Site closed due to PI leaving|30|||
145918195|NCT02348112|526207418|FG000|Overall Study|Sponsor withdrawal|0|||
145918196|NCT02348112|526207419|FG001|Overall Study|Sponsor withdrawal|7|||
145918197|NCT02348112|526207418|FG000|Overall Study|Death|0|||
145918198|NCT02348112|526207419|FG001|Overall Study|Death|1|||
145918199|NCT01998841|526207420|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
145918200|NCT01998841|526207421|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
145918201|NCT01998841|526207422|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
145918202|NCT01998841|526207423|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145918203|NCT01998841|526207424|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145918204|NCT01998841|526207420|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145918205|NCT01998841|526207421|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145918206|NCT01998841|526207422|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145918207|NCT01998841|526207423|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
145918208|NCT01998841|526207424|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
145918209|NCT02552121|526207425|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
145918210|NCT02552121|526207426|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918211|NCT02552121|526207427|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918212|NCT02552121|526207428|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918213|NCT02552121|526207429|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918214|NCT02552121|526207430|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918215|NCT02552121|526207431|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918216|NCT02552121|526207432|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145918217|NCT02552121|526207425|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
145918218|NCT02552121|526207426|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918219|NCT02552121|526207427|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918220|NCT02552121|526207428|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918221|NCT02552121|526207429|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918222|NCT02552121|526207430|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918223|NCT02552121|526207431|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918224|NCT02552121|526207432|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145918225|NCT02552121|526207425|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918226|NCT02552121|526207426|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
145918227|NCT02552121|526207427|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918228|NCT02552121|526207428|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918229|NCT02552121|526207429|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918230|NCT02552121|526207430|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918231|NCT02552121|526207431|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918232|NCT02552121|526207432|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145918233|NCT02552121|526207425|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918234|NCT02552121|526207426|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
145918235|NCT02552121|526207427|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918236|NCT02552121|526207428|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918237|NCT02552121|526207429|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918238|NCT02552121|526207430|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918239|NCT02552121|526207431|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918240|NCT02552121|526207432|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145918241|NCT02552121|526207425|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918242|NCT02552121|526207426|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
145918243|NCT02552121|526207427|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918244|NCT02552121|526207428|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918245|NCT02552121|526207429|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918246|NCT02552121|526207430|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918247|NCT02552121|526207431|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918248|NCT02552121|526207432|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145918249|NCT02552121|526207425|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918250|NCT02552121|526207426|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
145918251|NCT02552121|526207427|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918252|NCT02552121|526207428|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918253|NCT02552121|526207429|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918254|NCT02552121|526207430|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918255|NCT02552121|526207431|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918256|NCT02552121|526207432|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145918257|NCT02552121|526207425|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
145918258|NCT02552121|526207426|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
145918259|NCT02552121|526207427|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
145918260|NCT02552121|526207428|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
145918261|NCT02552121|526207429|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
145918262|NCT02552121|526207430|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
145918263|NCT02552121|526207431|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
145918264|NCT02552121|526207432|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
145918265|NCT02552121|526207425|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
145918266|NCT02552121|526207426|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
145918267|NCT02552121|526207427|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
145918268|NCT02552121|526207428|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
145918269|NCT02552121|526207429|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
145918270|NCT02552121|526207430|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
145918271|NCT02552121|526207431|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
145918272|NCT02552121|526207432|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
145918273|NCT02552121|526207425|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
145918274|NCT02552121|526207426|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
145918275|NCT02552121|526207427|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
145918276|NCT02552121|526207428|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
145918277|NCT02552121|526207429|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
145918278|NCT02552121|526207430|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
145918279|NCT02552121|526207431|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
145918280|NCT02552121|526207432|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
145918281|NCT02552121|526207425|FG000|Part 2: Cohort Expansion|Death|0|||
145918282|NCT02552121|526207426|FG001|Part 2: Cohort Expansion|Death|0|||
145918283|NCT02552121|526207427|FG002|Part 2: Cohort Expansion|Death|1|||
145918284|NCT02552121|526207428|FG003|Part 2: Cohort Expansion|Death|0|||
145918285|NCT02552121|526207429|FG004|Part 2: Cohort Expansion|Death|0|||
145918286|NCT02552121|526207430|FG005|Part 2: Cohort Expansion|Death|0|||
145918287|NCT02552121|526207431|FG006|Part 2: Cohort Expansion|Death|0|||
145918288|NCT02552121|526207432|FG007|Part 2: Cohort Expansion|Death|0|||
145918289|NCT04052620|526207434|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
145918290|NCT04052620|526207435|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
145918291|NCT04052620|526207434|FG000|Overall Study|Withdrawal by Subject|1|||
145918292|NCT04052620|526207435|FG001|Overall Study|Withdrawal by Subject|0|||
145918293|NCT04052620|526207434|FG000|Overall Study|Lost to Follow-up|1|||
145918294|NCT04052620|526207435|FG001|Overall Study|Lost to Follow-up|1|||
145918295|NCT04052620|526207434|FG000|Overall Study|Adverse Event|1|||
145918296|NCT04052620|526207435|FG001|Overall Study|Adverse Event|0|||
145918297|NCT04052620|526207434|FG000|Overall Study|Subject did not meet study Criteria|0|||
145918298|NCT04052620|526207435|FG001|Overall Study|Subject did not meet study Criteria|1|||
145918299|NCT04052620|526207434|FG000|Overall Study|Screened failure, randomized by mistake|0|||
145918300|NCT04052620|526207435|FG001|Overall Study|Screened failure, randomized by mistake|1|||
145918301|NCT04052620|526207434|FG000|Overall Study|Personal reasons|2|||
145918302|NCT04052620|526207435|FG001|Overall Study|Personal reasons|4|||
145918303|NCT04052620|526207434|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
145918304|NCT04052620|526207435|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
145918305|NCT02201784|526207436|FG000|Overall Study|Failure to achieve adequate block|2|||
145918306|NCT02201784|526207437|FG001|Overall Study|Failure to achieve adequate block|0|||
145918307|NCT00193050|526207438|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
145918308|NCT00193050|526207438|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
145918309|NCT00193050|526207438|FG000|Neoadjuvant Treatment|Physician Decision|2|||
145918310|NCT00193050|526207438|FG000|Neoadjuvant Treatment|Adverse Event|2|||
145918311|NCT00193050|526207438|FG000|Adjuvant|Physician Decision|5|||
145918312|NCT00193050|526207438|FG000|Adjuvant|Intercurrent Hospitalization|3|||
145918313|NCT00193050|526207438|FG000|Adjuvant|Lack of Efficacy|2|||
145918314|NCT00061932|526207439|FG000|Overall Study|Withdrawal by Subject|13|||
145918315|NCT00061932|526207440|FG001|Overall Study|Withdrawal by Subject|4|||
146240472|NCT03489369|527394916|FG000|Overall Study|Documented Progressive Disease|3|||
146240473|NCT03489369|527394917|FG001|Overall Study|Documented Progressive Disease|2|||
146240474|NCT03489369|527394918|FG002|Overall Study|Documented Progressive Disease|3|||
146240475|NCT03489369|527394919|FG003|Overall Study|Documented Progressive Disease|6|||
146240476|NCT03489369|527394916|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
146240477|NCT03489369|527394917|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
146240478|NCT03489369|527394918|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
145918316|NCT00916383|526207441|FG000|Overall Study|Adverse Event|1|||
145918317|NCT00916383|526207441|FG000|Overall Study|Death|1|||
145918318|NCT00916383|526207441|FG000|Overall Study|Protocol Violation|1|||
145918319|NCT02899962|526207442|FG000|Open-label Phase|Adverse Event|2|||
145918320|NCT02899962|526207443|FG001|Open-label Phase|Adverse Event|0|||
145918321|NCT02899962|526207444|FG002|Open-label Phase|Adverse Event|0|||
145918322|NCT02899962|526207442|FG000|Open-label Phase|Lost to Follow-up|9|||
145974388|NCT00157755|526418771|FG002|Overall Study|Explant due to infection|1|||
145918323|NCT02899962|526207443|FG001|Open-label Phase|Lost to Follow-up|0|||
145918324|NCT02899962|526207444|FG002|Open-label Phase|Lost to Follow-up|0|||
145918325|NCT02899962|526207442|FG000|Open-label Phase|Other reasons|9|||
145918326|NCT02899962|526207443|FG001|Open-label Phase|Other reasons|0|||
145918327|NCT02899962|526207444|FG002|Open-label Phase|Other reasons|0|||
145918328|NCT02899962|526207442|FG000|Open-label Phase|Withdrawal by Subject|7|||
145918329|NCT02899962|526207443|FG001|Open-label Phase|Withdrawal by Subject|0|||
145918330|NCT02899962|526207444|FG002|Open-label Phase|Withdrawal by Subject|0|||
145918331|NCT02899962|526207442|FG000|Maintenance Phase|Adverse Event|0|||
145918332|NCT02899962|526207443|FG001|Maintenance Phase|Adverse Event|2|||
145918333|NCT02899962|526207444|FG002|Maintenance Phase|Adverse Event|1|||
145918334|NCT02899962|526207442|FG000|Maintenance Phase|Death|0|||
145918335|NCT02899962|526207443|FG001|Maintenance Phase|Death|0|||
145918336|NCT02899962|526207444|FG002|Maintenance Phase|Death|1|||
145918337|NCT02899962|526207442|FG000|Maintenance Phase|Lack of Efficacy|0|||
145918338|NCT02899962|526207443|FG001|Maintenance Phase|Lack of Efficacy|20|||
145918339|NCT02899962|526207444|FG002|Maintenance Phase|Lack of Efficacy|16|||
145918340|NCT02899962|526207442|FG000|Maintenance Phase|Lost to Follow-up|0|||
145918341|NCT02899962|526207443|FG001|Maintenance Phase|Lost to Follow-up|12|||
145918342|NCT02899962|526207444|FG002|Maintenance Phase|Lost to Follow-up|14|||
145918343|NCT02899962|526207442|FG000|Maintenance Phase|Other reasons|0|||
145918344|NCT02899962|526207443|FG001|Maintenance Phase|Other reasons|9|||
145918345|NCT02899962|526207444|FG002|Maintenance Phase|Other reasons|13|||
145918346|NCT02899962|526207442|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
145918347|NCT02899962|526207443|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
145918348|NCT02899962|526207444|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
145918349|NCT02899962|526207442|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
145918350|NCT02899962|526207443|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
145918351|NCT02899962|526207444|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
145918352|NCT02899962|526207442|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145918353|NCT02899962|526207443|FG001|Maintenance Phase|Withdrawal by Subject|30|||
145918354|NCT02899962|526207444|FG002|Maintenance Phase|Withdrawal by Subject|36|||
145918355|NCT00258960|526207445|FG000|Overall Study|Death|2|||
145918356|NCT00258960|526207445|FG000|Overall Study|Disease Progression|7|||
145918357|NCT00258960|526207445|FG000|Overall Study|Adverse Event|4|||
145918358|NCT00258960|526207445|FG000|Overall Study|Physician Decision|1|||
145918359|NCT00258960|526207445|FG000|Overall Study|Withdrawal by Subject|1|||
145918360|NCT00258960|526207445|FG000|Overall Study|Mistake|2|||
145918361|NCT00473590|526207446|FG000|Overall Study|Adverse Event|3|||
145918362|NCT00473590|526207447|FG001|Overall Study|Adverse Event|3|||
145918363|NCT00473590|526207446|FG000|Overall Study|Death|4|||
145918364|NCT00473590|526207447|FG001|Overall Study|Death|2|||
145918365|NCT00473590|526207446|FG000|Overall Study|Progression not resulting in death|24|||
145918366|NCT00473590|526207447|FG001|Overall Study|Progression not resulting in death|20|||
145918367|NCT00473590|526207446|FG000|Overall Study|Non-protocol-specified therapy|7|||
145918368|NCT00473590|526207447|FG001|Overall Study|Non-protocol-specified therapy|5|||
145918369|NCT00473590|526207446|FG000|Overall Study|Physician Decision|2|||
145918370|NCT00473590|526207447|FG001|Overall Study|Physician Decision|4|||
145918371|NCT00473590|526207446|FG000|Overall Study|Withdrawal by Subject|5|||
145918372|NCT00473590|526207447|FG001|Overall Study|Withdrawal by Subject|3|||
145918373|NCT00473590|526207446|FG000|Overall Study|Other|0|||
145918374|NCT00473590|526207447|FG001|Overall Study|Other|1|||
145918375|NCT01245283|526207450|FG000|Overall Study|Lost to Follow-up|14|||
145918376|NCT01245283|526207451|FG001|Overall Study|Lost to Follow-up|11|||
145918377|NCT01245283|526207452|FG002|Overall Study|Lost to Follow-up|11|||
145918378|NCT01610492|526207461|FG000|Overall Study|Adverse Event|1|||
145918379|NCT01610492|526207461|FG000|Overall Study|Lack of Efficacy|3|||
145918380|NCT01610492|526207461|FG000|Overall Study|Other: Reached stopping criteria|1|||
145918381|NCT01610492|526207461|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
145918382|NCT03093259|526207463|FG000|Overall Study|Adverse Event|1|||
145918383|NCT03093259|526207464|FG001|Overall Study|Adverse Event|0|||
145918384|NCT03093259|526207463|FG000|Overall Study|Withdrawal by Subject|1|||
145918385|NCT03093259|526207464|FG001|Overall Study|Withdrawal by Subject|0|||
145918386|NCT02575833|526207465|FG000|Overall Study|Withdrawal by Subject|0|||
145918387|NCT02575833|526207466|FG001|Overall Study|Withdrawal by Subject|1|||
145918388|NCT02575833|526207465|FG000|Overall Study|Lost to Follow-up|1|||
145918389|NCT02575833|526207466|FG001|Overall Study|Lost to Follow-up|0|||
145918390|NCT01757275|526207467|FG000|Overall Study|Lost to Follow-up|1|||
145918391|NCT01757275|526207468|FG001|Overall Study|Lost to Follow-up|2|||
145918392|NCT01757275|526207467|FG000|Overall Study|Adverse Event|3|||
145918393|NCT01757275|526207468|FG001|Overall Study|Adverse Event|3|||
145918394|NCT01757275|526207467|FG000|Overall Study|Withdrawal by Subject|2|||
145918395|NCT01757275|526207468|FG001|Overall Study|Withdrawal by Subject|4|||
145918396|NCT01757275|526207467|FG000|Overall Study|Not treated|3|||
145918397|NCT01757275|526207468|FG001|Overall Study|Not treated|4|||
145918398|NCT01821807|526207471|FG000|Overall Study|Lost to Follow-up|3|||
145918399|NCT01821807|526207472|FG001|Overall Study|Lost to Follow-up|1|||
145918400|NCT03367819|526207474|FG000|Overall Study|Adverse Event|4|||
145918401|NCT03367819|526207475|FG001|Overall Study|Adverse Event|4|||
145918402|NCT03367819|526207474|FG000|Overall Study|Progressive Disease|15|||
145918403|NCT03367819|526207475|FG001|Overall Study|Progressive Disease|13|||
145918404|NCT03367819|526207474|FG000|Overall Study|Withdrawal by Subject|1|||
145918405|NCT03367819|526207475|FG001|Overall Study|Withdrawal by Subject|0|||
145918406|NCT03367819|526207474|FG000|Overall Study|Other|4|||
145918407|NCT03367819|526207475|FG001|Overall Study|Other|2|||
145918408|NCT01401452|526207476|FG000|Overall Study|Adverse reaction|9|||
145918409|NCT01401452|526207476|FG000|Overall Study|Lost to Follow-up|12|||
145918410|NCT01401452|526207476|FG000|Overall Study|Lack of Efficacy|30|||
145918411|NCT01401452|526207476|FG000|Overall Study|Participant developed breast cancer|1|||
145918412|NCT01401452|526207476|FG000|Overall Study|Tx stopped due to financial reasons|1|||
145918413|NCT01401452|526207476|FG000|Overall Study|Tx stopped by psychiatrist|1|||
145918414|NCT01401452|526207476|FG000|Overall Study|No more visits within the 36 wk followup|4|||
145918415|NCT01401452|526207476|FG000|Overall Study|Subject did not come to follow up visits|2|||
145918416|NCT01401452|526207476|FG000|Overall Study|Subject didn't return for routine visits|1|||
145918417|NCT01401452|526207476|FG000|Overall Study|Subject moved to another city|1|||
145918418|NCT01401452|526207476|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
145918419|NCT01401452|526207476|FG000|Overall Study|Psoriatic arthritis|1|||
145918420|NCT01401452|526207476|FG000|Overall Study|Participant stopped Tx|2|||
145918421|NCT01401452|526207476|FG000|Overall Study|Discontinuation for personal reasons|1|||
145918422|NCT01401452|526207476|FG000|Overall Study|Treatment failure|1|||
145918423|NCT01401452|526207476|FG000|Overall Study|Unsatisfactory output|1|||
145918424|NCT01401452|526207476|FG000|Overall Study|Subject withdrew because of Tx success|1|||
145918425|NCT01401452|526207476|FG000|Overall Study|Subject chose to discontinue treatment|1|||
145918426|NCT01401452|526207476|FG000|Overall Study|Participant withdrew consent|1|||
145918427|NCT00550459|526207477|FG000|Overall Study|Adverse Event|0|||
145918428|NCT00550459|526207478|FG001|Overall Study|Adverse Event|2|||
145918429|NCT00550459|526207477|FG000|Overall Study|Withdrawal by Subject|1|||
145918430|NCT00550459|526207478|FG001|Overall Study|Withdrawal by Subject|1|||
145918431|NCT00584454|526207479|FG000|Overall Study|Adverse Event|1|||
145918432|NCT00584454|526207479|FG000|Overall Study|Relocation|1|||
145918433|NCT00584454|526207479|FG000|Overall Study|Clinical Hold|2|||
145918434|NCT01742897|526207480|FG000|Overall Study|Adverse Event|3|||
145918435|NCT01742897|526207480|FG000|Overall Study|Withdrawal by Subject|1|||
145918436|NCT01742897|526207480|FG000|Overall Study|Other|1|||
145918437|NCT02404805|526207481|FG000|Overall Study|Withdrawal by Subject|1|||
145918438|NCT02404805|526207482|FG001|Overall Study|Withdrawal by Subject|0|||
145918439|NCT02404805|526207483|FG002|Overall Study|Withdrawal by Subject|0|||
145918440|NCT02404805|526207484|FG003|Overall Study|Withdrawal by Subject|0|||
145918441|NCT02404805|526207485|FG004|Overall Study|Withdrawal by Subject|0|||
145918442|NCT02404805|526207486|FG005|Overall Study|Withdrawal by Subject|0|||
145918443|NCT01459783|526207490|FG000|Baseline to 6 Months|Death|1|||
145918444|NCT01459783|526207491|FG001|Baseline to 6 Months|Death|0|||
145918445|NCT01459783|526207490|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
145918446|NCT01459783|526207491|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
145918447|NCT01459783|526207490|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
145918448|NCT01459783|526207491|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
145918449|NCT01459783|526207490|FG000|6 Months to 12 Months|Death|0|||
145918450|NCT01459783|526207491|FG001|6 Months to 12 Months|Death|1|||
145918451|NCT01459783|526207490|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
145918452|NCT01459783|526207491|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
145918453|NCT01459783|526207490|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
145918454|NCT01459783|526207491|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
145918455|NCT01459783|526207490|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
145974389|NCT00157755|526418772|FG003|Overall Study|Explant due to infection|0|||
146240479|NCT03489369|527394919|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
146240480|NCT02384382|527394926|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
146240481|NCT02384382|527394926|FG000|Overall Study|Death|1|||
146240482|NCT02384382|527394926|FG000|Overall Study|Adverse Event|1|||
146240483|NCT02384382|527394926|FG000|Overall Study|Disease progression|16|||
146240484|NCT02113449|527394927|FG000|Overall Study|Adverse Event|4|||
146240485|NCT01328496|527394928|FG000|Overall Study|Significant Change in Health Status|1|||
146240486|NCT01328496|527394929|FG001|Overall Study|Significant Change in Health Status|0|||
145918456|NCT01459783|526207491|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
145918457|NCT04211831|526207492|FG000|Overall Study|Withdrawal by Subject|4|||
145918458|NCT04211831|526207493|FG001|Overall Study|Withdrawal by Subject|1|||
145918459|NCT04211831|526207494|FG002|Overall Study|Withdrawal by Subject|1|||
145918460|NCT04211831|526207492|FG000|Overall Study|Protocol Violation|0|||
145918461|NCT04211831|526207493|FG001|Overall Study|Protocol Violation|0|||
145918462|NCT04211831|526207494|FG002|Overall Study|Protocol Violation|1|||
145918463|NCT04211831|526207492|FG000|Overall Study|Adverse Event|0|||
145918464|NCT04211831|526207493|FG001|Overall Study|Adverse Event|1|||
145918465|NCT04211831|526207494|FG002|Overall Study|Adverse Event|0|||
145918466|NCT04211831|526207492|FG000|Overall Study|Lack of Efficacy|0|||
145974390|NCT00157755|526418773|FG004|Overall Study|Explant due to infection|0|||
145918467|NCT04211831|526207493|FG001|Overall Study|Lack of Efficacy|0|||
145918468|NCT04211831|526207494|FG002|Overall Study|Lack of Efficacy|1|||
145918469|NCT04211831|526207492|FG000|Overall Study|Lost to Follow-up|0|||
145918470|NCT04211831|526207493|FG001|Overall Study|Lost to Follow-up|0|||
145918471|NCT04211831|526207494|FG002|Overall Study|Lost to Follow-up|2|||
145918472|NCT04211831|526207492|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
145918473|NCT04211831|526207493|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
145918474|NCT04211831|526207494|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
145918475|NCT04211831|526207492|FG000|Overall Study|Other|0|||
145918476|NCT04211831|526207493|FG001|Overall Study|Other|1|||
145918477|NCT04211831|526207494|FG002|Overall Study|Other|0|||
145918478|NCT00967330|526207495|FG000|Overall Study|Protocol Violation|3|||
145918479|NCT00967330|526207496|FG001|Overall Study|Protocol Violation|4|||
145918480|NCT00967330|526207495|FG000|Overall Study|Regular|10|||
145918481|NCT00967330|526207496|FG001|Overall Study|Regular|3|||
145918482|NCT00967330|526207495|FG000|Overall Study|Withdrawal by Subject|6|||
145918483|NCT00967330|526207496|FG001|Overall Study|Withdrawal by Subject|0|||
145918484|NCT00967330|526207495|FG000|Overall Study|Lost to Follow-up|1|||
145918485|NCT00967330|526207496|FG001|Overall Study|Lost to Follow-up|1|||
145918486|NCT00967330|526207495|FG000|Overall Study|Death|102|||
145918487|NCT00967330|526207496|FG001|Overall Study|Death|51|||
145918488|NCT00967330|526207495|FG000|Overall Study|Severe protocol deviation|0|||
145918489|NCT00967330|526207496|FG001|Overall Study|Severe protocol deviation|1|||
145918490|NCT02698163|526207497|FG000|Overall Study|Lost to Follow-up|0|||
145918491|NCT02698163|526207498|FG001|Overall Study|Lost to Follow-up|1|||
145918492|NCT01168232|526209512|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
145918493|NCT01168232|526209512|FG000|Overall Study|Ineligible- Wrong cell type|6|||
145918494|NCT01168232|526209512|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
145918495|NCT04510090|526209515|FG000|FE-HS|Withdrawal by Subject|0|||
145918496|NCT04510090|526209516|FG001|FE-HS|Withdrawal by Subject|0|||
145918497|NCT04510090|526209517|FG002|FE-HS|Withdrawal by Subject|0|||
145918498|NCT04510090|526209518|FG003|FE-HS|Withdrawal by Subject|0|||
145918499|NCT04510090|526209519|FG004|FE-HS|Withdrawal by Subject|1|||
145918500|NCT04510090|526209520|FG005|FE-HS|Withdrawal by Subject|0|||
145918501|NCT04510090|526209521|FG006|FE-HS|Withdrawal by Subject|0|||
145918502|NCT04510090|526209522|FG007|FE-HS|Withdrawal by Subject|0|||
145918503|NCT01749826|526209523|FG000|Overall Study|Study Terminated|20|||
145918504|NCT01749826|526209524|FG001|Overall Study|Study Terminated|0|||
145918505|NCT05085834|526209525|FG000|Overall Study|Lost to Follow-up|9|||
145918506|NCT05085834|526209526|FG001|Overall Study|Lost to Follow-up|2|||
145918507|NCT05085834|526209525|FG000|Overall Study|Adverse Event|6|||
145918508|NCT05085834|526209526|FG001|Overall Study|Adverse Event|0|||
145918509|NCT05085834|526209525|FG000|Overall Study|Death|1|||
145918510|NCT05085834|526209526|FG001|Overall Study|Death|0|||
145918511|NCT05085834|526209525|FG000|Overall Study|Inability to swallow the pill|0|||
145918512|NCT05085834|526209526|FG001|Overall Study|Inability to swallow the pill|1|||
145918513|NCT03657797|526209532|FG000|Overall Study|Lost to Follow-up|0|||
145918514|NCT03657797|526209533|FG001|Overall Study|Lost to Follow-up|1|||
145918515|NCT03657797|526209534|FG002|Overall Study|Lost to Follow-up|1|||
145918516|NCT03657797|526209535|FG003|Overall Study|Lost to Follow-up|0|||
145918517|NCT03657797|526209532|FG000|Overall Study|Physician Decision|0|||
145918518|NCT03657797|526209533|FG001|Overall Study|Physician Decision|1|||
145918519|NCT03657797|526209534|FG002|Overall Study|Physician Decision|0|||
145918520|NCT03657797|526209535|FG003|Overall Study|Physician Decision|0|||
145918521|NCT03657797|526209532|FG000|Overall Study|Withdrawal by Subject|0|||
145918522|NCT03657797|526209533|FG001|Overall Study|Withdrawal by Subject|1|||
145918523|NCT03657797|526209534|FG002|Overall Study|Withdrawal by Subject|2|||
145918524|NCT03657797|526209535|FG003|Overall Study|Withdrawal by Subject|0|||
145918525|NCT03657797|526209532|FG000|Overall Study|Adverse Event|0|||
145918526|NCT03657797|526209533|FG001|Overall Study|Adverse Event|0|||
145918527|NCT03657797|526209534|FG002|Overall Study|Adverse Event|2|||
145918528|NCT03657797|526209535|FG003|Overall Study|Adverse Event|0|||
145918529|NCT00725283|526209538|FG000|Overall Study|Missing Code|3|||
145918530|NCT00725283|526209538|FG000|Overall Study|Death|5|||
146089168|NCT00096954|526847284|FG001|Overall Study|Sponsors Decision|1|||
146089169|NCT00096954|526847283|FG000|Overall Study|Pregnancy|1|||
145918531|NCT00725283|526209538|FG000|Overall Study|Other|6|||
145918532|NCT00725283|526209538|FG000|Overall Study|Withdrawal by Subject|10|||
145918533|NCT02115269|526209539|FG000|Overall Study|Lost to Follow-up|43|||
145918534|NCT02115269|526209539|FG000|Overall Study|Did not complete patient diary|3|||
145918535|NCT02115269|526209539|FG000|Overall Study|Moved to another city|7|||
145918536|NCT02115269|526209539|FG000|Overall Study|Withdrawal by Subject|2|||
145918537|NCT02115269|526209539|FG000|Overall Study|Didn't take study drug|2|||
145918538|NCT01402570|526209542|FG000|Overall Study|Adverse Event|1|||
145918539|NCT03642262|526209543|FG000|Period 1|Withdrawal by Subject|1|||
145918540|NCT03642262|526209544|FG001|Period 1|Withdrawal by Subject|1|||
145918541|NCT03642262|526209543|FG000|Period 1|Adverse Event|0|||
145918542|NCT03642262|526209544|FG001|Period 1|Adverse Event|1|||
146089170|NCT00096954|526847284|FG001|Overall Study|Pregnancy|1|||
145918543|NCT02572570|526209545|FG000|Overall Study|Study Terminated|27|||
145918544|NCT01417156|526209546|FG000|Overall Study|Adverse Event|12|||
145918545|NCT01417156|526209546|FG000|Overall Study|Protocol Violation|2|||
145918546|NCT01103180|526209547|FG000|Overall Study|Withdrawal by Subject|8|||
145918547|NCT01103180|526209548|FG001|Overall Study|Withdrawal by Subject|13|||
145918548|NCT01103180|526209547|FG000|Overall Study|Lost to Follow-up|13|||
145918549|NCT01103180|526209548|FG001|Overall Study|Lost to Follow-up|7|||
145918550|NCT01103180|526209547|FG000|Overall Study|Physician Decision|1|||
145918551|NCT01103180|526209548|FG001|Overall Study|Physician Decision|0|||
145918552|NCT01103180|526209547|FG000|Overall Study|Protocol Violation|0|||
145918553|NCT01103180|526209548|FG001|Overall Study|Protocol Violation|1|||
145918554|NCT00742209|526209551|FG000|Overall Study|Adverse Event|11|||
145918555|NCT00742209|526209552|FG001|Overall Study|Adverse Event|4|||
145918556|NCT00742209|526209553|FG002|Overall Study|Adverse Event|17|||
145918557|NCT00742209|526209554|FG003|Overall Study|Adverse Event|16|||
145918558|NCT00742209|526209555|FG004|Overall Study|Adverse Event|13|||
145918559|NCT00742209|526209551|FG000|Overall Study|Participant Withdrew Consent|8|||
145918560|NCT00742209|526209552|FG001|Overall Study|Participant Withdrew Consent|4|||
145918561|NCT00742209|526209553|FG002|Overall Study|Participant Withdrew Consent|14|||
145918562|NCT00742209|526209554|FG003|Overall Study|Participant Withdrew Consent|7|||
145918563|NCT00742209|526209555|FG004|Overall Study|Participant Withdrew Consent|4|||
145918564|NCT00742209|526209551|FG000|Overall Study|Protocol Violation|6|||
145918565|NCT00742209|526209552|FG001|Overall Study|Protocol Violation|5|||
145918566|NCT00742209|526209553|FG002|Overall Study|Protocol Violation|4|||
145918567|NCT00742209|526209554|FG003|Overall Study|Protocol Violation|5|||
145918568|NCT00742209|526209555|FG004|Overall Study|Protocol Violation|3|||
145918569|NCT00742209|526209551|FG000|Overall Study|Lost to Follow-up|3|||
145918570|NCT00742209|526209552|FG001|Overall Study|Lost to Follow-up|4|||
145918571|NCT00742209|526209553|FG002|Overall Study|Lost to Follow-up|5|||
145918572|NCT00742209|526209554|FG003|Overall Study|Lost to Follow-up|5|||
146297590|NCT04427501|527604738|FG006|Overall Study|Withdrawal by Subject|15|||
146297591|NCT04427501|527604739|FG007|Overall Study|Withdrawal by Subject|7|||
146297592|NCT04427501|527604740|FG008|Overall Study|Withdrawal by Subject|4|||
146297593|NCT04427501|527604741|FG009|Overall Study|Withdrawal by Subject|1|||
146297594|NCT04427501|527604742|FG010|Overall Study|Withdrawal by Subject|4|||
146297595|NCT04427501|527604743|FG011|Overall Study|Withdrawal by Subject|0|||
146297596|NCT04427501|527604732|FG000|Overall Study|Other - as reported by the investigator|1|||
146297597|NCT04427501|527604733|FG001|Overall Study|Other - as reported by the investigator|0|||
146297598|NCT04427501|527604734|FG002|Overall Study|Other - as reported by the investigator|0|||
146297599|NCT04427501|527604735|FG003|Overall Study|Other - as reported by the investigator|0|||
146297600|NCT04427501|527604736|FG004|Overall Study|Other - as reported by the investigator|0|||
146297601|NCT04427501|527604737|FG005|Overall Study|Other - as reported by the investigator|6|||
146297602|NCT04427501|527604738|FG006|Overall Study|Other - as reported by the investigator|6|||
145974391|NCT00157755|526418774|FG005|Overall Study|Explant due to infection|0|||
145974392|NCT00157755|526418769|FG000|Overall Study|Medical reason|0|||
145974393|NCT00157755|526418770|FG001|Overall Study|Medical reason|0|||
145918573|NCT00742209|526209555|FG004|Overall Study|Lost to Follow-up|3|||
145918574|NCT00742209|526209551|FG000|Overall Study|Lack of Efficacy|6|||
145918575|NCT00742209|526209552|FG001|Overall Study|Lack of Efficacy|1|||
145918576|NCT00742209|526209553|FG002|Overall Study|Lack of Efficacy|1|||
145918577|NCT00742209|526209554|FG003|Overall Study|Lack of Efficacy|3|||
145918578|NCT00742209|526209555|FG004|Overall Study|Lack of Efficacy|1|||
145918579|NCT00742209|526209551|FG000|Overall Study|Investigator Discretion|0|||
145918580|NCT00742209|526209552|FG001|Overall Study|Investigator Discretion|0|||
145918581|NCT00742209|526209553|FG002|Overall Study|Investigator Discretion|5|||
145918582|NCT00742209|526209554|FG003|Overall Study|Investigator Discretion|1|||
145918583|NCT00742209|526209555|FG004|Overall Study|Investigator Discretion|1|||
145974394|NCT00157755|526418771|FG002|Overall Study|Medical reason|1|||
145974395|NCT00157755|526418772|FG003|Overall Study|Medical reason|1|||
145974396|NCT00157755|526418773|FG004|Overall Study|Medical reason|0|||
145918584|NCT03499067|526209558|FG000|First Intervention|Physician Decision|2|||
145918585|NCT03499067|526209559|FG001|First Intervention|Physician Decision|1|||
145974397|NCT00157755|526418774|FG005|Overall Study|Medical reason|0|||
145918586|NCT03499067|526209558|FG000|First Intervention|Withdrawal by Subject|3|||
145918587|NCT03499067|526209559|FG001|First Intervention|Withdrawal by Subject|6|||
145918588|NCT02440464|526209560|FG000|Overall Study|Withdrawal by Subject|3|||
145918589|NCT02440464|526209561|FG001|Overall Study|Withdrawal by Subject|2|||
145918590|NCT03565900|526209562|FG000|Overall Study|Disposition Unknown|4|||
145974398|NCT00157755|526418769|FG000|Overall Study|Study site closure|0|||
145974399|NCT00157755|526418770|FG001|Overall Study|Study site closure|1|||
145918591|NCT03565900|526209563|FG001|Overall Study|Disposition Unknown|1|||
145918592|NCT03565900|526209562|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145918593|NCT03565900|526209563|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
145918594|NCT03565900|526209562|FG000|Overall Study|Withdrawal by Subject|4|||
145918595|NCT03565900|526209563|FG001|Overall Study|Withdrawal by Subject|5|||
145918596|NCT03565900|526209562|FG000|Overall Study|Randomized By Mistake|0|||
145918597|NCT03565900|526209563|FG001|Overall Study|Randomized By Mistake|2|||
145918598|NCT03565900|526209562|FG000|Overall Study|Physician Decision|7|||
145918599|NCT03565900|526209563|FG001|Overall Study|Physician Decision|11|||
145918600|NCT03565900|526209562|FG000|Overall Study|Death|9|||
145918601|NCT03565900|526209563|FG001|Overall Study|Death|7|||
145918602|NCT02058069|526209566|FG000|Overall Study|Exclusion due to implant size|5|||
145918603|NCT02058069|526209566|FG000|Overall Study|Withdrawal by Subject|6|||
145918604|NCT03359850|526209570|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
145918605|NCT03359850|526209571|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
145918606|NCT03359850|526209570|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
145918607|NCT03359850|526209571|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
145918608|NCT03359850|526209570|FG000|Extension Phase (Up to 28 Months)|Death|2|||
145918609|NCT03359850|526209571|FG001|Extension Phase (Up to 28 Months)|Death|4|||
145918610|NCT03359850|526209570|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
145918611|NCT03359850|526209571|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
145918612|NCT03359850|526209570|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
145918613|NCT03359850|526209571|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
145918614|NCT01037218|526209591|FG000|Overall Study|Adverse Event|4|||
145918615|NCT01037218|526209592|FG001|Overall Study|Adverse Event|2|||
145918616|NCT01037218|526209593|FG002|Overall Study|Adverse Event|2|||
145918617|NCT01037218|526209594|FG003|Overall Study|Adverse Event|1|||
145918618|NCT01037218|526209591|FG000|Overall Study|Lack of Efficacy|0|||
145918619|NCT01037218|526209592|FG001|Overall Study|Lack of Efficacy|2|||
145918620|NCT01037218|526209593|FG002|Overall Study|Lack of Efficacy|1|||
145918621|NCT01037218|526209594|FG003|Overall Study|Lack of Efficacy|5|||
145918622|NCT01037218|526209591|FG000|Overall Study|Lost to Follow-up|3|||
145918623|NCT01037218|526209592|FG001|Overall Study|Lost to Follow-up|5|||
145918624|NCT01037218|526209593|FG002|Overall Study|Lost to Follow-up|4|||
146240487|NCT02091752|527394932|FG000|Overall Study|Study terminated by Sponsor|2|||
146240488|NCT02091752|527394932|FG000|Overall Study|Adverse Event|1|||
146240489|NCT04029090|527394933|FG000|Overall Study|Protocol Violation|1|||
146240490|NCT04029090|527394934|FG001|Overall Study|Protocol Violation|0|||
145918625|NCT01037218|526209594|FG003|Overall Study|Lost to Follow-up|2|||
145918626|NCT01037218|526209591|FG000|Overall Study|Withdrawal by Subject|6|||
145918627|NCT01037218|526209592|FG001|Overall Study|Withdrawal by Subject|7|||
145918628|NCT01037218|526209593|FG002|Overall Study|Withdrawal by Subject|7|||
145918629|NCT01037218|526209594|FG003|Overall Study|Withdrawal by Subject|4|||
145918630|NCT01037218|526209591|FG000|Overall Study|Partner Withdrew Consent|0|||
145918631|NCT01037218|526209592|FG001|Overall Study|Partner Withdrew Consent|3|||
145918632|NCT01037218|526209593|FG002|Overall Study|Partner Withdrew Consent|2|||
145918633|NCT01037218|526209594|FG003|Overall Study|Partner Withdrew Consent|1|||
145918634|NCT01037218|526209591|FG000|Overall Study|Protocol Violation|0|||
145918635|NCT01037218|526209592|FG001|Overall Study|Protocol Violation|0|||
145918636|NCT01037218|526209593|FG002|Overall Study|Protocol Violation|2|||
145918637|NCT01037218|526209594|FG003|Overall Study|Protocol Violation|2|||
145918638|NCT01037218|526209591|FG000|Overall Study|Various|3|||
145918639|NCT01037218|526209592|FG001|Overall Study|Various|2|||
145918640|NCT01037218|526209593|FG002|Overall Study|Various|3|||
145918641|NCT01037218|526209594|FG003|Overall Study|Various|1|||
145918642|NCT00897715|526209595|FG000|Overall Study|Lost to Follow-up|0|||
145918643|NCT00897715|526209596|FG001|Overall Study|Lost to Follow-up|1|||
145918644|NCT00897715|526209595|FG000|Overall Study|Physician Decision|1|||
145918645|NCT00897715|526209596|FG001|Overall Study|Physician Decision|0|||
145918646|NCT00897715|526209595|FG000|Overall Study|increased risk of infection|1|||
145918647|NCT00897715|526209596|FG001|Overall Study|increased risk of infection|0|||
145918648|NCT01199939|526209597|FG000|Overall Study|Adverse Event|4|||
145918649|NCT01199939|526209597|FG000|Overall Study|Protocol Violation|3|||
145918650|NCT01199939|526209597|FG000|Overall Study|Lost to Follow-up|2|||
145918651|NCT01199939|526209597|FG000|Overall Study|Reached a virologic endpoint|4|||
145918652|NCT02289729|526209598|FG000|Overall Study|Lack of Efficacy|3|||
145918653|NCT02289729|526209598|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
146240491|NCT04029090|527394935|FG002|Overall Study|Protocol Violation|0|||
146240492|NCT04029090|527394933|FG000|Overall Study|Withdrawal by Subject|0|||
146240493|NCT04029090|527394934|FG001|Overall Study|Withdrawal by Subject|1|||
145918654|NCT02289729|526209598|FG000|Overall Study|Withdrawal by Subject|1|||
145918655|NCT02289729|526209598|FG000|Overall Study|Death|1|||
145918656|NCT00931411|526209599|FG000|First Intervention - 42 Days|Adverse Event|2|||
145918657|NCT00931411|526209600|FG001|First Intervention - 42 Days|Adverse Event|3|||
145918658|NCT00931411|526209599|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
145918659|NCT00931411|526209600|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
145918660|NCT00931411|526209599|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
145918661|NCT00931411|526209600|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
145918662|NCT01949662|526209601|FG000|Overall Study|Death|9|||
145918663|NCT01949662|526209602|FG001|Overall Study|Death|7|||
145918664|NCT01949662|526209601|FG000|Overall Study|Discharged before an agitation event|8|||
145918665|NCT01949662|526209602|FG001|Overall Study|Discharged before an agitation event|3|||
146240494|NCT04029090|527394935|FG002|Overall Study|Withdrawal by Subject|0|||
145974400|NCT00157755|526418771|FG002|Overall Study|Study site closure|0|||
146240495|NCT01065779|527394936|FG000|Overall Study|Duplicate Investigation|1|||
146240496|NCT01065779|527394936|FG000|Overall Study|Investigation Before Contract Date|37|||
146240497|NCT01065779|527394936|FG000|Overall Study|Non-enrollment Period Administration|10|||
146240498|NCT01065779|527394936|FG000|Overall Study|Not Administered With Study Drug|17|||
146240499|NCT01065779|527394936|FG000|Overall Study|Failed to Follow-up|10|||
146240500|NCT01065779|527394936|FG000|Overall Study|Inclusion Criteria Violation|7|||
146240501|NCT02157948|527394937|FG000|Overall Study|Withdrawal by Subject|4|||
146240502|NCT02157948|527394938|FG001|Overall Study|Withdrawal by Subject|5|||
146240503|NCT02157948|527394937|FG000|Overall Study|Lost to Follow-up|3|||
145918666|NCT01949662|526209601|FG000|Overall Study|Dropped out|1|||
145918667|NCT01949662|526209602|FG001|Overall Study|Dropped out|3|||
145918668|NCT01949662|526209601|FG000|Overall Study|Ineligible|0|||
145918669|NCT01949662|526209602|FG001|Overall Study|Ineligible|1|||
145918670|NCT02291237|526209603|FG000|Overall Study|Study Terminated by Sponsor|72|||
145918671|NCT02291237|526209604|FG001|Overall Study|Study Terminated by Sponsor|67|||
145918672|NCT02291237|526209603|FG000|Overall Study|Adverse Event|1|||
145918673|NCT02291237|526209604|FG001|Overall Study|Adverse Event|3|||
145918674|NCT02291237|526209603|FG000|Overall Study|Investigator's Discretion|0|||
145918675|NCT02291237|526209604|FG001|Overall Study|Investigator's Discretion|3|||
145918676|NCT02291237|526209603|FG000|Overall Study|Withdrew Consent|11|||
145918677|NCT02291237|526209604|FG001|Overall Study|Withdrew Consent|11|||
145918678|NCT02291237|526209603|FG000|Overall Study|Lost to Follow-up|0|||
145918679|NCT02291237|526209604|FG001|Overall Study|Lost to Follow-up|2|||
145918680|NCT02291237|526209603|FG000|Overall Study|Subject Required Prohibited Medication|2|||
145918681|NCT02291237|526209604|FG001|Overall Study|Subject Required Prohibited Medication|0|||
145918682|NCT00729937|526209607|FG000|Overall Study|Lost to Follow-up|49|||
145918683|NCT00729937|526209608|FG001|Overall Study|Lost to Follow-up|58|||
145918684|NCT00729937|526209609|FG002|Overall Study|Lost to Follow-up|18|||
145918685|NCT00729937|526209610|FG003|Overall Study|Lost to Follow-up|33|||
145918686|NCT00729937|526209611|FG004|Overall Study|Lost to Follow-up|18|||
145918687|NCT00729937|526209612|FG005|Overall Study|Lost to Follow-up|23|||
145918688|NCT00729937|526209607|FG000|Overall Study|Physician Decision|7|||
145918689|NCT00729937|526209608|FG001|Overall Study|Physician Decision|16|||
145918690|NCT00729937|526209609|FG002|Overall Study|Physician Decision|2|||
145918691|NCT00729937|526209610|FG003|Overall Study|Physician Decision|0|||
145918692|NCT00729937|526209611|FG004|Overall Study|Physician Decision|5|||
145918693|NCT00729937|526209612|FG005|Overall Study|Physician Decision|8|||
145918694|NCT00729937|526209607|FG000|Overall Study|Death|1|||
145918695|NCT00729937|526209608|FG001|Overall Study|Death|0|||
145918696|NCT00729937|526209609|FG002|Overall Study|Death|1|||
145918697|NCT00729937|526209610|FG003|Overall Study|Death|0|||
145918698|NCT00729937|526209611|FG004|Overall Study|Death|0|||
145918699|NCT00729937|526209612|FG005|Overall Study|Death|1|||
145918700|NCT00729937|526209607|FG000|Overall Study|Withdrawal by Subject|3|||
145918701|NCT00729937|526209608|FG001|Overall Study|Withdrawal by Subject|5|||
145918702|NCT00729937|526209609|FG002|Overall Study|Withdrawal by Subject|6|||
145918703|NCT00729937|526209610|FG003|Overall Study|Withdrawal by Subject|0|||
145918704|NCT00729937|526209611|FG004|Overall Study|Withdrawal by Subject|4|||
145918705|NCT00729937|526209612|FG005|Overall Study|Withdrawal by Subject|2|||
145918706|NCT00729937|526209607|FG000|Overall Study|Randomized but not treated|12|||
145918707|NCT00729937|526209608|FG001|Overall Study|Randomized but not treated|6|||
145918708|NCT00729937|526209609|FG002|Overall Study|Randomized but not treated|1|||
145918709|NCT00729937|526209610|FG003|Overall Study|Randomized but not treated|0|||
145918710|NCT00729937|526209611|FG004|Overall Study|Randomized but not treated|1|||
145918711|NCT00729937|526209612|FG005|Overall Study|Randomized but not treated|3|||
145918712|NCT00729937|526209607|FG000|Overall Study|Did not meet eligibility criteria|2|||
145918713|NCT00729937|526209608|FG001|Overall Study|Did not meet eligibility criteria|1|||
145918714|NCT00729937|526209609|FG002|Overall Study|Did not meet eligibility criteria|0|||
146240504|NCT02157948|527394938|FG001|Overall Study|Lost to Follow-up|2|||
145918715|NCT00729937|526209610|FG003|Overall Study|Did not meet eligibility criteria|0|||
145918716|NCT00729937|526209611|FG004|Overall Study|Did not meet eligibility criteria|0|||
145918717|NCT00729937|526209612|FG005|Overall Study|Did not meet eligibility criteria|0|||
145918718|NCT00729937|526209607|FG000|Overall Study|Incarcerated|0|||
145974401|NCT00157755|526418772|FG003|Overall Study|Study site closure|0|||
145974402|NCT00157755|526418773|FG004|Overall Study|Study site closure|0|||
145974403|NCT00157755|526418774|FG005|Overall Study|Study site closure|0|||
145918719|NCT00729937|526209608|FG001|Overall Study|Incarcerated|2|||
145974404|NCT00157755|526418769|FG000|Overall Study|Subject non-compliance|0|||
145974405|NCT00157755|526418770|FG001|Overall Study|Subject non-compliance|0|||
146240505|NCT02157948|527394937|FG000|Overall Study|Protocol Specified Criteria|2|||
145918720|NCT00729937|526209609|FG002|Overall Study|Incarcerated|1|||
145918721|NCT00729937|526209610|FG003|Overall Study|Incarcerated|1|||
145918722|NCT00729937|526209611|FG004|Overall Study|Incarcerated|0|||
145918723|NCT00729937|526209612|FG005|Overall Study|Incarcerated|0|||
145918724|NCT01478373|526209614|FG000|Treatment Phase|Protocol Violation|1|||
145918725|NCT01478373|526209614|FG000|Survival Phase|Adverse Event|8|||
145918726|NCT01478373|526209614|FG000|Survival Phase|Protocol Violation|1|||
146240506|NCT02157948|527394938|FG001|Overall Study|Protocol Specified Criteria|1|||
146240507|NCT02157948|527394937|FG000|Overall Study|Decision by Sponsor|0|||
146240508|NCT02157948|527394938|FG001|Overall Study|Decision by Sponsor|1|||
146240509|NCT01604824|527394940|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146240510|NCT01604824|527394941|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146240511|NCT01604824|527394942|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146240512|NCT01604824|527394943|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146240513|NCT01604824|527394944|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
146240514|NCT01604824|527394945|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
146240515|NCT01604824|527394940|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
146240516|NCT01604824|527394941|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
146240517|NCT01604824|527394942|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
146240518|NCT01604824|527394943|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
146240519|NCT01604824|527394944|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
146240520|NCT01604824|527394945|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
146240521|NCT02630966|527394946|FG000|Overall Study|Adverse Event|1|||
146240522|NCT02630966|527394947|FG001|Overall Study|Adverse Event|3|||
146240523|NCT02630966|527394946|FG000|Overall Study|Significant Protocol Deviation|0|||
146240524|NCT02630966|527394947|FG001|Overall Study|Significant Protocol Deviation|2|||
146240525|NCT02630966|527394946|FG000|Overall Study|Voluntary Withdrawal|1|||
146240526|NCT02630966|527394947|FG001|Overall Study|Voluntary Withdrawal|1|||
146240527|NCT02630966|527394946|FG000|Overall Study|Lack of Efficacy|0|||
146240528|NCT02630966|527394947|FG001|Overall Study|Lack of Efficacy|2|||
146240529|NCT03822832|527394952|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
146240530|NCT03822832|527394953|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
146240531|NCT03822832|527394952|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
146240532|NCT03822832|527394953|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
146240533|NCT03822832|527394952|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
146240534|NCT03822832|527394953|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
146240535|NCT03822832|527394952|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
146240536|NCT03822832|527394953|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
146240537|NCT03822832|527394952|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
146240538|NCT03822832|527394953|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
146240539|NCT03822832|527394952|FG000|Re-allocation|Not re-allocated to open label period|2|||
146240540|NCT03822832|527394953|FG001|Re-allocation|Not re-allocated to open label period|6|||
146240541|NCT03822832|527394952|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
146240542|NCT03822832|527394953|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
146240543|NCT03822832|527394952|FG000|Period 2 - Open Label Period|Adverse Event|0|||
146240544|NCT03822832|527394953|FG001|Period 2 - Open Label Period|Adverse Event|3|||
146240545|NCT04248803|527394958|FG000|Overall Study|Lost to Follow-up|7|||
146240546|NCT04248803|527394959|FG001|Overall Study|Lost to Follow-up|7|||
146240547|NCT04248803|527394960|FG002|Overall Study|Lost to Follow-up|7|||
146240548|NCT04248803|527394961|FG003|Overall Study|Lost to Follow-up|7|||
146240549|NCT04248803|527394962|FG004|Overall Study|Lost to Follow-up|7|||
146240550|NCT04248803|527394963|FG005|Overall Study|Lost to Follow-up|7|||
146240551|NCT05352230|527394964|FG000|First Intervention (3 Months)|study terminated|2|||
146240552|NCT05352230|527394965|FG001|First Intervention (3 Months)|study terminated|2|||
146240553|NCT04399837|527394967|FG000|Overall Study|Other than listed|0|||
146240554|NCT04399837|527394968|FG001|Overall Study|Other than listed|2|||
146240555|NCT04399837|527394969|FG002|Overall Study|Other than listed|2|||
146240556|NCT04399837|527394970|FG003|Overall Study|Other than listed|3|||
146240557|NCT04399837|527394967|FG000|Overall Study|Withdrawal by Subject|1|||
146240558|NCT04399837|527394968|FG001|Overall Study|Withdrawal by Subject|2|||
146240559|NCT04399837|527394969|FG002|Overall Study|Withdrawal by Subject|1|||
146240560|NCT04399837|527394970|FG003|Overall Study|Withdrawal by Subject|1|||
146240561|NCT00614614|527394977|FG000|Primary Vaccination Phase|Adverse Event|6|||
146240562|NCT00614614|527394978|FG001|Primary Vaccination Phase|Adverse Event|0|||
146240563|NCT00614614|527394979|FG002|Primary Vaccination Phase|Adverse Event|0|||
146240564|NCT00614614|527394980|FG003|Primary Vaccination Phase|Adverse Event|0|||
146240565|NCT00614614|527394981|FG004|Primary Vaccination Phase|Adverse Event|0|||
146240566|NCT00614614|527394977|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
146240567|NCT00614614|527394978|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
146240568|NCT00614614|527394979|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
146240569|NCT00614614|527394980|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
146240570|NCT00614614|527394981|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
146240571|NCT00614614|527394977|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
146240572|NCT00614614|527394978|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
146240573|NCT00614614|527394979|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
146240574|NCT00614614|527394980|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
146240575|NCT00614614|527394981|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
146240576|NCT00614614|527394977|FG000|Primary Vaccination Phase|Protocol Violation|9|||
146089171|NCT00096954|526847283|FG000|Overall Study|Initiation of immunotherapy|1|||
146089172|NCT00096954|526847284|FG001|Overall Study|Initiation of immunotherapy|0|||
146089173|NCT00096954|526847283|FG000|Overall Study|Non-compliance|0|||
146089174|NCT00096954|526847284|FG001|Overall Study|Non-compliance|3|||
146089175|NCT00096954|526847283|FG000|Overall Study|Lost to Follow-up|8|||
146089176|NCT00096954|526847284|FG001|Overall Study|Lost to Follow-up|5|||
146089177|NCT03442764|526847285|FG000|Overall Study|Adverse Event|1|||
146089178|NCT03442764|526847286|FG001|Overall Study|Adverse Event|0|||
146089179|NCT03442764|526847287|FG002|Overall Study|Adverse Event|0|||
146089180|NCT04478123|526847288|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
146089181|NCT04478123|526847288|FG000|Overall Study|NE|1|||
146089182|NCT02395016|526847289|FG000|Overall Study|Adverse Event|4|||
146089183|NCT02395016|526847290|FG001|Overall Study|Adverse Event|3|||
146089184|NCT02395016|526847289|FG000|Overall Study|Withdrawal by Subject|9|||
146089185|NCT02395016|526847290|FG001|Overall Study|Withdrawal by Subject|6|||
146089186|NCT02395016|526847289|FG000|Overall Study|Protocol Violation|2|||
146089187|NCT02395016|526847290|FG001|Overall Study|Protocol Violation|3|||
146089188|NCT04444895|526847291|FG000|Overall Study|Adverse Event|2|||
146089189|NCT04444895|526847291|FG000|Overall Study|Lost to Follow-up|2|||
146089190|NCT04444895|526847291|FG000|Overall Study|Withdrawal by Subject|5|||
146089191|NCT00814879|526847292|FG000|By Week 24|Cancer Diagnosis|1|||
146089192|NCT00814879|526847293|FG001|By Week 24|Cancer Diagnosis|0|||
146240577|NCT00614614|527394978|FG001|Primary Vaccination Phase|Protocol Violation|3|||
146240578|NCT00614614|527394979|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145918727|NCT01478373|526209614|FG000|Survival Phase|crossover to another study|2|||
145918728|NCT01478373|526209614|FG000|Survival Phase|Progressive Disease|27|||
145918729|NCT01074944|526209617|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
145918730|NCT01074944|526209618|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145918731|NCT01074944|526209619|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145918732|NCT01074944|526209620|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145918733|NCT01074944|526209621|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145918734|NCT01074944|526209617|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
145918735|NCT01074944|526209618|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145918736|NCT01074944|526209619|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145918737|NCT01074944|526209620|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145918738|NCT01074944|526209621|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145918739|NCT01074944|526209617|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
145918740|NCT01074944|526209618|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145918741|NCT01074944|526209619|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145918742|NCT01074944|526209620|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145918743|NCT01074944|526209621|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145918744|NCT01074944|526209617|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
145918745|NCT01074944|526209618|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145918746|NCT01074944|526209619|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145918747|NCT01074944|526209620|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145918748|NCT01074944|526209621|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145918749|NCT01074944|526209617|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145918750|NCT01074944|526209618|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
145918751|NCT01074944|526209619|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
145918752|NCT01074944|526209620|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145918753|NCT01074944|526209621|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145918754|NCT01074944|526209617|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145974406|NCT00157755|526418771|FG002|Overall Study|Subject non-compliance|0|||
145974407|NCT00157755|526418772|FG003|Overall Study|Subject non-compliance|0|||
145974408|NCT00157755|526418773|FG004|Overall Study|Subject non-compliance|0|||
145974409|NCT00157755|526418774|FG005|Overall Study|Subject non-compliance|1|||
145974410|NCT00157755|526418769|FG000|Overall Study|Study completion|0|||
145974411|NCT00157755|526418770|FG001|Overall Study|Study completion|0|||
145974412|NCT00157755|526418771|FG002|Overall Study|Study completion|0|||
145974413|NCT00157755|526418772|FG003|Overall Study|Study completion|0|||
145974414|NCT00157755|526418773|FG004|Overall Study|Study completion|1|||
145974415|NCT00157755|526418774|FG005|Overall Study|Study completion|2|||
146240579|NCT00614614|527394980|FG003|Primary Vaccination Phase|Protocol Violation|0|||
146240580|NCT00614614|527394981|FG004|Primary Vaccination Phase|Protocol Violation|0|||
146240581|NCT00614614|527394977|FG000|Primary Vaccination Phase|Other|4|||
145918755|NCT01074944|526209618|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
145918756|NCT01074944|526209619|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
145974416|NCT03314935|526418783|FG000|Phase 1|Death|4|||
145974417|NCT03314935|526418784|FG001|Phase 1|Death|2|||
146089193|NCT00814879|526847292|FG000|By Week 24|Incarceration|0|||
146089194|NCT00814879|526847293|FG001|By Week 24|Incarceration|1|||
146089195|NCT00814879|526847292|FG000|By Week 48|Lost to Follow-up|2|||
146089196|NCT00814879|526847293|FG001|By Week 48|Lost to Follow-up|2|||
146089197|NCT00814879|526847292|FG000|By Week 48|Death|0|||
145918757|NCT01074944|526209620|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145918758|NCT01074944|526209621|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145918759|NCT01074944|526209617|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145918760|NCT01074944|526209618|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
145918761|NCT01074944|526209619|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
145918762|NCT01074944|526209620|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145918763|NCT01074944|526209621|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145974418|NCT03314935|526418785|FG002|Phase 1|Death|5|||
145974419|NCT03314935|526418786|FG003|Phase 1|Death|4|||
145974420|NCT03314935|526418787|FG004|Phase 1|Death|3|||
145974421|NCT03314935|526418788|FG005|Phase 1|Death|4|||
145974422|NCT03314935|526418789|FG006|Phase 1|Death|5|||
145974423|NCT03314935|526418790|FG007|Phase 1|Death|4|||
145974424|NCT03314935|526418791|FG008|Phase 1|Death|3|||
145974425|NCT03314935|526418792|FG009|Phase 1|Death|0|||
145974426|NCT03314935|526418793|FG010|Phase 1|Death|0|||
145974427|NCT03314935|526418794|FG011|Phase 1|Death|0|||
145974428|NCT03314935|526418795|FG012|Phase 1|Death|0|||
145974429|NCT03314935|526418796|FG013|Phase 1|Death|0|||
145974430|NCT03314935|526418797|FG014|Phase 1|Death|0|||
145974431|NCT03314935|526418783|FG000|Phase 1|Withdrawal by Subject|2|||
145974432|NCT03314935|526418784|FG001|Phase 1|Withdrawal by Subject|1|||
145974433|NCT03314935|526418785|FG002|Phase 1|Withdrawal by Subject|1|||
145974434|NCT03314935|526418786|FG003|Phase 1|Withdrawal by Subject|2|||
145974435|NCT03314935|526418787|FG004|Phase 1|Withdrawal by Subject|1|||
145974436|NCT03314935|526418788|FG005|Phase 1|Withdrawal by Subject|0|||
145974437|NCT03314935|526418789|FG006|Phase 1|Withdrawal by Subject|1|||
145974438|NCT03314935|526418790|FG007|Phase 1|Withdrawal by Subject|0|||
145974439|NCT03314935|526418791|FG008|Phase 1|Withdrawal by Subject|1|||
145974440|NCT03314935|526418792|FG009|Phase 1|Withdrawal by Subject|0|||
145974441|NCT03314935|526418793|FG010|Phase 1|Withdrawal by Subject|0|||
145974442|NCT03314935|526418794|FG011|Phase 1|Withdrawal by Subject|0|||
145974443|NCT03314935|526418795|FG012|Phase 1|Withdrawal by Subject|0|||
145974444|NCT03314935|526418796|FG013|Phase 1|Withdrawal by Subject|0|||
145974445|NCT03314935|526418797|FG014|Phase 1|Withdrawal by Subject|0|||
145974446|NCT03314935|526418783|FG000|Phase 1|Progressive Disease|2|||
145918764|NCT01074944|526209617|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145918765|NCT01074944|526209618|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
145918766|NCT01074944|526209619|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145918767|NCT01074944|526209620|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145918768|NCT01074944|526209621|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145974447|NCT03314935|526418784|FG001|Phase 1|Progressive Disease|0|||
145974448|NCT03314935|526418785|FG002|Phase 1|Progressive Disease|0|||
145974449|NCT03314935|526418786|FG003|Phase 1|Progressive Disease|1|||
145974450|NCT03314935|526418787|FG004|Phase 1|Progressive Disease|0|||
145974451|NCT03314935|526418788|FG005|Phase 1|Progressive Disease|0|||
145974452|NCT03314935|526418789|FG006|Phase 1|Progressive Disease|0|||
145974453|NCT03314935|526418790|FG007|Phase 1|Progressive Disease|0|||
145974454|NCT03314935|526418791|FG008|Phase 1|Progressive Disease|0|||
145974455|NCT03314935|526418792|FG009|Phase 1|Progressive Disease|0|||
145974456|NCT03314935|526418793|FG010|Phase 1|Progressive Disease|0|||
145974457|NCT03314935|526418794|FG011|Phase 1|Progressive Disease|0|||
145974458|NCT03314935|526418795|FG012|Phase 1|Progressive Disease|0|||
145974459|NCT03314935|526418796|FG013|Phase 1|Progressive Disease|0|||
145974460|NCT03314935|526418797|FG014|Phase 1|Progressive Disease|0|||
145974461|NCT03314935|526418783|FG000|Phase 1|Study Terminated by Sponsor|0|||
145974462|NCT03314935|526418784|FG001|Phase 1|Study Terminated by Sponsor|1|||
145974463|NCT03314935|526418785|FG002|Phase 1|Study Terminated by Sponsor|0|||
145974464|NCT03314935|526418786|FG003|Phase 1|Study Terminated by Sponsor|0|||
145974465|NCT03314935|526418787|FG004|Phase 1|Study Terminated by Sponsor|0|||
145974466|NCT03314935|526418788|FG005|Phase 1|Study Terminated by Sponsor|0|||
145974467|NCT03314935|526418789|FG006|Phase 1|Study Terminated by Sponsor|0|||
145974468|NCT03314935|526418790|FG007|Phase 1|Study Terminated by Sponsor|0|||
145974469|NCT03314935|526418791|FG008|Phase 1|Study Terminated by Sponsor|1|||
145974470|NCT03314935|526418792|FG009|Phase 1|Study Terminated by Sponsor|0|||
145974471|NCT03314935|526418793|FG010|Phase 1|Study Terminated by Sponsor|0|||
145974472|NCT03314935|526418794|FG011|Phase 1|Study Terminated by Sponsor|0|||
146089198|NCT00814879|526847293|FG001|By Week 48|Death|1|||
146089199|NCT01277042|526847294|FG000|Overall Study|Adverse Event|4|||
146089200|NCT01277042|526847295|FG001|Overall Study|Adverse Event|3|||
145974473|NCT03314935|526418795|FG012|Phase 1|Study Terminated by Sponsor|0|||
145974474|NCT03314935|526418796|FG013|Phase 1|Study Terminated by Sponsor|0|||
145974475|NCT03314935|526418797|FG014|Phase 1|Study Terminated by Sponsor|0|||
145974476|NCT03314935|526418783|FG000|Phase 1|"Captured as Other in Database"|0|||
145974477|NCT03314935|526418784|FG001|Phase 1|"Captured as Other in Database"|2|||
145974478|NCT03314935|526418785|FG002|Phase 1|"Captured as Other in Database"|0|||
145974479|NCT03314935|526418786|FG003|Phase 1|"Captured as Other in Database"|0|||
145974480|NCT03314935|526418787|FG004|Phase 1|"Captured as Other in Database"|0|||
145918769|NCT01074944|526209617|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145918770|NCT01074944|526209618|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
145918771|NCT01074944|526209619|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
145918772|NCT01074944|526209620|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145918773|NCT01074944|526209621|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145918774|NCT01074944|526209617|FG000|Long Term Treatment|Adverse Event|0|||
145918775|NCT01074944|526209618|FG001|Long Term Treatment|Adverse Event|0|||
145918776|NCT01074944|526209619|FG002|Long Term Treatment|Adverse Event|0|||
145918777|NCT01074944|526209620|FG003|Long Term Treatment|Adverse Event|3|||
145918778|NCT01074944|526209621|FG004|Long Term Treatment|Adverse Event|0|||
145918779|NCT01074944|526209617|FG000|Long Term Treatment|Lost to Follow-up|0|||
145918780|NCT01074944|526209618|FG001|Long Term Treatment|Lost to Follow-up|0|||
145918781|NCT01074944|526209619|FG002|Long Term Treatment|Lost to Follow-up|0|||
145918782|NCT01074944|526209620|FG003|Long Term Treatment|Lost to Follow-up|2|||
145918783|NCT01074944|526209621|FG004|Long Term Treatment|Lost to Follow-up|0|||
145918784|NCT01074944|526209617|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145918785|NCT01074944|526209618|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145918786|NCT01074944|526209619|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145918787|NCT01074944|526209620|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
145918788|NCT01074944|526209621|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145918789|NCT01074944|526209617|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
145918790|NCT01074944|526209618|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
145918791|NCT01074944|526209619|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
145918792|NCT01074944|526209620|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
145974481|NCT03314935|526418788|FG005|Phase 1|"Captured as Other in Database"|0|||
145974482|NCT03314935|526418789|FG006|Phase 1|"Captured as Other in Database"|1|||
146240582|NCT00614614|527394978|FG001|Primary Vaccination Phase|Other|0|||
145974483|NCT03314935|526418790|FG007|Phase 1|"Captured as Other in Database"|1|||
145974484|NCT03314935|526418791|FG008|Phase 1|"Captured as Other in Database"|1|||
146240583|NCT00614614|527394979|FG002|Primary Vaccination Phase|Other|0|||
146240584|NCT00614614|527394980|FG003|Primary Vaccination Phase|Other|0|||
146240585|NCT00614614|527394981|FG004|Primary Vaccination Phase|Other|0|||
146240586|NCT00614614|527394977|FG000|Booster Vaccination Phase|Adverse Event|0|||
146240587|NCT00614614|527394978|FG001|Booster Vaccination Phase|Adverse Event|0|||
146240588|NCT00614614|527394979|FG002|Booster Vaccination Phase|Adverse Event|1|||
146240589|NCT00614614|527394980|FG003|Booster Vaccination Phase|Adverse Event|1|||
146240590|NCT00614614|527394981|FG004|Booster Vaccination Phase|Adverse Event|0|||
146240591|NCT00614614|527394977|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
146240592|NCT00614614|527394978|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
146240593|NCT00614614|527394979|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
146240594|NCT00614614|527394980|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
146240595|NCT00614614|527394981|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
146240596|NCT00614614|527394977|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
146240597|NCT00614614|527394978|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
146240598|NCT00614614|527394979|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
146240599|NCT00614614|527394980|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
146240600|NCT00614614|527394981|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
146240601|NCT00614614|527394977|FG000|Booster Vaccination Phase|Protocol Violation|0|||
146240602|NCT00614614|527394978|FG001|Booster Vaccination Phase|Protocol Violation|0|||
146240603|NCT00614614|527394979|FG002|Booster Vaccination Phase|Protocol Violation|2|||
146240604|NCT00614614|527394980|FG003|Booster Vaccination Phase|Protocol Violation|3|||
146240605|NCT00614614|527394981|FG004|Booster Vaccination Phase|Protocol Violation|0|||
146240606|NCT00614614|527394977|FG000|Booster Vaccination Phase|Other|0|||
146240607|NCT00614614|527394978|FG001|Booster Vaccination Phase|Other|1|||
146240608|NCT00614614|527394979|FG002|Booster Vaccination Phase|Other|3|||
146240609|NCT00614614|527394980|FG003|Booster Vaccination Phase|Other|2|||
146240610|NCT00614614|527394981|FG004|Booster Vaccination Phase|Other|1|||
146240611|NCT04745676|527394982|FG000|Overall Study|Death|1|||
146240612|NCT04745676|527394983|FG001|Overall Study|Death|0|||
146240613|NCT04745676|527394984|FG002|Overall Study|Death|0|||
146240614|NCT05212285|527394985|FG000|Overall Study|Lack of Efficacy|12|||
146240615|NCT05212285|527394986|FG001|Overall Study|Lack of Efficacy|8|||
146297603|NCT04427501|527604739|FG007|Overall Study|Other - as reported by the investigator|0|||
145918793|NCT01074944|526209621|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
145918794|NCT01074944|526209617|FG000|Long Term Treatment|Withdrawal by Subject|0|||
145918795|NCT01074944|526209618|FG001|Long Term Treatment|Withdrawal by Subject|0|||
145918796|NCT01074944|526209619|FG002|Long Term Treatment|Withdrawal by Subject|0|||
145918797|NCT01074944|526209620|FG003|Long Term Treatment|Withdrawal by Subject|2|||
145918798|NCT01074944|526209621|FG004|Long Term Treatment|Withdrawal by Subject|0|||
146240616|NCT05212285|527394985|FG000|Overall Study|Withdrawal by Subject|8|||
146240617|NCT05212285|527394986|FG001|Overall Study|Withdrawal by Subject|1|||
146240618|NCT05212285|527394985|FG000|Overall Study|Lost to Follow-up|13|||
146240619|NCT05212285|527394986|FG001|Overall Study|Lost to Follow-up|1|||
145918799|NCT01074944|526209617|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145918800|NCT01074944|526209618|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145918801|NCT01074944|526209619|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145918802|NCT01074944|526209620|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145918803|NCT01074944|526209621|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
145918804|NCT01074944|526209617|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145918805|NCT01074944|526209618|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145918806|NCT01074944|526209619|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145918807|NCT01074944|526209620|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145918808|NCT01074944|526209621|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
145918809|NCT01408043|526209623|FG000|Overall Study|unable to collect cells|1|||
145918810|NCT00972595|526209629|FG000|Period 1|Adverse Event|1|||
145918811|NCT00972595|526209630|FG001|Period 1|Adverse Event|0|||
145918812|NCT02586155|526209631|FG000|Overall Study|Adverse Event|2|||
145918813|NCT02586155|526209632|FG001|Overall Study|Adverse Event|3|||
145918814|NCT02586155|526209631|FG000|Overall Study|Withdrawal by Subject|31|||
145918815|NCT02586155|526209632|FG001|Overall Study|Withdrawal by Subject|24|||
145918816|NCT02586155|526209631|FG000|Overall Study|Lost to Follow-up|7|||
145918817|NCT02586155|526209632|FG001|Overall Study|Lost to Follow-up|13|||
145918818|NCT02586155|526209631|FG000|Overall Study|Death|61|||
145918819|NCT02586155|526209632|FG001|Overall Study|Death|72|||
145918820|NCT02586155|526209631|FG000|Overall Study|Other reasons|26|||
145918821|NCT02586155|526209632|FG001|Overall Study|Other reasons|15|||
145918822|NCT01522456|526209633|FG000|Overall Study|Adverse Event|2|||
145918823|NCT01522456|526209633|FG000|Overall Study|Lost to Follow-up|2|||
145918824|NCT01522456|526209633|FG000|Overall Study|Withdrawal by Subject|2|||
145918825|NCT01522456|526209633|FG000|Overall Study|Pregnancy|1|||
145918826|NCT01522456|526209633|FG000|Overall Study|Tolerability Assessment|1|||
145918827|NCT02072980|526209635|FG000|Period 2, Second Wear|Adverse Event|0|||
145918828|NCT02072980|526209636|FG001|Period 2, Second Wear|Adverse Event|1|||
145918829|NCT02431364|526209637|FG000|Overall Study|Adverse Event|0|||
145918830|NCT02431364|526209638|FG001|Overall Study|Adverse Event|1|||
145918831|NCT02431364|526209639|FG002|Overall Study|Adverse Event|0|||
145918832|NCT02431364|526209640|FG003|Overall Study|Adverse Event|0|||
145918833|NCT02431364|526209641|FG004|Overall Study|Adverse Event|0|||
145918834|NCT02431364|526209637|FG000|Overall Study|Randomized but never treated|0|||
145918835|NCT02431364|526209638|FG001|Overall Study|Randomized but never treated|0|||
145918836|NCT02431364|526209639|FG002|Overall Study|Randomized but never treated|0|||
145918837|NCT02431364|526209640|FG003|Overall Study|Randomized but never treated|1|||
145918838|NCT02431364|526209641|FG004|Overall Study|Randomized but never treated|0|||
145918839|NCT02601014|526209642|FG000|Overall Study|Adverse Event|3|||
145918840|NCT02601014|526209643|FG001|Overall Study|Adverse Event|3|||
145918841|NCT02601014|526209642|FG000|Overall Study|Death|3|||
145918842|NCT02601014|526209643|FG001|Overall Study|Death|1|||
145918843|NCT02601014|526209642|FG000|Overall Study|Disease progression|4|||
145918844|NCT02601014|526209643|FG001|Overall Study|Disease progression|8|||
145918845|NCT01168427|526209644|FG000|Overall Study|Patient exited prior to implant|1|||
145918846|NCT00640315|526209647|FG000|Overall Study|Withdrawal by Subject|0|||
145918847|NCT00640315|526209648|FG001|Overall Study|Withdrawal by Subject|1|||
145918848|NCT00445146|526209649|FG000|Overall Study|Withdrew Consent|29|||
145918849|NCT00445146|526209649|FG000|Overall Study|Lack of Efficacy|28|||
145918850|NCT00445146|526209649|FG000|Overall Study|Investigator's Discretion|22|||
145918851|NCT00445146|526209649|FG000|Overall Study|Adverse Event|13|||
145918852|NCT00445146|526209649|FG000|Overall Study|Lost to Follow-up|13|||
145918853|NCT00445146|526209649|FG000|Overall Study|Death|9|||
145918854|NCT00445146|526209649|FG000|Overall Study|Protocol Violation|4|||
145918855|NCT00445146|526209649|FG000|Overall Study|Pregnancy|1|||
145918856|NCT01256879|526209650|FG000|Overall Study|Withdrawal by Subject|1|||
145918857|NCT00397514|526209651|FG000|Overall Study|Withdrawal by Subject|1|||
145918858|NCT00397514|526209651|FG000|Overall Study|Pacing wire malfunction|1|||
145918859|NCT00397514|526209651|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
145918860|NCT00397514|526209651|FG000|Overall Study|early extubation|2|||
145918861|NCT00397514|526209651|FG000|Overall Study|poor echocardiographic windows|1|||
145918862|NCT00725920|526209654|FG000|Overall Study|Lack of Efficacy|3|||
145918863|NCT00725920|526209655|FG001|Overall Study|Lack of Efficacy|6|||
145918864|NCT02456740|526209657|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145918865|NCT02456740|526209658|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145918866|NCT02456740|526209659|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145918867|NCT02456740|526209660|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145918868|NCT02456740|526209661|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145918869|NCT02456740|526209662|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145918870|NCT02456740|526209663|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145918871|NCT02456740|526209664|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
146089201|NCT01277042|526847294|FG000|Overall Study|Lost to Follow-up|2|||
146089202|NCT01277042|526847295|FG001|Overall Study|Lost to Follow-up|2|||
146089203|NCT01277042|526847294|FG000|Overall Study|Withdrawal by Subject|2|||
146089204|NCT01277042|526847295|FG001|Overall Study|Withdrawal by Subject|0|||
146089205|NCT01461057|526847296|FG000|Overall Study|Death|10|||
146089206|NCT01461057|526847297|FG001|Overall Study|Death|9|||
146089207|NCT01461057|526847296|FG000|Overall Study|Withdrawal by Subject|2|||
146089208|NCT01461057|526847297|FG001|Overall Study|Withdrawal by Subject|3|||
145918872|NCT02456740|526209665|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
146089209|NCT01461057|526847296|FG000|Overall Study|Physician Decision|0|||
146089210|NCT01461057|526847297|FG001|Overall Study|Physician Decision|2|||
146089211|NCT01461057|526847296|FG000|Overall Study|Adverse Event|0|||
146089212|NCT01461057|526847297|FG001|Overall Study|Adverse Event|1|||
146089213|NCT01461057|526847296|FG000|Overall Study|Progression of Disease|1|||
145918873|NCT02456740|526209657|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
145918874|NCT02456740|526209658|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
145918875|NCT02456740|526209659|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
145918876|NCT02456740|526209660|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918877|NCT02456740|526209661|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918878|NCT02456740|526209662|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918879|NCT02456740|526209663|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918880|NCT02456740|526209664|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918881|NCT02456740|526209665|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145918882|NCT02456740|526209657|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
145918883|NCT02456740|526209658|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
145918884|NCT02456740|526209659|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
145918885|NCT02456740|526209660|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145918886|NCT02456740|526209661|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145918887|NCT02456740|526209662|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
146089214|NCT01461057|526847297|FG001|Overall Study|Progression of Disease|0|||
146089215|NCT01461057|526847296|FG000|Overall Study|Study Terminated by Sponsor|2|||
146089216|NCT01461057|526847297|FG001|Overall Study|Study Terminated by Sponsor|0|||
146089217|NCT03034200|526847298|FG000|Overall Study|Disease progression|8|||
146089218|NCT03034200|526847299|FG001|Overall Study|Disease progression|10|||
146089219|NCT03034200|526847300|FG002|Overall Study|Disease progression|4|||
146089220|NCT03034200|526847298|FG000|Overall Study|Physician Decision|2|||
146089221|NCT03034200|526847299|FG001|Overall Study|Physician Decision|0|||
146089222|NCT03034200|526847300|FG002|Overall Study|Physician Decision|3|||
146089223|NCT03034200|526847298|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
146089224|NCT03034200|526847299|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
146089225|NCT03034200|526847300|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
146089226|NCT03034200|526847298|FG000|Overall Study|Adjuvant Therapy|0|||
146089227|NCT03034200|526847299|FG001|Overall Study|Adjuvant Therapy|0|||
146089228|NCT03034200|526847300|FG002|Overall Study|Adjuvant Therapy|1|||
146240620|NCT05212285|527394985|FG000|Overall Study|miss data|21|||
146240621|NCT05212285|527394986|FG001|Overall Study|miss data|2|||
146240622|NCT03683030|527394987|FG000|Overall Study|Enrolled but screen failures|12|||
146240623|NCT03683030|527394988|FG001|Overall Study|Enrolled but screen failures|7|||
146240624|NCT03683030|527394987|FG000|Overall Study|Enrolled but no catheter inserted|11|||
146240625|NCT03683030|527394988|FG001|Overall Study|Enrolled but no catheter inserted|13|||
145918888|NCT02456740|526209663|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145918889|NCT02456740|526209664|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145918890|NCT02456740|526209665|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145918891|NCT02456740|526209657|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918892|NCT02456740|526209658|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918893|NCT02456740|526209659|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918894|NCT02456740|526209660|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
146240626|NCT03683030|527394987|FG000|Overall Study|Withdrawal by Subject|0|||
145918895|NCT02456740|526209661|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
145918896|NCT02456740|526209662|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918897|NCT02456740|526209663|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918898|NCT02456740|526209664|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145918899|NCT02456740|526209665|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
146089229|NCT01288976|526847301|FG000|Overall Study|Withdrawal by Subject|58|||
146089230|NCT01288976|526847302|FG001|Overall Study|Withdrawal by Subject|12|||
146089231|NCT01288976|526847303|FG002|Overall Study|Withdrawal by Subject|9|||
146089232|NCT01288976|526847301|FG000|Overall Study|Death|98|||
146089233|NCT01288976|526847302|FG001|Overall Study|Death|6|||
146089234|NCT01288976|526847303|FG002|Overall Study|Death|4|||
146089235|NCT01288976|526847301|FG000|Overall Study|Data unavailable|22|||
146089236|NCT01288976|526847302|FG001|Overall Study|Data unavailable|9|||
145918900|NCT02456740|526209657|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145918901|NCT02456740|526209658|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145918902|NCT02456740|526209659|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145918903|NCT02456740|526209660|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
145918904|NCT02456740|526209661|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
145918905|NCT02456740|526209662|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
145918906|NCT02456740|526209663|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
145918907|NCT02456740|526209664|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
145918908|NCT02456740|526209665|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
145918909|NCT02456740|526209657|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918910|NCT02456740|526209658|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918911|NCT02456740|526209659|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918912|NCT02456740|526209660|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918913|NCT02456740|526209661|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918914|NCT02456740|526209662|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918915|NCT02456740|526209663|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918916|NCT02456740|526209664|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
145918917|NCT02456740|526209665|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145918918|NCT02456740|526209657|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145918919|NCT02456740|526209658|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145918920|NCT02456740|526209659|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145918921|NCT02456740|526209660|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
145918922|NCT02456740|526209661|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
145918923|NCT02456740|526209662|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
145918924|NCT02456740|526209663|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
145918925|NCT02456740|526209664|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
145918926|NCT02456740|526209665|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
145918927|NCT04720105|526209666|FG000|Overall Study|Lack of Efficacy|1|||
145918928|NCT04720105|526209666|FG000|Overall Study|Lost to Follow-up|1|||
145918929|NCT04720105|526209666|FG000|Overall Study|Withdrawal by Subject|3|||
145918930|NCT02892331|526209669|FG000|Overall Study|Withdrawal by Subject|0|||
145918931|NCT02892331|526209670|FG001|Overall Study|Withdrawal by Subject|1|||
145918932|NCT02892331|526209671|FG002|Overall Study|Withdrawal by Subject|1|||
145918933|NCT02892331|526209669|FG000|Overall Study|Sick family member|0|||
145918934|NCT02892331|526209670|FG001|Overall Study|Sick family member|0|||
145918935|NCT02892331|526209671|FG002|Overall Study|Sick family member|1|||
145918936|NCT02892331|526209669|FG000|Overall Study|Corona virus pandemic|1|||
145918937|NCT02892331|526209670|FG001|Overall Study|Corona virus pandemic|0|||
145918938|NCT02892331|526209671|FG002|Overall Study|Corona virus pandemic|1|||
145918939|NCT02892331|526209669|FG000|Overall Study|Lost to Follow-up|1|||
145918940|NCT02892331|526209670|FG001|Overall Study|Lost to Follow-up|0|||
145918941|NCT02892331|526209671|FG002|Overall Study|Lost to Follow-up|1|||
145918942|NCT02892331|526209669|FG000|Overall Study|Blood pressure was too elevated|0|||
145918943|NCT02892331|526209670|FG001|Overall Study|Blood pressure was too elevated|1|||
145918944|NCT02892331|526209671|FG002|Overall Study|Blood pressure was too elevated|0|||
145918945|NCT02892331|526209669|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
145918946|NCT02892331|526209670|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
145918947|NCT02892331|526209671|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
145918948|NCT01133067|526209672|FG000|Overall Study|Death|136|||
145918949|NCT01133067|526209672|FG000|Overall Study|Lost to Follow-up|3|||
145974485|NCT03314935|526418792|FG009|Phase 1|"Captured as Other in Database"|0|||
145974486|NCT03314935|526418793|FG010|Phase 1|"Captured as Other in Database"|0|||
145974487|NCT03314935|526418794|FG011|Phase 1|"Captured as Other in Database"|0|||
145974488|NCT03314935|526418795|FG012|Phase 1|"Captured as Other in Database"|0|||
145974489|NCT03314935|526418796|FG013|Phase 1|"Captured as Other in Database"|0|||
145974490|NCT03314935|526418797|FG014|Phase 1|"Captured as Other in Database"|0|||
145974491|NCT03314935|526418783|FG000|Phase 1|Lost to Follow-up|0|||
145974492|NCT03314935|526418784|FG001|Phase 1|Lost to Follow-up|0|||
145974493|NCT03314935|526418785|FG002|Phase 1|Lost to Follow-up|0|||
145918950|NCT04135937|526209677|FG000|Overall Study|Lost to Follow-up|2|||
145918951|NCT04135937|526209677|FG000|Overall Study|Withdrawal by Subject|1|||
145918952|NCT02548143|526209678|FG000|Overall Study|Adverse Event|1|||
145918953|NCT02548143|526209679|FG001|Overall Study|Adverse Event|0|||
145918954|NCT02548143|526209678|FG000|Overall Study|Withdrawal by Subject|0|||
145918955|NCT02548143|526209679|FG001|Overall Study|Withdrawal by Subject|1|||
145918956|NCT06018129|526209681|FG000|Overall Study|Death|1|||
145918957|NCT06018129|526209682|FG001|Overall Study|Death|1|||
145918958|NCT06018129|526209683|FG002|Overall Study|Death|2|||
145918959|NCT06018129|526209681|FG000|Overall Study|Sponsor Decision|2|||
145974494|NCT03314935|526418786|FG003|Phase 1|Lost to Follow-up|0|||
145974495|NCT03314935|526418787|FG004|Phase 1|Lost to Follow-up|0|||
145974496|NCT03314935|526418788|FG005|Phase 1|Lost to Follow-up|0|||
145918960|NCT06018129|526209682|FG001|Overall Study|Sponsor Decision|2|||
145918961|NCT06018129|526209683|FG002|Overall Study|Sponsor Decision|1|||
145918962|NCT00858273|526209684|FG000|Overall Study|Protocol Violation|3|||
145918963|NCT00858273|526209685|FG001|Overall Study|Protocol Violation|5|||
145918964|NCT00982657|526209686|FG000|Overall Study|Death|1|||
145918965|NCT00982657|526209687|FG001|Overall Study|Death|0|||
145918966|NCT00982657|526209688|FG002|Overall Study|Death|1|||
145918967|NCT00982657|526209689|FG003|Overall Study|Death|1|||
145918968|NCT00982657|526209686|FG000|Overall Study|Withdrawal by Subject|0|||
145918969|NCT00982657|526209687|FG001|Overall Study|Withdrawal by Subject|0|||
145918970|NCT00982657|526209688|FG002|Overall Study|Withdrawal by Subject|1|||
145918971|NCT00982657|526209689|FG003|Overall Study|Withdrawal by Subject|3|||
145918972|NCT00982657|526209686|FG000|Overall Study|Other|0|||
145918973|NCT00982657|526209687|FG001|Overall Study|Other|0|||
145918974|NCT00982657|526209688|FG002|Overall Study|Other|0|||
145918975|NCT00982657|526209689|FG003|Overall Study|Other|4|||
145918976|NCT00982657|526209686|FG000|Overall Study|On going at date of cut-off|0|||
145918977|NCT00982657|526209687|FG001|Overall Study|On going at date of cut-off|0|||
145918978|NCT00982657|526209688|FG002|Overall Study|On going at date of cut-off|0|||
145918979|NCT00982657|526209689|FG003|Overall Study|On going at date of cut-off|1|||
145918980|NCT00625820|526209690|FG000|Overall Study|Withdrawal by Subject|1|||
145918981|NCT00070564|526212094|FG000|Overall Study|Progression|2|||
145918982|NCT00070564|526212095|FG001|Overall Study|Progression|4|||
145918983|NCT00070564|526212096|FG002|Overall Study|Progression|7|||
145918984|NCT00070564|526212097|FG003|Overall Study|Progression|7|||
145918985|NCT00070564|526212098|FG004|Overall Study|Progression|1|||
145918986|NCT00070564|526212099|FG005|Overall Study|Progression|0|||
145918987|NCT00070564|526212094|FG000|Overall Study|Delinquent|1|||
145918988|NCT00070564|526212095|FG001|Overall Study|Delinquent|4|||
145918989|NCT00070564|526212096|FG002|Overall Study|Delinquent|2|||
145918990|NCT00070564|526212097|FG003|Overall Study|Delinquent|0|||
145918991|NCT00070564|526212098|FG004|Overall Study|Delinquent|0|||
145918992|NCT00070564|526212099|FG005|Overall Study|Delinquent|0|||
145918993|NCT00070564|526212094|FG000|Overall Study|Adverse Event|150|||
145918994|NCT00070564|526212095|FG001|Overall Study|Adverse Event|142|||
145918995|NCT00070564|526212096|FG002|Overall Study|Adverse Event|120|||
145918996|NCT00070564|526212097|FG003|Overall Study|Adverse Event|108|||
145918997|NCT00070564|526212098|FG004|Overall Study|Adverse Event|63|||
145918998|NCT00070564|526212099|FG005|Overall Study|Adverse Event|36|||
145918999|NCT00070564|526212094|FG000|Overall Study|Death|4|||
145919000|NCT00070564|526212095|FG001|Overall Study|Death|1|||
145919001|NCT00070564|526212096|FG002|Overall Study|Death|5|||
145919002|NCT00070564|526212097|FG003|Overall Study|Death|3|||
145919003|NCT00070564|526212098|FG004|Overall Study|Death|0|||
145919004|NCT00070564|526212099|FG005|Overall Study|Death|1|||
145919005|NCT00070564|526212094|FG000|Overall Study|Other, not protocol specified|17|||
145919006|NCT00070564|526212095|FG001|Overall Study|Other, not protocol specified|15|||
145919007|NCT00070564|526212096|FG002|Overall Study|Other, not protocol specified|14|||
145919008|NCT00070564|526212097|FG003|Overall Study|Other, not protocol specified|19|||
145919009|NCT00070564|526212098|FG004|Overall Study|Other, not protocol specified|6|||
145919010|NCT00070564|526212099|FG005|Overall Study|Other, not protocol specified|7|||
145919011|NCT00070564|526212094|FG000|Overall Study|Withdrawal by Subject|26|||
145919012|NCT00070564|526212095|FG001|Overall Study|Withdrawal by Subject|37|||
145919013|NCT00070564|526212096|FG002|Overall Study|Withdrawal by Subject|23|||
145919014|NCT00070564|526212097|FG003|Overall Study|Withdrawal by Subject|30|||
145919015|NCT00070564|526212098|FG004|Overall Study|Withdrawal by Subject|8|||
145919016|NCT00070564|526212099|FG005|Overall Study|Withdrawal by Subject|8|||
145919017|NCT00070564|526212094|FG000|Overall Study|Not reported|0|||
145919018|NCT00070564|526212095|FG001|Overall Study|Not reported|0|||
145919019|NCT00070564|526212096|FG002|Overall Study|Not reported|0|||
145919020|NCT00070564|526212097|FG003|Overall Study|Not reported|0|||
145974497|NCT03314935|526418789|FG006|Phase 1|Lost to Follow-up|0|||
145974498|NCT03314935|526418790|FG007|Phase 1|Lost to Follow-up|0|||
145974499|NCT03314935|526418791|FG008|Phase 1|Lost to Follow-up|1|||
145974500|NCT03314935|526418792|FG009|Phase 1|Lost to Follow-up|0|||
145919021|NCT00070564|526212098|FG004|Overall Study|Not reported|1|||
145919022|NCT00070564|526212099|FG005|Overall Study|Not reported|0|||
145919023|NCT05825404|526212103|FG000|First Intervention (Weeks 2-5)|Death|0|||
145974501|NCT03314935|526418793|FG010|Phase 1|Lost to Follow-up|0|||
145919024|NCT05825404|526212104|FG001|First Intervention (Weeks 2-5)|Death|1|||
145919025|NCT05825404|526212103|FG000|Second Intervention (Weeks 8-11)|Death|0|||
145919026|NCT05825404|526212104|FG001|Second Intervention (Weeks 8-11)|Death|1|||
145919027|NCT01127256|526212105|FG000|Overall Study|Adverse Event|13|||
145919028|NCT01127256|526212106|FG001|Overall Study|Adverse Event|13|||
145919029|NCT01127256|526212105|FG000|Overall Study|Lack of Efficacy|4|||
145919030|NCT01127256|526212106|FG001|Overall Study|Lack of Efficacy|0|||
145919031|NCT01127256|526212105|FG000|Overall Study|Lost to Follow-up|16|||
145919032|NCT01127256|526212106|FG001|Overall Study|Lost to Follow-up|17|||
145919033|NCT01127256|526212105|FG000|Overall Study|Withdrawal by Subject|5|||
145919034|NCT01127256|526212106|FG001|Overall Study|Withdrawal by Subject|9|||
145919035|NCT01127256|526212105|FG000|Overall Study|Protocol Violation|1|||
145919036|NCT01127256|526212106|FG001|Overall Study|Protocol Violation|0|||
145919037|NCT00931528|526212107|FG000|Overall Study|Protocol Violation|9|||
145919038|NCT00931528|526212108|FG001|Overall Study|Protocol Violation|12|||
145919039|NCT00931528|526212107|FG000|Overall Study|Withdrawal by Subject|4|||
145919040|NCT00931528|526212108|FG001|Overall Study|Withdrawal by Subject|12|||
145919041|NCT00931528|526212107|FG000|Overall Study|Lost to Follow-up|6|||
145919042|NCT00931528|526212108|FG001|Overall Study|Lost to Follow-up|13|||
145919043|NCT00931528|526212107|FG000|Overall Study|Assessment outside of Time Frame|22|||
145919044|NCT00931528|526212108|FG001|Overall Study|Assessment outside of Time Frame|23|||
145919045|NCT01730053|526212109|FG000|Overall Study|Participant moved|0|||
145919046|NCT01730053|526212110|FG001|Overall Study|Participant moved|0|||
145919047|NCT01730053|526212111|FG002|Overall Study|Participant moved|1|||
145919048|NCT01730053|526212112|FG003|Overall Study|Participant moved|0|||
145919049|NCT01730053|526212113|FG004|Overall Study|Participant moved|0|||
145919050|NCT01730053|526212114|FG005|Overall Study|Participant moved|0|||
145919051|NCT01730053|526212109|FG000|Overall Study|Physician Decision|0|||
145919052|NCT01730053|526212110|FG001|Overall Study|Physician Decision|0|||
145919053|NCT01730053|526212111|FG002|Overall Study|Physician Decision|0|||
145919054|NCT01730053|526212112|FG003|Overall Study|Physician Decision|1|||
145919055|NCT01730053|526212113|FG004|Overall Study|Physician Decision|0|||
145919056|NCT01730053|526212114|FG005|Overall Study|Physician Decision|0|||
145919057|NCT01730053|526212109|FG000|Overall Study|Adverse Event|2|||
145919058|NCT01730053|526212110|FG001|Overall Study|Adverse Event|6|||
145919059|NCT01730053|526212111|FG002|Overall Study|Adverse Event|3|||
145919060|NCT01730053|526212112|FG003|Overall Study|Adverse Event|3|||
145919061|NCT01730053|526212113|FG004|Overall Study|Adverse Event|2|||
145919062|NCT01730053|526212114|FG005|Overall Study|Adverse Event|2|||
145919063|NCT01730053|526212109|FG000|Overall Study|Poor compliance to protocol|1|||
145919064|NCT01730053|526212110|FG001|Overall Study|Poor compliance to protocol|2|||
145919065|NCT01730053|526212111|FG002|Overall Study|Poor compliance to protocol|2|||
145919066|NCT01730053|526212112|FG003|Overall Study|Poor compliance to protocol|0|||
145919067|NCT01730053|526212113|FG004|Overall Study|Poor compliance to protocol|0|||
145919068|NCT01730053|526212114|FG005|Overall Study|Poor compliance to protocol|2|||
145919069|NCT01730053|526212109|FG000|Overall Study|Other than specified|2|||
145919070|NCT01730053|526212110|FG001|Overall Study|Other than specified|6|||
145919071|NCT01730053|526212111|FG002|Overall Study|Other than specified|5|||
145919072|NCT01730053|526212112|FG003|Overall Study|Other than specified|4|||
145919073|NCT01730053|526212113|FG004|Overall Study|Other than specified|7|||
145919074|NCT01730053|526212114|FG005|Overall Study|Other than specified|9|||
145919075|NCT01470248|526212115|FG000|Overall Study|Withdrawal by Subject|1|||
145919076|NCT05364931|526212122|FG000|Overall Study|Adverse Event|0|||
145919077|NCT05364931|526212123|FG001|Overall Study|Adverse Event|2|||
145919078|NCT05364931|526212124|FG002|Overall Study|Adverse Event|1|||
145919079|NCT05364931|526212125|FG003|Overall Study|Adverse Event|0|||
145919080|NCT05364931|526212122|FG000|Overall Study|Lost to Follow-up|1|||
146240627|NCT03683030|527394988|FG001|Overall Study|Withdrawal by Subject|2|||
145919081|NCT05364931|526212123|FG001|Overall Study|Lost to Follow-up|0|||
145919082|NCT05364931|526212124|FG002|Overall Study|Lost to Follow-up|0|||
145919083|NCT05364931|526212125|FG003|Overall Study|Lost to Follow-up|0|||
145919084|NCT05364931|526212122|FG000|Overall Study|Withdrawal by Subject|1|||
145919085|NCT05364931|526212123|FG001|Overall Study|Withdrawal by Subject|1|||
145919086|NCT05364931|526212124|FG002|Overall Study|Withdrawal by Subject|3|||
145919087|NCT05364931|526212125|FG003|Overall Study|Withdrawal by Subject|2|||
145919088|NCT05364931|526212122|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145919089|NCT05364931|526212123|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
145919090|NCT05364931|526212124|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145919091|NCT05364931|526212125|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145919092|NCT05364931|526212122|FG000|Overall Study|Discontinued|1|||
145974502|NCT03314935|526418794|FG011|Phase 1|Lost to Follow-up|0|||
146240628|NCT03683030|527394987|FG000|Overall Study|Early termination by subject|1|||
146240629|NCT03683030|527394988|FG001|Overall Study|Early termination by subject|0|||
146240630|NCT03683030|527394987|FG000|Overall Study|Lost to Follow-up|0|||
145919093|NCT05364931|526212123|FG001|Overall Study|Discontinued|0|||
145919094|NCT05364931|526212124|FG002|Overall Study|Discontinued|0|||
145919095|NCT05364931|526212125|FG003|Overall Study|Discontinued|0|||
145919096|NCT05842967|526212126|FG000|Period 1: SSA|Adverse Event|1|||
145919097|NCT05842967|526212127|FG001|Period 1: SSA|Adverse Event|1|||
145919098|NCT05842967|526212128|FG002|Period 1: SSA|Adverse Event|0|||
145919099|NCT05842967|526212129|FG003|Period 1: SSA|Adverse Event|0|||
146240631|NCT03683030|527394988|FG001|Overall Study|Lost to Follow-up|6|||
146240632|NCT03683030|527394987|FG000|Overall Study|Death|0|||
145919100|NCT05842967|526212126|FG000|Period 1: SSA|Death|1|||
145919101|NCT05842967|526212127|FG001|Period 1: SSA|Death|0|||
145919102|NCT05842967|526212128|FG002|Period 1: SSA|Death|0|||
145919103|NCT05842967|526212129|FG003|Period 1: SSA|Death|0|||
145919104|NCT05842967|526212126|FG000|Period 1: SSA|Lost to Follow-up|16|||
145919105|NCT05842967|526212127|FG001|Period 1: SSA|Lost to Follow-up|4|||
145919106|NCT05842967|526212128|FG002|Period 1: SSA|Lost to Follow-up|0|||
145919107|NCT05842967|526212129|FG003|Period 1: SSA|Lost to Follow-up|0|||
145919108|NCT05842967|526212126|FG000|Period 1: SSA|Physician Decision|1|||
145919109|NCT05842967|526212127|FG001|Period 1: SSA|Physician Decision|0|||
145919110|NCT05842967|526212128|FG002|Period 1: SSA|Physician Decision|0|||
145919111|NCT05842967|526212129|FG003|Period 1: SSA|Physician Decision|0|||
145919112|NCT05842967|526212126|FG000|Period 1: SSA|Withdrawal by Subject|2|||
145974503|NCT03314935|526418795|FG012|Phase 1|Lost to Follow-up|0|||
145919113|NCT05842967|526212127|FG001|Period 1: SSA|Withdrawal by Subject|2|||
145919114|NCT05842967|526212128|FG002|Period 1: SSA|Withdrawal by Subject|0|||
145919115|NCT05842967|526212129|FG003|Period 1: SSA|Withdrawal by Subject|0|||
145919116|NCT05842967|526212126|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
145919117|NCT05842967|526212127|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
145919118|NCT05842967|526212128|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
145919119|NCT05842967|526212129|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
145974504|NCT03314935|526418796|FG013|Phase 1|Lost to Follow-up|0|||
145974505|NCT03314935|526418797|FG014|Phase 1|Lost to Follow-up|0|||
145974506|NCT03314935|526418783|FG000|Phase 2|Death|0|||
145974507|NCT03314935|526418784|FG001|Phase 2|Death|0|||
145974508|NCT03314935|526418785|FG002|Phase 2|Death|0|||
145974509|NCT03314935|526418786|FG003|Phase 2|Death|0|||
145974510|NCT03314935|526418787|FG004|Phase 2|Death|0|||
145974511|NCT03314935|526418788|FG005|Phase 2|Death|0|||
145974512|NCT03314935|526418789|FG006|Phase 2|Death|0|||
145974513|NCT03314935|526418790|FG007|Phase 2|Death|0|||
145974514|NCT03314935|526418791|FG008|Phase 2|Death|0|||
145974515|NCT03314935|526418792|FG009|Phase 2|Death|5|||
145974516|NCT03314935|526418793|FG010|Phase 2|Death|20|||
145974517|NCT03314935|526418794|FG011|Phase 2|Death|6|||
145974518|NCT03314935|526418795|FG012|Phase 2|Death|7|||
145974519|NCT03314935|526418796|FG013|Phase 2|Death|6|||
145974520|NCT03314935|526418797|FG014|Phase 2|Death|17|||
145974521|NCT03314935|526418783|FG000|Phase 2|Withdrawal by Subject|0|||
145974522|NCT03314935|526418784|FG001|Phase 2|Withdrawal by Subject|0|||
145974523|NCT03314935|526418785|FG002|Phase 2|Withdrawal by Subject|0|||
145974524|NCT03314935|526418786|FG003|Phase 2|Withdrawal by Subject|0|||
145974525|NCT03314935|526418787|FG004|Phase 2|Withdrawal by Subject|0|||
145974526|NCT03314935|526418788|FG005|Phase 2|Withdrawal by Subject|0|||
145974527|NCT03314935|526418789|FG006|Phase 2|Withdrawal by Subject|0|||
145974528|NCT03314935|526418790|FG007|Phase 2|Withdrawal by Subject|0|||
145974529|NCT03314935|526418791|FG008|Phase 2|Withdrawal by Subject|0|||
145974530|NCT03314935|526418792|FG009|Phase 2|Withdrawal by Subject|1|||
145974531|NCT03314935|526418793|FG010|Phase 2|Withdrawal by Subject|4|||
145974532|NCT03314935|526418794|FG011|Phase 2|Withdrawal by Subject|0|||
145974533|NCT03314935|526418795|FG012|Phase 2|Withdrawal by Subject|1|||
145974534|NCT03314935|526418796|FG013|Phase 2|Withdrawal by Subject|0|||
145974535|NCT03314935|526418797|FG014|Phase 2|Withdrawal by Subject|1|||
145974536|NCT03314935|526418783|FG000|Phase 2|Progressive Disease|0|||
145974537|NCT03314935|526418784|FG001|Phase 2|Progressive Disease|0|||
145974538|NCT03314935|526418785|FG002|Phase 2|Progressive Disease|0|||
145974539|NCT03314935|526418786|FG003|Phase 2|Progressive Disease|0|||
145974540|NCT03314935|526418787|FG004|Phase 2|Progressive Disease|0|||
145974541|NCT03314935|526418788|FG005|Phase 2|Progressive Disease|0|||
145974542|NCT03314935|526418789|FG006|Phase 2|Progressive Disease|0|||
145974543|NCT03314935|526418790|FG007|Phase 2|Progressive Disease|0|||
145974544|NCT03314935|526418791|FG008|Phase 2|Progressive Disease|0|||
145974545|NCT03314935|526418792|FG009|Phase 2|Progressive Disease|1|||
145974546|NCT03314935|526418793|FG010|Phase 2|Progressive Disease|1|||
145974547|NCT03314935|526418794|FG011|Phase 2|Progressive Disease|1|||
145974548|NCT03314935|526418795|FG012|Phase 2|Progressive Disease|2|||
145974549|NCT03314935|526418796|FG013|Phase 2|Progressive Disease|0|||
145974550|NCT03314935|526418797|FG014|Phase 2|Progressive Disease|1|||
145974551|NCT03314935|526418783|FG000|Phase 2|Study Terminated by Sponsor|0|||
145919120|NCT05842967|526212126|FG000|Period 2: SSB|Adverse Event|0|||
145919121|NCT05842967|526212127|FG001|Period 2: SSB|Adverse Event|0|||
145919122|NCT05842967|526212128|FG002|Period 2: SSB|Adverse Event|2|||
145919123|NCT05842967|526212129|FG003|Period 2: SSB|Adverse Event|0|||
145974552|NCT03314935|526418784|FG001|Phase 2|Study Terminated by Sponsor|0|||
145974553|NCT03314935|526418785|FG002|Phase 2|Study Terminated by Sponsor|0|||
145974554|NCT03314935|526418786|FG003|Phase 2|Study Terminated by Sponsor|0|||
145974555|NCT03314935|526418787|FG004|Phase 2|Study Terminated by Sponsor|0|||
145974556|NCT03314935|526418788|FG005|Phase 2|Study Terminated by Sponsor|0|||
145974557|NCT03314935|526418789|FG006|Phase 2|Study Terminated by Sponsor|0|||
145919124|NCT05842967|526212126|FG000|Period 2: SSB|Lost to Follow-up|0|||
145974558|NCT03314935|526418790|FG007|Phase 2|Study Terminated by Sponsor|0|||
145974559|NCT03314935|526418791|FG008|Phase 2|Study Terminated by Sponsor|0|||
145974560|NCT03314935|526418792|FG009|Phase 2|Study Terminated by Sponsor|0|||
145919125|NCT05842967|526212127|FG001|Period 2: SSB|Lost to Follow-up|0|||
145974561|NCT03314935|526418793|FG010|Phase 2|Study Terminated by Sponsor|7|||
145974562|NCT03314935|526418794|FG011|Phase 2|Study Terminated by Sponsor|2|||
145974563|NCT03314935|526418795|FG012|Phase 2|Study Terminated by Sponsor|1|||
145974564|NCT03314935|526418796|FG013|Phase 2|Study Terminated by Sponsor|4|||
145974565|NCT03314935|526418797|FG014|Phase 2|Study Terminated by Sponsor|4|||
145919126|NCT05842967|526212128|FG002|Period 2: SSB|Lost to Follow-up|4|||
145919127|NCT05842967|526212129|FG003|Period 2: SSB|Lost to Follow-up|3|||
145919128|NCT05842967|526212126|FG000|Period 2: SSB|Withdrawal by Subject|0|||
145919129|NCT05842967|526212127|FG001|Period 2: SSB|Withdrawal by Subject|0|||
145919130|NCT05842967|526212128|FG002|Period 2: SSB|Withdrawal by Subject|1|||
145919131|NCT05842967|526212129|FG003|Period 2: SSB|Withdrawal by Subject|0|||
145919132|NCT05842967|526212126|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
145919133|NCT05842967|526212127|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
145919134|NCT05842967|526212128|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
145919135|NCT05842967|526212129|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
145919136|NCT05842967|526212126|FG000|Period 2: SSB|Protocol Violation|0|||
145919137|NCT05842967|526212127|FG001|Period 2: SSB|Protocol Violation|0|||
145919138|NCT05842967|526212128|FG002|Period 2: SSB|Protocol Violation|0|||
145919139|NCT05842967|526212129|FG003|Period 2: SSB|Protocol Violation|1|||
145974566|NCT03314935|526418783|FG000|Phase 2|Lost to Follow-up|0|||
145974567|NCT03314935|526418784|FG001|Phase 2|Lost to Follow-up|0|||
145974568|NCT03314935|526418785|FG002|Phase 2|Lost to Follow-up|0|||
145974569|NCT03314935|526418786|FG003|Phase 2|Lost to Follow-up|0|||
145974570|NCT03314935|526418787|FG004|Phase 2|Lost to Follow-up|0|||
145974571|NCT03314935|526418788|FG005|Phase 2|Lost to Follow-up|0|||
145974572|NCT03314935|526418789|FG006|Phase 2|Lost to Follow-up|0|||
145974573|NCT03314935|526418790|FG007|Phase 2|Lost to Follow-up|0|||
145974574|NCT03314935|526418791|FG008|Phase 2|Lost to Follow-up|0|||
145974575|NCT03314935|526418792|FG009|Phase 2|Lost to Follow-up|1|||
145974576|NCT03314935|526418793|FG010|Phase 2|Lost to Follow-up|0|||
145974577|NCT03314935|526418794|FG011|Phase 2|Lost to Follow-up|0|||
145974578|NCT03314935|526418795|FG012|Phase 2|Lost to Follow-up|0|||
145974579|NCT03314935|526418796|FG013|Phase 2|Lost to Follow-up|0|||
145974580|NCT03314935|526418797|FG014|Phase 2|Lost to Follow-up|1|||
145974581|NCT03314935|526418783|FG000|Phase 2|Physician Decision|0|||
145974582|NCT03314935|526418784|FG001|Phase 2|Physician Decision|0|||
145974583|NCT03314935|526418785|FG002|Phase 2|Physician Decision|0|||
145974584|NCT03314935|526418786|FG003|Phase 2|Physician Decision|0|||
145974585|NCT03314935|526418787|FG004|Phase 2|Physician Decision|0|||
145974586|NCT03314935|526418788|FG005|Phase 2|Physician Decision|0|||
145974587|NCT03314935|526418789|FG006|Phase 2|Physician Decision|0|||
145974588|NCT03314935|526418790|FG007|Phase 2|Physician Decision|0|||
145974589|NCT03314935|526418791|FG008|Phase 2|Physician Decision|0|||
145974590|NCT03314935|526418792|FG009|Phase 2|Physician Decision|0|||
145974591|NCT03314935|526418793|FG010|Phase 2|Physician Decision|1|||
145974592|NCT03314935|526418794|FG011|Phase 2|Physician Decision|0|||
145974593|NCT03314935|526418795|FG012|Phase 2|Physician Decision|0|||
145974594|NCT03314935|526418796|FG013|Phase 2|Physician Decision|0|||
145974595|NCT03314935|526418797|FG014|Phase 2|Physician Decision|0|||
145974596|NCT01910441|526418798|FG000|Overall Study|Sponsor decision|0|||
145974597|NCT01910441|526418799|FG001|Overall Study|Sponsor decision|2|||
145974598|NCT01910441|526418798|FG000|Overall Study|Lost to Follow-up|6|||
145974599|NCT01910441|526418799|FG001|Overall Study|Lost to Follow-up|5|||
145974600|NCT01910441|526418798|FG000|Overall Study|Withdrawal by Subject|0|||
145974601|NCT01910441|526418799|FG001|Overall Study|Withdrawal by Subject|1|||
145974602|NCT01910441|526418798|FG000|Overall Study|Non-compliance|0|||
145974603|NCT01910441|526418799|FG001|Overall Study|Non-compliance|1|||
145974604|NCT01910441|526418798|FG000|Overall Study|Adverse Event|1|||
145974605|NCT01910441|526418799|FG001|Overall Study|Adverse Event|0|||
145974606|NCT01910441|526418798|FG000|Overall Study|Physician Decision|0|||
145974607|NCT01910441|526418799|FG001|Overall Study|Physician Decision|1|||
145974608|NCT04958707|526418800|FG000|Post Intervention|Withdrawal by Subject|1|||
145974609|NCT04958707|526418801|FG001|Post Intervention|Withdrawal by Subject|0|||
145974610|NCT04958707|526418802|FG002|Post Intervention|Withdrawal by Subject|0|||
145974611|NCT04958707|526418800|FG000|3 Months Follow- up|Lost to Follow-up|0|||
145974612|NCT04958707|526418801|FG001|3 Months Follow- up|Lost to Follow-up|3|||
145919140|NCT00413699|526212130|FG000|Initial Period|Death|25|||
145919141|NCT00413699|526212131|FG001|Initial Period|Death|30|||
145919142|NCT00413699|526212132|FG002|Initial Period|Death|0|||
145919143|NCT00413699|526212130|FG000|Initial Period|Lack of Efficacy|59|||
145919144|NCT00413699|526212131|FG001|Initial Period|Lack of Efficacy|115|||
145919145|NCT00413699|526212132|FG002|Initial Period|Lack of Efficacy|0|||
145919146|NCT00413699|526212130|FG000|Initial Period|Lost to Follow-up|31|||
145919147|NCT00413699|526212131|FG001|Initial Period|Lost to Follow-up|101|||
145974613|NCT04958707|526418802|FG002|3 Months Follow- up|Lost to Follow-up|0|||
145974614|NCT04958707|526418800|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
145974615|NCT04958707|526418801|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
146240633|NCT03683030|527394988|FG001|Overall Study|Death|2|||
145974616|NCT04958707|526418802|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
145974617|NCT04279522|526418803|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
145974618|NCT04279522|526418804|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
145974619|NCT04279522|526418803|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
145974620|NCT04279522|526418804|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
145974621|NCT04279522|526418803|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
145919148|NCT00413699|526212132|FG002|Initial Period|Lost to Follow-up|0|||
145919149|NCT00413699|526212130|FG000|Initial Period|Protocol Violation|38|||
145919150|NCT00413699|526212131|FG001|Initial Period|Protocol Violation|89|||
145919151|NCT00413699|526212132|FG002|Initial Period|Protocol Violation|0|||
145919152|NCT00413699|526212130|FG000|Initial Period|Pregnancy|10|||
145919153|NCT00413699|526212131|FG001|Initial Period|Pregnancy|8|||
145919154|NCT00413699|526212132|FG002|Initial Period|Pregnancy|0|||
145919155|NCT00413699|526212130|FG000|Initial Period|Did not meet entrance criteria|2|||
145919156|NCT00413699|526212131|FG001|Initial Period|Did not meet entrance criteria|2|||
145919157|NCT00413699|526212132|FG002|Initial Period|Did not meet entrance criteria|0|||
145919158|NCT00413699|526212130|FG000|Initial Period|Medication error without adverse event|0|||
145919159|NCT00413699|526212131|FG001|Initial Period|Medication error without adverse event|1|||
145919160|NCT00413699|526212132|FG002|Initial Period|Medication error without adverse event|0|||
145919161|NCT00413699|526212130|FG000|Initial Period|Study terminated by Sponsor|0|||
145919162|NCT00413699|526212131|FG001|Initial Period|Study terminated by Sponsor|1|||
145919163|NCT00413699|526212132|FG002|Initial Period|Study terminated by Sponsor|0|||
145919164|NCT00413699|526212130|FG000|Initial Period|Other|67|||
145919165|NCT00413699|526212131|FG001|Initial Period|Other|211|||
145919166|NCT00413699|526212132|FG002|Initial Period|Other|0|||
145919167|NCT00413699|526212130|FG000|Initial Period|Adverse event related to study drug|178|||
145919168|NCT00413699|526212131|FG001|Initial Period|Adverse event related to study drug|527|||
145919169|NCT00413699|526212132|FG002|Initial Period|Adverse event related to study drug|0|||
145919170|NCT00413699|526212130|FG000|Initial Period|Adverse event not related to study drug|113|||
145919171|NCT00413699|526212131|FG001|Initial Period|Adverse event not related to study drug|248|||
145919172|NCT00413699|526212132|FG002|Initial Period|Adverse event not related to study drug|0|||
145919173|NCT00413699|526212130|FG000|Initial Period|Missing end of study page|0|||
145919174|NCT00413699|526212131|FG001|Initial Period|Missing end of study page|4|||
145919175|NCT00413699|526212132|FG002|Initial Period|Missing end of study page|0|||
145919176|NCT00413699|526212130|FG000|Initial Period|No longer willing to participate|116|||
145919177|NCT00413699|526212131|FG001|Initial Period|No longer willing to participate|368|||
145919178|NCT00413699|526212132|FG002|Initial Period|No longer willing to participate|0|||
145919179|NCT00413699|526212130|FG000|Extension Period|No Longer Willing to Participate|0|||
145919180|NCT00413699|526212131|FG001|Extension Period|No Longer Willing to Participate|0|||
145919181|NCT00413699|526212132|FG002|Extension Period|No Longer Willing to Participate|2|||
145919182|NCT00413699|526212130|FG000|Extension Period|Protocol Violation|0|||
145919183|NCT00413699|526212131|FG001|Extension Period|Protocol Violation|0|||
145919184|NCT00413699|526212132|FG002|Extension Period|Protocol Violation|1|||
145919185|NCT00413699|526212130|FG000|Extension Period|Adverse Event|0|||
145919186|NCT00413699|526212131|FG001|Extension Period|Adverse Event|0|||
145919187|NCT00413699|526212132|FG002|Extension Period|Adverse Event|2|||
145919188|NCT03511105|526212134|FG000|Overall Study|Adverse Event|1|||
145919189|NCT03511105|526212135|FG001|Overall Study|Adverse Event|0|||
145919190|NCT03511105|526212134|FG000|Overall Study|Withdrew consent|1|||
145919191|NCT03511105|526212135|FG001|Overall Study|Withdrew consent|0|||
145919192|NCT00075816|526212136|FG000|Overall Study|Did not undergo transplantation|14|||
145919193|NCT00075816|526212137|FG001|Overall Study|Did not undergo transplantation|11|||
145919194|NCT02810457|526212138|FG000|Overall Study|Randomised but no treatment received|2|||
145919195|NCT02810457|526212139|FG001|Overall Study|Randomised but no treatment received|1|||
145919196|NCT02810457|526212138|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
145919197|NCT02810457|526212139|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
145919198|NCT02810457|526212138|FG000|Overall Study|Adverse Event|37|||
145919199|NCT02810457|526212139|FG001|Overall Study|Adverse Event|43|||
145919200|NCT02810457|526212138|FG000|Overall Study|Patient decision|31|||
145919201|NCT02810457|526212139|FG001|Overall Study|Patient decision|35|||
145919202|NCT02810457|526212138|FG000|Overall Study|Patient lost to follow-up|2|||
145919203|NCT02810457|526212139|FG001|Overall Study|Patient lost to follow-up|2|||
145919204|NCT02810457|526212138|FG000|Overall Study|Death|39|||
145919205|NCT02810457|526212139|FG001|Overall Study|Death|28|||
145919206|NCT02810457|526212138|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
145919207|NCT02810457|526212139|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
145919208|NCT02810457|526212138|FG000|Overall Study|Clinical progression|15|||
145919209|NCT02810457|526212139|FG001|Overall Study|Clinical progression|16|||
145919210|NCT02810457|526212138|FG000|Overall Study|Investigator decision|3|||
145919211|NCT02810457|526212139|FG001|Overall Study|Investigator decision|2|||
145919212|NCT02810457|526212138|FG000|Overall Study|Patient ineligibility|3|||
145919213|NCT02810457|526212139|FG001|Overall Study|Patient ineligibility|0|||
145919214|NCT02810457|526212138|FG000|Overall Study|Miscalculated PD|1|||
145919215|NCT02810457|526212139|FG001|Overall Study|Miscalculated PD|0|||
145919216|NCT02810457|526212138|FG000|Overall Study|Physician Decision|0|||
145919217|NCT02810457|526212139|FG001|Overall Study|Physician Decision|1|||
145919218|NCT01823328|526212140|FG000|Overall Study|Withdrawal by Subject|8|||
145919219|NCT01823328|526212141|FG001|Overall Study|Withdrawal by Subject|6|||
145919220|NCT01557504|526212142|FG000|Overall Study|Physician Decision|1|||
145919221|NCT01557504|526212143|FG001|Overall Study|Physician Decision|0|||
145919222|NCT02750618|526212146|FG000|Overall Study|Withdrawal by Subject|1|||
145974622|NCT04279522|526418804|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
145974623|NCT04279522|526418803|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
145974624|NCT04279522|526418804|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
145974625|NCT04279522|526418803|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
145974626|NCT04279522|526418804|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
145974627|NCT04279522|526418803|FG000|Period 2: Open Label Phase|Physician Decision|0|||
145974628|NCT04279522|526418804|FG001|Period 2: Open Label Phase|Physician Decision|3|||
145974629|NCT04279522|526418803|FG000|Period 2: Open Label Phase|Adverse Event|0|||
145919223|NCT02019472|526212149|FG000|Overall Study|Adverse Event|14|||
145919224|NCT02019472|526212150|FG001|Overall Study|Adverse Event|23|||
145919225|NCT02019472|526212151|FG002|Overall Study|Adverse Event|17|||
145919226|NCT02019472|526212149|FG000|Overall Study|Death|0|||
145919227|NCT02019472|526212150|FG001|Overall Study|Death|1|||
145919228|NCT02019472|526212151|FG002|Overall Study|Death|1|||
145919229|NCT02019472|526212149|FG000|Overall Study|Lack of Efficacy|7|||
145919230|NCT02019472|526212150|FG001|Overall Study|Lack of Efficacy|4|||
145919231|NCT02019472|526212151|FG002|Overall Study|Lack of Efficacy|4|||
145919232|NCT02019472|526212149|FG000|Overall Study|Lost to Follow-up|0|||
145919233|NCT02019472|526212150|FG001|Overall Study|Lost to Follow-up|2|||
145919234|NCT02019472|526212151|FG002|Overall Study|Lost to Follow-up|1|||
145919235|NCT02019472|526212149|FG000|Overall Study|Physician Decision|1|||
145919236|NCT02019472|526212150|FG001|Overall Study|Physician Decision|2|||
145919237|NCT02019472|526212151|FG002|Overall Study|Physician Decision|0|||
145919238|NCT02019472|526212149|FG000|Overall Study|Pregnancy|1|||
145919239|NCT02019472|526212150|FG001|Overall Study|Pregnancy|2|||
145919240|NCT02019472|526212151|FG002|Overall Study|Pregnancy|2|||
145919241|NCT02019472|526212149|FG000|Overall Study|Withdrawal by Subject|11|||
145919242|NCT02019472|526212150|FG001|Overall Study|Withdrawal by Subject|10|||
145919243|NCT02019472|526212151|FG002|Overall Study|Withdrawal by Subject|11|||
145919244|NCT02019472|526212149|FG000|Overall Study|Other|3|||
145919245|NCT02019472|526212150|FG001|Overall Study|Other|8|||
145919246|NCT02019472|526212151|FG002|Overall Study|Other|6|||
145919247|NCT00513695|526212152|FG000|Overall Study|Discontinued therapy|2|||
145974630|NCT04279522|526418804|FG001|Period 2: Open Label Phase|Adverse Event|1|||
145974631|NCT04279522|526418803|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
145974632|NCT04279522|526418804|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
145974633|NCT02629159|526418805|FG000|Overall Study|Adverse Event|17|||
145974634|NCT02629159|526418806|FG001|Overall Study|Adverse Event|20|||
145974635|NCT02629159|526418807|FG002|Overall Study|Adverse Event|22|||
145974636|NCT02629159|526418805|FG000|Overall Study|Withdrawal by Subject|22|||
145974637|NCT02629159|526418806|FG001|Overall Study|Withdrawal by Subject|11|||
145974638|NCT02629159|526418807|FG002|Overall Study|Withdrawal by Subject|15|||
145974639|NCT02629159|526418805|FG000|Overall Study|Lost to Follow-up|7|||
145974640|NCT02629159|526418806|FG001|Overall Study|Lost to Follow-up|4|||
145974641|NCT02629159|526418807|FG002|Overall Study|Lost to Follow-up|5|||
145974642|NCT02629159|526418805|FG000|Overall Study|Lack of Efficacy|4|||
145974643|NCT02629159|526418806|FG001|Overall Study|Lack of Efficacy|0|||
145974644|NCT02629159|526418807|FG002|Overall Study|Lack of Efficacy|1|||
145974645|NCT02629159|526418805|FG000|Overall Study|Other|6|||
145974646|NCT02629159|526418806|FG001|Overall Study|Other|4|||
145974647|NCT02629159|526418807|FG002|Overall Study|Other|8|||
145974648|NCT05523297|526418812|FG000|Overall Study|Death|7|||
145974649|NCT05523297|526418813|FG001|Overall Study|Death|8|||
145974650|NCT05523297|526418812|FG000|Overall Study|Lost to Follow-up|2|||
145974651|NCT05523297|526418813|FG001|Overall Study|Lost to Follow-up|1|||
145974652|NCT02401230|526418814|FG000|Overall Study|Adverse Event|3|||
145974653|NCT02401230|526418815|FG001|Overall Study|Adverse Event|2|||
145974654|NCT02401230|526418816|FG002|Overall Study|Adverse Event|0|||
145974655|NCT02401230|526418814|FG000|Overall Study|Withdrawal by Subject|2|||
145974656|NCT02401230|526418815|FG001|Overall Study|Withdrawal by Subject|1|||
145974657|NCT02401230|526418816|FG002|Overall Study|Withdrawal by Subject|1|||
145974658|NCT02401230|526418814|FG000|Overall Study|Lost to Follow-up|1|||
145919248|NCT00513695|526212152|FG000|Overall Study|Progression prior to surgery|3|||
145919249|NCT02157935|526212153|FG000|Overall Study|Withdrawal by Subject|25|||
145919250|NCT02157935|526212154|FG001|Overall Study|Withdrawal by Subject|39|||
145919251|NCT02157935|526212153|FG000|Overall Study|Screen failure|1|||
145974659|NCT02401230|526418815|FG001|Overall Study|Lost to Follow-up|3|||
145974660|NCT02401230|526418816|FG002|Overall Study|Lost to Follow-up|3|||
145974661|NCT00831844|526418817|FG000|Overall Study|Adverse Event|2|||
145919252|NCT02157935|526212154|FG001|Overall Study|Screen failure|2|||
145919253|NCT02157935|526212153|FG000|Overall Study|Protocol Violation|1|||
145919254|NCT02157935|526212154|FG001|Overall Study|Protocol Violation|0|||
145974662|NCT00831844|526418818|FG001|Overall Study|Adverse Event|0|||
145974663|NCT00831844|526418819|FG002|Overall Study|Adverse Event|0|||
145974664|NCT00831844|526418820|FG003|Overall Study|Adverse Event|0|||
145919255|NCT02157935|526212153|FG000|Overall Study|Progressive disease|0|||
145919256|NCT02157935|526212154|FG001|Overall Study|Progressive disease|2|||
145919257|NCT02157935|526212153|FG000|Overall Study|Other|5|||
145919258|NCT02157935|526212154|FG001|Overall Study|Other|12|||
145919259|NCT02157935|526212153|FG000|Overall Study|Lack of Efficacy|0|||
145919260|NCT02157935|526212154|FG001|Overall Study|Lack of Efficacy|1|||
145919261|NCT02157935|526212153|FG000|Overall Study|Death|4|||
145919262|NCT02157935|526212154|FG001|Overall Study|Death|4|||
145919263|NCT02157935|526212153|FG000|Overall Study|Adverse Event|3|||
145919264|NCT02157935|526212154|FG001|Overall Study|Adverse Event|5|||
145919265|NCT03192488|526212155|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
145919266|NCT03192488|526212156|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
145919267|NCT03192488|526212157|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
145919268|NCT03192488|526212158|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
145919269|NCT03192488|526212159|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
145919270|NCT03192488|526212160|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
145919271|NCT03192488|526212155|FG000|Third Intervention (d1)|Adverse Event|0|||
145919272|NCT03192488|526212156|FG001|Third Intervention (d1)|Adverse Event|0|||
145919273|NCT03192488|526212157|FG002|Third Intervention (d1)|Adverse Event|0|||
145919274|NCT03192488|526212158|FG003|Third Intervention (d1)|Adverse Event|0|||
145919275|NCT03192488|526212159|FG004|Third Intervention (d1)|Adverse Event|1|||
145919276|NCT03192488|526212160|FG005|Third Intervention (d1)|Adverse Event|0|||
145919277|NCT03588910|526212162|FG000|Overall Study|Withdrawal by Subject|1|||
145919278|NCT03588910|526212163|FG001|Overall Study|Withdrawal by Subject|0|||
145919279|NCT03588910|526212162|FG000|Overall Study|Allergy|2|||
145919280|NCT03588910|526212163|FG001|Overall Study|Allergy|0|||
145919281|NCT03588910|526212162|FG000|Overall Study|Protocol Violation|0|||
145919282|NCT03588910|526212163|FG001|Overall Study|Protocol Violation|3|||
145919283|NCT03588910|526212162|FG000|Overall Study|Did not complete Day 1 Survey|5|||
145919284|NCT03588910|526212163|FG001|Overall Study|Did not complete Day 1 Survey|10|||
145919285|NCT03588910|526212162|FG000|Overall Study|Did not complete Day 7 Survey|5|||
145919286|NCT03588910|526212163|FG001|Overall Study|Did not complete Day 7 Survey|2|||
145919287|NCT02547428|526212173|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
145919288|NCT02547428|526212174|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
145919289|NCT02547428|526212173|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
145919290|NCT02547428|526212174|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
145919291|NCT02547428|526212173|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
145919292|NCT02547428|526212174|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
145919293|NCT02547428|526212173|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
145919294|NCT02547428|526212174|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
145919295|NCT02547428|526212173|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
145919296|NCT02547428|526212174|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
145919297|NCT02547428|526212173|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
145919298|NCT02547428|526212174|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
145919299|NCT02547428|526212173|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
145919300|NCT02547428|526212174|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
145919301|NCT02547428|526212173|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
145919302|NCT02547428|526212174|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
145919303|NCT01173523|526212175|FG000|Overall Study|Clinical Progression|1|||
145919304|NCT01173523|526212176|FG001|Overall Study|Clinical Progression|1|||
145919305|NCT01173523|526212175|FG000|Overall Study|Progressive Disease|10|||
145919306|NCT01173523|526212176|FG001|Overall Study|Progressive Disease|8|||
145919307|NCT01173523|526212175|FG000|Overall Study|Other|2|||
145919308|NCT01173523|526212176|FG001|Overall Study|Other|3|||
145919309|NCT02302833|526212181|FG000|Overall Study|Lost to Follow-up|3|||
145919310|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
145919311|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
145919312|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145919313|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145919314|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145919315|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145919316|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
145919317|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
145919318|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
145919319|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
145919320|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
145919321|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
145919322|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
145919323|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
145919324|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
145919325|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145919326|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145919327|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145919328|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
145974665|NCT00831844|526418821|FG004|Overall Study|Adverse Event|1|||
145919329|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
145919330|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
145919331|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145919332|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145919333|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145919334|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
145919335|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
145919336|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
145919337|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145919338|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145919339|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145919340|NCT04429503|526212182|FG000|Main Study (Up to Wk 96)|Death|9|||
145919341|NCT04429503|526212183|FG001|Main Study (Up to Wk 96)|Death|18|||
145919342|NCT04429503|526212184|FG002|Main Study (Up to Wk 96)|Death|5|||
145919343|NCT04429503|526212185|FG003|Main Study (Up to Wk 96)|Death|0|||
145919344|NCT04429503|526212186|FG004|Main Study (Up to Wk 96)|Death|0|||
145919345|NCT04429503|526212187|FG005|Main Study (Up to Wk 96)|Death|0|||
145919346|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145919347|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145919348|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145919349|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
145919350|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145919351|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145919352|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145919353|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145919354|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145919355|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145919356|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145919357|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145919358|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145919359|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145919360|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145919361|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145919362|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
145919363|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
145919364|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145919365|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145919366|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145919367|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
145919368|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
145919369|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
145919370|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145919371|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145919372|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145919373|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
145919374|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
145919375|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
145919376|NCT04429503|526212182|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145919377|NCT04429503|526212183|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145919378|NCT04429503|526212184|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145919379|NCT04429503|526212185|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
145919380|NCT04429503|526212186|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
145919381|NCT04429503|526212187|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
145919382|NCT05516108|526212188|FG000|Overall Study|Time Commitment|3|||
145919383|NCT05516108|526212189|FG001|Overall Study|Time Commitment|1|||
145919384|NCT05516108|526212188|FG000|Overall Study|Reason Unknown|2|||
145919385|NCT05516108|526212189|FG001|Overall Study|Reason Unknown|4|||
145919386|NCT02717507|526212194|FG000|Overall Study|Lost to Follow-up|5|||
145974666|NCT00831844|526418822|FG005|Overall Study|Adverse Event|1|||
145974667|NCT00831844|526418823|FG006|Overall Study|Adverse Event|2|||
145974668|NCT00831844|526418824|FG007|Overall Study|Adverse Event|0|||
145974669|NCT00831844|526418825|FG008|Overall Study|Adverse Event|0|||
145974670|NCT00831844|526418826|FG009|Overall Study|Adverse Event|0|||
145974671|NCT00831844|526418817|FG000|Overall Study|Death|0|||
145974672|NCT00831844|526418818|FG001|Overall Study|Death|0|||
145974673|NCT00831844|526418819|FG002|Overall Study|Death|0|||
145974674|NCT00831844|526418820|FG003|Overall Study|Death|1|||
145974675|NCT00831844|526418821|FG004|Overall Study|Death|0|||
145974676|NCT00831844|526418822|FG005|Overall Study|Death|0|||
145974677|NCT00831844|526418823|FG006|Overall Study|Death|0|||
145974678|NCT00831844|526418824|FG007|Overall Study|Death|0|||
145974679|NCT00831844|526418825|FG008|Overall Study|Death|0|||
146297604|NCT04427501|527604740|FG008|Overall Study|Other - as reported by the investigator|0|||
146297605|NCT04427501|527604741|FG009|Overall Study|Other - as reported by the investigator|0|||
146297606|NCT04427501|527604742|FG010|Overall Study|Other - as reported by the investigator|0|||
146297607|NCT04427501|527604743|FG011|Overall Study|Other - as reported by the investigator|0|||
145974680|NCT00831844|526418826|FG009|Overall Study|Death|0|||
145974681|NCT00831844|526418817|FG000|Overall Study|Lack of Efficacy|8|||
145974682|NCT00831844|526418818|FG001|Overall Study|Lack of Efficacy|10|||
145974683|NCT00831844|526418819|FG002|Overall Study|Lack of Efficacy|15|||
145974684|NCT00831844|526418820|FG003|Overall Study|Lack of Efficacy|8|||
145974685|NCT00831844|526418821|FG004|Overall Study|Lack of Efficacy|11|||
145974686|NCT00831844|526418822|FG005|Overall Study|Lack of Efficacy|17|||
145974687|NCT00831844|526418823|FG006|Overall Study|Lack of Efficacy|8|||
145974688|NCT00831844|526418824|FG007|Overall Study|Lack of Efficacy|9|||
145974689|NCT00831844|526418825|FG008|Overall Study|Lack of Efficacy|7|||
145974690|NCT00831844|526418826|FG009|Overall Study|Lack of Efficacy|0|||
145974691|NCT00831844|526418817|FG000|Overall Study|Physician Decision|0|||
145974692|NCT00831844|526418818|FG001|Overall Study|Physician Decision|1|||
145974693|NCT00831844|526418819|FG002|Overall Study|Physician Decision|3|||
145974694|NCT00831844|526418820|FG003|Overall Study|Physician Decision|1|||
145974695|NCT00831844|526418821|FG004|Overall Study|Physician Decision|1|||
145974696|NCT00831844|526418822|FG005|Overall Study|Physician Decision|1|||
145974697|NCT00831844|526418823|FG006|Overall Study|Physician Decision|0|||
145974698|NCT00831844|526418824|FG007|Overall Study|Physician Decision|0|||
145974699|NCT00831844|526418825|FG008|Overall Study|Physician Decision|1|||
145974700|NCT00831844|526418826|FG009|Overall Study|Physician Decision|0|||
145974701|NCT00831844|526418817|FG000|Overall Study|Withdrawal by Subject|0|||
145974702|NCT00831844|526418818|FG001|Overall Study|Withdrawal by Subject|0|||
145974703|NCT00831844|526418819|FG002|Overall Study|Withdrawal by Subject|1|||
145974704|NCT00831844|526418820|FG003|Overall Study|Withdrawal by Subject|0|||
145974705|NCT00831844|526418821|FG004|Overall Study|Withdrawal by Subject|0|||
145974706|NCT00831844|526418822|FG005|Overall Study|Withdrawal by Subject|0|||
145974707|NCT00831844|526418823|FG006|Overall Study|Withdrawal by Subject|0|||
145974708|NCT00831844|526418824|FG007|Overall Study|Withdrawal by Subject|1|||
145974709|NCT00831844|526418825|FG008|Overall Study|Withdrawal by Subject|1|||
145974710|NCT00831844|526418826|FG009|Overall Study|Withdrawal by Subject|0|||
145974711|NCT00831844|526418817|FG000|Overall Study|Ineligible|0|||
145974712|NCT00831844|526418818|FG001|Overall Study|Ineligible|1|||
145974713|NCT00831844|526418819|FG002|Overall Study|Ineligible|1|||
145974714|NCT00831844|526418820|FG003|Overall Study|Ineligible|0|||
145974715|NCT00831844|526418821|FG004|Overall Study|Ineligible|1|||
146297608|NCT04427501|527604732|FG000|Overall Study|Other|0|||
146297609|NCT04427501|527604733|FG001|Overall Study|Other|0|||
146297610|NCT04427501|527604734|FG002|Overall Study|Other|0|||
146297611|NCT04427501|527604735|FG003|Overall Study|Other|0|||
145974716|NCT00831844|526418822|FG005|Overall Study|Ineligible|0|||
145974717|NCT00831844|526418823|FG006|Overall Study|Ineligible|0|||
145974718|NCT00831844|526418824|FG007|Overall Study|Ineligible|0|||
145974719|NCT00831844|526418825|FG008|Overall Study|Ineligible|0|||
145974720|NCT00831844|526418826|FG009|Overall Study|Ineligible|0|||
145974721|NCT00830765|526418829|FG000|Overall Study|Protocol Violation|3|||
145974722|NCT00830765|526418830|FG001|Overall Study|Protocol Violation|2|||
145974723|NCT00315445|526418831|FG000|Overall Study|Adverse Event|7|||
145974724|NCT00315445|526418832|FG001|Overall Study|Adverse Event|12|||
145974725|NCT00315445|526418833|FG002|Overall Study|Adverse Event|15|||
145974726|NCT00315445|526418831|FG000|Overall Study|Lack of Efficacy|16|||
145974727|NCT00315445|526418832|FG001|Overall Study|Lack of Efficacy|1|||
145974728|NCT00315445|526418833|FG002|Overall Study|Lack of Efficacy|7|||
145974729|NCT00315445|526418831|FG000|Overall Study|Lost to Follow-up|1|||
145974730|NCT00315445|526418832|FG001|Overall Study|Lost to Follow-up|0|||
145974731|NCT00315445|526418833|FG002|Overall Study|Lost to Follow-up|1|||
145974732|NCT00315445|526418831|FG000|Overall Study|Protocol Violation|2|||
145974733|NCT00315445|526418832|FG001|Overall Study|Protocol Violation|0|||
145974734|NCT00315445|526418833|FG002|Overall Study|Protocol Violation|1|||
145974735|NCT00315445|526418831|FG000|Overall Study|Other|1|||
145974736|NCT00315445|526418832|FG001|Overall Study|Other|3|||
145974737|NCT00315445|526418833|FG002|Overall Study|Other|0|||
145974738|NCT01299909|526418834|FG000|Overall Study|Lost to Follow-up|22|||
146240634|NCT03683030|527394987|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
146240635|NCT03683030|527394988|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
146240636|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
146240637|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
146240638|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
146240639|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
146240640|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
146240641|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
146240642|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
146297612|NCT04427501|527604736|FG004|Overall Study|Other|0|||
146297613|NCT04427501|527604737|FG005|Overall Study|Other|0|||
145974739|NCT01299909|526418835|FG001|Overall Study|Lost to Follow-up|18|||
145974740|NCT01299909|526418836|FG002|Overall Study|Lost to Follow-up|17|||
145974741|NCT01192178|526418837|FG000|Overall Study|Withdrawal by Subject|6|||
145974742|NCT01192178|526418838|FG001|Overall Study|Withdrawal by Subject|10|||
145974743|NCT01192178|526418837|FG000|Overall Study|Protocol Violation|10|||
145974744|NCT01192178|526418838|FG001|Overall Study|Protocol Violation|3|||
145974745|NCT01192178|526418837|FG000|Overall Study|Physician Decision|2|||
145974746|NCT01192178|526418838|FG001|Overall Study|Physician Decision|4|||
145974747|NCT01192178|526418837|FG000|Overall Study|Lost to Follow-up|3|||
145974748|NCT01192178|526418838|FG001|Overall Study|Lost to Follow-up|3|||
146240643|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
146240644|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
146240645|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
145919387|NCT02717507|526212195|FG001|Overall Study|Lost to Follow-up|8|||
145919388|NCT02717507|526212194|FG000|Overall Study|Pregnancy|1|||
145919389|NCT02717507|526212195|FG001|Overall Study|Pregnancy|1|||
145919390|NCT02717507|526212194|FG000|Overall Study|Protocol Violation|2|||
145919391|NCT02717507|526212195|FG001|Overall Study|Protocol Violation|2|||
145919392|NCT02717507|526212194|FG000|Overall Study|Withdrawal by Subject|20|||
145919393|NCT02717507|526212195|FG001|Overall Study|Withdrawal by Subject|20|||
145919394|NCT02717507|526212194|FG000|Overall Study|Relapse|1|||
145919395|NCT02717507|526212195|FG001|Overall Study|Relapse|1|||
145919396|NCT02717507|526212194|FG000|Overall Study|Cardiac Event|2|||
145919397|NCT02717507|526212195|FG001|Overall Study|Cardiac Event|6|||
145919398|NCT05017246|526212196|FG000|Overall Study|Withdrawal by Subject|5|||
145919399|NCT05017246|526212197|FG001|Overall Study|Withdrawal by Subject|3|||
145919400|NCT05017246|526212196|FG000|Overall Study|Determined to be ineligible|0|||
145919401|NCT05017246|526212197|FG001|Overall Study|Determined to be ineligible|1|||
145919402|NCT05017246|526212196|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
145919403|NCT05017246|526212197|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
145919404|NCT05017246|526212196|FG000|Overall Study|Technical failure|1|||
145919405|NCT05017246|526212197|FG001|Overall Study|Technical failure|3|||
145919406|NCT01866826|526212198|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
145919407|NCT01866826|526212199|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
145919408|NCT01866826|526212198|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
145919409|NCT01866826|526212199|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
145919410|NCT01866826|526212198|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
145919411|NCT01866826|526212199|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
145919412|NCT00709995|526212201|FG000|Overall Study|Adverse Event|4|||
145919413|NCT00709995|526212202|FG001|Overall Study|Adverse Event|2|||
145919414|NCT00709995|526212201|FG000|Overall Study|Withdrawal by Subject|1|||
145919415|NCT00709995|526212202|FG001|Overall Study|Withdrawal by Subject|3|||
145919416|NCT00638508|526212206|FG000|Overall Study|Physician Decision|5|||
145919417|NCT00638508|526212207|FG001|Overall Study|Physician Decision|2|||
145919418|NCT00485264|526212208|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
145919419|NCT00485264|526212209|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
145919420|NCT00485264|526212210|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
145919421|NCT00485264|526212211|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
145919422|NCT00485264|526212212|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
145919423|NCT00485264|526212213|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
145919424|NCT00485264|526212208|FG000|Overall Study|Death|1|||
145919425|NCT00485264|526212209|FG001|Overall Study|Death|0|||
145919426|NCT00485264|526212210|FG002|Overall Study|Death|0|||
145919427|NCT00485264|526212211|FG003|Overall Study|Death|0|||
145919428|NCT00485264|526212212|FG004|Overall Study|Death|1|||
145919429|NCT00485264|526212213|FG005|Overall Study|Death|0|||
145974749|NCT01192178|526418837|FG000|Overall Study|Adverse Event|2|||
146240646|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
145919430|NCT00485264|526212208|FG000|Overall Study|Adverse Event|1|||
145919431|NCT00485264|526212209|FG001|Overall Study|Adverse Event|0|||
146240647|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
146240648|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
146240649|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
146297614|NCT04427501|527604738|FG006|Overall Study|Other|0|||
145919432|NCT00485264|526212210|FG002|Overall Study|Adverse Event|2|||
145919433|NCT00485264|526212211|FG003|Overall Study|Adverse Event|3|||
145919434|NCT00485264|526212212|FG004|Overall Study|Adverse Event|1|||
145919435|NCT00485264|526212213|FG005|Overall Study|Adverse Event|3|||
145919436|NCT00485264|526212208|FG000|Overall Study|Pregnancy|4|||
145919437|NCT00485264|526212209|FG001|Overall Study|Pregnancy|0|||
145919438|NCT00485264|526212210|FG002|Overall Study|Pregnancy|0|||
145919439|NCT00485264|526212211|FG003|Overall Study|Pregnancy|0|||
145919440|NCT00485264|526212212|FG004|Overall Study|Pregnancy|0|||
145919441|NCT00485264|526212213|FG005|Overall Study|Pregnancy|0|||
145919442|NCT00485264|526212208|FG000|Overall Study|Disallowed Medication|0|||
145919443|NCT00485264|526212209|FG001|Overall Study|Disallowed Medication|0|||
145974750|NCT01192178|526418838|FG001|Overall Study|Adverse Event|1|||
145919444|NCT00485264|526212210|FG002|Overall Study|Disallowed Medication|0|||
145919445|NCT00485264|526212211|FG003|Overall Study|Disallowed Medication|0|||
145919446|NCT00485264|526212212|FG004|Overall Study|Disallowed Medication|0|||
145919447|NCT00485264|526212213|FG005|Overall Study|Disallowed Medication|1|||
145919448|NCT00485264|526212208|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
145919449|NCT00485264|526212209|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
145919450|NCT00485264|526212210|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
145919451|NCT00485264|526212211|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
145919452|NCT00485264|526212212|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
145919453|NCT00485264|526212213|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
145919454|NCT00485264|526212208|FG000|Overall Study|Lack of Efficacy|0|||
145919455|NCT00485264|526212209|FG001|Overall Study|Lack of Efficacy|1|||
145919456|NCT00485264|526212210|FG002|Overall Study|Lack of Efficacy|0|||
145919457|NCT00485264|526212211|FG003|Overall Study|Lack of Efficacy|0|||
145919458|NCT00485264|526212212|FG004|Overall Study|Lack of Efficacy|0|||
145919459|NCT00485264|526212213|FG005|Overall Study|Lack of Efficacy|0|||
145919460|NCT00485264|526212208|FG000|Overall Study|Guardian Consent Withdrawn|1|||
145919461|NCT00485264|526212209|FG001|Overall Study|Guardian Consent Withdrawn|0|||
145919462|NCT00485264|526212210|FG002|Overall Study|Guardian Consent Withdrawn|0|||
145919463|NCT00485264|526212211|FG003|Overall Study|Guardian Consent Withdrawn|0|||
145919464|NCT00485264|526212212|FG004|Overall Study|Guardian Consent Withdrawn|1|||
145919465|NCT00485264|526212213|FG005|Overall Study|Guardian Consent Withdrawn|0|||
145919466|NCT00485264|526212208|FG000|Overall Study|Physician Decision|0|||
145919467|NCT00485264|526212209|FG001|Overall Study|Physician Decision|2|||
145919468|NCT00485264|526212210|FG002|Overall Study|Physician Decision|0|||
145919469|NCT00485264|526212211|FG003|Overall Study|Physician Decision|0|||
145919470|NCT00485264|526212212|FG004|Overall Study|Physician Decision|0|||
145919471|NCT00485264|526212213|FG005|Overall Study|Physician Decision|0|||
145919472|NCT00485264|526212208|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145919473|NCT00485264|526212209|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145919474|NCT00485264|526212210|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
145919475|NCT00485264|526212211|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145919476|NCT00485264|526212212|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145919477|NCT00485264|526212213|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145919478|NCT00485264|526212208|FG000|Overall Study|Not Able to Attend Clinic|5|||
145919479|NCT00485264|526212209|FG001|Overall Study|Not Able to Attend Clinic|0|||
145919480|NCT00485264|526212210|FG002|Overall Study|Not Able to Attend Clinic|0|||
145919481|NCT00485264|526212211|FG003|Overall Study|Not Able to Attend Clinic|1|||
145919482|NCT00485264|526212212|FG004|Overall Study|Not Able to Attend Clinic|1|||
145919483|NCT00485264|526212213|FG005|Overall Study|Not Able to Attend Clinic|2|||
145919484|NCT00485264|526212208|FG000|Overall Study|Non-Compliant|17|||
145919485|NCT00485264|526212209|FG001|Overall Study|Non-Compliant|2|||
145919486|NCT00485264|526212210|FG002|Overall Study|Non-Compliant|1|||
145919487|NCT00485264|526212211|FG003|Overall Study|Non-Compliant|0|||
145919488|NCT00485264|526212212|FG004|Overall Study|Non-Compliant|1|||
145919489|NCT00485264|526212213|FG005|Overall Study|Non-Compliant|0|||
145919490|NCT00485264|526212208|FG000|Overall Study|Lost to Follow-up|2|||
145919491|NCT00485264|526212209|FG001|Overall Study|Lost to Follow-up|1|||
145919492|NCT00485264|526212210|FG002|Overall Study|Lost to Follow-up|1|||
145919493|NCT00485264|526212211|FG003|Overall Study|Lost to Follow-up|0|||
145919494|NCT00485264|526212212|FG004|Overall Study|Lost to Follow-up|0|||
145919495|NCT00485264|526212213|FG005|Overall Study|Lost to Follow-up|1|||
145919496|NCT00485264|526212208|FG000|Overall Study|Other Reason|3|||
145919497|NCT00485264|526212209|FG001|Overall Study|Other Reason|0|||
145919498|NCT00485264|526212210|FG002|Overall Study|Other Reason|0|||
145919499|NCT00485264|526212211|FG003|Overall Study|Other Reason|0|||
145919500|NCT00485264|526212212|FG004|Overall Study|Other Reason|0|||
145919501|NCT00485264|526212213|FG005|Overall Study|Other Reason|0|||
145919502|NCT01514461|526212214|FG000|Overall Study|Adverse Event|2|||
145919503|NCT01514461|526212215|FG001|Overall Study|Adverse Event|1|||
145919504|NCT01514461|526212216|FG002|Overall Study|Adverse Event|3|||
145919505|NCT01514461|526212214|FG000|Overall Study|Physician Decision|1|||
145919506|NCT01514461|526212215|FG001|Overall Study|Physician Decision|1|||
145919507|NCT01514461|526212216|FG002|Overall Study|Physician Decision|0|||
145919508|NCT01514461|526212214|FG000|Overall Study|Patient/guardian decision|1|||
145919509|NCT01514461|526212215|FG001|Overall Study|Patient/guardian decision|1|||
145919510|NCT01514461|526212216|FG002|Overall Study|Patient/guardian decision|1|||
145919511|NCT01514461|526212214|FG000|Overall Study|Death|1|||
145919512|NCT01514461|526212215|FG001|Overall Study|Death|0|||
145919513|NCT01514461|526212216|FG002|Overall Study|Death|0|||
145919514|NCT00654095|526212217|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
145919515|NCT00654095|526212217|FG000|Overall Study|Elevated triglyceride level (2)|1|||
145919516|NCT00654095|526212217|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
145919517|NCT00654095|526212217|FG000|Overall Study|Adverse Event|11|||
145919518|NCT00654095|526212217|FG000|Overall Study|Withdrawal by Subject|5|||
145919519|NCT00654095|526212217|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
145919520|NCT00654095|526212217|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
146240650|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
146240651|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
146240652|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
146240653|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
146240654|NCT02222493|527394991|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
146240655|NCT02222493|527394992|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
146240656|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
146240657|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
146240658|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
146240659|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
145919521|NCT00654095|526212217|FG000|Overall Study|Did not meet inclusion criteria|1|||
145919522|NCT00324987|526212223|FG000|Overall Study|Adverse Event|2|||
145919523|NCT00324987|526212224|FG001|Overall Study|Adverse Event|1|||
145919524|NCT00324987|526212223|FG000|Overall Study|Withdrawal by Subject|1|||
145919525|NCT00324987|526212224|FG001|Overall Study|Withdrawal by Subject|1|||
145919526|NCT00324987|526212223|FG000|Overall Study|Progression|1|||
145919527|NCT00324987|526212224|FG001|Overall Study|Progression|1|||
145919528|NCT00324987|526212223|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
145919529|NCT00324987|526212224|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
145919530|NCT02392481|526212225|FG000|Overall Study|Adverse Event|0|||
145919531|NCT02392481|526212226|FG001|Overall Study|Adverse Event|0|||
145919532|NCT02392481|526212227|FG002|Overall Study|Adverse Event|1|||
145919533|NCT02392481|526212228|FG003|Overall Study|Adverse Event|2|||
145919534|NCT02392481|526212225|FG000|Overall Study|Withdrawal by Subject|0|||
145919535|NCT02392481|526212226|FG001|Overall Study|Withdrawal by Subject|0|||
145919536|NCT02392481|526212227|FG002|Overall Study|Withdrawal by Subject|1|||
145919537|NCT02392481|526212228|FG003|Overall Study|Withdrawal by Subject|0|||
145919538|NCT02548832|526212230|FG000|Overall Study|Lost to Follow-up|2|||
145919539|NCT02548832|526212231|FG001|Overall Study|Lost to Follow-up|2|||
145919540|NCT02548832|526212232|FG002|Overall Study|Lost to Follow-up|2|||
145919541|NCT02222922|526212233|FG000|Overall Study|Death|0|||
145919542|NCT02222922|526212234|FG001|Overall Study|Death|0|||
145919543|NCT02222922|526212235|FG002|Overall Study|Death|0|||
145919544|NCT02222922|526212236|FG003|Overall Study|Death|0|||
145919545|NCT02222922|526212237|FG004|Overall Study|Death|13|||
145919546|NCT02222922|526212238|FG005|Overall Study|Death|0|||
145919547|NCT02222922|526212239|FG006|Overall Study|Death|0|||
145919548|NCT02222922|526212240|FG007|Overall Study|Death|0|||
145919549|NCT02222922|526212241|FG008|Overall Study|Death|2|||
145919550|NCT02222922|526212233|FG000|Overall Study|Lost to Follow-up|0|||
145919551|NCT02222922|526212234|FG001|Overall Study|Lost to Follow-up|0|||
145919552|NCT02222922|526212235|FG002|Overall Study|Lost to Follow-up|1|||
145919553|NCT02222922|526212236|FG003|Overall Study|Lost to Follow-up|0|||
145919554|NCT02222922|526212237|FG004|Overall Study|Lost to Follow-up|9|||
145919555|NCT02222922|526212238|FG005|Overall Study|Lost to Follow-up|1|||
145919556|NCT02222922|526212239|FG006|Overall Study|Lost to Follow-up|0|||
145919557|NCT02222922|526212240|FG007|Overall Study|Lost to Follow-up|0|||
145974751|NCT01192178|526418837|FG000|Overall Study|Lack of Efficacy|1|||
145974752|NCT01192178|526418838|FG001|Overall Study|Lack of Efficacy|2|||
145974753|NCT02460289|526418839|FG000|Overall Study|Adverse Event|1|||
145974754|NCT02460289|526418839|FG000|Overall Study|Withdrawal by Subject|8|||
145974755|NCT02460289|526418839|FG000|Overall Study|Lost to Follow-up|1|||
145974756|NCT02164916|526418840|FG000|Overall Study|Adverse Event|3|||
145974757|NCT02164916|526418841|FG001|Overall Study|Adverse Event|8|||
146240660|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
145919558|NCT02222922|526212241|FG008|Overall Study|Lost to Follow-up|0|||
145919559|NCT02222922|526212233|FG000|Overall Study|Other|0|||
145919560|NCT02222922|526212234|FG001|Overall Study|Other|0|||
145919561|NCT02222922|526212235|FG002|Overall Study|Other|0|||
145919562|NCT02222922|526212236|FG003|Overall Study|Other|2|||
145919563|NCT02222922|526212237|FG004|Overall Study|Other|10|||
145974758|NCT02164916|526418840|FG000|Overall Study|Death|1|||
145974759|NCT02164916|526418841|FG001|Overall Study|Death|1|||
145974760|NCT02164916|526418840|FG000|Overall Study|Refusal unrelated to adverse event|3|||
145974761|NCT02164916|526418841|FG001|Overall Study|Refusal unrelated to adverse event|7|||
145974762|NCT02164916|526418840|FG000|Overall Study|Progression|37|||
146297615|NCT04427501|527604739|FG007|Overall Study|Other|0|||
145974763|NCT02164916|526418841|FG001|Overall Study|Progression|26|||
145919564|NCT02222922|526212238|FG005|Overall Study|Other|2|||
145919565|NCT02222922|526212239|FG006|Overall Study|Other|2|||
145919566|NCT02222922|526212240|FG007|Overall Study|Other|4|||
145919567|NCT02222922|526212241|FG008|Overall Study|Other|1|||
145919568|NCT02222922|526212233|FG000|Overall Study|Participant refused further follow-up|1|||
145919569|NCT02222922|526212234|FG001|Overall Study|Participant refused further follow-up|0|||
145919570|NCT02222922|526212235|FG002|Overall Study|Participant refused further follow-up|0|||
145919571|NCT02222922|526212236|FG003|Overall Study|Participant refused further follow-up|1|||
145919572|NCT02222922|526212237|FG004|Overall Study|Participant refused further follow-up|6|||
145974764|NCT02164916|526418840|FG000|Overall Study|Not protocol specified|5|||
145919573|NCT02222922|526212238|FG005|Overall Study|Participant refused further follow-up|0|||
145919574|NCT02222922|526212239|FG006|Overall Study|Participant refused further follow-up|0|||
145919575|NCT02222922|526212240|FG007|Overall Study|Participant refused further follow-up|0|||
145919576|NCT02222922|526212241|FG008|Overall Study|Participant refused further follow-up|3|||
145919577|NCT01254643|526212242|FG000|Overall Study|Withdrawal by Subject|1|||
145919578|NCT03817125|526212244|FG000|Overall Study|Adverse Event|1|||
145919579|NCT03817125|526212245|FG001|Overall Study|Adverse Event|0|||
145919580|NCT03817125|526212244|FG000|Overall Study|Physician Decision|0|||
145919581|NCT03817125|526212245|FG001|Overall Study|Physician Decision|1|||
145919582|NCT03817125|526212244|FG000|Overall Study|Lack of Efficacy|1|||
145919583|NCT03817125|526212245|FG001|Overall Study|Lack of Efficacy|5|||
145919584|NCT02002221|526212246|FG000|Overall Study|Adverse Event|2|||
145919585|NCT02002221|526212247|FG001|Overall Study|Adverse Event|1|||
145919586|NCT02002221|526212246|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145919587|NCT02002221|526212247|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145919588|NCT02002221|526212246|FG000|Overall Study|Patient withdrew consent|0|||
145919589|NCT02002221|526212247|FG001|Overall Study|Patient withdrew consent|1|||
145919590|NCT00942084|526212248|FG000|Overall Study|Death|2|||
145919591|NCT01998919|526212249|FG000|Overall Study|Death|2|||
145919592|NCT01998919|526212250|FG001|Overall Study|Death|2|||
145919593|NCT01998919|526212249|FG000|Overall Study|Adverse Event|0|||
145919594|NCT01998919|526212250|FG001|Overall Study|Adverse Event|5|||
145919595|NCT01998919|526212249|FG000|Overall Study|Disease progression|31|||
145919596|NCT01998919|526212250|FG001|Overall Study|Disease progression|22|||
145919597|NCT01998919|526212249|FG000|Overall Study|Withdrawal by Subject|2|||
145919598|NCT01998919|526212250|FG001|Overall Study|Withdrawal by Subject|4|||
145919599|NCT01998919|526212249|FG000|Overall Study|Lost to Follow-up|2|||
145919600|NCT01998919|526212250|FG001|Overall Study|Lost to Follow-up|0|||
145919601|NCT01998919|526212249|FG000|Overall Study|Other|5|||
145919602|NCT01998919|526212250|FG001|Overall Study|Other|2|||
145919603|NCT01068860|526212251|FG000|Overall Study|Withdrawal by Subject|0|||
145919604|NCT01068860|526212252|FG001|Overall Study|Withdrawal by Subject|0|||
145919605|NCT01068860|526212253|FG002|Overall Study|Withdrawal by Subject|0|||
145919606|NCT01068860|526212254|FG003|Overall Study|Withdrawal by Subject|0|||
145919607|NCT01068860|526212255|FG004|Overall Study|Withdrawal by Subject|0|||
145919608|NCT01068860|526212256|FG005|Overall Study|Withdrawal by Subject|2|||
145919609|NCT01068860|526212257|FG006|Overall Study|Withdrawal by Subject|0|||
145919610|NCT01068860|526212258|FG007|Overall Study|Withdrawal by Subject|0|||
145919611|NCT01068860|526212259|FG008|Overall Study|Withdrawal by Subject|0|||
145919612|NCT01068860|526212260|FG009|Overall Study|Withdrawal by Subject|3|||
145919613|NCT01068860|526212251|FG000|Overall Study|Administrative problems; misrandomized|0|||
145919614|NCT01068860|526212252|FG001|Overall Study|Administrative problems; misrandomized|0|||
145919615|NCT01068860|526212253|FG002|Overall Study|Administrative problems; misrandomized|0|||
145919616|NCT01068860|526212254|FG003|Overall Study|Administrative problems; misrandomized|1|||
145919617|NCT01068860|526212255|FG004|Overall Study|Administrative problems; misrandomized|0|||
145919618|NCT01068860|526212256|FG005|Overall Study|Administrative problems; misrandomized|0|||
145919619|NCT01068860|526212257|FG006|Overall Study|Administrative problems; misrandomized|0|||
145919620|NCT01068860|526212258|FG007|Overall Study|Administrative problems; misrandomized|0|||
145919621|NCT01068860|526212259|FG008|Overall Study|Administrative problems; misrandomized|0|||
145919622|NCT01068860|526212260|FG009|Overall Study|Administrative problems; misrandomized|1|||
145919623|NCT01068860|526212251|FG000|Overall Study|Lost to Follow-up|0|||
145919624|NCT01068860|526212252|FG001|Overall Study|Lost to Follow-up|1|||
145919625|NCT01068860|526212253|FG002|Overall Study|Lost to Follow-up|0|||
145919626|NCT01068860|526212254|FG003|Overall Study|Lost to Follow-up|0|||
145974765|NCT02164916|526418841|FG001|Overall Study|Not protocol specified|1|||
145974766|NCT02164916|526418840|FG000|Overall Study|Reason under review|1|||
145974767|NCT02164916|526418841|FG001|Overall Study|Reason under review|6|||
145974768|NCT02164916|526418840|FG000|Overall Study|Not eligible|2|||
145974769|NCT02164916|526418841|FG001|Overall Study|Not eligible|5|||
145919627|NCT01068860|526212255|FG004|Overall Study|Lost to Follow-up|0|||
145919628|NCT01068860|526212256|FG005|Overall Study|Lost to Follow-up|0|||
145919629|NCT01068860|526212257|FG006|Overall Study|Lost to Follow-up|0|||
145974770|NCT01155570|526418842|FG000|Overall Study|Adverse Event|39|||
145974771|NCT01155570|526418842|FG000|Overall Study|Lack of Efficacy|46|||
145974772|NCT01155570|526418842|FG000|Overall Study|Participant's Economic Reasons|17|||
145919630|NCT01068860|526212258|FG007|Overall Study|Lost to Follow-up|0|||
145919631|NCT01068860|526212259|FG008|Overall Study|Lost to Follow-up|0|||
145919632|NCT01068860|526212260|FG009|Overall Study|Lost to Follow-up|0|||
145919633|NCT02568072|526212261|FG000|Overall Study|Unavailable for appointment|23|||
145919634|NCT02568072|526212261|FG000|Overall Study|Unable to contact|3|||
145919635|NCT02568072|526212261|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
145919636|NCT02568072|526212261|FG000|Overall Study|Withdrawal by Subject|1|||
145919637|NCT02568072|526212261|FG000|Overall Study|Sustained injury, marathon not run|24|||
145919638|NCT02714218|526212263|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145919639|NCT02714218|526212264|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146240661|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
146240662|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
146240663|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
146240664|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
146240665|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
146240666|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
146240667|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
146240668|NCT02222493|527394991|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
146240669|NCT02222493|527394992|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
146240670|NCT02222493|527394991|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
146240671|NCT02222493|527394992|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
146240672|NCT02222493|527394991|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
146240673|NCT02222493|527394992|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
146240674|NCT02222493|527394991|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
146240675|NCT02222493|527394992|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
146240676|NCT02222493|527394991|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
146240677|NCT02222493|527394992|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
146240678|NCT02222493|527394991|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
146240679|NCT02222493|527394992|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
146240680|NCT01000805|527394996|FG000|Overall Study|Adverse Event|21|||
146240681|NCT01000805|527394997|FG001|Overall Study|Adverse Event|9|||
146240682|NCT01000805|527394996|FG000|Overall Study|Lack of Efficacy|5|||
146240683|NCT01000805|527394997|FG001|Overall Study|Lack of Efficacy|16|||
146240684|NCT01000805|527394996|FG000|Overall Study|Lost to Follow-up|16|||
146240685|NCT01000805|527394997|FG001|Overall Study|Lost to Follow-up|21|||
146240686|NCT01000805|527394996|FG000|Overall Study|Physician Decision|0|||
146240687|NCT01000805|527394997|FG001|Overall Study|Physician Decision|1|||
146240688|NCT01000805|527394996|FG000|Overall Study|Protocol Violation|12|||
146240689|NCT01000805|527394997|FG001|Overall Study|Protocol Violation|8|||
146240690|NCT01000805|527394996|FG000|Overall Study|Withdrawal by Subject|16|||
146240691|NCT01000805|527394997|FG001|Overall Study|Withdrawal by Subject|6|||
146240692|NCT01000805|527394996|FG000|Overall Study|Sponsor Decision|0|||
146240693|NCT01000805|527394997|FG001|Overall Study|Sponsor Decision|1|||
146240694|NCT00302211|527395001|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
146240695|NCT00302211|527395002|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
146240696|NCT00302211|527395003|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146240697|NCT00302211|527395004|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146240698|NCT00302211|527395005|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
146240699|NCT00302211|527395001|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
146240700|NCT00302211|527395002|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
146240701|NCT00302211|527395003|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
146240702|NCT00302211|527395004|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
146240703|NCT00302211|527395005|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
146240704|NCT00302211|527395001|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
146240705|NCT00302211|527395002|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
146240706|NCT00302211|527395003|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
146240707|NCT00302211|527395004|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
146240708|NCT00302211|527395005|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
146240709|NCT00302211|527395001|FG000|Double Blind Period (New Patients)|Disease progression|0|||
146240710|NCT00302211|527395002|FG001|Double Blind Period (New Patients)|Disease progression|1|||
146240711|NCT00302211|527395003|FG002|Double Blind Period (New Patients)|Disease progression|1|||
146240712|NCT00302211|527395004|FG003|Double Blind Period (New Patients)|Disease progression|0|||
146240713|NCT00302211|527395005|FG004|Double Blind Period (New Patients)|Disease progression|0|||
146240714|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146240715|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146240716|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
146240717|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
146240718|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
146240719|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
146240720|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
146240721|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
146240722|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
146240723|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
146240724|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146240725|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
145974773|NCT01155570|526418842|FG000|Overall Study|No Hospital Visits|7|||
145919640|NCT02714218|526212265|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145919641|NCT02714218|526212263|FG000|Pre-Treatment Period|Other reasons|0|||
145919642|NCT02714218|526212264|FG001|Pre-Treatment Period|Other reasons|1|||
145919643|NCT02714218|526212265|FG002|Pre-Treatment Period|Other reasons|0|||
145919644|NCT02714218|526212263|FG000|Treatment Period|Disease Progression|55|||
145919645|NCT02714218|526212264|FG001|Treatment Period|Disease Progression|52|||
145919646|NCT02714218|526212265|FG002|Treatment Period|Disease Progression|14|||
145919647|NCT02714218|526212263|FG000|Treatment Period|Study drug toxicity|46|||
145919648|NCT02714218|526212264|FG001|Treatment Period|Study drug toxicity|70|||
145919649|NCT02714218|526212265|FG002|Treatment Period|Study drug toxicity|6|||
145919650|NCT02714218|526212263|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
145919651|NCT02714218|526212264|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
145919652|NCT02714218|526212265|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
145919653|NCT02714218|526212263|FG000|Treatment Period|Request to discontinue treatment|1|||
145919654|NCT02714218|526212264|FG001|Treatment Period|Request to discontinue treatment|4|||
145919655|NCT02714218|526212265|FG002|Treatment Period|Request to discontinue treatment|1|||
145919656|NCT02714218|526212263|FG000|Treatment Period|Participant withdrew consent|2|||
145919657|NCT02714218|526212264|FG001|Treatment Period|Participant withdrew consent|2|||
145919658|NCT02714218|526212265|FG002|Treatment Period|Participant withdrew consent|0|||
145919659|NCT02714218|526212263|FG000|Treatment Period|Maximum clinical benefit|4|||
145919660|NCT02714218|526212264|FG001|Treatment Period|Maximum clinical benefit|2|||
145919661|NCT02714218|526212265|FG002|Treatment Period|Maximum clinical benefit|0|||
145919662|NCT02714218|526212263|FG000|Treatment Period|Administrative reason by sponsor|2|||
145919663|NCT02714218|526212264|FG001|Treatment Period|Administrative reason by sponsor|1|||
145919664|NCT02714218|526212265|FG002|Treatment Period|Administrative reason by sponsor|0|||
145919665|NCT02714218|526212263|FG000|Treatment Period|Other reasons|6|||
145919666|NCT02714218|526212264|FG001|Treatment Period|Other reasons|6|||
145919667|NCT02714218|526212265|FG002|Treatment Period|Other reasons|0|||
145919668|NCT02714218|526212263|FG000|Treatment Period|Completed treatment as per protocol|36|||
145919669|NCT02714218|526212264|FG001|Treatment Period|Completed treatment as per protocol|27|||
145919670|NCT02714218|526212265|FG002|Treatment Period|Completed treatment as per protocol|3|||
145919671|NCT02714218|526212263|FG000|Treatment Period|Not reported|9|||
145919672|NCT02714218|526212264|FG001|Treatment Period|Not reported|6|||
145919673|NCT02714218|526212265|FG002|Treatment Period|Not reported|0|||
145919674|NCT00882518|526212268|FG000|Overall Study|Adverse Event|9|||
145919675|NCT00882518|526212269|FG001|Overall Study|Adverse Event|18|||
145919676|NCT00882518|526212268|FG000|Overall Study|Withdrawal by Subject|9|||
145974774|NCT01155570|526418842|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
145974775|NCT01155570|526418842|FG000|Overall Study|Adverse Event + Other Reasons|7|||
145974776|NCT01155570|526418842|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
145919677|NCT00882518|526212269|FG001|Overall Study|Withdrawal by Subject|13|||
145919678|NCT00882518|526212268|FG000|Overall Study|Lack of Efficacy|12|||
145919679|NCT00882518|526212269|FG001|Overall Study|Lack of Efficacy|9|||
145919680|NCT00882518|526212268|FG000|Overall Study|Severe non-compliance to protocol|3|||
145919681|NCT00882518|526212269|FG001|Overall Study|Severe non-compliance to protocol|1|||
145919682|NCT00882518|526212268|FG000|Overall Study|Incorrect enrolment|4|||
145919683|NCT00882518|526212269|FG001|Overall Study|Incorrect enrolment|2|||
145919684|NCT00882518|526212268|FG000|Overall Study|Central lab closure for National day|1|||
145974777|NCT01155570|526418842|FG000|Overall Study|Other Reasons|23|||
145974778|NCT00141817|526418845|FG000|Overall Study|Protocol Violation|0|||
145974779|NCT00141817|526418846|FG001|Overall Study|Protocol Violation|0|||
145974780|NCT00141817|526418847|FG002|Overall Study|Protocol Violation|1|||
146240726|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146240727|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
146240728|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
146240729|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
146240730|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
146240731|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
146240732|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
146240733|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
146240734|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Death|0|||
146240735|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Death|0|||
146240736|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Death|0|||
146240737|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Death|1|||
146240738|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Death|1|||
146240739|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146240740|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146240741|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146240742|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
146240743|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
146240744|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146240745|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146240746|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146240747|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
146240748|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
146240749|NCT00302211|527395001|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146240750|NCT00302211|527395002|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146240751|NCT00302211|527395003|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146240752|NCT00302211|527395004|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
145919685|NCT00882518|526212269|FG001|Overall Study|Central lab closure for National day|0|||
145919686|NCT00882518|526212268|FG000|Overall Study|Allocating random number by mistake|0|||
145919687|NCT00882518|526212269|FG001|Overall Study|Allocating random number by mistake|1|||
145919688|NCT03238651|526212270|FG000|Overall Study|Other|0|||
145919689|NCT03238651|526212271|FG001|Overall Study|Other|0|||
145919690|NCT03238651|526212272|FG002|Overall Study|Other|0|||
145919691|NCT03238651|526212273|FG003|Overall Study|Other|0|||
145919692|NCT03238651|526212274|FG004|Overall Study|Other|1|||
145919693|NCT03238651|526212270|FG000|Overall Study|Progressive Disease|2|||
145919694|NCT03238651|526212271|FG001|Overall Study|Progressive Disease|2|||
145919695|NCT03238651|526212272|FG002|Overall Study|Progressive Disease|2|||
145919696|NCT03238651|526212273|FG003|Overall Study|Progressive Disease|2|||
145919697|NCT03238651|526212274|FG004|Overall Study|Progressive Disease|0|||
145919698|NCT03238651|526212270|FG000|Overall Study|Withdrawal by Subject|0|||
145919699|NCT03238651|526212271|FG001|Overall Study|Withdrawal by Subject|1|||
145919700|NCT03238651|526212272|FG002|Overall Study|Withdrawal by Subject|0|||
145919701|NCT03238651|526212273|FG003|Overall Study|Withdrawal by Subject|1|||
145919702|NCT03238651|526212274|FG004|Overall Study|Withdrawal by Subject|0|||
145919703|NCT03238651|526212270|FG000|Overall Study|Adverse Event|1|||
145919704|NCT03238651|526212271|FG001|Overall Study|Adverse Event|3|||
145919705|NCT03238651|526212272|FG002|Overall Study|Adverse Event|2|||
145919706|NCT03238651|526212273|FG003|Overall Study|Adverse Event|0|||
145919707|NCT03238651|526212274|FG004|Overall Study|Adverse Event|0|||
145919708|NCT02623725|526212275|FG000|Overall Study|Non compliance with protocol|9|||
145919709|NCT02623725|526212276|FG001|Overall Study|Non compliance with protocol|3|||
145919710|NCT02623725|526212275|FG000|Overall Study|Serious adverse event|0|||
145919711|NCT02623725|526212276|FG001|Overall Study|Serious adverse event|2|||
145919712|NCT02623725|526212275|FG000|Overall Study|Withdrawal by Subject|7|||
145919713|NCT02623725|526212276|FG001|Overall Study|Withdrawal by Subject|1|||
145919714|NCT00752128|526212279|FG000|Overall Study|Withdrawal by Subject|4|||
145919715|NCT02286713|526212280|FG000|One Week Follow-Up|Death|1|||
145919716|NCT02286713|526212281|FG001|One Week Follow-Up|Death|0|||
145919717|NCT02286713|526212280|FG000|One Week Follow-Up|Lost to Follow-up|17|||
145919718|NCT02286713|526212281|FG001|One Week Follow-Up|Lost to Follow-up|21|||
145919719|NCT02286713|526212280|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
145919720|NCT02286713|526212281|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
145919721|NCT02286713|526212280|FG000|Three Month Follow-Up|Death|1|||
145919722|NCT02286713|526212281|FG001|Three Month Follow-Up|Death|1|||
145919723|NCT02286713|526212280|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
145919724|NCT02286713|526212281|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
145919725|NCT02286713|526212280|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
145919726|NCT02286713|526212281|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
145919727|NCT02286713|526212280|FG000|Six Month Follow-Up|Death|2|||
145919728|NCT02286713|526212281|FG001|Six Month Follow-Up|Death|0|||
145919729|NCT02286713|526212280|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
145919730|NCT02286713|526212281|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
145919731|NCT02654054|526212282|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
145919732|NCT02654054|526212283|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
145919733|NCT02654054|526212284|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
145919734|NCT02654054|526212282|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145919735|NCT02654054|526212283|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145919736|NCT02654054|526212284|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
145919737|NCT02654054|526212282|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145919738|NCT02654054|526212283|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145919739|NCT02654054|526212284|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145919740|NCT02654054|526212282|FG000|Post-Treatment Follow-Up Period|Other|1|||
145919741|NCT02654054|526212283|FG001|Post-Treatment Follow-Up Period|Other|0|||
145919742|NCT02654054|526212284|FG002|Post-Treatment Follow-Up Period|Other|4|||
145919743|NCT02654054|526212282|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145919744|NCT02654054|526212283|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145919745|NCT02654054|526212284|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
145919746|NCT02325973|526214122|FG000|Overall Study|Death|5|||
145919747|NCT02325973|526214122|FG000|Overall Study|Withdrawal by subject or investigator|16|||
145974781|NCT00141817|526418848|FG003|Overall Study|Protocol Violation|0|||
146089237|NCT01288976|526847303|FG002|Overall Study|Data unavailable|7|||
146089238|NCT05523323|526847310|FG000|Overall Study|Death|26|||
146089239|NCT05523323|526847311|FG001|Overall Study|Death|21|||
146089240|NCT05523323|526847310|FG000|Overall Study|Ongoing participants|35|||
146089241|NCT05523323|526847311|FG001|Overall Study|Ongoing participants|30|||
146089242|NCT02469038|526847312|FG000|Overall Study|Physician Decision|4|||
146089243|NCT02469038|526847313|FG001|Overall Study|Physician Decision|5|||
146089244|NCT03435640|526847314|FG000|Overall Study|Withdrawal by Subject|0|||
146089245|NCT03435640|526847315|FG001|Overall Study|Withdrawal by Subject|1|||
146089246|NCT03435640|526847316|FG002|Overall Study|Withdrawal by Subject|0|||
146089247|NCT03435640|526847317|FG003|Overall Study|Withdrawal by Subject|2|||
146089248|NCT03435640|526847318|FG004|Overall Study|Withdrawal by Subject|0|||
146089249|NCT03435640|526847319|FG005|Overall Study|Withdrawal by Subject|0|||
146089250|NCT03435640|526847320|FG006|Overall Study|Withdrawal by Subject|3|||
146089251|NCT03435640|526847321|FG007|Overall Study|Withdrawal by Subject|0|||
146089252|NCT03435640|526847322|FG008|Overall Study|Withdrawal by Subject|0|||
146089253|NCT03435640|526847323|FG009|Overall Study|Withdrawal by Subject|2|||
146089254|NCT03435640|526847324|FG010|Overall Study|Withdrawal by Subject|3|||
146089255|NCT03435640|526847314|FG000|Overall Study|Lost to Follow-up|0|||
146089256|NCT03435640|526847315|FG001|Overall Study|Lost to Follow-up|0|||
146089257|NCT03435640|526847316|FG002|Overall Study|Lost to Follow-up|1|||
146089258|NCT03435640|526847317|FG003|Overall Study|Lost to Follow-up|0|||
146089259|NCT03435640|526847318|FG004|Overall Study|Lost to Follow-up|0|||
146089260|NCT03435640|526847319|FG005|Overall Study|Lost to Follow-up|0|||
146089261|NCT03435640|526847320|FG006|Overall Study|Lost to Follow-up|0|||
146089262|NCT03435640|526847321|FG007|Overall Study|Lost to Follow-up|0|||
146089263|NCT03435640|526847322|FG008|Overall Study|Lost to Follow-up|0|||
146089264|NCT03435640|526847323|FG009|Overall Study|Lost to Follow-up|0|||
146089265|NCT03435640|526847324|FG010|Overall Study|Lost to Follow-up|0|||
146089266|NCT00636987|526847325|FG000|Overall Study|Death|44|||
146089267|NCT00636987|526847325|FG000|Overall Study|Explanted|13|||
146089268|NCT00636987|526847325|FG000|Overall Study|Lost to Follow-up|63|||
146089269|NCT00636987|526847325|FG000|Overall Study|5 year visit window not complete|69|||
146089270|NCT01251146|526847326|FG000|Overall Study|Lost to Follow-up|3|||
146089271|NCT01251146|526847327|FG001|Overall Study|Lost to Follow-up|10|||
146089272|NCT01739400|526847328|FG000|Overall Study|Physician Decision|3|||
146089273|NCT01739400|526847329|FG001|Overall Study|Physician Decision|0|||
146089274|NCT01739400|526847328|FG000|Overall Study|Lost to Follow-up|2|||
146089275|NCT01739400|526847329|FG001|Overall Study|Lost to Follow-up|0|||
146089276|NCT01739400|526847328|FG000|Overall Study|Death|5|||
146089277|NCT01739400|526847329|FG001|Overall Study|Death|2|||
146089278|NCT01739400|526847328|FG000|Overall Study|Withdrawal by Subject|7|||
146089279|NCT01739400|526847329|FG001|Overall Study|Withdrawal by Subject|7|||
146089280|NCT03350984|526847330|FG000|Overall Study|Death|1|||
146089281|NCT03350984|526847331|FG001|Overall Study|Death|0|||
146089282|NCT03350984|526847330|FG000|Overall Study|Lost to Follow-up|5|||
146089283|NCT03350984|526847331|FG001|Overall Study|Lost to Follow-up|6|||
146089284|NCT03350984|526847330|FG000|Overall Study|Protocol Violation|1|||
146089285|NCT03350984|526847331|FG001|Overall Study|Protocol Violation|2|||
146089286|NCT03350984|526847330|FG000|Overall Study|Physician Decision|1|||
146089287|NCT03350984|526847331|FG001|Overall Study|Physician Decision|0|||
146089288|NCT00642473|526847332|FG000|Overall Study|Withdrawal by Subject|0|||
146089289|NCT00642473|526847333|FG001|Overall Study|Withdrawal by Subject|5|||
146089290|NCT00642473|526847332|FG000|Overall Study|Progression or death|2|||
146089291|NCT00642473|526847333|FG001|Overall Study|Progression or death|4|||
146089292|NCT00642473|526847332|FG000|Overall Study|Other|2|||
146089293|NCT00642473|526847333|FG001|Overall Study|Other|2|||
146089294|NCT01347307|526847334|FG000|Overall Study|Death|0|||
146089295|NCT01347307|526847335|FG001|Overall Study|Death|4|||
146089296|NCT01347307|526847334|FG000|Overall Study|Physician Decision|0|||
146297616|NCT04427501|527604740|FG008|Overall Study|Other|0|||
146297617|NCT04427501|527604741|FG009|Overall Study|Other|0|||
146297618|NCT04427501|527604742|FG010|Overall Study|Other|0|||
146089297|NCT01347307|526847335|FG001|Overall Study|Physician Decision|1|||
146089298|NCT00920829|526847337|FG000|Allocation|No post randomization data|3|||
146089299|NCT00920829|526847338|FG001|Allocation|No post randomization data|1|||
146089300|NCT00920829|526847339|FG002|Allocation|No post randomization data|0|||
146089301|NCT00920829|526847340|FG003|Allocation|No post randomization data|2|||
146089302|NCT00920829|526847337|FG000|Available for Analysis|Withdrawal by Subject|6|||
146089303|NCT00920829|526847338|FG001|Available for Analysis|Withdrawal by Subject|6|||
146089304|NCT00920829|526847339|FG002|Available for Analysis|Withdrawal by Subject|6|||
146089305|NCT00920829|526847340|FG003|Available for Analysis|Withdrawal by Subject|10|||
146089306|NCT00920829|526847337|FG000|Available for Analysis|Required Medical Treatment|0|||
146089307|NCT00920829|526847338|FG001|Available for Analysis|Required Medical Treatment|1|||
146089308|NCT00920829|526847339|FG002|Available for Analysis|Required Medical Treatment|2|||
146089309|NCT00920829|526847340|FG003|Available for Analysis|Required Medical Treatment|0|||
146089310|NCT00920829|526847337|FG000|Available for Analysis|Adverse Event|1|||
146089311|NCT00920829|526847338|FG001|Available for Analysis|Adverse Event|2|||
146089312|NCT00920829|526847339|FG002|Available for Analysis|Adverse Event|1|||
145919748|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
145919749|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145919750|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145919751|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145919752|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
145919753|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145919754|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145919755|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145919756|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
145919757|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145974782|NCT00141817|526418845|FG000|Overall Study|Parent request|1|||
145974783|NCT00141817|526418846|FG001|Overall Study|Parent request|0|||
145974784|NCT00141817|526418847|FG002|Overall Study|Parent request|0|||
145974785|NCT00141817|526418848|FG003|Overall Study|Parent request|0|||
145974786|NCT01349595|526418849|FG000|Overall Study|Lack of funding|2|||
145974787|NCT01349595|526418850|FG001|Overall Study|Lack of funding|2|||
145974788|NCT00549055|526420681|FG000|Overall Study|Adverse Event|4|||
145974789|NCT00549055|526420681|FG000|Overall Study|Lack of Efficacy|18|||
145974790|NCT00549055|526420681|FG000|Overall Study|Stabilization|5|||
145974791|NCT00549055|526420681|FG000|Overall Study|Progression to fibrosis|2|||
145974792|NCT00549055|526420681|FG000|Overall Study|Decrease of size|1|||
145974793|NCT00549055|526420681|FG000|Overall Study|Active choroidal neovascula increased|1|||
145974794|NCT00549055|526420681|FG000|Overall Study|Vitreous hemorrhage|1|||
145974795|NCT00549055|526420681|FG000|Overall Study|Growth choroidal neovascularisation|1|||
145974796|NCT00549055|526420681|FG000|Overall Study|Choroidal neovascularization|1|||
145974797|NCT00549055|526420681|FG000|Overall Study|Very low visual acuity (VA)|1|||
145974798|NCT01787838|526420687|FG000|Overall Study|refused|1413|||
145974799|NCT01240746|526420688|FG000|Overall Study|Adverse Event|2|||
145974800|NCT01240746|526420689|FG001|Overall Study|Adverse Event|0|||
145974801|NCT01240746|526420690|FG002|Overall Study|Adverse Event|10|||
145974802|NCT01240746|526420688|FG000|Overall Study|Lost to Follow-up|23|||
145974803|NCT01240746|526420689|FG001|Overall Study|Lost to Follow-up|20|||
145974804|NCT01240746|526420690|FG002|Overall Study|Lost to Follow-up|102|||
145974805|NCT01240746|526420688|FG000|Overall Study|Protocol Violation|24|||
145974806|NCT01240746|526420689|FG001|Overall Study|Protocol Violation|15|||
145974807|NCT01240746|526420690|FG002|Overall Study|Protocol Violation|72|||
145974808|NCT01240746|526420688|FG000|Overall Study|Withdrawal by Subject|10|||
145974809|NCT01240746|526420689|FG001|Overall Study|Withdrawal by Subject|13|||
145974810|NCT01240746|526420690|FG002|Overall Study|Withdrawal by Subject|59|||
145974811|NCT01126424|526420697|FG000|Overall Study|Adverse Event|0|||
145974812|NCT01126424|526420698|FG001|Overall Study|Adverse Event|0|||
145974813|NCT01126424|526420699|FG002|Overall Study|Adverse Event|0|||
145974814|NCT01126424|526420700|FG003|Overall Study|Adverse Event|0|||
145974815|NCT01126424|526420701|FG004|Overall Study|Adverse Event|1|||
145974816|NCT01126424|526420702|FG005|Overall Study|Adverse Event|0|||
145974817|NCT01126424|526420697|FG000|Overall Study|Withdrawal by Subject|0|||
145974818|NCT01126424|526420698|FG001|Overall Study|Withdrawal by Subject|0|||
145974819|NCT01126424|526420699|FG002|Overall Study|Withdrawal by Subject|1|||
145974820|NCT01126424|526420700|FG003|Overall Study|Withdrawal by Subject|3|||
145974821|NCT01126424|526420701|FG004|Overall Study|Withdrawal by Subject|1|||
145974822|NCT01126424|526420702|FG005|Overall Study|Withdrawal by Subject|0|||
145974823|NCT02127671|526420703|FG000|Overall Study|Death|2|||
145974824|NCT02127671|526420704|FG001|Overall Study|Death|2|||
145974825|NCT02127671|526420703|FG000|Overall Study|Lost to Follow-up|4|||
145974826|NCT02127671|526420704|FG001|Overall Study|Lost to Follow-up|2|||
145974827|NCT02127671|526420703|FG000|Overall Study|Physician Decision|1|||
145974828|NCT02127671|526420704|FG001|Overall Study|Physician Decision|0|||
145974829|NCT02127671|526420703|FG000|Overall Study|incarceration|0|||
145974830|NCT02127671|526420704|FG001|Overall Study|incarceration|1|||
145974831|NCT02127671|526420703|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
146089313|NCT00920829|526847340|FG003|Available for Analysis|Adverse Event|0|||
146089314|NCT00920829|526847337|FG000|Available for Analysis|Death|1|||
145919758|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145919759|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145974832|NCT02127671|526420704|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
145974833|NCT00764517|526420708|FG000|Overall Study|Adverse Event|9|||
145974834|NCT00764517|526420709|FG001|Overall Study|Adverse Event|3|||
145974835|NCT00764517|526420708|FG000|Overall Study|Death|3|||
145974836|NCT00764517|526420709|FG001|Overall Study|Death|11|||
145974837|NCT00764517|526420708|FG000|Overall Study|Physician Decision|3|||
145974838|NCT00764517|526420709|FG001|Overall Study|Physician Decision|0|||
145974839|NCT02239328|526420715|FG000|Overall Study|Benign disease noted at time of surgery|6|||
145974840|NCT02239328|526420715|FG000|Overall Study|Equipment or website malfunction|2|||
145974841|NCT03517137|526420720|FG000|Overall Study|Lack of Efficacy|1|||
145974842|NCT03517137|526420720|FG000|Overall Study|Adverse Event|2|||
146240753|NCT00302211|527395005|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
146240754|NCT05432986|527395008|FG000|Overall Study|Withdrawal by Subject|2|||
145919760|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
145919761|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145919762|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145919763|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145919764|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
145919765|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145919766|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145919767|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145919768|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
145919769|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145974843|NCT03517137|526420720|FG000|Overall Study|Withdrawal by Subject|2|||
145974844|NCT03517137|526420720|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
145974845|NCT01838876|526420723|FG000|Overall Study|Adverse Event|49|||
145974846|NCT01838876|526420723|FG000|Overall Study|Insufficient Therapeutic Response|10|||
145974847|NCT01838876|526420723|FG000|Overall Study|Protocol Violation|34|||
145974848|NCT01838876|526420723|FG000|Overall Study|Withdrawal of Consent|33|||
145974849|NCT01838876|526420723|FG000|Overall Study|Lost to Follow-up|21|||
145974850|NCT01838876|526420723|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
145974851|NCT01838876|526420723|FG000|Overall Study|Reason not Specified|7|||
145974852|NCT01838876|526420723|FG000|Overall Study|Did not meet eligibility criteria|78|||
145974853|NCT02313155|526420728|FG000|Overall Study|Lost to Follow-up|0|||
145974854|NCT02313155|526420729|FG001|Overall Study|Lost to Follow-up|1|||
145974855|NCT01682031|526420730|FG000|Overall Study|Withdrawal by Subject|0|||
145974856|NCT01682031|526420731|FG001|Overall Study|Withdrawal by Subject|1|||
145974857|NCT01682031|526420730|FG000|Overall Study|Adverse Event|0|||
145974858|NCT01682031|526420731|FG001|Overall Study|Adverse Event|2|||
146240755|NCT05432986|527395008|FG000|Overall Study|incomplete measurement|7|||
146240756|NCT01970878|527396459|FG000|Overall Study|Withdrawal by Subject|11|||
146240757|NCT01970878|527396460|FG001|Overall Study|Withdrawal by Subject|10|||
146240758|NCT01970878|527396461|FG002|Overall Study|Withdrawal by Subject|14|||
146240759|NCT01970878|527396462|FG003|Overall Study|Withdrawal by Subject|7|||
146240760|NCT01970878|527396459|FG000|Overall Study|Lost to Follow-up|1|||
146240761|NCT01970878|527396460|FG001|Overall Study|Lost to Follow-up|3|||
146240762|NCT01970878|527396461|FG002|Overall Study|Lost to Follow-up|2|||
146240763|NCT01970878|527396462|FG003|Overall Study|Lost to Follow-up|4|||
146240764|NCT01970878|527396459|FG000|Overall Study|Administrative Reasons|1|||
146240765|NCT01970878|527396460|FG001|Overall Study|Administrative Reasons|0|||
146240766|NCT01970878|527396461|FG002|Overall Study|Administrative Reasons|0|||
146240767|NCT01970878|527396462|FG003|Overall Study|Administrative Reasons|4|||
146240768|NCT01970878|527396459|FG000|Overall Study|Lack of Efficacy|2|||
146240769|NCT01970878|527396460|FG001|Overall Study|Lack of Efficacy|1|||
146240770|NCT01970878|527396461|FG002|Overall Study|Lack of Efficacy|2|||
146240771|NCT01970878|527396462|FG003|Overall Study|Lack of Efficacy|0|||
146240772|NCT01970878|527396459|FG000|Overall Study|Adverse Event|12|||
146240773|NCT01970878|527396460|FG001|Overall Study|Adverse Event|7|||
146240774|NCT01970878|527396461|FG002|Overall Study|Adverse Event|4|||
146240775|NCT01970878|527396462|FG003|Overall Study|Adverse Event|3|||
146240776|NCT01970878|527396459|FG000|Overall Study|Protocol Specified Criteria|10|||
146240777|NCT01970878|527396460|FG001|Overall Study|Protocol Specified Criteria|4|||
146240778|NCT01970878|527396461|FG002|Overall Study|Protocol Specified Criteria|3|||
146240779|NCT01970878|527396462|FG003|Overall Study|Protocol Specified Criteria|6|||
146240780|NCT01970878|527396459|FG000|Overall Study|Physician Decision|0|||
146240781|NCT01970878|527396460|FG001|Overall Study|Physician Decision|1|||
146240782|NCT01970878|527396461|FG002|Overall Study|Physician Decision|1|||
146240783|NCT01970878|527396462|FG003|Overall Study|Physician Decision|0|||
146240784|NCT01970878|527396459|FG000|Overall Study|No Completion Status|0|||
145974859|NCT01682031|526420730|FG000|Overall Study|MRI results indicate increased nodul|0|||
146240785|NCT01970878|527396460|FG001|Overall Study|No Completion Status|1|||
146240786|NCT01970878|527396461|FG002|Overall Study|No Completion Status|0|||
146240787|NCT01970878|527396462|FG003|Overall Study|No Completion Status|0|||
146297619|NCT04427501|527604743|FG011|Overall Study|Other|1|||
146240788|NCT06571695|527396464|FG000|Overall Study|Lost to Follow-up|1|||
146297620|NCT04936841|527604744|FG000|Overall Study|Death|1|||
146297621|NCT04598477|527604749|FG000|Overall Study|Adverse Event|2|||
145974860|NCT01682031|526420731|FG001|Overall Study|MRI results indicate increased nodul|1|||
145974861|NCT01682031|526420730|FG000|Overall Study|Patient could not swallow tablets|1|||
145974862|NCT01682031|526420731|FG001|Overall Study|Patient could not swallow tablets|0|||
145974863|NCT01682031|526420730|FG000|Overall Study|Patient stopped selenium on his own|0|||
145974864|NCT01682031|526420731|FG001|Overall Study|Patient stopped selenium on his own|1|||
145974865|NCT03881371|526420734|FG000|Overall Study|Adverse Event|8|||
145974866|NCT03881371|526420735|FG001|Overall Study|Adverse Event|9|||
146240789|NCT06571695|527396465|FG001|Overall Study|Lost to Follow-up|6|||
145919770|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145919771|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145919772|NCT02513160|526214123|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
145919773|NCT02513160|526214124|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145919774|NCT02513160|526214125|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145919775|NCT02513160|526214126|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145919776|NCT02513160|526214123|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
145919777|NCT02513160|526214124|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
145919778|NCT02513160|526214125|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
145919779|NCT02513160|526214126|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
145919780|NCT02513160|526214123|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
145919781|NCT02513160|526214124|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145919782|NCT02513160|526214125|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145919783|NCT02513160|526214126|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145919784|NCT02513160|526214123|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
145919785|NCT02513160|526214124|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
146297622|NCT04598477|527604750|FG001|Overall Study|Adverse Event|0|||
145919786|NCT02513160|526214125|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
145919787|NCT02513160|526214126|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
145919788|NCT02513160|526214123|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
145919789|NCT02513160|526214124|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145919790|NCT02513160|526214125|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145919791|NCT02513160|526214126|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145919792|NCT02513160|526214123|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145919793|NCT02513160|526214124|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
145919794|NCT02513160|526214125|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145919795|NCT02513160|526214126|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145919796|NCT02861586|526214130|FG000|Overall Study|Withdrawal by Subject|1|||
145919797|NCT02861586|526214131|FG001|Overall Study|Withdrawal by Subject|2|||
145919798|NCT02861586|526214132|FG002|Overall Study|Withdrawal by Subject|0|||
145919799|NCT02861586|526214133|FG003|Overall Study|Withdrawal by Subject|0|||
145919800|NCT02861586|526214134|FG004|Overall Study|Withdrawal by Subject|0|||
145919801|NCT02861586|526214135|FG005|Overall Study|Withdrawal by Subject|1|||
145919802|NCT02861586|526214136|FG006|Overall Study|Withdrawal by Subject|1|||
145919803|NCT02861586|526214137|FG007|Overall Study|Withdrawal by Subject|0|||
145919804|NCT02861586|526214130|FG000|Overall Study|Lost to Follow-up|3|||
145919805|NCT02861586|526214131|FG001|Overall Study|Lost to Follow-up|1|||
145919806|NCT02861586|526214132|FG002|Overall Study|Lost to Follow-up|1|||
145919807|NCT02861586|526214133|FG003|Overall Study|Lost to Follow-up|0|||
145919808|NCT02861586|526214134|FG004|Overall Study|Lost to Follow-up|0|||
145919809|NCT02861586|526214135|FG005|Overall Study|Lost to Follow-up|3|||
145919810|NCT02861586|526214136|FG006|Overall Study|Lost to Follow-up|0|||
145919811|NCT02861586|526214137|FG007|Overall Study|Lost to Follow-up|0|||
145919812|NCT02861586|526214130|FG000|Overall Study|Adverse Event|0|||
145919813|NCT02861586|526214131|FG001|Overall Study|Adverse Event|0|||
145919814|NCT02861586|526214132|FG002|Overall Study|Adverse Event|0|||
145919815|NCT02861586|526214133|FG003|Overall Study|Adverse Event|0|||
145919816|NCT02861586|526214134|FG004|Overall Study|Adverse Event|0|||
145919817|NCT02861586|526214135|FG005|Overall Study|Adverse Event|1|||
145919818|NCT02861586|526214136|FG006|Overall Study|Adverse Event|0|||
145919819|NCT02861586|526214137|FG007|Overall Study|Adverse Event|0|||
145919820|NCT03428958|526214138|FG000|Overall Study|Adverse Event|0|||
145919821|NCT03428958|526214139|FG001|Overall Study|Adverse Event|0|||
145919822|NCT03428958|526214140|FG002|Overall Study|Adverse Event|0|||
145919823|NCT03428958|526214141|FG003|Overall Study|Adverse Event|1|||
145919824|NCT03428958|526214142|FG004|Overall Study|Adverse Event|0|||
145919825|NCT03428958|526214143|FG005|Overall Study|Adverse Event|2|||
145919826|NCT03428958|526214144|FG006|Overall Study|Adverse Event|1|||
145919827|NCT03428958|526214145|FG007|Overall Study|Adverse Event|0|||
145919828|NCT03428958|526214146|FG008|Overall Study|Adverse Event|0|||
145919829|NCT03428958|526214147|FG009|Overall Study|Adverse Event|0|||
145919830|NCT03428958|526214148|FG010|Overall Study|Adverse Event|0|||
145919831|NCT03428958|526214149|FG011|Overall Study|Adverse Event|0|||
145919832|NCT03428958|526214150|FG012|Overall Study|Adverse Event|0|||
145919833|NCT03428958|526214151|FG013|Overall Study|Adverse Event|0|||
145919834|NCT03428958|526214152|FG014|Overall Study|Adverse Event|0|||
145919835|NCT03428958|526214153|FG015|Overall Study|Adverse Event|0|||
145919836|NCT03428958|526214154|FG016|Overall Study|Adverse Event|0|||
145919837|NCT03428958|526214138|FG000|Overall Study|Clinical Progression|2|||
145919838|NCT03428958|526214139|FG001|Overall Study|Clinical Progression|3|||
145919839|NCT03428958|526214140|FG002|Overall Study|Clinical Progression|2|||
145919840|NCT03428958|526214141|FG003|Overall Study|Clinical Progression|1|||
145919841|NCT03428958|526214142|FG004|Overall Study|Clinical Progression|0|||
146240790|NCT04921358|527396466|FG000|Overall Study|Withdrawal by Subject|6|||
146240791|NCT04921358|527396467|FG001|Overall Study|Withdrawal by Subject|13|||
146240792|NCT04921358|527396466|FG000|Overall Study|Lost to Follow-up|3|||
146240793|NCT04921358|527396467|FG001|Overall Study|Lost to Follow-up|6|||
145919842|NCT03428958|526214143|FG005|Overall Study|Clinical Progression|2|||
145919843|NCT03428958|526214144|FG006|Overall Study|Clinical Progression|0|||
145919844|NCT03428958|526214145|FG007|Overall Study|Clinical Progression|0|||
145919845|NCT03428958|526214146|FG008|Overall Study|Clinical Progression|0|||
145919846|NCT03428958|526214147|FG009|Overall Study|Clinical Progression|0|||
145919847|NCT03428958|526214148|FG010|Overall Study|Clinical Progression|0|||
145919848|NCT03428958|526214149|FG011|Overall Study|Clinical Progression|0|||
145919849|NCT03428958|526214150|FG012|Overall Study|Clinical Progression|0|||
145919850|NCT03428958|526214151|FG013|Overall Study|Clinical Progression|0|||
145919851|NCT03428958|526214152|FG014|Overall Study|Clinical Progression|0|||
145919852|NCT03428958|526214153|FG015|Overall Study|Clinical Progression|0|||
145919853|NCT03428958|526214154|FG016|Overall Study|Clinical Progression|0|||
145919854|NCT03428958|526214138|FG000|Overall Study|Progression per RECIST|6|||
145919855|NCT03428958|526214139|FG001|Overall Study|Progression per RECIST|6|||
145919856|NCT03428958|526214140|FG002|Overall Study|Progression per RECIST|7|||
145919857|NCT03428958|526214141|FG003|Overall Study|Progression per RECIST|4|||
145919858|NCT03428958|526214142|FG004|Overall Study|Progression per RECIST|0|||
145919859|NCT03428958|526214143|FG005|Overall Study|Progression per RECIST|7|||
145919860|NCT03428958|526214144|FG006|Overall Study|Progression per RECIST|8|||
145919861|NCT03428958|526214145|FG007|Overall Study|Progression per RECIST|0|||
145919862|NCT03428958|526214146|FG008|Overall Study|Progression per RECIST|0|||
145919863|NCT03428958|526214147|FG009|Overall Study|Progression per RECIST|0|||
145919864|NCT03428958|526214148|FG010|Overall Study|Progression per RECIST|0|||
145919865|NCT03428958|526214149|FG011|Overall Study|Progression per RECIST|0|||
145919866|NCT03428958|526214150|FG012|Overall Study|Progression per RECIST|1|||
145919867|NCT03428958|526214151|FG013|Overall Study|Progression per RECIST|0|||
145919868|NCT03428958|526214152|FG014|Overall Study|Progression per RECIST|0|||
145919869|NCT03428958|526214153|FG015|Overall Study|Progression per RECIST|0|||
145919870|NCT03428958|526214154|FG016|Overall Study|Progression per RECIST|0|||
145919871|NCT03428958|526214138|FG000|Overall Study|Death|2|||
145919872|NCT03428958|526214139|FG001|Overall Study|Death|2|||
145919873|NCT03428958|526214140|FG002|Overall Study|Death|0|||
145919874|NCT03428958|526214141|FG003|Overall Study|Death|0|||
145919875|NCT03428958|526214142|FG004|Overall Study|Death|0|||
145919876|NCT03428958|526214143|FG005|Overall Study|Death|7|||
145919877|NCT03428958|526214144|FG006|Overall Study|Death|9|||
145919878|NCT03428958|526214145|FG007|Overall Study|Death|6|||
145919879|NCT03428958|526214146|FG008|Overall Study|Death|0|||
145919880|NCT03428958|526214147|FG009|Overall Study|Death|0|||
145919881|NCT03428958|526214148|FG010|Overall Study|Death|3|||
145919882|NCT03428958|526214149|FG011|Overall Study|Death|0|||
145919883|NCT03428958|526214150|FG012|Overall Study|Death|4|||
145919884|NCT03428958|526214151|FG013|Overall Study|Death|0|||
145919885|NCT03428958|526214152|FG014|Overall Study|Death|0|||
145919886|NCT03428958|526214153|FG015|Overall Study|Death|0|||
146240794|NCT04921358|527396466|FG000|Overall Study|Study Terminated by Sponsor|86|||
146240795|NCT04921358|527396467|FG001|Overall Study|Study Terminated by Sponsor|89|||
145919887|NCT03428958|526214154|FG016|Overall Study|Death|0|||
145919888|NCT03428958|526214138|FG000|Overall Study|Lost to Follow-up|0|||
145919889|NCT03428958|526214139|FG001|Overall Study|Lost to Follow-up|0|||
145919890|NCT03428958|526214140|FG002|Overall Study|Lost to Follow-up|0|||
145919891|NCT03428958|526214141|FG003|Overall Study|Lost to Follow-up|0|||
145919892|NCT03428958|526214142|FG004|Overall Study|Lost to Follow-up|0|||
145919893|NCT03428958|526214143|FG005|Overall Study|Lost to Follow-up|1|||
145919894|NCT03428958|526214144|FG006|Overall Study|Lost to Follow-up|1|||
145919895|NCT03428958|526214145|FG007|Overall Study|Lost to Follow-up|0|||
145919896|NCT03428958|526214146|FG008|Overall Study|Lost to Follow-up|0|||
145919897|NCT03428958|526214147|FG009|Overall Study|Lost to Follow-up|0|||
145919898|NCT03428958|526214148|FG010|Overall Study|Lost to Follow-up|0|||
145919899|NCT03428958|526214149|FG011|Overall Study|Lost to Follow-up|0|||
145974867|NCT03881371|526420734|FG000|Overall Study|Death|1|||
145974868|NCT03881371|526420735|FG001|Overall Study|Death|0|||
146240796|NCT04921358|527396466|FG000|Overall Study|Death|92|||
145919900|NCT03428958|526214150|FG012|Overall Study|Lost to Follow-up|0|||
145919901|NCT03428958|526214151|FG013|Overall Study|Lost to Follow-up|0|||
145919902|NCT03428958|526214152|FG014|Overall Study|Lost to Follow-up|0|||
145919903|NCT03428958|526214153|FG015|Overall Study|Lost to Follow-up|0|||
145919904|NCT03428958|526214154|FG016|Overall Study|Lost to Follow-up|0|||
145919905|NCT03428958|526214138|FG000|Overall Study|Physician/Sponsor Decision|1|||
145919906|NCT03428958|526214139|FG001|Overall Study|Physician/Sponsor Decision|0|||
145919907|NCT03428958|526214140|FG002|Overall Study|Physician/Sponsor Decision|1|||
145919908|NCT03428958|526214141|FG003|Overall Study|Physician/Sponsor Decision|0|||
145919909|NCT03428958|526214142|FG004|Overall Study|Physician/Sponsor Decision|0|||
145919910|NCT03428958|526214143|FG005|Overall Study|Physician/Sponsor Decision|2|||
145919911|NCT03428958|526214144|FG006|Overall Study|Physician/Sponsor Decision|2|||
146240797|NCT04921358|527396467|FG001|Overall Study|Death|82|||
145919912|NCT03428958|526214145|FG007|Overall Study|Physician/Sponsor Decision|2|||
145919913|NCT03428958|526214146|FG008|Overall Study|Physician/Sponsor Decision|0|||
145919914|NCT03428958|526214147|FG009|Overall Study|Physician/Sponsor Decision|0|||
145919915|NCT03428958|526214148|FG010|Overall Study|Physician/Sponsor Decision|2|||
145919916|NCT03428958|526214149|FG011|Overall Study|Physician/Sponsor Decision|0|||
145919917|NCT03428958|526214150|FG012|Overall Study|Physician/Sponsor Decision|4|||
145919918|NCT03428958|526214151|FG013|Overall Study|Physician/Sponsor Decision|0|||
145919919|NCT03428958|526214152|FG014|Overall Study|Physician/Sponsor Decision|0|||
145919920|NCT03428958|526214153|FG015|Overall Study|Physician/Sponsor Decision|0|||
145919921|NCT03428958|526214154|FG016|Overall Study|Physician/Sponsor Decision|0|||
145919922|NCT03428958|526214138|FG000|Overall Study|Withdrawal by Subject|0|||
145919923|NCT03428958|526214139|FG001|Overall Study|Withdrawal by Subject|0|||
145919924|NCT03428958|526214140|FG002|Overall Study|Withdrawal by Subject|2|||
145919925|NCT03428958|526214141|FG003|Overall Study|Withdrawal by Subject|0|||
145919926|NCT03428958|526214142|FG004|Overall Study|Withdrawal by Subject|0|||
145919927|NCT03428958|526214143|FG005|Overall Study|Withdrawal by Subject|2|||
145919928|NCT03428958|526214144|FG006|Overall Study|Withdrawal by Subject|4|||
145919929|NCT03428958|526214145|FG007|Overall Study|Withdrawal by Subject|1|||
145919930|NCT03428958|526214146|FG008|Overall Study|Withdrawal by Subject|0|||
145919931|NCT03428958|526214147|FG009|Overall Study|Withdrawal by Subject|0|||
145919932|NCT03428958|526214148|FG010|Overall Study|Withdrawal by Subject|0|||
145919933|NCT03428958|526214149|FG011|Overall Study|Withdrawal by Subject|0|||
145919934|NCT03428958|526214150|FG012|Overall Study|Withdrawal by Subject|0|||
145919935|NCT03428958|526214151|FG013|Overall Study|Withdrawal by Subject|0|||
145919936|NCT03428958|526214152|FG014|Overall Study|Withdrawal by Subject|0|||
145919937|NCT03428958|526214153|FG015|Overall Study|Withdrawal by Subject|0|||
145919938|NCT03428958|526214154|FG016|Overall Study|Withdrawal by Subject|0|||
145919939|NCT03874117|526214155|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
145919940|NCT03874117|526214156|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
145919941|NCT03874117|526214155|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
145919942|NCT03874117|526214156|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
145919943|NCT03874117|526214155|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145919944|NCT03874117|526214156|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145919945|NCT03874117|526214155|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
145919946|NCT03874117|526214156|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
145919947|NCT03874117|526214155|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145919948|NCT03874117|526214156|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145919949|NCT05012098|526214157|FG000|Overall Study|Disease progression|5|||
145919950|NCT05012098|526214158|FG001|Overall Study|Disease progression|2|||
145919951|NCT05012098|526214157|FG000|Overall Study|Adverse Event|1|||
145919952|NCT05012098|526214158|FG001|Overall Study|Adverse Event|0|||
145919953|NCT05012098|526214157|FG000|Overall Study|Withdrawal by Subject|1|||
145919954|NCT05012098|526214158|FG001|Overall Study|Withdrawal by Subject|0|||
145919955|NCT05012098|526214157|FG000|Overall Study|Discontinuation per protocol|1|||
145919956|NCT05012098|526214158|FG001|Overall Study|Discontinuation per protocol|0|||
145919957|NCT05258773|526214159|FG000|Overall Study|Screen Failure|1|||
145919958|NCT05258773|526214160|FG001|Overall Study|Screen Failure|1|||
145919959|NCT05258773|526214159|FG000|Overall Study|Adverse Event|1|||
145919960|NCT05258773|526214160|FG001|Overall Study|Adverse Event|0|||
145919961|NCT05258773|526214159|FG000|Overall Study|Withdrawal by Subject|0|||
145919962|NCT05258773|526214160|FG001|Overall Study|Withdrawal by Subject|1|||
145919963|NCT03018288|526214161|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
145919964|NCT03018288|526214162|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
145974869|NCT03881371|526420734|FG000|Overall Study|Lost to Follow-up|1|||
145974870|NCT03881371|526420735|FG001|Overall Study|Lost to Follow-up|0|||
145974871|NCT03881371|526420734|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145974872|NCT03881371|526420735|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145974873|NCT03881371|526420734|FG000|Overall Study|Physician Decision|3|||
145974874|NCT03881371|526420735|FG001|Overall Study|Physician Decision|3|||
145974875|NCT03881371|526420734|FG000|Overall Study|Withdrawal by Subject|2|||
145974876|NCT03881371|526420735|FG001|Overall Study|Withdrawal by Subject|10|||
145919965|NCT03018288|526214163|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
145919966|NCT03018288|526214164|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
145919967|NCT03018288|526214161|FG000|Overall Study|Participant withdrew consent.|0|||
145919968|NCT03018288|526214162|FG001|Overall Study|Participant withdrew consent.|0|||
145919969|NCT03018288|526214163|FG002|Overall Study|Participant withdrew consent.|1|||
145974877|NCT03881371|526420734|FG000|Overall Study|Discontinuation from Study|1|||
145974878|NCT03881371|526420735|FG001|Overall Study|Discontinuation from Study|0|||
146297623|NCT04598477|527604749|FG000|Overall Study|Death|0|||
145919970|NCT03018288|526214164|FG003|Overall Study|Participant withdrew consent.|0|||
145919971|NCT03018288|526214161|FG000|Overall Study|Switched to alternative treatment.|0|||
145919972|NCT03018288|526214162|FG001|Overall Study|Switched to alternative treatment.|0|||
146240798|NCT04926857|527396468|FG000|Overall Study|Withdrawal by Subject|40|||
146240799|NCT04926857|527396468|FG000|Overall Study|Death|9|||
146240800|NCT04926857|527396468|FG000|Overall Study|Study product no longer in use|44|||
146240801|NCT04926857|527396468|FG000|Overall Study|Inadequate data to address primary objective|16|||
146240802|NCT02637063|527396469|FG000|Overall Study|Lost to Follow-up|3|||
146240803|NCT02637063|527396470|FG001|Overall Study|Lost to Follow-up|2|||
146240804|NCT02637063|527396471|FG002|Overall Study|Lost to Follow-up|3|||
146240805|NCT02637063|527396469|FG000|Overall Study|Withdrawal by Subject|2|||
146240806|NCT02637063|527396470|FG001|Overall Study|Withdrawal by Subject|2|||
146240807|NCT02637063|527396471|FG002|Overall Study|Withdrawal by Subject|3|||
145919973|NCT03018288|526214163|FG002|Overall Study|Switched to alternative treatment.|1|||
146240808|NCT02132949|527396476|FG000|Overall Study|Death|7|||
146240809|NCT02132949|527396477|FG001|Overall Study|Death|13|||
146240810|NCT02132949|527396476|FG000|Overall Study|Lost to Follow-up|14|||
146240811|NCT02132949|527396477|FG001|Overall Study|Lost to Follow-up|4|||
146240812|NCT02132949|527396476|FG000|Overall Study|Withdrawal by Subject|6|||
146240813|NCT02132949|527396477|FG001|Overall Study|Withdrawal by Subject|5|||
146240814|NCT02132949|527396476|FG000|Overall Study|Noncompliance|5|||
146240815|NCT02132949|527396477|FG001|Overall Study|Noncompliance|1|||
146240816|NCT02132949|527396476|FG000|Overall Study|Physician Decision|3|||
146240817|NCT02132949|527396477|FG001|Overall Study|Physician Decision|1|||
146240818|NCT02132949|527396476|FG000|Overall Study|Disease Progression|3|||
146240819|NCT02132949|527396477|FG001|Overall Study|Disease Progression|0|||
146240820|NCT02132949|527396476|FG000|Overall Study|Adverse Event|2|||
146240821|NCT02132949|527396477|FG001|Overall Study|Adverse Event|1|||
146240822|NCT02132949|527396476|FG000|Overall Study|Withdrew Prior to Treatment|1|||
146240823|NCT02132949|527396477|FG001|Overall Study|Withdrew Prior to Treatment|2|||
146240824|NCT02132949|527396476|FG000|Overall Study|Reason Unspecified|0|||
146240825|NCT02132949|527396477|FG001|Overall Study|Reason Unspecified|1|||
146240826|NCT00745875|527396481|FG000|Overall Study|Continuing study treatment|4|||
146240827|NCT00745875|527396482|FG001|Overall Study|Continuing study treatment|4|||
146240828|NCT02310581|527396483|FG000|Overall Study|Adverse Event|1|||
146240829|NCT02310581|527396484|FG001|Overall Study|Adverse Event|1|||
146240830|NCT02310581|527396485|FG002|Overall Study|Adverse Event|1|||
146240831|NCT02310581|527396486|FG003|Overall Study|Adverse Event|0|||
146240832|NCT02310581|527396483|FG000|Overall Study|Withdrawal by Subject|2|||
146240833|NCT02310581|527396484|FG001|Overall Study|Withdrawal by Subject|1|||
146240834|NCT02310581|527396485|FG002|Overall Study|Withdrawal by Subject|0|||
146240835|NCT02310581|527396486|FG003|Overall Study|Withdrawal by Subject|1|||
146240836|NCT02824198|527396487|FG000|Overall Study|Non-compliance with the protocol|5|||
146240837|NCT02824198|527396488|FG001|Overall Study|Non-compliance with the protocol|1|||
146240838|NCT02824198|527396487|FG000|Overall Study|Lost to Follow-up|5|||
146240839|NCT02824198|527396488|FG001|Overall Study|Lost to Follow-up|2|||
146240840|NCT02824198|527396487|FG000|Overall Study|Withdrawal by Subject|5|||
146240841|NCT02824198|527396488|FG001|Overall Study|Withdrawal by Subject|0|||
145919974|NCT03018288|526214164|FG003|Overall Study|Switched to alternative treatment.|0|||
145919975|NCT03018288|526214161|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
145919976|NCT03018288|526214162|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
146240842|NCT03883828|527396489|FG000|Overall Study|Did not start radiotherapy|1|||
146240843|NCT03883828|527396490|FG001|Overall Study|Did not start radiotherapy|2|||
146240844|NCT01256359|527396491|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
146240845|NCT01256359|527396492|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
146240846|NCT01256359|527396491|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
145919977|NCT03018288|526214163|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
145919978|NCT03018288|526214164|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
145919979|NCT03018288|526214161|FG000|Overall Study|Screen failures|0|||
145919980|NCT03018288|526214162|FG001|Overall Study|Screen failures|0|||
145919981|NCT03018288|526214163|FG002|Overall Study|Screen failures|0|||
145919982|NCT03018288|526214164|FG003|Overall Study|Screen failures|51|||
145919983|NCT03018288|526214161|FG000|Overall Study|Chose treatment outside of UNC|0|||
145974879|NCT00933933|526420736|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
145974880|NCT00933933|526420737|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
145974881|NCT00933933|526420738|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
145974882|NCT00933933|526420736|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
145919984|NCT03018288|526214162|FG001|Overall Study|Chose treatment outside of UNC|0|||
145919985|NCT03018288|526214163|FG002|Overall Study|Chose treatment outside of UNC|0|||
145974883|NCT00933933|526420737|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
145974884|NCT00933933|526420738|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
145974885|NCT01995201|526420743|FG000|From Baseline Until Week 24|Adverse Event|4|||
146240847|NCT01256359|527396492|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
146297624|NCT04598477|527604750|FG001|Overall Study|Death|1|||
146297625|NCT04598477|527604749|FG000|Overall Study|Lost to Follow-up|1|||
145919986|NCT03018288|526214164|FG003|Overall Study|Chose treatment outside of UNC|1|||
145919987|NCT03018288|526214161|FG000|Overall Study|Unable to comply with protocol requirements|1|||
145919988|NCT03018288|526214162|FG001|Overall Study|Unable to comply with protocol requirements|1|||
145919989|NCT03018288|526214163|FG002|Overall Study|Unable to comply with protocol requirements|0|||
145919990|NCT03018288|526214164|FG003|Overall Study|Unable to comply with protocol requirements|1|||
145919991|NCT03018288|526214161|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
145919992|NCT03018288|526214162|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
145919993|NCT03018288|526214163|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
145919994|NCT03018288|526214164|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
145919995|NCT03018288|526214161|FG000|Overall Study|Physician Decision|0|||
145919996|NCT03018288|526214162|FG001|Overall Study|Physician Decision|0|||
145919997|NCT03018288|526214163|FG002|Overall Study|Physician Decision|0|||
145919998|NCT03018288|526214164|FG003|Overall Study|Physician Decision|1|||
145919999|NCT01490086|526214168|FG000|Overall Study|Consent withdrawn|4|||
145920000|NCT01490086|526214169|FG001|Overall Study|Consent withdrawn|4|||
146240848|NCT00487240|527396493|FG000|Overall Study|Withdrawal by Subject|12|||
146240849|NCT00487240|527396494|FG001|Overall Study|Withdrawal by Subject|6|||
146240850|NCT00487240|527396493|FG000|Overall Study|Lost to Follow-up|7|||
146240851|NCT00487240|527396494|FG001|Overall Study|Lost to Follow-up|6|||
146240852|NCT00487240|527396493|FG000|Overall Study|Adverse Event|0|||
146240853|NCT00487240|527396494|FG001|Overall Study|Adverse Event|4|||
146240854|NCT00487240|527396493|FG000|Overall Study|Protocol Violation|5|||
146240855|NCT00487240|527396494|FG001|Overall Study|Protocol Violation|5|||
146240856|NCT00487240|527396493|FG000|Overall Study|Entry Criteria Not Met|3|||
146240857|NCT00487240|527396494|FG001|Overall Study|Entry Criteria Not Met|4|||
146240858|NCT00487240|527396493|FG000|Overall Study|Sponsor Decision|2|||
146240859|NCT00487240|527396494|FG001|Overall Study|Sponsor Decision|1|||
146240860|NCT00487240|527396493|FG000|Overall Study|Physician Decision|2|||
146240861|NCT00487240|527396494|FG001|Overall Study|Physician Decision|0|||
146240862|NCT01019135|527396495|FG000|Overall Study|Did not receive allocated intervention|12|||
146240863|NCT01019135|527396496|FG001|Overall Study|Did not receive allocated intervention|6|||
146240864|NCT01019135|527396497|FG002|Overall Study|Did not receive allocated intervention|25|||
146240865|NCT01019135|527396495|FG000|Overall Study|Did not attend CR|8|||
146240866|NCT01019135|527396496|FG001|Overall Study|Did not attend CR|13|||
146240867|NCT01019135|527396497|FG002|Overall Study|Did not attend CR|6|||
146240868|NCT04237792|527396499|FG000|Treatment (Day 1)|Adverse Event|1|||
146240869|NCT04237792|527396500|FG001|Treatment (Day 1)|Adverse Event|0|||
146240870|NCT04237792|527396501|FG002|Treatment (Day 1)|Adverse Event|0|||
146240871|NCT04237792|527396502|FG003|Treatment (Day 1)|Adverse Event|0|||
146240872|NCT04237792|527396503|FG004|Treatment (Day 1)|Adverse Event|1|||
146240873|NCT04237792|527396504|FG005|Treatment (Day 1)|Adverse Event|1|||
146240874|NCT04237792|527396499|FG000|Treatment (Day 1)|Other|0|||
146240875|NCT04237792|527396500|FG001|Treatment (Day 1)|Other|0|||
146240876|NCT04237792|527396501|FG002|Treatment (Day 1)|Other|1|||
146240877|NCT04237792|527396502|FG003|Treatment (Day 1)|Other|0|||
146240878|NCT04237792|527396503|FG004|Treatment (Day 1)|Other|0|||
146240879|NCT04237792|527396504|FG005|Treatment (Day 1)|Other|1|||
146240880|NCT04237792|527396499|FG000|Treatment (Day 1)|Not treated|1|||
146240881|NCT04237792|527396500|FG001|Treatment (Day 1)|Not treated|1|||
146240882|NCT04237792|527396501|FG002|Treatment (Day 1)|Not treated|2|||
146240883|NCT04237792|527396502|FG003|Treatment (Day 1)|Not treated|1|||
146240884|NCT04237792|527396503|FG004|Treatment (Day 1)|Not treated|0|||
146240885|NCT04237792|527396504|FG005|Treatment (Day 1)|Not treated|1|||
146240886|NCT04885998|527396505|FG000|Overall Study|Withdrawal by Subject|0|||
146240887|NCT04885998|527396506|FG001|Overall Study|Withdrawal by Subject|2|||
146240888|NCT04885998|527396507|FG002|Overall Study|Withdrawal by Subject|0|||
146240889|NCT04885998|527396508|FG003|Overall Study|Withdrawal by Subject|3|||
146240890|NCT04885998|527396505|FG000|Overall Study|Lost to Follow-up|1|||
145920001|NCT01490086|526214170|FG002|Overall Study|Consent withdrawn|3|||
145920002|NCT01490086|526214171|FG003|Overall Study|Consent withdrawn|0|||
145920003|NCT01490086|526214172|FG004|Overall Study|Consent withdrawn|1|||
145920004|NCT01490086|526214168|FG000|Overall Study|Non-compliance|0|||
145920005|NCT01490086|526214169|FG001|Overall Study|Non-compliance|1|||
145920006|NCT01490086|526214170|FG002|Overall Study|Non-compliance|0|||
145920007|NCT01490086|526214171|FG003|Overall Study|Non-compliance|0|||
145920008|NCT01490086|526214172|FG004|Overall Study|Non-compliance|0|||
145920009|NCT01490086|526214168|FG000|Overall Study|Abnormal laboratory findings|1|||
145920010|NCT01490086|526214169|FG001|Overall Study|Abnormal laboratory findings|0|||
145920011|NCT01490086|526214170|FG002|Overall Study|Abnormal laboratory findings|0|||
145920012|NCT01490086|526214171|FG003|Overall Study|Abnormal laboratory findings|0|||
145920013|NCT01490086|526214172|FG004|Overall Study|Abnormal laboratory findings|0|||
145920014|NCT01490086|526214168|FG000|Overall Study|Lost to Follow-up|0|||
145920015|NCT01490086|526214169|FG001|Overall Study|Lost to Follow-up|0|||
145920016|NCT01490086|526214170|FG002|Overall Study|Lost to Follow-up|0|||
145920017|NCT01490086|526214171|FG003|Overall Study|Lost to Follow-up|0|||
145920018|NCT01490086|526214172|FG004|Overall Study|Lost to Follow-up|1|||
146240891|NCT04885998|527396506|FG001|Overall Study|Lost to Follow-up|1|||
146240892|NCT04885998|527396507|FG002|Overall Study|Lost to Follow-up|0|||
146089315|NCT00920829|526847338|FG001|Available for Analysis|Death|0|||
146089316|NCT00920829|526847339|FG002|Available for Analysis|Death|0|||
146089317|NCT00920829|526847340|FG003|Available for Analysis|Death|0|||
146089318|NCT00920829|526847337|FG000|Available for Analysis|Protocol Violation|0|||
146089319|NCT00920829|526847338|FG001|Available for Analysis|Protocol Violation|0|||
146089320|NCT00920829|526847339|FG002|Available for Analysis|Protocol Violation|1|||
146089321|NCT00920829|526847340|FG003|Available for Analysis|Protocol Violation|0|||
146089322|NCT00920829|526847337|FG000|Available for Analysis|Required more treatment|0|||
146089323|NCT00920829|526847338|FG001|Available for Analysis|Required more treatment|2|||
146089324|NCT00920829|526847339|FG002|Available for Analysis|Required more treatment|0|||
146089325|NCT00920829|526847340|FG003|Available for Analysis|Required more treatment|1|||
146089326|NCT04533880|526847341|FG000|Overall Study|Lost to Follow-up|0|||
146089327|NCT04533880|526847342|FG001|Overall Study|Lost to Follow-up|1|||
146089328|NCT04533880|526847343|FG002|Overall Study|Lost to Follow-up|1|||
146089329|NCT02284178|526847346|FG000|Overall Study|Met exclusion criteria|49|||
146089330|NCT02284178|526847347|FG001|Overall Study|Met exclusion criteria|54|||
146089331|NCT04123665|526847348|FG000|Overall Study|Withdrawal by Subject|7|||
146089332|NCT04123665|526847349|FG001|Overall Study|Withdrawal by Subject|0|||
145920019|NCT01490086|526214168|FG000|Overall Study|Physician Decision|3|||
145920020|NCT01490086|526214169|FG001|Overall Study|Physician Decision|4|||
145920021|NCT01490086|526214170|FG002|Overall Study|Physician Decision|2|||
145920022|NCT01490086|526214171|FG003|Overall Study|Physician Decision|3|||
145920023|NCT01490086|526214172|FG004|Overall Study|Physician Decision|1|||
145920024|NCT01490086|526214168|FG000|Overall Study|Adverse Event|0|||
145920025|NCT01490086|526214169|FG001|Overall Study|Adverse Event|0|||
145920026|NCT01490086|526214170|FG002|Overall Study|Adverse Event|1|||
145920027|NCT01490086|526214171|FG003|Overall Study|Adverse Event|2|||
145920028|NCT01490086|526214172|FG004|Overall Study|Adverse Event|0|||
145920029|NCT01490086|526214168|FG000|Overall Study|Lack of Efficacy|0|||
145920030|NCT01490086|526214169|FG001|Overall Study|Lack of Efficacy|3|||
146089333|NCT04123665|526847348|FG000|Overall Study|Lost to Follow-up|1|||
146089334|NCT04123665|526847349|FG001|Overall Study|Lost to Follow-up|0|||
145920031|NCT01490086|526214170|FG002|Overall Study|Lack of Efficacy|1|||
145920032|NCT01490086|526214171|FG003|Overall Study|Lack of Efficacy|0|||
145920033|NCT01490086|526214172|FG004|Overall Study|Lack of Efficacy|8|||
145920034|NCT01490086|526214168|FG000|Overall Study|Worsening of symptoms|0|||
145920035|NCT01490086|526214169|FG001|Overall Study|Worsening of symptoms|1|||
145920036|NCT01490086|526214170|FG002|Overall Study|Worsening of symptoms|0|||
145920037|NCT01490086|526214171|FG003|Overall Study|Worsening of symptoms|1|||
146089335|NCT01711879|526847356|FG000|Overall Study|Death|1|||
146089336|NCT01711879|526847357|FG001|Overall Study|Death|0|||
146089337|NCT01483690|526847358|FG000|Overall Study|Adverse Event|1|||
146089338|NCT01483690|526847359|FG001|Overall Study|Adverse Event|2|||
146089339|NCT01483690|526847358|FG000|Overall Study|clinical deterioration|1|||
146089340|NCT01483690|526847359|FG001|Overall Study|clinical deterioration|0|||
146089341|NCT01483690|526847358|FG000|Overall Study|Physician Decision|0|||
146089342|NCT01483690|526847359|FG001|Overall Study|Physician Decision|2|||
146089343|NCT01483690|526847358|FG000|Overall Study|exclusionary procedure|0|||
146089344|NCT01483690|526847359|FG001|Overall Study|exclusionary procedure|1|||
146089345|NCT00958789|526847363|FG000|Overall Study|Death|5|||
146089346|NCT00958789|526847363|FG000|Overall Study|Lost to Follow-up|14|||
146089347|NCT00958789|526847363|FG000|Overall Study|Withdrawal by Subject|17|||
146089348|NCT00958789|526847363|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
146089349|NCT00958789|526847363|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
146089350|NCT00958789|526847363|FG000|Overall Study|Subject terminated|2|||
146089351|NCT00958789|526847363|FG000|Overall Study|Revision|7|||
146089352|NCT02239224|526847371|FG000|Overall Study|Administrative|0|||
146089353|NCT02239224|526847372|FG001|Overall Study|Administrative|0|||
146089354|NCT02239224|526847373|FG002|Overall Study|Administrative|3|||
146089355|NCT02239224|526847374|FG003|Overall Study|Administrative|1|||
146089356|NCT00478881|526847375|FG000|Overall Study|Adverse Event|31|||
146089357|NCT00478881|526847376|FG001|Overall Study|Adverse Event|12|||
145920038|NCT01490086|526214172|FG004|Overall Study|Worsening of symptoms|0|||
145920039|NCT01490086|526214168|FG000|Overall Study|Subject uncontrollable and abusive|0|||
145920040|NCT01490086|526214169|FG001|Overall Study|Subject uncontrollable and abusive|1|||
145920041|NCT01490086|526214170|FG002|Overall Study|Subject uncontrollable and abusive|0|||
146089358|NCT00478881|526847375|FG000|Overall Study|Lack of Efficacy|0|||
146089359|NCT00478881|526847376|FG001|Overall Study|Lack of Efficacy|3|||
146089360|NCT00478881|526847375|FG000|Overall Study|Lost to Follow-up|0|||
145920042|NCT01490086|526214171|FG003|Overall Study|Subject uncontrollable and abusive|0|||
145920043|NCT01490086|526214172|FG004|Overall Study|Subject uncontrollable and abusive|0|||
146089361|NCT00478881|526847376|FG001|Overall Study|Lost to Follow-up|1|||
146089362|NCT00478881|526847375|FG000|Overall Study|Protocol Violation|2|||
146089363|NCT00478881|526847376|FG001|Overall Study|Protocol Violation|2|||
146089364|NCT00478881|526847375|FG000|Overall Study|Withdrawal by Subject|6|||
146089365|NCT00478881|526847376|FG001|Overall Study|Withdrawal by Subject|2|||
146089366|NCT00478881|526847375|FG000|Overall Study|Non-Compliance with Study Medication|0|||
146089367|NCT00478881|526847376|FG001|Overall Study|Non-Compliance with Study Medication|2|||
145920044|NCT01490086|526214168|FG000|Overall Study|Subject left hospital|0|||
145920045|NCT01490086|526214169|FG001|Overall Study|Subject left hospital|1|||
145920046|NCT01490086|526214170|FG002|Overall Study|Subject left hospital|0|||
145920047|NCT01490086|526214171|FG003|Overall Study|Subject left hospital|1|||
145920048|NCT01490086|526214172|FG004|Overall Study|Subject left hospital|0|||
145920049|NCT01922037|526214173|FG000|Overall Study|Withdrawal by Subject|2|||
145920050|NCT01922037|526214174|FG001|Overall Study|Withdrawal by Subject|44|||
145920051|NCT01922037|526214173|FG000|Overall Study|Adverse Event|1|||
145920052|NCT01922037|526214174|FG001|Overall Study|Adverse Event|7|||
145920053|NCT01922037|526214173|FG000|Overall Study|Death|0|||
145920054|NCT01922037|526214174|FG001|Overall Study|Death|5|||
145920055|NCT01922037|526214173|FG000|Overall Study|Pregnancy|0|||
145974886|NCT01995201|526420744|FG001|From Baseline Until Week 24|Adverse Event|15|||
145974887|NCT01995201|526420745|FG002|From Baseline Until Week 24|Adverse Event|0|||
145974888|NCT01995201|526420746|FG003|From Baseline Until Week 24|Adverse Event|0|||
145974889|NCT01995201|526420747|FG004|From Baseline Until Week 24|Adverse Event|0|||
145974890|NCT01995201|526420748|FG005|From Baseline Until Week 24|Adverse Event|0|||
145974891|NCT01995201|526420749|FG006|From Baseline Until Week 24|Adverse Event|0|||
145974892|NCT01995201|526420743|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974893|NCT01995201|526420744|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
145974894|NCT01995201|526420745|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974895|NCT01995201|526420746|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974896|NCT01995201|526420747|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974897|NCT01995201|526420748|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974898|NCT01995201|526420749|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145974899|NCT01995201|526420743|FG000|From Baseline Until Week 24|Death|0|||
145974900|NCT01995201|526420744|FG001|From Baseline Until Week 24|Death|1|||
145974901|NCT01995201|526420745|FG002|From Baseline Until Week 24|Death|0|||
145974902|NCT01995201|526420746|FG003|From Baseline Until Week 24|Death|0|||
145974903|NCT01995201|526420747|FG004|From Baseline Until Week 24|Death|0|||
145974904|NCT01995201|526420748|FG005|From Baseline Until Week 24|Death|0|||
145974905|NCT01995201|526420749|FG006|From Baseline Until Week 24|Death|0|||
145974906|NCT01995201|526420743|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
145974907|NCT01995201|526420744|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
145974908|NCT01995201|526420745|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
145974909|NCT01995201|526420746|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
145974910|NCT01995201|526420747|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
145974911|NCT01995201|526420748|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
145974912|NCT01995201|526420749|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
145974913|NCT01995201|526420743|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
145974914|NCT01995201|526420744|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
145974915|NCT01995201|526420745|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
146240893|NCT04885998|527396508|FG003|Overall Study|Lost to Follow-up|0|||
146240894|NCT04885998|527396505|FG000|Overall Study|Death|2|||
146240895|NCT04885998|527396506|FG001|Overall Study|Death|1|||
146240896|NCT04885998|527396507|FG002|Overall Study|Death|2|||
146240897|NCT04885998|527396508|FG003|Overall Study|Death|2|||
145920056|NCT01922037|526214174|FG001|Overall Study|Pregnancy|2|||
145920057|NCT01922037|526214173|FG000|Overall Study|Participant non-compliance|4|||
145920058|NCT01922037|526214174|FG001|Overall Study|Participant non-compliance|46|||
145920059|NCT01922037|526214173|FG000|Overall Study|Investigator/Sponsor decision|1|||
145920060|NCT01922037|526214174|FG001|Overall Study|Investigator/Sponsor decision|4|||
145974916|NCT01995201|526420746|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
146240898|NCT04885998|527396505|FG000|Overall Study|Decision by sponsor|1|||
145974917|NCT01995201|526420747|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
145974918|NCT01995201|526420748|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
145974919|NCT01995201|526420749|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
145974920|NCT01995201|526420743|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
146240899|NCT04885998|527396506|FG001|Overall Study|Decision by sponsor|1|||
146240900|NCT04885998|527396507|FG002|Overall Study|Decision by sponsor|0|||
146240901|NCT04885998|527396508|FG003|Overall Study|Decision by sponsor|0|||
146240902|NCT00910962|527396509|FG000|Overall Study|Adverse Event|5|||
146240903|NCT00910962|527396510|FG001|Overall Study|Adverse Event|20|||
145920061|NCT01922037|526214173|FG000|Overall Study|Other unspecified|2|||
145920062|NCT01922037|526214174|FG001|Overall Study|Other unspecified|66|||
145920063|NCT00679211|526214175|FG000|Overall Study|Progressive disease|82|||
146240904|NCT00910962|527396511|FG002|Overall Study|Adverse Event|17|||
145920064|NCT00679211|526214175|FG000|Overall Study|Adverse Event|7|||
145920065|NCT00679211|526214175|FG000|Overall Study|Withdrawal by Subject|2|||
145974921|NCT01995201|526420744|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
145974922|NCT01995201|526420745|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
146240905|NCT00910962|527396509|FG000|Overall Study|Protocol Violation|1|||
146240906|NCT00910962|527396510|FG001|Overall Study|Protocol Violation|3|||
146240907|NCT00910962|527396511|FG002|Overall Study|Protocol Violation|3|||
145920066|NCT00679211|526214175|FG000|Overall Study|Physician Decision|5|||
146240908|NCT00910962|527396509|FG000|Overall Study|Lost to Follow-up|0|||
146240909|NCT00910962|527396510|FG001|Overall Study|Lost to Follow-up|3|||
146240910|NCT00910962|527396511|FG002|Overall Study|Lost to Follow-up|1|||
146240911|NCT00910962|527396509|FG000|Overall Study|Physician Decision|0|||
146240912|NCT00910962|527396510|FG001|Overall Study|Physician Decision|6|||
146240913|NCT00910962|527396511|FG002|Overall Study|Physician Decision|6|||
146240914|NCT00910962|527396509|FG000|Overall Study|Withdrawal by Subject|25|||
146240915|NCT00910962|527396510|FG001|Overall Study|Withdrawal by Subject|32|||
146240916|NCT00910962|527396511|FG002|Overall Study|Withdrawal by Subject|32|||
146240917|NCT00910962|527396509|FG000|Overall Study|Reached defined stopping criteria|12|||
146240918|NCT00910962|527396510|FG001|Overall Study|Reached defined stopping criteria|14|||
146240919|NCT00910962|527396511|FG002|Overall Study|Reached defined stopping criteria|17|||
146240920|NCT01485887|527396513|FG000|Overall Study|Withdrawal by Subject|2|||
146240921|NCT01485887|527396513|FG000|Overall Study|Adverse Event|8|||
146240922|NCT01485887|527396513|FG000|Overall Study|Deterioration of primary disease|1|||
146240923|NCT01485887|527396513|FG000|Overall Study|Primary disease markedly improved|1|||
146240924|NCT02106884|527396518|FG000|Overall Study|Change of diagnosis/exclusion|0|||
146240925|NCT02106884|527396519|FG001|Overall Study|Change of diagnosis/exclusion|1|||
146240926|NCT04638816|527396525|FG000|Overall Study|Withdrawal by Subject|0|||
146240927|NCT04638816|527396526|FG001|Overall Study|Withdrawal by Subject|1|||
146240928|NCT04638816|527396525|FG000|Overall Study|Lost to Follow-up|0|||
146240929|NCT04638816|527396526|FG001|Overall Study|Lost to Follow-up|1|||
146240930|NCT01822756|527396529|FG000|Overall Study|Adverse Event|0|||
146240931|NCT01822756|527396530|FG001|Overall Study|Adverse Event|0|||
146240932|NCT01822756|527396531|FG002|Overall Study|Adverse Event|0|||
146240933|NCT01822756|527396532|FG003|Overall Study|Adverse Event|2|||
146240934|NCT01822756|527396533|FG004|Overall Study|Adverse Event|0|||
146240935|NCT01822756|527396529|FG000|Overall Study|Disease progression|11|||
146240936|NCT01822756|527396530|FG001|Overall Study|Disease progression|1|||
146240937|NCT01822756|527396531|FG002|Overall Study|Disease progression|7|||
146240938|NCT01822756|527396532|FG003|Overall Study|Disease progression|2|||
146240939|NCT01822756|527396533|FG004|Overall Study|Disease progression|6|||
146240940|NCT01822756|527396529|FG000|Overall Study|Death|2|||
146240941|NCT01822756|527396530|FG001|Overall Study|Death|2|||
146240942|NCT01822756|527396531|FG002|Overall Study|Death|1|||
146240943|NCT01822756|527396532|FG003|Overall Study|Death|0|||
146240944|NCT01822756|527396533|FG004|Overall Study|Death|0|||
146240945|NCT01822756|527396529|FG000|Overall Study|Lost to Follow-up|1|||
146240946|NCT01822756|527396530|FG001|Overall Study|Lost to Follow-up|0|||
146240947|NCT01822756|527396531|FG002|Overall Study|Lost to Follow-up|1|||
146240948|NCT01822756|527396532|FG003|Overall Study|Lost to Follow-up|0|||
146240949|NCT01822756|527396533|FG004|Overall Study|Lost to Follow-up|1|||
146240950|NCT01822756|527396529|FG000|Overall Study|Physician Decision|0|||
146240951|NCT01822756|527396530|FG001|Overall Study|Physician Decision|1|||
146240952|NCT01822756|527396531|FG002|Overall Study|Physician Decision|0|||
146240953|NCT01822756|527396532|FG003|Overall Study|Physician Decision|0|||
146240954|NCT01822756|527396533|FG004|Overall Study|Physician Decision|0|||
146240955|NCT01822756|527396529|FG000|Overall Study|disease progression & patient preference|2|||
146240956|NCT01822756|527396530|FG001|Overall Study|disease progression & patient preference|0|||
146240957|NCT01822756|527396531|FG002|Overall Study|disease progression & patient preference|1|||
146240958|NCT01822756|527396532|FG003|Overall Study|disease progression & patient preference|0|||
146240959|NCT01822756|527396533|FG004|Overall Study|disease progression & patient preference|0|||
146240960|NCT02060487|527396534|FG000|Overall Study|Other|1|||
146240961|NCT02060487|527396535|FG001|Overall Study|Other|2|||
146240962|NCT02060487|527396536|FG002|Overall Study|Other|1|||
146240963|NCT02060487|527396534|FG000|Overall Study|Lack of Efficacy|0|||
145920067|NCT00679211|526214175|FG000|Overall Study|Refused to undergo protocol procedures|1|||
145920068|NCT00679211|526214175|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
146240964|NCT02060487|527396535|FG001|Overall Study|Lack of Efficacy|1|||
146240965|NCT02060487|527396536|FG002|Overall Study|Lack of Efficacy|0|||
146240966|NCT02060487|527396534|FG000|Overall Study|Withdrawal by Subject|3|||
146240967|NCT02060487|527396535|FG001|Overall Study|Withdrawal by Subject|10|||
146240968|NCT02060487|527396536|FG002|Overall Study|Withdrawal by Subject|4|||
146240969|NCT02060487|527396534|FG000|Overall Study|Study Terminated By Sponsor|87|||
146240970|NCT02060487|527396535|FG001|Overall Study|Study Terminated By Sponsor|89|||
146240971|NCT02060487|527396536|FG002|Overall Study|Study Terminated By Sponsor|100|||
146240972|NCT02060487|527396534|FG000|Overall Study|Randomized in error|1|||
145920069|NCT00679211|526214175|FG000|Overall Study|Other|1|||
145920070|NCT03103087|526214176|FG000|Overall Study|Did not receive any study drug|1|||
146240973|NCT02060487|527396535|FG001|Overall Study|Randomized in error|0|||
146240974|NCT02060487|527396536|FG002|Overall Study|Randomized in error|0|||
146240975|NCT02060487|527396534|FG000|Overall Study|Protocol Violation|0|||
146240976|NCT02060487|527396535|FG001|Overall Study|Protocol Violation|1|||
146240977|NCT02060487|527396536|FG002|Overall Study|Protocol Violation|1|||
146240978|NCT02060487|527396534|FG000|Overall Study|Lost to Follow-up|3|||
146240979|NCT02060487|527396535|FG001|Overall Study|Lost to Follow-up|0|||
146240980|NCT02060487|527396536|FG002|Overall Study|Lost to Follow-up|2|||
146240981|NCT02060487|527396534|FG000|Overall Study|Death|34|||
145974923|NCT01995201|526420746|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
145974924|NCT01995201|526420747|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
145974925|NCT01995201|526420748|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
145974926|NCT01995201|526420749|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
145974927|NCT01995201|526420743|FG000|From Baseline Until Week 24|Physician Decision|0|||
145974928|NCT01995201|526420744|FG001|From Baseline Until Week 24|Physician Decision|2|||
145974929|NCT01995201|526420745|FG002|From Baseline Until Week 24|Physician Decision|0|||
145974930|NCT01995201|526420746|FG003|From Baseline Until Week 24|Physician Decision|0|||
145974931|NCT01995201|526420747|FG004|From Baseline Until Week 24|Physician Decision|0|||
145974932|NCT01995201|526420748|FG005|From Baseline Until Week 24|Physician Decision|0|||
145974933|NCT01995201|526420749|FG006|From Baseline Until Week 24|Physician Decision|0|||
145974934|NCT01995201|526420743|FG000|From Baseline Until Week 24|Protocol Violation|0|||
145974935|NCT01995201|526420744|FG001|From Baseline Until Week 24|Protocol Violation|9|||
145974936|NCT01995201|526420745|FG002|From Baseline Until Week 24|Protocol Violation|0|||
145974937|NCT01995201|526420746|FG003|From Baseline Until Week 24|Protocol Violation|0|||
145974938|NCT01995201|526420747|FG004|From Baseline Until Week 24|Protocol Violation|0|||
145974939|NCT01995201|526420748|FG005|From Baseline Until Week 24|Protocol Violation|0|||
145974940|NCT01995201|526420749|FG006|From Baseline Until Week 24|Protocol Violation|0|||
145974941|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Adverse Event|0|||
145974942|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Adverse Event|0|||
145974943|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Adverse Event|2|||
145974944|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Adverse Event|1|||
145974945|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Adverse Event|1|||
145974946|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Adverse Event|3|||
145974947|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Adverse Event|1|||
145974948|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Death|0|||
145974949|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Death|0|||
145974950|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Death|0|||
145974951|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Death|0|||
145974952|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Death|0|||
145974953|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Death|2|||
145974954|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Death|0|||
145974955|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
145920071|NCT03103087|526214177|FG001|Overall Study|Did not receive any study drug|0|||
145974956|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
145974957|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
145974958|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
145974959|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
145920072|NCT03103087|526214178|FG002|Overall Study|Did not receive any study drug|0|||
145920073|NCT03103087|526214176|FG000|Overall Study|Protocol Violation|1|||
145920074|NCT03103087|526214177|FG001|Overall Study|Protocol Violation|2|||
145920075|NCT03103087|526214178|FG002|Overall Study|Protocol Violation|1|||
145920076|NCT03103087|526214176|FG000|Overall Study|Lack of Efficacy|2|||
145920077|NCT03103087|526214177|FG001|Overall Study|Lack of Efficacy|1|||
145920078|NCT03103087|526214178|FG002|Overall Study|Lack of Efficacy|1|||
145920079|NCT03103087|526214176|FG000|Overall Study|Pregnancy|0|||
145920080|NCT03103087|526214177|FG001|Overall Study|Pregnancy|0|||
145920081|NCT03103087|526214178|FG002|Overall Study|Pregnancy|1|||
145920082|NCT03103087|526214176|FG000|Overall Study|Adverse Event|2|||
145920083|NCT03103087|526214177|FG001|Overall Study|Adverse Event|15|||
145974960|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
145974961|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
145974962|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
145974963|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
145974964|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
145974965|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
145974966|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
145974967|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
145974968|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
145974969|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145974970|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145974971|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
145974972|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145974973|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
145974974|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145974975|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145974976|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Physician Decision|0|||
145974977|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Physician Decision|0|||
145974978|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Physician Decision|0|||
145974979|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Physician Decision|0|||
145920084|NCT03103087|526214178|FG002|Overall Study|Adverse Event|6|||
145920085|NCT03103087|526214176|FG000|Overall Study|Withdrawal by Subject|13|||
145920086|NCT03103087|526214177|FG001|Overall Study|Withdrawal by Subject|6|||
146240982|NCT02060487|527396535|FG001|Overall Study|Death|25|||
146240983|NCT02060487|527396536|FG002|Overall Study|Death|19|||
146240984|NCT02060487|527396534|FG000|Overall Study|Adverse Event|0|||
146240985|NCT02060487|527396535|FG001|Overall Study|Adverse Event|0|||
146240986|NCT02060487|527396536|FG002|Overall Study|Adverse Event|1|||
146240987|NCT02309294|527396537|FG000|Overall Study|Withdrawal by Subject|2|||
146240988|NCT01227421|527396538|FG000|Overall Study|Lost to Follow-up|6|||
146240989|NCT01227421|527396539|FG001|Overall Study|Lost to Follow-up|7|||
146240990|NCT01227421|527396540|FG002|Overall Study|Lost to Follow-up|5|||
146240991|NCT01227421|527396538|FG000|Overall Study|Adverse Event|2|||
146240992|NCT01227421|527396539|FG001|Overall Study|Adverse Event|7|||
146240993|NCT01227421|527396540|FG002|Overall Study|Adverse Event|2|||
146240994|NCT01227421|527396538|FG000|Overall Study|Withdrawal by Subject|1|||
146240995|NCT01227421|527396539|FG001|Overall Study|Withdrawal by Subject|2|||
146240996|NCT01227421|527396540|FG002|Overall Study|Withdrawal by Subject|1|||
146240997|NCT01227421|527396538|FG000|Overall Study|Protocol Violation|1|||
146240998|NCT01227421|527396539|FG001|Overall Study|Protocol Violation|1|||
146240999|NCT01227421|527396540|FG002|Overall Study|Protocol Violation|2|||
146241000|NCT01227421|527396538|FG000|Overall Study|Randomized in error|1|||
146241001|NCT01227421|527396539|FG001|Overall Study|Randomized in error|1|||
146241002|NCT01227421|527396540|FG002|Overall Study|Randomized in error|0|||
146241003|NCT01827839|527396543|FG000|Overall Study|Adverse Event|1|||
146241004|NCT01827839|527396543|FG000|Overall Study|Consent Withdrawal|2|||
146241005|NCT05426109|527396544|FG000|Overall Study|Withdrawal by Subject|0|||
146241006|NCT05426109|527396545|FG001|Overall Study|Withdrawal by Subject|1|||
146241007|NCT02542943|527396546|FG000|Overall Study|Lost to Follow-up|1|||
146241008|NCT02542943|527396547|FG001|Overall Study|Lost to Follow-up|0|||
146241009|NCT02542943|527396548|FG002|Overall Study|Lost to Follow-up|0|||
146241010|NCT02542943|527396546|FG000|Overall Study|Withdrawal by Subject|0|||
146241011|NCT02542943|527396547|FG001|Overall Study|Withdrawal by Subject|1|||
146241012|NCT02542943|527396548|FG002|Overall Study|Withdrawal by Subject|0|||
146241013|NCT03476798|527396549|FG000|Overall Study|Death|1|||
146241014|NCT03476798|527396549|FG000|Overall Study|Withdrawal by Subject|2|||
146241015|NCT03476798|527396549|FG000|Overall Study|Protocol Violation|2|||
146241016|NCT06269003|527396550|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146241017|NCT06269003|527396551|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146241018|NCT06269003|527396552|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
146241019|NCT06269003|527396553|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
146241020|NCT05865392|527396557|FG000|Overall Study|Withdrawal by Subject|4|||
146297626|NCT04598477|527604750|FG001|Overall Study|Lost to Follow-up|0|||
146297627|NCT04598477|527604749|FG000|Overall Study|Physician Decision|7|||
146297628|NCT04598477|527604750|FG001|Overall Study|Physician Decision|2|||
145920087|NCT03103087|526214178|FG002|Overall Study|Withdrawal by Subject|6|||
145920088|NCT03103087|526214176|FG000|Overall Study|Lost to Follow-up|4|||
145920089|NCT03103087|526214177|FG001|Overall Study|Lost to Follow-up|2|||
145920090|NCT03103087|526214178|FG002|Overall Study|Lost to Follow-up|7|||
145920091|NCT03103087|526214176|FG000|Overall Study|Other reason not reported|1|||
145920092|NCT03103087|526214177|FG001|Overall Study|Other reason not reported|3|||
145920093|NCT03103087|526214178|FG002|Overall Study|Other reason not reported|5|||
145920094|NCT03664232|526214179|FG000|Overall Study|Withdrawal by Subject|0|||
145920095|NCT03664232|526214180|FG001|Overall Study|Withdrawal by Subject|1|||
145920096|NCT03664232|526214181|FG002|Overall Study|Withdrawal by Subject|0|||
145920097|NCT03664232|526214182|FG003|Overall Study|Withdrawal by Subject|1|||
145920098|NCT03664232|526214179|FG000|Overall Study|Adverse Event|0|||
145920099|NCT03664232|526214180|FG001|Overall Study|Adverse Event|0|||
145920100|NCT03664232|526214181|FG002|Overall Study|Adverse Event|1|||
145920101|NCT03664232|526214182|FG003|Overall Study|Adverse Event|0|||
145920102|NCT03664232|526214179|FG000|Overall Study|Other-Non-compliance with study drug|0|||
146241021|NCT05865392|527396558|FG001|Overall Study|Withdrawal by Subject|0|||
145920103|NCT03664232|526214180|FG001|Overall Study|Other-Non-compliance with study drug|1|||
145920104|NCT03664232|526214181|FG002|Overall Study|Other-Non-compliance with study drug|0|||
145920105|NCT03664232|526214182|FG003|Overall Study|Other-Non-compliance with study drug|2|||
145920106|NCT03664232|526214179|FG000|Overall Study|Other-Unspecified|0|||
146241022|NCT05865392|527396557|FG000|Overall Study|Didn't meet inclusion criteria|4|||
146241023|NCT05865392|527396558|FG001|Overall Study|Didn't meet inclusion criteria|0|||
146241024|NCT04447027|527396561|FG000|Dose Escalation|Withdrawal by Subject|1|||
146241025|NCT04447027|527396562|FG001|Dose Escalation|Withdrawal by Subject|4|||
146241026|NCT04447027|527396563|FG002|Dose Escalation|Withdrawal by Subject|3|||
146241027|NCT04447027|527396564|FG003|Dose Escalation|Withdrawal by Subject|3|||
146241028|NCT04447027|527396565|FG004|Dose Escalation|Withdrawal by Subject|1|||
146241029|NCT04447027|527396566|FG005|Dose Escalation|Withdrawal by Subject|0|||
146297629|NCT04598477|527604749|FG000|Overall Study|Pregnancy|0|||
146297630|NCT04598477|527604750|FG001|Overall Study|Pregnancy|1|||
145920107|NCT03664232|526214180|FG001|Overall Study|Other-Unspecified|3|||
145920108|NCT03664232|526214181|FG002|Overall Study|Other-Unspecified|0|||
145920109|NCT03664232|526214182|FG003|Overall Study|Other-Unspecified|1|||
146241030|NCT04447027|527396567|FG006|Dose Escalation|Withdrawal by Subject|0|||
146241031|NCT04447027|527396568|FG007|Dose Escalation|Withdrawal by Subject|0|||
146241032|NCT04447027|527396569|FG008|Dose Escalation|Withdrawal by Subject|0|||
146241033|NCT04447027|527396561|FG000|Dose Escalation|Refused further treatment|0|||
146241034|NCT04447027|527396562|FG001|Dose Escalation|Refused further treatment|1|||
146241035|NCT04447027|527396563|FG002|Dose Escalation|Refused further treatment|1|||
146241036|NCT04447027|527396564|FG003|Dose Escalation|Refused further treatment|0|||
146241037|NCT04447027|527396565|FG004|Dose Escalation|Refused further treatment|0|||
146241038|NCT04447027|527396566|FG005|Dose Escalation|Refused further treatment|0|||
146241039|NCT04447027|527396567|FG006|Dose Escalation|Refused further treatment|0|||
146241040|NCT04447027|527396568|FG007|Dose Escalation|Refused further treatment|0|||
146241041|NCT04447027|527396569|FG008|Dose Escalation|Refused further treatment|0|||
146297631|NCT04598477|527604749|FG000|Overall Study|Requires Prohibited Medication|0|||
146297632|NCT04598477|527604750|FG001|Overall Study|Requires Prohibited Medication|1|||
145920110|NCT03664232|526214179|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
145920111|NCT03664232|526214180|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
145920112|NCT03664232|526214181|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
145920113|NCT03664232|526214182|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
145920114|NCT02003209|526214187|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
145920115|NCT02003209|526214188|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
145920116|NCT03500198|526214189|FG000|Overall Study|Lost to Follow-up|0|||
145920117|NCT03500198|526214190|FG001|Overall Study|Lost to Follow-up|1|||
145920118|NCT00595621|526214191|FG000|Open Label Run in|Adverse Event|1|||
145920119|NCT00595621|526214192|FG001|Open Label Run in|Adverse Event|0|||
145920120|NCT00595621|526214191|FG000|Open Label Run in|Physician Decision|1|||
145920121|NCT00595621|526214192|FG001|Open Label Run in|Physician Decision|0|||
145920122|NCT00595621|526214191|FG000|Open Label Run in|Withdrawal by Subject|1|||
145920123|NCT00595621|526214192|FG001|Open Label Run in|Withdrawal by Subject|0|||
145920124|NCT00595621|526214191|FG000|Randomization and Study|Adverse Event|2|||
145920125|NCT00595621|526214192|FG001|Randomization and Study|Adverse Event|0|||
145920126|NCT00595621|526214191|FG000|Randomization and Study|Withdrawal by Subject|0|||
145920127|NCT00595621|526214192|FG001|Randomization and Study|Withdrawal by Subject|1|||
145920128|NCT03875508|526214198|FG000|Overall Study|Adverse Event|1|||
145920129|NCT03875508|526214198|FG000|Overall Study|Lost to Follow-up|8|||
145920130|NCT03875508|526214198|FG000|Overall Study|Lack of Efficacy|1|||
145920131|NCT03875508|526214198|FG000|Overall Study|Other, not specified|2|||
145920132|NCT02137252|526214199|FG000|Overall Study|trial terminated early|2|||
145920133|NCT02137252|526214200|FG001|Overall Study|trial terminated early|1|||
145920134|NCT04341363|526214202|FG000|Overall Study|Adverse Event|1|||
145920135|NCT04341363|526214202|FG000|Overall Study|Withdrawal by Subject|1|||
145920136|NCT00063934|526214203|FG000|Overall Study|Ineligible|1|||
145920137|NCT01930162|526214204|FG000|Overall Study|Abnormal test procedure result(s)|4|||
145920138|NCT01930162|526214204|FG000|Overall Study|Death|1|||
145920139|NCT02570308|526214210|FG000|Overall Study|Death|1|||
145920140|NCT02570308|526214211|FG001|Overall Study|Death|5|||
145920141|NCT02570308|526214212|FG002|Overall Study|Death|4|||
145920142|NCT02570308|526214213|FG003|Overall Study|Death|4|||
145920143|NCT02570308|526214214|FG004|Overall Study|Death|69|||
145920144|NCT02570308|526214210|FG000|Overall Study|Lost to Follow-up|0|||
145920145|NCT02570308|526214211|FG001|Overall Study|Lost to Follow-up|0|||
145920146|NCT02570308|526214212|FG002|Overall Study|Lost to Follow-up|0|||
145920147|NCT02570308|526214213|FG003|Overall Study|Lost to Follow-up|0|||
145920148|NCT02570308|526214214|FG004|Overall Study|Lost to Follow-up|2|||
145920149|NCT02570308|526214210|FG000|Overall Study|Withdrawal by Subject|0|||
145974980|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Physician Decision|1|||
145974981|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Physician Decision|0|||
145974982|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Physician Decision|0|||
145974983|NCT01995201|526420743|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
145974984|NCT01995201|526420744|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
145974985|NCT01995201|526420745|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
145974986|NCT01995201|526420746|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
145974987|NCT01995201|526420747|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
145920150|NCT02570308|526214211|FG001|Overall Study|Withdrawal by Subject|0|||
145920151|NCT02570308|526214212|FG002|Overall Study|Withdrawal by Subject|0|||
146241042|NCT04447027|527396561|FG000|Dose Expansion|Withdrawal by Subject|0|||
146241043|NCT04447027|527396562|FG001|Dose Expansion|Withdrawal by Subject|0|||
145920152|NCT02570308|526214213|FG003|Overall Study|Withdrawal by Subject|0|||
145920153|NCT02570308|526214214|FG004|Overall Study|Withdrawal by Subject|1|||
145920154|NCT02570308|526214210|FG000|Overall Study|Other|0|||
145920155|NCT02570308|526214211|FG001|Overall Study|Other|0|||
145920156|NCT02570308|526214212|FG002|Overall Study|Other|0|||
145920157|NCT02570308|526214213|FG003|Overall Study|Other|0|||
145920158|NCT02570308|526214214|FG004|Overall Study|Other|2|||
145920159|NCT01283464|526214215|FG000|Overall Study|Lost to Follow-up|0|||
145920160|NCT01283464|526214216|FG001|Overall Study|Lost to Follow-up|1|||
145920161|NCT01283464|526214215|FG000|Overall Study|Withdrawal by Subject|1|||
145974988|NCT01995201|526420748|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
145974989|NCT01995201|526420749|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
145974990|NCT03329001|526420750|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974991|NCT03329001|526420751|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974992|NCT03329001|526420752|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
145974993|NCT03329001|526420753|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
145974994|NCT03329001|526420754|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974995|NCT03329001|526420755|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974996|NCT03329001|526420756|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974997|NCT03329001|526420757|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145974998|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145974999|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975000|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975001|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
145975002|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975003|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975004|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975005|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145975006|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975007|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975008|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975009|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
145975010|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975011|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975012|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975013|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145975014|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145920162|NCT01283464|526214216|FG001|Overall Study|Withdrawal by Subject|0|||
145920163|NCT01283464|526214215|FG000|Overall Study|Physician Decision|1|||
145920164|NCT01283464|526214216|FG001|Overall Study|Physician Decision|0|||
145920165|NCT03051100|526214217|FG000|Overall Study|Withdrawal by Subject|1|||
145920166|NCT03051100|526214218|FG001|Overall Study|Withdrawal by Subject|0|||
145920167|NCT01778855|526214219|FG000|Overall Study|Death|0|||
145920168|NCT01778855|526214220|FG001|Overall Study|Death|1|||
145920169|NCT02059135|526214221|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
145920170|NCT02059135|526214222|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
145920171|NCT02059135|526214221|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
145920172|NCT02059135|526214222|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
145920173|NCT02059135|526214221|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
145975015|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145975016|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145975017|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
145975018|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
146241044|NCT04447027|527396563|FG002|Dose Expansion|Withdrawal by Subject|0|||
146241045|NCT04447027|527396564|FG003|Dose Expansion|Withdrawal by Subject|0|||
146241046|NCT04447027|527396565|FG004|Dose Expansion|Withdrawal by Subject|0|||
146241047|NCT04447027|527396566|FG005|Dose Expansion|Withdrawal by Subject|2|||
146241048|NCT04447027|527396567|FG006|Dose Expansion|Withdrawal by Subject|0|||
146241049|NCT04447027|527396568|FG007|Dose Expansion|Withdrawal by Subject|2|||
146241050|NCT04447027|527396569|FG008|Dose Expansion|Withdrawal by Subject|0|||
146241051|NCT04118894|527396572|FG000|Overall Study|Lost to Follow-up|21|||
146241052|NCT04118894|527396572|FG000|Overall Study|Withdrawal by Subject|10|||
146241053|NCT04118894|527396572|FG000|Overall Study|Adverse Event|4|||
146241054|NCT00551421|527397881|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
146241055|NCT00799409|527397883|FG000|Overall Study|Withdrawal by Subject|1|||
146241056|NCT00799409|527397884|FG001|Overall Study|Withdrawal by Subject|0|||
146241057|NCT00799409|527397885|FG002|Overall Study|Withdrawal by Subject|0|||
146241058|NCT00799409|527397883|FG000|Overall Study|Lost to Follow-up|1|||
146241059|NCT00799409|527397884|FG001|Overall Study|Lost to Follow-up|0|||
146241060|NCT00799409|527397885|FG002|Overall Study|Lost to Follow-up|0|||
146241061|NCT00799409|527397883|FG000|Overall Study|Optimal Dose Not Achieved|2|||
146241062|NCT00799409|527397884|FG001|Overall Study|Optimal Dose Not Achieved|0|||
146241063|NCT00799409|527397885|FG002|Overall Study|Optimal Dose Not Achieved|0|||
146241064|NCT00799409|527397883|FG000|Overall Study|Failure to follow study protocol)|1|||
146241065|NCT00799409|527397884|FG001|Overall Study|Failure to follow study protocol)|0|||
145920174|NCT02059135|526214222|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
145920175|NCT02059135|526214221|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
145920176|NCT02059135|526214222|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
145920177|NCT02059135|526214221|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
145920178|NCT02059135|526214222|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
145920179|NCT02059135|526214221|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
145920180|NCT02059135|526214222|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
145920181|NCT02059135|526214221|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
145920182|NCT02059135|526214222|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
145920183|NCT02059135|526214221|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
145920184|NCT02059135|526214222|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
145920185|NCT03335475|526214225|FG000|Overall Study|Did not wear accelerometer|4|||
145920186|NCT03335475|526214226|FG001|Overall Study|Did not wear accelerometer|0|||
145920187|NCT03335475|526214225|FG000|Overall Study|Withdrawal by Subject|0|||
145920188|NCT03335475|526214226|FG001|Overall Study|Withdrawal by Subject|1|||
145920189|NCT06481709|526214227|FG000|Overall Study|Withdrawal by Subject|0|||
145920190|NCT06481709|526214228|FG001|Overall Study|Withdrawal by Subject|0|||
145920191|NCT06481709|526214229|FG002|Overall Study|Withdrawal by Subject|2|||
145920192|NCT06481709|526214230|FG003|Overall Study|Withdrawal by Subject|0|||
145920193|NCT05921903|526214231|FG000|Overall Study|Unsolicited non-SAE|0|||
145920194|NCT05921903|526214232|FG001|Overall Study|Unsolicited non-SAE|1|||
145920195|NCT05921903|526214233|FG002|Overall Study|Unsolicited non-SAE|0|||
145920196|NCT05921903|526214231|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
145920197|NCT05921903|526214232|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
145920198|NCT05921903|526214233|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
145920199|NCT05921903|526214231|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
145920200|NCT05921903|526214232|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
145920201|NCT05921903|526214233|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
145920202|NCT00789854|526214236|FG000|Overall Study|Adverse Event|28|||
145920203|NCT00789854|526214237|FG001|Overall Study|Adverse Event|23|||
145920204|NCT00789854|526214238|FG002|Overall Study|Adverse Event|18|||
145920205|NCT00789854|526214236|FG000|Overall Study|Lost to Follow-up|1|||
145920206|NCT00789854|526214237|FG001|Overall Study|Lost to Follow-up|1|||
145920207|NCT00789854|526214238|FG002|Overall Study|Lost to Follow-up|4|||
145920208|NCT00789854|526214236|FG000|Overall Study|Withdrawal by Subject|9|||
145920209|NCT00789854|526214237|FG001|Overall Study|Withdrawal by Subject|6|||
145920210|NCT00789854|526214238|FG002|Overall Study|Withdrawal by Subject|17|||
145920211|NCT00789854|526214236|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145920212|NCT00789854|526214237|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
145920213|NCT00789854|526214238|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145920214|NCT00789854|526214236|FG000|Overall Study|Severe non-compliance to the protocol|3|||
145920215|NCT00789854|526214237|FG001|Overall Study|Severe non-compliance to the protocol|0|||
145920216|NCT00789854|526214238|FG002|Overall Study|Severe non-compliance to the protocol|0|||
145920217|NCT00789854|526214236|FG000|Overall Study|Safety reasons|0|||
145920218|NCT00789854|526214237|FG001|Overall Study|Safety reasons|0|||
145920219|NCT00789854|526214238|FG002|Overall Study|Safety reasons|2|||
145920220|NCT00789854|526214236|FG000|Overall Study|Other|6|||
145920221|NCT00789854|526214237|FG001|Overall Study|Other|0|||
145920222|NCT00789854|526214238|FG002|Overall Study|Other|5|||
145920223|NCT00923013|526214239|FG000|Overall Study|Refused further treatment|0|||
145920224|NCT00923013|526214240|FG001|Overall Study|Refused further treatment|1|||
145920225|NCT00923013|526214241|FG002|Overall Study|Refused further treatment|2|||
145920226|NCT00923013|526214242|FG003|Overall Study|Refused further treatment|0|||
145920227|NCT00923013|526214243|FG004|Overall Study|Refused further treatment|0|||
145920228|NCT00923013|526214244|FG005|Overall Study|Refused further treatment|0|||
145920229|NCT00923013|526214239|FG000|Overall Study|Switched to alternative treatment|0|||
145920230|NCT00923013|526214240|FG001|Overall Study|Switched to alternative treatment|1|||
145920231|NCT00923013|526214241|FG002|Overall Study|Switched to alternative treatment|0|||
145920232|NCT00923013|526214242|FG003|Overall Study|Switched to alternative treatment|0|||
145920233|NCT00923013|526214243|FG004|Overall Study|Switched to alternative treatment|0|||
145920234|NCT00923013|526214244|FG005|Overall Study|Switched to alternative treatment|0|||
145920235|NCT00923013|526214239|FG000|Overall Study|Death on study|2|||
145920236|NCT00923013|526214240|FG001|Overall Study|Death on study|2|||
145920237|NCT00923013|526214241|FG002|Overall Study|Death on study|0|||
145920238|NCT00923013|526214242|FG003|Overall Study|Death on study|1|||
145920239|NCT00923013|526214243|FG004|Overall Study|Death on study|0|||
145920240|NCT00923013|526214244|FG005|Overall Study|Death on study|0|||
145920241|NCT05906628|526214246|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
145920242|NCT05906628|526214247|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
145920243|NCT05906628|526214246|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
145920244|NCT05906628|526214247|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
145920245|NCT05906628|526214246|FG000|16-Week DBVC Period|Protocol Violation|4|||
145920246|NCT05906628|526214247|FG001|16-Week DBVC Period|Protocol Violation|2|||
145920247|NCT05906628|526214246|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
146241066|NCT00799409|527397885|FG002|Overall Study|Failure to follow study protocol)|0|||
146241067|NCT00799409|527397883|FG000|Overall Study|Did not attend lab school day 1|1|||
145920248|NCT05906628|526214247|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
145920249|NCT05906628|526214246|FG000|16-Week OLE Period|Death|1|||
145920250|NCT05906628|526214247|FG001|16-Week OLE Period|Death|0|||
145920251|NCT05906628|526214246|FG000|16-Week OLE Period|Lost to Follow-up|1|||
145920252|NCT05906628|526214247|FG001|16-Week OLE Period|Lost to Follow-up|1|||
145920253|NCT05906628|526214246|FG000|16-Week OLE Period|Protocol Violation|0|||
145920254|NCT05906628|526214247|FG001|16-Week OLE Period|Protocol Violation|1|||
145920255|NCT05906628|526214246|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
145920256|NCT05906628|526214247|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
145920257|NCT01108718|526214248|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
145920258|NCT01108718|526214249|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
145920259|NCT05317312|526214250|FG000|Overall Study|Withdrawal by Subject|0|||
145920260|NCT05317312|526214251|FG001|Overall Study|Withdrawal by Subject|1|||
145920261|NCT05317312|526214252|FG002|Overall Study|Withdrawal by Subject|0|||
145920262|NCT05317312|526214253|FG003|Overall Study|Withdrawal by Subject|0|||
145920263|NCT05317312|526214250|FG000|Overall Study|Lost to Follow-up|0|||
145920264|NCT05317312|526214251|FG001|Overall Study|Lost to Follow-up|0|||
145920265|NCT05317312|526214252|FG002|Overall Study|Lost to Follow-up|0|||
145920266|NCT05317312|526214253|FG003|Overall Study|Lost to Follow-up|1|||
145920267|NCT05317312|526214250|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
145920268|NCT05317312|526214251|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
145920269|NCT05317312|526214252|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
145920270|NCT05317312|526214253|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
145920271|NCT00837148|526214254|FG000|Overall Study|Adverse Event|1|||
145920272|NCT00837148|526214254|FG000|Overall Study|Death|1|||
145920273|NCT01422213|526214255|FG000|Overall Study|Adverse Event|8|||
145920274|NCT01422213|526214256|FG001|Overall Study|Adverse Event|7|||
145920275|NCT01422213|526214257|FG002|Overall Study|Adverse Event|11|||
145920276|NCT01422213|526214255|FG000|Overall Study|Lack of Efficacy|10|||
145920277|NCT01422213|526214256|FG001|Overall Study|Lack of Efficacy|2|||
145920278|NCT01422213|526214257|FG002|Overall Study|Lack of Efficacy|2|||
145920279|NCT01422213|526214255|FG000|Overall Study|Non-compliance with study drug|0|||
145920280|NCT01422213|526214256|FG001|Overall Study|Non-compliance with study drug|1|||
145920281|NCT01422213|526214257|FG002|Overall Study|Non-compliance with study drug|0|||
145920282|NCT01422213|526214255|FG000|Overall Study|Protocol Violation|0|||
145920283|NCT01422213|526214256|FG001|Overall Study|Protocol Violation|2|||
145920284|NCT01422213|526214257|FG002|Overall Study|Protocol Violation|4|||
145920285|NCT01422213|526214255|FG000|Overall Study|Withdrawal of Consent|7|||
145920286|NCT01422213|526214256|FG001|Overall Study|Withdrawal of Consent|3|||
145920287|NCT01422213|526214257|FG002|Overall Study|Withdrawal of Consent|5|||
145920288|NCT01422213|526214255|FG000|Overall Study|Lost to Follow-up|3|||
145920289|NCT01422213|526214256|FG001|Overall Study|Lost to Follow-up|3|||
145920290|NCT01422213|526214257|FG002|Overall Study|Lost to Follow-up|5|||
145920291|NCT01422213|526214255|FG000|Overall Study|Administrative or Other Reason(s)|5|||
145920292|NCT01422213|526214256|FG001|Overall Study|Administrative or Other Reason(s)|4|||
145920293|NCT01422213|526214257|FG002|Overall Study|Administrative or Other Reason(s)|2|||
145920294|NCT02857816|526214258|FG000|Overall Study|Screen Failure|33|||
145920295|NCT02857816|526214258|FG000|Overall Study|Withdrawal by Subject|4|||
145920296|NCT02857816|526214258|FG000|Overall Study|Lost to Follow-up|1|||
145920297|NCT01320293|526214260|FG000|Overall Study|Lack of Efficacy|1|||
145920298|NCT01320293|526214260|FG000|Overall Study|Adverse Event|1|||
145920299|NCT00470470|526214261|FG000|Overall Study|Adverse Event|2|||
145920300|NCT00470470|526214261|FG000|Overall Study|Death|2|||
145920301|NCT00470470|526214261|FG000|Overall Study|Not treated|1|||
145920302|NCT01532934|526214262|FG000|Overall Study|Lost to Follow-up|11|||
145920303|NCT01532934|526214263|FG001|Overall Study|Lost to Follow-up|11|||
145920304|NCT01532934|526214262|FG000|Overall Study|In controlled environment|3|||
145920305|NCT01532934|526214263|FG001|Overall Study|In controlled environment|2|||
145920306|NCT03483012|526214264|FG000|Overall Study|Lack of Efficacy|6|||
145920307|NCT01597778|526214267|FG000|Overall Study|Death|7|||
145975019|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145975020|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145975021|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145975022|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975023|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975024|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
145975025|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975026|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975027|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145920308|NCT01597778|526214268|FG001|Overall Study|Death|10|||
145920309|NCT01597778|526214267|FG000|Overall Study|Withdrawal by Subject|3|||
145920310|NCT01597778|526214268|FG001|Overall Study|Withdrawal by Subject|4|||
145920311|NCT01597778|526214267|FG000|Overall Study|Adverse Event|1|||
145920312|NCT01597778|526214268|FG001|Overall Study|Adverse Event|1|||
145920313|NCT01597778|526214267|FG000|Overall Study|Protocol Violation|1|||
145920314|NCT01597778|526214268|FG001|Overall Study|Protocol Violation|11|||
145920315|NCT01597778|526214267|FG000|Overall Study|Transplanted off protocol|2|||
145920316|NCT01597778|526214268|FG001|Overall Study|Transplanted off protocol|3|||
145920317|NCT01149863|526214278|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
145920318|NCT03918629|526214279|FG000|Overall Study|Adverse Event|19|||
145920319|NCT03918629|526214280|FG001|Overall Study|Adverse Event|20|||
145920320|NCT03918629|526214279|FG000|Overall Study|Death|14|||
145920321|NCT03918629|526214280|FG001|Overall Study|Death|7|||
145920322|NCT03918629|526214279|FG000|Overall Study|Lost to Follow-up|36|||
145920323|NCT03918629|526214280|FG001|Overall Study|Lost to Follow-up|28|||
145920324|NCT03918629|526214279|FG000|Overall Study|Physician Decision|1|||
145920325|NCT03918629|526214280|FG001|Overall Study|Physician Decision|0|||
145920326|NCT03918629|526214279|FG000|Overall Study|Protocol Violation|7|||
145920327|NCT03918629|526214280|FG001|Overall Study|Protocol Violation|4|||
145920328|NCT03918629|526214279|FG000|Overall Study|Withdrawal by Subject|47|||
145920329|NCT03918629|526214280|FG001|Overall Study|Withdrawal by Subject|47|||
145920330|NCT03918629|526214279|FG000|Overall Study|Other|7|||
145920331|NCT03918629|526214280|FG001|Overall Study|Other|11|||
145920332|NCT03918629|526214279|FG000|Overall Study|Randomized but not vaccinated|2|||
145920333|NCT03918629|526214280|FG001|Overall Study|Randomized but not vaccinated|1|||
145920334|NCT01891864|526214282|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
145920335|NCT01891864|526214283|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
145920336|NCT01891864|526214284|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145920337|NCT01891864|526214285|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145920338|NCT01891864|526214286|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145920339|NCT01891864|526214287|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145920340|NCT01891864|526214282|FG000|Treatment Period 1|Physician Decision|0|||
145920341|NCT01891864|526214283|FG001|Treatment Period 1|Physician Decision|1|||
145920342|NCT01891864|526214284|FG002|Treatment Period 1|Physician Decision|0|||
145920343|NCT01891864|526214285|FG003|Treatment Period 1|Physician Decision|0|||
145920344|NCT01891864|526214286|FG004|Treatment Period 1|Physician Decision|0|||
145920345|NCT01891864|526214287|FG005|Treatment Period 1|Physician Decision|0|||
145920346|NCT01891864|526214282|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145920347|NCT01891864|526214283|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
145920348|NCT01891864|526214284|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145920349|NCT01891864|526214285|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145920350|NCT01891864|526214286|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145920351|NCT01891864|526214287|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145920352|NCT01891864|526214282|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
145920353|NCT01891864|526214283|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
145920354|NCT01891864|526214284|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145920355|NCT01891864|526214285|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145975028|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975029|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145975030|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975031|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975032|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
145975033|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975034|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975035|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975036|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975037|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145975038|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975039|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975040|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
146089368|NCT01466179|526847378|FG000|Overall Study|Ongoing in core study|2|||
146089369|NCT01466179|526847378|FG000|Overall Study|Physician Decision|46|||
146089370|NCT01466179|526847378|FG000|Overall Study|Progressive disease|43|||
145920356|NCT01891864|526214286|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145920357|NCT01891864|526214287|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145920358|NCT01891864|526214282|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145920359|NCT01891864|526214283|FG001|Treatment Period 1|Withdrawal by Subject|5|||
145920360|NCT01891864|526214284|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145920361|NCT01891864|526214285|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145920362|NCT01891864|526214286|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145920363|NCT01891864|526214287|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145920364|NCT01891864|526214282|FG000|Treatment Period 1|Lost to Follow-up|1|||
145920365|NCT01891864|526214283|FG001|Treatment Period 1|Lost to Follow-up|0|||
145920366|NCT01891864|526214284|FG002|Treatment Period 1|Lost to Follow-up|0|||
145920367|NCT01891864|526214285|FG003|Treatment Period 1|Lost to Follow-up|0|||
145920368|NCT01891864|526214286|FG004|Treatment Period 1|Lost to Follow-up|0|||
145920369|NCT01891864|526214287|FG005|Treatment Period 1|Lost to Follow-up|0|||
145920370|NCT01891864|526214282|FG000|Treatment Period 2|Protocol Violation|0|||
145920371|NCT01891864|526214283|FG001|Treatment Period 2|Protocol Violation|0|||
145920372|NCT01891864|526214284|FG002|Treatment Period 2|Protocol Violation|0|||
145920373|NCT01891864|526214285|FG003|Treatment Period 2|Protocol Violation|1|||
145920374|NCT01891864|526214286|FG004|Treatment Period 2|Protocol Violation|0|||
145920375|NCT01891864|526214287|FG005|Treatment Period 2|Protocol Violation|0|||
146241068|NCT00799409|527397884|FG001|Overall Study|Did not attend lab school day 1|0|||
146241069|NCT00799409|527397885|FG002|Overall Study|Did not attend lab school day 1|0|||
146241070|NCT00799409|527397883|FG000|Overall Study|medication compliance|1|||
146241071|NCT00799409|527397884|FG001|Overall Study|medication compliance|0|||
146241072|NCT00799409|527397885|FG002|Overall Study|medication compliance|0|||
146241073|NCT04323800|527397887|FG000|Overall Study|Withdrawal by Subject|4|||
146241074|NCT04323800|527397888|FG001|Overall Study|Withdrawal by Subject|4|||
146241075|NCT04323800|527397887|FG000|Overall Study|Incomplete transfusion|1|||
146241076|NCT04323800|527397888|FG001|Overall Study|Incomplete transfusion|0|||
146241077|NCT04323800|527397887|FG000|Overall Study|Other|0|||
146241078|NCT04323800|527397888|FG001|Overall Study|Other|1|||
146241079|NCT04323800|527397887|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
146241080|NCT04323800|527397888|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
146241081|NCT00489554|527397889|FG000|Overall Study|Adverse Event|2|||
146241082|NCT00489554|527397889|FG000|Overall Study|Withdrawal by Subject|1|||
146241083|NCT00489554|527397889|FG000|Overall Study|Lost to Follow-up|1|||
146241084|NCT00731692|527397890|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
146241085|NCT00731692|527397891|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
146241086|NCT00731692|527397892|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
146241087|NCT00731692|527397890|FG000|Core Study (36 Months)|Physician Decision|1|||
146241088|NCT00731692|527397891|FG001|Core Study (36 Months)|Physician Decision|0|||
146241089|NCT00731692|527397892|FG002|Core Study (36 Months)|Physician Decision|2|||
146241090|NCT00731692|527397890|FG000|Core Study (36 Months)|Death|2|||
146241091|NCT00731692|527397891|FG001|Core Study (36 Months)|Death|1|||
146241092|NCT00731692|527397892|FG002|Core Study (36 Months)|Death|2|||
146241093|NCT00731692|527397890|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
146241094|NCT00731692|527397891|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
146241095|NCT00731692|527397892|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
146241096|NCT00731692|527397890|FG000|Core Study (36 Months)|Administrative|2|||
146241097|NCT00731692|527397891|FG001|Core Study (36 Months)|Administrative|2|||
146241098|NCT00731692|527397892|FG002|Core Study (36 Months)|Administrative|6|||
146241099|NCT00731692|527397890|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
146241100|NCT00731692|527397891|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
146241101|NCT00731692|527397892|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
146241102|NCT00731692|527397890|FG000|Core Study (36 Months)|Protocol Violation|4|||
146241103|NCT00731692|527397891|FG001|Core Study (36 Months)|Protocol Violation|5|||
146241104|NCT00731692|527397892|FG002|Core Study (36 Months)|Protocol Violation|8|||
146241105|NCT00731692|527397890|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
146241106|NCT00731692|527397891|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
146241107|NCT00731692|527397892|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
146241108|NCT00731692|527397890|FG000|Core Study (36 Months)|Adverse Event|25|||
146241109|NCT00731692|527397891|FG001|Core Study (36 Months)|Adverse Event|28|||
146241110|NCT00731692|527397892|FG002|Core Study (36 Months)|Adverse Event|29|||
146241111|NCT00731692|527397890|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
146241112|NCT00731692|527397891|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
146241113|NCT00731692|527397892|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
145920376|NCT01891864|526214282|FG000|Treatment Period 2|Physician Decision|0|||
146241114|NCT00731692|527397890|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
146241115|NCT00731692|527397891|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
145920377|NCT01891864|526214283|FG001|Treatment Period 2|Physician Decision|0|||
146241116|NCT00731692|527397892|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
146241117|NCT00731692|527397890|FG000|Extension Phase|Abnormal test procedure|0|||
146241118|NCT00731692|527397891|FG001|Extension Phase|Abnormal test procedure|0|||
146241119|NCT00731692|527397892|FG002|Extension Phase|Abnormal test procedure|1|||
146241120|NCT00731692|527397890|FG000|Extension Phase|Abnormal lab values|0|||
145920378|NCT01891864|526214284|FG002|Treatment Period 2|Physician Decision|1|||
146089371|NCT01466179|526847378|FG000|Overall Study|Adverse Event|32|||
146241121|NCT00731692|527397891|FG001|Extension Phase|Abnormal lab values|0|||
146241122|NCT00731692|527397892|FG002|Extension Phase|Abnormal lab values|1|||
146241123|NCT00731692|527397890|FG000|Extension Phase|Lost to Follow-up|0|||
146241124|NCT00731692|527397891|FG001|Extension Phase|Lost to Follow-up|1|||
146241125|NCT00731692|527397892|FG002|Extension Phase|Lost to Follow-up|4|||
146241126|NCT00731692|527397890|FG000|Extension Phase|Withdrawal by Subject|4|||
146241127|NCT00731692|527397891|FG001|Extension Phase|Withdrawal by Subject|5|||
146241128|NCT00731692|527397892|FG002|Extension Phase|Withdrawal by Subject|3|||
146241129|NCT00731692|527397890|FG000|Extension Phase|Adverse Event|1|||
146241130|NCT00731692|527397891|FG001|Extension Phase|Adverse Event|1|||
146241131|NCT00731692|527397892|FG002|Extension Phase|Adverse Event|15|||
146241132|NCT00597376|527397893|FG000|Overall Study|Withdrawal by Subject|4|||
146241133|NCT00597376|527397894|FG001|Overall Study|Withdrawal by Subject|3|||
146241134|NCT00597376|527397893|FG000|Overall Study|Adverse Event|4|||
146241135|NCT00597376|527397894|FG001|Overall Study|Adverse Event|1|||
146241136|NCT02634307|527397895|FG000|Overall Study|Adverse Event|50|||
146241137|NCT02634307|527397896|FG001|Overall Study|Adverse Event|24|||
146241138|NCT02634307|527397897|FG002|Overall Study|Adverse Event|14|||
146241139|NCT02634307|527397895|FG000|Overall Study|Lost to Follow-up|21|||
146241140|NCT02634307|527397896|FG001|Overall Study|Lost to Follow-up|5|||
146241141|NCT02634307|527397897|FG002|Overall Study|Lost to Follow-up|6|||
146241142|NCT02634307|527397895|FG000|Overall Study|Pregnancy|5|||
146241143|NCT02634307|527397896|FG001|Overall Study|Pregnancy|1|||
146241144|NCT02634307|527397897|FG002|Overall Study|Pregnancy|3|||
146241145|NCT02634307|527397895|FG000|Overall Study|Withdrawal by Subject|38|||
146241146|NCT02634307|527397896|FG001|Overall Study|Withdrawal by Subject|24|||
146241147|NCT02634307|527397897|FG002|Overall Study|Withdrawal by Subject|18|||
146241148|NCT02634307|527397895|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146241149|NCT02634307|527397896|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146241150|NCT02634307|527397897|FG002|Overall Study|Non-Compliance with Study Drug|2|||
146241151|NCT02634307|527397895|FG000|Overall Study|Lack of Efficacy|1|||
146241152|NCT02634307|527397896|FG001|Overall Study|Lack of Efficacy|5|||
146241153|NCT02634307|527397897|FG002|Overall Study|Lack of Efficacy|3|||
146241154|NCT02634307|527397895|FG000|Overall Study|Physician Decision|7|||
146241155|NCT02634307|527397896|FG001|Overall Study|Physician Decision|5|||
146241156|NCT02634307|527397897|FG002|Overall Study|Physician Decision|5|||
146241157|NCT02634307|527397895|FG000|Overall Study|Reason not Specified|3|||
146241158|NCT02634307|527397896|FG001|Overall Study|Reason not Specified|5|||
146241159|NCT02634307|527397897|FG002|Overall Study|Reason not Specified|10|||
146241160|NCT01214200|527397902|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
146241161|NCT01214200|527397902|FG000|Overall Study|Withdrawal by Subject|2|||
146241162|NCT00667017|527397903|FG000|Overall Study|Withdrawal by Subject|1|||
145975041|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975042|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975043|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975044|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975045|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145975046|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145975047|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
146241163|NCT01823224|527397904|FG000|Overall Study|Lost to Follow-up|5|||
146241164|NCT01823224|527397905|FG001|Overall Study|Lost to Follow-up|6|||
146241165|NCT01823224|527397904|FG000|Overall Study|didn't qualify|1|||
146241166|NCT01823224|527397905|FG001|Overall Study|didn't qualify|2|||
146241167|NCT01823224|527397904|FG000|Overall Study|pharmacy error|0|||
146241168|NCT01823224|527397905|FG001|Overall Study|pharmacy error|1|||
146241169|NCT01823224|527397904|FG000|Overall Study|missed med dose|0|||
146241170|NCT01823224|527397905|FG001|Overall Study|missed med dose|1|||
146241171|NCT01823224|527397904|FG000|Overall Study|Withdrawal by Subject|0|||
146241172|NCT01823224|527397905|FG001|Overall Study|Withdrawal by Subject|1|||
145975048|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
146241173|NCT01532648|527397906|FG000|Overall Study|Lost to Follow-up|3|||
146241174|NCT01532648|527397907|FG001|Overall Study|Lost to Follow-up|4|||
146241175|NCT01532648|527397906|FG000|Overall Study|Lack of Efficacy|4|||
146241176|NCT01532648|527397907|FG001|Overall Study|Lack of Efficacy|1|||
146241177|NCT01532648|527397906|FG000|Overall Study|Protocol Violation|1|||
146241178|NCT01532648|527397907|FG001|Overall Study|Protocol Violation|1|||
146241179|NCT01532648|527397906|FG000|Overall Study|Adverse Event|12|||
146241180|NCT01532648|527397907|FG001|Overall Study|Adverse Event|9|||
146241181|NCT01532648|527397906|FG000|Overall Study|Withdrawal by Subject|16|||
146241182|NCT01532648|527397907|FG001|Overall Study|Withdrawal by Subject|2|||
146241183|NCT01833455|527397908|FG000|Overall Study|Withdrawal by Subject|1|||
146241184|NCT01833455|527397909|FG001|Overall Study|Withdrawal by Subject|0|||
146241185|NCT03960645|527397910|FG000|Overall Study|Protocol Violation|1|||
146241186|NCT03960645|527397911|FG001|Overall Study|Protocol Violation|0|||
146241187|NCT04938453|527397912|FG000|Washout Period 1|Adverse Event|1|||
145920379|NCT01891864|526214285|FG003|Treatment Period 2|Physician Decision|0|||
145920380|NCT01891864|526214286|FG004|Treatment Period 2|Physician Decision|0|||
145920381|NCT01891864|526214287|FG005|Treatment Period 2|Physician Decision|0|||
145920382|NCT01891864|526214282|FG000|Treatment Period 2|Site Termination|0|||
145920383|NCT01891864|526214283|FG001|Treatment Period 2|Site Termination|0|||
145920384|NCT01891864|526214284|FG002|Treatment Period 2|Site Termination|1|||
145920385|NCT01891864|526214285|FG003|Treatment Period 2|Site Termination|2|||
145920386|NCT01891864|526214286|FG004|Treatment Period 2|Site Termination|0|||
145920387|NCT01891864|526214287|FG005|Treatment Period 2|Site Termination|0|||
145920388|NCT01891864|526214282|FG000|Treatment Period 2|Lack of Efficacy|0|||
145920389|NCT01891864|526214283|FG001|Treatment Period 2|Lack of Efficacy|0|||
145920390|NCT01891864|526214284|FG002|Treatment Period 2|Lack of Efficacy|1|||
145920391|NCT01891864|526214285|FG003|Treatment Period 2|Lack of Efficacy|0|||
146241188|NCT04938453|527397913|FG001|Washout Period 1|Adverse Event|0|||
146241189|NCT04938453|527397912|FG000|Washout Period 1|Physician Decision|0|||
146241190|NCT04938453|527397913|FG001|Washout Period 1|Physician Decision|1|||
146241191|NCT03292406|527397916|FG000|Overall Study|Progressive Disease|6|||
146241192|NCT03292406|527397917|FG001|Overall Study|Progressive Disease|3|||
145920392|NCT01891864|526214286|FG004|Treatment Period 2|Lack of Efficacy|1|||
145920393|NCT01891864|526214287|FG005|Treatment Period 2|Lack of Efficacy|0|||
145920394|NCT01891864|526214282|FG000|Treatment Period 2|Adverse Event|0|||
145920395|NCT01891864|526214283|FG001|Treatment Period 2|Adverse Event|0|||
145920396|NCT01891864|526214284|FG002|Treatment Period 2|Adverse Event|1|||
145920397|NCT01891864|526214285|FG003|Treatment Period 2|Adverse Event|2|||
145920398|NCT01891864|526214286|FG004|Treatment Period 2|Adverse Event|0|||
145920399|NCT01891864|526214287|FG005|Treatment Period 2|Adverse Event|4|||
145920400|NCT01891864|526214282|FG000|Treatment Period 2|Termination of Site|0|||
145920401|NCT01891864|526214283|FG001|Treatment Period 2|Termination of Site|0|||
145920402|NCT01891864|526214284|FG002|Treatment Period 2|Termination of Site|0|||
145920403|NCT01891864|526214285|FG003|Treatment Period 2|Termination of Site|0|||
145920404|NCT01891864|526214286|FG004|Treatment Period 2|Termination of Site|2|||
145920405|NCT01891864|526214287|FG005|Treatment Period 2|Termination of Site|0|||
145920406|NCT01891864|526214282|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145920407|NCT01891864|526214283|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145920408|NCT01891864|526214284|FG002|Treatment Period 2|Withdrawal by Subject|3|||
145920409|NCT01891864|526214285|FG003|Treatment Period 2|Withdrawal by Subject|4|||
145920410|NCT01891864|526214286|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145920411|NCT01891864|526214287|FG005|Treatment Period 2|Withdrawal by Subject|1|||
145920412|NCT01891864|526214282|FG000|Extension Period|Lack of Efficacy|0|||
145920413|NCT01891864|526214283|FG001|Extension Period|Lack of Efficacy|0|||
145920414|NCT01891864|526214284|FG002|Extension Period|Lack of Efficacy|0|||
145920415|NCT01891864|526214285|FG003|Extension Period|Lack of Efficacy|1|||
145920416|NCT01891864|526214286|FG004|Extension Period|Lack of Efficacy|1|||
145920417|NCT01891864|526214287|FG005|Extension Period|Lack of Efficacy|0|||
145920418|NCT01891864|526214282|FG000|Extension Period|Pregnancy|0|||
145920419|NCT01891864|526214283|FG001|Extension Period|Pregnancy|0|||
145920420|NCT01891864|526214284|FG002|Extension Period|Pregnancy|1|||
145920421|NCT01891864|526214285|FG003|Extension Period|Pregnancy|0|||
145920422|NCT01891864|526214286|FG004|Extension Period|Pregnancy|0|||
145920423|NCT01891864|526214287|FG005|Extension Period|Pregnancy|0|||
145920424|NCT01891864|526214282|FG000|Extension Period|Adverse Event|0|||
145920425|NCT01891864|526214283|FG001|Extension Period|Adverse Event|0|||
145920426|NCT01891864|526214284|FG002|Extension Period|Adverse Event|4|||
145920427|NCT01891864|526214285|FG003|Extension Period|Adverse Event|2|||
145920428|NCT01891864|526214286|FG004|Extension Period|Adverse Event|2|||
145920429|NCT01891864|526214287|FG005|Extension Period|Adverse Event|0|||
145920430|NCT01891864|526214282|FG000|Extension Period|Withdrawal by Subject|0|||
145920431|NCT01891864|526214283|FG001|Extension Period|Withdrawal by Subject|0|||
145920432|NCT01891864|526214284|FG002|Extension Period|Withdrawal by Subject|1|||
145920433|NCT01891864|526214285|FG003|Extension Period|Withdrawal by Subject|2|||
145920434|NCT01891864|526214286|FG004|Extension Period|Withdrawal by Subject|4|||
145920435|NCT01891864|526214287|FG005|Extension Period|Withdrawal by Subject|0|||
145920436|NCT01891864|526214282|FG000|Extension Period|Lost to Follow-up|0|||
145920437|NCT01891864|526214283|FG001|Extension Period|Lost to Follow-up|0|||
145920438|NCT01891864|526214284|FG002|Extension Period|Lost to Follow-up|2|||
145920439|NCT01891864|526214285|FG003|Extension Period|Lost to Follow-up|0|||
145920440|NCT01891864|526214286|FG004|Extension Period|Lost to Follow-up|0|||
145920441|NCT01891864|526214287|FG005|Extension Period|Lost to Follow-up|0|||
145920442|NCT04314037|526214293|FG000|Treatment Period 2|Adverse Event|1|||
145920443|NCT04314037|526214294|FG001|Treatment Period 2|Adverse Event|0|||
145920444|NCT04314037|526214293|FG000|Treatment Period 3|Protocol Violation|1|||
145920445|NCT04314037|526214294|FG001|Treatment Period 3|Protocol Violation|0|||
145920446|NCT04314037|526214293|FG000|Treatment Period 3|Adverse Event|0|||
145920447|NCT04314037|526214294|FG001|Treatment Period 3|Adverse Event|1|||
145920448|NCT00273182|526214296|FG000|Overall Study|Death|450|||
145920449|NCT00273182|526214296|FG000|Overall Study|Lost to Follow-up|88|||
145920450|NCT00273182|526214296|FG000|Overall Study|Withdrawal by Subject|257|||
146241193|NCT03292406|527397918|FG002|Overall Study|Progressive Disease|4|||
146241194|NCT03292406|527397916|FG000|Overall Study|Adverse Event|7|||
146241195|NCT03292406|527397917|FG001|Overall Study|Adverse Event|1|||
146241196|NCT03292406|527397918|FG002|Overall Study|Adverse Event|4|||
146241197|NCT03292406|527397916|FG000|Overall Study|Withdrawal by Subject|0|||
146241198|NCT03292406|527397917|FG001|Overall Study|Withdrawal by Subject|7|||
146241199|NCT03292406|527397918|FG002|Overall Study|Withdrawal by Subject|2|||
146241200|NCT03292406|527397916|FG000|Overall Study|Protocol Violation|0|||
146241201|NCT03292406|527397917|FG001|Overall Study|Protocol Violation|1|||
146241202|NCT03292406|527397918|FG002|Overall Study|Protocol Violation|1|||
146241203|NCT03292406|527397916|FG000|Overall Study|Other|0|||
146241204|NCT03292406|527397917|FG001|Overall Study|Other|1|||
146241205|NCT03292406|527397918|FG002|Overall Study|Other|2|||
146241206|NCT00022672|527397920|FG000|Main Phase: 24 Months|Adverse Event|6|||
146241207|NCT00022672|527397921|FG001|Main Phase: 24 Months|Adverse Event|0|||
146241208|NCT00022672|527397920|FG000|Main Phase: 24 Months|Death|0|||
146241209|NCT00022672|527397921|FG001|Main Phase: 24 Months|Death|3|||
146241210|NCT00022672|527397920|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
146241211|NCT00022672|527397921|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
146241212|NCT00022672|527397920|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
146241213|NCT00022672|527397921|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
146241214|NCT00022672|527397920|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
146241215|NCT00022672|527397921|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
146241216|NCT00022672|527397920|FG000|Main Phase: 24 Months|Refused Treatment|3|||
146241217|NCT00022672|527397921|FG001|Main Phase: 24 Months|Refused Treatment|4|||
146241218|NCT00022672|527397920|FG000|Main Phase: 24 Months|Failure to Return|1|||
146241219|NCT00022672|527397921|FG001|Main Phase: 24 Months|Failure to Return|1|||
145920451|NCT00273182|526214296|FG000|Overall Study|Device/System Explant|154|||
145920452|NCT00273182|526214296|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
145920453|NCT00856492|526214299|FG000|Overall Study|Ineligible or withdrew consent|1|||
145920454|NCT00856492|526214300|FG001|Overall Study|Ineligible or withdrew consent|1|||
146089372|NCT01466179|526847378|FG000|Overall Study|Disease relapse|23|||
146089373|NCT01466179|526847378|FG000|Overall Study|Lack of Efficacy|14|||
146089374|NCT01466179|526847378|FG000|Overall Study|Death|7|||
146089375|NCT01466179|526847378|FG000|Overall Study|Withdrawal by Subject|7|||
146089376|NCT01466179|526847378|FG000|Overall Study|Protocol Violation|2|||
146089377|NCT01466179|526847378|FG000|Overall Study|Other|3|||
146089378|NCT01083173|526847379|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
146089379|NCT01083173|526847380|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
146089380|NCT01083173|526847379|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
145920455|NCT00856492|526214301|FG002|Overall Study|Ineligible or withdrew consent|2|||
145920456|NCT03832686|526214302|FG000|Overall Study|Lost to Follow-up|6|||
145920457|NCT03832686|526214303|FG001|Overall Study|Lost to Follow-up|9|||
145920458|NCT03832686|526214302|FG000|Overall Study|Discontinued Intervention|5|||
145920459|NCT03832686|526214303|FG001|Overall Study|Discontinued Intervention|4|||
145920460|NCT02235454|526214304|FG000|Overall Study|Withdrawal by Subject|2|||
145920461|NCT04199104|526216028|FG000|Overall Study|Death|148|||
145920462|NCT04199104|526216029|FG001|Overall Study|Death|134|||
145920463|NCT04199104|526216028|FG000|Overall Study|Lost to Follow-up|1|||
146089381|NCT01083173|526847380|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
146089382|NCT01083173|526847379|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
146089383|NCT01083173|526847380|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
146241220|NCT00022672|527397920|FG000|Main Phase: 24 Months|Other|1|||
146241221|NCT00022672|527397921|FG001|Main Phase: 24 Months|Other|0|||
146241222|NCT00022672|527397920|FG000|Extension Phase|Adverse Event|1|||
146241223|NCT00022672|527397921|FG001|Extension Phase|Adverse Event|3|||
146241224|NCT00022672|527397920|FG000|Extension Phase|Death|0|||
146241225|NCT00022672|527397921|FG001|Extension Phase|Death|1|||
146241226|NCT00022672|527397920|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
146241227|NCT00022672|527397921|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
146241228|NCT00022672|527397920|FG000|Extension Phase|Refused Treatment|0|||
146241229|NCT00022672|527397921|FG001|Extension Phase|Refused Treatment|2|||
146241230|NCT00022672|527397920|FG000|Extension Phase|Other|1|||
146241231|NCT00022672|527397921|FG001|Extension Phase|Other|1|||
145920464|NCT04199104|526216029|FG001|Overall Study|Lost to Follow-up|1|||
145920465|NCT04199104|526216028|FG000|Overall Study|Withdrawal by Subject|4|||
145920466|NCT04199104|526216029|FG001|Overall Study|Withdrawal by Subject|4|||
145920467|NCT04199104|526216028|FG000|Overall Study|Participants Ongoing|103|||
145920468|NCT04199104|526216029|FG001|Overall Study|Participants Ongoing|116|||
145920469|NCT04563754|526216032|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
145920470|NCT04563754|526216033|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
145920471|NCT04563754|526216034|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
145920472|NCT04563754|526216032|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
145920473|NCT04563754|526216033|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
145975049|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145920474|NCT04563754|526216034|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
145920475|NCT04563754|526216032|FG000|Follow up|Lost to Follow-up|61|||
145920476|NCT04563754|526216033|FG001|Follow up|Lost to Follow-up|23|||
145920477|NCT04563754|526216034|FG002|Follow up|Lost to Follow-up|5|||
145920478|NCT04563754|526216032|FG000|Follow up|Death|0|||
145920479|NCT04563754|526216033|FG001|Follow up|Death|2|||
145920480|NCT04563754|526216034|FG002|Follow up|Death|0|||
145920481|NCT04563754|526216032|FG000|Follow up|Ongoing|0|||
145920482|NCT04563754|526216033|FG001|Follow up|Ongoing|28|||
145920483|NCT04563754|526216034|FG002|Follow up|Ongoing|0|||
145920484|NCT04023396|526216035|FG000|Overall Study|Adverse Event|16|||
145920485|NCT04023396|526216035|FG000|Overall Study|Death|1|||
145920486|NCT04023396|526216035|FG000|Overall Study|Lost to Follow-up|1|||
145920487|NCT04023396|526216035|FG000|Overall Study|Withdrawal by Subject|14|||
145920488|NCT04023396|526216035|FG000|Overall Study|Pregnancy|4|||
145920489|NCT04023396|526216035|FG000|Overall Study|Lack of Efficacy|3|||
145920490|NCT04023396|526216035|FG000|Overall Study|Physician Decision|4|||
145920491|NCT04023396|526216035|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
145920492|NCT04796961|526216038|FG000|Overall Study|Lost to Follow-up|10|||
145920493|NCT04796961|526216038|FG000|Overall Study|Withdrawal by Subject|3|||
145920494|NCT04796961|526216038|FG000|Overall Study|Left Organization|10|||
145920495|NCT04075825|526216039|FG000|Overall Study|Withdrawal by Subject|6|||
145920496|NCT04075825|526216040|FG001|Overall Study|Withdrawal by Subject|8|||
145920497|NCT04075825|526216039|FG000|Overall Study|Physician Decision|3|||
145920498|NCT04075825|526216040|FG001|Overall Study|Physician Decision|1|||
145920499|NCT04075825|526216039|FG000|Overall Study|Lost to Follow-up|5|||
145920500|NCT04075825|526216040|FG001|Overall Study|Lost to Follow-up|1|||
145920501|NCT04075825|526216039|FG000|Overall Study|Participation in New Clinical Trial|1|||
145920502|NCT04075825|526216040|FG001|Overall Study|Participation in New Clinical Trial|1|||
145920503|NCT04075825|526216039|FG000|Overall Study|Reason Not Specified|2|||
145920504|NCT04075825|526216040|FG001|Overall Study|Reason Not Specified|2|||
145920505|NCT04581824|526216044|FG000|Overall Study|Lost to Follow-up|1|||
145920506|NCT04581824|526216045|FG001|Overall Study|Lost to Follow-up|0|||
145920507|NCT04581824|526216044|FG000|Overall Study|Withdrawal by Subject|2|||
145920508|NCT04581824|526216045|FG001|Overall Study|Withdrawal by Subject|7|||
145920509|NCT04581824|526216044|FG000|Overall Study|Study terminated by sponsor|37|||
145920510|NCT04581824|526216045|FG001|Overall Study|Study terminated by sponsor|23|||
145920511|NCT04796909|526216046|FG000|Overall Study|Withdrawal by Subject|1|||
145920512|NCT04796909|526216047|FG001|Overall Study|Withdrawal by Subject|1|||
145920513|NCT03879135|526216048|FG000|Overall Study|Physician Decision|0|||
145920514|NCT03879135|526216049|FG001|Overall Study|Physician Decision|0|||
145920515|NCT03879135|526216050|FG002|Overall Study|Physician Decision|0|||
145920516|NCT03879135|526216051|FG003|Overall Study|Physician Decision|1|||
145975050|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145975051|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145975052|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145975053|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145975054|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145975055|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145975056|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
145975057|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
145975058|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145975059|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
146241232|NCT00403494|527397922|FG000|Overall Study|Adverse Event|10|||
146241233|NCT00403494|527397923|FG001|Overall Study|Adverse Event|8|||
146241234|NCT00403494|527397922|FG000|Overall Study|Withdrew Consent|3|||
146241235|NCT00403494|527397923|FG001|Overall Study|Withdrew Consent|2|||
145920517|NCT03879135|526216052|FG004|Overall Study|Physician Decision|0|||
145920518|NCT03879135|526216053|FG005|Overall Study|Physician Decision|0|||
145920519|NCT03879135|526216048|FG000|Overall Study|Withdrawal by Subject|0|||
145920520|NCT03879135|526216049|FG001|Overall Study|Withdrawal by Subject|0|||
145920521|NCT03879135|526216050|FG002|Overall Study|Withdrawal by Subject|0|||
145920522|NCT03879135|526216051|FG003|Overall Study|Withdrawal by Subject|0|||
145920523|NCT03879135|526216052|FG004|Overall Study|Withdrawal by Subject|0|||
145920524|NCT03879135|526216053|FG005|Overall Study|Withdrawal by Subject|1|||
145920525|NCT03879135|526216048|FG000|Overall Study|Site Closed by Sponsor|0|||
145920526|NCT03879135|526216049|FG001|Overall Study|Site Closed by Sponsor|0|||
145920527|NCT03879135|526216050|FG002|Overall Study|Site Closed by Sponsor|0|||
145920528|NCT03879135|526216051|FG003|Overall Study|Site Closed by Sponsor|1|||
145920529|NCT03879135|526216052|FG004|Overall Study|Site Closed by Sponsor|1|||
145920530|NCT03879135|526216053|FG005|Overall Study|Site Closed by Sponsor|0|||
145920531|NCT04162847|526216054|FG000|Overall Study|Withdrawal by Subject|7|||
146297633|NCT04598477|527604749|FG000|Overall Study|Study Terminated by Sponsor|18|||
145920532|NCT04162847|526216055|FG001|Overall Study|Withdrawal by Subject|1|||
145920533|NCT04815083|526216056|FG000|Overall Study|Physician Decision|1|||
145920534|NCT04815083|526216056|FG000|Overall Study|Study pause|2|||
145920535|NCT04815083|526216056|FG000|Overall Study|Screening failure|4|||
145920536|NCT02243605|526216057|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
145920537|NCT02243605|526216058|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
145920538|NCT02243605|526216057|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
145920539|NCT02243605|526216058|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
145920540|NCT02243605|526216057|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
145920541|NCT02243605|526216058|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
145920542|NCT02243605|526216057|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
145920543|NCT02243605|526216058|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
145920544|NCT02243605|526216057|FG000|Stage 2 - Final Analysis Population|Progression|0|||
145920545|NCT02243605|526216058|FG001|Stage 2 - Final Analysis Population|Progression|1|||
145920546|NCT01439802|526216059|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
145920547|NCT01439802|526216059|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
145920548|NCT02502149|526216060|FG000|Intermediate|Discontinued prematurely|1|||
145920549|NCT02502149|526216061|FG001|Intermediate|Discontinued prematurely|0|||
145920550|NCT02502149|526216062|FG002|Intermediate|Discontinued prematurely|0|||
145920551|NCT02502149|526216063|FG003|Intermediate|Discontinued prematurely|0|||
145920552|NCT02502149|526216064|FG004|Intermediate|Discontinued prematurely|0|||
145920553|NCT02968576|526216065|FG000|Overall Study|Pregnancy|0|||
145920554|NCT02968576|526216066|FG001|Overall Study|Pregnancy|1|||
145920555|NCT00513240|526216067|FG000|Overall Study|Did not have intended surgery|3|||
145920556|NCT00513240|526216068|FG001|Overall Study|Did not have intended surgery|0|||
145920557|NCT00513240|526216067|FG000|Overall Study|Death|3|||
145920558|NCT00513240|526216068|FG001|Overall Study|Death|3|||
145920559|NCT00513240|526216067|FG000|Overall Study|Withdrawal by Subject|7|||
145920560|NCT00513240|526216068|FG001|Overall Study|Withdrawal by Subject|4|||
145920561|NCT05263908|526216069|FG000|Overall Study|No informed consent for publication of study results|397|||
145920562|NCT05263908|526216069|FG000|Overall Study|CRF not collected|1|||
145920563|NCT01641640|526216077|FG000|Overall Study|Enrolled but not treated|1|||
145920564|NCT01641640|526216077|FG000|Overall Study|Efficacy failure|29|||
145920565|NCT01641640|526216077|FG000|Overall Study|Lost to Follow-up|3|||
145920566|NCT01641640|526216077|FG000|Overall Study|Withdrawal by Subject|2|||
145920567|NCT01641640|526216077|FG000|Overall Study|Adverse Event|1|||
145920568|NCT01433471|526216078|FG000|Overall Study|Withdrawal by Subject|0|||
145920569|NCT01433471|526216079|FG001|Overall Study|Withdrawal by Subject|1|||
145920570|NCT03711188|526216080|FG000|Overall Study|Disease progression|11|||
145920571|NCT03711188|526216080|FG000|Overall Study|Adverse Event|1|||
145920572|NCT02550561|526216081|FG000|Overall Study|Lost to Follow-up|5|||
145920573|NCT02550561|526216081|FG000|Overall Study|Withdrawal by Subject|1|||
145920574|NCT02069015|526216083|FG000|Overall Study|Lost to Follow-up|39|||
145920575|NCT02069015|526216084|FG001|Overall Study|Lost to Follow-up|32|||
145920576|NCT02069015|526216083|FG000|Overall Study|Withdrawal by Subject|1|||
145920577|NCT02069015|526216084|FG001|Overall Study|Withdrawal by Subject|1|||
145920578|NCT02285361|526216085|FG000|Overall Study|Protocol Violation|43|||
145920579|NCT02285361|526216085|FG000|Overall Study|Lost to Follow-up|5|||
145920580|NCT02285361|526216085|FG000|Overall Study|Not taken GIOTRIF|2|||
145920581|NCT02285361|526216085|FG000|Overall Study|Consented prior to the contract date|1|||
145920582|NCT05506046|526216086|FG000|Overall Study|Lost to Follow-up|89|||
145920583|NCT05506046|526216087|FG001|Overall Study|Lost to Follow-up|101|||
145920584|NCT05506046|526216088|FG002|Overall Study|Lost to Follow-up|102|||
145920585|NCT05506046|526216089|FG003|Overall Study|Lost to Follow-up|99|||
145920586|NCT00191477|526216090|FG000|Overall Study|Tumor Recurrence|49|||
145920587|NCT00191477|526216091|FG001|Overall Study|Tumor Recurrence|48|||
145920588|NCT00191477|526216090|FG000|Overall Study|Death, Study Disease|1|||
145920589|NCT00191477|526216091|FG001|Overall Study|Death, Study Disease|1|||
145920590|NCT00191477|526216090|FG000|Overall Study|Death, Other Cause|3|||
145920591|NCT00191477|526216091|FG001|Overall Study|Death, Other Cause|6|||
145920592|NCT00191477|526216090|FG000|Overall Study|Lost to Follow-up|23|||
146297634|NCT04598477|527604750|FG001|Overall Study|Study Terminated by Sponsor|12|||
145920593|NCT00191477|526216091|FG001|Overall Study|Lost to Follow-up|21|||
145920594|NCT00191477|526216090|FG000|Overall Study|Protocol Violation|1|||
145920595|NCT00191477|526216091|FG001|Overall Study|Protocol Violation|1|||
145920596|NCT00191477|526216090|FG000|Overall Study|Treatment Change|2|||
145920597|NCT00191477|526216091|FG001|Overall Study|Treatment Change|0|||
145920598|NCT00191477|526216090|FG000|Overall Study|Withdrawal by Subject|2|||
145920599|NCT00191477|526216091|FG001|Overall Study|Withdrawal by Subject|0|||
145920600|NCT00191477|526216090|FG000|Overall Study|Other|2|||
145920601|NCT00191477|526216091|FG001|Overall Study|Other|0|||
145920602|NCT00191477|526216090|FG000|Overall Study|Not Eligible|41|||
145920603|NCT00191477|526216091|FG001|Overall Study|Not Eligible|38|||
145920604|NCT00191477|526216090|FG000|Overall Study|Pathological Specimen Lost|1|||
145920605|NCT00191477|526216091|FG001|Overall Study|Pathological Specimen Lost|0|||
145920606|NCT00191477|526216090|FG000|Overall Study|Discontinued Prior to Instillation|13|||
145920607|NCT00191477|526216091|FG001|Overall Study|Discontinued Prior to Instillation|14|||
145920608|NCT03776357|526216098|FG000|Overall Study|Lost to Follow-up|3|||
145920609|NCT05366010|526216104|FG000|Overall Study|Withdrawal by Subject|1|||
145920610|NCT05366010|526216104|FG000|Overall Study|Protocol Violation|1|||
145920611|NCT05366010|526216104|FG000|Overall Study|Lost to Follow-up|2|||
145920612|NCT05366010|526216104|FG000|Overall Study|Screen Failure|2|||
145920613|NCT01060072|526216105|FG000|Overall Study|Adverse Event|1|||
145920614|NCT01060072|526216106|FG001|Overall Study|Adverse Event|1|||
145920615|NCT01060072|526216105|FG000|Overall Study|Physician Decision|0|||
145920616|NCT01060072|526216106|FG001|Overall Study|Physician Decision|2|||
145920617|NCT01060072|526216105|FG000|Overall Study|Protocol Violation|0|||
145920618|NCT01060072|526216106|FG001|Overall Study|Protocol Violation|1|||
145920619|NCT01060072|526216105|FG000|Overall Study|Acute cholecystitis|1|||
145920620|NCT01060072|526216106|FG001|Overall Study|Acute cholecystitis|0|||
145920621|NCT01060072|526216105|FG000|Overall Study|Excluded Medications|0|||
145920622|NCT01060072|526216106|FG001|Overall Study|Excluded Medications|1|||
145920623|NCT02301169|526216107|FG000|Overall Study|Adverse Event|1|||
145920624|NCT02301169|526216108|FG001|Overall Study|Adverse Event|0|||
145920625|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
145920626|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
145920627|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
145920628|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
145920629|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
145920630|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
145920631|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
145920632|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
145920633|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
145920634|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
145920635|NCT03762265|526216113|FG000|BT Period: Weeks 1 to 37|Other|0|||
145920636|NCT03762265|526216114|FG001|BT Period: Weeks 1 to 37|Other|1|||
145920637|NCT03762265|526216113|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
145920638|NCT03762265|526216114|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
145920639|NCT03762265|526216113|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
145920640|NCT03762265|526216114|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
145920641|NCT03762265|526216113|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
145975060|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145975061|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145975062|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975063|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975064|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
145975065|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975066|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975067|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975068|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145975069|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
146089384|NCT01083173|526847379|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
146089385|NCT01083173|526847380|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
146241236|NCT00403494|527397922|FG000|Overall Study|Inappropriately enrolled|0|||
146241237|NCT00403494|527397923|FG001|Overall Study|Inappropriately enrolled|1|||
146241238|NCT00403494|527397922|FG000|Overall Study|Lost to Follow-up|0|||
146241239|NCT00403494|527397923|FG001|Overall Study|Lost to Follow-up|2|||
146241240|NCT00403494|527397922|FG000|Overall Study|Protocol noncompliance|0|||
146241241|NCT00403494|527397923|FG001|Overall Study|Protocol noncompliance|1|||
146241242|NCT00403494|527397922|FG000|Overall Study|Death|1|||
146241243|NCT00403494|527397923|FG001|Overall Study|Death|0|||
146241244|NCT00403494|527397922|FG000|Overall Study|Sponsor Request|1|||
146241245|NCT00403494|527397923|FG001|Overall Study|Sponsor Request|0|||
146241246|NCT04658784|527397930|FG000|6-month Follow-up|Lost to Follow-up|2|||
146241247|NCT04658784|527397931|FG001|6-month Follow-up|Lost to Follow-up|5|||
146241248|NCT02575365|527397932|FG000|Overall Study|Lost to Follow-up|4|||
146241249|NCT00670488|527397937|FG000|Overall Study|Adverse Event|0|||
145920642|NCT03762265|526216114|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
145920643|NCT03762265|526216113|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
146297635|NCT04598477|527604749|FG000|Overall Study|Withdrawal by Subject|16|||
146297636|NCT04598477|527604750|FG001|Overall Study|Withdrawal by Subject|12|||
146297637|NCT04598477|527604749|FG000|Overall Study|Other|15|||
145920644|NCT03762265|526216114|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
146241250|NCT00670488|527397938|FG001|Overall Study|Adverse Event|7|||
146241251|NCT00670488|527397939|FG002|Overall Study|Adverse Event|0|||
146241252|NCT00670488|527397940|FG003|Overall Study|Adverse Event|3|||
146241253|NCT00670488|527397941|FG004|Overall Study|Adverse Event|1|||
146241254|NCT00670488|527397942|FG005|Overall Study|Adverse Event|1|||
145920645|NCT03762265|526216113|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
145920646|NCT03762265|526216114|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
145920647|NCT03762265|526216113|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
145920648|NCT03762265|526216114|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
146089386|NCT01083173|526847379|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
146089387|NCT01083173|526847380|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
146089388|NCT01083173|526847379|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
146089389|NCT01083173|526847380|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
146089390|NCT01083173|526847379|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
146089391|NCT01083173|526847380|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
146089392|NCT01083173|526847379|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
146089393|NCT01083173|526847380|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
146089394|NCT01083173|526847379|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
146089395|NCT01083173|526847380|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
146089396|NCT01083173|526847379|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
146089397|NCT01083173|526847380|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
146089398|NCT01083173|526847379|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
146089399|NCT01083173|526847380|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
146089400|NCT03139604|526847383|FG000|Overall Study|Other|7|||
146089401|NCT03139604|526847384|FG001|Overall Study|Other|3|||
146089402|NCT03139604|526847383|FG000|Overall Study|Withdrawal by Subject|16|||
146089403|NCT03139604|526847384|FG001|Overall Study|Withdrawal by Subject|17|||
146089404|NCT03139604|526847383|FG000|Overall Study|Physician Decision|1|||
146089405|NCT03139604|526847384|FG001|Overall Study|Physician Decision|2|||
146089406|NCT03139604|526847383|FG000|Overall Study|Lost to Follow-up|3|||
146089407|NCT03139604|526847384|FG001|Overall Study|Lost to Follow-up|1|||
146089408|NCT03139604|526847383|FG000|Overall Study|Death|65|||
146089409|NCT03139604|526847384|FG001|Overall Study|Death|67|||
146089410|NCT03139604|526847383|FG000|Overall Study|Study Terminated by Sponsor|122|||
146089411|NCT03139604|526847384|FG001|Overall Study|Study Terminated by Sponsor|127|||
146089412|NCT03139604|526847383|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
146089413|NCT03139604|526847384|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
146089414|NCT00662532|526847388|FG000|Overall Study|Adverse Event|0|||
146089415|NCT00662532|526847389|FG001|Overall Study|Adverse Event|1|||
146089416|NCT00662532|526847388|FG000|Overall Study|Lost to Follow-up|0|||
146089417|NCT00662532|526847389|FG001|Overall Study|Lost to Follow-up|1|||
146089418|NCT00442468|526847390|FG000|Overall Study|Adverse Event|4|||
146089419|NCT00442468|526847390|FG000|Overall Study|Withdrawal by Subject|91|||
146089420|NCT00442468|526847390|FG000|Overall Study|Did not complete all study procedures|88|||
146089421|NCT00589784|526847391|FG000|Overall Study|Withdrawal by Subject|0|||
146089422|NCT00589784|526847392|FG001|Overall Study|Withdrawal by Subject|6|||
146089423|NCT00589784|526847391|FG000|Overall Study|Patient inevaluable|1|||
146089424|NCT00589784|526847392|FG001|Overall Study|Patient inevaluable|0|||
146089425|NCT00589784|526847391|FG000|Overall Study|Adverse Event|0|||
146089426|NCT00589784|526847392|FG001|Overall Study|Adverse Event|4|||
146241255|NCT00670488|527397943|FG006|Overall Study|Adverse Event|5|||
146241256|NCT00670488|527397944|FG007|Overall Study|Adverse Event|1|||
146241257|NCT00670488|527397945|FG008|Overall Study|Adverse Event|0|||
146241258|NCT00670488|527397946|FG009|Overall Study|Adverse Event|1|||
146241259|NCT00670488|527397937|FG000|Overall Study|Physician Decision|1|||
146241260|NCT00670488|527397938|FG001|Overall Study|Physician Decision|9|||
146241261|NCT00670488|527397939|FG002|Overall Study|Physician Decision|0|||
146241262|NCT00670488|527397940|FG003|Overall Study|Physician Decision|1|||
146241263|NCT00670488|527397941|FG004|Overall Study|Physician Decision|0|||
146241264|NCT00670488|527397942|FG005|Overall Study|Physician Decision|0|||
146241265|NCT00670488|527397943|FG006|Overall Study|Physician Decision|0|||
146241266|NCT00670488|527397944|FG007|Overall Study|Physician Decision|0|||
146241267|NCT00670488|527397945|FG008|Overall Study|Physician Decision|0|||
146241268|NCT00670488|527397946|FG009|Overall Study|Physician Decision|0|||
146241269|NCT00670488|527397937|FG000|Overall Study|Progressive Disease|2|||
146241270|NCT00670488|527397938|FG001|Overall Study|Progressive Disease|41|||
146241271|NCT00670488|527397939|FG002|Overall Study|Progressive Disease|3|||
146241272|NCT00670488|527397940|FG003|Overall Study|Progressive Disease|2|||
146241273|NCT00670488|527397941|FG004|Overall Study|Progressive Disease|2|||
146241274|NCT00670488|527397942|FG005|Overall Study|Progressive Disease|4|||
146241275|NCT00670488|527397943|FG006|Overall Study|Progressive Disease|11|||
146241276|NCT00670488|527397944|FG007|Overall Study|Progressive Disease|2|||
145920649|NCT03762265|526216113|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
146241277|NCT00670488|527397945|FG008|Overall Study|Progressive Disease|2|||
146241278|NCT00670488|527397946|FG009|Overall Study|Progressive Disease|1|||
146241279|NCT00670488|527397937|FG000|Overall Study|Withdrawal by Subject|0|||
146241280|NCT00670488|527397938|FG001|Overall Study|Withdrawal by Subject|1|||
146241281|NCT00670488|527397939|FG002|Overall Study|Withdrawal by Subject|0|||
146241282|NCT00670488|527397940|FG003|Overall Study|Withdrawal by Subject|1|||
146241283|NCT00670488|527397941|FG004|Overall Study|Withdrawal by Subject|0|||
146241284|NCT00670488|527397942|FG005|Overall Study|Withdrawal by Subject|0|||
146241285|NCT00670488|527397943|FG006|Overall Study|Withdrawal by Subject|1|||
146241286|NCT00670488|527397944|FG007|Overall Study|Withdrawal by Subject|0|||
146241287|NCT00670488|527397945|FG008|Overall Study|Withdrawal by Subject|1|||
146241288|NCT00670488|527397946|FG009|Overall Study|Withdrawal by Subject|0|||
146241289|NCT02708498|527397947|FG000|Overall Study|Death|20|||
146241290|NCT02708498|527397948|FG001|Overall Study|Death|19|||
146241291|NCT02708498|527397949|FG002|Overall Study|Death|0|||
146241292|NCT02708498|527397950|FG003|Overall Study|Death|0|||
146241293|NCT02708498|527397951|FG004|Overall Study|Death|1|||
146241294|NCT02708498|527397952|FG005|Overall Study|Death|0|||
146241295|NCT02708498|527397953|FG006|Overall Study|Death|0|||
145975070|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145975071|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145975072|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
145975073|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
145975074|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145975075|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
146241296|NCT02708498|527397954|FG007|Overall Study|Death|0|||
146241297|NCT02708498|527397947|FG000|Overall Study|Unknown reason, missing data|0|||
146241298|NCT02708498|527397948|FG001|Overall Study|Unknown reason, missing data|0|||
146241299|NCT02708498|527397949|FG002|Overall Study|Unknown reason, missing data|62|||
146241300|NCT02708498|527397950|FG003|Overall Study|Unknown reason, missing data|51|||
146241301|NCT02708498|527397951|FG004|Overall Study|Unknown reason, missing data|195|||
146241302|NCT02708498|527397952|FG005|Overall Study|Unknown reason, missing data|132|||
146241303|NCT02708498|527397953|FG006|Overall Study|Unknown reason, missing data|0|||
145975076|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145975077|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145975078|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975079|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975080|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
145975081|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
145975082|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975083|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975084|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975085|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145975086|NCT03329001|526420750|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975087|NCT03329001|526420751|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975088|NCT03329001|526420752|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
145975089|NCT03329001|526420753|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
145975090|NCT03329001|526420754|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975091|NCT03329001|526420755|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975092|NCT03329001|526420756|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975093|NCT03329001|526420757|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145975094|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975095|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975096|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975097|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
145975098|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975099|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975100|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975101|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145975102|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975103|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975104|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975105|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
145975106|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975107|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975108|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
146089427|NCT03823378|526847395|FG000|Overall Study|Adverse Event|2|||
146241304|NCT02708498|527397954|FG007|Overall Study|Unknown reason, missing data|0|||
146241305|NCT00195819|527397955|FG000|Double-Blind|Withdrawal by Subject|1|||
146241306|NCT00195819|527397956|FG001|Double-Blind|Withdrawal by Subject|0|||
146241307|NCT00195819|527397955|FG000|Double-Blind|Moved|1|||
146241308|NCT00195819|527397956|FG001|Double-Blind|Moved|0|||
146241309|NCT00195819|527397955|FG000|Open-label|Adverse Event|0|||
146241310|NCT00195819|527397956|FG001|Open-label|Adverse Event|9|||
145975109|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145975110|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975111|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975112|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
145975113|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975114|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975115|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975116|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975117|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145975118|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975119|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975120|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
145975121|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
145975122|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975123|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975124|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975125|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145975126|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975127|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975128|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
145975129|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975130|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975131|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975132|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975133|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145975134|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975135|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975136|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
145975137|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975138|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975139|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975140|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145975141|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
146241311|NCT00195819|527397955|FG000|Open-label|Lack of Efficacy|0|||
146241312|NCT00195819|527397956|FG001|Open-label|Lack of Efficacy|2|||
146241313|NCT00195819|527397955|FG000|Open-label|Pregnancy|0|||
146241314|NCT00195819|527397956|FG001|Open-label|Pregnancy|1|||
146241315|NCT00195819|527397955|FG000|Open-label|Protocol Violation|0|||
146241316|NCT00195819|527397956|FG001|Open-label|Protocol Violation|2|||
146241317|NCT00195819|527397955|FG000|Open-label|Moved|0|||
146241318|NCT00195819|527397956|FG001|Open-label|Moved|1|||
146241319|NCT00195819|527397955|FG000|Open-label|Withdrawal by Subject|0|||
146241320|NCT00195819|527397956|FG001|Open-label|Withdrawal by Subject|5|||
146241321|NCT01124045|527397957|FG000|Overall Study|Lost to Follow-up|0|||
146241322|NCT01124045|527397958|FG001|Overall Study|Lost to Follow-up|1|||
146241323|NCT01124045|527397957|FG000|Overall Study|Physician Decision|0|||
146241324|NCT01124045|527397958|FG001|Overall Study|Physician Decision|2|||
146241325|NCT03298087|527397959|FG000|Overall Study|Withdrawal by Subject|4|||
146241326|NCT01629589|527397960|FG000|Overall Study|Protocol Violation|4|||
146241327|NCT01629589|527397961|FG001|Overall Study|Protocol Violation|2|||
146241328|NCT01629589|527397960|FG000|Overall Study|Lost to Follow-up|2|||
146241329|NCT01629589|527397961|FG001|Overall Study|Lost to Follow-up|1|||
146241330|NCT01629589|527397960|FG000|Overall Study|Withdrawal by Subject|2|||
146241331|NCT01629589|527397961|FG001|Overall Study|Withdrawal by Subject|3|||
146241332|NCT01629589|527397960|FG000|Overall Study|Did not receive study vaccine|0|||
146241333|NCT01629589|527397961|FG001|Overall Study|Did not receive study vaccine|1|||
146241334|NCT00822900|527397962|FG000|Overall Study|Withdrawal by Subject|14|||
146241335|NCT00822900|527397963|FG001|Overall Study|Withdrawal by Subject|14|||
146241336|NCT00822900|527397962|FG000|Overall Study|Lost to Follow-up|9|||
146241337|NCT00822900|527397963|FG001|Overall Study|Lost to Follow-up|9|||
146241338|NCT00822900|527397962|FG000|Overall Study|Death|83|||
146241339|NCT00822900|527397963|FG001|Overall Study|Death|69|||
146241340|NCT00822900|527397962|FG000|Overall Study|Became a ward of the state|2|||
146241341|NCT00822900|527397963|FG001|Overall Study|Became a ward of the state|1|||
145920650|NCT03762265|526216114|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
145920651|NCT03762265|526216113|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
145920652|NCT03762265|526216114|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
145920653|NCT03762265|526216113|FG000|LTE Period: Weeks 61 to 109|Other|1|||
145920654|NCT03762265|526216114|FG001|LTE Period: Weeks 61 to 109|Other|0|||
145920655|NCT03326193|526216115|FG000|Overall Study|Sponsor decision|35|||
145920656|NCT01964976|526216118|FG000|Overall Study|Protocol Violation|31|||
145920657|NCT00699998|526216119|FG000|Overall Study|Withdrawal by Subject|194|||
145920658|NCT00699998|526216120|FG001|Overall Study|Withdrawal by Subject|83|||
145920659|NCT00699998|526216121|FG002|Overall Study|Withdrawal by Subject|202|||
145975142|NCT03329001|526420750|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975143|NCT03329001|526420751|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975144|NCT03329001|526420752|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975145|NCT03329001|526420753|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
145975146|NCT03329001|526420754|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975147|NCT03329001|526420755|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975148|NCT03329001|526420756|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145975149|NCT03329001|526420757|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
146089428|NCT03823378|526847396|FG001|Overall Study|Adverse Event|2|||
146089429|NCT03823378|526847397|FG002|Overall Study|Adverse Event|0|||
146241342|NCT02234141|527397964|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241343|NCT02234141|527397965|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241344|NCT02234141|527397966|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241345|NCT02234141|527397967|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
146241346|NCT02234141|527397968|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241347|NCT02234141|527397969|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241348|NCT02234141|527397970|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
146241349|NCT02234141|527397964|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241350|NCT02234141|527397965|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
146241351|NCT02234141|527397966|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241352|NCT02234141|527397967|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241353|NCT02234141|527397968|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241354|NCT02234141|527397969|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241355|NCT02234141|527397970|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
146241356|NCT02234141|527397964|FG000|Treatment Period (24 Weeks)|Death|1|||
146241357|NCT02234141|527397965|FG001|Treatment Period (24 Weeks)|Death|2|||
146241358|NCT02234141|527397966|FG002|Treatment Period (24 Weeks)|Death|0|||
146241359|NCT02234141|527397967|FG003|Treatment Period (24 Weeks)|Death|1|||
146241360|NCT02234141|527397968|FG004|Treatment Period (24 Weeks)|Death|0|||
146241361|NCT02234141|527397969|FG005|Treatment Period (24 Weeks)|Death|0|||
146241362|NCT02234141|527397970|FG006|Treatment Period (24 Weeks)|Death|0|||
146241363|NCT02234141|527397964|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
146241364|NCT02234141|527397965|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
146241365|NCT02234141|527397966|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
146241366|NCT02234141|527397967|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
146241367|NCT02234141|527397968|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
146241368|NCT02234141|527397969|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
146241369|NCT02234141|527397970|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
146241370|NCT02234141|527397964|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241371|NCT02234141|527397965|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
146241372|NCT02234141|527397966|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241373|NCT02234141|527397967|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241374|NCT02234141|527397968|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241375|NCT02234141|527397969|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241376|NCT02234141|527397970|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
146241377|NCT02234141|527397964|FG000|Long-Term Treatment Period|Death|0|||
146241378|NCT02234141|527397965|FG001|Long-Term Treatment Period|Death|0|||
146241379|NCT02234141|527397966|FG002|Long-Term Treatment Period|Death|0|||
146241380|NCT02234141|527397967|FG003|Long-Term Treatment Period|Death|0|||
146241381|NCT02234141|527397968|FG004|Long-Term Treatment Period|Death|0|||
146241382|NCT02234141|527397969|FG005|Long-Term Treatment Period|Death|1|||
146241383|NCT02234141|527397970|FG006|Long-Term Treatment Period|Death|0|||
146241384|NCT02234141|527397964|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
146241385|NCT02234141|527397965|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
146241386|NCT02234141|527397966|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
146241387|NCT02234141|527397967|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
145920660|NCT00699998|526216122|FG003|Overall Study|Withdrawal by Subject|80|||
146241388|NCT02234141|527397968|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
146241389|NCT02234141|527397969|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
146241390|NCT02234141|527397970|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
145920661|NCT00699998|526216119|FG000|Overall Study|Physician Decision|3|||
145920662|NCT00699998|526216120|FG001|Overall Study|Physician Decision|2|||
145920663|NCT00699998|526216121|FG002|Overall Study|Physician Decision|1|||
145920664|NCT00699998|526216122|FG003|Overall Study|Physician Decision|1|||
145920665|NCT00699998|526216119|FG000|Overall Study|Lost to Follow-up|2|||
145920666|NCT00699998|526216120|FG001|Overall Study|Lost to Follow-up|1|||
145920667|NCT00699998|526216121|FG002|Overall Study|Lost to Follow-up|3|||
145920668|NCT00699998|526216122|FG003|Overall Study|Lost to Follow-up|1|||
145920669|NCT01406574|526216123|FG000|Overall Study|Adverse Event|0|||
145920670|NCT01406574|526216124|FG001|Overall Study|Adverse Event|0|||
145920671|NCT01406574|526216125|FG002|Overall Study|Adverse Event|1|||
145920672|NCT01406574|526216126|FG003|Overall Study|Adverse Event|3|||
145920673|NCT01406574|526216123|FG000|Overall Study|Physician Decision|0|||
145920674|NCT01406574|526216124|FG001|Overall Study|Physician Decision|0|||
145920675|NCT01406574|526216125|FG002|Overall Study|Physician Decision|0|||
145920676|NCT01406574|526216126|FG003|Overall Study|Physician Decision|1|||
145920677|NCT01406574|526216123|FG000|Overall Study|Withdrawal by Subject|0|||
145920678|NCT01406574|526216124|FG001|Overall Study|Withdrawal by Subject|1|||
145920679|NCT01406574|526216125|FG002|Overall Study|Withdrawal by Subject|0|||
145920680|NCT01406574|526216126|FG003|Overall Study|Withdrawal by Subject|0|||
145920681|NCT01406574|526216123|FG000|Overall Study|Definite progression of primary disease|1|||
145920682|NCT01406574|526216124|FG001|Overall Study|Definite progression of primary disease|0|||
145920683|NCT01406574|526216125|FG002|Overall Study|Definite progression of primary disease|0|||
145920684|NCT01406574|526216126|FG003|Overall Study|Definite progression of primary disease|0|||
145920685|NCT04616612|526216133|FG000|Overall Study|Lost to Follow-up|6|||
145920686|NCT04616612|526216134|FG001|Overall Study|Lost to Follow-up|3|||
145920687|NCT04740918|526216136|FG000|Overall Study|Study Terminated by Sponsor|41|||
145920688|NCT04740918|526216137|FG001|Overall Study|Study Terminated by Sponsor|32|||
145920689|NCT04740918|526216136|FG000|Overall Study|Death|3|||
145920690|NCT04740918|526216137|FG001|Overall Study|Death|6|||
145920691|NCT04740918|526216136|FG000|Overall Study|Withdrawal by Subject|5|||
145920692|NCT04740918|526216137|FG001|Overall Study|Withdrawal by Subject|4|||
145920693|NCT04740918|526216136|FG000|Overall Study|Lost to Follow-up|1|||
145920694|NCT04740918|526216137|FG001|Overall Study|Lost to Follow-up|3|||
145920695|NCT04740918|526216136|FG000|Overall Study|Progressive disease|0|||
145920696|NCT04740918|526216137|FG001|Overall Study|Progressive disease|1|||
145920697|NCT03759392|526216139|FG000|Overall Study|Adverse Event|12|||
145920698|NCT03759392|526216140|FG001|Overall Study|Adverse Event|4|||
145920699|NCT03759392|526216139|FG000|Overall Study|Death|2|||
145920700|NCT03759392|526216140|FG001|Overall Study|Death|1|||
145920701|NCT03759392|526216139|FG000|Overall Study|Withdrawal by Subject|2|||
145920702|NCT03759392|526216140|FG001|Overall Study|Withdrawal by Subject|0|||
145920703|NCT03759392|526216139|FG000|Overall Study|Protocol Violation|2|||
145920704|NCT03759392|526216140|FG001|Overall Study|Protocol Violation|0|||
145920705|NCT03759392|526216139|FG000|Overall Study|Physician Decision|0|||
145920706|NCT03759392|526216140|FG001|Overall Study|Physician Decision|1|||
145920707|NCT03759392|526216139|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
145920708|NCT03759392|526216140|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
145920709|NCT03759392|526216139|FG000|Overall Study|No longer able to take medicines|1|||
145920710|NCT03759392|526216140|FG001|Overall Study|No longer able to take medicines|0|||
145920711|NCT03759392|526216139|FG000|Overall Study|Stopped taking study drug|1|||
145920712|NCT03759392|526216140|FG001|Overall Study|Stopped taking study drug|0|||
145920713|NCT01709500|526216141|FG000|Overall Study|Randomized but not treated|0|||
145920714|NCT01709500|526216142|FG001|Overall Study|Randomized but not treated|1|||
145920715|NCT01709500|526216141|FG000|Overall Study|Adverse Event|5|||
145920716|NCT01709500|526216142|FG001|Overall Study|Adverse Event|1|||
145920717|NCT01709500|526216141|FG000|Overall Study|Poor compliance to protocol|2|||
145920718|NCT01709500|526216142|FG001|Overall Study|Poor compliance to protocol|1|||
146089430|NCT03823378|526847398|FG003|Overall Study|Adverse Event|0|||
145920719|NCT01709500|526216141|FG000|Overall Study|Other|3|||
145920720|NCT01709500|526216142|FG001|Overall Study|Other|1|||
145920721|NCT01709500|526216141|FG000|Overall Study|Related to IMP administration|1|||
145920722|NCT01709500|526216142|FG001|Overall Study|Related to IMP administration|0|||
145920723|NCT01709500|526216141|FG000|Overall Study|Treatment ongoing|156|||
145920724|NCT01709500|526216142|FG001|Overall Study|Treatment ongoing|78|||
145920725|NCT03170544|526216143|FG000|Part 1|Lost to Follow-up|1|||
146089431|NCT03823378|526847399|FG004|Overall Study|Adverse Event|0|||
146089432|NCT03823378|526847400|FG005|Overall Study|Adverse Event|0|||
146089433|NCT03823378|526847395|FG000|Overall Study|Lost to Follow-up|0|||
145920726|NCT03170544|526216144|FG001|Part 1|Lost to Follow-up|0|||
145920727|NCT03170544|526216145|FG002|Part 1|Lost to Follow-up|0|||
145920728|NCT03170544|526216146|FG003|Part 1|Lost to Follow-up|0|||
145920729|NCT03170544|526216147|FG004|Part 1|Lost to Follow-up|0|||
145920730|NCT03170544|526216148|FG005|Part 1|Lost to Follow-up|0|||
145920731|NCT03170544|526216149|FG006|Part 1|Lost to Follow-up|0|||
145920732|NCT03170544|526216150|FG007|Part 1|Lost to Follow-up|0|||
145920733|NCT03170544|526216151|FG008|Part 1|Lost to Follow-up|0|||
145920734|NCT03170544|526216152|FG009|Part 1|Lost to Follow-up|0|||
145920735|NCT03170544|526216153|FG010|Part 1|Lost to Follow-up|0|||
145920736|NCT03170544|526216154|FG011|Part 1|Lost to Follow-up|0|||
145920737|NCT03170544|526216143|FG000|Part 1|Not treated|0|||
145920738|NCT03170544|526216144|FG001|Part 1|Not treated|0|||
145920739|NCT03170544|526216145|FG002|Part 1|Not treated|0|||
145920740|NCT03170544|526216146|FG003|Part 1|Not treated|1|||
145920741|NCT03170544|526216147|FG004|Part 1|Not treated|0|||
145920742|NCT03170544|526216148|FG005|Part 1|Not treated|0|||
145920743|NCT03170544|526216149|FG006|Part 1|Not treated|0|||
146241391|NCT02234141|527397964|FG000|Long-Term Treatment Period|Adverse Event|4|||
146241392|NCT02234141|527397965|FG001|Long-Term Treatment Period|Adverse Event|0|||
146241393|NCT02234141|527397966|FG002|Long-Term Treatment Period|Adverse Event|5|||
146241394|NCT02234141|527397967|FG003|Long-Term Treatment Period|Adverse Event|0|||
146241395|NCT02234141|527397968|FG004|Long-Term Treatment Period|Adverse Event|1|||
146241396|NCT02234141|527397969|FG005|Long-Term Treatment Period|Adverse Event|1|||
146241397|NCT02234141|527397970|FG006|Long-Term Treatment Period|Adverse Event|1|||
146241398|NCT02234141|527397964|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
146241399|NCT02234141|527397965|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
146241400|NCT02234141|527397966|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
146241401|NCT02234141|527397967|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
146241402|NCT02234141|527397968|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
146241403|NCT02234141|527397969|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
146241404|NCT02234141|527397970|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
146241405|NCT02234141|527397964|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
146241406|NCT02234141|527397965|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
146241407|NCT02234141|527397966|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
146241408|NCT02234141|527397967|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
146241409|NCT02234141|527397968|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
146241410|NCT02234141|527397969|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
146241411|NCT02234141|527397970|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
146241412|NCT03418545|527397971|FG000|Overall Study|Withdrawal by Participant|2|||
146241413|NCT03418545|527397972|FG001|Overall Study|Withdrawal by Participant|4|||
146241414|NCT03418545|527397971|FG000|Overall Study|Lost to Follow-up|3|||
146241415|NCT03418545|527397972|FG001|Overall Study|Lost to Follow-up|5|||
146241416|NCT03418545|527397971|FG000|Overall Study|Reason Not Specified|0|||
146241417|NCT03418545|527397972|FG001|Overall Study|Reason Not Specified|1|||
146241418|NCT03418545|527397971|FG000|Overall Study|Missing Completion Status|0|||
146241419|NCT03418545|527397972|FG001|Overall Study|Missing Completion Status|1|||
146241420|NCT02251652|527397973|FG000|Overall Study|Withdrawal by Subject|1|||
146241421|NCT01074242|527397974|FG000|Overall Study|Case report before date of contract|40|||
146241422|NCT01074242|527397974|FG000|Overall Study|Lost to Follow-up|1|||
146241423|NCT01074242|527397974|FG000|Overall Study|Case report unclear|6|||
146241424|NCT01074242|527397974|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
146241425|NCT01074242|527397974|FG000|Overall Study|Duplicate Case Report Form|5|||
146241426|NCT00109031|527397975|FG000|Overall Study|Adverse Event|0|||
146241427|NCT00109031|527397976|FG001|Overall Study|Adverse Event|0|||
146241428|NCT00109031|527397977|FG002|Overall Study|Adverse Event|1|||
146241429|NCT00109031|527397978|FG003|Overall Study|Adverse Event|0|||
146241430|NCT00109031|527397975|FG000|Overall Study|Withdrawal by Subject|0|||
146241431|NCT00109031|527397976|FG001|Overall Study|Withdrawal by Subject|1|||
146241432|NCT00109031|527397977|FG002|Overall Study|Withdrawal by Subject|0|||
146241433|NCT00109031|527397978|FG003|Overall Study|Withdrawal by Subject|0|||
146241434|NCT00109031|527397975|FG000|Overall Study|Physician Decision|0|||
146241435|NCT00109031|527397976|FG001|Overall Study|Physician Decision|1|||
146241436|NCT00109031|527397977|FG002|Overall Study|Physician Decision|0|||
146241437|NCT00109031|527397978|FG003|Overall Study|Physician Decision|0|||
146241438|NCT00109031|527397975|FG000|Overall Study|Protocol Violation|0|||
146241439|NCT00109031|527397976|FG001|Overall Study|Protocol Violation|0|||
146241440|NCT00109031|527397977|FG002|Overall Study|Protocol Violation|1|||
146241441|NCT00109031|527397978|FG003|Overall Study|Protocol Violation|0|||
146241442|NCT01957163|527397979|FG000|Overall Study|Adverse Event|5|||
146241443|NCT01957163|527397980|FG001|Overall Study|Adverse Event|2|||
146241444|NCT01957163|527397981|FG002|Overall Study|Adverse Event|4|||
146241445|NCT01957163|527397979|FG000|Overall Study|Lack of Efficacy|5|||
146241446|NCT01957163|527397980|FG001|Overall Study|Lack of Efficacy|4|||
146297638|NCT04598477|527604750|FG001|Overall Study|Other|8|||
146241447|NCT01957163|527397981|FG002|Overall Study|Lack of Efficacy|9|||
146241448|NCT01957163|527397979|FG000|Overall Study|Protocol Violation|1|||
146241449|NCT01957163|527397980|FG001|Overall Study|Protocol Violation|2|||
146241450|NCT01957163|527397981|FG002|Overall Study|Protocol Violation|0|||
146241451|NCT01957163|527397979|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
146241452|NCT01957163|527397980|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
146241453|NCT01957163|527397981|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
146241454|NCT01957163|527397979|FG000|Overall Study|Lost to Follow-up|0|||
146241455|NCT01957163|527397980|FG001|Overall Study|Lost to Follow-up|1|||
145920744|NCT03170544|526216150|FG007|Part 1|Not treated|0|||
145920745|NCT03170544|526216151|FG008|Part 1|Not treated|0|||
145920746|NCT03170544|526216152|FG009|Part 1|Not treated|0|||
145920747|NCT03170544|526216153|FG010|Part 1|Not treated|0|||
145920748|NCT03170544|526216154|FG011|Part 1|Not treated|0|||
145920749|NCT00420420|526216157|FG000|Overall Study|Adverse Event|5|||
145920750|NCT00420420|526216158|FG001|Overall Study|Adverse Event|3|||
145920751|NCT00420420|526216157|FG000|Overall Study|Protocol Violation|1|||
145920752|NCT00420420|526216158|FG001|Overall Study|Protocol Violation|1|||
145920753|NCT00420420|526216157|FG000|Overall Study|Withdrawal by Subject|1|||
145920754|NCT00420420|526216158|FG001|Overall Study|Withdrawal by Subject|0|||
145920755|NCT00420420|526216157|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
145920756|NCT00420420|526216158|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
145920757|NCT03323398|526216161|FG000|Overall Study|Other than Specified|0|||
145920758|NCT03323398|526216162|FG001|Overall Study|Other than Specified|1|||
145920759|NCT03323398|526216163|FG002|Overall Study|Other than Specified|2|||
145920760|NCT03323398|526216164|FG003|Overall Study|Other than Specified|0|||
145920761|NCT03323398|526216165|FG004|Overall Study|Other than Specified|0|||
145920762|NCT03323398|526216166|FG005|Overall Study|Other than Specified|0|||
145920763|NCT03323398|526216167|FG006|Overall Study|Other than Specified|1|||
145920764|NCT03323398|526216168|FG007|Overall Study|Other than Specified|0|||
145920765|NCT03323398|526216169|FG008|Overall Study|Other than Specified|2|||
145920766|NCT03323398|526216161|FG000|Overall Study|Lost to Follow-up|1|||
145920767|NCT03323398|526216162|FG001|Overall Study|Lost to Follow-up|2|||
145920768|NCT03323398|526216163|FG002|Overall Study|Lost to Follow-up|1|||
146241456|NCT01957163|527397981|FG002|Overall Study|Lost to Follow-up|0|||
145920769|NCT03323398|526216164|FG003|Overall Study|Lost to Follow-up|0|||
145920770|NCT03323398|526216165|FG004|Overall Study|Lost to Follow-up|0|||
145920771|NCT03323398|526216166|FG005|Overall Study|Lost to Follow-up|0|||
145920772|NCT03323398|526216167|FG006|Overall Study|Lost to Follow-up|0|||
145920773|NCT03323398|526216168|FG007|Overall Study|Lost to Follow-up|0|||
145920774|NCT03323398|526216169|FG008|Overall Study|Lost to Follow-up|0|||
145920775|NCT03323398|526216161|FG000|Overall Study|Death|4|||
145920776|NCT03323398|526216162|FG001|Overall Study|Death|6|||
146241457|NCT01957163|527397979|FG000|Overall Study|Withdrawal by Subject|4|||
145920777|NCT03323398|526216163|FG002|Overall Study|Death|2|||
145920778|NCT03323398|526216164|FG003|Overall Study|Death|2|||
145920779|NCT03323398|526216165|FG004|Overall Study|Death|1|||
145920780|NCT03323398|526216166|FG005|Overall Study|Death|2|||
145920781|NCT03323398|526216167|FG006|Overall Study|Death|0|||
145920782|NCT03323398|526216168|FG007|Overall Study|Death|0|||
145920783|NCT03323398|526216169|FG008|Overall Study|Death|6|||
146241458|NCT01957163|527397980|FG001|Overall Study|Withdrawal by Subject|2|||
146241459|NCT01957163|527397981|FG002|Overall Study|Withdrawal by Subject|4|||
146241460|NCT00243867|527397986|FG000|Overall Study|Adverse Event|24|||
146241461|NCT00243867|527397987|FG001|Overall Study|Adverse Event|34|||
146241462|NCT00243867|527397986|FG000|Overall Study|Lack of Efficacy|115|||
146241463|NCT00243867|527397987|FG001|Overall Study|Lack of Efficacy|78|||
146241464|NCT00243867|527397986|FG000|Overall Study|Withdrawal by Subject|11|||
146241465|NCT00243867|527397987|FG001|Overall Study|Withdrawal by Subject|23|||
146241466|NCT00243867|527397986|FG000|Overall Study|Lost to Follow-up|2|||
146241467|NCT00243867|527397987|FG001|Overall Study|Lost to Follow-up|1|||
146241468|NCT00243867|527397986|FG000|Overall Study|Physician Decision|2|||
146241469|NCT00243867|527397987|FG001|Overall Study|Physician Decision|7|||
146241470|NCT00243867|527397986|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
146241471|NCT00243867|527397987|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
146241472|NCT05182606|527398008|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
146241473|NCT02686658|527398010|FG000|Overall Study|Adverse Event|0|||
146241474|NCT02686658|527398011|FG001|Overall Study|Adverse Event|0|||
146241475|NCT02686658|527398012|FG002|Overall Study|Adverse Event|1|||
146241476|NCT02686658|527398013|FG003|Overall Study|Adverse Event|1|||
146241477|NCT02686658|527398014|FG004|Overall Study|Adverse Event|2|||
146241478|NCT02686658|527398015|FG005|Overall Study|Adverse Event|1|||
146241479|NCT02686658|527398010|FG000|Overall Study|Investigator decision|0|||
146241480|NCT02686658|527398011|FG001|Overall Study|Investigator decision|0|||
146241481|NCT02686658|527398012|FG002|Overall Study|Investigator decision|0|||
146241482|NCT02686658|527398013|FG003|Overall Study|Investigator decision|1|||
146241483|NCT02686658|527398014|FG004|Overall Study|Investigator decision|2|||
146297639|NCT05579990|527604751|FG000|Overall Study|Lost to Follow-up|3|||
145920784|NCT03323398|526216161|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
145920785|NCT03323398|526216162|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
145920786|NCT03323398|526216163|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
145920787|NCT03323398|526216164|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
145920788|NCT03323398|526216165|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
145920789|NCT03323398|526216166|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
145920790|NCT03323398|526216167|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
145920791|NCT03323398|526216168|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
145920792|NCT03323398|526216169|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
145920793|NCT03323398|526216161|FG000|Overall Study|Withdrawal by Subject|2|||
145920794|NCT03323398|526216162|FG001|Overall Study|Withdrawal by Subject|1|||
145920795|NCT03323398|526216163|FG002|Overall Study|Withdrawal by Subject|3|||
145920796|NCT03323398|526216164|FG003|Overall Study|Withdrawal by Subject|0|||
145920797|NCT03323398|526216165|FG004|Overall Study|Withdrawal by Subject|0|||
145920798|NCT03323398|526216166|FG005|Overall Study|Withdrawal by Subject|1|||
145920799|NCT03323398|526216167|FG006|Overall Study|Withdrawal by Subject|0|||
145920800|NCT03323398|526216168|FG007|Overall Study|Withdrawal by Subject|0|||
145920801|NCT03323398|526216169|FG008|Overall Study|Withdrawal by Subject|0|||
145920802|NCT03323398|526216161|FG000|Overall Study|Participant was Put on Hospice|0|||
145920803|NCT03323398|526216162|FG001|Overall Study|Participant was Put on Hospice|0|||
145920804|NCT03323398|526216163|FG002|Overall Study|Participant was Put on Hospice|0|||
145920805|NCT03323398|526216164|FG003|Overall Study|Participant was Put on Hospice|0|||
145920806|NCT03323398|526216165|FG004|Overall Study|Participant was Put on Hospice|0|||
145920807|NCT03323398|526216166|FG005|Overall Study|Participant was Put on Hospice|0|||
145920808|NCT03323398|526216167|FG006|Overall Study|Participant was Put on Hospice|1|||
145920809|NCT03323398|526216168|FG007|Overall Study|Participant was Put on Hospice|0|||
145920810|NCT03323398|526216169|FG008|Overall Study|Participant was Put on Hospice|0|||
145920811|NCT03323398|526216161|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
145920812|NCT03323398|526216162|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
145920813|NCT03323398|526216163|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
145920814|NCT03323398|526216164|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
145920815|NCT03323398|526216165|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
145920816|NCT03323398|526216166|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
145920817|NCT03323398|526216167|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
145920818|NCT03323398|526216168|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
146241484|NCT02686658|527398015|FG005|Overall Study|Investigator decision|1|||
146241485|NCT02686658|527398010|FG000|Overall Study|Sponsor decision|1|||
146241486|NCT02686658|527398011|FG001|Overall Study|Sponsor decision|2|||
146241487|NCT02686658|527398012|FG002|Overall Study|Sponsor decision|1|||
146241488|NCT02686658|527398013|FG003|Overall Study|Sponsor decision|5|||
146241489|NCT02686658|527398014|FG004|Overall Study|Sponsor decision|13|||
146241490|NCT02686658|527398015|FG005|Overall Study|Sponsor decision|2|||
146241491|NCT02686658|527398010|FG000|Overall Study|Lost to Follow-up|0|||
146241492|NCT02686658|527398011|FG001|Overall Study|Lost to Follow-up|0|||
146241493|NCT02686658|527398012|FG002|Overall Study|Lost to Follow-up|2|||
146241494|NCT02686658|527398013|FG003|Overall Study|Lost to Follow-up|0|||
146241495|NCT02686658|527398014|FG004|Overall Study|Lost to Follow-up|0|||
146241496|NCT02686658|527398015|FG005|Overall Study|Lost to Follow-up|1|||
146241497|NCT02686658|527398010|FG000|Overall Study|Death|1|||
146241498|NCT02686658|527398011|FG001|Overall Study|Death|0|||
146241499|NCT02686658|527398012|FG002|Overall Study|Death|0|||
146241500|NCT02686658|527398013|FG003|Overall Study|Death|1|||
146241501|NCT02686658|527398014|FG004|Overall Study|Death|1|||
146241502|NCT02686658|527398015|FG005|Overall Study|Death|1|||
146241503|NCT02686658|527398010|FG000|Overall Study|Withdrawal by Subject|2|||
146241504|NCT02686658|527398011|FG001|Overall Study|Withdrawal by Subject|5|||
146241505|NCT02686658|527398012|FG002|Overall Study|Withdrawal by Subject|4|||
146241506|NCT02686658|527398013|FG003|Overall Study|Withdrawal by Subject|4|||
146241507|NCT02686658|527398014|FG004|Overall Study|Withdrawal by Subject|17|||
146241508|NCT02686658|527398015|FG005|Overall Study|Withdrawal by Subject|8|||
146241509|NCT02686658|527398010|FG000|Overall Study|Placed in hospice care|0|||
146241510|NCT02686658|527398011|FG001|Overall Study|Placed in hospice care|0|||
146241511|NCT02686658|527398012|FG002|Overall Study|Placed in hospice care|1|||
146241512|NCT02686658|527398013|FG003|Overall Study|Placed in hospice care|0|||
146241513|NCT02686658|527398014|FG004|Overall Study|Placed in hospice care|0|||
146241514|NCT02686658|527398015|FG005|Overall Study|Placed in hospice care|0|||
146241515|NCT02686658|527398010|FG000|Overall Study|Participant non-compliance|0|||
145920819|NCT03323398|526216169|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
145920820|NCT03641469|526216170|FG000|Overall Study|Ineligible|2|||
145920821|NCT03641469|526216170|FG000|Overall Study|Withdrawal by Subject|5|||
145920822|NCT03641469|526216170|FG000|Overall Study|Physician Decision|1|||
145920823|NCT03641469|526216170|FG000|Overall Study|Protocol Violation|1|||
145920824|NCT03641469|526216170|FG000|Overall Study|Lost to Follow-up|2|||
145920825|NCT05479435|526216171|FG000|Overall Study|Withdrawal by Subject|1|||
145920826|NCT05479435|526216172|FG001|Overall Study|Withdrawal by Subject|0|||
145920827|NCT05479435|526216173|FG002|Overall Study|Withdrawal by Subject|0|||
146089434|NCT03823378|526847396|FG001|Overall Study|Lost to Follow-up|1|||
146241516|NCT02686658|527398011|FG001|Overall Study|Participant non-compliance|0|||
146241517|NCT02686658|527398012|FG002|Overall Study|Participant non-compliance|0|||
146241518|NCT02686658|527398013|FG003|Overall Study|Participant non-compliance|0|||
146241519|NCT02686658|527398014|FG004|Overall Study|Participant non-compliance|0|||
146241520|NCT02686658|527398015|FG005|Overall Study|Participant non-compliance|1|||
146241521|NCT02686658|527398010|FG000|Overall Study|Concern over coronavirus disease care|0|||
146241522|NCT02686658|527398011|FG001|Overall Study|Concern over coronavirus disease care|0|||
146241523|NCT02686658|527398012|FG002|Overall Study|Concern over coronavirus disease care|0|||
146241524|NCT02686658|527398013|FG003|Overall Study|Concern over coronavirus disease care|0|||
146241525|NCT02686658|527398014|FG004|Overall Study|Concern over coronavirus disease care|2|||
146241526|NCT02686658|527398015|FG005|Overall Study|Concern over coronavirus disease care|1|||
146241527|NCT02969356|527398023|FG000|Overall Study|Adverse Event|7|||
146241528|NCT02969356|527398023|FG000|Overall Study|Consent withdrawn|2|||
146241529|NCT02969356|527398023|FG000|Overall Study|Lost to Follow-up|3|||
146241530|NCT02969356|527398023|FG000|Overall Study|Did not need to be reinjected|6|||
146241531|NCT02969356|527398023|FG000|Overall Study|Personal reasons|5|||
146241532|NCT02556918|527399449|FG000|Overall Study|Protocol Violation|5|||
146241533|NCT02556918|527399450|FG001|Overall Study|Protocol Violation|6|||
146241534|NCT02556918|527399449|FG000|Overall Study|Withdrawal by Subject|4|||
146241535|NCT02556918|527399450|FG001|Overall Study|Withdrawal by Subject|4|||
146241536|NCT04511702|527399456|FG000|Overall Study|Lost to Follow-up|3|||
146241537|NCT04511702|527399457|FG001|Overall Study|Lost to Follow-up|0|||
146241538|NCT04511702|527399458|FG002|Overall Study|Lost to Follow-up|4|||
146241539|NCT04511702|527399456|FG000|Overall Study|Withdrawal by Subject|17|||
146241540|NCT04511702|527399457|FG001|Overall Study|Withdrawal by Subject|1|||
146241541|NCT04511702|527399458|FG002|Overall Study|Withdrawal by Subject|8|||
146241542|NCT04493424|527399459|FG000|Overall Study|Termination of the trial by the sponsor|89|||
146241543|NCT04493424|527399459|FG000|Overall Study|Withdrawal by Subject|9|||
146241544|NCT04493424|527399459|FG000|Overall Study|Lost to Follow-up|2|||
146241545|NCT04493424|527399459|FG000|Overall Study|Lack of Efficacy|3|||
146241546|NCT04493424|527399459|FG000|Overall Study|Adverse Event|5|||
146241547|NCT00108355|527399463|FG000|Overall Study|Peritonitis at index paracentesis|1|||
146241548|NCT00108355|527399464|FG001|Overall Study|Peritonitis at index paracentesis|1|||
146241549|NCT00108355|527399463|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
146241550|NCT00108355|527399464|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
146241551|NCT04992273|527399465|FG000|Overall Study|Lost to Follow-up|0|||
146241552|NCT04992273|527399466|FG001|Overall Study|Lost to Follow-up|1|||
146241553|NCT01364597|527399467|FG000|Overall Study|Adverse Event|4|||
146241554|NCT01364597|527399468|FG001|Overall Study|Adverse Event|5|||
146241555|NCT01364597|527399469|FG002|Overall Study|Adverse Event|16|||
146241556|NCT01364597|527399470|FG003|Overall Study|Adverse Event|7|||
146241557|NCT01364597|527399467|FG000|Overall Study|Lack of Efficacy|4|||
146241558|NCT01364597|527399468|FG001|Overall Study|Lack of Efficacy|4|||
146241559|NCT01364597|527399469|FG002|Overall Study|Lack of Efficacy|23|||
146241560|NCT01364597|527399470|FG003|Overall Study|Lack of Efficacy|8|||
146241561|NCT01364597|527399467|FG000|Overall Study|Protocol Violation|0|||
146241562|NCT01364597|527399468|FG001|Overall Study|Protocol Violation|0|||
146241563|NCT01364597|527399469|FG002|Overall Study|Protocol Violation|2|||
146241564|NCT01364597|527399470|FG003|Overall Study|Protocol Violation|0|||
146241565|NCT01364597|527399467|FG000|Overall Study|Lost to Follow-up|0|||
146241566|NCT01364597|527399468|FG001|Overall Study|Lost to Follow-up|0|||
146241567|NCT01364597|527399469|FG002|Overall Study|Lost to Follow-up|5|||
146241568|NCT01364597|527399470|FG003|Overall Study|Lost to Follow-up|3|||
146241569|NCT01364597|527399467|FG000|Overall Study|Withdrawal by Subject|4|||
146241570|NCT01364597|527399468|FG001|Overall Study|Withdrawal by Subject|1|||
146241571|NCT01364597|527399469|FG002|Overall Study|Withdrawal by Subject|18|||
146241572|NCT01364597|527399470|FG003|Overall Study|Withdrawal by Subject|6|||
146241573|NCT01364597|527399467|FG000|Overall Study|Non compliance|1|||
146241574|NCT01364597|527399468|FG001|Overall Study|Non compliance|0|||
146241575|NCT01364597|527399469|FG002|Overall Study|Non compliance|1|||
146241576|NCT01364597|527399470|FG003|Overall Study|Non compliance|0|||
146241577|NCT01364597|527399467|FG000|Overall Study|Lack of compliance|1|||
146241578|NCT01364597|527399468|FG001|Overall Study|Lack of compliance|0|||
146241579|NCT01364597|527399469|FG002|Overall Study|Lack of compliance|0|||
146241580|NCT01364597|527399470|FG003|Overall Study|Lack of compliance|0|||
146241581|NCT01364597|527399467|FG000|Overall Study|End of treatment epilepsy|1|||
146241582|NCT01364597|527399468|FG001|Overall Study|End of treatment epilepsy|0|||
146241583|NCT01364597|527399469|FG002|Overall Study|End of treatment epilepsy|0|||
146241584|NCT01364597|527399470|FG003|Overall Study|End of treatment epilepsy|0|||
146241585|NCT01364597|527399467|FG000|Overall Study|No Seizures|1|||
146241586|NCT01364597|527399468|FG001|Overall Study|No Seizures|0|||
146241587|NCT01364597|527399469|FG002|Overall Study|No Seizures|0|||
146241588|NCT01364597|527399470|FG003|Overall Study|No Seizures|0|||
146241589|NCT01364597|527399467|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
146241590|NCT01364597|527399468|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
146241591|NCT01364597|527399469|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
146241592|NCT01364597|527399470|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
146241593|NCT01364597|527399467|FG000|Overall Study|Cure|1|||
146241594|NCT01364597|527399468|FG001|Overall Study|Cure|0|||
146241595|NCT01364597|527399469|FG002|Overall Study|Cure|0|||
146241596|NCT01364597|527399470|FG003|Overall Study|Cure|0|||
146241597|NCT01364597|527399467|FG000|Overall Study|Patient was moving|0|||
146241598|NCT01364597|527399468|FG001|Overall Study|Patient was moving|1|||
146241599|NCT01364597|527399469|FG002|Overall Study|Patient was moving|0|||
145975150|NCT03329001|526420750|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975151|NCT03329001|526420751|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975152|NCT03329001|526420752|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975153|NCT03329001|526420753|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975154|NCT03329001|526420754|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975155|NCT03329001|526420755|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
145975156|NCT03329001|526420756|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975157|NCT03329001|526420757|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145975158|NCT03329001|526420750|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975159|NCT03329001|526420751|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975160|NCT03329001|526420752|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975161|NCT03329001|526420753|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975162|NCT03329001|526420754|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
145975163|NCT03329001|526420755|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975164|NCT03329001|526420756|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975165|NCT03329001|526420757|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145975166|NCT03329001|526420750|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975167|NCT03329001|526420751|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975168|NCT03329001|526420752|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975169|NCT03329001|526420753|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975170|NCT03329001|526420754|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
145975171|NCT03329001|526420755|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
145975172|NCT03329001|526420756|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975173|NCT03329001|526420757|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145975174|NCT03329001|526420750|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975175|NCT03329001|526420751|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975176|NCT03329001|526420752|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975177|NCT03329001|526420753|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975178|NCT03329001|526420754|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
145975179|NCT03329001|526420755|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975180|NCT03329001|526420756|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975181|NCT03329001|526420757|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145975182|NCT03329001|526420750|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975183|NCT03329001|526420751|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975184|NCT03329001|526420752|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975185|NCT03329001|526420753|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975186|NCT03329001|526420754|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
145975187|NCT03329001|526420755|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
145975188|NCT03329001|526420756|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975189|NCT03329001|526420757|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145975190|NCT03329001|526420750|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975191|NCT03329001|526420751|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975192|NCT03329001|526420752|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975193|NCT03329001|526420753|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975194|NCT03329001|526420754|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975195|NCT03329001|526420755|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145975196|NCT03329001|526420756|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
145975197|NCT03329001|526420757|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
145975198|NCT03329001|526420750|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975199|NCT03329001|526420751|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975200|NCT03329001|526420752|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975201|NCT03329001|526420753|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975202|NCT03329001|526420754|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975203|NCT03329001|526420755|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975204|NCT03329001|526420756|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
145975205|NCT03329001|526420757|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145975206|NCT03329001|526420750|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145975207|NCT03329001|526420751|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145975208|NCT03329001|526420752|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145975209|NCT03329001|526420753|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
146297640|NCT05118204|527604752|FG000|Overall Study|Lost to Follow-up|3|||
146297641|NCT05118204|527604753|FG001|Overall Study|Lost to Follow-up|2|||
146297642|NCT05118204|527604752|FG000|Overall Study|Withdrawal by Subject|0|||
145920828|NCT05479435|526216171|FG000|Overall Study|Covid 19|0|||
145920829|NCT05479435|526216172|FG001|Overall Study|Covid 19|0|||
145920830|NCT05479435|526216173|FG002|Overall Study|Covid 19|2|||
145920831|NCT00955617|526216177|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
145920832|NCT00955617|526216178|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
145920833|NCT00955617|526216177|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
145920834|NCT00955617|526216178|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
145920835|NCT00955617|526216177|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
145920836|NCT00955617|526216178|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
145920837|NCT00955617|526216177|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
145920838|NCT00955617|526216178|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
145920839|NCT04231825|526217782|FG000|Overall Study|Protocol Violation|3|||
145920840|NCT04231825|526217783|FG001|Overall Study|Protocol Violation|3|||
145920841|NCT04231825|526217782|FG000|Overall Study|Lost to Follow-up|0|||
145920842|NCT04231825|526217783|FG001|Overall Study|Lost to Follow-up|1|||
145920843|NCT01662635|526217784|FG000|Overall Study|scarce samples for evaluation|30|||
145920844|NCT02596971|526217787|FG000|Overall Study|Death|5|||
145920845|NCT02596971|526217788|FG001|Overall Study|Death|1|||
145920846|NCT02596971|526217789|FG002|Overall Study|Death|5|||
145920847|NCT02596971|526217787|FG000|Overall Study|Withdrawal by Subject|5|||
145920848|NCT02596971|526217788|FG001|Overall Study|Withdrawal by Subject|1|||
146241600|NCT01364597|527399470|FG003|Overall Study|Patient was moving|0|||
146241601|NCT01364597|527399467|FG000|Overall Study|Seizures resolved|0|||
146241602|NCT01364597|527399468|FG001|Overall Study|Seizures resolved|0|||
146241603|NCT01364597|527399469|FG002|Overall Study|Seizures resolved|1|||
146241604|NCT01364597|527399470|FG003|Overall Study|Seizures resolved|0|||
146241605|NCT01364597|527399467|FG000|Overall Study|Patient became seizure-free after surgery|0|||
146241606|NCT01364597|527399468|FG001|Overall Study|Patient became seizure-free after surgery|0|||
146241607|NCT01364597|527399469|FG002|Overall Study|Patient became seizure-free after surgery|1|||
146241608|NCT01364597|527399470|FG003|Overall Study|Patient became seizure-free after surgery|0|||
146241609|NCT01364597|527399467|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
146241610|NCT01364597|527399468|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
146241611|NCT01364597|527399469|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
146241612|NCT01364597|527399470|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
146241613|NCT01364597|527399467|FG000|Overall Study|Patient cured from Epilepsy|0|||
146241614|NCT01364597|527399468|FG001|Overall Study|Patient cured from Epilepsy|0|||
146241615|NCT01364597|527399469|FG002|Overall Study|Patient cured from Epilepsy|1|||
146241616|NCT01364597|527399470|FG003|Overall Study|Patient cured from Epilepsy|0|||
146241617|NCT01364597|527399467|FG000|Overall Study|Investigator decision|0|||
146241618|NCT01364597|527399468|FG001|Overall Study|Investigator decision|0|||
146241619|NCT01364597|527399469|FG002|Overall Study|Investigator decision|1|||
146241620|NCT01364597|527399470|FG003|Overall Study|Investigator decision|0|||
146241621|NCT01364597|527399467|FG000|Overall Study|Sponsor recommended discontinuation|0|||
146241622|NCT01364597|527399468|FG001|Overall Study|Sponsor recommended discontinuation|0|||
146241623|NCT01364597|527399469|FG002|Overall Study|Sponsor recommended discontinuation|0|||
146241624|NCT01364597|527399470|FG003|Overall Study|Sponsor recommended discontinuation|1|||
146241625|NCT01364597|527399467|FG000|Overall Study|Parents went abroad with the patient|0|||
146241626|NCT01364597|527399468|FG001|Overall Study|Parents went abroad with the patient|0|||
146241627|NCT01364597|527399469|FG002|Overall Study|Parents went abroad with the patient|1|||
146241628|NCT01364597|527399470|FG003|Overall Study|Parents went abroad with the patient|0|||
146241629|NCT01364597|527399467|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146241630|NCT01364597|527399468|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146241631|NCT01364597|527399469|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
146241632|NCT01364597|527399470|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
146241633|NCT01364597|527399467|FG000|Overall Study|BRV administration dropout|0|||
146241634|NCT01364597|527399468|FG001|Overall Study|BRV administration dropout|0|||
146241635|NCT01364597|527399469|FG002|Overall Study|BRV administration dropout|1|||
146241636|NCT01364597|527399470|FG003|Overall Study|BRV administration dropout|0|||
146241637|NCT01364597|527399467|FG000|Overall Study|Dropout|0|||
146241638|NCT01364597|527399468|FG001|Overall Study|Dropout|0|||
146241639|NCT01364597|527399469|FG002|Overall Study|Dropout|3|||
146241640|NCT01364597|527399470|FG003|Overall Study|Dropout|1|||
146241641|NCT01364597|527399467|FG000|Overall Study|Unreliable subject|0|||
146241642|NCT01364597|527399468|FG001|Overall Study|Unreliable subject|0|||
146241643|NCT01364597|527399469|FG002|Overall Study|Unreliable subject|0|||
146241644|NCT01364597|527399470|FG003|Overall Study|Unreliable subject|1|||
146241645|NCT01364597|527399467|FG000|Overall Study|Other|0|||
146241646|NCT01364597|527399468|FG001|Overall Study|Other|0|||
146241647|NCT01364597|527399469|FG002|Overall Study|Other|0|||
146241648|NCT01364597|527399470|FG003|Overall Study|Other|1|||
146241649|NCT03493282|527399474|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
146241650|NCT03493282|527399475|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
146241651|NCT03493282|527399476|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
145975210|NCT03329001|526420754|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145975211|NCT03329001|526420755|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145975212|NCT03329001|526420756|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
145975213|NCT03329001|526420757|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
145975214|NCT03329001|526420750|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975215|NCT03329001|526420751|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975216|NCT03329001|526420752|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975217|NCT03329001|526420753|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975218|NCT03329001|526420754|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975219|NCT03329001|526420755|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145975220|NCT03329001|526420756|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
145975221|NCT03329001|526420757|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
145975222|NCT00963235|526420762|FG000|Overall Study|Withdrawal by Subject|22|||
145975223|NCT00963235|526420762|FG000|Overall Study|Lost to Follow-up|14|||
145975224|NCT00963235|526420762|FG000|Overall Study|Failed to return|9|||
145975225|NCT00963235|526420762|FG000|Overall Study|Protocol Violation|7|||
146241652|NCT03493282|527399474|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
146241653|NCT03493282|527399475|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
146241654|NCT03493282|527399476|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
146241655|NCT01380145|527399477|FG000|Overall Study|Progressive disease|4|||
146241656|NCT02698475|527399478|FG000|Main Study Period|Lack of Efficacy|1|||
146241657|NCT02698475|527399478|FG000|Main Study Period|Protocol Violation|2|||
146241658|NCT02698475|527399478|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
146241659|NCT02698475|527399478|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
146241660|NCT02698475|527399478|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
146241661|NCT02698475|527399478|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
146241662|NCT02698475|527399478|FG000|Long-Term Extension Period|Other|1|||
146241663|NCT02038049|527399479|FG000|Overall Study|Lost to Follow-up|1|||
146241664|NCT02038049|527399480|FG001|Overall Study|Lost to Follow-up|0|||
146241665|NCT02771366|527399481|FG000|Period 1|Withdrawal by Subject|0|||
146241666|NCT02771366|527399482|FG001|Period 1|Withdrawal by Subject|2|||
146241667|NCT02771366|527399481|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
146241668|NCT02771366|527399482|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
146241669|NCT00587171|527399485|FG000|Overall Study|Lost to Follow-up|1|||
146241670|NCT00587171|527399486|FG001|Overall Study|Lost to Follow-up|1|||
146241671|NCT02148705|527399490|FG000|Overall Study|Death|2|||
146241672|NCT02148705|527399491|FG001|Overall Study|Death|0|||
146241673|NCT02148705|527399492|FG002|Overall Study|Death|0|||
146241674|NCT02148705|527399490|FG000|Overall Study|Lost to Follow-up|13|||
146241675|NCT02148705|527399491|FG001|Overall Study|Lost to Follow-up|4|||
146241676|NCT02148705|527399492|FG002|Overall Study|Lost to Follow-up|10|||
146241677|NCT02148705|527399490|FG000|Overall Study|Withdrawal by Subject|3|||
146241678|NCT02148705|527399491|FG001|Overall Study|Withdrawal by Subject|0|||
146241679|NCT02148705|527399492|FG002|Overall Study|Withdrawal by Subject|2|||
146241680|NCT02148705|527399490|FG000|Overall Study|Not Treated|0|||
146241681|NCT02148705|527399491|FG001|Overall Study|Not Treated|1|||
146241682|NCT02148705|527399492|FG002|Overall Study|Not Treated|5|||
146241683|NCT01737021|527399495|FG000|Overall Study|Lost to Follow-up|5|||
146241684|NCT01737021|527399496|FG001|Overall Study|Lost to Follow-up|3|||
146241685|NCT01673594|527399497|FG000|Overall Study|Adverse Event|3|||
146241686|NCT01673594|527399498|FG001|Overall Study|Adverse Event|1|||
146241687|NCT01673594|527399497|FG000|Overall Study|Lost to Follow-up|1|||
146241688|NCT01673594|527399498|FG001|Overall Study|Lost to Follow-up|0|||
146241689|NCT01673594|527399497|FG000|Overall Study|Physician Decision|2|||
146241690|NCT01673594|527399498|FG001|Overall Study|Physician Decision|4|||
146241691|NCT01673594|527399497|FG000|Overall Study|Withdrawal by Subject|0|||
146241692|NCT01673594|527399498|FG001|Overall Study|Withdrawal by Subject|1|||
146241693|NCT02605174|527399502|FG000|Overall Study|Adverse Event|0|||
146241694|NCT02605174|527399503|FG001|Overall Study|Adverse Event|0|||
146241695|NCT02605174|527399504|FG002|Overall Study|Adverse Event|1|||
146241696|NCT02605174|527399505|FG003|Overall Study|Adverse Event|0|||
146241697|NCT02605174|527399506|FG004|Overall Study|Adverse Event|4|||
146297643|NCT05118204|527604753|FG001|Overall Study|Withdrawal by Subject|2|||
146297644|NCT01313650|527604755|FG000|Overall Study|Adverse Event|9|||
146297645|NCT01313650|527604756|FG001|Overall Study|Adverse Event|34|||
145975226|NCT00963235|526420762|FG000|Overall Study|Adverse Event|5|||
146241698|NCT02605174|527399507|FG005|Overall Study|Adverse Event|0|||
146241699|NCT02605174|527399508|FG006|Overall Study|Adverse Event|0|||
146241700|NCT02605174|527399502|FG000|Overall Study|Lost to Follow-up|20|||
146241701|NCT02605174|527399503|FG001|Overall Study|Lost to Follow-up|7|||
146241702|NCT02605174|527399504|FG002|Overall Study|Lost to Follow-up|27|||
146241703|NCT02605174|527399505|FG003|Overall Study|Lost to Follow-up|10|||
146241704|NCT02605174|527399506|FG004|Overall Study|Lost to Follow-up|20|||
146241705|NCT02605174|527399507|FG005|Overall Study|Lost to Follow-up|10|||
146241706|NCT02605174|527399508|FG006|Overall Study|Lost to Follow-up|29|||
146297646|NCT01313650|527604757|FG002|Overall Study|Adverse Event|24|||
145975227|NCT00963235|526420762|FG000|Overall Study|Physician Decision|2|||
145975228|NCT00963235|526420762|FG000|Overall Study|Other|1|||
145975229|NCT01341470|526420764|FG000|Overall Study|Sponsor decision|0|||
145975230|NCT01341470|526420765|FG001|Overall Study|Sponsor decision|0|||
145975231|NCT01341470|526420766|FG002|Overall Study|Sponsor decision|1|||
145975232|NCT01341470|526420767|FG003|Overall Study|Sponsor decision|1|||
145975233|NCT01341470|526420768|FG004|Overall Study|Sponsor decision|0|||
145975234|NCT01341470|526420769|FG005|Overall Study|Sponsor decision|1|||
145975235|NCT05376358|526420771|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
145975236|NCT05376358|526420772|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
145975237|NCT05376358|526420771|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
145975238|NCT05376358|526420772|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
145975239|NCT05376358|526420771|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
145975240|NCT05376358|526420772|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
145975241|NCT05376358|526420771|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
145975242|NCT05376358|526420772|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
145975243|NCT05376358|526420771|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
145975244|NCT05376358|526420772|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
145975245|NCT05376358|526420771|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
145975246|NCT05376358|526420772|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
145975247|NCT04225832|526420775|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
145975248|NCT04225832|526420776|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
145975249|NCT04225832|526420775|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
145975250|NCT04225832|526420776|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
145975251|NCT00311168|526420777|FG000|First Intervention|Withdrawal by Subject|2|||
145975252|NCT00311168|526420778|FG001|First Intervention|Withdrawal by Subject|2|||
145975253|NCT00311168|526420777|FG000|First Intervention|Lost to Follow-up|1|||
145975254|NCT00311168|526420778|FG001|First Intervention|Lost to Follow-up|1|||
145975255|NCT00311168|526420777|FG000|First Intervention|Protocol Violation|1|||
145975256|NCT00311168|526420778|FG001|First Intervention|Protocol Violation|1|||
145975257|NCT00311168|526420777|FG000|First Intervention|Adverse Event|1|||
145975258|NCT00311168|526420778|FG001|First Intervention|Adverse Event|0|||
145975259|NCT00311168|526420777|FG000|First Intervention|Other|2|||
145975260|NCT00311168|526420778|FG001|First Intervention|Other|2|||
145975261|NCT00311168|526420777|FG000|Second Intervention|Lost to Follow-up|9|||
145975262|NCT00311168|526420778|FG001|Second Intervention|Lost to Follow-up|2|||
145975263|NCT00311168|526420777|FG000|Second Intervention|Withdrawal by Subject|0|||
145975264|NCT00311168|526420778|FG001|Second Intervention|Withdrawal by Subject|1|||
145975265|NCT00311168|526420777|FG000|Second Intervention|Other|1|||
145975266|NCT00311168|526420778|FG001|Second Intervention|Other|1|||
145975267|NCT03323502|526420781|FG000|Overall Study|Resident could not be linked to CMS data|594|||
145975268|NCT03323502|526420782|FG001|Overall Study|Resident could not be linked to CMS data|435|||
145975269|NCT03323502|526420781|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
145975270|NCT03323502|526420782|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
145975271|NCT03323502|526420781|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
145975272|NCT03323502|526420782|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
145975273|NCT03323502|526420781|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
145975274|NCT03323502|526420782|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
145975275|NCT03323502|526420781|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
146241707|NCT02605174|527399502|FG000|Overall Study|Protocol Violation|10|||
146241708|NCT02605174|527399503|FG001|Overall Study|Protocol Violation|4|||
146241709|NCT02605174|527399504|FG002|Overall Study|Protocol Violation|14|||
146241710|NCT02605174|527399505|FG003|Overall Study|Protocol Violation|6|||
146241711|NCT02605174|527399506|FG004|Overall Study|Protocol Violation|7|||
146241712|NCT02605174|527399507|FG005|Overall Study|Protocol Violation|7|||
146241713|NCT02605174|527399508|FG006|Overall Study|Protocol Violation|12|||
146241714|NCT02605174|527399502|FG000|Overall Study|Pregnancy|1|||
146241715|NCT02605174|527399503|FG001|Overall Study|Pregnancy|0|||
146241716|NCT02605174|527399504|FG002|Overall Study|Pregnancy|0|||
146241717|NCT02605174|527399505|FG003|Overall Study|Pregnancy|2|||
146241718|NCT02605174|527399506|FG004|Overall Study|Pregnancy|0|||
146241719|NCT02605174|527399507|FG005|Overall Study|Pregnancy|0|||
146241720|NCT02605174|527399508|FG006|Overall Study|Pregnancy|0|||
146241721|NCT02605174|527399502|FG000|Overall Study|Withdrawal by Subject|9|||
146241722|NCT02605174|527399503|FG001|Overall Study|Withdrawal by Subject|6|||
146241723|NCT02605174|527399504|FG002|Overall Study|Withdrawal by Subject|14|||
146241724|NCT02605174|527399505|FG003|Overall Study|Withdrawal by Subject|11|||
146241725|NCT02605174|527399506|FG004|Overall Study|Withdrawal by Subject|6|||
146241726|NCT02605174|527399507|FG005|Overall Study|Withdrawal by Subject|4|||
146241727|NCT02605174|527399508|FG006|Overall Study|Withdrawal by Subject|15|||
146241728|NCT02605174|527399502|FG000|Overall Study|Physician Decision|2|||
146241729|NCT02605174|527399503|FG001|Overall Study|Physician Decision|0|||
146241730|NCT02605174|527399504|FG002|Overall Study|Physician Decision|0|||
146241731|NCT02605174|527399505|FG003|Overall Study|Physician Decision|0|||
146241732|NCT02605174|527399506|FG004|Overall Study|Physician Decision|0|||
146241733|NCT02605174|527399507|FG005|Overall Study|Physician Decision|0|||
146241734|NCT02605174|527399508|FG006|Overall Study|Physician Decision|3|||
146241735|NCT02605174|527399502|FG000|Overall Study|Randomization Failure|22|||
146241736|NCT02605174|527399503|FG001|Overall Study|Randomization Failure|6|||
146241737|NCT02605174|527399504|FG002|Overall Study|Randomization Failure|20|||
146241738|NCT02605174|527399505|FG003|Overall Study|Randomization Failure|7|||
146241739|NCT02605174|527399506|FG004|Overall Study|Randomization Failure|16|||
146241740|NCT02605174|527399507|FG005|Overall Study|Randomization Failure|11|||
146241741|NCT02605174|527399508|FG006|Overall Study|Randomization Failure|30|||
146241742|NCT04250636|527399509|FG000|Overall Study|Lost to Follow-up|2|||
146241743|NCT01779050|527399511|FG000|Overall Study|Withdrawal by Subject|1|||
146241744|NCT01779050|527399512|FG001|Overall Study|Withdrawal by Subject|0|||
146241745|NCT01353274|527399513|FG000|Overall Study|No case report form (CRF) collected|28|||
146241746|NCT03737110|527399516|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
146241747|NCT03737110|527399517|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
146241748|NCT03737110|527399518|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
146241749|NCT03737110|527399519|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
146241750|NCT03737110|527399520|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
146241751|NCT03737110|527399521|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
146241752|NCT03737110|527399516|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
146241753|NCT03737110|527399517|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146241754|NCT03737110|527399518|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146241755|NCT03737110|527399519|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146241756|NCT03737110|527399520|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146241757|NCT03737110|527399521|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
146241758|NCT03737110|527399516|FG000|Run-in (RI) Period|Adverse Event|4|||
146241759|NCT03737110|527399517|FG001|Run-in (RI) Period|Adverse Event|0|||
146241760|NCT03737110|527399518|FG002|Run-in (RI) Period|Adverse Event|0|||
146241761|NCT03737110|527399519|FG003|Run-in (RI) Period|Adverse Event|0|||
146241762|NCT03737110|527399520|FG004|Run-in (RI) Period|Adverse Event|0|||
146241763|NCT03737110|527399521|FG005|Run-in (RI) Period|Adverse Event|0|||
146241764|NCT03737110|527399516|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146241765|NCT03737110|527399517|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
146241766|NCT03737110|527399518|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146241767|NCT03737110|527399519|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146241768|NCT03737110|527399520|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146241769|NCT03737110|527399521|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
146241770|NCT03737110|527399516|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146241771|NCT03737110|527399517|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146241772|NCT03737110|527399518|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
146241773|NCT03737110|527399519|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146241774|NCT03737110|527399520|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146241775|NCT03737110|527399521|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
146241776|NCT03737110|527399516|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146241777|NCT03737110|527399517|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146241778|NCT03737110|527399518|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146241779|NCT03737110|527399519|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
146241780|NCT03737110|527399520|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146241781|NCT03737110|527399521|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145920849|NCT02596971|526217789|FG002|Overall Study|Withdrawal by Subject|4|||
145920850|NCT01401361|526217790|FG000|Overall Study|Withdrawal by Subject|16|||
145920851|NCT01401361|526217790|FG000|Overall Study|Lack of Efficacy|6|||
146241782|NCT03737110|527399516|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146241783|NCT03737110|527399517|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146241784|NCT03737110|527399518|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146241785|NCT03737110|527399519|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
146241786|NCT03737110|527399520|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
146241787|NCT03737110|527399521|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
146241788|NCT03737110|527399516|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146297647|NCT01313650|527604758|FG003|Overall Study|Adverse Event|23|||
145920852|NCT01401361|526217790|FG000|Overall Study|Physician Decision|1|||
145975276|NCT03323502|526420782|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
145975277|NCT03965923|526420785|FG000|Overall Study|Withdrawal by Subject|1|||
145975278|NCT03965923|526420786|FG001|Overall Study|Withdrawal by Subject|2|||
145975279|NCT03965923|526420787|FG002|Overall Study|Withdrawal by Subject|3|||
145975280|NCT03965923|526420788|FG003|Overall Study|Withdrawal by Subject|1|||
145975281|NCT03965923|526420789|FG004|Overall Study|Withdrawal by Subject|2|||
145975282|NCT03965923|526420790|FG005|Overall Study|Withdrawal by Subject|0|||
145975283|NCT03965923|526420791|FG006|Overall Study|Withdrawal by Subject|4|||
145975284|NCT03965923|526420792|FG007|Overall Study|Withdrawal by Subject|3|||
145975285|NCT03965923|526420793|FG008|Overall Study|Withdrawal by Subject|4|||
146241789|NCT03737110|527399517|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146241790|NCT03737110|527399518|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146241791|NCT03737110|527399519|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146241792|NCT03737110|527399520|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
146241793|NCT03737110|527399521|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
146241794|NCT03648541|527399522|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
146241795|NCT03648541|527399523|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
146241796|NCT03648541|527399522|FG000|Re-induction Period Only|Lack of Efficacy|7|||
146241797|NCT03648541|527399523|FG001|Re-induction Period Only|Lack of Efficacy|0|||
146241798|NCT03648541|527399522|FG000|Maintenance Period Only|Missing|0|||
146241799|NCT03648541|527399523|FG001|Maintenance Period Only|Missing|1|||
146241800|NCT03648541|527399522|FG000|Maintenance Period Only|Other not listed below|0|||
146241801|NCT03648541|527399523|FG001|Maintenance Period Only|Other not listed below|4|||
146241802|NCT03648541|527399522|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
146241803|NCT03648541|527399523|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
146241804|NCT03648541|527399522|FG000|Maintenance Period Only|Protocol Violation|0|||
146241805|NCT03648541|527399523|FG001|Maintenance Period Only|Protocol Violation|1|||
146241806|NCT03648541|527399522|FG000|Maintenance Period Only|Lack of Efficacy|0|||
146241807|NCT03648541|527399523|FG001|Maintenance Period Only|Lack of Efficacy|18|||
146241808|NCT03648541|527399522|FG000|Maintenance Period Only|Adverse Event|0|||
146241809|NCT03648541|527399523|FG001|Maintenance Period Only|Adverse Event|4|||
146241810|NCT03648541|527399522|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
146241811|NCT03648541|527399523|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
146241812|NCT03052517|527399524|FG000|Overall Study|Study Terminated By Sponsor|928|||
146241813|NCT03052517|527399525|FG001|Overall Study|Study Terminated By Sponsor|938|||
146241814|NCT03052517|527399526|FG002|Overall Study|Study Terminated By Sponsor|296|||
146241815|NCT03052517|527399524|FG000|Overall Study|Subject/Guardian Decision|50|||
146241816|NCT03052517|527399525|FG001|Overall Study|Subject/Guardian Decision|45|||
146241817|NCT03052517|527399526|FG002|Overall Study|Subject/Guardian Decision|22|||
146241818|NCT03052517|527399524|FG000|Overall Study|Lack of Efficacy|23|||
146241819|NCT03052517|527399525|FG001|Overall Study|Lack of Efficacy|14|||
146241820|NCT03052517|527399526|FG002|Overall Study|Lack of Efficacy|7|||
146241821|NCT03052517|527399524|FG000|Overall Study|Adverse Event|6|||
146241822|NCT03052517|527399525|FG001|Overall Study|Adverse Event|5|||
146241823|NCT03052517|527399526|FG002|Overall Study|Adverse Event|0|||
146241824|NCT03052517|527399524|FG000|Overall Study|Physician Decision|4|||
146241825|NCT03052517|527399525|FG001|Overall Study|Physician Decision|5|||
146241826|NCT03052517|527399526|FG002|Overall Study|Physician Decision|1|||
146241827|NCT03052517|527399524|FG000|Overall Study|Death|3|||
146241828|NCT03052517|527399525|FG001|Overall Study|Death|0|||
146241829|NCT03052517|527399526|FG002|Overall Study|Death|1|||
146241830|NCT03052517|527399524|FG000|Overall Study|Lost to Follow-up|2|||
146241831|NCT03052517|527399525|FG001|Overall Study|Lost to Follow-up|4|||
146241832|NCT03052517|527399526|FG002|Overall Study|Lost to Follow-up|0|||
146241833|NCT03052517|527399524|FG000|Overall Study|Pregnancy|1|||
146241834|NCT03052517|527399525|FG001|Overall Study|Pregnancy|0|||
145975286|NCT03965923|526420794|FG009|Overall Study|Withdrawal by Subject|0|||
145975287|NCT03965923|526420795|FG010|Overall Study|Withdrawal by Subject|2|||
145975288|NCT03965923|526420796|FG011|Overall Study|Withdrawal by Subject|0|||
146089435|NCT03823378|526847397|FG002|Overall Study|Lost to Follow-up|0|||
146089436|NCT03823378|526847398|FG003|Overall Study|Lost to Follow-up|0|||
146241835|NCT03052517|527399526|FG002|Overall Study|Pregnancy|1|||
146241836|NCT03052517|527399524|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146241837|NCT03052517|527399525|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
146297648|NCT01313650|527604755|FG000|Overall Study|Lack of Efficacy|37|||
146297649|NCT01313650|527604756|FG001|Overall Study|Lack of Efficacy|20|||
146241838|NCT03052517|527399526|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
146241839|NCT03052517|527399524|FG000|Overall Study|Technical Problems|0|||
146241840|NCT03052517|527399525|FG001|Overall Study|Technical Problems|1|||
146241841|NCT03052517|527399526|FG002|Overall Study|Technical Problems|0|||
146241842|NCT05260437|527399529|FG000|Overall Study|Lost to Follow-up|5|||
146241843|NCT05260437|527399530|FG001|Overall Study|Lost to Follow-up|2|||
146241844|NCT05260437|527399531|FG002|Overall Study|Lost to Follow-up|1|||
146241845|NCT05260437|527399532|FG003|Overall Study|Lost to Follow-up|2|||
145920853|NCT01401361|526217790|FG000|Overall Study|Lost to Follow-up|3|||
145920854|NCT01401361|526217790|FG000|Overall Study|Subject/family decision post procedure|2|||
145920855|NCT00595920|526217791|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
145920856|NCT00351468|526217792|FG000|Overall Study|Adverse Event|42|||
146089437|NCT03823378|526847399|FG004|Overall Study|Lost to Follow-up|1|||
146089438|NCT03823378|526847400|FG005|Overall Study|Lost to Follow-up|0|||
146089439|NCT03823378|526847395|FG000|Overall Study|Withdrawal by Subject|0|||
146241846|NCT05260437|527399533|FG004|Overall Study|Lost to Follow-up|2|||
145920857|NCT00351468|526217792|FG000|Overall Study|Withdrawal by Subject|39|||
145920858|NCT00351468|526217792|FG000|Overall Study|Various -follow up w clinical team|39|||
145920859|NCT00351468|526217792|FG000|Overall Study|Lack of Efficacy|32|||
145920860|NCT00351468|526217792|FG000|Overall Study|Non-compliance|8|||
145920861|NCT00351468|526217792|FG000|Overall Study|Lost to Follow-up|4|||
145920862|NCT00351468|526217792|FG000|Overall Study|Protocol Violation|3|||
145920863|NCT00611923|526217793|FG000|Overall Study|Withdrawal by Subject|2|||
145920864|NCT00611923|526217794|FG001|Overall Study|Withdrawal by Subject|2|||
145920865|NCT04565145|526217795|FG000|Overall Study|Withdrawal by Subject|1|||
145920866|NCT04565145|526217796|FG001|Overall Study|Withdrawal by Subject|1|||
145920867|NCT03096314|526217797|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
145920868|NCT03096314|526217798|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
145920869|NCT02764762|526217799|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145920870|NCT02764762|526217799|FG000|Overall Study|Lost to Follow-up|4|||
145920871|NCT02764762|526217799|FG000|Overall Study|Voluntary Withdrawal|8|||
145920872|NCT02764762|526217799|FG000|Overall Study|Site Termination|1|||
145920873|NCT02764762|526217799|FG000|Overall Study|Lack of Efficacy|16|||
145920874|NCT02764762|526217799|FG000|Overall Study|Reason not Specified|1|||
145920875|NCT03318861|526217803|FG000|Overall Study|Death|2|||
145920876|NCT03318861|526217804|FG001|Overall Study|Death|3|||
145920877|NCT03318861|526217805|FG002|Overall Study|Death|3|||
145920878|NCT03318861|526217806|FG003|Overall Study|Death|2|||
145920879|NCT03318861|526217807|FG004|Overall Study|Death|2|||
145920880|NCT03318861|526217803|FG000|Overall Study|Enrolled But Never Treated|0|||
145920881|NCT03318861|526217804|FG001|Overall Study|Enrolled But Never Treated|1|||
145920882|NCT03318861|526217805|FG002|Overall Study|Enrolled But Never Treated|0|||
145920883|NCT03318861|526217806|FG003|Overall Study|Enrolled But Never Treated|1|||
145920884|NCT03318861|526217807|FG004|Overall Study|Enrolled But Never Treated|1|||
145920885|NCT03318861|526217803|FG000|Overall Study|Informed Consent Withdraw|0|||
145920886|NCT03318861|526217804|FG001|Overall Study|Informed Consent Withdraw|0|||
145920887|NCT03318861|526217805|FG002|Overall Study|Informed Consent Withdraw|0|||
145920888|NCT03318861|526217806|FG003|Overall Study|Informed Consent Withdraw|1|||
145920889|NCT03318861|526217807|FG004|Overall Study|Informed Consent Withdraw|0|||
145920890|NCT03318861|526217803|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
145920891|NCT03318861|526217804|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145920892|NCT03318861|526217805|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145920893|NCT03318861|526217806|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145920894|NCT03318861|526217807|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145920895|NCT00471081|526217808|FG000|Active Phase|Protocol Violation|1|||
145920896|NCT00471081|526217809|FG001|Active Phase|Protocol Violation|1|||
145920897|NCT00471081|526217808|FG000|Active Phase|Withdrawal by Subject|0|||
145920898|NCT00471081|526217809|FG001|Active Phase|Withdrawal by Subject|3|||
146089440|NCT03823378|526847396|FG001|Overall Study|Withdrawal by Subject|1|||
146089441|NCT03823378|526847397|FG002|Overall Study|Withdrawal by Subject|4|||
146241847|NCT05260437|527399529|FG000|Overall Study|Withdrawal by Subject|3|||
146241848|NCT05260437|527399530|FG001|Overall Study|Withdrawal by Subject|0|||
146241849|NCT05260437|527399531|FG002|Overall Study|Withdrawal by Subject|4|||
146241850|NCT05260437|527399532|FG003|Overall Study|Withdrawal by Subject|5|||
146241851|NCT05260437|527399533|FG004|Overall Study|Withdrawal by Subject|0|||
146241852|NCT05260437|527399529|FG000|Overall Study|Vaccine Not Administered|0|||
146241853|NCT05260437|527399530|FG001|Overall Study|Vaccine Not Administered|1|||
146241854|NCT05260437|527399531|FG002|Overall Study|Vaccine Not Administered|0|||
146241855|NCT05260437|527399532|FG003|Overall Study|Vaccine Not Administered|0|||
146241856|NCT05260437|527399533|FG004|Overall Study|Vaccine Not Administered|0|||
146241857|NCT01858688|527399534|FG000|Overall Study|Withdrawal by Subject|8|||
146241858|NCT01858688|527399534|FG000|Overall Study|Participant began another therapy|3|||
146241859|NCT01858688|527399534|FG000|Overall Study|Physician Decision|2|||
146241860|NCT01858688|527399534|FG000|Overall Study|Progressive Disease|2|||
146241861|NCT01858688|527399534|FG000|Overall Study|Reason not reproted|5|||
146089442|NCT03823378|526847398|FG003|Overall Study|Withdrawal by Subject|2|||
146241862|NCT01530334|527399536|FG000|Overall Study|Adverse Event|3|||
145920899|NCT00471081|526217808|FG000|Active Phase|Lost to Follow-up|0|||
145920900|NCT00471081|526217809|FG001|Active Phase|Lost to Follow-up|1|||
145920901|NCT00471081|526217808|FG000|Active Phase|Lost health plan/insurance|1|||
145920902|NCT00471081|526217809|FG001|Active Phase|Lost health plan/insurance|8|||
145920903|NCT00471081|526217808|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
145920904|NCT00471081|526217809|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
146089443|NCT03823378|526847399|FG004|Overall Study|Withdrawal by Subject|0|||
146089444|NCT03823378|526847400|FG005|Overall Study|Withdrawal by Subject|1|||
146089445|NCT03823378|526847395|FG000|Overall Study|Other, not specified|19|||
146089446|NCT03823378|526847396|FG001|Overall Study|Other, not specified|12|||
146089447|NCT03823378|526847397|FG002|Overall Study|Other, not specified|6|||
146089448|NCT03823378|526847398|FG003|Overall Study|Other, not specified|8|||
146089449|NCT03823378|526847399|FG004|Overall Study|Other, not specified|17|||
146089450|NCT03823378|526847400|FG005|Overall Study|Other, not specified|7|||
146089451|NCT03190369|526847401|FG000|Overall Study|Poor compliance to protocol|0|||
145920905|NCT00471081|526217808|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
145920906|NCT00471081|526217809|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
145920907|NCT00471081|526217808|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
145920908|NCT00471081|526217809|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
145920909|NCT02844933|526217810|FG000|Overall Study|Discontinued due to premature termination of study|3|||
145920910|NCT02844933|526217811|FG001|Overall Study|Discontinued due to premature termination of study|2|||
145920911|NCT01479465|526217812|FG000|Overall Study|Disease Progression|9|||
145920912|NCT01479465|526217813|FG001|Overall Study|Disease Progression|61|||
145920913|NCT01479465|526217814|FG002|Overall Study|Disease Progression|65|||
145920914|NCT01479465|526217815|FG003|Overall Study|Disease Progression|70|||
145920915|NCT01479465|526217812|FG000|Overall Study|Study Discontinued by Sponsor|0|||
145920916|NCT01479465|526217813|FG001|Overall Study|Study Discontinued by Sponsor|7|||
145920917|NCT01479465|526217814|FG002|Overall Study|Study Discontinued by Sponsor|5|||
146089452|NCT03190369|526847402|FG001|Overall Study|Poor compliance to protocol|1|||
146089453|NCT03190369|526847401|FG000|Overall Study|Withdraw before treatment|1|||
146089454|NCT03190369|526847402|FG001|Overall Study|Withdraw before treatment|5|||
146089455|NCT03190369|526847401|FG000|Overall Study|Randomized but not treated|0|||
146089456|NCT03190369|526847402|FG001|Overall Study|Randomized but not treated|2|||
146089457|NCT01606254|526847403|FG000|Overall Study|Withdrawal by Subject|1|||
146089458|NCT01606254|526847404|FG001|Overall Study|Withdrawal by Subject|3|||
146089459|NCT01606254|526847405|FG002|Overall Study|Withdrawal by Subject|0|||
146089460|NCT01606254|526847406|FG003|Overall Study|Withdrawal by Subject|2|||
146089461|NCT01606254|526847403|FG000|Overall Study|Adverse Event|1|||
146089462|NCT01606254|526847404|FG001|Overall Study|Adverse Event|1|||
145920918|NCT01479465|526217815|FG003|Overall Study|Study Discontinued by Sponsor|3|||
145920919|NCT01479465|526217812|FG000|Overall Study|Adverse Event|0|||
145920920|NCT01479465|526217813|FG001|Overall Study|Adverse Event|3|||
145920921|NCT01479465|526217814|FG002|Overall Study|Adverse Event|6|||
145920922|NCT01479465|526217815|FG003|Overall Study|Adverse Event|4|||
145920923|NCT01479465|526217812|FG000|Overall Study|Investigator Discretion|1|||
145920924|NCT01479465|526217813|FG001|Overall Study|Investigator Discretion|4|||
145920925|NCT01479465|526217814|FG002|Overall Study|Investigator Discretion|2|||
145920926|NCT01479465|526217815|FG003|Overall Study|Investigator Discretion|4|||
145920927|NCT01479465|526217812|FG000|Overall Study|Subject Request|1|||
145920928|NCT01479465|526217813|FG001|Overall Study|Subject Request|3|||
145920929|NCT01479465|526217814|FG002|Overall Study|Subject Request|4|||
145920930|NCT01479465|526217815|FG003|Overall Study|Subject Request|2|||
145920931|NCT01479465|526217812|FG000|Overall Study|Subject Withdrew Consent|0|||
145920932|NCT01479465|526217813|FG001|Overall Study|Subject Withdrew Consent|5|||
145920933|NCT01479465|526217814|FG002|Overall Study|Subject Withdrew Consent|2|||
145920934|NCT01479465|526217815|FG003|Overall Study|Subject Withdrew Consent|1|||
145920935|NCT01479465|526217812|FG000|Overall Study|Protocol Violation|0|||
145920936|NCT01479465|526217813|FG001|Overall Study|Protocol Violation|1|||
145920937|NCT01479465|526217814|FG002|Overall Study|Protocol Violation|1|||
145920938|NCT01479465|526217815|FG003|Overall Study|Protocol Violation|0|||
145920939|NCT01479465|526217812|FG000|Overall Study|Death|0|||
145920940|NCT01479465|526217813|FG001|Overall Study|Death|0|||
145920941|NCT01479465|526217814|FG002|Overall Study|Death|0|||
145920942|NCT01479465|526217815|FG003|Overall Study|Death|1|||
145920943|NCT01479465|526217812|FG000|Overall Study|Lost to Follow-up|0|||
145920944|NCT01479465|526217813|FG001|Overall Study|Lost to Follow-up|0|||
145920945|NCT01479465|526217814|FG002|Overall Study|Lost to Follow-up|1|||
145920946|NCT01479465|526217815|FG003|Overall Study|Lost to Follow-up|0|||
145920947|NCT01892501|526217816|FG000|Overall Study|Protocol Violation|2|||
146089463|NCT01606254|526847405|FG002|Overall Study|Adverse Event|0|||
146089464|NCT01606254|526847406|FG003|Overall Study|Adverse Event|1|||
146089465|NCT04543409|526847407|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146297650|NCT01313650|527604757|FG002|Overall Study|Lack of Efficacy|32|||
145920948|NCT01892501|526217816|FG000|Overall Study|Puncture not carried out|9|||
145920949|NCT01892501|526217816|FG000|Overall Study|Radiological monitoring not carried out|5|||
145920950|NCT01892501|526217816|FG000|Overall Study|Non-contributory histological result|12|||
145920951|NCT02393950|526217821|FG000|Overall Study|Adverse Event|1|||
145920952|NCT02393950|526217822|FG001|Overall Study|Adverse Event|0|||
145920953|NCT02393950|526217821|FG000|Overall Study|Withdrawal by Subject|0|||
145920954|NCT02393950|526217822|FG001|Overall Study|Withdrawal by Subject|1|||
145920955|NCT01062425|526217828|FG000|Overall Study|Protocol Violation|3|||
145920956|NCT01062425|526217829|FG001|Overall Study|Protocol Violation|6|||
146241863|NCT01530334|527399536|FG000|Overall Study|unknown reason|1|||
146241864|NCT01530334|527399536|FG000|Overall Study|Progressive disease|47|||
146241865|NCT01303510|527399537|FG000|Overall Study|Lost to Follow-up|1|||
146241866|NCT01303510|527399538|FG001|Overall Study|Lost to Follow-up|0|||
146241867|NCT00701415|527399539|FG000|Overall Study|Adverse Event|0|||
146241868|NCT00701415|527399540|FG001|Overall Study|Adverse Event|1|||
146241869|NCT00701415|527399539|FG000|Overall Study|Social/family issues and needle phobia|1|||
146241870|NCT00701415|527399540|FG001|Overall Study|Social/family issues and needle phobia|0|||
146241871|NCT02208843|527399543|FG000|Overall Study|Clinical symptoms of progression|2|||
146241872|NCT02208843|527399543|FG000|Overall Study|Progression disease according to RECIST|24|||
146241873|NCT02208843|527399543|FG000|Overall Study|Adverse Event|12|||
146241874|NCT02208843|527399543|FG000|Overall Study|Protocol Violation|1|||
146241875|NCT02208843|527399543|FG000|Overall Study|Withdrawal by Subject|1|||
146241876|NCT02208843|527399543|FG000|Overall Study|Switched to commercial afatinib|20|||
146241877|NCT03162614|527399548|FG000|Overall Study|Lost to Follow-up|2|||
146241878|NCT03162614|527399549|FG001|Overall Study|Lost to Follow-up|1|||
146241879|NCT03162614|527399550|FG002|Overall Study|Lost to Follow-up|1|||
146241880|NCT03162614|527399551|FG003|Overall Study|Lost to Follow-up|1|||
146241881|NCT03162614|527399552|FG004|Overall Study|Lost to Follow-up|2|||
146241882|NCT03162614|527399553|FG005|Overall Study|Lost to Follow-up|0|||
146241883|NCT03162614|527399548|FG000|Overall Study|Protocol Violation|0|||
146241884|NCT03162614|527399549|FG001|Overall Study|Protocol Violation|1|||
146241885|NCT03162614|527399550|FG002|Overall Study|Protocol Violation|0|||
146241886|NCT03162614|527399551|FG003|Overall Study|Protocol Violation|1|||
146241887|NCT03162614|527399552|FG004|Overall Study|Protocol Violation|0|||
146241888|NCT03162614|527399553|FG005|Overall Study|Protocol Violation|0|||
146241889|NCT03162614|527399548|FG000|Overall Study|Withdrawal by Subject|2|||
146241890|NCT03162614|527399549|FG001|Overall Study|Withdrawal by Subject|1|||
145920957|NCT02383017|526217830|FG000|Overall Study|Injury Sustained Outside Study|1|||
145920958|NCT02383017|526217831|FG001|Overall Study|Injury Sustained Outside Study|0|||
145920959|NCT02383017|526217830|FG000|Overall Study|Compliance|3|||
145920960|NCT02383017|526217831|FG001|Overall Study|Compliance|2|||
145920961|NCT02383017|526217830|FG000|Overall Study|Found to be Hypogonadal|1|||
145920962|NCT02383017|526217831|FG001|Overall Study|Found to be Hypogonadal|0|||
145920963|NCT00927589|526217832|FG000|Overall Study|Death|1|||
145920964|NCT00927589|526217832|FG000|Overall Study|Physician Decision|1|||
145920965|NCT00927589|526217832|FG000|Overall Study|Withdrawal by Subject|3|||
145920966|NCT00927589|526217832|FG000|Overall Study|Adverse Event|2|||
145920967|NCT00927589|526217832|FG000|Overall Study|Disease Progression|8|||
145920968|NCT00927589|526217832|FG000|Overall Study|Non-compliance|1|||
145920969|NCT01651117|526217834|FG000|Overall Study|Death|2|||
145920970|NCT01651117|526217835|FG001|Overall Study|Death|3|||
145920971|NCT01651117|526217836|FG002|Overall Study|Death|2|||
145920972|NCT01651117|526217837|FG003|Overall Study|Death|2|||
145920973|NCT02088177|526217838|FG000|Overall Study|Lost to Follow-up|3|||
145920974|NCT00289848|526217840|FG000|Overall Study|Adverse Event|6|||
145920975|NCT00289848|526217841|FG001|Overall Study|Adverse Event|4|||
145920976|NCT00289848|526217840|FG000|Overall Study|Death|1|||
145920977|NCT00289848|526217841|FG001|Overall Study|Death|0|||
145920978|NCT00289848|526217840|FG000|Overall Study|Lack of Efficacy|20|||
145920979|NCT00289848|526217841|FG001|Overall Study|Lack of Efficacy|24|||
145920980|NCT00289848|526217840|FG000|Overall Study|Lost to Follow-up|3|||
145920981|NCT00289848|526217841|FG001|Overall Study|Lost to Follow-up|1|||
145920982|NCT00289848|526217840|FG000|Overall Study|Protocol Violation|5|||
145920983|NCT00289848|526217841|FG001|Overall Study|Protocol Violation|2|||
145975289|NCT03965923|526420785|FG000|Overall Study|Lost to Follow-up|2|||
145975290|NCT03965923|526420786|FG001|Overall Study|Lost to Follow-up|1|||
145975291|NCT03965923|526420787|FG002|Overall Study|Lost to Follow-up|1|||
145975292|NCT03965923|526420788|FG003|Overall Study|Lost to Follow-up|0|||
145975293|NCT03965923|526420789|FG004|Overall Study|Lost to Follow-up|2|||
145975294|NCT03965923|526420790|FG005|Overall Study|Lost to Follow-up|1|||
145975295|NCT03965923|526420791|FG006|Overall Study|Lost to Follow-up|2|||
146241891|NCT03162614|527399550|FG002|Overall Study|Withdrawal by Subject|1|||
146241892|NCT03162614|527399551|FG003|Overall Study|Withdrawal by Subject|1|||
146241893|NCT03162614|527399552|FG004|Overall Study|Withdrawal by Subject|0|||
146241894|NCT03162614|527399553|FG005|Overall Study|Withdrawal by Subject|0|||
146241895|NCT03162614|527399548|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
146241896|NCT03162614|527399549|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
146297651|NCT01313650|527604758|FG003|Overall Study|Lack of Efficacy|20|||
145920984|NCT00289848|526217840|FG000|Overall Study|Withdrawal by Subject|5|||
145920985|NCT00289848|526217841|FG001|Overall Study|Withdrawal by Subject|11|||
145920986|NCT00289848|526217840|FG000|Overall Study|Patient Moved|6|||
145920987|NCT00289848|526217841|FG001|Overall Study|Patient Moved|2|||
145920988|NCT00289848|526217840|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
145920989|NCT00289848|526217841|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
145920990|NCT01234350|526217842|FG000|Overall Study|Adverse Event|277|||
145920991|NCT01234350|526217843|FG001|Overall Study|Adverse Event|92|||
145920992|NCT01234350|526217842|FG000|Overall Study|Withdrawal by Subject|61|||
145920993|NCT01234350|526217843|FG001|Overall Study|Withdrawal by Subject|36|||
145975296|NCT03965923|526420792|FG007|Overall Study|Lost to Follow-up|1|||
145975297|NCT03965923|526420793|FG008|Overall Study|Lost to Follow-up|0|||
145975298|NCT03965923|526420794|FG009|Overall Study|Lost to Follow-up|2|||
145975299|NCT03965923|526420795|FG010|Overall Study|Lost to Follow-up|0|||
145975300|NCT03965923|526420796|FG011|Overall Study|Lost to Follow-up|0|||
145975301|NCT03965923|526420785|FG000|Overall Study|Death|0|||
145975302|NCT03965923|526420786|FG001|Overall Study|Death|0|||
145975303|NCT03965923|526420787|FG002|Overall Study|Death|0|||
145975304|NCT03965923|526420788|FG003|Overall Study|Death|0|||
145975305|NCT03965923|526420789|FG004|Overall Study|Death|0|||
145975306|NCT03965923|526420790|FG005|Overall Study|Death|0|||
145975307|NCT03965923|526420791|FG006|Overall Study|Death|0|||
145975308|NCT03965923|526420792|FG007|Overall Study|Death|1|||
145975309|NCT03965923|526420793|FG008|Overall Study|Death|4|||
145975310|NCT03965923|526420794|FG009|Overall Study|Death|0|||
145975311|NCT03965923|526420795|FG010|Overall Study|Death|4|||
145975312|NCT03965923|526420796|FG011|Overall Study|Death|0|||
145975313|NCT03965923|526420785|FG000|Overall Study|Other reason|0|||
145975314|NCT03965923|526420786|FG001|Overall Study|Other reason|0|||
145975315|NCT03965923|526420787|FG002|Overall Study|Other reason|0|||
145975316|NCT03965923|526420788|FG003|Overall Study|Other reason|1|||
145975317|NCT03965923|526420789|FG004|Overall Study|Other reason|0|||
145975318|NCT03965923|526420790|FG005|Overall Study|Other reason|0|||
145975319|NCT03965923|526420791|FG006|Overall Study|Other reason|0|||
145975320|NCT03965923|526420792|FG007|Overall Study|Other reason|0|||
145975321|NCT03965923|526420793|FG008|Overall Study|Other reason|0|||
145975322|NCT03965923|526420794|FG009|Overall Study|Other reason|0|||
145975323|NCT03965923|526420795|FG010|Overall Study|Other reason|2|||
145975324|NCT03965923|526420796|FG011|Overall Study|Other reason|0|||
145975325|NCT02452190|526420797|FG000|Overall Study|Withdrawal by Sponsor|1|||
145975326|NCT02452190|526420798|FG001|Overall Study|Withdrawal by Sponsor|3|||
145975327|NCT02452190|526420797|FG000|Overall Study|Pregnancy|1|||
145975328|NCT02452190|526420798|FG001|Overall Study|Pregnancy|0|||
145975329|NCT02452190|526420797|FG000|Overall Study|Investigator's Decision|2|||
145975330|NCT02452190|526420798|FG001|Overall Study|Investigator's Decision|0|||
145975331|NCT02452190|526420797|FG000|Overall Study|Lack of Efficacy|3|||
145975332|NCT02452190|526420798|FG001|Overall Study|Lack of Efficacy|1|||
145975333|NCT02452190|526420797|FG000|Overall Study|Lost to Follow-up|4|||
145975334|NCT02452190|526420798|FG001|Overall Study|Lost to Follow-up|3|||
145975335|NCT02452190|526420797|FG000|Overall Study|Adverse Event|2|||
145975336|NCT02452190|526420798|FG001|Overall Study|Adverse Event|5|||
145975337|NCT02452190|526420797|FG000|Overall Study|Withdrawal by Subject|20|||
145975338|NCT02452190|526420798|FG001|Overall Study|Withdrawal by Subject|11|||
145975339|NCT02452190|526420797|FG000|Overall Study|Noncompliance with study drug|1|||
145975340|NCT02452190|526420798|FG001|Overall Study|Noncompliance with study drug|0|||
145975341|NCT02452190|526420797|FG000|Overall Study|Participant traveled abroad|1|||
145975342|NCT02452190|526420798|FG001|Overall Study|Participant traveled abroad|0|||
145975343|NCT02452190|526420797|FG000|Overall Study|Death|0|||
145975344|NCT02452190|526420798|FG001|Overall Study|Death|1|||
145975345|NCT06001021|526420801|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
145975346|NCT06001021|526420802|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145975347|NCT06001021|526420803|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145975348|NCT06001021|526420804|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
145975349|NCT06001021|526420805|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
145975350|NCT06001021|526420806|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
145975351|NCT06001021|526420807|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145975352|NCT06001021|526420801|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
145975353|NCT06001021|526420802|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145975354|NCT06001021|526420803|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145975355|NCT06001021|526420804|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
145975356|NCT06001021|526420805|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
145975357|NCT06001021|526420806|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145975358|NCT06001021|526420807|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145975359|NCT00390013|526420808|FG000|Phase 1|tired|0|||
145975360|NCT00390013|526420809|FG001|Phase 1|tired|0|||
145975361|NCT00390013|526420810|FG002|Phase 1|tired|0|||
145975362|NCT00390013|526420811|FG003|Phase 1|tired|1|||
145975363|NCT00390013|526420808|FG000|Phase 2 First Treatment|tired|1|||
145975364|NCT00390013|526420809|FG001|Phase 2 First Treatment|tired|0|||
145975365|NCT00390013|526420810|FG002|Phase 2 First Treatment|tired|0|||
145975366|NCT00390013|526420811|FG003|Phase 2 First Treatment|tired|0|||
145975367|NCT00390013|526420808|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
145975368|NCT00390013|526420809|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
145975369|NCT00390013|526420810|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
146089466|NCT04543409|526847408|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145975370|NCT00390013|526420811|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
145975371|NCT02550795|526420812|FG000|Overall Study|Physician Decision|0|||
145975372|NCT02550795|526420813|FG001|Overall Study|Physician Decision|1|||
145920994|NCT01234350|526217842|FG000|Overall Study|Lost to Follow-up|115|||
145920995|NCT01234350|526217843|FG001|Overall Study|Lost to Follow-up|47|||
145920996|NCT01234350|526217842|FG000|Overall Study|Covers a diverse set of reasons|234|||
145920997|NCT01234350|526217843|FG001|Overall Study|Covers a diverse set of reasons|92|||
145920998|NCT02792517|526217851|FG000|Overall Study|Withdrawal by Subject|10|||
145920999|NCT02792517|526217851|FG000|Overall Study|Decision by Sponsor|7|||
145921000|NCT02792517|526217851|FG000|Overall Study|Lost to Follow-up|3|||
145921001|NCT01894919|526217852|FG000|Overall Study|Withdrawal by Subject|1|||
145921002|NCT01894919|526217853|FG001|Overall Study|Withdrawal by Subject|0|||
145921003|NCT01894919|526217854|FG002|Overall Study|Withdrawal by Subject|0|||
145975373|NCT02550795|526420814|FG002|Overall Study|Physician Decision|0|||
145975374|NCT02802228|526420815|FG000|Overall Study|Withdrawal by Subject|2|||
145975375|NCT02802228|526420816|FG001|Overall Study|Withdrawal by Subject|0|||
146241897|NCT03162614|527399550|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
146241898|NCT03162614|527399551|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
146241899|NCT03162614|527399552|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
146241900|NCT03162614|527399553|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
146241901|NCT01321073|527399558|FG000|Overall Study|Did not attempt implant|4|||
146241902|NCT01321073|527399558|FG000|Overall Study|Death|3|||
146241903|NCT02609048|527399565|FG000|Overall Study|Adverse Event|3|||
146241904|NCT02609048|527399566|FG001|Overall Study|Adverse Event|0|||
146241905|NCT02609048|527399567|FG002|Overall Study|Adverse Event|0|||
146241906|NCT02609048|527399565|FG000|Overall Study|Randomized but never treated|1|||
146241907|NCT02609048|527399566|FG001|Overall Study|Randomized but never treated|1|||
146241908|NCT02609048|527399567|FG002|Overall Study|Randomized but never treated|1|||
146241909|NCT02609048|527399565|FG000|Overall Study|Withdrawal of informed consent|1|||
146241910|NCT02609048|527399566|FG001|Overall Study|Withdrawal of informed consent|0|||
146241911|NCT02609048|527399567|FG002|Overall Study|Withdrawal of informed consent|0|||
146241912|NCT02609048|527399565|FG000|Overall Study|Reason not specified|6|||
146241913|NCT02609048|527399566|FG001|Overall Study|Reason not specified|9|||
146241914|NCT02609048|527399567|FG002|Overall Study|Reason not specified|9|||
146241915|NCT04186247|527399568|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
146241916|NCT04186247|527399569|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146241917|NCT04186247|527399570|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146241918|NCT04186247|527399571|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146241919|NCT04186247|527399572|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
146241920|NCT03769090|527401009|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
146241921|NCT03769090|527401010|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
146241922|NCT03769090|527401011|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
146241923|NCT03769090|527401009|FG000|Overall Study|Withdrawal by Subject|52|||
146241924|NCT03769090|527401010|FG001|Overall Study|Withdrawal by Subject|62|||
146241925|NCT03769090|527401011|FG002|Overall Study|Withdrawal by Subject|74|||
146241926|NCT03769090|527401009|FG000|Overall Study|Death|4|||
146241927|NCT03769090|527401010|FG001|Overall Study|Death|2|||
146241928|NCT03769090|527401011|FG002|Overall Study|Death|2|||
146241929|NCT03769090|527401009|FG000|Overall Study|Adverse Event|7|||
146241930|NCT03769090|527401010|FG001|Overall Study|Adverse Event|7|||
146241931|NCT03769090|527401011|FG002|Overall Study|Adverse Event|8|||
146241932|NCT03769090|527401009|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
146241933|NCT03769090|527401010|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
146241934|NCT03769090|527401011|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
146241935|NCT03769090|527401009|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
146241936|NCT03769090|527401010|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
146241937|NCT03769090|527401011|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
146241938|NCT03769090|527401009|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
146241939|NCT03769090|527401010|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
146241940|NCT03769090|527401011|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
146241941|NCT03769090|527401009|FG000|Overall Study|Protocol Violation|5|||
146241942|NCT03769090|527401010|FG001|Overall Study|Protocol Violation|6|||
146241943|NCT03769090|527401011|FG002|Overall Study|Protocol Violation|8|||
145921004|NCT01894919|526217855|FG003|Overall Study|Withdrawal by Subject|0|||
145921005|NCT01894919|526217856|FG004|Overall Study|Withdrawal by Subject|1|||
145921006|NCT01894919|526217857|FG005|Overall Study|Withdrawal by Subject|0|||
145921007|NCT01894919|526217858|FG006|Overall Study|Withdrawal by Subject|0|||
145921008|NCT01894919|526217859|FG007|Overall Study|Withdrawal by Subject|0|||
145975376|NCT02802228|526420815|FG000|Overall Study|Lost to Follow-up|1|||
146241944|NCT03769090|527401009|FG000|Overall Study|Pregnancy|1|||
146241945|NCT03769090|527401010|FG001|Overall Study|Pregnancy|0|||
146241946|NCT03769090|527401011|FG002|Overall Study|Pregnancy|3|||
145921009|NCT01894919|526217860|FG008|Overall Study|Withdrawal by Subject|0|||
145921010|NCT01894919|526217861|FG009|Overall Study|Withdrawal by Subject|1|||
145921011|NCT01894919|526217862|FG010|Overall Study|Withdrawal by Subject|1|||
145975377|NCT02802228|526420816|FG001|Overall Study|Lost to Follow-up|0|||
145975378|NCT02802228|526420815|FG000|Overall Study|Adverse Event|1|||
145975379|NCT02802228|526420816|FG001|Overall Study|Adverse Event|0|||
145975380|NCT02802228|526420815|FG000|Overall Study|Physician Decision|1|||
145975381|NCT02802228|526420816|FG001|Overall Study|Physician Decision|0|||
145975382|NCT00695019|526420817|FG000|Overall Study|Withdrawal by Subject|8|||
145975383|NCT00695019|526420818|FG001|Overall Study|Withdrawal by Subject|6|||
145975384|NCT00695019|526420819|FG002|Overall Study|Withdrawal by Subject|4|||
145975385|NCT00695019|526420817|FG000|Overall Study|Protocol Violation|1|||
145975386|NCT00695019|526420818|FG001|Overall Study|Protocol Violation|3|||
145975387|NCT00695019|526420819|FG002|Overall Study|Protocol Violation|1|||
145975388|NCT00695019|526420817|FG000|Overall Study|Lack of Efficacy|0|||
145975389|NCT00695019|526420818|FG001|Overall Study|Lack of Efficacy|0|||
145975390|NCT00695019|526420819|FG002|Overall Study|Lack of Efficacy|1|||
145975391|NCT00695019|526420817|FG000|Overall Study|Various|4|||
145975392|NCT00695019|526420818|FG001|Overall Study|Various|5|||
145975393|NCT00695019|526420819|FG002|Overall Study|Various|4|||
145975394|NCT02225587|526420820|FG000|Overall Study|Adverse Event|5|||
145975395|NCT02225587|526420821|FG001|Overall Study|Adverse Event|5|||
145975396|NCT02225587|526420820|FG000|Overall Study|Lost to Follow-up|5|||
145975397|NCT02225587|526420821|FG001|Overall Study|Lost to Follow-up|5|||
145975398|NCT02225587|526420820|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145975399|NCT02225587|526420821|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145975400|NCT02225587|526420820|FG000|Overall Study|Physician Decision|2|||
145975401|NCT02225587|526420821|FG001|Overall Study|Physician Decision|0|||
145975402|NCT02225587|526420820|FG000|Overall Study|Protocol Violation|1|||
145975403|NCT02225587|526420821|FG001|Overall Study|Protocol Violation|0|||
145975404|NCT02225587|526420820|FG000|Overall Study|Participant Moved|1|||
145975405|NCT02225587|526420821|FG001|Overall Study|Participant Moved|0|||
145975406|NCT02225587|526420820|FG000|Overall Study|Withdrawal by Subject|13|||
145975407|NCT02225587|526420821|FG001|Overall Study|Withdrawal by Subject|28|||
145975408|NCT00924898|526420822|FG000|Overall Study|Withdrawal by Subject|2|||
145975409|NCT05291689|526420828|FG000|Overall Study|Adverse Event|3|||
145975410|NCT05291689|526420828|FG000|Overall Study|Lack of Efficacy|10|||
145975411|NCT05291689|526420828|FG000|Overall Study|Withdrawal by Subject|4|||
145975412|NCT01931098|526420829|FG000|Overall Study|Withdrawal by Subject|0|||
145975413|NCT01931098|526420830|FG001|Overall Study|Withdrawal by Subject|1|||
145975414|NCT01931098|526420829|FG000|Overall Study|Enrolled in different protocol|0|||
145975415|NCT01931098|526420830|FG001|Overall Study|Enrolled in different protocol|1|||
145975416|NCT01931098|526420829|FG000|Overall Study|Unable to begin trmt:active infection|0|||
145975417|NCT01931098|526420830|FG001|Overall Study|Unable to begin trmt:active infection|1|||
145975418|NCT01931098|526420829|FG000|Overall Study|Refused further treatment|0|||
145975419|NCT01931098|526420830|FG001|Overall Study|Refused further treatment|1|||
145975420|NCT02278354|526420834|FG000|Overall Study|Lost to Follow-up|2|||
145921012|NCT01894919|526217863|FG011|Overall Study|Withdrawal by Subject|0|||
145921013|NCT01894919|526217864|FG012|Overall Study|Withdrawal by Subject|0|||
145921014|NCT01894919|526217852|FG000|Overall Study|Adverse Event|0|||
145921015|NCT01894919|526217853|FG001|Overall Study|Adverse Event|0|||
145921016|NCT01894919|526217854|FG002|Overall Study|Adverse Event|0|||
145921017|NCT01894919|526217855|FG003|Overall Study|Adverse Event|0|||
145921018|NCT01894919|526217856|FG004|Overall Study|Adverse Event|0|||
145921019|NCT01894919|526217857|FG005|Overall Study|Adverse Event|0|||
145921020|NCT01894919|526217858|FG006|Overall Study|Adverse Event|0|||
145921021|NCT01894919|526217859|FG007|Overall Study|Adverse Event|0|||
145975421|NCT02278354|526420835|FG001|Overall Study|Lost to Follow-up|2|||
146168145|NCT02496767|527128086|FG001|Open-label Lead-in Phase|Adverse Event|0|||
145921022|NCT01894919|526217860|FG008|Overall Study|Adverse Event|0|||
145921023|NCT01894919|526217861|FG009|Overall Study|Adverse Event|0|||
145921024|NCT01894919|526217862|FG010|Overall Study|Adverse Event|1|||
145921025|NCT01894919|526217863|FG011|Overall Study|Adverse Event|0|||
145921026|NCT01894919|526217864|FG012|Overall Study|Adverse Event|0|||
145921027|NCT01894919|526217852|FG000|Overall Study|Other-Unspecified|1|||
145921028|NCT01894919|526217853|FG001|Overall Study|Other-Unspecified|0|||
145975422|NCT02278354|526420834|FG000|Overall Study|Withdrawal by Subject|0|||
145975423|NCT02278354|526420835|FG001|Overall Study|Withdrawal by Subject|1|||
145975424|NCT02278354|526420834|FG000|Overall Study|<10 professional fights|2|||
145975425|NCT02278354|526420835|FG001|Overall Study|<10 professional fights|0|||
145975426|NCT01901562|526420837|FG000|Overall Study|Protocol Violation|5|||
145975427|NCT01901562|526420837|FG000|Overall Study|Excluded intraoperatively|4|||
145975428|NCT01925794|526420838|FG000|180 Days|Death|2|||
145975429|NCT01925794|526420838|FG000|180 Days|Withdrawal by Subject|2|||
145975430|NCT01925794|526420838|FG000|270 Days|Death|2|||
145975431|NCT01925794|526420838|FG000|270 Days|Protocol Violation|3|||
145975432|NCT02612155|526420839|FG000|Overall Study|Death|1|||
146168146|NCT02496767|527128087|FG002|Open-label Lead-in Phase|Adverse Event|0|||
146168147|NCT02496767|527128088|FG003|Open-label Lead-in Phase|Adverse Event|0|||
146168148|NCT02496767|527128089|FG004|Open-label Lead-in Phase|Adverse Event|0|||
146168149|NCT02496767|527128090|FG005|Open-label Lead-in Phase|Adverse Event|0|||
146168150|NCT02496767|527128091|FG006|Open-label Lead-in Phase|Adverse Event|0|||
145921029|NCT01894919|526217854|FG002|Overall Study|Other-Unspecified|0|||
145921030|NCT01894919|526217855|FG003|Overall Study|Other-Unspecified|0|||
145921031|NCT01894919|526217856|FG004|Overall Study|Other-Unspecified|0|||
145921032|NCT01894919|526217857|FG005|Overall Study|Other-Unspecified|0|||
145921033|NCT01894919|526217858|FG006|Overall Study|Other-Unspecified|0|||
145921034|NCT01894919|526217859|FG007|Overall Study|Other-Unspecified|0|||
145921035|NCT01894919|526217860|FG008|Overall Study|Other-Unspecified|0|||
145921036|NCT01894919|526217861|FG009|Overall Study|Other-Unspecified|0|||
145921037|NCT01894919|526217862|FG010|Overall Study|Other-Unspecified|0|||
145921038|NCT01894919|526217863|FG011|Overall Study|Other-Unspecified|0|||
145921039|NCT01894919|526217864|FG012|Overall Study|Other-Unspecified|0|||
145921040|NCT01894919|526217852|FG000|Overall Study|Lost to Follow-up|0|||
145921041|NCT01894919|526217853|FG001|Overall Study|Lost to Follow-up|0|||
145921042|NCT01894919|526217854|FG002|Overall Study|Lost to Follow-up|0|||
145921043|NCT01894919|526217855|FG003|Overall Study|Lost to Follow-up|0|||
145921044|NCT01894919|526217856|FG004|Overall Study|Lost to Follow-up|2|||
145921045|NCT01894919|526217857|FG005|Overall Study|Lost to Follow-up|0|||
145921046|NCT01894919|526217858|FG006|Overall Study|Lost to Follow-up|0|||
145921047|NCT01894919|526217859|FG007|Overall Study|Lost to Follow-up|0|||
145921048|NCT01894919|526217860|FG008|Overall Study|Lost to Follow-up|0|||
145921049|NCT01894919|526217861|FG009|Overall Study|Lost to Follow-up|0|||
145921050|NCT01894919|526217862|FG010|Overall Study|Lost to Follow-up|0|||
145921051|NCT01894919|526217863|FG011|Overall Study|Lost to Follow-up|0|||
145921052|NCT01894919|526217864|FG012|Overall Study|Lost to Follow-up|0|||
145921053|NCT03428152|526217870|FG000|Overall Study|Physician Decision|4|||
145921054|NCT03428152|526217871|FG001|Overall Study|Physician Decision|2|||
145921055|NCT03428152|526217870|FG000|Overall Study|Protocol Violation|3|||
145921056|NCT03428152|526217871|FG001|Overall Study|Protocol Violation|5|||
145921057|NCT03428152|526217870|FG000|Overall Study|Lack of Efficacy|0|||
145921058|NCT03428152|526217871|FG001|Overall Study|Lack of Efficacy|4|||
145921059|NCT00395629|526217872|FG000|Core Study|Adverse Event|0|||
145921060|NCT00395629|526217873|FG001|Core Study|Adverse Event|3|||
145921061|NCT00395629|526217874|FG002|Core Study|Adverse Event|4|||
145921062|NCT00395629|526217872|FG000|Core Study|Abnormal laboratory value(s)|0|||
145921063|NCT00395629|526217873|FG001|Core Study|Abnormal laboratory value(s)|0|||
145921064|NCT00395629|526217874|FG002|Core Study|Abnormal laboratory value(s)|1|||
145921065|NCT00395629|526217872|FG000|Core Study|Protocol Violation|1|||
145921066|NCT00395629|526217873|FG001|Core Study|Protocol Violation|0|||
145921067|NCT00395629|526217874|FG002|Core Study|Protocol Violation|0|||
145921068|NCT00395629|526217872|FG000|Core Study|Withdrawal by Subject|0|||
145921069|NCT00395629|526217873|FG001|Core Study|Withdrawal by Subject|1|||
145921070|NCT00395629|526217874|FG002|Core Study|Withdrawal by Subject|1|||
145921071|NCT00395629|526217872|FG000|Core Study|Lost to Follow-up|0|||
145921072|NCT00395629|526217873|FG001|Core Study|Lost to Follow-up|0|||
145921073|NCT00395629|526217874|FG002|Core Study|Lost to Follow-up|1|||
145921074|NCT00395629|526217872|FG000|Extension Study|Adverse Event|0|||
145921075|NCT00395629|526217873|FG001|Extension Study|Adverse Event|0|||
145921076|NCT00395629|526217874|FG002|Extension Study|Adverse Event|2|||
145921077|NCT00395629|526217872|FG000|Extension Study|Administrative problems|0|||
145921078|NCT00395629|526217873|FG001|Extension Study|Administrative problems|0|||
145921079|NCT00395629|526217874|FG002|Extension Study|Administrative problems|1|||
145921080|NCT03534687|526217875|FG000|Overall Study|Lost to Follow-up|7|||
145921081|NCT03534687|526217876|FG001|Overall Study|Lost to Follow-up|2|||
145921082|NCT01686373|526217877|FG000|Overall Study|Lost to Follow-up|3|||
145921083|NCT01686373|526217878|FG001|Overall Study|Lost to Follow-up|0|||
145921084|NCT01686373|526217877|FG000|Overall Study|Withdrawal by Subject|0|||
145921085|NCT01686373|526217878|FG001|Overall Study|Withdrawal by Subject|1|||
145975433|NCT02612155|526420840|FG001|Overall Study|Death|1|||
145975434|NCT02612155|526420839|FG000|Overall Study|Lost to Follow-up|2|||
145975435|NCT02612155|526420840|FG001|Overall Study|Lost to Follow-up|2|||
145975436|NCT02879695|526420844|FG000|Overall Study|Did not start study treatment|2|||
145975437|NCT02879695|526420845|FG001|Overall Study|Did not start study treatment|0|||
145975438|NCT02879695|526420846|FG002|Overall Study|Did not start study treatment|3|||
145975439|NCT02879695|526420847|FG003|Overall Study|Did not start study treatment|0|||
145921086|NCT01686373|526217877|FG000|Overall Study|Adverse Event|0|||
145921087|NCT01686373|526217878|FG001|Overall Study|Adverse Event|1|||
145921088|NCT01836471|526217885|FG000|Overall Study|Pregnancy|1|||
145921089|NCT01836471|526217886|FG001|Overall Study|Pregnancy|0|||
145921090|NCT01836471|526217887|FG002|Overall Study|Pregnancy|0|||
145921091|NCT01836471|526217888|FG003|Overall Study|Pregnancy|0|||
145921092|NCT01836471|526217889|FG004|Overall Study|Pregnancy|0|||
145921093|NCT01836471|526217885|FG000|Overall Study|Withdrawal by Subject|3|||
145921094|NCT01836471|526217886|FG001|Overall Study|Withdrawal by Subject|4|||
145921095|NCT01836471|526217887|FG002|Overall Study|Withdrawal by Subject|1|||
145921096|NCT01836471|526217888|FG003|Overall Study|Withdrawal by Subject|0|||
145921097|NCT01836471|526217889|FG004|Overall Study|Withdrawal by Subject|2|||
145975440|NCT01160614|526420849|FG000|Overall Study|Withdrawal by Subject|0|||
145975441|NCT01160614|526420850|FG001|Overall Study|Withdrawal by Subject|2|||
145975442|NCT03805841|526420851|FG000|Overall Study|Clinical Progression|2|||
145975443|NCT03805841|526420852|FG001|Overall Study|Clinical Progression|0|||
145921098|NCT01836471|526217885|FG000|Overall Study|Physician Decision|0|||
145921099|NCT01836471|526217886|FG001|Overall Study|Physician Decision|1|||
145921100|NCT01836471|526217887|FG002|Overall Study|Physician Decision|0|||
145921101|NCT01836471|526217888|FG003|Overall Study|Physician Decision|0|||
145921102|NCT01836471|526217889|FG004|Overall Study|Physician Decision|0|||
145921103|NCT01836471|526217885|FG000|Overall Study|Lost to Follow-up|0|||
145921104|NCT01836471|526217886|FG001|Overall Study|Lost to Follow-up|0|||
145921105|NCT01836471|526217887|FG002|Overall Study|Lost to Follow-up|0|||
145921106|NCT01836471|526217888|FG003|Overall Study|Lost to Follow-up|1|||
145921107|NCT01836471|526217889|FG004|Overall Study|Lost to Follow-up|1|||
145921108|NCT01836471|526217885|FG000|Overall Study|Adverse Event|6|||
145921109|NCT01836471|526217886|FG001|Overall Study|Adverse Event|3|||
145921110|NCT01836471|526217887|FG002|Overall Study|Adverse Event|1|||
145921111|NCT01836471|526217888|FG003|Overall Study|Adverse Event|1|||
145921112|NCT01836471|526217889|FG004|Overall Study|Adverse Event|2|||
145921113|NCT01836471|526217885|FG000|Overall Study|Non compliance with tx|1|||
145921114|NCT01836471|526217886|FG001|Overall Study|Non compliance with tx|1|||
145921115|NCT01836471|526217887|FG002|Overall Study|Non compliance with tx|0|||
145921116|NCT01836471|526217888|FG003|Overall Study|Non compliance with tx|0|||
145921117|NCT01836471|526217889|FG004|Overall Study|Non compliance with tx|0|||
145921118|NCT01286467|526217890|FG000|Overall Study|Death|1|||
145921119|NCT01286467|526217891|FG001|Overall Study|Death|1|||
145921120|NCT01286467|526217892|FG002|Overall Study|Death|1|||
145921121|NCT01286467|526217893|FG003|Overall Study|Death|0|||
145921122|NCT01286467|526217890|FG000|Overall Study|Lost to Follow-up|0|||
145921123|NCT01286467|526217891|FG001|Overall Study|Lost to Follow-up|0|||
145921124|NCT01286467|526217892|FG002|Overall Study|Lost to Follow-up|0|||
145921125|NCT01286467|526217893|FG003|Overall Study|Lost to Follow-up|1|||
145921126|NCT01286467|526217890|FG000|Overall Study|Withdrawal by Subject|0|||
145921127|NCT01286467|526217891|FG001|Overall Study|Withdrawal by Subject|0|||
145921128|NCT01286467|526217892|FG002|Overall Study|Withdrawal by Subject|1|||
145921129|NCT01286467|526217893|FG003|Overall Study|Withdrawal by Subject|0|||
145921130|NCT01286467|526217890|FG000|Overall Study|Physician Decision|0|||
145921131|NCT01286467|526217891|FG001|Overall Study|Physician Decision|0|||
145921132|NCT01286467|526217892|FG002|Overall Study|Physician Decision|0|||
145975444|NCT03805841|526420853|FG002|Overall Study|Clinical Progression|0|||
145975445|NCT03805841|526420851|FG000|Overall Study|Death|0|||
145975446|NCT03805841|526420852|FG001|Overall Study|Death|3|||
145975447|NCT03805841|526420853|FG002|Overall Study|Death|1|||
146241947|NCT03769090|527401009|FG000|Overall Study|Lost to Follow-up|19|||
146241948|NCT03769090|527401010|FG001|Overall Study|Lost to Follow-up|25|||
146241949|NCT03769090|527401011|FG002|Overall Study|Lost to Follow-up|21|||
146241950|NCT03769090|527401009|FG000|Overall Study|Condition under investigation worsened|2|||
146297652|NCT01313650|527604755|FG000|Overall Study|Lost to Follow-up|1|||
146297653|NCT01313650|527604756|FG001|Overall Study|Lost to Follow-up|0|||
146297654|NCT01313650|527604757|FG002|Overall Study|Lost to Follow-up|3|||
146297655|NCT01313650|527604758|FG003|Overall Study|Lost to Follow-up|2|||
146241951|NCT03769090|527401010|FG001|Overall Study|Condition under investigation worsened|0|||
146241952|NCT03769090|527401011|FG002|Overall Study|Condition under investigation worsened|1|||
146241953|NCT03769090|527401009|FG000|Overall Study|Lack of Efficacy|1|||
146241954|NCT03769090|527401010|FG001|Overall Study|Lack of Efficacy|2|||
146241955|NCT03769090|527401011|FG002|Overall Study|Lack of Efficacy|2|||
146241956|NCT03769090|527401009|FG000|Overall Study|Other reasons|8|||
146241957|NCT03769090|527401010|FG001|Overall Study|Other reasons|12|||
146241958|NCT03769090|527401011|FG002|Overall Study|Other reasons|15|||
146241959|NCT03964974|527401012|FG000|Overall Study|Lost to Follow-up|3|||
146241960|NCT03964974|527401013|FG001|Overall Study|Lost to Follow-up|2|||
146241961|NCT03964974|527401012|FG000|Overall Study|Withdrawal by Subject|0|||
146241962|NCT03964974|527401013|FG001|Overall Study|Withdrawal by Subject|3|||
146241963|NCT02713594|527401014|FG000|Overall Study|Withdrawal by Subject|32|||
146241964|NCT02713594|527401015|FG001|Overall Study|Withdrawal by Subject|22|||
146241965|NCT02713594|527401014|FG000|Overall Study|Lost to Follow-up|358|||
145921133|NCT01286467|526217893|FG003|Overall Study|Physician Decision|1|||
145921134|NCT01286467|526217890|FG000|Overall Study|Disease progression|3|||
145921135|NCT01286467|526217891|FG001|Overall Study|Disease progression|2|||
145921136|NCT01286467|526217892|FG002|Overall Study|Disease progression|2|||
145921137|NCT01286467|526217893|FG003|Overall Study|Disease progression|3|||
145921138|NCT01286467|526217890|FG000|Overall Study|Adverse Event|0|||
145921139|NCT01286467|526217891|FG001|Overall Study|Adverse Event|1|||
145921140|NCT01286467|526217892|FG002|Overall Study|Adverse Event|2|||
145921141|NCT01286467|526217893|FG003|Overall Study|Adverse Event|3|||
145921142|NCT01286467|526217890|FG000|Overall Study|Study drug stop longer than 14 days|0|||
145921143|NCT01286467|526217891|FG001|Overall Study|Study drug stop longer than 14 days|0|||
146241966|NCT02713594|527401015|FG001|Overall Study|Lost to Follow-up|374|||
146241967|NCT02660086|527401016|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
145921144|NCT01286467|526217892|FG002|Overall Study|Study drug stop longer than 14 days|1|||
145921145|NCT01286467|526217893|FG003|Overall Study|Study drug stop longer than 14 days|0|||
145975448|NCT03805841|526420851|FG000|Overall Study|Lost to Follow-up|0|||
145975449|NCT03805841|526420852|FG001|Overall Study|Lost to Follow-up|0|||
145921146|NCT01058642|526217894|FG000|Treatment Period 1|Adverse Event|0|||
145921147|NCT01058642|526217895|FG001|Treatment Period 1|Adverse Event|1|||
145921148|NCT01058642|526217896|FG002|Treatment Period 1|Adverse Event|1|||
145921149|NCT01058642|526217897|FG003|Treatment Period 1|Adverse Event|0|||
145921150|NCT01058642|526217894|FG000|Treatment Period 1|Physician Decision|0|||
145921151|NCT01058642|526217895|FG001|Treatment Period 1|Physician Decision|0|||
145921152|NCT01058642|526217896|FG002|Treatment Period 1|Physician Decision|1|||
145921153|NCT01058642|526217897|FG003|Treatment Period 1|Physician Decision|0|||
145921154|NCT01058642|526217894|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145921155|NCT01058642|526217895|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145921156|NCT01058642|526217896|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145921157|NCT01058642|526217897|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145921158|NCT01058642|526217894|FG000|Treatment Period 1|Lack of Efficacy|0|||
145921159|NCT01058642|526217895|FG001|Treatment Period 1|Lack of Efficacy|0|||
145921160|NCT01058642|526217896|FG002|Treatment Period 1|Lack of Efficacy|0|||
145921161|NCT01058642|526217897|FG003|Treatment Period 1|Lack of Efficacy|1|||
145921162|NCT01058642|526217894|FG000|Treatment Period 1|Protocol Violation|0|||
145921163|NCT01058642|526217895|FG001|Treatment Period 1|Protocol Violation|0|||
145921164|NCT01058642|526217896|FG002|Treatment Period 1|Protocol Violation|0|||
145921165|NCT01058642|526217897|FG003|Treatment Period 1|Protocol Violation|1|||
145921166|NCT01058642|526217894|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
145921167|NCT01058642|526217895|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145921168|NCT01058642|526217896|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145921169|NCT01058642|526217897|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145921170|NCT02411656|526217898|FG000|Overall Study|Adverse Event|4|||
145921171|NCT02411656|526217898|FG000|Overall Study|Clinical Progression|33|||
145921172|NCT03305848|526217899|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
145921173|NCT03305848|526217899|FG000|Overall Study|Physician Decision|2|||
145921174|NCT02224157|526217901|FG000|Overall Study|Severe non-compliance to protocol|2|||
145921175|NCT02224157|526217902|FG001|Overall Study|Severe non-compliance to protocol|2|||
145921176|NCT02224157|526217901|FG000|Overall Study|Other|13|||
145975450|NCT03805841|526420853|FG002|Overall Study|Lost to Follow-up|1|||
146241968|NCT02660086|527401017|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
146241969|NCT02660086|527401016|FG000|Overall Study- 12-month|Left full-time employment|12|||
146241970|NCT02660086|527401017|FG001|Overall Study- 12-month|Left full-time employment|20|||
146241971|NCT02660086|527401016|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
146241972|NCT02660086|527401017|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
146241973|NCT02660086|527401016|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
146241974|NCT02660086|527401017|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
146241975|NCT02660086|527401016|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
146241976|NCT02660086|527401017|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
146241977|NCT02660086|527401016|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
146241978|NCT02660086|527401017|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
146241979|NCT05005247|527401023|FG000|Overall Study|Withdrawal by Subject|0|||
146241980|NCT05005247|527401024|FG001|Overall Study|Withdrawal by Subject|1|||
146241981|NCT05005247|527401025|FG002|Overall Study|Withdrawal by Subject|0|||
146241982|NCT01450007|527401026|FG000|Overall Study|Late exclusion before treatment|2|||
146241983|NCT01450007|527401027|FG001|Overall Study|Late exclusion before treatment|3|||
146241984|NCT01450007|527401028|FG002|Overall Study|Late exclusion before treatment|2|||
146241985|NCT01450007|527401026|FG000|Overall Study|Protocol Violation|0|||
146241986|NCT01450007|527401027|FG001|Overall Study|Protocol Violation|1|||
146241987|NCT01450007|527401028|FG002|Overall Study|Protocol Violation|1|||
146241988|NCT01450007|527401026|FG000|Overall Study|Adverse Event|0|||
146241989|NCT01450007|527401027|FG001|Overall Study|Adverse Event|1|||
146241990|NCT01450007|527401028|FG002|Overall Study|Adverse Event|0|||
146241991|NCT02958553|527401029|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
146241992|NCT02958553|527401029|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
146241993|NCT02224755|527401043|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
146241994|NCT02224755|527401044|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
146241995|NCT02224755|527401043|FG000|Two Year Follow up Post-implant|Death|103|||
146241996|NCT02224755|527401044|FG001|Two Year Follow up Post-implant|Death|98|||
146241997|NCT02224755|527401043|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
146241998|NCT02224755|527401044|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
146241999|NCT02224755|527401043|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
146282342|NCT01879722|527546477|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
145921177|NCT02224157|526217902|FG001|Overall Study|Other|10|||
145921178|NCT02224157|526217901|FG000|Overall Study|Subject decision|58|||
145921179|NCT02224157|526217902|FG001|Overall Study|Subject decision|50|||
145921180|NCT02224157|526217901|FG000|Overall Study|Prematurely closed site|4|||
145921181|NCT02224157|526217902|FG001|Overall Study|Prematurely closed site|2|||
145975451|NCT03805841|526420851|FG000|Overall Study|Withdrawal by Subject|2|||
145975452|NCT03805841|526420852|FG001|Overall Study|Withdrawal by Subject|3|||
145921182|NCT02224157|526217901|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
145921183|NCT02224157|526217902|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
145921184|NCT02224157|526217901|FG000|Overall Study|Lost to Follow-up|27|||
145921185|NCT02224157|526217902|FG001|Overall Study|Lost to Follow-up|35|||
145921186|NCT02224157|526217901|FG000|Overall Study|Death|1|||
145921187|NCT02224157|526217902|FG001|Overall Study|Death|1|||
145921188|NCT02224157|526217901|FG000|Overall Study|Adverse Event|1|||
145921189|NCT02224157|526217902|FG001|Overall Study|Adverse Event|3|||
145921190|NCT04578535|526217905|FG000|Overall Study|Lost to Follow-up|1|||
145921191|NCT04578535|526217906|FG001|Overall Study|Lost to Follow-up|0|||
145921192|NCT04578535|526217907|FG002|Overall Study|Lost to Follow-up|0|||
145921193|NCT04578535|526217908|FG003|Overall Study|Lost to Follow-up|1|||
145921194|NCT04578535|526217909|FG004|Overall Study|Lost to Follow-up|0|||
145921195|NCT04578535|526217910|FG005|Overall Study|Lost to Follow-up|2|||
145921196|NCT04578535|526217905|FG000|Overall Study|Pregnancy|1|||
145921197|NCT04578535|526217906|FG001|Overall Study|Pregnancy|0|||
145921198|NCT04578535|526217907|FG002|Overall Study|Pregnancy|0|||
145921199|NCT04578535|526217908|FG003|Overall Study|Pregnancy|0|||
145921200|NCT04578535|526217909|FG004|Overall Study|Pregnancy|0|||
145921201|NCT04578535|526217910|FG005|Overall Study|Pregnancy|0|||
145921202|NCT04578535|526217905|FG000|Overall Study|Withdrawal by Subject|0|||
145921203|NCT04578535|526217906|FG001|Overall Study|Withdrawal by Subject|0|||
145921204|NCT04578535|526217907|FG002|Overall Study|Withdrawal by Subject|0|||
145921205|NCT04578535|526217908|FG003|Overall Study|Withdrawal by Subject|1|||
145921206|NCT04578535|526217909|FG004|Overall Study|Withdrawal by Subject|1|||
145921207|NCT04578535|526217910|FG005|Overall Study|Withdrawal by Subject|5|||
146089467|NCT04543409|526847407|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
146089468|NCT04543409|526847408|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
146089469|NCT04543409|526847407|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
146089470|NCT04543409|526847408|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146089471|NCT04543409|526847407|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
146089472|NCT04543409|526847408|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
146089473|NCT04543409|526847407|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
146089474|NCT04543409|526847408|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
146089475|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
146089476|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
146089477|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
146089478|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
145921208|NCT04578535|526217905|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
146089479|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
146089480|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
146089481|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
146089482|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
146089483|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
146089484|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
146089485|NCT04543409|526847407|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
146089486|NCT04543409|526847408|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
146089487|NCT01289782|526847409|FG000|Overall Study|Lost to Follow-up|14|||
146089488|NCT01289782|526847410|FG001|Overall Study|Lost to Follow-up|7|||
146089489|NCT01289782|526847409|FG000|Overall Study|Protocol Violation|1|||
146089490|NCT01289782|526847410|FG001|Overall Study|Protocol Violation|1|||
146089491|NCT01289782|526847409|FG000|Overall Study|Withdrawal by Subject|8|||
146089492|NCT01289782|526847410|FG001|Overall Study|Withdrawal by Subject|2|||
146089493|NCT01289782|526847409|FG000|Overall Study|Sponsor's Decision|1|||
146089494|NCT01289782|526847410|FG001|Overall Study|Sponsor's Decision|0|||
146089495|NCT01289782|526847409|FG000|Overall Study|Reason not specified|1|||
146089496|NCT01289782|526847410|FG001|Overall Study|Reason not specified|2|||
146089497|NCT02131532|526847411|FG000|Overall Study|Withdrawal by Subject|1|||
146089498|NCT02131532|526847411|FG000|Overall Study|Physician Decision|1|||
146089499|NCT02131532|526847411|FG000|Overall Study|Other health conditions|2|||
146089500|NCT02093026|526847412|FG000|Overall Study|Adverse Event|26|||
146242000|NCT02224755|527401044|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
146242001|NCT02224755|527401043|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
146242002|NCT02224755|527401044|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
146242003|NCT00273052|527401045|FG000|Overall Study|Withdrawal by Subject|16|||
145921209|NCT04578535|526217906|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
145921210|NCT04578535|526217907|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
145921211|NCT04578535|526217908|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
145921212|NCT04578535|526217909|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
145921213|NCT04578535|526217910|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
145921214|NCT00235755|526217913|FG000|4-Week Titration Phase|Adverse Event|6|||
145921215|NCT00235755|526217914|FG001|4-Week Titration Phase|Adverse Event|14|||
146242004|NCT00273052|527401046|FG001|Overall Study|Withdrawal by Subject|19|||
146242005|NCT00273052|527401045|FG000|Overall Study|Adverse Event|21|||
146242006|NCT00273052|527401046|FG001|Overall Study|Adverse Event|19|||
146242007|NCT00273052|527401045|FG000|Overall Study|Protocol Violation|14|||
146242008|NCT00273052|527401046|FG001|Overall Study|Protocol Violation|18|||
146242009|NCT00273052|527401045|FG000|Overall Study|Lost to Follow-up|7|||
146242010|NCT00273052|527401046|FG001|Overall Study|Lost to Follow-up|25|||
146242011|NCT00273052|527401045|FG000|Overall Study|Lack of Efficacy|6|||
146242012|NCT00273052|527401046|FG001|Overall Study|Lack of Efficacy|4|||
146242013|NCT00273052|527401045|FG000|Overall Study|Non-Compliance|3|||
146242014|NCT00273052|527401046|FG001|Overall Study|Non-Compliance|1|||
146242015|NCT00273052|527401045|FG000|Overall Study|Other|2|||
146242016|NCT00273052|527401046|FG001|Overall Study|Other|0|||
146242017|NCT00273052|527401045|FG000|Overall Study|Worsening serum lipid levels|0|||
146242018|NCT00273052|527401046|FG001|Overall Study|Worsening serum lipid levels|2|||
146242019|NCT01852045|527401047|FG000|Overall Study|Adverse Event|1|||
146242020|NCT01852045|527401048|FG001|Overall Study|Adverse Event|0|||
145921216|NCT00235755|526217915|FG002|4-Week Titration Phase|Adverse Event|20|||
145921217|NCT00235755|526217913|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
145921218|NCT00235755|526217914|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
145921219|NCT00235755|526217915|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
145921220|NCT00235755|526217913|FG000|4-Week Titration Phase|Protocol Violation|2|||
146242021|NCT01852045|527401049|FG002|Overall Study|Adverse Event|0|||
146242022|NCT01852045|527401047|FG000|Overall Study|Lack of Efficacy|3|||
146242023|NCT01852045|527401048|FG001|Overall Study|Lack of Efficacy|0|||
146242024|NCT01852045|527401049|FG002|Overall Study|Lack of Efficacy|0|||
146242025|NCT01852045|527401047|FG000|Overall Study|Lost to Follow-up|0|||
146242026|NCT01852045|527401048|FG001|Overall Study|Lost to Follow-up|1|||
146242027|NCT01852045|527401049|FG002|Overall Study|Lost to Follow-up|1|||
146242028|NCT01852045|527401047|FG000|Overall Study|Withdrawal by Subject|1|||
146242029|NCT01852045|527401048|FG001|Overall Study|Withdrawal by Subject|0|||
145921221|NCT00235755|526217914|FG001|4-Week Titration Phase|Protocol Violation|2|||
145921222|NCT00235755|526217915|FG002|4-Week Titration Phase|Protocol Violation|1|||
145921223|NCT00235755|526217913|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
145921224|NCT00235755|526217914|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
145921225|NCT00235755|526217915|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
145921226|NCT00235755|526217913|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145921227|NCT00235755|526217914|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145921228|NCT00235755|526217915|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
145921229|NCT00235755|526217913|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
145921230|NCT00235755|526217914|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
145921231|NCT00235755|526217915|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
145921232|NCT00235755|526217913|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
145921233|NCT00235755|526217914|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
145921234|NCT00235755|526217915|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
145921235|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Adverse Event|8|||
145921236|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Adverse Event|12|||
145975453|NCT03805841|526420853|FG002|Overall Study|Withdrawal by Subject|0|||
145975454|NCT03805841|526420851|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
145975455|NCT03805841|526420852|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
145975456|NCT03805841|526420853|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
145975457|NCT02382380|526420854|FG000|Overall Study|Withdrawal by Subject|2|||
145975458|NCT02382380|526420855|FG001|Overall Study|Withdrawal by Subject|2|||
145975459|NCT02382380|526420854|FG000|Overall Study|Lost to Follow-up|0|||
145975460|NCT02382380|526420855|FG001|Overall Study|Lost to Follow-up|1|||
146242030|NCT01852045|527401049|FG002|Overall Study|Withdrawal by Subject|1|||
145921237|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Adverse Event|26|||
145921238|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
145921239|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
145921240|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
145921241|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
146242031|NCT01852045|527401047|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146242032|NCT01852045|527401048|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146242033|NCT01852045|527401049|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146242034|NCT01951703|527401050|FG000|First Intervention|Withdrawal by Subject|1|||
145921242|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
145921243|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
145921244|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
145921245|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
145975461|NCT01295944|526420856|FG000|Overall Study|Switched to alternative treatment|1|||
145975462|NCT01295944|526420856|FG000|Overall Study|Ineligible|9|||
145975463|NCT01295944|526420856|FG000|Overall Study|Withdrawal by Subject|1|||
146242035|NCT01951703|527401051|FG001|First Intervention|Withdrawal by Subject|0|||
146242036|NCT01951703|527401050|FG000|First Intervention|Subject was not compliant|1|||
146242037|NCT01951703|527401051|FG001|First Intervention|Subject was not compliant|1|||
146242038|NCT01951703|527401050|FG000|First Intervention|Physician Decision|1|||
146242039|NCT01951703|527401051|FG001|First Intervention|Physician Decision|0|||
146242040|NCT01951703|527401050|FG000|Second Intervention|Protocol Violation|0|||
146242041|NCT01951703|527401051|FG001|Second Intervention|Protocol Violation|1|||
146242042|NCT01951703|527401050|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
146242043|NCT01951703|527401051|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
146242044|NCT02827201|527401052|FG000|Overall Study|Death|1|||
146242045|NCT02827201|527401053|FG001|Overall Study|Death|2|||
146242046|NCT02827201|527401052|FG000|Overall Study|Patients not treated|1|||
146242047|NCT02827201|527401053|FG001|Overall Study|Patients not treated|1|||
146242048|NCT02736188|527401056|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
146242049|NCT02736188|527401056|FG000|Overall Study|Adverse Event|1|||
146242050|NCT02736188|527401056|FG000|Overall Study|Withdrawal by Subject|1|||
146242051|NCT02736188|527401056|FG000|Overall Study|Other|6|||
146242052|NCT00240994|527401057|FG000|Overall Study|Lost to Follow-up|1|||
146242053|NCT00240994|527401057|FG000|Overall Study|Protocol Violation|1|||
146242054|NCT00240994|527401057|FG000|Overall Study|Graft failure|1|||
146242055|NCT02630186|527401058|FG000|Overall Study|Withdrawal by Subject|1|||
146242056|NCT00439218|527401059|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
146242057|NCT03176407|527401060|FG000|Overall Study|Protocol Violation|1|||
146242058|NCT03176407|527401060|FG000|Overall Study|human failure|1|||
146242059|NCT03176407|527401060|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
146242060|NCT01428583|527401061|FG000|Overall Study|Adverse Event|75|||
146242061|NCT01428583|527401061|FG000|Overall Study|Withdrawal by Subject|51|||
146242062|NCT01428583|527401061|FG000|Overall Study|Lack of Efficacy|37|||
146242063|NCT01428583|527401061|FG000|Overall Study|Lost to Follow-up|17|||
146242064|NCT01428583|527401061|FG000|Overall Study|Death|1|||
146242065|NCT01428583|527401061|FG000|Overall Study|Pregnancy|1|||
146242066|NCT01428583|527401061|FG000|Overall Study|Protocol Violation|1|||
146242067|NCT01428583|527401061|FG000|Overall Study|Physician Decision|12|||
146242068|NCT01428583|527401061|FG000|Overall Study|Non-compliant|25|||
146242069|NCT01428583|527401061|FG000|Overall Study|Confirmed positive urine drug test|8|||
146242070|NCT01428583|527401061|FG000|Overall Study|Sponsor's request|3|||
145921246|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
145921247|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
145921248|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
145921249|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
145921250|NCT00235755|526217913|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
145921251|NCT00235755|526217914|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
145921252|NCT00235755|526217915|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
145921253|NCT03839628|526217918|FG000|Overall Study|Withdrawal by Subject|1|||
145921254|NCT01147068|526217919|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
145921255|NCT01147068|526217920|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145921256|NCT01147068|526217921|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145921257|NCT01147068|526217922|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145921258|NCT01147068|526217923|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145921259|NCT01147068|526217924|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
145921260|NCT01147068|526217925|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145921261|NCT01147068|526217919|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
145921262|NCT01147068|526217920|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
145921263|NCT01147068|526217921|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
145921264|NCT01147068|526217922|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
145921265|NCT01147068|526217923|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
145921266|NCT01147068|526217924|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
145921267|NCT01147068|526217925|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
145921268|NCT01147068|526217919|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
145921269|NCT01147068|526217920|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
145921270|NCT01147068|526217921|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
145921271|NCT01147068|526217922|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
145921272|NCT01147068|526217923|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
145921273|NCT01147068|526217924|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
145921274|NCT01147068|526217925|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
146242071|NCT01428583|527401061|FG000|Overall Study|Other|6|||
146242072|NCT05124210|527401062|FG000|Overall Study|Lost to Follow-up|1|||
146242073|NCT05124210|527401063|FG001|Overall Study|Lost to Follow-up|0|||
145921275|NCT01147068|526217919|FG000|Subjects That Received 2nd Dose|Other|0|||
146242074|NCT05124210|527401062|FG000|Overall Study|Withdrawal by Subject|1|||
146242075|NCT05124210|527401063|FG001|Overall Study|Withdrawal by Subject|0|||
146242076|NCT00768755|527401066|FG000|Phase 1|Death|6|||
145921276|NCT01147068|526217920|FG001|Subjects That Received 2nd Dose|Other|3|||
145921277|NCT01147068|526217921|FG002|Subjects That Received 2nd Dose|Other|3|||
146242077|NCT00768755|527401067|FG001|Phase 1|Death|0|||
146242078|NCT00768755|527401068|FG002|Phase 1|Death|0|||
146242079|NCT00768755|527401069|FG003|Phase 1|Death|0|||
146297656|NCT01313650|527604755|FG000|Overall Study|Withdrawal by Subject|16|||
146297657|NCT01313650|527604756|FG001|Overall Study|Withdrawal by Subject|20|||
146297658|NCT01313650|527604757|FG002|Overall Study|Withdrawal by Subject|15|||
146297659|NCT01313650|527604758|FG003|Overall Study|Withdrawal by Subject|15|||
146297660|NCT01313650|527604755|FG000|Overall Study|Protocol Violation|4|||
146297661|NCT01313650|527604756|FG001|Overall Study|Protocol Violation|7|||
146297662|NCT01313650|527604757|FG002|Overall Study|Protocol Violation|5|||
146297663|NCT01313650|527604758|FG003|Overall Study|Protocol Violation|6|||
146297664|NCT01313650|527604755|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
146297665|NCT01313650|527604756|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
146297666|NCT01313650|527604757|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
146297667|NCT01313650|527604758|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
146297668|NCT05393037|527604761|FG000|Part A|Death|1|||
146297669|NCT05393037|527604762|FG001|Part A|Death|0|||
146297670|NCT05393037|527604761|FG000|Part A|Lost to Follow-up|1|||
146297671|NCT05393037|527604762|FG001|Part A|Lost to Follow-up|1|||
146297672|NCT05393037|527604761|FG000|Part A|Withdrawal by Subject|2|||
146297673|NCT05393037|527604762|FG001|Part A|Withdrawal by Subject|4|||
146297674|NCT05393037|527604761|FG000|Part B|Lost to Follow-up|1|||
146297675|NCT05393037|527604762|FG001|Part B|Lost to Follow-up|0|||
146297676|NCT01012739|527604763|FG000|Treatment Period 1|Adverse Event|0|||
146242080|NCT00768755|527401066|FG000|Phase 1|Other|4|||
146242081|NCT00768755|527401067|FG001|Phase 1|Other|0|||
146242082|NCT00768755|527401068|FG002|Phase 1|Other|0|||
146242083|NCT00768755|527401069|FG003|Phase 1|Other|0|||
146242084|NCT00768755|527401066|FG000|Phase 2|Death|0|||
146242085|NCT00768755|527401067|FG001|Phase 2|Death|37|||
146242086|NCT00768755|527401068|FG002|Phase 2|Death|48|||
146242087|NCT00768755|527401069|FG003|Phase 2|Death|31|||
146242088|NCT00768755|527401066|FG000|Phase 2|Protocol Violation|0|||
146242089|NCT00768755|527401067|FG001|Phase 2|Protocol Violation|2|||
146242090|NCT00768755|527401068|FG002|Phase 2|Protocol Violation|0|||
146242091|NCT00768755|527401069|FG003|Phase 2|Protocol Violation|1|||
146242092|NCT00768755|527401066|FG000|Phase 2|Lost to Follow-up|0|||
146242093|NCT00768755|527401067|FG001|Phase 2|Lost to Follow-up|1|||
146242094|NCT00768755|527401068|FG002|Phase 2|Lost to Follow-up|1|||
146242095|NCT00768755|527401069|FG003|Phase 2|Lost to Follow-up|4|||
146242096|NCT00768755|527401066|FG000|Phase 2|Withdrawal by Subject|0|||
146242097|NCT00768755|527401067|FG001|Phase 2|Withdrawal by Subject|1|||
146242098|NCT00768755|527401068|FG002|Phase 2|Withdrawal by Subject|0|||
146242099|NCT00768755|527401069|FG003|Phase 2|Withdrawal by Subject|1|||
146242100|NCT00768755|527401066|FG000|Phase 2|Other|0|||
146242101|NCT00768755|527401067|FG001|Phase 2|Other|1|||
146242102|NCT00768755|527401068|FG002|Phase 2|Other|2|||
146242103|NCT00768755|527401069|FG003|Phase 2|Other|4|||
146242104|NCT00768755|527401066|FG000|Phase 2|Study Terminated by Sponsor|0|||
146242105|NCT00768755|527401067|FG001|Phase 2|Study Terminated by Sponsor|13|||
146242106|NCT00768755|527401068|FG002|Phase 2|Study Terminated by Sponsor|7|||
146242107|NCT00768755|527401069|FG003|Phase 2|Study Terminated by Sponsor|14|||
146242108|NCT00768755|527401066|FG000|Phase 2|Randomized but not treated|0|||
146242109|NCT00768755|527401067|FG001|Phase 2|Randomized but not treated|0|||
146242110|NCT00768755|527401068|FG002|Phase 2|Randomized but not treated|0|||
146242111|NCT00768755|527401069|FG003|Phase 2|Randomized but not treated|2|||
146242112|NCT03142932|527401072|FG000|Overall Study|Lost to Follow-up|2|||
146242113|NCT03142932|527401073|FG001|Overall Study|Lost to Follow-up|11|||
146242114|NCT02128269|527401074|FG000|Treatment Period|Adverse Event|1|||
146297677|NCT01012739|527604764|FG001|Treatment Period 1|Adverse Event|0|||
146297678|NCT01012739|527604765|FG002|Treatment Period 1|Adverse Event|0|||
146297679|NCT01012739|527604766|FG003|Treatment Period 1|Adverse Event|1|||
146089501|NCT02093026|526847412|FG000|Overall Study|Death|10|||
146242115|NCT02128269|527401074|FG000|Treatment Period|Physician Decision|1|||
146242116|NCT00878189|527401075|FG000|Overall Study|Death|0|||
146242117|NCT00878189|527401076|FG001|Overall Study|Death|1|||
146242118|NCT00878189|527401077|FG002|Overall Study|Death|0|||
146297680|NCT01012739|527604763|FG000|Treatment Period 2|Abnormal test procedure results|0|||
146297681|NCT01012739|527604764|FG001|Treatment Period 2|Abnormal test procedure results|0|||
146297682|NCT01012739|527604765|FG002|Treatment Period 2|Abnormal test procedure results|0|||
146297683|NCT01012739|527604766|FG003|Treatment Period 2|Abnormal test procedure results|1|||
146297684|NCT02593786|527604771|FG000|Overall Study|Disease progression|12|||
146242119|NCT00878189|527401078|FG003|Overall Study|Death|1|||
146242120|NCT00878189|527401079|FG004|Overall Study|Death|0|||
146242121|NCT00878189|527401080|FG005|Overall Study|Death|0|||
146242122|NCT00878189|527401081|FG006|Overall Study|Death|0|||
146242123|NCT00878189|527401082|FG007|Overall Study|Death|0|||
146242124|NCT00878189|527401083|FG008|Overall Study|Death|1|||
146297685|NCT02593786|527604772|FG001|Overall Study|Disease progression|16|||
146242125|NCT00878189|527401075|FG000|Overall Study|Participant Refused to Follow-up|0|||
146242126|NCT00878189|527401076|FG001|Overall Study|Participant Refused to Follow-up|0|||
146242127|NCT00878189|527401077|FG002|Overall Study|Participant Refused to Follow-up|0|||
146242128|NCT00878189|527401078|FG003|Overall Study|Participant Refused to Follow-up|0|||
146242129|NCT00878189|527401079|FG004|Overall Study|Participant Refused to Follow-up|0|||
146242130|NCT00878189|527401080|FG005|Overall Study|Participant Refused to Follow-up|4|||
146242131|NCT00878189|527401081|FG006|Overall Study|Participant Refused to Follow-up|0|||
146242132|NCT00878189|527401082|FG007|Overall Study|Participant Refused to Follow-up|0|||
146242133|NCT00878189|527401083|FG008|Overall Study|Participant Refused to Follow-up|0|||
145921278|NCT01147068|526217922|FG003|Subjects That Received 2nd Dose|Other|0|||
145921279|NCT01147068|526217923|FG004|Subjects That Received 2nd Dose|Other|1|||
145921280|NCT01147068|526217924|FG005|Subjects That Received 2nd Dose|Other|0|||
145921281|NCT01147068|526217925|FG006|Subjects That Received 2nd Dose|Other|0|||
145921282|NCT01147068|526217919|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145921283|NCT01147068|526217920|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
146242134|NCT00878189|527401075|FG000|Overall Study|Other|3|||
146242135|NCT00878189|527401076|FG001|Overall Study|Other|2|||
146242136|NCT00878189|527401077|FG002|Overall Study|Other|4|||
146242137|NCT00878189|527401078|FG003|Overall Study|Other|7|||
146242138|NCT00878189|527401079|FG004|Overall Study|Other|4|||
146242139|NCT00878189|527401080|FG005|Overall Study|Other|18|||
146242140|NCT00878189|527401081|FG006|Overall Study|Other|15|||
146242141|NCT00878189|527401082|FG007|Overall Study|Other|3|||
146242142|NCT00878189|527401083|FG008|Overall Study|Other|4|||
146242143|NCT00878189|527401075|FG000|Overall Study|Lost to Follow-up|0|||
146242144|NCT00878189|527401076|FG001|Overall Study|Lost to Follow-up|0|||
146242145|NCT00878189|527401077|FG002|Overall Study|Lost to Follow-up|0|||
146242146|NCT00878189|527401078|FG003|Overall Study|Lost to Follow-up|0|||
146242147|NCT00878189|527401079|FG004|Overall Study|Lost to Follow-up|0|||
146242148|NCT00878189|527401080|FG005|Overall Study|Lost to Follow-up|1|||
146242149|NCT00878189|527401081|FG006|Overall Study|Lost to Follow-up|1|||
146242150|NCT00878189|527401082|FG007|Overall Study|Lost to Follow-up|0|||
146242151|NCT00878189|527401083|FG008|Overall Study|Lost to Follow-up|0|||
146242152|NCT00878189|527401075|FG000|Overall Study|Objection Progression or Relapse|0|||
146242153|NCT00878189|527401076|FG001|Overall Study|Objection Progression or Relapse|0|||
146242154|NCT00878189|527401077|FG002|Overall Study|Objection Progression or Relapse|0|||
146242155|NCT00878189|527401078|FG003|Overall Study|Objection Progression or Relapse|0|||
146242156|NCT00878189|527401079|FG004|Overall Study|Objection Progression or Relapse|0|||
146242157|NCT00878189|527401080|FG005|Overall Study|Objection Progression or Relapse|0|||
146242158|NCT00878189|527401081|FG006|Overall Study|Objection Progression or Relapse|0|||
146242159|NCT00878189|527401082|FG007|Overall Study|Objection Progression or Relapse|0|||
146242160|NCT00878189|527401083|FG008|Overall Study|Objection Progression or Relapse|3|||
146242161|NCT00638456|527401084|FG000|Overall Study|Withdrawal by Subject|6|||
146242162|NCT00638456|527401085|FG001|Overall Study|Withdrawal by Subject|2|||
146242163|NCT01640288|527401088|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
146242164|NCT01640288|527401089|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
146242165|NCT01640288|527401088|FG000|Overall Study|Screen Failure|20|||
146242166|NCT01640288|527401089|FG001|Overall Study|Screen Failure|18|||
146242167|NCT01640288|527401088|FG000|Overall Study|Withdrawn by PI|5|||
146242168|NCT01640288|527401089|FG001|Overall Study|Withdrawn by PI|0|||
146242169|NCT01640288|527401088|FG000|Overall Study|Withdrawal by Subject|1|||
146242170|NCT01640288|527401089|FG001|Overall Study|Withdrawal by Subject|0|||
146242171|NCT00787176|527401091|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
146242172|NCT00787176|527401092|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
146242173|NCT00787176|527401093|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
146242174|NCT00787176|527401094|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
146242175|NCT00895245|527401100|FG000|Overall Study|Lack of Efficacy|6|||
146242176|NCT02095678|527401101|FG000|Overall Study|Withdrawal by Subject|0|||
146242177|NCT02095678|527401102|FG001|Overall Study|Withdrawal by Subject|1|||
146242178|NCT02095678|527401101|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
146242179|NCT02095678|527401102|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
146242180|NCT02095678|527401101|FG000|Overall Study|lesion impacted by previous treatment|1|||
145921284|NCT01147068|526217921|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145921285|NCT01147068|526217922|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
146242181|NCT02095678|527401102|FG001|Overall Study|lesion impacted by previous treatment|1|||
146242182|NCT02095678|527401101|FG000|Overall Study|No Confirmed Diagnosis|0|||
146242183|NCT02095678|527401102|FG001|Overall Study|No Confirmed Diagnosis|3|||
146242184|NCT02095678|527401101|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
146242185|NCT02095678|527401102|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
146242186|NCT02095678|527401101|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
146242187|NCT02095678|527401102|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
146242188|NCT00681109|527401103|FG000|Overall Study|Lost to Follow-up|2|||
146242189|NCT00681109|527401104|FG001|Overall Study|Lost to Follow-up|6|||
146242190|NCT00681109|527401105|FG002|Overall Study|Lost to Follow-up|0|||
146242191|NCT04660799|527401106|FG000|Overall Study|Progressive Disease|1|||
146242192|NCT04660799|527401107|FG001|Overall Study|Progressive Disease|1|||
146242193|NCT04660799|527401106|FG000|Overall Study|Death|2|||
146242194|NCT04660799|527401107|FG001|Overall Study|Death|1|||
145921286|NCT01147068|526217923|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145921287|NCT01147068|526217924|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145921288|NCT01147068|526217925|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145921289|NCT01147068|526217919|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145921290|NCT01147068|526217920|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145921291|NCT01147068|526217921|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145921292|NCT01147068|526217922|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
145921293|NCT01147068|526217923|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
146089502|NCT02093026|526847412|FG000|Overall Study|Other|157|||
146242195|NCT04660799|527401106|FG000|Overall Study|Adverse Event|2|||
146242196|NCT04660799|527401107|FG001|Overall Study|Adverse Event|1|||
146242197|NCT04660799|527401106|FG000|Overall Study|Withdrawal by Subject|2|||
146242198|NCT04660799|527401107|FG001|Overall Study|Withdrawal by Subject|5|||
146242199|NCT02706483|527401108|FG000|Overall Study|Adverse Event|97|||
146242200|NCT02706483|527401108|FG000|Overall Study|Death|1|||
146242201|NCT02706483|527401108|FG000|Overall Study|Lack of Efficacy|39|||
146242202|NCT02706483|527401108|FG000|Overall Study|Lost to Follow-up|101|||
146242203|NCT02706483|527401108|FG000|Overall Study|Non-compliance with study drug|15|||
146242204|NCT02706483|527401108|FG000|Overall Study|Physician Decision|6|||
146242205|NCT02706483|527401108|FG000|Overall Study|Pregnancy|6|||
146242206|NCT02706483|527401108|FG000|Overall Study|Protocol Violation|18|||
146242207|NCT02706483|527401108|FG000|Overall Study|Withdrawal by Subject|136|||
146242208|NCT02706483|527401108|FG000|Overall Study|Non-compliance with visits|6|||
146242209|NCT02706483|527401108|FG000|Overall Study|Site closure|4|||
146242210|NCT02706483|527401108|FG000|Overall Study|Subject moved|1|||
146242211|NCT03131713|527401111|FG000|Overall Study|Lost to Follow-up|5|||
146242212|NCT03131713|527401112|FG001|Overall Study|Lost to Follow-up|0|||
146242213|NCT01972776|527401121|FG000|Part 1|Withdrawal by Subject|0|||
146242214|NCT01972776|527401122|FG001|Part 1|Withdrawal by Subject|0|||
146242215|NCT01972776|527401123|FG002|Part 1|Withdrawal by Subject|1|||
146242216|NCT01972776|527401124|FG003|Part 1|Withdrawal by Subject|0|||
146242217|NCT01972776|527401125|FG004|Part 1|Withdrawal by Subject|0|||
146242218|NCT01972776|527401126|FG005|Part 1|Withdrawal by Subject|0|||
146242219|NCT01972776|527401121|FG000|Part 1|Adverse Event|0|||
146242220|NCT01972776|527401122|FG001|Part 1|Adverse Event|0|||
146242221|NCT01972776|527401123|FG002|Part 1|Adverse Event|1|||
146242222|NCT01972776|527401124|FG003|Part 1|Adverse Event|1|||
146242223|NCT01972776|527401125|FG004|Part 1|Adverse Event|0|||
146242224|NCT01972776|527401126|FG005|Part 1|Adverse Event|0|||
146242225|NCT01972776|527401121|FG000|Part 2|Adverse Event|0|||
146242226|NCT01972776|527401122|FG001|Part 2|Adverse Event|0|||
146242227|NCT01972776|527401123|FG002|Part 2|Adverse Event|0|||
146242228|NCT01972776|527401124|FG003|Part 2|Adverse Event|0|||
146242229|NCT01972776|527401125|FG004|Part 2|Adverse Event|3|||
146242230|NCT01972776|527401126|FG005|Part 2|Adverse Event|0|||
146242231|NCT01972776|527401121|FG000|Part 2|Administrative problems|0|||
146242232|NCT01972776|527401122|FG001|Part 2|Administrative problems|0|||
146242233|NCT01972776|527401123|FG002|Part 2|Administrative problems|0|||
146242234|NCT01972776|527401124|FG003|Part 2|Administrative problems|0|||
146242235|NCT01972776|527401125|FG004|Part 2|Administrative problems|10|||
146242236|NCT01972776|527401126|FG005|Part 2|Administrative problems|7|||
146242237|NCT02382640|527401136|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
146242238|NCT02382640|527401137|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146242239|NCT02382640|527401138|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146242240|NCT02382640|527401139|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
146242241|NCT01560429|527401140|FG000|Overall Study|Protocol Violation|3|||
146242242|NCT01560429|527401141|FG001|Overall Study|Protocol Violation|6|||
146242243|NCT01638000|527401145|FG000|Overall Study|Randomized but Never Received Drug|7|||
146242244|NCT01638000|527401146|FG001|Overall Study|Randomized but Never Received Drug|10|||
146242245|NCT01638000|527401145|FG000|Overall Study|Adverse Event|14|||
146242246|NCT01638000|527401146|FG001|Overall Study|Adverse Event|16|||
146242247|NCT01638000|527401145|FG000|Overall Study|Lack of Efficacy|5|||
146242248|NCT01638000|527401146|FG001|Overall Study|Lack of Efficacy|6|||
146242249|NCT01638000|527401145|FG000|Overall Study|Protocol Violation|11|||
146242250|NCT01638000|527401146|FG001|Overall Study|Protocol Violation|13|||
146242251|NCT01638000|527401145|FG000|Overall Study|Withdrawal by Subject|21|||
146242252|NCT01638000|527401146|FG001|Overall Study|Withdrawal by Subject|24|||
146242253|NCT01638000|527401145|FG000|Overall Study|Miscellaneous|2|||
146242254|NCT01638000|527401146|FG001|Overall Study|Miscellaneous|2|||
146242255|NCT05484661|527401147|FG000|Overall Study|Withdrawal by Subject|1|||
146242256|NCT05484661|527401148|FG001|Overall Study|Withdrawal by Subject|0|||
146242257|NCT00570505|527401151|FG000|Overall Study|Adverse Event|7|||
146242258|NCT00570505|527401151|FG000|Overall Study|Withdrawal by Subject|7|||
146242259|NCT00570505|527401151|FG000|Overall Study|Lost to Follow-up|23|||
146242260|NCT00570505|527401151|FG000|Overall Study|Other loss to follow-up|4|||
146297686|NCT02593786|527604773|FG002|Overall Study|Disease progression|10|||
146242261|NCT04224272|527401152|FG000|Part 1 - Dose Finding|Death|4|||
146089503|NCT02195011|526847426|FG000|Overall Study|Adverse Event|4|||
146089504|NCT02195011|526847427|FG001|Overall Study|Adverse Event|0|||
145921294|NCT01147068|526217924|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145921295|NCT01147068|526217925|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145921296|NCT01147068|526217919|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921297|NCT01147068|526217920|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
145921298|NCT01147068|526217921|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921299|NCT01147068|526217922|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921300|NCT01147068|526217923|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921301|NCT01147068|526217924|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921302|NCT01147068|526217925|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
145921303|NCT03181633|526217926|FG000|Overall Study|Withdrawal by Subject|1|||
145921304|NCT03181633|526217926|FG000|Overall Study|Missing follow-up visit|1|||
145921305|NCT01306305|526217929|FG000|Overall Study|Lost to Follow-up|1|||
145921306|NCT01306305|526217930|FG001|Overall Study|Lost to Follow-up|0|||
145921307|NCT01306305|526217929|FG000|Overall Study|Withdrew consent|1|||
145921308|NCT01306305|526217930|FG001|Overall Study|Withdrew consent|0|||
145921309|NCT01288079|526217931|FG000|Overall Study|Withdrawal by Subject|2|||
145921310|NCT01288079|526217932|FG001|Overall Study|Withdrawal by Subject|4|||
145921311|NCT01288079|526217933|FG002|Overall Study|Withdrawal by Subject|1|||
145921312|NCT01288079|526217934|FG003|Overall Study|Withdrawal by Subject|0|||
146089505|NCT02195011|526847426|FG000|Overall Study|Progressive Disease|18|||
146089506|NCT02195011|526847427|FG001|Overall Study|Progressive Disease|1|||
146242262|NCT04224272|527401152|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
146242263|NCT04224272|527401152|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
146242264|NCT04224272|527401152|FG000|Part 2 - Dose Expansion|Death|10|||
146242265|NCT04224272|527401152|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
146242266|NCT02485925|527401153|FG000|Overall Study|Withdrawal by Subject|3|||
146242267|NCT02485925|527401153|FG000|Overall Study|Death|1|||
146242268|NCT02485925|527401153|FG000|Overall Study|Lost to Follow-up|11|||
146242269|NCT04924608|527403276|FG000|Overall Study|Adverse Event|10|||
146242270|NCT04924608|527403277|FG001|Overall Study|Adverse Event|6|||
146242271|NCT04924608|527403276|FG000|Overall Study|Lost to Follow-up|1|||
146242272|NCT04924608|527403277|FG001|Overall Study|Lost to Follow-up|1|||
146242273|NCT04924608|527403276|FG000|Overall Study|Ongoing at the data cut-off date|54|||
146242274|NCT04924608|527403277|FG001|Overall Study|Ongoing at the data cut-off date|60|||
146242275|NCT04924608|527403276|FG000|Overall Study|Progressive Disease|2|||
146242276|NCT04924608|527403277|FG001|Overall Study|Progressive Disease|0|||
146242277|NCT04924608|527403276|FG000|Overall Study|Withdrawal by Subject|3|||
146242278|NCT04924608|527403277|FG001|Overall Study|Withdrawal by Subject|6|||
146242279|NCT04924608|527403276|FG000|Overall Study|Other reason|1|||
146242280|NCT04924608|527403277|FG001|Overall Study|Other reason|1|||
146242281|NCT00949117|527403278|FG000|Overall Study|Lack of Efficacy|2|||
146242282|NCT00949117|527403279|FG001|Overall Study|Lack of Efficacy|3|||
145921313|NCT01288079|526217931|FG000|Overall Study|Adverse Event|2|||
145921314|NCT01288079|526217932|FG001|Overall Study|Adverse Event|1|||
145921315|NCT01288079|526217933|FG002|Overall Study|Adverse Event|2|||
146242283|NCT00949117|527403278|FG000|Overall Study|Protocol Violation|1|||
146242284|NCT00949117|527403279|FG001|Overall Study|Protocol Violation|1|||
146242285|NCT00949117|527403278|FG000|Overall Study|Adverse Event|0|||
146242286|NCT00949117|527403279|FG001|Overall Study|Adverse Event|1|||
146242287|NCT02014402|527403280|FG000|Overall Study|Adverse Event|1|||
146242288|NCT02014402|527403281|FG001|Overall Study|Adverse Event|0|||
146242289|NCT02014402|527403282|FG002|Overall Study|Adverse Event|0|||
146242290|NCT02014402|527403283|FG003|Overall Study|Adverse Event|0|||
146242291|NCT02014402|527403280|FG000|Overall Study|Withdrawal by Subject|1|||
146242292|NCT02014402|527403281|FG001|Overall Study|Withdrawal by Subject|2|||
146242293|NCT02014402|527403282|FG002|Overall Study|Withdrawal by Subject|2|||
146242294|NCT02014402|527403283|FG003|Overall Study|Withdrawal by Subject|1|||
146242295|NCT02014402|527403280|FG000|Overall Study|Subject did not have transportation|0|||
146242296|NCT02014402|527403281|FG001|Overall Study|Subject did not have transportation|1|||
146242297|NCT02014402|527403282|FG002|Overall Study|Subject did not have transportation|0|||
146242298|NCT02014402|527403283|FG003|Overall Study|Subject did not have transportation|0|||
146242299|NCT02014402|527403280|FG000|Overall Study|Lost to Follow-up|0|||
146242300|NCT02014402|527403281|FG001|Overall Study|Lost to Follow-up|0|||
146242301|NCT02014402|527403282|FG002|Overall Study|Lost to Follow-up|1|||
146242302|NCT02014402|527403283|FG003|Overall Study|Lost to Follow-up|2|||
146242303|NCT03928743|527403287|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
146242304|NCT03928743|527403288|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
146282343|NCT01879722|527546478|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
146282344|NCT01879722|527546469|FG000|Overall Study|Voluntary Withdrawal|0|||
145921316|NCT01288079|526217934|FG003|Overall Study|Adverse Event|3|||
145921317|NCT01288079|526217931|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
145921318|NCT01288079|526217932|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
146089507|NCT02195011|526847426|FG000|Overall Study|Withdrawal by Subject|3|||
145921319|NCT01288079|526217933|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
145921320|NCT01288079|526217934|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
145921321|NCT01288079|526217931|FG000|Overall Study|Condition under Investigation Worsened|0|||
145921322|NCT01288079|526217932|FG001|Overall Study|Condition under Investigation Worsened|0|||
145921323|NCT01288079|526217933|FG002|Overall Study|Condition under Investigation Worsened|0|||
145921324|NCT01288079|526217934|FG003|Overall Study|Condition under Investigation Worsened|1|||
145921325|NCT01288079|526217931|FG000|Overall Study|Lack of Efficacy|2|||
145921326|NCT01288079|526217932|FG001|Overall Study|Lack of Efficacy|2|||
145921327|NCT01288079|526217933|FG002|Overall Study|Lack of Efficacy|0|||
145975464|NCT01295944|526420856|FG000|Overall Study|Participant chose to be treated in Peru|1|||
145975465|NCT01295944|526420856|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
145975466|NCT01295944|526420856|FG000|Overall Study|Physician Decision|1|||
145975467|NCT01295944|526420856|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
146242305|NCT03928743|527403289|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
146242306|NCT03928743|527403287|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
146242307|NCT03928743|527403288|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
146242308|NCT03928743|527403289|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
146242309|NCT03928743|527403287|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
146242310|NCT03928743|527403288|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
146242311|NCT03928743|527403289|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
146242312|NCT03928743|527403287|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
146242313|NCT03928743|527403288|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
146242314|NCT03928743|527403289|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
146242315|NCT03928743|527403287|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
146242316|NCT03928743|527403288|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
146242317|NCT03928743|527403289|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
146242318|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
146242319|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
146242320|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
146242321|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
146242322|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
146242323|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
146242324|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
146242325|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
146242326|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
146242327|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
146242328|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
146242329|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
146242330|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
146242331|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
146242332|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
145921328|NCT01288079|526217934|FG003|Overall Study|Lack of Efficacy|2|||
145921329|NCT01288079|526217931|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
145975468|NCT01295944|526420856|FG000|Overall Study|Disease progression|4|||
145975469|NCT01295944|526420856|FG000|Overall Study|Transferred care before starting new treatment|1|||
145975470|NCT02783274|526420857|FG000|Overall Study|Withdrawal by Subject|16|||
145975471|NCT02783274|526420857|FG000|Overall Study|Physician Decision|6|||
145975472|NCT02783274|526420857|FG000|Overall Study|Death|9|||
145975473|NCT02783274|526420857|FG000|Overall Study|Lost to Follow-up|22|||
145975474|NCT02783274|526420857|FG000|Overall Study|Other|22|||
145975475|NCT01802281|526420858|FG000|Overall Study|Death|1|||
145975476|NCT01802281|526420859|FG001|Overall Study|Death|2|||
145975477|NCT01802281|526420858|FG000|Overall Study|Withdrawal by Subject|2|||
145975478|NCT01802281|526420859|FG001|Overall Study|Withdrawal by Subject|1|||
145975479|NCT01802281|526420858|FG000|Overall Study|Ineligible|5|||
145975480|NCT01802281|526420859|FG001|Overall Study|Ineligible|3|||
145975481|NCT04133909|526420860|FG000|Overall Study|Death|11|||
145975482|NCT04133909|526420861|FG001|Overall Study|Death|11|||
145975483|NCT04133909|526420860|FG000|Overall Study|Adverse Event|4|||
145975484|NCT04133909|526420861|FG001|Overall Study|Adverse Event|5|||
145975485|NCT04133909|526420860|FG000|Overall Study|Lost to Follow-up|3|||
146297687|NCT02593786|527604774|FG003|Overall Study|Disease progression|7|||
146297688|NCT02593786|527604771|FG000|Overall Study|Study drug toxicity|1|||
145975486|NCT04133909|526420861|FG001|Overall Study|Lost to Follow-up|5|||
145975487|NCT04133909|526420860|FG000|Overall Study|Physician Decision|4|||
145975488|NCT04133909|526420861|FG001|Overall Study|Physician Decision|7|||
145975489|NCT04133909|526420860|FG000|Overall Study|Withdrawal by Subject|40|||
145975490|NCT04133909|526420861|FG001|Overall Study|Withdrawal by Subject|35|||
145975491|NCT04133909|526420860|FG000|Overall Study|Lack of Efficacy|2|||
145975492|NCT04133909|526420861|FG001|Overall Study|Lack of Efficacy|7|||
145921330|NCT01288079|526217932|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145921331|NCT01288079|526217933|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
145921332|NCT01288079|526217934|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
145921333|NCT01288079|526217931|FG000|Overall Study|Lost to Follow-up|1|||
145921334|NCT01288079|526217932|FG001|Overall Study|Lost to Follow-up|1|||
145921335|NCT01288079|526217933|FG002|Overall Study|Lost to Follow-up|1|||
145921336|NCT01288079|526217934|FG003|Overall Study|Lost to Follow-up|0|||
145921337|NCT01288079|526217931|FG000|Overall Study|Other or Study Termination|11|||
145921338|NCT01288079|526217932|FG001|Overall Study|Other or Study Termination|15|||
145921339|NCT01288079|526217933|FG002|Overall Study|Other or Study Termination|14|||
145921340|NCT01288079|526217934|FG003|Overall Study|Other or Study Termination|8|||
145921341|NCT02387840|526217935|FG000|Overall Study|Death|0|||
145921342|NCT02387840|526217936|FG001|Overall Study|Death|0|||
145921343|NCT02387840|526217937|FG002|Overall Study|Death|0|||
145921344|NCT02387840|526217938|FG003|Overall Study|Death|0|||
145921345|NCT02387840|526217939|FG004|Overall Study|Death|0|||
145921346|NCT02387840|526217940|FG005|Overall Study|Death|1|||
145921347|NCT00868530|526217941|FG000|Overall Study|Adverse Event|3|||
145921348|NCT00868530|526217941|FG000|Overall Study|Lost to Follow-up|1|||
145921349|NCT01609790|526217942|FG000|Overall Study|Protocol Violation|1|||
145921350|NCT01609790|526217943|FG001|Overall Study|Protocol Violation|7|||
145921351|NCT01609790|526217944|FG002|Overall Study|Protocol Violation|8|||
145921352|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Adverse Event|7|||
145921353|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
145921354|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Non-compliance|3|||
145921355|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Other|17|||
145921356|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Physician Decision|2|||
145921357|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Pregnancy|1|||
145921358|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
145921359|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
145921360|NCT05207865|526219476|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
145921361|NCT05207865|526219476|FG000|Follow-up Phase|Lost to Follow-up|1|||
145921362|NCT05207865|526219476|FG000|Follow-up Phase|Non-compliance|1|||
145921363|NCT05207865|526219476|FG000|Follow-up Phase|Not reported|2|||
145921364|NCT05207865|526219476|FG000|Follow-up Phase|Not collected|11|||
145921365|NCT02546986|526219477|FG000|Treatment Period|Progressive Disease|20|||
145921366|NCT02546986|526219478|FG001|Treatment Period|Progressive Disease|22|||
145921367|NCT02546986|526219477|FG000|Treatment Period|Adverse Event|14|||
145921368|NCT02546986|526219478|FG001|Treatment Period|Adverse Event|6|||
145921369|NCT02546986|526219477|FG000|Treatment Period|Symptomatic Deterioration|4|||
145975493|NCT04133909|526420860|FG000|Overall Study|Randomized in error|1|||
145975494|NCT04133909|526420861|FG001|Overall Study|Randomized in error|1|||
145975495|NCT00858988|526420868|FG000|Analysis|Lactulose unable to be detected in urine|2|||
145975496|NCT00858988|526420869|FG001|Analysis|Lactulose unable to be detected in urine|1|||
145975497|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
145975498|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
146242333|NCT03928743|527403287|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
146242334|NCT03928743|527403288|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
146242335|NCT03928743|527403289|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
146242336|NCT00703092|527403293|FG000|Overall Study|Withdrawal by Subject|2|||
146242337|NCT02007070|527403294|FG000|Overall Study|Adverse Event|4|||
146242338|NCT02007070|527403294|FG000|Overall Study|Clinical Progression|4|||
146242339|NCT02007070|527403294|FG000|Overall Study|Death|1|||
146242340|NCT02007070|527403294|FG000|Overall Study|Protocol Violation|2|||
146242341|NCT02007070|527403294|FG000|Overall Study|Physician Decision|1|||
146242342|NCT02007070|527403294|FG000|Overall Study|Progressive Disease|21|||
146242343|NCT01480258|527403295|FG000|Infant Series|Protocol Violation|2|||
146242344|NCT01480258|527403296|FG001|Infant Series|Protocol Violation|0|||
146242345|NCT01480258|527403295|FG000|Infant Series|Physician Decision|0|||
146242346|NCT01480258|527403296|FG001|Infant Series|Physician Decision|1|||
146242347|NCT01480258|527403295|FG000|Infant Series|Not Vaccinated|3|||
146242348|NCT01480258|527403296|FG001|Infant Series|Not Vaccinated|0|||
146242349|NCT01480258|527403295|FG000|Infant Series|Adverse Event|1|||
146242350|NCT01480258|527403296|FG001|Infant Series|Adverse Event|1|||
146242351|NCT01480258|527403295|FG000|Infant Series|Withdrawal by Subject|1|||
145921370|NCT02546986|526219478|FG001|Treatment Period|Symptomatic Deterioration|3|||
145921371|NCT02546986|526219477|FG000|Treatment Period|Death|3|||
145975499|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
145975500|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
146242352|NCT01480258|527403296|FG001|Infant Series|Withdrawal by Subject|6|||
146242353|NCT01480258|527403295|FG000|Interim Period|Lost to Follow-up|0|||
145921372|NCT02546986|526219478|FG001|Treatment Period|Death|4|||
145921373|NCT02546986|526219477|FG000|Treatment Period|Physician Decision|1|||
145921374|NCT02546986|526219478|FG001|Treatment Period|Physician Decision|2|||
145921375|NCT02546986|526219477|FG000|Treatment Period|Protocol Violation|1|||
146242354|NCT01480258|527403296|FG001|Interim Period|Lost to Follow-up|2|||
146242355|NCT01480258|527403295|FG000|Interim Period|Physician Decision|1|||
146242356|NCT01480258|527403296|FG001|Interim Period|Physician Decision|0|||
146242357|NCT01480258|527403295|FG000|Interim Period|Protocol Violation|0|||
146242358|NCT01480258|527403296|FG001|Interim Period|Protocol Violation|1|||
146242359|NCT01480258|527403295|FG000|Interim Period|Withdrawal by Subject|9|||
146242360|NCT01480258|527403296|FG001|Interim Period|Withdrawal by Subject|6|||
146242361|NCT00659373|527403298|FG000|Overall Study|Withdrawal by Subject|3|||
146242362|NCT00659373|527403299|FG001|Overall Study|Withdrawal by Subject|5|||
146242363|NCT00659373|527403298|FG000|Overall Study|Assessment Missed|2|||
146242364|NCT00659373|527403299|FG001|Overall Study|Assessment Missed|2|||
146242365|NCT03042767|527403300|FG000|Overall Study|Lost to Follow-up|1|||
146242366|NCT03042767|527403301|FG001|Overall Study|Lost to Follow-up|2|||
146242367|NCT01543204|527403302|FG000|Overall Study|Non-compliance|1|||
146242368|NCT01543204|527403302|FG000|Overall Study|Adverse Event|1|||
146242369|NCT01543204|527403302|FG000|Overall Study|Withdrawal by Subject|4|||
146242370|NCT01543204|527403302|FG000|Overall Study|Requirement for Alternative Therapy|1|||
146242371|NCT01543204|527403302|FG000|Overall Study|Lost to Follow-up|1|||
145921376|NCT02546986|526219478|FG001|Treatment Period|Protocol Violation|0|||
145921377|NCT02546986|526219477|FG000|Treatment Period|Withdrawal by Subject|1|||
145921378|NCT02546986|526219478|FG001|Treatment Period|Withdrawal by Subject|1|||
145921379|NCT02546986|526219477|FG000|Treatment Period|Non-compliance with Study Drug|0|||
145921380|NCT02546986|526219478|FG001|Treatment Period|Non-compliance with Study Drug|1|||
145921381|NCT02546986|526219477|FG000|Treatment Period|Study Terminated by Sponsor|0|||
145921382|NCT02546986|526219478|FG001|Treatment Period|Study Terminated by Sponsor|1|||
145921383|NCT02546986|526219477|FG000|Treatment Period|Miscellaneous|7|||
145921384|NCT02546986|526219478|FG001|Treatment Period|Miscellaneous|9|||
145921385|NCT02546986|526219477|FG000|Survival Follow-Up Phase|Missing Status|3|||
145921386|NCT02546986|526219478|FG001|Survival Follow-Up Phase|Missing Status|5|||
145921387|NCT02546986|526219477|FG000|Survival Follow-Up Phase|Death|18|||
145921388|NCT02546986|526219478|FG001|Survival Follow-Up Phase|Death|12|||
145921389|NCT02546986|526219477|FG000|Survival Follow-Up Phase|Alive|13|||
145921390|NCT02546986|526219478|FG001|Survival Follow-Up Phase|Alive|16|||
145921391|NCT02546986|526219477|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
145921392|NCT02546986|526219478|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
145921393|NCT00739882|526219479|FG000|Double-blind Period|Adverse Event|1|||
145921394|NCT00739882|526219480|FG001|Double-blind Period|Adverse Event|2|||
145921395|NCT00739882|526219479|FG000|Double-blind Period|Protocol Violation|1|||
145921396|NCT00739882|526219480|FG001|Double-blind Period|Protocol Violation|0|||
145921397|NCT00739882|526219479|FG000|Double-blind Period|Lack of Efficacy|1|||
145921398|NCT00739882|526219480|FG001|Double-blind Period|Lack of Efficacy|1|||
145921399|NCT00739882|526219479|FG000|Double-blind Period|Other|16|||
145921400|NCT00739882|526219480|FG001|Double-blind Period|Other|8|||
145921401|NCT00739882|526219479|FG000|Open-label Period|Adverse Event|1|||
145921402|NCT00739882|526219480|FG001|Open-label Period|Adverse Event|0|||
145921403|NCT00739882|526219479|FG000|Open-label Period|Other|9|||
145921404|NCT00739882|526219480|FG001|Open-label Period|Other|5|||
145921405|NCT04021914|526219481|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
145921406|NCT02844543|526219482|FG000|Overall Study|Withdrawal by Subject|4|||
145921407|NCT02844543|526219482|FG000|Overall Study|Did not meet eligibility criteria|1|||
145921408|NCT03985800|526219483|FG000|Overall Study|Death|1|||
145921409|NCT03985800|526219484|FG001|Overall Study|Death|2|||
145921410|NCT03985800|526219483|FG000|Overall Study|Withdrawal by Subject|3|||
145921411|NCT03985800|526219484|FG001|Overall Study|Withdrawal by Subject|6|||
145921412|NCT03985800|526219483|FG000|Overall Study|Protocol Violation|2|||
145921413|NCT03985800|526219484|FG001|Overall Study|Protocol Violation|0|||
145921414|NCT06025721|526219487|FG000|Overall Study|Physician Decision|1|||
145921415|NCT06025721|526219487|FG000|Overall Study|Protocol Violation|1|||
145921416|NCT06025721|526219487|FG000|Overall Study|Incarceration|1|||
145921417|NCT02068508|526219490|FG000|Overall Study|Case report forms uncollected|27|||
145921418|NCT02068508|526219490|FG000|Overall Study|Patient did not visit the study site|1|||
145921419|NCT02068508|526219490|FG000|Overall Study|Protocol Violation|4|||
145921420|NCT00813150|526219491|FG000|Treatment Period|Adverse Event|16|||
145921421|NCT00813150|526219492|FG001|Treatment Period|Adverse Event|15|||
146242372|NCT01220999|527403303|FG000|Overall Study|Progressive disease|0|||
145921422|NCT00813150|526219491|FG000|Treatment Period|Death|2|||
145921423|NCT00813150|526219492|FG001|Treatment Period|Death|0|||
145921424|NCT00813150|526219491|FG000|Treatment Period|Progressive disease|1|||
145921425|NCT00813150|526219492|FG001|Treatment Period|Progressive disease|0|||
145921426|NCT00813150|526219491|FG000|Treatment Period|Complete response|0|||
145921427|NCT00813150|526219492|FG001|Treatment Period|Complete response|1|||
145921428|NCT00813150|526219491|FG000|Treatment Period|Stable disease|1|||
145921429|NCT00813150|526219492|FG001|Treatment Period|Stable disease|2|||
145921430|NCT00813150|526219491|FG000|Treatment Period|Protocol Violation|3|||
146242373|NCT01220999|527403304|FG001|Overall Study|Progressive disease|0|||
146242374|NCT01220999|527403305|FG002|Overall Study|Progressive disease|1|||
146242375|NCT01220999|527403306|FG003|Overall Study|Progressive disease|0|||
146242376|NCT01220999|527403307|FG004|Overall Study|Progressive disease|0|||
146242377|NCT03326856|527403309|FG000|Overall Study|Lost to Follow-up|1|||
146242378|NCT03326856|527403310|FG001|Overall Study|Lost to Follow-up|1|||
146242379|NCT03326856|527403311|FG002|Overall Study|Lost to Follow-up|0|||
146242380|NCT03326856|527403312|FG003|Overall Study|Lost to Follow-up|0|||
146242381|NCT03326856|527403313|FG004|Overall Study|Lost to Follow-up|0|||
146242382|NCT02037568|527403314|FG000|Overall Study|Withdrawal by Subject|17|||
146242383|NCT02037568|527403315|FG001|Overall Study|Withdrawal by Subject|24|||
146242384|NCT02037568|527403314|FG000|Overall Study|Lost to Follow-up|16|||
146242385|NCT02037568|527403315|FG001|Overall Study|Lost to Follow-up|13|||
146242386|NCT02037568|527403314|FG000|Overall Study|Screen Failure|3|||
146242387|NCT02037568|527403315|FG001|Overall Study|Screen Failure|1|||
146242388|NCT02037568|527403314|FG000|Overall Study|Patient did not receive transplant|0|||
146242389|NCT02037568|527403315|FG001|Overall Study|Patient did not receive transplant|1|||
146242390|NCT00721734|527403318|FG000|Overall Study|Progressive Disease|3|||
146242391|NCT00721734|527403319|FG001|Overall Study|Progressive Disease|10|||
146242392|NCT00721734|527403320|FG002|Overall Study|Progressive Disease|4|||
145921431|NCT00813150|526219492|FG001|Treatment Period|Protocol Violation|4|||
145921432|NCT00813150|526219491|FG000|Treatment Period|Withdrawal by Subject|5|||
145921433|NCT00813150|526219492|FG001|Treatment Period|Withdrawal by Subject|3|||
145921434|NCT00813150|526219491|FG000|Treatment Period|Non compliance|0|||
145921435|NCT00813150|526219492|FG001|Treatment Period|Non compliance|1|||
145921436|NCT00813150|526219491|FG000|Treatment Period|Reason not specified|3|||
145921437|NCT00813150|526219492|FG001|Treatment Period|Reason not specified|4|||
145921438|NCT00813150|526219491|FG000|Treatment Period|Data not available|1|||
145921439|NCT00813150|526219492|FG001|Treatment Period|Data not available|2|||
145921440|NCT00813150|526219491|FG000|Long Term Follow-up|Death|0|||
145921441|NCT00813150|526219492|FG001|Long Term Follow-up|Death|4|||
145921442|NCT00813150|526219491|FG000|Long Term Follow-up|Other|0|||
145921443|NCT00813150|526219492|FG001|Long Term Follow-up|Other|3|||
145921444|NCT00813150|526219491|FG000|Long Term Follow-up|Lost to Follow-up|2|||
145921445|NCT00813150|526219492|FG001|Long Term Follow-up|Lost to Follow-up|0|||
145921446|NCT00813150|526219491|FG000|Long Term Follow-up|Progression/Relapse|22|||
145921447|NCT00813150|526219492|FG001|Long Term Follow-up|Progression/Relapse|24|||
145921448|NCT05423093|526219500|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
145921449|NCT05423093|526219500|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
145921450|NCT05423093|526219500|FG000|Attended Intervention Session|Lost to Follow-up|3|||
145921451|NCT05423093|526219500|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
145921452|NCT05423093|526219500|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
145921453|NCT03593525|526219501|FG000|Overall Study|Withdrawal by Subject|1|||
145921454|NCT03593525|526219502|FG001|Overall Study|Withdrawal by Subject|0|||
145921455|NCT03593525|526219501|FG000|Overall Study|Lost to Follow-up|7|||
145921456|NCT03593525|526219502|FG001|Overall Study|Lost to Follow-up|5|||
145921457|NCT04173507|526219510|FG000|Overall Study|On Treatment|3|||
145921458|NCT04173507|526219510|FG000|Overall Study|Adverse Event|3|||
145921459|NCT04173507|526219510|FG000|Overall Study|Progression/Relapse|34|||
145921460|NCT04173507|526219510|FG000|Overall Study|Death|2|||
145921461|NCT02832687|526219511|FG000|Overall Study|Adverse Event|0|||
145921462|NCT02832687|526219512|FG001|Overall Study|Adverse Event|2|||
145921463|NCT00210210|526219513|FG000|Overall Study|Withdrawal by Subject|3|||
145921464|NCT00210210|526219514|FG001|Overall Study|Withdrawal by Subject|2|||
145921465|NCT00210210|526219513|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
145921466|NCT00210210|526219514|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
145921467|NCT01217112|526219515|FG000|Overall Study|Adverse Event|0|||
145921468|NCT01217112|526219516|FG001|Overall Study|Adverse Event|2|||
145921469|NCT01217112|526219517|FG002|Overall Study|Adverse Event|0|||
145921470|NCT01217112|526219518|FG003|Overall Study|Adverse Event|2|||
145921471|NCT01217112|526219519|FG004|Overall Study|Adverse Event|0|||
145921472|NCT01217112|526219515|FG000|Overall Study|Withdrawal by Subject|0|||
145921473|NCT01217112|526219516|FG001|Overall Study|Withdrawal by Subject|0|||
145921474|NCT01217112|526219517|FG002|Overall Study|Withdrawal by Subject|1|||
145921475|NCT01217112|526219518|FG003|Overall Study|Withdrawal by Subject|0|||
145921476|NCT01217112|526219519|FG004|Overall Study|Withdrawal by Subject|0|||
145921477|NCT01217112|526219515|FG000|Overall Study|Physician Decision|0|||
145921478|NCT01217112|526219516|FG001|Overall Study|Physician Decision|0|||
145921479|NCT01217112|526219517|FG002|Overall Study|Physician Decision|0|||
145921480|NCT01217112|526219518|FG003|Overall Study|Physician Decision|0|||
145921481|NCT01217112|526219519|FG004|Overall Study|Physician Decision|1|||
146242393|NCT00721734|527403321|FG003|Overall Study|Progressive Disease|5|||
146242394|NCT00721734|527403322|FG004|Overall Study|Progressive Disease|2|||
145921482|NCT00917852|526219520|FG000|Overall Study|Death|6|||
145921483|NCT04335123|526219522|FG000|Overall Study|Withdrawal by Subject|2|||
146242395|NCT00721734|527403318|FG000|Overall Study|Adverse Event|3|||
146242396|NCT00721734|527403319|FG001|Overall Study|Adverse Event|1|||
145921484|NCT04335123|526219523|FG001|Overall Study|Withdrawal by Subject|0|||
145921485|NCT04335123|526219522|FG000|Overall Study|Physician Decision|2|||
145921486|NCT04335123|526219523|FG001|Overall Study|Physician Decision|0|||
145921487|NCT05486091|526219524|FG000|Overall Study|Withdrawal by Subject|1|||
146242397|NCT00721734|527403320|FG002|Overall Study|Adverse Event|4|||
146242398|NCT00721734|527403321|FG003|Overall Study|Adverse Event|0|||
145921488|NCT05486091|526219524|FG000|Overall Study|Lost to Follow-up|2|||
145921489|NCT00370552|526219525|FG000|Overall Study|Adverse Event|2|||
146242399|NCT00721734|527403322|FG004|Overall Study|Adverse Event|3|||
146242400|NCT00721734|527403318|FG000|Overall Study|Withdrawal by Subject|2|||
146242401|NCT00721734|527403319|FG001|Overall Study|Withdrawal by Subject|1|||
146242402|NCT00721734|527403320|FG002|Overall Study|Withdrawal by Subject|0|||
146242403|NCT00721734|527403321|FG003|Overall Study|Withdrawal by Subject|0|||
146242404|NCT00721734|527403322|FG004|Overall Study|Withdrawal by Subject|1|||
146242405|NCT00721734|527403318|FG000|Overall Study|Other|0|||
146242406|NCT00721734|527403319|FG001|Overall Study|Other|0|||
146242407|NCT00721734|527403320|FG002|Overall Study|Other|0|||
146242408|NCT00721734|527403321|FG003|Overall Study|Other|1|||
146242409|NCT00721734|527403322|FG004|Overall Study|Other|0|||
146242410|NCT01989689|527403325|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
146242411|NCT01989689|527403326|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
146242412|NCT01989689|527403325|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
146242413|NCT01989689|527403326|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
146242414|NCT02066636|527403327|FG000|Overall Study|Disease progression|51|||
146242415|NCT02066636|527403328|FG001|Overall Study|Disease progression|60|||
146242416|NCT02066636|527403329|FG002|Overall Study|Disease progression|700|||
146242417|NCT02066636|527403327|FG000|Overall Study|Study drug toxicity|13|||
146242418|NCT02066636|527403328|FG001|Overall Study|Study drug toxicity|2|||
146242419|NCT02066636|527403329|FG002|Overall Study|Study drug toxicity|58|||
146242420|NCT02066636|527403327|FG000|Overall Study|Death|4|||
146242421|NCT02066636|527403328|FG001|Overall Study|Death|2|||
146242422|NCT02066636|527403329|FG002|Overall Study|Death|158|||
146242423|NCT02066636|527403327|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146242424|NCT02066636|527403328|FG001|Overall Study|Adverse event unrelated to study drug|4|||
146242425|NCT02066636|527403329|FG002|Overall Study|Adverse event unrelated to study drug|45|||
146242426|NCT02066636|527403327|FG000|Overall Study|Participant request to discontinue treatment|12|||
146242427|NCT02066636|527403328|FG001|Overall Study|Participant request to discontinue treatment|12|||
145921490|NCT00370552|526219526|FG001|Overall Study|Adverse Event|2|||
145921491|NCT00370552|526219527|FG002|Overall Study|Adverse Event|2|||
145921492|NCT00370552|526219525|FG000|Overall Study|Disease progression|23|||
145921493|NCT00370552|526219526|FG001|Overall Study|Disease progression|23|||
145921494|NCT00370552|526219527|FG002|Overall Study|Disease progression|15|||
145921495|NCT00370552|526219525|FG000|Overall Study|Maximum clinical benefit|3|||
145921496|NCT00370552|526219526|FG001|Overall Study|Maximum clinical benefit|5|||
145921497|NCT00370552|526219527|FG002|Overall Study|Maximum clinical benefit|5|||
145921498|NCT00370552|526219525|FG000|Overall Study|Poor or noncompliance|0|||
145921499|NCT00370552|526219526|FG001|Overall Study|Poor or noncompliance|0|||
145921500|NCT00370552|526219527|FG002|Overall Study|Poor or noncompliance|1|||
145921501|NCT00370552|526219525|FG000|Overall Study|Study drug toxicity|11|||
145921502|NCT00370552|526219526|FG001|Overall Study|Study drug toxicity|8|||
145921503|NCT00370552|526219527|FG002|Overall Study|Study drug toxicity|6|||
145921504|NCT00370552|526219525|FG000|Overall Study|Withdrawal by Subject|2|||
145921505|NCT00370552|526219526|FG001|Overall Study|Withdrawal by Subject|0|||
145921506|NCT00370552|526219527|FG002|Overall Study|Withdrawal by Subject|1|||
145921507|NCT00370552|526219525|FG000|Overall Study|Still on treatment|1|||
145921508|NCT00370552|526219526|FG001|Overall Study|Still on treatment|3|||
145921509|NCT00370552|526219527|FG002|Overall Study|Still on treatment|2|||
145921510|NCT00370552|526219525|FG000|Overall Study|Never treated|1|||
145921511|NCT00370552|526219526|FG001|Overall Study|Never treated|0|||
145921512|NCT00370552|526219527|FG002|Overall Study|Never treated|0|||
145921513|NCT00370552|526219525|FG000|Overall Study|Physician Decision|1|||
145975501|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
145975502|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
145975503|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145975504|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145975505|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
146242428|NCT02066636|527403329|FG002|Overall Study|Participant request to discontinue treatment|70|||
146242429|NCT02066636|527403327|FG000|Overall Study|Participant withdrew consent|10|||
146242430|NCT02066636|527403328|FG001|Overall Study|Participant withdrew consent|18|||
145921514|NCT00370552|526219526|FG001|Overall Study|Physician Decision|1|||
145921515|NCT00370552|526219527|FG002|Overall Study|Physician Decision|0|||
145921516|NCT00370552|526219525|FG000|Overall Study|Investigator decision|2|||
145975506|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
146242431|NCT02066636|527403329|FG002|Overall Study|Participant withdrew consent|61|||
146242432|NCT02066636|527403327|FG000|Overall Study|Lost to Follow-up|0|||
145921517|NCT00370552|526219526|FG001|Overall Study|Investigator decision|1|||
145921518|NCT00370552|526219527|FG002|Overall Study|Investigator decision|0|||
146242433|NCT02066636|527403328|FG001|Overall Study|Lost to Follow-up|2|||
146242434|NCT02066636|527403329|FG002|Overall Study|Lost to Follow-up|2|||
146242435|NCT02066636|527403327|FG000|Overall Study|Maximum clinical benefit|2|||
145921519|NCT00370552|526219525|FG000|Overall Study|High risk of allergic reaction|0|||
145921520|NCT00370552|526219526|FG001|Overall Study|High risk of allergic reaction|1|||
146242436|NCT02066636|527403328|FG001|Overall Study|Maximum clinical benefit|2|||
146242437|NCT02066636|527403329|FG002|Overall Study|Maximum clinical benefit|3|||
146242438|NCT02066636|527403327|FG000|Overall Study|Poor/non-compliance|2|||
146242439|NCT02066636|527403328|FG001|Overall Study|Poor/non-compliance|1|||
146242440|NCT02066636|527403329|FG002|Overall Study|Poor/non-compliance|1|||
146242441|NCT02066636|527403327|FG000|Overall Study|Participant no loner meets study criteria|3|||
146242442|NCT02066636|527403328|FG001|Overall Study|Participant no loner meets study criteria|2|||
146242443|NCT02066636|527403329|FG002|Overall Study|Participant no loner meets study criteria|28|||
146242444|NCT02066636|527403327|FG000|Overall Study|Administrative reasons by sponsor|8|||
146242445|NCT02066636|527403328|FG001|Overall Study|Administrative reasons by sponsor|5|||
146242446|NCT02066636|527403329|FG002|Overall Study|Administrative reasons by sponsor|0|||
146242447|NCT02066636|527403327|FG000|Overall Study|Other reasons|16|||
146242448|NCT02066636|527403328|FG001|Overall Study|Other reasons|15|||
146242449|NCT02066636|527403329|FG002|Overall Study|Other reasons|50|||
146242450|NCT00391170|527403332|FG000|Overall Study|Withdrawal by Subject|1|||
146242451|NCT00391170|527403333|FG001|Overall Study|Withdrawal by Subject|0|||
146242452|NCT00391170|527403332|FG000|Overall Study|Adverse Event|3|||
146242453|NCT00391170|527403333|FG001|Overall Study|Adverse Event|2|||
146242454|NCT00391170|527403332|FG000|Overall Study|Physician Decision|2|||
146242455|NCT00391170|527403333|FG001|Overall Study|Physician Decision|2|||
146242456|NCT03567616|527403338|FG000|Overall Study|Disease progression|4|||
146242457|NCT03567616|527403338|FG000|Overall Study|Withdrawal by Subject|1|||
146242458|NCT03567616|527403338|FG000|Overall Study|Physician Decision|1|||
146242459|NCT03567616|527403338|FG000|Overall Study|Death|1|||
146242460|NCT03567616|527403338|FG000|Overall Study|Adverse Event|1|||
146242461|NCT00526994|527403343|FG000|Overall Study|Lost to Follow-up|98|||
146242462|NCT00526994|527403344|FG001|Overall Study|Lost to Follow-up|108|||
146242463|NCT00526994|527403345|FG002|Overall Study|Lost to Follow-up|96|||
146242464|NCT00526994|527403343|FG000|Overall Study|Death|4|||
146242465|NCT00526994|527403344|FG001|Overall Study|Death|3|||
146242466|NCT00526994|527403345|FG002|Overall Study|Death|3|||
146242467|NCT00526994|527403343|FG000|Overall Study|Withdrawal by Subject|2|||
146242468|NCT00526994|527403344|FG001|Overall Study|Withdrawal by Subject|7|||
146242469|NCT00526994|527403345|FG002|Overall Study|Withdrawal by Subject|5|||
146242470|NCT00526994|527403343|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
146242471|NCT00526994|527403344|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
146242472|NCT00526994|527403345|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
146242473|NCT02833948|527403348|FG000|Overall Study|Death|2|||
146242474|NCT02833948|527403349|FG001|Overall Study|Death|3|||
146242475|NCT02833948|527403348|FG000|Overall Study|were not scanned|8|||
146242476|NCT02833948|527403349|FG001|Overall Study|were not scanned|13|||
146242477|NCT02833948|527403348|FG000|Overall Study|scans could not be evaluated|5|||
146242478|NCT02833948|527403349|FG001|Overall Study|scans could not be evaluated|2|||
146242479|NCT05169684|527403353|FG000|Overall Study|Adverse Event|1|||
146242480|NCT05169684|527403354|FG001|Overall Study|Adverse Event|3|||
146242481|NCT05169684|527403353|FG000|Overall Study|Physician Decision|0|||
146242482|NCT05169684|527403354|FG001|Overall Study|Physician Decision|1|||
146242483|NCT05169684|527403353|FG000|Overall Study|Progressive Disease|1|||
146242484|NCT05169684|527403354|FG001|Overall Study|Progressive Disease|1|||
146242485|NCT05169684|527403353|FG000|Overall Study|Participant request to discontinue treatment|0|||
146242486|NCT05169684|527403354|FG001|Overall Study|Participant request to discontinue treatment|1|||
146242487|NCT05169684|527403353|FG000|Overall Study|Other Reason|0|||
146242488|NCT05169684|527403354|FG001|Overall Study|Other Reason|1|||
146242489|NCT03539055|527403355|FG000|Overall Study|Death|4|||
146242490|NCT03539055|527403355|FG000|Overall Study|Lost to Follow-up|1|||
146242491|NCT03539055|527403355|FG000|Overall Study|Withdrawal by Subject|2|||
146242492|NCT03539055|527403355|FG000|Overall Study|Screen Fail|7|||
146242493|NCT03539055|527403355|FG000|Overall Study|Drug Intolerance|2|||
146242494|NCT03775213|527403359|FG000|Overall Study|Withdrawal by Subject|51|||
146297689|NCT02593786|527604772|FG001|Overall Study|Study drug toxicity|0|||
146297690|NCT02593786|527604773|FG002|Overall Study|Study drug toxicity|0|||
146297691|NCT02593786|527604774|FG003|Overall Study|Study drug toxicity|0|||
145921521|NCT00370552|526219527|FG002|Overall Study|High risk of allergic reaction|0|||
145921522|NCT00370552|526219525|FG000|Overall Study|Planned radiation for palliation|0|||
145921523|NCT00370552|526219526|FG001|Overall Study|Planned radiation for palliation|1|||
146297692|NCT02593786|527604771|FG000|Overall Study|Adverse event unrelated to study drug|1|||
145921524|NCT00370552|526219527|FG002|Overall Study|Planned radiation for palliation|0|||
145921525|NCT00586703|526219532|FG000|Overall Study|Death|12|||
146242495|NCT03775213|527403360|FG001|Overall Study|Withdrawal by Subject|53|||
146242496|NCT03775213|527403359|FG000|Overall Study|Incomplete Survey|7|||
146242497|NCT03775213|527403360|FG001|Overall Study|Incomplete Survey|7|||
146242498|NCT00786188|527403361|FG000|Overall Study|Adverse Event|3|||
146242499|NCT00786188|527403362|FG001|Overall Study|Adverse Event|1|||
146242500|NCT00786188|527403361|FG000|Overall Study|Withdrawal by Subject|2|||
146242501|NCT00786188|527403362|FG001|Overall Study|Withdrawal by Subject|0|||
146242502|NCT05163353|527403366|FG000|Overall Study|Adverse Event|1|||
146242503|NCT05163353|527403367|FG001|Overall Study|Adverse Event|0|||
146297693|NCT02593786|527604772|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146297694|NCT02593786|527604773|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146297695|NCT02593786|527604774|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146297696|NCT02593786|527604771|FG000|Overall Study|Participant request to discontinue study therapy|0|||
146297697|NCT02593786|527604772|FG001|Overall Study|Participant request to discontinue study therapy|2|||
146297698|NCT02593786|527604773|FG002|Overall Study|Participant request to discontinue study therapy|0|||
146297699|NCT02593786|527604774|FG003|Overall Study|Participant request to discontinue study therapy|0|||
146297700|NCT02593786|527604771|FG000|Overall Study|Other reasons|1|||
146297701|NCT02593786|527604772|FG001|Overall Study|Other reasons|1|||
146297702|NCT02593786|527604773|FG002|Overall Study|Other reasons|0|||
146297703|NCT02593786|527604774|FG003|Overall Study|Other reasons|5|||
146297704|NCT03901053|527604782|FG000|Overall Study|Lost to Follow-up|6|||
146297705|NCT03901053|527604783|FG001|Overall Study|Lost to Follow-up|2|||
146297706|NCT03901053|527604782|FG000|Overall Study|Withdrawal by Subject|4|||
146297707|NCT03901053|527604783|FG001|Overall Study|Withdrawal by Subject|3|||
145921526|NCT00806403|526219533|FG000|Overall Study|Death|4|||
145921527|NCT00806403|526219534|FG001|Overall Study|Death|3|||
145921528|NCT00765102|526219535|FG000|Overall Study|Progressive disease|18|||
145921529|NCT00765102|526219535|FG000|Overall Study|Adverse Event|6|||
145921530|NCT00765102|526219535|FG000|Overall Study|Physician Decision|4|||
145921531|NCT00765102|526219535|FG000|Overall Study|Withdrawal by Subject|2|||
145921532|NCT00765102|526219535|FG000|Overall Study|Protocol Violation|1|||
145921533|NCT04383327|526219549|FG000|Overall Study|Lost to Follow-up|112|||
145921534|NCT04383327|526219550|FG001|Overall Study|Lost to Follow-up|14|||
145921535|NCT04383327|526219551|FG002|Overall Study|Lost to Follow-up|78|||
145921536|NCT04383327|526219552|FG003|Overall Study|Lost to Follow-up|13|||
145921537|NCT04383327|526219553|FG004|Overall Study|Lost to Follow-up|110|||
145921538|NCT04383327|526219554|FG005|Overall Study|Lost to Follow-up|13|||
145921539|NCT04383327|526219555|FG006|Overall Study|Lost to Follow-up|74|||
145921540|NCT04383327|526219556|FG007|Overall Study|Lost to Follow-up|13|||
145921541|NCT04383327|526219557|FG008|Overall Study|Lost to Follow-up|78|||
145921542|NCT04383327|526219558|FG009|Overall Study|Lost to Follow-up|10|||
145921543|NCT04383327|526219559|FG010|Overall Study|Lost to Follow-up|160|||
145921544|NCT04383327|526219560|FG011|Overall Study|Lost to Follow-up|13|||
145921545|NCT05271175|526219570|FG000|One Week Follow up|Lost to Follow-up|10|||
145921546|NCT05271175|526219571|FG001|One Week Follow up|Lost to Follow-up|7|||
145921547|NCT05271175|526219572|FG002|One Week Follow up|Lost to Follow-up|5|||
145921548|NCT05271175|526219570|FG000|One Month Follow up|Lost to Follow-up|12|||
145921549|NCT05271175|526219571|FG001|One Month Follow up|Lost to Follow-up|7|||
145921550|NCT05271175|526219572|FG002|One Month Follow up|Lost to Follow-up|9|||
145921551|NCT05271175|526219570|FG000|Six Months Follow up|Lost to Follow-up|8|||
145921552|NCT05271175|526219571|FG001|Six Months Follow up|Lost to Follow-up|2|||
146297708|NCT03901053|527604782|FG000|Overall Study|Unsatisfactory Device|1|||
145921553|NCT05271175|526219572|FG002|Six Months Follow up|Lost to Follow-up|2|||
145921554|NCT00226499|526219573|FG000|Overall Study|Adverse Event|10|||
145921555|NCT00226499|526219574|FG001|Overall Study|Adverse Event|6|||
145921556|NCT00226499|526219575|FG002|Overall Study|Adverse Event|3|||
145921557|NCT00226499|526219573|FG000|Overall Study|Others|1064|||
145921558|NCT00226499|526219574|FG001|Overall Study|Others|1066|||
145921559|NCT00226499|526219575|FG002|Overall Study|Others|356|||
145921560|NCT00991887|526219576|FG000|Overall Study|Lost to Follow-up|2|||
145921561|NCT00991887|526219577|FG001|Overall Study|Lost to Follow-up|1|||
145921562|NCT04030299|526219578|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
145921563|NCT04030299|526219578|FG000|Overall Study|Withdrawal by Subject|3|||
145921564|NCT00946920|526219579|FG000|Overall Study|Withdrawal by Subject|28|||
145921565|NCT00946920|526219580|FG001|Overall Study|Withdrawal by Subject|15|||
145921566|NCT00946920|526219579|FG000|Overall Study|Lost to Follow-up|2|||
145921567|NCT00946920|526219580|FG001|Overall Study|Lost to Follow-up|2|||
145921568|NCT00946920|526219579|FG000|Overall Study|Physician Decision|5|||
145921569|NCT00946920|526219580|FG001|Overall Study|Physician Decision|2|||
145921570|NCT00946920|526219579|FG000|Overall Study|Adverse Event|41|||
145921571|NCT00946920|526219580|FG001|Overall Study|Adverse Event|14|||
145921572|NCT00946920|526219579|FG000|Overall Study|Protocol Violation|16|||
145921573|NCT00946920|526219580|FG001|Overall Study|Protocol Violation|8|||
145921574|NCT00946920|526219579|FG000|Overall Study|Miscellaneous reasons|18|||
146089508|NCT02195011|526847427|FG001|Overall Study|Withdrawal by Subject|0|||
146297709|NCT03901053|527604783|FG001|Overall Study|Unsatisfactory Device|2|||
145921575|NCT00946920|526219580|FG001|Overall Study|Miscellaneous reasons|3|||
145921576|NCT02964247|526219581|FG000|Overall Study|Lost to Follow-up|2|||
145921577|NCT02964247|526219582|FG001|Overall Study|Lost to Follow-up|0|||
145921578|NCT02964247|526219581|FG000|Overall Study|Withdrawal by Subject|1|||
146089509|NCT00174291|526847429|FG000|Overall Study|Lost to Follow-up|1|||
145921579|NCT02964247|526219582|FG001|Overall Study|Withdrawal by Subject|2|||
145921580|NCT01530464|526219583|FG000|Washout (24h)|Withdrawal by Subject|1|||
145921581|NCT01530464|526219584|FG001|Washout (24h)|Withdrawal by Subject|0|||
145921582|NCT01530464|526219583|FG000|Washout (24h)|Withdrawal by Subject|0|||
145921583|NCT01530464|526219584|FG001|Washout (24h)|Withdrawal by Subject|1|||
145921584|NCT03539302|526219589|FG000|Overall Study|Spontaneous cardio version|0|||
145921585|NCT03539302|526219590|FG001|Overall Study|Spontaneous cardio version|0|||
145921586|NCT03539302|526219591|FG002|Overall Study|Spontaneous cardio version|0|||
145921587|NCT03539302|526219592|FG003|Overall Study|Spontaneous cardio version|0|||
145921588|NCT03539302|526219593|FG004|Overall Study|Spontaneous cardio version|0|||
145921589|NCT03539302|526219594|FG005|Overall Study|Spontaneous cardio version|1|||
145921590|NCT03539302|526219595|FG006|Overall Study|Spontaneous cardio version|1|||
145921591|NCT02107131|526219598|FG000|Overall Study|Lost to Follow-up|4|||
145921592|NCT02107131|526219599|FG001|Overall Study|Lost to Follow-up|4|||
145921593|NCT02107131|526219598|FG000|Overall Study|Physician Decision|1|||
145921594|NCT02107131|526219599|FG001|Overall Study|Physician Decision|0|||
145921595|NCT02107131|526219598|FG000|Overall Study|Withdrawal by Subject|2|||
145921596|NCT02107131|526219599|FG001|Overall Study|Withdrawal by Subject|0|||
145921597|NCT02107131|526219598|FG000|Overall Study|mental instability|1|||
145921598|NCT02107131|526219599|FG001|Overall Study|mental instability|0|||
145921599|NCT02107131|526219598|FG000|Overall Study|Death|0|||
145921600|NCT02107131|526219599|FG001|Overall Study|Death|1|||
145921601|NCT02107131|526219598|FG000|Overall Study|Protocol Violation|0|||
145921602|NCT02107131|526219599|FG001|Overall Study|Protocol Violation|4|||
145921603|NCT00471822|526220758|FG000|Overall Study|Protocol Violation|2|||
145921604|NCT04570670|526220759|FG000|Overall Study|Withdrawal by Subject|1|||
145921605|NCT04570670|526220760|FG001|Overall Study|Withdrawal by Subject|0|||
145921606|NCT02342678|526220778|FG000|Overall Study|Lost to Follow-up|0|||
145921607|NCT02342678|526220779|FG001|Overall Study|Lost to Follow-up|1|||
145921608|NCT02342678|526220778|FG000|Overall Study|Too busy to complete study|0|||
145921609|NCT02342678|526220779|FG001|Overall Study|Too busy to complete study|2|||
145921610|NCT02342678|526220778|FG000|Overall Study|Family illness/emergency|0|||
145921611|NCT02342678|526220779|FG001|Overall Study|Family illness/emergency|1|||
145921612|NCT02342678|526220778|FG000|Overall Study|Illness/medical reason|1|||
145921613|NCT02342678|526220779|FG001|Overall Study|Illness/medical reason|1|||
145921614|NCT00314340|526220780|FG000|Overall Study|lost interest|1|||
145921615|NCT01082328|526220782|FG000|Overall Study|Adverse Event|1|||
145921616|NCT00957801|526220783|FG000|Overall Study|Withdrawal by Subject|0|||
145921617|NCT00957801|526220784|FG001|Overall Study|Withdrawal by Subject|0|||
145921618|NCT00957801|526220785|FG002|Overall Study|Withdrawal by Subject|0|||
145921619|NCT00957801|526220786|FG003|Overall Study|Withdrawal by Subject|1|||
145921620|NCT01568892|526220790|FG000|Open-label Phase|Adverse Event|2|||
145921621|NCT01568892|526220791|FG001|Open-label Phase|Adverse Event|0|||
145921622|NCT01568892|526220790|FG000|Open-label Phase|Lack of Efficacy|4|||
145921623|NCT01568892|526220791|FG001|Open-label Phase|Lack of Efficacy|2|||
145921624|NCT01568892|526220790|FG000|Open-label Phase|Lost to Follow-up|0|||
145921625|NCT01568892|526220791|FG001|Open-label Phase|Lost to Follow-up|1|||
145921626|NCT02755103|526220798|FG000|Overall Study|Lost to Follow-up|17|||
145921627|NCT02755103|526220799|FG001|Overall Study|Lost to Follow-up|15|||
145921628|NCT02755103|526220798|FG000|Overall Study|Death|0|||
145921629|NCT02755103|526220799|FG001|Overall Study|Death|1|||
145921630|NCT02755103|526220798|FG000|Overall Study|Physician Decision|0|||
145921631|NCT02755103|526220799|FG001|Overall Study|Physician Decision|1|||
145921632|NCT02755103|526220798|FG000|Overall Study|Pregnancy|0|||
145921633|NCT02755103|526220799|FG001|Overall Study|Pregnancy|1|||
145921634|NCT02755103|526220798|FG000|Overall Study|Withdrawal by Subject|3|||
146242504|NCT05163353|527403366|FG000|Overall Study|Withdrawal by Subject|21|||
146242505|NCT05163353|527403367|FG001|Overall Study|Withdrawal by Subject|6|||
146242506|NCT05163353|527403366|FG000|Overall Study|Protocol Violation|0|||
145921635|NCT02755103|526220799|FG001|Overall Study|Withdrawal by Subject|0|||
145921636|NCT04177095|526220800|FG000|Overall Study|Withdrawal by Subject|3|||
145921637|NCT04177095|526220800|FG000|Overall Study|Screen Failure|3|||
145921638|NCT04177095|526220800|FG000|Overall Study|Problems with the Trugraf assay|1|||
145921639|NCT00777296|526220801|FG000|Overall Study|Adverse Event|0|||
145921640|NCT00777296|526220802|FG001|Overall Study|Adverse Event|1|||
145921641|NCT00777296|526220803|FG002|Overall Study|Adverse Event|0|||
145921642|NCT00777296|526220804|FG003|Overall Study|Adverse Event|1|||
145921643|NCT00777296|526220801|FG000|Overall Study|Withdrawal by Subject|1|||
145921644|NCT00777296|526220802|FG001|Overall Study|Withdrawal by Subject|0|||
146242507|NCT05163353|527403367|FG001|Overall Study|Protocol Violation|1|||
146242508|NCT05163353|527403366|FG000|Overall Study|Lost to Follow-up|13|||
145921645|NCT00777296|526220803|FG002|Overall Study|Withdrawal by Subject|0|||
145921646|NCT00777296|526220804|FG003|Overall Study|Withdrawal by Subject|0|||
145921647|NCT00777296|526220801|FG000|Overall Study|CRF form not completed|0|||
145921648|NCT00777296|526220802|FG001|Overall Study|CRF form not completed|0|||
145921649|NCT00777296|526220803|FG002|Overall Study|CRF form not completed|2|||
145921650|NCT00777296|526220804|FG003|Overall Study|CRF form not completed|0|||
145921651|NCT00658723|526220807|FG000|Overall Study|Lost to Follow-up|0|||
145921652|NCT00658723|526220808|FG001|Overall Study|Lost to Follow-up|2|||
145921653|NCT00658723|526220809|FG002|Overall Study|Lost to Follow-up|2|||
145921654|NCT00658723|526220807|FG000|Overall Study|Death|2|||
145921655|NCT00658723|526220808|FG001|Overall Study|Death|1|||
146242509|NCT05163353|527403367|FG001|Overall Study|Lost to Follow-up|2|||
146242510|NCT06086028|527403369|FG000|Overall Study|Withdrawal by Subject|1|||
146242511|NCT06086028|527403370|FG001|Overall Study|Withdrawal by Subject|1|||
146242512|NCT06086028|527403369|FG000|Overall Study|Lost to Follow-up|2|||
146242513|NCT06086028|527403370|FG001|Overall Study|Lost to Follow-up|3|||
146242514|NCT00824408|527403371|FG000|Run-in Phase|Progressive disease|4|||
146242515|NCT00824408|527403372|FG001|Run-in Phase|Progressive disease|4|||
146242516|NCT00824408|527403373|FG002|Run-in Phase|Progressive disease|0|||
146242517|NCT00824408|527403374|FG003|Run-in Phase|Progressive disease|0|||
146242518|NCT00824408|527403375|FG004|Run-in Phase|Progressive disease|0|||
146242519|NCT00824408|527403371|FG000|Run-in Phase|Adverse Event|1|||
146242520|NCT00824408|527403372|FG001|Run-in Phase|Adverse Event|1|||
146242521|NCT00824408|527403373|FG002|Run-in Phase|Adverse Event|0|||
146242522|NCT00824408|527403374|FG003|Run-in Phase|Adverse Event|0|||
145921656|NCT00658723|526220809|FG002|Overall Study|Death|4|||
145921657|NCT00658723|526220807|FG000|Overall Study|Scheduling Issue|1|||
145921658|NCT00658723|526220808|FG001|Overall Study|Scheduling Issue|1|||
145921659|NCT00658723|526220809|FG002|Overall Study|Scheduling Issue|0|||
145921660|NCT00658723|526220807|FG000|Overall Study|Withdrawal by Subject|1|||
145921661|NCT00658723|526220808|FG001|Overall Study|Withdrawal by Subject|0|||
145921662|NCT00658723|526220809|FG002|Overall Study|Withdrawal by Subject|1|||
145921663|NCT03751098|526220811|FG000|Overall Study|Withdrawal by Subject|0|||
145921664|NCT03751098|526220812|FG001|Overall Study|Withdrawal by Subject|1|||
145921665|NCT01592786|526220813|FG000|Overall Study|Adverse Event|60|||
145921666|NCT01592786|526220813|FG000|Overall Study|Lack of Efficacy|19|||
145921667|NCT01592786|526220813|FG000|Overall Study|Protocol Violation|14|||
145921668|NCT01592786|526220813|FG000|Overall Study|Withdrawal by Subject|23|||
145921669|NCT01592786|526220813|FG000|Overall Study|Lost to Follow-up|19|||
145921670|NCT01592786|526220813|FG000|Overall Study|Other|3|||
145921671|NCT01909934|526220816|FG000|Overall Study|Withdrawal by Subject|3|||
145921672|NCT01909934|526220816|FG000|Overall Study|Lost to Follow-up|1|||
145921673|NCT01909934|526220816|FG000|Overall Study|Death|25|||
145921674|NCT01909934|526220816|FG000|Overall Study|Withdrawal of Informed Consent|1|||
145921675|NCT01909934|526220816|FG000|Overall Study|Reason Not Specified|1|||
145921676|NCT03810092|526220817|FG000|Overall Study|no ground support|17|||
145921677|NCT03810092|526220817|FG000|Overall Study|ADL not done at J0|16|||
145921678|NCT03810092|526220817|FG000|Overall Study|No hemoglobin measure at J5|27|||
145921679|NCT03380429|526220821|FG000|Overall Study|Physician Decision|0|||
145921680|NCT03380429|526220822|FG001|Overall Study|Physician Decision|1|||
145921681|NCT03380429|526220823|FG002|Overall Study|Physician Decision|0|||
145921682|NCT03380429|526220824|FG003|Overall Study|Physician Decision|1|||
145921683|NCT03380429|526220825|FG004|Overall Study|Physician Decision|1|||
145921684|NCT03380429|526220821|FG000|Overall Study|Withdrawal by Subject|3|||
146242523|NCT00824408|527403375|FG004|Run-in Phase|Adverse Event|0|||
146242524|NCT00824408|527403371|FG000|Run-in Phase|Refused to continue medication|1|||
146242525|NCT00824408|527403372|FG001|Run-in Phase|Refused to continue medication|0|||
146242526|NCT00824408|527403373|FG002|Run-in Phase|Refused to continue medication|0|||
146242527|NCT00824408|527403374|FG003|Run-in Phase|Refused to continue medication|0|||
146242528|NCT00824408|527403375|FG004|Run-in Phase|Refused to continue medication|0|||
146242529|NCT00824408|527403371|FG000|Run-in Phase|Other reason not defined above|0|||
146242530|NCT00824408|527403372|FG001|Run-in Phase|Other reason not defined above|1|||
146242531|NCT00824408|527403373|FG002|Run-in Phase|Other reason not defined above|0|||
146242532|NCT00824408|527403374|FG003|Run-in Phase|Other reason not defined above|0|||
146242533|NCT00824408|527403375|FG004|Run-in Phase|Other reason not defined above|0|||
145921685|NCT03380429|526220822|FG001|Overall Study|Withdrawal by Subject|3|||
145921686|NCT03380429|526220823|FG002|Overall Study|Withdrawal by Subject|5|||
145921687|NCT03380429|526220824|FG003|Overall Study|Withdrawal by Subject|2|||
145921688|NCT03380429|526220825|FG004|Overall Study|Withdrawal by Subject|1|||
145921689|NCT03380429|526220821|FG000|Overall Study|Lost to Follow-up|0|||
145921690|NCT03380429|526220822|FG001|Overall Study|Lost to Follow-up|2|||
145921691|NCT03380429|526220823|FG002|Overall Study|Lost to Follow-up|4|||
145921692|NCT03380429|526220824|FG003|Overall Study|Lost to Follow-up|3|||
145921693|NCT03380429|526220825|FG004|Overall Study|Lost to Follow-up|1|||
145921694|NCT03380429|526220821|FG000|Overall Study|Protocol Violation|1|||
145921695|NCT03380429|526220822|FG001|Overall Study|Protocol Violation|0|||
145921696|NCT03380429|526220823|FG002|Overall Study|Protocol Violation|1|||
146242534|NCT00824408|527403371|FG000|Randomized Phase|Not treated|0|||
145921697|NCT03380429|526220824|FG003|Overall Study|Protocol Violation|0|||
145921698|NCT03380429|526220825|FG004|Overall Study|Protocol Violation|1|||
146089510|NCT00174291|526847430|FG001|Overall Study|Lost to Follow-up|1|||
145921699|NCT03380429|526220821|FG000|Overall Study|Lack of Efficacy|0|||
145921700|NCT03380429|526220822|FG001|Overall Study|Lack of Efficacy|0|||
145921701|NCT03380429|526220823|FG002|Overall Study|Lack of Efficacy|0|||
145921702|NCT03380429|526220824|FG003|Overall Study|Lack of Efficacy|2|||
146242535|NCT00824408|527403372|FG001|Randomized Phase|Not treated|0|||
146242536|NCT00824408|527403373|FG002|Randomized Phase|Not treated|1|||
146242537|NCT00824408|527403374|FG003|Randomized Phase|Not treated|1|||
146242538|NCT00824408|527403375|FG004|Randomized Phase|Not treated|1|||
146242539|NCT00824408|527403371|FG000|Randomized Phase|Progressive disease|0|||
145921703|NCT03380429|526220825|FG004|Overall Study|Lack of Efficacy|1|||
145921704|NCT03380429|526220821|FG000|Overall Study|Adverse Event|1|||
145921705|NCT03380429|526220822|FG001|Overall Study|Adverse Event|1|||
145921706|NCT03380429|526220823|FG002|Overall Study|Adverse Event|1|||
145921707|NCT03380429|526220824|FG003|Overall Study|Adverse Event|2|||
145921708|NCT03380429|526220825|FG004|Overall Study|Adverse Event|0|||
145921709|NCT01198470|526220826|FG000|Overall Study|Adverse Event|2|||
145921710|NCT02949973|526220827|FG000|Overall Study|Physician Decision|1|||
145921711|NCT01882985|526220830|FG000|Overall Study|Lost to Follow-up|1|||
145921712|NCT01882985|526220830|FG000|Overall Study|Withdrawal by Subject|1|||
145921713|NCT04129125|526220831|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
145921714|NCT04129125|526220831|FG000|Overall Study|Study device was not used|3|||
145921715|NCT01827111|526220834|FG000|Overall Study|Disease Progression|1|||
145921716|NCT02962648|526220835|FG000|Overall Study|Withdrawal by Subject|3|||
145921717|NCT02962648|526220835|FG000|Overall Study|Lost to Follow-up|3|||
145921718|NCT02962648|526220835|FG000|Overall Study|Physician Decision|1|||
145921719|NCT02962648|526220835|FG000|Overall Study|Subject had problems with transportation|2|||
145921720|NCT02174627|526220838|FG000|Overall Study|Missing|0|||
145921721|NCT02174627|526220839|FG001|Overall Study|Missing|1|||
145921722|NCT02174627|526220838|FG000|Overall Study|Incorrect enrolment before randomization|0|||
145921723|NCT02174627|526220839|FG001|Overall Study|Incorrect enrolment before randomization|1|||
145921724|NCT02174627|526220838|FG000|Overall Study|Participant decision|84|||
145921725|NCT02174627|526220839|FG001|Overall Study|Participant decision|128|||
145921726|NCT04564092|526220840|FG000|Overall Study|Withdrawal by Subject|1|||
145921727|NCT02208362|526220842|FG000|Overall Study|Participant did not complete treatment|0|||
145921728|NCT02208362|526220843|FG001|Overall Study|Participant did not complete treatment|1|||
145921729|NCT02208362|526220844|FG002|Overall Study|Participant did not complete treatment|0|||
145921730|NCT02208362|526220845|FG003|Overall Study|Participant did not complete treatment|0|||
145921731|NCT02208362|526220846|FG004|Overall Study|Participant did not complete treatment|0|||
145921732|NCT02208362|526220847|FG005|Overall Study|Participant did not complete treatment|0|||
145921733|NCT02208362|526220848|FG006|Overall Study|Participant did not complete treatment|1|||
145921734|NCT02208362|526220849|FG007|Overall Study|Participant did not complete treatment|1|||
145921735|NCT02208362|526220850|FG008|Overall Study|Participant did not complete treatment|2|||
145921736|NCT02208362|526220851|FG009|Overall Study|Participant did not complete treatment|0|||
145921737|NCT02208362|526220852|FG010|Overall Study|Participant did not complete treatment|1|||
145921738|NCT02208362|526220853|FG011|Overall Study|Participant did not complete treatment|0|||
145921739|NCT02208362|526220842|FG000|Overall Study|Participant received disallowed treatment|0|||
145921740|NCT02208362|526220843|FG001|Overall Study|Participant received disallowed treatment|0|||
145921741|NCT02208362|526220844|FG002|Overall Study|Participant received disallowed treatment|0|||
145921742|NCT02208362|526220845|FG003|Overall Study|Participant received disallowed treatment|0|||
145921743|NCT02208362|526220846|FG004|Overall Study|Participant received disallowed treatment|0|||
145921744|NCT02208362|526220847|FG005|Overall Study|Participant received disallowed treatment|0|||
145921745|NCT02208362|526220848|FG006|Overall Study|Participant received disallowed treatment|0|||
145921746|NCT02208362|526220849|FG007|Overall Study|Participant received disallowed treatment|0|||
145921747|NCT02208362|526220850|FG008|Overall Study|Participant received disallowed treatment|1|||
145921748|NCT02208362|526220851|FG009|Overall Study|Participant received disallowed treatment|0|||
145921749|NCT02208362|526220852|FG010|Overall Study|Participant received disallowed treatment|0|||
145921750|NCT02208362|526220853|FG011|Overall Study|Participant received disallowed treatment|0|||
145921751|NCT03349060|526222408|FG000|Overall Study|Adverse Event|9|||
145921752|NCT03349060|526222409|FG001|Overall Study|Adverse Event|9|||
145921753|NCT03349060|526222410|FG002|Overall Study|Adverse Event|7|||
145921754|NCT03349060|526222408|FG000|Overall Study|Lack of Efficacy|1|||
145921755|NCT03349060|526222409|FG001|Overall Study|Lack of Efficacy|0|||
145921756|NCT03349060|526222410|FG002|Overall Study|Lack of Efficacy|2|||
145921757|NCT03349060|526222408|FG000|Overall Study|Lost to Follow-up|2|||
145921758|NCT03349060|526222409|FG001|Overall Study|Lost to Follow-up|1|||
145921759|NCT03349060|526222410|FG002|Overall Study|Lost to Follow-up|1|||
145921760|NCT03349060|526222408|FG000|Overall Study|Protocol Violation|2|||
145921761|NCT03349060|526222409|FG001|Overall Study|Protocol Violation|2|||
145921762|NCT03349060|526222410|FG002|Overall Study|Protocol Violation|1|||
145975507|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
145975508|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
145975509|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
145975510|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
145975511|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
145975512|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
145975513|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145975514|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
145975515|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
146089511|NCT00174291|526847429|FG000|Overall Study|Protocol Violation|0|||
146089512|NCT00174291|526847430|FG001|Overall Study|Protocol Violation|2|||
145921763|NCT03349060|526222408|FG000|Overall Study|Withdrawal by Subject|5|||
145921764|NCT03349060|526222409|FG001|Overall Study|Withdrawal by Subject|3|||
145975516|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145975517|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145975518|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
145975519|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145975520|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145975521|NCT00620542|526422246|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
145921765|NCT03349060|526222410|FG002|Overall Study|Withdrawal by Subject|4|||
145921766|NCT03349060|526222408|FG000|Overall Study|Medication error,no linked adverse event|0|||
145921767|NCT03349060|526222409|FG001|Overall Study|Medication error,no linked adverse event|0|||
145921768|NCT03349060|526222410|FG002|Overall Study|Medication error,no linked adverse event|1|||
145921769|NCT03349060|526222408|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145921770|NCT03349060|526222409|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
145921771|NCT03349060|526222410|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
145921772|NCT03349060|526222408|FG000|Overall Study|Other|2|||
145921773|NCT03349060|526222409|FG001|Overall Study|Other|1|||
145921774|NCT03349060|526222410|FG002|Overall Study|Other|0|||
145921775|NCT00955409|526222411|FG000|Overall Study|Lack of Efficacy|1|||
145921776|NCT00955409|526222412|FG001|Overall Study|Lack of Efficacy|0|||
145921777|NCT00955409|526222413|FG002|Overall Study|Lack of Efficacy|0|||
145921778|NCT00955409|526222414|FG003|Overall Study|Lack of Efficacy|0|||
145921779|NCT00955409|526222415|FG004|Overall Study|Lack of Efficacy|0|||
145921780|NCT00955409|526222416|FG005|Overall Study|Lack of Efficacy|0|||
145921781|NCT00955409|526222417|FG006|Overall Study|Lack of Efficacy|0|||
145921782|NCT00955409|526222418|FG007|Overall Study|Lack of Efficacy|0|||
145921783|NCT00955409|526222419|FG008|Overall Study|Lack of Efficacy|0|||
145921784|NCT00955409|526222420|FG009|Overall Study|Lack of Efficacy|0|||
145921785|NCT00955409|526222411|FG000|Overall Study|Withdrawal by Subject|1|||
145921786|NCT00955409|526222412|FG001|Overall Study|Withdrawal by Subject|0|||
145921787|NCT00955409|526222413|FG002|Overall Study|Withdrawal by Subject|5|||
145921788|NCT00955409|526222414|FG003|Overall Study|Withdrawal by Subject|2|||
145921789|NCT00955409|526222415|FG004|Overall Study|Withdrawal by Subject|0|||
145921790|NCT00955409|526222416|FG005|Overall Study|Withdrawal by Subject|0|||
145921791|NCT00955409|526222417|FG006|Overall Study|Withdrawal by Subject|2|||
145921792|NCT00955409|526222418|FG007|Overall Study|Withdrawal by Subject|0|||
145921793|NCT00955409|526222419|FG008|Overall Study|Withdrawal by Subject|1|||
145921794|NCT00955409|526222420|FG009|Overall Study|Withdrawal by Subject|0|||
145921795|NCT00955409|526222411|FG000|Overall Study|Caregiver Request|2|||
145921796|NCT00955409|526222412|FG001|Overall Study|Caregiver Request|0|||
145921797|NCT00955409|526222413|FG002|Overall Study|Caregiver Request|6|||
145921798|NCT00955409|526222414|FG003|Overall Study|Caregiver Request|5|||
145921799|NCT00955409|526222415|FG004|Overall Study|Caregiver Request|0|||
145921800|NCT00955409|526222416|FG005|Overall Study|Caregiver Request|2|||
145921801|NCT00955409|526222417|FG006|Overall Study|Caregiver Request|3|||
145921802|NCT00955409|526222418|FG007|Overall Study|Caregiver Request|1|||
145921803|NCT00955409|526222419|FG008|Overall Study|Caregiver Request|3|||
145921804|NCT00955409|526222420|FG009|Overall Study|Caregiver Request|0|||
145921805|NCT00955409|526222411|FG000|Overall Study|Investigator Request|0|||
145921806|NCT00955409|526222412|FG001|Overall Study|Investigator Request|0|||
145921807|NCT00955409|526222413|FG002|Overall Study|Investigator Request|1|||
145921808|NCT00955409|526222414|FG003|Overall Study|Investigator Request|0|||
145921809|NCT00955409|526222415|FG004|Overall Study|Investigator Request|0|||
145921810|NCT00955409|526222416|FG005|Overall Study|Investigator Request|0|||
145921811|NCT00955409|526222417|FG006|Overall Study|Investigator Request|0|||
145921812|NCT00955409|526222418|FG007|Overall Study|Investigator Request|0|||
145921813|NCT00955409|526222419|FG008|Overall Study|Investigator Request|0|||
145921814|NCT00955409|526222420|FG009|Overall Study|Investigator Request|0|||
145921815|NCT00955409|526222411|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
145921816|NCT00955409|526222412|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145921817|NCT00955409|526222413|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
145921818|NCT00955409|526222414|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145975522|NCT00620542|526422247|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
145975523|NCT00620542|526422248|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
145975524|NCT00620542|526422249|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
145975525|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
145975526|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
145975527|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
145921819|NCT00955409|526222415|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
145921820|NCT00955409|526222416|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
145921821|NCT00955409|526222417|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
146089513|NCT00174291|526847429|FG000|Overall Study|Study terminated by sponsor|1|||
145921822|NCT00955409|526222418|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
145921823|NCT00955409|526222419|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
145921824|NCT00955409|526222420|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
145921825|NCT00955409|526222411|FG000|Overall Study|Lost to Follow-up|0|||
145921826|NCT00955409|526222412|FG001|Overall Study|Lost to Follow-up|0|||
145921827|NCT00955409|526222413|FG002|Overall Study|Lost to Follow-up|1|||
145921828|NCT00955409|526222414|FG003|Overall Study|Lost to Follow-up|0|||
145921829|NCT00955409|526222415|FG004|Overall Study|Lost to Follow-up|0|||
145921830|NCT00955409|526222416|FG005|Overall Study|Lost to Follow-up|0|||
145921831|NCT00955409|526222417|FG006|Overall Study|Lost to Follow-up|1|||
145921832|NCT00955409|526222418|FG007|Overall Study|Lost to Follow-up|0|||
145921833|NCT00955409|526222419|FG008|Overall Study|Lost to Follow-up|0|||
145975528|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
145975529|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
145975530|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
145975531|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
145975532|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
145975533|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
145975534|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
145975535|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
145975536|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
145975537|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
145975538|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
145975539|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
145975540|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
145975541|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
145975542|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
145975543|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
145975544|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
145975545|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
145975546|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
145975547|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
145975548|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
145975549|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
145975550|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
145975551|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
145975552|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
145975553|NCT00620542|526422246|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
145975554|NCT00620542|526422247|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
145975555|NCT00620542|526422248|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
145975556|NCT00620542|526422249|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
145975557|NCT01970371|526422250|FG000|Overall Study|Death|8|||
145975558|NCT01970371|526422251|FG001|Overall Study|Death|13|||
145975559|NCT01970371|526422252|FG002|Overall Study|Death|12|||
145975560|NCT01970371|526422250|FG000|Overall Study|Lost to Follow-up|0|||
145975561|NCT01970371|526422251|FG001|Overall Study|Lost to Follow-up|0|||
145975562|NCT01970371|526422252|FG002|Overall Study|Lost to Follow-up|1|||
145975563|NCT01481779|526422253|FG000|Overall Study|Adverse Event|23|||
145975564|NCT01481779|526422254|FG001|Overall Study|Adverse Event|5|||
145975565|NCT01481779|526422253|FG000|Overall Study|Lost to Follow-up|3|||
145975566|NCT01481779|526422254|FG001|Overall Study|Lost to Follow-up|2|||
145975567|NCT01481779|526422253|FG000|Overall Study|Protocol Violation|2|||
145975568|NCT01481779|526422254|FG001|Overall Study|Protocol Violation|3|||
145921834|NCT00955409|526222420|FG009|Overall Study|Lost to Follow-up|0|||
145975569|NCT01481779|526422253|FG000|Overall Study|Withdrawal by Subject|26|||
145975570|NCT01481779|526422254|FG001|Overall Study|Withdrawal by Subject|13|||
145975571|NCT01481779|526422253|FG000|Overall Study|Physician Decision|13|||
145975572|NCT01481779|526422254|FG001|Overall Study|Physician Decision|4|||
145975573|NCT01481779|526422253|FG000|Overall Study|Sponsor Decision|3|||
145975574|NCT01481779|526422254|FG001|Overall Study|Sponsor Decision|1|||
145975575|NCT04115059|526422258|FG000|Overall Study|Withdrawal by Subject|1|||
145975576|NCT04115059|526422258|FG000|Overall Study|Lack of Efficacy|2|||
145975577|NCT03575364|526422266|FG000|Overall Study|Death|45|||
145975578|NCT03575364|526422266|FG000|Overall Study|Lost to Follow-up|114|||
145975579|NCT03575364|526422266|FG000|Overall Study|Withdrawal by Subject|21|||
145975580|NCT03575364|526422266|FG000|Overall Study|Physician Decision|11|||
145975581|NCT03575364|526422266|FG000|Overall Study|Subject Refused Follow-up|13|||
145921835|NCT00955409|526222411|FG000|Overall Study|Failed to Return|2|||
145975582|NCT03575364|526422266|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
145975583|NCT03575364|526422266|FG000|Overall Study|Patient moved out of the state|1|||
145975584|NCT03575364|526422266|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
145975585|NCT03575364|526422266|FG000|Overall Study|Patient is lost to follow up|1|||
145975586|NCT03575364|526422266|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
145921836|NCT00955409|526222412|FG001|Overall Study|Failed to Return|0|||
145921837|NCT00955409|526222413|FG002|Overall Study|Failed to Return|0|||
145975587|NCT05522751|526422267|FG000|Overall Study|Adverse Event|1|||
145975588|NCT06420232|526422268|FG000|Overall Study|Withdrawal by Subject|3|||
145921838|NCT00955409|526222414|FG003|Overall Study|Failed to Return|0|||
145975589|NCT01582451|526422274|FG000|Overall Study|Adverse Event|1|||
145975590|NCT01582451|526422275|FG001|Overall Study|Adverse Event|3|||
145975591|NCT01582451|526422274|FG000|Overall Study|Death|3|||
145975592|NCT01582451|526422275|FG001|Overall Study|Death|3|||
145975593|NCT01582451|526422274|FG000|Overall Study|Lost to Follow-up|0|||
145975594|NCT01582451|526422275|FG001|Overall Study|Lost to Follow-up|2|||
145975595|NCT01582451|526422274|FG000|Overall Study|Protocol Violation|11|||
145975596|NCT01582451|526422275|FG001|Overall Study|Protocol Violation|3|||
145975597|NCT01582451|526422274|FG000|Overall Study|Withdrawal by Subject|13|||
145975598|NCT01582451|526422275|FG001|Overall Study|Withdrawal by Subject|9|||
146089514|NCT00174291|526847430|FG001|Overall Study|Study terminated by sponsor|0|||
146089515|NCT00174291|526847429|FG000|Overall Study|Withdrawal by Subject|3|||
146089516|NCT00174291|526847430|FG001|Overall Study|Withdrawal by Subject|3|||
146089517|NCT00450112|526847431|FG000|Overall Study|Other Treatment Required|5|||
146089518|NCT00450112|526847432|FG001|Overall Study|Other Treatment Required|1|||
146089519|NCT00450112|526847431|FG000|Overall Study|Withdrawal by Subject|4|||
146089520|NCT00450112|526847432|FG001|Overall Study|Withdrawal by Subject|1|||
146089521|NCT00450112|526847431|FG000|Overall Study|Lost to Follow-up|2|||
146089522|NCT00450112|526847432|FG001|Overall Study|Lost to Follow-up|1|||
146089523|NCT00450112|526847431|FG000|Overall Study|Others|2|||
146089524|NCT00450112|526847432|FG001|Overall Study|Others|3|||
146089525|NCT01909453|526847442|FG000|Overall Study|Ongoing|118|||
146089526|NCT01909453|526847443|FG001|Overall Study|Ongoing|103|||
146089527|NCT01909453|526847444|FG002|Overall Study|Ongoing|83|||
146089528|NCT01909453|526847445|FG003|Overall Study|Ongoing|164|||
145921839|NCT00955409|526222415|FG004|Overall Study|Failed to Return|0|||
145975599|NCT01582451|526422274|FG000|Overall Study|Physician Decision|3|||
145975600|NCT01582451|526422275|FG001|Overall Study|Physician Decision|0|||
145975601|NCT01582451|526422274|FG000|Overall Study|Sponsor Decision|1|||
145975602|NCT01582451|526422275|FG001|Overall Study|Sponsor Decision|0|||
145975603|NCT01369433|526422276|FG000|Overall Study|Adverse Event|31|||
145975604|NCT01369433|526422277|FG001|Overall Study|Adverse Event|1|||
145975605|NCT01369433|526422276|FG000|Overall Study|Required significant surgical procedure|1|||
145975606|NCT01369433|526422277|FG001|Overall Study|Required significant surgical procedure|0|||
145975607|NCT01369433|526422276|FG000|Overall Study|Non-compliance|1|||
145975608|NCT01369433|526422277|FG001|Overall Study|Non-compliance|0|||
145975609|NCT01369433|526422276|FG000|Overall Study|Withdrawal by Subject|5|||
145975610|NCT01369433|526422277|FG001|Overall Study|Withdrawal by Subject|2|||
145975611|NCT01369433|526422276|FG000|Overall Study|Study terminated by Sponsor|67|||
145975612|NCT01369433|526422277|FG001|Overall Study|Study terminated by Sponsor|0|||
145975613|NCT01369433|526422276|FG000|Overall Study|Lost to Follow-up|1|||
145975614|NCT01369433|526422277|FG001|Overall Study|Lost to Follow-up|0|||
145975615|NCT01369433|526422276|FG000|Overall Study|Death|5|||
145975616|NCT01369433|526422277|FG001|Overall Study|Death|0|||
145921840|NCT00955409|526222416|FG005|Overall Study|Failed to Return|0|||
145921841|NCT00955409|526222417|FG006|Overall Study|Failed to Return|0|||
145921842|NCT00955409|526222418|FG007|Overall Study|Failed to Return|2|||
145921843|NCT00955409|526222419|FG008|Overall Study|Failed to Return|0|||
145921844|NCT00955409|526222420|FG009|Overall Study|Failed to Return|0|||
145921845|NCT00955409|526222411|FG000|Overall Study|Adverse Event (AE)|2|||
145921846|NCT00955409|526222412|FG001|Overall Study|Adverse Event (AE)|0|||
145921847|NCT00955409|526222413|FG002|Overall Study|Adverse Event (AE)|0|||
145921848|NCT00955409|526222414|FG003|Overall Study|Adverse Event (AE)|0|||
145921849|NCT00955409|526222415|FG004|Overall Study|Adverse Event (AE)|0|||
145921850|NCT00955409|526222416|FG005|Overall Study|Adverse Event (AE)|1|||
145921851|NCT00955409|526222417|FG006|Overall Study|Adverse Event (AE)|2|||
145921852|NCT00955409|526222418|FG007|Overall Study|Adverse Event (AE)|0|||
145921853|NCT00955409|526222419|FG008|Overall Study|Adverse Event (AE)|2|||
145921854|NCT00955409|526222420|FG009|Overall Study|Adverse Event (AE)|0|||
145921855|NCT00955409|526222411|FG000|Overall Study|Reason not Specified|2|||
145975617|NCT01369433|526422276|FG000|Overall Study|Investigator discretion|6|||
145975618|NCT01369433|526422277|FG001|Overall Study|Investigator discretion|1|||
145975619|NCT01369433|526422276|FG000|Overall Study|Progressive Disease|92|||
145975620|NCT01369433|526422277|FG001|Overall Study|Progressive Disease|12|||
145975621|NCT00689936|526422278|FG000|Active Treatment Phase|Adverse Event|68|||
145975622|NCT00689936|526422279|FG001|Active Treatment Phase|Adverse Event|71|||
145921856|NCT00955409|526222412|FG001|Overall Study|Reason not Specified|1|||
145975623|NCT00689936|526422280|FG002|Active Treatment Phase|Adverse Event|76|||
145975624|NCT00689936|526422278|FG000|Active Treatment Phase|Disease Progression|273|||
145975625|NCT00689936|526422279|FG001|Active Treatment Phase|Disease Progression|362|||
145921857|NCT00955409|526222413|FG002|Overall Study|Reason not Specified|13|||
145975626|NCT00689936|526422280|FG002|Active Treatment Phase|Disease Progression|339|||
145975627|NCT00689936|526422278|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
145975628|NCT00689936|526422279|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
146089529|NCT01909453|526847446|FG004|Overall Study|Ongoing|50|||
146089530|NCT01909453|526847442|FG000|Overall Study|Death|69|||
146089531|NCT01909453|526847443|FG001|Overall Study|Death|74|||
146089532|NCT01909453|526847444|FG002|Overall Study|Death|88|||
146089533|NCT01909453|526847445|FG003|Overall Study|Death|86|||
146089534|NCT01909453|526847446|FG004|Overall Study|Death|29|||
146242540|NCT00824408|527403372|FG001|Randomized Phase|Progressive disease|0|||
146242541|NCT00824408|527403373|FG002|Randomized Phase|Progressive disease|25|||
146242542|NCT00824408|527403374|FG003|Randomized Phase|Progressive disease|36|||
146242543|NCT00824408|527403375|FG004|Randomized Phase|Progressive disease|34|||
146242544|NCT00824408|527403371|FG000|Randomized Phase|Adverse Event|0|||
146242545|NCT00824408|527403372|FG001|Randomized Phase|Adverse Event|0|||
146242546|NCT00824408|527403373|FG002|Randomized Phase|Adverse Event|4|||
146242547|NCT00824408|527403374|FG003|Randomized Phase|Adverse Event|5|||
146242548|NCT00824408|527403375|FG004|Randomized Phase|Adverse Event|5|||
146242549|NCT00824408|527403371|FG000|Randomized Phase|Refused to continue medication|0|||
146242550|NCT00824408|527403372|FG001|Randomized Phase|Refused to continue medication|0|||
146242551|NCT00824408|527403373|FG002|Randomized Phase|Refused to continue medication|2|||
146242552|NCT00824408|527403374|FG003|Randomized Phase|Refused to continue medication|2|||
146242553|NCT00824408|527403375|FG004|Randomized Phase|Refused to continue medication|2|||
146242554|NCT00824408|527403371|FG000|Randomized Phase|Other reason not defined above|0|||
146242555|NCT00824408|527403372|FG001|Randomized Phase|Other reason not defined above|0|||
146242556|NCT00824408|527403373|FG002|Randomized Phase|Other reason not defined above|4|||
146242557|NCT00824408|527403374|FG003|Randomized Phase|Other reason not defined above|2|||
146242558|NCT00824408|527403375|FG004|Randomized Phase|Other reason not defined above|4|||
146242559|NCT04821271|527403376|FG000|Period 1|Withdrawal by Subject|2|||
146242560|NCT04821271|527403377|FG001|Period 1|Withdrawal by Subject|0|||
146242561|NCT02521493|527403379|FG000|Overall Study|Death|3|||
146242562|NCT02521493|527403380|FG001|Overall Study|Death|4|||
146242563|NCT02521493|527403381|FG002|Overall Study|Death|1|||
146242564|NCT02521493|527403379|FG000|Overall Study|Physician Decision|19|||
146242565|NCT02521493|527403380|FG001|Overall Study|Physician Decision|1|||
146242566|NCT02521493|527403381|FG002|Overall Study|Physician Decision|2|||
146242567|NCT02521493|527403379|FG000|Overall Study|Withdrawal by Subject|3|||
146242568|NCT02521493|527403380|FG001|Overall Study|Withdrawal by Subject|0|||
146242569|NCT02521493|527403381|FG002|Overall Study|Withdrawal by Subject|0|||
146242570|NCT02521493|527403379|FG000|Overall Study|Ineligible|0|||
146242571|NCT02521493|527403380|FG001|Overall Study|Ineligible|1|||
146242572|NCT02521493|527403381|FG002|Overall Study|Ineligible|0|||
146242573|NCT02521493|527403379|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
146242574|NCT02521493|527403380|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
146242575|NCT02521493|527403381|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
146242576|NCT02521493|527403379|FG000|Overall Study|No MRD result|0|||
146242577|NCT02521493|527403380|FG001|Overall Study|No MRD result|0|||
146242578|NCT02521493|527403381|FG002|Overall Study|No MRD result|4|||
146242579|NCT04083781|527403382|FG000|Main Part|Physician Decision|0|||
146242580|NCT04083781|527403383|FG001|Main Part|Physician Decision|1|||
146242581|NCT04083781|527403384|FG002|Main Part|Physician Decision|2|||
146242582|NCT04083781|527403385|FG003|Main Part|Physician Decision|0|||
146242583|NCT04083781|527403382|FG000|Main Part|Death|1|||
146242584|NCT04083781|527403383|FG001|Main Part|Death|3|||
146242585|NCT04083781|527403384|FG002|Main Part|Death|1|||
145921858|NCT00955409|526222414|FG003|Overall Study|Reason not Specified|1|||
145921859|NCT00955409|526222415|FG004|Overall Study|Reason not Specified|2|||
145921860|NCT00955409|526222416|FG005|Overall Study|Reason not Specified|0|||
145921861|NCT00955409|526222417|FG006|Overall Study|Reason not Specified|16|||
145921862|NCT00955409|526222418|FG007|Overall Study|Reason not Specified|0|||
145921863|NCT00955409|526222419|FG008|Overall Study|Reason not Specified|8|||
145921864|NCT00955409|526222420|FG009|Overall Study|Reason not Specified|1|||
145921865|NCT00485732|526222421|FG000|Overall Study|Protocol Violation|1|||
145921866|NCT00485732|526222422|FG001|Overall Study|Protocol Violation|3|||
145921867|NCT00485732|526222421|FG000|Overall Study|Withdrawal by Subject|5|||
145921868|NCT00485732|526222422|FG001|Overall Study|Withdrawal by Subject|4|||
145921869|NCT00485732|526222421|FG000|Overall Study|Lost to Follow-up|2|||
145921870|NCT00485732|526222422|FG001|Overall Study|Lost to Follow-up|2|||
146242586|NCT04083781|527403385|FG003|Main Part|Death|0|||
146297710|NCT03901053|527604782|FG000|Overall Study|No longer meets study criteria|1|||
146242587|NCT04083781|527403382|FG000|Main Part|Withdrawal by Subject|5|||
146297711|NCT03901053|527604783|FG001|Overall Study|No longer meets study criteria|3|||
145921871|NCT00803790|526222423|FG000|Period 1|Adverse Event|0|||
145921872|NCT00803790|526222424|FG001|Period 1|Adverse Event|1|||
146242588|NCT04083781|527403383|FG001|Main Part|Withdrawal by Subject|2|||
146242589|NCT04083781|527403384|FG002|Main Part|Withdrawal by Subject|3|||
146242590|NCT04083781|527403385|FG003|Main Part|Withdrawal by Subject|7|||
146242591|NCT04083781|527403382|FG000|Extension Part|Physician Decision|0|||
146242592|NCT04083781|527403383|FG001|Extension Part|Physician Decision|0|||
146242593|NCT04083781|527403384|FG002|Extension Part|Physician Decision|0|||
146242594|NCT04083781|527403385|FG003|Extension Part|Physician Decision|1|||
146242595|NCT04083781|527403382|FG000|Extension Part|Death|0|||
146242596|NCT04083781|527403383|FG001|Extension Part|Death|1|||
146242597|NCT04083781|527403384|FG002|Extension Part|Death|0|||
145921873|NCT00803790|526222425|FG002|Period 1|Adverse Event|0|||
146242598|NCT04083781|527403385|FG003|Extension Part|Death|1|||
146242599|NCT04083781|527403382|FG000|Extension Part|Withdrawal by Subject|0|||
146242600|NCT04083781|527403383|FG001|Extension Part|Withdrawal by Subject|1|||
145921874|NCT00803790|526222426|FG003|Period 1|Adverse Event|0|||
145921875|NCT00803790|526222423|FG000|Period 1|Lost to Follow-up|1|||
145921876|NCT00803790|526222424|FG001|Period 1|Lost to Follow-up|2|||
145921877|NCT00803790|526222425|FG002|Period 1|Lost to Follow-up|0|||
145921878|NCT00803790|526222426|FG003|Period 1|Lost to Follow-up|0|||
145921879|NCT00803790|526222423|FG000|Period 1|Withdrawal by Subject|8|||
145921880|NCT00803790|526222424|FG001|Period 1|Withdrawal by Subject|6|||
145921881|NCT00803790|526222425|FG002|Period 1|Withdrawal by Subject|0|||
145921882|NCT00803790|526222426|FG003|Period 1|Withdrawal by Subject|0|||
145921883|NCT00803790|526222423|FG000|Period 1|positive drug screen or personal reasons|0|||
145921884|NCT00803790|526222424|FG001|Period 1|positive drug screen or personal reasons|3|||
145921885|NCT00803790|526222425|FG002|Period 1|positive drug screen or personal reasons|0|||
145921886|NCT00803790|526222426|FG003|Period 1|positive drug screen or personal reasons|4|||
145921887|NCT00803790|526222423|FG000|Period 1|Protocol Violation|0|||
145921888|NCT00803790|526222424|FG001|Period 1|Protocol Violation|0|||
145921889|NCT00803790|526222425|FG002|Period 1|Protocol Violation|1|||
145921890|NCT00803790|526222426|FG003|Period 1|Protocol Violation|0|||
145921891|NCT00803790|526222423|FG000|Period 2|Adverse Event|0|||
145921892|NCT00803790|526222424|FG001|Period 2|Adverse Event|0|||
145921893|NCT00803790|526222425|FG002|Period 2|Adverse Event|1|||
145921894|NCT00803790|526222426|FG003|Period 2|Adverse Event|1|||
145921895|NCT00803790|526222423|FG000|Period 2|Withdrawal by Subject|1|||
145921896|NCT00803790|526222424|FG001|Period 2|Withdrawal by Subject|0|||
145921897|NCT00803790|526222425|FG002|Period 2|Withdrawal by Subject|0|||
145921898|NCT00803790|526222426|FG003|Period 2|Withdrawal by Subject|0|||
145921899|NCT00803790|526222423|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
145921900|NCT00803790|526222424|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
145921901|NCT00803790|526222425|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
145921902|NCT00803790|526222426|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
145921903|NCT04710576|526222427|FG000|Overall Study|Participants still in the study|73|||
145921904|NCT04710576|526222428|FG001|Overall Study|Participants still in the study|70|||
145921905|NCT04710576|526222429|FG002|Overall Study|Participants still in the study|60|||
145921906|NCT04710576|526222427|FG000|Overall Study|Death|2|||
145921907|NCT04710576|526222428|FG001|Overall Study|Death|7|||
145921908|NCT04710576|526222429|FG002|Overall Study|Death|12|||
146242601|NCT04083781|527403384|FG002|Extension Part|Withdrawal by Subject|0|||
146242602|NCT04083781|527403385|FG003|Extension Part|Withdrawal by Subject|0|||
146242603|NCT04083781|527403382|FG000|Extension Part|Ongoing|13|||
146242604|NCT04083781|527403383|FG001|Extension Part|Ongoing|25|||
146242605|NCT04083781|527403384|FG002|Extension Part|Ongoing|15|||
146242606|NCT04083781|527403385|FG003|Extension Part|Ongoing|51|||
146242607|NCT02334215|527403388|FG000|Overall Study|Death|1|||
146242608|NCT02334215|527403389|FG001|Overall Study|Death|1|||
146242609|NCT02334215|527403390|FG002|Overall Study|Death|0|||
146242610|NCT02334215|527403388|FG000|Overall Study|Lost to Follow-up|1|||
146242611|NCT02334215|527403389|FG001|Overall Study|Lost to Follow-up|0|||
146242612|NCT02334215|527403390|FG002|Overall Study|Lost to Follow-up|4|||
146242613|NCT02334215|527403388|FG000|Overall Study|Withdrawal by Subject|2|||
146242614|NCT02334215|527403389|FG001|Overall Study|Withdrawal by Subject|2|||
146242615|NCT02334215|527403390|FG002|Overall Study|Withdrawal by Subject|1|||
146242616|NCT02334215|527403388|FG000|Overall Study|Not released from incarceration on time|3|||
146242617|NCT02334215|527403389|FG001|Overall Study|Not released from incarceration on time|3|||
146242618|NCT02334215|527403390|FG002|Overall Study|Not released from incarceration on time|3|||
146242619|NCT02334215|527403388|FG000|Overall Study|Incarcerated|0|||
146242620|NCT02334215|527403389|FG001|Overall Study|Incarcerated|0|||
146242621|NCT02334215|527403390|FG002|Overall Study|Incarcerated|7|||
146242622|NCT05615363|527403391|FG000|Overall Study|Adverse Event|0|||
146242623|NCT05615363|527403392|FG001|Overall Study|Adverse Event|4|||
146242624|NCT05615363|527403393|FG002|Overall Study|Adverse Event|4|||
145921909|NCT04710576|526222427|FG000|Overall Study|Withdrawal by Subject|4|||
145921910|NCT04710576|526222428|FG001|Overall Study|Withdrawal by Subject|3|||
145921911|NCT04710576|526222429|FG002|Overall Study|Withdrawal by Subject|7|||
145921912|NCT04710576|526222427|FG000|Overall Study|Sponsor decision|1|||
145921913|NCT04710576|526222428|FG001|Overall Study|Sponsor decision|0|||
145921914|NCT04710576|526222429|FG002|Overall Study|Sponsor decision|0|||
146242625|NCT05615363|527403394|FG003|Overall Study|Adverse Event|3|||
145921915|NCT01415518|526222432|FG000|Overall Study|Withdrawal by Subject|2|||
145921916|NCT01415518|526222433|FG001|Overall Study|Withdrawal by Subject|12|||
145921917|NCT01415518|526222432|FG000|Overall Study|Protocol Violation|6|||
145921918|NCT01415518|526222433|FG001|Overall Study|Protocol Violation|8|||
145921919|NCT01415518|526222432|FG000|Overall Study|Lost to Follow-up|3|||
145921920|NCT01415518|526222433|FG001|Overall Study|Lost to Follow-up|5|||
145921921|NCT01415518|526222432|FG000|Overall Study|Adverse Event|3|||
145921922|NCT01415518|526222433|FG001|Overall Study|Adverse Event|4|||
146242626|NCT05615363|527403395|FG004|Overall Study|Adverse Event|1|||
146242627|NCT05615363|527403391|FG000|Overall Study|Physician Decision|2|||
145921923|NCT01415518|526222432|FG000|Overall Study|Death|1|||
145921924|NCT01415518|526222433|FG001|Overall Study|Death|1|||
146242628|NCT05615363|527403392|FG001|Overall Study|Physician Decision|0|||
146242629|NCT05615363|527403393|FG002|Overall Study|Physician Decision|4|||
146242630|NCT05615363|527403394|FG003|Overall Study|Physician Decision|1|||
146242631|NCT05615363|527403395|FG004|Overall Study|Physician Decision|3|||
146242632|NCT05615363|527403391|FG000|Overall Study|Protocol Violation|2|||
146242633|NCT05615363|527403392|FG001|Overall Study|Protocol Violation|0|||
146242634|NCT05615363|527403393|FG002|Overall Study|Protocol Violation|0|||
146242635|NCT05615363|527403394|FG003|Overall Study|Protocol Violation|0|||
146242636|NCT05615363|527403395|FG004|Overall Study|Protocol Violation|1|||
146242637|NCT05615363|527403391|FG000|Overall Study|Withdrawal by Subject|0|||
146242638|NCT05615363|527403392|FG001|Overall Study|Withdrawal by Subject|0|||
146242639|NCT05615363|527403393|FG002|Overall Study|Withdrawal by Subject|1|||
146242640|NCT05615363|527403394|FG003|Overall Study|Withdrawal by Subject|0|||
146242641|NCT05615363|527403395|FG004|Overall Study|Withdrawal by Subject|0|||
146242642|NCT04602728|527403400|FG000|Overall Study|Lost to Follow-up|4|||
146242643|NCT04602728|527403401|FG001|Overall Study|Lost to Follow-up|4|||
146242644|NCT03905642|527403403|FG000|Overall Study|Withdrawal by Subject|3|||
146242645|NCT03905642|527403403|FG000|Overall Study|Pregnancy|1|||
146242646|NCT03905642|527403403|FG000|Overall Study|Adverse Event|1|||
146242647|NCT03905642|527403403|FG000|Overall Study|Lack of Efficacy|1|||
146242648|NCT03905642|527403403|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
146242649|NCT02159989|527403404|FG000|Overall Study|Adverse Event|1|||
146242650|NCT02159989|527403405|FG001|Overall Study|Adverse Event|0|||
146242651|NCT02159989|527403406|FG002|Overall Study|Adverse Event|0|||
146242652|NCT02159989|527403407|FG003|Overall Study|Adverse Event|0|||
146242653|NCT02159989|527403408|FG004|Overall Study|Adverse Event|1|||
146242654|NCT02159989|527403409|FG005|Overall Study|Adverse Event|0|||
146242655|NCT02159989|527403410|FG006|Overall Study|Adverse Event|1|||
146242656|NCT02159989|527403411|FG007|Overall Study|Adverse Event|2|||
146242657|NCT02159989|527403412|FG008|Overall Study|Adverse Event|0|||
146242658|NCT02159989|527403413|FG009|Overall Study|Adverse Event|2|||
145921925|NCT01415518|526222432|FG000|Overall Study|Condition under Investigation Worsened|1|||
145921926|NCT01415518|526222433|FG001|Overall Study|Condition under Investigation Worsened|1|||
145921927|NCT02445248|526222435|FG000|Overall Study|Death|45|||
145921928|NCT02445248|526222436|FG001|Overall Study|Death|12|||
145921929|NCT02445248|526222435|FG000|Overall Study|Progressive disease|13|||
145921930|NCT02445248|526222436|FG001|Overall Study|Progressive disease|1|||
145921931|NCT02445248|526222435|FG000|Overall Study|Subject decision|8|||
145921932|NCT02445248|526222436|FG001|Overall Study|Subject decision|0|||
145921933|NCT02445248|526222435|FG000|Overall Study|Physician Decision|5|||
145921934|NCT02445248|526222436|FG001|Overall Study|Physician Decision|0|||
145921935|NCT02445248|526222435|FG000|Overall Study|Adverse Event|1|||
145921936|NCT02445248|526222436|FG001|Overall Study|Adverse Event|0|||
145921937|NCT02445248|526222435|FG000|Overall Study|Lost to Follow-up|1|||
145921938|NCT02445248|526222436|FG001|Overall Study|Lost to Follow-up|0|||
145921939|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
145921940|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
145921941|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
145921942|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
145921943|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
145921944|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
145921945|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
146242659|NCT02159989|527403414|FG010|Overall Study|Adverse Event|1|||
146242660|NCT02159989|527403404|FG000|Overall Study|Death|0|||
146242661|NCT02159989|527403405|FG001|Overall Study|Death|0|||
146242662|NCT02159989|527403406|FG002|Overall Study|Death|0|||
146242663|NCT02159989|527403407|FG003|Overall Study|Death|0|||
146242664|NCT02159989|527403408|FG004|Overall Study|Death|0|||
146242665|NCT02159989|527403409|FG005|Overall Study|Death|0|||
146242666|NCT02159989|527403410|FG006|Overall Study|Death|0|||
145921946|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
145921947|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
145921948|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
146242667|NCT02159989|527403411|FG007|Overall Study|Death|0|||
146242668|NCT02159989|527403412|FG008|Overall Study|Death|0|||
146242669|NCT02159989|527403413|FG009|Overall Study|Death|0|||
146242670|NCT02159989|527403414|FG010|Overall Study|Death|1|||
145921949|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
146242671|NCT02159989|527403404|FG000|Overall Study|Lack of Efficacy|2|||
146242672|NCT02159989|527403405|FG001|Overall Study|Lack of Efficacy|3|||
146297712|NCT03901053|527604782|FG000|Overall Study|Subject's Medical Status|0|||
145921950|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
145921951|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145921952|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
146242673|NCT02159989|527403406|FG002|Overall Study|Lack of Efficacy|3|||
146242674|NCT02159989|527403407|FG003|Overall Study|Lack of Efficacy|0|||
146242675|NCT02159989|527403408|FG004|Overall Study|Lack of Efficacy|2|||
146242676|NCT02159989|527403409|FG005|Overall Study|Lack of Efficacy|3|||
146242677|NCT02159989|527403410|FG006|Overall Study|Lack of Efficacy|3|||
145921953|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
145921954|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145921955|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
145921956|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
145921957|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
145921958|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
145921959|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
145921960|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
145921961|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
145921962|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
145921963|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
145921964|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
145921965|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
145921966|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
145921967|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
145921968|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
145921969|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
145921970|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
145921971|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145921972|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
145921973|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145921974|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145921975|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145921976|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145921977|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145921978|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
145921979|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
145921980|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145921981|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145921982|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145921983|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
145921984|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
145921985|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
145921986|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
145921987|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145921988|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145921989|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
145921990|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145921991|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Site closed|0|||
145921992|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Site closed|0|||
145921993|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Site closed|1|||
145921994|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Site closed|0|||
145921995|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
145921996|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145921997|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145921998|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145921999|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
145922000|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
145922001|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
145922002|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
145922003|NCT00838903|526222441|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
146242678|NCT02159989|527403411|FG007|Overall Study|Lack of Efficacy|1|||
146242679|NCT02159989|527403412|FG008|Overall Study|Lack of Efficacy|3|||
146242680|NCT02159989|527403413|FG009|Overall Study|Lack of Efficacy|6|||
146242681|NCT02159989|527403414|FG010|Overall Study|Lack of Efficacy|7|||
145922004|NCT00838903|526222442|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145922005|NCT00838903|526222443|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145922006|NCT00838903|526222444|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145922007|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
146242682|NCT02159989|527403404|FG000|Overall Study|Lost to Follow-up|0|||
146242683|NCT02159989|527403405|FG001|Overall Study|Lost to Follow-up|0|||
146242684|NCT02159989|527403406|FG002|Overall Study|Lost to Follow-up|0|||
145922008|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
145922009|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
145922010|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
145922011|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
146242685|NCT02159989|527403407|FG003|Overall Study|Lost to Follow-up|1|||
145922012|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
145922013|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
145922014|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
145922015|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
145922016|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
145922017|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
145922018|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
145922019|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
145922020|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
145922021|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
145922022|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
145922023|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
145922024|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
145922025|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
145922026|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
145922027|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
145922028|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
145922029|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
145922030|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
145922031|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
145922032|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145922033|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
145922034|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145922035|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145922036|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
145922037|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145922038|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145922039|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145922040|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
145922041|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145922042|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145922043|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145922044|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145922045|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145922046|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
145922047|NCT00838903|526222441|FG000|Follow-up Period (8 Weeks)|Missing|1|||
145922048|NCT00838903|526222442|FG001|Follow-up Period (8 Weeks)|Missing|2|||
145922049|NCT00838903|526222443|FG002|Follow-up Period (8 Weeks)|Missing|1|||
145922050|NCT00838903|526222444|FG003|Follow-up Period (8 Weeks)|Missing|1|||
145922051|NCT04225715|526222445|FG000|Overall Study|Reason not Specified|1|||
145922052|NCT04225715|526222446|FG001|Overall Study|Reason not Specified|0|||
145922053|NCT04225715|526222447|FG002|Overall Study|Reason not Specified|0|||
145922054|NCT04225715|526222448|FG003|Overall Study|Reason not Specified|0|||
145922055|NCT04225715|526222449|FG004|Overall Study|Reason not Specified|0|||
145922056|NCT04225715|526222450|FG005|Overall Study|Reason not Specified|0|||
145922057|NCT04225715|526222451|FG006|Overall Study|Reason not Specified|0|||
145922058|NCT04225715|526222452|FG007|Overall Study|Reason not Specified|0|||
145922059|NCT04225715|526222453|FG008|Overall Study|Reason not Specified|0|||
145922060|NCT04225715|526222445|FG000|Overall Study|Protocol Violation|1|||
145922061|NCT04225715|526222446|FG001|Overall Study|Protocol Violation|0|||
145922062|NCT04225715|526222447|FG002|Overall Study|Protocol Violation|0|||
145922063|NCT04225715|526222448|FG003|Overall Study|Protocol Violation|0|||
145922064|NCT04225715|526222449|FG004|Overall Study|Protocol Violation|0|||
145922065|NCT04225715|526222450|FG005|Overall Study|Protocol Violation|9|||
145922066|NCT04225715|526222451|FG006|Overall Study|Protocol Violation|0|||
145922067|NCT04225715|526222452|FG007|Overall Study|Protocol Violation|0|||
145922068|NCT04225715|526222453|FG008|Overall Study|Protocol Violation|0|||
146089535|NCT01909453|526847442|FG000|Overall Study|Lost to Follow-up|3|||
146089536|NCT01909453|526847443|FG001|Overall Study|Lost to Follow-up|4|||
145922069|NCT04225715|526222445|FG000|Overall Study|Withdrawal by Subject|4|||
146089537|NCT01909453|526847444|FG002|Overall Study|Lost to Follow-up|4|||
146089538|NCT01909453|526847445|FG003|Overall Study|Lost to Follow-up|3|||
145922070|NCT04225715|526222446|FG001|Overall Study|Withdrawal by Subject|1|||
145922071|NCT04225715|526222447|FG002|Overall Study|Withdrawal by Subject|1|||
145922072|NCT04225715|526222448|FG003|Overall Study|Withdrawal by Subject|0|||
145922073|NCT04225715|526222449|FG004|Overall Study|Withdrawal by Subject|3|||
145922074|NCT04225715|526222450|FG005|Overall Study|Withdrawal by Subject|1|||
145922075|NCT04225715|526222451|FG006|Overall Study|Withdrawal by Subject|1|||
145922076|NCT04225715|526222452|FG007|Overall Study|Withdrawal by Subject|1|||
145922077|NCT04225715|526222453|FG008|Overall Study|Withdrawal by Subject|0|||
146089539|NCT01909453|526847446|FG004|Overall Study|Lost to Follow-up|3|||
146089540|NCT01909453|526847442|FG000|Overall Study|Withdrawal by Subject|2|||
145922078|NCT04225715|526222445|FG000|Overall Study|Adverse Event|0|||
145922079|NCT04225715|526222446|FG001|Overall Study|Adverse Event|0|||
145922080|NCT04225715|526222447|FG002|Overall Study|Adverse Event|0|||
145922081|NCT04225715|526222448|FG003|Overall Study|Adverse Event|0|||
145922082|NCT04225715|526222449|FG004|Overall Study|Adverse Event|0|||
145922083|NCT04225715|526222450|FG005|Overall Study|Adverse Event|0|||
145922084|NCT04225715|526222451|FG006|Overall Study|Adverse Event|0|||
145922085|NCT04225715|526222452|FG007|Overall Study|Adverse Event|0|||
145922086|NCT04225715|526222453|FG008|Overall Study|Adverse Event|1|||
145922087|NCT04225715|526222445|FG000|Overall Study|Arm Terminated By Sponsor|0|||
145922088|NCT04225715|526222446|FG001|Overall Study|Arm Terminated By Sponsor|0|||
145922089|NCT04225715|526222447|FG002|Overall Study|Arm Terminated By Sponsor|0|||
145922090|NCT04225715|526222448|FG003|Overall Study|Arm Terminated By Sponsor|0|||
145922091|NCT04225715|526222449|FG004|Overall Study|Arm Terminated By Sponsor|0|||
145922092|NCT04225715|526222450|FG005|Overall Study|Arm Terminated By Sponsor|0|||
145922093|NCT04225715|526222451|FG006|Overall Study|Arm Terminated By Sponsor|0|||
145922094|NCT04225715|526222452|FG007|Overall Study|Arm Terminated By Sponsor|17|||
145922095|NCT04225715|526222453|FG008|Overall Study|Arm Terminated By Sponsor|18|||
145922096|NCT02512302|526222454|FG000|Period 1|Adverse Event|0|||
145922097|NCT02512302|526222455|FG001|Period 1|Adverse Event|1|||
145922098|NCT02512302|526222456|FG002|Period 1|Adverse Event|0|||
145922099|NCT02512302|526222457|FG003|Period 1|Adverse Event|0|||
145922100|NCT02512302|526222458|FG004|Period 1|Adverse Event|0|||
145922101|NCT02512302|526222459|FG005|Period 1|Adverse Event|0|||
145922102|NCT02512302|526222460|FG006|Period 1|Adverse Event|0|||
145922103|NCT02512302|526222461|FG007|Period 1|Adverse Event|0|||
145922104|NCT02512302|526222462|FG008|Period 1|Adverse Event|0|||
145922105|NCT02512302|526222463|FG009|Period 1|Adverse Event|0|||
145922106|NCT02512302|526222454|FG000|Period 2|Adverse Event|0|||
145922107|NCT02512302|526222455|FG001|Period 2|Adverse Event|0|||
145922108|NCT02512302|526222456|FG002|Period 2|Adverse Event|0|||
145922109|NCT02512302|526222457|FG003|Period 2|Adverse Event|0|||
145922110|NCT02512302|526222458|FG004|Period 2|Adverse Event|0|||
145922111|NCT02512302|526222459|FG005|Period 2|Adverse Event|0|||
145922112|NCT02512302|526222460|FG006|Period 2|Adverse Event|0|||
145922113|NCT02512302|526222461|FG007|Period 2|Adverse Event|0|||
145922114|NCT02512302|526222462|FG008|Period 2|Adverse Event|0|||
145922115|NCT02512302|526222463|FG009|Period 2|Adverse Event|1|||
145922116|NCT02512302|526222454|FG000|Period 3|Lost to Follow-up|0|||
145922117|NCT02512302|526222455|FG001|Period 3|Lost to Follow-up|0|||
145922118|NCT02512302|526222456|FG002|Period 3|Lost to Follow-up|1|||
145922119|NCT02512302|526222457|FG003|Period 3|Lost to Follow-up|0|||
145922120|NCT02512302|526222458|FG004|Period 3|Lost to Follow-up|0|||
145922121|NCT02512302|526222459|FG005|Period 3|Lost to Follow-up|0|||
145922122|NCT02512302|526222460|FG006|Period 3|Lost to Follow-up|0|||
145922123|NCT02512302|526222461|FG007|Period 3|Lost to Follow-up|0|||
145922124|NCT02512302|526222462|FG008|Period 3|Lost to Follow-up|0|||
145922125|NCT02512302|526222463|FG009|Period 3|Lost to Follow-up|0|||
145922126|NCT02512302|526222454|FG000|Period 4|Adverse Event|0|||
145922127|NCT02512302|526222455|FG001|Period 4|Adverse Event|0|||
145922128|NCT02512302|526222456|FG002|Period 4|Adverse Event|0|||
145922129|NCT02512302|526222457|FG003|Period 4|Adverse Event|0|||
145922130|NCT02512302|526222458|FG004|Period 4|Adverse Event|0|||
145922131|NCT02512302|526222459|FG005|Period 4|Adverse Event|0|||
145922132|NCT02512302|526222460|FG006|Period 4|Adverse Event|1|||
145922133|NCT02512302|526222461|FG007|Period 4|Adverse Event|0|||
146242686|NCT02159989|527403408|FG004|Overall Study|Lost to Follow-up|0|||
146242687|NCT02159989|527403409|FG005|Overall Study|Lost to Follow-up|0|||
146242688|NCT02159989|527403410|FG006|Overall Study|Lost to Follow-up|0|||
146242689|NCT02159989|527403411|FG007|Overall Study|Lost to Follow-up|0|||
145922134|NCT02512302|526222462|FG008|Period 4|Adverse Event|0|||
145922135|NCT02512302|526222463|FG009|Period 4|Adverse Event|0|||
145975629|NCT00689936|526422280|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
145922136|NCT00683618|526222464|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
145975630|NCT00689936|526422278|FG000|Active Treatment Phase|Death|60|||
145922137|NCT00683618|526222465|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
145922138|NCT00683618|526222466|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
145922139|NCT00683618|526222464|FG000|Randomised Treatment Period|Protocol Violation|0|||
145922140|NCT00683618|526222465|FG001|Randomised Treatment Period|Protocol Violation|1|||
145922141|NCT00683618|526222466|FG002|Randomised Treatment Period|Protocol Violation|0|||
145922142|NCT00683618|526222464|FG000|Randomised Treatment Period|Adverse Event|2|||
145922143|NCT00683618|526222465|FG001|Randomised Treatment Period|Adverse Event|0|||
145922144|NCT00683618|526222466|FG002|Randomised Treatment Period|Adverse Event|2|||
145922145|NCT00683618|526222464|FG000|Randomised Treatment Period|Reason not provided|0|||
145922146|NCT00683618|526222465|FG001|Randomised Treatment Period|Reason not provided|0|||
145922147|NCT00683618|526222466|FG002|Randomised Treatment Period|Reason not provided|2|||
145922148|NCT00683618|526222464|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
146242690|NCT02159989|527403412|FG008|Overall Study|Lost to Follow-up|0|||
145922149|NCT00683618|526222465|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145922150|NCT00683618|526222466|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
146242691|NCT02159989|527403413|FG009|Overall Study|Lost to Follow-up|0|||
145922151|NCT00683618|526222464|FG000|Extension Treatment Period|Adverse Event|1|||
145922152|NCT00683618|526222465|FG001|Extension Treatment Period|Adverse Event|0|||
145922153|NCT00683618|526222466|FG002|Extension Treatment Period|Adverse Event|0|||
145922154|NCT00683618|526222464|FG000|Extension Treatment Period|Protocol Violation|1|||
145922155|NCT00683618|526222465|FG001|Extension Treatment Period|Protocol Violation|0|||
145922156|NCT00683618|526222466|FG002|Extension Treatment Period|Protocol Violation|0|||
145922157|NCT01002989|526222467|FG000|Overall Study|exclusion criteria, no consent|5|||
145922158|NCT05177484|526222468|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
145922159|NCT05177484|526222469|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
145922160|NCT05177484|526222468|FG000|Overall Study|Inadvertently withdrawn|3|||
145922161|NCT05177484|526222469|FG001|Overall Study|Inadvertently withdrawn|1|||
145922162|NCT05177484|526222468|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
145922163|NCT05177484|526222469|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
145922164|NCT02549859|526222470|FG000|Long-term 60 Hz DBS|Study Closed|1|||
145922165|NCT00729612|526222471|FG000|Overall Study|Non evaluable for response|10|||
145922166|NCT00360282|526222476|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
145922167|NCT00360282|526222477|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
145922168|NCT00360282|526222478|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
145922169|NCT00360282|526222479|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
145922170|NCT00360282|526222476|FG000|Second Intervention|Adverse Event|0|||
145922171|NCT00360282|526222477|FG001|Second Intervention|Adverse Event|1|||
145922172|NCT00360282|526222478|FG002|Second Intervention|Adverse Event|0|||
145922173|NCT00360282|526222479|FG003|Second Intervention|Adverse Event|0|||
145922174|NCT01293695|526222483|FG000|Overall Study|Withdrawal by Subject|7|||
145922175|NCT01293695|526222484|FG001|Overall Study|Withdrawal by Subject|1|||
145922176|NCT01293695|526222483|FG000|Overall Study|Lost to Follow-up|8|||
145922177|NCT01293695|526222484|FG001|Overall Study|Lost to Follow-up|6|||
145922178|NCT00031590|526222487|FG000|Overall Study|Adverse Event|1|||
145922179|NCT00031590|526222487|FG000|Overall Study|Withdrawal by parents|2|||
145922180|NCT02626026|526222488|FG000|Overall Study|Randomized but Never Treated|0|||
145922181|NCT02626026|526222489|FG001|Overall Study|Randomized but Never Treated|0|||
145922182|NCT02626026|526222490|FG002|Overall Study|Randomized but Never Treated|0|||
145922183|NCT02626026|526222491|FG003|Overall Study|Randomized but Never Treated|0|||
145922184|NCT02626026|526222492|FG004|Overall Study|Randomized but Never Treated|1|||
145922185|NCT02626026|526222493|FG005|Overall Study|Randomized but Never Treated|0|||
145922186|NCT02375971|526222494|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
145922187|NCT02375971|526222495|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
145922188|NCT02375971|526222496|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
145922189|NCT02375971|526222494|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145922190|NCT02375971|526222495|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145922191|NCT02375971|526222496|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145922192|NCT02375971|526222494|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
145922193|NCT02375971|526222495|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
145922194|NCT02375971|526222496|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
145922195|NCT02375971|526222494|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
145922196|NCT02375971|526222495|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
146242692|NCT02159989|527403414|FG010|Overall Study|Lost to Follow-up|1|||
145922197|NCT02375971|526222496|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
145922198|NCT02375971|526222494|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
145922199|NCT02375971|526222495|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
145922200|NCT02375971|526222496|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
145922201|NCT02375971|526222494|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
145922202|NCT02375971|526222495|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
145922203|NCT02375971|526222496|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
145922204|NCT02375971|526222494|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
145922205|NCT02375971|526222495|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
145922206|NCT02375971|526222496|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
145922207|NCT02375971|526222494|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
145922208|NCT02375971|526222495|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
145922209|NCT02375971|526222496|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
145922210|NCT01139125|526222497|FG000|Overall Study|Withdrawal by Subject|1|||
146242693|NCT02159989|527403404|FG000|Overall Study|Withdrawal by Subject|2|||
146242694|NCT02159989|527403405|FG001|Overall Study|Withdrawal by Subject|0|||
146242695|NCT02159989|527403406|FG002|Overall Study|Withdrawal by Subject|0|||
145922211|NCT02172664|526222505|FG000|Overall Study|Lost to Follow-up|4|||
145922212|NCT02172664|526222506|FG001|Overall Study|Lost to Follow-up|4|||
145922213|NCT02172664|526222505|FG000|Overall Study|Death|1|||
145922214|NCT02172664|526222506|FG001|Overall Study|Death|1|||
145922215|NCT02172664|526222505|FG000|Overall Study|Moved out of area|1|||
145922216|NCT02172664|526222506|FG001|Overall Study|Moved out of area|1|||
145922217|NCT00380874|526222507|FG000|Overall Study|Adverse Event|7|||
145922218|NCT00380874|526222508|FG001|Overall Study|Adverse Event|7|||
146242696|NCT02159989|527403407|FG003|Overall Study|Withdrawal by Subject|2|||
145922219|NCT00380874|526222507|FG000|Overall Study|Death|1|||
145922220|NCT00380874|526222508|FG001|Overall Study|Death|0|||
145922221|NCT00380874|526222507|FG000|Overall Study|Withdrawal by Subject|2|||
145922222|NCT00380874|526222508|FG001|Overall Study|Withdrawal by Subject|1|||
145922223|NCT00380874|526222507|FG000|Overall Study|Not related to study drug|3|||
145922224|NCT00380874|526222508|FG001|Overall Study|Not related to study drug|2|||
145922225|NCT01707290|526222511|FG000|Overall Study|Adverse event (AE)|1|||
145922226|NCT01707290|526222512|FG001|Overall Study|Adverse event (AE)|0|||
145922227|NCT01707290|526222511|FG000|Overall Study|Physician Decision|1|||
145922228|NCT01707290|526222512|FG001|Overall Study|Physician Decision|0|||
145922229|NCT01707290|526222511|FG000|Overall Study|Lost to Follow-up|3|||
145922230|NCT01707290|526222512|FG001|Overall Study|Lost to Follow-up|0|||
145922231|NCT01707290|526222511|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
145922232|NCT01707290|526222512|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
145922233|NCT01707290|526222511|FG000|Overall Study|Commercial drug available|60|||
145922234|NCT01707290|526222512|FG001|Overall Study|Commercial drug available|1|||
145922235|NCT01707290|526222511|FG000|Overall Study|Other unspecified|17|||
145922236|NCT01707290|526222512|FG001|Overall Study|Other unspecified|0|||
145922237|NCT02314026|526222513|FG000|Overall Study|Protocol Violation|28|||
145922238|NCT01139775|526222514|FG000|Overall Study|Adverse Event|0|||
145922239|NCT01139775|526222515|FG001|Overall Study|Adverse Event|6|||
145922240|NCT01139775|526222516|FG002|Overall Study|Adverse Event|2|||
145922241|NCT01139775|526222514|FG000|Overall Study|Protocol Violation|0|||
145922242|NCT01139775|526222515|FG001|Overall Study|Protocol Violation|5|||
145922243|NCT01139775|526222516|FG002|Overall Study|Protocol Violation|0|||
145922244|NCT01139775|526222514|FG000|Overall Study|Withdrawal by Subject|1|||
145922245|NCT01139775|526222515|FG001|Overall Study|Withdrawal by Subject|0|||
145922246|NCT01139775|526222516|FG002|Overall Study|Withdrawal by Subject|2|||
145922247|NCT01139775|526222514|FG000|Overall Study|Physician Decision|0|||
145922248|NCT01139775|526222515|FG001|Overall Study|Physician Decision|2|||
145922249|NCT01139775|526222516|FG002|Overall Study|Physician Decision|2|||
145922250|NCT04760626|526222517|FG000|Overall Study|Withdrawal by Subject|24|||
145922251|NCT04760626|526222518|FG001|Overall Study|Withdrawal by Subject|20|||
145922252|NCT04760626|526222517|FG000|Overall Study|Lost to Follow-up|14|||
145922253|NCT04760626|526222518|FG001|Overall Study|Lost to Follow-up|19|||
145922254|NCT04760626|526222517|FG000|Overall Study|Physician Decision|3|||
145922255|NCT04760626|526222518|FG001|Overall Study|Physician Decision|5|||
145922256|NCT04760626|526222517|FG000|Overall Study|Death|3|||
145922257|NCT04760626|526222518|FG001|Overall Study|Death|6|||
145922258|NCT04760626|526222517|FG000|Overall Study|Site closure|1|||
145922259|NCT04760626|526222518|FG001|Overall Study|Site closure|0|||
145922260|NCT03193853|526222521|FG000|Overall Study|Death|6|||
145922261|NCT03267212|526222522|FG000|First Intervention|Lost to Follow-up|0|||
145922262|NCT03267212|526222523|FG001|First Intervention|Lost to Follow-up|2|||
145922263|NCT03267212|526222522|FG000|First Intervention|Withdrawal by Subject|1|||
145922264|NCT03267212|526222523|FG001|First Intervention|Withdrawal by Subject|1|||
145922265|NCT03267212|526222522|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
145922266|NCT03267212|526222523|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
145922267|NCT05303194|526222525|FG000|Overall Study|Lost to Follow-up|1|||
145922268|NCT05303194|526222526|FG001|Overall Study|Lost to Follow-up|1|||
145922269|NCT05303194|526222525|FG000|Overall Study|Withdrawal by Subject|0|||
145922270|NCT05303194|526222526|FG001|Overall Study|Withdrawal by Subject|1|||
145922271|NCT04837196|526222527|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145922272|NCT04837196|526222528|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
145922273|NCT04837196|526222529|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145922274|NCT04837196|526222530|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145922275|NCT04837196|526222531|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
145922276|NCT04837196|526222527|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145922277|NCT04837196|526222528|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
145922278|NCT04837196|526222529|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
145922279|NCT04837196|526222530|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145922280|NCT04837196|526222531|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145922281|NCT04837196|526222527|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145922282|NCT04837196|526222528|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
146242697|NCT02159989|527403408|FG004|Overall Study|Withdrawal by Subject|1|||
145922283|NCT04837196|526222529|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145922284|NCT04837196|526222530|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145922285|NCT04837196|526222531|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145922286|NCT04837196|526222527|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145922287|NCT04837196|526222528|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145922288|NCT04837196|526222529|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
146242698|NCT02159989|527403409|FG005|Overall Study|Withdrawal by Subject|0|||
146242699|NCT02159989|527403410|FG006|Overall Study|Withdrawal by Subject|3|||
146242700|NCT02159989|527403411|FG007|Overall Study|Withdrawal by Subject|1|||
146089541|NCT01909453|526847443|FG001|Overall Study|Withdrawal by Subject|13|||
146089542|NCT01909453|526847444|FG002|Overall Study|Withdrawal by Subject|16|||
145922289|NCT04837196|526222530|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145922290|NCT04837196|526222531|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145922291|NCT04837196|526222527|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145922292|NCT04837196|526222528|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145922293|NCT04837196|526222529|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
145922294|NCT04837196|526222530|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145922295|NCT04837196|526222531|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145922296|NCT01289678|526222532|FG000|Overall Study|Physician Decision|6|||
145922297|NCT01597973|526222535|FG000|Overall Study|Found ineligible before study medication started|4|||
145922298|NCT01597973|526222536|FG001|Overall Study|Found ineligible before study medication started|2|||
145922299|NCT01597973|526222535|FG000|Overall Study|Eligible pathogen not confirmed|14|||
145922300|NCT01597973|526222536|FG001|Overall Study|Eligible pathogen not confirmed|15|||
145922301|NCT01597973|526222535|FG000|Overall Study|LAR not authorized to consent|0|||
145922302|NCT01597973|526222536|FG001|Overall Study|LAR not authorized to consent|1|||
145922303|NCT01597973|526222535|FG000|Overall Study|Ineligible due to early seizures|1|||
145922304|NCT01597973|526222536|FG001|Overall Study|Ineligible due to early seizures|0|||
145922305|NCT01597973|526222535|FG000|Overall Study|Ineligible due to non-target infection|1|||
145922306|NCT01597973|526222536|FG001|Overall Study|Ineligible due to non-target infection|1|||
145922307|NCT02723344|526222537|FG000|Overall Study|Lost to Follow-up|0|||
145922308|NCT02723344|526222538|FG001|Overall Study|Lost to Follow-up|4|||
145922309|NCT04352101|526222539|FG000|Overall Study|Physician Decision|2|||
145922310|NCT04352101|526222540|FG001|Overall Study|Physician Decision|1|||
145922311|NCT00908544|526222542|FG000|Overall Study|Withdrawal by Subject|2|||
145922312|NCT00908544|526222543|FG001|Overall Study|Withdrawal by Subject|4|||
145922313|NCT00908544|526222542|FG000|Overall Study|Lack of Efficacy|0|||
145922314|NCT00908544|526222543|FG001|Overall Study|Lack of Efficacy|1|||
145922315|NCT00908544|526222542|FG000|Overall Study|Pregnancy|1|||
145922316|NCT00908544|526222543|FG001|Overall Study|Pregnancy|0|||
145922317|NCT00908544|526222542|FG000|Overall Study|Relocation abroad|1|||
145922318|NCT00908544|526222543|FG001|Overall Study|Relocation abroad|1|||
145922319|NCT00908544|526222542|FG000|Overall Study|Unable to visit sutdy center|1|||
145922320|NCT00908544|526222543|FG001|Overall Study|Unable to visit sutdy center|0|||
145922321|NCT00740636|526222548|FG000|Overall Study|Adverse Event|0|||
145922322|NCT00740636|526222549|FG001|Overall Study|Adverse Event|2|||
145922323|NCT00740636|526222548|FG000|Overall Study|Patient Ineligible|0|||
145922324|NCT00740636|526222549|FG001|Overall Study|Patient Ineligible|1|||
145922325|NCT00740636|526222548|FG000|Overall Study|Patient Not Treated|0|||
145922326|NCT00740636|526222549|FG001|Overall Study|Patient Not Treated|1|||
145922327|NCT00740636|526222548|FG000|Overall Study|Progressive Disease|1|||
145922328|NCT00740636|526222549|FG001|Overall Study|Progressive Disease|0|||
145922329|NCT00740636|526222548|FG000|Overall Study|Death|1|||
145922330|NCT00740636|526222549|FG001|Overall Study|Death|0|||
145922331|NCT02362360|526222555|FG000|Period 1|Lack of Efficacy|1|||
145922332|NCT02362360|526222556|FG001|Period 1|Lack of Efficacy|0|||
145922333|NCT02362360|526222555|FG000|Period 1|Withdrawal by Subject|2|||
145922334|NCT02362360|526222556|FG001|Period 1|Withdrawal by Subject|1|||
145922335|NCT05573464|526224159|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
145922336|NCT05573464|526224160|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
145922337|NCT05573464|526224159|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
145922338|NCT05573464|526224160|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
145922339|NCT05573464|526224159|FG000|12-week Treatment Period|Protocol Violation|3|||
145922340|NCT05573464|526224160|FG001|12-week Treatment Period|Protocol Violation|1|||
145922341|NCT05573464|526224159|FG000|12-week Treatment Period|Physician Decision|1|||
145922342|NCT05573464|526224160|FG001|12-week Treatment Period|Physician Decision|2|||
145922343|NCT05573464|526224159|FG000|12-week Treatment Period|Lost to Follow-up|2|||
145922344|NCT05573464|526224160|FG001|12-week Treatment Period|Lost to Follow-up|0|||
145922345|NCT05573464|526224159|FG000|12-week Treatment Period|Adverse Event|20|||
145922346|NCT05573464|526224160|FG001|12-week Treatment Period|Adverse Event|9|||
145922347|NCT05573464|526224159|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
145922348|NCT05573464|526224160|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
145922349|NCT05573464|526224159|FG000|12-week Treatment Period|Randomised, not treated|0|||
145922350|NCT05573464|526224160|FG001|12-week Treatment Period|Randomised, not treated|1|||
145922351|NCT05573464|526224159|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
145922352|NCT05573464|526224160|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
145922353|NCT05573464|526224159|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
146089543|NCT01909453|526847445|FG003|Overall Study|Withdrawal by Subject|5|||
145922354|NCT05573464|526224160|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
145922355|NCT05573464|526224159|FG000|52-week Treatment Period|Protocol Violation|1|||
146089544|NCT01909453|526847446|FG004|Overall Study|Withdrawal by Subject|4|||
146089545|NCT00076024|526849207|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
145922356|NCT05573464|526224160|FG001|52-week Treatment Period|Protocol Violation|1|||
145922357|NCT05573464|526224159|FG000|52-week Treatment Period|Physician Decision|2|||
145922358|NCT05573464|526224160|FG001|52-week Treatment Period|Physician Decision|2|||
145922359|NCT05573464|526224159|FG000|52-week Treatment Period|Lost to Follow-up|1|||
145922360|NCT05573464|526224160|FG001|52-week Treatment Period|Lost to Follow-up|1|||
145922361|NCT05573464|526224159|FG000|52-week Treatment Period|Adverse Event|11|||
145922362|NCT05573464|526224160|FG001|52-week Treatment Period|Adverse Event|8|||
145922363|NCT05573464|526224159|FG000|52-week Treatment Period|Death|1|||
145922364|NCT05573464|526224160|FG001|52-week Treatment Period|Death|1|||
145922365|NCT04632927|526224161|FG000|Overall Study|Adverse Event|0|||
145922366|NCT04632927|526224162|FG001|Overall Study|Adverse Event|1|||
145922367|NCT04632927|526224161|FG000|Overall Study|Lack of Efficacy|0|||
145922368|NCT04632927|526224162|FG001|Overall Study|Lack of Efficacy|4|||
145922369|NCT04632927|526224161|FG000|Overall Study|Loss of efficacy|0|||
145922370|NCT04632927|526224162|FG001|Overall Study|Loss of efficacy|1|||
145922371|NCT04632927|526224161|FG000|Overall Study|Non-compliance with study drug|0|||
145922372|NCT04632927|526224162|FG001|Overall Study|Non-compliance with study drug|1|||
145922373|NCT04632927|526224161|FG000|Overall Study|Physician Decision|0|||
145922374|NCT04632927|526224162|FG001|Overall Study|Physician Decision|1|||
145922375|NCT04632927|526224161|FG000|Overall Study|Subject decision|0|||
145922376|NCT04632927|526224162|FG001|Overall Study|Subject decision|1|||
145922377|NCT04632927|526224161|FG000|Overall Study|Withdrawal by Subject|0|||
145922378|NCT04632927|526224162|FG001|Overall Study|Withdrawal by Subject|1|||
145922379|NCT05734157|526224163|FG000|Overall Study|Death|3|||
145922380|NCT05734157|526224163|FG000|Overall Study|Withdrawal by Subject|2|||
145922381|NCT05734157|526224163|FG000|Overall Study|Lost to Follow-up|1|||
145922382|NCT05734157|526224163|FG000|Overall Study|Telephone call|3|||
145922383|NCT01611935|526224164|FG000|Overall Study|Family Declined Participation|1|||
145922384|NCT01611935|526224165|FG001|Overall Study|Family Declined Participation|0|||
145922385|NCT04067050|526224168|FG000|One Month|Lost to Follow-up|4|||
145922386|NCT04067050|526224169|FG001|One Month|Lost to Follow-up|0|||
145975631|NCT00689936|526422279|FG001|Active Treatment Phase|Death|28|||
145975632|NCT00689936|526422280|FG002|Active Treatment Phase|Death|37|||
145975633|NCT00689936|526422278|FG000|Active Treatment Phase|Lost to Follow-up|0|||
145975634|NCT00689936|526422279|FG001|Active Treatment Phase|Lost to Follow-up|2|||
145975635|NCT00689936|526422280|FG002|Active Treatment Phase|Lost to Follow-up|2|||
145975636|NCT00689936|526422278|FG000|Active Treatment Phase|Protocol Violation|2|||
145975637|NCT00689936|526422279|FG001|Active Treatment Phase|Protocol Violation|2|||
145975638|NCT00689936|526422280|FG002|Active Treatment Phase|Protocol Violation|4|||
145975639|NCT00689936|526422278|FG000|Active Treatment Phase|Study Close Out|64|||
145975640|NCT00689936|526422279|FG001|Active Treatment Phase|Study Close Out|26|||
145975641|NCT00689936|526422280|FG002|Active Treatment Phase|Study Close Out|21|||
145975642|NCT00689936|526422278|FG000|Active Treatment Phase|Miscellaneous|52|||
145975643|NCT00689936|526422279|FG001|Active Treatment Phase|Miscellaneous|34|||
145975644|NCT00689936|526422280|FG002|Active Treatment Phase|Miscellaneous|47|||
145975645|NCT00689936|526422278|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
145975646|NCT00689936|526422279|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
145975647|NCT00689936|526422280|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
145975648|NCT06001866|526422283|FG000|Overall Study|Withdrawal by Subject|0|||
145975649|NCT06001866|526422284|FG001|Overall Study|Withdrawal by Subject|2|||
145975650|NCT06001866|526422283|FG000|Overall Study|Protocol Violation|0|||
145975651|NCT06001866|526422284|FG001|Overall Study|Protocol Violation|2|||
145975652|NCT03330197|526422285|FG000|Overall Study|Adverse Event|0|||
145975653|NCT03330197|526422286|FG001|Overall Study|Adverse Event|1|||
145975654|NCT03330197|526422285|FG000|Overall Study|Withdrawal by Subject|0|||
145975655|NCT03330197|526422286|FG001|Overall Study|Withdrawal by Subject|1|||
145975656|NCT04235374|526422287|FG000|Overall Study|Death|91|||
145975657|NCT04235374|526422288|FG001|Overall Study|Death|91|||
145975658|NCT04235374|526422287|FG000|Overall Study|Refused|2|||
145975659|NCT04235374|526422288|FG001|Overall Study|Refused|2|||
145975660|NCT04235374|526422287|FG000|Overall Study|Unavailable|12|||
145975661|NCT04235374|526422288|FG001|Overall Study|Unavailable|3|||
145922387|NCT04067050|526224168|FG000|Two Month|Lost to Follow-up|1|||
145922388|NCT04067050|526224169|FG001|Two Month|Lost to Follow-up|0|||
145975662|NCT04235374|526422287|FG000|Overall Study|Withdrawal by Subject|0|||
145975663|NCT04235374|526422288|FG001|Overall Study|Withdrawal by Subject|1|||
145975664|NCT04235374|526422287|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
146242701|NCT02159989|527403412|FG008|Overall Study|Withdrawal by Subject|0|||
145975665|NCT04235374|526422288|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
145975666|NCT00314145|526422289|FG000|Overall Study|Withdrawal by Subject|8|||
145975667|NCT00314145|526422290|FG001|Overall Study|Withdrawal by Subject|10|||
145975668|NCT00314145|526422289|FG000|Overall Study|Lost to Follow-up|5|||
145975669|NCT00314145|526422290|FG001|Overall Study|Lost to Follow-up|12|||
145975670|NCT00314145|526422289|FG000|Overall Study|Physician Decision|3|||
145975671|NCT00314145|526422290|FG001|Overall Study|Physician Decision|4|||
145922389|NCT04067050|526224168|FG000|Two Month|Adverse Event|1|||
145922390|NCT04067050|526224169|FG001|Two Month|Adverse Event|0|||
145975672|NCT00314145|526422289|FG000|Overall Study|Adverse Event|0|||
145975673|NCT00314145|526422290|FG001|Overall Study|Adverse Event|3|||
145975674|NCT00314145|526422289|FG000|Overall Study|Protocol Violation|3|||
145975675|NCT00314145|526422290|FG001|Overall Study|Protocol Violation|0|||
145975676|NCT00314145|526422289|FG000|Overall Study|Sponsor Decision|2|||
145975677|NCT00314145|526422290|FG001|Overall Study|Sponsor Decision|0|||
145975678|NCT02572167|526422291|FG000|Overall Study|Withdrawal by Subject|0|||
145975679|NCT02572167|526422292|FG001|Overall Study|Withdrawal by Subject|3|||
145975680|NCT02572167|526422293|FG002|Overall Study|Withdrawal by Subject|0|||
145975681|NCT02572167|526422291|FG000|Overall Study|Lost to Follow-up|2|||
145975682|NCT02572167|526422292|FG001|Overall Study|Lost to Follow-up|5|||
145975683|NCT02572167|526422293|FG002|Overall Study|Lost to Follow-up|3|||
145975684|NCT02572167|526422291|FG000|Overall Study|Death|0|||
145975685|NCT02572167|526422292|FG001|Overall Study|Death|8|||
145975686|NCT02572167|526422293|FG002|Overall Study|Death|3|||
145975687|NCT02572167|526422291|FG000|Overall Study|Did not meet inclusion criteria|0|||
145975688|NCT02572167|526422292|FG001|Overall Study|Did not meet inclusion criteria|0|||
145975689|NCT02572167|526422293|FG002|Overall Study|Did not meet inclusion criteria|1|||
145975690|NCT02572167|526422291|FG000|Overall Study|Study closure by Sponsor|4|||
145975691|NCT02572167|526422292|FG001|Overall Study|Study closure by Sponsor|40|||
145975692|NCT02572167|526422293|FG002|Overall Study|Study closure by Sponsor|24|||
145975693|NCT00976027|526422296|FG000|Overall Study|Serious Adverse Event|36|||
145975694|NCT00976027|526422297|FG001|Overall Study|Serious Adverse Event|17|||
145975695|NCT00976027|526422296|FG000|Overall Study|Adverse Event|0|||
145975696|NCT00976027|526422297|FG001|Overall Study|Adverse Event|2|||
145975697|NCT00976027|526422296|FG000|Overall Study|Protocol Violation|60|||
145975698|NCT00976027|526422297|FG001|Overall Study|Protocol Violation|27|||
145975699|NCT00976027|526422296|FG000|Overall Study|Lost to Follow-up|208|||
145975700|NCT00976027|526422297|FG001|Overall Study|Lost to Follow-up|103|||
145975701|NCT00976027|526422296|FG000|Overall Study|Withdrawal by Subject|107|||
145975702|NCT00976027|526422297|FG001|Overall Study|Withdrawal by Subject|66|||
145975703|NCT04435626|526422300|FG000|Overall Study|Lost to Follow-up|1|||
145975704|NCT04435626|526422301|FG001|Overall Study|Lost to Follow-up|5|||
145975705|NCT04435626|526422300|FG000|Overall Study|Withdrawal by Subject|6|||
145975706|NCT04435626|526422301|FG001|Overall Study|Withdrawal by Subject|7|||
145975707|NCT04435626|526422300|FG000|Overall Study|major GCP violations|8|||
145975708|NCT04435626|526422301|FG001|Overall Study|major GCP violations|7|||
145975709|NCT01771107|526422309|FG000|Overall Study|Adverse Event|1|||
145975710|NCT01771107|526422310|FG001|Overall Study|Adverse Event|3|||
145975711|NCT01771107|526422309|FG000|Overall Study|Withdrawal by Subject|0|||
145975712|NCT01771107|526422310|FG001|Overall Study|Withdrawal by Subject|2|||
145975713|NCT01771107|526422309|FG000|Overall Study|Lost to Follow-up|0|||
145975714|NCT01771107|526422310|FG001|Overall Study|Lost to Follow-up|1|||
145975715|NCT01771107|526422309|FG000|Overall Study|participant moved|0|||
145975716|NCT01771107|526422310|FG001|Overall Study|participant moved|1|||
145975717|NCT01771107|526422309|FG000|Overall Study|Other|0|||
145975718|NCT01771107|526422310|FG001|Overall Study|Other|1|||
145975719|NCT02296125|526422315|FG000|Overall Study|Withdrawal by Subject|18|||
145975720|NCT02296125|526422316|FG001|Overall Study|Withdrawal by Subject|8|||
145975721|NCT02296125|526422317|FG002|Overall Study|Withdrawal by Subject|6|||
145975722|NCT02296125|526422318|FG003|Overall Study|Withdrawal by Subject|2|||
145975723|NCT02296125|526422315|FG000|Overall Study|Adverse Event|41|||
145975724|NCT02296125|526422316|FG001|Overall Study|Adverse Event|52|||
145975725|NCT02296125|526422317|FG002|Overall Study|Adverse Event|9|||
145975726|NCT02296125|526422318|FG003|Overall Study|Adverse Event|4|||
145975727|NCT02296125|526422315|FG000|Overall Study|Severe non-compliance to protocol|0|||
145975728|NCT02296125|526422316|FG001|Overall Study|Severe non-compliance to protocol|1|||
145975729|NCT02296125|526422317|FG002|Overall Study|Severe non-compliance to protocol|0|||
145975730|NCT02296125|526422318|FG003|Overall Study|Severe non-compliance to protocol|0|||
145975731|NCT02296125|526422315|FG000|Overall Study|Condition under investigation worsened|153|||
146242702|NCT02159989|527403413|FG009|Overall Study|Withdrawal by Subject|0|||
146242703|NCT02159989|527403414|FG010|Overall Study|Withdrawal by Subject|0|||
145975732|NCT02296125|526422316|FG001|Overall Study|Condition under investigation worsened|199|||
145975733|NCT02296125|526422317|FG002|Overall Study|Condition under investigation worsened|39|||
145975734|NCT02296125|526422318|FG003|Overall Study|Condition under investigation worsened|56|||
145975735|NCT02296125|526422315|FG000|Overall Study|Any reason not specifically recorded|6|||
145975736|NCT02296125|526422316|FG001|Overall Study|Any reason not specifically recorded|4|||
145975737|NCT02296125|526422317|FG002|Overall Study|Any reason not specifically recorded|2|||
145975738|NCT02296125|526422318|FG003|Overall Study|Any reason not specifically recorded|0|||
145975739|NCT05248386|526422319|FG000|Overall Study|Technical problems|0|||
145975740|NCT05248386|526422320|FG001|Overall Study|Technical problems|1|||
145975741|NCT05248386|526422319|FG000|Overall Study|Withdrawal by Subject|15|||
145975742|NCT05248386|526422320|FG001|Overall Study|Withdrawal by Subject|10|||
145975743|NCT05248386|526422319|FG000|Overall Study|Physician Decision|0|||
146242704|NCT02159989|527403404|FG000|Overall Study|New treatment|0|||
145975744|NCT05248386|526422320|FG001|Overall Study|Physician Decision|1|||
145975745|NCT05248386|526422319|FG000|Overall Study|Adverse Event|2|||
145922391|NCT00460603|526224172|FG000|Phase 1|Death|1|||
145922392|NCT00460603|526224173|FG001|Phase 1|Death|0|||
145922393|NCT00460603|526224174|FG002|Phase 1|Death|0|||
145922394|NCT00460603|526224175|FG003|Phase 1|Death|2|||
145922395|NCT00460603|526224176|FG004|Phase 1|Death|0|||
145922396|NCT00460603|526224177|FG005|Phase 1|Death|0|||
145922397|NCT00460603|526224178|FG006|Phase 1|Death|0|||
145922398|NCT00460603|526224179|FG007|Phase 1|Death|0|||
145922399|NCT00460603|526224180|FG008|Phase 1|Death|1|||
145922400|NCT00460603|526224181|FG009|Phase 1|Death|0|||
145922401|NCT00460603|526224182|FG010|Phase 1|Death|0|||
145922402|NCT00460603|526224183|FG011|Phase 1|Death|0|||
145922403|NCT00460603|526224172|FG000|Phase 1|Adverse Event|3|||
145922404|NCT00460603|526224173|FG001|Phase 1|Adverse Event|1|||
145922405|NCT00460603|526224174|FG002|Phase 1|Adverse Event|1|||
145922406|NCT00460603|526224175|FG003|Phase 1|Adverse Event|2|||
146242705|NCT02159989|527403405|FG001|Overall Study|New treatment|1|||
146242706|NCT02159989|527403406|FG002|Overall Study|New treatment|0|||
146242707|NCT02159989|527403407|FG003|Overall Study|New treatment|0|||
146242708|NCT02159989|527403408|FG004|Overall Study|New treatment|0|||
145922407|NCT00460603|526224176|FG004|Phase 1|Adverse Event|0|||
145922408|NCT00460603|526224177|FG005|Phase 1|Adverse Event|0|||
145922409|NCT00460603|526224178|FG006|Phase 1|Adverse Event|3|||
145922410|NCT00460603|526224179|FG007|Phase 1|Adverse Event|0|||
146242709|NCT02159989|527403409|FG005|Overall Study|New treatment|0|||
146242710|NCT02159989|527403410|FG006|Overall Study|New treatment|0|||
146242711|NCT02159989|527403411|FG007|Overall Study|New treatment|0|||
146242712|NCT02159989|527403412|FG008|Overall Study|New treatment|0|||
146242713|NCT02159989|527403413|FG009|Overall Study|New treatment|0|||
146242714|NCT02159989|527403414|FG010|Overall Study|New treatment|0|||
146242715|NCT02159989|527403404|FG000|Overall Study|Insurance Issues|0|||
146242716|NCT02159989|527403405|FG001|Overall Study|Insurance Issues|0|||
146242717|NCT02159989|527403406|FG002|Overall Study|Insurance Issues|0|||
146297713|NCT03901053|527604783|FG001|Overall Study|Subject's Medical Status|1|||
146297714|NCT03901053|527604782|FG000|Overall Study|Screening Failure|1|||
145922411|NCT00460603|526224180|FG008|Phase 1|Adverse Event|4|||
145922412|NCT00460603|526224181|FG009|Phase 1|Adverse Event|0|||
145922413|NCT00460603|526224182|FG010|Phase 1|Adverse Event|0|||
145922414|NCT00460603|526224183|FG011|Phase 1|Adverse Event|0|||
145922415|NCT00460603|526224172|FG000|Phase 1|Lack of Efficacy|1|||
145922416|NCT00460603|526224173|FG001|Phase 1|Lack of Efficacy|0|||
145922417|NCT00460603|526224174|FG002|Phase 1|Lack of Efficacy|1|||
145922418|NCT00460603|526224175|FG003|Phase 1|Lack of Efficacy|2|||
145922419|NCT00460603|526224176|FG004|Phase 1|Lack of Efficacy|2|||
145922420|NCT00460603|526224177|FG005|Phase 1|Lack of Efficacy|2|||
145922421|NCT00460603|526224178|FG006|Phase 1|Lack of Efficacy|2|||
145922422|NCT00460603|526224179|FG007|Phase 1|Lack of Efficacy|2|||
145922423|NCT00460603|526224180|FG008|Phase 1|Lack of Efficacy|11|||
145922424|NCT00460603|526224181|FG009|Phase 1|Lack of Efficacy|0|||
145922425|NCT00460603|526224182|FG010|Phase 1|Lack of Efficacy|0|||
145922426|NCT00460603|526224183|FG011|Phase 1|Lack of Efficacy|0|||
145922427|NCT00460603|526224172|FG000|Phase 1|Withdrawal by Subject|1|||
145922428|NCT00460603|526224173|FG001|Phase 1|Withdrawal by Subject|2|||
145922429|NCT00460603|526224174|FG002|Phase 1|Withdrawal by Subject|1|||
145922430|NCT00460603|526224175|FG003|Phase 1|Withdrawal by Subject|1|||
145922431|NCT00460603|526224176|FG004|Phase 1|Withdrawal by Subject|3|||
145922432|NCT00460603|526224177|FG005|Phase 1|Withdrawal by Subject|0|||
145922433|NCT00460603|526224178|FG006|Phase 1|Withdrawal by Subject|1|||
145922434|NCT00460603|526224179|FG007|Phase 1|Withdrawal by Subject|0|||
145922435|NCT00460603|526224180|FG008|Phase 1|Withdrawal by Subject|2|||
145922436|NCT00460603|526224181|FG009|Phase 1|Withdrawal by Subject|0|||
145922437|NCT00460603|526224182|FG010|Phase 1|Withdrawal by Subject|0|||
146242718|NCT02159989|527403407|FG003|Overall Study|Insurance Issues|0|||
146297715|NCT03901053|527604783|FG001|Overall Study|Screening Failure|0|||
145922438|NCT00460603|526224183|FG011|Phase 1|Withdrawal by Subject|0|||
145922439|NCT00460603|526224172|FG000|Phase 1|Other|0|||
145922440|NCT00460603|526224173|FG001|Phase 1|Other|3|||
145922441|NCT00460603|526224174|FG002|Phase 1|Other|1|||
145975746|NCT05248386|526422320|FG001|Overall Study|Adverse Event|4|||
145922442|NCT00460603|526224175|FG003|Phase 1|Other|1|||
145922443|NCT00460603|526224176|FG004|Phase 1|Other|1|||
145922444|NCT00460603|526224177|FG005|Phase 1|Other|2|||
145922445|NCT00460603|526224178|FG006|Phase 1|Other|0|||
145922446|NCT00460603|526224179|FG007|Phase 1|Other|1|||
145922447|NCT00460603|526224180|FG008|Phase 1|Other|0|||
145922448|NCT00460603|526224181|FG009|Phase 1|Other|0|||
145922449|NCT00460603|526224182|FG010|Phase 1|Other|0|||
145922450|NCT00460603|526224183|FG011|Phase 1|Other|0|||
145922451|NCT00460603|526224172|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922452|NCT00460603|526224173|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922453|NCT00460603|526224174|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922454|NCT00460603|526224175|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922455|NCT00460603|526224176|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922456|NCT00460603|526224177|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922457|NCT00460603|526224178|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
146242719|NCT02159989|527403408|FG004|Overall Study|Insurance Issues|0|||
146089546|NCT00076024|526849208|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
146089547|NCT00076024|526849209|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
146089548|NCT00076024|526849210|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
146089549|NCT00076024|526849207|FG000|Phase 1, Lead-in|Adverse Event|1|||
146089550|NCT00076024|526849208|FG001|Phase 1, Lead-in|Adverse Event|0|||
146089551|NCT00076024|526849209|FG002|Phase 1, Lead-in|Adverse Event|0|||
146089552|NCT00076024|526849210|FG003|Phase 1, Lead-in|Adverse Event|0|||
146089553|NCT00076024|526849207|FG000|Phase 1, Lead-in|Clinical progression|1|||
146089554|NCT00076024|526849208|FG001|Phase 1, Lead-in|Clinical progression|0|||
146089555|NCT00076024|526849209|FG002|Phase 1, Lead-in|Clinical progression|0|||
146089556|NCT00076024|526849210|FG003|Phase 1, Lead-in|Clinical progression|0|||
146089557|NCT00076024|526849207|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
146089558|NCT00076024|526849208|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
146089559|NCT00076024|526849209|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
146089560|NCT00076024|526849210|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
146089561|NCT00076024|526849207|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
146089562|NCT00076024|526849208|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
146089563|NCT00076024|526849209|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
146089564|NCT00076024|526849210|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
146089565|NCT00076024|526849207|FG000|Phase 2, Double-blind|Adverse Event|0|||
146089566|NCT00076024|526849208|FG001|Phase 2, Double-blind|Adverse Event|25|||
146089567|NCT00076024|526849209|FG002|Phase 2, Double-blind|Adverse Event|6|||
146089568|NCT00076024|526849210|FG003|Phase 2, Double-blind|Adverse Event|0|||
146089569|NCT00076024|526849207|FG000|Phase 2, Double-blind|Un-specified|0|||
146089570|NCT00076024|526849208|FG001|Phase 2, Double-blind|Un-specified|14|||
146089571|NCT00076024|526849209|FG002|Phase 2, Double-blind|Un-specified|6|||
146089572|NCT00076024|526849210|FG003|Phase 2, Double-blind|Un-specified|0|||
145975747|NCT05248386|526422319|FG000|Overall Study|Other|1|||
145975748|NCT05248386|526422320|FG001|Overall Study|Other|0|||
145975749|NCT05248386|526422319|FG000|Overall Study|Lack of Efficacy|14|||
145975750|NCT05248386|526422320|FG001|Overall Study|Lack of Efficacy|12|||
145975751|NCT02864992|526422321|FG000|Overall Study|still on treatment|15|||
145975752|NCT02864992|526422322|FG001|Overall Study|still on treatment|1|||
145975753|NCT02864992|526422323|FG002|Overall Study|still on treatment|33|||
145975754|NCT03621592|526422324|FG000|Overall Study|Lost to Follow-up|1|||
145975755|NCT03621592|526422325|FG001|Overall Study|Lost to Follow-up|0|||
145975756|NCT03621592|526422324|FG000|Overall Study|Lack of Improvement|1|||
145975757|NCT03621592|526422325|FG001|Overall Study|Lack of Improvement|0|||
145975758|NCT03621592|526422324|FG000|Overall Study|Preference to receive wound care closer to home|1|||
145975759|NCT03621592|526422325|FG001|Overall Study|Preference to receive wound care closer to home|0|||
145975760|NCT03621592|526422324|FG000|Overall Study|Lack of healing|0|||
145975761|NCT03621592|526422325|FG001|Overall Study|Lack of healing|2|||
145975762|NCT04967222|526422327|FG000|Randomized|Lost to Follow-up|0|||
146089573|NCT00076024|526849207|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
146089574|NCT00076024|526849208|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
146089575|NCT00076024|526849209|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
146089576|NCT00076024|526849210|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
146089577|NCT00076024|526849207|FG000|Phase 2, Open-label|Adverse Event|0|||
146089578|NCT00076024|526849208|FG001|Phase 2, Open-label|Adverse Event|0|||
146089579|NCT00076024|526849209|FG002|Phase 2, Open-label|Adverse Event|0|||
146089580|NCT00076024|526849210|FG003|Phase 2, Open-label|Adverse Event|2|||
146089581|NCT00076024|526849207|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
146089582|NCT00076024|526849208|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
146089583|NCT00076024|526849209|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
146089584|NCT00076024|526849210|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
146089585|NCT00076024|526849207|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
146089586|NCT00076024|526849208|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
146089587|NCT00076024|526849209|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
146089588|NCT00076024|526849210|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
145975763|NCT04967222|526422328|FG001|Randomized|Lost to Follow-up|1|||
146089589|NCT00076024|526849207|FG000|Phase 2, Open-label|Other|0|||
146089590|NCT00076024|526849208|FG001|Phase 2, Open-label|Other|0|||
146089591|NCT00076024|526849209|FG002|Phase 2, Open-label|Other|0|||
146089592|NCT00076024|526849210|FG003|Phase 2, Open-label|Other|2|||
146089593|NCT00301821|526849217|FG000|Overall Study|Ineligible|25|||
146089594|NCT00301821|526849217|FG000|Overall Study|Cancel|1|||
146089595|NCT02294773|526849218|FG000|Overall Study|Withdrawal by Subject|0|||
146089596|NCT02294773|526849219|FG001|Overall Study|Withdrawal by Subject|2|||
146089597|NCT03052764|526849220|FG000|Double-Blind Treatment Period|Adverse Event|2|||
146089598|NCT03052764|526849221|FG001|Double-Blind Treatment Period|Adverse Event|0|||
146089599|NCT03052764|526849220|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
146242720|NCT02159989|527403409|FG005|Overall Study|Insurance Issues|0|||
146242721|NCT02159989|527403410|FG006|Overall Study|Insurance Issues|0|||
145975764|NCT04967222|526422329|FG002|Randomized|Lost to Follow-up|1|||
145975765|NCT04967222|526422327|FG000|Randomized|Physician Decision|0|||
145975766|NCT04967222|526422328|FG001|Randomized|Physician Decision|0|||
145975767|NCT04967222|526422329|FG002|Randomized|Physician Decision|1|||
146242722|NCT02159989|527403411|FG007|Overall Study|Insurance Issues|0|||
146242723|NCT02159989|527403412|FG008|Overall Study|Insurance Issues|0|||
146242724|NCT02159989|527403413|FG009|Overall Study|Insurance Issues|1|||
146242725|NCT02159989|527403414|FG010|Overall Study|Insurance Issues|0|||
146242726|NCT05338476|527403416|FG000|Period 2|Adverse Event|0|||
146242727|NCT05338476|527403417|FG001|Period 2|Adverse Event|1|||
146242728|NCT05289037|527403420|FG000|Overall Study|Withdrawal by Subject|7|||
146242729|NCT05289037|527403421|FG001|Overall Study|Withdrawal by Subject|0|||
146242730|NCT05289037|527403422|FG002|Overall Study|Withdrawal by Subject|3|||
146242731|NCT05289037|527403423|FG003|Overall Study|Withdrawal by Subject|3|||
146242732|NCT05289037|527403424|FG004|Overall Study|Withdrawal by Subject|1|||
146242733|NCT05289037|527403425|FG005|Overall Study|Withdrawal by Subject|5|||
146242734|NCT05289037|527403426|FG006|Overall Study|Withdrawal by Subject|2|||
146242735|NCT05289037|527403427|FG007|Overall Study|Withdrawal by Subject|1|||
146242736|NCT05289037|527403428|FG008|Overall Study|Withdrawal by Subject|2|||
146242737|NCT05289037|527403429|FG009|Overall Study|Withdrawal by Subject|2|||
146242738|NCT05289037|527403430|FG010|Overall Study|Withdrawal by Subject|1|||
146242739|NCT05289037|527403431|FG011|Overall Study|Withdrawal by Subject|0|||
146242740|NCT05289037|527403432|FG012|Overall Study|Withdrawal by Subject|1|||
146242741|NCT05289037|527403433|FG013|Overall Study|Withdrawal by Subject|2|||
146242742|NCT05289037|527403434|FG014|Overall Study|Withdrawal by Subject|0|||
146242743|NCT05289037|527403435|FG015|Overall Study|Withdrawal by Subject|3|||
146242744|NCT05289037|527403436|FG016|Overall Study|Withdrawal by Subject|3|||
146242745|NCT05289037|527403420|FG000|Overall Study|Lost to Follow-up|1|||
146242746|NCT05289037|527403421|FG001|Overall Study|Lost to Follow-up|4|||
146242747|NCT05289037|527403422|FG002|Overall Study|Lost to Follow-up|3|||
146242748|NCT05289037|527403423|FG003|Overall Study|Lost to Follow-up|3|||
146242749|NCT05289037|527403424|FG004|Overall Study|Lost to Follow-up|3|||
146242750|NCT05289037|527403425|FG005|Overall Study|Lost to Follow-up|2|||
146242751|NCT05289037|527403426|FG006|Overall Study|Lost to Follow-up|3|||
146242752|NCT05289037|527403427|FG007|Overall Study|Lost to Follow-up|2|||
146242753|NCT05289037|527403428|FG008|Overall Study|Lost to Follow-up|2|||
146242754|NCT05289037|527403429|FG009|Overall Study|Lost to Follow-up|1|||
146242755|NCT05289037|527403430|FG010|Overall Study|Lost to Follow-up|3|||
146242756|NCT05289037|527403431|FG011|Overall Study|Lost to Follow-up|4|||
146242757|NCT05289037|527403432|FG012|Overall Study|Lost to Follow-up|2|||
146242758|NCT05289037|527403433|FG013|Overall Study|Lost to Follow-up|7|||
146242759|NCT05289037|527403434|FG014|Overall Study|Lost to Follow-up|4|||
146242760|NCT05289037|527403435|FG015|Overall Study|Lost to Follow-up|6|||
146242761|NCT05289037|527403436|FG016|Overall Study|Lost to Follow-up|4|||
146242762|NCT05289037|527403420|FG000|Overall Study|Death|0|||
146242763|NCT05289037|527403421|FG001|Overall Study|Death|0|||
146242764|NCT05289037|527403422|FG002|Overall Study|Death|0|||
146242765|NCT05289037|527403423|FG003|Overall Study|Death|0|||
146242766|NCT05289037|527403424|FG004|Overall Study|Death|0|||
146242767|NCT05289037|527403425|FG005|Overall Study|Death|1|||
146242768|NCT05289037|527403426|FG006|Overall Study|Death|0|||
146242769|NCT05289037|527403427|FG007|Overall Study|Death|0|||
146242770|NCT05289037|527403428|FG008|Overall Study|Death|0|||
146242771|NCT05289037|527403429|FG009|Overall Study|Death|0|||
146242772|NCT05289037|527403430|FG010|Overall Study|Death|0|||
146242773|NCT05289037|527403431|FG011|Overall Study|Death|0|||
146242774|NCT05289037|527403432|FG012|Overall Study|Death|0|||
146242775|NCT05289037|527403433|FG013|Overall Study|Death|0|||
146242776|NCT05289037|527403434|FG014|Overall Study|Death|1|||
146242777|NCT05289037|527403435|FG015|Overall Study|Death|0|||
146242778|NCT05289037|527403436|FG016|Overall Study|Death|0|||
146242779|NCT05289037|527403420|FG000|Overall Study|Did not receive vaccine|0|||
146242780|NCT05289037|527403421|FG001|Overall Study|Did not receive vaccine|3|||
146242781|NCT05289037|527403422|FG002|Overall Study|Did not receive vaccine|0|||
146242782|NCT05289037|527403423|FG003|Overall Study|Did not receive vaccine|0|||
146242783|NCT05289037|527403424|FG004|Overall Study|Did not receive vaccine|1|||
146242784|NCT05289037|527403425|FG005|Overall Study|Did not receive vaccine|1|||
146242785|NCT05289037|527403426|FG006|Overall Study|Did not receive vaccine|1|||
146242786|NCT05289037|527403427|FG007|Overall Study|Did not receive vaccine|0|||
146242787|NCT05289037|527403428|FG008|Overall Study|Did not receive vaccine|0|||
146242788|NCT05289037|527403429|FG009|Overall Study|Did not receive vaccine|0|||
146242789|NCT05289037|527403430|FG010|Overall Study|Did not receive vaccine|0|||
146242790|NCT05289037|527403431|FG011|Overall Study|Did not receive vaccine|0|||
146242791|NCT05289037|527403432|FG012|Overall Study|Did not receive vaccine|0|||
146242792|NCT05289037|527403433|FG013|Overall Study|Did not receive vaccine|0|||
146242793|NCT05289037|527403434|FG014|Overall Study|Did not receive vaccine|1|||
146242794|NCT05289037|527403435|FG015|Overall Study|Did not receive vaccine|0|||
146297716|NCT01306890|527605964|FG000|Overall Study|Adverse Event|2|||
146297717|NCT01306890|527605964|FG000|Overall Study|Death|1223|||
146242795|NCT05289037|527403436|FG016|Overall Study|Did not receive vaccine|0|||
146242796|NCT05289037|527403420|FG000|Overall Study|Unable to make last visit|0|||
146242797|NCT05289037|527403421|FG001|Overall Study|Unable to make last visit|0|||
146242798|NCT05289037|527403422|FG002|Overall Study|Unable to make last visit|1|||
146242799|NCT05289037|527403423|FG003|Overall Study|Unable to make last visit|0|||
146242800|NCT05289037|527403424|FG004|Overall Study|Unable to make last visit|0|||
146242801|NCT05289037|527403425|FG005|Overall Study|Unable to make last visit|0|||
146242802|NCT05289037|527403426|FG006|Overall Study|Unable to make last visit|0|||
146242803|NCT05289037|527403427|FG007|Overall Study|Unable to make last visit|0|||
146242804|NCT05289037|527403428|FG008|Overall Study|Unable to make last visit|0|||
146242805|NCT05289037|527403429|FG009|Overall Study|Unable to make last visit|0|||
146242806|NCT05289037|527403430|FG010|Overall Study|Unable to make last visit|0|||
146242807|NCT05289037|527403431|FG011|Overall Study|Unable to make last visit|0|||
145922458|NCT00460603|526224179|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922459|NCT00460603|526224180|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922460|NCT00460603|526224181|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
145922461|NCT00460603|526224182|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922462|NCT00460603|526224183|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145922463|NCT00460603|526224172|FG000|Phase 2|Adverse Event|0|||
145922464|NCT00460603|526224173|FG001|Phase 2|Adverse Event|0|||
145922465|NCT00460603|526224174|FG002|Phase 2|Adverse Event|0|||
145922466|NCT00460603|526224175|FG003|Phase 2|Adverse Event|0|||
146242808|NCT05289037|527403432|FG012|Overall Study|Unable to make last visit|0|||
146242809|NCT05289037|527403433|FG013|Overall Study|Unable to make last visit|0|||
146242810|NCT05289037|527403434|FG014|Overall Study|Unable to make last visit|0|||
146242811|NCT05289037|527403435|FG015|Overall Study|Unable to make last visit|0|||
146242812|NCT05289037|527403436|FG016|Overall Study|Unable to make last visit|0|||
146242813|NCT05289037|527403420|FG000|Overall Study|Protocol deviation|0|||
146242814|NCT05289037|527403421|FG001|Overall Study|Protocol deviation|0|||
146242815|NCT05289037|527403422|FG002|Overall Study|Protocol deviation|0|||
146242816|NCT05289037|527403423|FG003|Overall Study|Protocol deviation|0|||
146242817|NCT05289037|527403424|FG004|Overall Study|Protocol deviation|0|||
146242818|NCT05289037|527403425|FG005|Overall Study|Protocol deviation|0|||
146242819|NCT05289037|527403426|FG006|Overall Study|Protocol deviation|0|||
145922467|NCT00460603|526224176|FG004|Phase 2|Adverse Event|0|||
145922468|NCT00460603|526224177|FG005|Phase 2|Adverse Event|0|||
145922469|NCT00460603|526224178|FG006|Phase 2|Adverse Event|0|||
145922470|NCT00460603|526224179|FG007|Phase 2|Adverse Event|0|||
145922471|NCT00460603|526224180|FG008|Phase 2|Adverse Event|0|||
145922472|NCT00460603|526224181|FG009|Phase 2|Adverse Event|12|||
145922473|NCT00460603|526224182|FG010|Phase 2|Adverse Event|9|||
145922474|NCT00460603|526224183|FG011|Phase 2|Adverse Event|10|||
145922475|NCT00460603|526224172|FG000|Phase 2|Death|0|||
145922476|NCT00460603|526224173|FG001|Phase 2|Death|0|||
145922477|NCT00460603|526224174|FG002|Phase 2|Death|0|||
145922478|NCT00460603|526224175|FG003|Phase 2|Death|0|||
146242820|NCT05289037|527403427|FG007|Overall Study|Protocol deviation|0|||
146242821|NCT05289037|527403428|FG008|Overall Study|Protocol deviation|0|||
146242822|NCT05289037|527403429|FG009|Overall Study|Protocol deviation|0|||
146242823|NCT05289037|527403430|FG010|Overall Study|Protocol deviation|0|||
146242824|NCT05289037|527403431|FG011|Overall Study|Protocol deviation|0|||
146242825|NCT05289037|527403432|FG012|Overall Study|Protocol deviation|0|||
146242826|NCT05289037|527403433|FG013|Overall Study|Protocol deviation|0|||
146242827|NCT05289037|527403434|FG014|Overall Study|Protocol deviation|0|||
146242828|NCT05289037|527403435|FG015|Overall Study|Protocol deviation|1|||
146242829|NCT05289037|527403436|FG016|Overall Study|Protocol deviation|0|||
146242830|NCT00070707|527405242|FG000|Overall Study|Adverse Event|1|||
146242831|NCT00070707|527405243|FG001|Overall Study|Adverse Event|2|||
146242832|NCT00070707|527405242|FG000|Overall Study|Lack of Efficacy|4|||
146242833|NCT00070707|527405243|FG001|Overall Study|Lack of Efficacy|1|||
146242834|NCT00070707|527405242|FG000|Overall Study|Protocol Violation|8|||
146242835|NCT00070707|527405243|FG001|Overall Study|Protocol Violation|4|||
146242836|NCT00070707|527405242|FG000|Overall Study|Unrelated to Study Medication|1|||
145922479|NCT00460603|526224176|FG004|Phase 2|Death|0|||
145922480|NCT00460603|526224177|FG005|Phase 2|Death|0|||
145922481|NCT00460603|526224178|FG006|Phase 2|Death|0|||
145922482|NCT00460603|526224179|FG007|Phase 2|Death|0|||
145922483|NCT00460603|526224180|FG008|Phase 2|Death|0|||
146089600|NCT03052764|526849221|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
146242837|NCT00070707|527405243|FG001|Overall Study|Unrelated to Study Medication|0|||
146242838|NCT00670449|527405244|FG000|Overall Study|Adverse Event|6|||
146242839|NCT00670449|527405245|FG001|Overall Study|Adverse Event|2|||
146242840|NCT00670449|527405246|FG002|Overall Study|Adverse Event|8|||
146242841|NCT00670449|527405247|FG003|Overall Study|Adverse Event|5|||
145922484|NCT00460603|526224181|FG009|Phase 2|Death|4|||
145922485|NCT00460603|526224182|FG010|Phase 2|Death|2|||
145922486|NCT00460603|526224183|FG011|Phase 2|Death|2|||
145922487|NCT00460603|526224172|FG000|Phase 2|Protocol Violation|0|||
145922488|NCT00460603|526224173|FG001|Phase 2|Protocol Violation|0|||
146242842|NCT00670449|527405244|FG000|Overall Study|Protocol Deviation|1|||
146242843|NCT00670449|527405245|FG001|Overall Study|Protocol Deviation|2|||
145922489|NCT00460603|526224174|FG002|Phase 2|Protocol Violation|0|||
145922490|NCT00460603|526224175|FG003|Phase 2|Protocol Violation|0|||
146242844|NCT00670449|527405246|FG002|Overall Study|Protocol Deviation|0|||
146242845|NCT00670449|527405247|FG003|Overall Study|Protocol Deviation|1|||
146242846|NCT00670449|527405244|FG000|Overall Study|Administrative Problems|0|||
146242847|NCT00670449|527405245|FG001|Overall Study|Administrative Problems|2|||
146297718|NCT01306890|527605964|FG000|Overall Study|Lost to Follow-up|58|||
146297719|NCT01306890|527605964|FG000|Overall Study|Withdrawal by Subject|88|||
146297720|NCT01306890|527605964|FG000|Overall Study|Unspecified reasons|104|||
146297721|NCT01306890|527605964|FG000|Overall Study|Study Termination|3|||
146297722|NCT01306890|527605964|FG000|Overall Study|No discontinuation documentation|41|||
146297723|NCT02217436|527605965|FG000|Overall Study|Protocol Violation|1|||
146297724|NCT02217436|527605966|FG001|Overall Study|Protocol Violation|1|||
145922491|NCT00460603|526224176|FG004|Phase 2|Protocol Violation|0|||
145922492|NCT00460603|526224177|FG005|Phase 2|Protocol Violation|0|||
145922493|NCT00460603|526224178|FG006|Phase 2|Protocol Violation|0|||
145922494|NCT00460603|526224179|FG007|Phase 2|Protocol Violation|0|||
145922495|NCT00460603|526224180|FG008|Phase 2|Protocol Violation|0|||
145922496|NCT00460603|526224181|FG009|Phase 2|Protocol Violation|1|||
145922497|NCT00460603|526224182|FG010|Phase 2|Protocol Violation|1|||
145922498|NCT00460603|526224183|FG011|Phase 2|Protocol Violation|0|||
145922499|NCT00460603|526224172|FG000|Phase 2|Lost to Follow-up|0|||
145922500|NCT00460603|526224173|FG001|Phase 2|Lost to Follow-up|0|||
145922501|NCT00460603|526224174|FG002|Phase 2|Lost to Follow-up|0|||
145922502|NCT00460603|526224175|FG003|Phase 2|Lost to Follow-up|0|||
145922503|NCT00460603|526224176|FG004|Phase 2|Lost to Follow-up|0|||
145922504|NCT00460603|526224177|FG005|Phase 2|Lost to Follow-up|0|||
145922505|NCT00460603|526224178|FG006|Phase 2|Lost to Follow-up|0|||
145922506|NCT00460603|526224179|FG007|Phase 2|Lost to Follow-up|0|||
145922507|NCT00460603|526224180|FG008|Phase 2|Lost to Follow-up|0|||
145922508|NCT00460603|526224181|FG009|Phase 2|Lost to Follow-up|1|||
145922509|NCT00460603|526224182|FG010|Phase 2|Lost to Follow-up|0|||
145922510|NCT00460603|526224183|FG011|Phase 2|Lost to Follow-up|0|||
145922511|NCT00460603|526224172|FG000|Phase 2|Other|0|||
145922512|NCT00460603|526224173|FG001|Phase 2|Other|0|||
145922513|NCT00460603|526224174|FG002|Phase 2|Other|0|||
145922514|NCT00460603|526224175|FG003|Phase 2|Other|0|||
145922515|NCT00460603|526224176|FG004|Phase 2|Other|0|||
145922516|NCT00460603|526224177|FG005|Phase 2|Other|0|||
145922517|NCT00460603|526224178|FG006|Phase 2|Other|0|||
145922518|NCT00460603|526224179|FG007|Phase 2|Other|0|||
145922519|NCT00460603|526224180|FG008|Phase 2|Other|0|||
145922520|NCT00460603|526224181|FG009|Phase 2|Other|6|||
145922521|NCT00460603|526224182|FG010|Phase 2|Other|16|||
145922522|NCT00460603|526224183|FG011|Phase 2|Other|7|||
145922523|NCT00460603|526224172|FG000|Phase 2|Objective Progression or Relapse|0|||
145922524|NCT00460603|526224173|FG001|Phase 2|Objective Progression or Relapse|0|||
145922525|NCT00460603|526224174|FG002|Phase 2|Objective Progression or Relapse|0|||
145922526|NCT00460603|526224175|FG003|Phase 2|Objective Progression or Relapse|0|||
145922527|NCT00460603|526224176|FG004|Phase 2|Objective Progression or Relapse|0|||
145922528|NCT00460603|526224177|FG005|Phase 2|Objective Progression or Relapse|0|||
145922529|NCT00460603|526224178|FG006|Phase 2|Objective Progression or Relapse|0|||
145922530|NCT00460603|526224179|FG007|Phase 2|Objective Progression or Relapse|0|||
145922531|NCT00460603|526224180|FG008|Phase 2|Objective Progression or Relapse|0|||
145922532|NCT00460603|526224181|FG009|Phase 2|Objective Progression or Relapse|9|||
145922533|NCT00460603|526224182|FG010|Phase 2|Objective Progression or Relapse|10|||
145922534|NCT00460603|526224183|FG011|Phase 2|Objective Progression or Relapse|17|||
145922535|NCT00460603|526224172|FG000|Phase 2|Global Deterioration of Health Status|0|||
145922536|NCT00460603|526224173|FG001|Phase 2|Global Deterioration of Health Status|0|||
145922537|NCT00460603|526224174|FG002|Phase 2|Global Deterioration of Health Status|0|||
145922538|NCT00460603|526224175|FG003|Phase 2|Global Deterioration of Health Status|0|||
145922539|NCT00460603|526224176|FG004|Phase 2|Global Deterioration of Health Status|0|||
145922540|NCT00460603|526224177|FG005|Phase 2|Global Deterioration of Health Status|0|||
145922541|NCT00460603|526224178|FG006|Phase 2|Global Deterioration of Health Status|0|||
145922542|NCT00460603|526224179|FG007|Phase 2|Global Deterioration of Health Status|0|||
145922543|NCT00460603|526224180|FG008|Phase 2|Global Deterioration of Health Status|0|||
145922544|NCT00460603|526224181|FG009|Phase 2|Global Deterioration of Health Status|0|||
145922545|NCT00460603|526224182|FG010|Phase 2|Global Deterioration of Health Status|1|||
145922546|NCT00460603|526224183|FG011|Phase 2|Global Deterioration of Health Status|0|||
145922547|NCT00460603|526224172|FG000|Phase 2|Withdrawal by Subject|0|||
145975768|NCT04967222|526422327|FG000|Randomized|Withdrawal by Subject|0|||
145922548|NCT00460603|526224173|FG001|Phase 2|Withdrawal by Subject|0|||
145922549|NCT00460603|526224174|FG002|Phase 2|Withdrawal by Subject|0|||
145922550|NCT00460603|526224175|FG003|Phase 2|Withdrawal by Subject|0|||
145922551|NCT00460603|526224176|FG004|Phase 2|Withdrawal by Subject|0|||
145922552|NCT00460603|526224177|FG005|Phase 2|Withdrawal by Subject|0|||
145922553|NCT00460603|526224178|FG006|Phase 2|Withdrawal by Subject|0|||
145922554|NCT00460603|526224179|FG007|Phase 2|Withdrawal by Subject|0|||
145922555|NCT00460603|526224180|FG008|Phase 2|Withdrawal by Subject|0|||
146297725|NCT02217436|527605965|FG000|Overall Study|Incomplete data|0|||
146297726|NCT02217436|527605966|FG001|Overall Study|Incomplete data|1|||
145922556|NCT00460603|526224181|FG009|Phase 2|Withdrawal by Subject|5|||
145922557|NCT00460603|526224182|FG010|Phase 2|Withdrawal by Subject|4|||
145922558|NCT00460603|526224183|FG011|Phase 2|Withdrawal by Subject|5|||
145922559|NCT00460603|526224172|FG000|Phase 2|Randomized, but not treated|0|||
145922560|NCT00460603|526224173|FG001|Phase 2|Randomized, but not treated|0|||
146297727|NCT01890148|527605967|FG000|Overall Study|Adverse Event|1|||
146242848|NCT00670449|527405246|FG002|Overall Study|Administrative Problems|0|||
146242849|NCT00670449|527405247|FG003|Overall Study|Administrative Problems|1|||
146242850|NCT00670449|527405244|FG000|Overall Study|Subject Withdrew Consent|0|||
146242851|NCT00670449|527405245|FG001|Overall Study|Subject Withdrew Consent|2|||
146242852|NCT00670449|527405246|FG002|Overall Study|Subject Withdrew Consent|0|||
146242853|NCT00670449|527405247|FG003|Overall Study|Subject Withdrew Consent|1|||
146242854|NCT00670449|527405244|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
146242855|NCT00670449|527405245|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146242856|NCT00670449|527405246|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146242857|NCT00670449|527405247|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146242858|NCT00670449|527405244|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146242859|NCT00670449|527405245|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
146242860|NCT00670449|527405246|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146242861|NCT00670449|527405247|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146242862|NCT03690219|527405248|FG000|Overall Study|no injuries|9|||
146242863|NCT03690219|527405249|FG001|Overall Study|no injuries|20|||
146242864|NCT03690219|527405248|FG000|Overall Study|missing information|7|||
146242865|NCT03690219|527405249|FG001|Overall Study|missing information|7|||
146242866|NCT04809623|527405250|FG000|Overall Study|Study Terminated by Sponsor|1|||
146242867|NCT04809623|527405251|FG001|Overall Study|Study Terminated by Sponsor|0|||
146242868|NCT00413283|527405252|FG000|Overall Study|Withdrawal by Subject|1|||
146242869|NCT00413283|527405253|FG001|Overall Study|Withdrawal by Subject|0|||
146242870|NCT00413283|527405254|FG002|Overall Study|Withdrawal by Subject|0|||
146242871|NCT00413283|527405255|FG003|Overall Study|Withdrawal by Subject|1|||
146242872|NCT00413283|527405252|FG000|Overall Study|Death|0|||
146242873|NCT00413283|527405253|FG001|Overall Study|Death|0|||
146242874|NCT00413283|527405254|FG002|Overall Study|Death|1|||
146242875|NCT00413283|527405255|FG003|Overall Study|Death|1|||
146242876|NCT00413283|527405252|FG000|Overall Study|Adverse Event|0|||
146242877|NCT00413283|527405253|FG001|Overall Study|Adverse Event|0|||
146242878|NCT00413283|527405254|FG002|Overall Study|Adverse Event|0|||
145922561|NCT00460603|526224174|FG002|Phase 2|Randomized, but not treated|0|||
145922562|NCT00460603|526224175|FG003|Phase 2|Randomized, but not treated|0|||
145922563|NCT00460603|526224176|FG004|Phase 2|Randomized, but not treated|0|||
145922564|NCT00460603|526224177|FG005|Phase 2|Randomized, but not treated|0|||
145922565|NCT00460603|526224178|FG006|Phase 2|Randomized, but not treated|0|||
145922566|NCT00460603|526224179|FG007|Phase 2|Randomized, but not treated|0|||
145922567|NCT00460603|526224180|FG008|Phase 2|Randomized, but not treated|0|||
145922568|NCT00460603|526224181|FG009|Phase 2|Randomized, but not treated|3|||
145922569|NCT00460603|526224182|FG010|Phase 2|Randomized, but not treated|0|||
145922570|NCT00460603|526224183|FG011|Phase 2|Randomized, but not treated|0|||
145922571|NCT03003962|526224184|FG000|Overall Study|Withdrawal by Subject|5|||
145922572|NCT03003962|526224185|FG001|Overall Study|Withdrawal by Subject|17|||
145922573|NCT03003962|526224184|FG000|Overall Study|Death|274|||
145922574|NCT03003962|526224185|FG001|Overall Study|Death|277|||
145922575|NCT03003962|526224184|FG000|Overall Study|Participants ongoing at DCO|55|||
145922576|NCT03003962|526224185|FG001|Overall Study|Participants ongoing at DCO|40|||
145922577|NCT03871543|526224186|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
145922578|NCT03871543|526224186|FG000|Period 1|Investigator Error|1|||
145922579|NCT03871543|526224186|FG000|Period 1|Protocol Violation|2|||
145922580|NCT03871543|526224186|FG000|Period 1|COVID-19 Related|1|||
145922581|NCT03871543|526224186|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
145922582|NCT03871543|526224186|FG000|Period 1|Withdrawal by Subject|10|||
145922583|NCT03871543|526224186|FG000|Period 2|Adverse Event|1|||
145922584|NCT03871543|526224186|FG000|Period 2|Withdrawal by Subject|1|||
145922585|NCT03802825|526224189|FG000|Overall Study|Lost to follow-up for intervention|12|||
145922586|NCT03802825|526224190|FG001|Overall Study|Lost to follow-up for intervention|3|||
145922587|NCT03802825|526224189|FG000|Overall Study|Received only 1 component of intervention|0|||
145922588|NCT03802825|526224190|FG001|Overall Study|Received only 1 component of intervention|13|||
145922589|NCT01051960|526224191|FG000|Overall Study|Adverse Event|1|||
145922590|NCT04537078|526224194|FG000|Overall Study|Protocol Violation|3|||
145922591|NCT04537078|526224195|FG001|Overall Study|Protocol Violation|2|||
145922592|NCT04537078|526224194|FG000|Overall Study|Lost to Follow-up|1|||
145922593|NCT04537078|526224195|FG001|Overall Study|Lost to Follow-up|0|||
146242879|NCT00413283|527405255|FG003|Overall Study|Adverse Event|1|||
145922594|NCT04537078|526224194|FG000|Overall Study|Withdrawal by Subject|0|||
145922595|NCT04537078|526224195|FG001|Overall Study|Withdrawal by Subject|1|||
145922596|NCT03922308|526224196|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
145922597|NCT03922308|526224197|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
145922598|NCT03922308|526224198|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
146242880|NCT00413283|527405252|FG000|Overall Study|Ineligibility determined|0|||
146242881|NCT00413283|527405253|FG001|Overall Study|Ineligibility determined|0|||
146242882|NCT00413283|527405254|FG002|Overall Study|Ineligibility determined|0|||
146242883|NCT00413283|527405255|FG003|Overall Study|Ineligibility determined|1|||
146242884|NCT00413283|527405252|FG000|Overall Study|Protocol deviation|0|||
146242885|NCT00413283|527405253|FG001|Overall Study|Protocol deviation|1|||
145975769|NCT04967222|526422328|FG001|Randomized|Withdrawal by Subject|0|||
145975770|NCT04967222|526422329|FG002|Randomized|Withdrawal by Subject|2|||
145975771|NCT04967222|526422327|FG000|Randomized|abnormal finding in MRI|0|||
145975772|NCT04967222|526422328|FG001|Randomized|abnormal finding in MRI|2|||
145975773|NCT04967222|526422329|FG002|Randomized|abnormal finding in MRI|0|||
145975774|NCT03785366|526422337|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
146242886|NCT00413283|527405254|FG002|Overall Study|Protocol deviation|0|||
146242887|NCT00413283|527405255|FG003|Overall Study|Protocol deviation|0|||
146242888|NCT00413283|527405252|FG000|Overall Study|Requirement for alternative therapy|0|||
146242889|NCT00413283|527405253|FG001|Overall Study|Requirement for alternative therapy|2|||
146242890|NCT00413283|527405254|FG002|Overall Study|Requirement for alternative therapy|0|||
146242891|NCT00413283|527405255|FG003|Overall Study|Requirement for alternative therapy|0|||
146242892|NCT00413283|527405252|FG000|Overall Study|Other|0|||
146242893|NCT00413283|527405253|FG001|Overall Study|Other|0|||
146242894|NCT00413283|527405254|FG002|Overall Study|Other|1|||
146242895|NCT00413283|527405255|FG003|Overall Study|Other|0|||
146242896|NCT02002689|527405256|FG000|Overall Study|Disease Progression|7|||
146242897|NCT02002689|527405256|FG000|Overall Study|Adverse Event|3|||
146242898|NCT00671853|527405257|FG000|Overall Study|Lack of Efficacy|3|||
146242899|NCT00671853|527405258|FG001|Overall Study|Lack of Efficacy|7|||
146242900|NCT00671853|527405257|FG000|Overall Study|Adverse Event|7|||
146242901|NCT00671853|527405258|FG001|Overall Study|Adverse Event|1|||
146242902|NCT00671853|527405257|FG000|Overall Study|Withdrawal by Subject|1|||
146242903|NCT00671853|527405258|FG001|Overall Study|Withdrawal by Subject|5|||
146242904|NCT00671853|527405257|FG000|Overall Study|Lost to Follow-up|8|||
146242905|NCT00671853|527405258|FG001|Overall Study|Lost to Follow-up|8|||
146242906|NCT00671853|527405257|FG000|Overall Study|Physician Decision|0|||
146242907|NCT00671853|527405258|FG001|Overall Study|Physician Decision|2|||
146242908|NCT00671853|527405257|FG000|Overall Study|Non-adherence with study procedures|1|||
146242909|NCT00671853|527405258|FG001|Overall Study|Non-adherence with study procedures|4|||
146242910|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
146242911|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146242912|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146242913|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146242914|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
146242915|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146242916|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146242917|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146242918|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
146242919|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146242920|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146242921|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146242922|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
146242923|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146242924|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146242925|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146242926|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
146242927|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146242928|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146242929|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146242930|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
146242931|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146242932|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146242933|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146242934|NCT01185340|527405261|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
146242935|NCT01185340|527405262|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146242936|NCT01185340|527405263|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146242937|NCT01185340|527405264|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146242938|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146242939|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146242940|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
146242941|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146242942|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146242943|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
146242944|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
146242945|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
146242946|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146242947|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
146242948|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
146242949|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
145975775|NCT03785366|526422338|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
145922599|NCT03922308|526224196|FG000|Overall Study|Lost to Follow-up|1|||
145922600|NCT03922308|526224197|FG001|Overall Study|Lost to Follow-up|0|||
145922601|NCT03922308|526224198|FG002|Overall Study|Lost to Follow-up|0|||
145922602|NCT03922308|526224196|FG000|Overall Study|Reason not Specified|0|||
145922603|NCT03922308|526224197|FG001|Overall Study|Reason not Specified|2|||
145922604|NCT03922308|526224198|FG002|Overall Study|Reason not Specified|1|||
145922605|NCT01256450|526224199|FG000|Open-label Titration|Adverse Event|39|||
145922606|NCT01256450|526224200|FG001|Open-label Titration|Adverse Event|0|||
145922607|NCT01256450|526224201|FG002|Open-label Titration|Adverse Event|0|||
145922608|NCT01256450|526224199|FG000|Open-label Titration|Lost to Follow-up|7|||
145922609|NCT01256450|526224200|FG001|Open-label Titration|Lost to Follow-up|0|||
145922610|NCT01256450|526224201|FG002|Open-label Titration|Lost to Follow-up|0|||
145922611|NCT01256450|526224199|FG000|Open-label Titration|Lack of analgesic effect|30|||
145922612|NCT01256450|526224200|FG001|Open-label Titration|Lack of analgesic effect|0|||
145922613|NCT01256450|526224201|FG002|Open-label Titration|Lack of analgesic effect|0|||
145922614|NCT01256450|526224199|FG000|Open-label Titration|Non-compliance|9|||
145975776|NCT03785366|526422337|FG000|Overall Study|Lost to Follow-up|1|||
145975777|NCT03785366|526422338|FG001|Overall Study|Lost to Follow-up|0|||
145975778|NCT03785366|526422337|FG000|Overall Study|Partial IUD Expulsion|0|||
145975779|NCT03785366|526422338|FG001|Overall Study|Partial IUD Expulsion|2|||
145975780|NCT03785366|526422337|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
145975781|NCT03785366|526422338|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
145975782|NCT03240874|526422339|FG000|Overall Study|Lost to Follow-up|0|||
145975783|NCT03240874|526422340|FG001|Overall Study|Lost to Follow-up|2|||
145975784|NCT03240874|526422341|FG002|Overall Study|Lost to Follow-up|4|||
145975785|NCT03240874|526422342|FG003|Overall Study|Lost to Follow-up|1|||
145975786|NCT05252702|526422343|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
145975787|NCT05252702|526422343|FG000|Overall Study|Death|16|||
145975788|NCT05252702|526422343|FG000|Overall Study|System explant|5|||
145975789|NCT05252702|526422343|FG000|Overall Study|Lost to Follow-up|1|||
145975790|NCT05252702|526422343|FG000|Overall Study|Withdrawn by investigator|1|||
145975791|NCT05252702|526422343|FG000|Overall Study|Visit not due|306|||
145975792|NCT05252702|526422343|FG000|Overall Study|Visit within window but not completed|92|||
145975793|NCT05252702|526422343|FG000|Overall Study|Unsuccessful implant|1|||
145975794|NCT04153864|526422344|FG000|Overall Study|Withdrawal by Subject|21|||
145975795|NCT04153864|526422345|FG001|Overall Study|Withdrawal by Subject|7|||
145975796|NCT04153864|526422346|FG002|Overall Study|Withdrawal by Subject|23|||
145975797|NCT04153864|526422347|FG003|Overall Study|Withdrawal by Subject|2|||
145975798|NCT04153864|526422344|FG000|Overall Study|Lost to Follow-up|4|||
145975799|NCT04153864|526422345|FG001|Overall Study|Lost to Follow-up|0|||
145975800|NCT04153864|526422346|FG002|Overall Study|Lost to Follow-up|3|||
145975801|NCT04153864|526422347|FG003|Overall Study|Lost to Follow-up|0|||
145975802|NCT04153864|526422344|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
145975803|NCT04153864|526422345|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
145975804|NCT04153864|526422346|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
145975805|NCT04153864|526422347|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
145975806|NCT03036254|526422348|FG000|Overall Study|Adverse Event|6|||
145975807|NCT03036254|526422349|FG001|Overall Study|Adverse Event|4|||
145975808|NCT03036254|526422348|FG000|Overall Study|Death|3|||
145975809|NCT03036254|526422349|FG001|Overall Study|Death|1|||
145975810|NCT03036254|526422348|FG000|Overall Study|Lack of Efficacy|5|||
145922615|NCT01256450|526224200|FG001|Open-label Titration|Non-compliance|0|||
145975811|NCT03036254|526422349|FG001|Overall Study|Lack of Efficacy|1|||
145975812|NCT03036254|526422348|FG000|Overall Study|Withdrawal by Subject|3|||
145922616|NCT01256450|526224201|FG002|Open-label Titration|Non-compliance|0|||
145922617|NCT01256450|526224199|FG000|Open-label Titration|Screen failure|1|||
145922618|NCT01256450|526224200|FG001|Open-label Titration|Screen failure|0|||
145922619|NCT01256450|526224201|FG002|Open-label Titration|Screen failure|0|||
145922620|NCT01256450|526224199|FG000|Open-label Titration|Other|13|||
145975813|NCT03036254|526422349|FG001|Overall Study|Withdrawal by Subject|5|||
145975814|NCT01811238|526422357|FG000|Overall Study|Withdrawal by Subject|42|||
145975815|NCT01811238|526422357|FG000|Overall Study|Adverse Event|25|||
145975816|NCT01811238|526422357|FG000|Overall Study|Protocol Violation|4|||
146242950|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145922621|NCT01256450|526224200|FG001|Open-label Titration|Other|0|||
145922622|NCT01256450|526224201|FG002|Open-label Titration|Other|0|||
145922623|NCT01256450|526224199|FG000|Double-blind Treatment|Adverse Event|0|||
145975817|NCT01811238|526422357|FG000|Overall Study|Lack of Efficacy|4|||
145975818|NCT01811238|526422357|FG000|Overall Study|subject refused study medication|6|||
145975819|NCT02916927|526422361|FG000|Overall Study|Discharged prior to study drug receipt|0|||
145975820|NCT02916927|526422362|FG001|Overall Study|Discharged prior to study drug receipt|2|||
145975821|NCT02916927|526422361|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
145922624|NCT01256450|526224200|FG001|Double-blind Treatment|Adverse Event|8|||
145922625|NCT01256450|526224201|FG002|Double-blind Treatment|Adverse Event|6|||
146297728|NCT01215175|527605968|FG000|Overall Study|Lost to Follow-up|0|||
146297729|NCT01215175|527605969|FG001|Overall Study|Lost to Follow-up|1|||
146297730|NCT01215175|527605970|FG002|Overall Study|Lost to Follow-up|0|||
146297731|NCT01215175|527605971|FG003|Overall Study|Lost to Follow-up|1|||
146297732|NCT01215175|527605972|FG004|Overall Study|Lost to Follow-up|0|||
146297733|NCT01678209|527605973|FG000|Overall Study|could not scan twice|1|||
146297734|NCT01678209|527605974|FG001|Overall Study|could not scan twice|1|||
146297735|NCT01678209|527605975|FG002|Overall Study|could not scan twice|1|||
146297736|NCT01678209|527605973|FG000|Overall Study|scheduling conflicts|0|||
146297737|NCT01678209|527605974|FG001|Overall Study|scheduling conflicts|0|||
146297738|NCT01678209|527605975|FG002|Overall Study|scheduling conflicts|1|||
145975822|NCT02916927|526422362|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
145975823|NCT02916927|526422361|FG000|Overall Study|Withdrawal before first time point|1|||
145975824|NCT02916927|526422362|FG001|Overall Study|Withdrawal before first time point|0|||
145975825|NCT01706328|526422366|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
145975826|NCT01706328|526422367|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145975827|NCT01706328|526422368|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145975828|NCT01706328|526422366|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
145975829|NCT01706328|526422367|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145975830|NCT01706328|526422368|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145975831|NCT01706328|526422366|FG000|2-week Run-in Period|Physician Decision|4|||
145975832|NCT01706328|526422367|FG001|2-week Run-in Period|Physician Decision|0|||
145975833|NCT01706328|526422368|FG002|2-week Run-in Period|Physician Decision|0|||
145975834|NCT01706328|526422366|FG000|2-week Run-in Period|Adverse Event|4|||
145975835|NCT01706328|526422367|FG001|2-week Run-in Period|Adverse Event|0|||
145975836|NCT01706328|526422368|FG002|2-week Run-in Period|Adverse Event|0|||
145975837|NCT01706328|526422366|FG000|2-week Run-in Period|Lost to Follow-up|2|||
145975838|NCT01706328|526422367|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145975839|NCT01706328|526422368|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145975840|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
145975841|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
145975842|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
145975843|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
145975844|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
145975845|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
145975846|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
145975847|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
145975848|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
145975849|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
145975850|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
145975851|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
145975852|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
145975853|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
145975854|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
145975855|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
145975856|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
145975857|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
145975858|NCT01706328|526422366|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145975859|NCT01706328|526422367|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
145975860|NCT01706328|526422368|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
145975861|NCT05759338|526422369|FG000|Overall Study|Withdrawal by Subject|3|||
146297739|NCT01678209|527605973|FG000|Overall Study|screen fail|16|||
145922626|NCT01256450|526224199|FG000|Double-blind Treatment|Lost to Follow-up|0|||
145922627|NCT01256450|526224200|FG001|Double-blind Treatment|Lost to Follow-up|1|||
145922628|NCT01256450|526224201|FG002|Double-blind Treatment|Lost to Follow-up|7|||
145922629|NCT01256450|526224199|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
145922630|NCT01256450|526224200|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
145922631|NCT01256450|526224201|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
145922632|NCT01256450|526224199|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
145922633|NCT01256450|526224200|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
145922634|NCT01256450|526224201|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
145922635|NCT01256450|526224199|FG000|Double-blind Treatment|Non-compliance|0|||
145922636|NCT01256450|526224200|FG001|Double-blind Treatment|Non-compliance|5|||
145922637|NCT01256450|526224201|FG002|Double-blind Treatment|Non-compliance|4|||
145922638|NCT01256450|526224199|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
145922639|NCT01256450|526224200|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
145922640|NCT01256450|526224201|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
145975862|NCT04409002|526422370|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
146297740|NCT01678209|527605974|FG001|Overall Study|screen fail|17|||
146297741|NCT01678209|527605975|FG002|Overall Study|screen fail|16|||
146089601|NCT03052764|526849220|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
146089602|NCT03052764|526849221|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
146089603|NCT03052764|526849220|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
146089604|NCT03052764|526849221|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146089605|NCT03052764|526849220|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
146089606|NCT03052764|526849221|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
146089607|NCT03206073|526849222|FG000|Overall Study|Participant Noncompliance|0|||
146089608|NCT03206073|526849223|FG001|Overall Study|Participant Noncompliance|1|||
146089609|NCT03206073|526849224|FG002|Overall Study|Participant Noncompliance|0|||
146089610|NCT03206073|526849225|FG003|Overall Study|Participant Noncompliance|0|||
146089611|NCT03206073|526849222|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
146089612|NCT03206073|526849223|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146089613|NCT03206073|526849224|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146089614|NCT03206073|526849225|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
146089615|NCT03206073|526849222|FG000|Overall Study|Death|0|||
146089616|NCT03206073|526849223|FG001|Overall Study|Death|0|||
146089617|NCT03206073|526849224|FG002|Overall Study|Death|1|||
146089618|NCT03206073|526849225|FG003|Overall Study|Death|0|||
146089619|NCT03206073|526849222|FG000|Overall Study|Taken off active treatment|0|||
146089620|NCT03206073|526849223|FG001|Overall Study|Taken off active treatment|0|||
146089621|NCT03206073|526849224|FG002|Overall Study|Taken off active treatment|3|||
146089622|NCT03206073|526849225|FG003|Overall Study|Taken off active treatment|0|||
146089623|NCT03332771|526849226|FG000|Overall Study|Adverse Event|6|||
146089624|NCT03332771|526849227|FG001|Overall Study|Adverse Event|4|||
146089625|NCT03332771|526849228|FG002|Overall Study|Adverse Event|1|||
146089626|NCT03332771|526849229|FG003|Overall Study|Adverse Event|3|||
146089627|NCT03332771|526849226|FG000|Overall Study|Poor Compliance to Protocol|0|||
146089628|NCT03332771|526849227|FG001|Overall Study|Poor Compliance to Protocol|1|||
146089629|NCT03332771|526849228|FG002|Overall Study|Poor Compliance to Protocol|0|||
146089630|NCT03332771|526849229|FG003|Overall Study|Poor Compliance to Protocol|1|||
146089631|NCT03332771|526849226|FG000|Overall Study|Lost to Follow-up|2|||
146089632|NCT03332771|526849227|FG001|Overall Study|Lost to Follow-up|2|||
146089633|NCT03332771|526849228|FG002|Overall Study|Lost to Follow-up|1|||
146089634|NCT03332771|526849229|FG003|Overall Study|Lost to Follow-up|2|||
146089635|NCT03332771|526849226|FG000|Overall Study|At the Participant's own request|20|||
146089636|NCT03332771|526849227|FG001|Overall Study|At the Participant's own request|26|||
146089637|NCT03332771|526849228|FG002|Overall Study|At the Participant's own request|14|||
146089638|NCT03332771|526849229|FG003|Overall Study|At the Participant's own request|23|||
146089639|NCT03332771|526849226|FG000|Overall Study|Reason Not Specified|6|||
146089640|NCT03332771|526849227|FG001|Overall Study|Reason Not Specified|18|||
146089641|NCT03332771|526849228|FG002|Overall Study|Reason Not Specified|16|||
146089642|NCT03332771|526849229|FG003|Overall Study|Reason Not Specified|19|||
146089643|NCT00719264|526849231|FG000|Overall Study|Adverse Event|41|||
146089644|NCT00719264|526849232|FG001|Overall Study|Adverse Event|49|||
146089645|NCT00719264|526849231|FG000|Overall Study|Death|13|||
146089646|NCT00719264|526849232|FG001|Overall Study|Death|10|||
146089647|NCT00719264|526849231|FG000|Overall Study|Administrative Problems|6|||
146089648|NCT00719264|526849232|FG001|Overall Study|Administrative Problems|4|||
146089649|NCT00719264|526849231|FG000|Overall Study|Lost to Follow-up|1|||
146089650|NCT00719264|526849232|FG001|Overall Study|Lost to Follow-up|1|||
146089651|NCT00719264|526849231|FG000|Overall Study|Withdrawal by Subject|12|||
146089652|NCT00719264|526849232|FG001|Overall Study|Withdrawal by Subject|7|||
146089653|NCT00719264|526849231|FG000|Overall Study|Protocol Deviation|1|||
146089654|NCT00719264|526849232|FG001|Overall Study|Protocol Deviation|3|||
146089655|NCT00719264|526849231|FG000|Overall Study|New Cancer Therapy|4|||
146089656|NCT00719264|526849232|FG001|Overall Study|New Cancer Therapy|2|||
146089657|NCT00719264|526849231|FG000|Overall Study|Disease Progression|104|||
146089658|NCT00719264|526849232|FG001|Overall Study|Disease Progression|107|||
146089659|NCT00588952|526849233|FG000|Overall Study|Adverse Event|0|||
146089660|NCT00588952|526849234|FG001|Overall Study|Adverse Event|2|||
146089661|NCT00588952|526849233|FG000|Overall Study|Withdrawal by Subject|3|||
146089662|NCT00588952|526849234|FG001|Overall Study|Withdrawal by Subject|5|||
146089663|NCT00737464|526849235|FG000|Overall Study|Adverse Event|1|||
146089664|NCT00737464|526849235|FG000|Overall Study|Death|6|||
146242951|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146242952|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146242953|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146242954|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146089665|NCT00737464|526849235|FG000|Overall Study|Other - Failure to Return|1|||
146089666|NCT00737464|526849235|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
146089667|NCT00737464|526849235|FG000|Overall Study|Other reasons|4|||
146089668|NCT04177355|526849244|FG000|Overall Study|Lost to Follow-up|0|||
146089669|NCT04177355|526849245|FG001|Overall Study|Lost to Follow-up|2|||
146089670|NCT04177355|526849246|FG002|Overall Study|Lost to Follow-up|0|||
146089671|NCT04177355|526849247|FG003|Overall Study|Lost to Follow-up|1|||
145975863|NCT02924376|526422371|FG000|Overall Study|Progressive Disease|4|||
145975864|NCT02924376|526422372|FG001|Overall Study|Progressive Disease|0|||
145975865|NCT02924376|526422373|FG002|Overall Study|Progressive Disease|1|||
145975866|NCT02924376|526422374|FG003|Overall Study|Progressive Disease|0|||
145975867|NCT02924376|526422371|FG000|Overall Study|Death|73|||
145975868|NCT02924376|526422372|FG001|Overall Study|Death|18|||
145975869|NCT02924376|526422373|FG002|Overall Study|Death|15|||
145975870|NCT02924376|526422374|FG003|Overall Study|Death|2|||
145975871|NCT02924376|526422371|FG000|Overall Study|Lost to Follow-up|3|||
145975872|NCT02924376|526422372|FG001|Overall Study|Lost to Follow-up|0|||
145975873|NCT02924376|526422373|FG002|Overall Study|Lost to Follow-up|0|||
145975874|NCT02924376|526422374|FG003|Overall Study|Lost to Follow-up|0|||
145975875|NCT02924376|526422371|FG000|Overall Study|Study Terminated by Sponsor|19|||
145975876|NCT02924376|526422372|FG001|Overall Study|Study Terminated by Sponsor|0|||
145975877|NCT02924376|526422373|FG002|Overall Study|Study Terminated by Sponsor|0|||
145975878|NCT02924376|526422374|FG003|Overall Study|Study Terminated by Sponsor|0|||
145975879|NCT02924376|526422371|FG000|Overall Study|Physician Decision|1|||
145975880|NCT02924376|526422372|FG001|Overall Study|Physician Decision|0|||
145975881|NCT02924376|526422373|FG002|Overall Study|Physician Decision|0|||
145975882|NCT02924376|526422374|FG003|Overall Study|Physician Decision|0|||
145975883|NCT02924376|526422371|FG000|Overall Study|Withdrawal by Subject|7|||
145975884|NCT02924376|526422372|FG001|Overall Study|Withdrawal by Subject|2|||
145975885|NCT02924376|526422373|FG002|Overall Study|Withdrawal by Subject|1|||
145975886|NCT02924376|526422374|FG003|Overall Study|Withdrawal by Subject|0|||
145975887|NCT02924376|526422371|FG000|Overall Study|Rolled Over to Another Study|1|||
145975888|NCT02924376|526422372|FG001|Overall Study|Rolled Over to Another Study|0|||
145975889|NCT02924376|526422373|FG002|Overall Study|Rolled Over to Another Study|0|||
145975890|NCT02924376|526422374|FG003|Overall Study|Rolled Over to Another Study|0|||
145975891|NCT04835441|526422376|FG000|Overall Study|Physician Decision|4|||
145975892|NCT04835441|526422377|FG001|Overall Study|Physician Decision|4|||
145975893|NCT04835441|526422376|FG000|Overall Study|Other|1|||
145975894|NCT04835441|526422377|FG001|Overall Study|Other|1|||
145975895|NCT04835441|526422376|FG000|Overall Study|Lost to Follow-up|0|||
145975896|NCT04835441|526422377|FG001|Overall Study|Lost to Follow-up|1|||
145975897|NCT06481579|526422378|FG000|Overall Study|Death|1|||
145975898|NCT06481579|526422379|FG001|Overall Study|Death|0|||
145975899|NCT06481579|526422378|FG000|Overall Study|Withdrawal by Subject|3|||
145975900|NCT06481579|526422379|FG001|Overall Study|Withdrawal by Subject|0|||
145975901|NCT06481579|526422378|FG000|Overall Study|Other|1|||
145975902|NCT06481579|526422379|FG001|Overall Study|Other|1|||
145975903|NCT05253807|526422380|FG000|Overall Study|Death|1|||
145975904|NCT05253807|526422381|FG001|Overall Study|Death|4|||
145975905|NCT05253807|526422380|FG000|Overall Study|Withdrawal by Subject|1|||
145975906|NCT05253807|526422381|FG001|Overall Study|Withdrawal by Subject|0|||
145975907|NCT05253807|526422380|FG000|Overall Study|Study Terminated by Sponsor|1|||
145922641|NCT01256450|526224199|FG000|Double-blind Treatment|Other|0|||
145922642|NCT01256450|526224200|FG001|Double-blind Treatment|Other|9|||
145922643|NCT01256450|526224201|FG002|Double-blind Treatment|Other|12|||
145922644|NCT01704495|526224202|FG000|Subjects Randomized|Other Reason|3|||
145922645|NCT01704495|526224203|FG001|Subjects Randomized|Other Reason|2|||
145922646|NCT01704495|526224204|FG002|Subjects Randomized|Other Reason|3|||
145922647|NCT01704495|526224205|FG003|Subjects Randomized|Other Reason|2|||
145922648|NCT01704495|526224202|FG000|Subjects Randomized|Discontinuation criteria met|4|||
145922649|NCT01704495|526224203|FG001|Subjects Randomized|Discontinuation criteria met|2|||
145922650|NCT01704495|526224204|FG002|Subjects Randomized|Discontinuation criteria met|2|||
145922651|NCT01704495|526224205|FG003|Subjects Randomized|Discontinuation criteria met|0|||
145922652|NCT01704495|526224202|FG000|Subjects Randomized|Adverse Event|8|||
145922653|NCT01704495|526224203|FG001|Subjects Randomized|Adverse Event|2|||
145922654|NCT01704495|526224204|FG002|Subjects Randomized|Adverse Event|0|||
145922655|NCT01704495|526224205|FG003|Subjects Randomized|Adverse Event|7|||
145922656|NCT01704495|526224202|FG000|Subjects Randomized|Withdrawal by Subject|5|||
145922657|NCT01704495|526224203|FG001|Subjects Randomized|Withdrawal by Subject|5|||
145922658|NCT01704495|526224204|FG002|Subjects Randomized|Withdrawal by Subject|5|||
145922659|NCT01704495|526224205|FG003|Subjects Randomized|Withdrawal by Subject|5|||
145922660|NCT01704495|526224202|FG000|Subjects Randomized|Protocol Violation|1|||
145922661|NCT01704495|526224203|FG001|Subjects Randomized|Protocol Violation|1|||
145922662|NCT01704495|526224204|FG002|Subjects Randomized|Protocol Violation|2|||
145922663|NCT01704495|526224205|FG003|Subjects Randomized|Protocol Violation|0|||
145922664|NCT01704495|526224202|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
145922665|NCT01704495|526224203|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
145975908|NCT05253807|526422381|FG001|Overall Study|Study Terminated by Sponsor|1|||
145975909|NCT03595748|526423590|FG000|Overall Study|Death|11|||
145975910|NCT03595748|526423591|FG001|Overall Study|Death|12|||
145975911|NCT03595748|526423590|FG000|Overall Study|Withdrawal by Subject|28|||
145975912|NCT03595748|526423591|FG001|Overall Study|Withdrawal by Subject|29|||
145975913|NCT03595748|526423590|FG000|Overall Study|Protocol Violation|0|||
145975914|NCT03595748|526423591|FG001|Overall Study|Protocol Violation|1|||
145975915|NCT04809974|526423592|FG000|Lead-in Phase|Withdrawal by Subject|3|||
145975916|NCT04809974|526423593|FG001|Lead-in Phase|Withdrawal by Subject|0|||
145975917|NCT04809974|526423594|FG002|Lead-in Phase|Withdrawal by Subject|0|||
145975918|NCT04809974|526423592|FG000|Lead-in Phase|No longer eligible|11|||
145975919|NCT04809974|526423593|FG001|Lead-in Phase|No longer eligible|0|||
145975920|NCT04809974|526423594|FG002|Lead-in Phase|No longer eligible|0|||
145975921|NCT04809974|526423592|FG000|Randomized Phase|Lost to Follow-up|0|||
145975922|NCT04809974|526423593|FG001|Randomized Phase|Lost to Follow-up|1|||
145975923|NCT04809974|526423594|FG002|Randomized Phase|Lost to Follow-up|5|||
145975924|NCT04809974|526423592|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
145975925|NCT04809974|526423593|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
145975926|NCT04809974|526423594|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
145975927|NCT04809974|526423592|FG000|Randomized Phase|Adverse Event|0|||
145975928|NCT04809974|526423593|FG001|Randomized Phase|Adverse Event|1|||
145975929|NCT04809974|526423594|FG002|Randomized Phase|Adverse Event|4|||
145975930|NCT04809974|526423592|FG000|Randomized Phase|Withdrawal by Subject|0|||
145975931|NCT04809974|526423593|FG001|Randomized Phase|Withdrawal by Subject|0|||
145975932|NCT04809974|526423594|FG002|Randomized Phase|Withdrawal by Subject|5|||
145975933|NCT00770809|526423595|FG000|Overall Study|Adverse Event|9|||
145975934|NCT00770809|526423596|FG001|Overall Study|Adverse Event|1|||
145975935|NCT00770809|526423597|FG002|Overall Study|Adverse Event|12|||
145975936|NCT00770809|526423595|FG000|Overall Study|Death|1|||
145975937|NCT00770809|526423596|FG001|Overall Study|Death|0|||
145975938|NCT00770809|526423597|FG002|Overall Study|Death|0|||
145975939|NCT00770809|526423595|FG000|Overall Study|Withdrawal by Subject|3|||
145975940|NCT00770809|526423596|FG001|Overall Study|Withdrawal by Subject|3|||
145975941|NCT00770809|526423597|FG002|Overall Study|Withdrawal by Subject|7|||
145975942|NCT00770809|526423595|FG000|Overall Study|Progression|2|||
145975943|NCT00770809|526423596|FG001|Overall Study|Progression|2|||
145975944|NCT00770809|526423597|FG002|Overall Study|Progression|0|||
145975945|NCT00770809|526423595|FG000|Overall Study|Complicating illness|0|||
145975946|NCT00770809|526423596|FG001|Overall Study|Complicating illness|0|||
145975947|NCT00770809|526423597|FG002|Overall Study|Complicating illness|1|||
145975948|NCT00770809|526423595|FG000|Overall Study|Other Medical Reasons|2|||
145975949|NCT00770809|526423596|FG001|Overall Study|Other Medical Reasons|4|||
145975950|NCT00770809|526423597|FG002|Overall Study|Other Medical Reasons|3|||
145975951|NCT00690898|526423598|FG000|SCREENING|Screen failure|18|||
145975952|NCT00690898|526423598|FG000|TREATMENT|Adverse Event|3|||
145975953|NCT00690898|526423598|FG000|TREATMENT|Lack of Efficacy|18|||
145975954|NCT00690898|526423598|FG000|TREATMENT|Withdrawal by Subject|4|||
145975955|NCT00690898|526423598|FG000|TREATMENT|Other (not otherwise specified)|1|||
145975956|NCT05977868|526423599|FG000|Overall Study|Withdrawal by Subject|1|||
145975957|NCT05977868|526423600|FG001|Overall Study|Withdrawal by Subject|2|||
145975958|NCT05977868|526423599|FG000|Overall Study|Transitioned to comfort care|1|||
145975959|NCT05977868|526423600|FG001|Overall Study|Transitioned to comfort care|0|||
145975960|NCT00487188|526423613|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
145975961|NCT00487188|526423614|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
145975962|NCT00487188|526423615|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
145975963|NCT00487188|526423613|FG000|Induction Phase|Adverse Event|5|||
145975964|NCT00487188|526423614|FG001|Induction Phase|Adverse Event|0|||
145975965|NCT00487188|526423615|FG002|Induction Phase|Adverse Event|0|||
146089672|NCT04177355|526849248|FG004|Overall Study|Lost to Follow-up|2|||
146089673|NCT04177355|526849249|FG005|Overall Study|Lost to Follow-up|0|||
146242955|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146242956|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
146242957|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145975966|NCT00487188|526423613|FG000|Induction Phase|Lack of Efficacy|0|||
145975967|NCT00487188|526423614|FG001|Induction Phase|Lack of Efficacy|1|||
145975968|NCT00487188|526423615|FG002|Induction Phase|Lack of Efficacy|0|||
146242958|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146242959|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
146242960|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
146242961|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
145975969|NCT00487188|526423613|FG000|Induction Phase|Protocol Violation|1|||
145975970|NCT00487188|526423614|FG001|Induction Phase|Protocol Violation|0|||
145975971|NCT00487188|526423615|FG002|Induction Phase|Protocol Violation|0|||
145975972|NCT00487188|526423613|FG000|Induction Phase|Refused Treatment|1|||
145975973|NCT00487188|526423614|FG001|Induction Phase|Refused Treatment|2|||
145975974|NCT00487188|526423615|FG002|Induction Phase|Refused Treatment|0|||
145975975|NCT00487188|526423613|FG000|Induction Phase|Lost to Follow-up|2|||
145975976|NCT00487188|526423614|FG001|Induction Phase|Lost to Follow-up|2|||
145975977|NCT00487188|526423615|FG002|Induction Phase|Lost to Follow-up|0|||
145975978|NCT00487188|526423613|FG000|Induction Phase|Administrative|0|||
145975979|NCT00487188|526423614|FG001|Induction Phase|Administrative|1|||
145975980|NCT00487188|526423615|FG002|Induction Phase|Administrative|0|||
145975981|NCT00487188|526423613|FG000|Maintenance Phase|Adverse Event|1|||
145975982|NCT00487188|526423614|FG001|Maintenance Phase|Adverse Event|0|||
145975983|NCT00487188|526423615|FG002|Maintenance Phase|Adverse Event|0|||
145975984|NCT00487188|526423613|FG000|Maintenance Phase|Death|1|||
145975985|NCT00487188|526423614|FG001|Maintenance Phase|Death|0|||
145975986|NCT00487188|526423615|FG002|Maintenance Phase|Death|0|||
145922666|NCT01704495|526224204|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
145922667|NCT01704495|526224205|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
145922668|NCT01704495|526224202|FG000|Optional Safety Extension|Adverse Event|0|||
145922669|NCT01704495|526224203|FG001|Optional Safety Extension|Adverse Event|4|||
145922670|NCT01704495|526224204|FG002|Optional Safety Extension|Adverse Event|0|||
145922671|NCT01704495|526224205|FG003|Optional Safety Extension|Adverse Event|1|||
145922672|NCT01704495|526224202|FG000|Optional Safety Extension|Other reason|27|||
145922673|NCT01704495|526224203|FG001|Optional Safety Extension|Other reason|29|||
145975987|NCT00487188|526423613|FG000|Maintenance Phase|Lost to Follow-up|1|||
145975988|NCT00487188|526423614|FG001|Maintenance Phase|Lost to Follow-up|0|||
145975989|NCT00487188|526423615|FG002|Maintenance Phase|Lost to Follow-up|0|||
145975990|NCT00487188|526423613|FG000|Maintenance Phase|Administrative|0|||
145975991|NCT00487188|526423614|FG001|Maintenance Phase|Administrative|0|||
145975992|NCT00487188|526423615|FG002|Maintenance Phase|Administrative|1|||
145975993|NCT05696847|526423617|FG000|Overall Study|Withdrawal by Subject|1|||
145975994|NCT05696847|526423618|FG001|Overall Study|Withdrawal by Subject|0|||
145975995|NCT05696847|526423619|FG002|Overall Study|Withdrawal by Subject|0|||
145975996|NCT05696847|526423620|FG003|Overall Study|Withdrawal by Subject|0|||
145975997|NCT05696847|526423621|FG004|Overall Study|Withdrawal by Subject|0|||
145975998|NCT05696847|526423622|FG005|Overall Study|Withdrawal by Subject|0|||
145975999|NCT05696847|526423617|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145976000|NCT05696847|526423618|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145976001|NCT05696847|526423619|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145976002|NCT05696847|526423620|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145976003|NCT05696847|526423621|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145976004|NCT05696847|526423622|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145976005|NCT05696847|526423617|FG000|Overall Study|Adverse Event|0|||
145976006|NCT05696847|526423618|FG001|Overall Study|Adverse Event|0|||
145976007|NCT05696847|526423619|FG002|Overall Study|Adverse Event|0|||
145976008|NCT05696847|526423620|FG003|Overall Study|Adverse Event|0|||
145976009|NCT05696847|526423621|FG004|Overall Study|Adverse Event|0|||
145976010|NCT05696847|526423622|FG005|Overall Study|Adverse Event|1|||
145976011|NCT05696847|526423617|FG000|Overall Study|Sponsor Decision|0|||
145976012|NCT05696847|526423618|FG001|Overall Study|Sponsor Decision|0|||
145976013|NCT05696847|526423619|FG002|Overall Study|Sponsor Decision|0|||
145976014|NCT05696847|526423620|FG003|Overall Study|Sponsor Decision|1|||
145976015|NCT05696847|526423621|FG004|Overall Study|Sponsor Decision|0|||
145976016|NCT05696847|526423622|FG005|Overall Study|Sponsor Decision|0|||
145976017|NCT03112603|526423625|FG000|End of Randomization Period|Lost to Follow-up|3|||
145976018|NCT03112603|526423626|FG001|End of Randomization Period|Lost to Follow-up|0|||
145976019|NCT03112603|526423627|FG002|End of Randomization Period|Lost to Follow-up|0|||
145976020|NCT03112603|526423625|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
145976021|NCT03112603|526423626|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
145976022|NCT03112603|526423627|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
145976023|NCT03112603|526423625|FG000|End of Randomization Period|Physician Decision|43|||
145976024|NCT03112603|526423626|FG001|End of Randomization Period|Physician Decision|18|||
145976025|NCT03112603|526423627|FG002|End of Randomization Period|Physician Decision|0|||
145976026|NCT03112603|526423625|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
145976027|NCT03112603|526423626|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
145976028|NCT03112603|526423627|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
145976029|NCT03112603|526423625|FG000|End of Randomization Period|Death|10|||
145976030|NCT03112603|526423626|FG001|End of Randomization Period|Death|7|||
145976031|NCT03112603|526423627|FG002|End of Randomization Period|Death|0|||
145976032|NCT03112603|526423625|FG000|End of Randomization Period|Disease Relapse|12|||
145976033|NCT03112603|526423626|FG001|End of Randomization Period|Disease Relapse|7|||
145976034|NCT03112603|526423627|FG002|End of Randomization Period|Disease Relapse|0|||
145976035|NCT03112603|526423625|FG000|End of Randomization Period|Lack of Efficacy|25|||
145976036|NCT03112603|526423626|FG001|End of Randomization Period|Lack of Efficacy|77|||
145976037|NCT03112603|526423627|FG002|End of Randomization Period|Lack of Efficacy|0|||
145976038|NCT03112603|526423625|FG000|End of Randomization Period|Adverse Event|32|||
145976039|NCT03112603|526423626|FG001|End of Randomization Period|Adverse Event|12|||
145976040|NCT03112603|526423627|FG002|End of Randomization Period|Adverse Event|0|||
145976041|NCT03112603|526423625|FG000|End of Cross Over Period|Death|0|||
145976042|NCT03112603|526423626|FG001|End of Cross Over Period|Death|0|||
145976043|NCT03112603|526423627|FG002|End of Cross Over Period|Death|2|||
145976044|NCT03112603|526423625|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
145976045|NCT03112603|526423626|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
145976046|NCT03112603|526423627|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
145922674|NCT01704495|526224204|FG002|Optional Safety Extension|Other reason|30|||
145922675|NCT01704495|526224205|FG003|Optional Safety Extension|Other reason|28|||
145922676|NCT01704495|526224202|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
145922677|NCT01704495|526224203|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
145922678|NCT01704495|526224204|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
145922679|NCT01704495|526224205|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
145922680|NCT01787292|526224211|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
145922681|NCT01787292|526224212|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
145922682|NCT01787292|526224211|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
145922683|NCT01787292|526224212|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
145976047|NCT03112603|526423625|FG000|End of Cross Over Period|Physician Decision|0|||
145976048|NCT03112603|526423626|FG001|End of Cross Over Period|Physician Decision|0|||
145976049|NCT03112603|526423627|FG002|End of Cross Over Period|Physician Decision|29|||
145976050|NCT03112603|526423625|FG000|End of Cross Over Period|Lack of Efficacy|0|||
145976051|NCT03112603|526423626|FG001|End of Cross Over Period|Lack of Efficacy|0|||
145976052|NCT03112603|526423627|FG002|End of Cross Over Period|Lack of Efficacy|8|||
145976053|NCT03112603|526423625|FG000|End of Cross Over Period|Adverse Event|0|||
145976054|NCT03112603|526423626|FG001|End of Cross Over Period|Adverse Event|0|||
145976055|NCT03112603|526423627|FG002|End of Cross Over Period|Adverse Event|6|||
145976056|NCT03112603|526423625|FG000|End of Cross Over Period|Disease Relapse|0|||
145976057|NCT03112603|526423626|FG001|End of Cross Over Period|Disease Relapse|0|||
145976058|NCT03112603|526423627|FG002|End of Cross Over Period|Disease Relapse|2|||
145976059|NCT00207740|526423628|FG000|Overall Study|Adverse Event|4|||
145976060|NCT00207740|526423629|FG001|Overall Study|Adverse Event|14|||
145976061|NCT00207740|526423630|FG002|Overall Study|Adverse Event|14|||
145976062|NCT00207740|526423631|FG003|Overall Study|Adverse Event|11|||
145976063|NCT00207740|526423628|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145976064|NCT00207740|526423629|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145976065|NCT00207740|526423630|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145976066|NCT00207740|526423631|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
145976067|NCT00207740|526423628|FG000|Overall Study|Lost to Follow-up|0|||
145976068|NCT00207740|526423629|FG001|Overall Study|Lost to Follow-up|2|||
145976069|NCT00207740|526423630|FG002|Overall Study|Lost to Follow-up|1|||
145976070|NCT00207740|526423631|FG003|Overall Study|Lost to Follow-up|1|||
145976071|NCT00207740|526423628|FG000|Overall Study|Death|0|||
145976072|NCT00207740|526423629|FG001|Overall Study|Death|0|||
145976073|NCT00207740|526423630|FG002|Overall Study|Death|0|||
145976074|NCT00207740|526423631|FG003|Overall Study|Death|1|||
145976075|NCT00207740|526423628|FG000|Overall Study|Sponsor Directive|22|||
145976076|NCT00207740|526423629|FG001|Overall Study|Sponsor Directive|15|||
145976077|NCT00207740|526423630|FG002|Overall Study|Sponsor Directive|16|||
145976078|NCT00207740|526423631|FG003|Overall Study|Sponsor Directive|21|||
145976079|NCT00207740|526423628|FG000|Overall Study|Other|2|||
145976080|NCT00207740|526423629|FG001|Overall Study|Other|10|||
145976081|NCT00207740|526423630|FG002|Overall Study|Other|7|||
145976082|NCT00207740|526423631|FG003|Overall Study|Other|5|||
145976083|NCT03916926|526423632|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
145976084|NCT03916926|526423633|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
145976085|NCT03916926|526423632|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
145976086|NCT03916926|526423633|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
145976087|NCT03916926|526423632|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
145976088|NCT03916926|526423633|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
145976089|NCT03916926|526423632|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
145976090|NCT03916926|526423633|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
145976091|NCT04725188|526423634|FG000|Overall Study|Death|72|||
145976092|NCT04725188|526423635|FG001|Overall Study|Death|69|||
145976093|NCT04725188|526423636|FG002|Overall Study|Death|76|||
145976094|NCT04725188|526423634|FG000|Overall Study|Lost to Follow-up|1|||
145976095|NCT04725188|526423635|FG001|Overall Study|Lost to Follow-up|0|||
145976096|NCT04725188|526423636|FG002|Overall Study|Lost to Follow-up|1|||
146089674|NCT04177355|526849250|FG006|Overall Study|Lost to Follow-up|1|||
145922684|NCT01924689|526224213|FG000|Overall Study|Death|0|||
145922685|NCT01924689|526224214|FG001|Overall Study|Death|1|||
145976097|NCT04725188|526423634|FG000|Overall Study|Withdrawal by Subject|2|||
145976098|NCT04725188|526423635|FG001|Overall Study|Withdrawal by Subject|2|||
145976099|NCT04725188|526423636|FG002|Overall Study|Withdrawal by Subject|1|||
145976100|NCT04725188|526423634|FG000|Overall Study|Sponsor Decision|12|||
145976101|NCT04725188|526423635|FG001|Overall Study|Sponsor Decision|12|||
145976102|NCT04725188|526423636|FG002|Overall Study|Sponsor Decision|7|||
145976103|NCT00088153|526423643|FG000|Overall Study|Physician Decision|3|||
145976104|NCT00088153|526423644|FG001|Overall Study|Physician Decision|3|||
145922686|NCT01924689|526224215|FG002|Overall Study|Death|0|||
145976105|NCT00088153|526423643|FG000|Overall Study|Withdrawal by Subject|10|||
145976106|NCT00088153|526423644|FG001|Overall Study|Withdrawal by Subject|10|||
145976107|NCT00088153|526423643|FG000|Overall Study|Lost to Follow-up|11|||
145976108|NCT00088153|526423644|FG001|Overall Study|Lost to Follow-up|12|||
145976109|NCT06354257|526423655|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145976110|NCT06354257|526423655|FG000|Treatment Period 2|Adverse Event|1|||
145976111|NCT02685735|526423656|FG000|Overall Study|Surgery Cancelled|4|||
145976112|NCT02685735|526423657|FG001|Overall Study|Surgery Cancelled|9|||
145976113|NCT02685735|526423656|FG000|Overall Study|Adverse Event|10|||
145976114|NCT02685735|526423657|FG001|Overall Study|Adverse Event|3|||
145976115|NCT02685735|526423656|FG000|Overall Study|Preop testing found to be incomplete|2|||
145976116|NCT02685735|526423657|FG001|Overall Study|Preop testing found to be incomplete|2|||
145976117|NCT02685735|526423656|FG000|Overall Study|Withdrawal by Subject|1|||
145976118|NCT02685735|526423657|FG001|Overall Study|Withdrawal by Subject|2|||
145976119|NCT02685735|526423656|FG000|Overall Study|Death|1|||
145976120|NCT02685735|526423657|FG001|Overall Study|Death|0|||
145976121|NCT04132050|526423658|FG000|Period I (Double-blind Period)|Adverse Event|3|||
145976122|NCT04132050|526423659|FG001|Period I (Double-blind Period)|Adverse Event|0|||
145976123|NCT04132050|526423658|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
145976124|NCT04132050|526423659|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
145976125|NCT04132050|526423658|FG000|R788 Treatment Period|Adverse Event|5|||
145976126|NCT04132050|526423659|FG001|R788 Treatment Period|Adverse Event|0|||
145976127|NCT04132050|526423658|FG000|R788 Treatment Period|Lack of Efficacy|5|||
145976128|NCT04132050|526423659|FG001|R788 Treatment Period|Lack of Efficacy|0|||
145976129|NCT04132050|526423658|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
145976130|NCT04132050|526423659|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
145976131|NCT02246777|526423660|FG000|Overall Study|Adverse Event|2|||
145976132|NCT02246777|526423660|FG000|Overall Study|Change of residence|1|||
145976133|NCT01063114|526423661|FG000|Overall Study|Lost to Follow-up|1|||
145976134|NCT04635423|526423662|FG000|Overall Study|Ongoing|493|||
145976135|NCT04635423|526423663|FG001|Overall Study|Ongoing|501|||
145976136|NCT04635423|526423662|FG000|Overall Study|Withdrawal by Subject|36|||
145976137|NCT04635423|526423663|FG001|Overall Study|Withdrawal by Subject|29|||
145976138|NCT05556057|526423664|FG000|Overall Study|Lost to Follow-up|5|||
145976139|NCT05556057|526423665|FG001|Overall Study|Lost to Follow-up|4|||
145976140|NCT05556057|526423664|FG000|Overall Study|Withdrawal by Subject|0|||
145976141|NCT05556057|526423665|FG001|Overall Study|Withdrawal by Subject|2|||
145976142|NCT05020743|526423675|FG000|Overall Study|Enrollment in Interventional Study|2|||
145976143|NCT05020743|526423676|FG001|Overall Study|Enrollment in Interventional Study|9|||
145976144|NCT05020743|526423677|FG002|Overall Study|Enrollment in Interventional Study|0|||
145976145|NCT05020743|526423675|FG000|Overall Study|Withdrawal by Subject|0|||
145976146|NCT05020743|526423676|FG001|Overall Study|Withdrawal by Subject|3|||
145976147|NCT05020743|526423677|FG002|Overall Study|Withdrawal by Subject|1|||
145976148|NCT05020743|526423675|FG000|Overall Study|Lost to Follow-up|1|||
145976149|NCT05020743|526423676|FG001|Overall Study|Lost to Follow-up|0|||
145976150|NCT05020743|526423677|FG002|Overall Study|Lost to Follow-up|0|||
145976151|NCT05020743|526423675|FG000|Overall Study|Study Termination by Sponsor|10|||
145976152|NCT05020743|526423676|FG001|Overall Study|Study Termination by Sponsor|11|||
145922687|NCT01924689|526224216|FG003|Overall Study|Death|1|||
145922688|NCT01924689|526224217|FG004|Overall Study|Death|0|||
145922689|NCT01924689|526224218|FG005|Overall Study|Death|0|||
145922690|NCT01924689|526224213|FG000|Overall Study|Disease progression|0|||
145922691|NCT01924689|526224214|FG001|Overall Study|Disease progression|0|||
145922692|NCT01924689|526224215|FG002|Overall Study|Disease progression|2|||
145922693|NCT01924689|526224216|FG003|Overall Study|Disease progression|0|||
145922694|NCT01924689|526224217|FG004|Overall Study|Disease progression|3|||
145922695|NCT01924689|526224218|FG005|Overall Study|Disease progression|2|||
145922696|NCT01924689|526224213|FG000|Overall Study|New therapy or study|3|||
145922697|NCT01924689|526224214|FG001|Overall Study|New therapy or study|2|||
145922698|NCT01924689|526224215|FG002|Overall Study|New therapy or study|1|||
145922699|NCT01924689|526224216|FG003|Overall Study|New therapy or study|4|||
145976153|NCT05020743|526423677|FG002|Overall Study|Study Termination by Sponsor|10|||
145976154|NCT03488524|526423678|FG000|Overall Study|Withdrawal by Subject|51|||
145976155|NCT03488524|526423678|FG000|Overall Study|Death|19|||
145922700|NCT01924689|526224217|FG004|Overall Study|New therapy or study|2|||
145922701|NCT01924689|526224218|FG005|Overall Study|New therapy or study|0|||
145922702|NCT01924689|526224213|FG000|Overall Study|Withdrawal of consent|0|||
145922703|NCT01924689|526224214|FG001|Overall Study|Withdrawal of consent|0|||
145976156|NCT03488524|526423678|FG000|Overall Study|Study Sponsor|11|||
145976157|NCT03488524|526423678|FG000|Overall Study|Physician Decision|4|||
145976158|NCT03488524|526423678|FG000|Overall Study|Lost to Follow-up|3|||
145976159|NCT02390284|526423679|FG000|Overall Study|Physician Decision|0|||
145976160|NCT02390284|526423680|FG001|Overall Study|Physician Decision|0|||
145976161|NCT02390284|526423681|FG002|Overall Study|Physician Decision|9|||
145976162|NCT03980223|526423682|FG000|Overall Study|Lost to Follow-up|3|||
145976163|NCT03980223|526423683|FG001|Overall Study|Lost to Follow-up|7|||
145976164|NCT03980223|526423684|FG002|Overall Study|Lost to Follow-up|10|||
145976165|NCT03980223|526423685|FG003|Overall Study|Lost to Follow-up|8|||
145922704|NCT01924689|526224215|FG002|Overall Study|Withdrawal of consent|1|||
145922705|NCT01924689|526224216|FG003|Overall Study|Withdrawal of consent|1|||
145922706|NCT01924689|526224217|FG004|Overall Study|Withdrawal of consent|0|||
145922707|NCT01924689|526224218|FG005|Overall Study|Withdrawal of consent|0|||
145922708|NCT01924689|526224213|FG000|Overall Study|Other|0|||
145922709|NCT01924689|526224214|FG001|Overall Study|Other|0|||
145922710|NCT01924689|526224215|FG002|Overall Study|Other|0|||
145922711|NCT01924689|526224216|FG003|Overall Study|Other|0|||
145922712|NCT01924689|526224217|FG004|Overall Study|Other|1|||
145922713|NCT01924689|526224218|FG005|Overall Study|Other|0|||
145976166|NCT03980223|526423682|FG000|Overall Study|Withdrawal by Subject|0|||
145976167|NCT03980223|526423683|FG001|Overall Study|Withdrawal by Subject|0|||
145976168|NCT03980223|526423684|FG002|Overall Study|Withdrawal by Subject|1|||
145976169|NCT03980223|526423685|FG003|Overall Study|Withdrawal by Subject|2|||
145976170|NCT03980223|526423682|FG000|Overall Study|Physician Decision|0|||
145976171|NCT03980223|526423683|FG001|Overall Study|Physician Decision|0|||
145976172|NCT03980223|526423684|FG002|Overall Study|Physician Decision|1|||
145976173|NCT03980223|526423685|FG003|Overall Study|Physician Decision|0|||
145976174|NCT03980223|526423682|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
145976175|NCT03980223|526423683|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
145976176|NCT03980223|526423684|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
145976177|NCT03980223|526423685|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
145976178|NCT01922934|526423689|FG000|Eligible Patients|Death|0|||
145976179|NCT01922934|526423690|FG001|Eligible Patients|Death|7|||
145976180|NCT01922934|526423689|FG000|Eligible Patients|Physician Decision|17|||
145976181|NCT01922934|526423690|FG001|Eligible Patients|Physician Decision|0|||
145976182|NCT01922934|526423689|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
145976183|NCT01922934|526423690|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
145976184|NCT01922934|526423689|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
145976185|NCT01922934|526423690|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
145976186|NCT01922934|526423689|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
145976187|NCT01922934|526423690|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
145976188|NCT01922934|526423689|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
145976189|NCT01922934|526423690|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
145976190|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
145976191|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
145976192|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
145976193|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
145976194|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
145976195|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
145976196|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
145976197|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
145976198|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
145976199|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
145976200|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
145976201|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
145976202|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
145976203|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
145976204|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
145976205|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
145976206|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
145976207|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
145976208|NCT01069939|526423695|FG000|Randomised and Included in the Analyses|Removal|1|||
145976209|NCT01069939|526423696|FG001|Randomised and Included in the Analyses|Removal|0|||
145976210|NCT00724945|526423697|FG000|Period 1|non-compliance|1|||
145976211|NCT00724945|526423698|FG001|Period 1|non-compliance|0|||
145976212|NCT00724945|526423697|FG000|Period 1|Adverse Event|1|||
145976213|NCT00724945|526423698|FG001|Period 1|Adverse Event|1|||
145976214|NCT00724945|526423697|FG000|Period 1|Lost to Follow-up|1|||
145976215|NCT00724945|526423698|FG001|Period 1|Lost to Follow-up|0|||
145976216|NCT00724945|526423697|FG000|Period 2|lens comfort issue|3|||
145976217|NCT00724945|526423698|FG001|Period 2|lens comfort issue|0|||
145976218|NCT00724945|526423697|FG000|Period 2|lens physiology issue|1|||
145976219|NCT00724945|526423698|FG001|Period 2|lens physiology issue|0|||
145976220|NCT05166876|526423699|FG000|Overall Study|Withdrawal by Subject|1|||
146089675|NCT04177355|526849251|FG007|Overall Study|Lost to Follow-up|0|||
146089676|NCT04177355|526849252|FG008|Overall Study|Lost to Follow-up|0|||
146089677|NCT04177355|526849253|FG009|Overall Study|Lost to Follow-up|0|||
145922714|NCT05691712|526224219|FG000|Overall Study|Adverse Event|0|||
145922715|NCT05691712|526224220|FG001|Overall Study|Adverse Event|1|||
145922716|NCT05691712|526224221|FG002|Overall Study|Adverse Event|2|||
145922717|NCT05691712|526224222|FG003|Overall Study|Adverse Event|1|||
146089678|NCT04177355|526849254|FG010|Overall Study|Lost to Follow-up|0|||
146089679|NCT04177355|526849244|FG000|Overall Study|Withdrawal by Subject|0|||
146089680|NCT04177355|526849245|FG001|Overall Study|Withdrawal by Subject|0|||
146089681|NCT04177355|526849246|FG002|Overall Study|Withdrawal by Subject|0|||
146089682|NCT04177355|526849247|FG003|Overall Study|Withdrawal by Subject|1|||
146089683|NCT04177355|526849248|FG004|Overall Study|Withdrawal by Subject|1|||
146089684|NCT04177355|526849249|FG005|Overall Study|Withdrawal by Subject|0|||
146089685|NCT04177355|526849250|FG006|Overall Study|Withdrawal by Subject|0|||
146089686|NCT04177355|526849251|FG007|Overall Study|Withdrawal by Subject|0|||
146089687|NCT04177355|526849252|FG008|Overall Study|Withdrawal by Subject|1|||
146089688|NCT04177355|526849253|FG009|Overall Study|Withdrawal by Subject|0|||
146089689|NCT04177355|526849254|FG010|Overall Study|Withdrawal by Subject|0|||
146089690|NCT00366340|526849256|FG000|Infant Series|Protocol Violation|3|||
146089691|NCT00366340|526849257|FG001|Infant Series|Protocol Violation|4|||
146089692|NCT00366340|526849256|FG000|Infant Series|Withdrawal by Subject|3|||
146089693|NCT00366340|526849257|FG001|Infant Series|Withdrawal by Subject|3|||
146089694|NCT00366340|526849256|FG000|Infant Series|Adverse Event|0|||
146089695|NCT00366340|526849257|FG001|Infant Series|Adverse Event|2|||
146089696|NCT00366340|526849256|FG000|Infant Series|Lost to Follow-up|1|||
146089697|NCT00366340|526849257|FG001|Infant Series|Lost to Follow-up|1|||
146089698|NCT00366340|526849256|FG000|Infant Series|Failure to return|1|||
146089699|NCT00366340|526849257|FG001|Infant Series|Failure to return|0|||
146089700|NCT00366340|526849256|FG000|After the Infant Series|Parent/legal guardian request|1|||
146089701|NCT00366340|526849257|FG001|After the Infant Series|Parent/legal guardian request|1|||
146089702|NCT00366340|526849256|FG000|After the Infant Series|Failed to return|0|||
146089703|NCT00366340|526849257|FG001|After the Infant Series|Failed to return|1|||
146089704|NCT00366340|526849256|FG000|After the Infant Series|Protocol Violation|2|||
146089705|NCT00366340|526849257|FG001|After the Infant Series|Protocol Violation|2|||
146089706|NCT00366340|526849256|FG000|After the Infant Series|Adverse Event|0|||
146089707|NCT00366340|526849257|FG001|After the Infant Series|Adverse Event|1|||
146089708|NCT00366340|526849256|FG000|After the Infant Series|Lost to Follow-up|0|||
146089709|NCT00366340|526849257|FG001|After the Infant Series|Lost to Follow-up|1|||
146089710|NCT00366340|526849256|FG000|Toddler Dose|Failed to return|1|||
146089711|NCT00366340|526849257|FG001|Toddler Dose|Failed to return|0|||
146089712|NCT00366340|526849256|FG000|Toddler Dose|Parent/legal guardian request|0|||
146089713|NCT00366340|526849257|FG001|Toddler Dose|Parent/legal guardian request|1|||
146089714|NCT03418571|526849264|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
146089715|NCT03418571|526849265|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
146089716|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
146089717|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
146089718|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
146089719|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
146089720|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
146089721|NCT00586326|526849266|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
146089722|NCT00586326|526849266|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
146089723|NCT00586326|526849266|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
146089724|NCT00586326|526849266|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
146089725|NCT00586326|526849266|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
146089726|NCT00586326|526849266|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
146089727|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
146089728|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
146089729|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
146089730|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
146089731|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
146089732|NCT00586326|526849266|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
146089733|NCT03595774|526849267|FG000|Overall Study|Adverse Event|1|||
146089734|NCT03595774|526849268|FG001|Overall Study|Adverse Event|0|||
146089735|NCT03595774|526849269|FG002|Overall Study|Adverse Event|1|||
146089736|NCT03595774|526849270|FG003|Overall Study|Adverse Event|0|||
146089737|NCT03595774|526849267|FG000|Overall Study|screen failure|0|||
146089738|NCT03595774|526849268|FG001|Overall Study|screen failure|1|||
146089739|NCT03595774|526849269|FG002|Overall Study|screen failure|0|||
146089740|NCT03595774|526849270|FG003|Overall Study|screen failure|1|||
146089741|NCT03519386|526849271|FG000|Overall Study|Withdrawal by Subject|4|||
146089742|NCT03519386|526849272|FG001|Overall Study|Withdrawal by Subject|1|||
146089743|NCT03519386|526849273|FG002|Overall Study|Withdrawal by Subject|2|||
146089744|NCT03519386|526849271|FG000|Overall Study|Physician Decision|1|||
146297742|NCT03739762|527605976|FG000|Overall Study|Lost to Follow-up|1|||
146297743|NCT03739762|527605977|FG001|Overall Study|Lost to Follow-up|1|||
146089745|NCT03519386|526849272|FG001|Overall Study|Physician Decision|1|||
146089746|NCT03519386|526849273|FG002|Overall Study|Physician Decision|1|||
146089747|NCT03519386|526849271|FG000|Overall Study|Lost to Follow-up|0|||
146089748|NCT03519386|526849272|FG001|Overall Study|Lost to Follow-up|1|||
146089749|NCT03519386|526849273|FG002|Overall Study|Lost to Follow-up|1|||
145922718|NCT05691712|526224219|FG000|Overall Study|Withdrawal by Subject|2|||
145922719|NCT05691712|526224220|FG001|Overall Study|Withdrawal by Subject|3|||
145922720|NCT05691712|526224221|FG002|Overall Study|Withdrawal by Subject|3|||
145922721|NCT05691712|526224222|FG003|Overall Study|Withdrawal by Subject|1|||
145922722|NCT05691712|526224219|FG000|Overall Study|Death|1|||
145922723|NCT05691712|526224220|FG001|Overall Study|Death|0|||
145922724|NCT05691712|526224221|FG002|Overall Study|Death|0|||
145922725|NCT05691712|526224222|FG003|Overall Study|Death|0|||
145922726|NCT05691712|526224219|FG000|Overall Study|Pregnancy|0|||
145922727|NCT05691712|526224220|FG001|Overall Study|Pregnancy|1|||
145922728|NCT05691712|526224221|FG002|Overall Study|Pregnancy|0|||
145922729|NCT05691712|526224222|FG003|Overall Study|Pregnancy|0|||
145922730|NCT05691712|526224219|FG000|Overall Study|Assigned Treatment by Mistake|1|||
145922731|NCT05691712|526224220|FG001|Overall Study|Assigned Treatment by Mistake|0|||
145922732|NCT05691712|526224221|FG002|Overall Study|Assigned Treatment by Mistake|0|||
145922733|NCT05691712|526224222|FG003|Overall Study|Assigned Treatment by Mistake|1|||
145922734|NCT00468819|526224223|FG000|Overall Study|Withdrawal by Subject|4|||
145922735|NCT00468819|526224224|FG001|Overall Study|Withdrawal by Subject|0|||
145922736|NCT00468819|526224225|FG002|Overall Study|Withdrawal by Subject|1|||
145922737|NCT00468819|526224223|FG000|Overall Study|Lost to Follow-up|0|||
145922738|NCT00468819|526224224|FG001|Overall Study|Lost to Follow-up|0|||
145922739|NCT00468819|526224225|FG002|Overall Study|Lost to Follow-up|1|||
145922740|NCT00468819|526224223|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
145922741|NCT00468819|526224224|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
145922742|NCT00468819|526224225|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
145922743|NCT02492867|526224226|FG000|Overall Study|Alternate therapy|1|||
145922744|NCT02492867|526224226|FG000|Overall Study|Withdrawal by Subject|2|||
145922745|NCT02492867|526224226|FG000|Overall Study|Disease progression after treatment started|1|||
145922746|NCT02492867|526224226|FG000|Overall Study|Death|1|||
145922747|NCT03296527|526224227|FG000|Overall Study|Adverse Event|15|||
145922748|NCT03296527|526224228|FG001|Overall Study|Adverse Event|33|||
145922749|NCT03296527|526224227|FG000|Overall Study|Protocol Deviation|4|||
145922750|NCT03296527|526224228|FG001|Overall Study|Protocol Deviation|0|||
145922751|NCT03296527|526224227|FG000|Overall Study|Participant withdrew consent|3|||
145922752|NCT03296527|526224228|FG001|Overall Study|Participant withdrew consent|1|||
145922753|NCT03296527|526224227|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
145922754|NCT03296527|526224228|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
145922755|NCT03296527|526224227|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
145922756|NCT03296527|526224228|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
145922757|NCT03296527|526224227|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
145922758|NCT03296527|526224228|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
145922759|NCT03296527|526224227|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
145922760|NCT03296527|526224228|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
145922761|NCT03296527|526224227|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
145922762|NCT03296527|526224228|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
145922763|NCT02524847|526224230|FG000|Overall Study|Adverse Event|4|||
145922764|NCT02524847|526224230|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
145922765|NCT02524847|526224230|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
145922766|NCT02524847|526224230|FG000|Overall Study|Death|1|||
145922767|NCT02524847|526224230|FG000|Overall Study|Reason not Specified|1|||
145922768|NCT01326845|526224231|FG000|Overall Study|Administrative Problems|5|||
145922769|NCT01326845|526224232|FG001|Overall Study|Administrative Problems|2|||
145922770|NCT01326845|526224231|FG000|Overall Study|Adverse Event|1|||
145922771|NCT01326845|526224232|FG001|Overall Study|Adverse Event|0|||
145922772|NCT01326845|526224231|FG000|Overall Study|Misisng|1|||
145922773|NCT01326845|526224232|FG001|Overall Study|Misisng|3|||
145922774|NCT00122382|526224237|FG000|Double-Blind Study|Adverse Event|9|||
145922775|NCT00122382|526224238|FG001|Double-Blind Study|Adverse Event|11|||
145922776|NCT00122382|526224239|FG002|Double-Blind Study|Adverse Event|0|||
145922777|NCT00122382|526224237|FG000|Double-Blind Study|Death|2|||
145922778|NCT00122382|526224238|FG001|Double-Blind Study|Death|2|||
145922779|NCT00122382|526224239|FG002|Double-Blind Study|Death|0|||
145922780|NCT00122382|526224237|FG000|Double-Blind Study|Lack of Efficacy|0|||
145922781|NCT00122382|526224238|FG001|Double-Blind Study|Lack of Efficacy|8|||
145922782|NCT00122382|526224239|FG002|Double-Blind Study|Lack of Efficacy|0|||
145922783|NCT00122382|526224237|FG000|Double-Blind Study|Lost to Follow-up|2|||
145922784|NCT00122382|526224238|FG001|Double-Blind Study|Lost to Follow-up|1|||
145922785|NCT00122382|526224239|FG002|Double-Blind Study|Lost to Follow-up|0|||
145922786|NCT00122382|526224237|FG000|Double-Blind Study|Pregnancy|2|||
145922787|NCT00122382|526224238|FG001|Double-Blind Study|Pregnancy|0|||
145922788|NCT00122382|526224239|FG002|Double-Blind Study|Pregnancy|0|||
145922789|NCT00122382|526224237|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
145922790|NCT00122382|526224238|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
145922791|NCT00122382|526224239|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
146242962|NCT01185340|527405261|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145922792|NCT00122382|526224237|FG000|Double-Blind Study|Withdrawal of Consent|7|||
145922793|NCT00122382|526224238|FG001|Double-Blind Study|Withdrawal of Consent|3|||
145922794|NCT00122382|526224239|FG002|Double-Blind Study|Withdrawal of Consent|0|||
145922795|NCT00122382|526224237|FG000|Double-Blind Study|Protocol Violation|1|||
145922796|NCT00122382|526224238|FG001|Double-Blind Study|Protocol Violation|0|||
145922797|NCT00122382|526224239|FG002|Double-Blind Study|Protocol Violation|0|||
145922798|NCT00122382|526224237|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
145922799|NCT00122382|526224238|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
145922800|NCT00122382|526224239|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
145922801|NCT00122382|526224237|FG000|Double-Blind Study|Randomized but not treated|0|||
145922802|NCT00122382|526224238|FG001|Double-Blind Study|Randomized but not treated|2|||
145922803|NCT00122382|526224239|FG002|Double-Blind Study|Randomized but not treated|0|||
145922804|NCT00122382|526224237|FG000|Open-Label Study|Adverse Event|0|||
145922805|NCT00122382|526224238|FG001|Open-Label Study|Adverse Event|0|||
145922806|NCT00122382|526224239|FG002|Open-Label Study|Adverse Event|11|||
145922807|NCT00122382|526224237|FG000|Open-Label Study|Death|0|||
145922808|NCT00122382|526224238|FG001|Open-Label Study|Death|0|||
145922809|NCT00122382|526224239|FG002|Open-Label Study|Death|2|||
145922810|NCT00122382|526224237|FG000|Open-Label Study|Lack of Efficacy|0|||
145922811|NCT00122382|526224238|FG001|Open-Label Study|Lack of Efficacy|0|||
145922812|NCT00122382|526224239|FG002|Open-Label Study|Lack of Efficacy|3|||
145922813|NCT00122382|526224237|FG000|Open-Label Study|Lost to Follow-up|0|||
145922814|NCT00122382|526224238|FG001|Open-Label Study|Lost to Follow-up|0|||
145922815|NCT00122382|526224239|FG002|Open-Label Study|Lost to Follow-up|3|||
145922816|NCT00122382|526224237|FG000|Open-Label Study|Pregnancy|0|||
145922817|NCT00122382|526224238|FG001|Open-Label Study|Pregnancy|0|||
145922818|NCT00122382|526224239|FG002|Open-Label Study|Pregnancy|2|||
145922819|NCT00122382|526224237|FG000|Open-Label Study|Poor/Non-Compliance|0|||
145922820|NCT00122382|526224238|FG001|Open-Label Study|Poor/Non-Compliance|0|||
145922821|NCT00122382|526224239|FG002|Open-Label Study|Poor/Non-Compliance|1|||
145922822|NCT00122382|526224237|FG000|Open-Label Study|Withdrawal of Consent|0|||
145922823|NCT00122382|526224238|FG001|Open-Label Study|Withdrawal of Consent|0|||
145922824|NCT00122382|526224239|FG002|Open-Label Study|Withdrawal of Consent|4|||
145922825|NCT01213966|526224243|FG000|Overall Study|Protocol Violation|1|||
145922826|NCT01213966|526224244|FG001|Overall Study|Protocol Violation|0|||
145922827|NCT01213966|526224245|FG002|Overall Study|Protocol Violation|3|||
145922828|NCT01213966|526224246|FG003|Overall Study|Protocol Violation|1|||
145922829|NCT04762160|526224251|FG000|Overall Study|Study terminated early due to business reasons|5|||
146242963|NCT01185340|527405262|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145922830|NCT01591096|526224253|FG000|Overall Study|Adverse Event|1|||
145922831|NCT01831635|526224254|FG000|Overall Study|Withdrawal by Subject|0|||
145922832|NCT01831635|526224255|FG001|Overall Study|Withdrawal by Subject|2|||
145922833|NCT01831635|526224256|FG002|Overall Study|Withdrawal by Subject|0|||
145922834|NCT02859337|526224257|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
145922835|NCT02859337|526224258|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
145922836|NCT02859337|526224259|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
145922837|NCT02859337|526224257|FG000|Overall Study|Withdrawal by Subject|3|||
145922838|NCT02859337|526224258|FG001|Overall Study|Withdrawal by Subject|1|||
145922839|NCT02859337|526224259|FG002|Overall Study|Withdrawal by Subject|0|||
145922840|NCT02859337|526224257|FG000|Overall Study|Lost to Follow-up|1|||
145922841|NCT02859337|526224258|FG001|Overall Study|Lost to Follow-up|0|||
145922842|NCT02859337|526224259|FG002|Overall Study|Lost to Follow-up|0|||
145922843|NCT04146012|526224262|FG000|Overall Study|Study Terminated|30|||
145922844|NCT04146012|526224263|FG001|Overall Study|Study Terminated|15|||
145922845|NCT01546025|526224264|FG000|Overall Study|Lost to Follow-up|0|||
145922846|NCT01546025|526224265|FG001|Overall Study|Lost to Follow-up|1|||
145922847|NCT02729025|526224266|FG000|Overall Study|Sponsor Decision|0|||
145922848|NCT02729025|526224267|FG001|Overall Study|Sponsor Decision|1|||
145922849|NCT02141438|526225694|FG000|Overall Study|Death|1308|||
145922850|NCT02141438|526225694|FG000|Overall Study|Lost to Follow-up|84|||
145922851|NCT02141438|526225694|FG000|Overall Study|Withdrawal by Subject|52|||
145922852|NCT02141438|526225694|FG000|Overall Study|Physician Decision|1|||
145922853|NCT02141438|526225694|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
145922854|NCT01880554|526225697|FG000|Overall Study|Protocol Violation|14|||
145922855|NCT01880554|526225697|FG000|Overall Study|Simon's design requirements|2|||
145922856|NCT05161481|526225698|FG000|Overall Study|Withdrawal of consent|0|||
145922857|NCT05161481|526225699|FG001|Overall Study|Withdrawal of consent|1|||
145922858|NCT05161481|526225700|FG002|Overall Study|Withdrawal of consent|1|||
145922859|NCT05161481|526225698|FG000|Overall Study|Study terminated by sponsor|3|||
145922860|NCT05161481|526225699|FG001|Overall Study|Study terminated by sponsor|3|||
145922861|NCT05161481|526225700|FG002|Overall Study|Study terminated by sponsor|2|||
145922862|NCT05161481|526225698|FG000|Overall Study|Adverse Event|3|||
145976221|NCT05166876|526423700|FG001|Overall Study|Withdrawal by Subject|0|||
145922863|NCT05161481|526225699|FG001|Overall Study|Adverse Event|0|||
145922864|NCT05161481|526225700|FG002|Overall Study|Adverse Event|6|||
146089750|NCT03519386|526849271|FG000|Overall Study|Death|1|||
146089751|NCT03519386|526849272|FG001|Overall Study|Death|0|||
146089752|NCT03519386|526849273|FG002|Overall Study|Death|4|||
145922865|NCT05161481|526225698|FG000|Overall Study|Randomised in error and was not treated|1|||
145922866|NCT05161481|526225699|FG001|Overall Study|Randomised in error and was not treated|0|||
145922867|NCT05161481|526225700|FG002|Overall Study|Randomised in error and was not treated|0|||
145922868|NCT05161481|526225698|FG000|Overall Study|Subject decision|0|||
145922869|NCT05161481|526225699|FG001|Overall Study|Subject decision|0|||
146089753|NCT03519386|526849271|FG000|Overall Study|Adverse Event|2|||
146089754|NCT03519386|526849272|FG001|Overall Study|Adverse Event|1|||
146089755|NCT03519386|526849273|FG002|Overall Study|Adverse Event|2|||
146089756|NCT03519386|526849271|FG000|Overall Study|Explanted|2|||
146089757|NCT03519386|526849272|FG001|Overall Study|Explanted|1|||
146089758|NCT03519386|526849273|FG002|Overall Study|Explanted|0|||
146089759|NCT03519386|526849271|FG000|Overall Study|Ongoing in study|190|||
146089760|NCT03519386|526849272|FG001|Overall Study|Ongoing in study|192|||
146089761|NCT03519386|526849273|FG002|Overall Study|Ongoing in study|183|||
146089762|NCT03101267|526849275|FG000|Primary Study Period|Withdrawal by Subject|1|||
146089763|NCT03101267|526849276|FG001|Primary Study Period|Withdrawal by Subject|2|||
146089764|NCT03101267|526849277|FG002|Primary Study Period|Withdrawal by Subject|3|||
146089765|NCT03101267|526849275|FG000|Primary Study Period|Miscellaneous|2|||
146089766|NCT03101267|526849276|FG001|Primary Study Period|Miscellaneous|0|||
146089767|NCT03101267|526849277|FG002|Primary Study Period|Miscellaneous|0|||
146089768|NCT00107952|526849278|FG000|Overall Study|Death|75|||
146089769|NCT00107952|526849279|FG001|Overall Study|Death|61|||
146089770|NCT00107952|526849278|FG000|Overall Study|Lost to Follow-up|0|||
146089771|NCT00107952|526849279|FG001|Overall Study|Lost to Follow-up|3|||
146089772|NCT00107952|526849278|FG000|Overall Study|Withdrawal by Subject|9|||
146089773|NCT00107952|526849279|FG001|Overall Study|Withdrawal by Subject|6|||
146089774|NCT00107952|526849278|FG000|Overall Study|Other|2|||
146089775|NCT00107952|526849279|FG001|Overall Study|Other|5|||
146089776|NCT00107952|526849278|FG000|Overall Study|Never received study treatment|9|||
146089777|NCT00107952|526849279|FG001|Overall Study|Never received study treatment|6|||
146089778|NCT02045303|526849287|FG000|Overall Study|Protocol Violation|2|||
146089779|NCT02045303|526849288|FG001|Overall Study|Protocol Violation|1|||
146089780|NCT02045303|526849289|FG002|Overall Study|Protocol Violation|0|||
146089781|NCT02045303|526849287|FG000|Overall Study|Withdrawal by Subject|0|||
146089782|NCT02045303|526849288|FG001|Overall Study|Withdrawal by Subject|2|||
146089783|NCT02045303|526849289|FG002|Overall Study|Withdrawal by Subject|0|||
146089784|NCT03063203|526849290|FG000|Overall Study|Chose alternative therapy|3|||
146089785|NCT03063203|526849290|FG000|Overall Study|Death|2|||
146089786|NCT03063203|526849290|FG000|Overall Study|Disease progression|4|||
146089787|NCT03063203|526849290|FG000|Overall Study|Physician Decision|5|||
146089788|NCT01642407|526849291|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
146089789|NCT01642407|526849291|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
146089790|NCT01642407|526849291|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
146089791|NCT01856023|526849292|FG000|Overall Study|Death|1|||
146089792|NCT01856023|526849293|FG001|Overall Study|Death|2|||
146089793|NCT01856023|526849292|FG000|Overall Study|Adverse Event|2|||
146089794|NCT01856023|526849293|FG001|Overall Study|Adverse Event|1|||
146089795|NCT01856023|526849292|FG000|Overall Study|Lack of Efficacy|5|||
146089796|NCT01856023|526849293|FG001|Overall Study|Lack of Efficacy|5|||
146089797|NCT01856023|526849292|FG000|Overall Study|non compliance, study closure|1|||
146089798|NCT01856023|526849293|FG001|Overall Study|non compliance, study closure|3|||
146089799|NCT01856023|526849292|FG000|Overall Study|Withdrawal by Subject|1|||
146089800|NCT01856023|526849293|FG001|Overall Study|Withdrawal by Subject|1|||
146089801|NCT00829283|526849294|FG000|Overall Study|Lost to Follow-up|7|||
146089802|NCT00829283|526849295|FG001|Overall Study|Lost to Follow-up|25|||
146089803|NCT00424255|526849296|FG000|Overall Study|Death|115|||
146089804|NCT00424255|526849297|FG001|Overall Study|Death|111|||
146089805|NCT00424255|526849296|FG000|Overall Study|Lost to Follow-up|26|||
146089806|NCT00424255|526849297|FG001|Overall Study|Lost to Follow-up|20|||
146089807|NCT00424255|526849296|FG000|Overall Study|Protocol Violation|0|||
146089808|NCT00424255|526849297|FG001|Overall Study|Protocol Violation|1|||
146089809|NCT00424255|526849296|FG000|Overall Study|Withdrawal by Subject|34|||
145922870|NCT05161481|526225700|FG002|Overall Study|Subject decision|1|||
146089810|NCT00424255|526849297|FG001|Overall Study|Withdrawal by Subject|38|||
146089811|NCT00424255|526849296|FG000|Overall Study|Physician Decision|3|||
146089812|NCT00424255|526849297|FG001|Overall Study|Physician Decision|7|||
146089813|NCT00424255|526849296|FG000|Overall Study|Cognitive Disturbance|1|||
145922871|NCT04846569|526225701|FG000|Overall Study|Withdrawal by Subject|3|||
146089814|NCT00424255|526849297|FG001|Overall Study|Cognitive Disturbance|0|||
146089815|NCT00424255|526849296|FG000|Overall Study|Non-compliance by Participants|1|||
146089816|NCT00424255|526849297|FG001|Overall Study|Non-compliance by Participants|0|||
146089817|NCT00424255|526849296|FG000|Overall Study|Fatigue|1|||
146089818|NCT00424255|526849297|FG001|Overall Study|Fatigue|0|||
146089819|NCT00424255|526849296|FG000|Overall Study|Disease Progression|0|||
146089820|NCT00424255|526849297|FG001|Overall Study|Disease Progression|2|||
145922872|NCT04846569|526225702|FG001|Overall Study|Withdrawal by Subject|1|||
145922873|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
146242964|NCT01185340|527405263|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
146242965|NCT01185340|527405264|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
146242966|NCT01719172|527405265|FG000|Overall Study|Lost to Follow-up|1|||
145922874|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
145922875|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
145922876|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
145922877|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
145922878|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145976222|NCT05166876|526423701|FG002|Overall Study|Withdrawal by Subject|0|||
145976223|NCT00658528|526423702|FG000|Overall Study|Adverse Event|5|||
145976224|NCT00658528|526423703|FG001|Overall Study|Adverse Event|7|||
145976225|NCT00658528|526423702|FG000|Overall Study|Lost to Follow-up|14|||
145976226|NCT00658528|526423703|FG001|Overall Study|Lost to Follow-up|22|||
145976227|NCT00658528|526423702|FG000|Overall Study|Withdrawal by Subject|8|||
146297744|NCT03739762|527605976|FG000|Overall Study|Withdrawal by Subject|2|||
145976228|NCT00658528|526423703|FG001|Overall Study|Withdrawal by Subject|6|||
146242967|NCT01719172|527405265|FG000|Overall Study|Death|1|||
146242968|NCT01848483|527405266|FG000|Overall Study|Death|2|||
146242969|NCT01848483|527405267|FG001|Overall Study|Death|1|||
146242970|NCT01848483|527405266|FG000|Overall Study|Lost to Follow-up|6|||
146242971|NCT01848483|527405267|FG001|Overall Study|Lost to Follow-up|8|||
146242972|NCT01848483|527405266|FG000|Overall Study|Withdrawal by Subject|1|||
146242973|NCT01848483|527405267|FG001|Overall Study|Withdrawal by Subject|0|||
146242974|NCT01848483|527405266|FG000|Overall Study|Incarceration|2|||
146242975|NCT01848483|527405267|FG001|Overall Study|Incarceration|2|||
146242976|NCT01148017|527405268|FG000|Overall Study|Withdrawal by Subject|31|||
146242977|NCT01148017|527405269|FG001|Overall Study|Withdrawal by Subject|14|||
146242978|NCT01148017|527405270|FG002|Overall Study|Withdrawal by Subject|0|||
146242979|NCT01148017|527405271|FG003|Overall Study|Withdrawal by Subject|0|||
146242980|NCT01148017|527405268|FG000|Overall Study|Lost to Follow-up|23|||
146242981|NCT01148017|527405269|FG001|Overall Study|Lost to Follow-up|10|||
146297745|NCT03739762|527605977|FG001|Overall Study|Withdrawal by Subject|6|||
146297746|NCT00607880|527605978|FG000|Overall Study|Unable to place port due to occlusion|1|||
146297747|NCT00607880|527605979|FG001|Overall Study|Unable to place port due to occlusion|0|||
146297748|NCT04964960|527605980|FG000|Overall Study|Withdrawal by Subject|1|||
146297749|NCT04964960|527605980|FG000|Overall Study|Did not complete cycles|1|||
145976229|NCT00658528|526423702|FG000|Overall Study|Withdrawal of consent|5|||
145976230|NCT00658528|526423703|FG001|Overall Study|Withdrawal of consent|6|||
145976231|NCT00658528|526423702|FG000|Overall Study|Other|8|||
145976232|NCT00658528|526423703|FG001|Overall Study|Other|4|||
145976233|NCT01147458|526423704|FG000|First Intervention|Study terminated by sponsor|8|||
145976234|NCT01147458|526423705|FG001|First Intervention|Study terminated by sponsor|8|||
145976235|NCT01147458|526423706|FG002|First Intervention|Study terminated by sponsor|7|||
145976236|NCT01147458|526423707|FG003|First Intervention|Study terminated by sponsor|8|||
145976237|NCT01147458|526423704|FG000|First Intervention|Protocol Violation|2|||
145976238|NCT01147458|526423705|FG001|First Intervention|Protocol Violation|3|||
145976239|NCT01147458|526423706|FG002|First Intervention|Protocol Violation|2|||
145976240|NCT01147458|526423707|FG003|First Intervention|Protocol Violation|3|||
145976241|NCT01147458|526423704|FG000|First Intervention|Withdrawal by Subject|3|||
145976242|NCT01147458|526423705|FG001|First Intervention|Withdrawal by Subject|0|||
145976243|NCT01147458|526423706|FG002|First Intervention|Withdrawal by Subject|1|||
145976244|NCT01147458|526423707|FG003|First Intervention|Withdrawal by Subject|0|||
145976245|NCT01147458|526423704|FG000|First Intervention|Adverse Event|0|||
145976246|NCT01147458|526423705|FG001|First Intervention|Adverse Event|3|||
145976247|NCT01147458|526423706|FG002|First Intervention|Adverse Event|2|||
145976248|NCT01147458|526423707|FG003|First Intervention|Adverse Event|3|||
145976249|NCT01147458|526423704|FG000|First Intervention|Other|1|||
145976250|NCT01147458|526423705|FG001|First Intervention|Other|2|||
145976251|NCT01147458|526423706|FG002|First Intervention|Other|0|||
145976252|NCT01147458|526423707|FG003|First Intervention|Other|0|||
145976253|NCT01147458|526423704|FG000|Second Intervention|Study terminated by sponsor|7|||
145976254|NCT01147458|526423705|FG001|Second Intervention|Study terminated by sponsor|5|||
145976255|NCT01147458|526423706|FG002|Second Intervention|Study terminated by sponsor|5|||
145976256|NCT01147458|526423707|FG003|Second Intervention|Study terminated by sponsor|3|||
145976257|NCT01147458|526423704|FG000|Second Intervention|Protocol Violation|0|||
145976258|NCT01147458|526423705|FG001|Second Intervention|Protocol Violation|1|||
145976259|NCT01147458|526423706|FG002|Second Intervention|Protocol Violation|1|||
146242982|NCT01148017|527405270|FG002|Overall Study|Lost to Follow-up|0|||
146242983|NCT01148017|527405271|FG003|Overall Study|Lost to Follow-up|0|||
145922879|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922880|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922881|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922882|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922883|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922884|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922885|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922886|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922887|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145922888|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
145922889|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
145922890|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
145922891|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
145922892|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
145922893|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922894|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922895|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922896|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922897|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922898|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922899|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922900|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922901|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922902|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145922903|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
145922904|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
145922905|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
145922906|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
145922907|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
145922908|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922909|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922910|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922911|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922912|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922913|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922914|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922915|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922916|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922917|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145922918|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
145922919|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
145922920|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
145922921|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
145922922|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
145922923|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922924|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922925|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922926|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922927|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922928|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922929|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922930|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922931|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922932|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145922933|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
145922934|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922935|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
145922936|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
145976260|NCT01147458|526423707|FG003|Second Intervention|Protocol Violation|0|||
146242984|NCT01148017|527405268|FG000|Overall Study|Inappropriate enrollment|1|||
146242985|NCT01148017|527405269|FG001|Overall Study|Inappropriate enrollment|0|||
146242986|NCT01148017|527405270|FG002|Overall Study|Inappropriate enrollment|0|||
146242987|NCT01148017|527405271|FG003|Overall Study|Inappropriate enrollment|0|||
146242988|NCT01148017|527405268|FG000|Overall Study|Administrative reason|22|||
146242989|NCT01148017|527405269|FG001|Overall Study|Administrative reason|9|||
146242990|NCT01148017|527405270|FG002|Overall Study|Administrative reason|0|||
146242991|NCT01148017|527405271|FG003|Overall Study|Administrative reason|0|||
146242992|NCT01148017|527405268|FG000|Overall Study|Unable to classify|3|||
146242993|NCT01148017|527405269|FG001|Overall Study|Unable to classify|1|||
146242994|NCT01148017|527405270|FG002|Overall Study|Unable to classify|0|||
146242995|NCT01148017|527405271|FG003|Overall Study|Unable to classify|0|||
146242996|NCT00246129|527405276|FG000|Overall Study|Lost to Follow-up|1|||
146242997|NCT00246129|527405277|FG001|Overall Study|Lost to Follow-up|0|||
146242998|NCT00246129|527405276|FG000|Overall Study|Death|2|||
146242999|NCT00246129|527405277|FG001|Overall Study|Death|1|||
145922937|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
145922938|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922939|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922940|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922941|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922942|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922943|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922944|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922945|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145976261|NCT01147458|526423704|FG000|Second Intervention|Withdrawal by Subject|0|||
145976262|NCT01147458|526423705|FG001|Second Intervention|Withdrawal by Subject|1|||
145976263|NCT01147458|526423706|FG002|Second Intervention|Withdrawal by Subject|0|||
146243000|NCT00246129|527405276|FG000|Overall Study|suffered primary non-function|1|||
146243001|NCT00246129|527405277|FG001|Overall Study|suffered primary non-function|0|||
146243002|NCT00246129|527405276|FG000|Overall Study|grafts failed|3|||
146243003|NCT00246129|527405277|FG001|Overall Study|grafts failed|1|||
146243004|NCT03740737|527405278|FG000|Overall Study|Protocol deviation|13|||
146243005|NCT03740737|527405279|FG001|Overall Study|Protocol deviation|0|||
146243006|NCT03740737|527405278|FG000|Overall Study|Adverse Event|2|||
146243007|NCT03740737|527405279|FG001|Overall Study|Adverse Event|0|||
146243008|NCT03740737|527405278|FG000|Overall Study|Lost to Follow-up|1|||
146243009|NCT03740737|527405279|FG001|Overall Study|Lost to Follow-up|0|||
146243010|NCT03740737|527405278|FG000|Overall Study|Randomization failure|1|||
146243011|NCT03740737|527405279|FG001|Overall Study|Randomization failure|0|||
146243012|NCT03740737|527405278|FG000|Overall Study|Participant withdrew consent|1|||
146243013|NCT03740737|527405279|FG001|Overall Study|Participant withdrew consent|0|||
146243014|NCT03740737|527405278|FG000|Overall Study|Participant withdrew from trial|2|||
146243015|NCT03740737|527405279|FG001|Overall Study|Participant withdrew from trial|1|||
146243016|NCT03469258|527405280|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
146243017|NCT02236611|527405283|FG000|Overall Study|Adverse Event|10|||
146243018|NCT02236611|527405284|FG001|Overall Study|Adverse Event|16|||
146243019|NCT02236611|527405283|FG000|Overall Study|Lack of Efficacy|4|||
146243020|NCT02236611|527405284|FG001|Overall Study|Lack of Efficacy|7|||
146243021|NCT02236611|527405283|FG000|Overall Study|Lost to Follow-up|0|||
146243022|NCT02236611|527405284|FG001|Overall Study|Lost to Follow-up|2|||
146243023|NCT02236611|527405283|FG000|Overall Study|Protocol deviation|3|||
146243024|NCT02236611|527405284|FG001|Overall Study|Protocol deviation|5|||
146243025|NCT02236611|527405283|FG000|Overall Study|Withdrew consent|9|||
146243026|NCT02236611|527405284|FG001|Overall Study|Withdrew consent|4|||
146243027|NCT03041090|527405285|FG000|Overall Study|technical error|0|||
146243028|NCT03041090|527405286|FG001|Overall Study|technical error|3|||
146243029|NCT03403036|527405287|FG000|Overall Study|Lack of Efficacy|5|||
146243030|NCT01128959|527405288|FG000|Lead in Period|Adverse Event|3|||
146243031|NCT01128959|527405288|FG000|Treatment Period|Adverse Event|3|||
146243032|NCT01128959|527405288|FG000|Treatment Period|Withdrawal by Subject|1|||
146243033|NCT02338999|527405289|FG000|First Intervention|Withdrawal by Subject|3|||
145976264|NCT01147458|526423707|FG003|Second Intervention|Withdrawal by Subject|0|||
145976265|NCT01147458|526423704|FG000|Second Intervention|Adverse Event|2|||
145976266|NCT01147458|526423705|FG001|Second Intervention|Adverse Event|0|||
145976267|NCT01147458|526423706|FG002|Second Intervention|Adverse Event|1|||
145976268|NCT01147458|526423707|FG003|Second Intervention|Adverse Event|1|||
145976269|NCT01147458|526423704|FG000|Second Intervention|Other|0|||
145976270|NCT01147458|526423705|FG001|Second Intervention|Other|0|||
145976271|NCT01147458|526423706|FG002|Second Intervention|Other|1|||
145976272|NCT01147458|526423707|FG003|Second Intervention|Other|0|||
145976273|NCT00832975|526423715|FG000|Overall Study|Lost to Follow-up|7|||
145976274|NCT00832975|526423715|FG000|Overall Study|Protocol Violation|6|||
145976275|NCT00832975|526423715|FG000|Overall Study|Death|5|||
145976276|NCT00832975|526423715|FG000|Overall Study|Physician Decision|4|||
146243034|NCT02338999|527405290|FG001|First Intervention|Withdrawal by Subject|1|||
146243035|NCT02338999|527405289|FG000|Washout Period|Withdrawal by Subject|0|||
146243036|NCT02338999|527405290|FG001|Washout Period|Withdrawal by Subject|2|||
146243037|NCT02338999|527405289|FG000|Second Intervention|Withdrawal by Subject|0|||
146243038|NCT02338999|527405290|FG001|Second Intervention|Withdrawal by Subject|2|||
145922946|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922947|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145922948|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922949|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922950|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922951|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
145922952|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922953|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922954|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922955|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922956|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922957|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922958|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922959|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922960|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922961|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922962|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
145922963|NCT03334435|526225703|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922964|NCT03334435|526225704|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
145922965|NCT03334435|526225705|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
145922966|NCT03334435|526225706|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
145922967|NCT03334435|526225707|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
145922968|NCT03334435|526225708|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922969|NCT03334435|526225709|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922970|NCT03334435|526225710|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922971|NCT03334435|526225711|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922972|NCT03334435|526225712|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922973|NCT03334435|526225713|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922974|NCT03334435|526225714|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922975|NCT03334435|526225715|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
145976277|NCT00832975|526423715|FG000|Overall Study|Withdrawal by Subject|3|||
145976278|NCT00832975|526423715|FG000|Overall Study|Other reasons|14|||
145976279|NCT04603066|526423724|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
145976280|NCT04603066|526423725|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
145976281|NCT04611126|526423726|FG000|Overall Study|TIL expansion unsuccessful|1|||
145976282|NCT04611126|526423727|FG001|Overall Study|TIL expansion unsuccessful|0|||
145976283|NCT03459846|526423728|FG000|Overall Study|Death|52|||
145976284|NCT03459846|526423729|FG001|Overall Study|Death|46|||
145976285|NCT03459846|526423728|FG000|Overall Study|Study terminated by sponsor|24|||
145976286|NCT03459846|526423729|FG001|Overall Study|Study terminated by sponsor|28|||
145976287|NCT03459846|526423728|FG000|Overall Study|Withdrawal by Subject|2|||
145976288|NCT03459846|526423729|FG001|Overall Study|Withdrawal by Subject|2|||
145976289|NCT00177671|526425170|FG000|Overall Study|Withdrawal by Subject|5|||
145976290|NCT00177671|526425171|FG001|Overall Study|Withdrawal by Subject|6|||
145976291|NCT00177671|526425170|FG000|Overall Study|medical complications|2|||
145976292|NCT00177671|526425171|FG001|Overall Study|medical complications|0|||
145976293|NCT00177671|526425170|FG000|Overall Study|Adverse Event|6|||
145976294|NCT00177671|526425171|FG001|Overall Study|Adverse Event|0|||
145976295|NCT00177671|526425170|FG000|Overall Study|Physician Decision|12|||
145976296|NCT00177671|526425171|FG001|Overall Study|Physician Decision|8|||
145976297|NCT02293499|526425172|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
145976298|NCT02293499|526425173|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
145976299|NCT02293499|526425174|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
145976300|NCT02293499|526425172|FG000|Intervention - Camp|Withdrawal by Subject|3|||
145976301|NCT02293499|526425173|FG001|Intervention - Camp|Withdrawal by Subject|6|||
145976302|NCT02293499|526425174|FG002|Intervention - Camp|Withdrawal by Subject|2|||
145976303|NCT02293499|526425172|FG000|Intervention - Camp|these are those not showing up at camp|24|||
145922976|NCT03334435|526225716|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922977|NCT03334435|526225717|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
145922978|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145922979|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145976304|NCT02293499|526425173|FG001|Intervention - Camp|these are those not showing up at camp|28|||
145976305|NCT02293499|526425174|FG002|Intervention - Camp|these are those not showing up at camp|4|||
145976306|NCT02293499|526425172|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
146089821|NCT00424255|526849296|FG000|Overall Study|Sponsor Terminated Study|161|||
146243039|NCT02701296|527405291|FG000|Overall Study|Incomplete Data|0|||
146243040|NCT02701296|527405292|FG001|Overall Study|Incomplete Data|2|||
146089822|NCT00424255|526849297|FG001|Overall Study|Sponsor Terminated Study|167|||
146089823|NCT00256282|526849298|FG000|Overall Study|Disease progression, relapse during acti|12|||
146089824|NCT00256282|526849298|FG000|Overall Study|Adverse Event|3|||
146089825|NCT00256282|526849298|FG000|Overall Study|Physician Decision|1|||
146089826|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
146089827|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
146089828|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
146089829|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
146089830|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
146089831|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
146089832|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
146089833|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
146089834|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
146089835|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
146089836|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
146089837|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
146089838|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
146089839|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
146089840|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
146089841|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
146089842|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
146089843|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
146089844|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
146089845|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
146089846|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
146089847|NCT02431247|526849299|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
146089848|NCT02431247|526849300|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
146089849|NCT02431247|526849301|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
146089850|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146089851|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146089852|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
146089853|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146089854|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146089855|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
146089856|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146089857|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146089858|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
146089859|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146089860|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146089861|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
146089862|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146089863|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146089864|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
146089865|NCT02431247|526849299|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146089866|NCT02431247|526849300|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146089867|NCT02431247|526849301|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
146089868|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
146089869|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
146089870|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Other|2|||
146089871|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Other|2|||
146089872|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Personal reasons|2|||
146089873|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Personal reasons|2|||
146089874|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
146089875|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
146089876|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
146089877|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
146089878|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
146089879|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
146089880|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
146089881|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
146243041|NCT01409837|527405293|FG000|Overall Study|Withdrawal by Subject|2|||
146089882|NCT00667446|526849302|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
146089883|NCT00667446|526849303|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
146089884|NCT00667446|526849302|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
146089885|NCT00667446|526849303|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
146089886|NCT00322153|526849306|FG000|Overall Study|Adverse Event|21|||
146243042|NCT01409837|527405294|FG001|Overall Study|Withdrawal by Subject|1|||
146243043|NCT01409837|527405293|FG000|Overall Study|Lost to Follow-up|1|||
146089887|NCT00322153|526849307|FG001|Overall Study|Adverse Event|34|||
146089888|NCT00322153|526849306|FG000|Overall Study|Protocol Violation|6|||
146089889|NCT00322153|526849307|FG001|Overall Study|Protocol Violation|14|||
146089890|NCT00322153|526849306|FG000|Overall Study|Withdrawal by Subject|18|||
146089891|NCT00322153|526849307|FG001|Overall Study|Withdrawal by Subject|10|||
146089892|NCT00322153|526849306|FG000|Overall Study|Lack of Efficacy|8|||
146089893|NCT00322153|526849307|FG001|Overall Study|Lack of Efficacy|3|||
146089894|NCT00322153|526849306|FG000|Overall Study|Lost to Follow-up|5|||
146089895|NCT00322153|526849307|FG001|Overall Study|Lost to Follow-up|4|||
146089896|NCT00322153|526849306|FG000|Overall Study|Withdrawn for other reasons|5|||
146089897|NCT00322153|526849307|FG001|Overall Study|Withdrawn for other reasons|4|||
146089898|NCT02414139|526849309|FG000|Treatment Period|Adverse Event|11|||
146089899|NCT02414139|526849310|FG001|Treatment Period|Adverse Event|6|||
146089900|NCT02414139|526849311|FG002|Treatment Period|Adverse Event|8|||
146089901|NCT02414139|526849312|FG003|Treatment Period|Adverse Event|5|||
146089902|NCT02414139|526849313|FG004|Treatment Period|Adverse Event|14|||
146089903|NCT02414139|526849314|FG005|Treatment Period|Adverse Event|3|||
146089904|NCT02414139|526849315|FG006|Treatment Period|Adverse Event|6|||
146089905|NCT02414139|526849316|FG007|Treatment Period|Adverse Event|1|||
146089906|NCT02414139|526849317|FG008|Treatment Period|Adverse Event|6|||
146089907|NCT02414139|526849318|FG009|Treatment Period|Adverse Event|8|||
146089908|NCT02414139|526849309|FG000|Treatment Period|Death|0|||
146089909|NCT02414139|526849310|FG001|Treatment Period|Death|0|||
146089910|NCT02414139|526849311|FG002|Treatment Period|Death|1|||
146089911|NCT02414139|526849312|FG003|Treatment Period|Death|1|||
146089912|NCT02414139|526849313|FG004|Treatment Period|Death|0|||
146089913|NCT02414139|526849314|FG005|Treatment Period|Death|0|||
146089914|NCT02414139|526849315|FG006|Treatment Period|Death|0|||
146089915|NCT02414139|526849316|FG007|Treatment Period|Death|0|||
146089916|NCT02414139|526849317|FG008|Treatment Period|Death|0|||
146089917|NCT02414139|526849318|FG009|Treatment Period|Death|1|||
146089918|NCT02414139|526849309|FG000|Treatment Period|Physician Decision|5|||
146089919|NCT02414139|526849310|FG001|Treatment Period|Physician Decision|4|||
146089920|NCT02414139|526849311|FG002|Treatment Period|Physician Decision|6|||
146089921|NCT02414139|526849312|FG003|Treatment Period|Physician Decision|1|||
146089922|NCT02414139|526849313|FG004|Treatment Period|Physician Decision|4|||
146089923|NCT02414139|526849314|FG005|Treatment Period|Physician Decision|0|||
146089924|NCT02414139|526849315|FG006|Treatment Period|Physician Decision|2|||
146089925|NCT02414139|526849316|FG007|Treatment Period|Physician Decision|0|||
146089926|NCT02414139|526849317|FG008|Treatment Period|Physician Decision|1|||
146089927|NCT02414139|526849318|FG009|Treatment Period|Physician Decision|4|||
146089928|NCT02414139|526849309|FG000|Treatment Period|Progressive disease|48|||
146089929|NCT02414139|526849310|FG001|Treatment Period|Progressive disease|31|||
146089930|NCT02414139|526849311|FG002|Treatment Period|Progressive disease|37|||
146089931|NCT02414139|526849312|FG003|Treatment Period|Progressive disease|21|||
146089932|NCT02414139|526849313|FG004|Treatment Period|Progressive disease|43|||
146089933|NCT02414139|526849314|FG005|Treatment Period|Progressive disease|12|||
146089934|NCT02414139|526849315|FG006|Treatment Period|Progressive disease|16|||
146089935|NCT02414139|526849316|FG007|Treatment Period|Progressive disease|2|||
146089936|NCT02414139|526849317|FG008|Treatment Period|Progressive disease|20|||
146089937|NCT02414139|526849318|FG009|Treatment Period|Progressive disease|14|||
146089938|NCT02414139|526849309|FG000|Treatment Period|Protocol deviation|0|||
146089939|NCT02414139|526849310|FG001|Treatment Period|Protocol deviation|0|||
146089940|NCT02414139|526849311|FG002|Treatment Period|Protocol deviation|1|||
146089941|NCT02414139|526849312|FG003|Treatment Period|Protocol deviation|0|||
146089942|NCT02414139|526849313|FG004|Treatment Period|Protocol deviation|0|||
146089943|NCT02414139|526849314|FG005|Treatment Period|Protocol deviation|0|||
146089944|NCT02414139|526849315|FG006|Treatment Period|Protocol deviation|0|||
146089945|NCT02414139|526849316|FG007|Treatment Period|Protocol deviation|0|||
146089946|NCT02414139|526849317|FG008|Treatment Period|Protocol deviation|0|||
146089947|NCT02414139|526849318|FG009|Treatment Period|Protocol deviation|0|||
146089948|NCT02414139|526849309|FG000|Treatment Period|Subject/Guardian decision|5|||
146089949|NCT02414139|526849310|FG001|Treatment Period|Subject/Guardian decision|1|||
146089950|NCT02414139|526849311|FG002|Treatment Period|Subject/Guardian decision|1|||
146089951|NCT02414139|526849312|FG003|Treatment Period|Subject/Guardian decision|2|||
146089952|NCT02414139|526849313|FG004|Treatment Period|Subject/Guardian decision|5|||
146089953|NCT02414139|526849314|FG005|Treatment Period|Subject/Guardian decision|0|||
146089954|NCT02414139|526849315|FG006|Treatment Period|Subject/Guardian decision|2|||
146089955|NCT02414139|526849316|FG007|Treatment Period|Subject/Guardian decision|0|||
146089956|NCT02414139|526849317|FG008|Treatment Period|Subject/Guardian decision|1|||
146089957|NCT02414139|526849318|FG009|Treatment Period|Subject/Guardian decision|1|||
146089958|NCT02414139|526849309|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146089959|NCT02414139|526849310|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146089960|NCT02414139|526849311|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146089961|NCT02414139|526849312|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146089962|NCT02414139|526849313|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
145922980|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145922981|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145922982|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145922983|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145922984|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
145922985|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145922986|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
145922987|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
145922988|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145922989|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
145922990|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
145922991|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
145922992|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
145922993|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145922994|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145976307|NCT02293499|526425173|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
145976308|NCT02293499|526425174|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
145976309|NCT02293499|526425172|FG000|3 Month Follow Up|Lost to Follow-up|14|||
145976310|NCT02293499|526425173|FG001|3 Month Follow Up|Lost to Follow-up|15|||
145976311|NCT02293499|526425174|FG002|3 Month Follow Up|Lost to Follow-up|6|||
145976312|NCT02293499|526425172|FG000|6 Month Follow Up|Lost to Follow-up|17|||
145976313|NCT02293499|526425173|FG001|6 Month Follow Up|Lost to Follow-up|27|||
145976314|NCT02293499|526425174|FG002|6 Month Follow Up|Lost to Follow-up|6|||
145976315|NCT02293499|526425172|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
145976316|NCT02293499|526425173|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
145976317|NCT02293499|526425174|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
145976318|NCT02293499|526425172|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
145976319|NCT02293499|526425173|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
145976320|NCT02293499|526425174|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
145976321|NCT02293499|526425172|FG000|9 Month Follow Up|Lost to Follow-up|24|||
145976322|NCT02293499|526425173|FG001|9 Month Follow Up|Lost to Follow-up|28|||
145976323|NCT02293499|526425174|FG002|9 Month Follow Up|Lost to Follow-up|4|||
145976324|NCT02293499|526425172|FG000|12 Month Follow Up|Lost to Follow-up|26|||
145976325|NCT02293499|526425173|FG001|12 Month Follow Up|Lost to Follow-up|25|||
145976326|NCT02293499|526425174|FG002|12 Month Follow Up|Lost to Follow-up|6|||
145976327|NCT02293499|526425172|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
145976328|NCT02293499|526425173|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
145976329|NCT02293499|526425174|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
145976330|NCT02293499|526425172|FG000|15 Month Follow Up|Lost to Follow-up|22|||
145976331|NCT02293499|526425173|FG001|15 Month Follow Up|Lost to Follow-up|22|||
145976332|NCT02293499|526425174|FG002|15 Month Follow Up|Lost to Follow-up|7|||
145976333|NCT01991314|526425177|FG000|Overall Study|Adverse Event|5|||
145976334|NCT01991314|526425178|FG001|Overall Study|Adverse Event|1|||
145976335|NCT01991314|526425177|FG000|Overall Study|Lost to Follow-up|6|||
145976336|NCT01991314|526425178|FG001|Overall Study|Lost to Follow-up|10|||
145976337|NCT01136954|526425179|FG000|Overall Study|Adverse Event|3|||
145976338|NCT01136954|526425180|FG001|Overall Study|Adverse Event|2|||
145976339|NCT01136954|526425179|FG000|Overall Study|Withdrawal by Subject|6|||
145976340|NCT01136954|526425180|FG001|Overall Study|Withdrawal by Subject|2|||
145976341|NCT01136954|526425179|FG000|Overall Study|Lack of Efficacy|14|||
145976342|NCT01136954|526425180|FG001|Overall Study|Lack of Efficacy|13|||
145976343|NCT01136954|526425179|FG000|Overall Study|Physician Decision|0|||
145976344|NCT01136954|526425180|FG001|Overall Study|Physician Decision|1|||
145976345|NCT01136954|526425179|FG000|Overall Study|Other|1|||
145976346|NCT01136954|526425180|FG001|Overall Study|Other|3|||
145976347|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
145976348|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
145976349|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
145922995|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145922996|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145922997|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145976350|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
145976351|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
145976352|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145976353|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
145976354|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145976355|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145976356|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145976357|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Death|0|||
145976358|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Death|0|||
145976359|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Death|1|||
145976360|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Death|0|||
146089963|NCT02414139|526849314|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146297750|NCT02616614|527605981|FG000|Overall Study|Withdrawal by Subject|10|||
146297751|NCT02616614|527605982|FG001|Overall Study|Withdrawal by Subject|5|||
146297752|NCT02616614|527605983|FG002|Overall Study|Withdrawal by Subject|6|||
145922998|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
145922999|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
145923000|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
145923001|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
145923002|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
145923003|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
145923004|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
145923005|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
145923006|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
145923007|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
145923008|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145923009|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145923010|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145976361|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Death|0|||
145976362|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
145976363|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
145976364|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
145976365|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
145976366|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
145976367|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Other|2|||
145976368|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Other|1|||
145976369|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Other|0|||
145976370|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Other|0|||
145976371|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Other|0|||
145976372|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145976373|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145976374|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
145976375|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145976376|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145976377|NCT03317496|526425181|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145976378|NCT03317496|526425182|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
145976379|NCT03317496|526425183|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145976380|NCT03317496|526425184|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
145976381|NCT03317496|526425185|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145976382|NCT03317496|526425181|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
145976383|NCT03317496|526425182|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
145976384|NCT03317496|526425183|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
145976385|NCT03317496|526425184|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
145976386|NCT03317496|526425185|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
145976387|NCT03317496|526425181|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
145976388|NCT03317496|526425182|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145976389|NCT03317496|526425183|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145976390|NCT03317496|526425184|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145976391|NCT03317496|526425185|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145976392|NCT03317496|526425181|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145976393|NCT03317496|526425182|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145976394|NCT03317496|526425183|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
145976395|NCT03317496|526425184|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145976396|NCT03317496|526425185|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145976397|NCT03317496|526425181|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
145976398|NCT03317496|526425182|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
145976399|NCT03317496|526425183|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
145976400|NCT03317496|526425184|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
145976401|NCT03317496|526425185|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
145976402|NCT03317496|526425181|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
145976403|NCT03317496|526425182|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
145976404|NCT03317496|526425183|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
145976405|NCT03317496|526425184|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
145976406|NCT03317496|526425185|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
145976407|NCT03317496|526425181|FG000|Phase 2: Treatment|Adverse Event|0|||
145976408|NCT03317496|526425182|FG001|Phase 2: Treatment|Adverse Event|0|||
145976409|NCT03317496|526425183|FG002|Phase 2: Treatment|Adverse Event|0|||
145976410|NCT03317496|526425184|FG003|Phase 2: Treatment|Adverse Event|0|||
145976411|NCT03317496|526425185|FG004|Phase 2: Treatment|Adverse Event|6|||
145976412|NCT03317496|526425181|FG000|Phase 2: Treatment|Progressive disease|0|||
145976413|NCT03317496|526425182|FG001|Phase 2: Treatment|Progressive disease|0|||
145976414|NCT03317496|526425183|FG002|Phase 2: Treatment|Progressive disease|0|||
145923011|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145923012|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145923013|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
145923014|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
145923015|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
145923016|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
145923017|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
145923018|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
145923019|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
145923020|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145923021|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
145923022|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
145923023|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145923024|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145923025|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145923026|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145923027|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145923028|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
145923029|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
145923030|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145923031|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145923032|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
145923033|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
145923034|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
145923035|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145923036|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
145923037|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
145923038|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923039|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923040|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923041|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923042|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923043|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923044|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
145923045|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
145923046|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
145923047|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145923048|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145923049|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145923050|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145923051|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
145923052|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
145923053|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923054|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923055|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923056|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923057|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923058|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923059|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923060|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923061|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923062|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923063|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923064|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
145923065|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923066|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
145923067|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145923068|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923069|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923070|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923071|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
146297753|NCT02616614|527605981|FG000|Overall Study|Physician Decision|2|||
146243044|NCT01409837|527405294|FG001|Overall Study|Lost to Follow-up|0|||
146243045|NCT01409837|527405293|FG000|Overall Study|Physician Decision|0|||
145923072|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923073|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
145923074|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923075|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923076|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923077|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923078|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923079|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923080|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923081|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
145923082|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
145923083|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923084|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923085|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923086|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923087|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923088|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923089|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923090|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923091|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923092|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
145923093|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923094|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145923095|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923096|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923097|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145923098|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923099|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923100|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923101|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923102|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923103|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145923104|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145923105|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923106|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923107|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145923108|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145976415|NCT03317496|526425184|FG003|Phase 2: Treatment|Progressive disease|0|||
145976416|NCT03317496|526425185|FG004|Phase 2: Treatment|Progressive disease|22|||
145976417|NCT03317496|526425181|FG000|Phase 2: Treatment|Other|0|||
145976418|NCT03317496|526425182|FG001|Phase 2: Treatment|Other|0|||
145976419|NCT03317496|526425183|FG002|Phase 2: Treatment|Other|0|||
145976420|NCT03317496|526425184|FG003|Phase 2: Treatment|Other|0|||
145976421|NCT03317496|526425185|FG004|Phase 2: Treatment|Other|4|||
145976422|NCT03317496|526425181|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
145976423|NCT03317496|526425182|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
145976424|NCT03317496|526425183|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
145976425|NCT03317496|526425184|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
145976426|NCT03317496|526425185|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
145976427|NCT03317496|526425181|FG000|Phase 2: Treatment|Physician Decision|0|||
145976428|NCT03317496|526425182|FG001|Phase 2: Treatment|Physician Decision|0|||
145976429|NCT03317496|526425183|FG002|Phase 2: Treatment|Physician Decision|0|||
145976430|NCT03317496|526425184|FG003|Phase 2: Treatment|Physician Decision|0|||
145976431|NCT03317496|526425185|FG004|Phase 2: Treatment|Physician Decision|1|||
145976432|NCT03317496|526425181|FG000|Phase 2: Treatment|Death|0|||
145976433|NCT03317496|526425182|FG001|Phase 2: Treatment|Death|0|||
145976434|NCT03317496|526425183|FG002|Phase 2: Treatment|Death|0|||
145976435|NCT03317496|526425184|FG003|Phase 2: Treatment|Death|0|||
145976436|NCT03317496|526425185|FG004|Phase 2: Treatment|Death|1|||
145976437|NCT03317496|526425181|FG000|Phase 2: Follow-up|Death|0|||
145976438|NCT03317496|526425182|FG001|Phase 2: Follow-up|Death|0|||
145976439|NCT03317496|526425183|FG002|Phase 2: Follow-up|Death|0|||
145976440|NCT03317496|526425184|FG003|Phase 2: Follow-up|Death|0|||
145976441|NCT03317496|526425185|FG004|Phase 2: Follow-up|Death|24|||
145976442|NCT03317496|526425181|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
145976443|NCT03317496|526425182|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
146243046|NCT01409837|527405294|FG001|Overall Study|Physician Decision|1|||
146243047|NCT03490032|527405298|FG000|Overall Study|family issue (child custody)|1|||
146243048|NCT03490032|527405299|FG001|Overall Study|family issue (child custody)|0|||
146243049|NCT03490032|527405300|FG002|Overall Study|family issue (child custody)|0|||
146243050|NCT00308308|527405301|FG000|Overall Study|Adverse Event|17|||
146243051|NCT00308308|527405302|FG001|Overall Study|Adverse Event|2|||
146243052|NCT00308308|527405301|FG000|Overall Study|Lost to Follow-up|5|||
146243053|NCT00308308|527405302|FG001|Overall Study|Lost to Follow-up|5|||
146243054|NCT00308308|527405301|FG000|Overall Study|Physician Decision|15|||
146243055|NCT00308308|527405302|FG001|Overall Study|Physician Decision|7|||
146243056|NCT00308308|527405301|FG000|Overall Study|Protocol Violation|3|||
146243057|NCT00308308|527405302|FG001|Overall Study|Protocol Violation|14|||
146243058|NCT00308308|527405301|FG000|Overall Study|Withdrawal by Subject|47|||
146297754|NCT02616614|527605982|FG001|Overall Study|Physician Decision|1|||
146297755|NCT02616614|527605983|FG002|Overall Study|Physician Decision|0|||
145923109|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145923110|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145923111|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
145923112|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
145923113|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923114|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923115|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923116|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923117|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923118|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145923119|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923120|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923121|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923122|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923123|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145923124|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923125|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923126|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145923127|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145923128|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923129|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923130|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923131|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923132|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923133|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923134|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145976444|NCT03317496|526425183|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
145976445|NCT03317496|526425184|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
145976446|NCT03317496|526425185|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
145976447|NCT03317496|526425181|FG000|Phase 2: Follow-up|Other|0|||
145976448|NCT03317496|526425182|FG001|Phase 2: Follow-up|Other|0|||
145976449|NCT03317496|526425183|FG002|Phase 2: Follow-up|Other|0|||
145976450|NCT03317496|526425184|FG003|Phase 2: Follow-up|Other|0|||
145976451|NCT03317496|526425185|FG004|Phase 2: Follow-up|Other|1|||
145976452|NCT03317496|526425181|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
145976453|NCT03317496|526425182|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
145976454|NCT03317496|526425183|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
145976455|NCT03317496|526425184|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
145976456|NCT03317496|526425185|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
145976457|NCT02034591|526425194|FG000|Overall Study|Withdrawal by Subject|0|||
145976458|NCT02034591|526425195|FG001|Overall Study|Withdrawal by Subject|0|||
145976459|NCT02034591|526425196|FG002|Overall Study|Withdrawal by Subject|0|||
145976460|NCT02034591|526425197|FG003|Overall Study|Withdrawal by Subject|0|||
145976461|NCT02034591|526425198|FG004|Overall Study|Withdrawal by Subject|1|||
145976462|NCT02034591|526425199|FG005|Overall Study|Withdrawal by Subject|0|||
145976463|NCT00817063|526425200|FG000|Overall Study|Adverse Event|32|||
145976464|NCT00817063|526425201|FG001|Overall Study|Adverse Event|13|||
145976465|NCT00817063|526425200|FG000|Overall Study|Death|1|||
146243059|NCT00308308|527405302|FG001|Overall Study|Withdrawal by Subject|19|||
145923135|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145923136|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145976466|NCT00817063|526425201|FG001|Overall Study|Death|1|||
145976467|NCT00817063|526425200|FG000|Overall Study|Lack of Efficacy|33|||
145976468|NCT00817063|526425201|FG001|Overall Study|Lack of Efficacy|86|||
145976469|NCT00817063|526425200|FG000|Overall Study|Failure to Return|13|||
145976470|NCT00817063|526425201|FG001|Overall Study|Failure to Return|12|||
145976471|NCT00817063|526425200|FG000|Overall Study|Violation of Selection at Entry|7|||
146243060|NCT00308308|527405301|FG000|Overall Study|Various|7|||
146243061|NCT00308308|527405302|FG001|Overall Study|Various|5|||
146243062|NCT00308308|527405301|FG000|Overall Study|Randomized but not dosed|8|||
146089964|NCT02414139|526849315|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
146089965|NCT02414139|526849316|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
146089966|NCT02414139|526849317|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
146089967|NCT02414139|526849318|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
146089968|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
146089969|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089970|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089971|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089972|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
146089973|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089974|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089975|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146089976|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146243063|NCT00308308|527405302|FG001|Overall Study|Randomized but not dosed|16|||
146243064|NCT00308308|527405301|FG000|Overall Study|Other|1|||
145923137|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923138|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145923139|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
145923140|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145923141|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923142|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145923143|NCT03334435|526225703|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923144|NCT03334435|526225704|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923145|NCT03334435|526225705|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923146|NCT03334435|526225706|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923147|NCT03334435|526225707|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923148|NCT03334435|526225708|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923149|NCT03334435|526225709|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923150|NCT03334435|526225710|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923151|NCT03334435|526225711|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923152|NCT03334435|526225712|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923153|NCT03334435|526225713|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923154|NCT03334435|526225714|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145923155|NCT03334435|526225715|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145923156|NCT03334435|526225716|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145923157|NCT03334435|526225717|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145923158|NCT03922321|526225718|FG000|Overall Study|Participant Moved|1|||
145923159|NCT03922321|526225718|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
145923160|NCT00350207|526225719|FG000|Overall Study|Adverse Event|5|||
145923161|NCT00350207|526225720|FG001|Overall Study|Adverse Event|2|||
145923162|NCT00350207|526225721|FG002|Overall Study|Adverse Event|2|||
145923163|NCT00350207|526225719|FG000|Overall Study|Lack of Efficacy|1|||
145923164|NCT00350207|526225720|FG001|Overall Study|Lack of Efficacy|0|||
145923165|NCT00350207|526225721|FG002|Overall Study|Lack of Efficacy|2|||
145923166|NCT00350207|526225719|FG000|Overall Study|Lost to Follow-up|1|||
145923167|NCT00350207|526225720|FG001|Overall Study|Lost to Follow-up|0|||
145923168|NCT00350207|526225721|FG002|Overall Study|Lost to Follow-up|1|||
145923169|NCT00350207|526225719|FG000|Overall Study|Withdrawal by Subject|0|||
145923170|NCT00350207|526225720|FG001|Overall Study|Withdrawal by Subject|1|||
145923171|NCT00350207|526225721|FG002|Overall Study|Withdrawal by Subject|1|||
145923172|NCT00350207|526225719|FG000|Overall Study|Other|1|||
145923173|NCT00350207|526225720|FG001|Overall Study|Other|3|||
145923174|NCT00350207|526225721|FG002|Overall Study|Other|1|||
145923175|NCT00495391|526225722|FG000|Overall Study|Lack of Efficacy|34|||
145923176|NCT00495391|526225723|FG001|Overall Study|Lack of Efficacy|18|||
145923177|NCT00495391|526225722|FG000|Overall Study|Withdrawal by Subject|2|||
145923178|NCT00495391|526225723|FG001|Overall Study|Withdrawal by Subject|3|||
145923179|NCT03214224|526225724|FG000|Overall Study|Protocol Violation|1|||
145923180|NCT03214224|526225724|FG000|Overall Study|Withdrawal by Subject|2|||
145923181|NCT03214224|526225724|FG000|Overall Study|Practice controls or therapists|6|||
146089977|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
146243065|NCT00308308|527405302|FG001|Overall Study|Other|0|||
146243066|NCT01021748|527405305|FG000|Overall Study|Adverse Event|2|||
146243067|NCT01021748|527405306|FG001|Overall Study|Adverse Event|1|||
145923182|NCT02712320|526225725|FG000|Overall Study|Lost to Follow-up|1|||
145923183|NCT02712320|526225725|FG000|Overall Study|Withdrawal by Subject|1|||
145923184|NCT02712320|526225725|FG000|Overall Study|Transferred to another facility|1|||
145923185|NCT02712320|526225725|FG000|Overall Study|Treating with the prohibited medications|2|||
145923186|NCT00444535|526225728|FG000|Overall Study|Withdrawal by Subject|5|||
145923187|NCT00444535|526225728|FG000|Overall Study|Physician Decision|5|||
145923188|NCT00444535|526225728|FG000|Overall Study|progressive disease|1|||
145923189|NCT00444535|526225728|FG000|Overall Study|Adverse Event|2|||
145923190|NCT03313180|526225732|FG000|Overall Study|Adverse Event|120|||
145976472|NCT00817063|526425201|FG001|Overall Study|Violation of Selection at Entry|4|||
145976473|NCT00817063|526425200|FG000|Overall Study|Protocol Violation|3|||
145976474|NCT00817063|526425201|FG001|Overall Study|Protocol Violation|8|||
145976475|NCT00817063|526425200|FG000|Overall Study|Withdrawal by Subject|17|||
145976476|NCT00817063|526425201|FG001|Overall Study|Withdrawal by Subject|37|||
145976477|NCT00817063|526425200|FG000|Overall Study|Early Improvement|19|||
145976478|NCT00817063|526425201|FG001|Overall Study|Early Improvement|4|||
145976479|NCT00817063|526425200|FG000|Overall Study|Administrative|10|||
145976480|NCT00817063|526425201|FG001|Overall Study|Administrative|4|||
145976481|NCT00817063|526425200|FG000|Overall Study|Abnormality of Laboratory Test|2|||
145976482|NCT00817063|526425201|FG001|Overall Study|Abnormality of Laboratory Test|1|||
145976483|NCT01496456|526425202|FG000|Overall Study|Protocol Violation|1|||
145976484|NCT01496456|526425202|FG000|Overall Study|Lost to Follow-up|7|||
145976485|NCT04919161|526425203|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
145976486|NCT04919161|526425204|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
145976487|NCT04919161|526425203|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
145976488|NCT04919161|526425204|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
145976489|NCT04919161|526425203|FG000|Overall Study|Acute ankle sprain after session 1|0|||
145976490|NCT04919161|526425204|FG001|Overall Study|Acute ankle sprain after session 1|1|||
145976491|NCT00712920|526425205|FG000|Overall Study|Adverse Event|3|||
145976492|NCT00712920|526425206|FG001|Overall Study|Adverse Event|4|||
145976493|NCT00712920|526425207|FG002|Overall Study|Adverse Event|7|||
145976494|NCT00712920|526425205|FG000|Overall Study|Withdrawal by Subject|4|||
145976495|NCT00712920|526425206|FG001|Overall Study|Withdrawal by Subject|2|||
145976496|NCT00712920|526425207|FG002|Overall Study|Withdrawal by Subject|1|||
145976497|NCT00712920|526425205|FG000|Overall Study|Lost to Follow-up|1|||
145976498|NCT00712920|526425206|FG001|Overall Study|Lost to Follow-up|4|||
145976499|NCT00712920|526425207|FG002|Overall Study|Lost to Follow-up|0|||
145976500|NCT00712920|526425205|FG000|Overall Study|Lack of Efficacy|1|||
145976501|NCT00712920|526425206|FG001|Overall Study|Lack of Efficacy|0|||
145976502|NCT00712920|526425207|FG002|Overall Study|Lack of Efficacy|1|||
145976503|NCT00712920|526425205|FG000|Overall Study|Other|5|||
145976504|NCT00712920|526425206|FG001|Overall Study|Other|7|||
145976505|NCT00712920|526425207|FG002|Overall Study|Other|3|||
145976506|NCT00712920|526425205|FG000|Overall Study|Non-compliance|3|||
146089978|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Death|0|||
146089979|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Death|1|||
145923191|NCT03313180|526225732|FG000|Overall Study|Lost to Follow-up|3|||
145923192|NCT03313180|526225732|FG000|Overall Study|Withdrawal by Subject|39|||
145923193|NCT03313180|526225732|FG000|Overall Study|Other than listed above|15|||
145923194|NCT03313180|526225732|FG000|Overall Study|Covid-19 related|2|||
145923195|NCT01697748|526225733|FG000|Overall Study|ineligible skin incision|1|||
145923196|NCT01697748|526225734|FG001|Overall Study|ineligible skin incision|2|||
145923197|NCT01697748|526225733|FG000|Overall Study|ineligible uterine incision|4|||
145923198|NCT01697748|526225734|FG001|Overall Study|ineligible uterine incision|1|||
145923199|NCT01697748|526225733|FG000|Overall Study|Lost to Follow-up|53|||
145923200|NCT01697748|526225734|FG001|Overall Study|Lost to Follow-up|65|||
145923201|NCT03866512|526225736|FG000|Overall Study|Lost to Follow-up|1|||
145923202|NCT03866512|526225737|FG001|Overall Study|Lost to Follow-up|2|||
145923203|NCT03866512|526225738|FG002|Overall Study|Lost to Follow-up|1|||
145923204|NCT03866512|526225736|FG000|Overall Study|Cannulation issues|0|||
145923205|NCT03866512|526225737|FG001|Overall Study|Cannulation issues|1|||
145923206|NCT03866512|526225738|FG002|Overall Study|Cannulation issues|2|||
145923207|NCT00832455|526225743|FG000|Overall Study|Adverse Event|13|||
145923208|NCT00832455|526225743|FG000|Overall Study|Lost to Follow-up|26|||
145923209|NCT00832455|526225743|FG000|Overall Study|Protocol Violation|4|||
145923210|NCT00832455|526225743|FG000|Overall Study|Withdrawal by Subject|17|||
145923211|NCT00832455|526225743|FG000|Overall Study|Screening Failure|2|||
145923212|NCT00832455|526225743|FG000|Overall Study|Stopped Medication|4|||
145923213|NCT00832455|526225743|FG000|Overall Study|Parent misunderstood study|1|||
145923214|NCT00832455|526225743|FG000|Overall Study|Parent dissatisfied|1|||
145923215|NCT00832455|526225743|FG000|Overall Study|No improvement|3|||
145923216|NCT00832455|526225743|FG000|Overall Study|Patient moved|1|||
145923217|NCT03376789|526225745|FG000|Overall Study|Withdrawal by Subject|3|||
145923218|NCT03376789|526225746|FG001|Overall Study|Withdrawal by Subject|5|||
145923219|NCT03376789|526225745|FG000|Overall Study|Protocol Violation|0|||
145976507|NCT00712920|526425206|FG001|Overall Study|Non-compliance|0|||
145976508|NCT00712920|526425207|FG002|Overall Study|Non-compliance|0|||
145976509|NCT02489773|526425208|FG000|Overall Study|Lost to Follow-up|4|||
145976510|NCT02489773|526425209|FG001|Overall Study|Lost to Follow-up|1|||
145976511|NCT02489773|526425208|FG000|Overall Study|Physician Decision|1|||
145976512|NCT02489773|526425209|FG001|Overall Study|Physician Decision|0|||
145976513|NCT02489773|526425208|FG000|Overall Study|Withdrawal by Subject|1|||
145976514|NCT02489773|526425209|FG001|Overall Study|Withdrawal by Subject|0|||
145976515|NCT02489773|526425208|FG000|Overall Study|Leave the country or the state|1|||
145923220|NCT03376789|526225746|FG001|Overall Study|Protocol Violation|1|||
145923221|NCT03376789|526225745|FG000|Overall Study|Adverse Event|0|||
145976516|NCT02489773|526425209|FG001|Overall Study|Leave the country or the state|1|||
145976517|NCT02696616|526425211|FG000|Overall Study|Adverse Event|0|||
145976518|NCT02696616|526425212|FG001|Overall Study|Adverse Event|1|||
145976519|NCT02696616|526425213|FG002|Overall Study|Adverse Event|0|||
145976520|NCT02696616|526425214|FG003|Overall Study|Adverse Event|0|||
145976521|NCT02696616|526425215|FG004|Overall Study|Adverse Event|0|||
145976522|NCT02696616|526425216|FG005|Overall Study|Adverse Event|0|||
145976523|NCT02696616|526425217|FG006|Overall Study|Adverse Event|0|||
145976524|NCT01732783|526425220|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
145976525|NCT01732783|526425221|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
145976526|NCT01732783|526425222|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
145976527|NCT01732783|526425220|FG000|Overall Study|Death|13|||
145976528|NCT01732783|526425221|FG001|Overall Study|Death|4|||
145976529|NCT01732783|526425222|FG002|Overall Study|Death|1|||
145976530|NCT01732783|526425220|FG000|Overall Study|Lost to Follow-up|7|||
145976531|NCT01732783|526425221|FG001|Overall Study|Lost to Follow-up|1|||
145976532|NCT01732783|526425222|FG002|Overall Study|Lost to Follow-up|1|||
145976533|NCT01732783|526425220|FG000|Overall Study|Administrative Decision|8|||
145976534|NCT01732783|526425221|FG001|Overall Study|Administrative Decision|2|||
145976535|NCT01732783|526425222|FG002|Overall Study|Administrative Decision|1|||
145976536|NCT01732783|526425220|FG000|Overall Study|Withdrawal by Subject|1|||
145976537|NCT01732783|526425221|FG001|Overall Study|Withdrawal by Subject|0|||
145976538|NCT01732783|526425222|FG002|Overall Study|Withdrawal by Subject|0|||
145976539|NCT01500083|526425223|FG000|Overall Study|Adverse Event|4|||
145976540|NCT01500083|526425224|FG001|Overall Study|Adverse Event|17|||
145976541|NCT01500083|526425223|FG000|Overall Study|Death|0|||
145976542|NCT01500083|526425224|FG001|Overall Study|Death|2|||
145976543|NCT01500083|526425223|FG000|Overall Study|Lost to Follow-up|1|||
145976544|NCT01500083|526425224|FG001|Overall Study|Lost to Follow-up|0|||
145976545|NCT01500083|526425223|FG000|Overall Study|Withdrawal of Consent|0|||
145976546|NCT01500083|526425224|FG001|Overall Study|Withdrawal of Consent|1|||
145976547|NCT01500083|526425223|FG000|Overall Study|Disease Progression|2|||
145976548|NCT01500083|526425224|FG001|Overall Study|Disease Progression|10|||
145976549|NCT01500083|526425223|FG000|Overall Study|Investigator Discretion|3|||
145976550|NCT01500083|526425224|FG001|Overall Study|Investigator Discretion|8|||
145976551|NCT01500083|526425223|FG000|Overall Study|Other Reasons|2|||
145976552|NCT01500083|526425224|FG001|Overall Study|Other Reasons|5|||
145976553|NCT01555931|526425225|FG000|Overall Study|Lost to Follow-up|2|||
145976554|NCT01555931|526425226|FG001|Overall Study|Lost to Follow-up|5|||
145976555|NCT01697579|526425230|FG000|Base Study-Cycle 1|Adverse Event|1|||
145976556|NCT01697579|526425231|FG001|Base Study-Cycle 1|Adverse Event|0|||
145976557|NCT01697579|526425232|FG002|Base Study-Cycle 1|Adverse Event|0|||
145976558|NCT01697579|526425233|FG003|Base Study-Cycle 1|Adverse Event|0|||
145976559|NCT01697579|526425234|FG004|Base Study-Cycle 1|Adverse Event|0|||
145976560|NCT01697579|526425235|FG005|Base Study-Cycle 1|Adverse Event|0|||
145976561|NCT01697579|526425236|FG006|Base Study-Cycle 1|Adverse Event|0|||
145976562|NCT01697579|526425230|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
145976563|NCT01697579|526425231|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976564|NCT01697579|526425232|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976565|NCT01697579|526425233|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976566|NCT01697579|526425234|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976567|NCT01697579|526425235|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976568|NCT01697579|526425236|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145976569|NCT01697579|526425230|FG000|Base Study-Cycle 1|Protocol Violation|0|||
145976570|NCT01697579|526425231|FG001|Base Study-Cycle 1|Protocol Violation|0|||
145976571|NCT01697579|526425232|FG002|Base Study-Cycle 1|Protocol Violation|0|||
145976572|NCT01697579|526425233|FG003|Base Study-Cycle 1|Protocol Violation|0|||
145976573|NCT01697579|526425234|FG004|Base Study-Cycle 1|Protocol Violation|3|||
145976574|NCT01697579|526425235|FG005|Base Study-Cycle 1|Protocol Violation|0|||
145976575|NCT01697579|526425236|FG006|Base Study-Cycle 1|Protocol Violation|0|||
145976576|NCT01697579|526425230|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976577|NCT01697579|526425231|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
145976578|NCT01697579|526425232|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976579|NCT01697579|526425233|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976580|NCT01697579|526425234|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976581|NCT01697579|526425235|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976582|NCT01697579|526425236|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145976583|NCT01697579|526425230|FG000|Base Study-Cycle 1|Technical Problems|0|||
145976584|NCT01697579|526425231|FG001|Base Study-Cycle 1|Technical Problems|0|||
145976585|NCT01697579|526425232|FG002|Base Study-Cycle 1|Technical Problems|1|||
145976586|NCT01697579|526425233|FG003|Base Study-Cycle 1|Technical Problems|1|||
145976587|NCT01697579|526425234|FG004|Base Study-Cycle 1|Technical Problems|0|||
145976588|NCT01697579|526425235|FG005|Base Study-Cycle 1|Technical Problems|0|||
145976589|NCT01697579|526425236|FG006|Base Study-Cycle 1|Technical Problems|0|||
145976590|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Death|0|||
145976591|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Death|0|||
145923222|NCT03376789|526225746|FG001|Overall Study|Adverse Event|1|||
145923223|NCT03376789|526225745|FG000|Overall Study|Lost to Follow-up|1|||
145923224|NCT03376789|526225746|FG001|Overall Study|Lost to Follow-up|1|||
145923225|NCT03376789|526225745|FG000|Overall Study|Per sponsor due to noncompliance|1|||
145923226|NCT03376789|526225746|FG001|Overall Study|Per sponsor due to noncompliance|0|||
145923227|NCT03376789|526225745|FG000|Overall Study|Subject off study medication|0|||
145923228|NCT03376789|526225746|FG001|Overall Study|Subject off study medication|1|||
145923229|NCT03876743|526225754|FG000|Overall Study|Lost to Follow-up|6|||
145923230|NCT03876743|526225755|FG001|Overall Study|Lost to Follow-up|4|||
145923231|NCT03876743|526225756|FG002|Overall Study|Lost to Follow-up|4|||
145923232|NCT03876743|526225757|FG003|Overall Study|Lost to Follow-up|7|||
145923233|NCT03889418|526225758|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
145923234|NCT03889418|526225759|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923235|NCT03889418|526225760|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923236|NCT03889418|526225761|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923237|NCT03889418|526225762|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923238|NCT03889418|526225763|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923239|NCT03889418|526225764|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923240|NCT03889418|526225765|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923241|NCT03889418|526225766|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923242|NCT03889418|526225767|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145923243|NCT03889418|526225758|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923244|NCT03889418|526225759|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
145923245|NCT03889418|526225760|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
145923246|NCT03889418|526225761|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923247|NCT03889418|526225762|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923248|NCT03889418|526225763|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923249|NCT03889418|526225764|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923250|NCT03889418|526225765|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923251|NCT03889418|526225766|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923252|NCT03889418|526225767|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145923253|NCT03889418|526225758|FG000|October-December 2019 (Month 7-9)|Death|0|||
145923254|NCT03889418|526225759|FG001|October-December 2019 (Month 7-9)|Death|0|||
145923255|NCT03889418|526225760|FG002|October-December 2019 (Month 7-9)|Death|0|||
145923256|NCT03889418|526225761|FG003|October-December 2019 (Month 7-9)|Death|0|||
145923257|NCT03889418|526225762|FG004|October-December 2019 (Month 7-9)|Death|0|||
145923258|NCT03889418|526225763|FG005|October-December 2019 (Month 7-9)|Death|0|||
145923259|NCT03889418|526225764|FG006|October-December 2019 (Month 7-9)|Death|0|||
146243068|NCT01021748|527405307|FG002|Overall Study|Adverse Event|2|||
146243069|NCT01021748|527405308|FG003|Overall Study|Adverse Event|0|||
146243070|NCT01021748|527405309|FG004|Overall Study|Adverse Event|2|||
145923260|NCT03889418|526225765|FG007|October-December 2019 (Month 7-9)|Death|0|||
145923261|NCT03889418|526225766|FG008|October-December 2019 (Month 7-9)|Death|1|||
145923262|NCT03889418|526225767|FG009|October-December 2019 (Month 7-9)|Death|0|||
145923263|NCT03889418|526225758|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923264|NCT03889418|526225759|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923265|NCT03889418|526225760|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923266|NCT03889418|526225761|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
145923267|NCT03889418|526225762|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923268|NCT03889418|526225763|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923269|NCT03889418|526225764|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923270|NCT03889418|526225765|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
145923271|NCT03889418|526225766|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923272|NCT03889418|526225767|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145923273|NCT03889418|526225758|FG000|April - June 2020 (Month 13-15)|Death|0|||
145923274|NCT03889418|526225759|FG001|April - June 2020 (Month 13-15)|Death|1|||
145923275|NCT03889418|526225760|FG002|April - June 2020 (Month 13-15)|Death|0|||
145923276|NCT03889418|526225761|FG003|April - June 2020 (Month 13-15)|Death|0|||
145923277|NCT03889418|526225762|FG004|April - June 2020 (Month 13-15)|Death|0|||
145923278|NCT03889418|526225763|FG005|April - June 2020 (Month 13-15)|Death|0|||
145923279|NCT03889418|526225764|FG006|April - June 2020 (Month 13-15)|Death|0|||
145923280|NCT03889418|526225765|FG007|April - June 2020 (Month 13-15)|Death|0|||
145923281|NCT03889418|526225766|FG008|April - June 2020 (Month 13-15)|Death|0|||
145923282|NCT03889418|526225767|FG009|April - June 2020 (Month 13-15)|Death|0|||
145923283|NCT03889418|526225758|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923284|NCT03889418|526225759|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923285|NCT03889418|526225760|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923286|NCT03889418|526225761|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
145923287|NCT03889418|526225762|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145976592|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Death|0|||
145976593|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Death|0|||
146089980|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Death|0|||
146089981|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Death|0|||
146089982|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Death|1|||
146089983|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Death|0|||
146089984|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Death|0|||
146089985|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Death|0|||
146089986|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Death|0|||
146089987|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Death|1|||
146089988|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
146089989|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089990|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089991|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089992|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089993|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089994|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145976594|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Death|0|||
145976595|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Death|0|||
145976596|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Death|2|||
145976597|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145976598|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145976599|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
146243071|NCT01021748|527405310|FG005|Overall Study|Adverse Event|0|||
145976600|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145976601|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145976602|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
145976603|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
145976604|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
145976605|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
145976606|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
145976607|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
145976608|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
145976609|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
145976610|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
145976611|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976612|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976613|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976614|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976615|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976616|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145976617|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
145976618|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
146089995|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089996|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089997|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
146089998|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
146089999|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146090000|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
146243072|NCT01021748|527405311|FG006|Overall Study|Adverse Event|1|||
146243073|NCT01021748|527405312|FG007|Overall Study|Adverse Event|0|||
146243074|NCT01021748|527405313|FG008|Overall Study|Adverse Event|7|||
146243075|NCT01021748|527405305|FG000|Overall Study|Physician Decision|1|||
145923288|NCT03889418|526225763|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923289|NCT03889418|526225764|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923290|NCT03889418|526225765|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923291|NCT03889418|526225766|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923292|NCT03889418|526225767|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145923293|NCT03889418|526225758|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
145923294|NCT03889418|526225759|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
145923295|NCT03889418|526225760|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
145923296|NCT03889418|526225761|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
145923297|NCT03889418|526225762|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
145923298|NCT03889418|526225763|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
145923299|NCT03889418|526225764|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
145923300|NCT03889418|526225765|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
145923301|NCT03889418|526225766|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
146090001|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145923302|NCT03889418|526225767|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
145976619|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145976620|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145923303|NCT03889418|526225758|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145923304|NCT03889418|526225759|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
145923305|NCT03889418|526225760|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
145923306|NCT03889418|526225761|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
145923307|NCT03889418|526225762|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145923308|NCT03889418|526225763|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145923309|NCT03889418|526225764|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145923310|NCT03889418|526225765|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
145923311|NCT03889418|526225766|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145923312|NCT03889418|526225767|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
145923313|NCT00092118|526225769|FG000|Overall Study|Adverse Event|35|||
145923314|NCT00092118|526225770|FG001|Overall Study|Adverse Event|32|||
145923315|NCT00092118|526225769|FG000|Overall Study|Lack of Efficacy|12|||
145923316|NCT00092118|526225770|FG001|Overall Study|Lack of Efficacy|14|||
145923317|NCT00092118|526225769|FG000|Overall Study|Lost to Follow-up|4|||
145923318|NCT00092118|526225770|FG001|Overall Study|Lost to Follow-up|3|||
145923319|NCT00092118|526225769|FG000|Overall Study|Protocol Violation|23|||
145976621|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145976622|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145976623|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
145976624|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
145976625|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976626|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976627|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976628|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976629|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976630|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
145976631|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145976632|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145976633|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145976634|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145976635|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145976636|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145976637|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
145976638|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
145976639|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145976640|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145976641|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145976642|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145976643|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145976644|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
145976645|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
145976646|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976647|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976648|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976649|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976650|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976651|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145976652|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
145976653|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976654|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976655|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976656|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976657|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976658|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
145976659|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
145976660|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976661|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976662|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976663|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976664|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976665|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
145976666|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
145976667|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145976668|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145923320|NCT00092118|526225770|FG001|Overall Study|Protocol Violation|25|||
145923321|NCT00092118|526225769|FG000|Overall Study|Withdrawal by Subject|4|||
145923322|NCT00092118|526225770|FG001|Overall Study|Withdrawal by Subject|10|||
145923323|NCT00092118|526225769|FG000|Overall Study|Other|6|||
145923324|NCT00092118|526225770|FG001|Overall Study|Other|5|||
145923325|NCT02025725|526225771|FG000|Overall Study|Adverse Event|5|||
145923326|NCT02025725|526225772|FG001|Overall Study|Adverse Event|0|||
145923327|NCT02025725|526225771|FG000|Overall Study|Lost to Follow-up|2|||
145923328|NCT02025725|526225772|FG001|Overall Study|Lost to Follow-up|0|||
145923329|NCT02025725|526225771|FG000|Overall Study|Protocol Violation|1|||
145923330|NCT02025725|526225772|FG001|Overall Study|Protocol Violation|1|||
145923331|NCT02025725|526225771|FG000|Overall Study|Withdrawal by Subject|3|||
145923332|NCT02025725|526225772|FG001|Overall Study|Withdrawal by Subject|2|||
145923333|NCT02025725|526225771|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
145923334|NCT02025725|526225772|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
145923335|NCT02946463|526225773|FG000|Primary Evaluation Period|Physician Decision|0|||
145923336|NCT02946463|526225774|FG001|Primary Evaluation Period|Physician Decision|1|||
145923337|NCT02946463|526225775|FG002|Primary Evaluation Period|Physician Decision|0|||
145923338|NCT02946463|526225776|FG003|Primary Evaluation Period|Physician Decision|0|||
145923339|NCT02946463|526225773|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
145923340|NCT02946463|526225774|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
145923341|NCT02946463|526225775|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
145923342|NCT02946463|526225776|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
145923343|NCT02946463|526225773|FG000|Extension Period|Death|4|||
145923344|NCT02946463|526225774|FG001|Extension Period|Death|4|||
145923345|NCT02946463|526225775|FG002|Extension Period|Death|0|||
145923346|NCT02946463|526225776|FG003|Extension Period|Death|0|||
145923347|NCT02946463|526225773|FG000|Extension Period|Withdrawal by Subject|4|||
145923348|NCT02946463|526225774|FG001|Extension Period|Withdrawal by Subject|3|||
145923349|NCT02946463|526225775|FG002|Extension Period|Withdrawal by Subject|0|||
145923350|NCT02946463|526225776|FG003|Extension Period|Withdrawal by Subject|0|||
145923351|NCT02946463|526225773|FG000|Extension Period|Other than specified|2|||
145923352|NCT02946463|526225774|FG001|Extension Period|Other than specified|3|||
145923353|NCT02946463|526225775|FG002|Extension Period|Other than specified|2|||
145923354|NCT02946463|526225776|FG003|Extension Period|Other than specified|0|||
145923355|NCT02946463|526225773|FG000|Extension Period|Physician Decision|1|||
145923356|NCT02946463|526225774|FG001|Extension Period|Physician Decision|4|||
145923357|NCT02946463|526225775|FG002|Extension Period|Physician Decision|0|||
145923358|NCT02946463|526225776|FG003|Extension Period|Physician Decision|0|||
145923359|NCT02946463|526225773|FG000|Extension Period|Pregnancy|3|||
145923360|NCT02946463|526225774|FG001|Extension Period|Pregnancy|1|||
145923361|NCT02946463|526225775|FG002|Extension Period|Pregnancy|0|||
145923362|NCT02946463|526225776|FG003|Extension Period|Pregnancy|0|||
145923363|NCT02946463|526225773|FG000|Extension Period|Adverse Event|1|||
145923364|NCT02946463|526225774|FG001|Extension Period|Adverse Event|2|||
145923365|NCT02946463|526225775|FG002|Extension Period|Adverse Event|0|||
145923366|NCT02946463|526225776|FG003|Extension Period|Adverse Event|0|||
145923367|NCT02946463|526225773|FG000|Extension Period|Lost to Follow-up|1|||
145923368|NCT02946463|526225774|FG001|Extension Period|Lost to Follow-up|0|||
145923369|NCT02946463|526225775|FG002|Extension Period|Lost to Follow-up|0|||
145923370|NCT02946463|526225776|FG003|Extension Period|Lost to Follow-up|0|||
145923371|NCT05581641|526225777|FG000|Overall Study|Withdrawal by Subject|0|||
145923372|NCT05581641|526225778|FG001|Overall Study|Withdrawal by Subject|1|||
145923373|NCT05581641|526225779|FG002|Overall Study|Withdrawal by Subject|3|||
145923374|NCT05581641|526225780|FG003|Overall Study|Withdrawal by Subject|1|||
145923375|NCT05581641|526225777|FG000|Overall Study|Lost to Follow-up|0|||
145923376|NCT05581641|526225778|FG001|Overall Study|Lost to Follow-up|1|||
145923377|NCT05581641|526225779|FG002|Overall Study|Lost to Follow-up|0|||
145923378|NCT05581641|526225780|FG003|Overall Study|Lost to Follow-up|1|||
145923379|NCT05581641|526225777|FG000|Overall Study|Protocol Violation|1|||
145923380|NCT05581641|526225778|FG001|Overall Study|Protocol Violation|0|||
145923381|NCT05581641|526225779|FG002|Overall Study|Protocol Violation|0|||
145923382|NCT05581641|526225780|FG003|Overall Study|Protocol Violation|0|||
145923383|NCT05581641|526225777|FG000|Overall Study|Other|1|||
145923384|NCT05581641|526225778|FG001|Overall Study|Other|0|||
146243076|NCT01021748|527405306|FG001|Overall Study|Physician Decision|0|||
145923385|NCT05581641|526225779|FG002|Overall Study|Other|2|||
145923386|NCT05581641|526225780|FG003|Overall Study|Other|1|||
145923387|NCT01565889|526225781|FG000|Part A|Withdrawal by Subject|1|||
145923388|NCT01565889|526225782|FG001|Part A|Withdrawal by Subject|0|||
145923389|NCT01565889|526225783|FG002|Part A|Withdrawal by Subject|0|||
146243077|NCT01021748|527405307|FG002|Overall Study|Physician Decision|1|||
145923390|NCT01565889|526225784|FG003|Part A|Withdrawal by Subject|0|||
145923391|NCT01565889|526225785|FG004|Part A|Withdrawal by Subject|0|||
145923392|NCT01565889|526225786|FG005|Part A|Withdrawal by Subject|0|||
145923393|NCT01565889|526225781|FG000|Part B|Withdrawal by Subject|0|||
145923394|NCT01565889|526225782|FG001|Part B|Withdrawal by Subject|0|||
145923395|NCT01565889|526225783|FG002|Part B|Withdrawal by Subject|0|||
145923396|NCT01565889|526225784|FG003|Part B|Withdrawal by Subject|0|||
145976669|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145976670|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145976671|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145976672|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
145976673|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
145923397|NCT01565889|526225785|FG004|Part B|Withdrawal by Subject|0|||
145923398|NCT01565889|526225786|FG005|Part B|Withdrawal by Subject|1|||
145976674|NCT01697579|526425230|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145976675|NCT01697579|526425231|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145976676|NCT01697579|526425232|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145976677|NCT01697579|526425233|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145976678|NCT01697579|526425234|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145976679|NCT01697579|526425235|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145923399|NCT01565889|526225781|FG000|Part B|Lack of Efficacy|0|||
145923400|NCT01565889|526225782|FG001|Part B|Lack of Efficacy|0|||
145923401|NCT01565889|526225783|FG002|Part B|Lack of Efficacy|0|||
145923402|NCT01565889|526225784|FG003|Part B|Lack of Efficacy|0|||
145923403|NCT01565889|526225785|FG004|Part B|Lack of Efficacy|0|||
145923404|NCT01565889|526225786|FG005|Part B|Lack of Efficacy|2|||
145923405|NCT01565889|526225781|FG000|Part B|Lost to Follow-up|0|||
145923406|NCT01565889|526225782|FG001|Part B|Lost to Follow-up|0|||
145923407|NCT01565889|526225783|FG002|Part B|Lost to Follow-up|0|||
145923408|NCT01565889|526225784|FG003|Part B|Lost to Follow-up|0|||
145923409|NCT01565889|526225785|FG004|Part B|Lost to Follow-up|0|||
145923410|NCT01565889|526225786|FG005|Part B|Lost to Follow-up|1|||
145923411|NCT02166333|526225787|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
145923412|NCT02166333|526225788|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145923413|NCT02166333|526225789|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145923414|NCT02166333|526225790|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145923415|NCT02166333|526225791|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
145923416|NCT02166333|526225792|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
145923417|NCT02166333|526225787|FG000|Stage 1|Death|4|||
145923418|NCT02166333|526225788|FG001|Stage 1|Death|0|||
145923419|NCT02166333|526225789|FG002|Stage 1|Death|2|||
145923420|NCT02166333|526225790|FG003|Stage 1|Death|0|||
145923421|NCT02166333|526225791|FG004|Stage 1|Death|3|||
145923422|NCT02166333|526225792|FG005|Stage 1|Death|2|||
145923423|NCT02166333|526225787|FG000|Stage 1|Lost to Follow-up|12|||
145923424|NCT02166333|526225788|FG001|Stage 1|Lost to Follow-up|0|||
145923425|NCT02166333|526225789|FG002|Stage 1|Lost to Follow-up|6|||
145923426|NCT02166333|526225790|FG003|Stage 1|Lost to Follow-up|0|||
145923427|NCT02166333|526225791|FG004|Stage 1|Lost to Follow-up|3|||
145923428|NCT02166333|526225792|FG005|Stage 1|Lost to Follow-up|3|||
145923429|NCT02166333|526225787|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
145923430|NCT02166333|526225788|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
145923431|NCT02166333|526225789|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
145923432|NCT02166333|526225790|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
145923433|NCT02166333|526225791|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
145923434|NCT02166333|526225792|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
145923435|NCT02166333|526225787|FG000|Stage 2|Death|4|||
145923436|NCT02166333|526225788|FG001|Stage 2|Death|2|||
145923437|NCT02166333|526225789|FG002|Stage 2|Death|1|||
145923438|NCT02166333|526225790|FG003|Stage 2|Death|0|||
145923439|NCT02166333|526225791|FG004|Stage 2|Death|0|||
145923440|NCT02166333|526225792|FG005|Stage 2|Death|1|||
145923441|NCT02166333|526225787|FG000|Stage 2|Lost to Follow-up|23|||
145923442|NCT02166333|526225788|FG001|Stage 2|Lost to Follow-up|4|||
145923443|NCT02166333|526225789|FG002|Stage 2|Lost to Follow-up|11|||
145923444|NCT02166333|526225790|FG003|Stage 2|Lost to Follow-up|9|||
145976680|NCT01697579|526425236|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
145976681|NCT01044498|526425237|FG000|Overall Study|Withdrew consent|1|||
145976682|NCT01044498|526425238|FG001|Overall Study|Withdrew consent|1|||
145976683|NCT01044498|526425237|FG000|Overall Study|Adverse Event|1|||
145976684|NCT01044498|526425238|FG001|Overall Study|Adverse Event|1|||
146090002|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
145923445|NCT02166333|526225791|FG004|Stage 2|Lost to Follow-up|3|||
145923446|NCT02166333|526225792|FG005|Stage 2|Lost to Follow-up|6|||
145976685|NCT01044498|526425237|FG000|Overall Study|Other|1|||
146090003|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145923447|NCT02269098|526225793|FG000|Overall Study|Lost to Follow-up|14|||
145923448|NCT02269098|526225794|FG001|Overall Study|Lost to Follow-up|9|||
145923449|NCT00682786|526225802|FG000|Overall Study|Withdrawal by Subject|2|||
145923450|NCT00682786|526225803|FG001|Overall Study|Withdrawal by Subject|2|||
145923451|NCT00682786|526225802|FG000|Overall Study|Did not receive irinotecan|0|||
145923452|NCT00682786|526225803|FG001|Overall Study|Did not receive irinotecan|1|||
145923453|NCT00359424|526225804|FG000|Overall Study|Death|99|||
145923454|NCT00359424|526225805|FG001|Overall Study|Death|58|||
145923455|NCT00359424|526225804|FG000|Overall Study|Lost to Follow-up|19|||
145923456|NCT00359424|526225805|FG001|Overall Study|Lost to Follow-up|7|||
145923457|NCT00359424|526225804|FG000|Overall Study|Withdrawal by Subject|10|||
145923458|NCT00359424|526225805|FG001|Overall Study|Withdrawal by Subject|2|||
145923459|NCT00359424|526225804|FG000|Overall Study|follow up not conducted|2|||
145923460|NCT00359424|526225805|FG001|Overall Study|follow up not conducted|0|||
145923461|NCT02259010|526225810|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
145923462|NCT01445730|526225813|FG000|Overall Study|Adverse Event|1|||
145923463|NCT01445730|526225813|FG000|Overall Study|For the advice of a dentist|1|||
145923464|NCT01445730|526225813|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
145923465|NCT01167140|526225816|FG000|Overall Study|Withdrawal by Subject|1|||
145923466|NCT03805412|526225817|FG000|Overall Study|Lost to Follow-up|0|||
145923467|NCT03805412|526225818|FG001|Overall Study|Lost to Follow-up|1|||
145923468|NCT05514873|526225824|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
145923469|NCT05514873|526225824|FG000|Main Treatment Period|Adverse Event|2|||
145923470|NCT05514873|526225824|FG000|Extension Treatment Period|Lost to Follow-up|3|||
145923471|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
145923472|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
145923473|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
145923474|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
145923475|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
145923476|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
145923477|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
145923478|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145923479|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145923480|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145923481|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
145923482|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
145923483|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
145923484|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
145923485|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
145923486|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
145923487|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
145923488|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
145923489|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
145923490|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
145923491|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
145923492|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
145923493|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
145923494|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
145923495|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
145923496|NCT03525678|526225828|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
145923497|NCT03525678|526225829|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
145923498|NCT03525678|526225830|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145923499|NCT03525678|526225831|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145923500|NCT03525678|526225832|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145923501|NCT05966584|526225833|FG000|Overall Study|Lost to Follow-up|1|||
145923502|NCT05142722|526227622|FG000|Overall Study|Lost to Follow-up|16|||
145923503|NCT05142722|526227623|FG001|Overall Study|Lost to Follow-up|38|||
145923504|NCT05142722|526227622|FG000|Overall Study|Withdrawal by Subject|20|||
145923505|NCT05142722|526227623|FG001|Overall Study|Withdrawal by Subject|27|||
145923506|NCT05142722|526227622|FG000|Overall Study|Death|11|||
145923507|NCT05142722|526227623|FG001|Overall Study|Death|17|||
145923508|NCT05142722|526227622|FG000|Overall Study|Physician Decision|0|||
145923509|NCT05142722|526227623|FG001|Overall Study|Physician Decision|1|||
145923510|NCT05142722|526227622|FG000|Overall Study|Participant Moved Away|0|||
145923511|NCT05142722|526227623|FG001|Overall Study|Participant Moved Away|2|||
145923512|NCT05142722|526227622|FG000|Overall Study|Adverse Event|2|||
145923513|NCT05142722|526227623|FG001|Overall Study|Adverse Event|1|||
145923514|NCT05086744|526227624|FG000|Part A|Adverse Event|0|||
145923515|NCT05086744|526227625|FG001|Part A|Adverse Event|1|||
145923516|NCT05086744|526227624|FG000|Part A|Lack of Efficacy|3|||
145923517|NCT05086744|526227625|FG001|Part A|Lack of Efficacy|0|||
145976686|NCT01044498|526425238|FG001|Overall Study|Other|0|||
145923518|NCT05086744|526227624|FG000|Part A|Protocol deviation|1|||
145923519|NCT05086744|526227625|FG001|Part A|Protocol deviation|0|||
145923520|NCT05086744|526227624|FG000|Part A|Subject decision|1|||
145923521|NCT05086744|526227625|FG001|Part A|Subject decision|0|||
145923522|NCT05086744|526227624|FG000|Part B|Adverse Event|0|||
146297756|NCT02616614|527605981|FG000|Overall Study|Adverse Event|1|||
146297757|NCT02616614|527605982|FG001|Overall Study|Adverse Event|4|||
146090004|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146090005|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146090006|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146090007|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146090008|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
146090009|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146090010|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
146090011|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146090012|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
146090013|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
146090014|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
146090015|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
146090016|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146090017|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146090018|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090019|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
146090020|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090021|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090022|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090023|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090024|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145923523|NCT05086744|526227625|FG001|Part B|Adverse Event|1|||
145923524|NCT05086744|526227624|FG000|Part B|Lack of Efficacy|0|||
145923525|NCT05086744|526227625|FG001|Part B|Lack of Efficacy|1|||
145923526|NCT05086744|526227624|FG000|Part B|Study terminated by sponsor|1|||
145923527|NCT05086744|526227625|FG001|Part B|Study terminated by sponsor|6|||
145923528|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145923529|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145923530|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145923531|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145923532|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145923533|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145923534|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145923535|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145923536|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923537|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923538|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
145923539|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923540|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923541|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
145923542|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923543|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145923544|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145923545|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145923546|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145923547|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145923548|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145923549|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145923550|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145923551|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145923552|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145923553|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145923554|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145923555|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145923556|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145923557|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145923558|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145923559|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145923560|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923561|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923562|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
145923563|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923564|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923565|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923566|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
145923567|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923568|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145923569|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145923570|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
145923571|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145923572|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145923573|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
145923574|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145923575|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
145923576|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
145923577|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
145923578|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923579|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923580|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923581|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923582|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923583|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145923584|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923585|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
145923586|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923587|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923588|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923589|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923590|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923591|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145923592|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923593|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923594|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923595|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923596|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
145923597|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923598|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923599|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145923600|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923601|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923602|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923603|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923604|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923605|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
145923606|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923607|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145923608|NCT03896503|526227626|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923609|NCT03896503|526227627|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923610|NCT03896503|526227628|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923611|NCT03896503|526227629|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923612|NCT03896503|526227630|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923613|NCT03896503|526227631|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
145923614|NCT03896503|526227632|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
145923615|NCT03896503|526227633|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145923616|NCT00437021|526227634|FG000|Overall Study|Adverse Event|0|||
145923617|NCT00437021|526227635|FG001|Overall Study|Adverse Event|0|||
145923618|NCT00437021|526227636|FG002|Overall Study|Adverse Event|0|||
145923619|NCT00437021|526227637|FG003|Overall Study|Adverse Event|0|||
145923620|NCT00437021|526227638|FG004|Overall Study|Adverse Event|0|||
145976687|NCT05513950|526425241|FG000|Overall Study|Not treated due to technical reasons|0|||
145976688|NCT05513950|526425242|FG001|Overall Study|Not treated due to technical reasons|0|||
145976689|NCT05513950|526425243|FG002|Overall Study|Not treated due to technical reasons|1|||
145976690|NCT05513950|526425244|FG003|Overall Study|Not treated due to technical reasons|0|||
145923621|NCT00437021|526227639|FG005|Overall Study|Adverse Event|0|||
145923622|NCT00437021|526227640|FG006|Overall Study|Adverse Event|1|||
145923623|NCT00437021|526227641|FG007|Overall Study|Adverse Event|0|||
145923624|NCT00437021|526227642|FG008|Overall Study|Adverse Event|0|||
145923625|NCT00437021|526227643|FG009|Overall Study|Adverse Event|0|||
145923626|NCT00437021|526227644|FG010|Overall Study|Adverse Event|0|||
145923627|NCT00437021|526227645|FG011|Overall Study|Adverse Event|0|||
145923628|NCT00437021|526227634|FG000|Overall Study|Lost to Follow-up|0|||
145923629|NCT00437021|526227635|FG001|Overall Study|Lost to Follow-up|3|||
145923630|NCT00437021|526227636|FG002|Overall Study|Lost to Follow-up|0|||
145923631|NCT00437021|526227637|FG003|Overall Study|Lost to Follow-up|0|||
145923632|NCT00437021|526227638|FG004|Overall Study|Lost to Follow-up|0|||
145923633|NCT00437021|526227639|FG005|Overall Study|Lost to Follow-up|2|||
145923634|NCT00437021|526227640|FG006|Overall Study|Lost to Follow-up|0|||
145923635|NCT00437021|526227641|FG007|Overall Study|Lost to Follow-up|1|||
145923636|NCT00437021|526227642|FG008|Overall Study|Lost to Follow-up|0|||
145923637|NCT00437021|526227643|FG009|Overall Study|Lost to Follow-up|0|||
145923638|NCT00437021|526227644|FG010|Overall Study|Lost to Follow-up|0|||
145923639|NCT00437021|526227645|FG011|Overall Study|Lost to Follow-up|0|||
145923640|NCT00437021|526227634|FG000|Overall Study|Withdrawal by Subject|2|||
145923641|NCT00437021|526227635|FG001|Overall Study|Withdrawal by Subject|1|||
145923642|NCT00437021|526227636|FG002|Overall Study|Withdrawal by Subject|0|||
145923643|NCT00437021|526227637|FG003|Overall Study|Withdrawal by Subject|0|||
145923644|NCT00437021|526227638|FG004|Overall Study|Withdrawal by Subject|0|||
145923645|NCT00437021|526227639|FG005|Overall Study|Withdrawal by Subject|0|||
145923646|NCT00437021|526227640|FG006|Overall Study|Withdrawal by Subject|0|||
145923647|NCT00437021|526227641|FG007|Overall Study|Withdrawal by Subject|0|||
145923648|NCT00437021|526227642|FG008|Overall Study|Withdrawal by Subject|0|||
145923649|NCT00437021|526227643|FG009|Overall Study|Withdrawal by Subject|0|||
145923650|NCT00437021|526227644|FG010|Overall Study|Withdrawal by Subject|0|||
145923651|NCT00437021|526227645|FG011|Overall Study|Withdrawal by Subject|0|||
145923652|NCT01120184|526227654|FG000|Overall Study|Adverse Event|0|||
145923653|NCT01120184|526227655|FG001|Overall Study|Adverse Event|1|||
145923654|NCT01120184|526227656|FG002|Overall Study|Adverse Event|0|||
145923655|NCT01120184|526227654|FG000|Overall Study|Lost to Follow-up|13|||
145923656|NCT01120184|526227655|FG001|Overall Study|Lost to Follow-up|13|||
145923657|NCT01120184|526227656|FG002|Overall Study|Lost to Follow-up|11|||
145923658|NCT01120184|526227654|FG000|Overall Study|Physician Decision|9|||
145923659|NCT01120184|526227655|FG001|Overall Study|Physician Decision|1|||
145923660|NCT01120184|526227656|FG002|Overall Study|Physician Decision|3|||
145923661|NCT01120184|526227654|FG000|Overall Study|Reason not Specified|8|||
145923662|NCT01120184|526227655|FG001|Overall Study|Reason not Specified|3|||
145923663|NCT01120184|526227656|FG002|Overall Study|Reason not Specified|12|||
145923664|NCT01120184|526227654|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
145923665|NCT01120184|526227655|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
145923666|NCT01120184|526227656|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
145923667|NCT01120184|526227654|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
145923668|NCT01120184|526227655|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
145923669|NCT01120184|526227656|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
145923670|NCT01120184|526227654|FG000|Overall Study|Death|170|||
145923671|NCT01120184|526227655|FG001|Overall Study|Death|176|||
145923672|NCT01120184|526227656|FG002|Overall Study|Death|169|||
145923673|NCT00536939|526227658|FG000|Overall Study|Withdrawal by Subject|1|||
145923674|NCT00536939|526227659|FG001|Overall Study|Withdrawal by Subject|0|||
145923675|NCT00536939|526227658|FG000|Overall Study|Other Complicating Disease|1|||
145923676|NCT00536939|526227659|FG001|Overall Study|Other Complicating Disease|0|||
145923677|NCT01894841|526227662|FG000|Overall Study|Withdrawal by Subject|9|||
145923678|NCT01894841|526227663|FG001|Overall Study|Withdrawal by Subject|4|||
145923679|NCT01894841|526227662|FG000|Overall Study|Withdrawn by investigator|2|||
145923680|NCT01894841|526227663|FG001|Overall Study|Withdrawn by investigator|2|||
145923681|NCT01894841|526227662|FG000|Overall Study|Lost to Follow-up|7|||
145923682|NCT01894841|526227663|FG001|Overall Study|Lost to Follow-up|3|||
145923683|NCT00529087|526227668|FG000|Overall Study|Adverse Event|10|||
145923684|NCT00529087|526227669|FG001|Overall Study|Adverse Event|13|||
145923685|NCT00529087|526227670|FG002|Overall Study|Adverse Event|4|||
145976691|NCT02903914|526425245|FG000|Overall Study|Adverse Event|0|||
145923686|NCT00529087|526227668|FG000|Overall Study|Lost to Follow-up|6|||
145923687|NCT00529087|526227669|FG001|Overall Study|Lost to Follow-up|4|||
145923688|NCT00529087|526227670|FG002|Overall Study|Lost to Follow-up|1|||
145923689|NCT00529087|526227668|FG000|Overall Study|Protocol Violation|8|||
145923690|NCT00529087|526227669|FG001|Overall Study|Protocol Violation|7|||
145923691|NCT00529087|526227670|FG002|Overall Study|Protocol Violation|6|||
145923692|NCT00529087|526227668|FG000|Overall Study|Withdrawal by Subject|3|||
145923693|NCT00529087|526227669|FG001|Overall Study|Withdrawal by Subject|3|||
145976692|NCT02903914|526425246|FG001|Overall Study|Adverse Event|0|||
145923694|NCT00529087|526227670|FG002|Overall Study|Withdrawal by Subject|3|||
145923695|NCT00529087|526227668|FG000|Overall Study|Protocol deviation|1|||
146243078|NCT01021748|527405308|FG003|Overall Study|Physician Decision|1|||
145923696|NCT00529087|526227669|FG001|Overall Study|Protocol deviation|1|||
145923697|NCT00529087|526227670|FG002|Overall Study|Protocol deviation|2|||
145923698|NCT02954601|526227671|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
145923699|NCT02954601|526227672|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
145923700|NCT02954601|526227673|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
145923701|NCT02954601|526227674|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
145923702|NCT00318474|526227675|FG000|Overall Study|Adverse Event|1|||
145923703|NCT00318474|526227676|FG001|Overall Study|Adverse Event|1|||
145923704|NCT00318474|526227675|FG000|Overall Study|Lost to Follow-up|0|||
145923705|NCT00318474|526227676|FG001|Overall Study|Lost to Follow-up|1|||
145923706|NCT00318474|526227675|FG000|Overall Study|Pregnancy|0|||
145923707|NCT00318474|526227676|FG001|Overall Study|Pregnancy|2|||
145923708|NCT00318474|526227675|FG000|Overall Study|Protocol Violation|1|||
145923709|NCT00318474|526227676|FG001|Overall Study|Protocol Violation|0|||
145923710|NCT00318474|526227675|FG000|Overall Study|Withdrawal by Subject|3|||
145923711|NCT00318474|526227676|FG001|Overall Study|Withdrawal by Subject|2|||
145923712|NCT00318474|526227675|FG000|Overall Study|Fall in GFR|3|||
145923713|NCT00318474|526227676|FG001|Overall Study|Fall in GFR|3|||
145923714|NCT00318474|526227675|FG000|Overall Study|Post-therapy hyperflycemia|0|||
145923715|NCT00318474|526227676|FG001|Overall Study|Post-therapy hyperflycemia|1|||
145976693|NCT02903914|526425247|FG002|Overall Study|Adverse Event|1|||
145976694|NCT02903914|526425248|FG003|Overall Study|Adverse Event|0|||
145976695|NCT02903914|526425249|FG004|Overall Study|Adverse Event|0|||
145976696|NCT02903914|526425250|FG005|Overall Study|Adverse Event|0|||
145976697|NCT02903914|526425251|FG006|Overall Study|Adverse Event|2|||
145976698|NCT02903914|526425252|FG007|Overall Study|Adverse Event|0|||
145976699|NCT02903914|526425245|FG000|Overall Study|Withdrawal by Subject|3|||
145976700|NCT02903914|526425246|FG001|Overall Study|Withdrawal by Subject|1|||
145976701|NCT02903914|526425247|FG002|Overall Study|Withdrawal by Subject|28|||
145976702|NCT02903914|526425248|FG003|Overall Study|Withdrawal by Subject|0|||
145976703|NCT02903914|526425249|FG004|Overall Study|Withdrawal by Subject|1|||
145976704|NCT02903914|526425250|FG005|Overall Study|Withdrawal by Subject|2|||
145976705|NCT02903914|526425251|FG006|Overall Study|Withdrawal by Subject|12|||
145976706|NCT02903914|526425252|FG007|Overall Study|Withdrawal by Subject|0|||
145976707|NCT02903914|526425245|FG000|Overall Study|Progressive Disease|1|||
145976708|NCT02903914|526425246|FG001|Overall Study|Progressive Disease|0|||
145976709|NCT02903914|526425247|FG002|Overall Study|Progressive Disease|4|||
145976710|NCT02903914|526425248|FG003|Overall Study|Progressive Disease|0|||
145976711|NCT02903914|526425249|FG004|Overall Study|Progressive Disease|0|||
145976712|NCT02903914|526425250|FG005|Overall Study|Progressive Disease|0|||
145976713|NCT02903914|526425251|FG006|Overall Study|Progressive Disease|2|||
145976714|NCT02903914|526425252|FG007|Overall Study|Progressive Disease|0|||
145976715|NCT02903914|526425245|FG000|Overall Study|Death|0|||
145976716|NCT02903914|526425246|FG001|Overall Study|Death|0|||
145976717|NCT02903914|526425247|FG002|Overall Study|Death|9|||
145976718|NCT02903914|526425248|FG003|Overall Study|Death|0|||
145976719|NCT02903914|526425249|FG004|Overall Study|Death|1|||
145976720|NCT02903914|526425250|FG005|Overall Study|Death|3|||
145976721|NCT02903914|526425251|FG006|Overall Study|Death|24|||
145976722|NCT02903914|526425252|FG007|Overall Study|Death|2|||
145976723|NCT02903914|526425245|FG000|Overall Study|Lost to Follow-up|0|||
145976724|NCT02903914|526425246|FG001|Overall Study|Lost to Follow-up|1|||
145976725|NCT02903914|526425247|FG002|Overall Study|Lost to Follow-up|0|||
145976726|NCT02903914|526425248|FG003|Overall Study|Lost to Follow-up|0|||
145976727|NCT02903914|526425249|FG004|Overall Study|Lost to Follow-up|2|||
145976728|NCT02903914|526425250|FG005|Overall Study|Lost to Follow-up|0|||
145976729|NCT02903914|526425251|FG006|Overall Study|Lost to Follow-up|1|||
145976730|NCT02903914|526425252|FG007|Overall Study|Lost to Follow-up|0|||
145976731|NCT02903914|526425245|FG000|Overall Study|Physician Decision|0|||
145976732|NCT02903914|526425246|FG001|Overall Study|Physician Decision|0|||
145976733|NCT02903914|526425247|FG002|Overall Study|Physician Decision|1|||
145976734|NCT02903914|526425248|FG003|Overall Study|Physician Decision|0|||
146243079|NCT01021748|527405309|FG004|Overall Study|Physician Decision|0|||
145976735|NCT02903914|526425249|FG004|Overall Study|Physician Decision|0|||
146243080|NCT01021748|527405310|FG005|Overall Study|Physician Decision|0|||
146243081|NCT01021748|527405311|FG006|Overall Study|Physician Decision|1|||
146243082|NCT01021748|527405312|FG007|Overall Study|Physician Decision|1|||
146243083|NCT01021748|527405313|FG008|Overall Study|Physician Decision|2|||
145923716|NCT00318474|526227675|FG000|Overall Study|Trial terminated|10|||
145923717|NCT00318474|526227676|FG001|Overall Study|Trial terminated|7|||
145923718|NCT01735916|526227685|FG000|Overall Study|Subject not eligible to be randomized|11|||
145923719|NCT01735916|526227686|FG001|Overall Study|Subject not eligible to be randomized|0|||
145976736|NCT02903914|526425250|FG005|Overall Study|Physician Decision|0|||
145976737|NCT02903914|526425251|FG006|Overall Study|Physician Decision|1|||
145976738|NCT02903914|526425252|FG007|Overall Study|Physician Decision|0|||
145976739|NCT02903914|526425245|FG000|Overall Study|Symptomatic Deterioration|0|||
145976740|NCT02903914|526425246|FG001|Overall Study|Symptomatic Deterioration|0|||
145976741|NCT02903914|526425247|FG002|Overall Study|Symptomatic Deterioration|1|||
146090025|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090026|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
146090027|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
146090028|NCT02414139|526849309|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
146090029|NCT02414139|526849310|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146090030|NCT02414139|526849311|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
146090031|NCT02414139|526849312|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146090032|NCT02414139|526849313|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146090033|NCT02414139|526849314|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
146090034|NCT02414139|526849315|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146090035|NCT02414139|526849316|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146090036|NCT02414139|526849317|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146090037|NCT02414139|526849318|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146090038|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
146090039|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
146090040|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
146090041|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
146090042|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
146090043|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
146090044|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
146090045|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
146090046|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
146090047|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146090048|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146090049|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
146090050|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
146090051|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
146090052|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146090053|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
146090054|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
146090055|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
146090056|NCT00591578|526849319|FG000|Double-Blind Treatment Phase|Other|4|||
146090057|NCT00591578|526849320|FG001|Double-Blind Treatment Phase|Other|9|||
146090058|NCT00591578|526849321|FG002|Double-Blind Treatment Phase|Other|4|||
146090059|NCT00591578|526849319|FG000|Open-Label Extension Phase|Adverse Event|3|||
146090060|NCT00591578|526849320|FG001|Open-Label Extension Phase|Adverse Event|5|||
146090061|NCT00591578|526849321|FG002|Open-Label Extension Phase|Adverse Event|0|||
146090062|NCT00591578|526849319|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
146090063|NCT00591578|526849320|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
146090064|NCT00591578|526849321|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146090065|NCT00591578|526849319|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
146090066|NCT00591578|526849320|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
146090067|NCT00591578|526849321|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146090068|NCT00591578|526849319|FG000|Open-Label Extension Phase|Other|1|||
146090069|NCT00591578|526849320|FG001|Open-Label Extension Phase|Other|0|||
146090070|NCT00591578|526849321|FG002|Open-Label Extension Phase|Other|0|||
146090071|NCT02632838|526849322|FG000|Overall Study|Withdrawal by Subject|3|||
146090072|NCT02632838|526849323|FG001|Overall Study|Withdrawal by Subject|0|||
146090073|NCT02632838|526849322|FG000|Overall Study|Lost to Follow-up|0|||
146090074|NCT02632838|526849323|FG001|Overall Study|Lost to Follow-up|2|||
146090075|NCT03945175|526849324|FG000|Overall Study|Did not meet inclusion criteria|31|||
146090076|NCT03945175|526849324|FG000|Overall Study|Withdrew consent|2|||
146090077|NCT03945175|526849324|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
146090078|NCT03945175|526849324|FG000|Overall Study|Early termination during Mydayis treatment|1|||
146090079|NCT00769483|526849332|FG000|Overall Study|Withdrawal by Subject|0|||
146090080|NCT00769483|526849333|FG001|Overall Study|Withdrawal by Subject|1|||
146090081|NCT00769483|526849334|FG002|Overall Study|Withdrawal by Subject|0|||
146090082|NCT00769483|526849335|FG003|Overall Study|Withdrawal by Subject|0|||
146090083|NCT00769483|526849336|FG004|Overall Study|Withdrawal by Subject|1|||
146090084|NCT00769483|526849337|FG005|Overall Study|Withdrawal by Subject|0|||
146090085|NCT01306877|526849338|FG000|Overall Study|Lost to Follow-up|3|||
146090086|NCT01306877|526849339|FG001|Overall Study|Lost to Follow-up|3|||
146090087|NCT01306877|526849338|FG000|Overall Study|Physician Decision|0|||
146090088|NCT01306877|526849339|FG001|Overall Study|Physician Decision|1|||
146090089|NCT00006389|526849340|FG000|Overall Study|Adverse Event|1|||
146090090|NCT00999921|526849344|FG000|Overall Study|Lost to Follow-up|10|||
146090091|NCT00999921|526849345|FG001|Overall Study|Lost to Follow-up|19|||
146090092|NCT00772070|526849352|FG000|Overall Study|Lost to Follow-up|0|||
146090093|NCT00772070|526849353|FG001|Overall Study|Lost to Follow-up|8|||
146090094|NCT00772070|526849352|FG000|Overall Study|Withdrawal by Subject|0|||
146090095|NCT00772070|526849353|FG001|Overall Study|Withdrawal by Subject|2|||
145923720|NCT01735916|526227687|FG002|Overall Study|Subject not eligible to be randomized|0|||
145923721|NCT01735916|526227685|FG000|Overall Study|Early termination of study by sponsor|4|||
145923722|NCT01735916|526227686|FG001|Overall Study|Early termination of study by sponsor|19|||
145923723|NCT01735916|526227687|FG002|Overall Study|Early termination of study by sponsor|7|||
145923724|NCT01735916|526227685|FG000|Overall Study|Withdrawal by Subject|3|||
145923725|NCT01735916|526227686|FG001|Overall Study|Withdrawal by Subject|0|||
145923726|NCT01735916|526227687|FG002|Overall Study|Withdrawal by Subject|0|||
145923727|NCT04227197|526227712|FG000|Randomization|Protocol Violation|1|||
145923728|NCT04227197|526227713|FG001|Randomization|Protocol Violation|0|||
145923729|NCT04227197|526227712|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
145923730|NCT04227197|526227713|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
145923731|NCT04227197|526227712|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
145923732|NCT04227197|526227713|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
145923733|NCT04227197|526227712|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
145923734|NCT04227197|526227713|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
145923735|NCT04227197|526227712|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
145923736|NCT04227197|526227713|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
145923737|NCT04227197|526227712|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
145923738|NCT04227197|526227713|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
145923739|NCT04227197|526227712|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
145923740|NCT04227197|526227713|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
145923741|NCT01209949|526227723|FG000|Overall Study|Lost to Follow-up|3|||
145923742|NCT00708552|526227728|FG000|Overall Study|Adverse Event|10|||
145923743|NCT00708552|526227729|FG001|Overall Study|Adverse Event|3|||
145923744|NCT00708552|526227730|FG002|Overall Study|Adverse Event|4|||
145923745|NCT00708552|526227731|FG003|Overall Study|Adverse Event|6|||
145923746|NCT00708552|526227728|FG000|Overall Study|Lack of Efficacy|0|||
145923747|NCT00708552|526227729|FG001|Overall Study|Lack of Efficacy|4|||
145923748|NCT00708552|526227730|FG002|Overall Study|Lack of Efficacy|1|||
145923749|NCT00708552|526227731|FG003|Overall Study|Lack of Efficacy|0|||
145923750|NCT00708552|526227728|FG000|Overall Study|Protocol Violation|0|||
145923751|NCT00708552|526227729|FG001|Overall Study|Protocol Violation|0|||
145923752|NCT00708552|526227730|FG002|Overall Study|Protocol Violation|2|||
145923753|NCT00708552|526227731|FG003|Overall Study|Protocol Violation|4|||
145923754|NCT00708552|526227728|FG000|Overall Study|Lost to Follow-up|4|||
145923755|NCT00708552|526227729|FG001|Overall Study|Lost to Follow-up|2|||
145923756|NCT00708552|526227730|FG002|Overall Study|Lost to Follow-up|0|||
145923757|NCT00708552|526227731|FG003|Overall Study|Lost to Follow-up|1|||
145923758|NCT00708552|526227728|FG000|Overall Study|Physician Decision|1|||
145923759|NCT00708552|526227729|FG001|Overall Study|Physician Decision|2|||
145923760|NCT00708552|526227730|FG002|Overall Study|Physician Decision|0|||
145923761|NCT00708552|526227731|FG003|Overall Study|Physician Decision|0|||
145923762|NCT00708552|526227728|FG000|Overall Study|Withdrawal by Subject|12|||
145923763|NCT00708552|526227729|FG001|Overall Study|Withdrawal by Subject|7|||
145923764|NCT00708552|526227730|FG002|Overall Study|Withdrawal by Subject|8|||
145923765|NCT00708552|526227731|FG003|Overall Study|Withdrawal by Subject|10|||
145923766|NCT04878432|526227733|FG000|Overall Study|Adverse Event|1|||
145923767|NCT04878432|526227733|FG000|Overall Study|Death|2|||
145923768|NCT04878432|526227733|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145923769|NCT04878432|526227733|FG000|Overall Study|Withdrawal by Subject|6|||
145923770|NCT04878432|526227733|FG000|Overall Study|Progressive Disease|7|||
145923771|NCT04878432|526227733|FG000|Overall Study|New Therapy for Study Indication|7|||
145923772|NCT04878432|526227733|FG000|Overall Study|Physician Decision|11|||
145923773|NCT03971071|526227734|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145923774|NCT03971071|526227735|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
145923775|NCT03971071|526227736|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145923776|NCT03971071|526227737|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145923777|NCT03971071|526227738|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145923778|NCT03971071|526227734|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
145923779|NCT03971071|526227735|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
145923780|NCT03971071|526227736|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
145923781|NCT03971071|526227737|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145923782|NCT03971071|526227738|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145923783|NCT03971071|526227734|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
145923784|NCT03971071|526227735|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
145923785|NCT03971071|526227736|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
145923786|NCT03971071|526227737|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
145923787|NCT03971071|526227738|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
145976742|NCT02903914|526425248|FG003|Overall Study|Symptomatic Deterioration|0|||
145976743|NCT02903914|526425249|FG004|Overall Study|Symptomatic Deterioration|0|||
145976744|NCT02903914|526425250|FG005|Overall Study|Symptomatic Deterioration|0|||
145976745|NCT02903914|526425251|FG006|Overall Study|Symptomatic Deterioration|0|||
146090096|NCT00772070|526849352|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
146090097|NCT00772070|526849353|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
146090098|NCT01309308|526849354|FG000|Overall Study|Lost to Follow-up|6|||
146090099|NCT01309308|526849355|FG001|Overall Study|Lost to Follow-up|4|||
146090100|NCT01307020|526849357|FG000|Overall Study|Lost to Follow-up|0|||
146090101|NCT01307020|526849358|FG001|Overall Study|Lost to Follow-up|0|||
146090102|NCT01307020|526849359|FG002|Overall Study|Lost to Follow-up|1|||
146090103|NCT01307020|526849360|FG003|Overall Study|Lost to Follow-up|1|||
146090104|NCT01307020|526849361|FG004|Overall Study|Lost to Follow-up|0|||
146090105|NCT01307020|526849362|FG005|Overall Study|Lost to Follow-up|0|||
146090106|NCT01307020|526849363|FG006|Overall Study|Lost to Follow-up|1|||
146090107|NCT01307020|526849364|FG007|Overall Study|Lost to Follow-up|0|||
146090108|NCT01307020|526849365|FG008|Overall Study|Lost to Follow-up|0|||
146090109|NCT01307020|526849366|FG009|Overall Study|Lost to Follow-up|0|||
146090110|NCT01307020|526849357|FG000|Overall Study|Electronic data capture failure|0|||
146090111|NCT01307020|526849358|FG001|Overall Study|Electronic data capture failure|1|||
146090112|NCT01307020|526849359|FG002|Overall Study|Electronic data capture failure|0|||
146090113|NCT01307020|526849360|FG003|Overall Study|Electronic data capture failure|0|||
146090114|NCT01307020|526849361|FG004|Overall Study|Electronic data capture failure|0|||
146090115|NCT01307020|526849362|FG005|Overall Study|Electronic data capture failure|0|||
146090116|NCT01307020|526849363|FG006|Overall Study|Electronic data capture failure|0|||
146090117|NCT01307020|526849364|FG007|Overall Study|Electronic data capture failure|0|||
146090118|NCT01307020|526849365|FG008|Overall Study|Electronic data capture failure|0|||
146090119|NCT01307020|526849366|FG009|Overall Study|Electronic data capture failure|0|||
146090120|NCT02380690|526849367|FG000|Overall Study|Lost to Follow-up|14|||
146090121|NCT02380690|526849368|FG001|Overall Study|Lost to Follow-up|4|||
146090122|NCT02380690|526849367|FG000|Overall Study|Withdrawal by Subject|20|||
146090123|NCT02380690|526849368|FG001|Overall Study|Withdrawal by Subject|8|||
146090124|NCT00266864|526849369|FG000|Overall Study|Lost to Follow-up|4|||
146090125|NCT00266864|526849370|FG001|Overall Study|Lost to Follow-up|1|||
146090126|NCT00266864|526849369|FG000|Overall Study|Withdrawal by Subject|1|||
146090127|NCT00266864|526849370|FG001|Overall Study|Withdrawal by Subject|1|||
146090128|NCT03687970|526849378|FG000|Overall Study|visit scheduling conflicts|2|||
146090129|NCT03687970|526849379|FG001|Overall Study|visit scheduling conflicts|0|||
146090130|NCT03119701|526849380|FG000|6-day Dosing|Death|4|||
146090131|NCT03119701|526849381|FG001|6-day Dosing|Death|1|||
146090132|NCT03119701|526849380|FG000|6-day Dosing|Adverse Event|3|||
146090133|NCT03119701|526849381|FG001|6-day Dosing|Adverse Event|0|||
146090134|NCT03119701|526849380|FG000|6-day Dosing|Physician Decision|0|||
146090135|NCT03119701|526849381|FG001|6-day Dosing|Physician Decision|1|||
146090136|NCT03119701|526849380|FG000|6-day Dosing|Withdrawal by Subject|0|||
146090137|NCT03119701|526849381|FG001|6-day Dosing|Withdrawal by Subject|1|||
146090138|NCT03119701|526849380|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
146090139|NCT03119701|526849381|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
146090140|NCT03607422|526851255|FG000|Overall Study|Adverse Event|7|||
146090141|NCT03607422|526851256|FG001|Overall Study|Adverse Event|3|||
146090142|NCT03607422|526851257|FG002|Overall Study|Adverse Event|2|||
146090143|NCT03607422|526851258|FG003|Overall Study|Adverse Event|0|||
146090144|NCT03607422|526851259|FG004|Overall Study|Adverse Event|2|||
146090145|NCT03607422|526851260|FG005|Overall Study|Adverse Event|0|||
146090146|NCT03607422|526851255|FG000|Overall Study|Withdrawal by Subject|11|||
146090147|NCT03607422|526851256|FG001|Overall Study|Withdrawal by Subject|3|||
146090148|NCT03607422|526851257|FG002|Overall Study|Withdrawal by Subject|6|||
146090149|NCT03607422|526851258|FG003|Overall Study|Withdrawal by Subject|2|||
146090150|NCT03607422|526851259|FG004|Overall Study|Withdrawal by Subject|0|||
146090151|NCT03607422|526851260|FG005|Overall Study|Withdrawal by Subject|0|||
146090152|NCT03607422|526851255|FG000|Overall Study|Lost to Follow-up|0|||
146090153|NCT03607422|526851256|FG001|Overall Study|Lost to Follow-up|0|||
146243084|NCT01021748|527405305|FG000|Overall Study|Progressive Disease|3|||
146243085|NCT01021748|527405306|FG001|Overall Study|Progressive Disease|3|||
146243086|NCT01021748|527405307|FG002|Overall Study|Progressive Disease|4|||
146243087|NCT01021748|527405308|FG003|Overall Study|Progressive Disease|6|||
146243088|NCT01021748|527405309|FG004|Overall Study|Progressive Disease|7|||
146243089|NCT01021748|527405310|FG005|Overall Study|Progressive Disease|3|||
146243090|NCT01021748|527405311|FG006|Overall Study|Progressive Disease|0|||
146243091|NCT01021748|527405312|FG007|Overall Study|Progressive Disease|5|||
146090154|NCT03607422|526851257|FG002|Overall Study|Lost to Follow-up|1|||
146090155|NCT03607422|526851258|FG003|Overall Study|Lost to Follow-up|0|||
146090156|NCT03607422|526851259|FG004|Overall Study|Lost to Follow-up|0|||
146090157|NCT03607422|526851260|FG005|Overall Study|Lost to Follow-up|0|||
146090158|NCT03607422|526851255|FG000|Overall Study|Other|12|||
146090159|NCT03607422|526851256|FG001|Overall Study|Other|4|||
146090160|NCT03607422|526851257|FG002|Overall Study|Other|1|||
146090161|NCT03607422|526851258|FG003|Overall Study|Other|2|||
146090162|NCT03607422|526851259|FG004|Overall Study|Other|0|||
146243092|NCT01021748|527405313|FG008|Overall Study|Progressive Disease|6|||
146090163|NCT03607422|526851260|FG005|Overall Study|Other|2|||
146090164|NCT03607422|526851255|FG000|Overall Study|Ongoing at Time of Analysis|8|||
146090165|NCT03607422|526851256|FG001|Overall Study|Ongoing at Time of Analysis|0|||
146090166|NCT03607422|526851257|FG002|Overall Study|Ongoing at Time of Analysis|2|||
146090167|NCT03607422|526851258|FG003|Overall Study|Ongoing at Time of Analysis|1|||
146090168|NCT03607422|526851259|FG004|Overall Study|Ongoing at Time of Analysis|1|||
146090169|NCT03607422|526851260|FG005|Overall Study|Ongoing at Time of Analysis|1|||
146090170|NCT00053365|526851261|FG000|Overall Study|Incorrect cell type|1|||
146090171|NCT00053365|526851261|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
146090172|NCT00053365|526851261|FG000|Overall Study|Never treated|4|||
146090173|NCT03183778|526851264|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
146090174|NCT00721123|526851266|FG000|Overall Study|Adverse Event|96|||
146090175|NCT00721123|526851266|FG000|Overall Study|Death|10|||
146090176|NCT00721123|526851266|FG000|Overall Study|Insufficient Therapeutic Response|21|||
146090177|NCT00721123|526851266|FG000|Overall Study|Protocol Violation|1|||
146090178|NCT00721123|526851266|FG000|Overall Study|Refused Treatment|41|||
146090179|NCT00721123|526851266|FG000|Overall Study|Failure to Return|9|||
146090180|NCT00721123|526851266|FG000|Overall Study|Withdrawal by Subject|5|||
146090181|NCT03228420|526851271|FG000|Overall Study|Lost to Follow-up|5|||
146090182|NCT03228420|526851272|FG001|Overall Study|Lost to Follow-up|3|||
146090183|NCT03228420|526851271|FG000|Overall Study|Withdrawal by Subject|10|||
146090184|NCT03228420|526851272|FG001|Overall Study|Withdrawal by Subject|0|||
146090185|NCT03228420|526851271|FG000|Overall Study|Adverse Event|5|||
146090186|NCT03228420|526851272|FG001|Overall Study|Adverse Event|2|||
146090187|NCT03954041|526851275|FG000|Overall Study|Lost to Follow-up|3|||
146090188|NCT03954041|526851276|FG001|Overall Study|Lost to Follow-up|3|||
146243093|NCT01021748|527405305|FG000|Overall Study|Withdrawal by Subject|0|||
146243094|NCT01021748|527405306|FG001|Overall Study|Withdrawal by Subject|0|||
146243095|NCT01021748|527405307|FG002|Overall Study|Withdrawal by Subject|0|||
146243096|NCT01021748|527405308|FG003|Overall Study|Withdrawal by Subject|0|||
146243097|NCT01021748|527405309|FG004|Overall Study|Withdrawal by Subject|0|||
146243098|NCT01021748|527405310|FG005|Overall Study|Withdrawal by Subject|0|||
146243099|NCT01021748|527405311|FG006|Overall Study|Withdrawal by Subject|1|||
146243100|NCT01021748|527405312|FG007|Overall Study|Withdrawal by Subject|0|||
146090189|NCT03954041|526851277|FG002|Overall Study|Lost to Follow-up|6|||
146090190|NCT03954041|526851275|FG000|Overall Study|Death|4|||
146090191|NCT03954041|526851276|FG001|Overall Study|Death|0|||
146090192|NCT03954041|526851277|FG002|Overall Study|Death|1|||
146090193|NCT03954041|526851275|FG000|Overall Study|Death by neurologic criteria|0|||
146090194|NCT03954041|526851276|FG001|Overall Study|Death by neurologic criteria|0|||
146090195|NCT03954041|526851277|FG002|Overall Study|Death by neurologic criteria|1|||
146090196|NCT03954041|526851275|FG000|Overall Study|Reason not specified|7|||
146090197|NCT03954041|526851276|FG001|Overall Study|Reason not specified|4|||
146090198|NCT03954041|526851277|FG002|Overall Study|Reason not specified|2|||
146090199|NCT03954041|526851275|FG000|Overall Study|Withdrew prior to dosing|4|||
146090200|NCT03954041|526851276|FG001|Overall Study|Withdrew prior to dosing|2|||
146090201|NCT03954041|526851277|FG002|Overall Study|Withdrew prior to dosing|0|||
146090202|NCT03981822|526851278|FG000|Overall Study|Lost to Follow-up|0|||
146090203|NCT03981822|526851279|FG001|Overall Study|Lost to Follow-up|1|||
146090204|NCT03981822|526851280|FG002|Overall Study|Lost to Follow-up|1|||
146090205|NCT03981822|526851281|FG003|Overall Study|Lost to Follow-up|0|||
146090206|NCT03981822|526851282|FG004|Overall Study|Lost to Follow-up|6|||
146090207|NCT03981822|526851283|FG005|Overall Study|Lost to Follow-up|4|||
146090208|NCT03981822|526851284|FG006|Overall Study|Lost to Follow-up|4|||
146090209|NCT03981822|526851285|FG007|Overall Study|Lost to Follow-up|2|||
146090210|NCT03981822|526851278|FG000|Overall Study|Withdrawal by Subject|0|||
146090211|NCT03981822|526851279|FG001|Overall Study|Withdrawal by Subject|1|||
146090212|NCT03981822|526851280|FG002|Overall Study|Withdrawal by Subject|0|||
146090213|NCT03981822|526851281|FG003|Overall Study|Withdrawal by Subject|0|||
146090214|NCT03981822|526851282|FG004|Overall Study|Withdrawal by Subject|0|||
146090215|NCT03981822|526851283|FG005|Overall Study|Withdrawal by Subject|1|||
146090216|NCT03981822|526851284|FG006|Overall Study|Withdrawal by Subject|0|||
146243101|NCT01021748|527405313|FG008|Overall Study|Withdrawal by Subject|1|||
146243102|NCT01021748|527405305|FG000|Overall Study|Not Treated|0|||
146243103|NCT01021748|527405306|FG001|Overall Study|Not Treated|1|||
146297758|NCT02616614|527605983|FG002|Overall Study|Adverse Event|1|||
146297759|NCT02616614|527605981|FG000|Overall Study|Protocol Violation|0|||
146297760|NCT02616614|527605982|FG001|Overall Study|Protocol Violation|3|||
146090217|NCT03981822|526851285|FG007|Overall Study|Withdrawal by Subject|2|||
146090218|NCT03981822|526851278|FG000|Overall Study|COVID-19 Related|0|||
146090219|NCT03981822|526851279|FG001|Overall Study|COVID-19 Related|0|||
146243104|NCT01021748|527405307|FG002|Overall Study|Not Treated|0|||
146243105|NCT01021748|527405308|FG003|Overall Study|Not Treated|0|||
146090220|NCT03981822|526851280|FG002|Overall Study|COVID-19 Related|0|||
146090221|NCT03981822|526851281|FG003|Overall Study|COVID-19 Related|0|||
146090222|NCT03981822|526851282|FG004|Overall Study|COVID-19 Related|2|||
146090223|NCT03981822|526851283|FG005|Overall Study|COVID-19 Related|1|||
146090224|NCT03981822|526851284|FG006|Overall Study|COVID-19 Related|2|||
146090225|NCT03981822|526851285|FG007|Overall Study|COVID-19 Related|1|||
146090226|NCT02742246|526851286|FG000|Overall Study|Never initiated treatment|5|||
146090227|NCT02742246|526851287|FG001|Overall Study|Never initiated treatment|3|||
146090228|NCT02742246|526851288|FG002|Overall Study|Never initiated treatment|1|||
146090229|NCT02742246|526851286|FG000|Overall Study|dropped out during treatment|7|||
146090230|NCT02742246|526851287|FG001|Overall Study|dropped out during treatment|13|||
146090231|NCT02742246|526851288|FG002|Overall Study|dropped out during treatment|10|||
146090232|NCT02742246|526851286|FG000|Overall Study|Death|1|||
146090233|NCT02742246|526851287|FG001|Overall Study|Death|0|||
146090234|NCT02742246|526851288|FG002|Overall Study|Death|0|||
146090235|NCT03489551|526851289|FG000|Overall Study|Withdrawal by Subject|2|||
146090236|NCT00054717|526851290|FG000|Overall Study|Randomized but not treated|2|||
146090237|NCT00054717|526851291|FG001|Overall Study|Randomized but not treated|8|||
146090238|NCT00054717|526851290|FG000|Overall Study|Adverse Event|70|||
146090239|NCT00054717|526851291|FG001|Overall Study|Adverse Event|22|||
146090240|NCT00054717|526851290|FG000|Overall Study|Protocol Violation|18|||
146090241|NCT00054717|526851291|FG001|Overall Study|Protocol Violation|19|||
146090242|NCT00054717|526851290|FG000|Overall Study|Lost to Follow-up|23|||
146090243|NCT00054717|526851291|FG001|Overall Study|Lost to Follow-up|13|||
146090244|NCT00054717|526851290|FG000|Overall Study|Withdrawal by Subject|32|||
146090245|NCT00054717|526851291|FG001|Overall Study|Withdrawal by Subject|20|||
146090246|NCT00054717|526851290|FG000|Overall Study|Other reason not defined above|117|||
146090247|NCT00054717|526851291|FG001|Overall Study|Other reason not defined above|217|||
146090248|NCT00206076|526851294|FG000|Overall Study|Physician Decision|2|||
146090249|NCT00206076|526851295|FG001|Overall Study|Physician Decision|0|||
146090250|NCT00206076|526851294|FG000|Overall Study|Withdrawal by Subject|1|||
146090251|NCT00206076|526851295|FG001|Overall Study|Withdrawal by Subject|1|||
146090252|NCT01142128|526851297|FG000|Overall Study|Physician Decision|1|||
146090253|NCT01142128|526851297|FG000|Overall Study|Lost to Follow-up|1|||
146090254|NCT01142128|526851297|FG000|Overall Study|Withdrawal by Subject|2|||
146090255|NCT03355664|526851298|FG000|Overall Study|Adverse Event|1|||
146090256|NCT03355664|526851299|FG001|Overall Study|Adverse Event|2|||
146090257|NCT03355664|526851298|FG000|Overall Study|Lost to Follow-up|11|||
146090258|NCT03355664|526851299|FG001|Overall Study|Lost to Follow-up|7|||
146090259|NCT03355664|526851298|FG000|Overall Study|Protocol Violation|1|||
146090260|NCT03355664|526851299|FG001|Overall Study|Protocol Violation|2|||
146090261|NCT03355664|526851298|FG000|Overall Study|Withdrawal by Subject|2|||
146090262|NCT03355664|526851299|FG001|Overall Study|Withdrawal by Subject|1|||
146090263|NCT04163718|526851305|FG000|Overall Study|Study terminated|12|||
146090264|NCT01466595|526851306|FG000|Overall Study|Withdrawal by Subject|0|||
146090265|NCT01466595|526851307|FG001|Overall Study|Withdrawal by Subject|1|||
146090266|NCT02376829|526851310|FG000|Overall Study|Withdrawal by Subject|27|||
146090267|NCT02376829|526851311|FG001|Overall Study|Withdrawal by Subject|44|||
146090268|NCT03631355|526851312|FG000|Overall Study|Lost to Follow-up|1|||
146090269|NCT03631355|526851313|FG001|Overall Study|Lost to Follow-up|2|||
146090270|NCT02810340|526851314|FG000|Overall Study|Withdrawal by Subject|1|||
146090271|NCT02810340|526851315|FG001|Overall Study|Withdrawal by Subject|0|||
146090272|NCT02810340|526851316|FG002|Overall Study|Withdrawal by Subject|0|||
146090273|NCT02810340|526851314|FG000|Overall Study|Incarceration|0|||
146243106|NCT01021748|527405309|FG004|Overall Study|Not Treated|0|||
146243107|NCT01021748|527405310|FG005|Overall Study|Not Treated|0|||
146243108|NCT01021748|527405311|FG006|Overall Study|Not Treated|0|||
146243109|NCT01021748|527405312|FG007|Overall Study|Not Treated|0|||
146243110|NCT01021748|527405313|FG008|Overall Study|Not Treated|0|||
146243111|NCT01829711|527405314|FG000|Overall Study|Lost to Follow-up|2|||
146243112|NCT01829711|527405314|FG000|Overall Study|Withdrawal by Subject|3|||
146243113|NCT01829711|527405314|FG000|Overall Study|Death|4|||
146243114|NCT01829711|527405314|FG000|Overall Study|Started new therapies|17|||
146243115|NCT01829711|527405314|FG000|Overall Study|Adverse Event|3|||
146243116|NCT01829711|527405314|FG000|Overall Study|Due to progression of disease|13|||
146243117|NCT01829711|527405314|FG000|Overall Study|Due to lack of response|1|||
146243118|NCT02935673|527405317|FG000|Overall Study|Adverse Event|0|||
146243119|NCT02935673|527405318|FG001|Overall Study|Adverse Event|1|||
146243120|NCT02935673|527405319|FG002|Overall Study|Adverse Event|0|||
146243121|NCT02935673|527405317|FG000|Overall Study|Withdrawal by Subject|1|||
146090274|NCT02810340|526851315|FG001|Overall Study|Incarceration|1|||
146090275|NCT02810340|526851316|FG002|Overall Study|Incarceration|0|||
146090276|NCT02810340|526851314|FG000|Overall Study|Lost to Follow-up|0|||
146090277|NCT02810340|526851315|FG001|Overall Study|Lost to Follow-up|0|||
146090278|NCT02810340|526851316|FG002|Overall Study|Lost to Follow-up|1|||
146090279|NCT00870233|526851319|FG000|Overall Study|Withdrawal by Subject|18|||
146090280|NCT00870233|526851319|FG000|Overall Study|Did not undergo laparotomy|3|||
146090281|NCT00870233|526851319|FG000|Overall Study|Incompatible internet browser|2|||
146090282|NCT00870233|526851319|FG000|Overall Study|Death|1|||
146090283|NCT01962922|526851329|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
146090284|NCT01962922|526851330|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
146243122|NCT02935673|527405318|FG001|Overall Study|Withdrawal by Subject|2|||
146090285|NCT01962922|526851329|FG000|PK Portion Day 7|non-compliance|1|||
146090286|NCT01962922|526851330|FG001|PK Portion Day 7|non-compliance|0|||
146243123|NCT02935673|527405319|FG002|Overall Study|Withdrawal by Subject|0|||
146297761|NCT02616614|527605983|FG002|Overall Study|Protocol Violation|1|||
145923788|NCT03971071|526227734|FG000|Open-label Treatment Period|Sponsor decision|0|||
145923789|NCT03971071|526227735|FG001|Open-label Treatment Period|Sponsor decision|0|||
145923790|NCT03971071|526227736|FG002|Open-label Treatment Period|Sponsor decision|0|||
145923791|NCT03971071|526227737|FG003|Open-label Treatment Period|Sponsor decision|0|||
145923792|NCT03971071|526227738|FG004|Open-label Treatment Period|Sponsor decision|1|||
145923793|NCT03971071|526227734|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
145923794|NCT03971071|526227735|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145923795|NCT03971071|526227736|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
145923796|NCT03971071|526227737|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
145923797|NCT03971071|526227738|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
145923798|NCT03971071|526227734|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145923799|NCT03971071|526227735|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
145923800|NCT03971071|526227736|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
145923801|NCT03971071|526227737|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
145923802|NCT03971071|526227738|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
145923803|NCT05266053|526227746|FG000|Overall Study|Withdrawal by Subject|8|||
145923804|NCT05266053|526227747|FG001|Overall Study|Withdrawal by Subject|4|||
145923805|NCT02996968|526227748|FG000|Overall Study|Withdrawal by Subject|1|||
145923806|NCT02996968|526227749|FG001|Overall Study|Withdrawal by Subject|0|||
145923807|NCT03817853|526227750|FG000|Induction Phase|Adverse Event|5|||
145923808|NCT03817853|526227751|FG001|Induction Phase|Adverse Event|0|||
145923809|NCT03817853|526227752|FG002|Induction Phase|Adverse Event|0|||
145923810|NCT03817853|526227750|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
145923811|NCT03817853|526227751|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
145923812|NCT03817853|526227752|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
145923813|NCT03817853|526227750|FG000|Induction Phase|Physician Decision|2|||
145923814|NCT03817853|526227751|FG001|Induction Phase|Physician Decision|0|||
145923815|NCT03817853|526227752|FG002|Induction Phase|Physician Decision|0|||
145923816|NCT03817853|526227750|FG000|Induction Phase|Progressive Disease|6|||
145923817|NCT03817853|526227751|FG001|Induction Phase|Progressive Disease|0|||
145976746|NCT02903914|526425252|FG007|Overall Study|Symptomatic Deterioration|0|||
145976747|NCT02903914|526425245|FG000|Overall Study|New Cancer Therapy|2|||
145923818|NCT03817853|526227752|FG002|Induction Phase|Progressive Disease|0|||
145923819|NCT03817853|526227750|FG000|Induction Phase|Withdrawal by Subject|4|||
145923820|NCT03817853|526227751|FG001|Induction Phase|Withdrawal by Subject|0|||
145923821|NCT03817853|526227752|FG002|Induction Phase|Withdrawal by Subject|0|||
145923822|NCT03817853|526227750|FG000|Maintenance Phase|Adverse Event|0|||
145923823|NCT03817853|526227751|FG001|Maintenance Phase|Adverse Event|8|||
145923824|NCT03817853|526227752|FG002|Maintenance Phase|Adverse Event|0|||
145923825|NCT03817853|526227750|FG000|Maintenance Phase|Death|0|||
145923826|NCT03817853|526227751|FG001|Maintenance Phase|Death|5|||
145923827|NCT03817853|526227752|FG002|Maintenance Phase|Death|0|||
145923828|NCT03817853|526227750|FG000|Maintenance Phase|Progressive Disease|0|||
145976748|NCT02903914|526425246|FG001|Overall Study|New Cancer Therapy|2|||
145976749|NCT02903914|526425247|FG002|Overall Study|New Cancer Therapy|21|||
145976750|NCT02903914|526425248|FG003|Overall Study|New Cancer Therapy|4|||
145976751|NCT02903914|526425249|FG004|Overall Study|New Cancer Therapy|3|||
145976752|NCT02903914|526425250|FG005|Overall Study|New Cancer Therapy|6|||
145976753|NCT02903914|526425251|FG006|Overall Study|New Cancer Therapy|56|||
145976754|NCT02903914|526425252|FG007|Overall Study|New Cancer Therapy|3|||
145976755|NCT02903914|526425245|FG000|Overall Study|Didn't Return to Site|1|||
145976756|NCT02903914|526425246|FG001|Overall Study|Didn't Return to Site|0|||
145976757|NCT02903914|526425247|FG002|Overall Study|Didn't Return to Site|1|||
145976758|NCT02903914|526425248|FG003|Overall Study|Didn't Return to Site|1|||
145976759|NCT02903914|526425249|FG004|Overall Study|Didn't Return to Site|0|||
145976760|NCT02903914|526425250|FG005|Overall Study|Didn't Return to Site|0|||
145976761|NCT02903914|526425251|FG006|Overall Study|Didn't Return to Site|2|||
145976762|NCT02903914|526425252|FG007|Overall Study|Didn't Return to Site|0|||
145976763|NCT02903914|526425245|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
145976764|NCT02903914|526425246|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
145976765|NCT02903914|526425247|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
145976766|NCT02903914|526425248|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
145976767|NCT02903914|526425249|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
145976768|NCT02903914|526425250|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
145976769|NCT02903914|526425251|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
145976770|NCT02903914|526425252|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
145976771|NCT02903914|526425245|FG000|Overall Study|Follow-up Did Not Occur|0|||
145976772|NCT02903914|526425246|FG001|Overall Study|Follow-up Did Not Occur|1|||
145976773|NCT02903914|526425247|FG002|Overall Study|Follow-up Did Not Occur|1|||
145976774|NCT02903914|526425248|FG003|Overall Study|Follow-up Did Not Occur|0|||
145976775|NCT02903914|526425249|FG004|Overall Study|Follow-up Did Not Occur|2|||
145976776|NCT02903914|526425250|FG005|Overall Study|Follow-up Did Not Occur|0|||
145976777|NCT02903914|526425251|FG006|Overall Study|Follow-up Did Not Occur|8|||
145976778|NCT02903914|526425252|FG007|Overall Study|Follow-up Did Not Occur|0|||
145976779|NCT02903914|526425245|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
145976780|NCT02903914|526425246|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
145976781|NCT02903914|526425247|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
145976782|NCT02903914|526425248|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
145976783|NCT02903914|526425249|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
145976784|NCT02903914|526425250|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
145976785|NCT02903914|526425251|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
145976786|NCT02903914|526425252|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
145976787|NCT02903914|526425245|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
145976788|NCT02903914|526425246|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
145976789|NCT02903914|526425247|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
145976790|NCT02903914|526425248|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
145923829|NCT03817853|526227751|FG001|Maintenance Phase|Progressive Disease|7|||
145923830|NCT03817853|526227752|FG002|Maintenance Phase|Progressive Disease|0|||
145923831|NCT03817853|526227750|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145923832|NCT03817853|526227751|FG001|Maintenance Phase|Withdrawal by Subject|2|||
145923833|NCT03817853|526227752|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145923834|NCT03817853|526227750|FG000|Maintenance Phase|Physician Decision|0|||
145923835|NCT03817853|526227751|FG001|Maintenance Phase|Physician Decision|1|||
145923836|NCT03817853|526227752|FG002|Maintenance Phase|Physician Decision|0|||
145923837|NCT03817853|526227750|FG000|Maintenance Phase|Various reasons|0|||
145923838|NCT03817853|526227751|FG001|Maintenance Phase|Various reasons|4|||
145923839|NCT03817853|526227752|FG002|Maintenance Phase|Various reasons|0|||
145923840|NCT03817853|526227750|FG000|Maintenance Phase|Protocol Deviation|0|||
145923841|NCT03817853|526227751|FG001|Maintenance Phase|Protocol Deviation|1|||
145923842|NCT03817853|526227752|FG002|Maintenance Phase|Protocol Deviation|0|||
145976791|NCT02903914|526425249|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
145976792|NCT02903914|526425250|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
145976793|NCT02903914|526425251|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
145976794|NCT02903914|526425252|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
145976795|NCT02903914|526425245|FG000|Overall Study|Clinical Disease Progression|0|||
145976796|NCT02903914|526425246|FG001|Overall Study|Clinical Disease Progression|0|||
145976797|NCT02903914|526425247|FG002|Overall Study|Clinical Disease Progression|2|||
145976798|NCT02903914|526425248|FG003|Overall Study|Clinical Disease Progression|0|||
145976799|NCT02903914|526425249|FG004|Overall Study|Clinical Disease Progression|0|||
145976800|NCT02903914|526425250|FG005|Overall Study|Clinical Disease Progression|0|||
145976801|NCT02903914|526425251|FG006|Overall Study|Clinical Disease Progression|0|||
145976802|NCT02903914|526425252|FG007|Overall Study|Clinical Disease Progression|0|||
145976803|NCT02903914|526425245|FG000|Overall Study|Completed Follow-up Period|0|||
145976804|NCT02903914|526425246|FG001|Overall Study|Completed Follow-up Period|0|||
145976805|NCT02903914|526425247|FG002|Overall Study|Completed Follow-up Period|6|||
145976806|NCT02903914|526425248|FG003|Overall Study|Completed Follow-up Period|2|||
145976807|NCT02903914|526425249|FG004|Overall Study|Completed Follow-up Period|1|||
145976808|NCT02903914|526425250|FG005|Overall Study|Completed Follow-up Period|0|||
145976809|NCT02903914|526425251|FG006|Overall Study|Completed Follow-up Period|9|||
145976810|NCT02903914|526425252|FG007|Overall Study|Completed Follow-up Period|1|||
145976811|NCT02903914|526425245|FG000|Overall Study|Taken off Treatment per Protocol|0|||
145976812|NCT02903914|526425246|FG001|Overall Study|Taken off Treatment per Protocol|0|||
145976813|NCT02903914|526425247|FG002|Overall Study|Taken off Treatment per Protocol|0|||
145976814|NCT02903914|526425248|FG003|Overall Study|Taken off Treatment per Protocol|0|||
145976815|NCT02903914|526425249|FG004|Overall Study|Taken off Treatment per Protocol|0|||
145976816|NCT02903914|526425250|FG005|Overall Study|Taken off Treatment per Protocol|1|||
145976817|NCT02903914|526425251|FG006|Overall Study|Taken off Treatment per Protocol|0|||
145976818|NCT02903914|526425252|FG007|Overall Study|Taken off Treatment per Protocol|0|||
145976819|NCT02903914|526425245|FG000|Overall Study|Refused Further Treatment/Contact|0|||
145976820|NCT02903914|526425246|FG001|Overall Study|Refused Further Treatment/Contact|0|||
145976821|NCT02903914|526425247|FG002|Overall Study|Refused Further Treatment/Contact|0|||
145976822|NCT02903914|526425248|FG003|Overall Study|Refused Further Treatment/Contact|0|||
146090287|NCT01962922|526851329|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
146243124|NCT04679675|527405320|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
145923843|NCT03817853|526227750|FG000|Follow-up Phase|Adverse Event|0|||
145923844|NCT03817853|526227751|FG001|Follow-up Phase|Adverse Event|0|||
145923845|NCT03817853|526227752|FG002|Follow-up Phase|Adverse Event|2|||
145923846|NCT03817853|526227750|FG000|Follow-up Phase|Death|0|||
145923847|NCT03817853|526227751|FG001|Follow-up Phase|Death|0|||
145923848|NCT03817853|526227752|FG002|Follow-up Phase|Death|1|||
145923849|NCT03817853|526227750|FG000|Follow-up Phase|Progressive Disease|0|||
145923850|NCT03817853|526227751|FG001|Follow-up Phase|Progressive Disease|0|||
145923851|NCT03817853|526227752|FG002|Follow-up Phase|Progressive Disease|3|||
145976823|NCT02903914|526425249|FG004|Overall Study|Refused Further Treatment/Contact|0|||
145976824|NCT02903914|526425250|FG005|Overall Study|Refused Further Treatment/Contact|0|||
145976825|NCT02903914|526425251|FG006|Overall Study|Refused Further Treatment/Contact|1|||
145976826|NCT02903914|526425252|FG007|Overall Study|Refused Further Treatment/Contact|0|||
145976827|NCT02903914|526425245|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976828|NCT02903914|526425246|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976829|NCT02903914|526425247|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976830|NCT02903914|526425248|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976831|NCT02903914|526425249|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976832|NCT02903914|526425250|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976833|NCT02903914|526425251|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
145976834|NCT02903914|526425252|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145976835|NCT04092777|526425254|FG000|Overall Study|Lost to Follow-up|28|||
145976836|NCT04092777|526425255|FG001|Overall Study|Lost to Follow-up|46|||
145976837|NCT04092777|526425254|FG000|Overall Study|Withdrawal by Subject|8|||
145976838|NCT04092777|526425255|FG001|Overall Study|Withdrawal by Subject|5|||
145976839|NCT04225039|526425262|FG000|Overall Study|Withdrawal by Subject|1|||
145976840|NCT04225039|526425263|FG001|Overall Study|Withdrawal by Subject|0|||
145976841|NCT04225039|526425264|FG002|Overall Study|Withdrawal by Subject|0|||
145976842|NCT04225039|526425265|FG003|Overall Study|Withdrawal by Subject|1|||
145976843|NCT04225039|526425262|FG000|Overall Study|Currently active on study treatment|0|||
145976844|NCT04225039|526425263|FG001|Overall Study|Currently active on study treatment|1|||
145976845|NCT04225039|526425264|FG002|Overall Study|Currently active on study treatment|0|||
145976846|NCT04225039|526425265|FG003|Overall Study|Currently active on study treatment|0|||
145976847|NCT04225039|526425262|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
145976848|NCT04225039|526425263|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145976849|NCT04225039|526425264|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145976850|NCT04225039|526425265|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145976851|NCT04225039|526425262|FG000|Overall Study|Ineligible for treatment|0|||
145976852|NCT04225039|526425263|FG001|Overall Study|Ineligible for treatment|0|||
145976853|NCT04225039|526425264|FG002|Overall Study|Ineligible for treatment|0|||
145976854|NCT04225039|526425265|FG003|Overall Study|Ineligible for treatment|4|||
145976855|NCT00876343|526425272|FG000|Overall Study|Adverse Event|7|||
145976856|NCT00876343|526425273|FG001|Overall Study|Adverse Event|8|||
145976857|NCT00876343|526425274|FG002|Overall Study|Adverse Event|2|||
145976858|NCT00876343|526425272|FG000|Overall Study|Withdrawal by Subject|4|||
145976859|NCT00876343|526425273|FG001|Overall Study|Withdrawal by Subject|4|||
145976860|NCT00876343|526425274|FG002|Overall Study|Withdrawal by Subject|3|||
145976861|NCT00876343|526425272|FG000|Overall Study|Lack of Efficacy|0|||
145976862|NCT00876343|526425273|FG001|Overall Study|Lack of Efficacy|0|||
145976863|NCT00876343|526425274|FG002|Overall Study|Lack of Efficacy|1|||
145976864|NCT00876343|526425272|FG000|Overall Study|Protocol Violation|4|||
145976865|NCT00876343|526425273|FG001|Overall Study|Protocol Violation|1|||
145976866|NCT00876343|526425274|FG002|Overall Study|Protocol Violation|1|||
145976867|NCT00876343|526425272|FG000|Overall Study|Physician Decision|0|||
145976868|NCT00876343|526425273|FG001|Overall Study|Physician Decision|1|||
145976869|NCT00876343|526425274|FG002|Overall Study|Physician Decision|1|||
145976870|NCT00876343|526425272|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
145976871|NCT00876343|526425273|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
145976872|NCT00876343|526425274|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
145976873|NCT00876343|526425272|FG000|Overall Study|Change of residence or other commitments|2|||
145976874|NCT00876343|526425273|FG001|Overall Study|Change of residence or other commitments|2|||
145976875|NCT00876343|526425274|FG002|Overall Study|Change of residence or other commitments|3|||
145976876|NCT04717557|526425278|FG000|Overall Study|Withdrawal by Subject|2|||
145976877|NCT04717557|526425279|FG001|Overall Study|Withdrawal by Subject|0|||
145976878|NCT04717557|526425278|FG000|Overall Study|Death|1|||
145976879|NCT04717557|526425279|FG001|Overall Study|Death|0|||
145976880|NCT00927472|526425289|FG000|Overall Study|Withdrawal by Subject|10|||
145976881|NCT00927472|526425290|FG001|Overall Study|Withdrawal by Subject|11|||
145976882|NCT00927472|526425289|FG000|Overall Study|Lost to Follow-up|1|||
145976883|NCT00927472|526425290|FG001|Overall Study|Lost to Follow-up|6|||
145976884|NCT00927472|526425289|FG000|Overall Study|Protocol Violation|0|||
145976885|NCT00927472|526425290|FG001|Overall Study|Protocol Violation|1|||
145976886|NCT00927472|526425289|FG000|Overall Study|Post treatment Assessment out of window|0|||
145976887|NCT00927472|526425290|FG001|Overall Study|Post treatment Assessment out of window|4|||
145976888|NCT00433537|526425291|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
145976889|NCT00433537|526425292|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
145976890|NCT00433537|526425293|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
145976891|NCT00433537|526425291|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
145976892|NCT00433537|526425292|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
145976893|NCT00433537|526425293|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
146090288|NCT01962922|526851330|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
146090289|NCT01962922|526851329|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
146090290|NCT01962922|526851330|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
146090291|NCT03224546|526851331|FG000|Overall Study|Lost to Follow-up|9|||
146090292|NCT03224546|526851332|FG001|Overall Study|Lost to Follow-up|8|||
146090293|NCT03224546|526851333|FG002|Overall Study|Lost to Follow-up|3|||
146090294|NCT03224546|526851331|FG000|Overall Study|Withdrawal by Subject|7|||
146090295|NCT03224546|526851332|FG001|Overall Study|Withdrawal by Subject|14|||
146090296|NCT03224546|526851333|FG002|Overall Study|Withdrawal by Subject|12|||
146090297|NCT00744471|526851334|FG000|Overall Study|Randomized but not treated|1|||
146090298|NCT00744471|526851335|FG001|Overall Study|Randomized but not treated|1|||
146090299|NCT00744471|526851336|FG002|Overall Study|Randomized but not treated|4|||
146090300|NCT00744471|526851337|FG003|Overall Study|Randomized but not treated|0|||
146090301|NCT00744471|526851334|FG000|Overall Study|Death|0|||
146090302|NCT00744471|526851335|FG001|Overall Study|Death|0|||
146090303|NCT00744471|526851336|FG002|Overall Study|Death|0|||
146090304|NCT00744471|526851337|FG003|Overall Study|Death|1|||
146090305|NCT00744471|526851334|FG000|Overall Study|Adverse Event|6|||
146090306|NCT00744471|526851335|FG001|Overall Study|Adverse Event|7|||
146090307|NCT00744471|526851336|FG002|Overall Study|Adverse Event|5|||
146090308|NCT00744471|526851337|FG003|Overall Study|Adverse Event|9|||
146090309|NCT00744471|526851334|FG000|Overall Study|Withdrawal by Subject|9|||
146090310|NCT00744471|526851335|FG001|Overall Study|Withdrawal by Subject|9|||
146090311|NCT00744471|526851336|FG002|Overall Study|Withdrawal by Subject|15|||
146090312|NCT00744471|526851337|FG003|Overall Study|Withdrawal by Subject|12|||
146090313|NCT00744471|526851334|FG000|Overall Study|Protocol Violation|1|||
146090314|NCT00744471|526851335|FG001|Overall Study|Protocol Violation|4|||
146090315|NCT00744471|526851336|FG002|Overall Study|Protocol Violation|1|||
146090316|NCT00744471|526851337|FG003|Overall Study|Protocol Violation|2|||
146090317|NCT00744471|526851334|FG000|Overall Study|Entered extension study|41|||
146090318|NCT00744471|526851335|FG001|Overall Study|Entered extension study|84|||
146090319|NCT00744471|526851336|FG002|Overall Study|Entered extension study|100|||
146090320|NCT00744471|526851337|FG003|Overall Study|Entered extension study|91|||
146090321|NCT00744471|526851334|FG000|Overall Study|Other|2|||
145923852|NCT03817853|526227750|FG000|Follow-up Phase|Withdrawal by Subject|0|||
145923853|NCT03817853|526227751|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145923854|NCT03817853|526227752|FG002|Follow-up Phase|Withdrawal by Subject|1|||
146090322|NCT00744471|526851335|FG001|Overall Study|Other|3|||
146090323|NCT00744471|526851336|FG002|Overall Study|Other|6|||
146090324|NCT00744471|526851337|FG003|Overall Study|Other|2|||
146090325|NCT00744471|526851334|FG000|Overall Study|Lack of Efficacy|83|||
146090326|NCT00744471|526851335|FG001|Overall Study|Lack of Efficacy|37|||
146090327|NCT00744471|526851336|FG002|Overall Study|Lack of Efficacy|19|||
146090328|NCT00744471|526851337|FG003|Overall Study|Lack of Efficacy|31|||
146090329|NCT00744471|526851334|FG000|Overall Study|Lost to Follow-up|0|||
146090330|NCT00744471|526851335|FG001|Overall Study|Lost to Follow-up|0|||
146090331|NCT00744471|526851336|FG002|Overall Study|Lost to Follow-up|2|||
146090332|NCT00744471|526851337|FG003|Overall Study|Lost to Follow-up|0|||
146090333|NCT04706416|526851338|FG000|Overall Study|Lost to Follow-up|2|||
146090334|NCT04706416|526851339|FG001|Overall Study|Lost to Follow-up|0|||
146090335|NCT00976573|526851347|FG000|Overall Study|Ineligible|0|||
146090336|NCT00976573|526851348|FG001|Overall Study|Ineligible|1|||
146090337|NCT00976573|526851347|FG000|Overall Study|Cancel prior to receiving treatment|4|||
146090338|NCT00976573|526851348|FG001|Overall Study|Cancel prior to receiving treatment|2|||
146090339|NCT02117427|526851349|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
146090340|NCT02117427|526851350|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
146090341|NCT02117427|526851351|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
146090342|NCT02117427|526851349|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
146243125|NCT04679675|527405321|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
146243126|NCT04679675|527405322|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
146243127|NCT04679675|527405323|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
145923855|NCT05005507|526227753|FG000|Overall Study|Premature termination of study|1|||
146090343|NCT02117427|526851350|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
146090344|NCT02117427|526851351|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
146090345|NCT02117427|526851349|FG000|Overall Study|Physician Decision|0|||
146090346|NCT02117427|526851350|FG001|Overall Study|Physician Decision|2|||
146090347|NCT02117427|526851351|FG002|Overall Study|Physician Decision|0|||
146090348|NCT02117427|526851349|FG000|Overall Study|No longer meets inclusion criteria|0|||
146090349|NCT02117427|526851350|FG001|Overall Study|No longer meets inclusion criteria|1|||
146090350|NCT02117427|526851351|FG002|Overall Study|No longer meets inclusion criteria|0|||
146090351|NCT02117427|526851349|FG000|Overall Study|Death|0|||
146090352|NCT02117427|526851350|FG001|Overall Study|Death|1|||
145923856|NCT02556775|526227755|FG000|Overall Study|Withdrawal by Subject|1|||
146090353|NCT02117427|526851351|FG002|Overall Study|Death|0|||
146090354|NCT02730208|526851352|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146243128|NCT04679675|527405320|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
146243129|NCT04679675|527405321|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
145923857|NCT02556775|526227756|FG001|Overall Study|Withdrawal by Subject|0|||
145923858|NCT02556775|526227757|FG002|Overall Study|Withdrawal by Subject|1|||
145923859|NCT02556775|526227758|FG003|Overall Study|Withdrawal by Subject|0|||
145923860|NCT02556775|526227755|FG000|Overall Study|Lost to Follow-up|1|||
145923861|NCT02556775|526227756|FG001|Overall Study|Lost to Follow-up|0|||
145923862|NCT02556775|526227757|FG002|Overall Study|Lost to Follow-up|0|||
145923863|NCT02556775|526227758|FG003|Overall Study|Lost to Follow-up|0|||
145923864|NCT01786993|526227761|FG000|Overall Study|Death|6|||
145923865|NCT01786993|526227762|FG001|Overall Study|Death|7|||
145923866|NCT01786993|526227761|FG000|Overall Study|Withdrawal by Subject|3|||
145923867|NCT01786993|526227762|FG001|Overall Study|Withdrawal by Subject|2|||
145923868|NCT01786993|526227761|FG000|Overall Study|Lost to Follow-up|0|||
145923869|NCT01786993|526227762|FG001|Overall Study|Lost to Follow-up|1|||
145923870|NCT01786993|526227761|FG000|Overall Study|Subject Non-Compliance|1|||
145923871|NCT01786993|526227762|FG001|Overall Study|Subject Non-Compliance|0|||
145923872|NCT01786993|526227761|FG000|Overall Study|System Explant|1|||
145923873|NCT01786993|526227762|FG001|Overall Study|System Explant|0|||
145923874|NCT01786993|526227761|FG000|Overall Study|Hospice Admission|1|||
145923875|NCT01786993|526227762|FG001|Overall Study|Hospice Admission|0|||
145923876|NCT00071110|526227763|FG000|Overall Study|Protocol Violation|0|||
145923877|NCT00071110|526227764|FG001|Overall Study|Protocol Violation|4|||
145923878|NCT03655405|526227765|FG000|Overall Study|Death after initial data collection|4|||
145923879|NCT03655405|526227766|FG001|Overall Study|Death after initial data collection|2|||
145923880|NCT03655405|526227765|FG000|Overall Study|Died before initial data collection|1|||
145923881|NCT03655405|526227766|FG001|Overall Study|Died before initial data collection|2|||
145923882|NCT03655405|526227765|FG000|Overall Study|Protocol Violation|0|||
145923883|NCT03655405|526227766|FG001|Overall Study|Protocol Violation|1|||
145923884|NCT00848718|526227769|FG000|Overall Study|Adverse Event|2|||
145923885|NCT00848718|526227770|FG001|Overall Study|Adverse Event|2|||
145923886|NCT00848718|526227771|FG002|Overall Study|Adverse Event|1|||
145923887|NCT00848718|526227772|FG003|Overall Study|Adverse Event|1|||
145923888|NCT00848718|526227773|FG004|Overall Study|Adverse Event|1|||
145923889|NCT00848718|526227774|FG005|Overall Study|Adverse Event|0|||
145923890|NCT00848718|526227775|FG006|Overall Study|Adverse Event|0|||
145923891|NCT00848718|526227776|FG007|Overall Study|Adverse Event|1|||
145923892|NCT00848718|526227777|FG008|Overall Study|Adverse Event|1|||
145923893|NCT00848718|526227778|FG009|Overall Study|Adverse Event|0|||
145923894|NCT00848718|526227779|FG010|Overall Study|Adverse Event|0|||
145923895|NCT00848718|526227780|FG011|Overall Study|Adverse Event|0|||
145923896|NCT00848718|526227781|FG012|Overall Study|Adverse Event|2|||
145923897|NCT00848718|526227769|FG000|Overall Study|Lack of Efficacy|0|||
145923898|NCT00848718|526227770|FG001|Overall Study|Lack of Efficacy|0|||
145923899|NCT00848718|526227771|FG002|Overall Study|Lack of Efficacy|1|||
145923900|NCT00848718|526227772|FG003|Overall Study|Lack of Efficacy|0|||
145923901|NCT00848718|526227773|FG004|Overall Study|Lack of Efficacy|0|||
145923902|NCT00848718|526227774|FG005|Overall Study|Lack of Efficacy|0|||
145923903|NCT00848718|526227775|FG006|Overall Study|Lack of Efficacy|1|||
145923904|NCT00848718|526227776|FG007|Overall Study|Lack of Efficacy|0|||
145923905|NCT00848718|526227777|FG008|Overall Study|Lack of Efficacy|0|||
145923906|NCT00848718|526227778|FG009|Overall Study|Lack of Efficacy|0|||
145923907|NCT00848718|526227779|FG010|Overall Study|Lack of Efficacy|0|||
145923908|NCT00848718|526227780|FG011|Overall Study|Lack of Efficacy|0|||
145923909|NCT00848718|526227781|FG012|Overall Study|Lack of Efficacy|0|||
145923910|NCT00848718|526227769|FG000|Overall Study|Physician Decision|0|||
145923911|NCT00848718|526227770|FG001|Overall Study|Physician Decision|1|||
145923912|NCT00848718|526227771|FG002|Overall Study|Physician Decision|0|||
145923913|NCT00848718|526227772|FG003|Overall Study|Physician Decision|0|||
145923914|NCT00848718|526227773|FG004|Overall Study|Physician Decision|1|||
145923915|NCT00848718|526227774|FG005|Overall Study|Physician Decision|1|||
145923916|NCT00848718|526227775|FG006|Overall Study|Physician Decision|0|||
145976894|NCT00433537|526425291|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
145976895|NCT00433537|526425292|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
145923917|NCT00848718|526227776|FG007|Overall Study|Physician Decision|0|||
145923918|NCT00848718|526227777|FG008|Overall Study|Physician Decision|1|||
145923919|NCT00848718|526227778|FG009|Overall Study|Physician Decision|2|||
145923920|NCT00848718|526227779|FG010|Overall Study|Physician Decision|0|||
145923921|NCT00848718|526227780|FG011|Overall Study|Physician Decision|0|||
145923922|NCT00848718|526227781|FG012|Overall Study|Physician Decision|1|||
145923923|NCT00848718|526227769|FG000|Overall Study|Progressive disease before treatment|1|||
145923924|NCT00848718|526227770|FG001|Overall Study|Progressive disease before treatment|5|||
145923925|NCT00848718|526227771|FG002|Overall Study|Progressive disease before treatment|1|||
145923926|NCT00848718|526227772|FG003|Overall Study|Progressive disease before treatment|3|||
145923927|NCT00848718|526227773|FG004|Overall Study|Progressive disease before treatment|4|||
145923928|NCT00848718|526227774|FG005|Overall Study|Progressive disease before treatment|4|||
145976896|NCT00433537|526425293|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
146090355|NCT02730208|526851353|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
146090356|NCT00995865|526851354|FG000|Overall Study|Protocol Violation|2|||
146090357|NCT00995865|526851355|FG001|Overall Study|Protocol Violation|0|||
146090358|NCT00995865|526851356|FG002|Overall Study|Protocol Violation|0|||
146090359|NCT00995865|526851354|FG000|Overall Study|Lost to Follow-up|0|||
146090360|NCT00995865|526851355|FG001|Overall Study|Lost to Follow-up|0|||
146090361|NCT00995865|526851356|FG002|Overall Study|Lost to Follow-up|1|||
146243130|NCT04679675|527405322|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
146243131|NCT04679675|527405323|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
145923929|NCT00848718|526227775|FG006|Overall Study|Progressive disease before treatment|2|||
145923930|NCT00848718|526227776|FG007|Overall Study|Progressive disease before treatment|1|||
146090362|NCT00410202|526851358|FG000|On-Treatment|Continuing treatment|69|||
146090363|NCT00410202|526851359|FG001|On-Treatment|Continuing treatment|71|||
146090364|NCT00410202|526851360|FG002|On-Treatment|Continuing treatment|66|||
146090365|NCT00410202|526851358|FG000|On-Treatment|Adverse Event|1|||
146090366|NCT00410202|526851359|FG001|On-Treatment|Adverse Event|3|||
146090367|NCT00410202|526851360|FG002|On-Treatment|Adverse Event|2|||
146090368|NCT00410202|526851358|FG000|On-Treatment|Death|1|||
146090369|NCT00410202|526851359|FG001|On-Treatment|Death|0|||
146090370|NCT00410202|526851360|FG002|On-Treatment|Death|0|||
146090371|NCT00410202|526851358|FG000|On-Treatment|Lost to Follow-up|1|||
146090372|NCT00410202|526851359|FG001|On-Treatment|Lost to Follow-up|0|||
146090373|NCT00410202|526851360|FG002|On-Treatment|Lost to Follow-up|1|||
146090374|NCT00410202|526851358|FG000|On-Treatment|Lack of Efficacy|1|||
146090375|NCT00410202|526851359|FG001|On-Treatment|Lack of Efficacy|4|||
146090376|NCT00410202|526851360|FG002|On-Treatment|Lack of Efficacy|0|||
146090377|NCT00410202|526851358|FG000|On-Treatment|Withdrawal by Subject|2|||
146090378|NCT00410202|526851359|FG001|On-Treatment|Withdrawal by Subject|1|||
146090379|NCT00410202|526851360|FG002|On-Treatment|Withdrawal by Subject|1|||
146090380|NCT00410202|526851358|FG000|On-Treatment|Other Reason|0|||
146090381|NCT00410202|526851359|FG001|On-Treatment|Other Reason|0|||
146090382|NCT00410202|526851360|FG002|On-Treatment|Other Reason|1|||
146090383|NCT00410202|526851358|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
146090384|NCT00410202|526851359|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
146090385|NCT00410202|526851360|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
146090386|NCT00410202|526851358|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
146090387|NCT00410202|526851359|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
146090388|NCT00410202|526851360|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
146090389|NCT00410202|526851358|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
146090390|NCT00410202|526851359|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
146090391|NCT00410202|526851360|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
146090392|NCT00144027|526851361|FG000|Overall Study|Lost to Follow-up|1|||
146090393|NCT00144027|526851362|FG001|Overall Study|Lost to Follow-up|3|||
146090394|NCT00144027|526851361|FG000|Overall Study|Withdrawal by Subject|2|||
146090395|NCT00144027|526851362|FG001|Overall Study|Withdrawal by Subject|2|||
146090396|NCT00144027|526851361|FG000|Overall Study|did not complete baseline assessment|0|||
146090397|NCT00144027|526851362|FG001|Overall Study|did not complete baseline assessment|6|||
146090398|NCT05080660|526851363|FG000|Overall Study|Adverse Event|4|||
146090399|NCT05080660|526851364|FG001|Overall Study|Adverse Event|0|||
146090400|NCT05080660|526851363|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
146090401|NCT05080660|526851364|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
146090402|NCT05080660|526851363|FG000|Overall Study|Physician Decision|1|||
146090403|NCT05080660|526851364|FG001|Overall Study|Physician Decision|0|||
146090404|NCT05080660|526851363|FG000|Overall Study|Protocol Deviation|2|||
146090405|NCT05080660|526851364|FG001|Overall Study|Protocol Deviation|0|||
146090406|NCT05080660|526851363|FG000|Overall Study|Withdrawal by Subject|5|||
146090407|NCT05080660|526851364|FG001|Overall Study|Withdrawal by Subject|2|||
146090408|NCT00596362|526851366|FG000|Overall Study|Progressive Disease|1|||
145923931|NCT00848718|526227777|FG008|Overall Study|Progressive disease before treatment|2|||
145923932|NCT00848718|526227778|FG009|Overall Study|Progressive disease before treatment|7|||
145923933|NCT00848718|526227779|FG010|Overall Study|Progressive disease before treatment|3|||
145923934|NCT00848718|526227780|FG011|Overall Study|Progressive disease before treatment|6|||
145923935|NCT00848718|526227781|FG012|Overall Study|Progressive disease before treatment|2|||
145923936|NCT00848718|526227769|FG000|Overall Study|Protocol Violation|0|||
146090409|NCT00817479|526851367|FG000|Overall Study|Physician Decision|1|||
145923937|NCT00848718|526227770|FG001|Overall Study|Protocol Violation|1|||
145923938|NCT00848718|526227771|FG002|Overall Study|Protocol Violation|0|||
145923939|NCT00848718|526227772|FG003|Overall Study|Protocol Violation|0|||
145923940|NCT00848718|526227773|FG004|Overall Study|Protocol Violation|0|||
146090410|NCT00817479|526851368|FG001|Overall Study|Physician Decision|1|||
146090411|NCT02793128|526851372|FG000|Overall Study|Death|4|||
145923941|NCT00848718|526227774|FG005|Overall Study|Protocol Violation|0|||
146090412|NCT02793128|526851372|FG000|Overall Study|Withdrawal by Subject|2|||
146090413|NCT02793128|526851372|FG000|Overall Study|Physician Decision|1|||
146090414|NCT02793128|526851372|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
145923942|NCT00848718|526227775|FG006|Overall Study|Protocol Violation|0|||
145923943|NCT00848718|526227776|FG007|Overall Study|Protocol Violation|1|||
145923944|NCT00848718|526227777|FG008|Overall Study|Protocol Violation|0|||
145923945|NCT00848718|526227778|FG009|Overall Study|Protocol Violation|0|||
145923946|NCT00848718|526227779|FG010|Overall Study|Protocol Violation|0|||
145923947|NCT00848718|526227780|FG011|Overall Study|Protocol Violation|0|||
145923948|NCT00848718|526227781|FG012|Overall Study|Protocol Violation|1|||
145923949|NCT00848718|526227769|FG000|Overall Study|Withdrawal by Subject|1|||
145923950|NCT00848718|526227770|FG001|Overall Study|Withdrawal by Subject|0|||
145923951|NCT00848718|526227771|FG002|Overall Study|Withdrawal by Subject|0|||
145923952|NCT00848718|526227772|FG003|Overall Study|Withdrawal by Subject|1|||
145923953|NCT00848718|526227773|FG004|Overall Study|Withdrawal by Subject|0|||
145923954|NCT00848718|526227774|FG005|Overall Study|Withdrawal by Subject|0|||
145923955|NCT00848718|526227775|FG006|Overall Study|Withdrawal by Subject|0|||
145923956|NCT00848718|526227776|FG007|Overall Study|Withdrawal by Subject|0|||
145923957|NCT00848718|526227777|FG008|Overall Study|Withdrawal by Subject|0|||
145923958|NCT00848718|526227778|FG009|Overall Study|Withdrawal by Subject|0|||
145923959|NCT00848718|526227779|FG010|Overall Study|Withdrawal by Subject|1|||
145923960|NCT00848718|526227780|FG011|Overall Study|Withdrawal by Subject|0|||
145923961|NCT00848718|526227781|FG012|Overall Study|Withdrawal by Subject|0|||
145923962|NCT00848718|526227769|FG000|Overall Study|Progressive disease during treatment|3|||
145923963|NCT00848718|526227770|FG001|Overall Study|Progressive disease during treatment|0|||
145923964|NCT00848718|526227771|FG002|Overall Study|Progressive disease during treatment|3|||
145923965|NCT00848718|526227772|FG003|Overall Study|Progressive disease during treatment|0|||
145923966|NCT00848718|526227773|FG004|Overall Study|Progressive disease during treatment|0|||
145923967|NCT00848718|526227774|FG005|Overall Study|Progressive disease during treatment|0|||
145923968|NCT00848718|526227775|FG006|Overall Study|Progressive disease during treatment|0|||
145923969|NCT00848718|526227776|FG007|Overall Study|Progressive disease during treatment|2|||
145923970|NCT00848718|526227777|FG008|Overall Study|Progressive disease during treatment|0|||
145923971|NCT00848718|526227778|FG009|Overall Study|Progressive disease during treatment|0|||
145923972|NCT00848718|526227779|FG010|Overall Study|Progressive disease during treatment|0|||
145923973|NCT00848718|526227780|FG011|Overall Study|Progressive disease during treatment|0|||
145923974|NCT00848718|526227781|FG012|Overall Study|Progressive disease during treatment|2|||
145923975|NCT02389829|526227782|FG000|Overall Study|Lost to Follow-up|0|||
145923976|NCT02389829|526227783|FG001|Overall Study|Lost to Follow-up|1|||
145923977|NCT00571727|526227784|FG000|Overall Study|Did not enter in this study|1|||
145923978|NCT00571727|526227784|FG000|Overall Study|Non-compliance|4|||
145923979|NCT00571727|526227784|FG000|Overall Study|Lost to Follow-up|30|||
145923980|NCT00571727|526227784|FG000|Overall Study|Poor growth|1|||
145923981|NCT00571727|526227784|FG000|Overall Study|Parent/patient decision|2|||
145923982|NCT00571727|526227784|FG000|Overall Study|Participant transferred to commercial drug|14|||
145923983|NCT00571727|526227784|FG000|Overall Study|Unable to provide study drug|6|||
145923984|NCT00571727|526227784|FG000|Overall Study|On-treatment at end of study|8|||
145923985|NCT03817190|526227785|FG000|Overall Study|Early Termination|13|||
145923986|NCT03817190|526227786|FG001|Overall Study|Early Termination|20|||
145923987|NCT03817190|526227785|FG000|Overall Study|Adverse Event|10|||
145923988|NCT03817190|526227786|FG001|Overall Study|Adverse Event|17|||
145923989|NCT03817190|526227785|FG000|Overall Study|Withdrawal by Subject|12|||
145923990|NCT03817190|526227786|FG001|Overall Study|Withdrawal by Subject|8|||
145923991|NCT03817190|526227785|FG000|Overall Study|Lost to Follow-up|11|||
145923992|NCT03817190|526227786|FG001|Overall Study|Lost to Follow-up|7|||
145923993|NCT03817190|526227785|FG000|Overall Study|Lack of Efficacy|7|||
145923994|NCT03817190|526227786|FG001|Overall Study|Lack of Efficacy|5|||
145923995|NCT03817190|526227785|FG000|Overall Study|Investigator Decision|5|||
145923996|NCT03817190|526227786|FG001|Overall Study|Investigator Decision|1|||
145923997|NCT03817190|526227785|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
145923998|NCT03817190|526227786|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
145923999|NCT03817190|526227785|FG000|Overall Study|Lack of Contact|1|||
145924000|NCT03817190|526227786|FG001|Overall Study|Lack of Contact|0|||
145924001|NCT03817190|526227785|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
145924002|NCT03817190|526227786|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
145924003|NCT00824772|526229200|FG000|Overall Study|Withdrawal by Subject|8|||
145924004|NCT02275546|526229204|FG000|Treatment Period 2|Withdrawal by Subject|2|||
145976897|NCT00433537|526425291|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
145976898|NCT00433537|526425292|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
145976899|NCT00433537|526425293|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
145976900|NCT00433537|526425291|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
145924005|NCT02275546|526229205|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145924006|NCT02275546|526229204|FG000|Treatment Period 2|Protocol Violation|0|||
145924007|NCT02275546|526229205|FG001|Treatment Period 2|Protocol Violation|1|||
145924008|NCT02955355|526229209|FG000|Overall Study|Adverse Event|4|||
145924009|NCT02955355|526229209|FG000|Overall Study|Death|1|||
145924010|NCT02955355|526229209|FG000|Overall Study|Physician Decision|21|||
145924011|NCT02955355|526229209|FG000|Overall Study|Site Terminated by Sponsor|35|||
145924012|NCT02955355|526229209|FG000|Overall Study|Withdrawal by Subject|19|||
145924013|NCT02955355|526229209|FG000|Overall Study|Reason Not Specified|5|||
145924014|NCT00333983|526229210|FG000|Overall Study|Lost to Follow-up|2|||
145924015|NCT00333983|526229211|FG001|Overall Study|Lost to Follow-up|1|||
145924016|NCT00333983|526229212|FG002|Overall Study|Lost to Follow-up|0|||
145924017|NCT00333983|526229210|FG000|Overall Study|Adverse Event|1|||
145924018|NCT00333983|526229211|FG001|Overall Study|Adverse Event|1|||
146090415|NCT02793128|526851372|FG000|Overall Study|Patient elected nephroureterectomy|1|||
146090416|NCT00282347|526851375|FG000|Treatment Period|Death|2|||
146090417|NCT00282347|526851376|FG001|Treatment Period|Death|0|||
146090418|NCT00282347|526851375|FG000|Treatment Period|Lost to Follow-up|2|||
146090419|NCT00282347|526851376|FG001|Treatment Period|Lost to Follow-up|5|||
146090420|NCT00282347|526851375|FG000|Treatment Period|Withdrawal by Subject|1|||
146090421|NCT00282347|526851376|FG001|Treatment Period|Withdrawal by Subject|3|||
146090422|NCT00282347|526851375|FG000|Treatment Period|Physician Decision|0|||
146090423|NCT00282347|526851376|FG001|Treatment Period|Physician Decision|1|||
146090424|NCT00282347|526851375|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
146090425|NCT00282347|526851376|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
146090426|NCT00282347|526851375|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
146090427|NCT00282347|526851376|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
146090428|NCT00282347|526851375|FG000|Safety Follow-up Period|Physician Decision|1|||
146090429|NCT00282347|526851376|FG001|Safety Follow-up Period|Physician Decision|1|||
146090430|NCT00282347|526851375|FG000|Safety Follow-up Period|Protocol Deviation|0|||
146090431|NCT00282347|526851376|FG001|Safety Follow-up Period|Protocol Deviation|2|||
146090432|NCT00282347|526851375|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
146090433|NCT00282347|526851376|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
146090434|NCT00282347|526851375|FG000|B Cell Follow-up Period|Physician Decision|1|||
146090435|NCT00282347|526851376|FG001|B Cell Follow-up Period|Physician Decision|0|||
146090436|NCT00282347|526851375|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
146090437|NCT00282347|526851376|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
146090438|NCT02125604|526851377|FG000|Overall Study|Other|4|||
146090439|NCT02125604|526851377|FG000|Overall Study|Investigator Decision|1|||
146090440|NCT02125604|526851377|FG000|Overall Study|Lost to Follow-up|2|||
146090441|NCT02125604|526851377|FG000|Overall Study|Consent Withdrawn|4|||
146090442|NCT02125604|526851377|FG000|Overall Study|Adverse Event|20|||
146090443|NCT04340063|526851378|FG000|Overall Study|Withdrawal by Subject|1|||
146090444|NCT04340063|526851379|FG001|Overall Study|Withdrawal by Subject|2|||
146090445|NCT04340063|526851378|FG000|Overall Study|Lost to Follow-up|3|||
146090446|NCT04340063|526851379|FG001|Overall Study|Lost to Follow-up|1|||
146090447|NCT04340063|526851378|FG000|Overall Study|Protocol Violation|0|||
146090448|NCT04340063|526851379|FG001|Overall Study|Protocol Violation|1|||
146090449|NCT00356122|526851380|FG000|TREATMENT|Lack of Efficacy|26|||
146090450|NCT00356122|526851380|FG000|TREATMENT|Adverse Event|10|||
146090451|NCT00356122|526851380|FG000|TREATMENT|Subject's request|4|||
146090452|NCT00356122|526851380|FG000|TREATMENT|Other|4|||
146090453|NCT00356122|526851380|FG000|TREATMENT|Did not receive study medication|1|||
146090454|NCT00356122|526851380|FG000|FOLLOW-UP|Death|37|||
146090455|NCT00356122|526851380|FG000|FOLLOW-UP|Lost to Follow-up|2|||
146090456|NCT00356122|526851380|FG000|FOLLOW-UP|Other|2|||
146090457|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
146090458|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
146090459|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
146090460|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
146090461|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
146090462|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
146090463|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
146090464|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
146090465|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
146090466|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
146090467|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
146090468|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
146090469|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
146090470|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
146090471|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
146090472|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
146090473|NCT00491556|526851381|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
146090474|NCT00491556|526851382|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
146090475|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
146090476|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
146090477|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
146297762|NCT02616614|527605981|FG000|Overall Study|Prohibited Medication|12|||
145924019|NCT00333983|526229212|FG002|Overall Study|Adverse Event|1|||
145976901|NCT00433537|526425292|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
145976902|NCT00433537|526425293|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
145976903|NCT00433537|526425291|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
145976904|NCT00433537|526425292|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
145976905|NCT00433537|526425293|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
145976906|NCT00433537|526425291|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
145976907|NCT00433537|526425292|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
145976908|NCT00433537|526425293|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
145976909|NCT00433537|526425291|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
145976910|NCT00433537|526425292|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
145976911|NCT00433537|526425293|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
145976912|NCT00433537|526425291|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
145976913|NCT00433537|526425292|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
145976914|NCT00433537|526425293|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
145976915|NCT02811159|526425295|FG000|Treatment Course 1|Lost to Follow-up|1|||
145976916|NCT01525589|526425296|FG000|Overall Study|Non-treatment-related AE|1|||
145976917|NCT01525589|526425297|FG001|Overall Study|Non-treatment-related AE|0|||
145976918|NCT01525589|526425298|FG002|Overall Study|Non-treatment-related AE|0|||
145976919|NCT01525589|526425296|FG000|Overall Study|Progressive disease|48|||
145976920|NCT01525589|526425297|FG001|Overall Study|Progressive disease|15|||
145976921|NCT01525589|526425298|FG002|Overall Study|Progressive disease|29|||
145976922|NCT01525589|526425296|FG000|Overall Study|Never treated|2|||
145976923|NCT01525589|526425297|FG001|Overall Study|Never treated|0|||
145976924|NCT01525589|526425298|FG002|Overall Study|Never treated|0|||
145976925|NCT01525589|526425296|FG000|Overall Study|Physician Decision|4|||
145976926|NCT01525589|526425297|FG001|Overall Study|Physician Decision|2|||
145976927|NCT01525589|526425298|FG002|Overall Study|Physician Decision|2|||
146090478|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
146090479|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
146090480|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
145976928|NCT01525589|526425296|FG000|Overall Study|Death|0|||
145976929|NCT01525589|526425297|FG001|Overall Study|Death|0|||
145976930|NCT01525589|526425298|FG002|Overall Study|Death|2|||
145976931|NCT01525589|526425296|FG000|Overall Study|Treatment-related AE|1|||
145976932|NCT01525589|526425297|FG001|Overall Study|Treatment-related AE|1|||
145976933|NCT01525589|526425298|FG002|Overall Study|Treatment-related AE|2|||
145976934|NCT01525589|526425296|FG000|Overall Study|Other reasons|0|||
145976935|NCT01525589|526425297|FG001|Overall Study|Other reasons|1|||
145976936|NCT01525589|526425298|FG002|Overall Study|Other reasons|0|||
145976937|NCT01525589|526425296|FG000|Overall Study|Withdrawal by Subject|0|||
145976938|NCT01525589|526425297|FG001|Overall Study|Withdrawal by Subject|1|||
146090481|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
146090482|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
146090483|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
146090484|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
146090485|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
146090486|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
146090487|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
146090488|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
146090489|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
146090490|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
146090491|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
146090492|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
146090493|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
146090494|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
145976939|NCT01525589|526425298|FG002|Overall Study|Withdrawal by Subject|0|||
145976940|NCT06717399|526425299|FG000|Overall Study|Death|1|||
145976941|NCT02145390|526425300|FG000|Overall Study|Withdrawal by Subject|1|||
145976942|NCT00143507|526426021|FG000|Overall Study|Death|572|||
145976943|NCT00143507|526426022|FG001|Overall Study|Death|547|||
145976944|NCT00143507|526426021|FG000|Overall Study|Withdrawal by Subject|114|||
145976945|NCT00143507|526426022|FG001|Overall Study|Withdrawal by Subject|102|||
145976946|NCT00143507|526426021|FG000|Overall Study|Lost to Follow-up|1|||
145976947|NCT00143507|526426022|FG001|Overall Study|Lost to Follow-up|0|||
145976948|NCT00143507|526426021|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
145976949|NCT00143507|526426022|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
145976950|NCT00876395|526426023|FG000|Overall Study|Untreated|8|||
145976951|NCT00876395|526426024|FG001|Overall Study|Untreated|1|||
145976952|NCT00876395|526426023|FG000|Overall Study|Adverse Event|63|||
145976953|NCT00876395|526426024|FG001|Overall Study|Adverse Event|11|||
146090495|NCT00491556|526851381|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
146090496|NCT00491556|526851382|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
146243132|NCT01228734|527405327|FG000|Overall Study|Randomized, but not treated|0|||
146243133|NCT01228734|527405328|FG001|Overall Study|Randomized, but not treated|4|||
146243134|NCT00089791|527405329|FG000|Overall Study|Physician Decision|6|||
146243135|NCT00089791|527405330|FG001|Overall Study|Physician Decision|3|||
146243136|NCT00089791|527405329|FG000|Overall Study|Adverse Event|81|||
145924020|NCT00333983|526229210|FG000|Overall Study|Withdrawal by Subject|0|||
145924021|NCT00333983|526229211|FG001|Overall Study|Withdrawal by Subject|3|||
145924022|NCT00333983|526229212|FG002|Overall Study|Withdrawal by Subject|1|||
145924023|NCT01379768|526229215|FG000|Overall Study|Adverse Event|1|||
145924024|NCT01379768|526229216|FG001|Overall Study|Adverse Event|1|||
145924025|NCT01379768|526229217|FG002|Overall Study|Adverse Event|0|||
145924026|NCT01379768|526229215|FG000|Overall Study|Lost to Follow-up|2|||
145924027|NCT01379768|526229216|FG001|Overall Study|Lost to Follow-up|0|||
145924028|NCT01379768|526229217|FG002|Overall Study|Lost to Follow-up|0|||
145924029|NCT02075203|526229219|FG000|Overall Study|Withdrawal by Subject|1|||
145924030|NCT02075203|526229220|FG001|Overall Study|Withdrawal by Subject|0|||
145924031|NCT02075203|526229221|FG002|Overall Study|Withdrawal by Subject|1|||
145924032|NCT02075203|526229219|FG000|Overall Study|Adverse Event|1|||
145924033|NCT02075203|526229220|FG001|Overall Study|Adverse Event|0|||
145924034|NCT02075203|526229221|FG002|Overall Study|Adverse Event|0|||
145924035|NCT02075203|526229219|FG000|Overall Study|participant refused to use contraception|1|||
145924036|NCT02075203|526229220|FG001|Overall Study|participant refused to use contraception|0|||
146243137|NCT00089791|527405330|FG001|Overall Study|Adverse Event|93|||
146243138|NCT00089791|527405329|FG000|Overall Study|Withdrawal by Subject|403|||
146243139|NCT00089791|527405330|FG001|Overall Study|Withdrawal by Subject|344|||
145924037|NCT02075203|526229221|FG002|Overall Study|participant refused to use contraception|0|||
145924038|NCT00568451|526229230|FG000|Overall Study|Disease Progression|0|||
145924039|NCT00568451|526229231|FG001|Overall Study|Disease Progression|0|||
145924040|NCT00568451|526229232|FG002|Overall Study|Disease Progression|2|||
145924041|NCT00568451|526229233|FG003|Overall Study|Disease Progression|7|||
145924042|NCT05344560|526229234|FG000|Period 1|Subject out of visit window|1|||
145924043|NCT05344560|526229235|FG001|Period 1|Subject out of visit window|1|||
145924044|NCT05344560|526229234|FG000|Period 2|Covid-19 Related|1|||
145924045|NCT05344560|526229235|FG001|Period 2|Covid-19 Related|0|||
145924046|NCT05344560|526229234|FG000|Period 2|Adverse Event|1|||
145924047|NCT05344560|526229235|FG001|Period 2|Adverse Event|0|||
145924048|NCT05344560|526229234|FG000|Period 2|Subject out of visit window|1|||
145924049|NCT05344560|526229235|FG001|Period 2|Subject out of visit window|1|||
145924050|NCT05344560|526229234|FG000|Period 3|Subject out of visit window|1|||
145924051|NCT05344560|526229235|FG001|Period 3|Subject out of visit window|0|||
145924052|NCT00391768|526229236|FG000|Overall Study|Withdrawal by Subject|0|||
145924053|NCT00391768|526229237|FG001|Overall Study|Withdrawal by Subject|0|||
145924054|NCT00391768|526229238|FG002|Overall Study|Withdrawal by Subject|1|||
145924055|NCT00391768|526229239|FG003|Overall Study|Withdrawal by Subject|0|||
145924056|NCT00391768|526229240|FG004|Overall Study|Withdrawal by Subject|0|||
145924057|NCT00391768|526229241|FG005|Overall Study|Withdrawal by Subject|1|||
145924058|NCT00391768|526229242|FG006|Overall Study|Withdrawal by Subject|1|||
145924059|NCT00391768|526229236|FG000|Overall Study|Lost to Follow-up|0|||
145924060|NCT00391768|526229237|FG001|Overall Study|Lost to Follow-up|0|||
145924061|NCT00391768|526229238|FG002|Overall Study|Lost to Follow-up|0|||
145924062|NCT00391768|526229239|FG003|Overall Study|Lost to Follow-up|1|||
145924063|NCT00391768|526229240|FG004|Overall Study|Lost to Follow-up|2|||
145924064|NCT00391768|526229241|FG005|Overall Study|Lost to Follow-up|2|||
145924065|NCT00391768|526229242|FG006|Overall Study|Lost to Follow-up|3|||
145924066|NCT01620138|526229243|FG000|Overall Study|Withdrawal by Subject|3|||
145924067|NCT01620138|526229244|FG001|Overall Study|Withdrawal by Subject|0|||
145924068|NCT01620138|526229243|FG000|Overall Study|Lack of Efficacy|1|||
145924069|NCT01620138|526229244|FG001|Overall Study|Lack of Efficacy|0|||
145924070|NCT01620138|526229243|FG000|Overall Study|Adverse Event|2|||
145924071|NCT01620138|526229244|FG001|Overall Study|Adverse Event|0|||
145924072|NCT00449865|526229247|FG000|Overall Study|Withdrawal by Subject|110|||
145924073|NCT00449865|526229248|FG001|Overall Study|Withdrawal by Subject|110|||
145924074|NCT00449865|526229247|FG000|Overall Study|Lost to Follow-up|36|||
145924075|NCT00449865|526229248|FG001|Overall Study|Lost to Follow-up|37|||
145924076|NCT00449865|526229247|FG000|Overall Study|Physician Decision|13|||
145924077|NCT00449865|526229248|FG001|Overall Study|Physician Decision|12|||
145924078|NCT00449865|526229247|FG000|Overall Study|Death|31|||
145924079|NCT00449865|526229248|FG001|Overall Study|Death|40|||
145924080|NCT00449865|526229247|FG000|Overall Study|Protocol Violation|8|||
145924081|NCT00449865|526229248|FG001|Overall Study|Protocol Violation|7|||
145924082|NCT00449865|526229247|FG000|Overall Study|Study was stopped|324|||
145924083|NCT00449865|526229248|FG001|Overall Study|Study was stopped|328|||
145924084|NCT00406367|526229249|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
145924085|NCT00406367|526229250|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145924086|NCT00406367|526229249|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
145924087|NCT00406367|526229250|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
146243140|NCT00089791|527405329|FG000|Overall Study|Death|78|||
146243141|NCT00089791|527405330|FG001|Overall Study|Death|62|||
145924088|NCT00406367|526229249|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
145924089|NCT00406367|526229250|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
145924090|NCT00406367|526229249|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
145924091|NCT00406367|526229250|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
145924092|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
145924093|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
145924094|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
145924095|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
145924096|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
145924097|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
145924098|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
145924099|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
145924100|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
145924101|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
145924102|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
145924103|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
145924104|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
145924105|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
145976954|NCT00876395|526426023|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145976955|NCT00876395|526426024|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145976956|NCT00876395|526426023|FG000|Overall Study|Disease progression|259|||
145976957|NCT00876395|526426024|FG001|Overall Study|Disease progression|162|||
145924106|NCT00406367|526229249|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
145924107|NCT00406367|526229250|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
145924108|NCT00171210|526229251|FG000|Overall Study|Adverse Event|16|||
145924109|NCT00171210|526229252|FG001|Overall Study|Adverse Event|27|||
145924110|NCT00171210|526229251|FG000|Overall Study|Abnormal laboratory value(s)|6|||
145924111|NCT00171210|526229252|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145924112|NCT00171210|526229251|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145924113|NCT00171210|526229252|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145924114|NCT00171210|526229251|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
145924115|NCT00171210|526229252|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
145924116|NCT00171210|526229251|FG000|Overall Study|Protocol Violation|0|||
145924117|NCT00171210|526229252|FG001|Overall Study|Protocol Violation|2|||
145924118|NCT00171210|526229251|FG000|Overall Study|Withdrawal by Subject|32|||
145924119|NCT00171210|526229252|FG001|Overall Study|Withdrawal by Subject|30|||
145924120|NCT00171210|526229251|FG000|Overall Study|Lost to Follow-up|1|||
145924121|NCT00171210|526229252|FG001|Overall Study|Lost to Follow-up|0|||
145924122|NCT00171210|526229251|FG000|Overall Study|Administrative problems|1|||
145924123|NCT00171210|526229252|FG001|Overall Study|Administrative problems|1|||
145924124|NCT00171210|526229251|FG000|Overall Study|Death|2|||
145924125|NCT00171210|526229252|FG001|Overall Study|Death|3|||
145924126|NCT00171210|526229251|FG000|Overall Study|Stopped at end of core|0|||
145924127|NCT00171210|526229252|FG001|Overall Study|Stopped at end of core|32|||
145924128|NCT00171210|526229251|FG000|Overall Study|Stopped at end of extension 1|0|||
145924129|NCT00171210|526229252|FG001|Overall Study|Stopped at end of extension 1|1|||
145924130|NCT03187301|526229255|FG000|Titration Period|Adverse Event|0|||
145976958|NCT00876395|526426023|FG000|Overall Study|New cancer therapy|25|||
145976959|NCT00876395|526426024|FG001|Overall Study|New cancer therapy|7|||
145976960|NCT00876395|526426023|FG000|Overall Study|Protocol Violation|5|||
145976961|NCT00876395|526426024|FG001|Overall Study|Protocol Violation|2|||
145976962|NCT00876395|526426023|FG000|Overall Study|Withdrawal by Subject|66|||
145976963|NCT00876395|526426024|FG001|Overall Study|Withdrawal by Subject|33|||
145976964|NCT00876395|526426023|FG000|Overall Study|Lost to Follow-up|2|||
145976965|NCT00876395|526426024|FG001|Overall Study|Lost to Follow-up|0|||
145976966|NCT00876395|526426023|FG000|Overall Study|Administrative problems|39|||
145976967|NCT00876395|526426024|FG001|Overall Study|Administrative problems|23|||
145976968|NCT00876395|526426023|FG000|Overall Study|Death|12|||
145976969|NCT00876395|526426024|FG001|Overall Study|Death|0|||
145976970|NCT00662259|526426025|FG000|Overall Study|Adverse Event|2|||
145976971|NCT00662259|526426026|FG001|Overall Study|Adverse Event|0|||
145976972|NCT01121926|526426029|FG000|First Intervention Period|Adverse Event|1|||
145976973|NCT01121926|526426030|FG001|First Intervention Period|Adverse Event|0|||
145976974|NCT01121926|526426029|FG000|Washout Period|Adverse Event|0|||
145976975|NCT01121926|526426030|FG001|Washout Period|Adverse Event|1|||
145924131|NCT03187301|526229256|FG001|Titration Period|Adverse Event|0|||
145924132|NCT03187301|526229257|FG002|Titration Period|Adverse Event|0|||
145924133|NCT03187301|526229258|FG003|Titration Period|Adverse Event|0|||
145924134|NCT03187301|526229259|FG004|Titration Period|Adverse Event|0|||
145976976|NCT01121926|526426029|FG000|Washout Period|Positive pregnancy test|0|||
145976977|NCT01121926|526426030|FG001|Washout Period|Positive pregnancy test|1|||
145976978|NCT02362451|526426038|FG000|Overall Study|Withdrawal by Subject|0|||
145924135|NCT03187301|526229260|FG005|Titration Period|Adverse Event|0|||
145924136|NCT03187301|526229261|FG006|Titration Period|Adverse Event|5|||
145924137|NCT03187301|526229255|FG000|Titration Period|Withdrawal by Subject|0|||
145924138|NCT03187301|526229256|FG001|Titration Period|Withdrawal by Subject|0|||
145924139|NCT03187301|526229257|FG002|Titration Period|Withdrawal by Subject|0|||
145924140|NCT03187301|526229258|FG003|Titration Period|Withdrawal by Subject|0|||
145924141|NCT03187301|526229259|FG004|Titration Period|Withdrawal by Subject|0|||
145924142|NCT03187301|526229260|FG005|Titration Period|Withdrawal by Subject|0|||
145976979|NCT02362451|526426039|FG001|Overall Study|Withdrawal by Subject|1|||
145976980|NCT02362451|526426038|FG000|Overall Study|Lack of Efficacy|2|||
145976981|NCT02362451|526426039|FG001|Overall Study|Lack of Efficacy|0|||
145976982|NCT02362451|526426038|FG000|Overall Study|Progression|1|||
145976983|NCT02362451|526426039|FG001|Overall Study|Progression|0|||
145976984|NCT02362451|526426038|FG000|Overall Study|Participant chose other therapy.|1|||
145976985|NCT02362451|526426039|FG001|Overall Study|Participant chose other therapy.|0|||
145976986|NCT02299167|526426040|FG000|Overall Study|patients were excluded from the study|11|||
145976987|NCT03600428|526426041|FG000|Overall Study|Not eligible|0|||
145976988|NCT03600428|526426042|FG001|Overall Study|Not eligible|1|||
145976989|NCT03600428|526426041|FG000|Overall Study|Lost to Follow-up|5|||
145976990|NCT03600428|526426042|FG001|Overall Study|Lost to Follow-up|4|||
145976991|NCT00975923|526426048|FG000|Overall Study|Withdrawal by Subject|0|||
145976992|NCT00975923|526426049|FG001|Overall Study|Withdrawal by Subject|1|||
145976993|NCT00005047|526426051|FG000|Overall Study|Withdrawal by Subject|12|||
145976994|NCT00005047|526426052|FG001|Overall Study|Withdrawal by Subject|0|||
145976995|NCT00005047|526426053|FG002|Overall Study|Withdrawal by Subject|0|||
145976996|NCT00005047|526426054|FG003|Overall Study|Withdrawal by Subject|0|||
145976997|NCT00005047|526426051|FG000|Overall Study|Adverse Event|5|||
145976998|NCT00005047|526426052|FG001|Overall Study|Adverse Event|0|||
145976999|NCT00005047|526426053|FG002|Overall Study|Adverse Event|0|||
145977000|NCT00005047|526426054|FG003|Overall Study|Adverse Event|0|||
145977001|NCT00005047|526426051|FG000|Overall Study|Lost to Follow-up|1|||
145977002|NCT00005047|526426052|FG001|Overall Study|Lost to Follow-up|0|||
145977003|NCT00005047|526426053|FG002|Overall Study|Lost to Follow-up|0|||
145977004|NCT00005047|526426054|FG003|Overall Study|Lost to Follow-up|0|||
145977005|NCT00005047|526426051|FG000|Overall Study|Lack of Efficacy|1|||
145977006|NCT00005047|526426052|FG001|Overall Study|Lack of Efficacy|0|||
145977007|NCT00005047|526426053|FG002|Overall Study|Lack of Efficacy|0|||
145977008|NCT00005047|526426054|FG003|Overall Study|Lack of Efficacy|0|||
145977009|NCT03168672|526426060|FG000|Overall Study|Withdrawal by Subject|13|||
145977010|NCT03168672|526426060|FG000|Overall Study|Death|3|||
145977011|NCT03168672|526426060|FG000|Overall Study|Investigator's Decision|137|||
145977012|NCT03168672|526426060|FG000|Overall Study|Adverse Event|1|||
145977013|NCT03168672|526426060|FG000|Overall Study|Other|2|||
145977014|NCT03168672|526426060|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
145977015|NCT05436613|526426061|FG000|Overall Study|Lost to Follow-up|9|||
145977016|NCT05436613|526426061|FG000|Overall Study|Withdrawal by Subject|3|||
145977017|NCT05317546|526426064|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
145977018|NCT05317546|526426065|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
145977019|NCT03331250|526426066|FG000|Overall Study|Withdrawal by Subject|1|||
145977020|NCT04590963|526426067|FG000|Overall Study|Death|118|||
145977021|NCT04590963|526426068|FG001|Overall Study|Death|59|||
145977022|NCT04590963|526426067|FG000|Overall Study|Lost to Follow-up|1|||
145977023|NCT04590963|526426068|FG001|Overall Study|Lost to Follow-up|1|||
145977024|NCT04590963|526426067|FG000|Overall Study|Progressive disease|0|||
145977025|NCT04590963|526426068|FG001|Overall Study|Progressive disease|1|||
145977026|NCT04590963|526426067|FG000|Overall Study|Study terminated by sponsor|103|||
145977027|NCT04590963|526426068|FG001|Overall Study|Study terminated by sponsor|50|||
145977028|NCT04590963|526426067|FG000|Overall Study|Withdrawal by Subject|15|||
145977029|NCT04590963|526426068|FG001|Overall Study|Withdrawal by Subject|8|||
145977030|NCT04590963|526426067|FG000|Overall Study|Ongoing at data cut-off|9|||
145977031|NCT04590963|526426068|FG001|Overall Study|Ongoing at data cut-off|4|||
145977032|NCT04590963|526426067|FG000|Overall Study|Screen failure|1|||
145977033|NCT04590963|526426068|FG001|Overall Study|Screen failure|0|||
145977034|NCT05350202|526426069|FG000|Visit 1 - Baseline|Not-treated|18|||
145977035|NCT05350202|526426070|FG001|Visit 1 - Baseline|Not-treated|0|||
145977036|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
145977037|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
145977038|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
145977039|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
145977040|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
145977041|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
145977042|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
145977043|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
145977044|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
145977045|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
145977046|NCT05350202|526426069|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
145924143|NCT03187301|526229261|FG006|Titration Period|Withdrawal by Subject|1|||
145924144|NCT03187301|526229255|FG000|Titration Period|Exclusion Criteria Met|0|||
145924145|NCT03187301|526229256|FG001|Titration Period|Exclusion Criteria Met|0|||
145924146|NCT03187301|526229257|FG002|Titration Period|Exclusion Criteria Met|0|||
145924147|NCT03187301|526229258|FG003|Titration Period|Exclusion Criteria Met|0|||
145924148|NCT03187301|526229259|FG004|Titration Period|Exclusion Criteria Met|0|||
145924149|NCT03187301|526229260|FG005|Titration Period|Exclusion Criteria Met|0|||
145924150|NCT03187301|526229261|FG006|Titration Period|Exclusion Criteria Met|1|||
145924151|NCT03187301|526229255|FG000|Pre-Intervention|Withdrawal by Subject|1|||
145924152|NCT03187301|526229256|FG001|Pre-Intervention|Withdrawal by Subject|0|||
145924153|NCT03187301|526229257|FG002|Pre-Intervention|Withdrawal by Subject|0|||
145924154|NCT03187301|526229258|FG003|Pre-Intervention|Withdrawal by Subject|0|||
145924155|NCT03187301|526229259|FG004|Pre-Intervention|Withdrawal by Subject|0|||
145924156|NCT03187301|526229260|FG005|Pre-Intervention|Withdrawal by Subject|0|||
145924157|NCT03187301|526229261|FG006|Pre-Intervention|Withdrawal by Subject|0|||
145924158|NCT03252535|526229263|FG000|Overall Study|Withdrawal by Subject|1|||
145924159|NCT03252535|526229264|FG001|Overall Study|Withdrawal by Subject|0|||
145924160|NCT03252535|526229265|FG002|Overall Study|Withdrawal by Subject|0|||
145924161|NCT03252535|526229263|FG000|Overall Study|Physician Decision|0|||
145924162|NCT03252535|526229264|FG001|Overall Study|Physician Decision|1|||
145924163|NCT03252535|526229265|FG002|Overall Study|Physician Decision|0|||
145924164|NCT03252535|526229263|FG000|Overall Study|Met discontinuation criteria|0|||
145924165|NCT03252535|526229264|FG001|Overall Study|Met discontinuation criteria|1|||
145924166|NCT03252535|526229265|FG002|Overall Study|Met discontinuation criteria|0|||
145924167|NCT00461630|526229270|FG000|Overall Study|Death|798|||
145924168|NCT00461630|526229271|FG001|Overall Study|Death|732|||
145924169|NCT00461630|526229270|FG000|Overall Study|Lost to Follow-up|108|||
145924170|NCT00461630|526229271|FG001|Overall Study|Lost to Follow-up|95|||
145924171|NCT00442897|526229274|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
145924172|NCT00442897|526229275|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
145924173|NCT00442897|526229274|FG000|Base Study (12 Week Follow-up)|Death|0|||
145924174|NCT00442897|526229275|FG001|Base Study (12 Week Follow-up)|Death|1|||
145924175|NCT00442897|526229274|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
145924176|NCT00442897|526229275|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
145924177|NCT00442897|526229274|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
145924178|NCT00442897|526229275|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
145924179|NCT00442897|526229274|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
145924180|NCT00442897|526229275|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
145924181|NCT00442897|526229274|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
145924182|NCT00442897|526229275|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
145924183|NCT00442897|526229274|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
145924184|NCT00442897|526229275|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
145924185|NCT00442897|526229274|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
145924186|NCT00442897|526229275|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
145924187|NCT04498182|526229276|FG000|Overall Study|Adverse Event|2|||
145924188|NCT04498182|526229277|FG001|Overall Study|Adverse Event|3|||
145924189|NCT04498182|526229278|FG002|Overall Study|Adverse Event|2|||
145924190|NCT04498182|526229276|FG000|Overall Study|Withdrawal of Consent|3|||
145924191|NCT04498182|526229277|FG001|Overall Study|Withdrawal of Consent|4|||
145924192|NCT04498182|526229278|FG002|Overall Study|Withdrawal of Consent|3|||
145924193|NCT04498182|526229276|FG000|Overall Study|Non-Compliant|1|||
145924194|NCT04498182|526229277|FG001|Overall Study|Non-Compliant|0|||
145924195|NCT04498182|526229278|FG002|Overall Study|Non-Compliant|1|||
145924196|NCT04498182|526229276|FG000|Overall Study|Lost to Follow-up|0|||
145924197|NCT04498182|526229277|FG001|Overall Study|Lost to Follow-up|0|||
145924198|NCT04498182|526229278|FG002|Overall Study|Lost to Follow-up|1|||
145924199|NCT04498182|526229276|FG000|Overall Study|Investigator Decision|0|||
145924200|NCT04498182|526229277|FG001|Overall Study|Investigator Decision|0|||
145924201|NCT04498182|526229278|FG002|Overall Study|Investigator Decision|1|||
145924202|NCT04498182|526229276|FG000|Overall Study|Protocol Violation|1|||
145924203|NCT04498182|526229277|FG001|Overall Study|Protocol Violation|0|||
145924204|NCT04498182|526229278|FG002|Overall Study|Protocol Violation|2|||
145924205|NCT00997373|526229281|FG000|Overall Study|Withdrawal by Subject|5|||
145924206|NCT00997373|526229282|FG001|Overall Study|Withdrawal by Subject|0|||
145924207|NCT00997373|526229281|FG000|Overall Study|wrong tumor type|4|||
145924208|NCT00997373|526229282|FG001|Overall Study|wrong tumor type|0|||
145924209|NCT00997373|526229281|FG000|Overall Study|could not have hysterectomy|6|||
145924210|NCT00997373|526229282|FG001|Overall Study|could not have hysterectomy|0|||
145924211|NCT03809663|526229283|FG000|Overall Study|Decision by sponsor|24|||
145924212|NCT03809663|526229284|FG001|Overall Study|Decision by sponsor|18|||
145924213|NCT03809663|526229285|FG002|Overall Study|Decision by sponsor|20|||
145924214|NCT03809663|526229286|FG003|Overall Study|Decision by sponsor|20|||
145924215|NCT03809663|526229287|FG004|Overall Study|Decision by sponsor|0|||
145924216|NCT03809663|526229288|FG005|Overall Study|Decision by sponsor|0|||
145924217|NCT03809663|526229283|FG000|Overall Study|Withdrawal by Subject|26|||
145924218|NCT03809663|526229284|FG001|Overall Study|Withdrawal by Subject|22|||
145924219|NCT03809663|526229285|FG002|Overall Study|Withdrawal by Subject|27|||
145924220|NCT03809663|526229286|FG003|Overall Study|Withdrawal by Subject|26|||
145924221|NCT03809663|526229287|FG004|Overall Study|Withdrawal by Subject|0|||
145924222|NCT03809663|526229288|FG005|Overall Study|Withdrawal by Subject|0|||
145924223|NCT03809663|526229283|FG000|Overall Study|Lost to Follow-up|1|||
145924224|NCT03809663|526229284|FG001|Overall Study|Lost to Follow-up|4|||
145924225|NCT03809663|526229285|FG002|Overall Study|Lost to Follow-up|1|||
145924226|NCT03809663|526229286|FG003|Overall Study|Lost to Follow-up|1|||
145924227|NCT03809663|526229287|FG004|Overall Study|Lost to Follow-up|0|||
145924228|NCT03809663|526229288|FG005|Overall Study|Lost to Follow-up|0|||
145924229|NCT02275819|526229290|FG000|Overall Study|Adverse Event|0|||
145924230|NCT02275819|526229291|FG001|Overall Study|Adverse Event|1|||
145924231|NCT01346059|526229292|FG000|Overall Study|Withdrawal by Subject|1|||
145924232|NCT01346059|526229293|FG001|Overall Study|Withdrawal by Subject|0|||
145924233|NCT02792062|526229300|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
145924234|NCT02792062|526229301|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145924235|NCT02792062|526229302|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145924236|NCT02792062|526229303|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145924237|NCT02792062|526229304|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145924238|NCT02792062|526229305|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145924239|NCT01464424|526229306|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
145924240|NCT01464424|526229307|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
145924241|NCT01464333|526229311|FG000|Overall Study|Adverse Event|34|||
145924242|NCT01464333|526229311|FG000|Overall Study|Lack of Efficacy|72|||
145924243|NCT01464333|526229311|FG000|Overall Study|Withdrawal by Subject|11|||
145924244|NCT01464333|526229311|FG000|Overall Study|Other|4|||
145924245|NCT01464333|526229311|FG000|Overall Study|No Hospital Visit|42|||
145924246|NCT02022202|526229312|FG000|Overall Study|Withdrawal by Subject|2|||
145924247|NCT02022202|526229312|FG000|Overall Study|Disease Progression|3|||
145924248|NCT02022202|526229312|FG000|Overall Study|Desire go to immediately to surgery|3|||
145924249|NCT04390763|526229314|FG000|Safety run-in Part|Adverse Event|4|||
145924250|NCT04390763|526229315|FG001|Safety run-in Part|Adverse Event|0|||
145924251|NCT04390763|526229316|FG002|Safety run-in Part|Adverse Event|0|||
145924252|NCT04390763|526229317|FG003|Safety run-in Part|Adverse Event|0|||
145924253|NCT04390763|526229314|FG000|Safety run-in Part|Physician Decision|1|||
145924254|NCT04390763|526229315|FG001|Safety run-in Part|Physician Decision|0|||
145924255|NCT04390763|526229316|FG002|Safety run-in Part|Physician Decision|0|||
145924256|NCT04390763|526229317|FG003|Safety run-in Part|Physician Decision|0|||
145924257|NCT04390763|526229314|FG000|Safety run-in Part|Progressive Disease|6|||
145924258|NCT04390763|526229315|FG001|Safety run-in Part|Progressive Disease|0|||
145924259|NCT04390763|526229316|FG002|Safety run-in Part|Progressive Disease|0|||
145924260|NCT04390763|526229317|FG003|Safety run-in Part|Progressive Disease|0|||
145924261|NCT04390763|526229314|FG000|Randomized Part|Adverse Event|0|||
145924262|NCT04390763|526229315|FG001|Randomized Part|Adverse Event|11|||
145924263|NCT04390763|526229316|FG002|Randomized Part|Adverse Event|5|||
145924264|NCT04390763|526229317|FG003|Randomized Part|Adverse Event|5|||
145924265|NCT04390763|526229314|FG000|Randomized Part|Death|0|||
145924266|NCT04390763|526229315|FG001|Randomized Part|Death|3|||
145924267|NCT04390763|526229316|FG002|Randomized Part|Death|4|||
145924268|NCT04390763|526229317|FG003|Randomized Part|Death|2|||
145977047|NCT05350202|526426070|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
145977048|NCT06455111|526426091|FG000|Overall Study|Withdrawal by Subject|11|||
145977049|NCT06455111|526426092|FG001|Overall Study|Withdrawal by Subject|4|||
145977050|NCT03069989|526426100|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
145977051|NCT03069989|526426101|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
145924269|NCT04390763|526229314|FG000|Randomized Part|Physician Decision|0|||
145924270|NCT04390763|526229315|FG001|Randomized Part|Physician Decision|2|||
145924271|NCT04390763|526229316|FG002|Randomized Part|Physician Decision|2|||
145924272|NCT04390763|526229317|FG003|Randomized Part|Physician Decision|9|||
145924273|NCT04390763|526229314|FG000|Randomized Part|Progressive Disease|0|||
145924274|NCT04390763|526229315|FG001|Randomized Part|Progressive Disease|24|||
145924275|NCT04390763|526229316|FG002|Randomized Part|Progressive Disease|31|||
145924276|NCT04390763|526229317|FG003|Randomized Part|Progressive Disease|23|||
145924277|NCT04390763|526229314|FG000|Randomized Part|Study terminated by sponsor|0|||
145924278|NCT04390763|526229315|FG001|Randomized Part|Study terminated by sponsor|1|||
146297763|NCT02616614|527605982|FG001|Overall Study|Prohibited Medication|9|||
145924279|NCT04390763|526229316|FG002|Randomized Part|Study terminated by sponsor|0|||
145924280|NCT04390763|526229317|FG003|Randomized Part|Study terminated by sponsor|0|||
145924281|NCT04390763|526229314|FG000|Randomized Part|Participant Decision|0|||
145977052|NCT00970944|526428019|FG000|Overall Study|Death|1|||
145924282|NCT04390763|526229315|FG001|Randomized Part|Participant Decision|5|||
145924283|NCT04390763|526229316|FG002|Randomized Part|Participant Decision|7|||
145924284|NCT04390763|526229317|FG003|Randomized Part|Participant Decision|6|||
145924285|NCT04390763|526229314|FG000|Randomized Part|Not treated|0|||
145924286|NCT04390763|526229315|FG001|Randomized Part|Not treated|4|||
145924287|NCT04390763|526229316|FG002|Randomized Part|Not treated|2|||
145924288|NCT04390763|526229317|FG003|Randomized Part|Not treated|7|||
145924289|NCT01956773|526229322|FG000|Overall Study|Lost to Follow-up|628|||
145924290|NCT01956773|526229323|FG001|Overall Study|Lost to Follow-up|1|||
145924291|NCT01153815|526229324|FG000|Overall Study|Adverse Event|3|||
145924292|NCT01153815|526229325|FG001|Overall Study|Adverse Event|1|||
145924293|NCT01153815|526229324|FG000|Overall Study|Withdrawal by Subject|6|||
145924294|NCT01153815|526229325|FG001|Overall Study|Withdrawal by Subject|4|||
145924295|NCT00450437|526229326|FG000|Overall Study|Withdrawal by Subject|10|||
145924296|NCT00450437|526229327|FG001|Overall Study|Withdrawal by Subject|2|||
145924297|NCT00450437|526229328|FG002|Overall Study|Withdrawal by Subject|0|||
145924298|NCT00450437|526229329|FG003|Overall Study|Withdrawal by Subject|1|||
145924299|NCT00450437|526229326|FG000|Overall Study|Lost to Follow-up|31|||
145924300|NCT00450437|526229327|FG001|Overall Study|Lost to Follow-up|12|||
145924301|NCT00450437|526229328|FG002|Overall Study|Lost to Follow-up|19|||
145924302|NCT00450437|526229329|FG003|Overall Study|Lost to Follow-up|9|||
145924303|NCT00450437|526229326|FG000|Overall Study|Protocol Violation|0|||
145924304|NCT00450437|526229327|FG001|Overall Study|Protocol Violation|1|||
145924305|NCT00450437|526229328|FG002|Overall Study|Protocol Violation|0|||
145924306|NCT00450437|526229329|FG003|Overall Study|Protocol Violation|1|||
145924307|NCT00450437|526229326|FG000|Overall Study|Inappropriate enrollment|4|||
145924308|NCT00450437|526229327|FG001|Overall Study|Inappropriate enrollment|1|||
145924309|NCT00450437|526229328|FG002|Overall Study|Inappropriate enrollment|3|||
145924310|NCT00450437|526229329|FG003|Overall Study|Inappropriate enrollment|0|||
145924311|NCT00450437|526229326|FG000|Overall Study|Administrative reason|0|||
145924312|NCT00450437|526229327|FG001|Overall Study|Administrative reason|0|||
145924313|NCT00450437|526229328|FG002|Overall Study|Administrative reason|1|||
145924314|NCT00450437|526229329|FG003|Overall Study|Administrative reason|0|||
145924315|NCT00450437|526229326|FG000|Overall Study|Unable to Classify|1|||
145924316|NCT00450437|526229327|FG001|Overall Study|Unable to Classify|0|||
145924317|NCT00450437|526229328|FG002|Overall Study|Unable to Classify|1|||
145924318|NCT00450437|526229329|FG003|Overall Study|Unable to Classify|0|||
145924319|NCT02040805|526229330|FG000|Overall Study|Lost to Follow-up|14|||
145924320|NCT02040805|526229331|FG001|Overall Study|Lost to Follow-up|9|||
145924321|NCT02040805|526229330|FG000|Overall Study|Withdrawal by Subject|28|||
145924322|NCT02040805|526229331|FG001|Overall Study|Withdrawal by Subject|41|||
145924323|NCT03591874|526229332|FG000|Overall Study|Adverse Event|4|||
145924324|NCT03591874|526229333|FG001|Overall Study|Adverse Event|0|||
145924325|NCT03591874|526229332|FG000|Overall Study|Withdrawal by Subject|2|||
145924326|NCT03591874|526229333|FG001|Overall Study|Withdrawal by Subject|1|||
145924327|NCT03591874|526229332|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
145924328|NCT03591874|526229333|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
145924329|NCT03591874|526229332|FG000|Overall Study|On Study at Time of Study Termination|12|||
145924330|NCT03591874|526229333|FG001|Overall Study|On Study at Time of Study Termination|6|||
145924331|NCT00503698|526229337|FG000|Overall Study|Protocol Violation|5|||
145924332|NCT00503698|526229338|FG001|Overall Study|Protocol Violation|6|||
145924333|NCT00503698|526229337|FG000|Overall Study|Adverse Event|52|||
145924334|NCT00503698|526229338|FG001|Overall Study|Adverse Event|41|||
145924335|NCT00503698|526229337|FG000|Overall Study|Death|1|||
145924336|NCT00503698|526229338|FG001|Overall Study|Death|0|||
145924337|NCT00503698|526229337|FG000|Overall Study|Lack of Efficacy|3|||
145924338|NCT00503698|526229338|FG001|Overall Study|Lack of Efficacy|4|||
145924339|NCT00503698|526229337|FG000|Overall Study|Trial terminated|216|||
145924340|NCT00503698|526229338|FG001|Overall Study|Trial terminated|253|||
145924341|NCT00503698|526229337|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
145924342|NCT00503698|526229338|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
145924343|NCT00503698|526229337|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
145924344|NCT00503698|526229338|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
145924345|NCT00503698|526229337|FG000|Overall Study|Any condition in exclusion criteria|4|||
145924346|NCT00503698|526229338|FG001|Overall Study|Any condition in exclusion criteria|6|||
145924347|NCT00503698|526229337|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
145924348|NCT00503698|526229338|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
145924349|NCT00503698|526229337|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
145977053|NCT00970944|526428020|FG001|Overall Study|Death|0|||
145977054|NCT00970944|526428019|FG000|Overall Study|Physician Decision|0|||
145977055|NCT00970944|526428020|FG001|Overall Study|Physician Decision|2|||
146243142|NCT00089791|527405329|FG000|Overall Study|Disease progression|7|||
146243143|NCT00089791|527405330|FG001|Overall Study|Disease progression|3|||
146243144|NCT00089791|527405329|FG000|Overall Study|Ineligibility determined|12|||
145924350|NCT00503698|526229338|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
145924351|NCT00503698|526229337|FG000|Overall Study|Critically ill|2|||
145924352|NCT00503698|526229338|FG001|Overall Study|Critically ill|0|||
145924353|NCT00503698|526229337|FG000|Overall Study|Unclassified|48|||
145924354|NCT00503698|526229338|FG001|Overall Study|Unclassified|32|||
145924355|NCT00503698|526229337|FG000|Overall Study|Not exposed to trial drug|11|||
145924356|NCT00503698|526229338|FG001|Overall Study|Not exposed to trial drug|6|||
145924357|NCT03644342|526229340|FG000|Overall Study|Adverse Event|2|||
145977056|NCT02008370|526428021|FG000|Overall Study|Lost to Follow-up|7|||
145924358|NCT03644342|526229341|FG001|Overall Study|Adverse Event|0|||
145924359|NCT03644342|526229340|FG000|Overall Study|Protocol Violation|0|||
145924360|NCT03644342|526229341|FG001|Overall Study|Protocol Violation|1|||
145924361|NCT02462603|526229342|FG000|Overall Study|Investigator Decision|1|||
145924362|NCT02462603|526229342|FG000|Overall Study|Non-Compliance|1|||
145924363|NCT02462603|526229342|FG000|Overall Study|Withdrawal by Subject|2|||
145924364|NCT03194542|526229343|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
145924365|NCT03194542|526229344|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145924366|NCT03194542|526229345|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145924367|NCT03194542|526229346|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145924368|NCT03194542|526229343|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
145924369|NCT03194542|526229344|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
145924370|NCT03194542|526229345|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
145924371|NCT03194542|526229346|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
145924372|NCT03194542|526229343|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
145924373|NCT03194542|526229344|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
145924374|NCT03194542|526229345|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
145924375|NCT03194542|526229346|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
145924376|NCT03194542|526229343|FG000|Overall Study|Loss of Response|4|||
145924377|NCT03194542|526229344|FG001|Overall Study|Loss of Response|2|||
145924378|NCT03194542|526229345|FG002|Overall Study|Loss of Response|3|||
145924379|NCT03194542|526229346|FG003|Overall Study|Loss of Response|4|||
145924380|NCT03194542|526229343|FG000|Overall Study|Physician Decision|0|||
145924381|NCT03194542|526229344|FG001|Overall Study|Physician Decision|1|||
145924382|NCT03194542|526229345|FG002|Overall Study|Physician Decision|0|||
145924383|NCT03194542|526229346|FG003|Overall Study|Physician Decision|0|||
145924384|NCT03194542|526229343|FG000|Overall Study|Lack of Efficacy|2|||
145924385|NCT03194542|526229344|FG001|Overall Study|Lack of Efficacy|2|||
145924386|NCT03194542|526229345|FG002|Overall Study|Lack of Efficacy|2|||
145924387|NCT03194542|526229346|FG003|Overall Study|Lack of Efficacy|6|||
145924388|NCT03194542|526229343|FG000|Overall Study|Withdrawal by Subject|2|||
145924389|NCT03194542|526229344|FG001|Overall Study|Withdrawal by Subject|1|||
145924390|NCT03194542|526229345|FG002|Overall Study|Withdrawal by Subject|5|||
145924391|NCT03194542|526229346|FG003|Overall Study|Withdrawal by Subject|4|||
145924392|NCT03194542|526229343|FG000|Overall Study|Progressive Disease|1|||
145924393|NCT03194542|526229344|FG001|Overall Study|Progressive Disease|0|||
145924394|NCT03194542|526229345|FG002|Overall Study|Progressive Disease|1|||
145924395|NCT03194542|526229346|FG003|Overall Study|Progressive Disease|1|||
145924396|NCT03194542|526229343|FG000|Overall Study|Adverse Event|1|||
145924397|NCT03194542|526229344|FG001|Overall Study|Adverse Event|2|||
145924398|NCT03194542|526229345|FG002|Overall Study|Adverse Event|0|||
145924399|NCT03194542|526229346|FG003|Overall Study|Adverse Event|5|||
145924400|NCT03194542|526229343|FG000|Overall Study|Death|1|||
145924401|NCT03194542|526229344|FG001|Overall Study|Death|2|||
145924402|NCT03194542|526229345|FG002|Overall Study|Death|0|||
145924403|NCT03194542|526229346|FG003|Overall Study|Death|5|||
145924404|NCT03194542|526229343|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
145924405|NCT03194542|526229344|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
145924406|NCT03194542|526229345|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
145924407|NCT03194542|526229346|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
145924408|NCT00030901|526229347|FG000|Initial Registration|Ineligible|167|||
145924409|NCT00030901|526229348|FG001|Initial Registration|Ineligible|0|||
145924410|NCT00030901|526229349|FG002|Initial Registration|Ineligible|0|||
145924411|NCT00030901|526229347|FG000|Randomization|Adverse Event|0|||
145924412|NCT00030901|526229348|FG001|Randomization|Adverse Event|11|||
145924413|NCT00030901|526229349|FG002|Randomization|Adverse Event|7|||
145924414|NCT00030901|526229347|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
145924415|NCT00030901|526229348|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
145924416|NCT00030901|526229349|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
145924417|NCT00030901|526229347|FG000|Randomization|Progression/Relapse|0|||
145924418|NCT00030901|526229348|FG001|Randomization|Progression/Relapse|22|||
145924419|NCT00030901|526229349|FG002|Randomization|Progression/Relapse|21|||
145924420|NCT00030901|526229347|FG000|Randomization|Death|0|||
145924421|NCT00030901|526229348|FG001|Randomization|Death|1|||
145924422|NCT00030901|526229349|FG002|Randomization|Death|3|||
145977057|NCT00972738|526428022|FG000|Overall Study|Adverse Event|7|||
145924423|NCT00030901|526229347|FG000|Randomization|Other|0|||
145924424|NCT00030901|526229348|FG001|Randomization|Other|36|||
145924425|NCT00030901|526229349|FG002|Randomization|Other|33|||
145924426|NCT00030901|526229347|FG000|Randomization|Ineligible|0|||
145924427|NCT00030901|526229348|FG001|Randomization|Ineligible|15|||
145924428|NCT00030901|526229349|FG002|Randomization|Ineligible|14|||
145924429|NCT02576847|526229350|FG000|Overall Study|Adverse Event|27|||
145977058|NCT00972738|526428023|FG001|Overall Study|Adverse Event|1|||
145924430|NCT02576847|526229350|FG000|Overall Study|Lost to Follow-up|22|||
145924431|NCT02576847|526229350|FG000|Overall Study|Physician Decision|1|||
145977059|NCT00972738|526428024|FG002|Overall Study|Adverse Event|8|||
145977060|NCT00972738|526428022|FG000|Overall Study|Protocol Violation|2|||
145977061|NCT00972738|526428023|FG001|Overall Study|Protocol Violation|1|||
145977062|NCT00972738|526428024|FG002|Overall Study|Protocol Violation|3|||
145977063|NCT00972738|526428022|FG000|Overall Study|Lost to Follow-up|1|||
145977064|NCT00972738|526428023|FG001|Overall Study|Lost to Follow-up|0|||
145977065|NCT00972738|526428024|FG002|Overall Study|Lost to Follow-up|1|||
145977066|NCT00972738|526428022|FG000|Overall Study|Lack of Efficacy|5|||
145977067|NCT00972738|526428023|FG001|Overall Study|Lack of Efficacy|1|||
145977068|NCT00972738|526428024|FG002|Overall Study|Lack of Efficacy|11|||
145977069|NCT00972738|526428022|FG000|Overall Study|Withdrawal by Subject|5|||
146090497|NCT00782795|526851383|FG000|Overall Study|Withdrawal by Subject|1|||
145924432|NCT02576847|526229350|FG000|Overall Study|Pregnancy|1|||
145924433|NCT02576847|526229350|FG000|Overall Study|Protocol Violation|3|||
145924434|NCT02576847|526229350|FG000|Overall Study|Withdrawal by Subject|78|||
145924435|NCT02576847|526229350|FG000|Overall Study|Other|5|||
145924436|NCT01806051|526229351|FG000|Overall Study|Withdrawal by Subject|6|||
145924437|NCT02747108|526229357|FG000|Overall Study|Death|2|||
145924438|NCT02747108|526229358|FG001|Overall Study|Death|2|||
145924439|NCT02747108|526229357|FG000|Overall Study|Withdrawal by Subject|1|||
145924440|NCT02747108|526229358|FG001|Overall Study|Withdrawal by Subject|0|||
145924441|NCT02747108|526229357|FG000|Overall Study|Protocol Violation|2|||
145924442|NCT02747108|526229358|FG001|Overall Study|Protocol Violation|0|||
145924443|NCT04955691|526231203|FG000|Period 2|Discontinued intervention|1|||
145924444|NCT04955691|526231204|FG001|Period 2|Discontinued intervention|2|||
145924445|NCT03760744|526231205|FG000|Overall Study|Lost to Follow-up|3|||
145924446|NCT03760744|526231206|FG001|Overall Study|Lost to Follow-up|0|||
145924447|NCT01068678|526231215|FG000|Overall Study|Lack of Efficacy|3|||
145924448|NCT01068678|526231216|FG001|Overall Study|Lack of Efficacy|2|||
145924449|NCT01068678|526231215|FG000|Overall Study|Protocol Violation|5|||
145924450|NCT01068678|526231216|FG001|Overall Study|Protocol Violation|1|||
145924451|NCT01068678|526231215|FG000|Overall Study|Withdrawal criteria|12|||
145924452|NCT01068678|526231216|FG001|Overall Study|Withdrawal criteria|6|||
145924453|NCT01068678|526231215|FG000|Overall Study|Unclassified|18|||
145924454|NCT01068678|526231216|FG001|Overall Study|Unclassified|15|||
145924455|NCT03055338|526231219|FG000|Overall Study|Lost to Follow-up|9|||
145924456|NCT03055338|526231220|FG001|Overall Study|Lost to Follow-up|2|||
145924457|NCT03055338|526231221|FG002|Overall Study|Lost to Follow-up|3|||
145924458|NCT03055338|526231219|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
145924459|NCT03055338|526231220|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
145924460|NCT03055338|526231221|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
145924461|NCT03055338|526231219|FG000|Overall Study|Physician Decision|0|||
145977070|NCT00972738|526428023|FG001|Overall Study|Withdrawal by Subject|1|||
145977071|NCT00972738|526428024|FG002|Overall Study|Withdrawal by Subject|4|||
145977072|NCT00972738|526428022|FG000|Overall Study|Moved|0|||
146090498|NCT00782795|526851384|FG001|Overall Study|Withdrawal by Subject|2|||
146090499|NCT04480424|526851385|FG000|Overall Study|Withdrawal by Subject|0|||
146090500|NCT04480424|526851386|FG001|Overall Study|Withdrawal by Subject|2|||
146090501|NCT04480424|526851385|FG000|Overall Study|Lost to Follow-up|3|||
146090502|NCT04480424|526851386|FG001|Overall Study|Lost to Follow-up|3|||
146090503|NCT04480424|526851385|FG000|Overall Study|Death|14|||
146090504|NCT04480424|526851386|FG001|Overall Study|Death|16|||
146090505|NCT04480424|526851385|FG000|Overall Study|Reason not Specified|5|||
146090506|NCT04480424|526851386|FG001|Overall Study|Reason not Specified|5|||
146090507|NCT02418156|526851387|FG000|Overall Study|Lost to Follow-up|12|||
146090508|NCT02418156|526851387|FG000|Overall Study|Death|2|||
146090509|NCT02418156|526851387|FG000|Overall Study|Physician Decision|1|||
146090510|NCT02418156|526851387|FG000|Overall Study|Withdrawal by Subject|1|||
146243145|NCT00089791|527405330|FG001|Overall Study|Ineligibility determined|9|||
146243146|NCT00089791|527405329|FG000|Overall Study|Lost to Follow-up|57|||
146243147|NCT00089791|527405330|FG001|Overall Study|Lost to Follow-up|57|||
146243148|NCT00089791|527405329|FG000|Overall Study|Noncompliance|17|||
145924462|NCT03055338|526231220|FG001|Overall Study|Physician Decision|0|||
145977073|NCT00972738|526428023|FG001|Overall Study|Moved|0|||
145977074|NCT00972738|526428024|FG002|Overall Study|Moved|1|||
145977075|NCT00972738|526428022|FG000|Overall Study|Other|1|||
145924463|NCT03055338|526231221|FG002|Overall Study|Physician Decision|2|||
145924464|NCT03055338|526231219|FG000|Overall Study|Withdrawal by Subject|9|||
145924465|NCT03055338|526231220|FG001|Overall Study|Withdrawal by Subject|8|||
145924466|NCT03055338|526231221|FG002|Overall Study|Withdrawal by Subject|7|||
145924467|NCT03058705|526231222|FG000|Overall Study|Withdrawal by Subject|2|||
145924468|NCT03058705|526231222|FG000|Overall Study|Physician Decision|2|||
145924469|NCT03827291|526231231|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
145977076|NCT00972738|526428023|FG001|Overall Study|Other|2|||
145977077|NCT00972738|526428024|FG002|Overall Study|Other|1|||
145977078|NCT03915067|526428026|FG000|Overall Study|Adverse Event|0|||
146090511|NCT02418156|526851387|FG000|Overall Study|Subject refused to return|1|||
146090512|NCT00734747|526851391|FG000|SRS Procedure|No staples placed|3|||
146090513|NCT00734747|526851391|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
145924470|NCT03827291|526231232|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
145924471|NCT04795466|526231233|FG000|Overall Study|Adverse Event|3|||
145924472|NCT04795466|526231234|FG001|Overall Study|Adverse Event|1|||
145924473|NCT04795466|526231233|FG000|Overall Study|Physician Decision|1|||
145924474|NCT04795466|526231234|FG001|Overall Study|Physician Decision|0|||
145924475|NCT04795466|526231233|FG000|Overall Study|Withdrawal by Subject|2|||
145924476|NCT04795466|526231234|FG001|Overall Study|Withdrawal by Subject|1|||
145924477|NCT01102257|526231237|FG000|Overall Study|Adverse Event|1|||
145924478|NCT01102257|526231238|FG001|Overall Study|Adverse Event|0|||
145924479|NCT01102257|526231237|FG000|Overall Study|Adverse Event|1|||
145924480|NCT01102257|526231238|FG001|Overall Study|Adverse Event|0|||
145924481|NCT03752970|526231239|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
145924482|NCT03752970|526231240|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
145924483|NCT03752970|526231241|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
145924484|NCT03752970|526231239|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
145924485|NCT03752970|526231240|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
145924486|NCT03752970|526231241|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
145924487|NCT03752970|526231239|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
145924488|NCT03752970|526231240|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
145924489|NCT03752970|526231241|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
145924490|NCT03752970|526231239|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
145924491|NCT03752970|526231240|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
145924492|NCT03752970|526231241|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
145924493|NCT03752970|526231239|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
145924494|NCT03752970|526231240|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
145924495|NCT03752970|526231241|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
145924496|NCT04767282|526231242|FG000|Overall Study|Refused or did not begin surveys|6|||
145924497|NCT04767282|526231243|FG001|Overall Study|Refused or did not begin surveys|2|||
145924498|NCT04767282|526231244|FG002|Overall Study|Refused or did not begin surveys|2|||
145924499|NCT04767282|526231242|FG000|Overall Study|Duplicate household previously enrolled|2|||
145924500|NCT04767282|526231243|FG001|Overall Study|Duplicate household previously enrolled|0|||
145977079|NCT03915067|526428027|FG001|Overall Study|Adverse Event|0|||
145977080|NCT03915067|526428028|FG002|Overall Study|Adverse Event|1|||
145977081|NCT03915067|526428026|FG000|Overall Study|Withdrawal by Subject|4|||
145977082|NCT03915067|526428027|FG001|Overall Study|Withdrawal by Subject|3|||
145977083|NCT03915067|526428028|FG002|Overall Study|Withdrawal by Subject|0|||
145977084|NCT03915067|526428026|FG000|Overall Study|Lost to Follow-up|3|||
145977085|NCT03915067|526428027|FG001|Overall Study|Lost to Follow-up|2|||
145977086|NCT03915067|526428028|FG002|Overall Study|Lost to Follow-up|0|||
145977087|NCT03915067|526428026|FG000|Overall Study|Protocol Deviation|0|||
145977088|NCT03915067|526428027|FG001|Overall Study|Protocol Deviation|0|||
145977089|NCT03915067|526428028|FG002|Overall Study|Protocol Deviation|1|||
145977090|NCT03915067|526428026|FG000|Overall Study|Covid-19 Related Issues|2|||
145977091|NCT03915067|526428027|FG001|Overall Study|Covid-19 Related Issues|4|||
145977092|NCT03915067|526428028|FG002|Overall Study|Covid-19 Related Issues|4|||
145977093|NCT03915067|526428026|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
145977094|NCT03915067|526428027|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
145977095|NCT03915067|526428028|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
145977096|NCT02693418|526428029|FG000|Overall Study|Lost to Follow-up|1|||
145977097|NCT02693418|526428030|FG001|Overall Study|Lost to Follow-up|2|||
145977098|NCT02693418|526428031|FG002|Overall Study|Lost to Follow-up|0|||
146090514|NCT03287635|526851395|FG000|Overall Study|Lost to Follow-up|5|||
146090515|NCT03287635|526851395|FG000|Overall Study|Withdrawal by Subject|1|||
146090516|NCT03287635|526851395|FG000|Overall Study|Physician Decision|1|||
146090517|NCT03670836|526851396|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
145977099|NCT02693418|526428032|FG003|Overall Study|Lost to Follow-up|0|||
145977100|NCT02693418|526428033|FG004|Overall Study|Lost to Follow-up|0|||
145977101|NCT02693418|526428029|FG000|Overall Study|Menses during study period|0|||
146090518|NCT03670836|526851397|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
146090519|NCT03670836|526851396|FG000|Per Protocol Population (PP)|Physician Decision|9|||
146090520|NCT03670836|526851397|FG001|Per Protocol Population (PP)|Physician Decision|10|||
146090521|NCT03670836|526851396|FG000|Per Protocol Population (PP)|Physician Decision|4|||
146243149|NCT00089791|527405330|FG001|Overall Study|Noncompliance|13|||
145924501|NCT04767282|526231244|FG002|Overall Study|Duplicate household previously enrolled|8|||
145924502|NCT04767282|526231242|FG000|Overall Study|Unable to confirm legal guardian|0|||
145924503|NCT04767282|526231243|FG001|Overall Study|Unable to confirm legal guardian|2|||
145924504|NCT04767282|526231244|FG002|Overall Study|Unable to confirm legal guardian|8|||
145924505|NCT04767282|526231242|FG000|Overall Study|Withdrawal by Subject|0|||
145977102|NCT02693418|526428030|FG001|Overall Study|Menses during study period|0|||
146090522|NCT03670836|526851397|FG001|Per Protocol Population (PP)|Physician Decision|6|||
146090523|NCT03670836|526851396|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
146243150|NCT00089791|527405329|FG000|Overall Study|Other|20|||
145924506|NCT04767282|526231243|FG001|Overall Study|Withdrawal by Subject|0|||
145924507|NCT04767282|526231244|FG002|Overall Study|Withdrawal by Subject|6|||
145924508|NCT04767282|526231242|FG000|Overall Study|Survey comprehension challenges|4|||
145924509|NCT04767282|526231243|FG001|Overall Study|Survey comprehension challenges|0|||
145924510|NCT04767282|526231244|FG002|Overall Study|Survey comprehension challenges|0|||
145924511|NCT01467713|526231246|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
145924512|NCT01467713|526231247|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
145924513|NCT01467713|526231248|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
145924514|NCT01467713|526231249|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
145924515|NCT01467713|526231246|FG000|Overall Study|Major Protocol Deviation|2|||
145924516|NCT01467713|526231247|FG001|Overall Study|Major Protocol Deviation|4|||
145924517|NCT01467713|526231248|FG002|Overall Study|Major Protocol Deviation|4|||
145924518|NCT01467713|526231249|FG003|Overall Study|Major Protocol Deviation|1|||
145924519|NCT01467713|526231246|FG000|Overall Study|Lost to Follow-up|9|||
145924520|NCT01467713|526231247|FG001|Overall Study|Lost to Follow-up|12|||
145924521|NCT01467713|526231248|FG002|Overall Study|Lost to Follow-up|6|||
145924522|NCT01467713|526231249|FG003|Overall Study|Lost to Follow-up|9|||
145924523|NCT01467713|526231246|FG000|Overall Study|Voluntary Withdrawal|18|||
145924524|NCT01467713|526231247|FG001|Overall Study|Voluntary Withdrawal|14|||
145924525|NCT01467713|526231248|FG002|Overall Study|Voluntary Withdrawal|21|||
145924526|NCT01467713|526231249|FG003|Overall Study|Voluntary Withdrawal|20|||
145924527|NCT01467713|526231246|FG000|Overall Study|Study Termination|23|||
145924528|NCT01467713|526231247|FG001|Overall Study|Study Termination|33|||
145924529|NCT01467713|526231248|FG002|Overall Study|Study Termination|28|||
145924530|NCT01467713|526231249|FG003|Overall Study|Study Termination|29|||
145924531|NCT01467713|526231246|FG000|Overall Study|Pregnancy|0|||
145924532|NCT01467713|526231247|FG001|Overall Study|Pregnancy|1|||
145924533|NCT01467713|526231248|FG002|Overall Study|Pregnancy|1|||
145924534|NCT01467713|526231249|FG003|Overall Study|Pregnancy|3|||
145924535|NCT01467713|526231246|FG000|Overall Study|Relapse|35|||
145924536|NCT01467713|526231247|FG001|Overall Study|Relapse|25|||
145924537|NCT01467713|526231248|FG002|Overall Study|Relapse|28|||
145924538|NCT01467713|526231249|FG003|Overall Study|Relapse|35|||
145977103|NCT02693418|526428031|FG002|Overall Study|Menses during study period|2|||
145977104|NCT02693418|526428032|FG003|Overall Study|Menses during study period|0|||
145977105|NCT02693418|526428033|FG004|Overall Study|Menses during study period|0|||
145977106|NCT01750346|526428035|FG000|Overall Study|Adverse Event|1|||
145977107|NCT01750346|526428036|FG001|Overall Study|Adverse Event|0|||
145977108|NCT01750346|526428037|FG002|Overall Study|Adverse Event|0|||
145977109|NCT01001104|526428038|FG000|Overall Study|Adverse Event|2|||
145977110|NCT01001104|526428039|FG001|Overall Study|Adverse Event|1|||
145977111|NCT01001104|526428040|FG002|Overall Study|Adverse Event|0|||
145977112|NCT01001104|526428041|FG003|Overall Study|Adverse Event|0|||
145977113|NCT01001104|526428038|FG000|Overall Study|Lost to Follow-up|0|||
145977114|NCT01001104|526428039|FG001|Overall Study|Lost to Follow-up|0|||
145977115|NCT01001104|526428040|FG002|Overall Study|Lost to Follow-up|1|||
145977116|NCT01001104|526428041|FG003|Overall Study|Lost to Follow-up|0|||
145977117|NCT01001104|526428038|FG000|Overall Study|Entry Criteria Not Met|0|||
145977118|NCT01001104|526428039|FG001|Overall Study|Entry Criteria Not Met|0|||
145977119|NCT01001104|526428040|FG002|Overall Study|Entry Criteria Not Met|0|||
145977120|NCT01001104|526428041|FG003|Overall Study|Entry Criteria Not Met|1|||
145977121|NCT01001104|526428038|FG000|Overall Study|Withdrawal by Subject|0|||
145977122|NCT01001104|526428039|FG001|Overall Study|Withdrawal by Subject|0|||
145977123|NCT01001104|526428040|FG002|Overall Study|Withdrawal by Subject|0|||
145977124|NCT01001104|526428041|FG003|Overall Study|Withdrawal by Subject|2|||
145977125|NCT00599313|526428042|FG000|Overall Study|Adverse Event|19|||
145977126|NCT00599313|526428042|FG000|Overall Study|Disease Progression|12|||
145977127|NCT00599313|526428042|FG000|Overall Study|Patient Request|4|||
145977128|NCT00599313|526428042|FG000|Overall Study|Ineligible|1|||
145977129|NCT01793935|526428043|FG000|Overall Study|Pregnancy|1|||
145977130|NCT01793935|526428044|FG001|Overall Study|Pregnancy|0|||
145977131|NCT01793935|526428043|FG000|Overall Study|Protocol Violation|2|||
145977132|NCT01793935|526428044|FG001|Overall Study|Protocol Violation|1|||
145977133|NCT01793935|526428043|FG000|Overall Study|Adverse Event|2|||
145977134|NCT01793935|526428044|FG001|Overall Study|Adverse Event|0|||
145977135|NCT01793935|526428043|FG000|Overall Study|Patient did not take study medication|1|||
145977136|NCT01793935|526428044|FG001|Overall Study|Patient did not take study medication|1|||
145977137|NCT01793935|526428043|FG000|Overall Study|Lost to Follow-up|0|||
145977138|NCT01793935|526428044|FG001|Overall Study|Lost to Follow-up|1|||
145924539|NCT01467713|526231246|FG000|Overall Study|Reason not Specified|6|||
145924540|NCT01467713|526231247|FG001|Overall Study|Reason not Specified|11|||
145924541|NCT01467713|526231248|FG002|Overall Study|Reason not Specified|8|||
145924542|NCT01467713|526231249|FG003|Overall Study|Reason not Specified|7|||
145924543|NCT02525783|526231250|FG000|Overall Study|Lost to Follow-up|10|||
145924544|NCT00866281|526231251|FG000|Overall Study|Adverse Event|1|||
145924545|NCT00866281|526231252|FG001|Overall Study|Adverse Event|0|||
145977139|NCT02782468|526428045|FG000|Overall Study|Progressive Disease|2|||
146243151|NCT00089791|527405330|FG001|Overall Study|Other|32|||
145924546|NCT00866281|526231251|FG000|Overall Study|Withdrawal by participants|3|||
145924547|NCT00866281|526231252|FG001|Overall Study|Withdrawal by participants|0|||
145924548|NCT00866281|526231251|FG000|Overall Study|Disease progression|3|||
145924549|NCT00866281|526231252|FG001|Overall Study|Disease progression|11|||
145924550|NCT00866281|526231251|FG000|Overall Study|New cancer therapy|0|||
145924551|NCT00866281|526231252|FG001|Overall Study|New cancer therapy|4|||
145924552|NCT01100086|526231253|FG000|Period 1|Withdrawal by Subject|1|||
145924553|NCT01100086|526231254|FG001|Period 1|Withdrawal by Subject|0|||
145924554|NCT02612623|526231260|FG000|Overall Study|Withdrawal by Subject|0|||
145924555|NCT02612623|526231261|FG001|Overall Study|Withdrawal by Subject|1|||
145924556|NCT02612623|526231262|FG002|Overall Study|Withdrawal by Subject|0|||
145924557|NCT02612623|526231263|FG003|Overall Study|Withdrawal by Subject|0|||
145924558|NCT02612623|526231260|FG000|Overall Study|Adverse Event|1|||
145924559|NCT02612623|526231261|FG001|Overall Study|Adverse Event|0|||
145924560|NCT02612623|526231262|FG002|Overall Study|Adverse Event|1|||
145924561|NCT02612623|526231263|FG003|Overall Study|Adverse Event|0|||
145924562|NCT00570141|526231268|FG000|Overall Study|Adverse Event|1|||
145924563|NCT00570141|526231268|FG000|Overall Study|Missed visits|1|||
145924564|NCT00570141|526231268|FG000|Overall Study|Lost to Follow-up|1|||
145924565|NCT03270657|526231273|FG000|Overall Study|Withdrawal by Subject|1|||
145924566|NCT00455403|526231274|FG000|Overall Study|Lost to Follow-up|2|||
145924567|NCT00455403|526231275|FG001|Overall Study|Lost to Follow-up|1|||
145924568|NCT00455403|526231274|FG000|Overall Study|Withdrawal by Subject|1|||
145924569|NCT00455403|526231275|FG001|Overall Study|Withdrawal by Subject|3|||
145924570|NCT00455403|526231274|FG000|Overall Study|Protocol Violation|0|||
145924571|NCT00455403|526231275|FG001|Overall Study|Protocol Violation|2|||
145924572|NCT01343043|526231276|FG000|Overall Study|Disease progression before treatment|1|||
145924573|NCT01343043|526231277|FG001|Overall Study|Disease progression before treatment|0|||
145924574|NCT01343043|526231278|FG002|Overall Study|Disease progression before treatment|0|||
145924575|NCT01343043|526231279|FG003|Overall Study|Disease progression before treatment|0|||
145924576|NCT01343043|526231276|FG000|Overall Study|Withdrawal by Subject|1|||
145924577|NCT01343043|526231277|FG001|Overall Study|Withdrawal by Subject|0|||
145924578|NCT01343043|526231278|FG002|Overall Study|Withdrawal by Subject|0|||
145924579|NCT01343043|526231279|FG003|Overall Study|Withdrawal by Subject|0|||
145924580|NCT01343043|526231276|FG000|Overall Study|Death|1|||
145924581|NCT01343043|526231277|FG001|Overall Study|Death|1|||
145924582|NCT01343043|526231278|FG002|Overall Study|Death|0|||
145924583|NCT01343043|526231279|FG003|Overall Study|Death|1|||
145924584|NCT00925704|526231280|FG000|First Intervention|Withdrew consent|0|||
145924585|NCT00925704|526231281|FG001|First Intervention|Withdrew consent|0|||
145924586|NCT00925704|526231282|FG002|First Intervention|Withdrew consent|0|||
145924587|NCT00925704|526231283|FG003|First Intervention|Withdrew consent|1|||
145924588|NCT00925704|526231284|FG004|First Intervention|Withdrew consent|1|||
145977140|NCT02782468|526428046|FG001|Overall Study|Progressive Disease|5|||
145977141|NCT02782468|526428047|FG002|Overall Study|Progressive Disease|0|||
145977142|NCT02782468|526428048|FG003|Overall Study|Progressive Disease|4|||
145977143|NCT02782468|526428045|FG000|Overall Study|Adverse Event|0|||
145977144|NCT02782468|526428046|FG001|Overall Study|Adverse Event|2|||
145977145|NCT02782468|526428047|FG002|Overall Study|Adverse Event|2|||
145924589|NCT00925704|526231285|FG005|First Intervention|Withdrew consent|0|||
145977146|NCT02782468|526428048|FG003|Overall Study|Adverse Event|3|||
145977147|NCT02782468|526428045|FG000|Overall Study|Other|0|||
145977148|NCT02782468|526428046|FG001|Overall Study|Other|0|||
145977149|NCT02782468|526428047|FG002|Overall Study|Other|1|||
145977150|NCT02782468|526428048|FG003|Overall Study|Other|1|||
145977151|NCT02782468|526428045|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145977152|NCT02782468|526428046|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145977153|NCT02782468|526428047|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145977154|NCT02782468|526428048|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
145977155|NCT02782468|526428045|FG000|Overall Study|Symptomatic Deterioration|0|||
145977156|NCT02782468|526428046|FG001|Overall Study|Symptomatic Deterioration|0|||
145977157|NCT02782468|526428047|FG002|Overall Study|Symptomatic Deterioration|0|||
145977158|NCT02782468|526428048|FG003|Overall Study|Symptomatic Deterioration|1|||
145977159|NCT02782468|526428045|FG000|Overall Study|Withdrawal by Subject|1|||
145977160|NCT02782468|526428046|FG001|Overall Study|Withdrawal by Subject|0|||
145977161|NCT02782468|526428047|FG002|Overall Study|Withdrawal by Subject|0|||
145977162|NCT02782468|526428048|FG003|Overall Study|Withdrawal by Subject|0|||
145924590|NCT00925704|526231280|FG000|Second Intervention|Withdrawal by Subject|1|||
145924591|NCT00925704|526231281|FG001|Second Intervention|Withdrawal by Subject|0|||
145924592|NCT00925704|526231282|FG002|Second Intervention|Withdrawal by Subject|0|||
145924593|NCT00925704|526231283|FG003|Second Intervention|Withdrawal by Subject|0|||
145924594|NCT00925704|526231284|FG004|Second Intervention|Withdrawal by Subject|1|||
145924595|NCT00925704|526231285|FG005|Second Intervention|Withdrawal by Subject|0|||
145924596|NCT00925704|526231280|FG000|Third Intervention|Withdrew consent|0|||
145924597|NCT00925704|526231281|FG001|Third Intervention|Withdrew consent|0|||
145924598|NCT00925704|526231282|FG002|Third Intervention|Withdrew consent|0|||
145924599|NCT00925704|526231283|FG003|Third Intervention|Withdrew consent|0|||
145924600|NCT00925704|526231284|FG004|Third Intervention|Withdrew consent|0|||
145924601|NCT00925704|526231285|FG005|Third Intervention|Withdrew consent|1|||
145924602|NCT00502242|526231291|FG000|Overall Study|Lack of Efficacy|1|||
145924603|NCT00502242|526231292|FG001|Overall Study|Lack of Efficacy|11|||
145924604|NCT00502242|526231291|FG000|Overall Study|Adverse Event|31|||
145924605|NCT00502242|526231292|FG001|Overall Study|Adverse Event|20|||
145924606|NCT00502242|526231291|FG000|Overall Study|Physician Decision|2|||
145924607|NCT00502242|526231292|FG001|Overall Study|Physician Decision|3|||
145924608|NCT00502242|526231291|FG000|Overall Study|Other - Unspecified|8|||
145924609|NCT00502242|526231292|FG001|Overall Study|Other - Unspecified|14|||
145924610|NCT00502242|526231291|FG000|Overall Study|Protocol Violation|3|||
145924611|NCT00502242|526231292|FG001|Overall Study|Protocol Violation|1|||
145924612|NCT00502242|526231291|FG000|Overall Study|Withdrawal by Subject|6|||
145924613|NCT00502242|526231292|FG001|Overall Study|Withdrawal by Subject|7|||
145924614|NCT03207815|526231293|FG000|Overall Study|Protocol Violation|3|||
145924615|NCT03207815|526231294|FG001|Overall Study|Protocol Violation|1|||
145924616|NCT03207815|526231293|FG000|Overall Study|Adverse Event|1|||
145924617|NCT03207815|526231294|FG001|Overall Study|Adverse Event|2|||
145924618|NCT03207815|526231293|FG000|Overall Study|Lost to Follow-up|1|||
145924619|NCT03207815|526231294|FG001|Overall Study|Lost to Follow-up|2|||
145924620|NCT03207815|526231293|FG000|Overall Study|Investigator's Discretion|1|||
145924621|NCT03207815|526231294|FG001|Overall Study|Investigator's Discretion|1|||
145924622|NCT03207815|526231293|FG000|Overall Study|Lack of Efficacy|0|||
145924623|NCT03207815|526231294|FG001|Overall Study|Lack of Efficacy|1|||
145924624|NCT03207815|526231293|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
145924625|NCT03207815|526231294|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
145924626|NCT03207815|526231293|FG000|Overall Study|Withdrew Consent|1|||
145924627|NCT03207815|526231294|FG001|Overall Study|Withdrew Consent|0|||
145924628|NCT01671007|526231295|FG000|Overall Study|Other reasons than listed|166|||
145924629|NCT01671007|526231296|FG001|Overall Study|Other reasons than listed|373|||
145924630|NCT01671007|526231297|FG002|Overall Study|Other reasons than listed|197|||
145924631|NCT01671007|526231298|FG003|Overall Study|Other reasons than listed|228|||
145924632|NCT01671007|526231299|FG004|Overall Study|Other reasons than listed|14|||
145924633|NCT01671007|526231300|FG005|Overall Study|Other reasons than listed|71|||
145924634|NCT01671007|526231301|FG006|Overall Study|Other reasons than listed|17|||
145924635|NCT01671007|526231302|FG007|Overall Study|Other reasons than listed|66|||
145924636|NCT01671007|526231303|FG008|Overall Study|Other reasons than listed|0|||
145924637|NCT01671007|526231295|FG000|Overall Study|Withdrawal by Subject|36|||
145924638|NCT01671007|526231296|FG001|Overall Study|Withdrawal by Subject|59|||
145924639|NCT01671007|526231297|FG002|Overall Study|Withdrawal by Subject|53|||
145924640|NCT01671007|526231298|FG003|Overall Study|Withdrawal by Subject|58|||
145924641|NCT01671007|526231299|FG004|Overall Study|Withdrawal by Subject|4|||
145924642|NCT01671007|526231300|FG005|Overall Study|Withdrawal by Subject|15|||
145924643|NCT01671007|526231301|FG006|Overall Study|Withdrawal by Subject|1|||
145924644|NCT01671007|526231302|FG007|Overall Study|Withdrawal by Subject|19|||
145924645|NCT01671007|526231303|FG008|Overall Study|Withdrawal by Subject|0|||
145924646|NCT01671007|526231295|FG000|Overall Study|Lost to Follow-up|93|||
145924647|NCT01671007|526231296|FG001|Overall Study|Lost to Follow-up|142|||
145924648|NCT01671007|526231297|FG002|Overall Study|Lost to Follow-up|91|||
145924649|NCT01671007|526231298|FG003|Overall Study|Lost to Follow-up|63|||
145924650|NCT01671007|526231299|FG004|Overall Study|Lost to Follow-up|7|||
145924651|NCT01671007|526231300|FG005|Overall Study|Lost to Follow-up|20|||
145924652|NCT01671007|526231301|FG006|Overall Study|Lost to Follow-up|2|||
145924653|NCT01671007|526231302|FG007|Overall Study|Lost to Follow-up|28|||
145924654|NCT01671007|526231303|FG008|Overall Study|Lost to Follow-up|0|||
145924655|NCT01671007|526231295|FG000|Overall Study|No end of study case report form|3|||
145924656|NCT01671007|526231296|FG001|Overall Study|No end of study case report form|1|||
145924657|NCT01671007|526231297|FG002|Overall Study|No end of study case report form|0|||
145924658|NCT01671007|526231298|FG003|Overall Study|No end of study case report form|2|||
145924659|NCT01671007|526231299|FG004|Overall Study|No end of study case report form|0|||
145924660|NCT01671007|526231300|FG005|Overall Study|No end of study case report form|0|||
145977163|NCT00356590|526428049|FG000|Overall Study|Adverse Event|54|||
145977164|NCT00356590|526428049|FG000|Overall Study|Death|10|||
145977165|NCT00356590|526428049|FG000|Overall Study|Lost to Follow-up|35|||
145924661|NCT01671007|526231301|FG006|Overall Study|No end of study case report form|0|||
145924662|NCT01671007|526231302|FG007|Overall Study|No end of study case report form|0|||
145924663|NCT01671007|526231303|FG008|Overall Study|No end of study case report form|0|||
145924664|NCT01671007|526231295|FG000|Overall Study|Not eligible|23|||
145924665|NCT01671007|526231296|FG001|Overall Study|Not eligible|76|||
145924666|NCT01671007|526231297|FG002|Overall Study|Not eligible|25|||
145924667|NCT01671007|526231298|FG003|Overall Study|Not eligible|17|||
145924668|NCT01671007|526231299|FG004|Overall Study|Not eligible|0|||
145924669|NCT01671007|526231300|FG005|Overall Study|Not eligible|6|||
145924670|NCT01671007|526231301|FG006|Overall Study|Not eligible|1|||
145924671|NCT01671007|526231302|FG007|Overall Study|Not eligible|19|||
145924672|NCT01671007|526231303|FG008|Overall Study|Not eligible|0|||
145924673|NCT03877068|526231304|FG000|Overall Study|Physician Decision|9|||
145924674|NCT03877068|526231305|FG001|Overall Study|Physician Decision|3|||
145924675|NCT01812109|526231306|FG000|Overall Study|research personnel delay|16|||
145924676|NCT01812109|526231306|FG000|Overall Study|NIRS Unattainable|17|||
145924677|NCT04630002|526231307|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
145924678|NCT04630002|526231308|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145924679|NCT04630002|526231309|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145924680|NCT04630002|526231307|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
145924681|NCT04630002|526231308|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145924682|NCT04630002|526231309|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145924683|NCT04630002|526231307|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
145924684|NCT04630002|526231308|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145924685|NCT04630002|526231309|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145924686|NCT04630002|526231307|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145924687|NCT04630002|526231308|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
145924688|NCT04630002|526231309|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145924689|NCT04630002|526231307|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145924690|NCT04630002|526231308|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
145924691|NCT04630002|526231309|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145924692|NCT04630002|526231307|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145924693|NCT04630002|526231308|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
145924694|NCT04630002|526231309|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145924695|NCT04630002|526231307|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
145924696|NCT04630002|526231308|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
145924697|NCT04630002|526231309|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
145924698|NCT04630002|526231307|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
145924699|NCT04630002|526231308|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
145924700|NCT04630002|526231309|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
145924701|NCT02182843|526231311|FG000|Overall Study|Withdrawal by Subject|7|||
145924702|NCT02182843|526231311|FG000|Overall Study|Lost to Follow-up|2|||
145924703|NCT02182843|526231311|FG000|Overall Study|Adverse Event|1|||
145924704|NCT00891020|526231317|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
145924705|NCT00891020|526231318|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
145924706|NCT00891020|526231319|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
145924707|NCT00891020|526231317|FG000|24 Week Treatment Period|Death|0|||
145924708|NCT00891020|526231318|FG001|24 Week Treatment Period|Death|2|||
145924709|NCT00891020|526231319|FG002|24 Week Treatment Period|Death|0|||
145924710|NCT00891020|526231317|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
145924711|NCT00891020|526231318|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
145924712|NCT00891020|526231319|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
145924713|NCT00891020|526231317|FG000|24 Week Treatment Period|Failure to return|4|||
145924714|NCT00891020|526231318|FG001|24 Week Treatment Period|Failure to return|5|||
145924715|NCT00891020|526231319|FG002|24 Week Treatment Period|Failure to return|5|||
145924716|NCT00891020|526231317|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
145924717|NCT00891020|526231318|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
145924718|NCT00891020|526231319|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
145924719|NCT00891020|526231317|FG000|24 Week Treatment Period|Other protocol violation|1|||
145924720|NCT00891020|526231318|FG001|24 Week Treatment Period|Other protocol violation|1|||
145924721|NCT00891020|526231319|FG002|24 Week Treatment Period|Other protocol violation|2|||
145924722|NCT00891020|526231317|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
145924723|NCT00891020|526231318|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
145924724|NCT00891020|526231319|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
145924725|NCT00891020|526231317|FG000|24 Week Treatment Period|Withdrew consent|6|||
145924726|NCT00891020|526231318|FG001|24 Week Treatment Period|Withdrew consent|3|||
145924727|NCT00891020|526231319|FG002|24 Week Treatment Period|Withdrew consent|15|||
145924728|NCT00891020|526231317|FG000|24 Week Treatment Period|Administrative/Other|5|||
145924729|NCT00891020|526231318|FG001|24 Week Treatment Period|Administrative/Other|6|||
145924730|NCT00891020|526231319|FG002|24 Week Treatment Period|Administrative/Other|1|||
145924731|NCT00891020|526231317|FG000|Long-term Extension Period|Adverse Event|1|||
145924732|NCT00891020|526231318|FG001|Long-term Extension Period|Adverse Event|11|||
145924733|NCT00891020|526231319|FG002|Long-term Extension Period|Adverse Event|10|||
145924734|NCT00891020|526231317|FG000|Long-term Extension Period|Death|0|||
145924735|NCT00891020|526231318|FG001|Long-term Extension Period|Death|0|||
145924736|NCT00891020|526231319|FG002|Long-term Extension Period|Death|1|||
145924737|NCT00891020|526231317|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
145977166|NCT00356590|526428049|FG000|Overall Study|Physician Decision|46|||
146243152|NCT00089791|527405329|FG000|Overall Study|Protocol deviation|12|||
146243153|NCT00089791|527405330|FG001|Overall Study|Protocol deviation|10|||
146243154|NCT00089791|527405329|FG000|Overall Study|Requirement for alternative therapy|7|||
146243155|NCT00089791|527405330|FG001|Overall Study|Requirement for alternative therapy|4|||
145924738|NCT00891020|526231318|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
145924739|NCT00891020|526231319|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
145924740|NCT00891020|526231317|FG000|Long-term Extension Period|Protocol Violation|0|||
145924741|NCT00891020|526231318|FG001|Long-term Extension Period|Protocol Violation|1|||
145924742|NCT00891020|526231319|FG002|Long-term Extension Period|Protocol Violation|1|||
145924743|NCT00891020|526231317|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
145924744|NCT00891020|526231318|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
145924745|NCT00891020|526231319|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
145924746|NCT00891020|526231317|FG000|Long-term Extension Period|Failure to return|0|||
145924747|NCT00891020|526231318|FG001|Long-term Extension Period|Failure to return|2|||
145924748|NCT00891020|526231319|FG002|Long-term Extension Period|Failure to return|3|||
145924749|NCT00891020|526231317|FG000|Long-term Extension Period|Administrative|1|||
145924750|NCT00891020|526231318|FG001|Long-term Extension Period|Administrative|2|||
145924751|NCT00891020|526231319|FG002|Long-term Extension Period|Administrative|2|||
145924752|NCT00320710|526231326|FG000|Overall Study|Disease progression|24|||
145924753|NCT00320710|526231327|FG001|Overall Study|Disease progression|19|||
145924754|NCT00320710|526231328|FG002|Overall Study|Disease progression|2|||
145924755|NCT00320710|526231326|FG000|Overall Study|Death|10|||
145924756|NCT00320710|526231327|FG001|Overall Study|Death|7|||
145924757|NCT00320710|526231328|FG002|Overall Study|Death|1|||
145924758|NCT00320710|526231326|FG000|Overall Study|Administrative problems|1|||
145924759|NCT00320710|526231327|FG001|Overall Study|Administrative problems|2|||
145924760|NCT00320710|526231328|FG002|Overall Study|Administrative problems|0|||
145924761|NCT00320710|526231326|FG000|Overall Study|Withdrawal by Subject|20|||
145924762|NCT00320710|526231327|FG001|Overall Study|Withdrawal by Subject|26|||
145924763|NCT00320710|526231328|FG002|Overall Study|Withdrawal by Subject|1|||
145924764|NCT00320710|526231326|FG000|Overall Study|Protocol Violation|6|||
145924765|NCT00320710|526231327|FG001|Overall Study|Protocol Violation|5|||
145924766|NCT00320710|526231328|FG002|Overall Study|Protocol Violation|0|||
145924767|NCT00320710|526231326|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145924768|NCT00320710|526231327|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145924769|NCT00320710|526231328|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145924770|NCT00320710|526231326|FG000|Overall Study|Abnormal laboratory value(s)|12|||
145924771|NCT00320710|526231327|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145924772|NCT00320710|526231328|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145924773|NCT00320710|526231326|FG000|Overall Study|Adverse Event|18|||
145924774|NCT00320710|526231327|FG001|Overall Study|Adverse Event|14|||
145924775|NCT00320710|526231328|FG002|Overall Study|Adverse Event|1|||
145924776|NCT00320710|526231326|FG000|Overall Study|Lost to Follow-up|1|||
145924777|NCT00320710|526231327|FG001|Overall Study|Lost to Follow-up|0|||
145924778|NCT00320710|526231328|FG002|Overall Study|Lost to Follow-up|0|||
145924779|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
145924780|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145924781|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145924782|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145924783|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
145924784|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145924785|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145924786|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145924787|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
145924788|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145924789|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145977167|NCT00356590|526428049|FG000|Overall Study|Withdrawal by Subject|41|||
145977168|NCT00356590|526428049|FG000|Overall Study|Completed month 12 only|2|||
145977169|NCT00356590|526428049|FG000|Overall Study|Protocol issues|6|||
145977170|NCT00356590|526428049|FG000|Overall Study|Response status|28|||
145977171|NCT00356590|526428049|FG000|Overall Study|Other|52|||
145977172|NCT03439514|526428055|FG000|Double-Blind Treatment Period|Other|4|||
145977173|NCT03439514|526428056|FG001|Double-Blind Treatment Period|Other|1|||
145977174|NCT03439514|526428055|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
145977175|NCT03439514|526428056|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146090524|NCT03670836|526851397|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
145924790|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145977176|NCT03439514|526428055|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
145924791|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
145924792|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145924793|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145924794|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
146090525|NCT00323869|526851400|FG000|Overall Study|Death|1|||
146297764|NCT02616614|527605983|FG002|Overall Study|Prohibited Medication|5|||
145924795|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
145924796|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924797|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924798|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924799|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
145924800|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924801|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924802|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924803|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
145924804|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145924805|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145924806|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145924807|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
145924808|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145924809|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145924810|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145924811|NCT00506415|526231330|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
145924812|NCT00506415|526231331|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924813|NCT00506415|526231332|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924814|NCT00506415|526231333|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924815|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
145924816|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
145924817|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
145924818|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
145924819|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
145924820|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
145924821|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
145924822|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
145924823|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
145924824|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
145924825|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
145924826|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
145924827|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
145924828|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
145924829|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
145924830|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
145924831|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
145924832|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
145924833|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
145924834|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
145924835|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
145924836|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
145924837|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
145924838|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
145924839|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
145924840|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
145924841|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
145924842|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
145924843|NCT00506415|526231330|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145924844|NCT00506415|526231331|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145924845|NCT00506415|526231332|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
145924846|NCT00506415|526231333|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145977177|NCT03439514|526428056|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
145977178|NCT03439514|526428055|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
145977179|NCT03439514|526428056|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
145977180|NCT03439514|526428055|FG000|Double-Blind Treatment Period|Death|1|||
145977181|NCT03439514|526428056|FG001|Double-Blind Treatment Period|Death|2|||
145977182|NCT02175758|526428057|FG000|Treatment Phase|Lost to Follow-up|0|||
145977183|NCT02175758|526428058|FG001|Treatment Phase|Lost to Follow-up|1|||
145977184|NCT02175758|526428059|FG002|Treatment Phase|Lost to Follow-up|0|||
145977185|NCT02175758|526428060|FG003|Treatment Phase|Lost to Follow-up|0|||
145977186|NCT02175758|526428061|FG004|Treatment Phase|Lost to Follow-up|0|||
145977187|NCT02175758|526428062|FG005|Treatment Phase|Lost to Follow-up|0|||
145977188|NCT02175758|526428057|FG000|Treatment Phase|Adverse Event|0|||
145977189|NCT02175758|526428058|FG001|Treatment Phase|Adverse Event|0|||
145977190|NCT02175758|526428059|FG002|Treatment Phase|Adverse Event|0|||
145977191|NCT02175758|526428060|FG003|Treatment Phase|Adverse Event|0|||
145924847|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145924848|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145924849|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145924850|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
145924851|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
146090526|NCT03437512|526852616|FG000|Randomized|Withdrawal by Subject|0|||
145924852|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145924853|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145924854|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
145924855|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924856|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924857|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145924858|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
145924859|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924860|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924861|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145924862|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
145924863|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924864|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924865|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145924866|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
145924867|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145924868|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145924869|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145924870|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
145924871|NCT00506415|526231330|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145924872|NCT00506415|526231331|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145924873|NCT00506415|526231332|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145924874|NCT00506415|526231333|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
145924875|NCT04578457|526231334|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
145924876|NCT04578457|526231334|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
145924877|NCT04578457|526231334|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
145924878|NCT04578457|526231334|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
145924879|NCT02841995|526231335|FG000|Overall Study|Disease progression|5|||
145924880|NCT02841995|526231336|FG001|Overall Study|Disease progression|11|||
145924881|NCT02841995|526231337|FG002|Overall Study|Disease progression|8|||
146090527|NCT03437512|526852617|FG001|Randomized|Withdrawal by Subject|2|||
146090528|NCT03437512|526852616|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
146090529|NCT03437512|526852617|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
146090530|NCT01897714|526852618|FG000|Phase I (Dose Escalation)|Disease progression|3|||
146090531|NCT01897714|526852619|FG001|Phase I (Dose Escalation)|Disease progression|5|||
146243156|NCT02449902|527405333|FG000|Overall Study|Adverse Event|0|||
146243157|NCT02449902|527405334|FG001|Overall Study|Adverse Event|1|||
146243158|NCT02449902|527405333|FG000|Overall Study|Withdrawal by Subject|0|||
145924882|NCT02841995|526231335|FG000|Overall Study|Withdrawal by Subject|2|||
145924883|NCT02841995|526231336|FG001|Overall Study|Withdrawal by Subject|4|||
145924884|NCT02841995|526231337|FG002|Overall Study|Withdrawal by Subject|4|||
145924885|NCT02841995|526231335|FG000|Overall Study|Adverse Event|2|||
145924886|NCT02841995|526231336|FG001|Overall Study|Adverse Event|0|||
145924887|NCT02841995|526231337|FG002|Overall Study|Adverse Event|1|||
145924888|NCT02841995|526231335|FG000|Overall Study|Investigator decision|2|||
145924889|NCT02841995|526231336|FG001|Overall Study|Investigator decision|0|||
145924890|NCT02841995|526231337|FG002|Overall Study|Investigator decision|1|||
145924891|NCT02841995|526231335|FG000|Overall Study|Death|0|||
145924892|NCT02841995|526231336|FG001|Overall Study|Death|0|||
145924893|NCT02841995|526231337|FG002|Overall Study|Death|2|||
145924894|NCT02841995|526231335|FG000|Overall Study|Noncompliance to protocol|1|||
145924895|NCT02841995|526231336|FG001|Overall Study|Noncompliance to protocol|0|||
145924896|NCT02841995|526231337|FG002|Overall Study|Noncompliance to protocol|0|||
145924897|NCT02841995|526231335|FG000|Overall Study|Sponsor decision|1|||
145924898|NCT02841995|526231336|FG001|Overall Study|Sponsor decision|0|||
145924899|NCT02841995|526231337|FG002|Overall Study|Sponsor decision|0|||
145924900|NCT02841995|526231335|FG000|Overall Study|Other|4|||
145924901|NCT02841995|526231336|FG001|Overall Study|Other|1|||
145924902|NCT02841995|526231337|FG002|Overall Study|Other|5|||
145924903|NCT01703260|526231345|FG000|Overall Study|Adverse Event|1|||
145924904|NCT01703260|526231346|FG001|Overall Study|Adverse Event|2|||
146243159|NCT02449902|527405334|FG001|Overall Study|Withdrawal by Subject|1|||
145924905|NCT01703260|526231347|FG002|Overall Study|Adverse Event|2|||
145924906|NCT01703260|526231345|FG000|Overall Study|Lost to Follow-up|1|||
145924907|NCT01703260|526231346|FG001|Overall Study|Lost to Follow-up|0|||
145977192|NCT02175758|526428061|FG004|Treatment Phase|Adverse Event|1|||
145977193|NCT02175758|526428062|FG005|Treatment Phase|Adverse Event|0|||
145977194|NCT04398134|526428065|FG000|Overall Study|Adverse Event|0|||
145977195|NCT04398134|526428066|FG001|Overall Study|Adverse Event|0|||
145977196|NCT04398134|526428067|FG002|Overall Study|Adverse Event|1|||
145977197|NCT04398134|526428068|FG003|Overall Study|Adverse Event|0|||
145977198|NCT04398134|526428065|FG000|Overall Study|Withdrawal by Subject|2|||
145977199|NCT04398134|526428066|FG001|Overall Study|Withdrawal by Subject|0|||
145977200|NCT04398134|526428067|FG002|Overall Study|Withdrawal by Subject|0|||
145924908|NCT01703260|526231347|FG002|Overall Study|Lost to Follow-up|0|||
145924909|NCT01703260|526231345|FG000|Overall Study|Withdrawal by Subject|0|||
145924910|NCT01703260|526231346|FG001|Overall Study|Withdrawal by Subject|0|||
145924911|NCT01703260|526231347|FG002|Overall Study|Withdrawal by Subject|1|||
145924912|NCT01703260|526231345|FG000|Overall Study|Study Termination|1|||
145924913|NCT01703260|526231346|FG001|Overall Study|Study Termination|2|||
145924914|NCT01703260|526231347|FG002|Overall Study|Study Termination|0|||
145924915|NCT00561392|526231349|FG000|Overall Study|Adverse Event|38|||
145924916|NCT00561392|526231349|FG000|Overall Study|Lack of Efficacy|2|||
145924917|NCT00561392|526231349|FG000|Overall Study|Protocol Violation|1|||
145924918|NCT00561392|526231349|FG000|Overall Study|Withdrawal by Subject|8|||
145924919|NCT00561392|526231349|FG000|Overall Study|Administrative problems|4|||
145924920|NCT02632409|526231353|FG000|Randomized|AE unrelated to study Drug|0|||
145924921|NCT02632409|526231354|FG001|Randomized|AE unrelated to study Drug|1|||
145924922|NCT02632409|526231353|FG000|Randomized|Participant withdrew consent|2|||
145924923|NCT02632409|526231354|FG001|Randomized|Participant withdrew consent|1|||
145924924|NCT02632409|526231353|FG000|Randomized|No Longer meets study criteria|5|||
145924925|NCT02632409|526231354|FG001|Randomized|No Longer meets study criteria|0|||
145924926|NCT02632409|526231353|FG000|Randomized|other reasons|1|||
145924927|NCT02632409|526231354|FG001|Randomized|other reasons|0|||
145924928|NCT02632409|526231353|FG000|Treatment Period|Ongoing Treatment|20|||
145924929|NCT02632409|526231354|FG001|Treatment Period|Ongoing Treatment|21|||
145924930|NCT02632409|526231353|FG000|Treatment Period|Disease Recurrence|147|||
145924931|NCT02632409|526231354|FG001|Treatment Period|Disease Recurrence|90|||
145924932|NCT02632409|526231353|FG000|Treatment Period|Study Drug Toxicity|8|||
145924933|NCT02632409|526231354|FG001|Treatment Period|Study Drug Toxicity|49|||
145924934|NCT02632409|526231353|FG000|Treatment Period|Death|1|||
145924935|NCT02632409|526231354|FG001|Treatment Period|Death|0|||
145924936|NCT02632409|526231353|FG000|Treatment Period|AE unrelated to study drug|15|||
145924937|NCT02632409|526231354|FG001|Treatment Period|AE unrelated to study drug|16|||
145924938|NCT02632409|526231353|FG000|Treatment Period|Request to discontinue treatment|4|||
145924939|NCT02632409|526231354|FG001|Treatment Period|Request to discontinue treatment|19|||
145924940|NCT02632409|526231353|FG000|Treatment Period|Participant withdrew consent|7|||
145924941|NCT02632409|526231354|FG001|Treatment Period|Participant withdrew consent|5|||
145924942|NCT02632409|526231353|FG000|Treatment Period|Lost to Follow-up|0|||
145924943|NCT02632409|526231354|FG001|Treatment Period|Lost to Follow-up|1|||
145924944|NCT02632409|526231353|FG000|Treatment Period|Maximum clinical benefit|1|||
145924945|NCT02632409|526231354|FG001|Treatment Period|Maximum clinical benefit|0|||
145924946|NCT02632409|526231353|FG000|Treatment Period|No longer meets study criteria|3|||
145924947|NCT02632409|526231354|FG001|Treatment Period|No longer meets study criteria|0|||
146243160|NCT02362789|527405338|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
146243161|NCT02362789|527405339|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
146243162|NCT02362789|527405340|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
146243163|NCT02362789|527405338|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
146243164|NCT02362789|527405339|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
146243165|NCT02362789|527405340|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
146243166|NCT02362789|527405338|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
146243167|NCT02362789|527405339|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
146243168|NCT02362789|527405340|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
146243169|NCT02362789|527405338|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
146243170|NCT02362789|527405339|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
145924948|NCT02632409|526231353|FG000|Treatment Period|Administrative Reason by sponsor|0|||
145924949|NCT02632409|526231354|FG001|Treatment Period|Administrative Reason by sponsor|1|||
145924950|NCT02632409|526231353|FG000|Treatment Period|Other Reasons|10|||
145924951|NCT02632409|526231354|FG001|Treatment Period|Other Reasons|6|||
145924952|NCT05600283|526231355|FG000|Overall Study|Withdrawal by Subject|3|||
145924953|NCT05600283|526231356|FG001|Overall Study|Withdrawal by Subject|8|||
145924954|NCT05600283|526231355|FG000|Overall Study|invalid individual swab|1|||
145924955|NCT05600283|526231356|FG001|Overall Study|invalid individual swab|0|||
145977201|NCT04398134|526428068|FG003|Overall Study|Withdrawal by Subject|1|||
145977202|NCT04398134|526428065|FG000|Overall Study|Study Terminated by Sponsor|30|||
145977203|NCT04398134|526428066|FG001|Overall Study|Study Terminated by Sponsor|11|||
145977204|NCT04398134|526428067|FG002|Overall Study|Study Terminated by Sponsor|32|||
145977205|NCT04398134|526428068|FG003|Overall Study|Study Terminated by Sponsor|11|||
146243171|NCT02362789|527405340|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
146243172|NCT02362789|527405338|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
146243173|NCT02362789|527405339|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
146243174|NCT02362789|527405340|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
146243175|NCT01365546|527405341|FG000|Overall Study|Withdrawal by Subject|1|||
146243176|NCT01365546|527405341|FG000|Overall Study|Screen failure|9|||
146243177|NCT01365546|527405341|FG000|Overall Study|Study termination|1|||
146243178|NCT03861234|527405343|FG000|Overall Study|Not treated|0|||
146243179|NCT03861234|527405344|FG001|Overall Study|Not treated|0|||
146243180|NCT03861234|527405345|FG002|Overall Study|Not treated|0|||
145924956|NCT05600283|526231355|FG000|Overall Study|missing clinician collection|3|||
145924957|NCT05600283|526231356|FG001|Overall Study|missing clinician collection|0|||
145924958|NCT05600283|526231355|FG000|Overall Study|screening failure|0|||
145924959|NCT05600283|526231356|FG001|Overall Study|screening failure|2|||
145924960|NCT02883062|526231357|FG000|Overall Study|Withdrawal by Subject|6|||
145924961|NCT02883062|526231358|FG001|Overall Study|Withdrawal by Subject|0|||
145924962|NCT04426006|526231359|FG000|Inclusion|Protocol Violation|1|||
145924963|NCT04426006|526231359|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
145924964|NCT04426006|526231359|FG000|Inclusion|Blood sample at inclusion not done|1|||
145924965|NCT04426006|526231359|FG000|3 Months|Lost to Follow-up|17|||
145924966|NCT04426006|526231359|FG000|12 Months|Lost to Follow-up|38|||
145924967|NCT00720213|526231362|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
145924968|NCT00720213|526231363|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
145924969|NCT00720213|526231364|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
145924970|NCT01808066|526231368|FG000|Overall Study|Withdrawal by Subject|15|||
145924971|NCT01420068|526231370|FG000|Overall Study|Administrative problems|1|||
145924972|NCT01420068|526231371|FG001|Overall Study|Administrative problems|3|||
145924973|NCT01420068|526231370|FG000|Overall Study|Withdrawal by Subject|1|||
145924974|NCT01420068|526231371|FG001|Overall Study|Withdrawal by Subject|2|||
145924975|NCT01252095|526231372|FG000|Overall Study|Disease progression|1|||
145924976|NCT01252095|526231373|FG001|Overall Study|Disease progression|0|||
145924977|NCT00745901|526231374|FG000|Overall Study|Adverse Event|3|||
145924978|NCT00745901|526231375|FG001|Overall Study|Adverse Event|4|||
145924979|NCT00745901|526231374|FG000|Overall Study|Protocol Violation|0|||
145924980|NCT00745901|526231375|FG001|Overall Study|Protocol Violation|1|||
145924981|NCT00745901|526231374|FG000|Overall Study|Withdrawal by Subject|1|||
145924982|NCT00745901|526231375|FG001|Overall Study|Withdrawal by Subject|0|||
145924983|NCT00745901|526231374|FG000|Overall Study|Lost to Follow-up|7|||
145924984|NCT00745901|526231375|FG001|Overall Study|Lost to Follow-up|4|||
145924985|NCT00745901|526231374|FG000|Overall Study|Pregnancy|2|||
145924986|NCT00745901|526231375|FG001|Overall Study|Pregnancy|4|||
145924987|NCT00745901|526231374|FG000|Overall Study|Lack of compliance|2|||
145924988|NCT00745901|526231375|FG001|Overall Study|Lack of compliance|2|||
145924989|NCT00745901|526231374|FG000|Overall Study|Patient's next menses did not start with|1|||
145924990|NCT00745901|526231375|FG001|Overall Study|Patient's next menses did not start with|0|||
145924991|NCT00745901|526231374|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
145924992|NCT00745901|526231375|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
145924993|NCT00745901|526231374|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
145924994|NCT00745901|526231375|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
145924995|NCT00745901|526231374|FG000|Overall Study|Patient didn't take any study medication|7|||
145924996|NCT00745901|526231375|FG001|Overall Study|Patient didn't take any study medication|3|||
145924997|NCT00884117|526231378|FG000|Overall Study|Adverse Event|2|||
145924998|NCT00884117|526231378|FG000|Overall Study|Withdrawal by Subject|89|||
145924999|NCT00884117|526231378|FG000|Overall Study|Death|3|||
145925000|NCT00884117|526231378|FG000|Overall Study|Lost to Follow-up|143|||
145925001|NCT00884117|526231378|FG000|Overall Study|Other|12|||
145925002|NCT01753310|526231379|FG000|Overall Study|Entered into open label extension study|25|||
145925003|NCT01753310|526231380|FG001|Overall Study|Entered into open label extension study|22|||
145925004|NCT01753310|526231379|FG000|Overall Study|Adverse Event|1|||
145925005|NCT01753310|526231380|FG001|Overall Study|Adverse Event|0|||
145925006|NCT01753310|526231379|FG000|Overall Study|Lost to Follow-up|2|||
145925007|NCT01753310|526231380|FG001|Overall Study|Lost to Follow-up|0|||
145925008|NCT01753310|526231379|FG000|Overall Study|Subject decision|2|||
145925009|NCT01753310|526231380|FG001|Overall Study|Subject decision|2|||
145925010|NCT01753310|526231379|FG000|Overall Study|Sponsor decision|1|||
145925011|NCT01753310|526231380|FG001|Overall Study|Sponsor decision|0|||
145925012|NCT01753310|526231379|FG000|Overall Study|Withdrawal by Subject|1|||
145925013|NCT01753310|526231380|FG001|Overall Study|Withdrawal by Subject|0|||
145925014|NCT00952068|526231382|FG000|Overall Study|Adverse Event|3|||
145925015|NCT00952068|526231382|FG000|Overall Study|Withdrawal by Subject|4|||
145925016|NCT04340843|526231383|FG000|Overall Study|Adverse Event|0|||
145925017|NCT04340843|526231384|FG001|Overall Study|Adverse Event|2|||
145925018|NCT04340843|526231383|FG000|Overall Study|Withdrawal by Subject|0|||
145925019|NCT04340843|526231384|FG001|Overall Study|Withdrawal by Subject|2|||
145925020|NCT01383174|526231387|FG000|3 Month Assessment|Death|0|||
146243181|NCT03861234|527405346|FG003|Overall Study|Not treated|0|||
146243182|NCT03861234|527405347|FG004|Overall Study|Not treated|0|||
145925021|NCT01383174|526231388|FG001|3 Month Assessment|Death|1|||
145925022|NCT01383174|526231387|FG000|3 Month Assessment|Lost to Follow-up|2|||
145925023|NCT01383174|526231388|FG001|3 Month Assessment|Lost to Follow-up|0|||
145925024|NCT01383174|526231387|FG000|3 Month Assessment|Refused to complete|4|||
145925025|NCT01383174|526231388|FG001|3 Month Assessment|Refused to complete|0|||
145925026|NCT01383174|526231387|FG000|6 Month Assessment|Lost to Follow-up|1|||
145925027|NCT01383174|526231388|FG001|6 Month Assessment|Lost to Follow-up|1|||
145925028|NCT01383174|526231387|FG000|6 Month Assessment|Refused to complete|4|||
145925029|NCT01383174|526231388|FG001|6 Month Assessment|Refused to complete|0|||
145925030|NCT01890122|526231391|FG000|Overall Study|Adverse Event|1|||
145925031|NCT01890122|526231392|FG001|Overall Study|Adverse Event|1|||
145925032|NCT01890122|526231393|FG002|Overall Study|Adverse Event|1|||
145925033|NCT01890122|526231394|FG003|Overall Study|Adverse Event|2|||
145925034|NCT01890122|526231391|FG000|Overall Study|Major Protocol Deviation|3|||
145925035|NCT01890122|526231392|FG001|Overall Study|Major Protocol Deviation|1|||
145925036|NCT01890122|526231393|FG002|Overall Study|Major Protocol Deviation|0|||
145925037|NCT01890122|526231394|FG003|Overall Study|Major Protocol Deviation|1|||
145925038|NCT01890122|526231391|FG000|Overall Study|Lost to Follow-up|0|||
145925039|NCT01890122|526231392|FG001|Overall Study|Lost to Follow-up|1|||
145925040|NCT01890122|526231393|FG002|Overall Study|Lost to Follow-up|2|||
145925041|NCT01890122|526231394|FG003|Overall Study|Lost to Follow-up|2|||
145925042|NCT01890122|526231391|FG000|Overall Study|Voluntary Withdrawal|8|||
145925043|NCT01890122|526231392|FG001|Overall Study|Voluntary Withdrawal|8|||
145925044|NCT01890122|526231393|FG002|Overall Study|Voluntary Withdrawal|2|||
145925045|NCT01890122|526231394|FG003|Overall Study|Voluntary Withdrawal|11|||
145925046|NCT01890122|526231391|FG000|Overall Study|Lack of Efficacy|14|||
145925047|NCT01890122|526231392|FG001|Overall Study|Lack of Efficacy|24|||
145925048|NCT01890122|526231393|FG002|Overall Study|Lack of Efficacy|7|||
145925049|NCT01890122|526231394|FG003|Overall Study|Lack of Efficacy|41|||
145925050|NCT01890122|526231391|FG000|Overall Study|Reason not Specified|0|||
145925051|NCT01890122|526231392|FG001|Overall Study|Reason not Specified|1|||
145925052|NCT01890122|526231393|FG002|Overall Study|Reason not Specified|1|||
145925053|NCT01890122|526231394|FG003|Overall Study|Reason not Specified|2|||
145925054|NCT01890122|526231391|FG000|Overall Study|Randomized but not Treated|1|||
145925055|NCT01890122|526231392|FG001|Overall Study|Randomized but not Treated|1|||
145925056|NCT01890122|526231393|FG002|Overall Study|Randomized but not Treated|0|||
145925057|NCT01890122|526231394|FG003|Overall Study|Randomized but not Treated|0|||
145925058|NCT04495829|526231396|FG000|Overall Study|Lost to Follow-up|2|||
145925059|NCT04495829|526231396|FG000|Overall Study|Inclusion criterion not met|3|||
145925060|NCT05795153|526233215|FG000|Overall Study|Adverse Event|2|||
145925061|NCT05795153|526233215|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145925062|NCT05795153|526233215|FG000|Overall Study|Lost to Follow-up|1|||
145925063|NCT05795153|526233215|FG000|Overall Study|Subject decision|2|||
145925064|NCT03668119|526233216|FG000|Pre-treatment|Disease Progression|1|||
145925065|NCT03668119|526233217|FG001|Pre-treatment|Disease Progression|0|||
145925066|NCT03668119|526233216|FG000|Treatment|Disease Progression|76|||
145925067|NCT03668119|526233217|FG001|Treatment|Disease Progression|57|||
145925068|NCT03668119|526233216|FG000|Treatment|Study drug toxicity|19|||
145925069|NCT03668119|526233217|FG001|Treatment|Study drug toxicity|1|||
145925070|NCT03668119|526233216|FG000|Treatment|Death|3|||
145925071|NCT03668119|526233217|FG001|Treatment|Death|0|||
145925072|NCT03668119|526233216|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
145925073|NCT03668119|526233217|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
145925074|NCT03668119|526233216|FG000|Treatment|Withdrawal by Subject|1|||
145925075|NCT03668119|526233217|FG001|Treatment|Withdrawal by Subject|1|||
145925076|NCT03668119|526233216|FG000|Treatment|Participant request to discontinue study treatment|3|||
145925077|NCT03668119|526233217|FG001|Treatment|Participant request to discontinue study treatment|1|||
145925078|NCT03668119|526233216|FG000|Treatment|Maximum Clinical Benefit|0|||
145925079|NCT03668119|526233217|FG001|Treatment|Maximum Clinical Benefit|1|||
145925080|NCT03668119|526233216|FG000|Treatment|Participants completed treatment|27|||
145925081|NCT03668119|526233217|FG001|Treatment|Participants completed treatment|11|||
145925082|NCT03668119|526233216|FG000|Treatment|Other reasons|2|||
145925083|NCT03668119|526233217|FG001|Treatment|Other reasons|1|||
145925084|NCT03769168|526233218|FG000|Overall Study|Adverse Event|0|||
145925085|NCT03769168|526233219|FG001|Overall Study|Adverse Event|1|||
145925086|NCT03769168|526233218|FG000|Overall Study|Lack of Efficacy|2|||
145925087|NCT03769168|526233219|FG001|Overall Study|Lack of Efficacy|4|||
145925088|NCT03769168|526233218|FG000|Overall Study|Post study access to treatment|3|||
145925089|NCT03769168|526233219|FG001|Overall Study|Post study access to treatment|11|||
145925090|NCT03769168|526233218|FG000|Overall Study|Physician Decision|1|||
145925091|NCT03769168|526233219|FG001|Overall Study|Physician Decision|4|||
145925092|NCT03769168|526233218|FG000|Overall Study|Subject Decision|2|||
145925093|NCT03769168|526233219|FG001|Overall Study|Subject Decision|4|||
145925094|NCT03769168|526233218|FG000|Overall Study|Guardian decision|1|||
145925095|NCT03769168|526233219|FG001|Overall Study|Guardian decision|0|||
145925096|NCT05336227|526233220|FG000|Overall Study|Adverse Event|1|||
145925097|NCT05336227|526233221|FG001|Overall Study|Adverse Event|0|||
145925098|NCT05336227|526233220|FG000|Overall Study|Lost to Follow-up|2|||
145925099|NCT05336227|526233221|FG001|Overall Study|Lost to Follow-up|0|||
145925100|NCT05336227|526233220|FG000|Overall Study|Withdrawal by Subject|1|||
145925101|NCT05336227|526233221|FG001|Overall Study|Withdrawal by Subject|0|||
145925102|NCT04050462|526233222|FG000|Overall Study|Withdrawal by Subject|1|||
145925103|NCT04050462|526233223|FG001|Overall Study|Withdrawal by Subject|0|||
145925104|NCT04050462|526233224|FG002|Overall Study|Withdrawal by Subject|0|||
145925105|NCT05151744|526233227|FG000|Overall Study|Adverse Event|6|||
145925106|NCT05151744|526233228|FG001|Overall Study|Adverse Event|2|||
145925107|NCT05151744|526233227|FG000|Overall Study|Death|1|||
145925108|NCT05151744|526233228|FG001|Overall Study|Death|2|||
145925109|NCT05151744|526233227|FG000|Overall Study|Lack of Efficacy|1|||
145925110|NCT05151744|526233228|FG001|Overall Study|Lack of Efficacy|1|||
145925111|NCT05151744|526233227|FG000|Overall Study|Lost to Follow-up|2|||
145925112|NCT05151744|526233228|FG001|Overall Study|Lost to Follow-up|2|||
145925113|NCT05151744|526233227|FG000|Overall Study|Need for Rescue Treatment|0|||
145925114|NCT05151744|526233228|FG001|Overall Study|Need for Rescue Treatment|1|||
145925115|NCT05151744|526233227|FG000|Overall Study|Non-compliance with Study Drug|0|||
145925116|NCT05151744|526233228|FG001|Overall Study|Non-compliance with Study Drug|1|||
145925117|NCT05151744|526233227|FG000|Overall Study|Reason not Specified|10|||
145925118|NCT05151744|526233228|FG001|Overall Study|Reason not Specified|0|||
145925119|NCT05151744|526233227|FG000|Overall Study|Physician Decision|2|||
145925120|NCT05151744|526233228|FG001|Overall Study|Physician Decision|1|||
145925121|NCT05151744|526233227|FG000|Overall Study|Protocol Violation|1|||
145925122|NCT05151744|526233228|FG001|Overall Study|Protocol Violation|0|||
145925123|NCT05151744|526233227|FG000|Overall Study|Withdrawal by Subject|6|||
145925124|NCT05151744|526233228|FG001|Overall Study|Withdrawal by Subject|3|||
145925125|NCT05228470|526233229|FG000|Overall Study|Death|6|||
145925126|NCT05228470|526233230|FG001|Overall Study|Death|11|||
145925127|NCT05228470|526233229|FG000|Overall Study|Withdrawal by Subject|1|||
145925128|NCT05228470|526233230|FG001|Overall Study|Withdrawal by Subject|8|||
145925129|NCT05228470|526233229|FG000|Overall Study|Ongoing|1|||
145925130|NCT05228470|526233230|FG001|Overall Study|Ongoing|11|||
145925131|NCT04053868|526233231|FG000|Overall Study|Withdrawal by Subject|1|||
145925132|NCT04053868|526233232|FG001|Overall Study|Withdrawal by Subject|0|||
145925133|NCT05731700|526233233|FG000|Overall Study|Death|1|||
145925134|NCT04010240|526233236|FG000|Overall Study|IHC not performed|2299|||
145925135|NCT00570687|526233237|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925136|NCT00570687|526233238|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925137|NCT00570687|526233239|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925138|NCT00570687|526233240|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925139|NCT00570687|526233241|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145925140|NCT00570687|526233242|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145925141|NCT00570687|526233243|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
145925142|NCT00570687|526233244|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145925143|NCT00570687|526233245|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
145925144|NCT00570687|526233246|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145925145|NCT00570687|526233237|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925146|NCT00570687|526233238|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925147|NCT00570687|526233239|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925148|NCT00570687|526233240|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925149|NCT00570687|526233241|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925150|NCT00570687|526233242|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925151|NCT00570687|526233243|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925152|NCT00570687|526233244|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925153|NCT00570687|526233245|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
145925154|NCT00570687|526233246|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925155|NCT00570687|526233237|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925156|NCT00570687|526233238|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925157|NCT00570687|526233239|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925158|NCT00570687|526233240|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925159|NCT00570687|526233241|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925160|NCT00570687|526233242|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925161|NCT00570687|526233243|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
145925162|NCT00570687|526233244|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925163|NCT00570687|526233245|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925164|NCT00570687|526233246|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145925165|NCT00975611|526233247|FG000|Overall Study|Screen Fail|16|||
145925166|NCT00975611|526233247|FG000|Overall Study|Physician Decision|1|||
145925167|NCT03771898|526233248|FG000|Overall Study|Adverse Event|1|||
145925168|NCT03771898|526233249|FG001|Overall Study|Adverse Event|0|||
145925169|NCT03771898|526233250|FG002|Overall Study|Adverse Event|0|||
145925170|NCT03771898|526233251|FG003|Overall Study|Adverse Event|0|||
145925171|NCT03771898|526233252|FG004|Overall Study|Adverse Event|0|||
145925172|NCT03771898|526233248|FG000|Overall Study|Lost to Follow-up|1|||
145925173|NCT03771898|526233249|FG001|Overall Study|Lost to Follow-up|1|||
145925174|NCT03771898|526233250|FG002|Overall Study|Lost to Follow-up|1|||
145925175|NCT03771898|526233251|FG003|Overall Study|Lost to Follow-up|0|||
145925176|NCT03771898|526233252|FG004|Overall Study|Lost to Follow-up|0|||
145925177|NCT03771898|526233248|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145925178|NCT03771898|526233249|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145925179|NCT03771898|526233250|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145925180|NCT03771898|526233251|FG003|Overall Study|Withdrawal by parent/guardian|0|||
145925181|NCT03771898|526233252|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145925182|NCT03771898|526233248|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145925183|NCT03771898|526233249|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145925184|NCT03771898|526233250|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145925185|NCT03771898|526233251|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145925186|NCT03771898|526233252|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
145925187|NCT04623216|526233256|FG000|Overall Study|Death|5|||
145925188|NCT04623216|526233257|FG001|Overall Study|Death|2|||
145925189|NCT04623216|526233258|FG002|Overall Study|Death|0|||
145925190|NCT04623216|526233259|FG003|Overall Study|Death|0|||
145925191|NCT04623216|526233256|FG000|Overall Study|Terminated by Sponsor|3|||
145925192|NCT04623216|526233257|FG001|Overall Study|Terminated by Sponsor|2|||
145925193|NCT04623216|526233258|FG002|Overall Study|Terminated by Sponsor|2|||
145925194|NCT04623216|526233259|FG003|Overall Study|Terminated by Sponsor|0|||
145925195|NCT04623216|526233256|FG000|Overall Study|Physician Decision|1|||
145925196|NCT04623216|526233257|FG001|Overall Study|Physician Decision|0|||
145925197|NCT04623216|526233258|FG002|Overall Study|Physician Decision|0|||
145925198|NCT04623216|526233259|FG003|Overall Study|Physician Decision|0|||
145925199|NCT03521154|526233262|FG000|Overall Study|Ongoing study at data cut-off|111|||
145925200|NCT03521154|526233263|FG001|Overall Study|Ongoing study at data cut-off|52|||
145925201|NCT05468164|526233264|FG000|Treatment Period 4|Adverse Event|0|||
145925202|NCT05468164|526233265|FG001|Treatment Period 4|Adverse Event|0|||
145925203|NCT05468164|526233266|FG002|Treatment Period 4|Adverse Event|0|||
145925204|NCT05468164|526233267|FG003|Treatment Period 4|Adverse Event|1|||
145925205|NCT05386680|526233268|FG000|Overall Study|Guardian decision|2|||
145925206|NCT04652726|526233269|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
145925207|NCT04652726|526233270|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
145925208|NCT04652726|526233271|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
145925209|NCT04652726|526233269|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
145925210|NCT04652726|526233270|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
145925211|NCT04652726|526233271|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
145925212|NCT04066244|526233278|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
145925213|NCT04066244|526233279|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
145925214|NCT04066244|526233280|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
145925215|NCT04066244|526233281|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
145925216|NCT04066244|526233282|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
145925217|NCT04066244|526233283|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
145925218|NCT04066244|526233278|FG000|Part 2 (Cohort 5)|Death|0|||
145925219|NCT04066244|526233279|FG001|Part 2 (Cohort 5)|Death|0|||
145925220|NCT04066244|526233280|FG002|Part 2 (Cohort 5)|Death|0|||
145925221|NCT04066244|526233281|FG003|Part 2 (Cohort 5)|Death|0|||
145925222|NCT04066244|526233282|FG004|Part 2 (Cohort 5)|Death|0|||
145925223|NCT04066244|526233283|FG005|Part 2 (Cohort 5)|Death|2|||
145925224|NCT04066244|526233278|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145925225|NCT04066244|526233279|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145977206|NCT03506477|526428074|FG000|Overall Study|Withdrawal by Subject|1|||
145977207|NCT03506477|526428075|FG001|Overall Study|Withdrawal by Subject|0|||
145977208|NCT03462680|526428076|FG000|Overall Study|Withdrawal by Subject|3|||
145925226|NCT04066244|526233280|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145925227|NCT04066244|526233281|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145925228|NCT04066244|526233282|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145925229|NCT04066244|526233283|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
145925230|NCT04066244|526233278|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145925231|NCT04066244|526233279|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145925232|NCT04066244|526233280|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145977209|NCT03462680|526428077|FG001|Overall Study|Withdrawal by Subject|5|||
145977210|NCT01757847|526428078|FG000|Overall Study|Withdrawal by Subject|3|||
145977211|NCT01757847|526428079|FG001|Overall Study|Withdrawal by Subject|4|||
145925233|NCT04066244|526233281|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145925234|NCT04066244|526233282|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
145925235|NCT04066244|526233283|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145925236|NCT03976362|526233284|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
145977212|NCT04556097|526428080|FG000|Overall Study|Death|0|||
145977213|NCT04556097|526428081|FG001|Overall Study|Death|5|||
145977214|NCT04556097|526428082|FG002|Overall Study|Death|0|||
145977215|NCT04556097|526428083|FG003|Overall Study|Death|0|||
145925237|NCT03976362|526233285|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145925238|NCT03976362|526233286|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145925239|NCT03976362|526233284|FG000|Induction Phase|Death|62|||
145925240|NCT03976362|526233285|FG001|Induction Phase|Death|0|||
145925241|NCT03976362|526233286|FG002|Induction Phase|Death|0|||
145925242|NCT03976362|526233284|FG000|Maintenance Phase|Participants Ongoing|0|||
145925243|NCT03976362|526233285|FG001|Maintenance Phase|Participants Ongoing|106|||
145925244|NCT03976362|526233286|FG002|Maintenance Phase|Participants Ongoing|103|||
145925245|NCT03976362|526233284|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145925246|NCT03976362|526233285|FG001|Maintenance Phase|Withdrawal by Subject|4|||
145925247|NCT03976362|526233286|FG002|Maintenance Phase|Withdrawal by Subject|4|||
145925248|NCT03976362|526233284|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
145925249|NCT03976362|526233285|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
145925250|NCT03976362|526233286|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
145925251|NCT03976362|526233284|FG000|Maintenance Phase|Death|0|||
145925252|NCT03976362|526233285|FG001|Maintenance Phase|Death|186|||
145925253|NCT03976362|526233286|FG002|Maintenance Phase|Death|187|||
145925254|NCT01780038|526233289|FG000|Overall Study|Lost to Follow-up|4|||
145925255|NCT01780038|526233290|FG001|Overall Study|Lost to Follow-up|1|||
145925256|NCT03168711|526233291|FG000|Overall Study|Adverse Event|2|||
145925257|NCT03168711|526233292|FG001|Overall Study|Adverse Event|0|||
145925258|NCT03168711|526233291|FG000|Overall Study|Withdrawal by Subject|0|||
145925259|NCT03168711|526233292|FG001|Overall Study|Withdrawal by Subject|1|||
145925260|NCT03168711|526233291|FG000|Overall Study|Death|0|||
145925261|NCT03168711|526233292|FG001|Overall Study|Death|1|||
145925262|NCT04509076|526233293|FG000|Overall Study|Withdrawal by Subject|1|||
145925263|NCT04509076|526233294|FG001|Overall Study|Withdrawal by Subject|2|||
145925264|NCT04509076|526233293|FG000|Overall Study|Lost to Follow-up|1|||
145925265|NCT04509076|526233294|FG001|Overall Study|Lost to Follow-up|2|||
145925266|NCT01966120|526233299|FG000|Overall Study|Withdrawal by Subject|0|||
145925267|NCT01966120|526233300|FG001|Overall Study|Withdrawal by Subject|5|||
145925268|NCT01966120|526233299|FG000|Overall Study|Lost to Follow-up|1|||
145925269|NCT01966120|526233300|FG001|Overall Study|Lost to Follow-up|1|||
145925270|NCT01346696|526233301|FG000|Overall Study|Death|1|||
145925271|NCT02588612|526233304|FG000|Overall Study|Physician Decision|1|||
145925272|NCT02588612|526233304|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
145925273|NCT02588612|526233304|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
145925274|NCT02588612|526233304|FG000|Overall Study|Death prior to T-cell infusion|1|||
145925275|NCT03448419|526233305|FG000|Overall Study|Adverse Event|10|||
145925276|NCT03448419|526233306|FG001|Overall Study|Adverse Event|9|||
145977216|NCT04556097|526428080|FG000|Overall Study|No caregiver|43|||
145977217|NCT04556097|526428081|FG001|Overall Study|No caregiver|53|||
145977218|NCT04556097|526428082|FG002|Overall Study|No caregiver|0|||
145977219|NCT04556097|526428083|FG003|Overall Study|No caregiver|0|||
145977220|NCT04556097|526428080|FG000|Overall Study|Ineligible, SNF|2|||
145977221|NCT04556097|526428081|FG001|Overall Study|Ineligible, SNF|2|||
145977222|NCT04556097|526428082|FG002|Overall Study|Ineligible, SNF|0|||
145977223|NCT04556097|526428083|FG003|Overall Study|Ineligible, SNF|0|||
145977224|NCT04556097|526428080|FG000|Overall Study|Ineligible, health|3|||
145977225|NCT04556097|526428081|FG001|Overall Study|Ineligible, health|4|||
145977226|NCT04556097|526428082|FG002|Overall Study|Ineligible, health|0|||
145977227|NCT04556097|526428083|FG003|Overall Study|Ineligible, health|0|||
145977228|NCT04556097|526428080|FG000|Overall Study|Ineligible, language|0|||
145977229|NCT04556097|526428081|FG001|Overall Study|Ineligible, language|1|||
145977230|NCT04556097|526428082|FG002|Overall Study|Ineligible, language|0|||
145977231|NCT04556097|526428083|FG003|Overall Study|Ineligible, language|0|||
145977232|NCT04556097|526428080|FG000|Overall Study|Ineligible, no longer in care management|0|||
145977233|NCT04556097|526428081|FG001|Overall Study|Ineligible, no longer in care management|2|||
145977234|NCT04556097|526428082|FG002|Overall Study|Ineligible, no longer in care management|1|||
145977235|NCT04556097|526428083|FG003|Overall Study|Ineligible, no longer in care management|0|||
145977236|NCT04556097|526428080|FG000|Overall Study|No dementia|13|||
145925277|NCT03448419|526233305|FG000|Overall Study|Lost to Follow-up|0|||
145925278|NCT03448419|526233306|FG001|Overall Study|Lost to Follow-up|2|||
145925279|NCT03448419|526233305|FG000|Overall Study|Withdrawal by Subject|3|||
145977237|NCT04556097|526428081|FG001|Overall Study|No dementia|3|||
145925280|NCT03448419|526233306|FG001|Overall Study|Withdrawal by Subject|1|||
145925281|NCT03448419|526233305|FG000|Overall Study|Not treated|0|||
145925282|NCT03448419|526233306|FG001|Overall Study|Not treated|1|||
145977238|NCT04556097|526428082|FG002|Overall Study|No dementia|0|||
145977239|NCT04556097|526428083|FG003|Overall Study|No dementia|0|||
145977240|NCT04556097|526428080|FG000|Overall Study|Missing identifier|2|||
145977241|NCT04556097|526428081|FG001|Overall Study|Missing identifier|4|||
145977242|NCT04556097|526428082|FG002|Overall Study|Missing identifier|0|||
145977243|NCT04556097|526428083|FG003|Overall Study|Missing identifier|0|||
145925283|NCT03448419|526233305|FG000|Overall Study|Patient did not attend all visits|0|||
145925284|NCT03448419|526233306|FG001|Overall Study|Patient did not attend all visits|2|||
145925285|NCT03448419|526233305|FG000|Overall Study|Withdrawn by Sponsor|0|||
145925286|NCT03448419|526233306|FG001|Overall Study|Withdrawn by Sponsor|1|||
145977244|NCT04556097|526428080|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
145977245|NCT04556097|526428081|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
145977246|NCT04556097|526428082|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
145977247|NCT04556097|526428083|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
145977248|NCT02516241|526428084|FG000|Overall Study|Death|255|||
145977249|NCT02516241|526428085|FG001|Overall Study|Death|262|||
145977250|NCT02516241|526428086|FG002|Overall Study|Death|270|||
145977251|NCT02516241|526428084|FG000|Overall Study|Lost to Follow-up|1|||
145977252|NCT02516241|526428085|FG001|Overall Study|Lost to Follow-up|1|||
145977253|NCT02516241|526428086|FG002|Overall Study|Lost to Follow-up|3|||
145977254|NCT02516241|526428084|FG000|Overall Study|Withdrawal by Subject|2|||
145977255|NCT02516241|526428085|FG001|Overall Study|Withdrawal by Subject|7|||
145977256|NCT02516241|526428086|FG002|Overall Study|Withdrawal by Subject|12|||
145977257|NCT02516241|526428084|FG000|Overall Study|participants ongoing at data cut-off|84|||
145977258|NCT02516241|526428085|FG001|Overall Study|participants ongoing at data cut-off|76|||
145977259|NCT02516241|526428086|FG002|Overall Study|participants ongoing at data cut-off|59|||
145977260|NCT04057365|526428087|FG000|Overall Study|Withdrawal by Subject|2|||
145977261|NCT04057365|526428088|FG001|Overall Study|Withdrawal by Subject|0|||
145977262|NCT04738487|526428089|FG000|Overall Study|Participant Ongoing in Study|298|||
145977263|NCT04738487|526428090|FG001|Overall Study|Participant Ongoing in Study|297|||
145977264|NCT04738487|526428089|FG000|Overall Study|Withdrawal by Subject|7|||
145977265|NCT04738487|526428090|FG001|Overall Study|Withdrawal by Subject|9|||
145977266|NCT04738487|526428089|FG000|Overall Study|Lost to Follow-up|2|||
145977267|NCT04738487|526428090|FG001|Overall Study|Lost to Follow-up|0|||
145977268|NCT04738487|526428089|FG000|Overall Study|Death|287|||
145977269|NCT04738487|526428090|FG001|Overall Study|Death|306|||
145977270|NCT00325416|526428105|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
145977271|NCT00325416|526428106|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
145977272|NCT00325416|526428105|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
145977273|NCT00325416|526428106|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
145977274|NCT00325416|526428105|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
145977275|NCT00325416|526428106|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
145977276|NCT00325416|526428105|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
145977277|NCT00325416|526428106|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
145977278|NCT00325416|526428105|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
145925287|NCT04548193|526233319|FG000|Overall Study|Lost to Follow-up|0|||
145925288|NCT04548193|526233320|FG001|Overall Study|Lost to Follow-up|1|||
145925289|NCT04548193|526233319|FG000|Overall Study|Death|0|||
145925290|NCT04548193|526233320|FG001|Overall Study|Death|1|||
145925291|NCT04548193|526233319|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
145925292|NCT04548193|526233320|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
145925293|NCT04548193|526233319|FG000|Overall Study|Withdrawal by Subject|2|||
145925294|NCT04548193|526233320|FG001|Overall Study|Withdrawal by Subject|2|||
145925295|NCT00630825|526233321|FG000|Overall Study|Adverse Event|4|||
145925296|NCT00630825|526233322|FG001|Overall Study|Adverse Event|4|||
145925297|NCT00630825|526233323|FG002|Overall Study|Adverse Event|3|||
145925298|NCT00630825|526233324|FG003|Overall Study|Adverse Event|1|||
145925299|NCT00630825|526233321|FG000|Overall Study|Entry Criteria Not Met|1|||
145925300|NCT00630825|526233322|FG001|Overall Study|Entry Criteria Not Met|0|||
145925301|NCT00630825|526233323|FG002|Overall Study|Entry Criteria Not Met|2|||
145925302|NCT00630825|526233324|FG003|Overall Study|Entry Criteria Not Met|1|||
145925303|NCT00630825|526233321|FG000|Overall Study|Lost to Follow-up|1|||
145977279|NCT00325416|526428106|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
145977280|NCT00325416|526428105|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
145977281|NCT00325416|526428106|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
145977282|NCT06239610|526428107|FG000|Overall Study|no usable migration data for minimum of one day|11|||
145925304|NCT00630825|526233322|FG001|Overall Study|Lost to Follow-up|1|||
145925305|NCT00630825|526233323|FG002|Overall Study|Lost to Follow-up|1|||
145925306|NCT00630825|526233324|FG003|Overall Study|Lost to Follow-up|1|||
145925307|NCT00630825|526233321|FG000|Overall Study|Physician Decision|1|||
145925308|NCT00630825|526233322|FG001|Overall Study|Physician Decision|0|||
145925309|NCT00630825|526233323|FG002|Overall Study|Physician Decision|0|||
145925310|NCT00630825|526233324|FG003|Overall Study|Physician Decision|0|||
145925311|NCT00630825|526233321|FG000|Overall Study|Withdrawal by Subject|2|||
145925312|NCT00630825|526233322|FG001|Overall Study|Withdrawal by Subject|2|||
145925313|NCT00630825|526233323|FG002|Overall Study|Withdrawal by Subject|2|||
145925314|NCT00630825|526233324|FG003|Overall Study|Withdrawal by Subject|3|||
145925315|NCT02042014|526233325|FG000|Overall Study|Adverse Event|1|||
145925316|NCT02042014|526233325|FG000|Overall Study|Physician Decision|7|||
145925317|NCT02211209|526233328|FG000|Overall Study|Investigator judgment|0|||
145925318|NCT02211209|526233329|FG001|Overall Study|Investigator judgment|1|||
145925319|NCT02211209|526233328|FG000|Overall Study|Voluntary withdrawal|1|||
145925320|NCT02211209|526233329|FG001|Overall Study|Voluntary withdrawal|4|||
145925321|NCT02211209|526233328|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145925322|NCT02211209|526233329|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
145925323|NCT02211209|526233328|FG000|Overall Study|Reason Not Specified|1|||
145925324|NCT02211209|526233329|FG001|Overall Study|Reason Not Specified|0|||
145925325|NCT03123393|526233332|FG000|Overall Study|Study Terminated by Sponsor|6|||
145925326|NCT03123393|526233333|FG001|Overall Study|Study Terminated by Sponsor|9|||
145925327|NCT03123393|526233332|FG000|Overall Study|Withdrawal by Subject|2|||
145925328|NCT03123393|526233333|FG001|Overall Study|Withdrawal by Subject|1|||
145925329|NCT03123393|526233332|FG000|Overall Study|Reason not Specified|13|||
145925330|NCT03123393|526233333|FG001|Overall Study|Reason not Specified|13|||
145925331|NCT00558701|526233335|FG000|Overall Study|Protocol Deviations|1|||
145925332|NCT00558701|526233336|FG001|Overall Study|Protocol Deviations|4|||
145925333|NCT00427648|526233337|FG000|Overall Study|Protocol Violation|1|||
145925334|NCT00427648|526233338|FG001|Overall Study|Protocol Violation|2|||
145925335|NCT00427648|526233337|FG000|Overall Study|Adverse Event|0|||
145925336|NCT00427648|526233338|FG001|Overall Study|Adverse Event|1|||
145925337|NCT02230904|526233341|FG000|Overall Study|Safety follow up could not take place|0|||
145925338|NCT02230904|526233342|FG001|Overall Study|Safety follow up could not take place|1|||
145925339|NCT01681212|526233343|FG000|Overall Study|No longer met study criteria|5|||
145925340|NCT01681212|526233343|FG000|Overall Study|Administrative reason by sponsor|1|||
145925341|NCT05047211|526233346|FG000|Overall Study|Lost to Follow-up|8|||
145925342|NCT05047211|526233347|FG001|Overall Study|Lost to Follow-up|5|||
145925343|NCT02187198|526233348|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
145925344|NCT02187198|526233349|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
145925345|NCT02187198|526233348|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
145925346|NCT02187198|526233349|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
145925347|NCT03321968|526233350|FG000|Overall Study|Withdrawal by Subject|1|||
145925348|NCT03321968|526233351|FG001|Overall Study|Withdrawal by Subject|2|||
145925349|NCT03321968|526233352|FG002|Overall Study|Withdrawal by Subject|1|||
145925350|NCT03321968|526233350|FG000|Overall Study|Lost to Follow-up|2|||
145925351|NCT03321968|526233351|FG001|Overall Study|Lost to Follow-up|0|||
145925352|NCT03321968|526233352|FG002|Overall Study|Lost to Follow-up|1|||
145925353|NCT03321968|526233350|FG000|Overall Study|Other than specified|0|||
145925354|NCT03321968|526233351|FG001|Overall Study|Other than specified|0|||
145925355|NCT03321968|526233352|FG002|Overall Study|Other than specified|1|||
145925356|NCT03822468|526233353|FG000|Treatment Period|Progressive disease|98|||
145925357|NCT03822468|526233354|FG001|Treatment Period|Progressive disease|94|||
145925358|NCT03822468|526233353|FG000|Treatment Period|Adverse Event|21|||
145925359|NCT03822468|526233354|FG001|Treatment Period|Adverse Event|24|||
145925360|NCT03822468|526233353|FG000|Treatment Period|Withdrawal by Subject|9|||
145925361|NCT03822468|526233354|FG001|Treatment Period|Withdrawal by Subject|5|||
145925362|NCT03822468|526233353|FG000|Treatment Period|Physician Decision|9|||
145925363|NCT03822468|526233354|FG001|Treatment Period|Physician Decision|7|||
146243183|NCT03861234|527405348|FG005|Overall Study|Not treated|1|||
145925364|NCT03822468|526233353|FG000|Treatment Period|Protocol Violation|2|||
145925365|NCT03822468|526233354|FG001|Treatment Period|Protocol Violation|1|||
145925366|NCT03822468|526233353|FG000|Treatment Period|Death|2|||
145925367|NCT03822468|526233354|FG001|Treatment Period|Death|3|||
145925368|NCT03822468|526233353|FG000|Treatment Period|Lost to Follow-up|1|||
145925369|NCT03822468|526233354|FG001|Treatment Period|Lost to Follow-up|1|||
145925370|NCT03822468|526233353|FG000|Treatment Period|Sponsor decision|46|||
145925371|NCT03822468|526233354|FG001|Treatment Period|Sponsor decision|53|||
145925372|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
145925373|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
145925374|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
145925375|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
146243184|NCT03861234|527405349|FG006|Overall Study|Not treated|0|||
146243185|NCT03861234|527405350|FG007|Overall Study|Not treated|0|||
145925376|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Death|1|||
145925377|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Death|0|||
145925378|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146243186|NCT03861234|527405343|FG000|Overall Study|Adverse Event|0|||
146243187|NCT03861234|527405344|FG001|Overall Study|Adverse Event|0|||
145925379|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146090532|NCT01897714|526852620|FG002|Phase I (Dose Escalation)|Disease progression|1|||
145925380|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
145925381|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145925382|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
145925383|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145925384|NCT03822468|526233353|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
145925385|NCT03822468|526233354|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
145925386|NCT01532518|526233355|FG000|Overall Study|Withdrawal by Subject|0|||
145925387|NCT01532518|526233356|FG001|Overall Study|Withdrawal by Subject|0|||
145925388|NCT01532518|526233357|FG002|Overall Study|Withdrawal by Subject|1|||
145925389|NCT01575834|526233358|FG000|Overall Study|Withdrawal by Subject|352|||
145925390|NCT01575834|526233359|FG001|Overall Study|Withdrawal by Subject|390|||
145925391|NCT01575834|526233358|FG000|Overall Study|Death|81|||
145925392|NCT01575834|526233359|FG001|Overall Study|Death|74|||
145925393|NCT01575834|526233358|FG000|Overall Study|Other|70|||
145925394|NCT01575834|526233359|FG001|Overall Study|Other|70|||
145925395|NCT01575834|526233358|FG000|Overall Study|Adverse Event|63|||
145925396|NCT01575834|526233359|FG001|Overall Study|Adverse Event|61|||
145925397|NCT01575834|526233358|FG000|Overall Study|Lost to Follow-up|55|||
145925398|NCT01575834|526233359|FG001|Overall Study|Lost to Follow-up|68|||
145925399|NCT01575834|526233358|FG000|Overall Study|Noncompliance|52|||
145925400|NCT01575834|526233359|FG001|Overall Study|Noncompliance|27|||
145925401|NCT01575834|526233358|FG000|Overall Study|Administrative decision|15|||
145925402|NCT01575834|526233359|FG001|Overall Study|Administrative decision|33|||
145925403|NCT01575834|526233358|FG000|Overall Study|Ineligibility Determined|5|||
145925404|NCT01575834|526233359|FG001|Overall Study|Ineligibility Determined|8|||
145925405|NCT01575834|526233358|FG000|Overall Study|Protocol Deviation|4|||
145925406|NCT01575834|526233359|FG001|Overall Study|Protocol Deviation|3|||
145925407|NCT01575834|526233358|FG000|Overall Study|Requirement for Alternative Therapy|2|||
145925408|NCT01575834|526233359|FG001|Overall Study|Requirement for Alternative Therapy|4|||
145925409|NCT02155283|526233360|FG000|Overall Study|Lost to Follow-up|3|||
145925410|NCT02155283|526233360|FG000|Overall Study|Withdrawal by Subject|1|||
145925411|NCT02155283|526233360|FG000|Overall Study|Protocol Violation|3|||
145925412|NCT01741688|526233362|FG000|Overall Study|Lack of insurance coverage|2|||
145925413|NCT01741688|526233362|FG000|Overall Study|Withdrawal by Subject|1|||
145925414|NCT02282813|526233367|FG000|Overall Study|Withdrawal by Subject|4|||
145925415|NCT02282813|526233368|FG001|Overall Study|Withdrawal by Subject|5|||
145925416|NCT02282813|526233369|FG002|Overall Study|Withdrawal by Subject|0|||
145925417|NCT02282813|526233367|FG000|Overall Study|Adverse Event|3|||
145925418|NCT02282813|526233368|FG001|Overall Study|Adverse Event|10|||
146090533|NCT01897714|526852621|FG003|Phase I (Dose Escalation)|Disease progression|3|||
146090534|NCT01897714|526852622|FG004|Phase I (Dose Escalation)|Disease progression|0|||
146090535|NCT01897714|526852623|FG005|Phase I (Dose Escalation)|Disease progression|0|||
146090536|NCT01897714|526852618|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
146090537|NCT01897714|526852619|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
146243188|NCT03861234|527405345|FG002|Overall Study|Adverse Event|0|||
145925419|NCT02282813|526233369|FG002|Overall Study|Adverse Event|1|||
146090538|NCT01897714|526852620|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
145925420|NCT02282813|526233367|FG000|Overall Study|Subject non-compliance|1|||
145925421|NCT02282813|526233368|FG001|Overall Study|Subject non-compliance|4|||
145925422|NCT02282813|526233369|FG002|Overall Study|Subject non-compliance|0|||
145925423|NCT02282813|526233367|FG000|Overall Study|Physician Decision|0|||
145925424|NCT02282813|526233368|FG001|Overall Study|Physician Decision|3|||
145925425|NCT02282813|526233369|FG002|Overall Study|Physician Decision|1|||
145925426|NCT02282813|526233367|FG000|Overall Study|Lost to Follow-up|2|||
145925427|NCT02282813|526233368|FG001|Overall Study|Lost to Follow-up|0|||
145925428|NCT02282813|526233369|FG002|Overall Study|Lost to Follow-up|1|||
145925429|NCT02282813|526233367|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
146090539|NCT01897714|526852621|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
145925430|NCT02282813|526233368|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
145925431|NCT02282813|526233369|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
145925432|NCT02282813|526233367|FG000|Overall Study|Lack of Efficacy|1|||
145925433|NCT02282813|526233368|FG001|Overall Study|Lack of Efficacy|0|||
145925434|NCT02282813|526233369|FG002|Overall Study|Lack of Efficacy|0|||
145925435|NCT02282813|526233367|FG000|Overall Study|Administrative reasons|0|||
145925436|NCT02282813|526233368|FG001|Overall Study|Administrative reasons|1|||
145925437|NCT02282813|526233369|FG002|Overall Study|Administrative reasons|0|||
146090540|NCT01897714|526852622|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
146090541|NCT01897714|526852623|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
145925438|NCT00463047|526233371|FG000|Titration Period 1|Adverse Event|10|||
145925439|NCT00463047|526233372|FG001|Titration Period 1|Adverse Event|8|||
145925440|NCT00463047|526233371|FG000|Titration Period 1|Lack of Efficacy|10|||
145925441|NCT00463047|526233372|FG001|Titration Period 1|Lack of Efficacy|4|||
146090542|NCT01897714|526852618|FG000|Phase I (Dose Escalation)|Other|0|||
146090543|NCT01897714|526852619|FG001|Phase I (Dose Escalation)|Other|1|||
145925442|NCT00463047|526233371|FG000|Titration Period 1|Lost to Follow-up|2|||
145925443|NCT00463047|526233372|FG001|Titration Period 1|Lost to Follow-up|0|||
145925444|NCT00463047|526233371|FG000|Titration Period 1|Non-compliance with study medication|3|||
145925445|NCT00463047|526233372|FG001|Titration Period 1|Non-compliance with study medication|5|||
145925446|NCT00463047|526233371|FG000|Titration Period 1|Protocol Violation|5|||
145925447|NCT00463047|526233372|FG001|Titration Period 1|Protocol Violation|5|||
145925448|NCT00463047|526233371|FG000|Titration Period 1|Withdrawal by Subject|3|||
145925449|NCT00463047|526233372|FG001|Titration Period 1|Withdrawal by Subject|5|||
145925450|NCT00463047|526233371|FG000|Titration Period 1|Non-compliance procedures|4|||
145925451|NCT00463047|526233372|FG001|Titration Period 1|Non-compliance procedures|10|||
145925452|NCT00463047|526233371|FG000|Titration Period 1|Other|0|||
145925453|NCT00463047|526233372|FG001|Titration Period 1|Other|2|||
145925454|NCT00463047|526233371|FG000|Titration Period 2|Adverse Event|9|||
145925455|NCT00463047|526233372|FG001|Titration Period 2|Adverse Event|9|||
145925456|NCT00463047|526233371|FG000|Titration Period 2|Lack of Efficacy|6|||
145925457|NCT00463047|526233372|FG001|Titration Period 2|Lack of Efficacy|4|||
145925458|NCT00463047|526233371|FG000|Titration Period 2|Withdrawal by Subject|1|||
145925459|NCT00463047|526233372|FG001|Titration Period 2|Withdrawal by Subject|0|||
145925460|NCT00463047|526233371|FG000|Titration Period 2|Protocol Violation|2|||
145925461|NCT00463047|526233372|FG001|Titration Period 2|Protocol Violation|3|||
145925462|NCT00463047|526233371|FG000|Titration Period 2|Lost to Follow-up|1|||
145925463|NCT00463047|526233372|FG001|Titration Period 2|Lost to Follow-up|2|||
145925464|NCT00463047|526233371|FG000|Titration Period 2|Non-compliance study medication|4|||
145925465|NCT00463047|526233372|FG001|Titration Period 2|Non-compliance study medication|2|||
145925466|NCT00463047|526233371|FG000|Titration Period 2|Non-compliance procedures|4|||
145925467|NCT00463047|526233372|FG001|Titration Period 2|Non-compliance procedures|1|||
145925468|NCT00463047|526233371|FG000|Titration Period 2|Other|3|||
145925469|NCT00463047|526233372|FG001|Titration Period 2|Other|2|||
145925470|NCT00463047|526233371|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
145925471|NCT00463047|526233372|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
145925472|NCT00463047|526233371|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
145925473|NCT00463047|526233372|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
145925474|NCT00463047|526233371|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
145925475|NCT00463047|526233372|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
145925476|NCT00463047|526233371|FG000|Double-Blind Treatment Period 1|Other|1|||
145925477|NCT00463047|526233372|FG001|Double-Blind Treatment Period 1|Other|0|||
145925478|NCT00463047|526233371|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
145925479|NCT00463047|526233372|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
145925480|NCT00463047|526233371|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
145925481|NCT00463047|526233372|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
145925482|NCT00463047|526233371|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
145925483|NCT00463047|526233372|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
145925484|NCT00739661|526233376|FG000|Overall Study|Adverse Event|2|||
145925485|NCT00739661|526233377|FG001|Overall Study|Adverse Event|0|||
145925486|NCT00739661|526233376|FG000|Overall Study|Physician decision to withdraw patient|1|||
145925487|NCT00739661|526233377|FG001|Overall Study|Physician decision to withdraw patient|0|||
145925488|NCT00739661|526233376|FG000|Overall Study|Patient decision to withdraw|9|||
145925489|NCT00739661|526233377|FG001|Overall Study|Patient decision to withdraw|4|||
145925490|NCT00739661|526233376|FG000|Overall Study|Disease progression, radiographic|33|||
145925491|NCT00739661|526233377|FG001|Overall Study|Disease progression, radiographic|37|||
145925492|NCT00739661|526233376|FG000|Overall Study|Reason for discontinuation not available|1|||
145925493|NCT00739661|526233377|FG001|Overall Study|Reason for discontinuation not available|1|||
145925494|NCT00410813|526233378|FG000|Overall Study|Adverse Event|6|||
145925495|NCT00410813|526233379|FG001|Overall Study|Adverse Event|11|||
145925496|NCT00410813|526233378|FG000|Overall Study|Progression|32|||
145925497|NCT00410813|526233379|FG001|Overall Study|Progression|21|||
145925498|NCT00410813|526233378|FG000|Overall Study|Not protocol specified|3|||
145925499|NCT00410813|526233379|FG001|Overall Study|Not protocol specified|4|||
145925500|NCT00410813|526233378|FG000|Overall Study|Ineligible|2|||
145925501|NCT00410813|526233379|FG001|Overall Study|Ineligible|4|||
145925502|NCT00410813|526233378|FG000|Overall Study|Death|0|||
145925503|NCT00410813|526233379|FG001|Overall Study|Death|2|||
145925504|NCT02198664|526233380|FG000|Overall Study|Adverse Event|2|||
145925505|NCT02198664|526233381|FG001|Overall Study|Adverse Event|0|||
145925506|NCT02198664|526233380|FG000|Overall Study|Withdrawal by Subject|11|||
145925507|NCT02198664|526233381|FG001|Overall Study|Withdrawal by Subject|8|||
145925508|NCT02198664|526233380|FG000|Overall Study|Failure to tolerate|2|||
145925509|NCT02198664|526233381|FG001|Overall Study|Failure to tolerate|0|||
145925510|NCT02198664|526233380|FG000|Overall Study|Not stated|1|||
145925511|NCT02198664|526233381|FG001|Overall Study|Not stated|0|||
145925512|NCT01991743|526233382|FG000|Overall Study|external cephalic version not performed|0|||
145925513|NCT01991743|526233383|FG001|Overall Study|external cephalic version not performed|0|||
145925514|NCT01991743|526233384|FG002|Overall Study|external cephalic version not performed|1|||
145925515|NCT01991743|526233385|FG003|Overall Study|external cephalic version not performed|0|||
145925516|NCT01611883|526233387|FG000|Overall Study|Adverse Event|1|||
145925517|NCT01611883|526233388|FG001|Overall Study|Adverse Event|1|||
145925518|NCT00734994|526233391|FG000|Overall Study|Withdrawal by Subject|1|||
145925519|NCT01622673|526233392|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145925520|NCT01622673|526233393|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145925521|NCT01622673|526233394|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145925522|NCT01622673|526233395|FG003|Treatment Period 1|Withdrawal by Subject|1|||
145925523|NCT01622673|526233396|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145925524|NCT01622673|526233397|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145925525|NCT01622673|526233392|FG000|Treatment Period 1|Protocol Violation|0|||
145925526|NCT01622673|526233393|FG001|Treatment Period 1|Protocol Violation|1|||
145925527|NCT01622673|526233394|FG002|Treatment Period 1|Protocol Violation|0|||
145925528|NCT01622673|526233395|FG003|Treatment Period 1|Protocol Violation|0|||
145925529|NCT01622673|526233396|FG004|Treatment Period 1|Protocol Violation|0|||
145925530|NCT01622673|526233397|FG005|Treatment Period 1|Protocol Violation|0|||
145925531|NCT01622673|526233392|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145925532|NCT01622673|526233393|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145925533|NCT01622673|526233394|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145925534|NCT01622673|526233395|FG003|Treatment Period 2|Withdrawal by Subject|1|||
145925535|NCT01622673|526233396|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145925536|NCT01622673|526233397|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145925537|NCT01622673|526233392|FG000|Treatment Period 3|Protocol Violation|0|||
145925538|NCT01622673|526233393|FG001|Treatment Period 3|Protocol Violation|1|||
145925539|NCT01622673|526233394|FG002|Treatment Period 3|Protocol Violation|0|||
145925540|NCT01622673|526233395|FG003|Treatment Period 3|Protocol Violation|0|||
145925541|NCT01622673|526233396|FG004|Treatment Period 3|Protocol Violation|0|||
145925542|NCT01622673|526233397|FG005|Treatment Period 3|Protocol Violation|0|||
145925543|NCT05400655|526235356|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
145925544|NCT05400655|526235357|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
145925545|NCT05400655|526235358|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
145925546|NCT05400655|526235359|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
145925547|NCT05400655|526235360|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
145925548|NCT05400655|526235361|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
145925549|NCT05400655|526235362|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
145925550|NCT05400655|526235363|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
145925551|NCT05400655|526235364|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
145925552|NCT05400655|526235365|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
145925553|NCT05400655|526235366|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
145925554|NCT05400655|526235367|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
145925555|NCT05400655|526235368|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
145925556|NCT05400655|526235369|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
145925557|NCT05400655|526235370|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
145925558|NCT05400655|526235371|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
145925559|NCT05400655|526235372|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
145925560|NCT05400655|526235373|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
145925561|NCT05400655|526235374|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
145925562|NCT05400655|526235375|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
145925563|NCT05400655|526235376|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
145925564|NCT05400655|526235377|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
145925565|NCT05400655|526235356|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925566|NCT05400655|526235357|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925567|NCT05400655|526235358|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925568|NCT05400655|526235359|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925569|NCT05400655|526235360|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925570|NCT05400655|526235361|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925571|NCT05400655|526235362|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925572|NCT05400655|526235363|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925573|NCT05400655|526235364|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925574|NCT05400655|526235365|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925575|NCT05400655|526235366|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925576|NCT05400655|526235367|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925577|NCT05400655|526235368|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145925578|NCT05400655|526235369|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925579|NCT05400655|526235370|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925580|NCT05400655|526235371|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925581|NCT05400655|526235372|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145925582|NCT05400655|526235373|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925583|NCT05400655|526235374|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145925584|NCT05400655|526235375|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
145925585|NCT05400655|526235376|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925586|NCT05400655|526235377|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145925587|NCT05400655|526235356|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925588|NCT05400655|526235357|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925589|NCT05400655|526235358|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925590|NCT05400655|526235359|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925591|NCT05400655|526235360|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925592|NCT05400655|526235361|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925593|NCT05400655|526235362|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925594|NCT05400655|526235363|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925595|NCT05400655|526235364|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925596|NCT05400655|526235365|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925597|NCT05400655|526235366|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925598|NCT05400655|526235367|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925599|NCT05400655|526235368|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925600|NCT05400655|526235369|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
145925601|NCT05400655|526235370|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925602|NCT05400655|526235371|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925603|NCT05400655|526235372|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
145925604|NCT05400655|526235373|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925605|NCT05400655|526235374|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
145925606|NCT05400655|526235375|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925607|NCT05400655|526235376|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925608|NCT05400655|526235377|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145925609|NCT05400655|526235356|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925610|NCT05400655|526235357|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925611|NCT05400655|526235358|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925612|NCT05400655|526235359|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925613|NCT05400655|526235360|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925614|NCT05400655|526235361|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925615|NCT05400655|526235362|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925616|NCT05400655|526235363|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925617|NCT05400655|526235364|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925618|NCT05400655|526235365|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925619|NCT05400655|526235366|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925620|NCT05400655|526235367|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925621|NCT05400655|526235368|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925622|NCT05400655|526235369|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925623|NCT05400655|526235370|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925624|NCT05400655|526235371|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925625|NCT05400655|526235372|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145925626|NCT05400655|526235373|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145925627|NCT05400655|526235374|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
145925628|NCT05400655|526235375|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145925629|NCT05400655|526235376|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
145925630|NCT05400655|526235377|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145925631|NCT05400655|526235356|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925632|NCT05400655|526235357|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925633|NCT05400655|526235358|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925634|NCT05400655|526235359|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145977319|NCT02324153|526428116|FG000|Overall Study|Withdrawal by Subject|4|||
145977320|NCT02324153|526428117|FG001|Overall Study|Withdrawal by Subject|1|||
145977321|NCT02324153|526428116|FG000|Overall Study|Surgery postponed after randomization|3|||
146243189|NCT03861234|527405346|FG003|Overall Study|Adverse Event|0|||
145925635|NCT05400655|526235360|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925636|NCT05400655|526235361|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925637|NCT05400655|526235362|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925638|NCT05400655|526235363|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925639|NCT05400655|526235364|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925640|NCT05400655|526235365|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925641|NCT05400655|526235366|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925642|NCT05400655|526235367|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925643|NCT05400655|526235368|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925644|NCT05400655|526235369|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925645|NCT05400655|526235370|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925646|NCT05400655|526235371|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925647|NCT05400655|526235372|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925648|NCT05400655|526235373|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
145925649|NCT05400655|526235374|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
145925650|NCT05400655|526235375|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925651|NCT05400655|526235376|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925652|NCT05400655|526235377|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145925653|NCT05400655|526235356|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925654|NCT05400655|526235357|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925655|NCT05400655|526235358|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925656|NCT05400655|526235359|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925657|NCT05400655|526235360|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925658|NCT05400655|526235361|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925659|NCT05400655|526235362|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925660|NCT05400655|526235363|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925661|NCT05400655|526235364|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925662|NCT05400655|526235365|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925663|NCT05400655|526235366|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925664|NCT05400655|526235367|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925665|NCT05400655|526235368|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925666|NCT05400655|526235369|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925667|NCT05400655|526235370|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925668|NCT05400655|526235371|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925669|NCT05400655|526235372|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145925670|NCT05400655|526235373|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145925671|NCT05400655|526235374|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145925672|NCT05400655|526235375|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
145925673|NCT05400655|526235376|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145925674|NCT05400655|526235377|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
145925675|NCT01682226|526235378|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
145925676|NCT01682226|526235378|FG000|Overall Study|Participants did not receive treatment|2|||
145925677|NCT01682226|526235378|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
145925678|NCT03263936|526235379|FG000|Overall Study|Adverse Event|0|||
145925679|NCT03263936|526235380|FG001|Overall Study|Adverse Event|1|||
145925680|NCT03263936|526235381|FG002|Overall Study|Adverse Event|0|||
145925681|NCT03263936|526235379|FG000|Overall Study|Death|0|||
145925682|NCT03263936|526235380|FG001|Overall Study|Death|1|||
145925683|NCT03263936|526235381|FG002|Overall Study|Death|0|||
145925684|NCT05343000|526235382|FG000|Overall Study|Physician Decision|2|||
145925685|NCT03123120|526235383|FG000|Overall Study|Lost to Follow-up|0|||
145925686|NCT03123120|526235384|FG001|Overall Study|Lost to Follow-up|1|||
145925687|NCT03123120|526235383|FG000|Overall Study|Withdrawal by Subject|0|||
145925688|NCT03123120|526235384|FG001|Overall Study|Withdrawal by Subject|1|||
145925689|NCT03135548|526235385|FG000|Overall Study|Lost to Follow-up|3|||
145925690|NCT03135548|526235386|FG001|Overall Study|Lost to Follow-up|0|||
145925691|NCT03135548|526235387|FG002|Overall Study|Lost to Follow-up|0|||
145925692|NCT03135548|526235385|FG000|Overall Study|Withdrawal by Subject|2|||
145925693|NCT03135548|526235386|FG001|Overall Study|Withdrawal by Subject|2|||
145925694|NCT03135548|526235387|FG002|Overall Study|Withdrawal by Subject|1|||
145925695|NCT03135548|526235385|FG000|Overall Study|Other than listed|0|||
145925696|NCT03135548|526235386|FG001|Overall Study|Other than listed|2|||
145925697|NCT03135548|526235387|FG002|Overall Study|Other than listed|2|||
145925698|NCT02632175|526235388|FG000|Overall Study|Withdrawal by Subject|6|||
145925699|NCT02632175|526235388|FG000|Overall Study|Lost to Follow-up|1|||
145925700|NCT02632175|526235388|FG000|Overall Study|Lack of Efficacy|18|||
145925701|NCT02632175|526235388|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
145925702|NCT02632175|526235388|FG000|Overall Study|Subject noncompliance|3|||
146090544|NCT01897714|526852620|FG002|Phase I (Dose Escalation)|Other|0|||
146297765|NCT02616614|527605981|FG000|Overall Study|More than 3 applications missed|6|||
146297766|NCT02616614|527605982|FG001|Overall Study|More than 3 applications missed|8|||
145925703|NCT02632175|526235388|FG000|Overall Study|other|2|||
145925704|NCT02088554|526235389|FG000|Overall Study|Exited before procedure|130|||
145925705|NCT02088554|526235389|FG000|Overall Study|Attempted but not implanted|31|||
145925706|NCT02088554|526235389|FG000|Overall Study|Implant not attempted|19|||
145925707|NCT02088554|526235389|FG000|Overall Study|Pending next visit|532|||
145925708|NCT02088554|526235389|FG000|Overall Study|Death|170|||
145925709|NCT02088554|526235389|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
145925710|NCT02088554|526235389|FG000|Overall Study|Lost to Follow-up|23|||
145925711|NCT02088554|526235389|FG000|Overall Study|Explanted|32|||
145925712|NCT02088554|526235389|FG000|Overall Study|Any other reason not covered by previous categories|11|||
145925713|NCT02283268|526235407|FG000|Overall Study|Withdrawal by Subject|1|||
145925714|NCT00454246|526235408|FG000|Overall Study|Adverse Event|2|||
145925715|NCT00454246|526235409|FG001|Overall Study|Adverse Event|2|||
145925716|NCT00454246|526235410|FG002|Overall Study|Adverse Event|0|||
145925717|NCT00454246|526235408|FG000|Overall Study|Violation of selection criteria at entry|6|||
145925718|NCT00454246|526235409|FG001|Overall Study|Violation of selection criteria at entry|0|||
145925719|NCT00454246|526235410|FG002|Overall Study|Violation of selection criteria at entry|0|||
145925720|NCT00454246|526235408|FG000|Overall Study|Protocol Violation|1|||
145925721|NCT00454246|526235409|FG001|Overall Study|Protocol Violation|0|||
145925722|NCT00454246|526235410|FG002|Overall Study|Protocol Violation|0|||
145925723|NCT00454246|526235408|FG000|Overall Study|Refused Treatment|1|||
145925724|NCT00454246|526235409|FG001|Overall Study|Refused Treatment|1|||
145925725|NCT00454246|526235410|FG002|Overall Study|Refused Treatment|0|||
145925726|NCT00454246|526235408|FG000|Overall Study|Failure to return|1|||
145925727|NCT00454246|526235409|FG001|Overall Study|Failure to return|0|||
145925728|NCT00454246|526235410|FG002|Overall Study|Failure to return|0|||
145925729|NCT00454246|526235408|FG000|Overall Study|Early termination of study|62|||
145925730|NCT00454246|526235409|FG001|Overall Study|Early termination of study|26|||
145925731|NCT00454246|526235410|FG002|Overall Study|Early termination of study|9|||
145925732|NCT05326529|526235411|FG000|Overall Study|Lack of Efficacy|0|||
145925733|NCT05326529|526235412|FG001|Overall Study|Lack of Efficacy|1|||
145925734|NCT05326529|526235413|FG002|Overall Study|Lack of Efficacy|0|||
145925735|NCT05326529|526235411|FG000|Overall Study|Physician Decision|0|||
145925736|NCT05326529|526235412|FG001|Overall Study|Physician Decision|0|||
145925737|NCT05326529|526235413|FG002|Overall Study|Physician Decision|2|||
145925738|NCT02126579|526235414|FG000|Overall Study|disease progression|0|||
145925739|NCT02126579|526235415|FG001|Overall Study|disease progression|0|||
145925740|NCT02126579|526235416|FG002|Overall Study|disease progression|0|||
145925741|NCT02126579|526235417|FG003|Overall Study|disease progression|1|||
145925742|NCT02126579|526235418|FG004|Overall Study|disease progression|0|||
145925743|NCT02126579|526235419|FG005|Overall Study|disease progression|0|||
145925744|NCT02126579|526235420|FG006|Overall Study|disease progression|1|||
145925745|NCT02309411|526235422|FG000|Overall Study|Physician Decision|1|||
145925746|NCT02309411|526235423|FG001|Overall Study|Physician Decision|0|||
145925747|NCT02309411|526235424|FG002|Overall Study|Physician Decision|0|||
145925748|NCT02309411|526235422|FG000|Overall Study|Withdrawal by Subject|1|||
145925749|NCT02309411|526235423|FG001|Overall Study|Withdrawal by Subject|1|||
145925750|NCT02309411|526235424|FG002|Overall Study|Withdrawal by Subject|0|||
145925751|NCT04278417|526235427|FG000|Overall Study|Withdrawal by Subject|20|||
145925752|NCT04278417|526235428|FG001|Overall Study|Withdrawal by Subject|20|||
145925753|NCT04278417|526235427|FG000|Overall Study|Progressive disease|0|||
145977322|NCT02324153|526428117|FG001|Overall Study|Surgery postponed after randomization|0|||
145977323|NCT02324153|526428116|FG000|Overall Study|Developed delirium preoperatively|1|||
145977324|NCT02324153|526428117|FG001|Overall Study|Developed delirium preoperatively|0|||
145977325|NCT01937299|526428119|FG000|Overall Study|Adverse Event|13|||
145977326|NCT01937299|526428120|FG001|Overall Study|Adverse Event|0|||
145977327|NCT01937299|526428119|FG000|Overall Study|Lack of Efficacy|0|||
145977328|NCT01937299|526428120|FG001|Overall Study|Lack of Efficacy|4|||
145977329|NCT01937299|526428119|FG000|Overall Study|Withdrawal by Subject|1|||
145977330|NCT01937299|526428120|FG001|Overall Study|Withdrawal by Subject|0|||
145977331|NCT04017962|526428121|FG000|Overall Study|Death|2|||
146090545|NCT01897714|526852621|FG003|Phase I (Dose Escalation)|Other|0|||
146090546|NCT01897714|526852622|FG004|Phase I (Dose Escalation)|Other|0|||
145925754|NCT04278417|526235428|FG001|Overall Study|Progressive disease|2|||
145925755|NCT04278417|526235427|FG000|Overall Study|Physician Decision|4|||
145925756|NCT04278417|526235428|FG001|Overall Study|Physician Decision|6|||
145925757|NCT04278417|526235427|FG000|Overall Study|Lost to Follow-up|11|||
145925758|NCT04278417|526235428|FG001|Overall Study|Lost to Follow-up|13|||
145925759|NCT04278417|526235427|FG000|Overall Study|Death|8|||
145925760|NCT04278417|526235428|FG001|Overall Study|Death|9|||
145925761|NCT04278417|526235427|FG000|Overall Study|Adverse Event|3|||
145925762|NCT04278417|526235428|FG001|Overall Study|Adverse Event|5|||
145925763|NCT06509438|526235429|FG000|Overall Study|Adverse Event|1|||
145925764|NCT06509438|526235429|FG000|Overall Study|Lost to Follow-up|3|||
145977332|NCT04017962|526428122|FG001|Overall Study|Death|0|||
145977333|NCT04017962|526428121|FG000|Overall Study|Lost to Follow-up|2|||
146243190|NCT03861234|527405347|FG004|Overall Study|Adverse Event|0|||
145925831|NCT01262872|526235437|FG000|Step 2|Death|0|||
145925832|NCT01262872|526235438|FG001|Step 2|Death|0|||
145925833|NCT01262872|526235439|FG002|Step 2|Death|0|||
146243191|NCT03861234|527405348|FG005|Overall Study|Adverse Event|1|||
146243192|NCT03861234|527405349|FG006|Overall Study|Adverse Event|0|||
145925834|NCT01262872|526235440|FG003|Step 2|Death|1|||
145925835|NCT01262872|526235441|FG004|Step 2|Death|0|||
145925836|NCT01262872|526235442|FG005|Step 2|Death|2|||
145925837|NCT01262872|526235443|FG006|Step 2|Death|2|||
145925838|NCT01262872|526235444|FG007|Step 2|Death|1|||
145925839|NCT01262872|526235437|FG000|Step 2|Protocol Violation|0|||
145925840|NCT01262872|526235438|FG001|Step 2|Protocol Violation|0|||
145925841|NCT01262872|526235439|FG002|Step 2|Protocol Violation|1|||
145925842|NCT01262872|526235440|FG003|Step 2|Protocol Violation|0|||
145925843|NCT01262872|526235441|FG004|Step 2|Protocol Violation|0|||
145925844|NCT01262872|526235442|FG005|Step 2|Protocol Violation|0|||
145925845|NCT01262872|526235443|FG006|Step 2|Protocol Violation|3|||
145925846|NCT01262872|526235444|FG007|Step 2|Protocol Violation|1|||
145925847|NCT01262872|526235437|FG000|Step 2|Withdrawal by Subject|0|||
145925848|NCT01262872|526235438|FG001|Step 2|Withdrawal by Subject|0|||
145925849|NCT01262872|526235439|FG002|Step 2|Withdrawal by Subject|4|||
145925850|NCT01262872|526235440|FG003|Step 2|Withdrawal by Subject|6|||
145925851|NCT01262872|526235441|FG004|Step 2|Withdrawal by Subject|3|||
145925852|NCT01262872|526235442|FG005|Step 2|Withdrawal by Subject|1|||
145925853|NCT01262872|526235443|FG006|Step 2|Withdrawal by Subject|2|||
145925854|NCT01262872|526235444|FG007|Step 2|Withdrawal by Subject|1|||
145925855|NCT01262872|526235437|FG000|Step 2|Migrated/moved from study area|0|||
145925856|NCT01262872|526235438|FG001|Step 2|Migrated/moved from study area|0|||
145925857|NCT01262872|526235439|FG002|Step 2|Migrated/moved from study area|4|||
145925858|NCT01262872|526235440|FG003|Step 2|Migrated/moved from study area|3|||
145925859|NCT01262872|526235441|FG004|Step 2|Migrated/moved from study area|2|||
145925860|NCT01262872|526235442|FG005|Step 2|Migrated/moved from study area|6|||
145925861|NCT01262872|526235443|FG006|Step 2|Migrated/moved from study area|2|||
145925862|NCT01262872|526235444|FG007|Step 2|Migrated/moved from study area|3|||
145925863|NCT01000155|526235445|FG000|Overall Study|Withdrawal by Subject|1|||
145925864|NCT01000155|526235445|FG000|Overall Study|Adverse Event|1|||
145925865|NCT00365794|526235447|FG000|Overall Study|Withdrawal by Subject|2|||
145925866|NCT02554682|526235448|FG000|Overall Study|Lost to Follow-up|11|||
145925867|NCT02554682|526235449|FG001|Overall Study|Lost to Follow-up|9|||
145925868|NCT02554682|526235450|FG002|Overall Study|Lost to Follow-up|4|||
145925869|NCT02554682|526235451|FG003|Overall Study|Lost to Follow-up|3|||
145925870|NCT02554682|526235452|FG004|Overall Study|Lost to Follow-up|2|||
145925871|NCT02554682|526235453|FG005|Overall Study|Lost to Follow-up|1|||
145925872|NCT02554682|526235454|FG006|Overall Study|Lost to Follow-up|6|||
145925873|NCT02554682|526235455|FG007|Overall Study|Lost to Follow-up|6|||
145925874|NCT02554682|526235456|FG008|Overall Study|Lost to Follow-up|2|||
145925875|NCT02554682|526235457|FG009|Overall Study|Lost to Follow-up|2|||
145925876|NCT02554682|526235448|FG000|Overall Study|Withdrawal by Subject|2|||
145925877|NCT02554682|526235449|FG001|Overall Study|Withdrawal by Subject|1|||
145925878|NCT02554682|526235450|FG002|Overall Study|Withdrawal by Subject|0|||
145925879|NCT02554682|526235451|FG003|Overall Study|Withdrawal by Subject|0|||
145925880|NCT02554682|526235452|FG004|Overall Study|Withdrawal by Subject|0|||
145925881|NCT02554682|526235453|FG005|Overall Study|Withdrawal by Subject|0|||
145925882|NCT02554682|526235454|FG006|Overall Study|Withdrawal by Subject|0|||
145925883|NCT02554682|526235455|FG007|Overall Study|Withdrawal by Subject|0|||
145925884|NCT02554682|526235456|FG008|Overall Study|Withdrawal by Subject|0|||
145925885|NCT02554682|526235457|FG009|Overall Study|Withdrawal by Subject|0|||
145925886|NCT02554682|526235448|FG000|Overall Study|Physician Decision|2|||
145925887|NCT02554682|526235449|FG001|Overall Study|Physician Decision|2|||
145925888|NCT02554682|526235450|FG002|Overall Study|Physician Decision|0|||
145925889|NCT02554682|526235451|FG003|Overall Study|Physician Decision|0|||
145925890|NCT02554682|526235452|FG004|Overall Study|Physician Decision|0|||
145925891|NCT02554682|526235453|FG005|Overall Study|Physician Decision|0|||
145925892|NCT02554682|526235454|FG006|Overall Study|Physician Decision|0|||
145925893|NCT02554682|526235455|FG007|Overall Study|Physician Decision|0|||
145925894|NCT02554682|526235456|FG008|Overall Study|Physician Decision|0|||
145925895|NCT02554682|526235457|FG009|Overall Study|Physician Decision|0|||
145925896|NCT04526288|526235458|FG000|Overall Study|Disease Progression|1|||
145925897|NCT04526288|526235459|FG001|Overall Study|Disease Progression|0|||
145925898|NCT00594165|526235460|FG000|Overall Study|Major protocol violation|1|||
145977334|NCT04017962|526428122|FG001|Overall Study|Lost to Follow-up|0|||
145977335|NCT04017962|526428121|FG000|Overall Study|Physician Decision|1|||
145977336|NCT04017962|526428122|FG001|Overall Study|Physician Decision|0|||
145925899|NCT00594165|526235460|FG000|Overall Study|Lack of Efficacy|12|||
145925900|NCT00594165|526235460|FG000|Overall Study|Adverse Event|52|||
145925901|NCT00594165|526235460|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
145925902|NCT00594165|526235460|FG000|Overall Study|Subject withdrew consent|27|||
145925903|NCT00594165|526235460|FG000|Overall Study|Study ended per sponsor|102|||
145925904|NCT00594165|526235460|FG000|Overall Study|Lost to Follow-up|4|||
145925905|NCT00594165|526235460|FG000|Overall Study|Other: PI discretion|5|||
145925906|NCT00594165|526235460|FG000|Overall Study|Other: Subject moving|3|||
145925907|NCT00594165|526235460|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
145925908|NCT00594165|526235460|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
145925909|NCT00594165|526235460|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
145925910|NCT00594165|526235460|FG000|Overall Study|Other: Site terminated participation|2|||
145925911|NCT02169271|526235461|FG000|Overall Study|Protocol Violation|1|||
145925912|NCT02169271|526235462|FG001|Overall Study|Protocol Violation|2|||
145925913|NCT04926831|526235463|FG000|Overall Study|Withdrawal by Subject|2|||
145925914|NCT04926831|526235463|FG000|Overall Study|Adverse Event|2|||
145925915|NCT03482635|526235464|FG000|Overall Study|Lack of Efficacy|0|||
145925916|NCT03482635|526235465|FG001|Overall Study|Lack of Efficacy|0|||
145925917|NCT03482635|526235466|FG002|Overall Study|Lack of Efficacy|1|||
145925918|NCT03482635|526235467|FG003|Overall Study|Lack of Efficacy|3|||
145925919|NCT03482635|526235464|FG000|Overall Study|Adverse Event|2|||
145925920|NCT03482635|526235465|FG001|Overall Study|Adverse Event|2|||
145925921|NCT03482635|526235466|FG002|Overall Study|Adverse Event|0|||
145925922|NCT03482635|526235467|FG003|Overall Study|Adverse Event|3|||
145925923|NCT03482635|526235464|FG000|Overall Study|Withdrawal by Subject|2|||
145925924|NCT03482635|526235465|FG001|Overall Study|Withdrawal by Subject|1|||
145925925|NCT03482635|526235466|FG002|Overall Study|Withdrawal by Subject|0|||
145925926|NCT03482635|526235467|FG003|Overall Study|Withdrawal by Subject|1|||
145925927|NCT03482635|526235464|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
145925928|NCT03482635|526235465|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
145925929|NCT03482635|526235466|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
145925930|NCT03482635|526235467|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
145925931|NCT03482635|526235464|FG000|Overall Study|Not treated|0|||
145925932|NCT03482635|526235465|FG001|Overall Study|Not treated|0|||
145925933|NCT03482635|526235466|FG002|Overall Study|Not treated|0|||
145925934|NCT03482635|526235467|FG003|Overall Study|Not treated|1|||
145925935|NCT02712554|526235480|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
145925936|NCT02712554|526235481|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
145925937|NCT02712554|526235480|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
145925938|NCT02712554|526235481|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
145925939|NCT02712554|526235480|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
145925940|NCT02712554|526235481|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
145925941|NCT02712554|526235480|FG000|Part B: Qualification Phase|Adverse Event|0|||
145925942|NCT02712554|526235481|FG001|Part B: Qualification Phase|Adverse Event|1|||
145925943|NCT02712554|526235480|FG000|Part B: Treatment Phase|Adverse Event|0|||
145925944|NCT02712554|526235481|FG001|Part B: Treatment Phase|Adverse Event|1|||
145925945|NCT02712554|526235480|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
145925946|NCT02712554|526235481|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
145925947|NCT02712554|526235480|FG000|Part B: Treatment Phase|Other|0|||
145925948|NCT02712554|526235481|FG001|Part B: Treatment Phase|Other|1|||
145925949|NCT02503540|526235482|FG000|Overall Study|Death|2|||
145925950|NCT02503540|526235482|FG000|Overall Study|Withdrawal by Subject|1|||
145925951|NCT01662492|526235483|FG000|Overall Study|Other miscellaneous reasons.|1|||
145925952|NCT01662492|526235484|FG001|Overall Study|Other miscellaneous reasons.|0|||
145925953|NCT01662492|526235485|FG002|Overall Study|Other miscellaneous reasons.|1|||
145925954|NCT01662492|526235483|FG000|Overall Study|Withdrawal by Subject|0|||
145925955|NCT01662492|526235484|FG001|Overall Study|Withdrawal by Subject|0|||
145925956|NCT01662492|526235485|FG002|Overall Study|Withdrawal by Subject|1|||
145925957|NCT01662492|526235483|FG000|Overall Study|Protocol Violation|1|||
145925958|NCT01662492|526235484|FG001|Overall Study|Protocol Violation|0|||
145925959|NCT01662492|526235485|FG002|Overall Study|Protocol Violation|0|||
145925960|NCT01662492|526235483|FG000|Overall Study|Lost to Follow-up|0|||
145925961|NCT01662492|526235484|FG001|Overall Study|Lost to Follow-up|0|||
145925962|NCT01662492|526235485|FG002|Overall Study|Lost to Follow-up|2|||
145925963|NCT01662492|526235483|FG000|Overall Study|Lack of Efficacy|1|||
145925964|NCT01662492|526235484|FG001|Overall Study|Lack of Efficacy|1|||
145925965|NCT01662492|526235485|FG002|Overall Study|Lack of Efficacy|2|||
145925966|NCT00979654|526235486|FG000|Overall Study|Lost to Follow-up|1|||
145925967|NCT00979654|526235486|FG000|Overall Study|Withdrawal by Subject|22|||
145925968|NCT00979654|526235486|FG000|Overall Study|Death|1|||
145925969|NCT00979654|526235486|FG000|Overall Study|Lack of Efficacy|6|||
145925970|NCT00979654|526235486|FG000|Overall Study|Adverse Event|1|||
145925971|NCT00979654|526235486|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
145925972|NCT00979654|526235486|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
145925973|NCT00979654|526235486|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
145925974|NCT00979654|526235486|FG000|Overall Study|Serious Adverse Event|1|||
145925975|NCT00979654|526235486|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
145977337|NCT04017962|526428121|FG000|Overall Study|Discontinued LTV|5|||
145977338|NCT04017962|526428122|FG001|Overall Study|Discontinued LTV|0|||
145925976|NCT01804946|526235489|FG000|Overall Study|Protocol Violation|1|||
145925977|NCT01804946|526235490|FG001|Overall Study|Protocol Violation|0|||
145925978|NCT01804946|526235489|FG000|Overall Study|Adverse Event|0|||
145925979|NCT01804946|526235490|FG001|Overall Study|Adverse Event|1|||
145925980|NCT01804946|526235489|FG000|Overall Study|Insufficient data available|0|||
145925981|NCT01804946|526235490|FG001|Overall Study|Insufficient data available|1|||
145925982|NCT01804946|526235489|FG000|Overall Study|Do not meet inclusion criteria|1|||
145925983|NCT01804946|526235490|FG001|Overall Study|Do not meet inclusion criteria|2|||
145925984|NCT03830333|526235491|FG000|Overall Study|Death|0|||
145925985|NCT03830333|526235492|FG001|Overall Study|Death|1|||
145925986|NCT03830333|526235491|FG000|Overall Study|Withdrawal by Subject|5|||
145925987|NCT03830333|526235492|FG001|Overall Study|Withdrawal by Subject|1|||
145925988|NCT03830333|526235491|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
145925989|NCT03830333|526235492|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
145925990|NCT00722137|526235493|FG000|Overall Study|Overt Disease Progression|5|||
145925991|NCT00722137|526235494|FG001|Overall Study|Overt Disease Progression|4|||
145925992|NCT00722137|526235493|FG000|Overall Study|Adverse Event|17|||
145925993|NCT00722137|526235494|FG001|Overall Study|Adverse Event|21|||
145925994|NCT00722137|526235493|FG000|Overall Study|Death|12|||
145925995|NCT00722137|526235494|FG001|Overall Study|Death|7|||
145925996|NCT00722137|526235493|FG000|Overall Study|Withdrawal by Subject|6|||
145925997|NCT00722137|526235494|FG001|Overall Study|Withdrawal by Subject|9|||
145925998|NCT00722137|526235493|FG000|Overall Study|Other Reason Unknown|3|||
145925999|NCT00722137|526235494|FG001|Overall Study|Other Reason Unknown|4|||
145926000|NCT00722137|526235493|FG000|Overall Study|Randomized But Not Treated|2|||
145926001|NCT00722137|526235494|FG001|Overall Study|Randomized But Not Treated|3|||
145926002|NCT01129557|526235495|FG000|Overall Study|Adverse Event|1|||
145926003|NCT01129557|526235496|FG001|Overall Study|Adverse Event|2|||
145926004|NCT01129557|526235497|FG002|Overall Study|Adverse Event|2|||
145926005|NCT01129557|526235495|FG000|Overall Study|Novartis terminated study early|3|||
145926006|NCT01129557|526235496|FG001|Overall Study|Novartis terminated study early|3|||
145926007|NCT01129557|526235497|FG002|Overall Study|Novartis terminated study early|2|||
145926008|NCT01486446|526235498|FG000|Overall Study|Adverse Event|1|||
145926009|NCT01486446|526235499|FG001|Overall Study|Adverse Event|0|||
145926010|NCT00985504|526235500|FG000|Acute Treatment Period|Adverse Event|3|||
145926011|NCT00985504|526235501|FG001|Acute Treatment Period|Adverse Event|4|||
145926012|NCT00985504|526235500|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
145926013|NCT00985504|526235501|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
145926014|NCT00985504|526235500|FG000|Acute Treatment Period|Protocol Violation|2|||
145926015|NCT00985504|526235501|FG001|Acute Treatment Period|Protocol Violation|0|||
145926016|NCT00985504|526235500|FG000|Acute Treatment Period|Sponsor Decision|0|||
145926017|NCT00985504|526235501|FG001|Acute Treatment Period|Sponsor Decision|1|||
145926018|NCT00985504|526235500|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
145926019|NCT00985504|526235501|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
145926020|NCT00985504|526235500|FG000|Optimization Period|Adverse Event|7|||
145926021|NCT00985504|526235501|FG001|Optimization Period|Adverse Event|9|||
145926022|NCT00985504|526235500|FG000|Optimization Period|Death|0|||
145926023|NCT00985504|526235501|FG001|Optimization Period|Death|1|||
145926024|NCT00985504|526235500|FG000|Optimization Period|Lack of Efficacy|5|||
145926025|NCT00985504|526235501|FG001|Optimization Period|Lack of Efficacy|3|||
145926026|NCT00985504|526235500|FG000|Optimization Period|Lost to Follow-up|0|||
145926027|NCT00985504|526235501|FG001|Optimization Period|Lost to Follow-up|1|||
145926028|NCT00985504|526235500|FG000|Optimization Period|Physician Decision|1|||
145926029|NCT00985504|526235501|FG001|Optimization Period|Physician Decision|0|||
145926030|NCT00985504|526235500|FG000|Optimization Period|Protocol Violation|3|||
145926031|NCT00985504|526235501|FG001|Optimization Period|Protocol Violation|1|||
145926032|NCT00985504|526235500|FG000|Optimization Period|Withdrawal by Subject|10|||
145926033|NCT00985504|526235501|FG001|Optimization Period|Withdrawal by Subject|8|||
145926034|NCT04390113|526235510|FG000|Overall Study|Not Treated|0|||
145926035|NCT04390113|526235511|FG001|Overall Study|Not Treated|1|||
145926036|NCT04390113|526235510|FG000|Overall Study|Adverse Event|1|||
145926037|NCT04390113|526235511|FG001|Overall Study|Adverse Event|0|||
145926038|NCT04390113|526235510|FG000|Overall Study|Death|2|||
145926039|NCT04390113|526235511|FG001|Overall Study|Death|1|||
145926040|NCT04390113|526235510|FG000|Overall Study|Physician Decision|1|||
145926041|NCT04390113|526235511|FG001|Overall Study|Physician Decision|3|||
145926042|NCT04390113|526235510|FG000|Overall Study|Study Terminated by Sponsor|5|||
145926043|NCT04390113|526235511|FG001|Overall Study|Study Terminated by Sponsor|3|||
145926044|NCT04390113|526235510|FG000|Overall Study|Withdrawal by Subject|10|||
145926045|NCT04390113|526235511|FG001|Overall Study|Withdrawal by Subject|5|||
145926046|NCT04390113|526235510|FG000|Overall Study|Other|1|||
145926047|NCT04390113|526235511|FG001|Overall Study|Other|0|||
145926048|NCT04390113|526235510|FG000|Overall Study|Missing|0|||
145926049|NCT04390113|526235511|FG001|Overall Study|Missing|1|||
145926050|NCT03474965|526235514|FG000|Overall Study|Pregnancy|1|||
145926051|NCT03474965|526235515|FG001|Overall Study|Pregnancy|0|||
145926052|NCT03474965|526235516|FG002|Overall Study|Pregnancy|0|||
145926053|NCT03474965|526235517|FG003|Overall Study|Pregnancy|0|||
145926054|NCT03474965|526235514|FG000|Overall Study|Lost to Follow-up|0|||
146090547|NCT01897714|526852623|FG005|Phase I (Dose Escalation)|Other|0|||
145926055|NCT03474965|526235515|FG001|Overall Study|Lost to Follow-up|0|||
145926056|NCT03474965|526235516|FG002|Overall Study|Lost to Follow-up|1|||
145926057|NCT03474965|526235517|FG003|Overall Study|Lost to Follow-up|0|||
145926058|NCT03474965|526235514|FG000|Overall Study|Death|1|||
145926059|NCT03474965|526235515|FG001|Overall Study|Death|0|||
145926060|NCT03474965|526235516|FG002|Overall Study|Death|0|||
145926061|NCT03474965|526235517|FG003|Overall Study|Death|0|||
145926062|NCT03474965|526235514|FG000|Overall Study|Adverse Event|1|||
145926063|NCT03474965|526235515|FG001|Overall Study|Adverse Event|0|||
145926064|NCT03474965|526235516|FG002|Overall Study|Adverse Event|0|||
145926065|NCT03474965|526235517|FG003|Overall Study|Adverse Event|1|||
145926066|NCT03474965|526235514|FG000|Overall Study|Physician Decision|3|||
145926067|NCT03474965|526235515|FG001|Overall Study|Physician Decision|1|||
145926068|NCT03474965|526235516|FG002|Overall Study|Physician Decision|2|||
145926069|NCT03474965|526235517|FG003|Overall Study|Physician Decision|0|||
145926070|NCT03474965|526235514|FG000|Overall Study|Participant Decision|7|||
145926071|NCT03474965|526235515|FG001|Overall Study|Participant Decision|0|||
145926072|NCT03474965|526235516|FG002|Overall Study|Participant Decision|1|||
145926073|NCT03474965|526235517|FG003|Overall Study|Participant Decision|0|||
145926074|NCT03474965|526235514|FG000|Overall Study|Guardian Decision|4|||
145926075|NCT03474965|526235515|FG001|Overall Study|Guardian Decision|2|||
145926076|NCT03474965|526235516|FG002|Overall Study|Guardian Decision|7|||
145926077|NCT03474965|526235517|FG003|Overall Study|Guardian Decision|2|||
145926078|NCT03100903|526237180|FG000|Overall Study|Withdrawal by Subject|0|||
145926079|NCT03100903|526237181|FG001|Overall Study|Withdrawal by Subject|0|||
145926080|NCT03100903|526237182|FG002|Overall Study|Withdrawal by Subject|1|||
145926081|NCT04659993|526237183|FG000|Overall Study|Withdrawal by Subject|2|||
145926082|NCT04659993|526237183|FG000|Overall Study|Lost to Follow-up|2|||
145926083|NCT00298272|526237184|FG000|Double-blind Phase|Adverse Event|2|||
145926084|NCT00298272|526237185|FG001|Double-blind Phase|Adverse Event|0|||
145926085|NCT00298272|526237184|FG000|Double-blind Phase|Failure to Return|2|||
145926086|NCT00298272|526237185|FG001|Double-blind Phase|Failure to Return|0|||
145926087|NCT00298272|526237184|FG000|Double-blind Phase|Protocol Violation|2|||
145926088|NCT00298272|526237185|FG001|Double-blind Phase|Protocol Violation|0|||
145926089|NCT00298272|526237184|FG000|Double-blind Phase|Withdrawal by Subject|2|||
145926090|NCT00298272|526237185|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145926091|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Adverse Event|1|||
145926092|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Adverse Event|2|||
145926093|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
145926094|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
145926095|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Failure to Return|1|||
145926096|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Failure to Return|0|||
145926097|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
145926098|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
145926099|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
145926100|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
145926101|NCT00298272|526237184|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
145926102|NCT00298272|526237185|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
145926103|NCT00298272|526237184|FG000|Safety Follow-up Phase|Failure to Return|1|||
145926104|NCT00298272|526237185|FG001|Safety Follow-up Phase|Failure to Return|1|||
145926105|NCT00298272|526237184|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
145926106|NCT00298272|526237185|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
145926107|NCT00298272|526237184|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
145926108|NCT00298272|526237185|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
145926109|NCT00915018|526237186|FG000|Overall Study|Death|75|||
145926110|NCT00915018|526237187|FG001|Overall Study|Death|70|||
145926111|NCT00915018|526237186|FG000|Overall Study|Lost to Follow-up|10|||
145926112|NCT00915018|526237187|FG001|Overall Study|Lost to Follow-up|5|||
145926113|NCT00915018|526237186|FG000|Overall Study|Withdrawal by Subject|38|||
145926114|NCT00915018|526237187|FG001|Overall Study|Withdrawal by Subject|27|||
145926115|NCT00915018|526237186|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
145926116|NCT00915018|526237187|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
145926117|NCT00457002|526237188|FG000|Overall Study|Death|40|||
145926118|NCT00457002|526237189|FG001|Overall Study|Death|47|||
145926119|NCT00457002|526237188|FG000|Overall Study|Adverse Event|284|||
145926120|NCT00457002|526237189|FG001|Overall Study|Adverse Event|260|||
145926121|NCT00457002|526237188|FG000|Overall Study|Withdrawal by Subject|299|||
145926122|NCT00457002|526237189|FG001|Overall Study|Withdrawal by Subject|271|||
145977339|NCT01260948|526428123|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
145977340|NCT01260948|526428124|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
145977341|NCT01260948|526428123|FG000|Second Intervention|Emesis|0|||
145977342|NCT01260948|526428124|FG001|Second Intervention|Emesis|1|||
145977343|NCT02555878|526428125|FG000|Overall Study|Lost to Follow-up|2|||
145977344|NCT02555878|526428126|FG001|Overall Study|Lost to Follow-up|3|||
145926123|NCT00457002|526237188|FG000|Overall Study|Lost to Follow-up|72|||
145977345|NCT02555878|526428125|FG000|Overall Study|Withdrawal by Subject|48|||
145977346|NCT02555878|526428126|FG001|Overall Study|Withdrawal by Subject|48|||
145977347|NCT02555878|526428125|FG000|Overall Study|Adverse Event|12|||
145926124|NCT00457002|526237189|FG001|Overall Study|Lost to Follow-up|71|||
145926125|NCT00457002|526237188|FG000|Overall Study|Poor/Non-compliance|46|||
145926126|NCT00457002|526237189|FG001|Overall Study|Poor/Non-compliance|33|||
145926127|NCT00457002|526237188|FG000|Overall Study|No longer met criteria|41|||
145926128|NCT00457002|526237189|FG001|Overall Study|No longer met criteria|37|||
145926129|NCT00457002|526237188|FG000|Overall Study|Administrative reason by Sponsor|1|||
145926130|NCT00457002|526237189|FG001|Overall Study|Administrative reason by Sponsor|0|||
145977348|NCT02555878|526428126|FG001|Overall Study|Adverse Event|8|||
146090548|NCT01897714|526852618|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
146090549|NCT01897714|526852619|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
145926131|NCT00457002|526237188|FG000|Overall Study|non-specified|29|||
145926132|NCT00457002|526237189|FG001|Overall Study|non-specified|38|||
145926133|NCT00457002|526237188|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
145926134|NCT00457002|526237189|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
145926135|NCT04168112|526237190|FG000|Overall Study|Lost to Follow-up|1|||
145926136|NCT04168112|526237191|FG001|Overall Study|Lost to Follow-up|0|||
145926137|NCT04168112|526237190|FG000|Overall Study|Withdrawal by Subject|1|||
145926138|NCT04168112|526237191|FG001|Overall Study|Withdrawal by Subject|0|||
145926139|NCT00833105|526237192|FG000|Overall Study|Withdrawal by Subject|1|||
145926140|NCT00833105|526237192|FG000|Overall Study|Adverse Event|2|||
145926141|NCT02898597|526237193|FG000|Overall Study|Protocol Violation|4|||
145926142|NCT02898597|526237194|FG001|Overall Study|Protocol Violation|2|||
145926143|NCT02898597|526237193|FG000|Overall Study|Lost to Follow-up|0|||
145926144|NCT02898597|526237194|FG001|Overall Study|Lost to Follow-up|9|||
145926145|NCT02898597|526237193|FG000|Overall Study|Death|0|||
145926146|NCT02898597|526237194|FG001|Overall Study|Death|1|||
145926147|NCT03656068|526237195|FG000|Overall Study|Withdrawal by Subject|4|||
145926148|NCT03656068|526237195|FG000|Overall Study|Adverse Event|1|||
145926149|NCT00154284|526237196|FG000|Overall Study|Adverse Event|6|||
145926150|NCT00154284|526237197|FG001|Overall Study|Adverse Event|9|||
145926151|NCT00154284|526237196|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145926152|NCT00154284|526237197|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145926153|NCT00154284|526237196|FG000|Overall Study|Lack of Efficacy|1|||
145926154|NCT00154284|526237197|FG001|Overall Study|Lack of Efficacy|2|||
145926155|NCT00154284|526237196|FG000|Overall Study|Protocol Violation|0|||
146090550|NCT01897714|526852620|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
145926156|NCT00154284|526237197|FG001|Overall Study|Protocol Violation|1|||
145926157|NCT00326716|526237198|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
145926158|NCT00326716|526237199|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
145926159|NCT00326716|526237200|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
145926160|NCT00326716|526237201|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
145926161|NCT00684411|526237202|FG000|Overall Study|New Primary Cancer|1|||
145926162|NCT00684411|526237202|FG000|Overall Study|Disease Progression|10|||
145926163|NCT00684411|526237202|FG000|Overall Study|Adverse Event|1|||
145926164|NCT05253573|526237203|FG000|Overall Study|Death|1|||
145926165|NCT05253573|526237204|FG001|Overall Study|Death|0|||
145926166|NCT01344824|526237205|FG000|Overall Study|Adverse Event|15|||
145926167|NCT01344824|526237205|FG000|Overall Study|Withdrawal by Subject|6|||
145926168|NCT01344824|526237205|FG000|Overall Study|Other complicating disease|1|||
145926169|NCT01344824|526237205|FG000|Overall Study|Progression|15|||
145926170|NCT01609010|526237210|FG000|Overall Study|Stable disease (SD)|22|||
145926171|NCT01609010|526237211|FG001|Overall Study|Stable disease (SD)|16|||
145926172|NCT01609010|526237210|FG000|Overall Study|Progressive disease (PD)|8|||
145926173|NCT01609010|526237211|FG001|Overall Study|Progressive disease (PD)|10|||
145926174|NCT01609010|526237210|FG000|Overall Study|Adverse Event|3|||
145926175|NCT01609010|526237211|FG001|Overall Study|Adverse Event|6|||
145926176|NCT01609010|526237210|FG000|Overall Study|Withdrawal by Subject|2|||
145926177|NCT01609010|526237211|FG001|Overall Study|Withdrawal by Subject|2|||
145926178|NCT01609010|526237210|FG000|Overall Study|Other|2|||
145926179|NCT01609010|526237211|FG001|Overall Study|Other|0|||
145926180|NCT01609010|526237210|FG000|Overall Study|Other malignancy|1|||
145926181|NCT01609010|526237211|FG001|Overall Study|Other malignancy|0|||
145926182|NCT01609010|526237210|FG000|Overall Study|Pathology review|2|||
145926183|NCT01609010|526237211|FG001|Overall Study|Pathology review|1|||
145926184|NCT01609010|526237210|FG000|Overall Study|Protocol Violation|1|||
145926185|NCT01609010|526237211|FG001|Overall Study|Protocol Violation|1|||
145926186|NCT01609010|526237210|FG000|Overall Study|New cancer|1|||
145926187|NCT01609010|526237211|FG001|Overall Study|New cancer|0|||
145926188|NCT01609010|526237210|FG000|Overall Study|Lost to Follow-up|1|||
145926189|NCT01609010|526237211|FG001|Overall Study|Lost to Follow-up|1|||
145926190|NCT02770170|526237215|FG000|Overall Study|Withdrawal by Subject|0|||
145926191|NCT02770170|526237216|FG001|Overall Study|Withdrawal by Subject|0|||
145926192|NCT02770170|526237217|FG002|Overall Study|Withdrawal by Subject|0|||
145926193|NCT02770170|526237218|FG003|Overall Study|Withdrawal by Subject|2|||
145926194|NCT02770170|526237215|FG000|Overall Study|due to pregnancy|1|||
145926195|NCT02770170|526237216|FG001|Overall Study|due to pregnancy|0|||
145926196|NCT02770170|526237217|FG002|Overall Study|due to pregnancy|0|||
145926197|NCT02770170|526237218|FG003|Overall Study|due to pregnancy|0|||
145926198|NCT02770170|526237215|FG000|Overall Study|Lack of Efficacy|2|||
145926199|NCT02770170|526237216|FG001|Overall Study|Lack of Efficacy|0|||
145926200|NCT02770170|526237217|FG002|Overall Study|Lack of Efficacy|0|||
145926201|NCT02770170|526237218|FG003|Overall Study|Lack of Efficacy|1|||
145926202|NCT02770170|526237215|FG000|Overall Study|Adverse Event|4|||
145926203|NCT02770170|526237216|FG001|Overall Study|Adverse Event|3|||
145926204|NCT02770170|526237217|FG002|Overall Study|Adverse Event|5|||
145926205|NCT02770170|526237218|FG003|Overall Study|Adverse Event|3|||
145926206|NCT02770170|526237215|FG000|Overall Study|due to disease worsening|0|||
145926207|NCT02770170|526237216|FG001|Overall Study|due to disease worsening|0|||
145926208|NCT02770170|526237217|FG002|Overall Study|due to disease worsening|0|||
145926209|NCT02770170|526237218|FG003|Overall Study|due to disease worsening|1|||
145926210|NCT03581123|526237221|FG000|2-month Follow-up|Withdrawal by Subject|5|||
145926211|NCT03581123|526237222|FG001|2-month Follow-up|Withdrawal by Subject|4|||
145926212|NCT03581123|526237223|FG002|2-month Follow-up|Withdrawal by Subject|6|||
145926213|NCT03581123|526237224|FG003|2-month Follow-up|Withdrawal by Subject|4|||
145926214|NCT03581123|526237221|FG000|2-month Follow-up|Lost to Follow-up|8|||
145926215|NCT03581123|526237222|FG001|2-month Follow-up|Lost to Follow-up|1|||
145926216|NCT03581123|526237223|FG002|2-month Follow-up|Lost to Follow-up|2|||
145926217|NCT03581123|526237224|FG003|2-month Follow-up|Lost to Follow-up|2|||
145926218|NCT03581123|526237221|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
145926219|NCT03581123|526237222|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
145926220|NCT03581123|526237223|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
145926221|NCT03581123|526237224|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
145926222|NCT03581123|526237221|FG000|6-Month Follow-up|Lost to Follow-up|3|||
145926223|NCT03581123|526237222|FG001|6-Month Follow-up|Lost to Follow-up|3|||
145926224|NCT03581123|526237223|FG002|6-Month Follow-up|Lost to Follow-up|1|||
145926225|NCT03581123|526237224|FG003|6-Month Follow-up|Lost to Follow-up|1|||
145926226|NCT03581123|526237221|FG000|12-Month Follow-up|Lost to Follow-up|4|||
145926227|NCT03581123|526237222|FG001|12-Month Follow-up|Lost to Follow-up|3|||
145926228|NCT03581123|526237223|FG002|12-Month Follow-up|Lost to Follow-up|4|||
145926229|NCT03581123|526237224|FG003|12-Month Follow-up|Lost to Follow-up|5|||
145926230|NCT00162981|526237225|FG000|Overall Study|Adverse Event|2|||
145926231|NCT00162981|526237226|FG001|Overall Study|Adverse Event|5|||
145926232|NCT00162981|526237225|FG000|Overall Study|Withdrawal by Subject|1|||
145926233|NCT00162981|526237226|FG001|Overall Study|Withdrawal by Subject|1|||
145926234|NCT00162981|526237225|FG000|Overall Study|Physician Decision|1|||
145926235|NCT00162981|526237226|FG001|Overall Study|Physician Decision|0|||
145926236|NCT04195685|526237227|FG000|Overall Study|Withdrawal by Subject|6|||
145926237|NCT04195685|526237228|FG001|Overall Study|Withdrawal by Subject|2|||
145926238|NCT04195685|526237227|FG000|Overall Study|Lost to Follow-up|1|||
145926239|NCT04195685|526237228|FG001|Overall Study|Lost to Follow-up|4|||
145926240|NCT03351608|526237235|FG000|Overall Study|Lost to Follow-up|0|||
145926241|NCT03351608|526237236|FG001|Overall Study|Lost to Follow-up|1|||
145926242|NCT03351608|526237237|FG002|Overall Study|Lost to Follow-up|1|||
145926243|NCT03351608|526237238|FG003|Overall Study|Lost to Follow-up|1|||
145926244|NCT03351608|526237239|FG004|Overall Study|Lost to Follow-up|1|||
145926245|NCT03351608|526237235|FG000|Overall Study|Physician Decision|1|||
145926246|NCT03351608|526237236|FG001|Overall Study|Physician Decision|0|||
145926247|NCT03351608|526237237|FG002|Overall Study|Physician Decision|0|||
145926248|NCT03351608|526237238|FG003|Overall Study|Physician Decision|2|||
145926249|NCT03351608|526237239|FG004|Overall Study|Physician Decision|1|||
145926250|NCT03351608|526237235|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
145926251|NCT03351608|526237236|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
145926252|NCT03351608|526237237|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
145926253|NCT03351608|526237238|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
146297767|NCT02616614|527605983|FG002|Overall Study|More than 3 applications missed|1|||
146297768|NCT02616614|527605981|FG000|Overall Study|Lost to Follow-up|31|||
145926254|NCT03351608|526237239|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
145926255|NCT03351608|526237235|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145926256|NCT03351608|526237236|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145926257|NCT03351608|526237237|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145926258|NCT03351608|526237238|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145926259|NCT03351608|526237239|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145926260|NCT03351608|526237235|FG000|Overall Study|Other|0|||
145926261|NCT03351608|526237236|FG001|Overall Study|Other|1|||
145926262|NCT03351608|526237237|FG002|Overall Study|Other|1|||
145926263|NCT03351608|526237238|FG003|Overall Study|Other|3|||
145926264|NCT03351608|526237239|FG004|Overall Study|Other|0|||
145926265|NCT02877004|526237240|FG000|Overall Study|Pregnancy|0|||
145926266|NCT02877004|526237241|FG001|Overall Study|Pregnancy|0|||
145926267|NCT02877004|526237242|FG002|Overall Study|Pregnancy|1|||
145926268|NCT02044302|526237244|FG000|Overall Study|study terminated|2|||
145926269|NCT02044302|526237245|FG001|Overall Study|study terminated|0|||
145926270|NCT02019264|526237248|FG000|Overall Study|Not treated|6|||
145926271|NCT02019264|526237249|FG001|Overall Study|Not treated|4|||
145926272|NCT02019264|526237248|FG000|Overall Study|Lost to Follow-up|50|||
145926273|NCT02019264|526237249|FG001|Overall Study|Lost to Follow-up|47|||
145926274|NCT02019264|526237248|FG000|Overall Study|Withdrawal by Subject|142|||
145926275|NCT02019264|526237249|FG001|Overall Study|Withdrawal by Subject|117|||
145926276|NCT02019264|526237248|FG000|Overall Study|Administrative reason|36|||
145926277|NCT02019264|526237249|FG001|Overall Study|Administrative reason|28|||
145926278|NCT02019264|526237248|FG000|Overall Study|Missing|14|||
145926279|NCT02019264|526237249|FG001|Overall Study|Missing|11|||
145926280|NCT01297517|526237255|FG000|Overall Study|Adverse Event|21|||
145926281|NCT01297517|526237256|FG001|Overall Study|Adverse Event|7|||
146297769|NCT02616614|527605982|FG001|Overall Study|Lost to Follow-up|28|||
145926282|NCT01297517|526237257|FG002|Overall Study|Adverse Event|16|||
145926283|NCT01297517|526237255|FG000|Overall Study|Lost to Follow-up|1|||
145926284|NCT01297517|526237256|FG001|Overall Study|Lost to Follow-up|0|||
145926285|NCT01297517|526237257|FG002|Overall Study|Lost to Follow-up|1|||
145926286|NCT01297517|526237255|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
145926287|NCT01297517|526237256|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
145926288|NCT01297517|526237257|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
145926289|NCT01297517|526237255|FG000|Overall Study|Noncompliance|1|||
145926290|NCT01297517|526237256|FG001|Overall Study|Noncompliance|0|||
145926291|NCT01297517|526237257|FG002|Overall Study|Noncompliance|0|||
145926292|NCT01297517|526237255|FG000|Overall Study|Protocol Violation|1|||
145926293|NCT01297517|526237256|FG001|Overall Study|Protocol Violation|1|||
145926294|NCT01297517|526237257|FG002|Overall Study|Protocol Violation|1|||
145926295|NCT01297517|526237255|FG000|Overall Study|Inadequate Control of IOP|1|||
145926296|NCT01297517|526237256|FG001|Overall Study|Inadequate Control of IOP|1|||
145926297|NCT01297517|526237257|FG002|Overall Study|Inadequate Control of IOP|2|||
145926298|NCT01609296|526237258|FG000|Overall Study|Death|253|||
145926299|NCT01609296|526237258|FG000|Overall Study|Withdrawal by Subject|151|||
145926300|NCT01609296|526237258|FG000|Overall Study|Lost to Follow-up|21|||
145926301|NCT01609296|526237258|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
145926302|NCT01609296|526237258|FG000|Overall Study|missed visit but known to be alive|28|||
145926303|NCT00386360|526237259|FG000|Overall Study|Adverse Event|4|||
145926304|NCT00386360|526237260|FG001|Overall Study|Adverse Event|2|||
145926305|NCT00386360|526237259|FG000|Overall Study|Physician Decision|2|||
145926306|NCT00386360|526237260|FG001|Overall Study|Physician Decision|2|||
145926307|NCT00386360|526237259|FG000|Overall Study|Lost to Follow-up|0|||
145926308|NCT00386360|526237260|FG001|Overall Study|Lost to Follow-up|2|||
145926309|NCT00386360|526237259|FG000|Overall Study|Protocol Violation|0|||
145926310|NCT00386360|526237260|FG001|Overall Study|Protocol Violation|3|||
145926311|NCT00386360|526237259|FG000|Overall Study|Withdrawal by Subject|3|||
145926312|NCT00386360|526237260|FG001|Overall Study|Withdrawal by Subject|6|||
145926313|NCT00386360|526237259|FG000|Overall Study|Did not take any study medication|0|||
145926314|NCT00386360|526237260|FG001|Overall Study|Did not take any study medication|2|||
145926315|NCT00628212|526237261|FG000|Overall Study|Adverse Event|2|||
145926316|NCT00628212|526237262|FG001|Overall Study|Adverse Event|0|||
145926317|NCT00628212|526237263|FG002|Overall Study|Adverse Event|1|||
145926318|NCT00628212|526237264|FG003|Overall Study|Adverse Event|2|||
145926319|NCT00628212|526237261|FG000|Overall Study|Physician Decision|1|||
145926320|NCT00628212|526237262|FG001|Overall Study|Physician Decision|1|||
145926321|NCT00628212|526237263|FG002|Overall Study|Physician Decision|2|||
145926322|NCT00628212|526237264|FG003|Overall Study|Physician Decision|3|||
145926323|NCT00546377|526237265|FG000|Overall Study|Deemed ineligible|1|||
145926324|NCT00546377|526237265|FG000|Overall Study|Adverse Event|6|||
145926325|NCT02220764|526237267|FG000|Overall Study|Lost to Follow-up|3|||
145926326|NCT02220764|526237268|FG001|Overall Study|Lost to Follow-up|1|||
145926327|NCT02220764|526237267|FG000|Overall Study|Death|1|||
145926328|NCT02220764|526237268|FG001|Overall Study|Death|0|||
145926329|NCT05000164|526237269|FG000|Overall Study|Adverse Event|1|||
145926330|NCT05000164|526237269|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145926331|NCT05000164|526237269|FG000|Overall Study|Lens Discomfort|3|||
145926332|NCT05000164|526237269|FG000|Overall Study|Withdrew Consent during Study|2|||
145926333|NCT05000164|526237269|FG000|Overall Study|Subject Withdrawn by PI|2|||
145926334|NCT05000164|526237269|FG000|Overall Study|Other Fractured Test Article|1|||
145926335|NCT02861807|526237270|FG000|Overall Study|Lost to Follow-up|7|||
145926336|NCT02861807|526237271|FG001|Overall Study|Lost to Follow-up|6|||
145926337|NCT02861807|526237270|FG000|Overall Study|Withdrawal by Subject|5|||
145926338|NCT02861807|526237271|FG001|Overall Study|Withdrawal by Subject|8|||
145926339|NCT03020992|526237272|FG000|Overall Study|Adverse Event|5|||
145926340|NCT03020992|526237272|FG000|Overall Study|Withdrawal by Subject|1|||
145926341|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
145926342|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
145926343|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
145926344|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
145926345|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Pregnancy|0|||
145926346|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Pregnancy|1|||
145926347|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
146297770|NCT02616614|527605983|FG002|Overall Study|Lost to Follow-up|13|||
145926348|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
145926349|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
145926350|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
145926351|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
145926352|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
145926353|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Other|3|||
145926354|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Other|0|||
145926355|NCT01006122|526237273|FG000|First Double-blind Intervention Period|Adverse Event|0|||
145926356|NCT01006122|526237274|FG001|First Double-blind Intervention Period|Adverse Event|4|||
145926357|NCT01006122|526237273|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
145926358|NCT01006122|526237274|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
145926359|NCT01006122|526237273|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
145926360|NCT01006122|526237274|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
145926361|NCT01006122|526237273|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
145926362|NCT01006122|526237274|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
145926363|NCT01006122|526237273|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
145926364|NCT01006122|526237274|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
145926365|NCT01006122|526237273|FG000|Second Double-blind Intervention Period|Death|0|||
145977349|NCT02555878|526428125|FG000|Overall Study|Death|74|||
145977350|NCT02555878|526428126|FG001|Overall Study|Death|59|||
145977351|NCT02555878|526428125|FG000|Overall Study|Protocol Violation|1|||
145977352|NCT02555878|526428126|FG001|Overall Study|Protocol Violation|2|||
145977353|NCT02555878|526428125|FG000|Overall Study|Physician Decision|12|||
145977354|NCT02555878|526428126|FG001|Overall Study|Physician Decision|13|||
145977355|NCT02555878|526428125|FG000|Overall Study|Other|17|||
145977356|NCT02555878|526428126|FG001|Overall Study|Other|17|||
145977357|NCT00765076|526428127|FG000|Overall Study|Adverse Event|1|||
145977358|NCT00765076|526428128|FG001|Overall Study|Adverse Event|0|||
145926366|NCT01006122|526237274|FG001|Second Double-blind Intervention Period|Death|1|||
145926367|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
145926368|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
145926369|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
145926370|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
145926371|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
145926372|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
145926373|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
145926374|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
145926375|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
145926376|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
145926377|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
145926378|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
146090551|NCT01897714|526852621|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
146090552|NCT01897714|526852622|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
146090553|NCT01897714|526852623|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
146090554|NCT01897714|526852618|FG000|Phase II (MTD)|Lost to Follow-up|0|||
146090555|NCT01897714|526852619|FG001|Phase II (MTD)|Lost to Follow-up|0|||
145926379|NCT03493854|526237275|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
145926380|NCT03493854|526237276|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
145926381|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
145926382|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
145926383|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
145926384|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
145926385|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
145926386|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
145926387|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
145926388|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
145926389|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
145926390|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
145926391|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
145926392|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
145926393|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
145926394|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
145926395|NCT03493854|526237275|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
145926396|NCT03493854|526237276|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
145926397|NCT03493854|526237275|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
145926398|NCT03493854|526237276|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
145926399|NCT03493854|526237275|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
145977359|NCT00765076|526428129|FG002|Overall Study|Adverse Event|0|||
145977360|NCT00765076|526428127|FG000|Overall Study|Withdrawal by Subject|0|||
145977361|NCT00765076|526428128|FG001|Overall Study|Withdrawal by Subject|0|||
145926400|NCT03493854|526237276|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
145977362|NCT00765076|526428129|FG002|Overall Study|Withdrawal by Subject|1|||
146090556|NCT01897714|526852620|FG002|Phase II (MTD)|Lost to Follow-up|0|||
146090557|NCT01897714|526852621|FG003|Phase II (MTD)|Lost to Follow-up|0|||
145977363|NCT01163617|526428130|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145977364|NCT01163617|526428131|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
145977365|NCT01163617|526428132|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145926401|NCT03493854|526237275|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
145926402|NCT03493854|526237276|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
145926403|NCT02062450|526237291|FG000|Overall Study|No follow-up visit|124|||
145926404|NCT04025879|526237292|FG000|Randomization|Participant withdrew consent|0|||
145926405|NCT04025879|526237293|FG001|Randomization|Participant withdrew consent|1|||
145926406|NCT04025879|526237292|FG000|Randomization|Participant no longer met study criteria|1|||
145926407|NCT04025879|526237293|FG001|Randomization|Participant no longer met study criteria|1|||
145926408|NCT04025879|526237292|FG000|Treatment|Ongoing treatment|10|||
145926409|NCT04025879|526237293|FG001|Treatment|Ongoing treatment|8|||
145926410|NCT04025879|526237292|FG000|Treatment|Disease progression/recurrence|36|||
145926411|NCT04025879|526237293|FG001|Treatment|Disease progression/recurrence|72|||
145926412|NCT04025879|526237292|FG000|Treatment|Study drug toxicity|36|||
145926413|NCT04025879|526237293|FG001|Treatment|Study drug toxicity|13|||
145926414|NCT04025879|526237292|FG000|Treatment|Death|2|||
145926415|NCT04025879|526237293|FG001|Treatment|Death|0|||
145926416|NCT04025879|526237292|FG000|Treatment|Adverse event unrelated to study drug|21|||
145926417|NCT04025879|526237293|FG001|Treatment|Adverse event unrelated to study drug|14|||
145926418|NCT04025879|526237292|FG000|Treatment|Participant request to discontinue study treatment|16|||
145926419|NCT04025879|526237293|FG001|Treatment|Participant request to discontinue study treatment|8|||
145926420|NCT04025879|526237292|FG000|Treatment|Participant withdrew consent|1|||
145926421|NCT04025879|526237293|FG001|Treatment|Participant withdrew consent|3|||
145926422|NCT04025879|526237292|FG000|Treatment|Participant no longer meets study criteria|3|||
145926423|NCT04025879|526237293|FG001|Treatment|Participant no longer meets study criteria|2|||
145926424|NCT04025879|526237292|FG000|Treatment|Lost to Follow-up|1|||
145926425|NCT04025879|526237293|FG001|Treatment|Lost to Follow-up|0|||
145926426|NCT04025879|526237292|FG000|Treatment|Other reasons|15|||
145926427|NCT04025879|526237293|FG001|Treatment|Other reasons|17|||
145926428|NCT04025879|526237292|FG000|Treatment|Administrative reason by sponsor|0|||
145926429|NCT04025879|526237293|FG001|Treatment|Administrative reason by sponsor|1|||
145926430|NCT04025879|526237292|FG000|Treatment|Not reported|2|||
145926431|NCT04025879|526237293|FG001|Treatment|Not reported|0|||
146090558|NCT01897714|526852622|FG004|Phase II (MTD)|Lost to Follow-up|1|||
146090559|NCT01897714|526852623|FG005|Phase II (MTD)|Lost to Follow-up|0|||
146090560|NCT01897714|526852618|FG000|Phase II (MTD)|Death|0|||
145926432|NCT03859427|526237294|FG000|Overall Study|Withdrawal by Subject|4|||
145926433|NCT03859427|526237295|FG001|Overall Study|Withdrawal by Subject|7|||
145926434|NCT03859427|526237294|FG000|Overall Study|Decision by sponsor|0|||
145926435|NCT03859427|526237295|FG001|Overall Study|Decision by sponsor|3|||
145926436|NCT03859427|526237294|FG000|Overall Study|Lost to Follow-up|3|||
145926437|NCT03859427|526237295|FG001|Overall Study|Lost to Follow-up|2|||
145926438|NCT03859427|526237294|FG000|Overall Study|Death|22|||
145926439|NCT03859427|526237295|FG001|Overall Study|Death|25|||
145926440|NCT01367886|526237301|FG000|Overall Study|Lost to Follow-up|4|||
145926441|NCT01367886|526237301|FG000|Overall Study|Lack of Efficacy|2|||
145926442|NCT01367886|526237301|FG000|Overall Study|Death|1|||
145926443|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
145926444|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
145926445|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
145926446|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
145926447|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
145926448|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
145926449|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
146090561|NCT01897714|526852619|FG001|Phase II (MTD)|Death|0|||
145926450|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
145926451|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
145926452|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
145926453|NCT03711786|526237302|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
145926454|NCT03711786|526237303|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
145926455|NCT03379727|526237304|FG000|Overall Study|Lack of Efficacy|73|||
145926456|NCT03379727|526237304|FG000|Overall Study|Adverse Event|32|||
145926457|NCT03379727|526237304|FG000|Overall Study|Death|18|||
145926458|NCT03379727|526237304|FG000|Overall Study|Patient/guardian decision|17|||
145926459|NCT03379727|526237304|FG000|Overall Study|Physician Decision|104|||
145926460|NCT03379727|526237304|FG000|Overall Study|Protocol Violation|4|||
145926461|NCT03379727|526237304|FG000|Overall Study|Lost to Follow-up|1|||
146090562|NCT01897714|526852620|FG002|Phase II (MTD)|Death|0|||
145926462|NCT02418182|526237307|FG000|Overall Study|Unable to re-consent|18|||
145926463|NCT02418182|526237308|FG001|Overall Study|Unable to re-consent|15|||
145926464|NCT02418182|526237307|FG000|Overall Study|Lost to Follow-up|0|||
145926465|NCT02418182|526237308|FG001|Overall Study|Lost to Follow-up|2|||
145926466|NCT02431676|526237309|FG000|Overall Study|no lab obtained|0|||
145926467|NCT02431676|526237310|FG001|Overall Study|no lab obtained|1|||
145926468|NCT02431676|526237311|FG002|Overall Study|no lab obtained|2|||
146090563|NCT01897714|526852621|FG003|Phase II (MTD)|Death|0|||
146090564|NCT01897714|526852622|FG004|Phase II (MTD)|Death|25|||
146090565|NCT01897714|526852623|FG005|Phase II (MTD)|Death|10|||
145926469|NCT03103152|526237312|FG000|Overall Study|Physician Decision|5|||
145926470|NCT03103152|526237313|FG001|Overall Study|Physician Decision|2|||
145926471|NCT03103152|526237314|FG002|Overall Study|Physician Decision|6|||
145926472|NCT03103152|526237315|FG003|Overall Study|Physician Decision|3|||
145926473|NCT03103152|526237316|FG004|Overall Study|Physician Decision|3|||
145926474|NCT03103152|526237317|FG005|Overall Study|Physician Decision|1|||
145926475|NCT03103152|526237312|FG000|Overall Study|Protocol Violation|2|||
145926476|NCT03103152|526237313|FG001|Overall Study|Protocol Violation|2|||
145926477|NCT03103152|526237314|FG002|Overall Study|Protocol Violation|1|||
145926478|NCT03103152|526237315|FG003|Overall Study|Protocol Violation|2|||
145926479|NCT03103152|526237316|FG004|Overall Study|Protocol Violation|1|||
145926480|NCT03103152|526237317|FG005|Overall Study|Protocol Violation|1|||
145926481|NCT03103152|526237312|FG000|Overall Study|Inter-current illness|0|||
145926482|NCT03103152|526237313|FG001|Overall Study|Inter-current illness|0|||
145926483|NCT03103152|526237314|FG002|Overall Study|Inter-current illness|1|||
145926484|NCT03103152|526237315|FG003|Overall Study|Inter-current illness|0|||
145926485|NCT03103152|526237316|FG004|Overall Study|Inter-current illness|0|||
145926486|NCT03103152|526237317|FG005|Overall Study|Inter-current illness|0|||
145926487|NCT03103152|526237312|FG000|Overall Study|Death|0|||
145926488|NCT03103152|526237313|FG001|Overall Study|Death|1|||
145926489|NCT03103152|526237314|FG002|Overall Study|Death|0|||
145926490|NCT03103152|526237315|FG003|Overall Study|Death|0|||
145926491|NCT03103152|526237316|FG004|Overall Study|Death|0|||
145926492|NCT03103152|526237317|FG005|Overall Study|Death|0|||
145926493|NCT03103152|526237312|FG000|Overall Study|Adverse Event|0|||
145926494|NCT03103152|526237313|FG001|Overall Study|Adverse Event|0|||
145926495|NCT03103152|526237314|FG002|Overall Study|Adverse Event|1|||
145926496|NCT03103152|526237315|FG003|Overall Study|Adverse Event|0|||
145926497|NCT03103152|526237316|FG004|Overall Study|Adverse Event|0|||
145926498|NCT03103152|526237317|FG005|Overall Study|Adverse Event|1|||
145926499|NCT03103152|526237312|FG000|Overall Study|Withdrawal by Subject|1|||
145926500|NCT03103152|526237313|FG001|Overall Study|Withdrawal by Subject|0|||
145926501|NCT03103152|526237314|FG002|Overall Study|Withdrawal by Subject|1|||
145926502|NCT03103152|526237315|FG003|Overall Study|Withdrawal by Subject|1|||
145926503|NCT03103152|526237316|FG004|Overall Study|Withdrawal by Subject|1|||
145926504|NCT03103152|526237317|FG005|Overall Study|Withdrawal by Subject|1|||
145926505|NCT03103152|526237312|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
145926506|NCT03103152|526237313|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
145926507|NCT03103152|526237314|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
145926508|NCT03103152|526237315|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
145926509|NCT03103152|526237316|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
145926510|NCT03103152|526237317|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
145926511|NCT03103152|526237312|FG000|Overall Study|Unacceptable side effects|0|||
145926512|NCT03103152|526237313|FG001|Overall Study|Unacceptable side effects|0|||
146243193|NCT03861234|527405350|FG007|Overall Study|Adverse Event|0|||
146243194|NCT03861234|527405343|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
146243195|NCT03861234|527405344|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
146243196|NCT03861234|527405345|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
146243197|NCT03861234|527405346|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
146243198|NCT03861234|527405347|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
146243199|NCT03861234|527405348|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
146243200|NCT03861234|527405349|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
146243201|NCT03861234|527405350|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
146243202|NCT03861234|527405343|FG000|Overall Study|As per sponsor decision|0|||
145926513|NCT03103152|526237314|FG002|Overall Study|Unacceptable side effects|0|||
145926514|NCT03103152|526237315|FG003|Overall Study|Unacceptable side effects|0|||
145926515|NCT03103152|526237316|FG004|Overall Study|Unacceptable side effects|0|||
145926516|NCT03103152|526237317|FG005|Overall Study|Unacceptable side effects|1|||
145926517|NCT03103152|526237312|FG000|Overall Study|Lost to Follow-up|0|||
145926518|NCT03103152|526237313|FG001|Overall Study|Lost to Follow-up|1|||
145926519|NCT03103152|526237314|FG002|Overall Study|Lost to Follow-up|0|||
145926520|NCT03103152|526237315|FG003|Overall Study|Lost to Follow-up|1|||
145926521|NCT03103152|526237316|FG004|Overall Study|Lost to Follow-up|0|||
145926522|NCT03103152|526237317|FG005|Overall Study|Lost to Follow-up|1|||
145926523|NCT03103152|526237312|FG000|Overall Study|Testicular pain|0|||
145926524|NCT03103152|526237313|FG001|Overall Study|Testicular pain|0|||
145926525|NCT03103152|526237314|FG002|Overall Study|Testicular pain|0|||
145926526|NCT03103152|526237315|FG003|Overall Study|Testicular pain|1|||
145926527|NCT03103152|526237316|FG004|Overall Study|Testicular pain|0|||
145926528|NCT03103152|526237317|FG005|Overall Study|Testicular pain|0|||
145926529|NCT01085630|526239367|FG000|Overall Study|Insufficient data|1|||
145926530|NCT01085630|526239368|FG001|Overall Study|Insufficient data|0|||
145926531|NCT01085630|526239367|FG000|Overall Study|Ineligible|3|||
145926532|NCT01085630|526239368|FG001|Overall Study|Ineligible|0|||
145926533|NCT02366637|526239374|FG000|First Intervention Period|Adverse Event|0|||
146243203|NCT03861234|527405344|FG001|Overall Study|As per sponsor decision|0|||
146243204|NCT03861234|527405345|FG002|Overall Study|As per sponsor decision|0|||
146243205|NCT03861234|527405346|FG003|Overall Study|As per sponsor decision|0|||
146243206|NCT03861234|527405347|FG004|Overall Study|As per sponsor decision|0|||
146243207|NCT03861234|527405348|FG005|Overall Study|As per sponsor decision|0|||
146243208|NCT03861234|527405349|FG006|Overall Study|As per sponsor decision|1|||
146243209|NCT03861234|527405350|FG007|Overall Study|As per sponsor decision|0|||
146243210|NCT03861234|527405343|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
146243211|NCT03861234|527405344|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
146243212|NCT03861234|527405345|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
146243213|NCT03861234|527405346|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
146243214|NCT03861234|527405347|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
146243215|NCT03861234|527405348|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
146243216|NCT03861234|527405349|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
146243217|NCT03861234|527405350|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
146243218|NCT00621842|527405351|FG000|Overall Study|Adverse Event|6|||
146243219|NCT00621842|527405351|FG000|Overall Study|Withdrawal by Subject|7|||
146243220|NCT00621842|527405351|FG000|Overall Study|Protocol Violation|4|||
145926534|NCT02366637|526239375|FG001|First Intervention Period|Adverse Event|1|||
145926535|NCT02366637|526239374|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
145926536|NCT02366637|526239375|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
145926537|NCT02366637|526239374|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
145926538|NCT02366637|526239375|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
145926539|NCT02609607|526239381|FG000|Overall Study|Lost to Follow-up|0|||
145926540|NCT02609607|526239382|FG001|Overall Study|Lost to Follow-up|1|||
145926541|NCT02027545|526239383|FG000|Overall Study|Failed to sign HIPAA|0|||
145926542|NCT02027545|526239384|FG001|Overall Study|Failed to sign HIPAA|2|||
145926543|NCT02027545|526239383|FG000|Overall Study|Failed to attend study visit|2|||
145926544|NCT02027545|526239384|FG001|Overall Study|Failed to attend study visit|0|||
145926545|NCT02027545|526239383|FG000|Overall Study|Protocol Violation|1|||
145926546|NCT02027545|526239384|FG001|Overall Study|Protocol Violation|0|||
145926547|NCT02356588|526239390|FG000|Overall Study|Lack of Efficacy|4|||
145926548|NCT02356588|526239391|FG001|Overall Study|Lack of Efficacy|10|||
145926549|NCT02356588|526239390|FG000|Overall Study|Adverse Event|0|||
145926550|NCT02356588|526239391|FG001|Overall Study|Adverse Event|2|||
145926551|NCT02356588|526239390|FG000|Overall Study|Withdrawal by Subject|1|||
145926552|NCT02356588|526239391|FG001|Overall Study|Withdrawal by Subject|0|||
145926553|NCT02356588|526239390|FG000|Overall Study|Protocol Violation|0|||
145926554|NCT02356588|526239391|FG001|Overall Study|Protocol Violation|1|||
145926555|NCT01418378|526239392|FG000|Overall Study|Death|1|||
145926556|NCT01418378|526239393|FG001|Overall Study|Death|2|||
145926557|NCT01418378|526239392|FG000|Overall Study|Physician Decision|0|||
145926558|NCT01418378|526239393|FG001|Overall Study|Physician Decision|1|||
145926559|NCT01418378|526239392|FG000|Overall Study|ligament imbalance|0|||
145926560|NCT01418378|526239393|FG001|Overall Study|ligament imbalance|1|||
145926561|NCT01418378|526239392|FG000|Overall Study|developed chronic myopathy|0|||
145926562|NCT01418378|526239393|FG001|Overall Study|developed chronic myopathy|1|||
145926563|NCT03150719|526239396|FG000|Overall Study|Adverse Event|0|||
145926564|NCT03150719|526239397|FG001|Overall Study|Adverse Event|1|||
145926565|NCT03150719|526239396|FG000|Overall Study|Death|0|||
145926566|NCT03150719|526239397|FG001|Overall Study|Death|1|||
145926567|NCT03150719|526239396|FG000|Overall Study|Other|1|||
145926568|NCT03150719|526239397|FG001|Overall Study|Other|0|||
145926569|NCT01790984|526239398|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
145977366|NCT01163617|526428133|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145977367|NCT01163617|526428134|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145977368|NCT01163617|526428135|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145977369|NCT01163617|526428136|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145977370|NCT01163617|526428137|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145926570|NCT01790984|526239399|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
145977371|NCT01163617|526428130|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
146243221|NCT00621842|527405351|FG000|Overall Study|Lack of Efficacy|2|||
146243222|NCT05074433|527405353|FG000|Overall Study|Adverse Event|0|||
146243223|NCT05074433|527405354|FG001|Overall Study|Adverse Event|2|||
145926571|NCT01790984|526239400|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
145926572|NCT01790984|526239401|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
145926573|NCT01051791|526239405|FG000|Overall Study|Failed screening|3|||
145926574|NCT01051791|526239405|FG000|Overall Study|Withdrawal by Subject|1|||
145926575|NCT00288626|526239410|FG000|Overall Study|Death|3|||
145926576|NCT00288626|526239410|FG000|Overall Study|Withdrawal by Subject|4|||
145926577|NCT04610346|526239415|FG000|Overall Study|Withdrawal by Subject|1|||
145926578|NCT04610346|526239416|FG001|Overall Study|Withdrawal by Subject|1|||
145926579|NCT04610346|526239415|FG000|Overall Study|did not complete shelter onboarding|2|||
145926580|NCT04610346|526239416|FG001|Overall Study|did not complete shelter onboarding|1|||
145926581|NCT00558467|526239417|FG000|Overall Study|Adverse Event|1|||
145926582|NCT00558467|526239418|FG001|Overall Study|Adverse Event|2|||
145926583|NCT00558467|526239417|FG000|Overall Study|Lack of Efficacy|0|||
145926584|NCT00558467|526239418|FG001|Overall Study|Lack of Efficacy|1|||
145926585|NCT00558467|526239417|FG000|Overall Study|Patient moving out of state|0|||
145926586|NCT00558467|526239418|FG001|Overall Study|Patient moving out of state|1|||
145926587|NCT00507455|526239419|FG000|Overall Study|Adverse Event|3|||
145926588|NCT00507455|526239420|FG001|Overall Study|Adverse Event|3|||
145926589|NCT00507455|526239421|FG002|Overall Study|Adverse Event|6|||
145926590|NCT00507455|526239419|FG000|Overall Study|Withdrawal by Subject|2|||
145926591|NCT00507455|526239420|FG001|Overall Study|Withdrawal by Subject|1|||
145926592|NCT00507455|526239421|FG002|Overall Study|Withdrawal by Subject|2|||
145926593|NCT00507455|526239419|FG000|Overall Study|Protocol Violation|4|||
145926594|NCT00507455|526239420|FG001|Overall Study|Protocol Violation|1|||
145926595|NCT00507455|526239421|FG002|Overall Study|Protocol Violation|1|||
145926596|NCT00507455|526239419|FG000|Overall Study|Lost to Follow-up|2|||
145926597|NCT00507455|526239420|FG001|Overall Study|Lost to Follow-up|0|||
145926598|NCT00507455|526239421|FG002|Overall Study|Lost to Follow-up|2|||
145926599|NCT00507455|526239419|FG000|Overall Study|Lack of Efficacy|0|||
145926600|NCT00507455|526239420|FG001|Overall Study|Lack of Efficacy|1|||
145926601|NCT00507455|526239421|FG002|Overall Study|Lack of Efficacy|0|||
145926602|NCT00507455|526239419|FG000|Overall Study|Other - miscellaneous reason|1|||
145926603|NCT00507455|526239420|FG001|Overall Study|Other - miscellaneous reason|0|||
145926604|NCT00507455|526239421|FG002|Overall Study|Other - miscellaneous reason|1|||
145926605|NCT03309943|526239422|FG000|Overall Study|Withdrawal by Subject|0|||
145926606|NCT03309943|526239423|FG001|Overall Study|Withdrawal by Subject|1|||
145926607|NCT03309943|526239422|FG000|Overall Study|Inappropriate behavior towards staff|0|||
145926608|NCT03309943|526239423|FG001|Overall Study|Inappropriate behavior towards staff|1|||
145926609|NCT00931255|526239424|FG000|Overall Study|Follow up biopsy not done|2|||
145926610|NCT00931255|526239425|FG001|Overall Study|Follow up biopsy not done|3|||
145926611|NCT01372995|526239426|FG000|Overall Study|Spouse withdrew participant from study|0|||
145926612|NCT01372995|526239427|FG001|Overall Study|Spouse withdrew participant from study|1|||
145926613|NCT01372995|526239428|FG002|Overall Study|Spouse withdrew participant from study|0|||
145926614|NCT01372995|526239426|FG000|Overall Study|Physician Decision|0|||
145926615|NCT01372995|526239427|FG001|Overall Study|Physician Decision|0|||
145926616|NCT01372995|526239428|FG002|Overall Study|Physician Decision|1|||
145926617|NCT01684423|526239442|FG000|Overall Study|Withdrawal by Subject|0|||
145926618|NCT01684423|526239443|FG001|Overall Study|Withdrawal by Subject|0|||
145926619|NCT01684423|526239444|FG002|Overall Study|Withdrawal by Subject|1|||
145926620|NCT01684423|526239445|FG003|Overall Study|Withdrawal by Subject|0|||
145926621|NCT01684423|526239446|FG004|Overall Study|Withdrawal by Subject|0|||
145926622|NCT03363776|526239451|FG000|Overall Study|Progressive disease|2|||
145926623|NCT03363776|526239452|FG001|Overall Study|Progressive disease|3|||
145926624|NCT03363776|526239453|FG002|Overall Study|Progressive disease|1|||
145926625|NCT03363776|526239451|FG000|Overall Study|Study drug toxicity|0|||
145926626|NCT03363776|526239452|FG001|Overall Study|Study drug toxicity|0|||
145977372|NCT01163617|526428131|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
145977373|NCT01163617|526428132|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977374|NCT01163617|526428133|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977375|NCT01163617|526428134|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977376|NCT01163617|526428135|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977377|NCT01163617|526428136|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977378|NCT01163617|526428137|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145977379|NCT01163617|526428130|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977380|NCT01163617|526428131|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977381|NCT01163617|526428132|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
145977382|NCT01163617|526428133|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977383|NCT01163617|526428134|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977384|NCT01163617|526428135|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977385|NCT01163617|526428136|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977386|NCT01163617|526428137|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145977387|NCT02875080|526428138|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
146243224|NCT05074433|527405355|FG002|Overall Study|Adverse Event|0|||
146243225|NCT05074433|527405356|FG003|Overall Study|Adverse Event|1|||
146243226|NCT05074433|527405353|FG000|Overall Study|Sponsor Request|0|||
146243227|NCT05074433|527405354|FG001|Overall Study|Sponsor Request|1|||
145926627|NCT03363776|526239453|FG002|Overall Study|Study drug toxicity|1|||
145926628|NCT03363776|526239451|FG000|Overall Study|Death|1|||
145926629|NCT03363776|526239452|FG001|Overall Study|Death|0|||
145926630|NCT03363776|526239453|FG002|Overall Study|Death|0|||
145926631|NCT04157348|526239454|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
145926632|NCT04157348|526239455|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
145926633|NCT04157348|526239454|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145926634|NCT04157348|526239455|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145926635|NCT04157348|526239454|FG000|Double-blind Treatment Period|Adverse Event|0|||
145926636|NCT04157348|526239455|FG001|Double-blind Treatment Period|Adverse Event|1|||
145926637|NCT04157348|526239454|FG000|Open-label Extension Period|Adverse Event|1|||
145926638|NCT04157348|526239455|FG001|Open-label Extension Period|Adverse Event|1|||
145926639|NCT04157348|526239454|FG000|Open-label Extension Period|Death|0|||
145926640|NCT04157348|526239455|FG001|Open-label Extension Period|Death|1|||
145926641|NCT04157348|526239454|FG000|Open-label Extension Period|Lack of Efficacy|2|||
145926642|NCT04157348|526239455|FG001|Open-label Extension Period|Lack of Efficacy|2|||
145926643|NCT04157348|526239454|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
145926644|NCT04157348|526239455|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
145926645|NCT04157348|526239454|FG000|Open-label Extension Period|Ongoing|60|||
145926646|NCT04157348|526239455|FG001|Open-label Extension Period|Ongoing|57|||
145926647|NCT04157348|526239454|FG000|Open-label Extension Period|other reasons|1|||
145926648|NCT04157348|526239455|FG001|Open-label Extension Period|other reasons|1|||
145926649|NCT00568061|526239456|FG000|Overall Study|Inclusion / exclusion criteria|5|||
145926650|NCT00568061|526239457|FG001|Overall Study|Inclusion / exclusion criteria|1|||
145926651|NCT00568061|526239456|FG000|Overall Study|Adverse Event|0|||
145926652|NCT00568061|526239457|FG001|Overall Study|Adverse Event|1|||
145926653|NCT00529308|526239459|FG000|Overall Study|Withdrawal by Subject|1|||
145926654|NCT00529308|526239460|FG001|Overall Study|Withdrawal by Subject|1|||
145926655|NCT02693002|526239461|FG000|Overall Study|Withdrawal by Subject|1|||
145926656|NCT02693002|526239462|FG001|Overall Study|Withdrawal by Subject|0|||
145926657|NCT00812981|526239465|FG000|Overall Study|Other|0|||
145926658|NCT00812981|526239466|FG001|Overall Study|Other|1|||
145926659|NCT04666259|526239467|FG000|Treatment Phase|Physician Decision|9|||
145926660|NCT04666259|526239468|FG001|Treatment Phase|Physician Decision|3|||
145926661|NCT04666259|526239469|FG002|Treatment Phase|Physician Decision|3|||
145926662|NCT04666259|526239467|FG000|Treatment Phase|Adverse Event|3|||
145926663|NCT04666259|526239468|FG001|Treatment Phase|Adverse Event|1|||
145926664|NCT04666259|526239469|FG002|Treatment Phase|Adverse Event|0|||
145926665|NCT04666259|526239467|FG000|Treatment Phase|Subject decision|1|||
145926666|NCT04666259|526239468|FG001|Treatment Phase|Subject decision|2|||
145926667|NCT04666259|526239469|FG002|Treatment Phase|Subject decision|0|||
145926668|NCT04666259|526239467|FG000|Treatment Phase|Progressive disease|0|||
145926669|NCT04666259|526239468|FG001|Treatment Phase|Progressive disease|1|||
145926670|NCT04666259|526239469|FG002|Treatment Phase|Progressive disease|0|||
145926671|NCT04666259|526239467|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
145926672|NCT04666259|526239468|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
145926673|NCT04666259|526239469|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
145926674|NCT04666259|526239467|FG000|Safety Follow-up Phase|Physician Decision|2|||
145926675|NCT04666259|526239468|FG001|Safety Follow-up Phase|Physician Decision|0|||
145926676|NCT04666259|526239469|FG002|Safety Follow-up Phase|Physician Decision|0|||
145926677|NCT04666259|526239467|FG000|Safety Follow-up Phase|Subject decision|1|||
145926678|NCT04666259|526239468|FG001|Safety Follow-up Phase|Subject decision|0|||
145926679|NCT04666259|526239469|FG002|Safety Follow-up Phase|Subject decision|0|||
145926680|NCT04666259|526239467|FG000|Safety Follow-up Phase|Death|0|||
145926681|NCT04666259|526239468|FG001|Safety Follow-up Phase|Death|1|||
145926682|NCT04666259|526239469|FG002|Safety Follow-up Phase|Death|0|||
145926683|NCT04178122|526239470|FG000|Overall Study|Withdrawal by Subject|1|||
145926684|NCT04178122|526239471|FG001|Overall Study|Withdrawal by Subject|1|||
145926685|NCT04178122|526239470|FG000|Overall Study|Death|2|||
145926686|NCT04178122|526239471|FG001|Overall Study|Death|0|||
145926687|NCT04178122|526239470|FG000|Overall Study|Did not complete testing|3|||
145977388|NCT02875080|526428139|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
145977389|NCT02875080|526428140|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
145977390|NCT02394756|526428141|FG000|Period 1|Lens Discomfort|0|||
145977391|NCT02394756|526428142|FG001|Period 1|Lens Discomfort|0|||
146243228|NCT05074433|527405355|FG002|Overall Study|Sponsor Request|1|||
145926688|NCT04178122|526239471|FG001|Overall Study|Did not complete testing|13|||
145926689|NCT02677922|526239472|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
145926690|NCT02677922|526239473|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
145926691|NCT02677922|526239474|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
145926692|NCT02677922|526239475|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
145926693|NCT02677922|526239476|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
145926694|NCT02677922|526239477|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
145926695|NCT02677922|526239472|FG000|Treatment Period|Adverse Event|0|||
145926696|NCT02677922|526239473|FG001|Treatment Period|Adverse Event|0|||
145926697|NCT02677922|526239474|FG002|Treatment Period|Adverse Event|1|||
145926698|NCT02677922|526239475|FG003|Treatment Period|Adverse Event|3|||
145926699|NCT02677922|526239476|FG004|Treatment Period|Adverse Event|5|||
145926700|NCT02677922|526239477|FG005|Treatment Period|Adverse Event|2|||
145977392|NCT02394756|526428143|FG002|Period 1|Lens Discomfort|0|||
146090566|NCT01897714|526852618|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
146090567|NCT01897714|526852619|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
146090568|NCT01897714|526852620|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
146090569|NCT01897714|526852621|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
146090570|NCT01897714|526852622|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
146090571|NCT01897714|526852623|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
146090572|NCT01897714|526852618|FG000|Phase II (MTD)|Other|0|||
146090573|NCT01897714|526852619|FG001|Phase II (MTD)|Other|0|||
146090574|NCT01897714|526852620|FG002|Phase II (MTD)|Other|0|||
146090575|NCT01897714|526852621|FG003|Phase II (MTD)|Other|0|||
146090576|NCT01897714|526852622|FG004|Phase II (MTD)|Other|3|||
146090577|NCT01897714|526852623|FG005|Phase II (MTD)|Other|0|||
146090578|NCT01994590|526852624|FG000|Overall Study|Adverse Event|1|||
146090579|NCT01994590|526852624|FG000|Overall Study|Trial Terminated|1|||
146090580|NCT01801072|526852625|FG000|Overall Study|Lost to Follow-up|17|||
146090581|NCT01801072|526852626|FG001|Overall Study|Lost to Follow-up|14|||
146090582|NCT01801072|526852625|FG000|Overall Study|Physician Decision|2|||
146243229|NCT05074433|527405356|FG003|Overall Study|Sponsor Request|0|||
145926701|NCT02677922|526239472|FG000|Treatment Period|Progressive Disease|1|||
145926702|NCT02677922|526239473|FG001|Treatment Period|Progressive Disease|1|||
145926703|NCT02677922|526239474|FG002|Treatment Period|Progressive Disease|0|||
145926704|NCT02677922|526239475|FG003|Treatment Period|Progressive Disease|0|||
145926705|NCT02677922|526239476|FG004|Treatment Period|Progressive Disease|8|||
145926706|NCT02677922|526239477|FG005|Treatment Period|Progressive Disease|7|||
145926707|NCT02677922|526239472|FG000|Treatment Period|Lack of Efficacy|0|||
145926708|NCT02677922|526239473|FG001|Treatment Period|Lack of Efficacy|0|||
145926709|NCT02677922|526239474|FG002|Treatment Period|Lack of Efficacy|0|||
145926710|NCT02677922|526239475|FG003|Treatment Period|Lack of Efficacy|1|||
145926711|NCT02677922|526239476|FG004|Treatment Period|Lack of Efficacy|1|||
145926712|NCT02677922|526239477|FG005|Treatment Period|Lack of Efficacy|6|||
145926713|NCT02677922|526239472|FG000|Treatment Period|Withdrawal by Subject|0|||
145926714|NCT02677922|526239473|FG001|Treatment Period|Withdrawal by Subject|0|||
145926715|NCT02677922|526239474|FG002|Treatment Period|Withdrawal by Subject|1|||
145926716|NCT02677922|526239475|FG003|Treatment Period|Withdrawal by Subject|3|||
145926717|NCT02677922|526239476|FG004|Treatment Period|Withdrawal by Subject|5|||
145926718|NCT02677922|526239477|FG005|Treatment Period|Withdrawal by Subject|5|||
145926719|NCT02677922|526239472|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
145926720|NCT02677922|526239473|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
145926721|NCT02677922|526239474|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
145926722|NCT02677922|526239475|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
145926723|NCT02677922|526239476|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
145926724|NCT02677922|526239477|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
145926725|NCT02677922|526239472|FG000|Treatment Period|Disease Relapse|0|||
145926726|NCT02677922|526239473|FG001|Treatment Period|Disease Relapse|0|||
145926727|NCT02677922|526239474|FG002|Treatment Period|Disease Relapse|0|||
145926728|NCT02677922|526239475|FG003|Treatment Period|Disease Relapse|3|||
145926729|NCT02677922|526239476|FG004|Treatment Period|Disease Relapse|6|||
145926730|NCT02677922|526239477|FG005|Treatment Period|Disease Relapse|1|||
145926731|NCT02677922|526239472|FG000|Treatment Period|Allogeneic HSCT|1|||
145926732|NCT02677922|526239473|FG001|Treatment Period|Allogeneic HSCT|0|||
145926733|NCT02677922|526239474|FG002|Treatment Period|Allogeneic HSCT|0|||
145926734|NCT02677922|526239475|FG003|Treatment Period|Allogeneic HSCT|1|||
145926735|NCT02677922|526239476|FG004|Treatment Period|Allogeneic HSCT|4|||
145926736|NCT02677922|526239477|FG005|Treatment Period|Allogeneic HSCT|1|||
145926737|NCT02677922|526239472|FG000|Treatment Period|Other Reasons|0|||
145926738|NCT02677922|526239473|FG001|Treatment Period|Other Reasons|0|||
145926739|NCT02677922|526239474|FG002|Treatment Period|Other Reasons|0|||
145926740|NCT02677922|526239475|FG003|Treatment Period|Other Reasons|1|||
145926741|NCT02677922|526239476|FG004|Treatment Period|Other Reasons|3|||
146090583|NCT01801072|526852626|FG001|Overall Study|Physician Decision|3|||
146090584|NCT01801072|526852625|FG000|Overall Study|Withdrawal by Subject|1|||
146090585|NCT01801072|526852626|FG001|Overall Study|Withdrawal by Subject|0|||
146090586|NCT01801072|526852625|FG000|Overall Study|Protocol Violation|2|||
146090587|NCT01801072|526852626|FG001|Overall Study|Protocol Violation|0|||
146090588|NCT01801072|526852625|FG000|Overall Study|Death|7|||
145926742|NCT02677922|526239477|FG005|Treatment Period|Other Reasons|5|||
145926743|NCT02677922|526239472|FG000|Treatment Period|Death|0|||
146090589|NCT01801072|526852626|FG001|Overall Study|Death|8|||
146090590|NCT03693170|526852627|FG000|Overall Study|Disease Progression|48|||
146090591|NCT03693170|526852627|FG000|Overall Study|Adverse Event|16|||
146090592|NCT03693170|526852627|FG000|Overall Study|Physician Decision|6|||
146090593|NCT03693170|526852627|FG000|Overall Study|Protocol Violation|2|||
145926744|NCT02677922|526239473|FG001|Treatment Period|Death|0|||
145926745|NCT02677922|526239474|FG002|Treatment Period|Death|0|||
145926746|NCT02677922|526239475|FG003|Treatment Period|Death|0|||
145926747|NCT02677922|526239476|FG004|Treatment Period|Death|12|||
145926748|NCT02677922|526239477|FG005|Treatment Period|Death|1|||
145926749|NCT02677922|526239472|FG000|Treatment Period|Non-compliance with Study Drug|0|||
145926750|NCT02677922|526239473|FG001|Treatment Period|Non-compliance with Study Drug|0|||
145926751|NCT02677922|526239474|FG002|Treatment Period|Non-compliance with Study Drug|0|||
145926752|NCT02677922|526239475|FG003|Treatment Period|Non-compliance with Study Drug|0|||
145926753|NCT02677922|526239476|FG004|Treatment Period|Non-compliance with Study Drug|1|||
145926754|NCT02677922|526239477|FG005|Treatment Period|Non-compliance with Study Drug|0|||
145926755|NCT02677922|526239472|FG000|Treatment Period|Physician Decision|0|||
145926756|NCT02677922|526239473|FG001|Treatment Period|Physician Decision|0|||
145926757|NCT02677922|526239474|FG002|Treatment Period|Physician Decision|0|||
145926758|NCT02677922|526239475|FG003|Treatment Period|Physician Decision|0|||
145926759|NCT02677922|526239476|FG004|Treatment Period|Physician Decision|0|||
145926760|NCT02677922|526239477|FG005|Treatment Period|Physician Decision|1|||
145926761|NCT02677922|526239472|FG000|Treatment Period|Symptomatic Deterioration|0|||
145926762|NCT02677922|526239473|FG001|Treatment Period|Symptomatic Deterioration|0|||
145926763|NCT02677922|526239474|FG002|Treatment Period|Symptomatic Deterioration|0|||
145926764|NCT02677922|526239475|FG003|Treatment Period|Symptomatic Deterioration|0|||
145926765|NCT02677922|526239476|FG004|Treatment Period|Symptomatic Deterioration|1|||
145926766|NCT02677922|526239477|FG005|Treatment Period|Symptomatic Deterioration|0|||
145926767|NCT05343364|526239485|FG000|Overall Study|Miscellaneous|0|||
145926768|NCT05343364|526239486|FG001|Overall Study|Miscellaneous|1|||
145926769|NCT03331796|526239487|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
145926770|NCT03331796|526239488|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
145926771|NCT03331796|526239489|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
145926772|NCT03331796|526239487|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
145926773|NCT03331796|526239488|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
145926774|NCT03331796|526239489|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
145926775|NCT03331796|526239487|FG000|Extended Follow-up|Adverse Event|1|||
145926776|NCT03331796|526239488|FG001|Extended Follow-up|Adverse Event|0|||
145926777|NCT03331796|526239489|FG002|Extended Follow-up|Adverse Event|1|||
145926778|NCT03331796|526239487|FG000|Extended Follow-up|Lost to Follow-up|0|||
145926779|NCT03331796|526239488|FG001|Extended Follow-up|Lost to Follow-up|0|||
145926780|NCT03331796|526239489|FG002|Extended Follow-up|Lost to Follow-up|1|||
145926781|NCT03331796|526239487|FG000|Extended Follow-up|Withdrawal by Subject|1|||
145926782|NCT03331796|526239488|FG001|Extended Follow-up|Withdrawal by Subject|0|||
145926783|NCT03331796|526239489|FG002|Extended Follow-up|Withdrawal by Subject|0|||
145926784|NCT03331796|526239487|FG000|Extended Follow-up|Termination of Funding|0|||
145926785|NCT03331796|526239488|FG001|Extended Follow-up|Termination of Funding|1|||
145926786|NCT03331796|526239489|FG002|Extended Follow-up|Termination of Funding|0|||
145926787|NCT01753570|526239490|FG000|Overall Study|Adverse Event|1|||
145926788|NCT01753570|526239491|FG001|Overall Study|Adverse Event|0|||
145926789|NCT01753570|526239492|FG002|Overall Study|Adverse Event|1|||
145926790|NCT01753570|526239490|FG000|Overall Study|Physician Decision|0|||
145926791|NCT01753570|526239491|FG001|Overall Study|Physician Decision|1|||
145926792|NCT01753570|526239492|FG002|Overall Study|Physician Decision|0|||
145926793|NCT01753570|526239490|FG000|Overall Study|Withdrawal by Subject|1|||
145926794|NCT01753570|526239491|FG001|Overall Study|Withdrawal by Subject|4|||
145926795|NCT01753570|526239492|FG002|Overall Study|Withdrawal by Subject|0|||
145926796|NCT01791894|526239499|FG000|Overall Study|Adverse Event|1|||
145926797|NCT02268916|526239502|FG000|Overall Study|Lost to Follow-up|1|||
145926798|NCT02268916|526239503|FG001|Overall Study|Lost to Follow-up|1|||
145926799|NCT02268916|526239502|FG000|Overall Study|Withdrawal by Subject|6|||
145926800|NCT02268916|526239503|FG001|Overall Study|Withdrawal by Subject|5|||
145977393|NCT02394756|526428144|FG003|Period 1|Lens Discomfort|0|||
145977394|NCT02394756|526428145|FG004|Period 1|Lens Discomfort|0|||
145977395|NCT02394756|526428146|FG005|Period 1|Lens Discomfort|1|||
145977396|NCT02394756|526428141|FG000|Period 1|Withdrawal by Subject|0|||
145977397|NCT02394756|526428142|FG001|Period 1|Withdrawal by Subject|1|||
145977398|NCT02394756|526428143|FG002|Period 1|Withdrawal by Subject|1|||
145977399|NCT02394756|526428144|FG003|Period 1|Withdrawal by Subject|1|||
145977400|NCT02394756|526428145|FG004|Period 1|Withdrawal by Subject|0|||
145977401|NCT02394756|526428146|FG005|Period 1|Withdrawal by Subject|0|||
145926801|NCT02268916|526239502|FG000|Overall Study|Participant did not have diabetes|1|||
145926802|NCT02268916|526239503|FG001|Overall Study|Participant did not have diabetes|0|||
145926803|NCT02268916|526239502|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
145926804|NCT02268916|526239503|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
145926805|NCT04830969|526239509|FG000|Overall Study|Withdrawal by Subject|6|||
145926806|NCT04830969|526239510|FG001|Overall Study|Withdrawal by Subject|2|||
145926807|NCT04830969|526239509|FG000|Overall Study|Protocol Violation|3|||
145926808|NCT04830969|526239510|FG001|Overall Study|Protocol Violation|9|||
145926809|NCT04830969|526239509|FG000|Overall Study|Lost to Follow-up|4|||
145926810|NCT04830969|526239510|FG001|Overall Study|Lost to Follow-up|4|||
145977402|NCT02394756|526428141|FG000|Period 2|Unsatisfactory Visual Response|0|||
145977403|NCT02394756|526428142|FG001|Period 2|Unsatisfactory Visual Response|0|||
145977404|NCT02394756|526428143|FG002|Period 2|Unsatisfactory Visual Response|0|||
145977405|NCT02394756|526428144|FG003|Period 2|Unsatisfactory Visual Response|0|||
145977406|NCT02394756|526428145|FG004|Period 2|Unsatisfactory Visual Response|1|||
145977407|NCT02394756|526428146|FG005|Period 2|Unsatisfactory Visual Response|0|||
145977408|NCT00768053|526428147|FG000|Overall Study|Adverse Event|10|||
145977409|NCT00768053|526428147|FG000|Overall Study|Lost to Follow-up|1|||
145977410|NCT01164475|526428148|FG000|Overall Study|Lack of Efficacy|1|||
145977411|NCT01164475|526428149|FG001|Overall Study|Lack of Efficacy|0|||
145977412|NCT01164475|526428148|FG000|Overall Study|Other|0|||
145977413|NCT01164475|526428149|FG001|Overall Study|Other|1|||
145977414|NCT01164475|526428148|FG000|Overall Study|Progressive disease|0|||
146090594|NCT03693170|526852627|FG000|Overall Study|Death|1|||
146090595|NCT03693170|526852627|FG000|Overall Study|Non compliance with study drug|1|||
146090596|NCT03693170|526852627|FG000|Overall Study|Withdrawal by Subject|1|||
146090597|NCT03868124|526852630|FG000|Overall Study|Withdrawal by Subject|4|||
146090598|NCT03868124|526852631|FG001|Overall Study|Withdrawal by Subject|0|||
146090599|NCT03868124|526852632|FG002|Overall Study|Withdrawal by Subject|1|||
146090600|NCT03868124|526852630|FG000|Overall Study|Physician Decision|1|||
146090601|NCT03868124|526852631|FG001|Overall Study|Physician Decision|0|||
146090602|NCT03868124|526852632|FG002|Overall Study|Physician Decision|1|||
146090603|NCT03868124|526852630|FG000|Overall Study|Lost to Follow-up|1|||
146090604|NCT03868124|526852631|FG001|Overall Study|Lost to Follow-up|1|||
146090605|NCT03868124|526852632|FG002|Overall Study|Lost to Follow-up|2|||
146090606|NCT03868124|526852630|FG000|Overall Study|Death|1|||
145926811|NCT01422889|526239511|FG000|Overall Study|No Data Entered for Study Stent|9|||
146090607|NCT03868124|526852631|FG001|Overall Study|Death|1|||
146090608|NCT03868124|526852632|FG002|Overall Study|Death|2|||
146090609|NCT03868124|526852630|FG000|Overall Study|Adverse Event|0|||
146090610|NCT03868124|526852631|FG001|Overall Study|Adverse Event|0|||
146090611|NCT03868124|526852632|FG002|Overall Study|Adverse Event|3|||
146090612|NCT03868124|526852630|FG000|Overall Study|Explanted|2|||
146090613|NCT03868124|526852631|FG001|Overall Study|Explanted|1|||
146090614|NCT03868124|526852632|FG002|Overall Study|Explanted|0|||
146090615|NCT03868124|526852630|FG000|Overall Study|Ongoing in study|176|||
146090616|NCT03868124|526852631|FG001|Overall Study|Ongoing in study|180|||
146090617|NCT03868124|526852632|FG002|Overall Study|Ongoing in study|183|||
146090618|NCT00427960|526852633|FG000|Overall Study|Adverse Event|2|||
146090619|NCT00427960|526852634|FG001|Overall Study|Adverse Event|0|||
146090620|NCT00427960|526852633|FG000|Overall Study|Withdrawal by Subject|0|||
146090621|NCT00427960|526852634|FG001|Overall Study|Withdrawal by Subject|3|||
146090622|NCT00427960|526852633|FG000|Overall Study|Other|0|||
146090623|NCT00427960|526852634|FG001|Overall Study|Other|1|||
146090624|NCT00423670|526852635|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
146090625|NCT00423670|526852636|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
146243230|NCT05074433|527405353|FG000|Overall Study|Death|1|||
146243231|NCT05074433|527405354|FG001|Overall Study|Death|0|||
145926812|NCT01580670|526239512|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
145926813|NCT01580670|526239512|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
145926814|NCT02748356|526239513|FG000|Overall Study|Withdrawal by Subject|1|||
145926815|NCT00996125|526239514|FG000|Overall Study|Adverse Event|0|||
145926816|NCT00996125|526239515|FG001|Overall Study|Adverse Event|2|||
145926817|NCT00996125|526239514|FG000|Overall Study|Lost to Follow-up|1|||
145926818|NCT00996125|526239515|FG001|Overall Study|Lost to Follow-up|6|||
145926819|NCT00996125|526239514|FG000|Overall Study|Withdrawal by Subject|4|||
145926820|NCT00996125|526239515|FG001|Overall Study|Withdrawal by Subject|3|||
145926821|NCT00488644|526239517|FG000|Overall Study|Not Eligible|1|||
145926822|NCT00488644|526239517|FG000|Overall Study|Not Evaluable|1|||
145926823|NCT04331067|526239518|FG000|Overall Study|Adverse Event|1|||
145977415|NCT01164475|526428149|FG001|Overall Study|Progressive disease|1|||
145977416|NCT01164475|526428148|FG000|Overall Study|Protocol Violation|1|||
145977417|NCT01164475|526428149|FG001|Overall Study|Protocol Violation|0|||
145977418|NCT02335944|526428150|FG000|Treatment Phase|Progressive Disease|2|||
146090626|NCT00423670|526852637|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
146090627|NCT00423670|526852638|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
146090628|NCT00423670|526852639|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
146090629|NCT00423670|526852640|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
146243232|NCT05074433|527405355|FG002|Overall Study|Death|0|||
146243233|NCT05074433|527405356|FG003|Overall Study|Death|0|||
146243234|NCT05074433|527405353|FG000|Overall Study|Lost to Follow-up|0|||
145926824|NCT04331067|526239519|FG001|Overall Study|Adverse Event|3|||
145926825|NCT04331067|526239520|FG002|Overall Study|Adverse Event|1|||
146090630|NCT00423670|526852641|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
146090631|NCT00423670|526852642|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
146090632|NCT00423670|526852635|FG000|Treatment Period|Adverse Event|8|||
146090633|NCT00423670|526852636|FG001|Treatment Period|Adverse Event|12|||
146090634|NCT00423670|526852637|FG002|Treatment Period|Adverse Event|15|||
146090635|NCT00423670|526852638|FG003|Treatment Period|Adverse Event|20|||
145977419|NCT02335944|526428151|FG001|Treatment Phase|Progressive Disease|5|||
145977420|NCT02335944|526428152|FG002|Treatment Phase|Progressive Disease|2|||
146090636|NCT00423670|526852639|FG004|Treatment Period|Adverse Event|9|||
146090637|NCT00423670|526852640|FG005|Treatment Period|Adverse Event|4|||
146243235|NCT05074433|527405354|FG001|Overall Study|Lost to Follow-up|0|||
146090638|NCT00423670|526852641|FG006|Treatment Period|Adverse Event|7|||
146090639|NCT00423670|526852642|FG007|Treatment Period|Adverse Event|2|||
146090640|NCT00423670|526852635|FG000|Treatment Period|Protocol-defined clinical event|0|||
146090641|NCT00423670|526852636|FG001|Treatment Period|Protocol-defined clinical event|7|||
146090642|NCT00423670|526852637|FG002|Treatment Period|Protocol-defined clinical event|4|||
145926826|NCT04331067|526239518|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
145926827|NCT04331067|526239519|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
145926828|NCT04331067|526239520|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
145926829|NCT02203721|526239525|FG000|Overall Study|Lost to Follow-up|1|||
145926830|NCT02203721|526239526|FG001|Overall Study|Lost to Follow-up|0|||
145926831|NCT02203721|526239525|FG000|Overall Study|Death|0|||
145926832|NCT02203721|526239526|FG001|Overall Study|Death|2|||
145926833|NCT02203721|526239525|FG000|Overall Study|Illness|0|||
145926834|NCT02203721|526239526|FG001|Overall Study|Illness|1|||
145926835|NCT04745689|526239527|FG000|Overall Study|Death|9|||
145926836|NCT04745689|526239528|FG001|Overall Study|Death|6|||
145926837|NCT04745689|526239527|FG000|Overall Study|Lost to Follow-up|1|||
145926838|NCT04745689|526239528|FG001|Overall Study|Lost to Follow-up|0|||
145926839|NCT04745689|526239527|FG000|Overall Study|Withdrawal by Subject|2|||
145926840|NCT04745689|526239528|FG001|Overall Study|Withdrawal by Subject|0|||
145926841|NCT04745689|526239527|FG000|Overall Study|Study terminated by sponsor|10|||
145926842|NCT04745689|526239528|FG001|Overall Study|Study terminated by sponsor|3|||
145926843|NCT00153179|526239529|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
145926844|NCT00153179|526239530|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
145926845|NCT00153179|526239531|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
146090643|NCT00423670|526852638|FG003|Treatment Period|Protocol-defined clinical event|12|||
146090644|NCT00423670|526852639|FG004|Treatment Period|Protocol-defined clinical event|5|||
146090645|NCT00423670|526852640|FG005|Treatment Period|Protocol-defined clinical event|4|||
146090646|NCT00423670|526852641|FG006|Treatment Period|Protocol-defined clinical event|16|||
146243236|NCT05074433|527405355|FG002|Overall Study|Lost to Follow-up|2|||
146243237|NCT05074433|527405356|FG003|Overall Study|Lost to Follow-up|0|||
146243238|NCT05074433|527405353|FG000|Overall Study|Subject Decision|8|||
146243239|NCT05074433|527405354|FG001|Overall Study|Subject Decision|6|||
146243240|NCT05074433|527405355|FG002|Overall Study|Subject Decision|4|||
146243241|NCT05074433|527405356|FG003|Overall Study|Subject Decision|5|||
146243242|NCT04397263|527405357|FG000|Overall Study|Withdrawal by Subject|2|||
146243243|NCT03026166|527405365|FG000|Overall Study|Death|22|||
146243244|NCT03026166|527405366|FG001|Overall Study|Death|7|||
146243245|NCT03026166|527405365|FG000|Overall Study|Physician Decision|2|||
146243246|NCT03026166|527405366|FG001|Overall Study|Physician Decision|0|||
146243247|NCT03026166|527405365|FG000|Overall Study|Withdrawal by Subject|1|||
146243248|NCT03026166|527405366|FG001|Overall Study|Withdrawal by Subject|2|||
146243249|NCT03026166|527405365|FG000|Overall Study|Lost to Follow-up|1|||
146243250|NCT03026166|527405366|FG001|Overall Study|Lost to Follow-up|0|||
146243251|NCT03026166|527405365|FG000|Overall Study|Study Terminated by Sponsor|3|||
146243252|NCT03026166|527405366|FG001|Overall Study|Study Terminated by Sponsor|3|||
146243253|NCT03026166|527405365|FG000|Overall Study|Other|1|||
146243254|NCT03026166|527405366|FG001|Overall Study|Other|0|||
146243255|NCT05270460|527405369|FG000|Overall Study|Adverse Event|0|||
146243256|NCT05270460|527405370|FG001|Overall Study|Adverse Event|1|||
146243257|NCT05270460|527405371|FG002|Overall Study|Adverse Event|0|||
146243258|NCT05270460|527405369|FG000|Overall Study|Early Termination|0|||
146243259|NCT05270460|527405370|FG001|Overall Study|Early Termination|1|||
146243260|NCT05270460|527405371|FG002|Overall Study|Early Termination|0|||
146243261|NCT00380250|527405372|FG000|Overall Study|Withdrawal by Subject|39|||
146243262|NCT00380250|527405373|FG001|Overall Study|Withdrawal by Subject|28|||
146243263|NCT00380250|527405372|FG000|Overall Study|Adverse Event|20|||
146243264|NCT00380250|527405373|FG001|Overall Study|Adverse Event|9|||
146243265|NCT00380250|527405372|FG000|Overall Study|Lack of Efficacy|10|||
146243266|NCT00380250|527405373|FG001|Overall Study|Lack of Efficacy|8|||
146243267|NCT00380250|527405372|FG000|Overall Study|Protocol Violation|15|||
146243268|NCT00380250|527405373|FG001|Overall Study|Protocol Violation|5|||
146243269|NCT00380250|527405372|FG000|Overall Study|Lost to Follow-up|14|||
146243270|NCT00380250|527405373|FG001|Overall Study|Lost to Follow-up|5|||
146243271|NCT00380250|527405372|FG000|Overall Study|Physician Decision|1|||
145926846|NCT00153179|526239532|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
145926847|NCT01408303|526239533|FG000|Overall Study|Adverse Event|3|||
145926848|NCT01408303|526239534|FG001|Overall Study|Adverse Event|7|||
145926849|NCT01408303|526239535|FG002|Overall Study|Adverse Event|2|||
145926850|NCT01408303|526239533|FG000|Overall Study|Lost to Follow-up|0|||
145926851|NCT01408303|526239534|FG001|Overall Study|Lost to Follow-up|1|||
145926852|NCT01408303|526239535|FG002|Overall Study|Lost to Follow-up|2|||
146090647|NCT00423670|526852642|FG007|Treatment Period|Protocol-defined clinical event|15|||
146243272|NCT00380250|527405373|FG001|Overall Study|Physician Decision|0|||
146243273|NCT05613088|527405374|FG000|Treatment|Ongoing Study Treatment|9|||
145926853|NCT01408303|526239533|FG000|Overall Study|Withdrawal by Subject|2|||
146243274|NCT05613088|527405375|FG001|Treatment|Ongoing Study Treatment|2|||
146243275|NCT05613088|527405374|FG000|Treatment|Adverse Event|3|||
145926854|NCT01408303|526239534|FG001|Overall Study|Withdrawal by Subject|3|||
145926855|NCT01408303|526239535|FG002|Overall Study|Withdrawal by Subject|1|||
145926856|NCT01408303|526239533|FG000|Overall Study|Protocol Violation|0|||
145926857|NCT01408303|526239534|FG001|Overall Study|Protocol Violation|1|||
145926858|NCT01408303|526239535|FG002|Overall Study|Protocol Violation|0|||
145926859|NCT01408303|526239533|FG000|Overall Study|Noncompliance|1|||
145926860|NCT01408303|526239534|FG001|Overall Study|Noncompliance|0|||
145926861|NCT01408303|526239535|FG002|Overall Study|Noncompliance|1|||
145926862|NCT00669669|526239536|FG000|Overall Study|To late to start treatment|1|||
145926863|NCT01205776|526239540|FG000|Overall Study|Lost to Follow-up|53|||
145926864|NCT01205776|526239541|FG001|Overall Study|Lost to Follow-up|61|||
145926865|NCT01205776|526239540|FG000|Overall Study|Withdrawal by Subject|11|||
145926866|NCT01205776|526239541|FG001|Overall Study|Withdrawal by Subject|34|||
145926867|NCT04031846|526239542|FG000|Overall Study|Lost to Follow-up|4|||
145926868|NCT04031846|526239543|FG001|Overall Study|Lost to Follow-up|4|||
145926869|NCT04031846|526239542|FG000|Overall Study|Physician Decision|0|||
145926870|NCT04031846|526239543|FG001|Overall Study|Physician Decision|1|||
145926871|NCT04031846|526239542|FG000|Overall Study|Protocol Violation|1|||
145926872|NCT04031846|526239543|FG001|Overall Study|Protocol Violation|1|||
145926873|NCT04031846|526239542|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
145926874|NCT04031846|526239543|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
145926875|NCT03782792|526241354|FG000|Overall Study|Patient left the country|0|||
145926876|NCT03782792|526241355|FG001|Overall Study|Patient left the country|1|||
145926877|NCT03782792|526241354|FG000|Overall Study|Withdrawal by Subject|1|||
145926878|NCT03782792|526241355|FG001|Overall Study|Withdrawal by Subject|2|||
145926879|NCT05271370|526241356|FG000|Overall Study|Study early termination|8|||
145926880|NCT05271370|526241357|FG001|Overall Study|Study early termination|16|||
145926881|NCT05271370|526241358|FG002|Overall Study|Study early termination|29|||
145926882|NCT03048747|526241360|FG000|Overall Study|Adverse Event|2|||
145926883|NCT03048747|526241360|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
145977421|NCT02335944|526428153|FG003|Treatment Phase|Progressive Disease|11|||
145977422|NCT02335944|526428154|FG004|Treatment Phase|Progressive Disease|4|||
145977423|NCT02335944|526428155|FG005|Treatment Phase|Progressive Disease|25|||
145977424|NCT02335944|526428156|FG006|Treatment Phase|Progressive Disease|2|||
145977425|NCT02335944|526428157|FG007|Treatment Phase|Progressive Disease|30|||
145977426|NCT02335944|526428158|FG008|Treatment Phase|Progressive Disease|27|||
145977427|NCT02335944|526428159|FG009|Treatment Phase|Progressive Disease|0|||
145977428|NCT02335944|526428150|FG000|Treatment Phase|Adverse Event|2|||
145977429|NCT02335944|526428151|FG001|Treatment Phase|Adverse Event|0|||
145977430|NCT02335944|526428152|FG002|Treatment Phase|Adverse Event|0|||
145977431|NCT02335944|526428153|FG003|Treatment Phase|Adverse Event|2|||
145977432|NCT02335944|526428154|FG004|Treatment Phase|Adverse Event|1|||
145977433|NCT02335944|526428155|FG005|Treatment Phase|Adverse Event|15|||
145977434|NCT02335944|526428156|FG006|Treatment Phase|Adverse Event|0|||
145977435|NCT02335944|526428157|FG007|Treatment Phase|Adverse Event|5|||
145977436|NCT02335944|526428158|FG008|Treatment Phase|Adverse Event|7|||
145977437|NCT02335944|526428159|FG009|Treatment Phase|Adverse Event|0|||
145977438|NCT02335944|526428150|FG000|Treatment Phase|Physician Decision|0|||
145977439|NCT02335944|526428151|FG001|Treatment Phase|Physician Decision|0|||
145977440|NCT02335944|526428152|FG002|Treatment Phase|Physician Decision|0|||
145977441|NCT02335944|526428153|FG003|Treatment Phase|Physician Decision|1|||
145977442|NCT02335944|526428154|FG004|Treatment Phase|Physician Decision|0|||
145977443|NCT02335944|526428155|FG005|Treatment Phase|Physician Decision|6|||
145977444|NCT02335944|526428156|FG006|Treatment Phase|Physician Decision|1|||
145977445|NCT02335944|526428157|FG007|Treatment Phase|Physician Decision|2|||
145977446|NCT02335944|526428158|FG008|Treatment Phase|Physician Decision|1|||
145977447|NCT02335944|526428159|FG009|Treatment Phase|Physician Decision|0|||
145977448|NCT02335944|526428150|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
145977449|NCT02335944|526428151|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
145977450|NCT02335944|526428152|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
146243276|NCT05613088|527405375|FG001|Treatment|Adverse Event|1|||
145926884|NCT03048747|526241360|FG000|Overall Study|Physician Decision|1|||
145926885|NCT01295671|526241367|FG000|Overall Study|Lost to Follow-up|4|||
145977451|NCT02335944|526428153|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
145977452|NCT02335944|526428154|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
145977453|NCT02335944|526428155|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
145977454|NCT02335944|526428156|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
145977455|NCT02335944|526428157|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
145977456|NCT02335944|526428158|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
145926886|NCT01295671|526241368|FG001|Overall Study|Lost to Follow-up|6|||
145926887|NCT01295671|526241369|FG002|Overall Study|Lost to Follow-up|3|||
145926888|NCT01295671|526241367|FG000|Overall Study|Withdrawal by Subject|3|||
145926889|NCT01295671|526241368|FG001|Overall Study|Withdrawal by Subject|1|||
145926890|NCT01295671|526241369|FG002|Overall Study|Withdrawal by Subject|0|||
145926891|NCT01436370|526241372|FG000|Overall Study|Lost to Follow-up|0|||
146243277|NCT05613088|527405374|FG000|Treatment|Other Reasons|0|||
145926892|NCT01436370|526241373|FG001|Overall Study|Lost to Follow-up|0|||
145926893|NCT01436370|526241374|FG002|Overall Study|Lost to Follow-up|0|||
145926894|NCT01436370|526241375|FG003|Overall Study|Lost to Follow-up|0|||
145926895|NCT01436370|526241376|FG004|Overall Study|Lost to Follow-up|1|||
145926896|NCT01436370|526241377|FG005|Overall Study|Lost to Follow-up|0|||
145926897|NCT01436370|526241378|FG006|Overall Study|Lost to Follow-up|0|||
145926898|NCT01436370|526241379|FG007|Overall Study|Lost to Follow-up|0|||
145926899|NCT02395848|526241380|FG000|Overall Study|Lost to Follow-up|2|||
145926900|NCT01754129|526241381|FG000|Overall Study|Death|13|||
145926901|NCT01754129|526241381|FG000|Overall Study|Duodopa discontinuation|9|||
145926902|NCT01754129|526241381|FG000|Overall Study|Lost to Follow-up|7|||
145926903|NCT01754129|526241381|FG000|Overall Study|Withdrew consent|1|||
145926904|NCT01754129|526241381|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
145926905|NCT02276560|526241382|FG000|Overall Study|Adverse Event|1|||
145926906|NCT02276560|526241383|FG001|Overall Study|Adverse Event|0|||
145926907|NCT02276560|526241384|FG002|Overall Study|Adverse Event|0|||
145926908|NCT00651261|526241386|FG000|Overall Study|Adverse Event|32|||
145926909|NCT00651261|526241387|FG001|Overall Study|Adverse Event|22|||
145926910|NCT00651261|526241386|FG000|Overall Study|Death|18|||
145926911|NCT00651261|526241387|FG001|Overall Study|Death|18|||
145926912|NCT00651261|526241386|FG000|Overall Study|Withdrawal by Subject|22|||
145926913|NCT00651261|526241387|FG001|Overall Study|Withdrawal by Subject|40|||
145926914|NCT00651261|526241386|FG000|Overall Study|Induction failure|24|||
145926915|NCT00651261|526241387|FG001|Overall Study|Induction failure|35|||
145926916|NCT00651261|526241386|FG000|Overall Study|Disease progression|58|||
145926917|NCT00651261|526241387|FG001|Overall Study|Disease progression|58|||
145926918|NCT00651261|526241386|FG000|Overall Study|Alternative therapy|109|||
145926919|NCT00651261|526241387|FG001|Overall Study|Alternative therapy|107|||
145926920|NCT00651261|526241386|FG000|Overall Study|Other disease or participant decisions|23|||
145926921|NCT00651261|526241387|FG001|Overall Study|Other disease or participant decisions|23|||
145926922|NCT00651261|526241386|FG000|Overall Study|Never treated|5|||
145926923|NCT00651261|526241387|FG001|Overall Study|Never treated|3|||
145926924|NCT01134107|526241389|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
145926925|NCT01134107|526241390|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
145926926|NCT01134107|526241389|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
145926927|NCT01134107|526241390|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
145926928|NCT01134107|526241389|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
145926929|NCT01134107|526241390|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
145926930|NCT01134107|526241389|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
145926931|NCT01134107|526241390|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
145926932|NCT01134107|526241389|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
145926933|NCT01134107|526241390|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
145926934|NCT01134107|526241389|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
145926935|NCT01134107|526241390|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
145926936|NCT01134107|526241389|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
145926937|NCT01134107|526241390|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
145926938|NCT00687271|526241391|FG000|Overall Study|Adverse Event|1|||
145926939|NCT00687271|526241392|FG001|Overall Study|Adverse Event|3|||
145926940|NCT00687271|526241393|FG002|Overall Study|Adverse Event|1|||
145926941|NCT00687271|526241394|FG003|Overall Study|Adverse Event|0|||
145926942|NCT00687271|526241391|FG000|Overall Study|Lost to Follow-up|0|||
145926943|NCT00687271|526241392|FG001|Overall Study|Lost to Follow-up|1|||
145926944|NCT00687271|526241393|FG002|Overall Study|Lost to Follow-up|0|||
145926945|NCT00687271|526241394|FG003|Overall Study|Lost to Follow-up|0|||
145926946|NCT00687271|526241391|FG000|Overall Study|Protocol Violation|2|||
145926947|NCT00687271|526241392|FG001|Overall Study|Protocol Violation|1|||
145926948|NCT00687271|526241393|FG002|Overall Study|Protocol Violation|1|||
145926949|NCT00687271|526241394|FG003|Overall Study|Protocol Violation|0|||
145926950|NCT00687271|526241391|FG000|Overall Study|Withdrawal by Subject|0|||
145926951|NCT00687271|526241392|FG001|Overall Study|Withdrawal by Subject|1|||
145926952|NCT00687271|526241393|FG002|Overall Study|Withdrawal by Subject|3|||
145926953|NCT00687271|526241394|FG003|Overall Study|Withdrawal by Subject|0|||
145926954|NCT05483686|526241395|FG000|Overall Study|Lost to Follow-up|5|||
145926955|NCT05483686|526241396|FG001|Overall Study|Lost to Follow-up|7|||
146243278|NCT05613088|527405375|FG001|Treatment|Other Reasons|1|||
146243279|NCT05613088|527405374|FG000|Treatment|Progressive Disease|58|||
146243280|NCT05613088|527405375|FG001|Treatment|Progressive Disease|26|||
146243281|NCT05613088|527405374|FG000|Treatment|Withdrawal by Subject|0|||
146243282|NCT05613088|527405375|FG001|Treatment|Withdrawal by Subject|4|||
145926956|NCT05780983|526241397|FG000|Overall Study|Withdrawal by Subject|1|||
145926957|NCT04541589|526241398|FG000|Treatment Period|Adverse Event|8|||
145926958|NCT04541589|526241399|FG001|Treatment Period|Adverse Event|2|||
145926959|NCT04541589|526241398|FG000|Treatment Period|Physician Decision|3|||
145926960|NCT04541589|526241399|FG001|Treatment Period|Physician Decision|1|||
145926961|NCT04541589|526241398|FG000|Treatment Period|Subject decision|7|||
145926962|NCT04541589|526241399|FG001|Treatment Period|Subject decision|4|||
145926963|NCT04541589|526241398|FG000|Treatment Period|Withdrawal by Subject|1|||
146090648|NCT00423670|526852635|FG000|Treatment Period|Lost to Follow-up|2|||
146090649|NCT00423670|526852636|FG001|Treatment Period|Lost to Follow-up|1|||
146090650|NCT00423670|526852637|FG002|Treatment Period|Lost to Follow-up|3|||
146090651|NCT00423670|526852638|FG003|Treatment Period|Lost to Follow-up|1|||
146090652|NCT00423670|526852639|FG004|Treatment Period|Lost to Follow-up|6|||
146090653|NCT00423670|526852640|FG005|Treatment Period|Lost to Follow-up|0|||
146090654|NCT00423670|526852641|FG006|Treatment Period|Lost to Follow-up|3|||
146090655|NCT00423670|526852642|FG007|Treatment Period|Lost to Follow-up|1|||
146090656|NCT00423670|526852635|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
145926964|NCT04541589|526241399|FG001|Treatment Period|Withdrawal by Subject|0|||
145926965|NCT04541589|526241398|FG000|Safety Follow-up Period|Adverse Event|2|||
145926966|NCT04541589|526241399|FG001|Safety Follow-up Period|Adverse Event|1|||
145926967|NCT04541589|526241398|FG000|Safety Follow-up Period|Physician Decision|1|||
145926968|NCT04541589|526241399|FG001|Safety Follow-up Period|Physician Decision|0|||
145926969|NCT04541589|526241398|FG000|Safety Follow-up Period|Subject decision|5|||
145926970|NCT04541589|526241399|FG001|Safety Follow-up Period|Subject decision|3|||
145926971|NCT04541589|526241398|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
145926972|NCT04541589|526241399|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
145926973|NCT02727478|526241400|FG000|Overall Study|Withdrawal by Subject|8|||
145926974|NCT02727478|526241401|FG001|Overall Study|Withdrawal by Subject|10|||
145926975|NCT02633293|526241402|FG000|Overall Study|Death|56|||
145926976|NCT02633293|526241402|FG000|Overall Study|Progressive Disease|12|||
145926977|NCT02633293|526241402|FG000|Overall Study|Adverse Event|29|||
145926978|NCT02633293|526241402|FG000|Overall Study|Withdrawal by Subject|41|||
145926979|NCT02633293|526241402|FG000|Overall Study|Protocol Violation|1|||
145926980|NCT02633293|526241402|FG000|Overall Study|Lost to Follow-up|1|||
145926981|NCT02633293|526241402|FG000|Overall Study|Study Terminated by Sponsor|24|||
145926982|NCT02633293|526241402|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
145926983|NCT02633293|526241402|FG000|Overall Study|Lung Transplant|5|||
145926984|NCT02633293|526241402|FG000|Overall Study|Lack of Efficacy|2|||
145926985|NCT02633293|526241402|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
145926986|NCT01017874|526241403|FG000|Overall Study|Withdrawal by Subject|23|||
145926987|NCT01017874|526241404|FG001|Overall Study|Withdrawal by Subject|20|||
145926988|NCT01017874|526241403|FG000|Overall Study|Sponsor decision|3|||
145926989|NCT01017874|526241404|FG001|Overall Study|Sponsor decision|1|||
145926990|NCT01017874|526241403|FG000|Overall Study|Lost to Follow-up|3|||
145926991|NCT01017874|526241404|FG001|Overall Study|Lost to Follow-up|2|||
145926992|NCT01017874|526241403|FG000|Overall Study|Physician Decision|1|||
145926993|NCT01017874|526241404|FG001|Overall Study|Physician Decision|3|||
145926994|NCT00808210|526241405|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
145926995|NCT00808210|526241406|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
145926996|NCT00808210|526241405|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
145926997|NCT00808210|526241406|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
145926998|NCT00808210|526241405|FG000|Double-Blind TX Period|Adverse Event|0|||
145926999|NCT00808210|526241406|FG001|Double-Blind TX Period|Adverse Event|1|||
145927000|NCT00808210|526241405|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
145927001|NCT00808210|526241406|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
145927002|NCT00808210|526241405|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
145927003|NCT00808210|526241406|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
145927004|NCT00808210|526241405|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
145927005|NCT00808210|526241406|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
145927006|NCT00778817|526241411|FG000|Overall Study|Adverse Event|2|||
145927007|NCT00778817|526241411|FG000|Overall Study|Withdrawal by Subject|2|||
145927008|NCT01372618|526241412|FG000|Overall Study|PI Died. Study Terminated|9|||
145927009|NCT02914613|526241417|FG000|Overall Study|Withdrawal by Subject|1|||
145927010|NCT02914613|526241418|FG001|Overall Study|Withdrawal by Subject|2|||
145927011|NCT02914613|526241417|FG000|Overall Study|Adverse Event|1|||
145927012|NCT02914613|526241418|FG001|Overall Study|Adverse Event|0|||
145927013|NCT01455597|526241421|FG000|Overall Study|Adverse Event|7|||
145927014|NCT01455597|526241422|FG001|Overall Study|Adverse Event|0|||
145927015|NCT01455597|526241423|FG002|Overall Study|Adverse Event|5|||
145927016|NCT01455597|526241424|FG003|Overall Study|Adverse Event|1|||
145927017|NCT01455597|526241421|FG000|Overall Study|Lack of Efficacy|0|||
145927018|NCT01455597|526241422|FG001|Overall Study|Lack of Efficacy|1|||
145927019|NCT01455597|526241423|FG002|Overall Study|Lack of Efficacy|2|||
145927020|NCT01455597|526241424|FG003|Overall Study|Lack of Efficacy|0|||
146243283|NCT01668719|527405376|FG000|Phase I|On treatment|1|||
145927021|NCT01455597|526241421|FG000|Overall Study|Lost to Follow-up|3|||
145927022|NCT01455597|526241422|FG001|Overall Study|Lost to Follow-up|0|||
145927023|NCT01455597|526241423|FG002|Overall Study|Lost to Follow-up|2|||
145927024|NCT01455597|526241424|FG003|Overall Study|Lost to Follow-up|1|||
145927025|NCT01455597|526241421|FG000|Overall Study|Withdrew Consent|6|||
145927026|NCT01455597|526241422|FG001|Overall Study|Withdrew Consent|5|||
146243284|NCT01668719|527405377|FG001|Phase I|On treatment|0|||
145927027|NCT01455597|526241423|FG002|Overall Study|Withdrew Consent|8|||
145927028|NCT01455597|526241424|FG003|Overall Study|Withdrew Consent|5|||
145927029|NCT01455597|526241421|FG000|Overall Study|Reason not Specified|1|||
145927030|NCT01455597|526241422|FG001|Overall Study|Reason not Specified|2|||
145927031|NCT01455597|526241423|FG002|Overall Study|Reason not Specified|3|||
145927032|NCT01455597|526241424|FG003|Overall Study|Reason not Specified|3|||
145927033|NCT00441129|526241425|FG000|Overall Study|Withdrawal by Subject|6|||
145927034|NCT00441129|526241426|FG001|Overall Study|Withdrawal by Subject|14|||
145927035|NCT03850496|526241427|FG000|Overall Study|Withdrawal by Subject|1|||
145927036|NCT03850496|526241428|FG001|Overall Study|Withdrawal by Subject|0|||
145927037|NCT03850496|526241429|FG002|Overall Study|Withdrawal by Subject|0|||
145927038|NCT03850496|526241427|FG000|Overall Study|Lost to Follow-up|0|||
145927039|NCT03850496|526241428|FG001|Overall Study|Lost to Follow-up|1|||
145927040|NCT03850496|526241429|FG002|Overall Study|Lost to Follow-up|4|||
145927041|NCT02527434|526241431|FG000|Overall Study|Lost to Follow-up|2|||
145927042|NCT02527434|526241432|FG001|Overall Study|Lost to Follow-up|2|||
145927043|NCT02527434|526241433|FG002|Overall Study|Lost to Follow-up|0|||
145927044|NCT02527434|526241431|FG000|Overall Study|Death|19|||
145927045|NCT02527434|526241432|FG001|Overall Study|Death|6|||
145927046|NCT02527434|526241433|FG002|Overall Study|Death|17|||
145927047|NCT02527434|526241431|FG000|Overall Study|Withdrawal by Subject|5|||
145927048|NCT02527434|526241432|FG001|Overall Study|Withdrawal by Subject|3|||
145927049|NCT02527434|526241433|FG002|Overall Study|Withdrawal by Subject|3|||
145927050|NCT02527434|526241431|FG000|Overall Study|Reason Not Specified|1|||
145927051|NCT02527434|526241432|FG001|Overall Study|Reason Not Specified|0|||
145927052|NCT02527434|526241433|FG002|Overall Study|Reason Not Specified|0|||
145927053|NCT02527434|526241431|FG000|Overall Study|Site closure|1|||
145927054|NCT02527434|526241432|FG001|Overall Study|Site closure|0|||
145927055|NCT02527434|526241433|FG002|Overall Study|Site closure|0|||
145927056|NCT05027451|526241434|FG000|Overall Study|Lost to Follow-up|1|||
145927057|NCT05027451|526241435|FG001|Overall Study|Lost to Follow-up|1|||
145927058|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
145927059|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145927060|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145927061|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145927062|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145927063|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145927064|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
145927065|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
145927066|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145927067|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145927068|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145927069|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145927070|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
145927071|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
145927072|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927073|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927074|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927075|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927076|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145927077|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145927078|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927079|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927080|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927081|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927082|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
145927083|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
145927084|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145927085|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145927086|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145927087|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145927088|NCT02105987|526241440|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
146243285|NCT01668719|527405378|FG002|Phase I|On treatment|0|||
145927089|NCT02105987|526241441|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
145927090|NCT02105987|526241442|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145927091|NCT02105987|526241443|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145927092|NCT02105987|526241444|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145927093|NCT02105987|526241445|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145927094|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145927095|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145927096|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
145927097|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
145927098|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145927099|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145927100|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145927101|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145927102|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
145927103|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
145927104|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145927105|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145927106|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927107|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927108|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
145927109|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
145927110|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927111|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145927112|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927113|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927114|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
145927115|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145927116|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927117|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145927118|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145927119|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145927120|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
145927121|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145927122|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145927123|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145927124|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145927125|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145927126|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145927127|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
145927128|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145927129|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145927130|NCT02105987|526241440|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145927131|NCT02105987|526241441|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145927132|NCT02105987|526241442|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
145927133|NCT02105987|526241443|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145927134|NCT02105987|526241444|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145927135|NCT02105987|526241445|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145927136|NCT02105987|526241440|FG000|Continuation Phase|Protocol Violation|0|||
145927137|NCT02105987|526241441|FG001|Continuation Phase|Protocol Violation|0|||
145927138|NCT02105987|526241442|FG002|Continuation Phase|Protocol Violation|0|||
145927139|NCT02105987|526241443|FG003|Continuation Phase|Protocol Violation|0|||
145927140|NCT02105987|526241444|FG004|Continuation Phase|Protocol Violation|1|||
145927141|NCT02105987|526241445|FG005|Continuation Phase|Protocol Violation|0|||
145927142|NCT03926117|526241452|FG000|Overall Study|Unclassified|1|||
145927143|NCT03926117|526241453|FG001|Overall Study|Unclassified|4|||
145927144|NCT03926117|526241454|FG002|Overall Study|Unclassified|1|||
145927145|NCT03926117|526241455|FG003|Overall Study|Unclassified|4|||
145927146|NCT03926117|526241452|FG000|Overall Study|Withdrawal by Subject|3|||
145927147|NCT03926117|526241453|FG001|Overall Study|Withdrawal by Subject|0|||
145927148|NCT03926117|526241454|FG002|Overall Study|Withdrawal by Subject|1|||
145927149|NCT03926117|526241455|FG003|Overall Study|Withdrawal by Subject|1|||
145927150|NCT03926117|526241452|FG000|Overall Study|Lost to Follow-up|0|||
145927151|NCT03926117|526241453|FG001|Overall Study|Lost to Follow-up|2|||
145927152|NCT03926117|526241454|FG002|Overall Study|Lost to Follow-up|1|||
145927153|NCT03926117|526241455|FG003|Overall Study|Lost to Follow-up|0|||
145927154|NCT03926117|526241452|FG000|Overall Study|Adverse Event|1|||
145927155|NCT03926117|526241453|FG001|Overall Study|Adverse Event|2|||
145927156|NCT03926117|526241454|FG002|Overall Study|Adverse Event|3|||
145927157|NCT03926117|526241455|FG003|Overall Study|Adverse Event|1|||
145927158|NCT03926117|526241452|FG000|Overall Study|Randomized but not treated|1|||
145927159|NCT03926117|526241453|FG001|Overall Study|Randomized but not treated|1|||
145927160|NCT03926117|526241454|FG002|Overall Study|Randomized but not treated|0|||
145927161|NCT03926117|526241455|FG003|Overall Study|Randomized but not treated|1|||
145927162|NCT05107492|526241462|FG000|Overall Study|Lost to Follow-up|1|||
145927163|NCT05107492|526241463|FG001|Overall Study|Lost to Follow-up|0|||
145927164|NCT05236764|526241464|FG000|Overall Study|In follow up (ongoing)|1|||
145927165|NCT05236764|526241464|FG000|Overall Study|Taken off study - secondary graft failure|1|||
145927166|NCT05236764|526241464|FG000|Overall Study|Death|1|||
145927167|NCT05870371|526241465|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
145927168|NCT05870371|526241466|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
145927169|NCT04495751|526241470|FG000|Overall Study|Withdrawal by Subject|1|||
145927170|NCT04495751|526241471|FG001|Overall Study|Withdrawal by Subject|0|||
145927171|NCT04495751|526241470|FG000|Overall Study|Lost to Follow-up|1|||
145927172|NCT04495751|526241471|FG001|Overall Study|Lost to Follow-up|0|||
145927173|NCT03289754|526241472|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
145927174|NCT03584854|526241473|FG000|Overall Study|Primary outcome not measured|1|||
145927175|NCT03584854|526241474|FG001|Overall Study|Primary outcome not measured|2|||
145927176|NCT02670525|526241475|FG000|Overall Study|Death|94|||
145927177|NCT02670525|526241476|FG001|Overall Study|Death|14|||
145927178|NCT02670525|526241475|FG000|Overall Study|Lost to Follow-up|4|||
145927179|NCT02670525|526241476|FG001|Overall Study|Lost to Follow-up|1|||
145927180|NCT02670525|526241475|FG000|Overall Study|Subject withdrew consent|1|||
145927181|NCT02670525|526241476|FG001|Overall Study|Subject withdrew consent|0|||
145927182|NCT02670525|526241475|FG000|Overall Study|Unknown, data entry delayed|123|||
145927183|NCT02670525|526241476|FG001|Overall Study|Unknown, data entry delayed|78|||
145927184|NCT01796392|526241477|FG000|Overall Study|Withdrawal by Subject|2|||
145927185|NCT01796392|526241478|FG001|Overall Study|Withdrawal by Subject|0|||
145927186|NCT01796392|526241477|FG000|Overall Study|Death|5|||
145927187|NCT01796392|526241478|FG001|Overall Study|Death|1|||
145927188|NCT01796392|526241477|FG000|Overall Study|Excluded for medical reasons|1|||
145927189|NCT01796392|526241478|FG001|Overall Study|Excluded for medical reasons|2|||
145927190|NCT01796392|526241477|FG000|Overall Study|Lost to Follow-up|1|||
145927191|NCT01796392|526241478|FG001|Overall Study|Lost to Follow-up|0|||
145927192|NCT02505217|526241479|FG000|Overall Study|Withdrawal by Subject|1|||
145927193|NCT02505217|526241480|FG001|Overall Study|Withdrawal by Subject|2|||
145927194|NCT04639219|526241481|FG000|Overall Study|Withdrawal by Subject|8|||
145927195|NCT04639219|526241481|FG000|Overall Study|Lost to Follow-up|6|||
145927196|NCT04639219|526241481|FG000|Overall Study|Death|55|||
145927197|NCT04681066|526241482|FG000|Overall Study|Lost to Follow-up|3|||
145927198|NCT04681066|526241483|FG001|Overall Study|Lost to Follow-up|1|||
145927199|NCT04681066|526241484|FG002|Overall Study|Lost to Follow-up|2|||
145927200|NCT04681066|526241485|FG003|Overall Study|Lost to Follow-up|1|||
145927201|NCT04681066|526241482|FG000|Overall Study|Withdrawal by Subject|2|||
145927202|NCT04681066|526241483|FG001|Overall Study|Withdrawal by Subject|1|||
145927203|NCT04681066|526241484|FG002|Overall Study|Withdrawal by Subject|0|||
145927204|NCT04681066|526241485|FG003|Overall Study|Withdrawal by Subject|3|||
145927205|NCT04681066|526241482|FG000|Overall Study|Death|0|||
145927206|NCT04681066|526241483|FG001|Overall Study|Death|1|||
145927207|NCT04681066|526241484|FG002|Overall Study|Death|0|||
145927208|NCT04681066|526241485|FG003|Overall Study|Death|0|||
145927209|NCT03517540|526241494|FG000|Overall Study|Protocol Violation|2|||
145927210|NCT03517540|526241495|FG001|Overall Study|Protocol Violation|0|||
145927211|NCT03517540|526241496|FG002|Overall Study|Protocol Violation|0|||
145927212|NCT03517540|526241497|FG003|Overall Study|Protocol Violation|1|||
145927213|NCT03517540|526241494|FG000|Overall Study|Adverse Event|9|||
145927214|NCT03517540|526241495|FG001|Overall Study|Adverse Event|3|||
145927215|NCT03517540|526241496|FG002|Overall Study|Adverse Event|8|||
145927216|NCT03517540|526241497|FG003|Overall Study|Adverse Event|1|||
145927217|NCT03517540|526241494|FG000|Overall Study|Withdrawal by Subject|3|||
145927218|NCT03517540|526241495|FG001|Overall Study|Withdrawal by Subject|4|||
145927219|NCT03517540|526241496|FG002|Overall Study|Withdrawal by Subject|1|||
145927220|NCT03517540|526241497|FG003|Overall Study|Withdrawal by Subject|3|||
145927221|NCT00564850|526241502|FG000|Overall Study|Protocol Violation|2|||
145977457|NCT02335944|526428159|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
145977458|NCT02335944|526428150|FG000|Treatment Phase|Subject/Guardian Decision|0|||
145977459|NCT02335944|526428151|FG001|Treatment Phase|Subject/Guardian Decision|0|||
145977460|NCT02335944|526428152|FG002|Treatment Phase|Subject/Guardian Decision|1|||
145977461|NCT02335944|526428153|FG003|Treatment Phase|Subject/Guardian Decision|0|||
145977462|NCT02335944|526428154|FG004|Treatment Phase|Subject/Guardian Decision|0|||
145977463|NCT02335944|526428155|FG005|Treatment Phase|Subject/Guardian Decision|1|||
145977464|NCT02335944|526428156|FG006|Treatment Phase|Subject/Guardian Decision|0|||
145977465|NCT02335944|526428157|FG007|Treatment Phase|Subject/Guardian Decision|4|||
145977466|NCT02335944|526428158|FG008|Treatment Phase|Subject/Guardian Decision|0|||
145977467|NCT02335944|526428159|FG009|Treatment Phase|Subject/Guardian Decision|0|||
145927222|NCT02640664|526241503|FG000|Epoch 1|Withdrawal of informed consent|1|||
145977468|NCT02335944|526428150|FG000|Post-treatment Follow-up|Progressive Disease|0|||
145927223|NCT02640664|526241504|FG001|Epoch 1|Withdrawal of informed consent|0|||
145927224|NCT02640664|526241505|FG002|Epoch 1|Withdrawal of informed consent|0|||
145927225|NCT02640664|526241503|FG000|Epoch 1|Death|0|||
145927226|NCT02640664|526241504|FG001|Epoch 1|Death|0|||
145927227|NCT02640664|526241505|FG002|Epoch 1|Death|1|||
145927228|NCT02640664|526241503|FG000|Epoch 2|Withdrawal of informed consent|3|||
145927229|NCT02640664|526241504|FG001|Epoch 2|Withdrawal of informed consent|4|||
145927230|NCT02640664|526241505|FG002|Epoch 2|Withdrawal of informed consent|2|||
145927231|NCT02640664|526241503|FG000|Epoch 2|Subject/guardian decision|0|||
145927232|NCT02640664|526241504|FG001|Epoch 2|Subject/guardian decision|2|||
145927233|NCT02640664|526241505|FG002|Epoch 2|Subject/guardian decision|2|||
145977469|NCT02335944|526428151|FG001|Post-treatment Follow-up|Progressive Disease|0|||
145927234|NCT02640664|526241503|FG000|Epoch 2|Lost to Follow-up|3|||
145977470|NCT02335944|526428152|FG002|Post-treatment Follow-up|Progressive Disease|0|||
145927235|NCT02640664|526241504|FG001|Epoch 2|Lost to Follow-up|4|||
145927236|NCT02640664|526241505|FG002|Epoch 2|Lost to Follow-up|1|||
145927237|NCT02640664|526241503|FG000|Epoch 2|Death|0|||
145927238|NCT02640664|526241504|FG001|Epoch 2|Death|0|||
145927239|NCT02640664|526241505|FG002|Epoch 2|Death|1|||
145927240|NCT00314327|526241506|FG000|Overall Study|Withdrawal by Subject|1|||
145927241|NCT01205269|526241507|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145927242|NCT01205269|526241508|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145927243|NCT01205269|526241509|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145927244|NCT01205269|526241510|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
145927245|NCT01205269|526241511|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145927246|NCT01205269|526241512|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145927247|NCT01207687|526241513|FG000|Overall Study|Adverse Event|1|||
145927248|NCT01207687|526241513|FG000|Overall Study|Withdrawal by Subject|1|||
145927249|NCT00987337|526241514|FG000|Overall Study|Adverse Event|10|||
145927250|NCT00987337|526241515|FG001|Overall Study|Adverse Event|9|||
145927251|NCT00987337|526241516|FG002|Overall Study|Adverse Event|8|||
145927252|NCT00987337|526241514|FG000|Overall Study|Insufficient Virologic Response|10|||
145927253|NCT00987337|526241515|FG001|Overall Study|Insufficient Virologic Response|7|||
145927254|NCT00987337|526241516|FG002|Overall Study|Insufficient Virologic Response|12|||
145927255|NCT00987337|526241514|FG000|Overall Study|Virologic Breakthrough|2|||
145927256|NCT00987337|526241515|FG001|Overall Study|Virologic Breakthrough|2|||
145927257|NCT00987337|526241516|FG002|Overall Study|Virologic Breakthrough|8|||
145927258|NCT00987337|526241514|FG000|Overall Study|Lost to Follow-up|10|||
145927259|NCT00987337|526241515|FG001|Overall Study|Lost to Follow-up|6|||
145927260|NCT00987337|526241516|FG002|Overall Study|Lost to Follow-up|2|||
145927261|NCT00987337|526241514|FG000|Overall Study|Withdrawal by Subject|6|||
145927262|NCT00987337|526241515|FG001|Overall Study|Withdrawal by Subject|9|||
145927263|NCT00987337|526241516|FG002|Overall Study|Withdrawal by Subject|9|||
145927264|NCT00987337|526241514|FG000|Overall Study|Other|0|||
145927265|NCT00987337|526241515|FG001|Overall Study|Other|2|||
145927266|NCT00987337|526241516|FG002|Overall Study|Other|5|||
145927267|NCT00987337|526241514|FG000|Overall Study|Protocol Violation|1|||
145927268|NCT00987337|526241515|FG001|Overall Study|Protocol Violation|0|||
145927269|NCT00987337|526241516|FG002|Overall Study|Protocol Violation|2|||
145927270|NCT00987337|526241514|FG000|Overall Study|Participant Relapsed|18|||
145927271|NCT00987337|526241515|FG001|Overall Study|Participant Relapsed|20|||
145927272|NCT00987337|526241516|FG002|Overall Study|Participant Relapsed|5|||
145927273|NCT01801865|526241518|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
145927274|NCT01801865|526241518|FG000|Overall Study|Physician Decision|7|||
145927275|NCT00433511|526243400|FG000|Step 1|Adverse Event|50|||
145927276|NCT00433511|526243401|FG001|Step 1|Adverse Event|157|||
145927277|NCT00433511|526243402|FG002|Step 1|Adverse Event|153|||
145927278|NCT00433511|526243400|FG000|Step 1|Withdrawal by Subject|45|||
145927279|NCT00433511|526243401|FG001|Step 1|Withdrawal by Subject|143|||
145927280|NCT00433511|526243402|FG002|Step 1|Withdrawal by Subject|154|||
145927281|NCT00433511|526243400|FG000|Step 1|Death|3|||
145927282|NCT00433511|526243401|FG001|Step 1|Death|1|||
145927283|NCT00433511|526243402|FG002|Step 1|Death|1|||
145927284|NCT00433511|526243400|FG000|Step 1|Physician Decision|1|||
145927285|NCT00433511|526243401|FG001|Step 1|Physician Decision|4|||
145927286|NCT00433511|526243402|FG002|Step 1|Physician Decision|3|||
145927287|NCT00433511|526243400|FG000|Step 1|Never started protocol therapy|28|||
145927288|NCT00433511|526243401|FG001|Step 1|Never started protocol therapy|64|||
145927289|NCT00433511|526243402|FG002|Step 1|Never started protocol therapy|66|||
145927290|NCT00433511|526243400|FG000|Step 1|Alternative therapy|2|||
145927291|NCT00433511|526243401|FG001|Step 1|Alternative therapy|1|||
145927292|NCT00433511|526243402|FG002|Step 1|Alternative therapy|3|||
145927293|NCT00433511|526243400|FG000|Step 1|Disease progression, relapse|5|||
145927294|NCT00433511|526243401|FG001|Step 1|Disease progression, relapse|3|||
145927295|NCT00433511|526243402|FG002|Step 1|Disease progression, relapse|3|||
145927296|NCT00433511|526243400|FG000|Step 1|Other complicating disease|2|||
145927297|NCT00433511|526243401|FG001|Step 1|Other complicating disease|6|||
145927298|NCT00433511|526243402|FG002|Step 1|Other complicating disease|3|||
145927299|NCT00433511|526243400|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
145927300|NCT00433511|526243401|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
145927301|NCT00433511|526243402|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
145927302|NCT00433511|526243400|FG000|Step 1|Suspected recurrence|0|||
145927303|NCT00433511|526243401|FG001|Step 1|Suspected recurrence|1|||
145927304|NCT00433511|526243402|FG002|Step 1|Suspected recurrence|0|||
145927305|NCT00433511|526243400|FG000|Step 1|Insurance/drug distribution issues|0|||
145927306|NCT00433511|526243401|FG001|Step 1|Insurance/drug distribution issues|1|||
145927307|NCT00433511|526243402|FG002|Step 1|Insurance/drug distribution issues|2|||
145927308|NCT00433511|526243400|FG000|Step 1|Patient moved|0|||
145927309|NCT00433511|526243401|FG001|Step 1|Patient moved|0|||
145927310|NCT00433511|526243402|FG002|Step 1|Patient moved|1|||
145927311|NCT00433511|526243400|FG000|Step 2 (Arm D)|Adverse Event|0|||
145927312|NCT00433511|526243401|FG001|Step 2 (Arm D)|Adverse Event|0|||
145927313|NCT00433511|526243402|FG002|Step 2 (Arm D)|Adverse Event|135|||
145927314|NCT00433511|526243400|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
145927315|NCT00433511|526243401|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
145927316|NCT00433511|526243402|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
145927317|NCT00433511|526243400|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
145927318|NCT00433511|526243401|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
145927319|NCT00433511|526243402|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
145927320|NCT00433511|526243400|FG000|Step 2 (Arm D)|Physician Decision|0|||
145927321|NCT00433511|526243401|FG001|Step 2 (Arm D)|Physician Decision|0|||
145927322|NCT00433511|526243402|FG002|Step 2 (Arm D)|Physician Decision|9|||
145927323|NCT00433511|526243400|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
145927324|NCT00433511|526243401|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
145927325|NCT00433511|526243402|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
145927326|NCT00433511|526243400|FG000|Step 2 (Arm D)|Other complicating disease|0|||
145927327|NCT00433511|526243401|FG001|Step 2 (Arm D)|Other complicating disease|0|||
145927328|NCT00433511|526243402|FG002|Step 2 (Arm D)|Other complicating disease|3|||
145927329|NCT00433511|526243400|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
145927330|NCT00433511|526243401|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
145927331|NCT00433511|526243402|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
145927332|NCT00433511|526243400|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
145927333|NCT00433511|526243401|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
145927334|NCT00433511|526243402|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
145927335|NCT00433511|526243400|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
145927336|NCT00433511|526243401|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
145927337|NCT00433511|526243402|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
145927338|NCT00433511|526243400|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
145927339|NCT00433511|526243401|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
145927340|NCT00433511|526243402|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
145927341|NCT02151851|526243405|FG000|Overall Study|Lack of Efficacy|67|||
145927342|NCT02151851|526243406|FG001|Overall Study|Lack of Efficacy|94|||
145927343|NCT02151851|526243405|FG000|Overall Study|Protocol Violation|0|||
145927344|NCT02151851|526243406|FG001|Overall Study|Protocol Violation|1|||
145927345|NCT02151851|526243405|FG000|Overall Study|Withdrawal by Subject|2|||
145927346|NCT02151851|526243406|FG001|Overall Study|Withdrawal by Subject|5|||
145927347|NCT02151851|526243405|FG000|Overall Study|Medical impairment|1|||
145927348|NCT02151851|526243406|FG001|Overall Study|Medical impairment|0|||
145927349|NCT02151851|526243405|FG000|Overall Study|Low compliance to study visits|0|||
145927350|NCT02151851|526243406|FG001|Overall Study|Low compliance to study visits|1|||
145927351|NCT02151851|526243405|FG000|Overall Study|Subject entered into study in error|0|||
145927352|NCT02151851|526243406|FG001|Overall Study|Subject entered into study in error|1|||
145927353|NCT02151851|526243405|FG000|Overall Study|Adverse Event|6|||
145927354|NCT02151851|526243406|FG001|Overall Study|Adverse Event|28|||
145927355|NCT02159053|526243407|FG000|Overall Study|Death|2|||
145927356|NCT02159053|526243408|FG001|Overall Study|Death|0|||
145927357|NCT02159053|526243409|FG002|Overall Study|Death|1|||
145927358|NCT02159053|526243407|FG000|Overall Study|Physician Decision|0|||
145927359|NCT02159053|526243408|FG001|Overall Study|Physician Decision|1|||
145927360|NCT02159053|526243409|FG002|Overall Study|Physician Decision|1|||
145927361|NCT02159053|526243407|FG000|Overall Study|Lack of Efficacy|3|||
145927362|NCT02159053|526243408|FG001|Overall Study|Lack of Efficacy|4|||
145927363|NCT02159053|526243409|FG002|Overall Study|Lack of Efficacy|7|||
145927364|NCT02159053|526243407|FG000|Overall Study|Adverse Event|7|||
145927365|NCT02159053|526243408|FG001|Overall Study|Adverse Event|6|||
145927366|NCT02159053|526243409|FG002|Overall Study|Adverse Event|5|||
145927367|NCT02159053|526243407|FG000|Overall Study|Participants/guardian decision|8|||
145927368|NCT02159053|526243408|FG001|Overall Study|Participants/guardian decision|10|||
145927369|NCT02159053|526243409|FG002|Overall Study|Participants/guardian decision|6|||
145927370|NCT01540487|526243410|FG000|Overall Study|Protocol Violation|1|||
145927371|NCT01540487|526243411|FG001|Overall Study|Protocol Violation|0|||
145927372|NCT00617890|526243412|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
145927373|NCT00617890|526243413|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
145927374|NCT00617890|526243414|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
145927375|NCT00617890|526243415|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
145927376|NCT00617890|526243412|FG000|Overall Study|Lack of Efficacy|23|||
145927377|NCT00617890|526243413|FG001|Overall Study|Lack of Efficacy|26|||
145927378|NCT00617890|526243414|FG002|Overall Study|Lack of Efficacy|30|||
145927379|NCT00617890|526243415|FG003|Overall Study|Lack of Efficacy|97|||
145927380|NCT00617890|526243412|FG000|Overall Study|Lost to Follow-up|0|||
145927381|NCT00617890|526243413|FG001|Overall Study|Lost to Follow-up|0|||
145927382|NCT00617890|526243414|FG002|Overall Study|Lost to Follow-up|1|||
145927383|NCT00617890|526243415|FG003|Overall Study|Lost to Follow-up|2|||
145927384|NCT00617890|526243412|FG000|Overall Study|Withdrawal by Subject|4|||
145927385|NCT00617890|526243413|FG001|Overall Study|Withdrawal by Subject|1|||
145927386|NCT00617890|526243414|FG002|Overall Study|Withdrawal by Subject|0|||
145927387|NCT00617890|526243415|FG003|Overall Study|Withdrawal by Subject|2|||
145927388|NCT00617890|526243412|FG000|Overall Study|Protocol Violation|2|||
145927389|NCT00617890|526243413|FG001|Overall Study|Protocol Violation|1|||
145977471|NCT02335944|526428153|FG003|Post-treatment Follow-up|Progressive Disease|1|||
145977472|NCT02335944|526428154|FG004|Post-treatment Follow-up|Progressive Disease|0|||
145977473|NCT02335944|526428155|FG005|Post-treatment Follow-up|Progressive Disease|9|||
145977474|NCT02335944|526428156|FG006|Post-treatment Follow-up|Progressive Disease|0|||
145927390|NCT00617890|526243414|FG002|Overall Study|Protocol Violation|0|||
145927391|NCT00617890|526243415|FG003|Overall Study|Protocol Violation|0|||
145927392|NCT00617890|526243412|FG000|Overall Study|Adverse Event|1|||
145927393|NCT00617890|526243413|FG001|Overall Study|Adverse Event|0|||
145927394|NCT00617890|526243414|FG002|Overall Study|Adverse Event|3|||
145927395|NCT00617890|526243415|FG003|Overall Study|Adverse Event|8|||
145927396|NCT00617890|526243412|FG000|Overall Study|Not treated|1|||
145927397|NCT00617890|526243413|FG001|Overall Study|Not treated|0|||
145927398|NCT00617890|526243414|FG002|Overall Study|Not treated|1|||
145927399|NCT00617890|526243415|FG003|Overall Study|Not treated|1|||
145927400|NCT03503370|526243416|FG000|Overall Study|Death|3|||
145927401|NCT03503370|526243417|FG001|Overall Study|Death|1|||
145927402|NCT03483961|526243418|FG000|Overall Study|Lost to Follow-up|7|||
145927403|NCT03483961|526243419|FG001|Overall Study|Lost to Follow-up|6|||
145927404|NCT03483961|526243420|FG002|Overall Study|Lost to Follow-up|6|||
145927405|NCT03483961|526243421|FG003|Overall Study|Lost to Follow-up|6|||
145927406|NCT03483961|526243422|FG004|Overall Study|Lost to Follow-up|6|||
145927407|NCT03483961|526243423|FG005|Overall Study|Lost to Follow-up|4|||
145927408|NCT03483961|526243424|FG006|Overall Study|Lost to Follow-up|4|||
145927409|NCT03483961|526243425|FG007|Overall Study|Lost to Follow-up|11|||
145927410|NCT03483961|526243426|FG008|Overall Study|Lost to Follow-up|1|||
145927411|NCT03483961|526243427|FG009|Overall Study|Lost to Follow-up|0|||
145927412|NCT03483961|526243418|FG000|Overall Study|Withdrawal by Subject|3|||
145927413|NCT03483961|526243419|FG001|Overall Study|Withdrawal by Subject|4|||
145927414|NCT03483961|526243420|FG002|Overall Study|Withdrawal by Subject|5|||
145927415|NCT03483961|526243421|FG003|Overall Study|Withdrawal by Subject|3|||
145927416|NCT03483961|526243422|FG004|Overall Study|Withdrawal by Subject|4|||
145927417|NCT03483961|526243423|FG005|Overall Study|Withdrawal by Subject|2|||
145927418|NCT03483961|526243424|FG006|Overall Study|Withdrawal by Subject|1|||
145927419|NCT03483961|526243425|FG007|Overall Study|Withdrawal by Subject|2|||
145927420|NCT03483961|526243426|FG008|Overall Study|Withdrawal by Subject|1|||
145927421|NCT03483961|526243427|FG009|Overall Study|Withdrawal by Subject|0|||
145927422|NCT03483961|526243418|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
145927423|NCT03483961|526243419|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927424|NCT03483961|526243420|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927425|NCT03483961|526243421|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927426|NCT03483961|526243422|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927427|NCT03483961|526243423|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927428|NCT03483961|526243424|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927429|NCT03483961|526243425|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927430|NCT03483961|526243426|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927431|NCT03483961|526243427|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145927432|NCT03483961|526243418|FG000|Overall Study|Adverse Event|0|||
145927433|NCT03483961|526243419|FG001|Overall Study|Adverse Event|0|||
145927434|NCT03483961|526243420|FG002|Overall Study|Adverse Event|1|||
145977475|NCT02335944|526428157|FG007|Post-treatment Follow-up|Progressive Disease|2|||
145977476|NCT02335944|526428158|FG008|Post-treatment Follow-up|Progressive Disease|3|||
145927435|NCT03483961|526243421|FG003|Overall Study|Adverse Event|0|||
145927436|NCT03483961|526243422|FG004|Overall Study|Adverse Event|0|||
145927437|NCT03483961|526243423|FG005|Overall Study|Adverse Event|0|||
145927438|NCT03483961|526243424|FG006|Overall Study|Adverse Event|0|||
145927439|NCT03483961|526243425|FG007|Overall Study|Adverse Event|0|||
145927440|NCT03483961|526243426|FG008|Overall Study|Adverse Event|0|||
145927441|NCT03483961|526243427|FG009|Overall Study|Adverse Event|0|||
145927442|NCT02640950|526243428|FG000|Overall Study|Adverse Event|1|||
145927443|NCT02640950|526243428|FG000|Overall Study|Withdrawal by Subject|1|||
145927444|NCT04545489|526243429|FG000|Overall Study|Withdrawal by Subject|12|||
145927445|NCT04545489|526243430|FG001|Overall Study|Withdrawal by Subject|4|||
145927446|NCT04545489|526243429|FG000|Overall Study|Lost to Follow-up|17|||
145927447|NCT04545489|526243430|FG001|Overall Study|Lost to Follow-up|18|||
145927448|NCT04545489|526243429|FG000|Overall Study|12month BP not collected|4|||
145927449|NCT04545489|526243430|FG001|Overall Study|12month BP not collected|4|||
145927450|NCT00652626|526243431|FG000|Initial Treatment Phase|Adverse Event|0|||
145927451|NCT00652626|526243432|FG001|Initial Treatment Phase|Adverse Event|0|||
145927452|NCT00652626|526243433|FG002|Initial Treatment Phase|Adverse Event|0|||
145927453|NCT00652626|526243434|FG003|Initial Treatment Phase|Adverse Event|0|||
145977477|NCT02335944|526428159|FG009|Post-treatment Follow-up|Progressive Disease|0|||
145927454|NCT00652626|526243435|FG004|Initial Treatment Phase|Adverse Event|1|||
145927455|NCT00652626|526243436|FG005|Initial Treatment Phase|Adverse Event|0|||
145927456|NCT00652626|526243437|FG006|Initial Treatment Phase|Adverse Event|0|||
145927457|NCT00652626|526243431|FG000|Initial Treatment Phase|Protocol Violation|0|||
145927458|NCT00652626|526243432|FG001|Initial Treatment Phase|Protocol Violation|0|||
145927459|NCT00652626|526243433|FG002|Initial Treatment Phase|Protocol Violation|0|||
145927460|NCT00652626|526243434|FG003|Initial Treatment Phase|Protocol Violation|1|||
145927461|NCT00652626|526243435|FG004|Initial Treatment Phase|Protocol Violation|0|||
145927462|NCT00652626|526243436|FG005|Initial Treatment Phase|Protocol Violation|0|||
145927463|NCT00652626|526243437|FG006|Initial Treatment Phase|Protocol Violation|0|||
145927464|NCT00652626|526243431|FG000|Initial Treatment Phase|Physician Decision|0|||
145927465|NCT00652626|526243432|FG001|Initial Treatment Phase|Physician Decision|0|||
145927466|NCT00652626|526243433|FG002|Initial Treatment Phase|Physician Decision|0|||
145927467|NCT00652626|526243434|FG003|Initial Treatment Phase|Physician Decision|0|||
145927468|NCT00652626|526243435|FG004|Initial Treatment Phase|Physician Decision|1|||
145927469|NCT00652626|526243436|FG005|Initial Treatment Phase|Physician Decision|0|||
145927470|NCT00652626|526243437|FG006|Initial Treatment Phase|Physician Decision|0|||
145927471|NCT00652626|526243431|FG000|Initial Treatment Phase|Sponsor Request|0|||
145927472|NCT00652626|526243432|FG001|Initial Treatment Phase|Sponsor Request|0|||
145927473|NCT00652626|526243433|FG002|Initial Treatment Phase|Sponsor Request|1|||
145927474|NCT00652626|526243434|FG003|Initial Treatment Phase|Sponsor Request|0|||
145927475|NCT00652626|526243435|FG004|Initial Treatment Phase|Sponsor Request|0|||
145927476|NCT00652626|526243436|FG005|Initial Treatment Phase|Sponsor Request|0|||
145927477|NCT00652626|526243437|FG006|Initial Treatment Phase|Sponsor Request|0|||
145927478|NCT00652626|526243431|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
145927479|NCT00652626|526243432|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
145927480|NCT00652626|526243433|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
145927481|NCT00652626|526243434|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
145927482|NCT00652626|526243435|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
145927483|NCT00652626|526243436|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
145927484|NCT00652626|526243437|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
145927485|NCT00652626|526243431|FG000|Extension Phase|Withdrawal by Subject|0|||
145927486|NCT00652626|526243432|FG001|Extension Phase|Withdrawal by Subject|0|||
145927487|NCT00652626|526243433|FG002|Extension Phase|Withdrawal by Subject|0|||
145927488|NCT00652626|526243434|FG003|Extension Phase|Withdrawal by Subject|0|||
145927489|NCT00652626|526243435|FG004|Extension Phase|Withdrawal by Subject|0|||
145927490|NCT00652626|526243436|FG005|Extension Phase|Withdrawal by Subject|2|||
145927491|NCT00652626|526243437|FG006|Extension Phase|Withdrawal by Subject|0|||
145927492|NCT00652626|526243431|FG000|Extension Phase|Adverse Event|0|||
145927493|NCT00652626|526243432|FG001|Extension Phase|Adverse Event|0|||
145927494|NCT00652626|526243433|FG002|Extension Phase|Adverse Event|0|||
145927495|NCT00652626|526243434|FG003|Extension Phase|Adverse Event|0|||
145927496|NCT00652626|526243435|FG004|Extension Phase|Adverse Event|0|||
145927497|NCT00652626|526243436|FG005|Extension Phase|Adverse Event|2|||
145927498|NCT00652626|526243437|FG006|Extension Phase|Adverse Event|1|||
145927499|NCT00652626|526243431|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927500|NCT00652626|526243432|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927501|NCT00652626|526243433|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927502|NCT00652626|526243434|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927503|NCT00652626|526243435|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927504|NCT00652626|526243436|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
145927505|NCT00652626|526243437|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145927506|NCT00652626|526243431|FG000|Extension Phase|Physician Decision|0|||
145927507|NCT00652626|526243432|FG001|Extension Phase|Physician Decision|0|||
145927508|NCT00652626|526243433|FG002|Extension Phase|Physician Decision|0|||
145927509|NCT00652626|526243434|FG003|Extension Phase|Physician Decision|0|||
145927510|NCT00652626|526243435|FG004|Extension Phase|Physician Decision|0|||
145927511|NCT00652626|526243436|FG005|Extension Phase|Physician Decision|1|||
145927512|NCT00652626|526243437|FG006|Extension Phase|Physician Decision|1|||
145927513|NCT00652626|526243431|FG000|Extension Phase|Death|0|||
145927514|NCT00652626|526243432|FG001|Extension Phase|Death|0|||
145927515|NCT00652626|526243433|FG002|Extension Phase|Death|0|||
145927516|NCT00652626|526243434|FG003|Extension Phase|Death|0|||
145927517|NCT00652626|526243435|FG004|Extension Phase|Death|0|||
146243286|NCT01668719|527405376|FG000|Phase I|Adverse Event|2|||
146243287|NCT01668719|527405377|FG001|Phase I|Adverse Event|0|||
146243288|NCT01668719|527405378|FG002|Phase I|Adverse Event|0|||
146243289|NCT01668719|527405376|FG000|Phase I|Progression/relapse|1|||
145927518|NCT00652626|526243436|FG005|Extension Phase|Death|1|||
145927519|NCT00652626|526243437|FG006|Extension Phase|Death|1|||
145927520|NCT04003636|526243438|FG000|Overall Study|Death|409|||
145927521|NCT04003636|526243439|FG001|Overall Study|Death|443|||
145927522|NCT04003636|526243438|FG000|Overall Study|Lost to Follow-up|0|||
145927523|NCT04003636|526243439|FG001|Overall Study|Lost to Follow-up|1|||
146243290|NCT01668719|527405377|FG001|Phase I|Progression/relapse|0|||
146243291|NCT01668719|527405378|FG002|Phase I|Progression/relapse|0|||
145927524|NCT04003636|526243438|FG000|Overall Study|Withdrawal by Subject|5|||
145927525|NCT04003636|526243439|FG001|Overall Study|Withdrawal by Subject|2|||
145927526|NCT04003636|526243438|FG000|Overall Study|Participant On-going|119|||
145927527|NCT04003636|526243439|FG001|Overall Study|Participant On-going|90|||
145927528|NCT02693106|526243443|FG000|Overall Study|No time|3|||
145927529|NCT06028438|526243452|FG000|Overall Study|Adverse Event|3|||
145927530|NCT06028438|526243453|FG001|Overall Study|Adverse Event|9|||
145927531|NCT06028438|526243452|FG000|Overall Study|Lack of Efficacy|1|||
145927532|NCT06028438|526243453|FG001|Overall Study|Lack of Efficacy|1|||
145927533|NCT06028438|526243452|FG000|Overall Study|Lost to Follow-up|1|||
145927534|NCT06028438|526243453|FG001|Overall Study|Lost to Follow-up|0|||
145927535|NCT06028438|526243452|FG000|Overall Study|Withdrawal by Subject|1|||
145927536|NCT06028438|526243453|FG001|Overall Study|Withdrawal by Subject|0|||
145927537|NCT06028438|526243452|FG000|Overall Study|Other|3|||
145927538|NCT06028438|526243453|FG001|Overall Study|Other|3|||
145927539|NCT05625802|526243454|FG000|Overall Study|Lost to Follow-up|1|||
145927540|NCT05625802|526243455|FG001|Overall Study|Lost to Follow-up|0|||
145927541|NCT01954056|526243457|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
145927542|NCT01954056|526243458|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
145927543|NCT01081769|526243462|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
145927544|NCT01081769|526243463|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
145927545|NCT01081769|526243462|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
145927546|NCT01081769|526243463|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
145927547|NCT01081769|526243462|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
145927548|NCT01081769|526243463|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
145927549|NCT01081769|526243462|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
145927550|NCT01081769|526243463|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
145927551|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Adverse Event|14|||
145927552|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Adverse Event|11|||
145927553|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Death|1|||
145927554|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Death|1|||
145927555|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
145927556|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
145927557|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
145927558|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
145927559|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Pregnancy|1|||
145927560|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Pregnancy|0|||
145927561|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
145927562|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
145927563|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
145927564|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
145927565|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Other|0|||
145927566|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Other|1|||
145927567|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Ineligibility|3|||
145927568|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Ineligibility|4|||
145927569|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
145927570|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
145977478|NCT02335944|526428150|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977479|NCT02335944|526428151|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145927571|NCT01081769|526243462|FG000|CORE Intent-To-Treat|Patient Moved|2|||
145927572|NCT01081769|526243463|FG001|CORE Intent-To-Treat|Patient Moved|2|||
145927573|NCT00105079|526243464|FG000|Overall Study|Adverse Event|5|||
145927574|NCT00105079|526243465|FG001|Overall Study|Adverse Event|12|||
145927575|NCT00105079|526243464|FG000|Overall Study|Death|3|||
145927576|NCT00105079|526243465|FG001|Overall Study|Death|1|||
145927577|NCT00105079|526243464|FG000|Overall Study|Lost to Follow-up|12|||
145927578|NCT00105079|526243465|FG001|Overall Study|Lost to Follow-up|12|||
145927579|NCT00105079|526243464|FG000|Overall Study|Lack of Efficacy|9|||
145977480|NCT02335944|526428152|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977481|NCT02335944|526428153|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977482|NCT02335944|526428154|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977483|NCT02335944|526428155|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
145927580|NCT00105079|526243465|FG001|Overall Study|Lack of Efficacy|3|||
145977484|NCT02335944|526428156|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977485|NCT02335944|526428157|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145927581|NCT00105079|526243464|FG000|Overall Study|Refused treatment|6|||
145977486|NCT02335944|526428158|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145927582|NCT00105079|526243465|FG001|Overall Study|Refused treatment|4|||
146243292|NCT01668719|527405376|FG000|Phase I|not protocol specified|2|||
145927583|NCT00105079|526243464|FG000|Overall Study|Violation of selection criteria at entry|0|||
145927584|NCT00105079|526243465|FG001|Overall Study|Violation of selection criteria at entry|2|||
145927585|NCT00105079|526243464|FG000|Overall Study|Protocol Violation|1|||
145927586|NCT00105079|526243465|FG001|Overall Study|Protocol Violation|0|||
145927587|NCT00105079|526243464|FG000|Overall Study|Other|3|||
145927588|NCT00105079|526243465|FG001|Overall Study|Other|1|||
145927589|NCT01464593|526243468|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
145927590|NCT00789373|526243474|FG000|Induction|Adverse Event|64|||
145927591|NCT00789373|526243475|FG001|Induction|Adverse Event|0|||
145927592|NCT00789373|526243476|FG002|Induction|Adverse Event|0|||
145927593|NCT00789373|526243474|FG000|Induction|Death Due to study disease|24|||
145927594|NCT00789373|526243475|FG001|Induction|Death Due to study disease|0|||
145927595|NCT00789373|526243476|FG002|Induction|Death Due to study disease|0|||
145927596|NCT00789373|526243474|FG000|Induction|Death due to adverse event|19|||
145927597|NCT00789373|526243475|FG001|Induction|Death due to adverse event|0|||
145927598|NCT00789373|526243476|FG002|Induction|Death due to adverse event|0|||
145927599|NCT00789373|526243474|FG000|Induction|Death due to toxicity|11|||
145927600|NCT00789373|526243475|FG001|Induction|Death due to toxicity|0|||
145927601|NCT00789373|526243476|FG002|Induction|Death due to toxicity|0|||
145927602|NCT00789373|526243474|FG000|Induction|Death due to procedure|1|||
145927603|NCT00789373|526243475|FG001|Induction|Death due to procedure|0|||
145927604|NCT00789373|526243476|FG002|Induction|Death due to procedure|0|||
145927605|NCT00789373|526243474|FG000|Induction|Investigator decision|7|||
145927606|NCT00789373|526243475|FG001|Induction|Investigator decision|0|||
145927607|NCT00789373|526243476|FG002|Induction|Investigator decision|0|||
145927608|NCT00789373|526243474|FG000|Induction|Protocol entry criteria not met|9|||
145927609|NCT00789373|526243475|FG001|Induction|Protocol entry criteria not met|0|||
145927610|NCT00789373|526243476|FG002|Induction|Protocol entry criteria not met|0|||
145927611|NCT00789373|526243474|FG000|Induction|Lost to Follow-up|6|||
145927612|NCT00789373|526243475|FG001|Induction|Lost to Follow-up|0|||
145927613|NCT00789373|526243476|FG002|Induction|Lost to Follow-up|0|||
145927614|NCT00789373|526243474|FG000|Induction|Protocol Violation|1|||
145927615|NCT00789373|526243475|FG001|Induction|Protocol Violation|0|||
145927616|NCT00789373|526243476|FG002|Induction|Protocol Violation|0|||
145927617|NCT00789373|526243474|FG000|Induction|Progressive Disease|220|||
145927618|NCT00789373|526243475|FG001|Induction|Progressive Disease|0|||
145927619|NCT00789373|526243476|FG002|Induction|Progressive Disease|0|||
145927620|NCT00789373|526243474|FG000|Induction|Withdrawal by Subject|37|||
145927621|NCT00789373|526243475|FG001|Induction|Withdrawal by Subject|0|||
145927622|NCT00789373|526243476|FG002|Induction|Withdrawal by Subject|0|||
145927623|NCT00789373|526243474|FG000|Maintenance|Adverse Event|0|||
145927624|NCT00789373|526243475|FG001|Maintenance|Adverse Event|65|||
145927625|NCT00789373|526243476|FG002|Maintenance|Adverse Event|12|||
145927626|NCT00789373|526243474|FG000|Maintenance|Death due to study disease|0|||
145927627|NCT00789373|526243475|FG001|Maintenance|Death due to study disease|3|||
145927628|NCT00789373|526243476|FG002|Maintenance|Death due to study disease|1|||
145927629|NCT00789373|526243474|FG000|Maintenance|Death due to adverse event|0|||
145927630|NCT00789373|526243475|FG001|Maintenance|Death due to adverse event|4|||
145927631|NCT00789373|526243476|FG002|Maintenance|Death due to adverse event|1|||
145927632|NCT00789373|526243474|FG000|Maintenance|Death due to toxicity|0|||
145927633|NCT00789373|526243475|FG001|Maintenance|Death due to toxicity|1|||
145927634|NCT00789373|526243476|FG002|Maintenance|Death due to toxicity|2|||
145927635|NCT00789373|526243474|FG000|Maintenance|Investigator Decision|0|||
145927636|NCT00789373|526243475|FG001|Maintenance|Investigator Decision|4|||
145927637|NCT00789373|526243476|FG002|Maintenance|Investigator Decision|2|||
145927638|NCT00789373|526243474|FG000|Maintenance|Protocol entry criteria not met|0|||
145977487|NCT02335944|526428159|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145977488|NCT02335944|526428150|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977489|NCT02335944|526428151|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977490|NCT02335944|526428152|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977491|NCT02335944|526428153|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977492|NCT02335944|526428154|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977493|NCT02335944|526428155|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977494|NCT02335944|526428156|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977495|NCT02335944|526428157|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
145977496|NCT02335944|526428158|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977497|NCT02335944|526428159|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
145977498|NCT02335944|526428150|FG000|Post-treatment Follow-up|Adverse Event|0|||
145977499|NCT02335944|526428151|FG001|Post-treatment Follow-up|Adverse Event|0|||
145927639|NCT00789373|526243475|FG001|Maintenance|Protocol entry criteria not met|2|||
145977500|NCT02335944|526428152|FG002|Post-treatment Follow-up|Adverse Event|0|||
145977501|NCT02335944|526428153|FG003|Post-treatment Follow-up|Adverse Event|0|||
146243293|NCT01668719|527405377|FG001|Phase I|not protocol specified|0|||
145927640|NCT00789373|526243476|FG002|Maintenance|Protocol entry criteria not met|0|||
145927641|NCT00789373|526243474|FG000|Maintenance|Lost to Follow-up|0|||
145927642|NCT00789373|526243475|FG001|Maintenance|Lost to Follow-up|2|||
145927643|NCT00789373|526243476|FG002|Maintenance|Lost to Follow-up|0|||
145927644|NCT00789373|526243474|FG000|Maintenance|Progressive Disease|0|||
145927645|NCT00789373|526243475|FG001|Maintenance|Progressive Disease|253|||
145927646|NCT00789373|526243476|FG002|Maintenance|Progressive Disease|152|||
145927647|NCT00789373|526243474|FG000|Maintenance|Withdrawal by Subject|0|||
145927648|NCT00789373|526243475|FG001|Maintenance|Withdrawal by Subject|21|||
145927649|NCT00789373|526243476|FG002|Maintenance|Withdrawal by Subject|8|||
145927650|NCT00789373|526243474|FG000|Maintenance|Sponsor Decision|0|||
145927651|NCT00789373|526243475|FG001|Maintenance|Sponsor Decision|0|||
145927652|NCT00789373|526243476|FG002|Maintenance|Sponsor Decision|2|||
145927653|NCT00789373|526243474|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
145927654|NCT00789373|526243475|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
145927655|NCT00789373|526243476|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
145927656|NCT01964222|526243482|FG000|Overall Study|Lost to Follow-up|7|||
145927657|NCT01964222|526243483|FG001|Overall Study|Lost to Follow-up|5|||
145927658|NCT01964222|526243482|FG000|Overall Study|Withdrawal by Subject|6|||
145927659|NCT01964222|526243483|FG001|Overall Study|Withdrawal by Subject|6|||
145927660|NCT01964222|526243482|FG000|Overall Study|Screening Failure|2|||
145927661|NCT01964222|526243483|FG001|Overall Study|Screening Failure|0|||
145927662|NCT01019694|526243488|FG000|Overall Study|Adverse Event|12|||
145927663|NCT01019694|526243489|FG001|Overall Study|Adverse Event|16|||
145927664|NCT01019694|526243490|FG002|Overall Study|Adverse Event|19|||
145927665|NCT01019694|526243488|FG000|Overall Study|Protocol Violation|2|||
145927666|NCT01019694|526243489|FG001|Overall Study|Protocol Violation|6|||
145927667|NCT01019694|526243490|FG002|Overall Study|Protocol Violation|4|||
145927668|NCT01019694|526243488|FG000|Overall Study|Lost to Follow-up|5|||
145927669|NCT01019694|526243489|FG001|Overall Study|Lost to Follow-up|3|||
145927670|NCT01019694|526243490|FG002|Overall Study|Lost to Follow-up|3|||
145927671|NCT01019694|526243488|FG000|Overall Study|Withdrawal by Subject|4|||
145927672|NCT01019694|526243489|FG001|Overall Study|Withdrawal by Subject|6|||
145927673|NCT01019694|526243490|FG002|Overall Study|Withdrawal by Subject|12|||
145927674|NCT01019694|526243488|FG000|Overall Study|Not treated|0|||
145927675|NCT01019694|526243489|FG001|Overall Study|Not treated|2|||
145927676|NCT01019694|526243490|FG002|Overall Study|Not treated|3|||
145927677|NCT01019694|526243488|FG000|Overall Study|Other reason (not specified)|1|||
145927678|NCT01019694|526243489|FG001|Overall Study|Other reason (not specified)|5|||
145927679|NCT01019694|526243490|FG002|Overall Study|Other reason (not specified)|6|||
145927680|NCT00026494|526243497|FG000|Overall Study|Withdrawal by Subject|1|||
145927681|NCT00026494|526243498|FG001|Overall Study|Withdrawal by Subject|0|||
145927682|NCT00026494|526243499|FG002|Overall Study|Withdrawal by Subject|1|||
145927683|NCT00026494|526243500|FG003|Overall Study|Withdrawal by Subject|0|||
145927684|NCT00026494|526243497|FG000|Overall Study|Patient non-compliance|1|||
145927685|NCT00026494|526243498|FG001|Overall Study|Patient non-compliance|0|||
145927686|NCT00026494|526243499|FG002|Overall Study|Patient non-compliance|0|||
145927687|NCT00026494|526243500|FG003|Overall Study|Patient non-compliance|0|||
145927688|NCT00026494|526243497|FG000|Overall Study|Patient not treated|0|||
145927689|NCT00026494|526243498|FG001|Overall Study|Patient not treated|0|||
145927690|NCT00026494|526243499|FG002|Overall Study|Patient not treated|2|||
145927691|NCT00026494|526243500|FG003|Overall Study|Patient not treated|0|||
145927692|NCT00026494|526243497|FG000|Overall Study|Clinical progression|0|||
145927693|NCT00026494|526243498|FG001|Overall Study|Clinical progression|0|||
145927694|NCT00026494|526243499|FG002|Overall Study|Clinical progression|3|||
145927695|NCT00026494|526243500|FG003|Overall Study|Clinical progression|0|||
145927696|NCT01737710|526243501|FG000|Overall Study|Lost to Follow-up|0|||
145927697|NCT01737710|526243502|FG001|Overall Study|Lost to Follow-up|2|||
145927698|NCT01737710|526243503|FG002|Overall Study|Lost to Follow-up|2|||
145927699|NCT01737710|526243504|FG003|Overall Study|Lost to Follow-up|0|||
145927700|NCT01737710|526243505|FG004|Overall Study|Lost to Follow-up|0|||
145927701|NCT01737710|526243501|FG000|Overall Study|Withdrawal by Subject|1|||
145927702|NCT01737710|526243502|FG001|Overall Study|Withdrawal by Subject|1|||
145927703|NCT01737710|526243503|FG002|Overall Study|Withdrawal by Subject|1|||
145927704|NCT01737710|526243504|FG003|Overall Study|Withdrawal by Subject|0|||
145927705|NCT01737710|526243505|FG004|Overall Study|Withdrawal by Subject|0|||
145927706|NCT01737710|526243501|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
145977502|NCT02335944|526428154|FG004|Post-treatment Follow-up|Adverse Event|0|||
145977503|NCT02335944|526428155|FG005|Post-treatment Follow-up|Adverse Event|1|||
145977504|NCT02335944|526428156|FG006|Post-treatment Follow-up|Adverse Event|0|||
145977505|NCT02335944|526428157|FG007|Post-treatment Follow-up|Adverse Event|0|||
145977506|NCT02335944|526428158|FG008|Post-treatment Follow-up|Adverse Event|0|||
145927707|NCT01737710|526243502|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
145927708|NCT01737710|526243503|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
146297771|NCT02616614|527605981|FG000|Overall Study|Pregnancy|2|||
145927709|NCT01737710|526243504|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
145927710|NCT01737710|526243505|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
145927711|NCT04747886|526243506|FG000|Overall Study|Withdrawal by Subject|1|||
145977507|NCT02335944|526428159|FG009|Post-treatment Follow-up|Adverse Event|0|||
145927712|NCT04747886|526243507|FG001|Overall Study|Withdrawal by Subject|4|||
145927713|NCT03777436|526243513|FG000|Placebo-controlled Phase|Adverse Event|8|||
145927714|NCT03777436|526243514|FG001|Placebo-controlled Phase|Adverse Event|10|||
145927715|NCT03777436|526243515|FG002|Placebo-controlled Phase|Adverse Event|0|||
145927716|NCT03777436|526243513|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
145927717|NCT03777436|526243514|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
145927718|NCT03777436|526243515|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
145977508|NCT02335944|526428150|FG000|Post-treatment Follow-up|Death|0|||
145927719|NCT03777436|526243513|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
145927720|NCT03777436|526243514|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
145927721|NCT03777436|526243515|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
145927722|NCT03777436|526243513|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
145927723|NCT03777436|526243514|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
145927724|NCT03777436|526243515|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
145927725|NCT03777436|526243513|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
145927726|NCT03777436|526243514|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
145927727|NCT03777436|526243515|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
145927728|NCT03777436|526243513|FG000|Placebo-controlled Phase|Physician Decision|0|||
145927729|NCT03777436|526243514|FG001|Placebo-controlled Phase|Physician Decision|1|||
145927730|NCT03777436|526243515|FG002|Placebo-controlled Phase|Physician Decision|0|||
145927731|NCT03777436|526243513|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
145927732|NCT03777436|526243514|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
145927733|NCT03777436|526243515|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
145927734|NCT03777436|526243513|FG000|Apremilast Extension Phase|Adverse Event|0|||
145927735|NCT03777436|526243514|FG001|Apremilast Extension Phase|Adverse Event|0|||
145927736|NCT03777436|526243515|FG002|Apremilast Extension Phase|Adverse Event|6|||
145927737|NCT03777436|526243513|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
145927738|NCT03777436|526243514|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
145927739|NCT03777436|526243515|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
145927740|NCT03777436|526243513|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
145927741|NCT03777436|526243514|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
145927742|NCT03777436|526243515|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
145927743|NCT03777436|526243513|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
145927744|NCT03777436|526243514|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
145927745|NCT03777436|526243515|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
145927746|NCT03777436|526243513|FG000|Apremilast Extension Phase|Miscellaneous|0|||
145927747|NCT03777436|526243514|FG001|Apremilast Extension Phase|Miscellaneous|0|||
145927748|NCT03777436|526243515|FG002|Apremilast Extension Phase|Miscellaneous|1|||
145977509|NCT02335944|526428151|FG001|Post-treatment Follow-up|Death|0|||
145977510|NCT02335944|526428152|FG002|Post-treatment Follow-up|Death|0|||
145977511|NCT02335944|526428153|FG003|Post-treatment Follow-up|Death|1|||
145977512|NCT02335944|526428154|FG004|Post-treatment Follow-up|Death|0|||
145977513|NCT02335944|526428155|FG005|Post-treatment Follow-up|Death|1|||
145977514|NCT02335944|526428156|FG006|Post-treatment Follow-up|Death|0|||
145977515|NCT02335944|526428157|FG007|Post-treatment Follow-up|Death|0|||
145977516|NCT02335944|526428158|FG008|Post-treatment Follow-up|Death|0|||
145977517|NCT02335944|526428159|FG009|Post-treatment Follow-up|Death|0|||
145977518|NCT02335944|526428150|FG000|Post-treatment Follow-up|Physician Decision|1|||
145977519|NCT02335944|526428151|FG001|Post-treatment Follow-up|Physician Decision|0|||
145977520|NCT02335944|526428152|FG002|Post-treatment Follow-up|Physician Decision|0|||
145977521|NCT02335944|526428153|FG003|Post-treatment Follow-up|Physician Decision|0|||
145977522|NCT02335944|526428154|FG004|Post-treatment Follow-up|Physician Decision|0|||
145977523|NCT02335944|526428155|FG005|Post-treatment Follow-up|Physician Decision|0|||
145977524|NCT02335944|526428156|FG006|Post-treatment Follow-up|Physician Decision|0|||
145977525|NCT02335944|526428157|FG007|Post-treatment Follow-up|Physician Decision|1|||
145977526|NCT02335944|526428158|FG008|Post-treatment Follow-up|Physician Decision|0|||
145977527|NCT02335944|526428159|FG009|Post-treatment Follow-up|Physician Decision|0|||
145977528|NCT01202591|526428160|FG000|Overall Study|Adverse Event|2|||
145977529|NCT01202591|526428161|FG001|Overall Study|Adverse Event|1|||
145977530|NCT01202591|526428162|FG002|Overall Study|Adverse Event|4|||
145977531|NCT01202591|526428163|FG003|Overall Study|Adverse Event|4|||
145977532|NCT01202591|526428164|FG004|Overall Study|Adverse Event|0|||
145977533|NCT01202591|526428165|FG005|Overall Study|Adverse Event|0|||
145977534|NCT01202591|526428160|FG000|Overall Study|Other reason as per investigator|3|||
145977535|NCT01202591|526428161|FG001|Overall Study|Other reason as per investigator|4|||
145977536|NCT01202591|526428162|FG002|Overall Study|Other reason as per investigator|7|||
146243294|NCT01668719|527405378|FG002|Phase I|not protocol specified|0|||
146243295|NCT01668719|527405376|FG000|Phase II|On treatment|0|||
146243296|NCT01668719|527405377|FG001|Phase II|On treatment|4|||
145977537|NCT01202591|526428163|FG003|Overall Study|Other reason as per investigator|3|||
145977538|NCT01202591|526428164|FG004|Overall Study|Other reason as per investigator|1|||
145977539|NCT01202591|526428165|FG005|Overall Study|Other reason as per investigator|3|||
145977540|NCT01202591|526428160|FG000|Overall Study|Withdrawal by Subject|0|||
145977541|NCT01202591|526428161|FG001|Overall Study|Withdrawal by Subject|0|||
145977542|NCT01202591|526428162|FG002|Overall Study|Withdrawal by Subject|0|||
145977543|NCT01202591|526428163|FG003|Overall Study|Withdrawal by Subject|0|||
146243297|NCT01668719|527405378|FG002|Phase II|On treatment|3|||
145927749|NCT00869999|526243518|FG000|Overall Study|Withdrawal by Subject|1|||
145927750|NCT00869999|526243518|FG000|Overall Study|removed prior to starting therapy|1|||
145927751|NCT00685399|526243520|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145927752|NCT00685399|526243521|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146090657|NCT00423670|526852636|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
145927753|NCT00685399|526243522|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145927754|NCT00685399|526243523|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145927755|NCT00685399|526243524|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145927756|NCT00685399|526243525|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145927757|NCT00685399|526243526|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145927758|NCT00685399|526243527|FG007|Treatment Period 1|Withdrawal by Subject|0|||
145927759|NCT00685399|526243520|FG000|Treatment Period 1|Protocol Violation|1|||
145927760|NCT00685399|526243521|FG001|Treatment Period 1|Protocol Violation|0|||
145927761|NCT00685399|526243522|FG002|Treatment Period 1|Protocol Violation|0|||
145927762|NCT00685399|526243523|FG003|Treatment Period 1|Protocol Violation|0|||
145927763|NCT00685399|526243524|FG004|Treatment Period 1|Protocol Violation|0|||
145927764|NCT00685399|526243525|FG005|Treatment Period 1|Protocol Violation|0|||
145927765|NCT00685399|526243526|FG006|Treatment Period 1|Protocol Violation|0|||
145927766|NCT00685399|526243527|FG007|Treatment Period 1|Protocol Violation|0|||
145927767|NCT00685399|526243520|FG000|Treatment Period 1|Administrative|2|||
145927768|NCT00685399|526243521|FG001|Treatment Period 1|Administrative|0|||
145927769|NCT00685399|526243522|FG002|Treatment Period 1|Administrative|0|||
145927770|NCT00685399|526243523|FG003|Treatment Period 1|Administrative|0|||
145927771|NCT00685399|526243524|FG004|Treatment Period 1|Administrative|0|||
145927772|NCT00685399|526243525|FG005|Treatment Period 1|Administrative|0|||
145927773|NCT00685399|526243526|FG006|Treatment Period 1|Administrative|0|||
145927774|NCT00685399|526243527|FG007|Treatment Period 1|Administrative|0|||
145927775|NCT00685399|526243520|FG000|Treatment Period 1|Lack of Efficacy|1|||
145927776|NCT00685399|526243521|FG001|Treatment Period 1|Lack of Efficacy|0|||
145927777|NCT00685399|526243522|FG002|Treatment Period 1|Lack of Efficacy|0|||
145927778|NCT00685399|526243523|FG003|Treatment Period 1|Lack of Efficacy|0|||
145927779|NCT00685399|526243524|FG004|Treatment Period 1|Lack of Efficacy|0|||
145927780|NCT00685399|526243525|FG005|Treatment Period 1|Lack of Efficacy|0|||
145927781|NCT00685399|526243526|FG006|Treatment Period 1|Lack of Efficacy|0|||
145927782|NCT00685399|526243527|FG007|Treatment Period 1|Lack of Efficacy|0|||
145927783|NCT00685399|526243520|FG000|Treatment Period 2|Administrative Problems|0|||
145927784|NCT00685399|526243521|FG001|Treatment Period 2|Administrative Problems|2|||
145927785|NCT00685399|526243522|FG002|Treatment Period 2|Administrative Problems|1|||
145927786|NCT00685399|526243523|FG003|Treatment Period 2|Administrative Problems|0|||
145927787|NCT00685399|526243524|FG004|Treatment Period 2|Administrative Problems|0|||
145927788|NCT00685399|526243525|FG005|Treatment Period 2|Administrative Problems|0|||
145927789|NCT00685399|526243526|FG006|Treatment Period 2|Administrative Problems|0|||
145927790|NCT00685399|526243527|FG007|Treatment Period 2|Administrative Problems|0|||
145927791|NCT00685399|526243520|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145927792|NCT00685399|526243521|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145927793|NCT00685399|526243522|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145927794|NCT00685399|526243523|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145927795|NCT00685399|526243524|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145927796|NCT00685399|526243525|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145927797|NCT00685399|526243526|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145927798|NCT00685399|526243527|FG007|Treatment Period 2|Withdrawal by Subject|2|||
145927799|NCT00685399|526243520|FG000|Treatment Period 2|Adverse Event|0|||
145927800|NCT00685399|526243521|FG001|Treatment Period 2|Adverse Event|0|||
145927801|NCT00685399|526243522|FG002|Treatment Period 2|Adverse Event|0|||
145927802|NCT00685399|526243523|FG003|Treatment Period 2|Adverse Event|0|||
145927803|NCT00685399|526243524|FG004|Treatment Period 2|Adverse Event|0|||
145927804|NCT00685399|526243525|FG005|Treatment Period 2|Adverse Event|1|||
146243298|NCT01668719|527405376|FG000|Phase II|Adverse Event|0|||
145927805|NCT00685399|526243526|FG006|Treatment Period 2|Adverse Event|0|||
145927806|NCT00685399|526243527|FG007|Treatment Period 2|Adverse Event|0|||
145927807|NCT00685399|526243520|FG000|Treatment Period 2|Lack of Efficacy|0|||
145927808|NCT00685399|526243521|FG001|Treatment Period 2|Lack of Efficacy|10|||
145927809|NCT00685399|526243522|FG002|Treatment Period 2|Lack of Efficacy|2|||
145927810|NCT00685399|526243523|FG003|Treatment Period 2|Lack of Efficacy|0|||
145927811|NCT00685399|526243524|FG004|Treatment Period 2|Lack of Efficacy|0|||
145927812|NCT00685399|526243525|FG005|Treatment Period 2|Lack of Efficacy|1|||
145927813|NCT00685399|526243526|FG006|Treatment Period 2|Lack of Efficacy|0|||
145927814|NCT00685399|526243527|FG007|Treatment Period 2|Lack of Efficacy|0|||
145927815|NCT00685399|526243520|FG000|Extension|Administrative Issues|0|||
145927816|NCT00685399|526243521|FG001|Extension|Administrative Issues|0|||
145927817|NCT00685399|526243522|FG002|Extension|Administrative Issues|0|||
145927818|NCT00685399|526243523|FG003|Extension|Administrative Issues|1|||
145927819|NCT00685399|526243524|FG004|Extension|Administrative Issues|0|||
145927820|NCT00685399|526243525|FG005|Extension|Administrative Issues|0|||
145927821|NCT00685399|526243526|FG006|Extension|Administrative Issues|0|||
145927822|NCT00685399|526243527|FG007|Extension|Administrative Issues|0|||
145927823|NCT00685399|526243520|FG000|Extension|Withdrawal by Subject|0|||
145927824|NCT00685399|526243521|FG001|Extension|Withdrawal by Subject|0|||
145927825|NCT00685399|526243522|FG002|Extension|Withdrawal by Subject|0|||
146243299|NCT01668719|527405377|FG001|Phase II|Adverse Event|18|||
146243300|NCT01668719|527405378|FG002|Phase II|Adverse Event|18|||
145927826|NCT00685399|526243523|FG003|Extension|Withdrawal by Subject|1|||
145927827|NCT00685399|526243524|FG004|Extension|Withdrawal by Subject|0|||
145927828|NCT00685399|526243525|FG005|Extension|Withdrawal by Subject|0|||
145927829|NCT00685399|526243526|FG006|Extension|Withdrawal by Subject|0|||
145927830|NCT00685399|526243527|FG007|Extension|Withdrawal by Subject|0|||
145927831|NCT00685399|526243520|FG000|Extension|Protocol Violation|0|||
145927832|NCT00685399|526243521|FG001|Extension|Protocol Violation|0|||
145927833|NCT00685399|526243522|FG002|Extension|Protocol Violation|0|||
145927834|NCT00685399|526243523|FG003|Extension|Protocol Violation|1|||
145927835|NCT00685399|526243524|FG004|Extension|Protocol Violation|0|||
145927836|NCT00685399|526243525|FG005|Extension|Protocol Violation|0|||
145927837|NCT00685399|526243526|FG006|Extension|Protocol Violation|0|||
145927838|NCT00685399|526243527|FG007|Extension|Protocol Violation|0|||
145927839|NCT00685399|526243520|FG000|Extension|Lack of Efficacy|0|||
145927840|NCT00685399|526243521|FG001|Extension|Lack of Efficacy|0|||
145927841|NCT00685399|526243522|FG002|Extension|Lack of Efficacy|0|||
145927842|NCT00685399|526243523|FG003|Extension|Lack of Efficacy|2|||
145927843|NCT00685399|526243524|FG004|Extension|Lack of Efficacy|0|||
145927844|NCT00685399|526243525|FG005|Extension|Lack of Efficacy|0|||
145927845|NCT00685399|526243526|FG006|Extension|Lack of Efficacy|0|||
145927846|NCT00685399|526243527|FG007|Extension|Lack of Efficacy|0|||
145927847|NCT00685399|526243520|FG000|Extension|Adverse Event|0|||
145927848|NCT00685399|526243521|FG001|Extension|Adverse Event|0|||
145927849|NCT00685399|526243522|FG002|Extension|Adverse Event|0|||
145927850|NCT00685399|526243523|FG003|Extension|Adverse Event|2|||
145927851|NCT00685399|526243524|FG004|Extension|Adverse Event|0|||
145927852|NCT00685399|526243525|FG005|Extension|Adverse Event|0|||
145927853|NCT00685399|526243526|FG006|Extension|Adverse Event|0|||
145927854|NCT00685399|526243527|FG007|Extension|Adverse Event|0|||
145927855|NCT00656292|526243528|FG000|Overall Study|Withdrawal by Subject|2|||
145927856|NCT00656292|526243529|FG001|Overall Study|Withdrawal by Subject|3|||
145927857|NCT00656292|526243528|FG000|Overall Study|Screen failure|1|||
145927858|NCT00656292|526243529|FG001|Overall Study|Screen failure|2|||
145927859|NCT03674112|526243530|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
145927860|NCT03674112|526243531|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
145927861|NCT03674112|526243530|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
145927862|NCT03674112|526243531|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
145927863|NCT03674112|526243530|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
145927864|NCT03674112|526243531|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
145927865|NCT03674112|526243530|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
145927866|NCT03674112|526243531|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
145927867|NCT03674112|526243530|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
145927868|NCT03674112|526243531|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
145927869|NCT03674112|526243530|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
145927870|NCT03674112|526243531|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
145927871|NCT03674112|526243530|FG000|Follow-Up Period (≥3 Years)|Death|2|||
145927872|NCT03674112|526243531|FG001|Follow-Up Period (≥3 Years)|Death|0|||
145927873|NCT03674112|526243530|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
145927874|NCT03674112|526243531|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
145927875|NCT02684097|526243538|FG000|Overall Study|Lack of Efficacy|13|||
145927876|NCT02684097|526243539|FG001|Overall Study|Lack of Efficacy|6|||
145927877|NCT02064816|526243540|FG000|Overall Study|Adverse Event|3|||
145927878|NCT02064816|526243541|FG001|Overall Study|Adverse Event|2|||
145927879|NCT02064816|526243540|FG000|Overall Study|Withdrawal by Subject|2|||
145927880|NCT02064816|526243541|FG001|Overall Study|Withdrawal by Subject|1|||
145927881|NCT02064816|526243540|FG000|Overall Study|Lost to Follow-up|2|||
145927882|NCT02064816|526243541|FG001|Overall Study|Lost to Follow-up|1|||
145927883|NCT02064816|526243540|FG000|Overall Study|Therapeutic failure|0|||
145927884|NCT02064816|526243541|FG001|Overall Study|Therapeutic failure|1|||
145977544|NCT01202591|526428164|FG004|Overall Study|Withdrawal by Subject|2|||
145977545|NCT01202591|526428165|FG005|Overall Study|Withdrawal by Subject|1|||
145977546|NCT01202591|526428160|FG000|Overall Study|Objective Disease Progression|0|||
145977547|NCT01202591|526428161|FG001|Overall Study|Objective Disease Progression|0|||
145927885|NCT02064816|526243540|FG000|Overall Study|Other|1|||
145927886|NCT02064816|526243541|FG001|Overall Study|Other|3|||
145927887|NCT01732458|526243542|FG000|Overall Study|Lost to Follow-up|0|||
145927888|NCT01732458|526243543|FG001|Overall Study|Lost to Follow-up|2|||
145927889|NCT01732458|526243544|FG002|Overall Study|Lost to Follow-up|0|||
145927890|NCT01732458|526243545|FG003|Overall Study|Lost to Follow-up|0|||
145927891|NCT01732458|526243542|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145927892|NCT01732458|526243543|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145927893|NCT01732458|526243544|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146297772|NCT02616614|527605982|FG001|Overall Study|Pregnancy|0|||
145927894|NCT01732458|526243545|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145927895|NCT01732458|526243542|FG000|Overall Study|Physician Decision|1|||
145927896|NCT01732458|526243543|FG001|Overall Study|Physician Decision|2|||
145927897|NCT01732458|526243544|FG002|Overall Study|Physician Decision|2|||
145927898|NCT01732458|526243545|FG003|Overall Study|Physician Decision|0|||
145927899|NCT01732458|526243542|FG000|Overall Study|Protocol Violation|2|||
145927900|NCT01732458|526243543|FG001|Overall Study|Protocol Violation|0|||
145927901|NCT01732458|526243544|FG002|Overall Study|Protocol Violation|0|||
145927902|NCT01732458|526243545|FG003|Overall Study|Protocol Violation|2|||
145927903|NCT01732458|526243542|FG000|Overall Study|Screen Failure|0|||
145927904|NCT01732458|526243543|FG001|Overall Study|Screen Failure|1|||
145927905|NCT01732458|526243544|FG002|Overall Study|Screen Failure|0|||
145927906|NCT01732458|526243545|FG003|Overall Study|Screen Failure|0|||
145927907|NCT01197534|526243546|FG000|Overall Study|Not reported|16|||
145927908|NCT01197534|526243547|FG001|Overall Study|Not reported|10|||
145927909|NCT01197534|526243548|FG002|Overall Study|Not reported|16|||
145927910|NCT01197534|526243546|FG000|Overall Study|Enrolment in long term extension|57|||
145927911|NCT01197534|526243547|FG001|Overall Study|Enrolment in long term extension|66|||
145927912|NCT01197534|526243548|FG002|Overall Study|Enrolment in long term extension|119|||
145927913|NCT01197534|526243546|FG000|Overall Study|Severe non-compliance to protocol|3|||
145927914|NCT01197534|526243547|FG001|Overall Study|Severe non-compliance to protocol|4|||
145927915|NCT01197534|526243548|FG002|Overall Study|Severe non-compliance to protocol|1|||
145927916|NCT01197534|526243546|FG000|Overall Study|Lack of therapeutic response|9|||
145927917|NCT01197534|526243547|FG001|Overall Study|Lack of therapeutic response|4|||
145927918|NCT01197534|526243548|FG002|Overall Study|Lack of therapeutic response|9|||
145927919|NCT01197534|526243546|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
145927920|NCT01197534|526243547|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
145927921|NCT01197534|526243548|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
145927922|NCT01197534|526243546|FG000|Overall Study|Lost to Follow-up|1|||
145927923|NCT01197534|526243547|FG001|Overall Study|Lost to Follow-up|4|||
145927924|NCT01197534|526243548|FG002|Overall Study|Lost to Follow-up|2|||
145927925|NCT01197534|526243546|FG000|Overall Study|Adverse Event|35|||
145927926|NCT01197534|526243547|FG001|Overall Study|Adverse Event|36|||
145927927|NCT01197534|526243548|FG002|Overall Study|Adverse Event|24|||
145927928|NCT06868654|526243555|FG000|Overall Study|Death|4|||
145927929|NCT06868654|526243556|FG001|Overall Study|Death|14|||
145927930|NCT06868654|526243555|FG000|Overall Study|Lost to Follow-up|0|||
145927931|NCT06868654|526243556|FG001|Overall Study|Lost to Follow-up|1|||
145927932|NCT06868654|526243555|FG000|Overall Study|Withdrawal by Subject|5|||
145927933|NCT06868654|526243556|FG001|Overall Study|Withdrawal by Subject|3|||
145927934|NCT06868654|526243555|FG000|Overall Study|Physician Decision|0|||
145927935|NCT06868654|526243556|FG001|Overall Study|Physician Decision|1|||
145927936|NCT06868654|526243555|FG000|Overall Study|Ongoing|23|||
145927937|NCT06868654|526243556|FG001|Overall Study|Ongoing|21|||
145927938|NCT02134015|526243559|FG000|Overall Study|Protocol Violation|0|||
145927939|NCT02134015|526243560|FG001|Overall Study|Protocol Violation|1|||
145927940|NCT02134015|526243559|FG000|Overall Study|Death|2|||
145927941|NCT02134015|526243560|FG001|Overall Study|Death|1|||
145927942|NCT02134015|526243559|FG000|Overall Study|Reason not provided|1|||
145927943|NCT02134015|526243560|FG001|Overall Study|Reason not provided|2|||
145927944|NCT02134015|526243559|FG000|Overall Study|Clinical progression|14|||
145927945|NCT02134015|526243560|FG001|Overall Study|Clinical progression|7|||
145927946|NCT02134015|526243559|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
145927947|NCT02134015|526243560|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
145927948|NCT02134015|526243559|FG000|Overall Study|Study terminated by sponsor|2|||
145927949|NCT02134015|526243560|FG001|Overall Study|Study terminated by sponsor|3|||
145927950|NCT02134015|526243559|FG000|Overall Study|Adverse Event|9|||
145927951|NCT02134015|526243560|FG001|Overall Study|Adverse Event|10|||
145927952|NCT02134015|526243559|FG000|Overall Study|Withdrawal by Subject|3|||
145927953|NCT02134015|526243560|FG001|Overall Study|Withdrawal by Subject|7|||
145927954|NCT03867201|526243561|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
145927955|NCT03867201|526243562|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
145927956|NCT03867201|526243561|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
145927957|NCT03867201|526243562|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
145927958|NCT03867201|526243561|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
145927959|NCT03867201|526243562|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
145977548|NCT01202591|526428162|FG002|Overall Study|Objective Disease Progression|0|||
145977549|NCT01202591|526428163|FG003|Overall Study|Objective Disease Progression|0|||
145977550|NCT01202591|526428164|FG004|Overall Study|Objective Disease Progression|2|||
146243301|NCT01668719|527405376|FG000|Phase II|Refusal unrelated to adverse event|0|||
146243302|NCT01668719|527405377|FG001|Phase II|Refusal unrelated to adverse event|4|||
146243303|NCT01668719|527405378|FG002|Phase II|Refusal unrelated to adverse event|1|||
146243304|NCT01668719|527405376|FG000|Phase II|Progression/relapse|0|||
145927960|NCT03867201|526243561|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
145927961|NCT03867201|526243562|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
145927962|NCT03867201|526243561|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
145927963|NCT03867201|526243562|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
145927964|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Adverse Event|5|||
145927965|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Adverse Event|11|||
145927966|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
145927967|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
145927968|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Physician Decision|6|||
145927969|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Physician Decision|3|||
145927970|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Pregnancy|2|||
145927971|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Pregnancy|2|||
145927972|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
145927973|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
145927974|NCT03867201|526243561|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
145927975|NCT03867201|526243562|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
145927976|NCT03867201|526243561|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
145927977|NCT03867201|526243562|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
145927978|NCT03867201|526243561|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
145927979|NCT03867201|526243562|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
145927980|NCT05763875|526243563|FG000|Overall Study|Subject decision|5|||
145927981|NCT05763875|526243564|FG001|Overall Study|Subject decision|2|||
145927982|NCT05763875|526243565|FG002|Overall Study|Subject decision|1|||
145927983|NCT05763875|526243563|FG000|Overall Study|Lost to Follow-up|4|||
145927984|NCT05763875|526243564|FG001|Overall Study|Lost to Follow-up|1|||
145927985|NCT05763875|526243565|FG002|Overall Study|Lost to Follow-up|2|||
145927986|NCT05763875|526243563|FG000|Overall Study|Adverse Event|1|||
145927987|NCT05763875|526243564|FG001|Overall Study|Adverse Event|0|||
145927988|NCT05763875|526243565|FG002|Overall Study|Adverse Event|0|||
145927989|NCT01777282|526243566|FG000|Overall Study|Persistent Hyperglycemia|0|||
145927990|NCT01777282|526243567|FG001|Overall Study|Persistent Hyperglycemia|0|||
145927991|NCT01777282|526243568|FG002|Overall Study|Persistent Hyperglycemia|1|||
145927992|NCT01777282|526243569|FG003|Overall Study|Persistent Hyperglycemia|0|||
145927993|NCT01777282|526243570|FG004|Overall Study|Persistent Hyperglycemia|0|||
145927994|NCT01777282|526243566|FG000|Overall Study|New Antidiabetic Medication|0|||
145927995|NCT01777282|526243567|FG001|Overall Study|New Antidiabetic Medication|0|||
145927996|NCT01777282|526243568|FG002|Overall Study|New Antidiabetic Medication|1|||
145927997|NCT01777282|526243569|FG003|Overall Study|New Antidiabetic Medication|0|||
145927998|NCT01777282|526243570|FG004|Overall Study|New Antidiabetic Medication|0|||
145927999|NCT01777282|526243566|FG000|Overall Study|Adverse Event|4|||
145928000|NCT01777282|526243567|FG001|Overall Study|Adverse Event|4|||
145928001|NCT01777282|526243568|FG002|Overall Study|Adverse Event|2|||
145928002|NCT01777282|526243569|FG003|Overall Study|Adverse Event|1|||
145928003|NCT01777282|526243570|FG004|Overall Study|Adverse Event|3|||
145928004|NCT01777282|526243566|FG000|Overall Study|Withdrawal by Subject|4|||
145928005|NCT01777282|526243567|FG001|Overall Study|Withdrawal by Subject|0|||
145928006|NCT01777282|526243568|FG002|Overall Study|Withdrawal by Subject|0|||
145928007|NCT01777282|526243569|FG003|Overall Study|Withdrawal by Subject|1|||
145928008|NCT01777282|526243570|FG004|Overall Study|Withdrawal by Subject|2|||
145928009|NCT01777282|526243566|FG000|Overall Study|Protocol Violation|2|||
145928010|NCT01777282|526243567|FG001|Overall Study|Protocol Violation|0|||
145928011|NCT01777282|526243568|FG002|Overall Study|Protocol Violation|1|||
145928012|NCT01777282|526243569|FG003|Overall Study|Protocol Violation|0|||
145928013|NCT01777282|526243570|FG004|Overall Study|Protocol Violation|2|||
145928014|NCT01777282|526243566|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
145928015|NCT01777282|526243567|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145928016|NCT01777282|526243568|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
146090658|NCT00423670|526852637|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
145928017|NCT01777282|526243569|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145928018|NCT01777282|526243570|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145928019|NCT02186873|526244928|FG000|Overall Study|Adverse Event|1|||
145928020|NCT02186873|526244929|FG001|Overall Study|Adverse Event|3|||
145928021|NCT02186873|526244928|FG000|Overall Study|Lack of Efficacy|0|||
145928022|NCT02186873|526244929|FG001|Overall Study|Lack of Efficacy|1|||
145928023|NCT02186873|526244928|FG000|Overall Study|Lost to Follow-up|1|||
145928024|NCT02186873|526244929|FG001|Overall Study|Lost to Follow-up|2|||
145928025|NCT02186873|526244928|FG000|Overall Study|Withdrawal by Subject|7|||
145928026|NCT02186873|526244929|FG001|Overall Study|Withdrawal by Subject|2|||
145928027|NCT00347958|526244930|FG000|Overall Study|Adverse Event|1|||
145928028|NCT00347958|526244930|FG000|Overall Study|Protocol Violation|2|||
145928029|NCT00347958|526244930|FG000|Overall Study|Withdrawal by Subject|1|||
145928030|NCT01623310|526244935|FG000|Overall Study|Adverse Event|21|||
145928031|NCT01623310|526244935|FG000|Overall Study|Lost to Follow-up|18|||
145928032|NCT01623310|526244935|FG000|Overall Study|Lack of Efficacy|6|||
145928033|NCT01623310|526244935|FG000|Overall Study|Protocol Violation|6|||
145928034|NCT01623310|526244935|FG000|Overall Study|Withdrawal by Subject|25|||
145928035|NCT01623310|526244935|FG000|Overall Study|Became potentially child-bearing|1|||
145928036|NCT01623310|526244935|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
145928037|NCT01623310|526244935|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
145928038|NCT00356603|526244936|FG000|Overall Study|Other|6|||
145928039|NCT00356603|526244937|FG001|Overall Study|Other|3|||
145928040|NCT00566020|526244939|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
145928041|NCT00566020|526244940|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
145928042|NCT00566020|526244939|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
145928043|NCT00566020|526244940|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
145928044|NCT00566020|526244939|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
145928045|NCT00566020|526244940|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
145928046|NCT00566020|526244939|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
145928047|NCT00566020|526244940|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
145928048|NCT00566020|526244939|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
145928049|NCT00566020|526244940|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
145928050|NCT00566020|526244939|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
145977551|NCT01202591|526428165|FG005|Overall Study|Objective Disease Progression|0|||
145977552|NCT03018938|526428166|FG000|Overall Study|Death|0|||
145977553|NCT03018938|526428167|FG001|Overall Study|Death|1|||
145977554|NCT03018938|526428166|FG000|Overall Study|Lost to Follow-up|21|||
145977555|NCT03018938|526428167|FG001|Overall Study|Lost to Follow-up|32|||
145977556|NCT03018938|526428166|FG000|Overall Study|Withdrawal by Subject|38|||
146090659|NCT00423670|526852638|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
146090660|NCT00423670|526852639|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
146090661|NCT00423670|526852640|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
146090662|NCT00423670|526852641|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
146090663|NCT00423670|526852642|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
146090664|NCT00423670|526852635|FG000|Treatment Period|Investigator decision|0|||
146090665|NCT00423670|526852636|FG001|Treatment Period|Investigator decision|0|||
146090666|NCT00423670|526852637|FG002|Treatment Period|Investigator decision|0|||
146090667|NCT00423670|526852638|FG003|Treatment Period|Investigator decision|0|||
146090668|NCT00423670|526852639|FG004|Treatment Period|Investigator decision|0|||
146090669|NCT00423670|526852640|FG005|Treatment Period|Investigator decision|0|||
146090670|NCT00423670|526852641|FG006|Treatment Period|Investigator decision|0|||
146090671|NCT00423670|526852642|FG007|Treatment Period|Investigator decision|1|||
146090672|NCT00423670|526852635|FG000|Treatment Period|Non-compliance with protocol|3|||
146090673|NCT00423670|526852636|FG001|Treatment Period|Non-compliance with protocol|1|||
146090674|NCT00423670|526852637|FG002|Treatment Period|Non-compliance with protocol|1|||
146090675|NCT00423670|526852638|FG003|Treatment Period|Non-compliance with protocol|3|||
146090676|NCT00423670|526852639|FG004|Treatment Period|Non-compliance with protocol|2|||
146090677|NCT00423670|526852640|FG005|Treatment Period|Non-compliance with protocol|0|||
146090678|NCT00423670|526852641|FG006|Treatment Period|Non-compliance with protocol|2|||
146090679|NCT00423670|526852642|FG007|Treatment Period|Non-compliance with protocol|2|||
146090680|NCT00423670|526852635|FG000|Follow-up Period|Lost to Follow-up|0|||
146090681|NCT00423670|526852636|FG001|Follow-up Period|Lost to Follow-up|12|||
146090682|NCT00423670|526852637|FG002|Follow-up Period|Lost to Follow-up|8|||
146090683|NCT00423670|526852638|FG003|Follow-up Period|Lost to Follow-up|3|||
146090684|NCT00423670|526852639|FG004|Follow-up Period|Lost to Follow-up|1|||
146090685|NCT00423670|526852640|FG005|Follow-up Period|Lost to Follow-up|0|||
146090686|NCT00423670|526852641|FG006|Follow-up Period|Lost to Follow-up|5|||
146090687|NCT00423670|526852642|FG007|Follow-up Period|Lost to Follow-up|0|||
146090688|NCT00423670|526852635|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
146090689|NCT00423670|526852636|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
146090690|NCT00423670|526852637|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
146090691|NCT00423670|526852638|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
146090692|NCT00423670|526852639|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
146090693|NCT00423670|526852640|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
146090694|NCT00423670|526852641|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
146090695|NCT00423670|526852642|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
146090696|NCT00423670|526852635|FG000|Follow-up Period|Non-compliance with protocol|2|||
145977557|NCT03018938|526428167|FG001|Overall Study|Withdrawal by Subject|45|||
145977558|NCT03018938|526428166|FG000|Overall Study|Physician Decision|3|||
145977559|NCT03018938|526428167|FG001|Overall Study|Physician Decision|2|||
145977560|NCT03018938|526428166|FG000|Overall Study|Sponsor Decision|0|||
145977561|NCT03018938|526428167|FG001|Overall Study|Sponsor Decision|1|||
145977562|NCT03018938|526428166|FG000|Overall Study|Screen failure-After randomization|4|||
146090697|NCT00423670|526852636|FG001|Follow-up Period|Non-compliance with protocol|0|||
146090698|NCT00423670|526852637|FG002|Follow-up Period|Non-compliance with protocol|1|||
146090699|NCT00423670|526852638|FG003|Follow-up Period|Non-compliance with protocol|1|||
146090700|NCT00423670|526852639|FG004|Follow-up Period|Non-compliance with protocol|0|||
146243305|NCT01668719|527405377|FG001|Phase II|Progression/relapse|13|||
146243306|NCT01668719|527405378|FG002|Phase II|Progression/relapse|17|||
146243307|NCT01668719|527405376|FG000|Phase II|Death|0|||
145977563|NCT03018938|526428167|FG001|Overall Study|Screen failure-After randomization|2|||
145977564|NCT03018938|526428166|FG000|Overall Study|Not recorded|0|||
145977565|NCT03018938|526428167|FG001|Overall Study|Not recorded|2|||
145928051|NCT00566020|526244940|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
145928052|NCT00932373|526244941|FG000|Overall Study|Progressive disease|3|||
145928053|NCT00932373|526244942|FG001|Overall Study|Progressive disease|1|||
145928054|NCT00932373|526244943|FG002|Overall Study|Progressive disease|0|||
145928055|NCT00932373|526244944|FG003|Overall Study|Progressive disease|0|||
145928056|NCT00932373|526244945|FG004|Overall Study|Progressive disease|10|||
145928057|NCT00932373|526244946|FG005|Overall Study|Progressive disease|1|||
145928058|NCT00932373|526244947|FG006|Overall Study|Progressive disease|0|||
145928059|NCT00932373|526244948|FG007|Overall Study|Progressive disease|2|||
145928060|NCT00932373|526244949|FG008|Overall Study|Progressive disease|1|||
145928061|NCT00932373|526244950|FG009|Overall Study|Progressive disease|9|||
145928062|NCT00932373|526244951|FG010|Overall Study|Progressive disease|2|||
145928063|NCT00932373|526244941|FG000|Overall Study|Adverse Event|0|||
145928064|NCT00932373|526244942|FG001|Overall Study|Adverse Event|0|||
145928065|NCT00932373|526244943|FG002|Overall Study|Adverse Event|0|||
145928066|NCT00932373|526244944|FG003|Overall Study|Adverse Event|0|||
145928067|NCT00932373|526244945|FG004|Overall Study|Adverse Event|2|||
145928068|NCT00932373|526244946|FG005|Overall Study|Adverse Event|1|||
145928069|NCT00932373|526244947|FG006|Overall Study|Adverse Event|0|||
145928070|NCT00932373|526244948|FG007|Overall Study|Adverse Event|1|||
145928071|NCT00932373|526244949|FG008|Overall Study|Adverse Event|0|||
145928072|NCT00932373|526244950|FG009|Overall Study|Adverse Event|2|||
145928073|NCT00932373|526244951|FG010|Overall Study|Adverse Event|1|||
145928074|NCT00932373|526244941|FG000|Overall Study|Physician Decision|0|||
145928075|NCT00932373|526244942|FG001|Overall Study|Physician Decision|0|||
145928076|NCT00932373|526244943|FG002|Overall Study|Physician Decision|1|||
145928077|NCT00932373|526244944|FG003|Overall Study|Physician Decision|0|||
145928078|NCT00932373|526244945|FG004|Overall Study|Physician Decision|2|||
145928079|NCT00932373|526244946|FG005|Overall Study|Physician Decision|0|||
145928080|NCT00932373|526244947|FG006|Overall Study|Physician Decision|0|||
145928081|NCT00932373|526244948|FG007|Overall Study|Physician Decision|0|||
145928082|NCT00932373|526244949|FG008|Overall Study|Physician Decision|0|||
145928083|NCT00932373|526244950|FG009|Overall Study|Physician Decision|1|||
145928084|NCT00932373|526244951|FG010|Overall Study|Physician Decision|0|||
146090701|NCT00423670|526852640|FG005|Follow-up Period|Non-compliance with protocol|0|||
146090702|NCT00423670|526852641|FG006|Follow-up Period|Non-compliance with protocol|3|||
146090703|NCT00423670|526852642|FG007|Follow-up Period|Non-compliance with protocol|2|||
146090704|NCT01052844|526852651|FG000|Overall Study|Adverse Event|0|||
146090705|NCT01052844|526852652|FG001|Overall Study|Adverse Event|1|||
146090706|NCT01241240|526852653|FG000|Overall Study|Adverse Event|5|||
146090707|NCT01241240|526852654|FG001|Overall Study|Adverse Event|4|||
146090708|NCT01241240|526852653|FG000|Overall Study|Lost to Follow-up|2|||
146090709|NCT01241240|526852654|FG001|Overall Study|Lost to Follow-up|4|||
145928085|NCT00932373|526244941|FG000|Overall Study|Dose limiting toxicity|0|||
145928086|NCT00932373|526244942|FG001|Overall Study|Dose limiting toxicity|0|||
145977566|NCT00191100|526428168|FG000|Overall Study|Adverse Event|18|||
145977567|NCT00191100|526428169|FG001|Overall Study|Adverse Event|1|||
145977568|NCT00191100|526428168|FG000|Overall Study|Lost to Follow-up|2|||
145977569|NCT00191100|526428169|FG001|Overall Study|Lost to Follow-up|0|||
145977570|NCT00191100|526428168|FG000|Overall Study|Patient Moved|0|||
145977571|NCT00191100|526428169|FG001|Overall Study|Patient Moved|1|||
145977572|NCT00191100|526428168|FG000|Overall Study|Withdrawal by Subject|9|||
145977573|NCT00191100|526428169|FG001|Overall Study|Withdrawal by Subject|3|||
145977574|NCT00191100|526428168|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
145977575|NCT00191100|526428169|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
145977576|NCT00191100|526428168|FG000|Overall Study|Clinical Relapse|2|||
145977577|NCT00191100|526428169|FG001|Overall Study|Clinical Relapse|1|||
145977578|NCT00191100|526428168|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
145977579|NCT00191100|526428169|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
145977580|NCT00191100|526428168|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
145977581|NCT00191100|526428169|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
145928087|NCT00932373|526244943|FG002|Overall Study|Dose limiting toxicity|0|||
145977582|NCT00191100|526428168|FG000|Overall Study|Physician Decision|3|||
145977583|NCT00191100|526428169|FG001|Overall Study|Physician Decision|1|||
145977584|NCT00191100|526428168|FG000|Overall Study|Death from Study Drug Toxicity|2|||
146090710|NCT01241240|526852653|FG000|Overall Study|Personal Reasons|1|||
145928088|NCT00932373|526244944|FG003|Overall Study|Dose limiting toxicity|0|||
145928089|NCT00932373|526244945|FG004|Overall Study|Dose limiting toxicity|0|||
146243308|NCT01668719|527405377|FG001|Phase II|Death|0|||
145928090|NCT00932373|526244946|FG005|Overall Study|Dose limiting toxicity|1|||
145928091|NCT00932373|526244947|FG006|Overall Study|Dose limiting toxicity|0|||
145928092|NCT00932373|526244948|FG007|Overall Study|Dose limiting toxicity|0|||
145977585|NCT00191100|526428169|FG001|Overall Study|Death from Study Drug Toxicity|0|||
146090711|NCT01241240|526852654|FG001|Overall Study|Personal Reasons|1|||
145928093|NCT00932373|526244949|FG008|Overall Study|Dose limiting toxicity|0|||
145928094|NCT00932373|526244950|FG009|Overall Study|Dose limiting toxicity|0|||
145928095|NCT00932373|526244951|FG010|Overall Study|Dose limiting toxicity|0|||
146090712|NCT01439347|526852655|FG000|Overall Study|Death|10|||
146090713|NCT01439347|526852656|FG001|Overall Study|Death|9|||
146090714|NCT01439347|526852655|FG000|Overall Study|Withdrawal by Subject|0|||
146090715|NCT01439347|526852656|FG001|Overall Study|Withdrawal by Subject|1|||
146090716|NCT01439347|526852655|FG000|Overall Study|Physician Decision|1|||
146090717|NCT01439347|526852656|FG001|Overall Study|Physician Decision|0|||
146090718|NCT01439347|526852655|FG000|Overall Study|Sponsor Terminated Study|2|||
145928096|NCT00932373|526244941|FG000|Overall Study|Withdrawal by Subject|0|||
145928097|NCT00932373|526244942|FG001|Overall Study|Withdrawal by Subject|0|||
145928098|NCT00932373|526244943|FG002|Overall Study|Withdrawal by Subject|0|||
145928099|NCT00932373|526244944|FG003|Overall Study|Withdrawal by Subject|0|||
145928100|NCT00932373|526244945|FG004|Overall Study|Withdrawal by Subject|0|||
145928101|NCT00932373|526244946|FG005|Overall Study|Withdrawal by Subject|0|||
145928102|NCT00932373|526244947|FG006|Overall Study|Withdrawal by Subject|0|||
145928103|NCT00932373|526244948|FG007|Overall Study|Withdrawal by Subject|0|||
145928104|NCT00932373|526244949|FG008|Overall Study|Withdrawal by Subject|1|||
145928105|NCT00932373|526244950|FG009|Overall Study|Withdrawal by Subject|0|||
145928106|NCT00932373|526244951|FG010|Overall Study|Withdrawal by Subject|0|||
145928107|NCT00932373|526244941|FG000|Overall Study|Clinical progression|0|||
145928108|NCT00932373|526244942|FG001|Overall Study|Clinical progression|0|||
145928109|NCT00932373|526244943|FG002|Overall Study|Clinical progression|0|||
145928110|NCT00932373|526244944|FG003|Overall Study|Clinical progression|0|||
145928111|NCT00932373|526244945|FG004|Overall Study|Clinical progression|0|||
145928112|NCT00932373|526244946|FG005|Overall Study|Clinical progression|0|||
145928113|NCT00932373|526244947|FG006|Overall Study|Clinical progression|1|||
145928114|NCT00932373|526244948|FG007|Overall Study|Clinical progression|0|||
145928115|NCT00932373|526244949|FG008|Overall Study|Clinical progression|0|||
145928116|NCT00932373|526244950|FG009|Overall Study|Clinical progression|0|||
145928117|NCT00932373|526244951|FG010|Overall Study|Clinical progression|0|||
145928118|NCT00932373|526244941|FG000|Overall Study|Lack of Efficacy|0|||
145928119|NCT00932373|526244942|FG001|Overall Study|Lack of Efficacy|0|||
145928120|NCT00932373|526244943|FG002|Overall Study|Lack of Efficacy|0|||
145928121|NCT00932373|526244944|FG003|Overall Study|Lack of Efficacy|0|||
145928122|NCT00932373|526244945|FG004|Overall Study|Lack of Efficacy|0|||
145928123|NCT00932373|526244946|FG005|Overall Study|Lack of Efficacy|0|||
145928124|NCT00932373|526244947|FG006|Overall Study|Lack of Efficacy|0|||
145928125|NCT00932373|526244948|FG007|Overall Study|Lack of Efficacy|0|||
145928126|NCT00932373|526244949|FG008|Overall Study|Lack of Efficacy|0|||
145928127|NCT00932373|526244950|FG009|Overall Study|Lack of Efficacy|1|||
145928128|NCT00932373|526244951|FG010|Overall Study|Lack of Efficacy|0|||
145928129|NCT06098339|526244952|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
145928130|NCT06098339|526244953|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
145928131|NCT06098339|526244952|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
145928132|NCT06098339|526244953|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
145928133|NCT03831113|526244956|FG000|Overall Study|Withdrawal by Subject|0|||
145928134|NCT03831113|526244957|FG001|Overall Study|Withdrawal by Subject|2|||
145928135|NCT03831113|526244956|FG000|Overall Study|Protocol Violation|0|||
145928136|NCT03831113|526244957|FG001|Overall Study|Protocol Violation|9|||
145928137|NCT00459290|526244961|FG000|Overall Study|Adverse Event|3|||
145928138|NCT00459290|526244961|FG000|Overall Study|Ineligible|2|||
145928139|NCT06152224|526244962|FG000|Overall Study|Withdrawal by Subject|1|||
145928140|NCT06152224|526244963|FG001|Overall Study|Withdrawal by Subject|0|||
145928141|NCT06152224|526244962|FG000|Overall Study|Lost to Follow-up|0|||
145928142|NCT06152224|526244963|FG001|Overall Study|Lost to Follow-up|1|||
145928143|NCT06152224|526244962|FG000|Overall Study|On Follow Up|18|||
145928144|NCT06152224|526244963|FG001|Overall Study|On Follow Up|18|||
145928145|NCT03337113|526244970|FG000|Overall Study|Adverse Event|1|||
145928146|NCT03337113|526244971|FG001|Overall Study|Adverse Event|1|||
145928147|NCT03337113|526244972|FG002|Overall Study|Adverse Event|0|||
145928148|NCT03337113|526244973|FG003|Overall Study|Adverse Event|1|||
145928149|NCT03337113|526244970|FG000|Overall Study|Physician Decision|0|||
145928150|NCT03337113|526244971|FG001|Overall Study|Physician Decision|2|||
145928151|NCT03337113|526244972|FG002|Overall Study|Physician Decision|0|||
145928152|NCT03337113|526244973|FG003|Overall Study|Physician Decision|1|||
145928153|NCT03337113|526244970|FG000|Overall Study|Withdrawal by Subject|0|||
145928154|NCT03337113|526244971|FG001|Overall Study|Withdrawal by Subject|0|||
146090719|NCT01439347|526852656|FG001|Overall Study|Sponsor Terminated Study|3|||
146090720|NCT00542451|526852657|FG000|Overall Study|Adverse Event|31|||
146090721|NCT00542451|526852657|FG000|Overall Study|Withdrawal by Subject|30|||
145928155|NCT03337113|526244972|FG002|Overall Study|Withdrawal by Subject|1|||
145928156|NCT03337113|526244973|FG003|Overall Study|Withdrawal by Subject|0|||
145928157|NCT02476578|526244982|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
145928158|NCT02476578|526244983|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
145928159|NCT02476578|526244982|FG000|Overall Study|Lost to Follow-up|6|||
145928160|NCT02476578|526244983|FG001|Overall Study|Lost to Follow-up|13|||
145928161|NCT03491462|526244984|FG000|Overall Study|Lost to Follow-up|2|||
146090722|NCT00542451|526852657|FG000|Overall Study|Physician Decision|4|||
145928162|NCT03491462|526244985|FG001|Overall Study|Lost to Follow-up|0|||
145928163|NCT03491462|526244984|FG000|Overall Study|Adverse Event|11|||
145928164|NCT03491462|526244985|FG001|Overall Study|Adverse Event|1|||
145928165|NCT03491462|526244984|FG000|Overall Study|Physician Decision|3|||
145928166|NCT03491462|526244985|FG001|Overall Study|Physician Decision|0|||
145928167|NCT03491462|526244984|FG000|Overall Study|Withdrawal by Subject|22|||
145928168|NCT03491462|526244985|FG001|Overall Study|Withdrawal by Subject|15|||
145928169|NCT04938180|526244986|FG000|Overall Study|Adverse Event|1|||
145928170|NCT00462709|526244990|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
145928171|NCT00462709|526244990|FG000|Overall Study|Lost to Follow-up|10|||
145928172|NCT00462709|526244990|FG000|Overall Study|Withdrawal by Subject|8|||
145928173|NCT00462709|526244990|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
145928174|NCT00462709|526244990|FG000|Overall Study|Death|2|||
145928175|NCT00462709|526244990|FG000|Overall Study|Logistical reasons|2|||
145928176|NCT00462709|526244990|FG000|Overall Study|Physician Decision|1|||
145928177|NCT00462709|526244990|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
145977586|NCT00191100|526428168|FG000|Overall Study|Protocol Violation|1|||
145977587|NCT00191100|526428169|FG001|Overall Study|Protocol Violation|1|||
145977588|NCT00191100|526428168|FG000|Overall Study|Death from Other Cause|1|||
145977589|NCT00191100|526428169|FG001|Overall Study|Death from Other Cause|0|||
146243309|NCT01668719|527405378|FG002|Phase II|Death|2|||
146243310|NCT01668719|527405376|FG000|Phase II|not protocol specified|0|||
146243311|NCT01668719|527405377|FG001|Phase II|not protocol specified|13|||
146243312|NCT01668719|527405378|FG002|Phase II|not protocol specified|7|||
146243313|NCT00875706|527405381|FG000|Overall Study|Withdrawal by Subject|1|||
146243314|NCT00875706|527405382|FG001|Overall Study|Withdrawal by Subject|0|||
146243315|NCT00875706|527405383|FG002|Overall Study|Withdrawal by Subject|0|||
146243316|NCT03205488|527405384|FG000|Overall Study|Adverse Event|1|||
146243317|NCT03205488|527405385|FG001|Overall Study|Adverse Event|2|||
145928178|NCT04468347|526244991|FG000|Overall Study|Withdrawal by Subject|0|||
145928179|NCT04468347|526244992|FG001|Overall Study|Withdrawal by Subject|1|||
145928180|NCT04468347|526244993|FG002|Overall Study|Withdrawal by Subject|3|||
145928181|NCT04468347|526244994|FG003|Overall Study|Withdrawal by Subject|3|||
145977590|NCT00191100|526428168|FG000|Overall Study|Reason Not Specified|0|||
145977591|NCT00191100|526428169|FG001|Overall Study|Reason Not Specified|1|||
145977592|NCT02406612|526428500|FG000|Overall Study|Screening Failure|3|||
145977593|NCT02406612|526428501|FG001|Overall Study|Screening Failure|0|||
145977594|NCT02406612|526428500|FG000|Overall Study|Intra-procedural Exclusion|1|||
145977595|NCT02406612|526428501|FG001|Overall Study|Intra-procedural Exclusion|3|||
145977596|NCT02406612|526428500|FG000|Overall Study|Guidewire Failure|0|||
145977597|NCT02406612|526428501|FG001|Overall Study|Guidewire Failure|1|||
145977598|NCT02916771|526428506|FG000|Overall Study|Withdrawal by Subject|9|||
145977599|NCT02916771|526428506|FG000|Overall Study|Physician Decision|1|||
145977600|NCT02916771|526428506|FG000|Overall Study|Began treatment for another active malignancy|1|||
145977601|NCT02337686|526428517|FG000|Overall Study|Adverse Event|1|||
145977602|NCT05578872|526428520|FG000|Overall Study|Withdrawal by Subject|2|||
145977603|NCT05578872|526428521|FG001|Overall Study|Withdrawal by Subject|1|||
145977604|NCT05578872|526428520|FG000|Overall Study|Adverse Event|1|||
145977605|NCT05578872|526428521|FG001|Overall Study|Adverse Event|1|||
145977606|NCT05578872|526428520|FG000|Overall Study|Physician Decision|1|||
145977607|NCT05578872|526428521|FG001|Overall Study|Physician Decision|2|||
145977608|NCT05578872|526428520|FG000|Overall Study|Progressive disease|10|||
145977609|NCT05578872|526428521|FG001|Overall Study|Progressive disease|9|||
145977610|NCT05578872|526428520|FG000|Overall Study|Sponsor decision|0|||
145977611|NCT05578872|526428521|FG001|Overall Study|Sponsor decision|1|||
145977612|NCT05578872|526428520|FG000|Overall Study|Toxicity and Patient's decision|0|||
145977613|NCT05578872|526428521|FG001|Overall Study|Toxicity and Patient's decision|1|||
145977614|NCT02737618|526429247|FG000|Overall Study|Withdrawal by Subject|9|||
145977615|NCT00313170|526429249|FG000|Overall Study|Death|2|||
145977616|NCT00313170|526429250|FG001|Overall Study|Death|4|||
145977617|NCT00313170|526429251|FG002|Overall Study|Death|2|||
145977618|NCT00313170|526429249|FG000|Overall Study|Adverse Event|1|||
145977619|NCT00313170|526429250|FG001|Overall Study|Adverse Event|2|||
145977620|NCT00313170|526429251|FG002|Overall Study|Adverse Event|0|||
145977621|NCT00313170|526429249|FG000|Overall Study|Disease progression|31|||
145977622|NCT00313170|526429250|FG001|Overall Study|Disease progression|26|||
145977623|NCT00313170|526429251|FG002|Overall Study|Disease progression|27|||
145977624|NCT00313170|526429249|FG000|Overall Study|Withdrawal by Subject|1|||
145977625|NCT00313170|526429250|FG001|Overall Study|Withdrawal by Subject|0|||
146243318|NCT03205488|527405386|FG002|Overall Study|Adverse Event|4|||
146243319|NCT03205488|527405384|FG000|Overall Study|Protocol Violation|0|||
146243320|NCT03205488|527405385|FG001|Overall Study|Protocol Violation|0|||
146297773|NCT02616614|527605983|FG002|Overall Study|Pregnancy|1|||
145928182|NCT04468347|526244991|FG000|Overall Study|Lost to Follow-up|0|||
145928183|NCT04468347|526244992|FG001|Overall Study|Lost to Follow-up|0|||
145928184|NCT04468347|526244993|FG002|Overall Study|Lost to Follow-up|1|||
145977626|NCT00313170|526429251|FG002|Overall Study|Withdrawal by Subject|1|||
146243321|NCT03205488|527405386|FG002|Overall Study|Protocol Violation|1|||
146243322|NCT01218594|527405387|FG000|Overall Study|Death|1|||
145928185|NCT04468347|526244994|FG003|Overall Study|Lost to Follow-up|1|||
145928186|NCT04468347|526244991|FG000|Overall Study|Physician Decision|1|||
145928187|NCT04468347|526244992|FG001|Overall Study|Physician Decision|0|||
145928188|NCT04468347|526244993|FG002|Overall Study|Physician Decision|2|||
145928189|NCT04468347|526244994|FG003|Overall Study|Physician Decision|0|||
145928190|NCT04468347|526244991|FG000|Overall Study|Protocol Violation|1|||
145928191|NCT04468347|526244992|FG001|Overall Study|Protocol Violation|0|||
145928192|NCT04468347|526244993|FG002|Overall Study|Protocol Violation|0|||
145928193|NCT04468347|526244994|FG003|Overall Study|Protocol Violation|0|||
145928194|NCT00237458|526244995|FG000|Overall Study|Lack of Efficacy|1|||
145928195|NCT00237458|526244995|FG000|Overall Study|Adverse Event|1|||
145928196|NCT00237458|526244995|FG000|Overall Study|Withdrawal by Subject|1|||
145928197|NCT04339062|526244996|FG000|Overall Study|Death|0|||
145928198|NCT04339062|526244997|FG001|Overall Study|Death|1|||
145928199|NCT03218826|526244998|FG000|Overall Study|Non-compliance with protocol|1|||
145928200|NCT03218826|526244999|FG001|Overall Study|Non-compliance with protocol|0|||
145928201|NCT03218826|526245000|FG002|Overall Study|Non-compliance with protocol|2|||
145928202|NCT03218826|526245001|FG003|Overall Study|Non-compliance with protocol|1|||
145928203|NCT03218826|526245002|FG004|Overall Study|Non-compliance with protocol|1|||
145928204|NCT01276756|526245003|FG000|Overall Study|Lost to Follow-up|2|||
145928205|NCT01276756|526245004|FG001|Overall Study|Lost to Follow-up|0|||
145928206|NCT01276756|526245003|FG000|Overall Study|Adverse Event|3|||
145928207|NCT01276756|526245004|FG001|Overall Study|Adverse Event|2|||
145928208|NCT02589639|526245005|FG000|Overall Study|Lost to Follow-up|1|||
145928209|NCT02589639|526245006|FG001|Overall Study|Lost to Follow-up|0|||
145928210|NCT02589639|526245007|FG002|Overall Study|Lost to Follow-up|0|||
145928211|NCT02589639|526245005|FG000|Overall Study|Protocol Violation|1|||
145928212|NCT02589639|526245006|FG001|Overall Study|Protocol Violation|0|||
145928213|NCT02589639|526245007|FG002|Overall Study|Protocol Violation|0|||
145928214|NCT02589639|526245005|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
145928215|NCT02589639|526245006|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
145928216|NCT02589639|526245007|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
145928217|NCT02589639|526245005|FG000|Overall Study|Adverse Event|4|||
145928218|NCT02589639|526245006|FG001|Overall Study|Adverse Event|5|||
145928219|NCT02589639|526245007|FG002|Overall Study|Adverse Event|3|||
145928220|NCT02589639|526245005|FG000|Overall Study|Other reason than specified above|1|||
145928221|NCT02589639|526245006|FG001|Overall Study|Other reason than specified above|2|||
145928222|NCT02589639|526245007|FG002|Overall Study|Other reason than specified above|1|||
145928223|NCT02589639|526245005|FG000|Overall Study|Not Treated|0|||
145928224|NCT02589639|526245006|FG001|Overall Study|Not Treated|3|||
145928225|NCT02589639|526245007|FG002|Overall Study|Not Treated|0|||
145928226|NCT00703157|526245008|FG000|Overall Study|Lost to Follow-up|0|||
145928227|NCT00703157|526245009|FG001|Overall Study|Lost to Follow-up|1|||
145928228|NCT00703157|526245008|FG000|Overall Study|source data permanently lost/ other|4|||
145928229|NCT00703157|526245009|FG001|Overall Study|source data permanently lost/ other|1|||
145928230|NCT00347009|526245010|FG000|Overall Study|Death|1|||
145928231|NCT00347009|526245010|FG000|Overall Study|Adverse Event|6|||
145928232|NCT00347009|526245010|FG000|Overall Study|Withdrawal by Subject|3|||
145928233|NCT00347009|526245010|FG000|Overall Study|Physician Decision|5|||
145928234|NCT00347009|526245010|FG000|Overall Study|Lost to Follow-up|4|||
145928235|NCT00347009|526245010|FG000|Overall Study|Protocol Violation|2|||
145928236|NCT00347009|526245010|FG000|Overall Study|Adverse Laboratory Experience|1|||
145928237|NCT00347009|526245010|FG000|Overall Study|Insufficient Viral Suppression|3|||
145928238|NCT00347009|526245010|FG000|Overall Study|Increased ALT/HBV DNA|1|||
145928239|NCT00347009|526245010|FG000|Overall Study|Serious Adverse Event|1|||
145928240|NCT05868577|526245011|FG000|Overall Study|Lost to Follow-up|5|||
145928241|NCT05868577|526245012|FG001|Overall Study|Lost to Follow-up|5|||
145928242|NCT02522884|526245013|FG000|Overall Study|Withdrawal by Subject|6|||
145928243|NCT02522884|526245013|FG000|Overall Study|Death|3|||
145928244|NCT02522884|526245013|FG000|Overall Study|Missed 12-month Follow-up|9|||
145928245|NCT04873934|526245014|FG000|Overall Study|Adverse Event|0|||
145928246|NCT04873934|526245015|FG001|Overall Study|Adverse Event|1|||
145928247|NCT04873934|526245014|FG000|Overall Study|Death|0|||
145928248|NCT04873934|526245015|FG001|Overall Study|Death|2|||
145928249|NCT04873934|526245014|FG000|Overall Study|Lost to Follow-up|13|||
145928250|NCT04873934|526245015|FG001|Overall Study|Lost to Follow-up|9|||
145928251|NCT04873934|526245014|FG000|Overall Study|Physician Decision|1|||
145928252|NCT04873934|526245015|FG001|Overall Study|Physician Decision|1|||
145928253|NCT04873934|526245014|FG000|Overall Study|Protocol deviation|2|||
145928254|NCT04873934|526245015|FG001|Overall Study|Protocol deviation|1|||
145928255|NCT04873934|526245014|FG000|Overall Study|Subject decision|1|||
145928256|NCT04873934|526245015|FG001|Overall Study|Subject decision|8|||
145928257|NCT04873934|526245014|FG000|Overall Study|Withdrew consent|0|||
145928258|NCT04873934|526245015|FG001|Overall Study|Withdrew consent|4|||
145928259|NCT04873934|526245014|FG000|Overall Study|Missing|1|||
145928260|NCT04873934|526245015|FG001|Overall Study|Missing|0|||
145928261|NCT00708461|526245017|FG000|Overall Study|Lost to Follow-up|18|||
145928262|NCT00708461|526245018|FG001|Overall Study|Lost to Follow-up|11|||
145928263|NCT00708461|526245017|FG000|Overall Study|Withdrawal by Subject|8|||
145928264|NCT00708461|526245018|FG001|Overall Study|Withdrawal by Subject|9|||
145928265|NCT00708461|526245017|FG000|Overall Study|left workforce|115|||
145928266|NCT00708461|526245018|FG001|Overall Study|left workforce|180|||
145928267|NCT02630251|526245023|FG000|Overall Study|Physician Decision|0|||
145928268|NCT02630251|526245024|FG001|Overall Study|Physician Decision|0|||
145928269|NCT02630251|526245025|FG002|Overall Study|Physician Decision|1|||
145928270|NCT02630251|526245026|FG003|Overall Study|Physician Decision|0|||
145928271|NCT02907177|526245027|FG000|Overall Study|Death|0|||
145928272|NCT02907177|526245028|FG001|Overall Study|Death|1|||
145928273|NCT02907177|526245027|FG000|Overall Study|Physician Decision|3|||
145928274|NCT02907177|526245028|FG001|Overall Study|Physician Decision|3|||
145928275|NCT02907177|526245027|FG000|Overall Study|Withdrawal by Subject|15|||
145928276|NCT02907177|526245028|FG001|Overall Study|Withdrawal by Subject|7|||
145928277|NCT02907177|526245027|FG000|Overall Study|Sponsor's Decision|50|||
145928278|NCT02907177|526245028|FG001|Overall Study|Sponsor's Decision|57|||
145928279|NCT02968173|526245031|FG000|Overall Study|Withdrawal by Subject|1|||
145928280|NCT04586244|526245032|FG000|Overall Study|Lost to Follow-up|1|||
145928281|NCT04586244|526245033|FG001|Overall Study|Lost to Follow-up|0|||
145928282|NCT04586244|526245034|FG002|Overall Study|Lost to Follow-up|0|||
145928283|NCT04586244|526245035|FG003|Overall Study|Lost to Follow-up|1|||
145928284|NCT04586244|526245036|FG004|Overall Study|Lost to Follow-up|0|||
145928285|NCT04586244|526245032|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145928286|NCT04586244|526245033|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
145928287|NCT04586244|526245034|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145928288|NCT04586244|526245035|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145928289|NCT04586244|526245036|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145928290|NCT03564119|526245039|FG000|Overall Study|Adverse Event|4|||
145928291|NCT03564119|526245040|FG001|Overall Study|Adverse Event|0|||
145928292|NCT03564119|526245039|FG000|Overall Study|Lost to Follow-up|1|||
145928293|NCT03564119|526245040|FG001|Overall Study|Lost to Follow-up|4|||
145928294|NCT03564119|526245039|FG000|Overall Study|Protocol Violation|1|||
145928295|NCT03564119|526245040|FG001|Overall Study|Protocol Violation|0|||
145928296|NCT03564119|526245039|FG000|Overall Study|Withdrawal by Subject|9|||
145928297|NCT03564119|526245040|FG001|Overall Study|Withdrawal by Subject|4|||
145928298|NCT03564119|526245039|FG000|Overall Study|Other Than Specified|0|||
145928299|NCT03564119|526245040|FG001|Overall Study|Other Than Specified|1|||
145928300|NCT00634036|526245041|FG000|Overall Study|Lost to Follow-up|1|||
145928301|NCT00634036|526245042|FG001|Overall Study|Lost to Follow-up|1|||
145928302|NCT00634036|526245041|FG000|Overall Study|Withdrawal by Subject|1|||
145928303|NCT00634036|526245042|FG001|Overall Study|Withdrawal by Subject|1|||
145928304|NCT03896022|526245043|FG000|Overall Study|Withdrawal by Subject|1|||
145928305|NCT03896022|526245044|FG001|Overall Study|Withdrawal by Subject|0|||
145928306|NCT03896022|526245045|FG002|Overall Study|Withdrawal by Subject|0|||
145928307|NCT03896022|526245043|FG000|Overall Study|Did not have procedure|3|||
145928308|NCT03896022|526245044|FG001|Overall Study|Did not have procedure|0|||
145977627|NCT00313170|526429249|FG000|Overall Study|Incorrect enrollment|0|||
145977628|NCT00313170|526429250|FG001|Overall Study|Incorrect enrollment|2|||
145977629|NCT00313170|526429251|FG002|Overall Study|Incorrect enrollment|1|||
145977630|NCT00313170|526429249|FG000|Overall Study|Lost to Follow-up|0|||
145977631|NCT00313170|526429250|FG001|Overall Study|Lost to Follow-up|0|||
145977632|NCT00313170|526429251|FG002|Overall Study|Lost to Follow-up|1|||
145977633|NCT00313170|526429249|FG000|Overall Study|Progression (investigators opinion)|1|||
145977634|NCT00313170|526429250|FG001|Overall Study|Progression (investigators opinion)|0|||
145977635|NCT00313170|526429251|FG002|Overall Study|Progression (investigators opinion)|0|||
145977636|NCT00529035|526429252|FG000|Overall Study|Withdrawal by Subject|1|||
145977637|NCT01879852|526429253|FG000|Overall Study|Withdrawal by Subject|2|||
145977638|NCT01879852|526429254|FG001|Overall Study|Withdrawal by Subject|0|||
145977639|NCT02115386|526429255|FG000|Overall Study|Protocol Violation|1|||
145977640|NCT02115386|526429255|FG000|Overall Study|Administrative - trial was terminated|6|||
145977641|NCT02453048|526429256|FG000|Overall Study|Only part of initial 6 mo. study|0|||
145977642|NCT02453048|526429257|FG001|Overall Study|Only part of initial 6 mo. study|0|||
145977643|NCT02453048|526429258|FG002|Overall Study|Only part of initial 6 mo. study|0|||
145977644|NCT02453048|526429259|FG003|Overall Study|Only part of initial 6 mo. study|0|||
145977645|NCT02453048|526429260|FG004|Overall Study|Only part of initial 6 mo. study|6|||
145928309|NCT03896022|526245045|FG002|Overall Study|Did not have procedure|0|||
145928310|NCT01500382|526245050|FG000|Washout Period|Study site went out of business|0|||
145928311|NCT01500382|526245051|FG001|Washout Period|Study site went out of business|0|||
145928312|NCT01500382|526245052|FG002|Washout Period|Study site went out of business|1|||
145977646|NCT02453048|526429256|FG000|Overall Study|Lost to Follow-up|0|||
145977647|NCT02453048|526429257|FG001|Overall Study|Lost to Follow-up|1|||
145977648|NCT02453048|526429258|FG002|Overall Study|Lost to Follow-up|2|||
145977649|NCT02453048|526429259|FG003|Overall Study|Lost to Follow-up|0|||
145977650|NCT02453048|526429260|FG004|Overall Study|Lost to Follow-up|0|||
145928313|NCT01500382|526245053|FG003|Washout Period|Study site went out of business|0|||
145928314|NCT04015518|526245058|FG000|Overall Study|Adverse Event|6|||
145928315|NCT04015518|526245059|FG001|Overall Study|Adverse Event|1|||
145928316|NCT04015518|526245060|FG002|Overall Study|Adverse Event|1|||
145928317|NCT04015518|526245061|FG003|Overall Study|Adverse Event|3|||
145928318|NCT04015518|526245062|FG004|Overall Study|Adverse Event|3|||
145928319|NCT04015518|526245058|FG000|Overall Study|Lack of Efficacy|1|||
145928320|NCT04015518|526245059|FG001|Overall Study|Lack of Efficacy|0|||
145928321|NCT04015518|526245060|FG002|Overall Study|Lack of Efficacy|1|||
145928322|NCT04015518|526245061|FG003|Overall Study|Lack of Efficacy|0|||
145928323|NCT04015518|526245062|FG004|Overall Study|Lack of Efficacy|4|||
145928324|NCT04015518|526245058|FG000|Overall Study|Lost to Follow-up|0|||
145928325|NCT04015518|526245059|FG001|Overall Study|Lost to Follow-up|0|||
145928326|NCT04015518|526245060|FG002|Overall Study|Lost to Follow-up|0|||
145928327|NCT04015518|526245061|FG003|Overall Study|Lost to Follow-up|0|||
145928328|NCT04015518|526245062|FG004|Overall Study|Lost to Follow-up|1|||
145928329|NCT04015518|526245058|FG000|Overall Study|Withdrawal by Subject|0|||
145928330|NCT04015518|526245059|FG001|Overall Study|Withdrawal by Subject|1|||
145928331|NCT04015518|526245060|FG002|Overall Study|Withdrawal by Subject|0|||
145928332|NCT04015518|526245061|FG003|Overall Study|Withdrawal by Subject|1|||
145928333|NCT04015518|526245062|FG004|Overall Study|Withdrawal by Subject|1|||
145928334|NCT04015518|526245058|FG000|Overall Study|Patient did not come for consecutive visits|0|||
145928335|NCT04015518|526245059|FG001|Overall Study|Patient did not come for consecutive visits|1|||
145928336|NCT04015518|526245060|FG002|Overall Study|Patient did not come for consecutive visits|0|||
145928337|NCT04015518|526245061|FG003|Overall Study|Patient did not come for consecutive visits|0|||
145928338|NCT04015518|526245062|FG004|Overall Study|Patient did not come for consecutive visits|0|||
145928339|NCT04015518|526245058|FG000|Overall Study|not willing to travel due to Covid-19|0|||
145977651|NCT01482221|526429262|FG000|Overall Study|Lack of Efficacy|1|||
145977652|NCT01482221|526429263|FG001|Overall Study|Lack of Efficacy|0|||
145977653|NCT01482221|526429264|FG002|Overall Study|Lack of Efficacy|1|||
145928340|NCT04015518|526245059|FG001|Overall Study|not willing to travel due to Covid-19|0|||
145928341|NCT04015518|526245060|FG002|Overall Study|not willing to travel due to Covid-19|1|||
145928342|NCT04015518|526245061|FG003|Overall Study|not willing to travel due to Covid-19|0|||
145928343|NCT04015518|526245062|FG004|Overall Study|not willing to travel due to Covid-19|0|||
145928344|NCT04015518|526245058|FG000|Overall Study|Patient wants to discontinue treatment|0|||
145928345|NCT04015518|526245059|FG001|Overall Study|Patient wants to discontinue treatment|0|||
145928346|NCT04015518|526245060|FG002|Overall Study|Patient wants to discontinue treatment|0|||
145928347|NCT04015518|526245061|FG003|Overall Study|Patient wants to discontinue treatment|1|||
145928348|NCT04015518|526245062|FG004|Overall Study|Patient wants to discontinue treatment|0|||
145928349|NCT04015518|526245058|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
145928350|NCT04015518|526245059|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
145928351|NCT04015518|526245060|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
145928352|NCT04015518|526245061|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
145928353|NCT04015518|526245062|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
145928354|NCT04015518|526245058|FG000|Overall Study|Pregnancy|0|||
145928355|NCT04015518|526245059|FG001|Overall Study|Pregnancy|0|||
145928356|NCT04015518|526245060|FG002|Overall Study|Pregnancy|0|||
145928357|NCT04015518|526245061|FG003|Overall Study|Pregnancy|0|||
145928358|NCT04015518|526245062|FG004|Overall Study|Pregnancy|1|||
145928359|NCT04015518|526245058|FG000|Overall Study|Personal reasons|1|||
145928360|NCT04015518|526245059|FG001|Overall Study|Personal reasons|0|||
145928361|NCT04015518|526245060|FG002|Overall Study|Personal reasons|0|||
145928362|NCT04015518|526245061|FG003|Overall Study|Personal reasons|0|||
145928363|NCT04015518|526245062|FG004|Overall Study|Personal reasons|1|||
145928364|NCT04015518|526245058|FG000|Overall Study|Withdrew consent|1|||
145977654|NCT01482221|526429262|FG000|Overall Study|Lost to Follow-up|3|||
145977655|NCT01482221|526429263|FG001|Overall Study|Lost to Follow-up|2|||
145977656|NCT01482221|526429264|FG002|Overall Study|Lost to Follow-up|1|||
145977657|NCT01482221|526429262|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
145977658|NCT01482221|526429263|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
145977659|NCT01482221|526429264|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
145977660|NCT01482221|526429262|FG000|Overall Study|Condition under Investigation Worsened|3|||
145977661|NCT01482221|526429263|FG001|Overall Study|Condition under Investigation Worsened|2|||
145977662|NCT01482221|526429264|FG002|Overall Study|Condition under Investigation Worsened|4|||
145977663|NCT01482221|526429262|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
146090723|NCT00542451|526852657|FG000|Overall Study|Recurrent disease|1|||
146090724|NCT00542451|526852657|FG000|Overall Study|unknown reason|1|||
146090725|NCT00542451|526852657|FG000|Overall Study|Death|2|||
145928365|NCT04015518|526245059|FG001|Overall Study|Withdrew consent|0|||
145928366|NCT04015518|526245060|FG002|Overall Study|Withdrew consent|0|||
145928367|NCT04015518|526245061|FG003|Overall Study|Withdrew consent|0|||
145928368|NCT04015518|526245062|FG004|Overall Study|Withdrew consent|0|||
145928369|NCT04015518|526245058|FG000|Overall Study|Prostate carcinoma|1|||
145928370|NCT04015518|526245059|FG001|Overall Study|Prostate carcinoma|0|||
145928371|NCT04015518|526245060|FG002|Overall Study|Prostate carcinoma|0|||
145928372|NCT04015518|526245061|FG003|Overall Study|Prostate carcinoma|0|||
146090726|NCT00542451|526852657|FG000|Overall Study|Lost to Follow-up|10|||
146090727|NCT01309893|526852662|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
146090728|NCT01309893|526852663|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
146090729|NCT01309893|526852662|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
146090730|NCT01309893|526852663|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
146090731|NCT01343901|526852664|FG000|Overall Study|Death|85|||
146090732|NCT01343901|526852664|FG000|Overall Study|Physician Decision|4|||
146090733|NCT01343901|526852664|FG000|Overall Study|Lost to Follow-up|12|||
145928373|NCT04015518|526245062|FG004|Overall Study|Prostate carcinoma|0|||
145928374|NCT04015518|526245058|FG000|Overall Study|Could not keep appointments due to work|1|||
145928375|NCT04015518|526245059|FG001|Overall Study|Could not keep appointments due to work|0|||
145928376|NCT04015518|526245060|FG002|Overall Study|Could not keep appointments due to work|0|||
145928377|NCT04015518|526245061|FG003|Overall Study|Could not keep appointments due to work|0|||
145928378|NCT04015518|526245062|FG004|Overall Study|Could not keep appointments due to work|0|||
145928379|NCT00550745|526245063|FG000|Overall Study|Death|20|||
145928380|NCT00550745|526245064|FG001|Overall Study|Death|16|||
145928381|NCT00550745|526245063|FG000|Overall Study|Lost to Follow-up|45|||
145928382|NCT00550745|526245064|FG001|Overall Study|Lost to Follow-up|30|||
145928383|NCT00550745|526245063|FG000|Overall Study|Physician Decision|0|||
145928384|NCT00550745|526245064|FG001|Overall Study|Physician Decision|2|||
145928385|NCT00550745|526245063|FG000|Overall Study|Protocol Violation|4|||
145928386|NCT00550745|526245064|FG001|Overall Study|Protocol Violation|2|||
145928387|NCT00550745|526245063|FG000|Overall Study|Withdrawal by Subject|17|||
145928388|NCT00550745|526245064|FG001|Overall Study|Withdrawal by Subject|10|||
145928389|NCT00550745|526245063|FG000|Overall Study|Screen failure|1|||
145928390|NCT00550745|526245064|FG001|Overall Study|Screen failure|0|||
145928391|NCT01131455|526245065|FG000|Overall Study|Death of PI|6|||
145928392|NCT01131455|526245066|FG001|Overall Study|Death of PI|4|||
145928393|NCT01131455|526245067|FG002|Overall Study|Death of PI|0|||
145928394|NCT00764660|526245068|FG000|Overall Study|Adverse Event|6|||
145928395|NCT00764660|526245069|FG001|Overall Study|Adverse Event|3|||
145928396|NCT00764660|526245068|FG000|Overall Study|Lost to Follow-up|3|||
145928397|NCT00764660|526245069|FG001|Overall Study|Lost to Follow-up|4|||
145928398|NCT00764660|526245068|FG000|Overall Study|Withdrawal by Subject|7|||
145928399|NCT00764660|526245069|FG001|Overall Study|Withdrawal by Subject|3|||
145928400|NCT00764660|526245068|FG000|Overall Study|Noncompliance With Protocol|5|||
145928401|NCT00764660|526245069|FG001|Overall Study|Noncompliance With Protocol|1|||
145928402|NCT00764660|526245068|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
145928403|NCT00764660|526245069|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
145928404|NCT00734162|526246923|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
145928405|NCT00734162|526246924|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
145928406|NCT00734162|526246925|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
145928407|NCT00734162|526246926|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
145928408|NCT00734162|526246923|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145928409|NCT00734162|526246924|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145928410|NCT00734162|526246925|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145928411|NCT00734162|526246926|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
145928412|NCT00734162|526246923|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
145928413|NCT00734162|526246924|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145928414|NCT00734162|526246925|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145928415|NCT00734162|526246926|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145928416|NCT00734162|526246923|FG000|Open-Label Phase|Withdrew Consent|1|||
145977664|NCT01482221|526429263|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
145977665|NCT01482221|526429264|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
145977666|NCT01482221|526429262|FG000|Overall Study|Adverse Event|1|||
145977667|NCT01482221|526429263|FG001|Overall Study|Adverse Event|7|||
145977668|NCT01482221|526429264|FG002|Overall Study|Adverse Event|3|||
145977669|NCT01482221|526429262|FG000|Overall Study|Withdrawal by Subject|10|||
145977670|NCT01482221|526429263|FG001|Overall Study|Withdrawal by Subject|7|||
145977671|NCT01482221|526429264|FG002|Overall Study|Withdrawal by Subject|12|||
146090734|NCT01343901|526852664|FG000|Overall Study|Management by another medical team|11|||
146090735|NCT01343901|526852664|FG000|Overall Study|Participant decision|1|||
146090736|NCT01369485|526852665|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
146243323|NCT01218594|527405387|FG000|Overall Study|Withdrawal by Subject|3|||
145928417|NCT00734162|526246924|FG001|Open-Label Phase|Withdrew Consent|0|||
145977672|NCT01482221|526429262|FG000|Overall Study|Incorrect randomization|0|||
145977673|NCT01482221|526429263|FG001|Overall Study|Incorrect randomization|1|||
145977674|NCT01482221|526429264|FG002|Overall Study|Incorrect randomization|0|||
146090737|NCT01369485|526852666|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
146090738|NCT01369485|526852665|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
145928418|NCT00734162|526246925|FG002|Open-Label Phase|Withdrew Consent|1|||
145928419|NCT00734162|526246926|FG003|Open-Label Phase|Withdrew Consent|1|||
145928420|NCT00734162|526246923|FG000|Open-Label Phase|Lost to Follow-up|1|||
146243324|NCT01218594|527405387|FG000|Overall Study|Adverse Event|2|||
145928421|NCT00734162|526246924|FG001|Open-Label Phase|Lost to Follow-up|2|||
145928422|NCT00734162|526246925|FG002|Open-Label Phase|Lost to Follow-up|0|||
145928423|NCT00734162|526246926|FG003|Open-Label Phase|Lost to Follow-up|1|||
145928424|NCT00734162|526246923|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145928425|NCT00734162|526246924|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145928426|NCT00734162|526246925|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145928427|NCT00734162|526246926|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
146090739|NCT01369485|526852666|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
146090740|NCT01369485|526852665|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
146090741|NCT01369485|526852666|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
146090742|NCT01369485|526852665|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
146090743|NCT01369485|526852666|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
146090744|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
146090745|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
146090746|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
146090747|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
146090748|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
146090749|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
146090750|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
146090751|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
146090752|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
146090753|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
146090754|NCT01369485|526852665|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
146090755|NCT01369485|526852666|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
146090756|NCT00873860|526852667|FG000|Overall Study|Lost to Follow-up|1|||
145928428|NCT00300885|526246927|FG000|Treatment|Adverse Event|134|||
145928429|NCT00300885|526246928|FG001|Treatment|Adverse Event|82|||
146090757|NCT00873860|526852668|FG001|Overall Study|Lost to Follow-up|0|||
145928430|NCT00300885|526246927|FG000|Treatment|Death|20|||
145928431|NCT00300885|526246928|FG001|Treatment|Death|7|||
145928432|NCT00300885|526246927|FG000|Treatment|Lack of Efficacy|1|||
145928433|NCT00300885|526246928|FG001|Treatment|Lack of Efficacy|1|||
145928434|NCT00300885|526246927|FG000|Treatment|Lost to Follow-up|3|||
145928435|NCT00300885|526246928|FG001|Treatment|Lost to Follow-up|2|||
145928436|NCT00300885|526246927|FG000|Treatment|Physician Decision|4|||
145928437|NCT00300885|526246928|FG001|Treatment|Physician Decision|5|||
145928438|NCT00300885|526246927|FG000|Treatment|Protocol Violation|11|||
145928439|NCT00300885|526246928|FG001|Treatment|Protocol Violation|11|||
145928440|NCT00300885|526246927|FG000|Treatment|Withdrawal by Subject|26|||
145928441|NCT00300885|526246928|FG001|Treatment|Withdrawal by Subject|23|||
145928442|NCT00300885|526246927|FG000|Treatment|Disease progression|171|||
145928443|NCT00300885|526246928|FG001|Treatment|Disease progression|238|||
145928444|NCT00300885|526246927|FG000|Treatment|Random code broken (subject died)|0|||
145928445|NCT00300885|526246928|FG001|Treatment|Random code broken (subject died)|1|||
145928446|NCT00300885|526246927|FG000|Treatment|Non-compliant with study medication|3|||
145928447|NCT00300885|526246928|FG001|Treatment|Non-compliant with study medication|4|||
145928448|NCT00300885|526246927|FG000|Follow-up|Death|141|||
145928449|NCT00300885|526246928|FG001|Follow-up|Death|163|||
145928450|NCT00300885|526246927|FG000|Follow-up|Lost to Follow-up|11|||
145928451|NCT00300885|526246928|FG001|Follow-up|Lost to Follow-up|7|||
145928452|NCT00300885|526246927|FG000|Follow-up|Withdrawal by Subject|26|||
145928453|NCT00300885|526246928|FG001|Follow-up|Withdrawal by Subject|25|||
145928454|NCT02058537|526246929|FG000|Overall Study|Withdrawal by Subject|1|||
145928455|NCT02582242|526246930|FG000|Overall Study|Adverse Event|4|||
145928456|NCT02582242|526246931|FG001|Overall Study|Adverse Event|3|||
145928457|NCT02582242|526246930|FG000|Overall Study|Protocol Violation|3|||
145928458|NCT02582242|526246931|FG001|Overall Study|Protocol Violation|1|||
145928459|NCT02582242|526246930|FG000|Overall Study|Lost to Follow-up|0|||
145928460|NCT02582242|526246931|FG001|Overall Study|Lost to Follow-up|1|||
146090758|NCT00873860|526852669|FG002|Overall Study|Lost to Follow-up|0|||
146090759|NCT00873860|526852670|FG003|Overall Study|Lost to Follow-up|1|||
146090760|NCT00873860|526852667|FG000|Overall Study|Withdrawal by Subject|1|||
145928461|NCT02582242|526246930|FG000|Overall Study|Withdrawal by Subject|11|||
145928462|NCT02582242|526246931|FG001|Overall Study|Withdrawal by Subject|11|||
145928463|NCT02582242|526246930|FG000|Overall Study|Unclassified|2|||
145928464|NCT02582242|526246931|FG001|Overall Study|Unclassified|1|||
145928465|NCT02101736|526246932|FG000|Overall Study|Protocol Violation|3|||
145928466|NCT02101736|526246933|FG001|Overall Study|Protocol Violation|0|||
145928467|NCT02101736|526246932|FG000|Overall Study|Withdrawal by Subject|1|||
145928468|NCT02101736|526246933|FG001|Overall Study|Withdrawal by Subject|1|||
145928469|NCT03691207|526246934|FG000|Overall Study|Death|41|||
145928470|NCT03691207|526246935|FG001|Overall Study|Death|26|||
145928471|NCT03691207|526246934|FG000|Overall Study|Lost to Follow-up|1|||
145928472|NCT03691207|526246935|FG001|Overall Study|Lost to Follow-up|1|||
145928473|NCT03691207|526246934|FG000|Overall Study|Withdrawal by Subject|2|||
145928474|NCT03691207|526246935|FG001|Overall Study|Withdrawal by Subject|8|||
145928475|NCT03691207|526246934|FG000|Overall Study|Sponsor decision|1|||
145928476|NCT03691207|526246935|FG001|Overall Study|Sponsor decision|7|||
145928477|NCT02453334|526246936|FG000|Overall Study|Death|15|||
145928478|NCT02453334|526246937|FG001|Overall Study|Death|13|||
145928479|NCT02453334|526246936|FG000|Overall Study|Adverse Event|2|||
145928480|NCT02453334|526246937|FG001|Overall Study|Adverse Event|1|||
145928481|NCT02453334|526246936|FG000|Overall Study|Lost to Follow-up|5|||
145928482|NCT02453334|526246937|FG001|Overall Study|Lost to Follow-up|9|||
145928483|NCT02453334|526246936|FG000|Overall Study|Physician Decision|1|||
145928484|NCT02453334|526246937|FG001|Overall Study|Physician Decision|0|||
145928485|NCT02453334|526246936|FG000|Overall Study|Withdrawal by Subject|17|||
145928486|NCT02453334|526246937|FG001|Overall Study|Withdrawal by Subject|13|||
145928487|NCT02453334|526246936|FG000|Overall Study|Other reason|1|||
145928488|NCT02453334|526246937|FG001|Overall Study|Other reason|4|||
145928489|NCT03981900|526246938|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
145928490|NCT03981900|526246938|FG000|Overall Study|Adverse Event|5|||
145928491|NCT03981900|526246938|FG000|Overall Study|Protocol Violation|1|||
145928492|NCT03981900|526246938|FG000|Overall Study|Withdrawal by Subject|7|||
145928493|NCT03981900|526246938|FG000|Overall Study|Lost to Follow-up|46|||
145928494|NCT03981900|526246938|FG000|Overall Study|Decision of the researcher|3|||
145928495|NCT03981900|526246938|FG000|Overall Study|Death|3|||
145928496|NCT03981900|526246938|FG000|Overall Study|Other|5|||
145928497|NCT02509507|526246945|FG000|Overall Study|Death|21|||
145928498|NCT02509507|526246946|FG001|Overall Study|Death|3|||
145928499|NCT02509507|526246947|FG002|Overall Study|Death|22|||
145928500|NCT02509507|526246948|FG003|Overall Study|Death|14|||
145928501|NCT02509507|526246949|FG004|Overall Study|Death|8|||
145928502|NCT02509507|526246950|FG005|Overall Study|Death|12|||
145928503|NCT02509507|526246951|FG006|Overall Study|Death|5|||
145928504|NCT02509507|526246952|FG007|Overall Study|Death|4|||
145928505|NCT02509507|526246953|FG008|Overall Study|Death|8|||
145928506|NCT02509507|526246945|FG000|Overall Study|Lost to Follow-up|0|||
145928507|NCT02509507|526246946|FG001|Overall Study|Lost to Follow-up|1|||
145928508|NCT02509507|526246947|FG002|Overall Study|Lost to Follow-up|0|||
145928509|NCT02509507|526246948|FG003|Overall Study|Lost to Follow-up|0|||
145928510|NCT02509507|526246949|FG004|Overall Study|Lost to Follow-up|0|||
145928511|NCT02509507|526246950|FG005|Overall Study|Lost to Follow-up|2|||
145928512|NCT02509507|526246951|FG006|Overall Study|Lost to Follow-up|0|||
145928513|NCT02509507|526246952|FG007|Overall Study|Lost to Follow-up|0|||
145928514|NCT02509507|526246953|FG008|Overall Study|Lost to Follow-up|0|||
145928515|NCT02509507|526246945|FG000|Overall Study|Withdrawal by Subject|2|||
145928516|NCT02509507|526246946|FG001|Overall Study|Withdrawal by Subject|0|||
145928517|NCT02509507|526246947|FG002|Overall Study|Withdrawal by Subject|1|||
145928518|NCT02509507|526246948|FG003|Overall Study|Withdrawal by Subject|4|||
145928519|NCT02509507|526246949|FG004|Overall Study|Withdrawal by Subject|1|||
145928520|NCT02509507|526246950|FG005|Overall Study|Withdrawal by Subject|3|||
145928521|NCT02509507|526246951|FG006|Overall Study|Withdrawal by Subject|4|||
145928522|NCT02509507|526246952|FG007|Overall Study|Withdrawal by Subject|0|||
145928523|NCT02509507|526246953|FG008|Overall Study|Withdrawal by Subject|1|||
145928524|NCT04090060|526246962|FG000|Overall Study|Lost to Follow-up|76|||
145928525|NCT04090060|526246963|FG001|Overall Study|Lost to Follow-up|77|||
145928526|NCT02490371|526246964|FG000|Overall Study|Lost to Follow-up|1|||
145928527|NCT02490371|526246965|FG001|Overall Study|Lost to Follow-up|1|||
145928528|NCT01163851|526246968|FG000|Overall Study|Site Closure|0|||
145928529|NCT01163851|526246969|FG001|Overall Study|Site Closure|1|||
145928530|NCT01163851|526246968|FG000|Overall Study|Enrolled but not treated|1|||
145928531|NCT01163851|526246969|FG001|Overall Study|Enrolled but not treated|0|||
145928532|NCT03412734|526246975|FG000|Overall Study|Incorrect labeling of samples|2|||
145928533|NCT03412734|526246976|FG001|Overall Study|Incorrect labeling of samples|0|||
145928534|NCT03412734|526246975|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
145928535|NCT03412734|526246976|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
145928536|NCT00423332|526246977|FG000|Overall Study|Adverse Event|6|||
145928537|NCT00423332|526246978|FG001|Overall Study|Adverse Event|2|||
145928538|NCT00423332|526246977|FG000|Overall Study|Withdrawal by Subject|1|||
145928539|NCT00423332|526246978|FG001|Overall Study|Withdrawal by Subject|0|||
145928540|NCT00423332|526246977|FG000|Overall Study|Condition under investigation worsened|1|||
145928541|NCT00423332|526246978|FG001|Overall Study|Condition under investigation worsened|1|||
145928542|NCT00423332|526246977|FG000|Overall Study|Progressive at Week 6|0|||
145928543|NCT00423332|526246978|FG001|Overall Study|Progressive at Week 6|1|||
145928544|NCT00423332|526246977|FG000|Overall Study|Unblinded before 12 weeks|1|||
145928545|NCT00423332|526246978|FG001|Overall Study|Unblinded before 12 weeks|3|||
145928546|NCT02035202|526246980|FG000|Overall Study|Lost to Follow-up|8|||
145928547|NCT02035202|526246981|FG001|Overall Study|Lost to Follow-up|16|||
145928548|NCT02035202|526246982|FG002|Overall Study|Lost to Follow-up|2|||
145928549|NCT00644917|526246983|FG000|Overall Study|Withdrawal by Subject|2|||
145928550|NCT00758485|526246984|FG000|Overall Study|Lost to Follow-up|0|||
145928551|NCT00758485|526246985|FG001|Overall Study|Lost to Follow-up|1|||
145928552|NCT00758485|526246984|FG000|Overall Study|Not Treated|1|||
145928553|NCT00758485|526246985|FG001|Overall Study|Not Treated|2|||
145928554|NCT00921557|526246986|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
145928555|NCT00921557|526246987|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
145928556|NCT00921557|526246988|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
145928557|NCT00921557|526246986|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
145928558|NCT00921557|526246987|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
145928559|NCT00921557|526246988|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
145928560|NCT00921557|526246986|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
145928561|NCT00921557|526246987|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
145928562|NCT00921557|526246988|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
145928563|NCT00921557|526246986|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
145928564|NCT00921557|526246987|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
145928565|NCT00921557|526246988|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
145928566|NCT00921557|526246986|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
145928567|NCT00921557|526246987|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
145928568|NCT00921557|526246988|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
145928569|NCT03259425|526246998|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
145928570|NCT02097238|526247008|FG000|Overall Study|Death|1|||
145928571|NCT02097238|526247008|FG000|Overall Study|Physician Decision|1|||
145928572|NCT02097238|526247008|FG000|Overall Study|Progressive Disease|17|||
145928573|NCT01106911|526247009|FG000|Overall Study|Physician Decision|2|||
145928574|NCT01106911|526247009|FG000|Overall Study|deemed ineligible after screening|3|||
145928575|NCT01282372|526247011|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
145928576|NCT01282372|526247011|FG000|Overall Study|Lost to Follow-up|23|||
145928577|NCT01282372|526247011|FG000|Overall Study|Withdrawal by Subject|11|||
145928578|NCT01282372|526247011|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
145928579|NCT01282372|526247011|FG000|Overall Study|Death|1|||
145928580|NCT01282372|526247011|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
145928581|NCT01282372|526247011|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
145928582|NCT01282372|526247011|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
145928583|NCT01282372|526247011|FG000|Overall Study|Adverse Event|12|||
145928584|NCT01814696|526247012|FG000|Overall Study|Withdrawal by Subject|1|||
145928585|NCT01814696|526247013|FG001|Overall Study|Withdrawal by Subject|0|||
145928586|NCT01814696|526247012|FG000|Overall Study|Randomized to wrong group|1|||
145928587|NCT01814696|526247013|FG001|Overall Study|Randomized to wrong group|0|||
145928588|NCT00713258|526247014|FG000|Overall Study|Adverse Event|2|||
145928589|NCT00713258|526247015|FG001|Overall Study|Adverse Event|4|||
145928590|NCT00713258|526247014|FG000|Overall Study|Non-Compliance|2|||
145928591|NCT00713258|526247015|FG001|Overall Study|Non-Compliance|1|||
145928592|NCT00713258|526247014|FG000|Overall Study|Other|1|||
145928593|NCT00713258|526247015|FG001|Overall Study|Other|1|||
145928594|NCT01322490|526247016|FG000|Treatment Period|Adverse Event|12|||
145928595|NCT01322490|526247017|FG001|Treatment Period|Adverse Event|18|||
145928596|NCT01322490|526247018|FG002|Treatment Period|Adverse Event|15|||
145928597|NCT01322490|526247016|FG000|Treatment Period|Death|5|||
145928598|NCT01322490|526247017|FG001|Treatment Period|Death|7|||
145928599|NCT01322490|526247018|FG002|Treatment Period|Death|3|||
145928600|NCT01322490|526247016|FG000|Treatment Period|Lack of Efficacy|89|||
145928601|NCT01322490|526247017|FG001|Treatment Period|Lack of Efficacy|100|||
145928602|NCT01322490|526247018|FG002|Treatment Period|Lack of Efficacy|112|||
145928603|NCT01322490|526247016|FG000|Treatment Period|Physician Decision|0|||
145928604|NCT01322490|526247017|FG001|Treatment Period|Physician Decision|2|||
145928605|NCT01322490|526247018|FG002|Treatment Period|Physician Decision|1|||
145928606|NCT01322490|526247016|FG000|Treatment Period|Protocol Violation|7|||
145928607|NCT01322490|526247017|FG001|Treatment Period|Protocol Violation|5|||
145928608|NCT01322490|526247018|FG002|Treatment Period|Protocol Violation|4|||
145928609|NCT01322490|526247016|FG000|Treatment Period|Withdrawal by Subject|14|||
145928610|NCT01322490|526247017|FG001|Treatment Period|Withdrawal by Subject|16|||
145928611|NCT01322490|526247018|FG002|Treatment Period|Withdrawal by Subject|11|||
145928612|NCT01322490|526247016|FG000|Treatment Period|Non-compliance with study drug|0|||
145928613|NCT01322490|526247017|FG001|Treatment Period|Non-compliance with study drug|0|||
145928614|NCT01322490|526247018|FG002|Treatment Period|Non-compliance with study drug|1|||
145928615|NCT01322490|526247016|FG000|Treatment Period|Other per report|2|||
145928616|NCT01322490|526247017|FG001|Treatment Period|Other per report|2|||
145928617|NCT01322490|526247018|FG002|Treatment Period|Other per report|1|||
145928618|NCT01322490|526247016|FG000|Treatment Period|Randomized but Not Treated|3|||
145928619|NCT01322490|526247017|FG001|Treatment Period|Randomized but Not Treated|3|||
145928620|NCT01322490|526247018|FG002|Treatment Period|Randomized but Not Treated|5|||
145928621|NCT01322490|526247016|FG000|Long Term Follow-up Period|Death|235|||
145928622|NCT01322490|526247017|FG001|Long Term Follow-up Period|Death|239|||
145928623|NCT01322490|526247018|FG002|Long Term Follow-up Period|Death|236|||
145928624|NCT01322490|526247016|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
145928625|NCT01322490|526247017|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
145928626|NCT01322490|526247018|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
145928627|NCT01322490|526247016|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
145928628|NCT01322490|526247017|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
145928629|NCT01322490|526247018|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
145928630|NCT01322490|526247016|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
145928631|NCT01322490|526247017|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
145928632|NCT01322490|526247018|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
145928633|NCT01322490|526247016|FG000|Long Term Follow-up Period|Other per report|3|||
145928634|NCT01322490|526247017|FG001|Long Term Follow-up Period|Other per report|2|||
145928635|NCT01322490|526247018|FG002|Long Term Follow-up Period|Other per report|2|||
145928636|NCT01322490|526247016|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
145928637|NCT01322490|526247017|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
145928638|NCT01322490|526247018|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
145928639|NCT02199795|526247020|FG000|Overall Study|no longer met inclusion criteria|1|||
145928640|NCT02199795|526247021|FG001|Overall Study|no longer met inclusion criteria|0|||
145928641|NCT02199795|526247020|FG000|Overall Study|withdrew due to shoulder pain|1|||
145928642|NCT02199795|526247021|FG001|Overall Study|withdrew due to shoulder pain|0|||
145928643|NCT05310071|526247038|FG000|Overall Study|Death|0|||
145928644|NCT05310071|526247039|FG001|Overall Study|Death|3|||
145928645|NCT05310071|526247038|FG000|Overall Study|Adverse Event|4|||
145928646|NCT05310071|526247039|FG001|Overall Study|Adverse Event|31|||
145928647|NCT05310071|526247038|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
145928648|NCT05310071|526247039|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
145928649|NCT05310071|526247038|FG000|Overall Study|Protocol Deviation|2|||
145928650|NCT05310071|526247039|FG001|Overall Study|Protocol Deviation|0|||
145928651|NCT05310071|526247038|FG000|Overall Study|Randomized by Mistake|0|||
145928652|NCT05310071|526247039|FG001|Overall Study|Randomized by Mistake|1|||
145928653|NCT05310071|526247038|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
145928654|NCT05310071|526247039|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
145928655|NCT05310071|526247038|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
145928656|NCT05310071|526247039|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
145928657|NCT05310071|526247038|FG000|Overall Study|Site Terminated by Sponsor|0|||
145928658|NCT05310071|526247039|FG001|Overall Study|Site Terminated by Sponsor|2|||
145928659|NCT05310071|526247038|FG000|Overall Study|Study Terminated by Sponsor|282|||
145928660|NCT05310071|526247039|FG001|Overall Study|Study Terminated by Sponsor|559|||
145928661|NCT05310071|526247038|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
145928662|NCT05310071|526247039|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
145928663|NCT05310071|526247038|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
145928664|NCT05310071|526247039|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
145928665|NCT05310071|526247038|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
145928666|NCT05310071|526247039|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
145928667|NCT05310071|526247038|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
145928668|NCT05310071|526247039|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
145928669|NCT05310071|526247038|FG000|Overall Study|Withdrawal by Participant - Other|25|||
145928670|NCT05310071|526247039|FG001|Overall Study|Withdrawal by Participant - Other|30|||
145928671|NCT05310071|526247038|FG000|Overall Study|Lost to Follow-up|2|||
145928672|NCT05310071|526247039|FG001|Overall Study|Lost to Follow-up|4|||
145928673|NCT05310071|526247038|FG000|Overall Study|Reason Not Specified|1|||
145928674|NCT05310071|526247039|FG001|Overall Study|Reason Not Specified|3|||
145928675|NCT02418949|526247040|FG000|Overall Study|Withdrawal by Subject|1|||
145928676|NCT02418949|526247041|FG001|Overall Study|Withdrawal by Subject|0|||
145928677|NCT02418949|526247042|FG002|Overall Study|Withdrawal by Subject|1|||
145928678|NCT02418949|526247043|FG003|Overall Study|Withdrawal by Subject|1|||
145928679|NCT02418949|526247040|FG000|Overall Study|Lost to Follow-up|1|||
145928680|NCT02418949|526247041|FG001|Overall Study|Lost to Follow-up|0|||
145928681|NCT02418949|526247042|FG002|Overall Study|Lost to Follow-up|1|||
145928682|NCT02418949|526247043|FG003|Overall Study|Lost to Follow-up|0|||
145928683|NCT02418949|526247040|FG000|Overall Study|Physician Decision|1|||
145928684|NCT02418949|526247041|FG001|Overall Study|Physician Decision|1|||
145928685|NCT02418949|526247042|FG002|Overall Study|Physician Decision|1|||
145928686|NCT02418949|526247043|FG003|Overall Study|Physician Decision|0|||
145928687|NCT00984542|526247048|FG000|Overall Study|disease progression|19|||
145928688|NCT00984542|526247048|FG000|Overall Study|toxicity|7|||
145928689|NCT00984542|526247048|FG000|Overall Study|Death|7|||
145928690|NCT00984542|526247048|FG000|Overall Study|complicating disease|3|||
145928691|NCT00984542|526247048|FG000|Overall Study|Withdrawal by Subject|3|||
145928692|NCT00984542|526247048|FG000|Overall Study|clinical deterioration|2|||
145928693|NCT02343939|526247049|FG000|Overall Study|Death|0|||
145928694|NCT02343939|526247050|FG001|Overall Study|Death|15|||
145928695|NCT02343939|526247051|FG002|Overall Study|Death|4|||
145928696|NCT02343939|526247052|FG003|Overall Study|Death|2|||
145928697|NCT02343939|526247053|FG004|Overall Study|Death|5|||
145977675|NCT01482221|526429262|FG000|Overall Study|Physician Decision|0|||
145977676|NCT01482221|526429263|FG001|Overall Study|Physician Decision|1|||
145977677|NCT01482221|526429264|FG002|Overall Study|Physician Decision|0|||
145977678|NCT03086343|526429265|FG000|Period 1|Adverse Event|7|||
145977679|NCT03086343|526429266|FG001|Period 1|Adverse Event|7|||
145977680|NCT03086343|526429267|FG002|Period 1|Adverse Event|0|||
145977681|NCT03086343|526429268|FG003|Period 1|Adverse Event|1|||
145977682|NCT03086343|526429265|FG000|Period 1|Withdrawal by Subject|6|||
145977683|NCT03086343|526429266|FG001|Period 1|Withdrawal by Subject|10|||
145928698|NCT02343939|526247054|FG005|Overall Study|Death|11|||
145928699|NCT02343939|526247055|FG006|Overall Study|Death|8|||
145928700|NCT02343939|526247056|FG007|Overall Study|Death|22|||
145928701|NCT02343939|526247057|FG008|Overall Study|Death|1|||
145928702|NCT02343939|526247049|FG000|Overall Study|Study terminated by sponsor|0|||
145928703|NCT02343939|526247050|FG001|Overall Study|Study terminated by sponsor|27|||
145928704|NCT02343939|526247051|FG002|Overall Study|Study terminated by sponsor|0|||
145928705|NCT02343939|526247052|FG003|Overall Study|Study terminated by sponsor|1|||
145928706|NCT02343939|526247053|FG004|Overall Study|Study terminated by sponsor|1|||
145928707|NCT02343939|526247054|FG005|Overall Study|Study terminated by sponsor|5|||
145928708|NCT02343939|526247055|FG006|Overall Study|Study terminated by sponsor|3|||
145928709|NCT02343939|526247056|FG007|Overall Study|Study terminated by sponsor|4|||
145928710|NCT02343939|526247057|FG008|Overall Study|Study terminated by sponsor|0|||
145928711|NCT02343939|526247049|FG000|Overall Study|Withdrew consent|3|||
145928712|NCT02343939|526247050|FG001|Overall Study|Withdrew consent|6|||
145928713|NCT02343939|526247051|FG002|Overall Study|Withdrew consent|1|||
145928714|NCT02343939|526247052|FG003|Overall Study|Withdrew consent|2|||
145928715|NCT02343939|526247053|FG004|Overall Study|Withdrew consent|2|||
145928716|NCT02343939|526247054|FG005|Overall Study|Withdrew consent|0|||
145928717|NCT02343939|526247055|FG006|Overall Study|Withdrew consent|0|||
145928718|NCT02343939|526247056|FG007|Overall Study|Withdrew consent|8|||
145928719|NCT02343939|526247057|FG008|Overall Study|Withdrew consent|6|||
145928720|NCT02343939|526247049|FG000|Overall Study|Treatment failure|0|||
145928721|NCT02343939|526247050|FG001|Overall Study|Treatment failure|0|||
145928722|NCT02343939|526247051|FG002|Overall Study|Treatment failure|0|||
145928723|NCT02343939|526247052|FG003|Overall Study|Treatment failure|0|||
145928724|NCT02343939|526247053|FG004|Overall Study|Treatment failure|0|||
145928725|NCT02343939|526247054|FG005|Overall Study|Treatment failure|0|||
145928726|NCT02343939|526247055|FG006|Overall Study|Treatment failure|2|||
145928727|NCT02343939|526247056|FG007|Overall Study|Treatment failure|1|||
145928728|NCT02343939|526247057|FG008|Overall Study|Treatment failure|0|||
145928729|NCT02343939|526247049|FG000|Overall Study|Investigator's discretion|0|||
145928730|NCT02343939|526247050|FG001|Overall Study|Investigator's discretion|0|||
145928731|NCT02343939|526247051|FG002|Overall Study|Investigator's discretion|0|||
145928732|NCT02343939|526247052|FG003|Overall Study|Investigator's discretion|1|||
145928733|NCT02343939|526247053|FG004|Overall Study|Investigator's discretion|0|||
145928734|NCT02343939|526247054|FG005|Overall Study|Investigator's discretion|0|||
145928735|NCT02343939|526247055|FG006|Overall Study|Investigator's discretion|1|||
145928736|NCT02343939|526247056|FG007|Overall Study|Investigator's discretion|0|||
145928737|NCT02343939|526247057|FG008|Overall Study|Investigator's discretion|0|||
145928738|NCT02343939|526247049|FG000|Overall Study|Adverse Event|0|||
145928739|NCT02343939|526247050|FG001|Overall Study|Adverse Event|0|||
145928740|NCT02343939|526247051|FG002|Overall Study|Adverse Event|0|||
145928741|NCT02343939|526247052|FG003|Overall Study|Adverse Event|0|||
145928742|NCT02343939|526247053|FG004|Overall Study|Adverse Event|0|||
145928743|NCT02343939|526247054|FG005|Overall Study|Adverse Event|1|||
145928744|NCT02343939|526247055|FG006|Overall Study|Adverse Event|0|||
145928745|NCT02343939|526247056|FG007|Overall Study|Adverse Event|0|||
145928746|NCT02343939|526247057|FG008|Overall Study|Adverse Event|0|||
145928747|NCT02343939|526247049|FG000|Overall Study|Never Treated With ENTO|0|||
145928748|NCT02343939|526247050|FG001|Overall Study|Never Treated With ENTO|0|||
145928749|NCT02343939|526247051|FG002|Overall Study|Never Treated With ENTO|0|||
145928750|NCT02343939|526247052|FG003|Overall Study|Never Treated With ENTO|0|||
145928751|NCT02343939|526247053|FG004|Overall Study|Never Treated With ENTO|0|||
145928752|NCT02343939|526247054|FG005|Overall Study|Never Treated With ENTO|0|||
145928753|NCT02343939|526247055|FG006|Overall Study|Never Treated With ENTO|1|||
145928754|NCT02343939|526247056|FG007|Overall Study|Never Treated With ENTO|2|||
145928755|NCT02343939|526247057|FG008|Overall Study|Never Treated With ENTO|0|||
145928756|NCT00460811|526247058|FG000|Overall Study|Adverse Event|4|||
145928757|NCT00460811|526247059|FG001|Overall Study|Adverse Event|6|||
145928758|NCT00460811|526247060|FG002|Overall Study|Adverse Event|3|||
145928759|NCT00460811|526247061|FG003|Overall Study|Adverse Event|10|||
145928760|NCT00460811|526247062|FG004|Overall Study|Adverse Event|2|||
145928761|NCT00460811|526247058|FG000|Overall Study|Noncompliance|1|||
145928762|NCT00460811|526247059|FG001|Overall Study|Noncompliance|0|||
145928763|NCT00460811|526247060|FG002|Overall Study|Noncompliance|0|||
145977684|NCT03086343|526429267|FG002|Period 1|Withdrawal by Subject|0|||
145977685|NCT03086343|526429268|FG003|Period 1|Withdrawal by Subject|0|||
145977686|NCT03086343|526429265|FG000|Period 1|Lost to Follow-up|1|||
145928764|NCT00460811|526247061|FG003|Overall Study|Noncompliance|2|||
145928765|NCT00460811|526247062|FG004|Overall Study|Noncompliance|1|||
145928766|NCT00460811|526247058|FG000|Overall Study|Withdrawal by Subject|7|||
145928767|NCT00460811|526247059|FG001|Overall Study|Withdrawal by Subject|7|||
145928768|NCT00460811|526247060|FG002|Overall Study|Withdrawal by Subject|6|||
145928769|NCT00460811|526247061|FG003|Overall Study|Withdrawal by Subject|3|||
145928770|NCT00460811|526247062|FG004|Overall Study|Withdrawal by Subject|11|||
145928771|NCT00460811|526247058|FG000|Overall Study|Physician Decision|1|||
145928772|NCT00460811|526247059|FG001|Overall Study|Physician Decision|0|||
145928773|NCT00460811|526247060|FG002|Overall Study|Physician Decision|0|||
145928774|NCT00460811|526247061|FG003|Overall Study|Physician Decision|0|||
145928775|NCT00460811|526247062|FG004|Overall Study|Physician Decision|0|||
145928776|NCT00460811|526247058|FG000|Overall Study|Lost to Follow-up|3|||
145928777|NCT00460811|526247059|FG001|Overall Study|Lost to Follow-up|2|||
145928778|NCT00460811|526247060|FG002|Overall Study|Lost to Follow-up|5|||
145928779|NCT00460811|526247061|FG003|Overall Study|Lost to Follow-up|3|||
145928780|NCT00460811|526247062|FG004|Overall Study|Lost to Follow-up|6|||
145928781|NCT02097745|526247063|FG000|Overall Study|Adverse Event|25|||
145928782|NCT02097745|526247063|FG000|Overall Study|Death|16|||
145928783|NCT02097745|526247063|FG000|Overall Study|Failure to Return|14|||
145928784|NCT02097745|526247063|FG000|Overall Study|Administrative/Other|27|||
145928785|NCT02097745|526247063|FG000|Overall Study|Reason Not Specified|96|||
145928786|NCT00425750|526247069|FG000|Overall Study|Death|1|||
145928787|NCT00425750|526247069|FG000|Overall Study|Withdrawal by Subject|3|||
145928788|NCT00425750|526247069|FG000|Overall Study|Adverse Event|3|||
145928789|NCT00425750|526247069|FG000|Overall Study|Progression of disease|18|||
145977687|NCT03086343|526429266|FG001|Period 1|Lost to Follow-up|3|||
145977688|NCT03086343|526429267|FG002|Period 1|Lost to Follow-up|1|||
145977689|NCT03086343|526429268|FG003|Period 1|Lost to Follow-up|0|||
145977690|NCT03086343|526429265|FG000|Period 1|Other, Not Specified|10|||
145977691|NCT03086343|526429266|FG001|Period 1|Other, Not Specified|12|||
145977692|NCT03086343|526429267|FG002|Period 1|Other, Not Specified|2|||
145977693|NCT03086343|526429268|FG003|Period 1|Other, Not Specified|1|||
145977694|NCT03086343|526429265|FG000|Period 1|Missing|1|||
145977695|NCT03086343|526429266|FG001|Period 1|Missing|0|||
145977696|NCT03086343|526429267|FG002|Period 1|Missing|0|||
145977697|NCT03086343|526429268|FG003|Period 1|Missing|0|||
145977698|NCT03086343|526429265|FG000|Period 2|Adverse Event|20|||
145977699|NCT03086343|526429266|FG001|Period 2|Adverse Event|11|||
145977700|NCT03086343|526429267|FG002|Period 2|Adverse Event|1|||
145977701|NCT03086343|526429268|FG003|Period 2|Adverse Event|2|||
145977702|NCT03086343|526429265|FG000|Period 2|Withdrawal by Subject|15|||
145977703|NCT03086343|526429266|FG001|Period 2|Withdrawal by Subject|25|||
145977704|NCT03086343|526429267|FG002|Period 2|Withdrawal by Subject|2|||
145977705|NCT03086343|526429268|FG003|Period 2|Withdrawal by Subject|2|||
145977706|NCT03086343|526429265|FG000|Period 2|Lost to Follow-up|6|||
145977707|NCT03086343|526429266|FG001|Period 2|Lost to Follow-up|11|||
145977708|NCT03086343|526429267|FG002|Period 2|Lost to Follow-up|1|||
145977709|NCT03086343|526429268|FG003|Period 2|Lost to Follow-up|0|||
145977710|NCT03086343|526429265|FG000|Period 2|COVID-19 Infection|5|||
145977711|NCT03086343|526429266|FG001|Period 2|COVID-19 Infection|0|||
145977712|NCT03086343|526429267|FG002|Period 2|COVID-19 Infection|0|||
145977713|NCT03086343|526429268|FG003|Period 2|COVID-19 Infection|0|||
145977714|NCT03086343|526429265|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
145977715|NCT03086343|526429266|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
145977716|NCT03086343|526429267|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
145977717|NCT03086343|526429268|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
145977718|NCT03086343|526429265|FG000|Period 2|Other, Not Specified|23|||
145977719|NCT03086343|526429266|FG001|Period 2|Other, Not Specified|22|||
145977720|NCT03086343|526429267|FG002|Period 2|Other, Not Specified|2|||
145977721|NCT03086343|526429268|FG003|Period 2|Other, Not Specified|4|||
145977722|NCT00741611|526429269|FG000|Overall Study|Death|0|||
146243325|NCT01218594|527405387|FG000|Overall Study|Physician Decision|6|||
145928790|NCT02099110|526247070|FG000|Overall Study|Protocol Violation|2|||
145928791|NCT02099110|526247071|FG001|Overall Study|Protocol Violation|1|||
145928792|NCT02099110|526247072|FG002|Overall Study|Protocol Violation|0|||
145928793|NCT02099110|526247073|FG003|Overall Study|Protocol Violation|3|||
145928794|NCT02099110|526247074|FG004|Overall Study|Protocol Violation|1|||
145977723|NCT00741611|526429270|FG001|Overall Study|Death|0|||
145977724|NCT00741611|526429271|FG002|Overall Study|Death|1|||
145977725|NCT00741611|526429269|FG000|Overall Study|Withdrawal by Subject|0|||
145977726|NCT00741611|526429270|FG001|Overall Study|Withdrawal by Subject|2|||
145977727|NCT00741611|526429271|FG002|Overall Study|Withdrawal by Subject|2|||
145977728|NCT04339972|526429276|FG000|Overall Study|Scheduling Issues|3|||
145977729|NCT04339972|526429277|FG001|Overall Study|Scheduling Issues|3|||
146243326|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
145928795|NCT02099110|526247070|FG000|Overall Study|Participant moved|1|||
145928796|NCT02099110|526247071|FG001|Overall Study|Participant moved|1|||
145928797|NCT02099110|526247072|FG002|Overall Study|Participant moved|1|||
145928798|NCT02099110|526247073|FG003|Overall Study|Participant moved|0|||
145977730|NCT04339972|526429276|FG000|Overall Study|dropout|1|||
145977731|NCT04339972|526429277|FG001|Overall Study|dropout|1|||
145977732|NCT04339972|526429276|FG000|Overall Study|Technical issues|1|||
145977733|NCT04339972|526429277|FG001|Overall Study|Technical issues|0|||
145928799|NCT02099110|526247074|FG004|Overall Study|Participant moved|2|||
145928800|NCT02099110|526247070|FG000|Overall Study|Withdrawal by Subject|7|||
145928801|NCT02099110|526247071|FG001|Overall Study|Withdrawal by Subject|11|||
145928802|NCT02099110|526247072|FG002|Overall Study|Withdrawal by Subject|13|||
145928803|NCT02099110|526247073|FG003|Overall Study|Withdrawal by Subject|9|||
145928804|NCT02099110|526247074|FG004|Overall Study|Withdrawal by Subject|13|||
145928805|NCT02099110|526247070|FG000|Overall Study|Adverse Event|3|||
145928806|NCT02099110|526247071|FG001|Overall Study|Adverse Event|5|||
145928807|NCT02099110|526247072|FG002|Overall Study|Adverse Event|2|||
145928808|NCT02099110|526247073|FG003|Overall Study|Adverse Event|3|||
145928809|NCT02099110|526247074|FG004|Overall Study|Adverse Event|2|||
145928810|NCT02099110|526247070|FG000|Overall Study|Lost to Follow-up|6|||
145928811|NCT02099110|526247071|FG001|Overall Study|Lost to Follow-up|12|||
145928812|NCT02099110|526247072|FG002|Overall Study|Lost to Follow-up|11|||
145928813|NCT02099110|526247073|FG003|Overall Study|Lost to Follow-up|5|||
145928814|NCT02099110|526247074|FG004|Overall Study|Lost to Follow-up|6|||
145928815|NCT02099110|526247070|FG000|Overall Study|Death|0|||
145928816|NCT02099110|526247071|FG001|Overall Study|Death|1|||
145928817|NCT02099110|526247072|FG002|Overall Study|Death|0|||
145928818|NCT02099110|526247073|FG003|Overall Study|Death|0|||
145928819|NCT02099110|526247074|FG004|Overall Study|Death|0|||
145928820|NCT02099110|526247070|FG000|Overall Study|Screen failure|0|||
145928821|NCT02099110|526247071|FG001|Overall Study|Screen failure|0|||
145928822|NCT02099110|526247072|FG002|Overall Study|Screen failure|0|||
145928823|NCT02099110|526247073|FG003|Overall Study|Screen failure|0|||
145928824|NCT02099110|526247074|FG004|Overall Study|Screen failure|1|||
145928825|NCT02099110|526247070|FG000|Overall Study|Non-compliance with study drug|2|||
145928826|NCT02099110|526247071|FG001|Overall Study|Non-compliance with study drug|0|||
145928827|NCT02099110|526247072|FG002|Overall Study|Non-compliance with study drug|0|||
145928828|NCT02099110|526247073|FG003|Overall Study|Non-compliance with study drug|0|||
145928829|NCT02099110|526247074|FG004|Overall Study|Non-compliance with study drug|1|||
145928830|NCT02099110|526247070|FG000|Overall Study|Physician Decision|3|||
145928831|NCT02099110|526247071|FG001|Overall Study|Physician Decision|0|||
145928832|NCT02099110|526247072|FG002|Overall Study|Physician Decision|1|||
145977734|NCT04339972|526429276|FG000|Overall Study|Claustraphobia|0|||
145977735|NCT04339972|526429277|FG001|Overall Study|Claustraphobia|1|||
145977736|NCT00776997|526429278|FG000|Overall Study|Adverse Event|2|||
145977737|NCT02403271|526429279|FG000|Period 1|Other varied reasons|1|||
145977738|NCT02403271|526429280|FG001|Period 1|Other varied reasons|0|||
145977739|NCT02403271|526429279|FG000|Period 2|Withdrawal by Subject|0|||
145977740|NCT02403271|526429280|FG001|Period 2|Withdrawal by Subject|14|||
145977741|NCT02403271|526429279|FG000|Period 2|Death|0|||
145977742|NCT02403271|526429280|FG001|Period 2|Death|84|||
145977743|NCT02403271|526429279|FG000|Period 2|Lost to Follow-up|0|||
145977744|NCT02403271|526429280|FG001|Period 2|Lost to Follow-up|2|||
145977745|NCT02403271|526429279|FG000|Period 2|Study Terminated by Sponsor|0|||
145977746|NCT02403271|526429280|FG001|Period 2|Study Terminated by Sponsor|14|||
145977747|NCT02403271|526429279|FG000|Period 2|Other varied reasons|0|||
145977748|NCT02403271|526429280|FG001|Period 2|Other varied reasons|10|||
145977749|NCT00221104|526429283|FG000|Overall Study|Adverse Event|1|||
145977750|NCT00221104|526429284|FG001|Overall Study|Adverse Event|0|||
145977751|NCT00221104|526429283|FG000|Overall Study|Physician Decision|1|||
145977752|NCT00221104|526429284|FG001|Overall Study|Physician Decision|0|||
145977753|NCT00221104|526429283|FG000|Overall Study|Protocol Violation|2|||
145977754|NCT00221104|526429284|FG001|Overall Study|Protocol Violation|0|||
145977755|NCT00221104|526429283|FG000|Overall Study|Withdrawal by Subject|42|||
145977756|NCT00221104|526429284|FG001|Overall Study|Withdrawal by Subject|29|||
146090761|NCT00873860|526852668|FG001|Overall Study|Withdrawal by Subject|0|||
146090762|NCT00873860|526852669|FG002|Overall Study|Withdrawal by Subject|2|||
146090763|NCT00873860|526852670|FG003|Overall Study|Withdrawal by Subject|0|||
146090764|NCT00873860|526852667|FG000|Overall Study|Death|1|||
146090765|NCT00873860|526852668|FG001|Overall Study|Death|0|||
145928833|NCT02099110|526247073|FG003|Overall Study|Physician Decision|2|||
145928834|NCT02099110|526247074|FG004|Overall Study|Physician Decision|1|||
145928835|NCT01757184|526247081|FG000|Double-blind Period|Adverse Event|1|||
146090766|NCT00873860|526852669|FG002|Overall Study|Death|0|||
146090767|NCT00873860|526852670|FG003|Overall Study|Death|0|||
145977757|NCT00221104|526429283|FG000|Overall Study|Others|37|||
145977758|NCT00221104|526429284|FG001|Overall Study|Others|47|||
145977759|NCT02989389|526429285|FG000|Period 1|Lost to Follow-up|0|||
145977760|NCT02989389|526429286|FG001|Period 1|Lost to Follow-up|1|||
146090768|NCT00873860|526852667|FG000|Overall Study|Other|1|||
146090769|NCT00873860|526852668|FG001|Overall Study|Other|0|||
145928836|NCT01757184|526247082|FG001|Double-blind Period|Adverse Event|0|||
145928837|NCT01757184|526247083|FG002|Double-blind Period|Adverse Event|0|||
145928838|NCT01757184|526247084|FG003|Double-blind Period|Adverse Event|0|||
145928839|NCT01757184|526247081|FG000|Open-label Period|Lost to Follow-up|0|||
145928840|NCT01757184|526247082|FG001|Open-label Period|Lost to Follow-up|0|||
145977761|NCT02989389|526429287|FG002|Period 1|Lost to Follow-up|0|||
145977762|NCT02989389|526429288|FG003|Period 1|Lost to Follow-up|0|||
145928841|NCT01757184|526247083|FG002|Open-label Period|Lost to Follow-up|2|||
145928842|NCT01757184|526247084|FG003|Open-label Period|Lost to Follow-up|0|||
145928843|NCT01757184|526247081|FG000|Open-label Period|Withdrawal by Subject|0|||
145928844|NCT01757184|526247082|FG001|Open-label Period|Withdrawal by Subject|0|||
145928845|NCT01757184|526247083|FG002|Open-label Period|Withdrawal by Subject|1|||
145928846|NCT01757184|526247084|FG003|Open-label Period|Withdrawal by Subject|1|||
145928847|NCT01757184|526247081|FG000|Open-label Period|Discontinued by Sponsor|0|||
145928848|NCT01757184|526247082|FG001|Open-label Period|Discontinued by Sponsor|0|||
145928849|NCT01757184|526247083|FG002|Open-label Period|Discontinued by Sponsor|1|||
145928850|NCT01757184|526247084|FG003|Open-label Period|Discontinued by Sponsor|2|||
145928851|NCT03515811|526247087|FG000|Overall Study|Lost to Follow-up|2|||
145928852|NCT03515811|526247088|FG001|Overall Study|Lost to Follow-up|1|||
145928853|NCT03515811|526247087|FG000|Overall Study|Protocol Violation|1|||
145928854|NCT03515811|526247088|FG001|Overall Study|Protocol Violation|1|||
145928855|NCT03515811|526247087|FG000|Overall Study|Death|1|||
145928856|NCT03515811|526247088|FG001|Overall Study|Death|1|||
145928857|NCT03515811|526247087|FG000|Overall Study|Withdrawal by Subject|0|||
145928858|NCT03515811|526247088|FG001|Overall Study|Withdrawal by Subject|2|||
145928859|NCT03515811|526247087|FG000|Overall Study|Technical Problems|1|||
145928860|NCT03515811|526247088|FG001|Overall Study|Technical Problems|0|||
145928861|NCT03515811|526247087|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
145928862|NCT03515811|526247088|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
145928863|NCT03515811|526247087|FG000|Overall Study|COVID-19|0|||
145928864|NCT03515811|526247088|FG001|Overall Study|COVID-19|1|||
145928865|NCT02977572|526247089|FG000|Overall Study|Exclusion criterion|2|||
145928866|NCT02977572|526247090|FG001|Overall Study|Exclusion criterion|2|||
145928867|NCT03694002|526248454|FG000|Overall Study|Progression|4|||
145928868|NCT03694002|526248455|FG001|Overall Study|Progression|2|||
145928869|NCT03694002|526248454|FG000|Overall Study|Adverse Event|2|||
145928870|NCT03694002|526248455|FG001|Overall Study|Adverse Event|0|||
145928871|NCT03694002|526248454|FG000|Overall Study|Other not protocol specified|1|||
145928872|NCT03694002|526248455|FG001|Overall Study|Other not protocol specified|0|||
145928873|NCT03694002|526248454|FG000|Overall Study|Ineligible|0|||
145928874|NCT03694002|526248455|FG001|Overall Study|Ineligible|1|||
145928875|NCT03694002|526248454|FG000|Overall Study|Withdrew consent before starting treatment|0|||
145928876|NCT03694002|526248455|FG001|Overall Study|Withdrew consent before starting treatment|3|||
145928877|NCT05678959|526248456|FG000|Overall Study|Study Terminated by Sponsor|76|||
145928878|NCT05678959|526248457|FG001|Overall Study|Study Terminated by Sponsor|76|||
145928879|NCT05678959|526248456|FG000|Overall Study|Physician Decision|2|||
145928880|NCT05678959|526248457|FG001|Overall Study|Physician Decision|3|||
145928881|NCT05678959|526248456|FG000|Overall Study|Adverse Event|1|||
145928882|NCT05678959|526248457|FG001|Overall Study|Adverse Event|1|||
145928883|NCT05678959|526248456|FG000|Overall Study|Guardian Decision|1|||
145928884|NCT05678959|526248457|FG001|Overall Study|Guardian Decision|0|||
145928885|NCT05678959|526248456|FG000|Overall Study|Protocol Deviation|0|||
145928886|NCT05678959|526248457|FG001|Overall Study|Protocol Deviation|1|||
145928887|NCT05678959|526248456|FG000|Overall Study|Subject Decision|1|||
145928888|NCT05678959|526248457|FG001|Overall Study|Subject Decision|0|||
145928889|NCT05678959|526248456|FG000|Overall Study|Technical Problem|0|||
145928890|NCT05678959|526248457|FG001|Overall Study|Technical Problem|1|||
145928891|NCT06360588|526248458|FG000|Overall Study|Adverse Event|3|||
145928892|NCT06360588|526248458|FG000|Overall Study|Death|2|||
145928893|NCT06360588|526248458|FG000|Overall Study|Disease Progression|14|||
145928894|NCT06360588|526248458|FG000|Overall Study|Withdrawal by Subject|1|||
145928895|NCT06360588|526248458|FG000|Overall Study|Lack of Efficacy|1|||
145928896|NCT06360588|526248458|FG000|Overall Study|Ineligible|1|||
145928897|NCT01481766|526248459|FG000|4 months|Lost to Follow-up|3|||
145928898|NCT01481766|526248460|FG001|4 months|Lost to Follow-up|2|||
145928899|NCT01481766|526248461|FG002|4 months|Lost to Follow-up|1|||
145928900|NCT01481766|526248462|FG003|4 months|Lost to Follow-up|5|||
145928901|NCT01481766|526248459|FG000|12 months|Lost to Follow-up|7|||
145928902|NCT01481766|526248460|FG001|12 months|Lost to Follow-up|8|||
145928903|NCT01481766|526248461|FG002|12 months|Lost to Follow-up|5|||
146243327|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
146243328|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
146243329|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
145928904|NCT01481766|526248462|FG003|12 months|Lost to Follow-up|3|||
145928905|NCT00754234|526248463|FG000|Overall Study|Withdrawal by Subject|3|||
145928906|NCT03868930|526248464|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
145928907|NCT03868930|526248465|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
145928908|NCT03868930|526248464|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
145928909|NCT03868930|526248465|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
145928910|NCT03868930|526248464|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
145928911|NCT03868930|526248465|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
145928912|NCT03868930|526248464|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
145928913|NCT03868930|526248465|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
145928914|NCT03868930|526248464|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
145928915|NCT03868930|526248465|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
145928916|NCT04432831|526248466|FG000|Overall Study|Withdrawal by Subject|24|||
145928917|NCT04432831|526248467|FG001|Overall Study|Withdrawal by Subject|28|||
145928918|NCT04432831|526248468|FG002|Overall Study|Withdrawal by Subject|21|||
145928919|NCT04432831|526248466|FG000|Overall Study|Death|23|||
145928920|NCT04432831|526248467|FG001|Overall Study|Death|23|||
145928921|NCT04432831|526248468|FG002|Overall Study|Death|17|||
145928922|NCT04432831|526248466|FG000|Overall Study|Lost to Follow-up|15|||
145928923|NCT04432831|526248467|FG001|Overall Study|Lost to Follow-up|15|||
145928924|NCT04432831|526248468|FG002|Overall Study|Lost to Follow-up|12|||
145928925|NCT04432831|526248466|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
145928926|NCT04432831|526248467|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
145928927|NCT04432831|526248468|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
145928928|NCT04432831|526248466|FG000|Overall Study|Reason Not Specified|7|||
145928929|NCT04432831|526248467|FG001|Overall Study|Reason Not Specified|11|||
145928930|NCT04432831|526248468|FG002|Overall Study|Reason Not Specified|9|||
145928931|NCT04432831|526248466|FG000|Overall Study|Adverse Event|7|||
145928932|NCT04432831|526248467|FG001|Overall Study|Adverse Event|7|||
145928933|NCT04432831|526248468|FG002|Overall Study|Adverse Event|7|||
145928934|NCT04432831|526248466|FG000|Overall Study|Physician Decision|1|||
145928935|NCT04432831|526248467|FG001|Overall Study|Physician Decision|3|||
145928936|NCT04432831|526248468|FG002|Overall Study|Physician Decision|6|||
145928937|NCT04432831|526248466|FG000|Overall Study|Protocol Violation|1|||
145928938|NCT04432831|526248467|FG001|Overall Study|Protocol Violation|0|||
145928939|NCT04432831|526248468|FG002|Overall Study|Protocol Violation|2|||
145928940|NCT04432831|526248466|FG000|Overall Study|Pregnancy|0|||
145928941|NCT04432831|526248467|FG001|Overall Study|Pregnancy|1|||
145928942|NCT04432831|526248468|FG002|Overall Study|Pregnancy|0|||
145928943|NCT04432831|526248466|FG000|Overall Study|Lack of Efficacy|0|||
145928944|NCT04432831|526248467|FG001|Overall Study|Lack of Efficacy|0|||
145928945|NCT04432831|526248468|FG002|Overall Study|Lack of Efficacy|2|||
145928946|NCT00596687|526248471|FG000|Overall Study|< 24 hours of insulin treatment|8|||
145928947|NCT00596687|526248472|FG001|Overall Study|< 24 hours of insulin treatment|6|||
145928948|NCT00596687|526248471|FG000|Overall Study|continuous insulin infusion during TPN|2|||
145928949|NCT00596687|526248472|FG001|Overall Study|continuous insulin infusion during TPN|1|||
145928950|NCT00596687|526248471|FG000|Overall Study|Withdrawal by Subject|3|||
145928951|NCT00596687|526248472|FG001|Overall Study|Withdrawal by Subject|1|||
145928952|NCT00596687|526248471|FG000|Overall Study|cancelled surgery|1|||
145928953|NCT00596687|526248472|FG001|Overall Study|cancelled surgery|1|||
145928954|NCT01262287|526248473|FG000|Overall Study|Lost to Follow-up|2|||
145928955|NCT01262287|526248474|FG001|Overall Study|Lost to Follow-up|1|||
145928956|NCT04134767|526248475|FG000|Overall Study|Death|0|||
145928957|NCT04134767|526248476|FG001|Overall Study|Death|1|||
145928958|NCT04134767|526248475|FG000|Overall Study|Removed for harassing staff|0|||
145928959|NCT04134767|526248476|FG001|Overall Study|Removed for harassing staff|1|||
145928960|NCT04134767|526248475|FG000|Overall Study|Lost to Follow-up|44|||
145928961|NCT04134767|526248476|FG001|Overall Study|Lost to Follow-up|40|||
145928962|NCT00638404|526248477|FG000|Overall Study|Physician Decision|8|||
145928963|NCT00638404|526248478|FG001|Overall Study|Physician Decision|0|||
145928964|NCT02492984|526248479|FG000|Overall Study|Adverse Event|1|||
145928965|NCT02492984|526248480|FG001|Overall Study|Adverse Event|0|||
145928966|NCT02492984|526248479|FG000|Overall Study|Protocol Violation|1|||
145928967|NCT02492984|526248480|FG001|Overall Study|Protocol Violation|0|||
145928968|NCT02492984|526248479|FG000|Overall Study|Withdrawal by Subject|1|||
145928969|NCT02492984|526248480|FG001|Overall Study|Withdrawal by Subject|0|||
145928970|NCT02282631|526248481|FG000|Overall Study|Lost to Follow-up|2|||
145928971|NCT02282631|526248482|FG001|Overall Study|Lost to Follow-up|0|||
145928972|NCT01515865|526248484|FG000|Part A (Open-label)|Other|3|||
145928973|NCT01515865|526248485|FG001|Part A (Open-label)|Other|0|||
145928974|NCT01515865|526248486|FG002|Part A (Open-label)|Other|0|||
145928975|NCT01515865|526248484|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
145928976|NCT01515865|526248485|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
145928977|NCT01515865|526248486|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
145928978|NCT01515865|526248484|FG000|Part B (Open-label)|Other|1|||
145928979|NCT01515865|526248485|FG001|Part B (Open-label)|Other|0|||
145928980|NCT01515865|526248486|FG002|Part B (Open-label)|Other|0|||
145928981|NCT02510664|526248487|FG000|Overall Study|Transferred Care|9|||
145928982|NCT02510664|526248488|FG001|Overall Study|Transferred Care|9|||
145928983|NCT02510664|526248489|FG002|Overall Study|Transferred Care|0|||
145928984|NCT02510664|526248487|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
145928985|NCT02510664|526248488|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
145977763|NCT02989389|526429289|FG004|Period 1|Lost to Follow-up|0|||
145928986|NCT02510664|526248489|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
145928987|NCT02510664|526248487|FG000|Overall Study|Time Constraints|1|||
145928988|NCT02510664|526248488|FG001|Overall Study|Time Constraints|1|||
145928989|NCT02510664|526248489|FG002|Overall Study|Time Constraints|0|||
145928990|NCT02801617|526248490|FG000|Overall Study|Protocol Violation|2|||
145928991|NCT02801617|526248491|FG001|Overall Study|Protocol Violation|6|||
145928992|NCT01718535|526248499|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
145928993|NCT01718535|526248500|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
145928994|NCT01718535|526248501|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
145928995|NCT01718535|526248502|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
145928996|NCT01718535|526248503|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
145928997|NCT01718535|526248504|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
145928998|NCT01718535|526248505|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
145928999|NCT01718535|526248506|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
145929000|NCT01718535|526248507|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
145929001|NCT01718535|526248508|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
145929002|NCT00740792|526248514|FG000|Overall Study|Adverse Event|3|||
145929003|NCT00740792|526248515|FG001|Overall Study|Adverse Event|1|||
145929004|NCT00740792|526248516|FG002|Overall Study|Adverse Event|1|||
145929005|NCT00740792|526248517|FG003|Overall Study|Adverse Event|3|||
145929006|NCT00740792|526248514|FG000|Overall Study|Lack of Efficacy|1|||
145929007|NCT00740792|526248515|FG001|Overall Study|Lack of Efficacy|1|||
145929008|NCT00740792|526248516|FG002|Overall Study|Lack of Efficacy|0|||
145929009|NCT00740792|526248517|FG003|Overall Study|Lack of Efficacy|3|||
145929010|NCT00740792|526248514|FG000|Overall Study|Lost to Follow-up|2|||
145929011|NCT00740792|526248515|FG001|Overall Study|Lost to Follow-up|1|||
145929012|NCT00740792|526248516|FG002|Overall Study|Lost to Follow-up|0|||
145929013|NCT00740792|526248517|FG003|Overall Study|Lost to Follow-up|0|||
145929014|NCT00740792|526248514|FG000|Overall Study|Protocol Violation|0|||
145929015|NCT00740792|526248515|FG001|Overall Study|Protocol Violation|1|||
145929016|NCT00740792|526248516|FG002|Overall Study|Protocol Violation|0|||
145929017|NCT00740792|526248517|FG003|Overall Study|Protocol Violation|2|||
145929018|NCT00740792|526248514|FG000|Overall Study|Withdrawal by Subject|1|||
145929019|NCT00740792|526248515|FG001|Overall Study|Withdrawal by Subject|1|||
145929020|NCT00740792|526248516|FG002|Overall Study|Withdrawal by Subject|0|||
145929021|NCT00740792|526248517|FG003|Overall Study|Withdrawal by Subject|0|||
145929022|NCT00740792|526248514|FG000|Overall Study|administrative|3|||
145929023|NCT00740792|526248515|FG001|Overall Study|administrative|3|||
145929024|NCT00740792|526248516|FG002|Overall Study|administrative|8|||
145929025|NCT00740792|526248517|FG003|Overall Study|administrative|2|||
145929026|NCT00179660|526248520|FG000|Overall Study|Adverse Event|7|||
145929027|NCT00179660|526248520|FG000|Overall Study|Lack of therapeutic effect|28|||
145929028|NCT00179660|526248520|FG000|Overall Study|Withdrawal by Subject|2|||
145929029|NCT00179660|526248520|FG000|Overall Study|Lost to Follow-up|1|||
145929030|NCT00179660|526248520|FG000|Overall Study|Death|3|||
145929031|NCT00179660|526248520|FG000|Overall Study|Other - Unspecified|9|||
145929032|NCT01431716|526248530|FG000|Overall Study|Withdrawal of consent|1|||
145929033|NCT00708214|526248531|FG000|Overall Study|Other Adverse Event|3|||
145929034|NCT00708214|526248532|FG001|Overall Study|Other Adverse Event|6|||
145929035|NCT00708214|526248533|FG002|Overall Study|Other Adverse Event|2|||
145929036|NCT00708214|526248531|FG000|Overall Study|Other|0|||
145929037|NCT00708214|526248532|FG001|Overall Study|Other|1|||
145929038|NCT00708214|526248533|FG002|Overall Study|Other|1|||
145929039|NCT00708214|526248531|FG000|Overall Study|Progressive Disease|4|||
145929040|NCT00708214|526248532|FG001|Overall Study|Progressive Disease|6|||
145929041|NCT00708214|526248533|FG002|Overall Study|Progressive Disease|5|||
145929042|NCT05708976|526248543|FG000|Overall Study|Withdrawal by Subject|0|||
145929043|NCT05708976|526248544|FG001|Overall Study|Withdrawal by Subject|1|||
145929044|NCT00183885|526248547|FG000|Overall Study|Adverse Event|11|||
145929045|NCT00183885|526248547|FG000|Overall Study|Death|1|||
145929046|NCT00183885|526248547|FG000|Overall Study|Lost to Follow-up|3|||
145929047|NCT00183885|526248547|FG000|Overall Study|Physician Decision|6|||
145929048|NCT00183885|526248547|FG000|Overall Study|Withdrawal by Subject|5|||
145929049|NCT00183885|526248547|FG000|Overall Study|Switched to alternative treatment|8|||
145929050|NCT00183885|526248547|FG000|Overall Study|Treatment delayed too long|4|||
145929051|NCT00183885|526248547|FG000|Overall Study|Developed second malignancy|1|||
145929052|NCT00014495|526248548|FG000|Overall Study|Death|0|||
145929053|NCT00014495|526248549|FG001|Overall Study|Death|0|||
145929054|NCT00014495|526248550|FG002|Overall Study|Death|1|||
145929055|NCT00014495|526248551|FG003|Overall Study|Death|0|||
145977764|NCT02989389|526429290|FG005|Period 1|Lost to Follow-up|0|||
145929056|NCT00014495|526248548|FG000|Overall Study|Clinical deterioration|0|||
145929057|NCT00014495|526248549|FG001|Overall Study|Clinical deterioration|0|||
145929058|NCT00014495|526248550|FG002|Overall Study|Clinical deterioration|0|||
145929059|NCT00014495|526248551|FG003|Overall Study|Clinical deterioration|1|||
145929060|NCT02091089|526248586|FG000|Overall Study|Lost to Follow-up|2|||
145929061|NCT02929589|526248587|FG000|Overall Study|Withdrawal by Subject|1|||
145929062|NCT02929589|526248588|FG001|Overall Study|Withdrawal by Subject|0|||
145929063|NCT02929589|526248589|FG002|Overall Study|Withdrawal by Subject|0|||
145929064|NCT02929589|526248590|FG003|Overall Study|Withdrawal by Subject|0|||
145929065|NCT02929589|526248587|FG000|Overall Study|Physician Decision|2|||
145929066|NCT02929589|526248588|FG001|Overall Study|Physician Decision|0|||
145929067|NCT02929589|526248589|FG002|Overall Study|Physician Decision|0|||
145929068|NCT02929589|526248590|FG003|Overall Study|Physician Decision|0|||
145929069|NCT01303172|526248595|FG000|Overall Study|Physician Decision|9|||
145929070|NCT01303172|526248596|FG001|Overall Study|Physician Decision|6|||
145929071|NCT01303172|526248595|FG000|Overall Study|Adverse Event|5|||
145929072|NCT01303172|526248596|FG001|Overall Study|Adverse Event|2|||
145929073|NCT01303172|526248595|FG000|Overall Study|Withdrawal by Subject|4|||
145929074|NCT01303172|526248596|FG001|Overall Study|Withdrawal by Subject|2|||
145929075|NCT01303172|526248595|FG000|Overall Study|Death|20|||
145929076|NCT01303172|526248596|FG001|Overall Study|Death|7|||
145929077|NCT01303172|526248595|FG000|Overall Study|Lack of Efficacy|25|||
145929078|NCT01303172|526248596|FG001|Overall Study|Lack of Efficacy|17|||
145929079|NCT00994461|526248599|FG000|Overall Study|Adverse Event|2|||
145929080|NCT00994461|526248600|FG001|Overall Study|Adverse Event|1|||
145929081|NCT00994461|526248601|FG002|Overall Study|Adverse Event|0|||
145929082|NCT00591565|526248606|FG000|Overall Study|lost follow up, withdrawn|5|||
145929083|NCT01863667|526248608|FG000|Overall Study|Adverse Event|1|||
145929084|NCT01863667|526248609|FG001|Overall Study|Adverse Event|0|||
145929085|NCT01863667|526248608|FG000|Overall Study|Study terminated by Sponsor|30|||
145929086|NCT01863667|526248609|FG001|Overall Study|Study terminated by Sponsor|30|||
145929087|NCT01863667|526248608|FG000|Overall Study|Withdrawal by Subject|2|||
145929088|NCT01863667|526248609|FG001|Overall Study|Withdrawal by Subject|2|||
145929089|NCT03627546|526248610|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
145929090|NCT03627546|526248611|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
145929091|NCT03627546|526248612|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
145929092|NCT03627546|526248610|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
145929093|NCT03627546|526248611|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
145929094|NCT03627546|526248612|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
145929095|NCT00615550|526248615|FG000|Overall Study|Lost to Follow-up|6|||
145929096|NCT00615550|526248616|FG001|Overall Study|Lost to Follow-up|1|||
145929097|NCT01537042|526248617|FG000|Overall Study|Adverse Event|0|||
145929098|NCT01537042|526248618|FG001|Overall Study|Adverse Event|2|||
145929099|NCT01537042|526248617|FG000|Overall Study|Lack of Efficacy|0|||
145929100|NCT01537042|526248618|FG001|Overall Study|Lack of Efficacy|1|||
145929101|NCT01537042|526248617|FG000|Overall Study|Protocol Violation|0|||
145929102|NCT01537042|526248618|FG001|Overall Study|Protocol Violation|1|||
145929103|NCT01537042|526248617|FG000|Overall Study|Other|0|||
145929104|NCT01537042|526248618|FG001|Overall Study|Other|1|||
145929105|NCT02741076|526248619|FG000|Overall Study|Adverse Event|0|||
145929106|NCT02741076|526248620|FG001|Overall Study|Adverse Event|1|||
145929107|NCT02741076|526248621|FG002|Overall Study|Adverse Event|1|||
145929108|NCT02741076|526248622|FG003|Overall Study|Adverse Event|0|||
145929109|NCT02741076|526248619|FG000|Overall Study|Lack of Efficacy|1|||
145929110|NCT02741076|526248620|FG001|Overall Study|Lack of Efficacy|0|||
145929111|NCT02741076|526248621|FG002|Overall Study|Lack of Efficacy|0|||
145929112|NCT02741076|526248622|FG003|Overall Study|Lack of Efficacy|0|||
145929113|NCT02741076|526248619|FG000|Overall Study|Withdrawal by Subject|0|||
145929114|NCT02741076|526248620|FG001|Overall Study|Withdrawal by Subject|1|||
145929115|NCT02741076|526248621|FG002|Overall Study|Withdrawal by Subject|0|||
145929116|NCT02741076|526248622|FG003|Overall Study|Withdrawal by Subject|0|||
145929117|NCT02741076|526248619|FG000|Overall Study|Sponsor Request|2|||
145929118|NCT02741076|526248620|FG001|Overall Study|Sponsor Request|3|||
145929119|NCT02741076|526248621|FG002|Overall Study|Sponsor Request|0|||
145929120|NCT02741076|526248622|FG003|Overall Study|Sponsor Request|1|||
145929121|NCT02741076|526248619|FG000|Overall Study|No additional information available|0|||
145929122|NCT02741076|526248620|FG001|Overall Study|No additional information available|0|||
145929123|NCT02741076|526248621|FG002|Overall Study|No additional information available|1|||
145929124|NCT02741076|526248622|FG003|Overall Study|No additional information available|1|||
145929125|NCT01779440|526248623|FG000|Overall Study|Withdrawal by Subject|3|||
145929126|NCT01779440|526248624|FG001|Overall Study|Withdrawal by Subject|5|||
145929127|NCT02965573|526248627|FG000|Overall Study|Lack of Efficacy|1|||
145929128|NCT02965573|526248628|FG001|Overall Study|Lack of Efficacy|0|||
145929129|NCT00315458|526248630|FG000|Overall Study|Administrative|0|||
145929130|NCT00315458|526248631|FG001|Overall Study|Administrative|3|||
145929131|NCT00315458|526248632|FG002|Overall Study|Administrative|8|||
145929132|NCT00315458|526248633|FG003|Overall Study|Administrative|21|||
145929133|NCT00315458|526248630|FG000|Overall Study|Adverse Event|2|||
145929134|NCT00315458|526248631|FG001|Overall Study|Adverse Event|4|||
145929135|NCT00315458|526248632|FG002|Overall Study|Adverse Event|23|||
145929136|NCT00315458|526248633|FG003|Overall Study|Adverse Event|3|||
145929137|NCT00315458|526248630|FG000|Overall Study|Lost to Follow-up|1|||
145929138|NCT00315458|526248631|FG001|Overall Study|Lost to Follow-up|2|||
145929139|NCT00315458|526248632|FG002|Overall Study|Lost to Follow-up|0|||
145929140|NCT00315458|526248633|FG003|Overall Study|Lost to Follow-up|2|||
145929141|NCT00315458|526248630|FG000|Overall Study|Withdrawal by Subject|0|||
145929142|NCT00315458|526248631|FG001|Overall Study|Withdrawal by Subject|3|||
145929143|NCT00315458|526248632|FG002|Overall Study|Withdrawal by Subject|0|||
145929144|NCT00315458|526248633|FG003|Overall Study|Withdrawal by Subject|2|||
145929145|NCT00315458|526248630|FG000|Overall Study|Lack of Efficacy|0|||
145929146|NCT00315458|526248631|FG001|Overall Study|Lack of Efficacy|0|||
145929147|NCT00315458|526248632|FG002|Overall Study|Lack of Efficacy|20|||
145929148|NCT00315458|526248633|FG003|Overall Study|Lack of Efficacy|1|||
145929149|NCT00315458|526248630|FG000|Overall Study|Did not qualify|0|||
145929150|NCT00315458|526248631|FG001|Overall Study|Did not qualify|0|||
145929151|NCT00315458|526248632|FG002|Overall Study|Did not qualify|1|||
145929152|NCT00315458|526248633|FG003|Overall Study|Did not qualify|0|||
145929153|NCT00523848|526248634|FG000|Overall Study|Adverse Event|11|||
145929154|NCT00523848|526248634|FG000|Overall Study|Withdrawal by Subject|2|||
145929155|NCT00523848|526248634|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
145929156|NCT00523848|526248634|FG000|Overall Study|Disease Progression|5|||
145929157|NCT00523848|526248634|FG000|Overall Study|Other, unspecified|4|||
145929158|NCT00086619|526248635|FG000|Overall Study|Withdrawal by Subject|6|||
145929159|NCT00086619|526248636|FG001|Overall Study|Withdrawal by Subject|6|||
145929160|NCT00086619|526248635|FG000|Overall Study|Adverse Event|8|||
145929161|NCT00086619|526248636|FG001|Overall Study|Adverse Event|10|||
145929162|NCT00086619|526248635|FG000|Overall Study|Protocol Violation|1|||
145929163|NCT00086619|526248636|FG001|Overall Study|Protocol Violation|1|||
145929164|NCT00489918|526248637|FG000|Overall Study|Withdrawal by Subject|2|||
145929165|NCT00489918|526248638|FG001|Overall Study|Withdrawal by Subject|1|||
145929166|NCT00489918|526248639|FG002|Overall Study|Withdrawal by Subject|1|||
145929167|NCT00489918|526248640|FG003|Overall Study|Withdrawal by Subject|0|||
145929168|NCT00489918|526248641|FG004|Overall Study|Withdrawal by Subject|1|||
145929169|NCT00489918|526248637|FG000|Overall Study|Adverse Event|0|||
145929170|NCT00489918|526248638|FG001|Overall Study|Adverse Event|1|||
145929171|NCT00489918|526248639|FG002|Overall Study|Adverse Event|1|||
145929172|NCT00489918|526248640|FG003|Overall Study|Adverse Event|0|||
145929173|NCT00489918|526248641|FG004|Overall Study|Adverse Event|0|||
145929174|NCT00489918|526248637|FG000|Overall Study|Lost to Follow-up|0|||
145929175|NCT00489918|526248638|FG001|Overall Study|Lost to Follow-up|0|||
145929176|NCT00489918|526248639|FG002|Overall Study|Lost to Follow-up|1|||
145929177|NCT00489918|526248640|FG003|Overall Study|Lost to Follow-up|1|||
145929178|NCT00489918|526248641|FG004|Overall Study|Lost to Follow-up|0|||
145929179|NCT00489918|526248637|FG000|Overall Study|Physician Decision|0|||
145929180|NCT00489918|526248638|FG001|Overall Study|Physician Decision|0|||
145929181|NCT00489918|526248639|FG002|Overall Study|Physician Decision|1|||
145929182|NCT00489918|526248640|FG003|Overall Study|Physician Decision|0|||
145929183|NCT00489918|526248641|FG004|Overall Study|Physician Decision|0|||
145929184|NCT02748213|526248642|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
145929185|NCT02748213|526248643|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
145929186|NCT02748213|526248642|FG000|Overall Study|Abnormal Laboratory Test|1|||
145929187|NCT02748213|526248643|FG001|Overall Study|Abnormal Laboratory Test|0|||
145929188|NCT02748213|526248642|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
145929189|NCT02748213|526248643|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
145929190|NCT02748213|526248642|FG000|Overall Study|Death|5|||
145929191|NCT02748213|526248643|FG001|Overall Study|Death|3|||
145929192|NCT02748213|526248642|FG000|Overall Study|Insufficient Therapeutic Response|56|||
145929193|NCT02748213|526248643|FG001|Overall Study|Insufficient Therapeutic Response|57|||
145929194|NCT02748213|526248642|FG000|Overall Study|Violation of Selection Criteria|2|||
145929195|NCT02748213|526248643|FG001|Overall Study|Violation of Selection Criteria|0|||
145929196|NCT02748213|526248642|FG000|Overall Study|Protocol Violation|6|||
145929197|NCT02748213|526248643|FG001|Overall Study|Protocol Violation|4|||
145929198|NCT02748213|526248642|FG000|Overall Study|Refused Treatment*|6|||
145929199|NCT02748213|526248643|FG001|Overall Study|Refused Treatment*|6|||
145929200|NCT02748213|526248642|FG000|Overall Study|Failure to Return|1|||
145929201|NCT02748213|526248643|FG001|Overall Study|Failure to Return|0|||
145929202|NCT02748213|526248642|FG000|Overall Study|Other|30|||
145929203|NCT02748213|526248643|FG001|Overall Study|Other|29|||
145929204|NCT00961350|526248645|FG000|Overall Study|Adverse Event|18|||
145929205|NCT00961350|526248646|FG001|Overall Study|Adverse Event|33|||
145929206|NCT00961350|526248645|FG000|Overall Study|Withdrawal by Subject|10|||
145929207|NCT00961350|526248646|FG001|Overall Study|Withdrawal by Subject|10|||
145929208|NCT00961350|526248645|FG000|Overall Study|Lost to Follow-up|3|||
145929209|NCT00961350|526248646|FG001|Overall Study|Lost to Follow-up|3|||
145929210|NCT00961350|526248645|FG000|Overall Study|Misc|16|||
145929211|NCT00961350|526248646|FG001|Overall Study|Misc|21|||
145929212|NCT04284774|526248649|FG000|Overall Study|Progressive disease|5|||
145929213|NCT01760655|526250196|FG000|Overall Study|Death|18|||
145929214|NCT01760655|526250196|FG000|Overall Study|Physician Decision|1|||
145929215|NCT03056638|526250209|FG000|Overall Study|Death|1|||
145929216|NCT03056638|526250210|FG001|Overall Study|Death|0|||
145929217|NCT02530125|526250211|FG000|Completed Treatment|Early termination of study|1|||
145929218|NCT02530125|526250211|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
145929219|NCT00468481|526250212|FG000|Overall Study|Adverse Event|13|||
145929220|NCT00468481|526250213|FG001|Overall Study|Adverse Event|3|||
145929221|NCT00468481|526250212|FG000|Overall Study|Lost to Follow-up|25|||
145929222|NCT00468481|526250213|FG001|Overall Study|Lost to Follow-up|8|||
145929223|NCT00468481|526250212|FG000|Overall Study|Pregnancy|2|||
145929224|NCT00468481|526250213|FG001|Overall Study|Pregnancy|0|||
145929225|NCT00468481|526250212|FG000|Overall Study|Protocol Violation|18|||
145929226|NCT00468481|526250213|FG001|Overall Study|Protocol Violation|8|||
145929227|NCT00468481|526250212|FG000|Overall Study|Withdrawal by Subject|12|||
145929228|NCT00468481|526250213|FG001|Overall Study|Withdrawal by Subject|3|||
145929229|NCT00468481|526250212|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
145929230|NCT00468481|526250213|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
145929231|NCT00468481|526250212|FG000|Overall Study|Prohibited Medication|1|||
145929232|NCT00468481|526250213|FG001|Overall Study|Prohibited Medication|1|||
145929233|NCT00468481|526250212|FG000|Overall Study|Egg Donor|1|||
145929234|NCT00468481|526250213|FG001|Overall Study|Egg Donor|0|||
145929235|NCT00468481|526250212|FG000|Overall Study|Moved out of area|4|||
145929236|NCT00468481|526250213|FG001|Overall Study|Moved out of area|1|||
145929237|NCT00468481|526250212|FG000|Overall Study|Non-Compliance|5|||
145929238|NCT00468481|526250213|FG001|Overall Study|Non-Compliance|0|||
145929239|NCT00468481|526250212|FG000|Overall Study|Other|6|||
145929240|NCT00468481|526250213|FG001|Overall Study|Other|0|||
145929241|NCT00728468|526250215|FG000|Overall Study|Enrolled but not treated|1|||
145929242|NCT00728468|526250215|FG000|Overall Study|Death|1|||
145929243|NCT00728468|526250215|FG000|Overall Study|Protocol Violation|4|||
145929244|NCT00728468|526250215|FG000|Overall Study|Objective progression or relapse|9|||
145929245|NCT00728468|526250215|FG000|Overall Study|Study terminated by sponsor|1|||
145929246|NCT01568034|526250216|FG000|Overall Study|Withdrawal by Subject|1|||
145929247|NCT01568034|526250217|FG001|Overall Study|Withdrawal by Subject|0|||
145929248|NCT01568034|526250218|FG002|Overall Study|Withdrawal by Subject|0|||
145929249|NCT01568034|526250219|FG003|Overall Study|Withdrawal by Subject|0|||
145929250|NCT01637922|526250220|FG000|Overall Study|Adverse Event|0|||
145929251|NCT01637922|526250221|FG001|Overall Study|Adverse Event|1|||
145929252|NCT01637922|526250220|FG000|Overall Study|Protocol Violation|0|||
145929253|NCT01637922|526250221|FG001|Overall Study|Protocol Violation|1|||
145929254|NCT01637922|526250220|FG000|Overall Study|Withdrawal by Subject|0|||
145929255|NCT01637922|526250221|FG001|Overall Study|Withdrawal by Subject|3|||
145929256|NCT01637922|526250220|FG000|Overall Study|Lost to Follow-up|2|||
145929257|NCT01637922|526250221|FG001|Overall Study|Lost to Follow-up|0|||
145929258|NCT02498444|526250224|FG000|Overall Study|Withdrawal by Subject|3|||
145929259|NCT02498444|526250225|FG001|Overall Study|Withdrawal by Subject|0|||
145929260|NCT02498444|526250224|FG000|Overall Study|Physician Decision|1|||
145929261|NCT02498444|526250225|FG001|Overall Study|Physician Decision|0|||
145929262|NCT03656692|526250226|FG000|Overall Study|Worsening of disease activity|2|||
145929263|NCT03656692|526250226|FG000|Overall Study|Physician Decision|1|||
145929264|NCT01841762|526250227|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
145929265|NCT01841762|526250227|FG000|Treatment Period|Adverse Event|16|||
145929266|NCT01841762|526250227|FG000|Treatment Period|Death|1|||
145929267|NCT01841762|526250227|FG000|Treatment Period|Withdrawal by Subject|7|||
145929268|NCT01841762|526250227|FG000|Treatment Period|Lost to Follow-up|1|||
145929269|NCT01841762|526250227|FG000|Treatment Period|Physician Decision|2|||
145929270|NCT01841762|526250227|FG000|Treatment Period|Other, including non-compliance|5|||
145929271|NCT01841762|526250227|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
145929272|NCT01841762|526250227|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
145929273|NCT01841762|526250227|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
145929274|NCT01841762|526250227|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
145929275|NCT02448537|526250228|FG000|Overall Study|Withdrawal by Subject|1|||
145929276|NCT02448537|526250229|FG001|Overall Study|Withdrawal by Subject|1|||
145929277|NCT02448537|526250230|FG002|Overall Study|Withdrawal by Subject|1|||
145929278|NCT01270464|526250231|FG000|Overall Study|Protocol Violation|4|||
145929279|NCT01270464|526250232|FG001|Overall Study|Protocol Violation|3|||
145929280|NCT01270464|526250233|FG002|Overall Study|Protocol Violation|2|||
145929281|NCT01270464|526250231|FG000|Overall Study|Lack of Efficacy|2|||
145929282|NCT01270464|526250232|FG001|Overall Study|Lack of Efficacy|3|||
145929283|NCT01270464|526250233|FG002|Overall Study|Lack of Efficacy|1|||
145929284|NCT01270464|526250231|FG000|Overall Study|Adverse Event|9|||
145929285|NCT01270464|526250232|FG001|Overall Study|Adverse Event|1|||
145929286|NCT01270464|526250233|FG002|Overall Study|Adverse Event|7|||
145929287|NCT01270464|526250231|FG000|Overall Study|Withdrawal by Subject|2|||
145929288|NCT01270464|526250232|FG001|Overall Study|Withdrawal by Subject|1|||
145929289|NCT01270464|526250233|FG002|Overall Study|Withdrawal by Subject|4|||
145929290|NCT01270464|526250231|FG000|Overall Study|Lost to Follow-up|2|||
145929291|NCT01270464|526250232|FG001|Overall Study|Lost to Follow-up|3|||
145929292|NCT01270464|526250233|FG002|Overall Study|Lost to Follow-up|1|||
145929293|NCT01270464|526250231|FG000|Overall Study|Other|1|||
145929294|NCT01270464|526250232|FG001|Overall Study|Other|1|||
145929295|NCT01270464|526250233|FG002|Overall Study|Other|3|||
145929296|NCT04725812|526250234|FG000|Overall Study|Withdrawal by Subject|1|||
145929297|NCT05656534|526250236|FG000|Overall Study|Withdrawal by Subject|1|||
145929298|NCT05656534|526250237|FG001|Overall Study|Withdrawal by Subject|1|||
145929299|NCT05656534|526250238|FG002|Overall Study|Withdrawal by Subject|0|||
145929300|NCT05656534|526250239|FG003|Overall Study|Withdrawal by Subject|0|||
145929301|NCT05656534|526250236|FG000|Overall Study|Physician Decision|1|||
145929302|NCT05656534|526250237|FG001|Overall Study|Physician Decision|1|||
145929303|NCT05656534|526250238|FG002|Overall Study|Physician Decision|0|||
145929304|NCT05656534|526250239|FG003|Overall Study|Physician Decision|0|||
145929305|NCT00839800|526250241|FG000|Overall Study|Adverse Event|8|||
145929306|NCT00839800|526250242|FG001|Overall Study|Adverse Event|12|||
145929307|NCT00839800|526250241|FG000|Overall Study|Lost to Follow-up|31|||
145929308|NCT00839800|526250242|FG001|Overall Study|Lost to Follow-up|26|||
145929309|NCT00839800|526250241|FG000|Overall Study|Withdrawal by Subject|28|||
145929310|NCT00839800|526250242|FG001|Overall Study|Withdrawal by Subject|34|||
145929311|NCT00839800|526250241|FG000|Overall Study|Incorrect Enrolment|3|||
145929312|NCT00839800|526250242|FG001|Overall Study|Incorrect Enrolment|3|||
145929313|NCT00839800|526250241|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
145929314|NCT00839800|526250242|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
145929315|NCT00839800|526250241|FG000|Overall Study|Safety Reasons|2|||
145929316|NCT00839800|526250242|FG001|Overall Study|Safety Reasons|1|||
145929317|NCT00839800|526250241|FG000|Overall Study|Other|8|||
145929318|NCT00839800|526250242|FG001|Overall Study|Other|14|||
145929319|NCT00839800|526250241|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
145929320|NCT00839800|526250242|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
145929321|NCT01164579|526250243|FG000|Overall Study|Lack of Efficacy|0|||
145929322|NCT01164579|526250244|FG001|Overall Study|Lack of Efficacy|0|||
145929323|NCT01164579|526250245|FG002|Overall Study|Lack of Efficacy|6|||
145929324|NCT01164579|526250243|FG000|Overall Study|Lost to Follow-up|1|||
145929325|NCT01164579|526250244|FG001|Overall Study|Lost to Follow-up|1|||
145929326|NCT01164579|526250245|FG002|Overall Study|Lost to Follow-up|0|||
145929327|NCT01164579|526250243|FG000|Overall Study|Withdrawal by Subject|2|||
145929328|NCT01164579|526250244|FG001|Overall Study|Withdrawal by Subject|5|||
145929329|NCT01164579|526250245|FG002|Overall Study|Withdrawal by Subject|3|||
145929330|NCT01164579|526250243|FG000|Overall Study|Protocol Violation|0|||
145929331|NCT01164579|526250244|FG001|Overall Study|Protocol Violation|1|||
145929332|NCT01164579|526250245|FG002|Overall Study|Protocol Violation|2|||
146243330|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
146243331|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
145929333|NCT01164579|526250243|FG000|Overall Study|Adverse Event|4|||
145929334|NCT01164579|526250244|FG001|Overall Study|Adverse Event|2|||
145929335|NCT01164579|526250245|FG002|Overall Study|Adverse Event|5|||
145929336|NCT01164579|526250243|FG000|Overall Study|Reason not specified|1|||
145929337|NCT01164579|526250244|FG001|Overall Study|Reason not specified|0|||
145929338|NCT01164579|526250245|FG002|Overall Study|Reason not specified|0|||
145929339|NCT02176655|526250249|FG000|Overall Study|Subjects did not treat|6|||
145929340|NCT06110494|526250250|FG000|Overall Study|Protocol Violation|2|||
145929341|NCT06110494|526250251|FG001|Overall Study|Protocol Violation|0|||
145929342|NCT06110494|526250252|FG002|Overall Study|Protocol Violation|1|||
145929343|NCT06110494|526250250|FG000|Overall Study|Dixon's test for outlier analysis|1|||
145929344|NCT06110494|526250251|FG001|Overall Study|Dixon's test for outlier analysis|1|||
145929345|NCT06110494|526250252|FG002|Overall Study|Dixon's test for outlier analysis|0|||
145929346|NCT00302328|526250253|FG000|Overall Study|Physician Decision|0|||
145929347|NCT00302328|526250254|FG001|Overall Study|Physician Decision|1|||
145929348|NCT00302328|526250255|FG002|Overall Study|Physician Decision|0|||
145929349|NCT01288937|526250256|FG000|Overall Study|Adverse Event|1|||
145929350|NCT01288937|526250257|FG001|Overall Study|Adverse Event|0|||
145929351|NCT01073605|526250258|FG000|Overall Study|Ongoing at Cutoff Date|1|||
145929352|NCT01073605|526250259|FG001|Overall Study|Ongoing at Cutoff Date|1|||
145929353|NCT01073605|526250260|FG002|Overall Study|Ongoing at Cutoff Date|0|||
145929354|NCT01073605|526250258|FG000|Overall Study|Adverse Event|2|||
145929355|NCT01073605|526250259|FG001|Overall Study|Adverse Event|1|||
145929356|NCT01073605|526250260|FG002|Overall Study|Adverse Event|0|||
145929357|NCT01073605|526250258|FG000|Overall Study|Lost to Follow-up|3|||
145929358|NCT01073605|526250259|FG001|Overall Study|Lost to Follow-up|4|||
145929359|NCT01073605|526250260|FG002|Overall Study|Lost to Follow-up|9|||
145929360|NCT01073605|526250258|FG000|Overall Study|Other|25|||
145929361|NCT01073605|526250259|FG001|Overall Study|Other|21|||
145929362|NCT01073605|526250260|FG002|Overall Study|Other|29|||
145929363|NCT01073605|526250258|FG000|Overall Study|Withdrawal by Subject|31|||
145929364|NCT01073605|526250259|FG001|Overall Study|Withdrawal by Subject|39|||
145929365|NCT01073605|526250260|FG002|Overall Study|Withdrawal by Subject|22|||
145929366|NCT01073605|526250258|FG000|Overall Study|Randomized But Not Treated|0|||
145929367|NCT01073605|526250259|FG001|Overall Study|Randomized But Not Treated|1|||
145929368|NCT01073605|526250260|FG002|Overall Study|Randomized But Not Treated|1|||
145929369|NCT03018080|526250261|FG000|Overall Study|Death|12|||
145929370|NCT03018080|526250262|FG001|Overall Study|Death|19|||
145929371|NCT00912743|526250269|FG000|Overall Study|Adverse Event|3|||
145929372|NCT00912743|526250270|FG001|Overall Study|Adverse Event|1|||
145929373|NCT00912743|526250269|FG000|Overall Study|Lack of Efficacy|9|||
145929374|NCT00912743|526250270|FG001|Overall Study|Lack of Efficacy|18|||
145929375|NCT00912743|526250269|FG000|Overall Study|Toxicity|0|||
145929376|NCT00912743|526250270|FG001|Overall Study|Toxicity|1|||
145929377|NCT00912743|526250269|FG000|Overall Study|End of treatment form was not collected|1|||
145929378|NCT00912743|526250270|FG001|Overall Study|End of treatment form was not collected|0|||
145929379|NCT04478695|526250282|FG000|Overall Study|Death|1|||
145929380|NCT04478695|526250283|FG001|Overall Study|Death|0|||
145929381|NCT00402688|526250284|FG000|Overall Study|Adverse Event|12|||
145929382|NCT00402688|526250285|FG001|Overall Study|Adverse Event|9|||
145929383|NCT00402688|526250286|FG002|Overall Study|Adverse Event|3|||
145929384|NCT00402688|526250284|FG000|Overall Study|Withdrawal by Subject|3|||
145929385|NCT00402688|526250285|FG001|Overall Study|Withdrawal by Subject|1|||
145929386|NCT00402688|526250286|FG002|Overall Study|Withdrawal by Subject|1|||
145929387|NCT00402688|526250284|FG000|Overall Study|Physician Decision|0|||
145929388|NCT00402688|526250285|FG001|Overall Study|Physician Decision|0|||
145929389|NCT00402688|526250286|FG002|Overall Study|Physician Decision|1|||
145929390|NCT00402688|526250284|FG000|Overall Study|Lack of Efficacy|4|||
145929391|NCT00402688|526250285|FG001|Overall Study|Lack of Efficacy|4|||
145929392|NCT00402688|526250286|FG002|Overall Study|Lack of Efficacy|5|||
145977765|NCT02989389|526429291|FG006|Period 1|Lost to Follow-up|0|||
145929393|NCT00402688|526250284|FG000|Overall Study|Protocol Violation|1|||
145929394|NCT00402688|526250285|FG001|Overall Study|Protocol Violation|1|||
145929395|NCT00402688|526250286|FG002|Overall Study|Protocol Violation|1|||
145929396|NCT00402688|526250284|FG000|Overall Study|Lost to Follow-up|1|||
145929397|NCT00402688|526250285|FG001|Overall Study|Lost to Follow-up|0|||
145929398|NCT00402688|526250286|FG002|Overall Study|Lost to Follow-up|2|||
145929399|NCT00402688|526250284|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
145929400|NCT00402688|526250285|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
145929401|NCT00402688|526250286|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
145929402|NCT00402688|526250284|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
145929403|NCT00402688|526250285|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
145929404|NCT00402688|526250286|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
145929405|NCT00402688|526250284|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
145929406|NCT00402688|526250285|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
145929407|NCT00402688|526250286|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
145929408|NCT01053663|526250290|FG000|Overall Study|Death|2|||
145929409|NCT01053663|526250290|FG000|Overall Study|Lost to Follow-up|1|||
145929410|NCT01053663|526250290|FG000|Overall Study|Poor IV Access|1|||
145929411|NCT01053663|526250290|FG000|Overall Study|Transferred to Another Hospital|1|||
145929412|NCT01053663|526250290|FG000|Overall Study|Negative Influenza Diagnosis|1|||
145929413|NCT02737930|526250293|FG000|Overall Study|Withdrawal by Subject|0|||
145929414|NCT02737930|526250294|FG001|Overall Study|Withdrawal by Subject|1|||
145929415|NCT03852264|526250295|FG000|Third Research Visit|Lost to Follow-up|1|||
145929416|NCT03852264|526250296|FG001|Third Research Visit|Lost to Follow-up|0|||
145929417|NCT04481789|526250297|FG000|Period 1|Withdrawal by Subject|1|||
145929418|NCT04481789|526250298|FG001|Period 1|Withdrawal by Subject|0|||
145929419|NCT04481789|526250299|FG002|Period 1|Withdrawal by Subject|0|||
145929420|NCT04481789|526250300|FG003|Period 1|Withdrawal by Subject|0|||
145929421|NCT04481789|526250301|FG004|Period 1|Withdrawal by Subject|0|||
145929422|NCT04481789|526250302|FG005|Period 1|Withdrawal by Subject|0|||
145929423|NCT02837731|526250310|FG000|Allocation|Admitted to General Floor|3|||
145929424|NCT02837731|526250311|FG001|Allocation|Admitted to General Floor|4|||
145929425|NCT02837731|526250310|FG000|Allocation|Immediate surgery/withdrew|2|||
145929426|NCT02837731|526250311|FG001|Allocation|Immediate surgery/withdrew|0|||
145929427|NCT02837731|526250310|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
145977766|NCT02989389|526429292|FG007|Period 1|Lost to Follow-up|0|||
145977767|NCT02989389|526429293|FG008|Period 1|Lost to Follow-up|0|||
145977768|NCT02989389|526429294|FG009|Period 1|Lost to Follow-up|0|||
145977769|NCT02989389|526429285|FG000|Period 1|Physician Decision|0|||
145977770|NCT02989389|526429286|FG001|Period 1|Physician Decision|0|||
145977771|NCT02989389|526429287|FG002|Period 1|Physician Decision|0|||
145977772|NCT02989389|526429288|FG003|Period 1|Physician Decision|0|||
145929428|NCT02837731|526250311|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
145929429|NCT02837731|526250310|FG000|Allocation|Withdrawal by Subject|2|||
145929430|NCT02837731|526250311|FG001|Allocation|Withdrawal by Subject|0|||
145929431|NCT02837731|526250310|FG000|Allocation|Device not available|1|||
145977773|NCT02989389|526429289|FG004|Period 1|Physician Decision|0|||
145977774|NCT02989389|526429290|FG005|Period 1|Physician Decision|0|||
145977775|NCT02989389|526429291|FG006|Period 1|Physician Decision|0|||
145977776|NCT02989389|526429292|FG007|Period 1|Physician Decision|0|||
145977777|NCT02989389|526429293|FG008|Period 1|Physician Decision|1|||
145929432|NCT02837731|526250311|FG001|Allocation|Device not available|0|||
145929433|NCT02837731|526250310|FG000|Allocation|Protocol not implemented|7|||
145929434|NCT02837731|526250311|FG001|Allocation|Protocol not implemented|0|||
145929435|NCT02837731|526250310|FG000|Allocation|Moribund/Do not resuscitate|2|||
145929436|NCT02837731|526250311|FG001|Allocation|Moribund/Do not resuscitate|0|||
145929437|NCT02837731|526250310|FG000|Allocation|Did not meet sepsis criteria|1|||
145929438|NCT02837731|526250311|FG001|Allocation|Did not meet sepsis criteria|2|||
145929439|NCT02837731|526250310|FG000|Allocation|Known aortic abnormalities|0|||
145929440|NCT02837731|526250311|FG001|Allocation|Known aortic abnormalities|1|||
145977778|NCT02989389|526429294|FG009|Period 1|Physician Decision|0|||
145977779|NCT01018979|526429295|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
146297774|NCT02616614|527605981|FG000|Overall Study|Other|1|||
146297775|NCT02616614|527605982|FG001|Overall Study|Other|2|||
146297776|NCT02616614|527605983|FG002|Overall Study|Other|1|||
146297777|NCT01975428|527605986|FG000|Overall Study|Lost to Follow-up|17|||
146297778|NCT01975428|527605987|FG001|Overall Study|Lost to Follow-up|4|||
145929441|NCT01209520|526250313|FG000|Overall Study|Withdrawal by Subject|3|||
145929442|NCT03850483|526250317|FG000|Treatment for Stage 1|Adverse Event|1|||
145929443|NCT03850483|526250318|FG001|Treatment for Stage 1|Adverse Event|1|||
145929444|NCT03850483|526250319|FG002|Treatment for Stage 1|Adverse Event|3|||
145929445|NCT03850483|526250320|FG003|Treatment for Stage 1|Adverse Event|0|||
145929446|NCT03850483|526250321|FG004|Treatment for Stage 1|Adverse Event|2|||
145929447|NCT03850483|526250322|FG005|Treatment for Stage 1|Adverse Event|0|||
145929448|NCT03850483|526250323|FG006|Treatment for Stage 1|Adverse Event|2|||
145929449|NCT03850483|526250324|FG007|Treatment for Stage 1|Adverse Event|2|||
145929450|NCT03850483|526250325|FG008|Treatment for Stage 1|Adverse Event|0|||
145929451|NCT03850483|526250326|FG009|Treatment for Stage 1|Adverse Event|0|||
145929452|NCT03850483|526250317|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
145929453|NCT03850483|526250318|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
145929454|NCT03850483|526250319|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
145929455|NCT03850483|526250320|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
145929456|NCT03850483|526250321|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
145929457|NCT03850483|526250322|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
145929458|NCT03850483|526250323|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
145929459|NCT03850483|526250324|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
145929460|NCT03850483|526250325|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
145929461|NCT03850483|526250326|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
145929462|NCT03850483|526250317|FG000|Treatment for Stage 1|Protocol Violation|1|||
145929463|NCT03850483|526250318|FG001|Treatment for Stage 1|Protocol Violation|0|||
145929464|NCT03850483|526250319|FG002|Treatment for Stage 1|Protocol Violation|0|||
145929465|NCT03850483|526250320|FG003|Treatment for Stage 1|Protocol Violation|0|||
145929466|NCT03850483|526250321|FG004|Treatment for Stage 1|Protocol Violation|0|||
145929467|NCT03850483|526250322|FG005|Treatment for Stage 1|Protocol Violation|0|||
145929468|NCT03850483|526250323|FG006|Treatment for Stage 1|Protocol Violation|1|||
145929469|NCT03850483|526250324|FG007|Treatment for Stage 1|Protocol Violation|0|||
145929470|NCT03850483|526250325|FG008|Treatment for Stage 1|Protocol Violation|0|||
145929471|NCT03850483|526250326|FG009|Treatment for Stage 1|Protocol Violation|0|||
145929472|NCT03850483|526250317|FG000|Treatment for Stage 1|Physician Decision|0|||
145929473|NCT03850483|526250318|FG001|Treatment for Stage 1|Physician Decision|0|||
145929474|NCT03850483|526250319|FG002|Treatment for Stage 1|Physician Decision|0|||
145929475|NCT03850483|526250320|FG003|Treatment for Stage 1|Physician Decision|0|||
145929476|NCT03850483|526250321|FG004|Treatment for Stage 1|Physician Decision|0|||
145929477|NCT03850483|526250322|FG005|Treatment for Stage 1|Physician Decision|1|||
145929478|NCT03850483|526250323|FG006|Treatment for Stage 1|Physician Decision|0|||
145929479|NCT03850483|526250324|FG007|Treatment for Stage 1|Physician Decision|0|||
145929480|NCT03850483|526250325|FG008|Treatment for Stage 1|Physician Decision|0|||
145929481|NCT03850483|526250326|FG009|Treatment for Stage 1|Physician Decision|0|||
145929482|NCT03850483|526250317|FG000|Treatment for Stage 1|Other|0|||
145929483|NCT03850483|526250318|FG001|Treatment for Stage 1|Other|0|||
145929484|NCT03850483|526250319|FG002|Treatment for Stage 1|Other|0|||
145929485|NCT03850483|526250320|FG003|Treatment for Stage 1|Other|0|||
145929486|NCT03850483|526250321|FG004|Treatment for Stage 1|Other|2|||
145929487|NCT03850483|526250322|FG005|Treatment for Stage 1|Other|1|||
145929488|NCT03850483|526250323|FG006|Treatment for Stage 1|Other|0|||
145929489|NCT03850483|526250324|FG007|Treatment for Stage 1|Other|0|||
145929490|NCT03850483|526250325|FG008|Treatment for Stage 1|Other|0|||
145929491|NCT03850483|526250326|FG009|Treatment for Stage 1|Other|0|||
145929492|NCT03850483|526250317|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929493|NCT03850483|526250318|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929494|NCT03850483|526250319|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
145929495|NCT03850483|526250320|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929496|NCT03850483|526250321|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929497|NCT03850483|526250322|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929498|NCT03850483|526250323|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929499|NCT03850483|526250324|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929500|NCT03850483|526250325|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929501|NCT03850483|526250326|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145929502|NCT03850483|526250317|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929503|NCT03850483|526250318|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929504|NCT03850483|526250319|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929505|NCT03850483|526250320|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929506|NCT03850483|526250321|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
146297779|NCT01975428|527605986|FG000|Overall Study|Withdrawal by Subject|3|||
146297780|NCT01975428|527605987|FG001|Overall Study|Withdrawal by Subject|10|||
146297781|NCT01843218|527605994|FG000|Overall Study|Withdrawal by Subject|5|||
145929507|NCT03850483|526250322|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
145929508|NCT03850483|526250323|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929509|NCT03850483|526250324|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929510|NCT03850483|526250325|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929511|NCT03850483|526250326|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145929512|NCT03850483|526250317|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
145929513|NCT03850483|526250318|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
145929514|NCT03850483|526250319|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
145929515|NCT03850483|526250320|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
145929516|NCT03850483|526250321|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
145929517|NCT03850483|526250322|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
145929518|NCT03850483|526250323|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
145929519|NCT03850483|526250324|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
145929520|NCT03850483|526250325|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
145929521|NCT03850483|526250326|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
145929522|NCT03850483|526250317|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
145929523|NCT03850483|526250318|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
145929524|NCT03850483|526250319|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
145929525|NCT03850483|526250320|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
145929526|NCT03850483|526250321|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
145929527|NCT03850483|526250322|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
145929528|NCT03850483|526250323|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
145929529|NCT03850483|526250324|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
145929530|NCT03850483|526250325|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
145929531|NCT03850483|526250326|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
145929532|NCT03850483|526250317|FG000|Treatment for Stage 1|Death|0|||
145929533|NCT03850483|526250318|FG001|Treatment for Stage 1|Death|0|||
145929534|NCT03850483|526250319|FG002|Treatment for Stage 1|Death|0|||
145929535|NCT03850483|526250320|FG003|Treatment for Stage 1|Death|0|||
145929536|NCT03850483|526250321|FG004|Treatment for Stage 1|Death|0|||
145929537|NCT03850483|526250322|FG005|Treatment for Stage 1|Death|1|||
145929538|NCT03850483|526250323|FG006|Treatment for Stage 1|Death|0|||
145929539|NCT03850483|526250324|FG007|Treatment for Stage 1|Death|0|||
145929540|NCT03850483|526250325|FG008|Treatment for Stage 1|Death|0|||
145929541|NCT03850483|526250326|FG009|Treatment for Stage 1|Death|0|||
145929542|NCT03850483|526250317|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
145929543|NCT03850483|526250318|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
145929544|NCT03850483|526250319|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
145929545|NCT03850483|526250320|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
145977780|NCT01018979|526429296|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
145977781|NCT01018979|526429295|FG000|Overall Study|Not received at least one dose|0|||
145977782|NCT01018979|526429296|FG001|Overall Study|Not received at least one dose|1|||
145977783|NCT01695746|526429297|FG000|Overall Study|Adverse Event|1|||
145977784|NCT01695746|526429297|FG000|Overall Study|Non-compliance by the participant|3|||
145977785|NCT01695746|526429297|FG000|Overall Study|Protocol Violation|5|||
145977786|NCT01695746|526429297|FG000|Overall Study|Participant not willing to participate|3|||
145977787|NCT03976375|526429300|FG000|Overall Study|Death|158|||
145977788|NCT03976375|526429301|FG001|Overall Study|Death|160|||
145977789|NCT03976375|526429302|FG002|Overall Study|Death|42|||
145977790|NCT03976375|526429300|FG000|Overall Study|Lost to Follow-up|2|||
145977791|NCT03976375|526429301|FG001|Overall Study|Lost to Follow-up|1|||
145977792|NCT03976375|526429302|FG002|Overall Study|Lost to Follow-up|1|||
145977793|NCT03976375|526429300|FG000|Overall Study|Withdrawal by Subject|5|||
145977794|NCT03976375|526429301|FG001|Overall Study|Withdrawal by Subject|9|||
145977795|NCT03976375|526429302|FG002|Overall Study|Withdrawal by Subject|4|||
145977796|NCT03976375|526429300|FG000|Overall Study|Sponsor decision|20|||
145977797|NCT03976375|526429301|FG001|Overall Study|Sponsor decision|19|||
145977798|NCT03976375|526429302|FG002|Overall Study|Sponsor decision|1|||
145977799|NCT02676973|526429303|FG000|Overall Study|Withdrawal by Subject|9|||
146243332|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
146243333|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
146243334|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
146243335|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146297782|NCT01431534|527605995|FG000|Treatment Phase|Adverse Event|0|||
145929546|NCT03850483|526250321|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
145929547|NCT03850483|526250322|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
145929548|NCT03850483|526250323|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
145977800|NCT02676973|526429304|FG001|Overall Study|Withdrawal by Subject|8|||
145977801|NCT02676973|526429305|FG002|Overall Study|Withdrawal by Subject|11|||
145977802|NCT02676973|526429303|FG000|Overall Study|Lost to Follow-up|8|||
145929549|NCT03850483|526250324|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
145929550|NCT03850483|526250325|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
145929551|NCT03850483|526250326|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
145977803|NCT02676973|526429304|FG001|Overall Study|Lost to Follow-up|12|||
145977804|NCT02676973|526429305|FG002|Overall Study|Lost to Follow-up|8|||
145929552|NCT03850483|526250317|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
145929553|NCT03850483|526250318|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
145929554|NCT03850483|526250319|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
145929555|NCT03850483|526250320|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
145929556|NCT03850483|526250321|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
145929557|NCT03850483|526250322|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
145929558|NCT03850483|526250323|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
145929559|NCT03850483|526250324|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
145929560|NCT03850483|526250325|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
145929561|NCT03850483|526250326|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
145929562|NCT03850483|526250317|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929563|NCT03850483|526250318|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929564|NCT03850483|526250319|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929565|NCT03850483|526250320|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929566|NCT03850483|526250321|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929567|NCT03850483|526250322|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929568|NCT03850483|526250323|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
145929569|NCT03850483|526250324|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
145929570|NCT03850483|526250325|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929571|NCT03850483|526250326|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
145929572|NCT03850483|526250317|FG000|Follow-up for Stage 1|Physician Decision|0|||
145929573|NCT03850483|526250318|FG001|Follow-up for Stage 1|Physician Decision|0|||
145929574|NCT03850483|526250319|FG002|Follow-up for Stage 1|Physician Decision|0|||
145929575|NCT03850483|526250320|FG003|Follow-up for Stage 1|Physician Decision|0|||
145929576|NCT03850483|526250321|FG004|Follow-up for Stage 1|Physician Decision|1|||
145929577|NCT03850483|526250322|FG005|Follow-up for Stage 1|Physician Decision|0|||
145929578|NCT03850483|526250323|FG006|Follow-up for Stage 1|Physician Decision|1|||
145929579|NCT03850483|526250324|FG007|Follow-up for Stage 1|Physician Decision|0|||
145929580|NCT03850483|526250325|FG008|Follow-up for Stage 1|Physician Decision|0|||
145929581|NCT03850483|526250326|FG009|Follow-up for Stage 1|Physician Decision|0|||
145929582|NCT03850483|526250317|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
145929583|NCT03850483|526250318|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
145929584|NCT03850483|526250319|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
145929585|NCT03850483|526250320|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
145929586|NCT03850483|526250321|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
145929587|NCT03850483|526250322|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
145929588|NCT03850483|526250323|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
145929589|NCT03850483|526250324|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
145929590|NCT03850483|526250325|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
145929591|NCT03850483|526250326|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
145929592|NCT03850483|526250317|FG000|Follow-up for Stage 1|Adverse Event|0|||
145929593|NCT03850483|526250318|FG001|Follow-up for Stage 1|Adverse Event|0|||
145929594|NCT03850483|526250319|FG002|Follow-up for Stage 1|Adverse Event|1|||
145929595|NCT03850483|526250320|FG003|Follow-up for Stage 1|Adverse Event|0|||
145929596|NCT03850483|526250321|FG004|Follow-up for Stage 1|Adverse Event|0|||
145929597|NCT03850483|526250322|FG005|Follow-up for Stage 1|Adverse Event|1|||
145929598|NCT03850483|526250323|FG006|Follow-up for Stage 1|Adverse Event|0|||
145929599|NCT03850483|526250324|FG007|Follow-up for Stage 1|Adverse Event|0|||
145929600|NCT03850483|526250325|FG008|Follow-up for Stage 1|Adverse Event|0|||
145929601|NCT03850483|526250326|FG009|Follow-up for Stage 1|Adverse Event|0|||
145929602|NCT03850483|526250317|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929603|NCT03850483|526250318|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
145929604|NCT03850483|526250319|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929605|NCT03850483|526250320|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929606|NCT03850483|526250321|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
145929607|NCT03850483|526250322|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
145929608|NCT03850483|526250323|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929609|NCT03850483|526250324|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929610|NCT03850483|526250325|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929611|NCT03850483|526250326|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145929612|NCT03850483|526250317|FG000|Follow-up for Stage 1|Other|0|||
146297783|NCT01431534|527605996|FG001|Treatment Phase|Adverse Event|0|||
145929613|NCT03850483|526250318|FG001|Follow-up for Stage 1|Other|2|||
145929614|NCT03850483|526250319|FG002|Follow-up for Stage 1|Other|0|||
145929615|NCT03850483|526250320|FG003|Follow-up for Stage 1|Other|2|||
145929616|NCT03850483|526250321|FG004|Follow-up for Stage 1|Other|0|||
145929617|NCT03850483|526250322|FG005|Follow-up for Stage 1|Other|1|||
145929618|NCT03850483|526250323|FG006|Follow-up for Stage 1|Other|0|||
145929619|NCT03850483|526250324|FG007|Follow-up for Stage 1|Other|0|||
145929620|NCT03850483|526250325|FG008|Follow-up for Stage 1|Other|0|||
145929621|NCT03850483|526250326|FG009|Follow-up for Stage 1|Other|0|||
145929622|NCT03850483|526250317|FG000|Treatment for Stage 2|Adverse Event|0|||
145929623|NCT03850483|526250318|FG001|Treatment for Stage 2|Adverse Event|0|||
145929624|NCT03850483|526250319|FG002|Treatment for Stage 2|Adverse Event|0|||
145977805|NCT02676973|526429303|FG000|Overall Study|Death|2|||
145977806|NCT02676973|526429304|FG001|Overall Study|Death|1|||
145977807|NCT02676973|526429305|FG002|Overall Study|Death|5|||
145977808|NCT01078662|526429306|FG000|Overall Study|Death|41|||
145977809|NCT01078662|526429307|FG001|Overall Study|Death|103|||
145977810|NCT01078662|526429308|FG002|Overall Study|Death|18|||
145929625|NCT03850483|526250320|FG003|Treatment for Stage 2|Adverse Event|0|||
145929626|NCT03850483|526250321|FG004|Treatment for Stage 2|Adverse Event|0|||
145929627|NCT03850483|526250322|FG005|Treatment for Stage 2|Adverse Event|0|||
145929628|NCT03850483|526250323|FG006|Treatment for Stage 2|Adverse Event|0|||
145929629|NCT03850483|526250324|FG007|Treatment for Stage 2|Adverse Event|0|||
145929630|NCT03850483|526250325|FG008|Treatment for Stage 2|Adverse Event|0|||
145929631|NCT03850483|526250326|FG009|Treatment for Stage 2|Adverse Event|1|||
145929632|NCT03850483|526250317|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
145929633|NCT03850483|526250318|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
145929634|NCT03850483|526250319|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
145929635|NCT03850483|526250320|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
145929636|NCT03850483|526250321|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
145929637|NCT03850483|526250322|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
145929638|NCT03850483|526250323|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
145929639|NCT03850483|526250324|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
145929640|NCT03850483|526250325|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
145929641|NCT03850483|526250326|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
145929642|NCT03850483|526250317|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
145929643|NCT03850483|526250318|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
145929644|NCT03850483|526250319|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
145929645|NCT03850483|526250320|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
145977811|NCT01078662|526429309|FG003|Overall Study|Death|5|||
145977812|NCT01078662|526429310|FG004|Overall Study|Death|8|||
145977813|NCT01078662|526429306|FG000|Overall Study|Patients reached data cut-off|12|||
145977814|NCT01078662|526429307|FG001|Overall Study|Patients reached data cut-off|53|||
145977815|NCT01078662|526429308|FG002|Overall Study|Patients reached data cut-off|2|||
145977816|NCT01078662|526429309|FG003|Overall Study|Patients reached data cut-off|2|||
145977817|NCT01078662|526429310|FG004|Overall Study|Patients reached data cut-off|3|||
145977818|NCT01078662|526429306|FG000|Overall Study|Withdrawal by Subject|4|||
145977819|NCT01078662|526429307|FG001|Overall Study|Withdrawal by Subject|11|||
145977820|NCT01078662|526429308|FG002|Overall Study|Withdrawal by Subject|1|||
145977821|NCT01078662|526429309|FG003|Overall Study|Withdrawal by Subject|0|||
145977822|NCT01078662|526429310|FG004|Overall Study|Withdrawal by Subject|0|||
145977823|NCT01078662|526429306|FG000|Overall Study|Protocol Violation|0|||
145977824|NCT01078662|526429307|FG001|Overall Study|Protocol Violation|1|||
145977825|NCT01078662|526429308|FG002|Overall Study|Protocol Violation|0|||
145977826|NCT01078662|526429309|FG003|Overall Study|Protocol Violation|0|||
145977827|NCT01078662|526429310|FG004|Overall Study|Protocol Violation|0|||
145977828|NCT01078662|526429306|FG000|Overall Study|Lost to Follow-up|1|||
145977829|NCT01078662|526429307|FG001|Overall Study|Lost to Follow-up|0|||
145977830|NCT01078662|526429308|FG002|Overall Study|Lost to Follow-up|0|||
145977831|NCT01078662|526429309|FG003|Overall Study|Lost to Follow-up|0|||
145977832|NCT01078662|526429310|FG004|Overall Study|Lost to Follow-up|0|||
145977833|NCT03122106|526429313|FG000|Overall Study|Not enough tissue|1|||
145977834|NCT03122106|526429313|FG000|Overall Study|Disease progression during screening|2|||
145977835|NCT03122106|526429313|FG000|Overall Study|Poor RNA quality for vaccine|1|||
145977836|NCT01913353|526429314|FG000|Overall Study|Adverse Event|2|||
145977837|NCT01913353|526429315|FG001|Overall Study|Adverse Event|0|||
145977838|NCT01913353|526429314|FG000|Overall Study|Physician Decision|0|||
145977839|NCT01913353|526429315|FG001|Overall Study|Physician Decision|2|||
145977840|NCT01913353|526429314|FG000|Overall Study|Withdrawal by Subject|20|||
145977841|NCT01913353|526429315|FG001|Overall Study|Withdrawal by Subject|6|||
145977842|NCT01913353|526429314|FG000|Overall Study|multiple reasons|10|||
145977843|NCT01913353|526429315|FG001|Overall Study|multiple reasons|7|||
145977844|NCT00385840|526429316|FG000|Overall Study|Adverse Event|1|||
145977845|NCT00385840|526429317|FG001|Overall Study|Adverse Event|1|||
145977846|NCT00385840|526429316|FG000|Overall Study|Lost to Follow-up|3|||
145977847|NCT00385840|526429317|FG001|Overall Study|Lost to Follow-up|13|||
145977848|NCT00462462|526429319|FG000|Overall Study|Physician Decision|0|||
145977849|NCT00462462|526429320|FG001|Overall Study|Physician Decision|1|||
145977850|NCT02830087|526429321|FG000|Overall Study|No study staff to follow-up patients|4|||
145977851|NCT02830087|526429322|FG001|Overall Study|No study staff to follow-up patients|4|||
145977852|NCT02830087|526429323|FG002|Overall Study|No study staff to follow-up patients|4|||
146090770|NCT00873860|526852669|FG002|Overall Study|Other|1|||
146090771|NCT00873860|526852670|FG003|Overall Study|Other|0|||
145929646|NCT03850483|526250321|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
145929647|NCT03850483|526250322|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
145977853|NCT02830087|526429324|FG003|Overall Study|No study staff to follow-up patients|3|||
145977854|NCT02830087|526429325|FG004|Overall Study|No study staff to follow-up patients|3|||
145977855|NCT02830087|526429326|FG005|Overall Study|No study staff to follow-up patients|3|||
145929648|NCT03850483|526250323|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
145929649|NCT03850483|526250324|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
145929650|NCT03850483|526250325|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
145929651|NCT03850483|526250326|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
145929652|NCT03850483|526250317|FG000|Treatment for Stage 2|Physician Decision|0|||
145929653|NCT03850483|526250318|FG001|Treatment for Stage 2|Physician Decision|0|||
145929654|NCT03850483|526250319|FG002|Treatment for Stage 2|Physician Decision|0|||
145929655|NCT03850483|526250320|FG003|Treatment for Stage 2|Physician Decision|0|||
145929656|NCT03850483|526250321|FG004|Treatment for Stage 2|Physician Decision|0|||
145929657|NCT03850483|526250322|FG005|Treatment for Stage 2|Physician Decision|0|||
145929658|NCT03850483|526250323|FG006|Treatment for Stage 2|Physician Decision|0|||
145929659|NCT03850483|526250324|FG007|Treatment for Stage 2|Physician Decision|0|||
145929660|NCT03850483|526250325|FG008|Treatment for Stage 2|Physician Decision|0|||
145929661|NCT03850483|526250326|FG009|Treatment for Stage 2|Physician Decision|1|||
145929662|NCT03850483|526250317|FG000|Treatment for Stage 2|Protocol Violation|0|||
145929663|NCT03850483|526250318|FG001|Treatment for Stage 2|Protocol Violation|0|||
145929664|NCT03850483|526250319|FG002|Treatment for Stage 2|Protocol Violation|0|||
145929665|NCT03850483|526250320|FG003|Treatment for Stage 2|Protocol Violation|0|||
145929666|NCT03850483|526250321|FG004|Treatment for Stage 2|Protocol Violation|0|||
145929667|NCT03850483|526250322|FG005|Treatment for Stage 2|Protocol Violation|0|||
145929668|NCT03850483|526250323|FG006|Treatment for Stage 2|Protocol Violation|0|||
145929669|NCT03850483|526250324|FG007|Treatment for Stage 2|Protocol Violation|0|||
145929670|NCT03850483|526250325|FG008|Treatment for Stage 2|Protocol Violation|1|||
145929671|NCT03850483|526250326|FG009|Treatment for Stage 2|Protocol Violation|0|||
146090772|NCT00704808|526852674|FG000|Overall Study|Discontinued prior to starting treatment|14|||
146090773|NCT00704808|526852674|FG000|Overall Study|Death|7|||
146090774|NCT00704808|526852674|FG000|Overall Study|Tumor progression|80|||
146090775|NCT00704808|526852674|FG000|Overall Study|Patient's decision|11|||
146090776|NCT00704808|526852674|FG000|Overall Study|Early therapy discontinuation|16|||
146090777|NCT00704808|526852674|FG000|Overall Study|Adverse Event|1|||
146090778|NCT00704808|526852674|FG000|Overall Study|Lost to Follow-up|1|||
146090779|NCT00704808|526852674|FG000|Overall Study|Treatment change|1|||
146090780|NCT05308290|526852680|FG000|Overall Study|Death|1|||
146090781|NCT05308290|526852681|FG001|Overall Study|Death|0|||
146090782|NCT05308290|526852680|FG000|Overall Study|Lost to Follow-up|2|||
146090783|NCT05308290|526852681|FG001|Overall Study|Lost to Follow-up|1|||
146090784|NCT05308290|526852680|FG000|Overall Study|still in study followup|0|||
146090785|NCT05308290|526852681|FG001|Overall Study|still in study followup|1|||
146090786|NCT01017575|526852685|FG000|Overall Study|Lack of Efficacy|0|||
146090787|NCT01017575|526852686|FG001|Overall Study|Lack of Efficacy|1|||
146090788|NCT01017575|526852687|FG002|Overall Study|Lack of Efficacy|0|||
146090789|NCT01017575|526852688|FG003|Overall Study|Lack of Efficacy|1|||
145929672|NCT03850483|526250317|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
145929673|NCT03850483|526250318|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
145929674|NCT03850483|526250319|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
145929675|NCT03850483|526250320|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
145929676|NCT03850483|526250321|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
145929677|NCT03850483|526250322|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
145929678|NCT03850483|526250323|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
145929679|NCT03850483|526250324|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
145929680|NCT03850483|526250325|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
145929681|NCT03850483|526250326|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
145929682|NCT03850483|526250317|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929683|NCT03850483|526250318|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929684|NCT03850483|526250319|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929685|NCT03850483|526250320|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929686|NCT03850483|526250321|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929687|NCT03850483|526250322|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929688|NCT03850483|526250323|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929689|NCT03850483|526250324|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929690|NCT03850483|526250325|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145929691|NCT03850483|526250326|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
145929692|NCT03850483|526250317|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
145929693|NCT03850483|526250318|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
146090790|NCT01017575|526852689|FG004|Overall Study|Lack of Efficacy|1|||
146090791|NCT01017575|526852685|FG000|Overall Study|Adverse Event|0|||
146090792|NCT01017575|526852686|FG001|Overall Study|Adverse Event|1|||
146090793|NCT01017575|526852687|FG002|Overall Study|Adverse Event|0|||
146090794|NCT01017575|526852688|FG003|Overall Study|Adverse Event|0|||
146090795|NCT01017575|526852689|FG004|Overall Study|Adverse Event|2|||
145929694|NCT03850483|526250319|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
145929695|NCT03850483|526250320|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
146090796|NCT01017575|526852685|FG000|Overall Study|Withdrawal by Subject|1|||
145929696|NCT03850483|526250321|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
145929697|NCT03850483|526250322|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
145929698|NCT03850483|526250323|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
145929699|NCT03850483|526250324|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
145929700|NCT03850483|526250325|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
145929701|NCT03850483|526250326|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
145929702|NCT03850483|526250317|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
145929703|NCT03850483|526250318|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
145929704|NCT03850483|526250319|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
145929705|NCT03850483|526250320|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
145929706|NCT03850483|526250321|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
145929707|NCT03850483|526250322|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
145929708|NCT03850483|526250323|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
145929709|NCT03850483|526250324|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
145929710|NCT03850483|526250325|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
145929711|NCT03850483|526250326|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
145929712|NCT03850483|526250317|FG000|Follow-up For Stage 2|Other|0|||
145929713|NCT03850483|526250318|FG001|Follow-up For Stage 2|Other|0|||
145929714|NCT03850483|526250319|FG002|Follow-up For Stage 2|Other|0|||
145929715|NCT03850483|526250320|FG003|Follow-up For Stage 2|Other|0|||
145929716|NCT03850483|526250321|FG004|Follow-up For Stage 2|Other|0|||
145929717|NCT03850483|526250322|FG005|Follow-up For Stage 2|Other|0|||
145929718|NCT03850483|526250323|FG006|Follow-up For Stage 2|Other|0|||
145929719|NCT03850483|526250324|FG007|Follow-up For Stage 2|Other|0|||
145929720|NCT03850483|526250325|FG008|Follow-up For Stage 2|Other|0|||
145929721|NCT03850483|526250326|FG009|Follow-up For Stage 2|Other|1|||
145929722|NCT01136356|526252145|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
145929723|NCT01136356|526252146|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
145929724|NCT01136356|526252145|FG000|First 18-day Withdrawal|Physician Decision|1|||
145929725|NCT01136356|526252146|FG001|First 18-day Withdrawal|Physician Decision|0|||
145929726|NCT01136356|526252145|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
145929727|NCT01136356|526252146|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
145929728|NCT02347774|526252147|FG000|Study Participation|Lost to Follow-up|3|||
145929729|NCT02347774|526252148|FG001|Study Participation|Lost to Follow-up|6|||
145929730|NCT02347774|526252149|FG002|Study Participation|Lost to Follow-up|2|||
145929731|NCT02347774|526252147|FG000|Study Participation|Withdrawal by Subject|8|||
145929732|NCT02347774|526252148|FG001|Study Participation|Withdrawal by Subject|9|||
145929733|NCT02347774|526252149|FG002|Study Participation|Withdrawal by Subject|15|||
145929734|NCT02347774|526252147|FG000|Study Participation|Adverse Event|1|||
145929735|NCT02347774|526252148|FG001|Study Participation|Adverse Event|4|||
145929736|NCT02347774|526252149|FG002|Study Participation|Adverse Event|6|||
145929737|NCT02347774|526252147|FG000|Study Participation|withdrew consent|1|||
145929738|NCT02347774|526252148|FG001|Study Participation|withdrew consent|1|||
145929739|NCT02347774|526252149|FG002|Study Participation|withdrew consent|1|||
145929740|NCT02347774|526252147|FG000|Study Participation|Met Prolonged QT criteria|1|||
145929741|NCT02347774|526252148|FG001|Study Participation|Met Prolonged QT criteria|0|||
145929742|NCT02347774|526252149|FG002|Study Participation|Met Prolonged QT criteria|0|||
145929743|NCT02347774|526252147|FG000|Study Participation|non-compliance with study drug|0|||
145929744|NCT02347774|526252148|FG001|Study Participation|non-compliance with study drug|1|||
145929745|NCT02347774|526252149|FG002|Study Participation|non-compliance with study drug|0|||
145929746|NCT02347774|526252147|FG000|Study Participation|incarceration|1|||
145929747|NCT02347774|526252148|FG001|Study Participation|incarceration|0|||
145929748|NCT02347774|526252149|FG002|Study Participation|incarceration|0|||
145929749|NCT02347774|526252147|FG000|Study Participation|randomized in error|0|||
145929750|NCT02347774|526252148|FG001|Study Participation|randomized in error|0|||
145929751|NCT02347774|526252149|FG002|Study Participation|randomized in error|1|||
145929752|NCT02347774|526252147|FG000|On Study Treatment|Adverse Event|9|||
145929753|NCT02347774|526252148|FG001|On Study Treatment|Adverse Event|15|||
145929754|NCT02347774|526252149|FG002|On Study Treatment|Adverse Event|19|||
145929755|NCT02347774|526252147|FG000|On Study Treatment|Lack of Efficacy|3|||
145929756|NCT02347774|526252148|FG001|On Study Treatment|Lack of Efficacy|0|||
145929757|NCT02347774|526252149|FG002|On Study Treatment|Lack of Efficacy|2|||
145929758|NCT02347774|526252147|FG000|On Study Treatment|non-complicance with study medication|0|||
145929759|NCT02347774|526252148|FG001|On Study Treatment|non-complicance with study medication|2|||
145929760|NCT02347774|526252149|FG002|On Study Treatment|non-complicance with study medication|0|||
145929761|NCT02347774|526252147|FG000|On Study Treatment|Protocol Violation|0|||
145929762|NCT02347774|526252148|FG001|On Study Treatment|Protocol Violation|0|||
145929763|NCT02347774|526252149|FG002|On Study Treatment|Protocol Violation|1|||
145929764|NCT02347774|526252147|FG000|On Study Treatment|withdrew consent|9|||
145929765|NCT02347774|526252148|FG001|On Study Treatment|withdrew consent|8|||
145929766|NCT02347774|526252149|FG002|On Study Treatment|withdrew consent|12|||
145929767|NCT02347774|526252147|FG000|On Study Treatment|Lost to Follow-up|2|||
145929768|NCT02347774|526252148|FG001|On Study Treatment|Lost to Follow-up|6|||
145929769|NCT02347774|526252149|FG002|On Study Treatment|Lost to Follow-up|1|||
146297784|NCT01431534|527605997|FG002|Treatment Phase|Adverse Event|1|||
145929770|NCT02347774|526252147|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
145929771|NCT02347774|526252148|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
145929772|NCT02347774|526252149|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
145929773|NCT02347774|526252147|FG000|On Study Treatment|ranomized in error|0|||
145929774|NCT02347774|526252148|FG001|On Study Treatment|ranomized in error|0|||
145929775|NCT02347774|526252149|FG002|On Study Treatment|ranomized in error|1|||
145929776|NCT00927862|526252150|FG000|Overall Study|Missing data needed for endpt analyses|27|||
145929777|NCT00927862|526252151|FG001|Overall Study|Missing data needed for endpt analyses|45|||
145929778|NCT00820248|526252153|FG000|Overall Study|No treated|4|||
145929779|NCT00820248|526252154|FG001|Overall Study|No treated|1|||
145929780|NCT02237196|526252155|FG000|Overall Study|Adverse Event|0|||
145929781|NCT02237196|526252156|FG001|Overall Study|Adverse Event|1|||
145929782|NCT02237196|526252157|FG002|Overall Study|Adverse Event|1|||
145929783|NCT02237196|526252158|FG003|Overall Study|Adverse Event|0|||
145929784|NCT02237196|526252155|FG000|Overall Study|Lost to Follow-up|4|||
145929785|NCT02237196|526252156|FG001|Overall Study|Lost to Follow-up|2|||
145929786|NCT02237196|526252157|FG002|Overall Study|Lost to Follow-up|4|||
145929787|NCT02237196|526252158|FG003|Overall Study|Lost to Follow-up|6|||
145929788|NCT02237196|526252155|FG000|Overall Study|Physician Decision|2|||
145929789|NCT02237196|526252156|FG001|Overall Study|Physician Decision|0|||
145929790|NCT02237196|526252157|FG002|Overall Study|Physician Decision|0|||
145929791|NCT02237196|526252158|FG003|Overall Study|Physician Decision|1|||
145929792|NCT02237196|526252155|FG000|Overall Study|Pregnancy|0|||
145929793|NCT02237196|526252156|FG001|Overall Study|Pregnancy|0|||
145929794|NCT02237196|526252157|FG002|Overall Study|Pregnancy|1|||
145929795|NCT02237196|526252158|FG003|Overall Study|Pregnancy|1|||
145929796|NCT02237196|526252155|FG000|Overall Study|Withdrawal by Subject|1|||
145929797|NCT02237196|526252156|FG001|Overall Study|Withdrawal by Subject|1|||
145929798|NCT02237196|526252157|FG002|Overall Study|Withdrawal by Subject|4|||
145929799|NCT02237196|526252158|FG003|Overall Study|Withdrawal by Subject|1|||
145929800|NCT02237196|526252155|FG000|Overall Study|Site Error|1|||
145929801|NCT02237196|526252156|FG001|Overall Study|Site Error|2|||
145929802|NCT02237196|526252157|FG002|Overall Study|Site Error|0|||
145929803|NCT02237196|526252158|FG003|Overall Study|Site Error|2|||
145929804|NCT04157296|526252159|FG000|Overall Study|Withdrawal by Subject|0|||
145929805|NCT04157296|526252160|FG001|Overall Study|Withdrawal by Subject|1|||
145929806|NCT04157296|526252159|FG000|Overall Study|Did not obtain second fMRI.|0|||
145929807|NCT04157296|526252160|FG001|Overall Study|Did not obtain second fMRI.|1|||
145929808|NCT04157296|526252159|FG000|Overall Study|MRI failed/no second fMRI|0|||
145929809|NCT04157296|526252160|FG001|Overall Study|MRI failed/no second fMRI|1|||
145929810|NCT00267969|526252163|FG000|Controlled Period|Adverse Event|6|||
145929811|NCT00267969|526252164|FG001|Controlled Period|Adverse Event|0|||
145929812|NCT00267969|526252165|FG002|Controlled Period|Adverse Event|2|||
145929813|NCT00267969|526252166|FG003|Controlled Period|Adverse Event|0|||
145929814|NCT00267969|526252167|FG004|Controlled Period|Adverse Event|0|||
145929815|NCT00267969|526252168|FG005|Controlled Period|Adverse Event|0|||
145929816|NCT00267969|526252169|FG006|Controlled Period|Adverse Event|0|||
145929817|NCT00267969|526252163|FG000|Controlled Period|Lack of Efficacy|3|||
145929818|NCT00267969|526252164|FG001|Controlled Period|Lack of Efficacy|0|||
145929819|NCT00267969|526252165|FG002|Controlled Period|Lack of Efficacy|1|||
145929820|NCT00267969|526252166|FG003|Controlled Period|Lack of Efficacy|0|||
145929821|NCT00267969|526252167|FG004|Controlled Period|Lack of Efficacy|0|||
145929822|NCT00267969|526252168|FG005|Controlled Period|Lack of Efficacy|0|||
145929823|NCT00267969|526252169|FG006|Controlled Period|Lack of Efficacy|0|||
145929824|NCT00267969|526252163|FG000|Controlled Period|Lost to Follow-up|1|||
145929825|NCT00267969|526252164|FG001|Controlled Period|Lost to Follow-up|0|||
145929826|NCT00267969|526252165|FG002|Controlled Period|Lost to Follow-up|1|||
145929827|NCT00267969|526252166|FG003|Controlled Period|Lost to Follow-up|0|||
145929828|NCT00267969|526252167|FG004|Controlled Period|Lost to Follow-up|0|||
145929829|NCT00267969|526252168|FG005|Controlled Period|Lost to Follow-up|0|||
145929830|NCT00267969|526252169|FG006|Controlled Period|Lost to Follow-up|0|||
145977856|NCT00632359|526429332|FG000|Overall Study|Withdrawal by Subject|2|||
145977857|NCT03043573|526429333|FG000|Overall Study|Lost to Follow-up|3|||
145977858|NCT03043573|526429334|FG001|Overall Study|Lost to Follow-up|3|||
145977859|NCT03043573|526429333|FG000|Overall Study|Physician Decision|0|||
145929831|NCT00267969|526252163|FG000|Controlled Period|Randomized but not treated|0|||
145929832|NCT00267969|526252164|FG001|Controlled Period|Randomized but not treated|0|||
145929833|NCT00267969|526252165|FG002|Controlled Period|Randomized but not treated|1|||
145929834|NCT00267969|526252166|FG003|Controlled Period|Randomized but not treated|0|||
145929835|NCT00267969|526252167|FG004|Controlled Period|Randomized but not treated|0|||
145929836|NCT00267969|526252168|FG005|Controlled Period|Randomized but not treated|0|||
145977860|NCT03043573|526429334|FG001|Overall Study|Physician Decision|5|||
145929837|NCT00267969|526252169|FG006|Controlled Period|Randomized but not treated|0|||
145929838|NCT00267969|526252163|FG000|Controlled Period|Other|2|||
145977861|NCT03043573|526429333|FG000|Overall Study|Withdrawal by Subject|0|||
145929839|NCT00267969|526252164|FG001|Controlled Period|Other|1|||
145929840|NCT00267969|526252165|FG002|Controlled Period|Other|6|||
145929841|NCT00267969|526252166|FG003|Controlled Period|Other|0|||
145977862|NCT03043573|526429334|FG001|Overall Study|Withdrawal by Subject|4|||
145977863|NCT01239680|526431099|FG000|Overall Study|Withdrawal by Subject|2|||
145977864|NCT01239680|526431100|FG001|Overall Study|Withdrawal by Subject|0|||
145977865|NCT03033901|526431101|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
145977866|NCT03033901|526431101|FG000|Overall Study|Refused PSG|23|||
145977867|NCT03033901|526431101|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
145977868|NCT03033901|526431101|FG000|Overall Study|Missing Oximetry Data|3|||
145977869|NCT00729586|526431102|FG000|Overall Study|Ineligible|0|||
145977870|NCT00729586|526431103|FG001|Overall Study|Ineligible|1|||
145929842|NCT00267969|526252167|FG004|Controlled Period|Other|0|||
145929843|NCT00267969|526252168|FG005|Controlled Period|Other|0|||
145929844|NCT00267969|526252169|FG006|Controlled Period|Other|0|||
145929845|NCT00267969|526252163|FG000|After Controlled Period|Adverse Event|0|||
145929846|NCT00267969|526252164|FG001|After Controlled Period|Adverse Event|0|||
145929847|NCT00267969|526252165|FG002|After Controlled Period|Adverse Event|0|||
145929848|NCT00267969|526252166|FG003|After Controlled Period|Adverse Event|7|||
145929849|NCT00267969|526252167|FG004|After Controlled Period|Adverse Event|8|||
145929850|NCT00267969|526252168|FG005|After Controlled Period|Adverse Event|23|||
145929851|NCT00267969|526252169|FG006|After Controlled Period|Adverse Event|21|||
145929852|NCT00267969|526252163|FG000|After Controlled Period|Death|0|||
145929853|NCT00267969|526252164|FG001|After Controlled Period|Death|0|||
145929854|NCT00267969|526252165|FG002|After Controlled Period|Death|0|||
145929855|NCT00267969|526252166|FG003|After Controlled Period|Death|1|||
145929856|NCT00267969|526252167|FG004|After Controlled Period|Death|2|||
145929857|NCT00267969|526252168|FG005|After Controlled Period|Death|0|||
145929858|NCT00267969|526252169|FG006|After Controlled Period|Death|1|||
145929859|NCT00267969|526252163|FG000|After Controlled Period|Lack of Efficacy|0|||
145929860|NCT00267969|526252164|FG001|After Controlled Period|Lack of Efficacy|0|||
145929861|NCT00267969|526252165|FG002|After Controlled Period|Lack of Efficacy|0|||
145929862|NCT00267969|526252166|FG003|After Controlled Period|Lack of Efficacy|10|||
145929863|NCT00267969|526252167|FG004|After Controlled Period|Lack of Efficacy|6|||
145929864|NCT00267969|526252168|FG005|After Controlled Period|Lack of Efficacy|28|||
145929865|NCT00267969|526252169|FG006|After Controlled Period|Lack of Efficacy|15|||
145929866|NCT00267969|526252163|FG000|After Controlled Period|Lost to Follow-up|0|||
145929867|NCT00267969|526252164|FG001|After Controlled Period|Lost to Follow-up|0|||
145929868|NCT00267969|526252165|FG002|After Controlled Period|Lost to Follow-up|0|||
145929869|NCT00267969|526252166|FG003|After Controlled Period|Lost to Follow-up|5|||
145929870|NCT00267969|526252167|FG004|After Controlled Period|Lost to Follow-up|8|||
145929871|NCT00267969|526252168|FG005|After Controlled Period|Lost to Follow-up|9|||
145929872|NCT00267969|526252169|FG006|After Controlled Period|Lost to Follow-up|10|||
145929873|NCT00267969|526252163|FG000|After Controlled Period|Other|0|||
145929874|NCT00267969|526252164|FG001|After Controlled Period|Other|0|||
145929875|NCT00267969|526252165|FG002|After Controlled Period|Other|0|||
145929876|NCT00267969|526252166|FG003|After Controlled Period|Other|13|||
145929877|NCT00267969|526252167|FG004|After Controlled Period|Other|11|||
145929878|NCT00267969|526252168|FG005|After Controlled Period|Other|22|||
145929879|NCT00267969|526252169|FG006|After Controlled Period|Other|25|||
145929880|NCT04075682|526252170|FG000|Overall Study|Lost to Follow-up|5|||
145929881|NCT04075682|526252171|FG001|Overall Study|Lost to Follow-up|5|||
145929882|NCT04075682|526252172|FG002|Overall Study|Lost to Follow-up|2|||
145929883|NCT04075682|526252173|FG003|Overall Study|Lost to Follow-up|2|||
145929884|NCT04075682|526252170|FG000|Overall Study|Withdrawal by Subject|1|||
145929885|NCT04075682|526252171|FG001|Overall Study|Withdrawal by Subject|0|||
145929886|NCT04075682|526252172|FG002|Overall Study|Withdrawal by Subject|1|||
145977871|NCT00729586|526431102|FG000|Overall Study|never treated|1|||
145977872|NCT00729586|526431103|FG001|Overall Study|never treated|0|||
145977873|NCT05177094|526431106|FG000|Overall Study|Adverse Event|5|||
145977874|NCT05177094|526431107|FG001|Overall Study|Adverse Event|5|||
145977875|NCT05177094|526431106|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
145977876|NCT05177094|526431107|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
145929887|NCT04075682|526252173|FG003|Overall Study|Withdrawal by Subject|0|||
145929888|NCT04075682|526252170|FG000|Overall Study|Protocol Violation|0|||
145929889|NCT04075682|526252171|FG001|Overall Study|Protocol Violation|1|||
145929890|NCT04075682|526252172|FG002|Overall Study|Protocol Violation|1|||
145929891|NCT04075682|526252173|FG003|Overall Study|Protocol Violation|0|||
145929892|NCT04075682|526252170|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
145977877|NCT05177094|526431106|FG000|Overall Study|Protocol Deviation|3|||
145929893|NCT04075682|526252171|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
145929894|NCT04075682|526252172|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
145929895|NCT04075682|526252173|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
145929896|NCT04075682|526252170|FG000|Overall Study|Lost study phone the first day of study participation|0|||
145977878|NCT05177094|526431107|FG001|Overall Study|Protocol Deviation|0|||
145977879|NCT05177094|526431106|FG000|Overall Study|Withdrawal by Subject|6|||
146243336|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146243337|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
146243338|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
145929897|NCT04075682|526252171|FG001|Overall Study|Lost study phone the first day of study participation|1|||
145929898|NCT04075682|526252172|FG002|Overall Study|Lost study phone the first day of study participation|0|||
145929899|NCT04075682|526252173|FG003|Overall Study|Lost study phone the first day of study participation|0|||
145929900|NCT00862823|526252176|FG000|First Intervention|Withdrawal by Subject|1|||
145929901|NCT00862823|526252177|FG001|First Intervention|Withdrawal by Subject|1|||
145929902|NCT00887315|526252178|FG000|Overall Study|Study termination|7|||
145929903|NCT00887315|526252179|FG001|Overall Study|Study termination|4|||
145929904|NCT00619892|526252180|FG000|Overall Study|Adverse Event|3|||
145929905|NCT00619892|526252181|FG001|Overall Study|Adverse Event|0|||
145929906|NCT00619892|526252180|FG000|Overall Study|Lost to Follow-up|0|||
145929907|NCT00619892|526252181|FG001|Overall Study|Lost to Follow-up|1|||
145929908|NCT00619892|526252180|FG000|Overall Study|Intercurrent illness|0|||
145929909|NCT00619892|526252181|FG001|Overall Study|Intercurrent illness|1|||
145929910|NCT01562782|526252188|FG000|Overall Study|Withdrawal by Subject|3|||
145929911|NCT01562782|526252189|FG001|Overall Study|Withdrawal by Subject|3|||
145929912|NCT01562782|526252188|FG000|Overall Study|screen failure|1|||
145929913|NCT01562782|526252189|FG001|Overall Study|screen failure|2|||
145929914|NCT00857896|526252193|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
145929915|NCT02308540|526252194|FG000|Overall Study|Lost to Follow-up|0|||
145929916|NCT02308540|526252195|FG001|Overall Study|Lost to Follow-up|0|||
145929917|NCT02308540|526252196|FG002|Overall Study|Lost to Follow-up|0|||
145929918|NCT02308540|526252197|FG003|Overall Study|Lost to Follow-up|0|||
145929919|NCT02308540|526252198|FG004|Overall Study|Lost to Follow-up|0|||
145929920|NCT02308540|526252199|FG005|Overall Study|Lost to Follow-up|1|||
145929921|NCT04109391|526252200|FG000|Overall Study|Adverse Event|2|||
145929922|NCT04109391|526252201|FG001|Overall Study|Adverse Event|2|||
145929923|NCT04109391|526252202|FG002|Overall Study|Adverse Event|0|||
145929924|NCT04109391|526252200|FG000|Overall Study|Withdrawal by Subject|2|||
145929925|NCT04109391|526252201|FG001|Overall Study|Withdrawal by Subject|0|||
145929926|NCT04109391|526252202|FG002|Overall Study|Withdrawal by Subject|0|||
145929927|NCT04109391|526252200|FG000|Overall Study|Pregnancy|1|||
145929928|NCT04109391|526252201|FG001|Overall Study|Pregnancy|0|||
145929929|NCT04109391|526252202|FG002|Overall Study|Pregnancy|0|||
145929930|NCT04109391|526252200|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
145929931|NCT04109391|526252201|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
145929932|NCT04109391|526252202|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
145929933|NCT04109391|526252200|FG000|Overall Study|Lost to Follow-up|0|||
145929934|NCT04109391|526252201|FG001|Overall Study|Lost to Follow-up|0|||
145929935|NCT04109391|526252202|FG002|Overall Study|Lost to Follow-up|1|||
145929936|NCT04109391|526252200|FG000|Overall Study|Lack of Efficacy|2|||
145929937|NCT04109391|526252201|FG001|Overall Study|Lack of Efficacy|2|||
145929938|NCT04109391|526252202|FG002|Overall Study|Lack of Efficacy|3|||
145977880|NCT05177094|526431107|FG001|Overall Study|Withdrawal by Subject|3|||
145977881|NCT05177094|526431106|FG000|Overall Study|Participant could not tolerate long study visits|1|||
145977882|NCT05177094|526431107|FG001|Overall Study|Participant could not tolerate long study visits|0|||
145977883|NCT01033942|526431110|FG000|Overall Study|Withdrawal by Subject|1|||
145977884|NCT01033942|526431111|FG001|Overall Study|Withdrawal by Subject|1|||
145977885|NCT01033942|526431112|FG002|Overall Study|Withdrawal by Subject|1|||
145977886|NCT01033942|526431110|FG000|Overall Study|Lost to Follow-up|1|||
145977887|NCT01033942|526431111|FG001|Overall Study|Lost to Follow-up|0|||
145977888|NCT01033942|526431112|FG002|Overall Study|Lost to Follow-up|0|||
145977889|NCT01033942|526431110|FG000|Overall Study|Enrolled in Extension Study|0|||
145977890|NCT01033942|526431111|FG001|Overall Study|Enrolled in Extension Study|3|||
145977891|NCT01033942|526431112|FG002|Overall Study|Enrolled in Extension Study|0|||
145977892|NCT02513199|526431113|FG000|Treatment|Death|1|||
145977893|NCT02513199|526431113|FG000|Treatment|Lost to Follow-up|1|||
145977894|NCT02513199|526431113|FG000|Follow-Up|Death|11|||
145977895|NCT02260986|526431121|FG000|Overall Study|Adverse Event|24|||
145977896|NCT02260986|526431122|FG001|Overall Study|Adverse Event|0|||
145977897|NCT02260986|526431123|FG002|Overall Study|Adverse Event|11|||
146090797|NCT01017575|526852686|FG001|Overall Study|Withdrawal by Subject|0|||
145977898|NCT02260986|526431121|FG000|Overall Study|Lack of Efficacy|27|||
146090798|NCT01017575|526852687|FG002|Overall Study|Withdrawal by Subject|0|||
145977899|NCT02260986|526431122|FG001|Overall Study|Lack of Efficacy|3|||
145929939|NCT00443079|526252209|FG000|Overall Study|Lost to Follow-up|0|||
145977900|NCT02260986|526431123|FG002|Overall Study|Lack of Efficacy|0|||
145977901|NCT02260986|526431121|FG000|Overall Study|Protocol Violation|14|||
145977902|NCT02260986|526431122|FG001|Overall Study|Protocol Violation|5|||
145977903|NCT02260986|526431123|FG002|Overall Study|Protocol Violation|16|||
145977904|NCT02260986|526431121|FG000|Overall Study|Car accident|0|||
145929940|NCT00443079|526252210|FG001|Overall Study|Lost to Follow-up|1|||
145929941|NCT02049814|526252213|FG000|Overall Study|Reason not Specified|4|||
145929942|NCT02049814|526252214|FG001|Overall Study|Reason not Specified|3|||
145929943|NCT02049814|526252213|FG000|Overall Study|Pregnancy|1|||
145929944|NCT02049814|526252214|FG001|Overall Study|Pregnancy|0|||
145929945|NCT02049814|526252213|FG000|Overall Study|Lost to Follow-up|2|||
145929946|NCT02049814|526252214|FG001|Overall Study|Lost to Follow-up|3|||
145929947|NCT02049814|526252213|FG000|Overall Study|Serious Protocol Violation|5|||
145929948|NCT02049814|526252214|FG001|Overall Study|Serious Protocol Violation|7|||
145929949|NCT02049814|526252213|FG000|Overall Study|Study Termination|0|||
145929950|NCT02049814|526252214|FG001|Overall Study|Study Termination|1|||
145929951|NCT02049814|526252213|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
145929952|NCT02049814|526252214|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
145929953|NCT02049814|526252213|FG000|Overall Study|Voluntary withdrawal|9|||
145929954|NCT02049814|526252214|FG001|Overall Study|Voluntary withdrawal|8|||
145929955|NCT02993250|526252215|FG000|Overall Study|Lost to Follow-up|0|||
145929956|NCT02993250|526252216|FG001|Overall Study|Lost to Follow-up|1|||
145929957|NCT00954941|526252218|FG000|Overall Study|Received treatment at home|1|||
145929958|NCT00954941|526252219|FG001|Overall Study|Received treatment at home|0|||
146243339|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
146243340|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
146243341|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
145929959|NCT00954941|526252218|FG000|Overall Study|Withdrawal by Subject|1|||
145929960|NCT00954941|526252219|FG001|Overall Study|Withdrawal by Subject|0|||
145929961|NCT00954941|526252218|FG000|Overall Study|Insurance Denial|2|||
145929962|NCT00954941|526252219|FG001|Overall Study|Insurance Denial|2|||
145929963|NCT00954941|526252218|FG000|Overall Study|Physician Decision|2|||
145929964|NCT00954941|526252219|FG001|Overall Study|Physician Decision|2|||
145929965|NCT00954941|526252218|FG000|Overall Study|Ineligible|2|||
145929966|NCT00954941|526252219|FG001|Overall Study|Ineligible|2|||
145929967|NCT00954941|526252218|FG000|Overall Study|Adverse Event|0|||
145929968|NCT00954941|526252219|FG001|Overall Study|Adverse Event|1|||
145929969|NCT00356148|526252222|FG000|Overall Study|Reoperation within 30 days|2|||
145929970|NCT00356148|526252223|FG001|Overall Study|Reoperation within 30 days|1|||
145929971|NCT02484456|526252224|FG000|Washout Period|Withdrawal by Subject|0|||
145929972|NCT02484456|526252225|FG001|Washout Period|Withdrawal by Subject|1|||
145929973|NCT02484456|526252224|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
145929974|NCT02484456|526252225|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
145929975|NCT02484456|526252224|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
145929976|NCT02484456|526252225|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
145929977|NCT02484456|526252224|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
145929978|NCT02484456|526252225|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
145929979|NCT02865499|526252231|FG000|Baseline|Adverse Event|1|||
145929980|NCT02865499|526252231|FG000|Baseline|Withdrawal by Subject|1|||
145929981|NCT02247440|526252232|FG000|Overall Study|Withdrawal by Subject|1|||
145929982|NCT02247440|526252232|FG000|Overall Study|Lack of Efficacy|3|||
145929983|NCT02792192|526252233|FG000|Overall Study|Death|1|||
145929984|NCT02792192|526252234|FG001|Overall Study|Death|0|||
145929985|NCT02792192|526252235|FG002|Overall Study|Death|0|||
145929986|NCT02792192|526252236|FG003|Overall Study|Death|0|||
145929987|NCT02792192|526252233|FG000|Overall Study|Informed Consent Withdrawn|4|||
145929988|NCT02792192|526252234|FG001|Overall Study|Informed Consent Withdrawn|0|||
145929989|NCT02792192|526252235|FG002|Overall Study|Informed Consent Withdrawn|0|||
145929990|NCT02792192|526252236|FG003|Overall Study|Informed Consent Withdrawn|0|||
145929991|NCT02792192|526252233|FG000|Overall Study|Physician Decision|1|||
145929992|NCT02792192|526252234|FG001|Overall Study|Physician Decision|0|||
145929993|NCT02792192|526252235|FG002|Overall Study|Physician Decision|0|||
145929994|NCT02792192|526252236|FG003|Overall Study|Physician Decision|0|||
145929995|NCT02792192|526252233|FG000|Overall Study|Progressive Disease|0|||
145929996|NCT02792192|526252234|FG001|Overall Study|Progressive Disease|1|||
145929997|NCT02792192|526252235|FG002|Overall Study|Progressive Disease|0|||
145929998|NCT02792192|526252236|FG003|Overall Study|Progressive Disease|0|||
145929999|NCT02792192|526252233|FG000|Overall Study|Study Terminated By Sponsor|6|||
145930000|NCT02792192|526252234|FG001|Overall Study|Study Terminated By Sponsor|10|||
145930001|NCT02792192|526252235|FG002|Overall Study|Study Terminated By Sponsor|0|||
146243342|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
146243343|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
145930002|NCT02792192|526252236|FG003|Overall Study|Study Terminated By Sponsor|0|||
145930003|NCT00661609|526252237|FG000|Overall Study|Adverse Event|4|||
145930004|NCT00661609|526252237|FG000|Overall Study|Death|20|||
145930005|NCT00661609|526252237|FG000|Overall Study|Withdrawal by Subject|2|||
145930006|NCT00661609|526252237|FG000|Overall Study|PI Decision|1|||
145930007|NCT00661609|526252237|FG000|Overall Study|Survival follow up stage discontinued|11|||
145930008|NCT00661609|526252237|FG000|Overall Study|Disease progression|3|||
145977905|NCT02260986|526431122|FG001|Overall Study|Car accident|0|||
145977906|NCT02260986|526431123|FG002|Overall Study|Car accident|1|||
145930009|NCT01430403|526252238|FG000|Overall Study|Lost to Follow-up|5|||
145930010|NCT01430403|526252239|FG001|Overall Study|Lost to Follow-up|5|||
145930011|NCT01430403|526252240|FG002|Overall Study|Lost to Follow-up|3|||
145930012|NCT01430403|526252238|FG000|Overall Study|Physician Decision|1|||
145977907|NCT02260986|526431121|FG000|Overall Study|Withdrawal by Subject|17|||
145930013|NCT01430403|526252239|FG001|Overall Study|Physician Decision|0|||
145930014|NCT01430403|526252240|FG002|Overall Study|Physician Decision|0|||
145977908|NCT02260986|526431122|FG001|Overall Study|Withdrawal by Subject|4|||
145930015|NCT01430403|526252238|FG000|Overall Study|Protocol Violation|2|||
145930016|NCT01430403|526252239|FG001|Overall Study|Protocol Violation|3|||
145930017|NCT01430403|526252240|FG002|Overall Study|Protocol Violation|2|||
145930018|NCT01430403|526252238|FG000|Overall Study|Withdrawal by Subject|9|||
145930019|NCT01430403|526252239|FG001|Overall Study|Withdrawal by Subject|1|||
145930020|NCT01430403|526252240|FG002|Overall Study|Withdrawal by Subject|3|||
145930021|NCT03124407|526252243|FG000|Overall Study|Lost to Follow-up|1|||
145930022|NCT03124407|526252244|FG001|Overall Study|Lost to Follow-up|0|||
145930023|NCT03124407|526252245|FG002|Overall Study|Lost to Follow-up|0|||
145930024|NCT03124407|526252246|FG003|Overall Study|Lost to Follow-up|0|||
145930025|NCT03124407|526252243|FG000|Overall Study|Adverse Event|0|||
145930026|NCT03124407|526252244|FG001|Overall Study|Adverse Event|0|||
145930027|NCT03124407|526252245|FG002|Overall Study|Adverse Event|1|||
145930028|NCT03124407|526252246|FG003|Overall Study|Adverse Event|0|||
145930029|NCT00396656|526252251|FG000|First Treatment Period|Withdrawal by Subject|0|||
145930030|NCT00396656|526252252|FG001|First Treatment Period|Withdrawal by Subject|2|||
145930031|NCT00396656|526252251|FG000|Second Treatment Period|Adverse Event|0|||
145930032|NCT00396656|526252252|FG001|Second Treatment Period|Adverse Event|1|||
145930033|NCT00554515|526252255|FG000|Overall Study|Withdrawal by Subject|3|||
145930034|NCT00554515|526252255|FG000|Overall Study|Disease progression|52|||
145930035|NCT00554515|526252255|FG000|Overall Study|Physician Decision|18|||
145930036|NCT00554515|526252255|FG000|Overall Study|Withdrawal by Subject|11|||
145930037|NCT00554515|526252255|FG000|Overall Study|Adverse Event|9|||
145930038|NCT00554515|526252255|FG000|Overall Study|Death|2|||
145930039|NCT00554515|526252255|FG000|Overall Study|Achieved Stable Disease|7|||
145930040|NCT00554515|526252255|FG000|Overall Study|Other|1|||
145930041|NCT00554515|526252255|FG000|Overall Study|Misc|15|||
145930042|NCT02477332|526252256|FG000|Overall Study|Adverse Event|0|||
145930043|NCT02477332|526252257|FG001|Overall Study|Adverse Event|1|||
145930044|NCT02477332|526252258|FG002|Overall Study|Adverse Event|1|||
145930045|NCT02477332|526252259|FG003|Overall Study|Adverse Event|2|||
145930046|NCT02477332|526252260|FG004|Overall Study|Adverse Event|1|||
145930047|NCT02477332|526252261|FG005|Overall Study|Adverse Event|2|||
145930048|NCT02477332|526252256|FG000|Overall Study|Lack of Efficacy|1|||
145930049|NCT02477332|526252257|FG001|Overall Study|Lack of Efficacy|2|||
145977909|NCT02260986|526431123|FG002|Overall Study|Withdrawal by Subject|9|||
145977910|NCT02260986|526431121|FG000|Overall Study|Incorrect randomization|0|||
145977911|NCT02260986|526431122|FG001|Overall Study|Incorrect randomization|1|||
145977912|NCT02260986|526431123|FG002|Overall Study|Incorrect randomization|0|||
145977913|NCT02260986|526431121|FG000|Overall Study|Lack of investigation product supply|2|||
145977914|NCT02260986|526431122|FG001|Overall Study|Lack of investigation product supply|0|||
145977915|NCT02260986|526431123|FG002|Overall Study|Lack of investigation product supply|1|||
145977916|NCT02260986|526431121|FG000|Overall Study|Lost to Follow-up|4|||
145977917|NCT02260986|526431122|FG001|Overall Study|Lost to Follow-up|0|||
145977918|NCT02260986|526431123|FG002|Overall Study|Lost to Follow-up|3|||
145977919|NCT02260986|526431121|FG000|Overall Study|Pregnancy|2|||
145977920|NCT02260986|526431122|FG001|Overall Study|Pregnancy|0|||
145977921|NCT02260986|526431123|FG002|Overall Study|Pregnancy|0|||
145977922|NCT02397837|526431125|FG000|Overall Study|Withdrawal by Subject|6|||
145977923|NCT02397837|526431126|FG001|Overall Study|Withdrawal by Subject|5|||
145977924|NCT02397837|526431125|FG000|Overall Study|Physician Decision|1|||
145977925|NCT02397837|526431126|FG001|Overall Study|Physician Decision|1|||
145977926|NCT00407511|526431134|FG000|Overall Study|Adverse Event|9|||
145977927|NCT00407511|526431134|FG000|Overall Study|Lost to Follow-up|4|||
145977928|NCT00407511|526431134|FG000|Overall Study|Other|5|||
145977929|NCT00407511|526431134|FG000|Overall Study|Withdrawal by Subject|4|||
145977930|NCT02493855|526431135|FG000|Overall Study|Non-compliance|1|||
145977931|NCT02493855|526431136|FG001|Overall Study|Non-compliance|0|||
145977932|NCT02493855|526431137|FG002|Overall Study|Non-compliance|0|||
145930050|NCT02477332|526252258|FG002|Overall Study|Lack of Efficacy|1|||
145930051|NCT02477332|526252259|FG003|Overall Study|Lack of Efficacy|2|||
145977933|NCT02493855|526431135|FG000|Overall Study|Adverse Event|0|||
145977934|NCT02493855|526431136|FG001|Overall Study|Adverse Event|1|||
145977935|NCT02493855|526431137|FG002|Overall Study|Adverse Event|0|||
145977936|NCT02493855|526431135|FG000|Overall Study|Withdrawal by Subject|1|||
145930052|NCT02477332|526252260|FG004|Overall Study|Lack of Efficacy|1|||
145977937|NCT02493855|526431136|FG001|Overall Study|Withdrawal by Subject|0|||
146090799|NCT01017575|526852688|FG003|Overall Study|Withdrawal by Subject|0|||
145930053|NCT02477332|526252261|FG005|Overall Study|Lack of Efficacy|1|||
145930054|NCT02477332|526252256|FG000|Overall Study|Non-compliance with study treatment|0|||
145930055|NCT02477332|526252257|FG001|Overall Study|Non-compliance with study treatment|1|||
145930056|NCT02477332|526252258|FG002|Overall Study|Non-compliance with study treatment|2|||
145930057|NCT02477332|526252259|FG003|Overall Study|Non-compliance with study treatment|0|||
145977938|NCT02493855|526431137|FG002|Overall Study|Withdrawal by Subject|0|||
145977939|NCT02447029|526431140|FG000|Overall Study|Withdrawal by Subject|3|||
145977940|NCT02447029|526431141|FG001|Overall Study|Withdrawal by Subject|2|||
145977941|NCT02202616|526431146|FG000|Overall Study|Screen failed|24|||
145930058|NCT02477332|526252260|FG004|Overall Study|Non-compliance with study treatment|0|||
145930059|NCT02477332|526252261|FG005|Overall Study|Non-compliance with study treatment|0|||
145930060|NCT02477332|526252256|FG000|Overall Study|Pregnancy|0|||
145930061|NCT02477332|526252257|FG001|Overall Study|Pregnancy|0|||
145930062|NCT02477332|526252258|FG002|Overall Study|Pregnancy|0|||
145930063|NCT02477332|526252259|FG003|Overall Study|Pregnancy|1|||
145930064|NCT02477332|526252260|FG004|Overall Study|Pregnancy|0|||
145930065|NCT02477332|526252261|FG005|Overall Study|Pregnancy|0|||
145930066|NCT02477332|526252256|FG000|Overall Study|Protocol Violation|2|||
145930067|NCT02477332|526252257|FG001|Overall Study|Protocol Violation|0|||
145930068|NCT02477332|526252258|FG002|Overall Study|Protocol Violation|3|||
145930069|NCT02477332|526252259|FG003|Overall Study|Protocol Violation|3|||
145930070|NCT02477332|526252260|FG004|Overall Study|Protocol Violation|1|||
145930071|NCT02477332|526252261|FG005|Overall Study|Protocol Violation|1|||
145930072|NCT02477332|526252256|FG000|Overall Study|Technical problems|0|||
145930073|NCT02477332|526252257|FG001|Overall Study|Technical problems|0|||
145930074|NCT02477332|526252258|FG002|Overall Study|Technical problems|1|||
145930075|NCT02477332|526252259|FG003|Overall Study|Technical problems|0|||
145930076|NCT02477332|526252260|FG004|Overall Study|Technical problems|0|||
145930077|NCT02477332|526252261|FG005|Overall Study|Technical problems|0|||
145930078|NCT02477332|526252256|FG000|Overall Study|Lost to Follow-up|0|||
145930079|NCT02477332|526252257|FG001|Overall Study|Lost to Follow-up|0|||
145930080|NCT02477332|526252258|FG002|Overall Study|Lost to Follow-up|2|||
145930081|NCT02477332|526252259|FG003|Overall Study|Lost to Follow-up|0|||
145930082|NCT02477332|526252260|FG004|Overall Study|Lost to Follow-up|0|||
145930083|NCT02477332|526252261|FG005|Overall Study|Lost to Follow-up|0|||
145930084|NCT02477332|526252256|FG000|Overall Study|Physician Decision|0|||
145930085|NCT02477332|526252257|FG001|Overall Study|Physician Decision|0|||
145930086|NCT02477332|526252258|FG002|Overall Study|Physician Decision|1|||
145930087|NCT02477332|526252259|FG003|Overall Study|Physician Decision|3|||
145930088|NCT02477332|526252260|FG004|Overall Study|Physician Decision|0|||
145930089|NCT02477332|526252261|FG005|Overall Study|Physician Decision|1|||
145930090|NCT02477332|526252256|FG000|Overall Study|Withdrawal by Subject|0|||
145930091|NCT02477332|526252257|FG001|Overall Study|Withdrawal by Subject|3|||
145930092|NCT02477332|526252258|FG002|Overall Study|Withdrawal by Subject|1|||
145930093|NCT02477332|526252259|FG003|Overall Study|Withdrawal by Subject|2|||
145930094|NCT02477332|526252260|FG004|Overall Study|Withdrawal by Subject|1|||
145930095|NCT02477332|526252261|FG005|Overall Study|Withdrawal by Subject|0|||
145930096|NCT00900159|526252266|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
145930097|NCT00900159|526252267|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
145930098|NCT01075256|526252268|FG000|Overall Study|Withdrawal by Subject|1|||
145930099|NCT01075256|526252269|FG001|Overall Study|Withdrawal by Subject|0|||
145930100|NCT01075256|526252270|FG002|Overall Study|Withdrawal by Subject|0|||
145930101|NCT02593097|526252284|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
145930102|NCT02593097|526252285|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
145930103|NCT02593097|526252284|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145930104|NCT02593097|526252285|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
145930105|NCT02593097|526252284|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
145930106|NCT02593097|526252285|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
145930107|NCT02593097|526252284|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
145930108|NCT02593097|526252285|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
145930109|NCT02593097|526252284|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
145930110|NCT02593097|526252285|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
145930111|NCT03759587|526252286|FG000|Overall Study|Adverse Event|5|||
145930112|NCT03759587|526252286|FG000|Overall Study|Progressive Disease|10|||
145930113|NCT03759587|526252286|FG000|Overall Study|Site Terminated by Sponsor|3|||
145930114|NCT03759587|526252286|FG000|Overall Study|Withdrawal by Subject|1|||
145930115|NCT00665431|526252288|FG000|Overall Study|Adverse Event|16|||
145930116|NCT00665431|526252289|FG001|Overall Study|Adverse Event|22|||
145930117|NCT00665431|526252290|FG002|Overall Study|Adverse Event|6|||
145930118|NCT00665431|526252288|FG000|Overall Study|Withdrawal by Subject|17|||
145930119|NCT00665431|526252289|FG001|Overall Study|Withdrawal by Subject|25|||
145930120|NCT00665431|526252290|FG002|Overall Study|Withdrawal by Subject|15|||
146243344|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
145930121|NCT00665431|526252288|FG000|Overall Study|Lost to Follow-up|3|||
145930122|NCT00665431|526252289|FG001|Overall Study|Lost to Follow-up|3|||
145930123|NCT00665431|526252290|FG002|Overall Study|Lost to Follow-up|1|||
145930124|NCT00665431|526252288|FG000|Overall Study|Other|4|||
145930125|NCT00665431|526252289|FG001|Overall Study|Other|7|||
145930126|NCT00665431|526252290|FG002|Overall Study|Other|2|||
145930127|NCT03340454|526252293|FG000|Overall Study|Lost to Follow-up|0|||
145930128|NCT03340454|526252294|FG001|Overall Study|Lost to Follow-up|4|||
145930129|NCT01464164|526252295|FG000|Overall Study|Screen failure|0|||
145930130|NCT01464164|526252296|FG001|Overall Study|Screen failure|1|||
145930131|NCT01464164|526252297|FG002|Overall Study|Screen failure|2|||
145930132|NCT01464164|526252298|FG003|Overall Study|Screen failure|0|||
145930133|NCT01464164|526252299|FG004|Overall Study|Screen failure|0|||
145930134|NCT01464164|526252300|FG005|Overall Study|Screen failure|0|||
145930135|NCT01464164|526252301|FG006|Overall Study|Screen failure|0|||
145930136|NCT01464164|526252295|FG000|Overall Study|Physician Decision|0|||
145930137|NCT01464164|526252296|FG001|Overall Study|Physician Decision|1|||
145930138|NCT01464164|526252297|FG002|Overall Study|Physician Decision|0|||
145930139|NCT01464164|526252298|FG003|Overall Study|Physician Decision|0|||
145930140|NCT01464164|526252299|FG004|Overall Study|Physician Decision|0|||
145930141|NCT01464164|526252300|FG005|Overall Study|Physician Decision|0|||
145930142|NCT01464164|526252301|FG006|Overall Study|Physician Decision|2|||
145930143|NCT03682848|526252302|FG000|Overall Study|Withdrawal by Subject|2|||
145930144|NCT03682848|526252302|FG000|Overall Study|Site closed|5|||
145930145|NCT03682848|526252302|FG000|Overall Study|Protocol Deviation|1|||
145930146|NCT03682848|526252302|FG000|Overall Study|Adverse Event|1|||
145930147|NCT00454363|526252303|FG000|Overall Study|Adverse Event|1|||
145930148|NCT00454363|526252304|FG001|Overall Study|Adverse Event|2|||
145930149|NCT00454363|526252303|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
145930150|NCT00454363|526252304|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
145930151|NCT01578239|526252305|FG000|Treatment Period|Progressive Disease|19|||
145930152|NCT01578239|526252306|FG001|Treatment Period|Progressive Disease|64|||
145930153|NCT01578239|526252305|FG000|Treatment Period|Physician Decision|17|||
145930154|NCT01578239|526252306|FG001|Treatment Period|Physician Decision|17|||
145930155|NCT01578239|526252305|FG000|Treatment Period|Adverse Event|13|||
145930156|NCT01578239|526252306|FG001|Treatment Period|Adverse Event|10|||
145930157|NCT01578239|526252305|FG000|Treatment Period|Non-compliance|2|||
145930158|NCT01578239|526252306|FG001|Treatment Period|Non-compliance|0|||
145930159|NCT01578239|526252305|FG000|Treatment Period|Withdrawal by Subject|10|||
145930160|NCT01578239|526252306|FG001|Treatment Period|Withdrawal by Subject|9|||
145930161|NCT01578239|526252305|FG000|Treatment Period|Other|6|||
145930162|NCT01578239|526252306|FG001|Treatment Period|Other|1|||
145930163|NCT01578239|526252305|FG000|Long-term Follow-Up Period|Death|69|||
145930164|NCT01578239|526252306|FG001|Long-term Follow-Up Period|Death|64|||
145930165|NCT01578239|526252305|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
145930166|NCT01578239|526252306|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
145930167|NCT01578239|526252305|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
145930168|NCT01578239|526252306|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
145930169|NCT01578239|526252305|FG000|Long-term Follow-Up Period|Other|2|||
145930170|NCT01578239|526252306|FG001|Long-term Follow-Up Period|Other|2|||
145930171|NCT02347813|526252307|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
145930172|NCT02347813|526252308|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
145930173|NCT02347813|526252307|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
145930174|NCT02347813|526252308|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
145930175|NCT01119859|526252309|FG000|Overall Study|Adverse Event|9|||
145930176|NCT01119859|526252310|FG001|Overall Study|Adverse Event|10|||
145930177|NCT01119859|526252309|FG000|Overall Study|Death|2|||
145930178|NCT01119859|526252310|FG001|Overall Study|Death|0|||
145930179|NCT01119859|526252309|FG000|Overall Study|Insufficient therapeutic response|7|||
145930180|NCT01119859|526252310|FG001|Overall Study|Insufficient therapeutic response|14|||
145930181|NCT01119859|526252309|FG000|Overall Study|Refused treatment|3|||
145930182|NCT01119859|526252310|FG001|Overall Study|Refused treatment|6|||
145930183|NCT01119859|526252309|FG000|Overall Study|Failure to return|3|||
145930184|NCT01119859|526252310|FG001|Overall Study|Failure to return|0|||
145930185|NCT02644668|526252312|FG000|Overall Study|Adverse Event|2|||
145930186|NCT02644668|526252313|FG001|Overall Study|Adverse Event|0|||
145930187|NCT02644668|526252314|FG002|Overall Study|Adverse Event|1|||
145930188|NCT02644668|526252312|FG000|Overall Study|Protocol Violation|0|||
145930189|NCT02644668|526252313|FG001|Overall Study|Protocol Violation|0|||
145930190|NCT02644668|526252314|FG002|Overall Study|Protocol Violation|1|||
145930191|NCT02644668|526252312|FG000|Overall Study|Withdrawal by Subject|0|||
145930192|NCT02644668|526252313|FG001|Overall Study|Withdrawal by Subject|0|||
145930193|NCT02644668|526252314|FG002|Overall Study|Withdrawal by Subject|1|||
145930194|NCT01134939|526252315|FG000|Overall Study|Adverse Event|9|||
145930195|NCT01134939|526252316|FG001|Overall Study|Adverse Event|3|||
145930196|NCT01134939|526252317|FG002|Overall Study|Adverse Event|4|||
145930197|NCT01134939|526252318|FG003|Overall Study|Adverse Event|5|||
145930198|NCT01134939|526252319|FG004|Overall Study|Adverse Event|5|||
145930199|NCT01134939|526252320|FG005|Overall Study|Adverse Event|5|||
145930200|NCT01134939|526252321|FG006|Overall Study|Adverse Event|1|||
145930201|NCT01134939|526252322|FG007|Overall Study|Adverse Event|0|||
145930202|NCT01134939|526252315|FG000|Overall Study|Lack of Efficacy|2|||
145930203|NCT01134939|526252316|FG001|Overall Study|Lack of Efficacy|5|||
145930204|NCT01134939|526252317|FG002|Overall Study|Lack of Efficacy|1|||
145930205|NCT01134939|526252318|FG003|Overall Study|Lack of Efficacy|0|||
145930206|NCT01134939|526252319|FG004|Overall Study|Lack of Efficacy|3|||
145930207|NCT01134939|526252320|FG005|Overall Study|Lack of Efficacy|0|||
145930208|NCT01134939|526252321|FG006|Overall Study|Lack of Efficacy|1|||
145930209|NCT01134939|526252322|FG007|Overall Study|Lack of Efficacy|0|||
145930210|NCT01134939|526252315|FG000|Overall Study|Lost to Follow-up|2|||
145930211|NCT01134939|526252316|FG001|Overall Study|Lost to Follow-up|3|||
145930212|NCT01134939|526252317|FG002|Overall Study|Lost to Follow-up|0|||
145930213|NCT01134939|526252318|FG003|Overall Study|Lost to Follow-up|1|||
145930214|NCT01134939|526252319|FG004|Overall Study|Lost to Follow-up|2|||
145930215|NCT01134939|526252320|FG005|Overall Study|Lost to Follow-up|1|||
145930216|NCT01134939|526252321|FG006|Overall Study|Lost to Follow-up|0|||
145930217|NCT01134939|526252322|FG007|Overall Study|Lost to Follow-up|0|||
145930218|NCT01134939|526252315|FG000|Overall Study|Death|0|||
145930219|NCT01134939|526252316|FG001|Overall Study|Death|1|||
145930220|NCT01134939|526252317|FG002|Overall Study|Death|0|||
145930221|NCT01134939|526252318|FG003|Overall Study|Death|0|||
145930222|NCT01134939|526252319|FG004|Overall Study|Death|0|||
145930223|NCT01134939|526252320|FG005|Overall Study|Death|0|||
145930224|NCT01134939|526252321|FG006|Overall Study|Death|0|||
145930225|NCT01134939|526252322|FG007|Overall Study|Death|0|||
145930226|NCT01134939|526252315|FG000|Overall Study|Termination page not available|4|||
145930227|NCT01134939|526252316|FG001|Overall Study|Termination page not available|6|||
145930228|NCT01134939|526252317|FG002|Overall Study|Termination page not available|5|||
145930229|NCT01134939|526252318|FG003|Overall Study|Termination page not available|8|||
145930230|NCT01134939|526252319|FG004|Overall Study|Termination page not available|0|||
145930231|NCT01134939|526252320|FG005|Overall Study|Termination page not available|3|||
145930232|NCT01134939|526252321|FG006|Overall Study|Termination page not available|7|||
145930233|NCT01134939|526252322|FG007|Overall Study|Termination page not available|0|||
145930234|NCT03817229|526252325|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
145930235|NCT03817229|526252326|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
145930236|NCT03817229|526252327|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
145930237|NCT03817229|526252328|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
145930238|NCT03817229|526252325|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145930239|NCT03817229|526252326|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
145930240|NCT03817229|526252327|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145930241|NCT03817229|526252328|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145930242|NCT03817229|526252325|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
145930243|NCT03817229|526252326|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
145930244|NCT03817229|526252327|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
145930245|NCT03817229|526252328|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
145930246|NCT03817229|526252325|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
145930247|NCT03817229|526252326|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
145930248|NCT03817229|526252327|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
145930249|NCT03817229|526252328|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
145930250|NCT03817229|526252325|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145930251|NCT03817229|526252326|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145930252|NCT03817229|526252327|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145930253|NCT03817229|526252328|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
145930254|NCT03817229|526252325|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
145930255|NCT03817229|526252326|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
145930256|NCT03817229|526252327|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
145930257|NCT03817229|526252328|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
145930258|NCT03817229|526252325|FG000|Post-Intervention|Withdrawal by Subject|6|||
145930259|NCT03817229|526252326|FG001|Post-Intervention|Withdrawal by Subject|0|||
145930260|NCT03817229|526252327|FG002|Post-Intervention|Withdrawal by Subject|2|||
145930261|NCT03817229|526252328|FG003|Post-Intervention|Withdrawal by Subject|2|||
145930262|NCT03817229|526252325|FG000|Post-Intervention|Withdrawal by Study Team|3|||
145930263|NCT03817229|526252326|FG001|Post-Intervention|Withdrawal by Study Team|1|||
145930264|NCT03817229|526252327|FG002|Post-Intervention|Withdrawal by Study Team|1|||
145930265|NCT03817229|526252328|FG003|Post-Intervention|Withdrawal by Study Team|4|||
145930266|NCT03817229|526252325|FG000|Post-Intervention|Weaned from medication|3|||
145930267|NCT03817229|526252326|FG001|Post-Intervention|Weaned from medication|0|||
145930268|NCT03817229|526252327|FG002|Post-Intervention|Weaned from medication|2|||
145930269|NCT03817229|526252328|FG003|Post-Intervention|Weaned from medication|1|||
145930270|NCT03817229|526252325|FG000|Post-Intervention|Transferred care to another institution|1|||
145930271|NCT03817229|526252326|FG001|Post-Intervention|Transferred care to another institution|0|||
145930272|NCT03817229|526252327|FG002|Post-Intervention|Transferred care to another institution|0|||
145977942|NCT02202616|526431146|FG000|Overall Study|Adverse Event|32|||
145977943|NCT02202616|526431146|FG000|Overall Study|Protocol deviation|18|||
145930273|NCT03817229|526252328|FG003|Post-Intervention|Transferred care to another institution|0|||
145930274|NCT03817229|526252325|FG000|Post-Intervention|Change in parental guardianship|0|||
145930275|NCT03817229|526252326|FG001|Post-Intervention|Change in parental guardianship|0|||
145930276|NCT03817229|526252327|FG002|Post-Intervention|Change in parental guardianship|1|||
145930277|NCT03817229|526252328|FG003|Post-Intervention|Change in parental guardianship|0|||
145930278|NCT03817229|526252325|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
145977944|NCT02202616|526431146|FG000|Overall Study|Patient withdrew consent|12|||
145977945|NCT02202616|526431146|FG000|Overall Study|Lost to Follow-up|6|||
145977946|NCT02202616|526431146|FG000|Overall Study|Administrative problems|6|||
145977947|NCT02202616|526431146|FG000|Overall Study|Abnormal test procedure result|1|||
145930279|NCT03817229|526252326|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
145930280|NCT03817229|526252327|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
145930281|NCT03817229|526252328|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
145930282|NCT03817229|526252325|FG000|Follow-up 1|Withdrawal by Subject|1|||
145930283|NCT03817229|526252326|FG001|Follow-up 1|Withdrawal by Subject|2|||
145930284|NCT03817229|526252327|FG002|Follow-up 1|Withdrawal by Subject|0|||
145930285|NCT03817229|526252328|FG003|Follow-up 1|Withdrawal by Subject|0|||
145930286|NCT03817229|526252325|FG000|Follow-up 1|Withdrawal by Study Team|3|||
145930287|NCT03817229|526252326|FG001|Follow-up 1|Withdrawal by Study Team|1|||
145930288|NCT03817229|526252327|FG002|Follow-up 1|Withdrawal by Study Team|0|||
145930289|NCT03817229|526252328|FG003|Follow-up 1|Withdrawal by Study Team|0|||
145930290|NCT03817229|526252325|FG000|Follow-up 1|Wean from medication|3|||
145930291|NCT03817229|526252326|FG001|Follow-up 1|Wean from medication|4|||
145930292|NCT03817229|526252327|FG002|Follow-up 1|Wean from medication|0|||
145930293|NCT03817229|526252328|FG003|Follow-up 1|Wean from medication|1|||
145930294|NCT03817229|526252325|FG000|Follow-up 1|Transferred care to another hospital|1|||
145930295|NCT03817229|526252326|FG001|Follow-up 1|Transferred care to another hospital|0|||
145930296|NCT03817229|526252327|FG002|Follow-up 1|Transferred care to another hospital|0|||
145930297|NCT03817229|526252328|FG003|Follow-up 1|Transferred care to another hospital|0|||
145930298|NCT03817229|526252325|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
145930299|NCT03817229|526252326|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
145930300|NCT03817229|526252327|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
145930301|NCT03817229|526252328|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
145930302|NCT03817229|526252325|FG000|Follow-up 2|Withdrawal by Subject|2|||
145930303|NCT03817229|526252326|FG001|Follow-up 2|Withdrawal by Subject|0|||
145930304|NCT03817229|526252327|FG002|Follow-up 2|Withdrawal by Subject|1|||
145930305|NCT03817229|526252328|FG003|Follow-up 2|Withdrawal by Subject|1|||
145930306|NCT03817229|526252325|FG000|Follow-up 2|Withdrawal by Study Team|2|||
145930307|NCT03817229|526252326|FG001|Follow-up 2|Withdrawal by Study Team|0|||
145930308|NCT03817229|526252327|FG002|Follow-up 2|Withdrawal by Study Team|1|||
145930309|NCT03817229|526252328|FG003|Follow-up 2|Withdrawal by Study Team|0|||
145930310|NCT03817229|526252325|FG000|Follow-up 2|Wean from medication|1|||
145930311|NCT03817229|526252326|FG001|Follow-up 2|Wean from medication|0|||
145930312|NCT03817229|526252327|FG002|Follow-up 2|Wean from medication|0|||
145930313|NCT03817229|526252328|FG003|Follow-up 2|Wean from medication|0|||
145930314|NCT03817229|526252325|FG000|Follow-up 2|Transferred care|0|||
145930315|NCT03817229|526252326|FG001|Follow-up 2|Transferred care|0|||
145930316|NCT03817229|526252327|FG002|Follow-up 2|Transferred care|1|||
145930317|NCT03817229|526252328|FG003|Follow-up 2|Transferred care|0|||
145930318|NCT04402138|526253883|FG000|Overall Study|Progressive Disease|2|||
145930319|NCT04402138|526253883|FG000|Overall Study|Adverse Event|1|||
145930320|NCT04390503|526253884|FG000|Overall Study|Physician Decision|2|||
145930321|NCT04390503|526253885|FG001|Overall Study|Physician Decision|1|||
145930322|NCT04390503|526253884|FG000|Overall Study|Adverse Event|1|||
145930323|NCT04390503|526253885|FG001|Overall Study|Adverse Event|0|||
145930324|NCT03508726|526253886|FG000|Overall Study|Withdrawal by Subject|0|||
145930325|NCT03508726|526253887|FG001|Overall Study|Withdrawal by Subject|1|||
145930326|NCT02875613|526253891|FG000|Overall Study|Withdrawal by Subject|1|||
145930327|NCT02875613|526253891|FG000|Overall Study|Screen Failure|1|||
145930328|NCT01057810|526253892|FG000|Overall Study|Disease progression|156|||
145930329|NCT01057810|526253893|FG001|Overall Study|Disease progression|197|||
145930330|NCT01057810|526253892|FG000|Overall Study|Study drug toxicity|5|||
145930331|NCT01057810|526253893|FG001|Overall Study|Study drug toxicity|114|||
145930332|NCT01057810|526253892|FG000|Overall Study|Adverse event unrelated to study drug|13|||
145977948|NCT02202616|526431146|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145977949|NCT05221866|526431149|FG000|Overall Study|Withdrawal by Subject|5|||
145977950|NCT05221866|526431150|FG001|Overall Study|Withdrawal by Subject|7|||
145977951|NCT05221866|526431151|FG002|Overall Study|Withdrawal by Subject|6|||
145977952|NCT05221866|526431152|FG003|Overall Study|Withdrawal by Subject|4|||
145977953|NCT05221866|526431149|FG000|Overall Study|Physician Decision|3|||
145977954|NCT05221866|526431150|FG001|Overall Study|Physician Decision|2|||
145977955|NCT05221866|526431151|FG002|Overall Study|Physician Decision|1|||
145977956|NCT05221866|526431152|FG003|Overall Study|Physician Decision|4|||
145977957|NCT05221866|526431149|FG000|Overall Study|Lost to Follow-up|12|||
145930333|NCT01057810|526253893|FG001|Overall Study|Adverse event unrelated to study drug|29|||
145930334|NCT01057810|526253892|FG000|Overall Study|Withdrawal by Subject|10|||
145930335|NCT01057810|526253893|FG001|Overall Study|Withdrawal by Subject|25|||
145930336|NCT01057810|526253892|FG000|Overall Study|Death|2|||
145977958|NCT05221866|526431150|FG001|Overall Study|Lost to Follow-up|17|||
145930337|NCT01057810|526253893|FG001|Overall Study|Death|12|||
145930338|NCT01057810|526253892|FG000|Overall Study|Maximum clinical benefit|5|||
145930339|NCT01057810|526253893|FG001|Overall Study|Maximum clinical benefit|5|||
145930340|NCT01057810|526253892|FG000|Overall Study|Poor/non-compliance|0|||
145977959|NCT05221866|526431151|FG002|Overall Study|Lost to Follow-up|14|||
145977960|NCT05221866|526431152|FG003|Overall Study|Lost to Follow-up|14|||
145930341|NCT01057810|526253893|FG001|Overall Study|Poor/non-compliance|1|||
145930342|NCT01057810|526253892|FG000|Overall Study|No longer met study criteria|0|||
145930343|NCT01057810|526253893|FG001|Overall Study|No longer met study criteria|1|||
145930344|NCT01057810|526253892|FG000|Overall Study|Other|7|||
145930345|NCT01057810|526253893|FG001|Overall Study|Other|14|||
145930346|NCT02088905|526253894|FG000|Overall Study|Withdrawal by Subject|5|||
145930347|NCT02088905|526253895|FG001|Overall Study|Withdrawal by Subject|1|||
145930348|NCT01091662|526253897|FG000|Overall Study|Adverse Event|1|||
145930349|NCT01091662|526253898|FG001|Overall Study|Adverse Event|9|||
145930350|NCT01091662|526253897|FG000|Overall Study|Physician Decision|1|||
145930351|NCT01091662|526253898|FG001|Overall Study|Physician Decision|1|||
145930352|NCT01091662|526253897|FG000|Overall Study|Withdrawal by Subject|7|||
145930353|NCT01091662|526253898|FG001|Overall Study|Withdrawal by Subject|6|||
145930354|NCT01091662|526253897|FG000|Overall Study|met exit criteria|7|||
145930355|NCT01091662|526253898|FG001|Overall Study|met exit criteria|13|||
145930356|NCT01091662|526253897|FG000|Overall Study|met exclusion criteria|1|||
145930357|NCT01091662|526253898|FG001|Overall Study|met exclusion criteria|0|||
145930358|NCT01091662|526253897|FG000|Overall Study|Lost to Follow-up|0|||
145930359|NCT01091662|526253898|FG001|Overall Study|Lost to Follow-up|1|||
145930360|NCT01091662|526253897|FG000|Overall Study|Pregnancy|0|||
145930361|NCT01091662|526253898|FG001|Overall Study|Pregnancy|1|||
145930362|NCT01091662|526253897|FG000|Overall Study|Protocol Violation|0|||
145930363|NCT01091662|526253898|FG001|Overall Study|Protocol Violation|2|||
145930364|NCT01091662|526253897|FG000|Overall Study|unable to swallow capsule|0|||
145930365|NCT01091662|526253898|FG001|Overall Study|unable to swallow capsule|1|||
145930366|NCT01421225|526253899|FG000|Overall Study|Withdrawal by Subject|0|||
145930367|NCT01421225|526253900|FG001|Overall Study|Withdrawal by Subject|1|||
145930368|NCT02649439|526253901|FG000|Overall Study|Switched to alternative treatment|6|||
145930369|NCT02649439|526253902|FG001|Overall Study|Switched to alternative treatment|4|||
145930370|NCT02649439|526253901|FG000|Overall Study|Patient decision|1|||
145930371|NCT02649439|526253902|FG001|Overall Study|Patient decision|0|||
145930372|NCT02649439|526253901|FG000|Overall Study|Patient going out of country|1|||
145930373|NCT02649439|526253902|FG001|Overall Study|Patient going out of country|0|||
145930374|NCT02649439|526253901|FG000|Overall Study|To start finasteride|1|||
145930375|NCT02649439|526253902|FG001|Overall Study|To start finasteride|0|||
145930376|NCT02649439|526253901|FG000|Overall Study|Physician Decision|1|||
145930377|NCT02649439|526253902|FG001|Overall Study|Physician Decision|0|||
145930378|NCT02649439|526253901|FG000|Overall Study|Disease progression on study|12|||
145930379|NCT02649439|526253902|FG001|Overall Study|Disease progression on study|13|||
145930380|NCT02649439|526253901|FG000|Overall Study|Refused further treatment|1|||
145930381|NCT02649439|526253902|FG001|Overall Study|Refused further treatment|0|||
145930382|NCT02649439|526253901|FG000|Overall Study|Refused further follow up|2|||
145930383|NCT02649439|526253902|FG001|Overall Study|Refused further follow up|7|||
145930384|NCT02649439|526253901|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
145930385|NCT02649439|526253902|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
145930386|NCT02649439|526253901|FG000|Overall Study|No treatment, per protocol|1|||
145930387|NCT02649439|526253902|FG001|Overall Study|No treatment, per protocol|0|||
145930388|NCT02649439|526253901|FG000|Overall Study|PSA DT makes ineligible|0|||
145930389|NCT02649439|526253902|FG001|Overall Study|PSA DT makes ineligible|1|||
145930390|NCT02649439|526253901|FG000|Overall Study|Rising PSA No Mets|0|||
145930391|NCT02649439|526253902|FG001|Overall Study|Rising PSA No Mets|1|||
145930392|NCT02649439|526253901|FG000|Overall Study|Rising PSA|0|||
145930393|NCT02649439|526253902|FG001|Overall Study|Rising PSA|1|||
145930394|NCT02649439|526253901|FG000|Overall Study|Signed follow up protocol|0|||
145930395|NCT02649439|526253902|FG001|Overall Study|Signed follow up protocol|1|||
145977961|NCT05221866|526431149|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
145977962|NCT05221866|526431150|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
145977963|NCT05221866|526431151|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
145977964|NCT05221866|526431152|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
145930396|NCT02714595|526253905|FG000|Overall Study|Lost to Follow-up|1|||
145930397|NCT02714595|526253906|FG001|Overall Study|Lost to Follow-up|0|||
145930398|NCT02714595|526253905|FG000|Overall Study|Withdrawal by Subject|1|||
145930399|NCT02714595|526253906|FG001|Overall Study|Withdrawal by Subject|2|||
145930400|NCT02714595|526253905|FG000|Overall Study|Lack of Efficacy|0|||
145930401|NCT02714595|526253906|FG001|Overall Study|Lack of Efficacy|1|||
145930402|NCT02714595|526253905|FG000|Overall Study|Death|30|||
145930403|NCT02714595|526253906|FG001|Overall Study|Death|9|||
145930404|NCT02714595|526253905|FG000|Overall Study|Other-Miscellaneous|0|||
145930405|NCT02714595|526253906|FG001|Overall Study|Other-Miscellaneous|1|||
145930406|NCT04606394|526253909|FG000|Overall Study|Withdrawal by Subject|3|||
145930407|NCT04606394|526253909|FG000|Overall Study|Exclusion criteria screen failure|12|||
145930408|NCT01896128|526253910|FG000|Overall Study|Withdrawal by Subject|3|||
145930409|NCT01896128|526253911|FG001|Overall Study|Withdrawal by Subject|3|||
145930410|NCT00955955|526253912|FG000|Overall Study|Lost to Follow-up|2|||
145930411|NCT00955955|526253913|FG001|Overall Study|Lost to Follow-up|0|||
145930412|NCT00955955|526253914|FG002|Overall Study|Lost to Follow-up|0|||
145930413|NCT01996254|526253916|FG000|Overall Study|Change in Eligibility|0|||
145930414|NCT01996254|526253917|FG001|Overall Study|Change in Eligibility|2|||
145930415|NCT01996254|526253918|FG002|Overall Study|Change in Eligibility|0|||
145930416|NCT01996254|526253916|FG000|Overall Study|Withdrawal by Subject|0|||
145930417|NCT01996254|526253917|FG001|Overall Study|Withdrawal by Subject|3|||
145930418|NCT01996254|526253918|FG002|Overall Study|Withdrawal by Subject|4|||
145930419|NCT01996254|526253916|FG000|Overall Study|Lost to Follow-up|1|||
145930420|NCT01996254|526253917|FG001|Overall Study|Lost to Follow-up|0|||
145930421|NCT01996254|526253918|FG002|Overall Study|Lost to Follow-up|4|||
145930422|NCT03423173|526253919|FG000|Overall Study|Randomized but not vaccinated|1|||
145930423|NCT03423173|526253920|FG001|Overall Study|Randomized but not vaccinated|0|||
145930424|NCT03423173|526253921|FG002|Overall Study|Randomized but not vaccinated|2|||
145930425|NCT03423173|526253922|FG003|Overall Study|Randomized but not vaccinated|1|||
145930426|NCT03423173|526253919|FG000|Overall Study|Adverse Event|1|||
145930427|NCT03423173|526253920|FG001|Overall Study|Adverse Event|1|||
145930428|NCT03423173|526253921|FG002|Overall Study|Adverse Event|1|||
145930429|NCT03423173|526253922|FG003|Overall Study|Adverse Event|1|||
145930430|NCT03423173|526253919|FG000|Overall Study|Lost to Follow-up|10|||
145930431|NCT03423173|526253920|FG001|Overall Study|Lost to Follow-up|19|||
145930432|NCT03423173|526253921|FG002|Overall Study|Lost to Follow-up|17|||
145930433|NCT03423173|526253922|FG003|Overall Study|Lost to Follow-up|22|||
145930434|NCT03423173|526253919|FG000|Overall Study|Withdrawal of consent|4|||
145930435|NCT03423173|526253920|FG001|Overall Study|Withdrawal of consent|10|||
145930436|NCT03423173|526253921|FG002|Overall Study|Withdrawal of consent|4|||
145930437|NCT03423173|526253922|FG003|Overall Study|Withdrawal of consent|5|||
145930438|NCT03423173|526253919|FG000|Overall Study|Death|1|||
145930439|NCT03423173|526253920|FG001|Overall Study|Death|0|||
145930440|NCT03423173|526253921|FG002|Overall Study|Death|0|||
145930441|NCT03423173|526253922|FG003|Overall Study|Death|0|||
145930442|NCT03423173|526253919|FG000|Overall Study|Reason not Specified|2|||
145930443|NCT03423173|526253920|FG001|Overall Study|Reason not Specified|5|||
145930444|NCT03423173|526253921|FG002|Overall Study|Reason not Specified|3|||
145930445|NCT03423173|526253922|FG003|Overall Study|Reason not Specified|1|||
145930446|NCT03348930|526253923|FG000|Washout (1 Week)|Lost to Follow-up|1|||
145930447|NCT03348930|526253924|FG001|Washout (1 Week)|Lost to Follow-up|1|||
145930448|NCT03533114|526253925|FG000|Overall|Adverse Event|16|||
145930449|NCT03533114|526253926|FG001|Overall|Adverse Event|11|||
145930450|NCT03533114|526253925|FG000|Overall|Consent Withdrawal by Participant|7|||
145930451|NCT03533114|526253926|FG001|Overall|Consent Withdrawal by Participant|6|||
145930452|NCT03533114|526253925|FG000|Overall|Lack of Efficacy|5|||
145930453|NCT03533114|526253926|FG001|Overall|Lack of Efficacy|3|||
145930454|NCT03533114|526253925|FG000|Overall|Lost to Follow-up|1|||
145930455|NCT03533114|526253926|FG001|Overall|Lost to Follow-up|1|||
145930456|NCT03533114|526253925|FG000|Overall|Physician Decision|0|||
145930457|NCT03533114|526253926|FG001|Overall|Physician Decision|2|||
145977965|NCT03487445|526431153|FG000|Randomization|Not treated for administrative reasons|1|||
145977966|NCT03487445|526431154|FG001|Randomization|Not treated for administrative reasons|0|||
145977967|NCT01666652|526431155|FG000|Overall Study|Serious Adverse Event|0|||
145977968|NCT01666652|526431156|FG001|Overall Study|Serious Adverse Event|0|||
145977969|NCT01666652|526431157|FG002|Overall Study|Serious Adverse Event|0|||
145977970|NCT01666652|526431158|FG003|Overall Study|Serious Adverse Event|1|||
145977971|NCT01666652|526431159|FG004|Overall Study|Serious Adverse Event|0|||
145977972|NCT01666652|526431155|FG000|Overall Study|Withdrawal by Subject|0|||
145977973|NCT01666652|526431156|FG001|Overall Study|Withdrawal by Subject|0|||
145977974|NCT01666652|526431157|FG002|Overall Study|Withdrawal by Subject|0|||
145977975|NCT01666652|526431158|FG003|Overall Study|Withdrawal by Subject|0|||
145977976|NCT01666652|526431159|FG004|Overall Study|Withdrawal by Subject|1|||
145977977|NCT01666652|526431155|FG000|Overall Study|Moved from study area|1|||
145977978|NCT01666652|526431156|FG001|Overall Study|Moved from study area|0|||
145930458|NCT03533114|526253925|FG000|Overall|Protocol deviation|1|||
145930459|NCT03533114|526253926|FG001|Overall|Protocol deviation|1|||
145930460|NCT03533114|526253925|FG000|Overall|Failure to meet randomization criteria|1|||
145930461|NCT03533114|526253926|FG001|Overall|Failure to meet randomization criteria|2|||
145930462|NCT03533114|526253925|FG000|Overall|Non-Compliance with study drug|0|||
145977979|NCT01666652|526431157|FG002|Overall Study|Moved from study area|0|||
145977980|NCT01666652|526431158|FG003|Overall Study|Moved from study area|2|||
145977981|NCT01666652|526431159|FG004|Overall Study|Moved from study area|0|||
145930463|NCT03533114|526253926|FG001|Overall|Non-Compliance with study drug|1|||
145930464|NCT03533114|526253925|FG000|Overall|Other|0|||
145930465|NCT03533114|526253926|FG001|Overall|Other|1|||
145930466|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Adverse Event|11|||
145930467|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Adverse Event|8|||
145930468|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
145977982|NCT01666652|526431155|FG000|Overall Study|Lost to Follow-up|1|||
145977983|NCT01666652|526431156|FG001|Overall Study|Lost to Follow-up|1|||
145930469|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
145930470|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
145930471|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
145930472|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
145930473|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
145930474|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
145930475|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
145930476|NCT03533114|526253925|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
145930477|NCT03533114|526253926|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
145930478|NCT03533114|526253925|FG000|Stable Dose|Adverse Event|0|||
145930479|NCT03533114|526253926|FG001|Stable Dose|Adverse Event|2|||
145930480|NCT03533114|526253925|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
145930481|NCT03533114|526253926|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
145930482|NCT03533114|526253925|FG000|Stable Dose|Lack of Efficacy|1|||
145930483|NCT03533114|526253926|FG001|Stable Dose|Lack of Efficacy|0|||
145930484|NCT03533114|526253925|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
145930485|NCT03533114|526253926|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
145930486|NCT03533114|526253925|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
145930487|NCT03533114|526253926|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
145930488|NCT03533114|526253925|FG000|Open-Label Safety Extension|Adverse Event|3|||
145930489|NCT03533114|526253926|FG001|Open-Label Safety Extension|Adverse Event|0|||
145930490|NCT03533114|526253925|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
145930491|NCT03533114|526253926|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
145930492|NCT03533114|526253925|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
145930493|NCT03533114|526253926|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
145930494|NCT03533114|526253925|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
145930495|NCT03533114|526253926|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
145930496|NCT03533114|526253925|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
145930497|NCT03533114|526253926|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
145930498|NCT02411396|526253929|FG000|Overall Study|Lost to Follow-up|31|||
145930499|NCT02411396|526253929|FG000|Overall Study|Death|10|||
145930500|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
145930501|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
145930502|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
145930503|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
145930504|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
145930505|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
145930506|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
145930507|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
145930508|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
145930509|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
145930510|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
145930511|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
145930512|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
145930513|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
145930514|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145930515|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145930516|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145930517|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145930518|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
145930519|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
145930520|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
145930521|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
145930522|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
145930523|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
145930524|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
145930525|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
145930526|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
145930527|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
145930528|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
145930529|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
145930530|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
145930531|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
145930532|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145930533|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145930534|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145930535|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145930536|NCT02016105|526253936|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
145930537|NCT02016105|526253937|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
145930538|NCT02016105|526253938|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145930539|NCT02016105|526253939|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145930540|NCT02016105|526253940|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145930541|NCT02016105|526253941|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145930542|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
145930543|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
145930544|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
145930545|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
145930546|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
145930547|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
145930548|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
145930549|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
145930550|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
145930551|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
145930552|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
145930553|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
145930554|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
145930555|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
145930556|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
145930557|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
145930558|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
145930559|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
145930560|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Death|0|||
145930561|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Death|0|||
145930562|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Death|0|||
145930563|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Death|0|||
145930564|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Death|0|||
145930565|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Death|1|||
145930566|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
145930567|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
145930568|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
146090800|NCT01017575|526852689|FG004|Overall Study|Withdrawal by Subject|0|||
146090801|NCT03500679|526852696|FG000|Overall Study|Lost to Follow-up|6|||
146090802|NCT03500679|526852697|FG001|Overall Study|Lost to Follow-up|3|||
146090803|NCT03500679|526852696|FG000|Overall Study|Withdrawal by Subject|3|||
146090804|NCT03500679|526852697|FG001|Overall Study|Withdrawal by Subject|0|||
146090805|NCT00095628|526852698|FG000|Overall Study|Disease progression prior to treatment|1|||
146090806|NCT02021656|526852721|FG000|Overall Study|Adverse Event|1|||
146090807|NCT02021656|526852721|FG000|Overall Study|Lack of Efficacy|2|||
146090808|NCT02021656|526852721|FG000|Overall Study|Lost to Follow-up|1|||
146090809|NCT02021656|526852721|FG000|Overall Study|Withdrew Consent|2|||
146090810|NCT00510952|526852724|FG000|Overall Study|Adverse Event|1|||
146090811|NCT00510952|526852725|FG001|Overall Study|Adverse Event|0|||
146090812|NCT00510952|526852724|FG000|Overall Study|Entry Criteria Not Met|3|||
146090813|NCT00510952|526852725|FG001|Overall Study|Entry Criteria Not Met|1|||
146090814|NCT00510952|526852724|FG000|Overall Study|Lost to Follow-up|5|||
146090815|NCT00510952|526852725|FG001|Overall Study|Lost to Follow-up|3|||
146090816|NCT00510952|526852724|FG000|Overall Study|Physician Decision|1|||
146090817|NCT00510952|526852725|FG001|Overall Study|Physician Decision|1|||
146090818|NCT00510952|526852724|FG000|Overall Study|Protocol Violation|7|||
146090819|NCT00510952|526852725|FG001|Overall Study|Protocol Violation|4|||
146090820|NCT00510952|526852724|FG000|Overall Study|Sponsor Decision|1|||
146090821|NCT00510952|526852725|FG001|Overall Study|Sponsor Decision|0|||
146090822|NCT00510952|526852724|FG000|Overall Study|Withdrawal by Subject|6|||
146090823|NCT00510952|526852725|FG001|Overall Study|Withdrawal by Subject|7|||
146090824|NCT00510952|526852724|FG000|Overall Study|Did Not Receive Study Drug|2|||
146090825|NCT00510952|526852725|FG001|Overall Study|Did Not Receive Study Drug|0|||
146090826|NCT00055471|526852731|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
146090827|NCT00055471|526852732|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
146090828|NCT00055471|526852733|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
146090829|NCT00055471|526852731|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
146090830|NCT00055471|526852732|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
145930569|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
145930570|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
145930571|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
145930572|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
145930573|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
145930574|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
145930575|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
146090831|NCT00055471|526852733|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
145930576|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
145930577|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
146090832|NCT00055471|526852731|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
146090833|NCT00055471|526852732|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
146090834|NCT00055471|526852733|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
146090835|NCT01854944|526852734|FG000|Overall Study|Withdrawal by Subject|0|||
145930578|NCT02016105|526253936|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145930579|NCT02016105|526253937|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145930580|NCT02016105|526253938|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
146090836|NCT01854944|526852735|FG001|Overall Study|Withdrawal by Subject|0|||
145930581|NCT02016105|526253939|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145930582|NCT02016105|526253940|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145930583|NCT02016105|526253941|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
145930584|NCT02016105|526253936|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
145930585|NCT02016105|526253937|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
145930586|NCT02016105|526253938|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
145930587|NCT02016105|526253939|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
145930588|NCT02016105|526253940|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
145930589|NCT02016105|526253941|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
145930590|NCT02016105|526253936|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
145930591|NCT02016105|526253937|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
145930592|NCT02016105|526253938|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
145930593|NCT02016105|526253939|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
145930594|NCT02016105|526253940|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
145930595|NCT02016105|526253941|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
145930596|NCT02016105|526253936|FG000|EXTENSION PERIOD|Adverse Event|0|||
145930597|NCT02016105|526253937|FG001|EXTENSION PERIOD|Adverse Event|0|||
145930598|NCT02016105|526253938|FG002|EXTENSION PERIOD|Adverse Event|2|||
145930599|NCT02016105|526253939|FG003|EXTENSION PERIOD|Adverse Event|0|||
145930600|NCT02016105|526253940|FG004|EXTENSION PERIOD|Adverse Event|1|||
145930601|NCT02016105|526253941|FG005|EXTENSION PERIOD|Adverse Event|0|||
145930602|NCT02016105|526253936|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
145930603|NCT02016105|526253937|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
145930604|NCT02016105|526253938|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
145930605|NCT02016105|526253939|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
145930606|NCT02016105|526253940|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
145930607|NCT02016105|526253941|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
145930608|NCT02016105|526253936|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
145930609|NCT02016105|526253937|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
145930610|NCT02016105|526253938|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
145930611|NCT02016105|526253939|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
145930612|NCT02016105|526253940|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
145930613|NCT02016105|526253941|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
145930614|NCT02016105|526253936|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
145930615|NCT02016105|526253937|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
145930616|NCT02016105|526253938|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
145930617|NCT02016105|526253939|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
145930618|NCT02016105|526253940|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
145930619|NCT02016105|526253941|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
145930620|NCT02071706|526253942|FG000|Overall Study|Adverse Event|1|||
145930621|NCT02071706|526253942|FG000|Overall Study|Withdrawal by Subject|2|||
145930622|NCT01908829|526253943|FG000|Overall Study|Adverse Event|13|||
145977984|NCT01666652|526431157|FG002|Overall Study|Lost to Follow-up|1|||
145977985|NCT01666652|526431158|FG003|Overall Study|Lost to Follow-up|1|||
145977986|NCT01666652|526431159|FG004|Overall Study|Lost to Follow-up|0|||
145977987|NCT04470427|526431160|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
145977988|NCT04470427|526431161|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
145977989|NCT04470427|526431162|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
145977990|NCT04470427|526431163|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
145977991|NCT04470427|526431164|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
145977992|NCT04470427|526431165|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
145977993|NCT04470427|526431160|FG000|Part B :Open-label|Other than specified|0|||
145977994|NCT04470427|526431161|FG001|Part B :Open-label|Other than specified|0|||
145977995|NCT04470427|526431162|FG002|Part B :Open-label|Other than specified|788|||
145977996|NCT04470427|526431163|FG003|Part B :Open-label|Other than specified|0|||
145977997|NCT04470427|526431164|FG004|Part B :Open-label|Other than specified|523|||
145977998|NCT04470427|526431165|FG005|Part B :Open-label|Other than specified|0|||
145977999|NCT04470427|526431160|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
145978000|NCT04470427|526431161|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
145978001|NCT04470427|526431162|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
145930623|NCT01908829|526253944|FG001|Overall Study|Adverse Event|11|||
145930624|NCT01908829|526253945|FG002|Overall Study|Adverse Event|13|||
145930625|NCT01908829|526253943|FG000|Overall Study|Lost to Follow-up|4|||
145930626|NCT01908829|526253944|FG001|Overall Study|Lost to Follow-up|2|||
145930627|NCT01908829|526253945|FG002|Overall Study|Lost to Follow-up|1|||
145930628|NCT01908829|526253943|FG000|Overall Study|Randomized no double-blind drug received|1|||
145930629|NCT01908829|526253944|FG001|Overall Study|Randomized no double-blind drug received|0|||
145930630|NCT01908829|526253945|FG002|Overall Study|Randomized no double-blind drug received|1|||
145930631|NCT01908829|526253943|FG000|Overall Study|Discontinued (no EoT page)|2|||
145930632|NCT01908829|526253944|FG001|Overall Study|Discontinued (no EoT page)|0|||
145930633|NCT01908829|526253945|FG002|Overall Study|Discontinued (no EoT page)|0|||
145930634|NCT01908829|526253943|FG000|Overall Study|Miscellaneous|0|||
145978002|NCT04470427|526431163|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
145978003|NCT04470427|526431164|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
146090837|NCT01854944|526852736|FG002|Overall Study|Withdrawal by Subject|1|||
146090838|NCT02101112|526852737|FG000|Overall Study|Adverse Event|0|||
146090839|NCT02101112|526852738|FG001|Overall Study|Adverse Event|0|||
146090840|NCT02101112|526852739|FG002|Overall Study|Adverse Event|1|||
146090841|NCT02101112|526852740|FG003|Overall Study|Adverse Event|0|||
146090842|NCT02101112|526852741|FG004|Overall Study|Adverse Event|0|||
146090843|NCT02101112|526852742|FG005|Overall Study|Adverse Event|0|||
146090844|NCT02101112|526852737|FG000|Overall Study|Withdrawal by Subject|0|||
146243345|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
146243346|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
146243347|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
146243348|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
145930635|NCT01908829|526253944|FG001|Overall Study|Miscellaneous|2|||
145930636|NCT01908829|526253945|FG002|Overall Study|Miscellaneous|0|||
145930637|NCT01908829|526253943|FG000|Overall Study|Protocol Violation|2|||
145930638|NCT01908829|526253944|FG001|Overall Study|Protocol Violation|2|||
145930639|NCT01908829|526253945|FG002|Overall Study|Protocol Violation|0|||
145930640|NCT01908829|526253943|FG000|Overall Study|Lack of Efficacy|1|||
145930641|NCT01908829|526253944|FG001|Overall Study|Lack of Efficacy|3|||
145930642|NCT01908829|526253945|FG002|Overall Study|Lack of Efficacy|2|||
145930643|NCT01908829|526253943|FG000|Overall Study|Withdrawal by Subject|26|||
145930644|NCT01908829|526253944|FG001|Overall Study|Withdrawal by Subject|29|||
145930645|NCT01908829|526253945|FG002|Overall Study|Withdrawal by Subject|22|||
145930646|NCT02320058|526253946|FG000|Overall Study|Death|25|||
145930647|NCT02320058|526253947|FG001|Overall Study|Death|10|||
145930648|NCT02320058|526253946|FG000|Overall Study|Lost to Follow-up|4|||
145930649|NCT02320058|526253947|FG001|Overall Study|Lost to Follow-up|0|||
145930650|NCT02320058|526253946|FG000|Overall Study|Other reasons|4|||
146243349|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
146243350|NCT02203032|527405389|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
145930651|NCT02320058|526253947|FG001|Overall Study|Other reasons|1|||
145930652|NCT02320058|526253946|FG000|Overall Study|Withdrawal by Subject|8|||
145930653|NCT02320058|526253947|FG001|Overall Study|Withdrawal by Subject|2|||
145930654|NCT02320058|526253946|FG000|Overall Study|Not reported|1|||
145930655|NCT02320058|526253947|FG001|Overall Study|Not reported|0|||
145930656|NCT01855243|526253950|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
145930657|NCT01855243|526253951|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
145930658|NCT01855243|526253952|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
145930659|NCT01860040|526253953|FG000|Overall Study|Withdrawal by Subject|1|||
145930660|NCT01860040|526253954|FG001|Overall Study|Withdrawal by Subject|0|||
145930661|NCT01931995|526253955|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
145930662|NCT01931995|526253956|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
145930663|NCT01931995|526253955|FG000|First Intervention (1 Day)|Physician Decision|1|||
145930664|NCT01931995|526253956|FG001|First Intervention (1 Day)|Physician Decision|1|||
145930665|NCT01931995|526253955|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
145930666|NCT01931995|526253956|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
145930667|NCT02477826|526253975|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
145930668|NCT02477826|526253976|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
145930669|NCT02477826|526253977|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
145930670|NCT02477826|526253978|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
145930671|NCT02477826|526253979|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
145930672|NCT02477826|526253980|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
145930673|NCT02477826|526253981|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
145930674|NCT02477826|526253982|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
145930675|NCT02477826|526253983|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
146243351|NCT02203032|527405390|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
146243352|NCT02203032|527405391|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
146243353|NCT02203032|527405392|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
145930676|NCT02477826|526253984|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
145930677|NCT02477826|526253975|FG000|Pre-Treatment|Other reasons|4|||
145930678|NCT02477826|526253976|FG001|Pre-Treatment|Other reasons|1|||
145930679|NCT02477826|526253977|FG002|Pre-Treatment|Other reasons|4|||
145930680|NCT02477826|526253978|FG003|Pre-Treatment|Other reasons|1|||
145930681|NCT02477826|526253979|FG004|Pre-Treatment|Other reasons|4|||
145930682|NCT02477826|526253980|FG005|Pre-Treatment|Other reasons|2|||
146090845|NCT02101112|526852738|FG001|Overall Study|Withdrawal by Subject|0|||
146243354|NCT02203032|527405389|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
145930683|NCT02477826|526253981|FG006|Pre-Treatment|Other reasons|0|||
145930684|NCT02477826|526253982|FG007|Pre-Treatment|Other reasons|0|||
145930685|NCT02477826|526253983|FG008|Pre-Treatment|Other reasons|0|||
145930686|NCT02477826|526253984|FG009|Pre-Treatment|Other reasons|0|||
145930687|NCT02477826|526253975|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
145930688|NCT02477826|526253976|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
146090846|NCT02101112|526852739|FG002|Overall Study|Withdrawal by Subject|0|||
146243355|NCT02203032|527405390|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
146243356|NCT02203032|527405391|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
146243357|NCT02203032|527405392|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
146243358|NCT02203032|527405389|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
146243359|NCT02203032|527405390|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
146243360|NCT02203032|527405391|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
145930689|NCT02477826|526253977|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
145930690|NCT02477826|526253978|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
145930691|NCT02477826|526253979|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
145930692|NCT02477826|526253980|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
145930693|NCT02477826|526253981|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
145930694|NCT02477826|526253982|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
145930695|NCT02477826|526253983|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
145930696|NCT02477826|526253984|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
145930697|NCT02477826|526253975|FG000|Pre-Treatment|Subject withdrew consent|0|||
145930698|NCT02477826|526253976|FG001|Pre-Treatment|Subject withdrew consent|0|||
145930699|NCT02477826|526253977|FG002|Pre-Treatment|Subject withdrew consent|3|||
145930700|NCT02477826|526253978|FG003|Pre-Treatment|Subject withdrew consent|0|||
145930701|NCT02477826|526253979|FG004|Pre-Treatment|Subject withdrew consent|0|||
145930702|NCT02477826|526253980|FG005|Pre-Treatment|Subject withdrew consent|1|||
145930703|NCT02477826|526253981|FG006|Pre-Treatment|Subject withdrew consent|0|||
145930704|NCT02477826|526253982|FG007|Pre-Treatment|Subject withdrew consent|1|||
145930705|NCT02477826|526253983|FG008|Pre-Treatment|Subject withdrew consent|0|||
145930706|NCT02477826|526253984|FG009|Pre-Treatment|Subject withdrew consent|3|||
145930707|NCT02477826|526253975|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930708|NCT02477826|526253976|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
145930709|NCT02477826|526253977|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930710|NCT02477826|526253978|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930711|NCT02477826|526253979|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930712|NCT02477826|526253980|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930713|NCT02477826|526253981|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930714|NCT02477826|526253982|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930715|NCT02477826|526253983|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
145930716|NCT02477826|526253984|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
145930717|NCT02477826|526253975|FG000|Pre-Treatment|Death|0|||
145930718|NCT02477826|526253976|FG001|Pre-Treatment|Death|0|||
145930719|NCT02477826|526253977|FG002|Pre-Treatment|Death|0|||
145930720|NCT02477826|526253978|FG003|Pre-Treatment|Death|0|||
145930721|NCT02477826|526253979|FG004|Pre-Treatment|Death|0|||
145930722|NCT02477826|526253980|FG005|Pre-Treatment|Death|0|||
145930723|NCT02477826|526253981|FG006|Pre-Treatment|Death|1|||
145930724|NCT02477826|526253982|FG007|Pre-Treatment|Death|0|||
145930725|NCT02477826|526253983|FG008|Pre-Treatment|Death|0|||
145930726|NCT02477826|526253984|FG009|Pre-Treatment|Death|0|||
145930727|NCT02477826|526253975|FG000|Treatment Period|Not reported|8|||
145930728|NCT02477826|526253976|FG001|Treatment Period|Not reported|6|||
145930729|NCT02477826|526253977|FG002|Treatment Period|Not reported|4|||
145930730|NCT02477826|526253978|FG003|Treatment Period|Not reported|4|||
145930731|NCT02477826|526253979|FG004|Treatment Period|Not reported|2|||
145930732|NCT02477826|526253980|FG005|Treatment Period|Not reported|1|||
145930733|NCT02477826|526253981|FG006|Treatment Period|Not reported|14|||
145930734|NCT02477826|526253982|FG007|Treatment Period|Not reported|8|||
145930735|NCT02477826|526253983|FG008|Treatment Period|Not reported|5|||
145930736|NCT02477826|526253984|FG009|Treatment Period|Not reported|2|||
145930737|NCT02477826|526253975|FG000|Treatment Period|Other reasons|5|||
145930738|NCT02477826|526253976|FG001|Treatment Period|Other reasons|6|||
145930739|NCT02477826|526253977|FG002|Treatment Period|Other reasons|12|||
145930740|NCT02477826|526253978|FG003|Treatment Period|Other reasons|7|||
145930741|NCT02477826|526253979|FG004|Treatment Period|Other reasons|5|||
145930742|NCT02477826|526253980|FG005|Treatment Period|Other reasons|1|||
145930743|NCT02477826|526253981|FG006|Treatment Period|Other reasons|8|||
145930744|NCT02477826|526253982|FG007|Treatment Period|Other reasons|8|||
145930745|NCT02477826|526253983|FG008|Treatment Period|Other reasons|21|||
145930746|NCT02477826|526253984|FG009|Treatment Period|Other reasons|1|||
145930747|NCT02477826|526253975|FG000|Treatment Period|Administrative reason by sponsor|0|||
145930748|NCT02477826|526253976|FG001|Treatment Period|Administrative reason by sponsor|3|||
145930749|NCT02477826|526253977|FG002|Treatment Period|Administrative reason by sponsor|0|||
145930750|NCT02477826|526253978|FG003|Treatment Period|Administrative reason by sponsor|0|||
145930751|NCT02477826|526253979|FG004|Treatment Period|Administrative reason by sponsor|0|||
145930752|NCT02477826|526253980|FG005|Treatment Period|Administrative reason by sponsor|0|||
145930753|NCT02477826|526253981|FG006|Treatment Period|Administrative reason by sponsor|0|||
145930754|NCT02477826|526253982|FG007|Treatment Period|Administrative reason by sponsor|0|||
145930755|NCT02477826|526253983|FG008|Treatment Period|Administrative reason by sponsor|0|||
145930756|NCT02477826|526253984|FG009|Treatment Period|Administrative reason by sponsor|0|||
145930757|NCT02477826|526253975|FG000|Treatment Period|Participant meet no longer study criteria|1|||
145930758|NCT02477826|526253976|FG001|Treatment Period|Participant meet no longer study criteria|1|||
145930759|NCT02477826|526253977|FG002|Treatment Period|Participant meet no longer study criteria|0|||
145930760|NCT02477826|526253978|FG003|Treatment Period|Participant meet no longer study criteria|0|||
145930761|NCT02477826|526253979|FG004|Treatment Period|Participant meet no longer study criteria|1|||
145930762|NCT02477826|526253980|FG005|Treatment Period|Participant meet no longer study criteria|1|||
145930763|NCT02477826|526253981|FG006|Treatment Period|Participant meet no longer study criteria|0|||
145930764|NCT02477826|526253982|FG007|Treatment Period|Participant meet no longer study criteria|1|||
145930765|NCT02477826|526253983|FG008|Treatment Period|Participant meet no longer study criteria|0|||
145930766|NCT02477826|526253984|FG009|Treatment Period|Participant meet no longer study criteria|0|||
145978004|NCT04470427|526431165|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
145978005|NCT04470427|526431160|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
145978006|NCT04470427|526431161|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
145978007|NCT04470427|526431162|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
145978008|NCT04470427|526431163|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
145978009|NCT04470427|526431164|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
145978010|NCT04470427|526431165|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
145978011|NCT02717611|526431166|FG000|Overall Study|Death|13|||
145978012|NCT02717611|526431166|FG000|Overall Study|Withdrawal by Subject|6|||
145978013|NCT02717611|526431166|FG000|Overall Study|Active, not recruiting|40|||
145978014|NCT02717611|526431166|FG000|Overall Study|Complicating disease|1|||
145978015|NCT04598828|526431167|FG000|Overall Study|Physician Decision|1|||
145978016|NCT04598828|526431168|FG001|Overall Study|Physician Decision|0|||
145978017|NCT04598828|526431167|FG000|Overall Study|Withdrawal by Subject|0|||
145978018|NCT04598828|526431168|FG001|Overall Study|Withdrawal by Subject|1|||
145978019|NCT04598828|526431167|FG000|Overall Study|Withdrawal by Subject|0|||
145978020|NCT04598828|526431168|FG001|Overall Study|Withdrawal by Subject|1|||
145978021|NCT04818112|526431169|FG000|Overall Study|Withdrawal by Subject|54|||
145978022|NCT04818112|526431170|FG001|Overall Study|Withdrawal by Subject|12|||
145978023|NCT04818112|526431169|FG000|Overall Study|Lost to Follow-up|38|||
145978024|NCT04818112|526431170|FG001|Overall Study|Lost to Follow-up|10|||
145978025|NCT00700635|526431172|FG000|Overall Study|Adverse Event|1|||
145978026|NCT00700635|526431173|FG001|Overall Study|Adverse Event|0|||
145978027|NCT00700635|526431174|FG002|Overall Study|Adverse Event|0|||
145978028|NCT00700635|526431172|FG000|Overall Study|Lost to Follow-up|1|||
145978029|NCT00700635|526431173|FG001|Overall Study|Lost to Follow-up|3|||
145978030|NCT00700635|526431174|FG002|Overall Study|Lost to Follow-up|0|||
145978031|NCT00700635|526431172|FG000|Overall Study|Protocol Violation|2|||
145978032|NCT00700635|526431173|FG001|Overall Study|Protocol Violation|2|||
145978033|NCT00700635|526431174|FG002|Overall Study|Protocol Violation|0|||
145978034|NCT00700635|526431172|FG000|Overall Study|Withdrawal by Subject|7|||
145978035|NCT00700635|526431173|FG001|Overall Study|Withdrawal by Subject|3|||
145978036|NCT00700635|526431174|FG002|Overall Study|Withdrawal by Subject|1|||
145978037|NCT03244189|526431175|FG000|Overall Study|Death|0|||
145978038|NCT03244189|526431176|FG001|Overall Study|Death|2|||
145978039|NCT03244189|526431175|FG000|Overall Study|Lost to Follow-up|92|||
145978040|NCT03244189|526431176|FG001|Overall Study|Lost to Follow-up|107|||
145978041|NCT03244189|526431175|FG000|Overall Study|Physician Decision|4|||
145978042|NCT03244189|526431176|FG001|Overall Study|Physician Decision|2|||
145978043|NCT03244189|526431175|FG000|Overall Study|Pregnancy|7|||
145978044|NCT03244189|526431176|FG001|Overall Study|Pregnancy|5|||
145978045|NCT03244189|526431175|FG000|Overall Study|Protocol Violation|0|||
145978046|NCT03244189|526431176|FG001|Overall Study|Protocol Violation|2|||
145978047|NCT03244189|526431175|FG000|Overall Study|Withdrawal by Subject|45|||
145978048|NCT03244189|526431176|FG001|Overall Study|Withdrawal by Subject|23|||
145978049|NCT03244189|526431175|FG000|Overall Study|Technical Problems|2|||
146090847|NCT02101112|526852740|FG003|Overall Study|Withdrawal by Subject|0|||
146090848|NCT02101112|526852741|FG004|Overall Study|Withdrawal by Subject|1|||
146090849|NCT02101112|526852742|FG005|Overall Study|Withdrawal by Subject|0|||
146090850|NCT02782923|526852745|FG000|Overall Study|Lost to Follow-up|15|||
146090851|NCT00993044|526852746|FG000|Irinotecan 50 mg|Physician Decision|1|||
146090852|NCT05063318|526852749|FG000|Overall Study|Progressive disease|2|||
145930767|NCT02477826|526253975|FG000|Treatment Period|Poor/Non Compliance|1|||
145978050|NCT03244189|526431176|FG001|Overall Study|Technical Problems|0|||
145978051|NCT06170827|526431177|FG000|Overall Study|Withdrawal by Subject|1|||
145978052|NCT06170827|526431178|FG001|Overall Study|Withdrawal by Subject|1|||
145978053|NCT03611946|526431181|FG000|Overall Study|Withdrawal by Subject|0|||
145978054|NCT03611946|526431182|FG001|Overall Study|Withdrawal by Subject|0|||
145978055|NCT03611946|526431183|FG002|Overall Study|Withdrawal by Subject|1|||
145978056|NCT03611946|526431184|FG003|Overall Study|Withdrawal by Subject|0|||
145978057|NCT02872714|526431188|FG000|Overall Study|Progressive Disease|1|||
145978058|NCT02872714|526431189|FG001|Overall Study|Progressive Disease|2|||
146090853|NCT05063318|526852750|FG001|Overall Study|Progressive disease|0|||
145978059|NCT02872714|526431190|FG002|Overall Study|Progressive Disease|0|||
145930768|NCT02477826|526253976|FG001|Treatment Period|Poor/Non Compliance|0|||
145930769|NCT02477826|526253977|FG002|Treatment Period|Poor/Non Compliance|2|||
145930770|NCT02477826|526253978|FG003|Treatment Period|Poor/Non Compliance|0|||
145930771|NCT02477826|526253979|FG004|Treatment Period|Poor/Non Compliance|0|||
145930772|NCT02477826|526253980|FG005|Treatment Period|Poor/Non Compliance|1|||
145930773|NCT02477826|526253981|FG006|Treatment Period|Poor/Non Compliance|1|||
145930774|NCT02477826|526253982|FG007|Treatment Period|Poor/Non Compliance|0|||
145930775|NCT02477826|526253983|FG008|Treatment Period|Poor/Non Compliance|0|||
145930776|NCT02477826|526253984|FG009|Treatment Period|Poor/Non Compliance|1|||
145930777|NCT02477826|526253975|FG000|Treatment Period|Maximum Clinical Benefit|3|||
145930778|NCT02477826|526253976|FG001|Treatment Period|Maximum Clinical Benefit|3|||
145930779|NCT02477826|526253977|FG002|Treatment Period|Maximum Clinical Benefit|1|||
145930780|NCT02477826|526253978|FG003|Treatment Period|Maximum Clinical Benefit|1|||
145930781|NCT02477826|526253979|FG004|Treatment Period|Maximum Clinical Benefit|3|||
145930782|NCT02477826|526253980|FG005|Treatment Period|Maximum Clinical Benefit|0|||
145930783|NCT02477826|526253981|FG006|Treatment Period|Maximum Clinical Benefit|3|||
145930784|NCT02477826|526253982|FG007|Treatment Period|Maximum Clinical Benefit|2|||
145930785|NCT02477826|526253983|FG008|Treatment Period|Maximum Clinical Benefit|2|||
145930786|NCT02477826|526253984|FG009|Treatment Period|Maximum Clinical Benefit|2|||
145930787|NCT02477826|526253975|FG000|Treatment Period|Lost to Follow-up|0|||
145930788|NCT02477826|526253976|FG001|Treatment Period|Lost to Follow-up|0|||
145930789|NCT02477826|526253977|FG002|Treatment Period|Lost to Follow-up|1|||
145930790|NCT02477826|526253978|FG003|Treatment Period|Lost to Follow-up|1|||
145930791|NCT02477826|526253979|FG004|Treatment Period|Lost to Follow-up|0|||
145930792|NCT02477826|526253980|FG005|Treatment Period|Lost to Follow-up|0|||
145930793|NCT02477826|526253981|FG006|Treatment Period|Lost to Follow-up|2|||
145930794|NCT02477826|526253982|FG007|Treatment Period|Lost to Follow-up|2|||
145930795|NCT02477826|526253983|FG008|Treatment Period|Lost to Follow-up|0|||
145930796|NCT02477826|526253984|FG009|Treatment Period|Lost to Follow-up|0|||
145930797|NCT02477826|526253975|FG000|Treatment Period|Participant withdrew Consent|5|||
145930798|NCT02477826|526253976|FG001|Treatment Period|Participant withdrew Consent|5|||
145930799|NCT02477826|526253977|FG002|Treatment Period|Participant withdrew Consent|3|||
145930800|NCT02477826|526253978|FG003|Treatment Period|Participant withdrew Consent|3|||
145930801|NCT02477826|526253979|FG004|Treatment Period|Participant withdrew Consent|1|||
145930802|NCT02477826|526253980|FG005|Treatment Period|Participant withdrew Consent|3|||
145930803|NCT02477826|526253981|FG006|Treatment Period|Participant withdrew Consent|3|||
145930804|NCT02477826|526253982|FG007|Treatment Period|Participant withdrew Consent|3|||
145930805|NCT02477826|526253983|FG008|Treatment Period|Participant withdrew Consent|2|||
145930806|NCT02477826|526253984|FG009|Treatment Period|Participant withdrew Consent|3|||
145930807|NCT02477826|526253975|FG000|Treatment Period|Participant request to discontinue treatment|5|||
145930808|NCT02477826|526253976|FG001|Treatment Period|Participant request to discontinue treatment|3|||
145930809|NCT02477826|526253977|FG002|Treatment Period|Participant request to discontinue treatment|15|||
145930810|NCT02477826|526253978|FG003|Treatment Period|Participant request to discontinue treatment|5|||
145930811|NCT02477826|526253979|FG004|Treatment Period|Participant request to discontinue treatment|3|||
145930812|NCT02477826|526253980|FG005|Treatment Period|Participant request to discontinue treatment|6|||
145930813|NCT02477826|526253981|FG006|Treatment Period|Participant request to discontinue treatment|13|||
145930814|NCT02477826|526253982|FG007|Treatment Period|Participant request to discontinue treatment|15|||
145930815|NCT02477826|526253983|FG008|Treatment Period|Participant request to discontinue treatment|4|||
145930816|NCT02477826|526253984|FG009|Treatment Period|Participant request to discontinue treatment|18|||
145930817|NCT02477826|526253975|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
145930818|NCT02477826|526253976|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
145930819|NCT02477826|526253977|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
145930820|NCT02477826|526253978|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
145930821|NCT02477826|526253979|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
145930822|NCT02477826|526253980|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
145930823|NCT02477826|526253981|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
145930824|NCT02477826|526253982|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
145930825|NCT02477826|526253983|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
145930826|NCT02477826|526253984|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
145930827|NCT02477826|526253975|FG000|Treatment Period|Death|4|||
145930828|NCT02477826|526253976|FG001|Treatment Period|Death|7|||
145930829|NCT02477826|526253977|FG002|Treatment Period|Death|0|||
145930830|NCT02477826|526253978|FG003|Treatment Period|Death|0|||
145930831|NCT02477826|526253979|FG004|Treatment Period|Death|1|||
145930832|NCT02477826|526253980|FG005|Treatment Period|Death|2|||
145978060|NCT02872714|526431191|FG003|Overall Study|Progressive Disease|0|||
145978061|NCT02872714|526431192|FG004|Overall Study|Progressive Disease|0|||
145930833|NCT02477826|526253981|FG006|Treatment Period|Death|6|||
145930834|NCT02477826|526253982|FG007|Treatment Period|Death|5|||
145930835|NCT02477826|526253983|FG008|Treatment Period|Death|9|||
145978062|NCT02872714|526431188|FG000|Overall Study|Death|87|||
145978063|NCT02872714|526431189|FG001|Overall Study|Death|36|||
145978064|NCT02872714|526431190|FG002|Overall Study|Death|8|||
145930836|NCT02477826|526253984|FG009|Treatment Period|Death|0|||
145930837|NCT02477826|526253975|FG000|Treatment Period|Study Drug Toxicity|79|||
145930838|NCT02477826|526253976|FG001|Treatment Period|Study Drug Toxicity|51|||
145930839|NCT02477826|526253977|FG002|Treatment Period|Study Drug Toxicity|31|||
145930840|NCT02477826|526253978|FG003|Treatment Period|Study Drug Toxicity|39|||
145930841|NCT02477826|526253979|FG004|Treatment Period|Study Drug Toxicity|12|||
145930842|NCT02477826|526253980|FG005|Treatment Period|Study Drug Toxicity|25|||
145930843|NCT02477826|526253981|FG006|Treatment Period|Study Drug Toxicity|52|||
145930844|NCT02477826|526253982|FG007|Treatment Period|Study Drug Toxicity|30|||
145930845|NCT02477826|526253983|FG008|Treatment Period|Study Drug Toxicity|20|||
145930846|NCT02477826|526253984|FG009|Treatment Period|Study Drug Toxicity|9|||
145930847|NCT02477826|526253975|FG000|Treatment Period|Disease progression|212|||
145930848|NCT02477826|526253976|FG001|Treatment Period|Disease progression|240|||
145930849|NCT02477826|526253977|FG002|Treatment Period|Disease progression|202|||
145930850|NCT02477826|526253978|FG003|Treatment Period|Disease progression|93|||
145930851|NCT02477826|526253979|FG004|Treatment Period|Disease progression|113|||
145930852|NCT02477826|526253980|FG005|Treatment Period|Disease progression|96|||
145930853|NCT02477826|526253981|FG006|Treatment Period|Disease progression|208|||
145930854|NCT02477826|526253982|FG007|Treatment Period|Disease progression|195|||
145930855|NCT02477826|526253983|FG008|Treatment Period|Disease progression|59|||
145930856|NCT02477826|526253984|FG009|Treatment Period|Disease progression|46|||
145930857|NCT02477826|526253975|FG000|Treatment Period|Pregnancy|0|||
145930858|NCT02477826|526253976|FG001|Treatment Period|Pregnancy|0|||
145930859|NCT02477826|526253977|FG002|Treatment Period|Pregnancy|0|||
145930860|NCT02477826|526253978|FG003|Treatment Period|Pregnancy|0|||
145930861|NCT02477826|526253979|FG004|Treatment Period|Pregnancy|0|||
145930862|NCT02477826|526253980|FG005|Treatment Period|Pregnancy|0|||
145930863|NCT02477826|526253981|FG006|Treatment Period|Pregnancy|0|||
145930864|NCT02477826|526253982|FG007|Treatment Period|Pregnancy|0|||
145930865|NCT02477826|526253983|FG008|Treatment Period|Pregnancy|0|||
145930866|NCT02477826|526253984|FG009|Treatment Period|Pregnancy|1|||
145930867|NCT02477826|526253975|FG000|Treatment Period|Other|0|||
145930868|NCT02477826|526253976|FG001|Treatment Period|Other|0|||
145930869|NCT02477826|526253977|FG002|Treatment Period|Other|0|||
145930870|NCT02477826|526253978|FG003|Treatment Period|Other|0|||
145930871|NCT02477826|526253979|FG004|Treatment Period|Other|0|||
145930872|NCT02477826|526253980|FG005|Treatment Period|Other|0|||
145930873|NCT02477826|526253981|FG006|Treatment Period|Other|0|||
145930874|NCT02477826|526253982|FG007|Treatment Period|Other|0|||
145930875|NCT02477826|526253983|FG008|Treatment Period|Other|0|||
145930876|NCT02477826|526253984|FG009|Treatment Period|Other|1|||
145930877|NCT00828568|526253985|FG000|Randomized|Withdrawal by Subject|1|||
145930878|NCT00828568|526253986|FG001|Randomized|Withdrawal by Subject|0|||
145930879|NCT00828568|526253987|FG002|Randomized|Withdrawal by Subject|2|||
145930880|NCT00828568|526253985|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
145930881|NCT00828568|526253986|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
145930882|NCT00828568|526253987|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
145930883|NCT00828568|526253985|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
145930884|NCT00828568|526253986|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
145930885|NCT00828568|526253987|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
145930886|NCT00828568|526253985|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
145930887|NCT00828568|526253986|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
145930888|NCT00828568|526253987|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
145930889|NCT00828568|526253985|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
145930890|NCT00828568|526253986|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
145930891|NCT00828568|526253987|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
145930892|NCT00403481|526253988|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
145930893|NCT00403481|526253988|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
146090854|NCT05063318|526852751|FG002|Overall Study|Progressive disease|3|||
146090855|NCT05063318|526852749|FG000|Overall Study|Compassionate use|1|||
145930894|NCT00403481|526253988|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
145930895|NCT00403481|526253988|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
145930896|NCT00403481|526253988|FG000|Olm 40 mg|Adverse Event|2|||
145930897|NCT00403481|526253988|FG000|Olm 40 mg|Protocol Violation|1|||
145930898|NCT00403481|526253988|FG000|Olm 40 mg|Withdrawal by Subject|1|||
145930899|NCT00403481|526253988|FG000|Olm 40 mg|Other|1|||
145930900|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
145930901|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
145930902|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
145930903|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
146090856|NCT05063318|526852750|FG001|Overall Study|Compassionate use|3|||
145930904|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
145930905|NCT00403481|526253988|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
145930906|NCT02821754|526253989|FG000|Overall Study|Procedure not required prior to amendment change|13|||
146090857|NCT05063318|526852751|FG002|Overall Study|Compassionate use|3|||
145978065|NCT02872714|526431191|FG003|Overall Study|Death|81|||
145978066|NCT02872714|526431192|FG004|Overall Study|Death|2|||
145978067|NCT02872714|526431188|FG000|Overall Study|Lost to Follow-up|2|||
145978068|NCT02872714|526431189|FG001|Overall Study|Lost to Follow-up|1|||
145978069|NCT02872714|526431190|FG002|Overall Study|Lost to Follow-up|0|||
145978070|NCT02872714|526431191|FG003|Overall Study|Lost to Follow-up|3|||
145978071|NCT02872714|526431192|FG004|Overall Study|Lost to Follow-up|0|||
145978072|NCT02872714|526431188|FG000|Overall Study|Physician Decision|0|||
145978073|NCT02872714|526431189|FG001|Overall Study|Physician Decision|0|||
145978074|NCT02872714|526431190|FG002|Overall Study|Physician Decision|0|||
145978075|NCT02872714|526431191|FG003|Overall Study|Physician Decision|1|||
145978076|NCT02872714|526431192|FG004|Overall Study|Physician Decision|0|||
145978077|NCT02872714|526431188|FG000|Overall Study|Withdrawal by Subject|1|||
145978078|NCT02872714|526431189|FG001|Overall Study|Withdrawal by Subject|3|||
145978079|NCT02872714|526431190|FG002|Overall Study|Withdrawal by Subject|0|||
145978080|NCT02872714|526431191|FG003|Overall Study|Withdrawal by Subject|2|||
145978081|NCT02872714|526431192|FG004|Overall Study|Withdrawal by Subject|0|||
145978082|NCT02872714|526431188|FG000|Overall Study|Captured as Other|2|||
145978083|NCT02872714|526431189|FG001|Overall Study|Captured as Other|0|||
145978084|NCT02872714|526431190|FG002|Overall Study|Captured as Other|0|||
145978085|NCT02872714|526431191|FG003|Overall Study|Captured as Other|1|||
145978086|NCT02872714|526431192|FG004|Overall Study|Captured as Other|0|||
145978087|NCT05800145|526431198|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
145978088|NCT05800145|526431199|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145978089|NCT05800145|526431200|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145978090|NCT05800145|526431201|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
145978091|NCT05800145|526431202|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145978092|NCT05800145|526431203|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145978093|NCT05800145|526431198|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
145978094|NCT05800145|526431199|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145978095|NCT05800145|526431200|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145978096|NCT05800145|526431201|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
145978097|NCT05800145|526431202|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145978098|NCT05800145|526431203|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145978099|NCT05800145|526431198|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
145978100|NCT05800145|526431199|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
146090858|NCT05063318|526852749|FG000|Overall Study|Adverse Event|0|||
146090859|NCT05063318|526852750|FG001|Overall Study|Adverse Event|1|||
146090860|NCT05063318|526852751|FG002|Overall Study|Adverse Event|0|||
146090861|NCT05063318|526852749|FG000|Overall Study|Withdrawal by Subject|0|||
146090862|NCT05063318|526852750|FG001|Overall Study|Withdrawal by Subject|1|||
146090863|NCT05063318|526852751|FG002|Overall Study|Withdrawal by Subject|0|||
146090864|NCT03581786|526854784|FG000|Overall Study|Death|67|||
146090865|NCT03581786|526854785|FG001|Overall Study|Death|47|||
146090866|NCT03581786|526854784|FG000|Overall Study|Withdrawal by Subject|2|||
146090867|NCT03581786|526854785|FG001|Overall Study|Withdrawal by Subject|5|||
145930907|NCT02821754|526253990|FG001|Overall Study|Procedure not required prior to amendment change|11|||
145930908|NCT02821754|526253991|FG002|Overall Study|Procedure not required prior to amendment change|0|||
145930909|NCT02821754|526253989|FG000|Overall Study|Participant's Clinical status|2|||
145930910|NCT02821754|526253990|FG001|Overall Study|Participant's Clinical status|0|||
145930911|NCT02821754|526253991|FG002|Overall Study|Participant's Clinical status|0|||
145930912|NCT02821754|526253989|FG000|Overall Study|Participant removed for noncompliance|1|||
145930913|NCT02821754|526253990|FG001|Overall Study|Participant removed for noncompliance|0|||
145930914|NCT02821754|526253991|FG002|Overall Study|Participant removed for noncompliance|0|||
145930915|NCT02821754|526253989|FG000|Overall Study|Drug not available.|0|||
145930916|NCT02821754|526253990|FG001|Overall Study|Drug not available.|0|||
146090868|NCT03581786|526854784|FG000|Overall Study|Lost to Follow-up|7|||
145930917|NCT02821754|526253991|FG002|Overall Study|Drug not available.|1|||
145978101|NCT05800145|526431200|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
145978102|NCT05800145|526431201|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
145978103|NCT05800145|526431202|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
145978104|NCT05800145|526431203|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
145978105|NCT02850406|526431204|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
146090869|NCT03581786|526854785|FG001|Overall Study|Lost to Follow-up|4|||
146243361|NCT02203032|527405392|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
145978106|NCT02850406|526431205|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
146243362|NCT02203032|527405389|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
145978107|NCT02850406|526431206|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
145978108|NCT02850406|526431207|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
146090870|NCT03581786|526854784|FG000|Overall Study|reason other than specified above|0|||
146243363|NCT02203032|527405390|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
146090871|NCT03581786|526854785|FG001|Overall Study|reason other than specified above|1|||
145930918|NCT02821754|526253989|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
145930919|NCT02821754|526253990|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
145930920|NCT02821754|526253991|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
145930921|NCT00766636|526253993|FG000|Overall Study|Withdrawal by Subject|1|||
145930922|NCT00766636|526253994|FG001|Overall Study|Withdrawal by Subject|1|||
145930923|NCT00766636|526253993|FG000|Overall Study|Incomplete Treatment|0|||
145930924|NCT00766636|526253994|FG001|Overall Study|Incomplete Treatment|1|||
145930925|NCT00766636|526253993|FG000|Overall Study|Adverse Event|1|||
145930926|NCT00766636|526253994|FG001|Overall Study|Adverse Event|0|||
145930927|NCT00766636|526253993|FG000|Overall Study|Disease Progression|1|||
145930928|NCT00766636|526253994|FG001|Overall Study|Disease Progression|0|||
145930929|NCT03793842|526253999|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
145930930|NCT03793842|526254000|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
145930931|NCT03793842|526253999|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
145930932|NCT03793842|526254000|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
145930933|NCT04657198|526254001|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
145930934|NCT04657198|526254002|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145930935|NCT04657198|526254003|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145930936|NCT04087720|526254004|FG000|Overall Study|Withdrawal by Subject|2|||
145930937|NCT04087720|526254004|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
145930938|NCT01166438|526254005|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
145930939|NCT01166438|526254006|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
145930940|NCT01166438|526254005|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
145930941|NCT01166438|526254006|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
145930942|NCT01166438|526254005|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
145930943|NCT01166438|526254006|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
145930944|NCT01166438|526254005|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
145930945|NCT01166438|526254006|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
145930946|NCT01166438|526254005|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
145930947|NCT01166438|526254006|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
145930948|NCT01166438|526254005|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
145930949|NCT01166438|526254006|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
145930950|NCT02547220|526254009|FG000|Overall Study|Withdrawal by Subject|1|||
145930951|NCT02547220|526254010|FG001|Overall Study|Withdrawal by Subject|0|||
145930952|NCT02547220|526254009|FG000|Overall Study|Study terminated by sponsor|18|||
145930953|NCT02547220|526254010|FG001|Overall Study|Study terminated by sponsor|20|||
145930954|NCT01029782|526254011|FG000|Overall Study|Lost to Follow-up|2|||
145930955|NCT01029782|526254012|FG001|Overall Study|Lost to Follow-up|2|||
145930956|NCT01029782|526254011|FG000|Overall Study|Diagnosis changed|1|||
145930957|NCT01029782|526254012|FG001|Overall Study|Diagnosis changed|1|||
145930958|NCT01029782|526254011|FG000|Overall Study|Adverse Event|0|||
145930959|NCT01029782|526254012|FG001|Overall Study|Adverse Event|1|||
145930960|NCT01029782|526254011|FG000|Overall Study|Physician Decision|0|||
145930961|NCT01029782|526254012|FG001|Overall Study|Physician Decision|1|||
145930962|NCT01029782|526254011|FG000|Overall Study|Protocol Violation|0|||
145930963|NCT01029782|526254012|FG001|Overall Study|Protocol Violation|2|||
145930964|NCT01029782|526254011|FG000|Overall Study|Withdrawal by Subject|0|||
145930965|NCT01029782|526254012|FG001|Overall Study|Withdrawal by Subject|1|||
145930966|NCT01186692|526254016|FG000|Overall Study|Not Catheterized|11|||
145930967|NCT01186692|526254016|FG000|Overall Study|Futher testing contraindicated implant|19|||
145930968|NCT01186692|526254016|FG000|Overall Study|Adverse Event|2|||
145930969|NCT02195869|526254017|FG000|Overall Study|cGVHD Progression|5|||
145930970|NCT02195869|526254017|FG000|Overall Study|Malignancy Progression/relapse|2|||
145930971|NCT02195869|526254017|FG000|Overall Study|Adverse Event|15|||
145930972|NCT02195869|526254017|FG000|Overall Study|Withdrawal by Subject|7|||
145930973|NCT02195869|526254017|FG000|Overall Study|Physician Decision|4|||
145930974|NCT02195869|526254017|FG000|Overall Study|Study Terminated by Sponsor|7|||
145930975|NCT02195869|526254017|FG000|Overall Study|Noncompliance with study drug|2|||
145930976|NCT03319732|526254021|FG000|Overall Study|Adverse Event|40|||
145930977|NCT03319732|526254021|FG000|Overall Study|Withdrawal by Subject|50|||
145930978|NCT03319732|526254021|FG000|Overall Study|MS relapse|10|||
145930979|NCT03319732|526254021|FG000|Overall Study|reason not specified|5|||
145930980|NCT00757042|526254022|FG000|Overall Study|Lost to Follow-up|0|||
145930981|NCT00757042|526254023|FG001|Overall Study|Lost to Follow-up|0|||
145930982|NCT00757042|526254024|FG002|Overall Study|Lost to Follow-up|0|||
145930983|NCT00757042|526254025|FG003|Overall Study|Lost to Follow-up|0|||
145930984|NCT00757042|526254026|FG004|Overall Study|Lost to Follow-up|0|||
145930985|NCT00757042|526254027|FG005|Overall Study|Lost to Follow-up|0|||
145930986|NCT00757042|526254028|FG006|Overall Study|Lost to Follow-up|0|||
145930987|NCT00757042|526254029|FG007|Overall Study|Lost to Follow-up|0|||
145930988|NCT00757042|526254030|FG008|Overall Study|Lost to Follow-up|1|||
145930989|NCT00757042|526254031|FG009|Overall Study|Lost to Follow-up|0|||
145930990|NCT00757042|526254032|FG010|Overall Study|Lost to Follow-up|0|||
146243364|NCT02203032|527405391|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
145930991|NCT00757042|526254022|FG000|Overall Study|Ineligibility Determined|0|||
145930992|NCT00757042|526254023|FG001|Overall Study|Ineligibility Determined|0|||
145930993|NCT00757042|526254024|FG002|Overall Study|Ineligibility Determined|0|||
145930994|NCT00757042|526254025|FG003|Overall Study|Ineligibility Determined|0|||
145930995|NCT00757042|526254026|FG004|Overall Study|Ineligibility Determined|0|||
145930996|NCT00757042|526254027|FG005|Overall Study|Ineligibility Determined|0|||
145930997|NCT00757042|526254028|FG006|Overall Study|Ineligibility Determined|0|||
145930998|NCT00757042|526254029|FG007|Overall Study|Ineligibility Determined|0|||
145930999|NCT00757042|526254030|FG008|Overall Study|Ineligibility Determined|0|||
145931000|NCT00757042|526254031|FG009|Overall Study|Ineligibility Determined|0|||
145931001|NCT00757042|526254032|FG010|Overall Study|Ineligibility Determined|1|||
145931002|NCT00757042|526254022|FG000|Overall Study|Withdrawal by Subject|0|||
145931003|NCT00757042|526254023|FG001|Overall Study|Withdrawal by Subject|0|||
145931004|NCT00757042|526254024|FG002|Overall Study|Withdrawal by Subject|0|||
145931005|NCT00757042|526254025|FG003|Overall Study|Withdrawal by Subject|0|||
145931006|NCT00757042|526254026|FG004|Overall Study|Withdrawal by Subject|0|||
145931007|NCT00757042|526254027|FG005|Overall Study|Withdrawal by Subject|0|||
145931008|NCT00757042|526254028|FG006|Overall Study|Withdrawal by Subject|0|||
145931009|NCT00757042|526254029|FG007|Overall Study|Withdrawal by Subject|0|||
145931010|NCT00757042|526254030|FG008|Overall Study|Withdrawal by Subject|0|||
145931011|NCT00757042|526254031|FG009|Overall Study|Withdrawal by Subject|1|||
145931012|NCT00757042|526254032|FG010|Overall Study|Withdrawal by Subject|0|||
145931013|NCT02654977|526254033|FG000|Overall Study|Death|1|||
145931014|NCT02654977|526254033|FG000|Overall Study|Lost to Follow-up|1|||
145931015|NCT02654977|526254033|FG000|Overall Study|Adverse Event|1|||
145931016|NCT02654977|526254033|FG000|Overall Study|Withdrawal by Subject|1|||
145931017|NCT02654977|526254033|FG000|Overall Study|Lack of Efficacy|3|||
145931018|NCT01921101|526254035|FG000|Overall Study|Death|16|||
145931019|NCT01921101|526254036|FG001|Overall Study|Death|6|||
145931020|NCT00767455|526254037|FG000|Overall Study|Investigator error|19|||
145931021|NCT01266291|526254039|FG000|Overall Study|Adverse Event|1|||
145931022|NCT03291431|526254040|FG000|Overall Study|Protocol Violation|2|||
145931023|NCT03291431|526254041|FG001|Overall Study|Protocol Violation|1|||
145931024|NCT03291431|526254040|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
145931025|NCT03291431|526254041|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
145931026|NCT03291431|526254040|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
145931027|NCT03291431|526254041|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
145931028|NCT04925557|526255260|FG000|Overall Study|Study closed|5|||
145931029|NCT04925557|526255261|FG001|Overall Study|Study closed|3|||
145931030|NCT05488470|526255262|FG000|Overall Study|Physician Decision|2|||
145931031|NCT05488470|526255262|FG000|Overall Study|Withdrawal by Subject|1|||
145931032|NCT05488470|526255262|FG000|Overall Study|Death|1|||
145931033|NCT00068393|526255267|FG000|Overall Study|Adverse Event|2|||
145931034|NCT00068393|526255267|FG000|Overall Study|Death|3|||
145931035|NCT00068393|526255267|FG000|Overall Study|Withdrawal by Subject|3|||
145931036|NCT00068393|526255267|FG000|Overall Study|Alternative treatment|1|||
145931037|NCT00068393|526255267|FG000|Overall Study|Quality of life worsening|1|||
145931038|NCT01108341|526255272|FG000|Overall Study|Death|2|||
145931039|NCT01108341|526255272|FG000|Overall Study|Withdrawal by Subject|1|||
145931040|NCT01108341|526255272|FG000|Overall Study|Lost to Follow-up|1|||
145931041|NCT01108341|526255272|FG000|Overall Study|Other|1|||
145931042|NCT01068730|526255273|FG000|Period 3|Personal reason|1|||
145931043|NCT01068730|526255274|FG001|Period 3|Personal reason|0|||
145931044|NCT01068730|526255275|FG002|Period 3|Personal reason|0|||
145931045|NCT01068730|526255276|FG003|Period 3|Personal reason|0|||
145931046|NCT01068730|526255273|FG000|Period 4|Family emergency|0|||
145931047|NCT01068730|526255274|FG001|Period 4|Family emergency|1|||
145931048|NCT01068730|526255275|FG002|Period 4|Family emergency|0|||
145931049|NCT01068730|526255276|FG003|Period 4|Family emergency|0|||
145931050|NCT00178685|526255278|FG000|Overall Study|Death|3|||
145931051|NCT00178685|526255279|FG001|Overall Study|Death|3|||
145931052|NCT00178685|526255280|FG002|Overall Study|Death|6|||
145931053|NCT00178685|526255278|FG000|Overall Study|Lost to Follow-up|100|||
145931054|NCT00178685|526255279|FG001|Overall Study|Lost to Follow-up|187|||
145931055|NCT00178685|526255280|FG002|Overall Study|Lost to Follow-up|183|||
145931056|NCT00178685|526255278|FG000|Overall Study|Withdrawal by Subject|8|||
145931057|NCT00178685|526255279|FG001|Overall Study|Withdrawal by Subject|14|||
145931058|NCT00178685|526255280|FG002|Overall Study|Withdrawal by Subject|7|||
145931059|NCT04112043|526255281|FG000|Overall Study|Withdrawal by Subject|1|||
145931060|NCT04112043|526255282|FG001|Overall Study|Withdrawal by Subject|1|||
145931061|NCT04112043|526255283|FG002|Overall Study|Withdrawal by Subject|1|||
145931062|NCT04112043|526255281|FG000|Overall Study|Taking NR supplement|1|||
145931063|NCT04112043|526255282|FG001|Overall Study|Taking NR supplement|0|||
145931064|NCT04112043|526255283|FG002|Overall Study|Taking NR supplement|0|||
145931065|NCT04112043|526255281|FG000|Overall Study|Adverse Event|0|||
145931066|NCT04112043|526255282|FG001|Overall Study|Adverse Event|1|||
145978109|NCT02850406|526431208|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
145978110|NCT02850406|526431209|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
145978111|NCT02850406|526431210|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
145978112|NCT02850406|526431211|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
145978113|NCT02850406|526431204|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978114|NCT02850406|526431205|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978115|NCT02850406|526431206|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
145978116|NCT02850406|526431207|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
145978117|NCT02850406|526431208|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978118|NCT02850406|526431209|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978119|NCT02850406|526431210|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978120|NCT02850406|526431211|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145978121|NCT02850406|526431204|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978122|NCT02850406|526431205|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978123|NCT02850406|526431206|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
145978124|NCT02850406|526431207|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978125|NCT02850406|526431208|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978126|NCT02850406|526431209|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978127|NCT02850406|526431210|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978128|NCT02850406|526431211|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145978129|NCT02850406|526431204|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
145978130|NCT02850406|526431205|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
145978131|NCT02850406|526431206|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
145978132|NCT02850406|526431207|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
145931067|NCT04112043|526255283|FG002|Overall Study|Adverse Event|0|||
145931068|NCT01750697|526255286|FG000|Overall Study|Transferred Back to Local Hospital|1|||
145931069|NCT01750697|526255286|FG000|Overall Study|Physician and Family Decision|1|||
145931070|NCT01750697|526255286|FG000|Overall Study|Transferred to Adult Services|5|||
145931071|NCT01750697|526255286|FG000|Overall Study|Physician Decision|1|||
145931072|NCT01750697|526255286|FG000|Overall Study|Withdrawal by Subject|1|||
145931073|NCT00384839|526255289|FG000|Overall Study|Adverse Event|4|||
145931074|NCT00384839|526255289|FG000|Overall Study|Investigator Request|1|||
145931075|NCT00384839|526255289|FG000|Overall Study|Patient Request|1|||
145931076|NCT00384839|526255289|FG000|Overall Study|Ineligible|2|||
145931077|NCT02257489|526255292|FG000|Overall Study|Withdrawal by Subject|0|||
145931078|NCT02257489|526255293|FG001|Overall Study|Withdrawal by Subject|0|||
145931079|NCT02257489|526255294|FG002|Overall Study|Withdrawal by Subject|0|||
145931080|NCT02257489|526255295|FG003|Overall Study|Withdrawal by Subject|1|||
145931081|NCT02257489|526255296|FG004|Overall Study|Withdrawal by Subject|0|||
145931082|NCT02257489|526255297|FG005|Overall Study|Withdrawal by Subject|0|||
145931083|NCT02257489|526255298|FG006|Overall Study|Withdrawal by Subject|0|||
145931084|NCT02257489|526255299|FG007|Overall Study|Withdrawal by Subject|0|||
145931085|NCT02257489|526255300|FG008|Overall Study|Withdrawal by Subject|0|||
145931086|NCT01028014|526255302|FG000|Overall Study|Lost to Follow-up|1|||
145931087|NCT01028014|526255303|FG001|Overall Study|Lost to Follow-up|2|||
145931088|NCT01028014|526255304|FG002|Overall Study|Lost to Follow-up|0|||
145931089|NCT01028014|526255305|FG003|Overall Study|Lost to Follow-up|1|||
145931090|NCT01028014|526255306|FG004|Overall Study|Lost to Follow-up|1|||
145931091|NCT01028014|526255307|FG005|Overall Study|Lost to Follow-up|2|||
145931092|NCT00090493|526255308|FG000|Overall Study|Physician Decision|2|||
145931093|NCT01339923|526255309|FG000|Overall Study|Adverse Event|1|||
145931094|NCT01339923|526255310|FG001|Overall Study|Adverse Event|1|||
145931095|NCT01339923|526255311|FG002|Overall Study|Adverse Event|1|||
145931096|NCT01339923|526255312|FG003|Overall Study|Adverse Event|0|||
145931097|NCT01339923|526255313|FG004|Overall Study|Adverse Event|0|||
145931098|NCT01339923|526255314|FG005|Overall Study|Adverse Event|0|||
145978133|NCT02850406|526431208|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
145978134|NCT02850406|526431209|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
145978135|NCT02850406|526431210|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
145978136|NCT02850406|526431211|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
145978137|NCT02850406|526431204|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
145978138|NCT02850406|526431205|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
145978139|NCT02850406|526431206|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
145978140|NCT02850406|526431207|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
145931099|NCT01339923|526255315|FG006|Overall Study|Adverse Event|1|||
145978141|NCT02850406|526431208|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
145978142|NCT02850406|526431209|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
145978143|NCT02850406|526431210|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
145978144|NCT02850406|526431211|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
145978145|NCT02850406|526431204|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978146|NCT02850406|526431205|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145931100|NCT01339923|526255309|FG000|Overall Study|Inappropriate Enrollment|1|||
145931101|NCT01339923|526255310|FG001|Overall Study|Inappropriate Enrollment|0|||
145931102|NCT01339923|526255311|FG002|Overall Study|Inappropriate Enrollment|0|||
145931103|NCT01339923|526255312|FG003|Overall Study|Inappropriate Enrollment|0|||
145931104|NCT01339923|526255313|FG004|Overall Study|Inappropriate Enrollment|0|||
145931105|NCT01339923|526255314|FG005|Overall Study|Inappropriate Enrollment|1|||
145931106|NCT01339923|526255315|FG006|Overall Study|Inappropriate Enrollment|0|||
145931107|NCT01339923|526255309|FG000|Overall Study|Lost to Follow-up|4|||
145931108|NCT01339923|526255310|FG001|Overall Study|Lost to Follow-up|4|||
145931109|NCT01339923|526255311|FG002|Overall Study|Lost to Follow-up|0|||
145931110|NCT01339923|526255312|FG003|Overall Study|Lost to Follow-up|3|||
145931111|NCT01339923|526255313|FG004|Overall Study|Lost to Follow-up|1|||
145931112|NCT01339923|526255314|FG005|Overall Study|Lost to Follow-up|1|||
145931113|NCT01339923|526255315|FG006|Overall Study|Lost to Follow-up|5|||
145931114|NCT01339923|526255309|FG000|Overall Study|Protocol Violation|0|||
145931115|NCT01339923|526255310|FG001|Overall Study|Protocol Violation|0|||
145931116|NCT01339923|526255311|FG002|Overall Study|Protocol Violation|0|||
145931117|NCT01339923|526255312|FG003|Overall Study|Protocol Violation|0|||
145931118|NCT01339923|526255313|FG004|Overall Study|Protocol Violation|0|||
145931119|NCT01339923|526255314|FG005|Overall Study|Protocol Violation|3|||
145931120|NCT01339923|526255315|FG006|Overall Study|Protocol Violation|1|||
145931121|NCT01339923|526255309|FG000|Overall Study|Unable to Classify|1|||
145931122|NCT01339923|526255310|FG001|Overall Study|Unable to Classify|0|||
145931123|NCT01339923|526255311|FG002|Overall Study|Unable to Classify|1|||
145931124|NCT01339923|526255312|FG003|Overall Study|Unable to Classify|0|||
145931125|NCT01339923|526255313|FG004|Overall Study|Unable to Classify|0|||
145931126|NCT01339923|526255314|FG005|Overall Study|Unable to Classify|1|||
145931127|NCT01339923|526255315|FG006|Overall Study|Unable to Classify|5|||
145931128|NCT01339923|526255309|FG000|Overall Study|Withdrawal by Subject|7|||
145931129|NCT01339923|526255310|FG001|Overall Study|Withdrawal by Subject|11|||
145931130|NCT01339923|526255311|FG002|Overall Study|Withdrawal by Subject|6|||
145931131|NCT01339923|526255312|FG003|Overall Study|Withdrawal by Subject|1|||
145931132|NCT01339923|526255313|FG004|Overall Study|Withdrawal by Subject|4|||
145931133|NCT01339923|526255314|FG005|Overall Study|Withdrawal by Subject|3|||
145931134|NCT01339923|526255315|FG006|Overall Study|Withdrawal by Subject|2|||
145931135|NCT00637000|526255316|FG000|Overall Study|Withdrawal by Subject|4|||
145931136|NCT00637000|526255317|FG001|Overall Study|Withdrawal by Subject|3|||
145931137|NCT02549287|526255321|FG000|Overall Study|Lost to Follow-up|65|||
145931138|NCT02549287|526255322|FG001|Overall Study|Lost to Follow-up|26|||
145931139|NCT02549287|526255321|FG000|Overall Study|Withdrawal by Subject|15|||
145931140|NCT02549287|526255322|FG001|Overall Study|Withdrawal by Subject|6|||
145931141|NCT00520533|526255323|FG000|Overall Study|Death|1|||
145931142|NCT00520533|526255323|FG000|Overall Study|Suspension of the study for safety reasons|1|||
145931143|NCT00520533|526255323|FG000|Overall Study|Withdrawal by Subject|1|||
145931144|NCT00520533|526255323|FG000|Overall Study|Physician Decision|1|||
145931145|NCT01377922|526255324|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
145931146|NCT01377922|526255325|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
145931147|NCT01218087|526255326|FG000|Overall Study|Death|2|||
145931148|NCT01218087|526255327|FG001|Overall Study|Death|1|||
145931149|NCT01218087|526255326|FG000|Overall Study|Withdrawal by Subject|5|||
145931150|NCT01218087|526255327|FG001|Overall Study|Withdrawal by Subject|0|||
145931151|NCT01218087|526255326|FG000|Overall Study|Transferred|8|||
145931152|NCT01218087|526255327|FG001|Overall Study|Transferred|5|||
145931153|NCT02157376|526255330|FG000|Overall Study|Death|10|||
145931154|NCT02157376|526255331|FG001|Overall Study|Death|4|||
145931155|NCT02157376|526255330|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145931156|NCT02157376|526255331|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145931157|NCT02157376|526255330|FG000|Overall Study|Withdrawal by Subject|3|||
145931158|NCT02157376|526255331|FG001|Overall Study|Withdrawal by Subject|8|||
145931159|NCT02157376|526255330|FG000|Overall Study|Not treated|8|||
145931160|NCT02157376|526255331|FG001|Overall Study|Not treated|3|||
145931161|NCT02157376|526255330|FG000|Overall Study|Investigator's misjudgement|1|||
145931162|NCT02157376|526255331|FG001|Overall Study|Investigator's misjudgement|2|||
145931163|NCT00529373|526255338|FG000|Base Study|Adverse Event|525|||
145931164|NCT00529373|526255339|FG001|Base Study|Adverse Event|470|||
145931165|NCT00529373|526255338|FG000|Base Study|Lack of Efficacy|16|||
145931166|NCT00529373|526255339|FG001|Base Study|Lack of Efficacy|75|||
145931167|NCT00529373|526255338|FG000|Base Study|Lost to Follow-up|221|||
145931168|NCT00529373|526255339|FG001|Base Study|Lost to Follow-up|208|||
145931169|NCT00529373|526255338|FG000|Base Study|Other Protocol Specified Criteria|19|||
145931170|NCT00529373|526255339|FG001|Base Study|Other Protocol Specified Criteria|20|||
145931171|NCT00529373|526255338|FG000|Base Study|Physician Decision|60|||
145931172|NCT00529373|526255339|FG001|Base Study|Physician Decision|52|||
145931173|NCT00529373|526255338|FG000|Base Study|Protocol Violation|48|||
145931174|NCT00529373|526255339|FG001|Base Study|Protocol Violation|38|||
145931175|NCT00529373|526255338|FG000|Base Study|Withdrawal by Subject|1062|||
145931176|NCT00529373|526255339|FG001|Base Study|Withdrawal by Subject|967|||
145931177|NCT00529373|526255338|FG000|Base Study|Did not continue into Extension|1795|||
145931178|NCT00529373|526255339|FG001|Base Study|Did not continue into Extension|2238|||
145931179|NCT00529373|526255338|FG000|First Extension Study|Adverse Event|162|||
145931180|NCT00529373|526255339|FG001|First Extension Study|Adverse Event|142|||
145978147|NCT02850406|526431206|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145931181|NCT00529373|526255338|FG000|First Extension Study|Lack of Efficacy|65|||
145931182|NCT00529373|526255339|FG001|First Extension Study|Lack of Efficacy|427|||
145931183|NCT00529373|526255338|FG000|First Extension Study|Lost to Follow-up|41|||
145931184|NCT00529373|526255339|FG001|First Extension Study|Lost to Follow-up|37|||
145931185|NCT00529373|526255338|FG000|First Extension Study|Other|27|||
145931186|NCT00529373|526255339|FG001|First Extension Study|Other|47|||
145931187|NCT00529373|526255338|FG000|First Extension Study|Physician Decision|50|||
145931188|NCT00529373|526255339|FG001|First Extension Study|Physician Decision|45|||
145931189|NCT00529373|526255338|FG000|First Extension Study|Protocol Violation|16|||
145931190|NCT00529373|526255339|FG001|First Extension Study|Protocol Violation|13|||
145931191|NCT00529373|526255338|FG000|First Extension Study|Withdrawal by Subject|296|||
145931192|NCT00529373|526255339|FG001|First Extension Study|Withdrawal by Subject|287|||
145931193|NCT00529373|526255338|FG000|First Extension Study|Disposition record non-existing|0|||
145931194|NCT00529373|526255339|FG001|First Extension Study|Disposition record non-existing|1|||
145931195|NCT00529373|526255338|FG000|First Extension Study|Discontinued after 5 years completion|208|||
145931196|NCT00529373|526255339|FG001|First Extension Study|Discontinued after 5 years completion|346|||
145931197|NCT00529373|526255338|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
145931198|NCT00529373|526255339|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
145931199|NCT00529373|526255338|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
145931200|NCT00529373|526255339|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
145931201|NCT00529373|526255338|FG000|Second Extension Study|Adverse Event|101|||
145931202|NCT00529373|526255339|FG001|Second Extension Study|Adverse Event|51|||
145931203|NCT00529373|526255338|FG000|Second Extension Study|Lack of Efficacy|7|||
145931204|NCT00529373|526255339|FG001|Second Extension Study|Lack of Efficacy|15|||
145931205|NCT00529373|526255338|FG000|Second Extension Study|Lost to Follow-up|18|||
145931206|NCT00529373|526255339|FG001|Second Extension Study|Lost to Follow-up|12|||
145931207|NCT00529373|526255338|FG000|Second Extension Study|Other|7|||
145931208|NCT00529373|526255339|FG001|Second Extension Study|Other|12|||
145931209|NCT00529373|526255338|FG000|Second Extension Study|Physician Decision|63|||
145931210|NCT00529373|526255339|FG001|Second Extension Study|Physician Decision|26|||
145931211|NCT00529373|526255338|FG000|Second Extension Study|Protocol Violation|2|||
145931212|NCT00529373|526255339|FG001|Second Extension Study|Protocol Violation|1|||
145931213|NCT00529373|526255338|FG000|Second Extension Study|Withdrawal by Subject|97|||
145931214|NCT00529373|526255339|FG001|Second Extension Study|Withdrawal by Subject|75|||
145931215|NCT00529373|526255338|FG000|Second Extension Study|Status Missing|5|||
145931216|NCT00529373|526255339|FG001|Second Extension Study|Status Missing|5|||
145931217|NCT01074268|526255340|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
145931218|NCT01074268|526255341|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
145931219|NCT01074268|526255340|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
145931220|NCT01074268|526255341|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
145931221|NCT01074268|526255340|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
145931222|NCT01074268|526255341|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
145931223|NCT01074268|526255340|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
145931224|NCT01074268|526255341|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
145931225|NCT01074268|526255340|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
145931226|NCT01074268|526255341|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
145931227|NCT01074268|526255340|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
145931228|NCT01074268|526255341|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
145931229|NCT01074268|526255340|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
145931230|NCT01074268|526255341|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
145931231|NCT01074268|526255340|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
145931232|NCT01074268|526255341|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
145931233|NCT01074268|526255340|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
145931234|NCT01074268|526255341|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
145931235|NCT00603473|526255342|FG000|Overall Study|Adverse Event|4|||
145931236|NCT00603473|526255342|FG000|Overall Study|Lack of Efficacy|4|||
145931237|NCT00603473|526255342|FG000|Overall Study|Protocol Violation|1|||
145931238|NCT04200651|526255343|FG000|Overall Study|Moved to another country during follow-up|2|||
145931239|NCT04200651|526255344|FG001|Overall Study|Moved to another country during follow-up|2|||
145931240|NCT04200651|526255343|FG000|Overall Study|Lost to Follow-up|1|||
145931241|NCT04200651|526255344|FG001|Overall Study|Lost to Follow-up|3|||
145931242|NCT00733421|526255348|FG000|Overall Study|Withdrawal by Subject|1|||
145931243|NCT00733421|526255349|FG001|Overall Study|Withdrawal by Subject|1|||
145931244|NCT04185220|526255350|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
145931245|NCT04185220|526255351|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
145931246|NCT04185220|526255350|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
145931247|NCT04185220|526255351|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
145931248|NCT01031680|526255356|FG000|Overall Study|Adverse Event|8|||
145931249|NCT01031680|526255357|FG001|Overall Study|Adverse Event|3|||
145931250|NCT01031680|526255356|FG000|Overall Study|Lost to Follow-up|2|||
145931251|NCT01031680|526255357|FG001|Overall Study|Lost to Follow-up|10|||
145931252|NCT01031680|526255356|FG000|Overall Study|Withdrawal by Subject|12|||
145931253|NCT01031680|526255357|FG001|Overall Study|Withdrawal by Subject|16|||
145931254|NCT01031680|526255356|FG000|Overall Study|Death|2|||
145931255|NCT01031680|526255357|FG001|Overall Study|Death|1|||
145931256|NCT01031680|526255356|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
145931257|NCT01031680|526255357|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
145931258|NCT01031680|526255356|FG000|Overall Study|Poor/Non-compliance|5|||
145931259|NCT01031680|526255357|FG001|Overall Study|Poor/Non-compliance|6|||
145931260|NCT01031680|526255356|FG000|Overall Study|Safety|1|||
145931261|NCT01031680|526255357|FG001|Overall Study|Safety|0|||
145931262|NCT01031680|526255356|FG000|Overall Study|Incorrect Enrolment|1|||
145931263|NCT01031680|526255357|FG001|Overall Study|Incorrect Enrolment|2|||
145931264|NCT01031680|526255356|FG000|Overall Study|Administrative Reason by Sponsor|0|||
145931265|NCT01031680|526255357|FG001|Overall Study|Administrative Reason by Sponsor|1|||
145931266|NCT01031680|526255356|FG000|Overall Study|Various|0|||
145931267|NCT01031680|526255357|FG001|Overall Study|Various|2|||
145931268|NCT01870973|526255361|FG000|Overall Study|Lost to Follow-up|10|||
145931269|NCT01870973|526255362|FG001|Overall Study|Lost to Follow-up|3|||
145931270|NCT02702388|526255365|FG000|Overall Study|Disease Progression|18|||
145931271|NCT02702388|526255366|FG001|Overall Study|Disease Progression|25|||
145931272|NCT02702388|526255365|FG000|Overall Study|Withdrawal by Subject|9|||
145931273|NCT02702388|526255366|FG001|Overall Study|Withdrawal by Subject|7|||
145931274|NCT02702388|526255365|FG000|Overall Study|Adverse Event|11|||
145931275|NCT02702388|526255366|FG001|Overall Study|Adverse Event|15|||
145931276|NCT02702388|526255365|FG000|Overall Study|Other|2|||
145931277|NCT02702388|526255366|FG001|Overall Study|Other|4|||
145931278|NCT02729051|526255367|FG000|Overall Study|Adverse Event|21|||
145931279|NCT02729051|526255368|FG001|Overall Study|Adverse Event|11|||
145931280|NCT02729051|526255367|FG000|Overall Study|Lack of Efficacy|1|||
145931281|NCT02729051|526255368|FG001|Overall Study|Lack of Efficacy|1|||
145931282|NCT02729051|526255367|FG000|Overall Study|Lost to Follow-up|1|||
145931283|NCT02729051|526255368|FG001|Overall Study|Lost to Follow-up|2|||
145931284|NCT02729051|526255367|FG000|Overall Study|Physician Decision|1|||
145931285|NCT02729051|526255368|FG001|Overall Study|Physician Decision|1|||
145931286|NCT02729051|526255367|FG000|Overall Study|Withdrawal by Subject|6|||
145931287|NCT02729051|526255368|FG001|Overall Study|Withdrawal by Subject|17|||
145931288|NCT00596817|526255369|FG000|Open-label Period|Adverse Event|0|||
145931289|NCT00596817|526255370|FG001|Open-label Period|Adverse Event|49|||
145931290|NCT00596817|526255369|FG000|Open-label Period|Lack of Efficacy|0|||
145931291|NCT00596817|526255370|FG001|Open-label Period|Lack of Efficacy|33|||
145931292|NCT00596817|526255369|FG000|Open-label Period|Other Reasons|0|||
145931293|NCT00596817|526255370|FG001|Open-label Period|Other Reasons|65|||
145931294|NCT00596817|526255369|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
145931295|NCT00596817|526255370|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
145931296|NCT00596817|526255369|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
145931297|NCT00596817|526255370|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
145931298|NCT00596817|526255369|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
145931299|NCT00596817|526255370|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
145931300|NCT00596817|526255369|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
145931301|NCT00596817|526255370|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
145931302|NCT00596817|526255369|FG000|Double-blind Period|Adverse Event|5|||
145931303|NCT00596817|526255370|FG001|Double-blind Period|Adverse Event|16|||
145931304|NCT00596817|526255369|FG000|Double-blind Period|Lack of Efficacy|52|||
145931305|NCT00596817|526255370|FG001|Double-blind Period|Lack of Efficacy|28|||
145931306|NCT00596817|526255369|FG000|Double-blind Period|Non-compliance With Study Product|3|||
145931307|NCT00596817|526255370|FG001|Double-blind Period|Non-compliance With Study Product|4|||
145931308|NCT00596817|526255369|FG000|Double-blind Period|Protocol Violation|11|||
145931309|NCT00596817|526255370|FG001|Double-blind Period|Protocol Violation|8|||
145978148|NCT02850406|526431207|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978149|NCT02850406|526431208|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
145931310|NCT00596817|526255369|FG000|Double-blind Period|Withdrawal of Consent|7|||
145931311|NCT00596817|526255370|FG001|Double-blind Period|Withdrawal of Consent|3|||
145931312|NCT00596817|526255369|FG000|Double-blind Period|Lost to Follow-up|0|||
145931313|NCT00596817|526255370|FG001|Double-blind Period|Lost to Follow-up|2|||
145931314|NCT00596817|526255369|FG000|Double-blind Period|Other Reasons|10|||
145931315|NCT00596817|526255370|FG001|Double-blind Period|Other Reasons|18|||
145931316|NCT03232931|526257049|FG000|Overall Study|Physician Decision|1|||
145931317|NCT03232931|526257050|FG001|Overall Study|Physician Decision|1|||
145931318|NCT03232931|526257049|FG000|Overall Study|Withdrawal by Subject|6|||
145931319|NCT03232931|526257050|FG001|Overall Study|Withdrawal by Subject|0|||
145931320|NCT03232931|526257049|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
145931321|NCT03232931|526257050|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
145931322|NCT03232931|526257049|FG000|Overall Study|Parent did not record voice|1|||
145931323|NCT03232931|526257050|FG001|Overall Study|Parent did not record voice|2|||
145931324|NCT03232931|526257049|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
145931325|NCT03232931|526257050|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
145931326|NCT01190410|526257051|FG000|Overall Study|Adverse Event|0|||
145931327|NCT01190410|526257052|FG001|Overall Study|Adverse Event|3|||
145931328|NCT01190410|526257051|FG000|Overall Study|Lack of Efficacy|0|||
145931329|NCT01190410|526257052|FG001|Overall Study|Lack of Efficacy|2|||
145931330|NCT01190410|526257051|FG000|Overall Study|Withdrawal by Subject|0|||
145931331|NCT01190410|526257052|FG001|Overall Study|Withdrawal by Subject|2|||
145931332|NCT01190410|526257051|FG000|Overall Study|Administrative decision|1|||
145931333|NCT01190410|526257052|FG001|Overall Study|Administrative decision|0|||
145931334|NCT01190410|526257051|FG000|Overall Study|PI discretion|0|||
145931335|NCT01190410|526257052|FG001|Overall Study|PI discretion|2|||
145931336|NCT03300505|526257057|FG000|Overall Study|Death|0|||
145931337|NCT03300505|526257058|FG001|Overall Study|Death|1|||
145931338|NCT03300505|526257059|FG002|Overall Study|Death|0|||
145931339|NCT03300505|526257057|FG000|Overall Study|Withdrawal by Subject|0|||
145931340|NCT03300505|526257058|FG001|Overall Study|Withdrawal by Subject|1|||
145931341|NCT03300505|526257059|FG002|Overall Study|Withdrawal by Subject|1|||
145931342|NCT03300505|526257057|FG000|Overall Study|Sponsor Termination|0|||
145931343|NCT03300505|526257058|FG001|Overall Study|Sponsor Termination|1|||
145931344|NCT03300505|526257059|FG002|Overall Study|Sponsor Termination|0|||
145931345|NCT03300505|526257057|FG000|Overall Study|Adverse Event|0|||
145931346|NCT03300505|526257058|FG001|Overall Study|Adverse Event|0|||
145931347|NCT03300505|526257059|FG002|Overall Study|Adverse Event|2|||
145931348|NCT05088603|526257063|FG000|Overall Study|Protocol Violation|6|||
145931349|NCT05088603|526257064|FG001|Overall Study|Protocol Violation|1|||
146243365|NCT02203032|527405392|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
145931350|NCT03233529|526257067|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
145931351|NCT03233529|526257067|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
145931352|NCT03260244|526257071|FG000|Overall Study|Death|19|||
145931353|NCT03260244|526257071|FG000|Overall Study|Lost to Follow-up|60|||
145931354|NCT03260244|526257071|FG000|Overall Study|Withdrawal by Subject|48|||
145931355|NCT03260244|526257071|FG000|Overall Study|Procedure Not Performed|21|||
145931356|NCT03260244|526257071|FG000|Overall Study|Enrollment Criteria Not Met|31|||
145931357|NCT03260244|526257071|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
145931358|NCT03260244|526257071|FG000|Overall Study|Subject Noncompliance|6|||
145931359|NCT03260244|526257071|FG000|Overall Study|No inducible Arrhythmia|2|||
145931360|NCT03260244|526257071|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
145931361|NCT03260244|526257071|FG000|Overall Study|Screen Failure|2|||
145931362|NCT03260244|526257071|FG000|Overall Study|Treated Off Label|69|||
145931363|NCT03260244|526257071|FG000|Overall Study|No Radiofrequency Ablation|14|||
145931364|NCT00594100|526257078|FG000|Procedure|Technical Failure|9|||
145931365|NCT00594100|526257078|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
145931366|NCT00594100|526257078|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
145931367|NCT00594100|526257078|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
145931368|NCT04696055|526257083|FG000|Overall Study|Adverse Event|10|||
145931369|NCT04696055|526257084|FG001|Overall Study|Adverse Event|2|||
145931370|NCT04696055|526257083|FG000|Overall Study|Death|4|||
145931371|NCT04696055|526257084|FG001|Overall Study|Death|0|||
145931372|NCT04696055|526257083|FG000|Overall Study|Other|7|||
145931373|NCT04696055|526257084|FG001|Overall Study|Other|2|||
145931374|NCT04696055|526257083|FG000|Overall Study|Physician Decision|3|||
145931375|NCT04696055|526257084|FG001|Overall Study|Physician Decision|0|||
145931376|NCT04696055|526257083|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
145931377|NCT04696055|526257084|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
145931378|NCT04696055|526257083|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
145978150|NCT02850406|526431209|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
145978151|NCT02850406|526431210|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978152|NCT02850406|526431211|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978153|NCT02850406|526431204|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978154|NCT02850406|526431205|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978155|NCT02850406|526431206|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978156|NCT02850406|526431207|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
146090872|NCT00510874|526854786|FG000|Overall Study|Withdrawal by Subject|1|||
146243366|NCT02203032|527405389|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
145931379|NCT04696055|526257084|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
145931380|NCT04696055|526257083|FG000|Overall Study|Subject Decision|1|||
145931381|NCT04696055|526257084|FG001|Overall Study|Subject Decision|2|||
145931382|NCT03969901|526257085|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145931383|NCT03969901|526257086|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145931384|NCT03969901|526257087|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145931385|NCT03969901|526257088|FG003|Overall Study|Withdrawal by parent/guardian|0|||
145931386|NCT03969901|526257089|FG004|Overall Study|Withdrawal by parent/guardian|1|||
145931387|NCT03969901|526257090|FG005|Overall Study|Withdrawal by parent/guardian|0|||
145931388|NCT03969901|526257091|FG006|Overall Study|Withdrawal by parent/guardian|0|||
145931389|NCT03969901|526257092|FG007|Overall Study|Withdrawal by parent/guardian|1|||
145931390|NCT03969901|526257093|FG008|Overall Study|Withdrawal by parent/guardian|1|||
145931391|NCT03969901|526257094|FG009|Overall Study|Withdrawal by parent/guardian|0|||
145931392|NCT01920958|526257095|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
145931393|NCT00610155|526257096|FG000|Period 1|Withdrawal by Subject|0|||
145931394|NCT00610155|526257097|FG001|Period 1|Withdrawal by Subject|0|||
145931395|NCT00610155|526257098|FG002|Period 1|Withdrawal by Subject|1|||
145931396|NCT00610155|526257099|FG003|Period 1|Withdrawal by Subject|0|||
145931397|NCT00610155|526257100|FG004|Period 1|Withdrawal by Subject|0|||
145931398|NCT00610155|526257101|FG005|Period 1|Withdrawal by Subject|0|||
145931399|NCT00610155|526257096|FG000|Period 3|Adverse Event|1|||
145931400|NCT00610155|526257097|FG001|Period 3|Adverse Event|0|||
145931401|NCT00610155|526257098|FG002|Period 3|Adverse Event|0|||
145931402|NCT00610155|526257099|FG003|Period 3|Adverse Event|0|||
145931403|NCT00610155|526257100|FG004|Period 3|Adverse Event|0|||
145931404|NCT00610155|526257101|FG005|Period 3|Adverse Event|0|||
145931405|NCT01284348|526257102|FG000|Overall Study|Death|1|||
145931406|NCT01284348|526257103|FG001|Overall Study|Death|1|||
145931407|NCT01284348|526257102|FG000|Overall Study|Withdrew consent|0|||
145931408|NCT01284348|526257103|FG001|Overall Study|Withdrew consent|1|||
145931409|NCT01284348|526257102|FG000|Overall Study|Status not recorded|9|||
145931410|NCT01284348|526257103|FG001|Overall Study|Status not recorded|10|||
145931411|NCT00083759|526257106|FG000|Overall Study|Adverse Event|5|||
145931412|NCT00083759|526257107|FG001|Overall Study|Adverse Event|3|||
145931413|NCT00083759|526257106|FG000|Overall Study|Lost to Follow-up|1|||
145931414|NCT00083759|526257107|FG001|Overall Study|Lost to Follow-up|0|||
145931415|NCT00083759|526257106|FG000|Overall Study|Death|1|||
145931416|NCT00083759|526257107|FG001|Overall Study|Death|1|||
145931417|NCT00083759|526257106|FG000|Overall Study|Inadequate Therapeutic Response|32|||
145931418|NCT00083759|526257107|FG001|Overall Study|Inadequate Therapeutic Response|35|||
145931419|NCT00083759|526257106|FG000|Overall Study|Subject Withdrew Consent|2|||
145931420|NCT00083759|526257107|FG001|Overall Study|Subject Withdrew Consent|2|||
145931421|NCT00083759|526257106|FG000|Overall Study|Non-Compliance|1|||
145931422|NCT00083759|526257107|FG001|Overall Study|Non-Compliance|0|||
145931423|NCT00083759|526257106|FG000|Overall Study|Sponsor's Discretion|28|||
145931424|NCT00083759|526257107|FG001|Overall Study|Sponsor's Discretion|29|||
145931425|NCT00083759|526257106|FG000|Overall Study|Other|14|||
145931426|NCT00083759|526257107|FG001|Overall Study|Other|13|||
145931427|NCT03645395|526257108|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
145931428|NCT03645395|526257109|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
145931429|NCT03645395|526257110|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
145931430|NCT03645395|526257111|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
145931431|NCT03645395|526257108|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
145931432|NCT03645395|526257109|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
145931433|NCT03645395|526257110|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
145931434|NCT03645395|526257111|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
145931435|NCT03645395|526257108|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145931436|NCT03645395|526257109|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145931437|NCT03645395|526257110|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
145931438|NCT03645395|526257111|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145931439|NCT03645395|526257108|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
145931440|NCT03645395|526257109|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
145931441|NCT03645395|526257110|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
145931442|NCT03645395|526257111|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
145931443|NCT02564900|526257112|FG000|Dose Escalation|Progressive disease per RECIST|2|||
145931444|NCT02564900|526257113|FG001|Dose Escalation|Progressive disease per RECIST|3|||
145931445|NCT02564900|526257114|FG002|Dose Escalation|Progressive disease per RECIST|3|||
145978157|NCT02850406|526431208|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
145978158|NCT02850406|526431209|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978159|NCT02850406|526431210|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978160|NCT02850406|526431211|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
145978161|NCT02850406|526431204|FG000|Part C (Up to 52 Weeks)|Other|0|||
145931446|NCT02564900|526257115|FG003|Dose Escalation|Progressive disease per RECIST|3|||
145931447|NCT02564900|526257116|FG004|Dose Escalation|Progressive disease per RECIST|3|||
145931448|NCT02564900|526257117|FG005|Dose Escalation|Progressive disease per RECIST|1|||
145931449|NCT02564900|526257118|FG006|Dose Escalation|Progressive disease per RECIST|0|||
145931450|NCT02564900|526257119|FG007|Dose Escalation|Progressive disease per RECIST|0|||
145931451|NCT02564900|526257120|FG008|Dose Escalation|Progressive disease per RECIST|0|||
145931452|NCT02564900|526257121|FG009|Dose Escalation|Progressive disease per RECIST|0|||
145931453|NCT02564900|526257122|FG010|Dose Escalation|Progressive disease per RECIST|0|||
145931454|NCT02564900|526257123|FG011|Dose Escalation|Progressive disease per RECIST|0|||
145931455|NCT02564900|526257124|FG012|Dose Escalation|Progressive disease per RECIST|0|||
145931456|NCT02564900|526257125|FG013|Dose Escalation|Progressive disease per RECIST|0|||
146090873|NCT00510874|526854787|FG001|Overall Study|Withdrawal by Subject|1|||
146090874|NCT00510874|526854788|FG002|Overall Study|Withdrawal by Subject|0|||
146090875|NCT00510874|526854789|FG003|Overall Study|Withdrawal by Subject|0|||
146090876|NCT00510874|526854790|FG004|Overall Study|Withdrawal by Subject|3|||
146090877|NCT00510874|526854791|FG005|Overall Study|Withdrawal by Subject|0|||
146090878|NCT00510874|526854792|FG006|Overall Study|Withdrawal by Subject|0|||
146090879|NCT00510874|526854786|FG000|Overall Study|Lost to Follow-up|2|||
146090880|NCT00510874|526854787|FG001|Overall Study|Lost to Follow-up|3|||
146090881|NCT00510874|526854788|FG002|Overall Study|Lost to Follow-up|1|||
146090882|NCT00510874|526854789|FG003|Overall Study|Lost to Follow-up|3|||
146090883|NCT00510874|526854790|FG004|Overall Study|Lost to Follow-up|4|||
146090884|NCT00510874|526854791|FG005|Overall Study|Lost to Follow-up|0|||
146090885|NCT00510874|526854792|FG006|Overall Study|Lost to Follow-up|1|||
146090886|NCT00397943|526854798|FG000|Overall Study|Unspecified reasons|12|||
146090887|NCT00397943|526854799|FG001|Overall Study|Unspecified reasons|9|||
146090888|NCT00397943|526854800|FG002|Overall Study|Unspecified reasons|0|||
146090889|NCT00397943|526854801|FG003|Overall Study|Unspecified reasons|0|||
146090890|NCT00397943|526854802|FG004|Overall Study|Unspecified reasons|0|||
146090891|NCT02806973|526854805|FG000|Period 1|Withdrawal by Subject|0|||
146090892|NCT02806973|526854806|FG001|Period 1|Withdrawal by Subject|2|||
146090893|NCT02806973|526854807|FG002|Period 1|Withdrawal by Subject|1|||
146090894|NCT02806973|526854808|FG003|Period 1|Withdrawal by Subject|1|||
146090895|NCT02806973|526854805|FG000|Period 1|Adverse Event|0|||
146090896|NCT02806973|526854806|FG001|Period 1|Adverse Event|0|||
146090897|NCT02806973|526854807|FG002|Period 1|Adverse Event|0|||
146090898|NCT02806973|526854808|FG003|Period 1|Adverse Event|1|||
146090899|NCT02806973|526854805|FG000|Period 3|Withdrawal by Subject|0|||
146090900|NCT02806973|526854806|FG001|Period 3|Withdrawal by Subject|0|||
146090901|NCT02806973|526854807|FG002|Period 3|Withdrawal by Subject|0|||
146090902|NCT02806973|526854808|FG003|Period 3|Withdrawal by Subject|3|||
146090903|NCT02806973|526854805|FG000|Period 3|Adverse Event|0|||
146090904|NCT02806973|526854806|FG001|Period 3|Adverse Event|0|||
146090905|NCT02806973|526854807|FG002|Period 3|Adverse Event|1|||
146090906|NCT02806973|526854808|FG003|Period 3|Adverse Event|0|||
146090907|NCT04209426|526854811|FG000|Overall Study|Lost to Follow-up|3|||
146090908|NCT04209426|526854812|FG001|Overall Study|Lost to Follow-up|2|||
146090909|NCT01751802|526854818|FG000|Overall Study|Adverse Event|4|||
146090910|NCT01751802|526854819|FG001|Overall Study|Adverse Event|2|||
146090911|NCT00521001|526854821|FG000|Overall Study|Ineligible|1|||
146090912|NCT02821910|526854822|FG000|Overall Study|Withdrawal by Subject|0|||
146090913|NCT02821910|526854823|FG001|Overall Study|Withdrawal by Subject|0|||
146090914|NCT02821910|526854824|FG002|Overall Study|Withdrawal by Subject|1|||
146090915|NCT02821910|526854825|FG003|Overall Study|Withdrawal by Subject|0|||
146090916|NCT02821910|526854826|FG004|Overall Study|Withdrawal by Subject|0|||
146090917|NCT02821910|526854827|FG005|Overall Study|Withdrawal by Subject|1|||
145931457|NCT02564900|526257126|FG014|Dose Escalation|Progressive disease per RECIST|0|||
145931458|NCT02564900|526257112|FG000|Dose Escalation|Ongoing|1|||
145931459|NCT02564900|526257113|FG001|Dose Escalation|Ongoing|0|||
145931460|NCT02564900|526257114|FG002|Dose Escalation|Ongoing|0|||
145931461|NCT02564900|526257115|FG003|Dose Escalation|Ongoing|2|||
145931462|NCT02564900|526257116|FG004|Dose Escalation|Ongoing|2|||
145931463|NCT02564900|526257117|FG005|Dose Escalation|Ongoing|2|||
145931464|NCT02564900|526257118|FG006|Dose Escalation|Ongoing|0|||
145931465|NCT02564900|526257119|FG007|Dose Escalation|Ongoing|0|||
145931466|NCT02564900|526257120|FG008|Dose Escalation|Ongoing|0|||
145931467|NCT02564900|526257121|FG009|Dose Escalation|Ongoing|0|||
145931468|NCT02564900|526257122|FG010|Dose Escalation|Ongoing|0|||
146090918|NCT02821910|526854822|FG000|Overall Study|Other than specified|1|||
146090919|NCT02821910|526854823|FG001|Overall Study|Other than specified|0|||
146090920|NCT02821910|526854824|FG002|Overall Study|Other than specified|1|||
146243367|NCT02203032|527405390|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
145931469|NCT02564900|526257123|FG011|Dose Escalation|Ongoing|0|||
145931470|NCT02564900|526257124|FG012|Dose Escalation|Ongoing|0|||
145931471|NCT02564900|526257125|FG013|Dose Escalation|Ongoing|0|||
146090921|NCT02821910|526854825|FG003|Overall Study|Other than specified|0|||
146090922|NCT02821910|526854826|FG004|Overall Study|Other than specified|0|||
146090923|NCT02821910|526854827|FG005|Overall Study|Other than specified|0|||
146090924|NCT00900601|526854828|FG000|Overall Study|Physician Decision|1|||
146090925|NCT01082640|526854829|FG000|Overall Study|Adverse Event|9|||
146090926|NCT01082640|526854830|FG001|Overall Study|Adverse Event|5|||
146090927|NCT01082640|526854831|FG002|Overall Study|Adverse Event|3|||
145931472|NCT02564900|526257126|FG014|Dose Escalation|Ongoing|0|||
145931473|NCT02564900|526257112|FG000|Dose Escalation|Adverse Event|0|||
145931474|NCT02564900|526257113|FG001|Dose Escalation|Adverse Event|0|||
145931475|NCT02564900|526257114|FG002|Dose Escalation|Adverse Event|0|||
145931476|NCT02564900|526257115|FG003|Dose Escalation|Adverse Event|1|||
145931477|NCT02564900|526257116|FG004|Dose Escalation|Adverse Event|1|||
146090928|NCT01082640|526854829|FG000|Overall Study|Withdrawal by Subject|3|||
146090929|NCT01082640|526854830|FG001|Overall Study|Withdrawal by Subject|3|||
146090930|NCT01082640|526854831|FG002|Overall Study|Withdrawal by Subject|2|||
146090931|NCT01082640|526854829|FG000|Overall Study|Major protocol deviation|3|||
145931478|NCT02564900|526257117|FG005|Dose Escalation|Adverse Event|3|||
145931479|NCT02564900|526257118|FG006|Dose Escalation|Adverse Event|0|||
145931480|NCT02564900|526257119|FG007|Dose Escalation|Adverse Event|0|||
145931481|NCT02564900|526257120|FG008|Dose Escalation|Adverse Event|0|||
145931482|NCT02564900|526257121|FG009|Dose Escalation|Adverse Event|0|||
145931483|NCT02564900|526257122|FG010|Dose Escalation|Adverse Event|0|||
145931484|NCT02564900|526257123|FG011|Dose Escalation|Adverse Event|0|||
145931485|NCT02564900|526257124|FG012|Dose Escalation|Adverse Event|0|||
145931486|NCT02564900|526257125|FG013|Dose Escalation|Adverse Event|0|||
145931487|NCT02564900|526257126|FG014|Dose Escalation|Adverse Event|0|||
145931488|NCT02564900|526257112|FG000|Dose Expansion|Progressive disease per RECIST|0|||
145931489|NCT02564900|526257113|FG001|Dose Expansion|Progressive disease per RECIST|0|||
145931490|NCT02564900|526257114|FG002|Dose Expansion|Progressive disease per RECIST|0|||
145931491|NCT02564900|526257115|FG003|Dose Expansion|Progressive disease per RECIST|0|||
145931492|NCT02564900|526257116|FG004|Dose Expansion|Progressive disease per RECIST|0|||
145931493|NCT02564900|526257117|FG005|Dose Expansion|Progressive disease per RECIST|0|||
145931494|NCT02564900|526257118|FG006|Dose Expansion|Progressive disease per RECIST|19|||
145931495|NCT02564900|526257119|FG007|Dose Expansion|Progressive disease per RECIST|17|||
145931496|NCT02564900|526257120|FG008|Dose Expansion|Progressive disease per RECIST|8|||
145931497|NCT02564900|526257121|FG009|Dose Expansion|Progressive disease per RECIST|16|||
145931498|NCT02564900|526257122|FG010|Dose Expansion|Progressive disease per RECIST|13|||
145931499|NCT02564900|526257123|FG011|Dose Expansion|Progressive disease per RECIST|19|||
145931500|NCT02564900|526257124|FG012|Dose Expansion|Progressive disease per RECIST|10|||
145931501|NCT02564900|526257125|FG013|Dose Expansion|Progressive disease per RECIST|13|||
145931502|NCT02564900|526257126|FG014|Dose Expansion|Progressive disease per RECIST|11|||
145931503|NCT02564900|526257112|FG000|Dose Expansion|Clinical progression|0|||
145931504|NCT02564900|526257113|FG001|Dose Expansion|Clinical progression|0|||
145931505|NCT02564900|526257114|FG002|Dose Expansion|Clinical progression|0|||
145931506|NCT02564900|526257115|FG003|Dose Expansion|Clinical progression|0|||
145931507|NCT02564900|526257116|FG004|Dose Expansion|Clinical progression|0|||
145931508|NCT02564900|526257117|FG005|Dose Expansion|Clinical progression|0|||
145931509|NCT02564900|526257118|FG006|Dose Expansion|Clinical progression|5|||
145931510|NCT02564900|526257119|FG007|Dose Expansion|Clinical progression|12|||
145931511|NCT02564900|526257120|FG008|Dose Expansion|Clinical progression|0|||
145931512|NCT02564900|526257121|FG009|Dose Expansion|Clinical progression|3|||
145931513|NCT02564900|526257122|FG010|Dose Expansion|Clinical progression|2|||
145931514|NCT02564900|526257123|FG011|Dose Expansion|Clinical progression|0|||
145931515|NCT02564900|526257124|FG012|Dose Expansion|Clinical progression|1|||
145931516|NCT02564900|526257125|FG013|Dose Expansion|Clinical progression|3|||
145931517|NCT02564900|526257126|FG014|Dose Expansion|Clinical progression|1|||
145931518|NCT02564900|526257112|FG000|Dose Expansion|Adverse Event|0|||
145931519|NCT02564900|526257113|FG001|Dose Expansion|Adverse Event|0|||
145931520|NCT02564900|526257114|FG002|Dose Expansion|Adverse Event|0|||
145931521|NCT02564900|526257115|FG003|Dose Expansion|Adverse Event|0|||
145931522|NCT02564900|526257116|FG004|Dose Expansion|Adverse Event|0|||
145931523|NCT02564900|526257117|FG005|Dose Expansion|Adverse Event|0|||
145931524|NCT02564900|526257118|FG006|Dose Expansion|Adverse Event|9|||
145931525|NCT02564900|526257119|FG007|Dose Expansion|Adverse Event|22|||
145931526|NCT02564900|526257120|FG008|Dose Expansion|Adverse Event|0|||
145931527|NCT02564900|526257121|FG009|Dose Expansion|Adverse Event|11|||
145931528|NCT02564900|526257122|FG010|Dose Expansion|Adverse Event|0|||
145931529|NCT02564900|526257123|FG011|Dose Expansion|Adverse Event|5|||
145931530|NCT02564900|526257124|FG012|Dose Expansion|Adverse Event|2|||
145931531|NCT02564900|526257125|FG013|Dose Expansion|Adverse Event|2|||
145931532|NCT02564900|526257126|FG014|Dose Expansion|Adverse Event|1|||
145931533|NCT02564900|526257112|FG000|Dose Expansion|Ongoing|0|||
145931534|NCT02564900|526257113|FG001|Dose Expansion|Ongoing|0|||
145931535|NCT02564900|526257114|FG002|Dose Expansion|Ongoing|0|||
145931536|NCT02564900|526257115|FG003|Dose Expansion|Ongoing|0|||
145931537|NCT02564900|526257116|FG004|Dose Expansion|Ongoing|0|||
145931538|NCT02564900|526257117|FG005|Dose Expansion|Ongoing|0|||
145931539|NCT02564900|526257118|FG006|Dose Expansion|Ongoing|9|||
145931540|NCT02564900|526257119|FG007|Dose Expansion|Ongoing|10|||
145931541|NCT02564900|526257120|FG008|Dose Expansion|Ongoing|11|||
145931542|NCT02564900|526257121|FG009|Dose Expansion|Ongoing|3|||
145931543|NCT02564900|526257122|FG010|Dose Expansion|Ongoing|0|||
145931544|NCT02564900|526257123|FG011|Dose Expansion|Ongoing|0|||
145931545|NCT02564900|526257124|FG012|Dose Expansion|Ongoing|4|||
145931546|NCT02564900|526257125|FG013|Dose Expansion|Ongoing|0|||
145931547|NCT02564900|526257126|FG014|Dose Expansion|Ongoing|6|||
145931548|NCT02564900|526257112|FG000|Dose Expansion|Death|0|||
145931549|NCT02564900|526257113|FG001|Dose Expansion|Death|0|||
145931550|NCT02564900|526257114|FG002|Dose Expansion|Death|0|||
145931551|NCT02564900|526257115|FG003|Dose Expansion|Death|0|||
145931552|NCT02564900|526257116|FG004|Dose Expansion|Death|0|||
145931553|NCT02564900|526257117|FG005|Dose Expansion|Death|0|||
145931554|NCT02564900|526257118|FG006|Dose Expansion|Death|1|||
145931555|NCT02564900|526257119|FG007|Dose Expansion|Death|0|||
145931556|NCT02564900|526257120|FG008|Dose Expansion|Death|0|||
145931557|NCT02564900|526257121|FG009|Dose Expansion|Death|0|||
145931558|NCT02564900|526257122|FG010|Dose Expansion|Death|1|||
145931559|NCT02564900|526257123|FG011|Dose Expansion|Death|0|||
145931560|NCT02564900|526257124|FG012|Dose Expansion|Death|1|||
145931561|NCT02564900|526257125|FG013|Dose Expansion|Death|1|||
145931562|NCT02564900|526257126|FG014|Dose Expansion|Death|0|||
145931563|NCT02564900|526257112|FG000|Dose Expansion|Withdrawal by Subject|0|||
145931564|NCT02564900|526257113|FG001|Dose Expansion|Withdrawal by Subject|0|||
145931565|NCT02564900|526257114|FG002|Dose Expansion|Withdrawal by Subject|0|||
145931566|NCT02564900|526257115|FG003|Dose Expansion|Withdrawal by Subject|0|||
145931567|NCT02564900|526257116|FG004|Dose Expansion|Withdrawal by Subject|0|||
145931568|NCT02564900|526257117|FG005|Dose Expansion|Withdrawal by Subject|0|||
145931569|NCT02564900|526257118|FG006|Dose Expansion|Withdrawal by Subject|4|||
145931570|NCT02564900|526257119|FG007|Dose Expansion|Withdrawal by Subject|0|||
145931571|NCT02564900|526257120|FG008|Dose Expansion|Withdrawal by Subject|0|||
145931572|NCT02564900|526257121|FG009|Dose Expansion|Withdrawal by Subject|0|||
145931573|NCT02564900|526257122|FG010|Dose Expansion|Withdrawal by Subject|1|||
145931574|NCT02564900|526257123|FG011|Dose Expansion|Withdrawal by Subject|0|||
145931575|NCT02564900|526257124|FG012|Dose Expansion|Withdrawal by Subject|0|||
145931576|NCT02564900|526257125|FG013|Dose Expansion|Withdrawal by Subject|1|||
145931577|NCT02564900|526257126|FG014|Dose Expansion|Withdrawal by Subject|1|||
145931578|NCT02564900|526257112|FG000|Dose Expansion|Other|0|||
145931579|NCT02564900|526257113|FG001|Dose Expansion|Other|0|||
145931580|NCT02564900|526257114|FG002|Dose Expansion|Other|0|||
145931581|NCT02564900|526257115|FG003|Dose Expansion|Other|0|||
145931582|NCT02564900|526257116|FG004|Dose Expansion|Other|0|||
145931583|NCT02564900|526257117|FG005|Dose Expansion|Other|0|||
145931584|NCT02564900|526257118|FG006|Dose Expansion|Other|1|||
145931585|NCT02564900|526257119|FG007|Dose Expansion|Other|0|||
145931586|NCT02564900|526257120|FG008|Dose Expansion|Other|1|||
145931587|NCT02564900|526257121|FG009|Dose Expansion|Other|0|||
145931588|NCT02564900|526257122|FG010|Dose Expansion|Other|0|||
145931589|NCT02564900|526257123|FG011|Dose Expansion|Other|0|||
145931590|NCT02564900|526257124|FG012|Dose Expansion|Other|0|||
145931591|NCT02564900|526257125|FG013|Dose Expansion|Other|0|||
145931592|NCT02564900|526257126|FG014|Dose Expansion|Other|1|||
145931593|NCT02564900|526257112|FG000|Dose Expansion|Did not receive treatment|0|||
145931594|NCT02564900|526257113|FG001|Dose Expansion|Did not receive treatment|0|||
145931595|NCT02564900|526257114|FG002|Dose Expansion|Did not receive treatment|0|||
145931596|NCT02564900|526257115|FG003|Dose Expansion|Did not receive treatment|0|||
145931597|NCT02564900|526257116|FG004|Dose Expansion|Did not receive treatment|0|||
145931598|NCT02564900|526257117|FG005|Dose Expansion|Did not receive treatment|0|||
145931599|NCT02564900|526257118|FG006|Dose Expansion|Did not receive treatment|1|||
145931600|NCT02564900|526257119|FG007|Dose Expansion|Did not receive treatment|1|||
145931601|NCT02564900|526257120|FG008|Dose Expansion|Did not receive treatment|0|||
145931602|NCT02564900|526257121|FG009|Dose Expansion|Did not receive treatment|0|||
145931603|NCT02564900|526257122|FG010|Dose Expansion|Did not receive treatment|0|||
145931604|NCT02564900|526257123|FG011|Dose Expansion|Did not receive treatment|0|||
145931605|NCT02564900|526257124|FG012|Dose Expansion|Did not receive treatment|0|||
145931606|NCT02564900|526257125|FG013|Dose Expansion|Did not receive treatment|0|||
145931607|NCT02564900|526257126|FG014|Dose Expansion|Did not receive treatment|1|||
145931608|NCT00892151|526257127|FG000|Overall Study|Protocol Violation|1|||
146090932|NCT01082640|526854830|FG001|Overall Study|Major protocol deviation|3|||
146090933|NCT01082640|526854831|FG002|Overall Study|Major protocol deviation|0|||
146090934|NCT01082640|526854829|FG000|Overall Study|Lost to Follow-up|0|||
146090935|NCT01082640|526854830|FG001|Overall Study|Lost to Follow-up|3|||
146090936|NCT01082640|526854831|FG002|Overall Study|Lost to Follow-up|0|||
145931609|NCT00379080|526257130|FG000|Overall Study|Withdrawal by Subject|0|||
146090937|NCT01082640|526854829|FG000|Overall Study|Other|2|||
145931610|NCT00379080|526257131|FG001|Overall Study|Withdrawal by Subject|4|||
145931611|NCT00379080|526257132|FG002|Overall Study|Withdrawal by Subject|0|||
145931612|NCT01222520|526257133|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
145931613|NCT01222520|526257134|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
145931614|NCT01222520|526257133|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
145931615|NCT01222520|526257134|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
145931616|NCT01222520|526257133|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
145931617|NCT01222520|526257134|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
145931618|NCT01222520|526257133|FG000|Double-blind Period|Adverse Event|0|||
145931619|NCT01222520|526257134|FG001|Double-blind Period|Adverse Event|1|||
145931620|NCT01222520|526257133|FG000|Double-blind Period|Lack of Efficacy|0|||
145931621|NCT01222520|526257134|FG001|Double-blind Period|Lack of Efficacy|1|||
145931622|NCT01222520|526257133|FG000|Double-blind Period|Study medication stolen|1|||
145931623|NCT01222520|526257134|FG001|Double-blind Period|Study medication stolen|0|||
145931624|NCT02285166|526257135|FG000|Overall Study|Case Report Forms Uncollected|564|||
146243368|NCT02203032|527405391|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
145931625|NCT02285166|526257135|FG000|Overall Study|Protocol Deviation|402|||
145931626|NCT01089608|526257136|FG000|Overall Study|Adverse Event|0|||
146090938|NCT01082640|526854830|FG001|Overall Study|Other|1|||
146090939|NCT01082640|526854831|FG002|Overall Study|Other|3|||
145931627|NCT01089608|526257137|FG001|Overall Study|Adverse Event|4|||
145931628|NCT01089608|526257136|FG000|Overall Study|Lost to Follow-up|0|||
145931629|NCT01089608|526257137|FG001|Overall Study|Lost to Follow-up|2|||
145931630|NCT02920008|526257138|FG000|Overall Study|Death|117|||
145931631|NCT02920008|526257139|FG001|Overall Study|Death|127|||
145931632|NCT02920008|526257138|FG000|Overall Study|Withdrawal by Subject|3|||
145931633|NCT02920008|526257139|FG001|Overall Study|Withdrawal by Subject|6|||
145931634|NCT02920008|526257138|FG000|Overall Study|Lost to Follow-up|0|||
145931635|NCT02920008|526257139|FG001|Overall Study|Lost to Follow-up|1|||
145931636|NCT01862250|526257140|FG000|Overall Study|Adverse Event|4|||
145931637|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
145931638|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
145931639|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
145931640|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
145931641|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
145931642|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
145931643|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
145931644|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
145931645|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
145931646|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
145931647|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
145931648|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
145931649|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
145931650|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
145931651|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
145931652|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
145931653|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
145931654|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
145931655|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
145931656|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
145931657|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
145931658|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
145931659|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
145931660|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
145931661|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
145931662|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
145931663|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
145931664|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
145931665|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145931666|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145931667|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
145931668|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
145931669|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
145931670|NCT00839527|526257145|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
145931671|NCT00839527|526257146|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
145931672|NCT00839527|526257147|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
145931673|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145931674|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
145931675|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145931676|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
145931677|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
145931678|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
145931679|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
145931680|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
145931681|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
145931682|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
145931683|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
145931684|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
145931685|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
145931686|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
145931687|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145931688|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
145931689|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
145931690|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
145931691|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
145931692|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
146090940|NCT01025154|526854836|FG000|Overall Study|Lost to Follow-up|1|||
146090941|NCT01025154|526854836|FG000|Overall Study|Withdrawal by Subject|1|||
145931693|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
145931694|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
145931695|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
145931696|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
145931697|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
145931698|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
145931699|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
145931700|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
145931701|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
145931702|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
145931703|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
145931704|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
145931705|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
145931706|NCT00839527|526257145|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
145931707|NCT00839527|526257146|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
145931708|NCT00839527|526257147|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
145931709|NCT02751450|526257148|FG000|Overall Study|Adverse Event|1|||
145931710|NCT02751450|526257149|FG001|Overall Study|Adverse Event|0|||
145931711|NCT01598090|526257150|FG000|Treatment Period|Poor/non-compliance|0|||
145931712|NCT01598090|526257151|FG001|Treatment Period|Poor/non-compliance|2|||
145931713|NCT01598090|526257152|FG002|Treatment Period|Poor/non-compliance|0|||
145931714|NCT01598090|526257150|FG000|Treatment Period|No longer meet study criteria|0|||
145931715|NCT01598090|526257151|FG001|Treatment Period|No longer meet study criteria|1|||
145931716|NCT01598090|526257152|FG002|Treatment Period|No longer meet study criteria|0|||
145931717|NCT01598090|526257150|FG000|Treatment Period|Lack of Efficacy|5|||
145931718|NCT01598090|526257151|FG001|Treatment Period|Lack of Efficacy|14|||
145931719|NCT01598090|526257152|FG002|Treatment Period|Lack of Efficacy|6|||
145931720|NCT01598090|526257150|FG000|Treatment Period|Adverse Event|2|||
145931721|NCT01598090|526257151|FG001|Treatment Period|Adverse Event|33|||
145931722|NCT01598090|526257152|FG002|Treatment Period|Adverse Event|17|||
145931723|NCT01598090|526257150|FG000|Treatment Period|Other reasons|0|||
145931724|NCT01598090|526257151|FG001|Treatment Period|Other reasons|4|||
145931725|NCT01598090|526257152|FG002|Treatment Period|Other reasons|1|||
145931726|NCT01598090|526257150|FG000|Treatment Period|Withdrawal by Subject|3|||
145931727|NCT01598090|526257151|FG001|Treatment Period|Withdrawal by Subject|13|||
145931728|NCT01598090|526257152|FG002|Treatment Period|Withdrawal by Subject|10|||
145931729|NCT01598090|526257150|FG000|Treatment Period|Lost to Follow-up|1|||
145931730|NCT01598090|526257151|FG001|Treatment Period|Lost to Follow-up|5|||
145931731|NCT01598090|526257152|FG002|Treatment Period|Lost to Follow-up|1|||
145931732|NCT01598090|526257150|FG000|Follow-up Period|Death|0|||
145931733|NCT01598090|526257151|FG001|Follow-up Period|Death|1|||
145931734|NCT01598090|526257152|FG002|Follow-up Period|Death|0|||
145931735|NCT01598090|526257150|FG000|Follow-up Period|No longer required per protocol|1|||
145931736|NCT01598090|526257151|FG001|Follow-up Period|No longer required per protocol|3|||
145931737|NCT01598090|526257152|FG002|Follow-up Period|No longer required per protocol|2|||
145931738|NCT01598090|526257150|FG000|Follow-up Period|Not reported|0|||
145931739|NCT01598090|526257151|FG001|Follow-up Period|Not reported|10|||
145931740|NCT01598090|526257152|FG002|Follow-up Period|Not reported|4|||
145931741|NCT01598090|526257150|FG000|Follow-up Period|Withdrawal by Subject|0|||
145931742|NCT01598090|526257151|FG001|Follow-up Period|Withdrawal by Subject|3|||
145931743|NCT01598090|526257152|FG002|Follow-up Period|Withdrawal by Subject|2|||
145931744|NCT01598090|526257150|FG000|Follow-up Period|Other reasons|2|||
145931745|NCT01598090|526257151|FG001|Follow-up Period|Other reasons|8|||
145931746|NCT01598090|526257152|FG002|Follow-up Period|Other reasons|8|||
145931747|NCT01598090|526257150|FG000|Follow-up Period|Lost to Follow-up|2|||
145931748|NCT01598090|526257151|FG001|Follow-up Period|Lost to Follow-up|10|||
145931749|NCT01598090|526257152|FG002|Follow-up Period|Lost to Follow-up|12|||
145931750|NCT00427921|526257156|FG000|Overall Study|Adverse Event|26|||
145931751|NCT00427921|526257156|FG000|Overall Study|Withdrawal by Subject|4|||
145931752|NCT00427921|526257156|FG000|Overall Study|Lost to Follow-up|2|||
145931753|NCT00427921|526257156|FG000|Overall Study|Other reason not specified|10|||
145931754|NCT00427921|526257156|FG000|Overall Study|Adverse Event + Hospitalization|1|||
145931755|NCT00427921|526257156|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
145931756|NCT00427921|526257156|FG000|Overall Study|Adverse Event + No Response|1|||
145931757|NCT00427921|526257156|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
145931758|NCT00427921|526257156|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
145931759|NCT00427921|526257156|FG000|Overall Study|Adverse Event + Lost Response|1|||
145931760|NCT00427921|526257156|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
145931761|NCT00427921|526257156|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
145931762|NCT03502070|526257157|FG000|Overall Study|Withdrawal by Subject|1|||
145978162|NCT02850406|526431205|FG001|Part C (Up to 52 Weeks)|Other|0|||
145931763|NCT03502070|526257157|FG000|Overall Study|Screen Failure|1|||
145931764|NCT02858583|526257158|FG000|Overall Study|Declined consent|1|||
146090942|NCT05153473|526854838|FG000|Overall Study|Death|46|||
146090943|NCT05153473|526854838|FG000|Overall Study|Lost to Follow-up|3|||
146090944|NCT02788474|526854839|FG000|Double Blind Treatment Period|Not treated|1|||
146090945|NCT02788474|526854840|FG001|Double Blind Treatment Period|Not treated|0|||
146090946|NCT02788474|526854839|FG000|Double Blind Treatment Period|Patient's refusal|3|||
145931765|NCT02858583|526257159|FG001|Overall Study|Declined consent|1|||
145931766|NCT04615403|526257163|FG000|Overall Study|Death|1|||
145931767|NCT03170362|526257164|FG000|Overall Study|Death|2|||
145931768|NCT03170362|526257165|FG001|Overall Study|Death|2|||
145931769|NCT03170362|526257164|FG000|Overall Study|Withdrawal by Subject|23|||
145931770|NCT03170362|526257165|FG001|Overall Study|Withdrawal by Subject|22|||
145931771|NCT03170362|526257164|FG000|Overall Study|Lost to Follow-up|187|||
145931772|NCT03170362|526257165|FG001|Overall Study|Lost to Follow-up|167|||
145931773|NCT01972438|526257166|FG000|Baseline-Month 3 Crossover Period|Death|1|||
145931774|NCT01972438|526257167|FG001|Baseline-Month 3 Crossover Period|Death|0|||
145931775|NCT01972438|526257166|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
145931776|NCT01972438|526257167|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
145931777|NCT01972438|526257166|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
145931778|NCT01972438|526257167|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
145931779|NCT01972438|526257166|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
145931780|NCT01972438|526257167|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
145931781|NCT01972438|526257166|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
145931782|NCT01972438|526257167|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
145931783|NCT01972438|526257166|FG000|Months 6-12 Study Period|Death|1|||
145931784|NCT01972438|526257167|FG001|Months 6-12 Study Period|Death|0|||
145931785|NCT01972438|526257166|FG000|Months 6-12 Study Period|Early Study Closure|2|||
145931786|NCT01972438|526257167|FG001|Months 6-12 Study Period|Early Study Closure|2|||
145931787|NCT01972438|526257166|FG000|Post Month 12 Study Period|Early Study Closure|3|||
145931788|NCT01972438|526257167|FG001|Post Month 12 Study Period|Early Study Closure|4|||
145931789|NCT00697463|526257173|FG000|Overall Study|Withdrawal by Subject|1|||
145931790|NCT03307252|526257174|FG000|Part 2, Period 1|Treatment not received|0|||
145931791|NCT03307252|526257175|FG001|Part 2, Period 1|Treatment not received|0|||
145931792|NCT03307252|526257176|FG002|Part 2, Period 1|Treatment not received|0|||
145931793|NCT03307252|526257177|FG003|Part 2, Period 1|Treatment not received|0|||
145931794|NCT03307252|526257178|FG004|Part 2, Period 1|Treatment not received|0|||
145931795|NCT03307252|526257179|FG005|Part 2, Period 1|Treatment not received|1|||
145931796|NCT03307252|526257180|FG006|Part 2, Period 1|Treatment not received|0|||
145931797|NCT03307252|526257181|FG007|Part 2, Period 1|Treatment not received|0|||
145931798|NCT03307252|526257182|FG008|Part 2, Period 1|Treatment not received|0|||
145931799|NCT03307252|526257183|FG009|Part 2, Period 1|Treatment not received|0|||
145931800|NCT03307252|526257184|FG010|Part 2, Period 1|Treatment not received|0|||
145931801|NCT03307252|526257174|FG000|Part 2, Period 3|Other than listed|0|||
145931802|NCT03307252|526257175|FG001|Part 2, Period 3|Other than listed|0|||
145931803|NCT03307252|526257176|FG002|Part 2, Period 3|Other than listed|0|||
145931804|NCT03307252|526257177|FG003|Part 2, Period 3|Other than listed|0|||
145931805|NCT03307252|526257178|FG004|Part 2, Period 3|Other than listed|1|||
145931806|NCT03307252|526257179|FG005|Part 2, Period 3|Other than listed|0|||
145931807|NCT03307252|526257180|FG006|Part 2, Period 3|Other than listed|0|||
145931808|NCT03307252|526257181|FG007|Part 2, Period 3|Other than listed|0|||
145931809|NCT03307252|526257182|FG008|Part 2, Period 3|Other than listed|0|||
145931810|NCT03307252|526257183|FG009|Part 2, Period 3|Other than listed|0|||
145931811|NCT03307252|526257184|FG010|Part 2, Period 3|Other than listed|0|||
145931812|NCT03307252|526257174|FG000|Part 2, Period 4|Other than listed|0|||
145931813|NCT03307252|526257175|FG001|Part 2, Period 4|Other than listed|0|||
145931814|NCT03307252|526257176|FG002|Part 2, Period 4|Other than listed|0|||
145931815|NCT03307252|526257177|FG003|Part 2, Period 4|Other than listed|0|||
145931816|NCT03307252|526257178|FG004|Part 2, Period 4|Other than listed|0|||
145931817|NCT03307252|526257179|FG005|Part 2, Period 4|Other than listed|0|||
146090947|NCT02788474|526854840|FG001|Double Blind Treatment Period|Patient's refusal|0|||
146090948|NCT02788474|526854839|FG000|Double Blind Treatment Period|Adverse Event|6|||
146090949|NCT02788474|526854840|FG001|Double Blind Treatment Period|Adverse Event|4|||
146090950|NCT02788474|526854839|FG000|Open Label Treatment Period|Adverse Event|29|||
145931818|NCT03307252|526257180|FG006|Part 2, Period 4|Other than listed|1|||
145931819|NCT03307252|526257181|FG007|Part 2, Period 4|Other than listed|0|||
145931820|NCT03307252|526257182|FG008|Part 2, Period 4|Other than listed|0|||
145931821|NCT03307252|526257183|FG009|Part 2, Period 4|Other than listed|0|||
145931822|NCT03307252|526257184|FG010|Part 2, Period 4|Other than listed|0|||
145931823|NCT03307252|526257174|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931824|NCT03307252|526257175|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931825|NCT03307252|526257176|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931826|NCT03307252|526257177|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
146090951|NCT02788474|526854840|FG001|Open Label Treatment Period|Adverse Event|9|||
146090952|NCT02788474|526854839|FG000|Open Label Treatment Period|Other than reason specified|1|||
145931827|NCT03307252|526257178|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931828|NCT03307252|526257179|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931829|NCT03307252|526257180|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931830|NCT03307252|526257181|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931831|NCT03307252|526257182|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931832|NCT03307252|526257183|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145931833|NCT03307252|526257184|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
145931834|NCT03482453|526257185|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931835|NCT03482453|526257186|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931836|NCT03482453|526257187|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931837|NCT03482453|526257188|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931838|NCT03482453|526257189|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931839|NCT03482453|526257190|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931840|NCT03482453|526257191|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931841|NCT03482453|526257192|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931842|NCT03482453|526257193|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931843|NCT03482453|526257194|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931844|NCT03482453|526257195|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
145931845|NCT03482453|526257196|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145931846|NCT02568189|526257197|FG000|Overall Study|Protocol Violation|0|||
145931847|NCT02568189|526257198|FG001|Overall Study|Protocol Violation|0|||
145931848|NCT02568189|526257199|FG002|Overall Study|Protocol Violation|19|||
145931849|NCT02568189|526257200|FG003|Overall Study|Protocol Violation|18|||
145931850|NCT01052480|526257201|FG000|Overall Study|Lost to Follow-up|3|||
145931851|NCT01052480|526257202|FG001|Overall Study|Lost to Follow-up|3|||
145931852|NCT01052480|526257201|FG000|Overall Study|Protocol Violation|1|||
145931853|NCT01052480|526257202|FG001|Overall Study|Protocol Violation|0|||
145931854|NCT01052480|526257201|FG000|Overall Study|Withdrawal by Subject|3|||
145931855|NCT01052480|526257202|FG001|Overall Study|Withdrawal by Subject|7|||
145931856|NCT01052480|526257201|FG000|Overall Study|Physician Decision|0|||
145931857|NCT01052480|526257202|FG001|Overall Study|Physician Decision|2|||
145931858|NCT01052480|526257201|FG000|Overall Study|Death|1|||
145931859|NCT01052480|526257202|FG001|Overall Study|Death|5|||
145931860|NCT02887183|526257210|FG000|Overall Study|Adverse Event|44|||
145931861|NCT02887183|526257210|FG000|Overall Study|Death|30|||
145931862|NCT02887183|526257210|FG000|Overall Study|Pregnancy|1|||
145931863|NCT02887183|526257210|FG000|Overall Study|Protocol Violation|6|||
145931864|NCT02887183|526257210|FG000|Overall Study|Technical Problems|2|||
145931865|NCT02887183|526257210|FG000|Overall Study|Lost to Follow-up|13|||
145931866|NCT02887183|526257210|FG000|Overall Study|Physician Decision|10|||
145931867|NCT02887183|526257210|FG000|Overall Study|Withdrawal by Subject|35|||
145931868|NCT00789698|526257213|FG000|Overall Study|Lack of Efficacy|10|||
145931869|NCT00789698|526257214|FG001|Overall Study|Lack of Efficacy|4|||
145931870|NCT00789698|526257215|FG002|Overall Study|Lack of Efficacy|5|||
145931871|NCT00789698|526257216|FG003|Overall Study|Lack of Efficacy|18|||
145931872|NCT00789698|526257213|FG000|Overall Study|Adverse Event|5|||
145931873|NCT00789698|526257214|FG001|Overall Study|Adverse Event|5|||
145931874|NCT00789698|526257215|FG002|Overall Study|Adverse Event|3|||
145931875|NCT00789698|526257216|FG003|Overall Study|Adverse Event|4|||
145931876|NCT00789698|526257213|FG000|Overall Study|Lost to Follow-up|5|||
145931877|NCT00789698|526257214|FG001|Overall Study|Lost to Follow-up|5|||
145931878|NCT00789698|526257215|FG002|Overall Study|Lost to Follow-up|2|||
145931879|NCT00789698|526257216|FG003|Overall Study|Lost to Follow-up|9|||
145931880|NCT00789698|526257213|FG000|Overall Study|Protocol Violation|6|||
145931881|NCT00789698|526257214|FG001|Overall Study|Protocol Violation|1|||
145931882|NCT00789698|526257215|FG002|Overall Study|Protocol Violation|2|||
145931883|NCT00789698|526257216|FG003|Overall Study|Protocol Violation|1|||
145931884|NCT00789698|526257213|FG000|Overall Study|Withdrawal by Subject|14|||
145931885|NCT00789698|526257214|FG001|Overall Study|Withdrawal by Subject|15|||
145931886|NCT00789698|526257215|FG002|Overall Study|Withdrawal by Subject|12|||
145931887|NCT00789698|526257216|FG003|Overall Study|Withdrawal by Subject|19|||
145931888|NCT00789698|526257213|FG000|Overall Study|Administrative|0|||
145931889|NCT00789698|526257214|FG001|Overall Study|Administrative|3|||
145931890|NCT00789698|526257215|FG002|Overall Study|Administrative|3|||
145931891|NCT00789698|526257216|FG003|Overall Study|Administrative|1|||
145931892|NCT03225105|526257217|FG000|Overall Study|Withdrawal by Subject|1|||
145931893|NCT03225105|526257218|FG001|Overall Study|Withdrawal by Subject|0|||
145931894|NCT03225105|526257219|FG002|Overall Study|Withdrawal by Subject|0|||
145931895|NCT03225105|526257220|FG003|Overall Study|Withdrawal by Subject|0|||
145931896|NCT03225105|526257217|FG000|Overall Study|Death|0|||
145931897|NCT03225105|526257218|FG001|Overall Study|Death|4|||
145931898|NCT03225105|526257219|FG002|Overall Study|Death|2|||
145931899|NCT03225105|526257220|FG003|Overall Study|Death|0|||
145931900|NCT03225105|526257217|FG000|Overall Study|Study termination per Sponsor Decision|2|||
145931901|NCT03225105|526257218|FG001|Overall Study|Study termination per Sponsor Decision|0|||
146243369|NCT02203032|527405392|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
146243370|NCT02203032|527405389|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
145931902|NCT03225105|526257219|FG002|Overall Study|Study termination per Sponsor Decision|3|||
145931903|NCT03225105|526257220|FG003|Overall Study|Study termination per Sponsor Decision|3|||
145931904|NCT05119595|526258880|FG000|Overall Study|Death|1|||
145931905|NCT05119595|526258880|FG000|Overall Study|Lost to Follow-up|7|||
145931906|NCT01283334|526258884|FG000|Overall Study|Withdrawal by Subject|1|||
145931907|NCT01283334|526258884|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
145931908|NCT01283334|526258884|FG000|Overall Study|Adverse Event|4|||
145931909|NCT01283334|526258884|FG000|Overall Study|Physician Decision|1|||
145931910|NCT03467217|526258885|FG000|Overall Study|Trial stopped early|5|||
145931911|NCT03467217|526258886|FG001|Overall Study|Trial stopped early|2|||
145931912|NCT03467217|526258885|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
145931913|NCT03467217|526258886|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
145931914|NCT03467217|526258885|FG000|Overall Study|Lost to Follow-up|0|||
145931915|NCT03467217|526258886|FG001|Overall Study|Lost to Follow-up|2|||
145931916|NCT04981470|526258887|FG000|Overall Study|Device failure in all 4 patients|4|||
145931917|NCT00784238|526258888|FG000|Overall Study|Adverse Event|14|||
145931918|NCT00784238|526258888|FG000|Overall Study|Death|2|||
145931919|NCT00784238|526258888|FG000|Overall Study|Lack of Efficacy|33|||
145931920|NCT00784238|526258888|FG000|Overall Study|Lost to Follow-up|29|||
145931921|NCT00784238|526258888|FG000|Overall Study|Pregnancy|1|||
145931922|NCT00784238|526258888|FG000|Overall Study|Withdrawal by Subject|26|||
145931923|NCT00784238|526258888|FG000|Overall Study|Other|14|||
145931924|NCT03806933|526258889|FG000|Main Period|Physician Decision|0|||
145978163|NCT02850406|526431206|FG002|Part C (Up to 52 Weeks)|Other|0|||
145978164|NCT02850406|526431207|FG003|Part C (Up to 52 Weeks)|Other|0|||
145978165|NCT02850406|526431208|FG004|Part C (Up to 52 Weeks)|Other|1|||
145978166|NCT02850406|526431209|FG005|Part C (Up to 52 Weeks)|Other|3|||
145978167|NCT02850406|526431210|FG006|Part C (Up to 52 Weeks)|Other|0|||
145978168|NCT02850406|526431211|FG007|Part C (Up to 52 Weeks)|Other|0|||
145978169|NCT02850406|526431204|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978170|NCT02850406|526431205|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978171|NCT02850406|526431206|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978172|NCT02850406|526431207|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978173|NCT02850406|526431208|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978174|NCT02850406|526431209|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978175|NCT02850406|526431210|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
145978176|NCT02850406|526431211|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
145978177|NCT02850406|526431204|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978178|NCT02850406|526431205|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978179|NCT02850406|526431206|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978180|NCT02850406|526431207|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978181|NCT02850406|526431208|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978182|NCT02850406|526431209|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978183|NCT02850406|526431210|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145978184|NCT02850406|526431211|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
145978185|NCT02850406|526431204|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978186|NCT02850406|526431205|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978187|NCT02850406|526431206|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978188|NCT02850406|526431207|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978189|NCT02850406|526431208|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978190|NCT02850406|526431209|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
145978191|NCT02850406|526431210|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
145978192|NCT02850406|526431211|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
145978193|NCT02850406|526431204|FG000|Part D (Up to 52 Weeks)|Other|0|||
145978194|NCT02850406|526431205|FG001|Part D (Up to 52 Weeks)|Other|0|||
145978195|NCT02850406|526431206|FG002|Part D (Up to 52 Weeks)|Other|0|||
145978196|NCT02850406|526431207|FG003|Part D (Up to 52 Weeks)|Other|0|||
145978197|NCT02850406|526431208|FG004|Part D (Up to 52 Weeks)|Other|0|||
145978198|NCT02850406|526431209|FG005|Part D (Up to 52 Weeks)|Other|0|||
145978199|NCT02850406|526431210|FG006|Part D (Up to 52 Weeks)|Other|0|||
145978200|NCT02850406|526431211|FG007|Part D (Up to 52 Weeks)|Other|1|||
145978201|NCT03641924|526432162|FG000|Overall Study|Withdrawal by Subject|26|||
146243371|NCT02203032|527405390|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
146243372|NCT02203032|527405391|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
145931925|NCT03806933|526258890|FG001|Main Period|Physician Decision|0|||
145978202|NCT03641924|526432162|FG000|Overall Study|Lost to Follow-up|16|||
146243373|NCT02203032|527405392|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
145978203|NCT03641924|526432162|FG000|Overall Study|Protocol Violation|10|||
145978204|NCT04333498|526432163|FG000|Overall Study|Lost to Follow-up|1|||
145931926|NCT03806933|526258891|FG002|Main Period|Physician Decision|0|||
145931927|NCT03806933|526258892|FG003|Main Period|Physician Decision|1|||
145931928|NCT03806933|526258889|FG000|Main Period|Pregnancy|0|||
145931929|NCT03806933|526258890|FG001|Main Period|Pregnancy|0|||
145931930|NCT03806933|526258891|FG002|Main Period|Pregnancy|1|||
145931931|NCT03806933|526258892|FG003|Main Period|Pregnancy|0|||
145931932|NCT03806933|526258889|FG000|Main Period|Withdrawal by Subject|2|||
145931933|NCT03806933|526258890|FG001|Main Period|Withdrawal by Subject|1|||
145931934|NCT03806933|526258891|FG002|Main Period|Withdrawal by Subject|1|||
145931935|NCT03806933|526258892|FG003|Main Period|Withdrawal by Subject|2|||
145931936|NCT03806933|526258889|FG000|Main Period|Lost to Follow-up|2|||
145931937|NCT03806933|526258890|FG001|Main Period|Lost to Follow-up|2|||
145931938|NCT03806933|526258891|FG002|Main Period|Lost to Follow-up|0|||
145931939|NCT03806933|526258892|FG003|Main Period|Lost to Follow-up|0|||
145931940|NCT03806933|526258889|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145931941|NCT03806933|526258890|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145931942|NCT03806933|526258891|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145931943|NCT03806933|526258892|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
145931944|NCT00078767|526258893|FG000|Overall Study|Withdrawal by Subject|1|||
145931945|NCT00078767|526258894|FG001|Overall Study|Withdrawal by Subject|1|||
145931946|NCT01736397|526258895|FG000|Overall Study|Lack of Efficacy|1|||
145931947|NCT01736397|526258896|FG001|Overall Study|Lack of Efficacy|11|||
145931948|NCT01736397|526258895|FG000|Overall Study|Withdrawal by Subject|6|||
145931949|NCT01736397|526258896|FG001|Overall Study|Withdrawal by Subject|5|||
145931950|NCT01736397|526258895|FG000|Overall Study|Lost to Follow-up|0|||
145931951|NCT01736397|526258896|FG001|Overall Study|Lost to Follow-up|1|||
145931952|NCT01736397|526258895|FG000|Overall Study|Adverse Event|6|||
145931953|NCT01736397|526258896|FG001|Overall Study|Adverse Event|3|||
145931954|NCT01736397|526258895|FG000|Overall Study|Not stated|1|||
145931955|NCT01736397|526258896|FG001|Overall Study|Not stated|4|||
145931956|NCT01868438|526258897|FG000|First Intervention|Withdrawal by Subject|5|||
145931957|NCT01868438|526258898|FG001|First Intervention|Withdrawal by Subject|1|||
145931958|NCT01868438|526258897|FG000|First Intervention|Lost to Follow-up|2|||
145931959|NCT01868438|526258898|FG001|First Intervention|Lost to Follow-up|3|||
145931960|NCT01868438|526258897|FG000|First Intervention|Meeting the non-redosing criteria|0|||
145931961|NCT01868438|526258898|FG001|First Intervention|Meeting the non-redosing criteria|1|||
145931962|NCT01868438|526258897|FG000|Second Intervention|Adverse Event|3|||
145931963|NCT01868438|526258898|FG001|Second Intervention|Adverse Event|3|||
145931964|NCT01177293|526258899|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
145931965|NCT01177293|526258900|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
145931966|NCT00956592|526258901|FG000|Overall Study|Protocol Violation|1|||
145931967|NCT00956592|526258902|FG001|Overall Study|Protocol Violation|3|||
145931968|NCT03528369|526258903|FG000|Overall Study|Withdrawal by Subject|2|||
145931969|NCT03528369|526258904|FG001|Overall Study|Withdrawal by Subject|0|||
145931970|NCT03528369|526258905|FG002|Overall Study|Withdrawal by Subject|0|||
145931971|NCT03528369|526258903|FG000|Overall Study|Lost to Follow-up|1|||
145931972|NCT03528369|526258904|FG001|Overall Study|Lost to Follow-up|0|||
145931973|NCT03528369|526258905|FG002|Overall Study|Lost to Follow-up|0|||
145931974|NCT03528369|526258903|FG000|Overall Study|Adverse Event|0|||
145931975|NCT03528369|526258904|FG001|Overall Study|Adverse Event|1|||
145931976|NCT03528369|526258905|FG002|Overall Study|Adverse Event|0|||
145931977|NCT02162719|526258906|FG000|Overall Study|Death|41|||
145931978|NCT02162719|526258907|FG001|Overall Study|Death|46|||
145931979|NCT02162719|526258906|FG000|Overall Study|Lost to Follow-up|1|||
145931980|NCT02162719|526258907|FG001|Overall Study|Lost to Follow-up|3|||
145931981|NCT02162719|526258906|FG000|Overall Study|Disease Progression|2|||
145931982|NCT02162719|526258907|FG001|Overall Study|Disease Progression|1|||
145931983|NCT02162719|526258906|FG000|Overall Study|Withdrawal by Subject|8|||
145931984|NCT02162719|526258907|FG001|Overall Study|Withdrawal by Subject|2|||
145931985|NCT02162719|526258906|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
145931986|NCT02162719|526258907|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
145931987|NCT03555565|526258908|FG000|Overall Study|Case Report Forms Uncollected|2|||
145931988|NCT03555565|526258908|FG000|Overall Study|Protocol Deviation|13|||
145931989|NCT00076752|526258912|FG000|Overall Study|Death|2|||
145931990|NCT00076752|526258912|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
145931991|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
145931992|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
145931993|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
145931994|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
145931995|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
145931996|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
145931997|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
146090953|NCT02788474|526854840|FG001|Open Label Treatment Period|Other than reason specified|0|||
145931998|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
145931999|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Death|0|||
145932000|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Death|1|||
145932001|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
145932002|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
145932003|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
145932004|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
145932005|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
145932006|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
145932007|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
145932008|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
145932009|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
145932010|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
145932011|NCT00394836|526258915|FG000|Teatment or Follow-up Phase|Non compliance|0|||
145932012|NCT00394836|526258916|FG001|Teatment or Follow-up Phase|Non compliance|1|||
145932013|NCT00394836|526258915|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
145932014|NCT00394836|526258916|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
145932015|NCT00394836|526258915|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
145932016|NCT00394836|526258916|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
145932017|NCT00394836|526258915|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
145932018|NCT00394836|526258916|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
145932019|NCT00394836|526258915|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
145932020|NCT00394836|526258916|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
145932021|NCT00748189|526258917|FG000|Overall Study|Death|99|||
145932022|NCT00748189|526258918|FG001|Overall Study|Death|84|||
145932023|NCT00748189|526258917|FG000|Overall Study|Withdrawal by Subject|23|||
145932024|NCT00748189|526258918|FG001|Overall Study|Withdrawal by Subject|29|||
145932025|NCT00748189|526258917|FG000|Overall Study|Physician Decision|16|||
145932026|NCT00748189|526258918|FG001|Overall Study|Physician Decision|5|||
145932027|NCT00748189|526258917|FG000|Overall Study|Lost to Follow-up|8|||
145932028|NCT00748189|526258918|FG001|Overall Study|Lost to Follow-up|15|||
145932029|NCT00748189|526258917|FG000|Overall Study|Study terminated by Sponsor|70|||
145932030|NCT00748189|526258918|FG001|Overall Study|Study terminated by Sponsor|79|||
145932031|NCT04411810|526258921|FG000|Overall Study|Screen failure|1|||
145932032|NCT04411810|526258921|FG000|Overall Study|Withdrawal by Subject|1|||
145932033|NCT02028767|526258924|FG000|Treatment Period 2|Non compliant with protocol|1|||
145932034|NCT02028767|526258925|FG001|Treatment Period 2|Non compliant with protocol|0|||
145932035|NCT02028767|526258924|FG000|Treatment Period 2|Reason other than those specified above|1|||
145932036|NCT02028767|526258925|FG001|Treatment Period 2|Reason other than those specified above|0|||
145932037|NCT03192306|526258928|FG000|Overall Study|Did not treat cold sore during study|149|||
145932038|NCT03192306|526258929|FG001|Overall Study|Did not treat cold sore during study|143|||
145932039|NCT03192306|526258928|FG000|Overall Study|Withdrawal by Subject|1|||
145932040|NCT03192306|526258929|FG001|Overall Study|Withdrawal by Subject|1|||
145932041|NCT03192306|526258928|FG000|Overall Study|Lost to Follow-up|1|||
145932042|NCT03192306|526258929|FG001|Overall Study|Lost to Follow-up|0|||
145932043|NCT03192306|526258928|FG000|Overall Study|Protocol Violation|1|||
145932044|NCT03192306|526258929|FG001|Overall Study|Protocol Violation|1|||
145932045|NCT02589626|526258939|FG000|Overall Study|Other than the reason specified|1|||
145932046|NCT02589626|526258940|FG001|Overall Study|Other than the reason specified|0|||
145932047|NCT02589626|526258939|FG000|Overall Study|Withdrawal by Subject|1|||
145932048|NCT02589626|526258940|FG001|Overall Study|Withdrawal by Subject|1|||
145932049|NCT02589626|526258939|FG000|Overall Study|Adverse Event|1|||
145932050|NCT02589626|526258940|FG001|Overall Study|Adverse Event|1|||
145932051|NCT05338502|526258941|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
145932052|NCT05338502|526258942|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
145932053|NCT05338502|526258943|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
145932054|NCT05338502|526258941|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
145932055|NCT05338502|526258942|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
145932056|NCT05338502|526258943|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
145932057|NCT03575793|526258944|FG000|Overall Study|Withdrawal by Subject|0|||
145932058|NCT03575793|526258945|FG001|Overall Study|Withdrawal by Subject|1|||
145932059|NCT03575793|526258944|FG000|Overall Study|Never Treated|0|||
145932060|NCT03575793|526258945|FG001|Overall Study|Never Treated|2|||
145932061|NCT01127451|526258946|FG000|Overall Study|Other|2|||
145932062|NCT01127451|526258947|FG001|Overall Study|Other|1|||
146243374|NCT02241785|527405395|FG000|Overall Study|Sponsor Termination|43|||
145932063|NCT01127451|526258946|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
145932064|NCT01127451|526258947|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
145932065|NCT01127451|526258946|FG000|Overall Study|Death|22|||
145932066|NCT01127451|526258947|FG001|Overall Study|Death|17|||
145932067|NCT01127451|526258946|FG000|Overall Study|Lost to Follow-up|3|||
145932068|NCT01127451|526258947|FG001|Overall Study|Lost to Follow-up|0|||
145932069|NCT01127451|526258946|FG000|Overall Study|Administrative Reason by Sponsor|2|||
145932070|NCT01127451|526258947|FG001|Overall Study|Administrative Reason by Sponsor|2|||
145932071|NCT02111577|526258948|FG000|Overall Study|Protocol Violation|2|||
145932072|NCT02111577|526258949|FG001|Overall Study|Protocol Violation|0|||
145932073|NCT02111577|526258948|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
145932074|NCT02111577|526258949|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
146243375|NCT02241785|527405395|FG000|Overall Study|Withdrawal by Subject|1|||
146243376|NCT02241785|527405395|FG000|Overall Study|Lost to Follow-up|2|||
145932075|NCT02111577|526258948|FG000|Overall Study|Failure to produce study treatment|6|||
145932076|NCT02111577|526258949|FG001|Overall Study|Failure to produce study treatment|0|||
145932077|NCT02111577|526258948|FG000|Overall Study|Death|518|||
145932078|NCT02111577|526258949|FG001|Overall Study|Death|254|||
145932079|NCT02111577|526258948|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
145932080|NCT02111577|526258949|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
145932081|NCT02111577|526258948|FG000|Overall Study|Adverse Event|1|||
145932082|NCT02111577|526258949|FG001|Overall Study|Adverse Event|1|||
145932083|NCT02111577|526258948|FG000|Overall Study|Withdrawal by Subject|51|||
145932084|NCT02111577|526258949|FG001|Overall Study|Withdrawal by Subject|23|||
145932085|NCT02111577|526258948|FG000|Overall Study|Disease progression|0|||
145932086|NCT02111577|526258949|FG001|Overall Study|Disease progression|1|||
145932087|NCT02111577|526258948|FG000|Overall Study|Lost to Follow-up|19|||
145932088|NCT02111577|526258949|FG001|Overall Study|Lost to Follow-up|10|||
145932089|NCT01014988|526258950|FG000|Overall Study|Adverse Event|20|||
145932090|NCT01014988|526258951|FG001|Overall Study|Adverse Event|0|||
145932091|NCT01014988|526258952|FG002|Overall Study|Adverse Event|1|||
145932092|NCT01014988|526258953|FG003|Overall Study|Adverse Event|0|||
145932093|NCT01014988|526258954|FG004|Overall Study|Adverse Event|1|||
145932094|NCT01014988|526258955|FG005|Overall Study|Adverse Event|3|||
145932095|NCT01014988|526258950|FG000|Overall Study|Lost to Follow-up|1|||
145932096|NCT01014988|526258951|FG001|Overall Study|Lost to Follow-up|0|||
145932097|NCT01014988|526258952|FG002|Overall Study|Lost to Follow-up|1|||
145932098|NCT01014988|526258953|FG003|Overall Study|Lost to Follow-up|0|||
145932099|NCT01014988|526258954|FG004|Overall Study|Lost to Follow-up|0|||
145932100|NCT01014988|526258955|FG005|Overall Study|Lost to Follow-up|0|||
145932101|NCT01014988|526258950|FG000|Overall Study|Physician Decision|1|||
145932102|NCT01014988|526258951|FG001|Overall Study|Physician Decision|0|||
145932103|NCT01014988|526258952|FG002|Overall Study|Physician Decision|0|||
145932104|NCT01014988|526258953|FG003|Overall Study|Physician Decision|0|||
145932105|NCT01014988|526258954|FG004|Overall Study|Physician Decision|0|||
145932106|NCT01014988|526258955|FG005|Overall Study|Physician Decision|0|||
145932107|NCT01014988|526258950|FG000|Overall Study|Withdrawal by Subject|1|||
145932108|NCT01014988|526258951|FG001|Overall Study|Withdrawal by Subject|0|||
145932109|NCT01014988|526258952|FG002|Overall Study|Withdrawal by Subject|0|||
145932110|NCT01014988|526258953|FG003|Overall Study|Withdrawal by Subject|0|||
145932111|NCT01014988|526258954|FG004|Overall Study|Withdrawal by Subject|0|||
145932112|NCT01014988|526258955|FG005|Overall Study|Withdrawal by Subject|0|||
145932113|NCT00729157|526258956|FG000|Overall Study|Withdrawal by Subject|1|||
145932114|NCT00886743|526258957|FG000|Overall Study|Adverse Event|3|||
145932115|NCT00886743|526258957|FG000|Overall Study|Other|1|||
145932116|NCT02429778|526258959|FG000|Overall Study|Lost to Follow-up|2|||
145932117|NCT02429778|526258960|FG001|Overall Study|Lost to Follow-up|0|||
145932118|NCT02429778|526258959|FG000|Overall Study|Withdrawal by Subject|5|||
145932119|NCT02429778|526258960|FG001|Overall Study|Withdrawal by Subject|0|||
145932120|NCT02475265|526258961|FG000|Overall Study|Physician Decision|1|||
145932121|NCT02475265|526258961|FG000|Overall Study|Withdrawal by Subject|2|||
145932122|NCT02587598|526258962|FG000|Overall Study|Death|4|||
145932123|NCT02587598|526258963|FG001|Overall Study|Death|8|||
145932124|NCT02587598|526258964|FG002|Overall Study|Death|4|||
145932125|NCT02587598|526258965|FG003|Overall Study|Death|16|||
145932126|NCT02587598|526258966|FG004|Overall Study|Death|9|||
145932127|NCT02587598|526258967|FG005|Overall Study|Death|4|||
145932128|NCT02587598|526258968|FG006|Overall Study|Death|6|||
145932129|NCT02587598|526258969|FG007|Overall Study|Death|7|||
145932130|NCT02587598|526258970|FG008|Overall Study|Death|9|||
145932131|NCT02587598|526258971|FG009|Overall Study|Death|1|||
145932132|NCT02587598|526258972|FG010|Overall Study|Death|3|||
145932133|NCT02587598|526258962|FG000|Overall Study|Study Terminated by the Sponsor|0|||
145932134|NCT02587598|526258963|FG001|Overall Study|Study Terminated by the Sponsor|1|||
145932135|NCT02587598|526258964|FG002|Overall Study|Study Terminated by the Sponsor|0|||
145932136|NCT02587598|526258965|FG003|Overall Study|Study Terminated by the Sponsor|3|||
145932137|NCT02587598|526258966|FG004|Overall Study|Study Terminated by the Sponsor|0|||
145932138|NCT02587598|526258967|FG005|Overall Study|Study Terminated by the Sponsor|1|||
145932139|NCT02587598|526258968|FG006|Overall Study|Study Terminated by the Sponsor|0|||
145932140|NCT02587598|526258969|FG007|Overall Study|Study Terminated by the Sponsor|0|||
145932141|NCT02587598|526258970|FG008|Overall Study|Study Terminated by the Sponsor|0|||
145932142|NCT02587598|526258971|FG009|Overall Study|Study Terminated by the Sponsor|1|||
145932143|NCT02587598|526258972|FG010|Overall Study|Study Terminated by the Sponsor|6|||
145932144|NCT02587598|526258962|FG000|Overall Study|Reason for study withdrawal not specified|0|||
145932145|NCT02587598|526258963|FG001|Overall Study|Reason for study withdrawal not specified|1|||
145932146|NCT02587598|526258964|FG002|Overall Study|Reason for study withdrawal not specified|0|||
145932147|NCT02587598|526258965|FG003|Overall Study|Reason for study withdrawal not specified|0|||
145932148|NCT02587598|526258966|FG004|Overall Study|Reason for study withdrawal not specified|0|||
145932149|NCT02587598|526258967|FG005|Overall Study|Reason for study withdrawal not specified|0|||
145932150|NCT02587598|526258968|FG006|Overall Study|Reason for study withdrawal not specified|0|||
145932151|NCT02587598|526258969|FG007|Overall Study|Reason for study withdrawal not specified|0|||
145932152|NCT02587598|526258970|FG008|Overall Study|Reason for study withdrawal not specified|0|||
145932153|NCT02587598|526258971|FG009|Overall Study|Reason for study withdrawal not specified|0|||
145932154|NCT02587598|526258972|FG010|Overall Study|Reason for study withdrawal not specified|0|||
145932155|NCT02587598|526258962|FG000|Overall Study|Withdrawal by Subject|0|||
145932156|NCT02587598|526258963|FG001|Overall Study|Withdrawal by Subject|1|||
145932157|NCT02587598|526258964|FG002|Overall Study|Withdrawal by Subject|0|||
145932158|NCT02587598|526258965|FG003|Overall Study|Withdrawal by Subject|2|||
145932159|NCT02587598|526258966|FG004|Overall Study|Withdrawal by Subject|3|||
145932160|NCT02587598|526258967|FG005|Overall Study|Withdrawal by Subject|1|||
145932161|NCT02587598|526258968|FG006|Overall Study|Withdrawal by Subject|0|||
145932162|NCT02587598|526258969|FG007|Overall Study|Withdrawal by Subject|0|||
145932163|NCT02587598|526258970|FG008|Overall Study|Withdrawal by Subject|0|||
145932164|NCT02587598|526258971|FG009|Overall Study|Withdrawal by Subject|1|||
145932165|NCT02587598|526258972|FG010|Overall Study|Withdrawal by Subject|2|||
145932166|NCT02587598|526258962|FG000|Overall Study|Physician Decision|0|||
145932167|NCT02587598|526258963|FG001|Overall Study|Physician Decision|0|||
145932168|NCT02587598|526258964|FG002|Overall Study|Physician Decision|0|||
145932169|NCT02587598|526258965|FG003|Overall Study|Physician Decision|0|||
145932170|NCT02587598|526258966|FG004|Overall Study|Physician Decision|0|||
145932171|NCT02587598|526258967|FG005|Overall Study|Physician Decision|0|||
145932172|NCT02587598|526258968|FG006|Overall Study|Physician Decision|0|||
145932173|NCT02587598|526258969|FG007|Overall Study|Physician Decision|0|||
145932174|NCT02587598|526258970|FG008|Overall Study|Physician Decision|0|||
145932175|NCT02587598|526258971|FG009|Overall Study|Physician Decision|0|||
145932176|NCT02587598|526258972|FG010|Overall Study|Physician Decision|3|||
145932177|NCT01704651|526258979|FG000|Overall Study|Pre-op withdrawal by subject|1|||
145932178|NCT01704651|526258980|FG001|Overall Study|Pre-op withdrawal by subject|1|||
145932179|NCT01704651|526258979|FG000|Overall Study|Pre-op change in treatment plan|1|||
145932180|NCT01704651|526258980|FG001|Overall Study|Pre-op change in treatment plan|4|||
145932181|NCT01704651|526258979|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
145932182|NCT01704651|526258980|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
145932183|NCT01704651|526258979|FG000|Overall Study|Post-op did not have laparotomy|2|||
145932184|NCT01704651|526258980|FG001|Overall Study|Post-op did not have laparotomy|1|||
145932185|NCT03474731|526258983|FG000|Overall Study|Withdrawal by Subject|36|||
145932186|NCT03474731|526258984|FG001|Overall Study|Withdrawal by Subject|29|||
145932187|NCT03474731|526258985|FG002|Overall Study|Withdrawal by Subject|11|||
145932188|NCT03474731|526258986|FG003|Overall Study|Withdrawal by Subject|27|||
145932189|NCT03474731|526258983|FG000|Overall Study|COVID|0|||
145932190|NCT03474731|526258984|FG001|Overall Study|COVID|23|||
145932191|NCT03474731|526258985|FG002|Overall Study|COVID|0|||
145932192|NCT03474731|526258986|FG003|Overall Study|COVID|0|||
145932193|NCT03474731|526258983|FG000|Overall Study|Participant moved from area|1|||
145932194|NCT03474731|526258984|FG001|Overall Study|Participant moved from area|0|||
145932195|NCT03474731|526258985|FG002|Overall Study|Participant moved from area|0|||
145932196|NCT03474731|526258986|FG003|Overall Study|Participant moved from area|0|||
145932197|NCT03474731|526258983|FG000|Overall Study|Lost to Follow-up|11|||
145932198|NCT03474731|526258984|FG001|Overall Study|Lost to Follow-up|3|||
145932199|NCT03474731|526258985|FG002|Overall Study|Lost to Follow-up|18|||
145932200|NCT03474731|526258986|FG003|Overall Study|Lost to Follow-up|17|||
145932201|NCT03474731|526258983|FG000|Overall Study|Death|0|||
145932202|NCT03474731|526258984|FG001|Overall Study|Death|1|||
145932203|NCT03474731|526258985|FG002|Overall Study|Death|0|||
145932204|NCT03474731|526258986|FG003|Overall Study|Death|0|||
145932205|NCT03474731|526258983|FG000|Overall Study|Participant Removed|0|||
145932206|NCT03474731|526258984|FG001|Overall Study|Participant Removed|0|||
145932207|NCT03474731|526258985|FG002|Overall Study|Participant Removed|0|||
145932208|NCT03474731|526258986|FG003|Overall Study|Participant Removed|1|||
145932209|NCT02887248|526258990|FG000|Overall Study|Withdrawal by Subject|1|||
145932210|NCT02887248|526258990|FG000|Overall Study|Adverse Event|1|||
146243377|NCT02241785|527405395|FG000|Overall Study|Adverse Event|1|||
145932211|NCT02887248|526258990|FG000|Overall Study|Progressive Disease|1|||
145932212|NCT00765336|526258991|FG000|Overall Study|Protocol Violation|4|||
145932213|NCT00765336|526258992|FG001|Overall Study|Protocol Violation|2|||
145932214|NCT00765336|526258991|FG000|Overall Study|Withdrawal by Subject|6|||
145932215|NCT00765336|526258992|FG001|Overall Study|Withdrawal by Subject|4|||
145932216|NCT00765336|526258991|FG000|Overall Study|Lost to Follow-up|7|||
145932217|NCT00765336|526258992|FG001|Overall Study|Lost to Follow-up|9|||
145932218|NCT00765336|526258991|FG000|Overall Study|Adverse Event|2|||
145932219|NCT00765336|526258992|FG001|Overall Study|Adverse Event|1|||
145932220|NCT00478777|526258993|FG000|Overall Study|Adverse Event|29|||
145932221|NCT00478777|526258993|FG000|Overall Study|Lack of Efficacy|23|||
145932222|NCT00478777|526258993|FG000|Overall Study|Withdrawal by Subject|4|||
145932223|NCT00478777|526258993|FG000|Overall Study|Death|3|||
145932224|NCT00478777|526258993|FG000|Overall Study|Protocol Violation|3|||
145932225|NCT00478777|526258993|FG000|Overall Study|Lost to Follow-up|3|||
145932226|NCT00478777|526258993|FG000|Overall Study|Physician Decision|1|||
145932227|NCT00478777|526258993|FG000|Overall Study|Intolerance of therapy|1|||
145932228|NCT00478777|526258993|FG000|Overall Study|Lack of compliance|1|||
146090954|NCT02788474|526854839|FG000|Open Label Treatment Period|Patient's refusal|1|||
146090955|NCT02788474|526854840|FG001|Open Label Treatment Period|Patient's refusal|3|||
146090956|NCT02788474|526854839|FG000|Open Label Treatment Period|Non-compliance|1|||
146090957|NCT02788474|526854840|FG001|Open Label Treatment Period|Non-compliance|0|||
146090958|NCT00048061|526854841|FG000|Overall Study|Adverse Event|41|||
146090959|NCT00048061|526854842|FG001|Overall Study|Adverse Event|32|||
146243378|NCT04748341|527405396|FG000|Overall Study|Lost to Follow-up|1|||
146243379|NCT04748341|527405397|FG001|Overall Study|Lost to Follow-up|1|||
145932229|NCT00478777|526258993|FG000|Overall Study|Lymphocytes infusion|1|||
145932230|NCT00478777|526258993|FG000|Overall Study|End of therapy|2|||
145932231|NCT00478777|526258993|FG000|Overall Study|Not treated with lenalidomide|6|||
145932232|NCT04105218|526258999|FG000|Overall Study|Withdrawal by Subject|3|||
145932233|NCT04105218|526259000|FG001|Overall Study|Withdrawal by Subject|2|||
145932234|NCT04105218|526258999|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
145932235|NCT04105218|526259000|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
145932236|NCT04105218|526258999|FG000|Overall Study|Failed screening tests|2|||
145932237|NCT04105218|526259000|FG001|Overall Study|Failed screening tests|1|||
145932238|NCT01323387|526259006|FG000|Overall Study|Withdrawal by Subject|41|||
145932239|NCT01323387|526259006|FG000|Overall Study|Radiographic Data Unavailable|1|||
145932240|NCT01323387|526259006|FG000|Overall Study|Revision|14|||
145932241|NCT01323387|526259006|FG000|Overall Study|Protocol Violation|12|||
145932242|NCT01323387|526259006|FG000|Overall Study|Randomized but Never Treated|16|||
145932243|NCT00570063|526259009|FG000|Overall Study|Adverse Event|4|||
145932244|NCT00570063|526259010|FG001|Overall Study|Adverse Event|1|||
145932245|NCT00570063|526259009|FG000|Overall Study|Lack of Efficacy|0|||
145932246|NCT00570063|526259010|FG001|Overall Study|Lack of Efficacy|1|||
145932247|NCT00570063|526259009|FG000|Overall Study|Withdrawal by Subject|4|||
145932248|NCT00570063|526259010|FG001|Overall Study|Withdrawal by Subject|3|||
145932249|NCT00570063|526259009|FG000|Overall Study|Sponsor's Decision|7|||
145932250|NCT00570063|526259010|FG001|Overall Study|Sponsor's Decision|3|||
145932251|NCT01554527|526259011|FG000|Overall Study|Withdrawal by Subject|1|||
145932252|NCT01554527|526259012|FG001|Overall Study|Withdrawal by Subject|0|||
145932253|NCT01554527|526259013|FG002|Overall Study|Withdrawal by Subject|3|||
145932254|NCT01554527|526259011|FG000|Overall Study|Lost to Follow-up|0|||
145932255|NCT01554527|526259012|FG001|Overall Study|Lost to Follow-up|0|||
145932256|NCT01554527|526259013|FG002|Overall Study|Lost to Follow-up|4|||
145932257|NCT01554527|526259011|FG000|Overall Study|Physician Decision|0|||
145932258|NCT01554527|526259012|FG001|Overall Study|Physician Decision|0|||
145978205|NCT04333498|526432164|FG001|Overall Study|Lost to Follow-up|0|||
145978206|NCT04333498|526432163|FG000|Overall Study|Lost to Follow-up|0|||
145978207|NCT04333498|526432164|FG001|Overall Study|Lost to Follow-up|1|||
145978208|NCT01565694|526432165|FG000|Dose-Titration Period|Adverse Event|4|||
145978209|NCT01565694|526432165|FG000|Dose-Titration Period|Protocol Violation|10|||
145978210|NCT01565694|526432165|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
145978211|NCT00479232|526432166|FG000|Overall Study|Adverse Event|0|||
145978212|NCT00479232|526432167|FG001|Overall Study|Adverse Event|0|||
145978213|NCT00479232|526432168|FG002|Overall Study|Adverse Event|5|||
145978214|NCT00479232|526432169|FG003|Overall Study|Adverse Event|0|||
145978215|NCT00479232|526432170|FG004|Overall Study|Adverse Event|0|||
145978216|NCT00479232|526432171|FG005|Overall Study|Adverse Event|10|||
145978217|NCT00479232|526432166|FG000|Overall Study|Deviation from Protocol|0|||
145978218|NCT00479232|526432167|FG001|Overall Study|Deviation from Protocol|0|||
145978219|NCT00479232|526432168|FG002|Overall Study|Deviation from Protocol|1|||
146090960|NCT00048061|526854843|FG002|Overall Study|Adverse Event|44|||
146243380|NCT00452114|527405398|FG000|Overall Study|Physician Decision|3|||
146243381|NCT00452114|527405399|FG001|Overall Study|Physician Decision|3|||
146243382|NCT04197713|527405400|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
146243383|NCT04197713|527405401|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
146243384|NCT02831049|527405415|FG000|Overall Study|Lost to Follow-up|0|||
146243385|NCT02831049|527405416|FG001|Overall Study|Lost to Follow-up|0|||
146243386|NCT02831049|527405417|FG002|Overall Study|Lost to Follow-up|1|||
146243387|NCT02831049|527405415|FG000|Overall Study|Withdrawal by Subject|0|||
146243388|NCT02831049|527405416|FG001|Overall Study|Withdrawal by Subject|1|||
146243389|NCT02831049|527405417|FG002|Overall Study|Withdrawal by Subject|1|||
145932259|NCT01554527|526259013|FG002|Overall Study|Physician Decision|1|||
145932260|NCT00550043|526259014|FG000|Overall Study|Adverse Event|0|||
145932261|NCT00550043|526259015|FG001|Overall Study|Adverse Event|0|||
145932262|NCT00550043|526259016|FG002|Overall Study|Adverse Event|0|||
145932263|NCT00550043|526259017|FG003|Overall Study|Adverse Event|1|||
145932264|NCT00550043|526259018|FG004|Overall Study|Adverse Event|1|||
145932265|NCT00550043|526259014|FG000|Overall Study|Subject Withdrew Consent|0|||
145932266|NCT00550043|526259015|FG001|Overall Study|Subject Withdrew Consent|2|||
145932267|NCT00550043|526259016|FG002|Overall Study|Subject Withdrew Consent|1|||
145932268|NCT00550043|526259017|FG003|Overall Study|Subject Withdrew Consent|0|||
145978220|NCT00479232|526432169|FG003|Overall Study|Deviation from Protocol|0|||
146090961|NCT00048061|526854844|FG003|Overall Study|Adverse Event|37|||
145932269|NCT00550043|526259018|FG004|Overall Study|Subject Withdrew Consent|0|||
145932270|NCT00550043|526259014|FG000|Overall Study|Other Reasons- Unspecified|0|||
145932271|NCT00550043|526259015|FG001|Overall Study|Other Reasons- Unspecified|1|||
145932272|NCT00550043|526259016|FG002|Overall Study|Other Reasons- Unspecified|0|||
145932273|NCT00550043|526259017|FG003|Overall Study|Other Reasons- Unspecified|1|||
145932274|NCT00550043|526259018|FG004|Overall Study|Other Reasons- Unspecified|0|||
145932275|NCT02073929|526259019|FG000|Overall Study|Lost to Follow-up|2|||
145932276|NCT02073929|526259020|FG001|Overall Study|Lost to Follow-up|1|||
145932277|NCT02073929|526259019|FG000|Overall Study|Adverse Event|2|||
145932278|NCT02073929|526259020|FG001|Overall Study|Adverse Event|1|||
145932279|NCT02073929|526259019|FG000|Overall Study|Withdrawal by Subject|0|||
145932280|NCT02073929|526259020|FG001|Overall Study|Withdrawal by Subject|1|||
145932281|NCT01483027|526259021|FG000|Overall Study|Administrative Reasons|2|||
145932282|NCT01483027|526259022|FG001|Overall Study|Administrative Reasons|1|||
145932283|NCT01483027|526259021|FG000|Overall Study|Withdrawal by Subject|21|||
145932284|NCT01483027|526259022|FG001|Overall Study|Withdrawal by Subject|32|||
145932285|NCT01483027|526259021|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
145932286|NCT01483027|526259022|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
145932287|NCT01483027|526259021|FG000|Overall Study|Lost to Follow-up|1|||
145932288|NCT01483027|526259022|FG001|Overall Study|Lost to Follow-up|1|||
145932289|NCT01483027|526259021|FG000|Overall Study|Adverse Event|0|||
145932290|NCT01483027|526259022|FG001|Overall Study|Adverse Event|1|||
145932291|NCT01483027|526259021|FG000|Overall Study|Withdrawal by Subject|0|||
145932292|NCT01483027|526259022|FG001|Overall Study|Withdrawal by Subject|1|||
145932293|NCT01314872|526259025|FG000|Treatment Period 1|Protocol Violation|2|||
145932294|NCT01314872|526259026|FG001|Treatment Period 1|Protocol Violation|1|||
145932295|NCT01314872|526259027|FG002|Treatment Period 1|Protocol Violation|1|||
145932296|NCT01314872|526259028|FG003|Treatment Period 1|Protocol Violation|0|||
145932297|NCT01314872|526259029|FG004|Treatment Period 1|Protocol Violation|1|||
145932298|NCT01314872|526259030|FG005|Treatment Period 1|Protocol Violation|0|||
145932299|NCT01314872|526259031|FG006|Treatment Period 1|Protocol Violation|0|||
145932300|NCT01314872|526259032|FG007|Treatment Period 1|Protocol Violation|0|||
145932301|NCT01314872|526259033|FG008|Treatment Period 1|Protocol Violation|0|||
145932302|NCT01314872|526259034|FG009|Treatment Period 1|Protocol Violation|1|||
145932303|NCT01314872|526259035|FG010|Treatment Period 1|Protocol Violation|1|||
145932304|NCT01314872|526259036|FG011|Treatment Period 1|Protocol Violation|0|||
145932305|NCT01314872|526259037|FG012|Treatment Period 1|Protocol Violation|0|||
145932306|NCT01314872|526259038|FG013|Treatment Period 1|Protocol Violation|0|||
145932307|NCT01314872|526259039|FG014|Treatment Period 1|Protocol Violation|0|||
145932308|NCT01314872|526259025|FG000|Treatment Period 1|Physician Decision|0|||
145932309|NCT01314872|526259026|FG001|Treatment Period 1|Physician Decision|1|||
145932310|NCT01314872|526259027|FG002|Treatment Period 1|Physician Decision|0|||
145932311|NCT01314872|526259028|FG003|Treatment Period 1|Physician Decision|1|||
145932312|NCT01314872|526259029|FG004|Treatment Period 1|Physician Decision|0|||
145932313|NCT01314872|526259030|FG005|Treatment Period 1|Physician Decision|0|||
145932314|NCT01314872|526259031|FG006|Treatment Period 1|Physician Decision|0|||
145932315|NCT01314872|526259032|FG007|Treatment Period 1|Physician Decision|0|||
145932316|NCT01314872|526259033|FG008|Treatment Period 1|Physician Decision|0|||
145932317|NCT01314872|526259034|FG009|Treatment Period 1|Physician Decision|1|||
145932318|NCT01314872|526259035|FG010|Treatment Period 1|Physician Decision|0|||
145978221|NCT00479232|526432170|FG004|Overall Study|Deviation from Protocol|0|||
145978222|NCT00479232|526432171|FG005|Overall Study|Deviation from Protocol|0|||
145978223|NCT00479232|526432166|FG000|Overall Study|Lack of Efficacy|0|||
145978224|NCT00479232|526432167|FG001|Overall Study|Lack of Efficacy|0|||
145978225|NCT00479232|526432168|FG002|Overall Study|Lack of Efficacy|2|||
145978226|NCT00479232|526432169|FG003|Overall Study|Lack of Efficacy|0|||
145978227|NCT00479232|526432170|FG004|Overall Study|Lack of Efficacy|0|||
145978228|NCT00479232|526432171|FG005|Overall Study|Lack of Efficacy|4|||
145978229|NCT00479232|526432166|FG000|Overall Study|Physician Decision|0|||
145978230|NCT00479232|526432167|FG001|Overall Study|Physician Decision|0|||
146243390|NCT02831049|527405415|FG000|Overall Study|Pandemic shutdown|1|||
146243391|NCT02831049|527405416|FG001|Overall Study|Pandemic shutdown|0|||
146243392|NCT02831049|527405417|FG002|Overall Study|Pandemic shutdown|0|||
146243393|NCT04937504|527405418|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
146243394|NCT04937504|527405419|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
145932319|NCT01314872|526259036|FG011|Treatment Period 1|Physician Decision|0|||
145932320|NCT01314872|526259037|FG012|Treatment Period 1|Physician Decision|0|||
145932321|NCT01314872|526259038|FG013|Treatment Period 1|Physician Decision|0|||
145932322|NCT01314872|526259039|FG014|Treatment Period 1|Physician Decision|0|||
145932323|NCT01314872|526259025|FG000|Treatment Period 1|Lack of Efficacy|1|||
145932324|NCT01314872|526259026|FG001|Treatment Period 1|Lack of Efficacy|0|||
145932325|NCT01314872|526259027|FG002|Treatment Period 1|Lack of Efficacy|0|||
145978231|NCT00479232|526432168|FG002|Overall Study|Physician Decision|2|||
145978232|NCT00479232|526432169|FG003|Overall Study|Physician Decision|0|||
145932326|NCT01314872|526259028|FG003|Treatment Period 1|Lack of Efficacy|0|||
145932327|NCT01314872|526259029|FG004|Treatment Period 1|Lack of Efficacy|0|||
146090962|NCT00048061|526854841|FG000|Overall Study|Lost to Follow-up|3|||
146090963|NCT00048061|526854842|FG001|Overall Study|Lost to Follow-up|2|||
146090964|NCT00048061|526854843|FG002|Overall Study|Lost to Follow-up|4|||
146090965|NCT00048061|526854844|FG003|Overall Study|Lost to Follow-up|5|||
146090966|NCT00048061|526854841|FG000|Overall Study|Withdrawal by Subject|20|||
146090967|NCT00048061|526854842|FG001|Overall Study|Withdrawal by Subject|29|||
146090968|NCT00048061|526854843|FG002|Overall Study|Withdrawal by Subject|29|||
146090969|NCT00048061|526854844|FG003|Overall Study|Withdrawal by Subject|32|||
146090970|NCT00048061|526854841|FG000|Overall Study|Did not follow-up|5|||
146090971|NCT00048061|526854842|FG001|Overall Study|Did not follow-up|5|||
145932328|NCT01314872|526259030|FG005|Treatment Period 1|Lack of Efficacy|1|||
145932329|NCT01314872|526259031|FG006|Treatment Period 1|Lack of Efficacy|0|||
145932330|NCT01314872|526259032|FG007|Treatment Period 1|Lack of Efficacy|2|||
145932331|NCT01314872|526259033|FG008|Treatment Period 1|Lack of Efficacy|0|||
145932332|NCT01314872|526259034|FG009|Treatment Period 1|Lack of Efficacy|0|||
145932333|NCT01314872|526259035|FG010|Treatment Period 1|Lack of Efficacy|0|||
145932334|NCT01314872|526259036|FG011|Treatment Period 1|Lack of Efficacy|0|||
145932335|NCT01314872|526259037|FG012|Treatment Period 1|Lack of Efficacy|0|||
145932336|NCT01314872|526259038|FG013|Treatment Period 1|Lack of Efficacy|0|||
145932337|NCT01314872|526259039|FG014|Treatment Period 1|Lack of Efficacy|0|||
145932338|NCT01314872|526259025|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
145932339|NCT01314872|526259026|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
145932340|NCT01314872|526259027|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
145932341|NCT01314872|526259028|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
145932342|NCT01314872|526259029|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
145932343|NCT01314872|526259030|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
145932344|NCT01314872|526259031|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
145932345|NCT01314872|526259032|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
145932346|NCT01314872|526259033|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
145932347|NCT01314872|526259034|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
145932348|NCT01314872|526259035|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
145932349|NCT01314872|526259036|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
145932350|NCT01314872|526259037|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
145932351|NCT01314872|526259038|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
145932352|NCT01314872|526259039|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
145932353|NCT01314872|526259025|FG000|Treatment Period 1|Withdrawal by Subject|3|||
145932354|NCT01314872|526259026|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145932355|NCT01314872|526259027|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145932356|NCT01314872|526259028|FG003|Treatment Period 1|Withdrawal by Subject|2|||
145932357|NCT01314872|526259029|FG004|Treatment Period 1|Withdrawal by Subject|3|||
145932358|NCT01314872|526259030|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145932359|NCT01314872|526259031|FG006|Treatment Period 1|Withdrawal by Subject|3|||
145932360|NCT01314872|526259032|FG007|Treatment Period 1|Withdrawal by Subject|2|||
145932361|NCT01314872|526259033|FG008|Treatment Period 1|Withdrawal by Subject|2|||
145932362|NCT01314872|526259034|FG009|Treatment Period 1|Withdrawal by Subject|2|||
145932363|NCT01314872|526259035|FG010|Treatment Period 1|Withdrawal by Subject|1|||
145932364|NCT01314872|526259036|FG011|Treatment Period 1|Withdrawal by Subject|0|||
145932365|NCT01314872|526259037|FG012|Treatment Period 1|Withdrawal by Subject|0|||
145932366|NCT01314872|526259038|FG013|Treatment Period 1|Withdrawal by Subject|0|||
145932367|NCT01314872|526259039|FG014|Treatment Period 1|Withdrawal by Subject|0|||
145932368|NCT01314872|526259025|FG000|Treatment Period 1|Lost to Follow-up|0|||
145932369|NCT01314872|526259026|FG001|Treatment Period 1|Lost to Follow-up|1|||
145932370|NCT01314872|526259027|FG002|Treatment Period 1|Lost to Follow-up|2|||
145932371|NCT01314872|526259028|FG003|Treatment Period 1|Lost to Follow-up|2|||
145932372|NCT01314872|526259029|FG004|Treatment Period 1|Lost to Follow-up|1|||
145932373|NCT01314872|526259030|FG005|Treatment Period 1|Lost to Follow-up|1|||
145932374|NCT01314872|526259031|FG006|Treatment Period 1|Lost to Follow-up|1|||
146090972|NCT00048061|526854843|FG002|Overall Study|Did not follow-up|4|||
146090973|NCT00048061|526854844|FG003|Overall Study|Did not follow-up|5|||
146090974|NCT00048061|526854841|FG000|Overall Study|Early improvement|6|||
146090975|NCT00048061|526854842|FG001|Overall Study|Early improvement|5|||
146243395|NCT04937504|527405418|FG000|9 Months Assessment|Lost to Follow-up|3|||
146243396|NCT04937504|527405419|FG001|9 Months Assessment|Lost to Follow-up|2|||
146243397|NCT04535414|527405421|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
145932375|NCT01314872|526259032|FG007|Treatment Period 1|Lost to Follow-up|1|||
146282345|NCT01879722|527546470|FG001|Overall Study|Voluntary Withdrawal|0|||
145932376|NCT01314872|526259033|FG008|Treatment Period 1|Lost to Follow-up|1|||
145932377|NCT01314872|526259034|FG009|Treatment Period 1|Lost to Follow-up|0|||
145932378|NCT01314872|526259035|FG010|Treatment Period 1|Lost to Follow-up|0|||
145932379|NCT01314872|526259036|FG011|Treatment Period 1|Lost to Follow-up|0|||
146090976|NCT00048061|526854843|FG002|Overall Study|Early improvement|3|||
146090977|NCT00048061|526854844|FG003|Overall Study|Early improvement|0|||
146090978|NCT03555435|526854845|FG000|Overall Study|Lost to Follow-up|17|||
146090979|NCT03555435|526854846|FG001|Overall Study|Lost to Follow-up|19|||
146090980|NCT03555435|526854847|FG002|Overall Study|Lost to Follow-up|8|||
145932380|NCT01314872|526259037|FG012|Treatment Period 1|Lost to Follow-up|0|||
145932381|NCT01314872|526259038|FG013|Treatment Period 1|Lost to Follow-up|0|||
145932382|NCT01314872|526259039|FG014|Treatment Period 1|Lost to Follow-up|0|||
145932383|NCT01314872|526259025|FG000|Period 2|Protocol Violation|0|||
145932384|NCT01314872|526259026|FG001|Period 2|Protocol Violation|0|||
145932385|NCT01314872|526259027|FG002|Period 2|Protocol Violation|0|||
145932386|NCT01314872|526259028|FG003|Period 2|Protocol Violation|0|||
145932387|NCT01314872|526259029|FG004|Period 2|Protocol Violation|0|||
145932388|NCT01314872|526259030|FG005|Period 2|Protocol Violation|0|||
145932389|NCT01314872|526259031|FG006|Period 2|Protocol Violation|0|||
145932390|NCT01314872|526259032|FG007|Period 2|Protocol Violation|0|||
145932391|NCT01314872|526259033|FG008|Period 2|Protocol Violation|0|||
146243398|NCT04535414|527405422|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
146243399|NCT04535414|527405421|FG000|Overall Study|Cancelled appointment|1|||
146243400|NCT04535414|527405422|FG001|Overall Study|Cancelled appointment|0|||
146243401|NCT04535414|527405421|FG000|Overall Study|cancelled - food in stomach|2|||
146243402|NCT04535414|527405422|FG001|Overall Study|cancelled - food in stomach|0|||
146243403|NCT04535414|527405421|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
146243404|NCT04535414|527405422|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
146243405|NCT04535414|527405421|FG000|Overall Study|Withdrawal by Subject|0|||
146243406|NCT04535414|527405422|FG001|Overall Study|Withdrawal by Subject|1|||
146243407|NCT03662659|527405423|FG000|Pre-treatment|Participant no longer met study criteria|1|||
146243408|NCT03662659|527405424|FG001|Pre-treatment|Participant no longer met study criteria|1|||
146243409|NCT03662659|527405423|FG000|Pre-treatment|Other reasons|1|||
146243410|NCT03662659|527405424|FG001|Pre-treatment|Other reasons|0|||
146243411|NCT03662659|527405423|FG000|Treatment|Completed Treatment|0|||
146243412|NCT03662659|527405424|FG001|Treatment|Completed Treatment|2|||
146243413|NCT03662659|527405423|FG000|Treatment|Disease Progression|85|||
146243414|NCT03662659|527405424|FG001|Treatment|Disease Progression|97|||
146243415|NCT03662659|527405423|FG000|Treatment|Study Drug Toxicity|19|||
146243416|NCT03662659|527405424|FG001|Treatment|Study Drug Toxicity|9|||
146243417|NCT03662659|527405423|FG000|Treatment|Death|11|||
146243418|NCT03662659|527405424|FG001|Treatment|Death|9|||
146243419|NCT03662659|527405423|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
146243420|NCT03662659|527405424|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
146243421|NCT03662659|527405423|FG000|Treatment|Withdrawal by Subject|1|||
146243422|NCT03662659|527405424|FG001|Treatment|Withdrawal by Subject|1|||
146243423|NCT03662659|527405423|FG000|Treatment|Poor/Non-compliance|1|||
146243424|NCT03662659|527405424|FG001|Treatment|Poor/Non-compliance|0|||
146243425|NCT03662659|527405423|FG000|Treatment|Participant no longer meets study criteria|1|||
146243426|NCT03662659|527405424|FG001|Treatment|Participant no longer meets study criteria|0|||
146243427|NCT03662659|527405423|FG000|Treatment|Other reasons|10|||
146243428|NCT03662659|527405424|FG001|Treatment|Other reasons|8|||
146243429|NCT03662659|527405423|FG000|Treatment|Administrative reasons by sponsor|1|||
146243430|NCT03662659|527405424|FG001|Treatment|Administrative reasons by sponsor|0|||
146243431|NCT03662659|527405423|FG000|Treatment|maximum clinical benefit|0|||
146243432|NCT03662659|527405424|FG001|Treatment|maximum clinical benefit|2|||
146243433|NCT01668355|527407193|FG000|Overall Study|Death|3|||
146243434|NCT01668355|527407194|FG001|Overall Study|Death|1|||
146243435|NCT01668355|527407193|FG000|Overall Study|Withdrawal by Subject|6|||
146243436|NCT01668355|527407194|FG001|Overall Study|Withdrawal by Subject|1|||
146243437|NCT01277302|527407198|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
146243438|NCT01277302|527407199|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
145932392|NCT01314872|526259034|FG009|Period 2|Protocol Violation|0|||
145932393|NCT01314872|526259035|FG010|Period 2|Protocol Violation|0|||
145932394|NCT01314872|526259036|FG011|Period 2|Protocol Violation|3|||
145932395|NCT01314872|526259037|FG012|Period 2|Protocol Violation|3|||
145932396|NCT01314872|526259038|FG013|Period 2|Protocol Violation|2|||
145932397|NCT01314872|526259039|FG014|Period 2|Protocol Violation|0|||
145932398|NCT01314872|526259025|FG000|Period 2|Non-compliance with study drug|0|||
145932399|NCT01314872|526259026|FG001|Period 2|Non-compliance with study drug|0|||
145932400|NCT01314872|526259027|FG002|Period 2|Non-compliance with study drug|0|||
145932401|NCT01314872|526259028|FG003|Period 2|Non-compliance with study drug|0|||
145932402|NCT01314872|526259029|FG004|Period 2|Non-compliance with study drug|0|||
145932403|NCT01314872|526259030|FG005|Period 2|Non-compliance with study drug|0|||
145932404|NCT01314872|526259031|FG006|Period 2|Non-compliance with study drug|0|||
146243439|NCT01277302|527407200|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
145932405|NCT01314872|526259032|FG007|Period 2|Non-compliance with study drug|0|||
145932406|NCT01314872|526259033|FG008|Period 2|Non-compliance with study drug|0|||
145932407|NCT01314872|526259034|FG009|Period 2|Non-compliance with study drug|0|||
146243440|NCT01277302|527407198|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
146243441|NCT01277302|527407199|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
146243442|NCT01277302|527407200|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
146243443|NCT01277302|527407198|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
146243444|NCT01277302|527407199|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
145932408|NCT01314872|526259035|FG010|Period 2|Non-compliance with study drug|0|||
145932409|NCT01314872|526259036|FG011|Period 2|Non-compliance with study drug|3|||
145932410|NCT01314872|526259037|FG012|Period 2|Non-compliance with study drug|3|||
145932411|NCT01314872|526259038|FG013|Period 2|Non-compliance with study drug|1|||
145932412|NCT01314872|526259039|FG014|Period 2|Non-compliance with study drug|2|||
145932413|NCT01314872|526259025|FG000|Period 2|Lack of Efficacy|0|||
145932414|NCT01314872|526259026|FG001|Period 2|Lack of Efficacy|0|||
145932415|NCT01314872|526259027|FG002|Period 2|Lack of Efficacy|0|||
145978233|NCT00479232|526432170|FG004|Overall Study|Physician Decision|0|||
146243445|NCT01277302|527407200|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
146243446|NCT01277302|527407198|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
146243447|NCT01277302|527407199|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
146243448|NCT01277302|527407200|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
146243449|NCT01277302|527407198|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
146243450|NCT01277302|527407199|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
146243451|NCT01277302|527407200|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
146243452|NCT01277302|527407198|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
146243453|NCT01277302|527407199|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
146243454|NCT01277302|527407200|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
146243455|NCT01277302|527407198|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
146243456|NCT01277302|527407199|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
146243457|NCT01277302|527407200|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
146243458|NCT01277302|527407198|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
146243459|NCT01277302|527407199|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
146243460|NCT01277302|527407200|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
146243461|NCT01277302|527407198|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
146243462|NCT01277302|527407199|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
146243463|NCT01277302|527407200|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
146243464|NCT02710669|527407203|FG000|Overall Study|Physician Decision|2|||
146243465|NCT02710669|527407204|FG001|Overall Study|Physician Decision|1|||
146243466|NCT02710669|527407205|FG002|Overall Study|Physician Decision|0|||
146243467|NCT02710669|527407203|FG000|Overall Study|Institutional delays (including COVID)|2|||
146243468|NCT02710669|527407204|FG001|Overall Study|Institutional delays (including COVID)|2|||
146243469|NCT02710669|527407205|FG002|Overall Study|Institutional delays (including COVID)|0|||
146243470|NCT02710669|527407203|FG000|Overall Study|arrived in afib/aflutter|10|||
146243471|NCT02710669|527407204|FG001|Overall Study|arrived in afib/aflutter|8|||
146243472|NCT02710669|527407205|FG002|Overall Study|arrived in afib/aflutter|2|||
146243473|NCT01190124|527407207|FG000|Overall Study|Death|3|||
146243474|NCT01190124|527407208|FG001|Overall Study|Death|0|||
146243475|NCT01190124|527407209|FG002|Overall Study|Death|0|||
146243476|NCT01190124|527407207|FG000|Overall Study|Therapeutic Failure|12|||
146243477|NCT01190124|527407208|FG001|Overall Study|Therapeutic Failure|0|||
146243478|NCT01190124|527407209|FG002|Overall Study|Therapeutic Failure|1|||
146243479|NCT01190124|527407207|FG000|Overall Study|Lost to Follow-up|2|||
146243480|NCT01190124|527407208|FG001|Overall Study|Lost to Follow-up|0|||
146243481|NCT01190124|527407209|FG002|Overall Study|Lost to Follow-up|0|||
146243482|NCT01523392|527407210|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146243483|NCT01523392|527407211|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146243484|NCT01523392|527407210|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
146243485|NCT01523392|527407211|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
146243486|NCT01523392|527407210|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
146243487|NCT01523392|527407211|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
146243488|NCT03851094|527407214|FG000|Overall Study|Withdrawal by Subject|0|||
146243489|NCT03851094|527407215|FG001|Overall Study|Withdrawal by Subject|1|||
146243490|NCT03851094|527407214|FG000|Overall Study|Participant lost device|0|||
146243491|NCT03851094|527407215|FG001|Overall Study|Participant lost device|1|||
146243492|NCT03851094|527407214|FG000|Overall Study|Participant returned device|0|||
146243493|NCT03851094|527407215|FG001|Overall Study|Participant returned device|2|||
146243494|NCT01332266|527407216|FG000|Phase 1b|Death|3|||
146243495|NCT01332266|527407217|FG001|Phase 1b|Death|3|||
146243496|NCT01332266|527407218|FG002|Phase 1b|Death|2|||
146243497|NCT01332266|527407219|FG003|Phase 1b|Death|0|||
146243498|NCT01332266|527407220|FG004|Phase 1b|Death|0|||
146243499|NCT01332266|527407216|FG000|Phase 1b|Lost to Follow-up|0|||
146243500|NCT01332266|527407217|FG001|Phase 1b|Lost to Follow-up|1|||
146243501|NCT01332266|527407218|FG002|Phase 1b|Lost to Follow-up|0|||
146243502|NCT01332266|527407219|FG003|Phase 1b|Lost to Follow-up|0|||
146243503|NCT01332266|527407220|FG004|Phase 1b|Lost to Follow-up|0|||
146243504|NCT01332266|527407216|FG000|Phase 1b|Withdrawal by Subject|1|||
146243505|NCT01332266|527407217|FG001|Phase 1b|Withdrawal by Subject|1|||
145932416|NCT01314872|526259028|FG003|Period 2|Lack of Efficacy|0|||
145932417|NCT01314872|526259029|FG004|Period 2|Lack of Efficacy|0|||
145932418|NCT01314872|526259030|FG005|Period 2|Lack of Efficacy|0|||
145978234|NCT00479232|526432171|FG005|Overall Study|Physician Decision|1|||
145932419|NCT01314872|526259031|FG006|Period 2|Lack of Efficacy|0|||
146243506|NCT01332266|527407218|FG002|Phase 1b|Withdrawal by Subject|1|||
146243507|NCT01332266|527407219|FG003|Phase 1b|Withdrawal by Subject|0|||
146243508|NCT01332266|527407220|FG004|Phase 1b|Withdrawal by Subject|0|||
146243509|NCT01332266|527407216|FG000|Phase 2|Death|0|||
146243510|NCT01332266|527407217|FG001|Phase 2|Death|0|||
146243511|NCT01332266|527407218|FG002|Phase 2|Death|0|||
146243512|NCT01332266|527407219|FG003|Phase 2|Death|33|||
146243513|NCT01332266|527407220|FG004|Phase 2|Death|36|||
146243514|NCT01332266|527407216|FG000|Phase 2|Lost to Follow-up|0|||
146243515|NCT01332266|527407217|FG001|Phase 2|Lost to Follow-up|0|||
146243516|NCT01332266|527407218|FG002|Phase 2|Lost to Follow-up|0|||
146243517|NCT01332266|527407219|FG003|Phase 2|Lost to Follow-up|2|||
146243518|NCT01332266|527407220|FG004|Phase 2|Lost to Follow-up|0|||
146243519|NCT01332266|527407216|FG000|Phase 2|Physician Decision|0|||
146243520|NCT01332266|527407217|FG001|Phase 2|Physician Decision|0|||
146243521|NCT01332266|527407218|FG002|Phase 2|Physician Decision|0|||
146243522|NCT01332266|527407219|FG003|Phase 2|Physician Decision|3|||
146243523|NCT01332266|527407220|FG004|Phase 2|Physician Decision|1|||
146243524|NCT01332266|527407216|FG000|Phase 2|Symptomatic deterioration|0|||
146243525|NCT01332266|527407217|FG001|Phase 2|Symptomatic deterioration|0|||
146243526|NCT01332266|527407218|FG002|Phase 2|Symptomatic deterioration|0|||
145932420|NCT01314872|526259032|FG007|Period 2|Lack of Efficacy|0|||
145932421|NCT01314872|526259033|FG008|Period 2|Lack of Efficacy|0|||
145932422|NCT01314872|526259034|FG009|Period 2|Lack of Efficacy|0|||
145932423|NCT01314872|526259035|FG010|Period 2|Lack of Efficacy|0|||
146243527|NCT01332266|527407219|FG003|Phase 2|Symptomatic deterioration|0|||
146243528|NCT01332266|527407220|FG004|Phase 2|Symptomatic deterioration|1|||
146243529|NCT01332266|527407216|FG000|Phase 2|Progression Disease|0|||
145932424|NCT01314872|526259036|FG011|Period 2|Lack of Efficacy|7|||
146243530|NCT01332266|527407217|FG001|Phase 2|Progression Disease|0|||
146243531|NCT01332266|527407218|FG002|Phase 2|Progression Disease|0|||
146243532|NCT01332266|527407219|FG003|Phase 2|Progression Disease|2|||
146243533|NCT01332266|527407220|FG004|Phase 2|Progression Disease|1|||
146243534|NCT01332266|527407216|FG000|Phase 2|Withdrawal by Subject|0|||
146243535|NCT01332266|527407217|FG001|Phase 2|Withdrawal by Subject|0|||
146243536|NCT01332266|527407218|FG002|Phase 2|Withdrawal by Subject|0|||
146243537|NCT01332266|527407219|FG003|Phase 2|Withdrawal by Subject|2|||
146243538|NCT01332266|527407220|FG004|Phase 2|Withdrawal by Subject|2|||
146243539|NCT01536704|527407223|FG000|Washout Period 1|Withdrawal by Subject|1|||
146243540|NCT01536704|527407224|FG001|Washout Period 1|Withdrawal by Subject|2|||
146243541|NCT01536704|527407225|FG002|Washout Period 1|Withdrawal by Subject|0|||
146243542|NCT01536704|527407226|FG003|Washout Period 1|Withdrawal by Subject|0|||
146243543|NCT01536704|527407223|FG000|Washout Period 2|Adverse Event|1|||
146243544|NCT01536704|527407224|FG001|Washout Period 2|Adverse Event|0|||
146243545|NCT01536704|527407225|FG002|Washout Period 2|Adverse Event|0|||
146243546|NCT01536704|527407226|FG003|Washout Period 2|Adverse Event|0|||
146243547|NCT01536704|527407223|FG000|Washout Period 2|Withdrawal by Subject|0|||
146243548|NCT01536704|527407224|FG001|Washout Period 2|Withdrawal by Subject|0|||
146243549|NCT01536704|527407225|FG002|Washout Period 2|Withdrawal by Subject|0|||
146243550|NCT01536704|527407226|FG003|Washout Period 2|Withdrawal by Subject|1|||
146243551|NCT01536704|527407223|FG000|Period 3|Adverse Event|0|||
146243552|NCT01536704|527407224|FG001|Period 3|Adverse Event|0|||
146243553|NCT01536704|527407225|FG002|Period 3|Adverse Event|0|||
146243554|NCT01536704|527407226|FG003|Period 3|Adverse Event|1|||
146243555|NCT01536704|527407223|FG000|Washout Period 3|Adverse Event|0|||
146243556|NCT01536704|527407224|FG001|Washout Period 3|Adverse Event|0|||
146243557|NCT01536704|527407225|FG002|Washout Period 3|Adverse Event|1|||
146243558|NCT01536704|527407226|FG003|Washout Period 3|Adverse Event|0|||
146243559|NCT02392507|527407227|FG000|Induction Regimen|Death|3|||
146243560|NCT02392507|527407227|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
146243561|NCT02392507|527407227|FG000|Induction Regimen|Physician Decision|1|||
146243562|NCT02392507|527407227|FG000|Induction Regimen|Withdrawal by Subject|2|||
145932425|NCT01314872|526259037|FG012|Period 2|Lack of Efficacy|12|||
145932426|NCT01314872|526259038|FG013|Period 2|Lack of Efficacy|9|||
146243563|NCT02392507|527407227|FG000|Maintenance Regimen|Death|1|||
146243564|NCT02392507|527407227|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
146243565|NCT01802333|527407228|FG000|Overall Study|Ineligible|2|||
146243566|NCT01802333|527407229|FG001|Overall Study|Ineligible|6|||
146243567|NCT01802333|527407230|FG002|Overall Study|Ineligible|8|||
146243568|NCT01802333|527407228|FG000|Overall Study|Adverse Event|1|||
146243569|NCT01802333|527407229|FG001|Overall Study|Adverse Event|8|||
146243570|NCT01802333|527407230|FG002|Overall Study|Adverse Event|8|||
146243571|NCT01802333|527407228|FG000|Overall Study|Withdrawal by Subject|6|||
146243572|NCT01802333|527407229|FG001|Overall Study|Withdrawal by Subject|6|||
146243573|NCT01802333|527407230|FG002|Overall Study|Withdrawal by Subject|5|||
145932427|NCT01314872|526259039|FG014|Period 2|Lack of Efficacy|2|||
146243574|NCT01802333|527407228|FG000|Overall Study|Progression/relapse|1|||
146243575|NCT01802333|527407229|FG001|Overall Study|Progression/relapse|3|||
146243576|NCT01802333|527407230|FG002|Overall Study|Progression/relapse|0|||
145932428|NCT01314872|526259025|FG000|Period 2|Pregnancy|0|||
145932429|NCT01314872|526259026|FG001|Period 2|Pregnancy|0|||
146243577|NCT01802333|527407228|FG000|Overall Study|Death|7|||
146243578|NCT01802333|527407229|FG001|Overall Study|Death|14|||
146243579|NCT01802333|527407230|FG002|Overall Study|Death|13|||
146243580|NCT01802333|527407228|FG000|Overall Study|Other - not protocol specified|32|||
146243581|NCT01802333|527407229|FG001|Overall Study|Other - not protocol specified|22|||
146243582|NCT01802333|527407230|FG002|Overall Study|Other - not protocol specified|24|||
146243583|NCT01802333|527407228|FG000|Overall Study|Did not start treatment|0|||
146243584|NCT01802333|527407229|FG001|Overall Study|Did not start treatment|2|||
146243585|NCT01802333|527407230|FG002|Overall Study|Did not start treatment|5|||
146243586|NCT02067663|527407232|FG000|Overall Study|Lost to Follow-up|13|||
146243587|NCT02067663|527407233|FG001|Overall Study|Lost to Follow-up|14|||
146243588|NCT00486954|527407238|FG000|Pilot Part|Adverse Event|4|||
146243589|NCT00486954|527407239|FG001|Pilot Part|Adverse Event|0|||
146243590|NCT00486954|527407240|FG002|Pilot Part|Adverse Event|5|||
146243591|NCT00486954|527407241|FG003|Pilot Part|Adverse Event|0|||
146243592|NCT00486954|527407242|FG004|Pilot Part|Adverse Event|0|||
146243593|NCT00486954|527407238|FG000|Pilot Part|Disease Progression|2|||
146243594|NCT00486954|527407239|FG001|Pilot Part|Disease Progression|0|||
146243595|NCT00486954|527407240|FG002|Pilot Part|Disease Progression|1|||
146243596|NCT00486954|527407241|FG003|Pilot Part|Disease Progression|0|||
146243597|NCT00486954|527407242|FG004|Pilot Part|Disease Progression|0|||
146243598|NCT00486954|527407238|FG000|Randomized Part|Lost to Follow-up|0|||
146243599|NCT00486954|527407239|FG001|Randomized Part|Lost to Follow-up|0|||
146243600|NCT00486954|527407240|FG002|Randomized Part|Lost to Follow-up|0|||
146243601|NCT00486954|527407241|FG003|Randomized Part|Lost to Follow-up|0|||
146243602|NCT00486954|527407242|FG004|Randomized Part|Lost to Follow-up|1|||
146243603|NCT00486954|527407238|FG000|Randomized Part|Withdrawal by Subject|0|||
146243604|NCT00486954|527407239|FG001|Randomized Part|Withdrawal by Subject|0|||
146243605|NCT00486954|527407240|FG002|Randomized Part|Withdrawal by Subject|0|||
146243606|NCT00486954|527407241|FG003|Randomized Part|Withdrawal by Subject|1|||
146243607|NCT00486954|527407242|FG004|Randomized Part|Withdrawal by Subject|0|||
146243608|NCT00486954|527407238|FG000|Randomized Part|Sponsor Terminated Study|0|||
146243609|NCT00486954|527407239|FG001|Randomized Part|Sponsor Terminated Study|0|||
146243610|NCT00486954|527407240|FG002|Randomized Part|Sponsor Terminated Study|0|||
146243611|NCT00486954|527407241|FG003|Randomized Part|Sponsor Terminated Study|19|||
146243612|NCT00486954|527407242|FG004|Randomized Part|Sponsor Terminated Study|13|||
146243613|NCT03236779|527407243|FG000|Overall Study|Lost to Follow-up|13|||
146243614|NCT03236779|527407244|FG001|Overall Study|Lost to Follow-up|21|||
146243615|NCT01836523|527407249|FG000|Overall Study|Adverse Event|15|||
146243616|NCT01836523|527407250|FG001|Overall Study|Adverse Event|41|||
145932430|NCT01314872|526259027|FG002|Period 2|Pregnancy|0|||
145932431|NCT01314872|526259028|FG003|Period 2|Pregnancy|0|||
145932432|NCT01314872|526259029|FG004|Period 2|Pregnancy|0|||
145932433|NCT01314872|526259030|FG005|Period 2|Pregnancy|0|||
145932434|NCT01314872|526259031|FG006|Period 2|Pregnancy|0|||
145932435|NCT01314872|526259032|FG007|Period 2|Pregnancy|0|||
145932436|NCT01314872|526259033|FG008|Period 2|Pregnancy|0|||
145932437|NCT01314872|526259034|FG009|Period 2|Pregnancy|0|||
145932438|NCT01314872|526259035|FG010|Period 2|Pregnancy|0|||
145932439|NCT01314872|526259036|FG011|Period 2|Pregnancy|0|||
145932440|NCT01314872|526259037|FG012|Period 2|Pregnancy|0|||
145932441|NCT01314872|526259038|FG013|Period 2|Pregnancy|0|||
145932442|NCT01314872|526259039|FG014|Period 2|Pregnancy|1|||
145932443|NCT01314872|526259025|FG000|Period 2|Study terminated by Sponsor|0|||
145932444|NCT01314872|526259026|FG001|Period 2|Study terminated by Sponsor|0|||
145932445|NCT01314872|526259027|FG002|Period 2|Study terminated by Sponsor|0|||
145932446|NCT01314872|526259028|FG003|Period 2|Study terminated by Sponsor|0|||
145932447|NCT01314872|526259029|FG004|Period 2|Study terminated by Sponsor|0|||
145932448|NCT01314872|526259030|FG005|Period 2|Study terminated by Sponsor|0|||
145932449|NCT01314872|526259031|FG006|Period 2|Study terminated by Sponsor|0|||
145932450|NCT01314872|526259032|FG007|Period 2|Study terminated by Sponsor|0|||
145932451|NCT01314872|526259033|FG008|Period 2|Study terminated by Sponsor|0|||
145932452|NCT01314872|526259034|FG009|Period 2|Study terminated by Sponsor|0|||
145932453|NCT01314872|526259035|FG010|Period 2|Study terminated by Sponsor|0|||
145932454|NCT01314872|526259036|FG011|Period 2|Study terminated by Sponsor|2|||
145932455|NCT01314872|526259037|FG012|Period 2|Study terminated by Sponsor|2|||
145932456|NCT01314872|526259038|FG013|Period 2|Study terminated by Sponsor|3|||
145932457|NCT01314872|526259039|FG014|Period 2|Study terminated by Sponsor|0|||
145978235|NCT00479232|526432166|FG000|Overall Study|Progressive Disease|3|||
145978236|NCT00479232|526432167|FG001|Overall Study|Progressive Disease|1|||
146243617|NCT01836523|527407251|FG002|Overall Study|Adverse Event|49|||
146243618|NCT01836523|527407252|FG003|Overall Study|Adverse Event|14|||
145932458|NCT01314872|526259025|FG000|Period 2|Adverse event, non-fatal|0|||
145932459|NCT01314872|526259026|FG001|Period 2|Adverse event, non-fatal|0|||
145932460|NCT01314872|526259027|FG002|Period 2|Adverse event, non-fatal|0|||
145932461|NCT01314872|526259028|FG003|Period 2|Adverse event, non-fatal|0|||
145932462|NCT01314872|526259029|FG004|Period 2|Adverse event, non-fatal|0|||
146243619|NCT01836523|527407249|FG000|Overall Study|Protocol Violation|6|||
145932463|NCT01314872|526259030|FG005|Period 2|Adverse event, non-fatal|0|||
145978237|NCT00479232|526432168|FG002|Overall Study|Progressive Disease|12|||
146243620|NCT01836523|527407250|FG001|Overall Study|Protocol Violation|3|||
146243621|NCT01836523|527407251|FG002|Overall Study|Protocol Violation|2|||
146243622|NCT01836523|527407252|FG003|Overall Study|Protocol Violation|4|||
146243623|NCT01836523|527407249|FG000|Overall Study|Met Withdrawal Criteria|13|||
146243624|NCT01836523|527407250|FG001|Overall Study|Met Withdrawal Criteria|13|||
146243625|NCT01836523|527407251|FG002|Overall Study|Met Withdrawal Criteria|21|||
146243626|NCT01836523|527407252|FG003|Overall Study|Met Withdrawal Criteria|27|||
145932464|NCT01314872|526259031|FG006|Period 2|Adverse event, non-fatal|0|||
145932465|NCT01314872|526259032|FG007|Period 2|Adverse event, non-fatal|0|||
145932466|NCT01314872|526259033|FG008|Period 2|Adverse event, non-fatal|0|||
145932467|NCT01314872|526259034|FG009|Period 2|Adverse event, non-fatal|0|||
145932468|NCT01314872|526259035|FG010|Period 2|Adverse event, non-fatal|0|||
145932469|NCT01314872|526259036|FG011|Period 2|Adverse event, non-fatal|13|||
145932470|NCT01314872|526259037|FG012|Period 2|Adverse event, non-fatal|16|||
145932471|NCT01314872|526259038|FG013|Period 2|Adverse event, non-fatal|24|||
145932472|NCT01314872|526259039|FG014|Period 2|Adverse event, non-fatal|9|||
145932473|NCT01314872|526259025|FG000|Period 2|Withdrawal by Subject|0|||
145932474|NCT01314872|526259026|FG001|Period 2|Withdrawal by Subject|0|||
145932475|NCT01314872|526259027|FG002|Period 2|Withdrawal by Subject|0|||
145932476|NCT01314872|526259028|FG003|Period 2|Withdrawal by Subject|0|||
145932477|NCT01314872|526259029|FG004|Period 2|Withdrawal by Subject|0|||
145932478|NCT01314872|526259030|FG005|Period 2|Withdrawal by Subject|0|||
145932479|NCT01314872|526259031|FG006|Period 2|Withdrawal by Subject|0|||
145932480|NCT01314872|526259032|FG007|Period 2|Withdrawal by Subject|0|||
145932481|NCT01314872|526259033|FG008|Period 2|Withdrawal by Subject|0|||
145932482|NCT01314872|526259034|FG009|Period 2|Withdrawal by Subject|0|||
145932483|NCT01314872|526259035|FG010|Period 2|Withdrawal by Subject|0|||
145932484|NCT01314872|526259036|FG011|Period 2|Withdrawal by Subject|14|||
145932485|NCT01314872|526259037|FG012|Period 2|Withdrawal by Subject|17|||
145932486|NCT01314872|526259038|FG013|Period 2|Withdrawal by Subject|12|||
145932487|NCT01314872|526259039|FG014|Period 2|Withdrawal by Subject|4|||
145932488|NCT01314872|526259025|FG000|Period 2|Lost to Follow-up|0|||
145932489|NCT01314872|526259026|FG001|Period 2|Lost to Follow-up|0|||
145932490|NCT01314872|526259027|FG002|Period 2|Lost to Follow-up|0|||
145932491|NCT01314872|526259028|FG003|Period 2|Lost to Follow-up|0|||
145932492|NCT01314872|526259029|FG004|Period 2|Lost to Follow-up|0|||
145932493|NCT01314872|526259030|FG005|Period 2|Lost to Follow-up|0|||
145932494|NCT01314872|526259031|FG006|Period 2|Lost to Follow-up|0|||
145932495|NCT01314872|526259032|FG007|Period 2|Lost to Follow-up|0|||
145932496|NCT01314872|526259033|FG008|Period 2|Lost to Follow-up|0|||
145932497|NCT01314872|526259034|FG009|Period 2|Lost to Follow-up|0|||
146243627|NCT01836523|527407249|FG000|Overall Study|Unclassified|17|||
146243628|NCT01836523|527407250|FG001|Overall Study|Unclassified|28|||
146243629|NCT01836523|527407251|FG002|Overall Study|Unclassified|19|||
146243630|NCT01836523|527407252|FG003|Overall Study|Unclassified|29|||
146243631|NCT04070105|527407256|FG000|Overall Study|Lost to Follow-up|0|||
146243632|NCT04070105|527407257|FG001|Overall Study|Lost to Follow-up|0|||
146243633|NCT04070105|527407258|FG002|Overall Study|Lost to Follow-up|0|||
146243634|NCT04070105|527407259|FG003|Overall Study|Lost to Follow-up|0|||
146243635|NCT04070105|527407260|FG004|Overall Study|Lost to Follow-up|0|||
146243636|NCT04070105|527407261|FG005|Overall Study|Lost to Follow-up|1|||
146243637|NCT03909100|527407262|FG000|Overall Study|Protocol Deviation|2|||
146243638|NCT03909100|527407262|FG000|Overall Study|Technical Problems|4|||
146243639|NCT03909100|527407262|FG000|Overall Study|Withdrawal by Subject|4|||
146243640|NCT03909100|527407262|FG000|Overall Study|Lost to Follow-up|1|||
146243641|NCT03909100|527407262|FG000|Overall Study|Reason not Specified|4|||
146243642|NCT03259568|527407263|FG000|Overall Study|Participant performance was low|3|||
146243643|NCT04248868|527407266|FG000|Overall Study|Death|1|||
146243644|NCT04248868|527407266|FG000|Overall Study|Lost to Follow-up|3|||
146243645|NCT04248868|527407266|FG000|Overall Study|Protocol Violation|2|||
146243646|NCT03128099|527407267|FG000|Overall Study|High dose task was too long|0|||
146243647|NCT03128099|527407268|FG001|Overall Study|High dose task was too long|4|||
146243648|NCT03128099|527407269|FG002|Overall Study|High dose task was too long|0|||
146243649|NCT03128099|527407267|FG000|Overall Study|Participant got a full time job.|1|||
146243650|NCT03128099|527407268|FG001|Overall Study|Participant got a full time job.|0|||
146243651|NCT03128099|527407269|FG002|Overall Study|Participant got a full time job.|0|||
146243652|NCT03128099|527407267|FG000|Overall Study|Became homeless and lost contact|1|||
146243653|NCT03128099|527407268|FG001|Overall Study|Became homeless and lost contact|0|||
146243654|NCT03128099|527407269|FG002|Overall Study|Became homeless and lost contact|0|||
146243655|NCT03128099|527407267|FG000|Overall Study|Did not complete all the assessments|0|||
145932498|NCT01314872|526259035|FG010|Period 2|Lost to Follow-up|0|||
145932499|NCT01314872|526259036|FG011|Period 2|Lost to Follow-up|6|||
145932500|NCT01314872|526259037|FG012|Period 2|Lost to Follow-up|7|||
145932501|NCT01314872|526259038|FG013|Period 2|Lost to Follow-up|2|||
145932502|NCT01314872|526259039|FG014|Period 2|Lost to Follow-up|6|||
145932503|NCT01399047|526260297|FG000|Overall Study|Withdrawal by Subject|0|||
145932504|NCT01399047|526260298|FG001|Overall Study|Withdrawal by Subject|1|||
145932505|NCT03652636|526260306|FG000|Overall Study|Withdrawal by Subject|7|||
145932506|NCT01806961|526260308|FG000|Overall Study|sponsor decision|16|||
145932507|NCT00679029|526260311|FG000|Overall Study|Adverse Event|3|||
146243656|NCT03128099|527407268|FG001|Overall Study|Did not complete all the assessments|0|||
146243657|NCT03128099|527407269|FG002|Overall Study|Did not complete all the assessments|1|||
146243658|NCT00148122|527407270|FG000|Overall Study|Withdrawal by Subject|2|||
146243659|NCT00274287|527407273|FG000|Overall Study|Withdrawal by Subject|1|||
146243660|NCT00274287|527407273|FG000|Overall Study|subject non-compliance|1|||
146243661|NCT03200574|527407274|FG000|Overall Study|Death|4|||
146243662|NCT03200574|527407274|FG000|Overall Study|Withdrawal by Subject|8|||
146243663|NCT03200574|527407274|FG000|Overall Study|Long-Term need for anticoagulation|1|||
146243664|NCT03200574|527407274|FG000|Overall Study|Relocation|2|||
146243665|NCT03200574|527407274|FG000|Overall Study|Lost to Follow-up|2|||
146243666|NCT00705159|527407278|FG000|Overall Study|Withdrawal by Subject|0|||
146243667|NCT00705159|527407279|FG001|Overall Study|Withdrawal by Subject|1|||
146243668|NCT00705159|527407280|FG002|Overall Study|Withdrawal by Subject|1|||
146243669|NCT00705159|527407281|FG003|Overall Study|Withdrawal by Subject|1|||
146243670|NCT00705159|527407278|FG000|Overall Study|Protocol Violation|0|||
146243671|NCT00705159|527407279|FG001|Overall Study|Protocol Violation|1|||
146243672|NCT00705159|527407280|FG002|Overall Study|Protocol Violation|0|||
146243673|NCT00705159|527407281|FG003|Overall Study|Protocol Violation|0|||
146243674|NCT00705159|527407278|FG000|Overall Study|Adverse Event|0|||
146243675|NCT00705159|527407279|FG001|Overall Study|Adverse Event|0|||
146243676|NCT00705159|527407280|FG002|Overall Study|Adverse Event|1|||
146243677|NCT00705159|527407281|FG003|Overall Study|Adverse Event|0|||
146243678|NCT00705159|527407278|FG000|Overall Study|Lost to Follow-up|0|||
146243679|NCT00705159|527407279|FG001|Overall Study|Lost to Follow-up|0|||
146243680|NCT00705159|527407280|FG002|Overall Study|Lost to Follow-up|3|||
146243681|NCT00705159|527407281|FG003|Overall Study|Lost to Follow-up|2|||
146243682|NCT00705159|527407278|FG000|Overall Study|Screen Failure|0|||
146243683|NCT00705159|527407279|FG001|Overall Study|Screen Failure|0|||
146243684|NCT00705159|527407280|FG002|Overall Study|Screen Failure|0|||
146243685|NCT00705159|527407281|FG003|Overall Study|Screen Failure|1|||
146243686|NCT03035942|527407282|FG000|Overall Study|Adverse Event|8|||
146243687|NCT03035942|527407283|FG001|Overall Study|Adverse Event|4|||
146243688|NCT03035942|527407284|FG002|Overall Study|Adverse Event|5|||
146243689|NCT02538094|527407285|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
146243690|NCT02538094|527407286|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
146243691|NCT02538094|527407285|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
146243692|NCT02538094|527407286|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
146243693|NCT01989104|527407287|FG000|Overall Study|Withdrawal by Subject|3|||
146243694|NCT01989104|527407288|FG001|Overall Study|Withdrawal by Subject|0|||
146243695|NCT01989104|527407289|FG002|Overall Study|Withdrawal by Subject|0|||
146243696|NCT01989104|527407290|FG003|Overall Study|Withdrawal by Subject|0|||
146243697|NCT01989104|527407291|FG004|Overall Study|Withdrawal by Subject|0|||
146243698|NCT00680771|527407292|FG000|Overall Study|Withdrawal by Subject|1|||
146243699|NCT00680771|527407293|FG001|Overall Study|Withdrawal by Subject|0|||
146243700|NCT00680771|527407292|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
146243701|NCT00680771|527407293|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
146243702|NCT00680771|527407292|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
146243703|NCT00680771|527407293|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
146243704|NCT02691702|527407294|FG000|Overall Study|Adverse Event|1|||
146243705|NCT02691702|527407295|FG001|Overall Study|Adverse Event|0|||
146243706|NCT02691702|527407296|FG002|Overall Study|Adverse Event|0|||
146243707|NCT02691702|527407297|FG003|Overall Study|Adverse Event|0|||
146243708|NCT02691702|527407298|FG004|Overall Study|Adverse Event|0|||
146243709|NCT02691702|527407299|FG005|Overall Study|Adverse Event|0|||
146243710|NCT02691702|527407300|FG006|Overall Study|Adverse Event|0|||
146243711|NCT02691702|527407301|FG007|Overall Study|Adverse Event|0|||
146243712|NCT02691702|527407302|FG008|Overall Study|Adverse Event|1|||
146243713|NCT02691702|527407303|FG009|Overall Study|Adverse Event|0|||
146243714|NCT02691702|527407304|FG010|Overall Study|Adverse Event|1|||
146243715|NCT02691702|527407294|FG000|Overall Study|Lost to Follow-up|0|||
146297785|NCT01431534|527605995|FG000|Treatment Phase|Progressive Disease|4|||
146297786|NCT01431534|527605996|FG001|Treatment Phase|Progressive Disease|3|||
145978238|NCT00479232|526432169|FG003|Overall Study|Progressive Disease|3|||
145978239|NCT00479232|526432170|FG004|Overall Study|Progressive Disease|3|||
145978240|NCT00479232|526432171|FG005|Overall Study|Progressive Disease|12|||
145978241|NCT00479232|526432166|FG000|Overall Study|Withdrew Consent|0|||
146243716|NCT02691702|527407295|FG001|Overall Study|Lost to Follow-up|0|||
146243717|NCT02691702|527407296|FG002|Overall Study|Lost to Follow-up|1|||
146243718|NCT02691702|527407297|FG003|Overall Study|Lost to Follow-up|0|||
146297787|NCT01431534|527605997|FG002|Treatment Phase|Progressive Disease|10|||
145978242|NCT00479232|526432167|FG001|Overall Study|Withdrew Consent|2|||
146243719|NCT02691702|527407298|FG004|Overall Study|Lost to Follow-up|0|||
146243720|NCT02691702|527407299|FG005|Overall Study|Lost to Follow-up|2|||
146243721|NCT02691702|527407300|FG006|Overall Study|Lost to Follow-up|0|||
146243722|NCT02691702|527407301|FG007|Overall Study|Lost to Follow-up|0|||
146243723|NCT02691702|527407302|FG008|Overall Study|Lost to Follow-up|0|||
146297788|NCT01009554|527605998|FG000|Overall Study|Adverse Event|1|||
146297789|NCT01009554|527605999|FG001|Overall Study|Adverse Event|1|||
146090981|NCT01058265|526854850|FG000|Overall Study|Lost to Follow-up|11|||
146090982|NCT01058265|526854851|FG001|Overall Study|Lost to Follow-up|12|||
146090983|NCT02869438|526854852|FG000|Overall Study|Lost to Follow-up|1|||
146090984|NCT02869438|526854853|FG001|Overall Study|Lost to Follow-up|0|||
146243724|NCT02691702|527407303|FG009|Overall Study|Lost to Follow-up|0|||
146243725|NCT02691702|527407304|FG010|Overall Study|Lost to Follow-up|1|||
146243726|NCT02691702|527407294|FG000|Overall Study|Withdrawal by Subject|1|||
146243727|NCT02691702|527407295|FG001|Overall Study|Withdrawal by Subject|1|||
146243728|NCT02691702|527407296|FG002|Overall Study|Withdrawal by Subject|0|||
146243729|NCT02691702|527407297|FG003|Overall Study|Withdrawal by Subject|0|||
146243730|NCT02691702|527407298|FG004|Overall Study|Withdrawal by Subject|0|||
146243731|NCT02691702|527407299|FG005|Overall Study|Withdrawal by Subject|1|||
146243732|NCT02691702|527407300|FG006|Overall Study|Withdrawal by Subject|2|||
146243733|NCT02691702|527407301|FG007|Overall Study|Withdrawal by Subject|0|||
146243734|NCT02691702|527407302|FG008|Overall Study|Withdrawal by Subject|0|||
146243735|NCT02691702|527407303|FG009|Overall Study|Withdrawal by Subject|0|||
146243736|NCT02691702|527407304|FG010|Overall Study|Withdrawal by Subject|0|||
146243737|NCT02691702|527407294|FG000|Overall Study|Other|0|||
146243738|NCT02691702|527407295|FG001|Overall Study|Other|0|||
146243739|NCT02691702|527407296|FG002|Overall Study|Other|0|||
146243740|NCT02691702|527407297|FG003|Overall Study|Other|0|||
146243741|NCT02691702|527407298|FG004|Overall Study|Other|0|||
146243742|NCT02691702|527407299|FG005|Overall Study|Other|0|||
146243743|NCT02691702|527407300|FG006|Overall Study|Other|1|||
146243744|NCT02691702|527407301|FG007|Overall Study|Other|0|||
146243745|NCT02691702|527407302|FG008|Overall Study|Other|1|||
146243746|NCT02691702|527407303|FG009|Overall Study|Other|0|||
146243747|NCT02691702|527407304|FG010|Overall Study|Other|0|||
146090985|NCT02869438|526854852|FG000|Overall Study|Adverse Event|1|||
146090986|NCT02869438|526854853|FG001|Overall Study|Adverse Event|0|||
146090987|NCT02869438|526854852|FG000|Overall Study|Withdrawal by Subject|1|||
146090988|NCT02869438|526854853|FG001|Overall Study|Withdrawal by Subject|2|||
146090989|NCT02964507|526854854|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090990|NCT02964507|526854855|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
146090991|NCT02964507|526854856|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090992|NCT02964507|526854857|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090993|NCT02964507|526854858|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
146090994|NCT02964507|526854859|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090995|NCT02964507|526854860|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090996|NCT02964507|526854861|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
146090997|NCT02964507|526854854|FG000|Overall Study|Study terminated by Sponsor|9|||
146090998|NCT02964507|526854855|FG001|Overall Study|Study terminated by Sponsor|1|||
146243748|NCT02691702|527407294|FG000|Overall Study|Protocol Violation|0|||
146243749|NCT02691702|527407295|FG001|Overall Study|Protocol Violation|0|||
146243750|NCT02691702|527407296|FG002|Overall Study|Protocol Violation|0|||
146090999|NCT02964507|526854856|FG002|Overall Study|Study terminated by Sponsor|9|||
146091000|NCT02964507|526854857|FG003|Overall Study|Study terminated by Sponsor|3|||
146091001|NCT02964507|526854858|FG004|Overall Study|Study terminated by Sponsor|3|||
146091002|NCT02964507|526854859|FG005|Overall Study|Study terminated by Sponsor|2|||
146091003|NCT02964507|526854860|FG006|Overall Study|Study terminated by Sponsor|0|||
146091004|NCT02964507|526854861|FG007|Overall Study|Study terminated by Sponsor|0|||
146091005|NCT02964507|526854854|FG000|Overall Study|Other|3|||
146091006|NCT02964507|526854855|FG001|Overall Study|Other|0|||
146091007|NCT02964507|526854856|FG002|Overall Study|Other|0|||
146091008|NCT02964507|526854857|FG003|Overall Study|Other|0|||
146091009|NCT02964507|526854858|FG004|Overall Study|Other|1|||
146091010|NCT02964507|526854859|FG005|Overall Study|Other|0|||
146091011|NCT02964507|526854860|FG006|Overall Study|Other|0|||
146091012|NCT02964507|526854861|FG007|Overall Study|Other|0|||
146091013|NCT02964507|526854854|FG000|Overall Study|Death|11|||
146091014|NCT02964507|526854855|FG001|Overall Study|Death|9|||
146243751|NCT02691702|527407297|FG003|Overall Study|Protocol Violation|0|||
146243752|NCT02691702|527407298|FG004|Overall Study|Protocol Violation|0|||
146243753|NCT02691702|527407299|FG005|Overall Study|Protocol Violation|0|||
146243754|NCT02691702|527407300|FG006|Overall Study|Protocol Violation|0|||
146243755|NCT02691702|527407301|FG007|Overall Study|Protocol Violation|0|||
146243756|NCT02691702|527407302|FG008|Overall Study|Protocol Violation|0|||
146243757|NCT02691702|527407303|FG009|Overall Study|Protocol Violation|2|||
146243758|NCT02691702|527407304|FG010|Overall Study|Protocol Violation|0|||
146243759|NCT03652610|527407305|FG000|Overall Study|Lost to Follow-up|1|||
146091015|NCT02964507|526854856|FG002|Overall Study|Death|12|||
146091016|NCT02964507|526854857|FG003|Overall Study|Death|2|||
146091017|NCT02964507|526854858|FG004|Overall Study|Death|10|||
146091018|NCT02964507|526854859|FG005|Overall Study|Death|5|||
146091019|NCT02964507|526854860|FG006|Overall Study|Death|0|||
146091020|NCT02964507|526854861|FG007|Overall Study|Death|0|||
146091021|NCT02964507|526854854|FG000|Overall Study|Withdrawal by Subject|1|||
146091022|NCT02964507|526854855|FG001|Overall Study|Withdrawal by Subject|0|||
146243760|NCT03652610|527407306|FG001|Overall Study|Lost to Follow-up|0|||
146243761|NCT03652610|527407305|FG000|Overall Study|Withdrawal by Subject|3|||
146243762|NCT03652610|527407306|FG001|Overall Study|Withdrawal by Subject|5|||
145932508|NCT00679029|526260311|FG000|Overall Study|Withdrawal by Subject|1|||
145932509|NCT00679029|526260311|FG000|Overall Study|Lost to Follow-up|1|||
145932510|NCT00769067|526260315|FG000|Overall Study|Death|89|||
145932511|NCT00769067|526260316|FG001|Overall Study|Death|86|||
145932512|NCT00769067|526260315|FG000|Overall Study|Lost to Follow-up|3|||
145932513|NCT00769067|526260316|FG001|Overall Study|Lost to Follow-up|1|||
145932514|NCT00769067|526260315|FG000|Overall Study|Study terminated by sponsor|1|||
145932515|NCT00769067|526260316|FG001|Overall Study|Study terminated by sponsor|3|||
145932516|NCT00769067|526260315|FG000|Overall Study|Other|1|||
145932517|NCT00769067|526260316|FG001|Overall Study|Other|3|||
145932518|NCT00769067|526260315|FG000|Overall Study|Withdrawal by Subject|0|||
145932519|NCT00769067|526260316|FG001|Overall Study|Withdrawal by Subject|1|||
145932520|NCT00809471|526260320|FG000|Overall Study|Protocol non-compliance|15|||
145932521|NCT00809471|526260321|FG001|Overall Study|Protocol non-compliance|15|||
145932522|NCT00809471|526260322|FG002|Overall Study|Protocol non-compliance|6|||
145932523|NCT00809471|526260320|FG000|Overall Study|Lost to Follow-up|4|||
145932524|NCT00809471|526260321|FG001|Overall Study|Lost to Follow-up|2|||
145932525|NCT00809471|526260322|FG002|Overall Study|Lost to Follow-up|9|||
145932526|NCT00809471|526260320|FG000|Overall Study|Adverse Event|0|||
145932527|NCT00809471|526260321|FG001|Overall Study|Adverse Event|2|||
145932528|NCT00809471|526260322|FG002|Overall Study|Adverse Event|2|||
145932529|NCT00809471|526260320|FG000|Overall Study|Requirement for restricted medication|1|||
145932530|NCT00809471|526260321|FG001|Overall Study|Requirement for restricted medication|1|||
145932531|NCT00809471|526260322|FG002|Overall Study|Requirement for restricted medication|0|||
145932532|NCT00831311|526260323|FG000|Overall Study|Definitive Contraindication|3|||
145932533|NCT00831311|526260324|FG001|Overall Study|Definitive Contraindication|3|||
145932534|NCT00831311|526260323|FG000|Overall Study|Lost to Follow-up|3|||
145932535|NCT00831311|526260324|FG001|Overall Study|Lost to Follow-up|0|||
145932536|NCT00831311|526260323|FG000|Overall Study|Physician Decision|0|||
145932537|NCT00831311|526260324|FG001|Overall Study|Physician Decision|1|||
145932538|NCT00831311|526260323|FG000|Overall Study|Withdrawal by Subject|6|||
145932539|NCT00831311|526260324|FG001|Overall Study|Withdrawal by Subject|4|||
145932540|NCT00160706|526260330|FG000|Overall Study|Adverse Event|53|||
145932541|NCT00160706|526260330|FG000|Overall Study|Adverse Event and Other Reason|105|||
145932542|NCT00160706|526260330|FG000|Overall Study|Protocol Violation|3|||
145932543|NCT00160706|526260330|FG000|Overall Study|Withdrawal by Subject|41|||
145932544|NCT00160706|526260330|FG000|Overall Study|Withdrawal by Subject and Other|12|||
145932545|NCT00160706|526260330|FG000|Overall Study|Physician Decision|10|||
145932546|NCT00160706|526260330|FG000|Overall Study|Physician Decision and Other|3|||
145932547|NCT00160706|526260330|FG000|Overall Study|Lost to Follow-up|4|||
145932548|NCT00160706|526260330|FG000|Overall Study|Lost to Follow-up and Other|1|||
145932549|NCT00160706|526260330|FG000|Overall Study|Lack of Efficacy|42|||
145932550|NCT00160706|526260330|FG000|Overall Study|Lack of Efficacy and Other|1|||
145932551|NCT00160706|526260330|FG000|Overall Study|Other Reason|11|||
145932552|NCT03214380|526260331|FG000|Lead-in|Adverse Event|3|||
145932553|NCT03214380|526260332|FG001|Lead-in|Adverse Event|0|||
145932554|NCT03214380|526260333|FG002|Lead-in|Adverse Event|0|||
145932555|NCT03214380|526260334|FG003|Lead-in|Adverse Event|1|||
145932556|NCT03214380|526260335|FG004|Lead-in|Adverse Event|0|||
145932557|NCT03214380|526260336|FG005|Lead-in|Adverse Event|0|||
145932558|NCT03214380|526260331|FG000|Lead-in|Lost to Follow-up|4|||
145932559|NCT03214380|526260332|FG001|Lead-in|Lost to Follow-up|0|||
145932560|NCT03214380|526260333|FG002|Lead-in|Lost to Follow-up|0|||
145932561|NCT03214380|526260334|FG003|Lead-in|Lost to Follow-up|1|||
145932562|NCT03214380|526260335|FG004|Lead-in|Lost to Follow-up|0|||
145932563|NCT03214380|526260336|FG005|Lead-in|Lost to Follow-up|0|||
145932564|NCT03214380|526260331|FG000|Lead-in|Eligibility Criteria|3|||
145932565|NCT03214380|526260332|FG001|Lead-in|Eligibility Criteria|0|||
145932566|NCT03214380|526260333|FG002|Lead-in|Eligibility Criteria|0|||
145932567|NCT03214380|526260334|FG003|Lead-in|Eligibility Criteria|0|||
145932568|NCT03214380|526260335|FG004|Lead-in|Eligibility Criteria|0|||
145932569|NCT03214380|526260336|FG005|Lead-in|Eligibility Criteria|0|||
145932570|NCT03214380|526260331|FG000|Lead-in|Physician Decision|6|||
145932571|NCT03214380|526260332|FG001|Lead-in|Physician Decision|0|||
145932572|NCT03214380|526260333|FG002|Lead-in|Physician Decision|0|||
145932573|NCT03214380|526260334|FG003|Lead-in|Physician Decision|0|||
145932574|NCT03214380|526260335|FG004|Lead-in|Physician Decision|0|||
145932575|NCT03214380|526260336|FG005|Lead-in|Physician Decision|0|||
145932576|NCT03214380|526260331|FG000|Lead-in|Protocol Deviation|7|||
145932577|NCT03214380|526260332|FG001|Lead-in|Protocol Deviation|0|||
145932578|NCT03214380|526260333|FG002|Lead-in|Protocol Deviation|0|||
145932579|NCT03214380|526260334|FG003|Lead-in|Protocol Deviation|3|||
145932580|NCT03214380|526260335|FG004|Lead-in|Protocol Deviation|0|||
145932581|NCT03214380|526260336|FG005|Lead-in|Protocol Deviation|0|||
146243763|NCT01860079|527407307|FG000|Overall Study|Physician Decision|14|||
146243764|NCT01860079|527407308|FG001|Overall Study|Physician Decision|22|||
145932582|NCT03214380|526260331|FG000|Lead-in|Withdrawal by Subject|41|||
145932583|NCT03214380|526260332|FG001|Lead-in|Withdrawal by Subject|0|||
145932584|NCT03214380|526260333|FG002|Lead-in|Withdrawal by Subject|0|||
145978243|NCT00479232|526432168|FG002|Overall Study|Withdrew Consent|6|||
145978244|NCT00479232|526432169|FG003|Overall Study|Withdrew Consent|0|||
145978245|NCT00479232|526432170|FG004|Overall Study|Withdrew Consent|1|||
145978246|NCT00479232|526432171|FG005|Overall Study|Withdrew Consent|3|||
145978247|NCT05399771|526432172|FG000|Overall Study|Physician Decision|3|||
145978248|NCT05399771|526432172|FG000|Overall Study|Adverse Event|1|||
145978249|NCT01373229|526432173|FG000|Overall Study|Death|3|||
145978250|NCT01373229|526432173|FG000|Overall Study|Physician Decision|3|||
145978251|NCT00484159|526432176|FG000|Overall Study|Lost to Follow-up|1|||
145978252|NCT00484159|526432177|FG001|Overall Study|Lost to Follow-up|1|||
145978253|NCT00484159|526432178|FG002|Overall Study|Lost to Follow-up|0|||
145978254|NCT04766333|526432179|FG000|Overall Study|Lost to Follow-up|40|||
145978255|NCT04766333|526432180|FG001|Overall Study|Lost to Follow-up|826|||
145978256|NCT03234881|526432181|FG000|Overall Study|Lost to Follow-up|9|||
145978257|NCT03234881|526432182|FG001|Overall Study|Lost to Follow-up|3|||
145978258|NCT03807843|526432183|FG000|Overall Study|Lost to Follow-up|1|||
145978259|NCT03807843|526432184|FG001|Overall Study|Lost to Follow-up|0|||
145978260|NCT01312129|526432185|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
145978261|NCT01312129|526432186|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
145978262|NCT03720847|526432187|FG000|Washout|Physician Decision|1|||
145978263|NCT03720847|526432188|FG001|Washout|Physician Decision|2|||
145978264|NCT01797185|526432193|FG000|Overall Study|Adverse Event|5|||
145978265|NCT01797185|526432194|FG001|Overall Study|Adverse Event|15|||
145978266|NCT01797185|526432195|FG002|Overall Study|Adverse Event|6|||
145978267|NCT01797185|526432193|FG000|Overall Study|Withdrawal by Subject|6|||
145978268|NCT01797185|526432194|FG001|Overall Study|Withdrawal by Subject|9|||
145978269|NCT01797185|526432195|FG002|Overall Study|Withdrawal by Subject|5|||
145978270|NCT01797185|526432193|FG000|Overall Study|Site terminated|8|||
145978271|NCT01797185|526432194|FG001|Overall Study|Site terminated|4|||
145978272|NCT01797185|526432195|FG002|Overall Study|Site terminated|0|||
145978273|NCT01797185|526432193|FG000|Overall Study|Lost to Follow-up|2|||
145978274|NCT01797185|526432194|FG001|Overall Study|Lost to Follow-up|6|||
145978275|NCT01797185|526432195|FG002|Overall Study|Lost to Follow-up|1|||
145978276|NCT01797185|526432193|FG000|Overall Study|Withdrawn per sponsor|5|||
145978277|NCT01797185|526432194|FG001|Overall Study|Withdrawn per sponsor|0|||
145978278|NCT01797185|526432195|FG002|Overall Study|Withdrawn per sponsor|0|||
145978279|NCT01797185|526432193|FG000|Overall Study|Physician Decision|1|||
145978280|NCT01797185|526432194|FG001|Overall Study|Physician Decision|3|||
145978281|NCT01797185|526432195|FG002|Overall Study|Physician Decision|0|||
145978282|NCT01797185|526432193|FG000|Overall Study|Protocol Violation|1|||
145978283|NCT01797185|526432194|FG001|Overall Study|Protocol Violation|1|||
145978284|NCT01797185|526432195|FG002|Overall Study|Protocol Violation|0|||
145978285|NCT01047501|526432197|FG000|Overall Study|Adverse Event|7|||
145978286|NCT01047501|526432198|FG001|Overall Study|Adverse Event|8|||
145978287|NCT01047501|526432199|FG002|Overall Study|Adverse Event|5|||
145978288|NCT01047501|526432197|FG000|Overall Study|Withdrew Consent|6|||
145978289|NCT01047501|526432198|FG001|Overall Study|Withdrew Consent|2|||
145978290|NCT01047501|526432199|FG002|Overall Study|Withdrew Consent|4|||
145978291|NCT01047501|526432197|FG000|Overall Study|Lost to Follow-up|0|||
145978292|NCT01047501|526432198|FG001|Overall Study|Lost to Follow-up|1|||
145978293|NCT01047501|526432199|FG002|Overall Study|Lost to Follow-up|1|||
145978294|NCT01047501|526432197|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
145978295|NCT01047501|526432198|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
145978296|NCT01047501|526432199|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
145978297|NCT01047501|526432197|FG000|Overall Study|Death|1|||
145978298|NCT01047501|526432198|FG001|Overall Study|Death|0|||
145978299|NCT01047501|526432199|FG002|Overall Study|Death|0|||
145978300|NCT01047501|526432197|FG000|Overall Study|Other discontinuation|1|||
145978301|NCT01047501|526432198|FG001|Overall Study|Other discontinuation|0|||
145978302|NCT01047501|526432199|FG002|Overall Study|Other discontinuation|1|||
145978303|NCT01047501|526432197|FG000|Overall Study|Investigator judgement|0|||
145978304|NCT01047501|526432198|FG001|Overall Study|Investigator judgement|0|||
145978305|NCT01047501|526432199|FG002|Overall Study|Investigator judgement|1|||
145978306|NCT04602000|526432200|FG000|Overall Study|Withdrawal by Subject|3|||
145978307|NCT04602000|526432201|FG001|Overall Study|Withdrawal by Subject|6|||
145978308|NCT04602000|526432202|FG002|Overall Study|Withdrawal by Subject|3|||
145978309|NCT04602000|526432203|FG003|Overall Study|Withdrawal by Subject|27|||
145978310|NCT04602000|526432204|FG004|Overall Study|Withdrawal by Subject|39|||
145978311|NCT04602000|526432200|FG000|Overall Study|Physician Decision|1|||
145978312|NCT04602000|526432201|FG001|Overall Study|Physician Decision|0|||
145978313|NCT04602000|526432202|FG002|Overall Study|Physician Decision|0|||
145978314|NCT04602000|526432203|FG003|Overall Study|Physician Decision|2|||
145978315|NCT04602000|526432204|FG004|Overall Study|Physician Decision|2|||
145978316|NCT04602000|526432200|FG000|Overall Study|Death|0|||
145978317|NCT04602000|526432201|FG001|Overall Study|Death|1|||
145978318|NCT04602000|526432202|FG002|Overall Study|Death|0|||
145978319|NCT04602000|526432203|FG003|Overall Study|Death|1|||
145978320|NCT04602000|526432204|FG004|Overall Study|Death|2|||
145978321|NCT04602000|526432200|FG000|Overall Study|Lost to Follow-up|0|||
145978322|NCT04602000|526432201|FG001|Overall Study|Lost to Follow-up|0|||
146243765|NCT00326183|527407309|FG000|Overall Study|Lost to Follow-up|104|||
146243766|NCT00326183|527407310|FG001|Overall Study|Lost to Follow-up|56|||
146243767|NCT00326183|527407309|FG000|Overall Study|Protocol Violation|6|||
146243768|NCT00326183|527407310|FG001|Overall Study|Protocol Violation|3|||
146243769|NCT00326183|527407309|FG000|Overall Study|Withdrawal by Subject|35|||
146243770|NCT00326183|527407310|FG001|Overall Study|Withdrawal by Subject|7|||
146243771|NCT00326183|527407309|FG000|Overall Study|Subject Moved|7|||
146243772|NCT00326183|527407310|FG001|Overall Study|Subject Moved|4|||
146243773|NCT00326183|527407309|FG000|Overall Study|Other|47|||
146243774|NCT00326183|527407310|FG001|Overall Study|Other|13|||
146243775|NCT00326183|527407309|FG000|Overall Study|Adverse Event|1|||
146243776|NCT00326183|527407310|FG001|Overall Study|Adverse Event|0|||
146243777|NCT03803475|527407317|FG000|Overall Study|Physician Decision|1|||
146243778|NCT01880736|527407318|FG000|Overall Study|Adverse Event|0|||
146243779|NCT01880736|527407319|FG001|Overall Study|Adverse Event|0|||
146243780|NCT01880736|527407320|FG002|Overall Study|Adverse Event|0|||
146243781|NCT01880736|527407321|FG003|Overall Study|Adverse Event|1|||
146243782|NCT01880736|527407318|FG000|Overall Study|Withdrawal Criteria|1|||
146243783|NCT01880736|527407319|FG001|Overall Study|Withdrawal Criteria|2|||
145932585|NCT03214380|526260334|FG003|Lead-in|Withdrawal by Subject|14|||
145932586|NCT03214380|526260335|FG004|Lead-in|Withdrawal by Subject|0|||
145932587|NCT03214380|526260336|FG005|Lead-in|Withdrawal by Subject|0|||
145932588|NCT03214380|526260331|FG000|Lead-in|Family Emergency|1|||
145932589|NCT03214380|526260332|FG001|Lead-in|Family Emergency|0|||
145932590|NCT03214380|526260333|FG002|Lead-in|Family Emergency|0|||
145932591|NCT03214380|526260334|FG003|Lead-in|Family Emergency|0|||
146243784|NCT01880736|527407320|FG002|Overall Study|Withdrawal Criteria|1|||
146243785|NCT01880736|527407321|FG003|Overall Study|Withdrawal Criteria|5|||
146243786|NCT01263496|527407325|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
146243787|NCT01263496|527407326|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243788|NCT01263496|527407327|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243789|NCT01263496|527407328|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243790|NCT01263496|527407329|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243791|NCT01263496|527407330|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243792|NCT01263496|527407331|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243793|NCT01263496|527407332|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243794|NCT01263496|527407333|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
146243795|NCT01263496|527407325|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243796|NCT01263496|527407326|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243797|NCT01263496|527407327|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243798|NCT01263496|527407328|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146243799|NCT01263496|527407329|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
146243800|NCT01263496|527407330|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243801|NCT01263496|527407331|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243802|NCT01263496|527407332|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243803|NCT01263496|527407333|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146243804|NCT01263496|527407325|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
146243805|NCT01263496|527407326|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
146243806|NCT01263496|527407327|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
146243807|NCT01263496|527407328|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
146243808|NCT01263496|527407329|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
146243809|NCT01263496|527407330|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
146243810|NCT01263496|527407331|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
146243811|NCT01263496|527407332|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
146243812|NCT01263496|527407333|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
146243813|NCT01263496|527407325|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243814|NCT01263496|527407326|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
146243815|NCT01263496|527407327|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243816|NCT01263496|527407328|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243817|NCT01263496|527407329|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243818|NCT01263496|527407330|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243819|NCT01263496|527407331|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145932592|NCT03214380|526260335|FG004|Lead-in|Family Emergency|0|||
145932593|NCT03214380|526260336|FG005|Lead-in|Family Emergency|0|||
145932594|NCT03214380|526260331|FG000|Lead-in|Natural Disaster|9|||
145932595|NCT03214380|526260332|FG001|Lead-in|Natural Disaster|0|||
145932596|NCT03214380|526260333|FG002|Lead-in|Natural Disaster|0|||
146243820|NCT01263496|527407332|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243821|NCT01263496|527407333|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146243822|NCT01263496|527407325|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145932597|NCT03214380|526260334|FG003|Lead-in|Natural Disaster|0|||
145932598|NCT03214380|526260335|FG004|Lead-in|Natural Disaster|0|||
145932599|NCT03214380|526260336|FG005|Lead-in|Natural Disaster|0|||
145932600|NCT03214380|526260331|FG000|Lead-in|Non Compliance|1|||
145932601|NCT03214380|526260332|FG001|Lead-in|Non Compliance|0|||
145932602|NCT03214380|526260333|FG002|Lead-in|Non Compliance|0|||
145932603|NCT03214380|526260334|FG003|Lead-in|Non Compliance|0|||
145932604|NCT03214380|526260335|FG004|Lead-in|Non Compliance|0|||
145932605|NCT03214380|526260336|FG005|Lead-in|Non Compliance|0|||
145932606|NCT03214380|526260331|FG000|Lead-in|Participant Schedule|2|||
145932607|NCT03214380|526260332|FG001|Lead-in|Participant Schedule|0|||
145932608|NCT03214380|526260333|FG002|Lead-in|Participant Schedule|0|||
145932609|NCT03214380|526260334|FG003|Lead-in|Participant Schedule|0|||
145932610|NCT03214380|526260335|FG004|Lead-in|Participant Schedule|0|||
145932611|NCT03214380|526260336|FG005|Lead-in|Participant Schedule|0|||
145932612|NCT03214380|526260331|FG000|Treatment Period|Adverse Event|0|||
145978323|NCT04602000|526432202|FG002|Overall Study|Lost to Follow-up|0|||
145978324|NCT04602000|526432203|FG003|Overall Study|Lost to Follow-up|3|||
145978325|NCT04602000|526432204|FG004|Overall Study|Lost to Follow-up|4|||
145978326|NCT04602000|526432200|FG000|Overall Study|Other|4|||
145978327|NCT04602000|526432201|FG001|Overall Study|Other|1|||
145978328|NCT04602000|526432202|FG002|Overall Study|Other|2|||
145978329|NCT04602000|526432203|FG003|Overall Study|Other|5|||
145978330|NCT04602000|526432204|FG004|Overall Study|Other|4|||
145978331|NCT04602000|526432200|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145978332|NCT04602000|526432201|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145978333|NCT04602000|526432202|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
145978334|NCT04602000|526432203|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145978335|NCT04602000|526432204|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145978336|NCT05607043|526432205|FG000|Overall Study|Lost to Follow-up|2|||
145978337|NCT00429299|526432210|FG000|Overall Study|Disease Progression|1|||
145978338|NCT00429299|526432211|FG001|Overall Study|Disease Progression|1|||
145978339|NCT00429299|526432212|FG002|Overall Study|Disease Progression|0|||
145978340|NCT00429299|526432210|FG000|Overall Study|Adverse Event|2|||
145978341|NCT00429299|526432211|FG001|Overall Study|Adverse Event|5|||
145978342|NCT00429299|526432212|FG002|Overall Study|Adverse Event|1|||
145978343|NCT00429299|526432210|FG000|Overall Study|Protocol Violation|1|||
145978344|NCT00429299|526432211|FG001|Overall Study|Protocol Violation|0|||
145978345|NCT00429299|526432212|FG002|Overall Study|Protocol Violation|0|||
145978346|NCT00429299|526432210|FG000|Overall Study|Withdrawal by Subject|0|||
145978347|NCT00429299|526432211|FG001|Overall Study|Withdrawal by Subject|1|||
145978348|NCT00429299|526432212|FG002|Overall Study|Withdrawal by Subject|3|||
145978349|NCT01510756|526432213|FG000|Overall Study|Death|1|||
145978350|NCT01510756|526432213|FG000|Overall Study|Lack of Efficacy|2|||
145978351|NCT01510756|526432213|FG000|Overall Study|Physician Decision|1|||
145978352|NCT04871113|526432214|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978353|NCT04871113|526432215|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978354|NCT04871113|526432216|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978355|NCT04871113|526432217|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978356|NCT04871113|526432218|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978357|NCT04871113|526432219|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
145978358|NCT04871113|526432220|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978359|NCT04871113|526432221|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978360|NCT04871113|526432222|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978361|NCT04871113|526432223|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145978362|NCT04871113|526432214|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978363|NCT04871113|526432215|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978364|NCT04871113|526432216|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978365|NCT04871113|526432217|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978366|NCT04871113|526432218|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978367|NCT04871113|526432219|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978368|NCT04871113|526432220|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
145978369|NCT04871113|526432221|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
145978370|NCT04871113|526432222|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978371|NCT04871113|526432223|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145978372|NCT01239745|526432224|FG000|Overall Study|Study terminated by sponsor|45|||
145978373|NCT01239745|526432224|FG000|Overall Study|Adverse Event|1|||
145978374|NCT00081458|526432225|FG000|Overall Study|Adverse Event|1|||
145978375|NCT00081458|526432226|FG001|Overall Study|Adverse Event|5|||
145978376|NCT00081458|526432227|FG002|Overall Study|Adverse Event|2|||
145932613|NCT03214380|526260332|FG001|Treatment Period|Adverse Event|1|||
145932614|NCT03214380|526260333|FG002|Treatment Period|Adverse Event|1|||
145932615|NCT03214380|526260334|FG003|Treatment Period|Adverse Event|0|||
145932616|NCT03214380|526260335|FG004|Treatment Period|Adverse Event|1|||
145932617|NCT03214380|526260336|FG005|Treatment Period|Adverse Event|0|||
145932618|NCT03214380|526260331|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
145932619|NCT03214380|526260332|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
146243823|NCT01263496|527407326|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146243824|NCT01263496|527407327|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146243825|NCT01263496|527407328|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146243826|NCT01263496|527407329|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
146243827|NCT01263496|527407330|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146243828|NCT01263496|527407331|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146243829|NCT01263496|527407332|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146243830|NCT01263496|527407333|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146243831|NCT01263496|527407325|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
146243832|NCT01263496|527407326|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146243833|NCT01263496|527407327|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146243834|NCT01263496|527407328|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146243835|NCT01263496|527407329|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
146243836|NCT01263496|527407330|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145978377|NCT00081458|526432225|FG000|Overall Study|Withdrawal by Subject|0|||
145978378|NCT00081458|526432226|FG001|Overall Study|Withdrawal by Subject|3|||
145978379|NCT00081458|526432227|FG002|Overall Study|Withdrawal by Subject|1|||
145978380|NCT00081458|526432225|FG000|Overall Study|Randomized but not dosed|0|||
145978381|NCT00081458|526432226|FG001|Overall Study|Randomized but not dosed|0|||
145978382|NCT00081458|526432227|FG002|Overall Study|Randomized but not dosed|1|||
145978383|NCT00549328|526432230|FG000|Overall Study|Adverse Event|2|||
145978384|NCT00549328|526432230|FG000|Overall Study|Disease Progression|10|||
145978385|NCT00549328|526432230|FG000|Overall Study|Death|1|||
145978386|NCT00549328|526432230|FG000|Overall Study|Use of Prohibited Medication|1|||
145978387|NCT03097315|526432235|FG000|Overall Study|Withdrawal by Subject|1|||
145978388|NCT01946802|526432236|FG000|Overall Study|Death|1|||
145978389|NCT01946802|526432236|FG000|Overall Study|Withdrawal by Subject|2|||
145978390|NCT01946802|526432236|FG000|Overall Study|Combined septic shock|1|||
145978391|NCT01946802|526432236|FG000|Overall Study|Protocol Violation|1|||
145978392|NCT00153920|526432237|FG000|Overall Study|Adverse Event|9|||
145978393|NCT00153920|526432237|FG000|Overall Study|Progressive Disease|9|||
145978394|NCT00153920|526432237|FG000|Overall Study|Physician Decision|3|||
145978395|NCT00153920|526432237|FG000|Overall Study|Lack of Response|3|||
145978396|NCT00153920|526432237|FG000|Overall Study|Death|2|||
145978397|NCT00153920|526432237|FG000|Overall Study|Withdrawal by Subject|1|||
145978398|NCT00153920|526432237|FG000|Overall Study|Non-Protocol Therapy|1|||
145978399|NCT00153920|526432237|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
145978400|NCT00153920|526432237|FG000|Overall Study|Progressive Disease before Trt|1|||
145978401|NCT02143778|526432238|FG000|Overall Study|Withdrawal by Subject|2|||
145978402|NCT02143778|526432238|FG000|Overall Study|Device malfunction|1|||
145978403|NCT03384966|526432242|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
145978404|NCT03384966|526432243|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
145978405|NCT03384966|526432244|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
145978406|NCT03384966|526432242|FG000|Follow-up Period|Adverse Event|1|||
145978407|NCT03384966|526432243|FG001|Follow-up Period|Adverse Event|0|||
145978408|NCT03384966|526432244|FG002|Follow-up Period|Adverse Event|0|||
145978409|NCT00367458|526432245|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
145978410|NCT00367458|526432246|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
145978411|NCT01334515|526432249|FG000|Overall Study|Adverse Event|1|||
145978412|NCT01334515|526432250|FG001|Overall Study|Adverse Event|6|||
145978413|NCT01334515|526432249|FG000|Overall Study|Death|1|||
145978414|NCT01334515|526432250|FG001|Overall Study|Death|0|||
145978415|NCT01334515|526432249|FG000|Overall Study|Lack of Efficacy|8|||
145978416|NCT01334515|526432250|FG001|Overall Study|Lack of Efficacy|21|||
145978417|NCT01334515|526432249|FG000|Overall Study|Physician Decision|1|||
145978418|NCT01334515|526432250|FG001|Overall Study|Physician Decision|1|||
145978419|NCT01334515|526432249|FG000|Overall Study|Withdrawal by Subject|1|||
145978420|NCT01334515|526432250|FG001|Overall Study|Withdrawal by Subject|1|||
145978421|NCT04327271|526432251|FG000|Overall Study|Death|1|||
145978422|NCT04327271|526432252|FG001|Overall Study|Death|0|||
145978423|NCT04327271|526432251|FG000|Overall Study|Withdrawal by Subject|1|||
145978424|NCT04327271|526432252|FG001|Overall Study|Withdrawal by Subject|0|||
145978425|NCT04327271|526432251|FG000|Overall Study|randomization error (data capture)|4|||
145978426|NCT04327271|526432252|FG001|Overall Study|randomization error (data capture)|3|||
145978427|NCT04795323|526432256|FG000|Overall Study|Did not interact with TARA|1|||
145978428|NCT04795323|526432257|FG001|Overall Study|Did not interact with TARA|0|||
145978429|NCT01479530|526432258|FG000|Overall Study|Adverse Event|5|||
145978430|NCT01479530|526432259|FG001|Overall Study|Adverse Event|6|||
145978431|NCT01479530|526432258|FG000|Overall Study|Lack of Efficacy|0|||
145978432|NCT01479530|526432259|FG001|Overall Study|Lack of Efficacy|1|||
145978433|NCT01479530|526432258|FG000|Overall Study|Protocol Violation|2|||
145978434|NCT01479530|526432259|FG001|Overall Study|Protocol Violation|3|||
145978435|NCT01479530|526432258|FG000|Overall Study|Withdrawal of Consent|3|||
145978436|NCT01479530|526432259|FG001|Overall Study|Withdrawal of Consent|2|||
145932620|NCT03214380|526260333|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
145932621|NCT03214380|526260334|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
145932622|NCT03214380|526260335|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
145932623|NCT03214380|526260336|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
145932624|NCT03214380|526260331|FG000|Treatment Period|Withdrawal by Subject|0|||
145932625|NCT03214380|526260332|FG001|Treatment Period|Withdrawal by Subject|10|||
145932626|NCT03214380|526260333|FG002|Treatment Period|Withdrawal by Subject|8|||
145932627|NCT03214380|526260334|FG003|Treatment Period|Withdrawal by Subject|0|||
145932628|NCT03214380|526260335|FG004|Treatment Period|Withdrawal by Subject|7|||
145978437|NCT00303628|526432262|FG000|Overall Study|Disease progression|0|||
145978438|NCT00303628|526432263|FG001|Overall Study|Disease progression|1|||
145978439|NCT00303628|526432262|FG000|Overall Study|Adverse Event|26|||
145978440|NCT00303628|526432263|FG001|Overall Study|Adverse Event|36|||
145978441|NCT00303628|526432262|FG000|Overall Study|Death|0|||
146243837|NCT01263496|527407331|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146243838|NCT01263496|527407332|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146243839|NCT01263496|527407333|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146243840|NCT01263496|527407325|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243841|NCT01263496|527407326|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243842|NCT01263496|527407327|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243843|NCT01263496|527407328|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243844|NCT01263496|527407329|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243845|NCT01263496|527407330|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243846|NCT01263496|527407331|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243847|NCT01263496|527407332|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146243848|NCT01263496|527407333|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146243849|NCT05995977|527407337|FG000|Overall Study|Withdrawal by Subject|1|||
146243850|NCT05995977|527407338|FG001|Overall Study|Withdrawal by Subject|4|||
146243851|NCT05995977|527407337|FG000|Overall Study|Lost to Follow-up|2|||
146243852|NCT05995977|527407338|FG001|Overall Study|Lost to Follow-up|0|||
146243853|NCT04181788|527407339|FG000|TREATMENT|Adverse Event|0|||
146243854|NCT04181788|527407340|FG001|TREATMENT|Adverse Event|2|||
146243855|NCT04181788|527407341|FG002|TREATMENT|Adverse Event|1|||
146243856|NCT04181788|527407342|FG003|TREATMENT|Adverse Event|0|||
146243857|NCT04181788|527407343|FG004|TREATMENT|Adverse Event|1|||
146243858|NCT04181788|527407344|FG005|TREATMENT|Adverse Event|3|||
146243859|NCT04181788|527407339|FG000|TREATMENT|Death|0|||
146243860|NCT04181788|527407340|FG001|TREATMENT|Death|0|||
146243861|NCT04181788|527407341|FG002|TREATMENT|Death|0|||
146243862|NCT04181788|527407342|FG003|TREATMENT|Death|0|||
146243863|NCT04181788|527407343|FG004|TREATMENT|Death|8|||
146243864|NCT04181788|527407344|FG005|TREATMENT|Death|8|||
146243865|NCT04181788|527407339|FG000|TREATMENT|Physician Decision|0|||
146243866|NCT04181788|527407340|FG001|TREATMENT|Physician Decision|0|||
146243867|NCT04181788|527407341|FG002|TREATMENT|Physician Decision|0|||
146243868|NCT04181788|527407342|FG003|TREATMENT|Physician Decision|0|||
146243869|NCT04181788|527407343|FG004|TREATMENT|Physician Decision|0|||
146243870|NCT04181788|527407344|FG005|TREATMENT|Physician Decision|1|||
146243871|NCT04181788|527407339|FG000|TREATMENT|Progressive disease|3|||
146243872|NCT04181788|527407340|FG001|TREATMENT|Progressive disease|3|||
146243873|NCT04181788|527407341|FG002|TREATMENT|Progressive disease|5|||
146243874|NCT04181788|527407342|FG003|TREATMENT|Progressive disease|7|||
146243875|NCT04181788|527407343|FG004|TREATMENT|Progressive disease|20|||
146243876|NCT04181788|527407344|FG005|TREATMENT|Progressive disease|38|||
146243877|NCT04181788|527407339|FG000|TREATMENT|Global deterioration of health status|0|||
146243878|NCT04181788|527407340|FG001|TREATMENT|Global deterioration of health status|2|||
146243879|NCT04181788|527407341|FG002|TREATMENT|Global deterioration of health status|0|||
146243880|NCT04181788|527407342|FG003|TREATMENT|Global deterioration of health status|0|||
146243881|NCT04181788|527407343|FG004|TREATMENT|Global deterioration of health status|2|||
146243882|NCT04181788|527407344|FG005|TREATMENT|Global deterioration of health status|8|||
146243883|NCT04181788|527407339|FG000|TREATMENT|Withdrawal by Subject|1|||
146243884|NCT04181788|527407340|FG001|TREATMENT|Withdrawal by Subject|2|||
146243885|NCT04181788|527407341|FG002|TREATMENT|Withdrawal by Subject|0|||
146243886|NCT04181788|527407342|FG003|TREATMENT|Withdrawal by Subject|0|||
146243887|NCT04181788|527407343|FG004|TREATMENT|Withdrawal by Subject|3|||
145932629|NCT03214380|526260336|FG005|Treatment Period|Withdrawal by Subject|11|||
145932630|NCT03214380|526260331|FG000|Treatment Period|Death|0|||
145932631|NCT03214380|526260332|FG001|Treatment Period|Death|1|||
145932632|NCT03214380|526260333|FG002|Treatment Period|Death|2|||
146243888|NCT04181788|527407344|FG005|TREATMENT|Withdrawal by Subject|5|||
146243889|NCT04181788|527407339|FG000|TREATMENT|Other unspecified|0|||
146243890|NCT04181788|527407340|FG001|TREATMENT|Other unspecified|0|||
145978442|NCT00303628|526432263|FG001|Overall Study|Death|1|||
146243891|NCT04181788|527407341|FG002|TREATMENT|Other unspecified|0|||
146243892|NCT04181788|527407342|FG003|TREATMENT|Other unspecified|0|||
146243893|NCT04181788|527407343|FG004|TREATMENT|Other unspecified|0|||
145978443|NCT00303628|526432262|FG000|Overall Study|Withdrawal by Subject|11|||
146243894|NCT04181788|527407344|FG005|TREATMENT|Other unspecified|2|||
146243895|NCT04181788|527407339|FG000|TREATMENT|Ongoing|0|||
146243896|NCT04181788|527407340|FG001|TREATMENT|Ongoing|3|||
146243897|NCT04181788|527407341|FG002|TREATMENT|Ongoing|0|||
146243898|NCT04181788|527407342|FG003|TREATMENT|Ongoing|5|||
145978444|NCT00303628|526432263|FG001|Overall Study|Withdrawal by Subject|20|||
145978445|NCT00303628|526432262|FG000|Overall Study|Alternative therapy|2|||
145978446|NCT00303628|526432263|FG001|Overall Study|Alternative therapy|0|||
145978447|NCT00303628|526432262|FG000|Overall Study|Other complicating disease|0|||
145978448|NCT00303628|526432263|FG001|Overall Study|Other complicating disease|1|||
145978449|NCT00303628|526432262|FG000|Overall Study|Not start protocol therapy|3|||
145978450|NCT00303628|526432263|FG001|Overall Study|Not start protocol therapy|5|||
145978451|NCT00303628|526432262|FG000|Overall Study|Other|8|||
145978452|NCT00303628|526432263|FG001|Overall Study|Other|9|||
145978453|NCT02948400|526432264|FG000|Overall Study|Withdrawal by Subject|17|||
145978454|NCT02948400|526432265|FG001|Overall Study|Withdrawal by Subject|10|||
145978455|NCT02948400|526432264|FG000|Overall Study|failed to attend appointments|47|||
145978456|NCT02948400|526432265|FG001|Overall Study|failed to attend appointments|34|||
145978457|NCT02948400|526432264|FG000|Overall Study|COVID-related closure|6|||
145978458|NCT02948400|526432265|FG001|Overall Study|COVID-related closure|2|||
145978459|NCT02948400|526432264|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
145978460|NCT02948400|526432265|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
145978461|NCT02948400|526432264|FG000|Overall Study|motion sickness in virtual reality|2|||
145978462|NCT02948400|526432265|FG001|Overall Study|motion sickness in virtual reality|0|||
145978463|NCT03599713|526432266|FG000|Overall Study|Death|38|||
145978464|NCT03599713|526432267|FG001|Overall Study|Death|3|||
145978465|NCT03599713|526432266|FG000|Overall Study|Withdrawal by Subject|17|||
145978466|NCT03599713|526432267|FG001|Overall Study|Withdrawal by Subject|0|||
145978467|NCT03599713|526432266|FG000|Overall Study|Lost to Follow-up|4|||
145978468|NCT03599713|526432267|FG001|Overall Study|Lost to Follow-up|0|||
145978469|NCT03599713|526432266|FG000|Overall Study|Discontinued Due to End of Study|42|||
145978470|NCT03599713|526432267|FG001|Overall Study|Discontinued Due to End of Study|3|||
145978471|NCT03580928|526432272|FG000|Overall Study|Death|0|||
145978472|NCT03580928|526432273|FG001|Overall Study|Death|3|||
145978473|NCT03580928|526432272|FG000|Overall Study|Withdrawal by Subject|2|||
145978474|NCT03580928|526432273|FG001|Overall Study|Withdrawal by Subject|1|||
145978475|NCT03580928|526432272|FG000|Overall Study|Lost to Follow-up|2|||
145978476|NCT03580928|526432273|FG001|Overall Study|Lost to Follow-up|0|||
145978477|NCT03580928|526432272|FG000|Overall Study|Progressive Disease|0|||
145978478|NCT03580928|526432273|FG001|Overall Study|Progressive Disease|1|||
145978479|NCT05643794|526433556|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
145978480|NCT05643794|526433557|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
145978481|NCT05643794|526433558|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145978482|NCT05643794|526433556|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145978483|NCT05643794|526433557|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145978484|NCT05643794|526433558|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145978485|NCT05643794|526433556|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145978486|NCT05643794|526433557|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
145978487|NCT05643794|526433558|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145978488|NCT05643794|526433556|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145978489|NCT05643794|526433557|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145978490|NCT05643794|526433558|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145978491|NCT05643794|526433556|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
145978492|NCT05643794|526433557|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145978493|NCT05643794|526433558|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145978494|NCT05643794|526433556|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
145978495|NCT05643794|526433557|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
145978496|NCT05643794|526433558|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
145978497|NCT04167670|526433561|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
145978498|NCT04167670|526433562|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
146243899|NCT04181788|527407343|FG004|TREATMENT|Ongoing|7|||
146243900|NCT04181788|527407344|FG005|TREATMENT|Ongoing|15|||
146243901|NCT04181788|527407339|FG000|FOLLOW-UP|Death|0|||
145978499|NCT04167670|526433563|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
145978500|NCT04167670|526433561|FG000|Overall Study|Significant protocol deviation|3|||
145978501|NCT04167670|526433562|FG001|Overall Study|Significant protocol deviation|1|||
145978502|NCT04167670|526433563|FG002|Overall Study|Significant protocol deviation|0|||
145978503|NCT04167670|526433561|FG000|Overall Study|Lost to Follow-up|0|||
145978504|NCT04167670|526433562|FG001|Overall Study|Lost to Follow-up|3|||
145978505|NCT04167670|526433563|FG002|Overall Study|Lost to Follow-up|3|||
146243902|NCT04181788|527407340|FG001|FOLLOW-UP|Death|0|||
146243903|NCT04181788|527407341|FG002|FOLLOW-UP|Death|1|||
146243904|NCT04181788|527407342|FG003|FOLLOW-UP|Death|2|||
146243905|NCT04181788|527407343|FG004|FOLLOW-UP|Death|8|||
146243906|NCT04181788|527407344|FG005|FOLLOW-UP|Death|20|||
146243907|NCT04181788|527407339|FG000|FOLLOW-UP|Lost to Follow-up|0|||
146243908|NCT04181788|527407340|FG001|FOLLOW-UP|Lost to Follow-up|0|||
146243909|NCT04181788|527407341|FG002|FOLLOW-UP|Lost to Follow-up|0|||
146243910|NCT04181788|527407342|FG003|FOLLOW-UP|Lost to Follow-up|0|||
146243911|NCT04181788|527407343|FG004|FOLLOW-UP|Lost to Follow-up|0|||
146243912|NCT04181788|527407344|FG005|FOLLOW-UP|Lost to Follow-up|2|||
146243913|NCT04181788|527407339|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
146243914|NCT04181788|527407340|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
146243915|NCT04181788|527407341|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
146243916|NCT04181788|527407342|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
146243917|NCT04181788|527407343|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
146243918|NCT04181788|527407344|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
146243919|NCT04181788|527407339|FG000|FOLLOW-UP|Other unspecified|0|||
146243920|NCT04181788|527407340|FG001|FOLLOW-UP|Other unspecified|1|||
146243921|NCT04181788|527407341|FG002|FOLLOW-UP|Other unspecified|0|||
146243922|NCT04181788|527407342|FG003|FOLLOW-UP|Other unspecified|0|||
145932633|NCT03214380|526260334|FG003|Treatment Period|Death|0|||
146243923|NCT04181788|527407343|FG004|FOLLOW-UP|Other unspecified|0|||
146243924|NCT04181788|527407344|FG005|FOLLOW-UP|Other unspecified|3|||
146243925|NCT04181788|527407339|FG000|FOLLOW-UP|Ongoing|0|||
146243926|NCT04181788|527407340|FG001|FOLLOW-UP|Ongoing|0|||
146243927|NCT04181788|527407341|FG002|FOLLOW-UP|Ongoing|1|||
146243928|NCT04181788|527407342|FG003|FOLLOW-UP|Ongoing|3|||
146243929|NCT04181788|527407343|FG004|FOLLOW-UP|Ongoing|2|||
146243930|NCT04181788|527407344|FG005|FOLLOW-UP|Ongoing|2|||
146243931|NCT01276509|527409285|FG000|Overall Study|Adverse Event|9|||
146243932|NCT01276509|527409286|FG001|Overall Study|Adverse Event|8|||
146243933|NCT01276509|527409287|FG002|Overall Study|Adverse Event|4|||
146243934|NCT01276509|527409288|FG003|Overall Study|Adverse Event|3|||
146243935|NCT01276509|527409285|FG000|Overall Study|Lack of Efficacy|2|||
146243936|NCT01276509|527409286|FG001|Overall Study|Lack of Efficacy|1|||
146243937|NCT01276509|527409287|FG002|Overall Study|Lack of Efficacy|1|||
146243938|NCT01276509|527409288|FG003|Overall Study|Lack of Efficacy|2|||
146243939|NCT01276509|527409285|FG000|Overall Study|Pregnancy|1|||
146243940|NCT01276509|527409286|FG001|Overall Study|Pregnancy|0|||
146243941|NCT01276509|527409287|FG002|Overall Study|Pregnancy|0|||
146243942|NCT01276509|527409288|FG003|Overall Study|Pregnancy|0|||
146243943|NCT01276509|527409285|FG000|Overall Study|Withdrawal by Subject|1|||
146243944|NCT01276509|527409286|FG001|Overall Study|Withdrawal by Subject|2|||
146243945|NCT01276509|527409287|FG002|Overall Study|Withdrawal by Subject|0|||
146243946|NCT01276509|527409288|FG003|Overall Study|Withdrawal by Subject|0|||
146243947|NCT01276509|527409285|FG000|Overall Study|Other|0|||
146243948|NCT01276509|527409286|FG001|Overall Study|Other|1|||
146243949|NCT01276509|527409287|FG002|Overall Study|Other|0|||
146243950|NCT01276509|527409288|FG003|Overall Study|Other|0|||
146243951|NCT00535626|527409292|FG000|Overall Study|Death|15|||
146243952|NCT00535626|527409292|FG000|Overall Study|Lost to Follow-up|29|||
146243953|NCT00535626|527409292|FG000|Overall Study|Withdrawal by Subject|20|||
146243954|NCT00535626|527409292|FG000|Overall Study|Removal/revision of study component|8|||
146243955|NCT00535626|527409292|FG000|Overall Study|Subject terminated|31|||
146243956|NCT00535626|527409292|FG000|Overall Study|Unable to return|2|||
146243957|NCT02830893|527409293|FG000|Overall Study|Relocation to out of the country|1|||
146243958|NCT02830893|527409294|FG001|Overall Study|Relocation to out of the country|0|||
146243959|NCT02830893|527409293|FG000|Overall Study|Lost to Follow-up|0|||
146243960|NCT02830893|527409294|FG001|Overall Study|Lost to Follow-up|2|||
146243961|NCT02830893|527409293|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
146243962|NCT02830893|527409294|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
146243963|NCT01567852|527409295|FG000|Overall Study|Withdrawal by Subject|3|||
146243964|NCT01567852|527409296|FG001|Overall Study|Withdrawal by Subject|6|||
146243965|NCT01567852|527409295|FG000|Overall Study|ECT discontinued|1|||
146243966|NCT01567852|527409296|FG001|Overall Study|ECT discontinued|1|||
146243967|NCT03332589|527409297|FG000|Overall Study|Lack of Efficacy|2|||
146243968|NCT03332589|527409298|FG001|Overall Study|Lack of Efficacy|0|||
146243969|NCT03332589|527409299|FG002|Overall Study|Lack of Efficacy|0|||
146243970|NCT03332589|527409297|FG000|Overall Study|Adverse Event|1|||
146243971|NCT03332589|527409298|FG001|Overall Study|Adverse Event|0|||
146243972|NCT03332589|527409299|FG002|Overall Study|Adverse Event|0|||
146243973|NCT03332589|527409297|FG000|Overall Study|Death|1|||
146243974|NCT03332589|527409298|FG001|Overall Study|Death|0|||
146243975|NCT03332589|527409299|FG002|Overall Study|Death|0|||
145932634|NCT03214380|526260335|FG004|Treatment Period|Death|0|||
145932635|NCT03214380|526260336|FG005|Treatment Period|Death|0|||
145932636|NCT03214380|526260331|FG000|Treatment Period|Lost to Follow-up|0|||
146243976|NCT00443820|527409300|FG000|Overall Study|Adverse Event|1|||
146243977|NCT00443820|527409301|FG001|Overall Study|Adverse Event|1|||
146243978|NCT00443820|527409302|FG002|Overall Study|Adverse Event|0|||
146243979|NCT00443820|527409303|FG003|Overall Study|Adverse Event|0|||
146243980|NCT00443820|527409300|FG000|Overall Study|Lack of Efficacy|3|||
146243981|NCT00443820|527409301|FG001|Overall Study|Lack of Efficacy|2|||
146243982|NCT00443820|527409302|FG002|Overall Study|Lack of Efficacy|1|||
146091023|NCT02964507|526854856|FG002|Overall Study|Withdrawal by Subject|1|||
146243983|NCT00443820|527409303|FG003|Overall Study|Lack of Efficacy|1|||
145932637|NCT03214380|526260332|FG001|Treatment Period|Lost to Follow-up|6|||
145932638|NCT03214380|526260333|FG002|Treatment Period|Lost to Follow-up|3|||
145932639|NCT03214380|526260334|FG003|Treatment Period|Lost to Follow-up|0|||
145932640|NCT03214380|526260335|FG004|Treatment Period|Lost to Follow-up|0|||
145932641|NCT03214380|526260336|FG005|Treatment Period|Lost to Follow-up|0|||
145932642|NCT03214380|526260331|FG000|Treatment Period|Participant schedule|0|||
145932643|NCT03214380|526260332|FG001|Treatment Period|Participant schedule|0|||
145932644|NCT03214380|526260333|FG002|Treatment Period|Participant schedule|1|||
145932645|NCT03214380|526260334|FG003|Treatment Period|Participant schedule|0|||
145932646|NCT03214380|526260335|FG004|Treatment Period|Participant schedule|0|||
146243984|NCT00443820|527409300|FG000|Overall Study|Protocol Violation|2|||
146243985|NCT00443820|527409301|FG001|Overall Study|Protocol Violation|1|||
146243986|NCT00443820|527409302|FG002|Overall Study|Protocol Violation|2|||
146243987|NCT00443820|527409303|FG003|Overall Study|Protocol Violation|1|||
146243988|NCT00443820|527409300|FG000|Overall Study|Withdrawal by Subject|6|||
146243989|NCT00443820|527409301|FG001|Overall Study|Withdrawal by Subject|7|||
146243990|NCT00443820|527409302|FG002|Overall Study|Withdrawal by Subject|8|||
146243991|NCT00443820|527409303|FG003|Overall Study|Withdrawal by Subject|9|||
146243992|NCT00443820|527409300|FG000|Overall Study|Lost to Follow-up|9|||
146243993|NCT00443820|527409301|FG001|Overall Study|Lost to Follow-up|8|||
146243994|NCT00443820|527409302|FG002|Overall Study|Lost to Follow-up|6|||
146243995|NCT00443820|527409303|FG003|Overall Study|Lost to Follow-up|5|||
146243996|NCT00443820|527409300|FG000|Overall Study|Administrative problems|0|||
146243997|NCT00443820|527409301|FG001|Overall Study|Administrative problems|0|||
146243998|NCT00443820|527409302|FG002|Overall Study|Administrative problems|0|||
146243999|NCT00443820|527409303|FG003|Overall Study|Administrative problems|1|||
146244000|NCT00443820|527409300|FG000|Overall Study|Death|0|||
146244001|NCT00443820|527409301|FG001|Overall Study|Death|0|||
146244002|NCT00443820|527409302|FG002|Overall Study|Death|1|||
146244003|NCT00443820|527409303|FG003|Overall Study|Death|0|||
146244004|NCT01808534|527409313|FG000|Overall Study|Disease progression|3|||
146244005|NCT01808534|527409313|FG000|Overall Study|Physician Decision|1|||
146244006|NCT02354417|527409314|FG000|Overall Study|Physician Decision|1|||
146244007|NCT01377844|527409315|FG000|Overall Study|Withdrawal by Subject|25|||
146244008|NCT01377844|527409316|FG001|Overall Study|Withdrawal by Subject|28|||
146244009|NCT01377844|527409315|FG000|Overall Study|Protocol Violation|2|||
146244010|NCT01377844|527409316|FG001|Overall Study|Protocol Violation|3|||
146244011|NCT01377844|527409315|FG000|Overall Study|Adverse Event|3|||
145932647|NCT03214380|526260336|FG005|Treatment Period|Participant schedule|0|||
145932648|NCT03214380|526260331|FG000|Treatment Period|Treatment Interruption|0|||
145932649|NCT03214380|526260332|FG001|Treatment Period|Treatment Interruption|0|||
145932650|NCT03214380|526260333|FG002|Treatment Period|Treatment Interruption|1|||
145932651|NCT03214380|526260334|FG003|Treatment Period|Treatment Interruption|0|||
145932652|NCT03214380|526260335|FG004|Treatment Period|Treatment Interruption|0|||
145932653|NCT03214380|526260336|FG005|Treatment Period|Treatment Interruption|0|||
145932654|NCT03692325|526260340|FG000|Overall Study|Adverse Event|2|||
145932655|NCT03692325|526260340|FG000|Overall Study|Progression/Recurrence|2|||
145932656|NCT04481191|526260341|FG000|Overall Study|Withdrawn by parent/guardian|15|||
145932657|NCT04481191|526260342|FG001|Overall Study|Withdrawn by parent/guardian|10|||
145932658|NCT04292912|526260347|FG000|Overall Study|Physician Decision|1|||
145932659|NCT04292912|526260347|FG000|Overall Study|Protocol Violation|6|||
145932660|NCT00280397|526260348|FG000|Overall Study|Adverse Event|1|||
146091024|NCT02964507|526854857|FG003|Overall Study|Withdrawal by Subject|1|||
146091025|NCT02964507|526854858|FG004|Overall Study|Withdrawal by Subject|0|||
146244012|NCT01377844|527409316|FG001|Overall Study|Adverse Event|0|||
146244013|NCT01377844|527409315|FG000|Overall Study|Physician Decision|6|||
145932661|NCT01250873|526260358|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
145932662|NCT01250873|526260358|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
145932663|NCT02278939|526260359|FG000|Overall Study|lack of time|1|||
145932664|NCT02278939|526260360|FG001|Overall Study|lack of time|0|||
145932665|NCT02278939|526260359|FG000|Overall Study|Lost to Follow-up|1|||
145932666|NCT02278939|526260360|FG001|Overall Study|Lost to Follow-up|1|||
145932667|NCT02278939|526260359|FG000|Overall Study|death in family|1|||
145932668|NCT02278939|526260360|FG001|Overall Study|death in family|0|||
145932669|NCT02278939|526260359|FG000|Overall Study|family emergency unable to commit|2|||
145932670|NCT02278939|526260360|FG001|Overall Study|family emergency unable to commit|0|||
146244014|NCT01377844|527409316|FG001|Overall Study|Physician Decision|3|||
146244015|NCT01377844|527409315|FG000|Overall Study|Study terminated by Sponsor|0|||
146244016|NCT01377844|527409316|FG001|Overall Study|Study terminated by Sponsor|1|||
145932671|NCT02423343|526260366|FG000|Overall Study|Withdrawal by Subject|0|||
145932672|NCT02423343|526260367|FG001|Overall Study|Withdrawal by Subject|1|||
146244017|NCT02202317|527409322|FG000|Overall Study|Lost to Follow-up|1|||
145932673|NCT02423343|526260368|FG002|Overall Study|Withdrawal by Subject|0|||
145932674|NCT02423343|526260369|FG003|Overall Study|Withdrawal by Subject|0|||
146091026|NCT02964507|526854859|FG005|Overall Study|Withdrawal by Subject|1|||
145932675|NCT02423343|526260370|FG004|Overall Study|Withdrawal by Subject|0|||
145932676|NCT02423343|526260371|FG005|Overall Study|Withdrawal by Subject|0|||
145932677|NCT02423343|526260366|FG000|Overall Study|Progressive Disease|0|||
145932678|NCT02423343|526260367|FG001|Overall Study|Progressive Disease|0|||
146244018|NCT00569166|527409324|FG000|Overall Study|Withdrawal by Subject|7|||
146244019|NCT00569166|527409325|FG001|Overall Study|Withdrawal by Subject|5|||
146244020|NCT00569166|527409326|FG002|Overall Study|Withdrawal by Subject|3|||
146244021|NCT00569166|527409324|FG000|Overall Study|Lost to Follow-up|2|||
146244022|NCT00569166|527409325|FG001|Overall Study|Lost to Follow-up|1|||
146244023|NCT00569166|527409326|FG002|Overall Study|Lost to Follow-up|1|||
146244024|NCT00484198|527409328|FG000|Overall Study|Participant Withdrew Consent|12|||
146244025|NCT00484198|527409329|FG001|Overall Study|Participant Withdrew Consent|21|||
146244026|NCT00484198|527409330|FG002|Overall Study|Participant Withdrew Consent|47|||
146244027|NCT00484198|527409331|FG003|Overall Study|Participant Withdrew Consent|59|||
146244028|NCT00484198|527409328|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
146244029|NCT00484198|527409329|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
146244030|NCT00484198|527409330|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
146244031|NCT00484198|527409331|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
146244032|NCT00484198|527409328|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
146244033|NCT00484198|527409329|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
146244034|NCT00484198|527409330|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
146244035|NCT00484198|527409331|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
146244036|NCT00484198|527409328|FG000|Overall Study|Adverse Event|3|||
146244037|NCT00484198|527409329|FG001|Overall Study|Adverse Event|11|||
146244038|NCT00484198|527409330|FG002|Overall Study|Adverse Event|32|||
146244039|NCT00484198|527409331|FG003|Overall Study|Adverse Event|31|||
146244040|NCT00484198|527409328|FG000|Overall Study|Protocol Violation|0|||
146244041|NCT00484198|527409329|FG001|Overall Study|Protocol Violation|5|||
146244042|NCT00484198|527409330|FG002|Overall Study|Protocol Violation|6|||
146091027|NCT02964507|526854860|FG006|Overall Study|Withdrawal by Subject|0|||
146091028|NCT02964507|526854861|FG007|Overall Study|Withdrawal by Subject|0|||
146091029|NCT02964507|526854854|FG000|Overall Study|Physician Decision|2|||
146244043|NCT00484198|527409331|FG003|Overall Study|Protocol Violation|8|||
146244044|NCT00484198|527409328|FG000|Overall Study|Other|7|||
146244045|NCT00484198|527409329|FG001|Overall Study|Other|10|||
146244046|NCT00484198|527409330|FG002|Overall Study|Other|31|||
146244047|NCT00484198|527409331|FG003|Overall Study|Other|28|||
146244048|NCT01853384|527409332|FG000|Randomized|Adverse Event|5|||
146244049|NCT01853384|527409333|FG001|Randomized|Adverse Event|3|||
146244050|NCT01853384|527409332|FG000|Randomized|Death|1|||
146244051|NCT01853384|527409333|FG001|Randomized|Death|2|||
146244052|NCT01853384|527409332|FG000|Randomized|Lost to Follow-up|1|||
146244053|NCT01853384|527409333|FG001|Randomized|Lost to Follow-up|1|||
146244054|NCT01853384|527409332|FG000|Randomized|Withdrawal by Subject|5|||
146244055|NCT01853384|527409333|FG001|Randomized|Withdrawal by Subject|3|||
146244056|NCT01853384|527409332|FG000|Randomized|Sponsor Decision|47|||
146244057|NCT01853384|527409333|FG001|Randomized|Sponsor Decision|34|||
146244058|NCT01853384|527409332|FG000|Randomized|Other|3|||
146244059|NCT01853384|527409333|FG001|Randomized|Other|3|||
146244060|NCT01853384|527409332|FG000|Completed Follow up Visit 1|Early Termination|13|||
146297790|NCT01009554|527605998|FG000|Overall Study|Withdrawal by Subject|1|||
146297791|NCT01009554|527605999|FG001|Overall Study|Withdrawal by Subject|3|||
145932679|NCT02423343|526260368|FG002|Overall Study|Progressive Disease|0|||
145932680|NCT02423343|526260369|FG003|Overall Study|Progressive Disease|0|||
145932681|NCT02423343|526260370|FG004|Overall Study|Progressive Disease|2|||
145932682|NCT02423343|526260371|FG005|Overall Study|Progressive Disease|0|||
145932683|NCT02423343|526260366|FG000|Overall Study|Adverse Event|0|||
145932684|NCT02423343|526260367|FG001|Overall Study|Adverse Event|0|||
145932685|NCT02423343|526260368|FG002|Overall Study|Adverse Event|0|||
145932686|NCT02423343|526260369|FG003|Overall Study|Adverse Event|0|||
145932687|NCT02423343|526260370|FG004|Overall Study|Adverse Event|2|||
145932688|NCT02423343|526260371|FG005|Overall Study|Adverse Event|0|||
146244061|NCT01853384|527409333|FG001|Completed Follow up Visit 1|Early Termination|9|||
146244062|NCT01853384|527409332|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
146244063|NCT01853384|527409333|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
146244064|NCT01853384|527409332|FG000|Completed Follow up Visit 2|Adverse Event|1|||
146244065|NCT01853384|527409333|FG001|Completed Follow up Visit 2|Adverse Event|0|||
145932689|NCT02423343|526260366|FG000|Overall Study|Death|0|||
145932690|NCT02423343|526260367|FG001|Overall Study|Death|0|||
145932691|NCT02423343|526260368|FG002|Overall Study|Death|0|||
145932692|NCT02423343|526260369|FG003|Overall Study|Death|0|||
146244066|NCT01853384|527409332|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
146244067|NCT01853384|527409333|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
146244068|NCT01853384|527409332|FG000|Completed Follow up Visit 2|Death|1|||
146244069|NCT01853384|527409333|FG001|Completed Follow up Visit 2|Death|0|||
145932693|NCT02423343|526260370|FG004|Overall Study|Death|1|||
146244070|NCT01853384|527409332|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
146297792|NCT01009554|527605998|FG000|Overall Study|Noncompliant with Study Product|0|||
146244071|NCT01853384|527409333|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
146244072|NCT01947491|527409334|FG000|Overall Study|Lost to Follow-up|5|||
146244073|NCT01947491|527409335|FG001|Overall Study|Lost to Follow-up|3|||
145932694|NCT02423343|526260371|FG005|Overall Study|Death|0|||
145932695|NCT00930774|526260374|FG000|Overall Study|Withdrawal by Subject|1|||
146244074|NCT01947491|527409336|FG002|Overall Study|Lost to Follow-up|1|||
146244075|NCT01947491|527409337|FG003|Overall Study|Lost to Follow-up|2|||
146244076|NCT01947491|527409334|FG000|Overall Study|Lack of Efficacy|1|||
146244077|NCT01947491|527409335|FG001|Overall Study|Lack of Efficacy|0|||
146244078|NCT01947491|527409336|FG002|Overall Study|Lack of Efficacy|0|||
146244079|NCT01947491|527409337|FG003|Overall Study|Lack of Efficacy|1|||
146244080|NCT01947491|527409334|FG000|Overall Study|Protocol Violation|1|||
146244081|NCT01947491|527409335|FG001|Overall Study|Protocol Violation|0|||
146244082|NCT01947491|527409336|FG002|Overall Study|Protocol Violation|0|||
146244083|NCT01947491|527409337|FG003|Overall Study|Protocol Violation|0|||
146244084|NCT01947491|527409334|FG000|Overall Study|Withdrawal by Subject|1|||
146244085|NCT01947491|527409335|FG001|Overall Study|Withdrawal by Subject|1|||
146244086|NCT01947491|527409336|FG002|Overall Study|Withdrawal by Subject|1|||
146244087|NCT01947491|527409337|FG003|Overall Study|Withdrawal by Subject|0|||
146244088|NCT01947491|527409334|FG000|Overall Study|Worsening of condition|0|||
145932696|NCT00930774|526260375|FG001|Overall Study|Withdrawal by Subject|9|||
145932697|NCT00930774|526260376|FG002|Overall Study|Withdrawal by Subject|2|||
145932698|NCT00930774|526260377|FG003|Overall Study|Withdrawal by Subject|0|||
145932699|NCT02042950|526260378|FG000|Overall Study|Progressive Disease|4|||
145932700|NCT02217410|526260379|FG000|Overall Study|Graft Loss|0|||
145932701|NCT02217410|526260380|FG001|Overall Study|Graft Loss|0|||
145932702|NCT02217410|526260381|FG002|Overall Study|Graft Loss|2|||
145932703|NCT02217410|526260379|FG000|Overall Study|Withdrawal by Subject|0|||
146244089|NCT01947491|527409335|FG001|Overall Study|Worsening of condition|1|||
146244090|NCT01947491|527409336|FG002|Overall Study|Worsening of condition|0|||
146244091|NCT01947491|527409337|FG003|Overall Study|Worsening of condition|0|||
146244092|NCT01947491|527409334|FG000|Overall Study|Adverse Event|0|||
146244093|NCT01947491|527409335|FG001|Overall Study|Adverse Event|1|||
146244094|NCT01947491|527409336|FG002|Overall Study|Adverse Event|0|||
146244095|NCT01947491|527409337|FG003|Overall Study|Adverse Event|2|||
146244096|NCT00704340|527409338|FG000|Overall Study|Lost to Follow-up|2|||
146244097|NCT00704340|527409339|FG001|Overall Study|Lost to Follow-up|1|||
146244098|NCT00704340|527409338|FG000|Overall Study|Death|0|||
146244099|NCT00704340|527409339|FG001|Overall Study|Death|1|||
146244100|NCT00929526|527409340|FG000|Overall Study|Withdrawal by Subject|1|||
146244101|NCT00929526|527409341|FG001|Overall Study|Withdrawal by Subject|11|||
146244102|NCT00929526|527409340|FG000|Overall Study|Lost to Follow-up|8|||
146244103|NCT00929526|527409341|FG001|Overall Study|Lost to Follow-up|12|||
146244104|NCT00929526|527409340|FG000|Overall Study|Other|8|||
146244105|NCT00929526|527409341|FG001|Overall Study|Other|6|||
146244106|NCT00403845|527409342|FG000|Treatment Period 1|Subject withdrew consent|1|||
146244107|NCT00403845|527409343|FG001|Treatment Period 1|Subject withdrew consent|0|||
146244108|NCT00403845|527409344|FG002|Treatment Period 1|Subject withdrew consent|0|||
146244109|NCT00403845|527409345|FG003|Treatment Period 1|Subject withdrew consent|0|||
146244110|NCT00403845|527409342|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
146244111|NCT00403845|527409343|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
146244112|NCT00403845|527409344|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
146244113|NCT00403845|527409345|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
146244114|NCT00403845|527409342|FG000|Treatment Period 2|Subject withdrew consent|1|||
146244115|NCT00403845|527409343|FG001|Treatment Period 2|Subject withdrew consent|0|||
145932704|NCT02217410|526260380|FG001|Overall Study|Withdrawal by Subject|0|||
145932705|NCT02217410|526260381|FG002|Overall Study|Withdrawal by Subject|2|||
145932706|NCT02217410|526260379|FG000|Overall Study|Lost to Follow-up|0|||
145932707|NCT02217410|526260380|FG001|Overall Study|Lost to Follow-up|0|||
145932708|NCT02217410|526260381|FG002|Overall Study|Lost to Follow-up|1|||
145932709|NCT02217410|526260379|FG000|Overall Study|Lack of Efficacy|0|||
145978506|NCT04167670|526433561|FG000|Overall Study|Voluntary Withdrawal|0|||
146244116|NCT00403845|527409344|FG002|Treatment Period 2|Subject withdrew consent|0|||
146244117|NCT00403845|527409345|FG003|Treatment Period 2|Subject withdrew consent|0|||
145932710|NCT02217410|526260380|FG001|Overall Study|Lack of Efficacy|1|||
145932711|NCT02217410|526260381|FG002|Overall Study|Lack of Efficacy|0|||
145932712|NCT02217410|526260379|FG000|Overall Study|Physician Decision|1|||
145932713|NCT02217410|526260380|FG001|Overall Study|Physician Decision|3|||
145978507|NCT04167670|526433562|FG001|Overall Study|Voluntary Withdrawal|1|||
146244118|NCT00403845|527409342|FG000|Treatment Period 3|Subject withdrew consent|0|||
146244119|NCT00403845|527409343|FG001|Treatment Period 3|Subject withdrew consent|0|||
146244120|NCT00403845|527409344|FG002|Treatment Period 3|Subject withdrew consent|0|||
146244121|NCT00403845|527409345|FG003|Treatment Period 3|Subject withdrew consent|1|||
146244122|NCT00403845|527409342|FG000|Treatment Period 3|Adverse Event|0|||
146244123|NCT00403845|527409343|FG001|Treatment Period 3|Adverse Event|0|||
146244124|NCT00403845|527409344|FG002|Treatment Period 3|Adverse Event|0|||
146091030|NCT02964507|526854855|FG001|Overall Study|Physician Decision|0|||
145932714|NCT02217410|526260381|FG002|Overall Study|Physician Decision|0|||
145932715|NCT03521115|526260386|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
145932716|NCT03521115|526260387|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
145932717|NCT03521115|526260386|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
145932718|NCT03521115|526260387|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
145932719|NCT04590586|526260390|FG000|Overall Study|Death|7|||
145932720|NCT04590586|526260391|FG001|Overall Study|Death|1|||
145932721|NCT04590586|526260392|FG002|Overall Study|Death|37|||
145932722|NCT04590586|526260393|FG003|Overall Study|Death|34|||
146091031|NCT02964507|526854856|FG002|Overall Study|Physician Decision|3|||
146091032|NCT02964507|526854857|FG003|Overall Study|Physician Decision|0|||
146091033|NCT02964507|526854858|FG004|Overall Study|Physician Decision|1|||
146091034|NCT02964507|526854859|FG005|Overall Study|Physician Decision|0|||
146091035|NCT02964507|526854860|FG006|Overall Study|Physician Decision|0|||
146091036|NCT02964507|526854861|FG007|Overall Study|Physician Decision|0|||
146091037|NCT04341662|526854862|FG000|Overall Study|Did not have source-verified blood loss data|423|||
146091038|NCT04341662|526854863|FG001|Overall Study|Did not have source-verified blood loss data|514|||
145932723|NCT04590586|526260394|FG004|Overall Study|Death|19|||
145932724|NCT04590586|526260395|FG005|Overall Study|Death|3|||
145932725|NCT04590586|526260390|FG000|Overall Study|Lost to Follow-up|3|||
145932726|NCT04590586|526260391|FG001|Overall Study|Lost to Follow-up|0|||
145932727|NCT04590586|526260392|FG002|Overall Study|Lost to Follow-up|11|||
145932728|NCT04590586|526260393|FG003|Overall Study|Lost to Follow-up|11|||
145932729|NCT04590586|526260394|FG004|Overall Study|Lost to Follow-up|6|||
145932730|NCT04590586|526260395|FG005|Overall Study|Lost to Follow-up|0|||
145932731|NCT04590586|526260390|FG000|Overall Study|Withdrawal by Subject|0|||
145932732|NCT04590586|526260391|FG001|Overall Study|Withdrawal by Subject|0|||
145932733|NCT04590586|526260392|FG002|Overall Study|Withdrawal by Subject|6|||
145932734|NCT04590586|526260393|FG003|Overall Study|Withdrawal by Subject|0|||
145932735|NCT04590586|526260394|FG004|Overall Study|Withdrawal by Subject|3|||
145932736|NCT04590586|526260395|FG005|Overall Study|Withdrawal by Subject|0|||
145932737|NCT04590586|526260390|FG000|Overall Study|Other|3|||
145932738|NCT04590586|526260391|FG001|Overall Study|Other|0|||
145932739|NCT04590586|526260392|FG002|Overall Study|Other|1|||
145932740|NCT04590586|526260393|FG003|Overall Study|Other|1|||
145932741|NCT04590586|526260394|FG004|Overall Study|Other|2|||
145932742|NCT04590586|526260395|FG005|Overall Study|Other|1|||
145932743|NCT03063086|526260396|FG000|Overall Study|technical problems|1|||
145932744|NCT03063086|526260397|FG001|Overall Study|technical problems|0|||
145932745|NCT03063086|526260398|FG002|Overall Study|technical problems|0|||
145932746|NCT03063086|526260399|FG003|Overall Study|technical problems|0|||
145932747|NCT03063086|526260400|FG004|Overall Study|technical problems|0|||
145932748|NCT03063086|526260401|FG005|Overall Study|technical problems|0|||
145932749|NCT03063086|526260396|FG000|Overall Study|Adverse Event|1|||
145932750|NCT03063086|526260397|FG001|Overall Study|Adverse Event|1|||
145932751|NCT03063086|526260398|FG002|Overall Study|Adverse Event|1|||
145932752|NCT03063086|526260399|FG003|Overall Study|Adverse Event|1|||
145932753|NCT03063086|526260400|FG004|Overall Study|Adverse Event|0|||
145932754|NCT03063086|526260401|FG005|Overall Study|Adverse Event|0|||
145932755|NCT03063086|526260396|FG000|Overall Study|subject/guardian decision|1|||
145932756|NCT03063086|526260397|FG001|Overall Study|subject/guardian decision|0|||
145932757|NCT03063086|526260398|FG002|Overall Study|subject/guardian decision|0|||
145932758|NCT03063086|526260399|FG003|Overall Study|subject/guardian decision|0|||
145932759|NCT03063086|526260400|FG004|Overall Study|subject/guardian decision|0|||
145932760|NCT03063086|526260401|FG005|Overall Study|subject/guardian decision|0|||
145932761|NCT03063086|526260396|FG000|Overall Study|Non-compliance with study treatment|0|||
145932762|NCT03063086|526260397|FG001|Overall Study|Non-compliance with study treatment|0|||
145932763|NCT03063086|526260398|FG002|Overall Study|Non-compliance with study treatment|0|||
145932764|NCT03063086|526260399|FG003|Overall Study|Non-compliance with study treatment|1|||
145932765|NCT03063086|526260400|FG004|Overall Study|Non-compliance with study treatment|0|||
145932766|NCT03063086|526260401|FG005|Overall Study|Non-compliance with study treatment|1|||
145932767|NCT03063086|526260396|FG000|Overall Study|Physician Decision|0|||
145932768|NCT03063086|526260397|FG001|Overall Study|Physician Decision|0|||
145932769|NCT03063086|526260398|FG002|Overall Study|Physician Decision|0|||
145932770|NCT03063086|526260399|FG003|Overall Study|Physician Decision|1|||
145932771|NCT03063086|526260400|FG004|Overall Study|Physician Decision|0|||
145932772|NCT03063086|526260401|FG005|Overall Study|Physician Decision|0|||
145932773|NCT05481125|526260402|FG000|Overall Study|Adverse Event|1|||
145932774|NCT05481125|526260403|FG001|Overall Study|Adverse Event|0|||
145932775|NCT05481125|526260402|FG000|Overall Study|Lost to Follow-up|0|||
145932776|NCT05481125|526260403|FG001|Overall Study|Lost to Follow-up|1|||
145932777|NCT05481125|526260402|FG000|Overall Study|Withdrawal by Subject|0|||
145932778|NCT05481125|526260403|FG001|Overall Study|Withdrawal by Subject|1|||
145932779|NCT02244463|526260404|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
145932780|NCT02244463|526260405|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145932781|NCT02244463|526260406|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145932782|NCT02244463|526260407|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
146091039|NCT02325791|526854864|FG000|Overall Study|Adverse Event|0|||
145932783|NCT02244463|526260408|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145932784|NCT02244463|526260409|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145932785|NCT02244463|526260404|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
145932786|NCT02244463|526260405|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
145932787|NCT02244463|526260406|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
145932788|NCT02244463|526260407|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
145932789|NCT02244463|526260408|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
145932790|NCT02244463|526260409|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
145932791|NCT02244463|526260404|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145932792|NCT02244463|526260405|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
145932793|NCT02244463|526260406|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145932794|NCT02244463|526260407|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145932795|NCT02244463|526260408|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145932796|NCT02244463|526260409|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145932797|NCT02244463|526260404|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145932798|NCT02244463|526260405|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145932799|NCT02244463|526260406|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
145932800|NCT02244463|526260407|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145932801|NCT02244463|526260408|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145932802|NCT02244463|526260409|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145932803|NCT02244463|526260404|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145932804|NCT02244463|526260405|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145932805|NCT02244463|526260406|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145932806|NCT02244463|526260407|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
145932807|NCT02244463|526260408|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145932808|NCT02244463|526260409|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145932809|NCT02244463|526260404|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145932810|NCT02244463|526260405|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145932811|NCT02244463|526260406|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145932812|NCT02244463|526260407|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
145932813|NCT02244463|526260408|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145932814|NCT02244463|526260409|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145932815|NCT02244463|526260404|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145932816|NCT02244463|526260405|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145932817|NCT02244463|526260406|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145932818|NCT02244463|526260407|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
145932819|NCT02244463|526260408|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145932820|NCT02244463|526260409|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145932821|NCT02244463|526260404|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145932822|NCT02244463|526260405|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145932823|NCT02244463|526260406|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
146091040|NCT02325791|526854865|FG001|Overall Study|Adverse Event|1|||
145932824|NCT02244463|526260407|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
145932825|NCT02244463|526260408|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145932826|NCT02244463|526260409|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145932827|NCT02244463|526260404|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145932828|NCT02244463|526260405|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145932829|NCT02244463|526260406|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145932830|NCT02244463|526260407|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
145932831|NCT02244463|526260408|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145932832|NCT02244463|526260409|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145932833|NCT02244463|526260404|FG000|Period 5: Phase II|Disease Progression|0|||
145932834|NCT02244463|526260405|FG001|Period 5: Phase II|Disease Progression|0|||
145932835|NCT02244463|526260406|FG002|Period 5: Phase II|Disease Progression|0|||
145932836|NCT02244463|526260407|FG003|Period 5: Phase II|Disease Progression|0|||
145932837|NCT02244463|526260408|FG004|Period 5: Phase II|Disease Progression|10|||
145932838|NCT02244463|526260409|FG005|Period 5: Phase II|Disease Progression|11|||
145932839|NCT02244463|526260404|FG000|Period 5: Phase II|Physician Decision|0|||
145932840|NCT02244463|526260405|FG001|Period 5: Phase II|Physician Decision|0|||
145932841|NCT02244463|526260406|FG002|Period 5: Phase II|Physician Decision|0|||
145932842|NCT02244463|526260407|FG003|Period 5: Phase II|Physician Decision|0|||
145932843|NCT02244463|526260408|FG004|Period 5: Phase II|Physician Decision|3|||
145932844|NCT02244463|526260409|FG005|Period 5: Phase II|Physician Decision|2|||
145932845|NCT02244463|526260404|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
145932846|NCT02244463|526260405|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
145932847|NCT02244463|526260406|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
145932848|NCT02244463|526260407|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
145932849|NCT02244463|526260408|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
145932850|NCT02244463|526260409|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
145932851|NCT02244463|526260404|FG000|Period 5: Phase II|Intercurrent Illness|0|||
145932852|NCT02244463|526260405|FG001|Period 5: Phase II|Intercurrent Illness|0|||
145932853|NCT02244463|526260406|FG002|Period 5: Phase II|Intercurrent Illness|0|||
145932854|NCT02244463|526260407|FG003|Period 5: Phase II|Intercurrent Illness|0|||
145932855|NCT02244463|526260408|FG004|Period 5: Phase II|Intercurrent Illness|2|||
145932856|NCT02244463|526260409|FG005|Period 5: Phase II|Intercurrent Illness|0|||
145932857|NCT02244463|526260404|FG000|Period 5: Phase II|Adverse Event|0|||
145932858|NCT02244463|526260405|FG001|Period 5: Phase II|Adverse Event|0|||
145932859|NCT02244463|526260406|FG002|Period 5: Phase II|Adverse Event|0|||
145932860|NCT02244463|526260407|FG003|Period 5: Phase II|Adverse Event|0|||
145932861|NCT02244463|526260408|FG004|Period 5: Phase II|Adverse Event|0|||
146244125|NCT00403845|527409345|FG003|Treatment Period 3|Adverse Event|1|||
146244126|NCT03316170|527409346|FG000|Overall Study|Death|1|||
146244127|NCT03316170|527409347|FG001|Overall Study|Death|0|||
145932862|NCT02244463|526260409|FG005|Period 5: Phase II|Adverse Event|2|||
145932863|NCT02244463|526260404|FG000|Period 5: Phase II|Still On treatment|0|||
145932864|NCT02244463|526260405|FG001|Period 5: Phase II|Still On treatment|0|||
145932865|NCT02244463|526260406|FG002|Period 5: Phase II|Still On treatment|0|||
145932866|NCT02244463|526260407|FG003|Period 5: Phase II|Still On treatment|0|||
145932867|NCT02244463|526260408|FG004|Period 5: Phase II|Still On treatment|0|||
145932868|NCT02244463|526260409|FG005|Period 5: Phase II|Still On treatment|3|||
145932869|NCT01769508|526260410|FG000|Overall Study|Death|3|||
145932870|NCT01769508|526260410|FG000|Overall Study|Withdrawal by Subject|1|||
145932871|NCT01769508|526260410|FG000|Overall Study|Adverse Event|1|||
145932872|NCT01769508|526260410|FG000|Overall Study|Lost to Follow-up|1|||
145932873|NCT01290679|526260411|FG000|Overall Study|Adverse Event|2|||
145932874|NCT01290679|526260412|FG001|Overall Study|Adverse Event|0|||
145932875|NCT01290679|526260411|FG000|Overall Study|Lost to Follow-up|8|||
145932876|NCT01290679|526260412|FG001|Overall Study|Lost to Follow-up|10|||
145932877|NCT01290679|526260411|FG000|Overall Study|Protocol Violation|0|||
145932878|NCT01290679|526260412|FG001|Overall Study|Protocol Violation|1|||
145932879|NCT01290679|526260411|FG000|Overall Study|Withdrawal by Subject|6|||
145932880|NCT01290679|526260412|FG001|Overall Study|Withdrawal by Subject|5|||
145932881|NCT01290679|526260411|FG000|Overall Study|Subject Entered Another Trial|0|||
145932882|NCT01290679|526260412|FG001|Overall Study|Subject Entered Another Trial|5|||
145932883|NCT00562302|526260413|FG000|Overall Study|Lost to Follow-up|3|||
145932884|NCT00562302|526260414|FG001|Overall Study|Lost to Follow-up|3|||
145932885|NCT00562302|526260413|FG000|Overall Study|Adverse Event|0|||
145932886|NCT00562302|526260414|FG001|Overall Study|Adverse Event|6|||
145932887|NCT00562302|526260413|FG000|Overall Study|Non-compliance|1|||
145932888|NCT00562302|526260414|FG001|Overall Study|Non-compliance|2|||
145932889|NCT00562302|526260413|FG000|Overall Study|Withdrawal by Subject|7|||
145932890|NCT00562302|526260414|FG001|Overall Study|Withdrawal by Subject|8|||
145932891|NCT00562302|526260413|FG000|Overall Study|Death|1|||
145932892|NCT00562302|526260414|FG001|Overall Study|Death|2|||
145932893|NCT00562302|526260413|FG000|Overall Study|Lung resection prior to study completion|7|||
145932894|NCT00562302|526260414|FG001|Overall Study|Lung resection prior to study completion|7|||
145932895|NCT00562302|526260413|FG000|Overall Study|Not stated|1|||
145932896|NCT00562302|526260414|FG001|Overall Study|Not stated|4|||
145932897|NCT03615144|526260415|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
145932898|NCT03615144|526260416|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
145932899|NCT04791319|526260417|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
145932900|NCT04791319|526260418|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
145932901|NCT04791319|526260419|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
146244128|NCT03316170|527409346|FG000|Overall Study|Lost to Follow-up|6|||
146244129|NCT03316170|527409347|FG001|Overall Study|Lost to Follow-up|7|||
146244130|NCT02169414|527409348|FG000|Overall Study|Withdrawal by Subject|1|||
146244131|NCT02169414|527409349|FG001|Overall Study|Withdrawal by Subject|0|||
146244132|NCT02169414|527409350|FG002|Overall Study|Withdrawal by Subject|0|||
146244133|NCT02169414|527409351|FG003|Overall Study|Withdrawal by Subject|0|||
146244134|NCT02169414|527409348|FG000|Overall Study|Adverse Event|0|||
146244135|NCT02169414|527409349|FG001|Overall Study|Adverse Event|1|||
146244136|NCT02169414|527409350|FG002|Overall Study|Adverse Event|0|||
146244137|NCT02169414|527409351|FG003|Overall Study|Adverse Event|0|||
146244138|NCT00578344|527409352|FG000|Overall Study|Insurance problems|1|||
146244139|NCT00578344|527409352|FG000|Overall Study|Graft failure|1|||
145932902|NCT04791319|526260420|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
145932903|NCT04791319|526260421|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932904|NCT04791319|526260422|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932905|NCT04791319|526260423|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932906|NCT04791319|526260424|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932907|NCT04791319|526260425|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932908|NCT04791319|526260426|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
146244140|NCT03374254|527409355|FG000|Overall Study|Death|5|||
146244141|NCT03374254|527409356|FG001|Overall Study|Death|16|||
146244142|NCT03374254|527409357|FG002|Overall Study|Death|13|||
146244143|NCT03374254|527409358|FG003|Overall Study|Death|11|||
146244144|NCT03374254|527409359|FG004|Overall Study|Death|9|||
146244145|NCT03374254|527409360|FG005|Overall Study|Death|12|||
146244146|NCT03374254|527409361|FG006|Overall Study|Death|11|||
146244147|NCT03374254|527409362|FG007|Overall Study|Death|6|||
146244148|NCT03374254|527409363|FG008|Overall Study|Death|7|||
146244149|NCT03374254|527409355|FG000|Overall Study|Lost to Follow-up|0|||
146244150|NCT03374254|527409356|FG001|Overall Study|Lost to Follow-up|0|||
146244151|NCT03374254|527409357|FG002|Overall Study|Lost to Follow-up|0|||
146244152|NCT03374254|527409358|FG003|Overall Study|Lost to Follow-up|0|||
146244153|NCT03374254|527409359|FG004|Overall Study|Lost to Follow-up|0|||
146244154|NCT03374254|527409360|FG005|Overall Study|Lost to Follow-up|0|||
146244155|NCT03374254|527409361|FG006|Overall Study|Lost to Follow-up|2|||
146244156|NCT03374254|527409362|FG007|Overall Study|Lost to Follow-up|0|||
146244157|NCT03374254|527409363|FG008|Overall Study|Lost to Follow-up|0|||
146244158|NCT03374254|527409355|FG000|Overall Study|Sponsor Decision|1|||
146244159|NCT03374254|527409356|FG001|Overall Study|Sponsor Decision|0|||
146244160|NCT03374254|527409357|FG002|Overall Study|Sponsor Decision|2|||
146244161|NCT03374254|527409358|FG003|Overall Study|Sponsor Decision|3|||
146244162|NCT03374254|527409359|FG004|Overall Study|Sponsor Decision|2|||
146244163|NCT03374254|527409360|FG005|Overall Study|Sponsor Decision|3|||
146244164|NCT03374254|527409361|FG006|Overall Study|Sponsor Decision|3|||
146244165|NCT03374254|527409362|FG007|Overall Study|Sponsor Decision|3|||
146244166|NCT03374254|527409363|FG008|Overall Study|Sponsor Decision|4|||
146244167|NCT03374254|527409355|FG000|Overall Study|Withdrawal by Subject|0|||
146244168|NCT03374254|527409356|FG001|Overall Study|Withdrawal by Subject|0|||
146244169|NCT03374254|527409357|FG002|Overall Study|Withdrawal by Subject|0|||
146244170|NCT03374254|527409358|FG003|Overall Study|Withdrawal by Subject|2|||
146244171|NCT03374254|527409359|FG004|Overall Study|Withdrawal by Subject|0|||
146244172|NCT03374254|527409360|FG005|Overall Study|Withdrawal by Subject|1|||
146244173|NCT03374254|527409361|FG006|Overall Study|Withdrawal by Subject|0|||
145932909|NCT04791319|526260427|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145932910|NCT04791319|526260417|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
145932911|NCT04791319|526260418|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932912|NCT04791319|526260419|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
145932913|NCT04791319|526260420|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
145932914|NCT04791319|526260421|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932915|NCT04791319|526260422|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932916|NCT04791319|526260423|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
146244174|NCT03374254|527409362|FG007|Overall Study|Withdrawal by Subject|0|||
146244175|NCT03374254|527409363|FG008|Overall Study|Withdrawal by Subject|0|||
146244176|NCT04803734|527409364|FG000|Overall Study|Withdrawal by Subject|0|||
146244177|NCT04803734|527409365|FG001|Overall Study|Withdrawal by Subject|1|||
146244178|NCT04803734|527409364|FG000|Overall Study|Protocol Violation|0|||
146244179|NCT04803734|527409365|FG001|Overall Study|Protocol Violation|1|||
146244180|NCT02309515|527409367|FG000|Overall Study|Withdrawal by Subject|0|||
146244181|NCT02309515|527409368|FG001|Overall Study|Withdrawal by Subject|1|||
146244182|NCT00749944|527409376|FG000|Overall Study|Lost to Follow-up|2|||
146244183|NCT00749944|527409377|FG001|Overall Study|Lost to Follow-up|1|||
146244184|NCT00749944|527409376|FG000|Overall Study|Other|1|||
146244185|NCT00749944|527409377|FG001|Overall Study|Other|0|||
146244186|NCT00749944|527409376|FG000|Overall Study|Withdrawal by Subject|2|||
146244187|NCT00749944|527409377|FG001|Overall Study|Withdrawal by Subject|0|||
146244188|NCT02547974|527409378|FG000|Overall Study|Withdrawal by Subject|1|||
146244189|NCT02547974|527409379|FG001|Overall Study|Withdrawal by Subject|0|||
146244190|NCT02547974|527409380|FG002|Overall Study|Withdrawal by Subject|0|||
146244191|NCT02547974|527409381|FG003|Overall Study|Withdrawal by Subject|0|||
146244192|NCT00624377|527409384|FG000|Overall Study|Lost to Follow-up|355|||
146244193|NCT00624377|527409384|FG000|Overall Study|Withdrawal by Subject|100|||
146244194|NCT00624377|527409384|FG000|Overall Study|Adverse Event|14|||
145978508|NCT04167670|526433563|FG002|Overall Study|Voluntary Withdrawal|1|||
145978509|NCT04167670|526433561|FG000|Overall Study|Withdrawal of Consent|4|||
145978510|NCT04167670|526433562|FG001|Overall Study|Withdrawal of Consent|1|||
145978511|NCT04167670|526433563|FG002|Overall Study|Withdrawal of Consent|3|||
145978512|NCT04167670|526433561|FG000|Overall Study|Miscellaneous|7|||
145978513|NCT04167670|526433562|FG001|Overall Study|Miscellaneous|5|||
146244195|NCT00624377|527409384|FG000|Overall Study|Other|91|||
146244196|NCT00624377|527409384|FG000|Overall Study|Non-evaluable population|84|||
146244197|NCT00923078|527409385|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
146244198|NCT00923078|527409386|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
146244199|NCT00923078|527409387|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
146244200|NCT00923078|527409385|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
146244201|NCT00923078|527409386|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
146244202|NCT00923078|527409387|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
146244203|NCT02245620|527409394|FG000|Overall Study|Physician Decision|1|||
145978514|NCT04167670|526433563|FG002|Overall Study|Miscellaneous|3|||
146091041|NCT02325791|526854866|FG002|Overall Study|Adverse Event|1|||
146091042|NCT02325791|526854867|FG003|Overall Study|Adverse Event|0|||
146091043|NCT02325791|526854864|FG000|Overall Study|Death|0|||
146091044|NCT02325791|526854865|FG001|Overall Study|Death|3|||
146091045|NCT02325791|526854866|FG002|Overall Study|Death|0|||
146091046|NCT02325791|526854867|FG003|Overall Study|Death|1|||
146091047|NCT02325791|526854864|FG000|Overall Study|Lost to Follow-up|0|||
146244204|NCT02245620|527409395|FG001|Overall Study|Physician Decision|1|||
146244205|NCT01999335|527409396|FG000|Overall Study|Discontinued before receiving treatment|0|||
146244206|NCT01999335|527409397|FG001|Overall Study|Discontinued before receiving treatment|0|||
146244207|NCT01999335|527409398|FG002|Overall Study|Discontinued before receiving treatment|0|||
146244208|NCT01999335|527409399|FG003|Overall Study|Discontinued before receiving treatment|0|||
146244209|NCT01999335|527409400|FG004|Overall Study|Discontinued before receiving treatment|2|||
146244210|NCT04766996|527409401|FG000|Overall Study|Withdrawal by Subject|1|||
146244211|NCT04766996|527409402|FG001|Overall Study|Withdrawal by Subject|0|||
146244212|NCT04766996|527409403|FG002|Overall Study|Withdrawal by Subject|13|||
146244213|NCT01102426|527409406|FG000|Overall Study|Randomized but not treated|4|||
146244214|NCT01102426|527409407|FG001|Overall Study|Randomized but not treated|1|||
146244215|NCT01102426|527409406|FG000|Overall Study|Adverse Events (treatment-related)|15|||
146244216|NCT01102426|527409407|FG001|Overall Study|Adverse Events (treatment-related)|8|||
146244217|NCT01102426|527409406|FG000|Overall Study|Physician Decision|9|||
146244218|NCT01102426|527409407|FG001|Overall Study|Physician Decision|6|||
146244219|NCT01102426|527409406|FG000|Overall Study|Progressive Disease|85|||
146244220|NCT01102426|527409407|FG001|Overall Study|Progressive Disease|44|||
145932917|NCT04791319|526260424|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932918|NCT04791319|526260425|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932919|NCT04791319|526260426|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932920|NCT04791319|526260427|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145932921|NCT04791319|526260417|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
145932922|NCT04791319|526260418|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
145932923|NCT04791319|526260419|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
145932924|NCT04791319|526260420|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
145932925|NCT04791319|526260421|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932926|NCT04791319|526260422|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932927|NCT04791319|526260423|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932928|NCT04791319|526260424|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
146244221|NCT01102426|527409406|FG000|Overall Study|Adverse Events (unrelated to|9|||
146244222|NCT01102426|527409407|FG001|Overall Study|Adverse Events (unrelated to|1|||
146091048|NCT02325791|526854865|FG001|Overall Study|Lost to Follow-up|15|||
146091049|NCT02325791|526854866|FG002|Overall Study|Lost to Follow-up|14|||
146091050|NCT02325791|526854867|FG003|Overall Study|Lost to Follow-up|9|||
146091051|NCT02325791|526854864|FG000|Overall Study|Physician Decision|0|||
146091052|NCT02325791|526854865|FG001|Overall Study|Physician Decision|1|||
146091053|NCT02325791|526854866|FG002|Overall Study|Physician Decision|1|||
146091054|NCT02325791|526854867|FG003|Overall Study|Physician Decision|0|||
146091055|NCT02325791|526854864|FG000|Overall Study|Protocol Violation|0|||
146091056|NCT02325791|526854865|FG001|Overall Study|Protocol Violation|0|||
146091057|NCT02325791|526854866|FG002|Overall Study|Protocol Violation|1|||
146091058|NCT02325791|526854867|FG003|Overall Study|Protocol Violation|0|||
146091059|NCT02325791|526854864|FG000|Overall Study|Withdrawal by Subject|0|||
146244223|NCT01102426|527409406|FG000|Overall Study|Patient Refusal|24|||
146244224|NCT01102426|527409407|FG001|Overall Study|Patient Refusal|12|||
146244225|NCT01102426|527409406|FG000|Overall Study|Death (due to adverse events|0|||
146244226|NCT01102426|527409407|FG001|Overall Study|Death (due to adverse events|1|||
146244227|NCT01102426|527409406|FG000|Overall Study|Death (non-related to the study|19|||
146244228|NCT01102426|527409407|FG001|Overall Study|Death (non-related to the study|8|||
146244229|NCT01393964|527409418|FG000|Overall Study|Disease Progression|4|||
146244230|NCT01393964|527409419|FG001|Overall Study|Disease Progression|3|||
146244231|NCT01393964|527409420|FG002|Overall Study|Disease Progression|5|||
146244232|NCT01393964|527409418|FG000|Overall Study|Study drug toxicity|1|||
145932929|NCT04791319|526260425|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932930|NCT04791319|526260426|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932931|NCT04791319|526260427|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145932932|NCT04791319|526260417|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
146091060|NCT02325791|526854865|FG001|Overall Study|Withdrawal by Subject|5|||
146091061|NCT02325791|526854866|FG002|Overall Study|Withdrawal by Subject|8|||
146091062|NCT02325791|526854867|FG003|Overall Study|Withdrawal by Subject|16|||
146091063|NCT01028378|526854868|FG000|Overall Study|Lost to Follow-up|12|||
146244233|NCT01393964|527409419|FG001|Overall Study|Study drug toxicity|0|||
146244234|NCT01393964|527409420|FG002|Overall Study|Study drug toxicity|0|||
146244235|NCT01393964|527409418|FG000|Overall Study|Withdrawal by Subject|0|||
146244236|NCT01393964|527409419|FG001|Overall Study|Withdrawal by Subject|0|||
146244237|NCT01393964|527409420|FG002|Overall Study|Withdrawal by Subject|1|||
146244238|NCT01393964|527409418|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145932933|NCT04791319|526260418|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
145932934|NCT04791319|526260419|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
145932935|NCT04791319|526260420|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
146244239|NCT01393964|527409419|FG001|Overall Study|Adverse event unrelated to study drug|3|||
146244240|NCT01393964|527409420|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146244241|NCT01393964|527409418|FG000|Overall Study|Subject request stop study treatment|0|||
146244242|NCT01393964|527409419|FG001|Overall Study|Subject request stop study treatment|1|||
146244243|NCT01393964|527409420|FG002|Overall Study|Subject request stop study treatment|0|||
146244244|NCT01393964|527409418|FG000|Overall Study|Subject decided to move to transplant|1|||
146244245|NCT01393964|527409419|FG001|Overall Study|Subject decided to move to transplant|0|||
146244246|NCT01393964|527409420|FG002|Overall Study|Subject decided to move to transplant|0|||
146244247|NCT01393964|527409418|FG000|Overall Study|Subject switched to commercial supply|1|||
146244248|NCT01393964|527409419|FG001|Overall Study|Subject switched to commercial supply|0|||
146244249|NCT01393964|527409420|FG002|Overall Study|Subject switched to commercial supply|2|||
146244250|NCT01393964|527409418|FG000|Overall Study|Subject plateaued in terms of effect|1|||
146244251|NCT01393964|527409419|FG001|Overall Study|Subject plateaued in terms of effect|0|||
146244252|NCT01393964|527409420|FG002|Overall Study|Subject plateaued in terms of effect|0|||
146244253|NCT01393964|527409418|FG000|Overall Study|Investigator removed subject from study|0|||
146244254|NCT01393964|527409419|FG001|Overall Study|Investigator removed subject from study|1|||
146244255|NCT01393964|527409420|FG002|Overall Study|Investigator removed subject from study|0|||
146244256|NCT01393964|527409418|FG000|Overall Study|Subject converted to roll-over study|0|||
146244257|NCT01393964|527409419|FG001|Overall Study|Subject converted to roll-over study|1|||
146244258|NCT01393964|527409420|FG002|Overall Study|Subject converted to roll-over study|0|||
146244259|NCT01393964|527409418|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
146244260|NCT01393964|527409419|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
146244261|NCT01393964|527409420|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
146244262|NCT04492475|527409423|FG000|Overall Study|Enrolled but not treated|8|||
146244263|NCT04492475|527409424|FG001|Overall Study|Enrolled but not treated|8|||
146244264|NCT04492475|527409423|FG000|Overall Study|Withdrawal by Subject|4|||
146244265|NCT04492475|527409424|FG001|Overall Study|Withdrawal by Subject|0|||
146244266|NCT04492475|527409423|FG000|Overall Study|Became ineligible after enrollment|2|||
146244267|NCT04492475|527409424|FG001|Overall Study|Became ineligible after enrollment|0|||
146244268|NCT03938272|527409433|FG000|Overall Study|Withdrawal by Subject|1|||
146244269|NCT03938272|527409434|FG001|Overall Study|Withdrawal by Subject|0|||
146244270|NCT03938272|527409433|FG000|Overall Study|Physician Decision|0|||
146244271|NCT03938272|527409434|FG001|Overall Study|Physician Decision|2|||
146244272|NCT03938272|527409433|FG000|Overall Study|Study termination by sponsor|10|||
146244273|NCT03938272|527409434|FG001|Overall Study|Study termination by sponsor|8|||
146244274|NCT01323790|527409442|FG000|Overall Study|Other|3|||
146244275|NCT01323790|527409443|FG001|Overall Study|Other|2|||
146244276|NCT01323790|527409444|FG002|Overall Study|Other|1|||
146244277|NCT01323790|527409442|FG000|Overall Study|Lost to Follow-up|11|||
146244278|NCT01323790|527409443|FG001|Overall Study|Lost to Follow-up|9|||
146244279|NCT01323790|527409444|FG002|Overall Study|Lost to Follow-up|9|||
146244280|NCT01323790|527409442|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
146244281|NCT01323790|527409443|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
146244282|NCT01323790|527409444|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
146244283|NCT01323790|527409442|FG000|Overall Study|Lack of Efficacy|3|||
146244284|NCT01323790|527409443|FG001|Overall Study|Lack of Efficacy|0|||
146244285|NCT01323790|527409444|FG002|Overall Study|Lack of Efficacy|3|||
146244286|NCT01323790|527409442|FG000|Overall Study|Adverse Event|11|||
146244287|NCT01323790|527409443|FG001|Overall Study|Adverse Event|24|||
146244288|NCT01323790|527409444|FG002|Overall Study|Adverse Event|12|||
146244289|NCT01323790|527409442|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146244290|NCT01323790|527409443|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146244291|NCT01323790|527409444|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
145932936|NCT04791319|526260421|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145932937|NCT04791319|526260422|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146091064|NCT01028378|526854868|FG000|Overall Study|Withdrawal by Subject|1|||
146244292|NCT01323790|527409442|FG000|Overall Study|Withdrawal by Subject|23|||
146244293|NCT01323790|527409443|FG001|Overall Study|Withdrawal by Subject|20|||
146091065|NCT01028378|526854868|FG000|Overall Study|Adminstrative Reasons|4|||
146091066|NCT01298193|526854869|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
146244294|NCT01323790|527409444|FG002|Overall Study|Withdrawal by Subject|13|||
146244295|NCT01323790|527409442|FG000|Overall Study|Did Not Receive Treatment|2|||
146244296|NCT01323790|527409443|FG001|Overall Study|Did Not Receive Treatment|0|||
146244297|NCT01323790|527409444|FG002|Overall Study|Did Not Receive Treatment|1|||
146244298|NCT01323790|527409442|FG000|Overall Study|Severe non-compliance with protocol|2|||
146244299|NCT01323790|527409443|FG001|Overall Study|Severe non-compliance with protocol|2|||
146244300|NCT01323790|527409444|FG002|Overall Study|Severe non-compliance with protocol|2|||
146244301|NCT00266656|527409448|FG000|Overall Study|Death|1|||
145932938|NCT04791319|526260423|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145932939|NCT04791319|526260424|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
146244302|NCT00266656|527409449|FG001|Overall Study|Death|0|||
146244303|NCT00266656|527409448|FG000|Overall Study|Lost to Follow-up|4|||
146244304|NCT00266656|527409449|FG001|Overall Study|Lost to Follow-up|1|||
146244305|NCT00266656|527409448|FG000|Overall Study|Withdrawal by Subject|4|||
145932940|NCT04791319|526260425|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145932941|NCT04791319|526260426|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145932942|NCT04791319|526260427|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145932943|NCT04791319|526260417|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932944|NCT04791319|526260418|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932945|NCT04791319|526260419|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932946|NCT04791319|526260420|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
145932947|NCT04791319|526260421|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932948|NCT04791319|526260422|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932949|NCT04791319|526260423|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932950|NCT04791319|526260424|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932951|NCT04791319|526260425|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932952|NCT04791319|526260426|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932953|NCT04791319|526260427|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145932954|NCT04791319|526260417|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932955|NCT04791319|526260418|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932956|NCT04791319|526260419|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932957|NCT04791319|526260420|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932958|NCT04791319|526260421|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
145932959|NCT04791319|526260422|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
145932960|NCT04791319|526260423|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
145932961|NCT04791319|526260424|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932962|NCT04791319|526260425|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932963|NCT04791319|526260426|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145932964|NCT04791319|526260427|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
145932965|NCT04791319|526260417|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932966|NCT04791319|526260418|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932967|NCT04791319|526260419|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932968|NCT04791319|526260420|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932969|NCT04791319|526260421|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932970|NCT04791319|526260422|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932971|NCT04791319|526260423|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932972|NCT04791319|526260424|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932973|NCT04791319|526260425|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932974|NCT04791319|526260426|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
145932975|NCT04791319|526260427|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145932976|NCT04791319|526260417|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145932977|NCT04791319|526260418|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145932978|NCT04791319|526260419|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145932979|NCT04791319|526260420|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145932980|NCT04791319|526260421|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
145932981|NCT04791319|526260422|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
145932982|NCT04791319|526260423|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
145932983|NCT04791319|526260424|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145932984|NCT04791319|526260425|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
145932985|NCT04791319|526260426|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
146244306|NCT00266656|527409449|FG001|Overall Study|Withdrawal by Subject|2|||
146244307|NCT00266656|527409448|FG000|Overall Study|Did Not Reach Final Height|4|||
146244308|NCT00266656|527409449|FG001|Overall Study|Did Not Reach Final Height|8|||
146244309|NCT00266656|527409448|FG000|Overall Study|Parent/Caregiver Decision|1|||
146244310|NCT00266656|527409449|FG001|Overall Study|Parent/Caregiver Decision|2|||
146244311|NCT03242863|527409452|FG000|Study Week 1|Withdrawal by Subject|0|||
145932986|NCT04791319|526260427|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
146091067|NCT01298193|526854869|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
146244312|NCT03242863|527409453|FG001|Study Week 1|Withdrawal by Subject|1|||
146244313|NCT03242863|527409454|FG002|Study Week 1|Withdrawal by Subject|0|||
146244314|NCT03242863|527409455|FG003|Study Week 1|Withdrawal by Subject|0|||
145932987|NCT04791319|526260417|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145932988|NCT04791319|526260418|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145932989|NCT04791319|526260419|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145932990|NCT04791319|526260420|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145932991|NCT04791319|526260421|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
145932992|NCT04791319|526260422|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
145932993|NCT04791319|526260423|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
145932994|NCT04791319|526260424|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
145932995|NCT04791319|526260425|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
145932996|NCT04791319|526260426|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
145932997|NCT04791319|526260427|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
145932998|NCT00791661|526260428|FG000|7 Day Wash-out|Adverse Event|0|||
145932999|NCT00791661|526260429|FG001|7 Day Wash-out|Adverse Event|0|||
145933000|NCT00791661|526260430|FG002|7 Day Wash-out|Adverse Event|1|||
145933001|NCT00791661|526260428|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
145933002|NCT00791661|526260429|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
145933003|NCT00791661|526260430|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
145933004|NCT03605862|526260431|FG000|Overall Study|Withdrawal by Subject|12|||
145933005|NCT03605862|526260432|FG001|Overall Study|Withdrawal by Subject|9|||
145933006|NCT03605862|526260431|FG000|Overall Study|Adverse Event|2|||
145933007|NCT03605862|526260432|FG001|Overall Study|Adverse Event|1|||
145933008|NCT03605862|526260431|FG000|Overall Study|Physician Decision|3|||
145978515|NCT04827446|526433566|FG000|Overall Study|Lost to Follow-up|1|||
145978516|NCT04827446|526433567|FG001|Overall Study|Lost to Follow-up|1|||
145978517|NCT04827446|526433566|FG000|Overall Study|Death|2|||
145978518|NCT04827446|526433567|FG001|Overall Study|Death|0|||
145978519|NCT04827446|526433566|FG000|Overall Study|Withdrawal by Subject|2|||
145978520|NCT04827446|526433567|FG001|Overall Study|Withdrawal by Subject|2|||
145978521|NCT01363076|526433570|FG000|Overall Study|Withdrawal by Subject|0|||
145978522|NCT01363076|526433571|FG001|Overall Study|Withdrawal by Subject|1|||
145978523|NCT01112267|526433572|FG000|Overall Study|Adverse Event|24|||
145978524|NCT01112267|526433573|FG001|Overall Study|Adverse Event|6|||
145978525|NCT01112267|526433572|FG000|Overall Study|Withdrawal by Subject|3|||
145978526|NCT01112267|526433573|FG001|Overall Study|Withdrawal by Subject|5|||
145978527|NCT01112267|526433572|FG000|Overall Study|Protocol Violation|5|||
145978528|NCT01112267|526433573|FG001|Overall Study|Protocol Violation|3|||
145978529|NCT01112267|526433572|FG000|Overall Study|Participants not compliant|1|||
145978530|NCT01112267|526433573|FG001|Overall Study|Participants not compliant|2|||
145978531|NCT01112267|526433572|FG000|Overall Study|Participants not receive any study drug|1|||
145978532|NCT01112267|526433573|FG001|Overall Study|Participants not receive any study drug|2|||
145978533|NCT00003456|526433574|FG000|Overall Study|Not evaluable|8|||
145978534|NCT01410604|526433578|FG000|Overall Study|Adverse Event|2|||
145978535|NCT01410604|526433579|FG001|Overall Study|Adverse Event|1|||
145978536|NCT01410604|526433578|FG000|Overall Study|Lost to Follow-up|1|||
145978537|NCT01410604|526433579|FG001|Overall Study|Lost to Follow-up|0|||
145978538|NCT01410604|526433578|FG000|Overall Study|Physician Decision|0|||
145978539|NCT01410604|526433579|FG001|Overall Study|Physician Decision|1|||
145978540|NCT02827708|526433580|FG000|Overall Study|Lost to Follow-up|3|||
145978541|NCT02827708|526433581|FG001|Overall Study|Lost to Follow-up|1|||
145978542|NCT02827708|526433580|FG000|Overall Study|Withdrawal by Subject|1|||
145978543|NCT02827708|526433581|FG001|Overall Study|Withdrawal by Subject|2|||
145978544|NCT02827708|526433580|FG000|Overall Study|Death|1|||
145978545|NCT02827708|526433581|FG001|Overall Study|Death|2|||
145978546|NCT00898807|526433582|FG000|Overall Study|Withdrawal by Subject|5|||
145978547|NCT00898807|526433583|FG001|Overall Study|Withdrawal by Subject|3|||
145978548|NCT00898807|526433582|FG000|Overall Study|Family pressure to discontinue|2|||
145978549|NCT00898807|526433583|FG001|Overall Study|Family pressure to discontinue|2|||
145978550|NCT00898807|526433582|FG000|Overall Study|Lost to Follow-up|1|||
145978551|NCT00898807|526433583|FG001|Overall Study|Lost to Follow-up|3|||
145978552|NCT00898807|526433582|FG000|Overall Study|Death|0|||
145978553|NCT00898807|526433583|FG001|Overall Study|Death|1|||
145978554|NCT01521364|526433586|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
145978555|NCT01521364|526433586|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
146091068|NCT01298193|526854869|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
145933009|NCT03605862|526260432|FG001|Overall Study|Physician Decision|1|||
145978556|NCT02636283|526433587|FG000|Overall Study|Adverse Event|2|||
145978557|NCT02636283|526433588|FG001|Overall Study|Adverse Event|0|||
146244315|NCT03242863|527409456|FG004|Study Week 1|Withdrawal by Subject|3|||
146244316|NCT03242863|527409457|FG005|Study Week 1|Withdrawal by Subject|0|||
146244317|NCT04852978|527409458|FG000|Overall Study|Physician Decision|0|||
145978558|NCT02636283|526433587|FG000|Overall Study|Trial Terminated Prematurely|0|||
146091069|NCT01298193|526854869|FG000|Efficacy Phase (Second Cycle)|Death|1|||
146244318|NCT04852978|527409459|FG001|Overall Study|Physician Decision|1|||
145933010|NCT03605862|526260431|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
145933011|NCT03605862|526260432|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
145933012|NCT00937040|526260433|FG000|Overall Study|Adverse Event|5|||
145933013|NCT00937040|526260434|FG001|Overall Study|Adverse Event|8|||
145933014|NCT00937040|526260433|FG000|Overall Study|Lost to Follow-up|12|||
145933015|NCT00937040|526260434|FG001|Overall Study|Lost to Follow-up|12|||
145933016|NCT00937040|526260433|FG000|Overall Study|Protocol Violation|3|||
145933017|NCT00937040|526260434|FG001|Overall Study|Protocol Violation|0|||
145933018|NCT00937040|526260433|FG000|Overall Study|Withdrawal by Subject|13|||
145933019|NCT00937040|526260434|FG001|Overall Study|Withdrawal by Subject|7|||
145933020|NCT00937040|526260433|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
145933021|NCT00937040|526260434|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
145933022|NCT00937040|526260433|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
145933023|NCT00937040|526260434|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
145933024|NCT00634803|526260437|FG000|Overall Study|Lost to Follow-up|6|||
145933025|NCT00634803|526260438|FG001|Overall Study|Lost to Follow-up|7|||
145933026|NCT00634803|526260439|FG002|Overall Study|Lost to Follow-up|7|||
145933027|NCT00364923|526260440|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
145933028|NCT00364923|526260440|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
145933029|NCT00972816|526262031|FG000|Overall Study|Adverse Event|0|||
145933030|NCT00972816|526262032|FG001|Overall Study|Adverse Event|0|||
145933031|NCT00972816|526262033|FG002|Overall Study|Adverse Event|1|||
145933032|NCT00972816|526262034|FG003|Overall Study|Adverse Event|0|||
145933033|NCT00972816|526262035|FG004|Overall Study|Adverse Event|0|||
145933034|NCT00972816|526262036|FG005|Overall Study|Adverse Event|0|||
145978559|NCT02636283|526433588|FG001|Overall Study|Trial Terminated Prematurely|3|||
145978560|NCT03418675|526433589|FG000|Overall Study|Lost to Follow-up|13|||
146244319|NCT04852978|527409460|FG002|Overall Study|Physician Decision|0|||
146244320|NCT04852978|527409461|FG003|Overall Study|Physician Decision|0|||
145978561|NCT03418675|526433590|FG001|Overall Study|Lost to Follow-up|10|||
145978562|NCT03418675|526433589|FG000|Overall Study|Adverse Event|2|||
145978563|NCT03418675|526433590|FG001|Overall Study|Adverse Event|0|||
145978564|NCT01178411|526433591|FG000|Overall Study|Adverse Event|5|||
145978565|NCT01178411|526433591|FG000|Overall Study|Withdrawal by Subject|4|||
145978566|NCT01178411|526433591|FG000|Overall Study|Protocol Violation|1|||
145978567|NCT01178411|526433591|FG000|Overall Study|Progressive disease per RECIST|32|||
145978568|NCT01178411|526433591|FG000|Overall Study|Progressive disease per clinician|9|||
145978569|NCT01178411|526433591|FG000|Overall Study|Physician Decision|6|||
145978570|NCT01178411|526433591|FG000|Overall Study|Death|1|||
145978571|NCT01178411|526433591|FG000|Overall Study|No reason provided|1|||
145978572|NCT01178411|526433591|FG000|Overall Study|Drug manufacturing ended|1|||
145978573|NCT02383173|526433595|FG000|Overall Study|Palliative Care Team withdrew|0|||
145978574|NCT02383173|526433596|FG001|Overall Study|Palliative Care Team withdrew|2|||
145978575|NCT04900272|526433597|FG000|Overall Study|Lost to Follow-up|2|||
145978576|NCT04900272|526433597|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
145978577|NCT04900272|526433597|FG000|Overall Study|Withdrawal by Subject|1|||
145978578|NCT01625182|526433598|FG000|Overall Study|Administrative problems|1|||
145978579|NCT01625182|526433599|FG001|Overall Study|Administrative problems|0|||
145978580|NCT01625182|526433598|FG000|Overall Study|Protocol deviation|0|||
146244321|NCT04852978|527409462|FG004|Overall Study|Physician Decision|0|||
146244322|NCT04852978|527409463|FG005|Overall Study|Physician Decision|0|||
146244323|NCT04852978|527409464|FG006|Overall Study|Physician Decision|0|||
145933035|NCT00972816|526262037|FG006|Overall Study|Adverse Event|0|||
145933036|NCT00972816|526262038|FG007|Overall Study|Adverse Event|0|||
145933037|NCT00972816|526262031|FG000|Overall Study|Withdrawal by Subject|4|||
145933038|NCT00972816|526262032|FG001|Overall Study|Withdrawal by Subject|2|||
145933039|NCT00972816|526262033|FG002|Overall Study|Withdrawal by Subject|1|||
145933040|NCT00972816|526262034|FG003|Overall Study|Withdrawal by Subject|3|||
145978581|NCT01625182|526433599|FG001|Overall Study|Protocol deviation|2|||
145978582|NCT01625182|526433598|FG000|Overall Study|Adverse Event|2|||
145978583|NCT01625182|526433599|FG001|Overall Study|Adverse Event|0|||
145978584|NCT01625182|526433598|FG000|Overall Study|Withdrawal by Subject|5|||
145978585|NCT01625182|526433599|FG001|Overall Study|Withdrawal by Subject|1|||
145978586|NCT01625182|526433598|FG000|Overall Study|Lack of Efficacy|12|||
145978587|NCT01625182|526433599|FG001|Overall Study|Lack of Efficacy|8|||
145978588|NCT05059080|526433600|FG000|Overall Study|Withdrawal by Subject|3|||
145978589|NCT05059080|526433600|FG000|Overall Study|Study Terminated by Sponsor|64|||
145978590|NCT00263562|526433601|FG000|Overall Study|Protocol Violation|3|||
145978591|NCT00263562|526433602|FG001|Overall Study|Protocol Violation|0|||
145978592|NCT01922011|526433603|FG000|Overall Study|Protocol Violation|0|||
145978593|NCT01922011|526433604|FG001|Overall Study|Protocol Violation|1|||
145978594|NCT01922011|526433603|FG000|Overall Study|Physician Decision|0|||
146091070|NCT00064298|526854870|FG000|Overall Study|Withdrawal by Subject|2|||
146244324|NCT04852978|527409465|FG007|Overall Study|Physician Decision|2|||
145978595|NCT01922011|526433604|FG001|Overall Study|Physician Decision|1|||
146244325|NCT04852978|527409466|FG008|Overall Study|Physician Decision|0|||
145933041|NCT00972816|526262035|FG004|Overall Study|Withdrawal by Subject|0|||
145933042|NCT00972816|526262036|FG005|Overall Study|Withdrawal by Subject|1|||
145933043|NCT00972816|526262037|FG006|Overall Study|Withdrawal by Subject|1|||
145933044|NCT00972816|526262038|FG007|Overall Study|Withdrawal by Subject|2|||
145933045|NCT00972816|526262031|FG000|Overall Study|Lost to Follow-up|11|||
145933046|NCT00972816|526262032|FG001|Overall Study|Lost to Follow-up|9|||
145933047|NCT00972816|526262033|FG002|Overall Study|Lost to Follow-up|7|||
145933048|NCT00972816|526262034|FG003|Overall Study|Lost to Follow-up|5|||
145933049|NCT00972816|526262035|FG004|Overall Study|Lost to Follow-up|11|||
145933050|NCT00972816|526262036|FG005|Overall Study|Lost to Follow-up|10|||
145933051|NCT00972816|526262037|FG006|Overall Study|Lost to Follow-up|7|||
145933052|NCT00972816|526262038|FG007|Overall Study|Lost to Follow-up|7|||
145933053|NCT00972816|526262031|FG000|Overall Study|Inappropriate enrolment|0|||
145933054|NCT00972816|526262032|FG001|Overall Study|Inappropriate enrolment|0|||
145933055|NCT00972816|526262033|FG002|Overall Study|Inappropriate enrolment|0|||
145933056|NCT00972816|526262034|FG003|Overall Study|Inappropriate enrolment|0|||
145933057|NCT00972816|526262035|FG004|Overall Study|Inappropriate enrolment|0|||
145933058|NCT00972816|526262036|FG005|Overall Study|Inappropriate enrolment|0|||
145933059|NCT00972816|526262037|FG006|Overall Study|Inappropriate enrolment|2|||
145933060|NCT00972816|526262038|FG007|Overall Study|Inappropriate enrolment|0|||
145933061|NCT00972816|526262031|FG000|Overall Study|Unable to classify|2|||
145933062|NCT00972816|526262032|FG001|Overall Study|Unable to classify|0|||
145933063|NCT00972816|526262033|FG002|Overall Study|Unable to classify|0|||
145933064|NCT00972816|526262034|FG003|Overall Study|Unable to classify|0|||
145933065|NCT00972816|526262035|FG004|Overall Study|Unable to classify|1|||
145933066|NCT00972816|526262036|FG005|Overall Study|Unable to classify|0|||
145933067|NCT00972816|526262037|FG006|Overall Study|Unable to classify|0|||
145933068|NCT00972816|526262038|FG007|Overall Study|Unable to classify|0|||
145933069|NCT00593684|526262041|FG000|Overall Study|Death|2|||
145933070|NCT00593684|526262042|FG001|Overall Study|Death|1|||
145933071|NCT03625466|526262043|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
145933072|NCT03625466|526262044|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
145933073|NCT03625466|526262045|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
145933074|NCT03625466|526262043|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145933075|NCT03625466|526262044|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
145933076|NCT03625466|526262045|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145933077|NCT03625466|526262043|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145933078|NCT03625466|526262044|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145933079|NCT03625466|526262045|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
145933080|NCT03200704|526262047|FG000|Overall Study|Withdrawal by Subject|1|||
145933081|NCT00654875|526262048|FG000|Overall Study|Adverse Event|5|||
145933082|NCT00654875|526262049|FG001|Overall Study|Adverse Event|5|||
145933083|NCT00654875|526262048|FG000|Overall Study|Withdrawal by Subject|4|||
145933084|NCT00654875|526262049|FG001|Overall Study|Withdrawal by Subject|4|||
145933085|NCT00654875|526262048|FG000|Overall Study|Protocol Violation|3|||
145933086|NCT00654875|526262049|FG001|Overall Study|Protocol Violation|3|||
145933087|NCT00654875|526262048|FG000|Overall Study|Lack of Efficacy|2|||
145933088|NCT00654875|526262049|FG001|Overall Study|Lack of Efficacy|2|||
145933089|NCT00654875|526262048|FG000|Overall Study|Lost to Follow-up|1|||
145933090|NCT00654875|526262049|FG001|Overall Study|Lost to Follow-up|3|||
145933091|NCT00654875|526262048|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
145933092|NCT00654875|526262049|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145933093|NCT00654875|526262048|FG000|Overall Study|Administrative Problems|1|||
145933094|NCT00654875|526262049|FG001|Overall Study|Administrative Problems|0|||
145933095|NCT01683266|526262058|FG000|Overall Study|Adverse Event|5|||
145933096|NCT01683266|526262059|FG001|Overall Study|Adverse Event|4|||
145933097|NCT01683266|526262058|FG000|Overall Study|Lack of Efficacy|5|||
145933098|NCT01683266|526262059|FG001|Overall Study|Lack of Efficacy|2|||
145933099|NCT01683266|526262058|FG000|Overall Study|Protocol Violation|13|||
145933100|NCT01683266|526262059|FG001|Overall Study|Protocol Violation|6|||
145933101|NCT01683266|526262058|FG000|Overall Study|Personal Reason|17|||
145933102|NCT01683266|526262059|FG001|Overall Study|Personal Reason|25|||
145933103|NCT01683266|526262058|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
145933104|NCT01683266|526262059|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
145978596|NCT01922011|526433603|FG000|Overall Study|Parent/Guardian Decision|3|||
146244326|NCT04852978|527409458|FG000|Overall Study|Sponsor request|0|||
146244327|NCT04852978|527409459|FG001|Overall Study|Sponsor request|0|||
145933105|NCT01683266|526262058|FG000|Overall Study|Lost to Follow-up|5|||
145933106|NCT01683266|526262059|FG001|Overall Study|Lost to Follow-up|0|||
145933107|NCT01683266|526262058|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
145933108|NCT01683266|526262059|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
145933109|NCT01683266|526262058|FG000|Overall Study|Nonserious Hypoglycemia|0|||
145933110|NCT01683266|526262059|FG001|Overall Study|Nonserious Hypoglycemia|3|||
146244328|NCT04852978|527409460|FG002|Overall Study|Sponsor request|1|||
145978597|NCT01922011|526433604|FG001|Overall Study|Parent/Guardian Decision|0|||
145933111|NCT01683266|526262058|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145933112|NCT01683266|526262059|FG001|Overall Study|Perceived Lack of Efficacy|1|||
145933113|NCT01683266|526262058|FG000|Overall Study|Possibly Hypoglycemia|1|||
145933114|NCT01683266|526262059|FG001|Overall Study|Possibly Hypoglycemia|0|||
145933115|NCT01683266|526262058|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
145933116|NCT01683266|526262059|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
145933117|NCT00626821|526262064|FG000|Overall Study|Adverse Event|44|||
145933118|NCT00626821|526262064|FG000|Overall Study|Protocol Violation|33|||
145933119|NCT00626821|526262064|FG000|Overall Study|Withdrawal by Subject|10|||
145933120|NCT00626821|526262064|FG000|Overall Study|Physician Decision|9|||
145933121|NCT00626821|526262064|FG000|Overall Study|Product dysfunction|21|||
145933122|NCT00626821|526262064|FG000|Overall Study|other/unknown reason|104|||
145933123|NCT01940887|526262065|FG000|Year 1|Protocol Violation|0|||
145933124|NCT01940887|526262066|FG001|Year 1|Protocol Violation|1|||
145933125|NCT01940887|526262065|FG000|Year 1|Physician Decision|7|||
145933126|NCT01940887|526262066|FG001|Year 1|Physician Decision|3|||
145933127|NCT01940887|526262065|FG000|Year 1|Death|5|||
145933128|NCT01940887|526262066|FG001|Year 1|Death|3|||
145933129|NCT01940887|526262065|FG000|Year 1|Adverse Event|7|||
145933130|NCT01940887|526262066|FG001|Year 1|Adverse Event|6|||
145933131|NCT01940887|526262065|FG000|Year 1|Withdrawal by Subject|18|||
145933132|NCT01940887|526262066|FG001|Year 1|Withdrawal by Subject|9|||
145933133|NCT01940887|526262065|FG000|Year 1|Lost to Follow-up|2|||
145933134|NCT01940887|526262066|FG001|Year 1|Lost to Follow-up|1|||
145933135|NCT01940887|526262065|FG000|Year 2|Physician Decision|8|||
145933136|NCT01940887|526262066|FG001|Year 2|Physician Decision|1|||
145933137|NCT01940887|526262065|FG000|Year 2|Death|0|||
145933138|NCT01940887|526262066|FG001|Year 2|Death|2|||
145933139|NCT01940887|526262065|FG000|Year 2|Sponsor Decision, early termination|192|||
145933140|NCT01940887|526262066|FG001|Year 2|Sponsor Decision, early termination|203|||
145933141|NCT01940887|526262065|FG000|Year 2|Adverse Event|8|||
145933142|NCT01940887|526262066|FG001|Year 2|Adverse Event|2|||
145933143|NCT01940887|526262065|FG000|Year 2|Withdrawal by Subject|8|||
145933144|NCT01940887|526262066|FG001|Year 2|Withdrawal by Subject|8|||
145933145|NCT01940887|526262065|FG000|Year 2|Lost to Follow-up|1|||
145933146|NCT01940887|526262066|FG001|Year 2|Lost to Follow-up|6|||
145933147|NCT01062113|526262067|FG000|Overall Study|Adverse Event|1|||
145933148|NCT01062113|526262068|FG001|Overall Study|Adverse Event|0|||
145933149|NCT01062113|526262069|FG002|Overall Study|Adverse Event|0|||
145933150|NCT01062113|526262067|FG000|Overall Study|Lack of Efficacy|38|||
145933151|NCT01062113|526262068|FG001|Overall Study|Lack of Efficacy|22|||
145933152|NCT01062113|526262069|FG002|Overall Study|Lack of Efficacy|31|||
145933153|NCT01062113|526262067|FG000|Overall Study|Withdrawal by Subject|1|||
145933154|NCT01062113|526262068|FG001|Overall Study|Withdrawal by Subject|0|||
145978598|NCT01922011|526433603|FG000|Overall Study|Lost to Follow-up|0|||
145978599|NCT01922011|526433604|FG001|Overall Study|Lost to Follow-up|1|||
145978600|NCT01922011|526433603|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
145978601|NCT01922011|526433604|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
145978602|NCT01922011|526433603|FG000|Overall Study|Not Treated|1|||
145978603|NCT01922011|526433604|FG001|Overall Study|Not Treated|0|||
145978604|NCT01922011|526433603|FG000|Overall Study|Lack of willing home health agency|1|||
145978605|NCT01922011|526433604|FG001|Overall Study|Lack of willing home health agency|0|||
145978606|NCT01922011|526433603|FG000|Overall Study|Randomized in error|1|||
145978607|NCT01922011|526433604|FG001|Overall Study|Randomized in error|0|||
145978608|NCT01257542|526433609|FG000|Overall Study|Protocol Violation|3|||
145978609|NCT01257542|526433610|FG001|Overall Study|Protocol Violation|5|||
145978610|NCT01257542|526433609|FG000|Overall Study|Withdrawal by Subject|0|||
145978611|NCT01257542|526433610|FG001|Overall Study|Withdrawal by Subject|2|||
145978612|NCT00770484|526433612|FG000|Overall Study|Withdrawal by Subject|1|||
145978613|NCT00770484|526433613|FG001|Overall Study|Withdrawal by Subject|0|||
145978614|NCT00195429|526433614|FG000|Overall Study|Adverse Event|2|||
146297793|NCT01009554|527605999|FG001|Overall Study|Noncompliant with Study Product|3|||
145978615|NCT00195429|526433615|FG001|Overall Study|Adverse Event|4|||
145933155|NCT01062113|526262069|FG002|Overall Study|Withdrawal by Subject|0|||
145933156|NCT03655470|526262075|FG000|Overall Study|Lost to Follow-up|6|||
145933157|NCT03655470|526262076|FG001|Overall Study|Lost to Follow-up|7|||
145933158|NCT01893281|526262078|FG000|Overall Study|Adverse Event|1|||
145933159|NCT01893281|526262078|FG000|Overall Study|Protocol Violation|1|||
145933160|NCT01893281|526262078|FG000|Overall Study|Withdrawal by Subject|1|||
145933161|NCT00679289|526262084|FG000|Overall Study|Progressive disease|4|||
145933162|NCT00679289|526262085|FG001|Overall Study|Progressive disease|5|||
145933163|NCT00679289|526262086|FG002|Overall Study|Progressive disease|18|||
145933164|NCT00679289|526262084|FG000|Overall Study|Withdrawal by Subject|0|||
145933165|NCT00679289|526262085|FG001|Overall Study|Withdrawal by Subject|1|||
145933166|NCT00679289|526262086|FG002|Overall Study|Withdrawal by Subject|1|||
145933167|NCT00679289|526262084|FG000|Overall Study|Adverse Event|0|||
145933168|NCT00679289|526262085|FG001|Overall Study|Adverse Event|0|||
145933169|NCT00679289|526262086|FG002|Overall Study|Adverse Event|3|||
145933170|NCT00679289|526262084|FG000|Overall Study|Physician Decision|1|||
145933171|NCT00679289|526262085|FG001|Overall Study|Physician Decision|0|||
146244329|NCT04852978|527409461|FG003|Overall Study|Sponsor request|0|||
146244330|NCT04852978|527409462|FG004|Overall Study|Sponsor request|0|||
146244331|NCT04852978|527409463|FG005|Overall Study|Sponsor request|0|||
146244332|NCT04852978|527409464|FG006|Overall Study|Sponsor request|0|||
146244333|NCT04852978|527409465|FG007|Overall Study|Sponsor request|0|||
146244334|NCT04852978|527409466|FG008|Overall Study|Sponsor request|0|||
146244335|NCT04852978|527409458|FG000|Overall Study|Death|0|||
146244336|NCT04852978|527409459|FG001|Overall Study|Death|0|||
146244337|NCT04852978|527409460|FG002|Overall Study|Death|0|||
146244338|NCT04852978|527409461|FG003|Overall Study|Death|0|||
146244339|NCT04852978|527409462|FG004|Overall Study|Death|0|||
146244340|NCT04852978|527409463|FG005|Overall Study|Death|0|||
146244341|NCT04852978|527409464|FG006|Overall Study|Death|1|||
146244342|NCT04852978|527409465|FG007|Overall Study|Death|0|||
146244343|NCT04852978|527409466|FG008|Overall Study|Death|0|||
146244344|NCT04852978|527409458|FG000|Overall Study|Lost to Follow-up|3|||
145933172|NCT00679289|526262086|FG002|Overall Study|Physician Decision|1|||
145933173|NCT01355575|526262090|FG000|Overall Study|Withdrawal by Subject|2|||
145933174|NCT02438826|526262095|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
145933175|NCT02438826|526262096|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
145933176|NCT02438826|526262097|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145933177|NCT02438826|526262098|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145933178|NCT02438826|526262095|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
145933179|NCT02438826|526262096|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145933180|NCT02438826|526262097|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145933181|NCT02438826|526262098|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145933182|NCT02438826|526262095|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
145933183|NCT02438826|526262096|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
145933184|NCT02438826|526262097|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145933185|NCT02438826|526262098|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145933186|NCT02438826|526262095|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
145933187|NCT02438826|526262096|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
145933188|NCT02438826|526262097|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145933189|NCT02438826|526262098|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
145933190|NCT02438826|526262095|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
145933191|NCT02438826|526262096|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
145933192|NCT02438826|526262097|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
145933193|NCT02438826|526262098|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
145933194|NCT02438826|526262095|FG000|Open-Label Treatment Phase|Adverse Event|11|||
145933195|NCT02438826|526262096|FG001|Open-Label Treatment Phase|Adverse Event|6|||
145933196|NCT02438826|526262097|FG002|Open-Label Treatment Phase|Adverse Event|0|||
145933197|NCT02438826|526262098|FG003|Open-Label Treatment Phase|Adverse Event|0|||
145933198|NCT02438826|526262095|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
145933199|NCT02438826|526262096|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
145933200|NCT02438826|526262097|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
145933201|NCT02438826|526262098|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
145933202|NCT02438826|526262095|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
145933203|NCT02438826|526262096|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
145933204|NCT02438826|526262097|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
145933205|NCT02438826|526262098|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
145933206|NCT02438826|526262095|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
145933207|NCT02438826|526262096|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
145933208|NCT02438826|526262097|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
145933209|NCT02438826|526262098|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
145978616|NCT00195429|526433614|FG000|Overall Study|Lack of Efficacy|2|||
145978617|NCT00195429|526433615|FG001|Overall Study|Lack of Efficacy|1|||
145978618|NCT00195429|526433614|FG000|Overall Study|Lost to Follow-up|1|||
145933210|NCT02438826|526262095|FG000|Post-Treatment Phase|Adverse Event|3|||
145933211|NCT02438826|526262096|FG001|Post-Treatment Phase|Adverse Event|0|||
145933212|NCT02438826|526262097|FG002|Post-Treatment Phase|Adverse Event|0|||
145978619|NCT00195429|526433615|FG001|Overall Study|Lost to Follow-up|0|||
145978620|NCT04925934|526433616|FG000|Overall Study|Adverse Event|1|||
145978621|NCT04925934|526433617|FG001|Overall Study|Adverse Event|0|||
145978622|NCT04925934|526433618|FG002|Overall Study|Adverse Event|0|||
146244345|NCT04852978|527409459|FG001|Overall Study|Lost to Follow-up|2|||
146244346|NCT04852978|527409460|FG002|Overall Study|Lost to Follow-up|2|||
146244347|NCT04852978|527409461|FG003|Overall Study|Lost to Follow-up|0|||
146244348|NCT04852978|527409462|FG004|Overall Study|Lost to Follow-up|2|||
145933213|NCT02438826|526262098|FG003|Post-Treatment Phase|Adverse Event|0|||
145933214|NCT02438826|526262095|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
145933215|NCT02438826|526262096|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
145978623|NCT04925934|526433616|FG000|Overall Study|Lost to Follow-up|2|||
146244349|NCT04852978|527409463|FG005|Overall Study|Lost to Follow-up|4|||
146244350|NCT04852978|527409464|FG006|Overall Study|Lost to Follow-up|1|||
146244351|NCT04852978|527409465|FG007|Overall Study|Lost to Follow-up|2|||
146244352|NCT04852978|527409466|FG008|Overall Study|Lost to Follow-up|2|||
146244353|NCT04852978|527409458|FG000|Overall Study|Withdrawal by Subject|4|||
145933216|NCT02438826|526262097|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
145933217|NCT02438826|526262098|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
145933218|NCT02438826|526262095|FG000|Post-Treatment Phase|Physician Decision|1|||
145933219|NCT02438826|526262096|FG001|Post-Treatment Phase|Physician Decision|0|||
145933220|NCT02438826|526262097|FG002|Post-Treatment Phase|Physician Decision|0|||
145933221|NCT02438826|526262098|FG003|Post-Treatment Phase|Physician Decision|0|||
145933222|NCT02438826|526262095|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
145933223|NCT02438826|526262096|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
145933224|NCT02438826|526262097|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
145933225|NCT02438826|526262098|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
145933226|NCT00552396|526262106|FG000|Overall Study|protocol withdrawal criteria|3|||
145933227|NCT00552396|526262107|FG001|Overall Study|protocol withdrawal criteria|3|||
145933228|NCT00552396|526262108|FG002|Overall Study|protocol withdrawal criteria|3|||
145933229|NCT00552396|526262109|FG003|Overall Study|protocol withdrawal criteria|6|||
145933230|NCT00552396|526262110|FG004|Overall Study|protocol withdrawal criteria|3|||
145933231|NCT00552396|526262111|FG005|Overall Study|protocol withdrawal criteria|3|||
145933232|NCT00552396|526262112|FG006|Overall Study|protocol withdrawal criteria|9|||
145933233|NCT02553499|526262119|FG000|Overall Study|Adverse Event|0|||
145933234|NCT02553499|526262120|FG001|Overall Study|Adverse Event|0|||
145933235|NCT02553499|526262121|FG002|Overall Study|Adverse Event|0|||
145933236|NCT02553499|526262122|FG003|Overall Study|Adverse Event|0|||
145933237|NCT02553499|526262123|FG004|Overall Study|Adverse Event|0|||
145933238|NCT02553499|526262124|FG005|Overall Study|Adverse Event|0|||
145933239|NCT02553499|526262125|FG006|Overall Study|Adverse Event|1|||
145933240|NCT02553499|526262126|FG007|Overall Study|Adverse Event|1|||
145933241|NCT02553499|526262127|FG008|Overall Study|Adverse Event|0|||
145933242|NCT02553499|526262128|FG009|Overall Study|Adverse Event|0|||
145933243|NCT02553499|526262129|FG010|Overall Study|Adverse Event|0|||
145933244|NCT02553499|526262130|FG011|Overall Study|Adverse Event|0|||
145933245|NCT02553499|526262131|FG012|Overall Study|Adverse Event|0|||
145933246|NCT02553499|526262132|FG013|Overall Study|Adverse Event|1|||
145933247|NCT02553499|526262119|FG000|Overall Study|Death|0|||
145933248|NCT02553499|526262120|FG001|Overall Study|Death|1|||
145933249|NCT02553499|526262121|FG002|Overall Study|Death|1|||
145933250|NCT02553499|526262122|FG003|Overall Study|Death|0|||
145933251|NCT02553499|526262123|FG004|Overall Study|Death|1|||
145933252|NCT02553499|526262124|FG005|Overall Study|Death|2|||
145933253|NCT02553499|526262125|FG006|Overall Study|Death|0|||
145933254|NCT02553499|526262126|FG007|Overall Study|Death|0|||
145933255|NCT02553499|526262127|FG008|Overall Study|Death|0|||
145933256|NCT02553499|526262128|FG009|Overall Study|Death|0|||
145933257|NCT02553499|526262129|FG010|Overall Study|Death|1|||
145933258|NCT02553499|526262130|FG011|Overall Study|Death|0|||
145933259|NCT02553499|526262131|FG012|Overall Study|Death|0|||
145933260|NCT02553499|526262132|FG013|Overall Study|Death|0|||
145933261|NCT02553499|526262119|FG000|Overall Study|Lost to Follow-up|0|||
145933262|NCT02553499|526262120|FG001|Overall Study|Lost to Follow-up|0|||
145933263|NCT02553499|526262121|FG002|Overall Study|Lost to Follow-up|0|||
145933264|NCT02553499|526262122|FG003|Overall Study|Lost to Follow-up|0|||
145933265|NCT02553499|526262123|FG004|Overall Study|Lost to Follow-up|0|||
145933266|NCT02553499|526262124|FG005|Overall Study|Lost to Follow-up|0|||
145933267|NCT02553499|526262125|FG006|Overall Study|Lost to Follow-up|1|||
145933268|NCT02553499|526262126|FG007|Overall Study|Lost to Follow-up|0|||
146244354|NCT04852978|527409459|FG001|Overall Study|Withdrawal by Subject|2|||
146244355|NCT04852978|527409460|FG002|Overall Study|Withdrawal by Subject|2|||
146244356|NCT04852978|527409461|FG003|Overall Study|Withdrawal by Subject|1|||
146244357|NCT04852978|527409462|FG004|Overall Study|Withdrawal by Subject|5|||
146244358|NCT04852978|527409463|FG005|Overall Study|Withdrawal by Subject|3|||
146244359|NCT04852978|527409464|FG006|Overall Study|Withdrawal by Subject|2|||
146244360|NCT04852978|527409465|FG007|Overall Study|Withdrawal by Subject|2|||
146244361|NCT04852978|527409466|FG008|Overall Study|Withdrawal by Subject|1|||
146244362|NCT04633200|527410877|FG000|Overall Study|Lost to Follow-up|3|||
146244363|NCT04633200|527410878|FG001|Overall Study|Lost to Follow-up|5|||
145933269|NCT02553499|526262127|FG008|Overall Study|Lost to Follow-up|0|||
145933270|NCT02553499|526262128|FG009|Overall Study|Lost to Follow-up|0|||
145933271|NCT02553499|526262129|FG010|Overall Study|Lost to Follow-up|0|||
145933272|NCT02553499|526262130|FG011|Overall Study|Lost to Follow-up|0|||
145933273|NCT02553499|526262131|FG012|Overall Study|Lost to Follow-up|0|||
145933274|NCT02553499|526262132|FG013|Overall Study|Lost to Follow-up|0|||
145933275|NCT02553499|526262119|FG000|Overall Study|Physician Decision|0|||
145933276|NCT02553499|526262120|FG001|Overall Study|Physician Decision|1|||
145933277|NCT02553499|526262121|FG002|Overall Study|Physician Decision|1|||
145933278|NCT02553499|526262122|FG003|Overall Study|Physician Decision|0|||
145933279|NCT02553499|526262123|FG004|Overall Study|Physician Decision|1|||
145933280|NCT02553499|526262124|FG005|Overall Study|Physician Decision|0|||
145933281|NCT02553499|526262125|FG006|Overall Study|Physician Decision|0|||
145933282|NCT02553499|526262126|FG007|Overall Study|Physician Decision|1|||
145933283|NCT02553499|526262127|FG008|Overall Study|Physician Decision|1|||
146244364|NCT02092285|527410879|FG000|Induction Phase|Adverse Event|7|||
146244365|NCT02092285|527410879|FG000|Induction Phase|Physician Decision|4|||
146244366|NCT02092285|527410879|FG000|Induction Phase|Pregnancy|1|||
146244367|NCT02092285|527410879|FG000|Induction Phase|Relapse/Recurrence|7|||
146244368|NCT02092285|527410879|FG000|Induction Phase|Withdrawal by Subject|2|||
146244369|NCT02092285|527410879|FG000|Induction Phase|Lack of Efficacy|14|||
146244370|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
146244371|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
146244372|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
146244373|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
146244374|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
146244375|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
146244376|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
146244377|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
146244378|NCT02092285|527410879|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
146244379|NCT00087516|527410880|FG000|Overall Study|Adverse Event|10|||
146244380|NCT00087516|527410881|FG001|Overall Study|Adverse Event|10|||
146244381|NCT00087516|527410882|FG002|Overall Study|Adverse Event|3|||
146244382|NCT00087516|527410883|FG003|Overall Study|Adverse Event|6|||
146244383|NCT00087516|527410880|FG000|Overall Study|Lack of Efficacy|82|||
146244384|NCT00087516|527410881|FG001|Overall Study|Lack of Efficacy|80|||
146244385|NCT00087516|527410882|FG002|Overall Study|Lack of Efficacy|39|||
146244386|NCT00087516|527410883|FG003|Overall Study|Lack of Efficacy|29|||
146244387|NCT00087516|527410880|FG000|Overall Study|Lost to Follow-up|8|||
146244388|NCT00087516|527410881|FG001|Overall Study|Lost to Follow-up|6|||
146244389|NCT00087516|527410882|FG002|Overall Study|Lost to Follow-up|5|||
146244390|NCT00087516|527410883|FG003|Overall Study|Lost to Follow-up|5|||
146244391|NCT00087516|527410880|FG000|Overall Study|Protocol Violation|4|||
146244392|NCT00087516|527410881|FG001|Overall Study|Protocol Violation|8|||
146244393|NCT00087516|527410882|FG002|Overall Study|Protocol Violation|3|||
146244394|NCT00087516|527410883|FG003|Overall Study|Protocol Violation|6|||
146244395|NCT00087516|527410880|FG000|Overall Study|Withdrawal by Subject|16|||
146244396|NCT00087516|527410881|FG001|Overall Study|Withdrawal by Subject|27|||
146244397|NCT00087516|527410882|FG002|Overall Study|Withdrawal by Subject|11|||
146244398|NCT00087516|527410883|FG003|Overall Study|Withdrawal by Subject|12|||
146244399|NCT00087516|527410880|FG000|Overall Study|Site terminated|0|||
146244400|NCT00087516|527410881|FG001|Overall Study|Site terminated|2|||
146244401|NCT00087516|527410882|FG002|Overall Study|Site terminated|1|||
146244402|NCT00087516|527410883|FG003|Overall Study|Site terminated|0|||
146244403|NCT00087516|527410880|FG000|Overall Study|Protocol specified discontinuation|35|||
146244404|NCT00087516|527410881|FG001|Overall Study|Protocol specified discontinuation|33|||
146244405|NCT00087516|527410882|FG002|Overall Study|Protocol specified discontinuation|33|||
146244406|NCT00087516|527410883|FG003|Overall Study|Protocol specified discontinuation|26|||
146244407|NCT00087516|527410880|FG000|Overall Study|Patient moved|3|||
145978624|NCT04925934|526433617|FG001|Overall Study|Lost to Follow-up|0|||
145978625|NCT04925934|526433618|FG002|Overall Study|Lost to Follow-up|1|||
146244408|NCT00087516|527410881|FG001|Overall Study|Patient moved|2|||
146244409|NCT00087516|527410882|FG002|Overall Study|Patient moved|1|||
146244410|NCT00087516|527410883|FG003|Overall Study|Patient moved|0|||
146244411|NCT00087516|527410880|FG000|Overall Study|Patient was non-compliant|3|||
146244412|NCT00087516|527410881|FG001|Overall Study|Patient was non-compliant|1|||
146244413|NCT00087516|527410882|FG002|Overall Study|Patient was non-compliant|0|||
146244414|NCT00087516|527410883|FG003|Overall Study|Patient was non-compliant|0|||
146244415|NCT00087516|527410880|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
146244416|NCT00087516|527410881|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
146244417|NCT00087516|527410882|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
146244418|NCT00087516|527410883|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
146244419|NCT00087516|527410880|FG000|Overall Study|Other|0|||
146244420|NCT00087516|527410881|FG001|Overall Study|Other|0|||
146244421|NCT00087516|527410882|FG002|Overall Study|Other|1|||
146244422|NCT00087516|527410883|FG003|Overall Study|Other|0|||
146244423|NCT00278395|527410884|FG000|Overall Study|Adverse Event|2|||
146244424|NCT00278395|527410884|FG000|Overall Study|Nonevaluable|1|||
146244425|NCT01686152|527410887|FG000|Overall Study|Withdrawal by Subject|11|||
146244426|NCT01686152|527410888|FG001|Overall Study|Withdrawal by Subject|11|||
146244427|NCT01686152|527410889|FG002|Overall Study|Withdrawal by Subject|3|||
146244428|NCT01686152|527410887|FG000|Overall Study|Drug Code Unblinded|0|||
146244429|NCT01686152|527410888|FG001|Overall Study|Drug Code Unblinded|1|||
145978626|NCT04925934|526433616|FG000|Overall Study|Death|0|||
145978627|NCT04925934|526433617|FG001|Overall Study|Death|1|||
146244430|NCT01686152|527410889|FG002|Overall Study|Drug Code Unblinded|0|||
146244431|NCT01686152|527410887|FG000|Overall Study|Protocol Violation|6|||
146244432|NCT01686152|527410888|FG001|Overall Study|Protocol Violation|1|||
146244433|NCT01686152|527410889|FG002|Overall Study|Protocol Violation|0|||
146244434|NCT01686152|527410887|FG000|Overall Study|Adverse Event|12|||
146244435|NCT01686152|527410888|FG001|Overall Study|Adverse Event|11|||
146244436|NCT01686152|527410889|FG002|Overall Study|Adverse Event|0|||
146244437|NCT01686152|527410887|FG000|Overall Study|Lack of Efficacy|0|||
146244438|NCT01686152|527410888|FG001|Overall Study|Lack of Efficacy|0|||
146244439|NCT01686152|527410889|FG002|Overall Study|Lack of Efficacy|1|||
146244440|NCT01686152|527410887|FG000|Overall Study|IP Non-compliance|5|||
146244441|NCT01686152|527410888|FG001|Overall Study|IP Non-compliance|5|||
146244442|NCT01686152|527410889|FG002|Overall Study|IP Non-compliance|0|||
146244443|NCT01686152|527410887|FG000|Overall Study|Lost to Follow-up|7|||
146244444|NCT01686152|527410888|FG001|Overall Study|Lost to Follow-up|6|||
146244445|NCT01686152|527410889|FG002|Overall Study|Lost to Follow-up|5|||
146244446|NCT02784834|527410893|FG000|Overall Study|Lack of Efficacy|1|||
146244447|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
146244448|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
146244449|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
146244450|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
146244451|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Adverse Event|7|||
146244452|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Adverse Event|8|||
146244453|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Adverse Event|8|||
146244454|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Adverse Event|9|||
146244455|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
146244456|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
146244457|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
146244458|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
146244459|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
146244460|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
146244461|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
146244462|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
146244463|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Pregnancy|0|||
146244464|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Pregnancy|2|||
146244465|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Pregnancy|2|||
146244466|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Pregnancy|0|||
146244467|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Non-compliance|1|||
146244468|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Non-compliance|0|||
146244469|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Non-compliance|0|||
146244470|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Non-compliance|3|||
146244471|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Other|3|||
146244472|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Other|0|||
146244473|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Other|3|||
146244474|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Other|2|||
146244475|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146244476|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146244477|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
146244478|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
146244479|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
146244480|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
146244481|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
146244482|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
146244483|NCT02143713|527410894|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
146244484|NCT02143713|527410895|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
146244485|NCT02143713|527410896|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
146244486|NCT02143713|527410897|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
146244487|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
146244488|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
146244489|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146244490|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
146244491|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146244492|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146244493|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
146244494|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
146244495|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
146244496|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
146244497|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
146244498|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
146244499|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
146244500|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
145978628|NCT04925934|526433618|FG002|Overall Study|Death|0|||
145978629|NCT04925934|526433616|FG000|Overall Study|Withdrawal by Subject|8|||
145978630|NCT04925934|526433617|FG001|Overall Study|Withdrawal by Subject|5|||
145978631|NCT04925934|526433618|FG002|Overall Study|Withdrawal by Subject|9|||
145978632|NCT04925934|526433616|FG000|Overall Study|Other|2|||
146244501|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
146244502|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
146244503|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
146244504|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
146244505|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
146244506|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
146244507|NCT02143713|527410894|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
146244508|NCT02143713|527410895|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
146244509|NCT02143713|527410896|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
146244510|NCT02143713|527410897|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
146244511|NCT01768572|527410898|FG000|Overall Study|Adverse Event|7|||
146244512|NCT01768572|527410899|FG001|Overall Study|Adverse Event|8|||
146244513|NCT01768572|527410900|FG002|Overall Study|Adverse Event|4|||
146244514|NCT01768572|527410898|FG000|Overall Study|Lack of Efficacy|1|||
146244515|NCT01768572|527410899|FG001|Overall Study|Lack of Efficacy|3|||
146244516|NCT01768572|527410900|FG002|Overall Study|Lack of Efficacy|1|||
146244517|NCT01768572|527410898|FG000|Overall Study|Other, Not due to an adverse event|1|||
146244518|NCT01768572|527410899|FG001|Overall Study|Other, Not due to an adverse event|1|||
146244519|NCT01768572|527410900|FG002|Overall Study|Other, Not due to an adverse event|1|||
146244520|NCT00080119|527410903|FG000|Overall Study|Discontinued because of study closure|0|||
146244521|NCT00080119|527410904|FG001|Overall Study|Discontinued because of study closure|0|||
146244522|NCT00080119|527410905|FG002|Overall Study|Discontinued because of study closure|130|||
146244523|NCT00080119|527410906|FG003|Overall Study|Discontinued because of study closure|141|||
146244524|NCT00080119|527410903|FG000|Overall Study|Unable to get to clinic|24|||
146244525|NCT00080119|527410904|FG001|Overall Study|Unable to get to clinic|24|||
146244526|NCT00080119|527410905|FG002|Overall Study|Unable to get to clinic|7|||
146244527|NCT00080119|527410906|FG003|Overall Study|Unable to get to clinic|1|||
146244528|NCT00080119|527410903|FG000|Overall Study|Consent withdrawn|13|||
146244529|NCT00080119|527410904|FG001|Overall Study|Consent withdrawn|17|||
146244530|NCT00080119|527410905|FG002|Overall Study|Consent withdrawn|4|||
146244531|NCT00080119|527410906|FG003|Overall Study|Consent withdrawn|6|||
146244532|NCT00080119|527410903|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
146244533|NCT00080119|527410904|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
146244534|NCT00080119|527410905|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
146244535|NCT00080119|527410906|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
146244536|NCT00080119|527410903|FG000|Overall Study|Lost to Follow-up|16|||
146244537|NCT00080119|527410904|FG001|Overall Study|Lost to Follow-up|19|||
146244538|NCT00080119|527410905|FG002|Overall Study|Lost to Follow-up|19|||
146244539|NCT00080119|527410906|FG003|Overall Study|Lost to Follow-up|14|||
146244540|NCT01322386|527410907|FG000|Overall Study|Protocol Violation|0|||
146244541|NCT01322386|527410908|FG001|Overall Study|Protocol Violation|1|||
146244542|NCT01322386|527410907|FG000|Overall Study|Physician Decision|0|||
146244543|NCT01322386|527410908|FG001|Overall Study|Physician Decision|1|||
146244544|NCT02988713|527410915|FG000|Overall Study|Withdrawal by Subject|1|||
146244545|NCT02988713|527410915|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
146244546|NCT01918033|527410916|FG000|Overall Study|Adverse Event|1|||
146244547|NCT01918033|527410917|FG001|Overall Study|Adverse Event|0|||
146244548|NCT01918033|527410918|FG002|Overall Study|Adverse Event|2|||
146244549|NCT01918033|527410916|FG000|Overall Study|Lost to Follow-up|0|||
146244550|NCT01918033|527410917|FG001|Overall Study|Lost to Follow-up|1|||
146244551|NCT01918033|527410918|FG002|Overall Study|Lost to Follow-up|0|||
146244552|NCT01918033|527410916|FG000|Overall Study|Protocol Violation|2|||
146244553|NCT01918033|527410917|FG001|Overall Study|Protocol Violation|0|||
146244554|NCT01918033|527410918|FG002|Overall Study|Protocol Violation|1|||
146244555|NCT01918033|527410916|FG000|Overall Study|Withdrawal by Subject|2|||
146244556|NCT01918033|527410917|FG001|Overall Study|Withdrawal by Subject|1|||
146244557|NCT01918033|527410918|FG002|Overall Study|Withdrawal by Subject|0|||
146244558|NCT02404441|527410919|FG000|Phase 1 Part|Adverse Event|1|||
146244559|NCT02404441|527410920|FG001|Phase 1 Part|Adverse Event|0|||
146244560|NCT02404441|527410921|FG002|Phase 1 Part|Adverse Event|0|||
145978633|NCT04925934|526433617|FG001|Overall Study|Other|2|||
145978634|NCT04925934|526433618|FG002|Overall Study|Other|2|||
145978635|NCT04925934|526433616|FG000|Overall Study|Eastern European Conflict|7|||
145978636|NCT04925934|526433617|FG001|Overall Study|Eastern European Conflict|3|||
145978637|NCT04925934|526433618|FG002|Overall Study|Eastern European Conflict|2|||
145978638|NCT00376506|526433619|FG000|Overall Study|Death|0|||
146244561|NCT02404441|527410922|FG003|Phase 1 Part|Adverse Event|0|||
145978639|NCT00376506|526433620|FG001|Overall Study|Death|2|||
145978640|NCT03158688|526433621|FG000|Overall Study|Withdrawal by Subject|14|||
145978641|NCT03158688|526433622|FG001|Overall Study|Withdrawal by Subject|28|||
146244562|NCT02404441|527410923|FG004|Phase 1 Part|Adverse Event|0|||
146244563|NCT02404441|527410924|FG005|Phase 1 Part|Adverse Event|0|||
146244564|NCT02404441|527410925|FG006|Phase 1 Part|Adverse Event|0|||
146244565|NCT02404441|527410926|FG007|Phase 1 Part|Adverse Event|0|||
146244566|NCT02404441|527410927|FG008|Phase 1 Part|Adverse Event|0|||
146244567|NCT02404441|527410928|FG009|Phase 1 Part|Adverse Event|0|||
146244568|NCT02404441|527410919|FG000|Phase 1 Part|Physician Decision|0|||
146244569|NCT02404441|527410920|FG001|Phase 1 Part|Physician Decision|1|||
146244570|NCT02404441|527410921|FG002|Phase 1 Part|Physician Decision|0|||
146244571|NCT02404441|527410922|FG003|Phase 1 Part|Physician Decision|0|||
146244572|NCT02404441|527410923|FG004|Phase 1 Part|Physician Decision|0|||
146244573|NCT02404441|527410924|FG005|Phase 1 Part|Physician Decision|0|||
146244574|NCT02404441|527410925|FG006|Phase 1 Part|Physician Decision|0|||
146244575|NCT02404441|527410926|FG007|Phase 1 Part|Physician Decision|0|||
146244576|NCT02404441|527410927|FG008|Phase 1 Part|Physician Decision|0|||
146244577|NCT02404441|527410928|FG009|Phase 1 Part|Physician Decision|0|||
146244578|NCT02404441|527410919|FG000|Phase 1 Part|Progressive Disease|14|||
146244579|NCT02404441|527410920|FG001|Phase 1 Part|Progressive Disease|11|||
146244580|NCT02404441|527410921|FG002|Phase 1 Part|Progressive Disease|7|||
146244581|NCT02404441|527410922|FG003|Phase 1 Part|Progressive Disease|6|||
146244582|NCT02404441|527410923|FG004|Phase 1 Part|Progressive Disease|9|||
146244583|NCT02404441|527410924|FG005|Phase 1 Part|Progressive Disease|0|||
146244584|NCT02404441|527410925|FG006|Phase 1 Part|Progressive Disease|0|||
146244585|NCT02404441|527410926|FG007|Phase 1 Part|Progressive Disease|0|||
146244586|NCT02404441|527410927|FG008|Phase 1 Part|Progressive Disease|0|||
146244587|NCT02404441|527410928|FG009|Phase 1 Part|Progressive Disease|0|||
146244588|NCT02404441|527410919|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
146244589|NCT02404441|527410920|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
146244590|NCT02404441|527410921|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
146244591|NCT02404441|527410922|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
146244592|NCT02404441|527410923|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
146244593|NCT02404441|527410924|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
146244594|NCT02404441|527410925|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
146244595|NCT02404441|527410926|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
145933284|NCT02553499|526262128|FG009|Overall Study|Physician Decision|2|||
145933285|NCT02553499|526262129|FG010|Overall Study|Physician Decision|1|||
145933286|NCT02553499|526262130|FG011|Overall Study|Physician Decision|3|||
145933287|NCT02553499|526262131|FG012|Overall Study|Physician Decision|1|||
145933288|NCT02553499|526262132|FG013|Overall Study|Physician Decision|0|||
145933289|NCT02553499|526262119|FG000|Overall Study|Progressive Disease|0|||
145933290|NCT02553499|526262120|FG001|Overall Study|Progressive Disease|0|||
145933291|NCT02553499|526262121|FG002|Overall Study|Progressive Disease|0|||
145933292|NCT02553499|526262122|FG003|Overall Study|Progressive Disease|2|||
145933293|NCT02553499|526262123|FG004|Overall Study|Progressive Disease|1|||
145933294|NCT02553499|526262124|FG005|Overall Study|Progressive Disease|1|||
145933295|NCT02553499|526262125|FG006|Overall Study|Progressive Disease|1|||
145933296|NCT02553499|526262126|FG007|Overall Study|Progressive Disease|0|||
145933297|NCT02553499|526262127|FG008|Overall Study|Progressive Disease|0|||
145933298|NCT02553499|526262128|FG009|Overall Study|Progressive Disease|1|||
145933299|NCT02553499|526262129|FG010|Overall Study|Progressive Disease|0|||
145933300|NCT02553499|526262130|FG011|Overall Study|Progressive Disease|0|||
145933301|NCT02553499|526262131|FG012|Overall Study|Progressive Disease|2|||
145933302|NCT02553499|526262132|FG013|Overall Study|Progressive Disease|1|||
145933303|NCT02553499|526262119|FG000|Overall Study|Study Terminated by Sponsor|0|||
145978642|NCT03158688|526433621|FG000|Overall Study|Decision by sponsor|13|||
145978643|NCT03158688|526433622|FG001|Overall Study|Decision by sponsor|37|||
145978644|NCT03158688|526433621|FG000|Overall Study|Lost to Follow-up|4|||
145978645|NCT03158688|526433622|FG001|Overall Study|Lost to Follow-up|3|||
146244596|NCT02404441|527410927|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
146244597|NCT02404441|527410928|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
146244598|NCT02404441|527410919|FG000|Phase 1 Part|Death|1|||
146244599|NCT02404441|527410920|FG001|Phase 1 Part|Death|1|||
146244600|NCT02404441|527410921|FG002|Phase 1 Part|Death|1|||
146244601|NCT02404441|527410922|FG003|Phase 1 Part|Death|0|||
145933304|NCT02553499|526262120|FG001|Overall Study|Study Terminated by Sponsor|0|||
145933305|NCT02553499|526262121|FG002|Overall Study|Study Terminated by Sponsor|0|||
145933306|NCT02553499|526262122|FG003|Overall Study|Study Terminated by Sponsor|0|||
145933307|NCT02553499|526262123|FG004|Overall Study|Study Terminated by Sponsor|0|||
145978646|NCT03158688|526433621|FG000|Overall Study|Death|74|||
145978647|NCT03158688|526433622|FG001|Overall Study|Death|142|||
145978648|NCT01716156|526433627|FG000|Overall Study|Protocol Violation|1|||
145978649|NCT01716156|526433628|FG001|Overall Study|Protocol Violation|0|||
145978650|NCT01716156|526433629|FG002|Overall Study|Protocol Violation|0|||
145978651|NCT01716156|526433627|FG000|Overall Study|Withdrawal by Subject|0|||
146091071|NCT00064298|526854871|FG001|Overall Study|Withdrawal by Subject|1|||
145933308|NCT02553499|526262124|FG005|Overall Study|Study Terminated by Sponsor|0|||
145978652|NCT01716156|526433628|FG001|Overall Study|Withdrawal by Subject|1|||
146091072|NCT00064298|526854870|FG000|Overall Study|Lost to Follow-up|2|||
145978653|NCT01716156|526433629|FG002|Overall Study|Withdrawal by Subject|2|||
145978654|NCT01716156|526433627|FG000|Overall Study|Lost to Follow-up|1|||
145978655|NCT01716156|526433628|FG001|Overall Study|Lost to Follow-up|0|||
146091073|NCT00064298|526854871|FG001|Overall Study|Lost to Follow-up|2|||
146244602|NCT02404441|527410923|FG004|Phase 1 Part|Death|1|||
146244603|NCT02404441|527410924|FG005|Phase 1 Part|Death|0|||
146244604|NCT02404441|527410925|FG006|Phase 1 Part|Death|0|||
146244605|NCT02404441|527410926|FG007|Phase 1 Part|Death|0|||
146244606|NCT02404441|527410927|FG008|Phase 1 Part|Death|0|||
146244607|NCT02404441|527410928|FG009|Phase 1 Part|Death|0|||
146244608|NCT02404441|527410919|FG000|Phase 2 Part|Adverse Event|0|||
146244609|NCT02404441|527410920|FG001|Phase 2 Part|Adverse Event|0|||
146244610|NCT02404441|527410921|FG002|Phase 2 Part|Adverse Event|0|||
146244611|NCT02404441|527410922|FG003|Phase 2 Part|Adverse Event|0|||
146244612|NCT02404441|527410923|FG004|Phase 2 Part|Adverse Event|0|||
146244613|NCT02404441|527410924|FG005|Phase 2 Part|Adverse Event|2|||
146244614|NCT02404441|527410925|FG006|Phase 2 Part|Adverse Event|3|||
146244615|NCT02404441|527410926|FG007|Phase 2 Part|Adverse Event|3|||
146244616|NCT02404441|527410927|FG008|Phase 2 Part|Adverse Event|6|||
146244617|NCT02404441|527410928|FG009|Phase 2 Part|Adverse Event|1|||
146244618|NCT02404441|527410919|FG000|Phase 2 Part|Physician Decision|0|||
146244619|NCT02404441|527410920|FG001|Phase 2 Part|Physician Decision|0|||
146244620|NCT02404441|527410921|FG002|Phase 2 Part|Physician Decision|0|||
146244621|NCT02404441|527410922|FG003|Phase 2 Part|Physician Decision|0|||
146244622|NCT02404441|527410923|FG004|Phase 2 Part|Physician Decision|0|||
146244623|NCT02404441|527410924|FG005|Phase 2 Part|Physician Decision|7|||
146244624|NCT02404441|527410925|FG006|Phase 2 Part|Physician Decision|9|||
146244625|NCT02404441|527410926|FG007|Phase 2 Part|Physician Decision|2|||
146244626|NCT02404441|527410927|FG008|Phase 2 Part|Physician Decision|1|||
146244627|NCT02404441|527410928|FG009|Phase 2 Part|Physician Decision|3|||
146244628|NCT02404441|527410919|FG000|Phase 2 Part|Progressive disease|0|||
146244629|NCT02404441|527410920|FG001|Phase 2 Part|Progressive disease|0|||
146244630|NCT02404441|527410921|FG002|Phase 2 Part|Progressive disease|0|||
146244631|NCT02404441|527410922|FG003|Phase 2 Part|Progressive disease|0|||
146244632|NCT02404441|527410923|FG004|Phase 2 Part|Progressive disease|0|||
146244633|NCT02404441|527410924|FG005|Phase 2 Part|Progressive disease|43|||
146244634|NCT02404441|527410925|FG006|Phase 2 Part|Progressive disease|32|||
146244635|NCT02404441|527410926|FG007|Phase 2 Part|Progressive disease|31|||
146244636|NCT02404441|527410927|FG008|Phase 2 Part|Progressive disease|39|||
146244637|NCT02404441|527410928|FG009|Phase 2 Part|Progressive disease|27|||
146244638|NCT02404441|527410919|FG000|Phase 2 Part|Subject/guardian decision|0|||
146244639|NCT02404441|527410920|FG001|Phase 2 Part|Subject/guardian decision|0|||
146244640|NCT02404441|527410921|FG002|Phase 2 Part|Subject/guardian decision|0|||
146244641|NCT02404441|527410922|FG003|Phase 2 Part|Subject/guardian decision|0|||
146244642|NCT02404441|527410923|FG004|Phase 2 Part|Subject/guardian decision|0|||
146244643|NCT02404441|527410924|FG005|Phase 2 Part|Subject/guardian decision|3|||
146244644|NCT02404441|527410925|FG006|Phase 2 Part|Subject/guardian decision|9|||
146244645|NCT02404441|527410926|FG007|Phase 2 Part|Subject/guardian decision|0|||
146244646|NCT02404441|527410927|FG008|Phase 2 Part|Subject/guardian decision|3|||
146244647|NCT02404441|527410928|FG009|Phase 2 Part|Subject/guardian decision|2|||
146244648|NCT02404441|527410919|FG000|Phase 2 Part|Death|0|||
146244649|NCT02404441|527410920|FG001|Phase 2 Part|Death|0|||
146244650|NCT02404441|527410921|FG002|Phase 2 Part|Death|0|||
146244651|NCT02404441|527410922|FG003|Phase 2 Part|Death|0|||
146244652|NCT02404441|527410923|FG004|Phase 2 Part|Death|0|||
146244653|NCT02404441|527410924|FG005|Phase 2 Part|Death|4|||
146244654|NCT02404441|527410925|FG006|Phase 2 Part|Death|8|||
146244655|NCT02404441|527410926|FG007|Phase 2 Part|Death|4|||
146244656|NCT02404441|527410927|FG008|Phase 2 Part|Death|10|||
146244657|NCT02404441|527410928|FG009|Phase 2 Part|Death|9|||
146244658|NCT03265132|527410929|FG000|Overall Study|Adverse Event|0|||
146244659|NCT03265132|527410930|FG001|Overall Study|Adverse Event|1|||
146244660|NCT03265132|527410929|FG000|Overall Study|Lack of Efficacy|0|||
146244661|NCT03265132|527410930|FG001|Overall Study|Lack of Efficacy|2|||
146244662|NCT03265132|527410929|FG000|Overall Study|Progressive disease|0|||
146244663|NCT03265132|527410930|FG001|Overall Study|Progressive disease|2|||
146244664|NCT03265132|527410929|FG000|Overall Study|Withdrawal by Subject|0|||
145933309|NCT02553499|526262125|FG006|Overall Study|Study Terminated by Sponsor|0|||
145933310|NCT02553499|526262126|FG007|Overall Study|Study Terminated by Sponsor|0|||
145933311|NCT02553499|526262127|FG008|Overall Study|Study Terminated by Sponsor|1|||
146244665|NCT03265132|527410930|FG001|Overall Study|Withdrawal by Subject|1|||
146244666|NCT01976507|527410934|FG000|Overall Study|Adverse Event|6|||
146244667|NCT01976507|527410934|FG000|Overall Study|ablation not done, drug not given|1|||
146244668|NCT01794299|527410936|FG000|Overall Study|ATIR manufacturing not possible|1|||
146244669|NCT01794299|527410936|FG000|Overall Study|Death|14|||
146244670|NCT01794299|527410936|FG000|Overall Study|Graft failure|1|||
146244671|NCT01794299|527410936|FG000|Overall Study|ATIR batch rejected|2|||
145933312|NCT02553499|526262128|FG009|Overall Study|Study Terminated by Sponsor|0|||
145933313|NCT02553499|526262129|FG010|Overall Study|Study Terminated by Sponsor|0|||
146244672|NCT01794299|527410936|FG000|Overall Study|Relapse|2|||
146244673|NCT01794299|527410936|FG000|Overall Study|Discontinued from active follow-up|1|||
146244674|NCT01794299|527410936|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
146244675|NCT03006393|527410937|FG000|Overall Study|Withdrawal by Subject|1|||
146244676|NCT03006393|527410938|FG001|Overall Study|Withdrawal by Subject|1|||
146244677|NCT03006393|527410937|FG000|Overall Study|Pregnancy|0|||
146244678|NCT03006393|527410938|FG001|Overall Study|Pregnancy|1|||
146244679|NCT03006393|527410937|FG000|Overall Study|Lost to Follow-up|0|||
146244680|NCT03006393|527410938|FG001|Overall Study|Lost to Follow-up|1|||
145933314|NCT02553499|526262130|FG011|Overall Study|Study Terminated by Sponsor|0|||
145933315|NCT02553499|526262131|FG012|Overall Study|Study Terminated by Sponsor|0|||
145933316|NCT02553499|526262132|FG013|Overall Study|Study Terminated by Sponsor|0|||
145933317|NCT02553499|526262119|FG000|Overall Study|Withdrawal by Subject|2|||
145933318|NCT02553499|526262120|FG001|Overall Study|Withdrawal by Subject|0|||
145933319|NCT02553499|526262121|FG002|Overall Study|Withdrawal by Subject|0|||
145933320|NCT02553499|526262122|FG003|Overall Study|Withdrawal by Subject|0|||
145933321|NCT02553499|526262123|FG004|Overall Study|Withdrawal by Subject|0|||
145933322|NCT02553499|526262124|FG005|Overall Study|Withdrawal by Subject|0|||
145933323|NCT02553499|526262125|FG006|Overall Study|Withdrawal by Subject|0|||
145933324|NCT02553499|526262126|FG007|Overall Study|Withdrawal by Subject|1|||
145933325|NCT02553499|526262127|FG008|Overall Study|Withdrawal by Subject|1|||
145933326|NCT02553499|526262128|FG009|Overall Study|Withdrawal by Subject|0|||
145933327|NCT02553499|526262129|FG010|Overall Study|Withdrawal by Subject|1|||
145933328|NCT02553499|526262130|FG011|Overall Study|Withdrawal by Subject|0|||
145933329|NCT02553499|526262131|FG012|Overall Study|Withdrawal by Subject|0|||
145933330|NCT02553499|526262132|FG013|Overall Study|Withdrawal by Subject|0|||
145933331|NCT01582178|526262133|FG000|Overall Study|Physician Decision|6|||
145933332|NCT01582178|526262134|FG001|Overall Study|Physician Decision|5|||
145933333|NCT01726270|526262135|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
145933334|NCT01726270|526262135|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
145933335|NCT01726270|526262135|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
145933336|NCT01726270|526262135|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
145933337|NCT01726270|526262135|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
145933338|NCT01726270|526262135|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
145933339|NCT00582608|526262137|FG000|Overall Study|Not Treated|7|||
145933340|NCT00582608|526262137|FG000|Overall Study|Patient Ineligible|1|||
145933341|NCT00582608|526262137|FG000|Overall Study|Lack of accrual|4|||
145933342|NCT03478644|526262141|FG000|Phase 2|Withdrawal by Subject|2|||
145933343|NCT03478644|526262142|FG001|Phase 2|Withdrawal by Subject|1|||
145933344|NCT03478644|526262141|FG000|Phase 2|Lost to Follow-up|1|||
145933345|NCT03478644|526262142|FG001|Phase 2|Lost to Follow-up|0|||
145933346|NCT04152837|526262145|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
145933347|NCT04152837|526262145|FG000|Maintenance Period|Adverse Event|1|||
145933348|NCT04152837|526262145|FG000|Maintenance Period|Withdrawal by Subject|1|||
145933349|NCT04152837|526262145|FG000|Maintenance Period|Sponsor Termination of Study|2|||
145933350|NCT00586820|526262146|FG000|Overall Study|Unsuccessful PCI|1|||
145933351|NCT00586820|526262147|FG001|Overall Study|Unsuccessful PCI|0|||
145933352|NCT04463251|526262150|FG000|Overall Study|Death|1|||
146244681|NCT02161458|527410939|FG000|Overall Study|Withdrawal by Subject|0|||
146244682|NCT02161458|527410940|FG001|Overall Study|Withdrawal by Subject|4|||
146244683|NCT02161458|527410941|FG002|Overall Study|Withdrawal by Subject|4|||
146244684|NCT02161458|527410942|FG003|Overall Study|Withdrawal by Subject|0|||
146244685|NCT02161458|527410939|FG000|Overall Study|Lost to Follow-up|0|||
146244686|NCT02161458|527410940|FG001|Overall Study|Lost to Follow-up|2|||
146244687|NCT02161458|527410941|FG002|Overall Study|Lost to Follow-up|1|||
146244688|NCT02161458|527410942|FG003|Overall Study|Lost to Follow-up|0|||
146244689|NCT03136861|527410946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
146244690|NCT03136861|527410947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
146244691|NCT03136861|527410948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146244692|NCT03136861|527410949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146244693|NCT03136861|527410950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146244694|NCT03136861|527410951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145933353|NCT04463251|526262151|FG001|Overall Study|Death|0|||
145933354|NCT04463251|526262152|FG002|Overall Study|Death|1|||
145933355|NCT04463251|526262150|FG000|Overall Study|Adverse Event|0|||
145933356|NCT04463251|526262151|FG001|Overall Study|Adverse Event|1|||
145933357|NCT04463251|526262152|FG002|Overall Study|Adverse Event|0|||
145933358|NCT04463251|526262150|FG000|Overall Study|Lost to Follow-up|0|||
145933359|NCT04463251|526262151|FG001|Overall Study|Lost to Follow-up|1|||
145933360|NCT04463251|526262152|FG002|Overall Study|Lost to Follow-up|0|||
145978656|NCT01716156|526433629|FG002|Overall Study|Lost to Follow-up|0|||
145978657|NCT01132755|526433636|FG000|Overall Study|Procedure not done due to medical reason|23|||
145978658|NCT01132755|526433636|FG000|Overall Study|Protocol Violation|15|||
146244695|NCT03136861|527410952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
146244696|NCT03136861|527410946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
146244697|NCT03136861|527410947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
145933361|NCT04463251|526262150|FG000|Overall Study|Withdrawal by Subject|0|||
145933362|NCT04463251|526262151|FG001|Overall Study|Withdrawal by Subject|2|||
145933363|NCT04463251|526262152|FG002|Overall Study|Withdrawal by Subject|2|||
145933364|NCT00101166|526262155|FG000|Overall Study|progressive disease|10|||
145933365|NCT00686829|526262156|FG000|Overall Study|Adverse Event|5|||
146244698|NCT03136861|527410948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145933366|NCT00686829|526262156|FG000|Overall Study|Lack of Efficacy|6|||
145933367|NCT00686829|526262156|FG000|Overall Study|Lost to Follow-up|4|||
146244699|NCT03136861|527410949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146244700|NCT03136861|527410950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146244701|NCT03136861|527410951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146244702|NCT03136861|527410952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
146244703|NCT03136861|527410946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
146244704|NCT03136861|527410947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
146244705|NCT03136861|527410948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146244706|NCT03136861|527410949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146244707|NCT03136861|527410950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146244708|NCT03136861|527410951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146244709|NCT03136861|527410952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
146244710|NCT03136861|527410946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244711|NCT03136861|527410947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
146244712|NCT03136861|527410948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244713|NCT03136861|527410949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244714|NCT03136861|527410950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244715|NCT03136861|527410951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244716|NCT03136861|527410952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
146244717|NCT03136861|527410946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
146244718|NCT03136861|527410947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
146244719|NCT03136861|527410948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146244720|NCT03136861|527410949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146244721|NCT03136861|527410950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146244722|NCT03136861|527410951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145933368|NCT00686829|526262156|FG000|Overall Study|Withdrawal by Subject|14|||
145933369|NCT00686829|526262156|FG000|Overall Study|Protocol Violation|3|||
145933370|NCT00686829|526262156|FG000|Overall Study|Sponsor discontinued VCV|47|||
145933371|NCT01827267|526262157|FG000|Overall Study|Did not receive study drug|1|||
145933372|NCT01827267|526262158|FG001|Overall Study|Did not receive study drug|1|||
145933373|NCT01827267|526262157|FG000|Overall Study|Physician Decision|1|||
145933374|NCT01827267|526262158|FG001|Overall Study|Physician Decision|0|||
145978659|NCT01132755|526433636|FG000|Overall Study|Withdrawal by Subject|4|||
145978660|NCT02393755|526433637|FG000|Overall Study|Withdrawal by Subject|0|||
145978661|NCT02393755|526433638|FG001|Overall Study|Withdrawal by Subject|3|||
145978662|NCT02393755|526433637|FG000|Overall Study|Adverse Event|0|||
145978663|NCT02393755|526433638|FG001|Overall Study|Adverse Event|2|||
145978664|NCT02393755|526433637|FG000|Overall Study|Physician Decision|0|||
145978665|NCT02393755|526433638|FG001|Overall Study|Physician Decision|2|||
145978666|NCT02949934|526433641|FG000|Natural Drinking Period|Adverse Event|1|||
145978667|NCT02949934|526433642|FG001|Natural Drinking Period|Adverse Event|0|||
145978668|NCT02949934|526433643|FG002|Natural Drinking Period|Adverse Event|0|||
145978669|NCT02949934|526433644|FG003|Natural Drinking Period|Adverse Event|1|||
145978670|NCT02949934|526433645|FG004|Natural Drinking Period|Adverse Event|0|||
145978671|NCT02949934|526433646|FG005|Natural Drinking Period|Adverse Event|0|||
145978672|NCT02949934|526433641|FG000|Natural Drinking Period|Lost to Follow-up|0|||
145978673|NCT02949934|526433642|FG001|Natural Drinking Period|Lost to Follow-up|0|||
145978674|NCT02949934|526433643|FG002|Natural Drinking Period|Lost to Follow-up|0|||
145978675|NCT02949934|526433644|FG003|Natural Drinking Period|Lost to Follow-up|0|||
145978676|NCT02949934|526433645|FG004|Natural Drinking Period|Lost to Follow-up|1|||
145978677|NCT02949934|526433646|FG005|Natural Drinking Period|Lost to Follow-up|0|||
145978678|NCT02949934|526433641|FG000|Neuroimaging|Protocol Violation|2|||
145978679|NCT02949934|526433642|FG001|Neuroimaging|Protocol Violation|0|||
145978680|NCT02949934|526433643|FG002|Neuroimaging|Protocol Violation|0|||
145978681|NCT02949934|526433644|FG003|Neuroimaging|Protocol Violation|0|||
145978682|NCT02949934|526433645|FG004|Neuroimaging|Protocol Violation|1|||
145978683|NCT02949934|526433646|FG005|Neuroimaging|Protocol Violation|0|||
145978684|NCT02949934|526433641|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
145978685|NCT02949934|526433642|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
145978686|NCT02949934|526433643|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
145978687|NCT02949934|526433644|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
145978688|NCT02949934|526433645|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
145978689|NCT02949934|526433646|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
145978690|NCT02949934|526433641|FG000|Neuroimaging|Not scanned|0|||
145978691|NCT02949934|526433642|FG001|Neuroimaging|Not scanned|0|||
145978692|NCT02949934|526433643|FG002|Neuroimaging|Not scanned|1|||
145978693|NCT02949934|526433644|FG003|Neuroimaging|Not scanned|0|||
145978694|NCT02949934|526433645|FG004|Neuroimaging|Not scanned|0|||
145933375|NCT01827267|526262157|FG000|Overall Study|Disease Progression|1|||
145978695|NCT02949934|526433646|FG005|Neuroimaging|Not scanned|2|||
145978696|NCT02949934|526433641|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
145978697|NCT02949934|526433642|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145933376|NCT01827267|526262158|FG001|Overall Study|Disease Progression|1|||
146244723|NCT03136861|527410952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
146244724|NCT03136861|527410946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146244725|NCT03136861|527410947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146244726|NCT03136861|527410948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146244727|NCT03136861|527410949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
146244728|NCT03136861|527410950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
146244729|NCT03136861|527410951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
146244730|NCT03136861|527410952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
146244731|NCT03136861|527410946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244732|NCT03136861|527410947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244733|NCT03136861|527410948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
146244734|NCT03136861|527410949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244735|NCT03136861|527410950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244736|NCT03136861|527410951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244737|NCT03136861|527410952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
146244738|NCT03136861|527410946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244739|NCT03136861|527410947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244740|NCT03136861|527410948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
146244741|NCT03136861|527410949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244742|NCT03136861|527410950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244743|NCT03136861|527410951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244744|NCT03136861|527410952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
146244745|NCT03390166|527410953|FG000|Overall Study|Death|0|||
146244746|NCT03390166|527410954|FG001|Overall Study|Death|1|||
146244747|NCT03390166|527410953|FG000|Overall Study|Lost to Follow-up|6|||
146244748|NCT03390166|527410954|FG001|Overall Study|Lost to Follow-up|4|||
146244749|NCT03390166|527410953|FG000|Overall Study|Physician Decision|2|||
146244750|NCT03390166|527410954|FG001|Overall Study|Physician Decision|1|||
146244751|NCT03390166|527410953|FG000|Overall Study|Move from study area|3|||
146244752|NCT03390166|527410954|FG001|Overall Study|Move from study area|2|||
146244753|NCT03390166|527410953|FG000|Overall Study|To militarycamp for conscript|1|||
146244754|NCT03390166|527410954|FG001|Overall Study|To militarycamp for conscript|0|||
146244755|NCT03390166|527410953|FG000|Overall Study|To drug therapy course|0|||
146244756|NCT03390166|527410954|FG001|Overall Study|To drug therapy course|1|||
146244757|NCT03390166|527410953|FG000|Overall Study|Move to work oversea|0|||
145933377|NCT01827267|526262157|FG000|Overall Study|Sponsor Discontinued Study|2|||
145933378|NCT01827267|526262158|FG001|Overall Study|Sponsor Discontinued Study|8|||
145933379|NCT01827267|526262157|FG000|Overall Study|Still on study|0|||
145933380|NCT01827267|526262158|FG001|Overall Study|Still on study|2|||
145933381|NCT01732640|526262159|FG000|Overall Study|Adverse Event|0|||
145933382|NCT01732640|526262160|FG001|Overall Study|Adverse Event|1|||
145933383|NCT01732640|526262159|FG000|Overall Study|Death|0|||
145933384|NCT01732640|526262160|FG001|Overall Study|Death|1|||
145933385|NCT03070002|526262163|FG000|Follow up for 2 Years|Death|1|||
145933386|NCT00712543|526262166|FG000|Day 8-14|Lost to Follow-up|0|||
145933387|NCT00712543|526262167|FG001|Day 8-14|Lost to Follow-up|2|||
145933388|NCT04520997|526262178|FG000|Overall Study|Lost to Follow-up|1|||
145933389|NCT04520997|526262179|FG001|Overall Study|Lost to Follow-up|1|||
145933390|NCT04520997|526262178|FG000|Overall Study|Withdrawal by Subject|1|||
145933391|NCT04520997|526262179|FG001|Overall Study|Withdrawal by Subject|0|||
145933392|NCT04520997|526262178|FG000|Overall Study|Not Treated|0|||
145933393|NCT04520997|526262179|FG001|Overall Study|Not Treated|1|||
145933394|NCT02981082|526262182|FG000|Overall Study|Withdrawal by Subject|2|||
145933395|NCT02981082|526262183|FG001|Overall Study|Withdrawal by Subject|0|||
145933396|NCT02981082|526262182|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
145933397|NCT02981082|526262183|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
145933398|NCT02981082|526262182|FG000|Overall Study|Adverse Event|0|||
145933399|NCT02981082|526262183|FG001|Overall Study|Adverse Event|1|||
145933400|NCT03689374|526262184|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
145933401|NCT03689374|526262185|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
146244758|NCT03390166|527410954|FG001|Overall Study|Move to work oversea|1|||
145933402|NCT03689374|526262186|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
145933403|NCT03689374|526262184|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
145933404|NCT03689374|526262185|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
145933405|NCT03689374|526262186|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
145933406|NCT03689374|526262184|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
145933407|NCT03689374|526262185|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
145933408|NCT03689374|526262186|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
145933409|NCT03689374|526262184|FG000|Treatment Period (Week 0 to 52)|Death|0|||
146091074|NCT00064298|526854870|FG000|Overall Study|Death|0|||
146244759|NCT03692871|527410961|FG000|Overall Study|Death|1|||
146244760|NCT03692871|527410962|FG001|Overall Study|Death|1|||
146244761|NCT03692871|527410961|FG000|Overall Study|Lost to Follow-up|24|||
146244762|NCT03692871|527410962|FG001|Overall Study|Lost to Follow-up|9|||
146244763|NCT03692871|527410961|FG000|Overall Study|Physician Decision|22|||
146244764|NCT03692871|527410962|FG001|Overall Study|Physician Decision|7|||
146244765|NCT03692871|527410961|FG000|Overall Study|Protocol Deviation|1|||
146244766|NCT03692871|527410962|FG001|Overall Study|Protocol Deviation|0|||
146244767|NCT03692871|527410961|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
146244768|NCT03692871|527410962|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
146244769|NCT02852824|527410963|FG000|Overall Study|Withdrawal by Subject|1|||
146244770|NCT02852824|527410964|FG001|Overall Study|Withdrawal by Subject|0|||
146244771|NCT02852824|527410965|FG002|Overall Study|Withdrawal by Subject|0|||
146244772|NCT02852824|527410966|FG003|Overall Study|Withdrawal by Subject|0|||
146244773|NCT02852824|527410967|FG004|Overall Study|Withdrawal by Subject|0|||
146244774|NCT02852824|527410968|FG005|Overall Study|Withdrawal by Subject|0|||
146244775|NCT02852824|527410969|FG006|Overall Study|Withdrawal by Subject|0|||
146244776|NCT02852824|527410963|FG000|Overall Study|Adverse Event|0|||
146244777|NCT02852824|527410964|FG001|Overall Study|Adverse Event|0|||
146244778|NCT02852824|527410965|FG002|Overall Study|Adverse Event|0|||
146244779|NCT02852824|527410966|FG003|Overall Study|Adverse Event|0|||
146244780|NCT02852824|527410967|FG004|Overall Study|Adverse Event|2|||
146244781|NCT02852824|527410968|FG005|Overall Study|Adverse Event|0|||
146244782|NCT02852824|527410969|FG006|Overall Study|Adverse Event|0|||
146244783|NCT01316913|527410970|FG000|Overall Study|Adverse Event|17|||
146244784|NCT01316913|527410971|FG001|Overall Study|Adverse Event|20|||
146244785|NCT01316913|527410972|FG002|Overall Study|Adverse Event|15|||
146244786|NCT01316913|527410973|FG003|Overall Study|Adverse Event|11|||
145978698|NCT02949934|526433643|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145978699|NCT02949934|526433644|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
145978700|NCT02949934|526433645|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145978701|NCT02949934|526433646|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
145978702|NCT02949934|526433641|FG000|Bar Laboratory|Adverse Event|1|||
145978703|NCT02949934|526433642|FG001|Bar Laboratory|Adverse Event|0|||
145978704|NCT02949934|526433643|FG002|Bar Laboratory|Adverse Event|2|||
145978705|NCT02949934|526433644|FG003|Bar Laboratory|Adverse Event|0|||
145978706|NCT02949934|526433645|FG004|Bar Laboratory|Adverse Event|1|||
145978707|NCT02949934|526433646|FG005|Bar Laboratory|Adverse Event|0|||
145978708|NCT02949934|526433641|FG000|Bar Laboratory|Protocol Violation|0|||
145978709|NCT02949934|526433642|FG001|Bar Laboratory|Protocol Violation|0|||
145978710|NCT02949934|526433643|FG002|Bar Laboratory|Protocol Violation|0|||
146091075|NCT00064298|526854871|FG001|Overall Study|Death|1|||
146091076|NCT00064298|526854870|FG000|Overall Study|Disease Progression|2|||
146244787|NCT01316913|527410970|FG000|Overall Study|Lack of Efficacy|22|||
146244788|NCT01316913|527410971|FG001|Overall Study|Lack of Efficacy|12|||
146244789|NCT01316913|527410972|FG002|Overall Study|Lack of Efficacy|9|||
146244790|NCT01316913|527410973|FG003|Overall Study|Lack of Efficacy|13|||
146244791|NCT01316913|527410970|FG000|Overall Study|Protocol Violation|1|||
146244792|NCT01316913|527410971|FG001|Overall Study|Protocol Violation|4|||
146244793|NCT01316913|527410972|FG002|Overall Study|Protocol Violation|4|||
146244794|NCT01316913|527410973|FG003|Overall Study|Protocol Violation|1|||
146244795|NCT01316913|527410970|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
146244796|NCT01316913|527410971|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
146244797|NCT01316913|527410972|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
146244798|NCT01316913|527410973|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
146244799|NCT01316913|527410970|FG000|Overall Study|Lost to Follow-up|0|||
146244800|NCT01316913|527410971|FG001|Overall Study|Lost to Follow-up|1|||
146244801|NCT01316913|527410972|FG002|Overall Study|Lost to Follow-up|0|||
146244802|NCT01316913|527410973|FG003|Overall Study|Lost to Follow-up|2|||
146091077|NCT00064298|526854871|FG001|Overall Study|Disease Progression|1|||
146091078|NCT03614975|526854872|FG000|Overall Study|Physician Decision|7|||
146244803|NCT01316913|527410970|FG000|Overall Study|Withdrawal by Subject|10|||
146244804|NCT01316913|527410971|FG001|Overall Study|Withdrawal by Subject|9|||
146244805|NCT01316913|527410972|FG002|Overall Study|Withdrawal by Subject|10|||
146244806|NCT01316913|527410973|FG003|Overall Study|Withdrawal by Subject|6|||
146244807|NCT05445557|527410974|FG000|Double Blind Part|Lost to Follow-up|1|||
145978711|NCT02949934|526433644|FG003|Bar Laboratory|Protocol Violation|1|||
146091079|NCT03614975|526854873|FG001|Overall Study|Physician Decision|5|||
146091080|NCT03614975|526854872|FG000|Overall Study|Withdrawal by Subject|2|||
146244808|NCT02915783|527410976|FG000|Overall Study|Death|21|||
146244809|NCT02915783|527410976|FG000|Overall Study|Lost to Follow-up|1|||
146244810|NCT02915783|527410976|FG000|Overall Study|Withdrawal by Subject|2|||
146244811|NCT02950961|527410977|FG000|Overall Study|Study had to stop due to COVID.|7|||
146244812|NCT03055988|527410978|FG000|Period 1|Adverse Event|0|||
146244813|NCT03055988|527410979|FG001|Period 1|Adverse Event|1|||
146244814|NCT03055988|527410978|FG000|Period 1|Lost to Follow-up|1|||
146297794|NCT04029480|527606006|FG000|Overall Study|Physician Decision|0|||
146244815|NCT03055988|527410979|FG001|Period 1|Lost to Follow-up|0|||
146244816|NCT03055988|527410978|FG000|Period 1|Withdrawal by Subject|0|||
146244817|NCT03055988|527410979|FG001|Period 1|Withdrawal by Subject|4|||
146244818|NCT03055988|527410978|FG000|Period 2|Adverse Event|0|||
146244819|NCT03055988|527410979|FG001|Period 2|Adverse Event|1|||
146244820|NCT03055988|527410978|FG000|Period 2|Other than listed|1|||
146244821|NCT03055988|527410979|FG001|Period 2|Other than listed|1|||
146244822|NCT01915914|527410982|FG000|Acute Phase|Withdrawal by Subject|4|||
146244823|NCT01915914|527410983|FG001|Acute Phase|Withdrawal by Subject|0|||
146244824|NCT01915914|527410984|FG002|Acute Phase|Withdrawal by Subject|0|||
146244825|NCT01915914|527410985|FG003|Acute Phase|Withdrawal by Subject|0|||
146244826|NCT01915914|527410982|FG000|Acute Phase|Lost to Follow-up|4|||
146244827|NCT01915914|527410983|FG001|Acute Phase|Lost to Follow-up|0|||
146244828|NCT01915914|527410984|FG002|Acute Phase|Lost to Follow-up|0|||
146244829|NCT01915914|527410985|FG003|Acute Phase|Lost to Follow-up|0|||
145978712|NCT02949934|526433645|FG004|Bar Laboratory|Protocol Violation|0|||
145978713|NCT02949934|526433646|FG005|Bar Laboratory|Protocol Violation|0|||
145978714|NCT04069520|526433650|FG000|Overall Study|Lost to Follow-up|0|||
145978715|NCT04069520|526433651|FG001|Overall Study|Lost to Follow-up|2|||
145978716|NCT04069520|526433650|FG000|Overall Study|Withdrawal by Subject|0|||
145978717|NCT04069520|526433651|FG001|Overall Study|Withdrawal by Subject|1|||
145978718|NCT04069520|526433650|FG000|Overall Study|Prior Injury|1|||
145978719|NCT04069520|526433651|FG001|Overall Study|Prior Injury|0|||
145978720|NCT04069520|526433650|FG000|Overall Study|Orthodontia|1|||
145978721|NCT04069520|526433651|FG001|Overall Study|Orthodontia|0|||
145978722|NCT04069520|526433650|FG000|Overall Study|Cut from team|0|||
145978723|NCT04069520|526433651|FG001|Overall Study|Cut from team|2|||
145978724|NCT00849472|526433652|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
145978725|NCT00849472|526433652|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
145978726|NCT00849472|526433652|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
145978727|NCT00849472|526433652|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
145978728|NCT00849472|526433652|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
145978729|NCT00849472|526433652|FG000|Weekly Paclitaxel|Disease Progression|1|||
145978730|NCT00849472|526433652|FG000|Weekly Paclitaxel|Adverse Event|11|||
145978731|NCT00849472|526433652|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
145978732|NCT00849472|526433652|FG000|Weekly Paclitaxel|Physician Decision|3|||
145978733|NCT00849472|526433652|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
145978734|NCT00849472|526433652|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
145978735|NCT00849472|526433652|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
145978736|NCT00849472|526433652|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
145978737|NCT00849472|526433652|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
145978738|NCT00849472|526433652|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
145978739|NCT00849472|526433652|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
145978740|NCT00849472|526433652|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
145978741|NCT00825175|526433653|FG000|Overall Study|Withdrawal by Subject|0|||
145978742|NCT00825175|526433654|FG001|Overall Study|Withdrawal by Subject|5|||
145978743|NCT04822194|526433655|FG000|Overall Study|Withdrawal by Subject|5|||
145978744|NCT04822194|526433656|FG001|Overall Study|Withdrawal by Subject|4|||
145978745|NCT04822194|526433655|FG000|Overall Study|Technical issues with MR scanner|1|||
145978746|NCT04822194|526433656|FG001|Overall Study|Technical issues with MR scanner|0|||
145978747|NCT04822194|526433655|FG000|Overall Study|Lost to Follow-up|5|||
145978748|NCT04822194|526433656|FG001|Overall Study|Lost to Follow-up|7|||
145978749|NCT04615507|526433657|FG000|Period 1|Covid-19 exposure|2|||
145978750|NCT04615507|526433658|FG001|Period 1|Covid-19 exposure|1|||
145978751|NCT04615507|526433657|FG000|Period 2|Covid-19 exposure|0|||
145978752|NCT04615507|526433658|FG001|Period 2|Covid-19 exposure|1|||
145978753|NCT04615507|526433657|FG000|Period 2|Protocol Violation|1|||
145978754|NCT04615507|526433658|FG001|Period 2|Protocol Violation|0|||
145978755|NCT04615507|526433657|FG000|Period 2|Withdrawal by Subject|1|||
145978756|NCT04615507|526433658|FG001|Period 2|Withdrawal by Subject|0|||
146091081|NCT03614975|526854873|FG001|Overall Study|Withdrawal by Subject|2|||
145978757|NCT04615507|526433657|FG000|Period 2|Adverse Event|0|||
145978758|NCT04615507|526433658|FG001|Period 2|Adverse Event|1|||
145978759|NCT04615507|526433657|FG000|Period 3|Covid-19 exposure|0|||
145978760|NCT04615507|526433658|FG001|Period 3|Covid-19 exposure|1|||
145978761|NCT00118287|526433661|FG000|Overall Study|Intracranial haemorrhage|1|||
145978762|NCT00118287|526433661|FG000|Overall Study|Muscle pain|1|||
146091082|NCT03614975|526854872|FG000|Overall Study|Specimens not in lab batch shipment|1|||
146244830|NCT01915914|527410982|FG000|Acute Phase|Physician Decision|1|||
146244831|NCT01915914|527410983|FG001|Acute Phase|Physician Decision|0|||
146244832|NCT01915914|527410984|FG002|Acute Phase|Physician Decision|0|||
146297795|NCT04029480|527606007|FG001|Overall Study|Physician Decision|0|||
145978763|NCT03091439|526433666|FG000|Overall Study|Study Terminated by the Sponsor|1|||
145978764|NCT03091439|526433667|FG001|Overall Study|Study Terminated by the Sponsor|0|||
145978765|NCT03010501|526433670|FG000|Study Week 1|Withdrawal by Subject|2|||
145978766|NCT03010501|526433671|FG001|Study Week 1|Withdrawal by Subject|1|||
146244833|NCT01915914|527410985|FG003|Acute Phase|Physician Decision|0|||
146244834|NCT01915914|527410982|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
146244835|NCT01915914|527410983|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
146244836|NCT01915914|527410984|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
146244837|NCT01915914|527410985|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
146244838|NCT01915914|527410982|FG000|Acute Phase|"Not Achieved treatment success"|1|||
146244839|NCT01915914|527410983|FG001|Acute Phase|"Not Achieved treatment success"|0|||
146244840|NCT01915914|527410984|FG002|Acute Phase|"Not Achieved treatment success"|0|||
146244841|NCT01915914|527410985|FG003|Acute Phase|"Not Achieved treatment success"|0|||
146244842|NCT01915914|527410982|FG000|Acute Phase|Missing|1|||
146244843|NCT01915914|527410983|FG001|Acute Phase|Missing|0|||
146244844|NCT01915914|527410984|FG002|Acute Phase|Missing|0|||
146244845|NCT01915914|527410985|FG003|Acute Phase|Missing|0|||
146244846|NCT01915914|527410982|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146244847|NCT01915914|527410983|FG001|Maintenance Phase|Withdrawal by Subject|1|||
146244848|NCT01915914|527410984|FG002|Maintenance Phase|Withdrawal by Subject|1|||
146244849|NCT01915914|527410985|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146244850|NCT01915914|527410982|FG000|Maintenance Phase|Lost to Follow-up|0|||
146244851|NCT01915914|527410983|FG001|Maintenance Phase|Lost to Follow-up|4|||
146244852|NCT01915914|527410984|FG002|Maintenance Phase|Lost to Follow-up|1|||
146244853|NCT01915914|527410985|FG003|Maintenance Phase|Lost to Follow-up|0|||
146244854|NCT01915914|527410982|FG000|Maintenance Phase|Missing|0|||
146244855|NCT01915914|527410983|FG001|Maintenance Phase|Missing|1|||
146244856|NCT01915914|527410984|FG002|Maintenance Phase|Missing|0|||
146244857|NCT01915914|527410985|FG003|Maintenance Phase|Missing|0|||
146244858|NCT01915914|527410982|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146244859|NCT01915914|527410983|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146244860|NCT01915914|527410984|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146244861|NCT01915914|527410985|FG003|Follow-up Phase|Withdrawal by Subject|1|||
146244862|NCT01915914|527410982|FG000|Follow-up Phase|Physician Decision|0|||
146244863|NCT01915914|527410983|FG001|Follow-up Phase|Physician Decision|0|||
146244864|NCT01915914|527410984|FG002|Follow-up Phase|Physician Decision|0|||
146244865|NCT01915914|527410985|FG003|Follow-up Phase|Physician Decision|1|||
146244866|NCT00428714|527410987|FG000|Overall Study|Progressive Disease|28|||
146244867|NCT00428714|527410988|FG001|Overall Study|Progressive Disease|36|||
146244868|NCT00428714|527410987|FG000|Overall Study|Withdrawal by Subject|0|||
146244869|NCT00428714|527410988|FG001|Overall Study|Withdrawal by Subject|3|||
146244870|NCT00428714|527410987|FG000|Overall Study|Adverse Event|0|||
146244871|NCT00428714|527410988|FG001|Overall Study|Adverse Event|2|||
146244872|NCT00428714|527410987|FG000|Overall Study|Physician Decision|1|||
146244873|NCT00428714|527410988|FG001|Overall Study|Physician Decision|1|||
146244874|NCT00428714|527410987|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
146244875|NCT00428714|527410988|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
146244876|NCT00428714|527410987|FG000|Overall Study|Death due to other then PD|1|||
146244877|NCT00428714|527410988|FG001|Overall Study|Death due to other then PD|0|||
146244878|NCT01736475|527410991|FG000|Overall Study|Adverse Event|4|||
146244879|NCT01736475|527410992|FG001|Overall Study|Adverse Event|0|||
146244880|NCT01736475|527410991|FG000|Overall Study|Withdrawal by Subject|2|||
146244881|NCT01736475|527410992|FG001|Overall Study|Withdrawal by Subject|0|||
146244882|NCT01736475|527410991|FG000|Overall Study|Protocol Violation|4|||
146244883|NCT01736475|527410992|FG001|Overall Study|Protocol Violation|0|||
146244884|NCT01736475|527410991|FG000|Overall Study|Other - Screen failure|1|||
146244885|NCT01736475|527410992|FG001|Overall Study|Other - Screen failure|0|||
146244886|NCT01736475|527410991|FG000|Overall Study|Other - Surgical procedure|1|||
146244887|NCT01736475|527410992|FG001|Overall Study|Other - Surgical procedure|0|||
146244888|NCT00513071|527410993|FG000|Overall Study|Adverse Event|1|||
146244889|NCT00513071|527410993|FG000|Overall Study|Withdrawal by Subject|1|||
146244890|NCT00513071|527410993|FG000|Overall Study|Physician Decision|3|||
145933410|NCT03689374|526262185|FG001|Treatment Period (Week 0 to 52)|Death|11|||
145933411|NCT03689374|526262186|FG002|Treatment Period (Week 0 to 52)|Death|1|||
145933412|NCT05367973|526262187|FG000|Overall Study|Adverse Event|0|||
145933413|NCT05367973|526262188|FG001|Overall Study|Adverse Event|2|||
145933414|NCT01905553|526263526|FG000|Period 2|Adverse Event|1|||
145933415|NCT01905553|526263527|FG001|Period 2|Adverse Event|0|||
145933416|NCT02817516|526263528|FG000|Overall Study|Other|0|||
145933417|NCT02817516|526263529|FG001|Overall Study|Other|0|||
145933418|NCT02817516|526263530|FG002|Overall Study|Other|1|||
145933419|NCT02817516|526263531|FG003|Overall Study|Other|0|||
145933420|NCT00664859|526263532|FG000|Overall Study|Adverse Event|2|||
145933421|NCT00664859|526263533|FG001|Overall Study|Adverse Event|1|||
145933422|NCT00664859|526263534|FG002|Overall Study|Adverse Event|3|||
145933423|NCT00664859|526263532|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
145933424|NCT00664859|526263533|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
145933425|NCT00664859|526263534|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
146244891|NCT02114515|527410997|FG000|Overall Study|Lost to Follow-up|52|||
145933426|NCT00664859|526263532|FG000|Overall Study|Noncompliance with protocol|1|||
146244892|NCT02114515|527410998|FG001|Overall Study|Lost to Follow-up|55|||
146244893|NCT02114515|527410997|FG000|Overall Study|Death|12|||
146244894|NCT02114515|527410998|FG001|Overall Study|Death|12|||
146244895|NCT02114515|527410997|FG000|Overall Study|Withdrawal by Subject|4|||
146244896|NCT02114515|527410998|FG001|Overall Study|Withdrawal by Subject|22|||
146244897|NCT02114515|527410997|FG000|Overall Study|Other|65|||
146244898|NCT02114515|527410998|FG001|Overall Study|Other|61|||
146244899|NCT00667732|527410999|FG000|Run -In (8 Weeks)|Adverse Event|4|||
146244900|NCT00667732|527411000|FG001|Run -In (8 Weeks)|Adverse Event|0|||
146244901|NCT00667732|527411001|FG002|Run -In (8 Weeks)|Adverse Event|0|||
146244902|NCT00667732|527410999|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
146244903|NCT00667732|527411000|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
146244904|NCT00667732|527411001|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
146244905|NCT00667732|527410999|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
146244906|NCT00667732|527411000|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
146244907|NCT00667732|527411001|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
146244908|NCT02106325|527411004|FG000|Phase 1|Lost to Follow-up|2|||
146244909|NCT02106325|527411005|FG001|Phase 1|Lost to Follow-up|2|||
146244910|NCT02106325|527411004|FG000|Phase 2|Lost to Follow-up|2|||
146244911|NCT02106325|527411005|FG001|Phase 2|Lost to Follow-up|3|||
146244912|NCT02106325|527411004|FG000|Phase 3|Lost to Follow-up|2|||
146244913|NCT02106325|527411005|FG001|Phase 3|Lost to Follow-up|1|||
146244914|NCT00824850|527411007|FG000|Overall Study|Withdrawal by Subject|0|||
146244915|NCT00824850|527411008|FG001|Overall Study|Withdrawal by Subject|1|||
146244916|NCT04820491|527411009|FG000|Overall Study|Withdrawal by Subject|1|||
146244917|NCT04820491|527411010|FG001|Overall Study|Withdrawal by Subject|0|||
146244918|NCT04369664|527412110|FG000|Overall Study|Physician Decision|1|||
146244919|NCT04369664|527412111|FG001|Overall Study|Physician Decision|0|||
146244920|NCT00215943|527412115|FG000|Overall Study|Disease Progression|3|||
146244921|NCT00215943|527412116|FG001|Overall Study|Disease Progression|5|||
146244922|NCT00215943|527412115|FG000|Overall Study|Alternate therapy|0|||
146244923|NCT00215943|527412116|FG001|Overall Study|Alternate therapy|1|||
146244924|NCT00215943|527412115|FG000|Overall Study|Adverse Event|3|||
146244925|NCT00215943|527412116|FG001|Overall Study|Adverse Event|6|||
146244926|NCT00215943|527412115|FG000|Overall Study|Other disease|0|||
146244927|NCT00215943|527412116|FG001|Overall Study|Other disease|1|||
146244928|NCT00215943|527412115|FG000|Overall Study|Other complications|3|||
146244929|NCT00215943|527412116|FG001|Overall Study|Other complications|1|||
146244930|NCT02507297|527412117|FG000|Overall Study|Withdrawal by Subject|1|||
146244931|NCT02507297|527412118|FG001|Overall Study|Withdrawal by Subject|0|||
146244932|NCT02507297|527412117|FG000|Overall Study|Lost to Follow-up|0|||
146244933|NCT02507297|527412118|FG001|Overall Study|Lost to Follow-up|1|||
146244934|NCT02489799|527412119|FG000|Overall Study|Lost to Follow-up|4|||
146244935|NCT02489799|527412120|FG001|Overall Study|Lost to Follow-up|1|||
146244936|NCT02489799|527412119|FG000|Overall Study|Failure to Maintain Eligibility|4|||
146244937|NCT02489799|527412120|FG001|Overall Study|Failure to Maintain Eligibility|6|||
146244938|NCT02489799|527412119|FG000|Overall Study|Withdrawal by Subject|1|||
146244939|NCT02489799|527412120|FG001|Overall Study|Withdrawal by Subject|1|||
146244940|NCT02489799|527412119|FG000|Overall Study|Death|0|||
146244941|NCT02489799|527412120|FG001|Overall Study|Death|1|||
146244942|NCT04909593|527412121|FG000|Overall Study|Withdrawal by Subject|1|||
146244943|NCT01018992|527412122|FG000|Overall Study|Adverse Event|8|||
146244944|NCT01018992|527412123|FG001|Overall Study|Adverse Event|3|||
146244945|NCT01018992|527412122|FG000|Overall Study|Withdrawal by Subject|3|||
146244946|NCT01018992|527412123|FG001|Overall Study|Withdrawal by Subject|8|||
146244947|NCT01018992|527412122|FG000|Overall Study|Protocol Violation|0|||
146244948|NCT01018992|527412123|FG001|Overall Study|Protocol Violation|4|||
146244949|NCT01018992|527412122|FG000|Overall Study|Lost to Follow-up|5|||
146244950|NCT01018992|527412123|FG001|Overall Study|Lost to Follow-up|1|||
146244951|NCT01825785|527412124|FG000|Overall Study|Adverse Event|0|||
146244952|NCT01825785|527412125|FG001|Overall Study|Adverse Event|0|||
146244953|NCT01825785|527412126|FG002|Overall Study|Adverse Event|0|||
146244954|NCT01825785|527412127|FG003|Overall Study|Adverse Event|0|||
146244955|NCT01825785|527412128|FG004|Overall Study|Adverse Event|1|||
146244956|NCT01825785|527412129|FG005|Overall Study|Adverse Event|0|||
146244957|NCT01825785|527412130|FG006|Overall Study|Adverse Event|0|||
146244958|NCT01825785|527412124|FG000|Overall Study|Withdrawal by Subject|0|||
146244959|NCT01825785|527412125|FG001|Overall Study|Withdrawal by Subject|0|||
146244960|NCT01825785|527412126|FG002|Overall Study|Withdrawal by Subject|0|||
146244961|NCT01825785|527412127|FG003|Overall Study|Withdrawal by Subject|0|||
146244962|NCT01825785|527412128|FG004|Overall Study|Withdrawal by Subject|1|||
146244963|NCT01825785|527412129|FG005|Overall Study|Withdrawal by Subject|1|||
146244964|NCT01825785|527412130|FG006|Overall Study|Withdrawal by Subject|0|||
146244965|NCT01304940|527412132|FG000|Overall Study|not meet symptom severity requirement|3|||
146244966|NCT01304940|527412133|FG001|Overall Study|not meet symptom severity requirement|0|||
146244967|NCT02065895|527412134|FG000|Overall Study|Protocol Violation|1|||
146244968|NCT02065895|527412135|FG001|Overall Study|Protocol Violation|0|||
146244969|NCT02065895|527412136|FG002|Overall Study|Protocol Violation|0|||
146244970|NCT02065895|527412137|FG003|Overall Study|Protocol Violation|1|||
146244971|NCT02065895|527412138|FG004|Overall Study|Protocol Violation|0|||
146244972|NCT02065895|527412139|FG005|Overall Study|Protocol Violation|0|||
146244973|NCT02065895|527412134|FG000|Overall Study|Scheduling conflicts|0|||
146244974|NCT02065895|527412135|FG001|Overall Study|Scheduling conflicts|1|||
146244975|NCT02065895|527412136|FG002|Overall Study|Scheduling conflicts|0|||
146244976|NCT02065895|527412137|FG003|Overall Study|Scheduling conflicts|0|||
146244977|NCT02065895|527412138|FG004|Overall Study|Scheduling conflicts|0|||
146244978|NCT02065895|527412139|FG005|Overall Study|Scheduling conflicts|0|||
146244979|NCT03137784|527412140|FG000|Overall Study|Adverse Event|1|||
146244980|NCT03137784|527412141|FG001|Overall Study|Adverse Event|1|||
146244981|NCT03137784|527412142|FG002|Overall Study|Adverse Event|0|||
146244982|NCT03137784|527412143|FG003|Overall Study|Adverse Event|0|||
146244983|NCT03137784|527412144|FG004|Overall Study|Adverse Event|0|||
146244984|NCT03137784|527412145|FG005|Overall Study|Adverse Event|0|||
146244985|NCT03137784|527412140|FG000|Overall Study|Subject/guardian decision|1|||
146244986|NCT03137784|527412141|FG001|Overall Study|Subject/guardian decision|0|||
146244987|NCT03137784|527412142|FG002|Overall Study|Subject/guardian decision|0|||
146244988|NCT03137784|527412143|FG003|Overall Study|Subject/guardian decision|0|||
146244989|NCT03137784|527412144|FG004|Overall Study|Subject/guardian decision|0|||
146244990|NCT03137784|527412145|FG005|Overall Study|Subject/guardian decision|0|||
146244991|NCT03137784|527412140|FG000|Overall Study|Non-compliance with study treatment|0|||
146244992|NCT03137784|527412141|FG001|Overall Study|Non-compliance with study treatment|0|||
146244993|NCT03137784|527412142|FG002|Overall Study|Non-compliance with study treatment|0|||
146244994|NCT03137784|527412143|FG003|Overall Study|Non-compliance with study treatment|0|||
146244995|NCT03137784|527412144|FG004|Overall Study|Non-compliance with study treatment|1|||
146244996|NCT03137784|527412145|FG005|Overall Study|Non-compliance with study treatment|0|||
146244997|NCT01205126|527412146|FG000|Titration Phase|Adverse Event|5|||
145933427|NCT00664859|526263533|FG001|Overall Study|Noncompliance with protocol|0|||
145933428|NCT00664859|526263534|FG002|Overall Study|Noncompliance with protocol|4|||
145933429|NCT00664859|526263532|FG000|Overall Study|Laboratory abnormality|2|||
145933430|NCT00664859|526263533|FG001|Overall Study|Laboratory abnormality|1|||
145933431|NCT00664859|526263534|FG002|Overall Study|Laboratory abnormality|4|||
145933432|NCT00664859|526263532|FG000|Overall Study|Withdrawal by Subject|4|||
145933433|NCT00664859|526263533|FG001|Overall Study|Withdrawal by Subject|1|||
145978767|NCT03010501|526433672|FG002|Study Week 1|Withdrawal by Subject|0|||
146244998|NCT01205126|527412147|FG001|Titration Phase|Adverse Event|3|||
146244999|NCT01205126|527412146|FG000|Titration Phase|Withdrawal by Subject|5|||
146245000|NCT01205126|527412147|FG001|Titration Phase|Withdrawal by Subject|5|||
146245001|NCT01205126|527412146|FG000|Titration Phase|Lost to Follow-up|2|||
146245002|NCT01205126|527412147|FG001|Titration Phase|Lost to Follow-up|2|||
146245003|NCT01205126|527412146|FG000|Titration Phase|No stable titration dose|1|||
146245004|NCT01205126|527412147|FG001|Titration Phase|No stable titration dose|0|||
146245005|NCT01205126|527412146|FG000|Titration Phase|More than maximum dosage required|2|||
146245006|NCT01205126|527412147|FG001|Titration Phase|More than maximum dosage required|3|||
146245007|NCT01205126|527412146|FG000|Titration Phase|Other|8|||
146245008|NCT01205126|527412147|FG001|Titration Phase|Other|6|||
146245009|NCT01205126|527412146|FG000|Between Titration & Maintenance Phase|Other|0|||
146245010|NCT01205126|527412147|FG001|Between Titration & Maintenance Phase|Other|4|||
146245011|NCT01205126|527412146|FG000|Maintenance Phase|Adverse Event|3|||
146245012|NCT01205126|527412147|FG001|Maintenance Phase|Adverse Event|7|||
146245013|NCT01205126|527412146|FG000|Maintenance Phase|Death|4|||
146245014|NCT01205126|527412147|FG001|Maintenance Phase|Death|4|||
146245015|NCT01205126|527412146|FG000|Maintenance Phase|More than the maximum dosage required|5|||
146245016|NCT01205126|527412147|FG001|Maintenance Phase|More than the maximum dosage required|5|||
146245017|NCT01205126|527412146|FG000|Maintenance Phase|Prohibited drugs used|1|||
146245018|NCT01205126|527412147|FG001|Maintenance Phase|Prohibited drugs used|0|||
146245019|NCT01205126|527412146|FG000|Maintenance Phase|Other|11|||
146245020|NCT01205126|527412147|FG001|Maintenance Phase|Other|8|||
146245021|NCT01205126|527412146|FG000|Maintenance Phase|Lost to Follow-up|5|||
146245022|NCT01205126|527412147|FG001|Maintenance Phase|Lost to Follow-up|5|||
146245023|NCT01205126|527412146|FG000|Maintenance Phase|Withdrawal by Subject|8|||
146245024|NCT01205126|527412147|FG001|Maintenance Phase|Withdrawal by Subject|11|||
146245025|NCT00805792|527412150|FG000|Overall Study|Death|3|||
146245026|NCT00805792|527412150|FG000|Overall Study|Lost to Follow-up|2|||
146245027|NCT04328467|527412153|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
146245028|NCT04328467|527412154|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
146245029|NCT04328467|527412155|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
146245030|NCT01655498|527412156|FG000|Overall Study|Unrelated health issue|2|||
146245031|NCT01655498|527412156|FG000|Overall Study|Protocol Violation|2|||
145933434|NCT00664859|526263534|FG002|Overall Study|Withdrawal by Subject|3|||
145933435|NCT00664859|526263532|FG000|Overall Study|Lost to Follow-up|2|||
145933436|NCT00664859|526263533|FG001|Overall Study|Lost to Follow-up|2|||
145933437|NCT00664859|526263534|FG002|Overall Study|Lost to Follow-up|1|||
145933438|NCT00664859|526263532|FG000|Overall Study|Other|0|||
145933439|NCT00664859|526263533|FG001|Overall Study|Other|1|||
145933440|NCT00664859|526263534|FG002|Overall Study|Other|2|||
145933441|NCT00348595|526263535|FG000|Overall Study|Adverse Event|5|||
146245032|NCT01655498|527412156|FG000|Overall Study|Withdrawal by Subject|1|||
146245033|NCT01393600|527412159|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146245034|NCT01393600|527412160|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
146245035|NCT01393600|527412161|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146245036|NCT01393600|527412162|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
146245037|NCT01393600|527412159|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146245038|NCT01393600|527412160|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146245039|NCT01393600|527412161|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
146245040|NCT01393600|527412162|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
146245041|NCT01393600|527412159|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146245042|NCT01393600|527412160|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146245043|NCT01393600|527412161|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
146245044|NCT01393600|527412162|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
146245045|NCT01393600|527412159|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146245046|NCT01393600|527412160|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146245047|NCT01393600|527412161|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
146245048|NCT01393600|527412162|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
146245049|NCT01393600|527412159|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
145978768|NCT03010501|526433673|FG003|Study Week 1|Withdrawal by Subject|2|||
145978769|NCT03010501|526433674|FG004|Study Week 1|Withdrawal by Subject|0|||
145978770|NCT03010501|526433675|FG005|Study Week 1|Withdrawal by Subject|0|||
145978771|NCT03010501|526433670|FG000|Study Week 3|Withdrawal by Subject|0|||
145978772|NCT03010501|526433671|FG001|Study Week 3|Withdrawal by Subject|0|||
145978773|NCT03010501|526433672|FG002|Study Week 3|Withdrawal by Subject|0|||
145978774|NCT03010501|526433673|FG003|Study Week 3|Withdrawal by Subject|1|||
145978775|NCT03010501|526433674|FG004|Study Week 3|Withdrawal by Subject|0|||
145978776|NCT03010501|526433675|FG005|Study Week 3|Withdrawal by Subject|0|||
145978777|NCT05172570|526433676|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
145978778|NCT05172570|526433677|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
146245050|NCT01393600|527412160|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
146245051|NCT01393600|527412161|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
146245052|NCT01393600|527412162|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
146245053|NCT01393600|527412159|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146245054|NCT01393600|527412160|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146245055|NCT01393600|527412161|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
146245056|NCT01393600|527412162|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
146245057|NCT01393600|527412159|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146245058|NCT01393600|527412160|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146245059|NCT01393600|527412161|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
146245060|NCT01393600|527412162|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
146245061|NCT01072149|527412163|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245062|NCT01072149|527412164|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245063|NCT01072149|527412165|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146245064|NCT01072149|527412166|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245065|NCT01072149|527412167|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245066|NCT01072149|527412168|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245067|NCT01072149|527412169|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245068|NCT01072149|527412170|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245069|NCT01072149|527412171|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245070|NCT01072149|527412172|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145978779|NCT05172570|526433678|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
145978780|NCT05172570|526433676|FG000|Overall Study|PI Decision due to equipment shortages|0|||
145978781|NCT05172570|526433677|FG001|Overall Study|PI Decision due to equipment shortages|0|||
146245071|NCT01072149|527412173|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245072|NCT01072149|527412174|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245073|NCT01072149|527412175|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245074|NCT01072149|527412176|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245075|NCT01072149|527412177|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245076|NCT01072149|527412178|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245077|NCT01072149|527412179|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245078|NCT01072149|527412180|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146245079|NCT01072149|527412163|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146091083|NCT03614975|526854873|FG001|Overall Study|Specimens not in lab batch shipment|1|||
146245080|NCT01072149|527412164|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146297796|NCT04029480|527606008|FG002|Overall Study|Physician Decision|2|||
145978782|NCT05172570|526433678|FG002|Overall Study|PI Decision due to equipment shortages|1|||
146091084|NCT01569464|526854874|FG000|Overall Study|Adverse Event|4|||
146091085|NCT01569464|526854875|FG001|Overall Study|Adverse Event|0|||
146091086|NCT01569464|526854874|FG000|Overall Study|Lack of Efficacy|1|||
146245081|NCT01072149|527412165|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245082|NCT01072149|527412166|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245083|NCT01072149|527412167|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245084|NCT01072149|527412168|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245085|NCT01072149|527412169|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245086|NCT01072149|527412170|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145933442|NCT00348595|526263536|FG001|Overall Study|Adverse Event|8|||
145933443|NCT00546117|526263537|FG000|Overall Study|Withdrawal by Subject|3|||
145933444|NCT00546117|526263538|FG001|Overall Study|Withdrawal by Subject|0|||
145933445|NCT00546117|526263537|FG000|Overall Study|Inability to schedule follow-up visit|1|||
145933446|NCT00546117|526263538|FG001|Overall Study|Inability to schedule follow-up visit|0|||
145933447|NCT01560234|526263541|FG000|Overall Study|Lost to Follow-up|3|||
145933448|NCT01560234|526263542|FG001|Overall Study|Lost to Follow-up|0|||
145933449|NCT01560234|526263543|FG002|Overall Study|Lost to Follow-up|1|||
145933450|NCT01560234|526263544|FG003|Overall Study|Lost to Follow-up|0|||
145933451|NCT01560234|526263545|FG004|Overall Study|Lost to Follow-up|0|||
145933452|NCT01560234|526263546|FG005|Overall Study|Lost to Follow-up|2|||
145933453|NCT01560234|526263547|FG006|Overall Study|Lost to Follow-up|0|||
145933454|NCT01560234|526263548|FG007|Overall Study|Lost to Follow-up|2|||
145933455|NCT01289639|526263549|FG000|Overall Study|Lost to Follow-up|1|||
145933456|NCT01289639|526263550|FG001|Overall Study|Lost to Follow-up|0|||
145933457|NCT01289639|526263551|FG002|Overall Study|Lost to Follow-up|0|||
145933458|NCT02780713|526263552|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145933459|NCT02780713|526263553|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145933460|NCT02780713|526263554|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
145933461|NCT02780713|526263555|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145933462|NCT02780713|526263556|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145933463|NCT01931475|526263559|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
145933464|NCT01931475|526263560|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
145933465|NCT01931475|526263559|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
145933466|NCT01931475|526263560|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
145933467|NCT01931475|526263559|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
145933468|NCT01931475|526263560|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
145933469|NCT01931475|526263559|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
145933470|NCT01931475|526263560|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
145933471|NCT01931475|526263559|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
145933472|NCT01931475|526263560|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
145933473|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
145933474|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
145933475|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
145933476|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
145933477|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
145933478|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
145933479|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
145933480|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
145978783|NCT00640289|526433681|FG000|Overall Study|Death|3|||
145978784|NCT00640289|526433681|FG000|Overall Study|Withdrawal by Subject|1|||
145978785|NCT00640289|526433681|FG000|Overall Study|Lost to Follow-up|1|||
145978786|NCT00640289|526433681|FG000|Overall Study|Data collected under different amendment|2|||
145978787|NCT00640289|526433681|FG000|Overall Study|Transferred to another center|1|||
145978788|NCT00640289|526433681|FG000|Overall Study|Missing status|5|||
145978789|NCT03550209|526433683|FG000|Overall Study|Lost to Follow-up|1|||
145978790|NCT03550209|526433684|FG001|Overall Study|Lost to Follow-up|0|||
145978791|NCT03550209|526433685|FG002|Overall Study|Lost to Follow-up|1|||
146091087|NCT01569464|526854875|FG001|Overall Study|Lack of Efficacy|0|||
145933481|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
145933482|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
145933483|NCT01931475|526263559|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
145933484|NCT01931475|526263560|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
145933485|NCT00425061|526263562|FG000|Overall Study|Adverse Event|1|||
145933486|NCT00425061|526263563|FG001|Overall Study|Adverse Event|0|||
145933487|NCT00425061|526263564|FG002|Overall Study|Adverse Event|0|||
145978792|NCT03550209|526433686|FG003|Overall Study|Lost to Follow-up|0|||
145978793|NCT03550209|526433683|FG000|Overall Study|Withdrawal by Subject|0|||
146245087|NCT01072149|527412171|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245088|NCT01072149|527412172|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145933488|NCT00425061|526263565|FG003|Overall Study|Adverse Event|2|||
145933489|NCT00425061|526263566|FG004|Overall Study|Adverse Event|2|||
145933490|NCT00425061|526263567|FG005|Overall Study|Adverse Event|0|||
145933491|NCT00425061|526263568|FG006|Overall Study|Adverse Event|0|||
145978794|NCT03550209|526433684|FG001|Overall Study|Withdrawal by Subject|3|||
145978795|NCT03550209|526433685|FG002|Overall Study|Withdrawal by Subject|1|||
145933492|NCT00425061|526263562|FG000|Overall Study|Lost to Follow-up|0|||
145933493|NCT00425061|526263563|FG001|Overall Study|Lost to Follow-up|1|||
145933494|NCT00425061|526263564|FG002|Overall Study|Lost to Follow-up|0|||
145933495|NCT00425061|526263565|FG003|Overall Study|Lost to Follow-up|0|||
145933496|NCT00425061|526263566|FG004|Overall Study|Lost to Follow-up|0|||
145933497|NCT00425061|526263567|FG005|Overall Study|Lost to Follow-up|0|||
145933498|NCT00425061|526263568|FG006|Overall Study|Lost to Follow-up|0|||
145933499|NCT00425061|526263562|FG000|Overall Study|Protocol Violation|1|||
145933500|NCT00425061|526263563|FG001|Overall Study|Protocol Violation|0|||
145933501|NCT00425061|526263564|FG002|Overall Study|Protocol Violation|0|||
145933502|NCT00425061|526263565|FG003|Overall Study|Protocol Violation|0|||
145933503|NCT00425061|526263566|FG004|Overall Study|Protocol Violation|0|||
145933504|NCT00425061|526263567|FG005|Overall Study|Protocol Violation|0|||
145933505|NCT00425061|526263568|FG006|Overall Study|Protocol Violation|0|||
145933506|NCT00425061|526263562|FG000|Overall Study|Withdrawal by Subject|0|||
145933507|NCT00425061|526263563|FG001|Overall Study|Withdrawal by Subject|1|||
145933508|NCT00425061|526263564|FG002|Overall Study|Withdrawal by Subject|0|||
145933509|NCT00425061|526263565|FG003|Overall Study|Withdrawal by Subject|0|||
145933510|NCT00425061|526263566|FG004|Overall Study|Withdrawal by Subject|1|||
145933511|NCT00425061|526263567|FG005|Overall Study|Withdrawal by Subject|0|||
145933512|NCT00425061|526263568|FG006|Overall Study|Withdrawal by Subject|3|||
145933513|NCT00425061|526263562|FG000|Overall Study|Sponsor's request|0|||
145933514|NCT00425061|526263563|FG001|Overall Study|Sponsor's request|0|||
145933515|NCT00425061|526263564|FG002|Overall Study|Sponsor's request|0|||
145933516|NCT00425061|526263565|FG003|Overall Study|Sponsor's request|0|||
145933517|NCT00425061|526263566|FG004|Overall Study|Sponsor's request|19|||
145933518|NCT00425061|526263567|FG005|Overall Study|Sponsor's request|4|||
145933519|NCT00425061|526263568|FG006|Overall Study|Sponsor's request|15|||
145933520|NCT00425061|526263562|FG000|Overall Study|Physician Decision|0|||
145933521|NCT00425061|526263563|FG001|Overall Study|Physician Decision|0|||
145933522|NCT00425061|526263564|FG002|Overall Study|Physician Decision|0|||
145933523|NCT00425061|526263565|FG003|Overall Study|Physician Decision|0|||
145933524|NCT00425061|526263566|FG004|Overall Study|Physician Decision|1|||
145933525|NCT00425061|526263567|FG005|Overall Study|Physician Decision|0|||
145933526|NCT00425061|526263568|FG006|Overall Study|Physician Decision|0|||
145933527|NCT00425061|526263562|FG000|Overall Study|Other|0|||
145933528|NCT00425061|526263563|FG001|Overall Study|Other|0|||
145933529|NCT00425061|526263564|FG002|Overall Study|Other|0|||
145933530|NCT00425061|526263565|FG003|Overall Study|Other|0|||
145933531|NCT00425061|526263566|FG004|Overall Study|Other|3|||
145933532|NCT00425061|526263567|FG005|Overall Study|Other|0|||
145933533|NCT00425061|526263568|FG006|Overall Study|Other|1|||
145933534|NCT03436693|526263569|FG000|Overall Study|Adverse Event|22|||
145933535|NCT03436693|526263570|FG001|Overall Study|Adverse Event|10|||
145933536|NCT03436693|526263569|FG000|Overall Study|Physician Decision|3|||
145933537|NCT03436693|526263570|FG001|Overall Study|Physician Decision|3|||
145933538|NCT03436693|526263569|FG000|Overall Study|Withdrawal by Subject|4|||
145933539|NCT03436693|526263570|FG001|Overall Study|Withdrawal by Subject|13|||
145933540|NCT03436693|526263569|FG000|Overall Study|Progressive Disease|1|||
145933541|NCT03436693|526263570|FG001|Overall Study|Progressive Disease|1|||
145933542|NCT01680861|526263571|FG000|Early Post-transplant Period|Protocol Violation|1|||
145933543|NCT01680861|526263572|FG001|Early Post-transplant Period|Protocol Violation|1|||
145933544|NCT04967885|526263575|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
145933545|NCT04967885|526263576|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
145933546|NCT04967885|526263575|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
145933547|NCT04967885|526263576|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
145933548|NCT04967885|526263575|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
145933549|NCT04967885|526263576|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
145933550|NCT04967885|526263575|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
145933551|NCT04967885|526263576|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
145933552|NCT04967885|526263575|FG000|EMI-II Intervention|Lost to Follow-up|14|||
145933553|NCT04967885|526263576|FG001|EMI-II Intervention|Lost to Follow-up|10|||
145933554|NCT01011465|526263577|FG000|Overall Study|Withdrawal by Subject|2|||
145933555|NCT01011465|526263578|FG001|Overall Study|Withdrawal by Subject|1|||
145933556|NCT01011465|526263579|FG002|Overall Study|Withdrawal by Subject|0|||
145933557|NCT01011465|526263580|FG003|Overall Study|Withdrawal by Subject|0|||
145933558|NCT01011465|526263581|FG004|Overall Study|Withdrawal by Subject|1|||
145933559|NCT01011465|526263582|FG005|Overall Study|Withdrawal by Subject|0|||
145933560|NCT01011465|526263583|FG006|Overall Study|Withdrawal by Subject|1|||
145933561|NCT01011465|526263584|FG007|Overall Study|Withdrawal by Subject|0|||
145933562|NCT00723008|526263585|FG000|Enrollment|Lost to Follow-up|1|||
145933563|NCT00723008|526263586|FG001|Enrollment|Lost to Follow-up|0|||
145933564|NCT00723008|526263585|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
145933565|NCT00723008|526263586|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
145933566|NCT00723008|526263585|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
145933567|NCT00723008|526263586|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
145933568|NCT00723008|526263585|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
145933569|NCT00723008|526263586|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
145933570|NCT00723008|526263585|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
146245089|NCT01072149|527412173|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245090|NCT01072149|527412174|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245091|NCT01072149|527412175|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245092|NCT01072149|527412176|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145933571|NCT00723008|526263586|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
145933572|NCT00723008|526263585|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
146245093|NCT01072149|527412177|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145933573|NCT00723008|526263586|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
145933574|NCT05835011|526263587|FG000|Overall Study|Study Terminated by the Sponsor|1|||
145933575|NCT05835011|526263587|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
145933576|NCT01471340|526263590|FG000|Overall Study|Death|5|||
145933577|NCT01471340|526263591|FG001|Overall Study|Death|4|||
145933578|NCT01471340|526263590|FG000|Overall Study|Lost to Follow-up|0|||
145933579|NCT01471340|526263591|FG001|Overall Study|Lost to Follow-up|1|||
145933580|NCT01471340|526263590|FG000|Overall Study|Investigational site closure|0|||
145933581|NCT01471340|526263591|FG001|Overall Study|Investigational site closure|1|||
145933582|NCT01471340|526263590|FG000|Overall Study|Invalid informed consent|1|||
145933583|NCT01471340|526263591|FG001|Overall Study|Invalid informed consent|0|||
145933584|NCT00526669|526263592|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
145933585|NCT00526669|526263593|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
145933586|NCT00526669|526263592|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
145933587|NCT00526669|526263593|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
145933588|NCT00526669|526263592|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
145933589|NCT00526669|526263593|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
145933590|NCT00526669|526263592|FG000|Combined Treatment Phase|Death|0|||
145933591|NCT00526669|526263593|FG001|Combined Treatment Phase|Death|2|||
145933592|NCT03499899|526263594|FG000|Overall Study|Adverse Event|2|||
145933593|NCT03499899|526263595|FG001|Overall Study|Adverse Event|3|||
145933594|NCT03499899|526263596|FG002|Overall Study|Adverse Event|3|||
145933595|NCT03499899|526263594|FG000|Overall Study|Death|0|||
145933596|NCT03499899|526263595|FG001|Overall Study|Death|0|||
145933597|NCT03499899|526263596|FG002|Overall Study|Death|1|||
145933598|NCT03499899|526263594|FG000|Overall Study|Physician Decision|3|||
145933599|NCT03499899|526263595|FG001|Overall Study|Physician Decision|6|||
145933600|NCT03499899|526263596|FG002|Overall Study|Physician Decision|6|||
145933601|NCT03499899|526263594|FG000|Overall Study|Progressive disease|15|||
145933602|NCT03499899|526263595|FG001|Overall Study|Progressive disease|23|||
145933603|NCT03499899|526263596|FG002|Overall Study|Progressive disease|23|||
145933604|NCT03499899|526263594|FG000|Overall Study|Patient decision|0|||
145933605|NCT03499899|526263595|FG001|Overall Study|Patient decision|1|||
145933606|NCT03499899|526263596|FG002|Overall Study|Patient decision|1|||
145933607|NCT03499899|526263594|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
145933608|NCT03499899|526263595|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
145933609|NCT03499899|526263596|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
145933610|NCT01981954|526263601|FG000|Titration Period|Protocol Deviation|1|||
145933611|NCT01981954|526263601|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
145933612|NCT01609543|526263609|FG000|Overall Study|Disease Progression|28|||
145933613|NCT01609543|526263609|FG000|Overall Study|Adverse Event|5|||
145933614|NCT01609543|526263609|FG000|Overall Study|Withdrawal by Subject|1|||
145933615|NCT01609543|526263609|FG000|Overall Study|Protocol Violation|1|||
145933616|NCT01609543|526263609|FG000|Overall Study|Death|7|||
145933617|NCT02218736|526263611|FG000|Overall Study|Withdrawal by Subject|10|||
145933618|NCT02218736|526263612|FG001|Overall Study|Withdrawal by Subject|9|||
145933619|NCT02218736|526263611|FG000|Overall Study|Protocol Violation|2|||
145933620|NCT02218736|526263612|FG001|Overall Study|Protocol Violation|0|||
145933621|NCT03702010|526263617|FG000|Follow-up (30days)|Lack of Efficacy|2|||
145933622|NCT03702010|526263618|FG001|Follow-up (30days)|Lack of Efficacy|2|||
145933623|NCT02295020|526263623|FG000|Overall Study|Adverse Event|0|||
145933624|NCT02295020|526263624|FG001|Overall Study|Adverse Event|1|||
145933625|NCT02295020|526263623|FG000|Overall Study|Withdrawal by Subject|3|||
145933626|NCT02295020|526263624|FG001|Overall Study|Withdrawal by Subject|2|||
145933627|NCT01137110|526263625|FG000|Overall Study|Protocol Violation|1|||
145933628|NCT01137110|526263626|FG001|Overall Study|Protocol Violation|0|||
145933629|NCT00355147|526263631|FG000|Overall Study|Lost to Follow-up|10|||
145933630|NCT00355147|526263632|FG001|Overall Study|Lost to Follow-up|8|||
145933631|NCT00355147|526263631|FG000|Overall Study|Withdrawal by Subject|8|||
145933632|NCT00355147|526263632|FG001|Overall Study|Withdrawal by Subject|12|||
146091088|NCT01569464|526854874|FG000|Overall Study|Protocol Violation|1|||
146245094|NCT01072149|527412178|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245095|NCT01072149|527412179|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
146245096|NCT01072149|527412180|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
145933633|NCT00638443|526263639|FG000|First Intervention|Adverse Event|2|||
145933634|NCT00638443|526263640|FG001|First Intervention|Adverse Event|1|||
145933635|NCT00675428|526263643|FG000|Overall Study|Disease Progression|2|||
145933636|NCT00675428|526263644|FG001|Overall Study|Disease Progression|2|||
145933637|NCT00675428|526263643|FG000|Overall Study|No Disease Response After Cycle 6|0|||
145933638|NCT00675428|526263644|FG001|Overall Study|No Disease Response After Cycle 6|1|||
145933639|NCT00675428|526263643|FG000|Overall Study|Physician Decision|1|||
145933640|NCT00675428|526263644|FG001|Overall Study|Physician Decision|0|||
145933641|NCT04740827|526263651|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
146245097|NCT01072149|527412163|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245098|NCT01072149|527412164|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245099|NCT01072149|527412165|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245100|NCT01072149|527412166|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245101|NCT01072149|527412167|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245102|NCT01072149|527412168|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245103|NCT01072149|527412169|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245104|NCT01072149|527412170|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245105|NCT01072149|527412171|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245106|NCT01072149|527412172|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245107|NCT01072149|527412173|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
146245108|NCT01072149|527412174|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245109|NCT01072149|527412175|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245110|NCT01072149|527412176|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245111|NCT01072149|527412177|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245112|NCT01072149|527412178|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245113|NCT01072149|527412179|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245114|NCT01072149|527412180|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146245115|NCT01072149|527412163|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245116|NCT01072149|527412164|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
146245117|NCT01072149|527412165|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245118|NCT01072149|527412166|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245119|NCT01072149|527412167|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245120|NCT01072149|527412168|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245121|NCT01072149|527412169|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245122|NCT01072149|527412170|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245123|NCT01072149|527412171|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245124|NCT01072149|527412172|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245125|NCT01072149|527412173|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245126|NCT01072149|527412174|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245127|NCT01072149|527412175|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245128|NCT01072149|527412176|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245129|NCT01072149|527412177|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245130|NCT01072149|527412178|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245131|NCT01072149|527412179|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245132|NCT01072149|527412180|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146245133|NCT01072149|527412163|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245134|NCT01072149|527412164|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245135|NCT01072149|527412165|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
146245136|NCT01072149|527412166|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245137|NCT01072149|527412167|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245138|NCT01072149|527412168|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245139|NCT01072149|527412169|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245140|NCT01072149|527412170|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245141|NCT01072149|527412171|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245142|NCT01072149|527412172|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245143|NCT01072149|527412173|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245144|NCT01072149|527412174|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245145|NCT01072149|527412175|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245146|NCT01072149|527412176|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245147|NCT01072149|527412177|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245148|NCT01072149|527412178|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245149|NCT01072149|527412179|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245150|NCT01072149|527412180|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
146245151|NCT01072149|527412163|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245152|NCT01072149|527412164|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245153|NCT01072149|527412165|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245154|NCT01072149|527412166|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245155|NCT01072149|527412167|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245156|NCT01072149|527412168|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245157|NCT01072149|527412169|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245158|NCT01072149|527412170|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
145933642|NCT04740827|526263652|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
145933643|NCT04740827|526263651|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
146091089|NCT01569464|526854875|FG001|Overall Study|Protocol Violation|0|||
146245159|NCT01072149|527412171|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245160|NCT01072149|527412172|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245161|NCT01072149|527412173|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245162|NCT01072149|527412174|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245163|NCT01072149|527412175|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245164|NCT01072149|527412176|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245165|NCT01072149|527412177|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245166|NCT01072149|527412178|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245167|NCT01072149|527412179|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245168|NCT01072149|527412180|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
146245169|NCT01072149|527412163|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
146245170|NCT01072149|527412164|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
146245171|NCT01072149|527412165|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
146245172|NCT01072149|527412166|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
146245173|NCT01072149|527412167|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
146245174|NCT01072149|527412168|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
146245175|NCT01072149|527412169|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
146245176|NCT01072149|527412170|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
146245177|NCT01072149|527412171|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
146245178|NCT01072149|527412172|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
146245179|NCT01072149|527412173|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
146245180|NCT01072149|527412174|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
146245181|NCT01072149|527412175|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
146245182|NCT01072149|527412176|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
146245183|NCT01072149|527412177|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
146245184|NCT01072149|527412178|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
146245185|NCT01072149|527412179|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
146245186|NCT01072149|527412180|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
146245187|NCT01072149|527412163|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245188|NCT01072149|527412164|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245189|NCT01072149|527412165|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245190|NCT01072149|527412166|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245191|NCT01072149|527412167|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245192|NCT01072149|527412168|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245193|NCT01072149|527412169|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245194|NCT01072149|527412170|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245195|NCT01072149|527412171|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245196|NCT01072149|527412172|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245197|NCT01072149|527412173|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245198|NCT01072149|527412174|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245199|NCT01072149|527412175|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245200|NCT01072149|527412176|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245201|NCT01072149|527412177|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245202|NCT01072149|527412178|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
146245203|NCT01072149|527412179|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245204|NCT01072149|527412180|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
146245205|NCT01072149|527412163|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
146245206|NCT01072149|527412164|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
146245207|NCT01072149|527412165|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
146245208|NCT01072149|527412166|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
146245209|NCT01072149|527412167|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
146245210|NCT01072149|527412168|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
146245211|NCT01072149|527412169|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
146245212|NCT01072149|527412170|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
146245213|NCT01072149|527412171|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
146245214|NCT01072149|527412172|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
146245215|NCT01072149|527412173|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
146245216|NCT01072149|527412174|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
146245217|NCT01072149|527412175|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
146245218|NCT01072149|527412176|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
145933644|NCT04740827|526263652|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
145933645|NCT04740827|526263651|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
145933646|NCT04740827|526263652|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
145933647|NCT04740827|526263651|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
146245219|NCT01072149|527412177|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
146245220|NCT01072149|527412178|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
146245221|NCT01072149|527412179|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
146245222|NCT01072149|527412180|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
146245223|NCT01072149|527412163|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145933648|NCT04740827|526263652|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
145933649|NCT04740827|526263651|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
146245224|NCT01072149|527412164|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245225|NCT01072149|527412165|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245226|NCT01072149|527412166|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245227|NCT01072149|527412167|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245228|NCT01072149|527412168|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245229|NCT01072149|527412169|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245230|NCT01072149|527412170|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245231|NCT01072149|527412171|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245232|NCT01072149|527412172|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245233|NCT01072149|527412173|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245234|NCT01072149|527412174|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245235|NCT01072149|527412175|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
146245236|NCT01072149|527412176|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245237|NCT01072149|527412177|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245238|NCT01072149|527412178|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245239|NCT01072149|527412179|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245240|NCT01072149|527412180|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
146245241|NCT01072149|527412163|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245242|NCT01072149|527412164|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245243|NCT01072149|527412165|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
146245244|NCT01072149|527412166|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245245|NCT01072149|527412167|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145933650|NCT04740827|526263652|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
145933651|NCT04740827|526263651|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
145933652|NCT04740827|526263652|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
145933653|NCT02147158|526263653|FG000|Treatment Course 1|Adverse Event|1|||
145933654|NCT02147158|526263654|FG001|Treatment Course 1|Adverse Event|4|||
145933655|NCT02147158|526263655|FG002|Treatment Course 1|Adverse Event|3|||
145933656|NCT02147158|526263656|FG003|Treatment Course 1|Adverse Event|4|||
145933657|NCT02147158|526263657|FG004|Treatment Course 1|Adverse Event|1|||
145933658|NCT02147158|526263658|FG005|Treatment Course 1|Adverse Event|2|||
145933659|NCT02147158|526263653|FG000|Treatment Course 1|Lost to Follow-up|2|||
145933660|NCT02147158|526263654|FG001|Treatment Course 1|Lost to Follow-up|4|||
145933661|NCT02147158|526263655|FG002|Treatment Course 1|Lost to Follow-up|3|||
145933662|NCT02147158|526263656|FG003|Treatment Course 1|Lost to Follow-up|3|||
145933663|NCT02147158|526263657|FG004|Treatment Course 1|Lost to Follow-up|2|||
145933664|NCT02147158|526263658|FG005|Treatment Course 1|Lost to Follow-up|4|||
145933665|NCT02147158|526263653|FG000|Treatment Course 1|Protocol Violation|0|||
145933666|NCT02147158|526263654|FG001|Treatment Course 1|Protocol Violation|0|||
145933667|NCT02147158|526263655|FG002|Treatment Course 1|Protocol Violation|1|||
145933668|NCT02147158|526263656|FG003|Treatment Course 1|Protocol Violation|1|||
145933669|NCT02147158|526263657|FG004|Treatment Course 1|Protocol Violation|0|||
145933670|NCT02147158|526263658|FG005|Treatment Course 1|Protocol Violation|0|||
145933671|NCT02147158|526263653|FG000|Treatment Course 1|Withdrawal of Consent|1|||
145933672|NCT02147158|526263654|FG001|Treatment Course 1|Withdrawal of Consent|1|||
145933673|NCT02147158|526263655|FG002|Treatment Course 1|Withdrawal of Consent|1|||
145933674|NCT02147158|526263656|FG003|Treatment Course 1|Withdrawal of Consent|5|||
145933675|NCT02147158|526263657|FG004|Treatment Course 1|Withdrawal of Consent|3|||
145933676|NCT02147158|526263658|FG005|Treatment Course 1|Withdrawal of Consent|2|||
145933677|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Adverse Event|1|||
145933678|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Adverse Event|0|||
145933679|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Adverse Event|0|||
145933680|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Adverse Event|1|||
145933681|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Adverse Event|0|||
145933682|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Adverse Event|0|||
145933683|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
145933684|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
145933685|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
145933686|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
145933687|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
145933688|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
145933689|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
145933690|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
145933691|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
145933692|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
145933693|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
145933694|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
145933695|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
146245246|NCT01072149|527412168|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245247|NCT01072149|527412169|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145933696|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
146091090|NCT01569464|526854874|FG000|Overall Study|Lost to Follow-up|2|||
145933697|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
145933698|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
145933699|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
145933700|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
145933701|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
145933702|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
145933703|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
145933704|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
145933705|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
145933706|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
145933707|NCT02147158|526263653|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
145933708|NCT02147158|526263654|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145933709|NCT02147158|526263655|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
145933710|NCT02147158|526263656|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
145933711|NCT02147158|526263657|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145933712|NCT02147158|526263658|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145933713|NCT02147158|526263653|FG000|Treatment Course 2|Adverse Event|0|||
145933714|NCT02147158|526263654|FG001|Treatment Course 2|Adverse Event|4|||
145933715|NCT02147158|526263655|FG002|Treatment Course 2|Adverse Event|2|||
145933716|NCT02147158|526263656|FG003|Treatment Course 2|Adverse Event|1|||
145933717|NCT02147158|526263657|FG004|Treatment Course 2|Adverse Event|0|||
145933718|NCT02147158|526263658|FG005|Treatment Course 2|Adverse Event|1|||
145933719|NCT02147158|526263653|FG000|Treatment Course 2|Withdrawal of Consent|0|||
145933720|NCT02147158|526263654|FG001|Treatment Course 2|Withdrawal of Consent|1|||
145933721|NCT02147158|526263655|FG002|Treatment Course 2|Withdrawal of Consent|2|||
145933722|NCT02147158|526263656|FG003|Treatment Course 2|Withdrawal of Consent|3|||
145933723|NCT02147158|526263657|FG004|Treatment Course 2|Withdrawal of Consent|0|||
145933724|NCT02147158|526263658|FG005|Treatment Course 2|Withdrawal of Consent|0|||
145933725|NCT02147158|526263653|FG000|Treatment Course 2|Lost to Follow-up|1|||
145933726|NCT02147158|526263654|FG001|Treatment Course 2|Lost to Follow-up|0|||
145933727|NCT02147158|526263655|FG002|Treatment Course 2|Lost to Follow-up|1|||
145933728|NCT02147158|526263656|FG003|Treatment Course 2|Lost to Follow-up|1|||
145933729|NCT02147158|526263657|FG004|Treatment Course 2|Lost to Follow-up|0|||
145933730|NCT02147158|526263658|FG005|Treatment Course 2|Lost to Follow-up|1|||
145933731|NCT02147158|526263653|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
145933732|NCT02147158|526263654|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
145933733|NCT02147158|526263655|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
145933734|NCT02147158|526263656|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
145933735|NCT02147158|526263657|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
145933736|NCT02147158|526263658|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
145933737|NCT02147158|526263653|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
145933738|NCT02147158|526263654|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
145933739|NCT02147158|526263655|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
145933740|NCT02147158|526263656|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
145933741|NCT02147158|526263657|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
145933742|NCT02147158|526263658|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
145933743|NCT02147158|526263653|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
145933744|NCT02147158|526263654|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
145933745|NCT02147158|526263655|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
145933746|NCT02147158|526263656|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
145933747|NCT02147158|526263657|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
145933748|NCT02147158|526263658|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
145933749|NCT02147158|526263653|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
145933750|NCT02147158|526263654|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
145933751|NCT02147158|526263655|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
145933752|NCT02147158|526263656|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
145933753|NCT02147158|526263657|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
145933754|NCT02147158|526263658|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
145933755|NCT02147158|526263653|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
145933756|NCT02147158|526263654|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
145933757|NCT02147158|526263655|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
145933758|NCT02147158|526263656|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
145933759|NCT02147158|526263657|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
145933760|NCT02147158|526263658|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
145933761|NCT01082211|526263659|FG000|Overall Study|Protocol Violation|4|||
145933762|NCT01082211|526263659|FG000|Overall Study|No protocol treatment received|3|||
146091091|NCT01569464|526854875|FG001|Overall Study|Lost to Follow-up|3|||
145933763|NCT00199797|526267226|FG000|Overall Study|Progressive Disease|1|||
145933764|NCT00199797|526267226|FG000|Overall Study|Adverse Event|1|||
145933765|NCT00199797|526267226|FG000|Overall Study|Physician Decision|1|||
145933766|NCT04250350|526267227|FG000|Overall Study|Withdrawal by Subject|13|||
145933767|NCT04250350|526267227|FG000|Overall Study|Lost to Follow-up|8|||
145933768|NCT04250350|526267227|FG000|Overall Study|Adverse Event|5|||
145933769|NCT04250350|526267227|FG000|Overall Study|Lack of Efficacy|4|||
145933770|NCT04250350|526267227|FG000|Overall Study|Physician Decision|1|||
145933771|NCT04250350|526267227|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
145933772|NCT00504725|526267232|FG000|Overall Study|Protocol Violation|1|||
145933773|NCT00504725|526267233|FG001|Overall Study|Protocol Violation|0|||
145933774|NCT00378508|526267234|FG000|Overall Study|Withdrawal by Subject|1|||
145933775|NCT00378508|526267235|FG001|Overall Study|Withdrawal by Subject|3|||
145933776|NCT00378508|526267234|FG000|Overall Study|Lost to Follow-up|1|||
145933777|NCT00378508|526267235|FG001|Overall Study|Lost to Follow-up|0|||
145933778|NCT01435018|526267236|FG000|Overall Study|Death|37|||
145933779|NCT01435018|526267237|FG001|Overall Study|Death|18|||
145933780|NCT01435018|526267238|FG002|Overall Study|Death|25|||
145933781|NCT01435018|526267236|FG000|Overall Study|Site is closing|4|||
145933782|NCT01435018|526267237|FG001|Overall Study|Site is closing|9|||
145933783|NCT01435018|526267238|FG002|Overall Study|Site is closing|7|||
145933784|NCT01435018|526267236|FG000|Overall Study|Withdrew consent|0|||
145933785|NCT01435018|526267237|FG001|Overall Study|Withdrew consent|3|||
145933786|NCT01435018|526267238|FG002|Overall Study|Withdrew consent|1|||
145933787|NCT01435018|526267236|FG000|Overall Study|Not willing to adhere to requirements|0|||
145933788|NCT01435018|526267237|FG001|Overall Study|Not willing to adhere to requirements|2|||
145933789|NCT01435018|526267238|FG002|Overall Study|Not willing to adhere to requirements|3|||
145933790|NCT01435018|526267236|FG000|Overall Study|Not able to get to clinic|2|||
145933791|NCT01435018|526267237|FG001|Overall Study|Not able to get to clinic|0|||
145933792|NCT01435018|526267238|FG002|Overall Study|Not able to get to clinic|2|||
145933793|NCT01435018|526267236|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145933794|NCT01435018|526267237|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145933795|NCT01435018|526267238|FG002|Overall Study|Severe debilitation, unable to continue|1|||
145933796|NCT01435018|526267236|FG000|Overall Study|Unable to contact participant/parent|1|||
145933797|NCT01435018|526267237|FG001|Overall Study|Unable to contact participant/parent|1|||
145933798|NCT01435018|526267238|FG002|Overall Study|Unable to contact participant/parent|1|||
145933799|NCT01435018|526267236|FG000|Overall Study|Enrollment Violation|0|||
145933800|NCT01435018|526267237|FG001|Overall Study|Enrollment Violation|1|||
145933801|NCT01435018|526267238|FG002|Overall Study|Enrollment Violation|0|||
145933802|NCT01435018|526267236|FG000|Overall Study|Never started chemotherapy|3|||
145933803|NCT01435018|526267237|FG001|Overall Study|Never started chemotherapy|0|||
145933804|NCT01435018|526267238|FG002|Overall Study|Never started chemotherapy|1|||
145933805|NCT03205761|526267239|FG000|Overall Study|Withdrawal by Subject|1|||
145933806|NCT03205761|526267239|FG000|Overall Study|Progressive Disease|10|||
145933807|NCT02656290|526267252|FG000|Overall Study|Lost to Follow-up|1|||
145933808|NCT02656290|526267252|FG000|Overall Study|Reintervention|3|||
145933809|NCT01608087|526267253|FG000|Overall Study|Lost to Follow-up|0|||
145933810|NCT01608087|526267254|FG001|Overall Study|Lost to Follow-up|1|||
145933811|NCT01608087|526267255|FG002|Overall Study|Lost to Follow-up|0|||
145933812|NCT01608087|526267253|FG000|Overall Study|Other Reason|0|||
145933813|NCT01608087|526267254|FG001|Overall Study|Other Reason|1|||
145933814|NCT01608087|526267255|FG002|Overall Study|Other Reason|0|||
145933815|NCT01943851|526267256|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933816|NCT01943851|526267257|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933817|NCT01943851|526267258|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933818|NCT01943851|526267259|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145933819|NCT01943851|526267260|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933820|NCT01943851|526267261|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933821|NCT01943851|526267262|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145933822|NCT01943851|526267263|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145933823|NCT01943851|526267264|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145933824|NCT01943851|526267265|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933825|NCT01943851|526267266|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933826|NCT01943851|526267267|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933827|NCT01943851|526267268|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933828|NCT01943851|526267269|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933829|NCT01943851|526267270|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933830|NCT01943851|526267271|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933831|NCT01943851|526267272|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933832|NCT01943851|526267273|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145933833|NCT01943851|526267256|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933834|NCT01943851|526267257|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933835|NCT01943851|526267258|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933836|NCT01943851|526267259|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933837|NCT01943851|526267260|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
145933838|NCT01943851|526267261|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933839|NCT01943851|526267262|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933840|NCT01943851|526267263|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
145933841|NCT01943851|526267264|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933842|NCT01943851|526267265|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933843|NCT01943851|526267266|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933844|NCT01943851|526267267|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933845|NCT01943851|526267268|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933846|NCT01943851|526267269|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933847|NCT01943851|526267270|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933848|NCT01943851|526267271|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933849|NCT01943851|526267272|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933850|NCT01943851|526267273|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145933851|NCT01943851|526267256|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933852|NCT01943851|526267257|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933853|NCT01943851|526267258|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933854|NCT01943851|526267259|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933855|NCT01943851|526267260|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933856|NCT01943851|526267261|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933857|NCT01943851|526267262|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933858|NCT01943851|526267263|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933859|NCT01943851|526267264|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933860|NCT01943851|526267265|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933861|NCT01943851|526267266|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933862|NCT01943851|526267267|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933863|NCT01943851|526267268|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933864|NCT01943851|526267269|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
145933865|NCT01943851|526267270|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933866|NCT01943851|526267271|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933867|NCT01943851|526267272|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933868|NCT01943851|526267273|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145933869|NCT01943851|526267256|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933870|NCT01943851|526267257|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933871|NCT01943851|526267258|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933872|NCT01943851|526267259|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933873|NCT01943851|526267260|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933874|NCT01943851|526267261|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933875|NCT01943851|526267262|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933876|NCT01943851|526267263|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933877|NCT01943851|526267264|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933878|NCT01943851|526267265|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145978796|NCT03550209|526433686|FG003|Overall Study|Withdrawal by Subject|2|||
145978797|NCT03550209|526433683|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
145978798|NCT03550209|526433684|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
145978799|NCT03550209|526433685|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
145978800|NCT03550209|526433686|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
145978801|NCT02347787|526433689|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
145978802|NCT02347787|526433690|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
145978803|NCT02347787|526433689|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
145933879|NCT01943851|526267266|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933880|NCT01943851|526267267|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933881|NCT01943851|526267268|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933882|NCT01943851|526267269|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145978804|NCT02347787|526433690|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
145978805|NCT02347787|526433689|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
145978806|NCT02347787|526433690|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
145978807|NCT02347787|526433689|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
145978808|NCT02347787|526433690|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
145978809|NCT01127061|526434465|FG000|Overall Study|Lost to Follow-up|7|||
145978810|NCT01127061|526434466|FG001|Overall Study|Lost to Follow-up|10|||
145978811|NCT01127061|526434465|FG000|Overall Study|Physician Decision|3|||
145978812|NCT01127061|526434466|FG001|Overall Study|Physician Decision|3|||
145978813|NCT00587457|526434467|FG000|Overall Study|Adverse Event|1|||
145978814|NCT00587457|526434468|FG001|Overall Study|Adverse Event|2|||
145978815|NCT00587457|526434469|FG002|Overall Study|Adverse Event|1|||
145978816|NCT00587457|526434467|FG000|Overall Study|Disease progression|2|||
145978817|NCT00587457|526434468|FG001|Overall Study|Disease progression|0|||
145978818|NCT00587457|526434469|FG002|Overall Study|Disease progression|2|||
146091092|NCT01569464|526854874|FG000|Overall Study|Withdrawal by Subject|1|||
145978819|NCT00587457|526434467|FG000|Overall Study|Initiation of alternative therapy|0|||
145978820|NCT00587457|526434468|FG001|Overall Study|Initiation of alternative therapy|1|||
145978821|NCT00587457|526434469|FG002|Overall Study|Initiation of alternative therapy|0|||
145978822|NCT00587457|526434467|FG000|Overall Study|Undefined|0|||
145978823|NCT00587457|526434468|FG001|Overall Study|Undefined|0|||
145978824|NCT00587457|526434469|FG002|Overall Study|Undefined|1|||
145978825|NCT00587457|526434467|FG000|Overall Study|Development of neutralizing Abs|0|||
146091093|NCT01569464|526854875|FG001|Overall Study|Withdrawal by Subject|1|||
145933883|NCT01943851|526267270|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933884|NCT01943851|526267271|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
145933885|NCT01943851|526267272|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933886|NCT01943851|526267273|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145933887|NCT01943851|526267256|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933888|NCT01943851|526267257|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933889|NCT01943851|526267258|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933890|NCT01943851|526267259|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933891|NCT01943851|526267260|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933892|NCT01943851|526267261|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933893|NCT01943851|526267262|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933894|NCT01943851|526267263|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933895|NCT01943851|526267264|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933896|NCT01943851|526267265|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933897|NCT01943851|526267266|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933898|NCT01943851|526267267|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933899|NCT01943851|526267268|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933900|NCT01943851|526267269|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
146245248|NCT01072149|527412170|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145933901|NCT01943851|526267270|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145933902|NCT01943851|526267271|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
145933903|NCT01943851|526267272|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
145933904|NCT01943851|526267273|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
145933905|NCT04984278|526267274|FG000|Period 1|Withdrawal by Subject|1|||
145933906|NCT04984278|526267275|FG001|Period 1|Withdrawal by Subject|0|||
145933907|NCT04984278|526267274|FG000|Period 1|Other|0|||
145933908|NCT04984278|526267275|FG001|Period 1|Other|1|||
145933909|NCT04984278|526267274|FG000|Period 2|Adverse Event|1|||
145933910|NCT04984278|526267275|FG001|Period 2|Adverse Event|0|||
145933911|NCT04984278|526267274|FG000|Period 2|Other|0|||
145933912|NCT04984278|526267275|FG001|Period 2|Other|1|||
145933913|NCT03535194|526267276|FG000|Induction Period|Adverse Event|2|||
145933914|NCT03535194|526267277|FG001|Induction Period|Adverse Event|2|||
145933915|NCT03535194|526267278|FG002|Induction Period|Adverse Event|1|||
145933916|NCT03535194|526267279|FG003|Induction Period|Adverse Event|3|||
145933917|NCT03535194|526267280|FG004|Induction Period|Adverse Event|0|||
145933918|NCT03535194|526267276|FG000|Induction Period|Death|0|||
145933919|NCT03535194|526267277|FG001|Induction Period|Death|1|||
145933920|NCT03535194|526267278|FG002|Induction Period|Death|0|||
145933921|NCT03535194|526267279|FG003|Induction Period|Death|0|||
145933922|NCT03535194|526267280|FG004|Induction Period|Death|0|||
145933923|NCT03535194|526267276|FG000|Induction Period|Lack of Efficacy|1|||
145933924|NCT03535194|526267277|FG001|Induction Period|Lack of Efficacy|3|||
145933925|NCT03535194|526267278|FG002|Induction Period|Lack of Efficacy|2|||
145933926|NCT03535194|526267279|FG003|Induction Period|Lack of Efficacy|2|||
145933927|NCT03535194|526267280|FG004|Induction Period|Lack of Efficacy|0|||
145933928|NCT03535194|526267276|FG000|Induction Period|Lost to Follow-up|3|||
145933929|NCT03535194|526267277|FG001|Induction Period|Lost to Follow-up|5|||
145933930|NCT03535194|526267278|FG002|Induction Period|Lost to Follow-up|2|||
145933931|NCT03535194|526267279|FG003|Induction Period|Lost to Follow-up|3|||
145933932|NCT03535194|526267280|FG004|Induction Period|Lost to Follow-up|0|||
145933933|NCT03535194|526267276|FG000|Induction Period|Physician Decision|1|||
145933934|NCT03535194|526267277|FG001|Induction Period|Physician Decision|1|||
145933935|NCT03535194|526267278|FG002|Induction Period|Physician Decision|0|||
145933936|NCT03535194|526267279|FG003|Induction Period|Physician Decision|0|||
145933937|NCT03535194|526267280|FG004|Induction Period|Physician Decision|0|||
145933938|NCT03535194|526267276|FG000|Induction Period|Protocol Violation|1|||
145933939|NCT03535194|526267277|FG001|Induction Period|Protocol Violation|0|||
145933940|NCT03535194|526267278|FG002|Induction Period|Protocol Violation|0|||
145933941|NCT03535194|526267279|FG003|Induction Period|Protocol Violation|1|||
145933942|NCT03535194|526267280|FG004|Induction Period|Protocol Violation|0|||
145933943|NCT03535194|526267276|FG000|Induction Period|Screen Failure|0|||
145933944|NCT03535194|526267277|FG001|Induction Period|Screen Failure|1|||
145933945|NCT03535194|526267278|FG002|Induction Period|Screen Failure|0|||
145933946|NCT03535194|526267279|FG003|Induction Period|Screen Failure|0|||
145933947|NCT03535194|526267280|FG004|Induction Period|Screen Failure|0|||
145978826|NCT00587457|526434468|FG001|Overall Study|Development of neutralizing Abs|0|||
145933948|NCT03535194|526267276|FG000|Induction Period|Withdrawal by Subject|3|||
145933949|NCT03535194|526267277|FG001|Induction Period|Withdrawal by Subject|4|||
145933950|NCT03535194|526267278|FG002|Induction Period|Withdrawal by Subject|3|||
145933951|NCT03535194|526267279|FG003|Induction Period|Withdrawal by Subject|2|||
145933952|NCT03535194|526267280|FG004|Induction Period|Withdrawal by Subject|0|||
145933953|NCT03535194|526267276|FG000|Maintenance Period|Adverse Event|6|||
145933954|NCT03535194|526267277|FG001|Maintenance Period|Adverse Event|5|||
145933955|NCT03535194|526267278|FG002|Maintenance Period|Adverse Event|1|||
145933956|NCT03535194|526267279|FG003|Maintenance Period|Adverse Event|11|||
145933957|NCT03535194|526267280|FG004|Maintenance Period|Adverse Event|4|||
145933958|NCT03535194|526267276|FG000|Maintenance Period|Lack of Efficacy|3|||
146245249|NCT01072149|527412171|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245250|NCT01072149|527412172|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245251|NCT01072149|527412173|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245252|NCT01072149|527412174|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245253|NCT01072149|527412175|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245254|NCT01072149|527412176|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
145933959|NCT03535194|526267277|FG001|Maintenance Period|Lack of Efficacy|2|||
145933960|NCT03535194|526267278|FG002|Maintenance Period|Lack of Efficacy|5|||
145933961|NCT03535194|526267279|FG003|Maintenance Period|Lack of Efficacy|9|||
145933962|NCT03535194|526267280|FG004|Maintenance Period|Lack of Efficacy|0|||
145933963|NCT03535194|526267276|FG000|Maintenance Period|Lost to Follow-up|4|||
145933964|NCT03535194|526267277|FG001|Maintenance Period|Lost to Follow-up|2|||
145933965|NCT03535194|526267278|FG002|Maintenance Period|Lost to Follow-up|1|||
145933966|NCT03535194|526267279|FG003|Maintenance Period|Lost to Follow-up|5|||
145933967|NCT03535194|526267280|FG004|Maintenance Period|Lost to Follow-up|2|||
145933968|NCT03535194|526267276|FG000|Maintenance Period|Other|1|||
145933969|NCT03535194|526267277|FG001|Maintenance Period|Other|2|||
145933970|NCT03535194|526267278|FG002|Maintenance Period|Other|0|||
145933971|NCT03535194|526267279|FG003|Maintenance Period|Other|0|||
145933972|NCT03535194|526267280|FG004|Maintenance Period|Other|0|||
145933973|NCT03535194|526267276|FG000|Maintenance Period|Physician Decision|1|||
145933974|NCT03535194|526267277|FG001|Maintenance Period|Physician Decision|2|||
145933975|NCT03535194|526267278|FG002|Maintenance Period|Physician Decision|0|||
145933976|NCT03535194|526267279|FG003|Maintenance Period|Physician Decision|2|||
145933977|NCT03535194|526267280|FG004|Maintenance Period|Physician Decision|0|||
145933978|NCT03535194|526267276|FG000|Maintenance Period|Pregnancy|0|||
145933979|NCT03535194|526267277|FG001|Maintenance Period|Pregnancy|0|||
145933980|NCT03535194|526267278|FG002|Maintenance Period|Pregnancy|0|||
145933981|NCT03535194|526267279|FG003|Maintenance Period|Pregnancy|2|||
145933982|NCT03535194|526267280|FG004|Maintenance Period|Pregnancy|0|||
145933983|NCT03535194|526267276|FG000|Maintenance Period|Protocol Violation|0|||
145933984|NCT03535194|526267277|FG001|Maintenance Period|Protocol Violation|1|||
145933985|NCT03535194|526267278|FG002|Maintenance Period|Protocol Violation|0|||
145933986|NCT03535194|526267279|FG003|Maintenance Period|Protocol Violation|0|||
145933987|NCT03535194|526267280|FG004|Maintenance Period|Protocol Violation|0|||
145933988|NCT03535194|526267276|FG000|Maintenance Period|Withdrawal by Subject|7|||
145933989|NCT03535194|526267277|FG001|Maintenance Period|Withdrawal by Subject|2|||
145933990|NCT03535194|526267278|FG002|Maintenance Period|Withdrawal by Subject|1|||
145933991|NCT03535194|526267279|FG003|Maintenance Period|Withdrawal by Subject|8|||
145933992|NCT03535194|526267280|FG004|Maintenance Period|Withdrawal by Subject|0|||
145933993|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Adverse Event|4|||
145933994|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Adverse Event|5|||
145933995|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Adverse Event|1|||
145933996|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Adverse Event|8|||
145933997|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Adverse Event|0|||
145933998|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
145933999|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
145934000|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
145934001|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
145934002|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
145934003|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
145934004|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
145934005|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
146245255|NCT01072149|527412177|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245256|NCT01072149|527412178|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245257|NCT01072149|527412179|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145934006|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
145934007|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
145934008|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Other|1|||
145934009|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Other|0|||
145934010|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Other|0|||
145934011|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Other|5|||
145934012|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Other|0|||
145934013|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Physician Decision|0|||
145934014|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Physician Decision|2|||
145934015|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Physician Decision|1|||
145934016|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Physician Decision|1|||
145934017|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Physician Decision|0|||
145934018|NCT03535194|526267276|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
145934019|NCT03535194|526267277|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
145934020|NCT03535194|526267278|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
145934021|NCT03535194|526267279|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
145934022|NCT03535194|526267280|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145934023|NCT03991299|526267281|FG000|Overall Study|Study closed, sponsor decision|3|||
145934024|NCT03991299|526267281|FG000|Overall Study|Withdrawal by Subject|1|||
145934025|NCT04429555|526267284|FG000|Overall Study|Death|0|||
145934026|NCT04429555|526267285|FG001|Overall Study|Death|2|||
145934027|NCT04429555|526267284|FG000|Overall Study|Other|2|||
145934028|NCT04429555|526267285|FG001|Overall Study|Other|0|||
145934029|NCT04470544|526267286|FG000|Overall Study|Withdrawal by Subject|4|||
145934030|NCT04470544|526267287|FG001|Overall Study|Withdrawal by Subject|6|||
145934031|NCT04720911|526267290|FG000|Overall Study|Withdrawal by Subject|0|||
145934032|NCT04720911|526267291|FG001|Overall Study|Withdrawal by Subject|1|||
145934033|NCT04720911|526267292|FG002|Overall Study|Withdrawal by Subject|0|||
145934034|NCT00090220|526267293|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
145934035|NCT00090220|526267294|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
145934036|NCT00090220|526267295|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145934037|NCT00090220|526267296|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145934038|NCT00090220|526267297|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145934039|NCT00090220|526267298|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145934040|NCT00090220|526267293|FG000|Base Study Vaccination Period|Adverse Event|6|||
145934041|NCT00090220|526267294|FG001|Base Study Vaccination Period|Adverse Event|1|||
145934042|NCT00090220|526267295|FG002|Base Study Vaccination Period|Adverse Event|0|||
145934043|NCT00090220|526267296|FG003|Base Study Vaccination Period|Adverse Event|0|||
145934044|NCT00090220|526267297|FG004|Base Study Vaccination Period|Adverse Event|0|||
145934045|NCT00090220|526267298|FG005|Base Study Vaccination Period|Adverse Event|0|||
145934046|NCT00090220|526267293|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
145934047|NCT00090220|526267294|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
145934048|NCT00090220|526267295|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
145934049|NCT00090220|526267296|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
145934050|NCT00090220|526267297|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
145934051|NCT00090220|526267298|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
145934052|NCT00090220|526267293|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
145934053|NCT00090220|526267294|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
145934054|NCT00090220|526267295|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
145934055|NCT00090220|526267296|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
145934056|NCT00090220|526267297|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
145934057|NCT00090220|526267298|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
145934058|NCT00090220|526267293|FG000|Base Study Vaccination Period|Patient Moved|6|||
145934059|NCT00090220|526267294|FG001|Base Study Vaccination Period|Patient Moved|2|||
145934060|NCT00090220|526267295|FG002|Base Study Vaccination Period|Patient Moved|0|||
145934061|NCT00090220|526267296|FG003|Base Study Vaccination Period|Patient Moved|0|||
145934062|NCT00090220|526267297|FG004|Base Study Vaccination Period|Patient Moved|0|||
145934063|NCT00090220|526267298|FG005|Base Study Vaccination Period|Patient Moved|0|||
145934064|NCT00090220|526267293|FG000|Base Study Vaccination Period|Other|4|||
145934065|NCT00090220|526267294|FG001|Base Study Vaccination Period|Other|4|||
145934066|NCT00090220|526267295|FG002|Base Study Vaccination Period|Other|0|||
145934067|NCT00090220|526267296|FG003|Base Study Vaccination Period|Other|0|||
145934068|NCT00090220|526267297|FG004|Base Study Vaccination Period|Other|0|||
145934069|NCT00090220|526267298|FG005|Base Study Vaccination Period|Other|0|||
145934070|NCT00090220|526267293|FG000|Base Study Follow-up Period|Adverse Event|6|||
145934071|NCT00090220|526267294|FG001|Base Study Follow-up Period|Adverse Event|1|||
145934072|NCT00090220|526267295|FG002|Base Study Follow-up Period|Adverse Event|0|||
145934073|NCT00090220|526267296|FG003|Base Study Follow-up Period|Adverse Event|0|||
145934074|NCT00090220|526267297|FG004|Base Study Follow-up Period|Adverse Event|0|||
145934075|NCT00090220|526267298|FG005|Base Study Follow-up Period|Adverse Event|0|||
145934076|NCT00090220|526267293|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
145934077|NCT00090220|526267294|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
145934078|NCT00090220|526267295|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
145934079|NCT00090220|526267296|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
145934080|NCT00090220|526267297|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
145934081|NCT00090220|526267298|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
145934082|NCT00090220|526267293|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
145978827|NCT00587457|526434469|FG002|Overall Study|Development of neutralizing Abs|1|||
145978828|NCT00541229|526434470|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
145934083|NCT00090220|526267294|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
145934084|NCT00090220|526267295|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
145934085|NCT00090220|526267296|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
145934086|NCT00090220|526267297|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
145934087|NCT00090220|526267298|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
145934088|NCT00090220|526267293|FG000|Base Study Follow-up Period|Patient Moved|20|||
145978829|NCT00541229|526434471|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
145978830|NCT00541229|526434472|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
145934089|NCT00090220|526267294|FG001|Base Study Follow-up Period|Patient Moved|28|||
145934090|NCT00090220|526267295|FG002|Base Study Follow-up Period|Patient Moved|0|||
145934091|NCT00090220|526267296|FG003|Base Study Follow-up Period|Patient Moved|0|||
145934092|NCT00090220|526267297|FG004|Base Study Follow-up Period|Patient Moved|0|||
145934093|NCT00090220|526267298|FG005|Base Study Follow-up Period|Patient Moved|0|||
145934094|NCT00090220|526267293|FG000|Base Study Follow-up Period|Other|19|||
145934095|NCT00090220|526267294|FG001|Base Study Follow-up Period|Other|21|||
145934096|NCT00090220|526267295|FG002|Base Study Follow-up Period|Other|0|||
145934097|NCT00090220|526267296|FG003|Base Study Follow-up Period|Other|0|||
145934098|NCT00090220|526267297|FG004|Base Study Follow-up Period|Other|0|||
145934099|NCT00090220|526267298|FG005|Base Study Follow-up Period|Other|0|||
145934100|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Adverse Event|0|||
145934101|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Adverse Event|0|||
145934102|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Adverse Event|4|||
145934103|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Adverse Event|0|||
145934104|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Adverse Event|0|||
145934105|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Adverse Event|0|||
145934106|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
145934107|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
145934108|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
145934109|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
145934110|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
145934111|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
145934112|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Moved|0|||
145934113|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Moved|0|||
145934114|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Moved|2|||
145934115|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Moved|1|||
145934116|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Moved|0|||
145934117|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Moved|0|||
145934118|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145934119|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145934120|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
145934121|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145934122|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145934123|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145934124|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
145934125|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
145934126|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
145934127|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
145934128|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
145934129|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
145934130|NCT00090220|526267293|FG000|Extension 1 (EXT1)|Other reason|0|||
145934131|NCT00090220|526267294|FG001|Extension 1 (EXT1)|Other reason|0|||
145934132|NCT00090220|526267295|FG002|Extension 1 (EXT1)|Other reason|2|||
145934133|NCT00090220|526267296|FG003|Extension 1 (EXT1)|Other reason|0|||
145934134|NCT00090220|526267297|FG004|Extension 1 (EXT1)|Other reason|0|||
145934135|NCT00090220|526267298|FG005|Extension 1 (EXT1)|Other reason|0|||
145934136|NCT00090220|526267293|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145934137|NCT00090220|526267294|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145934138|NCT00090220|526267295|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145934139|NCT00090220|526267296|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145934140|NCT00090220|526267297|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
145934141|NCT00090220|526267298|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
145934142|NCT00090220|526267293|FG000|Long-term Follow-up (EXT2)|Death|0|||
146245258|NCT01072149|527412180|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
146245259|NCT00871494|527412185|FG000|Overall Study|Protocol Violation|5|||
146245260|NCT00871494|527412185|FG000|Overall Study|Lack of Efficacy|4|||
146245261|NCT00871494|527412185|FG000|Overall Study|Adverse Event|4|||
146245262|NCT00871494|527412185|FG000|Overall Study|Lost to Follow-up|1|||
146245263|NCT00889863|527412189|FG000|Part I: Open Label|Death|1|||
145934143|NCT00090220|526267294|FG001|Long-term Follow-up (EXT2)|Death|0|||
145934144|NCT00090220|526267295|FG002|Long-term Follow-up (EXT2)|Death|0|||
145934145|NCT00090220|526267296|FG003|Long-term Follow-up (EXT2)|Death|0|||
145934146|NCT00090220|526267297|FG004|Long-term Follow-up (EXT2)|Death|1|||
145934147|NCT00090220|526267298|FG005|Long-term Follow-up (EXT2)|Death|1|||
145934148|NCT00090220|526267293|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145934149|NCT00090220|526267294|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145934150|NCT00090220|526267295|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145934151|NCT00090220|526267296|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145934152|NCT00090220|526267297|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
145934153|NCT00090220|526267298|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
145934154|NCT00090220|526267293|FG000|Long-term Follow-up (EXT2)|Other|0|||
145934155|NCT00090220|526267294|FG001|Long-term Follow-up (EXT2)|Other|0|||
145978831|NCT00541229|526434473|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
146091094|NCT01569464|526854874|FG000|Overall Study|Other|1|||
145934156|NCT00090220|526267295|FG002|Long-term Follow-up (EXT2)|Other|0|||
145934157|NCT00090220|526267296|FG003|Long-term Follow-up (EXT2)|Other|0|||
145934158|NCT00090220|526267297|FG004|Long-term Follow-up (EXT2)|Other|1|||
145934159|NCT00090220|526267298|FG005|Long-term Follow-up (EXT2)|Other|0|||
145934160|NCT00941863|526267299|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
145934161|NCT00941863|526267300|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
145934162|NCT00941863|526267301|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
145934163|NCT00941863|526267302|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
145934164|NCT00941863|526267303|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
145934165|NCT00941863|526267299|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
145934166|NCT00941863|526267300|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
145934167|NCT00941863|526267301|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
145934168|NCT00941863|526267302|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
145934169|NCT00941863|526267303|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
145934170|NCT00941863|526267299|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145934171|NCT00941863|526267300|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145934172|NCT00941863|526267301|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
145934173|NCT00941863|526267302|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145934174|NCT00941863|526267303|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
145934175|NCT00941863|526267299|FG000|Until Primary Completion Date (PCD)|Death|0|||
145934176|NCT00941863|526267300|FG001|Until Primary Completion Date (PCD)|Death|0|||
145934177|NCT00941863|526267301|FG002|Until Primary Completion Date (PCD)|Death|1|||
145934178|NCT00941863|526267302|FG003|Until Primary Completion Date (PCD)|Death|2|||
145934179|NCT00941863|526267303|FG004|Until Primary Completion Date (PCD)|Death|7|||
145934180|NCT00941863|526267299|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
145934181|NCT00941863|526267300|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
145934182|NCT00941863|526267301|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
145934183|NCT00941863|526267302|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
145934184|NCT00941863|526267303|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
145934185|NCT00941863|526267299|FG000|Continued After PCD|Withdrawal by Subject|0|||
145934186|NCT00941863|526267300|FG001|Continued After PCD|Withdrawal by Subject|0|||
145934187|NCT00941863|526267301|FG002|Continued After PCD|Withdrawal by Subject|0|||
145934188|NCT00941863|526267302|FG003|Continued After PCD|Withdrawal by Subject|0|||
145934189|NCT00941863|526267303|FG004|Continued After PCD|Withdrawal by Subject|1|||
145934190|NCT00941863|526267299|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
145934191|NCT00941863|526267300|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
145934192|NCT00941863|526267301|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
145934193|NCT00941863|526267302|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
145934194|NCT00941863|526267303|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
145934195|NCT01867710|526267309|FG000|Overall Study|Death|25|||
145934196|NCT01867710|526267310|FG001|Overall Study|Death|15|||
145934197|NCT01867710|526267311|FG002|Overall Study|Death|27|||
145934198|NCT01867710|526267312|FG003|Overall Study|Death|20|||
145934199|NCT01867710|526267309|FG000|Overall Study|Lost to Follow-up|3|||
145934200|NCT01867710|526267310|FG001|Overall Study|Lost to Follow-up|4|||
145934201|NCT01867710|526267311|FG002|Overall Study|Lost to Follow-up|3|||
145934202|NCT01867710|526267312|FG003|Overall Study|Lost to Follow-up|2|||
145934203|NCT01867710|526267309|FG000|Overall Study|Withdrawal of consent|2|||
145934204|NCT01867710|526267310|FG001|Overall Study|Withdrawal of consent|5|||
145934205|NCT01867710|526267311|FG002|Overall Study|Withdrawal of consent|1|||
145934206|NCT01867710|526267312|FG003|Overall Study|Withdrawal of consent|2|||
145934207|NCT01867710|526267309|FG000|Overall Study|Study Terminated by Sponsor|9|||
145934208|NCT01867710|526267310|FG001|Overall Study|Study Terminated by Sponsor|13|||
145934209|NCT01867710|526267311|FG002|Overall Study|Study Terminated by Sponsor|8|||
145934210|NCT01867710|526267312|FG003|Overall Study|Study Terminated by Sponsor|16|||
145934211|NCT01867710|526267309|FG000|Overall Study|Biochemical progression|0|||
145934212|NCT01867710|526267310|FG001|Overall Study|Biochemical progression|1|||
145934213|NCT01867710|526267311|FG002|Overall Study|Biochemical progression|0|||
145934214|NCT01867710|526267312|FG003|Overall Study|Biochemical progression|0|||
145934215|NCT01867710|526267309|FG000|Overall Study|Clinical progression|0|||
145934216|NCT01867710|526267310|FG001|Overall Study|Clinical progression|0|||
145934217|NCT01867710|526267311|FG002|Overall Study|Clinical progression|1|||
145934218|NCT01867710|526267312|FG003|Overall Study|Clinical progression|0|||
145934219|NCT01867710|526267309|FG000|Overall Study|Disease progression|1|||
145934220|NCT01867710|526267310|FG001|Overall Study|Disease progression|0|||
145934221|NCT01867710|526267311|FG002|Overall Study|Disease progression|0|||
145934222|NCT01867710|526267312|FG003|Overall Study|Disease progression|0|||
145934223|NCT01867710|526267309|FG000|Overall Study|Patient decision|0|||
145934224|NCT01867710|526267310|FG001|Overall Study|Patient decision|0|||
145934225|NCT01867710|526267311|FG002|Overall Study|Patient decision|0|||
146245264|NCT00889863|527412190|FG001|Part I: Open Label|Death|0|||
146245265|NCT00889863|527412189|FG000|Part I: Open Label|Adverse Event|4|||
145934226|NCT01867710|526267312|FG003|Overall Study|Patient decision|1|||
145934227|NCT01867710|526267309|FG000|Overall Study|Patient to follow subsequent treatment|0|||
145934228|NCT01867710|526267310|FG001|Overall Study|Patient to follow subsequent treatment|1|||
145934229|NCT01867710|526267311|FG002|Overall Study|Patient to follow subsequent treatment|0|||
145934230|NCT01867710|526267312|FG003|Overall Study|Patient to follow subsequent treatment|0|||
145934231|NCT01867710|526267309|FG000|Overall Study|Progressive disease|1|||
145934232|NCT01867710|526267310|FG001|Overall Study|Progressive disease|0|||
145934233|NCT01867710|526267311|FG002|Overall Study|Progressive disease|0|||
145934234|NCT01867710|526267312|FG003|Overall Study|Progressive disease|0|||
145934235|NCT01867710|526267309|FG000|Overall Study|Protocol Violation|0|||
145934236|NCT01867710|526267310|FG001|Overall Study|Protocol Violation|0|||
145934237|NCT01867710|526267311|FG002|Overall Study|Protocol Violation|0|||
145934238|NCT01867710|526267312|FG003|Overall Study|Protocol Violation|1|||
145934239|NCT01867710|526267309|FG000|Overall Study|PSA-progression|0|||
145934240|NCT01867710|526267310|FG001|Overall Study|PSA-progression|1|||
145934241|NCT01867710|526267311|FG002|Overall Study|PSA-progression|0|||
145934242|NCT01867710|526267312|FG003|Overall Study|PSA-progression|0|||
145934243|NCT01867710|526267309|FG000|Overall Study|Study medication no longer effective|0|||
145934244|NCT01867710|526267310|FG001|Overall Study|Study medication no longer effective|1|||
145934245|NCT01867710|526267311|FG002|Overall Study|Study medication no longer effective|0|||
145934246|NCT01867710|526267312|FG003|Overall Study|Study medication no longer effective|0|||
145934247|NCT01254318|526267315|FG000|Overall Study|Lost to Follow-up|5|||
145934248|NCT01254318|526267315|FG000|Overall Study|Death|47|||
145934249|NCT03557931|526267324|FG000|Overall Study|Adverse Event|4|||
145934250|NCT03557931|526267325|FG001|Overall Study|Adverse Event|6|||
145934251|NCT03557931|526267326|FG002|Overall Study|Adverse Event|1|||
145934252|NCT03557931|526267324|FG000|Overall Study|Lost to Follow-up|4|||
145934253|NCT03557931|526267325|FG001|Overall Study|Lost to Follow-up|4|||
145934254|NCT03557931|526267326|FG002|Overall Study|Lost to Follow-up|1|||
145934255|NCT03557931|526267324|FG000|Overall Study|Protocol Violation|1|||
145934256|NCT03557931|526267325|FG001|Overall Study|Protocol Violation|4|||
145934257|NCT03557931|526267326|FG002|Overall Study|Protocol Violation|1|||
145934258|NCT03557931|526267324|FG000|Overall Study|Withdrawal by Subject|14|||
145934259|NCT03557931|526267325|FG001|Overall Study|Withdrawal by Subject|0|||
145934260|NCT03557931|526267326|FG002|Overall Study|Withdrawal by Subject|7|||
145934261|NCT03557931|526267324|FG000|Overall Study|Miscellaneous|8|||
145934262|NCT03557931|526267325|FG001|Overall Study|Miscellaneous|5|||
145934263|NCT03557931|526267326|FG002|Overall Study|Miscellaneous|3|||
145934264|NCT02394340|526267327|FG000|Overall Study|Failed drug screen test|1|||
145934265|NCT02394340|526267327|FG000|Overall Study|Adverse Event|1|||
145934266|NCT03315286|526267330|FG000|Overall Study|Lost to Follow-up|0|||
145934267|NCT03315286|526267331|FG001|Overall Study|Lost to Follow-up|3|||
145934268|NCT03315286|526267330|FG000|Overall Study|Withdrawal by Subject|1|||
145934269|NCT03315286|526267331|FG001|Overall Study|Withdrawal by Subject|0|||
145934270|NCT03315286|526267330|FG000|Overall Study|Protocol Violation|0|||
145934271|NCT03315286|526267331|FG001|Overall Study|Protocol Violation|1|||
145934272|NCT02828124|526267332|FG000|Overall Study|Disease Progression|1|||
145934273|NCT02828124|526267333|FG001|Overall Study|Disease Progression|2|||
145934274|NCT02828124|526267334|FG002|Overall Study|Disease Progression|1|||
145934275|NCT02828124|526267335|FG003|Overall Study|Disease Progression|4|||
145934276|NCT02828124|526267332|FG000|Overall Study|AE Unrelated to Study Drug|0|||
145978832|NCT00541229|526434474|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
145978833|NCT00541229|526434475|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
145978834|NCT00541229|526434470|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145978835|NCT00541229|526434471|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145978836|NCT00541229|526434472|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145978837|NCT00541229|526434473|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145978838|NCT00541229|526434474|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145978839|NCT00541229|526434475|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
145978840|NCT00541229|526434470|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146091095|NCT01569464|526854875|FG001|Overall Study|Other|1|||
146091096|NCT03475875|526854876|FG000|Period 1|Lost to Follow-up|1|||
146091097|NCT03475875|526854877|FG001|Period 1|Lost to Follow-up|0|||
146091098|NCT03475875|526854876|FG000|Period 1|Adverse Event|2|||
146091099|NCT03475875|526854877|FG001|Period 1|Adverse Event|1|||
146245266|NCT00889863|527412190|FG001|Part I: Open Label|Adverse Event|0|||
145978841|NCT00541229|526434471|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145978842|NCT00541229|526434472|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145978843|NCT00541229|526434473|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145978844|NCT00541229|526434474|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
146245267|NCT00889863|527412189|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
146245268|NCT00889863|527412190|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
145934277|NCT02828124|526267333|FG001|Overall Study|AE Unrelated to Study Drug|0|||
145934278|NCT02828124|526267334|FG002|Overall Study|AE Unrelated to Study Drug|0|||
146091100|NCT03475875|526854876|FG000|Period 2|Adverse Event|3|||
146245269|NCT00889863|527412189|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
145934279|NCT02828124|526267335|FG003|Overall Study|AE Unrelated to Study Drug|1|||
145934280|NCT02828124|526267332|FG000|Overall Study|Subject Withdrew Consent|0|||
145934281|NCT02828124|526267333|FG001|Overall Study|Subject Withdrew Consent|0|||
145934282|NCT02828124|526267334|FG002|Overall Study|Subject Withdrew Consent|0|||
146091101|NCT03475875|526854877|FG001|Period 2|Adverse Event|0|||
146091102|NCT03475875|526854876|FG000|Period 2|Protocol Violation|0|||
145934283|NCT02828124|526267335|FG003|Overall Study|Subject Withdrew Consent|1|||
145934284|NCT00747474|526267337|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934285|NCT00747474|526267338|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934286|NCT00747474|526267339|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934287|NCT00747474|526267340|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934288|NCT00747474|526267341|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934289|NCT00747474|526267342|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934290|NCT00747474|526267343|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934291|NCT00747474|526267344|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
145934292|NCT00747474|526267345|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934293|NCT00747474|526267346|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934294|NCT00747474|526267347|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934295|NCT00747474|526267348|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145934296|NCT02829723|526267349|FG000|Overall Study|Adverse Event|0|||
145934297|NCT02829723|526267350|FG001|Overall Study|Adverse Event|0|||
145934298|NCT02829723|526267351|FG002|Overall Study|Adverse Event|1|||
145934299|NCT02829723|526267352|FG003|Overall Study|Adverse Event|1|||
145934300|NCT02829723|526267353|FG004|Overall Study|Adverse Event|0|||
145934301|NCT02829723|526267354|FG005|Overall Study|Adverse Event|0|||
145934302|NCT02829723|526267355|FG006|Overall Study|Adverse Event|0|||
145934303|NCT02829723|526267356|FG007|Overall Study|Adverse Event|1|||
145934304|NCT02829723|526267357|FG008|Overall Study|Adverse Event|0|||
145934305|NCT02829723|526267358|FG009|Overall Study|Adverse Event|0|||
145934306|NCT02829723|526267359|FG010|Overall Study|Adverse Event|0|||
145934307|NCT02829723|526267360|FG011|Overall Study|Adverse Event|0|||
145934308|NCT02829723|526267361|FG012|Overall Study|Adverse Event|0|||
145934309|NCT02829723|526267362|FG013|Overall Study|Adverse Event|0|||
145934310|NCT02829723|526267363|FG014|Overall Study|Adverse Event|1|||
145934311|NCT02829723|526267364|FG015|Overall Study|Adverse Event|1|||
145934312|NCT02829723|526267365|FG016|Overall Study|Adverse Event|1|||
145934313|NCT02829723|526267366|FG017|Overall Study|Adverse Event|2|||
145934314|NCT02829723|526267367|FG018|Overall Study|Adverse Event|1|||
145934315|NCT02829723|526267368|FG019|Overall Study|Adverse Event|1|||
145934316|NCT02829723|526267369|FG020|Overall Study|Adverse Event|3|||
145934317|NCT02829723|526267370|FG021|Overall Study|Adverse Event|0|||
145934318|NCT02829723|526267371|FG022|Overall Study|Adverse Event|0|||
145934319|NCT02829723|526267372|FG023|Overall Study|Adverse Event|1|||
145934320|NCT02829723|526267373|FG024|Overall Study|Adverse Event|1|||
145934321|NCT02829723|526267374|FG025|Overall Study|Adverse Event|3|||
145934322|NCT02829723|526267375|FG026|Overall Study|Adverse Event|5|||
145934323|NCT02829723|526267349|FG000|Overall Study|Death|1|||
145934324|NCT02829723|526267350|FG001|Overall Study|Death|0|||
145934325|NCT02829723|526267351|FG002|Overall Study|Death|1|||
146091103|NCT03475875|526854877|FG001|Period 2|Protocol Violation|1|||
146091104|NCT01390220|526854878|FG000|Test Dose Phase|Adverse Event|17|||
146091105|NCT01390220|526854879|FG001|Test Dose Phase|Adverse Event|0|||
146245270|NCT00889863|527412190|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
146245271|NCT00889863|527412189|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
146245272|NCT00889863|527412190|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
146245273|NCT00889863|527412189|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
146245274|NCT00889863|527412190|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
146245275|NCT00889863|527412189|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
146245276|NCT00889863|527412190|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
146245277|NCT01090739|527412191|FG000|Enrollment|Withdrawal by Subject|24|||
146245278|NCT01090739|527412191|FG000|Enrollment|Protocol Violation|14|||
146245279|NCT01090739|527412191|FG000|Enrollment|Lost to Follow-up|5|||
146245280|NCT01090739|527412191|FG000|Enrollment|Physician Decision|5|||
146245281|NCT01090739|527412191|FG000|Enrollment|Sponsor termination of site|4|||
146245282|NCT01090739|527412191|FG000|Enrollment|Study implant limit reached|2|||
146245283|NCT01090739|527412191|FG000|Enrollment|Adverse Event|1|||
146245284|NCT01090739|527412191|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
145934326|NCT02829723|526267352|FG003|Overall Study|Death|1|||
145934327|NCT02829723|526267353|FG004|Overall Study|Death|0|||
145934328|NCT02829723|526267354|FG005|Overall Study|Death|0|||
145934329|NCT02829723|526267355|FG006|Overall Study|Death|2|||
145934330|NCT02829723|526267356|FG007|Overall Study|Death|0|||
145934331|NCT02829723|526267357|FG008|Overall Study|Death|1|||
145934332|NCT02829723|526267358|FG009|Overall Study|Death|0|||
145934333|NCT02829723|526267359|FG010|Overall Study|Death|0|||
145934334|NCT02829723|526267360|FG011|Overall Study|Death|0|||
145934335|NCT02829723|526267361|FG012|Overall Study|Death|2|||
146091106|NCT01390220|526854880|FG002|Test Dose Phase|Adverse Event|0|||
146091107|NCT01390220|526854878|FG000|Test Dose Phase|Withdrawal by Subject|8|||
146091108|NCT01390220|526854879|FG001|Test Dose Phase|Withdrawal by Subject|0|||
145934336|NCT02829723|526267362|FG013|Overall Study|Death|1|||
145934337|NCT02829723|526267363|FG014|Overall Study|Death|0|||
145934338|NCT02829723|526267364|FG015|Overall Study|Death|0|||
145934339|NCT02829723|526267365|FG016|Overall Study|Death|0|||
145934340|NCT02829723|526267366|FG017|Overall Study|Death|0|||
145934341|NCT02829723|526267367|FG018|Overall Study|Death|0|||
145934342|NCT02829723|526267368|FG019|Overall Study|Death|0|||
145934343|NCT02829723|526267369|FG020|Overall Study|Death|0|||
145934344|NCT02829723|526267370|FG021|Overall Study|Death|2|||
145934345|NCT02829723|526267371|FG022|Overall Study|Death|0|||
145934346|NCT02829723|526267372|FG023|Overall Study|Death|0|||
145934347|NCT02829723|526267373|FG024|Overall Study|Death|0|||
145934348|NCT02829723|526267374|FG025|Overall Study|Death|1|||
145934349|NCT02829723|526267375|FG026|Overall Study|Death|2|||
145934350|NCT02829723|526267349|FG000|Overall Study|Physician Decision|0|||
145934351|NCT02829723|526267350|FG001|Overall Study|Physician Decision|0|||
145934352|NCT02829723|526267351|FG002|Overall Study|Physician Decision|0|||
145934353|NCT02829723|526267352|FG003|Overall Study|Physician Decision|0|||
145934354|NCT02829723|526267353|FG004|Overall Study|Physician Decision|0|||
145934355|NCT02829723|526267354|FG005|Overall Study|Physician Decision|0|||
145934356|NCT02829723|526267355|FG006|Overall Study|Physician Decision|0|||
145934357|NCT02829723|526267356|FG007|Overall Study|Physician Decision|0|||
145934358|NCT02829723|526267357|FG008|Overall Study|Physician Decision|0|||
145934359|NCT02829723|526267358|FG009|Overall Study|Physician Decision|1|||
145934360|NCT02829723|526267359|FG010|Overall Study|Physician Decision|1|||
145934361|NCT02829723|526267360|FG011|Overall Study|Physician Decision|0|||
145934362|NCT02829723|526267361|FG012|Overall Study|Physician Decision|0|||
145934363|NCT02829723|526267362|FG013|Overall Study|Physician Decision|1|||
145934364|NCT02829723|526267363|FG014|Overall Study|Physician Decision|0|||
145934365|NCT02829723|526267364|FG015|Overall Study|Physician Decision|0|||
145934366|NCT02829723|526267365|FG016|Overall Study|Physician Decision|2|||
145934367|NCT02829723|526267366|FG017|Overall Study|Physician Decision|0|||
145934368|NCT02829723|526267367|FG018|Overall Study|Physician Decision|0|||
145934369|NCT02829723|526267368|FG019|Overall Study|Physician Decision|0|||
145934370|NCT02829723|526267369|FG020|Overall Study|Physician Decision|0|||
145934371|NCT02829723|526267370|FG021|Overall Study|Physician Decision|0|||
145934372|NCT02829723|526267371|FG022|Overall Study|Physician Decision|1|||
145934373|NCT02829723|526267372|FG023|Overall Study|Physician Decision|1|||
145934374|NCT02829723|526267373|FG024|Overall Study|Physician Decision|1|||
145934375|NCT02829723|526267374|FG025|Overall Study|Physician Decision|1|||
145934376|NCT02829723|526267375|FG026|Overall Study|Physician Decision|3|||
145934377|NCT02829723|526267349|FG000|Overall Study|Progressive disease|4|||
145934378|NCT02829723|526267350|FG001|Overall Study|Progressive disease|6|||
146245285|NCT01090739|527412191|FG000|12 Month Follow-up|Lost to Follow-up|1|||
146245286|NCT01090739|527412191|FG000|12 Month Follow-up|Physician Decision|1|||
146245287|NCT01090739|527412191|FG000|12 Month Follow-up|Death|1|||
146245288|NCT01090739|527412191|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
146245289|NCT01090739|527412191|FG000|24 Month Follow-up|Lost to Follow-up|1|||
146245290|NCT01090739|527412191|FG000|24 Month Follow-up|Death|1|||
146245291|NCT01090739|527412191|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
146245292|NCT01090739|527412191|FG000|36 Month Follow-up|Visit still pending|17|||
146245293|NCT00988429|527412192|FG000|Overall Study|Adverse Event|9|||
146245294|NCT00988429|527412193|FG001|Overall Study|Adverse Event|21|||
146245295|NCT00988429|527412194|FG002|Overall Study|Adverse Event|45|||
146245296|NCT00988429|527412192|FG000|Overall Study|Lack of Efficacy|0|||
146245297|NCT00988429|527412193|FG001|Overall Study|Lack of Efficacy|0|||
146245298|NCT00988429|527412194|FG002|Overall Study|Lack of Efficacy|1|||
146245299|NCT00988429|527412192|FG000|Overall Study|Non-Compliance with Study Drug|5|||
146245300|NCT00988429|527412193|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146245301|NCT00988429|527412194|FG002|Overall Study|Non-Compliance with Study Drug|3|||
146245302|NCT00988429|527412192|FG000|Overall Study|Physician Decision|1|||
145934379|NCT02829723|526267351|FG002|Overall Study|Progressive disease|3|||
145934380|NCT02829723|526267352|FG003|Overall Study|Progressive disease|3|||
145934381|NCT02829723|526267353|FG004|Overall Study|Progressive disease|3|||
145934382|NCT02829723|526267354|FG005|Overall Study|Progressive disease|5|||
145934383|NCT02829723|526267355|FG006|Overall Study|Progressive disease|4|||
145934384|NCT02829723|526267356|FG007|Overall Study|Progressive disease|6|||
145934385|NCT02829723|526267357|FG008|Overall Study|Progressive disease|8|||
145934386|NCT02829723|526267358|FG009|Overall Study|Progressive disease|4|||
145934387|NCT02829723|526267359|FG010|Overall Study|Progressive disease|9|||
145934388|NCT02829723|526267360|FG011|Overall Study|Progressive disease|0|||
145934389|NCT02829723|526267361|FG012|Overall Study|Progressive disease|3|||
146245303|NCT00988429|527412193|FG001|Overall Study|Physician Decision|0|||
145934390|NCT02829723|526267362|FG013|Overall Study|Progressive disease|4|||
145934391|NCT02829723|526267363|FG014|Overall Study|Progressive disease|2|||
145934392|NCT02829723|526267364|FG015|Overall Study|Progressive disease|4|||
145934393|NCT02829723|526267365|FG016|Overall Study|Progressive disease|5|||
145934394|NCT02829723|526267366|FG017|Overall Study|Progressive disease|3|||
145934395|NCT02829723|526267367|FG018|Overall Study|Progressive disease|4|||
145934396|NCT02829723|526267368|FG019|Overall Study|Progressive disease|4|||
145934397|NCT02829723|526267369|FG020|Overall Study|Progressive disease|7|||
145934398|NCT02829723|526267370|FG021|Overall Study|Progressive disease|6|||
145934399|NCT02829723|526267371|FG022|Overall Study|Progressive disease|3|||
145934400|NCT02829723|526267372|FG023|Overall Study|Progressive disease|3|||
145934401|NCT02829723|526267373|FG024|Overall Study|Progressive disease|3|||
145934402|NCT02829723|526267374|FG025|Overall Study|Progressive disease|16|||
145934403|NCT02829723|526267375|FG026|Overall Study|Progressive disease|10|||
145934404|NCT02829723|526267349|FG000|Overall Study|Subject/guardian decision|0|||
145934405|NCT02829723|526267350|FG001|Overall Study|Subject/guardian decision|1|||
145934406|NCT02829723|526267351|FG002|Overall Study|Subject/guardian decision|0|||
145934407|NCT02829723|526267352|FG003|Overall Study|Subject/guardian decision|1|||
145934408|NCT02829723|526267353|FG004|Overall Study|Subject/guardian decision|0|||
145934409|NCT02829723|526267354|FG005|Overall Study|Subject/guardian decision|0|||
145934410|NCT02829723|526267355|FG006|Overall Study|Subject/guardian decision|0|||
145934411|NCT02829723|526267356|FG007|Overall Study|Subject/guardian decision|1|||
145934412|NCT02829723|526267357|FG008|Overall Study|Subject/guardian decision|0|||
145934413|NCT02829723|526267358|FG009|Overall Study|Subject/guardian decision|0|||
145934414|NCT02829723|526267359|FG010|Overall Study|Subject/guardian decision|0|||
145934415|NCT02829723|526267360|FG011|Overall Study|Subject/guardian decision|0|||
145934416|NCT02829723|526267361|FG012|Overall Study|Subject/guardian decision|0|||
145934417|NCT02829723|526267362|FG013|Overall Study|Subject/guardian decision|0|||
145934418|NCT02829723|526267363|FG014|Overall Study|Subject/guardian decision|1|||
145934419|NCT02829723|526267364|FG015|Overall Study|Subject/guardian decision|0|||
145934420|NCT02829723|526267365|FG016|Overall Study|Subject/guardian decision|1|||
145934421|NCT02829723|526267366|FG017|Overall Study|Subject/guardian decision|0|||
145934422|NCT02829723|526267367|FG018|Overall Study|Subject/guardian decision|1|||
145934423|NCT02829723|526267368|FG019|Overall Study|Subject/guardian decision|0|||
145934424|NCT02829723|526267369|FG020|Overall Study|Subject/guardian decision|1|||
145934425|NCT02829723|526267370|FG021|Overall Study|Subject/guardian decision|0|||
145934426|NCT02829723|526267371|FG022|Overall Study|Subject/guardian decision|0|||
145934427|NCT02829723|526267372|FG023|Overall Study|Subject/guardian decision|1|||
145934428|NCT02829723|526267373|FG024|Overall Study|Subject/guardian decision|0|||
145934429|NCT02829723|526267374|FG025|Overall Study|Subject/guardian decision|1|||
145934430|NCT02829723|526267375|FG026|Overall Study|Subject/guardian decision|1|||
145934431|NCT02829723|526267349|FG000|Overall Study|Study terminated by sponsor|0|||
145934432|NCT02829723|526267350|FG001|Overall Study|Study terminated by sponsor|0|||
145934433|NCT02829723|526267351|FG002|Overall Study|Study terminated by sponsor|0|||
145934434|NCT02829723|526267352|FG003|Overall Study|Study terminated by sponsor|0|||
145934435|NCT02829723|526267353|FG004|Overall Study|Study terminated by sponsor|0|||
145934436|NCT02829723|526267354|FG005|Overall Study|Study terminated by sponsor|0|||
145934437|NCT02829723|526267355|FG006|Overall Study|Study terminated by sponsor|0|||
145934438|NCT02829723|526267356|FG007|Overall Study|Study terminated by sponsor|0|||
145934439|NCT02829723|526267357|FG008|Overall Study|Study terminated by sponsor|0|||
145934440|NCT02829723|526267358|FG009|Overall Study|Study terminated by sponsor|0|||
145934441|NCT02829723|526267359|FG010|Overall Study|Study terminated by sponsor|0|||
145934442|NCT02829723|526267360|FG011|Overall Study|Study terminated by sponsor|0|||
145934443|NCT02829723|526267361|FG012|Overall Study|Study terminated by sponsor|0|||
145934444|NCT02829723|526267362|FG013|Overall Study|Study terminated by sponsor|0|||
145934445|NCT02829723|526267363|FG014|Overall Study|Study terminated by sponsor|0|||
145934446|NCT02829723|526267364|FG015|Overall Study|Study terminated by sponsor|0|||
145934447|NCT02829723|526267365|FG016|Overall Study|Study terminated by sponsor|0|||
145934448|NCT02829723|526267366|FG017|Overall Study|Study terminated by sponsor|0|||
145934449|NCT02829723|526267367|FG018|Overall Study|Study terminated by sponsor|0|||
145934450|NCT02829723|526267368|FG019|Overall Study|Study terminated by sponsor|0|||
145934451|NCT02829723|526267369|FG020|Overall Study|Study terminated by sponsor|0|||
145934452|NCT02829723|526267370|FG021|Overall Study|Study terminated by sponsor|1|||
145934453|NCT02829723|526267371|FG022|Overall Study|Study terminated by sponsor|0|||
145934454|NCT02829723|526267372|FG023|Overall Study|Study terminated by sponsor|0|||
145934455|NCT02829723|526267373|FG024|Overall Study|Study terminated by sponsor|0|||
145934456|NCT02829723|526267374|FG025|Overall Study|Study terminated by sponsor|0|||
145934457|NCT02829723|526267375|FG026|Overall Study|Study terminated by sponsor|0|||
145934458|NCT02989649|526267376|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
145934459|NCT02989649|526267376|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
145978845|NCT00541229|526434475|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
145978846|NCT00541229|526434470|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
145978847|NCT00541229|526434471|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
145978848|NCT00541229|526434472|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
146245304|NCT00988429|527412194|FG002|Overall Study|Physician Decision|3|||
145934460|NCT02989649|526267376|FG000|Overall Study|Lost For Observation During Study|3|||
145934461|NCT02989649|526267376|FG000|Overall Study|Reason Not Specified|13|||
145934462|NCT00256854|526267377|FG000|Overall Study|Withdrawal by Subject|2|||
145934463|NCT00256854|526267378|FG001|Overall Study|Withdrawal by Subject|3|||
145934464|NCT00256854|526267379|FG002|Overall Study|Withdrawal by Subject|0|||
145934465|NCT00256854|526267380|FG003|Overall Study|Withdrawal by Subject|0|||
145934466|NCT00256854|526267381|FG004|Overall Study|Withdrawal by Subject|0|||
145934467|NCT00256854|526267382|FG005|Overall Study|Withdrawal by Subject|0|||
145934468|NCT00256854|526267377|FG000|Overall Study|Lack of Efficacy|1|||
145934469|NCT00256854|526267378|FG001|Overall Study|Lack of Efficacy|0|||
145934470|NCT00256854|526267379|FG002|Overall Study|Lack of Efficacy|0|||
145934471|NCT00256854|526267380|FG003|Overall Study|Lack of Efficacy|0|||
145934472|NCT00256854|526267381|FG004|Overall Study|Lack of Efficacy|0|||
145934473|NCT00256854|526267382|FG005|Overall Study|Lack of Efficacy|0|||
145934474|NCT00256854|526267377|FG000|Overall Study|Protocol Violation|0|||
145934475|NCT00256854|526267378|FG001|Overall Study|Protocol Violation|1|||
145934476|NCT00256854|526267379|FG002|Overall Study|Protocol Violation|1|||
145934477|NCT00256854|526267380|FG003|Overall Study|Protocol Violation|1|||
145934478|NCT00256854|526267381|FG004|Overall Study|Protocol Violation|0|||
145934479|NCT00256854|526267382|FG005|Overall Study|Protocol Violation|0|||
145934480|NCT00256854|526267377|FG000|Overall Study|Adverse Event|0|||
145934481|NCT00256854|526267378|FG001|Overall Study|Adverse Event|0|||
145934482|NCT00256854|526267379|FG002|Overall Study|Adverse Event|2|||
145934483|NCT00256854|526267380|FG003|Overall Study|Adverse Event|2|||
145934484|NCT00256854|526267381|FG004|Overall Study|Adverse Event|0|||
145934485|NCT00256854|526267382|FG005|Overall Study|Adverse Event|1|||
145934486|NCT00256854|526267377|FG000|Overall Study|Not compliant with the study drug|0|||
145934487|NCT00256854|526267378|FG001|Overall Study|Not compliant with the study drug|0|||
145934488|NCT00256854|526267379|FG002|Overall Study|Not compliant with the study drug|0|||
145934489|NCT00256854|526267380|FG003|Overall Study|Not compliant with the study drug|0|||
145934490|NCT00256854|526267381|FG004|Overall Study|Not compliant with the study drug|1|||
145934491|NCT00256854|526267382|FG005|Overall Study|Not compliant with the study drug|0|||
145934492|NCT02353442|526267383|FG000|Overall Study|Withdrawal by Subject|3|||
145934493|NCT02353442|526267384|FG001|Overall Study|Withdrawal by Subject|4|||
145934494|NCT03990571|526267386|FG000|Overall Study|Withdrawal by Subject|1|||
145934495|NCT03990571|526267386|FG000|Overall Study|Insurance Issues|3|||
145934496|NCT03990571|526267386|FG000|Overall Study|Covid Restrictions|2|||
145934497|NCT03514485|526267387|FG000|Overall Study|Lost to Follow-up|5|||
145934498|NCT03514485|526267388|FG001|Overall Study|Lost to Follow-up|3|||
145934499|NCT03514485|526267389|FG002|Overall Study|Lost to Follow-up|2|||
145934500|NCT03514485|526267390|FG003|Overall Study|Lost to Follow-up|0|||
145934501|NCT03514485|526267391|FG004|Overall Study|Lost to Follow-up|1|||
145934502|NCT03514485|526267392|FG005|Overall Study|Lost to Follow-up|4|||
145934503|NCT03514485|526267387|FG000|Overall Study|Withdrawal by Subject|0|||
145934504|NCT03514485|526267388|FG001|Overall Study|Withdrawal by Subject|1|||
145934505|NCT03514485|526267389|FG002|Overall Study|Withdrawal by Subject|3|||
145934506|NCT03514485|526267390|FG003|Overall Study|Withdrawal by Subject|1|||
145934507|NCT03514485|526267391|FG004|Overall Study|Withdrawal by Subject|2|||
145934508|NCT03514485|526267392|FG005|Overall Study|Withdrawal by Subject|1|||
145934509|NCT03075891|526267394|FG000|Overall Study|Withdrawal by Subject|3|||
145934510|NCT03075891|526267395|FG001|Overall Study|Withdrawal by Subject|6|||
145934511|NCT03075891|526267394|FG000|Overall Study|Lost to Follow-up|1|||
145934512|NCT03075891|526267395|FG001|Overall Study|Lost to Follow-up|0|||
145934513|NCT03075891|526267394|FG000|Overall Study|Pregnancy|3|||
145934514|NCT03075891|526267395|FG001|Overall Study|Pregnancy|1|||
145934515|NCT03075891|526267394|FG000|Overall Study|visits not performed (no time)|1|||
145934516|NCT03075891|526267395|FG001|Overall Study|visits not performed (no time)|0|||
145934517|NCT03075891|526267394|FG000|Overall Study|Drug abuse relapse issue|0|||
145934518|NCT03075891|526267395|FG001|Overall Study|Drug abuse relapse issue|1|||
145934519|NCT03075891|526267394|FG000|Overall Study|Participant requiring study withdrawal|0|||
145934520|NCT03075891|526267395|FG001|Overall Study|Participant requiring study withdrawal|1|||
145934521|NCT03075891|526267394|FG000|Overall Study|Adverse event, non-fatal|1|||
145978849|NCT00541229|526434473|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
145978850|NCT00541229|526434474|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
146245305|NCT00988429|527412192|FG000|Overall Study|Pregnancy|2|||
146245306|NCT00988429|527412193|FG001|Overall Study|Pregnancy|1|||
146245307|NCT00988429|527412194|FG002|Overall Study|Pregnancy|0|||
146245308|NCT00988429|527412192|FG000|Overall Study|Protocol Violation|4|||
146245309|NCT00988429|527412193|FG001|Overall Study|Protocol Violation|3|||
146245310|NCT00988429|527412194|FG002|Overall Study|Protocol Violation|3|||
146245311|NCT00988429|527412192|FG000|Overall Study|Withdrawal by Subject|7|||
146245312|NCT00988429|527412193|FG001|Overall Study|Withdrawal by Subject|7|||
146245313|NCT00988429|527412194|FG002|Overall Study|Withdrawal by Subject|12|||
145934522|NCT03075891|526267395|FG001|Overall Study|Adverse event, non-fatal|4|||
145934523|NCT02004886|526267396|FG000|Overall Study|Adverse Event|0|||
145934524|NCT02004886|526267397|FG001|Overall Study|Adverse Event|1|||
145934525|NCT02004886|526267398|FG002|Overall Study|Adverse Event|0|||
145934526|NCT02004886|526267399|FG003|Overall Study|Adverse Event|0|||
145934527|NCT02004886|526267396|FG000|Overall Study|Unable to attend future visits|1|||
145934528|NCT02004886|526267397|FG001|Overall Study|Unable to attend future visits|0|||
145934529|NCT02004886|526267398|FG002|Overall Study|Unable to attend future visits|0|||
145934530|NCT02004886|526267399|FG003|Overall Study|Unable to attend future visits|0|||
146245314|NCT00988429|527412192|FG000|Overall Study|Administrative Reasons|1|||
146245315|NCT00988429|527412193|FG001|Overall Study|Administrative Reasons|2|||
145934531|NCT01878084|526267400|FG000|Overall Study|Physician Decision|2|||
145934532|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
145934533|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
145934534|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
145934535|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
145934536|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
145934537|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
145934538|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
145934539|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
145934540|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
145934541|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
145934542|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Death|1|||
145934543|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Death|0|||
145934544|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
145934545|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
145934546|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
145934547|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
145934548|NCT01876784|526267401|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
145934549|NCT01876784|526267402|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
145934550|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
145934551|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
145934552|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Adverse Event|2|||
145934553|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Adverse Event|6|||
145934554|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
145934555|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
145934556|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Progressive disease|4|||
145934557|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Progressive disease|35|||
145934558|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
145934559|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
145934560|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
145934561|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
145934562|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Death|0|||
145934563|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Death|1|||
145934564|NCT01876784|526267401|FG000|Open-label Period (31 Months)|Other than specified above|9|||
145934565|NCT01876784|526267402|FG001|Open-label Period (31 Months)|Other than specified above|18|||
145934566|NCT03891862|526267404|FG000|Open-label Period|Adverse Event|2|||
145934567|NCT03891862|526267405|FG001|Open-label Period|Adverse Event|0|||
145934568|NCT03891862|526267406|FG002|Open-label Period|Adverse Event|0|||
145934569|NCT03891862|526267404|FG000|Open-label Period|Protocol Violation|5|||
145934570|NCT03891862|526267405|FG001|Open-label Period|Protocol Violation|0|||
145934571|NCT03891862|526267406|FG002|Open-label Period|Protocol Violation|0|||
145934572|NCT03891862|526267404|FG000|Open-label Period|Withdrawal by Subject|6|||
145934573|NCT03891862|526267405|FG001|Open-label Period|Withdrawal by Subject|0|||
145934574|NCT03891862|526267406|FG002|Open-label Period|Withdrawal by Subject|0|||
145934575|NCT03891862|526267404|FG000|Open-label Period|Death|1|||
145934576|NCT03891862|526267405|FG001|Open-label Period|Death|0|||
145934577|NCT03891862|526267406|FG002|Open-label Period|Death|0|||
145934578|NCT03891862|526267404|FG000|Open-label Period|Lost to Follow-up|2|||
145934579|NCT03891862|526267405|FG001|Open-label Period|Lost to Follow-up|0|||
145934580|NCT03891862|526267406|FG002|Open-label Period|Lost to Follow-up|0|||
145978851|NCT00541229|526434475|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
145978852|NCT00541229|526434470|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
145978853|NCT00541229|526434471|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
145978854|NCT00541229|526434472|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
145978855|NCT00541229|526434473|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
145978856|NCT00541229|526434474|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
145978857|NCT00541229|526434475|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
145934581|NCT03891862|526267404|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
145934582|NCT03891862|526267405|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
145934583|NCT03891862|526267406|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
145934584|NCT03891862|526267404|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
145934585|NCT03891862|526267405|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
145934586|NCT03891862|526267406|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
145934587|NCT03891862|526267404|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
145978858|NCT00541229|526434470|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
145978859|NCT00541229|526434471|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
145978860|NCT00541229|526434472|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
145978861|NCT00541229|526434473|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
145978862|NCT00541229|526434474|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
145934588|NCT03891862|526267405|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
145934589|NCT03891862|526267406|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
145934590|NCT03891862|526267404|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
145934591|NCT03891862|526267405|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
145934592|NCT03891862|526267406|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
145934593|NCT01194531|526267407|FG000|Overall Study|Withdrawal by Subject|1|||
145934594|NCT01194531|526267408|FG001|Overall Study|Withdrawal by Subject|0|||
145934595|NCT01194531|526267407|FG000|Overall Study|Protocol Violation|4|||
145934596|NCT01194531|526267408|FG001|Overall Study|Protocol Violation|1|||
145934597|NCT01194531|526267407|FG000|Overall Study|Physician Decision|0|||
145934598|NCT01194531|526267408|FG001|Overall Study|Physician Decision|2|||
145934599|NCT01500187|526267410|FG000|Overall Study|Lost to Follow-up|6|||
145934600|NCT01500187|526267411|FG001|Overall Study|Lost to Follow-up|0|||
145934601|NCT01435460|526267419|FG000|Overall Study|Adverse Event|2|||
145934602|NCT01435460|526267420|FG001|Overall Study|Adverse Event|1|||
145934603|NCT01435460|526267419|FG000|Overall Study|Lost to Follow-up|6|||
145934604|NCT01435460|526267420|FG001|Overall Study|Lost to Follow-up|1|||
145934605|NCT01435460|526267419|FG000|Overall Study|Withdrawal by Subject|1|||
145934606|NCT01435460|526267420|FG001|Overall Study|Withdrawal by Subject|3|||
145934607|NCT01435460|526267419|FG000|Overall Study|Protocol Violation|0|||
145978863|NCT00541229|526434475|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
145978864|NCT00541229|526434470|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
145978865|NCT00541229|526434471|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
145978866|NCT00541229|526434472|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
145978867|NCT00541229|526434473|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
145978868|NCT00541229|526434474|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
145978869|NCT00541229|526434475|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
145978870|NCT00541229|526434470|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145978871|NCT00541229|526434471|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
145978872|NCT00541229|526434472|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145978873|NCT00541229|526434473|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145978874|NCT00541229|526434474|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
145978875|NCT00541229|526434475|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
145978876|NCT00541229|526434470|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
145978877|NCT00541229|526434471|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
145978878|NCT00541229|526434472|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
145978879|NCT00541229|526434473|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
145978880|NCT00541229|526434474|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
145978881|NCT00541229|526434475|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
145978882|NCT00541229|526434470|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
145978883|NCT00541229|526434471|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145978884|NCT00541229|526434472|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145978885|NCT00541229|526434473|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145978886|NCT00541229|526434474|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145978887|NCT00541229|526434475|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
145978888|NCT00541229|526434470|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
145978889|NCT00541229|526434471|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
145978890|NCT00541229|526434472|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
145978891|NCT00541229|526434473|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
145978892|NCT00541229|526434474|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
145978893|NCT00541229|526434475|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
145978894|NCT00541229|526434470|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145978895|NCT00541229|526434471|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145978896|NCT00541229|526434472|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145978897|NCT00541229|526434473|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145978898|NCT00541229|526434474|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
145978899|NCT00541229|526434475|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145978900|NCT00541229|526434470|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145978901|NCT00541229|526434471|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
145978902|NCT00541229|526434472|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
145978903|NCT00541229|526434473|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
145978904|NCT00541229|526434474|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145978905|NCT00541229|526434475|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145978906|NCT00541229|526434470|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
145978907|NCT00541229|526434471|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
145934608|NCT01435460|526267420|FG001|Overall Study|Protocol Violation|1|||
145934609|NCT01435460|526267419|FG000|Overall Study|Did not meet eligibility criteria|2|||
145978908|NCT00541229|526434472|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
145934610|NCT01435460|526267420|FG001|Overall Study|Did not meet eligibility criteria|0|||
145934611|NCT01706939|526267421|FG000|Pre Randomization|Screen Failure|1|||
145934612|NCT01706939|526267422|FG001|Pre Randomization|Screen Failure|0|||
145934613|NCT01706939|526267423|FG002|Pre Randomization|Screen Failure|0|||
145934614|NCT01706939|526267421|FG000|Pre Randomization|Ineligible for Randomization|1|||
145934615|NCT01706939|526267422|FG001|Pre Randomization|Ineligible for Randomization|0|||
145934616|NCT01706939|526267423|FG002|Pre Randomization|Ineligible for Randomization|0|||
145934617|NCT01706939|526267421|FG000|Pre Randomization|Withdrawal by Subject|1|||
145934618|NCT01706939|526267422|FG001|Pre Randomization|Withdrawal by Subject|0|||
145934619|NCT01706939|526267423|FG002|Pre Randomization|Withdrawal by Subject|0|||
145934620|NCT01706939|526267421|FG000|Randomization|Insufficient QoL survey compliance|0|||
145934621|NCT01706939|526267422|FG001|Randomization|Insufficient QoL survey compliance|1|||
145934622|NCT01706939|526267423|FG002|Randomization|Insufficient QoL survey compliance|1|||
145934623|NCT01706939|526267421|FG000|Randomization|Progression of disease|0|||
146091109|NCT01390220|526854880|FG002|Test Dose Phase|Withdrawal by Subject|0|||
146091110|NCT01390220|526854878|FG000|Test Dose Phase|Lost to Follow-up|2|||
146091111|NCT01390220|526854879|FG001|Test Dose Phase|Lost to Follow-up|0|||
146091112|NCT01390220|526854880|FG002|Test Dose Phase|Lost to Follow-up|0|||
146091113|NCT01390220|526854878|FG000|Test Dose Phase|Protocol Violation|8|||
145934624|NCT01706939|526267422|FG001|Randomization|Progression of disease|2|||
145934625|NCT01706939|526267423|FG002|Randomization|Progression of disease|1|||
145934626|NCT01046903|526267424|FG000|Overall Study|Lost to Follow-up|16|||
145934627|NCT01046903|526267424|FG000|Overall Study|Adverse Event|4|||
145934628|NCT01046903|526267424|FG000|Overall Study|Withdrawal by Subject|3|||
145934629|NCT01046903|526267424|FG000|Overall Study|Other|5|||
145934630|NCT01343277|526267425|FG000|Overall Study|Other|3|||
145934631|NCT01343277|526267426|FG001|Overall Study|Other|3|||
145934632|NCT01343277|526267425|FG000|Overall Study|Withdrawal by Subject|18|||
145934633|NCT01343277|526267426|FG001|Overall Study|Withdrawal by Subject|13|||
145934634|NCT01343277|526267425|FG000|Overall Study|Physician Decision|1|||
145934635|NCT01343277|526267426|FG001|Overall Study|Physician Decision|2|||
145934636|NCT01343277|526267425|FG000|Overall Study|Death|10|||
145934637|NCT01343277|526267426|FG001|Overall Study|Death|1|||
145934638|NCT01343277|526267425|FG000|Overall Study|Adverse Event|67|||
145934639|NCT01343277|526267426|FG001|Overall Study|Adverse Event|13|||
145934640|NCT01343277|526267425|FG000|Overall Study|Disease progression|270|||
145934641|NCT01343277|526267426|FG001|Overall Study|Disease progression|138|||
145934642|NCT01343277|526267425|FG000|Overall Study|Randomized not treated|6|||
145934643|NCT01343277|526267426|FG001|Overall Study|Randomized not treated|21|||
145934644|NCT01343277|526267425|FG000|Overall Study|Treatment ongoing|8|||
145934645|NCT01343277|526267426|FG001|Overall Study|Treatment ongoing|2|||
145934646|NCT01343277|526267425|FG000|Overall Study|Subsequent anticancer therapy|1|||
145934647|NCT01343277|526267426|FG001|Overall Study|Subsequent anticancer therapy|0|||
145934648|NCT01894100|526267427|FG000|Overall Study|Lost to Follow-up|0|||
145934649|NCT01894100|526267428|FG001|Overall Study|Lost to Follow-up|1|||
145934650|NCT01894100|526267427|FG000|Overall Study|Withdrawal by Subject|3|||
145934651|NCT01894100|526267428|FG001|Overall Study|Withdrawal by Subject|0|||
145934652|NCT01094301|526267429|FG000|Trial Stage|Withdrawal by Subject|1|||
145934653|NCT01094301|526267429|FG000|Implant Stage|Adverse Event|1|||
145934654|NCT01094301|526267429|FG000|Implant Stage|Protocol Violation|1|||
145934655|NCT01094301|526267429|FG000|Implant Stage|Withdrawal by Subject|2|||
145934656|NCT01094301|526267429|FG000|Implant Stage|No return of pain|4|||
145934657|NCT00135512|526267430|FG000|Overall Study|Adverse Event|56|||
145934658|NCT00135512|526267430|FG000|Overall Study|Lack of Efficacy|25|||
145934659|NCT00135512|526267430|FG000|Overall Study|Other|42|||
145934660|NCT04013672|526267432|FG000|Overall Study|Withdrawal by Subject|3|||
145934661|NCT04013672|526267433|FG001|Overall Study|Withdrawal by Subject|0|||
145934662|NCT04013672|526267432|FG000|Overall Study|Death|1|||
145934663|NCT04013672|526267433|FG001|Overall Study|Death|0|||
145934664|NCT04013672|526267432|FG000|Overall Study|Physician Decision|5|||
145934665|NCT04013672|526267433|FG001|Overall Study|Physician Decision|0|||
145934666|NCT00430573|526267434|FG000|Overall Study|Withdrawal by Subject|5|||
145934667|NCT05020665|526267437|FG000|Overall Study|Study terminated by Sponsor|5|||
146091114|NCT01390220|526854879|FG001|Test Dose Phase|Protocol Violation|0|||
146091115|NCT01390220|526854880|FG002|Test Dose Phase|Protocol Violation|0|||
145934668|NCT05020665|526267438|FG001|Overall Study|Study terminated by Sponsor|4|||
145934669|NCT05020665|526267437|FG000|Overall Study|Death|2|||
145934670|NCT05020665|526267438|FG001|Overall Study|Death|1|||
145934671|NCT05020665|526267437|FG000|Overall Study|Physician Decision|0|||
145934672|NCT05020665|526267438|FG001|Overall Study|Physician Decision|1|||
145934673|NCT05020665|526267437|FG000|Overall Study|Withdrawal by Subject|0|||
145934674|NCT05020665|526267438|FG001|Overall Study|Withdrawal by Subject|1|||
145934675|NCT05020665|526267437|FG000|Overall Study|Reason not specified|1|||
145934676|NCT05020665|526267438|FG001|Overall Study|Reason not specified|0|||
145934677|NCT01868022|526267439|FG000|Overall Study|Withdrawal by Subject|0|||
145934678|NCT01868022|526267440|FG001|Overall Study|Withdrawal by Subject|0|||
145934679|NCT01868022|526267441|FG002|Overall Study|Withdrawal by Subject|1|||
145934680|NCT01868022|526267442|FG003|Overall Study|Withdrawal by Subject|1|||
145934681|NCT01868022|526267443|FG004|Overall Study|Withdrawal by Subject|0|||
145934682|NCT01868022|526267444|FG005|Overall Study|Withdrawal by Subject|0|||
145934683|NCT01868022|526267445|FG006|Overall Study|Withdrawal by Subject|0|||
145934684|NCT01868022|526267446|FG007|Overall Study|Withdrawal by Subject|1|||
145934685|NCT01868022|526267447|FG008|Overall Study|Withdrawal by Subject|0|||
145934686|NCT01868022|526267439|FG000|Overall Study|Adverse Event|0|||
145934687|NCT01868022|526267440|FG001|Overall Study|Adverse Event|0|||
145934688|NCT01868022|526267441|FG002|Overall Study|Adverse Event|0|||
145934689|NCT01868022|526267442|FG003|Overall Study|Adverse Event|0|||
145934690|NCT01868022|526267443|FG004|Overall Study|Adverse Event|2|||
145934691|NCT01868022|526267444|FG005|Overall Study|Adverse Event|0|||
145934692|NCT01868022|526267445|FG006|Overall Study|Adverse Event|0|||
145934693|NCT01868022|526267446|FG007|Overall Study|Adverse Event|2|||
145934694|NCT01868022|526267447|FG008|Overall Study|Adverse Event|2|||
145934695|NCT01868022|526267439|FG000|Overall Study|Physician Decision|0|||
145934696|NCT01868022|526267440|FG001|Overall Study|Physician Decision|0|||
145934697|NCT01868022|526267441|FG002|Overall Study|Physician Decision|0|||
145934698|NCT01868022|526267442|FG003|Overall Study|Physician Decision|0|||
145934699|NCT01868022|526267443|FG004|Overall Study|Physician Decision|0|||
145934700|NCT01868022|526267444|FG005|Overall Study|Physician Decision|1|||
145934701|NCT01868022|526267445|FG006|Overall Study|Physician Decision|0|||
145934702|NCT01868022|526267446|FG007|Overall Study|Physician Decision|2|||
145934703|NCT01868022|526267447|FG008|Overall Study|Physician Decision|0|||
145934704|NCT01868022|526267439|FG000|Overall Study|Study closed/terminated|0|||
145934705|NCT01868022|526267440|FG001|Overall Study|Study closed/terminated|0|||
145978909|NCT00541229|526434473|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
145978910|NCT00541229|526434474|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
145978911|NCT00541229|526434475|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
145978912|NCT00541229|526434470|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145978913|NCT00541229|526434471|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145978914|NCT00541229|526434472|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145978915|NCT00541229|526434473|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145978916|NCT00541229|526434474|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145978917|NCT00541229|526434475|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
145978918|NCT00541229|526434470|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145978919|NCT00541229|526434471|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145978920|NCT00541229|526434472|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
145978921|NCT00541229|526434473|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145978922|NCT00541229|526434474|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145978923|NCT00541229|526434475|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145978924|NCT00924651|526434476|FG000|Overall Study|Chemo started too soon|2|||
145978925|NCT00924651|526434477|FG001|Overall Study|Chemo started too soon|3|||
145978926|NCT00924651|526434476|FG000|Overall Study|No Reason|3|||
145978927|NCT00924651|526434477|FG001|Overall Study|No Reason|7|||
145978928|NCT00924651|526434476|FG000|Overall Study|Overwhelmed|6|||
145978929|NCT00924651|526434477|FG001|Overall Study|Overwhelmed|6|||
145978930|NCT00924651|526434476|FG000|Overall Study|Noncompliant|1|||
145978931|NCT00924651|526434477|FG001|Overall Study|Noncompliant|4|||
145978932|NCT00924651|526434476|FG000|Overall Study|Medical|1|||
145978933|NCT00924651|526434477|FG001|Overall Study|Medical|3|||
145978934|NCT00924651|526434476|FG000|Overall Study|Changed Mind|10|||
145978935|NCT00924651|526434477|FG001|Overall Study|Changed Mind|1|||
145978936|NCT00924651|526434476|FG000|Overall Study|Incomplete Form|2|||
145978937|NCT00924651|526434477|FG001|Overall Study|Incomplete Form|1|||
145978938|NCT03298061|526434478|FG000|Overall Study|Adverse Event|3|||
145978939|NCT03298061|526434478|FG000|Overall Study|Lack of Efficacy|6|||
145978940|NCT03298061|526434478|FG000|Overall Study|Protocol Violation|1|||
145978941|NCT03298061|526434478|FG000|Overall Study|Physician Decision|7|||
145978942|NCT03298061|526434478|FG000|Overall Study|Withdrawal by Subject|10|||
145978943|NCT00992836|526434479|FG000|Overall Study|Lost to Follow-up|1|||
145978944|NCT00992836|526434479|FG000|Overall Study|Withdrawal by Subject|2|||
145978945|NCT00992836|526434479|FG000|Overall Study|Protocol Violation|2|||
145978946|NCT02506036|526434480|FG000|First Intervention (4-6 Weeks)|Death|1|||
145978947|NCT02506036|526434481|FG001|First Intervention (4-6 Weeks)|Death|0|||
145934706|NCT01868022|526267441|FG002|Overall Study|Study closed/terminated|0|||
145934707|NCT01868022|526267442|FG003|Overall Study|Study closed/terminated|0|||
145934708|NCT01868022|526267443|FG004|Overall Study|Study closed/terminated|0|||
145934709|NCT01868022|526267444|FG005|Overall Study|Study closed/terminated|0|||
145934710|NCT01868022|526267445|FG006|Overall Study|Study closed/terminated|0|||
145934711|NCT01868022|526267446|FG007|Overall Study|Study closed/terminated|1|||
145934712|NCT01868022|526267447|FG008|Overall Study|Study closed/terminated|0|||
145978948|NCT02506036|526434480|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
145978949|NCT02506036|526434481|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
145978950|NCT02506036|526434480|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
145978951|NCT02506036|526434481|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
145978952|NCT05276804|526434484|FG000|Overall Study|screen failure|23|||
145978953|NCT05276804|526434485|FG001|Overall Study|screen failure|0|||
145934713|NCT01868022|526267439|FG000|Overall Study|Ongoing|0|||
145934714|NCT01868022|526267440|FG001|Overall Study|Ongoing|0|||
145934715|NCT01868022|526267441|FG002|Overall Study|Ongoing|0|||
145934716|NCT01868022|526267442|FG003|Overall Study|Ongoing|0|||
145934717|NCT01868022|526267443|FG004|Overall Study|Ongoing|0|||
145934718|NCT01868022|526267444|FG005|Overall Study|Ongoing|0|||
145934719|NCT01868022|526267445|FG006|Overall Study|Ongoing|0|||
145934720|NCT01868022|526267446|FG007|Overall Study|Ongoing|3|||
145934721|NCT01868022|526267447|FG008|Overall Study|Ongoing|0|||
145934722|NCT03425396|526267456|FG000|Overall Study|Lost to Follow-up|2|||
145934723|NCT03425396|526267457|FG001|Overall Study|Lost to Follow-up|5|||
145934724|NCT03425396|526267458|FG002|Overall Study|Lost to Follow-up|2|||
145934725|NCT03425396|526267459|FG003|Overall Study|Lost to Follow-up|0|||
145934726|NCT03425396|526267460|FG004|Overall Study|Lost to Follow-up|0|||
145934727|NCT03425396|526267456|FG000|Overall Study|Withdrawal by Subject|0|||
145934728|NCT03425396|526267457|FG001|Overall Study|Withdrawal by Subject|1|||
145934729|NCT03425396|526267458|FG002|Overall Study|Withdrawal by Subject|0|||
145934730|NCT03425396|526267459|FG003|Overall Study|Withdrawal by Subject|1|||
145978954|NCT00800540|526434486|FG000|Period One: 6 Weeks|Noncompliance|1|||
145978955|NCT00800540|526434487|FG001|Period One: 6 Weeks|Noncompliance|0|||
145978956|NCT00800540|526434486|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
145978957|NCT00800540|526434487|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
145978958|NCT00800540|526434486|FG000|Period 2: 6 Weeks|Adverse Event|0|||
145978959|NCT00800540|526434487|FG001|Period 2: 6 Weeks|Adverse Event|1|||
145978960|NCT03927157|526434491|FG000|Overall Study|Adverse Event|1|||
145978961|NCT03927157|526434492|FG001|Overall Study|Adverse Event|3|||
145978962|NCT03927157|526434491|FG000|Overall Study|Protocol Violation|1|||
145978963|NCT03927157|526434492|FG001|Overall Study|Protocol Violation|2|||
145978964|NCT03927157|526434491|FG000|Overall Study|Withdrawal by Subject|8|||
145978965|NCT03927157|526434492|FG001|Overall Study|Withdrawal by Subject|21|||
145978966|NCT03927157|526434491|FG000|Overall Study|Due to COVID-19 pandemic|5|||
145978967|NCT03927157|526434492|FG001|Overall Study|Due to COVID-19 pandemic|2|||
145978968|NCT03927157|526434491|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
145978969|NCT03927157|526434492|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
145978970|NCT03927157|526434491|FG000|Overall Study|Other than above|0|||
145978971|NCT03927157|526434492|FG001|Overall Study|Other than above|1|||
145978972|NCT00726557|526434493|FG000|Overall Study|Screening failure|4|||
145978973|NCT00726557|526434493|FG000|Overall Study|No end of treatment documentation|37|||
145978974|NCT00726557|526434493|FG000|Overall Study|No follow-up documentation available|55|||
145978975|NCT00726557|526434493|FG000|Overall Study|Treatment less than 3 months|17|||
145978976|NCT00726557|526434493|FG000|Overall Study|Inclusion criteria not met|15|||
145978977|NCT03637374|526434494|FG000|Overall Study|Death|2|||
145978978|NCT03637374|526434495|FG001|Overall Study|Death|0|||
145978979|NCT05561140|526434500|FG000|Randomized Treatment Period|Adverse Event|1|||
145978980|NCT05561140|526434501|FG001|Randomized Treatment Period|Adverse Event|0|||
145978981|NCT05561140|526434500|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
145978982|NCT05561140|526434501|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
145978983|NCT05561140|526434500|FG000|Open Label Treatment Period|Adverse Event|6|||
145978984|NCT05561140|526434501|FG001|Open Label Treatment Period|Adverse Event|4|||
145978985|NCT05561140|526434500|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
145978986|NCT05561140|526434501|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
145978987|NCT05561140|526434500|FG000|Open Label Treatment Period|Physician Decision|0|||
145978988|NCT05561140|526434501|FG001|Open Label Treatment Period|Physician Decision|1|||
145978989|NCT05561140|526434500|FG000|Open Label Treatment Period|Pregnancy|1|||
145978990|NCT05561140|526434501|FG001|Open Label Treatment Period|Pregnancy|0|||
145978991|NCT05561140|526434500|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
145978992|NCT05561140|526434501|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
145978993|NCT05561140|526434500|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
145978994|NCT05561140|526434501|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
145978995|NCT05561140|526434500|FG000|Open Label Treatment Period|Other|1|||
145978996|NCT05561140|526434501|FG001|Open Label Treatment Period|Other|0|||
145978997|NCT03301714|526434504|FG000|Overall Study|Lost to Follow-up|10|||
145978998|NCT03301714|526434505|FG001|Overall Study|Lost to Follow-up|4|||
145978999|NCT03301714|526434506|FG002|Overall Study|Lost to Follow-up|4|||
145979000|NCT03301714|526434504|FG000|Overall Study|Did not receive allocated intervention|0|||
145979001|NCT03301714|526434505|FG001|Overall Study|Did not receive allocated intervention|2|||
145979002|NCT03301714|526434506|FG002|Overall Study|Did not receive allocated intervention|3|||
145979003|NCT02112552|526434509|FG000|Overall Study|Withdrawal by Subject|1|||
145979004|NCT02112552|526434509|FG000|Overall Study|Adverse Event|1|||
145979005|NCT03349515|526434510|FG000|Overall Study|Lack of Efficacy|2|||
145979006|NCT03349515|526434511|FG001|Overall Study|Lack of Efficacy|0|||
145979007|NCT03349515|526434510|FG000|Overall Study|Physician Decision|3|||
145979008|NCT03349515|526434511|FG001|Overall Study|Physician Decision|1|||
146091116|NCT01390220|526854878|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
145934731|NCT03425396|526267460|FG004|Overall Study|Withdrawal by Subject|0|||
145934732|NCT03425396|526267456|FG000|Overall Study|Other|0|||
145934733|NCT03425396|526267457|FG001|Overall Study|Other|1|||
145934734|NCT03425396|526267458|FG002|Overall Study|Other|1|||
145934735|NCT03425396|526267459|FG003|Overall Study|Other|0|||
145934736|NCT03425396|526267460|FG004|Overall Study|Other|1|||
145934737|NCT03033602|526267461|FG000|Overall Study|Withdrawal by Subject|11|||
145934738|NCT03033602|526267462|FG001|Overall Study|Withdrawal by Subject|21|||
145934739|NCT03033602|526267461|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
145934740|NCT03033602|526267462|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
145934741|NCT01441765|526267463|FG000|Overall Study|Death|1|||
145934742|NCT01441765|526267464|FG001|Overall Study|Death|0|||
145934743|NCT00940823|526267465|FG000|Overall Study|Death|8|||
145934744|NCT00940823|526267466|FG001|Overall Study|Death|12|||
145934745|NCT00940823|526267465|FG000|Overall Study|Lost to Follow-up|27|||
145934746|NCT00940823|526267466|FG001|Overall Study|Lost to Follow-up|20|||
145934747|NCT04999163|526267469|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
145934748|NCT04999163|526267470|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
145934749|NCT04999163|526267469|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
145934750|NCT04999163|526267470|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
145934751|NCT04999163|526267469|FG000|Overall Study|Withdrawal by Subject|1|||
145934752|NCT04999163|526267470|FG001|Overall Study|Withdrawal by Subject|0|||
145934753|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
145934754|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
145934755|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
145934756|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
145934757|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Death|0|||
145934758|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Death|0|||
145934759|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Death|1|||
145934760|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Death|0|||
145934761|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
145934762|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145934763|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145934764|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145934765|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
145934766|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
145934767|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
145934768|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
145934769|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
145934770|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
145934771|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
145934772|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
145934773|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
145934774|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
145934775|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
145934776|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
145934777|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
145934778|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145934779|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
145934780|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
145934781|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
145934782|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
145934783|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
145934784|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
145934785|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145934786|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
145934787|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145934788|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145979009|NCT01068912|526434516|FG000|Overall Study|Adverse Event|2|||
145979010|NCT01068912|526434517|FG001|Overall Study|Adverse Event|3|||
145979011|NCT01068912|526434518|FG002|Overall Study|Adverse Event|2|||
145979012|NCT01068912|526434516|FG000|Overall Study|Withdrawal by Subject|5|||
145979013|NCT01068912|526434517|FG001|Overall Study|Withdrawal by Subject|6|||
146245316|NCT00988429|527412194|FG002|Overall Study|Administrative Reasons|1|||
145934789|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
145934790|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
145934791|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
146245317|NCT00988429|527412192|FG000|Overall Study|other reasons|8|||
146245318|NCT00988429|527412193|FG001|Overall Study|other reasons|8|||
145979014|NCT01068912|526434518|FG002|Overall Study|Withdrawal by Subject|6|||
145979015|NCT01068912|526434516|FG000|Overall Study|Lost to Follow-up|3|||
146245319|NCT00988429|527412194|FG002|Overall Study|other reasons|1|||
145934792|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
145934793|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
145934794|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
145934795|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
145934796|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
145934797|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Other|8|||
145934798|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Other|14|||
145934799|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Other|8|||
145934800|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Other|23|||
145934801|NCT01106677|526269271|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
145934802|NCT01106677|526269272|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
145934803|NCT01106677|526269273|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
145934804|NCT01106677|526269274|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
145934805|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145934806|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145934807|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
145934808|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
145934809|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Death|0|||
145934810|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Death|0|||
145934811|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145934812|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Death|1|||
145934813|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
145934814|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
145934815|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
145934816|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
145934817|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145979016|NCT01068912|526434517|FG001|Overall Study|Lost to Follow-up|7|||
145979017|NCT01068912|526434518|FG002|Overall Study|Lost to Follow-up|3|||
145979018|NCT01068912|526434516|FG000|Overall Study|Protocol Violation|0|||
145979019|NCT01068912|526434517|FG001|Overall Study|Protocol Violation|2|||
145979020|NCT01068912|526434518|FG002|Overall Study|Protocol Violation|0|||
145979021|NCT01068912|526434516|FG000|Overall Study|aggravation influenza|1|||
145979022|NCT01068912|526434517|FG001|Overall Study|aggravation influenza|1|||
145979023|NCT01068912|526434518|FG002|Overall Study|aggravation influenza|1|||
145979024|NCT01068912|526434516|FG000|Overall Study|other underlying illness|0|||
145979025|NCT01068912|526434517|FG001|Overall Study|other underlying illness|3|||
145979026|NCT01068912|526434518|FG002|Overall Study|other underlying illness|3|||
145979027|NCT02762604|526434519|FG000|Overall Study|Lost to Follow-up|2|||
145979028|NCT02762604|526434520|FG001|Overall Study|Lost to Follow-up|7|||
145934818|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145934819|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145934820|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145934821|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145934822|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
145934823|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145934824|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
145934825|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145934826|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145934827|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145934828|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145934829|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145934830|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
145934831|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
145979029|NCT02762604|526434519|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
145934832|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145979030|NCT02762604|526434520|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
145979031|NCT00544882|526434532|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
145979032|NCT00544882|526434533|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
145979033|NCT00544882|526434534|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
145979034|NCT00544882|526434532|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
145979035|NCT00544882|526434533|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
145979036|NCT00544882|526434534|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
145979037|NCT00544882|526434532|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
145979038|NCT00544882|526434533|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
145979039|NCT00544882|526434534|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
146091117|NCT01390220|526854879|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
145979040|NCT00544882|526434532|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
145979041|NCT00544882|526434533|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
145979042|NCT00544882|526434534|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
145934833|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
145934834|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
145934835|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
145934836|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
145934837|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145934838|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145934839|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145934840|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145934841|NCT01106677|526269271|FG000|Extension Period: Week 26 to Week 52|Other|6|||
145934842|NCT01106677|526269272|FG001|Extension Period: Week 26 to Week 52|Other|5|||
145934843|NCT01106677|526269273|FG002|Extension Period: Week 26 to Week 52|Other|8|||
145934844|NCT01106677|526269274|FG003|Extension Period: Week 26 to Week 52|Other|5|||
145934845|NCT03937908|526269275|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
145934846|NCT03937908|526269276|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
145934847|NCT03875092|526269277|FG000|Overall Study|Adverse Event|2|||
145934848|NCT03875092|526269278|FG001|Overall Study|Adverse Event|5|||
145934849|NCT03875092|526269277|FG000|Overall Study|Death|44|||
145934850|NCT03875092|526269278|FG001|Overall Study|Death|51|||
145934851|NCT03875092|526269277|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
145934852|NCT03875092|526269278|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
145934853|NCT00636194|526269279|FG000|Overall Study|Study related symptoms and complaints|1|||
145934854|NCT00636194|526269280|FG001|Overall Study|Study related symptoms and complaints|0|||
145934855|NCT00636194|526269279|FG000|Overall Study|Protocol Violation|2|||
145934856|NCT00636194|526269280|FG001|Overall Study|Protocol Violation|0|||
145934857|NCT04114357|526269281|FG000|Baseline-Randomization|Adverse Event|2|||
145934858|NCT04114357|526269282|FG001|Baseline-Randomization|Adverse Event|1|||
145934859|NCT04114357|526269281|FG000|Baseline-Randomization|Lost to Follow-up|1|||
145934860|NCT04114357|526269282|FG001|Baseline-Randomization|Lost to Follow-up|1|||
145934861|NCT04114357|526269281|FG000|Cross-over|Adverse Event|0|||
145934862|NCT04114357|526269282|FG001|Cross-over|Adverse Event|1|||
145934863|NCT02163226|526269283|FG000|Overall Study|Death|2|||
145934864|NCT02163226|526269284|FG001|Overall Study|Death|1|||
145934865|NCT02163226|526269283|FG000|Overall Study|Withdrawal by Subject|5|||
145934866|NCT02163226|526269284|FG001|Overall Study|Withdrawal by Subject|2|||
145934867|NCT02163226|526269283|FG000|Overall Study|Returned home, local radiotherapy|3|||
145934868|NCT02163226|526269284|FG001|Overall Study|Returned home, local radiotherapy|0|||
145934869|NCT02163226|526269283|FG000|Overall Study|Repeat imaging showed no disease|2|||
145934870|NCT02163226|526269284|FG001|Overall Study|Repeat imaging showed no disease|0|||
145934871|NCT02163226|526269283|FG000|Overall Study|Incomplete radiotherapy|3|||
145934872|NCT02163226|526269284|FG001|Overall Study|Incomplete radiotherapy|0|||
145934873|NCT02163226|526269283|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
145934874|NCT02163226|526269284|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
145934875|NCT02163226|526269283|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
145934876|NCT02163226|526269284|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
145934877|NCT02163226|526269283|FG000|Overall Study|ineligible|0|||
145934878|NCT02163226|526269284|FG001|Overall Study|ineligible|3|||
145934879|NCT03693612|526269286|FG000|Overall Study|Lost to Follow-up|0|||
145934880|NCT03693612|526269287|FG001|Overall Study|Lost to Follow-up|0|||
145934881|NCT03693612|526269288|FG002|Overall Study|Lost to Follow-up|0|||
145934882|NCT03693612|526269289|FG003|Overall Study|Lost to Follow-up|0|||
145934883|NCT03693612|526269290|FG004|Overall Study|Lost to Follow-up|1|||
145934884|NCT03693612|526269291|FG005|Overall Study|Lost to Follow-up|0|||
145934885|NCT03693612|526269292|FG006|Overall Study|Lost to Follow-up|0|||
145934886|NCT03693612|526269286|FG000|Overall Study|Withdrawal by Subject|0|||
145934887|NCT03693612|526269287|FG001|Overall Study|Withdrawal by Subject|0|||
145934888|NCT03693612|526269288|FG002|Overall Study|Withdrawal by Subject|1|||
145934889|NCT03693612|526269289|FG003|Overall Study|Withdrawal by Subject|0|||
145934890|NCT03693612|526269290|FG004|Overall Study|Withdrawal by Subject|2|||
145934891|NCT03693612|526269291|FG005|Overall Study|Withdrawal by Subject|0|||
145934892|NCT03693612|526269292|FG006|Overall Study|Withdrawal by Subject|0|||
145934893|NCT03693612|526269286|FG000|Overall Study|Study Terminated by Sponsor|0|||
145934894|NCT03693612|526269287|FG001|Overall Study|Study Terminated by Sponsor|1|||
145934895|NCT03693612|526269288|FG002|Overall Study|Study Terminated by Sponsor|0|||
145934896|NCT03693612|526269289|FG003|Overall Study|Study Terminated by Sponsor|0|||
145934897|NCT03693612|526269290|FG004|Overall Study|Study Terminated by Sponsor|3|||
145934898|NCT03693612|526269291|FG005|Overall Study|Study Terminated by Sponsor|0|||
145934899|NCT03693612|526269292|FG006|Overall Study|Study Terminated by Sponsor|0|||
145934900|NCT05318092|526269293|FG000|Overall Study|Lost to Follow-up|3|||
145934901|NCT05318092|526269293|FG000|Overall Study|Withdrawal by Subject|1|||
145934902|NCT00452673|526269298|FG000|Dose Escalation Period|Disease Progression|6|||
145934903|NCT00452673|526269299|FG001|Dose Escalation Period|Disease Progression|6|||
145934904|NCT00452673|526269300|FG002|Dose Escalation Period|Disease Progression|2|||
145934905|NCT00452673|526269301|FG003|Dose Escalation Period|Disease Progression|6|||
145934906|NCT00452673|526269302|FG004|Dose Escalation Period|Disease Progression|0|||
145979043|NCT00544882|526434532|FG000|Cycle 3: Follow-up|Noncompliance|0|||
145979044|NCT00544882|526434533|FG001|Cycle 3: Follow-up|Noncompliance|1|||
145979045|NCT00544882|526434534|FG002|Cycle 3: Follow-up|Noncompliance|0|||
145979046|NCT00544882|526434532|FG000|Cycle 3: Follow-up|Pregnancy|0|||
145934907|NCT00452673|526269298|FG000|Dose Escalation Period|study drug toxicity|1|||
145934908|NCT00452673|526269299|FG001|Dose Escalation Period|study drug toxicity|3|||
145934909|NCT00452673|526269300|FG002|Dose Escalation Period|study drug toxicity|3|||
145934910|NCT00452673|526269301|FG003|Dose Escalation Period|study drug toxicity|1|||
145934911|NCT00452673|526269302|FG004|Dose Escalation Period|study drug toxicity|0|||
145934912|NCT00452673|526269298|FG000|Dose Escalation Period|Other|0|||
145934913|NCT00452673|526269299|FG001|Dose Escalation Period|Other|0|||
145934914|NCT00452673|526269300|FG002|Dose Escalation Period|Other|1|||
145934915|NCT00452673|526269301|FG003|Dose Escalation Period|Other|0|||
145934916|NCT00452673|526269302|FG004|Dose Escalation Period|Other|0|||
145934917|NCT00452673|526269298|FG000|Dose Escalation Period|Adverse Event|0|||
145934918|NCT00452673|526269299|FG001|Dose Escalation Period|Adverse Event|0|||
145934919|NCT00452673|526269300|FG002|Dose Escalation Period|Adverse Event|0|||
145934920|NCT00452673|526269301|FG003|Dose Escalation Period|Adverse Event|1|||
145934921|NCT00452673|526269302|FG004|Dose Escalation Period|Adverse Event|0|||
145934922|NCT00452673|526269298|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
145934923|NCT00452673|526269299|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
145934924|NCT00452673|526269300|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
145934925|NCT00452673|526269301|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
145934926|NCT00452673|526269302|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
145934927|NCT00452673|526269298|FG000|Dose Expansion Period|Disease Progression|0|||
145934928|NCT00452673|526269299|FG001|Dose Expansion Period|Disease Progression|0|||
145934929|NCT00452673|526269300|FG002|Dose Expansion Period|Disease Progression|0|||
145934930|NCT00452673|526269301|FG003|Dose Expansion Period|Disease Progression|0|||
145934931|NCT00452673|526269302|FG004|Dose Expansion Period|Disease Progression|19|||
145934932|NCT00452673|526269298|FG000|Dose Expansion Period|Other|0|||
145934933|NCT00452673|526269299|FG001|Dose Expansion Period|Other|0|||
145934934|NCT00452673|526269300|FG002|Dose Expansion Period|Other|0|||
145934935|NCT00452673|526269301|FG003|Dose Expansion Period|Other|0|||
145934936|NCT00452673|526269302|FG004|Dose Expansion Period|Other|2|||
145934937|NCT02461524|526269304|FG000|Overall Study|Death|16|||
145934938|NCT02461524|526269304|FG000|Overall Study|Withdrawal by Subject|4|||
145934939|NCT02461524|526269304|FG000|Overall Study|Device Explanted|5|||
145934940|NCT02461524|526269304|FG000|Overall Study|Missed Visit|6|||
145934941|NCT00843037|526269314|FG000|Overall Study|Lost to Follow-up|1|||
145934942|NCT04304235|526269317|FG000|Overall Study|incomplete triage data|0|||
145934943|NCT04304235|526269318|FG001|Overall Study|incomplete triage data|69|||
145934944|NCT04304235|526269319|FG002|Overall Study|incomplete triage data|0|||
145934945|NCT04304235|526269320|FG003|Overall Study|incomplete triage data|0|||
145934946|NCT04304235|526269321|FG004|Overall Study|incomplete triage data|289|||
145934947|NCT04304235|526269322|FG005|Overall Study|incomplete triage data|123|||
145934948|NCT04304235|526269323|FG006|Overall Study|incomplete triage data|65|||
145934949|NCT02048826|526269331|FG000|Overall Study|Withdrawal by Subject|1|||
145934950|NCT02048826|526269332|FG001|Overall Study|Withdrawal by Subject|0|||
145934951|NCT00712881|526269333|FG000|Overall Study|Adverse Event|3|||
145934952|NCT00712881|526269334|FG001|Overall Study|Adverse Event|3|||
145934953|NCT00712881|526269333|FG000|Overall Study|Withdrawal by Subject|1|||
145979047|NCT00544882|526434533|FG001|Cycle 3: Follow-up|Pregnancy|1|||
145979048|NCT00544882|526434534|FG002|Cycle 3: Follow-up|Pregnancy|0|||
145979049|NCT00308685|526434535|FG000|Overall Study|Lost to Follow-up|1|||
145979050|NCT00308685|526434536|FG001|Overall Study|Lost to Follow-up|0|||
145934954|NCT00712881|526269334|FG001|Overall Study|Withdrawal by Subject|1|||
145934955|NCT00712881|526269333|FG000|Overall Study|Disease Progression|2|||
145934956|NCT00712881|526269334|FG001|Overall Study|Disease Progression|1|||
145934957|NCT00712881|526269333|FG000|Overall Study|Lost to Follow-up|1|||
145934958|NCT00712881|526269334|FG001|Overall Study|Lost to Follow-up|1|||
145934959|NCT00712881|526269333|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
145934960|NCT00712881|526269334|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
145934961|NCT00712881|526269333|FG000|Overall Study|Protocol Violation|1|||
145934962|NCT00712881|526269334|FG001|Overall Study|Protocol Violation|1|||
145934963|NCT00712881|526269333|FG000|Overall Study|Randomized but not treated|1|||
145934964|NCT00712881|526269334|FG001|Overall Study|Randomized but not treated|0|||
145934965|NCT05113979|526269339|FG000|Overall Study|Death|2|||
145979051|NCT00308685|526434535|FG000|Overall Study|Need to administer prohibited medication|1|||
145979052|NCT00308685|526434536|FG001|Overall Study|Need to administer prohibited medication|2|||
145979053|NCT00308685|526434535|FG000|Overall Study|Other than specified|1|||
146245320|NCT00441168|527412195|FG000|Treatment Period|Death|3|||
145934966|NCT05113979|526269339|FG000|Overall Study|Lost to Follow-up|1|||
145934967|NCT00968981|526269340|FG000|Overall Study|Adverse Event|2|||
146245321|NCT00441168|527412196|FG001|Treatment Period|Death|0|||
145934968|NCT00968981|526269341|FG001|Overall Study|Adverse Event|0|||
145934969|NCT00968981|526269342|FG002|Overall Study|Adverse Event|0|||
145934970|NCT00968981|526269340|FG000|Overall Study|Disease Progression|14|||
145934971|NCT00968981|526269341|FG001|Overall Study|Disease Progression|16|||
145934972|NCT00968981|526269342|FG002|Overall Study|Disease Progression|13|||
145934973|NCT00968981|526269340|FG000|Overall Study|Lost to Follow-up|0|||
145934974|NCT00968981|526269341|FG001|Overall Study|Lost to Follow-up|0|||
145934975|NCT00968981|526269342|FG002|Overall Study|Lost to Follow-up|1|||
145934976|NCT00968981|526269340|FG000|Overall Study|Physician Decision|5|||
145934977|NCT00968981|526269341|FG001|Overall Study|Physician Decision|3|||
145934978|NCT00968981|526269342|FG002|Overall Study|Physician Decision|5|||
145934979|NCT00968981|526269340|FG000|Overall Study|Withdrawal by Subject|1|||
145934980|NCT00968981|526269341|FG001|Overall Study|Withdrawal by Subject|3|||
145934981|NCT00968981|526269342|FG002|Overall Study|Withdrawal by Subject|3|||
145934982|NCT04016779|526269348|FG000|Overall Study|Adverse Event|9|||
145934983|NCT04016779|526269349|FG001|Overall Study|Adverse Event|17|||
145934984|NCT04016779|526269348|FG000|Overall Study|Lack of Efficacy|4|||
145934985|NCT04016779|526269349|FG001|Overall Study|Lack of Efficacy|1|||
145934986|NCT04016779|526269348|FG000|Overall Study|Lost to Follow-up|5|||
145934987|NCT04016779|526269349|FG001|Overall Study|Lost to Follow-up|14|||
145934988|NCT04016779|526269348|FG000|Overall Study|Physician Decision|1|||
145934989|NCT04016779|526269349|FG001|Overall Study|Physician Decision|3|||
145934990|NCT04016779|526269348|FG000|Overall Study|Withdrawal by Subject|6|||
145934991|NCT04016779|526269349|FG001|Overall Study|Withdrawal by Subject|8|||
145934992|NCT04016779|526269348|FG000|Overall Study|Non-compliance with Study Drug|2|||
145934993|NCT04016779|526269349|FG001|Overall Study|Non-compliance with Study Drug|3|||
145934994|NCT04016779|526269348|FG000|Overall Study|Other, Multiple categories|17|||
145934995|NCT04016779|526269349|FG001|Overall Study|Other, Multiple categories|17|||
145934996|NCT00330343|526269350|FG000|Overall Study|Lost to Follow-up|5|||
145934997|NCT00281632|526269351|FG000|Overall Study|Adverse Event|7|||
145934998|NCT00281632|526269351|FG000|Overall Study|Withdrawal by Subject|2|||
145934999|NCT00281632|526269351|FG000|Overall Study|Disease Progression|22|||
145935000|NCT00281632|526269351|FG000|Overall Study|Death|1|||
145935001|NCT00281632|526269351|FG000|Overall Study|Physician Decision|1|||
145935002|NCT00281632|526269351|FG000|Overall Study|Ongoing|3|||
145935003|NCT06586788|526269352|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
145935004|NCT02691936|526269356|FG000|Overall Study|Withdrawal by Subject|2|||
145935005|NCT02691936|526269357|FG001|Overall Study|Withdrawal by Subject|5|||
145935006|NCT03696108|526269358|FG000|Overall Study|Physician Decision|1|||
145935007|NCT03696108|526269359|FG001|Overall Study|Physician Decision|0|||
145935008|NCT03696108|526269358|FG000|Overall Study|Withdrawal by Subject|3|||
145935009|NCT03696108|526269359|FG001|Overall Study|Withdrawal by Subject|6|||
145935010|NCT05239494|526269360|FG000|Overall Study|Lost to Follow-up|1|||
145935011|NCT01053962|526269361|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145935012|NCT01053962|526269362|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145935013|NCT01053962|526269363|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145935014|NCT01053962|526269364|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
145935015|NCT01053962|526269365|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
145935016|NCT01053962|526269361|FG000|Pretreatment Period|Venipuncture Failure|0|||
145935017|NCT01053962|526269362|FG001|Pretreatment Period|Venipuncture Failure|0|||
145935018|NCT01053962|526269363|FG002|Pretreatment Period|Venipuncture Failure|1|||
145935019|NCT01053962|526269364|FG003|Pretreatment Period|Venipuncture Failure|0|||
145935020|NCT01053962|526269365|FG004|Pretreatment Period|Venipuncture Failure|0|||
145935021|NCT01053962|526269361|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145935022|NCT01053962|526269362|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
145935023|NCT01053962|526269363|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145935024|NCT01053962|526269364|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145935025|NCT01053962|526269365|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145935026|NCT01053962|526269361|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145935027|NCT01053962|526269362|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
146245322|NCT00441168|527412195|FG000|Treatment Period|Adverse Event|1|||
146245323|NCT00441168|527412196|FG001|Treatment Period|Adverse Event|2|||
146245324|NCT00441168|527412195|FG000|Treatment Period|Progressive Disease|0|||
146245325|NCT00441168|527412196|FG001|Treatment Period|Progressive Disease|2|||
146245326|NCT00441168|527412195|FG000|Treatment Period|Protocol Violation|0|||
146245327|NCT00441168|527412196|FG001|Treatment Period|Protocol Violation|1|||
146245328|NCT00441168|527412195|FG000|Treatment Period|Lost to Follow-up|0|||
146245329|NCT00441168|527412196|FG001|Treatment Period|Lost to Follow-up|1|||
146245330|NCT00441168|527412195|FG000|Treatment Period|Withdrawal by Subject|3|||
146245331|NCT00441168|527412196|FG001|Treatment Period|Withdrawal by Subject|0|||
146245332|NCT00441168|527412195|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
146245333|NCT00441168|527412196|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
146245334|NCT00441168|527412195|FG000|Treatment Period|refractory disease|1|||
146245335|NCT00441168|527412196|FG001|Treatment Period|refractory disease|0|||
146245336|NCT00441168|527412195|FG000|Follow-up Period|Death|3|||
146297797|NCT04029480|527606009|FG003|Overall Study|Physician Decision|1|||
146245337|NCT00441168|527412196|FG001|Follow-up Period|Death|0|||
145935028|NCT01053962|526269363|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145935029|NCT01053962|526269364|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
145935030|NCT01053962|526269365|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145935031|NCT01053962|526269361|FG000|Treatment Period|Lack of Efficacy|0|||
145935032|NCT01053962|526269362|FG001|Treatment Period|Lack of Efficacy|0|||
145935033|NCT01053962|526269363|FG002|Treatment Period|Lack of Efficacy|0|||
145935034|NCT01053962|526269364|FG003|Treatment Period|Lack of Efficacy|0|||
145935035|NCT01053962|526269365|FG004|Treatment Period|Lack of Efficacy|1|||
145935036|NCT01053962|526269361|FG000|Treatment Period|Adverse Event|0|||
145935037|NCT01053962|526269362|FG001|Treatment Period|Adverse Event|0|||
145935038|NCT01053962|526269363|FG002|Treatment Period|Adverse Event|0|||
145935039|NCT01053962|526269364|FG003|Treatment Period|Adverse Event|0|||
145935040|NCT01053962|526269365|FG004|Treatment Period|Adverse Event|1|||
145935041|NCT01053962|526269361|FG000|Treatment Period|Withdrawal by Subject|0|||
145935042|NCT01053962|526269362|FG001|Treatment Period|Withdrawal by Subject|0|||
145935043|NCT01053962|526269363|FG002|Treatment Period|Withdrawal by Subject|0|||
145935044|NCT01053962|526269364|FG003|Treatment Period|Withdrawal by Subject|0|||
145935045|NCT01053962|526269365|FG004|Treatment Period|Withdrawal by Subject|1|||
145935046|NCT01053962|526269361|FG000|Treatment Period|Noncompliance with protocol|1|||
145935047|NCT01053962|526269362|FG001|Treatment Period|Noncompliance with protocol|0|||
145935048|NCT01053962|526269363|FG002|Treatment Period|Noncompliance with protocol|0|||
145935049|NCT01053962|526269364|FG003|Treatment Period|Noncompliance with protocol|0|||
145935050|NCT01053962|526269365|FG004|Treatment Period|Noncompliance with protocol|0|||
145935051|NCT02892422|526269368|FG000|Overall Study|Enrolled not treated|4|||
145935052|NCT02892422|526269368|FG000|Overall Study|Adverse Event|38|||
145935053|NCT02892422|526269368|FG000|Overall Study|Lack of Efficacy|32|||
145935054|NCT02892422|526269368|FG000|Overall Study|Non-compliance with study drug|11|||
145935055|NCT02892422|526269368|FG000|Overall Study|Protocol Violation|4|||
145935056|NCT02892422|526269368|FG000|Overall Study|Withdrawal by Subject|56|||
145935057|NCT02892422|526269368|FG000|Overall Study|Lost to Follow-up|5|||
145935058|NCT02892422|526269368|FG000|Overall Study|sponsor information 16159A results|21|||
145935059|NCT02892422|526269368|FG000|Overall Study|withdrawal of consent|13|||
145935060|NCT02892422|526269368|FG000|Overall Study|exclusion criteria met|3|||
145935061|NCT02892422|526269368|FG000|Overall Study|moving elsewhere|4|||
145935062|NCT02892422|526269368|FG000|Overall Study|non-compliance|10|||
145935063|NCT02892422|526269368|FG000|Overall Study|patient legally incapable|1|||
145935064|NCT02892422|526269368|FG000|Overall Study|patient decision|7|||
145935065|NCT02892422|526269368|FG000|Overall Study|Investigator decision|1|||
145935066|NCT03089697|526269369|FG000|Overall Study|Adverse Event|1|||
145935067|NCT03089697|526269370|FG001|Overall Study|Adverse Event|2|||
145935068|NCT03089697|526269369|FG000|Overall Study|Withdrawal by Subject|1|||
145935069|NCT03089697|526269370|FG001|Overall Study|Withdrawal by Subject|0|||
145935070|NCT02693171|526269382|FG000|Overall Study|Adverse Event|1|||
145935071|NCT02693171|526269382|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
145935072|NCT00595517|526269383|FG000|Overall Study|Adverse Event|6|||
145935073|NCT00595517|526269383|FG000|Overall Study|Withdrawal by Subject|4|||
145935074|NCT00595517|526269383|FG000|Overall Study|Protocol Violation|2|||
145935075|NCT00595517|526269383|FG000|Overall Study|Recurrence of ulcer|5|||
145935076|NCT00595517|526269383|FG000|Overall Study|usage of prohibited treatment|1|||
145935077|NCT00595517|526269383|FG000|Overall Study|No intention to attend regularly|1|||
145935078|NCT01167881|526269384|FG000|Overall Study|Adverse Event|47|||
145935079|NCT01167881|526269385|FG001|Overall Study|Adverse Event|51|||
145935080|NCT01167881|526269384|FG000|Overall Study|Lack of Efficacy|4|||
145935081|NCT01167881|526269385|FG001|Overall Study|Lack of Efficacy|7|||
145979054|NCT00308685|526434536|FG001|Overall Study|Other than specified|3|||
145979055|NCT03770455|526434537|FG000|Overall Study|Screen failures|3|||
145979056|NCT04937387|526434538|FG000|Overall Study|Adverse Event|1|||
145979057|NCT04937387|526434539|FG001|Overall Study|Adverse Event|0|||
145979058|NCT04937387|526434540|FG002|Overall Study|Adverse Event|2|||
145935082|NCT01167881|526269384|FG000|Overall Study|Non compliant with protocol|9|||
145935083|NCT01167881|526269385|FG001|Overall Study|Non compliant with protocol|18|||
145935084|NCT01167881|526269384|FG000|Overall Study|Lost to Follow-up|19|||
145935085|NCT01167881|526269385|FG001|Overall Study|Lost to Follow-up|20|||
145935086|NCT01167881|526269384|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
146245338|NCT00441168|527412195|FG000|Follow-up Period|Lost to Follow-up|5|||
146245339|NCT00441168|527412196|FG001|Follow-up Period|Lost to Follow-up|6|||
145935087|NCT01167881|526269385|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
145979059|NCT04937387|526434541|FG003|Overall Study|Adverse Event|0|||
145979060|NCT04937387|526434538|FG000|Overall Study|Lack of Efficacy|1|||
145979061|NCT04937387|526434539|FG001|Overall Study|Lack of Efficacy|0|||
145979062|NCT04937387|526434540|FG002|Overall Study|Lack of Efficacy|0|||
145979063|NCT04937387|526434541|FG003|Overall Study|Lack of Efficacy|1|||
145935088|NCT01167881|526269384|FG000|Overall Study|Not treated|4|||
145935089|NCT01167881|526269385|FG001|Overall Study|Not treated|0|||
145935090|NCT01167881|526269384|FG000|Overall Study|Other not defined above|31|||
145935091|NCT01167881|526269385|FG001|Overall Study|Other not defined above|55|||
145979064|NCT04937387|526434538|FG000|Overall Study|Withdrawal by Subject|1|||
145935092|NCT01992653|526269386|FG000|Overall Study|Death|0|||
145935093|NCT01992653|526269387|FG001|Overall Study|Death|0|||
145935094|NCT01992653|526269388|FG002|Overall Study|Death|1|||
145935095|NCT01992653|526269389|FG003|Overall Study|Death|0|||
145935096|NCT01992653|526269390|FG004|Overall Study|Death|1|||
145935097|NCT01992653|526269391|FG005|Overall Study|Death|0|||
145935098|NCT01992653|526269392|FG006|Overall Study|Death|4|||
145935099|NCT01992653|526269393|FG007|Overall Study|Death|2|||
145935100|NCT01992653|526269386|FG000|Overall Study|Lost to Follow-up|0|||
145935101|NCT01992653|526269387|FG001|Overall Study|Lost to Follow-up|0|||
145935102|NCT01992653|526269388|FG002|Overall Study|Lost to Follow-up|0|||
145935103|NCT01992653|526269389|FG003|Overall Study|Lost to Follow-up|0|||
145935104|NCT01992653|526269390|FG004|Overall Study|Lost to Follow-up|0|||
145935105|NCT01992653|526269391|FG005|Overall Study|Lost to Follow-up|0|||
145935106|NCT01992653|526269392|FG006|Overall Study|Lost to Follow-up|0|||
145935107|NCT01992653|526269393|FG007|Overall Study|Lost to Follow-up|1|||
145935108|NCT01992653|526269386|FG000|Overall Study|Study Completed|0|||
145935109|NCT01992653|526269387|FG001|Overall Study|Study Completed|0|||
145935110|NCT01992653|526269388|FG002|Overall Study|Study Completed|0|||
145935111|NCT01992653|526269389|FG003|Overall Study|Study Completed|0|||
145935112|NCT01992653|526269390|FG004|Overall Study|Study Completed|0|||
145935113|NCT01992653|526269391|FG005|Overall Study|Study Completed|0|||
145935114|NCT01992653|526269392|FG006|Overall Study|Study Completed|0|||
145935115|NCT01992653|526269393|FG007|Overall Study|Study Completed|1|||
145935116|NCT01992653|526269386|FG000|Overall Study|Disease Progression|0|||
145935117|NCT01992653|526269387|FG001|Overall Study|Disease Progression|0|||
145935118|NCT01992653|526269388|FG002|Overall Study|Disease Progression|0|||
145935119|NCT01992653|526269389|FG003|Overall Study|Disease Progression|0|||
145935120|NCT01992653|526269390|FG004|Overall Study|Disease Progression|0|||
145935121|NCT01992653|526269391|FG005|Overall Study|Disease Progression|0|||
145935122|NCT01992653|526269392|FG006|Overall Study|Disease Progression|4|||
145935123|NCT01992653|526269393|FG007|Overall Study|Disease Progression|0|||
145935124|NCT03887442|526269401|FG000|Overall Study|Adverse Event|1|||
145935125|NCT03887442|526269402|FG001|Overall Study|Adverse Event|0|||
145935126|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
145935127|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
145935128|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
145935129|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
145935130|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145935131|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145935132|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
145935133|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145935134|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
145935135|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145935136|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145935137|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145935138|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
145935139|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
145935140|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
145935141|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
145935142|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145935143|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
145935144|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145935145|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145935146|NCT00556933|526269403|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145935147|NCT00556933|526269404|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
145935148|NCT00556933|526269405|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145935149|NCT00556933|526269406|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145935150|NCT00556933|526269403|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
145935151|NCT00556933|526269404|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
145935152|NCT00556933|526269405|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
145935153|NCT00556933|526269406|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
145935154|NCT00556933|526269403|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
145935155|NCT00556933|526269404|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
145935156|NCT00556933|526269405|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
145935157|NCT00556933|526269406|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
145935158|NCT00556933|526269403|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
145979065|NCT04937387|526434539|FG001|Overall Study|Withdrawal by Subject|0|||
145935159|NCT00556933|526269404|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
145935160|NCT00556933|526269405|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
145935161|NCT00556933|526269406|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
145979066|NCT04937387|526434540|FG002|Overall Study|Withdrawal by Subject|1|||
146091118|NCT01390220|526854880|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
145935162|NCT00556933|526269403|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
145935163|NCT00556933|526269404|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
146091119|NCT01390220|526854878|FG000|Test Dose Phase|Study/Site closure|6|||
145935164|NCT00556933|526269405|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
145935165|NCT00556933|526269406|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
145935166|NCT00556933|526269403|FG000|CNI Withdrawal vs. Minimization|Death|0|||
145935167|NCT00556933|526269404|FG001|CNI Withdrawal vs. Minimization|Death|0|||
145935168|NCT00556933|526269405|FG002|CNI Withdrawal vs. Minimization|Death|0|||
145935169|NCT00556933|526269406|FG003|CNI Withdrawal vs. Minimization|Death|1|||
145935170|NCT01628198|526269409|FG000|Overall Study|Lost to Follow-up|7|||
145935171|NCT01628198|526269409|FG000|Overall Study|Withdrawal by Subject|10|||
145935172|NCT01628198|526269409|FG000|Overall Study|Screen failure|1|||
145935173|NCT00022698|526269411|FG000|Overall Study|Adverse Event|5|||
145935174|NCT00022698|526269412|FG001|Overall Study|Adverse Event|9|||
145935175|NCT00022698|526269411|FG000|Overall Study|Death|0|||
145935176|NCT00022698|526269412|FG001|Overall Study|Death|2|||
145935177|NCT00022698|526269411|FG000|Overall Study|Failure to return|0|||
145935178|NCT00022698|526269412|FG001|Overall Study|Failure to return|1|||
145935179|NCT00022698|526269411|FG000|Overall Study|Refused treatment|0|||
145935180|NCT00022698|526269412|FG001|Overall Study|Refused treatment|2|||
145935181|NCT00022698|526269411|FG000|Overall Study|Insufficient therapeutic response|2|||
145935182|NCT00022698|526269412|FG001|Overall Study|Insufficient therapeutic response|14|||
145935183|NCT00022698|526269411|FG000|Overall Study|Administrative /other|1|||
145935184|NCT00022698|526269412|FG001|Overall Study|Administrative /other|7|||
145935185|NCT02504827|526269413|FG000|Overall Study|Could not produce sputum|1|||
145935186|NCT01743560|526269414|FG000|Overall Study|Disease progression|26|||
145935187|NCT01743560|526269414|FG000|Overall Study|Adverse Event|8|||
145935188|NCT01743560|526269414|FG000|Overall Study|Death|3|||
145935189|NCT01743560|526269414|FG000|Overall Study|Withdrawal by Subject|2|||
145935190|NCT01743560|526269414|FG000|Overall Study|Protocol Violation|1|||
145935191|NCT01743560|526269414|FG000|Overall Study|>1 dose of study drug|3|||
145935192|NCT03386994|526269415|FG000|Overall Study|Lung transplant|1|||
145935193|NCT03386994|526269415|FG000|Overall Study|Adverse Event|14|||
145935194|NCT03386994|526269415|FG000|Overall Study|Lost to Follow-up|4|||
145935195|NCT03386994|526269415|FG000|Overall Study|Withdrawal by Subject|3|||
145935196|NCT03386994|526269415|FG000|Overall Study|Death|16|||
145935197|NCT03854370|526271034|FG000|Overall Study|samples not collected|1|||
145935198|NCT03854370|526271035|FG001|Overall Study|samples not collected|1|||
145935199|NCT03854370|526271036|FG002|Overall Study|samples not collected|1|||
145935200|NCT03854370|526271037|FG003|Overall Study|samples not collected|1|||
145935201|NCT01300338|526271046|FG000|Overall Study|Lost to Follow-up|5|||
145935202|NCT01300338|526271047|FG001|Overall Study|Lost to Follow-up|0|||
145935203|NCT00381238|526271052|FG000|Overall Study|Adverse Event|3|||
145935204|NCT00381238|526271052|FG000|Overall Study|Protocol Violation|1|||
145935205|NCT00381238|526271052|FG000|Overall Study|Withdrawal by Subject|4|||
145979067|NCT04937387|526434541|FG003|Overall Study|Withdrawal by Subject|1|||
145979068|NCT04937387|526434538|FG000|Overall Study|Randomized in error|0|||
145979069|NCT04937387|526434539|FG001|Overall Study|Randomized in error|0|||
145979070|NCT04937387|526434540|FG002|Overall Study|Randomized in error|0|||
145979071|NCT04937387|526434541|FG003|Overall Study|Randomized in error|1|||
145979072|NCT02583269|526434542|FG000|Overall Study|Patient hospitalized prior to start|1|||
145979073|NCT02583269|526434543|FG001|Overall Study|Patient hospitalized prior to start|0|||
145979074|NCT02583269|526434544|FG002|Overall Study|Patient hospitalized prior to start|0|||
145979075|NCT02583269|526434545|FG003|Overall Study|Patient hospitalized prior to start|0|||
145979076|NCT02583269|526434546|FG004|Overall Study|Patient hospitalized prior to start|0|||
145979077|NCT01039675|526434549|FG000|Overall Study|Adverse Event|0|||
146091120|NCT01390220|526854879|FG001|Test Dose Phase|Study/Site closure|0|||
146091121|NCT01390220|526854880|FG002|Test Dose Phase|Study/Site closure|0|||
146091122|NCT01390220|526854878|FG000|Test Dose Phase|Caregiver no longer available|5|||
145935206|NCT00381238|526271052|FG000|Overall Study|Lack of Efficacy|2|||
146091123|NCT01390220|526854879|FG001|Test Dose Phase|Caregiver no longer available|0|||
146091124|NCT01390220|526854880|FG002|Test Dose Phase|Caregiver no longer available|0|||
146245340|NCT00441168|527412195|FG000|Follow-up Period|Withdrawal by Subject|3|||
145935207|NCT00381238|526271052|FG000|Overall Study|Withdrew by physician|1|||
145935208|NCT00381238|526271052|FG000|Overall Study|Disease progression|1|||
145935209|NCT00401544|526271056|FG000|Overall Study|Adverse Event|5|||
145979078|NCT01039675|526434550|FG001|Overall Study|Adverse Event|2|||
145979079|NCT01039675|526434549|FG000|Overall Study|Lack of Efficacy|0|||
145979080|NCT01039675|526434550|FG001|Overall Study|Lack of Efficacy|2|||
145979081|NCT01039675|526434549|FG000|Overall Study|Withdrawal by Subject|0|||
145979082|NCT01039675|526434550|FG001|Overall Study|Withdrawal by Subject|1|||
145935210|NCT00401544|526271057|FG001|Overall Study|Adverse Event|1|||
145935211|NCT00401544|526271058|FG002|Overall Study|Adverse Event|1|||
145935212|NCT00401544|526271059|FG003|Overall Study|Adverse Event|1|||
145935213|NCT00401544|526271056|FG000|Overall Study|Death|3|||
145935214|NCT00401544|526271057|FG001|Overall Study|Death|6|||
146091125|NCT01390220|526854878|FG000|Test Dose Phase|Noncompliance|2|||
146091126|NCT01390220|526854879|FG001|Test Dose Phase|Noncompliance|0|||
146091127|NCT01390220|526854880|FG002|Test Dose Phase|Noncompliance|0|||
146091128|NCT01390220|526854878|FG000|Test Dose Phase|Logistical|6|||
146091129|NCT01390220|526854879|FG001|Test Dose Phase|Logistical|0|||
145935215|NCT00401544|526271058|FG002|Overall Study|Death|2|||
145935216|NCT00401544|526271059|FG003|Overall Study|Death|5|||
145935217|NCT00401544|526271056|FG000|Overall Study|Lost to Follow-up|2|||
145935218|NCT00401544|526271057|FG001|Overall Study|Lost to Follow-up|0|||
145935219|NCT00401544|526271058|FG002|Overall Study|Lost to Follow-up|1|||
145935220|NCT00401544|526271059|FG003|Overall Study|Lost to Follow-up|1|||
145935221|NCT00401544|526271056|FG000|Overall Study|Withdrawal by Subject|7|||
145935222|NCT00401544|526271057|FG001|Overall Study|Withdrawal by Subject|6|||
145935223|NCT00401544|526271058|FG002|Overall Study|Withdrawal by Subject|6|||
145935224|NCT00401544|526271059|FG003|Overall Study|Withdrawal by Subject|5|||
145935225|NCT00401544|526271056|FG000|Overall Study|Physician Decision|1|||
145935226|NCT00401544|526271057|FG001|Overall Study|Physician Decision|3|||
145935227|NCT00401544|526271058|FG002|Overall Study|Physician Decision|0|||
145935228|NCT00401544|526271059|FG003|Overall Study|Physician Decision|0|||
145935229|NCT00401544|526271056|FG000|Overall Study|Ineligibility determined|0|||
145935230|NCT00401544|526271057|FG001|Overall Study|Ineligibility determined|1|||
145935231|NCT00401544|526271058|FG002|Overall Study|Ineligibility determined|0|||
145935232|NCT00401544|526271059|FG003|Overall Study|Ineligibility determined|2|||
145935233|NCT00401544|526271056|FG000|Overall Study|Disease progression|0|||
145935234|NCT00401544|526271057|FG001|Overall Study|Disease progression|1|||
145935235|NCT00401544|526271058|FG002|Overall Study|Disease progression|0|||
145935236|NCT00401544|526271059|FG003|Overall Study|Disease progression|0|||
145935237|NCT00401544|526271056|FG000|Overall Study|Other|0|||
145935238|NCT00401544|526271057|FG001|Overall Study|Other|0|||
145935239|NCT00401544|526271058|FG002|Overall Study|Other|2|||
145935240|NCT00401544|526271059|FG003|Overall Study|Other|2|||
145935241|NCT02222545|526271061|FG000|Overall Study|Adverse Event|1|||
145935242|NCT02222545|526271062|FG001|Overall Study|Adverse Event|0|||
145935243|NCT02222545|526271063|FG002|Overall Study|Adverse Event|2|||
145935244|NCT02222545|526271061|FG000|Overall Study|Death|0|||
145935245|NCT02222545|526271062|FG001|Overall Study|Death|0|||
145935246|NCT02222545|526271063|FG002|Overall Study|Death|9|||
145935247|NCT02222545|526271061|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
145935248|NCT02222545|526271062|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
145935249|NCT02222545|526271063|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
145935250|NCT02222545|526271061|FG000|Overall Study|Withdrawal by Subject|0|||
145935251|NCT02222545|526271062|FG001|Overall Study|Withdrawal by Subject|0|||
145935252|NCT02222545|526271063|FG002|Overall Study|Withdrawal by Subject|3|||
145935253|NCT02222545|526271061|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
145935254|NCT02222545|526271062|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
145935255|NCT02222545|526271063|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
145935256|NCT02651155|526271065|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145935257|NCT02651155|526271066|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
145935258|NCT02651155|526271065|FG000|Overall Study|Voluntary Withdrawal|5|||
145935259|NCT02651155|526271066|FG001|Overall Study|Voluntary Withdrawal|0|||
145935260|NCT00537316|526271067|FG000|Part 1|Adverse Event|7|||
145935261|NCT00537316|526271068|FG001|Part 1|Adverse Event|11|||
145935262|NCT00537316|526271069|FG002|Part 1|Adverse Event|8|||
145935263|NCT00537316|526271070|FG003|Part 1|Adverse Event|0|||
145935264|NCT00537316|526271071|FG004|Part 1|Adverse Event|0|||
145935265|NCT00537316|526271072|FG005|Part 1|Adverse Event|0|||
145935266|NCT00537316|526271073|FG006|Part 1|Adverse Event|0|||
145935267|NCT00537316|526271067|FG000|Part 1|Protocol defined clinical event|1|||
145935268|NCT00537316|526271068|FG001|Part 1|Protocol defined clinical event|0|||
145935269|NCT00537316|526271069|FG002|Part 1|Protocol defined clinical event|0|||
145935270|NCT00537316|526271070|FG003|Part 1|Protocol defined clinical event|0|||
145935271|NCT00537316|526271071|FG004|Part 1|Protocol defined clinical event|0|||
145935272|NCT00537316|526271072|FG005|Part 1|Protocol defined clinical event|0|||
145935273|NCT00537316|526271073|FG006|Part 1|Protocol defined clinical event|0|||
145935274|NCT00537316|526271067|FG000|Part 1|Lost to Follow-up|1|||
145935275|NCT00537316|526271068|FG001|Part 1|Lost to Follow-up|0|||
145935276|NCT00537316|526271069|FG002|Part 1|Lost to Follow-up|0|||
145935277|NCT00537316|526271070|FG003|Part 1|Lost to Follow-up|0|||
145935278|NCT00537316|526271071|FG004|Part 1|Lost to Follow-up|0|||
145935279|NCT00537316|526271072|FG005|Part 1|Lost to Follow-up|0|||
145935280|NCT00537316|526271073|FG006|Part 1|Lost to Follow-up|0|||
145935281|NCT00537316|526271067|FG000|Part 1|Withdrawal by Subject|3|||
145935282|NCT00537316|526271068|FG001|Part 1|Withdrawal by Subject|8|||
145935283|NCT00537316|526271069|FG002|Part 1|Withdrawal by Subject|4|||
145935284|NCT00537316|526271070|FG003|Part 1|Withdrawal by Subject|0|||
145935285|NCT00537316|526271071|FG004|Part 1|Withdrawal by Subject|0|||
145935286|NCT00537316|526271072|FG005|Part 1|Withdrawal by Subject|0|||
145935287|NCT00537316|526271073|FG006|Part 1|Withdrawal by Subject|0|||
146091130|NCT01390220|526854880|FG002|Test Dose Phase|Logistical|0|||
145935288|NCT00537316|526271067|FG000|Part 1|Protocol Violation|1|||
145935289|NCT00537316|526271068|FG001|Part 1|Protocol Violation|5|||
145935290|NCT00537316|526271069|FG002|Part 1|Protocol Violation|1|||
145935291|NCT00537316|526271070|FG003|Part 1|Protocol Violation|0|||
145935292|NCT00537316|526271071|FG004|Part 1|Protocol Violation|0|||
145935293|NCT00537316|526271072|FG005|Part 1|Protocol Violation|0|||
145935294|NCT00537316|526271073|FG006|Part 1|Protocol Violation|0|||
145935295|NCT00537316|526271067|FG000|Part 1|Did not meet protocol eligibility|1|||
145935296|NCT00537316|526271068|FG001|Part 1|Did not meet protocol eligibility|3|||
145935297|NCT00537316|526271069|FG002|Part 1|Did not meet protocol eligibility|2|||
145935298|NCT00537316|526271070|FG003|Part 1|Did not meet protocol eligibility|0|||
145935299|NCT00537316|526271071|FG004|Part 1|Did not meet protocol eligibility|0|||
145935300|NCT00537316|526271072|FG005|Part 1|Did not meet protocol eligibility|0|||
145935301|NCT00537316|526271073|FG006|Part 1|Did not meet protocol eligibility|0|||
145935302|NCT00537316|526271067|FG000|Part 1|Administrative|0|||
145935303|NCT00537316|526271068|FG001|Part 1|Administrative|0|||
145935304|NCT00537316|526271069|FG002|Part 1|Administrative|2|||
145935305|NCT00537316|526271070|FG003|Part 1|Administrative|0|||
145935306|NCT00537316|526271071|FG004|Part 1|Administrative|0|||
145935307|NCT00537316|526271072|FG005|Part 1|Administrative|0|||
145935308|NCT00537316|526271073|FG006|Part 1|Administrative|0|||
145935309|NCT00537316|526271067|FG000|Part 2|Never entered follow-up|0|||
145935310|NCT00537316|526271068|FG001|Part 2|Never entered follow-up|0|||
145935311|NCT00537316|526271069|FG002|Part 2|Never entered follow-up|0|||
145935312|NCT00537316|526271070|FG003|Part 2|Never entered follow-up|0|||
145935313|NCT00537316|526271071|FG004|Part 2|Never entered follow-up|0|||
145935314|NCT00537316|526271072|FG005|Part 2|Never entered follow-up|0|||
145935315|NCT00537316|526271073|FG006|Part 2|Never entered follow-up|1|||
145935316|NCT00537316|526271067|FG000|Part 2|Adverse Event|4|||
145935317|NCT00537316|526271068|FG001|Part 2|Adverse Event|0|||
145935318|NCT00537316|526271069|FG002|Part 2|Adverse Event|2|||
145935319|NCT00537316|526271070|FG003|Part 2|Adverse Event|0|||
145935320|NCT00537316|526271071|FG004|Part 2|Adverse Event|0|||
145935321|NCT00537316|526271072|FG005|Part 2|Adverse Event|0|||
145935322|NCT00537316|526271073|FG006|Part 2|Adverse Event|0|||
145935323|NCT00537316|526271067|FG000|Part 2|Lost to Follow-up|1|||
145935324|NCT00537316|526271068|FG001|Part 2|Lost to Follow-up|0|||
145935325|NCT00537316|526271069|FG002|Part 2|Lost to Follow-up|2|||
145935326|NCT00537316|526271070|FG003|Part 2|Lost to Follow-up|0|||
145935327|NCT00537316|526271071|FG004|Part 2|Lost to Follow-up|0|||
145935328|NCT00537316|526271072|FG005|Part 2|Lost to Follow-up|0|||
145935329|NCT00537316|526271073|FG006|Part 2|Lost to Follow-up|0|||
145935330|NCT00537316|526271067|FG000|Part 2|Withdrawal by Subject|5|||
145935331|NCT00537316|526271068|FG001|Part 2|Withdrawal by Subject|1|||
145935332|NCT00537316|526271069|FG002|Part 2|Withdrawal by Subject|4|||
145935333|NCT00537316|526271070|FG003|Part 2|Withdrawal by Subject|0|||
145935334|NCT00537316|526271071|FG004|Part 2|Withdrawal by Subject|0|||
145935335|NCT00537316|526271072|FG005|Part 2|Withdrawal by Subject|0|||
145935336|NCT00537316|526271073|FG006|Part 2|Withdrawal by Subject|0|||
145979083|NCT01039675|526434549|FG000|Overall Study|Lost to Follow-up|0|||
145979084|NCT01039675|526434550|FG001|Overall Study|Lost to Follow-up|1|||
145979085|NCT01039675|526434549|FG000|Overall Study|Physician Decision|0|||
145979086|NCT01039675|526434550|FG001|Overall Study|Physician Decision|1|||
145979087|NCT02207608|526434554|FG000|Overall Study|Adverse Event|1|||
145979088|NCT02207608|526434555|FG001|Overall Study|Adverse Event|0|||
145979089|NCT03921541|526435931|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
145979090|NCT03921541|526435932|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
145935337|NCT00537316|526271067|FG000|Part 2|Administrative|16|||
145935338|NCT00537316|526271068|FG001|Part 2|Administrative|8|||
145935339|NCT00537316|526271069|FG002|Part 2|Administrative|24|||
145935340|NCT00537316|526271070|FG003|Part 2|Administrative|3|||
145979091|NCT05399485|526435933|FG000|DBT Phase|Other|6|||
145979092|NCT05399485|526435934|FG001|DBT Phase|Other|5|||
145935341|NCT00537316|526271071|FG004|Part 2|Administrative|1|||
145935342|NCT00537316|526271072|FG005|Part 2|Administrative|4|||
145935343|NCT00537316|526271073|FG006|Part 2|Administrative|1|||
145935344|NCT04533412|526271074|FG000|Overall Study|Withdrawal by Subject|1|||
145935345|NCT04533412|526271075|FG001|Overall Study|Withdrawal by Subject|1|||
145935346|NCT04533412|526271074|FG000|Overall Study|Lost to Follow-up|1|||
145935347|NCT04533412|526271075|FG001|Overall Study|Lost to Follow-up|4|||
145935348|NCT03452488|526271079|FG000|Overall Study|Adverse Event|4|||
145935349|NCT03452488|526271080|FG001|Overall Study|Adverse Event|6|||
145935350|NCT03452488|526271081|FG002|Overall Study|Adverse Event|1|||
145935351|NCT03452488|526271079|FG000|Overall Study|Death|0|||
145935352|NCT03452488|526271080|FG001|Overall Study|Death|0|||
145979093|NCT05399485|526435933|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
145979094|NCT05399485|526435934|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
145935353|NCT03452488|526271081|FG002|Overall Study|Death|1|||
145935354|NCT03452488|526271079|FG000|Overall Study|Lost to Follow-up|1|||
145935355|NCT03452488|526271080|FG001|Overall Study|Lost to Follow-up|2|||
145935356|NCT03452488|526271081|FG002|Overall Study|Lost to Follow-up|0|||
145935357|NCT03452488|526271079|FG000|Overall Study|PI Decision|1|||
145979095|NCT05399485|526435933|FG000|DBT Phase|Withdrawal by Subject|3|||
145935358|NCT03452488|526271080|FG001|Overall Study|PI Decision|0|||
145935359|NCT03452488|526271081|FG002|Overall Study|PI Decision|0|||
145935360|NCT03452488|526271079|FG000|Overall Study|Withdrew consent|4|||
145935361|NCT03452488|526271080|FG001|Overall Study|Withdrew consent|2|||
145935362|NCT03452488|526271081|FG002|Overall Study|Withdrew consent|2|||
145935363|NCT03452488|526271079|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
145935364|NCT03452488|526271080|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
145979096|NCT05399485|526435934|FG001|DBT Phase|Withdrawal by Subject|2|||
145979097|NCT05399485|526435933|FG000|DBT Phase|Protocol Violation|2|||
145979098|NCT05399485|526435934|FG001|DBT Phase|Protocol Violation|1|||
145979099|NCT05399485|526435933|FG000|DBT Phase|Physician Decision|0|||
145979100|NCT05399485|526435934|FG001|DBT Phase|Physician Decision|1|||
145979101|NCT05399485|526435933|FG000|DBT Phase|Adverse Event|2|||
145979102|NCT05399485|526435934|FG001|DBT Phase|Adverse Event|1|||
145979103|NCT05399485|526435933|FG000|OLE Phase|Protocol deviation|1|||
145979104|NCT05399485|526435934|FG001|OLE Phase|Protocol deviation|0|||
145979105|NCT05399485|526435933|FG000|OLE Phase|Other|5|||
145979106|NCT05399485|526435934|FG001|OLE Phase|Other|5|||
145935365|NCT03452488|526271081|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
145935366|NCT03452488|526271079|FG000|Overall Study|Other|0|||
145935367|NCT03452488|526271080|FG001|Overall Study|Other|2|||
145979107|NCT05399485|526435933|FG000|OLE Phase|Withdrawal by Subject|12|||
145979108|NCT05399485|526435934|FG001|OLE Phase|Withdrawal by Subject|7|||
145979109|NCT05399485|526435933|FG000|OLE Phase|Pregnancy|0|||
145979110|NCT05399485|526435934|FG001|OLE Phase|Pregnancy|2|||
145979111|NCT05399485|526435933|FG000|OLE Phase|Physician Decision|3|||
145979112|NCT05399485|526435934|FG001|OLE Phase|Physician Decision|0|||
145979113|NCT05399485|526435933|FG000|OLE Phase|Adverse Event|2|||
145979114|NCT05399485|526435934|FG001|OLE Phase|Adverse Event|2|||
145979115|NCT04706403|526435937|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
145979116|NCT04706403|526435938|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
145979117|NCT04706403|526435939|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
145979118|NCT04706403|526435940|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
145979119|NCT04706403|526435941|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
145979120|NCT00182637|526435942|FG000|Overall Study|Adverse Event|2|||
145979121|NCT00182637|526435942|FG000|Overall Study|Disease Progression|1|||
145979122|NCT02642679|526435943|FG000|Overall Study|Withdrawal by Subject|1|||
145979123|NCT02642679|526435943|FG000|Overall Study|Physician Decision|1|||
145979124|NCT02642679|526435943|FG000|Overall Study|Physician Decision|1|||
145979125|NCT04941898|526435944|FG000|Overall Study|Protocol Violation|1|||
145979126|NCT01653262|526435945|FG000|Overall Study|Lack of Efficacy|1|||
145979127|NCT01653262|526435945|FG000|Overall Study|SAE, non-fatal|1|||
145979128|NCT01653262|526435945|FG000|Overall Study|AE, non-serious non-fatal|1|||
145979129|NCT00420407|526435947|FG000|Overall Study|Lost to Follow-up|0|||
145979130|NCT00420407|526435948|FG001|Overall Study|Lost to Follow-up|3|||
145979131|NCT00420407|526435947|FG000|Overall Study|Physician Decision|2|||
145979132|NCT00420407|526435948|FG001|Overall Study|Physician Decision|1|||
145979133|NCT00420407|526435947|FG000|Overall Study|subject identified as detainee|1|||
145979134|NCT00420407|526435948|FG001|Overall Study|subject identified as detainee|0|||
145979135|NCT00420407|526435947|FG000|Overall Study|subject identified as Jehovah's witness|1|||
145979136|NCT00420407|526435948|FG001|Overall Study|subject identified as Jehovah's witness|0|||
145979137|NCT00420407|526435947|FG000|Overall Study|Withdrawal by Subject|0|||
145935368|NCT03452488|526271081|FG002|Overall Study|Other|2|||
145979138|NCT00420407|526435948|FG001|Overall Study|Withdrawal by Subject|2|||
145979139|NCT04633447|526435951|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
145979140|NCT04633447|526435952|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
145979141|NCT04633447|526435951|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
145979142|NCT04633447|526435952|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
145979143|NCT04633447|526435951|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
145979144|NCT04633447|526435952|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
145979145|NCT04633447|526435951|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
145979146|NCT04633447|526435952|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
145979147|NCT04633447|526435951|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
145979148|NCT04633447|526435952|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
145979149|NCT04633447|526435951|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
145979150|NCT04633447|526435952|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
145979151|NCT05417113|526435958|FG000|Overall Study|Lost to Follow-up|2|||
145935369|NCT02980341|526271084|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145979152|NCT05417113|526435959|FG001|Overall Study|Lost to Follow-up|2|||
145979153|NCT01022580|526435960|FG000|Overall Study|Death|18|||
145979154|NCT01022580|526435961|FG001|Overall Study|Death|22|||
145979155|NCT00134719|526435962|FG000|Primary Vaccination Phase|Adverse Event|4|||
145935370|NCT02980341|526271085|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145935371|NCT02980341|526271086|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
145935372|NCT02980341|526271087|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
145935373|NCT02980341|526271088|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145935374|NCT02980341|526271089|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935375|NCT02980341|526271090|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935376|NCT02980341|526271091|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935377|NCT02980341|526271092|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935378|NCT02980341|526271093|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935379|NCT02980341|526271094|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145935380|NCT02980341|526271084|FG000|Dose Escalation|Clinical progression|0|||
145935381|NCT02980341|526271085|FG001|Dose Escalation|Clinical progression|0|||
145935382|NCT02980341|526271086|FG002|Dose Escalation|Clinical progression|2|||
145935383|NCT02980341|526271087|FG003|Dose Escalation|Clinical progression|1|||
145935384|NCT02980341|526271088|FG004|Dose Escalation|Clinical progression|0|||
145935385|NCT02980341|526271089|FG005|Dose Escalation|Clinical progression|0|||
145935386|NCT02980341|526271090|FG006|Dose Escalation|Clinical progression|0|||
145935387|NCT02980341|526271091|FG007|Dose Escalation|Clinical progression|0|||
145935388|NCT02980341|526271092|FG008|Dose Escalation|Clinical progression|0|||
145935389|NCT02980341|526271093|FG009|Dose Escalation|Clinical progression|0|||
145935390|NCT02980341|526271094|FG010|Dose Escalation|Clinical progression|0|||
145935391|NCT02980341|526271084|FG000|Dose Escalation|Adverse Event|0|||
145935392|NCT02980341|526271085|FG001|Dose Escalation|Adverse Event|0|||
145935393|NCT02980341|526271086|FG002|Dose Escalation|Adverse Event|1|||
145935394|NCT02980341|526271087|FG003|Dose Escalation|Adverse Event|2|||
145935395|NCT02980341|526271088|FG004|Dose Escalation|Adverse Event|2|||
145935396|NCT02980341|526271089|FG005|Dose Escalation|Adverse Event|0|||
145935397|NCT02980341|526271090|FG006|Dose Escalation|Adverse Event|0|||
145935398|NCT02980341|526271091|FG007|Dose Escalation|Adverse Event|0|||
145935399|NCT02980341|526271092|FG008|Dose Escalation|Adverse Event|0|||
145935400|NCT02980341|526271093|FG009|Dose Escalation|Adverse Event|0|||
145935401|NCT02980341|526271094|FG010|Dose Escalation|Adverse Event|0|||
145935402|NCT02980341|526271084|FG000|Dose Escalation|Withdrawal by Subject|0|||
145935403|NCT02980341|526271085|FG001|Dose Escalation|Withdrawal by Subject|0|||
145935404|NCT02980341|526271086|FG002|Dose Escalation|Withdrawal by Subject|1|||
145935405|NCT02980341|526271087|FG003|Dose Escalation|Withdrawal by Subject|0|||
145935406|NCT02980341|526271088|FG004|Dose Escalation|Withdrawal by Subject|0|||
145935407|NCT02980341|526271089|FG005|Dose Escalation|Withdrawal by Subject|0|||
145935408|NCT02980341|526271090|FG006|Dose Escalation|Withdrawal by Subject|0|||
145935409|NCT02980341|526271091|FG007|Dose Escalation|Withdrawal by Subject|0|||
145935410|NCT02980341|526271092|FG008|Dose Escalation|Withdrawal by Subject|0|||
145935411|NCT02980341|526271093|FG009|Dose Escalation|Withdrawal by Subject|0|||
145935412|NCT02980341|526271094|FG010|Dose Escalation|Withdrawal by Subject|0|||
145935413|NCT02980341|526271084|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935414|NCT02980341|526271085|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935415|NCT02980341|526271086|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935416|NCT02980341|526271087|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
145935417|NCT02980341|526271088|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935418|NCT02980341|526271089|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935419|NCT02980341|526271090|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935420|NCT02980341|526271091|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935421|NCT02980341|526271092|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935422|NCT02980341|526271093|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935423|NCT02980341|526271094|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
145935424|NCT02980341|526271084|FG000|Dose Escalation|Due to investigator's decision|0|||
145935425|NCT02980341|526271085|FG001|Dose Escalation|Due to investigator's decision|0|||
145935426|NCT02980341|526271086|FG002|Dose Escalation|Due to investigator's decision|0|||
145935427|NCT02980341|526271087|FG003|Dose Escalation|Due to investigator's decision|0|||
145935428|NCT02980341|526271088|FG004|Dose Escalation|Due to investigator's decision|1|||
145935429|NCT02980341|526271089|FG005|Dose Escalation|Due to investigator's decision|0|||
145935430|NCT02980341|526271090|FG006|Dose Escalation|Due to investigator's decision|0|||
145935431|NCT02980341|526271091|FG007|Dose Escalation|Due to investigator's decision|0|||
145935432|NCT02980341|526271092|FG008|Dose Escalation|Due to investigator's decision|0|||
145935433|NCT02980341|526271093|FG009|Dose Escalation|Due to investigator's decision|0|||
145935434|NCT02980341|526271094|FG010|Dose Escalation|Due to investigator's decision|0|||
145935435|NCT02980341|526271084|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935436|NCT02980341|526271085|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935437|NCT02980341|526271086|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935438|NCT02980341|526271087|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935439|NCT02980341|526271088|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935440|NCT02980341|526271089|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
146091131|NCT01390220|526854878|FG000|Comparative Phase|Withdrawal by Subject|0|||
145935441|NCT02980341|526271090|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
145935442|NCT02980341|526271091|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935443|NCT02980341|526271092|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935444|NCT02980341|526271093|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935445|NCT02980341|526271094|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
145935446|NCT02980341|526271084|FG000|Dose Finding|Adverse Event|0|||
145935447|NCT02980341|526271085|FG001|Dose Finding|Adverse Event|0|||
145935448|NCT02980341|526271086|FG002|Dose Finding|Adverse Event|0|||
145935449|NCT02980341|526271087|FG003|Dose Finding|Adverse Event|0|||
145935450|NCT02980341|526271088|FG004|Dose Finding|Adverse Event|0|||
145935451|NCT02980341|526271089|FG005|Dose Finding|Adverse Event|3|||
145935452|NCT02980341|526271090|FG006|Dose Finding|Adverse Event|0|||
145935453|NCT02980341|526271091|FG007|Dose Finding|Adverse Event|0|||
145935454|NCT02980341|526271092|FG008|Dose Finding|Adverse Event|0|||
145935455|NCT02980341|526271093|FG009|Dose Finding|Adverse Event|0|||
145935456|NCT02980341|526271094|FG010|Dose Finding|Adverse Event|0|||
145935457|NCT02980341|526271084|FG000|Dose Finding|Withdrawal by Subject|0|||
145935458|NCT02980341|526271085|FG001|Dose Finding|Withdrawal by Subject|0|||
145935459|NCT02980341|526271086|FG002|Dose Finding|Withdrawal by Subject|0|||
145935460|NCT02980341|526271087|FG003|Dose Finding|Withdrawal by Subject|0|||
145935461|NCT02980341|526271088|FG004|Dose Finding|Withdrawal by Subject|0|||
145935462|NCT02980341|526271089|FG005|Dose Finding|Withdrawal by Subject|1|||
145935463|NCT02980341|526271090|FG006|Dose Finding|Withdrawal by Subject|1|||
145935464|NCT02980341|526271091|FG007|Dose Finding|Withdrawal by Subject|0|||
145935465|NCT02980341|526271092|FG008|Dose Finding|Withdrawal by Subject|0|||
145935466|NCT02980341|526271093|FG009|Dose Finding|Withdrawal by Subject|0|||
145935467|NCT02980341|526271094|FG010|Dose Finding|Withdrawal by Subject|0|||
145935468|NCT02980341|526271084|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935469|NCT02980341|526271085|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935470|NCT02980341|526271086|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935471|NCT02980341|526271087|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935472|NCT02980341|526271088|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935473|NCT02980341|526271089|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935474|NCT02980341|526271090|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145935475|NCT02980341|526271091|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
145935476|NCT02980341|526271092|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
145935477|NCT02980341|526271093|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
145935478|NCT02980341|526271094|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
145935479|NCT02980341|526271084|FG000|Dose Expansion|Clinical progression|0|||
145935480|NCT02980341|526271085|FG001|Dose Expansion|Clinical progression|0|||
145935481|NCT02980341|526271086|FG002|Dose Expansion|Clinical progression|0|||
145935482|NCT02980341|526271087|FG003|Dose Expansion|Clinical progression|0|||
145935483|NCT02980341|526271088|FG004|Dose Expansion|Clinical progression|0|||
145935484|NCT02980341|526271089|FG005|Dose Expansion|Clinical progression|0|||
145935485|NCT02980341|526271090|FG006|Dose Expansion|Clinical progression|0|||
145935486|NCT02980341|526271091|FG007|Dose Expansion|Clinical progression|4|||
145935487|NCT02980341|526271092|FG008|Dose Expansion|Clinical progression|3|||
145935488|NCT02980341|526271093|FG009|Dose Expansion|Clinical progression|1|||
145935489|NCT02980341|526271094|FG010|Dose Expansion|Clinical progression|4|||
145935490|NCT02980341|526271084|FG000|Dose Expansion|Adverse Event|0|||
145935491|NCT02980341|526271085|FG001|Dose Expansion|Adverse Event|0|||
145935492|NCT02980341|526271086|FG002|Dose Expansion|Adverse Event|0|||
145935493|NCT02980341|526271087|FG003|Dose Expansion|Adverse Event|0|||
145935494|NCT02980341|526271088|FG004|Dose Expansion|Adverse Event|0|||
145935495|NCT02980341|526271089|FG005|Dose Expansion|Adverse Event|0|||
145935496|NCT02980341|526271090|FG006|Dose Expansion|Adverse Event|0|||
145935497|NCT02980341|526271091|FG007|Dose Expansion|Adverse Event|3|||
145935498|NCT02980341|526271092|FG008|Dose Expansion|Adverse Event|0|||
145935499|NCT02980341|526271093|FG009|Dose Expansion|Adverse Event|1|||
145935500|NCT02980341|526271094|FG010|Dose Expansion|Adverse Event|3|||
145935501|NCT02980341|526271084|FG000|Dose Expansion|Death|0|||
145935502|NCT02980341|526271085|FG001|Dose Expansion|Death|0|||
145935503|NCT02980341|526271086|FG002|Dose Expansion|Death|0|||
145935504|NCT02980341|526271087|FG003|Dose Expansion|Death|0|||
145935505|NCT02980341|526271088|FG004|Dose Expansion|Death|0|||
145935506|NCT02980341|526271089|FG005|Dose Expansion|Death|0|||
145935507|NCT02980341|526271090|FG006|Dose Expansion|Death|0|||
145935508|NCT02980341|526271091|FG007|Dose Expansion|Death|0|||
145935509|NCT02980341|526271092|FG008|Dose Expansion|Death|2|||
145935510|NCT02980341|526271093|FG009|Dose Expansion|Death|1|||
145935511|NCT02980341|526271094|FG010|Dose Expansion|Death|0|||
145935512|NCT02980341|526271084|FG000|Dose Expansion|Withdrawal by Subject|0|||
145935513|NCT02980341|526271085|FG001|Dose Expansion|Withdrawal by Subject|0|||
145935514|NCT02980341|526271086|FG002|Dose Expansion|Withdrawal by Subject|0|||
145935515|NCT02980341|526271087|FG003|Dose Expansion|Withdrawal by Subject|0|||
145935516|NCT02980341|526271088|FG004|Dose Expansion|Withdrawal by Subject|0|||
145935517|NCT02980341|526271089|FG005|Dose Expansion|Withdrawal by Subject|0|||
145935518|NCT02980341|526271090|FG006|Dose Expansion|Withdrawal by Subject|0|||
145935519|NCT02980341|526271091|FG007|Dose Expansion|Withdrawal by Subject|2|||
145935520|NCT02980341|526271092|FG008|Dose Expansion|Withdrawal by Subject|0|||
145935521|NCT02980341|526271093|FG009|Dose Expansion|Withdrawal by Subject|1|||
145935522|NCT02980341|526271094|FG010|Dose Expansion|Withdrawal by Subject|0|||
145935523|NCT02980341|526271084|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935524|NCT02980341|526271085|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935525|NCT02980341|526271086|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935526|NCT02980341|526271087|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935527|NCT02980341|526271088|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935528|NCT02980341|526271089|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935529|NCT02980341|526271090|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935530|NCT02980341|526271091|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
145935531|NCT02980341|526271092|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935532|NCT02980341|526271093|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935533|NCT02980341|526271094|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145935534|NCT02980341|526271084|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935535|NCT02980341|526271085|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935536|NCT02980341|526271086|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935537|NCT02980341|526271087|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935538|NCT02980341|526271088|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935539|NCT02980341|526271089|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935540|NCT02980341|526271090|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935541|NCT02980341|526271091|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935542|NCT02980341|526271092|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
145935543|NCT02980341|526271093|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935544|NCT02980341|526271094|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145935545|NCT02980341|526271084|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935546|NCT02980341|526271085|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935547|NCT02980341|526271086|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935548|NCT02980341|526271087|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935549|NCT02980341|526271088|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935550|NCT02980341|526271089|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935551|NCT02980341|526271090|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935552|NCT02980341|526271091|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935553|NCT02980341|526271092|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
145935554|NCT02980341|526271093|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935555|NCT02980341|526271094|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145935556|NCT02980341|526271084|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935557|NCT02980341|526271085|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935558|NCT02980341|526271086|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935559|NCT02980341|526271087|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935560|NCT02980341|526271088|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935561|NCT02980341|526271089|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935562|NCT02980341|526271090|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935563|NCT02980341|526271091|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935564|NCT02980341|526271092|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935565|NCT02980341|526271093|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145935566|NCT02980341|526271094|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
145935567|NCT00749684|526271097|FG000|Overall Study|Death|1|||
145935568|NCT00749684|526271097|FG000|Overall Study|Adverse Event|27|||
145935569|NCT00749684|526271097|FG000|Overall Study|Participant's Wish|10|||
145935570|NCT00749684|526271097|FG000|Overall Study|Not Documented|1|||
145935571|NCT00749684|526271097|FG000|Overall Study|Progressive Desease|31|||
145935572|NCT00749684|526271097|FG000|Overall Study|Therapy according to protocol + AE|2|||
145935573|NCT00749684|526271097|FG000|Overall Study|AE+discontinuation on participants wish|1|||
145935574|NCT00749684|526271097|FG000|Overall Study|Missing|9|||
145935575|NCT04603482|526271098|FG000|Overall Study|Lost to Follow-up|15|||
145935576|NCT04603482|526271099|FG001|Overall Study|Lost to Follow-up|15|||
145935577|NCT04603482|526271100|FG002|Overall Study|Lost to Follow-up|15|||
145935578|NCT00373958|526271101|FG000|Infant Series|Withdrawal by Subject|13|||
145935579|NCT00373958|526271102|FG001|Infant Series|Withdrawal by Subject|15|||
145935580|NCT00373958|526271101|FG000|Infant Series|Failed to return|8|||
145935581|NCT00373958|526271102|FG001|Infant Series|Failed to return|13|||
145935582|NCT00373958|526271101|FG000|Infant Series|Lost to Follow-up|6|||
145935583|NCT00373958|526271102|FG001|Infant Series|Lost to Follow-up|5|||
145935584|NCT00373958|526271101|FG000|Infant Series|Protocol Violation|3|||
145935585|NCT00373958|526271102|FG001|Infant Series|Protocol Violation|7|||
145935586|NCT00373958|526271101|FG000|Infant Series|Lost Kaiser coverage|4|||
145935587|NCT00373958|526271102|FG001|Infant Series|Lost Kaiser coverage|0|||
145935588|NCT00373958|526271101|FG000|Infant Series|Child relocated|1|||
145935589|NCT00373958|526271102|FG001|Infant Series|Child relocated|0|||
145935590|NCT00373958|526271101|FG000|Infant Series|Consent was not received|1|||
145935591|NCT00373958|526271102|FG001|Infant Series|Consent was not received|0|||
145935592|NCT00373958|526271101|FG000|Infant Series|Adverse Event|3|||
145935593|NCT00373958|526271102|FG001|Infant Series|Adverse Event|1|||
145935594|NCT00373958|526271101|FG000|Infant Series|Physician Decision|1|||
145935595|NCT00373958|526271102|FG001|Infant Series|Physician Decision|1|||
145935596|NCT00373958|526271101|FG000|Toddler Dose|Lost to Follow-up|5|||
145935597|NCT00373958|526271102|FG001|Toddler Dose|Lost to Follow-up|8|||
145935598|NCT00373958|526271101|FG000|Toddler Dose|Withdrawal by Subject|2|||
145935599|NCT00373958|526271102|FG001|Toddler Dose|Withdrawal by Subject|2|||
145935600|NCT00373958|526271101|FG000|Toddler Dose|Failed to return|1|||
145935601|NCT00373958|526271102|FG001|Toddler Dose|Failed to return|2|||
145935602|NCT00373958|526271101|FG000|Toddler Dose|Protocol Violation|0|||
145935603|NCT00373958|526271102|FG001|Toddler Dose|Protocol Violation|1|||
145935604|NCT00373958|526271101|FG000|Toddler Dose|Withdrawn after infant series|22|||
145935605|NCT00373958|526271102|FG001|Toddler Dose|Withdrawn after infant series|25|||
145935606|NCT01054196|526271106|FG000|Overall Study|Physician Decision|0|||
145935607|NCT01054196|526271107|FG001|Overall Study|Physician Decision|0|||
145935608|NCT01054196|526271108|FG002|Overall Study|Physician Decision|0|||
145935609|NCT01054196|526271109|FG003|Overall Study|Physician Decision|1|||
145935610|NCT01054196|526271110|FG004|Overall Study|Physician Decision|0|||
145935611|NCT01054196|526271111|FG005|Overall Study|Physician Decision|0|||
145935612|NCT01054196|526271112|FG006|Overall Study|Physician Decision|1|||
145935613|NCT00179673|526271114|FG000|Overall Study|Adverse Event|7|||
145935614|NCT00179673|526271114|FG000|Overall Study|Lack of Efficacy|15|||
145935615|NCT00179673|526271114|FG000|Overall Study|Withdrawal by Subject|3|||
145935616|NCT00179673|526271114|FG000|Overall Study|Death|4|||
145935617|NCT00179673|526271114|FG000|Overall Study|Other Observations and options|14|||
145935618|NCT00492648|526271115|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
145935619|NCT00492648|526271116|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
145935620|NCT00282113|526271117|FG000|Overall Study|Removed at parents request|1|||
145935621|NCT00282113|526271118|FG001|Overall Study|Removed at parents request|0|||
145935622|NCT00282113|526271119|FG002|Overall Study|Removed at parents request|0|||
145935623|NCT03382834|526271120|FG000|Step 1|Lost to Follow-up|0|||
145935624|NCT03382834|526271121|FG001|Step 1|Lost to Follow-up|1|||
145935625|NCT03382834|526271120|FG000|Step 2|Death|1|||
145935626|NCT03382834|526271121|FG001|Step 2|Death|0|||
145935627|NCT03382834|526271120|FG000|Step 2|Lost to Follow-up|2|||
145935628|NCT03382834|526271121|FG001|Step 2|Lost to Follow-up|2|||
145935629|NCT03382834|526271120|FG000|Step 2|Site Terminated by Sponsor|1|||
145935630|NCT03382834|526271121|FG001|Step 2|Site Terminated by Sponsor|0|||
145935631|NCT02387957|526271122|FG000|Overall Study|The study was discontinued|21|||
145935632|NCT02387957|526271123|FG001|Overall Study|The study was discontinued|21|||
145935633|NCT02387957|526271124|FG002|Overall Study|The study was discontinued|20|||
145935634|NCT02294396|526271125|FG000|Overall Study|Adverse Event|26|||
145935635|NCT02294396|526271126|FG001|Overall Study|Adverse Event|25|||
145935636|NCT02294396|526271127|FG002|Overall Study|Adverse Event|21|||
145935637|NCT02294396|526271128|FG003|Overall Study|Adverse Event|24|||
145935638|NCT02294396|526271125|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
145935639|NCT02294396|526271126|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
145935640|NCT02294396|526271127|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
145935641|NCT02294396|526271128|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
145935642|NCT02294396|526271125|FG000|Overall Study|Withdrawal by Subject|8|||
145935643|NCT02294396|526271126|FG001|Overall Study|Withdrawal by Subject|6|||
146091132|NCT01390220|526854879|FG001|Comparative Phase|Withdrawal by Subject|1|||
145935644|NCT02294396|526271127|FG002|Overall Study|Withdrawal by Subject|6|||
145935645|NCT02294396|526271128|FG003|Overall Study|Withdrawal by Subject|8|||
145935646|NCT02294396|526271125|FG000|Overall Study|Lost to Follow-up|0|||
145935647|NCT02294396|526271126|FG001|Overall Study|Lost to Follow-up|0|||
145935648|NCT02294396|526271127|FG002|Overall Study|Lost to Follow-up|1|||
145935649|NCT02294396|526271128|FG003|Overall Study|Lost to Follow-up|1|||
145935650|NCT02294396|526271125|FG000|Overall Study|Protocol Deviation|3|||
145935651|NCT02294396|526271126|FG001|Overall Study|Protocol Deviation|2|||
145935652|NCT02294396|526271127|FG002|Overall Study|Protocol Deviation|2|||
145935653|NCT02294396|526271128|FG003|Overall Study|Protocol Deviation|1|||
145935654|NCT02294396|526271125|FG000|Overall Study|Miscellaneous|2|||
146245341|NCT00441168|527412196|FG001|Follow-up Period|Withdrawal by Subject|0|||
145935655|NCT02294396|526271126|FG001|Overall Study|Miscellaneous|0|||
145935656|NCT02294396|526271127|FG002|Overall Study|Miscellaneous|5|||
145935657|NCT02294396|526271128|FG003|Overall Study|Miscellaneous|2|||
145935658|NCT02949843|526271129|FG000|Overall Study|Withdrawal by Subject|0|||
145935659|NCT02949843|526271130|FG001|Overall Study|Withdrawal by Subject|1|||
145935660|NCT02949843|526271131|FG002|Overall Study|Withdrawal by Subject|1|||
145935661|NCT02120833|526271132|FG000|Overall Study|Adverse Event|1|||
145935662|NCT02120833|526271133|FG001|Overall Study|Adverse Event|0|||
145935663|NCT02120833|526271132|FG000|Overall Study|Withdrawal by Subject|2|||
145935664|NCT02120833|526271133|FG001|Overall Study|Withdrawal by Subject|0|||
145935665|NCT02120833|526271132|FG000|Overall Study|Lost to Follow-up|1|||
145935666|NCT02120833|526271133|FG001|Overall Study|Lost to Follow-up|1|||
145935667|NCT03613649|526271134|FG000|Second Treatment|Lost to Follow-up|0|||
145935668|NCT03613649|526271135|FG001|Second Treatment|Lost to Follow-up|0|||
145935669|NCT03613649|526271136|FG002|Second Treatment|Lost to Follow-up|1|||
145935670|NCT03613649|526271137|FG003|Second Treatment|Lost to Follow-up|0|||
145935671|NCT03613649|526271138|FG004|Second Treatment|Lost to Follow-up|0|||
145935672|NCT03613649|526271139|FG005|Second Treatment|Lost to Follow-up|0|||
145935673|NCT03613649|526271140|FG006|Second Treatment|Lost to Follow-up|0|||
145935674|NCT03613649|526271141|FG007|Second Treatment|Lost to Follow-up|0|||
145935675|NCT03613649|526271142|FG008|Second Treatment|Lost to Follow-up|0|||
145935676|NCT03613649|526271143|FG009|Second Treatment|Lost to Follow-up|0|||
145935677|NCT03613649|526271144|FG010|Second Treatment|Lost to Follow-up|0|||
145935678|NCT03613649|526271145|FG011|Second Treatment|Lost to Follow-up|0|||
145935679|NCT03613649|526271134|FG000|Second Treatment|Withdrawal by Subject|0|||
145935680|NCT03613649|526271135|FG001|Second Treatment|Withdrawal by Subject|0|||
145935681|NCT03613649|526271136|FG002|Second Treatment|Withdrawal by Subject|0|||
145935682|NCT03613649|526271137|FG003|Second Treatment|Withdrawal by Subject|0|||
145935683|NCT03613649|526271138|FG004|Second Treatment|Withdrawal by Subject|1|||
146245342|NCT00441168|527412195|FG000|Follow-up Period|Other|1|||
146245343|NCT00441168|527412196|FG001|Follow-up Period|Other|3|||
146245344|NCT02964234|527412197|FG000|Overall Study|Lost to Follow-up|22|||
145935684|NCT03613649|526271139|FG005|Second Treatment|Withdrawal by Subject|0|||
145935685|NCT03613649|526271140|FG006|Second Treatment|Withdrawal by Subject|0|||
145935686|NCT03613649|526271141|FG007|Second Treatment|Withdrawal by Subject|0|||
145935687|NCT03613649|526271142|FG008|Second Treatment|Withdrawal by Subject|0|||
145935688|NCT03613649|526271143|FG009|Second Treatment|Withdrawal by Subject|0|||
145935689|NCT03613649|526271144|FG010|Second Treatment|Withdrawal by Subject|0|||
145935690|NCT03613649|526271145|FG011|Second Treatment|Withdrawal by Subject|0|||
145935691|NCT03613649|526271134|FG000|Third Treatment|Lost to Follow-up|0|||
145935692|NCT03613649|526271135|FG001|Third Treatment|Lost to Follow-up|0|||
145935693|NCT03613649|526271136|FG002|Third Treatment|Lost to Follow-up|0|||
145935694|NCT03613649|526271137|FG003|Third Treatment|Lost to Follow-up|0|||
145935695|NCT03613649|526271138|FG004|Third Treatment|Lost to Follow-up|1|||
145935696|NCT03613649|526271139|FG005|Third Treatment|Lost to Follow-up|0|||
145935697|NCT03613649|526271140|FG006|Third Treatment|Lost to Follow-up|0|||
145935698|NCT03613649|526271141|FG007|Third Treatment|Lost to Follow-up|0|||
145935699|NCT03613649|526271142|FG008|Third Treatment|Lost to Follow-up|0|||
145935700|NCT03613649|526271143|FG009|Third Treatment|Lost to Follow-up|0|||
145935701|NCT03613649|526271144|FG010|Third Treatment|Lost to Follow-up|0|||
145935702|NCT03613649|526271145|FG011|Third Treatment|Lost to Follow-up|1|||
145935703|NCT03613649|526271134|FG000|Third Treatment|Protocol Violation|0|||
145935704|NCT03613649|526271135|FG001|Third Treatment|Protocol Violation|0|||
145935705|NCT03613649|526271136|FG002|Third Treatment|Protocol Violation|0|||
145935706|NCT03613649|526271137|FG003|Third Treatment|Protocol Violation|0|||
145935707|NCT03613649|526271138|FG004|Third Treatment|Protocol Violation|0|||
145935708|NCT03613649|526271139|FG005|Third Treatment|Protocol Violation|0|||
145935709|NCT03613649|526271140|FG006|Third Treatment|Protocol Violation|1|||
145935710|NCT03613649|526271141|FG007|Third Treatment|Protocol Violation|0|||
145935711|NCT03613649|526271142|FG008|Third Treatment|Protocol Violation|0|||
145935712|NCT03613649|526271143|FG009|Third Treatment|Protocol Violation|0|||
145935713|NCT03613649|526271144|FG010|Third Treatment|Protocol Violation|0|||
145935714|NCT03613649|526271145|FG011|Third Treatment|Protocol Violation|1|||
145935715|NCT03613649|526271134|FG000|Fourth Treatment|Protocol Violation|1|||
145935716|NCT03613649|526271135|FG001|Fourth Treatment|Protocol Violation|0|||
145935717|NCT03613649|526271136|FG002|Fourth Treatment|Protocol Violation|0|||
145935718|NCT03613649|526271137|FG003|Fourth Treatment|Protocol Violation|0|||
145935719|NCT03613649|526271138|FG004|Fourth Treatment|Protocol Violation|1|||
145935720|NCT03613649|526271139|FG005|Fourth Treatment|Protocol Violation|0|||
145935721|NCT03613649|526271140|FG006|Fourth Treatment|Protocol Violation|0|||
145935722|NCT03613649|526271141|FG007|Fourth Treatment|Protocol Violation|0|||
145935723|NCT03613649|526271142|FG008|Fourth Treatment|Protocol Violation|0|||
146245345|NCT02964234|527412198|FG001|Overall Study|Lost to Follow-up|13|||
145979156|NCT00134719|526435963|FG001|Primary Vaccination Phase|Adverse Event|0|||
145979157|NCT00134719|526435964|FG002|Primary Vaccination Phase|Adverse Event|0|||
145979158|NCT00134719|526435962|FG000|Primary Vaccination Phase|Protocol Violation|1|||
145979159|NCT00134719|526435963|FG001|Primary Vaccination Phase|Protocol Violation|0|||
145979160|NCT00134719|526435964|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145979161|NCT00134719|526435962|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
145979162|NCT00134719|526435963|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
145979163|NCT00134719|526435964|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
145979164|NCT00134719|526435962|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
145979165|NCT00134719|526435963|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
145979166|NCT00134719|526435964|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
145935724|NCT03613649|526271143|FG009|Fourth Treatment|Protocol Violation|0|||
145935725|NCT03613649|526271144|FG010|Fourth Treatment|Protocol Violation|0|||
145935726|NCT03613649|526271145|FG011|Fourth Treatment|Protocol Violation|0|||
145935727|NCT03613649|526271134|FG000|Fourth Treatment|Physician Decision|0|||
145935728|NCT03613649|526271135|FG001|Fourth Treatment|Physician Decision|0|||
145935729|NCT03613649|526271136|FG002|Fourth Treatment|Physician Decision|0|||
145935730|NCT03613649|526271137|FG003|Fourth Treatment|Physician Decision|0|||
145935731|NCT03613649|526271138|FG004|Fourth Treatment|Physician Decision|0|||
145935732|NCT03613649|526271139|FG005|Fourth Treatment|Physician Decision|0|||
145935733|NCT03613649|526271140|FG006|Fourth Treatment|Physician Decision|1|||
145935734|NCT03613649|526271141|FG007|Fourth Treatment|Physician Decision|0|||
145935735|NCT03613649|526271142|FG008|Fourth Treatment|Physician Decision|0|||
145935736|NCT03613649|526271143|FG009|Fourth Treatment|Physician Decision|0|||
145935737|NCT03613649|526271144|FG010|Fourth Treatment|Physician Decision|0|||
145935738|NCT03613649|526271145|FG011|Fourth Treatment|Physician Decision|0|||
145935739|NCT03429244|526271146|FG000|Overall Study|Withdrawal by Subject|2|||
145935740|NCT03429244|526271147|FG001|Overall Study|Withdrawal by Subject|1|||
145935741|NCT03429244|526271148|FG002|Overall Study|Withdrawal by Subject|1|||
145935742|NCT00750139|526271149|FG000|Overall Study|Adverse Event|1|||
145935743|NCT00750139|526271150|FG001|Overall Study|Adverse Event|2|||
145935744|NCT00750139|526271151|FG002|Overall Study|Adverse Event|0|||
145979167|NCT00134719|526435962|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
145979168|NCT00134719|526435963|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
145979169|NCT00134719|526435964|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
145979170|NCT00134719|526435962|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
145979171|NCT00134719|526435963|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
145979172|NCT00134719|526435964|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
145979173|NCT03439839|526435965|FG000|Overall Study|Death|3|||
145979174|NCT03439839|526435966|FG001|Overall Study|Death|0|||
145979175|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145979176|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
145979177|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
145979178|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145979179|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145979180|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145979181|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145979182|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
145979183|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145979184|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
145979185|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145979186|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145979187|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145979188|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145979189|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979190|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979191|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
145979192|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979193|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979194|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979195|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145979196|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
145979197|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145935745|NCT00750139|526271152|FG003|Overall Study|Adverse Event|1|||
145935746|NCT00750139|526271149|FG000|Overall Study|Lost to Follow-up|17|||
145935747|NCT00750139|526271150|FG001|Overall Study|Lost to Follow-up|12|||
145935748|NCT00750139|526271151|FG002|Overall Study|Lost to Follow-up|15|||
145935749|NCT00750139|526271152|FG003|Overall Study|Lost to Follow-up|6|||
145935750|NCT00750139|526271149|FG000|Overall Study|Withdrawal by Subject|3|||
145935751|NCT00750139|526271150|FG001|Overall Study|Withdrawal by Subject|2|||
145935752|NCT00750139|526271151|FG002|Overall Study|Withdrawal by Subject|6|||
145935753|NCT00750139|526271152|FG003|Overall Study|Withdrawal by Subject|2|||
145935754|NCT00750139|526271149|FG000|Overall Study|Physician Decision|1|||
145935755|NCT00750139|526271150|FG001|Overall Study|Physician Decision|1|||
145935756|NCT00750139|526271151|FG002|Overall Study|Physician Decision|0|||
145935757|NCT00750139|526271152|FG003|Overall Study|Physician Decision|0|||
145935758|NCT00750139|526271149|FG000|Overall Study|Non-compliance|1|||
145935759|NCT00750139|526271150|FG001|Overall Study|Non-compliance|0|||
145935760|NCT00750139|526271151|FG002|Overall Study|Non-compliance|1|||
145935761|NCT00750139|526271152|FG003|Overall Study|Non-compliance|3|||
145935762|NCT00750139|526271149|FG000|Overall Study|Termination by sponsor|4|||
145935763|NCT00750139|526271150|FG001|Overall Study|Termination by sponsor|0|||
145935764|NCT00750139|526271151|FG002|Overall Study|Termination by sponsor|0|||
145935765|NCT00750139|526271152|FG003|Overall Study|Termination by sponsor|1|||
145935766|NCT00750139|526271149|FG000|Overall Study|Non-specific|62|||
145935767|NCT00750139|526271150|FG001|Overall Study|Non-specific|42|||
145935768|NCT00750139|526271151|FG002|Overall Study|Non-specific|79|||
145935769|NCT00750139|526271152|FG003|Overall Study|Non-specific|33|||
145935770|NCT00658775|526271153|FG000|Overall Study|Adverse Event|4|||
145935771|NCT00658775|526271154|FG001|Overall Study|Adverse Event|6|||
145935772|NCT00658775|526271153|FG000|Overall Study|Lost to Follow-up|17|||
145935773|NCT00658775|526271154|FG001|Overall Study|Lost to Follow-up|18|||
145935774|NCT00658775|526271153|FG000|Overall Study|Withdrawal by Subject|6|||
145935775|NCT00658775|526271154|FG001|Overall Study|Withdrawal by Subject|4|||
145935776|NCT00658775|526271153|FG000|Overall Study|Withdrawal of consent|8|||
145935777|NCT00658775|526271154|FG001|Overall Study|Withdrawal of consent|7|||
145935778|NCT00658775|526271153|FG000|Overall Study|Other|7|||
145935779|NCT00658775|526271154|FG001|Overall Study|Other|8|||
145935780|NCT00977314|526271155|FG000|Overall Study|Withdrawal by Subject|1|||
145935781|NCT00977314|526271156|FG001|Overall Study|Withdrawal by Subject|0|||
145935782|NCT00977314|526271155|FG000|Overall Study|Physician Decision|1|||
145935783|NCT00977314|526271156|FG001|Overall Study|Physician Decision|0|||
145935784|NCT02107859|526271159|FG000|Overall Study|Withdrawal by Subject|14|||
145935785|NCT02107859|526271159|FG000|Overall Study|Adverse Event|3|||
145935786|NCT02107859|526271159|FG000|Overall Study|Study closure|41|||
145935787|NCT02107859|526271159|FG000|Overall Study|Other than specified|3|||
145935788|NCT00877487|526271162|FG000|Open-label Treatment Phase|Adverse Event|1|||
145935789|NCT00877487|526271163|FG001|Open-label Treatment Phase|Adverse Event|0|||
145935790|NCT00877487|526271162|FG000|Open-label Treatment Phase|Protocol Violation|3|||
145935791|NCT00877487|526271163|FG001|Open-label Treatment Phase|Protocol Violation|0|||
145935792|NCT00877487|526271162|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
145935793|NCT00877487|526271163|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
145935794|NCT00877487|526271162|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
145935795|NCT00877487|526271163|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
145935796|NCT00877487|526271162|FG000|Open-label Treatment Phase|Out of country for business|1|||
145935797|NCT00877487|526271163|FG001|Open-label Treatment Phase|Out of country for business|0|||
145935798|NCT00877487|526271162|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
145935799|NCT00877487|526271163|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
145935800|NCT00877487|526271162|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
145935801|NCT00877487|526271163|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
145935802|NCT00877487|526271162|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
145935803|NCT00877487|526271163|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
145935804|NCT00877487|526271162|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
145935805|NCT00877487|526271163|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
145935806|NCT01516008|526271164|FG000|Overall Study|Adverse Event|0|||
145935807|NCT01516008|526271165|FG001|Overall Study|Adverse Event|2|||
145935808|NCT01516008|526271166|FG002|Overall Study|Adverse Event|7|||
145935809|NCT01516008|526271164|FG000|Overall Study|Lack of Efficacy|44|||
145935810|NCT01516008|526271165|FG001|Overall Study|Lack of Efficacy|14|||
145935811|NCT01516008|526271166|FG002|Overall Study|Lack of Efficacy|10|||
145935812|NCT01516008|526271164|FG000|Overall Study|Protocol Violation|1|||
145935813|NCT01516008|526271165|FG001|Overall Study|Protocol Violation|0|||
145935814|NCT01516008|526271166|FG002|Overall Study|Protocol Violation|0|||
145935815|NCT01516008|526271164|FG000|Overall Study|Reason not specified|0|||
145935816|NCT01516008|526271165|FG001|Overall Study|Reason not specified|0|||
145935817|NCT01516008|526271166|FG002|Overall Study|Reason not specified|1|||
145935818|NCT01217476|526271167|FG000|Overall Study|Adverse Event|6|||
145935819|NCT01217476|526271168|FG001|Overall Study|Adverse Event|1|||
145935820|NCT01217476|526271167|FG000|Overall Study|Physician Decision|0|||
145935821|NCT01217476|526271168|FG001|Overall Study|Physician Decision|1|||
145935822|NCT01217476|526271167|FG000|Overall Study|Withdrawal by Subject|3|||
145935823|NCT01217476|526271168|FG001|Overall Study|Withdrawal by Subject|3|||
145935824|NCT01217476|526271167|FG000|Overall Study|Surgery on the Target Limb|0|||
145935825|NCT01217476|526271168|FG001|Overall Study|Surgery on the Target Limb|2|||
145935826|NCT01217476|526271167|FG000|Overall Study|Protocol Deviation|1|||
145935827|NCT01217476|526271168|FG001|Overall Study|Protocol Deviation|0|||
145935828|NCT01217476|526271167|FG000|Overall Study|Other|2|||
145935829|NCT01217476|526271168|FG001|Overall Study|Other|0|||
145935830|NCT00813813|526271173|FG000|Overall Study|Withdrawal by Subject|1|||
145935831|NCT00813813|526271174|FG001|Overall Study|Withdrawal by Subject|1|||
145935832|NCT00813813|526271173|FG000|Overall Study|Lost to Follow-up|2|||
145935833|NCT00813813|526271174|FG001|Overall Study|Lost to Follow-up|7|||
145935834|NCT00813813|526271173|FG000|Overall Study|Other|0|||
145935835|NCT00813813|526271174|FG001|Overall Study|Other|1|||
145935836|NCT00986921|526271175|FG000|Overall Study|Physician Decision|1|||
145935837|NCT00986921|526271176|FG001|Overall Study|Physician Decision|0|||
145935838|NCT04445714|526271177|FG000|Overall Study|Discontinuation of the study|14|||
145935839|NCT04445714|526271177|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
145935840|NCT04445714|526271177|FG000|Overall Study|Withdrawal of Informed Consent|8|||
145935841|NCT02805660|526271178|FG000|Overall Study|Death|5|||
145935842|NCT02805660|526271179|FG001|Overall Study|Death|2|||
145935843|NCT02805660|526271180|FG002|Overall Study|Death|9|||
145935844|NCT02805660|526271181|FG003|Overall Study|Death|5|||
145935845|NCT02805660|526271182|FG004|Overall Study|Death|0|||
145935846|NCT02805660|526271183|FG005|Overall Study|Death|14|||
145935847|NCT02805660|526271184|FG006|Overall Study|Death|12|||
145935848|NCT02805660|526271178|FG000|Overall Study|Lost to Follow-up|0|||
145935849|NCT02805660|526271179|FG001|Overall Study|Lost to Follow-up|1|||
145935850|NCT02805660|526271180|FG002|Overall Study|Lost to Follow-up|1|||
145935851|NCT02805660|526271181|FG003|Overall Study|Lost to Follow-up|2|||
145935852|NCT02805660|526271182|FG004|Overall Study|Lost to Follow-up|0|||
145935853|NCT02805660|526271183|FG005|Overall Study|Lost to Follow-up|0|||
145935854|NCT02805660|526271184|FG006|Overall Study|Lost to Follow-up|0|||
145935855|NCT02805660|526271178|FG000|Overall Study|Withdrawal by Subject|0|||
145935856|NCT02805660|526271179|FG001|Overall Study|Withdrawal by Subject|0|||
145935857|NCT02805660|526271180|FG002|Overall Study|Withdrawal by Subject|0|||
145935858|NCT02805660|526271181|FG003|Overall Study|Withdrawal by Subject|3|||
145935859|NCT02805660|526271182|FG004|Overall Study|Withdrawal by Subject|1|||
145935860|NCT02805660|526271183|FG005|Overall Study|Withdrawal by Subject|0|||
145935861|NCT02805660|526271184|FG006|Overall Study|Withdrawal by Subject|2|||
145935862|NCT02805660|526271178|FG000|Overall Study|Study terminated by Sponsor|0|||
145935863|NCT02805660|526271179|FG001|Overall Study|Study terminated by Sponsor|0|||
145935864|NCT02805660|526271180|FG002|Overall Study|Study terminated by Sponsor|1|||
145935865|NCT02805660|526271181|FG003|Overall Study|Study terminated by Sponsor|4|||
145935866|NCT02805660|526271182|FG004|Overall Study|Study terminated by Sponsor|2|||
145935867|NCT02805660|526271183|FG005|Overall Study|Study terminated by Sponsor|3|||
145935868|NCT02805660|526271184|FG006|Overall Study|Study terminated by Sponsor|1|||
145935869|NCT02805660|526271178|FG000|Overall Study|Miscellaneous|0|||
145935870|NCT02805660|526271179|FG001|Overall Study|Miscellaneous|1|||
145935871|NCT02805660|526271180|FG002|Overall Study|Miscellaneous|0|||
145935872|NCT02805660|526271181|FG003|Overall Study|Miscellaneous|4|||
145935873|NCT02805660|526271182|FG004|Overall Study|Miscellaneous|0|||
145935874|NCT02805660|526271183|FG005|Overall Study|Miscellaneous|6|||
145935875|NCT02805660|526271184|FG006|Overall Study|Miscellaneous|4|||
145935876|NCT02778074|526271185|FG000|Overall Study|Lost to Follow-up|7|||
145935877|NCT02778074|526271186|FG001|Overall Study|Lost to Follow-up|10|||
145935878|NCT01684943|526271187|FG000|Overall Study|Inadequate Venous Access|3|||
145935879|NCT01684943|526271188|FG001|Overall Study|Inadequate Venous Access|0|||
145935880|NCT01684943|526271189|FG002|Overall Study|Inadequate Venous Access|0|||
145935881|NCT01684943|526271187|FG000|Overall Study|Principal Investigator Determination|1|||
145935882|NCT01684943|526271188|FG001|Overall Study|Principal Investigator Determination|0|||
145935883|NCT01684943|526271189|FG002|Overall Study|Principal Investigator Determination|0|||
145935884|NCT01684943|526271187|FG000|Overall Study|Excluded from Analysis|1|||
145935885|NCT01684943|526271188|FG001|Overall Study|Excluded from Analysis|1|||
145935886|NCT01684943|526271189|FG002|Overall Study|Excluded from Analysis|1|||
145935887|NCT01684943|526271187|FG000|Overall Study|Lost to Follow-up|3|||
145935888|NCT01684943|526271188|FG001|Overall Study|Lost to Follow-up|0|||
145935889|NCT01684943|526271189|FG002|Overall Study|Lost to Follow-up|0|||
145935890|NCT01684943|526271187|FG000|Overall Study|Planning Pregnancy|1|||
145979198|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145979199|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145935891|NCT01684943|526271188|FG001|Overall Study|Planning Pregnancy|0|||
145935892|NCT01684943|526271189|FG002|Overall Study|Planning Pregnancy|0|||
145935893|NCT03963232|526271193|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145935894|NCT03963232|526271194|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
145935895|NCT03963232|526271193|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
145935896|NCT03963232|526271194|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145935897|NCT03963232|526271193|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
145935898|NCT03963232|526271194|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
145935899|NCT03963232|526271193|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
145935900|NCT03963232|526271194|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
145935901|NCT03963232|526271193|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
145979200|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145935902|NCT03963232|526271194|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
145935903|NCT03963232|526271193|FG000|Open-Label Treatment Phase|Adverse Event|1|||
145935904|NCT03963232|526271194|FG001|Open-Label Treatment Phase|Adverse Event|2|||
145935905|NCT03963232|526271193|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
145935906|NCT03963232|526271194|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
145935907|NCT03963232|526271193|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
145935908|NCT03963232|526271194|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
145935909|NCT03963232|526271193|FG000|Open-Label Treatment Phase|Pregnancy|1|||
145935910|NCT03963232|526271194|FG001|Open-Label Treatment Phase|Pregnancy|0|||
145935911|NCT03963232|526271193|FG000|Follow-up Phase|Withdrawal by Subject|7|||
145935912|NCT03963232|526271194|FG001|Follow-up Phase|Withdrawal by Subject|5|||
145935913|NCT03963232|526271193|FG000|Follow-up Phase|Protocol Violation|0|||
145935914|NCT03963232|526271194|FG001|Follow-up Phase|Protocol Violation|2|||
145935915|NCT03963232|526271193|FG000|Follow-up Phase|Adverse Event|0|||
145935916|NCT03963232|526271194|FG001|Follow-up Phase|Adverse Event|1|||
145935917|NCT03963232|526271193|FG000|Follow-up Phase|Lost to Follow-up|0|||
145935918|NCT03963232|526271194|FG001|Follow-up Phase|Lost to Follow-up|1|||
145935919|NCT03512210|526271196|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
145935920|NCT03512210|526271196|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
145935921|NCT03512210|526271196|FG000|Step 2:Post-MINMON|Death|2|||
145935922|NCT03512210|526271196|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
145935923|NCT03512210|526271196|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
145935924|NCT01672710|526271199|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
145935925|NCT01672710|526271200|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
145935926|NCT01672710|526271199|FG000|3 Month Follow up|Lost to Follow-up|2|||
145935927|NCT01672710|526271200|FG001|3 Month Follow up|Lost to Follow-up|3|||
145935928|NCT01672710|526271199|FG000|3 Month Follow up|follow up due after termination date|4|||
145935929|NCT01672710|526271200|FG001|3 Month Follow up|follow up due after termination date|1|||
145935930|NCT02122887|526271201|FG000|Overall Study|Withdrawal by Subject|20|||
145935931|NCT02122887|526271202|FG001|Overall Study|Withdrawal by Subject|2|||
145935932|NCT03725761|526271203|FG000|Overall Study|still on study|1|||
145935933|NCT03634033|526273262|FG000|Overall Study|Did not have a post-assessment|384|||
145935934|NCT03634033|526273263|FG001|Overall Study|Did not have a post-assessment|291|||
145935935|NCT03634033|526273264|FG002|Overall Study|Did not have a post-assessment|114|||
145935936|NCT03634033|526273265|FG003|Overall Study|Did not have a post-assessment|161|||
145935937|NCT03634033|526273266|FG004|Overall Study|Did not have a post-assessment|5|||
145935938|NCT03634033|526273267|FG005|Overall Study|Did not have a post-assessment|0|||
145935939|NCT03634033|526273268|FG006|Overall Study|Did not have a post-assessment|0|||
145935940|NCT03634033|526273262|FG000|Overall Study|Death|0|||
145935941|NCT03634033|526273263|FG001|Overall Study|Death|0|||
145935942|NCT03634033|526273264|FG002|Overall Study|Death|0|||
145935943|NCT03634033|526273265|FG003|Overall Study|Death|0|||
145935944|NCT03634033|526273266|FG004|Overall Study|Death|0|||
145935945|NCT03634033|526273267|FG005|Overall Study|Death|7|||
145935946|NCT03634033|526273268|FG006|Overall Study|Death|7|||
145935947|NCT03634033|526273262|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145935948|NCT03634033|526273263|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145935949|NCT03634033|526273264|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145935950|NCT03634033|526273265|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145935951|NCT03634033|526273266|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145935952|NCT03634033|526273267|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
145935953|NCT03634033|526273268|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
145935954|NCT03634033|526273262|FG000|Overall Study|Lost to Follow-up|0|||
145935955|NCT03634033|526273263|FG001|Overall Study|Lost to Follow-up|0|||
145935956|NCT03634033|526273264|FG002|Overall Study|Lost to Follow-up|0|||
145935957|NCT03634033|526273265|FG003|Overall Study|Lost to Follow-up|0|||
145935958|NCT03634033|526273266|FG004|Overall Study|Lost to Follow-up|0|||
146245346|NCT01799993|527412200|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
146245347|NCT01799993|527412201|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
146245348|NCT01799993|527412200|FG000|Overall Study|Death|61|||
146245349|NCT01799993|527412201|FG001|Overall Study|Death|45|||
146245350|NCT01799993|527412200|FG000|Overall Study|Withdrawal by Subject|23|||
145935959|NCT03634033|526273267|FG005|Overall Study|Lost to Follow-up|1|||
146245351|NCT01799993|527412201|FG001|Overall Study|Withdrawal by Subject|24|||
146245352|NCT01799993|527412200|FG000|Overall Study|Lost to Follow-up|5|||
146245353|NCT01799993|527412201|FG001|Overall Study|Lost to Follow-up|8|||
145935960|NCT03634033|526273268|FG006|Overall Study|Lost to Follow-up|2|||
145935961|NCT03634033|526273262|FG000|Overall Study|Withdrawal by Subject|0|||
145935962|NCT03634033|526273263|FG001|Overall Study|Withdrawal by Subject|0|||
145935963|NCT03634033|526273264|FG002|Overall Study|Withdrawal by Subject|0|||
145935964|NCT03634033|526273265|FG003|Overall Study|Withdrawal by Subject|0|||
145935965|NCT03634033|526273266|FG004|Overall Study|Withdrawal by Subject|0|||
145935966|NCT03634033|526273267|FG005|Overall Study|Withdrawal by Subject|0|||
146245354|NCT01799993|527412200|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
146245355|NCT01799993|527412201|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
146245356|NCT01799993|527412200|FG000|Overall Study|Protocol driven decision point|0|||
145935967|NCT03634033|526273268|FG006|Overall Study|Withdrawal by Subject|1|||
145935968|NCT06366087|526273269|FG000|Overall Study|Withdrawal by Subject|0|||
145935969|NCT06366087|526273270|FG001|Overall Study|Withdrawal by Subject|1|||
145935970|NCT02836236|526273271|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
145935971|NCT02836236|526273272|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
145935972|NCT02836236|526273273|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
145935973|NCT02836236|526273274|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145935974|NCT02836236|526273271|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
145935975|NCT02836236|526273272|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
145935976|NCT02836236|526273273|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145935977|NCT02836236|526273274|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145935978|NCT02836236|526273271|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145935979|NCT02836236|526273272|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
145935980|NCT02836236|526273273|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145935981|NCT02836236|526273274|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145935982|NCT02836236|526273271|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
145935983|NCT02836236|526273272|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145935984|NCT02836236|526273273|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145935985|NCT02836236|526273274|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145935986|NCT02836236|526273271|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145935987|NCT02836236|526273272|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145935988|NCT02836236|526273273|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
145935989|NCT02836236|526273274|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
145935990|NCT02836236|526273271|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145935991|NCT02836236|526273272|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145935992|NCT02836236|526273273|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
145935993|NCT02836236|526273274|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
145935994|NCT02836236|526273271|FG000|Open-Label TAF Treatment Phase|Death|0|||
145935995|NCT02836236|526273272|FG001|Open-Label TAF Treatment Phase|Death|0|||
145935996|NCT02836236|526273273|FG002|Open-Label TAF Treatment Phase|Death|1|||
145935997|NCT02836236|526273274|FG003|Open-Label TAF Treatment Phase|Death|1|||
145935998|NCT02836236|526273271|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145935999|NCT02836236|526273272|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145936000|NCT02836236|526273273|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
145936001|NCT02836236|526273274|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145936002|NCT01669174|526273282|FG000|Overall Study|Subject withdrew consent|2|||
145936003|NCT01669174|526273283|FG001|Overall Study|Subject withdrew consent|2|||
145936004|NCT01669174|526273282|FG000|Overall Study|Lost to Follow-up|1|||
145936005|NCT01669174|526273283|FG001|Overall Study|Lost to Follow-up|0|||
145936006|NCT01669174|526273282|FG000|Overall Study|Adverse Event|2|||
145936007|NCT01669174|526273283|FG001|Overall Study|Adverse Event|2|||
145936008|NCT01669174|526273282|FG000|Overall Study|Administrative problems|1|||
145936009|NCT01669174|526273283|FG001|Overall Study|Administrative problems|2|||
145936010|NCT01953601|526273284|FG000|Part 1 (Base Study)|Adverse Event|24|||
145936011|NCT01953601|526273285|FG001|Part 1 (Base Study)|Adverse Event|37|||
145936012|NCT01953601|526273286|FG002|Part 1 (Base Study)|Adverse Event|15|||
145936013|NCT01953601|526273284|FG000|Part 1 (Base Study)|Death|2|||
145936014|NCT01953601|526273285|FG001|Part 1 (Base Study)|Death|0|||
145936015|NCT01953601|526273286|FG002|Part 1 (Base Study)|Death|3|||
145936016|NCT01953601|526273284|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
145936017|NCT01953601|526273285|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
145936018|NCT01953601|526273286|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
145936019|NCT01953601|526273284|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
145936020|NCT01953601|526273285|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
145936021|NCT01953601|526273286|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
145936022|NCT01953601|526273284|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
145936023|NCT01953601|526273285|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
145936024|NCT01953601|526273286|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
145936025|NCT01953601|526273284|FG000|Part 1 (Base Study)|Physician Decision|3|||
145936026|NCT01953601|526273285|FG001|Part 1 (Base Study)|Physician Decision|7|||
145936027|NCT01953601|526273286|FG002|Part 1 (Base Study)|Physician Decision|4|||
145936028|NCT01953601|526273284|FG000|Part 1 (Base Study)|Screen failure|1|||
145936029|NCT01953601|526273285|FG001|Part 1 (Base Study)|Screen failure|0|||
145936030|NCT01953601|526273286|FG002|Part 1 (Base Study)|Screen failure|1|||
145936031|NCT01953601|526273284|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
145936032|NCT01953601|526273285|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
145936033|NCT01953601|526273286|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
145936034|NCT01953601|526273284|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
145936035|NCT01953601|526273285|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
145936036|NCT01953601|526273286|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
145936037|NCT01953601|526273284|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
145936038|NCT01953601|526273285|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
145936039|NCT01953601|526273286|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
145936040|NCT01953601|526273284|FG000|Part 1 (Base Study)|Subject moved|2|||
145936041|NCT01953601|526273285|FG001|Part 1 (Base Study)|Subject moved|2|||
145936042|NCT01953601|526273286|FG002|Part 1 (Base Study)|Subject moved|1|||
145936043|NCT01953601|526273284|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
145936044|NCT01953601|526273285|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
145936045|NCT01953601|526273286|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
145936046|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Adverse Event|1|||
145936047|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Adverse Event|1|||
145936048|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Adverse Event|10|||
145936049|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Death|0|||
145936050|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Death|3|||
145936051|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Death|0|||
145936052|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
145936053|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
145936054|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
145936055|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
145936056|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
145936057|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
145936058|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Physician Decision|2|||
145936059|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Physician Decision|0|||
145936060|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Physician Decision|2|||
145936061|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
145936062|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
145936063|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
145936064|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
145936065|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
145936066|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
145936067|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
145936068|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
145936069|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
145936070|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Subject moved|0|||
145936071|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Subject moved|0|||
145936072|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Subject moved|1|||
145936073|NCT01953601|526273284|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
145936074|NCT01953601|526273285|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
145936075|NCT01953601|526273286|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
145936076|NCT04310397|526273293|FG000|Overall Study|Lack of Efficacy|3|||
145936077|NCT04310397|526273293|FG000|Overall Study|Withdrawal by Subject|1|||
145936078|NCT00723255|526273294|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
145936079|NCT00723255|526273294|FG000|Overall Study|Ineligible: Second primary|1|||
145936080|NCT00723255|526273294|FG000|Overall Study|Ineligible: Wrong Primary|2|||
145936081|NCT00614523|526273295|FG000|Overall Study|Adverse Event|4|||
145936082|NCT00614523|526273296|FG001|Overall Study|Adverse Event|20|||
145936083|NCT00614523|526273295|FG000|Overall Study|Death|5|||
146245357|NCT01799993|527412201|FG001|Overall Study|Protocol driven decision point|3|||
145936084|NCT00614523|526273296|FG001|Overall Study|Death|8|||
145936085|NCT00614523|526273295|FG000|Overall Study|Lack of Efficacy|9|||
145936086|NCT00614523|526273296|FG001|Overall Study|Lack of Efficacy|11|||
145936087|NCT00614523|526273295|FG000|Overall Study|Lost to Follow-up|0|||
145936088|NCT00614523|526273296|FG001|Overall Study|Lost to Follow-up|1|||
145936089|NCT00614523|526273295|FG000|Overall Study|Protocol Violation|3|||
145936090|NCT00614523|526273296|FG001|Overall Study|Protocol Violation|2|||
145936091|NCT00614523|526273295|FG000|Overall Study|Withdrawal by Subject|12|||
145936092|NCT00614523|526273296|FG001|Overall Study|Withdrawal by Subject|22|||
145936093|NCT00614523|526273295|FG000|Overall Study|Other|6|||
145936094|NCT00614523|526273296|FG001|Overall Study|Other|11|||
145936095|NCT00614523|526273295|FG000|Overall Study|Ineligibility Determined|1|||
145936096|NCT00614523|526273296|FG001|Overall Study|Ineligibility Determined|2|||
145936097|NCT00614523|526273295|FG000|Overall Study|Disease Progression|0|||
145936098|NCT00614523|526273296|FG001|Overall Study|Disease Progression|8|||
145936099|NCT00614523|526273295|FG000|Overall Study|Administrative Decision|23|||
145936100|NCT00614523|526273296|FG001|Overall Study|Administrative Decision|46|||
145979201|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145979202|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145979203|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145979204|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145979205|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
145979206|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145979207|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145979208|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145936101|NCT03962790|526273297|FG000|Period 1|Adverse Event|0|||
145936102|NCT03962790|526273298|FG001|Period 1|Adverse Event|1|||
145936103|NCT03962790|526273297|FG000|Period 1|Failed to meet all eligibility criteria|1|||
145936104|NCT03962790|526273298|FG001|Period 1|Failed to meet all eligibility criteria|1|||
145936105|NCT03962790|526273297|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
145936106|NCT03962790|526273298|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
145936107|NCT03962790|526273297|FG000|Period 1|Withdrawal by Subject|1|||
145936108|NCT03962790|526273298|FG001|Period 1|Withdrawal by Subject|0|||
145936109|NCT00900757|526273304|FG000|Overall Study|screen failure|19|||
145936110|NCT02703272|526273305|FG000|Overall Study|Death|4|||
145936111|NCT02703272|526273306|FG001|Overall Study|Death|9|||
145936112|NCT02703272|526273307|FG002|Overall Study|Death|19|||
145936113|NCT02703272|526273308|FG003|Overall Study|Death|10|||
145936114|NCT02703272|526273305|FG000|Overall Study|Withdrawal by Subject|0|||
145936115|NCT02703272|526273306|FG001|Overall Study|Withdrawal by Subject|0|||
145936116|NCT02703272|526273307|FG002|Overall Study|Withdrawal by Subject|4|||
145936117|NCT02703272|526273308|FG003|Overall Study|Withdrawal by Subject|2|||
145936118|NCT02703272|526273305|FG000|Overall Study|Study Terminated by Sponsor|6|||
145936119|NCT02703272|526273306|FG001|Overall Study|Study Terminated by Sponsor|1|||
145936120|NCT02703272|526273307|FG002|Overall Study|Study Terminated by Sponsor|12|||
145936121|NCT02703272|526273308|FG003|Overall Study|Study Terminated by Sponsor|4|||
145936122|NCT02703272|526273305|FG000|Overall Study|Other|1|||
145936123|NCT02703272|526273306|FG001|Overall Study|Other|0|||
145936124|NCT02703272|526273307|FG002|Overall Study|Other|0|||
145936125|NCT02703272|526273308|FG003|Overall Study|Other|0|||
145936126|NCT00976820|526273309|FG000|Overall Study|Lost to Follow-up|5|||
145936127|NCT00976820|526273310|FG001|Overall Study|Lost to Follow-up|16|||
145936128|NCT00976820|526273311|FG002|Overall Study|Lost to Follow-up|2|||
145936129|NCT00976820|526273312|FG003|Overall Study|Lost to Follow-up|3|||
145936130|NCT00976820|526273309|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
145936131|NCT00976820|526273310|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
145936132|NCT00976820|526273311|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
145936133|NCT00976820|526273312|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
145936134|NCT00976820|526273309|FG000|Overall Study|Withdrawal by Subject|2|||
145936135|NCT00976820|526273310|FG001|Overall Study|Withdrawal by Subject|4|||
145936136|NCT00976820|526273311|FG002|Overall Study|Withdrawal by Subject|1|||
145936137|NCT00976820|526273312|FG003|Overall Study|Withdrawal by Subject|4|||
145936138|NCT01489254|526273313|FG000|Double-blind Part|Adverse Event|7|||
145936139|NCT01489254|526273314|FG001|Double-blind Part|Adverse Event|2|||
145936140|NCT01489254|526273315|FG002|Double-blind Part|Adverse Event|2|||
145936141|NCT01489254|526273316|FG003|Double-blind Part|Adverse Event|0|||
145936142|NCT01489254|526273313|FG000|Double-blind Part|Pregnancy|1|||
145936143|NCT01489254|526273314|FG001|Double-blind Part|Pregnancy|3|||
145936144|NCT01489254|526273315|FG002|Double-blind Part|Pregnancy|0|||
145936145|NCT01489254|526273316|FG003|Double-blind Part|Pregnancy|0|||
145936146|NCT01489254|526273313|FG000|Double-blind Part|Withdrawal by Subject|12|||
145936147|NCT01489254|526273314|FG001|Double-blind Part|Withdrawal by Subject|20|||
145936148|NCT01489254|526273315|FG002|Double-blind Part|Withdrawal by Subject|1|||
145936149|NCT01489254|526273316|FG003|Double-blind Part|Withdrawal by Subject|0|||
145936150|NCT01489254|526273313|FG000|Double-blind Part|Lost to Follow-up|1|||
145936151|NCT01489254|526273314|FG001|Double-blind Part|Lost to Follow-up|2|||
145936152|NCT01489254|526273315|FG002|Double-blind Part|Lost to Follow-up|0|||
145936153|NCT01489254|526273316|FG003|Double-blind Part|Lost to Follow-up|0|||
145936154|NCT01489254|526273313|FG000|Double-blind Part|Other reasons for not completing study|4|||
145936155|NCT01489254|526273314|FG001|Double-blind Part|Other reasons for not completing study|6|||
145936156|NCT01489254|526273315|FG002|Double-blind Part|Other reasons for not completing study|0|||
145936157|NCT01489254|526273316|FG003|Double-blind Part|Other reasons for not completing study|0|||
145936158|NCT01489254|526273313|FG000|Open-label Extension Part|Adverse Event|0|||
145936159|NCT01489254|526273314|FG001|Open-label Extension Part|Adverse Event|0|||
145936160|NCT01489254|526273315|FG002|Open-label Extension Part|Adverse Event|0|||
145936161|NCT01489254|526273316|FG003|Open-label Extension Part|Adverse Event|10|||
145936162|NCT01489254|526273313|FG000|Open-label Extension Part|Pregnancy|0|||
145979209|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145936163|NCT01489254|526273314|FG001|Open-label Extension Part|Pregnancy|0|||
145979210|NCT01807520|526435967|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
145936164|NCT01489254|526273315|FG002|Open-label Extension Part|Pregnancy|0|||
145936165|NCT01489254|526273316|FG003|Open-label Extension Part|Pregnancy|3|||
145936166|NCT01489254|526273313|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
145936167|NCT01489254|526273314|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
145936168|NCT01489254|526273315|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
145979211|NCT01807520|526435968|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145979212|NCT01807520|526435969|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145936169|NCT01489254|526273316|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
145979213|NCT01807520|526435970|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
146245358|NCT01799993|527412200|FG000|Overall Study|Protocol Violation|1|||
145936170|NCT01489254|526273313|FG000|Open-label Extension Part|Protocol Violation|0|||
145936171|NCT01489254|526273314|FG001|Open-label Extension Part|Protocol Violation|0|||
145936172|NCT01489254|526273315|FG002|Open-label Extension Part|Protocol Violation|0|||
145936173|NCT01489254|526273316|FG003|Open-label Extension Part|Protocol Violation|1|||
145936174|NCT01489254|526273313|FG000|Open-label Extension Part|Lost to Follow-up|0|||
145936175|NCT01489254|526273314|FG001|Open-label Extension Part|Lost to Follow-up|0|||
145936176|NCT01489254|526273315|FG002|Open-label Extension Part|Lost to Follow-up|0|||
145936177|NCT01489254|526273316|FG003|Open-label Extension Part|Lost to Follow-up|9|||
145936178|NCT01489254|526273313|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
145936179|NCT01489254|526273314|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
145936180|NCT01489254|526273315|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
145936181|NCT01489254|526273316|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
145936182|NCT04240457|526273318|FG000|Overall Study|Lost to Follow-up|5|||
145936183|NCT04240457|526273319|FG001|Overall Study|Lost to Follow-up|1|||
145936184|NCT00844480|526273320|FG000|Overall Study|Withdrawal by Subject|2|||
145936185|NCT00844480|526273321|FG001|Overall Study|Withdrawal by Subject|3|||
145936186|NCT00319592|526273324|FG000|Overall Study|Protocol Violation|1|||
145936187|NCT00319592|526273325|FG001|Overall Study|Protocol Violation|0|||
145936188|NCT00319592|526273324|FG000|Overall Study|Physician Decision|0|||
145936189|NCT00319592|526273325|FG001|Overall Study|Physician Decision|1|||
145936190|NCT01820572|526273332|FG000|Randomization|Not Treated|2|||
145936191|NCT01820572|526273333|FG001|Randomization|Not Treated|1|||
145936192|NCT01820572|526273332|FG000|Treatment Period|Adverse Event|12|||
145936193|NCT01820572|526273333|FG001|Treatment Period|Adverse Event|7|||
145936194|NCT01820572|526273332|FG000|Treatment Period|Death|3|||
145936195|NCT01820572|526273333|FG001|Treatment Period|Death|3|||
145936196|NCT01820572|526273332|FG000|Treatment Period|Lack of Efficacy|1|||
145936197|NCT01820572|526273333|FG001|Treatment Period|Lack of Efficacy|0|||
145936198|NCT01820572|526273332|FG000|Treatment Period|poor/non compliance|0|||
145936199|NCT01820572|526273333|FG001|Treatment Period|poor/non compliance|3|||
145936200|NCT01820572|526273332|FG000|Treatment Period|request to discontinue|6|||
145936201|NCT01820572|526273333|FG001|Treatment Period|request to discontinue|11|||
145936202|NCT01820572|526273332|FG000|Treatment Period|No longer meets study criteria|3|||
145936203|NCT01820572|526273333|FG001|Treatment Period|No longer meets study criteria|10|||
145936204|NCT01820572|526273332|FG000|Treatment Period|withdrew consent|1|||
145936205|NCT01820572|526273333|FG001|Treatment Period|withdrew consent|2|||
145936206|NCT04439214|526273339|FG000|Overall Study|Adverse Event|13|||
145936207|NCT04439214|526273339|FG000|Overall Study|Disease progression|16|||
145936208|NCT04439214|526273339|FG000|Overall Study|Death|1|||
145936209|NCT04439214|526273339|FG000|Overall Study|Withdrawal by Subject|2|||
145936210|NCT04439214|526273339|FG000|Overall Study|Declining health|1|||
145936211|NCT04439214|526273339|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
145936212|NCT04439214|526273339|FG000|Overall Study|Ineligible|5|||
145936213|NCT02235077|526273340|FG000|Overall Study|Death|5|||
145936214|NCT02235077|526273341|FG001|Overall Study|Death|7|||
145936215|NCT02235077|526273340|FG000|Overall Study|Lost to Follow-up|5|||
145936216|NCT02235077|526273341|FG001|Overall Study|Lost to Follow-up|6|||
145936217|NCT02235077|526273340|FG000|Overall Study|Withdrawal by Subject|8|||
145936218|NCT02235077|526273341|FG001|Overall Study|Withdrawal by Subject|5|||
145936219|NCT02235077|526273340|FG000|Overall Study|Physician Decision|0|||
145936220|NCT02235077|526273341|FG001|Overall Study|Physician Decision|1|||
145936221|NCT03852628|526273342|FG000|Overall Study|Lost to Follow-up|7|||
145936222|NCT03852628|526273343|FG001|Overall Study|Lost to Follow-up|6|||
145936223|NCT03852628|526273342|FG000|Overall Study|Lack of Efficacy|6|||
145936224|NCT03852628|526273343|FG001|Overall Study|Lack of Efficacy|6|||
145936225|NCT02964208|526273344|FG000|Overall Study|Death|103|||
145936226|NCT02964208|526273344|FG000|Overall Study|Withdrawal by Subject|6|||
145936227|NCT02964208|526273344|FG000|Overall Study|Lost to Follow-up|6|||
145936228|NCT02964208|526273344|FG000|Overall Study|Unsuccessful Procedure|5|||
145936229|NCT02964208|526273344|FG000|Overall Study|Device Explant|1|||
145936230|NCT02964208|526273344|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
145936231|NCT01668173|526273353|FG000|Overall Study|Adverse Event|3|||
145936232|NCT01668173|526273353|FG000|Overall Study|Trial suspension|4|||
145936233|NCT01295827|526273356|FG000|Overall Study|Adverse Event|1|||
145936234|NCT01295827|526273357|FG001|Overall Study|Adverse Event|2|||
145936235|NCT01295827|526273358|FG002|Overall Study|Adverse Event|2|||
145936236|NCT01295827|526273359|FG003|Overall Study|Adverse Event|1|||
145936237|NCT01295827|526273360|FG004|Overall Study|Adverse Event|1|||
145936238|NCT01295827|526273361|FG005|Overall Study|Adverse Event|4|||
145936239|NCT01295827|526273362|FG006|Overall Study|Adverse Event|15|||
145936240|NCT01295827|526273363|FG007|Overall Study|Adverse Event|49|||
145936241|NCT01295827|526273364|FG008|Overall Study|Adverse Event|22|||
145936242|NCT01295827|526273365|FG009|Overall Study|Adverse Event|7|||
145936243|NCT01295827|526273366|FG010|Overall Study|Adverse Event|50|||
145936244|NCT01295827|526273367|FG011|Overall Study|Adverse Event|21|||
145936245|NCT01295827|526273368|FG012|Overall Study|Adverse Event|0|||
145936246|NCT01295827|526273369|FG013|Overall Study|Adverse Event|0|||
145936247|NCT01295827|526273370|FG014|Overall Study|Adverse Event|0|||
145936248|NCT01295827|526273356|FG000|Overall Study|Lost to Follow-up|0|||
145936249|NCT01295827|526273357|FG001|Overall Study|Lost to Follow-up|0|||
145936250|NCT01295827|526273358|FG002|Overall Study|Lost to Follow-up|3|||
145936251|NCT01295827|526273359|FG003|Overall Study|Lost to Follow-up|0|||
145936252|NCT01295827|526273360|FG004|Overall Study|Lost to Follow-up|1|||
145936253|NCT01295827|526273361|FG005|Overall Study|Lost to Follow-up|0|||
145936254|NCT01295827|526273362|FG006|Overall Study|Lost to Follow-up|4|||
145936255|NCT01295827|526273363|FG007|Overall Study|Lost to Follow-up|8|||
145936256|NCT01295827|526273364|FG008|Overall Study|Lost to Follow-up|7|||
145936257|NCT01295827|526273365|FG009|Overall Study|Lost to Follow-up|4|||
145936258|NCT01295827|526273366|FG010|Overall Study|Lost to Follow-up|7|||
145936259|NCT01295827|526273367|FG011|Overall Study|Lost to Follow-up|3|||
145936260|NCT01295827|526273368|FG012|Overall Study|Lost to Follow-up|0|||
145936261|NCT01295827|526273369|FG013|Overall Study|Lost to Follow-up|0|||
145936262|NCT01295827|526273370|FG014|Overall Study|Lost to Follow-up|0|||
145936263|NCT01295827|526273356|FG000|Overall Study|Not Reported|0|||
145936264|NCT01295827|526273357|FG001|Overall Study|Not Reported|0|||
145936265|NCT01295827|526273358|FG002|Overall Study|Not Reported|0|||
145936266|NCT01295827|526273359|FG003|Overall Study|Not Reported|1|||
145936267|NCT01295827|526273360|FG004|Overall Study|Not Reported|0|||
145936268|NCT01295827|526273361|FG005|Overall Study|Not Reported|0|||
145936269|NCT01295827|526273362|FG006|Overall Study|Not Reported|24|||
145936270|NCT01295827|526273363|FG007|Overall Study|Not Reported|58|||
145936271|NCT01295827|526273364|FG008|Overall Study|Not Reported|41|||
145936272|NCT01295827|526273365|FG009|Overall Study|Not Reported|2|||
145936273|NCT01295827|526273366|FG010|Overall Study|Not Reported|23|||
145936274|NCT01295827|526273367|FG011|Overall Study|Not Reported|13|||
145936275|NCT01295827|526273368|FG012|Overall Study|Not Reported|0|||
145936276|NCT01295827|526273369|FG013|Overall Study|Not Reported|0|||
145936277|NCT01295827|526273370|FG014|Overall Study|Not Reported|0|||
145936278|NCT01295827|526273356|FG000|Overall Study|Progressive Disease|2|||
145936279|NCT01295827|526273357|FG001|Overall Study|Progressive Disease|1|||
145936280|NCT01295827|526273358|FG002|Overall Study|Progressive Disease|5|||
145936281|NCT01295827|526273359|FG003|Overall Study|Progressive Disease|2|||
145936282|NCT01295827|526273360|FG004|Overall Study|Progressive Disease|0|||
145936283|NCT01295827|526273361|FG005|Overall Study|Progressive Disease|1|||
145936284|NCT01295827|526273362|FG006|Overall Study|Progressive Disease|87|||
145936285|NCT01295827|526273363|FG007|Overall Study|Progressive Disease|144|||
145936286|NCT01295827|526273364|FG008|Overall Study|Progressive Disease|85|||
145936287|NCT01295827|526273365|FG009|Overall Study|Progressive Disease|40|||
145936288|NCT01295827|526273366|FG010|Overall Study|Progressive Disease|175|||
145936289|NCT01295827|526273367|FG011|Overall Study|Progressive Disease|136|||
145936290|NCT01295827|526273368|FG012|Overall Study|Progressive Disease|0|||
145936291|NCT01295827|526273369|FG013|Overall Study|Progressive Disease|0|||
145936292|NCT01295827|526273370|FG014|Overall Study|Progressive Disease|0|||
145936293|NCT01295827|526273356|FG000|Overall Study|Screen Failure|0|||
145936294|NCT01295827|526273357|FG001|Overall Study|Screen Failure|0|||
145936295|NCT01295827|526273358|FG002|Overall Study|Screen Failure|0|||
145936296|NCT01295827|526273359|FG003|Overall Study|Screen Failure|0|||
145936297|NCT01295827|526273360|FG004|Overall Study|Screen Failure|0|||
145936298|NCT01295827|526273361|FG005|Overall Study|Screen Failure|0|||
145936299|NCT01295827|526273362|FG006|Overall Study|Screen Failure|2|||
145936300|NCT01295827|526273363|FG007|Overall Study|Screen Failure|2|||
145936301|NCT01295827|526273364|FG008|Overall Study|Screen Failure|2|||
145936302|NCT01295827|526273365|FG009|Overall Study|Screen Failure|0|||
145936303|NCT01295827|526273366|FG010|Overall Study|Screen Failure|1|||
145936304|NCT01295827|526273367|FG011|Overall Study|Screen Failure|0|||
145936305|NCT01295827|526273368|FG012|Overall Study|Screen Failure|0|||
145936306|NCT01295827|526273369|FG013|Overall Study|Screen Failure|0|||
145936307|NCT01295827|526273370|FG014|Overall Study|Screen Failure|0|||
145936308|NCT01295827|526273356|FG000|Overall Study|Withdrawal by Subject|1|||
145936309|NCT01295827|526273357|FG001|Overall Study|Withdrawal by Subject|0|||
145936310|NCT01295827|526273358|FG002|Overall Study|Withdrawal by Subject|2|||
145936311|NCT01295827|526273359|FG003|Overall Study|Withdrawal by Subject|0|||
145936312|NCT01295827|526273360|FG004|Overall Study|Withdrawal by Subject|0|||
145936313|NCT01295827|526273361|FG005|Overall Study|Withdrawal by Subject|1|||
145936314|NCT01295827|526273362|FG006|Overall Study|Withdrawal by Subject|13|||
145936315|NCT01295827|526273363|FG007|Overall Study|Withdrawal by Subject|35|||
146245359|NCT01799993|527412201|FG001|Overall Study|Protocol Violation|1|||
145936316|NCT01295827|526273364|FG008|Overall Study|Withdrawal by Subject|11|||
145936317|NCT01295827|526273365|FG009|Overall Study|Withdrawal by Subject|2|||
145936318|NCT01295827|526273366|FG010|Overall Study|Withdrawal by Subject|18|||
145936319|NCT01295827|526273367|FG011|Overall Study|Withdrawal by Subject|13|||
145936320|NCT01295827|526273368|FG012|Overall Study|Withdrawal by Subject|0|||
145936321|NCT01295827|526273369|FG013|Overall Study|Withdrawal by Subject|0|||
145936322|NCT01295827|526273370|FG014|Overall Study|Withdrawal by Subject|0|||
145936323|NCT01295827|526273356|FG000|Overall Study|Other|0|||
145936324|NCT01295827|526273357|FG001|Overall Study|Other|0|||
145936325|NCT01295827|526273358|FG002|Overall Study|Other|0|||
145936326|NCT01295827|526273359|FG003|Overall Study|Other|0|||
145936327|NCT01295827|526273360|FG004|Overall Study|Other|0|||
145936328|NCT01295827|526273361|FG005|Overall Study|Other|0|||
145936329|NCT01295827|526273362|FG006|Overall Study|Other|1|||
145936330|NCT01295827|526273363|FG007|Overall Study|Other|1|||
145936331|NCT01295827|526273364|FG008|Overall Study|Other|1|||
145936332|NCT01295827|526273365|FG009|Overall Study|Other|0|||
145936333|NCT01295827|526273366|FG010|Overall Study|Other|2|||
145936334|NCT01295827|526273367|FG011|Overall Study|Other|0|||
145936335|NCT01295827|526273368|FG012|Overall Study|Other|0|||
145936336|NCT01295827|526273369|FG013|Overall Study|Other|0|||
145936337|NCT01295827|526273370|FG014|Overall Study|Other|0|||
145936338|NCT00072280|526273371|FG000|Treatment|Found ineligible|1|||
145936339|NCT00072280|526273372|FG001|Treatment|Found ineligible|2|||
145936340|NCT00072280|526273371|FG000|Follow-up|Early termination of study|2|||
145936341|NCT00072280|526273372|FG001|Follow-up|Early termination of study|2|||
145936342|NCT00746564|526273373|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
145936343|NCT03226769|526273376|FG000|Overall Study|Withdrawal by Subject|0|||
145936344|NCT03226769|526273377|FG001|Overall Study|Withdrawal by Subject|1|||
145936345|NCT02640677|526273380|FG000|Overall Study|Lost to Follow-up|1|||
145936346|NCT02640677|526273380|FG000|Overall Study|Withdrawal by Subject|1|||
145936347|NCT00957268|526273390|FG000|Overall Study|Voluntary Withdrawal|0|||
145936348|NCT00957268|526273391|FG001|Overall Study|Voluntary Withdrawal|0|||
145936349|NCT00957268|526273392|FG002|Overall Study|Voluntary Withdrawal|1|||
145936350|NCT00957268|526273393|FG003|Overall Study|Voluntary Withdrawal|0|||
145936351|NCT00957268|526273394|FG004|Overall Study|Voluntary Withdrawal|0|||
145936352|NCT01758731|526273395|FG000|Overall Study|Physician Decision|1|||
145936353|NCT02396420|526273401|FG000|Overall Study|Death|1|||
145936354|NCT01273623|526273403|FG000|Overall Study|did not meet IVUS criteria|29|||
145936355|NCT01493284|526273404|FG000|Overall Study|Death|29|||
145936356|NCT01493284|526273404|FG000|Overall Study|Withdrawal by Subject|32|||
145936357|NCT03489707|526273405|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
145936358|NCT03489707|526273406|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
145936359|NCT03489707|526273405|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
145936360|NCT03489707|526273406|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
145936361|NCT00519428|526273407|FG000|Overall Study|Adverse Event|5|||
145936362|NCT00519428|526273408|FG001|Overall Study|Adverse Event|2|||
145936363|NCT00519428|526273409|FG002|Overall Study|Adverse Event|10|||
145936364|NCT00519428|526273407|FG000|Overall Study|Lost to Follow-up|7|||
145936365|NCT00519428|526273408|FG001|Overall Study|Lost to Follow-up|7|||
145936366|NCT00519428|526273409|FG002|Overall Study|Lost to Follow-up|6|||
145936367|NCT00519428|526273407|FG000|Overall Study|Withdrawal by Subject|8|||
145936368|NCT00519428|526273408|FG001|Overall Study|Withdrawal by Subject|3|||
145936369|NCT00519428|526273409|FG002|Overall Study|Withdrawal by Subject|7|||
145936370|NCT00519428|526273407|FG000|Overall Study|unstated|1|||
145936371|NCT00519428|526273408|FG001|Overall Study|unstated|3|||
145936372|NCT00519428|526273409|FG002|Overall Study|unstated|2|||
145936373|NCT00325156|526273410|FG000|Overall Study|Protocol Violation|8|||
145936374|NCT00325156|526273410|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
145936375|NCT00325156|526273410|FG000|Overall Study|Migrated/moved from study area|12|||
145936376|NCT00325156|526273410|FG000|Overall Study|Adverse event, non-fatal|3|||
145936377|NCT00325156|526273410|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
145936378|NCT00325156|526273410|FG000|Overall Study|Other|1|||
145936379|NCT00325156|526273410|FG000|Overall Study|Withdrawal by Subject|31|||
145936380|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
145936381|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
145936382|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
145936383|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
146297798|NCT04029480|527606006|FG000|Overall Study|Withdrawal by Subject|2|||
145936384|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145936385|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145936386|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145936387|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145936388|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
146297799|NCT04029480|527606007|FG001|Overall Study|Withdrawal by Subject|0|||
146297800|NCT04029480|527606008|FG002|Overall Study|Withdrawal by Subject|1|||
145936389|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
145936390|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145936391|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145936392|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145936393|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145936394|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
145936395|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
145936396|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145936397|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145936398|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145936399|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145936400|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145936401|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936402|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
145936403|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936404|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936405|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936406|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936407|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145936408|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
145936409|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145936410|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
145936411|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145936412|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145936413|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145936414|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145936415|NCT03395184|526273411|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
145936416|NCT03395184|526273412|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
145936417|NCT03395184|526273413|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
145936418|NCT03395184|526273414|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
145936419|NCT03395184|526273415|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
145936420|NCT03395184|526273416|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
145936421|NCT03395184|526273417|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
145936422|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
145936423|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
145936424|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
145936425|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
145936426|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
145979214|NCT01807520|526435971|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145979215|NCT01807520|526435972|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145979216|NCT01807520|526435973|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145979217|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
145979218|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
145979219|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145979220|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145979221|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
145979222|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145979223|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145979224|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979225|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979226|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979227|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
145979228|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979229|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979230|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145979231|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
145979232|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979233|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979234|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979235|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979236|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979237|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145979238|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145936427|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
145936428|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
145936429|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145936430|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145936431|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145936432|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
145936433|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
145936434|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
145936435|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
145936436|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936437|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936438|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936439|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936440|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
145979239|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
145979240|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145936441|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936442|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145936443|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145936444|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145936445|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145936446|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
145936447|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
145936448|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
145936449|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
145936450|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145936451|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145936452|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145936453|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
145936454|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145936455|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
145936456|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145936457|NCT03395184|526273411|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145936458|NCT03395184|526273412|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145936459|NCT03395184|526273413|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145936460|NCT03395184|526273414|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
145936461|NCT03395184|526273415|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
145936462|NCT03395184|526273416|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
145936463|NCT03395184|526273417|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
145936464|NCT01817582|526273418|FG000|Overall Study|Withdrawal by Subject|0|||
145936465|NCT01817582|526273419|FG001|Overall Study|Withdrawal by Subject|1|||
145936466|NCT01817582|526273420|FG002|Overall Study|Withdrawal by Subject|0|||
145936467|NCT01817582|526273418|FG000|Overall Study|Participant revealed masked treatment|1|||
145936468|NCT01817582|526273419|FG001|Overall Study|Participant revealed masked treatment|0|||
145936469|NCT01817582|526273420|FG002|Overall Study|Participant revealed masked treatment|0|||
145936470|NCT01817582|526273418|FG000|Overall Study|Randomized but exclusion criteria met|1|||
145936471|NCT01817582|526273419|FG001|Overall Study|Randomized but exclusion criteria met|0|||
145936472|NCT01817582|526273420|FG002|Overall Study|Randomized but exclusion criteria met|0|||
145936473|NCT03053063|526273421|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
145936474|NCT03053063|526273422|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
145936475|NCT03053063|526273423|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
145936476|NCT03053063|526273424|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
145936477|NCT03053063|526273421|FG000|Randomized Phase|Withdrew consent|8|||
145936478|NCT03053063|526273422|FG001|Randomized Phase|Withdrew consent|11|||
145936479|NCT03053063|526273423|FG002|Randomized Phase|Withdrew consent|5|||
145936480|NCT03053063|526273424|FG003|Randomized Phase|Withdrew consent|0|||
145936481|NCT03053063|526273421|FG000|Randomized Phase|Investigator's Discretion|8|||
145936482|NCT03053063|526273422|FG001|Randomized Phase|Investigator's Discretion|6|||
145936483|NCT03053063|526273423|FG002|Randomized Phase|Investigator's Discretion|2|||
145936484|NCT03053063|526273424|FG003|Randomized Phase|Investigator's Discretion|0|||
145936485|NCT03053063|526273421|FG000|Randomized Phase|Lost to Follow-up|3|||
145936486|NCT03053063|526273422|FG001|Randomized Phase|Lost to Follow-up|5|||
145936487|NCT03053063|526273423|FG002|Randomized Phase|Lost to Follow-up|1|||
145936488|NCT03053063|526273424|FG003|Randomized Phase|Lost to Follow-up|0|||
145936489|NCT03053063|526273421|FG000|Randomized Phase|Adverse Event|0|||
145936490|NCT03053063|526273422|FG001|Randomized Phase|Adverse Event|1|||
145936491|NCT03053063|526273423|FG002|Randomized Phase|Adverse Event|0|||
145979241|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145979242|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145979243|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145979244|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145979245|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
145979246|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145979247|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145979248|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
145936492|NCT03053063|526273424|FG003|Randomized Phase|Adverse Event|0|||
145936493|NCT03053063|526273421|FG000|Randomized Phase|Randomized but Never Treated|1|||
145936494|NCT03053063|526273422|FG001|Randomized Phase|Randomized but Never Treated|3|||
145936495|NCT03053063|526273423|FG002|Randomized Phase|Randomized but Never Treated|2|||
145936496|NCT03053063|526273424|FG003|Randomized Phase|Randomized but Never Treated|0|||
145936497|NCT03053063|526273421|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
145979249|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
146297801|NCT04029480|527606009|FG003|Overall Study|Withdrawal by Subject|1|||
145936498|NCT03053063|526273422|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
145936499|NCT03053063|526273423|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
145936500|NCT03053063|526273424|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
145936501|NCT03053063|526273421|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
145936502|NCT03053063|526273422|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
145936503|NCT03053063|526273423|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
145936504|NCT03053063|526273424|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
145936505|NCT03053063|526273421|FG000|Open-Label Phase|Death|0|||
145936506|NCT03053063|526273422|FG001|Open-Label Phase|Death|0|||
145936507|NCT03053063|526273423|FG002|Open-Label Phase|Death|0|||
145936508|NCT03053063|526273424|FG003|Open-Label Phase|Death|2|||
145936509|NCT03053063|526273421|FG000|Open-Label Phase|Investigator's discretion|0|||
145936510|NCT03053063|526273422|FG001|Open-Label Phase|Investigator's discretion|0|||
145936511|NCT03053063|526273423|FG002|Open-Label Phase|Investigator's discretion|0|||
145936512|NCT03053063|526273424|FG003|Open-Label Phase|Investigator's discretion|2|||
145936513|NCT03617770|526273428|FG000|Overall Study|Lost to Follow-up|1|||
145936514|NCT03617770|526273429|FG001|Overall Study|Lost to Follow-up|0|||
145936515|NCT00356135|526273430|FG000|Overall Study|Protocol Violation|1|||
145936516|NCT00356135|526273431|FG001|Overall Study|Protocol Violation|0|||
145936517|NCT00356135|526273432|FG002|Overall Study|Protocol Violation|0|||
145936518|NCT00356135|526273430|FG000|Overall Study|Adverse Event|1|||
145936519|NCT00356135|526273431|FG001|Overall Study|Adverse Event|0|||
145936520|NCT00356135|526273432|FG002|Overall Study|Adverse Event|0|||
145936521|NCT00356135|526273430|FG000|Overall Study|Lost to Follow-up|0|||
145936522|NCT00356135|526273431|FG001|Overall Study|Lost to Follow-up|0|||
145936523|NCT00356135|526273432|FG002|Overall Study|Lost to Follow-up|1|||
145936524|NCT00356135|526273430|FG000|Overall Study|Physician Decision|1|||
145936525|NCT00356135|526273431|FG001|Overall Study|Physician Decision|1|||
145936526|NCT00356135|526273432|FG002|Overall Study|Physician Decision|1|||
145936527|NCT00356135|526273430|FG000|Overall Study|Subject non-compliance|1|||
145936528|NCT00356135|526273431|FG001|Overall Study|Subject non-compliance|1|||
145936529|NCT00356135|526273432|FG002|Overall Study|Subject non-compliance|3|||
145936530|NCT05033262|526273433|FG000|Overall Study|Lost to Follow-up|1|||
145936531|NCT05033262|526273434|FG001|Overall Study|Lost to Follow-up|0|||
145936532|NCT05033262|526273435|FG002|Overall Study|Lost to Follow-up|0|||
145936533|NCT05033262|526273436|FG003|Overall Study|Lost to Follow-up|1|||
145936534|NCT05270395|526273437|FG000|Overall Study|Lost to Follow-up|2|||
145936535|NCT05270395|526273438|FG001|Overall Study|Lost to Follow-up|2|||
145936536|NCT05270395|526273437|FG000|Overall Study|Death|1|||
145936537|NCT05270395|526273438|FG001|Overall Study|Death|2|||
145936538|NCT05270395|526273437|FG000|Overall Study|Study Team Withdrew|1|||
145936539|NCT05270395|526273438|FG001|Overall Study|Study Team Withdrew|0|||
145936540|NCT01397786|526275586|FG000|Phase A|Lost to Follow-up|0|||
145936541|NCT01397786|526275587|FG001|Phase A|Lost to Follow-up|0|||
145936542|NCT01397786|526275588|FG002|Phase A|Lost to Follow-up|6|||
145936543|NCT01397786|526275586|FG000|Phase A|Adverse Event|0|||
145936544|NCT01397786|526275587|FG001|Phase A|Adverse Event|0|||
145936545|NCT01397786|526275588|FG002|Phase A|Adverse Event|8|||
145936546|NCT01397786|526275586|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
145936547|NCT01397786|526275587|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
145936548|NCT01397786|526275588|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
145936549|NCT01397786|526275586|FG000|Phase A|Physician Decision|0|||
145936550|NCT01397786|526275587|FG001|Phase A|Physician Decision|0|||
145936551|NCT01397786|526275588|FG002|Phase A|Physician Decision|1|||
145936552|NCT01397786|526275586|FG000|Phase A|Withdrawal by Subject|0|||
145936553|NCT01397786|526275587|FG001|Phase A|Withdrawal by Subject|0|||
145936554|NCT01397786|526275588|FG002|Phase A|Withdrawal by Subject|5|||
145936555|NCT01397786|526275586|FG000|Phase A|Lack of Efficacy|0|||
145936556|NCT01397786|526275587|FG001|Phase A|Lack of Efficacy|0|||
146091133|NCT01390220|526854880|FG002|Comparative Phase|Withdrawal by Subject|0|||
146091134|NCT04025710|526854881|FG000|Overall Study|Death|3|||
146091135|NCT04025710|526854881|FG000|Overall Study|Lost to Follow-up|5|||
146091136|NCT04025710|526854881|FG000|Overall Study|Withdrawal by Subject|1|||
146091137|NCT04025710|526854881|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
145936557|NCT01397786|526275588|FG002|Phase A|Lack of Efficacy|1|||
145936558|NCT01397786|526275586|FG000|Phase B|Lost to Follow-up|22|||
146091138|NCT04025710|526854881|FG000|Overall Study|Drop-out according to protocol|34|||
145936559|NCT01397786|526275587|FG001|Phase B|Lost to Follow-up|12|||
145936560|NCT01397786|526275588|FG002|Phase B|Lost to Follow-up|22|||
145936561|NCT01397786|526275586|FG000|Phase B|Adverse Event|109|||
145936562|NCT01397786|526275587|FG001|Phase B|Adverse Event|23|||
145936563|NCT01397786|526275588|FG002|Phase B|Adverse Event|27|||
145936564|NCT01397786|526275586|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
146091139|NCT00245583|526854884|FG000|Overall Study|Lost to Follow-up|1|||
146091140|NCT00245583|526854885|FG001|Overall Study|Lost to Follow-up|5|||
145936565|NCT01397786|526275587|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
145936566|NCT01397786|526275588|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
145936567|NCT01397786|526275586|FG000|Phase B|Physician Decision|9|||
145936568|NCT01397786|526275587|FG001|Phase B|Physician Decision|1|||
145936569|NCT01397786|526275588|FG002|Phase B|Physician Decision|3|||
145936570|NCT01397786|526275586|FG000|Phase B|Withdrawal by Subject|102|||
145936571|NCT01397786|526275587|FG001|Phase B|Withdrawal by Subject|45|||
145936572|NCT01397786|526275588|FG002|Phase B|Withdrawal by Subject|30|||
145936573|NCT01397786|526275586|FG000|Phase B|Protocol Deviation|1|||
145936574|NCT01397786|526275587|FG001|Phase B|Protocol Deviation|2|||
145936575|NCT01397786|526275588|FG002|Phase B|Protocol Deviation|4|||
145936576|NCT01397786|526275586|FG000|Phase B|Lack of Efficacy|22|||
145936577|NCT01397786|526275587|FG001|Phase B|Lack of Efficacy|7|||
145936578|NCT01397786|526275588|FG002|Phase B|Lack of Efficacy|14|||
145936579|NCT00784550|526275592|FG000|Overall Study|Adverse Event|12|||
145936580|NCT00784550|526275593|FG001|Overall Study|Adverse Event|10|||
145936581|NCT00784550|526275592|FG000|Overall Study|Lack of Efficacy|0|||
145936582|NCT00784550|526275593|FG001|Overall Study|Lack of Efficacy|1|||
145936583|NCT00784550|526275592|FG000|Overall Study|Protocol Violation|10|||
145936584|NCT00784550|526275593|FG001|Overall Study|Protocol Violation|10|||
145936585|NCT00784550|526275592|FG000|Overall Study|Lost to Follow-up|8|||
145936586|NCT00784550|526275593|FG001|Overall Study|Lost to Follow-up|5|||
145936587|NCT00784550|526275592|FG000|Overall Study|Physician Decision|2|||
145936588|NCT00784550|526275593|FG001|Overall Study|Physician Decision|3|||
145936589|NCT00784550|526275592|FG000|Overall Study|Withdrawal by Subject|4|||
145936590|NCT00784550|526275593|FG001|Overall Study|Withdrawal by Subject|13|||
145936591|NCT00860249|526275594|FG000|Overall Study|trial was terminated prior to completion|21|||
145936592|NCT00860249|526275595|FG001|Overall Study|trial was terminated prior to completion|18|||
145936593|NCT00860249|526275596|FG002|Overall Study|trial was terminated prior to completion|21|||
145936594|NCT05903924|526275597|FG000|Overall Study|Lost to Follow-up|1|||
145936595|NCT05903924|526275598|FG001|Overall Study|Lost to Follow-up|0|||
145936596|NCT05903924|526275599|FG002|Overall Study|Lost to Follow-up|0|||
145936597|NCT01275755|526275609|FG000|Double-blind Treatment Period|Adverse Event|0|||
145936598|NCT01275755|526275610|FG001|Double-blind Treatment Period|Adverse Event|2|||
145936599|NCT01275755|526275609|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
145936600|NCT01275755|526275610|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
145936601|NCT01275755|526275609|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145936602|NCT01275755|526275610|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145936603|NCT01275755|526275609|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
145936604|NCT01275755|526275610|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
145936605|NCT00174967|526275615|FG000|Overall Study|Adverse Event|1|||
145936606|NCT00174967|526275616|FG001|Overall Study|Adverse Event|2|||
145936607|NCT00174967|526275617|FG002|Overall Study|Adverse Event|2|||
145936608|NCT00174967|526275618|FG003|Overall Study|Adverse Event|1|||
145936609|NCT00174967|526275615|FG000|Overall Study|Gout Flare|0|||
145936610|NCT00174967|526275616|FG001|Overall Study|Gout Flare|0|||
145936611|NCT00174967|526275617|FG002|Overall Study|Gout Flare|0|||
145936612|NCT00174967|526275618|FG003|Overall Study|Gout Flare|1|||
145936613|NCT00174967|526275615|FG000|Overall Study|Other|0|||
145936614|NCT00174967|526275616|FG001|Overall Study|Other|1|||
145936615|NCT00174967|526275617|FG002|Overall Study|Other|0|||
145936616|NCT00174967|526275618|FG003|Overall Study|Other|0|||
145936617|NCT04420585|526275619|FG000|Overall Study|Adverse Event|1|||
145936618|NCT04420585|526275619|FG000|Overall Study|Never initiated medication|2|||
145936619|NCT00477750|526275620|FG000|Overall Study|Currently Receiving Treatment|11|||
145936620|NCT03558152|526275621|FG000|Overall Study|Adverse Event|0|||
145936621|NCT03558152|526275622|FG001|Overall Study|Adverse Event|0|||
145936622|NCT03558152|526275623|FG002|Overall Study|Adverse Event|1|||
145936623|NCT03558152|526275624|FG003|Overall Study|Adverse Event|1|||
145936624|NCT03558152|526275625|FG004|Overall Study|Adverse Event|2|||
145936625|NCT03558152|526275626|FG005|Overall Study|Adverse Event|1|||
145936626|NCT03558152|526275627|FG006|Overall Study|Adverse Event|1|||
145936627|NCT03558152|526275628|FG007|Overall Study|Adverse Event|0|||
145936628|NCT03558152|526275621|FG000|Overall Study|Death|0|||
145936629|NCT03558152|526275622|FG001|Overall Study|Death|0|||
145936630|NCT03558152|526275623|FG002|Overall Study|Death|0|||
145936631|NCT03558152|526275624|FG003|Overall Study|Death|0|||
146297802|NCT04786119|527606010|FG000|Overall Study|Withdrawal by Subject|4|||
146297803|NCT04786119|527606011|FG001|Overall Study|Withdrawal by Subject|5|||
145936632|NCT03558152|526275625|FG004|Overall Study|Death|1|||
145936633|NCT03558152|526275626|FG005|Overall Study|Death|0|||
145936634|NCT03558152|526275627|FG006|Overall Study|Death|0|||
146297804|NCT04786119|527606010|FG000|Overall Study|Lost to Follow-up|5|||
145936635|NCT03558152|526275628|FG007|Overall Study|Death|0|||
145936636|NCT03558152|526275621|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
145936637|NCT03558152|526275622|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936638|NCT03558152|526275623|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936639|NCT03558152|526275624|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936640|NCT03558152|526275625|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936641|NCT03558152|526275626|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936642|NCT03558152|526275627|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145936643|NCT03558152|526275628|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
146091141|NCT00245583|526854884|FG000|Overall Study|Adverse Event|2|||
146245360|NCT01799993|527412200|FG000|Overall Study|Deterioration of general conditions|2|||
146245361|NCT01799993|527412201|FG001|Overall Study|Deterioration of general conditions|0|||
146245362|NCT01799993|527412200|FG000|Overall Study|Screen failure|0|||
146245363|NCT01799993|527412201|FG001|Overall Study|Screen failure|1|||
146245364|NCT01799993|527412200|FG000|Overall Study|Adverse Event|1|||
145936644|NCT03558152|526275621|FG000|Overall Study|Miscalculation in mmcs|0|||
145936645|NCT03558152|526275622|FG001|Overall Study|Miscalculation in mmcs|0|||
145936646|NCT03558152|526275623|FG002|Overall Study|Miscalculation in mmcs|0|||
145936647|NCT03558152|526275624|FG003|Overall Study|Miscalculation in mmcs|0|||
145936648|NCT03558152|526275625|FG004|Overall Study|Miscalculation in mmcs|0|||
145936649|NCT03558152|526275626|FG005|Overall Study|Miscalculation in mmcs|0|||
145936650|NCT03558152|526275627|FG006|Overall Study|Miscalculation in mmcs|1|||
145936651|NCT03558152|526275628|FG007|Overall Study|Miscalculation in mmcs|0|||
145936652|NCT03558152|526275621|FG000|Overall Study|Mistake in calculation|0|||
145936653|NCT03558152|526275622|FG001|Overall Study|Mistake in calculation|0|||
145936654|NCT03558152|526275623|FG002|Overall Study|Mistake in calculation|0|||
145936655|NCT03558152|526275624|FG003|Overall Study|Mistake in calculation|1|||
145936656|NCT03558152|526275625|FG004|Overall Study|Mistake in calculation|0|||
145936657|NCT03558152|526275626|FG005|Overall Study|Mistake in calculation|0|||
145936658|NCT03558152|526275627|FG006|Overall Study|Mistake in calculation|0|||
145936659|NCT03558152|526275628|FG007|Overall Study|Mistake in calculation|0|||
145936660|NCT03558152|526275621|FG000|Overall Study|Mistake in evaluation of disease status|0|||
145936661|NCT03558152|526275622|FG001|Overall Study|Mistake in evaluation of disease status|0|||
145936662|NCT03558152|526275623|FG002|Overall Study|Mistake in evaluation of disease status|0|||
145936663|NCT03558152|526275624|FG003|Overall Study|Mistake in evaluation of disease status|0|||
145936664|NCT03558152|526275625|FG004|Overall Study|Mistake in evaluation of disease status|0|||
145936665|NCT03558152|526275626|FG005|Overall Study|Mistake in evaluation of disease status|0|||
145936666|NCT03558152|526275627|FG006|Overall Study|Mistake in evaluation of disease status|0|||
145936667|NCT03558152|526275628|FG007|Overall Study|Mistake in evaluation of disease status|1|||
145936668|NCT03558152|526275621|FG000|Overall Study|Physician Decision|0|||
145936669|NCT03558152|526275622|FG001|Overall Study|Physician Decision|0|||
145936670|NCT03558152|526275623|FG002|Overall Study|Physician Decision|0|||
145936671|NCT03558152|526275624|FG003|Overall Study|Physician Decision|0|||
145936672|NCT03558152|526275625|FG004|Overall Study|Physician Decision|0|||
145936673|NCT03558152|526275626|FG005|Overall Study|Physician Decision|0|||
145936674|NCT03558152|526275627|FG006|Overall Study|Physician Decision|1|||
145936675|NCT03558152|526275628|FG007|Overall Study|Physician Decision|0|||
145936676|NCT03558152|526275621|FG000|Overall Study|Withdrawal by Subject|2|||
145936677|NCT03558152|526275622|FG001|Overall Study|Withdrawal by Subject|3|||
145936678|NCT03558152|526275623|FG002|Overall Study|Withdrawal by Subject|2|||
145936679|NCT03558152|526275624|FG003|Overall Study|Withdrawal by Subject|1|||
145936680|NCT03558152|526275625|FG004|Overall Study|Withdrawal by Subject|1|||
145936681|NCT03558152|526275626|FG005|Overall Study|Withdrawal by Subject|1|||
145936682|NCT03558152|526275627|FG006|Overall Study|Withdrawal by Subject|3|||
145936683|NCT03558152|526275628|FG007|Overall Study|Withdrawal by Subject|2|||
145936684|NCT03558152|526275621|FG000|Overall Study|Lack of Efficacy|11|||
145936685|NCT03558152|526275622|FG001|Overall Study|Lack of Efficacy|11|||
145936686|NCT03558152|526275623|FG002|Overall Study|Lack of Efficacy|10|||
145936687|NCT03558152|526275624|FG003|Overall Study|Lack of Efficacy|11|||
145936688|NCT03558152|526275625|FG004|Overall Study|Lack of Efficacy|14|||
146245365|NCT01799993|527412201|FG001|Overall Study|Adverse Event|0|||
146245366|NCT01799993|527412200|FG000|Overall Study|Lack of Efficacy|1|||
146245367|NCT01799993|527412201|FG001|Overall Study|Lack of Efficacy|0|||
146245368|NCT01799993|527412200|FG000|Overall Study|Recovery|0|||
145936689|NCT03558152|526275626|FG005|Overall Study|Lack of Efficacy|12|||
145936690|NCT03558152|526275627|FG006|Overall Study|Lack of Efficacy|14|||
145936691|NCT03558152|526275628|FG007|Overall Study|Lack of Efficacy|13|||
145936692|NCT03558152|526275621|FG000|Overall Study|Protocol Violation|1|||
145936693|NCT03558152|526275622|FG001|Overall Study|Protocol Violation|1|||
145936694|NCT03558152|526275623|FG002|Overall Study|Protocol Violation|0|||
145936695|NCT03558152|526275624|FG003|Overall Study|Protocol Violation|1|||
145936696|NCT03558152|526275625|FG004|Overall Study|Protocol Violation|1|||
145936697|NCT03558152|526275626|FG005|Overall Study|Protocol Violation|0|||
145936698|NCT03558152|526275627|FG006|Overall Study|Protocol Violation|2|||
145936699|NCT03558152|526275628|FG007|Overall Study|Protocol Violation|0|||
145936700|NCT00601172|526275629|FG000|Overall Study|Adverse Event|43|||
145936701|NCT00601172|526275630|FG001|Overall Study|Adverse Event|32|||
145936702|NCT00601172|526275629|FG000|Overall Study|Lack of Efficacy|11|||
145936703|NCT00601172|526275630|FG001|Overall Study|Lack of Efficacy|12|||
145936704|NCT00601172|526275629|FG000|Overall Study|Protocol Violation|2|||
145936705|NCT00601172|526275630|FG001|Overall Study|Protocol Violation|5|||
145936706|NCT00601172|526275629|FG000|Overall Study|Lost to Follow-up|4|||
145936707|NCT00601172|526275630|FG001|Overall Study|Lost to Follow-up|3|||
145936708|NCT00601172|526275629|FG000|Overall Study|Physician Decision|27|||
146245369|NCT01799993|527412201|FG001|Overall Study|Recovery|1|||
146245370|NCT01799993|527412200|FG000|Overall Study|Logistical difficulties|1|||
146245371|NCT01799993|527412201|FG001|Overall Study|Logistical difficulties|0|||
146245372|NCT01799993|527412200|FG000|Overall Study|Protocol deviation|1|||
146245373|NCT01799993|527412201|FG001|Overall Study|Protocol deviation|0|||
145936709|NCT00601172|526275630|FG001|Overall Study|Physician Decision|28|||
145936710|NCT00601172|526275629|FG000|Overall Study|Withdrawal by Subject|35|||
145936711|NCT00601172|526275630|FG001|Overall Study|Withdrawal by Subject|27|||
145936712|NCT00601172|526275629|FG000|Overall Study|Did not meet continuation criteria|19|||
145936713|NCT00601172|526275630|FG001|Overall Study|Did not meet continuation criteria|20|||
145936714|NCT04434469|526275634|FG000|Overall Study|Death|2|||
145936715|NCT04434469|526275635|FG001|Overall Study|Death|3|||
145936716|NCT04434469|526275636|FG002|Overall Study|Death|2|||
145936717|NCT04434469|526275637|FG003|Overall Study|Death|2|||
145936718|NCT04434469|526275638|FG004|Overall Study|Death|2|||
145936719|NCT04434469|526275639|FG005|Overall Study|Death|0|||
145936720|NCT04434469|526275634|FG000|Overall Study|Lost to Follow-up|0|||
145936721|NCT04434469|526275635|FG001|Overall Study|Lost to Follow-up|0|||
145936722|NCT04434469|526275636|FG002|Overall Study|Lost to Follow-up|0|||
145936723|NCT04434469|526275637|FG003|Overall Study|Lost to Follow-up|1|||
145936724|NCT04434469|526275638|FG004|Overall Study|Lost to Follow-up|1|||
145936725|NCT04434469|526275639|FG005|Overall Study|Lost to Follow-up|0|||
145936726|NCT04434469|526275634|FG000|Overall Study|Study terminated by sponsor|1|||
145936727|NCT04434469|526275635|FG001|Overall Study|Study terminated by sponsor|1|||
145936728|NCT04434469|526275636|FG002|Overall Study|Study terminated by sponsor|1|||
145936729|NCT04434469|526275637|FG003|Overall Study|Study terminated by sponsor|2|||
145936730|NCT04434469|526275638|FG004|Overall Study|Study terminated by sponsor|3|||
145936731|NCT04434469|526275639|FG005|Overall Study|Study terminated by sponsor|3|||
145936732|NCT04434469|526275634|FG000|Overall Study|Withdrawal by Subject|0|||
145936733|NCT04434469|526275635|FG001|Overall Study|Withdrawal by Subject|0|||
145936734|NCT04434469|526275636|FG002|Overall Study|Withdrawal by Subject|1|||
145936735|NCT04434469|526275637|FG003|Overall Study|Withdrawal by Subject|0|||
145936736|NCT04434469|526275638|FG004|Overall Study|Withdrawal by Subject|0|||
145936737|NCT04434469|526275639|FG005|Overall Study|Withdrawal by Subject|0|||
145936738|NCT01154296|526275640|FG000|Randomization and Intervention|Decided to decline|1|||
145936739|NCT01154296|526275641|FG001|Randomization and Intervention|Decided to decline|1|||
145936740|NCT01154296|526275640|FG000|Randomization and Intervention|Declined by staff|1|||
145936741|NCT01154296|526275641|FG001|Randomization and Intervention|Declined by staff|0|||
145936742|NCT01154296|526275640|FG000|Randomization and Intervention|Did not return|1|||
145936743|NCT01154296|526275641|FG001|Randomization and Intervention|Did not return|0|||
145936744|NCT01154296|526275640|FG000|Randomization and Intervention|Left before test|0|||
145936745|NCT01154296|526275641|FG001|Randomization and Intervention|Left before test|1|||
145936746|NCT01154296|526275640|FG000|Randomization and Intervention|Left clinic early|2|||
145936747|NCT01154296|526275641|FG001|Randomization and Intervention|Left clinic early|0|||
145936748|NCT01154296|526275640|FG000|6-month Follow-up|Lost contact|269|||
145936749|NCT01154296|526275641|FG001|6-month Follow-up|Lost contact|275|||
145936750|NCT01154296|526275640|FG000|6-month Follow-up|Incarcerated|37|||
145936751|NCT01154296|526275641|FG001|6-month Follow-up|Incarcerated|32|||
145936752|NCT01154296|526275640|FG000|6-month Follow-up|Withdrew consent|14|||
145936753|NCT01154296|526275641|FG001|6-month Follow-up|Withdrew consent|15|||
145936754|NCT01154296|526275640|FG000|6-month Follow-up|Death|3|||
145936755|NCT01154296|526275641|FG001|6-month Follow-up|Death|2|||
145936756|NCT01154296|526275640|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
145936757|NCT01154296|526275641|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
145936758|NCT01936181|526275648|FG000|Randomised, Double-blind|Adverse Event|27|||
145936759|NCT01936181|526275649|FG001|Randomised, Double-blind|Adverse Event|21|||
145936760|NCT01936181|526275650|FG002|Randomised, Double-blind|Adverse Event|0|||
145936761|NCT01936181|526275651|FG003|Randomised, Double-blind|Adverse Event|0|||
145936762|NCT01936181|526275648|FG000|Randomised, Double-blind|Protocol Violation|1|||
145936763|NCT01936181|526275649|FG001|Randomised, Double-blind|Protocol Violation|5|||
145936764|NCT01936181|526275650|FG002|Randomised, Double-blind|Protocol Violation|0|||
145936765|NCT01936181|526275651|FG003|Randomised, Double-blind|Protocol Violation|0|||
145936766|NCT01936181|526275648|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
145936767|NCT01936181|526275649|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
145936768|NCT01936181|526275650|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
145936769|NCT01936181|526275651|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
145936770|NCT01936181|526275648|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
145936771|NCT01936181|526275649|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
145936772|NCT01936181|526275650|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
145936773|NCT01936181|526275651|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
145936774|NCT01936181|526275648|FG000|Randomised, Double-blind|Pregnancy|0|||
145936775|NCT01936181|526275649|FG001|Randomised, Double-blind|Pregnancy|1|||
145936776|NCT01936181|526275650|FG002|Randomised, Double-blind|Pregnancy|0|||
145936777|NCT01936181|526275651|FG003|Randomised, Double-blind|Pregnancy|0|||
145936778|NCT01936181|526275648|FG000|Randomised, Double-blind|Physician Decision|4|||
145936779|NCT01936181|526275649|FG001|Randomised, Double-blind|Physician Decision|4|||
145936780|NCT01936181|526275650|FG002|Randomised, Double-blind|Physician Decision|0|||
146245374|NCT01799993|527412200|FG000|Overall Study|Non-compliance with medical device|1|||
145936781|NCT01936181|526275651|FG003|Randomised, Double-blind|Physician Decision|0|||
145936782|NCT01936181|526275648|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
145936783|NCT01936181|526275649|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
145936784|NCT01936181|526275650|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
145936785|NCT01936181|526275651|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
145936786|NCT01936181|526275648|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
145936787|NCT01936181|526275649|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
145936788|NCT01936181|526275650|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
145936789|NCT01936181|526275651|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
145936790|NCT01936181|526275648|FG000|Transition-extension|Adverse Event|3|||
145936791|NCT01936181|526275649|FG001|Transition-extension|Adverse Event|0|||
145936792|NCT01936181|526275650|FG002|Transition-extension|Adverse Event|3|||
145936793|NCT01936181|526275651|FG003|Transition-extension|Adverse Event|1|||
145936794|NCT01936181|526275648|FG000|Transition-extension|Lost to Follow-up|3|||
145936795|NCT01936181|526275649|FG001|Transition-extension|Lost to Follow-up|0|||
145936796|NCT01936181|526275650|FG002|Transition-extension|Lost to Follow-up|1|||
145936797|NCT01936181|526275651|FG003|Transition-extension|Lost to Follow-up|2|||
145936798|NCT01936181|526275648|FG000|Transition-extension|Physician Decision|2|||
145936799|NCT01936181|526275649|FG001|Transition-extension|Physician Decision|0|||
145936800|NCT01936181|526275650|FG002|Transition-extension|Physician Decision|0|||
145936801|NCT01936181|526275651|FG003|Transition-extension|Physician Decision|1|||
145936802|NCT01936181|526275648|FG000|Transition-extension|Withdrawal by Subject|7|||
145936803|NCT01936181|526275649|FG001|Transition-extension|Withdrawal by Subject|0|||
145936804|NCT01936181|526275650|FG002|Transition-extension|Withdrawal by Subject|2|||
145936805|NCT01936181|526275651|FG003|Transition-extension|Withdrawal by Subject|1|||
145936806|NCT00970632|526275654|FG000|Overall Study|Adverse Event|2|||
145936807|NCT00970632|526275655|FG001|Overall Study|Adverse Event|2|||
145936808|NCT00970632|526275656|FG002|Overall Study|Adverse Event|1|||
145936809|NCT00970632|526275654|FG000|Overall Study|Lack of Efficacy|3|||
145936810|NCT00970632|526275655|FG001|Overall Study|Lack of Efficacy|0|||
145936811|NCT00970632|526275656|FG002|Overall Study|Lack of Efficacy|0|||
145936812|NCT00970632|526275654|FG000|Overall Study|Lost to Follow-up|3|||
145936813|NCT00970632|526275655|FG001|Overall Study|Lost to Follow-up|0|||
145936814|NCT00970632|526275656|FG002|Overall Study|Lost to Follow-up|2|||
145936815|NCT00970632|526275654|FG000|Overall Study|Protocol Violation|8|||
145936816|NCT00970632|526275655|FG001|Overall Study|Protocol Violation|5|||
145936817|NCT00970632|526275656|FG002|Overall Study|Protocol Violation|8|||
145936818|NCT00970632|526275654|FG000|Overall Study|Withdrawal by Subject|7|||
145936819|NCT00970632|526275655|FG001|Overall Study|Withdrawal by Subject|6|||
145936820|NCT00970632|526275656|FG002|Overall Study|Withdrawal by Subject|4|||
145936821|NCT00970632|526275654|FG000|Overall Study|Entry criteria not met|0|||
145936822|NCT00970632|526275655|FG001|Overall Study|Entry criteria not met|2|||
145936823|NCT00970632|526275656|FG002|Overall Study|Entry criteria not met|2|||
145936824|NCT00970632|526275654|FG000|Overall Study|Sponsor decision|1|||
145936825|NCT00970632|526275655|FG001|Overall Study|Sponsor decision|0|||
145936826|NCT00970632|526275656|FG002|Overall Study|Sponsor decision|1|||
145936827|NCT03320850|526275659|FG000|Overall Study|Lost to Follow-up|0|||
145936828|NCT03320850|526275660|FG001|Overall Study|Lost to Follow-up|0|||
145936829|NCT03320850|526275661|FG002|Overall Study|Lost to Follow-up|0|||
145936830|NCT03320850|526275662|FG003|Overall Study|Lost to Follow-up|0|||
145936831|NCT03320850|526275663|FG004|Overall Study|Lost to Follow-up|1|||
145936832|NCT03320850|526275664|FG005|Overall Study|Lost to Follow-up|2|||
145936833|NCT03320850|526275665|FG006|Overall Study|Lost to Follow-up|2|||
145936834|NCT03320850|526275666|FG007|Overall Study|Lost to Follow-up|0|||
145936835|NCT03320850|526275667|FG008|Overall Study|Lost to Follow-up|6|||
145936836|NCT03320850|526275668|FG009|Overall Study|Lost to Follow-up|4|||
145936837|NCT03320850|526275659|FG000|Overall Study|Withdrawal by Subject|0|||
145936838|NCT03320850|526275660|FG001|Overall Study|Withdrawal by Subject|0|||
145936839|NCT03320850|526275661|FG002|Overall Study|Withdrawal by Subject|0|||
145936840|NCT03320850|526275662|FG003|Overall Study|Withdrawal by Subject|0|||
145936841|NCT03320850|526275663|FG004|Overall Study|Withdrawal by Subject|1|||
145936842|NCT03320850|526275664|FG005|Overall Study|Withdrawal by Subject|2|||
145936843|NCT03320850|526275665|FG006|Overall Study|Withdrawal by Subject|4|||
145979250|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145979251|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145979252|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
145979253|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
145979254|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145979255|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145979256|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
145979257|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145936844|NCT03320850|526275666|FG007|Overall Study|Withdrawal by Subject|5|||
145936845|NCT03320850|526275667|FG008|Overall Study|Withdrawal by Subject|2|||
145936846|NCT03320850|526275668|FG009|Overall Study|Withdrawal by Subject|1|||
145936847|NCT03320850|526275659|FG000|Overall Study|Lack of Efficacy|0|||
145936848|NCT03320850|526275660|FG001|Overall Study|Lack of Efficacy|0|||
145936849|NCT03320850|526275661|FG002|Overall Study|Lack of Efficacy|0|||
145936850|NCT03320850|526275662|FG003|Overall Study|Lack of Efficacy|1|||
145936851|NCT03320850|526275663|FG004|Overall Study|Lack of Efficacy|0|||
145936852|NCT03320850|526275664|FG005|Overall Study|Lack of Efficacy|1|||
145936853|NCT03320850|526275665|FG006|Overall Study|Lack of Efficacy|0|||
145936854|NCT03320850|526275666|FG007|Overall Study|Lack of Efficacy|2|||
145936855|NCT03320850|526275667|FG008|Overall Study|Lack of Efficacy|0|||
145936856|NCT03320850|526275668|FG009|Overall Study|Lack of Efficacy|3|||
145936857|NCT03320850|526275659|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145936858|NCT03320850|526275660|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145936859|NCT03320850|526275661|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145936860|NCT03320850|526275662|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
145936861|NCT03320850|526275663|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
145936862|NCT03320850|526275664|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
145936863|NCT03320850|526275665|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
145936864|NCT03320850|526275666|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
145936865|NCT03320850|526275667|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
145936866|NCT03320850|526275668|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
145936867|NCT03320850|526275659|FG000|Overall Study|Adverse Event|0|||
145936868|NCT03320850|526275660|FG001|Overall Study|Adverse Event|0|||
145936869|NCT03320850|526275661|FG002|Overall Study|Adverse Event|0|||
145936870|NCT03320850|526275662|FG003|Overall Study|Adverse Event|0|||
145936871|NCT03320850|526275663|FG004|Overall Study|Adverse Event|0|||
145936872|NCT03320850|526275664|FG005|Overall Study|Adverse Event|2|||
145936873|NCT03320850|526275665|FG006|Overall Study|Adverse Event|1|||
145936874|NCT03320850|526275666|FG007|Overall Study|Adverse Event|0|||
145936875|NCT03320850|526275667|FG008|Overall Study|Adverse Event|2|||
145936876|NCT03320850|526275668|FG009|Overall Study|Adverse Event|0|||
145936877|NCT03320850|526275659|FG000|Overall Study|Reason Not Specified|0|||
145936878|NCT03320850|526275660|FG001|Overall Study|Reason Not Specified|0|||
145936879|NCT03320850|526275661|FG002|Overall Study|Reason Not Specified|0|||
145936880|NCT03320850|526275662|FG003|Overall Study|Reason Not Specified|0|||
145936881|NCT03320850|526275663|FG004|Overall Study|Reason Not Specified|0|||
145936882|NCT03320850|526275664|FG005|Overall Study|Reason Not Specified|1|||
145936883|NCT03320850|526275665|FG006|Overall Study|Reason Not Specified|0|||
145936884|NCT03320850|526275666|FG007|Overall Study|Reason Not Specified|0|||
145936885|NCT03320850|526275667|FG008|Overall Study|Reason Not Specified|0|||
145936886|NCT03320850|526275668|FG009|Overall Study|Reason Not Specified|1|||
145936887|NCT01286168|526275675|FG000|Overall Study|Withdrawal by Subject|1|||
145936888|NCT01286168|526275675|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
145936889|NCT01424514|526275676|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
145936890|NCT01424514|526275677|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
145936891|NCT01424514|526275676|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
145936892|NCT01424514|526275677|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
145936893|NCT02002533|526275680|FG000|Overall Study|Withdrawal by Subject|6|||
145936894|NCT02002533|526275681|FG001|Overall Study|Withdrawal by Subject|13|||
145936895|NCT02002533|526275680|FG000|Overall Study|Protocol Violation|0|||
145936896|NCT02002533|526275681|FG001|Overall Study|Protocol Violation|1|||
145936897|NCT02002533|526275680|FG000|Overall Study|Adverse Event|0|||
145936898|NCT02002533|526275681|FG001|Overall Study|Adverse Event|3|||
145936899|NCT02002533|526275680|FG000|Overall Study|Lost to Follow-up|0|||
145936900|NCT02002533|526275681|FG001|Overall Study|Lost to Follow-up|1|||
145936901|NCT02653170|526275682|FG000|Overall Study|Withdrawal by Subject|3|||
145936902|NCT02653170|526275683|FG001|Overall Study|Withdrawal by Subject|8|||
145936903|NCT02653170|526275684|FG002|Overall Study|Withdrawal by Subject|3|||
145936904|NCT02653170|526275682|FG000|Overall Study|withdrawn by study team|2|||
145936905|NCT02653170|526275683|FG001|Overall Study|withdrawn by study team|4|||
145936906|NCT02653170|526275684|FG002|Overall Study|withdrawn by study team|5|||
145936907|NCT02653170|526275682|FG000|Overall Study|Lost to Follow-up|12|||
145936908|NCT02653170|526275683|FG001|Overall Study|Lost to Follow-up|4|||
145936909|NCT02653170|526275684|FG002|Overall Study|Lost to Follow-up|10|||
145936910|NCT04598451|526275685|FG000|Overall Study|Adverse Event|3|||
145936911|NCT04598451|526275686|FG001|Overall Study|Adverse Event|2|||
146091142|NCT00245583|526854885|FG001|Overall Study|Adverse Event|1|||
145936912|NCT04598451|526275685|FG000|Overall Study|Withdrawal by Subject|3|||
145936913|NCT04598451|526275686|FG001|Overall Study|Withdrawal by Subject|7|||
145936914|NCT04598451|526275685|FG000|Overall Study|Lost to Follow-up|2|||
145936915|NCT04598451|526275686|FG001|Overall Study|Lost to Follow-up|0|||
145936916|NCT04598451|526275685|FG000|Overall Study|Physician Decision|4|||
145936917|NCT04598451|526275686|FG001|Overall Study|Physician Decision|1|||
145936918|NCT04598451|526275685|FG000|Overall Study|Requires Prohibited Medication|1|||
146091143|NCT00245583|526854884|FG000|Overall Study|Lack of Efficacy|1|||
145936919|NCT04598451|526275686|FG001|Overall Study|Requires Prohibited Medication|0|||
145936920|NCT04598451|526275685|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
145936921|NCT04598451|526275686|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
145936922|NCT02086448|526275692|FG000|Overall Study|Withdrawal by Subject|1|||
145936923|NCT02086448|526275693|FG001|Overall Study|Withdrawal by Subject|0|||
145936924|NCT02086448|526275694|FG002|Overall Study|Withdrawal by Subject|0|||
145936925|NCT02086448|526275695|FG003|Overall Study|Withdrawal by Subject|2|||
145936926|NCT01482065|526275718|FG000|Overall Study|Withdrawal by Subject|0|||
145936927|NCT01482065|526275719|FG001|Overall Study|Withdrawal by Subject|1|||
145936928|NCT01942486|526275720|FG000|Overall Study|Lost to Follow-up|27|||
145936929|NCT03728426|526275721|FG000|Overall Study|Death|3|||
145936930|NCT00231114|526275722|FG000|Randomized|Withdrawal by Subject|6|||
145936931|NCT00231114|526275723|FG001|Randomized|Withdrawal by Subject|3|||
145936932|NCT00231114|526275722|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
145936933|NCT00231114|526275723|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
145936934|NCT00231114|526275722|FG000|Post-Treatment Period|Lost to Follow-up|6|||
145936935|NCT00231114|526275723|FG001|Post-Treatment Period|Lost to Follow-up|1|||
145936936|NCT00231114|526275722|FG000|Post-Treatment Period|Physician Decision|1|||
145936937|NCT00231114|526275723|FG001|Post-Treatment Period|Physician Decision|0|||
145936938|NCT00231114|526275722|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
145936939|NCT00231114|526275723|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
145936940|NCT02005692|526275724|FG000|Overall Study|Protocol Violation|1|||
145936941|NCT02005692|526275724|FG000|Overall Study|Withdrawal by Subject|1|||
145936942|NCT02005692|526275724|FG000|Overall Study|Discharged earlier than anticipated|5|||
145936943|NCT01194999|526275725|FG000|Overall Study|Lost to Follow-up|17|||
145936944|NCT02091375|526275726|FG000|Overall Study|Adverse Event|8|||
145936945|NCT02091375|526275727|FG001|Overall Study|Adverse Event|1|||
145936946|NCT02091375|526275726|FG000|Overall Study|Lost to Follow-up|0|||
145936947|NCT02091375|526275727|FG001|Overall Study|Lost to Follow-up|1|||
145936948|NCT02091375|526275726|FG000|Overall Study|Withdrawal by Subject|0|||
145936949|NCT02091375|526275727|FG001|Overall Study|Withdrawal by Subject|1|||
145936950|NCT02091375|526275726|FG000|Overall Study|Withdrawn by the investigator|1|||
145936951|NCT02091375|526275727|FG001|Overall Study|Withdrawn by the investigator|0|||
145936952|NCT02682823|526275728|FG000|Overall Study|Withdrawal by Subject|0|||
145936953|NCT02682823|526275729|FG001|Overall Study|Withdrawal by Subject|0|||
145936954|NCT02682823|526275730|FG002|Overall Study|Withdrawal by Subject|1|||
145936955|NCT02682823|526275731|FG003|Overall Study|Withdrawal by Subject|0|||
145936956|NCT02682823|526275732|FG004|Overall Study|Withdrawal by Subject|1|||
145936957|NCT02682823|526275728|FG000|Overall Study|Protocol Deviation|0|||
145936958|NCT02682823|526275729|FG001|Overall Study|Protocol Deviation|1|||
145936959|NCT02682823|526275730|FG002|Overall Study|Protocol Deviation|0|||
145936960|NCT02682823|526275731|FG003|Overall Study|Protocol Deviation|0|||
145936961|NCT02682823|526275732|FG004|Overall Study|Protocol Deviation|0|||
145936962|NCT02682823|526275728|FG000|Overall Study|Adverse Event|0|||
145936963|NCT02682823|526275729|FG001|Overall Study|Adverse Event|0|||
145936964|NCT02682823|526275730|FG002|Overall Study|Adverse Event|0|||
145936965|NCT02682823|526275731|FG003|Overall Study|Adverse Event|1|||
145936966|NCT02682823|526275732|FG004|Overall Study|Adverse Event|0|||
145936967|NCT03781583|526275733|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
145936968|NCT03781583|526275734|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
145936969|NCT03781583|526275735|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
145936970|NCT03781583|526275736|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
145936971|NCT03781583|526275733|FG000|Overall Study|Technology did not work for that person in that environment|1|||
145936972|NCT03781583|526275734|FG001|Overall Study|Technology did not work for that person in that environment|0|||
145936973|NCT03781583|526275735|FG002|Overall Study|Technology did not work for that person in that environment|0|||
145936974|NCT03781583|526275736|FG003|Overall Study|Technology did not work for that person in that environment|0|||
145936975|NCT03781583|526275733|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
145936976|NCT03781583|526275734|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
145936977|NCT03781583|526275735|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
145936978|NCT03781583|526275736|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
145936979|NCT03781583|526275733|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145936980|NCT03781583|526275734|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
145936981|NCT03781583|526275735|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145936982|NCT03781583|526275736|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145936983|NCT05139303|526275737|FG000|Overall Study|Lost to Follow-up|3|||
145936984|NCT05139303|526275738|FG001|Overall Study|Lost to Follow-up|0|||
145936985|NCT05139303|526275737|FG000|Overall Study|Adverse Event|1|||
145936986|NCT05139303|526275738|FG001|Overall Study|Adverse Event|0|||
145936987|NCT01938430|526275739|FG000|Overall Study|Randomized but Not Treated|0|||
146091144|NCT00245583|526854885|FG001|Overall Study|Lack of Efficacy|0|||
145936988|NCT01938430|526275740|FG001|Overall Study|Randomized but Not Treated|0|||
145936989|NCT01938430|526275741|FG002|Overall Study|Randomized but Not Treated|0|||
145936990|NCT01938430|526275742|FG003|Overall Study|Randomized but Not Treated|0|||
145936991|NCT01938430|526275743|FG004|Overall Study|Randomized but Not Treated|0|||
145936992|NCT01938430|526275744|FG005|Overall Study|Randomized but Not Treated|0|||
145936993|NCT01938430|526275745|FG006|Overall Study|Randomized but Not Treated|0|||
145936994|NCT01938430|526275746|FG007|Overall Study|Randomized but Not Treated|0|||
145936995|NCT01938430|526275747|FG008|Overall Study|Randomized but Not Treated|0|||
145936996|NCT01938430|526275748|FG009|Overall Study|Randomized but Not Treated|0|||
145936997|NCT01938430|526275749|FG010|Overall Study|Randomized but Not Treated|1|||
145936998|NCT01938430|526275750|FG011|Overall Study|Randomized but Not Treated|0|||
145936999|NCT01938430|526275751|FG012|Overall Study|Randomized but Not Treated|0|||
145937000|NCT01938430|526275752|FG013|Overall Study|Randomized but Not Treated|1|||
145937001|NCT01938430|526275739|FG000|Overall Study|Adverse Event|0|||
145937002|NCT01938430|526275740|FG001|Overall Study|Adverse Event|0|||
145937003|NCT01938430|526275741|FG002|Overall Study|Adverse Event|0|||
145937004|NCT01938430|526275742|FG003|Overall Study|Adverse Event|0|||
145937005|NCT01938430|526275743|FG004|Overall Study|Adverse Event|0|||
145937006|NCT01938430|526275744|FG005|Overall Study|Adverse Event|0|||
145937007|NCT01938430|526275745|FG006|Overall Study|Adverse Event|1|||
145937008|NCT01938430|526275746|FG007|Overall Study|Adverse Event|0|||
145937009|NCT01938430|526275747|FG008|Overall Study|Adverse Event|0|||
145937010|NCT01938430|526275748|FG009|Overall Study|Adverse Event|0|||
145937011|NCT01938430|526275749|FG010|Overall Study|Adverse Event|0|||
145937012|NCT01938430|526275750|FG011|Overall Study|Adverse Event|0|||
145937013|NCT01938430|526275751|FG012|Overall Study|Adverse Event|0|||
145937014|NCT01938430|526275752|FG013|Overall Study|Adverse Event|0|||
145937015|NCT01938430|526275739|FG000|Overall Study|Death|1|||
145937016|NCT01938430|526275740|FG001|Overall Study|Death|2|||
145937017|NCT01938430|526275741|FG002|Overall Study|Death|2|||
145937018|NCT01938430|526275742|FG003|Overall Study|Death|1|||
145937019|NCT01938430|526275743|FG004|Overall Study|Death|0|||
145937020|NCT01938430|526275744|FG005|Overall Study|Death|0|||
145937021|NCT01938430|526275745|FG006|Overall Study|Death|1|||
145937022|NCT01938430|526275746|FG007|Overall Study|Death|1|||
145937023|NCT01938430|526275747|FG008|Overall Study|Death|2|||
145937024|NCT01938430|526275748|FG009|Overall Study|Death|3|||
145937025|NCT01938430|526275749|FG010|Overall Study|Death|0|||
145937026|NCT01938430|526275750|FG011|Overall Study|Death|0|||
145937027|NCT01938430|526275751|FG012|Overall Study|Death|0|||
145937028|NCT01938430|526275752|FG013|Overall Study|Death|0|||
145937029|NCT01938430|526275739|FG000|Overall Study|Investigator's Discretion|0|||
145937030|NCT01938430|526275740|FG001|Overall Study|Investigator's Discretion|0|||
145937031|NCT01938430|526275741|FG002|Overall Study|Investigator's Discretion|1|||
145937032|NCT01938430|526275742|FG003|Overall Study|Investigator's Discretion|0|||
145937033|NCT01938430|526275743|FG004|Overall Study|Investigator's Discretion|0|||
145937034|NCT01938430|526275744|FG005|Overall Study|Investigator's Discretion|0|||
145937035|NCT01938430|526275745|FG006|Overall Study|Investigator's Discretion|0|||
145937036|NCT01938430|526275746|FG007|Overall Study|Investigator's Discretion|0|||
145937037|NCT01938430|526275747|FG008|Overall Study|Investigator's Discretion|0|||
145937038|NCT01938430|526275748|FG009|Overall Study|Investigator's Discretion|0|||
145937039|NCT01938430|526275749|FG010|Overall Study|Investigator's Discretion|0|||
145937040|NCT01938430|526275750|FG011|Overall Study|Investigator's Discretion|0|||
145937041|NCT01938430|526275751|FG012|Overall Study|Investigator's Discretion|0|||
145937042|NCT01938430|526275752|FG013|Overall Study|Investigator's Discretion|0|||
145937043|NCT01938430|526275739|FG000|Overall Study|Lack of Efficacy|3|||
145937044|NCT01938430|526275740|FG001|Overall Study|Lack of Efficacy|1|||
145937045|NCT01938430|526275741|FG002|Overall Study|Lack of Efficacy|1|||
145937046|NCT01938430|526275742|FG003|Overall Study|Lack of Efficacy|1|||
145937047|NCT01938430|526275743|FG004|Overall Study|Lack of Efficacy|0|||
145937048|NCT01938430|526275744|FG005|Overall Study|Lack of Efficacy|0|||
145937049|NCT01938430|526275745|FG006|Overall Study|Lack of Efficacy|0|||
145937050|NCT01938430|526275746|FG007|Overall Study|Lack of Efficacy|0|||
145937051|NCT01938430|526275747|FG008|Overall Study|Lack of Efficacy|1|||
145937052|NCT01938430|526275748|FG009|Overall Study|Lack of Efficacy|0|||
145937053|NCT01938430|526275749|FG010|Overall Study|Lack of Efficacy|2|||
145937054|NCT01938430|526275750|FG011|Overall Study|Lack of Efficacy|1|||
145937055|NCT01938430|526275751|FG012|Overall Study|Lack of Efficacy|0|||
145937056|NCT01938430|526275752|FG013|Overall Study|Lack of Efficacy|0|||
145937057|NCT01938430|526275739|FG000|Overall Study|Lost to Follow-up|0|||
145937058|NCT01938430|526275740|FG001|Overall Study|Lost to Follow-up|0|||
145937059|NCT01938430|526275741|FG002|Overall Study|Lost to Follow-up|1|||
145937060|NCT01938430|526275742|FG003|Overall Study|Lost to Follow-up|0|||
145937061|NCT01938430|526275743|FG004|Overall Study|Lost to Follow-up|0|||
145937062|NCT01938430|526275744|FG005|Overall Study|Lost to Follow-up|1|||
145937063|NCT01938430|526275745|FG006|Overall Study|Lost to Follow-up|0|||
145937064|NCT01938430|526275746|FG007|Overall Study|Lost to Follow-up|0|||
145937065|NCT01938430|526275747|FG008|Overall Study|Lost to Follow-up|0|||
145937066|NCT01938430|526275748|FG009|Overall Study|Lost to Follow-up|0|||
145937067|NCT01938430|526275749|FG010|Overall Study|Lost to Follow-up|0|||
145979258|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145979259|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145979260|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145979261|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145979262|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145937068|NCT01938430|526275750|FG011|Overall Study|Lost to Follow-up|0|||
145937069|NCT01938430|526275751|FG012|Overall Study|Lost to Follow-up|0|||
145937070|NCT01938430|526275752|FG013|Overall Study|Lost to Follow-up|0|||
145937071|NCT01938430|526275739|FG000|Overall Study|Withdrew Consent|0|||
145937072|NCT01938430|526275740|FG001|Overall Study|Withdrew Consent|0|||
145937073|NCT01938430|526275741|FG002|Overall Study|Withdrew Consent|0|||
145937074|NCT01938430|526275742|FG003|Overall Study|Withdrew Consent|0|||
145937075|NCT01938430|526275743|FG004|Overall Study|Withdrew Consent|0|||
145937076|NCT01938430|526275744|FG005|Overall Study|Withdrew Consent|0|||
145937077|NCT01938430|526275745|FG006|Overall Study|Withdrew Consent|0|||
145937078|NCT01938430|526275746|FG007|Overall Study|Withdrew Consent|0|||
145937079|NCT01938430|526275747|FG008|Overall Study|Withdrew Consent|1|||
145937080|NCT01938430|526275748|FG009|Overall Study|Withdrew Consent|0|||
145937081|NCT01938430|526275749|FG010|Overall Study|Withdrew Consent|0|||
145937082|NCT01938430|526275750|FG011|Overall Study|Withdrew Consent|0|||
145937083|NCT01938430|526275751|FG012|Overall Study|Withdrew Consent|0|||
145937084|NCT01938430|526275752|FG013|Overall Study|Withdrew Consent|0|||
145937085|NCT03875482|526275753|FG000|Overall Study|Adverse Event|0|||
145937086|NCT03875482|526275754|FG001|Overall Study|Adverse Event|1|||
145937087|NCT03875482|526275753|FG000|Overall Study|Withdrew consent|5|||
145937088|NCT03875482|526275754|FG001|Overall Study|Withdrew consent|6|||
145937089|NCT03875482|526275753|FG000|Overall Study|Lost to Follow-up|8|||
145937090|NCT03875482|526275754|FG001|Overall Study|Lost to Follow-up|2|||
145937091|NCT03875482|526275753|FG000|Overall Study|Lack of Efficacy|0|||
145937092|NCT03875482|526275754|FG001|Overall Study|Lack of Efficacy|11|||
145937093|NCT00507819|526275757|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
145937094|NCT00507819|526275758|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
145937095|NCT03261674|526275761|FG000|Overall Study|Lost to Follow-up|6|||
145937096|NCT03261674|526275762|FG001|Overall Study|Lost to Follow-up|7|||
145937097|NCT03261674|526275761|FG000|Overall Study|Protocol Violation|1|||
145937098|NCT03261674|526275762|FG001|Overall Study|Protocol Violation|4|||
145937099|NCT03261674|526275761|FG000|Overall Study|Withdrawal by Subject|1|||
145937100|NCT03261674|526275762|FG001|Overall Study|Withdrawal by Subject|4|||
145937101|NCT03261674|526275761|FG000|Overall Study|Physician Decision|1|||
145937102|NCT03261674|526275762|FG001|Overall Study|Physician Decision|0|||
145937103|NCT02045862|526275765|FG000|Overall Study|Death|0|||
145979263|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145979264|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145979265|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145979266|NCT01807520|526435967|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
145979267|NCT01807520|526435968|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
145979268|NCT01807520|526435969|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145979269|NCT01807520|526435970|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
145979270|NCT01807520|526435971|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
145979271|NCT01807520|526435972|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145979272|NCT01807520|526435973|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145979273|NCT01807520|526435967|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145979274|NCT01807520|526435968|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145979275|NCT01807520|526435969|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145979276|NCT01807520|526435970|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145979277|NCT01807520|526435971|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145979278|NCT01807520|526435972|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
145979279|NCT01807520|526435973|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
146091145|NCT00245583|526854884|FG000|Overall Study|Withdrawal by Subject|2|||
146091146|NCT00245583|526854885|FG001|Overall Study|Withdrawal by Subject|3|||
146245375|NCT01799993|527412201|FG001|Overall Study|Non-compliance with medical device|0|||
146245376|NCT01799993|527412200|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145937104|NCT02045862|526275766|FG001|Overall Study|Death|0|||
145937105|NCT02045862|526275767|FG002|Overall Study|Death|1|||
145937106|NCT02045862|526275765|FG000|Overall Study|Miscellaneous|5|||
145937107|NCT02045862|526275766|FG001|Overall Study|Miscellaneous|0|||
145937108|NCT02045862|526275767|FG002|Overall Study|Miscellaneous|8|||
145937109|NCT02045862|526275765|FG000|Overall Study|Withdrawal by Patient|18|||
145937110|NCT02045862|526275766|FG001|Overall Study|Withdrawal by Patient|27|||
145937111|NCT02045862|526275767|FG002|Overall Study|Withdrawal by Patient|57|||
145937112|NCT02045862|526275765|FG000|Overall Study|Protocol Violation|0|||
145937113|NCT02045862|526275766|FG001|Overall Study|Protocol Violation|0|||
145937114|NCT02045862|526275767|FG002|Overall Study|Protocol Violation|6|||
145979280|NCT01807520|526435967|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145979281|NCT01807520|526435968|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145979282|NCT01807520|526435969|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
146245377|NCT01799993|527412201|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146245378|NCT01799993|527412200|FG000|Overall Study|Other|1|||
146245379|NCT01799993|527412201|FG001|Overall Study|Other|0|||
146245380|NCT01799993|527412200|FG000|Overall Study|Subject didn't return for follow-up|0|||
146297805|NCT04786119|527606011|FG001|Overall Study|Lost to Follow-up|5|||
145937115|NCT02045862|526275765|FG000|Overall Study|Lack of Efficacy|8|||
145937116|NCT02045862|526275766|FG001|Overall Study|Lack of Efficacy|4|||
145937117|NCT02045862|526275767|FG002|Overall Study|Lack of Efficacy|13|||
145937118|NCT02045862|526275765|FG000|Overall Study|Randomized but not Received Study Drug|0|||
145937119|NCT02045862|526275766|FG001|Overall Study|Randomized but not Received Study Drug|2|||
145937120|NCT02045862|526275767|FG002|Overall Study|Randomized but not Received Study Drug|8|||
145937121|NCT02045862|526275765|FG000|Overall Study|Adverse Event|7|||
145937122|NCT02045862|526275766|FG001|Overall Study|Adverse Event|5|||
145937123|NCT02045862|526275767|FG002|Overall Study|Adverse Event|27|||
145937124|NCT02045862|526275765|FG000|Overall Study|Lost to Follow-up|1|||
145937125|NCT02045862|526275766|FG001|Overall Study|Lost to Follow-up|2|||
145937126|NCT02045862|526275767|FG002|Overall Study|Lost to Follow-up|6|||
145937127|NCT00623935|526275768|FG000|Overall Study|Death|1|||
145937128|NCT00623935|526275768|FG000|Overall Study|Patient Declined Transplant|1|||
145937129|NCT01075646|526275771|FG000|Overall Study|Lost to Follow-up|4|||
145937130|NCT01075646|526275772|FG001|Overall Study|Lost to Follow-up|3|||
145937131|NCT01075646|526275773|FG002|Overall Study|Lost to Follow-up|1|||
145937132|NCT01075646|526275774|FG003|Overall Study|Lost to Follow-up|2|||
145937133|NCT00732758|526275775|FG000|Overall Study|Lost to Follow-up|8|||
145937134|NCT00732758|526275776|FG001|Overall Study|Lost to Follow-up|16|||
145937135|NCT01552915|526275777|FG000|Overall Study|Adverse Event|3|||
145937136|NCT01552915|526275778|FG001|Overall Study|Adverse Event|14|||
145937137|NCT01552915|526275779|FG002|Overall Study|Adverse Event|3|||
145937138|NCT01552915|526275777|FG000|Overall Study|Lost to Follow-up|4|||
145937139|NCT01552915|526275778|FG001|Overall Study|Lost to Follow-up|6|||
145937140|NCT01552915|526275779|FG002|Overall Study|Lost to Follow-up|5|||
145937141|NCT01552915|526275777|FG000|Overall Study|Withdrawal by Subject|6|||
145937142|NCT01552915|526275778|FG001|Overall Study|Withdrawal by Subject|4|||
145937143|NCT01552915|526275779|FG002|Overall Study|Withdrawal by Subject|5|||
145937144|NCT01552915|526275777|FG000|Overall Study|Protocol Violation|0|||
145937145|NCT01552915|526275778|FG001|Overall Study|Protocol Violation|4|||
145937146|NCT01552915|526275779|FG002|Overall Study|Protocol Violation|4|||
145937147|NCT01552915|526275777|FG000|Overall Study|Lack of Efficacy|8|||
145937148|NCT01552915|526275778|FG001|Overall Study|Lack of Efficacy|1|||
145937149|NCT01552915|526275779|FG002|Overall Study|Lack of Efficacy|4|||
145937150|NCT01552915|526275777|FG000|Overall Study|Other|2|||
145937151|NCT01552915|526275778|FG001|Overall Study|Other|0|||
145937152|NCT01552915|526275779|FG002|Overall Study|Other|6|||
145937153|NCT02858180|526275783|FG000|Overall Study|Lost to Follow-up|0|||
145937154|NCT02858180|526275784|FG001|Overall Study|Lost to Follow-up|2|||
145937155|NCT00979420|526275785|FG000|Overall Study|Adverse Event|1|||
145937156|NCT00979420|526275786|FG001|Overall Study|Adverse Event|0|||
145937157|NCT00979420|526275787|FG002|Overall Study|Adverse Event|0|||
145937158|NCT00979420|526275788|FG003|Overall Study|Adverse Event|0|||
145937159|NCT00979420|526275785|FG000|Overall Study|Lack of Efficacy|3|||
145937160|NCT00979420|526275786|FG001|Overall Study|Lack of Efficacy|0|||
145937161|NCT00979420|526275787|FG002|Overall Study|Lack of Efficacy|1|||
145937162|NCT00979420|526275788|FG003|Overall Study|Lack of Efficacy|1|||
145937163|NCT00979420|526275785|FG000|Overall Study|Other reasons not related to Viramune|3|||
145937164|NCT00979420|526275786|FG001|Overall Study|Other reasons not related to Viramune|0|||
145937165|NCT00979420|526275787|FG002|Overall Study|Other reasons not related to Viramune|0|||
145937166|NCT00979420|526275788|FG003|Overall Study|Other reasons not related to Viramune|1|||
145937167|NCT02572076|526275790|FG000|Overall Study|Protocol Violation|1|||
145937168|NCT04064411|526275798|FG000|Overall Study|Adverse Event|29|||
145937169|NCT04064411|526275799|FG001|Overall Study|Adverse Event|19|||
145937170|NCT04064411|526275798|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
145937171|NCT04064411|526275799|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
145937172|NCT04064411|526275798|FG000|Overall Study|Protocol Deviation|0|||
145937173|NCT04064411|526275799|FG001|Overall Study|Protocol Deviation|2|||
145937174|NCT04064411|526275798|FG000|Overall Study|Withdrawal by Subject|25|||
145937175|NCT04064411|526275799|FG001|Overall Study|Withdrawal by Subject|29|||
145937176|NCT04064411|526275798|FG000|Overall Study|Lost to Follow-up|5|||
145937177|NCT04064411|526275799|FG001|Overall Study|Lost to Follow-up|2|||
145937178|NCT04064411|526275798|FG000|Overall Study|Other than Specified|4|||
145937179|NCT04064411|526275799|FG001|Overall Study|Other than Specified|1|||
145937180|NCT04064411|526275798|FG000|Overall Study|Death|1|||
145937181|NCT04064411|526275799|FG001|Overall Study|Death|0|||
145937182|NCT00743288|526277943|FG000|Overall Study|Adverse Event|1|||
145937183|NCT00743288|526277944|FG001|Overall Study|Adverse Event|1|||
145937184|NCT00743288|526277945|FG002|Overall Study|Adverse Event|2|||
145937185|NCT00743288|526277946|FG003|Overall Study|Adverse Event|2|||
145937186|NCT00743288|526277947|FG004|Overall Study|Adverse Event|1|||
145937187|NCT00743288|526277948|FG005|Overall Study|Adverse Event|1|||
145937188|NCT00743288|526277949|FG006|Overall Study|Adverse Event|2|||
145937189|NCT00743288|526277943|FG000|Overall Study|Withdrawal by Subject|0|||
145937190|NCT00743288|526277944|FG001|Overall Study|Withdrawal by Subject|0|||
145937191|NCT00743288|526277945|FG002|Overall Study|Withdrawal by Subject|1|||
145979283|NCT01807520|526435970|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145979284|NCT01807520|526435971|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145979285|NCT01807520|526435972|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
145979286|NCT01807520|526435973|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145979287|NCT01807520|526435967|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145979288|NCT01807520|526435968|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145979289|NCT01807520|526435969|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145979290|NCT01807520|526435970|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146091147|NCT02273739|526854886|FG000|Overall Study|Progression of Disease|3|||
146091148|NCT02273739|526854887|FG001|Overall Study|Progression of Disease|4|||
146091149|NCT02273739|526854888|FG002|Overall Study|Progression of Disease|5|||
146091150|NCT02273739|526854889|FG003|Overall Study|Progression of Disease|2|||
146091151|NCT02273739|526854886|FG000|Overall Study|Death|0|||
146091152|NCT02273739|526854887|FG001|Overall Study|Death|0|||
146091153|NCT02273739|526854888|FG002|Overall Study|Death|0|||
146091154|NCT02273739|526854889|FG003|Overall Study|Death|2|||
146091155|NCT02273739|526854886|FG000|Overall Study|Adverse Event|0|||
146091156|NCT02273739|526854887|FG001|Overall Study|Adverse Event|0|||
146091157|NCT02273739|526854888|FG002|Overall Study|Adverse Event|0|||
146091158|NCT02273739|526854889|FG003|Overall Study|Adverse Event|1|||
146091159|NCT02273739|526854886|FG000|Overall Study|Withdrawal by Subject|0|||
146091160|NCT02273739|526854887|FG001|Overall Study|Withdrawal by Subject|0|||
146091161|NCT02273739|526854888|FG002|Overall Study|Withdrawal by Subject|2|||
146091162|NCT02273739|526854889|FG003|Overall Study|Withdrawal by Subject|1|||
146091163|NCT02273739|526854886|FG000|Overall Study|Physician Decision|0|||
146091164|NCT02273739|526854887|FG001|Overall Study|Physician Decision|0|||
146091165|NCT02273739|526854888|FG002|Overall Study|Physician Decision|0|||
146091166|NCT02273739|526854889|FG003|Overall Study|Physician Decision|1|||
146091167|NCT04718103|526854890|FG000|Overall Study|Adverse Event|1|||
146091168|NCT04718103|526854891|FG001|Overall Study|Adverse Event|1|||
146091169|NCT04718103|526854890|FG000|Overall Study|Lack of Efficacy|4|||
146091170|NCT04718103|526854891|FG001|Overall Study|Lack of Efficacy|1|||
146091171|NCT04718103|526854890|FG000|Overall Study|Lost to Follow-up|2|||
146091172|NCT04718103|526854891|FG001|Overall Study|Lost to Follow-up|2|||
146091173|NCT04718103|526854890|FG000|Overall Study|Physician Decision|2|||
146091174|NCT04718103|526854891|FG001|Overall Study|Physician Decision|0|||
145937192|NCT00743288|526277946|FG003|Overall Study|Withdrawal by Subject|0|||
145937193|NCT00743288|526277947|FG004|Overall Study|Withdrawal by Subject|0|||
145937194|NCT00743288|526277948|FG005|Overall Study|Withdrawal by Subject|1|||
145937195|NCT00743288|526277949|FG006|Overall Study|Withdrawal by Subject|1|||
145937196|NCT00743288|526277943|FG000|Overall Study|Progressive disease (PD)|2|||
145937197|NCT00743288|526277944|FG001|Overall Study|Progressive disease (PD)|0|||
145937198|NCT00743288|526277945|FG002|Overall Study|Progressive disease (PD)|1|||
145937199|NCT00743288|526277946|FG003|Overall Study|Progressive disease (PD)|4|||
145937200|NCT00743288|526277947|FG004|Overall Study|Progressive disease (PD)|5|||
145937201|NCT00743288|526277948|FG005|Overall Study|Progressive disease (PD)|3|||
145937202|NCT00743288|526277949|FG006|Overall Study|Progressive disease (PD)|6|||
145937203|NCT00743288|526277943|FG000|Overall Study|Worsening of condition (Not PD)|0|||
145937204|NCT00743288|526277944|FG001|Overall Study|Worsening of condition (Not PD)|2|||
145937205|NCT00743288|526277945|FG002|Overall Study|Worsening of condition (Not PD)|1|||
145937206|NCT00743288|526277946|FG003|Overall Study|Worsening of condition (Not PD)|1|||
145937207|NCT00743288|526277947|FG004|Overall Study|Worsening of condition (Not PD)|0|||
145937208|NCT00743288|526277948|FG005|Overall Study|Worsening of condition (Not PD)|0|||
145979291|NCT01807520|526435971|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
146091175|NCT04718103|526854890|FG000|Overall Study|Pregnancy|0|||
146091176|NCT04718103|526854891|FG001|Overall Study|Pregnancy|1|||
146091177|NCT04718103|526854890|FG000|Overall Study|Withdrawal by Subject|10|||
145979292|NCT01807520|526435972|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
146091178|NCT04718103|526854891|FG001|Overall Study|Withdrawal by Subject|6|||
146091179|NCT04718103|526854890|FG000|Overall Study|Randomized, not treated|4|||
146091180|NCT04718103|526854891|FG001|Overall Study|Randomized, not treated|1|||
145937209|NCT00743288|526277949|FG006|Overall Study|Worsening of condition (Not PD)|0|||
145937210|NCT00688701|526277950|FG000|Overall Study|Adverse Event|1|||
145937211|NCT00688701|526277951|FG001|Overall Study|Adverse Event|0|||
145937212|NCT00688701|526277952|FG002|Overall Study|Adverse Event|5|||
145937213|NCT00688701|526277953|FG003|Overall Study|Adverse Event|3|||
145937214|NCT00688701|526277950|FG000|Overall Study|Lack of Efficacy|0|||
146091181|NCT04718103|526854890|FG000|Overall Study|GCP violations|7|||
146091182|NCT04718103|526854891|FG001|Overall Study|GCP violations|5|||
146091183|NCT01484938|526854897|FG000|Overall Study|Adverse Event|2|||
146091184|NCT01484938|526854897|FG000|Overall Study|Lost to Follow-up|1|||
146091185|NCT01484938|526854897|FG000|Overall Study|Noncompliance|1|||
146245381|NCT01799993|527412201|FG001|Overall Study|Subject didn't return for follow-up|1|||
146245382|NCT04410445|527412202|FG000|Overall Study|Lost to Follow-up|3|||
146245383|NCT04410445|527412203|FG001|Overall Study|Lost to Follow-up|9|||
146245384|NCT04410445|527412202|FG000|Overall Study|Withdrawal by Subject|27|||
146245385|NCT04410445|527412203|FG001|Overall Study|Withdrawal by Subject|15|||
145937215|NCT00688701|526277951|FG001|Overall Study|Lack of Efficacy|1|||
145937216|NCT00688701|526277952|FG002|Overall Study|Lack of Efficacy|0|||
145937217|NCT00688701|526277953|FG003|Overall Study|Lack of Efficacy|0|||
145937218|NCT00688701|526277950|FG000|Overall Study|Withdrawal by Subject|3|||
145937219|NCT00688701|526277951|FG001|Overall Study|Withdrawal by Subject|3|||
145937220|NCT00688701|526277952|FG002|Overall Study|Withdrawal by Subject|4|||
145937221|NCT00688701|526277953|FG003|Overall Study|Withdrawal by Subject|8|||
145937222|NCT00688701|526277950|FG000|Overall Study|Poor compliance to protocol|0|||
145937223|NCT00688701|526277951|FG001|Overall Study|Poor compliance to protocol|1|||
145937224|NCT00688701|526277952|FG002|Overall Study|Poor compliance to protocol|1|||
145937225|NCT00688701|526277953|FG003|Overall Study|Poor compliance to protocol|0|||
145937226|NCT03917472|526277954|FG000|Overall Study|Physician Decision|4|||
145937227|NCT03917472|526277955|FG001|Overall Study|Physician Decision|0|||
145937228|NCT03917472|526277954|FG000|Overall Study|Adverse Event|3|||
145937229|NCT03917472|526277955|FG001|Overall Study|Adverse Event|1|||
145937230|NCT03917472|526277954|FG000|Overall Study|Death|7|||
145937231|NCT03917472|526277955|FG001|Overall Study|Death|5|||
145937232|NCT03917472|526277954|FG000|Overall Study|Withdrawal by Subject|11|||
145937233|NCT03917472|526277955|FG001|Overall Study|Withdrawal by Subject|4|||
145937234|NCT03917472|526277954|FG000|Overall Study|Lost to Follow-up|10|||
145937235|NCT03917472|526277955|FG001|Overall Study|Lost to Follow-up|5|||
145937236|NCT02706886|526277956|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
145937237|NCT02706886|526277957|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
145937238|NCT02706886|526277958|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
145937239|NCT02706886|526277959|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
145937240|NCT02706886|526277960|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
145937241|NCT02706886|526277961|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
145937242|NCT02706886|526277962|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
145937243|NCT02706886|526277963|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
145937244|NCT02706886|526277964|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
145937245|NCT02759055|526277965|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
145937246|NCT02759055|526277966|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
145937247|NCT04934189|526277967|FG000|Overall Study|Lost to Follow-up|4|||
145937248|NCT04934189|526277967|FG000|Overall Study|Withdrawal by Subject|17|||
145937249|NCT02487771|526277969|FG000|Overall Study|Lost to Follow-up|2|||
145937250|NCT02487771|526277970|FG001|Overall Study|Lost to Follow-up|3|||
145937251|NCT02487771|526277969|FG000|Overall Study|Moved out of area|5|||
145937252|NCT02487771|526277970|FG001|Overall Study|Moved out of area|6|||
145937253|NCT02487771|526277969|FG000|Overall Study|Withdrawal by Subject|3|||
145937254|NCT02487771|526277970|FG001|Overall Study|Withdrawal by Subject|5|||
145937255|NCT01871402|526277971|FG000|Overall Study|Lost to Follow-up|1|||
145937256|NCT01871402|526277972|FG001|Overall Study|Lost to Follow-up|0|||
145937257|NCT01871402|526277971|FG000|Overall Study|Withdrawal by Subject|0|||
145937258|NCT01871402|526277972|FG001|Overall Study|Withdrawal by Subject|2|||
145937259|NCT01871402|526277971|FG000|Overall Study|Non-compliance|0|||
145937260|NCT01871402|526277972|FG001|Overall Study|Non-compliance|1|||
145937261|NCT04594941|526277973|FG000|Overall Study|Other|0|||
145937262|NCT04594941|526277974|FG001|Overall Study|Other|3|||
145937263|NCT04594941|526277975|FG002|Overall Study|Other|1|||
145937264|NCT04594941|526277976|FG003|Overall Study|Other|0|||
145937265|NCT01895270|526277979|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
145937266|NCT01895270|526277980|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
145937267|NCT01895270|526277979|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
145937268|NCT01895270|526277980|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
145937269|NCT01895270|526277979|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
145937270|NCT01895270|526277980|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
145937271|NCT01895270|526277979|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
146091186|NCT02942576|526854899|FG000|Overall Study|Adverse Event|28|||
146091187|NCT02942576|526854900|FG001|Overall Study|Adverse Event|6|||
146245386|NCT01320683|527412204|FG000|Overall Study|Positive antibody response|1|||
145937272|NCT01895270|526277980|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
145937273|NCT01895270|526277979|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
145937274|NCT01895270|526277980|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
145937275|NCT01895270|526277979|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
145937276|NCT01895270|526277980|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
145937277|NCT01895270|526277979|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
145937278|NCT01895270|526277980|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
145937279|NCT04507256|526277981|FG000|Overall Study|Withdrawal by Subject|1|||
145937280|NCT04507256|526277982|FG001|Overall Study|Withdrawal by Subject|0|||
145937281|NCT04507256|526277983|FG002|Overall Study|Withdrawal by Subject|0|||
145937282|NCT04507256|526277984|FG003|Overall Study|Withdrawal by Subject|1|||
145937283|NCT04507256|526277985|FG004|Overall Study|Withdrawal by Subject|0|||
145937284|NCT04507256|526277986|FG005|Overall Study|Withdrawal by Subject|0|||
145937285|NCT00631410|526277993|FG000|Overall Study|Adverse Event|1|||
145937286|NCT00631410|526277994|FG001|Overall Study|Adverse Event|3|||
145937287|NCT00631410|526277993|FG000|Overall Study|Objective Progression or Relapse|4|||
145937288|NCT00631410|526277994|FG001|Overall Study|Objective Progression or Relapse|3|||
145937289|NCT00631410|526277993|FG000|Overall Study|Surgery|1|||
145937290|NCT00631410|526277994|FG001|Overall Study|Surgery|0|||
145937291|NCT00782184|526278001|FG000|Overall Study|Adverse Event|1|||
145937292|NCT00782184|526278002|FG001|Overall Study|Adverse Event|2|||
145937293|NCT00782184|526278001|FG000|Overall Study|Protocol Violation|0|||
145937294|NCT00782184|526278002|FG001|Overall Study|Protocol Violation|1|||
145937295|NCT00782184|526278001|FG000|Overall Study|Withdrawal by Subject|3|||
145937296|NCT00782184|526278002|FG001|Overall Study|Withdrawal by Subject|2|||
145937297|NCT01647516|526278009|FG000|Induction Period (IP)|Physician Decision|2|||
145937298|NCT01647516|526278010|FG001|Induction Period (IP)|Physician Decision|0|||
145937299|NCT01647516|526278011|FG002|Induction Period (IP)|Physician Decision|0|||
145937300|NCT01647516|526278012|FG003|Induction Period (IP)|Physician Decision|0|||
145937301|NCT01647516|526278013|FG004|Induction Period (IP)|Physician Decision|0|||
145937302|NCT01647516|526278014|FG005|Induction Period (IP)|Physician Decision|0|||
145937303|NCT01647516|526278009|FG000|Induction Period (IP)|Adverse Event|1|||
145937304|NCT01647516|526278010|FG001|Induction Period (IP)|Adverse Event|2|||
145937305|NCT01647516|526278011|FG002|Induction Period (IP)|Adverse Event|0|||
145937306|NCT01647516|526278012|FG003|Induction Period (IP)|Adverse Event|0|||
145937307|NCT01647516|526278013|FG004|Induction Period (IP)|Adverse Event|0|||
145937308|NCT01647516|526278014|FG005|Induction Period (IP)|Adverse Event|0|||
145937309|NCT01647516|526278009|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
145937310|NCT01647516|526278010|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
145937311|NCT01647516|526278011|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
145937312|NCT01647516|526278012|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
145937313|NCT01647516|526278013|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
145937314|NCT01647516|526278014|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
145937315|NCT01647516|526278009|FG000|Induction Period (IP)|Participant Choice|0|||
145937316|NCT01647516|526278010|FG001|Induction Period (IP)|Participant Choice|0|||
145937317|NCT01647516|526278011|FG002|Induction Period (IP)|Participant Choice|1|||
145937318|NCT01647516|526278012|FG003|Induction Period (IP)|Participant Choice|0|||
145937319|NCT01647516|526278013|FG004|Induction Period (IP)|Participant Choice|0|||
145937320|NCT01647516|526278014|FG005|Induction Period (IP)|Participant Choice|0|||
145937321|NCT01647516|526278009|FG000|Induction Period (IP)|Lack of Efficacy|1|||
145937322|NCT01647516|526278010|FG001|Induction Period (IP)|Lack of Efficacy|0|||
145937323|NCT01647516|526278011|FG002|Induction Period (IP)|Lack of Efficacy|0|||
145937324|NCT01647516|526278012|FG003|Induction Period (IP)|Lack of Efficacy|0|||
145937325|NCT01647516|526278013|FG004|Induction Period (IP)|Lack of Efficacy|0|||
145937326|NCT01647516|526278014|FG005|Induction Period (IP)|Lack of Efficacy|0|||
145937327|NCT01647516|526278009|FG000|Induction Period (IP)|No study drug received|1|||
145937328|NCT01647516|526278010|FG001|Induction Period (IP)|No study drug received|1|||
145937329|NCT01647516|526278011|FG002|Induction Period (IP)|No study drug received|0|||
145937330|NCT01647516|526278012|FG003|Induction Period (IP)|No study drug received|0|||
145937331|NCT01647516|526278013|FG004|Induction Period (IP)|No study drug received|0|||
145937332|NCT01647516|526278014|FG005|Induction Period (IP)|No study drug received|0|||
145937333|NCT01647516|526278009|FG000|Maintenance Period (MP)|Adverse Event|2|||
145937334|NCT01647516|526278010|FG001|Maintenance Period (MP)|Adverse Event|1|||
145937335|NCT01647516|526278011|FG002|Maintenance Period (MP)|Adverse Event|0|||
145937336|NCT01647516|526278012|FG003|Maintenance Period (MP)|Adverse Event|0|||
145937337|NCT01647516|526278013|FG004|Maintenance Period (MP)|Adverse Event|0|||
145937338|NCT01647516|526278014|FG005|Maintenance Period (MP)|Adverse Event|0|||
145937339|NCT01647516|526278009|FG000|Maintenance Period (MP)|Non-compliance|1|||
145937340|NCT01647516|526278010|FG001|Maintenance Period (MP)|Non-compliance|0|||
145937341|NCT01647516|526278011|FG002|Maintenance Period (MP)|Non-compliance|0|||
145937342|NCT01647516|526278012|FG003|Maintenance Period (MP)|Non-compliance|0|||
145937343|NCT01647516|526278013|FG004|Maintenance Period (MP)|Non-compliance|0|||
145979293|NCT01807520|526435973|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
145937344|NCT01647516|526278014|FG005|Maintenance Period (MP)|Non-compliance|0|||
145937345|NCT01647516|526278009|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
145937346|NCT01647516|526278010|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
145937347|NCT01647516|526278011|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
145937348|NCT01647516|526278012|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
145937349|NCT01647516|526278013|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
145937350|NCT01647516|526278014|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
145937351|NCT01647516|526278009|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
145937352|NCT01647516|526278010|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
145937353|NCT01647516|526278011|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
145979294|NCT01500096|526435976|FG000|Overall Study|Lost to Follow-up|1|||
145979295|NCT01500096|526435977|FG001|Overall Study|Lost to Follow-up|0|||
145979296|NCT01500096|526435978|FG002|Overall Study|Lost to Follow-up|0|||
145979297|NCT01500096|526435979|FG003|Overall Study|Lost to Follow-up|2|||
145979298|NCT00639379|526435983|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
145979299|NCT00639379|526435984|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
145979300|NCT00639379|526435983|FG000|Period 1 - 2 Weeks|lens issue|3|||
145979301|NCT00639379|526435984|FG001|Period 1 - 2 Weeks|lens issue|0|||
145937354|NCT01647516|526278012|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
145979302|NCT00723944|526435987|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
145937355|NCT01647516|526278013|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
145937356|NCT01647516|526278014|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
145937357|NCT01647516|526278009|FG000|Open-Label Period|Adverse Event|0|||
145937358|NCT01647516|526278010|FG001|Open-Label Period|Adverse Event|0|||
145937359|NCT01647516|526278011|FG002|Open-Label Period|Adverse Event|0|||
145937360|NCT01647516|526278012|FG003|Open-Label Period|Adverse Event|5|||
145937361|NCT01647516|526278013|FG004|Open-Label Period|Adverse Event|6|||
145937362|NCT01647516|526278014|FG005|Open-Label Period|Adverse Event|3|||
145937363|NCT01647516|526278009|FG000|Open-Label Period|Pregnancy|0|||
145937364|NCT01647516|526278010|FG001|Open-Label Period|Pregnancy|0|||
145937365|NCT01647516|526278011|FG002|Open-Label Period|Pregnancy|0|||
145937366|NCT01647516|526278012|FG003|Open-Label Period|Pregnancy|0|||
145937367|NCT01647516|526278013|FG004|Open-Label Period|Pregnancy|0|||
145937368|NCT01647516|526278014|FG005|Open-Label Period|Pregnancy|1|||
145937369|NCT01647516|526278009|FG000|Open-Label Period|Non-compliance|0|||
145937370|NCT01647516|526278010|FG001|Open-Label Period|Non-compliance|0|||
145937371|NCT01647516|526278011|FG002|Open-Label Period|Non-compliance|0|||
145937372|NCT01647516|526278012|FG003|Open-Label Period|Non-compliance|1|||
145937373|NCT01647516|526278013|FG004|Open-Label Period|Non-compliance|0|||
145937374|NCT01647516|526278014|FG005|Open-Label Period|Non-compliance|1|||
145937375|NCT01647516|526278009|FG000|Open-Label Period|Physician Decision|0|||
145937376|NCT01647516|526278010|FG001|Open-Label Period|Physician Decision|0|||
145937377|NCT01647516|526278011|FG002|Open-Label Period|Physician Decision|0|||
145937378|NCT01647516|526278012|FG003|Open-Label Period|Physician Decision|1|||
145937379|NCT01647516|526278013|FG004|Open-Label Period|Physician Decision|1|||
145937380|NCT01647516|526278014|FG005|Open-Label Period|Physician Decision|0|||
145937381|NCT01647516|526278009|FG000|Open-Label Period|Withdrawal by Subject|0|||
145937382|NCT01647516|526278010|FG001|Open-Label Period|Withdrawal by Subject|0|||
145937383|NCT01647516|526278011|FG002|Open-Label Period|Withdrawal by Subject|0|||
145937384|NCT01647516|526278012|FG003|Open-Label Period|Withdrawal by Subject|9|||
145937385|NCT01647516|526278013|FG004|Open-Label Period|Withdrawal by Subject|11|||
145937386|NCT01647516|526278014|FG005|Open-Label Period|Withdrawal by Subject|6|||
145937387|NCT01647516|526278009|FG000|Open-Label Period|Lost to Follow-up|0|||
145937388|NCT01647516|526278010|FG001|Open-Label Period|Lost to Follow-up|0|||
145937389|NCT01647516|526278011|FG002|Open-Label Period|Lost to Follow-up|0|||
145937390|NCT01647516|526278012|FG003|Open-Label Period|Lost to Follow-up|1|||
145937391|NCT01647516|526278013|FG004|Open-Label Period|Lost to Follow-up|0|||
145937392|NCT01647516|526278014|FG005|Open-Label Period|Lost to Follow-up|1|||
145937393|NCT01647516|526278009|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145937394|NCT01647516|526278010|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145979303|NCT00723944|526435988|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
145979304|NCT00723944|526435987|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
145979305|NCT00723944|526435988|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
145979306|NCT00723944|526435987|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
145979307|NCT00723944|526435988|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
145979308|NCT02582632|526435989|FG000|Overall Study|Other|1|||
145979309|NCT04307394|526435993|FG000|Overall Study|Lost to Follow-up|3|||
146091188|NCT02942576|526854899|FG000|Overall Study|Withdrawal by Subject|7|||
146091189|NCT02942576|526854900|FG001|Overall Study|Withdrawal by Subject|5|||
146245387|NCT02291861|527412205|FG000|Overall Study|Adverse Event|2|||
146245388|NCT02291861|527412206|FG001|Overall Study|Adverse Event|4|||
145979310|NCT04307394|526435993|FG000|Overall Study|Withdrawal by Subject|2|||
145979311|NCT01617967|526435997|FG000|Overall Study|Protocol Violation|0|||
145979312|NCT01617967|526435998|FG001|Overall Study|Protocol Violation|0|||
145979313|NCT01617967|526435999|FG002|Overall Study|Protocol Violation|0|||
145979314|NCT01617967|526436000|FG003|Overall Study|Protocol Violation|1|||
145979315|NCT01617967|526436001|FG004|Overall Study|Protocol Violation|0|||
145979316|NCT01617967|526436002|FG005|Overall Study|Protocol Violation|0|||
145937395|NCT01647516|526278011|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145937396|NCT01647516|526278012|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
145937397|NCT01647516|526278013|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
145937398|NCT01647516|526278014|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
145937399|NCT01647516|526278009|FG000|Open-Label Period|Lack of Efficacy|0|||
145937400|NCT01647516|526278010|FG001|Open-Label Period|Lack of Efficacy|0|||
145979317|NCT01617967|526435997|FG000|Overall Study|Withdrawal by Subject|0|||
145979318|NCT01617967|526435998|FG001|Overall Study|Withdrawal by Subject|0|||
145937401|NCT01647516|526278011|FG002|Open-Label Period|Lack of Efficacy|0|||
145937402|NCT01647516|526278012|FG003|Open-Label Period|Lack of Efficacy|7|||
145937403|NCT01647516|526278013|FG004|Open-Label Period|Lack of Efficacy|9|||
145937404|NCT01647516|526278014|FG005|Open-Label Period|Lack of Efficacy|10|||
145937405|NCT01647516|526278009|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145937406|NCT01647516|526278010|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145937407|NCT01647516|526278011|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145937408|NCT01647516|526278012|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
145937409|NCT01647516|526278013|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
145937410|NCT01647516|526278014|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
145937411|NCT01647516|526278009|FG000|Open-Label Period|No completion / discontinuation visit|0|||
145937412|NCT01647516|526278010|FG001|Open-Label Period|No completion / discontinuation visit|0|||
145937413|NCT01647516|526278011|FG002|Open-Label Period|No completion / discontinuation visit|0|||
145937414|NCT01647516|526278012|FG003|Open-Label Period|No completion / discontinuation visit|0|||
145937415|NCT01647516|526278013|FG004|Open-Label Period|No completion / discontinuation visit|2|||
145937416|NCT01647516|526278014|FG005|Open-Label Period|No completion / discontinuation visit|1|||
146245389|NCT02291861|527412207|FG002|Overall Study|Adverse Event|1|||
146245390|NCT02291861|527412208|FG003|Overall Study|Adverse Event|2|||
146245391|NCT02291861|527412205|FG000|Overall Study|Death|0|||
145937417|NCT01676896|526278015|FG000|Overall Study|Withdrawal by Subject|12|||
145937418|NCT01676896|526278016|FG001|Overall Study|Withdrawal by Subject|7|||
145937419|NCT01676896|526278017|FG002|Overall Study|Withdrawal by Subject|19|||
145937420|NCT01613222|526278020|FG000|Overall Study|Physician Decision|1|||
145937421|NCT01613222|526278020|FG000|Overall Study|Unable to place arterial line|1|||
145937422|NCT01613222|526278020|FG000|Overall Study|Reused disposable sensors|10|||
145937423|NCT01895608|526278021|FG000|Overall Study|change in health status|0|||
145937424|NCT01895608|526278022|FG001|Overall Study|change in health status|1|||
145937425|NCT01895608|526278023|FG002|Overall Study|change in health status|1|||
145937426|NCT01895608|526278024|FG003|Overall Study|change in health status|0|||
145937427|NCT01895608|526278021|FG000|Overall Study|Withdrawal by Subject|0|||
145937428|NCT01895608|526278022|FG001|Overall Study|Withdrawal by Subject|0|||
145937429|NCT01895608|526278023|FG002|Overall Study|Withdrawal by Subject|2|||
145937430|NCT01895608|526278024|FG003|Overall Study|Withdrawal by Subject|0|||
145937431|NCT03505593|526278025|FG000|Overall Study|Withdrawal by Subject|1|||
145937432|NCT03505593|526278025|FG000|Overall Study|Died before procedure|1|||
145937433|NCT03505593|526278025|FG000|Overall Study|Anatomical abnormality|1|||
145937434|NCT03505593|526278025|FG000|Overall Study|Unable to pass through esophagus|1|||
145937435|NCT03505593|526278025|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
145937436|NCT02822573|526278026|FG000|Overall Study|Lost to Follow-up|5|||
145937437|NCT02822573|526278027|FG001|Overall Study|Lost to Follow-up|3|||
145937438|NCT02822573|526278026|FG000|Overall Study|Physician Decision|1|||
145937439|NCT02822573|526278027|FG001|Overall Study|Physician Decision|1|||
145937440|NCT02822573|526278026|FG000|Overall Study|Withdrawal by Subject|9|||
145937441|NCT02822573|526278027|FG001|Overall Study|Withdrawal by Subject|5|||
145937442|NCT02822573|526278026|FG000|Overall Study|Protocol Violation|6|||
145937443|NCT02822573|526278027|FG001|Overall Study|Protocol Violation|4|||
145937444|NCT02822573|526278026|FG000|Overall Study|Too sick or ill|2|||
145937445|NCT02822573|526278027|FG001|Overall Study|Too sick or ill|1|||
145937446|NCT02822573|526278026|FG000|Overall Study|Disease Progression|1|||
145979319|NCT01617967|526435999|FG002|Overall Study|Withdrawal by Subject|0|||
145979320|NCT01617967|526436000|FG003|Overall Study|Withdrawal by Subject|0|||
145979321|NCT01617967|526436001|FG004|Overall Study|Withdrawal by Subject|0|||
145979322|NCT01617967|526436002|FG005|Overall Study|Withdrawal by Subject|1|||
145979323|NCT01617967|526435997|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
145979324|NCT01617967|526435998|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
145979325|NCT01617967|526435999|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
146245392|NCT02291861|527412206|FG001|Overall Study|Death|0|||
146245393|NCT02291861|527412207|FG002|Overall Study|Death|1|||
145937447|NCT02822573|526278027|FG001|Overall Study|Disease Progression|1|||
145937448|NCT02822573|526278026|FG000|Overall Study|No reason given|6|||
145937449|NCT02822573|526278027|FG001|Overall Study|No reason given|4|||
145937450|NCT04143594|526278029|FG000|Overall Study|Withdrew consent|3|||
145937451|NCT04143594|526278030|FG001|Overall Study|Withdrew consent|10|||
145937452|NCT04143594|526278031|FG002|Overall Study|Withdrew consent|3|||
145937453|NCT04143594|526278032|FG003|Overall Study|Withdrew consent|1|||
145979326|NCT01617967|526436000|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
145979327|NCT01617967|526436001|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
145937454|NCT04143594|526278029|FG000|Overall Study|Lost to Follow-up|3|||
145937455|NCT04143594|526278030|FG001|Overall Study|Lost to Follow-up|5|||
145937456|NCT04143594|526278031|FG002|Overall Study|Lost to Follow-up|11|||
145937457|NCT04143594|526278032|FG003|Overall Study|Lost to Follow-up|0|||
145937458|NCT04143594|526278029|FG000|Overall Study|Investigator's discretion|2|||
145937459|NCT04143594|526278030|FG001|Overall Study|Investigator's discretion|2|||
145979328|NCT01617967|526436002|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
146245394|NCT02291861|527412208|FG003|Overall Study|Death|1|||
146245395|NCT02291861|527412205|FG000|Overall Study|Protocol Violation|1|||
145937460|NCT04143594|526278031|FG002|Overall Study|Investigator's discretion|0|||
145937461|NCT04143594|526278032|FG003|Overall Study|Investigator's discretion|0|||
145937462|NCT04143594|526278029|FG000|Overall Study|Randomized but never treated|0|||
145937463|NCT04143594|526278030|FG001|Overall Study|Randomized but never treated|0|||
145937464|NCT04143594|526278031|FG002|Overall Study|Randomized but never treated|0|||
145937465|NCT04143594|526278032|FG003|Overall Study|Randomized but never treated|1|||
145937466|NCT04143594|526278029|FG000|Overall Study|Death|1|||
145937467|NCT04143594|526278030|FG001|Overall Study|Death|0|||
145937468|NCT04143594|526278031|FG002|Overall Study|Death|1|||
145937469|NCT04143594|526278032|FG003|Overall Study|Death|0|||
145937470|NCT04143594|526278029|FG000|Overall Study|Adverse Event|1|||
145937471|NCT04143594|526278030|FG001|Overall Study|Adverse Event|0|||
145937472|NCT04143594|526278031|FG002|Overall Study|Adverse Event|0|||
145937473|NCT04143594|526278032|FG003|Overall Study|Adverse Event|0|||
145937474|NCT04143594|526278029|FG000|Overall Study|Pregnancy|0|||
145937475|NCT04143594|526278030|FG001|Overall Study|Pregnancy|0|||
145937476|NCT04143594|526278031|FG002|Overall Study|Pregnancy|1|||
145937477|NCT04143594|526278032|FG003|Overall Study|Pregnancy|0|||
145937478|NCT04143594|526278029|FG000|Overall Study|Lack of Efficacy|1|||
145937479|NCT04143594|526278030|FG001|Overall Study|Lack of Efficacy|1|||
145937480|NCT04143594|526278031|FG002|Overall Study|Lack of Efficacy|0|||
145937481|NCT04143594|526278032|FG003|Overall Study|Lack of Efficacy|0|||
145937482|NCT02855359|526278035|FG000|Overall Study|Death|2|||
145937483|NCT02855359|526278036|FG001|Overall Study|Death|2|||
145937484|NCT02855359|526278037|FG002|Overall Study|Death|0|||
145937485|NCT02855359|526278038|FG003|Overall Study|Death|0|||
145937486|NCT02855359|526278035|FG000|Overall Study|Study Termination by Sponsor|9|||
145937487|NCT02855359|526278036|FG001|Overall Study|Study Termination by Sponsor|11|||
145937488|NCT02855359|526278037|FG002|Overall Study|Study Termination by Sponsor|0|||
145937489|NCT02855359|526278038|FG003|Overall Study|Study Termination by Sponsor|0|||
145937490|NCT01023256|526278039|FG000|Overall Study|Protocol Violation|2|||
145937491|NCT01023256|526278040|FG001|Overall Study|Protocol Violation|3|||
145937492|NCT01023256|526278041|FG002|Overall Study|Protocol Violation|0|||
145937493|NCT01023256|526278042|FG003|Overall Study|Protocol Violation|0|||
145937494|NCT01023256|526278039|FG000|Overall Study|Randomized but not treated|1|||
145937495|NCT01023256|526278040|FG001|Overall Study|Randomized but not treated|0|||
145937496|NCT01023256|526278041|FG002|Overall Study|Randomized but not treated|1|||
145937497|NCT01023256|526278042|FG003|Overall Study|Randomized but not treated|0|||
145937498|NCT01023256|526278039|FG000|Overall Study|Other|1|||
145937499|NCT01023256|526278040|FG001|Overall Study|Other|0|||
145937500|NCT01023256|526278041|FG002|Overall Study|Other|0|||
145937501|NCT01023256|526278042|FG003|Overall Study|Other|2|||
145937502|NCT01023256|526278039|FG000|Overall Study|Adverse Event|0|||
145937503|NCT01023256|526278040|FG001|Overall Study|Adverse Event|0|||
145937504|NCT01023256|526278041|FG002|Overall Study|Adverse Event|0|||
145937505|NCT01023256|526278042|FG003|Overall Study|Adverse Event|1|||
145937506|NCT01023256|526278039|FG000|Overall Study|Withdrawal by Subject|0|||
145937507|NCT01023256|526278040|FG001|Overall Study|Withdrawal by Subject|0|||
145937508|NCT01023256|526278041|FG002|Overall Study|Withdrawal by Subject|0|||
145937509|NCT01023256|526278042|FG003|Overall Study|Withdrawal by Subject|2|||
145937510|NCT03155178|526278043|FG000|Overall Study|Did not meet treatment day baseline|7|||
145937511|NCT03155178|526278044|FG001|Overall Study|Did not meet treatment day baseline|7|||
145937512|NCT03155178|526278045|FG002|Overall Study|Did not meet treatment day baseline|7|||
145937513|NCT03155178|526278046|FG003|Overall Study|Did not meet treatment day baseline|7|||
145937514|NCT00308087|526278047|FG000|Overall Study|Progressive Disease|19|||
145937515|NCT00308087|526278048|FG001|Overall Study|Progressive Disease|21|||
145937516|NCT00308087|526278047|FG000|Overall Study|Study Closure|11|||
145937517|NCT00308087|526278048|FG001|Overall Study|Study Closure|12|||
145937518|NCT00308087|526278047|FG000|Overall Study|Withdrawal by Subject|2|||
145937519|NCT00308087|526278048|FG001|Overall Study|Withdrawal by Subject|1|||
145937520|NCT00308087|526278047|FG000|Overall Study|Other|4|||
145937521|NCT00308087|526278048|FG001|Overall Study|Other|3|||
145937522|NCT01044290|526278049|FG000|Follow-up 1|Death|3|||
145937523|NCT01044290|526278050|FG001|Follow-up 1|Death|3|||
145937524|NCT01044290|526278051|FG002|Follow-up 1|Death|1|||
145937525|NCT01044290|526278049|FG000|Follow-up 1|Withdrawal by Subject|2|||
145937526|NCT01044290|526278050|FG001|Follow-up 1|Withdrawal by Subject|2|||
145937527|NCT01044290|526278051|FG002|Follow-up 1|Withdrawal by Subject|0|||
145937528|NCT01044290|526278049|FG000|Follow-Up 2|Death|0|||
145937529|NCT01044290|526278050|FG001|Follow-Up 2|Death|1|||
146245396|NCT02291861|527412206|FG001|Overall Study|Protocol Violation|0|||
145937530|NCT01044290|526278051|FG002|Follow-Up 2|Death|1|||
145937531|NCT01044290|526278049|FG000|Follow-Up 2|Withdrawal by Subject|0|||
145937532|NCT01044290|526278050|FG001|Follow-Up 2|Withdrawal by Subject|1|||
146245397|NCT02291861|527412207|FG002|Overall Study|Protocol Violation|0|||
146245398|NCT02291861|527412208|FG003|Overall Study|Protocol Violation|1|||
145937533|NCT01044290|526278051|FG002|Follow-Up 2|Withdrawal by Subject|1|||
145937534|NCT04323306|526278052|FG000|Overall Study|Physician Decision|1|||
145937535|NCT04323306|526278053|FG001|Overall Study|Physician Decision|0|||
145937536|NCT04323306|526278054|FG002|Overall Study|Physician Decision|0|||
145937537|NCT04323306|526278055|FG003|Overall Study|Physician Decision|0|||
146245399|NCT02291861|527412205|FG000|Overall Study|Withdrawal by Subject|1|||
146245400|NCT02291861|527412206|FG001|Overall Study|Withdrawal by Subject|2|||
146245401|NCT02291861|527412207|FG002|Overall Study|Withdrawal by Subject|1|||
146245402|NCT02291861|527412208|FG003|Overall Study|Withdrawal by Subject|4|||
145937538|NCT04323306|526278056|FG004|Overall Study|Physician Decision|0|||
145937539|NCT04323306|526278057|FG005|Overall Study|Physician Decision|0|||
145937540|NCT04323306|526278058|FG006|Overall Study|Physician Decision|0|||
145937541|NCT04323306|526278059|FG007|Overall Study|Physician Decision|0|||
145937542|NCT04323306|526278060|FG008|Overall Study|Physician Decision|0|||
145937543|NCT04323306|526278052|FG000|Overall Study|Withdrawal by Subject|0|||
145937544|NCT04323306|526278053|FG001|Overall Study|Withdrawal by Subject|0|||
145937545|NCT04323306|526278054|FG002|Overall Study|Withdrawal by Subject|0|||
145937546|NCT04323306|526278055|FG003|Overall Study|Withdrawal by Subject|0|||
145937547|NCT04323306|526278056|FG004|Overall Study|Withdrawal by Subject|0|||
145937548|NCT04323306|526278057|FG005|Overall Study|Withdrawal by Subject|1|||
145937549|NCT04323306|526278058|FG006|Overall Study|Withdrawal by Subject|3|||
145937550|NCT04323306|526278059|FG007|Overall Study|Withdrawal by Subject|0|||
145937551|NCT04323306|526278060|FG008|Overall Study|Withdrawal by Subject|1|||
145937552|NCT04712019|526278063|FG000|Overall Study|Withdrawal by Subject|2|||
145937553|NCT04712019|526278064|FG001|Overall Study|Withdrawal by Subject|2|||
145937554|NCT04712019|526278063|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
145937555|NCT04712019|526278064|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
145937556|NCT01646021|526278065|FG000|Overall Study|Death|77|||
145937557|NCT01646021|526278066|FG001|Overall Study|Death|83|||
145937558|NCT01646021|526278065|FG000|Overall Study|Study Terminated by Sponsor|50|||
145937559|NCT01646021|526278066|FG001|Overall Study|Study Terminated by Sponsor|41|||
145937560|NCT01646021|526278065|FG000|Overall Study|Lost to Follow-up|2|||
145937561|NCT01646021|526278066|FG001|Overall Study|Lost to Follow-up|2|||
145937562|NCT01646021|526278065|FG000|Overall Study|Withdrawal by Subject|10|||
145937563|NCT01646021|526278066|FG001|Overall Study|Withdrawal by Subject|15|||
145937564|NCT01967706|526278076|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
145937565|NCT01967706|526278077|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
145937566|NCT01967706|526278078|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145937567|NCT01967706|526278079|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
145937568|NCT02347891|526278080|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
145937569|NCT02347891|526278081|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
145937570|NCT02347891|526278080|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
145937571|NCT02347891|526278081|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
145937572|NCT02541669|526278084|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145937573|NCT02541669|526278085|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145937574|NCT02541669|526278086|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
145937575|NCT02541669|526278087|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145937576|NCT02541669|526278088|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
145937577|NCT04739722|526278089|FG000|Overall Study|Lost to Follow-up|5301|||
145937578|NCT04739722|526278089|FG000|Overall Study|Withdrawal by Subject|42|||
145937579|NCT04739722|526278089|FG000|Overall Study|Non Average-risk|1157|||
145937580|NCT00834639|526278090|FG000|Second Intervention|Physician Decision|0|||
145937581|NCT00834639|526278091|FG001|Second Intervention|Physician Decision|2|||
145937582|NCT00725608|526278092|FG000|Overall Study|Lost to Follow-up|60|||
145937583|NCT00725608|526278092|FG000|Overall Study|Adverse Event|14|||
145937584|NCT00725608|526278092|FG000|Overall Study|Individual reasons|86|||
146245403|NCT02291861|527412205|FG000|Overall Study|Noncompliance|1|||
145937585|NCT00725608|526278092|FG000|Overall Study|Other|7|||
145937586|NCT00614120|526278096|FG000|Overall Study|Adverse Event|9|||
145937587|NCT00614120|526278097|FG001|Overall Study|Adverse Event|22|||
145937588|NCT00614120|526278098|FG002|Overall Study|Adverse Event|30|||
145937589|NCT00614120|526278099|FG003|Overall Study|Adverse Event|3|||
145937590|NCT00614120|526278096|FG000|Overall Study|Lack of Efficacy|3|||
145937591|NCT00614120|526278097|FG001|Overall Study|Lack of Efficacy|3|||
145937592|NCT00614120|526278098|FG002|Overall Study|Lack of Efficacy|2|||
145937593|NCT00614120|526278099|FG003|Overall Study|Lack of Efficacy|2|||
145937594|NCT00614120|526278096|FG000|Overall Study|Protocol Violation|2|||
145937595|NCT00614120|526278097|FG001|Overall Study|Protocol Violation|5|||
145937596|NCT00614120|526278098|FG002|Overall Study|Protocol Violation|3|||
145937597|NCT00614120|526278099|FG003|Overall Study|Protocol Violation|1|||
145937598|NCT00614120|526278096|FG000|Overall Study|Withdrawal criteria|1|||
145937599|NCT00614120|526278097|FG001|Overall Study|Withdrawal criteria|0|||
145937600|NCT00614120|526278098|FG002|Overall Study|Withdrawal criteria|0|||
145937601|NCT00614120|526278099|FG003|Overall Study|Withdrawal criteria|0|||
145937602|NCT00614120|526278096|FG000|Overall Study|Withdrawal by Subject|9|||
145937603|NCT00614120|526278097|FG001|Overall Study|Withdrawal by Subject|10|||
145937604|NCT00614120|526278098|FG002|Overall Study|Withdrawal by Subject|16|||
145937605|NCT00614120|526278099|FG003|Overall Study|Withdrawal by Subject|3|||
146245404|NCT02291861|527412206|FG001|Overall Study|Noncompliance|1|||
146245405|NCT02291861|527412207|FG002|Overall Study|Noncompliance|2|||
145937606|NCT00614120|526278096|FG000|Overall Study|Did not meet trial criteria|0|||
145937607|NCT00614120|526278097|FG001|Overall Study|Did not meet trial criteria|1|||
145937608|NCT00614120|526278098|FG002|Overall Study|Did not meet trial criteria|1|||
145937609|NCT00614120|526278099|FG003|Overall Study|Did not meet trial criteria|1|||
145937610|NCT00614120|526278096|FG000|Overall Study|hCG positive (not pregnant)|0|||
145937611|NCT00614120|526278097|FG001|Overall Study|hCG positive (not pregnant)|0|||
145937612|NCT00614120|526278098|FG002|Overall Study|hCG positive (not pregnant)|1|||
145937613|NCT00614120|526278099|FG003|Overall Study|hCG positive (not pregnant)|0|||
145937614|NCT00614120|526278096|FG000|Overall Study|Hypoglycaemia|0|||
145937615|NCT00614120|526278097|FG001|Overall Study|Hypoglycaemia|0|||
145937616|NCT00614120|526278098|FG002|Overall Study|Hypoglycaemia|0|||
145937617|NCT00614120|526278099|FG003|Overall Study|Hypoglycaemia|1|||
145937618|NCT00614120|526278096|FG000|Overall Study|Lack of trial product|3|||
145937619|NCT00614120|526278097|FG001|Overall Study|Lack of trial product|3|||
145937620|NCT00614120|526278098|FG002|Overall Study|Lack of trial product|2|||
145937621|NCT00614120|526278099|FG003|Overall Study|Lack of trial product|0|||
145937622|NCT00614120|526278096|FG000|Overall Study|Late syphilis, latent|1|||
145937623|NCT00614120|526278097|FG001|Overall Study|Late syphilis, latent|0|||
145937624|NCT00614120|526278098|FG002|Overall Study|Late syphilis, latent|0|||
145937625|NCT00614120|526278099|FG003|Overall Study|Late syphilis, latent|0|||
145937626|NCT00614120|526278096|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
145937627|NCT00614120|526278097|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
145937628|NCT00614120|526278098|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
145937629|NCT00614120|526278099|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
145937630|NCT00614120|526278096|FG000|Overall Study|Lost to Follow-up|1|||
145937631|NCT00614120|526278097|FG001|Overall Study|Lost to Follow-up|2|||
145937632|NCT00614120|526278098|FG002|Overall Study|Lost to Follow-up|3|||
145937633|NCT00614120|526278099|FG003|Overall Study|Lost to Follow-up|4|||
145937634|NCT03047720|526278100|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
145937635|NCT03047720|526278101|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
145937636|NCT01154088|526278102|FG000|Overall Study|Lost to Follow-up|4|||
145937637|NCT01154088|526278103|FG001|Overall Study|Lost to Follow-up|6|||
145937638|NCT01154088|526278104|FG002|Overall Study|Lost to Follow-up|7|||
145937639|NCT05129137|526278107|FG000|Second Period|Adverse Event|1|||
145937640|NCT05129137|526278108|FG001|Second Period|Adverse Event|0|||
145937641|NCT05129137|526278109|FG002|Second Period|Adverse Event|0|||
145937642|NCT05129137|526278110|FG003|Second Period|Adverse Event|0|||
145937643|NCT05129137|526278107|FG000|Second Period|Protocol Violation|0|||
145937644|NCT05129137|526278108|FG001|Second Period|Protocol Violation|0|||
145937645|NCT05129137|526278109|FG002|Second Period|Protocol Violation|0|||
145937646|NCT05129137|526278110|FG003|Second Period|Protocol Violation|1|||
145937647|NCT05129137|526278107|FG000|Third Period|Protocol Violation|0|||
145937648|NCT05129137|526278108|FG001|Third Period|Protocol Violation|0|||
145937649|NCT05129137|526278109|FG002|Third Period|Protocol Violation|0|||
145937650|NCT05129137|526278110|FG003|Third Period|Protocol Violation|1|||
145937651|NCT05129137|526278107|FG000|Forth Period|Protocol Violation|0|||
145937652|NCT05129137|526278108|FG001|Forth Period|Protocol Violation|1|||
145937653|NCT05129137|526278109|FG002|Forth Period|Protocol Violation|0|||
145937654|NCT05129137|526278110|FG003|Forth Period|Protocol Violation|0|||
145937655|NCT05129137|526278107|FG000|Forth Period|Withdrawal by Subject|0|||
145937656|NCT05129137|526278108|FG001|Forth Period|Withdrawal by Subject|0|||
145937657|NCT05129137|526278109|FG002|Forth Period|Withdrawal by Subject|1|||
145937658|NCT05129137|526278110|FG003|Forth Period|Withdrawal by Subject|0|||
145937659|NCT01084668|526278111|FG000|Overall Study|Lack of Efficacy|5|||
145937660|NCT01084668|526278111|FG000|Overall Study|Withdrawal by Subject|2|||
145937661|NCT01084668|526278111|FG000|Overall Study|Pregnancy|1|||
145937662|NCT01084668|526278111|FG000|Overall Study|Non-compliance|1|||
145937663|NCT01869699|526278113|FG000|Overall Study|Withdrawal by Subject|1|||
145979329|NCT02536794|526436003|FG000|Reached 1st Response Assessment|Adverse Event|2|||
145979330|NCT02536794|526436003|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
145979331|NCT02536794|526436003|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
145979332|NCT02536794|526436003|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
145979333|NCT02536794|526436003|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
145937664|NCT01869699|526278114|FG001|Overall Study|Withdrawal by Subject|0|||
145937665|NCT01475851|526278117|FG000|Overall Study|Protocol defined stopping criteria|1|||
145937666|NCT01475851|526278118|FG001|Overall Study|Protocol defined stopping criteria|0|||
145937667|NCT02447497|526278121|FG000|Overall Study|Did not meet treatment day baseline.|6|||
145937668|NCT02447497|526278122|FG001|Overall Study|Did not meet treatment day baseline.|5|||
145979334|NCT02536794|526436003|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
145979335|NCT00416949|526436004|FG000|Overall Study|Patients refused to participate|5|||
145937669|NCT02447497|526278123|FG002|Overall Study|Did not meet treatment day baseline.|2|||
145937670|NCT02447497|526278124|FG003|Overall Study|Did not meet treatment day baseline.|2|||
145937671|NCT02447497|526278121|FG000|Overall Study|Dressing was compromised|0|||
145937672|NCT02447497|526278122|FG001|Overall Study|Dressing was compromised|1|||
145937673|NCT02447497|526278123|FG002|Overall Study|Dressing was compromised|0|||
145937674|NCT02447497|526278124|FG003|Overall Study|Dressing was compromised|0|||
146245406|NCT02291861|527412208|FG003|Overall Study|Noncompliance|1|||
146245407|NCT02291861|527412205|FG000|Overall Study|Lost to Follow-up|2|||
146245408|NCT02291861|527412206|FG001|Overall Study|Lost to Follow-up|1|||
146245409|NCT02291861|527412207|FG002|Overall Study|Lost to Follow-up|4|||
146245410|NCT02291861|527412208|FG003|Overall Study|Lost to Follow-up|0|||
146245411|NCT02291861|527412205|FG000|Overall Study|Other|0|||
145937675|NCT01322035|526278125|FG000|Overall Study|Lost to Follow-up|8|||
145937676|NCT01322035|526278126|FG001|Overall Study|Lost to Follow-up|3|||
145937677|NCT00727844|526278127|FG000|Initial Randomization|Physician Decision|2|||
145937678|NCT00727844|526278128|FG001|Initial Randomization|Physician Decision|0|||
145937679|NCT00727844|526278129|FG002|Initial Randomization|Physician Decision|0|||
145937680|NCT00727844|526278130|FG003|Initial Randomization|Physician Decision|0|||
145937681|NCT04569968|526278131|FG000|Overall Study|Lost to Follow-up|2|||
145937682|NCT04569968|526278132|FG001|Overall Study|Lost to Follow-up|5|||
145937683|NCT04569968|526278131|FG000|Overall Study|Story of head and/or neck surgery|2|||
145937684|NCT04569968|526278132|FG001|Overall Study|Story of head and/or neck surgery|2|||
145937685|NCT04569968|526278131|FG000|Overall Study|Time of stroke onset|8|||
145937686|NCT04569968|526278132|FG001|Overall Study|Time of stroke onset|7|||
145937687|NCT04569968|526278131|FG000|Overall Study|Type of strokr|12|||
145937688|NCT04569968|526278132|FG001|Overall Study|Type of strokr|8|||
145937689|NCT04569968|526278131|FG000|Overall Study|Cooperation|8|||
145937690|NCT04569968|526278132|FG001|Overall Study|Cooperation|8|||
145937691|NCT04569968|526278131|FG000|Overall Study|Age interval|17|||
145937692|NCT04569968|526278132|FG001|Overall Study|Age interval|6|||
145937693|NCT04569968|526278131|FG000|Overall Study|Denial of participation to the study|0|||
145937694|NCT04569968|526278132|FG001|Overall Study|Denial of participation to the study|3|||
145979336|NCT01471574|526436009|FG000|Treatment Period|Lack of Efficacy|12|||
145937695|NCT04569968|526278131|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
145937696|NCT04569968|526278132|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
145937697|NCT04569968|526278131|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
145937698|NCT04569968|526278132|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
145937699|NCT04569968|526278131|FG000|Overall Study|Quarantine|1|||
145937700|NCT04569968|526278132|FG001|Overall Study|Quarantine|0|||
145937701|NCT04569968|526278131|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
145937702|NCT04569968|526278132|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
145937703|NCT04569968|526278131|FG000|Overall Study|Repetitive stroke|8|||
145937704|NCT04569968|526278132|FG001|Overall Study|Repetitive stroke|0|||
145937705|NCT04569968|526278131|FG000|Overall Study|Insufficient mastication|1|||
145937706|NCT04569968|526278132|FG001|Overall Study|Insufficient mastication|0|||
145937707|NCT04569968|526278131|FG000|Overall Study|Infection|1|||
145937708|NCT04569968|526278132|FG001|Overall Study|Infection|0|||
145937709|NCT00574249|526278139|FG000|Overall Study|Adverse Event|6|||
145937710|NCT00574249|526278140|FG001|Overall Study|Adverse Event|18|||
145937711|NCT00574249|526278139|FG000|Overall Study|Lack of Efficacy|5|||
145937712|NCT00574249|526278140|FG001|Overall Study|Lack of Efficacy|3|||
145937713|NCT00574249|526278139|FG000|Overall Study|Lost to Follow-up|4|||
145937714|NCT00574249|526278140|FG001|Overall Study|Lost to Follow-up|3|||
145937715|NCT00574249|526278139|FG000|Overall Study|Protocol Violation|5|||
145937716|NCT00574249|526278140|FG001|Overall Study|Protocol Violation|2|||
145937717|NCT00574249|526278139|FG000|Overall Study|History of carcinoma|1|||
145937718|NCT00574249|526278140|FG001|Overall Study|History of carcinoma|0|||
145937719|NCT00574249|526278139|FG000|Overall Study|Withdrawal by Subject|3|||
145937720|NCT00574249|526278140|FG001|Overall Study|Withdrawal by Subject|0|||
145937721|NCT00574249|526278139|FG000|Overall Study|Physician Decision|1|||
145937722|NCT00574249|526278140|FG001|Overall Study|Physician Decision|0|||
145937723|NCT00574249|526278139|FG000|Overall Study|Pregnancy|1|||
145937724|NCT00574249|526278140|FG001|Overall Study|Pregnancy|0|||
145937725|NCT00574249|526278139|FG000|Overall Study|Excluded by company|0|||
145979337|NCT01471574|526436010|FG001|Treatment Period|Lack of Efficacy|4|||
146245412|NCT02291861|527412206|FG001|Overall Study|Other|0|||
146245413|NCT02291861|527412207|FG002|Overall Study|Other|0|||
146245414|NCT02291861|527412208|FG003|Overall Study|Other|1|||
146245415|NCT03547154|527412213|FG000|Overall Study|Disease Progression/Recurrence|6|||
145937726|NCT00574249|526278140|FG001|Overall Study|Excluded by company|1|||
145937727|NCT00574249|526278139|FG000|Overall Study|PPD test taken twice|0|||
145937728|NCT00574249|526278140|FG001|Overall Study|PPD test taken twice|1|||
145979338|NCT01471574|526436011|FG002|Treatment Period|Lack of Efficacy|14|||
146245416|NCT03547154|527412214|FG001|Overall Study|Disease Progression/Recurrence|14|||
146245417|NCT03547154|527412213|FG000|Overall Study|Adverse Event|26|||
145937729|NCT01680159|526278142|FG000|Screening Period|Not meet criteria for dose-up period|7|||
145937730|NCT01680159|526278142|FG000|Increased Dose Period|Adverse Event|6|||
145937731|NCT01680159|526278142|FG000|Increased Dose Period|Withdrawal by Subject|2|||
145937732|NCT02783729|526278146|FG000|Overall Study|Lack of Efficacy|1|||
145937733|NCT02783729|526278147|FG001|Overall Study|Lack of Efficacy|0|||
145937734|NCT02783729|526278148|FG002|Overall Study|Lack of Efficacy|0|||
145937735|NCT02783729|526278149|FG003|Overall Study|Lack of Efficacy|0|||
146245418|NCT03547154|527412214|FG001|Overall Study|Adverse Event|31|||
145979339|NCT01471574|526436012|FG003|Treatment Period|Lack of Efficacy|1|||
145979340|NCT01471574|526436009|FG000|Treatment Period|Adverse Event|7|||
145979341|NCT01471574|526436010|FG001|Treatment Period|Adverse Event|3|||
145979342|NCT01471574|526436011|FG002|Treatment Period|Adverse Event|6|||
145979343|NCT01471574|526436012|FG003|Treatment Period|Adverse Event|1|||
145979344|NCT01471574|526436009|FG000|Treatment Period|Withdrawal by Subject|5|||
145979345|NCT01471574|526436010|FG001|Treatment Period|Withdrawal by Subject|1|||
145979346|NCT01471574|526436011|FG002|Treatment Period|Withdrawal by Subject|1|||
145979347|NCT01471574|526436012|FG003|Treatment Period|Withdrawal by Subject|0|||
145979348|NCT01471574|526436009|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
145979349|NCT01471574|526436010|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
145979350|NCT01471574|526436011|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
145979351|NCT01471574|526436012|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
145979352|NCT01471574|526436009|FG000|Treatment Period|Lost to Follow-up|1|||
145979353|NCT01471574|526436010|FG001|Treatment Period|Lost to Follow-up|2|||
145979354|NCT01471574|526436011|FG002|Treatment Period|Lost to Follow-up|2|||
145979355|NCT01471574|526436012|FG003|Treatment Period|Lost to Follow-up|0|||
145979356|NCT01471574|526436009|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
145979357|NCT01471574|526436010|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145979358|NCT01471574|526436011|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145937736|NCT02783729|526278146|FG000|Overall Study|Adverse Event|2|||
145937737|NCT02783729|526278147|FG001|Overall Study|Adverse Event|6|||
145937738|NCT02783729|526278148|FG002|Overall Study|Adverse Event|2|||
145937739|NCT02783729|526278149|FG003|Overall Study|Adverse Event|3|||
145937740|NCT02783729|526278146|FG000|Overall Study|Other|1|||
145937741|NCT02783729|526278147|FG001|Overall Study|Other|6|||
145937742|NCT02783729|526278148|FG002|Overall Study|Other|2|||
145937743|NCT02783729|526278149|FG003|Overall Study|Other|3|||
145937744|NCT02783729|526278146|FG000|Overall Study|Withdrawal by Subject|2|||
145937745|NCT02783729|526278147|FG001|Overall Study|Withdrawal by Subject|3|||
145937746|NCT02783729|526278148|FG002|Overall Study|Withdrawal by Subject|1|||
145937747|NCT02783729|526278149|FG003|Overall Study|Withdrawal by Subject|2|||
145937748|NCT02783729|526278146|FG000|Overall Study|Participant's choice|2|||
145937749|NCT02783729|526278147|FG001|Overall Study|Participant's choice|1|||
145937750|NCT02783729|526278148|FG002|Overall Study|Participant's choice|2|||
145937751|NCT02783729|526278149|FG003|Overall Study|Participant's choice|1|||
145937752|NCT02783729|526278146|FG000|Overall Study|Lost to Follow-up|2|||
145937753|NCT02783729|526278147|FG001|Overall Study|Lost to Follow-up|1|||
145937754|NCT02783729|526278148|FG002|Overall Study|Lost to Follow-up|1|||
145937755|NCT02783729|526278149|FG003|Overall Study|Lost to Follow-up|0|||
145937756|NCT02288091|526278154|FG000|Overall Study|Lost to Follow-up|1|||
145937757|NCT02288091|526278154|FG000|Overall Study|Screen fail|7|||
145937758|NCT04021121|526278155|FG000|Overall Study|Death|3|||
145937759|NCT04021121|526278156|FG001|Overall Study|Death|3|||
145937760|NCT04021121|526278157|FG002|Overall Study|Death|5|||
145937761|NCT04021121|526278158|FG003|Overall Study|Death|4|||
145937762|NCT04166591|526279652|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145937763|NCT04166591|526279653|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145937764|NCT04166591|526279654|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145937765|NCT04166591|526279655|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145937766|NCT04166591|526279652|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145937767|NCT04166591|526279653|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145937768|NCT04166591|526279654|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145937769|NCT04166591|526279655|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145937770|NCT03030989|526279656|FG000|Overall Study|Fever|2|||
145937771|NCT03030989|526279657|FG001|Overall Study|Fever|2|||
145937772|NCT03030989|526279656|FG000|Overall Study|Rash|2|||
145937773|NCT03030989|526279657|FG001|Overall Study|Rash|1|||
145937774|NCT03030989|526279656|FG000|Overall Study|Fatigue/Overwhelmed|1|||
145979359|NCT01471574|526436012|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145979360|NCT01471574|526436009|FG000|Treatment Period|Other|1|||
145979361|NCT01471574|526436010|FG001|Treatment Period|Other|0|||
145979362|NCT01471574|526436011|FG002|Treatment Period|Other|0|||
145979363|NCT01471574|526436012|FG003|Treatment Period|Other|0|||
145979364|NCT01471574|526436009|FG000|Follow-up Period|Withdrawal by Subject|3|||
145979365|NCT01471574|526436010|FG001|Follow-up Period|Withdrawal by Subject|0|||
145979366|NCT01471574|526436011|FG002|Follow-up Period|Withdrawal by Subject|3|||
145937775|NCT03030989|526279657|FG001|Overall Study|Fatigue/Overwhelmed|5|||
145937776|NCT03030989|526279656|FG000|Overall Study|Positive Blood Cultures|2|||
145979367|NCT01471574|526436012|FG003|Follow-up Period|Withdrawal by Subject|1|||
145979368|NCT01471574|526436009|FG000|Follow-up Period|Lost to Follow-up|4|||
145937777|NCT03030989|526279657|FG001|Overall Study|Positive Blood Cultures|1|||
145937778|NCT03030989|526279656|FG000|Overall Study|Line Removed|0|||
145937779|NCT03030989|526279657|FG001|Overall Study|Line Removed|2|||
145937780|NCT03030989|526279656|FG000|Overall Study|No longer interested|5|||
145937781|NCT03030989|526279657|FG001|Overall Study|No longer interested|3|||
145979369|NCT01471574|526436010|FG001|Follow-up Period|Lost to Follow-up|1|||
145979370|NCT01471574|526436011|FG002|Follow-up Period|Lost to Follow-up|3|||
146091190|NCT02942576|526854899|FG000|Overall Study|Physician Decision|1|||
146091191|NCT02942576|526854900|FG001|Overall Study|Physician Decision|4|||
146091192|NCT02942576|526854899|FG000|Overall Study|Other|10|||
146091193|NCT02942576|526854900|FG001|Overall Study|Other|8|||
145937782|NCT02730377|526279658|FG000|Overall Study|Other|5|||
145937783|NCT02730377|526279659|FG001|Overall Study|Other|4|||
145937784|NCT02730377|526279658|FG000|Overall Study|Death|1|||
145937785|NCT02730377|526279659|FG001|Overall Study|Death|8|||
145937786|NCT02730377|526279658|FG000|Overall Study|Inadequate glycaemic control|368|||
145937787|NCT02730377|526279659|FG001|Overall Study|Inadequate glycaemic control|473|||
145937788|NCT02730377|526279658|FG000|Overall Study|Adverse Event|79|||
145937789|NCT02730377|526279659|FG001|Overall Study|Adverse Event|41|||
145937790|NCT02730377|526279658|FG000|Overall Study|Protocol Violation|23|||
145937791|NCT02730377|526279659|FG001|Overall Study|Protocol Violation|30|||
145937792|NCT02730377|526279658|FG000|Overall Study|Lack of Efficacy|4|||
145937793|NCT02730377|526279659|FG001|Overall Study|Lack of Efficacy|13|||
145937794|NCT02730377|526279658|FG000|Overall Study|Pregnancy|0|||
145937795|NCT02730377|526279659|FG001|Overall Study|Pregnancy|1|||
145937796|NCT02730377|526279658|FG000|Overall Study|Withdrawal by Subject|45|||
145937797|NCT02730377|526279659|FG001|Overall Study|Withdrawal by Subject|42|||
145937798|NCT02730377|526279658|FG000|Overall Study|Lost to Follow-up|25|||
145937799|NCT02730377|526279659|FG001|Overall Study|Lost to Follow-up|21|||
145937800|NCT02424630|526279660|FG000|Overall Study|No rotator cuff tear|1|||
145937801|NCT02424630|526279661|FG001|Overall Study|No rotator cuff tear|2|||
145937802|NCT02424630|526279660|FG000|Overall Study|Open procedure|0|||
145937803|NCT02424630|526279661|FG001|Overall Study|Open procedure|1|||
145937804|NCT02637895|526279662|FG000|Overall Study|Lost to Follow-up|4|||
145937805|NCT02637895|526279663|FG001|Overall Study|Lost to Follow-up|0|||
145937806|NCT02637895|526279662|FG000|Overall Study|Protocol Violation|0|||
145937807|NCT02637895|526279663|FG001|Overall Study|Protocol Violation|1|||
145937808|NCT02637895|526279662|FG000|Overall Study|Lack of Efficacy|1|||
145937809|NCT02637895|526279663|FG001|Overall Study|Lack of Efficacy|0|||
145937810|NCT02637895|526279662|FG000|Overall Study|Withdrawal by Subject|1|||
145937811|NCT02637895|526279663|FG001|Overall Study|Withdrawal by Subject|1|||
145937812|NCT02637895|526279662|FG000|Overall Study|Abnormal baseline lab|0|||
145937813|NCT02637895|526279663|FG001|Overall Study|Abnormal baseline lab|1|||
145937814|NCT02031640|526279664|FG000|Screening Period|Adverse Event|1|||
145937815|NCT02031640|526279665|FG001|Screening Period|Adverse Event|0|||
145937816|NCT02031640|526279666|FG002|Screening Period|Adverse Event|0|||
145937817|NCT02031640|526279667|FG003|Screening Period|Adverse Event|0|||
146091194|NCT00938964|526854903|FG000|Overall Study|Death|3|||
145937818|NCT02031640|526279668|FG004|Screening Period|Adverse Event|0|||
145937819|NCT02031640|526279669|FG005|Screening Period|Adverse Event|0|||
145937820|NCT02031640|526279664|FG000|Screening Period|Withdrawal by Subject|29|||
145937821|NCT02031640|526279665|FG001|Screening Period|Withdrawal by Subject|0|||
145937822|NCT02031640|526279666|FG002|Screening Period|Withdrawal by Subject|0|||
145937823|NCT02031640|526279667|FG003|Screening Period|Withdrawal by Subject|0|||
145937824|NCT02031640|526279668|FG004|Screening Period|Withdrawal by Subject|0|||
145937825|NCT02031640|526279669|FG005|Screening Period|Withdrawal by Subject|0|||
145937826|NCT02031640|526279664|FG000|Screening Period|Inclusion criteria not met|312|||
145937827|NCT02031640|526279665|FG001|Screening Period|Inclusion criteria not met|0|||
145937828|NCT02031640|526279666|FG002|Screening Period|Inclusion criteria not met|0|||
145937829|NCT02031640|526279667|FG003|Screening Period|Inclusion criteria not met|0|||
145937830|NCT02031640|526279668|FG004|Screening Period|Inclusion criteria not met|0|||
145937831|NCT02031640|526279669|FG005|Screening Period|Inclusion criteria not met|0|||
145937832|NCT02031640|526279664|FG000|Screening Period|Exclusion criteria met|30|||
145937833|NCT02031640|526279665|FG001|Screening Period|Exclusion criteria met|0|||
145937834|NCT02031640|526279666|FG002|Screening Period|Exclusion criteria met|0|||
145937835|NCT02031640|526279667|FG003|Screening Period|Exclusion criteria met|0|||
145937836|NCT02031640|526279668|FG004|Screening Period|Exclusion criteria met|0|||
145937837|NCT02031640|526279669|FG005|Screening Period|Exclusion criteria met|0|||
146091195|NCT00938964|526854904|FG001|Overall Study|Death|3|||
146091196|NCT00938964|526854903|FG000|Overall Study|Lost to Follow-up|2|||
146091197|NCT00938964|526854904|FG001|Overall Study|Lost to Follow-up|3|||
145937838|NCT02031640|526279664|FG000|Screening Period|Lost to Follow-up|14|||
146091198|NCT00938964|526854903|FG000|Overall Study|Withdrawal by Subject|22|||
145937839|NCT02031640|526279665|FG001|Screening Period|Lost to Follow-up|0|||
145937840|NCT02031640|526279666|FG002|Screening Period|Lost to Follow-up|0|||
145937841|NCT02031640|526279667|FG003|Screening Period|Lost to Follow-up|0|||
145937842|NCT02031640|526279668|FG004|Screening Period|Lost to Follow-up|0|||
145937843|NCT02031640|526279669|FG005|Screening Period|Lost to Follow-up|0|||
146091199|NCT00938964|526854904|FG001|Overall Study|Withdrawal by Subject|18|||
145937844|NCT02031640|526279664|FG000|Screening Period|Enrollment closed|26|||
145937845|NCT02031640|526279665|FG001|Screening Period|Enrollment closed|0|||
145937846|NCT02031640|526279666|FG002|Screening Period|Enrollment closed|0|||
145937847|NCT02031640|526279667|FG003|Screening Period|Enrollment closed|0|||
146091200|NCT00938964|526854903|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
146091201|NCT00938964|526854904|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
145937848|NCT02031640|526279668|FG004|Screening Period|Enrollment closed|0|||
145937849|NCT02031640|526279669|FG005|Screening Period|Enrollment closed|0|||
145937850|NCT02031640|526279664|FG000|Run-In Period|Adverse Event|4|||
145937851|NCT02031640|526279665|FG001|Run-In Period|Adverse Event|0|||
145937852|NCT02031640|526279666|FG002|Run-In Period|Adverse Event|0|||
145937853|NCT02031640|526279667|FG003|Run-In Period|Adverse Event|0|||
145937854|NCT02031640|526279668|FG004|Run-In Period|Adverse Event|0|||
145937855|NCT02031640|526279669|FG005|Run-In Period|Adverse Event|0|||
145937856|NCT02031640|526279664|FG000|Run-In Period|Withdrawal by Subject|17|||
145937857|NCT02031640|526279665|FG001|Run-In Period|Withdrawal by Subject|0|||
145937858|NCT02031640|526279666|FG002|Run-In Period|Withdrawal by Subject|0|||
145937859|NCT02031640|526279667|FG003|Run-In Period|Withdrawal by Subject|0|||
145937860|NCT02031640|526279668|FG004|Run-In Period|Withdrawal by Subject|0|||
145937861|NCT02031640|526279669|FG005|Run-In Period|Withdrawal by Subject|0|||
145937862|NCT02031640|526279664|FG000|Run-In Period|Inclusion criteria not met|38|||
145937863|NCT02031640|526279665|FG001|Run-In Period|Inclusion criteria not met|0|||
145937864|NCT02031640|526279666|FG002|Run-In Period|Inclusion criteria not met|0|||
145937865|NCT02031640|526279667|FG003|Run-In Period|Inclusion criteria not met|0|||
145937866|NCT02031640|526279668|FG004|Run-In Period|Inclusion criteria not met|0|||
145937867|NCT02031640|526279669|FG005|Run-In Period|Inclusion criteria not met|0|||
145937868|NCT02031640|526279664|FG000|Run-In Period|Exclusion criteria met|8|||
145937869|NCT02031640|526279665|FG001|Run-In Period|Exclusion criteria met|0|||
145937870|NCT02031640|526279666|FG002|Run-In Period|Exclusion criteria met|0|||
145937871|NCT02031640|526279667|FG003|Run-In Period|Exclusion criteria met|0|||
145937872|NCT02031640|526279668|FG004|Run-In Period|Exclusion criteria met|0|||
145937873|NCT02031640|526279669|FG005|Run-In Period|Exclusion criteria met|0|||
145937874|NCT02031640|526279664|FG000|Run-In Period|Randomization criteria not met|85|||
145937875|NCT02031640|526279665|FG001|Run-In Period|Randomization criteria not met|0|||
145937876|NCT02031640|526279666|FG002|Run-In Period|Randomization criteria not met|0|||
145937877|NCT02031640|526279667|FG003|Run-In Period|Randomization criteria not met|0|||
145937878|NCT02031640|526279668|FG004|Run-In Period|Randomization criteria not met|0|||
145937879|NCT02031640|526279669|FG005|Run-In Period|Randomization criteria not met|0|||
145937880|NCT02031640|526279664|FG000|Run-In Period|Various administrative reasons|17|||
145937881|NCT02031640|526279665|FG001|Run-In Period|Various administrative reasons|0|||
145937882|NCT02031640|526279666|FG002|Run-In Period|Various administrative reasons|0|||
145937883|NCT02031640|526279667|FG003|Run-In Period|Various administrative reasons|0|||
145937884|NCT02031640|526279668|FG004|Run-In Period|Various administrative reasons|0|||
145937885|NCT02031640|526279669|FG005|Run-In Period|Various administrative reasons|0|||
145937886|NCT02031640|526279664|FG000|Double-blind Treatment Period|Protocol deviation|0|||
145937887|NCT02031640|526279665|FG001|Double-blind Treatment Period|Protocol deviation|2|||
145937888|NCT02031640|526279666|FG002|Double-blind Treatment Period|Protocol deviation|0|||
145937889|NCT02031640|526279667|FG003|Double-blind Treatment Period|Protocol deviation|1|||
145937890|NCT02031640|526279668|FG004|Double-blind Treatment Period|Protocol deviation|3|||
145937891|NCT02031640|526279669|FG005|Double-blind Treatment Period|Protocol deviation|1|||
145937892|NCT02031640|526279664|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145937893|NCT02031640|526279665|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
145937894|NCT02031640|526279666|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
145937895|NCT02031640|526279667|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
145937896|NCT02031640|526279668|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
145937897|NCT02031640|526279669|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
145937898|NCT02031640|526279664|FG000|Double-blind Treatment Period|Non-compliance|0|||
145937899|NCT02031640|526279665|FG001|Double-blind Treatment Period|Non-compliance|1|||
145937900|NCT02031640|526279666|FG002|Double-blind Treatment Period|Non-compliance|0|||
145937901|NCT02031640|526279667|FG003|Double-blind Treatment Period|Non-compliance|1|||
145937902|NCT02031640|526279668|FG004|Double-blind Treatment Period|Non-compliance|1|||
145937903|NCT02031640|526279669|FG005|Double-blind Treatment Period|Non-compliance|0|||
145937904|NCT02031640|526279664|FG000|Double-blind Treatment Period|Adverse Event|0|||
145937905|NCT02031640|526279665|FG001|Double-blind Treatment Period|Adverse Event|0|||
145937906|NCT02031640|526279666|FG002|Double-blind Treatment Period|Adverse Event|0|||
145937907|NCT02031640|526279667|FG003|Double-blind Treatment Period|Adverse Event|2|||
146091202|NCT01858636|526854905|FG000|Overall Study|No Device Deployment Attempted|24|||
146091203|NCT01858636|526854905|FG000|Overall Study|Physician Decision|1|||
146091204|NCT01858636|526854905|FG000|Overall Study|Death|1|||
146091205|NCT01858636|526854905|FG000|Overall Study|Lost to Follow-up|1|||
146091206|NCT01858636|526854905|FG000|Overall Study|Withdrawal by Subject|1|||
146091207|NCT01172275|526854908|FG000|Overall Study|Lost to Follow-up|1|||
146091208|NCT01172275|526854909|FG001|Overall Study|Lost to Follow-up|0|||
146091209|NCT01172275|526854908|FG000|Overall Study|Protocol Violation|1|||
146091210|NCT01172275|526854909|FG001|Overall Study|Protocol Violation|0|||
146091211|NCT01227564|526854914|FG000|Overall Study|No Longer Willing to Participate|4|||
146091212|NCT01227564|526854915|FG001|Overall Study|No Longer Willing to Participate|2|||
146091213|NCT01227564|526854916|FG002|Overall Study|No Longer Willing to Participate|5|||
146297806|NCT04786119|527606010|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
145937908|NCT02031640|526279668|FG004|Double-blind Treatment Period|Adverse Event|0|||
145937909|NCT02031640|526279669|FG005|Double-blind Treatment Period|Adverse Event|0|||
145937910|NCT02031640|526279664|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145937911|NCT02031640|526279665|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145937912|NCT02031640|526279666|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
145937913|NCT02031640|526279667|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
145937914|NCT02031640|526279668|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
145937915|NCT02031640|526279669|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
145937916|NCT02031640|526279664|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145937917|NCT02031640|526279665|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
145937918|NCT02031640|526279666|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145937919|NCT02031640|526279667|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145937920|NCT02031640|526279668|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
145937921|NCT02031640|526279669|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
145937922|NCT05896527|526279675|FG000|Overall Study|Withdrawal by Subject|11|||
145937923|NCT05896527|526279676|FG001|Overall Study|Withdrawal by Subject|10|||
145937924|NCT05896527|526279677|FG002|Overall Study|Withdrawal by Subject|4|||
145937925|NCT05896527|526279678|FG003|Overall Study|Withdrawal by Subject|3|||
145937926|NCT05896527|526279679|FG004|Overall Study|Withdrawal by Subject|2|||
145937927|NCT05896527|526279675|FG000|Overall Study|Lost to Follow-up|0|||
145937928|NCT05896527|526279676|FG001|Overall Study|Lost to Follow-up|2|||
145937929|NCT05896527|526279677|FG002|Overall Study|Lost to Follow-up|2|||
145937930|NCT05896527|526279678|FG003|Overall Study|Lost to Follow-up|2|||
145937931|NCT05896527|526279679|FG004|Overall Study|Lost to Follow-up|1|||
145937932|NCT05896527|526279675|FG000|Overall Study|Significant protocol noncompliance|0|||
145937933|NCT05896527|526279676|FG001|Overall Study|Significant protocol noncompliance|1|||
145937934|NCT05896527|526279677|FG002|Overall Study|Significant protocol noncompliance|0|||
145937935|NCT05896527|526279678|FG003|Overall Study|Significant protocol noncompliance|0|||
145937936|NCT05896527|526279679|FG004|Overall Study|Significant protocol noncompliance|0|||
145937937|NCT05896527|526279675|FG000|Overall Study|Eligibility criteria not met|1|||
145937938|NCT05896527|526279676|FG001|Overall Study|Eligibility criteria not met|0|||
145937939|NCT05896527|526279677|FG002|Overall Study|Eligibility criteria not met|0|||
145937940|NCT05896527|526279678|FG003|Overall Study|Eligibility criteria not met|0|||
145937941|NCT05896527|526279679|FG004|Overall Study|Eligibility criteria not met|0|||
145937942|NCT05896527|526279675|FG000|Overall Study|Sponsor's decision|0|||
145937943|NCT05896527|526279676|FG001|Overall Study|Sponsor's decision|0|||
145937944|NCT05896527|526279677|FG002|Overall Study|Sponsor's decision|0|||
145937945|NCT05896527|526279678|FG003|Overall Study|Sponsor's decision|1|||
145937946|NCT05896527|526279679|FG004|Overall Study|Sponsor's decision|0|||
145937947|NCT05896527|526279675|FG000|Overall Study|Investigator's decision|0|||
145937948|NCT05896527|526279676|FG001|Overall Study|Investigator's decision|1|||
145937949|NCT05896527|526279677|FG002|Overall Study|Investigator's decision|0|||
145937950|NCT05896527|526279678|FG003|Overall Study|Investigator's decision|0|||
145937951|NCT05896527|526279679|FG004|Overall Study|Investigator's decision|0|||
145937952|NCT05896527|526279675|FG000|Overall Study|Pregnancy of his partner|0|||
145937953|NCT05896527|526279676|FG001|Overall Study|Pregnancy of his partner|0|||
145937954|NCT05896527|526279677|FG002|Overall Study|Pregnancy of his partner|0|||
145937955|NCT05896527|526279678|FG003|Overall Study|Pregnancy of his partner|1|||
145937956|NCT05896527|526279679|FG004|Overall Study|Pregnancy of his partner|0|||
145937957|NCT03085238|526279680|FG000|Overall Study|Adverse Event|2|||
145937958|NCT03085238|526279680|FG000|Overall Study|Death|2|||
145937959|NCT01279070|526279681|FG000|Overall Study|Withdrawal by Subject|2|||
145937960|NCT01279070|526279682|FG001|Overall Study|Withdrawal by Subject|3|||
145937961|NCT01279070|526279681|FG000|Overall Study|Acute exacerbation|3|||
145937962|NCT01279070|526279682|FG001|Overall Study|Acute exacerbation|1|||
145937963|NCT01741792|526279683|FG000|Overall Study|Death|6|||
145937964|NCT01741792|526279684|FG001|Overall Study|Death|1|||
145937965|NCT01741792|526279685|FG002|Overall Study|Death|12|||
145937966|NCT00761280|526279686|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
145937967|NCT00761280|526279687|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
145937968|NCT00761280|526279686|FG000|Randomization to First Dose|Sponsor decision|1|||
145937969|NCT00761280|526279687|FG001|Randomization to First Dose|Sponsor decision|0|||
145937970|NCT00761280|526279686|FG000|Randomization to First Dose|Other|1|||
145937971|NCT00761280|526279687|FG001|Randomization to First Dose|Other|0|||
145937972|NCT00761280|526279686|FG000|First Dose to End of Study|End of trial|5|||
145979371|NCT01471574|526436012|FG003|Follow-up Period|Lost to Follow-up|2|||
145937973|NCT00761280|526279687|FG001|First Dose to End of Study|End of trial|5|||
145937974|NCT00761280|526279686|FG000|First Dose to End of Study|Progressive disease|5|||
145937975|NCT00761280|526279687|FG001|First Dose to End of Study|Progressive disease|3|||
145937976|NCT00761280|526279686|FG000|First Dose to End of Study|Sponsor decision|1|||
145979372|NCT01471574|526436009|FG000|Follow-up Period|Death|0|||
145937977|NCT00761280|526279687|FG001|First Dose to End of Study|Sponsor decision|2|||
145937978|NCT00761280|526279686|FG000|First Dose to End of Study|Death|1|||
145937979|NCT00761280|526279687|FG001|First Dose to End of Study|Death|0|||
145937980|NCT00761280|526279686|FG000|First Dose to End of Study|Lost to Follow-up|0|||
145937981|NCT00761280|526279687|FG001|First Dose to End of Study|Lost to Follow-up|1|||
145937982|NCT00890084|526279691|FG000|Overall Study|Adverse Event|16|||
145937983|NCT00890084|526279691|FG000|Overall Study|Lost to Follow-up|126|||
145937984|NCT02738879|526279692|FG000|Overall Study|Adverse Event|1|||
145937985|NCT02738879|526279693|FG001|Overall Study|Adverse Event|1|||
145937986|NCT02738879|526279692|FG000|Overall Study|Death|0|||
145937987|NCT02738879|526279693|FG001|Overall Study|Death|2|||
145937988|NCT02738879|526279692|FG000|Overall Study|Lost to Follow-up|1|||
145937989|NCT02738879|526279693|FG001|Overall Study|Lost to Follow-up|5|||
145937990|NCT02738879|526279692|FG000|Overall Study|Protocol Violation|1|||
145937991|NCT02738879|526279693|FG001|Overall Study|Protocol Violation|3|||
145937992|NCT02738879|526279692|FG000|Overall Study|Physician Decision|3|||
145937993|NCT02738879|526279693|FG001|Overall Study|Physician Decision|4|||
145937994|NCT02738879|526279692|FG000|Overall Study|Pregnancy|0|||
145937995|NCT02738879|526279693|FG001|Overall Study|Pregnancy|1|||
145937996|NCT02738879|526279692|FG000|Overall Study|Screen Failure|1|||
145937997|NCT02738879|526279693|FG001|Overall Study|Screen Failure|2|||
145937998|NCT02738879|526279692|FG000|Overall Study|Site Discontinued Study Participation|1|||
145937999|NCT02738879|526279693|FG001|Overall Study|Site Discontinued Study Participation|0|||
145938000|NCT02738879|526279692|FG000|Overall Study|Withdrawal by Subject|5|||
145938001|NCT02738879|526279693|FG001|Overall Study|Withdrawal by Subject|7|||
145938002|NCT01438294|526279694|FG000|Overall Study|Lost to Follow-up|3|||
145938003|NCT01438294|526279695|FG001|Overall Study|Lost to Follow-up|7|||
145938004|NCT01346189|526279696|FG000|Overall Study|Withdrawal by Subject|7|||
145938005|NCT01346189|526279697|FG001|Overall Study|Withdrawal by Subject|5|||
145938006|NCT01346189|526279698|FG002|Overall Study|Withdrawal by Subject|3|||
145938007|NCT01346189|526279699|FG003|Overall Study|Withdrawal by Subject|5|||
145938008|NCT01346189|526279696|FG000|Overall Study|Physician Decision|4|||
145938009|NCT01346189|526279697|FG001|Overall Study|Physician Decision|0|||
145938010|NCT01346189|526279698|FG002|Overall Study|Physician Decision|0|||
145938011|NCT01346189|526279699|FG003|Overall Study|Physician Decision|0|||
145938012|NCT01346189|526279696|FG000|Overall Study|Moved|3|||
145938013|NCT01346189|526279697|FG001|Overall Study|Moved|0|||
145938014|NCT01346189|526279698|FG002|Overall Study|Moved|4|||
145938015|NCT01346189|526279699|FG003|Overall Study|Moved|0|||
145938016|NCT01346189|526279696|FG000|Overall Study|Other|2|||
146297807|NCT04786119|527606011|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
145938017|NCT01346189|526279697|FG001|Overall Study|Other|4|||
145938018|NCT01346189|526279698|FG002|Overall Study|Other|7|||
145938019|NCT01346189|526279699|FG003|Overall Study|Other|3|||
145938020|NCT01346189|526279696|FG000|Overall Study|Death|0|||
145938021|NCT01346189|526279697|FG001|Overall Study|Death|3|||
145938022|NCT01346189|526279698|FG002|Overall Study|Death|0|||
145938023|NCT01346189|526279699|FG003|Overall Study|Death|0|||
145938024|NCT01346189|526279696|FG000|Overall Study|Non-health system primary care physician|0|||
145938025|NCT01346189|526279697|FG001|Overall Study|Non-health system primary care physician|5|||
145938026|NCT01346189|526279698|FG002|Overall Study|Non-health system primary care physician|0|||
145938027|NCT01346189|526279699|FG003|Overall Study|Non-health system primary care physician|0|||
145938028|NCT01346189|526279696|FG000|Overall Study|Travel|0|||
145938029|NCT01346189|526279697|FG001|Overall Study|Travel|0|||
145938030|NCT01346189|526279698|FG002|Overall Study|Travel|0|||
145938031|NCT01346189|526279699|FG003|Overall Study|Travel|3|||
145938032|NCT01730534|526279700|FG000|Overall Study|Withdrawal by Subject|97|||
145938033|NCT01730534|526279701|FG001|Overall Study|Withdrawal by Subject|127|||
145938034|NCT01730534|526279700|FG000|Overall Study|Lost to Follow-up|12|||
145938035|NCT01730534|526279701|FG001|Overall Study|Lost to Follow-up|18|||
145938036|NCT02256982|526279702|FG000|Overall Study|Disease Progression|0|||
145938037|NCT02256982|526279703|FG001|Overall Study|Disease Progression|1|||
145938038|NCT03614078|526279704|FG000|Overall Study|Withdrawal by Subject|2|||
145938039|NCT03614078|526279705|FG001|Overall Study|Withdrawal by Subject|2|||
145938040|NCT03614078|526279706|FG002|Overall Study|Withdrawal by Subject|3|||
145938041|NCT03614078|526279704|FG000|Overall Study|Participant Did Not Return for Visit|0|||
145938042|NCT03614078|526279705|FG001|Overall Study|Participant Did Not Return for Visit|1|||
145938043|NCT03614078|526279706|FG002|Overall Study|Participant Did Not Return for Visit|0|||
145938044|NCT03614078|526279704|FG000|Overall Study|High Neutrophils|0|||
145938045|NCT03614078|526279705|FG001|Overall Study|High Neutrophils|0|||
145938046|NCT03614078|526279706|FG002|Overall Study|High Neutrophils|2|||
145938047|NCT03614078|526279704|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
145938048|NCT03614078|526279705|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
145938049|NCT03614078|526279706|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
145938050|NCT03614078|526279704|FG000|Overall Study|Exacerbation of Psoriasis|0|||
145938051|NCT03614078|526279705|FG001|Overall Study|Exacerbation of Psoriasis|1|||
145938052|NCT03614078|526279706|FG002|Overall Study|Exacerbation of Psoriasis|0|||
145938053|NCT03614078|526279704|FG000|Overall Study|Adverse Event|0|||
145938054|NCT03614078|526279705|FG001|Overall Study|Adverse Event|2|||
145938055|NCT03614078|526279706|FG002|Overall Study|Adverse Event|0|||
145938056|NCT03614078|526279704|FG000|Overall Study|Dizziness and Rash|0|||
145979373|NCT01471574|526436010|FG001|Follow-up Period|Death|0|||
145979374|NCT01471574|526436011|FG002|Follow-up Period|Death|1|||
145979375|NCT01471574|526436012|FG003|Follow-up Period|Death|0|||
145979376|NCT01471574|526436009|FG000|Follow-up Period|Follow-up no longer required|0|||
145979377|NCT01471574|526436010|FG001|Follow-up Period|Follow-up no longer required|1|||
145979378|NCT01471574|526436011|FG002|Follow-up Period|Follow-up no longer required|0|||
145979379|NCT01471574|526436012|FG003|Follow-up Period|Follow-up no longer required|0|||
145979380|NCT01137812|526436013|FG000|Overall Study|Adverse Event|21|||
145979381|NCT01137812|526436014|FG001|Overall Study|Adverse Event|14|||
145979382|NCT01137812|526436013|FG000|Overall Study|Lost to Follow-up|6|||
145979383|NCT01137812|526436014|FG001|Overall Study|Lost to Follow-up|8|||
145979384|NCT01137812|526436013|FG000|Overall Study|Physician Decision|25|||
145979385|NCT01137812|526436014|FG001|Overall Study|Physician Decision|17|||
145979386|NCT01137812|526436013|FG000|Overall Study|Protocol Violation|5|||
145979387|NCT01137812|526436014|FG001|Overall Study|Protocol Violation|4|||
145979388|NCT01137812|526436013|FG000|Overall Study|Withdrawal by Subject|5|||
145979389|NCT01137812|526436014|FG001|Overall Study|Withdrawal by Subject|13|||
145979390|NCT01137812|526436013|FG000|Overall Study|Death|2|||
145979391|NCT01137812|526436014|FG001|Overall Study|Death|0|||
145979392|NCT01137812|526436013|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
145979393|NCT01137812|526436014|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
145979394|NCT01137812|526436013|FG000|Overall Study|Other|19|||
145979395|NCT01137812|526436014|FG001|Overall Study|Other|27|||
145979396|NCT01177410|526436019|FG000|Overall Study|Adverse Event|0|||
145979397|NCT01177410|526436020|FG001|Overall Study|Adverse Event|2|||
145979398|NCT01177410|526436021|FG002|Overall Study|Adverse Event|2|||
145979399|NCT01177410|526436019|FG000|Overall Study|Withdrawal by Subject|1|||
145979400|NCT01177410|526436020|FG001|Overall Study|Withdrawal by Subject|4|||
145938057|NCT03614078|526279705|FG001|Overall Study|Dizziness and Rash|1|||
145938058|NCT03614078|526279706|FG002|Overall Study|Dizziness and Rash|0|||
145938059|NCT04964544|526279709|FG000|Overall Study|Screen failure or other uncategorised|10|||
145938060|NCT04964544|526279709|FG000|Overall Study|Physician Decision|4|||
145938061|NCT04964544|526279709|FG000|Overall Study|Lost to Follow-up|9|||
145938062|NCT04964544|526279709|FG000|Overall Study|Withdrawal by Subject|18|||
145938063|NCT04964544|526279709|FG000|Overall Study|Death|1|||
145938064|NCT02833844|526279715|FG000|Double-Blind Period|Withdrawal by Subject|2|||
145938065|NCT02833844|526279716|FG001|Double-Blind Period|Withdrawal by Subject|3|||
145938066|NCT02833844|526279715|FG000|Double-Blind Period|Protocol Violation|0|||
145938067|NCT02833844|526279716|FG001|Double-Blind Period|Protocol Violation|4|||
145938068|NCT02833844|526279715|FG000|Open-Label Period|Death|0|||
145938069|NCT02833844|526279716|FG001|Open-Label Period|Death|2|||
145938070|NCT02833844|526279715|FG000|Open-Label Period|Lost to Follow-up|1|||
145938071|NCT02833844|526279716|FG001|Open-Label Period|Lost to Follow-up|0|||
145938072|NCT02833844|526279715|FG000|Open-Label Period|Withdrawal by Subject|1|||
145938073|NCT02833844|526279716|FG001|Open-Label Period|Withdrawal by Subject|0|||
145938074|NCT01899742|526279719|FG000|Overall Study|Adverse Event|5|||
145938075|NCT01899742|526279720|FG001|Overall Study|Adverse Event|4|||
145938076|NCT01899742|526279719|FG000|Overall Study|Lack of Efficacy|1|||
145938077|NCT01899742|526279720|FG001|Overall Study|Lack of Efficacy|5|||
145938078|NCT01899742|526279719|FG000|Overall Study|Protocol Violation|2|||
145938079|NCT01899742|526279720|FG001|Overall Study|Protocol Violation|2|||
145938080|NCT01899742|526279719|FG000|Overall Study|Withdrawal by Subject|9|||
145938081|NCT01899742|526279720|FG001|Overall Study|Withdrawal by Subject|5|||
145938082|NCT02662764|526279721|FG000|Overall Study|Adverse Event|6|||
145938083|NCT02662764|526279721|FG000|Overall Study|Lack of Efficacy|8|||
145938084|NCT02662764|526279721|FG000|Overall Study|Protocol Violation|1|||
145938085|NCT02662764|526279721|FG000|Overall Study|Withdrawal by Subject|5|||
145938086|NCT02662764|526279721|FG000|Overall Study|Device failure|4|||
145938087|NCT02662764|526279721|FG000|Overall Study|Patient changed treatment|1|||
145938088|NCT02662764|526279721|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
145938089|NCT00089778|526279728|FG000|Overall Study|Protocol Violation|0|||
145938090|NCT00089778|526279729|FG001|Overall Study|Protocol Violation|0|||
145979401|NCT01177410|526436021|FG002|Overall Study|Withdrawal by Subject|3|||
145979402|NCT01177410|526436019|FG000|Overall Study|Lost to Follow-up|0|||
145979403|NCT01177410|526436020|FG001|Overall Study|Lost to Follow-up|1|||
145979404|NCT01177410|526436021|FG002|Overall Study|Lost to Follow-up|0|||
145979405|NCT00471354|526436022|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
145979406|NCT00471354|526436022|FG000|Overall Study|Adverse Event|13|||
145979407|NCT00471354|526436022|FG000|Overall Study|Protocol Violation|12|||
145979408|NCT00471354|526436022|FG000|Overall Study|Withdrawal by Subject|1|||
145979409|NCT00471354|526436022|FG000|Overall Study|Physician Decision|4|||
145979410|NCT00471354|526436022|FG000|Overall Study|Sponsor Decision|1|||
145979411|NCT00471354|526436022|FG000|Overall Study|Lost to Follow-up|3|||
145979412|NCT00471354|526436022|FG000|Overall Study|Lack of Efficacy|5|||
145938091|NCT00089778|526279730|FG002|Overall Study|Protocol Violation|1|||
145938092|NCT00177307|526279731|FG000|Overall Study|Withdrawal by Subject|1|||
145938093|NCT02677038|526279732|FG000|Overall Study|Physician Decision|1|||
145938094|NCT02677038|526279732|FG000|Overall Study|Withdrawal by Subject|1|||
145938095|NCT02777970|526279738|FG000|Overall Study|Lost to Follow-up|0|||
146091214|NCT01227564|526854914|FG000|Overall Study|Participant moved to another town|0|||
146091215|NCT01227564|526854915|FG001|Overall Study|Participant moved to another town|0|||
146091216|NCT01227564|526854916|FG002|Overall Study|Participant moved to another town|1|||
146091217|NCT04650854|526854929|FG000|Overall Study|Adverse Event|1|||
146091218|NCT04650854|526854930|FG001|Overall Study|Adverse Event|12|||
146091219|NCT04650854|526854931|FG002|Overall Study|Adverse Event|14|||
146245419|NCT03547154|527412213|FG000|Overall Study|Protocol Violation|6|||
146245420|NCT03547154|527412214|FG001|Overall Study|Protocol Violation|1|||
146245421|NCT03547154|527412213|FG000|Overall Study|Physician Decision|4|||
146245422|NCT03547154|527412214|FG001|Overall Study|Physician Decision|3|||
146245423|NCT03547154|527412213|FG000|Overall Study|Insufficient Therapeutic Response|13|||
145938096|NCT02777970|526279739|FG001|Overall Study|Lost to Follow-up|1|||
145938097|NCT02777970|526279740|FG002|Overall Study|Lost to Follow-up|0|||
145938098|NCT02777970|526279738|FG000|Overall Study|Protocol Violation|1|||
145938099|NCT02777970|526279739|FG001|Overall Study|Protocol Violation|0|||
145938100|NCT02777970|526279740|FG002|Overall Study|Protocol Violation|0|||
145938101|NCT05845567|526279744|FG000|Overall Study|Withdrawal by Subject|1|||
145938102|NCT01104246|526279745|FG000|Overall Study|Withdrawal by Subject|1|||
145938103|NCT01104246|526279745|FG000|Overall Study|did not meet inclusion criteria|4|||
145938104|NCT05178641|526279746|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
145938105|NCT05178641|526279747|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
145938106|NCT05178641|526279746|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
145938107|NCT05178641|526279747|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
145938108|NCT01083186|526279749|FG000|Overall Study|Lost to Follow-up|48|||
145938109|NCT01083186|526279749|FG000|Overall Study|Consent Withdrawal|7|||
145938110|NCT01083186|526279749|FG000|Overall Study|Death|3|||
145938111|NCT01083186|526279749|FG000|Overall Study|Adverse Event|3|||
145938112|NCT01083186|526279749|FG000|Overall Study|Lack of Efficacy|2|||
145938113|NCT01083186|526279749|FG000|Overall Study|Hemodialysis Initiation|28|||
145938114|NCT01083186|526279749|FG000|Overall Study|Administrative Reasons|2|||
145938115|NCT01083186|526279749|FG000|Overall Study|Non-compliance to Study Treatment|1|||
145938116|NCT03729570|526279754|FG000|Overall Study|Lost to Follow-up|16|||
145938117|NCT03729570|526279755|FG001|Overall Study|Lost to Follow-up|20|||
145938118|NCT03729570|526279754|FG000|Overall Study|Seroconversion|5|||
145938119|NCT03729570|526279755|FG001|Overall Study|Seroconversion|0|||
145938120|NCT03729570|526279754|FG000|Overall Study|Moved out of the city|1|||
145938121|NCT03729570|526279755|FG001|Overall Study|Moved out of the city|0|||
145938122|NCT03729570|526279754|FG000|Overall Study|Time Conflict|1|||
145938123|NCT03729570|526279755|FG001|Overall Study|Time Conflict|0|||
145938124|NCT03729570|526279754|FG000|Overall Study|Time Commitment|2|||
145938125|NCT03729570|526279755|FG001|Overall Study|Time Commitment|0|||
145938126|NCT03729570|526279754|FG000|Overall Study|Bad Experience|0|||
145938127|NCT03729570|526279755|FG001|Overall Study|Bad Experience|1|||
145938128|NCT03729570|526279754|FG000|Overall Study|No reason provided|2|||
145938129|NCT03729570|526279755|FG001|Overall Study|No reason provided|1|||
145938130|NCT03729570|526279754|FG000|Overall Study|Family Conflict|0|||
145938131|NCT03729570|526279755|FG001|Overall Study|Family Conflict|1|||
145938132|NCT03729570|526279754|FG000|Overall Study|Did not want to continue taking medications|0|||
145938133|NCT03729570|526279755|FG001|Overall Study|Did not want to continue taking medications|1|||
145938134|NCT03729570|526279754|FG000|Overall Study|Found another PrEP provider|1|||
145938135|NCT03729570|526279755|FG001|Overall Study|Found another PrEP provider|0|||
145938136|NCT03729570|526279754|FG000|Overall Study|Did not enjoy being in the control group|0|||
145938137|NCT03729570|526279755|FG001|Overall Study|Did not enjoy being in the control group|1|||
145938138|NCT01867294|526279758|FG000|Overall Study|Withdrawal by Subject|1|||
145938139|NCT01867294|526279759|FG001|Overall Study|Withdrawal by Subject|1|||
145938140|NCT01867294|526279760|FG002|Overall Study|Withdrawal by Subject|0|||
145938141|NCT01867294|526279761|FG003|Overall Study|Withdrawal by Subject|0|||
145938142|NCT00278148|526279762|FG000|Phase II - Expansion Phase|Disease progression|0|||
145938143|NCT00278148|526279763|FG001|Phase II - Expansion Phase|Disease progression|0|||
145938144|NCT00278148|526279764|FG002|Phase II - Expansion Phase|Disease progression|4|||
145938145|NCT00278148|526279762|FG000|Phase II - Expansion Phase|Adverse Event|0|||
145938146|NCT00278148|526279763|FG001|Phase II - Expansion Phase|Adverse Event|0|||
145938147|NCT00278148|526279764|FG002|Phase II - Expansion Phase|Adverse Event|2|||
146091220|NCT04650854|526854929|FG000|Overall Study|Lack of Efficacy|1|||
146245424|NCT03547154|527412214|FG001|Overall Study|Insufficient Therapeutic Response|10|||
146245425|NCT03547154|527412213|FG000|Overall Study|Withdrawal by Subject|10|||
145938148|NCT02083185|526279766|FG000|Overall Study|Lost to Follow-up|0|||
145938149|NCT02083185|526279767|FG001|Overall Study|Lost to Follow-up|3|||
145938150|NCT02083185|526279768|FG002|Overall Study|Lost to Follow-up|0|||
145938151|NCT02083185|526279766|FG000|Overall Study|Withdrawal by Subject|9|||
145938152|NCT02083185|526279767|FG001|Overall Study|Withdrawal by Subject|15|||
145938153|NCT02083185|526279768|FG002|Overall Study|Withdrawal by Subject|1|||
145938154|NCT02083185|526279766|FG000|Overall Study|Death|2|||
145938155|NCT02083185|526279767|FG001|Overall Study|Death|2|||
145938156|NCT02083185|526279768|FG002|Overall Study|Death|1|||
146091221|NCT04650854|526854930|FG001|Overall Study|Lack of Efficacy|3|||
145979413|NCT00471354|526436022|FG000|Overall Study|Patient/Caregiver Decision|12|||
145979414|NCT05427916|526436023|FG000|Overall Study|Adverse Event|3|||
145979415|NCT05427916|526436024|FG001|Overall Study|Adverse Event|0|||
145979416|NCT05427916|526436023|FG000|Overall Study|Lack of Efficacy|6|||
145979417|NCT05427916|526436024|FG001|Overall Study|Lack of Efficacy|0|||
145979418|NCT05427916|526436023|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
145979419|NCT05427916|526436024|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
145979420|NCT05630755|526436026|FG000|Overall Study|Lost to Follow-up|7|||
145979421|NCT05630755|526436027|FG001|Overall Study|Lost to Follow-up|0|||
145979422|NCT05630755|526436026|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
145979423|NCT05630755|526436027|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
146091222|NCT04650854|526854931|FG002|Overall Study|Lack of Efficacy|6|||
146091223|NCT04650854|526854929|FG000|Overall Study|Lost to Follow-up|1|||
146091224|NCT04650854|526854930|FG001|Overall Study|Lost to Follow-up|1|||
146091225|NCT04650854|526854931|FG002|Overall Study|Lost to Follow-up|0|||
146091226|NCT04650854|526854929|FG000|Overall Study|Withdrawal by Subject|2|||
146091227|NCT04650854|526854930|FG001|Overall Study|Withdrawal by Subject|17|||
146091228|NCT04650854|526854931|FG002|Overall Study|Withdrawal by Subject|9|||
146091229|NCT04650854|526854929|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
146091230|NCT04650854|526854930|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
146091231|NCT04650854|526854931|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
146091232|NCT04650854|526854929|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
146091233|NCT04650854|526854930|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
146091234|NCT04650854|526854931|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
145938157|NCT02083185|526279766|FG000|Overall Study|Reason not Specified|9|||
145938158|NCT02083185|526279767|FG001|Overall Study|Reason not Specified|6|||
145938159|NCT02083185|526279768|FG002|Overall Study|Reason not Specified|5|||
145938160|NCT02083185|526279766|FG000|Overall Study|Study Terminated by Sponsor|0|||
145938161|NCT02083185|526279767|FG001|Overall Study|Study Terminated by Sponsor|1|||
145938162|NCT02083185|526279768|FG002|Overall Study|Study Terminated by Sponsor|0|||
145938163|NCT02083185|526279766|FG000|Overall Study|Did not Receive Study Drug|0|||
145938164|NCT02083185|526279767|FG001|Overall Study|Did not Receive Study Drug|2|||
145938165|NCT02083185|526279768|FG002|Overall Study|Did not Receive Study Drug|0|||
145938166|NCT03419598|526279769|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
145938167|NCT03843632|526279771|FG000|Overall Study|Withdrawal by Subject|1|||
145938168|NCT03843632|526279772|FG001|Overall Study|Withdrawal by Subject|0|||
145938169|NCT03843632|526279773|FG002|Overall Study|Withdrawal by Subject|0|||
145938170|NCT03843632|526279774|FG003|Overall Study|Withdrawal by Subject|0|||
145938171|NCT03403751|526279775|FG000|Overall Study|Death|5|||
145938172|NCT03403751|526279776|FG001|Overall Study|Death|6|||
145938173|NCT03403751|526279775|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
145938174|NCT03403751|526279776|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
145938175|NCT05036668|526279777|FG000|Overall Study|lost to follow Up|0|||
145938176|NCT05036668|526279778|FG001|Overall Study|lost to follow Up|0|||
145938177|NCT05036668|526279779|FG002|Overall Study|lost to follow Up|1|||
145938178|NCT02272842|526279782|FG000|Overall Study|Lost to Follow-up|8|||
145938179|NCT02272842|526279783|FG001|Overall Study|Lost to Follow-up|8|||
145938180|NCT02272842|526279782|FG000|Overall Study|Withdrawal by Subject|8|||
145938181|NCT02272842|526279783|FG001|Overall Study|Withdrawal by Subject|2|||
145938182|NCT02111785|526282061|FG000|Overall Study|Death|0|||
145938183|NCT02111785|526282062|FG001|Overall Study|Death|1|||
145938184|NCT02111785|526282063|FG002|Overall Study|Death|0|||
145938185|NCT02111785|526282064|FG003|Overall Study|Death|0|||
145938186|NCT00759785|526282071|FG000|Overall Study|Participant sample not evaluable|11|||
145938187|NCT00759785|526282072|FG001|Overall Study|Participant sample not evaluable|2|||
145938188|NCT00759785|526282071|FG000|Overall Study|Participant sample lost|0|||
145938189|NCT00759785|526282072|FG001|Overall Study|Participant sample lost|1|||
145938190|NCT00759785|526282071|FG000|Overall Study|Protocol Violation|1|||
145938191|NCT00759785|526282072|FG001|Overall Study|Protocol Violation|0|||
145938192|NCT00759785|526282071|FG000|Overall Study|Physician Decision|0|||
145938193|NCT00759785|526282072|FG001|Overall Study|Physician Decision|1|||
145938194|NCT00759785|526282071|FG000|Overall Study|Withdrawal by Subject|0|||
145938195|NCT00759785|526282072|FG001|Overall Study|Withdrawal by Subject|1|||
145938196|NCT04521621|526282076|FG000|Overall Study|Death|17|||
145938197|NCT04521621|526282077|FG001|Overall Study|Death|8|||
145938198|NCT04521621|526282078|FG002|Overall Study|Death|8|||
146091235|NCT04650854|526854929|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
146091236|NCT04650854|526854930|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
146245426|NCT03547154|527412214|FG001|Overall Study|Withdrawal by Subject|6|||
146245427|NCT03547154|527412213|FG000|Overall Study|Not Selected|0|||
146245428|NCT03547154|527412214|FG001|Overall Study|Not Selected|1|||
145938199|NCT04521621|526282079|FG003|Overall Study|Death|5|||
145979424|NCT05630755|526436026|FG000|Overall Study|Withdrawal by Subject|9|||
145938200|NCT04521621|526282080|FG004|Overall Study|Death|2|||
145938201|NCT04521621|526282081|FG005|Overall Study|Death|7|||
145938202|NCT04521621|526282082|FG006|Overall Study|Death|0|||
145938203|NCT04521621|526282083|FG007|Overall Study|Death|0|||
145938204|NCT04521621|526282076|FG000|Overall Study|Study Terminated by Sponsor|4|||
145938205|NCT04521621|526282077|FG001|Overall Study|Study Terminated by Sponsor|6|||
145938206|NCT04521621|526282078|FG002|Overall Study|Study Terminated by Sponsor|8|||
145938207|NCT04521621|526282079|FG003|Overall Study|Study Terminated by Sponsor|0|||
145938208|NCT04521621|526282080|FG004|Overall Study|Study Terminated by Sponsor|1|||
145938209|NCT04521621|526282081|FG005|Overall Study|Study Terminated by Sponsor|7|||
145938210|NCT04521621|526282082|FG006|Overall Study|Study Terminated by Sponsor|0|||
145938211|NCT04521621|526282083|FG007|Overall Study|Study Terminated by Sponsor|0|||
145938212|NCT04521621|526282076|FG000|Overall Study|Withdrawal by Subject|0|||
145938213|NCT04521621|526282077|FG001|Overall Study|Withdrawal by Subject|0|||
145938214|NCT04521621|526282078|FG002|Overall Study|Withdrawal by Subject|1|||
145938215|NCT04521621|526282079|FG003|Overall Study|Withdrawal by Subject|1|||
145938216|NCT04521621|526282080|FG004|Overall Study|Withdrawal by Subject|0|||
145938217|NCT04521621|526282081|FG005|Overall Study|Withdrawal by Subject|0|||
145938218|NCT04521621|526282082|FG006|Overall Study|Withdrawal by Subject|0|||
145938219|NCT04521621|526282083|FG007|Overall Study|Withdrawal by Subject|0|||
145938220|NCT04521621|526282076|FG000|Overall Study|Allocated in error without study intervention|1|||
145938221|NCT04521621|526282077|FG001|Overall Study|Allocated in error without study intervention|0|||
145938222|NCT04521621|526282078|FG002|Overall Study|Allocated in error without study intervention|0|||
145938223|NCT04521621|526282079|FG003|Overall Study|Allocated in error without study intervention|0|||
145938224|NCT04521621|526282080|FG004|Overall Study|Allocated in error without study intervention|0|||
145938225|NCT04521621|526282081|FG005|Overall Study|Allocated in error without study intervention|0|||
145938226|NCT04521621|526282082|FG006|Overall Study|Allocated in error without study intervention|0|||
145938227|NCT04521621|526282083|FG007|Overall Study|Allocated in error without study intervention|0|||
145938228|NCT03671564|526282084|FG000|Overall Study|Progressive Disease|3|||
145938229|NCT03671564|526282085|FG001|Overall Study|Progressive Disease|5|||
145938230|NCT03671564|526282086|FG002|Overall Study|Progressive Disease|3|||
145938231|NCT03671564|526282084|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
145938232|NCT03671564|526282085|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
145938233|NCT03671564|526282086|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
145938234|NCT03671564|526282084|FG000|Overall Study|Withdrawal by Subject|1|||
145938235|NCT03671564|526282085|FG001|Overall Study|Withdrawal by Subject|1|||
145938236|NCT03671564|526282086|FG002|Overall Study|Withdrawal by Subject|0|||
145938237|NCT01968707|526282092|FG000|Overall Study|Did not meet treatment day baseline|49|||
145938238|NCT01968707|526282093|FG001|Overall Study|Did not meet treatment day baseline|12|||
145938239|NCT01968707|526282094|FG002|Overall Study|Did not meet treatment day baseline|41|||
145938240|NCT01968707|526282095|FG003|Overall Study|Did not meet treatment day baseline|44|||
145938241|NCT01968707|526282096|FG004|Overall Study|Did not meet treatment day baseline|36|||
145938242|NCT01968707|526282097|FG005|Overall Study|Did not meet treatment day baseline|11|||
145938243|NCT01968707|526282098|FG006|Overall Study|Did not meet treatment day baseline|34|||
145938244|NCT01968707|526282099|FG007|Overall Study|Did not meet treatment day baseline|35|||
145938245|NCT01740128|526282104|FG000|Overall Study|Pregnancy|0|||
145938246|NCT01740128|526282105|FG001|Overall Study|Pregnancy|1|||
145938247|NCT01740128|526282104|FG000|Overall Study|Protocol Violation|1|||
145938248|NCT01740128|526282105|FG001|Overall Study|Protocol Violation|2|||
145938249|NCT01740128|526282104|FG000|Overall Study|Lost to Follow-up|2|||
145938250|NCT01740128|526282105|FG001|Overall Study|Lost to Follow-up|2|||
145938251|NCT01740128|526282104|FG000|Overall Study|Withdrawal by Subject|1|||
145938252|NCT01740128|526282105|FG001|Overall Study|Withdrawal by Subject|0|||
145938253|NCT01740128|526282104|FG000|Overall Study|Insufficient protocol compliance|2|||
145938254|NCT01740128|526282105|FG001|Overall Study|Insufficient protocol compliance|2|||
145938255|NCT02474589|526282106|FG000|Overall Study|Adverse Event|6|||
145938256|NCT02474589|526282107|FG001|Overall Study|Adverse Event|2|||
145938257|NCT02474589|526282106|FG000|Overall Study|Lost to Follow-up|6|||
145938258|NCT02474589|526282107|FG001|Overall Study|Lost to Follow-up|1|||
145938259|NCT02474589|526282106|FG000|Overall Study|Protocol Violation|4|||
145938260|NCT02474589|526282107|FG001|Overall Study|Protocol Violation|1|||
145938261|NCT02474589|526282106|FG000|Overall Study|Withdrawal by Subject|4|||
145938262|NCT02474589|526282107|FG001|Overall Study|Withdrawal by Subject|0|||
145938263|NCT02474589|526282106|FG000|Overall Study|Inability to complete study procedures|5|||
145938264|NCT02474589|526282107|FG001|Overall Study|Inability to complete study procedures|1|||
145938265|NCT00380081|526282110|FG000|Overall Study|Withdrawal by Subject|0|||
145938266|NCT00380081|526282111|FG001|Overall Study|Withdrawal by Subject|0|||
145938267|NCT00380081|526282112|FG002|Overall Study|Withdrawal by Subject|0|||
145938268|NCT00380081|526282113|FG003|Overall Study|Withdrawal by Subject|0|||
145938269|NCT00380081|526282114|FG004|Overall Study|Withdrawal by Subject|1|||
145938270|NCT00380081|526282115|FG005|Overall Study|Withdrawal by Subject|0|||
145938271|NCT00380081|526282110|FG000|Overall Study|Family Emergency|0|||
145938272|NCT00380081|526282111|FG001|Overall Study|Family Emergency|0|||
145938273|NCT00380081|526282112|FG002|Overall Study|Family Emergency|0|||
145938274|NCT00380081|526282113|FG003|Overall Study|Family Emergency|0|||
145938275|NCT00380081|526282114|FG004|Overall Study|Family Emergency|0|||
145979425|NCT05630755|526436027|FG001|Overall Study|Withdrawal by Subject|3|||
145979426|NCT05630755|526436026|FG000|Overall Study|Participant moved away from trial site|0|||
145979427|NCT05630755|526436027|FG001|Overall Study|Participant moved away from trial site|1|||
145979428|NCT05630755|526436026|FG000|Overall Study|Status not Recorded|316|||
145979429|NCT05630755|526436027|FG001|Overall Study|Status not Recorded|161|||
145979430|NCT05950906|526436028|FG000|Overall Study|Adverse Event|0|||
145979431|NCT05950906|526436029|FG001|Overall Study|Adverse Event|0|||
145979432|NCT05950906|526436030|FG002|Overall Study|Adverse Event|0|||
145979433|NCT05950906|526436031|FG003|Overall Study|Adverse Event|0|||
145979434|NCT05950906|526436032|FG004|Overall Study|Adverse Event|0|||
145979435|NCT05950906|526436033|FG005|Overall Study|Adverse Event|0|||
145979436|NCT05950906|526436034|FG006|Overall Study|Adverse Event|0|||
145979437|NCT05950906|526436035|FG007|Overall Study|Adverse Event|0|||
145979438|NCT05950906|526436036|FG008|Overall Study|Adverse Event|0|||
145979439|NCT05950906|526436037|FG009|Overall Study|Adverse Event|0|||
145979440|NCT05950906|526436038|FG010|Overall Study|Adverse Event|0|||
145979441|NCT05950906|526436039|FG011|Overall Study|Adverse Event|0|||
145938276|NCT00380081|526282115|FG005|Overall Study|Family Emergency|1|||
145938277|NCT02658734|526282116|FG000|Overall Study|Adverse Event|2|||
145938278|NCT02658734|526282116|FG000|Overall Study|Death|4|||
145938279|NCT02658734|526282116|FG000|Overall Study|Lost to Follow-up|7|||
145938280|NCT02658734|526282116|FG000|Overall Study|Withdrawal of Consent|16|||
145938281|NCT02658734|526282116|FG000|Overall Study|Disease Progression|28|||
145938282|NCT02231879|526282117|FG000|Overall Study|Adverse Event|2|||
145938283|NCT02231879|526282118|FG001|Overall Study|Adverse Event|1|||
145938284|NCT02231879|526282117|FG000|Overall Study|Lack of Efficacy|0|||
145938285|NCT02231879|526282118|FG001|Overall Study|Lack of Efficacy|1|||
145938286|NCT00459706|526282119|FG000|Overall Study|Adverse Event|19|||
145938287|NCT00459706|526282120|FG001|Overall Study|Adverse Event|13|||
145938288|NCT00459706|526282119|FG000|Overall Study|Withdrawal by Subject|1|||
145938289|NCT00459706|526282120|FG001|Overall Study|Withdrawal by Subject|6|||
145938290|NCT00459706|526282119|FG000|Overall Study|Physician Decision|2|||
145938291|NCT00459706|526282120|FG001|Overall Study|Physician Decision|0|||
145938292|NCT00459706|526282119|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
145938293|NCT00459706|526282120|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145938294|NCT00459706|526282119|FG000|Overall Study|Protocol Violation|2|||
145938295|NCT00459706|526282120|FG001|Overall Study|Protocol Violation|1|||
145938296|NCT00459706|526282119|FG000|Overall Study|Failed to Return|1|||
145938297|NCT00459706|526282120|FG001|Overall Study|Failed to Return|0|||
145938298|NCT00459706|526282119|FG000|Overall Study|Other|0|||
145938299|NCT00459706|526282120|FG001|Overall Study|Other|1|||
145938300|NCT00189306|526282121|FG000|Treatment Period|Withdrawal by Subject|2|||
145938301|NCT00189306|526282121|FG000|Treatment Period|Adverse Event|2|||
145938302|NCT00189306|526282121|FG000|Treatment Period|Protocol Violation|1|||
145938303|NCT00189306|526282121|FG000|Posttreatment Period|Death|1|||
145938304|NCT00189306|526282121|FG000|Posttreatment Period|Withdrawal by Subject|2|||
145938305|NCT00189306|526282121|FG000|Posttreatment Period|Noncompliance|1|||
145938306|NCT00189306|526282121|FG000|Posttreatment Period|Target lesion excised|1|||
145938307|NCT00189306|526282121|FG000|Posttreatment Period|Protocol Violation|1|||
145938308|NCT00189306|526282121|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
145938309|NCT00189306|526282121|FG000|Posttreatment Period|Local skin reaction/sign|1|||
145938310|NCT00189306|526282121|FG000|Long-Term Follow-up|Adverse Event|2|||
145938311|NCT00189306|526282121|FG000|Long-Term Follow-up|Death|4|||
145938312|NCT00189306|526282121|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
145938313|NCT00189306|526282121|FG000|Long-Term Follow-up|Intercurrent disease|2|||
145938314|NCT00189306|526282121|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
145938315|NCT00189306|526282121|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
145938316|NCT03640481|526282122|FG000|Overall Study|Death|14|||
145938317|NCT03640481|526282123|FG001|Overall Study|Death|14|||
145979442|NCT05950906|526436040|FG012|Overall Study|Adverse Event|1|||
145979443|NCT05950906|526436041|FG013|Overall Study|Adverse Event|0|||
145979444|NCT05950906|526436028|FG000|Overall Study|Physician Decision|0|||
145938318|NCT03640481|526282124|FG002|Overall Study|Death|0|||
145938319|NCT03640481|526282125|FG003|Overall Study|Death|0|||
145938320|NCT03640481|526282122|FG000|Overall Study|Lost to Follow-up|2|||
145938321|NCT03640481|526282123|FG001|Overall Study|Lost to Follow-up|0|||
145938322|NCT03640481|526282124|FG002|Overall Study|Lost to Follow-up|0|||
145938323|NCT03640481|526282125|FG003|Overall Study|Lost to Follow-up|0|||
145938324|NCT03640481|526282122|FG000|Overall Study|Site terminated by sponsor|1|||
145938325|NCT03640481|526282123|FG001|Overall Study|Site terminated by sponsor|3|||
145938326|NCT03640481|526282124|FG002|Overall Study|Site terminated by sponsor|0|||
145938327|NCT03640481|526282125|FG003|Overall Study|Site terminated by sponsor|0|||
145979445|NCT05950906|526436029|FG001|Overall Study|Physician Decision|0|||
145979446|NCT05950906|526436030|FG002|Overall Study|Physician Decision|0|||
145979447|NCT05950906|526436031|FG003|Overall Study|Physician Decision|0|||
145979448|NCT05950906|526436032|FG004|Overall Study|Physician Decision|0|||
145938328|NCT03640481|526282122|FG000|Overall Study|Study terminated by sponsor|29|||
145979449|NCT05950906|526436033|FG005|Overall Study|Physician Decision|0|||
145979450|NCT05950906|526436034|FG006|Overall Study|Physician Decision|0|||
145979451|NCT05950906|526436035|FG007|Overall Study|Physician Decision|0|||
145979452|NCT05950906|526436036|FG008|Overall Study|Physician Decision|0|||
145979453|NCT05950906|526436037|FG009|Overall Study|Physician Decision|0|||
145979454|NCT05950906|526436038|FG010|Overall Study|Physician Decision|0|||
145979455|NCT05950906|526436039|FG011|Overall Study|Physician Decision|0|||
145979456|NCT05950906|526436040|FG012|Overall Study|Physician Decision|1|||
145979457|NCT05950906|526436041|FG013|Overall Study|Physician Decision|0|||
145979458|NCT04868682|526436042|FG000|Post-treatment|Lost to Follow-up|1|||
145979459|NCT04868682|526436043|FG001|Post-treatment|Lost to Follow-up|1|||
145979460|NCT04868682|526436042|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
145979461|NCT04868682|526436043|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
145979462|NCT04868682|526436042|FG000|Six-month Assessment|Lost to Follow-up|1|||
145979463|NCT04868682|526436043|FG001|Six-month Assessment|Lost to Follow-up|0|||
145979464|NCT04868682|526436042|FG000|Six-month Assessment|Death|1|||
145979465|NCT04868682|526436043|FG001|Six-month Assessment|Death|0|||
145979466|NCT04868682|526436042|FG000|Six-month Assessment|Refused|0|||
145979467|NCT04868682|526436043|FG001|Six-month Assessment|Refused|1|||
145979468|NCT04868682|526436042|FG000|12-month Assessment|Lost to Follow-up|2|||
145979469|NCT04868682|526436043|FG001|12-month Assessment|Lost to Follow-up|1|||
145979470|NCT04868682|526436042|FG000|12-month Assessment|Death|0|||
145979471|NCT04868682|526436043|FG001|12-month Assessment|Death|1|||
145979472|NCT02541903|526436044|FG000|Overall Study|Death|1|||
145979473|NCT03880565|526436045|FG000|Overall Study|Withdrawal by Subject|1|||
145979474|NCT03880565|526436046|FG001|Overall Study|Withdrawal by Subject|0|||
145979475|NCT02503865|526436051|FG000|Overall Study|Moved out of area|1|||
145979476|NCT02503865|526436052|FG001|Overall Study|Moved out of area|8|||
145979477|NCT02503865|526436053|FG002|Overall Study|Moved out of area|0|||
145979478|NCT02503865|526436051|FG000|Overall Study|Refused treatment|4|||
145979479|NCT02503865|526436052|FG001|Overall Study|Refused treatment|39|||
145979480|NCT02503865|526436053|FG002|Overall Study|Refused treatment|2|||
145979481|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
145979482|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
145979483|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
145979484|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Death|1|||
145979485|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Death|0|||
145979486|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Death|0|||
145979487|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
145979488|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
145979489|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
145979490|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
145979491|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
145979492|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
145979493|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
145979494|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
145979495|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
145979496|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
145979497|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
145979498|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
145979499|NCT05073315|526436054|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
145979500|NCT05073315|526436055|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
145979501|NCT05073315|526436056|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
145979502|NCT05073315|526436054|FG000|Period 2|Adverse Event|0|||
145979503|NCT05073315|526436055|FG001|Period 2|Adverse Event|3|||
145979504|NCT05073315|526436056|FG002|Period 2|Adverse Event|6|||
145979505|NCT05073315|526436054|FG000|Period 2|Lost to Follow-up|0|||
145979506|NCT05073315|526436055|FG001|Period 2|Lost to Follow-up|5|||
145979507|NCT05073315|526436056|FG002|Period 2|Lost to Follow-up|5|||
145979508|NCT05073315|526436054|FG000|Period 2|Withdrawal by Subject|0|||
145979509|NCT05073315|526436055|FG001|Period 2|Withdrawal by Subject|4|||
145979510|NCT05073315|526436056|FG002|Period 2|Withdrawal by Subject|9|||
145979511|NCT05073315|526436054|FG000|Period 2|Protocol Violation|0|||
145979512|NCT05073315|526436055|FG001|Period 2|Protocol Violation|0|||
145979513|NCT05073315|526436056|FG002|Period 2|Protocol Violation|1|||
145979514|NCT00303953|526436057|FG000|Overall Study|Ineligible|1|||
145979515|NCT00303953|526436057|FG000|Overall Study|Death|1|||
145979516|NCT00303953|526436057|FG000|Overall Study|Adverse Event|4|||
145979517|NCT00303953|526436057|FG000|Overall Study|Lack of Efficacy|12|||
145979518|NCT00303953|526436057|FG000|Overall Study|Physician Decision|1|||
145979519|NCT00021255|526436058|FG000|Overall Study|Death|1|||
145979520|NCT00021255|526436059|FG001|Overall Study|Death|0|||
145979521|NCT00021255|526436060|FG002|Overall Study|Death|2|||
145979522|NCT00021255|526436058|FG000|Overall Study|Breast cancer relapse|5|||
145979523|NCT00021255|526436059|FG001|Overall Study|Breast cancer relapse|18|||
145979524|NCT00021255|526436060|FG002|Overall Study|Breast cancer relapse|11|||
145979525|NCT00021255|526436058|FG000|Overall Study|Second primary malignancy|0|||
145979526|NCT00021255|526436059|FG001|Overall Study|Second primary malignancy|4|||
145979527|NCT00021255|526436060|FG002|Overall Study|Second primary malignancy|1|||
145938329|NCT03640481|526282123|FG001|Overall Study|Study terminated by sponsor|42|||
145938330|NCT03640481|526282124|FG002|Overall Study|Study terminated by sponsor|1|||
145938331|NCT03640481|526282125|FG003|Overall Study|Study terminated by sponsor|0|||
145938332|NCT03640481|526282122|FG000|Overall Study|Withdrawal by Subject|5|||
145938333|NCT03640481|526282123|FG001|Overall Study|Withdrawal by Subject|4|||
145938334|NCT03640481|526282124|FG002|Overall Study|Withdrawal by Subject|0|||
145938335|NCT03640481|526282125|FG003|Overall Study|Withdrawal by Subject|1|||
145938336|NCT03640481|526282122|FG000|Overall Study|Other|26|||
145938337|NCT03640481|526282123|FG001|Overall Study|Other|12|||
145938338|NCT03640481|526282124|FG002|Overall Study|Other|1|||
145938339|NCT03640481|526282125|FG003|Overall Study|Other|0|||
145938340|NCT03640481|526282122|FG000|Overall Study|Randomized, but not treated|1|||
145938341|NCT03640481|526282123|FG001|Overall Study|Randomized, but not treated|3|||
145938342|NCT03640481|526282124|FG002|Overall Study|Randomized, but not treated|0|||
145938343|NCT03640481|526282125|FG003|Overall Study|Randomized, but not treated|0|||
145938344|NCT01546168|526282128|FG000|Overall Study|Lost to Follow-up|1|||
145938345|NCT01546168|526282129|FG001|Overall Study|Lost to Follow-up|0|||
145938346|NCT01546168|526282128|FG000|Overall Study|Withdrawal by Subject|1|||
145938347|NCT01546168|526282129|FG001|Overall Study|Withdrawal by Subject|0|||
145938348|NCT01546168|526282128|FG000|Overall Study|ineligible after signing consent|2|||
145938349|NCT01546168|526282129|FG001|Overall Study|ineligible after signing consent|0|||
145938350|NCT00423189|526282132|FG000|Overall Study|Death|0|||
145938351|NCT00423189|526282133|FG001|Overall Study|Death|1|||
145938352|NCT00423189|526282134|FG002|Overall Study|Death|0|||
145938353|NCT01258075|526282141|FG000|Overall Study|Adverse Event|8|||
145938354|NCT01258075|526282142|FG001|Overall Study|Adverse Event|3|||
145938355|NCT01258075|526282141|FG000|Overall Study|Lost to Follow-up|11|||
145938356|NCT01258075|526282142|FG001|Overall Study|Lost to Follow-up|6|||
145938357|NCT01258075|526282141|FG000|Overall Study|Withdrawal by Subject|10|||
145938358|NCT01258075|526282142|FG001|Overall Study|Withdrawal by Subject|7|||
145938359|NCT01258075|526282141|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
145938360|NCT01258075|526282142|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
145938361|NCT01258075|526282141|FG000|Overall Study|Other|12|||
145938362|NCT01258075|526282142|FG001|Overall Study|Other|5|||
145938363|NCT00070018|526282143|FG000|Overall Study|Adverse Event|2|||
145938364|NCT00070018|526282143|FG000|Overall Study|Lack of Efficacy|1|||
145938365|NCT00070018|526282143|FG000|Overall Study|Withdrawal by Subject|1|||
145938366|NCT02939716|526282144|FG000|Overall Study|scanner failure|0|||
145938367|NCT02939716|526282145|FG001|Overall Study|scanner failure|0|||
145938368|NCT02939716|526282146|FG002|Overall Study|scanner failure|0|||
145938369|NCT02939716|526282147|FG003|Overall Study|scanner failure|1|||
145938370|NCT02939716|526282148|FG004|Overall Study|scanner failure|1|||
145938371|NCT02939716|526282149|FG005|Overall Study|scanner failure|1|||
145938372|NCT00985959|526282152|FG000|Overall Study|Adverse Event|0|||
145938373|NCT00985959|526282153|FG001|Overall Study|Adverse Event|0|||
145938374|NCT00985959|526282154|FG002|Overall Study|Adverse Event|19|||
145938375|NCT00985959|526282152|FG000|Overall Study|Withdrawal by Subject|0|||
145938376|NCT00985959|526282153|FG001|Overall Study|Withdrawal by Subject|0|||
145938377|NCT00985959|526282154|FG002|Overall Study|Withdrawal by Subject|8|||
145938378|NCT00985959|526282152|FG000|Overall Study|Progressive disease|1|||
145938379|NCT00985959|526282153|FG001|Overall Study|Progressive disease|2|||
145938380|NCT00985959|526282154|FG002|Overall Study|Progressive disease|8|||
145938381|NCT00985959|526282152|FG000|Overall Study|Unrecovered toxicity|0|||
145938382|NCT00985959|526282153|FG001|Overall Study|Unrecovered toxicity|0|||
145938383|NCT00985959|526282154|FG002|Overall Study|Unrecovered toxicity|7|||
145938384|NCT00985959|526282152|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
145938385|NCT00985959|526282153|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
145938386|NCT00985959|526282154|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
145938387|NCT00985959|526282152|FG000|Overall Study|Complete response observed over 2 cycles|0|||
145938388|NCT00985959|526282153|FG001|Overall Study|Complete response observed over 2 cycles|1|||
145938389|NCT00985959|526282154|FG002|Overall Study|Complete response observed over 2 cycles|4|||
145938390|NCT00985959|526282152|FG000|Overall Study|Other|0|||
145938391|NCT00985959|526282153|FG001|Overall Study|Other|0|||
145938392|NCT00985959|526282154|FG002|Overall Study|Other|11|||
145938393|NCT03197870|526282162|FG000|Overall Study|Adverse Event|9|||
145938394|NCT03197870|526282163|FG001|Overall Study|Adverse Event|4|||
145938395|NCT03197870|526282164|FG002|Overall Study|Adverse Event|6|||
145938396|NCT03197870|526282162|FG000|Overall Study|Withdrawal by Subject|2|||
145938397|NCT03197870|526282163|FG001|Overall Study|Withdrawal by Subject|3|||
145938398|NCT03197870|526282164|FG002|Overall Study|Withdrawal by Subject|0|||
145938399|NCT03197870|526282162|FG000|Overall Study|Lost to Follow-up|2|||
145938400|NCT03197870|526282163|FG001|Overall Study|Lost to Follow-up|2|||
145938401|NCT03197870|526282164|FG002|Overall Study|Lost to Follow-up|0|||
145938402|NCT03197870|526282162|FG000|Overall Study|data not available|1|||
145938403|NCT03197870|526282163|FG001|Overall Study|data not available|1|||
145938404|NCT03197870|526282164|FG002|Overall Study|data not available|0|||
145938405|NCT01618019|526282165|FG000|Overall Study|Withdrawal by Subject|14|||
145938406|NCT01618019|526282166|FG001|Overall Study|Withdrawal by Subject|14|||
145979528|NCT00021255|526436058|FG000|Overall Study|Withdrawal by Subject|41|||
145979529|NCT00021255|526436059|FG001|Overall Study|Withdrawal by Subject|64|||
145979530|NCT00021255|526436060|FG002|Overall Study|Withdrawal by Subject|26|||
145979531|NCT00021255|526436058|FG000|Overall Study|Lost to Follow-up|0|||
145979532|NCT00021255|526436059|FG001|Overall Study|Lost to Follow-up|2|||
145979533|NCT00021255|526436060|FG002|Overall Study|Lost to Follow-up|3|||
145979534|NCT00021255|526436058|FG000|Overall Study|Cardiac toxicity|0|||
145979535|NCT00021255|526436059|FG001|Overall Study|Cardiac toxicity|61|||
145979536|NCT00021255|526436060|FG002|Overall Study|Cardiac toxicity|32|||
145979537|NCT00021255|526436058|FG000|Overall Study|Herceptin toxicity|0|||
145979538|NCT00021255|526436059|FG001|Overall Study|Herceptin toxicity|22|||
145979539|NCT00021255|526436060|FG002|Overall Study|Herceptin toxicity|6|||
145979540|NCT00021255|526436058|FG000|Overall Study|Adverse Event|46|||
145979541|NCT00021255|526436059|FG001|Overall Study|Adverse Event|30|||
145979542|NCT00021255|526436060|FG002|Overall Study|Adverse Event|18|||
145979543|NCT00021255|526436058|FG000|Overall Study|Protocol Violation|0|||
145979544|NCT00021255|526436059|FG001|Overall Study|Protocol Violation|2|||
145979545|NCT00021255|526436060|FG002|Overall Study|Protocol Violation|0|||
145979546|NCT00021255|526436058|FG000|Overall Study|Other than specified above|0|||
145979547|NCT00021255|526436059|FG001|Overall Study|Other than specified above|38|||
145979548|NCT00021255|526436060|FG002|Overall Study|Other than specified above|19|||
145979549|NCT00021255|526436058|FG000|Overall Study|Missing|0|||
145979550|NCT00021255|526436059|FG001|Overall Study|Missing|27|||
145979551|NCT00021255|526436060|FG002|Overall Study|Missing|13|||
145979552|NCT00021255|526436058|FG000|Overall Study|Randomized but not treated|28|||
145979553|NCT00021255|526436059|FG001|Overall Study|Randomized but not treated|2|||
145979554|NCT00021255|526436060|FG002|Overall Study|Randomized but not treated|18|||
145979555|NCT02232698|526436061|FG000|Overall Study|Pregnancy|1|||
145979556|NCT02232698|526436062|FG001|Overall Study|Pregnancy|1|||
145979557|NCT02232698|526436061|FG000|Overall Study|Met exclusion criteria|1|||
145979558|NCT02232698|526436062|FG001|Overall Study|Met exclusion criteria|1|||
145979559|NCT02232698|526436061|FG000|Overall Study|Had device-associated symptoms|7|||
145979560|NCT02232698|526436062|FG001|Overall Study|Had device-associated symptoms|0|||
145979561|NCT02232698|526436061|FG000|Overall Study|Non-compliance with study device|1|||
145979562|NCT02232698|526436062|FG001|Overall Study|Non-compliance with study device|4|||
145979563|NCT02232698|526436061|FG000|Overall Study|Allocated to control group|0|||
145979564|NCT02232698|526436062|FG001|Overall Study|Allocated to control group|3|||
145979565|NCT02232698|526436061|FG000|Overall Study|Withdrawal by Subject|0|||
145979566|NCT02232698|526436062|FG001|Overall Study|Withdrawal by Subject|11|||
145979567|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
145979568|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
145979569|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
145979570|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
145979571|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
145979572|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
145979573|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
145979574|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
145979575|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
145979576|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
145979577|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
145979578|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
145979579|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
145979580|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
145979581|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
145979582|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
145979583|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
145979584|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
145979585|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
145979586|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
145979587|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
145979588|NCT02337946|526436063|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
145979589|NCT02337946|526436064|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
146297808|NCT00835120|527606014|FG000|Overall Study|Lack of Efficacy|1|||
146297809|NCT00835120|527606014|FG000|Overall Study|Lost to Follow-up|3|||
146297810|NCT00835120|527606014|FG000|Overall Study|Adverse Event|2|||
146297811|NCT00835120|527606014|FG000|Overall Study|Withdrawal by Subject|2|||
145979590|NCT02337946|526436065|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
145979591|NCT02337946|526436063|FG000|In-between Period|Without Informed Consent|1|||
145979592|NCT02337946|526436064|FG001|In-between Period|Without Informed Consent|0|||
145979593|NCT02337946|526436065|FG002|In-between Period|Without Informed Consent|0|||
145979594|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
145979595|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
145979596|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
146297812|NCT01019980|527606018|FG000|Overall Study|Drug not available.|2|||
145979597|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
145979598|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
145979599|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
145979600|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
145979601|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
145979602|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
145979603|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
145979604|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
145979605|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
145979606|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
145979607|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
145979608|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
145979609|NCT02337946|526436063|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
145979610|NCT02337946|526436064|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
145979611|NCT02337946|526436065|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
145979612|NCT05324371|526436067|FG000|Overall Study|Withdrawal by Subject|1|||
145979613|NCT05324371|526436067|FG000|Overall Study|Death|1|||
145979614|NCT01131585|526436068|FG000|Overall Study|Adverse Event|0|||
145979615|NCT01131585|526436069|FG001|Overall Study|Adverse Event|2|||
145979616|NCT01131585|526436068|FG000|Overall Study|Abnormal laboratory value|1|||
145979617|NCT01131585|526436069|FG001|Overall Study|Abnormal laboratory value|0|||
145979618|NCT01131585|526436068|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145979619|NCT01131585|526436069|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145979620|NCT01131585|526436068|FG000|Overall Study|Protocol Violation|2|||
145979621|NCT01131585|526436069|FG001|Overall Study|Protocol Violation|1|||
145979622|NCT01131585|526436068|FG000|Overall Study|Withdrawal by Subject|3|||
145979623|NCT01131585|526436069|FG001|Overall Study|Withdrawal by Subject|3|||
145979624|NCT01131585|526436068|FG000|Overall Study|Lost to Follow-up|0|||
145979625|NCT01131585|526436069|FG001|Overall Study|Lost to Follow-up|1|||
145979626|NCT01131585|526436068|FG000|Overall Study|Administrative problems|1|||
145979627|NCT01131585|526436069|FG001|Overall Study|Administrative problems|1|||
145979628|NCT01131585|526436068|FG000|Overall Study|Study termination|78|||
145979629|NCT01131585|526436069|FG001|Overall Study|Study termination|32|||
145979630|NCT01786109|526436070|FG000|Overall Study|fail manometry barostat tube placement|1|||
145979631|NCT01786109|526436071|FG001|Overall Study|fail manometry barostat tube placement|0|||
145979632|NCT01786109|526436072|FG002|Overall Study|fail manometry barostat tube placement|0|||
145979633|NCT01786109|526436070|FG000|Overall Study|unrelated illness|0|||
145979634|NCT01786109|526436071|FG001|Overall Study|unrelated illness|0|||
145979635|NCT01786109|526436072|FG002|Overall Study|unrelated illness|1|||
145979636|NCT01786109|526436070|FG000|Overall Study|adverse effects colon preparation|0|||
145979637|NCT01786109|526436071|FG001|Overall Study|adverse effects colon preparation|0|||
145979638|NCT01786109|526436072|FG002|Overall Study|adverse effects colon preparation|1|||
145979639|NCT03442569|526436076|FG000|Overall Study|Subject was ineligible after enrollment|1|||
145979640|NCT01631188|526436976|FG000|Overall Study|Physician Decision|75|||
145979641|NCT03600350|526436979|FG000|Overall Study|Death|1|||
145979642|NCT03600350|526436979|FG000|Overall Study|On Follow Up|18|||
145979643|NCT04575324|526436980|FG000|Overall Study|Lost to Follow-up|29|||
145979644|NCT04575324|526436981|FG001|Overall Study|Lost to Follow-up|25|||
146245429|NCT03547154|527412213|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
146245430|NCT03547154|527412214|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
146245431|NCT00088166|527412219|FG000|Overall Study|Adverse Event|11|||
145979645|NCT04575324|526436980|FG000|Overall Study|Death|1|||
145979646|NCT04575324|526436981|FG001|Overall Study|Death|2|||
145979647|NCT04575324|526436980|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
145979648|NCT04575324|526436981|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
145979649|NCT01771913|526436987|FG000|Overall Study|Withdrawal by Subject|1|||
145979650|NCT01771913|526436988|FG001|Overall Study|Withdrawal by Subject|0|||
145979651|NCT00845182|526436992|FG000|Overall Study|Lost to Follow-up|3|||
145979652|NCT00845182|526436993|FG001|Overall Study|Lost to Follow-up|3|||
145979653|NCT00845182|526436994|FG002|Overall Study|Lost to Follow-up|4|||
145979654|NCT00845182|526436992|FG000|Overall Study|Adverse Event|0|||
145979655|NCT00845182|526436993|FG001|Overall Study|Adverse Event|1|||
145979656|NCT00845182|526436994|FG002|Overall Study|Adverse Event|1|||
145979657|NCT00845182|526436992|FG000|Overall Study|Physician Decision|0|||
145979658|NCT00845182|526436993|FG001|Overall Study|Physician Decision|0|||
145979659|NCT00845182|526436994|FG002|Overall Study|Physician Decision|1|||
145979660|NCT04621760|526436995|FG000|Overall Study|Lost to Follow-up|2|||
145979661|NCT04621760|526436996|FG001|Overall Study|Lost to Follow-up|4|||
145979662|NCT04621760|526436995|FG000|Overall Study|Withdrawal by Subject|1|||
145979663|NCT04621760|526436996|FG001|Overall Study|Withdrawal by Subject|0|||
146245432|NCT00088166|527412220|FG001|Overall Study|Adverse Event|9|||
146245433|NCT00088166|527412219|FG000|Overall Study|Death|3|||
146245434|NCT00088166|527412220|FG001|Overall Study|Death|1|||
146245435|NCT00088166|527412219|FG000|Overall Study|Lost to Follow-up|0|||
146245436|NCT00088166|527412220|FG001|Overall Study|Lost to Follow-up|1|||
146091237|NCT04650854|526854931|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
146091238|NCT04650854|526854929|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
145979664|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
145979665|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
145979666|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
145979667|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
145979668|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
145979669|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
145979670|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
145979671|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
145979672|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
145979673|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
145979674|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
145979675|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
145979676|NCT00447278|526436997|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
145979677|NCT00447278|526436998|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
146091239|NCT04650854|526854930|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
146245437|NCT00088166|527412219|FG000|Overall Study|Physician Decision|4|||
145938407|NCT01542034|526282167|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
145938408|NCT01542034|526282168|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
145938409|NCT01542034|526282167|FG000|Overall Study|Administrative decision|0|||
145938410|NCT01542034|526282168|FG001|Overall Study|Administrative decision|3|||
145938411|NCT01542034|526282167|FG000|Overall Study|Subject Noncompliance|1|||
145938412|NCT01542034|526282168|FG001|Overall Study|Subject Noncompliance|0|||
145938413|NCT01542034|526282167|FG000|Overall Study|Adverse Event|2|||
145938414|NCT01542034|526282168|FG001|Overall Study|Adverse Event|2|||
145938415|NCT01542034|526282167|FG000|Overall Study|Lost to Follow-up|7|||
145938416|NCT01542034|526282168|FG001|Overall Study|Lost to Follow-up|6|||
145938417|NCT01508130|526282172|FG000|Overall Study|Adverse Event|81|||
145938418|NCT01508130|526282173|FG001|Overall Study|Adverse Event|28|||
145938419|NCT01508130|526282172|FG000|Overall Study|Death|3|||
145938420|NCT01508130|526282173|FG001|Overall Study|Death|1|||
145938421|NCT01508130|526282172|FG000|Overall Study|Protocol Violation|2|||
145938422|NCT01508130|526282173|FG001|Overall Study|Protocol Violation|0|||
145938423|NCT01508130|526282172|FG000|Overall Study|Lost to Follow-up|25|||
145938424|NCT01508130|526282173|FG001|Overall Study|Lost to Follow-up|2|||
145938425|NCT01508130|526282172|FG000|Overall Study|Withdrawal by Subject|3|||
145938426|NCT01508130|526282173|FG001|Overall Study|Withdrawal by Subject|3|||
145938427|NCT01508130|526282172|FG000|Overall Study|Subject's substantial non-compliance|25|||
145938428|NCT01508130|526282173|FG001|Overall Study|Subject's substantial non-compliance|9|||
145938429|NCT01508130|526282172|FG000|Overall Study|Insufficient therapeutic response|74|||
145938430|NCT01508130|526282173|FG001|Overall Study|Insufficient therapeutic response|23|||
145938431|NCT01508130|526282172|FG000|Overall Study|Administrative|14|||
145938432|NCT01508130|526282173|FG001|Overall Study|Administrative|3|||
145938433|NCT00978250|526282175|FG000|Overall Study|Late determination of ineligibility|0|||
145938434|NCT00978250|526282176|FG001|Overall Study|Late determination of ineligibility|1|||
145938435|NCT00978250|526282177|FG002|Overall Study|Late determination of ineligibility|0|||
145938436|NCT00978250|526282178|FG003|Overall Study|Late determination of ineligibility|1|||
145938437|NCT00387010|526282180|FG000|Dose Titration Period|Adverse Event|12|||
145938438|NCT00387010|526282180|FG000|Dose Titration Period|Lack of Efficacy|5|||
145938439|NCT00387010|526282180|FG000|Dose Titration Period|Withdrawal by Subject|3|||
145938440|NCT00387010|526282180|FG000|Dose Titration Period|Protocol Violation|1|||
145938441|NCT00387010|526282180|FG000|Dose Titration Period|Lost to Follow-up|2|||
145938442|NCT00387010|526282180|FG000|Dose Titration Period|Noncompliance with study medication|8|||
145938443|NCT00387010|526282180|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
145938444|NCT00387010|526282180|FG000|Treatment Period|Adverse Event|4|||
145938445|NCT00387010|526282180|FG000|Treatment Period|Withdrawal by Subject|1|||
145938446|NCT00387010|526282180|FG000|Treatment Period|Noncompliance with study medication|2|||
145938447|NCT00387010|526282180|FG000|Treatment Period|Noncompliance with study procedures|3|||
145938448|NCT00387010|526282180|FG000|Treatment Period|Participant reported study drug stolen|1|||
145938449|NCT00520481|526282186|FG000|Overall Study|Adverse Event|4|||
145938450|NCT00520481|526282187|FG001|Overall Study|Adverse Event|1|||
145938451|NCT00520481|526282186|FG000|Overall Study|Withdrawal by Subject|3|||
145938452|NCT00520481|526282187|FG001|Overall Study|Withdrawal by Subject|0|||
145938453|NCT00471718|526282192|FG000|Overall Study|Adverse Event|3|||
145938454|NCT00471718|526282192|FG000|Overall Study|other complicating disease|1|||
145938455|NCT00471718|526282192|FG000|Overall Study|disease progression|22|||
145938456|NCT00471718|526282192|FG000|Overall Study|Withdrawal by Subject|1|||
145938457|NCT00381043|526282193|FG000|Overall Study|Lost to Follow-up|8|||
145938458|NCT00381043|526282194|FG001|Overall Study|Lost to Follow-up|6|||
145938459|NCT00381043|526282193|FG000|Overall Study|Withdrawal by Subject|3|||
145938460|NCT00381043|526282194|FG001|Overall Study|Withdrawal by Subject|1|||
145938461|NCT00381043|526282193|FG000|Overall Study|wanted more care|0|||
146245438|NCT00088166|527412220|FG001|Overall Study|Physician Decision|1|||
146245439|NCT00088166|527412219|FG000|Overall Study|Protocol Violation|1|||
145979678|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
146245440|NCT00088166|527412220|FG001|Overall Study|Protocol Violation|5|||
146245441|NCT00088166|527412219|FG000|Overall Study|Patient deterioration|29|||
146245442|NCT00088166|527412220|FG001|Overall Study|Patient deterioration|39|||
146245443|NCT00088166|527412219|FG000|Overall Study|Withdrawal by Subject|5|||
146245444|NCT00088166|527412220|FG001|Overall Study|Withdrawal by Subject|5|||
145979679|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
145979680|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
145979681|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
145979682|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
145979683|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
145979684|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
145979685|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
145979686|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
146297813|NCT01019980|527606019|FG001|Overall Study|Drug not available.|0|||
146297814|NCT00708175|527606025|FG000|Overall Study|Adverse Event|4|||
146297815|NCT00708175|527606026|FG001|Overall Study|Adverse Event|5|||
146297816|NCT00708175|527606025|FG000|Overall Study|Protocol Violation|2|||
146297817|NCT00708175|527606026|FG001|Overall Study|Protocol Violation|3|||
146297818|NCT00708175|527606025|FG000|Overall Study|Lost to Follow-up|5|||
146297819|NCT00708175|527606026|FG001|Overall Study|Lost to Follow-up|3|||
146297820|NCT00708175|527606025|FG000|Overall Study|Withdrawal by Subject|5|||
146297821|NCT00708175|527606026|FG001|Overall Study|Withdrawal by Subject|7|||
145979687|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
145979688|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
145979689|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
145979690|NCT00447278|526436997|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
145979691|NCT00447278|526436998|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
145979692|NCT03677401|526436999|FG000|Overall Study|Adverse Event|4|||
145979693|NCT03677401|526437000|FG001|Overall Study|Adverse Event|14|||
145979694|NCT03677401|526436999|FG000|Overall Study|Lack of Efficacy|3|||
145979695|NCT03677401|526437000|FG001|Overall Study|Lack of Efficacy|1|||
145979696|NCT03677401|526436999|FG000|Overall Study|Withdrawal by Subject|2|||
146297822|NCT00708175|527606025|FG000|Overall Study|BMD loss >7%|2|||
146297823|NCT00708175|527606026|FG001|Overall Study|BMD loss >7%|3|||
146297824|NCT02038920|527606027|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
146297825|NCT02038920|527606028|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
146297826|NCT02038920|527606029|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146297827|NCT02038920|527606030|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146297828|NCT02038920|527606031|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146297829|NCT02038920|527606032|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
146297830|NCT02038920|527606027|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
146297831|NCT02038920|527606028|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146297832|NCT02038920|527606029|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145979697|NCT03677401|526437000|FG001|Overall Study|Withdrawal by Subject|2|||
145979698|NCT03677401|526436999|FG000|Overall Study|Sponsor decision|0|||
145979699|NCT03677401|526437000|FG001|Overall Study|Sponsor decision|1|||
145979700|NCT03677401|526436999|FG000|Overall Study|Reason Unspecified|1|||
145979701|NCT03677401|526437000|FG001|Overall Study|Reason Unspecified|0|||
145979702|NCT06262607|526437006|FG000|Overall Study|Physician Decision|0|||
145979703|NCT06262607|526437007|FG001|Overall Study|Physician Decision|1|||
145979704|NCT06262607|526437006|FG000|Overall Study|Withdrawal by Subject|2|||
145979705|NCT06262607|526437007|FG001|Overall Study|Withdrawal by Subject|0|||
145979706|NCT02836769|526437008|FG000|Overall Study|Lost to Follow-up|10|||
145979707|NCT02836769|526437008|FG000|Overall Study|Medical withdrawal|2|||
145979708|NCT02836769|526437008|FG000|Overall Study|Withdrawal by Subject|3|||
145979709|NCT03142750|526437014|FG000|Overall Study|Lost to Follow-up|4|||
145979710|NCT03142750|526437015|FG001|Overall Study|Lost to Follow-up|1|||
145979711|NCT02942407|526437016|FG000|Overall Study|Lost to Follow-up|3|||
145979712|NCT02942407|526437017|FG001|Overall Study|Lost to Follow-up|2|||
145979713|NCT02942407|526437016|FG000|Overall Study|Withdrawal by Subject|7|||
145979714|NCT02942407|526437017|FG001|Overall Study|Withdrawal by Subject|9|||
145979715|NCT02942407|526437016|FG000|Overall Study|Death|16|||
145979716|NCT02942407|526437017|FG001|Overall Study|Death|13|||
145979717|NCT00933166|526437018|FG000|Overall Study|Lost to Follow-up|4|||
146245445|NCT02671266|527412221|FG000|Overall Study|Withdrawal by Subject|1|||
146245446|NCT02671266|527412222|FG001|Overall Study|Withdrawal by Subject|1|||
146297833|NCT02038920|527606030|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146297834|NCT02038920|527606031|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146297835|NCT02038920|527606032|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
146245447|NCT01328756|527412223|FG000|Overall Study|Protocol Violation|4|||
145979718|NCT00933166|526437018|FG000|Overall Study|Lack of Efficacy|9|||
145979719|NCT00933166|526437018|FG000|Overall Study|Unavailable|4|||
145979720|NCT00933166|526437018|FG000|Overall Study|Withdrawal by Subject|1|||
145979721|NCT04618471|526437019|FG000|Overall Study|Screen Failure|62|||
145979722|NCT04618471|526437019|FG000|Overall Study|Withdrawal by Subject|6|||
145979723|NCT04618471|526437019|FG000|Overall Study|Physician Decision|2|||
145979724|NCT04618471|526437019|FG000|Overall Study|Lost to Follow-up|1|||
145979725|NCT04618471|526437019|FG000|Overall Study|Various other reasons|2|||
145979726|NCT04618471|526437019|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
145979727|NCT05774977|526437022|FG000|Overall Study|Withdrawal by Subject|2|||
145979728|NCT00374868|526437023|FG000|Overall Study|Adverse Event|12|||
145979729|NCT00374868|526437023|FG000|Overall Study|Progressive Disease|7|||
145979730|NCT00374868|526437023|FG000|Overall Study|Physician Decision|13|||
145979731|NCT00374868|526437023|FG000|Overall Study|Lost to Follow-up|1|||
145979732|NCT00374868|526437023|FG000|Overall Study|Death|2|||
145979733|NCT00374868|526437023|FG000|Overall Study|Other - Not Specified|1|||
145979734|NCT03188185|526437024|FG000|Stage 1|Adverse Event|4|||
145979735|NCT03188185|526437025|FG001|Stage 1|Adverse Event|12|||
145979736|NCT03188185|526437026|FG002|Stage 1|Adverse Event|0|||
145979737|NCT03188185|526437027|FG003|Stage 1|Adverse Event|0|||
145979738|NCT03188185|526437024|FG000|Stage 1|Lack of Efficacy|0|||
145979739|NCT03188185|526437025|FG001|Stage 1|Lack of Efficacy|2|||
145979740|NCT03188185|526437026|FG002|Stage 1|Lack of Efficacy|0|||
145979741|NCT03188185|526437027|FG003|Stage 1|Lack of Efficacy|0|||
145979742|NCT03188185|526437024|FG000|Stage 1|Lost to Follow-up|6|||
145979743|NCT03188185|526437025|FG001|Stage 1|Lost to Follow-up|1|||
145979744|NCT03188185|526437026|FG002|Stage 1|Lost to Follow-up|0|||
145979745|NCT03188185|526437027|FG003|Stage 1|Lost to Follow-up|0|||
145979746|NCT03188185|526437024|FG000|Stage 1|Withdrawal by Subject|9|||
145979747|NCT03188185|526437025|FG001|Stage 1|Withdrawal by Subject|0|||
145979748|NCT03188185|526437026|FG002|Stage 1|Withdrawal by Subject|0|||
145979749|NCT03188185|526437027|FG003|Stage 1|Withdrawal by Subject|0|||
145979750|NCT03188185|526437024|FG000|Stage 1|Identified as a professional patient|0|||
145979751|NCT03188185|526437025|FG001|Stage 1|Identified as a professional patient|1|||
145979752|NCT03188185|526437026|FG002|Stage 1|Identified as a professional patient|0|||
145979753|NCT03188185|526437027|FG003|Stage 1|Identified as a professional patient|0|||
145979754|NCT03188185|526437024|FG000|Stage 2|Adverse Event|0|||
145979755|NCT03188185|526437025|FG001|Stage 2|Adverse Event|0|||
145979756|NCT03188185|526437026|FG002|Stage 2|Adverse Event|2|||
145979757|NCT03188185|526437027|FG003|Stage 2|Adverse Event|4|||
145979758|NCT03188185|526437024|FG000|Stage 2|Lack of Efficacy|0|||
145979759|NCT03188185|526437025|FG001|Stage 2|Lack of Efficacy|0|||
145979760|NCT03188185|526437026|FG002|Stage 2|Lack of Efficacy|3|||
145979761|NCT03188185|526437027|FG003|Stage 2|Lack of Efficacy|0|||
145979762|NCT03188185|526437024|FG000|Stage 2|Lost to Follow-up|0|||
145979763|NCT03188185|526437025|FG001|Stage 2|Lost to Follow-up|0|||
145979764|NCT03188185|526437026|FG002|Stage 2|Lost to Follow-up|1|||
145979765|NCT03188185|526437027|FG003|Stage 2|Lost to Follow-up|0|||
145979766|NCT03188185|526437024|FG000|Stage 2|Physician Decision|0|||
145979767|NCT03188185|526437025|FG001|Stage 2|Physician Decision|0|||
145979768|NCT03188185|526437026|FG002|Stage 2|Physician Decision|0|||
145979769|NCT03188185|526437027|FG003|Stage 2|Physician Decision|1|||
145979770|NCT03188185|526437024|FG000|Stage 2|Withdrawal by Subject|0|||
145979771|NCT03188185|526437025|FG001|Stage 2|Withdrawal by Subject|0|||
145979772|NCT03188185|526437026|FG002|Stage 2|Withdrawal by Subject|3|||
145979773|NCT03188185|526437027|FG003|Stage 2|Withdrawal by Subject|1|||
145979774|NCT03325439|526437028|FG000|Overall Study|Ineligibility|3|||
145979775|NCT00774748|526437029|FG000|Overall Study|Lost to Follow-up|3|||
145979776|NCT03412890|526437032|FG000|Overall Study|Adverse Event|5|||
145979777|NCT03412890|526437033|FG001|Overall Study|Adverse Event|5|||
145979778|NCT03412890|526437034|FG002|Overall Study|Adverse Event|9|||
145979779|NCT03412890|526437032|FG000|Overall Study|Protocol deviation|2|||
145979780|NCT03412890|526437033|FG001|Overall Study|Protocol deviation|1|||
145979781|NCT03412890|526437034|FG002|Overall Study|Protocol deviation|2|||
145979782|NCT03412890|526437032|FG000|Overall Study|Lost to Follow-up|7|||
145979783|NCT03412890|526437033|FG001|Overall Study|Lost to Follow-up|10|||
145979784|NCT03412890|526437034|FG002|Overall Study|Lost to Follow-up|10|||
145979785|NCT03412890|526437032|FG000|Overall Study|Withdrawal by Subject|9|||
145979786|NCT03412890|526437033|FG001|Overall Study|Withdrawal by Subject|12|||
145979787|NCT03412890|526437034|FG002|Overall Study|Withdrawal by Subject|11|||
145979788|NCT03412890|526437032|FG000|Overall Study|Lack of Efficacy|2|||
145979789|NCT03412890|526437033|FG001|Overall Study|Lack of Efficacy|7|||
145979790|NCT03412890|526437034|FG002|Overall Study|Lack of Efficacy|5|||
145979791|NCT03412890|526437032|FG000|Overall Study|Other|5|||
145979792|NCT03412890|526437033|FG001|Overall Study|Other|6|||
145979793|NCT03412890|526437034|FG002|Overall Study|Other|5|||
145979794|NCT03412890|526437032|FG000|Overall Study|Participants who did not receive any study drug|0|||
145979795|NCT03412890|526437033|FG001|Overall Study|Participants who did not receive any study drug|1|||
145979796|NCT03412890|526437034|FG002|Overall Study|Participants who did not receive any study drug|0|||
145979797|NCT01529268|526437035|FG000|Overall Study|Lost to Follow-up|9|||
145979798|NCT01529268|526437036|FG001|Overall Study|Lost to Follow-up|3|||
145979799|NCT01529268|526437035|FG000|Overall Study|Moved|3|||
145979800|NCT01529268|526437036|FG001|Overall Study|Moved|0|||
145979801|NCT02315625|526437037|FG000|First Intervention|Disease Progression|1|||
145979802|NCT02315625|526437038|FG001|First Intervention|Disease Progression|0|||
145979803|NCT02315625|526437037|FG000|Second Intervention|Physician Decision|2|||
145979804|NCT02315625|526437038|FG001|Second Intervention|Physician Decision|1|||
145979805|NCT02315625|526437037|FG000|Second Intervention|Study closure|1|||
145979806|NCT02315625|526437038|FG001|Second Intervention|Study closure|0|||
145979807|NCT02315625|526437037|FG000|Second Intervention|Disease Progression|1|||
145979808|NCT02315625|526437038|FG001|Second Intervention|Disease Progression|0|||
145979809|NCT00927082|526437039|FG000|Overall Study|Lost to Follow-up|9|||
145979810|NCT00927082|526437040|FG001|Overall Study|Lost to Follow-up|8|||
145979811|NCT00927082|526437041|FG002|Overall Study|Lost to Follow-up|12|||
145979812|NCT00927082|526437042|FG003|Overall Study|Lost to Follow-up|16|||
145979813|NCT00927082|526437039|FG000|Overall Study|Withdrawal by Subject|3|||
145979814|NCT00927082|526437040|FG001|Overall Study|Withdrawal by Subject|2|||
145979815|NCT00927082|526437041|FG002|Overall Study|Withdrawal by Subject|7|||
145979816|NCT00927082|526437042|FG003|Overall Study|Withdrawal by Subject|2|||
145979817|NCT00927082|526437039|FG000|Overall Study|Death|0|||
145979818|NCT00927082|526437040|FG001|Overall Study|Death|0|||
145979819|NCT00927082|526437041|FG002|Overall Study|Death|1|||
145979820|NCT00927082|526437042|FG003|Overall Study|Death|0|||
145979821|NCT00927082|526437039|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
145979822|NCT00927082|526437040|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
145979823|NCT00927082|526437041|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
145979824|NCT00927082|526437042|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
145979825|NCT02369458|526437046|FG000|Overall Study|Determined to be not eligible|1|||
145979826|NCT02369458|526437047|FG001|Overall Study|Determined to be not eligible|0|||
145979827|NCT03853798|526437050|FG000|Overall Study|Death|0|||
145979828|NCT03853798|526437051|FG001|Overall Study|Death|0|||
145979829|NCT03853798|526437052|FG002|Overall Study|Death|0|||
145979830|NCT03853798|526437053|FG003|Overall Study|Death|0|||
145979831|NCT03853798|526437054|FG004|Overall Study|Death|0|||
145979832|NCT03853798|526437055|FG005|Overall Study|Death|1|||
145979833|NCT03853798|526437056|FG006|Overall Study|Death|0|||
145979834|NCT03853798|526437057|FG007|Overall Study|Death|0|||
145979835|NCT03853798|526437058|FG008|Overall Study|Death|0|||
145979836|NCT03853798|526437050|FG000|Overall Study|Adverse Event|0|||
145979837|NCT03853798|526437051|FG001|Overall Study|Adverse Event|0|||
145979838|NCT03853798|526437052|FG002|Overall Study|Adverse Event|2|||
145979839|NCT03853798|526437053|FG003|Overall Study|Adverse Event|0|||
145979840|NCT03853798|526437054|FG004|Overall Study|Adverse Event|0|||
145979841|NCT03853798|526437055|FG005|Overall Study|Adverse Event|0|||
145979842|NCT03853798|526437056|FG006|Overall Study|Adverse Event|0|||
145979843|NCT03853798|526437057|FG007|Overall Study|Adverse Event|0|||
145979844|NCT03853798|526437058|FG008|Overall Study|Adverse Event|0|||
145979845|NCT03853798|526437050|FG000|Overall Study|Withdrawal by Subject|0|||
145979846|NCT03853798|526437051|FG001|Overall Study|Withdrawal by Subject|1|||
145979847|NCT03853798|526437052|FG002|Overall Study|Withdrawal by Subject|4|||
145979848|NCT03853798|526437053|FG003|Overall Study|Withdrawal by Subject|0|||
145979849|NCT03853798|526437054|FG004|Overall Study|Withdrawal by Subject|0|||
145979850|NCT03853798|526437055|FG005|Overall Study|Withdrawal by Subject|5|||
145979851|NCT03853798|526437056|FG006|Overall Study|Withdrawal by Subject|0|||
145979852|NCT03853798|526437057|FG007|Overall Study|Withdrawal by Subject|0|||
145979853|NCT03853798|526437058|FG008|Overall Study|Withdrawal by Subject|4|||
145979854|NCT03853798|526437050|FG000|Overall Study|Physician Decision|1|||
145979855|NCT03853798|526437051|FG001|Overall Study|Physician Decision|0|||
145979856|NCT03853798|526437052|FG002|Overall Study|Physician Decision|0|||
145979857|NCT03853798|526437053|FG003|Overall Study|Physician Decision|0|||
145979858|NCT03853798|526437054|FG004|Overall Study|Physician Decision|0|||
145979859|NCT03853798|526437055|FG005|Overall Study|Physician Decision|0|||
145979860|NCT03853798|526437056|FG006|Overall Study|Physician Decision|0|||
145979861|NCT03853798|526437057|FG007|Overall Study|Physician Decision|0|||
145979862|NCT03853798|526437058|FG008|Overall Study|Physician Decision|1|||
145979863|NCT03853798|526437050|FG000|Overall Study|Lack of Efficacy|0|||
145979864|NCT03853798|526437051|FG001|Overall Study|Lack of Efficacy|0|||
145979865|NCT03853798|526437052|FG002|Overall Study|Lack of Efficacy|2|||
145979866|NCT03853798|526437053|FG003|Overall Study|Lack of Efficacy|0|||
145979867|NCT03853798|526437054|FG004|Overall Study|Lack of Efficacy|0|||
145979868|NCT03853798|526437055|FG005|Overall Study|Lack of Efficacy|0|||
145979869|NCT03853798|526437056|FG006|Overall Study|Lack of Efficacy|0|||
145979870|NCT03853798|526437057|FG007|Overall Study|Lack of Efficacy|0|||
145979871|NCT03853798|526437058|FG008|Overall Study|Lack of Efficacy|1|||
145979872|NCT03853798|526437050|FG000|Overall Study|Approved Drug Available for Indication|0|||
145979873|NCT03853798|526437051|FG001|Overall Study|Approved Drug Available for Indication|0|||
145979874|NCT03853798|526437052|FG002|Overall Study|Approved Drug Available for Indication|1|||
145979875|NCT03853798|526437053|FG003|Overall Study|Approved Drug Available for Indication|0|||
145938462|NCT00381043|526282194|FG001|Overall Study|wanted more care|1|||
145938463|NCT00381043|526282193|FG000|Overall Study|incarcerated|1|||
145938464|NCT00381043|526282194|FG001|Overall Study|incarcerated|0|||
145938465|NCT01446237|526282195|FG000|Overall Study|Adverse Event|1|||
145938466|NCT01446237|526282195|FG000|Overall Study|Lost to Follow-up|2|||
145938467|NCT01446237|526282195|FG000|Overall Study|Withdrawal by Subject|7|||
145938468|NCT01931956|526282196|FG000|Overall Study|Death|42|||
145938469|NCT01931956|526282197|FG001|Overall Study|Death|7|||
145938470|NCT01931956|526282198|FG002|Overall Study|Death|379|||
145938471|NCT01931956|526282199|FG003|Overall Study|Death|96|||
145938472|NCT01931956|526282196|FG000|Overall Study|Withdrawal by Subject|5|||
145938473|NCT01931956|526282197|FG001|Overall Study|Withdrawal by Subject|0|||
145938474|NCT01931956|526282198|FG002|Overall Study|Withdrawal by Subject|70|||
145938475|NCT01931956|526282199|FG003|Overall Study|Withdrawal by Subject|30|||
145938476|NCT01931956|526282196|FG000|Overall Study|Lost to Follow-up|2|||
145938477|NCT01931956|526282197|FG001|Overall Study|Lost to Follow-up|0|||
145938478|NCT01931956|526282198|FG002|Overall Study|Lost to Follow-up|11|||
145938479|NCT01931956|526282199|FG003|Overall Study|Lost to Follow-up|7|||
145938480|NCT01931956|526282196|FG000|Overall Study|Expected|2|||
145938481|NCT01931956|526282197|FG001|Overall Study|Expected|0|||
145938482|NCT01931956|526282198|FG002|Overall Study|Expected|6|||
145938483|NCT01931956|526282199|FG003|Overall Study|Expected|0|||
145938484|NCT01931956|526282196|FG000|Overall Study|Not due|0|||
145938485|NCT01931956|526282197|FG001|Overall Study|Not due|0|||
145938486|NCT01931956|526282198|FG002|Overall Study|Not due|21|||
145938487|NCT01931956|526282199|FG003|Overall Study|Not due|0|||
145938488|NCT02847494|526282200|FG000|Overall Study|Lost to Follow-up|8|||
145938489|NCT02847494|526282201|FG001|Overall Study|Lost to Follow-up|5|||
145938490|NCT02294175|526282202|FG000|Overall Study|Withdrawal by Subject|1|||
145938491|NCT02294175|526282203|FG001|Overall Study|Withdrawal by Subject|2|||
145938492|NCT02294175|526282202|FG000|Overall Study|pt taking excluded medication|3|||
145938493|NCT02294175|526282203|FG001|Overall Study|pt taking excluded medication|1|||
145938494|NCT02294175|526282202|FG000|Overall Study|Protocol Violation|1|||
145938495|NCT02294175|526282203|FG001|Overall Study|Protocol Violation|0|||
145938496|NCT02294175|526282202|FG000|Overall Study|Lost to Follow-up|0|||
145938497|NCT02294175|526282203|FG001|Overall Study|Lost to Follow-up|1|||
145938498|NCT02294175|526282202|FG000|Overall Study|wound healed|0|||
145938499|NCT02294175|526282203|FG001|Overall Study|wound healed|2|||
145938500|NCT01901653|526282204|FG000|Overall Study|Death|2|||
145938501|NCT01901653|526282205|FG001|Overall Study|Death|1|||
145938502|NCT01901653|526282206|FG002|Overall Study|Death|8|||
145938503|NCT01901653|526282207|FG003|Overall Study|Death|3|||
145938504|NCT01901653|526282208|FG004|Overall Study|Death|2|||
145938505|NCT01901653|526282209|FG005|Overall Study|Death|2|||
145938506|NCT01901653|526282210|FG006|Overall Study|Death|6|||
145938507|NCT01901653|526282211|FG007|Overall Study|Death|9|||
145938508|NCT01901653|526282212|FG008|Overall Study|Death|1|||
145938509|NCT01901653|526282213|FG009|Overall Study|Death|16|||
145938510|NCT01901653|526282214|FG010|Overall Study|Death|2|||
145938511|NCT01901653|526282215|FG011|Overall Study|Death|15|||
145938512|NCT01901653|526282216|FG012|Overall Study|Death|4|||
145938513|NCT01901653|526282204|FG000|Overall Study|Lost to Follow-up|1|||
145938514|NCT01901653|526282205|FG001|Overall Study|Lost to Follow-up|0|||
145938515|NCT01901653|526282206|FG002|Overall Study|Lost to Follow-up|2|||
145938516|NCT01901653|526282207|FG003|Overall Study|Lost to Follow-up|0|||
145938517|NCT01901653|526282208|FG004|Overall Study|Lost to Follow-up|0|||
145938518|NCT01901653|526282209|FG005|Overall Study|Lost to Follow-up|1|||
145938519|NCT01901653|526282210|FG006|Overall Study|Lost to Follow-up|0|||
145938520|NCT01901653|526282211|FG007|Overall Study|Lost to Follow-up|1|||
145938521|NCT01901653|526282212|FG008|Overall Study|Lost to Follow-up|0|||
145938522|NCT01901653|526282213|FG009|Overall Study|Lost to Follow-up|0|||
145938523|NCT01901653|526282214|FG010|Overall Study|Lost to Follow-up|0|||
145938524|NCT01901653|526282215|FG011|Overall Study|Lost to Follow-up|0|||
145938525|NCT01901653|526282216|FG012|Overall Study|Lost to Follow-up|0|||
145938526|NCT01901653|526282204|FG000|Overall Study|Withdrawal by Subject|0|||
145938527|NCT01901653|526282205|FG001|Overall Study|Withdrawal by Subject|0|||
145938528|NCT01901653|526282206|FG002|Overall Study|Withdrawal by Subject|0|||
145938529|NCT01901653|526282207|FG003|Overall Study|Withdrawal by Subject|0|||
145938530|NCT01901653|526282208|FG004|Overall Study|Withdrawal by Subject|0|||
145938531|NCT01901653|526282209|FG005|Overall Study|Withdrawal by Subject|0|||
145938532|NCT01901653|526282210|FG006|Overall Study|Withdrawal by Subject|1|||
145938533|NCT01901653|526282211|FG007|Overall Study|Withdrawal by Subject|0|||
145938534|NCT01901653|526282212|FG008|Overall Study|Withdrawal by Subject|0|||
145938535|NCT01901653|526282213|FG009|Overall Study|Withdrawal by Subject|0|||
145938536|NCT01901653|526282214|FG010|Overall Study|Withdrawal by Subject|0|||
145938537|NCT01901653|526282215|FG011|Overall Study|Withdrawal by Subject|0|||
145938538|NCT01901653|526282216|FG012|Overall Study|Withdrawal by Subject|0|||
145938539|NCT01901653|526282204|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
145938540|NCT01901653|526282205|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
145938541|NCT01901653|526282206|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
146245448|NCT01328756|527412223|FG000|Overall Study|Adverse Event|39|||
145979876|NCT03853798|526437054|FG004|Overall Study|Approved Drug Available for Indication|0|||
145979877|NCT03853798|526437055|FG005|Overall Study|Approved Drug Available for Indication|1|||
145979878|NCT03853798|526437056|FG006|Overall Study|Approved Drug Available for Indication|0|||
145979879|NCT03853798|526437057|FG007|Overall Study|Approved Drug Available for Indication|0|||
145979880|NCT03853798|526437058|FG008|Overall Study|Approved Drug Available for Indication|0|||
145979881|NCT03853798|526437050|FG000|Overall Study|Other un-specified|0|||
145979882|NCT03853798|526437051|FG001|Overall Study|Other un-specified|0|||
145979883|NCT03853798|526437052|FG002|Overall Study|Other un-specified|2|||
145979884|NCT03853798|526437053|FG003|Overall Study|Other un-specified|0|||
145979885|NCT03853798|526437054|FG004|Overall Study|Other un-specified|0|||
145979886|NCT03853798|526437055|FG005|Overall Study|Other un-specified|1|||
145979887|NCT03853798|526437056|FG006|Overall Study|Other un-specified|0|||
145979888|NCT03853798|526437057|FG007|Overall Study|Other un-specified|0|||
145979889|NCT03853798|526437058|FG008|Overall Study|Other un-specified|0|||
145979890|NCT02743494|526437059|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
145979891|NCT02743494|526437060|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
145979892|NCT02743494|526437059|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
145979893|NCT02743494|526437060|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
145979894|NCT02743494|526437059|FG000|Treatment Period|Disease recurrence|152|||
145979895|NCT02743494|526437060|FG001|Treatment Period|Disease recurrence|115|||
145979896|NCT02743494|526437059|FG000|Treatment Period|Study drug toxicity|56|||
145979897|NCT02743494|526437060|FG001|Treatment Period|Study drug toxicity|8|||
145979898|NCT02743494|526437059|FG000|Treatment Period|Death|1|||
145979899|NCT02743494|526437060|FG001|Treatment Period|Death|1|||
145979900|NCT02743494|526437059|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
145979901|NCT02743494|526437060|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
145979902|NCT02743494|526437059|FG000|Treatment Period|Participant request to discontinue treatment|31|||
145979903|NCT02743494|526437060|FG001|Treatment Period|Participant request to discontinue treatment|5|||
145979904|NCT02743494|526437059|FG000|Treatment Period|Participant withdrew consent|11|||
145979905|NCT02743494|526437060|FG001|Treatment Period|Participant withdrew consent|4|||
145979906|NCT02743494|526437059|FG000|Treatment Period|Lost to Follow-up|0|||
145979907|NCT02743494|526437060|FG001|Treatment Period|Lost to Follow-up|1|||
145979908|NCT02743494|526437059|FG000|Treatment Period|Poor/Non-compliance|2|||
145979909|NCT02743494|526437060|FG001|Treatment Period|Poor/Non-compliance|0|||
145979910|NCT02743494|526437059|FG000|Treatment Period|Other reasons|4|||
145979911|NCT02743494|526437060|FG001|Treatment Period|Other reasons|1|||
145979912|NCT04439175|526438515|FG000|Overall Study|Never started treatment|4|||
145979913|NCT04439175|526438515|FG000|Overall Study|Ineligible|5|||
145979914|NCT04439175|526438515|FG000|Overall Study|Adverse Event|6|||
145979915|NCT04439175|526438515|FG000|Overall Study|Death|4|||
145979916|NCT04439175|526438515|FG000|Overall Study|Disease progression|44|||
145979917|NCT04439175|526438515|FG000|Overall Study|Withdrawal by Subject|4|||
145979918|NCT04439175|526438515|FG000|Overall Study|Alternative Therapy|1|||
145979919|NCT04439175|526438515|FG000|Overall Study|Other|2|||
145979920|NCT01847209|526438516|FG000|Overall Study|Withdrawal by Subject|1|||
145979921|NCT01847209|526438516|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
145979922|NCT03520569|526438520|FG000|Overall Study|Withdrawal by Subject|1|||
145979923|NCT02965716|526438522|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145979924|NCT02965716|526438523|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
145979925|NCT02965716|526438522|FG000|Overall Study|Progression/Relapse|8|||
145979926|NCT02965716|526438523|FG001|Overall Study|Progression/Relapse|16|||
145979927|NCT02965716|526438522|FG000|Overall Study|Death|1|||
145979928|NCT02965716|526438523|FG001|Overall Study|Death|0|||
145979929|NCT02965716|526438522|FG000|Overall Study|Not Protocol Specified|1|||
145979930|NCT02965716|526438523|FG001|Overall Study|Not Protocol Specified|3|||
145979931|NCT05558410|526438524|FG000|Overall Study|Adverse Event|1|||
145979932|NCT05558410|526438525|FG001|Overall Study|Adverse Event|2|||
145979933|NCT05558410|526438526|FG002|Overall Study|Adverse Event|0|||
145979934|NCT05558410|526438524|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
145979935|NCT05558410|526438525|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
145979936|NCT05558410|526438526|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
145979937|NCT05558410|526438524|FG000|Overall Study|Lost to Follow-up|10|||
145979938|NCT05558410|526438525|FG001|Overall Study|Lost to Follow-up|17|||
145979939|NCT05558410|526438526|FG002|Overall Study|Lost to Follow-up|19|||
145979940|NCT05558410|526438524|FG000|Overall Study|Death|1|||
145979941|NCT05558410|526438525|FG001|Overall Study|Death|0|||
145979942|NCT05558410|526438526|FG002|Overall Study|Death|0|||
145979943|NCT05558410|526438524|FG000|Overall Study|Other non-compliance|0|||
145979944|NCT05558410|526438525|FG001|Overall Study|Other non-compliance|1|||
145979945|NCT05558410|526438526|FG002|Overall Study|Other non-compliance|2|||
145979946|NCT05558410|526438524|FG000|Overall Study|Sponsor Decision|1|||
145979947|NCT05558410|526438525|FG001|Overall Study|Sponsor Decision|0|||
145979948|NCT05558410|526438526|FG002|Overall Study|Sponsor Decision|0|||
145979949|NCT05558410|526438524|FG000|Overall Study|Other|1|||
145979950|NCT05558410|526438525|FG001|Overall Study|Other|0|||
145979951|NCT05558410|526438526|FG002|Overall Study|Other|1|||
145979952|NCT02265744|526438527|FG000|Overall Study|Poor/Non-compliance|1|||
145979953|NCT02265744|526438528|FG001|Overall Study|Poor/Non-compliance|1|||
146245449|NCT01328756|527412223|FG000|Overall Study|Lack of Efficacy|5|||
146245450|NCT01328756|527412223|FG000|Overall Study|Withdrawal by Subject|41|||
146245451|NCT01328756|527412223|FG000|Overall Study|Lost to Follow-up|5|||
146245452|NCT01328756|527412223|FG000|Overall Study|Other|29|||
146245453|NCT01262456|527412224|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
146245454|NCT01262456|527412225|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
145979954|NCT02265744|526438529|FG002|Overall Study|Poor/Non-compliance|0|||
145979955|NCT02265744|526438530|FG003|Overall Study|Poor/Non-compliance|0|||
145979956|NCT02265744|526438531|FG004|Overall Study|Poor/Non-compliance|2|||
145979957|NCT02265744|526438527|FG000|Overall Study|Lost to Follow-up|0|||
145979958|NCT02265744|526438528|FG001|Overall Study|Lost to Follow-up|0|||
145979959|NCT02265744|526438529|FG002|Overall Study|Lost to Follow-up|0|||
145979960|NCT02265744|526438530|FG003|Overall Study|Lost to Follow-up|1|||
145979961|NCT02265744|526438531|FG004|Overall Study|Lost to Follow-up|0|||
145979962|NCT02265744|526438527|FG000|Overall Study|Death|0|||
145979963|NCT02265744|526438528|FG001|Overall Study|Death|0|||
145979964|NCT02265744|526438529|FG002|Overall Study|Death|0|||
145979965|NCT02265744|526438530|FG003|Overall Study|Death|2|||
145979966|NCT02265744|526438531|FG004|Overall Study|Death|0|||
145979967|NCT02265744|526438527|FG000|Overall Study|Withdrawal by Subject|2|||
145979968|NCT02265744|526438528|FG001|Overall Study|Withdrawal by Subject|0|||
145979969|NCT02265744|526438529|FG002|Overall Study|Withdrawal by Subject|0|||
145979970|NCT02265744|526438530|FG003|Overall Study|Withdrawal by Subject|2|||
145979971|NCT02265744|526438531|FG004|Overall Study|Withdrawal by Subject|0|||
145979972|NCT02265744|526438527|FG000|Overall Study|Participant request to discontinue|2|||
145979973|NCT02265744|526438528|FG001|Overall Study|Participant request to discontinue|2|||
145979974|NCT02265744|526438529|FG002|Overall Study|Participant request to discontinue|2|||
145979975|NCT02265744|526438530|FG003|Overall Study|Participant request to discontinue|0|||
145979976|NCT02265744|526438531|FG004|Overall Study|Participant request to discontinue|0|||
145979977|NCT02265744|526438527|FG000|Overall Study|Adverse Event|8|||
145979978|NCT02265744|526438528|FG001|Overall Study|Adverse Event|4|||
145979979|NCT02265744|526438529|FG002|Overall Study|Adverse Event|9|||
145979980|NCT02265744|526438530|FG003|Overall Study|Adverse Event|8|||
145979981|NCT02265744|526438531|FG004|Overall Study|Adverse Event|2|||
145979982|NCT02265744|526438527|FG000|Overall Study|Lack of Efficacy|2|||
145979983|NCT02265744|526438528|FG001|Overall Study|Lack of Efficacy|4|||
145979984|NCT02265744|526438529|FG002|Overall Study|Lack of Efficacy|3|||
145979985|NCT02265744|526438530|FG003|Overall Study|Lack of Efficacy|4|||
145979986|NCT02265744|526438531|FG004|Overall Study|Lack of Efficacy|5|||
145979987|NCT02265744|526438527|FG000|Overall Study|Reason not provided by Investigator|1|||
145979988|NCT02265744|526438528|FG001|Overall Study|Reason not provided by Investigator|0|||
145979989|NCT02265744|526438529|FG002|Overall Study|Reason not provided by Investigator|0|||
145979990|NCT02265744|526438530|FG003|Overall Study|Reason not provided by Investigator|2|||
145979991|NCT02265744|526438531|FG004|Overall Study|Reason not provided by Investigator|0|||
145979992|NCT02265744|526438527|FG000|Overall Study|Administrative reason by sponsor|3|||
145979993|NCT02265744|526438528|FG001|Overall Study|Administrative reason by sponsor|2|||
145979994|NCT02265744|526438529|FG002|Overall Study|Administrative reason by sponsor|2|||
145979995|NCT02265744|526438530|FG003|Overall Study|Administrative reason by sponsor|3|||
145979996|NCT02265744|526438531|FG004|Overall Study|Administrative reason by sponsor|3|||
145979997|NCT02265744|526438527|FG000|Overall Study|Subject no longer meets study criteria|0|||
145979998|NCT02265744|526438528|FG001|Overall Study|Subject no longer meets study criteria|0|||
145979999|NCT02265744|526438529|FG002|Overall Study|Subject no longer meets study criteria|0|||
145980000|NCT02265744|526438530|FG003|Overall Study|Subject no longer meets study criteria|0|||
145980001|NCT02265744|526438531|FG004|Overall Study|Subject no longer meets study criteria|1|||
145980002|NCT02265744|526438527|FG000|Overall Study|Pregnancy|1|||
146245455|NCT01262456|527412226|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
146245456|NCT01262456|527412224|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
146245457|NCT01262456|527412225|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
146245458|NCT01262456|527412226|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
146245459|NCT01262456|527412224|FG000|3-Month Double-Blind Period|Adverse Event|6|||
146245460|NCT01262456|527412225|FG001|3-Month Double-Blind Period|Adverse Event|4|||
146245461|NCT01262456|527412226|FG002|3-Month Double-Blind Period|Adverse Event|8|||
146245462|NCT01262456|527412224|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
145980003|NCT02265744|526438528|FG001|Overall Study|Pregnancy|2|||
145980004|NCT02265744|526438529|FG002|Overall Study|Pregnancy|1|||
145980005|NCT02265744|526438530|FG003|Overall Study|Pregnancy|1|||
145980006|NCT02265744|526438531|FG004|Overall Study|Pregnancy|0|||
145980007|NCT00574951|526438532|FG000|Overall Study|Ineligible - improper prior treatment|1|||
145980008|NCT05278065|526438533|FG000|Overall Study|Withdrawal by Subject|1|||
145980009|NCT05278065|526438534|FG001|Overall Study|Withdrawal by Subject|0|||
145980010|NCT02029443|526438535|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
145980011|NCT02029443|526438536|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
145980012|NCT02029443|526438537|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
145980013|NCT02029443|526438538|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
145980014|NCT02029443|526438539|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
145980015|NCT02029443|526438535|FG000|Overall Study|Death|13|||
146245463|NCT01262456|527412225|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
146245464|NCT01262456|527412226|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
146245465|NCT01262456|527412224|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
146245466|NCT01262456|527412225|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
145980016|NCT02029443|526438536|FG001|Overall Study|Death|2|||
145980017|NCT02029443|526438537|FG002|Overall Study|Death|2|||
145980018|NCT02029443|526438538|FG003|Overall Study|Death|11|||
145980019|NCT02029443|526438539|FG004|Overall Study|Death|2|||
145980020|NCT02029443|526438535|FG000|Overall Study|Lost to Follow-up|1|||
145980021|NCT02029443|526438536|FG001|Overall Study|Lost to Follow-up|0|||
145980022|NCT02029443|526438537|FG002|Overall Study|Lost to Follow-up|1|||
145980023|NCT02029443|526438538|FG003|Overall Study|Lost to Follow-up|1|||
145980024|NCT02029443|526438539|FG004|Overall Study|Lost to Follow-up|0|||
145980025|NCT02029443|526438535|FG000|Overall Study|Started other anti-cancer therapy|17|||
145980026|NCT02029443|526438536|FG001|Overall Study|Started other anti-cancer therapy|4|||
145980027|NCT02029443|526438537|FG002|Overall Study|Started other anti-cancer therapy|7|||
145980028|NCT02029443|526438538|FG003|Overall Study|Started other anti-cancer therapy|9|||
145980029|NCT02029443|526438539|FG004|Overall Study|Started other anti-cancer therapy|3|||
145980030|NCT02029443|526438535|FG000|Overall Study|Withdrawal by Subject|3|||
145980031|NCT02029443|526438536|FG001|Overall Study|Withdrawal by Subject|1|||
145980032|NCT02029443|526438537|FG002|Overall Study|Withdrawal by Subject|1|||
145980033|NCT02029443|526438538|FG003|Overall Study|Withdrawal by Subject|1|||
145980034|NCT02029443|526438539|FG004|Overall Study|Withdrawal by Subject|0|||
145980035|NCT02029443|526438535|FG000|Overall Study|Other|6|||
145980036|NCT02029443|526438536|FG001|Overall Study|Other|6|||
145980037|NCT02029443|526438537|FG002|Overall Study|Other|4|||
145980038|NCT02029443|526438538|FG003|Overall Study|Other|2|||
145980039|NCT02029443|526438539|FG004|Overall Study|Other|0|||
145980040|NCT02969018|526438546|FG000|Overall Study|Adverse Event|2|||
145980041|NCT02969018|526438547|FG001|Overall Study|Adverse Event|4|||
145980042|NCT02969018|526438548|FG002|Overall Study|Adverse Event|1|||
145980043|NCT02969018|526438549|FG003|Overall Study|Adverse Event|2|||
145980044|NCT02969018|526438550|FG004|Overall Study|Adverse Event|0|||
145980045|NCT02969018|526438551|FG005|Overall Study|Adverse Event|1|||
145980046|NCT02969018|526438552|FG006|Overall Study|Adverse Event|2|||
145980047|NCT02969018|526438553|FG007|Overall Study|Adverse Event|0|||
145980048|NCT02969018|526438546|FG000|Overall Study|Lack of Efficacy|0|||
145980049|NCT02969018|526438547|FG001|Overall Study|Lack of Efficacy|1|||
145980050|NCT02969018|526438548|FG002|Overall Study|Lack of Efficacy|0|||
145980051|NCT02969018|526438549|FG003|Overall Study|Lack of Efficacy|0|||
145980052|NCT02969018|526438550|FG004|Overall Study|Lack of Efficacy|1|||
145980053|NCT02969018|526438551|FG005|Overall Study|Lack of Efficacy|1|||
145980054|NCT02969018|526438552|FG006|Overall Study|Lack of Efficacy|1|||
145980055|NCT02969018|526438553|FG007|Overall Study|Lack of Efficacy|1|||
145980056|NCT02969018|526438546|FG000|Overall Study|Lost to Follow-up|1|||
145980057|NCT02969018|526438547|FG001|Overall Study|Lost to Follow-up|2|||
145980058|NCT02969018|526438548|FG002|Overall Study|Lost to Follow-up|2|||
145980059|NCT02969018|526438549|FG003|Overall Study|Lost to Follow-up|0|||
145980060|NCT02969018|526438550|FG004|Overall Study|Lost to Follow-up|1|||
145980061|NCT02969018|526438551|FG005|Overall Study|Lost to Follow-up|1|||
145980062|NCT02969018|526438552|FG006|Overall Study|Lost to Follow-up|0|||
145980063|NCT02969018|526438553|FG007|Overall Study|Lost to Follow-up|1|||
145980064|NCT02969018|526438546|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146245467|NCT01262456|527412226|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
145980065|NCT02969018|526438547|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145980066|NCT02969018|526438548|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
145980067|NCT02969018|526438549|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145980068|NCT02969018|526438550|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
145980069|NCT02969018|526438551|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146245468|NCT01262456|527412224|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
145980070|NCT02969018|526438552|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
145980071|NCT02969018|526438553|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
145980072|NCT02969018|526438546|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145980073|NCT02969018|526438547|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145980074|NCT02969018|526438548|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145980075|NCT02969018|526438549|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145980076|NCT02969018|526438550|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145980077|NCT02969018|526438551|FG005|Overall Study|Non-Compliance With Study Drug|0|||
145980078|NCT02969018|526438552|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145980079|NCT02969018|526438553|FG007|Overall Study|Non-Compliance With Study Drug|0|||
145980080|NCT02969018|526438546|FG000|Overall Study|Other|0|||
145980081|NCT02969018|526438547|FG001|Overall Study|Other|0|||
145980082|NCT02969018|526438548|FG002|Overall Study|Other|0|||
146091240|NCT04650854|526854931|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
146091241|NCT04650854|526854929|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
146245469|NCT01262456|527412225|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
146245470|NCT01262456|527412226|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
146245471|NCT01262456|527412224|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
146245472|NCT01262456|527412225|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
146245473|NCT01262456|527412226|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
146245474|NCT01262456|527412224|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
146245475|NCT01262456|527412225|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
146245476|NCT01262456|527412226|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
146245477|NCT01262456|527412224|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
146245478|NCT01262456|527412225|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
146245479|NCT01262456|527412226|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
146245480|NCT02326220|527412231|FG000|Double-blind Treatment Period|Adverse Event|1|||
145938542|NCT01901653|526282207|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
145938543|NCT01901653|526282208|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
145938544|NCT01901653|526282209|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
145938545|NCT01901653|526282210|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
145938546|NCT01901653|526282211|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
145938547|NCT01901653|526282212|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
145938548|NCT01901653|526282213|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
145938549|NCT01901653|526282214|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
145938550|NCT01901653|526282215|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
145938551|NCT01901653|526282216|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
145938552|NCT02841280|526282219|FG000|Overall Study|Adverse Event|2|||
145938553|NCT02841280|526282220|FG001|Overall Study|Adverse Event|1|||
145938554|NCT02841280|526282219|FG000|Overall Study|Death|1|||
145938555|NCT02841280|526282220|FG001|Overall Study|Death|0|||
145938556|NCT02841280|526282219|FG000|Overall Study|Lost to Follow-up|2|||
145938557|NCT02841280|526282220|FG001|Overall Study|Lost to Follow-up|2|||
145938558|NCT02841280|526282219|FG000|Overall Study|Withdrawal by Subject|7|||
145938559|NCT02841280|526282220|FG001|Overall Study|Withdrawal by Subject|3|||
145938560|NCT02841280|526282219|FG000|Overall Study|Stop Point: BP above threshold|2|||
145938561|NCT02841280|526282220|FG001|Overall Study|Stop Point: BP above threshold|0|||
145938562|NCT04553471|526282221|FG000|Overall Study|Did not start treatment on protocol|3|||
145938563|NCT04553471|526282221|FG000|Overall Study|Death|1|||
145938564|NCT01340027|526282223|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
145938565|NCT01340027|526282224|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
145938566|NCT01340027|526282225|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
145938567|NCT01340027|526282226|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
145938568|NCT01340027|526282227|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
145938569|NCT01340027|526282228|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
145938570|NCT01340027|526282229|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
145938571|NCT01340027|526282230|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
145938572|NCT01340027|526282231|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
145938573|NCT01340027|526282232|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
145938574|NCT01340027|526282233|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
145938575|NCT01340027|526282234|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
145938576|NCT01340027|526282223|FG000|Overall Study|Adverse Event|0|||
145938577|NCT01340027|526282224|FG001|Overall Study|Adverse Event|1|||
145938578|NCT01340027|526282225|FG002|Overall Study|Adverse Event|2|||
145938579|NCT01340027|526282226|FG003|Overall Study|Adverse Event|0|||
145938580|NCT01340027|526282227|FG004|Overall Study|Adverse Event|1|||
145938581|NCT01340027|526282228|FG005|Overall Study|Adverse Event|2|||
145938582|NCT01340027|526282229|FG006|Overall Study|Adverse Event|2|||
145938583|NCT01340027|526282230|FG007|Overall Study|Adverse Event|1|||
145938584|NCT01340027|526282231|FG008|Overall Study|Adverse Event|4|||
145938585|NCT01340027|526282232|FG009|Overall Study|Adverse Event|1|||
145938586|NCT01340027|526282233|FG010|Overall Study|Adverse Event|1|||
145938587|NCT01340027|526282234|FG011|Overall Study|Adverse Event|3|||
145938588|NCT01340027|526282223|FG000|Overall Study|Lack of Efficacy|0|||
145938589|NCT01340027|526282224|FG001|Overall Study|Lack of Efficacy|0|||
145938590|NCT01340027|526282225|FG002|Overall Study|Lack of Efficacy|0|||
145938591|NCT01340027|526282226|FG003|Overall Study|Lack of Efficacy|0|||
145938592|NCT01340027|526282227|FG004|Overall Study|Lack of Efficacy|0|||
145938593|NCT01340027|526282228|FG005|Overall Study|Lack of Efficacy|0|||
145938594|NCT01340027|526282229|FG006|Overall Study|Lack of Efficacy|1|||
145938595|NCT01340027|526282230|FG007|Overall Study|Lack of Efficacy|1|||
145938596|NCT01340027|526282231|FG008|Overall Study|Lack of Efficacy|1|||
145938597|NCT01340027|526282232|FG009|Overall Study|Lack of Efficacy|0|||
145938598|NCT01340027|526282233|FG010|Overall Study|Lack of Efficacy|0|||
145938599|NCT01340027|526282234|FG011|Overall Study|Lack of Efficacy|0|||
145938600|NCT01340027|526282223|FG000|Overall Study|Lost to Follow-up|0|||
145980083|NCT02969018|526438549|FG003|Overall Study|Other|1|||
145980084|NCT02969018|526438550|FG004|Overall Study|Other|0|||
145980085|NCT02969018|526438551|FG005|Overall Study|Other|0|||
145980086|NCT02969018|526438552|FG006|Overall Study|Other|0|||
145980087|NCT02969018|526438553|FG007|Overall Study|Other|2|||
145980088|NCT02969018|526438546|FG000|Overall Study|Pregnancy|0|||
145980089|NCT02969018|526438547|FG001|Overall Study|Pregnancy|0|||
145980090|NCT02969018|526438548|FG002|Overall Study|Pregnancy|0|||
145980091|NCT02969018|526438549|FG003|Overall Study|Pregnancy|0|||
145980092|NCT02969018|526438550|FG004|Overall Study|Pregnancy|0|||
145980093|NCT02969018|526438551|FG005|Overall Study|Pregnancy|1|||
145980094|NCT02969018|526438552|FG006|Overall Study|Pregnancy|0|||
145980095|NCT02969018|526438553|FG007|Overall Study|Pregnancy|0|||
145980096|NCT02969018|526438546|FG000|Overall Study|Protocol Violation|0|||
145980097|NCT02969018|526438547|FG001|Overall Study|Protocol Violation|0|||
145980098|NCT02969018|526438548|FG002|Overall Study|Protocol Violation|1|||
145980099|NCT02969018|526438549|FG003|Overall Study|Protocol Violation|1|||
145980100|NCT02969018|526438550|FG004|Overall Study|Protocol Violation|0|||
145980101|NCT02969018|526438551|FG005|Overall Study|Protocol Violation|0|||
145980102|NCT02969018|526438552|FG006|Overall Study|Protocol Violation|0|||
145980103|NCT02969018|526438553|FG007|Overall Study|Protocol Violation|0|||
145980104|NCT02969018|526438546|FG000|Overall Study|Withdrawal by Subject|0|||
145980105|NCT02969018|526438547|FG001|Overall Study|Withdrawal by Subject|1|||
145980106|NCT02969018|526438548|FG002|Overall Study|Withdrawal by Subject|2|||
145980107|NCT02969018|526438549|FG003|Overall Study|Withdrawal by Subject|1|||
145980108|NCT02969018|526438550|FG004|Overall Study|Withdrawal by Subject|0|||
145980109|NCT02969018|526438551|FG005|Overall Study|Withdrawal by Subject|4|||
145980110|NCT02969018|526438552|FG006|Overall Study|Withdrawal by Subject|4|||
145980111|NCT02969018|526438553|FG007|Overall Study|Withdrawal by Subject|3|||
145980112|NCT02691663|526438556|FG000|Overall Study|Screen failure after baseline|2|||
145980113|NCT02691663|526438557|FG001|Overall Study|Screen failure after baseline|2|||
145980114|NCT02691663|526438556|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
145980115|NCT02691663|526438557|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
145980116|NCT02691663|526438556|FG000|Overall Study|Withdrawn after Follow up 2|1|||
145980117|NCT02691663|526438557|FG001|Overall Study|Withdrawn after Follow up 2|1|||
145980118|NCT02691663|526438556|FG000|Overall Study|Lost to Follow-up|3|||
145980119|NCT02691663|526438557|FG001|Overall Study|Lost to Follow-up|2|||
145980120|NCT04425018|526438560|FG000|Overall Study|Withdrawal by Subject|1|||
145980121|NCT04425018|526438561|FG001|Overall Study|Withdrawal by Subject|2|||
145980122|NCT01944774|526438562|FG000|Overall Study|Withdrawal by Subject|2|||
145980123|NCT01944774|526438563|FG001|Overall Study|Withdrawal by Subject|3|||
145980124|NCT01944774|526438564|FG002|Overall Study|Withdrawal by Subject|3|||
145980125|NCT01944774|526438562|FG000|Overall Study|Adverse Event|3|||
145980126|NCT01944774|526438563|FG001|Overall Study|Adverse Event|2|||
145980127|NCT01944774|526438564|FG002|Overall Study|Adverse Event|3|||
145980128|NCT01944774|526438562|FG000|Overall Study|Lack of Efficacy|1|||
145980129|NCT01944774|526438563|FG001|Overall Study|Lack of Efficacy|2|||
145980130|NCT01944774|526438564|FG002|Overall Study|Lack of Efficacy|2|||
145980131|NCT01944774|526438562|FG000|Overall Study|Lost to Follow-up|0|||
145980132|NCT01944774|526438563|FG001|Overall Study|Lost to Follow-up|1|||
145980133|NCT01944774|526438564|FG002|Overall Study|Lost to Follow-up|0|||
145980134|NCT00387127|526438567|FG000|Overall Study|Lost to Follow-up|0|||
145980135|NCT00387127|526438568|FG001|Overall Study|Lost to Follow-up|4|||
145980136|NCT00387127|526438567|FG000|Overall Study|Death|16|||
145980137|NCT00387127|526438568|FG001|Overall Study|Death|16|||
145980138|NCT00387127|526438567|FG000|Overall Study|Physician Decision|0|||
145980139|NCT00387127|526438568|FG001|Overall Study|Physician Decision|1|||
145980140|NCT00387127|526438567|FG000|Overall Study|Withdrawal by Subject|3|||
145980141|NCT00387127|526438568|FG001|Overall Study|Withdrawal by Subject|2|||
145980142|NCT00387127|526438567|FG000|Overall Study|Required by Protocol Amendment #4|12|||
146091242|NCT04650854|526854930|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
146091243|NCT04650854|526854931|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
146091244|NCT04650854|526854929|FG000|Overall Study|Use of Rescue Medication|0|||
146091245|NCT04650854|526854930|FG001|Overall Study|Use of Rescue Medication|0|||
145980143|NCT00387127|526438568|FG001|Overall Study|Required by Protocol Amendment #4|10|||
145980144|NCT00387127|526438567|FG000|Overall Study|Serious Adverse Event|1|||
145980145|NCT00387127|526438568|FG001|Overall Study|Serious Adverse Event|1|||
145980146|NCT00387127|526438567|FG000|Overall Study|Sponsor Unblinded|1|||
145980147|NCT00387127|526438568|FG001|Overall Study|Sponsor Unblinded|0|||
145980148|NCT05101317|526438569|FG000|Week1-13|Adverse Event|0|||
145980149|NCT05101317|526438570|FG001|Week1-13|Adverse Event|1|||
145980150|NCT05101317|526438571|FG002|Week1-13|Adverse Event|0|||
145980151|NCT05101317|526438572|FG003|Week1-13|Adverse Event|0|||
145980152|NCT05101317|526438569|FG000|Week1-13|Withdrawal by Subject|0|||
145980153|NCT05101317|526438570|FG001|Week1-13|Withdrawal by Subject|2|||
145980154|NCT05101317|526438571|FG002|Week1-13|Withdrawal by Subject|0|||
145980155|NCT05101317|526438572|FG003|Week1-13|Withdrawal by Subject|0|||
145980156|NCT05101317|526438569|FG000|Week1-13|Early Withdrawl|0|||
145980157|NCT05101317|526438570|FG001|Week1-13|Early Withdrawl|0|||
145980158|NCT05101317|526438571|FG002|Week1-13|Early Withdrawl|0|||
145980159|NCT05101317|526438572|FG003|Week1-13|Early Withdrawl|1|||
145980160|NCT05101317|526438569|FG000|Week 13-25|Lost to Follow-up|0|||
145980161|NCT05101317|526438570|FG001|Week 13-25|Lost to Follow-up|0|||
145980162|NCT05101317|526438571|FG002|Week 13-25|Lost to Follow-up|1|||
145980163|NCT05101317|526438572|FG003|Week 13-25|Lost to Follow-up|0|||
145980164|NCT05101317|526438569|FG000|Week 13-25|Withdrawal by Subject|1|||
145980165|NCT05101317|526438570|FG001|Week 13-25|Withdrawal by Subject|1|||
145980166|NCT05101317|526438571|FG002|Week 13-25|Withdrawal by Subject|0|||
145980167|NCT05101317|526438572|FG003|Week 13-25|Withdrawal by Subject|0|||
145980168|NCT05101317|526438569|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
145980169|NCT05101317|526438570|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
145980170|NCT05101317|526438571|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
145980171|NCT05101317|526438572|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
145980172|NCT00812097|526438573|FG000|Overall Study|Death|3|||
145980173|NCT00812097|526438574|FG001|Overall Study|Death|10|||
145980174|NCT00812097|526438575|FG002|Overall Study|Death|3|||
145980175|NCT00812097|526438576|FG003|Overall Study|Death|3|||
145980176|NCT00812097|526438573|FG000|Overall Study|Withdrawal by Subject|14|||
145980177|NCT00812097|526438574|FG001|Overall Study|Withdrawal by Subject|12|||
145980178|NCT00812097|526438575|FG002|Overall Study|Withdrawal by Subject|8|||
145980179|NCT00812097|526438576|FG003|Overall Study|Withdrawal by Subject|2|||
145980180|NCT00812097|526438573|FG000|Overall Study|Lost to Follow-up|90|||
145980181|NCT00812097|526438574|FG001|Overall Study|Lost to Follow-up|14|||
145980182|NCT00812097|526438575|FG002|Overall Study|Lost to Follow-up|17|||
145980183|NCT00812097|526438576|FG003|Overall Study|Lost to Follow-up|5|||
145980184|NCT00812097|526438573|FG000|Overall Study|Explantation of study device(s)|27|||
145980185|NCT00812097|526438574|FG001|Overall Study|Explantation of study device(s)|29|||
145980186|NCT00812097|526438575|FG002|Overall Study|Explantation of study device(s)|14|||
145980187|NCT00812097|526438576|FG003|Overall Study|Explantation of study device(s)|20|||
145980188|NCT00812097|526438573|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
145980189|NCT00812097|526438574|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
145980190|NCT00812097|526438575|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
145980191|NCT00812097|526438576|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
145980192|NCT02513563|526438579|FG000|Overall Study|Death|4|||
145980193|NCT02513563|526438579|FG000|Overall Study|Withdrawal by Subject|4|||
145980194|NCT02513563|526438579|FG000|Overall Study|Physician Decision|1|||
145980195|NCT02227199|526438582|FG000|Overall Study|Physician Decision|0|||
145980196|NCT02227199|526438583|FG001|Overall Study|Physician Decision|0|||
145980197|NCT02227199|526438584|FG002|Overall Study|Physician Decision|1|||
145980198|NCT02227199|526438582|FG000|Overall Study|Adverse Event|0|||
145980199|NCT02227199|526438583|FG001|Overall Study|Adverse Event|0|||
145980200|NCT02227199|526438584|FG002|Overall Study|Adverse Event|3|||
145980201|NCT03998462|526438585|FG000|Overall Study|Withdrawal by Subject|10|||
145980202|NCT03998462|526438586|FG001|Overall Study|Withdrawal by Subject|4|||
146297836|NCT02038920|527606027|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
145980203|NCT03998462|526438585|FG000|Overall Study|Lost to Follow-up|1|||
145980204|NCT03998462|526438586|FG001|Overall Study|Lost to Follow-up|0|||
145980205|NCT03998462|526438585|FG000|Overall Study|Technical Difficulties|1|||
145980206|NCT03998462|526438586|FG001|Overall Study|Technical Difficulties|2|||
145980207|NCT03369223|526438587|FG000|Overall Study|Lost to Follow-up|0|||
145980208|NCT03369223|526438588|FG001|Overall Study|Lost to Follow-up|0|||
145980209|NCT03369223|526438589|FG002|Overall Study|Lost to Follow-up|0|||
145980210|NCT03369223|526438590|FG003|Overall Study|Lost to Follow-up|0|||
145980211|NCT03369223|526438591|FG004|Overall Study|Lost to Follow-up|0|||
145980212|NCT03369223|526438592|FG005|Overall Study|Lost to Follow-up|0|||
145980213|NCT03369223|526438593|FG006|Overall Study|Lost to Follow-up|0|||
145980214|NCT03369223|526438594|FG007|Overall Study|Lost to Follow-up|0|||
145980215|NCT03369223|526438595|FG008|Overall Study|Lost to Follow-up|0|||
145980216|NCT03369223|526438596|FG009|Overall Study|Lost to Follow-up|0|||
145980217|NCT03369223|526438597|FG010|Overall Study|Lost to Follow-up|0|||
145980218|NCT03369223|526438598|FG011|Overall Study|Lost to Follow-up|0|||
146297837|NCT02038920|527606028|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
146297838|NCT02038920|527606029|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145980219|NCT03369223|526438599|FG012|Overall Study|Lost to Follow-up|0|||
145980220|NCT03369223|526438600|FG013|Overall Study|Lost to Follow-up|0|||
145980221|NCT03369223|526438601|FG014|Overall Study|Lost to Follow-up|0|||
145980222|NCT03369223|526438602|FG015|Overall Study|Lost to Follow-up|0|||
145980223|NCT03369223|526438603|FG016|Overall Study|Lost to Follow-up|0|||
145980224|NCT03369223|526438604|FG017|Overall Study|Lost to Follow-up|0|||
145980225|NCT03369223|526438605|FG018|Overall Study|Lost to Follow-up|2|||
145980226|NCT03369223|526438606|FG019|Overall Study|Lost to Follow-up|1|||
145980227|NCT03369223|526438587|FG000|Overall Study|Participant no longer meets study criteria|0|||
145980228|NCT03369223|526438588|FG001|Overall Study|Participant no longer meets study criteria|0|||
145980229|NCT03369223|526438589|FG002|Overall Study|Participant no longer meets study criteria|0|||
145980230|NCT03369223|526438590|FG003|Overall Study|Participant no longer meets study criteria|0|||
145980231|NCT03369223|526438591|FG004|Overall Study|Participant no longer meets study criteria|0|||
145980232|NCT03369223|526438592|FG005|Overall Study|Participant no longer meets study criteria|0|||
145980233|NCT03369223|526438593|FG006|Overall Study|Participant no longer meets study criteria|0|||
145980234|NCT03369223|526438594|FG007|Overall Study|Participant no longer meets study criteria|0|||
145980235|NCT03369223|526438595|FG008|Overall Study|Participant no longer meets study criteria|0|||
145980236|NCT03369223|526438596|FG009|Overall Study|Participant no longer meets study criteria|0|||
145980237|NCT03369223|526438597|FG010|Overall Study|Participant no longer meets study criteria|0|||
145980238|NCT03369223|526438598|FG011|Overall Study|Participant no longer meets study criteria|0|||
145980239|NCT03369223|526438599|FG012|Overall Study|Participant no longer meets study criteria|0|||
145980240|NCT03369223|526438600|FG013|Overall Study|Participant no longer meets study criteria|0|||
145980241|NCT03369223|526438601|FG014|Overall Study|Participant no longer meets study criteria|2|||
145980242|NCT03369223|526438602|FG015|Overall Study|Participant no longer meets study criteria|0|||
145980243|NCT03369223|526438603|FG016|Overall Study|Participant no longer meets study criteria|2|||
145980244|NCT03369223|526438604|FG017|Overall Study|Participant no longer meets study criteria|0|||
145980245|NCT03369223|526438605|FG018|Overall Study|Participant no longer meets study criteria|0|||
145980246|NCT03369223|526438606|FG019|Overall Study|Participant no longer meets study criteria|0|||
145980247|NCT03369223|526438587|FG000|Overall Study|Other reasons|0|||
145980248|NCT03369223|526438588|FG001|Overall Study|Other reasons|0|||
145980249|NCT03369223|526438589|FG002|Overall Study|Other reasons|0|||
145980250|NCT03369223|526438590|FG003|Overall Study|Other reasons|0|||
145980251|NCT03369223|526438591|FG004|Overall Study|Other reasons|0|||
145980252|NCT03369223|526438592|FG005|Overall Study|Other reasons|0|||
145980253|NCT03369223|526438593|FG006|Overall Study|Other reasons|0|||
145980254|NCT03369223|526438594|FG007|Overall Study|Other reasons|0|||
145980255|NCT03369223|526438595|FG008|Overall Study|Other reasons|0|||
145980256|NCT03369223|526438596|FG009|Overall Study|Other reasons|0|||
145980257|NCT03369223|526438597|FG010|Overall Study|Other reasons|0|||
145980258|NCT03369223|526438598|FG011|Overall Study|Other reasons|0|||
145980259|NCT03369223|526438599|FG012|Overall Study|Other reasons|0|||
145980260|NCT03369223|526438600|FG013|Overall Study|Other reasons|1|||
145980261|NCT03369223|526438601|FG014|Overall Study|Other reasons|2|||
145980262|NCT03369223|526438602|FG015|Overall Study|Other reasons|0|||
145980263|NCT03369223|526438603|FG016|Overall Study|Other reasons|1|||
145980264|NCT03369223|526438604|FG017|Overall Study|Other reasons|0|||
145980265|NCT03369223|526438605|FG018|Overall Study|Other reasons|0|||
145980266|NCT03369223|526438606|FG019|Overall Study|Other reasons|2|||
145980267|NCT03369223|526438587|FG000|Overall Study|Death|0|||
145980268|NCT03369223|526438588|FG001|Overall Study|Death|0|||
145980269|NCT03369223|526438589|FG002|Overall Study|Death|0|||
145980270|NCT03369223|526438590|FG003|Overall Study|Death|0|||
145980271|NCT03369223|526438591|FG004|Overall Study|Death|0|||
145980272|NCT03369223|526438592|FG005|Overall Study|Death|0|||
145980273|NCT03369223|526438593|FG006|Overall Study|Death|0|||
145980274|NCT03369223|526438594|FG007|Overall Study|Death|0|||
145980275|NCT03369223|526438595|FG008|Overall Study|Death|0|||
145980276|NCT03369223|526438596|FG009|Overall Study|Death|0|||
145980277|NCT03369223|526438597|FG010|Overall Study|Death|0|||
145980278|NCT03369223|526438598|FG011|Overall Study|Death|0|||
145980279|NCT03369223|526438599|FG012|Overall Study|Death|0|||
145980280|NCT03369223|526438600|FG013|Overall Study|Death|1|||
145980281|NCT03369223|526438601|FG014|Overall Study|Death|0|||
145980282|NCT03369223|526438602|FG015|Overall Study|Death|0|||
145980283|NCT03369223|526438603|FG016|Overall Study|Death|0|||
145980284|NCT03369223|526438604|FG017|Overall Study|Death|0|||
145980285|NCT03369223|526438605|FG018|Overall Study|Death|1|||
145980286|NCT03369223|526438606|FG019|Overall Study|Death|0|||
145980287|NCT03369223|526438587|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145980288|NCT03369223|526438588|FG001|Overall Study|Adverse event unrelated to study drug|0|||
145980289|NCT03369223|526438589|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145980290|NCT03369223|526438590|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145980291|NCT03369223|526438591|FG004|Overall Study|Adverse event unrelated to study drug|0|||
145980292|NCT03369223|526438592|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145980293|NCT03369223|526438593|FG006|Overall Study|Adverse event unrelated to study drug|1|||
146245481|NCT02326220|527412232|FG001|Double-blind Treatment Period|Adverse Event|2|||
146245482|NCT02326220|527412233|FG002|Double-blind Treatment Period|Adverse Event|0|||
146245483|NCT02326220|527412231|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145980294|NCT03369223|526438594|FG007|Overall Study|Adverse event unrelated to study drug|0|||
145980295|NCT03369223|526438595|FG008|Overall Study|Adverse event unrelated to study drug|0|||
145980296|NCT03369223|526438596|FG009|Overall Study|Adverse event unrelated to study drug|1|||
145980297|NCT03369223|526438597|FG010|Overall Study|Adverse event unrelated to study drug|0|||
145980298|NCT03369223|526438598|FG011|Overall Study|Adverse event unrelated to study drug|0|||
145980299|NCT03369223|526438599|FG012|Overall Study|Adverse event unrelated to study drug|0|||
145980300|NCT03369223|526438600|FG013|Overall Study|Adverse event unrelated to study drug|4|||
145980301|NCT03369223|526438601|FG014|Overall Study|Adverse event unrelated to study drug|2|||
145980302|NCT03369223|526438602|FG015|Overall Study|Adverse event unrelated to study drug|0|||
145980303|NCT03369223|526438603|FG016|Overall Study|Adverse event unrelated to study drug|2|||
146245484|NCT02326220|527412232|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146245485|NCT02326220|527412233|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146245486|NCT02326220|527412231|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146245487|NCT02326220|527412232|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146245488|NCT02326220|527412233|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146245489|NCT02326220|527412231|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
146245490|NCT02326220|527412232|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145980304|NCT03369223|526438604|FG017|Overall Study|Adverse event unrelated to study drug|1|||
145980305|NCT03369223|526438605|FG018|Overall Study|Adverse event unrelated to study drug|3|||
145980306|NCT03369223|526438606|FG019|Overall Study|Adverse event unrelated to study drug|2|||
145980307|NCT03369223|526438587|FG000|Overall Study|Disease progression|6|||
145980308|NCT03369223|526438588|FG001|Overall Study|Disease progression|8|||
145980309|NCT03369223|526438589|FG002|Overall Study|Disease progression|5|||
145980310|NCT03369223|526438590|FG003|Overall Study|Disease progression|1|||
145980311|NCT03369223|526438591|FG004|Overall Study|Disease progression|9|||
145980312|NCT03369223|526438592|FG005|Overall Study|Disease progression|9|||
145980313|NCT03369223|526438593|FG006|Overall Study|Disease progression|4|||
145980314|NCT03369223|526438594|FG007|Overall Study|Disease progression|6|||
145980315|NCT03369223|526438595|FG008|Overall Study|Disease progression|10|||
145980316|NCT03369223|526438596|FG009|Overall Study|Disease progression|7|||
145980317|NCT03369223|526438597|FG010|Overall Study|Disease progression|4|||
145980318|NCT03369223|526438598|FG011|Overall Study|Disease progression|1|||
145980319|NCT03369223|526438599|FG012|Overall Study|Disease progression|1|||
145980320|NCT03369223|526438600|FG013|Overall Study|Disease progression|25|||
145980321|NCT03369223|526438601|FG014|Overall Study|Disease progression|22|||
145980322|NCT03369223|526438602|FG015|Overall Study|Disease progression|2|||
145980323|NCT03369223|526438603|FG016|Overall Study|Disease progression|10|||
145980324|NCT03369223|526438604|FG017|Overall Study|Disease progression|1|||
145980325|NCT03369223|526438605|FG018|Overall Study|Disease progression|18|||
145980326|NCT03369223|526438606|FG019|Overall Study|Disease progression|28|||
145980327|NCT03369223|526438587|FG000|Overall Study|Study drug toxicity|0|||
145980328|NCT03369223|526438588|FG001|Overall Study|Study drug toxicity|1|||
145980329|NCT03369223|526438589|FG002|Overall Study|Study drug toxicity|4|||
145980330|NCT03369223|526438590|FG003|Overall Study|Study drug toxicity|0|||
145980331|NCT03369223|526438591|FG004|Overall Study|Study drug toxicity|1|||
145980332|NCT03369223|526438592|FG005|Overall Study|Study drug toxicity|2|||
145980333|NCT03369223|526438593|FG006|Overall Study|Study drug toxicity|4|||
145980334|NCT03369223|526438594|FG007|Overall Study|Study drug toxicity|2|||
145980335|NCT03369223|526438595|FG008|Overall Study|Study drug toxicity|2|||
145980336|NCT03369223|526438596|FG009|Overall Study|Study drug toxicity|0|||
145980337|NCT03369223|526438597|FG010|Overall Study|Study drug toxicity|6|||
145980338|NCT03369223|526438598|FG011|Overall Study|Study drug toxicity|1|||
145980339|NCT03369223|526438599|FG012|Overall Study|Study drug toxicity|2|||
145980340|NCT03369223|526438600|FG013|Overall Study|Study drug toxicity|19|||
145980341|NCT03369223|526438601|FG014|Overall Study|Study drug toxicity|19|||
145980342|NCT03369223|526438602|FG015|Overall Study|Study drug toxicity|0|||
145980343|NCT03369223|526438603|FG016|Overall Study|Study drug toxicity|18|||
145980344|NCT03369223|526438604|FG017|Overall Study|Study drug toxicity|3|||
145980345|NCT03369223|526438605|FG018|Overall Study|Study drug toxicity|11|||
145980346|NCT03369223|526438606|FG019|Overall Study|Study drug toxicity|7|||
145980347|NCT03369223|526438587|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145980348|NCT03369223|526438588|FG001|Overall Study|Participant request to discontinue study treatment|1|||
145980349|NCT03369223|526438589|FG002|Overall Study|Participant request to discontinue study treatment|0|||
145980350|NCT03369223|526438590|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145980351|NCT03369223|526438591|FG004|Overall Study|Participant request to discontinue study treatment|1|||
145980352|NCT03369223|526438592|FG005|Overall Study|Participant request to discontinue study treatment|1|||
145980353|NCT03369223|526438593|FG006|Overall Study|Participant request to discontinue study treatment|1|||
146091246|NCT04650854|526854931|FG002|Overall Study|Use of Rescue Medication|1|||
146091247|NCT04650854|526854929|FG000|Overall Study|Last Treatment Per Sponsor|0|||
146091248|NCT04650854|526854930|FG001|Overall Study|Last Treatment Per Sponsor|0|||
146091249|NCT04650854|526854931|FG002|Overall Study|Last Treatment Per Sponsor|2|||
146245491|NCT02326220|527412233|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
146245492|NCT02326220|527412231|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146245493|NCT02326220|527412232|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146245494|NCT02326220|527412233|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
145980354|NCT03369223|526438594|FG007|Overall Study|Participant request to discontinue study treatment|0|||
145980355|NCT03369223|526438595|FG008|Overall Study|Participant request to discontinue study treatment|0|||
145980356|NCT03369223|526438596|FG009|Overall Study|Participant request to discontinue study treatment|0|||
145980357|NCT03369223|526438597|FG010|Overall Study|Participant request to discontinue study treatment|0|||
145980358|NCT03369223|526438598|FG011|Overall Study|Participant request to discontinue study treatment|0|||
145980359|NCT03369223|526438599|FG012|Overall Study|Participant request to discontinue study treatment|0|||
145980360|NCT03369223|526438600|FG013|Overall Study|Participant request to discontinue study treatment|1|||
145980361|NCT03369223|526438601|FG014|Overall Study|Participant request to discontinue study treatment|1|||
146091250|NCT04650854|526854929|FG000|Overall Study|Rescue Medication|0|||
146245495|NCT02699099|527412234|FG000|Overall Study|Adverse Event|1|||
146245496|NCT02699099|527412235|FG001|Overall Study|Adverse Event|0|||
146245497|NCT02699099|527412236|FG002|Overall Study|Adverse Event|2|||
146245498|NCT02699099|527412234|FG000|Overall Study|Lost to Follow-up|0|||
146245499|NCT02699099|527412235|FG001|Overall Study|Lost to Follow-up|1|||
146245500|NCT02699099|527412236|FG002|Overall Study|Lost to Follow-up|0|||
146245501|NCT02699099|527412234|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
145938601|NCT01340027|526282224|FG001|Overall Study|Lost to Follow-up|1|||
145938602|NCT01340027|526282225|FG002|Overall Study|Lost to Follow-up|0|||
145938603|NCT01340027|526282226|FG003|Overall Study|Lost to Follow-up|0|||
145938604|NCT01340027|526282227|FG004|Overall Study|Lost to Follow-up|0|||
145938605|NCT01340027|526282228|FG005|Overall Study|Lost to Follow-up|0|||
145938606|NCT01340027|526282229|FG006|Overall Study|Lost to Follow-up|1|||
145938607|NCT01340027|526282230|FG007|Overall Study|Lost to Follow-up|0|||
145938608|NCT01340027|526282231|FG008|Overall Study|Lost to Follow-up|0|||
145938609|NCT01340027|526282232|FG009|Overall Study|Lost to Follow-up|1|||
145938610|NCT01340027|526282233|FG010|Overall Study|Lost to Follow-up|0|||
145938611|NCT01340027|526282234|FG011|Overall Study|Lost to Follow-up|0|||
145938612|NCT01340027|526282223|FG000|Overall Study|Protocol Violation|1|||
145938613|NCT01340027|526282224|FG001|Overall Study|Protocol Violation|2|||
145938614|NCT01340027|526282225|FG002|Overall Study|Protocol Violation|0|||
145938615|NCT01340027|526282226|FG003|Overall Study|Protocol Violation|0|||
145938616|NCT01340027|526282227|FG004|Overall Study|Protocol Violation|6|||
145938617|NCT01340027|526282228|FG005|Overall Study|Protocol Violation|0|||
145938618|NCT01340027|526282229|FG006|Overall Study|Protocol Violation|0|||
145938619|NCT01340027|526282230|FG007|Overall Study|Protocol Violation|1|||
145938620|NCT01340027|526282231|FG008|Overall Study|Protocol Violation|2|||
145938621|NCT01340027|526282232|FG009|Overall Study|Protocol Violation|2|||
145938622|NCT01340027|526282233|FG010|Overall Study|Protocol Violation|0|||
145938623|NCT01340027|526282234|FG011|Overall Study|Protocol Violation|0|||
145938624|NCT01340027|526282223|FG000|Overall Study|Withdrawal by Subject|4|||
145938625|NCT01340027|526282224|FG001|Overall Study|Withdrawal by Subject|3|||
145938626|NCT01340027|526282225|FG002|Overall Study|Withdrawal by Subject|1|||
145938627|NCT01340027|526282226|FG003|Overall Study|Withdrawal by Subject|3|||
145938628|NCT01340027|526282227|FG004|Overall Study|Withdrawal by Subject|3|||
145938629|NCT01340027|526282228|FG005|Overall Study|Withdrawal by Subject|2|||
145938630|NCT01340027|526282229|FG006|Overall Study|Withdrawal by Subject|3|||
145938631|NCT01340027|526282230|FG007|Overall Study|Withdrawal by Subject|4|||
145938632|NCT01340027|526282231|FG008|Overall Study|Withdrawal by Subject|1|||
145938633|NCT01340027|526282232|FG009|Overall Study|Withdrawal by Subject|2|||
145938634|NCT01340027|526282233|FG010|Overall Study|Withdrawal by Subject|0|||
145938635|NCT01340027|526282234|FG011|Overall Study|Withdrawal by Subject|1|||
145938636|NCT01340027|526282223|FG000|Overall Study|Miscellaneous|0|||
145938637|NCT01340027|526282224|FG001|Overall Study|Miscellaneous|0|||
145938638|NCT01340027|526282225|FG002|Overall Study|Miscellaneous|0|||
145938639|NCT01340027|526282226|FG003|Overall Study|Miscellaneous|1|||
145938640|NCT01340027|526282227|FG004|Overall Study|Miscellaneous|0|||
145938641|NCT01340027|526282228|FG005|Overall Study|Miscellaneous|0|||
145938642|NCT01340027|526282229|FG006|Overall Study|Miscellaneous|0|||
145938643|NCT01340027|526282230|FG007|Overall Study|Miscellaneous|0|||
145938644|NCT01340027|526282231|FG008|Overall Study|Miscellaneous|0|||
145938645|NCT01340027|526282232|FG009|Overall Study|Miscellaneous|0|||
145938646|NCT01340027|526282233|FG010|Overall Study|Miscellaneous|1|||
145938647|NCT01340027|526282234|FG011|Overall Study|Miscellaneous|0|||
145938648|NCT00833482|526282235|FG000|Days 11-20|Adverse Event|0|||
145938649|NCT00833482|526282236|FG001|Days 11-20|Adverse Event|2|||
145938650|NCT00833482|526282237|FG002|Days 11-20|Adverse Event|0|||
145938651|NCT00833482|526282238|FG003|Days 11-20|Adverse Event|0|||
145938652|NCT00833482|526282239|FG004|Days 11-20|Adverse Event|0|||
145938653|NCT00833482|526282240|FG005|Days 11-20|Adverse Event|0|||
145938654|NCT00833482|526282235|FG000|Days 11-20|Withdrawal by Subject|0|||
145938655|NCT00833482|526282236|FG001|Days 11-20|Withdrawal by Subject|1|||
145938656|NCT00833482|526282237|FG002|Days 11-20|Withdrawal by Subject|0|||
145938657|NCT00833482|526282238|FG003|Days 11-20|Withdrawal by Subject|0|||
145938658|NCT00833482|526282239|FG004|Days 11-20|Withdrawal by Subject|0|||
145938659|NCT00833482|526282240|FG005|Days 11-20|Withdrawal by Subject|0|||
145938660|NCT00833482|526282235|FG000|Days 21-30|Adverse Event|0|||
145938661|NCT00833482|526282236|FG001|Days 21-30|Adverse Event|0|||
145938662|NCT00833482|526282237|FG002|Days 21-30|Adverse Event|1|||
145938663|NCT00833482|526282238|FG003|Days 21-30|Adverse Event|0|||
145938664|NCT00833482|526282239|FG004|Days 21-30|Adverse Event|0|||
145938665|NCT00833482|526282240|FG005|Days 21-30|Adverse Event|0|||
145938666|NCT00833482|526282235|FG000|Days 21-30|Withdrawal by Subject|0|||
145938667|NCT00833482|526282236|FG001|Days 21-30|Withdrawal by Subject|0|||
145938668|NCT00833482|526282237|FG002|Days 21-30|Withdrawal by Subject|0|||
145938669|NCT00833482|526282238|FG003|Days 21-30|Withdrawal by Subject|0|||
145938670|NCT00833482|526282239|FG004|Days 21-30|Withdrawal by Subject|1|||
145938671|NCT00833482|526282240|FG005|Days 21-30|Withdrawal by Subject|0|||
146091251|NCT04650854|526854930|FG001|Overall Study|Rescue Medication|0|||
146091252|NCT04650854|526854931|FG002|Overall Study|Rescue Medication|1|||
146091253|NCT04650854|526854929|FG000|Overall Study|Participant Want to Start a Family|0|||
146091254|NCT04650854|526854930|FG001|Overall Study|Participant Want to Start a Family|0|||
145980362|NCT03369223|526438602|FG015|Overall Study|Participant request to discontinue study treatment|0|||
145980363|NCT03369223|526438603|FG016|Overall Study|Participant request to discontinue study treatment|0|||
145980364|NCT03369223|526438604|FG017|Overall Study|Participant request to discontinue study treatment|0|||
145980365|NCT03369223|526438605|FG018|Overall Study|Participant request to discontinue study treatment|1|||
145980366|NCT03369223|526438606|FG019|Overall Study|Participant request to discontinue study treatment|0|||
145980367|NCT03369223|526438587|FG000|Overall Study|Participant withdrew consent|0|||
145980368|NCT03369223|526438588|FG001|Overall Study|Participant withdrew consent|1|||
145980369|NCT03369223|526438589|FG002|Overall Study|Participant withdrew consent|1|||
145980370|NCT03369223|526438590|FG003|Overall Study|Participant withdrew consent|0|||
145980371|NCT03369223|526438591|FG004|Overall Study|Participant withdrew consent|0|||
145980372|NCT03369223|526438592|FG005|Overall Study|Participant withdrew consent|0|||
145980373|NCT03369223|526438593|FG006|Overall Study|Participant withdrew consent|1|||
145980374|NCT03369223|526438594|FG007|Overall Study|Participant withdrew consent|1|||
145980375|NCT03369223|526438595|FG008|Overall Study|Participant withdrew consent|1|||
145980376|NCT03369223|526438596|FG009|Overall Study|Participant withdrew consent|0|||
145980377|NCT03369223|526438597|FG010|Overall Study|Participant withdrew consent|0|||
145980378|NCT03369223|526438598|FG011|Overall Study|Participant withdrew consent|1|||
145980379|NCT03369223|526438599|FG012|Overall Study|Participant withdrew consent|0|||
145980380|NCT03369223|526438600|FG013|Overall Study|Participant withdrew consent|0|||
145980381|NCT03369223|526438601|FG014|Overall Study|Participant withdrew consent|3|||
145980382|NCT03369223|526438602|FG015|Overall Study|Participant withdrew consent|0|||
145980383|NCT03369223|526438603|FG016|Overall Study|Participant withdrew consent|1|||
145980384|NCT03369223|526438604|FG017|Overall Study|Participant withdrew consent|0|||
145980385|NCT03369223|526438605|FG018|Overall Study|Participant withdrew consent|4|||
145980386|NCT03369223|526438606|FG019|Overall Study|Participant withdrew consent|2|||
145980387|NCT03369223|526438587|FG000|Overall Study|Randomized but not treated|0|||
145980388|NCT03369223|526438588|FG001|Overall Study|Randomized but not treated|0|||
145980389|NCT03369223|526438589|FG002|Overall Study|Randomized but not treated|0|||
145980390|NCT03369223|526438590|FG003|Overall Study|Randomized but not treated|0|||
145980391|NCT03369223|526438591|FG004|Overall Study|Randomized but not treated|0|||
145980392|NCT03369223|526438592|FG005|Overall Study|Randomized but not treated|0|||
145980393|NCT03369223|526438593|FG006|Overall Study|Randomized but not treated|0|||
145980394|NCT03369223|526438594|FG007|Overall Study|Randomized but not treated|0|||
145980395|NCT03369223|526438595|FG008|Overall Study|Randomized but not treated|0|||
145980396|NCT03369223|526438596|FG009|Overall Study|Randomized but not treated|0|||
145980397|NCT03369223|526438597|FG010|Overall Study|Randomized but not treated|0|||
145980398|NCT03369223|526438598|FG011|Overall Study|Randomized but not treated|0|||
145980399|NCT03369223|526438599|FG012|Overall Study|Randomized but not treated|0|||
145980400|NCT03369223|526438600|FG013|Overall Study|Randomized but not treated|1|||
145980401|NCT03369223|526438601|FG014|Overall Study|Randomized but not treated|1|||
145980402|NCT03369223|526438602|FG015|Overall Study|Randomized but not treated|0|||
145980403|NCT03369223|526438603|FG016|Overall Study|Randomized but not treated|0|||
145980404|NCT03369223|526438604|FG017|Overall Study|Randomized but not treated|0|||
145980405|NCT03369223|526438605|FG018|Overall Study|Randomized but not treated|0|||
145980406|NCT03369223|526438606|FG019|Overall Study|Randomized but not treated|0|||
145980407|NCT02965833|526438607|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
145980408|NCT02965833|526438608|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
145980409|NCT02965833|526438607|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
145980410|NCT02965833|526438608|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146091255|NCT04650854|526854931|FG002|Overall Study|Participant Want to Start a Family|1|||
146091256|NCT04650854|526854929|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
145980411|NCT02965833|526438607|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
145980412|NCT02965833|526438608|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
145980413|NCT02965833|526438607|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
145980414|NCT02965833|526438608|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
145980415|NCT02965833|526438607|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
146245502|NCT02699099|527412235|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146245503|NCT02699099|527412236|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
146245504|NCT02659540|527412237|FG000|Overall Study|Adverse Event|3|||
145980416|NCT02965833|526438608|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
145980417|NCT03370302|526438610|FG000|Dose Escalation Phase|Other|0|||
145980418|NCT03370302|526438611|FG001|Dose Escalation Phase|Other|1|||
145980419|NCT03370302|526438612|FG002|Dose Escalation Phase|Other|1|||
145980420|NCT03370302|526438613|FG003|Dose Escalation Phase|Other|0|||
145980421|NCT03370302|526438614|FG004|Dose Escalation Phase|Other|0|||
145980422|NCT03370302|526438615|FG005|Dose Escalation Phase|Other|0|||
145980423|NCT03370302|526438610|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145980424|NCT03370302|526438611|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
145980425|NCT03370302|526438612|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
145980426|NCT03370302|526438613|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145980427|NCT03370302|526438614|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
145980428|NCT03370302|526438615|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
145980429|NCT03370302|526438610|FG000|Dose Escalation Phase|Adverse Event|1|||
145980430|NCT03370302|526438611|FG001|Dose Escalation Phase|Adverse Event|0|||
145980431|NCT03370302|526438612|FG002|Dose Escalation Phase|Adverse Event|2|||
145980432|NCT03370302|526438613|FG003|Dose Escalation Phase|Adverse Event|0|||
145980433|NCT03370302|526438614|FG004|Dose Escalation Phase|Adverse Event|0|||
145980434|NCT03370302|526438615|FG005|Dose Escalation Phase|Adverse Event|0|||
145980435|NCT03370302|526438610|FG000|Dose Escalation Phase|Progressive Disease|2|||
145980436|NCT03370302|526438611|FG001|Dose Escalation Phase|Progressive Disease|4|||
145980437|NCT03370302|526438612|FG002|Dose Escalation Phase|Progressive Disease|2|||
145980438|NCT03370302|526438613|FG003|Dose Escalation Phase|Progressive Disease|0|||
145980439|NCT03370302|526438614|FG004|Dose Escalation Phase|Progressive Disease|3|||
145980440|NCT03370302|526438615|FG005|Dose Escalation Phase|Progressive Disease|1|||
145980441|NCT03370302|526438610|FG000|Dose Expansion Phase|Progressive Disease|0|||
145980442|NCT03370302|526438611|FG001|Dose Expansion Phase|Progressive Disease|0|||
145980443|NCT03370302|526438612|FG002|Dose Expansion Phase|Progressive Disease|0|||
145980444|NCT03370302|526438613|FG003|Dose Expansion Phase|Progressive Disease|6|||
145980445|NCT03370302|526438614|FG004|Dose Expansion Phase|Progressive Disease|0|||
145980446|NCT03370302|526438615|FG005|Dose Expansion Phase|Progressive Disease|0|||
145980447|NCT03407482|526438619|FG000|Overall Study|Adverse Event|12|||
145980448|NCT03407482|526438619|FG000|Overall Study|Disease Relapse|1|||
145980449|NCT03407482|526438619|FG000|Overall Study|Lost to Follow-up|1|||
145980450|NCT03407482|526438619|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145980451|NCT03407482|526438619|FG000|Overall Study|Pregnancy|2|||
145980452|NCT03407482|526438619|FG000|Overall Study|Protocol Violation|1|||
145980453|NCT03407482|526438619|FG000|Overall Study|Study Terminated By Sponsor|106|||
145980454|NCT03407482|526438619|FG000|Overall Study|Withdrawal by Subject|6|||
145980455|NCT03407482|526438619|FG000|Overall Study|Data Entry Error|1|||
145980456|NCT05942040|526438620|FG000|Overall Study|No longer employed at study site.|0|||
145980457|NCT05942040|526438621|FG001|Overall Study|No longer employed at study site.|0|||
145980458|NCT05942040|526438622|FG002|Overall Study|No longer employed at study site.|3|||
146091257|NCT04650854|526854930|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
146091258|NCT04650854|526854931|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
146091259|NCT04650854|526854929|FG000|Overall Study|Participant Screened For MG0020|0|||
145980459|NCT06061952|526438624|FG000|Overall Study|Withdrawal by Subject|1|||
145980460|NCT06061952|526438625|FG001|Overall Study|Withdrawal by Subject|2|||
145980461|NCT06061952|526438624|FG000|Overall Study|Lost to Follow-up|2|||
145980462|NCT06061952|526438625|FG001|Overall Study|Lost to Follow-up|2|||
145980463|NCT03659916|526438626|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
145980464|NCT03659916|526438627|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
145980465|NCT03659916|526438628|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
145980466|NCT03659916|526438626|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
145980467|NCT03659916|526438627|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
145980468|NCT03659916|526438628|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
145980469|NCT03659916|526438626|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
145980470|NCT03659916|526438627|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
145980471|NCT03659916|526438628|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
145980472|NCT03659916|526438626|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
145980473|NCT03659916|526438627|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
145980474|NCT03659916|526438628|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
145980475|NCT03659916|526438626|FG000|Treatment Period (72 Weeks)|Other|1|||
145980476|NCT03659916|526438627|FG001|Treatment Period (72 Weeks)|Other|3|||
145980477|NCT03659916|526438628|FG002|Treatment Period (72 Weeks)|Other|9|||
145980478|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
145980479|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
145980480|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
146091260|NCT04650854|526854930|FG001|Overall Study|Participant Screened For MG0020|2|||
146091261|NCT04650854|526854931|FG002|Overall Study|Participant Screened For MG0020|3|||
146091262|NCT04650854|526854929|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
145980481|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
145980482|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
145980483|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
145980484|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
145980485|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
145980486|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
145980487|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
145980488|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
145980489|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
145980490|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
145980491|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
145980492|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
145980493|NCT03659916|526438626|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
145980494|NCT03659916|526438627|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
145980495|NCT03659916|526438628|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
145980496|NCT01685437|526438629|FG000|Overall Study|Withdrawal by Subject|22|||
145980497|NCT01685437|526438629|FG000|Overall Study|Lost to Follow-up|3|||
145980498|NCT01685437|526438629|FG000|Overall Study|Adverse Event|1|||
145980499|NCT01685437|526438629|FG000|Overall Study|Protocol Violation|4|||
145980500|NCT01685437|526438629|FG000|Overall Study|Unable to make visits due to work|1|||
145980501|NCT02068794|526439864|FG000|Overall Study|Withdrawal by Subject|0|||
145980502|NCT02068794|526439865|FG001|Overall Study|Withdrawal by Subject|1|||
145980503|NCT02068794|526439866|FG002|Overall Study|Withdrawal by Subject|2|||
145980504|NCT02068794|526439864|FG000|Overall Study|Early Progression|1|||
145980505|NCT02068794|526439865|FG001|Overall Study|Early Progression|0|||
145980506|NCT02068794|526439866|FG002|Overall Study|Early Progression|1|||
145980507|NCT02068794|526439864|FG000|Overall Study|Ineligible|0|||
145980508|NCT02068794|526439865|FG001|Overall Study|Ineligible|0|||
145980509|NCT02068794|526439866|FG002|Overall Study|Ineligible|1|||
145980510|NCT01002105|526439867|FG000|Overall Study|Lost to Follow-up|10|||
145980511|NCT01002105|526439868|FG001|Overall Study|Lost to Follow-up|16|||
145980512|NCT01002105|526439867|FG000|Overall Study|non compliance|5|||
145980513|NCT01002105|526439868|FG001|Overall Study|non compliance|3|||
145980514|NCT01002105|526439867|FG000|Overall Study|condition worsened|4|||
145980515|NCT01002105|526439868|FG001|Overall Study|condition worsened|2|||
145980516|NCT00266812|526439870|FG000|Overall Study|Disease Progression|9|||
145980517|NCT00266812|526439871|FG001|Overall Study|Disease Progression|3|||
145980518|NCT00266812|526439870|FG000|Overall Study|Death|5|||
145980519|NCT00266812|526439871|FG001|Overall Study|Death|4|||
145980520|NCT00266812|526439870|FG000|Overall Study|Adverse Event|3|||
145980521|NCT00266812|526439871|FG001|Overall Study|Adverse Event|1|||
145980522|NCT00266812|526439870|FG000|Overall Study|Protocol Violation|0|||
145980523|NCT00266812|526439871|FG001|Overall Study|Protocol Violation|1|||
145980524|NCT00266812|526439870|FG000|Overall Study|Withdrawal by Subject|0|||
145980525|NCT00266812|526439871|FG001|Overall Study|Withdrawal by Subject|2|||
145980526|NCT00266812|526439870|FG000|Overall Study|Discontinued before starting study drug|4|||
145980527|NCT00266812|526439871|FG001|Overall Study|Discontinued before starting study drug|0|||
145980528|NCT03695094|526439872|FG000|Overall Study|Adverse Event|1|||
145980529|NCT03695094|526439873|FG001|Overall Study|Adverse Event|1|||
145980530|NCT03695094|526439872|FG000|Overall Study|Withdrawal by Subject|1|||
145980531|NCT03695094|526439873|FG001|Overall Study|Withdrawal by Subject|0|||
145980532|NCT00552058|526439878|FG000|Overall Study|Adverse Event|8|||
145980533|NCT00552058|526439879|FG001|Overall Study|Adverse Event|7|||
145980534|NCT00552058|526439878|FG000|Overall Study|Lack of Efficacy|1|||
145980535|NCT00552058|526439879|FG001|Overall Study|Lack of Efficacy|5|||
145980536|NCT00552058|526439878|FG000|Overall Study|Lost to Follow-up|1|||
145980537|NCT00552058|526439879|FG001|Overall Study|Lost to Follow-up|0|||
145980538|NCT00552058|526439878|FG000|Overall Study|Withdrawal by Subject|4|||
145980539|NCT00552058|526439879|FG001|Overall Study|Withdrawal by Subject|4|||
145980540|NCT00552058|526439878|FG000|Overall Study|Other: Protocol Violation|0|||
145980541|NCT00552058|526439879|FG001|Overall Study|Other: Protocol Violation|1|||
145980542|NCT00552058|526439878|FG000|Overall Study|Other: Non Compliance|1|||
145980543|NCT00552058|526439879|FG001|Overall Study|Other: Non Compliance|2|||
145980544|NCT00552058|526439878|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
145980545|NCT00552058|526439879|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
145980546|NCT00552058|526439878|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
145980547|NCT00552058|526439879|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
145980548|NCT00552058|526439878|FG000|Overall Study|Other: Positive Stool Result|0|||
145980549|NCT00552058|526439879|FG001|Overall Study|Other: Positive Stool Result|1|||
145980550|NCT00552058|526439878|FG000|Overall Study|Other: Randomized in error|0|||
145980551|NCT00552058|526439879|FG001|Overall Study|Other: Randomized in error|1|||
145980552|NCT00552058|526439878|FG000|Overall Study|Other: Sponsors Decision|0|||
145980553|NCT00552058|526439879|FG001|Overall Study|Other: Sponsors Decision|1|||
145980554|NCT00552058|526439878|FG000|Overall Study|Other: Early Roll Over|1|||
145980555|NCT00552058|526439879|FG001|Overall Study|Other: Early Roll Over|0|||
145980556|NCT05161936|526439882|FG000|Overall Study|Study terminated by Sponsor|1|||
145980557|NCT05161936|526439883|FG001|Overall Study|Study terminated by Sponsor|0|||
145980558|NCT05161936|526439884|FG002|Overall Study|Study terminated by Sponsor|0|||
146297839|NCT02038920|527606030|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145980559|NCT05161936|526439882|FG000|Overall Study|Withdrawal by Subject|0|||
145980560|NCT05161936|526439883|FG001|Overall Study|Withdrawal by Subject|0|||
145980561|NCT05161936|526439884|FG002|Overall Study|Withdrawal by Subject|1|||
145980562|NCT02639559|526439885|FG000|Overall Study|Mobilization failure|0|||
145980563|NCT02639559|526439886|FG001|Overall Study|Mobilization failure|3|||
145980564|NCT02639559|526439885|FG000|Overall Study|Issues with vascular acess|1|||
145980565|NCT02639559|526439886|FG001|Overall Study|Issues with vascular acess|0|||
145980566|NCT04999020|526439887|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
145980567|NCT04999020|526439888|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
145980568|NCT04999020|526439889|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
145980569|NCT04999020|526439890|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
145980570|NCT04999020|526439887|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
145980571|NCT04999020|526439888|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
145980572|NCT04999020|526439889|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
145980573|NCT04999020|526439890|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
145980574|NCT04999020|526439887|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
145980575|NCT04999020|526439888|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
145980576|NCT04999020|526439889|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
145980577|NCT04999020|526439890|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
145980578|NCT04999020|526439887|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145980579|NCT04999020|526439888|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145980580|NCT04999020|526439889|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
145980581|NCT04999020|526439890|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
145980582|NCT04999020|526439887|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
145980583|NCT04999020|526439888|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
145980584|NCT04999020|526439889|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
145980585|NCT04999020|526439890|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
145980586|NCT04999020|526439887|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
145980587|NCT04999020|526439888|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
145980588|NCT04999020|526439889|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
145980589|NCT04999020|526439890|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
145980590|NCT04999020|526439887|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145980591|NCT04999020|526439888|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145980592|NCT04999020|526439889|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
145980593|NCT04999020|526439890|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145980594|NCT04999020|526439887|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
145980595|NCT04999020|526439888|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
145980596|NCT04999020|526439889|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
145980597|NCT04999020|526439890|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
145980598|NCT03925220|526439896|FG000|Overall Study|Withdrawal by Subject|4|||
145980599|NCT03925220|526439897|FG001|Overall Study|Withdrawal by Subject|4|||
145980600|NCT03925220|526439898|FG002|Overall Study|Withdrawal by Subject|4|||
145980601|NCT03925220|526439899|FG003|Overall Study|Withdrawal by Subject|4|||
145980602|NCT03925220|526439896|FG000|Overall Study|Lost to Follow-up|40|||
145980603|NCT03925220|526439897|FG001|Overall Study|Lost to Follow-up|46|||
145980604|NCT03925220|526439898|FG002|Overall Study|Lost to Follow-up|37|||
145980605|NCT03925220|526439899|FG003|Overall Study|Lost to Follow-up|38|||
145980606|NCT04828486|526439900|FG000|Overall Study|Adverse Event|2|||
145980607|NCT04828486|526439900|FG000|Overall Study|Death|1|||
145980608|NCT04828486|526439900|FG000|Overall Study|Disease Progression|8|||
145980609|NCT04828486|526439900|FG000|Overall Study|Other Complicating Disease|1|||
145980610|NCT04828486|526439900|FG000|Overall Study|Withdrawal by Subject|1|||
145980611|NCT00866320|526439901|FG000|Overall Study|Withdrawal by Subject|4|||
145980612|NCT00866320|526439901|FG000|Overall Study|Death|2|||
145980613|NCT00896233|526439902|FG000|Overall Study|Claustrophobia during MRI|1|||
145980614|NCT02965456|526439903|FG000|Overall Study|Lost to Follow-up|40|||
145980615|NCT02965456|526439904|FG001|Overall Study|Lost to Follow-up|18|||
145980616|NCT02965456|526439903|FG000|Overall Study|Subject Request|22|||
145980617|NCT02965456|526439904|FG001|Overall Study|Subject Request|13|||
145980618|NCT02965456|526439903|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
145980619|NCT02965456|526439904|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
145980620|NCT02965456|526439903|FG000|Overall Study|Adverse Event|3|||
145980621|NCT02965456|526439904|FG001|Overall Study|Adverse Event|0|||
145980622|NCT02965456|526439903|FG000|Overall Study|Noncompliance with Study Drug|1|||
145980623|NCT02965456|526439904|FG001|Overall Study|Noncompliance with Study Drug|1|||
145980624|NCT02965456|526439903|FG000|Overall Study|Worsening Condition|0|||
145980625|NCT02965456|526439904|FG001|Overall Study|Worsening Condition|2|||
145980626|NCT02965456|526439903|FG000|Overall Study|Lack of Efficacy|1|||
145980627|NCT02965456|526439904|FG001|Overall Study|Lack of Efficacy|0|||
145980628|NCT02965456|526439903|FG000|Overall Study|Physician Decision|0|||
145980629|NCT02965456|526439904|FG001|Overall Study|Physician Decision|1|||
145980630|NCT02965456|526439903|FG000|Overall Study|Pregnancy|1|||
146091263|NCT04650854|526854930|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
146245505|NCT02659540|527412238|FG001|Overall Study|Adverse Event|2|||
146245506|NCT02659540|527412237|FG000|Overall Study|Death|1|||
146245507|NCT02659540|527412238|FG001|Overall Study|Death|0|||
145980631|NCT02965456|526439904|FG001|Overall Study|Pregnancy|0|||
145980632|NCT02965456|526439903|FG000|Overall Study|Protocol Violation|0|||
145980633|NCT02965456|526439904|FG001|Overall Study|Protocol Violation|1|||
145980634|NCT02965456|526439903|FG000|Overall Study|Participant ran out of study drug|0|||
145980635|NCT02965456|526439904|FG001|Overall Study|Participant ran out of study drug|1|||
145980636|NCT04465955|526439905|FG000|Overall Study|Withdrew consent|6|||
145980637|NCT04465955|526439906|FG001|Overall Study|Withdrew consent|10|||
145980638|NCT04465955|526439907|FG002|Overall Study|Withdrew consent|7|||
145980639|NCT04465955|526439905|FG000|Overall Study|Adverse Event|6|||
145980640|NCT04465955|526439906|FG001|Overall Study|Adverse Event|5|||
145980641|NCT04465955|526439907|FG002|Overall Study|Adverse Event|1|||
145980642|NCT04465955|526439905|FG000|Overall Study|Lost to Follow-up|2|||
145980643|NCT04465955|526439906|FG001|Overall Study|Lost to Follow-up|0|||
145980644|NCT04465955|526439907|FG002|Overall Study|Lost to Follow-up|3|||
145980645|NCT04465955|526439905|FG000|Overall Study|Other|1|||
145980646|NCT04465955|526439906|FG001|Overall Study|Other|1|||
145980647|NCT04465955|526439907|FG002|Overall Study|Other|3|||
145980648|NCT01327703|526439910|FG000|Second Treatment Period|Adverse Event|1|||
145980649|NCT01327703|526439911|FG001|Second Treatment Period|Adverse Event|1|||
145980650|NCT01327703|526439910|FG000|Second Treatment Period|Protocol Violation|0|||
145980651|NCT01327703|526439911|FG001|Second Treatment Period|Protocol Violation|1|||
145980652|NCT00317369|526439913|FG000|Overall Study|Adverse Event|2|||
145980653|NCT00317369|526439914|FG001|Overall Study|Adverse Event|1|||
145980654|NCT00317369|526439915|FG002|Overall Study|Adverse Event|0|||
145980655|NCT00317369|526439913|FG000|Overall Study|Lack of Efficacy|0|||
145980656|NCT00317369|526439914|FG001|Overall Study|Lack of Efficacy|1|||
145980657|NCT00317369|526439915|FG002|Overall Study|Lack of Efficacy|1|||
145980658|NCT00317369|526439913|FG000|Overall Study|Withdrawal by Subject|0|||
145980659|NCT00317369|526439914|FG001|Overall Study|Withdrawal by Subject|0|||
145980660|NCT00317369|526439915|FG002|Overall Study|Withdrawal by Subject|1|||
145980661|NCT06042855|526439922|FG000|Overall Study|No Receipt of Study Drug|48|||
145980662|NCT06042855|526439923|FG001|Overall Study|No Receipt of Study Drug|57|||
145980663|NCT06042855|526439922|FG000|Overall Study|Administratively Withdrawn|59|||
145980664|NCT06042855|526439923|FG001|Overall Study|Administratively Withdrawn|59|||
145980665|NCT03674411|526439924|FG000|Overall Study|Non-treatment|4|||
145980666|NCT06038643|526439927|FG000|Overall Study|Withdrawal by Subject|9|||
145980667|NCT06038643|526439928|FG001|Overall Study|Withdrawal by Subject|4|||
145980668|NCT06038643|526439927|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
145980669|NCT06038643|526439928|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
145980670|NCT05710224|526439930|FG000|Overall Study|Death|1|||
145980671|NCT05710224|526439931|FG001|Overall Study|Death|0|||
145980672|NCT05710224|526439930|FG000|Overall Study|Lost to Follow-up|16|||
145980673|NCT05710224|526439931|FG001|Overall Study|Lost to Follow-up|7|||
145980674|NCT05710224|526439930|FG000|Overall Study|Withdrawal by Subject|4|||
145980675|NCT05710224|526439931|FG001|Overall Study|Withdrawal by Subject|6|||
145980676|NCT05710224|526439930|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145980677|NCT05710224|526439931|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145980678|NCT05710224|526439930|FG000|Overall Study|Participants Left The City|0|||
145980679|NCT05710224|526439931|FG001|Overall Study|Participants Left The City|2|||
145980680|NCT03573882|526439932|FG000|Overall Study|Study Terminated by Sponsor|22|||
145980681|NCT03573882|526439933|FG001|Overall Study|Study Terminated by Sponsor|17|||
145980682|NCT03573882|526439934|FG002|Overall Study|Study Terminated by Sponsor|18|||
145980683|NCT03573882|526439932|FG000|Overall Study|Withdrawal by Subject|6|||
145980684|NCT03573882|526439933|FG001|Overall Study|Withdrawal by Subject|11|||
145980685|NCT03573882|526439934|FG002|Overall Study|Withdrawal by Subject|7|||
145980686|NCT03573882|526439932|FG000|Overall Study|Adverse Event|7|||
145980687|NCT03573882|526439933|FG001|Overall Study|Adverse Event|5|||
145980688|NCT03573882|526439934|FG002|Overall Study|Adverse Event|6|||
145980689|NCT03573882|526439932|FG000|Overall Study|Lost to Follow-up|2|||
145980690|NCT03573882|526439933|FG001|Overall Study|Lost to Follow-up|5|||
145980691|NCT03573882|526439934|FG002|Overall Study|Lost to Follow-up|3|||
145980692|NCT03573882|526439932|FG000|Overall Study|Physician Decision|4|||
145980693|NCT03573882|526439933|FG001|Overall Study|Physician Decision|3|||
145980694|NCT03573882|526439934|FG002|Overall Study|Physician Decision|2|||
145980695|NCT03573882|526439932|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
145980696|NCT03573882|526439933|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
145980697|NCT03573882|526439934|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
145980698|NCT03573882|526439932|FG000|Overall Study|Pregnancy|1|||
145980699|NCT03573882|526439933|FG001|Overall Study|Pregnancy|2|||
145980700|NCT03573882|526439934|FG002|Overall Study|Pregnancy|0|||
145980701|NCT03573882|526439932|FG000|Overall Study|Other|4|||
145980702|NCT03573882|526439933|FG001|Overall Study|Other|2|||
145980703|NCT03573882|526439934|FG002|Overall Study|Other|2|||
145980704|NCT04439123|526439938|FG000|Overall Study|Adverse Event|11|||
145980705|NCT04439123|526439938|FG000|Overall Study|Death|1|||
145980706|NCT04439123|526439938|FG000|Overall Study|Disease progression|19|||
145980707|NCT04439123|526439938|FG000|Overall Study|Withdrawal by Subject|2|||
145980708|NCT04439123|526439938|FG000|Overall Study|Still on treatment|2|||
146091264|NCT04650854|526854931|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
146091265|NCT04650854|526854929|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
146091266|NCT04650854|526854930|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
146091267|NCT04650854|526854931|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
146245508|NCT02659540|527412237|FG000|Overall Study|Progressive disease|2|||
145938672|NCT02496091|526282241|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145938673|NCT01970475|526282245|FG000|Overall Study|Withdrawal by Subject|11|||
145938674|NCT01970475|526282246|FG001|Overall Study|Withdrawal by Subject|6|||
145938675|NCT01970475|526282245|FG000|Overall Study|Adverse Event|7|||
145938676|NCT01970475|526282246|FG001|Overall Study|Adverse Event|3|||
145938677|NCT01970475|526282245|FG000|Overall Study|Lost to Follow-up|2|||
145938678|NCT01970475|526282246|FG001|Overall Study|Lost to Follow-up|2|||
145938679|NCT01970475|526282245|FG000|Overall Study|Protocol Violation|1|||
145938680|NCT01970475|526282246|FG001|Overall Study|Protocol Violation|0|||
145938681|NCT03055494|526283588|FG000|Overall Study|Lost to Follow-up|6|||
145938682|NCT03055494|526283589|FG001|Overall Study|Lost to Follow-up|0|||
145938683|NCT03055494|526283588|FG000|Overall Study|Physician Decision|2|||
145938684|NCT03055494|526283589|FG001|Overall Study|Physician Decision|0|||
145938685|NCT03055494|526283588|FG000|Overall Study|Withdrawal by Subject|1|||
145938686|NCT03055494|526283589|FG001|Overall Study|Withdrawal by Subject|0|||
145938687|NCT03055494|526283588|FG000|Overall Study|Adverse Event|0|||
145938688|NCT03055494|526283589|FG001|Overall Study|Adverse Event|1|||
145938689|NCT03055494|526283588|FG000|Overall Study|Non-compliance with study treatment|1|||
145938690|NCT03055494|526283589|FG001|Overall Study|Non-compliance with study treatment|0|||
145938691|NCT03197467|526283592|FG000|Overall Study|Withdrawal by Subject|1|||
145938692|NCT04338269|526283596|FG000|Overall Study|Death|86|||
145938693|NCT04338269|526283597|FG001|Overall Study|Death|89|||
145938694|NCT04338269|526283596|FG000|Overall Study|Lost to Follow-up|1|||
145938695|NCT04338269|526283597|FG001|Overall Study|Lost to Follow-up|2|||
145938696|NCT04338269|526283596|FG000|Overall Study|Physician Decision|1|||
145938697|NCT04338269|526283597|FG001|Overall Study|Physician Decision|0|||
145938698|NCT04338269|526283596|FG000|Overall Study|Withdrawal by Subject|14|||
145938699|NCT04338269|526283597|FG001|Overall Study|Withdrawal by Subject|11|||
145938700|NCT03339726|526283598|FG000|Overall Study|Withdrawal by Subject|1|||
145938701|NCT03339726|526283599|FG001|Overall Study|Withdrawal by Subject|0|||
145938702|NCT03339726|526283600|FG002|Overall Study|Withdrawal by Subject|0|||
145938703|NCT03339726|526283598|FG000|Overall Study|Lost to Follow-up|0|||
145938704|NCT03339726|526283599|FG001|Overall Study|Lost to Follow-up|1|||
145938705|NCT03339726|526283600|FG002|Overall Study|Lost to Follow-up|0|||
145938706|NCT03960021|526283606|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
145938707|NCT02203851|526283607|FG000|Overall Study|Lost to Follow-up|4|||
145938708|NCT02203851|526283607|FG000|Overall Study|Withdrawal by Subject|6|||
145938709|NCT02203851|526283607|FG000|Overall Study|Other|1|||
145938710|NCT04161079|526283608|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
145938711|NCT02515994|526283609|FG000|Overall Study|Protocol Violation|3|||
145938712|NCT02515994|526283610|FG001|Overall Study|Protocol Violation|5|||
145938713|NCT02515994|526283609|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
145938714|NCT02515994|526283610|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
145938715|NCT02515994|526283609|FG000|Overall Study|Adverse Event|3|||
145938716|NCT02515994|526283610|FG001|Overall Study|Adverse Event|1|||
145938717|NCT02515994|526283609|FG000|Overall Study|Withdrawal by Subject|2|||
145938718|NCT02515994|526283610|FG001|Overall Study|Withdrawal by Subject|0|||
145938719|NCT04045132|526283611|FG000|Overall Study|Lost to Follow-up|3|||
145938720|NCT04045132|526283612|FG001|Overall Study|Lost to Follow-up|6|||
145938721|NCT02879994|526283615|FG000|Overall Study|off treatment early|7|||
145938722|NCT02879994|526283615|FG000|Overall Study|Adverse Event|2|||
145938723|NCT02879994|526283615|FG000|Overall Study|Death|2|||
145938724|NCT02143791|526283616|FG000|Enrolled|Withdrawal by Subject|4|||
145938725|NCT02143791|526283616|FG000|Trial Stimulation|Lack of Efficacy|21|||
145938726|NCT02143791|526283616|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
145938727|NCT02143791|526283616|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
145938728|NCT02143791|526283616|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
145938729|NCT02143791|526283616|FG000|Any Programming (3-6 Months)|Missing Data|1|||
145938730|NCT02143791|526283616|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
145938731|NCT04327661|526283617|FG000|Overall Study|Withdrawal by Subject|1|||
145938732|NCT04327661|526283618|FG001|Overall Study|Withdrawal by Subject|0|||
145938733|NCT04327661|526283619|FG002|Overall Study|Withdrawal by Subject|0|||
145938734|NCT03391232|526283620|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
145938735|NCT03391232|526283621|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
145938736|NCT03391232|526283620|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
145938737|NCT03391232|526283621|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
145938738|NCT02091960|526283622|FG000|Overall Study|Death|7|||
145938739|NCT02091960|526283622|FG000|Overall Study|Withdrawal by Subject|1|||
145938740|NCT02091960|526283622|FG000|Overall Study|Miscellaneous Reasons|37|||
145938741|NCT01995175|526283624|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
145980709|NCT06375655|526439940|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
145980710|NCT06375655|526439941|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
145980711|NCT01121575|526439952|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
145980712|NCT01121575|526439953|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
145980713|NCT01121575|526439954|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
145980714|NCT01121575|526439955|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
145980715|NCT01121575|526439956|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
145980716|NCT01121575|526439957|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
145980717|NCT01121575|526439952|FG000|Overall Study|Unspecified Reasons|8|||
145980718|NCT01121575|526439953|FG001|Overall Study|Unspecified Reasons|6|||
145980719|NCT01121575|526439954|FG002|Overall Study|Unspecified Reasons|7|||
145980720|NCT01121575|526439955|FG003|Overall Study|Unspecified Reasons|5|||
145980721|NCT01121575|526439956|FG004|Overall Study|Unspecified Reasons|13|||
145980722|NCT01121575|526439957|FG005|Overall Study|Unspecified Reasons|10|||
145980723|NCT01121575|526439952|FG000|Overall Study|Death|6|||
145980724|NCT01121575|526439953|FG001|Overall Study|Death|0|||
145980725|NCT01121575|526439954|FG002|Overall Study|Death|0|||
145980726|NCT01121575|526439955|FG003|Overall Study|Death|1|||
145980727|NCT01121575|526439956|FG004|Overall Study|Death|7|||
145980728|NCT01121575|526439957|FG005|Overall Study|Death|1|||
145980729|NCT03011372|526439967|FG000|Overall Study|Death|16|||
145980730|NCT03011372|526439967|FG000|Overall Study|Lost to Follow-up|2|||
145980731|NCT03011372|526439967|FG000|Overall Study|Sponsor Decision|17|||
145980732|NCT03011372|526439967|FG000|Overall Study|Withdrawal by Subject|7|||
145980733|NCT03011372|526439967|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
145980734|NCT03011372|526439967|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
145980735|NCT03011372|526439967|FG000|Overall Study|Sponsor's Decision|2|||
145980736|NCT03860584|526439968|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
145980737|NCT03860584|526439969|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
145980738|NCT03860584|526439968|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145980739|NCT03860584|526439969|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
145980740|NCT03860584|526439968|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
145980741|NCT03860584|526439969|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
145980742|NCT03860584|526439968|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
145980743|NCT03860584|526439969|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
145980744|NCT00504231|526440925|FG000|Overall Study|Discrepant chart documentation re route|0|||
145980745|NCT00504231|526440926|FG001|Overall Study|Discrepant chart documentation re route|0|||
145980746|NCT00504231|526440927|FG002|Overall Study|Discrepant chart documentation re route|1|||
145980747|NCT00504231|526440928|FG003|Overall Study|Discrepant chart documentation re route|0|||
145980748|NCT00835978|526440929|FG000|Overall Study|Death|33|||
145980749|NCT00835978|526440930|FG001|Overall Study|Death|40|||
145980750|NCT00835978|526440931|FG002|Overall Study|Death|49|||
145980751|NCT00835978|526440932|FG003|Overall Study|Death|4|||
145980752|NCT00835978|526440929|FG000|Overall Study|Lost to Follow-up|3|||
145980753|NCT00835978|526440930|FG001|Overall Study|Lost to Follow-up|4|||
145980754|NCT00835978|526440931|FG002|Overall Study|Lost to Follow-up|2|||
145980755|NCT00835978|526440932|FG003|Overall Study|Lost to Follow-up|1|||
145980756|NCT00835978|526440929|FG000|Overall Study|Other|5|||
145980757|NCT00835978|526440930|FG001|Overall Study|Other|1|||
145980758|NCT00835978|526440931|FG002|Overall Study|Other|8|||
145980759|NCT00835978|526440932|FG003|Overall Study|Other|0|||
145980760|NCT00835978|526440929|FG000|Overall Study|Objective progression or relapse|2|||
145980761|NCT00835978|526440930|FG001|Overall Study|Objective progression or relapse|0|||
145980762|NCT00835978|526440931|FG002|Overall Study|Objective progression or relapse|1|||
145980763|NCT00835978|526440932|FG003|Overall Study|Objective progression or relapse|0|||
145980764|NCT00835978|526440929|FG000|Overall Study|Adverse Event|1|||
145980765|NCT00835978|526440930|FG001|Overall Study|Adverse Event|0|||
145980766|NCT00835978|526440931|FG002|Overall Study|Adverse Event|1|||
145980767|NCT00835978|526440932|FG003|Overall Study|Adverse Event|0|||
145980768|NCT00835978|526440929|FG000|Overall Study|Withdrawal by Subject|0|||
145980769|NCT00835978|526440930|FG001|Overall Study|Withdrawal by Subject|3|||
145980770|NCT00835978|526440931|FG002|Overall Study|Withdrawal by Subject|0|||
145980771|NCT00835978|526440932|FG003|Overall Study|Withdrawal by Subject|5|||
145980772|NCT00835978|526440929|FG000|Overall Study|Study terminated by sponsor|12|||
145980773|NCT00835978|526440930|FG001|Overall Study|Study terminated by sponsor|8|||
145980774|NCT00835978|526440931|FG002|Overall Study|Study terminated by sponsor|30|||
145980775|NCT00835978|526440932|FG003|Overall Study|Study terminated by sponsor|0|||
145980776|NCT02400736|526440935|FG000|Overall Study|Lost to Follow-up|6|||
145980777|NCT02400736|526440936|FG001|Overall Study|Lost to Follow-up|6|||
145980778|NCT02400736|526440935|FG000|Overall Study|Withdrawal by Subject|2|||
145980779|NCT02400736|526440936|FG001|Overall Study|Withdrawal by Subject|1|||
145980780|NCT02400736|526440935|FG000|Overall Study|Moved from the area|3|||
145980781|NCT02400736|526440936|FG001|Overall Study|Moved from the area|1|||
145980782|NCT02927145|526440938|FG000|Initial Recruitment|Withdrawal by Subject|0|||
145980783|NCT02927145|526440939|FG001|Initial Recruitment|Withdrawal by Subject|1|||
145980784|NCT02927145|526440940|FG002|Initial Recruitment|Withdrawal by Subject|1|||
145980785|NCT02927145|526440941|FG003|Initial Recruitment|Withdrawal by Subject|4|||
145980786|NCT02927145|526440942|FG004|Initial Recruitment|Withdrawal by Subject|1|||
145980787|NCT02927145|526440943|FG005|Initial Recruitment|Withdrawal by Subject|1|||
145980788|NCT02927145|526440944|FG006|Initial Recruitment|Withdrawal by Subject|0|||
145980789|NCT02927145|526440945|FG007|Initial Recruitment|Withdrawal by Subject|0|||
145980790|NCT02927145|526440946|FG008|Initial Recruitment|Withdrawal by Subject|2|||
145980791|NCT02927145|526440938|FG000|Initial Recruitment|Adverse Event|0|||
145980792|NCT02927145|526440939|FG001|Initial Recruitment|Adverse Event|0|||
145980793|NCT02927145|526440940|FG002|Initial Recruitment|Adverse Event|0|||
145980794|NCT02927145|526440941|FG003|Initial Recruitment|Adverse Event|0|||
145980795|NCT02927145|526440942|FG004|Initial Recruitment|Adverse Event|2|||
145980796|NCT02927145|526440943|FG005|Initial Recruitment|Adverse Event|0|||
145980797|NCT02927145|526440944|FG006|Initial Recruitment|Adverse Event|0|||
145980798|NCT02927145|526440945|FG007|Initial Recruitment|Adverse Event|0|||
145980799|NCT02927145|526440946|FG008|Initial Recruitment|Adverse Event|0|||
145980800|NCT02927145|526440938|FG000|Invitation for Additional Challenge|Pregnancy|0|||
145980801|NCT02927145|526440939|FG001|Invitation for Additional Challenge|Pregnancy|0|||
145980802|NCT02927145|526440940|FG002|Invitation for Additional Challenge|Pregnancy|0|||
145980803|NCT02927145|526440941|FG003|Invitation for Additional Challenge|Pregnancy|0|||
145980804|NCT02927145|526440942|FG004|Invitation for Additional Challenge|Pregnancy|0|||
145980805|NCT02927145|526440943|FG005|Invitation for Additional Challenge|Pregnancy|0|||
145980806|NCT02927145|526440944|FG006|Invitation for Additional Challenge|Pregnancy|1|||
145980807|NCT02927145|526440945|FG007|Invitation for Additional Challenge|Pregnancy|0|||
145980808|NCT02927145|526440946|FG008|Invitation for Additional Challenge|Pregnancy|0|||
145980809|NCT01363440|526440947|FG000|Overall Study|Adverse Event|5|||
145980810|NCT01363440|526440948|FG001|Overall Study|Adverse Event|4|||
145980811|NCT01363440|526440949|FG002|Overall Study|Adverse Event|4|||
145980812|NCT01363440|526440947|FG000|Overall Study|Death|3|||
145980813|NCT01363440|526440948|FG001|Overall Study|Death|7|||
145980814|NCT01363440|526440949|FG002|Overall Study|Death|5|||
145980815|NCT01363440|526440947|FG000|Overall Study|Withdrawal by Subject|9|||
145980816|NCT01363440|526440948|FG001|Overall Study|Withdrawal by Subject|11|||
145980817|NCT01363440|526440949|FG002|Overall Study|Withdrawal by Subject|11|||
145980818|NCT01363440|526440947|FG000|Overall Study|Lost to Follow-up|2|||
145980819|NCT01363440|526440948|FG001|Overall Study|Lost to Follow-up|4|||
145980820|NCT01363440|526440949|FG002|Overall Study|Lost to Follow-up|5|||
145980821|NCT01363440|526440947|FG000|Overall Study|Other|4|||
145980822|NCT01363440|526440948|FG001|Overall Study|Other|5|||
145980823|NCT01363440|526440949|FG002|Overall Study|Other|2|||
145980824|NCT01166945|526440951|FG000|Randomized|diagnosed with Group A strep|4|||
145980825|NCT01166945|526440952|FG001|Randomized|diagnosed with Group A strep|4|||
145980826|NCT01166945|526440951|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
145980827|NCT01166945|526440952|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
145980828|NCT01166945|526440951|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
145980829|NCT01166945|526440952|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
145980830|NCT01166945|526440951|FG000|Day 30|Lost to Follow-up|4|||
145980831|NCT01166945|526440952|FG001|Day 30|Lost to Follow-up|3|||
145980832|NCT00923702|526440958|FG000|Overall Study|Ongoing enrollment|0|||
145980833|NCT00923702|526440959|FG001|Overall Study|Ongoing enrollment|0|||
145980834|NCT00923702|526440960|FG002|Overall Study|Ongoing enrollment|0|||
145980835|NCT00923702|526440961|FG003|Overall Study|Ongoing enrollment|0|||
145980836|NCT00923702|526440962|FG004|Overall Study|Ongoing enrollment|354|||
145980837|NCT01158404|526440965|FG000|Overall Study|Withdrawal by Subject|0|||
145980838|NCT01158404|526440966|FG001|Overall Study|Withdrawal by Subject|1|||
145980839|NCT01158404|526440967|FG002|Overall Study|Withdrawal by Subject|0|||
145980840|NCT01158404|526440968|FG003|Overall Study|Withdrawal by Subject|0|||
145980841|NCT01158404|526440969|FG004|Overall Study|Withdrawal by Subject|3|||
145980842|NCT01158404|526440970|FG005|Overall Study|Withdrawal by Subject|1|||
145980843|NCT01158404|526440971|FG006|Overall Study|Withdrawal by Subject|0|||
145980844|NCT01158404|526440972|FG007|Overall Study|Withdrawal by Subject|1|||
145980845|NCT01158404|526440965|FG000|Overall Study|Physician Decision|0|||
145980846|NCT01158404|526440966|FG001|Overall Study|Physician Decision|0|||
145980847|NCT01158404|526440967|FG002|Overall Study|Physician Decision|0|||
145980848|NCT01158404|526440968|FG003|Overall Study|Physician Decision|0|||
145980849|NCT01158404|526440969|FG004|Overall Study|Physician Decision|0|||
145980850|NCT01158404|526440970|FG005|Overall Study|Physician Decision|0|||
145980851|NCT01158404|526440971|FG006|Overall Study|Physician Decision|0|||
145980852|NCT01158404|526440972|FG007|Overall Study|Physician Decision|1|||
146091268|NCT04650854|526854929|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
145980853|NCT01158404|526440965|FG000|Overall Study|Progressive Disease|0|||
145980854|NCT01158404|526440966|FG001|Overall Study|Progressive Disease|0|||
145980855|NCT01158404|526440967|FG002|Overall Study|Progressive Disease|0|||
145980856|NCT01158404|526440968|FG003|Overall Study|Progressive Disease|0|||
145980857|NCT01158404|526440969|FG004|Overall Study|Progressive Disease|0|||
145980858|NCT01158404|526440970|FG005|Overall Study|Progressive Disease|0|||
145980859|NCT01158404|526440971|FG006|Overall Study|Progressive Disease|1|||
145980860|NCT01158404|526440972|FG007|Overall Study|Progressive Disease|0|||
145980861|NCT00827242|526440974|FG000|Overall Study|Withdrawal by Subject|2|||
146245509|NCT02659540|527412238|FG001|Overall Study|Progressive disease|6|||
146245510|NCT05522777|527413996|FG000|Overall Study|Lack of Efficacy|1|||
146245511|NCT05522777|527413996|FG000|Overall Study|Withdrawal by Subject|1|||
146245512|NCT01241448|527413997|FG000|Overall Study|Adverse Event|1|||
146245513|NCT01241448|527413998|FG001|Overall Study|Adverse Event|0|||
146245514|NCT01241448|527413999|FG002|Overall Study|Adverse Event|2|||
146245515|NCT01241448|527414000|FG003|Overall Study|Adverse Event|2|||
146245516|NCT01241448|527413997|FG000|Overall Study|Lost to Follow-up|2|||
146245517|NCT01241448|527413998|FG001|Overall Study|Lost to Follow-up|1|||
146245518|NCT01241448|527413999|FG002|Overall Study|Lost to Follow-up|1|||
146245519|NCT01241448|527414000|FG003|Overall Study|Lost to Follow-up|1|||
146245520|NCT01241448|527413997|FG000|Overall Study|Physician Decision|0|||
146245521|NCT01241448|527413998|FG001|Overall Study|Physician Decision|2|||
146245522|NCT01241448|527413999|FG002|Overall Study|Physician Decision|0|||
146245523|NCT01241448|527414000|FG003|Overall Study|Physician Decision|0|||
146245524|NCT01241448|527413997|FG000|Overall Study|Protocol Violation|10|||
146245525|NCT01241448|527413998|FG001|Overall Study|Protocol Violation|5|||
146245526|NCT01241448|527413999|FG002|Overall Study|Protocol Violation|3|||
146245527|NCT01241448|527414000|FG003|Overall Study|Protocol Violation|6|||
145938742|NCT01995175|526283624|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
145938743|NCT01995175|526283624|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
145938744|NCT01995175|526283624|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
145938745|NCT01995175|526283624|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
145938746|NCT01995175|526283624|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
145938747|NCT01995175|526283624|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
145938748|NCT01995175|526283624|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
145938749|NCT01995175|526283624|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
145938750|NCT00984061|526283625|FG000|Clarithromycin Alone|Protocol Violation|1|||
145938751|NCT02691013|526283626|FG000|Overall Study|Withdrawal by Subject|3|||
145938752|NCT02691013|526283627|FG001|Overall Study|Withdrawal by Subject|0|||
145938753|NCT00108485|526283639|FG000|Overall Study|Withdrawal by Subject|3|||
145938754|NCT00108485|526283640|FG001|Overall Study|Withdrawal by Subject|0|||
145938755|NCT00108485|526283639|FG000|Overall Study|Lost to Follow-up|0|||
145938756|NCT00108485|526283640|FG001|Overall Study|Lost to Follow-up|2|||
145938757|NCT02017912|526283644|FG000|Overall Study|Withdrawal by Subject|2|||
145938758|NCT02017912|526283645|FG001|Overall Study|Withdrawal by Subject|1|||
145938759|NCT02017912|526283644|FG000|Overall Study|miscellaneous|1|||
145938760|NCT02017912|526283645|FG001|Overall Study|miscellaneous|1|||
145938761|NCT00535847|526283646|FG000|Overall Study|Adverse Event|5|||
145938762|NCT00535847|526283647|FG001|Overall Study|Adverse Event|3|||
145938763|NCT00535847|526283648|FG002|Overall Study|Adverse Event|2|||
145938764|NCT00535847|526283646|FG000|Overall Study|Non compliance|1|||
145938765|NCT00535847|526283647|FG001|Overall Study|Non compliance|1|||
145938766|NCT00535847|526283648|FG002|Overall Study|Non compliance|0|||
145938767|NCT00535847|526283646|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
145938768|NCT00535847|526283647|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
145938769|NCT00535847|526283648|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
145938770|NCT05007041|526283649|FG000|Overall Study|Missing Diary Entries|0|||
145938771|NCT05007041|526283650|FG001|Overall Study|Missing Diary Entries|1|||
145938772|NCT02850016|526283651|FG000|Overall Study|Withdrawal by Subject|1|||
145938773|NCT02850016|526283652|FG001|Overall Study|Withdrawal by Subject|2|||
145938774|NCT00976209|526283654|FG000|Treatment Period 1|Protocol Violation|1|||
145938775|NCT00976209|526283655|FG001|Treatment Period 1|Protocol Violation|0|||
145938776|NCT00976209|526283654|FG000|Treatment Period 1|Lost to Follow-up|2|||
145938777|NCT00976209|526283655|FG001|Treatment Period 1|Lost to Follow-up|0|||
145938778|NCT00976209|526283654|FG000|Treatment Period 1|Other|0|||
145938779|NCT00976209|526283655|FG001|Treatment Period 1|Other|1|||
145938780|NCT00976209|526283654|FG000|Wash-out Period|Adverse Event|1|||
145938781|NCT00976209|526283655|FG001|Wash-out Period|Adverse Event|2|||
145938782|NCT00976209|526283654|FG000|Wash-out Period|Lost to Follow-up|1|||
145938783|NCT00976209|526283655|FG001|Wash-out Period|Lost to Follow-up|0|||
145938784|NCT00976209|526283654|FG000|Wash-out Period|Protocol Violation|1|||
145938785|NCT00976209|526283655|FG001|Wash-out Period|Protocol Violation|0|||
145938786|NCT00976209|526283654|FG000|Wash-out Period|Other|1|||
145980862|NCT00827242|526440975|FG001|Overall Study|Withdrawal by Subject|4|||
145980863|NCT00827242|526440974|FG000|Overall Study|Protocol Violation|1|||
145980864|NCT00827242|526440975|FG001|Overall Study|Protocol Violation|3|||
146245528|NCT01241448|527413997|FG000|Overall Study|Sponsor Decision|17|||
146245529|NCT01241448|527413998|FG001|Overall Study|Sponsor Decision|14|||
145938787|NCT00976209|526283655|FG001|Wash-out Period|Other|0|||
145938788|NCT00976209|526283654|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145938789|NCT00976209|526283655|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145938790|NCT00976209|526283654|FG000|Treatment Period 2|Lost to Follow-up|0|||
145938791|NCT00976209|526283655|FG001|Treatment Period 2|Lost to Follow-up|1|||
145938792|NCT01252563|526283656|FG000|Overall Study|Contract Deviation|41|||
145938793|NCT01252563|526283656|FG000|Overall Study|Centralized Registration Deviation|30|||
145980865|NCT00827242|526440974|FG000|Overall Study|Lost to Follow-up|0|||
145980866|NCT00827242|526440975|FG001|Overall Study|Lost to Follow-up|3|||
145980867|NCT00827242|526440974|FG000|Overall Study|Adverse Event Excluding Death|2|||
145980868|NCT00827242|526440975|FG001|Overall Study|Adverse Event Excluding Death|1|||
145980869|NCT00827242|526440974|FG000|Overall Study|Entry Criteria Not Met|4|||
145980870|NCT00827242|526440975|FG001|Overall Study|Entry Criteria Not Met|1|||
145980871|NCT00827242|526440974|FG000|Overall Study|Physician Decision|2|||
145980872|NCT00827242|526440975|FG001|Overall Study|Physician Decision|0|||
145980873|NCT00827242|526440974|FG000|Overall Study|Death|1|||
145980874|NCT00827242|526440975|FG001|Overall Study|Death|0|||
145980875|NCT00827242|526440974|FG000|Overall Study|Lack of Efficacy|1|||
145980876|NCT00827242|526440975|FG001|Overall Study|Lack of Efficacy|0|||
145980877|NCT04790201|526440976|FG000|Overall Study|Lost to Follow-up|0|||
145980878|NCT04790201|526440977|FG001|Overall Study|Lost to Follow-up|0|||
145980879|NCT04790201|526440978|FG002|Overall Study|Lost to Follow-up|2|||
145980880|NCT04790201|526440976|FG000|Overall Study|Death|0|||
145980881|NCT04790201|526440977|FG001|Overall Study|Death|1|||
145980882|NCT04790201|526440978|FG002|Overall Study|Death|0|||
145980883|NCT04790201|526440976|FG000|Overall Study|Protocol Violation|1|||
145980884|NCT04790201|526440977|FG001|Overall Study|Protocol Violation|0|||
145980885|NCT04790201|526440978|FG002|Overall Study|Protocol Violation|1|||
145980886|NCT02609633|526440979|FG000|Overall Study|Consent Withdrawn|0|||
145980887|NCT02609633|526440980|FG001|Overall Study|Consent Withdrawn|1|||
145938794|NCT01252563|526283656|FG000|Overall Study|Lost to Follow-up|161|||
145938795|NCT01252563|526283656|FG000|Overall Study|No visit after first day of treatment|194|||
145938796|NCT01252563|526283656|FG000|Overall Study|No drug administration|6|||
145938797|NCT02951533|526283660|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
145938798|NCT02951533|526283661|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
145938799|NCT02951533|526283662|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
145938800|NCT02951533|526283660|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
145938801|NCT02951533|526283661|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
145938802|NCT02951533|526283662|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
145938803|NCT02951533|526283660|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
145938804|NCT02951533|526283661|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
145938805|NCT02951533|526283662|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
145938806|NCT02951533|526283660|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
145938807|NCT02951533|526283661|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
145938808|NCT02951533|526283662|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
145938809|NCT02951533|526283660|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
145938810|NCT02951533|526283661|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
145938811|NCT02951533|526283662|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
145938812|NCT02951533|526283660|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
145938813|NCT02951533|526283661|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
145938814|NCT02951533|526283662|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
145938815|NCT02951533|526283660|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
145938816|NCT02951533|526283661|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
145938817|NCT02951533|526283662|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
145938818|NCT02951533|526283660|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
145938819|NCT02951533|526283661|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
145938820|NCT02951533|526283662|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
145938821|NCT02951533|526283660|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
145938822|NCT02951533|526283661|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
145938823|NCT02951533|526283662|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
145938824|NCT02951533|526283660|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
145938825|NCT02951533|526283661|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
145938826|NCT02951533|526283662|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
145938827|NCT02951533|526283660|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
145938828|NCT02951533|526283661|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
145938829|NCT02951533|526283662|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
145938830|NCT02029989|526283663|FG000|Overall Study|Withdrawal by Subject|1|||
145938831|NCT02029989|526283664|FG001|Overall Study|Withdrawal by Subject|0|||
145938832|NCT02029989|526283663|FG000|Overall Study|Withdrawal: Fear of needles|1|||
145938833|NCT02029989|526283664|FG001|Overall Study|Withdrawal: Fear of needles|0|||
145938834|NCT02029989|526283663|FG000|Overall Study|Change of location|2|||
145938835|NCT02029989|526283664|FG001|Overall Study|Change of location|3|||
145980888|NCT02609633|526440979|FG000|Overall Study|Protocol Deviation|1|||
145980889|NCT02609633|526440980|FG001|Overall Study|Protocol Deviation|0|||
145980890|NCT02609633|526440979|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
145980891|NCT02609633|526440980|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
145980892|NCT02609633|526440979|FG000|Overall Study|Reason not Specified|2|||
145980893|NCT02609633|526440980|FG001|Overall Study|Reason not Specified|1|||
146245530|NCT01241448|527413999|FG002|Overall Study|Sponsor Decision|12|||
145938836|NCT02029989|526283663|FG000|Overall Study|Physician Decision|2|||
145980894|NCT05762679|526440983|FG000|Overall Study|Withdrawal by Subject|1|||
145980895|NCT05762679|526440983|FG000|Overall Study|No analyzable imaging data|1|||
145980896|NCT03670628|526440984|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
145980897|NCT03670628|526440985|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
145980898|NCT03670628|526440984|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
145980899|NCT03670628|526440985|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
145980900|NCT00997126|526440986|FG000|Overall Study|Physician Decision|7|||
145980901|NCT00997126|526440987|FG001|Overall Study|Physician Decision|11|||
145980902|NCT00471107|526440988|FG000|Overall Study|Technical problems/data loss|3|||
145980903|NCT00471107|526440989|FG001|Overall Study|Technical problems/data loss|1|||
145980904|NCT00471107|526440990|FG002|Overall Study|Technical problems/data loss|3|||
145980905|NCT02063724|526440991|FG000|Overall Study|Disease progression|1|||
145980906|NCT01428128|526440992|FG000|Overall Study|Withdrawal by Subject|4|||
145980907|NCT01428128|526440992|FG000|Overall Study|Screen failure by p53|10|||
145980908|NCT01428128|526440992|FG000|Overall Study|Received Neulasta in one cycle|2|||
145980909|NCT01428128|526440992|FG000|Overall Study|Adverse Event|1|||
145980910|NCT00250718|526440996|FG000|Overall Study|Death|1|||
145980911|NCT00250718|526440996|FG000|Overall Study|Adverse Event|1|||
145980912|NCT00250718|526440996|FG000|Overall Study|Withdrawal by Subject|1|||
145980913|NCT05259033|526441001|FG000|Overall Study|Withdrawal by Subject|10|||
145980914|NCT05259033|526441002|FG001|Overall Study|Withdrawal by Subject|5|||
145980915|NCT05259033|526441001|FG000|Overall Study|Lost to Follow-up|1|||
145980916|NCT05259033|526441002|FG001|Overall Study|Lost to Follow-up|0|||
145980917|NCT05259033|526441001|FG000|Overall Study|Death|2|||
145980918|NCT05259033|526441002|FG001|Overall Study|Death|0|||
145980919|NCT01068249|526441003|FG000|Overall Study|Death|1|||
145980920|NCT01068249|526441003|FG000|Overall Study|Withdrawal by Subject|3|||
145980921|NCT04337021|526441009|FG000|Overall Study|Lost to Follow-up|54|||
145980922|NCT04337021|526441010|FG001|Overall Study|Lost to Follow-up|66|||
145980923|NCT01405911|526441011|FG000|Overall Study|Pre-treatment lab AE|0|||
145980924|NCT01405911|526441012|FG001|Overall Study|Pre-treatment lab AE|1|||
145980925|NCT01405911|526441013|FG002|Overall Study|Pre-treatment lab AE|0|||
145980926|NCT01405911|526441011|FG000|Overall Study|Lost to Follow-up|0|||
145980927|NCT01405911|526441012|FG001|Overall Study|Lost to Follow-up|1|||
145980928|NCT01405911|526441013|FG002|Overall Study|Lost to Follow-up|0|||
145980929|NCT01405911|526441011|FG000|Overall Study|Protocol Violation|1|||
145980930|NCT01405911|526441012|FG001|Overall Study|Protocol Violation|0|||
145980931|NCT01405911|526441013|FG002|Overall Study|Protocol Violation|0|||
145980932|NCT01405911|526441011|FG000|Overall Study|Withdrawal by Subject|3|||
145980933|NCT01405911|526441012|FG001|Overall Study|Withdrawal by Subject|1|||
145980934|NCT01405911|526441013|FG002|Overall Study|Withdrawal by Subject|1|||
145980935|NCT04124965|526441017|FG000|Overall Study|Adverse event, non-fatal|3|||
145980936|NCT04124965|526441018|FG001|Overall Study|Adverse event, non-fatal|1|||
145980937|NCT04124965|526441017|FG000|Overall Study|Withdrawal by Subject|1|||
145980938|NCT04124965|526441018|FG001|Overall Study|Withdrawal by Subject|1|||
145980939|NCT04124965|526441017|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
145980940|NCT04124965|526441018|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
145980941|NCT04124965|526441017|FG000|Overall Study|Pregnancy|1|||
145980942|NCT04124965|526441018|FG001|Overall Study|Pregnancy|0|||
145980943|NCT04124965|526441017|FG000|Overall Study|Sponsor and participant decision|0|||
145980944|NCT04124965|526441018|FG001|Overall Study|Sponsor and participant decision|1|||
145980945|NCT04124965|526441017|FG000|Overall Study|Personal surgery|0|||
145980946|NCT04124965|526441018|FG001|Overall Study|Personal surgery|1|||
145980947|NCT04124965|526441017|FG000|Overall Study|Physician Decision|0|||
145980948|NCT04124965|526441018|FG001|Overall Study|Physician Decision|1|||
145980949|NCT00002874|526441021|FG000|Overall Study|Withdrawal by Subject|1|||
145980950|NCT00002874|526441022|FG001|Overall Study|Withdrawal by Subject|1|||
145980951|NCT00002874|526441021|FG000|Overall Study|Protocol Violation|44|||
145980952|NCT00002874|526441022|FG001|Overall Study|Protocol Violation|34|||
145980953|NCT01397747|526441025|FG000|Overall Study|Multitarget DNA test excluded|689|||
146297840|NCT02038920|527606031|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146297841|NCT02038920|527606032|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
146297842|NCT02038920|527606027|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
146297843|NCT02038920|527606028|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
145980954|NCT01397747|526441025|FG000|Overall Study|Colonoscopy excluded|304|||
145980955|NCT01397747|526441025|FG000|Overall Study|FIT excluded|34|||
145980956|NCT03828383|526441026|FG000|Overall Study|Lost to Follow-up|3|||
145980957|NCT03828383|526441027|FG001|Overall Study|Lost to Follow-up|2|||
145980958|NCT03828383|526441026|FG000|Overall Study|Withdrawal by Subject|4|||
145980959|NCT03828383|526441027|FG001|Overall Study|Withdrawal by Subject|5|||
145980960|NCT00504309|526441028|FG000|Overall Study|Death|0|||
145980961|NCT00504309|526441029|FG001|Overall Study|Death|0|||
145980962|NCT00504309|526441030|FG002|Overall Study|Death|0|||
145980963|NCT00504309|526441031|FG003|Overall Study|Death|0|||
146245531|NCT01241448|527414000|FG003|Overall Study|Sponsor Decision|6|||
146245532|NCT01241448|527413997|FG000|Overall Study|Withdrawal by Subject|4|||
146245533|NCT01241448|527413998|FG001|Overall Study|Withdrawal by Subject|5|||
146245534|NCT01241448|527413999|FG002|Overall Study|Withdrawal by Subject|3|||
146245535|NCT01241448|527414000|FG003|Overall Study|Withdrawal by Subject|6|||
146245536|NCT01241448|527413997|FG000|Overall Study|Excluded due to data integrity issues|3|||
146245537|NCT01241448|527413998|FG001|Overall Study|Excluded due to data integrity issues|2|||
146245538|NCT01241448|527413999|FG002|Overall Study|Excluded due to data integrity issues|2|||
146245539|NCT01241448|527414000|FG003|Overall Study|Excluded due to data integrity issues|2|||
146245540|NCT03340961|527414001|FG000|Overall Study|Adverse Event|1|||
146245541|NCT03340961|527414002|FG001|Overall Study|Adverse Event|3|||
146245542|NCT03340961|527414003|FG002|Overall Study|Adverse Event|2|||
146245543|NCT03340961|527414004|FG003|Overall Study|Adverse Event|4|||
146245544|NCT03340961|527414001|FG000|Overall Study|Lost to Follow-up|0|||
146245545|NCT03340961|527414002|FG001|Overall Study|Lost to Follow-up|1|||
146245546|NCT03340961|527414003|FG002|Overall Study|Lost to Follow-up|0|||
146245547|NCT03340961|527414004|FG003|Overall Study|Lost to Follow-up|1|||
146245548|NCT03340961|527414001|FG000|Overall Study|Withdrawal by Subject|3|||
146245549|NCT03340961|527414002|FG001|Overall Study|Withdrawal by Subject|2|||
146245550|NCT03340961|527414003|FG002|Overall Study|Withdrawal by Subject|4|||
145938837|NCT02029989|526283664|FG001|Overall Study|Physician Decision|0|||
145938838|NCT02029989|526283663|FG000|Overall Study|Lost to Follow-up|9|||
145938839|NCT02029989|526283664|FG001|Overall Study|Lost to Follow-up|7|||
145938840|NCT02029989|526283663|FG000|Overall Study|Death|0|||
145938841|NCT02029989|526283664|FG001|Overall Study|Death|1|||
145938842|NCT02029989|526283663|FG000|Overall Study|Protocol Violation|1|||
145938843|NCT02029989|526283664|FG001|Overall Study|Protocol Violation|0|||
145938844|NCT02727777|526283671|FG000|Overall Study|Screen Failure|2|||
145938845|NCT02727777|526283672|FG001|Overall Study|Screen Failure|0|||
145938846|NCT02727777|526283673|FG002|Overall Study|Screen Failure|0|||
145938847|NCT02727777|526283671|FG000|Overall Study|Progressive disease|2|||
145938848|NCT02727777|526283672|FG001|Overall Study|Progressive disease|0|||
145938849|NCT02727777|526283673|FG002|Overall Study|Progressive disease|0|||
145938850|NCT01738503|526283674|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
145938851|NCT01738503|526283675|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938852|NCT01738503|526283676|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938853|NCT01738503|526283677|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938854|NCT01738503|526283678|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938855|NCT01738503|526283679|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938856|NCT01738503|526283680|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
145938857|NCT01738503|526283674|FG000|Treatment Period|Adverse Event|0|||
145938858|NCT01738503|526283675|FG001|Treatment Period|Adverse Event|1|||
145938859|NCT01738503|526283676|FG002|Treatment Period|Adverse Event|0|||
145938860|NCT01738503|526283677|FG003|Treatment Period|Adverse Event|1|||
145938861|NCT01738503|526283678|FG004|Treatment Period|Adverse Event|2|||
145938862|NCT01738503|526283679|FG005|Treatment Period|Adverse Event|2|||
145938863|NCT01738503|526283680|FG006|Treatment Period|Adverse Event|2|||
145938864|NCT01738503|526283674|FG000|Treatment Period|Lost to Follow-up|0|||
145938865|NCT01738503|526283675|FG001|Treatment Period|Lost to Follow-up|0|||
145938866|NCT01738503|526283676|FG002|Treatment Period|Lost to Follow-up|3|||
145938867|NCT01738503|526283677|FG003|Treatment Period|Lost to Follow-up|4|||
145938868|NCT01738503|526283678|FG004|Treatment Period|Lost to Follow-up|1|||
145938869|NCT01738503|526283679|FG005|Treatment Period|Lost to Follow-up|1|||
145938870|NCT01738503|526283680|FG006|Treatment Period|Lost to Follow-up|5|||
145938871|NCT01738503|526283674|FG000|Treatment Period|Withdrawal by Subject|0|||
145938872|NCT01738503|526283675|FG001|Treatment Period|Withdrawal by Subject|1|||
145938873|NCT01738503|526283676|FG002|Treatment Period|Withdrawal by Subject|0|||
145938874|NCT01738503|526283677|FG003|Treatment Period|Withdrawal by Subject|1|||
145938875|NCT01738503|526283678|FG004|Treatment Period|Withdrawal by Subject|1|||
145938876|NCT01738503|526283679|FG005|Treatment Period|Withdrawal by Subject|1|||
145938877|NCT01738503|526283680|FG006|Treatment Period|Withdrawal by Subject|1|||
145938878|NCT01738503|526283674|FG000|Treatment Period|Protocol Violation|0|||
145938879|NCT01738503|526283675|FG001|Treatment Period|Protocol Violation|3|||
145938880|NCT01738503|526283676|FG002|Treatment Period|Protocol Violation|1|||
145938881|NCT01738503|526283677|FG003|Treatment Period|Protocol Violation|0|||
145938882|NCT01738503|526283678|FG004|Treatment Period|Protocol Violation|4|||
145938883|NCT01738503|526283679|FG005|Treatment Period|Protocol Violation|2|||
146245551|NCT03340961|527414004|FG003|Overall Study|Withdrawal by Subject|7|||
146297844|NCT02038920|527606029|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
145938884|NCT01738503|526283680|FG006|Treatment Period|Protocol Violation|0|||
145938885|NCT01738503|526283674|FG000|Treatment Period|Other|0|||
145938886|NCT01738503|526283675|FG001|Treatment Period|Other|0|||
145938887|NCT01738503|526283676|FG002|Treatment Period|Other|1|||
145938888|NCT01738503|526283677|FG003|Treatment Period|Other|0|||
145938889|NCT01738503|526283678|FG004|Treatment Period|Other|0|||
145938890|NCT01738503|526283679|FG005|Treatment Period|Other|0|||
145938891|NCT01738503|526283680|FG006|Treatment Period|Other|0|||
145980964|NCT00504309|526441032|FG004|Overall Study|Death|1|||
145980965|NCT00504309|526441033|FG005|Overall Study|Death|0|||
145980966|NCT00504309|526441028|FG000|Overall Study|Withdrawal by Subject|0|||
145980967|NCT00504309|526441029|FG001|Overall Study|Withdrawal by Subject|0|||
145980968|NCT00504309|526441030|FG002|Overall Study|Withdrawal by Subject|1|||
146091269|NCT04650854|526854930|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
146091270|NCT04650854|526854931|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
146091271|NCT04650854|526854929|FG000|Overall Study|End Of Study|0|||
146091272|NCT04650854|526854930|FG001|Overall Study|End Of Study|2|||
146091273|NCT04650854|526854931|FG002|Overall Study|End Of Study|1|||
146091274|NCT04650854|526854929|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
146091275|NCT04650854|526854930|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
146091276|NCT04650854|526854931|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
146091277|NCT04650854|526854929|FG000|Overall Study|Participant Received Rescue Medication|0|||
146091278|NCT04650854|526854930|FG001|Overall Study|Participant Received Rescue Medication|1|||
146091279|NCT04650854|526854931|FG002|Overall Study|Participant Received Rescue Medication|0|||
146091280|NCT04650854|526854929|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
146091281|NCT04650854|526854930|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
146091282|NCT04650854|526854931|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
146091283|NCT04650854|526854929|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
146091284|NCT04650854|526854930|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
146091285|NCT04650854|526854931|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
146091286|NCT04650854|526854929|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
146091287|NCT04650854|526854930|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
146091288|NCT04650854|526854931|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
146091289|NCT04650854|526854929|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
146091290|NCT04650854|526854930|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
146091291|NCT04650854|526854931|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
146091292|NCT04650854|526854929|FG000|Overall Study|Enrollment Cup|0|||
146091293|NCT04650854|526854930|FG001|Overall Study|Enrollment Cup|0|||
146091294|NCT04650854|526854931|FG002|Overall Study|Enrollment Cup|1|||
146091295|NCT02862600|526854932|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
146091296|NCT02862600|526854932|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
146091297|NCT02862600|526854932|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
146245552|NCT03340961|527414001|FG000|Overall Study|Use of prohibited treatment|0|||
146245553|NCT03340961|527414002|FG001|Overall Study|Use of prohibited treatment|3|||
146245554|NCT03340961|527414003|FG002|Overall Study|Use of prohibited treatment|2|||
146245555|NCT03340961|527414004|FG003|Overall Study|Use of prohibited treatment|4|||
146245556|NCT03340961|527414001|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
146245557|NCT03340961|527414002|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
145980969|NCT00504309|526441031|FG003|Overall Study|Withdrawal by Subject|0|||
145980970|NCT00504309|526441032|FG004|Overall Study|Withdrawal by Subject|0|||
145980971|NCT00504309|526441033|FG005|Overall Study|Withdrawal by Subject|0|||
145980972|NCT03345095|526441035|FG000|Overall Study|Lack of Efficacy|184|||
145980973|NCT03345095|526441036|FG001|Overall Study|Lack of Efficacy|156|||
145980974|NCT03345095|526441035|FG000|Overall Study|Adverse Event|36|||
145980975|NCT03345095|526441036|FG001|Overall Study|Adverse Event|118|||
145980976|NCT03345095|526441035|FG000|Overall Study|Withdrawal by Subject|22|||
145980977|NCT03345095|526441036|FG001|Overall Study|Withdrawal by Subject|59|||
145980978|NCT03345095|526441035|FG000|Overall Study|Physician Decision|3|||
145980979|NCT03345095|526441036|FG001|Overall Study|Physician Decision|18|||
145980980|NCT03345095|526441035|FG000|Overall Study|Death|2|||
145980981|NCT03345095|526441036|FG001|Overall Study|Death|4|||
145980982|NCT03345095|526441035|FG000|Overall Study|Other reasons|2|||
146245558|NCT03340961|527414003|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
146245559|NCT03340961|527414004|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
145980983|NCT03345095|526441036|FG001|Overall Study|Other reasons|11|||
145980984|NCT03345095|526441035|FG000|Overall Study|Protocol Violation|0|||
145980985|NCT03345095|526441036|FG001|Overall Study|Protocol Violation|1|||
145980986|NCT03158311|526441037|FG000|Overall Study|Subject/Guardian Decision|10|||
145980987|NCT03158311|526441038|FG001|Overall Study|Subject/Guardian Decision|6|||
145980988|NCT03158311|526441039|FG002|Overall Study|Subject/Guardian Decision|11|||
145980989|NCT03158311|526441037|FG000|Overall Study|Adverse Event|5|||
145980990|NCT03158311|526441038|FG001|Overall Study|Adverse Event|3|||
145980991|NCT03158311|526441039|FG002|Overall Study|Adverse Event|3|||
146091298|NCT02862600|526854932|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
146245560|NCT03340961|527414001|FG000|Overall Study|Subject developed an exclusion criterion|0|||
145980992|NCT03158311|526441037|FG000|Overall Study|Techinical Problems|3|||
145980993|NCT03158311|526441038|FG001|Overall Study|Techinical Problems|1|||
145980994|NCT03158311|526441039|FG002|Overall Study|Techinical Problems|5|||
145980995|NCT03158311|526441037|FG000|Overall Study|Physician Decision|2|||
145980996|NCT03158311|526441038|FG001|Overall Study|Physician Decision|3|||
145980997|NCT03158311|526441039|FG002|Overall Study|Physician Decision|7|||
145980998|NCT03158311|526441037|FG000|Overall Study|Lost to Follow-up|1|||
145980999|NCT03158311|526441038|FG001|Overall Study|Lost to Follow-up|1|||
145981000|NCT03158311|526441039|FG002|Overall Study|Lost to Follow-up|1|||
145981001|NCT03158311|526441037|FG000|Overall Study|Sponsor decision|1|||
145981002|NCT03158311|526441038|FG001|Overall Study|Sponsor decision|0|||
145981003|NCT03158311|526441039|FG002|Overall Study|Sponsor decision|0|||
145981004|NCT03158311|526441037|FG000|Overall Study|Pregnancy|0|||
145981005|NCT03158311|526441038|FG001|Overall Study|Pregnancy|2|||
145981006|NCT03158311|526441039|FG002|Overall Study|Pregnancy|0|||
145981007|NCT03158311|526441037|FG000|Overall Study|Randomized in error|0|||
145981008|NCT03158311|526441038|FG001|Overall Study|Randomized in error|0|||
145981009|NCT03158311|526441039|FG002|Overall Study|Randomized in error|1|||
145981010|NCT02665455|526441040|FG000|Overall Study|Withdrawal by Subject|6|||
145981011|NCT02665455|526441040|FG000|Overall Study|Lost to Follow-up|1|||
145981012|NCT02665455|526441040|FG000|Overall Study|Adverse Event|1|||
145981013|NCT02665455|526441040|FG000|Overall Study|Protocol Violation|1|||
145981014|NCT05865886|526441044|FG000|Overall Study|Serious adverse event|0|||
145981015|NCT05865886|526441045|FG001|Overall Study|Serious adverse event|1|||
145981016|NCT01105130|526442863|FG000|Overall Study|Withdrawal by Subject|4|||
145981017|NCT01105130|526442864|FG001|Overall Study|Withdrawal by Subject|6|||
145981018|NCT01105130|526442865|FG002|Overall Study|Withdrawal by Subject|2|||
145981019|NCT01105130|526442863|FG000|Overall Study|Never Started|2|||
145981020|NCT01105130|526442864|FG001|Overall Study|Never Started|2|||
145981021|NCT01105130|526442865|FG002|Overall Study|Never Started|4|||
145981022|NCT01105130|526442863|FG000|Overall Study|Toxicity|1|||
145981023|NCT01105130|526442864|FG001|Overall Study|Toxicity|3|||
145981024|NCT01105130|526442865|FG002|Overall Study|Toxicity|2|||
145981025|NCT01105130|526442863|FG000|Overall Study|Multiple Reasons|3|||
145981026|NCT01105130|526442864|FG001|Overall Study|Multiple Reasons|0|||
145981027|NCT01105130|526442865|FG002|Overall Study|Multiple Reasons|2|||
145981028|NCT00327171|526442866|FG000|Overall Study|Did not receive study medication|3|||
145981029|NCT00327171|526442867|FG001|Overall Study|Did not receive study medication|0|||
145981030|NCT00327171|526442866|FG000|Overall Study|Adverse Event|23|||
145981031|NCT00327171|526442867|FG001|Overall Study|Adverse Event|23|||
145981032|NCT00327171|526442866|FG000|Overall Study|Disease progression/lack of efficacy|68|||
145981033|NCT00327171|526442867|FG001|Overall Study|Disease progression/lack of efficacy|69|||
145981034|NCT00327171|526442866|FG000|Overall Study|Investigator/participant request|1|||
145981035|NCT00327171|526442867|FG001|Overall Study|Investigator/participant request|8|||
145981036|NCT00327171|526442866|FG000|Overall Study|Clinical progression|12|||
145981037|NCT00327171|526442867|FG001|Overall Study|Clinical progression|8|||
145981038|NCT00327171|526442866|FG000|Overall Study|Undisclosed history of ischemia|0|||
145981039|NCT00327171|526442867|FG001|Overall Study|Undisclosed history of ischemia|1|||
145981040|NCT00327171|526442866|FG000|Overall Study|Other|1|||
145981041|NCT00327171|526442867|FG001|Overall Study|Other|0|||
145981042|NCT02323334|526442868|FG000|Period 3|Lost to Follow-up|0|||
145981043|NCT02323334|526442869|FG001|Period 3|Lost to Follow-up|0|||
145981044|NCT02323334|526442870|FG002|Period 3|Lost to Follow-up|1|||
145981045|NCT02323334|526442871|FG003|Period 3|Lost to Follow-up|0|||
145981046|NCT02323334|526442872|FG004|Period 3|Lost to Follow-up|0|||
145981047|NCT02323334|526442873|FG005|Period 3|Lost to Follow-up|0|||
145981048|NCT02323334|526442874|FG006|Period 3|Lost to Follow-up|0|||
145981049|NCT02323334|526442875|FG007|Period 3|Lost to Follow-up|0|||
145981050|NCT02323334|526442876|FG008|Period 3|Lost to Follow-up|0|||
145981051|NCT02323334|526442877|FG009|Period 3|Lost to Follow-up|0|||
145981052|NCT02323334|526442878|FG010|Period 3|Lost to Follow-up|0|||
146091299|NCT00194675|526854941|FG000|Overall Study|Lost to Follow-up|1|||
146091300|NCT00194675|526854942|FG001|Overall Study|Lost to Follow-up|1|||
146091301|NCT00194675|526854941|FG000|Overall Study|lack of interest|1|||
146091302|NCT00194675|526854942|FG001|Overall Study|lack of interest|1|||
146091303|NCT00194675|526854941|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
145981053|NCT02323334|526442879|FG011|Period 3|Lost to Follow-up|0|||
145981054|NCT02323334|526442880|FG012|Period 3|Lost to Follow-up|0|||
146091304|NCT00194675|526854942|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
145981055|NCT02323334|526442881|FG013|Period 3|Lost to Follow-up|0|||
145981056|NCT02323334|526442882|FG014|Period 3|Lost to Follow-up|0|||
146091305|NCT00194675|526854941|FG000|Overall Study|Protocol Violation|1|||
146091306|NCT00194675|526854942|FG001|Overall Study|Protocol Violation|0|||
146091307|NCT00194675|526854941|FG000|Overall Study|Death|1|||
146091308|NCT00194675|526854942|FG001|Overall Study|Death|0|||
146245561|NCT03340961|527414002|FG001|Overall Study|Subject developed an exclusion criterion|1|||
145981057|NCT02323334|526442883|FG015|Period 3|Lost to Follow-up|0|||
145981058|NCT02323334|526442884|FG016|Period 3|Lost to Follow-up|0|||
145981059|NCT02323334|526442868|FG000|Period 3|Withdrawal by Subject|1|||
145981060|NCT02323334|526442869|FG001|Period 3|Withdrawal by Subject|0|||
145981061|NCT02323334|526442870|FG002|Period 3|Withdrawal by Subject|0|||
145981062|NCT02323334|526442871|FG003|Period 3|Withdrawal by Subject|0|||
145981063|NCT02323334|526442872|FG004|Period 3|Withdrawal by Subject|0|||
145981064|NCT02323334|526442873|FG005|Period 3|Withdrawal by Subject|0|||
146091309|NCT01285960|526854943|FG000|Overall Study|Withdrawal by Subject|2|||
145981065|NCT02323334|526442874|FG006|Period 3|Withdrawal by Subject|0|||
145981066|NCT02323334|526442875|FG007|Period 3|Withdrawal by Subject|0|||
145981067|NCT02323334|526442876|FG008|Period 3|Withdrawal by Subject|0|||
145981068|NCT02323334|526442877|FG009|Period 3|Withdrawal by Subject|0|||
145981069|NCT02323334|526442878|FG010|Period 3|Withdrawal by Subject|0|||
145981070|NCT02323334|526442879|FG011|Period 3|Withdrawal by Subject|0|||
145981071|NCT02323334|526442880|FG012|Period 3|Withdrawal by Subject|0|||
145981072|NCT02323334|526442881|FG013|Period 3|Withdrawal by Subject|0|||
145981073|NCT02323334|526442882|FG014|Period 3|Withdrawal by Subject|0|||
145981074|NCT02323334|526442883|FG015|Period 3|Withdrawal by Subject|0|||
145981075|NCT02323334|526442884|FG016|Period 3|Withdrawal by Subject|0|||
145981076|NCT00530075|526442885|FG000|Overall Study|Adverse Event|1|||
145981077|NCT00530075|526442885|FG000|Overall Study|Death|1|||
145981078|NCT00530075|526442885|FG000|Overall Study|Lack of Efficacy|3|||
145981079|NCT00530075|526442885|FG000|Overall Study|Protocol Violation|1|||
145981080|NCT00530075|526442885|FG000|Overall Study|Withdrawal by Subject|1|||
145981081|NCT03422718|526442886|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
145981082|NCT03422718|526442887|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
145981083|NCT03422718|526442888|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
145981084|NCT03422718|526442889|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
145981085|NCT03422718|526442890|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
145981086|NCT03422718|526442891|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
145981087|NCT03422718|526442892|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
145981088|NCT03422718|526442893|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
145981089|NCT03422718|526442886|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
145981090|NCT03422718|526442887|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
145981091|NCT03422718|526442888|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
145981092|NCT03422718|526442889|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
145981093|NCT03422718|526442890|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
145981094|NCT03422718|526442891|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
145981095|NCT03422718|526442892|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
145981096|NCT03422718|526442893|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
145981097|NCT03422718|526442886|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
145981098|NCT03422718|526442887|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
145981099|NCT03422718|526442888|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
145981100|NCT03422718|526442889|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145981101|NCT03422718|526442890|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
145981102|NCT03422718|526442891|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145981103|NCT03422718|526442892|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145981104|NCT03422718|526442893|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
145981105|NCT03422718|526442886|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145981106|NCT03422718|526442887|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
145981107|NCT03422718|526442888|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145981108|NCT03422718|526442889|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145981109|NCT03422718|526442890|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
145981110|NCT03422718|526442891|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
145981111|NCT03422718|526442892|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145981112|NCT03422718|526442893|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145981113|NCT03422718|526442886|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
145981114|NCT03422718|526442887|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
145981115|NCT03422718|526442888|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
145981116|NCT03422718|526442889|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
145981117|NCT03422718|526442890|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
145981118|NCT03422718|526442891|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
145981119|NCT03422718|526442892|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
145981120|NCT03422718|526442893|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
145981121|NCT03422718|526442886|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
145981122|NCT03422718|526442887|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
145981123|NCT03422718|526442888|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
145981124|NCT03422718|526442889|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
145981125|NCT03422718|526442890|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
145981126|NCT03422718|526442891|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
145981127|NCT03422718|526442892|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
145981128|NCT03422718|526442893|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
145981129|NCT03309605|526442894|FG000|Overall Study|Adverse Event|0|||
145981130|NCT03309605|526442895|FG001|Overall Study|Adverse Event|0|||
146091310|NCT01285960|526854943|FG000|Overall Study|Lost to Follow-up|2|||
146091311|NCT01285960|526854943|FG000|Overall Study|2 subjects received less 10 sonications|2|||
145981131|NCT03309605|526442896|FG002|Overall Study|Adverse Event|0|||
145981132|NCT03309605|526442897|FG003|Overall Study|Adverse Event|1|||
145981133|NCT03309605|526442898|FG004|Overall Study|Adverse Event|0|||
145981134|NCT03309605|526442899|FG005|Overall Study|Adverse Event|0|||
145981135|NCT03309605|526442900|FG006|Overall Study|Adverse Event|2|||
145981136|NCT03309605|526442901|FG007|Overall Study|Adverse Event|1|||
145981137|NCT03309605|526442894|FG000|Overall Study|Withdrawal by Subject|0|||
145981138|NCT03309605|526442895|FG001|Overall Study|Withdrawal by Subject|0|||
145981139|NCT03309605|526442896|FG002|Overall Study|Withdrawal by Subject|0|||
145981140|NCT03309605|526442897|FG003|Overall Study|Withdrawal by Subject|0|||
145981141|NCT03309605|526442898|FG004|Overall Study|Withdrawal by Subject|1|||
145981142|NCT03309605|526442899|FG005|Overall Study|Withdrawal by Subject|0|||
145981143|NCT03309605|526442900|FG006|Overall Study|Withdrawal by Subject|1|||
145981144|NCT03309605|526442901|FG007|Overall Study|Withdrawal by Subject|1|||
145981145|NCT01129284|526442902|FG000|Overall Study|Adverse Event|2|||
145981146|NCT01129284|526442903|FG001|Overall Study|Adverse Event|0|||
145981147|NCT01129284|526442904|FG002|Overall Study|Adverse Event|1|||
145981148|NCT00784927|526442907|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
145981149|NCT00784927|526442907|FG000|Overall Study|Protocol Violation|1|||
145981150|NCT00784927|526442907|FG000|Overall Study|Ineligible|1|||
145981151|NCT00422461|526442914|FG000|Overall Study|Adverse Event|1|||
145981152|NCT00422461|526442915|FG001|Overall Study|Adverse Event|2|||
145981153|NCT00422461|526442916|FG002|Overall Study|Adverse Event|1|||
145981154|NCT00422461|526442917|FG003|Overall Study|Adverse Event|1|||
145981155|NCT00422461|526442914|FG000|Overall Study|Other|0|||
145981156|NCT00422461|526442915|FG001|Overall Study|Other|0|||
145981157|NCT00422461|526442916|FG002|Overall Study|Other|0|||
145981158|NCT00422461|526442917|FG003|Overall Study|Other|2|||
145981159|NCT00422461|526442914|FG000|Overall Study|Participants no longer willing to participate in study|1|||
145981160|NCT00422461|526442915|FG001|Overall Study|Participants no longer willing to participate in study|0|||
145981161|NCT00422461|526442916|FG002|Overall Study|Participants no longer willing to participate in study|0|||
145981162|NCT00422461|526442917|FG003|Overall Study|Participants no longer willing to participate in study|0|||
145981163|NCT00422461|526442914|FG000|Overall Study|Randomized but not treated|1|||
145981164|NCT00422461|526442915|FG001|Overall Study|Randomized but not treated|1|||
145981165|NCT00422461|526442916|FG002|Overall Study|Randomized but not treated|0|||
145981166|NCT00422461|526442917|FG003|Overall Study|Randomized but not treated|0|||
145981167|NCT01795937|526442919|FG000|Overall Study|Withdrawal by Subject|1|||
145981168|NCT01795937|526442920|FG001|Overall Study|Withdrawal by Subject|0|||
145981169|NCT01795937|526442921|FG002|Overall Study|Withdrawal by Subject|0|||
145981170|NCT01795937|526442919|FG000|Overall Study|Physician Decision|0|||
145981171|NCT01795937|526442920|FG001|Overall Study|Physician Decision|1|||
145981172|NCT01795937|526442921|FG002|Overall Study|Physician Decision|0|||
145981173|NCT01028053|526442922|FG000|Overall Study|Screen Failure|113|||
145981174|NCT01028053|526442922|FG000|Overall Study|Patient Request|11|||
145981175|NCT01028053|526442922|FG000|Overall Study|Protocol Violation|1|||
145981176|NCT01028053|526442922|FG000|Overall Study|Physician Decision|2|||
145981177|NCT01028053|526442922|FG000|Overall Study|Technical Problem|1|||
145981178|NCT01028053|526442922|FG000|Overall Study|Terminated by Sponsor|1|||
145981179|NCT01028053|526442922|FG000|Overall Study|Various reasons|4|||
145981180|NCT00245570|526442927|FG000|Washout Between Periods III and IV|Adverse Event|0|||
145981181|NCT00245570|526442928|FG001|Washout Between Periods III and IV|Adverse Event|1|||
145981182|NCT00245570|526442929|FG002|Washout Between Periods III and IV|Adverse Event|0|||
145981183|NCT00245570|526442930|FG003|Washout Between Periods III and IV|Adverse Event|0|||
145981184|NCT00245570|526442931|FG004|Washout Between Periods III and IV|Adverse Event|0|||
145981185|NCT00245570|526442932|FG005|Washout Between Periods III and IV|Adverse Event|0|||
145981186|NCT01913470|526442935|FG000|Overall Study|Lost to Follow-up|0|||
145981187|NCT01913470|526442936|FG001|Overall Study|Lost to Follow-up|1|||
145981188|NCT01913470|526442935|FG000|Overall Study|Physician Decision|0|||
145981189|NCT01913470|526442936|FG001|Overall Study|Physician Decision|1|||
145981190|NCT01913470|526442935|FG000|Overall Study|Withdrawal by Subject|0|||
145981191|NCT01913470|526442936|FG001|Overall Study|Withdrawal by Subject|1|||
145981192|NCT02400580|526442960|FG000|Overall Study|Withdrawal by Subject|1|||
145981193|NCT02400580|526442961|FG001|Overall Study|Withdrawal by Subject|1|||
145981194|NCT02400580|526442960|FG000|Overall Study|Adverse Event|1|||
145981195|NCT02400580|526442961|FG001|Overall Study|Adverse Event|0|||
145981196|NCT02384460|526442962|FG000|Overall Study|Protocol Violation|0|||
145981197|NCT02384460|526442963|FG001|Overall Study|Protocol Violation|1|||
145981198|NCT02384460|526442962|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
145981199|NCT02384460|526442963|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
145981200|NCT02384460|526442962|FG000|Overall Study|Adverse Event|5|||
145981201|NCT02384460|526442963|FG001|Overall Study|Adverse Event|2|||
145981202|NCT02384460|526442962|FG000|Overall Study|Withdrawal by Subject|0|||
145981203|NCT02384460|526442963|FG001|Overall Study|Withdrawal by Subject|3|||
145981204|NCT02384460|526442962|FG000|Overall Study|Elective medical treatment|1|||
145981205|NCT02384460|526442963|FG001|Overall Study|Elective medical treatment|0|||
145981206|NCT02384460|526442962|FG000|Overall Study|Non-compliance|1|||
145938892|NCT01738503|526283674|FG000|PET Imaging Sub-study|Adverse Event|0|||
145938893|NCT01738503|526283675|FG001|PET Imaging Sub-study|Adverse Event|0|||
145938894|NCT01738503|526283676|FG002|PET Imaging Sub-study|Adverse Event|0|||
145938895|NCT01738503|526283677|FG003|PET Imaging Sub-study|Adverse Event|0|||
145938896|NCT01738503|526283678|FG004|PET Imaging Sub-study|Adverse Event|0|||
145938897|NCT01738503|526283679|FG005|PET Imaging Sub-study|Adverse Event|1|||
145938898|NCT01738503|526283680|FG006|PET Imaging Sub-study|Adverse Event|0|||
145938899|NCT01738503|526283674|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145938900|NCT01738503|526283675|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145938901|NCT01738503|526283676|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145938902|NCT01738503|526283677|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145938903|NCT01738503|526283678|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145938904|NCT01738503|526283679|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
145938905|NCT01738503|526283680|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
145938906|NCT04696354|526283681|FG000|Overall Study|Study termination|6|||
145938907|NCT04696354|526283682|FG001|Overall Study|Study termination|6|||
145938908|NCT03005327|526283683|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145938909|NCT03005327|526283684|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145938910|NCT03005327|526283685|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
145938911|NCT03005327|526283686|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145938912|NCT03005327|526283683|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145938913|NCT03005327|526283684|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145938914|NCT03005327|526283685|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145938915|NCT03005327|526283686|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145938916|NCT04687072|526283687|FG000|Overall Study|Adverse Event|2|||
145938917|NCT04687072|526283688|FG001|Overall Study|Adverse Event|0|||
145938918|NCT04687072|526283687|FG000|Overall Study|Death|1|||
145938919|NCT04687072|526283688|FG001|Overall Study|Death|0|||
145938920|NCT04687072|526283687|FG000|Overall Study|Lack of Efficacy|2|||
145938921|NCT04687072|526283688|FG001|Overall Study|Lack of Efficacy|1|||
145938922|NCT04687072|526283687|FG000|Overall Study|Physician Decision|1|||
145938923|NCT04687072|526283688|FG001|Overall Study|Physician Decision|0|||
145938924|NCT04687072|526283687|FG000|Overall Study|Pregnancy|1|||
145938925|NCT04687072|526283688|FG001|Overall Study|Pregnancy|0|||
145938926|NCT04687072|526283687|FG000|Overall Study|Requires Prohibited Medication|2|||
145938927|NCT04687072|526283688|FG001|Overall Study|Requires Prohibited Medication|0|||
145938928|NCT04687072|526283687|FG000|Overall Study|Withdrawal of Consent|11|||
145938929|NCT04687072|526283688|FG001|Overall Study|Withdrawal of Consent|6|||
145938930|NCT04687072|526283687|FG000|Overall Study|Miscellaneous|4|||
145938931|NCT04687072|526283688|FG001|Overall Study|Miscellaneous|1|||
145938932|NCT02600845|526283693|FG000|Overall Study|Reason Not Specified|3|||
145938933|NCT02600845|526283693|FG000|Overall Study|Non-compliance with Study Procedures|10|||
145938934|NCT02600845|526283693|FG000|Overall Study|Consent Withdrawal|5|||
145938935|NCT00965341|526283694|FG000|Overall Study|Withdrew consent|1|||
145938936|NCT00965341|526283695|FG001|Overall Study|Withdrew consent|5|||
145938937|NCT00965341|526283694|FG000|Overall Study|Lost to Follow-up|1|||
145938938|NCT00965341|526283695|FG001|Overall Study|Lost to Follow-up|0|||
145938939|NCT00965341|526283694|FG000|Overall Study|Transportation issues|4|||
145938940|NCT00965341|526283695|FG001|Overall Study|Transportation issues|3|||
145938941|NCT02234596|526283696|FG000|Overall Study|Participant not treated|2|||
145938942|NCT03666533|526285801|FG000|Overall Study|Lost to Follow-up|2|||
145938943|NCT03666533|526285802|FG001|Overall Study|Lost to Follow-up|2|||
145938944|NCT02017717|526285803|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938945|NCT02017717|526285804|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938946|NCT02017717|526285805|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938947|NCT02017717|526285806|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938948|NCT02017717|526285807|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938949|NCT02017717|526285808|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938950|NCT02017717|526285809|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938951|NCT02017717|526285810|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
145938952|NCT02017717|526285811|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145938953|NCT02017717|526285803|FG000|Before Treatment Period|Participant request to stop therapy|0|||
145938954|NCT02017717|526285804|FG001|Before Treatment Period|Participant request to stop therapy|0|||
145938955|NCT02017717|526285805|FG002|Before Treatment Period|Participant request to stop therapy|0|||
145938956|NCT02017717|526285806|FG003|Before Treatment Period|Participant request to stop therapy|0|||
145938957|NCT02017717|526285807|FG004|Before Treatment Period|Participant request to stop therapy|0|||
145938958|NCT02017717|526285808|FG005|Before Treatment Period|Participant request to stop therapy|0|||
145938959|NCT02017717|526285809|FG006|Before Treatment Period|Participant request to stop therapy|0|||
145938960|NCT02017717|526285810|FG007|Before Treatment Period|Participant request to stop therapy|0|||
145938961|NCT02017717|526285811|FG008|Before Treatment Period|Participant request to stop therapy|5|||
146245562|NCT03340961|527414003|FG002|Overall Study|Subject developed an exclusion criterion|0|||
146245563|NCT03340961|527414004|FG003|Overall Study|Subject developed an exclusion criterion|0|||
146245564|NCT03340961|527414001|FG000|Overall Study|Protocol Violation|1|||
146245565|NCT03340961|527414002|FG001|Overall Study|Protocol Violation|0|||
146245566|NCT03340961|527414003|FG002|Overall Study|Protocol Violation|1|||
146245567|NCT03340961|527414004|FG003|Overall Study|Protocol Violation|0|||
146245568|NCT03340961|527414001|FG000|Overall Study|Adverse Event|1|||
146245569|NCT03340961|527414002|FG001|Overall Study|Adverse Event|1|||
145938962|NCT02017717|526285803|FG000|Before Treatment Period|Participant withdrew consent|0|||
145938963|NCT02017717|526285804|FG001|Before Treatment Period|Participant withdrew consent|0|||
145938964|NCT02017717|526285805|FG002|Before Treatment Period|Participant withdrew consent|0|||
145938965|NCT02017717|526285806|FG003|Before Treatment Period|Participant withdrew consent|0|||
145938966|NCT02017717|526285807|FG004|Before Treatment Period|Participant withdrew consent|0|||
145938967|NCT02017717|526285808|FG005|Before Treatment Period|Participant withdrew consent|0|||
145938968|NCT02017717|526285809|FG006|Before Treatment Period|Participant withdrew consent|2|||
145938969|NCT02017717|526285810|FG007|Before Treatment Period|Participant withdrew consent|0|||
145938970|NCT02017717|526285811|FG008|Before Treatment Period|Participant withdrew consent|11|||
145938971|NCT02017717|526285803|FG000|Before Treatment Period|Lost to Follow-up|0|||
145938972|NCT02017717|526285804|FG001|Before Treatment Period|Lost to Follow-up|0|||
145938973|NCT02017717|526285805|FG002|Before Treatment Period|Lost to Follow-up|0|||
145938974|NCT02017717|526285806|FG003|Before Treatment Period|Lost to Follow-up|0|||
145938975|NCT02017717|526285807|FG004|Before Treatment Period|Lost to Follow-up|0|||
145938976|NCT02017717|526285808|FG005|Before Treatment Period|Lost to Follow-up|0|||
145938977|NCT02017717|526285809|FG006|Before Treatment Period|Lost to Follow-up|0|||
145938978|NCT02017717|526285810|FG007|Before Treatment Period|Lost to Follow-up|0|||
145938979|NCT02017717|526285811|FG008|Before Treatment Period|Lost to Follow-up|1|||
145938980|NCT02017717|526285803|FG000|Before Treatment Period|Participant no longer met criteria|0|||
145938981|NCT02017717|526285804|FG001|Before Treatment Period|Participant no longer met criteria|0|||
145938982|NCT02017717|526285805|FG002|Before Treatment Period|Participant no longer met criteria|0|||
145938983|NCT02017717|526285806|FG003|Before Treatment Period|Participant no longer met criteria|0|||
145938984|NCT02017717|526285807|FG004|Before Treatment Period|Participant no longer met criteria|0|||
145938985|NCT02017717|526285808|FG005|Before Treatment Period|Participant no longer met criteria|1|||
145938986|NCT02017717|526285809|FG006|Before Treatment Period|Participant no longer met criteria|0|||
145938987|NCT02017717|526285810|FG007|Before Treatment Period|Participant no longer met criteria|1|||
145938988|NCT02017717|526285811|FG008|Before Treatment Period|Participant no longer met criteria|2|||
145938989|NCT02017717|526285803|FG000|Before Treatment Period|other reason|0|||
145938990|NCT02017717|526285804|FG001|Before Treatment Period|other reason|0|||
145938991|NCT02017717|526285805|FG002|Before Treatment Period|other reason|0|||
145938992|NCT02017717|526285806|FG003|Before Treatment Period|other reason|0|||
145938993|NCT02017717|526285807|FG004|Before Treatment Period|other reason|0|||
145938994|NCT02017717|526285808|FG005|Before Treatment Period|other reason|0|||
145938995|NCT02017717|526285809|FG006|Before Treatment Period|other reason|0|||
145938996|NCT02017717|526285810|FG007|Before Treatment Period|other reason|0|||
145938997|NCT02017717|526285811|FG008|Before Treatment Period|other reason|1|||
145938998|NCT02017717|526285803|FG000|Treatment Period|Disease progression|7|||
145938999|NCT02017717|526285804|FG001|Treatment Period|Disease progression|9|||
145939000|NCT02017717|526285805|FG002|Treatment Period|Disease progression|12|||
145939001|NCT02017717|526285806|FG003|Treatment Period|Disease progression|20|||
145939002|NCT02017717|526285807|FG004|Treatment Period|Disease progression|26|||
145939003|NCT02017717|526285808|FG005|Treatment Period|Disease progression|16|||
145939004|NCT02017717|526285809|FG006|Treatment Period|Disease progression|22|||
145939005|NCT02017717|526285810|FG007|Treatment Period|Disease progression|165|||
145939006|NCT02017717|526285811|FG008|Treatment Period|Disease progression|135|||
145939007|NCT02017717|526285803|FG000|Treatment Period|Study drug toxicity|3|||
145939008|NCT02017717|526285804|FG001|Treatment Period|Study drug toxicity|0|||
145939009|NCT02017717|526285805|FG002|Treatment Period|Study drug toxicity|1|||
145939010|NCT02017717|526285806|FG003|Treatment Period|Study drug toxicity|4|||
145939011|NCT02017717|526285807|FG004|Treatment Period|Study drug toxicity|4|||
145939012|NCT02017717|526285808|FG005|Treatment Period|Study drug toxicity|5|||
145939013|NCT02017717|526285809|FG006|Treatment Period|Study drug toxicity|3|||
145939014|NCT02017717|526285810|FG007|Treatment Period|Study drug toxicity|7|||
145939015|NCT02017717|526285811|FG008|Treatment Period|Study drug toxicity|11|||
145939016|NCT02017717|526285803|FG000|Treatment Period|Death|0|||
145939017|NCT02017717|526285804|FG001|Treatment Period|Death|0|||
145939018|NCT02017717|526285805|FG002|Treatment Period|Death|1|||
145939019|NCT02017717|526285806|FG003|Treatment Period|Death|0|||
145939020|NCT02017717|526285807|FG004|Treatment Period|Death|0|||
145939021|NCT02017717|526285808|FG005|Treatment Period|Death|2|||
145939022|NCT02017717|526285809|FG006|Treatment Period|Death|0|||
145939023|NCT02017717|526285810|FG007|Treatment Period|Death|0|||
145939024|NCT02017717|526285811|FG008|Treatment Period|Death|0|||
145939025|NCT02017717|526285803|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
146245570|NCT03340961|527414003|FG002|Overall Study|Adverse Event|0|||
145939026|NCT02017717|526285804|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
145939027|NCT02017717|526285805|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
145981207|NCT02384460|526442963|FG001|Overall Study|Non-compliance|0|||
145939028|NCT02017717|526285806|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
145939029|NCT02017717|526285807|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
145939030|NCT02017717|526285808|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
145939031|NCT02017717|526285809|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
145939032|NCT02017717|526285810|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
145939033|NCT02017717|526285811|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
145939034|NCT02017717|526285803|FG000|Treatment Period|Participant request to stop therapy|0|||
145939035|NCT02017717|526285804|FG001|Treatment Period|Participant request to stop therapy|0|||
145939036|NCT02017717|526285805|FG002|Treatment Period|Participant request to stop therapy|3|||
145939037|NCT02017717|526285806|FG003|Treatment Period|Participant request to stop therapy|6|||
145939038|NCT02017717|526285807|FG004|Treatment Period|Participant request to stop therapy|0|||
145939039|NCT02017717|526285808|FG005|Treatment Period|Participant request to stop therapy|2|||
145939040|NCT02017717|526285809|FG006|Treatment Period|Participant request to stop therapy|1|||
145939041|NCT02017717|526285810|FG007|Treatment Period|Participant request to stop therapy|4|||
145939042|NCT02017717|526285811|FG008|Treatment Period|Participant request to stop therapy|7|||
145939043|NCT02017717|526285803|FG000|Treatment Period|Participant withdrew consent|0|||
145939044|NCT02017717|526285804|FG001|Treatment Period|Participant withdrew consent|0|||
145939045|NCT02017717|526285805|FG002|Treatment Period|Participant withdrew consent|1|||
145939046|NCT02017717|526285806|FG003|Treatment Period|Participant withdrew consent|0|||
145939047|NCT02017717|526285807|FG004|Treatment Period|Participant withdrew consent|0|||
145939048|NCT02017717|526285808|FG005|Treatment Period|Participant withdrew consent|2|||
145939049|NCT02017717|526285809|FG006|Treatment Period|Participant withdrew consent|0|||
145939050|NCT02017717|526285810|FG007|Treatment Period|Participant withdrew consent|1|||
145939051|NCT02017717|526285811|FG008|Treatment Period|Participant withdrew consent|4|||
145939052|NCT02017717|526285803|FG000|Treatment Period|Participant no longer met criteria|0|||
145939053|NCT02017717|526285804|FG001|Treatment Period|Participant no longer met criteria|0|||
145939054|NCT02017717|526285805|FG002|Treatment Period|Participant no longer met criteria|0|||
145939055|NCT02017717|526285806|FG003|Treatment Period|Participant no longer met criteria|0|||
145939056|NCT02017717|526285807|FG004|Treatment Period|Participant no longer met criteria|0|||
145939057|NCT02017717|526285808|FG005|Treatment Period|Participant no longer met criteria|0|||
145939058|NCT02017717|526285809|FG006|Treatment Period|Participant no longer met criteria|0|||
145939059|NCT02017717|526285810|FG007|Treatment Period|Participant no longer met criteria|0|||
145939060|NCT02017717|526285811|FG008|Treatment Period|Participant no longer met criteria|1|||
145939061|NCT02017717|526285803|FG000|Treatment Period|Other reasons|0|||
145939062|NCT02017717|526285804|FG001|Treatment Period|Other reasons|0|||
145939063|NCT02017717|526285805|FG002|Treatment Period|Other reasons|0|||
145939064|NCT02017717|526285806|FG003|Treatment Period|Other reasons|1|||
145939065|NCT02017717|526285807|FG004|Treatment Period|Other reasons|0|||
145939066|NCT02017717|526285808|FG005|Treatment Period|Other reasons|1|||
145939067|NCT02017717|526285809|FG006|Treatment Period|Other reasons|1|||
145939068|NCT02017717|526285810|FG007|Treatment Period|Other reasons|1|||
145939069|NCT02017717|526285811|FG008|Treatment Period|Other reasons|1|||
145939070|NCT02017717|526285803|FG000|Treatment Period|Maximum clinical benefit|0|||
145939071|NCT02017717|526285804|FG001|Treatment Period|Maximum clinical benefit|0|||
145939072|NCT02017717|526285805|FG002|Treatment Period|Maximum clinical benefit|0|||
145939073|NCT02017717|526285806|FG003|Treatment Period|Maximum clinical benefit|0|||
145939074|NCT02017717|526285807|FG004|Treatment Period|Maximum clinical benefit|0|||
145939075|NCT02017717|526285808|FG005|Treatment Period|Maximum clinical benefit|0|||
145939076|NCT02017717|526285809|FG006|Treatment Period|Maximum clinical benefit|0|||
145939077|NCT02017717|526285810|FG007|Treatment Period|Maximum clinical benefit|0|||
145939078|NCT02017717|526285811|FG008|Treatment Period|Maximum clinical benefit|1|||
145939079|NCT02017717|526285803|FG000|Treatment Period|Not reported|0|||
145939080|NCT02017717|526285804|FG001|Treatment Period|Not reported|1|||
145939081|NCT02017717|526285805|FG002|Treatment Period|Not reported|0|||
145939082|NCT02017717|526285806|FG003|Treatment Period|Not reported|0|||
145939083|NCT02017717|526285807|FG004|Treatment Period|Not reported|0|||
145939084|NCT02017717|526285808|FG005|Treatment Period|Not reported|0|||
145939085|NCT02017717|526285809|FG006|Treatment Period|Not reported|0|||
145939086|NCT02017717|526285810|FG007|Treatment Period|Not reported|0|||
145939087|NCT02017717|526285811|FG008|Treatment Period|Not reported|0|||
145939088|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
145939089|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
145939090|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
145939091|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
145939092|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
145939093|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
145939094|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
145981208|NCT00965094|526442966|FG000|Overall Study|Adverse Event|5|||
145981209|NCT00965094|526442967|FG001|Overall Study|Adverse Event|0|||
145981210|NCT00965094|526442966|FG000|Overall Study|Lost to Follow-up|0|||
145981211|NCT00965094|526442967|FG001|Overall Study|Lost to Follow-up|1|||
145981212|NCT01060111|526442968|FG000|Overall Study|Adverse Event|9|||
145981213|NCT01060111|526442969|FG001|Overall Study|Adverse Event|5|||
145981214|NCT01060111|526442970|FG002|Overall Study|Adverse Event|18|||
145981215|NCT01060111|526442968|FG000|Overall Study|Lack of Efficacy|2|||
145981216|NCT01060111|526442969|FG001|Overall Study|Lack of Efficacy|1|||
145981217|NCT01060111|526442970|FG002|Overall Study|Lack of Efficacy|0|||
145981218|NCT01060111|526442968|FG000|Overall Study|Inappropriate participant|5|||
145981219|NCT01060111|526442969|FG001|Overall Study|Inappropriate participant|4|||
145981220|NCT01060111|526442970|FG002|Overall Study|Inappropriate participant|5|||
145981221|NCT01060111|526442968|FG000|Overall Study|Participants' evasion for hospital visit|0|||
145981222|NCT01060111|526442969|FG001|Overall Study|Participants' evasion for hospital visit|3|||
145981223|NCT01060111|526442970|FG002|Overall Study|Participants' evasion for hospital visit|2|||
145981224|NCT01060111|526442968|FG000|Overall Study|Participants' non-cooperation|8|||
145981225|NCT01060111|526442969|FG001|Overall Study|Participants' non-cooperation|6|||
145981226|NCT01060111|526442970|FG002|Overall Study|Participants' non-cooperation|6|||
145981227|NCT01060111|526442968|FG000|Overall Study|Adverse event and insufficient effect|0|||
145981228|NCT01060111|526442969|FG001|Overall Study|Adverse event and insufficient effect|1|||
145981229|NCT01060111|526442970|FG002|Overall Study|Adverse event and insufficient effect|0|||
145981230|NCT01060111|526442968|FG000|Overall Study|Participants' non-cooperation|1|||
145981231|NCT01060111|526442969|FG001|Overall Study|Participants' non-cooperation|0|||
145981232|NCT01060111|526442970|FG002|Overall Study|Participants' non-cooperation|0|||
145981233|NCT01060111|526442968|FG000|Overall Study|Other|2|||
145981234|NCT01060111|526442969|FG001|Overall Study|Other|3|||
145981235|NCT01060111|526442970|FG002|Overall Study|Other|4|||
145981236|NCT01336972|526442976|FG000|Overall Study|Adverse Event|1|||
145981237|NCT01336972|526442977|FG001|Overall Study|Adverse Event|1|||
145981238|NCT01336972|526442978|FG002|Overall Study|Adverse Event|0|||
145981239|NCT02441114|526442979|FG000|Washout2|Withdrawal by Subject|4|||
145981240|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
145981241|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
145981242|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
145981243|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
145981244|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
145981245|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
145981246|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
145981247|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
145981248|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
145981249|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
145981250|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
145981251|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
145981252|NCT03446573|526442981|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
145981253|NCT03446573|526442982|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
145981254|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
145981255|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
145981256|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
145981257|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
145981258|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
145981259|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
145981260|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
145981261|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
145981262|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
145981263|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
145981264|NCT03446573|526442981|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
145981265|NCT03446573|526442982|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
145981266|NCT00625378|526442987|FG000|Overall Study|Adverse Event|22|||
145981267|NCT00625378|526442988|FG001|Overall Study|Adverse Event|0|||
145981268|NCT00625378|526442987|FG000|Overall Study|Withdrawal by Subject|16|||
145981269|NCT00625378|526442988|FG001|Overall Study|Withdrawal by Subject|0|||
145981270|NCT00625378|526442987|FG000|Overall Study|Death|38|||
145981271|NCT00625378|526442988|FG001|Overall Study|Death|0|||
145981272|NCT00625378|526442987|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
145981273|NCT00625378|526442988|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
145981274|NCT00625378|526442987|FG000|Overall Study|Lost to Follow-up|17|||
146297845|NCT02038920|527606030|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
145981275|NCT00625378|526442988|FG001|Overall Study|Lost to Follow-up|0|||
145981276|NCT00625378|526442987|FG000|Overall Study|Non-compliant with study medication|3|||
146297846|NCT02038920|527606031|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
145981277|NCT00625378|526442988|FG001|Overall Study|Non-compliant with study medication|0|||
145981278|NCT00625378|526442987|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
145981279|NCT00625378|526442988|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
145981280|NCT00625378|526442987|FG000|Overall Study|Medical decision|1|||
145981281|NCT00625378|526442988|FG001|Overall Study|Medical decision|0|||
145981282|NCT00625378|526442987|FG000|Overall Study|Multiple toxicities|1|||
145981283|NCT00625378|526442988|FG001|Overall Study|Multiple toxicities|0|||
145981284|NCT00625378|526442987|FG000|Overall Study|New cancer|1|||
145981285|NCT00625378|526442988|FG001|Overall Study|New cancer|0|||
145981286|NCT00625378|526442987|FG000|Overall Study|PTA program|2|||
145981287|NCT00625378|526442988|FG001|Overall Study|PTA program|0|||
145981288|NCT00625378|526442987|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
145981289|NCT00625378|526442988|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
145981290|NCT00625378|526442987|FG000|Overall Study|Sponsor decision|1|||
145981291|NCT00625378|526442988|FG001|Overall Study|Sponsor decision|0|||
145981292|NCT00625378|526442987|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
145981293|NCT00625378|526442988|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
145981294|NCT00625378|526442987|FG000|Overall Study|Switch to commercial drug|6|||
145981295|NCT00625378|526442988|FG001|Overall Study|Switch to commercial drug|1|||
145981296|NCT00625378|526442987|FG000|Overall Study|Missing|2|||
145981297|NCT00625378|526442988|FG001|Overall Study|Missing|0|||
145981298|NCT00625378|526442987|FG000|Overall Study|End of treatment not available|2|||
145981299|NCT00625378|526442988|FG001|Overall Study|End of treatment not available|0|||
145981300|NCT00625378|526442987|FG000|Overall Study|Never treated|2|||
145981301|NCT00625378|526442988|FG001|Overall Study|Never treated|0|||
145981302|NCT04270760|526442989|FG000|Overall Study|Withdrawal by Subject|0|||
145981303|NCT04270760|526442990|FG001|Overall Study|Withdrawal by Subject|1|||
145981304|NCT04270760|526442991|FG002|Overall Study|Withdrawal by Subject|3|||
145981305|NCT04270760|526442992|FG003|Overall Study|Withdrawal by Subject|0|||
145981306|NCT04270760|526442993|FG004|Overall Study|Withdrawal by Subject|0|||
145981307|NCT04270760|526442989|FG000|Overall Study|Lost to Follow-up|1|||
145981308|NCT04270760|526442990|FG001|Overall Study|Lost to Follow-up|2|||
145981309|NCT04270760|526442991|FG002|Overall Study|Lost to Follow-up|1|||
145981310|NCT04270760|526442992|FG003|Overall Study|Lost to Follow-up|0|||
145981311|NCT04270760|526442993|FG004|Overall Study|Lost to Follow-up|0|||
145981312|NCT04270760|526442989|FG000|Overall Study|Death|0|||
145981313|NCT04270760|526442990|FG001|Overall Study|Death|0|||
145981314|NCT04270760|526442991|FG002|Overall Study|Death|0|||
145981315|NCT04270760|526442992|FG003|Overall Study|Death|0|||
145981316|NCT04270760|526442993|FG004|Overall Study|Death|1|||
145981317|NCT02070991|526442994|FG000|Overall Study|Death|2|||
145981318|NCT02070991|526442995|FG001|Overall Study|Death|0|||
145981319|NCT02070991|526442994|FG000|Overall Study|Withdrawal by Subject|1|||
145981320|NCT02070991|526442995|FG001|Overall Study|Withdrawal by Subject|0|||
145981321|NCT02448043|526442998|FG000|Overall Study|Withdrawal by Subject|2|||
145981322|NCT02448043|526442999|FG001|Overall Study|Withdrawal by Subject|2|||
145981323|NCT02448043|526442998|FG000|Overall Study|Protocol Violation|1|||
145981324|NCT02448043|526442999|FG001|Overall Study|Protocol Violation|2|||
145981325|NCT01769443|526443004|FG000|Overall Study|Study closure|1|||
145981326|NCT01769443|526443005|FG001|Overall Study|Study closure|0|||
145981327|NCT04149353|526443016|FG000|Overall Study|Study terminated|1|||
145981328|NCT02068599|526443017|FG000|Overall Study|Adverse Event|4|||
145981329|NCT02068599|526443018|FG001|Overall Study|Adverse Event|1|||
145981330|NCT02068599|526443019|FG002|Overall Study|Adverse Event|1|||
145981331|NCT02068599|526443017|FG000|Overall Study|Withdrawal by Subject|2|||
145981332|NCT02068599|526443018|FG001|Overall Study|Withdrawal by Subject|7|||
145981333|NCT02068599|526443019|FG002|Overall Study|Withdrawal by Subject|5|||
145981334|NCT02068599|526443017|FG000|Overall Study|Protocol Violation|4|||
145981335|NCT02068599|526443018|FG001|Overall Study|Protocol Violation|2|||
145981336|NCT02068599|526443019|FG002|Overall Study|Protocol Violation|3|||
145981337|NCT02068599|526443017|FG000|Overall Study|Lost to Follow-up|1|||
145981338|NCT02068599|526443018|FG001|Overall Study|Lost to Follow-up|0|||
145981339|NCT02068599|526443019|FG002|Overall Study|Lost to Follow-up|0|||
145981340|NCT02068599|526443017|FG000|Overall Study|Lack of Efficacy|0|||
145981341|NCT02068599|526443018|FG001|Overall Study|Lack of Efficacy|0|||
145981342|NCT02068599|526443019|FG002|Overall Study|Lack of Efficacy|3|||
145981343|NCT02068599|526443017|FG000|Overall Study|Noncompliance|0|||
145981344|NCT02068599|526443018|FG001|Overall Study|Noncompliance|0|||
145981345|NCT02068599|526443019|FG002|Overall Study|Noncompliance|1|||
145981346|NCT00699751|526443020|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
145981347|NCT00699751|526443021|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
145981348|NCT00699751|526443020|FG000|Period 1: Without/Before Drug Switch|Death|28|||
145981349|NCT00699751|526443021|FG001|Period 1: Without/Before Drug Switch|Death|29|||
145981350|NCT00699751|526443020|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
145981351|NCT00699751|526443021|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
145981352|NCT00699751|526443020|FG000|Period 1: Without/Before Drug Switch|Other|30|||
145981353|NCT00699751|526443021|FG001|Period 1: Without/Before Drug Switch|Other|20|||
145981354|NCT00699751|526443020|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
145981355|NCT00699751|526443021|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
145981356|NCT00699751|526443020|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
145981357|NCT00699751|526443021|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
145981358|NCT00699751|526443020|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
145981359|NCT00699751|526443021|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
145981360|NCT00699751|526443020|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
145981361|NCT00699751|526443021|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
145981362|NCT01947933|526443022|FG000|Overall Study|Withdrawal by Subject|0|||
145981363|NCT01947933|526443023|FG001|Overall Study|Withdrawal by Subject|0|||
145981364|NCT01947933|526443024|FG002|Overall Study|Withdrawal by Subject|1|||
145981365|NCT01947933|526443025|FG003|Overall Study|Withdrawal by Subject|0|||
145981366|NCT01947933|526443026|FG004|Overall Study|Withdrawal by Subject|0|||
145981367|NCT01947933|526443027|FG005|Overall Study|Withdrawal by Subject|0|||
145981368|NCT01947933|526443028|FG006|Overall Study|Withdrawal by Subject|0|||
145981369|NCT01947933|526443029|FG007|Overall Study|Withdrawal by Subject|0|||
145981370|NCT01947933|526443030|FG008|Overall Study|Withdrawal by Subject|0|||
145981371|NCT01947933|526443022|FG000|Overall Study|Lost to Follow-up|0|||
145981372|NCT01947933|526443023|FG001|Overall Study|Lost to Follow-up|0|||
145981373|NCT01947933|526443024|FG002|Overall Study|Lost to Follow-up|0|||
145981374|NCT01947933|526443025|FG003|Overall Study|Lost to Follow-up|0|||
145981375|NCT01947933|526443026|FG004|Overall Study|Lost to Follow-up|0|||
145981376|NCT01947933|526443027|FG005|Overall Study|Lost to Follow-up|0|||
145981377|NCT01947933|526443028|FG006|Overall Study|Lost to Follow-up|0|||
145981378|NCT01947933|526443029|FG007|Overall Study|Lost to Follow-up|0|||
145981379|NCT01947933|526443030|FG008|Overall Study|Lost to Follow-up|1|||
145981380|NCT00294398|526443031|FG000|Overall Study|Lost to Follow-up|21|||
145981381|NCT00294398|526443032|FG001|Overall Study|Lost to Follow-up|26|||
145981382|NCT00985790|526443033|FG000|Overall Study|Withdrawal by Subject|1|||
145981383|NCT00985790|526443034|FG001|Overall Study|Withdrawal by Subject|1|||
145981384|NCT00985790|526443033|FG000|Overall Study|Lost to Follow-up|6|||
145981385|NCT00985790|526443034|FG001|Overall Study|Lost to Follow-up|7|||
145981386|NCT02184156|526443038|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
145981387|NCT02184156|526443039|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
145981388|NCT02184156|526443038|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
145981389|NCT02184156|526443039|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
145981390|NCT02114684|526443048|FG000|Overall Study|Death|6|||
145981391|NCT02114684|526443049|FG001|Overall Study|Death|4|||
145981392|NCT02114684|526443048|FG000|Overall Study|Lost to Follow-up|1|||
145981393|NCT02114684|526443049|FG001|Overall Study|Lost to Follow-up|2|||
145981394|NCT02114684|526443048|FG000|Overall Study|Withdrawal by Subject|1|||
145981395|NCT02114684|526443049|FG001|Overall Study|Withdrawal by Subject|2|||
145981396|NCT02114684|526443048|FG000|Overall Study|Relocation|3|||
145981397|NCT02114684|526443049|FG001|Overall Study|Relocation|1|||
145981398|NCT02114684|526443048|FG000|Overall Study|Rifampicin resistant on culture|0|||
145981399|NCT02114684|526443049|FG001|Overall Study|Rifampicin resistant on culture|1|||
145981400|NCT02114684|526443048|FG000|Overall Study|Patient Incarcerated|1|||
145981401|NCT02114684|526443049|FG001|Overall Study|Patient Incarcerated|0|||
145981402|NCT02530242|526443050|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
145981403|NCT02530242|526443051|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
145981404|NCT00283959|526443052|FG000|Extension Period|Low Compliance|1|||
145981405|NCT01214720|526443053|FG000|Overall Study|Alive and still on treatment|34|||
145981406|NCT01214720|526443054|FG001|Overall Study|Alive and still on treatment|18|||
145981407|NCT01214720|526443053|FG000|Overall Study|Alive and in follow-up|45|||
145981408|NCT01214720|526443054|FG001|Overall Study|Alive and in follow-up|48|||
145981409|NCT01214720|526443053|FG000|Overall Study|Lost to Follow-up|6|||
145981410|NCT01214720|526443054|FG001|Overall Study|Lost to Follow-up|2|||
145981411|NCT05591755|526443055|FG000|Overall Study|Screen Failure|1|||
145981412|NCT05591755|526443056|FG001|Overall Study|Screen Failure|0|||
145981413|NCT05591755|526443057|FG002|Overall Study|Screen Failure|0|||
145981414|NCT05591755|526443058|FG003|Overall Study|Screen Failure|0|||
145981415|NCT05591755|526443055|FG000|Overall Study|Protocol Violation|0|||
145981416|NCT05591755|526443056|FG001|Overall Study|Protocol Violation|0|||
145981417|NCT05591755|526443057|FG002|Overall Study|Protocol Violation|2|||
145981418|NCT05591755|526443058|FG003|Overall Study|Protocol Violation|0|||
145981419|NCT05591755|526443055|FG000|Overall Study|Withdrawal by Subject|0|||
145981420|NCT05591755|526443056|FG001|Overall Study|Withdrawal by Subject|1|||
145981421|NCT05591755|526443057|FG002|Overall Study|Withdrawal by Subject|0|||
145981422|NCT05591755|526443058|FG003|Overall Study|Withdrawal by Subject|0|||
145981423|NCT01671059|526443059|FG000|Overall Study|Adverse Event|4|||
145981424|NCT01671059|526443059|FG000|Overall Study|Lack of Efficacy|1|||
145981425|NCT01033071|526443065|FG000|Overall Study|Adverse Event|28|||
146091312|NCT00473746|526854944|FG000|Period 1 (Phase 1)|Adverse Event|1|||
145981426|NCT01033071|526443066|FG001|Overall Study|Adverse Event|51|||
145981427|NCT01033071|526443067|FG002|Overall Study|Adverse Event|26|||
145981428|NCT01033071|526443065|FG000|Overall Study|Protocol Violation|0|||
145981429|NCT01033071|526443066|FG001|Overall Study|Protocol Violation|2|||
145981430|NCT01033071|526443067|FG002|Overall Study|Protocol Violation|1|||
145981431|NCT01033071|526443065|FG000|Overall Study|Lost to Follow-up|4|||
145981432|NCT01033071|526443066|FG001|Overall Study|Lost to Follow-up|5|||
145981433|NCT01033071|526443067|FG002|Overall Study|Lost to Follow-up|5|||
145981434|NCT01033071|526443065|FG000|Overall Study|Withdrawal by Subject|17|||
145981435|NCT01033071|526443066|FG001|Overall Study|Withdrawal by Subject|14|||
145981436|NCT01033071|526443067|FG002|Overall Study|Withdrawal by Subject|11|||
145981437|NCT01033071|526443065|FG000|Overall Study|Lack of Efficacy|0|||
145981438|NCT01033071|526443066|FG001|Overall Study|Lack of Efficacy|1|||
145981439|NCT01033071|526443067|FG002|Overall Study|Lack of Efficacy|1|||
145981440|NCT01033071|526443065|FG000|Overall Study|Other|6|||
145981441|NCT01033071|526443066|FG001|Overall Study|Other|4|||
145981442|NCT01033071|526443067|FG002|Overall Study|Other|3|||
145981443|NCT02564978|526443068|FG000|Overall Study|Adverse Event|8|||
145981444|NCT02564978|526443068|FG000|Overall Study|Death|1|||
145981445|NCT02564978|526443068|FG000|Overall Study|Lost to Follow-up|1|||
145981446|NCT02564978|526443068|FG000|Overall Study|Withdrawal by Subject|15|||
145981447|NCT02564978|526443068|FG000|Overall Study|Early Study Closure|2|||
145981448|NCT02564978|526443068|FG000|Overall Study|Other Reason|5|||
145981449|NCT03554473|526445086|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
145981450|NCT03554473|526445087|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
145981451|NCT03554473|526445088|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
145981452|NCT03554473|526445086|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
145981453|NCT03554473|526445087|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
145981454|NCT03554473|526445088|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
145981455|NCT03554473|526445086|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
145981456|NCT03554473|526445087|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
145981457|NCT03554473|526445088|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
145981458|NCT04971837|526445092|FG000|Overall Study|Long Term Illness|1|||
145981459|NCT04971837|526445092|FG000|Overall Study|BMI too low|9|||
145981460|NCT04971837|526445092|FG000|Overall Study|geographic location|1|||
145981461|NCT04971837|526445092|FG000|Overall Study|Discontinued scheduling conflict|1|||
145981462|NCT05206604|526445093|FG000|Overall Study|Non-compliance with study drug|0|||
145981463|NCT05206604|526445094|FG001|Overall Study|Non-compliance with study drug|0|||
145981464|NCT05206604|526445095|FG002|Overall Study|Non-compliance with study drug|0|||
145981465|NCT05206604|526445096|FG003|Overall Study|Non-compliance with study drug|0|||
145981466|NCT05206604|526445097|FG004|Overall Study|Non-compliance with study drug|0|||
145981467|NCT05206604|526445098|FG005|Overall Study|Non-compliance with study drug|1|||
145981468|NCT05206604|526445099|FG006|Overall Study|Non-compliance with study drug|0|||
145981469|NCT05206604|526445100|FG007|Overall Study|Non-compliance with study drug|0|||
145981470|NCT03735498|526445101|FG000|Overall Study|Withdrawal by Subject|3|||
145981471|NCT03735498|526445101|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
145981472|NCT00160615|526445102|FG000|Overall Study|Adverse Event|5|||
145981473|NCT00160615|526445103|FG001|Overall Study|Adverse Event|12|||
145981474|NCT00160615|526445102|FG000|Overall Study|Withdrawal by Subject|0|||
145981475|NCT00160615|526445103|FG001|Overall Study|Withdrawal by Subject|2|||
145981476|NCT00160615|526445102|FG000|Overall Study|Lack of Efficacy|11|||
145981477|NCT00160615|526445103|FG001|Overall Study|Lack of Efficacy|23|||
145981478|NCT00160615|526445102|FG000|Overall Study|Patient decision|1|||
145981479|NCT00160615|526445103|FG001|Overall Study|Patient decision|2|||
145981480|NCT00160615|526445102|FG000|Overall Study|Investigator decision|1|||
145981481|NCT00160615|526445103|FG001|Overall Study|Investigator decision|1|||
145981482|NCT00160615|526445102|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
145981483|NCT00160615|526445103|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
145981484|NCT00160615|526445102|FG000|Overall Study|Switch to surgical treatment|0|||
145981485|NCT00160615|526445103|FG001|Overall Study|Switch to surgical treatment|2|||
145981486|NCT00160615|526445102|FG000|Overall Study|Non-compliance was suspected|0|||
145981487|NCT00160615|526445103|FG001|Overall Study|Non-compliance was suspected|1|||
145981488|NCT00160615|526445102|FG000|Overall Study|Poor compliance|0|||
145981489|NCT00160615|526445103|FG001|Overall Study|Poor compliance|1|||
145981490|NCT03166631|526445104|FG000|Overall Study|Progressive disease|2|||
145981491|NCT03166631|526445105|FG001|Overall Study|Progressive disease|1|||
145981492|NCT03166631|526445106|FG002|Overall Study|Progressive disease|3|||
145981493|NCT03166631|526445107|FG003|Overall Study|Progressive disease|4|||
145981494|NCT03166631|526445108|FG004|Overall Study|Progressive disease|2|||
145981495|NCT03166631|526445109|FG005|Overall Study|Progressive disease|2|||
145981496|NCT03166631|526445110|FG006|Overall Study|Progressive disease|5|||
145981497|NCT03166631|526445111|FG007|Overall Study|Progressive disease|6|||
145981498|NCT03166631|526445112|FG008|Overall Study|Progressive disease|11|||
146091313|NCT00473746|526854945|FG001|Period 1 (Phase 1)|Adverse Event|0|||
146091314|NCT00473746|526854946|FG002|Period 1 (Phase 1)|Adverse Event|0|||
145981499|NCT03166631|526445113|FG009|Overall Study|Progressive disease|5|||
145981500|NCT03166631|526445114|FG010|Overall Study|Progressive disease|7|||
145981501|NCT03166631|526445104|FG000|Overall Study|Physician Decision|0|||
145981502|NCT03166631|526445105|FG001|Overall Study|Physician Decision|0|||
145981503|NCT03166631|526445106|FG002|Overall Study|Physician Decision|0|||
145981504|NCT03166631|526445107|FG003|Overall Study|Physician Decision|0|||
145981505|NCT03166631|526445108|FG004|Overall Study|Physician Decision|0|||
145981506|NCT03166631|526445109|FG005|Overall Study|Physician Decision|0|||
145981507|NCT03166631|526445110|FG006|Overall Study|Physician Decision|1|||
145981508|NCT03166631|526445111|FG007|Overall Study|Physician Decision|0|||
145981509|NCT03166631|526445112|FG008|Overall Study|Physician Decision|1|||
145981510|NCT03166631|526445113|FG009|Overall Study|Physician Decision|0|||
145981511|NCT03166631|526445114|FG010|Overall Study|Physician Decision|1|||
145981512|NCT03166631|526445104|FG000|Overall Study|Death|0|||
145981513|NCT03166631|526445105|FG001|Overall Study|Death|0|||
145981514|NCT03166631|526445106|FG002|Overall Study|Death|0|||
145981515|NCT03166631|526445107|FG003|Overall Study|Death|0|||
145981516|NCT03166631|526445108|FG004|Overall Study|Death|1|||
145981517|NCT03166631|526445109|FG005|Overall Study|Death|0|||
145981518|NCT03166631|526445110|FG006|Overall Study|Death|1|||
145981519|NCT03166631|526445111|FG007|Overall Study|Death|0|||
145981520|NCT03166631|526445112|FG008|Overall Study|Death|0|||
145981521|NCT03166631|526445113|FG009|Overall Study|Death|0|||
145981522|NCT03166631|526445114|FG010|Overall Study|Death|0|||
145981523|NCT03166631|526445104|FG000|Overall Study|Adverse Event|1|||
145981524|NCT03166631|526445105|FG001|Overall Study|Adverse Event|0|||
145981525|NCT03166631|526445106|FG002|Overall Study|Adverse Event|0|||
145981526|NCT03166631|526445107|FG003|Overall Study|Adverse Event|0|||
145981527|NCT03166631|526445108|FG004|Overall Study|Adverse Event|0|||
145981528|NCT03166631|526445109|FG005|Overall Study|Adverse Event|1|||
145981529|NCT03166631|526445110|FG006|Overall Study|Adverse Event|1|||
145981530|NCT03166631|526445111|FG007|Overall Study|Adverse Event|0|||
145981531|NCT03166631|526445112|FG008|Overall Study|Adverse Event|1|||
145981532|NCT03166631|526445113|FG009|Overall Study|Adverse Event|2|||
145981533|NCT03166631|526445114|FG010|Overall Study|Adverse Event|1|||
145981534|NCT03166631|526445104|FG000|Overall Study|Withdrawal by Subject|0|||
145981535|NCT03166631|526445105|FG001|Overall Study|Withdrawal by Subject|0|||
145981536|NCT03166631|526445106|FG002|Overall Study|Withdrawal by Subject|0|||
145981537|NCT03166631|526445107|FG003|Overall Study|Withdrawal by Subject|0|||
145981538|NCT03166631|526445108|FG004|Overall Study|Withdrawal by Subject|0|||
145981539|NCT03166631|526445109|FG005|Overall Study|Withdrawal by Subject|0|||
145981540|NCT03166631|526445110|FG006|Overall Study|Withdrawal by Subject|0|||
145981541|NCT03166631|526445111|FG007|Overall Study|Withdrawal by Subject|0|||
145981542|NCT03166631|526445112|FG008|Overall Study|Withdrawal by Subject|1|||
145981543|NCT03166631|526445113|FG009|Overall Study|Withdrawal by Subject|1|||
145981544|NCT03166631|526445114|FG010|Overall Study|Withdrawal by Subject|0|||
145981545|NCT03787212|526445118|FG000|Period 1|Study Termination|2|||
145981546|NCT03787212|526445119|FG001|Period 1|Study Termination|2|||
145981547|NCT02014103|526445120|FG000|Overall Study|Protocol Violation|7|||
145981548|NCT02014103|526445121|FG001|Overall Study|Protocol Violation|7|||
145981549|NCT02014103|526445120|FG000|Overall Study|Adverse Event|1|||
145981550|NCT02014103|526445121|FG001|Overall Study|Adverse Event|0|||
145981551|NCT02014103|526445120|FG000|Overall Study|Lost venous access|1|||
145981552|NCT02014103|526445121|FG001|Overall Study|Lost venous access|0|||
145981553|NCT02014103|526445120|FG000|Overall Study|Withdrawal by Subject|0|||
145981554|NCT02014103|526445121|FG001|Overall Study|Withdrawal by Subject|2|||
145981555|NCT05638737|526445122|FG000|Overall Study|Withdrawal by Subject|4|||
145981556|NCT05638737|526445123|FG001|Overall Study|Withdrawal by Subject|7|||
145981557|NCT00567580|526445126|FG000|Overall Study|Protocol Violation|28|||
145981558|NCT00567580|526445127|FG001|Overall Study|Protocol Violation|24|||
145981559|NCT00567580|526445128|FG002|Overall Study|Protocol Violation|24|||
145981560|NCT00884949|526445130|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
145981561|NCT00884949|526445130|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
145981562|NCT03022630|526445131|FG000|Overall Study|Death|9|||
145981563|NCT03022630|526445132|FG001|Overall Study|Death|7|||
145981564|NCT03022630|526445131|FG000|Overall Study|Withdrawal by Subject|0|||
145981565|NCT03022630|526445132|FG001|Overall Study|Withdrawal by Subject|5|||
145981566|NCT00382070|526445133|FG000|Overall Study|No follow up data mapped to Other|17|||
145981567|NCT00382070|526445134|FG001|Overall Study|No follow up data mapped to Other|19|||
145981568|NCT00382070|526445133|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
145981569|NCT00382070|526445134|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
145981570|NCT00382070|526445133|FG000|Overall Study|No clinical assessment|9|||
145981571|NCT00382070|526445134|FG001|Overall Study|No clinical assessment|11|||
145981572|NCT04289298|526445135|FG000|Overall Study|Lost to Follow-up|5|||
145981573|NCT04289298|526445136|FG001|Overall Study|Lost to Follow-up|0|||
145981574|NCT04289298|526445135|FG000|Overall Study|Withdrawal by Subject|2|||
145981575|NCT04289298|526445136|FG001|Overall Study|Withdrawal by Subject|0|||
145981576|NCT01734928|526445137|FG000|Randomization|Physician Decision|0|||
145981577|NCT01734928|526445138|FG001|Randomization|Physician Decision|1|||
145981578|NCT01734928|526445137|FG000|Randomization|clinical progression|0|||
145981579|NCT01734928|526445138|FG001|Randomization|clinical progression|1|||
145981580|NCT01734928|526445137|FG000|Randomization|progressive disease|0|||
145981581|NCT01734928|526445138|FG001|Randomization|progressive disease|2|||
145981582|NCT01734928|526445137|FG000|Randomization|Withdrew informed consent|0|||
145981583|NCT01734928|526445138|FG001|Randomization|Withdrew informed consent|4|||
145981584|NCT01734928|526445137|FG000|Randomization|Death|1|||
145981585|NCT01734928|526445138|FG001|Randomization|Death|0|||
145981586|NCT01734928|526445137|FG000|Randomization|Randomization error|1|||
145981587|NCT01734928|526445138|FG001|Randomization|Randomization error|0|||
145981588|NCT01734928|526445137|FG000|Randomization|Lost to Follow-up|1|||
145981589|NCT01734928|526445138|FG001|Randomization|Lost to Follow-up|0|||
145981590|NCT01734928|526445137|FG000|Treatment Period|Lost to Follow-up|0|||
145981591|NCT01734928|526445138|FG001|Treatment Period|Lost to Follow-up|2|||
145981592|NCT01734928|526445137|FG000|Treatment Period|Progressive Disease|167|||
145981593|NCT01734928|526445138|FG001|Treatment Period|Progressive Disease|165|||
145981594|NCT01734928|526445137|FG000|Treatment Period|Adverse Event|39|||
145981595|NCT01734928|526445138|FG001|Treatment Period|Adverse Event|52|||
145981596|NCT01734928|526445137|FG000|Treatment Period|Withdrawal of Consent|25|||
145981597|NCT01734928|526445138|FG001|Treatment Period|Withdrawal of Consent|22|||
145981598|NCT01734928|526445137|FG000|Treatment Period|Death|20|||
145981599|NCT01734928|526445138|FG001|Treatment Period|Death|9|||
145981600|NCT01734928|526445137|FG000|Treatment Period|Other Reasons|27|||
145981601|NCT01734928|526445138|FG001|Treatment Period|Other Reasons|19|||
145981602|NCT01734928|526445137|FG000|Treatment Period|Pregnancy|0|||
145981603|NCT01734928|526445138|FG001|Treatment Period|Pregnancy|1|||
145981604|NCT00620035|526445141|FG000|Overall Study|Adverse Event|106|||
145981605|NCT00620035|526445141|FG000|Overall Study|Withdrawal of Informed Consent|1|||
145981606|NCT00620035|526445141|FG000|Overall Study|Other Reason|38|||
145981607|NCT01778985|526445142|FG000|Overall Study|Lost to Follow-up|1|||
145981608|NCT01778985|526445143|FG001|Overall Study|Lost to Follow-up|0|||
145981609|NCT01778985|526445142|FG000|Overall Study|Physician Decision|2|||
145981610|NCT01778985|526445143|FG001|Overall Study|Physician Decision|2|||
145981611|NCT01778985|526445142|FG000|Overall Study|Protocol Violation|4|||
145981612|NCT01778985|526445143|FG001|Overall Study|Protocol Violation|1|||
145981613|NCT00088881|526445144|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
145981614|NCT00088881|526445144|FG000|Step 1 - R-CHOP|Adverse Event|1|||
145981615|NCT00088881|526445144|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
145981616|NCT00088881|526445144|FG000|Step 1 - R-CHOP|Physician Decision|1|||
145981617|NCT00088881|526445144|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
145981618|NCT00088881|526445144|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
145981619|NCT00088881|526445144|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
145981620|NCT00456612|526445145|FG000|Overall Study|Withdrawal by Subject|3|||
145981621|NCT00758043|526445148|FG000|Overall Study|Adverse Event|1|||
145981622|NCT00758043|526445149|FG001|Overall Study|Adverse Event|20|||
145981623|NCT00758043|526445150|FG002|Overall Study|Adverse Event|12|||
145981624|NCT00758043|526445151|FG003|Overall Study|Adverse Event|62|||
145981625|NCT00758043|526445148|FG000|Overall Study|Lack of Efficacy|0|||
145981626|NCT00758043|526445149|FG001|Overall Study|Lack of Efficacy|6|||
145981627|NCT00758043|526445150|FG002|Overall Study|Lack of Efficacy|18|||
145981628|NCT00758043|526445151|FG003|Overall Study|Lack of Efficacy|12|||
145981629|NCT00758043|526445148|FG000|Overall Study|Refused Further Treatment|0|||
145981630|NCT00758043|526445149|FG001|Overall Study|Refused Further Treatment|11|||
145981631|NCT00758043|526445150|FG002|Overall Study|Refused Further Treatment|5|||
145981632|NCT00758043|526445151|FG003|Overall Study|Refused Further Treatment|8|||
145981633|NCT00758043|526445148|FG000|Overall Study|Lost to Follow-up|0|||
145981634|NCT00758043|526445149|FG001|Overall Study|Lost to Follow-up|2|||
145981635|NCT00758043|526445150|FG002|Overall Study|Lost to Follow-up|2|||
145981636|NCT00758043|526445151|FG003|Overall Study|Lost to Follow-up|5|||
146245571|NCT03340961|527414004|FG003|Overall Study|Adverse Event|0|||
146245572|NCT03340961|527414001|FG000|Overall Study|Lack of Efficacy|0|||
146245573|NCT03340961|527414002|FG001|Overall Study|Lack of Efficacy|0|||
146245574|NCT03340961|527414003|FG002|Overall Study|Lack of Efficacy|0|||
145981637|NCT00758043|526445148|FG000|Overall Study|Withdrawal by Subject|0|||
146245575|NCT03340961|527414004|FG003|Overall Study|Lack of Efficacy|1|||
146245576|NCT04311983|527414005|FG000|Overall Study|Lost to Follow-up|421|||
145981638|NCT00758043|526445149|FG001|Overall Study|Withdrawal by Subject|1|||
145981639|NCT00758043|526445150|FG002|Overall Study|Withdrawal by Subject|1|||
145981640|NCT00758043|526445151|FG003|Overall Study|Withdrawal by Subject|4|||
145981641|NCT00758043|526445148|FG000|Overall Study|Required Prohibited Medication|0|||
145981642|NCT00758043|526445149|FG001|Overall Study|Required Prohibited Medication|0|||
145981643|NCT00758043|526445150|FG002|Overall Study|Required Prohibited Medication|1|||
145981644|NCT00758043|526445151|FG003|Overall Study|Required Prohibited Medication|3|||
145981645|NCT00758043|526445148|FG000|Overall Study|Non-Compliant With study Drug|0|||
145981646|NCT00758043|526445149|FG001|Overall Study|Non-Compliant With study Drug|0|||
145981647|NCT00758043|526445150|FG002|Overall Study|Non-Compliant With study Drug|0|||
146245577|NCT04311983|527414006|FG001|Overall Study|Lost to Follow-up|456|||
146245578|NCT04311983|527414005|FG000|Overall Study|Incomplete survey|7|||
145981648|NCT00758043|526445151|FG003|Overall Study|Non-Compliant With study Drug|1|||
145981649|NCT00758043|526445148|FG000|Overall Study|Other Reasons|0|||
146245579|NCT04311983|527414006|FG001|Overall Study|Incomplete survey|9|||
146245580|NCT04311983|527414005|FG000|Overall Study|Death|1|||
145981650|NCT00758043|526445149|FG001|Overall Study|Other Reasons|1|||
145981651|NCT00758043|526445150|FG002|Overall Study|Other Reasons|0|||
145981652|NCT00758043|526445151|FG003|Overall Study|Other Reasons|5|||
145981653|NCT05788328|526445160|FG000|Treatment Period 4 (5 Days)|Other|1|||
145981654|NCT05788328|526445160|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
145981655|NCT00145327|526445161|FG000|Overall Study|Withdrawal by Subject|77|||
145981656|NCT00145327|526445162|FG001|Overall Study|Withdrawal by Subject|72|||
145981657|NCT00145327|526445163|FG002|Overall Study|Withdrawal by Subject|164|||
145981658|NCT00145327|526445161|FG000|Overall Study|Death|26|||
145981659|NCT00145327|526445162|FG001|Overall Study|Death|18|||
145981660|NCT00145327|526445163|FG002|Overall Study|Death|30|||
145981661|NCT00145327|526445161|FG000|Overall Study|Adverse Event|14|||
145981662|NCT00145327|526445162|FG001|Overall Study|Adverse Event|11|||
145981663|NCT00145327|526445163|FG002|Overall Study|Adverse Event|22|||
145981664|NCT00145327|526445161|FG000|Overall Study|Lost to Follow-up|9|||
145981665|NCT00145327|526445162|FG001|Overall Study|Lost to Follow-up|14|||
145981666|NCT00145327|526445163|FG002|Overall Study|Lost to Follow-up|14|||
145981667|NCT00145327|526445161|FG000|Overall Study|Administrative problems|12|||
145981668|NCT00145327|526445162|FG001|Overall Study|Administrative problems|9|||
145981669|NCT00145327|526445163|FG002|Overall Study|Administrative problems|13|||
145981670|NCT00145327|526445161|FG000|Overall Study|Protocol Violation|2|||
145981671|NCT00145327|526445162|FG001|Overall Study|Protocol Violation|0|||
145981672|NCT00145327|526445163|FG002|Overall Study|Protocol Violation|2|||
145981673|NCT00145327|526445161|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145981674|NCT00145327|526445162|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145981675|NCT00145327|526445163|FG002|Overall Study|Abnormal laboratory value(s)|2|||
145981676|NCT00145327|526445161|FG000|Overall Study|Missing - not stated|1|||
145981677|NCT00145327|526445162|FG001|Overall Study|Missing - not stated|0|||
145981678|NCT00145327|526445163|FG002|Overall Study|Missing - not stated|1|||
145981679|NCT04027946|526445164|FG000|Overall Study|Screen failures|3|||
145981680|NCT03315689|526445169|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
145981681|NCT03315689|526445170|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
145981682|NCT03315689|526445169|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
145981683|NCT03315689|526445170|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
145981684|NCT03315689|526445169|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
145981685|NCT03315689|526445170|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
145981686|NCT00864513|526445171|FG000|Overall Study|Withdrawal by Subject|3|||
145981687|NCT03073109|526445172|FG000|Overall Study|Adverse Event|0|||
145981688|NCT03073109|526445173|FG001|Overall Study|Adverse Event|1|||
145981689|NCT03073109|526445172|FG000|Overall Study|Other|2|||
145981690|NCT03073109|526445173|FG001|Overall Study|Other|0|||
145981691|NCT03073109|526445172|FG000|Overall Study|Lost to Follow-up|8|||
145981692|NCT03073109|526445173|FG001|Overall Study|Lost to Follow-up|1|||
145981693|NCT01348698|526445174|FG000|Overall Study|Does not meet lesion size criteria|1|||
145981694|NCT01348698|526445174|FG000|Overall Study|Death|3|||
145981695|NCT01348698|526445174|FG000|Overall Study|PI decision to close study|68|||
145981696|NCT01297244|526445175|FG000|Overall Study|Progressive disease|22|||
145981697|NCT01297244|526445176|FG001|Overall Study|Progressive disease|3|||
145981698|NCT01297244|526445175|FG000|Overall Study|Adverse Event|9|||
145981699|NCT01297244|526445176|FG001|Overall Study|Adverse Event|1|||
145981700|NCT01297244|526445175|FG000|Overall Study|Death|1|||
145981701|NCT01297244|526445176|FG001|Overall Study|Death|1|||
145981702|NCT01297244|526445175|FG000|Overall Study|Clinical progression|1|||
145981703|NCT01297244|526445176|FG001|Overall Study|Clinical progression|1|||
145981704|NCT01297244|526445175|FG000|Overall Study|Withdrawal by Subject|2|||
145981705|NCT01297244|526445176|FG001|Overall Study|Withdrawal by Subject|0|||
145981706|NCT01875237|526445177|FG000|Overall Study|GVDH before DLI|1|||
145981707|NCT01875237|526445178|FG001|Overall Study|GVDH before DLI|0|||
145981708|NCT01875237|526445177|FG000|Overall Study|DLI cells could not be produced|1|||
145981709|NCT01875237|526445178|FG001|Overall Study|DLI cells could not be produced|0|||
145981710|NCT00875667|526445181|FG000|Overall Study|Adverse Event|29|||
145981711|NCT00875667|526445182|FG001|Overall Study|Adverse Event|10|||
145981712|NCT00875667|526445181|FG000|Overall Study|Withdrawal by Subject|17|||
145981713|NCT00875667|526445182|FG001|Overall Study|Withdrawal by Subject|5|||
145981714|NCT00875667|526445181|FG000|Overall Study|Death|7|||
145981715|NCT00875667|526445182|FG001|Overall Study|Death|2|||
146245581|NCT04311983|527414006|FG001|Overall Study|Death|0|||
146245582|NCT00990184|527414012|FG000|Overall Study|Physician Decision|1|||
146245583|NCT02446015|527414013|FG000|Overall Study|Adverse Event|0|||
146245584|NCT02446015|527414014|FG001|Overall Study|Adverse Event|1|||
146245585|NCT02446015|527414013|FG000|Overall Study|Withdrawal by Subject|1|||
146245586|NCT02446015|527414014|FG001|Overall Study|Withdrawal by Subject|0|||
145981716|NCT00875667|526445181|FG000|Overall Study|Protocol Violation|2|||
146245587|NCT00666705|527414022|FG000|Overall Study|Withdrawal by Subject|1|||
146091315|NCT00473746|526854947|FG003|Period 1 (Phase 1)|Adverse Event|0|||
146091316|NCT00473746|526854948|FG004|Period 1 (Phase 1)|Adverse Event|0|||
146091317|NCT00473746|526854944|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146091318|NCT00473746|526854945|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
146091319|NCT00473746|526854946|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146091320|NCT00473746|526854947|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
146091321|NCT00473746|526854948|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
145981717|NCT00875667|526445182|FG001|Overall Study|Protocol Violation|0|||
145981718|NCT00875667|526445181|FG000|Overall Study|Disease Progression|100|||
145981719|NCT00875667|526445182|FG001|Overall Study|Disease Progression|49|||
145981720|NCT00875667|526445181|FG000|Overall Study|Miscellaneous|12|||
145981721|NCT00875667|526445182|FG001|Overall Study|Miscellaneous|6|||
145981722|NCT00875667|526445181|FG000|Overall Study|Randomized but no Study Drug Given|3|||
145981723|NCT00875667|526445182|FG001|Overall Study|Randomized but no Study Drug Given|1|||
145981724|NCT01871727|526445190|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
145981725|NCT01871727|526445191|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
145981726|NCT01871727|526445192|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
145981727|NCT01871727|526445193|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
145981728|NCT01871727|526445194|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
145981729|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
145981730|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
145981731|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
145981732|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
145981733|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
145981734|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145981735|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145981736|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145981737|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145981738|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
145981739|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145981740|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145981741|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145981742|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145981743|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
145981744|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145981745|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145981746|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145981747|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145981748|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
145981749|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145981750|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145981751|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145981752|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145981753|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
145981754|NCT01871727|526445190|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
145981755|NCT01871727|526445191|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
145981756|NCT01871727|526445192|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
145981757|NCT01871727|526445193|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
145981758|NCT01871727|526445194|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
145981759|NCT01263028|526445195|FG000|Overall Study|Withdrawal by Subject|1|||
145981760|NCT01263028|526445195|FG000|Overall Study|Adverse Event|1|||
145981761|NCT01263028|526445195|FG000|Overall Study|Study terminated due to low enrollment.|4|||
145981762|NCT03019588|526445196|FG000|Overall Study|Death|44|||
145981763|NCT03019588|526445197|FG001|Overall Study|Death|46|||
145981764|NCT03019588|526445196|FG000|Overall Study|Study terminated by Sponsor|3|||
145981765|NCT03019588|526445197|FG001|Overall Study|Study terminated by Sponsor|1|||
145981766|NCT00887588|526445200|FG000|Core Period|Death|1|||
145981767|NCT00887588|526445201|FG001|Core Period|Death|1|||
145981768|NCT00887588|526445200|FG000|Core Period|Lost to Follow-up|3|||
145981769|NCT00887588|526445201|FG001|Core Period|Lost to Follow-up|1|||
145981770|NCT00887588|526445200|FG000|Core Period|Withdrawal by Subject|6|||
145981771|NCT00887588|526445201|FG001|Core Period|Withdrawal by Subject|8|||
145981772|NCT00887588|526445200|FG000|Core Period|Adverse Event|9|||
145981773|NCT00887588|526445201|FG001|Core Period|Adverse Event|11|||
145981774|NCT00887588|526445200|FG000|Extension Period|Adverse Event|4|||
145981775|NCT00887588|526445201|FG001|Extension Period|Adverse Event|4|||
145981776|NCT00887588|526445200|FG000|Extension Period|Death|0|||
145981777|NCT00887588|526445201|FG001|Extension Period|Death|1|||
145981778|NCT00887588|526445200|FG000|Extension Period|Protocol deviation|1|||
145981779|NCT00887588|526445201|FG001|Extension Period|Protocol deviation|0|||
145981780|NCT00887588|526445200|FG000|Extension Period|Lost to Follow-up|1|||
145981781|NCT00887588|526445201|FG001|Extension Period|Lost to Follow-up|0|||
146091322|NCT00473746|526854944|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
145981782|NCT00366535|526445202|FG000|First Phase: 12 Weeks|Adverse Event|1|||
145981783|NCT00366535|526445203|FG001|First Phase: 12 Weeks|Adverse Event|3|||
145981784|NCT00366535|526445202|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
145981785|NCT00366535|526445203|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
145981786|NCT00366535|526445202|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
145981787|NCT00366535|526445203|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
145981788|NCT00366535|526445202|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
145981789|NCT00366535|526445203|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
145981790|NCT02958527|526445208|FG000|Overall Study|Not collected CRFs|12|||
145981791|NCT02691572|526445209|FG000|Overall Study|Withdrawal by Subject|1|||
145981792|NCT02691572|526445210|FG001|Overall Study|Withdrawal by Subject|0|||
145981793|NCT02691572|526445209|FG000|Overall Study|Protocol Violation|0|||
145981794|NCT02691572|526445210|FG001|Overall Study|Protocol Violation|1|||
145981795|NCT03753542|526445211|FG000|Overall Study|Lost to Follow-up|9|||
145981796|NCT03753542|526445212|FG001|Overall Study|Lost to Follow-up|14|||
145981797|NCT06100250|526445213|FG000|Overall Study|Lost to Follow-up|5|||
145981798|NCT05089357|526445216|FG000|Overall Study|Withdrawal by Subject|23|||
145981799|NCT05089357|526445216|FG000|Overall Study|Lost to Follow-up|6|||
145981800|NCT05089357|526445216|FG000|Overall Study|Medical reason|1|||
145981801|NCT05089357|526445216|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
145981802|NCT05089357|526445216|FG000|Overall Study|Pregnancy|2|||
145981803|NCT04180696|526445217|FG000|Overall Study|Death|5|||
145981804|NCT04180696|526445218|FG001|Overall Study|Death|6|||
145981805|NCT04180696|526445217|FG000|Overall Study|Lost to Follow-up|1|||
145981806|NCT04180696|526445218|FG001|Overall Study|Lost to Follow-up|0|||
145981807|NCT04180696|526445217|FG000|Overall Study|Withdrawal by Subject|0|||
145981808|NCT04180696|526445218|FG001|Overall Study|Withdrawal by Subject|1|||
145981809|NCT05537571|526445219|FG000|Overall Study|Withdrawal by Subject|1|||
145981810|NCT05537571|526445220|FG001|Overall Study|Withdrawal by Subject|1|||
145981811|NCT05537571|526445221|FG002|Overall Study|Withdrawal by Subject|0|||
145981812|NCT05537571|526445222|FG003|Overall Study|Withdrawal by Subject|0|||
145981813|NCT05537571|526445223|FG004|Overall Study|Withdrawal by Subject|0|||
145981814|NCT05537571|526445219|FG000|Overall Study|Adverse Event|2|||
145981815|NCT05537571|526445220|FG001|Overall Study|Adverse Event|0|||
145981816|NCT05537571|526445221|FG002|Overall Study|Adverse Event|0|||
145981817|NCT05537571|526445222|FG003|Overall Study|Adverse Event|0|||
145981818|NCT05537571|526445223|FG004|Overall Study|Adverse Event|0|||
145981819|NCT05537571|526445219|FG000|Overall Study|Hepatitis A screening result|2|||
145981820|NCT05537571|526445220|FG001|Overall Study|Hepatitis A screening result|0|||
145981821|NCT05537571|526445221|FG002|Overall Study|Hepatitis A screening result|0|||
145981822|NCT05537571|526445222|FG003|Overall Study|Hepatitis A screening result|0|||
145981823|NCT05537571|526445223|FG004|Overall Study|Hepatitis A screening result|0|||
145981824|NCT05537571|526445219|FG000|Overall Study|Lost to Follow-up|0|||
145981825|NCT05537571|526445220|FG001|Overall Study|Lost to Follow-up|0|||
145981826|NCT05537571|526445221|FG002|Overall Study|Lost to Follow-up|1|||
145981827|NCT05537571|526445222|FG003|Overall Study|Lost to Follow-up|0|||
145981828|NCT05537571|526445223|FG004|Overall Study|Lost to Follow-up|1|||
145981829|NCT04210375|526445224|FG000|Overall Study|Death|0|||
145981830|NCT04210375|526445225|FG001|Overall Study|Death|1|||
145981831|NCT04210375|526445226|FG002|Overall Study|Death|0|||
145981832|NCT04210375|526445227|FG003|Overall Study|Death|0|||
145981833|NCT05752487|526445228|FG000|Overall Study|Enrolled, not treated|9|||
145981834|NCT05752487|526445228|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
145981835|NCT05752487|526445228|FG000|Overall Study|Withdrawal by Subject|2|||
145981836|NCT00424008|526445229|FG000|Overall Study|Adverse Event|8|||
145981837|NCT00424008|526445230|FG001|Overall Study|Adverse Event|6|||
145981838|NCT00424008|526445229|FG000|Overall Study|Lack of Efficacy|40|||
145981839|NCT00424008|526445230|FG001|Overall Study|Lack of Efficacy|34|||
145981840|NCT00424008|526445229|FG000|Overall Study|Lost to Follow-up|1|||
145981841|NCT00424008|526445230|FG001|Overall Study|Lost to Follow-up|2|||
145981842|NCT00424008|526445229|FG000|Overall Study|Withdrawal by Subject|5|||
146091323|NCT00473746|526854945|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
146091324|NCT00473746|526854946|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
145981843|NCT00424008|526445230|FG001|Overall Study|Withdrawal by Subject|8|||
145981844|NCT00424008|526445229|FG000|Overall Study|Noncompliance with protocol|13|||
145981845|NCT00424008|526445230|FG001|Overall Study|Noncompliance with protocol|7|||
146245588|NCT01029704|527414024|FG000|Overall Study|Adverse Event|0|||
145981846|NCT00424008|526445229|FG000|Overall Study|Did not meet protocol eligibility|16|||
145981847|NCT00424008|526445230|FG001|Overall Study|Did not meet protocol eligibility|21|||
145981848|NCT00424008|526445229|FG000|Overall Study|Administrative|266|||
145981849|NCT00424008|526445230|FG001|Overall Study|Administrative|257|||
145981850|NCT01860989|526445231|FG000|Overall Study|Unsatisfactory therapeutic|5|||
145981851|NCT02593864|526445232|FG000|Overall Study|Withdrawal by Subject|3|||
145981852|NCT02593864|526445232|FG000|Overall Study|Lost to Follow-up|3|||
145981853|NCT01018953|526445239|FG000|Overall Study|Adverse Event|2|||
145981854|NCT01018953|526445239|FG000|Overall Study|Withdrawal by Subject|1|||
145981855|NCT01018953|526445239|FG000|Overall Study|Study termination by sponsor|5|||
145981856|NCT01186419|526445242|FG000|Overall Study|Withdrawal by Subject|5|||
145981857|NCT01186419|526445243|FG001|Overall Study|Withdrawal by Subject|3|||
145981858|NCT01186419|526445242|FG000|Overall Study|Adverse Event|1|||
145981859|NCT01186419|526445243|FG001|Overall Study|Adverse Event|2|||
145981860|NCT01186419|526445242|FG000|Overall Study|Physician Decision|0|||
145981861|NCT01186419|526445243|FG001|Overall Study|Physician Decision|3|||
145981862|NCT01186419|526445242|FG000|Overall Study|Other|1|||
145981863|NCT01186419|526445243|FG001|Overall Study|Other|1|||
145981864|NCT01629563|526447139|FG000|Overall Study|Adverse Event|16|||
145981865|NCT01629563|526447140|FG001|Overall Study|Adverse Event|16|||
145981866|NCT01629563|526447139|FG000|Overall Study|Death|2|||
145981867|NCT01629563|526447140|FG001|Overall Study|Death|0|||
145981868|NCT01629563|526447139|FG000|Overall Study|Lack of Efficacy|2|||
145981869|NCT01629563|526447140|FG001|Overall Study|Lack of Efficacy|3|||
145981870|NCT01629563|526447139|FG000|Overall Study|Lost to Follow-up|1|||
145981871|NCT01629563|526447140|FG001|Overall Study|Lost to Follow-up|0|||
145981872|NCT01629563|526447139|FG000|Overall Study|Pregnancy|1|||
145981873|NCT01629563|526447140|FG001|Overall Study|Pregnancy|2|||
145981874|NCT01629563|526447139|FG000|Overall Study|Protocol Violation|0|||
145981875|NCT01629563|526447140|FG001|Overall Study|Protocol Violation|1|||
145981876|NCT01629563|526447139|FG000|Overall Study|Withdrawal by Subject|27|||
145981877|NCT01629563|526447140|FG001|Overall Study|Withdrawal by Subject|20|||
145981878|NCT01629563|526447139|FG000|Overall Study|surgery|0|||
145981879|NCT01629563|526447140|FG001|Overall Study|surgery|3|||
145981880|NCT01629563|526447139|FG000|Overall Study|Lack of return of menses|12|||
145981881|NCT01629563|526447140|FG001|Overall Study|Lack of return of menses|7|||
145981882|NCT01629563|526447139|FG000|Overall Study|Protocol Violation|0|||
145981883|NCT01629563|526447140|FG001|Overall Study|Protocol Violation|1|||
145981884|NCT02370394|526447150|FG000|Overall Study|Lost to Follow-up|2|||
145981885|NCT02370394|526447151|FG001|Overall Study|Lost to Follow-up|1|||
145981886|NCT02370394|526447150|FG000|Overall Study|Withdrawal by Subject|0|||
145981887|NCT02370394|526447151|FG001|Overall Study|Withdrawal by Subject|1|||
146091325|NCT00473746|526854947|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
145981888|NCT03684057|526447152|FG000|Overall Study|Withdrawal by Subject|4|||
145981889|NCT03684057|526447153|FG001|Overall Study|Withdrawal by Subject|5|||
145981890|NCT02316613|526447154|FG000|Overall Study|Death|63|||
145981891|NCT02316613|526447154|FG000|Overall Study|Lost to Follow-up|9|||
145981892|NCT02316613|526447154|FG000|Overall Study|Lymphoma transformation|2|||
145981893|NCT02316613|526447154|FG000|Overall Study|Participant moved/changed medical team|11|||
145981894|NCT02316613|526447154|FG000|Overall Study|No data and duplicate cases|5|||
145981895|NCT02316613|526447154|FG000|Overall Study|Did not met selection criteria|14|||
145981896|NCT01108796|526447155|FG000|Overall Study|Adverse Event|0|||
145981897|NCT01108796|526447156|FG001|Overall Study|Adverse Event|1|||
145981898|NCT01108796|526447155|FG000|Overall Study|Lost to Follow-up|7|||
145981899|NCT01108796|526447156|FG001|Overall Study|Lost to Follow-up|6|||
145981900|NCT03558672|526447157|FG000|Overall Study|Study Early Termination|10|||
145981901|NCT00983957|526447158|FG000|Overall Study|Adverse Event|1|||
145981902|NCT00983957|526447158|FG000|Overall Study|Personal Reasons|1|||
145981903|NCT03055195|526447159|FG000|Overall Study|Lack of Efficacy|1|||
145981904|NCT03055195|526447160|FG001|Overall Study|Lack of Efficacy|0|||
145981905|NCT03055195|526447159|FG000|Overall Study|Withdrawal by Subject|6|||
145981906|NCT03055195|526447160|FG001|Overall Study|Withdrawal by Subject|7|||
145981907|NCT03055195|526447159|FG000|Overall Study|Study Terminated by Sponsor|2|||
145981908|NCT03055195|526447160|FG001|Overall Study|Study Terminated by Sponsor|6|||
145981909|NCT03055195|526447159|FG000|Overall Study|Protocol Violation|2|||
145981910|NCT03055195|526447160|FG001|Overall Study|Protocol Violation|1|||
145981911|NCT03055195|526447159|FG000|Overall Study|Physician Decision|1|||
145981912|NCT03055195|526447160|FG001|Overall Study|Physician Decision|0|||
145981913|NCT00986232|526447161|FG000|Overall Study|Adverse Event|1|||
145981914|NCT00986232|526447162|FG001|Overall Study|Adverse Event|2|||
145981915|NCT00986232|526447163|FG002|Overall Study|Adverse Event|3|||
145981916|NCT00986232|526447164|FG003|Overall Study|Adverse Event|0|||
145981917|NCT00986232|526447161|FG000|Overall Study|Lost to Follow-up|19|||
145981918|NCT00986232|526447162|FG001|Overall Study|Lost to Follow-up|12|||
145981919|NCT00986232|526447163|FG002|Overall Study|Lost to Follow-up|12|||
145981920|NCT00986232|526447164|FG003|Overall Study|Lost to Follow-up|7|||
145981921|NCT00986232|526447161|FG000|Overall Study|Protocol Violation|2|||
145981922|NCT00986232|526447162|FG001|Overall Study|Protocol Violation|3|||
145981923|NCT00986232|526447163|FG002|Overall Study|Protocol Violation|0|||
145981924|NCT00986232|526447164|FG003|Overall Study|Protocol Violation|1|||
145981925|NCT00986232|526447161|FG000|Overall Study|Withdrawal by Subject|13|||
145981926|NCT00986232|526447162|FG001|Overall Study|Withdrawal by Subject|16|||
145981927|NCT00986232|526447163|FG002|Overall Study|Withdrawal by Subject|12|||
145981928|NCT00986232|526447164|FG003|Overall Study|Withdrawal by Subject|3|||
145981929|NCT00986232|526447161|FG000|Overall Study|Missed one or more bleeds|13|||
145981930|NCT00986232|526447162|FG001|Overall Study|Missed one or more bleeds|10|||
145981931|NCT00986232|526447163|FG002|Overall Study|Missed one or more bleeds|6|||
145981932|NCT00986232|526447164|FG003|Overall Study|Missed one or more bleeds|7|||
145981933|NCT00986232|526447161|FG000|Overall Study|Incomplete safety follow-up|3|||
146245589|NCT01029704|527414025|FG001|Overall Study|Adverse Event|0|||
146245590|NCT01029704|527414026|FG002|Overall Study|Adverse Event|0|||
146245591|NCT01029704|527414027|FG003|Overall Study|Adverse Event|0|||
146245592|NCT01029704|527414028|FG004|Overall Study|Adverse Event|0|||
146245593|NCT01029704|527414029|FG005|Overall Study|Adverse Event|0|||
146245594|NCT01029704|527414030|FG006|Overall Study|Adverse Event|1|||
146245595|NCT01029704|527414031|FG007|Overall Study|Adverse Event|1|||
146245596|NCT01029704|527414032|FG008|Overall Study|Adverse Event|0|||
145981934|NCT00986232|526447162|FG001|Overall Study|Incomplete safety follow-up|7|||
145981935|NCT00986232|526447163|FG002|Overall Study|Incomplete safety follow-up|2|||
145981936|NCT00986232|526447164|FG003|Overall Study|Incomplete safety follow-up|2|||
145981937|NCT00790933|526447165|FG000|Overall Study|Adverse Event|94|||
145981938|NCT00790933|526447166|FG001|Overall Study|Adverse Event|119|||
145981939|NCT00790933|526447167|FG002|Overall Study|Adverse Event|65|||
145981940|NCT00790933|526447168|FG003|Overall Study|Adverse Event|5|||
145981941|NCT00790933|526447169|FG004|Overall Study|Adverse Event|69|||
145981942|NCT00790933|526447165|FG000|Overall Study|Protocol Violation(s)|8|||
145981943|NCT00790933|526447166|FG001|Overall Study|Protocol Violation(s)|18|||
145981944|NCT00790933|526447167|FG002|Overall Study|Protocol Violation(s)|7|||
145981945|NCT00790933|526447168|FG003|Overall Study|Protocol Violation(s)|0|||
145981946|NCT00790933|526447169|FG004|Overall Study|Protocol Violation(s)|12|||
145981947|NCT00790933|526447165|FG000|Overall Study|Lack of Efficacy|192|||
145981948|NCT00790933|526447166|FG001|Overall Study|Lack of Efficacy|176|||
145981949|NCT00790933|526447167|FG002|Overall Study|Lack of Efficacy|130|||
145981950|NCT00790933|526447168|FG003|Overall Study|Lack of Efficacy|1|||
145981951|NCT00790933|526447169|FG004|Overall Study|Lack of Efficacy|121|||
145981952|NCT00790933|526447165|FG000|Overall Study|Study Terminated by Sponsor|0|||
145981953|NCT00790933|526447166|FG001|Overall Study|Study Terminated by Sponsor|0|||
145981954|NCT00790933|526447167|FG002|Overall Study|Study Terminated by Sponsor|1|||
145981955|NCT00790933|526447168|FG003|Overall Study|Study Terminated by Sponsor|0|||
145981956|NCT00790933|526447169|FG004|Overall Study|Study Terminated by Sponsor|0|||
145981957|NCT00790933|526447165|FG000|Overall Study|Withdrawal by Subject|123|||
145981958|NCT00790933|526447166|FG001|Overall Study|Withdrawal by Subject|120|||
145981959|NCT00790933|526447167|FG002|Overall Study|Withdrawal by Subject|52|||
145981960|NCT00790933|526447168|FG003|Overall Study|Withdrawal by Subject|6|||
145981961|NCT00790933|526447169|FG004|Overall Study|Withdrawal by Subject|50|||
145981962|NCT00790933|526447165|FG000|Overall Study|Lost to Follow-up|13|||
145981963|NCT00790933|526447166|FG001|Overall Study|Lost to Follow-up|31|||
145981964|NCT00790933|526447167|FG002|Overall Study|Lost to Follow-up|10|||
145981965|NCT00790933|526447168|FG003|Overall Study|Lost to Follow-up|1|||
145981966|NCT00790933|526447169|FG004|Overall Study|Lost to Follow-up|15|||
145981967|NCT00790933|526447165|FG000|Overall Study|Reason Not Specified|8|||
145981968|NCT00790933|526447166|FG001|Overall Study|Reason Not Specified|16|||
145981969|NCT00790933|526447167|FG002|Overall Study|Reason Not Specified|4|||
145981970|NCT00790933|526447168|FG003|Overall Study|Reason Not Specified|1|||
145981971|NCT00790933|526447169|FG004|Overall Study|Reason Not Specified|9|||
145981972|NCT00894647|526447170|FG000|Overall Study|Adverse Event|5|||
145981973|NCT00894647|526447171|FG001|Overall Study|Adverse Event|4|||
145981974|NCT00894647|526447170|FG000|Overall Study|Withdrawal by Subject|4|||
145981975|NCT00894647|526447171|FG001|Overall Study|Withdrawal by Subject|4|||
145981976|NCT00894647|526447170|FG000|Overall Study|Lost to Follow-up|0|||
145981977|NCT00894647|526447171|FG001|Overall Study|Lost to Follow-up|2|||
145981978|NCT00894647|526447170|FG000|Overall Study|Non-compliance with study procedures|0|||
145981979|NCT00894647|526447171|FG001|Overall Study|Non-compliance with study procedures|2|||
145981980|NCT00894647|526447170|FG000|Overall Study|Other, not due to AE|1|||
145981981|NCT00894647|526447171|FG001|Overall Study|Other, not due to AE|2|||
145981982|NCT01967277|526447172|FG000|Overall Study|Lost to Follow-up|1|||
145981983|NCT01967277|526447173|FG001|Overall Study|Lost to Follow-up|2|||
145981984|NCT01967277|526447172|FG000|Overall Study|Unrelated illness|0|||
145981985|NCT01967277|526447173|FG001|Overall Study|Unrelated illness|1|||
145981986|NCT02573467|526447174|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145981987|NCT02573467|526447175|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145981988|NCT02573467|526447176|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
145981989|NCT02573467|526447177|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145981990|NCT02573467|526447174|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
145981991|NCT02573467|526447175|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
145981992|NCT02573467|526447176|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
145981993|NCT02573467|526447177|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
145981994|NCT02573467|526447174|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
145981995|NCT02573467|526447175|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
145981996|NCT02573467|526447176|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
145981997|NCT02573467|526447177|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
146245597|NCT01029704|527414024|FG000|Overall Study|Withdrawal by Subject|0|||
145981998|NCT02573467|526447174|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
146245598|NCT01029704|527414025|FG001|Overall Study|Withdrawal by Subject|0|||
146245599|NCT01029704|527414026|FG002|Overall Study|Withdrawal by Subject|0|||
145981999|NCT02573467|526447175|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
145982000|NCT02573467|526447176|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
145982001|NCT02573467|526447177|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
145982002|NCT02573467|526447174|FG000|Post-treatment Follow up Epoch|Death|1|||
145982003|NCT02573467|526447175|FG001|Post-treatment Follow up Epoch|Death|1|||
145982004|NCT02573467|526447176|FG002|Post-treatment Follow up Epoch|Death|0|||
145982005|NCT02573467|526447177|FG003|Post-treatment Follow up Epoch|Death|1|||
145982006|NCT02573467|526447174|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
145982007|NCT02573467|526447175|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
145982008|NCT02573467|526447176|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
145982009|NCT02573467|526447177|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
145982010|NCT02573467|526447174|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
145982011|NCT02573467|526447175|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
145982012|NCT02573467|526447176|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
145982013|NCT02573467|526447177|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
145982014|NCT01829165|526447178|FG000|Overall Study|Did not complete intervention|2|||
145982015|NCT01829165|526447179|FG001|Overall Study|Did not complete intervention|0|||
145982016|NCT00710970|526447182|FG000|Overall Study|Never took drug|3|||
145982017|NCT01028560|526447183|FG000|Overall Study|Lack of Efficacy|3|||
145982018|NCT01028560|526447184|FG001|Overall Study|Lack of Efficacy|6|||
145982019|NCT01028560|526447183|FG000|Overall Study|Withdrawal by Subject|7|||
145982020|NCT01028560|526447184|FG001|Overall Study|Withdrawal by Subject|12|||
145982021|NCT02153827|526447185|FG000|Overall Study|Lost to Follow-up|3|||
145982022|NCT02153827|526447186|FG001|Overall Study|Lost to Follow-up|9|||
146245600|NCT01029704|527414027|FG003|Overall Study|Withdrawal by Subject|0|||
146245601|NCT01029704|527414028|FG004|Overall Study|Withdrawal by Subject|2|||
146245602|NCT01029704|527414029|FG005|Overall Study|Withdrawal by Subject|1|||
145982023|NCT01960842|526447189|FG000|Overall Study|Adverse Event|1|||
145982024|NCT01960842|526447189|FG000|Overall Study|Withdrawal by Subject|2|||
145982025|NCT00397930|526447190|FG000|Overall Study|Personal reasons|14|||
145982026|NCT00397930|526447191|FG001|Overall Study|Personal reasons|8|||
145982027|NCT00397930|526447190|FG000|Overall Study|Other medical|9|||
145982028|NCT00397930|526447191|FG001|Overall Study|Other medical|4|||
145982029|NCT00397930|526447190|FG000|Overall Study|Unknown reasons|9|||
145982030|NCT00397930|526447191|FG001|Overall Study|Unknown reasons|14|||
145982031|NCT00397930|526447190|FG000|Overall Study|Noncompliant|3|||
145982032|NCT00397930|526447191|FG001|Overall Study|Noncompliant|2|||
145982033|NCT00397930|526447190|FG000|Overall Study|Too time-consuming|2|||
145982034|NCT00397930|526447191|FG001|Overall Study|Too time-consuming|9|||
145982035|NCT00397930|526447190|FG000|Overall Study|Started own yoga program|1|||
145982036|NCT00397930|526447191|FG001|Overall Study|Started own yoga program|1|||
145982037|NCT00397930|526447190|FG000|Overall Study|Did not want to be in control group|0|||
145982038|NCT00397930|526447191|FG001|Overall Study|Did not want to be in control group|1|||
145982039|NCT00397930|526447190|FG000|Overall Study|Withdrawal by Subject|0|||
145982040|NCT00397930|526447191|FG001|Overall Study|Withdrawal by Subject|8|||
145982041|NCT00397930|526447190|FG000|Overall Study|Missing data|0|||
145982042|NCT00397930|526447191|FG001|Overall Study|Missing data|4|||
145982043|NCT02391584|526447192|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
145982044|NCT02391584|526447193|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
145982045|NCT02391584|526447192|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
145982046|NCT02391584|526447193|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
145982047|NCT02391584|526447192|FG000|3 Month|Lost to Follow-up|1|||
145982048|NCT02391584|526447193|FG001|3 Month|Lost to Follow-up|0|||
145982049|NCT02391584|526447192|FG000|6 Month|Withdrawal by Subject|1|||
145982050|NCT02391584|526447193|FG001|6 Month|Withdrawal by Subject|0|||
145982051|NCT02391584|526447192|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
145982052|NCT02391584|526447193|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
145982053|NCT04233580|526447207|FG000|Overall Study|Adverse Event|3|||
146245603|NCT01029704|527414030|FG006|Overall Study|Withdrawal by Subject|1|||
145982054|NCT04233580|526447208|FG001|Overall Study|Adverse Event|3|||
145982055|NCT04233580|526447207|FG000|Overall Study|Withdrawal by Subject|2|||
145982056|NCT04233580|526447208|FG001|Overall Study|Withdrawal by Subject|1|||
145982057|NCT01371565|526447209|FG000|Overall Study|Withdrawal by Subject|1|||
145982058|NCT01371565|526447209|FG000|Overall Study|Death|1|||
145982059|NCT01371565|526447209|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
145982060|NCT02061592|526447210|FG000|Period 1|Withdrawal by Subject|1|||
145982061|NCT02061592|526447211|FG001|Period 1|Withdrawal by Subject|0|||
145982062|NCT02061592|526447210|FG000|Period 1|Protocol Violation|1|||
145982063|NCT02061592|526447211|FG001|Period 1|Protocol Violation|0|||
145982064|NCT02061592|526447210|FG000|Period 2|Lost to Follow-up|0|||
145982065|NCT02061592|526447211|FG001|Period 2|Lost to Follow-up|1|||
145982066|NCT04996264|526447212|FG000|Overall Study|Lost to Follow-up|0|||
145982067|NCT04996264|526447213|FG001|Overall Study|Lost to Follow-up|1|||
146245604|NCT01029704|527414031|FG007|Overall Study|Withdrawal by Subject|1|||
145982068|NCT04996264|526447212|FG000|Overall Study|Withdrawal by Subject|4|||
145982069|NCT04996264|526447213|FG001|Overall Study|Withdrawal by Subject|3|||
145982070|NCT04996264|526447212|FG000|Overall Study|1 left AMA|0|||
145982071|NCT04996264|526447213|FG001|Overall Study|1 left AMA|1|||
145982072|NCT04996264|526447212|FG000|Overall Study|Subject changed hospitals|0|||
145982073|NCT04996264|526447213|FG001|Overall Study|Subject changed hospitals|1|||
145982074|NCT04996264|526447212|FG000|Overall Study|unable to complete due to work|0|||
145982075|NCT04996264|526447213|FG001|Overall Study|unable to complete due to work|1|||
145982076|NCT04433975|526447214|FG000|1-month Follow Up|Withdrawal by Subject|1|||
145982077|NCT04433975|526447215|FG001|1-month Follow Up|Withdrawal by Subject|1|||
145982078|NCT04433975|526447214|FG000|1-month Follow Up|Lost to Follow-up|21|||
145982079|NCT04433975|526447215|FG001|1-month Follow Up|Lost to Follow-up|25|||
145982080|NCT04433975|526447214|FG000|3-month Follow Up|Lost to Follow-up|20|||
145982081|NCT04433975|526447215|FG001|3-month Follow Up|Lost to Follow-up|24|||
145982082|NCT04433975|526447214|FG000|3-month Follow Up|Death|1|||
145982083|NCT04433975|526447215|FG001|3-month Follow Up|Death|0|||
145982084|NCT04433975|526447214|FG000|3-month Follow Up|Withdrawal by Subject|2|||
145982085|NCT04433975|526447215|FG001|3-month Follow Up|Withdrawal by Subject|0|||
145982086|NCT04433975|526447214|FG000|6-month Follow Up|Lost to Follow-up|23|||
145982087|NCT04433975|526447215|FG001|6-month Follow Up|Lost to Follow-up|28|||
145982088|NCT04433975|526447214|FG000|6-month Follow Up|Withdrawal by Subject|1|||
145982089|NCT04433975|526447215|FG001|6-month Follow Up|Withdrawal by Subject|1|||
145982090|NCT04433975|526447214|FG000|9-month Follow Up|Lost to Follow-up|27|||
145982091|NCT04433975|526447215|FG001|9-month Follow Up|Lost to Follow-up|36|||
145982092|NCT04433975|526447214|FG000|9-month Follow Up|Death|0|||
145982093|NCT04433975|526447215|FG001|9-month Follow Up|Death|1|||
145982094|NCT04433975|526447214|FG000|12-month Follow Up|Lost to Follow-up|27|||
145982095|NCT04433975|526447215|FG001|12-month Follow Up|Lost to Follow-up|31|||
145982096|NCT00685698|526447216|FG000|Overall Study|Withdrawal by Subject|1|||
145982097|NCT00685698|526447216|FG000|Overall Study|Protocol Violation|6|||
145982098|NCT00685698|526447216|FG000|Overall Study|Adverse Event|3|||
145982099|NCT00685698|526447216|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
145982100|NCT00685698|526447216|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
145982101|NCT00685698|526447216|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
145982102|NCT04392635|526447217|FG000|Overall Study|Lost to Follow-up|0|||
145982103|NCT04392635|526447218|FG001|Overall Study|Lost to Follow-up|1|||
145982104|NCT02030418|526447220|FG000|Overall Study|Death|78|||
145982105|NCT02030418|526447220|FG000|Overall Study|Missed 12-Month Visit|9|||
145982106|NCT02030418|526447220|FG000|Overall Study|Withdrawn|57|||
145982107|NCT01179516|526447221|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
145982108|NCT01179516|526447222|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
146245605|NCT01029704|527414032|FG008|Overall Study|Withdrawal by Subject|0|||
146245606|NCT01029704|527414024|FG000|Overall Study|Lost to Follow-up|0|||
146245607|NCT01029704|527414025|FG001|Overall Study|Lost to Follow-up|0|||
146245608|NCT01029704|527414026|FG002|Overall Study|Lost to Follow-up|0|||
146245609|NCT01029704|527414027|FG003|Overall Study|Lost to Follow-up|0|||
146245610|NCT01029704|527414028|FG004|Overall Study|Lost to Follow-up|0|||
146245611|NCT01029704|527414029|FG005|Overall Study|Lost to Follow-up|0|||
146245612|NCT01029704|527414030|FG006|Overall Study|Lost to Follow-up|1|||
146297847|NCT02038920|527606032|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
145982109|NCT01179516|526447223|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
145982110|NCT01179516|526447221|FG000|Overall Study|Lack of Efficacy|4|||
145982111|NCT01179516|526447222|FG001|Overall Study|Lack of Efficacy|2|||
145982112|NCT01179516|526447223|FG002|Overall Study|Lack of Efficacy|0|||
145982113|NCT01179516|526447221|FG000|Overall Study|Noncompliance with Study Drug|2|||
145982114|NCT01179516|526447222|FG001|Overall Study|Noncompliance with Study Drug|0|||
145982115|NCT01179516|526447223|FG002|Overall Study|Noncompliance with Study Drug|1|||
145982116|NCT01179516|526447221|FG000|Overall Study|Protocol Deviations|4|||
145982117|NCT01179516|526447222|FG001|Overall Study|Protocol Deviations|3|||
145982118|NCT01179516|526447223|FG002|Overall Study|Protocol Deviations|3|||
145982119|NCT01179516|526447221|FG000|Overall Study|Withdrawal of Consent|2|||
145982120|NCT01179516|526447222|FG001|Overall Study|Withdrawal of Consent|6|||
145982121|NCT01179516|526447223|FG002|Overall Study|Withdrawal of Consent|10|||
145982122|NCT01179516|526447221|FG000|Overall Study|Lost to Follow-up|7|||
145982123|NCT01179516|526447222|FG001|Overall Study|Lost to Follow-up|7|||
145982124|NCT01179516|526447223|FG002|Overall Study|Lost to Follow-up|3|||
145982125|NCT01179516|526447221|FG000|Overall Study|Other|2|||
145982126|NCT01179516|526447222|FG001|Overall Study|Other|0|||
145982127|NCT01179516|526447223|FG002|Overall Study|Other|2|||
145982128|NCT02697422|526447229|FG000|Overall Study|Declined exit survey|9|||
145982129|NCT02697422|526447230|FG001|Overall Study|Declined exit survey|2|||
145982130|NCT02697422|526447229|FG000|Overall Study|Lost to Follow-up|13|||
146245613|NCT01029704|527414031|FG007|Overall Study|Lost to Follow-up|1|||
146245614|NCT01029704|527414032|FG008|Overall Study|Lost to Follow-up|1|||
145982131|NCT02697422|526447230|FG001|Overall Study|Lost to Follow-up|8|||
145982132|NCT02697422|526447229|FG000|Overall Study|Death|2|||
145982133|NCT02697422|526447230|FG001|Overall Study|Death|1|||
145982134|NCT02697422|526447229|FG000|Overall Study|Withdrawal by Subject|0|||
145982135|NCT02697422|526447230|FG001|Overall Study|Withdrawal by Subject|1|||
145982136|NCT02697422|526447229|FG000|Overall Study|Physician Decision|1|||
145982137|NCT02697422|526447230|FG001|Overall Study|Physician Decision|1|||
145982138|NCT02697422|526447229|FG000|Overall Study|Exit survey data lost|1|||
145982139|NCT02697422|526447230|FG001|Overall Study|Exit survey data lost|0|||
145982140|NCT03501277|526447231|FG000|Intervention Period 1 (4 Days)|Other|0|||
145982141|NCT03501277|526447232|FG001|Intervention Period 1 (4 Days)|Other|0|||
145982142|NCT03501277|526447233|FG002|Intervention Period 1 (4 Days)|Other|1|||
145982143|NCT03501277|526447234|FG003|Intervention Period 1 (4 Days)|Other|0|||
145982144|NCT03501277|526447231|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
145982145|NCT03501277|526447232|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
145982146|NCT03501277|526447233|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
145982147|NCT03501277|526447234|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
145982148|NCT03501277|526447231|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
145982149|NCT03501277|526447232|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
145982150|NCT03501277|526447233|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
145982151|NCT03501277|526447234|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
145982152|NCT03501277|526447231|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
145982153|NCT03501277|526447232|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
145982154|NCT03501277|526447233|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
145982155|NCT03501277|526447234|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
145982156|NCT03983109|526447235|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
145982157|NCT03983109|526447236|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
145982158|NCT04739709|526447242|FG000|Overall Study|Physician Decision|1|||
145982159|NCT04739709|526447243|FG001|Overall Study|Physician Decision|0|||
145982160|NCT01980888|526447244|FG000|Overall Study|Study Terminated by Sponsor|116|||
145982161|NCT01980888|526447245|FG001|Overall Study|Study Terminated by Sponsor|122|||
145982162|NCT01980888|526447244|FG000|Overall Study|Withdrew Consent|17|||
145982163|NCT01980888|526447245|FG001|Overall Study|Withdrew Consent|6|||
145982164|NCT01980888|526447244|FG000|Overall Study|Investigator's Discretion|8|||
145982165|NCT01980888|526447245|FG001|Overall Study|Investigator's Discretion|3|||
145982166|NCT01980888|526447244|FG000|Overall Study|Non-Compliance with Study Drug|3|||
145982167|NCT01980888|526447245|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145982168|NCT04625972|526447247|FG000|Overall Study|Death|3|||
145982169|NCT04625972|526447248|FG001|Overall Study|Death|2|||
145982170|NCT04625972|526447247|FG000|Overall Study|Lost to Follow-up|82|||
145982171|NCT04625972|526447248|FG001|Overall Study|Lost to Follow-up|38|||
145982172|NCT04625972|526447247|FG000|Overall Study|Physician Decision|2|||
145982173|NCT04625972|526447248|FG001|Overall Study|Physician Decision|0|||
145982174|NCT04625972|526447247|FG000|Overall Study|Protocol Violation|0|||
145982175|NCT04625972|526447248|FG001|Overall Study|Protocol Violation|1|||
145982176|NCT04625972|526447247|FG000|Overall Study|Withdrawal by Subject|37|||
145982177|NCT04625972|526447248|FG001|Overall Study|Withdrawal by Subject|24|||
145982178|NCT04625972|526447247|FG000|Overall Study|Not specified elsewhere|8|||
145982179|NCT04625972|526447248|FG001|Overall Study|Not specified elsewhere|6|||
145982180|NCT00433290|526447249|FG000|Overall Study|Adverse Event|24|||
145982181|NCT00433290|526447250|FG001|Overall Study|Adverse Event|7|||
145982182|NCT00433290|526447249|FG000|Overall Study|Lack of Efficacy|1|||
145982183|NCT00433290|526447250|FG001|Overall Study|Lack of Efficacy|5|||
145982184|NCT00433290|526447249|FG000|Overall Study|Withdrawal by Subject|4|||
145982185|NCT00433290|526447250|FG001|Overall Study|Withdrawal by Subject|2|||
145982186|NCT00433290|526447249|FG000|Overall Study|Protocol Violation|3|||
145982187|NCT00433290|526447250|FG001|Overall Study|Protocol Violation|2|||
145982188|NCT00433290|526447249|FG000|Overall Study|Physician Decision|2|||
145982189|NCT00433290|526447250|FG001|Overall Study|Physician Decision|0|||
145982190|NCT00433290|526447249|FG000|Overall Study|Entry Criteria Not Met|0|||
145982191|NCT00433290|526447250|FG001|Overall Study|Entry Criteria Not Met|1|||
145982192|NCT00433290|526447249|FG000|Overall Study|Lost to Follow-up|1|||
145982193|NCT00433290|526447250|FG001|Overall Study|Lost to Follow-up|0|||
145982194|NCT01483651|526447251|FG000|Overall Study|Withdrawal by Subject|0|||
145982195|NCT01483651|526447252|FG001|Overall Study|Withdrawal by Subject|1|||
145982196|NCT01483651|526447253|FG002|Overall Study|Withdrawal by Subject|1|||
145982197|NCT01483651|526447254|FG003|Overall Study|Withdrawal by Subject|0|||
145982198|NCT01483651|526447255|FG004|Overall Study|Withdrawal by Subject|0|||
145982199|NCT01483651|526447256|FG005|Overall Study|Withdrawal by Subject|1|||
145982200|NCT00724503|526447258|FG000|Overall Study|Lost to Follow-up|4|||
145982201|NCT00724503|526447259|FG001|Overall Study|Lost to Follow-up|8|||
145982202|NCT00724503|526447258|FG000|Overall Study|Withdrawal by Subject|11|||
145982203|NCT00724503|526447259|FG001|Overall Study|Withdrawal by Subject|23|||
145982204|NCT00724503|526447258|FG000|Overall Study|Death|190|||
145982205|NCT00724503|526447259|FG001|Overall Study|Death|182|||
145982206|NCT00724503|526447258|FG000|Overall Study|Adverse Event|1|||
145982207|NCT00724503|526447259|FG001|Overall Study|Adverse Event|0|||
145982208|NCT00724503|526447258|FG000|Overall Study|Not otherwise specified|4|||
145982209|NCT00724503|526447259|FG001|Overall Study|Not otherwise specified|7|||
145982210|NCT01928771|526447261|FG000|Overall Study|Adverse Event|6|||
145982211|NCT01928771|526447262|FG001|Overall Study|Adverse Event|5|||
145982212|NCT01928771|526447263|FG002|Overall Study|Adverse Event|1|||
145982213|NCT01928771|526447261|FG000|Overall Study|Death|2|||
145982214|NCT01928771|526447262|FG001|Overall Study|Death|2|||
145982215|NCT01928771|526447263|FG002|Overall Study|Death|2|||
145982216|NCT01928771|526447261|FG000|Overall Study|Lost to Follow-up|5|||
145982217|NCT01928771|526447262|FG001|Overall Study|Lost to Follow-up|6|||
145982218|NCT01928771|526447263|FG002|Overall Study|Lost to Follow-up|3|||
145982219|NCT01928771|526447261|FG000|Overall Study|Withdrawal by Subject|20|||
145982220|NCT01928771|526447262|FG001|Overall Study|Withdrawal by Subject|15|||
145982221|NCT01928771|526447263|FG002|Overall Study|Withdrawal by Subject|17|||
145982222|NCT01928771|526447261|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
145982223|NCT01928771|526447262|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145982224|NCT01928771|526447263|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
145982225|NCT01928771|526447261|FG000|Overall Study|Other Reasons|9|||
145982226|NCT01928771|526447262|FG001|Overall Study|Other Reasons|9|||
145982227|NCT01928771|526447263|FG002|Overall Study|Other Reasons|14|||
145982228|NCT01928771|526447261|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
145982229|NCT01928771|526447262|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
145982230|NCT01928771|526447263|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
145982231|NCT01937117|526447264|FG000|Overall Study|Disease Progression|7|||
145982232|NCT01937117|526447264|FG000|Overall Study|Physician Decision|4|||
145982233|NCT01937117|526447264|FG000|Overall Study|Adverse Event|2|||
145982234|NCT01407367|526447269|FG000|Overall Study|Death|24|||
145982235|NCT01407367|526447270|FG001|Overall Study|Death|32|||
145982236|NCT01407367|526447269|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
145982237|NCT01407367|526447270|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
145982238|NCT01407367|526447269|FG000|Overall Study|Withdrawal by Subject|4|||
145982239|NCT01407367|526447270|FG001|Overall Study|Withdrawal by Subject|15|||
145982240|NCT01407367|526447269|FG000|Overall Study|Lost to Follow-up|0|||
145982241|NCT01407367|526447270|FG001|Overall Study|Lost to Follow-up|2|||
145982242|NCT01245062|526447272|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
145982243|NCT01245062|526447273|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
145982244|NCT01245062|526447274|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
145982245|NCT01245062|526447272|FG000|Randomization and Crossover Phase|Physician Decision|2|||
145982246|NCT01245062|526447273|FG001|Randomization and Crossover Phase|Physician Decision|4|||
145982247|NCT01245062|526447274|FG002|Randomization and Crossover Phase|Physician Decision|0|||
145982248|NCT01245062|526447272|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
145982249|NCT01245062|526447273|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
145982250|NCT01245062|526447274|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
145982251|NCT01245062|526447272|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
145982252|NCT01245062|526447273|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
145982253|NCT01245062|526447274|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
145982254|NCT01245062|526447272|FG000|Cross-over Phase|Lost to Follow-up|0|||
145982255|NCT01245062|526447273|FG001|Cross-over Phase|Lost to Follow-up|0|||
145982256|NCT01245062|526447274|FG002|Cross-over Phase|Lost to Follow-up|1|||
145982257|NCT01245062|526447272|FG000|Cross-over Phase|Physician Decision|0|||
145982258|NCT01245062|526447273|FG001|Cross-over Phase|Physician Decision|0|||
145982259|NCT01245062|526447274|FG002|Cross-over Phase|Physician Decision|1|||
145982260|NCT01245062|526447272|FG000|Cross-over Phase|Withdrew Consent|0|||
145982261|NCT01245062|526447273|FG001|Cross-over Phase|Withdrew Consent|0|||
145982262|NCT01245062|526447274|FG002|Cross-over Phase|Withdrew Consent|4|||
145982263|NCT01245062|526447272|FG000|Cross-over Phase|Study closed/ terminated|0|||
145982264|NCT01245062|526447273|FG001|Cross-over Phase|Study closed/ terminated|0|||
145982265|NCT01245062|526447274|FG002|Cross-over Phase|Study closed/ terminated|11|||
145982266|NCT01452347|526447275|FG000|Overall Study|Adverse Event|2|||
145982267|NCT01452347|526447276|FG001|Overall Study|Adverse Event|1|||
145982268|NCT01452347|526447275|FG000|Overall Study|Non compliance protocol|2|||
145982269|NCT01452347|526447276|FG001|Overall Study|Non compliance protocol|0|||
145982270|NCT01452347|526447275|FG000|Overall Study|Lost to Follow-up|2|||
145982271|NCT01452347|526447276|FG001|Overall Study|Lost to Follow-up|0|||
145982272|NCT01452347|526447275|FG000|Overall Study|Withdrawal by Subject|3|||
145982273|NCT01452347|526447276|FG001|Overall Study|Withdrawal by Subject|3|||
145982274|NCT01452347|526447275|FG000|Overall Study|Not treated|6|||
145982275|NCT01452347|526447276|FG001|Overall Study|Not treated|3|||
145982276|NCT01452347|526447275|FG000|Overall Study|Other reason not defined above|2|||
145982277|NCT01452347|526447276|FG001|Overall Study|Other reason not defined above|0|||
145982278|NCT00853047|526447277|FG000|Core Phase|Participant Request|0|||
145982279|NCT00853047|526447278|FG001|Core Phase|Participant Request|0|||
145982280|NCT00853047|526447279|FG002|Core Phase|Participant Request|0|||
145982281|NCT00853047|526447280|FG003|Core Phase|Participant Request|1|||
145982282|NCT00853047|526447281|FG004|Core Phase|Participant Request|0|||
145982283|NCT00853047|526447282|FG005|Core Phase|Participant Request|0|||
145982284|NCT00853047|526447277|FG000|Open-Label Extension Phase|Participant Request|0|||
145982285|NCT00853047|526447278|FG001|Open-Label Extension Phase|Participant Request|0|||
145982286|NCT00853047|526447279|FG002|Open-Label Extension Phase|Participant Request|0|||
145982287|NCT00853047|526447280|FG003|Open-Label Extension Phase|Participant Request|0|||
145982288|NCT00853047|526447281|FG004|Open-Label Extension Phase|Participant Request|0|||
145982289|NCT00853047|526447282|FG005|Open-Label Extension Phase|Participant Request|7|||
145982290|NCT00853047|526447277|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145982291|NCT00853047|526447278|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145982292|NCT00853047|526447279|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145982293|NCT00853047|526447280|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
145982294|NCT00853047|526447281|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
145982295|NCT00853047|526447282|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
145982296|NCT00853047|526447277|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145982297|NCT00853047|526447278|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145982298|NCT00853047|526447279|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145982299|NCT00853047|526447280|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145982300|NCT00853047|526447281|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145982301|NCT00853047|526447282|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
145982302|NCT00853047|526447277|FG000|Open-Label Extension Phase|Investigator Decision|0|||
145982303|NCT00853047|526447278|FG001|Open-Label Extension Phase|Investigator Decision|0|||
145982304|NCT00853047|526447279|FG002|Open-Label Extension Phase|Investigator Decision|0|||
145982305|NCT00853047|526447280|FG003|Open-Label Extension Phase|Investigator Decision|0|||
145982306|NCT00853047|526447281|FG004|Open-Label Extension Phase|Investigator Decision|0|||
145982307|NCT00853047|526447282|FG005|Open-Label Extension Phase|Investigator Decision|1|||
145982308|NCT00853047|526447277|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
145982309|NCT00853047|526447278|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
145982310|NCT00853047|526447279|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
145982311|NCT00853047|526447280|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
145982312|NCT00853047|526447281|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
145982313|NCT00853047|526447282|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
145982314|NCT01695772|526447285|FG000|Overall Study|Withdrawal by Subject|18|||
145982315|NCT01695772|526447285|FG000|Overall Study|Progressive Disease|8|||
145982316|NCT01695772|526447285|FG000|Overall Study|Investigator Decision|5|||
145982317|NCT01695772|526447285|FG000|Overall Study|Lost to Follow-up|4|||
145982318|NCT01695772|526447285|FG000|Overall Study|Protocol Violation|2|||
145982319|NCT01695772|526447285|FG000|Overall Study|Unspecified Reason|1|||
145982320|NCT00004859|526447288|FG000|Overall Study|Lack of Efficacy|43|||
145982321|NCT00004859|526447289|FG001|Overall Study|Lack of Efficacy|113|||
145982322|NCT00004859|526447288|FG000|Overall Study|Adverse Event|31|||
145982323|NCT00004859|526447289|FG001|Overall Study|Adverse Event|93|||
145982324|NCT00004859|526447288|FG000|Overall Study|Death|5|||
145982325|NCT00004859|526447289|FG001|Overall Study|Death|5|||
145982326|NCT00004859|526447288|FG000|Overall Study|Withdrawal by Subject|7|||
145982327|NCT00004859|526447289|FG001|Overall Study|Withdrawal by Subject|33|||
145982328|NCT00004859|526447288|FG000|Overall Study|Protocol Violation|2|||
145982329|NCT00004859|526447289|FG001|Overall Study|Protocol Violation|2|||
145982330|NCT00004859|526447288|FG000|Overall Study|other disease|0|||
145982331|NCT00004859|526447289|FG001|Overall Study|other disease|3|||
145982332|NCT00004859|526447288|FG000|Overall Study|error|3|||
145982333|NCT00004859|526447289|FG001|Overall Study|error|1|||
145982334|NCT00004859|526447288|FG000|Overall Study|missing data|14|||
145982335|NCT00004859|526447289|FG001|Overall Study|missing data|11|||
145982336|NCT00004859|526447288|FG000|Overall Study|Other|13|||
145982337|NCT00004859|526447289|FG001|Overall Study|Other|21|||
145982338|NCT04073407|526447290|FG000|Part 1|Withdrawal by Subject|1|||
145982339|NCT04073407|526447291|FG001|Part 1|Withdrawal by Subject|0|||
145982340|NCT04073407|526447290|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
145982341|NCT04073407|526447291|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
145982342|NCT04073407|526447290|FG000|Part 2|Withdrawal by Subject|0|||
145982343|NCT04073407|526447291|FG001|Part 2|Withdrawal by Subject|1|||
145982344|NCT02724644|526448731|FG000|Overall Study|Adverse Event|7|||
145982345|NCT02724644|526448732|FG001|Overall Study|Adverse Event|1|||
145982346|NCT02724644|526448731|FG000|Overall Study|Lost to Follow-up|6|||
145982347|NCT02724644|526448732|FG001|Overall Study|Lost to Follow-up|2|||
145982348|NCT02724644|526448731|FG000|Overall Study|Withdrawal by Subject|7|||
145982349|NCT02724644|526448732|FG001|Overall Study|Withdrawal by Subject|1|||
145982350|NCT02724644|526448731|FG000|Overall Study|Administrative|1|||
145982351|NCT02724644|526448732|FG001|Overall Study|Administrative|0|||
145982352|NCT02545127|526448737|FG000|Overall Study|Lost to Follow-up|1|||
145982353|NCT02545127|526448738|FG001|Overall Study|Lost to Follow-up|0|||
145982354|NCT03197935|526448739|FG000|Overall Study|Death due to any cause|26|||
145982355|NCT03197935|526448740|FG001|Overall Study|Death due to any cause|15|||
145982356|NCT03197935|526448739|FG000|Overall Study|Lost to Follow-up|3|||
145982357|NCT03197935|526448740|FG001|Overall Study|Lost to Follow-up|5|||
145982358|NCT03197935|526448739|FG000|Overall Study|Physician Decision|2|||
145982359|NCT03197935|526448740|FG001|Overall Study|Physician Decision|1|||
145982360|NCT03197935|526448739|FG000|Overall Study|Withdrawal by Subject|16|||
145982361|NCT03197935|526448740|FG001|Overall Study|Withdrawal by Subject|8|||
145982362|NCT00960856|526448742|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146245615|NCT01029704|527414024|FG000|Overall Study|Lack of Efficacy|0|||
145982363|NCT00960856|526448743|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
145982364|NCT00960856|526448744|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
145982365|NCT00960856|526448745|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
145982366|NCT00960856|526448742|FG000|Washout Period of 7 Days|Adverse Event|0|||
145982367|NCT00960856|526448743|FG001|Washout Period of 7 Days|Adverse Event|0|||
145982368|NCT00960856|526448744|FG002|Washout Period of 7 Days|Adverse Event|1|||
145982369|NCT00960856|526448745|FG003|Washout Period of 7 Days|Adverse Event|0|||
145982370|NCT05938010|526448746|FG000|Overall Study|Lost to Follow-up|2|||
145982371|NCT02595749|526448750|FG000|Overall Study|Withdrawal by Subject|12|||
145982372|NCT02595749|526448751|FG001|Overall Study|Withdrawal by Subject|7|||
145982373|NCT01562444|526448754|FG000|Overall Study|Did not meet entry criteria|2|||
145982374|NCT01562444|526448755|FG001|Overall Study|Did not meet entry criteria|0|||
145982375|NCT01562444|526448756|FG002|Overall Study|Did not meet entry criteria|3|||
145982376|NCT01562444|526448754|FG000|Overall Study|Did not comply with blood draw schedule|1|||
145982377|NCT01562444|526448755|FG001|Overall Study|Did not comply with blood draw schedule|0|||
145982378|NCT01562444|526448756|FG002|Overall Study|Did not comply with blood draw schedule|1|||
145982379|NCT01562444|526448754|FG000|Overall Study|Unavailable serological results|0|||
145982380|NCT01562444|526448755|FG001|Overall Study|Unavailable serological results|2|||
145982381|NCT01562444|526448756|FG002|Overall Study|Unavailable serological results|2|||
145982382|NCT01562444|526448754|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
145982383|NCT01562444|526448755|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
145982384|NCT01562444|526448756|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
145982385|NCT01562444|526448754|FG000|Overall Study|Protocol forbidden medication|1|||
145982386|NCT01562444|526448755|FG001|Overall Study|Protocol forbidden medication|0|||
145982387|NCT01562444|526448756|FG002|Overall Study|Protocol forbidden medication|0|||
145982388|NCT03387046|526448765|FG000|Overall Study|Adverse Event|1|||
145982389|NCT03387046|526448766|FG001|Overall Study|Adverse Event|1|||
145982390|NCT00509600|526448767|FG000|Overall Study|Adverse Event|1|||
145982391|NCT02568423|526448768|FG000|Overall Study|Lost to Follow-up|0|||
145982392|NCT02568423|526448769|FG001|Overall Study|Lost to Follow-up|2|||
145982393|NCT02568423|526448770|FG002|Overall Study|Lost to Follow-up|0|||
145982394|NCT02568423|526448771|FG003|Overall Study|Lost to Follow-up|0|||
145982395|NCT02568423|526448772|FG004|Overall Study|Lost to Follow-up|0|||
145982396|NCT02568423|526448773|FG005|Overall Study|Lost to Follow-up|0|||
145982397|NCT02568423|526448774|FG006|Overall Study|Lost to Follow-up|0|||
145982398|NCT02568423|526448775|FG007|Overall Study|Lost to Follow-up|0|||
145982399|NCT02568423|526448768|FG000|Overall Study|Physician Decision|0|||
145982400|NCT02568423|526448769|FG001|Overall Study|Physician Decision|0|||
145982401|NCT02568423|526448770|FG002|Overall Study|Physician Decision|0|||
145982402|NCT02568423|526448771|FG003|Overall Study|Physician Decision|0|||
145982403|NCT02568423|526448772|FG004|Overall Study|Physician Decision|0|||
145982404|NCT02568423|526448773|FG005|Overall Study|Physician Decision|1|||
145982405|NCT02568423|526448774|FG006|Overall Study|Physician Decision|0|||
145982406|NCT02568423|526448775|FG007|Overall Study|Physician Decision|0|||
145982407|NCT03794544|526448780|FG000|Overall Study|Withdrawal by Subject|1|||
145982408|NCT03794544|526448781|FG001|Overall Study|Withdrawal by Subject|1|||
145982409|NCT03794544|526448782|FG002|Overall Study|Withdrawal by Subject|0|||
145982410|NCT03794544|526448783|FG003|Overall Study|Withdrawal by Subject|0|||
145982411|NCT03794544|526448780|FG000|Overall Study|Death|0|||
145982412|NCT03794544|526448781|FG001|Overall Study|Death|0|||
145982413|NCT03794544|526448782|FG002|Overall Study|Death|0|||
145982414|NCT03794544|526448783|FG003|Overall Study|Death|1|||
145982415|NCT03794544|526448780|FG000|Overall Study|Lost to Follow-up|0|||
145982416|NCT03794544|526448781|FG001|Overall Study|Lost to Follow-up|1|||
145982417|NCT03794544|526448782|FG002|Overall Study|Lost to Follow-up|1|||
145982418|NCT03794544|526448783|FG003|Overall Study|Lost to Follow-up|0|||
145982419|NCT03794544|526448780|FG000|Overall Study|Other|0|||
145982420|NCT03794544|526448781|FG001|Overall Study|Other|1|||
145982421|NCT03794544|526448782|FG002|Overall Study|Other|0|||
145982422|NCT03794544|526448783|FG003|Overall Study|Other|0|||
145982423|NCT01027416|526448784|FG000|Overall Study|Withdrawal by Subject|0|||
145982424|NCT01027416|526448785|FG001|Overall Study|Withdrawal by Subject|1|||
145982425|NCT01027416|526448784|FG000|Overall Study|Physician Decision|1|||
145982426|NCT01027416|526448785|FG001|Overall Study|Physician Decision|4|||
145982427|NCT00421733|526448786|FG000|Overall Study|Adverse Event|4|||
145982428|NCT00421733|526448787|FG001|Overall Study|Adverse Event|9|||
145982429|NCT00421733|526448788|FG002|Overall Study|Adverse Event|2|||
145982430|NCT00421733|526448786|FG000|Overall Study|Lost to Follow-up|1|||
145982431|NCT00421733|526448787|FG001|Overall Study|Lost to Follow-up|2|||
145982432|NCT00421733|526448788|FG002|Overall Study|Lost to Follow-up|4|||
145982433|NCT00421733|526448786|FG000|Overall Study|Withdrawal by Subject|1|||
146245616|NCT01029704|527414025|FG001|Overall Study|Lack of Efficacy|0|||
145982434|NCT00421733|526448787|FG001|Overall Study|Withdrawal by Subject|2|||
145982435|NCT00421733|526448788|FG002|Overall Study|Withdrawal by Subject|7|||
145982436|NCT00421733|526448786|FG000|Overall Study|Death|0|||
146245617|NCT01029704|527414026|FG002|Overall Study|Lack of Efficacy|0|||
145982437|NCT00421733|526448787|FG001|Overall Study|Death|3|||
146245618|NCT01029704|527414027|FG003|Overall Study|Lack of Efficacy|0|||
146245619|NCT01029704|527414028|FG004|Overall Study|Lack of Efficacy|2|||
145982438|NCT00421733|526448788|FG002|Overall Study|Death|0|||
145982439|NCT00421733|526448786|FG000|Overall Study|Required dialysis|1|||
145982440|NCT00421733|526448787|FG001|Overall Study|Required dialysis|0|||
145982441|NCT00421733|526448788|FG002|Overall Study|Required dialysis|0|||
145982442|NCT00421733|526448786|FG000|Overall Study|Administrative|2|||
145982443|NCT00421733|526448787|FG001|Overall Study|Administrative|0|||
145982444|NCT00421733|526448788|FG002|Overall Study|Administrative|0|||
145982445|NCT00421733|526448786|FG000|Overall Study|Did not satisfy entry criteria|1|||
145982446|NCT00421733|526448787|FG001|Overall Study|Did not satisfy entry criteria|3|||
145982447|NCT00421733|526448788|FG002|Overall Study|Did not satisfy entry criteria|2|||
145982448|NCT00421733|526448786|FG000|Overall Study|Sponsor request|1|||
145982449|NCT00421733|526448787|FG001|Overall Study|Sponsor request|0|||
145982450|NCT00421733|526448788|FG002|Overall Study|Sponsor request|3|||
145982451|NCT00421733|526448786|FG000|Overall Study|Protocol deviation|4|||
145982452|NCT00421733|526448787|FG001|Overall Study|Protocol deviation|7|||
145982453|NCT00421733|526448788|FG002|Overall Study|Protocol deviation|2|||
145982454|NCT00120250|526448789|FG000|Overall Study|Lost to Follow-up|1|||
145982455|NCT00120250|526448790|FG001|Overall Study|Lost to Follow-up|1|||
145982456|NCT00120250|526448789|FG000|Overall Study|Protocol Violation|0|||
145982457|NCT00120250|526448790|FG001|Overall Study|Protocol Violation|1|||
145982458|NCT00720083|526448791|FG000|Overall Study|Ineligible|1|||
145982459|NCT00720083|526448792|FG001|Overall Study|Ineligible|2|||
145982460|NCT00585585|526448796|FG000|Overall Study|Adverse Event|1|||
145982461|NCT00103506|526448797|FG000|Overall Study|Study closed by sponsor|34|||
145982462|NCT00103506|526448798|FG001|Overall Study|Study closed by sponsor|37|||
145982463|NCT00103506|526448797|FG000|Overall Study|Death|257|||
145982464|NCT00103506|526448798|FG001|Overall Study|Death|253|||
145982465|NCT00103506|526448797|FG000|Overall Study|Lost to Follow-up|13|||
145982466|NCT00103506|526448798|FG001|Overall Study|Lost to Follow-up|13|||
145982467|NCT00103506|526448797|FG000|Overall Study|Withdrawal by Subject|18|||
145982468|NCT00103506|526448798|FG001|Overall Study|Withdrawal by Subject|21|||
145982469|NCT02056288|526448801|FG000|In-Hospital Data|Surgery cancelled|1|||
145982470|NCT02056288|526448802|FG001|In-Hospital Data|Surgery cancelled|0|||
145982471|NCT02056288|526448801|FG000|In-Hospital Data|Protocol Violation|3|||
145982472|NCT02056288|526448802|FG001|In-Hospital Data|Protocol Violation|0|||
145982473|NCT02056288|526448801|FG000|In-Hospital Data|Physician Decision|1|||
145982474|NCT02056288|526448802|FG001|In-Hospital Data|Physician Decision|0|||
145982475|NCT02056288|526448801|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
145982476|NCT02056288|526448802|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
145982477|NCT01441414|526448803|FG000|Overall Study|Participant died|9|||
145982478|NCT01441414|526448803|FG000|Overall Study|Other reasons|3|||
145982479|NCT01441414|526448803|FG000|Overall Study|Study terminated by sponsor|2|||
145982480|NCT01441414|526448803|FG000|Overall Study|Subject refused further follow-up|1|||
145982481|NCT01433978|526448804|FG000|Core Study|Adverse Event, Non-Fatal|0|||
145982482|NCT01433978|526448805|FG001|Core Study|Adverse Event, Non-Fatal|1|||
145982483|NCT01433978|526448806|FG002|Core Study|Adverse Event, Non-Fatal|0|||
145982484|NCT01433978|526448804|FG000|Core Study|Lack of Efficacy|5|||
145982485|NCT01433978|526448805|FG001|Core Study|Lack of Efficacy|1|||
145982486|NCT01433978|526448806|FG002|Core Study|Lack of Efficacy|0|||
145982487|NCT01433978|526448804|FG000|Core Study|Study Terminated by Sponsor|6|||
145982488|NCT01433978|526448805|FG001|Core Study|Study Terminated by Sponsor|9|||
145982489|NCT01433978|526448806|FG002|Core Study|Study Terminated by Sponsor|0|||
145982490|NCT01433978|526448804|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
145982491|NCT01433978|526448805|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
145982492|NCT01433978|526448806|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
145982493|NCT01433978|526448804|FG000|Extension Phase|Lack of Efficacy|0|||
145982494|NCT01433978|526448805|FG001|Extension Phase|Lack of Efficacy|0|||
145982495|NCT01433978|526448806|FG002|Extension Phase|Lack of Efficacy|1|||
145982496|NCT01433978|526448804|FG000|Extension Phase|Study Terminated by Sponsor|0|||
145982497|NCT01433978|526448805|FG001|Extension Phase|Study Terminated by Sponsor|0|||
145982498|NCT01433978|526448806|FG002|Extension Phase|Study Terminated by Sponsor|4|||
145982499|NCT01773889|526448807|FG000|Overall Study|lack of funding|2|||
145982500|NCT04676646|526448808|FG000|Open-label Run-in Phase|Adverse Event|3|||
145982501|NCT04676646|526448809|FG001|Open-label Run-in Phase|Adverse Event|0|||
145982502|NCT04676646|526448810|FG002|Open-label Run-in Phase|Adverse Event|0|||
145982503|NCT04676646|526448808|FG000|Open-label Run-in Phase|Death|3|||
145982504|NCT04676646|526448809|FG001|Open-label Run-in Phase|Death|0|||
145982505|NCT04676646|526448810|FG002|Open-label Run-in Phase|Death|0|||
145982506|NCT04676646|526448808|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
145982507|NCT04676646|526448809|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
145982508|NCT04676646|526448810|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
145982509|NCT04676646|526448808|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
145982510|NCT04676646|526448809|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
145982511|NCT04676646|526448810|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
146245620|NCT01029704|527414029|FG005|Overall Study|Lack of Efficacy|3|||
146245621|NCT01029704|527414030|FG006|Overall Study|Lack of Efficacy|1|||
145939095|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
145939096|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
145939097|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
145939098|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
145939099|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
145939100|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
145939101|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
145939102|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
145939103|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
145939104|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
145939105|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
145939106|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
145939107|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
145939108|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
145939109|NCT04488419|526285812|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
145939110|NCT04488419|526285813|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
145939111|NCT04488419|526285814|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
145939112|NCT04488419|526285812|FG000|Primary Analysis Population|Adverse Event|6|||
145939113|NCT04488419|526285813|FG001|Primary Analysis Population|Adverse Event|9|||
145939114|NCT04488419|526285814|FG002|Primary Analysis Population|Adverse Event|0|||
145939115|NCT04488419|526285812|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
145939116|NCT04488419|526285813|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
145939117|NCT04488419|526285814|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
145939118|NCT04488419|526285812|FG000|Primary Analysis Population|Protocol Violation|1|||
145939119|NCT04488419|526285813|FG001|Primary Analysis Population|Protocol Violation|1|||
145939120|NCT04488419|526285814|FG002|Primary Analysis Population|Protocol Violation|0|||
145939121|NCT04488419|526285812|FG000|Primary Analysis Population|Undetermined|7|||
145939122|NCT04488419|526285813|FG001|Primary Analysis Population|Undetermined|3|||
145939123|NCT04488419|526285814|FG002|Primary Analysis Population|Undetermined|0|||
145939124|NCT04488419|526285812|FG000|Primary Analysis Population|>1 Reason|2|||
145939125|NCT04488419|526285813|FG001|Primary Analysis Population|>1 Reason|4|||
145939126|NCT04488419|526285814|FG002|Primary Analysis Population|>1 Reason|0|||
145939127|NCT01632150|526285817|FG000|Overall Study|Disease progression|27|||
145939128|NCT01632150|526285817|FG000|Overall Study|Study drug toxicity|1|||
145939129|NCT01632150|526285817|FG000|Overall Study|Unrelated adverse event|7|||
145939130|NCT01632150|526285817|FG000|Overall Study|Withdrawal by Subject|2|||
145939131|NCT01632150|526285817|FG000|Overall Study|Patient underwent autologous transplant|1|||
145939132|NCT01632150|526285817|FG000|Overall Study|Moved to compassionate program|2|||
145939133|NCT01877551|526285830|FG000|Overall Study|Physician Decision|0|||
145939134|NCT01877551|526285831|FG001|Overall Study|Physician Decision|1|||
145939135|NCT01282164|526285835|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
145939136|NCT01282164|526285836|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
145939137|NCT01185509|526285837|FG000|Overall Study|Progression/Relapse|9|||
145939138|NCT01185509|526285838|FG001|Overall Study|Progression/Relapse|15|||
145939139|NCT01185509|526285837|FG000|Overall Study|Physician Decision|2|||
145939140|NCT01185509|526285838|FG001|Overall Study|Physician Decision|2|||
145939141|NCT01185509|526285837|FG000|Overall Study|Withdrawal by Subject|0|||
145939142|NCT01185509|526285838|FG001|Overall Study|Withdrawal by Subject|1|||
145939143|NCT01185509|526285837|FG000|Overall Study|Death|0|||
145939144|NCT01185509|526285838|FG001|Overall Study|Death|1|||
145939145|NCT01185509|526285837|FG000|Overall Study|Intercurrent Illness|0|||
145939146|NCT01185509|526285838|FG001|Overall Study|Intercurrent Illness|1|||
145939147|NCT02062944|526285847|FG000|Overall Study|Lost to Follow-up|1|||
145939148|NCT02062944|526285847|FG000|Overall Study|New hemotological disorder identified|1|||
145939149|NCT02062944|526285847|FG000|Overall Study|Uncontrolled Hypertension|1|||
145939150|NCT02062944|526285847|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
145939151|NCT02122770|526285848|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
145939152|NCT02122770|526285849|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145939153|NCT02122770|526285850|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
145939154|NCT02122770|526285851|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
145939155|NCT02122770|526285852|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145939156|NCT02122770|526285853|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145939157|NCT02122770|526285848|FG000|Part A: Drug-drug Interaction 2|Other|0|||
145939158|NCT02122770|526285849|FG001|Part A: Drug-drug Interaction 2|Other|0|||
145939159|NCT02122770|526285850|FG002|Part A: Drug-drug Interaction 2|Other|1|||
145939160|NCT02122770|526285851|FG003|Part A: Drug-drug Interaction 2|Other|0|||
145939161|NCT02122770|526285852|FG004|Part A: Drug-drug Interaction 2|Other|0|||
145939162|NCT02122770|526285853|FG005|Part A: Drug-drug Interaction 2|Other|0|||
146245622|NCT01029704|527414031|FG007|Overall Study|Lack of Efficacy|2|||
145982512|NCT04676646|526448808|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
145982513|NCT04676646|526448809|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
145982514|NCT04676646|526448810|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
145982515|NCT04676646|526448808|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
145982516|NCT04676646|526448809|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
145982517|NCT04676646|526448810|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
145982518|NCT04676646|526448808|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
145982519|NCT04676646|526448809|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
145982520|NCT04676646|526448810|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
145982521|NCT04676646|526448808|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
145982522|NCT04676646|526448809|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
145982523|NCT04676646|526448810|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
145982524|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
145982525|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
145982526|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
145982527|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Death|0|||
145982528|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Death|1|||
145982529|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Death|2|||
145982530|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
145982531|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
145982532|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
145982533|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
145982534|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
145982535|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
145982536|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
145982537|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
145982538|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
145982539|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
145982540|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
145982541|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
145982542|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
145982543|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
145982544|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
145982545|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
145982546|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
145982547|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
145982548|NCT04676646|526448808|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
145982549|NCT04676646|526448809|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
145982550|NCT04676646|526448810|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
145982551|NCT02421510|526448811|FG000|Overall Study|Other|4|||
145982552|NCT02421510|526448812|FG001|Overall Study|Other|2|||
145982553|NCT02421510|526448813|FG002|Overall Study|Other|3|||
145982554|NCT02421510|526448811|FG000|Overall Study|Protocol Violation|1|||
145982555|NCT02421510|526448812|FG001|Overall Study|Protocol Violation|2|||
145982556|NCT02421510|526448813|FG002|Overall Study|Protocol Violation|0|||
145982557|NCT02421510|526448811|FG000|Overall Study|Death|1|||
145982558|NCT02421510|526448812|FG001|Overall Study|Death|0|||
145982559|NCT02421510|526448813|FG002|Overall Study|Death|0|||
145982560|NCT02421510|526448811|FG000|Overall Study|Noncompliance with study drug|1|||
145982561|NCT02421510|526448812|FG001|Overall Study|Noncompliance with study drug|0|||
145982562|NCT02421510|526448813|FG002|Overall Study|Noncompliance with study drug|0|||
145982563|NCT02421510|526448811|FG000|Overall Study|Physician Decision|1|||
145982564|NCT02421510|526448812|FG001|Overall Study|Physician Decision|1|||
145982565|NCT02421510|526448813|FG002|Overall Study|Physician Decision|3|||
145982566|NCT02421510|526448811|FG000|Overall Study|Adverse Event|9|||
145982567|NCT02421510|526448812|FG001|Overall Study|Adverse Event|10|||
145982568|NCT02421510|526448813|FG002|Overall Study|Adverse Event|18|||
145982569|NCT02421510|526448811|FG000|Overall Study|Pregnancy|1|||
145982570|NCT02421510|526448812|FG001|Overall Study|Pregnancy|1|||
145982571|NCT02421510|526448813|FG002|Overall Study|Pregnancy|0|||
145982572|NCT02421510|526448811|FG000|Overall Study|Withdrawal by Subject|14|||
145982573|NCT02421510|526448812|FG001|Overall Study|Withdrawal by Subject|18|||
145982574|NCT02421510|526448813|FG002|Overall Study|Withdrawal by Subject|12|||
146245623|NCT01029704|527414032|FG008|Overall Study|Lack of Efficacy|0|||
146245624|NCT01029704|527414024|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
145982575|NCT02421510|526448811|FG000|Overall Study|Lost to Follow-up|1|||
145982576|NCT02421510|526448812|FG001|Overall Study|Lost to Follow-up|1|||
145982577|NCT02421510|526448813|FG002|Overall Study|Lost to Follow-up|0|||
145982578|NCT02852434|526448814|FG000|Overall Study|Withdrawal by Subject|0|||
145982579|NCT02852434|526448815|FG001|Overall Study|Withdrawal by Subject|1|||
145982580|NCT02852434|526448814|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
145982581|NCT02852434|526448815|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
145982582|NCT01717859|526448817|FG000|Overall Study|Adverse Event|5|||
145982583|NCT01717859|526448817|FG000|Overall Study|Moved out of state|1|||
145982584|NCT01717859|526448817|FG000|Overall Study|Patient concerned about mental health|1|||
145982585|NCT01717859|526448817|FG000|Overall Study|Lost to Follow-up|1|||
145982586|NCT01717859|526448817|FG000|Overall Study|Withdrawal by Subject|2|||
145982587|NCT01623752|526448818|FG000|Phase 1 (78 Weeks)|No Data|249|||
145982588|NCT01623752|526448819|FG001|Phase 1 (78 Weeks)|No Data|66|||
145982589|NCT01623752|526448820|FG002|Phase 1 (78 Weeks)|No Data|2|||
145982590|NCT01623752|526448818|FG000|Phase 1 (78 Weeks)|Other|33|||
145982591|NCT01623752|526448819|FG001|Phase 1 (78 Weeks)|Other|20|||
145982592|NCT01623752|526448820|FG002|Phase 1 (78 Weeks)|Other|0|||
145982593|NCT01623752|526448818|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
145982594|NCT01623752|526448819|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
145982595|NCT01623752|526448820|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
145982596|NCT01623752|526448818|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
145982597|NCT01623752|526448819|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
145982598|NCT01623752|526448820|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
145982599|NCT01623752|526448818|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
145982600|NCT01623752|526448819|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
145982601|NCT01623752|526448820|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
145982602|NCT01623752|526448818|FG000|Phase 2 (78 Weeks)|Other|5|||
145982603|NCT01623752|526448819|FG001|Phase 2 (78 Weeks)|Other|1|||
145982604|NCT01623752|526448820|FG002|Phase 2 (78 Weeks)|Other|0|||
145982605|NCT01623752|526448818|FG000|Phase 2 (78 Weeks)|No Data|43|||
145982606|NCT01623752|526448819|FG001|Phase 2 (78 Weeks)|No Data|11|||
145982607|NCT01623752|526448820|FG002|Phase 2 (78 Weeks)|No Data|0|||
145982608|NCT01623752|526448818|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
145982609|NCT01623752|526448819|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
145982610|NCT01623752|526448820|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
145982611|NCT01755637|526448822|FG000|Period 1|Adverse Event|0|||
145982612|NCT01755637|526448823|FG001|Period 1|Adverse Event|1|||
145982613|NCT01814332|526448824|FG000|Overall Study|Adverse Event|8|||
145982614|NCT01814332|526448825|FG001|Overall Study|Adverse Event|3|||
145982615|NCT01814332|526448824|FG000|Overall Study|Withdrawal by Subject|3|||
145982616|NCT01814332|526448825|FG001|Overall Study|Withdrawal by Subject|8|||
145982617|NCT01814332|526448824|FG000|Overall Study|Protocol Violation|0|||
145982618|NCT01814332|526448825|FG001|Overall Study|Protocol Violation|4|||
145982619|NCT01814332|526448824|FG000|Overall Study|Lost to Follow-up|5|||
145982620|NCT01814332|526448825|FG001|Overall Study|Lost to Follow-up|1|||
145982621|NCT05987540|526448827|FG000|Overall Study|Withdrawal by Subject|2|||
145982622|NCT05987540|526448827|FG000|Overall Study|Death|1|||
145982623|NCT05987540|526448827|FG000|Overall Study|Study Termination|1|||
145982624|NCT05987540|526448827|FG000|Overall Study|Adverse Event|2|||
145982625|NCT05061706|526448830|FG000|Overall Study|Adverse Event|29|||
145982626|NCT05061706|526448831|FG001|Overall Study|Adverse Event|1|||
145982627|NCT05061706|526448830|FG000|Overall Study|Lack of Efficacy|0|||
145982628|NCT05061706|526448831|FG001|Overall Study|Lack of Efficacy|1|||
145982629|NCT05061706|526448830|FG000|Overall Study|Lost to Follow-up|2|||
145982630|NCT05061706|526448831|FG001|Overall Study|Lost to Follow-up|2|||
145982631|NCT05061706|526448830|FG000|Overall Study|Protocol Violation|3|||
145982632|NCT05061706|526448831|FG001|Overall Study|Protocol Violation|1|||
145982633|NCT05061706|526448830|FG000|Overall Study|Withdrawal by Subject|3|||
145982634|NCT05061706|526448831|FG001|Overall Study|Withdrawal by Subject|9|||
145982635|NCT01149538|526448836|FG000|Overall Study|Lost to Follow-up|0|||
145982636|NCT01149538|526448837|FG001|Overall Study|Lost to Follow-up|1|||
145982637|NCT01149538|526448836|FG000|Overall Study|Withdrawal by Subject|5|||
145982638|NCT01149538|526448837|FG001|Overall Study|Withdrawal by Subject|3|||
145982639|NCT00888849|526448838|FG000|Overall Study|Death|4|||
145982640|NCT00888849|526448839|FG001|Overall Study|Death|7|||
145982641|NCT00888849|526448838|FG000|Overall Study|Lost to Follow-up|1|||
145982642|NCT00888849|526448839|FG001|Overall Study|Lost to Follow-up|2|||
145982643|NCT02336503|526448841|FG000|Overall Study|Lost to Follow-up|0|||
145982644|NCT02336503|526448842|FG001|Overall Study|Lost to Follow-up|3|||
145982645|NCT02336503|526448843|FG002|Overall Study|Lost to Follow-up|0|||
145982646|NCT02336503|526448844|FG003|Overall Study|Lost to Follow-up|2|||
145982647|NCT02336503|526448841|FG000|Overall Study|Withdrawal by Subject|2|||
145982648|NCT02336503|526448842|FG001|Overall Study|Withdrawal by Subject|0|||
146245625|NCT01029704|527414025|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
145982649|NCT02336503|526448843|FG002|Overall Study|Withdrawal by Subject|0|||
145982650|NCT02336503|526448844|FG003|Overall Study|Withdrawal by Subject|4|||
145982651|NCT02336503|526448841|FG000|Overall Study|Adverse Event|0|||
145982652|NCT02336503|526448842|FG001|Overall Study|Adverse Event|0|||
145982653|NCT02336503|526448843|FG002|Overall Study|Adverse Event|1|||
145982654|NCT02336503|526448844|FG003|Overall Study|Adverse Event|0|||
145982655|NCT02583477|526448845|FG000|Overall Study|Adverse Event|0|||
145982656|NCT02583477|526448846|FG001|Overall Study|Adverse Event|2|||
145982657|NCT02583477|526448845|FG000|Overall Study|Death|1|||
145982658|NCT02583477|526448846|FG001|Overall Study|Death|16|||
145982659|NCT02583477|526448845|FG000|Overall Study|Study terminated|2|||
145982660|NCT02583477|526448846|FG001|Overall Study|Study terminated|2|||
145982661|NCT01873833|526448852|FG000|Overall Study|Withdrawal by Subject|1|||
145982662|NCT02939781|526448855|FG000|Overall Study|Protocol Violation|8|||
145982663|NCT02939781|526448855|FG000|Overall Study|Withdrawal by Subject|1|||
145982664|NCT01740427|526448856|FG000|Overall Study|Objective Progression or Relapse|286|||
145982665|NCT01740427|526448857|FG001|Overall Study|Objective Progression or Relapse|172|||
145982666|NCT01740427|526448856|FG000|Overall Study|Adverse Event|32|||
145982667|NCT01740427|526448857|FG001|Overall Study|Adverse Event|9|||
145982668|NCT01740427|526448856|FG000|Overall Study|Global Deterioration of Health Status|28|||
145982669|NCT01740427|526448857|FG001|Overall Study|Global Deterioration of Health Status|12|||
145982670|NCT01740427|526448856|FG000|Overall Study|Participant Refused Continued Treatment|27|||
145982671|NCT01740427|526448857|FG001|Overall Study|Participant Refused Continued Treatment|15|||
145982672|NCT01740427|526448856|FG000|Overall Study|Unspecified reasons|52|||
145982673|NCT01740427|526448857|FG001|Overall Study|Unspecified reasons|8|||
145982674|NCT01740427|526448856|FG000|Overall Study|Death|10|||
145982675|NCT01740427|526448857|FG001|Overall Study|Death|3|||
145982676|NCT01740427|526448856|FG000|Overall Study|Protocol Violation|5|||
145982677|NCT01740427|526448857|FG001|Overall Study|Protocol Violation|3|||
145982678|NCT01740427|526448856|FG000|Overall Study|Lost to Follow-up|3|||
145982679|NCT01740427|526448857|FG001|Overall Study|Lost to Follow-up|0|||
145982680|NCT01740427|526448856|FG000|Overall Study|Site Terminated by Sponsor|1|||
145982681|NCT01740427|526448857|FG001|Overall Study|Site Terminated by Sponsor|0|||
145982682|NCT06025695|526448858|FG000|Overall Study|Adverse Event|5|||
145982683|NCT06025695|526448859|FG001|Overall Study|Adverse Event|6|||
145982684|NCT06025695|526448858|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
145982685|NCT06025695|526448859|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
145982686|NCT06025695|526448858|FG000|Overall Study|Other|23|||
145982687|NCT06025695|526448859|FG001|Overall Study|Other|19|||
145982688|NCT06025695|526448858|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
145982689|NCT06025695|526448859|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
145982690|NCT05762744|526448860|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
145982691|NCT05762744|526448861|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
145982692|NCT05762744|526448860|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
145982693|NCT05762744|526448861|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
145982694|NCT01560416|526448865|FG000|Randomized Phase|Crossover Participants|7|||
145982695|NCT01560416|526448866|FG001|Randomized Phase|Crossover Participants|0|||
145982696|NCT02082483|526450546|FG000|Overall Study|Lost to Follow-up|1|||
145982697|NCT02082483|526450547|FG001|Overall Study|Lost to Follow-up|1|||
145982698|NCT02082483|526450546|FG000|Overall Study|Withdrawal by Subject|2|||
145982699|NCT02082483|526450547|FG001|Overall Study|Withdrawal by Subject|1|||
145982700|NCT02082483|526450546|FG000|Overall Study|Physician Decision|1|||
145982701|NCT02082483|526450547|FG001|Overall Study|Physician Decision|1|||
145982702|NCT02082483|526450546|FG000|Overall Study|Death|2|||
145982703|NCT02082483|526450547|FG001|Overall Study|Death|3|||
145982704|NCT00762788|526450548|FG000|Overall Study|Lost to Follow-up|26|||
145982705|NCT00762788|526450549|FG001|Overall Study|Lost to Follow-up|37|||
145982706|NCT00762788|526450550|FG002|Overall Study|Lost to Follow-up|21|||
145982707|NCT00762788|526450551|FG003|Overall Study|Lost to Follow-up|26|||
145982708|NCT00762788|526450552|FG004|Overall Study|Lost to Follow-up|13|||
145982709|NCT00762788|526450553|FG005|Overall Study|Lost to Follow-up|21|||
145982710|NCT01783015|526450554|FG000|Blinded Treatment|Adverse Event|0|||
145982711|NCT01783015|526450555|FG001|Blinded Treatment|Adverse Event|1|||
145982712|NCT01783015|526450556|FG002|Blinded Treatment|Adverse Event|0|||
145982713|NCT01783015|526450554|FG000|Blinded Treatment|Protocol Violation|0|||
145982714|NCT01783015|526450555|FG001|Blinded Treatment|Protocol Violation|1|||
145982715|NCT01783015|526450556|FG002|Blinded Treatment|Protocol Violation|0|||
145982716|NCT01783015|526450554|FG000|Blinded Treatment|Withdrawal by Subject|0|||
145982717|NCT01783015|526450555|FG001|Blinded Treatment|Withdrawal by Subject|1|||
145982718|NCT01783015|526450556|FG002|Blinded Treatment|Withdrawal by Subject|0|||
145982719|NCT01783015|526450554|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
145982720|NCT01783015|526450555|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
145982721|NCT01783015|526450556|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
145982722|NCT01783015|526450554|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
145982723|NCT01783015|526450555|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
145982724|NCT01783015|526450556|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
145982725|NCT00985192|526450557|FG000|Overall Study|Withdrawal by Subject|1|||
145982726|NCT00985192|526450557|FG000|Overall Study|Disease Progression|1|||
145982727|NCT00985192|526450557|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
145982728|NCT00669331|526450558|FG000|Randomisation to First Dose|Adverse Event|1|||
145982729|NCT00669331|526450559|FG001|Randomisation to First Dose|Adverse Event|0|||
146245626|NCT01029704|527414026|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
146245627|NCT01029704|527414027|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
146245628|NCT01029704|527414028|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
146245629|NCT01029704|527414029|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
145982730|NCT00669331|526450558|FG000|Randomisation to First Dose|Protocol Violation|1|||
145982731|NCT00669331|526450559|FG001|Randomisation to First Dose|Protocol Violation|0|||
145982732|NCT00669331|526450558|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
145982733|NCT00669331|526450559|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
145982734|NCT00669331|526450558|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
145982735|NCT00669331|526450559|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
145982736|NCT00669331|526450558|FG000|Randomisation to First Dose|Death|1|||
145982737|NCT00669331|526450559|FG001|Randomisation to First Dose|Death|0|||
145982738|NCT00669331|526450558|FG000|Randomisation to First Dose|Sponsor decision|0|||
145982739|NCT00669331|526450559|FG001|Randomisation to First Dose|Sponsor decision|1|||
145982740|NCT00669331|526450558|FG000|Randomisation to First Dose|Randomised in error|3|||
145982741|NCT00669331|526450559|FG001|Randomisation to First Dose|Randomised in error|10|||
145982742|NCT00669331|526450558|FG000|Blinded Treatment Period|Adverse Event|16|||
145982743|NCT00669331|526450559|FG001|Blinded Treatment Period|Adverse Event|10|||
145982744|NCT00669331|526450558|FG000|Blinded Treatment Period|Protocol Violation|1|||
145982745|NCT00669331|526450559|FG001|Blinded Treatment Period|Protocol Violation|1|||
145982746|NCT00669331|526450558|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
145982747|NCT00669331|526450559|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
145982748|NCT00669331|526450558|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
145982749|NCT00669331|526450559|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
145982750|NCT00669331|526450558|FG000|Blinded Treatment Period|Death|0|||
145982751|NCT00669331|526450559|FG001|Blinded Treatment Period|Death|2|||
145982752|NCT00669331|526450558|FG000|Blinded Treatment Period|Physician Decision|3|||
145982753|NCT00669331|526450559|FG001|Blinded Treatment Period|Physician Decision|3|||
145982754|NCT00669331|526450558|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
145982755|NCT00669331|526450559|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
145982756|NCT01454063|526450560|FG000|Randomized|Adverse Event|1|||
145982757|NCT01454063|526450561|FG001|Randomized|Adverse Event|1|||
145982758|NCT01454063|526450560|FG000|Randomized|Protocol Violation|0|||
145982759|NCT01454063|526450561|FG001|Randomized|Protocol Violation|1|||
145982760|NCT00500110|526450563|FG000|Overall Study|Withdrawal by Subject|3|||
145982761|NCT03954938|526450564|FG000|Overall Study|Withdrawal by Subject|2|||
145982762|NCT03954938|526450564|FG000|Overall Study|Adverse Event|1|||
145982763|NCT00617903|526450570|FG000|Overall Study|Withdrawal by Subject|2|||
145982764|NCT00617903|526450571|FG001|Overall Study|Withdrawal by Subject|3|||
145982765|NCT00617903|526450570|FG000|Overall Study|Lost to Follow-up|1|||
145982766|NCT00617903|526450571|FG001|Overall Study|Lost to Follow-up|1|||
145982767|NCT00617903|526450570|FG000|Overall Study|Lack of Efficacy|0|||
145982768|NCT00617903|526450571|FG001|Overall Study|Lack of Efficacy|1|||
145982769|NCT00617903|526450570|FG000|Overall Study|Adverse Event|0|||
145982770|NCT00617903|526450571|FG001|Overall Study|Adverse Event|1|||
145982771|NCT00617903|526450570|FG000|Overall Study|noncompliance|0|||
145982772|NCT00617903|526450571|FG001|Overall Study|noncompliance|1|||
145982773|NCT02565186|526450572|FG000|Overall Study|Adverse Event|113|||
145982774|NCT02565186|526450573|FG001|Overall Study|Adverse Event|148|||
145982775|NCT02565186|526450572|FG000|Overall Study|Lost to Follow-up|102|||
145982776|NCT02565186|526450573|FG001|Overall Study|Lost to Follow-up|93|||
145982777|NCT02565186|526450572|FG000|Overall Study|Non-Compliance|57|||
145982778|NCT02565186|526450573|FG001|Overall Study|Non-Compliance|55|||
145982779|NCT02565186|526450572|FG000|Overall Study|Withdrawal by Subject|229|||
145982780|NCT02565186|526450573|FG001|Overall Study|Withdrawal by Subject|214|||
145982781|NCT02565186|526450572|FG000|Overall Study|Physician Decision|18|||
145982782|NCT02565186|526450573|FG001|Overall Study|Physician Decision|16|||
145982783|NCT02565186|526450572|FG000|Overall Study|Sponsor Request|5|||
145982784|NCT02565186|526450573|FG001|Overall Study|Sponsor Request|9|||
145982785|NCT02565186|526450572|FG000|Overall Study|Missing|1|||
145982786|NCT02565186|526450573|FG001|Overall Study|Missing|0|||
145982787|NCT02565186|526450572|FG000|Overall Study|Did Not Receive Study Drug|55|||
145982788|NCT02565186|526450573|FG001|Overall Study|Did Not Receive Study Drug|86|||
145982789|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
145982790|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
145982791|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
145982792|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
145982793|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
145982794|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
145982795|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
145982796|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
145982797|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
145982798|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
145982799|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
145982800|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
145982801|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
145982802|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
145982803|NCT00976391|526450574|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
145982804|NCT00976391|526450575|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
145982805|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
145982806|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
145982807|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
145982808|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
145982809|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
145982810|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
145982811|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
145982812|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
145982813|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
145982814|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
145982815|NCT00976391|526450574|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
145982816|NCT00976391|526450575|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145982817|NCT02217982|526450576|FG000|Overall Study|Trial discontinued|1|||
145982818|NCT02217982|526450577|FG001|Overall Study|Trial discontinued|0|||
145982819|NCT02217982|526450576|FG000|Overall Study|Adverse Event|0|||
145982820|NCT02217982|526450577|FG001|Overall Study|Adverse Event|1|||
145982821|NCT05156125|526450578|FG000|Overall Study|Lack of Efficacy|1|||
145982822|NCT05156125|526450579|FG001|Overall Study|Lack of Efficacy|1|||
145982823|NCT05156125|526450580|FG002|Overall Study|Lack of Efficacy|1|||
145982824|NCT05156125|526450578|FG000|Overall Study|Physician Decision|0|||
145982825|NCT05156125|526450579|FG001|Overall Study|Physician Decision|0|||
145982826|NCT05156125|526450580|FG002|Overall Study|Physician Decision|1|||
145982827|NCT05156125|526450578|FG000|Overall Study|Non-compliance|0|||
145982828|NCT05156125|526450579|FG001|Overall Study|Non-compliance|1|||
145982829|NCT05156125|526450580|FG002|Overall Study|Non-compliance|1|||
145982830|NCT05156125|526450578|FG000|Overall Study|Withdrawal by Subject|0|||
145982831|NCT05156125|526450579|FG001|Overall Study|Withdrawal by Subject|0|||
145982832|NCT05156125|526450580|FG002|Overall Study|Withdrawal by Subject|1|||
145982833|NCT05156125|526450578|FG000|Overall Study|Adverse Event|2|||
145982834|NCT05156125|526450579|FG001|Overall Study|Adverse Event|1|||
145982835|NCT05156125|526450580|FG002|Overall Study|Adverse Event|0|||
145982836|NCT03123588|526450588|FG000|Overall Study|Study Terminated by Sponsor|2|||
145982837|NCT03123588|526450589|FG001|Overall Study|Study Terminated by Sponsor|5|||
145982838|NCT03123588|526450588|FG000|Overall Study|Withdrawal by Subject|1|||
145982839|NCT03123588|526450589|FG001|Overall Study|Withdrawal by Subject|0|||
145982840|NCT03123588|526450588|FG000|Overall Study|Adverse Event|1|||
145982841|NCT03123588|526450589|FG001|Overall Study|Adverse Event|0|||
145982842|NCT03123588|526450588|FG000|Overall Study|Physician Decision|2|||
145982843|NCT03123588|526450589|FG001|Overall Study|Physician Decision|1|||
145982844|NCT04389671|526450590|FG000|Overall Study|Death|7|||
145982845|NCT02287025|526450591|FG000|Overall Study|Not treated|2|||
145982846|NCT02287025|526450592|FG001|Overall Study|Not treated|0|||
145982847|NCT02287025|526450591|FG000|Overall Study|Progression of disease|3|||
145982848|NCT02287025|526450592|FG001|Overall Study|Progression of disease|2|||
145982849|NCT02287025|526450591|FG000|Overall Study|Adverse Event|2|||
145982850|NCT02287025|526450592|FG001|Overall Study|Adverse Event|4|||
145982851|NCT02287025|526450591|FG000|Overall Study|Withdrawal by Subject|2|||
145982852|NCT02287025|526450592|FG001|Overall Study|Withdrawal by Subject|2|||
145982853|NCT02287025|526450591|FG000|Overall Study|Screening failed|1|||
145982854|NCT02287025|526450592|FG001|Overall Study|Screening failed|1|||
145982855|NCT00899847|526450593|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
145982856|NCT04053452|526450594|FG000|Overall Study|Withdrawal by Subject|1|||
145982857|NCT04053452|526450595|FG001|Overall Study|Withdrawal by Subject|0|||
145982858|NCT04053452|526450594|FG000|Overall Study|Time restraint due to inpatient needs|1|||
145982859|NCT04053452|526450595|FG001|Overall Study|Time restraint due to inpatient needs|2|||
146245630|NCT01029704|527414030|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
146245631|NCT01029704|527414031|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
145982860|NCT01421134|526450596|FG000|Overall Study|Adverse Event|3|||
145982861|NCT01421134|526450597|FG001|Overall Study|Adverse Event|5|||
145982862|NCT01421134|526450596|FG000|Overall Study|Lack of Efficacy|2|||
145982863|NCT01421134|526450597|FG001|Overall Study|Lack of Efficacy|4|||
145982864|NCT01421134|526450596|FG000|Overall Study|Protocol Violation|0|||
145982865|NCT01421134|526450597|FG001|Overall Study|Protocol Violation|3|||
145982866|NCT01421134|526450596|FG000|Overall Study|Withdrawal by Subject|1|||
145982867|NCT01421134|526450597|FG001|Overall Study|Withdrawal by Subject|1|||
145982868|NCT01421134|526450596|FG000|Overall Study|Administrative|0|||
145982869|NCT01421134|526450597|FG001|Overall Study|Administrative|1|||
145982870|NCT01421134|526450596|FG000|Overall Study|Lost to Follow-up|1|||
145982871|NCT01421134|526450597|FG001|Overall Study|Lost to Follow-up|1|||
145982872|NCT03528577|526450600|FG000|Sequence 1|Failed Spirometry|1|||
145982873|NCT03528577|526450600|FG000|Sequence 1|Restricted medication|1|||
145982874|NCT03528577|526450600|FG000|Sequence 2|Adverse Event|1|||
145982875|NCT03528577|526450600|FG000|Sequence 2|Withdrawal by Subject|1|||
145982876|NCT03528577|526450600|FG000|Sequence 2|Failed Spirometry|1|||
145982877|NCT03528577|526450600|FG000|Sequence 3|Failed Spirometry|1|||
145982878|NCT03528577|526450600|FG000|Sequence 4|Failed Spirometry|2|||
145982879|NCT03528577|526450600|FG000|Sequence 4|Adverse Event|1|||
145982880|NCT04882215|526450601|FG000|Overall Study|Withdrawal by Subject|5|||
145982881|NCT04882215|526450602|FG001|Overall Study|Withdrawal by Subject|0|||
145982882|NCT04098302|526450605|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
145982883|NCT04098302|526450606|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
145982884|NCT04098302|526450607|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
145982885|NCT04098302|526450608|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
145982886|NCT04098302|526450605|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
145982887|NCT04098302|526450606|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145982888|NCT04098302|526450607|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145982889|NCT04098302|526450608|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145982890|NCT04098302|526450605|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
145982891|NCT04098302|526450606|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
145982892|NCT04098302|526450607|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
145982893|NCT04098302|526450608|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
145982894|NCT04098302|526450605|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
145982895|NCT04098302|526450606|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
145982896|NCT04098302|526450607|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
145982897|NCT04098302|526450608|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
145982898|NCT04098302|526450605|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
145982899|NCT04098302|526450606|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
145982900|NCT04098302|526450607|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
145982901|NCT04098302|526450608|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
145982902|NCT04098302|526450605|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145982903|NCT04098302|526450606|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145982904|NCT04098302|526450607|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145982905|NCT04098302|526450608|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
145982906|NCT04098302|526450605|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145982907|NCT04098302|526450606|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145982908|NCT04098302|526450607|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
145982909|NCT04098302|526450608|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145982910|NCT04098302|526450605|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145982911|NCT04098302|526450606|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145982912|NCT04098302|526450607|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145982913|NCT04098302|526450608|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
145982914|NCT00724893|526450611|FG000|Overall Study|Adverse Event|76|||
145982915|NCT00724893|526450612|FG001|Overall Study|Adverse Event|142|||
145982916|NCT00724893|526450611|FG000|Overall Study|Withdrawal by Subject|0|||
145982917|NCT00724893|526450612|FG001|Overall Study|Withdrawal by Subject|1|||
145982918|NCT00724893|526450611|FG000|Overall Study|Lack of virologic response|94|||
145982919|NCT00724893|526450612|FG001|Overall Study|Lack of virologic response|202|||
145982920|NCT00724893|526450611|FG000|Overall Study|Reason not specified|193|||
145982921|NCT00724893|526450612|FG001|Overall Study|Reason not specified|7|||
145982922|NCT00724893|526450611|FG000|Overall Study|Patient choice|0|||
145982923|NCT00724893|526450612|FG001|Overall Study|Patient choice|26|||
145982924|NCT00724893|526450611|FG000|Overall Study|Geographic reasons|0|||
145982925|NCT00724893|526450612|FG001|Overall Study|Geographic reasons|11|||
145982926|NCT00724893|526450611|FG000|Overall Study|Incarceration|0|||
145982927|NCT00724893|526450612|FG001|Overall Study|Incarceration|9|||
145982928|NCT00724893|526450611|FG000|Overall Study|Substance abuse|0|||
145982929|NCT00724893|526450612|FG001|Overall Study|Substance abuse|3|||
145982930|NCT00724893|526450611|FG000|Overall Study|Financial reasons|0|||
145982931|NCT00724893|526450612|FG001|Overall Study|Financial reasons|2|||
145982932|NCT00724893|526450611|FG000|Overall Study|Assigned shorter treatment|0|||
145982933|NCT00724893|526450612|FG001|Overall Study|Assigned shorter treatment|2|||
145982934|NCT00724893|526450611|FG000|Overall Study|Lost to Follow-up|0|||
145982935|NCT00724893|526450612|FG001|Overall Study|Lost to Follow-up|52|||
145982936|NCT00724893|526450611|FG000|Overall Study|Unknown, missing data|1|||
145982937|NCT00724893|526450612|FG001|Overall Study|Unknown, missing data|1|||
145982938|NCT01290731|526450615|FG000|Overall Study|Withdrawal by Subject|1|||
145982939|NCT01279200|526450616|FG000|Overall Study|Withdrawal by Subject|1|||
145982940|NCT01279200|526450617|FG001|Overall Study|Withdrawal by Subject|3|||
145982941|NCT01279200|526450616|FG000|Overall Study|Patient withdrawal due to high cost|0|||
145982942|NCT01279200|526450617|FG001|Overall Study|Patient withdrawal due to high cost|1|||
145982943|NCT01279200|526450616|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
145982944|NCT01279200|526450617|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
145982945|NCT01279200|526450616|FG000|Overall Study|ultrasound screening failure|0|||
145982946|NCT01279200|526450617|FG001|Overall Study|ultrasound screening failure|1|||
145982947|NCT01279200|526450616|FG000|Overall Study|Lost to Follow-up|0|||
145982948|NCT01279200|526450617|FG001|Overall Study|Lost to Follow-up|1|||
145982949|NCT01279200|526450616|FG000|Overall Study|Adverse Event|1|||
145982950|NCT01279200|526450617|FG001|Overall Study|Adverse Event|0|||
145982951|NCT01399099|526450618|FG000|Overall Study|Lost to Follow-up|14|||
145982952|NCT01399099|526450618|FG000|Overall Study|Physician Decision|1|||
145982953|NCT01399099|526450618|FG000|Overall Study|Protocol Violation|1|||
145982954|NCT01399099|526450618|FG000|Overall Study|Skin Irritation|13|||
145982955|NCT01399099|526450618|FG000|Overall Study|Infection|1|||
145982956|NCT01399099|526450618|FG000|Overall Study|Miscellaneous|4|||
145982957|NCT01668537|526450620|FG000|Overall Study|Request to Discontinue Prematurely|1|||
145982958|NCT01668537|526450621|FG001|Overall Study|Request to Discontinue Prematurely|1|||
145982959|NCT01668537|526450620|FG000|Overall Study|Subject unwilling/unable to comply|5|||
145982960|NCT01668537|526450621|FG001|Overall Study|Subject unwilling/unable to comply|0|||
145982961|NCT01668537|526450620|FG000|Overall Study|Reason Precludes Participation|1|||
145982962|NCT01668537|526450621|FG001|Overall Study|Reason Precludes Participation|0|||
145982963|NCT01668537|526450620|FG000|Overall Study|Lost to Follow-up|13|||
145982964|NCT01668537|526450621|FG001|Overall Study|Lost to Follow-up|6|||
145982965|NCT01668537|526450620|FG000|Overall Study|Other|2|||
145982966|NCT01668537|526450621|FG001|Overall Study|Other|3|||
145982967|NCT04576949|526450624|FG000|Overall Study|Adverse Event|1|||
145982968|NCT04576949|526450625|FG001|Overall Study|Adverse Event|3|||
145982969|NCT04576949|526450626|FG002|Overall Study|Adverse Event|2|||
145982970|NCT04576949|526450624|FG000|Overall Study|Withdrawal by Subject|41|||
145982971|NCT04576949|526450625|FG001|Overall Study|Withdrawal by Subject|26|||
145982972|NCT04576949|526450626|FG002|Overall Study|Withdrawal by Subject|18|||
145982973|NCT04576949|526450624|FG000|Overall Study|Physician Decision|3|||
145982974|NCT04576949|526450625|FG001|Overall Study|Physician Decision|0|||
145982975|NCT04576949|526450626|FG002|Overall Study|Physician Decision|0|||
145982976|NCT04576949|526450624|FG000|Overall Study|Death|0|||
145982977|NCT04576949|526450625|FG001|Overall Study|Death|1|||
145982978|NCT04576949|526450626|FG002|Overall Study|Death|0|||
145982979|NCT04576949|526450624|FG000|Overall Study|Lost to Follow-up|29|||
145982980|NCT04576949|526450625|FG001|Overall Study|Lost to Follow-up|37|||
145982981|NCT04576949|526450626|FG002|Overall Study|Lost to Follow-up|24|||
145982982|NCT04576949|526450624|FG000|Overall Study|Other, Not Specified|2|||
145982983|NCT04576949|526450625|FG001|Overall Study|Other, Not Specified|3|||
145982984|NCT04576949|526450626|FG002|Overall Study|Other, Not Specified|1|||
145982985|NCT04576949|526450624|FG000|Overall Study|Other|1|||
145982986|NCT04576949|526450625|FG001|Overall Study|Other|0|||
145982987|NCT04576949|526450626|FG002|Overall Study|Other|0|||
145982988|NCT04584554|526450627|FG000|Overall Study|Withdrawal by Subject|2|||
145982989|NCT04584554|526450628|FG001|Overall Study|Withdrawal by Subject|2|||
145982990|NCT05507450|526450629|FG000|Overall Study|Death|0|||
145982991|NCT05507450|526450630|FG001|Overall Study|Death|0|||
145982992|NCT05507450|526450631|FG002|Overall Study|Death|1|||
145982993|NCT05507450|526450632|FG003|Overall Study|Death|0|||
145982994|NCT05507450|526450629|FG000|Overall Study|Lost to Follow-up|22|||
145982995|NCT05507450|526450630|FG001|Overall Study|Lost to Follow-up|20|||
145982996|NCT05507450|526450631|FG002|Overall Study|Lost to Follow-up|20|||
145982997|NCT05507450|526450632|FG003|Overall Study|Lost to Follow-up|7|||
145982998|NCT05507450|526450629|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145982999|NCT05507450|526450630|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145983000|NCT05507450|526450631|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145983001|NCT05507450|526450632|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145983002|NCT05507450|526450629|FG000|Overall Study|Withdrawal by Subject|4|||
145983003|NCT05507450|526450630|FG001|Overall Study|Withdrawal by Subject|11|||
145983004|NCT05507450|526450631|FG002|Overall Study|Withdrawal by Subject|7|||
145983005|NCT05507450|526450632|FG003|Overall Study|Withdrawal by Subject|3|||
145983006|NCT05507450|526450629|FG000|Overall Study|Participant left the country|0|||
145983007|NCT05507450|526450630|FG001|Overall Study|Participant left the country|0|||
145983008|NCT05507450|526450631|FG002|Overall Study|Participant left the country|1|||
145983009|NCT05507450|526450632|FG003|Overall Study|Participant left the country|0|||
145983010|NCT05436288|526450633|FG000|Overall Study|Lost to Follow-up|1|||
145983011|NCT05436288|526450633|FG000|Overall Study|Adverse Event|1|||
145983012|NCT03767894|526450637|FG000|Overall Study|Withdrawal by Subject|1|||
145983013|NCT01860404|526450642|FG000|Overall Study|Lost to Follow-up|3|||
145983014|NCT01860404|526450643|FG001|Overall Study|Lost to Follow-up|4|||
145983015|NCT01860404|526450644|FG002|Overall Study|Lost to Follow-up|1|||
145983016|NCT01860404|526450645|FG003|Overall Study|Lost to Follow-up|6|||
145983017|NCT01860404|526450646|FG004|Overall Study|Lost to Follow-up|4|||
145983018|NCT01860404|526450642|FG000|Overall Study|Withdrawal by Subject|0|||
145983019|NCT01860404|526450643|FG001|Overall Study|Withdrawal by Subject|0|||
145983020|NCT01860404|526450644|FG002|Overall Study|Withdrawal by Subject|4|||
145983021|NCT01860404|526450645|FG003|Overall Study|Withdrawal by Subject|0|||
145983022|NCT01860404|526450646|FG004|Overall Study|Withdrawal by Subject|0|||
145983023|NCT00356421|526450649|FG000|Overall Study|Lack of Efficacy|3|||
146245632|NCT01029704|527414032|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
145983024|NCT00356421|526450650|FG001|Overall Study|Lack of Efficacy|0|||
145983025|NCT00356421|526450649|FG000|Overall Study|Withdrawal by Subject|9|||
145983026|NCT00356421|526450650|FG001|Overall Study|Withdrawal by Subject|2|||
145983027|NCT00356421|526450649|FG000|Overall Study|Related to study drug|15|||
145983028|NCT00356421|526450650|FG001|Overall Study|Related to study drug|12|||
145983029|NCT00356421|526450649|FG000|Overall Study|Not related to study drug|5|||
145983030|NCT00356421|526450650|FG001|Overall Study|Not related to study drug|3|||
145983031|NCT02187055|526450651|FG000|Overall Study|Lack of Efficacy|10|||
145983032|NCT02187055|526450652|FG001|Overall Study|Lack of Efficacy|3|||
145983033|NCT02187055|526450653|FG002|Overall Study|Lack of Efficacy|7|||
145983034|NCT02187055|526450651|FG000|Overall Study|Lost to Follow-up|2|||
145983035|NCT02187055|526450652|FG001|Overall Study|Lost to Follow-up|7|||
145983036|NCT02187055|526450653|FG002|Overall Study|Lost to Follow-up|3|||
145983037|NCT02187055|526450651|FG000|Overall Study|No longer meets eligibility criteria|0|||
145983038|NCT02187055|526450652|FG001|Overall Study|No longer meets eligibility criteria|2|||
145983039|NCT02187055|526450653|FG002|Overall Study|No longer meets eligibility criteria|0|||
145983040|NCT02187055|526450651|FG000|Overall Study|No longer willing to participate|6|||
145983041|NCT02187055|526450652|FG001|Overall Study|No longer willing to participate|8|||
145983042|NCT02187055|526450653|FG002|Overall Study|No longer willing to participate|10|||
145983043|NCT02187055|526450651|FG000|Overall Study|Other|5|||
145983044|NCT02187055|526450652|FG001|Overall Study|Other|6|||
145983045|NCT02187055|526450653|FG002|Overall Study|Other|3|||
145983046|NCT02187055|526450651|FG000|Overall Study|Protocol Violation|9|||
145983047|NCT02187055|526450652|FG001|Overall Study|Protocol Violation|9|||
145983048|NCT02187055|526450653|FG002|Overall Study|Protocol Violation|4|||
145983049|NCT02187055|526450651|FG000|Overall Study|Pregnancy|3|||
145983050|NCT02187055|526450652|FG001|Overall Study|Pregnancy|1|||
145983051|NCT02187055|526450653|FG002|Overall Study|Pregnancy|0|||
145983052|NCT02187055|526450651|FG000|Overall Study|Withdrawal by Subject|11|||
145983053|NCT02187055|526450652|FG001|Overall Study|Withdrawal by Subject|11|||
145983054|NCT02187055|526450653|FG002|Overall Study|Withdrawal by Subject|11|||
145983055|NCT02187055|526450651|FG000|Overall Study|Adverse Event|21|||
145983056|NCT02187055|526450652|FG001|Overall Study|Adverse Event|26|||
145983057|NCT02187055|526450653|FG002|Overall Study|Adverse Event|36|||
145983058|NCT02187055|526450651|FG000|Overall Study|Death|2|||
145983059|NCT02187055|526450652|FG001|Overall Study|Death|0|||
145983060|NCT02187055|526450653|FG002|Overall Study|Death|0|||
145983061|NCT03462563|526450654|FG000|Overall Study|Death|1|||
145983062|NCT03462563|526450655|FG001|Overall Study|Death|1|||
145983063|NCT03462563|526450654|FG000|Overall Study|Termination of study|2|||
145983064|NCT03462563|526450655|FG001|Overall Study|Termination of study|1|||
145983065|NCT03462563|526450654|FG000|Overall Study|Adverse Event|1|||
145983066|NCT03462563|526450655|FG001|Overall Study|Adverse Event|3|||
145983067|NCT03462563|526450654|FG000|Overall Study|Unspecified reason|10|||
145983068|NCT03462563|526450655|FG001|Overall Study|Unspecified reason|12|||
145983069|NCT03462563|526450654|FG000|Overall Study|Physician Decision|1|||
145983070|NCT03462563|526450655|FG001|Overall Study|Physician Decision|0|||
145983071|NCT05737745|526450656|FG000|Overall Study|Withdrawal by Subject|0|||
145983072|NCT05737745|526450657|FG001|Overall Study|Withdrawal by Subject|6|||
145983073|NCT05737745|526450658|FG002|Overall Study|Withdrawal by Subject|1|||
145983074|NCT02021318|526450659|FG000|Overall Study|Adverse Event|2|||
145983075|NCT02021318|526450660|FG001|Overall Study|Adverse Event|1|||
145983076|NCT02021318|526450659|FG000|Overall Study|Death|33|||
145983077|NCT02021318|526450660|FG001|Overall Study|Death|34|||
145983078|NCT02021318|526450659|FG000|Overall Study|Lost to Follow-up|3|||
145983079|NCT02021318|526450660|FG001|Overall Study|Lost to Follow-up|3|||
145983080|NCT02021318|526450659|FG000|Overall Study|Progressive Disease|0|||
145983081|NCT02021318|526450660|FG001|Overall Study|Progressive Disease|1|||
145983082|NCT02021318|526450659|FG000|Overall Study|Withdrawal by Subject|30|||
145983083|NCT02021318|526450660|FG001|Overall Study|Withdrawal by Subject|18|||
145983084|NCT02021318|526450659|FG000|Overall Study|Physician Decision|3|||
145983085|NCT02021318|526450660|FG001|Overall Study|Physician Decision|3|||
145983086|NCT02021318|526450659|FG000|Overall Study|Miscellaneous|2|||
145983087|NCT02021318|526450660|FG001|Overall Study|Miscellaneous|3|||
145983088|NCT00689052|526450661|FG000|Overall Study|Adverse Event|4|||
145983089|NCT00689052|526450662|FG001|Overall Study|Adverse Event|6|||
145983090|NCT00689052|526450661|FG000|Overall Study|Protocol Violation|1|||
145983091|NCT00689052|526450662|FG001|Overall Study|Protocol Violation|0|||
145983092|NCT00689052|526450661|FG000|Overall Study|Lost to Follow-up|2|||
145983093|NCT00689052|526450662|FG001|Overall Study|Lost to Follow-up|0|||
145983094|NCT00689052|526450661|FG000|Overall Study|Withdrawal by Subject|2|||
145983095|NCT00689052|526450662|FG001|Overall Study|Withdrawal by Subject|0|||
145983096|NCT00689052|526450661|FG000|Overall Study|Early termination of the trial|22|||
145983097|NCT00689052|526450662|FG001|Overall Study|Early termination of the trial|24|||
145983098|NCT00421993|526450665|FG000|Overall Study|Withdrawal by Subject|22|||
145983099|NCT00421993|526450666|FG001|Overall Study|Withdrawal by Subject|23|||
145983100|NCT00421993|526450667|FG002|Overall Study|Withdrawal by Subject|23|||
145983101|NCT00421993|526450668|FG003|Overall Study|Withdrawal by Subject|24|||
145983102|NCT00421993|526450665|FG000|Overall Study|Lost to Follow-up|18|||
145983103|NCT00421993|526450666|FG001|Overall Study|Lost to Follow-up|19|||
145983104|NCT00421993|526450667|FG002|Overall Study|Lost to Follow-up|22|||
145983105|NCT00421993|526450668|FG003|Overall Study|Lost to Follow-up|20|||
145983106|NCT00421993|526450665|FG000|Overall Study|Adverse Event|11|||
145983107|NCT00421993|526450666|FG001|Overall Study|Adverse Event|1|||
145983108|NCT00421993|526450667|FG002|Overall Study|Adverse Event|6|||
145983109|NCT00421993|526450668|FG003|Overall Study|Adverse Event|4|||
145983110|NCT00421993|526450665|FG000|Overall Study|Protocol Violation|2|||
145983111|NCT00421993|526450666|FG001|Overall Study|Protocol Violation|2|||
145983112|NCT00421993|526450667|FG002|Overall Study|Protocol Violation|0|||
145983113|NCT00421993|526450668|FG003|Overall Study|Protocol Violation|1|||
145983114|NCT00421993|526450665|FG000|Overall Study|Lack of Efficacy|0|||
145983115|NCT00421993|526450666|FG001|Overall Study|Lack of Efficacy|3|||
145983116|NCT00421993|526450667|FG002|Overall Study|Lack of Efficacy|0|||
145983117|NCT00421993|526450668|FG003|Overall Study|Lack of Efficacy|5|||
145983118|NCT00421993|526450665|FG000|Overall Study|Pregnancy|0|||
145983119|NCT00421993|526450666|FG001|Overall Study|Pregnancy|1|||
145983120|NCT00421993|526450667|FG002|Overall Study|Pregnancy|1|||
145983121|NCT00421993|526450668|FG003|Overall Study|Pregnancy|2|||
145983122|NCT00421993|526450665|FG000|Overall Study|Subject transportation issues|0|||
145983123|NCT00421993|526450666|FG001|Overall Study|Subject transportation issues|0|||
145983124|NCT00421993|526450667|FG002|Overall Study|Subject transportation issues|0|||
145983125|NCT00421993|526450668|FG003|Overall Study|Subject transportation issues|1|||
145983126|NCT02547935|526450669|FG000|Overall Study|Other|0|||
145983127|NCT02547935|526450670|FG001|Overall Study|Other|1|||
145983128|NCT02547935|526450671|FG002|Overall Study|Other|0|||
145983129|NCT02547935|526450669|FG000|Overall Study|Withdrawal by Subject|2|||
145983130|NCT02547935|526450670|FG001|Overall Study|Withdrawal by Subject|3|||
145983131|NCT02547935|526450671|FG002|Overall Study|Withdrawal by Subject|4|||
145983132|NCT02547935|526450669|FG000|Overall Study|Screen Failure|2|||
145983133|NCT02547935|526450670|FG001|Overall Study|Screen Failure|0|||
145983134|NCT02547935|526450671|FG002|Overall Study|Screen Failure|0|||
145983135|NCT02547935|526450669|FG000|Overall Study|Physician Decision|0|||
145983136|NCT02547935|526450670|FG001|Overall Study|Physician Decision|1|||
145983137|NCT02547935|526450671|FG002|Overall Study|Physician Decision|0|||
145983138|NCT02547935|526450669|FG000|Overall Study|Lost to Follow-up|0|||
145983139|NCT02547935|526450670|FG001|Overall Study|Lost to Follow-up|2|||
145983140|NCT02547935|526450671|FG002|Overall Study|Lost to Follow-up|1|||
145983141|NCT02547935|526450669|FG000|Overall Study|Death|1|||
145983142|NCT02547935|526450670|FG001|Overall Study|Death|1|||
145983143|NCT02547935|526450671|FG002|Overall Study|Death|0|||
145983144|NCT00003474|526450675|FG000|Overall Study|Not Evaluable|14|||
145983145|NCT02015104|526450676|FG000|Overall Study|Withdrew consent after first dose drug|1|||
145983146|NCT02015104|526450677|FG001|Overall Study|Withdrew consent after first dose drug|0|||
145983147|NCT02015104|526450676|FG000|Overall Study|Withdrew consent prior to treatment|0|||
145983148|NCT02015104|526450677|FG001|Overall Study|Withdrew consent prior to treatment|1|||
145983149|NCT01301092|526450678|FG000|Overall Study|Lost to Follow-up|0|||
145983150|NCT01301092|526450679|FG001|Overall Study|Lost to Follow-up|0|||
145983151|NCT01301092|526450680|FG002|Overall Study|Lost to Follow-up|1|||
145983152|NCT03334175|526450681|FG000|Overall Study|Lost to Follow-up|0|||
145983153|NCT03334175|526450682|FG001|Overall Study|Lost to Follow-up|1|||
145983154|NCT01350973|526450683|FG000|Overall Study|Adverse Event|4|||
145983155|NCT01350973|526450684|FG001|Overall Study|Adverse Event|7|||
145983156|NCT01350973|526450685|FG002|Overall Study|Adverse Event|7|||
145983157|NCT01350973|526450683|FG000|Overall Study|Voluntary Withdrawal|2|||
145983158|NCT01350973|526450684|FG001|Overall Study|Voluntary Withdrawal|1|||
145983159|NCT01350973|526450685|FG002|Overall Study|Voluntary Withdrawal|1|||
145983160|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145983161|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
145983162|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145983163|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
145983164|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
145983165|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145983166|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
145983167|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
145983168|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
145983169|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
145983170|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
145983171|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
145983172|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
145983173|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145983174|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145983175|NCT03738215|526450686|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145983176|NCT03738215|526450687|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145983177|NCT03738215|526450688|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
145983178|NCT03738215|526450686|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
145983179|NCT03738215|526450687|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
145983180|NCT03738215|526450688|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
145983181|NCT03738215|526450686|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
145983182|NCT03738215|526450687|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
145983183|NCT03738215|526450688|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
145983184|NCT03738215|526450686|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
145983185|NCT03738215|526450687|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
145983186|NCT03738215|526450688|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
145983187|NCT03738215|526450686|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
145983188|NCT03738215|526450687|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
145983189|NCT03738215|526450688|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
145983190|NCT02638493|526450689|FG000|Overall Study|Inability to provide semen samples|2|||
145983191|NCT02638493|526450690|FG001|Overall Study|Inability to provide semen samples|0|||
145983192|NCT02638493|526450691|FG002|Overall Study|Inability to provide semen samples|0|||
145983193|NCT03882801|526452825|FG000|Period 1|Adverse Event|0|||
145983194|NCT03882801|526452826|FG001|Period 1|Adverse Event|1|||
145983195|NCT03882801|526452825|FG000|Period 1|Non-compliance with study drug|1|||
145983196|NCT03882801|526452826|FG001|Period 1|Non-compliance with study drug|1|||
145983197|NCT03882801|526452825|FG000|Period 1|Never treated with study drug|1|||
145983198|NCT03882801|526452826|FG001|Period 1|Never treated with study drug|0|||
145983199|NCT03882801|526452825|FG000|Washout Period|Physician Decision|0|||
145983200|NCT03882801|526452826|FG001|Washout Period|Physician Decision|1|||
145983201|NCT03882801|526452825|FG000|Period 2|Non-compliance with study drug|0|||
145983202|NCT03882801|526452826|FG001|Period 2|Non-compliance with study drug|1|||
145983203|NCT04193176|526452827|FG000|Overall Study|Withdrawal by Subject|6|||
145983204|NCT04193176|526452828|FG001|Overall Study|Withdrawal by Subject|10|||
145983205|NCT00944645|526452829|FG000|Period 2|Adverse Event|1|||
145983206|NCT00944645|526452830|FG001|Period 2|Adverse Event|0|||
145983207|NCT00944645|526452829|FG000|Period 2|Lost to Follow-up|0|||
145983208|NCT00944645|526452830|FG001|Period 2|Lost to Follow-up|3|||
145983209|NCT00944645|526452829|FG000|Period 2|Withdrawal by Subject|7|||
145983210|NCT00944645|526452830|FG001|Period 2|Withdrawal by Subject|6|||
145983211|NCT03928704|526452834|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145983212|NCT03928704|526452835|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
145983213|NCT03928704|526452836|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145983214|NCT03928704|526452837|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145983215|NCT03928704|526452838|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145983216|NCT03928704|526452839|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145983217|NCT03928704|526452834|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
145983218|NCT03928704|526452835|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145983219|NCT03928704|526452836|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145983220|NCT03928704|526452837|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145983221|NCT03928704|526452838|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145983222|NCT03928704|526452839|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145983223|NCT03928704|526452834|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
145983224|NCT03928704|526452835|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145983225|NCT03928704|526452836|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145983226|NCT03928704|526452837|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145983227|NCT03928704|526452838|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145983228|NCT03928704|526452839|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145983229|NCT03928704|526452834|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
145983230|NCT03928704|526452835|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
145983231|NCT03928704|526452836|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145983232|NCT03928704|526452837|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145983233|NCT03928704|526452838|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145983234|NCT03928704|526452839|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145983235|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145983236|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145983237|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
145983238|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145983239|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145983240|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145983241|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145983242|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145983243|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
145983244|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
146245633|NCT00687297|527414033|FG000|Randomization|Withdrawal by Subject|2|||
146245634|NCT00687297|527414034|FG001|Randomization|Withdrawal by Subject|0|||
146245635|NCT00687297|527414033|FG000|Randomization|Withdrew before treatment, ineligible|1|||
145983245|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145983246|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145983247|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
145983248|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
145983249|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
145983250|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
145983251|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
145983252|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
145983253|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145983254|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145983255|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
145983256|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145983257|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145983258|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145983259|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145983260|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145983261|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145983262|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145983263|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145983264|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
145983265|NCT03928704|526452834|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
145983266|NCT03928704|526452835|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
145983267|NCT03928704|526452836|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
145983268|NCT03928704|526452837|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
145983269|NCT03928704|526452838|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
145983270|NCT03928704|526452839|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
145983271|NCT01245751|526452844|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
145983272|NCT01245751|526452845|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
145983273|NCT01245751|526452846|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
145983274|NCT01245751|526452847|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
145983275|NCT01245751|526452844|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145983276|NCT01245751|526452845|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145983277|NCT01245751|526452846|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145983278|NCT01245751|526452847|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
145983279|NCT01245751|526452844|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145983280|NCT01245751|526452845|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
145983281|NCT01245751|526452846|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145983282|NCT01245751|526452847|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145983283|NCT02181621|526452848|FG000|Overall Study|Adverse Event|1|||
145983284|NCT02181621|526452849|FG001|Overall Study|Adverse Event|0|||
145983285|NCT02181621|526452848|FG000|Overall Study|Previously Enrolled|0|||
145983286|NCT02181621|526452849|FG001|Overall Study|Previously Enrolled|1|||
145983287|NCT02181621|526452848|FG000|Overall Study|Enrollment Hold|1|||
145983288|NCT02181621|526452849|FG001|Overall Study|Enrollment Hold|1|||
145983289|NCT00289978|526452853|FG000|Overall Study|Withdrawal by Subject|31|||
145983290|NCT00289978|526452854|FG001|Overall Study|Withdrawal by Subject|17|||
145983291|NCT00289978|526452855|FG002|Overall Study|Withdrawal by Subject|28|||
145983292|NCT00289978|526452853|FG000|Overall Study|Adverse Event|22|||
145983293|NCT00289978|526452854|FG001|Overall Study|Adverse Event|13|||
145983294|NCT00289978|526452855|FG002|Overall Study|Adverse Event|18|||
145983295|NCT00289978|526452853|FG000|Overall Study|Lack of Efficacy|13|||
145983296|NCT00289978|526452854|FG001|Overall Study|Lack of Efficacy|6|||
145983297|NCT00289978|526452855|FG002|Overall Study|Lack of Efficacy|25|||
145983298|NCT00289978|526452853|FG000|Overall Study|Abnormal laboratory value(s)|20|||
145983299|NCT00289978|526452854|FG001|Overall Study|Abnormal laboratory value(s)|9|||
145983300|NCT00289978|526452855|FG002|Overall Study|Abnormal laboratory value(s)|1|||
145983301|NCT00289978|526452853|FG000|Overall Study|Lost to Follow-up|3|||
145983302|NCT00289978|526452854|FG001|Overall Study|Lost to Follow-up|5|||
145983303|NCT00289978|526452855|FG002|Overall Study|Lost to Follow-up|7|||
145983304|NCT00289978|526452853|FG000|Overall Study|Protocol Violation|5|||
145983305|NCT00289978|526452854|FG001|Overall Study|Protocol Violation|5|||
145983306|NCT00289978|526452855|FG002|Overall Study|Protocol Violation|4|||
145983307|NCT00289978|526452853|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145983308|NCT00289978|526452854|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145983309|NCT00289978|526452855|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145983310|NCT00289978|526452853|FG000|Overall Study|Death|1|||
145983311|NCT00289978|526452854|FG001|Overall Study|Death|0|||
145983312|NCT00289978|526452855|FG002|Overall Study|Death|2|||
146245636|NCT00687297|527414034|FG001|Randomization|Withdrew before treatment, ineligible|1|||
146245637|NCT00687297|527414033|FG000|Induction|Withdrawal by Subject|4|||
146245638|NCT00687297|527414034|FG001|Induction|Withdrawal by Subject|4|||
146245639|NCT00687297|527414033|FG000|Induction|Adverse Event|16|||
146245640|NCT00687297|527414034|FG001|Induction|Adverse Event|15|||
145983313|NCT01524705|526452856|FG000|Overall Study|Adverse Event|2|||
145983314|NCT01524705|526452857|FG001|Overall Study|Adverse Event|0|||
145983315|NCT01524705|526452856|FG000|Overall Study|Death|1|||
145983316|NCT01524705|526452857|FG001|Overall Study|Death|0|||
145983317|NCT01524705|526452856|FG000|Overall Study|Lost to Follow-up|0|||
145983318|NCT01524705|526452857|FG001|Overall Study|Lost to Follow-up|1|||
145983319|NCT01524705|526452856|FG000|Overall Study|Withdrawal by Subject|0|||
145983320|NCT01524705|526452857|FG001|Overall Study|Withdrawal by Subject|1|||
145983321|NCT01524705|526452856|FG000|Overall Study|Pancreatic Cancer|0|||
145983322|NCT01524705|526452857|FG001|Overall Study|Pancreatic Cancer|1|||
145983323|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
145983324|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
145983325|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
145983326|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
145983327|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
145983328|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
145983329|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
145983330|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
145983331|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
145983332|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
145983333|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
145983334|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
145983335|NCT01243424|526452858|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
145983336|NCT01243424|526452859|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
145983337|NCT01243424|526452858|FG000|Discontinuation From Treatment|Not treated|5|||
145983338|NCT01243424|526452859|FG001|Discontinuation From Treatment|Not treated|4|||
145983339|NCT01243424|526452858|FG000|Discontinuation From Treatment|Adverse Event|457|||
145983340|NCT01243424|526452859|FG001|Discontinuation From Treatment|Adverse Event|523|||
145983341|NCT01243424|526452858|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
145983342|NCT01243424|526452859|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
145983343|NCT01243424|526452858|FG000|Discontinuation From Treatment|Protocol Violation|46|||
145983344|NCT01243424|526452859|FG001|Discontinuation From Treatment|Protocol Violation|47|||
145983345|NCT01243424|526452858|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
145983346|NCT01243424|526452859|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
145983347|NCT01243424|526452858|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
145983348|NCT01243424|526452859|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
145983349|NCT01243424|526452858|FG000|Discontinuation From Treatment|Other than listed above|230|||
145983350|NCT01243424|526452859|FG001|Discontinuation From Treatment|Other than listed above|211|||
145983351|NCT01160744|526452866|FG000|Overall Study|Withdrawal by Subject|11|||
145983352|NCT01160744|526452867|FG001|Overall Study|Withdrawal by Subject|5|||
145983353|NCT01160744|526452868|FG002|Overall Study|Withdrawal by Subject|6|||
145983354|NCT01160744|526452869|FG003|Overall Study|Withdrawal by Subject|4|||
145983355|NCT01160744|526452866|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
145983356|NCT01160744|526452867|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
145983357|NCT01160744|526452868|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
145983358|NCT01160744|526452869|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
145983359|NCT02959892|526452875|FG000|Overall Study|PET tracer synthesis failure|1|||
145983360|NCT02959892|526452876|FG001|Overall Study|PET tracer synthesis failure|0|||
145983361|NCT02959892|526452875|FG000|Overall Study|Study termination|0|||
145983362|NCT02959892|526452876|FG001|Overall Study|Study termination|1|||
145983363|NCT03338023|526452877|FG000|Overall Study|Withdrawal by Subject|3|||
145983364|NCT03338023|526452878|FG001|Overall Study|Withdrawal by Subject|4|||
145983365|NCT03338023|526452877|FG000|Overall Study|Protocol Violation|3|||
145983366|NCT03338023|526452878|FG001|Overall Study|Protocol Violation|3|||
145983367|NCT03338023|526452877|FG000|Overall Study|Lost to Follow-up|2|||
145983368|NCT03338023|526452878|FG001|Overall Study|Lost to Follow-up|1|||
145983369|NCT03338023|526452877|FG000|Overall Study|Physician Decision|1|||
145983370|NCT03338023|526452878|FG001|Overall Study|Physician Decision|2|||
145983371|NCT04865978|526452879|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
145983372|NCT04865978|526452880|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
145983373|NCT02181738|526452885|FG000|Overall Study|Participant Withdrew Consent|2|||
146245641|NCT00687297|527414033|FG000|Induction|Death|7|||
146245642|NCT00687297|527414034|FG001|Induction|Death|11|||
146245643|NCT00687297|527414033|FG000|Induction|Lack of Efficacy|17|||
146245644|NCT00687297|527414034|FG001|Induction|Lack of Efficacy|21|||
145983374|NCT02181738|526452886|FG001|Overall Study|Participant Withdrew Consent|1|||
145983375|NCT02181738|526452887|FG002|Overall Study|Participant Withdrew Consent|1|||
145983376|NCT02181738|526452888|FG003|Overall Study|Participant Withdrew Consent|1|||
145983377|NCT02181738|526452885|FG000|Overall Study|Lost to Follow-up|1|||
145983378|NCT02181738|526452886|FG001|Overall Study|Lost to Follow-up|2|||
145983379|NCT02181738|526452887|FG002|Overall Study|Lost to Follow-up|1|||
145983380|NCT02181738|526452888|FG003|Overall Study|Lost to Follow-up|1|||
145983381|NCT02181738|526452885|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
145983382|NCT02181738|526452886|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
145983383|NCT02181738|526452887|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
145983384|NCT02181738|526452888|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
145983385|NCT02181738|526452885|FG000|Overall Study|Poor/Non-Compliance|1|||
145983386|NCT02181738|526452886|FG001|Overall Study|Poor/Non-Compliance|0|||
145983387|NCT02181738|526452887|FG002|Overall Study|Poor/Non-Compliance|2|||
145983388|NCT02181738|526452888|FG003|Overall Study|Poor/Non-Compliance|1|||
145983389|NCT02181738|526452885|FG000|Overall Study|Disease Progression|28|||
145983390|NCT02181738|526452886|FG001|Overall Study|Disease Progression|35|||
145983391|NCT02181738|526452887|FG002|Overall Study|Disease Progression|40|||
145983392|NCT02181738|526452888|FG003|Overall Study|Disease Progression|0|||
145983393|NCT02181738|526452885|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
145983394|NCT02181738|526452886|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
145983395|NCT02181738|526452887|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
145983396|NCT02181738|526452888|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
145983397|NCT02181738|526452885|FG000|Overall Study|Study Drug Toxicity|6|||
145983398|NCT02181738|526452886|FG001|Overall Study|Study Drug Toxicity|11|||
145983399|NCT02181738|526452887|FG002|Overall Study|Study Drug Toxicity|8|||
145983400|NCT02181738|526452888|FG003|Overall Study|Study Drug Toxicity|1|||
145983401|NCT02181738|526452885|FG000|Overall Study|Other Reasons|14|||
145983402|NCT02181738|526452886|FG001|Overall Study|Other Reasons|16|||
145983403|NCT02181738|526452887|FG002|Overall Study|Other Reasons|28|||
145983404|NCT02181738|526452888|FG003|Overall Study|Other Reasons|0|||
145983405|NCT02181738|526452885|FG000|Overall Study|Maximum Clinical Benefit|3|||
145983406|NCT02181738|526452886|FG001|Overall Study|Maximum Clinical Benefit|0|||
145983407|NCT02181738|526452887|FG002|Overall Study|Maximum Clinical Benefit|1|||
145983408|NCT02181738|526452888|FG003|Overall Study|Maximum Clinical Benefit|0|||
145983409|NCT02181738|526452885|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145983410|NCT02181738|526452886|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145983411|NCT02181738|526452887|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
145983412|NCT02181738|526452888|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145983413|NCT05064800|526452894|FG000|Period 3|Withdrawal by Subject|0|||
145983414|NCT05064800|526452895|FG001|Period 3|Withdrawal by Subject|0|||
145983415|NCT05064800|526452896|FG002|Period 3|Withdrawal by Subject|0|||
145983416|NCT05064800|526452897|FG003|Period 3|Withdrawal by Subject|0|||
145983417|NCT05064800|526452898|FG004|Period 3|Withdrawal by Subject|1|||
145983418|NCT05064800|526452899|FG005|Period 3|Withdrawal by Subject|0|||
145983419|NCT01181128|526452900|FG000|Overall Study|Withdrawal by Subject|2|||
145983420|NCT01181128|526452901|FG001|Overall Study|Withdrawal by Subject|2|||
145983421|NCT01181128|526452902|FG002|Overall Study|Withdrawal by Subject|0|||
145983422|NCT01181128|526452900|FG000|Overall Study|Death|1|||
145983423|NCT01181128|526452901|FG001|Overall Study|Death|0|||
145983424|NCT01181128|526452902|FG002|Overall Study|Death|0|||
145983425|NCT01181128|526452900|FG000|Overall Study|Physician Decision|2|||
145983426|NCT01181128|526452901|FG001|Overall Study|Physician Decision|0|||
145983427|NCT01181128|526452902|FG002|Overall Study|Physician Decision|0|||
145983428|NCT01181128|526452900|FG000|Overall Study|Adverse Event|0|||
145983429|NCT01181128|526452901|FG001|Overall Study|Adverse Event|2|||
145983430|NCT01181128|526452902|FG002|Overall Study|Adverse Event|0|||
145983431|NCT01181128|526452900|FG000|Overall Study|Other|1|||
145983432|NCT01181128|526452901|FG001|Overall Study|Other|1|||
145983433|NCT01181128|526452902|FG002|Overall Study|Other|1|||
145983434|NCT00629239|526452903|FG000|Overall Study|Adverse Event|7|||
145983435|NCT00629239|526452904|FG001|Overall Study|Adverse Event|4|||
145983436|NCT00629239|526452903|FG000|Overall Study|Physician Decision|1|||
145983437|NCT00629239|526452904|FG001|Overall Study|Physician Decision|0|||
145983438|NCT04477486|526452907|FG000|Overall Study|Death|2|||
145983439|NCT04477486|526452907|FG000|Overall Study|Ongoing at Time of Analysis|11|||
145983440|NCT01851369|526452908|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983441|NCT01851369|526452909|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
146245645|NCT00687297|527414033|FG000|Induction|Ineligible|0|||
145983442|NCT01851369|526452910|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983443|NCT01851369|526452911|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983444|NCT01851369|526452912|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983445|NCT01851369|526452913|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
145983446|NCT01851369|526452914|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983447|NCT01851369|526452915|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983448|NCT01851369|526452916|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983449|NCT01851369|526452917|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983450|NCT01851369|526452918|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983451|NCT01851369|526452919|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983452|NCT01851369|526452920|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145983453|NCT00183391|526452921|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
145983454|NCT00183391|526452922|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
145983455|NCT00183391|526452921|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
145983456|NCT00183391|526452922|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
145983457|NCT01543503|526452924|FG000|Overall Study|Lost to Follow-up|32|||
145983458|NCT01543503|526452925|FG001|Overall Study|Lost to Follow-up|36|||
145983459|NCT01543503|526452924|FG000|Overall Study|Adverse Event|9|||
145983460|NCT01543503|526452925|FG001|Overall Study|Adverse Event|13|||
145983461|NCT01543503|526452924|FG000|Overall Study|Lack of Efficacy|4|||
145983462|NCT01543503|526452925|FG001|Overall Study|Lack of Efficacy|16|||
145983463|NCT01543503|526452924|FG000|Overall Study|Participant withdrew informed consent|8|||
145983464|NCT01543503|526452925|FG001|Overall Study|Participant withdrew informed consent|10|||
145983465|NCT01543503|526452924|FG000|Overall Study|Change of jobs|0|||
145983466|NCT01543503|526452925|FG001|Overall Study|Change of jobs|1|||
145983467|NCT01543503|526452924|FG000|Overall Study|Intolerance to the biologic treatment|0|||
145983468|NCT01543503|526452925|FG001|Overall Study|Intolerance to the biologic treatment|1|||
145983469|NCT01543503|526452924|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
145983470|NCT01543503|526452925|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
145983471|NCT01543503|526452924|FG000|Overall Study|Participant did not complete last visit|0|||
145983472|NCT01543503|526452925|FG001|Overall Study|Participant did not complete last visit|2|||
145983473|NCT01543503|526452924|FG000|Overall Study|Refused to continue treatment|7|||
145983474|NCT01543503|526452925|FG001|Overall Study|Refused to continue treatment|0|||
145983475|NCT01543503|526452924|FG000|Overall Study|Incorrect medication received|1|||
145983476|NCT01543503|526452925|FG001|Overall Study|Incorrect medication received|0|||
145983477|NCT01543503|526452924|FG000|Overall Study|Participant moved to another city|2|||
145983478|NCT01543503|526452925|FG001|Overall Study|Participant moved to another city|0|||
145983479|NCT01543503|526452924|FG000|Overall Study|Participant will not return for visits|0|||
145983480|NCT01543503|526452925|FG001|Overall Study|Participant will not return for visits|2|||
145983481|NCT01543503|526452924|FG000|Overall Study|Participant transferred to another city|1|||
145983482|NCT01543503|526452925|FG001|Overall Study|Participant transferred to another city|0|||
145983483|NCT01543503|526452924|FG000|Overall Study|Participant moved to Scotland|1|||
145983484|NCT01543503|526452925|FG001|Overall Study|Participant moved to Scotland|0|||
145983485|NCT01543503|526452924|FG000|Overall Study|Participant decision to stop treatment|1|||
145983486|NCT01543503|526452925|FG001|Overall Study|Participant decision to stop treatment|0|||
145983487|NCT01543503|526452924|FG000|Overall Study|Investigator did not wish to participate|1|||
145983488|NCT01543503|526452925|FG001|Overall Study|Investigator did not wish to participate|1|||
145983489|NCT01543503|526452924|FG000|Overall Study|Participant recruited after closing date|0|||
145983490|NCT01543503|526452925|FG001|Overall Study|Participant recruited after closing date|1|||
145983491|NCT01543503|526452924|FG000|Overall Study|Site stopped participation|5|||
145983492|NCT01543503|526452925|FG001|Overall Study|Site stopped participation|1|||
145983493|NCT01543503|526452924|FG000|Overall Study|Participant did not attend a visit|1|||
145983494|NCT01543503|526452925|FG001|Overall Study|Participant did not attend a visit|0|||
145983495|NCT01543503|526452924|FG000|Overall Study|Moved to other rheumatologic site|0|||
145983496|NCT01543503|526452925|FG001|Overall Study|Moved to other rheumatologic site|1|||
145983497|NCT01543503|526452924|FG000|Overall Study|Participant consented to another study|0|||
145983498|NCT01543503|526452925|FG001|Overall Study|Participant consented to another study|2|||
145983499|NCT01543503|526452924|FG000|Overall Study|Participant went to United States|1|||
145983500|NCT01543503|526452925|FG001|Overall Study|Participant went to United States|0|||
145983501|NCT01543503|526452924|FG000|Overall Study|Screen failure|1|||
145983502|NCT01543503|526452925|FG001|Overall Study|Screen failure|0|||
145983503|NCT02460380|526452926|FG000|Overall Study|Withdrawal by Subject|10|||
145983504|NCT02460380|526452927|FG001|Overall Study|Withdrawal by Subject|5|||
145983505|NCT00395512|526452928|FG000|Overall Study|Adverse Event|3|||
146091326|NCT00473746|526854948|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
145983506|NCT00395512|526452929|FG001|Overall Study|Adverse Event|8|||
145983507|NCT00395512|526452930|FG002|Overall Study|Adverse Event|6|||
146091327|NCT00473746|526854944|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
145983508|NCT00395512|526452931|FG003|Overall Study|Adverse Event|6|||
145983509|NCT00395512|526452928|FG000|Overall Study|Protocol Violation|2|||
146091328|NCT00473746|526854945|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
145983510|NCT00395512|526452929|FG001|Overall Study|Protocol Violation|3|||
145983511|NCT00395512|526452930|FG002|Overall Study|Protocol Violation|6|||
145983512|NCT00395512|526452931|FG003|Overall Study|Protocol Violation|7|||
145983513|NCT00395512|526452928|FG000|Overall Study|Lost to Follow-up|2|||
145983514|NCT00395512|526452929|FG001|Overall Study|Lost to Follow-up|6|||
145983515|NCT00395512|526452930|FG002|Overall Study|Lost to Follow-up|5|||
145983516|NCT00395512|526452931|FG003|Overall Study|Lost to Follow-up|5|||
145983517|NCT00395512|526452928|FG000|Overall Study|Withdrawal by Subject|6|||
145983518|NCT00395512|526452929|FG001|Overall Study|Withdrawal by Subject|5|||
145983519|NCT00395512|526452930|FG002|Overall Study|Withdrawal by Subject|5|||
145983520|NCT00395512|526452931|FG003|Overall Study|Withdrawal by Subject|12|||
145983521|NCT00395512|526452928|FG000|Overall Study|Physician Decision|6|||
145983522|NCT00395512|526452929|FG001|Overall Study|Physician Decision|4|||
145983523|NCT00395512|526452930|FG002|Overall Study|Physician Decision|2|||
145983524|NCT00395512|526452931|FG003|Overall Study|Physician Decision|2|||
145983525|NCT00395512|526452928|FG000|Overall Study|Other|1|||
145983526|NCT00395512|526452929|FG001|Overall Study|Other|1|||
145983527|NCT00395512|526452930|FG002|Overall Study|Other|0|||
145983528|NCT00395512|526452931|FG003|Overall Study|Other|0|||
145983529|NCT00395512|526452928|FG000|Overall Study|Hyperglycemic Rescue|18|||
145983530|NCT00395512|526452929|FG001|Overall Study|Hyperglycemic Rescue|10|||
145983531|NCT00395512|526452930|FG002|Overall Study|Hyperglycemic Rescue|4|||
145983532|NCT00395512|526452931|FG003|Overall Study|Hyperglycemic Rescue|6|||
145983533|NCT01478087|526452933|FG000|Overall Study|due to sponsor closing study|1|||
145983534|NCT00052715|526452938|FG000|Overall Study|wrong histology|1|||
145983535|NCT01936974|526452939|FG000|Overall Study|Physician Decision|2|||
145983536|NCT01936974|526452940|FG001|Overall Study|Physician Decision|5|||
145983537|NCT01078545|526452942|FG000|Overall Study|Lost to Follow-up|13|||
145983538|NCT01078545|526452942|FG000|Overall Study|Physician Decision|6|||
145983539|NCT01078545|526452942|FG000|Overall Study|Withdrawal by Subject|3|||
145983540|NCT01078545|526452942|FG000|Overall Study|Death|3|||
145983541|NCT01078545|526452942|FG000|Overall Study|Participant moved to another physician|1|||
145983542|NCT02497755|526452943|FG000|Overall Study|Protocol Violation|1|||
145983543|NCT02497755|526452944|FG001|Overall Study|Protocol Violation|0|||
145983544|NCT01774370|526452945|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
145983545|NCT01774370|526452945|FG000|Overall Study|Administered prior to the contract date|4|||
145983546|NCT01774370|526452945|FG000|Overall Study|Subjects of contraindications|34|||
145983547|NCT01774370|526452945|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
145983548|NCT01774370|526452945|FG000|Overall Study|Follow-up failure|34|||
145983549|NCT00514917|526452946|FG000|Overall Study|Death|4|||
145983550|NCT00514917|526452947|FG001|Overall Study|Death|10|||
145983551|NCT00514917|526452946|FG000|Overall Study|Protocol Violation|1|||
145983552|NCT00514917|526452947|FG001|Overall Study|Protocol Violation|0|||
145983553|NCT00514917|526452946|FG000|Overall Study|Lost to Follow-up|4|||
145983554|NCT00514917|526452947|FG001|Overall Study|Lost to Follow-up|3|||
145983555|NCT00514917|526452946|FG000|Overall Study|Withdrawal by Subject|18|||
145983556|NCT00514917|526452947|FG001|Overall Study|Withdrawal by Subject|16|||
145983557|NCT00514917|526452946|FG000|Overall Study|Discontinued due to study closure|88|||
145983558|NCT00514917|526452947|FG001|Overall Study|Discontinued due to study closure|81|||
145983559|NCT00514917|526452946|FG000|Overall Study|Undefined|11|||
145983560|NCT00514917|526452947|FG001|Overall Study|Undefined|5|||
145983561|NCT01436500|526452950|FG000|Overall Study|Death|1|||
145983562|NCT01436500|526452951|FG001|Overall Study|Death|0|||
145983563|NCT01436500|526452952|FG002|Overall Study|Death|0|||
145983564|NCT01436500|526452953|FG003|Overall Study|Death|0|||
145983565|NCT01436500|526452954|FG004|Overall Study|Death|0|||
145983566|NCT01436500|526452950|FG000|Overall Study|Adverse Event|0|||
145983567|NCT01436500|526452951|FG001|Overall Study|Adverse Event|2|||
145983568|NCT01436500|526452952|FG002|Overall Study|Adverse Event|2|||
145983569|NCT01436500|526452953|FG003|Overall Study|Adverse Event|0|||
145983570|NCT01436500|526452954|FG004|Overall Study|Adverse Event|1|||
145983571|NCT01436500|526452950|FG000|Overall Study|Withdrawal by Subject|0|||
145983572|NCT01436500|526452951|FG001|Overall Study|Withdrawal by Subject|0|||
145983573|NCT01436500|526452952|FG002|Overall Study|Withdrawal by Subject|2|||
145983574|NCT01436500|526452953|FG003|Overall Study|Withdrawal by Subject|0|||
145983575|NCT01436500|526452954|FG004|Overall Study|Withdrawal by Subject|2|||
145983576|NCT01436500|526452950|FG000|Overall Study|Physician Decision|0|||
145983577|NCT01436500|526452951|FG001|Overall Study|Physician Decision|0|||
145983578|NCT01436500|526452952|FG002|Overall Study|Physician Decision|1|||
145983579|NCT01436500|526452953|FG003|Overall Study|Physician Decision|0|||
145983580|NCT01436500|526452954|FG004|Overall Study|Physician Decision|0|||
145983581|NCT01436500|526452950|FG000|Overall Study|liver transplant|1|||
145983582|NCT01436500|526452951|FG001|Overall Study|liver transplant|0|||
145983583|NCT01436500|526452952|FG002|Overall Study|liver transplant|0|||
145983584|NCT01436500|526452953|FG003|Overall Study|liver transplant|0|||
145983585|NCT01436500|526452954|FG004|Overall Study|liver transplant|0|||
145983586|NCT01436500|526452950|FG000|Overall Study|initiation of dialysis|0|||
145983587|NCT01436500|526452951|FG001|Overall Study|initiation of dialysis|0|||
145983588|NCT01436500|526452952|FG002|Overall Study|initiation of dialysis|0|||
145983589|NCT01436500|526452953|FG003|Overall Study|initiation of dialysis|0|||
145983590|NCT01436500|526452954|FG004|Overall Study|initiation of dialysis|1|||
145983591|NCT01436500|526452950|FG000|Overall Study|discontinued study drug|1|||
145983592|NCT01436500|526452951|FG001|Overall Study|discontinued study drug|0|||
145983593|NCT01436500|526452952|FG002|Overall Study|discontinued study drug|0|||
145983594|NCT01436500|526452953|FG003|Overall Study|discontinued study drug|0|||
145983595|NCT01436500|526452954|FG004|Overall Study|discontinued study drug|0|||
145983596|NCT01436500|526452950|FG000|Overall Study|Other|0|||
145983597|NCT01436500|526452951|FG001|Overall Study|Other|1|||
145983598|NCT01436500|526452952|FG002|Overall Study|Other|0|||
145983599|NCT01436500|526452953|FG003|Overall Study|Other|1|||
145983600|NCT01436500|526452954|FG004|Overall Study|Other|0|||
145983601|NCT00977561|526452955|FG000|Overall Study|Death|3|||
145983602|NCT00977561|526452956|FG001|Overall Study|Death|2|||
145983603|NCT00977561|526452955|FG000|Overall Study|Study terminated|0|||
145983604|NCT00977561|526452956|FG001|Overall Study|Study terminated|2|||
145983605|NCT00977561|526452955|FG000|Overall Study|Other|2|||
145983606|NCT00977561|526452956|FG001|Overall Study|Other|0|||
145983607|NCT03511066|526452959|FG000|Overall Study|Withdrawal by Subject|1|||
145983608|NCT03511066|526452960|FG001|Overall Study|Withdrawal by Subject|2|||
145983609|NCT03511066|526452961|FG002|Overall Study|Withdrawal by Subject|3|||
145983610|NCT03511066|526452959|FG000|Overall Study|Lost to Follow-up|2|||
145983611|NCT03511066|526452960|FG001|Overall Study|Lost to Follow-up|3|||
145983612|NCT03511066|526452961|FG002|Overall Study|Lost to Follow-up|0|||
145983613|NCT04560309|526452965|FG000|Overall Study|Meet drop out criteria|1|||
145983614|NCT04560309|526452966|FG001|Overall Study|Meet drop out criteria|1|||
145983615|NCT05085405|526452967|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145983616|NCT05085405|526452968|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145983617|NCT05085405|526452969|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
145983618|NCT05085405|526452970|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
145983619|NCT05085405|526452971|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145983620|NCT05085405|526452972|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145983621|NCT05085405|526452967|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145983622|NCT05085405|526452968|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145983623|NCT05085405|526452969|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145983624|NCT05085405|526452970|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
145983625|NCT05085405|526452971|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145983626|NCT05085405|526452972|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145983627|NCT04146909|526452973|FG000|Overall Study|Withdrawal by Subject|3|||
145983628|NCT04146909|526452973|FG000|Overall Study|Did not qualify after consented|1|||
145983629|NCT01663987|526452974|FG000|Overall Study|Adverse Event|7|||
145983630|NCT01663987|526452975|FG001|Overall Study|Adverse Event|2|||
145983631|NCT01663987|526452974|FG000|Overall Study|Lost to Follow-up|1|||
145983632|NCT01663987|526452975|FG001|Overall Study|Lost to Follow-up|1|||
145983633|NCT01663987|526452974|FG000|Overall Study|Withdrawal by Subject|2|||
145983634|NCT01663987|526452975|FG001|Overall Study|Withdrawal by Subject|3|||
145983635|NCT01663987|526452974|FG000|Overall Study|Other reason not defined above|3|||
145983636|NCT01663987|526452975|FG001|Overall Study|Other reason not defined above|0|||
145983637|NCT00309244|526452978|FG000|Overall Study|Adverse Event|29|||
145983638|NCT00309244|526452979|FG001|Overall Study|Adverse Event|12|||
145983639|NCT00309244|526452978|FG000|Overall Study|Lost to Follow-up|6|||
145983640|NCT00309244|526452979|FG001|Overall Study|Lost to Follow-up|22|||
145983641|NCT00309244|526452978|FG000|Overall Study|Physician Decision|5|||
145983642|NCT00309244|526452979|FG001|Overall Study|Physician Decision|8|||
145983643|NCT00309244|526452978|FG000|Overall Study|Protocol Violation|6|||
145983644|NCT00309244|526452979|FG001|Overall Study|Protocol Violation|3|||
145983645|NCT00309244|526452978|FG000|Overall Study|Withdrawal by Subject|50|||
145983646|NCT00309244|526452979|FG001|Overall Study|Withdrawal by Subject|32|||
145983647|NCT00309244|526452978|FG000|Overall Study|Various|7|||
145983648|NCT00309244|526452979|FG001|Overall Study|Various|7|||
145983649|NCT00309244|526452978|FG000|Overall Study|Randomized but not dosed|11|||
145983650|NCT00309244|526452979|FG001|Overall Study|Randomized but not dosed|12|||
145983651|NCT00309244|526452978|FG000|Overall Study|Death|4|||
145983652|NCT00309244|526452979|FG001|Overall Study|Death|1|||
145983653|NCT04689009|526452980|FG000|Overall Study|Adverse Event|1|||
145983654|NCT04689009|526452981|FG001|Overall Study|Adverse Event|0|||
145983655|NCT04689009|526452980|FG000|Overall Study|Lost to Follow-up|1|||
145983656|NCT04689009|526452981|FG001|Overall Study|Lost to Follow-up|2|||
145983657|NCT04689009|526452980|FG000|Overall Study|Withdrawal by Subject|4|||
145983658|NCT04689009|526452981|FG001|Overall Study|Withdrawal by Subject|3|||
145983659|NCT04689009|526452980|FG000|Overall Study|Protocol Violation|1|||
145983660|NCT04689009|526452981|FG001|Overall Study|Protocol Violation|0|||
145983661|NCT03336866|526452982|FG000|Overall Study|Lost to Follow-up|2|||
145983662|NCT03336866|526452983|FG001|Overall Study|Lost to Follow-up|0|||
145983663|NCT03336866|526452984|FG002|Overall Study|Lost to Follow-up|3|||
145983664|NCT03336866|526452982|FG000|Overall Study|Withdrawal by Subject|1|||
145983665|NCT03336866|526452983|FG001|Overall Study|Withdrawal by Subject|1|||
146245646|NCT00687297|527414034|FG001|Induction|Ineligible|1|||
145983666|NCT03336866|526452984|FG002|Overall Study|Withdrawal by Subject|0|||
145983667|NCT03336866|526452982|FG000|Overall Study|Noncompliance with clinic house rules|0|||
145983668|NCT03336866|526452983|FG001|Overall Study|Noncompliance with clinic house rules|0|||
145983669|NCT03336866|526452984|FG002|Overall Study|Noncompliance with clinic house rules|1|||
146245647|NCT00687297|527414033|FG000|Induction|Patient Noncompliance|1|||
146245648|NCT00687297|527414034|FG001|Induction|Patient Noncompliance|0|||
145983670|NCT02569242|526452987|FG000|Overall Study|Death|1|||
145983671|NCT02569242|526452988|FG001|Overall Study|Death|0|||
145983672|NCT02569242|526452987|FG000|Overall Study|Withdrawal by Subject|0|||
145983673|NCT02569242|526452988|FG001|Overall Study|Withdrawal by Subject|1|||
145983674|NCT04796207|526452991|FG000|Overall Study|Lost to Follow-up|7|||
145983675|NCT04796207|526452992|FG001|Overall Study|Lost to Follow-up|2|||
145983676|NCT03003468|526452993|FG000|Overall Study|Withdrawal by Subject|0|||
145983677|NCT03003468|526452994|FG001|Overall Study|Withdrawal by Subject|0|||
145983678|NCT03003468|526452995|FG002|Overall Study|Withdrawal by Subject|1|||
145983679|NCT03003468|526452993|FG000|Overall Study|No measurable lesions|0|||
145983680|NCT03003468|526452994|FG001|Overall Study|No measurable lesions|0|||
145983681|NCT03003468|526452995|FG002|Overall Study|No measurable lesions|1|||
145983682|NCT02405962|526452996|FG000|Overall Study|Lost to Follow-up|1|||
145983683|NCT02405962|526452997|FG001|Overall Study|Lost to Follow-up|4|||
145983684|NCT02405962|526452996|FG000|Overall Study|A participant has moved to another place|0|||
145983685|NCT02405962|526452997|FG001|Overall Study|A participant has moved to another place|1|||
145983686|NCT00165698|526452998|FG000|Overall Study|Adverse Event|2|||
145983687|NCT00165698|526452999|FG001|Overall Study|Adverse Event|10|||
145983688|NCT00165698|526452998|FG000|Overall Study|Lost to Follow-up|2|||
145983689|NCT00165698|526452999|FG001|Overall Study|Lost to Follow-up|2|||
145983690|NCT00165698|526452998|FG000|Overall Study|Withdrawal by Subject|2|||
145983691|NCT00165698|526452999|FG001|Overall Study|Withdrawal by Subject|1|||
145983692|NCT00165698|526452998|FG000|Overall Study|Protocol Violation|1|||
145983693|NCT00165698|526452999|FG001|Overall Study|Protocol Violation|0|||
145983694|NCT00165698|526452998|FG000|Overall Study|Not Taken/Lost the medicine|1|||
145983695|NCT00165698|526452999|FG001|Overall Study|Not Taken/Lost the medicine|2|||
145983696|NCT01107457|526453000|FG000|Part A|Adverse Event|1|||
145983697|NCT01107457|526453001|FG001|Part A|Adverse Event|2|||
145983698|NCT01107457|526453002|FG002|Part A|Adverse Event|1|||
145983699|NCT01107457|526453003|FG003|Part A|Adverse Event|0|||
145983700|NCT01107457|526453004|FG004|Part A|Adverse Event|0|||
145983701|NCT01107457|526453005|FG005|Part A|Adverse Event|0|||
145983702|NCT01107457|526453000|FG000|Part A|Withdrawal by Subject|3|||
145983703|NCT01107457|526453001|FG001|Part A|Withdrawal by Subject|3|||
145983704|NCT01107457|526453002|FG002|Part A|Withdrawal by Subject|0|||
145983705|NCT01107457|526453003|FG003|Part A|Withdrawal by Subject|3|||
145983706|NCT01107457|526453004|FG004|Part A|Withdrawal by Subject|1|||
145983707|NCT01107457|526453005|FG005|Part A|Withdrawal by Subject|0|||
145983708|NCT01107457|526453000|FG000|Part A|Lost to Follow-up|0|||
145983709|NCT01107457|526453001|FG001|Part A|Lost to Follow-up|1|||
145983710|NCT01107457|526453002|FG002|Part A|Lost to Follow-up|0|||
145983711|NCT01107457|526453003|FG003|Part A|Lost to Follow-up|0|||
145983712|NCT01107457|526453004|FG004|Part A|Lost to Follow-up|0|||
145983713|NCT01107457|526453005|FG005|Part A|Lost to Follow-up|0|||
145983714|NCT01107457|526453000|FG000|Part A|Lack of Efficacy|1|||
145983715|NCT01107457|526453001|FG001|Part A|Lack of Efficacy|0|||
145983716|NCT01107457|526453002|FG002|Part A|Lack of Efficacy|0|||
145983717|NCT01107457|526453003|FG003|Part A|Lack of Efficacy|0|||
145983718|NCT01107457|526453004|FG004|Part A|Lack of Efficacy|0|||
145983719|NCT01107457|526453005|FG005|Part A|Lack of Efficacy|0|||
145983720|NCT01107457|526453000|FG000|Part A|Protocol Violation|0|||
146245649|NCT00687297|527414033|FG000|Induction|Physician Decision|0|||
146245650|NCT00687297|527414034|FG001|Induction|Physician Decision|2|||
146245651|NCT00687297|527414033|FG000|Induction|Other|0|||
146245652|NCT00687297|527414034|FG001|Induction|Other|1|||
146245653|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
145983721|NCT01107457|526453001|FG001|Part A|Protocol Violation|1|||
145983722|NCT01107457|526453002|FG002|Part A|Protocol Violation|0|||
145983723|NCT01107457|526453003|FG003|Part A|Protocol Violation|0|||
145983724|NCT01107457|526453004|FG004|Part A|Protocol Violation|0|||
145983725|NCT01107457|526453005|FG005|Part A|Protocol Violation|0|||
146245654|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
145983726|NCT01107457|526453000|FG000|Part B and C|Adverse Event|0|||
145983727|NCT01107457|526453001|FG001|Part B and C|Adverse Event|0|||
145983728|NCT01107457|526453002|FG002|Part B and C|Adverse Event|0|||
145983729|NCT01107457|526453003|FG003|Part B and C|Adverse Event|0|||
145983730|NCT01107457|526453004|FG004|Part B and C|Adverse Event|0|||
146245655|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
145983731|NCT01107457|526453005|FG005|Part B and C|Adverse Event|12|||
145983732|NCT01107457|526453000|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145983733|NCT01107457|526453001|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145983734|NCT01107457|526453002|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145983735|NCT01107457|526453003|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
146245656|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
146245657|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Death|0|||
145983736|NCT01107457|526453004|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145983737|NCT01107457|526453005|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
145983738|NCT01107457|526453000|FG000|Part B and C|Physician Decision|0|||
145983739|NCT01107457|526453001|FG001|Part B and C|Physician Decision|0|||
145983740|NCT01107457|526453002|FG002|Part B and C|Physician Decision|0|||
145983741|NCT01107457|526453003|FG003|Part B and C|Physician Decision|0|||
145983742|NCT01107457|526453004|FG004|Part B and C|Physician Decision|0|||
145983743|NCT01107457|526453005|FG005|Part B and C|Physician Decision|3|||
145983744|NCT01107457|526453000|FG000|Part B and C|Lack of Efficacy|0|||
145983745|NCT01107457|526453001|FG001|Part B and C|Lack of Efficacy|0|||
145983746|NCT01107457|526453002|FG002|Part B and C|Lack of Efficacy|0|||
145983747|NCT01107457|526453003|FG003|Part B and C|Lack of Efficacy|0|||
145983748|NCT01107457|526453004|FG004|Part B and C|Lack of Efficacy|0|||
145983749|NCT01107457|526453005|FG005|Part B and C|Lack of Efficacy|7|||
145983750|NCT01107457|526453000|FG000|Part B and C|Lost to Follow-up|0|||
145983751|NCT01107457|526453001|FG001|Part B and C|Lost to Follow-up|0|||
145983752|NCT01107457|526453002|FG002|Part B and C|Lost to Follow-up|0|||
145983753|NCT01107457|526453003|FG003|Part B and C|Lost to Follow-up|0|||
145983754|NCT01107457|526453004|FG004|Part B and C|Lost to Follow-up|0|||
145983755|NCT01107457|526453005|FG005|Part B and C|Lost to Follow-up|10|||
145983756|NCT01107457|526453000|FG000|Part B and C|Protocol Violation|0|||
145983757|NCT01107457|526453001|FG001|Part B and C|Protocol Violation|0|||
145983758|NCT01107457|526453002|FG002|Part B and C|Protocol Violation|0|||
145983759|NCT01107457|526453003|FG003|Part B and C|Protocol Violation|0|||
145983760|NCT01107457|526453004|FG004|Part B and C|Protocol Violation|0|||
145983761|NCT01107457|526453005|FG005|Part B and C|Protocol Violation|1|||
145983762|NCT01107457|526453000|FG000|Part B and C|Sponsor Decision|0|||
145983763|NCT01107457|526453001|FG001|Part B and C|Sponsor Decision|0|||
145983764|NCT01107457|526453002|FG002|Part B and C|Sponsor Decision|0|||
145983765|NCT01107457|526453003|FG003|Part B and C|Sponsor Decision|0|||
146245658|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Death|0|||
146245659|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Death|1|||
146245660|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Death|0|||
145983766|NCT01107457|526453004|FG004|Part B and C|Sponsor Decision|0|||
145983767|NCT01107457|526453005|FG005|Part B and C|Sponsor Decision|66|||
145983768|NCT01107457|526453000|FG000|Part B and C|Withdrawal by Subject|0|||
145983769|NCT01107457|526453001|FG001|Part B and C|Withdrawal by Subject|0|||
145983770|NCT01107457|526453002|FG002|Part B and C|Withdrawal by Subject|0|||
145983771|NCT01107457|526453003|FG003|Part B and C|Withdrawal by Subject|0|||
145983772|NCT01107457|526453004|FG004|Part B and C|Withdrawal by Subject|0|||
145983773|NCT01107457|526453005|FG005|Part B and C|Withdrawal by Subject|16|||
145983774|NCT01107457|526453000|FG000|Part B and C|Clinical Relapse|0|||
145983775|NCT01107457|526453001|FG001|Part B and C|Clinical Relapse|0|||
145983776|NCT01107457|526453002|FG002|Part B and C|Clinical Relapse|0|||
145983777|NCT01107457|526453003|FG003|Part B and C|Clinical Relapse|0|||
145983778|NCT01107457|526453004|FG004|Part B and C|Clinical Relapse|0|||
145983779|NCT01107457|526453005|FG005|Part B and C|Clinical Relapse|4|||
145983780|NCT02186171|526453006|FG000|Overall Study|Withdrawal by Subject|1|||
146245661|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
146245662|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
145983781|NCT02186171|526453007|FG001|Overall Study|Withdrawal by Subject|9|||
145983782|NCT02186171|526453006|FG000|Overall Study|Lost to Follow-up|2|||
145983783|NCT02186171|526453007|FG001|Overall Study|Lost to Follow-up|2|||
146245663|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
146245664|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
146245665|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146245666|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146245667|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146245668|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146245669|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
146245670|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
146245671|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
145983784|NCT02186171|526453006|FG000|Overall Study|Death|1|||
145983785|NCT02186171|526453007|FG001|Overall Study|Death|2|||
145983786|NCT02186171|526453006|FG000|Overall Study|Protocol-specified Criteria|0|||
145983787|NCT02186171|526453007|FG001|Overall Study|Protocol-specified Criteria|2|||
145983788|NCT01030900|526453009|FG000|Overall Study|Not treated due to congestive heart failure|1|||
145983789|NCT01030900|526453009|FG000|Overall Study|Not treated due to rapid disease|1|||
146245672|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
146245673|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
146245674|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
145983790|NCT01179399|526453010|FG000|Overall Study|Adverse Event|1|||
145983791|NCT01179399|526453010|FG000|Overall Study|Lack of Efficacy|30|||
145983792|NCT01179399|526453010|FG000|Overall Study|Withdrawal by Subject|1|||
145983793|NCT00441896|526453011|FG000|Overall Study|Withdrawal by Subject|0|||
145983794|NCT00441896|526453012|FG001|Overall Study|Withdrawal by Subject|0|||
145983795|NCT00441896|526453013|FG002|Overall Study|Withdrawal by Subject|0|||
145983796|NCT00441896|526453014|FG003|Overall Study|Withdrawal by Subject|1|||
145983797|NCT00441896|526453015|FG004|Overall Study|Withdrawal by Subject|0|||
145983798|NCT00441896|526453016|FG005|Overall Study|Withdrawal by Subject|0|||
145983799|NCT00441896|526453017|FG006|Overall Study|Withdrawal by Subject|0|||
145983800|NCT00441896|526453018|FG007|Overall Study|Withdrawal by Subject|0|||
145983801|NCT00441896|526453019|FG008|Overall Study|Withdrawal by Subject|0|||
145983802|NCT00441896|526453020|FG009|Overall Study|Withdrawal by Subject|0|||
145983803|NCT00441896|526453011|FG000|Overall Study|Other|0|||
145983804|NCT00441896|526453012|FG001|Overall Study|Other|0|||
145983805|NCT00441896|526453013|FG002|Overall Study|Other|0|||
145983806|NCT00441896|526453014|FG003|Overall Study|Other|0|||
145983807|NCT00441896|526453015|FG004|Overall Study|Other|1|||
145983808|NCT00441896|526453016|FG005|Overall Study|Other|0|||
145983809|NCT00441896|526453017|FG006|Overall Study|Other|0|||
145983810|NCT00441896|526453018|FG007|Overall Study|Other|0|||
145983811|NCT00441896|526453019|FG008|Overall Study|Other|0|||
145983812|NCT00441896|526453020|FG009|Overall Study|Other|0|||
145983813|NCT03055221|526455594|FG000|Overall Study|Adverse Event|2|||
145983814|NCT03055221|526455594|FG000|Overall Study|Withdrawal by Subject|4|||
145983815|NCT03055221|526455594|FG000|Overall Study|Death|6|||
145983816|NCT03055221|526455594|FG000|Overall Study|Physician Decision|1|||
145983817|NCT03055221|526455594|FG000|Overall Study|Study terminated by Sponsor|3|||
145983818|NCT03055221|526455594|FG000|Overall Study|Lost to Follow-up|4|||
145983819|NCT02301429|526455601|FG000|Overall Study|not acceptable vascular anatomy|3|||
145983820|NCT01502072|526455602|FG000|Overall Study|Withdrawal by Subject|1|||
145983821|NCT01502072|526455603|FG001|Overall Study|Withdrawal by Subject|0|||
145983822|NCT01502072|526455604|FG002|Overall Study|Withdrawal by Subject|0|||
145983823|NCT01502072|526455602|FG000|Overall Study|Death|0|||
145983824|NCT01502072|526455603|FG001|Overall Study|Death|1|||
145983825|NCT01502072|526455604|FG002|Overall Study|Death|0|||
145983826|NCT02018887|526455607|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
145983827|NCT02018887|526455608|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983828|NCT02018887|526455609|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983829|NCT02018887|526455610|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983830|NCT02018887|526455611|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983831|NCT02018887|526455612|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983832|NCT02018887|526455613|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983833|NCT02018887|526455614|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983834|NCT02018887|526455615|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983835|NCT02018887|526455616|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983836|NCT02018887|526455617|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145983837|NCT02018887|526455607|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983838|NCT02018887|526455608|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983839|NCT02018887|526455609|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983840|NCT02018887|526455610|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983841|NCT02018887|526455611|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
145983842|NCT02018887|526455612|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983843|NCT02018887|526455613|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
145983844|NCT02018887|526455614|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
145983845|NCT02018887|526455615|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983846|NCT02018887|526455616|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983847|NCT02018887|526455617|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145983848|NCT02018887|526455607|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
145983849|NCT02018887|526455608|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
145983850|NCT02018887|526455609|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
146245675|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
146245676|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
146245677|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
146245678|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146245679|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146245680|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
146245681|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Other|2|||
146297848|NCT02038920|527606027|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145983851|NCT02018887|526455610|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
145983852|NCT02018887|526455611|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
145983853|NCT02018887|526455612|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
146245682|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Other|0|||
145983854|NCT02018887|526455613|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
145983855|NCT02018887|526455614|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
145983856|NCT02018887|526455615|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
145983857|NCT02018887|526455616|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
145983858|NCT02018887|526455617|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
145983859|NCT02018887|526455607|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
145983860|NCT02018887|526455608|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
145983861|NCT02018887|526455609|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
145983862|NCT02018887|526455610|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
145983863|NCT02018887|526455611|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
145983864|NCT02018887|526455612|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
145983865|NCT02018887|526455613|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
145983866|NCT02018887|526455614|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
145983867|NCT02018887|526455615|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
145983868|NCT02018887|526455616|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
145983869|NCT02018887|526455617|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
145983870|NCT01058005|526455618|FG000|Overall Study|Adverse Event|0|||
145983871|NCT01058005|526455619|FG001|Overall Study|Adverse Event|2|||
145983872|NCT01058005|526455620|FG002|Overall Study|Adverse Event|1|||
145983873|NCT01058005|526455618|FG000|Overall Study|Physician Decision|2|||
145983874|NCT01058005|526455619|FG001|Overall Study|Physician Decision|2|||
145983875|NCT01058005|526455620|FG002|Overall Study|Physician Decision|0|||
145983876|NCT01058005|526455618|FG000|Overall Study|Withdrawal by Subject|4|||
145983877|NCT01058005|526455619|FG001|Overall Study|Withdrawal by Subject|5|||
145983878|NCT01058005|526455620|FG002|Overall Study|Withdrawal by Subject|11|||
145983879|NCT01058005|526455618|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
145983880|NCT01058005|526455619|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
145983881|NCT01058005|526455620|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
145983882|NCT01058005|526455618|FG000|Overall Study|Reason Missing|5|||
145983883|NCT01058005|526455619|FG001|Overall Study|Reason Missing|3|||
145983884|NCT01058005|526455620|FG002|Overall Study|Reason Missing|1|||
145983885|NCT01145222|526455621|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
145983886|NCT01145222|526455622|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
145983887|NCT01145222|526455623|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
145983888|NCT01145222|526455624|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
145983889|NCT01145222|526455621|FG000|Overall Study|Poor bowel preparation|0|||
145983890|NCT01145222|526455622|FG001|Overall Study|Poor bowel preparation|0|||
145983891|NCT01145222|526455623|FG002|Overall Study|Poor bowel preparation|0|||
145983892|NCT01145222|526455624|FG003|Overall Study|Poor bowel preparation|1|||
145983893|NCT01698008|526455625|FG000|Overall Study|Withdrawal by Subject|1|||
145983894|NCT01698008|526455626|FG001|Overall Study|Withdrawal by Subject|2|||
145983895|NCT01011283|526455630|FG000|Overall Study|Adverse Event|4|||
145983896|NCT01011283|526455631|FG001|Overall Study|Adverse Event|2|||
145983897|NCT01011283|526455630|FG000|Overall Study|Progressive Disease|0|||
145983898|NCT01011283|526455631|FG001|Overall Study|Progressive Disease|2|||
145983899|NCT01011283|526455630|FG000|Overall Study|Terminated by Sponsor|5|||
145983900|NCT01011283|526455631|FG001|Overall Study|Terminated by Sponsor|5|||
145983901|NCT01011283|526455630|FG000|Overall Study|Other|2|||
145983902|NCT01011283|526455631|FG001|Overall Study|Other|2|||
145983903|NCT01096186|526455632|FG000|Overall Study|Adverse Event|16|||
145983904|NCT01096186|526455632|FG000|Overall Study|Death|4|||
145983905|NCT01096186|526455632|FG000|Overall Study|Lack of Efficacy|4|||
145983906|NCT01096186|526455632|FG000|Overall Study|Lost to Follow-up|2|||
145983907|NCT01096186|526455632|FG000|Overall Study|Withdrawal by Subject|22|||
145983908|NCT01096186|526455632|FG000|Overall Study|Physician Decision|1|||
145983909|NCT01096186|526455632|FG000|Overall Study|Noncompliance with study drug|1|||
145983910|NCT00122187|526455637|FG000|Overall Study|Withdrew because of resource limitations|2|||
145983911|NCT00122187|526455638|FG001|Overall Study|Withdrew because of resource limitations|2|||
145983912|NCT00799864|526455642|FG000|Overall Study|Participant reached a virologic endpoint|9|||
145983913|NCT00799864|526455643|FG001|Overall Study|Participant reached a virologic endpoint|2|||
145983914|NCT00799864|526455644|FG002|Overall Study|Participant reached a virologic endpoint|2|||
145983915|NCT00799864|526455645|FG003|Overall Study|Participant reached a virologic endpoint|0|||
145983916|NCT00799864|526455646|FG004|Overall Study|Participant reached a virologic endpoint|0|||
145983917|NCT00799864|526455642|FG000|Overall Study|Other|2|||
145983918|NCT00799864|526455643|FG001|Overall Study|Other|1|||
145983919|NCT00799864|526455644|FG002|Overall Study|Other|0|||
145983920|NCT00799864|526455645|FG003|Overall Study|Other|0|||
145983921|NCT00799864|526455646|FG004|Overall Study|Other|0|||
145983922|NCT04263532|526455647|FG000|Overall Study|Withdrawal by Subject|2|||
145983923|NCT04263532|526455648|FG001|Overall Study|Withdrawal by Subject|0|||
145983924|NCT01210443|526455657|FG000|Overall Study|Study terminated by sponsor|2|||
145983925|NCT02807181|526455660|FG000|Overall Study|Death|28|||
145983926|NCT02807181|526455661|FG001|Overall Study|Death|24|||
145983927|NCT02807181|526455660|FG000|Overall Study|Withdrawal by Subject|1|||
145983928|NCT02807181|526455661|FG001|Overall Study|Withdrawal by Subject|1|||
145983929|NCT02807181|526455660|FG000|Overall Study|Lost to Follow-up|0|||
145983930|NCT02807181|526455661|FG001|Overall Study|Lost to Follow-up|2|||
145983931|NCT02807181|526455660|FG000|Overall Study|Subject decision|1|||
145983932|NCT02807181|526455661|FG001|Overall Study|Subject decision|0|||
145983933|NCT02807181|526455660|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
145983934|NCT02807181|526455661|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
145983935|NCT02807181|526455660|FG000|Overall Study|In Study|3|||
145983936|NCT02807181|526455661|FG001|Overall Study|In Study|3|||
145983937|NCT02807181|526455660|FG000|Overall Study|Post Progression|3|||
145983938|NCT02807181|526455661|FG001|Overall Study|Post Progression|2|||
145983939|NCT00063999|526455662|FG000|Overall Study|Withdrawal by Subject|1|||
145983940|NCT00063999|526455663|FG001|Overall Study|Withdrawal by Subject|0|||
145983941|NCT00063999|526455662|FG000|Overall Study|Ineligible|44|||
145983942|NCT00063999|526455663|FG001|Overall Study|Ineligible|24|||
145983943|NCT02280499|526455665|FG000|Overall Study|Death|14|||
145983944|NCT02280499|526455665|FG000|Overall Study|Lost to Follow-up|42|||
145983945|NCT02280499|526455665|FG000|Overall Study|Adverse Event|5|||
145983946|NCT04193527|526455675|FG000|Overall Study|Other|1|||
145983947|NCT04193527|526455676|FG001|Overall Study|Other|1|||
145983948|NCT04193527|526455677|FG002|Overall Study|Other|0|||
145983949|NCT03808909|526455678|FG000|Overall Study|Lost to Follow-up|3|||
145983950|NCT03808909|526455679|FG001|Overall Study|Lost to Follow-up|0|||
145983951|NCT00676689|526455680|FG000|Overall Study|Screen Failure|2|||
145983952|NCT00676689|526455680|FG000|Overall Study|Death|2|||
145983953|NCT00676689|526455680|FG000|Overall Study|Lost to Follow-up|4|||
145983954|NCT00676689|526455680|FG000|Overall Study|Physician Decision|1|||
145983955|NCT00676689|526455680|FG000|Overall Study|Withdrawal by Subject|3|||
145983956|NCT00676689|526455680|FG000|Overall Study|Continuing FU|49|||
145983957|NCT01827943|526455681|FG000|Overall Study|Protocol Violation|8|||
145983958|NCT01827943|526455681|FG000|Overall Study|Never treated because of an rapid progression|1|||
145983959|NCT00501085|526455683|FG000|Overall Study|Lost to Follow-up|195|||
145983960|NCT00501085|526455683|FG000|Overall Study|Withdrawal by Subject|34|||
145983961|NCT00501085|526455683|FG000|Overall Study|Subject Decision|1|||
145983962|NCT00501085|526455683|FG000|Overall Study|Revision Surgery|7|||
145983963|NCT00501085|526455683|FG000|Overall Study|Explantation Surgery|26|||
145983964|NCT00501085|526455683|FG000|Overall Study|Adverse Event|4|||
145983965|NCT00501085|526455683|FG000|Overall Study|Non-Compliance|24|||
145983966|NCT00501085|526455683|FG000|Overall Study|Study closed by sponsor|109|||
145983967|NCT00501085|526455683|FG000|Overall Study|Other loss to follow-up|32|||
145983968|NCT01487161|526455684|FG000|Overall Study|Adverse Event|1|||
145983969|NCT01487161|526455685|FG001|Overall Study|Adverse Event|0|||
145983970|NCT01487161|526455686|FG002|Overall Study|Adverse Event|0|||
145983971|NCT01487161|526455687|FG003|Overall Study|Adverse Event|0|||
145983972|NCT01487161|526455684|FG000|Overall Study|Withdrawal by Subject|1|||
145983973|NCT01487161|526455685|FG001|Overall Study|Withdrawal by Subject|1|||
145983974|NCT01487161|526455686|FG002|Overall Study|Withdrawal by Subject|1|||
145983975|NCT01487161|526455687|FG003|Overall Study|Withdrawal by Subject|2|||
145983976|NCT01487161|526455684|FG000|Overall Study|missing data|0|||
145983977|NCT01487161|526455685|FG001|Overall Study|missing data|1|||
145983978|NCT01487161|526455686|FG002|Overall Study|missing data|0|||
145983979|NCT01487161|526455687|FG003|Overall Study|missing data|0|||
145983980|NCT00663351|526455688|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
145983981|NCT00663351|526455689|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
145983982|NCT00663351|526455688|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
145983983|NCT00663351|526455689|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
145983984|NCT00663351|526455688|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
145983985|NCT00663351|526455689|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
145983986|NCT00663351|526455688|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
145983987|NCT00663351|526455689|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
145983988|NCT00663351|526455688|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
145983989|NCT00663351|526455689|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
145983990|NCT00663351|526455688|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
145983991|NCT00663351|526455689|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
145983992|NCT02945046|526455690|FG000|Overall Study|Adverse Event|1|||
145983993|NCT02945046|526455691|FG001|Overall Study|Adverse Event|0|||
145983994|NCT02945046|526455692|FG002|Overall Study|Adverse Event|2|||
145983995|NCT02945046|526455690|FG000|Overall Study|Withdrawal by Subject|3|||
145983996|NCT02945046|526455691|FG001|Overall Study|Withdrawal by Subject|3|||
145983997|NCT02945046|526455692|FG002|Overall Study|Withdrawal by Subject|3|||
145983998|NCT02945046|526455690|FG000|Overall Study|Protocol Violation|2|||
145983999|NCT02945046|526455691|FG001|Overall Study|Protocol Violation|3|||
145984000|NCT02945046|526455692|FG002|Overall Study|Protocol Violation|2|||
145984001|NCT02945046|526455690|FG000|Overall Study|Lost to Follow-up|1|||
145984002|NCT02945046|526455691|FG001|Overall Study|Lost to Follow-up|1|||
145984003|NCT02945046|526455692|FG002|Overall Study|Lost to Follow-up|0|||
145984004|NCT02945046|526455690|FG000|Overall Study|Lack of Efficacy|1|||
145984005|NCT02945046|526455691|FG001|Overall Study|Lack of Efficacy|2|||
145984006|NCT02945046|526455692|FG002|Overall Study|Lack of Efficacy|1|||
145984007|NCT02945046|526455690|FG000|Overall Study|Other than specified|5|||
145984008|NCT02945046|526455691|FG001|Overall Study|Other than specified|4|||
145984009|NCT02945046|526455692|FG002|Overall Study|Other than specified|7|||
145984010|NCT00567112|526455693|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
145984011|NCT00567112|526455694|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
145984012|NCT00567112|526455695|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
145984013|NCT00567112|526455693|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
146245683|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Other|0|||
146245684|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Other|0|||
146245685|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
146245686|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
146245687|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
146245688|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
146245689|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
145984014|NCT00567112|526455694|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
145984015|NCT00567112|526455695|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
145984016|NCT00567112|526455693|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
145984017|NCT00567112|526455694|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
145984018|NCT00567112|526455695|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
145984019|NCT03113136|526455696|FG000|Overall Study|Lost to Follow-up|22|||
145984020|NCT03113136|526455697|FG001|Overall Study|Lost to Follow-up|47|||
145984021|NCT03113136|526455698|FG002|Overall Study|Lost to Follow-up|54|||
145984022|NCT03113136|526455696|FG000|Overall Study|Withdrawal by Subject|4|||
145984023|NCT03113136|526455697|FG001|Overall Study|Withdrawal by Subject|13|||
145984024|NCT03113136|526455698|FG002|Overall Study|Withdrawal by Subject|14|||
145984025|NCT03113136|526455696|FG000|Overall Study|Ineligible|0|||
145984026|NCT03113136|526455697|FG001|Overall Study|Ineligible|2|||
145984027|NCT03113136|526455698|FG002|Overall Study|Ineligible|1|||
145984028|NCT03113136|526455696|FG000|Overall Study|Study Team Decision|1|||
145984029|NCT03113136|526455697|FG001|Overall Study|Study Team Decision|4|||
145984030|NCT03113136|526455698|FG002|Overall Study|Study Team Decision|0|||
145984031|NCT02362412|526455703|FG000|Treatment Period III|Lost to Follow-up|0|||
145984032|NCT02362412|526455704|FG001|Treatment Period III|Lost to Follow-up|1|||
145984033|NCT02675452|526455706|FG000|Overall Study|Sponsor decision|0|||
145984034|NCT02675452|526455707|FG001|Overall Study|Sponsor decision|0|||
145984035|NCT02675452|526455708|FG002|Overall Study|Sponsor decision|0|||
145984036|NCT02675452|526455709|FG003|Overall Study|Sponsor decision|0|||
145984037|NCT02675452|526455710|FG004|Overall Study|Sponsor decision|0|||
145984038|NCT02675452|526455711|FG005|Overall Study|Sponsor decision|0|||
145984039|NCT02675452|526455712|FG006|Overall Study|Sponsor decision|0|||
145984040|NCT02675452|526455713|FG007|Overall Study|Sponsor decision|0|||
145984041|NCT02675452|526455714|FG008|Overall Study|Sponsor decision|0|||
145984042|NCT02675452|526455715|FG009|Overall Study|Sponsor decision|1|||
145984043|NCT02675452|526455716|FG010|Overall Study|Sponsor decision|0|||
145984044|NCT02675452|526455717|FG011|Overall Study|Sponsor decision|0|||
145984045|NCT02675452|526455718|FG012|Overall Study|Sponsor decision|0|||
145984046|NCT02675452|526455719|FG013|Overall Study|Sponsor decision|2|||
145984047|NCT02675452|526455720|FG014|Overall Study|Sponsor decision|1|||
145984048|NCT02675452|526455721|FG015|Overall Study|Sponsor decision|0|||
145984049|NCT02675452|526455722|FG016|Overall Study|Sponsor decision|1|||
145984050|NCT02675452|526455723|FG017|Overall Study|Sponsor decision|0|||
145984051|NCT02675452|526455724|FG018|Overall Study|Sponsor decision|0|||
145984052|NCT02675452|526455725|FG019|Overall Study|Sponsor decision|0|||
145984053|NCT02675452|526455726|FG020|Overall Study|Sponsor decision|0|||
145984054|NCT02675452|526455727|FG021|Overall Study|Sponsor decision|0|||
145984055|NCT02675452|526455728|FG022|Overall Study|Sponsor decision|0|||
145984056|NCT02675452|526455729|FG023|Overall Study|Sponsor decision|0|||
145984057|NCT02675452|526455730|FG024|Overall Study|Sponsor decision|0|||
145984058|NCT02675452|526455731|FG025|Overall Study|Sponsor decision|0|||
145984059|NCT02675452|526455732|FG026|Overall Study|Sponsor decision|2|||
145984060|NCT02675452|526455733|FG027|Overall Study|Sponsor decision|0|||
145984061|NCT02675452|526455734|FG028|Overall Study|Sponsor decision|0|||
145984062|NCT02675452|526455706|FG000|Overall Study|Withdrawal by Subject|0|||
145984063|NCT02675452|526455707|FG001|Overall Study|Withdrawal by Subject|0|||
145984064|NCT02675452|526455708|FG002|Overall Study|Withdrawal by Subject|0|||
145984065|NCT02675452|526455709|FG003|Overall Study|Withdrawal by Subject|0|||
145984066|NCT02675452|526455710|FG004|Overall Study|Withdrawal by Subject|0|||
145984067|NCT02675452|526455711|FG005|Overall Study|Withdrawal by Subject|0|||
145984068|NCT02675452|526455712|FG006|Overall Study|Withdrawal by Subject|0|||
145984069|NCT02675452|526455713|FG007|Overall Study|Withdrawal by Subject|0|||
145984070|NCT02675452|526455714|FG008|Overall Study|Withdrawal by Subject|0|||
145984071|NCT02675452|526455715|FG009|Overall Study|Withdrawal by Subject|1|||
145984072|NCT02675452|526455716|FG010|Overall Study|Withdrawal by Subject|0|||
145984073|NCT02675452|526455717|FG011|Overall Study|Withdrawal by Subject|1|||
145984074|NCT02675452|526455718|FG012|Overall Study|Withdrawal by Subject|0|||
145984075|NCT02675452|526455719|FG013|Overall Study|Withdrawal by Subject|1|||
145984076|NCT02675452|526455720|FG014|Overall Study|Withdrawal by Subject|1|||
145984077|NCT02675452|526455721|FG015|Overall Study|Withdrawal by Subject|0|||
145984078|NCT02675452|526455722|FG016|Overall Study|Withdrawal by Subject|2|||
146245690|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
146245691|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
146245692|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
145984079|NCT02675452|526455723|FG017|Overall Study|Withdrawal by Subject|0|||
145984080|NCT02675452|526455724|FG018|Overall Study|Withdrawal by Subject|0|||
145984081|NCT02675452|526455725|FG019|Overall Study|Withdrawal by Subject|0|||
146245693|NCT03845517|527414035|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
146245694|NCT03845517|527414036|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
146245695|NCT03845517|527414037|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
146245696|NCT03845517|527414038|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146245697|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
146245698|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
146245699|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
146245700|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
146245701|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Death|0|||
146245702|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Death|0|||
146245703|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Death|1|||
146245704|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Death|1|||
145984082|NCT02675452|526455726|FG020|Overall Study|Withdrawal by Subject|0|||
145984083|NCT02675452|526455727|FG021|Overall Study|Withdrawal by Subject|0|||
145984084|NCT02675452|526455728|FG022|Overall Study|Withdrawal by Subject|3|||
145984085|NCT02675452|526455729|FG023|Overall Study|Withdrawal by Subject|0|||
145984086|NCT02675452|526455730|FG024|Overall Study|Withdrawal by Subject|1|||
145984087|NCT02675452|526455731|FG025|Overall Study|Withdrawal by Subject|0|||
145984088|NCT02675452|526455732|FG026|Overall Study|Withdrawal by Subject|1|||
145984089|NCT02675452|526455733|FG027|Overall Study|Withdrawal by Subject|3|||
145984090|NCT02675452|526455734|FG028|Overall Study|Withdrawal by Subject|4|||
145984091|NCT02675452|526455706|FG000|Overall Study|Death|0|||
145984092|NCT02675452|526455707|FG001|Overall Study|Death|0|||
145984093|NCT02675452|526455708|FG002|Overall Study|Death|1|||
145984094|NCT02675452|526455709|FG003|Overall Study|Death|0|||
145984095|NCT02675452|526455710|FG004|Overall Study|Death|0|||
145984096|NCT02675452|526455711|FG005|Overall Study|Death|1|||
145984097|NCT02675452|526455712|FG006|Overall Study|Death|0|||
145984098|NCT02675452|526455713|FG007|Overall Study|Death|0|||
145984099|NCT02675452|526455714|FG008|Overall Study|Death|1|||
145984100|NCT02675452|526455715|FG009|Overall Study|Death|0|||
145984101|NCT02675452|526455716|FG010|Overall Study|Death|0|||
145984102|NCT02675452|526455717|FG011|Overall Study|Death|0|||
145984103|NCT02675452|526455718|FG012|Overall Study|Death|1|||
145984104|NCT02675452|526455719|FG013|Overall Study|Death|0|||
145984105|NCT02675452|526455720|FG014|Overall Study|Death|0|||
145984106|NCT02675452|526455721|FG015|Overall Study|Death|2|||
145984107|NCT02675452|526455722|FG016|Overall Study|Death|0|||
145984108|NCT02675452|526455723|FG017|Overall Study|Death|0|||
145984109|NCT02675452|526455724|FG018|Overall Study|Death|4|||
145984110|NCT02675452|526455725|FG019|Overall Study|Death|3|||
145984111|NCT02675452|526455726|FG020|Overall Study|Death|3|||
145984112|NCT02675452|526455727|FG021|Overall Study|Death|3|||
145984113|NCT02675452|526455728|FG022|Overall Study|Death|7|||
145984114|NCT02675452|526455729|FG023|Overall Study|Death|5|||
145984115|NCT02675452|526455730|FG024|Overall Study|Death|3|||
145984116|NCT02675452|526455731|FG025|Overall Study|Death|4|||
145984117|NCT02675452|526455732|FG026|Overall Study|Death|7|||
146245705|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
145984118|NCT02675452|526455733|FG027|Overall Study|Death|6|||
145984119|NCT02675452|526455734|FG028|Overall Study|Death|9|||
145984120|NCT02675452|526455706|FG000|Overall Study|Lost to Follow-up|0|||
145984121|NCT02675452|526455707|FG001|Overall Study|Lost to Follow-up|1|||
145984122|NCT02675452|526455708|FG002|Overall Study|Lost to Follow-up|0|||
145984123|NCT02675452|526455709|FG003|Overall Study|Lost to Follow-up|0|||
145984124|NCT02675452|526455710|FG004|Overall Study|Lost to Follow-up|0|||
145984125|NCT02675452|526455711|FG005|Overall Study|Lost to Follow-up|0|||
145984126|NCT02675452|526455712|FG006|Overall Study|Lost to Follow-up|0|||
145984127|NCT02675452|526455713|FG007|Overall Study|Lost to Follow-up|0|||
145984128|NCT02675452|526455714|FG008|Overall Study|Lost to Follow-up|0|||
145984129|NCT02675452|526455715|FG009|Overall Study|Lost to Follow-up|0|||
145984130|NCT02675452|526455716|FG010|Overall Study|Lost to Follow-up|0|||
145984131|NCT02675452|526455717|FG011|Overall Study|Lost to Follow-up|0|||
145984132|NCT02675452|526455718|FG012|Overall Study|Lost to Follow-up|1|||
145984133|NCT02675452|526455719|FG013|Overall Study|Lost to Follow-up|0|||
145984134|NCT02675452|526455720|FG014|Overall Study|Lost to Follow-up|0|||
145984135|NCT02675452|526455721|FG015|Overall Study|Lost to Follow-up|0|||
145984136|NCT02675452|526455722|FG016|Overall Study|Lost to Follow-up|0|||
145984137|NCT02675452|526455723|FG017|Overall Study|Lost to Follow-up|0|||
145984138|NCT02675452|526455724|FG018|Overall Study|Lost to Follow-up|0|||
145984139|NCT02675452|526455725|FG019|Overall Study|Lost to Follow-up|0|||
145984140|NCT02675452|526455726|FG020|Overall Study|Lost to Follow-up|0|||
145984141|NCT02675452|526455727|FG021|Overall Study|Lost to Follow-up|0|||
145984142|NCT02675452|526455728|FG022|Overall Study|Lost to Follow-up|0|||
145984143|NCT02675452|526455729|FG023|Overall Study|Lost to Follow-up|0|||
145984144|NCT02675452|526455730|FG024|Overall Study|Lost to Follow-up|0|||
145984145|NCT02675452|526455731|FG025|Overall Study|Lost to Follow-up|0|||
145984146|NCT02675452|526455732|FG026|Overall Study|Lost to Follow-up|1|||
145984147|NCT02675452|526455733|FG027|Overall Study|Lost to Follow-up|0|||
145984148|NCT02675452|526455734|FG028|Overall Study|Lost to Follow-up|0|||
145984149|NCT02675452|526455706|FG000|Overall Study|Other|0|||
145984150|NCT02675452|526455707|FG001|Overall Study|Other|0|||
145984151|NCT02675452|526455708|FG002|Overall Study|Other|0|||
145984152|NCT02675452|526455709|FG003|Overall Study|Other|0|||
145984153|NCT02675452|526455710|FG004|Overall Study|Other|0|||
145984154|NCT02675452|526455711|FG005|Overall Study|Other|0|||
145984155|NCT02675452|526455712|FG006|Overall Study|Other|0|||
145984156|NCT02675452|526455713|FG007|Overall Study|Other|0|||
145984157|NCT02675452|526455714|FG008|Overall Study|Other|0|||
145984158|NCT02675452|526455715|FG009|Overall Study|Other|0|||
145984159|NCT02675452|526455716|FG010|Overall Study|Other|0|||
145984160|NCT02675452|526455717|FG011|Overall Study|Other|0|||
145984161|NCT02675452|526455718|FG012|Overall Study|Other|0|||
145984162|NCT02675452|526455719|FG013|Overall Study|Other|0|||
145984163|NCT02675452|526455720|FG014|Overall Study|Other|0|||
145984164|NCT02675452|526455721|FG015|Overall Study|Other|0|||
145984165|NCT02675452|526455722|FG016|Overall Study|Other|0|||
145984166|NCT02675452|526455723|FG017|Overall Study|Other|0|||
145984167|NCT02675452|526455724|FG018|Overall Study|Other|0|||
145984168|NCT02675452|526455725|FG019|Overall Study|Other|0|||
145984169|NCT02675452|526455726|FG020|Overall Study|Other|0|||
145984170|NCT02675452|526455727|FG021|Overall Study|Other|0|||
145984171|NCT02675452|526455728|FG022|Overall Study|Other|0|||
145984172|NCT02675452|526455729|FG023|Overall Study|Other|0|||
145984173|NCT02675452|526455730|FG024|Overall Study|Other|0|||
145984174|NCT02675452|526455731|FG025|Overall Study|Other|0|||
145984175|NCT02675452|526455732|FG026|Overall Study|Other|1|||
145984176|NCT02675452|526455733|FG027|Overall Study|Other|0|||
145984177|NCT02675452|526455734|FG028|Overall Study|Other|0|||
145984178|NCT00545948|526455735|FG000|Overall Study|Not Treated|1|||
145984179|NCT00545948|526455736|FG001|Overall Study|Not Treated|1|||
145984180|NCT00545948|526455737|FG002|Overall Study|Not Treated|7|||
145984181|NCT03467945|526455738|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145984182|NCT03467945|526455739|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145984183|NCT03467945|526455740|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145984184|NCT03467945|526455741|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145984185|NCT03467945|526455738|FG000|Treatment Period 3|Withdrawal by Subject|1|||
145984186|NCT03467945|526455739|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145984187|NCT03467945|526455740|FG002|Treatment Period 3|Withdrawal by Subject|2|||
145984188|NCT03467945|526455741|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145984189|NCT00541775|526455758|FG000|Overall Study|Adverse Event|3|||
145984190|NCT00541775|526455759|FG001|Overall Study|Adverse Event|2|||
145984191|NCT00541775|526455760|FG002|Overall Study|Adverse Event|1|||
145984192|NCT00541775|526455758|FG000|Overall Study|Lack of Efficacy|0|||
145984193|NCT00541775|526455759|FG001|Overall Study|Lack of Efficacy|0|||
145984194|NCT00541775|526455760|FG002|Overall Study|Lack of Efficacy|3|||
145984195|NCT00541775|526455758|FG000|Overall Study|Lost to Follow-up|0|||
145984196|NCT00541775|526455759|FG001|Overall Study|Lost to Follow-up|0|||
145984197|NCT00541775|526455760|FG002|Overall Study|Lost to Follow-up|2|||
145984198|NCT00541775|526455758|FG000|Overall Study|Protocol Violation|1|||
145984199|NCT00541775|526455759|FG001|Overall Study|Protocol Violation|0|||
145984200|NCT00541775|526455760|FG002|Overall Study|Protocol Violation|0|||
145984201|NCT00541775|526455758|FG000|Overall Study|Withdrawal by Subject and Other|5|||
145984202|NCT00541775|526455759|FG001|Overall Study|Withdrawal by Subject and Other|0|||
145984203|NCT00541775|526455760|FG002|Overall Study|Withdrawal by Subject and Other|2|||
145984204|NCT00032487|526455761|FG000|Overall Study|Withdrawal by Subject|67|||
145984205|NCT00032487|526455762|FG001|Overall Study|Withdrawal by Subject|43|||
145984206|NCT00032487|526455761|FG000|Overall Study|Adverse Event|3|||
145984207|NCT00032487|526455762|FG001|Overall Study|Adverse Event|7|||
145984208|NCT00032487|526455761|FG000|Overall Study|Lost to Follow-up|57|||
145984209|NCT00032487|526455762|FG001|Overall Study|Lost to Follow-up|58|||
145984210|NCT00032487|526455761|FG000|Overall Study|Had other reason|12|||
145984211|NCT00032487|526455762|FG001|Overall Study|Had other reason|12|||
145984212|NCT01666314|526455763|FG000|Overall Study|Adverse Event|3|||
145984213|NCT01666314|526455764|FG001|Overall Study|Adverse Event|13|||
145984214|NCT01666314|526455765|FG002|Overall Study|Adverse Event|7|||
145984215|NCT01666314|526455766|FG003|Overall Study|Adverse Event|7|||
145984216|NCT01666314|526455763|FG000|Overall Study|Progressive Disease|11|||
145984217|NCT01666314|526455764|FG001|Overall Study|Progressive Disease|9|||
145984218|NCT01666314|526455765|FG002|Overall Study|Progressive Disease|19|||
145984219|NCT01666314|526455766|FG003|Overall Study|Progressive Disease|20|||
145984220|NCT01666314|526455763|FG000|Overall Study|Symptomatic Deterioration|1|||
145984221|NCT01666314|526455764|FG001|Overall Study|Symptomatic Deterioration|0|||
145984222|NCT01666314|526455765|FG002|Overall Study|Symptomatic Deterioration|2|||
145984223|NCT01666314|526455766|FG003|Overall Study|Symptomatic Deterioration|0|||
145984224|NCT01666314|526455763|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
145984225|NCT01666314|526455764|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
145984226|NCT01666314|526455765|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
145984227|NCT01666314|526455766|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
145984228|NCT01666314|526455763|FG000|Overall Study|Withdrawal by Subject|1|||
145984229|NCT01666314|526455764|FG001|Overall Study|Withdrawal by Subject|1|||
145984230|NCT01666314|526455765|FG002|Overall Study|Withdrawal by Subject|2|||
145984231|NCT01666314|526455766|FG003|Overall Study|Withdrawal by Subject|3|||
146245706|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
145984232|NCT01666314|526455763|FG000|Overall Study|Reason not Specified|10|||
146245707|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
146245708|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
146245709|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
145984233|NCT01666314|526455764|FG001|Overall Study|Reason not Specified|7|||
145984234|NCT01666314|526455765|FG002|Overall Study|Reason not Specified|5|||
145984235|NCT01666314|526455766|FG003|Overall Study|Reason not Specified|5|||
145984236|NCT04913675|526455768|FG000|Main Study (Up to Week 36)|Death|0|||
145984237|NCT04913675|526455769|FG001|Main Study (Up to Week 36)|Death|2|||
145984238|NCT04913675|526455770|FG002|Main Study (Up to Week 36)|Death|2|||
145984239|NCT04913675|526455771|FG003|Main Study (Up to Week 36)|Death|0|||
145984240|NCT04913675|526455768|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
145984241|NCT04913675|526455769|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
145984242|NCT04913675|526455770|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
145984243|NCT04913675|526455771|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
145984244|NCT04913675|526455768|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
145984245|NCT04913675|526455769|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
145984246|NCT04913675|526455770|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
145984247|NCT04913675|526455771|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
145984248|NCT04913675|526455768|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
145984249|NCT04913675|526455769|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
145984250|NCT04913675|526455770|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
145984251|NCT04913675|526455771|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
145984252|NCT04913675|526455768|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145984253|NCT04913675|526455769|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145984254|NCT04913675|526455770|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145984255|NCT04913675|526455771|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
145984256|NCT02975700|526455772|FG000|Overall Study|Adverse Event|1|||
145984257|NCT02975700|526455772|FG000|Overall Study|Progressive disease|3|||
145984258|NCT02975700|526455772|FG000|Overall Study|Failed screening criteria|2|||
145984259|NCT01541254|526455774|FG000|Overall Study|Withdrawal by Subject|1|||
145984260|NCT01541254|526455774|FG000|Overall Study|excluded - metal allergy|1|||
145984261|NCT01541254|526455774|FG000|Overall Study|enrolled after study closed|1|||
145984262|NCT01541254|526455774|FG000|Overall Study|GI bleed prior to procedure|1|||
145984263|NCT01541254|526455774|FG000|Overall Study|stent not required|1|||
145984264|NCT01541254|526455774|FG000|Overall Study|alternate stent used|1|||
145984265|NCT05660538|526455775|FG000|Overall Study|Adverse Event|0|||
145984266|NCT05660538|526455776|FG001|Overall Study|Adverse Event|0|||
145984267|NCT05660538|526455777|FG002|Overall Study|Adverse Event|1|||
145984268|NCT05660538|526455778|FG003|Overall Study|Adverse Event|0|||
145984269|NCT05660538|526455775|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145984270|NCT05660538|526455776|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
145984271|NCT05660538|526455777|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
145984272|NCT05660538|526455778|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
145984273|NCT05660538|526455775|FG000|Overall Study|Lost to Follow-up|0|||
145984274|NCT05660538|526455776|FG001|Overall Study|Lost to Follow-up|0|||
145984275|NCT05660538|526455777|FG002|Overall Study|Lost to Follow-up|1|||
145984276|NCT05660538|526455778|FG003|Overall Study|Lost to Follow-up|1|||
145984277|NCT05660538|526455775|FG000|Overall Study|Death|0|||
145984278|NCT05660538|526455776|FG001|Overall Study|Death|0|||
145984279|NCT05660538|526455777|FG002|Overall Study|Death|1|||
145984280|NCT05660538|526455778|FG003|Overall Study|Death|0|||
145984281|NCT05660538|526455775|FG000|Overall Study|Physician Decision|0|||
145984282|NCT05660538|526455776|FG001|Overall Study|Physician Decision|0|||
145984283|NCT05660538|526455777|FG002|Overall Study|Physician Decision|0|||
145984284|NCT05660538|526455778|FG003|Overall Study|Physician Decision|1|||
145984285|NCT05660538|526455775|FG000|Overall Study|Sponsor Decision|1|||
145984286|NCT05660538|526455776|FG001|Overall Study|Sponsor Decision|0|||
145984287|NCT05660538|526455777|FG002|Overall Study|Sponsor Decision|0|||
145984288|NCT05660538|526455778|FG003|Overall Study|Sponsor Decision|0|||
145984289|NCT05660538|526455775|FG000|Overall Study|Other|1|||
145984290|NCT05660538|526455776|FG001|Overall Study|Other|0|||
145984291|NCT05660538|526455777|FG002|Overall Study|Other|0|||
145984292|NCT05660538|526455778|FG003|Overall Study|Other|1|||
145984293|NCT05660538|526455775|FG000|Overall Study|Randomized but did not receive study drug|1|||
146245710|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
145984294|NCT05660538|526455776|FG001|Overall Study|Randomized but did not receive study drug|0|||
145984295|NCT05660538|526455777|FG002|Overall Study|Randomized but did not receive study drug|0|||
145984296|NCT05660538|526455778|FG003|Overall Study|Randomized but did not receive study drug|1|||
145984297|NCT05660538|526455775|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145984298|NCT05660538|526455776|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
145984299|NCT05660538|526455777|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145984300|NCT05660538|526455778|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145984301|NCT04518410|526455780|FG000|Overall Study|Lost to Follow-up|1|||
145984302|NCT04518410|526455781|FG001|Overall Study|Lost to Follow-up|1|||
145984303|NCT04518410|526455782|FG002|Overall Study|Lost to Follow-up|8|||
145984304|NCT04518410|526455783|FG003|Overall Study|Lost to Follow-up|5|||
145984305|NCT04518410|526455784|FG004|Overall Study|Lost to Follow-up|92|||
145984306|NCT04518410|526455785|FG005|Overall Study|Lost to Follow-up|25|||
145984307|NCT04518410|526455786|FG006|Overall Study|Lost to Follow-up|25|||
145984308|NCT04518410|526455787|FG007|Overall Study|Lost to Follow-up|3|||
145984309|NCT04518410|526455788|FG008|Overall Study|Lost to Follow-up|2|||
145984310|NCT04518410|526455789|FG009|Overall Study|Lost to Follow-up|13|||
145984311|NCT04518410|526455790|FG010|Overall Study|Lost to Follow-up|9|||
145984312|NCT04518410|526455791|FG011|Overall Study|Lost to Follow-up|13|||
145984313|NCT04518410|526455792|FG012|Overall Study|Lost to Follow-up|9|||
145984314|NCT04518410|526455793|FG013|Overall Study|Lost to Follow-up|13|||
145984315|NCT04518410|526455794|FG014|Overall Study|Lost to Follow-up|8|||
145984316|NCT04518410|526455795|FG015|Overall Study|Lost to Follow-up|10|||
145984317|NCT04518410|526455796|FG016|Overall Study|Lost to Follow-up|6|||
145984318|NCT04518410|526455797|FG017|Overall Study|Lost to Follow-up|13|||
145984319|NCT04518410|526455798|FG018|Overall Study|Lost to Follow-up|21|||
145984320|NCT04518410|526455799|FG019|Overall Study|Lost to Follow-up|6|||
145984321|NCT04518410|526455800|FG020|Overall Study|Lost to Follow-up|7|||
145984322|NCT04518410|526455801|FG021|Overall Study|Lost to Follow-up|21|||
145984323|NCT04518410|526455802|FG022|Overall Study|Lost to Follow-up|1|||
145984324|NCT04518410|526455803|FG023|Overall Study|Lost to Follow-up|7|||
145984325|NCT04518410|526455804|FG024|Overall Study|Lost to Follow-up|6|||
145984326|NCT04518410|526455780|FG000|Overall Study|Withdrawal by Subject|1|||
145984327|NCT04518410|526455781|FG001|Overall Study|Withdrawal by Subject|2|||
145984328|NCT04518410|526455782|FG002|Overall Study|Withdrawal by Subject|2|||
145984329|NCT04518410|526455783|FG003|Overall Study|Withdrawal by Subject|3|||
145984330|NCT04518410|526455784|FG004|Overall Study|Withdrawal by Subject|20|||
145984331|NCT04518410|526455785|FG005|Overall Study|Withdrawal by Subject|20|||
145984332|NCT04518410|526455786|FG006|Overall Study|Withdrawal by Subject|25|||
145984333|NCT04518410|526455787|FG007|Overall Study|Withdrawal by Subject|6|||
145984334|NCT04518410|526455788|FG008|Overall Study|Withdrawal by Subject|1|||
145984335|NCT04518410|526455789|FG009|Overall Study|Withdrawal by Subject|12|||
145984336|NCT04518410|526455790|FG010|Overall Study|Withdrawal by Subject|5|||
145984337|NCT04518410|526455791|FG011|Overall Study|Withdrawal by Subject|7|||
145984338|NCT04518410|526455792|FG012|Overall Study|Withdrawal by Subject|2|||
145984339|NCT04518410|526455793|FG013|Overall Study|Withdrawal by Subject|13|||
145984340|NCT04518410|526455794|FG014|Overall Study|Withdrawal by Subject|4|||
145984341|NCT04518410|526455795|FG015|Overall Study|Withdrawal by Subject|9|||
145984342|NCT04518410|526455796|FG016|Overall Study|Withdrawal by Subject|0|||
145984343|NCT04518410|526455797|FG017|Overall Study|Withdrawal by Subject|15|||
145984344|NCT04518410|526455798|FG018|Overall Study|Withdrawal by Subject|12|||
145984345|NCT04518410|526455799|FG019|Overall Study|Withdrawal by Subject|9|||
145984346|NCT04518410|526455800|FG020|Overall Study|Withdrawal by Subject|14|||
145984347|NCT04518410|526455801|FG021|Overall Study|Withdrawal by Subject|3|||
145984348|NCT04518410|526455802|FG022|Overall Study|Withdrawal by Subject|2|||
145984349|NCT04518410|526455803|FG023|Overall Study|Withdrawal by Subject|9|||
145984350|NCT04518410|526455804|FG024|Overall Study|Withdrawal by Subject|8|||
145984351|NCT04518410|526455780|FG000|Overall Study|Other|1|||
145984352|NCT04518410|526455781|FG001|Overall Study|Other|0|||
145984353|NCT04518410|526455782|FG002|Overall Study|Other|0|||
145984354|NCT04518410|526455783|FG003|Overall Study|Other|1|||
145984355|NCT04518410|526455784|FG004|Overall Study|Other|6|||
145984356|NCT04518410|526455785|FG005|Overall Study|Other|6|||
145984357|NCT04518410|526455786|FG006|Overall Study|Other|5|||
145984358|NCT04518410|526455787|FG007|Overall Study|Other|2|||
145984359|NCT04518410|526455788|FG008|Overall Study|Other|0|||
145984360|NCT04518410|526455789|FG009|Overall Study|Other|1|||
145984361|NCT04518410|526455790|FG010|Overall Study|Other|0|||
145984362|NCT04518410|526455791|FG011|Overall Study|Other|2|||
145984363|NCT04518410|526455792|FG012|Overall Study|Other|0|||
145984364|NCT04518410|526455793|FG013|Overall Study|Other|0|||
145984365|NCT04518410|526455794|FG014|Overall Study|Other|0|||
145984366|NCT04518410|526455795|FG015|Overall Study|Other|3|||
145984367|NCT04518410|526455796|FG016|Overall Study|Other|1|||
145984368|NCT04518410|526455797|FG017|Overall Study|Other|1|||
145984369|NCT04518410|526455798|FG018|Overall Study|Other|1|||
145984370|NCT04518410|526455799|FG019|Overall Study|Other|0|||
145984371|NCT04518410|526455800|FG020|Overall Study|Other|1|||
145984372|NCT04518410|526455801|FG021|Overall Study|Other|0|||
145984373|NCT04518410|526455802|FG022|Overall Study|Other|1|||
145984374|NCT04518410|526455803|FG023|Overall Study|Other|2|||
145984375|NCT04518410|526455804|FG024|Overall Study|Other|2|||
145984376|NCT04518410|526455780|FG000|Overall Study|Protocol Violation|0|||
145984377|NCT04518410|526455781|FG001|Overall Study|Protocol Violation|0|||
145984378|NCT04518410|526455782|FG002|Overall Study|Protocol Violation|0|||
145984379|NCT04518410|526455783|FG003|Overall Study|Protocol Violation|2|||
146245711|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
145984380|NCT04518410|526455784|FG004|Overall Study|Protocol Violation|17|||
145984381|NCT04518410|526455785|FG005|Overall Study|Protocol Violation|1|||
145984382|NCT04518410|526455786|FG006|Overall Study|Protocol Violation|2|||
145984383|NCT04518410|526455787|FG007|Overall Study|Protocol Violation|1|||
145984384|NCT04518410|526455788|FG008|Overall Study|Protocol Violation|0|||
145984385|NCT04518410|526455789|FG009|Overall Study|Protocol Violation|0|||
145984386|NCT04518410|526455790|FG010|Overall Study|Protocol Violation|0|||
145984387|NCT04518410|526455791|FG011|Overall Study|Protocol Violation|0|||
145984388|NCT04518410|526455792|FG012|Overall Study|Protocol Violation|0|||
145984389|NCT04518410|526455793|FG013|Overall Study|Protocol Violation|0|||
145984390|NCT04518410|526455794|FG014|Overall Study|Protocol Violation|0|||
145984391|NCT04518410|526455795|FG015|Overall Study|Protocol Violation|0|||
145984392|NCT04518410|526455796|FG016|Overall Study|Protocol Violation|1|||
145984393|NCT04518410|526455797|FG017|Overall Study|Protocol Violation|1|||
145984394|NCT04518410|526455798|FG018|Overall Study|Protocol Violation|0|||
145984395|NCT04518410|526455799|FG019|Overall Study|Protocol Violation|0|||
145984396|NCT04518410|526455800|FG020|Overall Study|Protocol Violation|1|||
145984397|NCT04518410|526455801|FG021|Overall Study|Protocol Violation|2|||
145984398|NCT04518410|526455802|FG022|Overall Study|Protocol Violation|0|||
145984399|NCT04518410|526455803|FG023|Overall Study|Protocol Violation|3|||
145984400|NCT04518410|526455804|FG024|Overall Study|Protocol Violation|0|||
145984401|NCT04518410|526455780|FG000|Overall Study|Death|0|||
145984402|NCT04518410|526455781|FG001|Overall Study|Death|0|||
145984403|NCT04518410|526455782|FG002|Overall Study|Death|0|||
145984404|NCT04518410|526455783|FG003|Overall Study|Death|0|||
145984405|NCT04518410|526455784|FG004|Overall Study|Death|12|||
145984406|NCT04518410|526455785|FG005|Overall Study|Death|2|||
145984407|NCT04518410|526455786|FG006|Overall Study|Death|11|||
145984408|NCT04518410|526455787|FG007|Overall Study|Death|0|||
145984409|NCT04518410|526455788|FG008|Overall Study|Death|1|||
145984410|NCT04518410|526455789|FG009|Overall Study|Death|0|||
145984411|NCT04518410|526455790|FG010|Overall Study|Death|0|||
145984412|NCT04518410|526455791|FG011|Overall Study|Death|0|||
145984413|NCT04518410|526455792|FG012|Overall Study|Death|0|||
145984414|NCT04518410|526455793|FG013|Overall Study|Death|1|||
145984415|NCT04518410|526455794|FG014|Overall Study|Death|1|||
145984416|NCT04518410|526455795|FG015|Overall Study|Death|0|||
145984417|NCT04518410|526455796|FG016|Overall Study|Death|0|||
145984418|NCT04518410|526455797|FG017|Overall Study|Death|1|||
145984419|NCT04518410|526455798|FG018|Overall Study|Death|4|||
145984420|NCT04518410|526455799|FG019|Overall Study|Death|4|||
145984421|NCT04518410|526455800|FG020|Overall Study|Death|1|||
145984422|NCT04518410|526455801|FG021|Overall Study|Death|0|||
145984423|NCT04518410|526455802|FG022|Overall Study|Death|0|||
145984424|NCT04518410|526455803|FG023|Overall Study|Death|0|||
145984425|NCT04518410|526455804|FG024|Overall Study|Death|0|||
145984426|NCT04518410|526455780|FG000|Overall Study|Requirement to start alternative therapy|0|||
145984427|NCT04518410|526455781|FG001|Overall Study|Requirement to start alternative therapy|0|||
145984428|NCT04518410|526455782|FG002|Overall Study|Requirement to start alternative therapy|1|||
145984429|NCT04518410|526455783|FG003|Overall Study|Requirement to start alternative therapy|0|||
145984430|NCT04518410|526455784|FG004|Overall Study|Requirement to start alternative therapy|0|||
145984431|NCT04518410|526455785|FG005|Overall Study|Requirement to start alternative therapy|0|||
145984432|NCT04518410|526455786|FG006|Overall Study|Requirement to start alternative therapy|0|||
145984433|NCT04518410|526455787|FG007|Overall Study|Requirement to start alternative therapy|0|||
145984434|NCT04518410|526455788|FG008|Overall Study|Requirement to start alternative therapy|0|||
145984435|NCT04518410|526455789|FG009|Overall Study|Requirement to start alternative therapy|0|||
145984436|NCT04518410|526455790|FG010|Overall Study|Requirement to start alternative therapy|0|||
145984437|NCT04518410|526455791|FG011|Overall Study|Requirement to start alternative therapy|0|||
145984438|NCT04518410|526455792|FG012|Overall Study|Requirement to start alternative therapy|0|||
145984439|NCT04518410|526455793|FG013|Overall Study|Requirement to start alternative therapy|0|||
145984440|NCT04518410|526455794|FG014|Overall Study|Requirement to start alternative therapy|0|||
145984441|NCT04518410|526455795|FG015|Overall Study|Requirement to start alternative therapy|0|||
145984442|NCT04518410|526455796|FG016|Overall Study|Requirement to start alternative therapy|0|||
145984443|NCT04518410|526455797|FG017|Overall Study|Requirement to start alternative therapy|0|||
145984444|NCT04518410|526455798|FG018|Overall Study|Requirement to start alternative therapy|0|||
145984445|NCT04518410|526455799|FG019|Overall Study|Requirement to start alternative therapy|0|||
145984446|NCT04518410|526455800|FG020|Overall Study|Requirement to start alternative therapy|0|||
145984447|NCT04518410|526455801|FG021|Overall Study|Requirement to start alternative therapy|0|||
145984448|NCT04518410|526455802|FG022|Overall Study|Requirement to start alternative therapy|0|||
145984449|NCT04518410|526455803|FG023|Overall Study|Requirement to start alternative therapy|0|||
145984450|NCT04518410|526455804|FG024|Overall Study|Requirement to start alternative therapy|0|||
145984451|NCT04518410|526455780|FG000|Overall Study|Randomized but not treated|0|||
145984452|NCT04518410|526455781|FG001|Overall Study|Randomized but not treated|0|||
145984453|NCT04518410|526455782|FG002|Overall Study|Randomized but not treated|0|||
145984454|NCT04518410|526455783|FG003|Overall Study|Randomized but not treated|2|||
146245712|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
146245713|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146245714|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146245715|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
146245716|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
146245717|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Other|1|||
146245718|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Other|0|||
146245719|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Other|1|||
146245720|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Other|0|||
145984455|NCT04518410|526455784|FG004|Overall Study|Randomized but not treated|6|||
145984456|NCT04518410|526455785|FG005|Overall Study|Randomized but not treated|4|||
145984457|NCT04518410|526455786|FG006|Overall Study|Randomized but not treated|3|||
145984458|NCT04518410|526455787|FG007|Overall Study|Randomized but not treated|3|||
145984459|NCT04518410|526455788|FG008|Overall Study|Randomized but not treated|0|||
145984460|NCT04518410|526455789|FG009|Overall Study|Randomized but not treated|4|||
145984461|NCT04518410|526455790|FG010|Overall Study|Randomized but not treated|0|||
145984462|NCT04518410|526455791|FG011|Overall Study|Randomized but not treated|0|||
145984463|NCT04518410|526455792|FG012|Overall Study|Randomized but not treated|1|||
145984464|NCT04518410|526455793|FG013|Overall Study|Randomized but not treated|3|||
145984465|NCT04518410|526455794|FG014|Overall Study|Randomized but not treated|3|||
145984466|NCT04518410|526455795|FG015|Overall Study|Randomized but not treated|3|||
145984467|NCT04518410|526455796|FG016|Overall Study|Randomized but not treated|4|||
145984468|NCT04518410|526455797|FG017|Overall Study|Randomized but not treated|5|||
145984469|NCT04518410|526455798|FG018|Overall Study|Randomized but not treated|4|||
145984470|NCT04518410|526455799|FG019|Overall Study|Randomized but not treated|0|||
145984471|NCT04518410|526455800|FG020|Overall Study|Randomized but not treated|0|||
145984472|NCT04518410|526455801|FG021|Overall Study|Randomized but not treated|5|||
145984473|NCT04518410|526455802|FG022|Overall Study|Randomized but not treated|0|||
145984474|NCT04518410|526455803|FG023|Overall Study|Randomized but not treated|3|||
145984475|NCT04518410|526455804|FG024|Overall Study|Randomized but not treated|1|||
145984476|NCT04518410|526455780|FG000|Overall Study|Screen Fail but Randomized|0|||
145984477|NCT04518410|526455781|FG001|Overall Study|Screen Fail but Randomized|0|||
145984478|NCT04518410|526455782|FG002|Overall Study|Screen Fail but Randomized|0|||
145984479|NCT04518410|526455783|FG003|Overall Study|Screen Fail but Randomized|0|||
145984480|NCT04518410|526455784|FG004|Overall Study|Screen Fail but Randomized|2|||
145984481|NCT04518410|526455785|FG005|Overall Study|Screen Fail but Randomized|0|||
145984482|NCT04518410|526455786|FG006|Overall Study|Screen Fail but Randomized|0|||
145984483|NCT04518410|526455787|FG007|Overall Study|Screen Fail but Randomized|0|||
145984484|NCT04518410|526455788|FG008|Overall Study|Screen Fail but Randomized|0|||
145984485|NCT04518410|526455789|FG009|Overall Study|Screen Fail but Randomized|0|||
145984486|NCT04518410|526455790|FG010|Overall Study|Screen Fail but Randomized|0|||
145984487|NCT04518410|526455791|FG011|Overall Study|Screen Fail but Randomized|0|||
145984488|NCT04518410|526455792|FG012|Overall Study|Screen Fail but Randomized|0|||
145984489|NCT04518410|526455793|FG013|Overall Study|Screen Fail but Randomized|0|||
145984490|NCT04518410|526455794|FG014|Overall Study|Screen Fail but Randomized|0|||
145984491|NCT04518410|526455795|FG015|Overall Study|Screen Fail but Randomized|0|||
145984492|NCT04518410|526455796|FG016|Overall Study|Screen Fail but Randomized|0|||
145984493|NCT04518410|526455797|FG017|Overall Study|Screen Fail but Randomized|0|||
145984494|NCT04518410|526455798|FG018|Overall Study|Screen Fail but Randomized|0|||
145984495|NCT04518410|526455799|FG019|Overall Study|Screen Fail but Randomized|0|||
145984496|NCT04518410|526455800|FG020|Overall Study|Screen Fail but Randomized|0|||
145984497|NCT04518410|526455801|FG021|Overall Study|Screen Fail but Randomized|0|||
145984498|NCT04518410|526455802|FG022|Overall Study|Screen Fail but Randomized|0|||
145984499|NCT04518410|526455803|FG023|Overall Study|Screen Fail but Randomized|0|||
145984500|NCT04518410|526455804|FG024|Overall Study|Screen Fail but Randomized|0|||
145984501|NCT04518410|526455780|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984502|NCT04518410|526455781|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984503|NCT04518410|526455782|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984504|NCT04518410|526455783|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
146245721|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
146245722|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
146245723|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
146245724|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
145984505|NCT04518410|526455784|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
145984506|NCT04518410|526455785|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
145984507|NCT04518410|526455786|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
145984508|NCT04518410|526455787|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
146056132|NCT01620060|526721102|FG000|Overall Study|Per Sponsor Decision|2|||
146245725|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
146245726|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
145984509|NCT04518410|526455788|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
145984510|NCT04518410|526455789|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
145984511|NCT04518410|526455790|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145984512|NCT04518410|526455791|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984513|NCT04518410|526455792|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984514|NCT04518410|526455793|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145984515|NCT04518410|526455794|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145984516|NCT04518410|526455795|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
145984517|NCT04518410|526455796|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
145984518|NCT04518410|526455797|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
145984519|NCT04518410|526455798|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
145984520|NCT04518410|526455799|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
145984521|NCT04518410|526455800|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
145984522|NCT04518410|526455801|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
145984523|NCT04518410|526455802|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
145984524|NCT04518410|526455803|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145984525|NCT04518410|526455804|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
145984526|NCT04518410|526455780|FG000|Overall Study|Dual Enrolled Subject|0|||
145984527|NCT04518410|526455781|FG001|Overall Study|Dual Enrolled Subject|0|||
145984528|NCT04518410|526455782|FG002|Overall Study|Dual Enrolled Subject|0|||
145984529|NCT04518410|526455783|FG003|Overall Study|Dual Enrolled Subject|0|||
145984530|NCT04518410|526455784|FG004|Overall Study|Dual Enrolled Subject|0|||
145984531|NCT04518410|526455785|FG005|Overall Study|Dual Enrolled Subject|0|||
145984532|NCT04518410|526455786|FG006|Overall Study|Dual Enrolled Subject|0|||
145984533|NCT04518410|526455787|FG007|Overall Study|Dual Enrolled Subject|0|||
145984534|NCT04518410|526455788|FG008|Overall Study|Dual Enrolled Subject|0|||
145984535|NCT04518410|526455789|FG009|Overall Study|Dual Enrolled Subject|0|||
145984536|NCT04518410|526455790|FG010|Overall Study|Dual Enrolled Subject|0|||
145984537|NCT04518410|526455791|FG011|Overall Study|Dual Enrolled Subject|0|||
145984538|NCT04518410|526455792|FG012|Overall Study|Dual Enrolled Subject|0|||
145984539|NCT04518410|526455793|FG013|Overall Study|Dual Enrolled Subject|0|||
145984540|NCT04518410|526455794|FG014|Overall Study|Dual Enrolled Subject|0|||
145984541|NCT04518410|526455795|FG015|Overall Study|Dual Enrolled Subject|0|||
145984542|NCT04518410|526455796|FG016|Overall Study|Dual Enrolled Subject|0|||
145984543|NCT04518410|526455797|FG017|Overall Study|Dual Enrolled Subject|1|||
145984544|NCT04518410|526455798|FG018|Overall Study|Dual Enrolled Subject|0|||
145984545|NCT04518410|526455799|FG019|Overall Study|Dual Enrolled Subject|0|||
145984546|NCT04518410|526455800|FG020|Overall Study|Dual Enrolled Subject|0|||
145984547|NCT04518410|526455801|FG021|Overall Study|Dual Enrolled Subject|0|||
145984548|NCT04518410|526455802|FG022|Overall Study|Dual Enrolled Subject|0|||
145984549|NCT04518410|526455803|FG023|Overall Study|Dual Enrolled Subject|0|||
145984550|NCT04518410|526455804|FG024|Overall Study|Dual Enrolled Subject|0|||
145984551|NCT01125748|526455806|FG000|Overall Study|Adverse Event|0|||
145984552|NCT01125748|526455807|FG001|Overall Study|Adverse Event|2|||
145984553|NCT01125748|526455806|FG000|Overall Study|Lost to Follow-up|0|||
145984554|NCT01125748|526455807|FG001|Overall Study|Lost to Follow-up|1|||
145984555|NCT01125748|526455806|FG000|Overall Study|Physician Decision|8|||
145984556|NCT01125748|526455807|FG001|Overall Study|Physician Decision|7|||
145984557|NCT01125748|526455806|FG000|Overall Study|Patient Decision to Withdraw|2|||
145984558|NCT01125748|526455807|FG001|Overall Study|Patient Decision to Withdraw|4|||
145984559|NCT01751685|526455808|FG000|6-mo Followup|Missed study visit|1|||
145984560|NCT01751685|526455809|FG001|6-mo Followup|Missed study visit|0|||
145984561|NCT01751685|526455808|FG000|6-mo Followup|Withdrawal by Subject|2|||
145984562|NCT01751685|526455809|FG001|6-mo Followup|Withdrawal by Subject|2|||
145984563|NCT01751685|526455808|FG000|6-mo Followup|Lost to Follow-up|0|||
145984564|NCT01751685|526455809|FG001|6-mo Followup|Lost to Follow-up|1|||
145984565|NCT01751685|526455808|FG000|12-mo Followup|Lost to Follow-up|5|||
145984566|NCT01751685|526455809|FG001|12-mo Followup|Lost to Follow-up|0|||
145984567|NCT01028391|526455810|FG000|Overall Study|Adverse Event|4|||
145984568|NCT01028391|526455811|FG001|Overall Study|Adverse Event|0|||
146245727|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
146245728|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
146245729|NCT03845517|527414035|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
146245730|NCT03845517|527414036|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
145984569|NCT01028391|526455810|FG000|Overall Study|Lack of Efficacy|0|||
145984570|NCT01028391|526455811|FG001|Overall Study|Lack of Efficacy|2|||
145984571|NCT01028391|526455810|FG000|Overall Study|Lost to Follow-up|3|||
145984572|NCT01028391|526455811|FG001|Overall Study|Lost to Follow-up|4|||
145984573|NCT01028391|526455810|FG000|Overall Study|Physician Decision|0|||
145984574|NCT01028391|526455811|FG001|Overall Study|Physician Decision|1|||
145984575|NCT01028391|526455810|FG000|Overall Study|Withdrawal by Subject|6|||
145984576|NCT01028391|526455811|FG001|Overall Study|Withdrawal by Subject|3|||
145984577|NCT01028391|526455810|FG000|Overall Study|Needed excluded medication|1|||
145984578|NCT01028391|526455811|FG001|Overall Study|Needed excluded medication|1|||
145984579|NCT00694161|526455812|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
145984580|NCT00694161|526455812|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
145984581|NCT00694161|526455812|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
145984582|NCT03601052|526455813|FG000|Overall Study|Lost to Follow-up|2|||
145984583|NCT00837330|526455814|FG000|Overall Study|Lost to Follow-up|1|||
145984584|NCT00837330|526455815|FG001|Overall Study|Lost to Follow-up|3|||
145984585|NCT01227395|526455816|FG000|Overall Study|Protocol Violation|0|||
145984586|NCT01227395|526455817|FG001|Overall Study|Protocol Violation|1|||
145984587|NCT03259308|526455828|FG000|Overall Study|Adverse Event|5|||
145984588|NCT03259308|526455829|FG001|Overall Study|Adverse Event|4|||
145984589|NCT03259308|526455830|FG002|Overall Study|Adverse Event|1|||
145984590|NCT03259308|526455828|FG000|Overall Study|Withdrawal by Subject|2|||
145984591|NCT03259308|526455829|FG001|Overall Study|Withdrawal by Subject|1|||
145984592|NCT03259308|526455830|FG002|Overall Study|Withdrawal by Subject|3|||
145984593|NCT03259308|526455828|FG000|Overall Study|Lost to Follow-up|0|||
145984594|NCT03259308|526455829|FG001|Overall Study|Lost to Follow-up|0|||
145984595|NCT03259308|526455830|FG002|Overall Study|Lost to Follow-up|1|||
145984596|NCT03259308|526455828|FG000|Overall Study|Pregnancy|0|||
145984597|NCT03259308|526455829|FG001|Overall Study|Pregnancy|0|||
145984598|NCT03259308|526455830|FG002|Overall Study|Pregnancy|1|||
145984599|NCT03259308|526455828|FG000|Overall Study|Protocol Deviation|0|||
145984600|NCT03259308|526455829|FG001|Overall Study|Protocol Deviation|3|||
145984601|NCT03259308|526455830|FG002|Overall Study|Protocol Deviation|0|||
145984602|NCT03259308|526455828|FG000|Overall Study|Lack of Efficacy|0|||
145984603|NCT03259308|526455829|FG001|Overall Study|Lack of Efficacy|0|||
145984604|NCT03259308|526455830|FG002|Overall Study|Lack of Efficacy|1|||
145984605|NCT00694122|526455835|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
145984606|NCT00694122|526455836|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
145984607|NCT00694122|526455835|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
145984608|NCT00694122|526455836|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
145984609|NCT00694122|526455835|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
145984610|NCT00694122|526455836|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
145984611|NCT00105508|526455837|FG000|Overall Study|Prephase Dropout|1|||
145984612|NCT00105508|526455838|FG001|Overall Study|Prephase Dropout|0|||
145984613|NCT00105508|526455837|FG000|Overall Study|Adverse Event|16|||
145984614|NCT00105508|526455838|FG001|Overall Study|Adverse Event|19|||
145984615|NCT00105508|526455837|FG000|Overall Study|Insufficient Efficacy|1|||
145984616|NCT00105508|526455838|FG001|Overall Study|Insufficient Efficacy|0|||
146245731|NCT03845517|527414037|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
146245732|NCT03845517|527414038|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
146245733|NCT01109979|527414039|FG000|Overall Study|Physician Decision|2|||
146245734|NCT01109979|527414040|FG001|Overall Study|Physician Decision|0|||
146245735|NCT01109979|527414039|FG000|Overall Study|Withdrawal by Subject|0|||
146245736|NCT01109979|527414040|FG001|Overall Study|Withdrawal by Subject|1|||
146245737|NCT00807599|527414044|FG000|Overall Study|Not treated on protocol study|0|||
146245738|NCT00807599|527414045|FG001|Overall Study|Not treated on protocol study|0|||
146245739|NCT00807599|527414046|FG002|Overall Study|Not treated on protocol study|2|||
146245740|NCT00807599|527414044|FG000|Overall Study|Adverse Event|0|||
146245741|NCT00807599|527414045|FG001|Overall Study|Adverse Event|0|||
146245742|NCT00807599|527414046|FG002|Overall Study|Adverse Event|5|||
146245743|NCT00807599|527414044|FG000|Overall Study|Inadequate response to induction|0|||
146245744|NCT00807599|527414045|FG001|Overall Study|Inadequate response to induction|0|||
146245745|NCT00807599|527414046|FG002|Overall Study|Inadequate response to induction|9|||
146245746|NCT00807599|527414044|FG000|Overall Study|Withdrawal by Subject|0|||
146245747|NCT00807599|527414045|FG001|Overall Study|Withdrawal by Subject|0|||
146245748|NCT00807599|527414046|FG002|Overall Study|Withdrawal by Subject|1|||
146245749|NCT03695185|527414047|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
146245750|NCT03695185|527414047|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
146245751|NCT03695185|527414047|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
145984617|NCT00105508|526455837|FG000|Overall Study|Withdrawal by Subject|10|||
145984618|NCT00105508|526455838|FG001|Overall Study|Withdrawal by Subject|6|||
145984619|NCT00105508|526455837|FG000|Overall Study|Lost to Follow-up|3|||
145984620|NCT00105508|526455838|FG001|Overall Study|Lost to Follow-up|0|||
145984621|NCT00105508|526455837|FG000|Overall Study|Protocol Violation|1|||
145984622|NCT00105508|526455838|FG001|Overall Study|Protocol Violation|2|||
145984623|NCT00105508|526455837|FG000|Overall Study|Other|8|||
145984624|NCT00105508|526455838|FG001|Overall Study|Other|9|||
145984625|NCT00086307|526455839|FG000|Overall Study|Lack of Efficacy|1|||
145984626|NCT00086307|526455840|FG001|Overall Study|Lack of Efficacy|1|||
145984627|NCT00086307|526455841|FG002|Overall Study|Lack of Efficacy|2|||
145984628|NCT00086307|526455839|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
145984629|NCT00086307|526455840|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
145984630|NCT00086307|526455841|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
145984631|NCT00086307|526455839|FG000|Overall Study|Nausea and headaches|0|||
145984632|NCT00086307|526455840|FG001|Overall Study|Nausea and headaches|0|||
145984633|NCT00086307|526455841|FG002|Overall Study|Nausea and headaches|1|||
145984634|NCT00086307|526455839|FG000|Overall Study|Constipation and sleepiness|0|||
145984635|NCT00086307|526455840|FG001|Overall Study|Constipation and sleepiness|0|||
145984636|NCT00086307|526455841|FG002|Overall Study|Constipation and sleepiness|1|||
145984637|NCT00086307|526455839|FG000|Overall Study|Suicidal ideation|0|||
145984638|NCT00086307|526455840|FG001|Overall Study|Suicidal ideation|0|||
145984639|NCT00086307|526455841|FG002|Overall Study|Suicidal ideation|1|||
145984640|NCT00086307|526455839|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
145984641|NCT00086307|526455840|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
145984642|NCT00086307|526455841|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
145984643|NCT00086307|526455839|FG000|Overall Study|Withdrawal by Subject|0|||
145984644|NCT00086307|526455840|FG001|Overall Study|Withdrawal by Subject|0|||
145984645|NCT00086307|526455841|FG002|Overall Study|Withdrawal by Subject|2|||
145984646|NCT00683384|526455842|FG000|Overall Study|Death|1|||
145984647|NCT00683384|526455842|FG000|Overall Study|Adverse Event|1|||
145984648|NCT00120874|526455843|FG000|Overall Study|Death|0|||
145984649|NCT00120874|526455844|FG001|Overall Study|Death|1|||
145984650|NCT01727154|526455845|FG000|Overall Study|Death|17|||
145984651|NCT01727154|526455845|FG000|Overall Study|Withdrawal by Subject|14|||
145984652|NCT01727154|526455845|FG000|Overall Study|Subject Withdrew Consent|18|||
145984653|NCT01727154|526455845|FG000|Overall Study|Study Terminated|6|||
145984654|NCT01727154|526455845|FG000|Overall Study|No Discontinuation Documentation|4|||
145984655|NCT03020888|526455846|FG000|Overall Study|Physician Decision|4|||
145984656|NCT03020888|526455846|FG000|Overall Study|Withdrawal by Subject|6|||
145984657|NCT03020888|526455846|FG000|Overall Study|Insurance coverage|2|||
145984658|NCT03020888|526455846|FG000|Overall Study|Lost to Follow-up|1|||
145984659|NCT00300495|526455847|FG000|Overall Study|Protocol Violation|4|||
145984660|NCT00300495|526455848|FG001|Overall Study|Protocol Violation|1|||
145984661|NCT01348490|526455849|FG000|Overall Study|Death|1|||
145984662|NCT01348490|526455849|FG000|Overall Study|Adverse Event|3|||
145984663|NCT01348490|526455849|FG000|Overall Study|Consent withdrawn|7|||
145984664|NCT01348490|526455849|FG000|Overall Study|Disease progression|3|||
145984665|NCT01348490|526455849|FG000|Overall Study|Lost to Follow-up|1|||
145984666|NCT01348490|526455849|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
145984667|NCT01348490|526455849|FG000|Overall Study|Other Unspecified|8|||
145984668|NCT01198548|526455863|FG000|Overall Study|Disease Progression|9|||
145984669|NCT01198548|526455863|FG000|Overall Study|Administrative Decision|1|||
145984670|NCT01567085|526457522|FG000|Overall Study|Death|6|||
145984671|NCT01567085|526457522|FG000|Overall Study|Adverse Event|6|||
145984672|NCT01567085|526457522|FG000|Overall Study|Lost to Follow-up|3|||
145984673|NCT01567085|526457522|FG000|Overall Study|Graft loss|2|||
145984674|NCT01567085|526457522|FG000|Overall Study|Renal transplantectomy|1|||
145984675|NCT01567085|526457522|FG000|Overall Study|Returned to chronic dialysis|1|||
145984676|NCT01567085|526457522|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
145984677|NCT03312114|526457528|FG000|Overall Study|All the five enrolled dropped out of the|5|||
145984678|NCT03537729|526457529|FG000|Overall Study|Death|2|||
145984679|NCT03537729|526457530|FG001|Overall Study|Death|2|||
145984680|NCT03537729|526457531|FG002|Overall Study|Death|7|||
145984681|NCT03537729|526457529|FG000|Overall Study|Withdrawal by Subject|3|||
145984682|NCT03537729|526457530|FG001|Overall Study|Withdrawal by Subject|3|||
145984683|NCT03537729|526457531|FG002|Overall Study|Withdrawal by Subject|0|||
145984684|NCT03537729|526457529|FG000|Overall Study|Subject Moved|8|||
145984685|NCT03537729|526457530|FG001|Overall Study|Subject Moved|5|||
145984686|NCT03537729|526457531|FG002|Overall Study|Subject Moved|4|||
145984687|NCT03537729|526457529|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
145984688|NCT03537729|526457530|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
146245752|NCT03695185|527414047|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
145984689|NCT03537729|526457531|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
145984690|NCT03537729|526457529|FG000|Overall Study|COVID-19 Site Restrictions|11|||
145984691|NCT03537729|526457530|FG001|Overall Study|COVID-19 Site Restrictions|15|||
145984692|NCT03537729|526457531|FG002|Overall Study|COVID-19 Site Restrictions|18|||
145984693|NCT03537729|526457529|FG000|Overall Study|Decline in Health|5|||
145984694|NCT03537729|526457530|FG001|Overall Study|Decline in Health|9|||
145984695|NCT03537729|526457531|FG002|Overall Study|Decline in Health|4|||
145984696|NCT03537729|526457529|FG000|Overall Study|Determined Ineligible|0|||
145984697|NCT03537729|526457530|FG001|Overall Study|Determined Ineligible|0|||
145984698|NCT03537729|526457531|FG002|Overall Study|Determined Ineligible|1|||
145984699|NCT00284934|526457532|FG000|Overall Study|Adverse Event|1|||
145984700|NCT00284934|526457533|FG001|Overall Study|Adverse Event|2|||
145984701|NCT00284934|526457532|FG000|Overall Study|Other reasons|3|||
145984702|NCT00284934|526457533|FG001|Overall Study|Other reasons|1|||
145984703|NCT00454142|526457534|FG000|Overall Study|Withdrawal by Subject|1|||
145984704|NCT00520572|526457542|FG000|Overall Study|Adverse Event|9|||
145984705|NCT00520572|526457543|FG001|Overall Study|Adverse Event|3|||
145984706|NCT00520572|526457544|FG002|Overall Study|Adverse Event|6|||
145984707|NCT00520572|526457545|FG003|Overall Study|Adverse Event|9|||
145984708|NCT00520572|526457546|FG004|Overall Study|Adverse Event|7|||
145984709|NCT00520572|526457547|FG005|Overall Study|Adverse Event|2|||
145984710|NCT00520572|526457542|FG000|Overall Study|Withdrawal by Subject|0|||
145984711|NCT00520572|526457543|FG001|Overall Study|Withdrawal by Subject|9|||
145984712|NCT00520572|526457544|FG002|Overall Study|Withdrawal by Subject|5|||
145984713|NCT00520572|526457545|FG003|Overall Study|Withdrawal by Subject|2|||
145984714|NCT00520572|526457546|FG004|Overall Study|Withdrawal by Subject|2|||
145984715|NCT00520572|526457547|FG005|Overall Study|Withdrawal by Subject|0|||
145984716|NCT00520572|526457542|FG000|Overall Study|Protocol Violation|0|||
145984717|NCT00520572|526457543|FG001|Overall Study|Protocol Violation|0|||
145984718|NCT00520572|526457544|FG002|Overall Study|Protocol Violation|1|||
145984719|NCT00520572|526457545|FG003|Overall Study|Protocol Violation|0|||
145984720|NCT00520572|526457546|FG004|Overall Study|Protocol Violation|0|||
145984721|NCT00520572|526457547|FG005|Overall Study|Protocol Violation|0|||
145984722|NCT00520572|526457542|FG000|Overall Study|Lack of Efficacy|1|||
145984723|NCT00520572|526457543|FG001|Overall Study|Lack of Efficacy|1|||
145984724|NCT00520572|526457544|FG002|Overall Study|Lack of Efficacy|1|||
145984725|NCT00520572|526457545|FG003|Overall Study|Lack of Efficacy|2|||
145984726|NCT00520572|526457546|FG004|Overall Study|Lack of Efficacy|1|||
145984727|NCT00520572|526457547|FG005|Overall Study|Lack of Efficacy|0|||
145984728|NCT00520572|526457542|FG000|Overall Study|Lost to Follow-up|0|||
145984729|NCT00520572|526457543|FG001|Overall Study|Lost to Follow-up|0|||
145984730|NCT00520572|526457544|FG002|Overall Study|Lost to Follow-up|0|||
145984731|NCT00520572|526457545|FG003|Overall Study|Lost to Follow-up|0|||
145984732|NCT00520572|526457546|FG004|Overall Study|Lost to Follow-up|1|||
145984733|NCT00520572|526457547|FG005|Overall Study|Lost to Follow-up|0|||
145984734|NCT00520572|526457542|FG000|Overall Study|Incorrect enrollment|1|||
145984735|NCT00520572|526457543|FG001|Overall Study|Incorrect enrollment|0|||
145984736|NCT00520572|526457544|FG002|Overall Study|Incorrect enrollment|1|||
145984737|NCT00520572|526457545|FG003|Overall Study|Incorrect enrollment|0|||
145984738|NCT00520572|526457546|FG004|Overall Study|Incorrect enrollment|1|||
145984739|NCT00520572|526457547|FG005|Overall Study|Incorrect enrollment|0|||
145984740|NCT00520572|526457542|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
145984741|NCT00520572|526457543|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
145984742|NCT00520572|526457544|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
145984743|NCT00520572|526457545|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
145984744|NCT00520572|526457546|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
145984745|NCT00520572|526457547|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
145984746|NCT00520572|526457542|FG000|Overall Study|Long break in taking Medication|0|||
145984747|NCT00520572|526457543|FG001|Overall Study|Long break in taking Medication|0|||
145984748|NCT00520572|526457544|FG002|Overall Study|Long break in taking Medication|0|||
145984749|NCT00520572|526457545|FG003|Overall Study|Long break in taking Medication|1|||
145984750|NCT00520572|526457546|FG004|Overall Study|Long break in taking Medication|0|||
145984751|NCT00520572|526457547|FG005|Overall Study|Long break in taking Medication|0|||
145984752|NCT00520572|526457542|FG000|Overall Study|Did not receive Treatment|1|||
145984753|NCT00520572|526457543|FG001|Overall Study|Did not receive Treatment|0|||
145984754|NCT00520572|526457544|FG002|Overall Study|Did not receive Treatment|1|||
145984755|NCT00520572|526457545|FG003|Overall Study|Did not receive Treatment|0|||
145984756|NCT00520572|526457546|FG004|Overall Study|Did not receive Treatment|0|||
145984757|NCT00520572|526457547|FG005|Overall Study|Did not receive Treatment|0|||
145984758|NCT02802865|526457550|FG000|Overall Study|Pregnancy|1|||
145984759|NCT02802865|526457551|FG001|Overall Study|Pregnancy|1|||
145984760|NCT02802865|526457550|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
145984761|NCT02802865|526457551|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
145984762|NCT01748552|526457555|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
145984763|NCT01748552|526457556|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
145984764|NCT01748552|526457557|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
145984765|NCT01748552|526457558|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
145984766|NCT01748552|526457559|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
145984767|NCT01748552|526457560|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
145984768|NCT01748552|526457561|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
145984769|NCT01748552|526457562|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
145984770|NCT01748552|526457563|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
145984771|NCT01748552|526457564|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
145984772|NCT01748552|526457565|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
145984773|NCT01748552|526457566|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
145984774|NCT01748552|526457555|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984775|NCT01748552|526457556|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984776|NCT01748552|526457557|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984777|NCT01748552|526457558|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984778|NCT01748552|526457559|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984779|NCT01748552|526457560|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984780|NCT01748552|526457561|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145984781|NCT01748552|526457562|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145984782|NCT01748552|526457563|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145984783|NCT01748552|526457564|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984784|NCT01748552|526457565|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984785|NCT01748552|526457566|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145984786|NCT01529112|526457567|FG000|Overall Study|Adverse Event|2|||
145984787|NCT01529112|526457568|FG001|Overall Study|Adverse Event|0|||
145984788|NCT01529112|526457567|FG000|Overall Study|Death|59|||
145984789|NCT01529112|526457568|FG001|Overall Study|Death|38|||
145984790|NCT01529112|526457567|FG000|Overall Study|Protocol Violation|1|||
145984791|NCT01529112|526457568|FG001|Overall Study|Protocol Violation|0|||
145984792|NCT01529112|526457567|FG000|Overall Study|Withdrawal by Subject|7|||
145984793|NCT01529112|526457568|FG001|Overall Study|Withdrawal by Subject|3|||
145984794|NCT03607695|526457570|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
145984795|NCT03607695|526457570|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
145984796|NCT00676052|526457571|FG000|Overall Study|Adverse Event|0|||
145984797|NCT00676052|526457572|FG001|Overall Study|Adverse Event|1|||
145984798|NCT00676052|526457573|FG002|Overall Study|Adverse Event|1|||
145984799|NCT00676052|526457574|FG003|Overall Study|Adverse Event|2|||
145984800|NCT00676052|526457575|FG004|Overall Study|Adverse Event|2|||
145984801|NCT00676052|526457576|FG005|Overall Study|Adverse Event|2|||
145984802|NCT00676052|526457571|FG000|Overall Study|Lack of Efficacy|2|||
145984803|NCT00676052|526457572|FG001|Overall Study|Lack of Efficacy|2|||
145984804|NCT00676052|526457573|FG002|Overall Study|Lack of Efficacy|1|||
145984805|NCT00676052|526457574|FG003|Overall Study|Lack of Efficacy|1|||
145984806|NCT00676052|526457575|FG004|Overall Study|Lack of Efficacy|2|||
145984807|NCT00676052|526457576|FG005|Overall Study|Lack of Efficacy|1|||
145984808|NCT00676052|526457571|FG000|Overall Study|Protocol Violation|5|||
145984809|NCT00676052|526457572|FG001|Overall Study|Protocol Violation|3|||
145984810|NCT00676052|526457573|FG002|Overall Study|Protocol Violation|2|||
145984811|NCT00676052|526457574|FG003|Overall Study|Protocol Violation|2|||
145984812|NCT00676052|526457575|FG004|Overall Study|Protocol Violation|1|||
145984813|NCT00676052|526457576|FG005|Overall Study|Protocol Violation|2|||
145984814|NCT00676052|526457571|FG000|Overall Study|Lost to Follow-up|0|||
145984815|NCT00676052|526457572|FG001|Overall Study|Lost to Follow-up|0|||
145984816|NCT00676052|526457573|FG002|Overall Study|Lost to Follow-up|0|||
145984817|NCT00676052|526457574|FG003|Overall Study|Lost to Follow-up|0|||
145984818|NCT00676052|526457575|FG004|Overall Study|Lost to Follow-up|1|||
145984819|NCT00676052|526457576|FG005|Overall Study|Lost to Follow-up|0|||
145984820|NCT00676052|526457571|FG000|Overall Study|Physician Decision|1|||
145984821|NCT00676052|526457572|FG001|Overall Study|Physician Decision|1|||
145984822|NCT00676052|526457573|FG002|Overall Study|Physician Decision|1|||
145984823|NCT00676052|526457574|FG003|Overall Study|Physician Decision|0|||
145984824|NCT00676052|526457575|FG004|Overall Study|Physician Decision|0|||
145984825|NCT00676052|526457576|FG005|Overall Study|Physician Decision|1|||
145984826|NCT00676052|526457571|FG000|Overall Study|Withdrawal by Subject|1|||
145984827|NCT00676052|526457572|FG001|Overall Study|Withdrawal by Subject|0|||
145984828|NCT00676052|526457573|FG002|Overall Study|Withdrawal by Subject|1|||
145984829|NCT00676052|526457574|FG003|Overall Study|Withdrawal by Subject|0|||
145984830|NCT00676052|526457575|FG004|Overall Study|Withdrawal by Subject|0|||
145984831|NCT00676052|526457576|FG005|Overall Study|Withdrawal by Subject|0|||
145984832|NCT01428713|526457577|FG000|Overall Study|Non-compliance|2|||
145984833|NCT01428713|526457578|FG001|Overall Study|Non-compliance|2|||
145984834|NCT01428713|526457577|FG000|Overall Study|Withdrawal by Subject|1|||
145984835|NCT01428713|526457578|FG001|Overall Study|Withdrawal by Subject|1|||
145984836|NCT01428713|526457577|FG000|Overall Study|Adverse Event|0|||
145984837|NCT01428713|526457578|FG001|Overall Study|Adverse Event|2|||
145984838|NCT00585169|526457581|FG000|Overall Study|Withdrawal by Subject|1|||
145984839|NCT00527748|526457594|FG000|Overall Study|Other|3|||
145984840|NCT01964560|526457599|FG000|Overall Study|Adverse Event|23|||
145984841|NCT01964560|526457599|FG000|Overall Study|Lack of Efficacy|46|||
145984842|NCT01964560|526457599|FG000|Overall Study|Protocol deviation|2|||
145984843|NCT01964560|526457599|FG000|Overall Study|Lost to Follow-up|4|||
145984844|NCT01964560|526457599|FG000|Overall Study|Withdrawal by Subject|64|||
145984845|NCT01964560|526457599|FG000|Overall Study|Surgery-hemispherotomy|1|||
145984846|NCT01964560|526457599|FG000|Overall Study|Surgery|1|||
145984847|NCT01964560|526457599|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
145984848|NCT01964560|526457599|FG000|Overall Study|Patient and Investigator choice|1|||
145984849|NCT01964560|526457599|FG000|Overall Study|Patient was prescribed CBD|1|||
145984850|NCT01964560|526457599|FG000|Overall Study|Participant moved to another country|1|||
145984851|NCT00710554|526457605|FG000|Overall Study|Adverse Event|24|||
145984852|NCT00710554|526457606|FG001|Overall Study|Adverse Event|7|||
145984853|NCT00710554|526457605|FG000|Overall Study|Withdrawal by Subject|7|||
145984854|NCT00710554|526457606|FG001|Overall Study|Withdrawal by Subject|3|||
145984855|NCT00710554|526457605|FG000|Overall Study|Lost to Follow-up|7|||
145984856|NCT00710554|526457606|FG001|Overall Study|Lost to Follow-up|1|||
145984857|NCT00710554|526457605|FG000|Overall Study|Lack of Efficacy|11|||
145984858|NCT00710554|526457606|FG001|Overall Study|Lack of Efficacy|12|||
145984859|NCT00710554|526457605|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
145984860|NCT00710554|526457606|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
145984861|NCT01093885|526457607|FG000|Overall Study|Adverse Event|4|||
145984862|NCT01093885|526457607|FG000|Overall Study|Lost to Follow-up|1|||
145984863|NCT01301001|526457608|FG000|First Intervention|Lost to Follow-up|4|||
145984864|NCT01301001|526457609|FG001|First Intervention|Lost to Follow-up|4|||
145984865|NCT01301001|526457608|FG000|First Intervention|Withdrawal by Subject|1|||
145984866|NCT01301001|526457609|FG001|First Intervention|Withdrawal by Subject|4|||
145984867|NCT01301001|526457608|FG000|First Intervention|Adverse Event|5|||
145984868|NCT01301001|526457609|FG001|First Intervention|Adverse Event|0|||
145984869|NCT01301001|526457608|FG000|First Intervention|Protocol Violation|0|||
145984870|NCT01301001|526457609|FG001|First Intervention|Protocol Violation|1|||
145984871|NCT01301001|526457608|FG000|Second Intervention|Adverse Event|2|||
145984872|NCT01301001|526457609|FG001|Second Intervention|Adverse Event|0|||
145984873|NCT01301001|526457608|FG000|Second Intervention|Withdrawal by Subject|2|||
145984874|NCT01301001|526457609|FG001|Second Intervention|Withdrawal by Subject|0|||
145984875|NCT01560988|526457610|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
145984876|NCT01560988|526457611|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
145984877|NCT01560988|526457610|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
145984878|NCT01560988|526457611|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
145984879|NCT01560988|526457610|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
145984880|NCT01560988|526457611|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
145984881|NCT01975285|526457622|FG000|Overall Study|Failed Block and follow up|2|||
145984882|NCT01975285|526457623|FG001|Overall Study|Failed Block and follow up|2|||
145984883|NCT04535362|526457624|FG000|Overall Study|Lost to Follow-up|3|||
145984884|NCT04535362|526457625|FG001|Overall Study|Lost to Follow-up|1|||
145984885|NCT03791060|526457626|FG000|Overall Study|Withdrawal by Subject|1|||
145984886|NCT03774810|526457627|FG000|Phase 1|Lack of Efficacy|21|||
145984887|NCT03774810|526457628|FG001|Phase 1|Lack of Efficacy|0|||
145984888|NCT03774810|526457629|FG002|Phase 1|Lack of Efficacy|0|||
145984889|NCT03774810|526457630|FG003|Phase 1|Lack of Efficacy|0|||
145984890|NCT03774810|526457631|FG004|Phase 1|Lack of Efficacy|0|||
145984891|NCT03774810|526457627|FG000|Phase 1|Withdrawal by Subject|9|||
145984892|NCT03774810|526457628|FG001|Phase 1|Withdrawal by Subject|0|||
145984893|NCT03774810|526457629|FG002|Phase 1|Withdrawal by Subject|0|||
145984894|NCT03774810|526457630|FG003|Phase 1|Withdrawal by Subject|0|||
145984895|NCT03774810|526457631|FG004|Phase 1|Withdrawal by Subject|0|||
145984896|NCT03774810|526457627|FG000|Phase 1|Lost to Follow-up|2|||
145984897|NCT03774810|526457628|FG001|Phase 1|Lost to Follow-up|0|||
145984898|NCT03774810|526457629|FG002|Phase 1|Lost to Follow-up|0|||
145984899|NCT03774810|526457630|FG003|Phase 1|Lost to Follow-up|0|||
145984900|NCT03774810|526457631|FG004|Phase 1|Lost to Follow-up|0|||
145984901|NCT03774810|526457627|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
145984902|NCT03774810|526457628|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
145984903|NCT03774810|526457629|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
146245753|NCT03695185|527414047|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
146245754|NCT03695185|527414047|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
146245755|NCT05376397|527414050|FG000|Overall Study|Lost to Follow-up|1|||
146245756|NCT01535261|527414053|FG000|Overall Study|Physician Decision|8|||
146245757|NCT01535261|527414053|FG000|Overall Study|Protocol Violation|3|||
145984904|NCT03774810|526457630|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
145984905|NCT03774810|526457631|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
145984906|NCT03774810|526457627|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
145984907|NCT03774810|526457628|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
146245758|NCT01535261|527414053|FG000|Overall Study|Death|5|||
145984908|NCT03774810|526457629|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
145984909|NCT03774810|526457630|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
146245759|NCT01535261|527414053|FG000|Overall Study|Lost to Follow-up|8|||
145984910|NCT03774810|526457631|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
145984911|NCT03774810|526457627|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
145984912|NCT03774810|526457628|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
145984913|NCT03774810|526457629|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
145984914|NCT03774810|526457630|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
145984915|NCT03774810|526457631|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
145984916|NCT03774810|526457627|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
146245760|NCT01535261|527414053|FG000|Overall Study|Withdrawal by Subject|14|||
145984917|NCT03774810|526457628|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
145984918|NCT03774810|526457629|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
145984919|NCT03774810|526457630|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
145984920|NCT03774810|526457631|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
145984921|NCT03774810|526457627|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
145984922|NCT03774810|526457628|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
145984923|NCT03774810|526457629|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
145984924|NCT03774810|526457630|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
145984925|NCT03774810|526457631|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
145984926|NCT03774810|526457627|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145984927|NCT03774810|526457628|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145984928|NCT03774810|526457629|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145984929|NCT03774810|526457630|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
145984930|NCT03774810|526457631|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
145984931|NCT00927186|526457632|FG000|12 Months Primary Study|Adverse Event|5|||
145984932|NCT00927186|526457633|FG001|12 Months Primary Study|Adverse Event|2|||
145984933|NCT00927186|526457632|FG000|12 Months Primary Study|Lost to Follow-up|1|||
145984934|NCT00927186|526457633|FG001|12 Months Primary Study|Lost to Follow-up|0|||
145984935|NCT00927186|526457632|FG000|12 Months Primary Study|Protocol Violation|0|||
145984936|NCT00927186|526457633|FG001|12 Months Primary Study|Protocol Violation|1|||
145984937|NCT00927186|526457632|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
145984938|NCT00927186|526457633|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
145984939|NCT00604383|526457634|FG000|Overall Study|Withdrawal by Subject|33|||
145984940|NCT00604383|526457635|FG001|Overall Study|Withdrawal by Subject|31|||
145984941|NCT00604383|526457634|FG000|Overall Study|Lost to Follow-up|24|||
145984942|NCT00604383|526457635|FG001|Overall Study|Lost to Follow-up|19|||
145984943|NCT00604383|526457634|FG000|Overall Study|Death|14|||
145984944|NCT00604383|526457635|FG001|Overall Study|Death|22|||
145984945|NCT00604383|526457634|FG000|Overall Study|Adverse Event|16|||
145984946|NCT00604383|526457635|FG001|Overall Study|Adverse Event|9|||
145984947|NCT00604383|526457634|FG000|Overall Study|Physician Decision|0|||
145984948|NCT00604383|526457635|FG001|Overall Study|Physician Decision|3|||
145984949|NCT02619812|526457636|FG000|Overall Study|Withdrawal by Subject|0|||
145984950|NCT02619812|526457637|FG001|Overall Study|Withdrawal by Subject|0|||
145984951|NCT02619812|526457638|FG002|Overall Study|Withdrawal by Subject|1|||
145984952|NCT02619812|526457639|FG003|Overall Study|Withdrawal by Subject|2|||
145984953|NCT04243837|526457646|FG000|Overall Study|Adverse Event|2|||
145984954|NCT04243837|526457647|FG001|Overall Study|Adverse Event|1|||
145984955|NCT04243837|526457646|FG000|Overall Study|Withdrawal by Subject|4|||
145984956|NCT04243837|526457647|FG001|Overall Study|Withdrawal by Subject|2|||
145984957|NCT04243837|526457646|FG000|Overall Study|Covid-19 lock down|1|||
145984958|NCT04243837|526457647|FG001|Overall Study|Covid-19 lock down|0|||
145984959|NCT04243837|526457646|FG000|Overall Study|Study Terminated by Sponsor|11|||
145984960|NCT04243837|526457647|FG001|Overall Study|Study Terminated by Sponsor|12|||
145984961|NCT02829957|526457650|FG000|Overall Study|Lost to Follow-up|2|||
145984962|NCT02829957|526457651|FG001|Overall Study|Lost to Follow-up|1|||
145984963|NCT00455455|526457657|FG000|Washout|Withdrawal by Subject|0|||
145984964|NCT00455455|526457658|FG001|Washout|Withdrawal by Subject|1|||
145984965|NCT00455455|526457657|FG000|Washout|Withdrawal by Subject|1|||
145984966|NCT00455455|526457658|FG001|Washout|Withdrawal by Subject|0|||
145984967|NCT01370538|526457659|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
145984968|NCT01370538|526457660|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
145984969|NCT01370538|526457659|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145984970|NCT01370538|526457660|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145984971|NCT01370538|526457659|FG000|Overall Study|Adverse Event|1|||
145984972|NCT01370538|526457660|FG001|Overall Study|Adverse Event|0|||
145984973|NCT01370538|526457659|FG000|Overall Study|Protocol Violation|8|||
145984974|NCT01370538|526457660|FG001|Overall Study|Protocol Violation|5|||
145984975|NCT01370538|526457659|FG000|Overall Study|Development of study specific withdrawal|1|||
145984976|NCT01370538|526457660|FG001|Overall Study|Development of study specific withdrawal|1|||
145984977|NCT01370538|526457659|FG000|Overall Study|Lost to follow up|6|||
145984978|NCT01370538|526457660|FG001|Overall Study|Lost to follow up|10|||
146245761|NCT01535261|527414053|FG000|Overall Study|Adverse Event|12|||
145984979|NCT01184118|526457672|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
145984980|NCT01184118|526457672|FG000|Overall Study|No physiologic confirmation of asthma|8|||
145984981|NCT01184118|526457672|FG000|Overall Study|FEV1 <60% predicted|2|||
145984982|NCT01184118|526457672|FG000|Overall Study|Exclusionary medical condition|2|||
145984983|NCT01184118|526457672|FG000|Overall Study|Withdrawal by Subject|5|||
145984984|NCT01049828|526457675|FG000|Overall Study|Claustrophibia and Frustration|2|||
145984985|NCT00290238|526457676|FG000|Overall Study|Study terminated|27|||
145984986|NCT00290238|526457677|FG001|Overall Study|Study terminated|27|||
145984987|NCT00290238|526457676|FG000|Overall Study|Lost to Follow-up|0|||
145984988|NCT00290238|526457677|FG001|Overall Study|Lost to Follow-up|1|||
145984989|NCT00290238|526457676|FG000|Overall Study|Withdrawal by Subject|15|||
145984990|NCT00290238|526457677|FG001|Overall Study|Withdrawal by Subject|13|||
145984991|NCT03834883|526457678|FG000|Second Treatment|Withdrawal by Subject|1|||
145984992|NCT03834883|526457679|FG001|Second Treatment|Withdrawal by Subject|0|||
145984993|NCT03834883|526457680|FG002|Second Treatment|Withdrawal by Subject|0|||
145984994|NCT03834883|526457681|FG003|Second Treatment|Withdrawal by Subject|0|||
145984995|NCT03834883|526457678|FG000|Second Treatment|COVID-19 pandemic|1|||
145984996|NCT03834883|526457679|FG001|Second Treatment|COVID-19 pandemic|0|||
145984997|NCT03834883|526457680|FG002|Second Treatment|COVID-19 pandemic|1|||
145984998|NCT03834883|526457681|FG003|Second Treatment|COVID-19 pandemic|1|||
145984999|NCT03572218|526457685|FG000|Overall Study|Lost to Follow-up|3|||
145985000|NCT03572218|526457686|FG001|Overall Study|Lost to Follow-up|2|||
145985001|NCT03572218|526457685|FG000|Overall Study|No longer available for study visits|2|||
145985002|NCT03572218|526457686|FG001|Overall Study|No longer available for study visits|1|||
145985003|NCT03572218|526457685|FG000|Overall Study|No longer interested|1|||
145985004|NCT03572218|526457686|FG001|Overall Study|No longer interested|2|||
145985005|NCT02487199|526457687|FG000|Overall Study|Withdrew Consent|0|||
145985006|NCT02487199|526457688|FG001|Overall Study|Withdrew Consent|1|||
145985007|NCT01793129|526459351|FG000|Overall Study|Lost to Follow-up|3|||
145985008|NCT01793129|526459352|FG001|Overall Study|Lost to Follow-up|7|||
145985009|NCT01793129|526459351|FG000|Overall Study|Withdrawal by Subject|0|||
145985010|NCT01793129|526459352|FG001|Overall Study|Withdrawal by Subject|2|||
145985011|NCT03931785|526459355|FG000|Overall Study|Lost to Follow-up|4|||
145985012|NCT03931785|526459356|FG001|Overall Study|Lost to Follow-up|1|||
145985013|NCT03931785|526459357|FG002|Overall Study|Lost to Follow-up|4|||
145985014|NCT03931785|526459358|FG003|Overall Study|Lost to Follow-up|3|||
145985015|NCT03931785|526459355|FG000|Overall Study|Adverse Event|1|||
145985016|NCT03931785|526459356|FG001|Overall Study|Adverse Event|0|||
145985017|NCT03931785|526459357|FG002|Overall Study|Adverse Event|3|||
145985018|NCT03931785|526459358|FG003|Overall Study|Adverse Event|4|||
145985019|NCT03931785|526459355|FG000|Overall Study|Protocol Violation|0|||
145985020|NCT03931785|526459356|FG001|Overall Study|Protocol Violation|1|||
145985021|NCT03931785|526459357|FG002|Overall Study|Protocol Violation|0|||
145985022|NCT03931785|526459358|FG003|Overall Study|Protocol Violation|0|||
145985023|NCT03931785|526459355|FG000|Overall Study|Noncompliance With Study drug|0|||
145985024|NCT03931785|526459356|FG001|Overall Study|Noncompliance With Study drug|1|||
145985025|NCT03931785|526459357|FG002|Overall Study|Noncompliance With Study drug|0|||
145985026|NCT03931785|526459358|FG003|Overall Study|Noncompliance With Study drug|0|||
145985027|NCT03931785|526459355|FG000|Overall Study|Other Not specified|0|||
145985028|NCT03931785|526459356|FG001|Overall Study|Other Not specified|2|||
145985029|NCT03931785|526459357|FG002|Overall Study|Other Not specified|2|||
145985030|NCT03931785|526459358|FG003|Overall Study|Other Not specified|2|||
145985031|NCT03931785|526459355|FG000|Overall Study|Withdrawal by Subject|0|||
145985032|NCT03931785|526459356|FG001|Overall Study|Withdrawal by Subject|2|||
145985033|NCT03931785|526459357|FG002|Overall Study|Withdrawal by Subject|4|||
145985034|NCT03931785|526459358|FG003|Overall Study|Withdrawal by Subject|1|||
145985035|NCT03931785|526459355|FG000|Overall Study|Pregnancy|0|||
145985036|NCT03931785|526459356|FG001|Overall Study|Pregnancy|0|||
145985037|NCT03931785|526459357|FG002|Overall Study|Pregnancy|0|||
145985038|NCT03931785|526459358|FG003|Overall Study|Pregnancy|1|||
145985039|NCT03548415|526459359|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145985040|NCT03548415|526459360|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145985041|NCT03548415|526459361|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
145985042|NCT03548415|526459362|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
145985043|NCT03548415|526459363|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
145985044|NCT04605588|526459364|FG000|Overall Study|Withdrawal by Subject|1|||
145985045|NCT04605588|526459365|FG001|Overall Study|Withdrawal by Subject|0|||
145985046|NCT01230814|526459366|FG000|Overall Study|Lost to Follow-up|11|||
145985047|NCT01230814|526459367|FG001|Overall Study|Lost to Follow-up|3|||
145985048|NCT01230814|526459366|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
145985049|NCT01230814|526459367|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
145985050|NCT01803737|526459370|FG000|Overall Study|Lack of Time|1|||
145985051|NCT01803737|526459371|FG001|Overall Study|Lack of Time|0|||
145985052|NCT01803737|526459370|FG000|Overall Study|Medical Reason|0|||
145985053|NCT01803737|526459371|FG001|Overall Study|Medical Reason|1|||
145985054|NCT01803737|526459370|FG000|Overall Study|Lost to Follow-up|0|||
145985055|NCT01803737|526459371|FG001|Overall Study|Lost to Follow-up|2|||
146245762|NCT01137682|527414054|FG000|Overall Study|Adverse Event-CORE|2|||
146245763|NCT01137682|527414055|FG001|Overall Study|Adverse Event-CORE|4|||
145985056|NCT00504556|526459374|FG000|Overall Study|Adverse Event|11|||
145985057|NCT00504556|526459375|FG001|Overall Study|Adverse Event|11|||
145985058|NCT00504556|526459376|FG002|Overall Study|Adverse Event|14|||
145985059|NCT00504556|526459377|FG003|Overall Study|Adverse Event|13|||
145985060|NCT00504556|526459378|FG004|Overall Study|Adverse Event|5|||
145985061|NCT00504556|526459374|FG000|Overall Study|Death|3|||
146245764|NCT01137682|527414056|FG002|Overall Study|Adverse Event-CORE|0|||
146245765|NCT01137682|527414054|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
145985062|NCT00504556|526459375|FG001|Overall Study|Death|3|||
145985063|NCT00504556|526459376|FG002|Overall Study|Death|1|||
145985064|NCT00504556|526459377|FG003|Overall Study|Death|0|||
145985065|NCT00504556|526459378|FG004|Overall Study|Death|2|||
145985066|NCT00504556|526459374|FG000|Overall Study|Protocol Violation|1|||
145985067|NCT00504556|526459375|FG001|Overall Study|Protocol Violation|3|||
145985068|NCT00504556|526459376|FG002|Overall Study|Protocol Violation|2|||
145985069|NCT00504556|526459377|FG003|Overall Study|Protocol Violation|1|||
145985070|NCT00504556|526459378|FG004|Overall Study|Protocol Violation|2|||
145985071|NCT00504556|526459374|FG000|Overall Study|Lost to Follow-up|0|||
145985072|NCT00504556|526459375|FG001|Overall Study|Lost to Follow-up|0|||
145985073|NCT00504556|526459376|FG002|Overall Study|Lost to Follow-up|1|||
145985074|NCT00504556|526459377|FG003|Overall Study|Lost to Follow-up|1|||
145985075|NCT00504556|526459378|FG004|Overall Study|Lost to Follow-up|1|||
145985076|NCT00504556|526459374|FG000|Overall Study|Withdrawal by Subject|16|||
145985077|NCT00504556|526459375|FG001|Overall Study|Withdrawal by Subject|16|||
145985078|NCT00504556|526459376|FG002|Overall Study|Withdrawal by Subject|7|||
145985079|NCT00504556|526459377|FG003|Overall Study|Withdrawal by Subject|8|||
145985080|NCT00504556|526459378|FG004|Overall Study|Withdrawal by Subject|12|||
145985081|NCT00504556|526459374|FG000|Overall Study|administrative reasons|0|||
145985082|NCT00504556|526459375|FG001|Overall Study|administrative reasons|2|||
145985083|NCT00504556|526459376|FG002|Overall Study|administrative reasons|2|||
145985084|NCT00504556|526459377|FG003|Overall Study|administrative reasons|1|||
145985085|NCT00504556|526459378|FG004|Overall Study|administrative reasons|2|||
145985086|NCT00504556|526459374|FG000|Overall Study|did not meet entry criteria|2|||
145985087|NCT00504556|526459375|FG001|Overall Study|did not meet entry criteria|0|||
145985088|NCT00504556|526459376|FG002|Overall Study|did not meet entry criteria|1|||
145985089|NCT00504556|526459377|FG003|Overall Study|did not meet entry criteria|1|||
145985090|NCT00504556|526459378|FG004|Overall Study|did not meet entry criteria|0|||
145985091|NCT00504556|526459374|FG000|Overall Study|data monitor committee decision|0|||
145985092|NCT00504556|526459375|FG001|Overall Study|data monitor committee decision|0|||
145985093|NCT00504556|526459376|FG002|Overall Study|data monitor committee decision|0|||
145985094|NCT00504556|526459377|FG003|Overall Study|data monitor committee decision|100|||
145985095|NCT00504556|526459378|FG004|Overall Study|data monitor committee decision|0|||
145985096|NCT00504556|526459374|FG000|Overall Study|Other|2|||
145985097|NCT00504556|526459375|FG001|Overall Study|Other|2|||
145985098|NCT00504556|526459376|FG002|Overall Study|Other|2|||
145985099|NCT00504556|526459377|FG003|Overall Study|Other|3|||
145985100|NCT00504556|526459378|FG004|Overall Study|Other|0|||
145985101|NCT00504556|526459374|FG000|Overall Study|not in safety analysis set|0|||
145985102|NCT00504556|526459375|FG001|Overall Study|not in safety analysis set|1|||
145985103|NCT00504556|526459376|FG002|Overall Study|not in safety analysis set|1|||
145985104|NCT00504556|526459377|FG003|Overall Study|not in safety analysis set|0|||
145985105|NCT00504556|526459378|FG004|Overall Study|not in safety analysis set|1|||
145985106|NCT02741193|526459381|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
145985107|NCT02741193|526459381|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
145985108|NCT02502383|526459382|FG000|Overall Study|Lost to Follow-up|130|||
145985109|NCT02502383|526459383|FG001|Overall Study|Lost to Follow-up|131|||
145985110|NCT02502383|526459382|FG000|Overall Study|Withdrawal by Subject|31|||
145985111|NCT02502383|526459383|FG001|Overall Study|Withdrawal by Subject|24|||
145985112|NCT02930941|526459384|FG000|Overall Study|Lost to Follow-up|1|||
145985113|NCT02930941|526459385|FG001|Overall Study|Lost to Follow-up|2|||
145985114|NCT00903344|526459386|FG000|Overall Study|Pregnancy|2|||
145985115|NCT00903344|526459387|FG001|Overall Study|Pregnancy|3|||
145985116|NCT00903344|526459386|FG000|Overall Study|Lost to Follow-up|3|||
145985117|NCT00903344|526459387|FG001|Overall Study|Lost to Follow-up|0|||
145985118|NCT01530256|526459390|FG000|Overall Study|Death|2|||
145985119|NCT00292370|526459391|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
145985120|NCT00292370|526459392|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
145985121|NCT00292370|526459393|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
145985122|NCT00292370|526459391|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
145985123|NCT00292370|526459392|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
145985124|NCT00292370|526459393|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
145985125|NCT00292370|526459391|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
145985126|NCT00292370|526459392|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
145985127|NCT00292370|526459393|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
145985128|NCT00292370|526459391|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
145985129|NCT00292370|526459392|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
145985130|NCT00292370|526459393|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
146245766|NCT01137682|527414055|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
146245767|NCT01137682|527414056|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
146245768|NCT01137682|527414054|FG000|Overall Study|Administrative problems-CORE|2|||
145985131|NCT00292370|526459391|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
145985132|NCT00292370|526459392|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
145985133|NCT00292370|526459393|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
145985134|NCT00292370|526459391|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
145985135|NCT00292370|526459392|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
145985136|NCT00292370|526459393|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
145985137|NCT01346709|526459394|FG000|Overall Study|Protocol Violation|35|||
145985138|NCT01346709|526459394|FG000|Overall Study|Lost to Follow-up|31|||
145985139|NCT01346709|526459394|FG000|Overall Study|Missing data in candidate risk factor|285|||
145985140|NCT02365064|526459403|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
145985141|NCT02365064|526459404|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
145985142|NCT02365064|526459403|FG000|Overall Study|Withdrawal by Subject|6|||
145985143|NCT02365064|526459404|FG001|Overall Study|Withdrawal by Subject|9|||
146297849|NCT02038920|527606028|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146297850|NCT02038920|527606029|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
146297851|NCT02038920|527606030|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146297852|NCT02038920|527606031|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
146297853|NCT02038920|527606032|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145985144|NCT02365064|526459403|FG000|Overall Study|Treatment intolerance|2|||
145985145|NCT02365064|526459404|FG001|Overall Study|Treatment intolerance|4|||
145985146|NCT02123511|526459407|FG000|Overall Study|Cancelled treatment|1|||
145985147|NCT02123511|526459408|FG001|Overall Study|Cancelled treatment|0|||
145985148|NCT02123511|526459407|FG000|Overall Study|Incomplete data|1|||
145985149|NCT02123511|526459408|FG001|Overall Study|Incomplete data|3|||
145985150|NCT02123511|526459407|FG000|Overall Study|Ineligible|0|||
145985151|NCT02123511|526459408|FG001|Overall Study|Ineligible|1|||
145985152|NCT00605657|526459409|FG000|Overall Study|Adverse Event|1|||
145985153|NCT00605657|526459409|FG000|Overall Study|Protocol Violation|1|||
145985154|NCT04821245|526459410|FG000|Overall Study|Withdrawal by Subject|3|||
145985155|NCT04821245|526459410|FG000|Overall Study|Physician Decision|1|||
145985156|NCT04821245|526459410|FG000|Overall Study|Protocol Violation|5|||
145985157|NCT00458705|526459411|FG000|Overall Study|Adverse Event|4|||
145985158|NCT00458705|526459411|FG000|Overall Study|Not Treated|1|||
145985159|NCT00378560|526459416|FG000|Overall Study|Adverse Event|1|||
145985160|NCT00378560|526459417|FG001|Overall Study|Adverse Event|0|||
145985161|NCT00378560|526459416|FG000|Overall Study|Lost to Follow-up|24|||
145985162|NCT00378560|526459417|FG001|Overall Study|Lost to Follow-up|29|||
145985163|NCT00378560|526459416|FG000|Overall Study|Protocol Violation|2|||
145985164|NCT00378560|526459417|FG001|Overall Study|Protocol Violation|0|||
145985165|NCT00378560|526459416|FG000|Overall Study|Withdrawal by Subject|17|||
145985166|NCT00378560|526459417|FG001|Overall Study|Withdrawal by Subject|21|||
145985167|NCT00378560|526459416|FG000|Overall Study|Moved|4|||
145985168|NCT00378560|526459417|FG001|Overall Study|Moved|3|||
145985169|NCT00378560|526459416|FG000|Overall Study|Pregnancy|7|||
145985170|NCT00378560|526459417|FG001|Overall Study|Pregnancy|5|||
145985171|NCT00378560|526459416|FG000|Overall Study|Laboratory test values abnormal|1|||
145985172|NCT00378560|526459417|FG001|Overall Study|Laboratory test values abnormal|0|||
145985173|NCT02773537|526459418|FG000|Overall Study|Lost to Follow-up|0|||
145985174|NCT02773537|526459419|FG001|Overall Study|Lost to Follow-up|1|||
145985175|NCT02773537|526459420|FG002|Overall Study|Lost to Follow-up|4|||
145985176|NCT01174459|526459431|FG000|Overall Study|case report form (CRF) not collected|5|||
145985177|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
145985178|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
145985179|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
145985180|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
145985181|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
145985182|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
145985183|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
145985184|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
145985185|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
145985186|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
145985187|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
145985188|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
145985189|NCT00290758|526459438|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
145985190|NCT00290758|526459439|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
145985191|NCT00290758|526459438|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
145985192|NCT00290758|526459439|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
145985193|NCT03994120|526459441|FG000|Overall Study|Lost to Follow-up|3|||
145985194|NCT03994120|526459442|FG001|Overall Study|Lost to Follow-up|1|||
145985195|NCT01111292|526459443|FG000|Treatment|Physician Decision|1|||
145985196|NCT01111292|526459444|FG001|Treatment|Physician Decision|1|||
145985197|NCT05587998|526459447|FG000|Overall Study|Withdrawal by Subject|1|||
145985198|NCT05587998|526459448|FG001|Overall Study|Withdrawal by Subject|1|||
145985199|NCT05587998|526459447|FG000|Overall Study|Not treated|3|||
145985200|NCT05587998|526459448|FG001|Overall Study|Not treated|1|||
145985201|NCT05587998|526459447|FG000|Overall Study|Non-compliance with study procedures|0|||
145985202|NCT05587998|526459448|FG001|Overall Study|Non-compliance with study procedures|1|||
145985203|NCT03892915|526459449|FG000|Overall Study|Lost to Follow-up|6|||
145985204|NCT03892915|526459450|FG001|Overall Study|Lost to Follow-up|12|||
145985205|NCT03892915|526459449|FG000|Overall Study|Death|0|||
145985206|NCT03892915|526459450|FG001|Overall Study|Death|2|||
145985207|NCT03892915|526459449|FG000|Overall Study|Withdrawal by Subject|1|||
145985208|NCT03892915|526459450|FG001|Overall Study|Withdrawal by Subject|1|||
145985209|NCT03892915|526459449|FG000|Overall Study|unsuccessful delivery|13|||
145985210|NCT03892915|526459450|FG001|Overall Study|unsuccessful delivery|18|||
145985211|NCT00191152|526459451|FG000|Initial Treatment|Adverse Event|43|||
145985212|NCT00191152|526459452|FG001|Initial Treatment|Adverse Event|67|||
145985213|NCT00191152|526459451|FG000|Initial Treatment|Physician Decision|40|||
145985214|NCT00191152|526459452|FG001|Initial Treatment|Physician Decision|31|||
145985215|NCT00191152|526459451|FG000|Initial Treatment|Withdrawal by Subject|40|||
145985216|NCT00191152|526459452|FG001|Initial Treatment|Withdrawal by Subject|28|||
145985217|NCT00191152|526459451|FG000|Initial Treatment|Lost to Follow-up|0|||
145985218|NCT00191152|526459452|FG001|Initial Treatment|Lost to Follow-up|6|||
145985219|NCT00191152|526459451|FG000|Initial Treatment|Other|18|||
145985220|NCT00191152|526459452|FG001|Initial Treatment|Other|21|||
145985221|NCT00191152|526459451|FG000|Crossover Treatment|Adverse Event|8|||
145985222|NCT00191152|526459452|FG001|Crossover Treatment|Adverse Event|8|||
145985223|NCT00191152|526459451|FG000|Crossover Treatment|Physician Decision|7|||
145985224|NCT00191152|526459452|FG001|Crossover Treatment|Physician Decision|7|||
145985225|NCT00191152|526459451|FG000|Crossover Treatment|Withdrawal by Subject|6|||
145985226|NCT00191152|526459452|FG001|Crossover Treatment|Withdrawal by Subject|9|||
145985227|NCT00191152|526459451|FG000|Crossover Treatment|Lost to Follow-up|2|||
145985228|NCT00191152|526459452|FG001|Crossover Treatment|Lost to Follow-up|1|||
145985229|NCT00191152|526459451|FG000|Crossover Treatment|Other|4|||
145985230|NCT00191152|526459452|FG001|Crossover Treatment|Other|3|||
145985231|NCT00114777|526459453|FG000|Randomization to Month 36|Death|10|||
145985232|NCT00114777|526459454|FG001|Randomization to Month 36|Death|4|||
145985233|NCT00114777|526459455|FG002|Randomization to Month 36|Death|3|||
145985234|NCT00114777|526459453|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
145985235|NCT00114777|526459454|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
145985236|NCT00114777|526459455|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
145985237|NCT00114777|526459453|FG000|Randomization to Month 36|Lack of Efficacy|19|||
145985238|NCT00114777|526459454|FG001|Randomization to Month 36|Lack of Efficacy|15|||
145985239|NCT00114777|526459455|FG002|Randomization to Month 36|Lack of Efficacy|17|||
145985240|NCT00114777|526459453|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
145985241|NCT00114777|526459454|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
145985242|NCT00114777|526459455|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
145985243|NCT00114777|526459453|FG000|Randomization to Month 36|Adverse Event|34|||
145985244|NCT00114777|526459454|FG001|Randomization to Month 36|Adverse Event|35|||
145985245|NCT00114777|526459455|FG002|Randomization to Month 36|Adverse Event|44|||
145985246|NCT00114777|526459453|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
145985247|NCT00114777|526459454|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
145985248|NCT00114777|526459455|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
145985249|NCT00114777|526459453|FG000|Randomization to Month 36|Other|9|||
145985250|NCT00114777|526459454|FG001|Randomization to Month 36|Other|3|||
145985251|NCT00114777|526459455|FG002|Randomization to Month 36|Other|12|||
145985252|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Death|8|||
145985253|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Death|13|||
145985254|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Death|7|||
145985255|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
145985256|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
145985257|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
145985258|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
145985259|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
145985260|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
145985261|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
145985262|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
145985263|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
145985264|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
145985265|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
145985266|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
145985267|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
145985268|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
145985269|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
145985270|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
145985271|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
145985272|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
145985273|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
145985274|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
145985275|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
145985276|NCT00114777|526459453|FG000|Long-Term Extension to Month 84|Other|2|||
145985277|NCT00114777|526459454|FG001|Long-Term Extension to Month 84|Other|0|||
145985278|NCT00114777|526459455|FG002|Long-Term Extension to Month 84|Other|2|||
145985279|NCT01986751|526459464|FG000|Overall Study|improperly consented|10|||
145985280|NCT01986751|526459465|FG001|Overall Study|improperly consented|2|||
145985281|NCT03566550|526459467|FG000|Overall Study|Withdrawal by Subject|0|||
145985282|NCT03566550|526459468|FG001|Overall Study|Withdrawal by Subject|1|||
145985283|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Adverse Event|14|||
145985284|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Adverse Event|27|||
145985285|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Adverse Event|60|||
145985286|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Adverse Event|0|||
145985287|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Adverse Event|0|||
145985288|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Pregnancy|0|||
145985289|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Pregnancy|7|||
145985290|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Pregnancy|9|||
145985291|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Pregnancy|0|||
145985292|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Pregnancy|0|||
145985293|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
145985294|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
145985295|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
145985296|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
145985297|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
145985298|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
145985299|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
145985300|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
145985301|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
145985302|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
145985303|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Death|1|||
145985304|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Death|2|||
145985305|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Death|2|||
145985306|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Death|0|||
145985307|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Death|0|||
145985308|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
145985309|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
145985310|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
145985311|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
145985312|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
145985313|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
145985314|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
145985315|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
145985316|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
145985317|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
145985318|NCT00098293|526459469|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
145985319|NCT00098293|526459470|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
145985320|NCT00098293|526459471|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
145985321|NCT00098293|526459472|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
145985322|NCT00098293|526459473|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
145985323|NCT00098293|526459469|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145985324|NCT00098293|526459470|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
146245769|NCT01137682|527414055|FG001|Overall Study|Administrative problems-CORE|1|||
146245770|NCT01137682|527414056|FG002|Overall Study|Administrative problems-CORE|0|||
146245771|NCT01137682|527414054|FG000|Overall Study|Protocol Violation-CORE|0|||
146245772|NCT01137682|527414055|FG001|Overall Study|Protocol Violation-CORE|1|||
146245773|NCT01137682|527414056|FG002|Overall Study|Protocol Violation-CORE|1|||
146245774|NCT01137682|527414054|FG000|Overall Study|Adverse Event-Extension|4|||
146245775|NCT01137682|527414055|FG001|Overall Study|Adverse Event-Extension|8|||
146245776|NCT01137682|527414056|FG002|Overall Study|Adverse Event-Extension|7|||
146245777|NCT01137682|527414054|FG000|Overall Study|Lack of Efficacy-Extension|15|||
145985325|NCT00098293|526459471|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
145985326|NCT00098293|526459472|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145985327|NCT00098293|526459473|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145985328|NCT00098293|526459469|FG000|Open-label (OL) Phase|Adverse Event|0|||
145985329|NCT00098293|526459470|FG001|Open-label (OL) Phase|Adverse Event|3|||
145985330|NCT00098293|526459471|FG002|Open-label (OL) Phase|Adverse Event|7|||
145985331|NCT00098293|526459472|FG003|Open-label (OL) Phase|Adverse Event|6|||
145985332|NCT00098293|526459473|FG004|Open-label (OL) Phase|Adverse Event|0|||
145985333|NCT00098293|526459469|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
145985334|NCT00098293|526459470|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
145985335|NCT00098293|526459471|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
145985336|NCT00098293|526459472|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
146245778|NCT01137682|527414055|FG001|Overall Study|Lack of Efficacy-Extension|9|||
145985337|NCT00098293|526459473|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
145985338|NCT00098293|526459469|FG000|Open-label (OL) Phase|Pregnancy|0|||
145985339|NCT00098293|526459470|FG001|Open-label (OL) Phase|Pregnancy|1|||
145985340|NCT00098293|526459471|FG002|Open-label (OL) Phase|Pregnancy|0|||
145985341|NCT00098293|526459472|FG003|Open-label (OL) Phase|Pregnancy|3|||
145985342|NCT00098293|526459473|FG004|Open-label (OL) Phase|Pregnancy|0|||
145985343|NCT00098293|526459469|FG000|Open-label (OL) Phase|Protocol Violation|0|||
145985344|NCT00098293|526459470|FG001|Open-label (OL) Phase|Protocol Violation|6|||
145985345|NCT00098293|526459471|FG002|Open-label (OL) Phase|Protocol Violation|13|||
145985346|NCT00098293|526459472|FG003|Open-label (OL) Phase|Protocol Violation|16|||
145985347|NCT00098293|526459473|FG004|Open-label (OL) Phase|Protocol Violation|0|||
145985348|NCT00098293|526459469|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
145985349|NCT00098293|526459470|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
145985350|NCT00098293|526459471|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
145985351|NCT00098293|526459472|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
145985352|NCT00098293|526459473|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
145985353|NCT00098293|526459469|FG000|Open-label (OL) Phase|Death|0|||
145985354|NCT00098293|526459470|FG001|Open-label (OL) Phase|Death|2|||
145985355|NCT00098293|526459471|FG002|Open-label (OL) Phase|Death|3|||
145985356|NCT00098293|526459472|FG003|Open-label (OL) Phase|Death|0|||
145985357|NCT00098293|526459473|FG004|Open-label (OL) Phase|Death|0|||
145985358|NCT00098293|526459469|FG000|Supplemental Phase (SP)|Death|0|||
145985359|NCT00098293|526459470|FG001|Supplemental Phase (SP)|Death|0|||
145985360|NCT00098293|526459471|FG002|Supplemental Phase (SP)|Death|0|||
145985361|NCT00098293|526459472|FG003|Supplemental Phase (SP)|Death|0|||
145985362|NCT00098293|526459473|FG004|Supplemental Phase (SP)|Death|1|||
145985363|NCT00098293|526459469|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
145985364|NCT00098293|526459470|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
145985365|NCT00098293|526459471|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
145985366|NCT00098293|526459472|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
145985367|NCT00098293|526459473|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
145985368|NCT00098293|526459469|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145985369|NCT00098293|526459470|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145985370|NCT00098293|526459471|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145985371|NCT00098293|526459472|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145985372|NCT00098293|526459473|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
145985373|NCT00098293|526459469|FG000|Supplemental Phase (SP)|Other|0|||
145985374|NCT00098293|526459470|FG001|Supplemental Phase (SP)|Other|0|||
145985375|NCT00098293|526459471|FG002|Supplemental Phase (SP)|Other|0|||
145985376|NCT00098293|526459472|FG003|Supplemental Phase (SP)|Other|0|||
145985377|NCT00098293|526459473|FG004|Supplemental Phase (SP)|Other|22|||
145985378|NCT01968785|526459474|FG000|Overall Study|Withdrawal by Subject|1|||
145985379|NCT01968785|526459475|FG001|Overall Study|Withdrawal by Subject|0|||
145985380|NCT00754559|526459478|FG000|Overall Study|Adverse Event|15|||
145985381|NCT00754559|526459478|FG000|Overall Study|Protocol Violation|11|||
145985382|NCT00754559|526459478|FG000|Overall Study|Lack of Efficacy|10|||
145985383|NCT00754559|526459478|FG000|Overall Study|Lost to Follow-up|2|||
145985384|NCT00754559|526459478|FG000|Overall Study|Administrative reason|1|||
145985385|NCT00754559|526459478|FG000|Overall Study|Other|5|||
145985386|NCT00754559|526459478|FG000|Overall Study|Withdrawal by Subject|3|||
145985387|NCT04000724|526459479|FG000|Overall Study|Withdrawal by Subject|5|||
145985388|NCT04000724|526459480|FG001|Overall Study|Withdrawal by Subject|3|||
145985389|NCT04000724|526459481|FG002|Overall Study|Withdrawal by Subject|4|||
145985390|NCT04000724|526459479|FG000|Overall Study|Lost to Follow-up|11|||
145985391|NCT04000724|526459480|FG001|Overall Study|Lost to Follow-up|7|||
145985392|NCT04000724|526459481|FG002|Overall Study|Lost to Follow-up|13|||
145985393|NCT03335566|526459482|FG000|Overall Study|Adverse Event|0|||
145985394|NCT03335566|526459483|FG001|Overall Study|Adverse Event|1|||
145985395|NCT03335566|526459482|FG000|Overall Study|Lost to Follow-up|1|||
145985396|NCT03335566|526459483|FG001|Overall Study|Lost to Follow-up|0|||
145985397|NCT03335566|526459482|FG000|Overall Study|Technical Problems|1|||
145985398|NCT03335566|526459483|FG001|Overall Study|Technical Problems|0|||
145985399|NCT03335566|526459482|FG000|Overall Study|Protocol Violation|1|||
145985400|NCT03335566|526459483|FG001|Overall Study|Protocol Violation|0|||
145985401|NCT03335566|526459482|FG000|Overall Study|Other than specified above|1|||
145985402|NCT03335566|526459483|FG001|Overall Study|Other than specified above|2|||
145985403|NCT01084135|526459484|FG000|20 Week|Physician Decision|0|||
145985404|NCT01084135|526459485|FG001|20 Week|Physician Decision|1|||
145985405|NCT04595370|526459486|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
145985406|NCT04595370|526459487|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145985407|NCT04595370|526459488|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145985408|NCT04595370|526459489|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145985409|NCT04595370|526459490|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145985410|NCT04595370|526459491|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145985411|NCT04595370|526459486|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145985412|NCT04595370|526459487|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145985413|NCT04595370|526459488|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
145985414|NCT04595370|526459489|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145985415|NCT04595370|526459490|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145985416|NCT04595370|526459491|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145985417|NCT04595370|526459486|FG000|Overall Study|Adverse Event|0|||
145985418|NCT04595370|526459487|FG001|Overall Study|Adverse Event|4|||
145985419|NCT04595370|526459488|FG002|Overall Study|Adverse Event|3|||
145985420|NCT04595370|526459489|FG003|Overall Study|Adverse Event|1|||
145985421|NCT04595370|526459490|FG004|Overall Study|Adverse Event|1|||
145985422|NCT04595370|526459491|FG005|Overall Study|Adverse Event|1|||
145985423|NCT04595370|526459486|FG000|Overall Study|Withdrawal of Consent|1|||
145985424|NCT04595370|526459487|FG001|Overall Study|Withdrawal of Consent|1|||
145985425|NCT04595370|526459488|FG002|Overall Study|Withdrawal of Consent|1|||
145985426|NCT04595370|526459489|FG003|Overall Study|Withdrawal of Consent|0|||
145985427|NCT04595370|526459490|FG004|Overall Study|Withdrawal of Consent|0|||
145985428|NCT04595370|526459491|FG005|Overall Study|Withdrawal of Consent|0|||
145985429|NCT04595370|526459486|FG000|Overall Study|Death|0|||
145985430|NCT04595370|526459487|FG001|Overall Study|Death|1|||
145985431|NCT04595370|526459488|FG002|Overall Study|Death|0|||
145985432|NCT04595370|526459489|FG003|Overall Study|Death|0|||
145985433|NCT04595370|526459490|FG004|Overall Study|Death|1|||
145985434|NCT04595370|526459491|FG005|Overall Study|Death|0|||
145985435|NCT04595370|526459486|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145985436|NCT04595370|526459487|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145985437|NCT04595370|526459488|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145985438|NCT04595370|526459489|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145985439|NCT04595370|526459490|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145985440|NCT04595370|526459491|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145985441|NCT04595370|526459486|FG000|Overall Study|Withdrawal by Subject|0|||
145985442|NCT04595370|526459487|FG001|Overall Study|Withdrawal by Subject|0|||
145985443|NCT04595370|526459488|FG002|Overall Study|Withdrawal by Subject|1|||
145985444|NCT04595370|526459489|FG003|Overall Study|Withdrawal by Subject|0|||
145985445|NCT04595370|526459490|FG004|Overall Study|Withdrawal by Subject|2|||
145985446|NCT04595370|526459491|FG005|Overall Study|Withdrawal by Subject|0|||
145985447|NCT04595370|526459486|FG000|Overall Study|Lost to Follow-up|0|||
145985448|NCT04595370|526459487|FG001|Overall Study|Lost to Follow-up|0|||
145985449|NCT04595370|526459488|FG002|Overall Study|Lost to Follow-up|0|||
145985450|NCT04595370|526459489|FG003|Overall Study|Lost to Follow-up|0|||
145985451|NCT04595370|526459490|FG004|Overall Study|Lost to Follow-up|1|||
145985452|NCT04595370|526459491|FG005|Overall Study|Lost to Follow-up|0|||
145985453|NCT04595370|526459486|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145985454|NCT04595370|526459487|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
145985455|NCT04595370|526459488|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
145985456|NCT04595370|526459489|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145985457|NCT04595370|526459490|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
145985458|NCT04595370|526459491|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145985459|NCT02218268|526459492|FG000|24 Hour Washout|Physician Decision|11|||
145985460|NCT02218268|526459493|FG001|24 Hour Washout|Physician Decision|9|||
145985461|NCT03651336|526459494|FG000|Overall Study|Withdrawal by Subject|4|||
145985462|NCT01341990|526459495|FG000|Overall Study|Adverse Event|0|||
145985463|NCT01341990|526459496|FG001|Overall Study|Adverse Event|1|||
145985464|NCT01341990|526459495|FG000|Overall Study|Torn Study Lens|1|||
145985465|NCT01341990|526459496|FG001|Overall Study|Torn Study Lens|0|||
145985466|NCT01341990|526459495|FG000|Overall Study|Withdrawal by Subject|2|||
145985467|NCT01341990|526459496|FG001|Overall Study|Withdrawal by Subject|0|||
145985468|NCT03632720|526459497|FG000|Overall Study|Adverse Event|2|||
145985469|NCT03632720|526459498|FG001|Overall Study|Adverse Event|0|||
145985470|NCT03632720|526459499|FG002|Overall Study|Adverse Event|0|||
145985471|NCT03632720|526459497|FG000|Overall Study|Lost to Follow-up|0|||
145985472|NCT03632720|526459498|FG001|Overall Study|Lost to Follow-up|1|||
145985473|NCT03632720|526459499|FG002|Overall Study|Lost to Follow-up|0|||
145985474|NCT03632720|526459497|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
145985475|NCT03632720|526459498|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
145985476|NCT03632720|526459499|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
145985477|NCT03632720|526459497|FG000|Overall Study|Screen failure|0|||
145985478|NCT03632720|526459498|FG001|Overall Study|Screen failure|1|||
145985479|NCT03632720|526459499|FG002|Overall Study|Screen failure|0|||
145985480|NCT01117350|526459500|FG000|Comparative Period|Not Treated|5|||
145985481|NCT01117350|526459501|FG001|Comparative Period|Not Treated|8|||
145985482|NCT01117350|526459500|FG000|Comparative Period|Adverse Event|6|||
145985483|NCT01117350|526459501|FG001|Comparative Period|Adverse Event|33|||
145985484|NCT01117350|526459500|FG000|Comparative Period|Lost to Follow-up|11|||
145985485|NCT01117350|526459501|FG001|Comparative Period|Lost to Follow-up|7|||
145985486|NCT01117350|526459500|FG000|Comparative Period|Withdrawal by Subject|9|||
145985487|NCT01117350|526459501|FG001|Comparative Period|Withdrawal by Subject|13|||
145985488|NCT01117350|526459500|FG000|Comparative Period|Protocol Violation|8|||
145985489|NCT01117350|526459501|FG001|Comparative Period|Protocol Violation|12|||
145985490|NCT01117350|526459500|FG000|Comparative Period|Lack of Efficacy|1|||
145985491|NCT01117350|526459501|FG001|Comparative Period|Lack of Efficacy|0|||
145985492|NCT01117350|526459500|FG000|Comparative Period|Physician Decision|0|||
145985493|NCT01117350|526459501|FG001|Comparative Period|Physician Decision|1|||
145985494|NCT01117350|526459500|FG000|Comparative Period|Move to another city/country|2|||
145985495|NCT01117350|526459501|FG001|Comparative Period|Move to another city/country|1|||
145985496|NCT01117350|526459500|FG000|Extension Period|Not included in extension, not treated|0|||
145985497|NCT01117350|526459501|FG001|Extension Period|Not included in extension, not treated|50|||
145985498|NCT01117350|526459500|FG000|Extension Period|Adverse Event|0|||
145985499|NCT01117350|526459501|FG001|Extension Period|Adverse Event|2|||
145985500|NCT01117350|526459500|FG000|Extension Period|Protocol Violation|0|||
145985501|NCT01117350|526459501|FG001|Extension Period|Protocol Violation|2|||
145985502|NCT01117350|526459500|FG000|Extension Period|Lost to Follow-up|0|||
145985503|NCT01117350|526459501|FG001|Extension Period|Lost to Follow-up|2|||
145985504|NCT01117350|526459500|FG000|Extension Period|Withdrawal by Subject|0|||
145985505|NCT01117350|526459501|FG001|Extension Period|Withdrawal by Subject|3|||
145985506|NCT01117350|526459500|FG000|Extension Period|Lack of Efficacy|0|||
145985507|NCT01117350|526459501|FG001|Extension Period|Lack of Efficacy|2|||
145985508|NCT01117350|526459500|FG000|Extension Period|Inclusion criteria not respected|0|||
145985509|NCT01117350|526459501|FG001|Extension Period|Inclusion criteria not respected|1|||
145985510|NCT01117350|526459500|FG000|Extension Period|Prohibited medication|0|||
145985511|NCT01117350|526459501|FG001|Extension Period|Prohibited medication|1|||
145985512|NCT01213251|526461552|FG000|Overall Study|Death|2|||
145985513|NCT01213251|526461553|FG001|Overall Study|Death|1|||
145985514|NCT01213251|526461554|FG002|Overall Study|Death|2|||
145985515|NCT01213251|526461552|FG000|Overall Study|Exit|3|||
145985516|NCT01213251|526461553|FG001|Overall Study|Exit|2|||
145985517|NCT01213251|526461554|FG002|Overall Study|Exit|8|||
145985518|NCT01213251|526461552|FG000|Overall Study|Protocol Violation|1|||
145985519|NCT01213251|526461553|FG001|Overall Study|Protocol Violation|1|||
145985520|NCT01213251|526461554|FG002|Overall Study|Protocol Violation|0|||
145985521|NCT01213251|526461552|FG000|Overall Study|Missed 18-Month Follow-up|0|||
145985522|NCT01213251|526461553|FG001|Overall Study|Missed 18-Month Follow-up|0|||
145985523|NCT01213251|526461554|FG002|Overall Study|Missed 18-Month Follow-up|1|||
145985524|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
145985525|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145985526|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145985527|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145985528|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145985529|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
145985530|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145985531|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
145985532|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145985533|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
145985534|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145985535|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145985536|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145985537|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145985538|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
145985539|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985540|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985541|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985542|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985543|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985544|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145985545|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
145985546|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145985547|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145985548|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145985549|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145985550|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
145985551|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145985552|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985553|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
145985554|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985555|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985556|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985557|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985558|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145985559|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145985560|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145985561|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145985562|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145985563|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145985564|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
145985565|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
145985566|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145985567|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145985568|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145985569|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145985570|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145985571|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145985572|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145985573|NCT01557244|526461559|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
145985574|NCT01557244|526461560|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145985575|NCT01557244|526461561|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
145985576|NCT01557244|526461562|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145985577|NCT01557244|526461563|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145985578|NCT01557244|526461564|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145985579|NCT01557244|526461565|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145985580|NCT01557244|526461559|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145985581|NCT01557244|526461560|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145985582|NCT01557244|526461561|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145985583|NCT01557244|526461562|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145985584|NCT01557244|526461563|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145985585|NCT01557244|526461564|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145985586|NCT01557244|526461565|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145985587|NCT01557244|526461559|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
145985588|NCT01557244|526461560|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
145985589|NCT01557244|526461561|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145985590|NCT01557244|526461562|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145985591|NCT01557244|526461563|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145985592|NCT01557244|526461564|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145985593|NCT01557244|526461565|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145985594|NCT01557244|526461559|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985595|NCT01557244|526461560|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985596|NCT01557244|526461561|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985597|NCT01557244|526461562|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
145985598|NCT01557244|526461563|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985599|NCT01557244|526461564|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985600|NCT01557244|526461565|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145985601|NCT01557244|526461559|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
145985602|NCT01557244|526461560|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
145985603|NCT01557244|526461561|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145985604|NCT01557244|526461562|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145985605|NCT01557244|526461563|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145985606|NCT01557244|526461564|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145985607|NCT01557244|526461565|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145985608|NCT01313676|526461566|FG000|Overall Study|Adverse Event|395|||
145985609|NCT01313676|526461567|FG001|Overall Study|Adverse Event|365|||
145985610|NCT01313676|526461568|FG002|Overall Study|Adverse Event|372|||
145985611|NCT01313676|526461569|FG003|Overall Study|Adverse Event|333|||
145985612|NCT01313676|526461566|FG000|Overall Study|Lack of Efficacy|98|||
146091329|NCT00473746|526854946|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146091330|NCT00473746|526854947|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146245779|NCT01137682|527414056|FG002|Overall Study|Lack of Efficacy-Extension|13|||
146245780|NCT01137682|527414054|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
145985613|NCT01313676|526461567|FG001|Overall Study|Lack of Efficacy|90|||
145985614|NCT01313676|526461568|FG002|Overall Study|Lack of Efficacy|65|||
145985615|NCT01313676|526461569|FG003|Overall Study|Lack of Efficacy|46|||
145985616|NCT01313676|526461566|FG000|Overall Study|Protocol Violation|37|||
145985617|NCT01313676|526461567|FG001|Overall Study|Protocol Violation|44|||
145985618|NCT01313676|526461568|FG002|Overall Study|Protocol Violation|46|||
145985619|NCT01313676|526461569|FG003|Overall Study|Protocol Violation|44|||
145985620|NCT01313676|526461566|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
145985621|NCT01313676|526461567|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
145985622|NCT01313676|526461568|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
145985623|NCT01313676|526461569|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
145985624|NCT01313676|526461566|FG000|Overall Study|Study Closed/terminated|7|||
145985625|NCT01313676|526461567|FG001|Overall Study|Study Closed/terminated|6|||
145985626|NCT01313676|526461568|FG002|Overall Study|Study Closed/terminated|9|||
145985627|NCT01313676|526461569|FG003|Overall Study|Study Closed/terminated|9|||
145985628|NCT01313676|526461566|FG000|Overall Study|Lost to Follow-up|0|||
145985629|NCT01313676|526461567|FG001|Overall Study|Lost to Follow-up|0|||
145985630|NCT01313676|526461568|FG002|Overall Study|Lost to Follow-up|1|||
145985631|NCT01313676|526461569|FG003|Overall Study|Lost to Follow-up|0|||
145985632|NCT01313676|526461566|FG000|Overall Study|Physician Decision|53|||
145985633|NCT01313676|526461567|FG001|Overall Study|Physician Decision|64|||
145985634|NCT01313676|526461568|FG002|Overall Study|Physician Decision|62|||
145985635|NCT01313676|526461569|FG003|Overall Study|Physician Decision|48|||
145985636|NCT01313676|526461566|FG000|Overall Study|Decision by Participant or Proxy|643|||
145985637|NCT01313676|526461567|FG001|Overall Study|Decision by Participant or Proxy|527|||
145985638|NCT01313676|526461568|FG002|Overall Study|Decision by Participant or Proxy|515|||
145985639|NCT01313676|526461569|FG003|Overall Study|Decision by Participant or Proxy|492|||
145985640|NCT01313676|526461566|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
145985641|NCT01313676|526461567|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
145985642|NCT01313676|526461568|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
145985643|NCT01313676|526461569|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
145985644|NCT01313676|526461566|FG000|Overall Study|Investigator Site Closed|12|||
145985645|NCT01313676|526461567|FG001|Overall Study|Investigator Site Closed|11|||
145985646|NCT01313676|526461568|FG002|Overall Study|Investigator Site Closed|15|||
145985647|NCT01313676|526461569|FG003|Overall Study|Investigator Site Closed|10|||
145985648|NCT01313676|526461566|FG000|Overall Study|Missing|1|||
145985649|NCT01313676|526461567|FG001|Overall Study|Missing|1|||
145985650|NCT01313676|526461568|FG002|Overall Study|Missing|1|||
145985651|NCT01313676|526461569|FG003|Overall Study|Missing|0|||
145985652|NCT01862029|526461570|FG000|Overall Study|Physician Decision|1|||
145985653|NCT02004275|526461578|FG000|Phase 1|Ineligible|0|||
145985654|NCT02004275|526461579|FG001|Phase 1|Ineligible|0|||
145985655|NCT02004275|526461580|FG002|Phase 1|Ineligible|0|||
145985656|NCT02004275|526461581|FG003|Phase 1|Ineligible|1|||
145985657|NCT02004275|526461582|FG004|Phase 1|Ineligible|1|||
145985658|NCT02004275|526461583|FG005|Phase 1|Ineligible|0|||
145985659|NCT02004275|526461578|FG000|Phase 1|Protocol Violation|0|||
145985660|NCT02004275|526461579|FG001|Phase 1|Protocol Violation|0|||
145985661|NCT02004275|526461580|FG002|Phase 1|Protocol Violation|0|||
145985662|NCT02004275|526461581|FG003|Phase 1|Protocol Violation|1|||
145985663|NCT02004275|526461582|FG004|Phase 1|Protocol Violation|0|||
145985664|NCT02004275|526461583|FG005|Phase 1|Protocol Violation|5|||
145985665|NCT02004275|526461578|FG000|Phase 2 Part 1|Ineligible|6|||
145985666|NCT02004275|526461579|FG001|Phase 2 Part 1|Ineligible|9|||
145985667|NCT02004275|526461580|FG002|Phase 2 Part 1|Ineligible|0|||
145985668|NCT02004275|526461581|FG003|Phase 2 Part 1|Ineligible|0|||
145985669|NCT02004275|526461582|FG004|Phase 2 Part 1|Ineligible|0|||
145985670|NCT02004275|526461583|FG005|Phase 2 Part 1|Ineligible|0|||
145985671|NCT02004275|526461578|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
145985672|NCT02004275|526461579|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
145985673|NCT02004275|526461580|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
145985674|NCT02004275|526461581|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
145985675|NCT02004275|526461582|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
145985676|NCT02004275|526461583|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
145985677|NCT04621786|526461584|FG000|Overall Study|Lost to Follow-up|9|||
145985678|NCT04621786|526461584|FG000|Overall Study|Protocol Violation|3|||
145985679|NCT02533674|526461585|FG000|Dose Level I|Progressive disease|1|||
145985680|NCT02533674|526461586|FG001|Dose Level I|Progressive disease|0|||
145985681|NCT02533674|526461587|FG002|Dose Level I|Progressive disease|0|||
145985682|NCT02533674|526461588|FG003|Dose Level I|Progressive disease|0|||
145985683|NCT02533674|526461589|FG004|Dose Level I|Progressive disease|0|||
145985684|NCT02533674|526461590|FG005|Dose Level I|Progressive disease|0|||
145985685|NCT02533674|526461591|FG006|Dose Level I|Progressive disease|0|||
145985686|NCT02533674|526461592|FG007|Dose Level I|Progressive disease|0|||
145985687|NCT02533674|526461585|FG000|Dose Level I|Withdrawal by Subject|1|||
145985688|NCT02533674|526461586|FG001|Dose Level I|Withdrawal by Subject|0|||
145985689|NCT02533674|526461587|FG002|Dose Level I|Withdrawal by Subject|0|||
145985690|NCT02533674|526461588|FG003|Dose Level I|Withdrawal by Subject|0|||
145985691|NCT02533674|526461589|FG004|Dose Level I|Withdrawal by Subject|0|||
145985692|NCT02533674|526461590|FG005|Dose Level I|Withdrawal by Subject|0|||
145985693|NCT02533674|526461591|FG006|Dose Level I|Withdrawal by Subject|0|||
145985694|NCT02533674|526461592|FG007|Dose Level I|Withdrawal by Subject|0|||
145985695|NCT02533674|526461585|FG000|Dose Level I|Physician Decision|1|||
145985696|NCT02533674|526461586|FG001|Dose Level I|Physician Decision|0|||
145985697|NCT02533674|526461587|FG002|Dose Level I|Physician Decision|0|||
145985698|NCT02533674|526461588|FG003|Dose Level I|Physician Decision|0|||
145985699|NCT02533674|526461589|FG004|Dose Level I|Physician Decision|0|||
145985700|NCT02533674|526461590|FG005|Dose Level I|Physician Decision|0|||
145985701|NCT02533674|526461591|FG006|Dose Level I|Physician Decision|0|||
145985702|NCT02533674|526461592|FG007|Dose Level I|Physician Decision|0|||
145985703|NCT02533674|526461585|FG000|Dose Level I|Death|1|||
145985704|NCT02533674|526461586|FG001|Dose Level I|Death|0|||
145985705|NCT02533674|526461587|FG002|Dose Level I|Death|0|||
145985706|NCT02533674|526461588|FG003|Dose Level I|Death|0|||
145985707|NCT02533674|526461589|FG004|Dose Level I|Death|0|||
145985708|NCT02533674|526461590|FG005|Dose Level I|Death|0|||
145985709|NCT02533674|526461591|FG006|Dose Level I|Death|0|||
145985710|NCT02533674|526461592|FG007|Dose Level I|Death|0|||
145985711|NCT02533674|526461585|FG000|Dose Level I|Never Treated|1|||
145985712|NCT02533674|526461586|FG001|Dose Level I|Never Treated|0|||
145985713|NCT02533674|526461587|FG002|Dose Level I|Never Treated|0|||
145985714|NCT02533674|526461588|FG003|Dose Level I|Never Treated|0|||
145985715|NCT02533674|526461589|FG004|Dose Level I|Never Treated|0|||
145985716|NCT02533674|526461590|FG005|Dose Level I|Never Treated|0|||
145985717|NCT02533674|526461591|FG006|Dose Level I|Never Treated|0|||
145985718|NCT02533674|526461592|FG007|Dose Level I|Never Treated|0|||
145985719|NCT02533674|526461585|FG000|Dose Level II|Progressive disease|0|||
145985720|NCT02533674|526461586|FG001|Dose Level II|Progressive disease|3|||
145985721|NCT02533674|526461587|FG002|Dose Level II|Progressive disease|0|||
145985722|NCT02533674|526461588|FG003|Dose Level II|Progressive disease|0|||
145985723|NCT02533674|526461589|FG004|Dose Level II|Progressive disease|0|||
145985724|NCT02533674|526461590|FG005|Dose Level II|Progressive disease|0|||
145985725|NCT02533674|526461591|FG006|Dose Level II|Progressive disease|0|||
145985726|NCT02533674|526461592|FG007|Dose Level II|Progressive disease|0|||
145985727|NCT02533674|526461585|FG000|Dose Level II|Withdrawal by Subject|0|||
145985728|NCT02533674|526461586|FG001|Dose Level II|Withdrawal by Subject|1|||
145985729|NCT02533674|526461587|FG002|Dose Level II|Withdrawal by Subject|0|||
145985730|NCT02533674|526461588|FG003|Dose Level II|Withdrawal by Subject|0|||
145985731|NCT02533674|526461589|FG004|Dose Level II|Withdrawal by Subject|0|||
145985732|NCT02533674|526461590|FG005|Dose Level II|Withdrawal by Subject|0|||
145985733|NCT02533674|526461591|FG006|Dose Level II|Withdrawal by Subject|0|||
145985734|NCT02533674|526461592|FG007|Dose Level II|Withdrawal by Subject|0|||
145985735|NCT02533674|526461585|FG000|Dose Level II|Treatment-related AE|0|||
145985736|NCT02533674|526461586|FG001|Dose Level II|Treatment-related AE|1|||
145985737|NCT02533674|526461587|FG002|Dose Level II|Treatment-related AE|0|||
145985738|NCT02533674|526461588|FG003|Dose Level II|Treatment-related AE|0|||
146245781|NCT01137682|527414055|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
146245782|NCT01137682|527414056|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
146245783|NCT01137682|527414054|FG000|Overall Study|Lost to Follow Up-Extension|0|||
146245784|NCT01137682|527414055|FG001|Overall Study|Lost to Follow Up-Extension|1|||
146245785|NCT01137682|527414056|FG002|Overall Study|Lost to Follow Up-Extension|0|||
146245786|NCT01137682|527414054|FG000|Overall Study|Administrative problems-Extension|0|||
146245787|NCT01137682|527414055|FG001|Overall Study|Administrative problems-Extension|2|||
146245788|NCT01137682|527414056|FG002|Overall Study|Administrative problems-Extension|0|||
146245789|NCT01137682|527414054|FG000|Overall Study|Death-Extension|2|||
146245790|NCT01137682|527414055|FG001|Overall Study|Death-Extension|0|||
146245791|NCT01137682|527414056|FG002|Overall Study|Death-Extension|0|||
146245792|NCT01137682|527414054|FG000|Overall Study|Protocol Violation-Extension|2|||
146245793|NCT01137682|527414055|FG001|Overall Study|Protocol Violation-Extension|1|||
146245794|NCT01137682|527414056|FG002|Overall Study|Protocol Violation-Extension|0|||
146245795|NCT01137682|527414054|FG000|Overall Study|Did not enter extension|2|||
145985739|NCT02533674|526461589|FG004|Dose Level II|Treatment-related AE|0|||
145985740|NCT02533674|526461590|FG005|Dose Level II|Treatment-related AE|0|||
146245796|NCT01137682|527414055|FG001|Overall Study|Did not enter extension|3|||
146245797|NCT01137682|527414056|FG002|Overall Study|Did not enter extension|2|||
146245798|NCT01137682|527414054|FG000|Overall Study|Did not receive treatment in extension|0|||
146245799|NCT01137682|527414055|FG001|Overall Study|Did not receive treatment in extension|0|||
145985741|NCT02533674|526461591|FG006|Dose Level II|Treatment-related AE|0|||
145985742|NCT02533674|526461592|FG007|Dose Level II|Treatment-related AE|0|||
145985743|NCT02533674|526461585|FG000|Dose Level II|Physician Decision|0|||
145985744|NCT02533674|526461586|FG001|Dose Level II|Physician Decision|1|||
145985745|NCT02533674|526461587|FG002|Dose Level II|Physician Decision|0|||
145985746|NCT02533674|526461588|FG003|Dose Level II|Physician Decision|0|||
145985747|NCT02533674|526461589|FG004|Dose Level II|Physician Decision|0|||
145985748|NCT02533674|526461590|FG005|Dose Level II|Physician Decision|0|||
145985749|NCT02533674|526461591|FG006|Dose Level II|Physician Decision|0|||
145985750|NCT02533674|526461592|FG007|Dose Level II|Physician Decision|0|||
145985751|NCT02533674|526461585|FG000|Dose Level II|Non-treatment-related AE|0|||
145985752|NCT02533674|526461586|FG001|Dose Level II|Non-treatment-related AE|1|||
145985753|NCT02533674|526461587|FG002|Dose Level II|Non-treatment-related AE|0|||
145985754|NCT02533674|526461588|FG003|Dose Level II|Non-treatment-related AE|0|||
145985755|NCT02533674|526461589|FG004|Dose Level II|Non-treatment-related AE|0|||
145985756|NCT02533674|526461590|FG005|Dose Level II|Non-treatment-related AE|0|||
145985757|NCT02533674|526461591|FG006|Dose Level II|Non-treatment-related AE|0|||
145985758|NCT02533674|526461592|FG007|Dose Level II|Non-treatment-related AE|0|||
145985759|NCT02533674|526461585|FG000|Dose Level III|Progressive disease|0|||
145985760|NCT02533674|526461586|FG001|Dose Level III|Progressive disease|0|||
145985761|NCT02533674|526461587|FG002|Dose Level III|Progressive disease|2|||
145985762|NCT02533674|526461588|FG003|Dose Level III|Progressive disease|0|||
145985763|NCT02533674|526461589|FG004|Dose Level III|Progressive disease|0|||
145985764|NCT02533674|526461590|FG005|Dose Level III|Progressive disease|0|||
145985765|NCT02533674|526461591|FG006|Dose Level III|Progressive disease|0|||
145985766|NCT02533674|526461592|FG007|Dose Level III|Progressive disease|0|||
145985767|NCT02533674|526461585|FG000|Dose Level III|Withdrawal by Subject|0|||
145985768|NCT02533674|526461586|FG001|Dose Level III|Withdrawal by Subject|0|||
145985769|NCT02533674|526461587|FG002|Dose Level III|Withdrawal by Subject|1|||
145985770|NCT02533674|526461588|FG003|Dose Level III|Withdrawal by Subject|0|||
145985771|NCT02533674|526461589|FG004|Dose Level III|Withdrawal by Subject|0|||
145985772|NCT02533674|526461590|FG005|Dose Level III|Withdrawal by Subject|0|||
145985773|NCT02533674|526461591|FG006|Dose Level III|Withdrawal by Subject|0|||
145985774|NCT02533674|526461592|FG007|Dose Level III|Withdrawal by Subject|0|||
145985775|NCT02533674|526461585|FG000|Dose Level III|Treatment-related AE|0|||
145985776|NCT02533674|526461586|FG001|Dose Level III|Treatment-related AE|0|||
145985777|NCT02533674|526461587|FG002|Dose Level III|Treatment-related AE|1|||
145985778|NCT02533674|526461588|FG003|Dose Level III|Treatment-related AE|0|||
145985779|NCT02533674|526461589|FG004|Dose Level III|Treatment-related AE|0|||
145985780|NCT02533674|526461590|FG005|Dose Level III|Treatment-related AE|0|||
145985781|NCT02533674|526461591|FG006|Dose Level III|Treatment-related AE|0|||
145985782|NCT02533674|526461592|FG007|Dose Level III|Treatment-related AE|0|||
145985783|NCT02533674|526461585|FG000|Dose Level IV|Progressive disease|0|||
145985784|NCT02533674|526461586|FG001|Dose Level IV|Progressive disease|0|||
145985785|NCT02533674|526461587|FG002|Dose Level IV|Progressive disease|0|||
145985786|NCT02533674|526461588|FG003|Dose Level IV|Progressive disease|3|||
145985787|NCT02533674|526461589|FG004|Dose Level IV|Progressive disease|0|||
145985788|NCT02533674|526461590|FG005|Dose Level IV|Progressive disease|0|||
145985789|NCT02533674|526461591|FG006|Dose Level IV|Progressive disease|0|||
145985790|NCT02533674|526461592|FG007|Dose Level IV|Progressive disease|0|||
145985791|NCT02533674|526461585|FG000|Dose Level IV|Withdrawal by Subject|0|||
145985792|NCT02533674|526461586|FG001|Dose Level IV|Withdrawal by Subject|0|||
145985793|NCT02533674|526461587|FG002|Dose Level IV|Withdrawal by Subject|0|||
145985794|NCT02533674|526461588|FG003|Dose Level IV|Withdrawal by Subject|1|||
145985795|NCT02533674|526461589|FG004|Dose Level IV|Withdrawal by Subject|0|||
145985796|NCT02533674|526461590|FG005|Dose Level IV|Withdrawal by Subject|0|||
145985797|NCT02533674|526461591|FG006|Dose Level IV|Withdrawal by Subject|0|||
146297854|NCT02038920|527606027|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146297855|NCT02038920|527606028|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146297856|NCT02038920|527606029|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
145985798|NCT02533674|526461592|FG007|Dose Level IV|Withdrawal by Subject|0|||
145985799|NCT02533674|526461585|FG000|Dose Level IV|Physician Decision|0|||
145985800|NCT02533674|526461586|FG001|Dose Level IV|Physician Decision|0|||
145985801|NCT02533674|526461587|FG002|Dose Level IV|Physician Decision|0|||
145985802|NCT02533674|526461588|FG003|Dose Level IV|Physician Decision|1|||
145985803|NCT02533674|526461589|FG004|Dose Level IV|Physician Decision|0|||
145985804|NCT02533674|526461590|FG005|Dose Level IV|Physician Decision|0|||
145985805|NCT02533674|526461591|FG006|Dose Level IV|Physician Decision|0|||
145985806|NCT02533674|526461592|FG007|Dose Level IV|Physician Decision|0|||
145985807|NCT02533674|526461585|FG000|Dose Level V|Progressive disease|0|||
145985808|NCT02533674|526461586|FG001|Dose Level V|Progressive disease|0|||
145985809|NCT02533674|526461587|FG002|Dose Level V|Progressive disease|0|||
145985810|NCT02533674|526461588|FG003|Dose Level V|Progressive disease|0|||
145985811|NCT02533674|526461589|FG004|Dose Level V|Progressive disease|3|||
145985812|NCT02533674|526461590|FG005|Dose Level V|Progressive disease|0|||
145985813|NCT02533674|526461591|FG006|Dose Level V|Progressive disease|0|||
145985814|NCT02533674|526461592|FG007|Dose Level V|Progressive disease|0|||
145985815|NCT02533674|526461585|FG000|Dose Level V|Withdrawal by Subject|0|||
145985816|NCT02533674|526461586|FG001|Dose Level V|Withdrawal by Subject|0|||
145985817|NCT02533674|526461587|FG002|Dose Level V|Withdrawal by Subject|0|||
145985818|NCT02533674|526461588|FG003|Dose Level V|Withdrawal by Subject|0|||
145985819|NCT02533674|526461589|FG004|Dose Level V|Withdrawal by Subject|1|||
145985820|NCT02533674|526461590|FG005|Dose Level V|Withdrawal by Subject|0|||
145985821|NCT02533674|526461591|FG006|Dose Level V|Withdrawal by Subject|0|||
145985822|NCT02533674|526461592|FG007|Dose Level V|Withdrawal by Subject|0|||
145985823|NCT02533674|526461585|FG000|Dose Level V|Physician Decision|0|||
145985824|NCT02533674|526461586|FG001|Dose Level V|Physician Decision|0|||
145985825|NCT02533674|526461587|FG002|Dose Level V|Physician Decision|0|||
145985826|NCT02533674|526461588|FG003|Dose Level V|Physician Decision|0|||
145985827|NCT02533674|526461589|FG004|Dose Level V|Physician Decision|1|||
145985828|NCT02533674|526461590|FG005|Dose Level V|Physician Decision|0|||
145985829|NCT02533674|526461591|FG006|Dose Level V|Physician Decision|0|||
145985830|NCT02533674|526461592|FG007|Dose Level V|Physician Decision|0|||
145985831|NCT02533674|526461585|FG000|Dose Level VI|Progressive disease|0|||
145985832|NCT02533674|526461586|FG001|Dose Level VI|Progressive disease|0|||
145985833|NCT02533674|526461587|FG002|Dose Level VI|Progressive disease|0|||
145985834|NCT02533674|526461588|FG003|Dose Level VI|Progressive disease|0|||
145985835|NCT02533674|526461589|FG004|Dose Level VI|Progressive disease|0|||
145985836|NCT02533674|526461590|FG005|Dose Level VI|Progressive disease|7|||
145985837|NCT02533674|526461591|FG006|Dose Level VI|Progressive disease|0|||
145985838|NCT02533674|526461592|FG007|Dose Level VI|Progressive disease|0|||
145985839|NCT02533674|526461585|FG000|Dose Level VI|Withdrawal by Subject|0|||
145985840|NCT02533674|526461586|FG001|Dose Level VI|Withdrawal by Subject|0|||
145985841|NCT02533674|526461587|FG002|Dose Level VI|Withdrawal by Subject|0|||
145985842|NCT02533674|526461588|FG003|Dose Level VI|Withdrawal by Subject|0|||
145985843|NCT02533674|526461589|FG004|Dose Level VI|Withdrawal by Subject|0|||
145985844|NCT02533674|526461590|FG005|Dose Level VI|Withdrawal by Subject|1|||
145985845|NCT02533674|526461591|FG006|Dose Level VI|Withdrawal by Subject|0|||
145985846|NCT02533674|526461592|FG007|Dose Level VI|Withdrawal by Subject|0|||
145985847|NCT02533674|526461585|FG000|Dose Level VI|Treatment-related AE|0|||
145985848|NCT02533674|526461586|FG001|Dose Level VI|Treatment-related AE|0|||
145985849|NCT02533674|526461587|FG002|Dose Level VI|Treatment-related AE|0|||
145985850|NCT02533674|526461588|FG003|Dose Level VI|Treatment-related AE|0|||
145985851|NCT02533674|526461589|FG004|Dose Level VI|Treatment-related AE|0|||
145985852|NCT02533674|526461590|FG005|Dose Level VI|Treatment-related AE|1|||
145985853|NCT02533674|526461591|FG006|Dose Level VI|Treatment-related AE|0|||
145985854|NCT02533674|526461592|FG007|Dose Level VI|Treatment-related AE|0|||
145985855|NCT02533674|526461585|FG000|Dose Level VII|Progressive disease|0|||
145985856|NCT02533674|526461586|FG001|Dose Level VII|Progressive disease|0|||
145985857|NCT02533674|526461587|FG002|Dose Level VII|Progressive disease|0|||
145985858|NCT02533674|526461588|FG003|Dose Level VII|Progressive disease|0|||
145985859|NCT02533674|526461589|FG004|Dose Level VII|Progressive disease|0|||
145985860|NCT02533674|526461590|FG005|Dose Level VII|Progressive disease|0|||
145985861|NCT02533674|526461591|FG006|Dose Level VII|Progressive disease|10|||
145985862|NCT02533674|526461592|FG007|Dose Level VII|Progressive disease|0|||
145985863|NCT02533674|526461585|FG000|Dose Level VII|Withdrawal by Subject|0|||
145985864|NCT02533674|526461586|FG001|Dose Level VII|Withdrawal by Subject|0|||
145985865|NCT02533674|526461587|FG002|Dose Level VII|Withdrawal by Subject|0|||
145985866|NCT02533674|526461588|FG003|Dose Level VII|Withdrawal by Subject|0|||
145985867|NCT02533674|526461589|FG004|Dose Level VII|Withdrawal by Subject|0|||
145985868|NCT02533674|526461590|FG005|Dose Level VII|Withdrawal by Subject|0|||
145985869|NCT02533674|526461591|FG006|Dose Level VII|Withdrawal by Subject|3|||
145985870|NCT02533674|526461592|FG007|Dose Level VII|Withdrawal by Subject|0|||
145985871|NCT02533674|526461585|FG000|Dose Level VII|Treatment-related AE|0|||
145985872|NCT02533674|526461586|FG001|Dose Level VII|Treatment-related AE|0|||
145985873|NCT02533674|526461587|FG002|Dose Level VII|Treatment-related AE|0|||
145985874|NCT02533674|526461588|FG003|Dose Level VII|Treatment-related AE|0|||
145985875|NCT02533674|526461589|FG004|Dose Level VII|Treatment-related AE|0|||
145985876|NCT02533674|526461590|FG005|Dose Level VII|Treatment-related AE|0|||
145985877|NCT02533674|526461591|FG006|Dose Level VII|Treatment-related AE|1|||
145985878|NCT02533674|526461592|FG007|Dose Level VII|Treatment-related AE|0|||
145985879|NCT02533674|526461585|FG000|Dose Level VII|Death|0|||
145985880|NCT02533674|526461586|FG001|Dose Level VII|Death|0|||
145985881|NCT02533674|526461587|FG002|Dose Level VII|Death|0|||
145985882|NCT02533674|526461588|FG003|Dose Level VII|Death|0|||
145985883|NCT02533674|526461589|FG004|Dose Level VII|Death|0|||
145985884|NCT02533674|526461590|FG005|Dose Level VII|Death|0|||
145985885|NCT02533674|526461591|FG006|Dose Level VII|Death|2|||
146245800|NCT01137682|527414056|FG002|Overall Study|Did not receive treatment in extension|1|||
145985886|NCT02533674|526461592|FG007|Dose Level VII|Death|0|||
145985887|NCT02533674|526461585|FG000|Dose Level VIII|Progressive disease|0|||
146245801|NCT02525744|527414060|FG000|Period 1|Physician Decision|0|||
146245802|NCT02525744|527414061|FG001|Period 1|Physician Decision|0|||
146245803|NCT02525744|527414062|FG002|Period 1|Physician Decision|1|||
145985888|NCT02533674|526461586|FG001|Dose Level VIII|Progressive disease|0|||
145985889|NCT02533674|526461587|FG002|Dose Level VIII|Progressive disease|0|||
145985890|NCT02533674|526461588|FG003|Dose Level VIII|Progressive disease|0|||
145985891|NCT02533674|526461589|FG004|Dose Level VIII|Progressive disease|0|||
145985892|NCT02533674|526461590|FG005|Dose Level VIII|Progressive disease|0|||
145985893|NCT02533674|526461591|FG006|Dose Level VIII|Progressive disease|0|||
145985894|NCT02533674|526461592|FG007|Dose Level VIII|Progressive disease|3|||
145985895|NCT02533674|526461585|FG000|Dose Level VIII|Withdrawal by Subject|0|||
145985896|NCT02533674|526461586|FG001|Dose Level VIII|Withdrawal by Subject|0|||
146245804|NCT02525744|527414063|FG003|Period 1|Physician Decision|0|||
145985897|NCT02533674|526461587|FG002|Dose Level VIII|Withdrawal by Subject|0|||
145985898|NCT02533674|526461588|FG003|Dose Level VIII|Withdrawal by Subject|0|||
145985899|NCT02533674|526461589|FG004|Dose Level VIII|Withdrawal by Subject|0|||
145985900|NCT02533674|526461590|FG005|Dose Level VIII|Withdrawal by Subject|0|||
145985901|NCT02533674|526461591|FG006|Dose Level VIII|Withdrawal by Subject|0|||
145985902|NCT02533674|526461592|FG007|Dose Level VIII|Withdrawal by Subject|1|||
145985903|NCT02533674|526461585|FG000|Dose Level VIII|Treatment-related AE|0|||
145985904|NCT02533674|526461586|FG001|Dose Level VIII|Treatment-related AE|0|||
145985905|NCT02533674|526461587|FG002|Dose Level VIII|Treatment-related AE|0|||
145985906|NCT02533674|526461588|FG003|Dose Level VIII|Treatment-related AE|0|||
145985907|NCT02533674|526461589|FG004|Dose Level VIII|Treatment-related AE|0|||
145985908|NCT02533674|526461590|FG005|Dose Level VIII|Treatment-related AE|0|||
145985909|NCT02533674|526461591|FG006|Dose Level VIII|Treatment-related AE|0|||
145985910|NCT02533674|526461592|FG007|Dose Level VIII|Treatment-related AE|1|||
145985911|NCT02533674|526461585|FG000|Dose Level VIII|Never treated|0|||
145985912|NCT02533674|526461586|FG001|Dose Level VIII|Never treated|0|||
145985913|NCT02533674|526461587|FG002|Dose Level VIII|Never treated|0|||
145985914|NCT02533674|526461588|FG003|Dose Level VIII|Never treated|0|||
145985915|NCT02533674|526461589|FG004|Dose Level VIII|Never treated|0|||
146091331|NCT00473746|526854948|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
146091332|NCT00473746|526854944|FG000|Period 1 (Phase 1)|Reason not specified|0|||
146091333|NCT00473746|526854945|FG001|Period 1 (Phase 1)|Reason not specified|1|||
146091334|NCT00473746|526854946|FG002|Period 1 (Phase 1)|Reason not specified|0|||
145985916|NCT02533674|526461590|FG005|Dose Level VIII|Never treated|0|||
145985917|NCT02533674|526461591|FG006|Dose Level VIII|Never treated|0|||
145985918|NCT02533674|526461592|FG007|Dose Level VIII|Never treated|1|||
145985919|NCT00662038|526461595|FG000|Overall Study|Reason not specified|3|||
145985920|NCT00662038|526461595|FG000|Overall Study|Withdrawn consent|22|||
145985921|NCT00662038|526461595|FG000|Overall Study|Withdrawal by Subject|83|||
145985922|NCT00662038|526461595|FG000|Overall Study|Sponsor decision|1|||
145985923|NCT00662038|526461595|FG000|Overall Study|Physician Decision|19|||
145985924|NCT00662038|526461595|FG000|Overall Study|Lung transplantation|44|||
145985925|NCT00662038|526461595|FG000|Overall Study|Lost to Follow-up|1|||
145985926|NCT00662038|526461595|FG000|Overall Study|Death|95|||
145985927|NCT00662038|526461595|FG000|Overall Study|Adverse Event|358|||
145985928|NCT00662038|526461595|FG000|Overall Study|Continued treatment|5|||
145985929|NCT01840163|526461596|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
145985930|NCT01840163|526461597|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
145985931|NCT01840163|526461596|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
145985932|NCT01840163|526461597|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
145985933|NCT01840163|526461596|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
145985934|NCT01840163|526461597|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
145985935|NCT00397046|526461598|FG000|Overall Study|Disease Progression|3|||
145985936|NCT00397046|526461599|FG001|Overall Study|Disease Progression|3|||
145985937|NCT00397046|526461600|FG002|Overall Study|Disease Progression|10|||
145985938|NCT00397046|526461601|FG003|Overall Study|Disease Progression|5|||
145985939|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
145985940|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
145985941|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
145985942|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
145985943|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145985944|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145985945|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
145985946|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
145985947|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
145985948|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
146091335|NCT00473746|526854947|FG003|Period 1 (Phase 1)|Reason not specified|0|||
146091336|NCT00473746|526854948|FG004|Period 1 (Phase 1)|Reason not specified|0|||
146091337|NCT00473746|526854944|FG000|Period 2 (Phase 2)|Adverse Event|0|||
146091338|NCT00473746|526854945|FG001|Period 2 (Phase 2)|Adverse Event|0|||
146091339|NCT00473746|526854946|FG002|Period 2 (Phase 2)|Adverse Event|0|||
146091340|NCT00473746|526854947|FG003|Period 2 (Phase 2)|Adverse Event|0|||
146091341|NCT00473746|526854948|FG004|Period 2 (Phase 2)|Adverse Event|3|||
145985949|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
146091342|NCT00473746|526854944|FG000|Period 2 (Phase 2)|Death|0|||
146091343|NCT00473746|526854945|FG001|Period 2 (Phase 2)|Death|0|||
146091344|NCT00473746|526854946|FG002|Period 2 (Phase 2)|Death|0|||
146091345|NCT00473746|526854947|FG003|Period 2 (Phase 2)|Death|0|||
145985950|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
145985951|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Other|6|||
145985952|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Other|3|||
145985953|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Other|0|||
145985954|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
146091346|NCT00473746|526854948|FG004|Period 2 (Phase 2)|Death|1|||
146091347|NCT00473746|526854944|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
145985955|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145985956|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145985957|NCT03636269|526461603|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
145985958|NCT03636269|526461604|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
145985959|NCT03636269|526461605|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
145985960|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Adverse Event|0|||
145985961|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Adverse Event|0|||
145985962|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Adverse Event|21|||
145985963|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
145985964|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
145985965|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
145985966|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
145985967|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
145985968|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
145985969|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
145985970|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
145985971|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
145985972|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Administrative|0|||
145985973|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Administrative|0|||
145985974|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Administrative|36|||
145985975|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Other|0|||
145985976|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Other|0|||
145985977|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Other|9|||
145985978|NCT03636269|526461603|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
145985979|NCT03636269|526461604|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
145985980|NCT03636269|526461605|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
145985981|NCT00493285|526461611|FG000|Overall Study|Lost to Follow-up|0|||
145985982|NCT00493285|526461612|FG001|Overall Study|Lost to Follow-up|0|||
145985983|NCT00493285|526461613|FG002|Overall Study|Lost to Follow-up|0|||
145985984|NCT00493285|526461614|FG003|Overall Study|Lost to Follow-up|0|||
145985985|NCT00493285|526461615|FG004|Overall Study|Lost to Follow-up|1|||
145985986|NCT00493285|526461616|FG005|Overall Study|Lost to Follow-up|0|||
145985987|NCT03021005|526461617|FG000|Overall Study|Lost to Follow-up|39|||
145985988|NCT03021005|526461618|FG001|Overall Study|Lost to Follow-up|26|||
145985989|NCT00337194|526461619|FG000|Overall Study|Adverse Event|5|||
145985990|NCT00337194|526461620|FG001|Overall Study|Adverse Event|1|||
145985991|NCT00337194|526461619|FG000|Overall Study|Death|2|||
145985992|NCT00337194|526461620|FG001|Overall Study|Death|0|||
145985993|NCT00337194|526461619|FG000|Overall Study|Withdrawal by Subject|1|||
145985994|NCT00337194|526461620|FG001|Overall Study|Withdrawal by Subject|0|||
145985995|NCT00337194|526461619|FG000|Overall Study|Disease progression|1|||
145985996|NCT00337194|526461620|FG001|Overall Study|Disease progression|2|||
145985997|NCT00337194|526461619|FG000|Overall Study|Subsequent non-protocol therapy|3|||
145985998|NCT00337194|526461620|FG001|Overall Study|Subsequent non-protocol therapy|1|||
145985999|NCT03188705|526461621|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
145986000|NCT03188705|526461621|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
145986001|NCT04914000|526461628|FG000|Overall Study|Lost to Follow-up|8|||
145986002|NCT04914000|526461628|FG000|Overall Study|Withdrawal by Subject|1|||
145986003|NCT00981175|526461629|FG000|Primary Dose Vaccination|Adverse Event|1|||
145986004|NCT00981175|526461630|FG001|Primary Dose Vaccination|Adverse Event|0|||
145986005|NCT00981175|526461629|FG000|Primary Dose Vaccination|Protocol Violation|0|||
145986006|NCT00981175|526461630|FG001|Primary Dose Vaccination|Protocol Violation|1|||
145986007|NCT00981175|526461629|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
145986008|NCT00981175|526461630|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
145986009|NCT00981175|526461629|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
145986010|NCT00981175|526461630|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
145986011|NCT01750281|526461632|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
145986012|NCT01750281|526461633|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
145986013|NCT01750281|526461634|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
145986014|NCT01750281|526461632|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
145986015|NCT01750281|526461633|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
145986016|NCT01750281|526461634|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
145986017|NCT01750281|526461632|FG000|Overall Study|Did not receive treatment|0|||
145986018|NCT01750281|526461633|FG001|Overall Study|Did not receive treatment|1|||
145986019|NCT01750281|526461634|FG002|Overall Study|Did not receive treatment|0|||
145986020|NCT04189588|526461635|FG000|Overall Study|Death|0|||
145986021|NCT04189588|526461636|FG001|Overall Study|Death|1|||
145986022|NCT04189588|526461635|FG000|Overall Study|Lost to Follow-up|0|||
145986023|NCT04189588|526461636|FG001|Overall Study|Lost to Follow-up|1|||
145986024|NCT03757715|526461638|FG000|Overall Study|Lost to Follow-up|4|||
145986025|NCT03757715|526461639|FG001|Overall Study|Lost to Follow-up|9|||
145986026|NCT03757715|526461638|FG000|Overall Study|Withdrawal by Subject|1|||
145986027|NCT03757715|526461639|FG001|Overall Study|Withdrawal by Subject|1|||
145986028|NCT03156621|526461640|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
145986029|NCT03156621|526461641|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
145986030|NCT03156621|526461640|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145986031|NCT03156621|526461641|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
145986032|NCT03302936|526461642|FG000|Overall Study|Protocol Violation|3|||
145986033|NCT03302936|526461643|FG001|Overall Study|Protocol Violation|4|||
145986034|NCT01122680|526461644|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
145986035|NCT01122680|526461645|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
145986036|NCT01122680|526461646|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
145986037|NCT01122680|526461647|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
145986038|NCT01122680|526461644|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
145986039|NCT01122680|526461645|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
145986040|NCT01122680|526461646|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
145986041|NCT01122680|526461647|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
145986042|NCT01122680|526461644|FG000|Period 1 (4 Weeks)|Other|1|||
145986043|NCT01122680|526461645|FG001|Period 1 (4 Weeks)|Other|1|||
145986044|NCT01122680|526461646|FG002|Period 1 (4 Weeks)|Other|0|||
145986045|NCT01122680|526461647|FG003|Period 1 (4 Weeks)|Other|0|||
145986046|NCT01122680|526461644|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
145986047|NCT01122680|526461645|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
145986048|NCT01122680|526461646|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
145986049|NCT01122680|526461647|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
145986050|NCT01122680|526461644|FG000|Period 2 (4 Weeks)|Other|1|||
145986051|NCT01122680|526461645|FG001|Period 2 (4 Weeks)|Other|0|||
145986052|NCT01122680|526461646|FG002|Period 2 (4 Weeks)|Other|0|||
145986053|NCT01122680|526461647|FG003|Period 2 (4 Weeks)|Other|0|||
145986054|NCT01122680|526461644|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
145986055|NCT01122680|526461645|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
145986056|NCT01122680|526461646|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
145986057|NCT01122680|526461647|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
145986058|NCT01122680|526461644|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145986059|NCT01122680|526461645|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
145986060|NCT01122680|526461646|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145986061|NCT01122680|526461647|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145986062|NCT03016403|526461650|FG000|Baseline|Death|5|||
145986063|NCT03016403|526461651|FG001|Baseline|Death|8|||
145986064|NCT03016403|526461652|FG002|Baseline|Death|1|||
145986065|NCT03016403|526461653|FG003|Baseline|Death|0|||
145986066|NCT03016403|526461650|FG000|Baseline|Withdrawal by Subject|2|||
145986067|NCT03016403|526461651|FG001|Baseline|Withdrawal by Subject|8|||
145986068|NCT03016403|526461652|FG002|Baseline|Withdrawal by Subject|4|||
145986069|NCT03016403|526461653|FG003|Baseline|Withdrawal by Subject|10|||
145986070|NCT03016403|526461650|FG000|Baseline|Lost to Follow-up|9|||
145986071|NCT03016403|526461651|FG001|Baseline|Lost to Follow-up|11|||
145986072|NCT03016403|526461652|FG002|Baseline|Lost to Follow-up|6|||
145986073|NCT03016403|526461653|FG003|Baseline|Lost to Follow-up|24|||
145986074|NCT03016403|526461650|FG000|6-week Follow-up|Death|1|||
145986075|NCT03016403|526461651|FG001|6-week Follow-up|Death|4|||
145986076|NCT03016403|526461652|FG002|6-week Follow-up|Death|0|||
145986077|NCT03016403|526461653|FG003|6-week Follow-up|Death|0|||
145986078|NCT03016403|526461650|FG000|6-week Follow-up|Lost to Follow-up|2|||
145986079|NCT03016403|526461651|FG001|6-week Follow-up|Lost to Follow-up|7|||
145986080|NCT03016403|526461652|FG002|6-week Follow-up|Lost to Follow-up|4|||
145986081|NCT03016403|526461653|FG003|6-week Follow-up|Lost to Follow-up|8|||
145986082|NCT03016403|526461650|FG000|6-week Follow-up|Withdrawal by Subject|0|||
145986083|NCT03016403|526461651|FG001|6-week Follow-up|Withdrawal by Subject|2|||
145986084|NCT03016403|526461652|FG002|6-week Follow-up|Withdrawal by Subject|0|||
145986085|NCT03016403|526461653|FG003|6-week Follow-up|Withdrawal by Subject|1|||
145986086|NCT03016403|526461650|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
145986087|NCT03016403|526461651|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
145986088|NCT03016403|526461652|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
145986089|NCT03016403|526461653|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
145986090|NCT03016403|526461650|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
145986091|NCT03016403|526461651|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
145986092|NCT03016403|526461652|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
145986093|NCT03016403|526461653|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
145986094|NCT03016403|526461650|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145986095|NCT03016403|526461651|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145986096|NCT03016403|526461652|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145986097|NCT03016403|526461653|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
145986098|NCT05463705|526461654|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
145986099|NCT05463705|526461655|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
145986100|NCT05463705|526461656|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
145986101|NCT05463705|526461657|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
145986102|NCT05463705|526461658|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
145986103|NCT05463705|526461659|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
145986104|NCT00576407|526461660|FG000|Overall Study|Death|7|||
145986105|NCT00576407|526461660|FG000|Overall Study|Physician Decision|1|||
145986106|NCT00621322|526461661|FG000|Overall Study|Lost to Follow-up|0|||
145986107|NCT00621322|526461662|FG001|Overall Study|Lost to Follow-up|0|||
145986108|NCT00621322|526461663|FG002|Overall Study|Lost to Follow-up|0|||
145986109|NCT00621322|526461664|FG003|Overall Study|Lost to Follow-up|0|||
145986110|NCT00621322|526461665|FG004|Overall Study|Lost to Follow-up|1|||
145986111|NCT00621322|526461666|FG005|Overall Study|Lost to Follow-up|0|||
145986112|NCT00621322|526461661|FG000|Overall Study|Physician Decision|0|||
145986113|NCT00621322|526461662|FG001|Overall Study|Physician Decision|0|||
145986114|NCT00621322|526461663|FG002|Overall Study|Physician Decision|1|||
145986115|NCT00621322|526461664|FG003|Overall Study|Physician Decision|1|||
145986116|NCT00621322|526461665|FG004|Overall Study|Physician Decision|0|||
145986117|NCT00621322|526461666|FG005|Overall Study|Physician Decision|0|||
145986118|NCT00621322|526461661|FG000|Overall Study|Withdrawal by Subject|0|||
145986119|NCT00621322|526461662|FG001|Overall Study|Withdrawal by Subject|0|||
145986120|NCT00621322|526461663|FG002|Overall Study|Withdrawal by Subject|0|||
145986121|NCT00621322|526461664|FG003|Overall Study|Withdrawal by Subject|1|||
145986122|NCT00621322|526461665|FG004|Overall Study|Withdrawal by Subject|0|||
145986123|NCT00621322|526461666|FG005|Overall Study|Withdrawal by Subject|2|||
145986124|NCT00621322|526461661|FG000|Overall Study|Migrated/moved from study area|1|||
145986125|NCT00621322|526461662|FG001|Overall Study|Migrated/moved from study area|0|||
145986126|NCT00621322|526461663|FG002|Overall Study|Migrated/moved from study area|1|||
145986127|NCT00621322|526461664|FG003|Overall Study|Migrated/moved from study area|1|||
145986128|NCT00621322|526461665|FG004|Overall Study|Migrated/moved from study area|0|||
145986129|NCT00621322|526461666|FG005|Overall Study|Migrated/moved from study area|2|||
145986130|NCT02346370|526461667|FG000|Overall Study|Not treated|1|||
145986131|NCT02346370|526461668|FG001|Overall Study|Not treated|0|||
145986132|NCT02346370|526461669|FG002|Overall Study|Not treated|0|||
145986133|NCT02346370|526461667|FG000|Overall Study|Withdrawal of consent|1|||
145986134|NCT02346370|526461668|FG001|Overall Study|Withdrawal of consent|0|||
145986135|NCT02346370|526461669|FG002|Overall Study|Withdrawal of consent|0|||
145986136|NCT02346370|526461667|FG000|Overall Study|Death|1|||
145986137|NCT02346370|526461668|FG001|Overall Study|Death|3|||
145986138|NCT02346370|526461669|FG002|Overall Study|Death|1|||
145986139|NCT02346370|526461667|FG000|Overall Study|Sponsor discontinued study|5|||
145986140|NCT02346370|526461668|FG001|Overall Study|Sponsor discontinued study|0|||
145986141|NCT02346370|526461669|FG002|Overall Study|Sponsor discontinued study|2|||
145986142|NCT02346370|526461667|FG000|Overall Study|Radiologic progression|0|||
145986143|NCT02346370|526461668|FG001|Overall Study|Radiologic progression|0|||
145986144|NCT02346370|526461669|FG002|Overall Study|Radiologic progression|1|||
145986145|NCT02346370|526461667|FG000|Overall Study|Physician Decision|0|||
145986146|NCT02346370|526461668|FG001|Overall Study|Physician Decision|1|||
145986147|NCT02346370|526461669|FG002|Overall Study|Physician Decision|0|||
145986148|NCT01217047|526461670|FG000|Overall Study|Lost to Follow-up|0|||
145986149|NCT01217047|526461671|FG001|Overall Study|Lost to Follow-up|1|||
145986150|NCT01217047|526461672|FG002|Overall Study|Lost to Follow-up|0|||
145986151|NCT06399471|526461673|FG000|Overall Study|Withdrawal by Subject|1|||
145986152|NCT05529173|526461674|FG000|Overall Study|Physician Decision|3|||
145986153|NCT05529173|526461675|FG001|Overall Study|Physician Decision|6|||
145986154|NCT05529173|526461674|FG000|Overall Study|Sample shipment delay more than one day|4|||
145986155|NCT05529173|526461675|FG001|Overall Study|Sample shipment delay more than one day|0|||
145986156|NCT03835117|526461676|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
145986157|NCT03835117|526461677|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
145986158|NCT01362270|526461679|FG000|Overall Study|Withdrawal by Subject|1|||
145986159|NCT01362270|526461680|FG001|Overall Study|Withdrawal by Subject|0|||
145986160|NCT01362270|526461679|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
145986161|NCT01362270|526461680|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
145986162|NCT01362270|526461679|FG000|Overall Study|Met excl. criteria before 1st session|1|||
145986163|NCT01362270|526461680|FG001|Overall Study|Met excl. criteria before 1st session|1|||
145986164|NCT02318277|526461681|FG000|Overall Study|Physician Decision|0|||
145986165|NCT02318277|526461682|FG001|Overall Study|Physician Decision|0|||
145986166|NCT02318277|526461683|FG002|Overall Study|Physician Decision|0|||
145986167|NCT02318277|526461684|FG003|Overall Study|Physician Decision|0|||
145986168|NCT02318277|526461685|FG004|Overall Study|Physician Decision|0|||
145986169|NCT02318277|526461686|FG005|Overall Study|Physician Decision|0|||
145986170|NCT02318277|526461687|FG006|Overall Study|Physician Decision|0|||
145986171|NCT02318277|526461688|FG007|Overall Study|Physician Decision|1|||
145986172|NCT02318277|526461681|FG000|Overall Study|Other|0|||
145986173|NCT02318277|526461682|FG001|Overall Study|Other|0|||
145986174|NCT02318277|526461683|FG002|Overall Study|Other|0|||
146091348|NCT00473746|526854945|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
145986175|NCT02318277|526461684|FG003|Overall Study|Other|0|||
145986176|NCT02318277|526461685|FG004|Overall Study|Other|0|||
145986177|NCT02318277|526461686|FG005|Overall Study|Other|0|||
145986178|NCT02318277|526461687|FG006|Overall Study|Other|1|||
145986179|NCT02318277|526461688|FG007|Overall Study|Other|0|||
145986180|NCT02318277|526461681|FG000|Overall Study|Withdrawal by Subject|0|||
146245805|NCT02525744|527414060|FG000|Period 3|Adverse Event|0|||
145986181|NCT02318277|526461682|FG001|Overall Study|Withdrawal by Subject|0|||
145986182|NCT02318277|526461683|FG002|Overall Study|Withdrawal by Subject|1|||
145986183|NCT02318277|526461684|FG003|Overall Study|Withdrawal by Subject|0|||
145986184|NCT02318277|526461685|FG004|Overall Study|Withdrawal by Subject|1|||
145986185|NCT02318277|526461686|FG005|Overall Study|Withdrawal by Subject|1|||
145986186|NCT02318277|526461687|FG006|Overall Study|Withdrawal by Subject|6|||
145986187|NCT02318277|526461688|FG007|Overall Study|Withdrawal by Subject|14|||
145986188|NCT02318277|526461681|FG000|Overall Study|Participant trial terminated by sponsor|0|||
145986189|NCT02318277|526461682|FG001|Overall Study|Participant trial terminated by sponsor|0|||
145986190|NCT02318277|526461683|FG002|Overall Study|Participant trial terminated by sponsor|1|||
145986191|NCT02318277|526461684|FG003|Overall Study|Participant trial terminated by sponsor|0|||
145986192|NCT02318277|526461685|FG004|Overall Study|Participant trial terminated by sponsor|1|||
145986193|NCT02318277|526461686|FG005|Overall Study|Participant trial terminated by sponsor|2|||
145986194|NCT02318277|526461687|FG006|Overall Study|Participant trial terminated by sponsor|5|||
145986195|NCT02318277|526461688|FG007|Overall Study|Participant trial terminated by sponsor|16|||
145986196|NCT02318277|526461681|FG000|Overall Study|Lost to Follow-up|1|||
145986197|NCT02318277|526461682|FG001|Overall Study|Lost to Follow-up|0|||
145986198|NCT02318277|526461683|FG002|Overall Study|Lost to Follow-up|1|||
145986199|NCT02318277|526461684|FG003|Overall Study|Lost to Follow-up|0|||
145986200|NCT02318277|526461685|FG004|Overall Study|Lost to Follow-up|0|||
145986201|NCT02318277|526461686|FG005|Overall Study|Lost to Follow-up|0|||
145986202|NCT02318277|526461687|FG006|Overall Study|Lost to Follow-up|3|||
145986203|NCT02318277|526461688|FG007|Overall Study|Lost to Follow-up|4|||
145986204|NCT02318277|526461681|FG000|Overall Study|Death|5|||
145986205|NCT02318277|526461682|FG001|Overall Study|Death|3|||
145986206|NCT02318277|526461683|FG002|Overall Study|Death|1|||
146245806|NCT02525744|527414061|FG001|Period 3|Adverse Event|1|||
146245807|NCT02525744|527414062|FG002|Period 3|Adverse Event|0|||
146245808|NCT02525744|527414063|FG003|Period 3|Adverse Event|0|||
146245809|NCT02525744|527414060|FG000|Period 4|Withdrawal by Subject|1|||
146245810|NCT02525744|527414061|FG001|Period 4|Withdrawal by Subject|0|||
146245811|NCT02525744|527414062|FG002|Period 4|Withdrawal by Subject|0|||
146245812|NCT02525744|527414063|FG003|Period 4|Withdrawal by Subject|0|||
146245813|NCT02525744|527414060|FG000|Period 5|Physician Decision|1|||
146245814|NCT02525744|527414061|FG001|Period 5|Physician Decision|0|||
145986207|NCT02318277|526461684|FG003|Overall Study|Death|4|||
145986208|NCT02318277|526461685|FG004|Overall Study|Death|6|||
145986209|NCT02318277|526461686|FG005|Overall Study|Death|5|||
145986210|NCT02318277|526461687|FG006|Overall Study|Death|34|||
146245815|NCT02525744|527414062|FG002|Period 5|Physician Decision|0|||
146245816|NCT02525744|527414063|FG003|Period 5|Physician Decision|0|||
146245817|NCT00472082|527414064|FG000|Overall Study|Study prematurely terminated|5|||
146245818|NCT02069379|527414065|FG000|Baseline Measurements|Lost to Follow-up|1|||
146245819|NCT02069379|527414066|FG001|Baseline Measurements|Lost to Follow-up|0|||
146245820|NCT02069379|527414067|FG002|Baseline Measurements|Lost to Follow-up|0|||
146245821|NCT02069379|527414068|FG003|Baseline Measurements|Lost to Follow-up|0|||
145986211|NCT02318277|526461688|FG007|Overall Study|Death|58|||
145986212|NCT02318277|526461681|FG000|Overall Study|Transitioned to Hospice|0|||
145986213|NCT02318277|526461682|FG001|Overall Study|Transitioned to Hospice|0|||
145986214|NCT02318277|526461683|FG002|Overall Study|Transitioned to Hospice|0|||
145986215|NCT02318277|526461684|FG003|Overall Study|Transitioned to Hospice|0|||
145986216|NCT02318277|526461685|FG004|Overall Study|Transitioned to Hospice|0|||
145986217|NCT02318277|526461686|FG005|Overall Study|Transitioned to Hospice|1|||
145986218|NCT02318277|526461687|FG006|Overall Study|Transitioned to Hospice|0|||
145986219|NCT02318277|526461688|FG007|Overall Study|Transitioned to Hospice|0|||
145986220|NCT03364686|526461689|FG000|Overall Study|Physician Decision|2|||
145986221|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
145986222|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
146245822|NCT02069379|527414065|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
146245823|NCT02069379|527414066|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
145986223|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
145986224|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
145986225|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
145986226|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
145986227|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145986228|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145986229|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145986230|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
145986231|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
145986232|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
146245824|NCT02069379|527414067|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
146245825|NCT02069379|527414068|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
146245826|NCT02069379|527414065|FG000|First Treatment Arm|Lost to Follow-up|0|||
146245827|NCT02069379|527414066|FG001|First Treatment Arm|Lost to Follow-up|1|||
146091349|NCT00473746|526854946|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
146091350|NCT00473746|526854947|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
146091351|NCT00473746|526854948|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
146091352|NCT00473746|526854944|FG000|Period 2 (Phase 2)|Reason not specified|0|||
146091353|NCT00473746|526854945|FG001|Period 2 (Phase 2)|Reason not specified|0|||
146091354|NCT00473746|526854946|FG002|Period 2 (Phase 2)|Reason not specified|0|||
146091355|NCT00473746|526854947|FG003|Period 2 (Phase 2)|Reason not specified|0|||
146091356|NCT00473746|526854948|FG004|Period 2 (Phase 2)|Reason not specified|3|||
146091357|NCT00667420|526854949|FG000|Overall Study|Adverse Event|2|||
146091358|NCT00667420|526854949|FG000|Overall Study|Lack of Efficacy|5|||
146091359|NCT00667420|526854949|FG000|Overall Study|Physician Decision|1|||
146091360|NCT00667420|526854949|FG000|Overall Study|Withdrawal by Subject|2|||
146091361|NCT04437368|526854950|FG000|Overall Study|Death|3|||
146091362|NCT04437368|526854951|FG001|Overall Study|Death|0|||
146091363|NCT04437368|526854952|FG002|Overall Study|Death|2|||
146091364|NCT04437368|526854950|FG000|Overall Study|Study terminated by sponsor|16|||
146091365|NCT04437368|526854951|FG001|Overall Study|Study terminated by sponsor|1|||
146091366|NCT04437368|526854952|FG002|Overall Study|Study terminated by sponsor|25|||
146091367|NCT04437368|526854950|FG000|Overall Study|Withdrawal by Subject|4|||
146091368|NCT04437368|526854951|FG001|Overall Study|Withdrawal by Subject|0|||
146091369|NCT04437368|526854952|FG002|Overall Study|Withdrawal by Subject|3|||
146091370|NCT04437368|526854950|FG000|Overall Study|Sponsor instructions|23|||
146091371|NCT04437368|526854951|FG001|Overall Study|Sponsor instructions|0|||
146091372|NCT04437368|526854952|FG002|Overall Study|Sponsor instructions|0|||
146091373|NCT04271280|526854953|FG000|Overall Study|Lost to Follow-up|300|||
146091374|NCT04271280|526854953|FG000|Overall Study|Death|153|||
146091375|NCT04271280|526854953|FG000|Overall Study|Withdrawal of consent by patient|59|||
146091376|NCT04271280|526854953|FG000|Overall Study|Other|51|||
146091377|NCT04271280|526854953|FG000|Overall Study|No end of study information|42|||
146091378|NCT01280955|526854956|FG000|Overall Study|Death|2|||
146091379|NCT01280955|526854956|FG000|Overall Study|Withdrawal by Subject|1|||
146091380|NCT01484054|526854957|FG000|Period 1|Withdrawal by Subject|0|||
146091381|NCT01484054|526854958|FG001|Period 1|Withdrawal by Subject|1|||
146091382|NCT01539317|526854959|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
146091383|NCT01539317|526854960|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
146091384|NCT00364130|526854961|FG000|Intervention Period|Lost to Follow-up|4|||
146091385|NCT00364130|526854962|FG001|Intervention Period|Lost to Follow-up|3|||
146091386|NCT00364130|526854961|FG000|Intervention Period|Pregnancy|1|||
146091387|NCT00364130|526854962|FG001|Intervention Period|Pregnancy|0|||
146091388|NCT00364130|526854961|FG000|Intervention Period|Withdrawal by Subject|4|||
146091389|NCT00364130|526854962|FG001|Intervention Period|Withdrawal by Subject|5|||
146091390|NCT00364130|526854961|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
146091391|NCT00364130|526854962|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
145986233|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145986234|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145986235|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
145986236|NCT00407030|526461693|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
145986237|NCT00407030|526461694|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
145986238|NCT00407030|526461695|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
145986239|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
145986240|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
145986241|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
145986242|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
145986243|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
145986244|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
145986245|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
145986246|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
145986247|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
145986248|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
145986249|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
145986250|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
145986251|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
146091392|NCT01674634|526854966|FG000|Overall Study|Withdrawal by Subject|3|||
146091393|NCT01674634|526854966|FG000|Overall Study|Lost to Follow-up|3|||
146091394|NCT00937391|526854967|FG000|Stage 2|Withdrawal by Subject|1|||
146091395|NCT04221230|526854968|FG000|Overall Study|Lost to Follow-up|12|||
146091396|NCT04221230|526854969|FG001|Overall Study|Lost to Follow-up|12|||
146091397|NCT04221230|526854968|FG000|Overall Study|Protocol Violation|2|||
146091398|NCT04221230|526854969|FG001|Overall Study|Protocol Violation|2|||
146091399|NCT04221230|526854968|FG000|Overall Study|Adverse Event|0|||
146091400|NCT04221230|526854969|FG001|Overall Study|Adverse Event|8|||
146091401|NCT04221230|526854968|FG000|Overall Study|Physician Decision|1|||
146091402|NCT04221230|526854969|FG001|Overall Study|Physician Decision|0|||
146091403|NCT04221230|526854968|FG000|Overall Study|Withdrawal by Subject|13|||
145986252|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
145986253|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
145986254|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
145986255|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
145986256|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
145986257|NCT00407030|526461693|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
145986258|NCT00407030|526461694|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
145986259|NCT00407030|526461695|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
145986260|NCT01489358|526461696|FG000|Overall Study|Lost to Follow-up|0|||
145986261|NCT01489358|526461697|FG001|Overall Study|Lost to Follow-up|0|||
145986262|NCT01489358|526461698|FG002|Overall Study|Lost to Follow-up|2|||
145986263|NCT03722030|526461699|FG000|Overall Study|Withdrawal by Subject|1|||
145986264|NCT03722030|526461700|FG001|Overall Study|Withdrawal by Subject|0|||
146091404|NCT04221230|526854969|FG001|Overall Study|Withdrawal by Subject|11|||
146091405|NCT04221230|526854968|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146091406|NCT04221230|526854969|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146091407|NCT04221230|526854968|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146091408|NCT04221230|526854969|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145986265|NCT00736476|526461701|FG000|Overall Study|Adverse Event|1|||
145986266|NCT00736476|526461702|FG001|Overall Study|Adverse Event|0|||
145986267|NCT03518203|526461703|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
145986268|NCT03518203|526461703|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
146091409|NCT04221230|526854968|FG000|Overall Study|Pregnancy|0|||
146091410|NCT04221230|526854969|FG001|Overall Study|Pregnancy|1|||
146091411|NCT04221230|526854968|FG000|Overall Study|Other|1|||
146091412|NCT04221230|526854969|FG001|Overall Study|Other|2|||
146091413|NCT02359851|526854972|FG000|Overall Study|Death|1|||
146091414|NCT02359851|526854972|FG000|Overall Study|Disease progression|1|||
146091415|NCT03875118|526856801|FG000|Overall Study|Withdrawal by Subject|4|||
146091416|NCT03875118|526856802|FG001|Overall Study|Withdrawal by Subject|4|||
146091417|NCT02237911|526856803|FG000|Overall Study|Withdrawal by Subject|4|||
146091418|NCT02237911|526856804|FG001|Overall Study|Withdrawal by Subject|7|||
146091419|NCT02237911|526856805|FG002|Overall Study|Withdrawal by Subject|2|||
146091420|NCT02237911|526856803|FG000|Overall Study|Lost to Follow-up|3|||
146091421|NCT02237911|526856804|FG001|Overall Study|Lost to Follow-up|1|||
146091422|NCT02237911|526856805|FG002|Overall Study|Lost to Follow-up|1|||
146091423|NCT04521777|526856806|FG000|Overall Study|Death|2|||
146091424|NCT04521777|526856806|FG000|Overall Study|Withdrawal by Subject|2|||
146091425|NCT01869725|526856811|FG000|Overall Study|ineligible after registration|1|||
146091426|NCT01869725|526856811|FG000|Overall Study|Death|1|||
146091427|NCT01869725|526856811|FG000|Overall Study|Lost to Follow-up|2|||
146091428|NCT01143207|526856812|FG000|Overall Study|Lost to Follow-up|2|||
146091429|NCT03416374|526856819|FG000|Between Treatment Period I and II|Other|0|||
146091430|NCT03416374|526856820|FG001|Between Treatment Period I and II|Other|9|||
146091431|NCT03416374|526856819|FG000|Treatment Period II|Lack of Efficacy|3|||
146091432|NCT03416374|526856820|FG001|Treatment Period II|Lack of Efficacy|11|||
146091433|NCT03416374|526856819|FG000|Treatment Period II|Adverse Event|1|||
146091434|NCT03416374|526856820|FG001|Treatment Period II|Adverse Event|4|||
146091435|NCT03416374|526856819|FG000|Treatment Period II|Death|0|||
145986269|NCT00345592|526461704|FG000|Overall Study|Death|14|||
145986270|NCT00345592|526461705|FG001|Overall Study|Death|16|||
145986271|NCT00345592|526461704|FG000|Overall Study|Withdrawal by Subject|11|||
145986272|NCT00345592|526461705|FG001|Overall Study|Withdrawal by Subject|8|||
145986273|NCT02366130|526461707|FG000|Overall Study|Withdrawal by Subject|3|||
145986274|NCT02366130|526461707|FG000|Overall Study|Ineligible|6|||
145986275|NCT01065766|526461708|FG000|Overall Study|Assessed before the contracted date|1|||
145986276|NCT01065766|526461708|FG000|Overall Study|Contraindication to administration|6|||
145986277|NCT01065766|526461708|FG000|Overall Study|Violated dosage/administration|25|||
145986278|NCT04223687|526461709|FG000|Overall Study|Missing primary outcome|1|||
145986279|NCT04223687|526461710|FG001|Overall Study|Missing primary outcome|0|||
146091436|NCT03416374|526856820|FG001|Treatment Period II|Death|1|||
146091437|NCT03416374|526856819|FG000|Treatment Period II|Other|0|||
146091438|NCT03416374|526856820|FG001|Treatment Period II|Other|2|||
146091439|NCT03463031|526856823|FG000|Overall Study|Withdrawal by Subject|4|||
146091440|NCT03463031|526856824|FG001|Overall Study|Withdrawal by Subject|2|||
146091441|NCT03463031|526856823|FG000|Overall Study|Investigator/Sponsor Decision|0|||
146091442|NCT03463031|526856824|FG001|Overall Study|Investigator/Sponsor Decision|1|||
146091443|NCT03463031|526856823|FG000|Overall Study|Lost to Follow-up|1|||
146091444|NCT03463031|526856824|FG001|Overall Study|Lost to Follow-up|1|||
146091445|NCT03463031|526856823|FG000|Overall Study|Adverse Event|4|||
146091446|NCT03463031|526856824|FG001|Overall Study|Adverse Event|1|||
146091447|NCT03463031|526856823|FG000|Overall Study|Use of prohibited medication by subject|1|||
146091448|NCT03463031|526856824|FG001|Overall Study|Use of prohibited medication by subject|0|||
146091449|NCT01810432|526856825|FG000|Washout|Protocol Violation|0|||
146091450|NCT01810432|526856826|FG001|Washout|Protocol Violation|1|||
145986280|NCT01608308|526461711|FG000|Overall Study|pretreatment medical and billing reasons|0|||
145986281|NCT01608308|526461712|FG001|Overall Study|pretreatment medical and billing reasons|2|||
145986282|NCT01016015|526461713|FG000|Overall Study|Not Treated|3|||
145986283|NCT01016015|526461713|FG000|Overall Study|Withdrawal by Subject|1|||
145986284|NCT01016015|526461713|FG000|Overall Study|Adverse Event|15|||
145986285|NCT00682435|526461715|FG000|Overall Study|Insufficient data|5|||
145986286|NCT00682435|526461715|FG000|Overall Study|Erroneously enrolled twice|2|||
145986287|NCT00286455|526461717|FG000|Overall Study|Hyperglycemia rescue|19|||
145986288|NCT00286455|526461718|FG001|Overall Study|Hyperglycemia rescue|13|||
145986289|NCT00286455|526461719|FG002|Overall Study|Hyperglycemia rescue|10|||
145986290|NCT00286455|526461717|FG000|Overall Study|Adverse Event|1|||
145986291|NCT00286455|526461718|FG001|Overall Study|Adverse Event|3|||
145986292|NCT00286455|526461719|FG002|Overall Study|Adverse Event|2|||
145986293|NCT00286455|526461717|FG000|Overall Study|Lost to Follow-up|0|||
145986294|NCT00286455|526461718|FG001|Overall Study|Lost to Follow-up|3|||
145986295|NCT00286455|526461719|FG002|Overall Study|Lost to Follow-up|3|||
145986296|NCT00286455|526461717|FG000|Overall Study|Physician Decision|3|||
145986297|NCT00286455|526461718|FG001|Overall Study|Physician Decision|0|||
145986298|NCT00286455|526461719|FG002|Overall Study|Physician Decision|2|||
145986299|NCT00286455|526461717|FG000|Overall Study|Protocol Violation|1|||
145986300|NCT00286455|526461718|FG001|Overall Study|Protocol Violation|1|||
145986301|NCT00286455|526461719|FG002|Overall Study|Protocol Violation|0|||
145986302|NCT00286455|526461717|FG000|Overall Study|Participant Non-compliance|1|||
145986303|NCT00286455|526461718|FG001|Overall Study|Participant Non-compliance|0|||
145986304|NCT00286455|526461719|FG002|Overall Study|Participant Non-compliance|0|||
145986305|NCT00286455|526461717|FG000|Overall Study|Withdrawal by Subject|0|||
145986306|NCT00286455|526461718|FG001|Overall Study|Withdrawal by Subject|8|||
145986307|NCT00286455|526461719|FG002|Overall Study|Withdrawal by Subject|7|||
145986308|NCT04495478|526461720|FG000|Overall Study|Withdrawal by Subject|0|||
145986309|NCT04495478|526461721|FG001|Overall Study|Withdrawal by Subject|0|||
145986310|NCT04495478|526461722|FG002|Overall Study|Withdrawal by Subject|0|||
145986311|NCT04495478|526461723|FG003|Overall Study|Withdrawal by Subject|1|||
145986312|NCT04495478|526461724|FG004|Overall Study|Withdrawal by Subject|0|||
145986313|NCT04495478|526461725|FG005|Overall Study|Withdrawal by Subject|0|||
145986314|NCT04495478|526461726|FG006|Overall Study|Withdrawal by Subject|0|||
145986315|NCT04495478|526461720|FG000|Overall Study|Physician Decision|0|||
145986316|NCT04495478|526461721|FG001|Overall Study|Physician Decision|1|||
145986317|NCT04495478|526461722|FG002|Overall Study|Physician Decision|0|||
145986318|NCT04495478|526461723|FG003|Overall Study|Physician Decision|0|||
145986319|NCT04495478|526461724|FG004|Overall Study|Physician Decision|1|||
145986320|NCT04495478|526461725|FG005|Overall Study|Physician Decision|0|||
145986321|NCT04495478|526461726|FG006|Overall Study|Physician Decision|0|||
145986322|NCT01658735|526463161|FG000|Overall Study|Lack of Efficacy|1|||
145986323|NCT01658735|526463162|FG001|Overall Study|Lack of Efficacy|0|||
145986324|NCT01658735|526463163|FG002|Overall Study|Lack of Efficacy|1|||
145986325|NCT01658735|526463161|FG000|Overall Study|Lost to Follow-up|1|||
145986326|NCT01658735|526463162|FG001|Overall Study|Lost to Follow-up|1|||
145986327|NCT01658735|526463163|FG002|Overall Study|Lost to Follow-up|0|||
145986328|NCT01658735|526463161|FG000|Overall Study|Protocol Violation|0|||
145986329|NCT01658735|526463162|FG001|Overall Study|Protocol Violation|1|||
145986330|NCT01658735|526463163|FG002|Overall Study|Protocol Violation|0|||
145986331|NCT01658735|526463161|FG000|Overall Study|Withdrawal by Subject|3|||
145986332|NCT01658735|526463162|FG001|Overall Study|Withdrawal by Subject|5|||
145986333|NCT01658735|526463163|FG002|Overall Study|Withdrawal by Subject|3|||
145986334|NCT01379937|526463164|FG000|Overall Study|Protocol Violation|0|||
145986335|NCT01379937|526463165|FG001|Overall Study|Protocol Violation|0|||
145986336|NCT01379937|526463166|FG002|Overall Study|Protocol Violation|0|||
145986337|NCT01379937|526463167|FG003|Overall Study|Protocol Violation|1|||
145986338|NCT01379937|526463164|FG000|Overall Study|Consent withdrawal|0|||
145986339|NCT01379937|526463165|FG001|Overall Study|Consent withdrawal|1|||
145986340|NCT01379937|526463166|FG002|Overall Study|Consent withdrawal|0|||
145986341|NCT01379937|526463167|FG003|Overall Study|Consent withdrawal|0|||
145986342|NCT01379937|526463164|FG000|Overall Study|Lost to Follow-up|1|||
145986343|NCT01379937|526463165|FG001|Overall Study|Lost to Follow-up|2|||
145986344|NCT01379937|526463166|FG002|Overall Study|Lost to Follow-up|2|||
145986345|NCT01379937|526463167|FG003|Overall Study|Lost to Follow-up|0|||
145986346|NCT04985682|526463168|FG000|Overall Study|Withdrawal by Subject|1|||
145986347|NCT00225758|526463173|FG000|Overall Study|Adverse Event|4|||
145986348|NCT00079781|526463174|FG000|Pre-implant Period|Withdrawal by Subject|2|||
145986349|NCT00079781|526463175|FG001|Pre-implant Period|Withdrawal by Subject|0|||
145986350|NCT00079781|526463176|FG002|Pre-implant Period|Withdrawal by Subject|0|||
145986351|NCT00079781|526463174|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
145986352|NCT00079781|526463175|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
145986353|NCT00079781|526463176|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
145986354|NCT00079781|526463174|FG000|Follow-up Period|Withdrawal by Subject|3|||
145986355|NCT00079781|526463175|FG001|Follow-up Period|Withdrawal by Subject|0|||
145986356|NCT00079781|526463176|FG002|Follow-up Period|Withdrawal by Subject|1|||
146297857|NCT02038920|527606030|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
145986357|NCT00079781|526463174|FG000|Follow-up Period|Lost to Follow-up|1|||
145986358|NCT00079781|526463175|FG001|Follow-up Period|Lost to Follow-up|0|||
145986359|NCT00079781|526463176|FG002|Follow-up Period|Lost to Follow-up|0|||
145986360|NCT00079781|526463174|FG000|Follow-up Period|Death|0|||
145986361|NCT00079781|526463175|FG001|Follow-up Period|Death|0|||
145986362|NCT00079781|526463176|FG002|Follow-up Period|Death|1|||
145986363|NCT04641975|526463177|FG000|Overall Study|Protocol Violation|1|||
145986364|NCT04641975|526463178|FG001|Overall Study|Protocol Violation|2|||
145986365|NCT04641975|526463179|FG002|Overall Study|Protocol Violation|0|||
145986366|NCT04641975|526463180|FG003|Overall Study|Protocol Violation|0|||
145986367|NCT04641975|526463177|FG000|Overall Study|Adverse Event|0|||
145986368|NCT04641975|526463178|FG001|Overall Study|Adverse Event|0|||
145986369|NCT04641975|526463179|FG002|Overall Study|Adverse Event|1|||
145986370|NCT04641975|526463180|FG003|Overall Study|Adverse Event|1|||
145986371|NCT04641975|526463177|FG000|Overall Study|Withdrawal by Subject|1|||
145986372|NCT04641975|526463178|FG001|Overall Study|Withdrawal by Subject|0|||
145986373|NCT04641975|526463179|FG002|Overall Study|Withdrawal by Subject|0|||
145986374|NCT04641975|526463180|FG003|Overall Study|Withdrawal by Subject|0|||
145986375|NCT01259024|526463184|FG000|Overall Study|Physician Decision|1|||
145986376|NCT01657500|526463185|FG000|Overall Study|set impropperly matched|3|||
145986377|NCT01657500|526463186|FG001|Overall Study|set impropperly matched|3|||
145986378|NCT01657500|526463185|FG000|Overall Study|Lost to Follow-up|2|||
145986379|NCT01657500|526463186|FG001|Overall Study|Lost to Follow-up|2|||
145986380|NCT00756444|526463189|FG000|Overall Study|Adverse Event|1|||
145986381|NCT00756444|526463190|FG001|Overall Study|Adverse Event|1|||
145986382|NCT00756444|526463189|FG000|Overall Study|Withdrawal by Subject|6|||
145986383|NCT00756444|526463190|FG001|Overall Study|Withdrawal by Subject|8|||
145986384|NCT00756444|526463189|FG000|Overall Study|Lost to Follow-up|0|||
145986385|NCT00756444|526463190|FG001|Overall Study|Lost to Follow-up|1|||
145986386|NCT00756444|526463189|FG000|Overall Study|Death|5|||
145986387|NCT00756444|526463190|FG001|Overall Study|Death|4|||
145986388|NCT00756444|526463189|FG000|Overall Study|Disease Progression|2|||
145986389|NCT00756444|526463190|FG001|Overall Study|Disease Progression|7|||
145986390|NCT00756444|526463189|FG000|Overall Study|Ineligibility Determined|1|||
145986391|NCT00756444|526463190|FG001|Overall Study|Ineligibility Determined|0|||
145986392|NCT00564070|526463191|FG000|Overall Study|Lost to Follow-up|9|||
145986393|NCT00564070|526463192|FG001|Overall Study|Lost to Follow-up|7|||
145986394|NCT00564070|526463191|FG000|Overall Study|Worsening depression, referred to care|3|||
145986395|NCT00564070|526463192|FG001|Overall Study|Worsening depression, referred to care|0|||
145986396|NCT02264821|526463194|FG000|Overall Study|Protocol Violation|1|||
145986397|NCT02264821|526463195|FG001|Overall Study|Protocol Violation|3|||
145986398|NCT02264821|526463196|FG002|Overall Study|Protocol Violation|6|||
145986399|NCT00552279|526463197|FG000|Overall Study|Adverse Event|0|||
145986400|NCT00552279|526463198|FG001|Overall Study|Adverse Event|1|||
145986401|NCT00552279|526463197|FG000|Overall Study|Withdrawal by Subject|12|||
145986402|NCT00552279|526463198|FG001|Overall Study|Withdrawal by Subject|1|||
145986403|NCT00552279|526463197|FG000|Overall Study|Lost to Follow-up|1|||
145986404|NCT00552279|526463198|FG001|Overall Study|Lost to Follow-up|0|||
145986405|NCT00552279|526463197|FG000|Overall Study|Other|1|||
145986406|NCT00552279|526463198|FG001|Overall Study|Other|1|||
145986407|NCT03142334|526463200|FG000|Overall Study|Death|18|||
145986408|NCT03142334|526463201|FG001|Overall Study|Death|33|||
145986409|NCT03142334|526463200|FG000|Overall Study|Withdrawal by Subject|15|||
145986410|NCT03142334|526463201|FG001|Overall Study|Withdrawal by Subject|11|||
146245828|NCT02069379|527414067|FG002|First Treatment Arm|Lost to Follow-up|1|||
146245829|NCT02069379|527414068|FG003|First Treatment Arm|Lost to Follow-up|0|||
146245830|NCT02069379|527414065|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
145986411|NCT03142334|526463200|FG000|Overall Study|Ongoing on trial follow up|463|||
145986412|NCT03142334|526463201|FG001|Overall Study|Ongoing on trial follow up|454|||
145986413|NCT01655069|526463202|FG000|Overall Study|Physician Decision|0|||
145986414|NCT01655069|526463203|FG001|Overall Study|Physician Decision|0|||
145986415|NCT01655069|526463204|FG002|Overall Study|Physician Decision|0|||
145986416|NCT01655069|526463205|FG003|Overall Study|Physician Decision|1|||
146245831|NCT02069379|527414066|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
145986417|NCT01655069|526463202|FG000|Overall Study|Adverse Event|6|||
145986418|NCT01655069|526463203|FG001|Overall Study|Adverse Event|7|||
145986419|NCT01655069|526463204|FG002|Overall Study|Adverse Event|2|||
145986420|NCT01655069|526463205|FG003|Overall Study|Adverse Event|3|||
145986421|NCT01655069|526463202|FG000|Overall Study|Lack of Efficacy|0|||
145986422|NCT01655069|526463203|FG001|Overall Study|Lack of Efficacy|1|||
145986423|NCT01655069|526463204|FG002|Overall Study|Lack of Efficacy|0|||
145986424|NCT01655069|526463205|FG003|Overall Study|Lack of Efficacy|0|||
145986425|NCT01655069|526463202|FG000|Overall Study|No Treatment Needed|0|||
145986426|NCT01655069|526463203|FG001|Overall Study|No Treatment Needed|1|||
145986427|NCT01655069|526463204|FG002|Overall Study|No Treatment Needed|0|||
145986428|NCT01655069|526463205|FG003|Overall Study|No Treatment Needed|0|||
145986429|NCT01655069|526463202|FG000|Overall Study|Withdrawal by Subject|2|||
145986430|NCT01655069|526463203|FG001|Overall Study|Withdrawal by Subject|3|||
145986431|NCT01655069|526463204|FG002|Overall Study|Withdrawal by Subject|0|||
145986432|NCT01655069|526463205|FG003|Overall Study|Withdrawal by Subject|0|||
145986433|NCT06083493|526463206|FG000|Overall Study|Technical issues with the interventional device|2|||
145986434|NCT06083493|526463207|FG001|Overall Study|Technical issues with the interventional device|2|||
145986435|NCT06083493|526463206|FG000|Overall Study|Performed incorrect visual task|1|||
145986436|NCT06083493|526463207|FG001|Overall Study|Performed incorrect visual task|0|||
145986437|NCT06083493|526463206|FG000|Overall Study|Insufficient baseline performance|0|||
145986438|NCT06083493|526463207|FG001|Overall Study|Insufficient baseline performance|1|||
145986439|NCT04034056|526463208|FG000|Overall Study|Withdrawal by Subject|2|||
145986440|NCT04034056|526463208|FG000|Overall Study|Reason Not Specified|13|||
145986441|NCT04034056|526463208|FG000|Overall Study|Adverse Event|56|||
145986442|NCT03225989|526463209|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
145986443|NCT03225989|526463210|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
145986444|NCT03225989|526463211|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
145986445|NCT03225989|526463209|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
146245832|NCT02069379|527414067|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
146245833|NCT02069379|527414068|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
146245834|NCT02069379|527414065|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
146245835|NCT02069379|527414066|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
146245836|NCT02069379|527414067|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
146245837|NCT02069379|527414068|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
146245838|NCT02069379|527414065|FG000|Second Treatment Arm|Lost to Follow-up|0|||
146245839|NCT02069379|527414066|FG001|Second Treatment Arm|Lost to Follow-up|0|||
146245840|NCT02069379|527414067|FG002|Second Treatment Arm|Lost to Follow-up|1|||
146245841|NCT02069379|527414068|FG003|Second Treatment Arm|Lost to Follow-up|0|||
146245842|NCT04421456|527414069|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
146245843|NCT04421456|527414070|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
146245844|NCT04421456|527414071|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
146245845|NCT04421456|527414069|FG000|Randomized Treatment Period|Adverse Event|0|||
146245846|NCT04421456|527414070|FG001|Randomized Treatment Period|Adverse Event|1|||
146245847|NCT04421456|527414071|FG002|Randomized Treatment Period|Adverse Event|0|||
145986446|NCT03225989|526463210|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
145986447|NCT03225989|526463211|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
145986448|NCT03225989|526463209|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
145986449|NCT03225989|526463210|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
145986450|NCT03225989|526463211|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
145986451|NCT03225989|526463209|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
145986452|NCT03225989|526463210|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
145986453|NCT03225989|526463211|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
145986454|NCT03225989|526463209|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
145986455|NCT03225989|526463210|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
145986456|NCT03225989|526463211|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
145986457|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
145986458|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
145986459|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
145986460|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
145986461|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
145986462|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
145986463|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
145986464|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
145986465|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
145986466|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
145986467|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
145986468|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
145986469|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
146091451|NCT01810432|526856825|FG000|Washout|Adverse Event|1|||
146091452|NCT01810432|526856826|FG001|Washout|Adverse Event|0|||
146245848|NCT04421456|527414069|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
146245849|NCT04421456|527414070|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
146245850|NCT04421456|527414071|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
146245851|NCT04421456|527414069|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
146245852|NCT04421456|527414070|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
146245853|NCT04421456|527414071|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
146245854|NCT04421456|527414069|FG000|Randomized Treatment Period|Participant non-compliance|1|||
146245855|NCT04421456|527414070|FG001|Randomized Treatment Period|Participant non-compliance|1|||
146297858|NCT02038920|527606031|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
145986470|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
145986471|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
145986472|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
145986473|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
145986474|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
145986475|NCT03225989|526463209|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
145986476|NCT03225989|526463210|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
145986477|NCT03225989|526463211|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
145986478|NCT03093870|526463212|FG000|Overall Study|Withdrawal by Subject|2|||
145986479|NCT03093870|526463213|FG001|Overall Study|Withdrawal by Subject|6|||
145986480|NCT03093870|526463214|FG002|Overall Study|Withdrawal by Subject|5|||
145986481|NCT03093870|526463212|FG000|Overall Study|Death|1|||
145986482|NCT03093870|526463213|FG001|Overall Study|Death|35|||
145986483|NCT03093870|526463214|FG002|Overall Study|Death|35|||
145986484|NCT03093870|526463212|FG000|Overall Study|Radiographic disease progression|10|||
145986485|NCT03093870|526463213|FG001|Overall Study|Radiographic disease progression|0|||
145986486|NCT03093870|526463214|FG002|Overall Study|Radiographic disease progression|0|||
145986487|NCT03093870|526463212|FG000|Overall Study|Clinical disease progression|1|||
145986488|NCT03093870|526463213|FG001|Overall Study|Clinical disease progression|0|||
145986489|NCT03093870|526463214|FG002|Overall Study|Clinical disease progression|0|||
145986490|NCT03093870|526463212|FG000|Overall Study|Physician Decision|2|||
145986491|NCT03093870|526463213|FG001|Overall Study|Physician Decision|0|||
145986492|NCT03093870|526463214|FG002|Overall Study|Physician Decision|0|||
145986493|NCT03093870|526463212|FG000|Overall Study|Adverse Event|7|||
145986494|NCT03093870|526463213|FG001|Overall Study|Adverse Event|0|||
145986495|NCT03093870|526463214|FG002|Overall Study|Adverse Event|0|||
145986496|NCT03093870|526463212|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
145986497|NCT03093870|526463213|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
145986498|NCT03093870|526463214|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
145986499|NCT03093870|526463212|FG000|Overall Study|Lost to Follow-up|0|||
145986500|NCT03093870|526463213|FG001|Overall Study|Lost to Follow-up|0|||
145986501|NCT03093870|526463214|FG002|Overall Study|Lost to Follow-up|1|||
145986502|NCT00601107|526463215|FG000|Overall Study|Adverse Event|0|||
145986503|NCT00601107|526463216|FG001|Overall Study|Adverse Event|1|||
145986504|NCT00601107|526463217|FG002|Overall Study|Adverse Event|3|||
145986505|NCT00601107|526463218|FG003|Overall Study|Adverse Event|0|||
145986506|NCT00601107|526463215|FG000|Overall Study|Withdrawal by Subject|5|||
145986507|NCT00601107|526463216|FG001|Overall Study|Withdrawal by Subject|4|||
145986508|NCT00601107|526463217|FG002|Overall Study|Withdrawal by Subject|7|||
145986509|NCT00601107|526463218|FG003|Overall Study|Withdrawal by Subject|4|||
145986510|NCT00601107|526463215|FG000|Overall Study|Lost to Follow-up|3|||
145986511|NCT00601107|526463216|FG001|Overall Study|Lost to Follow-up|3|||
145986512|NCT00601107|526463217|FG002|Overall Study|Lost to Follow-up|0|||
145986513|NCT00601107|526463218|FG003|Overall Study|Lost to Follow-up|3|||
145986514|NCT00601107|526463215|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145986515|NCT00601107|526463216|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145986516|NCT00601107|526463217|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145986517|NCT00601107|526463218|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
145986518|NCT00601107|526463215|FG000|Overall Study|Worsening of Psoriasis|4|||
145986519|NCT00601107|526463216|FG001|Overall Study|Worsening of Psoriasis|1|||
145986520|NCT00601107|526463217|FG002|Overall Study|Worsening of Psoriasis|1|||
145986521|NCT00601107|526463218|FG003|Overall Study|Worsening of Psoriasis|4|||
145986522|NCT00601107|526463215|FG000|Overall Study|Undefined|1|||
145986523|NCT00601107|526463216|FG001|Overall Study|Undefined|0|||
145986524|NCT00601107|526463217|FG002|Overall Study|Undefined|1|||
145986525|NCT00601107|526463218|FG003|Overall Study|Undefined|0|||
145986526|NCT01530997|526463219|FG000|Overall Study|Physician Decision|1|||
145986527|NCT01530997|526463219|FG000|Overall Study|Withdrawal by Subject|1|||
145986528|NCT00609973|526463220|FG000|Overall Study|Adverse Event|2|||
145986529|NCT00609973|526463221|FG001|Overall Study|Adverse Event|1|||
145986530|NCT00609973|526463220|FG000|Overall Study|Protocol Violation|4|||
145986531|NCT00609973|526463221|FG001|Overall Study|Protocol Violation|3|||
145986532|NCT00609973|526463220|FG000|Overall Study|Lost to Follow-up|2|||
145986533|NCT00609973|526463221|FG001|Overall Study|Lost to Follow-up|1|||
145986534|NCT00609973|526463220|FG000|Overall Study|Withdrawal by Subject|0|||
145986535|NCT00609973|526463221|FG001|Overall Study|Withdrawal by Subject|1|||
145986536|NCT02453191|526463223|FG000|Overall Study|Withdrawal by Subject|1|||
145986537|NCT01520714|526463224|FG000|Overall Study|Protocol Violation|0|||
145986538|NCT01520714|526463225|FG001|Overall Study|Protocol Violation|3|||
145986539|NCT01520714|526463224|FG000|Overall Study|Adverse Event|0|||
145986540|NCT01520714|526463225|FG001|Overall Study|Adverse Event|2|||
145986541|NCT01520714|526463224|FG000|Overall Study|Lack of Efficacy|0|||
145986542|NCT01520714|526463225|FG001|Overall Study|Lack of Efficacy|1|||
145986543|NCT01063881|526463227|FG000|Overall Study|Adverse Event|12|||
145986544|NCT01063881|526463228|FG001|Overall Study|Adverse Event|2|||
145986545|NCT01063881|526463229|FG002|Overall Study|Adverse Event|0|||
145986546|NCT01063881|526463227|FG000|Overall Study|Lost to Follow-up|13|||
145986547|NCT01063881|526463228|FG001|Overall Study|Lost to Follow-up|7|||
145986548|NCT01063881|526463229|FG002|Overall Study|Lost to Follow-up|1|||
145986549|NCT01063881|526463227|FG000|Overall Study|Withdrawal by Subject|25|||
145986550|NCT01063881|526463228|FG001|Overall Study|Withdrawal by Subject|1|||
145986551|NCT01063881|526463229|FG002|Overall Study|Withdrawal by Subject|0|||
145986552|NCT01063881|526463227|FG000|Overall Study|Reason for not completed not specified|5|||
146245856|NCT04421456|527414071|FG002|Randomized Treatment Period|Participant non-compliance|2|||
146245857|NCT04421456|527414069|FG000|Randomized Treatment Period|Other|0|||
146245858|NCT04421456|527414070|FG001|Randomized Treatment Period|Other|1|||
146245859|NCT04421456|527414071|FG002|Randomized Treatment Period|Other|3|||
146245860|NCT04617847|527414072|FG000|Overall Study|Withdrawal by Subject|1|||
146245861|NCT04617847|527414073|FG001|Overall Study|Withdrawal by Subject|0|||
146245862|NCT04617847|527414072|FG000|Overall Study|Adverse Event|0|||
145986553|NCT01063881|526463228|FG001|Overall Study|Reason for not completed not specified|1|||
145986554|NCT01063881|526463229|FG002|Overall Study|Reason for not completed not specified|0|||
145986555|NCT01309100|526463230|FG000|Overall Study|Protocol Violation|1|||
146245863|NCT04617847|527414073|FG001|Overall Study|Adverse Event|2|||
145986556|NCT01309100|526463230|FG000|Overall Study|Positive Slit lamp finding|1|||
145986557|NCT01340170|526463233|FG000|Overall Study|Lost to Follow-up|2|||
145986558|NCT01340170|526463234|FG001|Overall Study|Lost to Follow-up|4|||
145986559|NCT01340170|526463235|FG002|Overall Study|Lost to Follow-up|0|||
145986560|NCT01340170|526463233|FG000|Overall Study|Implant failure|1|||
145986561|NCT01340170|526463234|FG001|Overall Study|Implant failure|3|||
145986562|NCT01340170|526463235|FG002|Overall Study|Implant failure|0|||
145986563|NCT01796470|526463238|FG000|Overall Study|Adverse Event|4|||
145986564|NCT01796470|526463239|FG001|Overall Study|Adverse Event|2|||
145986565|NCT01796470|526463240|FG002|Overall Study|Adverse Event|2|||
145986566|NCT01796470|526463241|FG003|Overall Study|Adverse Event|1|||
145986567|NCT01796470|526463242|FG004|Overall Study|Adverse Event|3|||
145986568|NCT01796470|526463238|FG000|Overall Study|Death|2|||
145986569|NCT01796470|526463239|FG001|Overall Study|Death|0|||
145986570|NCT01796470|526463240|FG002|Overall Study|Death|0|||
145986571|NCT01796470|526463241|FG003|Overall Study|Death|0|||
145986572|NCT01796470|526463242|FG004|Overall Study|Death|1|||
145986573|NCT01796470|526463238|FG000|Overall Study|Initiated New Therapy|9|||
145986574|NCT01796470|526463239|FG001|Overall Study|Initiated New Therapy|0|||
145986575|NCT01796470|526463240|FG002|Overall Study|Initiated New Therapy|0|||
145986576|NCT01796470|526463241|FG003|Overall Study|Initiated New Therapy|0|||
145986577|NCT01796470|526463242|FG004|Overall Study|Initiated New Therapy|2|||
145986578|NCT01796470|526463238|FG000|Overall Study|Lost to Follow-up|0|||
145986579|NCT01796470|526463239|FG001|Overall Study|Lost to Follow-up|1|||
146297859|NCT02038920|527606032|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
146297860|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146297861|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146297862|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146297863|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
146297864|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145986580|NCT01796470|526463240|FG002|Overall Study|Lost to Follow-up|0|||
145986581|NCT01796470|526463241|FG003|Overall Study|Lost to Follow-up|0|||
145986582|NCT01796470|526463242|FG004|Overall Study|Lost to Follow-up|0|||
145986583|NCT01796470|526463238|FG000|Overall Study|Physician Decision|5|||
145986584|NCT01796470|526463239|FG001|Overall Study|Physician Decision|4|||
145986585|NCT01796470|526463240|FG002|Overall Study|Physician Decision|1|||
145986586|NCT01796470|526463241|FG003|Overall Study|Physician Decision|0|||
145986587|NCT01796470|526463242|FG004|Overall Study|Physician Decision|1|||
145986588|NCT01796470|526463238|FG000|Overall Study|Progressive Disease|7|||
145986589|NCT01796470|526463239|FG001|Overall Study|Progressive Disease|7|||
146245864|NCT04617847|527414072|FG000|Overall Study|Death|0|||
146245865|NCT04617847|527414073|FG001|Overall Study|Death|1|||
146245866|NCT04617847|527414072|FG000|Overall Study|Termination of Study by Sponsor|2|||
146245867|NCT04617847|527414073|FG001|Overall Study|Termination of Study by Sponsor|21|||
145986590|NCT01796470|526463240|FG002|Overall Study|Progressive Disease|3|||
145986591|NCT01796470|526463241|FG003|Overall Study|Progressive Disease|2|||
145986592|NCT01796470|526463242|FG004|Overall Study|Progressive Disease|0|||
145986593|NCT01796470|526463238|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
145986594|NCT01796470|526463239|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
145986595|NCT01796470|526463240|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
145986596|NCT01796470|526463241|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
145986597|NCT01796470|526463242|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
145986598|NCT01796470|526463238|FG000|Overall Study|Withdrawal by Subject|7|||
145986599|NCT01796470|526463239|FG001|Overall Study|Withdrawal by Subject|0|||
145986600|NCT01796470|526463240|FG002|Overall Study|Withdrawal by Subject|0|||
145986601|NCT01796470|526463241|FG003|Overall Study|Withdrawal by Subject|0|||
145986602|NCT01796470|526463242|FG004|Overall Study|Withdrawal by Subject|1|||
146245868|NCT02206607|527414074|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
146245869|NCT02206607|527414075|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
146245870|NCT02206607|527414076|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
145986603|NCT00147537|526463243|FG000|Phase 1b|Death|0|||
145986604|NCT00147537|526463244|FG001|Phase 1b|Death|1|||
145986605|NCT00147537|526463245|FG002|Phase 1b|Death|2|||
145986606|NCT00147537|526463246|FG003|Phase 1b|Death|1|||
145986607|NCT00147537|526463247|FG004|Phase 1b|Death|2|||
145986608|NCT00147537|526463248|FG005|Phase 1b|Death|2|||
145986609|NCT00147537|526463249|FG006|Phase 1b|Death|1|||
145986610|NCT00147537|526463250|FG007|Phase 1b|Death|3|||
145986611|NCT00147537|526463251|FG008|Phase 1b|Death|9|||
145986612|NCT00147537|526463252|FG009|Phase 1b|Death|0|||
145986613|NCT00147537|526463253|FG010|Phase 1b|Death|0|||
145986614|NCT00147537|526463243|FG000|Phase 1b|Lost to Follow-up|2|||
145986615|NCT00147537|526463244|FG001|Phase 1b|Lost to Follow-up|1|||
145986616|NCT00147537|526463245|FG002|Phase 1b|Lost to Follow-up|0|||
145986617|NCT00147537|526463246|FG003|Phase 1b|Lost to Follow-up|0|||
145986618|NCT00147537|526463247|FG004|Phase 1b|Lost to Follow-up|0|||
145986619|NCT00147537|526463248|FG005|Phase 1b|Lost to Follow-up|0|||
145986620|NCT00147537|526463249|FG006|Phase 1b|Lost to Follow-up|2|||
145986621|NCT00147537|526463250|FG007|Phase 1b|Lost to Follow-up|0|||
145986622|NCT00147537|526463251|FG008|Phase 1b|Lost to Follow-up|1|||
145986623|NCT00147537|526463252|FG009|Phase 1b|Lost to Follow-up|0|||
145986624|NCT00147537|526463253|FG010|Phase 1b|Lost to Follow-up|0|||
145986625|NCT00147537|526463243|FG000|Phase 1b|Other|0|||
145986626|NCT00147537|526463244|FG001|Phase 1b|Other|0|||
145986627|NCT00147537|526463245|FG002|Phase 1b|Other|2|||
145986628|NCT00147537|526463246|FG003|Phase 1b|Other|1|||
145986629|NCT00147537|526463247|FG004|Phase 1b|Other|1|||
145986630|NCT00147537|526463248|FG005|Phase 1b|Other|1|||
145986631|NCT00147537|526463249|FG006|Phase 1b|Other|14|||
145986632|NCT00147537|526463250|FG007|Phase 1b|Other|4|||
145986633|NCT00147537|526463251|FG008|Phase 1b|Other|4|||
145986634|NCT00147537|526463252|FG009|Phase 1b|Other|0|||
145986635|NCT00147537|526463253|FG010|Phase 1b|Other|0|||
145986636|NCT00147537|526463243|FG000|Phase 1b|Withdrawal by Subject|0|||
145986637|NCT00147537|526463244|FG001|Phase 1b|Withdrawal by Subject|0|||
145986638|NCT00147537|526463245|FG002|Phase 1b|Withdrawal by Subject|0|||
145986639|NCT00147537|526463246|FG003|Phase 1b|Withdrawal by Subject|0|||
145986640|NCT00147537|526463247|FG004|Phase 1b|Withdrawal by Subject|0|||
145986641|NCT00147537|526463248|FG005|Phase 1b|Withdrawal by Subject|0|||
145986642|NCT00147537|526463249|FG006|Phase 1b|Withdrawal by Subject|0|||
145986643|NCT00147537|526463250|FG007|Phase 1b|Withdrawal by Subject|0|||
145986644|NCT00147537|526463251|FG008|Phase 1b|Withdrawal by Subject|2|||
145986645|NCT00147537|526463252|FG009|Phase 1b|Withdrawal by Subject|0|||
145986646|NCT00147537|526463253|FG010|Phase 1b|Withdrawal by Subject|0|||
145986647|NCT00147537|526463243|FG000|Phase 1b|Randomized but not treated|0|||
145986648|NCT00147537|526463244|FG001|Phase 1b|Randomized but not treated|0|||
145986649|NCT00147537|526463245|FG002|Phase 1b|Randomized but not treated|0|||
145986650|NCT00147537|526463246|FG003|Phase 1b|Randomized but not treated|0|||
145986651|NCT00147537|526463247|FG004|Phase 1b|Randomized but not treated|0|||
145986652|NCT00147537|526463248|FG005|Phase 1b|Randomized but not treated|0|||
145986653|NCT00147537|526463249|FG006|Phase 1b|Randomized but not treated|1|||
145986654|NCT00147537|526463250|FG007|Phase 1b|Randomized but not treated|0|||
145986655|NCT00147537|526463251|FG008|Phase 1b|Randomized but not treated|1|||
145986656|NCT00147537|526463252|FG009|Phase 1b|Randomized but not treated|0|||
145986657|NCT00147537|526463253|FG010|Phase 1b|Randomized but not treated|0|||
145986658|NCT00147537|526463243|FG000|Phase 2|Death|0|||
145986659|NCT00147537|526463244|FG001|Phase 2|Death|0|||
145986660|NCT00147537|526463245|FG002|Phase 2|Death|0|||
145986661|NCT00147537|526463246|FG003|Phase 2|Death|0|||
145986662|NCT00147537|526463247|FG004|Phase 2|Death|0|||
145986663|NCT00147537|526463248|FG005|Phase 2|Death|0|||
146091453|NCT01810432|526856825|FG000|Period 2|Withdrawal by Subject|2|||
146245871|NCT02206607|527414077|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
146245872|NCT02206607|527414078|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
146245873|NCT02206607|527414074|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
145986664|NCT00147537|526463249|FG006|Phase 2|Death|0|||
145986665|NCT00147537|526463250|FG007|Phase 2|Death|0|||
145986666|NCT00147537|526463251|FG008|Phase 2|Death|0|||
146245874|NCT02206607|527414075|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
145986667|NCT00147537|526463252|FG009|Phase 2|Death|85|||
145986668|NCT00147537|526463253|FG010|Phase 2|Death|31|||
145986669|NCT00147537|526463243|FG000|Phase 2|Lost to Follow-up|0|||
145986670|NCT00147537|526463244|FG001|Phase 2|Lost to Follow-up|0|||
145986671|NCT00147537|526463245|FG002|Phase 2|Lost to Follow-up|0|||
145986672|NCT00147537|526463246|FG003|Phase 2|Lost to Follow-up|0|||
145986673|NCT00147537|526463247|FG004|Phase 2|Lost to Follow-up|0|||
145986674|NCT00147537|526463248|FG005|Phase 2|Lost to Follow-up|0|||
145986675|NCT00147537|526463249|FG006|Phase 2|Lost to Follow-up|0|||
145986676|NCT00147537|526463250|FG007|Phase 2|Lost to Follow-up|0|||
145986677|NCT00147537|526463251|FG008|Phase 2|Lost to Follow-up|0|||
145986678|NCT00147537|526463252|FG009|Phase 2|Lost to Follow-up|12|||
145986679|NCT00147537|526463253|FG010|Phase 2|Lost to Follow-up|4|||
145986680|NCT00147537|526463243|FG000|Phase 2|Other|0|||
145986681|NCT00147537|526463244|FG001|Phase 2|Other|0|||
145986682|NCT00147537|526463245|FG002|Phase 2|Other|0|||
146245875|NCT02206607|527414076|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
146245876|NCT02206607|527414077|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
146245877|NCT02206607|527414078|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
146245878|NCT04183491|527414083|FG000|Overall Study|Withdrawal by Subject|0|||
145986683|NCT00147537|526463246|FG003|Phase 2|Other|0|||
145986684|NCT00147537|526463247|FG004|Phase 2|Other|0|||
145986685|NCT00147537|526463248|FG005|Phase 2|Other|0|||
145986686|NCT00147537|526463249|FG006|Phase 2|Other|0|||
145986687|NCT00147537|526463250|FG007|Phase 2|Other|0|||
145986688|NCT00147537|526463251|FG008|Phase 2|Other|0|||
145986689|NCT00147537|526463252|FG009|Phase 2|Other|47|||
145986690|NCT00147537|526463253|FG010|Phase 2|Other|12|||
145986691|NCT00147537|526463243|FG000|Phase 2|Withdrawal by Subject|0|||
145986692|NCT00147537|526463244|FG001|Phase 2|Withdrawal by Subject|0|||
145986693|NCT00147537|526463245|FG002|Phase 2|Withdrawal by Subject|0|||
145986694|NCT00147537|526463246|FG003|Phase 2|Withdrawal by Subject|0|||
145986695|NCT00147537|526463247|FG004|Phase 2|Withdrawal by Subject|0|||
145986696|NCT00147537|526463248|FG005|Phase 2|Withdrawal by Subject|0|||
145986697|NCT00147537|526463249|FG006|Phase 2|Withdrawal by Subject|0|||
145986698|NCT00147537|526463250|FG007|Phase 2|Withdrawal by Subject|0|||
145986699|NCT00147537|526463251|FG008|Phase 2|Withdrawal by Subject|0|||
145986700|NCT00147537|526463252|FG009|Phase 2|Withdrawal by Subject|16|||
145986701|NCT00147537|526463253|FG010|Phase 2|Withdrawal by Subject|4|||
145986702|NCT00147537|526463243|FG000|Phase 2|Randomized but not treated|0|||
145986703|NCT00147537|526463244|FG001|Phase 2|Randomized but not treated|0|||
145986704|NCT00147537|526463245|FG002|Phase 2|Randomized but not treated|0|||
145986705|NCT00147537|526463246|FG003|Phase 2|Randomized but not treated|0|||
145986706|NCT00147537|526463247|FG004|Phase 2|Randomized but not treated|0|||
145986707|NCT00147537|526463248|FG005|Phase 2|Randomized but not treated|0|||
145986708|NCT00147537|526463249|FG006|Phase 2|Randomized but not treated|0|||
145986709|NCT00147537|526463250|FG007|Phase 2|Randomized but not treated|0|||
145986710|NCT00147537|526463251|FG008|Phase 2|Randomized but not treated|0|||
145986711|NCT00147537|526463252|FG009|Phase 2|Randomized but not treated|1|||
145986712|NCT00147537|526463253|FG010|Phase 2|Randomized but not treated|1|||
145986713|NCT01927861|526463254|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
145986714|NCT01927861|526463255|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
145986715|NCT01927861|526463254|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
145986716|NCT01927861|526463255|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
145986717|NCT01248468|526463256|FG000|Overall Study|Administrative problem|1|||
145986718|NCT01248468|526463257|FG001|Overall Study|Administrative problem|0|||
145986719|NCT01248468|526463258|FG002|Overall Study|Administrative problem|0|||
145986720|NCT01248468|526463256|FG000|Overall Study|Lost to Follow-up|9|||
145986721|NCT01248468|526463257|FG001|Overall Study|Lost to Follow-up|12|||
145986722|NCT01248468|526463258|FG002|Overall Study|Lost to Follow-up|4|||
145986723|NCT01248468|526463256|FG000|Overall Study|Pregnancy|1|||
145986724|NCT01248468|526463257|FG001|Overall Study|Pregnancy|0|||
145986725|NCT01248468|526463258|FG002|Overall Study|Pregnancy|0|||
145986726|NCT01248468|526463256|FG000|Overall Study|Withdrawal by Subject|4|||
145986727|NCT01248468|526463257|FG001|Overall Study|Withdrawal by Subject|2|||
145986728|NCT01248468|526463258|FG002|Overall Study|Withdrawal by Subject|0|||
145986729|NCT02006654|526463260|FG000|Overall Study|Withdrawal before treatment|4|||
145986730|NCT02006654|526463261|FG001|Overall Study|Withdrawal before treatment|2|||
145986731|NCT02006654|526463260|FG000|Overall Study|Adverse Event|16|||
145986732|NCT02006654|526463261|FG001|Overall Study|Adverse Event|17|||
145986733|NCT02006654|526463260|FG000|Overall Study|Death|1|||
145986734|NCT02006654|526463261|FG001|Overall Study|Death|0|||
145986735|NCT02006654|526463260|FG000|Overall Study|Withdrawal by Subject|14|||
145986736|NCT02006654|526463261|FG001|Overall Study|Withdrawal by Subject|12|||
145986737|NCT02006654|526463260|FG000|Overall Study|Protocol Violation|5|||
145986738|NCT02006654|526463261|FG001|Overall Study|Protocol Violation|8|||
145986739|NCT02006654|526463260|FG000|Overall Study|Lost to Follow-up|1|||
145986740|NCT02006654|526463261|FG001|Overall Study|Lost to Follow-up|0|||
146245879|NCT04183491|527414084|FG001|Overall Study|Withdrawal by Subject|0|||
146245880|NCT04183491|527414085|FG002|Overall Study|Withdrawal by Subject|1|||
145986741|NCT02006654|526463260|FG000|Overall Study|patient's will|2|||
145986742|NCT02006654|526463261|FG001|Overall Study|patient's will|1|||
145986743|NCT02006654|526463260|FG000|Overall Study|insufficient compliance|1|||
145986744|NCT02006654|526463261|FG001|Overall Study|insufficient compliance|0|||
146245881|NCT04183491|527414086|FG003|Overall Study|Withdrawal by Subject|0|||
145986745|NCT02006654|526463260|FG000|Overall Study|worsening cognitive condition|0|||
145986746|NCT02006654|526463261|FG001|Overall Study|worsening cognitive condition|1|||
145986747|NCT02006654|526463260|FG000|Overall Study|faecal incontinence|0|||
145986748|NCT02006654|526463261|FG001|Overall Study|faecal incontinence|1|||
145986749|NCT02006654|526463260|FG000|Overall Study|mood disorder|0|||
145986750|NCT02006654|526463261|FG001|Overall Study|mood disorder|1|||
145986751|NCT02006654|526463260|FG000|Overall Study|disallowed medication|1|||
145986752|NCT02006654|526463261|FG001|Overall Study|disallowed medication|0|||
145986753|NCT02006654|526463260|FG000|Overall Study|moving out of state|0|||
146245882|NCT04183491|527414087|FG004|Overall Study|Withdrawal by Subject|0|||
146245883|NCT04183491|527414088|FG005|Overall Study|Withdrawal by Subject|1|||
145986754|NCT02006654|526463261|FG001|Overall Study|moving out of state|1|||
145986755|NCT04128228|526463269|FG000|Overall Study|Withdrawal by Subject|3|||
145986756|NCT04128228|526463270|FG001|Overall Study|Withdrawal by Subject|3|||
145986757|NCT04128228|526463271|FG002|Overall Study|Withdrawal by Subject|0|||
145986758|NCT04128228|526463272|FG003|Overall Study|Withdrawal by Subject|0|||
145986759|NCT04128228|526463269|FG000|Overall Study|noncompliance|2|||
145986760|NCT04128228|526463270|FG001|Overall Study|noncompliance|2|||
145986761|NCT04128228|526463271|FG002|Overall Study|noncompliance|0|||
145986762|NCT04128228|526463272|FG003|Overall Study|noncompliance|0|||
145986763|NCT01945242|526463273|FG000|Overall Study|Physician Decision|3|||
145986764|NCT01945242|526463274|FG001|Overall Study|Physician Decision|3|||
145986765|NCT02057666|526463277|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
145986766|NCT02057666|526463278|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
145986767|NCT02057666|526463277|FG000|Double Blind Treatment Period|Poor tolerability|7|||
145986768|NCT02057666|526463278|FG001|Double Blind Treatment Period|Poor tolerability|2|||
145986769|NCT02057666|526463277|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
145986770|NCT02057666|526463278|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
145986771|NCT02057666|526463277|FG000|Double Blind Treatment Period|Physician Decision|1|||
145986772|NCT02057666|526463278|FG001|Double Blind Treatment Period|Physician Decision|0|||
145986773|NCT02057666|526463277|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
145986774|NCT02057666|526463278|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
145986775|NCT02057666|526463277|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
145986776|NCT02057666|526463278|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
145986777|NCT02057666|526463277|FG000|Double Blind Treatment Period|Sponsor's request|70|||
145986778|NCT02057666|526463278|FG001|Double Blind Treatment Period|Sponsor's request|34|||
145986779|NCT02057666|526463277|FG000|Open-Label Treatment Period|Poor tolerability|0|||
145986780|NCT02057666|526463278|FG001|Open-Label Treatment Period|Poor tolerability|1|||
145986781|NCT02057666|526463277|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
145986782|NCT02057666|526463278|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
145986783|NCT02057666|526463277|FG000|Open-Label Treatment Period|Sponsor's request|0|||
145986784|NCT02057666|526463278|FG001|Open-Label Treatment Period|Sponsor's request|4|||
145986785|NCT05661734|526463279|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
145986786|NCT05661734|526463279|FG000|Overall Study|Lost to Follow-up|13|||
146245884|NCT04183491|527414089|FG006|Overall Study|Withdrawal by Subject|0|||
145986787|NCT05661734|526463279|FG000|Overall Study|Enrolled but not dosed|2|||
145986788|NCT04401293|526463281|FG000|Overall Study|Withdrawal by Subject|1|||
145986789|NCT04401293|526463282|FG001|Overall Study|Withdrawal by Subject|3|||
145986790|NCT01026038|526463283|FG000|Overall Study|Lost to Follow-up|1|||
145986791|NCT01026038|526463284|FG001|Overall Study|Lost to Follow-up|1|||
145986792|NCT01026038|526463285|FG002|Overall Study|Lost to Follow-up|0|||
145986793|NCT03679884|526463286|FG000|Overall Study|Other|12|||
145986794|NCT03679884|526463287|FG001|Overall Study|Other|12|||
145986795|NCT03679884|526463288|FG002|Overall Study|Other|12|||
145986796|NCT03679884|526463289|FG003|Overall Study|Other|7|||
145986797|NCT03679884|526463290|FG004|Overall Study|Other|8|||
145986798|NCT03679884|526463286|FG000|Overall Study|Lack of Efficacy|15|||
145986799|NCT03679884|526463287|FG001|Overall Study|Lack of Efficacy|29|||
145986800|NCT03679884|526463288|FG002|Overall Study|Lack of Efficacy|13|||
145986801|NCT03679884|526463289|FG003|Overall Study|Lack of Efficacy|29|||
145986802|NCT03679884|526463290|FG004|Overall Study|Lack of Efficacy|10|||
145986803|NCT03679884|526463286|FG000|Overall Study|Death|1|||
145986804|NCT03679884|526463287|FG001|Overall Study|Death|0|||
145986805|NCT03679884|526463288|FG002|Overall Study|Death|0|||
145986806|NCT03679884|526463289|FG003|Overall Study|Death|0|||
145986807|NCT03679884|526463290|FG004|Overall Study|Death|0|||
145986808|NCT03679884|526463286|FG000|Overall Study|Adverse Event|2|||
145986809|NCT03679884|526463287|FG001|Overall Study|Adverse Event|10|||
145986810|NCT03679884|526463288|FG002|Overall Study|Adverse Event|9|||
145986811|NCT03679884|526463289|FG003|Overall Study|Adverse Event|6|||
145986812|NCT03679884|526463290|FG004|Overall Study|Adverse Event|6|||
146245885|NCT03989232|527414093|FG000|Overall Study|Lost to Follow-up|3|||
145986813|NCT03679884|526463286|FG000|Overall Study|Withdrawal by Subject|12|||
145986814|NCT03679884|526463287|FG001|Overall Study|Withdrawal by Subject|23|||
145986815|NCT03679884|526463288|FG002|Overall Study|Withdrawal by Subject|8|||
145986816|NCT03679884|526463289|FG003|Overall Study|Withdrawal by Subject|8|||
145986817|NCT03679884|526463290|FG004|Overall Study|Withdrawal by Subject|9|||
145986818|NCT03679884|526463286|FG000|Overall Study|Lost to Follow-up|1|||
145986819|NCT03679884|526463287|FG001|Overall Study|Lost to Follow-up|4|||
145986820|NCT03679884|526463288|FG002|Overall Study|Lost to Follow-up|2|||
145986821|NCT03679884|526463289|FG003|Overall Study|Lost to Follow-up|0|||
145986822|NCT03679884|526463290|FG004|Overall Study|Lost to Follow-up|3|||
145986823|NCT00362609|526463291|FG000|Overall Study|Withdrawal by Subject|0|||
145986824|NCT00362609|526463292|FG001|Overall Study|Withdrawal by Subject|1|||
145986825|NCT00362609|526463291|FG000|Overall Study|Protocol Violation|0|||
145986826|NCT00362609|526463292|FG001|Overall Study|Protocol Violation|1|||
146056133|NCT02269124|526721103|FG000|Overall Study|Lost to Follow-up|1|||
145986827|NCT00236197|526463296|FG000|Overall Study|Withdrawal by Subject|3|||
145986828|NCT00236197|526463297|FG001|Overall Study|Withdrawal by Subject|2|||
145986829|NCT00236197|526463296|FG000|Overall Study|Lost to Follow-up|1|||
145986830|NCT00236197|526463297|FG001|Overall Study|Lost to Follow-up|5|||
145986831|NCT00236197|526463296|FG000|Overall Study|Protocol Violation|0|||
145986832|NCT00236197|526463297|FG001|Overall Study|Protocol Violation|3|||
145986833|NCT00236197|526463296|FG000|Overall Study|Medication non-compliance|1|||
145986834|NCT00236197|526463297|FG001|Overall Study|Medication non-compliance|2|||
145986835|NCT00236197|526463296|FG000|Overall Study|Other|0|||
145986836|NCT00236197|526463297|FG001|Overall Study|Other|2|||
145986837|NCT01800058|526463298|FG000|Overall Study|Lost to Follow-up|1|||
145986838|NCT00450749|526463299|FG000|Overall Study|Withdrawal by Subject|0|||
145986839|NCT00450749|526463300|FG001|Overall Study|Withdrawal by Subject|0|||
145986840|NCT00450749|526463301|FG002|Overall Study|Withdrawal by Subject|2|||
145986841|NCT00450749|526463299|FG000|Overall Study|Noncompliant|0|||
145986842|NCT00450749|526463300|FG001|Overall Study|Noncompliant|1|||
145986843|NCT00450749|526463301|FG002|Overall Study|Noncompliant|0|||
145986844|NCT03178942|526463302|FG000|Overall Study|Withdrawal by Subject|2|||
145986845|NCT03178942|526463303|FG001|Overall Study|Withdrawal by Subject|0|||
145986846|NCT03178942|526463302|FG000|Overall Study|Lost to Follow-up|1|||
145986847|NCT03178942|526463303|FG001|Overall Study|Lost to Follow-up|2|||
145986848|NCT02933151|526464884|FG000|Overall Study|Lost to Follow-up|19|||
145986849|NCT02933151|526464885|FG001|Overall Study|Lost to Follow-up|18|||
145986850|NCT02933151|526464884|FG000|Overall Study|Death|1732|||
145986851|NCT02933151|526464885|FG001|Overall Study|Death|1827|||
145986852|NCT02933151|526464884|FG000|Overall Study|Transplant|210|||
145986853|NCT02933151|526464885|FG001|Overall Study|Transplant|278|||
145986854|NCT02933151|526464884|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
145986855|NCT02933151|526464885|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
145986856|NCT02933151|526464884|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
145986857|NCT02933151|526464885|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
145986858|NCT02933151|526464884|FG000|Overall Study|Recovered Kidney Function|47|||
145986859|NCT02933151|526464885|FG001|Overall Study|Recovered Kidney Function|29|||
145986860|NCT00394472|526464886|FG000|Overall Study|Protocol Violation|1|||
145986861|NCT00394472|526464887|FG001|Overall Study|Protocol Violation|3|||
145986862|NCT00394472|526464886|FG000|Overall Study|incorrect enrolment|4|||
145986863|NCT00394472|526464887|FG001|Overall Study|incorrect enrolment|2|||
145986864|NCT00394472|526464886|FG000|Overall Study|Adverse Event|4|||
145986865|NCT00394472|526464887|FG001|Overall Study|Adverse Event|2|||
145986866|NCT00394472|526464886|FG000|Overall Study|Withdrawal by Subject|0|||
145986867|NCT00394472|526464887|FG001|Overall Study|Withdrawal by Subject|2|||
145986868|NCT00394472|526464886|FG000|Overall Study|Physician Decision|0|||
145986869|NCT00394472|526464887|FG001|Overall Study|Physician Decision|1|||
145986870|NCT00394472|526464886|FG000|Overall Study|Lost to Follow-up|0|||
145986871|NCT00394472|526464887|FG001|Overall Study|Lost to Follow-up|1|||
145986872|NCT00004228|526464890|FG000|Overall Study|Adverse Event|0|||
145986873|NCT00004228|526464891|FG001|Overall Study|Adverse Event|1|||
145986874|NCT00004228|526464892|FG002|Overall Study|Adverse Event|0|||
145986875|NCT00004228|526464893|FG003|Overall Study|Adverse Event|0|||
145986876|NCT00004228|526464894|FG004|Overall Study|Adverse Event|1|||
145986877|NCT00004228|526464895|FG005|Overall Study|Adverse Event|0|||
145986878|NCT00004228|526464896|FG006|Overall Study|Adverse Event|0|||
145986879|NCT00004228|526464890|FG000|Overall Study|Death|0|||
145986880|NCT00004228|526464891|FG001|Overall Study|Death|1|||
145986881|NCT00004228|526464892|FG002|Overall Study|Death|2|||
145986882|NCT00004228|526464893|FG003|Overall Study|Death|0|||
145986883|NCT00004228|526464894|FG004|Overall Study|Death|1|||
145986884|NCT00004228|526464895|FG005|Overall Study|Death|0|||
145986885|NCT00004228|526464896|FG006|Overall Study|Death|0|||
145986886|NCT00004228|526464890|FG000|Overall Study|Lack of Efficacy|1|||
145986887|NCT00004228|526464891|FG001|Overall Study|Lack of Efficacy|6|||
145986888|NCT00004228|526464892|FG002|Overall Study|Lack of Efficacy|5|||
145986889|NCT00004228|526464893|FG003|Overall Study|Lack of Efficacy|3|||
145986890|NCT00004228|526464894|FG004|Overall Study|Lack of Efficacy|9|||
145986891|NCT00004228|526464895|FG005|Overall Study|Lack of Efficacy|8|||
145986892|NCT00004228|526464896|FG006|Overall Study|Lack of Efficacy|4|||
145986893|NCT00004228|526464890|FG000|Overall Study|Lost to Follow-up|0|||
145986894|NCT00004228|526464891|FG001|Overall Study|Lost to Follow-up|0|||
145986895|NCT00004228|526464892|FG002|Overall Study|Lost to Follow-up|1|||
145986896|NCT00004228|526464893|FG003|Overall Study|Lost to Follow-up|0|||
145986897|NCT00004228|526464894|FG004|Overall Study|Lost to Follow-up|0|||
145986898|NCT00004228|526464895|FG005|Overall Study|Lost to Follow-up|0|||
145986899|NCT00004228|526464896|FG006|Overall Study|Lost to Follow-up|0|||
145986900|NCT00004228|526464890|FG000|Overall Study|Physician Decision|1|||
145986901|NCT00004228|526464891|FG001|Overall Study|Physician Decision|0|||
145986902|NCT00004228|526464892|FG002|Overall Study|Physician Decision|3|||
145986903|NCT00004228|526464893|FG003|Overall Study|Physician Decision|2|||
145986904|NCT00004228|526464894|FG004|Overall Study|Physician Decision|1|||
145986905|NCT00004228|526464895|FG005|Overall Study|Physician Decision|1|||
145986906|NCT00004228|526464896|FG006|Overall Study|Physician Decision|1|||
145986907|NCT00004228|526464890|FG000|Overall Study|Protocol Violation|0|||
145986908|NCT00004228|526464891|FG001|Overall Study|Protocol Violation|5|||
145986909|NCT00004228|526464892|FG002|Overall Study|Protocol Violation|2|||
145986910|NCT00004228|526464893|FG003|Overall Study|Protocol Violation|1|||
145986911|NCT00004228|526464894|FG004|Overall Study|Protocol Violation|1|||
145986912|NCT00004228|526464895|FG005|Overall Study|Protocol Violation|2|||
145986913|NCT00004228|526464896|FG006|Overall Study|Protocol Violation|0|||
145986914|NCT00004228|526464890|FG000|Overall Study|Withdrawal by Subject|3|||
145986915|NCT00004228|526464891|FG001|Overall Study|Withdrawal by Subject|0|||
145986916|NCT00004228|526464892|FG002|Overall Study|Withdrawal by Subject|1|||
145986917|NCT00004228|526464893|FG003|Overall Study|Withdrawal by Subject|0|||
145986918|NCT00004228|526464894|FG004|Overall Study|Withdrawal by Subject|2|||
145986919|NCT00004228|526464895|FG005|Overall Study|Withdrawal by Subject|1|||
145986920|NCT00004228|526464896|FG006|Overall Study|Withdrawal by Subject|2|||
145986921|NCT00004228|526464890|FG000|Overall Study|Other|0|||
145986922|NCT00004228|526464891|FG001|Overall Study|Other|0|||
145986923|NCT00004228|526464892|FG002|Overall Study|Other|1|||
145986924|NCT00004228|526464893|FG003|Overall Study|Other|0|||
145986925|NCT00004228|526464894|FG004|Overall Study|Other|0|||
145986926|NCT00004228|526464895|FG005|Overall Study|Other|0|||
145986927|NCT00004228|526464896|FG006|Overall Study|Other|0|||
145986928|NCT00004228|526464890|FG000|Overall Study|ineligible|4|||
145986929|NCT00004228|526464891|FG001|Overall Study|ineligible|2|||
145986930|NCT00004228|526464892|FG002|Overall Study|ineligible|4|||
145986931|NCT00004228|526464893|FG003|Overall Study|ineligible|1|||
145986932|NCT00004228|526464894|FG004|Overall Study|ineligible|1|||
145986933|NCT00004228|526464895|FG005|Overall Study|ineligible|2|||
145986934|NCT00004228|526464896|FG006|Overall Study|ineligible|5|||
145986935|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
145986936|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
145986937|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
145986938|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
145986939|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
145986940|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
145986941|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
145986942|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
145986943|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
145986944|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
145986945|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
145986946|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
145986947|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
145986948|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
145986949|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
145986950|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
145986951|NCT01755156|526464908|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
145986952|NCT01755156|526464909|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
145986953|NCT01755156|526464908|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
145986954|NCT01755156|526464909|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
145986955|NCT01755156|526464908|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
145986956|NCT01755156|526464909|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
145986957|NCT00348374|526464910|FG000|Overall Study|Adverse Event|1|||
145986958|NCT00348374|526464911|FG001|Overall Study|Adverse Event|4|||
145986959|NCT00348374|526464910|FG000|Overall Study|Lost to Follow-up|1|||
145986960|NCT00348374|526464911|FG001|Overall Study|Lost to Follow-up|3|||
145986961|NCT00348374|526464910|FG000|Overall Study|Withdrawal by Subject|5|||
145986962|NCT00348374|526464911|FG001|Overall Study|Withdrawal by Subject|5|||
145986963|NCT00348374|526464910|FG000|Overall Study|Other|11|||
145986964|NCT00348374|526464911|FG001|Overall Study|Other|12|||
145986965|NCT00348374|526464910|FG000|Overall Study|ongoing at date of cutoff|1|||
145986966|NCT00348374|526464911|FG001|Overall Study|ongoing at date of cutoff|1|||
146245886|NCT03989232|527414094|FG001|Overall Study|Lost to Follow-up|10|||
145986967|NCT00348374|526464910|FG000|Overall Study|randomized but did not receive treatment|0|||
145986968|NCT00348374|526464911|FG001|Overall Study|randomized but did not receive treatment|7|||
145986969|NCT03071965|526464920|FG000|Overall Study|Adverse Event|0|||
145986970|NCT03071965|526464921|FG001|Overall Study|Adverse Event|0|||
145986971|NCT03071965|526464922|FG002|Overall Study|Adverse Event|1|||
145986972|NCT03071965|526464923|FG003|Overall Study|Adverse Event|0|||
145986973|NCT03071965|526464920|FG000|Overall Study|Death|0|||
145986974|NCT03071965|526464921|FG001|Overall Study|Death|0|||
145986975|NCT03071965|526464922|FG002|Overall Study|Death|1|||
145986976|NCT03071965|526464923|FG003|Overall Study|Death|1|||
145986977|NCT03071965|526464920|FG000|Overall Study|COVID-19|0|||
145986978|NCT03071965|526464921|FG001|Overall Study|COVID-19|1|||
145986979|NCT03071965|526464922|FG002|Overall Study|COVID-19|0|||
145986980|NCT03071965|526464923|FG003|Overall Study|COVID-19|1|||
145986981|NCT03071965|526464920|FG000|Overall Study|Other Health Reason|0|||
145986982|NCT03071965|526464921|FG001|Overall Study|Other Health Reason|0|||
145986983|NCT03071965|526464922|FG002|Overall Study|Other Health Reason|0|||
145986984|NCT03071965|526464923|FG003|Overall Study|Other Health Reason|1|||
145986985|NCT00986102|526464924|FG000|Overall Study|Lost to Follow-up|0|||
145986986|NCT00986102|526464925|FG001|Overall Study|Lost to Follow-up|1|||
145986987|NCT00986102|526464926|FG002|Overall Study|Lost to Follow-up|0|||
145986988|NCT00986102|526464927|FG003|Overall Study|Lost to Follow-up|1|||
145986989|NCT00986102|526464924|FG000|Overall Study|Withdrawal by Subject|1|||
145986990|NCT00986102|526464925|FG001|Overall Study|Withdrawal by Subject|1|||
145986991|NCT00986102|526464926|FG002|Overall Study|Withdrawal by Subject|0|||
145986992|NCT00986102|526464927|FG003|Overall Study|Withdrawal by Subject|0|||
145986993|NCT01691482|526464930|FG000|Treatment Period 2|Adverse Event|0|||
145986994|NCT01691482|526464931|FG001|Treatment Period 2|Adverse Event|1|||
145986995|NCT01691482|526464930|FG000|Treatment Period 2|Protocol Violation|1|||
145986996|NCT01691482|526464931|FG001|Treatment Period 2|Protocol Violation|1|||
145986997|NCT01392495|526464932|FG000|Overall Study|Death|3|||
145986998|NCT01392495|526464932|FG000|Overall Study|Administrative problems|8|||
145986999|NCT01392495|526464932|FG000|Overall Study|Withdrawal by Subject|2|||
145987000|NCT01392495|526464932|FG000|Overall Study|Adverse Event|3|||
145987001|NCT01452789|526464943|FG000|Overall Study|Withdrawal by Subject|3|||
145987002|NCT01452789|526464944|FG001|Overall Study|Withdrawal by Subject|2|||
145987003|NCT01089543|526464945|FG000|Overall Study|Withdrawal by Subject|2|||
145987004|NCT01089543|526464946|FG001|Overall Study|Withdrawal by Subject|3|||
145987005|NCT01089543|526464947|FG002|Overall Study|Withdrawal by Subject|3|||
145987006|NCT01089543|526464948|FG003|Overall Study|Withdrawal by Subject|1|||
145987007|NCT01089543|526464945|FG000|Overall Study|Physician Decision|1|||
145987008|NCT01089543|526464946|FG001|Overall Study|Physician Decision|0|||
145987009|NCT01089543|526464947|FG002|Overall Study|Physician Decision|0|||
145987010|NCT01089543|526464948|FG003|Overall Study|Physician Decision|1|||
145987011|NCT01089543|526464945|FG000|Overall Study|Adverse Event|0|||
145987012|NCT01089543|526464946|FG001|Overall Study|Adverse Event|1|||
145987013|NCT01089543|526464947|FG002|Overall Study|Adverse Event|0|||
145987014|NCT01089543|526464948|FG003|Overall Study|Adverse Event|0|||
145987015|NCT00468546|526464950|FG000|Week 24 Analysis|Lack of Efficacy|83|||
145987016|NCT00468546|526464951|FG001|Week 24 Analysis|Lack of Efficacy|37|||
145987017|NCT00468546|526464950|FG000|Week 24 Analysis|Refused treatment|5|||
145987018|NCT00468546|526464951|FG001|Week 24 Analysis|Refused treatment|5|||
145987019|NCT00468546|526464950|FG000|Week 24 Analysis|Adverse Event|1|||
145987020|NCT00468546|526464951|FG001|Week 24 Analysis|Adverse Event|8|||
145987021|NCT00468546|526464950|FG000|Week 24 Analysis|Failure to return|3|||
145987022|NCT00468546|526464951|FG001|Week 24 Analysis|Failure to return|4|||
145987023|NCT00468546|526464950|FG000|Week 24 Analysis|Rescue therapy|2|||
145987024|NCT00468546|526464951|FG001|Week 24 Analysis|Rescue therapy|0|||
145987025|NCT00468546|526464950|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
145987026|NCT00468546|526464951|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
145987027|NCT00468546|526464950|FG000|Week 24 Analysis|Due to clinical hold|1|||
145987028|NCT00468546|526464951|FG001|Week 24 Analysis|Due to clinical hold|0|||
145987029|NCT00468546|526464950|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
145987030|NCT00468546|526464951|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
145987031|NCT00468546|526464950|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
145987032|NCT00468546|526464951|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
145987033|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
145987034|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
145987035|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Death|1|||
145987036|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Death|0|||
145987037|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
145987038|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
145987039|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
145987040|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
145987041|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
145987042|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
145987043|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
145987044|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
145987045|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
145987046|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
145987047|NCT00468546|526464950|FG000|Week 24 to Week 104 Analysis|Other|17|||
145987048|NCT00468546|526464951|FG001|Week 24 to Week 104 Analysis|Other|14|||
145987049|NCT00472641|526464953|FG000|Overall Study|Lack of Efficacy|3|||
145987050|NCT00472641|526464953|FG000|Overall Study|Adverse Event|3|||
145987051|NCT00472641|526464953|FG000|Overall Study|Lost to Follow-up|1|||
145987052|NCT01905267|526464956|FG000|Overall Study|Physician Decision|2|||
145987053|NCT01905267|526464957|FG001|Overall Study|Physician Decision|2|||
145987054|NCT03438656|526464958|FG000|Overall Study|Lost to Follow-up|2|||
145987055|NCT02991859|526464961|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
146056134|NCT02269124|526721104|FG001|Overall Study|Lost to Follow-up|0|||
146056135|NCT02269124|526721103|FG000|Overall Study|Withdrawal by Subject|0|||
146056136|NCT02269124|526721104|FG001|Overall Study|Withdrawal by Subject|2|||
146056137|NCT03452540|526721105|FG000|Overall Study|Adverse Event|1|||
145987056|NCT02991859|526464962|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
145987057|NCT02991859|526464963|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987058|NCT02991859|526464964|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987059|NCT02991859|526464965|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
145987060|NCT02991859|526464966|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987061|NCT02991859|526464967|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987062|NCT02991859|526464968|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987063|NCT02991859|526464969|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987064|NCT02991859|526464970|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987065|NCT02991859|526464971|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987066|NCT02991859|526464972|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987067|NCT02991859|526464973|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987068|NCT02991859|526464974|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987069|NCT02991859|526464975|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987070|NCT02991859|526464976|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987071|NCT02991859|526464977|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145987072|NCT02991859|526464961|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987073|NCT02991859|526464962|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987074|NCT02991859|526464963|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987075|NCT02991859|526464964|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987076|NCT02991859|526464965|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987077|NCT02991859|526464966|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987078|NCT02991859|526464967|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987079|NCT02991859|526464968|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987080|NCT02991859|526464969|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987081|NCT02991859|526464970|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987082|NCT02991859|526464971|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987083|NCT02991859|526464972|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987084|NCT02991859|526464973|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
145987085|NCT02991859|526464974|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
145987086|NCT02991859|526464975|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987087|NCT02991859|526464976|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987088|NCT02991859|526464977|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145987089|NCT02991859|526464961|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987090|NCT02991859|526464962|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987091|NCT02991859|526464963|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987092|NCT02991859|526464964|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987093|NCT02991859|526464965|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987094|NCT02991859|526464966|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
145987095|NCT02991859|526464967|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987096|NCT02991859|526464968|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987097|NCT02991859|526464969|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987098|NCT02991859|526464970|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987099|NCT02991859|526464971|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987100|NCT02991859|526464972|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987101|NCT02991859|526464973|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987102|NCT02991859|526464974|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987103|NCT02991859|526464975|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987104|NCT02991859|526464976|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987105|NCT02991859|526464977|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145987106|NCT02991859|526464961|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987107|NCT02991859|526464962|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987108|NCT02991859|526464963|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987109|NCT02991859|526464964|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987110|NCT02991859|526464965|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987111|NCT02991859|526464966|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987112|NCT02991859|526464967|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987113|NCT02991859|526464968|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987114|NCT02991859|526464969|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987115|NCT02991859|526464970|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
145987116|NCT02991859|526464971|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987117|NCT02991859|526464972|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987118|NCT02991859|526464973|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987119|NCT02991859|526464974|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987120|NCT02991859|526464975|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987121|NCT02991859|526464976|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987122|NCT02991859|526464977|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145987123|NCT02991859|526464961|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987124|NCT02991859|526464962|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987125|NCT02991859|526464963|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987126|NCT02991859|526464964|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987127|NCT02991859|526464965|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987128|NCT02991859|526464966|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987129|NCT02991859|526464967|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987130|NCT02991859|526464968|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987131|NCT02991859|526464969|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
145987132|NCT02991859|526464970|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987133|NCT02991859|526464971|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987134|NCT02991859|526464972|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987135|NCT02991859|526464973|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987136|NCT02991859|526464974|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987137|NCT02991859|526464975|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987138|NCT02991859|526464976|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987139|NCT02991859|526464977|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145987140|NCT03520387|526464978|FG000|Pre-Randomization|Withdrawal by Subject|1|||
145987141|NCT03520387|526464979|FG001|Pre-Randomization|Withdrawal by Subject|0|||
145987142|NCT03520387|526464980|FG002|Pre-Randomization|Withdrawal by Subject|0|||
145987143|NCT03520387|526464981|FG003|Pre-Randomization|Withdrawal by Subject|0|||
145987144|NCT03520387|526464982|FG004|Pre-Randomization|Withdrawal by Subject|0|||
145987145|NCT03520387|526464978|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
145987146|NCT03520387|526464979|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145987147|NCT03520387|526464980|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145987148|NCT03520387|526464981|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145987149|NCT03520387|526464982|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145987150|NCT05652140|526464983|FG000|Overall Study|Lost to Follow-up|7|||
145987151|NCT05652140|526464984|FG001|Overall Study|Lost to Follow-up|16|||
145987152|NCT05652140|526464985|FG002|Overall Study|Lost to Follow-up|22|||
145987153|NCT05652140|526464986|FG003|Overall Study|Lost to Follow-up|31|||
145987154|NCT03163264|526464988|FG000|Overall Study|Withdrawal by Subject|13|||
145987155|NCT03163264|526464989|FG001|Overall Study|Withdrawal by Subject|3|||
145987156|NCT03163264|526464990|FG002|Overall Study|Withdrawal by Subject|4|||
145987157|NCT03163264|526464991|FG003|Overall Study|Withdrawal by Subject|2|||
145987158|NCT03163264|526464988|FG000|Overall Study|Lost to Follow-up|17|||
145987159|NCT03163264|526464989|FG001|Overall Study|Lost to Follow-up|20|||
145987160|NCT03163264|526464990|FG002|Overall Study|Lost to Follow-up|0|||
145987161|NCT03163264|526464991|FG003|Overall Study|Lost to Follow-up|0|||
145987162|NCT03163264|526464988|FG000|Overall Study|Death|0|||
145987163|NCT03163264|526464989|FG001|Overall Study|Death|2|||
145987164|NCT03163264|526464990|FG002|Overall Study|Death|0|||
145987165|NCT03163264|526464991|FG003|Overall Study|Death|0|||
145987166|NCT04648241|526464992|FG000|Overall Study|Lost to Follow-up|1|||
145987167|NCT04648241|526464993|FG001|Overall Study|Lost to Follow-up|0|||
145987168|NCT02489045|526464994|FG000|Overall Study|unable to collect usable data|53|||
145987169|NCT02489045|526464994|FG000|Follow-up|Lost to Follow-up|10|||
145987170|NCT02774278|526464997|FG000|Overall Study|Lack of Efficacy|199|||
145987171|NCT02774278|526464997|FG000|Overall Study|Death|29|||
145987172|NCT02774278|526464997|FG000|Overall Study|Adverse event/intercurrent illness|16|||
145987173|NCT02774278|526464997|FG000|Overall Study|Refused treatment/did not cooperate|9|||
145987174|NCT02774278|526464997|FG000|Overall Study|Administrative reasons|6|||
145987175|NCT02774278|526464997|FG000|Overall Study|Withdrawal by Subject|3|||
145987176|NCT02774278|526464997|FG000|Overall Study|Protocol Violation|2|||
145987177|NCT00930176|526465007|FG000|Overall Study|Death|1|||
145987178|NCT01108055|526465008|FG000|Overall Study|Ineligible|11|||
145987179|NCT01108055|526465008|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
145987180|NCT03339453|526465010|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
145987181|NCT03339453|526465011|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
145987182|NCT03760666|526465016|FG000|Overall Study|Adverse Event|2|||
145987183|NCT03760666|526465017|FG001|Overall Study|Adverse Event|4|||
145987184|NCT03760666|526465018|FG002|Overall Study|Adverse Event|1|||
145987185|NCT03760666|526465016|FG000|Overall Study|AML Disease Progression|3|||
145987186|NCT03760666|526465017|FG001|Overall Study|AML Disease Progression|3|||
145987187|NCT03760666|526465018|FG002|Overall Study|AML Disease Progression|0|||
145987188|NCT03760666|526465016|FG000|Overall Study|Physician Decision|0|||
146091454|NCT01810432|526856826|FG001|Period 2|Withdrawal by Subject|1|||
146091455|NCT01810432|526856825|FG000|Period 2|Physician Decision|1|||
145987189|NCT03760666|526465017|FG001|Overall Study|Physician Decision|3|||
145987190|NCT03760666|526465018|FG002|Overall Study|Physician Decision|0|||
145987191|NCT03760666|526465016|FG000|Overall Study|Withdrawal by Subject|0|||
145987192|NCT03760666|526465017|FG001|Overall Study|Withdrawal by Subject|1|||
145987193|NCT03760666|526465018|FG002|Overall Study|Withdrawal by Subject|0|||
145987194|NCT00800384|526465024|FG000|Overall Study|Withdrawal by Subject|24|||
145987195|NCT00800384|526465025|FG001|Overall Study|Withdrawal by Subject|17|||
145987196|NCT00800384|526465024|FG000|Overall Study|Lost to Follow-up|17|||
145987197|NCT00800384|526465025|FG001|Overall Study|Lost to Follow-up|26|||
145987198|NCT05486065|526465026|FG000|Overall Study|Withdrawal by Subject|1|||
145987199|NCT05486065|526465027|FG001|Overall Study|Withdrawal by Subject|5|||
145987200|NCT05486065|526465028|FG002|Overall Study|Withdrawal by Subject|4|||
145987201|NCT05486065|526465029|FG003|Overall Study|Withdrawal by Subject|3|||
145987202|NCT05486065|526465026|FG000|Overall Study|Lost to Follow-up|4|||
145987203|NCT05486065|526465027|FG001|Overall Study|Lost to Follow-up|2|||
145987204|NCT05486065|526465028|FG002|Overall Study|Lost to Follow-up|2|||
145987205|NCT05486065|526465029|FG003|Overall Study|Lost to Follow-up|2|||
145987206|NCT05486065|526465026|FG000|Overall Study|Physician Decision|0|||
145987207|NCT05486065|526465027|FG001|Overall Study|Physician Decision|1|||
145987208|NCT05486065|526465028|FG002|Overall Study|Physician Decision|1|||
145987209|NCT05486065|526465029|FG003|Overall Study|Physician Decision|0|||
145987210|NCT05486065|526465026|FG000|Overall Study|Failure to meet randomization criteria|0|||
145987211|NCT05486065|526465027|FG001|Overall Study|Failure to meet randomization criteria|0|||
145987212|NCT05486065|526465028|FG002|Overall Study|Failure to meet randomization criteria|0|||
145987213|NCT05486065|526465029|FG003|Overall Study|Failure to meet randomization criteria|1|||
145987214|NCT01064622|526465030|FG000|Randomized Phase II|Withdrawal by Subject|2|||
145987215|NCT01064622|526465031|FG001|Randomized Phase II|Withdrawal by Subject|2|||
145987216|NCT01064622|526465030|FG000|Randomized Phase II|Protocol Violation|0|||
145987217|NCT01064622|526465031|FG001|Randomized Phase II|Protocol Violation|1|||
145987218|NCT02946996|526465034|FG000|Overall Study|non-evaluable|3|||
145987219|NCT02946996|526465035|FG001|Overall Study|non-evaluable|6|||
145987220|NCT02946996|526465036|FG002|Overall Study|non-evaluable|5|||
145987221|NCT05330429|526465039|FG000|Overall Study|Study Terminated by Sponsor|4|||
145987222|NCT05330429|526465040|FG001|Overall Study|Study Terminated by Sponsor|33|||
145987223|NCT05330429|526465041|FG002|Overall Study|Study Terminated by Sponsor|12|||
145987224|NCT05330429|526465039|FG000|Overall Study|Death|5|||
145987225|NCT05330429|526465040|FG001|Overall Study|Death|2|||
145987226|NCT05330429|526465041|FG002|Overall Study|Death|4|||
145987227|NCT05330429|526465039|FG000|Overall Study|Withdrew Consent|0|||
145987228|NCT05330429|526465040|FG001|Overall Study|Withdrew Consent|5|||
145987229|NCT05330429|526465041|FG002|Overall Study|Withdrew Consent|4|||
145987230|NCT05330429|526465039|FG000|Overall Study|Investigator's Discretion|0|||
145987231|NCT05330429|526465040|FG001|Overall Study|Investigator's Discretion|1|||
145987232|NCT05330429|526465041|FG002|Overall Study|Investigator's Discretion|3|||
145987233|NCT05330429|526465039|FG000|Overall Study|Subject Decision|1|||
145987234|NCT05330429|526465040|FG001|Overall Study|Subject Decision|2|||
145987235|NCT05330429|526465041|FG002|Overall Study|Subject Decision|0|||
145987236|NCT05330429|526465039|FG000|Overall Study|Lost to Follow-up|0|||
145987237|NCT05330429|526465040|FG001|Overall Study|Lost to Follow-up|1|||
145987238|NCT05330429|526465041|FG002|Overall Study|Lost to Follow-up|0|||
145987239|NCT01245049|526465042|FG000|Overall Study|Migrated/moved from study area|0|||
145987240|NCT01245049|526465043|FG001|Overall Study|Migrated/moved from study area|1|||
145987241|NCT01245049|526465042|FG000|Overall Study|Withdrawal by Subject|0|||
145987242|NCT01245049|526465043|FG001|Overall Study|Withdrawal by Subject|1|||
145987243|NCT01245049|526465042|FG000|Overall Study|Lost to Follow-up|1|||
145987244|NCT01245049|526465043|FG001|Overall Study|Lost to Follow-up|2|||
145987245|NCT02151604|526465044|FG000|Overall Study|Lost to Follow-up|3|||
145987246|NCT02151604|526465044|FG000|Overall Study|Withdrawal by Subject|2|||
145987247|NCT02151604|526465044|FG000|Overall Study|Physician Decision|3|||
145987248|NCT02151604|526465044|FG000|Overall Study|Death|1|||
145987249|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
145987250|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
145987251|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
145987252|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Adverse Event|5|||
145987253|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Adverse Event|1|||
146091456|NCT01810432|526856826|FG001|Period 2|Physician Decision|0|||
146245887|NCT03989232|527414093|FG000|Overall Study|Withdrawal by Subject|6|||
146245888|NCT03989232|527414094|FG001|Overall Study|Withdrawal by Subject|6|||
146245889|NCT03989232|527414093|FG000|Overall Study|Death|1|||
146245890|NCT03989232|527414094|FG001|Overall Study|Death|2|||
145987254|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Adverse Event|0|||
145987255|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
145987256|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
145987257|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
145987258|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Death|8|||
145987259|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Death|24|||
145987260|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Death|0|||
145987261|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
145987262|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
145987263|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
145987264|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
145987265|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
145987266|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
145987267|NCT02931539|526465046|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
145987268|NCT02931539|526465047|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
145987269|NCT02931539|526465048|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
145987270|NCT02931539|526465046|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
145987271|NCT02931539|526465047|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
145987272|NCT02931539|526465048|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
145987273|NCT00655746|526465049|FG000|Overall Study|Withdrawal by Subject|1|||
145987274|NCT06097273|526465050|FG000|Overall Study|Death|2|||
145987275|NCT06097273|526465051|FG001|Overall Study|Death|1|||
145987276|NCT06097273|526465052|FG002|Overall Study|Death|2|||
145987277|NCT06097273|526465053|FG003|Overall Study|Death|2|||
145987278|NCT06097273|526465050|FG000|Overall Study|Lost to Follow-up|27|||
145987279|NCT06097273|526465051|FG001|Overall Study|Lost to Follow-up|18|||
145987280|NCT06097273|526465052|FG002|Overall Study|Lost to Follow-up|36|||
145987281|NCT06097273|526465053|FG003|Overall Study|Lost to Follow-up|31|||
145987282|NCT06097273|526465050|FG000|Overall Study|Physician Decision|0|||
145987283|NCT06097273|526465051|FG001|Overall Study|Physician Decision|1|||
145987284|NCT06097273|526465052|FG002|Overall Study|Physician Decision|0|||
145987285|NCT06097273|526465053|FG003|Overall Study|Physician Decision|3|||
145987286|NCT06097273|526465050|FG000|Overall Study|Protocol Violation|1|||
145987287|NCT06097273|526465051|FG001|Overall Study|Protocol Violation|1|||
145987288|NCT06097273|526465052|FG002|Overall Study|Protocol Violation|2|||
145987289|NCT06097273|526465053|FG003|Overall Study|Protocol Violation|1|||
145987290|NCT06097273|526465050|FG000|Overall Study|Withdrawal by Subject|14|||
145987291|NCT06097273|526465051|FG001|Overall Study|Withdrawal by Subject|11|||
145987292|NCT06097273|526465052|FG002|Overall Study|Withdrawal by Subject|14|||
145987293|NCT06097273|526465053|FG003|Overall Study|Withdrawal by Subject|15|||
145987294|NCT06097273|526465050|FG000|Overall Study|Other Than Specified|7|||
145987295|NCT06097273|526465051|FG001|Overall Study|Other Than Specified|3|||
145987296|NCT06097273|526465052|FG002|Overall Study|Other Than Specified|11|||
145987297|NCT06097273|526465053|FG003|Overall Study|Other Than Specified|6|||
145987298|NCT01926509|526466530|FG000|Overall Study|vital sign met discontinuation criteria|1|||
145987299|NCT01926509|526466531|FG001|Overall Study|vital sign met discontinuation criteria|0|||
145987300|NCT01926509|526466532|FG002|Overall Study|vital sign met discontinuation criteria|0|||
145987301|NCT01926509|526466533|FG003|Overall Study|vital sign met discontinuation criteria|0|||
145987302|NCT02730169|526466534|FG000|Overall Study|Protocol Violation|1|||
145987303|NCT02730169|526466535|FG001|Overall Study|Protocol Violation|0|||
145987304|NCT02730169|526466536|FG002|Overall Study|Protocol Violation|0|||
145987305|NCT02730169|526466537|FG003|Overall Study|Protocol Violation|1|||
145987306|NCT02730169|526466534|FG000|Overall Study|Adverse Event|2|||
145987307|NCT02730169|526466535|FG001|Overall Study|Adverse Event|3|||
145987308|NCT02730169|526466536|FG002|Overall Study|Adverse Event|3|||
145987309|NCT02730169|526466537|FG003|Overall Study|Adverse Event|0|||
145987310|NCT02730169|526466534|FG000|Overall Study|Adverse Event of Special Interest|0|||
145987311|NCT02730169|526466535|FG001|Overall Study|Adverse Event of Special Interest|1|||
145987312|NCT02730169|526466536|FG002|Overall Study|Adverse Event of Special Interest|2|||
145987313|NCT02730169|526466537|FG003|Overall Study|Adverse Event of Special Interest|0|||
145987314|NCT02730169|526466534|FG000|Overall Study|Withdrawal by Subject|6|||
145987315|NCT02730169|526466535|FG001|Overall Study|Withdrawal by Subject|11|||
145987316|NCT02730169|526466536|FG002|Overall Study|Withdrawal by Subject|6|||
145987317|NCT02730169|526466537|FG003|Overall Study|Withdrawal by Subject|8|||
145987318|NCT02730169|526466534|FG000|Overall Study|Lost to Follow-up|5|||
145987319|NCT02730169|526466535|FG001|Overall Study|Lost to Follow-up|6|||
145987320|NCT02730169|526466536|FG002|Overall Study|Lost to Follow-up|5|||
145987321|NCT02730169|526466537|FG003|Overall Study|Lost to Follow-up|6|||
145987322|NCT02730169|526466534|FG000|Overall Study|Other|0|||
145987323|NCT02730169|526466535|FG001|Overall Study|Other|0|||
145987324|NCT02730169|526466536|FG002|Overall Study|Other|1|||
145987325|NCT02730169|526466537|FG003|Overall Study|Other|1|||
145987326|NCT03004183|526466538|FG000|Overall Study|Adverse Event|7|||
145987327|NCT03004183|526466538|FG000|Overall Study|Lost to Follow-up|1|||
145987328|NCT03004183|526466538|FG000|Overall Study|Physician Decision|40|||
145987329|NCT03004183|526466538|FG000|Overall Study|Withdrawal by Subject|1|||
145987330|NCT03004183|526466538|FG000|Overall Study|COVID-19|1|||
145987331|NCT01027754|526466539|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
145987332|NCT01027754|526466540|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
145987333|NCT01027754|526466539|FG000|Overall Study|Withdrawal by Subject|0|||
145987334|NCT01027754|526466540|FG001|Overall Study|Withdrawal by Subject|5|||
145987335|NCT02529488|526466541|FG000|Overall Study|Adverse Event|1|||
145987336|NCT02529488|526466541|FG000|Overall Study|Death|3|||
145987337|NCT02698787|526466542|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
145987338|NCT02698787|526466543|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
145987339|NCT02469961|526466553|FG000|Overall Study|Physician Decision|4|||
145987340|NCT02469961|526466554|FG001|Overall Study|Physician Decision|1|||
145987341|NCT01699685|526466560|FG000|Period 1|Adverse Event|1|||
145987342|NCT01699685|526466561|FG001|Period 1|Adverse Event|1|||
145987343|NCT01699685|526466560|FG000|Period 1|Medical or ethical, noncompliance|2|||
145987344|NCT01699685|526466561|FG001|Period 1|Medical or ethical, noncompliance|0|||
145987345|NCT01699685|526466560|FG000|Period 1|Other|0|||
145987346|NCT01699685|526466561|FG001|Period 1|Other|1|||
145987347|NCT01699685|526466560|FG000|Period 1|Patient request|0|||
145987348|NCT01699685|526466561|FG001|Period 1|Patient request|1|||
145987349|NCT01699685|526466560|FG000|Period 2|Lost to Follow-up|1|||
145987350|NCT01699685|526466561|FG001|Period 2|Lost to Follow-up|0|||
145987351|NCT03635996|526466562|FG000|Overall Study|Study terminated by Sponsor|94|||
145987352|NCT03635996|526466562|FG000|Overall Study|Withdrawal by Subject|20|||
145987353|NCT03635996|526466562|FG000|Overall Study|Ablation|26|||
145987354|NCT03635996|526466562|FG000|Overall Study|Adverse Event|7|||
145987355|NCT03635996|526466562|FG000|Overall Study|Physician Decision|3|||
145987356|NCT03635996|526466562|FG000|Overall Study|Prohibited medication|5|||
145987357|NCT03635996|526466562|FG000|Overall Study|Did not meet eligibility criteria|5|||
145987358|NCT03635996|526466562|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
145987359|NCT03635996|526466562|FG000|Overall Study|Protocol Violation|1|||
145987360|NCT03635996|526466562|FG000|Overall Study|Lost to Follow-up|1|||
145987361|NCT02821000|526466563|FG000|Overall Study|Death|89|||
145987362|NCT02821000|526466563|FG000|Overall Study|Sponsor Decision|12|||
145987363|NCT02821000|526466563|FG000|Overall Study|Withdrawal by Subject|2|||
145987364|NCT00326495|526466564|FG000|Overall Study|Switched to alternative treatment|1|||
145987365|NCT00326495|526466564|FG000|Overall Study|Disease progression before treatment|1|||
145987366|NCT00326495|526466564|FG000|Overall Study|Refused further treatment|2|||
145987367|NCT00326495|526466564|FG000|Overall Study|Subject off study before assessment|1|||
145987368|NCT04359680|526466565|FG000|Overall Study|Withdrawal by Subject|29|||
145987369|NCT04359680|526466566|FG001|Overall Study|Withdrawal by Subject|24|||
145987370|NCT04359680|526466565|FG000|Overall Study|Adverse Event|6|||
145987371|NCT04359680|526466566|FG001|Overall Study|Adverse Event|2|||
145987372|NCT04359680|526466565|FG000|Overall Study|Lost to Follow-up|56|||
145987373|NCT04359680|526466566|FG001|Overall Study|Lost to Follow-up|59|||
145987374|NCT04359680|526466565|FG000|Overall Study|Protocol Violation|3|||
145987375|NCT04359680|526466566|FG001|Overall Study|Protocol Violation|5|||
145987376|NCT04359680|526466565|FG000|Overall Study|Physician Decision|1|||
145987377|NCT04359680|526466566|FG001|Overall Study|Physician Decision|1|||
145987378|NCT04359680|526466565|FG000|Overall Study|Sponsor Decision|0|||
145987379|NCT04359680|526466566|FG001|Overall Study|Sponsor Decision|1|||
145987380|NCT01654250|526466567|FG000|Overall Study|Lost to Follow-up|1|||
145987381|NCT01654250|526466568|FG001|Overall Study|Lost to Follow-up|0|||
145987382|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
145987383|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
145987384|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
145987385|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
145987386|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
145987387|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
145987388|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
145987389|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
145987390|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145987391|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145987392|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145987393|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
145987394|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
145987395|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
145987396|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
145987397|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
145987398|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
146091457|NCT01810432|526856825|FG000|Period 2|Lost to Follow-up|1|||
146091458|NCT01810432|526856826|FG001|Period 2|Lost to Follow-up|1|||
146091459|NCT00057954|526856827|FG000|Overall Study|Death|1|||
146245891|NCT01930188|527414095|FG000|Overall Study|unclassified|4|||
145987399|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
145987400|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
145987401|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
145987402|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
145987403|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
145987404|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
145987405|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
145987406|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
146091460|NCT00057954|526856827|FG000|Overall Study|Disease progression|1|||
146245892|NCT01930188|527414096|FG001|Overall Study|unclassified|5|||
145987407|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145987408|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145987409|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145987410|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
145987411|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
145987412|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
145987413|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
145987414|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
145987415|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
145987416|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
145987417|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
145987418|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145987419|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145987420|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145987421|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
145987422|NCT02596893|526466569|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
145987423|NCT02596893|526466570|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
145987424|NCT02596893|526466571|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
145987425|NCT02596893|526466572|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
145987426|NCT03280615|526466573|FG000|Overall Study|Lost to Follow-up|1|||
145987427|NCT03280615|526466574|FG001|Overall Study|Lost to Follow-up|2|||
145987428|NCT03280615|526466573|FG000|Overall Study|Adverse Event|1|||
145987429|NCT03280615|526466574|FG001|Overall Study|Adverse Event|1|||
145987430|NCT03280615|526466573|FG000|Overall Study|Withdrawal by Subject|2|||
145987431|NCT03280615|526466574|FG001|Overall Study|Withdrawal by Subject|2|||
145987432|NCT02255279|526466575|FG000|Overall Study|Lost to Follow-up|2|||
145987433|NCT02255279|526466576|FG001|Overall Study|Lost to Follow-up|2|||
145987434|NCT02255279|526466575|FG000|Overall Study|Protocol Violation|0|||
145987435|NCT02255279|526466576|FG001|Overall Study|Protocol Violation|1|||
145987436|NCT02255279|526466575|FG000|Overall Study|Withdrawal by Subject|3|||
145987437|NCT02255279|526466576|FG001|Overall Study|Withdrawal by Subject|6|||
145987438|NCT01013870|526466577|FG000|Overall Study|Lost to Follow-up|1|||
145987439|NCT01013870|526466578|FG001|Overall Study|Lost to Follow-up|3|||
145987440|NCT01386645|526466579|FG000|Overall Study|Physician Decision|0|||
145987441|NCT01386645|526466580|FG001|Overall Study|Physician Decision|0|||
145987442|NCT01386645|526466581|FG002|Overall Study|Physician Decision|1|||
145987443|NCT01386645|526466579|FG000|Overall Study|Withdrawal by Subject|0|||
145987444|NCT01386645|526466580|FG001|Overall Study|Withdrawal by Subject|1|||
145987445|NCT01386645|526466581|FG002|Overall Study|Withdrawal by Subject|1|||
145987446|NCT00432991|526466582|FG000|Overall Study|Protocol Violation|7|||
145987447|NCT00432991|526466583|FG001|Overall Study|Protocol Violation|12|||
145987448|NCT03048019|526466584|FG000|Overall Study|Adverse Event|1|||
145987449|NCT03048019|526466585|FG001|Overall Study|Adverse Event|0|||
145987450|NCT00862277|526466586|FG000|Overall Study|Protocol Violation|1|||
145987451|NCT00862277|526466587|FG001|Overall Study|Protocol Violation|2|||
145987452|NCT00862277|526466588|FG002|Overall Study|Protocol Violation|5|||
145987453|NCT01052428|526466589|FG000|Overall Study|Death|1|||
145987454|NCT01052428|526466590|FG001|Overall Study|Death|0|||
145987455|NCT01052428|526466589|FG000|Overall Study|Withdrawal by Subject|0|||
145987456|NCT01052428|526466590|FG001|Overall Study|Withdrawal by Subject|1|||
145987457|NCT00382863|526466591|FG000|Overall Study|Death|9|||
145987458|NCT00382863|526466592|FG001|Overall Study|Death|9|||
145987459|NCT00382863|526466591|FG000|Overall Study|Lost to Follow-up|1|||
145987460|NCT00382863|526466592|FG001|Overall Study|Lost to Follow-up|2|||
145987461|NCT00382863|526466591|FG000|Overall Study|Withdrawal by Subject|5|||
145987462|NCT00382863|526466592|FG001|Overall Study|Withdrawal by Subject|25|||
145987463|NCT02168439|526466593|FG000|Overall Study|Protocol Violation|0|||
145987464|NCT02168439|526466594|FG001|Overall Study|Protocol Violation|2|||
145987465|NCT01292473|526466597|FG000|Overall Study|Adverse Event|1|||
145987466|NCT01292473|526466598|FG001|Overall Study|Adverse Event|0|||
145987467|NCT01292473|526466599|FG002|Overall Study|Adverse Event|1|||
145987468|NCT01292473|526466600|FG003|Overall Study|Adverse Event|1|||
145987469|NCT01292473|526466597|FG000|Overall Study|Lost to Follow-up|1|||
145987470|NCT01292473|526466598|FG001|Overall Study|Lost to Follow-up|1|||
145987471|NCT01292473|526466599|FG002|Overall Study|Lost to Follow-up|2|||
145987472|NCT01292473|526466600|FG003|Overall Study|Lost to Follow-up|2|||
145987473|NCT01292473|526466597|FG000|Overall Study|Withdrawal by Subject|3|||
145987474|NCT01292473|526466598|FG001|Overall Study|Withdrawal by Subject|4|||
145987475|NCT01292473|526466599|FG002|Overall Study|Withdrawal by Subject|3|||
145987476|NCT01292473|526466600|FG003|Overall Study|Withdrawal by Subject|3|||
145987477|NCT01292473|526466597|FG000|Overall Study|Physician Decision|0|||
145987478|NCT01292473|526466598|FG001|Overall Study|Physician Decision|1|||
145987479|NCT01292473|526466599|FG002|Overall Study|Physician Decision|0|||
145987480|NCT01292473|526466600|FG003|Overall Study|Physician Decision|0|||
145987481|NCT01292473|526466597|FG000|Overall Study|Disease Progression|0|||
145987482|NCT01292473|526466598|FG001|Overall Study|Disease Progression|1|||
145987483|NCT01292473|526466599|FG002|Overall Study|Disease Progression|3|||
145987484|NCT01292473|526466600|FG003|Overall Study|Disease Progression|6|||
145987485|NCT04432298|526466601|FG000|Overall Study|Other than specified|1|||
145987486|NCT04432298|526466602|FG001|Overall Study|Other than specified|0|||
145987487|NCT04432298|526466601|FG000|Overall Study|Lost to Follow-up|0|||
145987488|NCT04432298|526466602|FG001|Overall Study|Lost to Follow-up|1|||
145987489|NCT04432298|526466601|FG000|Overall Study|Death|3|||
145987490|NCT04432298|526466602|FG001|Overall Study|Death|2|||
145987491|NCT04432298|526466601|FG000|Overall Study|Withdrawal by Subject|2|||
145987492|NCT04432298|526466602|FG001|Overall Study|Withdrawal by Subject|0|||
145987493|NCT02451007|526466605|FG000|Overall Study|Withdrawal by Subject|4|||
145987494|NCT02451007|526466605|FG000|Overall Study|Adverse Event|1|||
145987495|NCT02451007|526466605|FG000|Overall Study|Disease Progression|2|||
145987496|NCT02595437|526466616|FG000|Triferic Via IV|Withdrawal by Subject|1|||
145987497|NCT00661687|526466620|FG000|Overall Study|Study related symptoms and complaints|5|||
145987498|NCT00661687|526466620|FG000|Overall Study|Positive slit lamp findings|4|||
145987499|NCT00661687|526466620|FG000|Overall Study|Inability to maintain wearing schedule|3|||
145987500|NCT00661687|526466620|FG000|Overall Study|Physician Decision|1|||
145987501|NCT00661687|526466620|FG000|Overall Study|Adverse Event|2|||
145987502|NCT01362530|526466626|FG000|Base Study (Cycle 1)|Adverse Event|2|||
145987503|NCT01362530|526466627|FG001|Base Study (Cycle 1)|Adverse Event|0|||
145987504|NCT01362530|526466626|FG000|Base Study (Cycle 1)|Physician Decision|0|||
145987505|NCT01362530|526466627|FG001|Base Study (Cycle 1)|Physician Decision|1|||
145987506|NCT01362530|526466626|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
145987507|NCT01362530|526466627|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
145987508|NCT01362530|526466626|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
145987509|NCT01362530|526466627|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
145987510|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
145987511|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
145987512|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
145987513|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
145987514|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
145987515|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
145987516|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
145987517|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
145987518|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
145987519|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
145987520|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
145987521|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
145987522|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
145987523|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
145987524|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
145987525|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
146245893|NCT01930188|527414097|FG002|Overall Study|unclassified|3|||
145987526|NCT01362530|526466626|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
145987527|NCT01362530|526466627|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
145987528|NCT01133977|526466628|FG000|Overall Study|Adverse Event|0|||
145987529|NCT01133977|526466629|FG001|Overall Study|Adverse Event|0|||
145987530|NCT01133977|526466630|FG002|Overall Study|Adverse Event|1|||
145987531|NCT01133977|526466631|FG003|Overall Study|Adverse Event|0|||
145987532|NCT01133977|526466632|FG004|Overall Study|Adverse Event|0|||
145987533|NCT01133977|526466628|FG000|Overall Study|Death|1|||
145987534|NCT01133977|526466629|FG001|Overall Study|Death|1|||
145987535|NCT01133977|526466630|FG002|Overall Study|Death|1|||
145987536|NCT01133977|526466631|FG003|Overall Study|Death|7|||
145987537|NCT01133977|526466632|FG004|Overall Study|Death|3|||
145987538|NCT01133977|526466628|FG000|Overall Study|Started a New Line of Therapy|2|||
145987539|NCT01133977|526466629|FG001|Overall Study|Started a New Line of Therapy|6|||
145987540|NCT01133977|526466630|FG002|Overall Study|Started a New Line of Therapy|4|||
145987541|NCT01133977|526466631|FG003|Overall Study|Started a New Line of Therapy|25|||
145987542|NCT01133977|526466632|FG004|Overall Study|Started a New Line of Therapy|33|||
145987543|NCT01133977|526466628|FG000|Overall Study|Lost to Follow-up|0|||
146245894|NCT01930188|527414095|FG000|Overall Study|Missing follow-up information|2|||
146245895|NCT01930188|527414096|FG001|Overall Study|Missing follow-up information|2|||
146245896|NCT01930188|527414097|FG002|Overall Study|Missing follow-up information|3|||
145987544|NCT01133977|526466629|FG001|Overall Study|Lost to Follow-up|0|||
145987545|NCT01133977|526466630|FG002|Overall Study|Lost to Follow-up|0|||
145987546|NCT01133977|526466631|FG003|Overall Study|Lost to Follow-up|2|||
145987547|NCT01133977|526466632|FG004|Overall Study|Lost to Follow-up|1|||
145987548|NCT01133977|526466628|FG000|Overall Study|Withdrawal by Subject|0|||
145987549|NCT01133977|526466629|FG001|Overall Study|Withdrawal by Subject|0|||
146245897|NCT01930188|527414095|FG000|Overall Study|Lost to Follow-up|5|||
145987550|NCT01133977|526466630|FG002|Overall Study|Withdrawal by Subject|0|||
145987551|NCT01133977|526466631|FG003|Overall Study|Withdrawal by Subject|5|||
145987552|NCT01133977|526466632|FG004|Overall Study|Withdrawal by Subject|1|||
145987553|NCT02105012|526466633|FG000|Overall Study|Withdrawal by Subject|11|||
145987554|NCT02105012|526466633|FG000|Overall Study|Protocol Specified Criteria|9|||
145987555|NCT02105012|526466633|FG000|Overall Study|Lost to Follow-up|4|||
145987556|NCT02105012|526466633|FG000|Overall Study|Protocol Violation|4|||
145987557|NCT02105012|526466633|FG000|Overall Study|Physician Decision|3|||
145987558|NCT02105012|526466633|FG000|Overall Study|Adverse Event|1|||
145987559|NCT02105012|526466633|FG000|Overall Study|Lack of Efficacy|1|||
145987560|NCT00474968|526466640|FG000|Overall Study|Withdrawal by Subject|8|||
145987561|NCT00474968|526466641|FG001|Overall Study|Withdrawal by Subject|7|||
145987562|NCT00474968|526466640|FG000|Overall Study|Protocol Violation|9|||
145987563|NCT00474968|526466641|FG001|Overall Study|Protocol Violation|8|||
145987564|NCT00474968|526466640|FG000|Overall Study|Sample not collected|1|||
145987565|NCT00474968|526466641|FG001|Overall Study|Sample not collected|1|||
145987566|NCT00215553|526466642|FG000|Overall Study|Adverse Event|0|||
145987567|NCT00215553|526466643|FG001|Overall Study|Adverse Event|1|||
145987568|NCT00215553|526466644|FG002|Overall Study|Adverse Event|2|||
145987569|NCT00215553|526466645|FG003|Overall Study|Adverse Event|1|||
145987570|NCT00215553|526466646|FG004|Overall Study|Adverse Event|2|||
145987571|NCT00215553|526466647|FG005|Overall Study|Adverse Event|6|||
145987572|NCT00215553|526466648|FG006|Overall Study|Adverse Event|0|||
145987573|NCT01429623|526466649|FG000|Overall Study|Death|1|||
145987574|NCT01429623|526466650|FG001|Overall Study|Death|0|||
145987575|NCT01429623|526466649|FG000|Overall Study|Adverse Event|7|||
145987576|NCT01429623|526466650|FG001|Overall Study|Adverse Event|14|||
145987577|NCT01429623|526466649|FG000|Overall Study|Withdrawal by Subject|19|||
145987578|NCT01429623|526466650|FG001|Overall Study|Withdrawal by Subject|13|||
145987579|NCT01429623|526466649|FG000|Overall Study|Physician Decision|2|||
145987580|NCT01429623|526466650|FG001|Overall Study|Physician Decision|3|||
145987581|NCT01429623|526466649|FG000|Overall Study|Protocol Violation|3|||
145987582|NCT01429623|526466650|FG001|Overall Study|Protocol Violation|2|||
145987583|NCT01429623|526466649|FG000|Overall Study|Assorted|1|||
145987584|NCT01429623|526466650|FG001|Overall Study|Assorted|2|||
145987585|NCT01429623|526466649|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
145987586|NCT01429623|526466650|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
145987587|NCT01429623|526466649|FG000|Overall Study|No post baseline data|4|||
145987588|NCT01429623|526466650|FG001|Overall Study|No post baseline data|4|||
145987589|NCT05345405|526466651|FG000|Overall Study|Withdrawal by Subject|2|||
145987590|NCT05345405|526466652|FG001|Overall Study|Withdrawal by Subject|0|||
145987591|NCT05345405|526466653|FG002|Overall Study|Withdrawal by Subject|0|||
145987592|NCT05345405|526466651|FG000|Overall Study|Did not meet eligibility criteria|0|||
145987593|NCT05345405|526466652|FG001|Overall Study|Did not meet eligibility criteria|2|||
145987594|NCT05345405|526466653|FG002|Overall Study|Did not meet eligibility criteria|0|||
145987595|NCT05345405|526466651|FG000|Overall Study|Lost to Follow-up|0|||
145987596|NCT05345405|526466652|FG001|Overall Study|Lost to Follow-up|0|||
145987597|NCT05345405|526466653|FG002|Overall Study|Lost to Follow-up|1|||
145987598|NCT01550965|526466654|FG000|Overall Study|Adverse Event|26|||
145987599|NCT01550965|526466654|FG000|Overall Study|Withdrawal by Subject|10|||
145987600|NCT01550965|526466654|FG000|Overall Study|Lost to Follow-up|2|||
145987601|NCT01550965|526466654|FG000|Overall Study|Lack of Efficacy|59|||
145987602|NCT01550965|526466654|FG000|Overall Study|Other|13|||
145987603|NCT04135352|526466658|FG000|Overall Study|Not treated-randomization error|0|||
145987604|NCT04135352|526466659|FG001|Overall Study|Not treated-randomization error|0|||
145987605|NCT04135352|526466660|FG002|Overall Study|Not treated-randomization error|1|||
145987606|NCT04135352|526466661|FG003|Overall Study|Not treated-randomization error|0|||
145987607|NCT04135352|526466662|FG004|Overall Study|Not treated-randomization error|0|||
145987608|NCT04135352|526466663|FG005|Overall Study|Not treated-randomization error|0|||
145987609|NCT04135352|526466664|FG006|Overall Study|Not treated-randomization error|0|||
145987610|NCT04135352|526466665|FG007|Overall Study|Not treated-randomization error|0|||
145987611|NCT04135352|526466658|FG000|Overall Study|Withdrawal by Subject|0|||
145987612|NCT04135352|526466659|FG001|Overall Study|Withdrawal by Subject|0|||
145987613|NCT04135352|526466660|FG002|Overall Study|Withdrawal by Subject|2|||
145987614|NCT04135352|526466661|FG003|Overall Study|Withdrawal by Subject|0|||
145987615|NCT04135352|526466662|FG004|Overall Study|Withdrawal by Subject|0|||
145987616|NCT04135352|526466663|FG005|Overall Study|Withdrawal by Subject|0|||
145987617|NCT04135352|526466664|FG006|Overall Study|Withdrawal by Subject|0|||
145987618|NCT04135352|526466665|FG007|Overall Study|Withdrawal by Subject|0|||
145987619|NCT04135352|526466658|FG000|Overall Study|Sponsor Decision|0|||
145987620|NCT04135352|526466659|FG001|Overall Study|Sponsor Decision|0|||
145987621|NCT04135352|526466660|FG002|Overall Study|Sponsor Decision|2|||
145987622|NCT04135352|526466661|FG003|Overall Study|Sponsor Decision|5|||
145987623|NCT04135352|526466662|FG004|Overall Study|Sponsor Decision|1|||
145987624|NCT04135352|526466663|FG005|Overall Study|Sponsor Decision|4|||
145987625|NCT04135352|526466664|FG006|Overall Study|Sponsor Decision|0|||
145987626|NCT04135352|526466665|FG007|Overall Study|Sponsor Decision|0|||
145987627|NCT04135352|526466658|FG000|Overall Study|Physician Decision|0|||
145987628|NCT04135352|526466659|FG001|Overall Study|Physician Decision|0|||
145987629|NCT04135352|526466660|FG002|Overall Study|Physician Decision|1|||
145987630|NCT04135352|526466661|FG003|Overall Study|Physician Decision|0|||
146245898|NCT01930188|527414096|FG001|Overall Study|Lost to Follow-up|2|||
146245899|NCT01930188|527414097|FG002|Overall Study|Lost to Follow-up|2|||
146245900|NCT01930188|527414095|FG000|Overall Study|Death|2|||
146245901|NCT01930188|527414096|FG001|Overall Study|Death|1|||
146245902|NCT01930188|527414097|FG002|Overall Study|Death|3|||
145987631|NCT04135352|526466662|FG004|Overall Study|Physician Decision|1|||
145987632|NCT04135352|526466663|FG005|Overall Study|Physician Decision|0|||
145987633|NCT04135352|526466664|FG006|Overall Study|Physician Decision|0|||
145987634|NCT04135352|526466665|FG007|Overall Study|Physician Decision|0|||
145987635|NCT04135352|526466658|FG000|Overall Study|Death|3|||
145987636|NCT04135352|526466659|FG001|Overall Study|Death|4|||
145987637|NCT04135352|526466660|FG002|Overall Study|Death|7|||
145987638|NCT04135352|526466661|FG003|Overall Study|Death|0|||
145987639|NCT04135352|526466662|FG004|Overall Study|Death|3|||
145987640|NCT04135352|526466663|FG005|Overall Study|Death|1|||
145987641|NCT04135352|526466664|FG006|Overall Study|Death|0|||
145987642|NCT04135352|526466665|FG007|Overall Study|Death|0|||
145987643|NCT01696214|526466666|FG000|Overall Study|Lost to Follow-up|1|||
145987644|NCT01696214|526466667|FG001|Overall Study|Lost to Follow-up|0|||
145987645|NCT01696214|526466668|FG002|Overall Study|Lost to Follow-up|0|||
145987646|NCT01696214|526466669|FG003|Overall Study|Lost to Follow-up|0|||
145987647|NCT00819832|526466670|FG000|Overall Study|Sponsor Termination of Study|3|||
145987648|NCT00819832|526466671|FG001|Overall Study|Sponsor Termination of Study|0|||
145987649|NCT00819832|526466672|FG002|Overall Study|Sponsor Termination of Study|0|||
145987650|NCT00819832|526466673|FG003|Overall Study|Sponsor Termination of Study|0|||
145987651|NCT00819832|526466674|FG004|Overall Study|Sponsor Termination of Study|0|||
145987652|NCT00819832|526466675|FG005|Overall Study|Sponsor Termination of Study|0|||
145987653|NCT00066170|526466677|FG000|Overall Study|Adverse Event|2|||
145987654|NCT00066170|526466678|FG001|Overall Study|Adverse Event|4|||
145987655|NCT00066170|526466679|FG002|Overall Study|Adverse Event|1|||
145987656|NCT00066170|526466680|FG003|Overall Study|Adverse Event|7|||
145987657|NCT00066170|526466677|FG000|Overall Study|Serious Adverse Event|0|||
145987658|NCT00066170|526466678|FG001|Overall Study|Serious Adverse Event|0|||
145987659|NCT00066170|526466679|FG002|Overall Study|Serious Adverse Event|1|||
145987660|NCT00066170|526466680|FG003|Overall Study|Serious Adverse Event|1|||
145987661|NCT00066170|526466677|FG000|Overall Study|Lost to Follow-up|0|||
145987662|NCT00066170|526466678|FG001|Overall Study|Lost to Follow-up|1|||
145987663|NCT00066170|526466679|FG002|Overall Study|Lost to Follow-up|0|||
145987664|NCT00066170|526466680|FG003|Overall Study|Lost to Follow-up|0|||
145987665|NCT00066170|526466677|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
145987666|NCT00066170|526466678|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
145987667|NCT00066170|526466679|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
145987668|NCT00066170|526466680|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
145987669|NCT00066170|526466677|FG000|Overall Study|Protocol Violation|3|||
145987670|NCT00066170|526466678|FG001|Overall Study|Protocol Violation|0|||
145987671|NCT00066170|526466679|FG002|Overall Study|Protocol Violation|0|||
145987672|NCT00066170|526466680|FG003|Overall Study|Protocol Violation|0|||
145987673|NCT00066170|526466677|FG000|Overall Study|Other|1|||
145987674|NCT00066170|526466678|FG001|Overall Study|Other|5|||
145987675|NCT00066170|526466679|FG002|Overall Study|Other|2|||
145987676|NCT00066170|526466680|FG003|Overall Study|Other|0|||
145987677|NCT00987935|526466681|FG000|Overall Study|Progressive disease|3|||
145987678|NCT00987935|526466682|FG001|Overall Study|Progressive disease|2|||
145987679|NCT00987935|526466683|FG002|Overall Study|Progressive disease|3|||
146245903|NCT01930188|527414095|FG000|Overall Study|Withdrawal by Subject|9|||
146245904|NCT01930188|527414096|FG001|Overall Study|Withdrawal by Subject|11|||
146245905|NCT01930188|527414097|FG002|Overall Study|Withdrawal by Subject|8|||
146245906|NCT00337610|527414100|FG000|Overall Study|Adverse Event|2|||
146245907|NCT00337610|527414101|FG001|Overall Study|Adverse Event|2|||
146245908|NCT00337610|527414100|FG000|Overall Study|Death|0|||
146245909|NCT00337610|527414101|FG001|Overall Study|Death|1|||
146245910|NCT00337610|527414100|FG000|Overall Study|Lack of Efficacy|6|||
146245911|NCT00337610|527414101|FG001|Overall Study|Lack of Efficacy|3|||
146245912|NCT00337610|527414100|FG000|Overall Study|Lost to Follow-up|3|||
145987680|NCT00987935|526466684|FG003|Overall Study|Progressive disease|2|||
145987681|NCT00987935|526466685|FG004|Overall Study|Progressive disease|5|||
145987682|NCT00987935|526466686|FG005|Overall Study|Progressive disease|3|||
145987683|NCT00987935|526466687|FG006|Overall Study|Progressive disease|9|||
145987684|NCT00987935|526466688|FG007|Overall Study|Progressive disease|48|||
145987685|NCT00987935|526466689|FG008|Overall Study|Progressive disease|23|||
146245913|NCT00337610|527414101|FG001|Overall Study|Lost to Follow-up|3|||
146245914|NCT00337610|527414100|FG000|Overall Study|Withdrawal by Subject|6|||
145987686|NCT00987935|526466681|FG000|Overall Study|Adverse Event|0|||
145987687|NCT00987935|526466682|FG001|Overall Study|Adverse Event|1|||
145987688|NCT00987935|526466683|FG002|Overall Study|Adverse Event|0|||
145987689|NCT00987935|526466684|FG003|Overall Study|Adverse Event|1|||
145987690|NCT00987935|526466685|FG004|Overall Study|Adverse Event|1|||
145987691|NCT00987935|526466686|FG005|Overall Study|Adverse Event|0|||
145987692|NCT00987935|526466687|FG006|Overall Study|Adverse Event|2|||
145987693|NCT00987935|526466688|FG007|Overall Study|Adverse Event|10|||
145987694|NCT00987935|526466689|FG008|Overall Study|Adverse Event|6|||
145987695|NCT00987935|526466681|FG000|Overall Study|Refused to continue taking trial med.|1|||
145987696|NCT00987935|526466682|FG001|Overall Study|Refused to continue taking trial med.|0|||
145987697|NCT00987935|526466683|FG002|Overall Study|Refused to continue taking trial med.|0|||
145987698|NCT00987935|526466684|FG003|Overall Study|Refused to continue taking trial med.|0|||
145987699|NCT00987935|526466685|FG004|Overall Study|Refused to continue taking trial med.|1|||
145987700|NCT00987935|526466686|FG005|Overall Study|Refused to continue taking trial med.|0|||
145987701|NCT00987935|526466687|FG006|Overall Study|Refused to continue taking trial med.|4|||
145987702|NCT00987935|526466688|FG007|Overall Study|Refused to continue taking trial med.|4|||
145987703|NCT00987935|526466689|FG008|Overall Study|Refused to continue taking trial med.|2|||
145987704|NCT00987935|526466681|FG000|Overall Study|Reason other than those specified above|0|||
145987705|NCT00987935|526466682|FG001|Overall Study|Reason other than those specified above|0|||
145987706|NCT00987935|526466683|FG002|Overall Study|Reason other than those specified above|0|||
145987707|NCT00987935|526466684|FG003|Overall Study|Reason other than those specified above|0|||
145987708|NCT00987935|526466685|FG004|Overall Study|Reason other than those specified above|0|||
145987709|NCT00987935|526466686|FG005|Overall Study|Reason other than those specified above|0|||
145987710|NCT00987935|526466687|FG006|Overall Study|Reason other than those specified above|0|||
145987711|NCT00987935|526466688|FG007|Overall Study|Reason other than those specified above|0|||
145987712|NCT00987935|526466689|FG008|Overall Study|Reason other than those specified above|1|||
145987713|NCT00452530|526466690|FG000|Overall Study|Death|1|||
145987714|NCT00452530|526466691|FG001|Overall Study|Death|0|||
145987715|NCT00452530|526466690|FG000|Overall Study|Adverse Event|40|||
145987716|NCT00452530|526466691|FG001|Overall Study|Adverse Event|44|||
145987717|NCT00452530|526466690|FG000|Overall Study|Withdrawal by Subject|68|||
145987718|NCT00452530|526466691|FG001|Overall Study|Withdrawal by Subject|57|||
145987719|NCT00452530|526466690|FG000|Overall Study|Lost to Follow-up|1|||
145987720|NCT00452530|526466691|FG001|Overall Study|Lost to Follow-up|0|||
145987721|NCT00452530|526466690|FG000|Overall Study|Poor compliance/noncompliance|1|||
145987722|NCT00452530|526466691|FG001|Overall Study|Poor compliance/noncompliance|2|||
145987723|NCT00452530|526466690|FG000|Overall Study|No longer met study criteria|18|||
145987724|NCT00452530|526466691|FG001|Overall Study|No longer met study criteria|22|||
145987725|NCT00452530|526466690|FG000|Overall Study|Other|7|||
145987726|NCT00452530|526466691|FG001|Overall Study|Other|11|||
145987727|NCT01189227|526466692|FG000|Overall Study|Study terminated due to low accrual|6|||
145987728|NCT01189227|526466693|FG001|Overall Study|Study terminated due to low accrual|3|||
145987729|NCT06868667|526466697|FG000|Overall Study|Death|0|||
145987730|NCT06868667|526466698|FG001|Overall Study|Death|4|||
145987731|NCT06868667|526466697|FG000|Overall Study|Lost to Follow-up|0|||
145987732|NCT06868667|526466698|FG001|Overall Study|Lost to Follow-up|1|||
145987733|NCT06868667|526466697|FG000|Overall Study|Withdrawal by Subject|1|||
145987734|NCT06868667|526466698|FG001|Overall Study|Withdrawal by Subject|0|||
145987735|NCT06868667|526466697|FG000|Overall Study|Ongoing|9|||
145987736|NCT06868667|526466698|FG001|Overall Study|Ongoing|9|||
145987737|NCT01569763|526468731|FG000|Overall Study|Lack of Efficacy|2|||
145987738|NCT01569763|526468732|FG001|Overall Study|Lack of Efficacy|7|||
145987739|NCT01569763|526468731|FG000|Overall Study|Adverse Event|1|||
145987740|NCT01569763|526468732|FG001|Overall Study|Adverse Event|0|||
145987741|NCT03681093|526468733|FG000|Overall Study|Subject decision|0|||
145987742|NCT03681093|526468734|FG001|Overall Study|Subject decision|2|||
145987743|NCT03681093|526468735|FG002|Overall Study|Subject decision|1|||
145987744|NCT01882829|526468736|FG000|Overall Study|Adverse Event|4|||
145987745|NCT01882829|526468736|FG000|Overall Study|Protocol Violation|1|||
145987746|NCT01882829|526468736|FG000|Overall Study|Withdrawal by Subject|1|||
145987747|NCT02562040|526468737|FG000|Overall Study|Lost to Follow-up|20|||
145987748|NCT02562040|526468738|FG001|Overall Study|Lost to Follow-up|28|||
145987749|NCT02562040|526468737|FG000|Overall Study|Withdrawal by Subject|8|||
145987750|NCT02562040|526468738|FG001|Overall Study|Withdrawal by Subject|7|||
145987751|NCT02562040|526468737|FG000|Overall Study|Adverse Event|1|||
145987752|NCT02562040|526468738|FG001|Overall Study|Adverse Event|0|||
145987753|NCT00368849|526468740|FG000|Overall Study|Withdrawal by Subject|0|||
145987754|NCT00368849|526468741|FG001|Overall Study|Withdrawal by Subject|1|||
145987755|NCT00368849|526468740|FG000|Overall Study|Physician Decision|0|||
145987756|NCT00368849|526468741|FG001|Overall Study|Physician Decision|1|||
145987757|NCT01902303|526468745|FG000|Overall Study|Adverse Event|0|||
145987758|NCT01902303|526468746|FG001|Overall Study|Adverse Event|1|||
145987759|NCT01902303|526468745|FG000|Overall Study|Lost to Follow-up|0|||
145987760|NCT01902303|526468746|FG001|Overall Study|Lost to Follow-up|1|||
145987761|NCT01902303|526468745|FG000|Overall Study|Protocol Violation|2|||
145987762|NCT01902303|526468746|FG001|Overall Study|Protocol Violation|2|||
145987763|NCT01902303|526468745|FG000|Overall Study|subject lost investigational product|0|||
145987764|NCT01902303|526468746|FG001|Overall Study|subject lost investigational product|1|||
145987765|NCT01902303|526468745|FG000|Overall Study|Did not develop a cold sore|21|||
145987766|NCT01902303|526468746|FG001|Overall Study|Did not develop a cold sore|19|||
145987767|NCT03211858|526468747|FG000|Overall Study|Adverse Event|8|||
145987768|NCT03211858|526468748|FG001|Overall Study|Adverse Event|6|||
145987769|NCT03211858|526468747|FG000|Overall Study|Lack of Efficacy|0|||
145987770|NCT03211858|526468748|FG001|Overall Study|Lack of Efficacy|4|||
145987771|NCT03211858|526468747|FG000|Overall Study|Poor compliance to protocol|6|||
145987772|NCT03211858|526468748|FG001|Overall Study|Poor compliance to protocol|2|||
145987773|NCT03211858|526468747|FG000|Overall Study|Non-serious Hypoglycemia|1|||
145987774|NCT03211858|526468748|FG001|Overall Study|Non-serious Hypoglycemia|0|||
145987775|NCT03211858|526468747|FG000|Overall Study|Other than specified above|22|||
145987776|NCT03211858|526468748|FG001|Overall Study|Other than specified above|21|||
145987777|NCT02457546|526468750|FG000|Overall Study|Other reasons|4|||
145987778|NCT02457546|526468751|FG001|Overall Study|Other reasons|1|||
145987779|NCT02457546|526468750|FG000|Overall Study|Refused to complete study/procedures|1|||
145987780|NCT02457546|526468751|FG001|Overall Study|Refused to complete study/procedures|1|||
145987781|NCT02457546|526468750|FG000|Overall Study|Lost to Follow-up|4|||
145987782|NCT02457546|526468751|FG001|Overall Study|Lost to Follow-up|1|||
145987783|NCT02457546|526468750|FG000|Overall Study|Adverse Event|0|||
145987784|NCT02457546|526468751|FG001|Overall Study|Adverse Event|1|||
145987785|NCT00363467|526468752|FG000|Overall Study|Physician Decision|1|||
145987786|NCT03142451|526468753|FG000|Overall Study|Adverse Event|5|||
145987787|NCT03142451|526468754|FG001|Overall Study|Adverse Event|2|||
145987788|NCT03142451|526468753|FG000|Overall Study|Lost to Follow-up|25|||
145987789|NCT03142451|526468754|FG001|Overall Study|Lost to Follow-up|8|||
145987790|NCT03142451|526468753|FG000|Overall Study|Participant request|24|||
145987791|NCT03142451|526468754|FG001|Overall Study|Participant request|12|||
145987792|NCT03142451|526468753|FG000|Overall Study|Protocol Violation|3|||
145987793|NCT03142451|526468754|FG001|Overall Study|Protocol Violation|1|||
145987794|NCT03142451|526468753|FG000|Overall Study|Other|1|||
145987795|NCT03142451|526468754|FG001|Overall Study|Other|1|||
145987796|NCT00090402|526468755|FG000|Overall Study|Death|1|||
145987797|NCT00090402|526468756|FG001|Overall Study|Death|1|||
145987798|NCT00090402|526468757|FG002|Overall Study|Death|0|||
145987799|NCT00090402|526468755|FG000|Overall Study|subject moved|0|||
145987800|NCT00090402|526468756|FG001|Overall Study|subject moved|1|||
145987801|NCT00090402|526468757|FG002|Overall Study|subject moved|0|||
145987802|NCT00090402|526468755|FG000|Overall Study|stopped taking study medication|1|||
145987803|NCT00090402|526468756|FG001|Overall Study|stopped taking study medication|0|||
145987804|NCT00090402|526468757|FG002|Overall Study|stopped taking study medication|1|||
145987805|NCT01730729|526468760|FG000|Overall Study|Adverse Event|1|||
145987806|NCT01730729|526468760|FG000|Overall Study|Death|1|||
145987807|NCT01730729|526468760|FG000|Overall Study|Progressive Disease|12|||
145987808|NCT00871000|526468761|FG000|Overall Study|Withdrawal by Subject|1|||
145987809|NCT00871000|526468762|FG001|Overall Study|Withdrawal by Subject|0|||
145987810|NCT03400787|526468763|FG000|Overall Study|Lost to Follow-up|1|||
145987811|NCT03400787|526468764|FG001|Overall Study|Lost to Follow-up|0|||
145987812|NCT03400787|526468763|FG000|Overall Study|Death|1|||
145987813|NCT03400787|526468764|FG001|Overall Study|Death|0|||
145987814|NCT03400787|526468763|FG000|Overall Study|Protocol Violation|0|||
145987815|NCT03400787|526468764|FG001|Overall Study|Protocol Violation|2|||
145987816|NCT03400787|526468763|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
145987817|NCT03400787|526468764|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
145987818|NCT02402907|526468769|FG000|Overall Study|Delivered vaginally|9|||
145987819|NCT02402907|526468770|FG001|Overall Study|Delivered vaginally|3|||
145987820|NCT02402907|526468769|FG000|Overall Study|Delivered outside of Sinai|1|||
145987821|NCT02402907|526468770|FG001|Overall Study|Delivered outside of Sinai|1|||
145987822|NCT02402907|526468769|FG000|Overall Study|Lost to follow up after C-Section|10|||
145987823|NCT02402907|526468770|FG001|Overall Study|Lost to follow up after C-Section|23|||
145987824|NCT01716559|526468771|FG000|Overall Study|Adverse Event|11|||
145987825|NCT01716559|526468771|FG000|Overall Study|Death|21|||
145987826|NCT01716559|526468771|FG000|Overall Study|Withdrawal by Subject|4|||
145987827|NCT01716559|526468771|FG000|Overall Study|Other withdrawal reason|75|||
145987828|NCT01423084|526468774|FG000|Overall Study|Adverse Event|0|||
145987829|NCT01423084|526468775|FG001|Overall Study|Adverse Event|1|||
145987830|NCT01423084|526468774|FG000|Overall Study|Withdrawal by Subject|2|||
145987831|NCT01423084|526468775|FG001|Overall Study|Withdrawal by Subject|3|||
145987832|NCT02180672|526468777|FG000|Overall Study|Lost to Follow-up|5|||
145987833|NCT02180672|526468778|FG001|Overall Study|Lost to Follow-up|7|||
145987834|NCT03574389|526468779|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
145987835|NCT03574389|526468780|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
145987836|NCT03574389|526468781|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
145987837|NCT03574389|526468782|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
145987838|NCT03574389|526468783|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
145987839|NCT03574389|526468784|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
145987840|NCT03574389|526468785|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
145987841|NCT03574389|526468779|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
145987842|NCT03574389|526468780|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
145987843|NCT03574389|526468781|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
145987844|NCT03574389|526468782|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
145987845|NCT03574389|526468783|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
145987846|NCT03574389|526468784|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
145987847|NCT03574389|526468785|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
145987848|NCT03574389|526468779|FG000|Vaccination Period|Other|6|||
145987849|NCT03574389|526468780|FG001|Vaccination Period|Other|0|||
145987850|NCT03574389|526468781|FG002|Vaccination Period|Other|0|||
145987851|NCT03574389|526468782|FG003|Vaccination Period|Other|0|||
145987852|NCT03574389|526468783|FG004|Vaccination Period|Other|0|||
145987853|NCT03574389|526468784|FG005|Vaccination Period|Other|0|||
145987854|NCT03574389|526468785|FG006|Vaccination Period|Other|0|||
145987855|NCT03574389|526468779|FG000|Vaccination Period|Adverse Event|0|||
145987856|NCT03574389|526468780|FG001|Vaccination Period|Adverse Event|1|||
145987857|NCT03574389|526468781|FG002|Vaccination Period|Adverse Event|0|||
145987858|NCT03574389|526468782|FG003|Vaccination Period|Adverse Event|0|||
145987859|NCT03574389|526468783|FG004|Vaccination Period|Adverse Event|0|||
145987860|NCT03574389|526468784|FG005|Vaccination Period|Adverse Event|0|||
145987861|NCT03574389|526468785|FG006|Vaccination Period|Adverse Event|0|||
145987862|NCT03574389|526468779|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
145987863|NCT03574389|526468780|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
145987864|NCT03574389|526468781|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
145987865|NCT03574389|526468782|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
145987866|NCT03574389|526468783|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
145987867|NCT03574389|526468784|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
145987868|NCT03574389|526468785|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
145987869|NCT02070380|526468789|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
145987870|NCT02070380|526468790|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
145987871|NCT02070380|526468791|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
145987872|NCT02070380|526468792|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
145987873|NCT02070380|526468789|FG000|Second Injection|Image sets missing or technically inadeq|0|||
145987874|NCT02070380|526468790|FG001|Second Injection|Image sets missing or technically inadeq|1|||
145987875|NCT02070380|526468791|FG002|Second Injection|Image sets missing or technically inadeq|0|||
145987876|NCT02070380|526468792|FG003|Second Injection|Image sets missing or technically inadeq|0|||
145987877|NCT02070380|526468789|FG000|Second Injection|Protocol Violation|0|||
145987878|NCT02070380|526468790|FG001|Second Injection|Protocol Violation|1|||
145987879|NCT02070380|526468791|FG002|Second Injection|Protocol Violation|1|||
145987880|NCT02070380|526468792|FG003|Second Injection|Protocol Violation|5|||
145987881|NCT02837952|526468793|FG000|Overall Study|Adverse Event|0|||
145987882|NCT02837952|526468794|FG001|Overall Study|Adverse Event|1|||
145987883|NCT02837952|526468793|FG000|Overall Study|Withdrawal by Subject|4|||
145987884|NCT02837952|526468794|FG001|Overall Study|Withdrawal by Subject|5|||
145987885|NCT02837952|526468793|FG000|Overall Study|Medication Error|1|||
145987886|NCT02837952|526468794|FG001|Overall Study|Medication Error|0|||
145987887|NCT02462057|526468805|FG000|Overall Study|Left Vitality|32|||
145987888|NCT02462057|526468806|FG001|Overall Study|Left Vitality|27|||
145987889|NCT02462057|526468807|FG002|Overall Study|Left Vitality|23|||
145987890|NCT02462057|526468808|FG003|Overall Study|Left Vitality|35|||
145987891|NCT02462057|526468809|FG004|Overall Study|Left Vitality|33|||
145987892|NCT02462057|526468805|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
145987893|NCT02462057|526468806|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
145987894|NCT02462057|526468807|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
145987895|NCT02462057|526468808|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
145987896|NCT02462057|526468809|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
145987897|NCT01682603|526468810|FG000|Overall Study|Lost to Follow-up|3|||
145987898|NCT01791205|526468812|FG000|Phase II|Lack of Efficacy|6|||
145987899|NCT01791205|526468813|FG001|Phase II|Lack of Efficacy|0|||
145987900|NCT01791205|526468812|FG000|Phase II|Adverse Event|2|||
145987901|NCT01791205|526468813|FG001|Phase II|Adverse Event|0|||
145987902|NCT01791205|526468812|FG000|Phase II|Safety|1|||
145987903|NCT01791205|526468813|FG001|Phase II|Safety|0|||
145987904|NCT01791205|526468812|FG000|Phase II|Lost to Follow-up|1|||
145987905|NCT01791205|526468813|FG001|Phase II|Lost to Follow-up|0|||
145987906|NCT01791205|526468812|FG000|Phase II|Remission of disease|1|||
145987907|NCT01791205|526468813|FG001|Phase II|Remission of disease|0|||
145987908|NCT01791205|526468812|FG000|Phase II|Physician's decision|1|||
145987909|NCT01791205|526468813|FG001|Phase II|Physician's decision|0|||
145987910|NCT01908699|526468814|FG000|Overall Study|Adverse Event|8|||
145987911|NCT01908699|526468815|FG001|Overall Study|Adverse Event|12|||
145987912|NCT01908699|526468814|FG000|Overall Study|Lack of Efficacy|2|||
145987913|NCT01908699|526468815|FG001|Overall Study|Lack of Efficacy|2|||
145987914|NCT01908699|526468814|FG000|Overall Study|Lost to Follow-up|2|||
145987915|NCT01908699|526468815|FG001|Overall Study|Lost to Follow-up|4|||
145987916|NCT01908699|526468814|FG000|Overall Study|Physician Decision|8|||
145987917|NCT01908699|526468815|FG001|Overall Study|Physician Decision|8|||
145987918|NCT01908699|526468814|FG000|Overall Study|Withdrawal by Subject|15|||
145987919|NCT01908699|526468815|FG001|Overall Study|Withdrawal by Subject|10|||
145987920|NCT01908699|526468814|FG000|Overall Study|Pregnancy|0|||
145987921|NCT01908699|526468815|FG001|Overall Study|Pregnancy|1|||
145987922|NCT01908699|526468814|FG000|Overall Study|Randomized in Error|1|||
145987923|NCT01908699|526468815|FG001|Overall Study|Randomized in Error|0|||
145987924|NCT01908699|526468814|FG000|Overall Study|Death|9|||
145987925|NCT01908699|526468815|FG001|Overall Study|Death|12|||
145987926|NCT01908699|526468814|FG000|Overall Study|Progressive Disease|30|||
145987927|NCT01908699|526468815|FG001|Overall Study|Progressive Disease|29|||
145987928|NCT01697501|526468816|FG000|Overall Study|Protocol Violation|2|||
145987929|NCT02242903|526468817|FG000|Overall Study|Withdrawal by Subject|1|||
145987930|NCT02242903|526468818|FG001|Overall Study|Withdrawal by Subject|0|||
145987931|NCT02242903|526468819|FG002|Overall Study|Withdrawal by Subject|0|||
145987932|NCT02242903|526468820|FG003|Overall Study|Withdrawal by Subject|0|||
145987933|NCT02242903|526468821|FG004|Overall Study|Withdrawal by Subject|0|||
145987934|NCT02242903|526468822|FG005|Overall Study|Withdrawal by Subject|0|||
145987935|NCT02242903|526468823|FG006|Overall Study|Withdrawal by Subject|0|||
145987936|NCT01896986|526468826|FG000|Overall Study|samples lost|14|||
145987937|NCT01896986|526468827|FG001|Overall Study|samples lost|23|||
145987938|NCT00281580|526468829|FG000|Overall Study|Adverse Event|2|||
145987939|NCT00281580|526468830|FG001|Overall Study|Adverse Event|0|||
145987940|NCT00281580|526468831|FG002|Overall Study|Adverse Event|2|||
145987941|NCT00281580|526468832|FG003|Overall Study|Adverse Event|4|||
145987942|NCT00281580|526468833|FG004|Overall Study|Adverse Event|1|||
145987943|NCT00281580|526468834|FG005|Overall Study|Adverse Event|0|||
145987944|NCT00281580|526468835|FG006|Overall Study|Adverse Event|1|||
145987945|NCT00281580|526468836|FG007|Overall Study|Adverse Event|0|||
145987946|NCT00281580|526468837|FG008|Overall Study|Adverse Event|1|||
145987947|NCT00281580|526468838|FG009|Overall Study|Adverse Event|6|||
145987948|NCT00281580|526468839|FG010|Overall Study|Adverse Event|0|||
145987949|NCT00281580|526468840|FG011|Overall Study|Adverse Event|5|||
145987950|NCT00281580|526468841|FG012|Overall Study|Adverse Event|8|||
145987951|NCT00281580|526468842|FG013|Overall Study|Adverse Event|2|||
145987952|NCT00281580|526468843|FG014|Overall Study|Adverse Event|3|||
145987953|NCT00281580|526468844|FG015|Overall Study|Adverse Event|3|||
145987954|NCT00281580|526468829|FG000|Overall Study|Protocol Violation|0|||
145987955|NCT00281580|526468830|FG001|Overall Study|Protocol Violation|0|||
145987956|NCT00281580|526468831|FG002|Overall Study|Protocol Violation|1|||
145987957|NCT00281580|526468832|FG003|Overall Study|Protocol Violation|1|||
145987958|NCT00281580|526468833|FG004|Overall Study|Protocol Violation|0|||
145987959|NCT00281580|526468834|FG005|Overall Study|Protocol Violation|0|||
145987960|NCT00281580|526468835|FG006|Overall Study|Protocol Violation|1|||
145987961|NCT00281580|526468836|FG007|Overall Study|Protocol Violation|0|||
145987962|NCT00281580|526468837|FG008|Overall Study|Protocol Violation|2|||
145987963|NCT00281580|526468838|FG009|Overall Study|Protocol Violation|0|||
145987964|NCT00281580|526468839|FG010|Overall Study|Protocol Violation|1|||
145987965|NCT00281580|526468840|FG011|Overall Study|Protocol Violation|2|||
145987966|NCT00281580|526468841|FG012|Overall Study|Protocol Violation|0|||
145987967|NCT00281580|526468842|FG013|Overall Study|Protocol Violation|1|||
145987968|NCT00281580|526468843|FG014|Overall Study|Protocol Violation|1|||
145987969|NCT00281580|526468844|FG015|Overall Study|Protocol Violation|3|||
145987970|NCT00281580|526468829|FG000|Overall Study|Withdrawal by Subject|3|||
145987971|NCT00281580|526468830|FG001|Overall Study|Withdrawal by Subject|0|||
145987972|NCT00281580|526468831|FG002|Overall Study|Withdrawal by Subject|1|||
145987973|NCT00281580|526468832|FG003|Overall Study|Withdrawal by Subject|1|||
145987974|NCT00281580|526468833|FG004|Overall Study|Withdrawal by Subject|1|||
145987975|NCT00281580|526468834|FG005|Overall Study|Withdrawal by Subject|2|||
145987976|NCT00281580|526468835|FG006|Overall Study|Withdrawal by Subject|2|||
145987977|NCT00281580|526468836|FG007|Overall Study|Withdrawal by Subject|0|||
145987978|NCT00281580|526468837|FG008|Overall Study|Withdrawal by Subject|1|||
145987979|NCT00281580|526468838|FG009|Overall Study|Withdrawal by Subject|4|||
145987980|NCT00281580|526468839|FG010|Overall Study|Withdrawal by Subject|1|||
145987981|NCT00281580|526468840|FG011|Overall Study|Withdrawal by Subject|1|||
145987982|NCT00281580|526468841|FG012|Overall Study|Withdrawal by Subject|2|||
145987983|NCT00281580|526468842|FG013|Overall Study|Withdrawal by Subject|2|||
145987984|NCT00281580|526468843|FG014|Overall Study|Withdrawal by Subject|1|||
145987985|NCT00281580|526468844|FG015|Overall Study|Withdrawal by Subject|5|||
145987986|NCT00281580|526468829|FG000|Overall Study|Lack of Efficacy|2|||
145987987|NCT00281580|526468830|FG001|Overall Study|Lack of Efficacy|1|||
145987988|NCT00281580|526468831|FG002|Overall Study|Lack of Efficacy|1|||
145987989|NCT00281580|526468832|FG003|Overall Study|Lack of Efficacy|6|||
145987990|NCT00281580|526468833|FG004|Overall Study|Lack of Efficacy|2|||
145987991|NCT00281580|526468834|FG005|Overall Study|Lack of Efficacy|0|||
145987992|NCT00281580|526468835|FG006|Overall Study|Lack of Efficacy|0|||
145987993|NCT00281580|526468836|FG007|Overall Study|Lack of Efficacy|0|||
145987994|NCT00281580|526468837|FG008|Overall Study|Lack of Efficacy|0|||
145987995|NCT00281580|526468838|FG009|Overall Study|Lack of Efficacy|0|||
145987996|NCT00281580|526468839|FG010|Overall Study|Lack of Efficacy|0|||
145987997|NCT00281580|526468840|FG011|Overall Study|Lack of Efficacy|1|||
145987998|NCT00281580|526468841|FG012|Overall Study|Lack of Efficacy|0|||
145987999|NCT00281580|526468842|FG013|Overall Study|Lack of Efficacy|2|||
145988000|NCT00281580|526468843|FG014|Overall Study|Lack of Efficacy|1|||
145988001|NCT00281580|526468844|FG015|Overall Study|Lack of Efficacy|0|||
145988002|NCT00281580|526468829|FG000|Overall Study|Lost to Follow-up|0|||
145988003|NCT00281580|526468830|FG001|Overall Study|Lost to Follow-up|0|||
145988004|NCT00281580|526468831|FG002|Overall Study|Lost to Follow-up|0|||
145988005|NCT00281580|526468832|FG003|Overall Study|Lost to Follow-up|3|||
145988006|NCT00281580|526468833|FG004|Overall Study|Lost to Follow-up|0|||
145988007|NCT00281580|526468834|FG005|Overall Study|Lost to Follow-up|1|||
145988008|NCT00281580|526468835|FG006|Overall Study|Lost to Follow-up|0|||
145988009|NCT00281580|526468836|FG007|Overall Study|Lost to Follow-up|1|||
145988010|NCT00281580|526468837|FG008|Overall Study|Lost to Follow-up|2|||
145988011|NCT00281580|526468838|FG009|Overall Study|Lost to Follow-up|1|||
145988012|NCT00281580|526468839|FG010|Overall Study|Lost to Follow-up|1|||
145988013|NCT00281580|526468840|FG011|Overall Study|Lost to Follow-up|0|||
145988014|NCT00281580|526468841|FG012|Overall Study|Lost to Follow-up|1|||
145988015|NCT00281580|526468842|FG013|Overall Study|Lost to Follow-up|0|||
145988016|NCT00281580|526468843|FG014|Overall Study|Lost to Follow-up|0|||
145988017|NCT00281580|526468844|FG015|Overall Study|Lost to Follow-up|0|||
145988018|NCT00281580|526468829|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
145988019|NCT00281580|526468830|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
145988020|NCT00281580|526468831|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
145988021|NCT00281580|526468832|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
145988022|NCT00281580|526468833|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
145988023|NCT00281580|526468834|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
145988024|NCT00281580|526468835|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
145988025|NCT00281580|526468836|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
145988026|NCT00281580|526468837|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
145988027|NCT00281580|526468838|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
145988028|NCT00281580|526468839|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
145988029|NCT00281580|526468840|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
145988030|NCT00281580|526468841|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
145988031|NCT00281580|526468842|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
145988032|NCT00281580|526468843|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
145988033|NCT00281580|526468844|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
145988034|NCT02771145|526468848|FG000|Overall Study|Adverse Event|3|||
145988035|NCT02771145|526468848|FG000|Overall Study|Lost to Follow-up|1|||
145988036|NCT02067156|526468856|FG000|Overall Study|Lost to Follow-up|4|||
145988037|NCT03596983|526468857|FG000|Overall Study|Withdrawal by Subject|3|||
145988038|NCT01370642|526468858|FG000|Overall Study|Adverse Event|2|||
145988039|NCT01370642|526468859|FG001|Overall Study|Adverse Event|1|||
145988040|NCT01370642|526468860|FG002|Overall Study|Adverse Event|1|||
145988041|NCT01370642|526468858|FG000|Overall Study|Detectable HCV RNA|0|||
145988042|NCT01370642|526468859|FG001|Overall Study|Detectable HCV RNA|0|||
145988043|NCT01370642|526468860|FG002|Overall Study|Detectable HCV RNA|22|||
145988044|NCT01370642|526468858|FG000|Overall Study|Lost to Follow-up|0|||
145988045|NCT01370642|526468859|FG001|Overall Study|Lost to Follow-up|0|||
145988046|NCT01370642|526468860|FG002|Overall Study|Lost to Follow-up|1|||
145988047|NCT01370642|526468858|FG000|Overall Study|Physician Decision|4|||
145988048|NCT01370642|526468859|FG001|Overall Study|Physician Decision|1|||
145988049|NCT01370642|526468860|FG002|Overall Study|Physician Decision|2|||
145988050|NCT01370642|526468858|FG000|Overall Study|Withdrawal by Subject|2|||
145988051|NCT01370642|526468859|FG001|Overall Study|Withdrawal by Subject|4|||
146091461|NCT00559754|526856828|FG000|Overall Study|Disease progression|1|||
145988052|NCT01370642|526468860|FG002|Overall Study|Withdrawal by Subject|3|||
145988053|NCT03888482|526468867|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
145988054|NCT03888482|526468868|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
145988055|NCT03888482|526468867|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
146091462|NCT00559754|526856828|FG000|Overall Study|Adverse Event|5|||
145988056|NCT03888482|526468868|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
145988057|NCT00563316|526468869|FG000|Overall Study|Adverse Event|2|||
145988058|NCT00563316|526468869|FG000|Overall Study|Physician Decision|1|||
145988059|NCT00563316|526468869|FG000|Overall Study|Lost to Follow-up|2|||
145988060|NCT00563316|526468869|FG000|Overall Study|Death|1|||
145988061|NCT00563316|526468869|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
145988062|NCT00563316|526468869|FG000|Overall Study|Other|1|||
145988063|NCT00425854|526468871|FG000|Overall Study|Progressive Disease|19|||
145988064|NCT00425854|526468872|FG001|Overall Study|Progressive Disease|12|||
145988065|NCT00425854|526468871|FG000|Overall Study|Dose reduction toxicity AE|8|||
145988066|NCT00425854|526468872|FG001|Overall Study|Dose reduction toxicity AE|7|||
145988067|NCT00425854|526468871|FG000|Overall Study|Other Adverse Event|2|||
145988068|NCT00425854|526468872|FG001|Overall Study|Other Adverse Event|2|||
145988069|NCT01630811|526468876|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
145988070|NCT01630811|526468877|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145988071|NCT04818086|526468882|FG000|Overall Study|Physician Decision|1|||
145988072|NCT04818086|526468883|FG001|Overall Study|Physician Decision|0|||
145988073|NCT04818086|526468882|FG000|Overall Study|Withdrawal by Subject|0|||
145988074|NCT04818086|526468883|FG001|Overall Study|Withdrawal by Subject|1|||
145988075|NCT00954538|526468896|FG000|Part III|Withdrawal by Subject|0|||
145988076|NCT00954538|526468897|FG001|Part III|Withdrawal by Subject|0|||
145988077|NCT00954538|526468898|FG002|Part III|Withdrawal by Subject|0|||
145988078|NCT00954538|526468899|FG003|Part III|Withdrawal by Subject|0|||
145988079|NCT00954538|526468900|FG004|Part III|Withdrawal by Subject|1|||
145988080|NCT00954538|526468901|FG005|Part III|Withdrawal by Subject|0|||
145988081|NCT01905683|526468904|FG000|Overall Study|Protocol Violation|1|||
145988082|NCT01905683|526468904|FG000|Overall Study|Re-injection criteria not met; others|13|||
145988083|NCT01905683|526468904|FG000|Overall Study|Physician Decision|1|||
145988084|NCT01905683|526468904|FG000|Overall Study|Lack of Efficacy|8|||
145988085|NCT01905683|526468904|FG000|Overall Study|Withdrawal by Subject|20|||
145988086|NCT01905683|526468904|FG000|Overall Study|Adverse Event|4|||
145988087|NCT01905683|526468904|FG000|Overall Study|Lost to Follow-up|4|||
145988088|NCT00537082|526468907|FG000|Overall Study|Adverse Event|6|||
145988089|NCT00537082|526468908|FG001|Overall Study|Adverse Event|6|||
145988090|NCT00537082|526468909|FG002|Overall Study|Adverse Event|3|||
145988091|NCT00537082|526468907|FG000|Overall Study|Protocol Violation|0|||
145988092|NCT00537082|526468908|FG001|Overall Study|Protocol Violation|2|||
145988093|NCT00537082|526468909|FG002|Overall Study|Protocol Violation|1|||
145988094|NCT00537082|526468907|FG000|Overall Study|Lack of Efficacy|0|||
145988095|NCT00537082|526468908|FG001|Overall Study|Lack of Efficacy|0|||
145988096|NCT00537082|526468909|FG002|Overall Study|Lack of Efficacy|2|||
145988097|NCT00537082|526468907|FG000|Overall Study|Withdrawal by Subject|0|||
145988098|NCT00537082|526468908|FG001|Overall Study|Withdrawal by Subject|1|||
145988099|NCT00537082|526468909|FG002|Overall Study|Withdrawal by Subject|0|||
145988100|NCT00537082|526468907|FG000|Overall Study|Discontinued before initiating treatment|3|||
145988101|NCT00537082|526468908|FG001|Overall Study|Discontinued before initiating treatment|0|||
145988102|NCT00537082|526468909|FG002|Overall Study|Discontinued before initiating treatment|0|||
145988103|NCT02568254|526468910|FG000|Period 2|Adverse Event|0|||
145988104|NCT02568254|526468911|FG001|Period 2|Adverse Event|0|||
145988105|NCT02568254|526468912|FG002|Period 2|Adverse Event|1|||
145988106|NCT02568254|526468913|FG003|Period 2|Adverse Event|0|||
145988107|NCT02568254|526468914|FG004|Period 2|Adverse Event|0|||
145988108|NCT02568254|526468915|FG005|Period 2|Adverse Event|0|||
145988109|NCT02568254|526468910|FG000|Period 3|Unstatisfactory Lens fitting|0|||
145988110|NCT02568254|526468911|FG001|Period 3|Unstatisfactory Lens fitting|0|||
145988111|NCT02568254|526468912|FG002|Period 3|Unstatisfactory Lens fitting|0|||
145988112|NCT02568254|526468913|FG003|Period 3|Unstatisfactory Lens fitting|0|||
145988113|NCT02568254|526468914|FG004|Period 3|Unstatisfactory Lens fitting|1|||
145988114|NCT02568254|526468915|FG005|Period 3|Unstatisfactory Lens fitting|0|||
145988115|NCT03061214|526468920|FG000|Overall Study|Withdrawal by Subject|21|||
145988116|NCT03061214|526468921|FG001|Overall Study|Withdrawal by Subject|26|||
145988117|NCT03061214|526468922|FG002|Overall Study|Withdrawal by Subject|9|||
145988118|NCT03061214|526468920|FG000|Overall Study|Lost to Follow-up|3|||
145988119|NCT03061214|526468921|FG001|Overall Study|Lost to Follow-up|1|||
145988120|NCT03061214|526468922|FG002|Overall Study|Lost to Follow-up|1|||
145988121|NCT03061214|526468920|FG000|Overall Study|Death|1|||
145988122|NCT03061214|526468921|FG001|Overall Study|Death|1|||
145988123|NCT03061214|526468922|FG002|Overall Study|Death|0|||
145988124|NCT05058456|526471104|FG000|Overall Study|Death|1|||
145988125|NCT05058456|526471104|FG000|Overall Study|End of Study data not yet due for release|34|||
145988126|NCT01832038|526471105|FG000|Overall Study|Death|5|||
145988127|NCT01832038|526471105|FG000|Overall Study|Adverse Event|50|||
145988128|NCT01832038|526471105|FG000|Overall Study|Lack of Efficacy|81|||
145988129|NCT01832038|526471105|FG000|Overall Study|Protocol Violation|7|||
145988130|NCT01832038|526471105|FG000|Overall Study|Lost to Follow-up|10|||
145988131|NCT01832038|526471105|FG000|Overall Study|Withdrawal by Subject|49|||
145988132|NCT01832038|526471105|FG000|Overall Study|Visit non-compliance|2|||
145988133|NCT01832038|526471105|FG000|Overall Study|Subject refused to return visit|2|||
145988134|NCT01832038|526471105|FG000|Overall Study|Not convenient to come back to site|2|||
145988135|NCT01832038|526471105|FG000|Overall Study|Participant was asked to quit|5|||
145988136|NCT01832038|526471105|FG000|Overall Study|Back home|1|||
145988137|NCT01832038|526471105|FG000|Overall Study|Pregnancy|1|||
145988138|NCT01832038|526471105|FG000|Overall Study|Low compliance|3|||
145988139|NCT01832038|526471105|FG000|Overall Study|Prohibit procedure|2|||
145988140|NCT01832038|526471105|FG000|Overall Study|Not possible to visit the hospital|1|||
145988141|NCT01832038|526471105|FG000|Overall Study|Changes of implementation system|3|||
145988142|NCT01832038|526471105|FG000|Overall Study|Plan to pregnancy|7|||
145988143|NCT01832038|526471105|FG000|Overall Study|Bad mood and has suicidal thought|1|||
145988144|NCT01832038|526471105|FG000|Overall Study|Prohibited concomitant medication|1|||
145988145|NCT01832038|526471105|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
145988146|NCT01832038|526471105|FG000|Overall Study|Subject considered the efficacy was poor|1|||
145988147|NCT01897896|526471116|FG000|Overall Study|Death|1|||
145988148|NCT01897896|526471117|FG001|Overall Study|Death|0|||
145988149|NCT01897896|526471116|FG000|Overall Study|Adverse Event|11|||
145988150|NCT01897896|526471117|FG001|Overall Study|Adverse Event|1|||
145988151|NCT01897896|526471116|FG000|Overall Study|Lost to Follow-up|1|||
145988152|NCT01897896|526471117|FG001|Overall Study|Lost to Follow-up|0|||
145988153|NCT01897896|526471116|FG000|Overall Study|Non-compliance with study drug dosing|1|||
145988154|NCT01897896|526471117|FG001|Overall Study|Non-compliance with study drug dosing|1|||
145988155|NCT01897896|526471116|FG000|Overall Study|Withdrawal by Subject|7|||
145988156|NCT01897896|526471117|FG001|Overall Study|Withdrawal by Subject|1|||
145988157|NCT01897896|526471116|FG000|Overall Study|Require drug that interfere with study|1|||
145988158|NCT01897896|526471117|FG001|Overall Study|Require drug that interfere with study|4|||
145988159|NCT01897896|526471116|FG000|Overall Study|Protocol Violation|1|||
145988160|NCT01897896|526471117|FG001|Overall Study|Protocol Violation|1|||
145988161|NCT01897896|526471116|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
145988162|NCT01897896|526471117|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
145988163|NCT01897896|526471116|FG000|Overall Study|Caregiver can no longer participate|0|||
145988164|NCT01897896|526471117|FG001|Overall Study|Caregiver can no longer participate|2|||
145988165|NCT01897896|526471116|FG000|Overall Study|Other than specified|2|||
145988166|NCT01897896|526471117|FG001|Overall Study|Other than specified|1|||
145988167|NCT05069415|526471120|FG000|Overall Study|Withdrawal by Subject|2|||
145988168|NCT05069415|526471121|FG001|Overall Study|Withdrawal by Subject|0|||
145988169|NCT05069415|526471120|FG000|Overall Study|Adverse Event|2|||
145988170|NCT05069415|526471121|FG001|Overall Study|Adverse Event|0|||
145988171|NCT03160573|526471122|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
145988172|NCT03160573|526471123|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
145988173|NCT03160573|526471124|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
145988174|NCT03160573|526471125|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
145988175|NCT00101400|526471126|FG000|Survival Follow-Up|Alive|7|||
145988176|NCT03436420|526471130|FG000|Overall Study|Lack of Efficacy|3|||
145988177|NCT01061710|526471131|FG000|Overall Study|Protocol Violation|14|||
145988178|NCT00159874|526471132|FG000|Overall Study|Adverse Event|2|||
145988179|NCT00159874|526471133|FG001|Overall Study|Adverse Event|2|||
145988180|NCT00159874|526471134|FG002|Overall Study|Adverse Event|5|||
145988181|NCT00159874|526471135|FG003|Overall Study|Adverse Event|1|||
145988182|NCT00159874|526471136|FG004|Overall Study|Adverse Event|1|||
145988183|NCT00159874|526471137|FG005|Overall Study|Adverse Event|2|||
145988184|NCT00159874|526471138|FG006|Overall Study|Adverse Event|0|||
145988185|NCT00159874|526471132|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
145988186|NCT00159874|526471133|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
145988187|NCT00159874|526471134|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
145988188|NCT00159874|526471135|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
145988189|NCT00159874|526471136|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
145988190|NCT00159874|526471137|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
145988191|NCT00159874|526471138|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
145988192|NCT00159874|526471132|FG000|Overall Study|Lack of Efficacy|2|||
145988193|NCT00159874|526471133|FG001|Overall Study|Lack of Efficacy|0|||
145988194|NCT00159874|526471134|FG002|Overall Study|Lack of Efficacy|1|||
145988195|NCT00159874|526471135|FG003|Overall Study|Lack of Efficacy|1|||
145988196|NCT00159874|526471136|FG004|Overall Study|Lack of Efficacy|0|||
145988197|NCT00159874|526471137|FG005|Overall Study|Lack of Efficacy|3|||
145988198|NCT00159874|526471138|FG006|Overall Study|Lack of Efficacy|0|||
145988199|NCT00159874|526471132|FG000|Overall Study|Lost to Follow-up|1|||
145988200|NCT00159874|526471133|FG001|Overall Study|Lost to Follow-up|0|||
145988201|NCT00159874|526471134|FG002|Overall Study|Lost to Follow-up|3|||
145988202|NCT00159874|526471135|FG003|Overall Study|Lost to Follow-up|0|||
145988203|NCT00159874|526471136|FG004|Overall Study|Lost to Follow-up|1|||
145988204|NCT00159874|526471137|FG005|Overall Study|Lost to Follow-up|2|||
145988205|NCT00159874|526471138|FG006|Overall Study|Lost to Follow-up|1|||
145988206|NCT00159874|526471132|FG000|Overall Study|Other|8|||
145988207|NCT00159874|526471133|FG001|Overall Study|Other|8|||
145988208|NCT00159874|526471134|FG002|Overall Study|Other|8|||
145988209|NCT00159874|526471135|FG003|Overall Study|Other|0|||
145988210|NCT00159874|526471136|FG004|Overall Study|Other|2|||
145988211|NCT00159874|526471137|FG005|Overall Study|Other|1|||
145988212|NCT00159874|526471138|FG006|Overall Study|Other|3|||
145988213|NCT00159874|526471132|FG000|Overall Study|Protocol Violation|0|||
145988214|NCT00159874|526471133|FG001|Overall Study|Protocol Violation|5|||
145988215|NCT00159874|526471134|FG002|Overall Study|Protocol Violation|2|||
145988216|NCT00159874|526471135|FG003|Overall Study|Protocol Violation|0|||
145988217|NCT00159874|526471136|FG004|Overall Study|Protocol Violation|0|||
145988218|NCT00159874|526471137|FG005|Overall Study|Protocol Violation|0|||
145988219|NCT00159874|526471138|FG006|Overall Study|Protocol Violation|0|||
145988220|NCT00159874|526471132|FG000|Overall Study|Death|3|||
145988221|NCT00159874|526471133|FG001|Overall Study|Death|8|||
145988222|NCT00159874|526471134|FG002|Overall Study|Death|15|||
145988223|NCT00159874|526471135|FG003|Overall Study|Death|0|||
145988224|NCT00159874|526471136|FG004|Overall Study|Death|1|||
145988225|NCT00159874|526471137|FG005|Overall Study|Death|2|||
145988226|NCT00159874|526471138|FG006|Overall Study|Death|0|||
145988227|NCT00159874|526471132|FG000|Overall Study|Withdrawal by Subject|2|||
145988228|NCT00159874|526471133|FG001|Overall Study|Withdrawal by Subject|6|||
145988229|NCT00159874|526471134|FG002|Overall Study|Withdrawal by Subject|8|||
145988230|NCT00159874|526471135|FG003|Overall Study|Withdrawal by Subject|4|||
145988231|NCT00159874|526471136|FG004|Overall Study|Withdrawal by Subject|3|||
146245915|NCT00337610|527414101|FG001|Overall Study|Withdrawal by Subject|5|||
146245916|NCT04867382|527414104|FG000|Overall Study|Did not complete the survey|2|||
146245917|NCT04867382|527414105|FG001|Overall Study|Did not complete the survey|1|||
146245918|NCT02102724|527414110|FG000|Overall Study|Lost to Follow-up|1|||
146245919|NCT02102724|527414111|FG001|Overall Study|Lost to Follow-up|0|||
146245920|NCT02102724|527414110|FG000|Overall Study|surgery for brain aneurysm|1|||
146245921|NCT02102724|527414111|FG001|Overall Study|surgery for brain aneurysm|1|||
146245922|NCT02203513|527414115|FG000|Overall Study|Refused further treatment|2|||
146245923|NCT02203513|527414116|FG001|Overall Study|Refused further treatment|0|||
146245924|NCT02203513|527414117|FG002|Overall Study|Refused further treatment|1|||
146245925|NCT02203513|527414118|FG003|Overall Study|Refused further treatment|0|||
146245926|NCT02203513|527414119|FG004|Overall Study|Refused further treatment|0|||
145988232|NCT00159874|526471137|FG005|Overall Study|Withdrawal by Subject|2|||
145988233|NCT00159874|526471138|FG006|Overall Study|Withdrawal by Subject|1|||
145988234|NCT00159874|526471132|FG000|Overall Study|Pregnancy|1|||
145988235|NCT00159874|526471133|FG001|Overall Study|Pregnancy|1|||
145988236|NCT00159874|526471134|FG002|Overall Study|Pregnancy|0|||
145988237|NCT00159874|526471135|FG003|Overall Study|Pregnancy|0|||
145988238|NCT00159874|526471136|FG004|Overall Study|Pregnancy|0|||
145988239|NCT00159874|526471137|FG005|Overall Study|Pregnancy|0|||
145988240|NCT00159874|526471138|FG006|Overall Study|Pregnancy|0|||
145988241|NCT00276380|526471149|FG000|Overall Study|Adverse Event|5|||
145988242|NCT00276380|526471150|FG001|Overall Study|Adverse Event|3|||
145988243|NCT00276380|526471149|FG000|Overall Study|Lost to Follow-up|1|||
145988244|NCT00276380|526471150|FG001|Overall Study|Lost to Follow-up|1|||
145988245|NCT00276380|526471149|FG000|Overall Study|Withdrawal by Subject|3|||
145988246|NCT00276380|526471150|FG001|Overall Study|Withdrawal by Subject|6|||
145988247|NCT00276380|526471149|FG000|Overall Study|Death|5|||
145988248|NCT00276380|526471150|FG001|Overall Study|Death|3|||
145988249|NCT00276380|526471149|FG000|Overall Study|Abnormal aPPT Levels|0|||
145988250|NCT00276380|526471150|FG001|Overall Study|Abnormal aPPT Levels|1|||
145988251|NCT01651208|526471151|FG000|Overall Study|Lost to Follow-up|14|||
145988252|NCT01651208|526471152|FG001|Overall Study|Lost to Follow-up|16|||
145988253|NCT03473301|526471153|FG000|Overall Study|Protocol Violation|4|||
145988254|NCT03473301|526471154|FG001|Overall Study|Protocol Violation|0|||
145988255|NCT03473301|526471155|FG002|Overall Study|Protocol Violation|0|||
145988256|NCT03473301|526471153|FG000|Overall Study|Withdrawal by Subject|0|||
145988257|NCT03473301|526471154|FG001|Overall Study|Withdrawal by Subject|1|||
145988258|NCT03473301|526471155|FG002|Overall Study|Withdrawal by Subject|0|||
145988259|NCT03473301|526471153|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
145988260|NCT03473301|526471154|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
145988261|NCT03473301|526471155|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
145988262|NCT05287685|526471156|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
145988263|NCT05287685|526471157|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
145988264|NCT05287685|526471156|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
145988265|NCT05287685|526471157|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
145988266|NCT04829214|526471158|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
145988267|NCT04829214|526471159|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
145988268|NCT04829214|526471158|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
145988269|NCT04829214|526471159|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
145988270|NCT02314247|526471161|FG000|Overall Study|Adverse Event|2|||
145988271|NCT02314247|526471162|FG001|Overall Study|Adverse Event|1|||
145988272|NCT02314247|526471163|FG002|Overall Study|Adverse Event|0|||
145988273|NCT02314247|526471161|FG000|Overall Study|Withdrawal by Subject|1|||
145988274|NCT02314247|526471162|FG001|Overall Study|Withdrawal by Subject|3|||
145988275|NCT02314247|526471163|FG002|Overall Study|Withdrawal by Subject|1|||
145988276|NCT02314247|526471161|FG000|Overall Study|Progression of Disease|6|||
145988277|NCT02314247|526471162|FG001|Overall Study|Progression of Disease|2|||
145988278|NCT02314247|526471163|FG002|Overall Study|Progression of Disease|0|||
145988279|NCT01953354|526471164|FG000|Overall Study|Withdrawal by Subject|0|||
145988280|NCT01953354|526471165|FG001|Overall Study|Withdrawal by Subject|1|||
145988281|NCT01953354|526471164|FG000|Overall Study|Decision of Sponsor|0|||
145988282|NCT01953354|526471165|FG001|Overall Study|Decision of Sponsor|1|||
145988283|NCT01953354|526471164|FG000|Overall Study|Disease Exacerbation|1|||
145988284|NCT01953354|526471165|FG001|Overall Study|Disease Exacerbation|0|||
145988285|NCT01570192|526471166|FG000|Overall Study|no qualifying organism|6|||
145988286|NCT01570192|526471167|FG001|Overall Study|no qualifying organism|12|||
145988287|NCT01570192|526471166|FG000|Overall Study|changed to palliative care|1|||
145988288|NCT01570192|526471167|FG001|Overall Study|changed to palliative care|0|||
145988289|NCT01570192|526471166|FG000|Overall Study|Physician Decision|0|||
145988290|NCT01570192|526471167|FG001|Overall Study|Physician Decision|1|||
145988291|NCT02965976|526471168|FG000|Overall Study|Withdrawal by Subject|2|||
145988292|NCT02965976|526471169|FG001|Overall Study|Withdrawal by Subject|0|||
145988293|NCT02134028|526471170|FG000|Overall Study|Lack of Efficacy|1|||
145988294|NCT02134028|526471171|FG001|Overall Study|Lack of Efficacy|0|||
145988295|NCT02134028|526471172|FG002|Overall Study|Lack of Efficacy|3|||
145988296|NCT02134028|526471173|FG003|Overall Study|Lack of Efficacy|2|||
145988297|NCT02134028|526471174|FG004|Overall Study|Lack of Efficacy|1|||
145988298|NCT02134028|526471175|FG005|Overall Study|Lack of Efficacy|2|||
145988299|NCT02134028|526471176|FG006|Overall Study|Lack of Efficacy|1|||
145988300|NCT02134028|526471177|FG007|Overall Study|Lack of Efficacy|0|||
145988301|NCT02134028|526471170|FG000|Overall Study|Poor compliance to protocol|1|||
145988302|NCT02134028|526471171|FG001|Overall Study|Poor compliance to protocol|1|||
145988303|NCT02134028|526471172|FG002|Overall Study|Poor compliance to protocol|3|||
145988304|NCT02134028|526471173|FG003|Overall Study|Poor compliance to protocol|7|||
145988305|NCT02134028|526471174|FG004|Overall Study|Poor compliance to protocol|1|||
145988306|NCT02134028|526471175|FG005|Overall Study|Poor compliance to protocol|1|||
145988307|NCT02134028|526471176|FG006|Overall Study|Poor compliance to protocol|0|||
145988308|NCT02134028|526471177|FG007|Overall Study|Poor compliance to protocol|0|||
145988309|NCT02134028|526471170|FG000|Overall Study|Other unspecified|4|||
145988310|NCT02134028|526471171|FG001|Overall Study|Other unspecified|22|||
145988311|NCT02134028|526471172|FG002|Overall Study|Other unspecified|33|||
145988312|NCT02134028|526471173|FG003|Overall Study|Other unspecified|64|||
145988313|NCT02134028|526471174|FG004|Overall Study|Other unspecified|8|||
145988314|NCT02134028|526471175|FG005|Overall Study|Other unspecified|6|||
145988315|NCT02134028|526471176|FG006|Overall Study|Other unspecified|2|||
145988316|NCT02134028|526471177|FG007|Overall Study|Other unspecified|1|||
145988317|NCT02134028|526471170|FG000|Overall Study|Adverse Event|3|||
145988318|NCT02134028|526471171|FG001|Overall Study|Adverse Event|19|||
145988319|NCT02134028|526471172|FG002|Overall Study|Adverse Event|13|||
145988320|NCT02134028|526471173|FG003|Overall Study|Adverse Event|32|||
145988321|NCT02134028|526471174|FG004|Overall Study|Adverse Event|4|||
145988322|NCT02134028|526471175|FG005|Overall Study|Adverse Event|5|||
145988323|NCT02134028|526471176|FG006|Overall Study|Adverse Event|1|||
145988324|NCT02134028|526471177|FG007|Overall Study|Adverse Event|2|||
145988325|NCT00806026|526471178|FG000|Overall Study|Death|0|||
145988326|NCT00806026|526471179|FG001|Overall Study|Death|0|||
145988327|NCT00806026|526471180|FG002|Overall Study|Death|0|||
145988328|NCT00806026|526471181|FG003|Overall Study|Death|1|||
145988329|NCT00806026|526471182|FG004|Overall Study|Death|0|||
145988330|NCT00806026|526471183|FG005|Overall Study|Death|0|||
145988331|NCT00806026|526471178|FG000|Overall Study|Did not meet entrance criteria|4|||
145988332|NCT00806026|526471179|FG001|Overall Study|Did not meet entrance criteria|1|||
145988333|NCT00806026|526471180|FG002|Overall Study|Did not meet entrance criteria|2|||
145988334|NCT00806026|526471181|FG003|Overall Study|Did not meet entrance criteria|1|||
145988335|NCT00806026|526471182|FG004|Overall Study|Did not meet entrance criteria|0|||
145988336|NCT00806026|526471183|FG005|Overall Study|Did not meet entrance criteria|0|||
145988337|NCT00806026|526471178|FG000|Overall Study|Lack of Efficacy|5|||
145988338|NCT00806026|526471179|FG001|Overall Study|Lack of Efficacy|18|||
145988339|NCT00806026|526471180|FG002|Overall Study|Lack of Efficacy|13|||
145988340|NCT00806026|526471181|FG003|Overall Study|Lack of Efficacy|4|||
145988341|NCT00806026|526471182|FG004|Overall Study|Lack of Efficacy|8|||
145988342|NCT00806026|526471183|FG005|Overall Study|Lack of Efficacy|7|||
145988343|NCT00806026|526471178|FG000|Overall Study|Lost to Follow-up|8|||
145988344|NCT00806026|526471179|FG001|Overall Study|Lost to Follow-up|15|||
145988345|NCT00806026|526471180|FG002|Overall Study|Lost to Follow-up|8|||
145988346|NCT00806026|526471181|FG003|Overall Study|Lost to Follow-up|2|||
145988347|NCT00806026|526471182|FG004|Overall Study|Lost to Follow-up|6|||
145988348|NCT00806026|526471183|FG005|Overall Study|Lost to Follow-up|6|||
145988349|NCT00806026|526471178|FG000|Overall Study|Withdrawal by Subject|14|||
145988350|NCT00806026|526471179|FG001|Overall Study|Withdrawal by Subject|17|||
145988351|NCT00806026|526471180|FG002|Overall Study|Withdrawal by Subject|9|||
145988352|NCT00806026|526471181|FG003|Overall Study|Withdrawal by Subject|2|||
145988353|NCT00806026|526471182|FG004|Overall Study|Withdrawal by Subject|5|||
145988354|NCT00806026|526471183|FG005|Overall Study|Withdrawal by Subject|3|||
145988355|NCT00806026|526471178|FG000|Overall Study|Other|3|||
145988356|NCT00806026|526471179|FG001|Overall Study|Other|6|||
145988357|NCT00806026|526471180|FG002|Overall Study|Other|8|||
145988358|NCT00806026|526471181|FG003|Overall Study|Other|2|||
145988359|NCT00806026|526471182|FG004|Overall Study|Other|0|||
145988360|NCT00806026|526471183|FG005|Overall Study|Other|4|||
145988361|NCT00806026|526471178|FG000|Overall Study|Protocol Violation|6|||
145988362|NCT00806026|526471179|FG001|Overall Study|Protocol Violation|9|||
145988363|NCT00806026|526471180|FG002|Overall Study|Protocol Violation|9|||
145988364|NCT00806026|526471181|FG003|Overall Study|Protocol Violation|0|||
145988365|NCT00806026|526471182|FG004|Overall Study|Protocol Violation|2|||
145988366|NCT00806026|526471183|FG005|Overall Study|Protocol Violation|3|||
145988367|NCT00806026|526471178|FG000|Overall Study|Adverse Event|52|||
145988368|NCT00806026|526471179|FG001|Overall Study|Adverse Event|35|||
145988369|NCT00806026|526471180|FG002|Overall Study|Adverse Event|44|||
145988370|NCT00806026|526471181|FG003|Overall Study|Adverse Event|17|||
145988371|NCT00806026|526471182|FG004|Overall Study|Adverse Event|9|||
145988372|NCT00806026|526471183|FG005|Overall Study|Adverse Event|9|||
145988373|NCT00489359|526471186|FG000|Overall Study|Death|0|||
145988374|NCT00489359|526471187|FG001|Overall Study|Death|2|||
145988375|NCT00489359|526471186|FG000|Overall Study|Progressive Disease|5|||
145988376|NCT00489359|526471187|FG001|Overall Study|Progressive Disease|6|||
145988377|NCT00489359|526471186|FG000|Overall Study|Lost to Follow-up|1|||
145988378|NCT00489359|526471187|FG001|Overall Study|Lost to Follow-up|0|||
145988379|NCT00489359|526471186|FG000|Overall Study|Withdrawal by Subject|1|||
145988380|NCT00489359|526471187|FG001|Overall Study|Withdrawal by Subject|5|||
145988381|NCT00489359|526471186|FG000|Overall Study|Adverse Event|0|||
145988382|NCT00489359|526471187|FG001|Overall Study|Adverse Event|16|||
145988383|NCT01260311|526471189|FG000|Overall Study|Adverse Event|11|||
145988384|NCT01260311|526471189|FG000|Overall Study|Lack of Efficacy|4|||
145988385|NCT01260311|526471189|FG000|Overall Study|Lost to Follow-up|25|||
145988386|NCT01260311|526471189|FG000|Overall Study|Withdrawal by Subject|6|||
145988387|NCT01260311|526471189|FG000|Overall Study|Financial Constraints|77|||
145988388|NCT01260311|526471189|FG000|Overall Study|Gone to Province|2|||
145988389|NCT01260311|526471189|FG000|Overall Study|Medication Stopped|1|||
145988390|NCT01260311|526471189|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
145988391|NCT01903733|526471192|FG000|Overall Study|Death|23|||
145988392|NCT01903733|526471193|FG001|Overall Study|Death|54|||
145988393|NCT01903733|526471194|FG002|Overall Study|Death|30|||
145988394|NCT01903733|526471195|FG003|Overall Study|Death|98|||
145988395|NCT01903733|526471192|FG000|Overall Study|Participant refused further follow-up|35|||
145988396|NCT01903733|526471193|FG001|Overall Study|Participant refused further follow-up|38|||
145988397|NCT01903733|526471194|FG002|Overall Study|Participant refused further follow-up|13|||
145988398|NCT01903733|526471195|FG003|Overall Study|Participant refused further follow-up|9|||
145988399|NCT01903733|526471192|FG000|Overall Study|Lost to Follow-up|18|||
145988400|NCT01903733|526471193|FG001|Overall Study|Lost to Follow-up|19|||
145988401|NCT01903733|526471194|FG002|Overall Study|Lost to Follow-up|6|||
145988402|NCT01903733|526471195|FG003|Overall Study|Lost to Follow-up|9|||
145988403|NCT01903733|526471192|FG000|Overall Study|Other|10|||
145988404|NCT01903733|526471193|FG001|Overall Study|Other|15|||
145988405|NCT01903733|526471194|FG002|Overall Study|Other|12|||
145988406|NCT01903733|526471195|FG003|Overall Study|Other|3|||
146091463|NCT00559754|526856828|FG000|Overall Study|Protocol Violation|1|||
145988407|NCT01903733|526471192|FG000|Overall Study|Missing|2|||
145988408|NCT01903733|526471193|FG001|Overall Study|Missing|0|||
145988409|NCT01903733|526471194|FG002|Overall Study|Missing|0|||
145988410|NCT01903733|526471195|FG003|Overall Study|Missing|0|||
145988411|NCT01903733|526471192|FG000|Overall Study|Investigator request|18|||
145988412|NCT01903733|526471193|FG001|Overall Study|Investigator request|0|||
145988413|NCT01903733|526471194|FG002|Overall Study|Investigator request|0|||
145988414|NCT01903733|526471195|FG003|Overall Study|Investigator request|0|||
145988415|NCT01714063|526471196|FG000|Overall Study|Equipment malfunction|2|||
145988416|NCT03878602|526471197|FG000|Overall Study|cord blood donation|7|||
145988417|NCT03878602|526471198|FG001|Overall Study|cord blood donation|1|||
145988418|NCT03878602|526471197|FG000|Overall Study|incomplete data collection|2|||
145988419|NCT03878602|526471198|FG001|Overall Study|incomplete data collection|0|||
145988420|NCT02191397|526471200|FG000|Overall Study|Adverse Event|28|||
145988421|NCT02191397|526471201|FG001|Overall Study|Adverse Event|17|||
145988422|NCT02191397|526471200|FG000|Overall Study|Lack of Efficacy|10|||
145988423|NCT02191397|526471201|FG001|Overall Study|Lack of Efficacy|5|||
145988424|NCT02191397|526471200|FG000|Overall Study|Protocol Violation|0|||
145988425|NCT02191397|526471201|FG001|Overall Study|Protocol Violation|3|||
145988426|NCT02191397|526471200|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
145988427|NCT02191397|526471201|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
145988428|NCT02191397|526471200|FG000|Overall Study|Lost to Follow-up|10|||
146091464|NCT00559754|526856828|FG000|Overall Study|Investigator criteria|2|||
146091465|NCT00559754|526856828|FG000|Overall Study|Withdrawal by Subject|2|||
146091466|NCT01264016|526856829|FG000|Overall Study|Withdrawal by Subject|1|||
146091467|NCT01264016|526856829|FG000|Overall Study|Felt faint at sight of blood|1|||
146091468|NCT01629706|526856830|FG000|Phase 1 PureVision|Screen Failure|4|||
146091469|NCT01629706|526856830|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
146091470|NCT01629706|526856830|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
146091471|NCT01629706|526856830|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
145988429|NCT02191397|526471201|FG001|Overall Study|Lost to Follow-up|11|||
145988430|NCT02191397|526471200|FG000|Overall Study|Physician Decision|8|||
145988431|NCT02191397|526471201|FG001|Overall Study|Physician Decision|3|||
146091472|NCT01629706|526856830|FG000|Phase 2 Habitual|Screen Failure|6|||
145988432|NCT02191397|526471200|FG000|Overall Study|Withdrawal by Subject|22|||
145988433|NCT02191397|526471201|FG001|Overall Study|Withdrawal by Subject|27|||
145988434|NCT03721107|526471204|FG000|Overall Study|Adverse Event|1|||
145988435|NCT03721107|526471205|FG001|Overall Study|Adverse Event|1|||
145988436|NCT03721107|526471206|FG002|Overall Study|Adverse Event|6|||
145988437|NCT03721107|526471207|FG003|Overall Study|Adverse Event|5|||
145988438|NCT03721107|526471204|FG000|Overall Study|Lost to Follow-up|2|||
145988439|NCT03721107|526471205|FG001|Overall Study|Lost to Follow-up|0|||
145988440|NCT03721107|526471206|FG002|Overall Study|Lost to Follow-up|3|||
145988441|NCT03721107|526471207|FG003|Overall Study|Lost to Follow-up|0|||
145988442|NCT03721107|526471204|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145988443|NCT03721107|526471205|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145988444|NCT03721107|526471206|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145988445|NCT03721107|526471207|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
145988446|NCT03721107|526471204|FG000|Overall Study|Physician Decision|0|||
145988447|NCT03721107|526471205|FG001|Overall Study|Physician Decision|1|||
145988448|NCT03721107|526471206|FG002|Overall Study|Physician Decision|0|||
145988449|NCT03721107|526471207|FG003|Overall Study|Physician Decision|0|||
145988450|NCT03721107|526471204|FG000|Overall Study|Pregnancy|0|||
145988451|NCT03721107|526471205|FG001|Overall Study|Pregnancy|0|||
145988452|NCT03721107|526471206|FG002|Overall Study|Pregnancy|1|||
145988453|NCT03721107|526471207|FG003|Overall Study|Pregnancy|0|||
145988454|NCT03721107|526471204|FG000|Overall Study|Withdrawal by Subject|1|||
145988455|NCT03721107|526471205|FG001|Overall Study|Withdrawal by Subject|1|||
145988456|NCT03721107|526471206|FG002|Overall Study|Withdrawal by Subject|5|||
145988457|NCT03721107|526471207|FG003|Overall Study|Withdrawal by Subject|5|||
145988458|NCT03721107|526471204|FG000|Overall Study|Other|1|||
145988459|NCT03721107|526471205|FG001|Overall Study|Other|0|||
145988460|NCT03721107|526471206|FG002|Overall Study|Other|0|||
145988461|NCT03721107|526471207|FG003|Overall Study|Other|1|||
145988462|NCT02294019|526471208|FG000|Overall Study|Adverse Event|2|||
145988463|NCT02294019|526471208|FG000|Overall Study|Protocol Violation|68|||
145988464|NCT02294019|526471208|FG000|Overall Study|Lost to Follow-up|31|||
145988465|NCT02294019|526471208|FG000|Overall Study|Other|1|||
145988466|NCT02294019|526471208|FG000|Overall Study|Withdrawal by Subject|1|||
145988467|NCT06048705|526471217|FG000|Overall Study|Physician Decision|1|||
145988468|NCT06048705|526471218|FG001|Overall Study|Physician Decision|0|||
145988469|NCT06048705|526471219|FG002|Overall Study|Physician Decision|0|||
145988470|NCT06048705|526471217|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
145988471|NCT06048705|526471218|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
145988472|NCT06048705|526471219|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
145988473|NCT06048705|526471217|FG000|Overall Study|Death prior to lymphodepletion|0|||
145988474|NCT06048705|526471218|FG001|Overall Study|Death prior to lymphodepletion|0|||
145988475|NCT06048705|526471219|FG002|Overall Study|Death prior to lymphodepletion|1|||
145988476|NCT02971137|526471220|FG000|Overall Study|Lost to Follow-up|44|||
145988477|NCT02971137|526471221|FG001|Overall Study|Lost to Follow-up|56|||
145988478|NCT00215657|526471222|FG000|Overall Study|Adverse Event|5|||
145988479|NCT00215657|526471223|FG001|Overall Study|Adverse Event|1|||
145988480|NCT00215657|526471224|FG002|Overall Study|Adverse Event|3|||
145988481|NCT00215657|526471225|FG003|Overall Study|Adverse Event|0|||
145988482|NCT00215657|526471226|FG004|Overall Study|Adverse Event|3|||
145988483|NCT00215657|526471227|FG005|Overall Study|Adverse Event|1|||
145988484|NCT00215657|526471228|FG006|Overall Study|Adverse Event|0|||
145988485|NCT00215657|526471229|FG007|Overall Study|Adverse Event|3|||
145988486|NCT00215657|526471222|FG000|Overall Study|Withdrawal by Subject|6|||
145988487|NCT00215657|526471223|FG001|Overall Study|Withdrawal by Subject|3|||
145988488|NCT00215657|526471224|FG002|Overall Study|Withdrawal by Subject|3|||
145988489|NCT00215657|526471225|FG003|Overall Study|Withdrawal by Subject|1|||
145988490|NCT00215657|526471226|FG004|Overall Study|Withdrawal by Subject|6|||
145988491|NCT00215657|526471227|FG005|Overall Study|Withdrawal by Subject|1|||
145988492|NCT00215657|526471228|FG006|Overall Study|Withdrawal by Subject|10|||
145988493|NCT00215657|526471229|FG007|Overall Study|Withdrawal by Subject|3|||
145988494|NCT00215657|526471222|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
145988495|NCT00215657|526471223|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
145988496|NCT00215657|526471224|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
145988497|NCT00215657|526471225|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
145988498|NCT00215657|526471226|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
145988499|NCT00215657|526471227|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
145988500|NCT00215657|526471228|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
145988501|NCT00215657|526471229|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
145988502|NCT00215657|526471222|FG000|Overall Study|Insufficient testosterone response|5|||
145988503|NCT00215657|526471223|FG001|Overall Study|Insufficient testosterone response|4|||
145988504|NCT00215657|526471224|FG002|Overall Study|Insufficient testosterone response|1|||
145988505|NCT00215657|526471225|FG003|Overall Study|Insufficient testosterone response|12|||
145988506|NCT00215657|526471226|FG004|Overall Study|Insufficient testosterone response|8|||
145988507|NCT00215657|526471227|FG005|Overall Study|Insufficient testosterone response|12|||
145988508|NCT00215657|526471228|FG006|Overall Study|Insufficient testosterone response|4|||
145988509|NCT00215657|526471229|FG007|Overall Study|Insufficient testosterone response|7|||
145988510|NCT00215657|526471222|FG000|Overall Study|Other|3|||
145988511|NCT00215657|526471223|FG001|Overall Study|Other|1|||
145988512|NCT00215657|526471224|FG002|Overall Study|Other|2|||
145988513|NCT00215657|526471225|FG003|Overall Study|Other|3|||
145988514|NCT00215657|526471226|FG004|Overall Study|Other|5|||
145988515|NCT00215657|526471227|FG005|Overall Study|Other|4|||
145988516|NCT00215657|526471228|FG006|Overall Study|Other|6|||
145988517|NCT00215657|526471229|FG007|Overall Study|Other|1|||
145988518|NCT02614066|526471230|FG000|Overall Study|Death|6|||
145988519|NCT02614066|526471231|FG001|Overall Study|Death|14|||
145988520|NCT02614066|526471232|FG002|Overall Study|Death|11|||
145988521|NCT02614066|526471233|FG003|Overall Study|Death|29|||
145988522|NCT02614066|526471230|FG000|Overall Study|Full consent withdrawn|0|||
145988523|NCT02614066|526471231|FG001|Overall Study|Full consent withdrawn|1|||
146091473|NCT01629706|526856830|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
146091474|NCT01629706|526856830|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
146091475|NCT01629706|526856830|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
146091476|NCT01629706|526856830|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
146091477|NCT02117414|526856831|FG000|Overall Study|Death|5|||
145988524|NCT02614066|526471232|FG002|Overall Study|Full consent withdrawn|0|||
145988525|NCT02614066|526471233|FG003|Overall Study|Full consent withdrawn|8|||
145988526|NCT02614066|526471230|FG000|Overall Study|Lost to Follow-up|0|||
145988527|NCT02614066|526471231|FG001|Overall Study|Lost to Follow-up|2|||
145988528|NCT02614066|526471232|FG002|Overall Study|Lost to Follow-up|2|||
145988529|NCT02614066|526471233|FG003|Overall Study|Lost to Follow-up|2|||
145988530|NCT02614066|526471230|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
145988531|NCT02614066|526471231|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
145988532|NCT02614066|526471232|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
145988533|NCT02614066|526471233|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
145988534|NCT02614066|526471230|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
145988535|NCT02614066|526471231|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
145988536|NCT02614066|526471232|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
145988537|NCT02614066|526471233|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
145988538|NCT02614066|526471230|FG000|Overall Study|Reason not specified|0|||
145988539|NCT02614066|526471231|FG001|Overall Study|Reason not specified|2|||
145988540|NCT02614066|526471232|FG002|Overall Study|Reason not specified|1|||
145988541|NCT02614066|526471233|FG003|Overall Study|Reason not specified|1|||
145988542|NCT00968968|526471236|FG000|Overall Study|Study closed/terminated|10|||
145988543|NCT00968968|526471237|FG001|Overall Study|Study closed/terminated|10|||
145988544|NCT00968968|526471236|FG000|Overall Study|Protocol defined stopping criteria|3|||
145988545|NCT00968968|526471237|FG001|Overall Study|Protocol defined stopping criteria|1|||
145988546|NCT00968968|526471236|FG000|Overall Study|Withdrawal by Subject|2|||
145988547|NCT00968968|526471237|FG001|Overall Study|Withdrawal by Subject|0|||
145988548|NCT00968968|526471236|FG000|Overall Study|Physician Decision|1|||
145988549|NCT00968968|526471237|FG001|Overall Study|Physician Decision|2|||
145988550|NCT00968968|526471236|FG000|Overall Study|Lost to Follow-up|0|||
145988551|NCT00968968|526471237|FG001|Overall Study|Lost to Follow-up|1|||
145988552|NCT01185366|526471238|FG000|First Line Therapy|Insurance Coverage Denied|1|||
145988553|NCT01185366|526471239|FG001|First Line Therapy|Insurance Coverage Denied|1|||
145988554|NCT01185366|526471238|FG000|First Line Therapy|Withdrawal by Subject|1|||
145988555|NCT01185366|526471239|FG001|First Line Therapy|Withdrawal by Subject|0|||
145988556|NCT01185366|526471238|FG000|First Line Therapy|Lack of Metastatic Site|1|||
145988557|NCT01185366|526471239|FG001|First Line Therapy|Lack of Metastatic Site|0|||
145988558|NCT01185366|526471238|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
145988559|NCT01185366|526471239|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
145988560|NCT01185366|526471238|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
145988561|NCT01185366|526471239|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
145988562|NCT01185366|526471238|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
145988563|NCT01185366|526471239|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
145988564|NCT01185366|526471238|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
145988565|NCT01185366|526471239|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
145988566|NCT00127933|526471246|FG000|Overall Study|Randomized but not dosed|1|||
145988567|NCT00127933|526471247|FG001|Overall Study|Randomized but not dosed|0|||
145988568|NCT01783938|526471253|FG000|Overall Study|Disease Progression|18|||
145988569|NCT01783938|526471254|FG001|Overall Study|Disease Progression|41|||
145988570|NCT01783938|526471253|FG000|Overall Study|Study Drug Toxicity|27|||
145988571|NCT01783938|526471254|FG001|Overall Study|Study Drug Toxicity|14|||
145988572|NCT01783938|526471253|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
145988573|NCT01783938|526471254|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
145988574|NCT01783938|526471253|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
145988575|NCT01783938|526471254|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
145988576|NCT01783938|526471253|FG000|Overall Study|Participant Withdrew Consent|2|||
145988577|NCT01783938|526471254|FG001|Overall Study|Participant Withdrew Consent|0|||
145988578|NCT01783938|526471253|FG000|Overall Study|Maximum Clinical Benefit|1|||
146091478|NCT02117414|526856832|FG001|Overall Study|Death|2|||
146245927|NCT02203513|527414115|FG000|Overall Study|Switched to alternative treatment|3|||
145988579|NCT01783938|526471254|FG001|Overall Study|Maximum Clinical Benefit|0|||
145988580|NCT01783938|526471253|FG000|Overall Study|Other Reasons|3|||
145988581|NCT01783938|526471254|FG001|Overall Study|Other Reasons|1|||
145988582|NCT03111732|526471258|FG000|Overall Study|Enrolled in different study|1|||
145988583|NCT03111732|526471258|FG000|Overall Study|Progressive disease|3|||
145988584|NCT03111732|526471258|FG000|Overall Study|Withdrawal by Subject|1|||
145988585|NCT03072875|526471259|FG000|Overall Study|Lost to Follow-up|1|||
146245928|NCT02203513|527414116|FG001|Overall Study|Switched to alternative treatment|4|||
146245929|NCT02203513|527414117|FG002|Overall Study|Switched to alternative treatment|0|||
146245930|NCT02203513|527414118|FG003|Overall Study|Switched to alternative treatment|0|||
146245931|NCT02203513|527414119|FG004|Overall Study|Switched to alternative treatment|4|||
145988586|NCT00401830|526471260|FG000|Overall Study|Adverse Event|10|||
145988587|NCT00401830|526471261|FG001|Overall Study|Adverse Event|18|||
145988588|NCT00401830|526471260|FG000|Overall Study|Lack of Efficacy|11|||
145988589|NCT00401830|526471261|FG001|Overall Study|Lack of Efficacy|5|||
145988590|NCT00401830|526471260|FG000|Overall Study|Withdrawal by Subject|4|||
145988591|NCT00401830|526471261|FG001|Overall Study|Withdrawal by Subject|3|||
145988592|NCT00401830|526471260|FG000|Overall Study|Protocol Violation|3|||
145988593|NCT00401830|526471261|FG001|Overall Study|Protocol Violation|3|||
145988594|NCT00401830|526471260|FG000|Overall Study|Non-compliance with drug study|1|||
145988595|NCT00401830|526471261|FG001|Overall Study|Non-compliance with drug study|0|||
145988596|NCT00401830|526471260|FG000|Overall Study|Lost to Follow-up|1|||
145988597|NCT00401830|526471261|FG001|Overall Study|Lost to Follow-up|3|||
145988598|NCT00401830|526471260|FG000|Overall Study|Other: Personal / Family problems|1|||
145988599|NCT00401830|526471261|FG001|Overall Study|Other: Personal / Family problems|0|||
145988600|NCT01943825|526471262|FG000|Overall Study|Lost to Follow-up|9|||
145988601|NCT01943825|526471263|FG001|Overall Study|Lost to Follow-up|3|||
145988602|NCT01943825|526471264|FG002|Overall Study|Lost to Follow-up|12|||
145988603|NCT01943825|526471265|FG003|Overall Study|Lost to Follow-up|8|||
145988604|NCT01943825|526471262|FG000|Overall Study|Withdrawal by Subject|1|||
145988605|NCT01943825|526471263|FG001|Overall Study|Withdrawal by Subject|0|||
145988606|NCT01943825|526471264|FG002|Overall Study|Withdrawal by Subject|3|||
145988607|NCT01943825|526471265|FG003|Overall Study|Withdrawal by Subject|2|||
145988608|NCT01943825|526471262|FG000|Overall Study|Other than specified above|0|||
145988609|NCT01943825|526471263|FG001|Overall Study|Other than specified above|1|||
145988610|NCT01943825|526471264|FG002|Overall Study|Other than specified above|0|||
145988611|NCT01943825|526471265|FG003|Overall Study|Other than specified above|1|||
145988612|NCT00452400|526471266|FG000|Overall Study|Adverse Event|1|||
145988613|NCT00452400|526471267|FG001|Overall Study|Adverse Event|1|||
145988614|NCT00452400|526471268|FG002|Overall Study|Adverse Event|5|||
145988615|NCT00452400|526471269|FG003|Overall Study|Adverse Event|0|||
145988616|NCT00452400|526471270|FG004|Overall Study|Adverse Event|2|||
145988617|NCT00452400|526471266|FG000|Overall Study|Protocol Violation|0|||
145988618|NCT00452400|526471267|FG001|Overall Study|Protocol Violation|0|||
145988619|NCT00452400|526471268|FG002|Overall Study|Protocol Violation|1|||
145988620|NCT00452400|526471269|FG003|Overall Study|Protocol Violation|0|||
145988621|NCT00452400|526471270|FG004|Overall Study|Protocol Violation|0|||
145988622|NCT00452400|526471266|FG000|Overall Study|Lost to Follow-up|1|||
145988623|NCT00452400|526471267|FG001|Overall Study|Lost to Follow-up|0|||
145988624|NCT00452400|526471268|FG002|Overall Study|Lost to Follow-up|0|||
145988625|NCT00452400|526471269|FG003|Overall Study|Lost to Follow-up|0|||
145988626|NCT00452400|526471270|FG004|Overall Study|Lost to Follow-up|0|||
145988627|NCT00452400|526471266|FG000|Overall Study|Withdrawal by Subject|1|||
145988628|NCT00452400|526471267|FG001|Overall Study|Withdrawal by Subject|0|||
145988629|NCT00452400|526471268|FG002|Overall Study|Withdrawal by Subject|1|||
145988630|NCT00452400|526471269|FG003|Overall Study|Withdrawal by Subject|0|||
145988631|NCT00452400|526471270|FG004|Overall Study|Withdrawal by Subject|0|||
145988632|NCT00452400|526471266|FG000|Overall Study|Lack of Efficacy|2|||
145988633|NCT00452400|526471267|FG001|Overall Study|Lack of Efficacy|0|||
145988634|NCT00452400|526471268|FG002|Overall Study|Lack of Efficacy|0|||
145988635|NCT00452400|526471269|FG003|Overall Study|Lack of Efficacy|0|||
145988636|NCT00452400|526471270|FG004|Overall Study|Lack of Efficacy|0|||
145988637|NCT00452400|526471266|FG000|Overall Study|Other reasons not listed above|0|||
145988638|NCT00452400|526471267|FG001|Overall Study|Other reasons not listed above|0|||
145988639|NCT00452400|526471268|FG002|Overall Study|Other reasons not listed above|0|||
145988640|NCT00452400|526471269|FG003|Overall Study|Other reasons not listed above|1|||
146245932|NCT02203513|527414115|FG000|Overall Study|Did not receive investigational product (IP)|0|||
145988641|NCT00452400|526471270|FG004|Overall Study|Other reasons not listed above|1|||
145988642|NCT01539525|526471275|FG000|Overall Study|Lost to Follow-up|19|||
145988643|NCT01539525|526471276|FG001|Overall Study|Lost to Follow-up|12|||
145988644|NCT01539525|526471277|FG002|Overall Study|Lost to Follow-up|11|||
145988645|NCT01539525|526471275|FG000|Overall Study|Withdrawal by Subject|0|||
145988646|NCT01539525|526471276|FG001|Overall Study|Withdrawal by Subject|3|||
145988647|NCT01539525|526471277|FG002|Overall Study|Withdrawal by Subject|2|||
145988648|NCT01539525|526471275|FG000|Overall Study|Protocol Violation|1|||
145988649|NCT01539525|526471276|FG001|Overall Study|Protocol Violation|1|||
145988650|NCT01539525|526471277|FG002|Overall Study|Protocol Violation|4|||
145988651|NCT02205359|526471279|FG000|Overall Study|Death|293|||
145988652|NCT02205359|526471280|FG001|Overall Study|Death|327|||
145988653|NCT02205359|526471279|FG000|Overall Study|Lost to Follow-up|182|||
145988654|NCT02205359|526471280|FG001|Overall Study|Lost to Follow-up|162|||
145988655|NCT02205359|526471279|FG000|Overall Study|Physician Decision|51|||
145988656|NCT02205359|526471280|FG001|Overall Study|Physician Decision|53|||
145988657|NCT02205359|526471279|FG000|Overall Study|Withdrawal by Subject|167|||
145988658|NCT02205359|526471280|FG001|Overall Study|Withdrawal by Subject|169|||
145988659|NCT02792257|526471283|FG000|Overall Study|Lost to Follow-up|3|||
145988660|NCT02792257|526471284|FG001|Overall Study|Lost to Follow-up|4|||
145988661|NCT02792257|526471283|FG000|Overall Study|Allergy|0|||
145988662|NCT02792257|526471284|FG001|Overall Study|Allergy|1|||
145988663|NCT02792257|526471283|FG000|Overall Study|Protocol Violation|2|||
145988664|NCT02792257|526471284|FG001|Overall Study|Protocol Violation|0|||
145988665|NCT02792257|526471283|FG000|Overall Study|Excessive Agitation|0|||
145988666|NCT02792257|526471284|FG001|Overall Study|Excessive Agitation|1|||
145988667|NCT02792257|526471283|FG000|Overall Study|Not Feeling Well|0|||
145988668|NCT02792257|526471284|FG001|Overall Study|Not Feeling Well|1|||
145988669|NCT00553475|526471285|FG000|Overall Study|Adverse Event|7|||
145988670|NCT00553475|526471286|FG001|Overall Study|Adverse Event|17|||
145988671|NCT00553475|526471287|FG002|Overall Study|Adverse Event|13|||
145988672|NCT00553475|526471285|FG000|Overall Study|Lack of Efficacy|7|||
145988673|NCT00553475|526471286|FG001|Overall Study|Lack of Efficacy|1|||
145988674|NCT00553475|526471287|FG002|Overall Study|Lack of Efficacy|0|||
145988675|NCT00553475|526471285|FG000|Overall Study|Withdrawal by Subject|1|||
145988676|NCT00553475|526471286|FG001|Overall Study|Withdrawal by Subject|1|||
145988677|NCT00553475|526471287|FG002|Overall Study|Withdrawal by Subject|0|||
145988678|NCT00553475|526471285|FG000|Overall Study|Physician Decision|1|||
145988679|NCT00553475|526471286|FG001|Overall Study|Physician Decision|0|||
145988680|NCT00553475|526471287|FG002|Overall Study|Physician Decision|0|||
145988681|NCT00553475|526471285|FG000|Overall Study|Due to moving|0|||
145988682|NCT00553475|526471286|FG001|Overall Study|Due to moving|1|||
145988683|NCT00553475|526471287|FG002|Overall Study|Due to moving|0|||
145988684|NCT01623154|526471288|FG000|Overall Study|Did not drink Pranactin Citric|4|||
145988685|NCT03810495|526471289|FG000|Overall Study|Lost to Follow-up|2|||
145988686|NCT03810495|526471289|FG000|Overall Study|Withdrawal by Subject|1|||
145988687|NCT00107614|526473262|FG000|Overall Study|Physician Decision|10|||
145988688|NCT00107614|526473262|FG000|Overall Study|Death|2|||
145988689|NCT00449787|526473265|FG000|Overall Study|Lost to Follow-up|10|||
145988690|NCT00449787|526473266|FG001|Overall Study|Lost to Follow-up|8|||
145988691|NCT00449787|526473265|FG000|Overall Study|Did not require medication|95|||
145988692|NCT00449787|526473266|FG001|Overall Study|Did not require medication|92|||
145988693|NCT01633112|526473267|FG000|Overall Study|Lack of Efficacy|1|||
145988694|NCT01633112|526473268|FG001|Overall Study|Lack of Efficacy|6|||
145988695|NCT01633112|526473269|FG002|Overall Study|Lack of Efficacy|13|||
145988696|NCT01633112|526473267|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145988697|NCT01633112|526473268|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145988698|NCT01633112|526473269|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145988699|NCT01633112|526473267|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145988700|NCT01633112|526473268|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145988701|NCT01633112|526473269|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145988702|NCT01633112|526473267|FG000|Overall Study|Administrative problems|1|||
145988703|NCT01633112|526473268|FG001|Overall Study|Administrative problems|2|||
145988704|NCT01633112|526473269|FG002|Overall Study|Administrative problems|5|||
145988705|NCT01633112|526473267|FG000|Overall Study|Adverse Event|16|||
145988706|NCT01633112|526473268|FG001|Overall Study|Adverse Event|18|||
145988707|NCT01633112|526473269|FG002|Overall Study|Adverse Event|20|||
145988708|NCT01633112|526473267|FG000|Overall Study|Lost to Follow-up|7|||
145988709|NCT01633112|526473268|FG001|Overall Study|Lost to Follow-up|19|||
145988710|NCT01633112|526473269|FG002|Overall Study|Lost to Follow-up|6|||
145988711|NCT01633112|526473267|FG000|Overall Study|Protocol Violation|4|||
145988712|NCT01633112|526473268|FG001|Overall Study|Protocol Violation|0|||
145988713|NCT01633112|526473269|FG002|Overall Study|Protocol Violation|2|||
146091479|NCT02117414|526856831|FG000|Overall Study|Withdrawal by Subject|10|||
146091480|NCT02117414|526856832|FG001|Overall Study|Withdrawal by Subject|4|||
146091481|NCT02537574|526856833|FG000|Overall Study|Adverse Event|1|||
146091482|NCT02537574|526856834|FG001|Overall Study|Adverse Event|3|||
146091483|NCT02537574|526856835|FG002|Overall Study|Adverse Event|2|||
146091484|NCT02537574|526856833|FG000|Overall Study|Lost to Follow-up|40|||
145988714|NCT01633112|526473267|FG000|Overall Study|Subject no longer requires study drug|0|||
145988715|NCT01633112|526473268|FG001|Overall Study|Subject no longer requires study drug|0|||
145988716|NCT01633112|526473269|FG002|Overall Study|Subject no longer requires study drug|1|||
145988717|NCT01633112|526473267|FG000|Overall Study|Withdrawal by Subject|20|||
145988718|NCT01633112|526473268|FG001|Overall Study|Withdrawal by Subject|12|||
145988719|NCT01633112|526473269|FG002|Overall Study|Withdrawal by Subject|41|||
145988720|NCT01633112|526473267|FG000|Overall Study|missing Study Completion CRF|1|||
145988721|NCT01633112|526473268|FG001|Overall Study|missing Study Completion CRF|1|||
145988722|NCT01633112|526473269|FG002|Overall Study|missing Study Completion CRF|4|||
145988723|NCT01959919|526473270|FG000|Overall Study|Did not meet the eligibility criteria|2|||
145988724|NCT03439072|526473271|FG000|Overall Study|Withdrawal by Subject|2|||
145988725|NCT03439072|526473272|FG001|Overall Study|Withdrawal by Subject|3|||
145988726|NCT03439072|526473271|FG000|Overall Study|Physician Decision|0|||
145988727|NCT03439072|526473272|FG001|Overall Study|Physician Decision|1|||
145988728|NCT02094885|526473274|FG000|Overall Study|Death|1|||
145988729|NCT02094885|526473275|FG001|Overall Study|Death|5|||
145988730|NCT02094885|526473274|FG000|Overall Study|Withdrawn due to age|1|||
145988731|NCT02094885|526473275|FG001|Overall Study|Withdrawn due to age|0|||
145988732|NCT02003898|526473276|FG000|Overall Study|Death|3|||
145988733|NCT02003898|526473276|FG000|Overall Study|Lost to Follow-up|12|||
145988734|NCT02003898|526473276|FG000|Overall Study|Withdrawal by Subject|52|||
145988735|NCT01537432|526473277|FG000|Overall Study|Lost to Follow-up|3|||
145988736|NCT01537432|526473278|FG001|Overall Study|Lost to Follow-up|1|||
145988737|NCT01537432|526473277|FG000|Overall Study|Withdrawal by Subject|0|||
145988738|NCT01537432|526473278|FG001|Overall Study|Withdrawal by Subject|1|||
145988739|NCT01537432|526473277|FG000|Overall Study|Administrative problems|1|||
145988740|NCT01537432|526473278|FG001|Overall Study|Administrative problems|0|||
145988741|NCT01537432|526473277|FG000|Overall Study|Adverse Event|1|||
145988742|NCT01537432|526473278|FG001|Overall Study|Adverse Event|0|||
145988743|NCT01537432|526473277|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145988744|NCT01537432|526473278|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145988745|NCT05166902|526473279|FG000|First Intervention|Lost to Follow-up|0|||
145988746|NCT05166902|526473280|FG001|First Intervention|Lost to Follow-up|1|||
145988747|NCT01998477|526473281|FG000|Overall Study|Lost to Follow-up|4|||
145988748|NCT01998477|526473282|FG001|Overall Study|Lost to Follow-up|5|||
145988749|NCT01998477|526473281|FG000|Overall Study|Withdrawal by Subject|6|||
145988750|NCT01998477|526473282|FG001|Overall Study|Withdrawal by Subject|0|||
145988751|NCT00779909|526473283|FG000|Overall Study|Lost to Follow-up|1|||
145988752|NCT00779909|526473284|FG001|Overall Study|Lost to Follow-up|0|||
145988753|NCT00779909|526473285|FG002|Overall Study|Lost to Follow-up|0|||
145988754|NCT00779909|526473286|FG003|Overall Study|Lost to Follow-up|1|||
145988755|NCT00779909|526473283|FG000|Overall Study|Withdrawal by Subject|0|||
145988756|NCT00779909|526473284|FG001|Overall Study|Withdrawal by Subject|1|||
145988757|NCT00779909|526473285|FG002|Overall Study|Withdrawal by Subject|0|||
145988758|NCT00779909|526473286|FG003|Overall Study|Withdrawal by Subject|0|||
145988759|NCT00128492|526473287|FG000|Overall Study|AE unrelated to study|2|||
145988760|NCT00128492|526473288|FG001|Overall Study|AE unrelated to study|9|||
145988761|NCT00128492|526473287|FG000|Overall Study|Study drug intolerance (AE)|2|||
145988762|NCT00128492|526473288|FG001|Overall Study|Study drug intolerance (AE)|8|||
145988763|NCT00128492|526473287|FG000|Overall Study|AE related to study|1|||
145988764|NCT00128492|526473288|FG001|Overall Study|AE related to study|4|||
145988765|NCT00128492|526473287|FG000|Overall Study|Death|1|||
145988766|NCT00128492|526473288|FG001|Overall Study|Death|0|||
145988767|NCT00128492|526473287|FG000|Overall Study|Lost to Follow-up|1|||
145988768|NCT00128492|526473288|FG001|Overall Study|Lost to Follow-up|5|||
145988769|NCT00128492|526473287|FG000|Overall Study|Noncompliance|0|||
145988770|NCT00128492|526473288|FG001|Overall Study|Noncompliance|5|||
145988771|NCT00128492|526473287|FG000|Overall Study|Personal or administrative|10|||
145988772|NCT00128492|526473288|FG001|Overall Study|Personal or administrative|22|||
145988773|NCT00128492|526473287|FG000|Overall Study|Withdrawal by Subject|3|||
145988774|NCT00128492|526473288|FG001|Overall Study|Withdrawal by Subject|5|||
145988775|NCT00128492|526473287|FG000|Overall Study|Pregnancy|0|||
145988776|NCT00128492|526473288|FG001|Overall Study|Pregnancy|1|||
145988777|NCT01104870|526473289|FG000|Overall Study|Adverse Event|1|||
145988778|NCT01104870|526473290|FG001|Overall Study|Adverse Event|1|||
145988779|NCT01104870|526473291|FG002|Overall Study|Adverse Event|0|||
145988780|NCT01104870|526473289|FG000|Overall Study|Death|0|||
145988781|NCT01104870|526473290|FG001|Overall Study|Death|0|||
145988782|NCT01104870|526473291|FG002|Overall Study|Death|1|||
145988783|NCT01104870|526473289|FG000|Overall Study|Withdrawal by Subject|0|||
145988784|NCT01104870|526473290|FG001|Overall Study|Withdrawal by Subject|0|||
145988785|NCT01104870|526473291|FG002|Overall Study|Withdrawal by Subject|1|||
145988786|NCT02150863|526473292|FG000|Overall Study|Lost to Follow-up|0|||
145988787|NCT02150863|526473293|FG001|Overall Study|Lost to Follow-up|1|||
145988788|NCT02150863|526473294|FG002|Overall Study|Lost to Follow-up|0|||
145988789|NCT00835549|526473297|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
145988790|NCT00835549|526473298|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145988791|NCT00835042|526473299|FG000|First Intervention|Withdrawal by Subject|3|||
145988792|NCT00835042|526473300|FG001|First Intervention|Withdrawal by Subject|0|||
145988793|NCT00835042|526473299|FG000|First Intervention|Adverse Event|1|||
145988794|NCT00835042|526473300|FG001|First Intervention|Adverse Event|2|||
145988795|NCT00835042|526473299|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
145988796|NCT00835042|526473300|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
145988797|NCT04008069|526473301|FG000|Open-Label Period|Adverse Event|1|||
145988798|NCT04008069|526473302|FG001|Open-Label Period|Adverse Event|0|||
145988799|NCT04008069|526473303|FG002|Open-Label Period|Adverse Event|0|||
145988800|NCT04008069|526473301|FG000|Open-Label Period|Lack of Efficacy|4|||
145988801|NCT04008069|526473302|FG001|Open-Label Period|Lack of Efficacy|0|||
145988802|NCT04008069|526473303|FG002|Open-Label Period|Lack of Efficacy|0|||
145988803|NCT04008069|526473301|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
145988804|NCT04008069|526473302|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
145988805|NCT04008069|526473303|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
145988806|NCT04008069|526473301|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
145988807|NCT04008069|526473302|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
145988808|NCT04008069|526473303|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
145988809|NCT00511199|526473304|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
145988810|NCT00511199|526473305|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
145988811|NCT00511199|526473304|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
145988812|NCT00511199|526473305|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
145988813|NCT00511199|526473304|FG000|Overall Study|Withdrawal of Informed Consent|19|||
145988814|NCT00511199|526473305|FG001|Overall Study|Withdrawal of Informed Consent|4|||
145988815|NCT00511199|526473304|FG000|Overall Study|Pregnancy|6|||
145988816|NCT00511199|526473305|FG001|Overall Study|Pregnancy|3|||
145988817|NCT00511199|526473304|FG000|Overall Study|Pregnancy Wish|16|||
145988818|NCT00511199|526473305|FG001|Overall Study|Pregnancy Wish|8|||
145988819|NCT00511199|526473304|FG000|Overall Study|Lost to Follow-up|40|||
145988820|NCT00511199|526473305|FG001|Overall Study|Lost to Follow-up|17|||
145988821|NCT00511199|526473304|FG000|Overall Study|Other Reason|78|||
145988822|NCT00511199|526473305|FG001|Overall Study|Other Reason|37|||
145988823|NCT02571244|526473310|FG000|Overall Study|Lost to Follow-up|0|||
145988824|NCT02571244|526473311|FG001|Overall Study|Lost to Follow-up|1|||
145988825|NCT02571244|526473310|FG000|Overall Study|Unable to reach out post discharge|3|||
145988826|NCT02571244|526473311|FG001|Overall Study|Unable to reach out post discharge|0|||
145988827|NCT01687595|526473312|FG000|Overall Study|Withdrawal by Subject|8|||
145988828|NCT01687595|526473313|FG001|Overall Study|Withdrawal by Subject|0|||
145988829|NCT01687595|526473312|FG000|Overall Study|Lost to Follow-up|3|||
145988830|NCT01687595|526473313|FG001|Overall Study|Lost to Follow-up|1|||
145988831|NCT01687595|526473312|FG000|Overall Study|Investigator's decision|1|||
145988832|NCT01687595|526473313|FG001|Overall Study|Investigator's decision|0|||
145988833|NCT01687595|526473312|FG000|Overall Study|Sponsor's decision|1|||
145988834|NCT01687595|526473313|FG001|Overall Study|Sponsor's decision|0|||
145988835|NCT01687595|526473312|FG000|Overall Study|Noncompliance|1|||
145988836|NCT01687595|526473313|FG001|Overall Study|Noncompliance|2|||
145988837|NCT01687595|526473312|FG000|Overall Study|Other than specified|56|||
145988838|NCT01687595|526473313|FG001|Overall Study|Other than specified|7|||
145988839|NCT03180138|526473314|FG000|Overall Study|Mobile-phone could not be verified|2|||
145988840|NCT03180138|526473315|FG001|Overall Study|Mobile-phone could not be verified|13|||
145988841|NCT03180138|526473316|FG002|Overall Study|Mobile-phone could not be verified|15|||
145988842|NCT03180138|526473314|FG000|Overall Study|No prior immunization records|17|||
145988843|NCT03180138|526473315|FG001|Overall Study|No prior immunization records|0|||
145988844|NCT03180138|526473316|FG002|Overall Study|No prior immunization records|6|||
145988845|NCT03180138|526473314|FG000|Overall Study|Found to be >24 mon after randomization|3|||
145988846|NCT03180138|526473315|FG001|Overall Study|Found to be >24 mon after randomization|0|||
145988847|NCT03180138|526473316|FG002|Overall Study|Found to be >24 mon after randomization|3|||
145988848|NCT04191733|526473318|FG000|Overall Study|Withdrawn due to study closure|13|||
145988849|NCT04191733|526473319|FG001|Overall Study|Withdrawn due to study closure|14|||
145988850|NCT04191733|526473318|FG000|Overall Study|Withdrawal by Subject|2|||
145988851|NCT04191733|526473319|FG001|Overall Study|Withdrawal by Subject|4|||
145988852|NCT04191733|526473318|FG000|Overall Study|Physician Decision|1|||
145988853|NCT04191733|526473319|FG001|Overall Study|Physician Decision|1|||
145988854|NCT04191733|526473318|FG000|Overall Study|Lost to Follow-up|5|||
145988855|NCT04191733|526473319|FG001|Overall Study|Lost to Follow-up|6|||
145988856|NCT04191733|526473318|FG000|Overall Study|Death|0|||
145988857|NCT04191733|526473319|FG001|Overall Study|Death|1|||
145988858|NCT02633527|526473320|FG000|Overall Study|Failed to meet eligibility|0|||
145988859|NCT02633527|526473321|FG001|Overall Study|Failed to meet eligibility|1|||
145988860|NCT02633527|526473322|FG002|Overall Study|Failed to meet eligibility|1|||
145988861|NCT02633527|526473323|FG003|Overall Study|Failed to meet eligibility|0|||
145988862|NCT02633527|526473324|FG004|Overall Study|Failed to meet eligibility|1|||
145988863|NCT02633527|526473320|FG000|Overall Study|Adverse Event|0|||
145988864|NCT02633527|526473321|FG001|Overall Study|Adverse Event|4|||
145988865|NCT02633527|526473322|FG002|Overall Study|Adverse Event|3|||
145988866|NCT02633527|526473323|FG003|Overall Study|Adverse Event|1|||
145988867|NCT02633527|526473324|FG004|Overall Study|Adverse Event|5|||
146091485|NCT02537574|526856834|FG001|Overall Study|Lost to Follow-up|51|||
145988868|NCT02633527|526473320|FG000|Overall Study|Lost to Follow-up|1|||
145988869|NCT02633527|526473321|FG001|Overall Study|Lost to Follow-up|2|||
145988870|NCT02633527|526473322|FG002|Overall Study|Lost to Follow-up|5|||
145988871|NCT02633527|526473323|FG003|Overall Study|Lost to Follow-up|5|||
145988872|NCT02633527|526473324|FG004|Overall Study|Lost to Follow-up|4|||
145988873|NCT02633527|526473320|FG000|Overall Study|Withdrawal by Subject|0|||
145988874|NCT02633527|526473321|FG001|Overall Study|Withdrawal by Subject|3|||
145988875|NCT02633527|526473322|FG002|Overall Study|Withdrawal by Subject|5|||
146091486|NCT02537574|526856835|FG002|Overall Study|Lost to Follow-up|55|||
145988876|NCT02633527|526473323|FG003|Overall Study|Withdrawal by Subject|4|||
145988877|NCT02633527|526473324|FG004|Overall Study|Withdrawal by Subject|4|||
145988878|NCT02633527|526473320|FG000|Overall Study|Protocol Violation|0|||
145988879|NCT02633527|526473321|FG001|Overall Study|Protocol Violation|1|||
145988880|NCT02633527|526473322|FG002|Overall Study|Protocol Violation|1|||
145988881|NCT02633527|526473323|FG003|Overall Study|Protocol Violation|1|||
145988882|NCT02633527|526473324|FG004|Overall Study|Protocol Violation|1|||
145988883|NCT02633527|526473320|FG000|Overall Study|Physician Decision|0|||
145988884|NCT02633527|526473321|FG001|Overall Study|Physician Decision|0|||
145988885|NCT02633527|526473322|FG002|Overall Study|Physician Decision|0|||
145988886|NCT02633527|526473323|FG003|Overall Study|Physician Decision|0|||
145988887|NCT02633527|526473324|FG004|Overall Study|Physician Decision|1|||
145988888|NCT02633527|526473320|FG000|Overall Study|Administrative reason|1|||
145988889|NCT02633527|526473321|FG001|Overall Study|Administrative reason|0|||
145988890|NCT02633527|526473322|FG002|Overall Study|Administrative reason|0|||
145988891|NCT02633527|526473323|FG003|Overall Study|Administrative reason|1|||
145988892|NCT02633527|526473324|FG004|Overall Study|Administrative reason|0|||
145988893|NCT02633527|526473320|FG000|Overall Study|Multiple reasons|1|||
145988894|NCT02633527|526473321|FG001|Overall Study|Multiple reasons|0|||
145988895|NCT02633527|526473322|FG002|Overall Study|Multiple reasons|2|||
145988896|NCT02633527|526473323|FG003|Overall Study|Multiple reasons|2|||
145988897|NCT02633527|526473324|FG004|Overall Study|Multiple reasons|1|||
145988898|NCT02176525|526473325|FG000|Overall Study|Adverse Event|0|||
145988899|NCT02176525|526473326|FG001|Overall Study|Adverse Event|0|||
145988900|NCT02176525|526473327|FG002|Overall Study|Adverse Event|0|||
145988901|NCT02176525|526473328|FG003|Overall Study|Adverse Event|1|||
145988902|NCT02176525|526473329|FG004|Overall Study|Adverse Event|1|||
145988903|NCT02176525|526473330|FG005|Overall Study|Adverse Event|0|||
145988904|NCT02176525|526473331|FG006|Overall Study|Adverse Event|1|||
145988905|NCT02176525|526473332|FG007|Overall Study|Adverse Event|0|||
145988906|NCT02176525|526473325|FG000|Overall Study|not treated|1|||
145988907|NCT02176525|526473326|FG001|Overall Study|not treated|0|||
145988908|NCT02176525|526473327|FG002|Overall Study|not treated|0|||
145988909|NCT02176525|526473328|FG003|Overall Study|not treated|0|||
145988910|NCT02176525|526473329|FG004|Overall Study|not treated|0|||
145988911|NCT02176525|526473330|FG005|Overall Study|not treated|1|||
145988912|NCT02176525|526473331|FG006|Overall Study|not treated|0|||
145988913|NCT02176525|526473332|FG007|Overall Study|not treated|0|||
145988914|NCT02100644|526473333|FG000|LTG Escalation Phase|Adverse Event|9|||
145988915|NCT02100644|526473334|FG001|LTG Escalation Phase|Adverse Event|0|||
145988916|NCT02100644|526473335|FG002|LTG Escalation Phase|Adverse Event|0|||
145988917|NCT02100644|526473333|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
145988918|NCT02100644|526473334|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
145988919|NCT02100644|526473335|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
145988920|NCT02100644|526473333|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
145988921|NCT02100644|526473334|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
145988922|NCT02100644|526473335|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
145988923|NCT02852005|526473336|FG000|Overall Study|Lost to Follow-up|0|||
145988924|NCT02852005|526473337|FG001|Overall Study|Lost to Follow-up|0|||
145988925|NCT02852005|526473338|FG002|Overall Study|Lost to Follow-up|0|||
145988926|NCT02852005|526473339|FG003|Overall Study|Lost to Follow-up|0|||
145988927|NCT02852005|526473340|FG004|Overall Study|Lost to Follow-up|1|||
145988928|NCT02852005|526473336|FG000|Overall Study|Withdrawal by Subject|1|||
145988929|NCT02852005|526473337|FG001|Overall Study|Withdrawal by Subject|0|||
145988930|NCT02852005|526473338|FG002|Overall Study|Withdrawal by Subject|0|||
145988931|NCT02852005|526473339|FG003|Overall Study|Withdrawal by Subject|0|||
145988932|NCT02852005|526473340|FG004|Overall Study|Withdrawal by Subject|0|||
145988933|NCT04629521|526473341|FG000|Overall Study|Death|1|||
145988934|NCT04629521|526473341|FG000|Overall Study|Lost to Follow-up|3|||
145988935|NCT04629521|526473341|FG000|Overall Study|Subject withdrew consent|3|||
145988936|NCT04629521|526473341|FG000|Overall Study|Enrolled in error|1|||
145988937|NCT00478140|526473344|FG000|Overall Study|Clinical Disease Progression|1|||
145988938|NCT00728182|526473345|FG000|Overall Study|Adverse Event|1|||
145988939|NCT00728182|526473346|FG001|Overall Study|Adverse Event|0|||
145988940|NCT00728182|526473345|FG000|Overall Study|Lost to Follow-up|2|||
145988941|NCT00728182|526473346|FG001|Overall Study|Lost to Follow-up|0|||
145988942|NCT00728182|526473345|FG000|Overall Study|Death|0|||
146245933|NCT02203513|527414116|FG001|Overall Study|Did not receive investigational product (IP)|1|||
146245934|NCT02203513|527414117|FG002|Overall Study|Did not receive investigational product (IP)|0|||
145988943|NCT00728182|526473346|FG001|Overall Study|Death|2|||
145988944|NCT00728182|526473345|FG000|Overall Study|Protocol Noncompliance|0|||
145988945|NCT00728182|526473346|FG001|Overall Study|Protocol Noncompliance|1|||
145988946|NCT02554474|526473347|FG000|Overall Study|Protocol Violation|1|||
145988947|NCT02554474|526473348|FG001|Overall Study|Protocol Violation|1|||
145988948|NCT02554474|526473347|FG000|Overall Study|Health issue not related to the study|1|||
145988949|NCT02554474|526473348|FG001|Overall Study|Health issue not related to the study|0|||
145988950|NCT02554474|526473347|FG000|Overall Study|Withdrawal by Subject|1|||
145988951|NCT02554474|526473348|FG001|Overall Study|Withdrawal by Subject|1|||
145988952|NCT03211832|526473349|FG000|Overall Study|No longer with agency|32|||
145988953|NCT03211832|526473350|FG001|Overall Study|No longer with agency|49|||
145988954|NCT03211832|526473351|FG002|Overall Study|No longer with agency|30|||
145988955|NCT03211832|526473349|FG000|Overall Study|Declined survey|3|||
146245935|NCT02203513|527414118|FG003|Overall Study|Did not receive investigational product (IP)|0|||
146245936|NCT02203513|527414119|FG004|Overall Study|Did not receive investigational product (IP)|0|||
146245937|NCT02203513|527414115|FG000|Overall Study|Death (unrelated to study therapy)|1|||
146245938|NCT02203513|527414116|FG001|Overall Study|Death (unrelated to study therapy)|3|||
146245939|NCT02203513|527414117|FG002|Overall Study|Death (unrelated to study therapy)|1|||
146245940|NCT02203513|527414118|FG003|Overall Study|Death (unrelated to study therapy)|0|||
146245941|NCT02203513|527414119|FG004|Overall Study|Death (unrelated to study therapy)|2|||
146245942|NCT02203513|527414115|FG000|Overall Study|Lost to Follow-up|0|||
146245943|NCT02203513|527414116|FG001|Overall Study|Lost to Follow-up|0|||
146245944|NCT02203513|527414117|FG002|Overall Study|Lost to Follow-up|1|||
146245945|NCT02203513|527414118|FG003|Overall Study|Lost to Follow-up|1|||
146245946|NCT02203513|527414119|FG004|Overall Study|Lost to Follow-up|0|||
146245947|NCT01441596|527414120|FG000|Overall Study|Other reason not defined below|0|||
146245948|NCT01441596|527414121|FG001|Overall Study|Other reason not defined below|2|||
146245949|NCT01441596|527414122|FG002|Overall Study|Other reason not defined below|1|||
146245950|NCT01441596|527414120|FG000|Overall Study|Withdrawal by Subject|4|||
145988956|NCT03211832|526473350|FG001|Overall Study|Declined survey|3|||
145988957|NCT03211832|526473351|FG002|Overall Study|Declined survey|2|||
145988958|NCT03211832|526473349|FG000|Overall Study|Not available during data collection|1|||
145988959|NCT03211832|526473350|FG001|Overall Study|Not available during data collection|0|||
145988960|NCT03211832|526473351|FG002|Overall Study|Not available during data collection|2|||
145988961|NCT01725308|526473354|FG000|Treatment Period I|Did Not Receive Drug|1|||
145988962|NCT01725308|526473355|FG001|Treatment Period I|Did Not Receive Drug|0|||
145988963|NCT01725308|526473356|FG002|Treatment Period I|Did Not Receive Drug|0|||
145988964|NCT01725308|526473354|FG000|Treatment Period I|Adverse Event|5|||
145988965|NCT01725308|526473355|FG001|Treatment Period I|Adverse Event|4|||
145988966|NCT01725308|526473356|FG002|Treatment Period I|Adverse Event|21|||
145988967|NCT01725308|526473354|FG000|Treatment Period I|Insufficient Response|7|||
145988968|NCT01725308|526473355|FG001|Treatment Period I|Insufficient Response|0|||
145988969|NCT01725308|526473356|FG002|Treatment Period I|Insufficient Response|5|||
145988970|NCT01725308|526473354|FG000|Treatment Period I|Worsening of the Target Disease|8|||
145988971|NCT01725308|526473355|FG001|Treatment Period I|Worsening of the Target Disease|0|||
145988972|NCT01725308|526473356|FG002|Treatment Period I|Worsening of the Target Disease|2|||
145988973|NCT01725308|526473354|FG000|Treatment Period I|Changes in the Episodes|3|||
145988974|NCT01725308|526473355|FG001|Treatment Period I|Changes in the Episodes|0|||
145988975|NCT01725308|526473356|FG002|Treatment Period I|Changes in the Episodes|2|||
145988976|NCT01725308|526473354|FG000|Treatment Period I|Withdrawal of Consent|12|||
145988977|NCT01725308|526473355|FG001|Treatment Period I|Withdrawal of Consent|7|||
145988978|NCT01725308|526473356|FG002|Treatment Period I|Withdrawal of Consent|5|||
145988979|NCT01725308|526473354|FG000|Treatment Period I|Lost to Follow-up|3|||
145988980|NCT01725308|526473355|FG001|Treatment Period I|Lost to Follow-up|2|||
145988981|NCT01725308|526473356|FG002|Treatment Period I|Lost to Follow-up|2|||
145988982|NCT01725308|526473354|FG000|Treatment Period I|Protocol Deviations|3|||
145988983|NCT01725308|526473355|FG001|Treatment Period I|Protocol Deviations|1|||
145988984|NCT01725308|526473356|FG002|Treatment Period I|Protocol Deviations|1|||
145988985|NCT01725308|526473354|FG000|Treatment Period I|Miscellaneous|2|||
145988986|NCT01725308|526473355|FG001|Treatment Period I|Miscellaneous|0|||
145988987|NCT01725308|526473356|FG002|Treatment Period I|Miscellaneous|3|||
145988988|NCT01725308|526473354|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
145988989|NCT01725308|526473355|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
145988990|NCT01725308|526473356|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
145988991|NCT01725308|526473354|FG000|Treatment Period II|Did Not Receive Drug|4|||
145988992|NCT01725308|526473355|FG001|Treatment Period II|Did Not Receive Drug|0|||
145988993|NCT01725308|526473356|FG002|Treatment Period II|Did Not Receive Drug|0|||
145988994|NCT01725308|526473354|FG000|Treatment Period II|Adverse Event|13|||
145988995|NCT01725308|526473355|FG001|Treatment Period II|Adverse Event|8|||
145988996|NCT01725308|526473356|FG002|Treatment Period II|Adverse Event|20|||
145988997|NCT01725308|526473354|FG000|Treatment Period II|Insufficient Response|2|||
145988998|NCT01725308|526473355|FG001|Treatment Period II|Insufficient Response|4|||
145988999|NCT01725308|526473356|FG002|Treatment Period II|Insufficient Response|6|||
145989000|NCT01725308|526473354|FG000|Treatment Period II|Worsening of the Target Disease|1|||
145989001|NCT01725308|526473355|FG001|Treatment Period II|Worsening of the Target Disease|4|||
145989002|NCT01725308|526473356|FG002|Treatment Period II|Worsening of the Target Disease|2|||
145989003|NCT01725308|526473354|FG000|Treatment Period II|Changes in the Episodes|1|||
145989004|NCT01725308|526473355|FG001|Treatment Period II|Changes in the Episodes|0|||
146245951|NCT01441596|527414121|FG001|Overall Study|Withdrawal by Subject|0|||
146245952|NCT01441596|527414122|FG002|Overall Study|Withdrawal by Subject|2|||
146245953|NCT01441596|527414120|FG000|Overall Study|Not treated|0|||
145989005|NCT01725308|526473356|FG002|Treatment Period II|Changes in the Episodes|5|||
145989006|NCT01725308|526473354|FG000|Treatment Period II|Withdrawal of Consent|28|||
145989007|NCT01725308|526473355|FG001|Treatment Period II|Withdrawal of Consent|2|||
145989008|NCT01725308|526473356|FG002|Treatment Period II|Withdrawal of Consent|16|||
145989009|NCT01725308|526473354|FG000|Treatment Period II|Lost to Follow-up|1|||
145989010|NCT01725308|526473355|FG001|Treatment Period II|Lost to Follow-up|5|||
145989011|NCT01725308|526473356|FG002|Treatment Period II|Lost to Follow-up|3|||
145989012|NCT01725308|526473354|FG000|Treatment Period II|Protocol Deviations|0|||
145989013|NCT01725308|526473355|FG001|Treatment Period II|Protocol Deviations|0|||
145989014|NCT01725308|526473356|FG002|Treatment Period II|Protocol Deviations|1|||
145989015|NCT01725308|526473354|FG000|Treatment Period II|Miscellaneous|5|||
145989016|NCT01725308|526473355|FG001|Treatment Period II|Miscellaneous|3|||
145989017|NCT01725308|526473356|FG002|Treatment Period II|Miscellaneous|7|||
145989018|NCT03511209|526473357|FG000|Overall Study|Withdrawal by Subject|2|||
145989019|NCT03511209|526473358|FG001|Overall Study|Withdrawal by Subject|4|||
145989020|NCT03511209|526473357|FG000|Overall Study|Death|1|||
145989021|NCT03511209|526473358|FG001|Overall Study|Death|0|||
145989022|NCT03511209|526473357|FG000|Overall Study|Lost to Follow-up|0|||
145989023|NCT03511209|526473358|FG001|Overall Study|Lost to Follow-up|2|||
145989024|NCT00911157|526473368|FG000|Overall Study|Adverse Event|4|||
145989025|NCT00911157|526473369|FG001|Overall Study|Adverse Event|1|||
145989026|NCT00911157|526473368|FG000|Overall Study|Withdrawal by Subject|1|||
145989027|NCT00911157|526473369|FG001|Overall Study|Withdrawal by Subject|1|||
145989028|NCT00911157|526473368|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
145989029|NCT00911157|526473369|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
145989030|NCT00911157|526473368|FG000|Overall Study|Need to treat for lung cancer|1|||
145989031|NCT00911157|526473369|FG001|Overall Study|Need to treat for lung cancer|0|||
145989032|NCT03478787|526473373|FG000|Overall Study|Adverse Event|5|||
145989033|NCT03478787|526473374|FG001|Overall Study|Adverse Event|1|||
145989034|NCT03478787|526473373|FG000|Overall Study|Protocol Violation|3|||
145989035|NCT03478787|526473374|FG001|Overall Study|Protocol Violation|0|||
145989036|NCT03478787|526473373|FG000|Overall Study|Lack of Efficacy|7|||
145989037|NCT03478787|526473374|FG001|Overall Study|Lack of Efficacy|1|||
145989038|NCT03478787|526473373|FG000|Overall Study|Lost to Follow-up|9|||
145989039|NCT03478787|526473374|FG001|Overall Study|Lost to Follow-up|5|||
145989040|NCT03478787|526473373|FG000|Overall Study|Withdrawal by Subject|2|||
145989041|NCT03478787|526473374|FG001|Overall Study|Withdrawal by Subject|6|||
145989042|NCT03478787|526473373|FG000|Overall Study|Other, Not Specified|3|||
145989043|NCT03478787|526473374|FG001|Overall Study|Other, Not Specified|0|||
145989044|NCT01712074|526473377|FG000|Placebo Run-in Period|Adverse Event|2|||
145989045|NCT01712074|526473378|FG001|Placebo Run-in Period|Adverse Event|0|||
145989046|NCT01712074|526473379|FG002|Placebo Run-in Period|Adverse Event|0|||
145989047|NCT01712074|526473377|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
145989048|NCT01712074|526473378|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
145989049|NCT01712074|526473379|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
145989050|NCT01712074|526473377|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
145989051|NCT01712074|526473378|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
145989052|NCT01712074|526473379|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
145989053|NCT01712074|526473377|FG000|Placebo Run-in Period|Other|1|||
145989054|NCT01712074|526473378|FG001|Placebo Run-in Period|Other|0|||
145989055|NCT01712074|526473379|FG002|Placebo Run-in Period|Other|0|||
145989056|NCT01712074|526473377|FG000|Placebo Run-in Period|No longer willing to participate|1|||
145989057|NCT01712074|526473378|FG001|Placebo Run-in Period|No longer willing to participate|0|||
145989058|NCT01712074|526473379|FG002|Placebo Run-in Period|No longer willing to participate|0|||
145989059|NCT01712074|526473377|FG000|Double Blind Period|Adverse Event|0|||
145989060|NCT01712074|526473378|FG001|Double Blind Period|Adverse Event|2|||
145989061|NCT01712074|526473379|FG002|Double Blind Period|Adverse Event|1|||
145989062|NCT01712074|526473377|FG000|Double Blind Period|No longer willing to participate|0|||
145989063|NCT01712074|526473378|FG001|Double Blind Period|No longer willing to participate|2|||
145989064|NCT01712074|526473379|FG002|Double Blind Period|No longer willing to participate|4|||
145989065|NCT01712074|526473377|FG000|Double Blind Period|Death|0|||
145989066|NCT01712074|526473378|FG001|Double Blind Period|Death|1|||
145989067|NCT01712074|526473379|FG002|Double Blind Period|Death|0|||
145989068|NCT01712074|526473377|FG000|Double Blind Period|Lost to Follow-up|0|||
145989069|NCT01712074|526473378|FG001|Double Blind Period|Lost to Follow-up|2|||
145989070|NCT01712074|526473379|FG002|Double Blind Period|Lost to Follow-up|1|||
145989071|NCT01712074|526473377|FG000|Double Blind Period|Other|0|||
145989072|NCT01712074|526473378|FG001|Double Blind Period|Other|4|||
145989073|NCT01712074|526473379|FG002|Double Blind Period|Other|1|||
145989074|NCT01712074|526473377|FG000|Double Blind Period|Protocol Violation|0|||
145989075|NCT01712074|526473378|FG001|Double Blind Period|Protocol Violation|0|||
145989076|NCT01712074|526473379|FG002|Double Blind Period|Protocol Violation|1|||
145989077|NCT01712074|526473377|FG000|Double Blind Period|No longer met eligibility criteria|0|||
145989078|NCT01712074|526473378|FG001|Double Blind Period|No longer met eligibility criteria|3|||
145989079|NCT01712074|526473379|FG002|Double Blind Period|No longer met eligibility criteria|0|||
145989080|NCT01835431|526473396|FG000|Overall Study|Adverse Event|1|||
145989081|NCT01835431|526473397|FG001|Overall Study|Adverse Event|0|||
145989082|NCT01835431|526473396|FG000|Overall Study|other|0|||
145989083|NCT01835431|526473397|FG001|Overall Study|other|2|||
145989084|NCT01835431|526473396|FG000|Overall Study|Withdrawal by Subject|6|||
146245954|NCT01441596|527414121|FG001|Overall Study|Not treated|1|||
145989085|NCT01835431|526473397|FG001|Overall Study|Withdrawal by Subject|10|||
145989086|NCT01835431|526473396|FG000|Overall Study|Protocol Violation|1|||
145989087|NCT01835431|526473397|FG001|Overall Study|Protocol Violation|0|||
145989088|NCT01684033|526473400|FG000|Period 1, First 30 Days|Adverse Event|1|||
145989089|NCT01684033|526473401|FG001|Period 1, First 30 Days|Adverse Event|1|||
145989090|NCT01684033|526473400|FG000|Period 1, First 30 Days|Noncompliance|1|||
145989091|NCT01684033|526473401|FG001|Period 1, First 30 Days|Noncompliance|0|||
145989092|NCT01684033|526473400|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
145989093|NCT01684033|526473401|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
145989094|NCT01684033|526473400|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
145989095|NCT01684033|526473401|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
145989096|NCT01684033|526473400|FG000|Period 2, Second 30 Days|Adverse Event|1|||
145989097|NCT01684033|526473401|FG001|Period 2, Second 30 Days|Adverse Event|0|||
145989098|NCT00480025|526473402|FG000|Overall Study|Protocol Violation|12|||
145989099|NCT00480025|526473403|FG001|Overall Study|Protocol Violation|7|||
145989100|NCT00480025|526473402|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
145989101|NCT00480025|526473403|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
145989102|NCT00480025|526473402|FG000|Overall Study|Disease Progression / Recurrence|449|||
145989103|NCT00480025|526473403|FG001|Overall Study|Disease Progression / Recurrence|224|||
145989104|NCT00480025|526473402|FG000|Overall Study|Adverse Event|44|||
145989105|NCT00480025|526473403|FG001|Overall Study|Adverse Event|12|||
145989106|NCT00480025|526473402|FG000|Overall Study|Other|70|||
145989107|NCT00480025|526473403|FG001|Overall Study|Other|29|||
145989108|NCT00480025|526473402|FG000|Overall Study|SAE including intercurrent illness|76|||
145989109|NCT00480025|526473403|FG001|Overall Study|SAE including intercurrent illness|42|||
145989110|NCT03726879|526473405|FG000|Overall Study|Death|11|||
145989111|NCT03726879|526473406|FG001|Overall Study|Death|13|||
145989112|NCT03726879|526473405|FG000|Overall Study|Physician Decision|0|||
145989113|NCT03726879|526473406|FG001|Overall Study|Physician Decision|2|||
145989114|NCT03726879|526473405|FG000|Overall Study|Protocol Violation|0|||
145989115|NCT03726879|526473406|FG001|Overall Study|Protocol Violation|1|||
145989116|NCT03726879|526473405|FG000|Overall Study|Withdrawal by Subject|5|||
145989117|NCT03726879|526473406|FG001|Overall Study|Withdrawal by Subject|6|||
145989118|NCT03726879|526473405|FG000|Overall Study|TSH result is unstable|0|||
145989119|NCT03726879|526473406|FG001|Overall Study|TSH result is unstable|1|||
145989120|NCT03726879|526473405|FG000|Overall Study|Disease relapse|1|||
145989121|NCT03726879|526473406|FG001|Overall Study|Disease relapse|0|||
145989122|NCT03726879|526473405|FG000|Overall Study|Lost to Follow-up|3|||
145989123|NCT03726879|526473406|FG001|Overall Study|Lost to Follow-up|0|||
145989124|NCT02766478|526473408|FG000|Overall Study|Withdrawal by Subject|1|||
145989125|NCT02766478|526473409|FG001|Overall Study|Withdrawal by Subject|1|||
145989126|NCT01093573|526473410|FG000|Overall Study|Physician Decision|0|||
145989127|NCT01093573|526473411|FG001|Overall Study|Physician Decision|0|||
145989128|NCT01093573|526473412|FG002|Overall Study|Physician Decision|1|||
145989129|NCT01093573|526473410|FG000|Overall Study|Insurance Denied|0|||
145989130|NCT01093573|526473411|FG001|Overall Study|Insurance Denied|0|||
145989131|NCT01093573|526473412|FG002|Overall Study|Insurance Denied|1|||
145989132|NCT02496156|526473413|FG000|Overall Study|Lost to Follow-up|5|||
145989133|NCT02496156|526473414|FG001|Overall Study|Lost to Follow-up|0|||
145989134|NCT02496156|526473413|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
145989135|NCT02496156|526473414|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
145989136|NCT00089583|526473415|FG000|Overall Study|Adverse Event|0|||
145989137|NCT00089583|526473416|FG001|Overall Study|Adverse Event|3|||
146091487|NCT02537574|526856833|FG000|Overall Study|Noncompliance with study drug|0|||
146091488|NCT02537574|526856834|FG001|Overall Study|Noncompliance with study drug|1|||
146091489|NCT02537574|526856835|FG002|Overall Study|Noncompliance with study drug|1|||
146091490|NCT02537574|526856833|FG000|Overall Study|Physician Decision|2|||
146091491|NCT02537574|526856834|FG001|Overall Study|Physician Decision|0|||
146091492|NCT02537574|526856835|FG002|Overall Study|Physician Decision|0|||
146091493|NCT02537574|526856833|FG000|Overall Study|Protocol Violation|4|||
146091494|NCT02537574|526856834|FG001|Overall Study|Protocol Violation|2|||
146091495|NCT02537574|526856835|FG002|Overall Study|Protocol Violation|3|||
146091496|NCT02537574|526856833|FG000|Overall Study|Withdrawal by Subject|37|||
145989138|NCT00089583|526473415|FG000|Overall Study|Insufficient Viral Load Response|5|||
145989139|NCT00089583|526473416|FG001|Overall Study|Insufficient Viral Load Response|5|||
145989140|NCT00089583|526473415|FG000|Overall Study|Withdrawal by Subject|0|||
145989141|NCT00089583|526473416|FG001|Overall Study|Withdrawal by Subject|4|||
145989142|NCT00089583|526473415|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
145989143|NCT00089583|526473416|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
145989144|NCT00089583|526473415|FG000|Overall Study|Participant Refused Study Medication|0|||
145989145|NCT00089583|526473416|FG001|Overall Study|Participant Refused Study Medication|2|||
145989146|NCT00089583|526473415|FG000|Overall Study|Non-Compliance|0|||
145989147|NCT00089583|526473416|FG001|Overall Study|Non-Compliance|4|||
145989148|NCT00089583|526473415|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
145989149|NCT00089583|526473416|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
146091497|NCT02537574|526856834|FG001|Overall Study|Withdrawal by Subject|27|||
145989150|NCT00089583|526473415|FG000|Overall Study|Participant Management Criteria Met|0|||
145989151|NCT00089583|526473416|FG001|Overall Study|Participant Management Criteria Met|1|||
145989152|NCT00089583|526473415|FG000|Overall Study|Reason Not Provided|0|||
145989153|NCT00089583|526473416|FG001|Overall Study|Reason Not Provided|1|||
145989154|NCT00089583|526473415|FG000|Overall Study|Protocol Violation|0|||
145989155|NCT00089583|526473416|FG001|Overall Study|Protocol Violation|3|||
145989156|NCT00089583|526473415|FG000|Overall Study|Principal Investigator Decision|0|||
145989157|NCT00089583|526473416|FG001|Overall Study|Principal Investigator Decision|10|||
145989158|NCT00089583|526473415|FG000|Overall Study|Start of Disallowed Medication|0|||
145989159|NCT00089583|526473416|FG001|Overall Study|Start of Disallowed Medication|1|||
145989160|NCT00089583|526473415|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
145989161|NCT00089583|526473416|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
145989162|NCT00089583|526473415|FG000|Overall Study|Participant Incarcerated|0|||
145989163|NCT00089583|526473416|FG001|Overall Study|Participant Incarcerated|1|||
145989164|NCT01412983|526473417|FG000|1st Period|Ineligible|0|||
145989165|NCT01412983|526473418|FG001|1st Period|Ineligible|1|||
145989166|NCT01412983|526473417|FG000|1st Period|Positive slit lamp finding|0|||
145989167|NCT01412983|526473418|FG001|1st Period|Positive slit lamp finding|1|||
145989168|NCT01412983|526473417|FG000|1st Period|Unacceptable lens movement|0|||
145989169|NCT01412983|526473418|FG001|1st Period|Unacceptable lens movement|1|||
145989170|NCT01412983|526473417|FG000|1st Period|Inability to maintain wear|0|||
145989171|NCT01412983|526473418|FG001|1st Period|Inability to maintain wear|1|||
145989172|NCT00890097|526473419|FG000|Overall Study|Adverse Event|21|||
145989173|NCT00890097|526473420|FG001|Overall Study|Adverse Event|32|||
145989174|NCT00890097|526473421|FG002|Overall Study|Adverse Event|28|||
145989175|NCT00890097|526473419|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
145989176|NCT00890097|526473420|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
145989177|NCT00890097|526473421|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
145989178|NCT00890097|526473419|FG000|Overall Study|Withdrew Consent|9|||
145989179|NCT00890097|526473420|FG001|Overall Study|Withdrew Consent|6|||
145989180|NCT00890097|526473421|FG002|Overall Study|Withdrew Consent|9|||
145989181|NCT00890097|526473419|FG000|Overall Study|Lost to Follow-up|5|||
145989182|NCT00890097|526473420|FG001|Overall Study|Lost to Follow-up|5|||
145989183|NCT00890097|526473421|FG002|Overall Study|Lost to Follow-up|5|||
145989184|NCT00890097|526473419|FG000|Overall Study|Noncompliance|0|||
145989185|NCT00890097|526473420|FG001|Overall Study|Noncompliance|4|||
145989186|NCT00890097|526473421|FG002|Overall Study|Noncompliance|4|||
145989187|NCT00890097|526473419|FG000|Overall Study|Sponsor Decision|7|||
145989188|NCT00890097|526473420|FG001|Overall Study|Sponsor Decision|11|||
145989189|NCT00890097|526473421|FG002|Overall Study|Sponsor Decision|7|||
145989190|NCT00890097|526473419|FG000|Overall Study|Did not attend final visit|2|||
145989191|NCT00890097|526473420|FG001|Overall Study|Did not attend final visit|3|||
145989192|NCT00890097|526473421|FG002|Overall Study|Did not attend final visit|0|||
145989193|NCT00890097|526473419|FG000|Overall Study|Subject Decision|3|||
145989194|NCT00890097|526473420|FG001|Overall Study|Subject Decision|2|||
145989195|NCT00890097|526473421|FG002|Overall Study|Subject Decision|6|||
145989196|NCT00890097|526473419|FG000|Overall Study|Randomization Error|2|||
145989197|NCT00890097|526473420|FG001|Overall Study|Randomization Error|0|||
145989198|NCT00890097|526473421|FG002|Overall Study|Randomization Error|0|||
145989199|NCT00890097|526473419|FG000|Overall Study|Failed inclusion criteria|3|||
145989200|NCT00890097|526473420|FG001|Overall Study|Failed inclusion criteria|4|||
145989201|NCT00890097|526473421|FG002|Overall Study|Failed inclusion criteria|0|||
145989202|NCT00890097|526473419|FG000|Overall Study|Transportation|0|||
145989203|NCT00890097|526473420|FG001|Overall Study|Transportation|2|||
145989204|NCT00890097|526473421|FG002|Overall Study|Transportation|0|||
145989205|NCT00890097|526473419|FG000|Overall Study|Subject Moved|0|||
145989206|NCT00890097|526473420|FG001|Overall Study|Subject Moved|4|||
145989207|NCT00890097|526473421|FG002|Overall Study|Subject Moved|0|||
145989208|NCT00890097|526473419|FG000|Overall Study|Protocol Deviation|1|||
145989209|NCT00890097|526473420|FG001|Overall Study|Protocol Deviation|1|||
145989210|NCT00890097|526473421|FG002|Overall Study|Protocol Deviation|1|||
145989211|NCT04349098|526473422|FG000|Overall Study|Death|16|||
145989212|NCT04349098|526473423|FG001|Overall Study|Death|8|||
145989213|NCT04349098|526473422|FG000|Overall Study|Lost to Follow-up|11|||
145989214|NCT04349098|526473423|FG001|Overall Study|Lost to Follow-up|8|||
145989215|NCT04349098|526473422|FG000|Overall Study|Withdrawal by Subject|8|||
145989216|NCT04349098|526473423|FG001|Overall Study|Withdrawal by Subject|5|||
145989217|NCT04349098|526473422|FG000|Overall Study|Other|3|||
145989218|NCT04349098|526473423|FG001|Overall Study|Other|5|||
145989219|NCT01703221|526473424|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
145989220|NCT01703221|526473425|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
145989221|NCT01703221|526473426|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145989222|NCT01703221|526473424|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
145989223|NCT01703221|526473425|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
145989224|NCT01703221|526473426|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
145989225|NCT01703221|526473424|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
145989226|NCT01703221|526473425|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146245955|NCT01441596|527414122|FG002|Overall Study|Not treated|1|||
145989227|NCT01703221|526473426|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145989228|NCT01703221|526473424|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
145989229|NCT01703221|526473425|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145989230|NCT01703221|526473426|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145989231|NCT01703221|526473424|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145989232|NCT01703221|526473425|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145989233|NCT01703221|526473426|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
145989234|NCT01703221|526473424|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
145989235|NCT01703221|526473425|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
145989236|NCT01703221|526473426|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
145989237|NCT01703221|526473424|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
145989238|NCT01703221|526473425|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
145989239|NCT01703221|526473426|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
145989240|NCT01703221|526473424|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
145989241|NCT01703221|526473425|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
145989242|NCT01703221|526473426|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
145989243|NCT05130281|526475040|FG000|Overall Study|Withdrawal by Subject|0|||
145989244|NCT05130281|526475041|FG001|Overall Study|Withdrawal by Subject|0|||
145989245|NCT05130281|526475042|FG002|Overall Study|Withdrawal by Subject|1|||
145989246|NCT03810365|526475045|FG000|Overall Study|Lost to Follow-up|2|||
145989247|NCT03810365|526475046|FG001|Overall Study|Lost to Follow-up|2|||
145989248|NCT03810365|526475045|FG000|Overall Study|Withdrawal by Subject|4|||
145989249|NCT03810365|526475046|FG001|Overall Study|Withdrawal by Subject|5|||
145989250|NCT02144337|526475050|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
145989251|NCT02144337|526475051|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
145989252|NCT02144337|526475050|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
145989253|NCT02144337|526475051|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
145989254|NCT02144337|526475050|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
145989255|NCT02144337|526475051|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
145989256|NCT02144337|526475050|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
145989257|NCT02144337|526475051|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
145989258|NCT02144337|526475050|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
145989259|NCT02144337|526475051|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
145989260|NCT05333965|526475052|FG000|First Intervention|Adverse Event|0|||
145989261|NCT05333965|526475053|FG001|First Intervention|Adverse Event|1|||
145989262|NCT05333965|526475052|FG000|First Intervention|Withdrawal by Subject|0|||
145989263|NCT05333965|526475053|FG001|First Intervention|Withdrawal by Subject|1|||
145989264|NCT03701074|526475054|FG000|Overall Study|Physician Decision|1|||
145989265|NCT03701074|526475055|FG001|Overall Study|Physician Decision|0|||
145989266|NCT01661595|526475056|FG000|Phase 1: Week 0-4|Adverse Event|1|||
145989267|NCT01661595|526475057|FG001|Phase 1: Week 0-4|Adverse Event|0|||
145989268|NCT01661595|526475058|FG002|Phase 1: Week 0-4|Adverse Event|0|||
145989269|NCT01661595|526475059|FG003|Phase 1: Week 0-4|Adverse Event|0|||
145989270|NCT01661595|526475056|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
145989271|NCT01661595|526475057|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
145989272|NCT01661595|526475058|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
145989273|NCT01661595|526475059|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
145989274|NCT01034657|526475060|FG000|Core Phase|Withdrawal by Subject|1|||
145989275|NCT01034657|526475061|FG001|Core Phase|Withdrawal by Subject|0|||
145989276|NCT01034657|526475062|FG002|Core Phase|Withdrawal by Subject|0|||
145989277|NCT01034657|526475060|FG000|Core Phase|Lack of Efficacy|2|||
145989278|NCT01034657|526475061|FG001|Core Phase|Lack of Efficacy|0|||
145989279|NCT01034657|526475062|FG002|Core Phase|Lack of Efficacy|0|||
145989280|NCT01034657|526475060|FG000|Core Phase|Abnormal laboratory value|1|||
145989281|NCT01034657|526475061|FG001|Core Phase|Abnormal laboratory value|0|||
145989282|NCT01034657|526475062|FG002|Core Phase|Abnormal laboratory value|0|||
145989283|NCT01034657|526475060|FG000|Core Phase|Adverse Event|8|||
145989284|NCT01034657|526475061|FG001|Core Phase|Adverse Event|0|||
145989285|NCT01034657|526475062|FG002|Core Phase|Adverse Event|0|||
145989286|NCT01034657|526475060|FG000|Core Phase|Protocol Violation|2|||
145989287|NCT01034657|526475061|FG001|Core Phase|Protocol Violation|0|||
146297865|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
146297866|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146297867|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
146297868|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145989288|NCT01034657|526475062|FG002|Core Phase|Protocol Violation|0|||
145989289|NCT01034657|526475060|FG000|Randomized Phase|Withdrawal by Subject|0|||
145989290|NCT01034657|526475061|FG001|Randomized Phase|Withdrawal by Subject|2|||
145989291|NCT01034657|526475062|FG002|Randomized Phase|Withdrawal by Subject|0|||
145989292|NCT01034657|526475060|FG000|Randomized Phase|Lack of Efficacy|5|||
145989293|NCT01034657|526475061|FG001|Randomized Phase|Lack of Efficacy|1|||
145989294|NCT01034657|526475062|FG002|Randomized Phase|Lack of Efficacy|0|||
145989295|NCT01034657|526475060|FG000|Randomized Phase|Abnormal laboratory value|0|||
145989296|NCT01034657|526475061|FG001|Randomized Phase|Abnormal laboratory value|1|||
145989297|NCT01034657|526475062|FG002|Randomized Phase|Abnormal laboratory value|0|||
145989298|NCT01034657|526475060|FG000|Randomized Phase|Adverse Event|0|||
145989299|NCT01034657|526475061|FG001|Randomized Phase|Adverse Event|2|||
145989300|NCT01034657|526475062|FG002|Randomized Phase|Adverse Event|1|||
145989301|NCT02715856|526475063|FG000|Overall Study|Software Issues|12|||
145989302|NCT02715856|526475064|FG001|Overall Study|Software Issues|7|||
145989303|NCT02715856|526475063|FG000|Overall Study|Death|6|||
145989304|NCT02715856|526475064|FG001|Overall Study|Death|5|||
145989305|NCT02715856|526475063|FG000|Overall Study|Non- Compliant|0|||
145989306|NCT02715856|526475064|FG001|Overall Study|Non- Compliant|40|||
145989307|NCT01517178|526475065|FG000|Period 1|Adverse Event|1|||
145989308|NCT01517178|526475066|FG001|Period 1|Adverse Event|2|||
145989309|NCT01517178|526475065|FG000|Period 1|Lack of Efficacy|0|||
145989310|NCT01517178|526475066|FG001|Period 1|Lack of Efficacy|1|||
145989311|NCT01517178|526475065|FG000|Period 1|E.g. study termination|3|||
145989312|NCT01517178|526475066|FG001|Period 1|E.g. study termination|1|||
145989313|NCT01517178|526475065|FG000|Period 1|Withdrawal by Subject|0|||
145989314|NCT01517178|526475066|FG001|Period 1|Withdrawal by Subject|1|||
145989315|NCT01517178|526475065|FG000|Period 2|Adverse Event|1|||
145989316|NCT01517178|526475066|FG001|Period 2|Adverse Event|0|||
145989317|NCT01517178|526475065|FG000|Period 2|Withdrawal by Subject|3|||
145989318|NCT01517178|526475066|FG001|Period 2|Withdrawal by Subject|0|||
145989319|NCT01517178|526475065|FG000|Period 2|E.g. study termination|2|||
145989320|NCT01517178|526475066|FG001|Period 2|E.g. study termination|2|||
145989321|NCT02872142|526475071|FG000|Overall Study|Adverse Event|2|||
145989322|NCT02872142|526475071|FG000|Overall Study|Death|1|||
145989323|NCT02872142|526475071|FG000|Overall Study|Participant Decision|3|||
145989324|NCT03627468|526475076|FG000|Overall Study|Adverse Event|5|||
145989325|NCT03627468|526475077|FG001|Overall Study|Adverse Event|33|||
145989326|NCT03627468|526475076|FG000|Overall Study|Withdrawal by Subject|13|||
145989327|NCT03627468|526475077|FG001|Overall Study|Withdrawal by Subject|23|||
145989328|NCT03627468|526475076|FG000|Overall Study|Physician Decision|1|||
145989329|NCT03627468|526475077|FG001|Overall Study|Physician Decision|0|||
145989330|NCT03627468|526475076|FG000|Overall Study|Protocol Violation|0|||
145989331|NCT03627468|526475077|FG001|Overall Study|Protocol Violation|2|||
145989332|NCT03627468|526475076|FG000|Overall Study|Lost to Follow-up|10|||
145989333|NCT03627468|526475077|FG001|Overall Study|Lost to Follow-up|16|||
145989334|NCT03627468|526475076|FG000|Overall Study|Death|1|||
145989335|NCT03627468|526475077|FG001|Overall Study|Death|0|||
145989336|NCT03627468|526475076|FG000|Overall Study|Pregnancy|1|||
145989337|NCT03627468|526475077|FG001|Overall Study|Pregnancy|1|||
145989338|NCT03627468|526475076|FG000|Overall Study|Lack of Efficacy|0|||
145989339|NCT03627468|526475077|FG001|Overall Study|Lack of Efficacy|2|||
145989340|NCT03627468|526475076|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
145989341|NCT03627468|526475077|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
145989342|NCT05122143|526475078|FG000|Overall Study|Adverse Event|1|||
145989343|NCT05122143|526475079|FG001|Overall Study|Adverse Event|0|||
145989344|NCT05122143|526475080|FG002|Overall Study|Adverse Event|0|||
145989345|NCT05122143|526475081|FG003|Overall Study|Adverse Event|0|||
145989346|NCT05122143|526475082|FG004|Overall Study|Adverse Event|1|||
145989347|NCT05122143|526475083|FG005|Overall Study|Adverse Event|0|||
145989348|NCT05122143|526475078|FG000|Overall Study|Protocol non-compliance|0|||
145989349|NCT05122143|526475079|FG001|Overall Study|Protocol non-compliance|0|||
146245956|NCT02008916|527414123|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
146245957|NCT02008916|527414124|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
146245958|NCT02008916|527414125|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
146245959|NCT02008916|527414123|FG000|Week 16 - 156|Adverse Event|4|||
146245960|NCT02008916|527414124|FG001|Week 16 - 156|Adverse Event|2|||
146245961|NCT02008916|527414125|FG002|Week 16 - 156|Adverse Event|3|||
146245962|NCT02008916|527414123|FG000|Week 16 - 156|Withdrawal by Subject|7|||
146245963|NCT02008916|527414124|FG001|Week 16 - 156|Withdrawal by Subject|3|||
146245964|NCT02008916|527414125|FG002|Week 16 - 156|Withdrawal by Subject|5|||
146245965|NCT02008916|527414123|FG000|Week 16 - 156|No longer requires treatment|0|||
146245966|NCT02008916|527414124|FG001|Week 16 - 156|No longer requires treatment|1|||
145989350|NCT05122143|526475080|FG002|Overall Study|Protocol non-compliance|1|||
145989351|NCT05122143|526475081|FG003|Overall Study|Protocol non-compliance|0|||
145989352|NCT05122143|526475082|FG004|Overall Study|Protocol non-compliance|0|||
145989353|NCT05122143|526475083|FG005|Overall Study|Protocol non-compliance|0|||
145989354|NCT05122143|526475078|FG000|Overall Study|Covid contact|0|||
145989355|NCT05122143|526475079|FG001|Overall Study|Covid contact|0|||
145989356|NCT05122143|526475080|FG002|Overall Study|Covid contact|0|||
145989357|NCT05122143|526475081|FG003|Overall Study|Covid contact|0|||
145989358|NCT05122143|526475082|FG004|Overall Study|Covid contact|1|||
146245967|NCT02008916|527414125|FG002|Week 16 - 156|No longer requires treatment|0|||
146245968|NCT02008916|527414123|FG000|Week 16 - 156|Lost to Follow-up|5|||
145989359|NCT05122143|526475083|FG005|Overall Study|Covid contact|0|||
145989360|NCT00309946|526475084|FG000|Overall Study|Withdrawal by Subject|1|||
145989361|NCT00395447|526475085|FG000|Overall Study|Death|37|||
145989362|NCT00395447|526475086|FG001|Overall Study|Death|32|||
145989363|NCT00395447|526475085|FG000|Overall Study|Lost to Follow-up|52|||
145989364|NCT00395447|526475086|FG001|Overall Study|Lost to Follow-up|43|||
145989365|NCT00395447|526475085|FG000|Overall Study|Withdrawal by Subject|24|||
145989366|NCT00395447|526475086|FG001|Overall Study|Withdrawal by Subject|19|||
145989367|NCT00395447|526475085|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
145989368|NCT00395447|526475086|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
145989369|NCT00347269|526475087|FG000|Overall Study|Lost to Follow-up|74|||
145989370|NCT00347269|526475088|FG001|Overall Study|Lost to Follow-up|65|||
145989371|NCT00347269|526475087|FG000|Overall Study|Withdrawal by Subject|18|||
145989372|NCT00347269|526475088|FG001|Overall Study|Withdrawal by Subject|38|||
145989373|NCT00347269|526475087|FG000|Overall Study|Death|2|||
145989374|NCT00347269|526475088|FG001|Overall Study|Death|3|||
145989375|NCT03654326|526475089|FG000|Overall Study|Withdrawal by Subject|5|||
145989376|NCT03654326|526475090|FG001|Overall Study|Withdrawal by Subject|3|||
145989377|NCT03654326|526475089|FG000|Overall Study|Physician Decision|0|||
145989378|NCT03654326|526475090|FG001|Overall Study|Physician Decision|1|||
145989379|NCT03654326|526475089|FG000|Overall Study|Unable to adhere to study schedule|0|||
145989380|NCT03654326|526475090|FG001|Overall Study|Unable to adhere to study schedule|1|||
145989381|NCT03654326|526475089|FG000|Overall Study|Lost to Follow-up|1|||
145989382|NCT03654326|526475090|FG001|Overall Study|Lost to Follow-up|1|||
145989383|NCT04893811|526475091|FG000|Vaccination Phase|Death|1|||
145989384|NCT04893811|526475092|FG001|Vaccination Phase|Death|0|||
145989385|NCT04893811|526475091|FG000|Vaccination Phase|Lost to Follow-up|1|||
145989386|NCT04893811|526475092|FG001|Vaccination Phase|Lost to Follow-up|1|||
145989387|NCT04893811|526475091|FG000|Vaccination Phase|Protocol Violation|2|||
145989388|NCT04893811|526475092|FG001|Vaccination Phase|Protocol Violation|0|||
145989389|NCT04893811|526475091|FG000|Vaccination Phase|Withdrawal by Subject|2|||
145989390|NCT04893811|526475092|FG001|Vaccination Phase|Withdrawal by Subject|1|||
145989391|NCT04893811|526475091|FG000|Vaccination Phase|Other|0|||
145989392|NCT04893811|526475092|FG001|Vaccination Phase|Other|1|||
145989393|NCT04893811|526475091|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
145989394|NCT04893811|526475092|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
145989395|NCT04893811|526475091|FG000|Follow-up Phase|Lost to Follow-up|0|||
145989396|NCT04893811|526475092|FG001|Follow-up Phase|Lost to Follow-up|1|||
145989397|NCT02662582|526475093|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
145989398|NCT02662582|526475094|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
145989399|NCT02662582|526475093|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
145989400|NCT02662582|526475094|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
145989401|NCT02662582|526475093|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
145989402|NCT02662582|526475094|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
145989403|NCT02662582|526475093|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145989404|NCT02662582|526475094|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145989405|NCT05451329|526475097|FG000|Overall Study|Adverse Event|1|||
145989406|NCT05451329|526475098|FG001|Overall Study|Adverse Event|1|||
145989407|NCT05451329|526475099|FG002|Overall Study|Adverse Event|0|||
145989408|NCT05451329|526475097|FG000|Overall Study|Withdrawal by Subject|1|||
145989409|NCT05451329|526475098|FG001|Overall Study|Withdrawal by Subject|0|||
145989410|NCT05451329|526475099|FG002|Overall Study|Withdrawal by Subject|0|||
145989411|NCT05451329|526475097|FG000|Overall Study|Investigational Product Lot exchange|1|||
145989412|NCT05451329|526475098|FG001|Overall Study|Investigational Product Lot exchange|1|||
145989413|NCT05451329|526475099|FG002|Overall Study|Investigational Product Lot exchange|0|||
145989414|NCT01898091|526475106|FG000|Overall Study|Lost to Follow-up|1|||
145989415|NCT01898091|526475107|FG001|Overall Study|Lost to Follow-up|1|||
145989416|NCT01898091|526475106|FG000|Overall Study|Withdrawal by Subject|1|||
145989417|NCT01898091|526475107|FG001|Overall Study|Withdrawal by Subject|5|||
145989418|NCT02369159|526475110|FG000|Overall Study|Adverse Event|0|||
145989419|NCT02369159|526475111|FG001|Overall Study|Adverse Event|1|||
145989420|NCT02369159|526475110|FG000|Overall Study|Lost to Follow-up|1|||
145989421|NCT02369159|526475111|FG001|Overall Study|Lost to Follow-up|1|||
145989422|NCT02369159|526475110|FG000|Overall Study|Withdrawal by Subject|7|||
145989423|NCT02369159|526475111|FG001|Overall Study|Withdrawal by Subject|0|||
145989424|NCT02913326|526475116|FG000|Overall Study|Reason not listed|0|||
145989425|NCT02913326|526475117|FG001|Overall Study|Reason not listed|1|||
145989426|NCT02913326|526475116|FG000|Overall Study|Lost to Follow-up|0|||
145989427|NCT02913326|526475117|FG001|Overall Study|Lost to Follow-up|1|||
145989428|NCT02913326|526475116|FG000|Overall Study|Adverse Event|1|||
145989429|NCT02913326|526475117|FG001|Overall Study|Adverse Event|0|||
145989430|NCT01514422|526475118|FG000|Overall Study|Lost to Follow-up|1|||
145989431|NCT03769467|526475120|FG000|Overall Study|Adverse Event|1|||
145989432|NCT03769467|526475121|FG001|Overall Study|Adverse Event|1|||
145989433|NCT03769467|526475122|FG002|Overall Study|Adverse Event|0|||
145989434|NCT03769467|526475120|FG000|Overall Study|Death|3|||
145989435|NCT03769467|526475121|FG001|Overall Study|Death|3|||
145989436|NCT03769467|526475122|FG002|Overall Study|Death|0|||
145989437|NCT03769467|526475120|FG000|Overall Study|Study Terminated By Sponsor|2|||
145989438|NCT03769467|526475121|FG001|Overall Study|Study Terminated By Sponsor|1|||
145989439|NCT03769467|526475122|FG002|Overall Study|Study Terminated By Sponsor|0|||
145989440|NCT03769467|526475120|FG000|Overall Study|Withdrawal by Subject|0|||
145989441|NCT03769467|526475121|FG001|Overall Study|Withdrawal by Subject|1|||
145989442|NCT03769467|526475122|FG002|Overall Study|Withdrawal by Subject|0|||
145989443|NCT04565756|526475123|FG000|Overall Study|Withdrawal by Subject|0|||
145989444|NCT04565756|526475124|FG001|Overall Study|Withdrawal by Subject|0|||
145989445|NCT04565756|526475125|FG002|Overall Study|Withdrawal by Subject|0|||
145989446|NCT04565756|526475126|FG003|Overall Study|Withdrawal by Subject|0|||
145989447|NCT04565756|526475127|FG004|Overall Study|Withdrawal by Subject|1|||
145989448|NCT04565756|526475128|FG005|Overall Study|Withdrawal by Subject|0|||
145989449|NCT04565756|526475123|FG000|Overall Study|Protocol Violation|0|||
145989450|NCT04565756|526475124|FG001|Overall Study|Protocol Violation|0|||
145989451|NCT04565756|526475125|FG002|Overall Study|Protocol Violation|0|||
145989452|NCT04565756|526475126|FG003|Overall Study|Protocol Violation|0|||
145989453|NCT04565756|526475127|FG004|Overall Study|Protocol Violation|0|||
145989454|NCT04565756|526475128|FG005|Overall Study|Protocol Violation|1|||
145989455|NCT05259722|526475129|FG000|Overall Study|Adverse Event|2|||
145989456|NCT05259722|526475130|FG001|Overall Study|Adverse Event|24|||
145989457|NCT05259722|526475129|FG000|Overall Study|Lost to Follow-up|5|||
145989458|NCT05259722|526475130|FG001|Overall Study|Lost to Follow-up|1|||
145989459|NCT05259722|526475129|FG000|Overall Study|Lack of Efficacy|8|||
145989460|NCT05259722|526475130|FG001|Overall Study|Lack of Efficacy|26|||
145989461|NCT05259722|526475129|FG000|Overall Study|Withdrawal by Subject|15|||
145989462|NCT05259722|526475130|FG001|Overall Study|Withdrawal by Subject|33|||
145989463|NCT05259722|526475129|FG000|Overall Study|Various reasons|3|||
145989464|NCT05259722|526475130|FG001|Overall Study|Various reasons|9|||
145989465|NCT05259722|526475129|FG000|Overall Study|Not exposed to IMP|1|||
145989466|NCT05259722|526475130|FG001|Overall Study|Not exposed to IMP|12|||
145989467|NCT05259722|526475129|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
145989468|NCT05259722|526475130|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
145989469|NCT01887600|526475131|FG000|Overall Study|Death|39|||
145989470|NCT01887600|526475132|FG001|Overall Study|Death|16|||
145989471|NCT01887600|526475131|FG000|Overall Study|Lack of Efficacy|3|||
145989472|NCT01887600|526475132|FG001|Overall Study|Lack of Efficacy|26|||
145989473|NCT01887600|526475131|FG000|Overall Study|Lost to Follow-up|5|||
145989474|NCT01887600|526475132|FG001|Overall Study|Lost to Follow-up|1|||
145989475|NCT01887600|526475131|FG000|Overall Study|Physician Decision|7|||
145989476|NCT01887600|526475132|FG001|Overall Study|Physician Decision|8|||
145989477|NCT01887600|526475131|FG000|Overall Study|Protocol Deviation|3|||
145989478|NCT01887600|526475132|FG001|Overall Study|Protocol Deviation|0|||
145989479|NCT01887600|526475131|FG000|Overall Study|Withdrawal by Subject|58|||
145989480|NCT01887600|526475132|FG001|Overall Study|Withdrawal by Subject|52|||
145989481|NCT01887600|526475131|FG000|Overall Study|Adverse Event|21|||
145989482|NCT01887600|526475132|FG001|Overall Study|Adverse Event|9|||
145989483|NCT01887600|526475131|FG000|Overall Study|Non-compliance with study drug|3|||
145989484|NCT01887600|526475132|FG001|Overall Study|Non-compliance with study drug|0|||
145989485|NCT01887600|526475131|FG000|Overall Study|Miscellaneous|6|||
145989486|NCT01887600|526475132|FG001|Overall Study|Miscellaneous|2|||
145989487|NCT01887600|526475131|FG000|Overall Study|Progressive Disease|1|||
145989488|NCT01887600|526475132|FG001|Overall Study|Progressive Disease|0|||
145989489|NCT00962650|526475133|FG000|Overall Study|Transgastric DP was not completed|2|||
145989490|NCT03688139|526475134|FG000|Overall Study|Lost to Follow-up|2|||
145989491|NCT03688139|526475135|FG001|Overall Study|Lost to Follow-up|0|||
145989492|NCT03688139|526475134|FG000|Overall Study|Physician Decision|0|||
145989493|NCT03688139|526475135|FG001|Overall Study|Physician Decision|1|||
145989494|NCT03688139|526475134|FG000|Overall Study|Withdrawal by Subject|2|||
145989495|NCT03688139|526475135|FG001|Overall Study|Withdrawal by Subject|3|||
145989496|NCT00231465|526475136|FG000|Overall Study|Completed only one cycle|1|||
145989497|NCT00231465|526475136|FG000|Overall Study|Did not have follow up CT scans|1|||
145989498|NCT00420056|526475137|FG000|Overall Study|Objective progression or relapse|17|||
145989499|NCT03624036|526475138|FG000|Overall Study|Death|2|||
145989500|NCT03624036|526475139|FG001|Overall Study|Death|3|||
145989501|NCT03624036|526475140|FG002|Overall Study|Death|0|||
145989502|NCT03624036|526475141|FG003|Overall Study|Death|1|||
145989503|NCT03624036|526475138|FG000|Overall Study|Withdrawal by Subject|1|||
145989504|NCT03624036|526475139|FG001|Overall Study|Withdrawal by Subject|0|||
145989505|NCT03624036|526475140|FG002|Overall Study|Withdrawal by Subject|1|||
145989506|NCT03624036|526475141|FG003|Overall Study|Withdrawal by Subject|0|||
145989507|NCT03624036|526475138|FG000|Overall Study|Enrolled but Never Treated|1|||
145989508|NCT03624036|526475139|FG001|Overall Study|Enrolled but Never Treated|0|||
145989509|NCT03624036|526475140|FG002|Overall Study|Enrolled but Never Treated|0|||
145989510|NCT03624036|526475141|FG003|Overall Study|Enrolled but Never Treated|0|||
145989511|NCT03624036|526475138|FG000|Overall Study|Reason not Specified|3|||
145989512|NCT03624036|526475139|FG001|Overall Study|Reason not Specified|0|||
145989513|NCT03624036|526475140|FG002|Overall Study|Reason not Specified|2|||
145989514|NCT03624036|526475141|FG003|Overall Study|Reason not Specified|2|||
145989515|NCT01390584|526475150|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
145989516|NCT01390584|526475151|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
145989517|NCT01390584|526475152|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
145989518|NCT00498485|526475153|FG000|Overall Study|Adverse Event|1|||
145989519|NCT00498485|526475154|FG001|Overall Study|Adverse Event|5|||
145989520|NCT02268851|526475155|FG000|Overall Study|Death|0|||
145989521|NCT02268851|526475156|FG001|Overall Study|Death|0|||
145989522|NCT02268851|526475157|FG002|Overall Study|Death|0|||
145989523|NCT02268851|526475158|FG003|Overall Study|Death|1|||
145989524|NCT02268851|526475159|FG004|Overall Study|Death|2|||
145989525|NCT02268851|526475160|FG005|Overall Study|Death|1|||
145989526|NCT02268851|526475155|FG000|Overall Study|Adverse Event|0|||
145989527|NCT02268851|526475156|FG001|Overall Study|Adverse Event|0|||
145989528|NCT02268851|526475157|FG002|Overall Study|Adverse Event|0|||
145989529|NCT02268851|526475158|FG003|Overall Study|Adverse Event|0|||
145989530|NCT02268851|526475159|FG004|Overall Study|Adverse Event|2|||
145989531|NCT02268851|526475160|FG005|Overall Study|Adverse Event|2|||
145989532|NCT02268851|526475155|FG000|Overall Study|Withdrawal by Subject|0|||
145989533|NCT02268851|526475156|FG001|Overall Study|Withdrawal by Subject|0|||
145989534|NCT02268851|526475157|FG002|Overall Study|Withdrawal by Subject|0|||
145989535|NCT02268851|526475158|FG003|Overall Study|Withdrawal by Subject|2|||
145989536|NCT02268851|526475159|FG004|Overall Study|Withdrawal by Subject|0|||
145989537|NCT02268851|526475160|FG005|Overall Study|Withdrawal by Subject|1|||
145989538|NCT02268851|526475155|FG000|Overall Study|Progressive Disease|1|||
145989539|NCT02268851|526475156|FG001|Overall Study|Progressive Disease|3|||
145989540|NCT02268851|526475157|FG002|Overall Study|Progressive Disease|0|||
145989541|NCT02268851|526475158|FG003|Overall Study|Progressive Disease|0|||
145989542|NCT02268851|526475159|FG004|Overall Study|Progressive Disease|1|||
145989543|NCT02268851|526475160|FG005|Overall Study|Progressive Disease|4|||
145989544|NCT02268851|526475155|FG000|Overall Study|Physician Decision|0|||
145989545|NCT02268851|526475156|FG001|Overall Study|Physician Decision|0|||
145989546|NCT02268851|526475157|FG002|Overall Study|Physician Decision|1|||
145989547|NCT02268851|526475158|FG003|Overall Study|Physician Decision|0|||
145989548|NCT02268851|526475159|FG004|Overall Study|Physician Decision|0|||
145989549|NCT02268851|526475160|FG005|Overall Study|Physician Decision|1|||
145989550|NCT02268851|526475155|FG000|Overall Study|Patient Compliance|0|||
145989551|NCT02268851|526475156|FG001|Overall Study|Patient Compliance|0|||
145989552|NCT02268851|526475157|FG002|Overall Study|Patient Compliance|0|||
145989553|NCT02268851|526475158|FG003|Overall Study|Patient Compliance|0|||
145989554|NCT02268851|526475159|FG004|Overall Study|Patient Compliance|1|||
145989555|NCT02268851|526475160|FG005|Overall Study|Patient Compliance|1|||
145989556|NCT02268851|526475155|FG000|Overall Study|Co-Morbid Condition|0|||
145989557|NCT02268851|526475156|FG001|Overall Study|Co-Morbid Condition|0|||
145989558|NCT02268851|526475157|FG002|Overall Study|Co-Morbid Condition|0|||
145989559|NCT02268851|526475158|FG003|Overall Study|Co-Morbid Condition|0|||
145989560|NCT02268851|526475159|FG004|Overall Study|Co-Morbid Condition|1|||
145989561|NCT02268851|526475160|FG005|Overall Study|Co-Morbid Condition|1|||
145989562|NCT03378635|526475163|FG000|Overall Study|Adverse Event|1|||
145989563|NCT03378635|526475164|FG001|Overall Study|Adverse Event|0|||
145989564|NCT03378635|526475165|FG002|Overall Study|Adverse Event|0|||
145989565|NCT03378635|526475163|FG000|Overall Study|Withdrawal by Subject|1|||
145989566|NCT03378635|526475164|FG001|Overall Study|Withdrawal by Subject|0|||
145989567|NCT03378635|526475165|FG002|Overall Study|Withdrawal by Subject|0|||
145989568|NCT01472835|526475168|FG000|Overall Study|Lost to Follow-up|2|||
145989569|NCT01472835|526475169|FG001|Overall Study|Lost to Follow-up|0|||
145989570|NCT02413346|526475170|FG000|Overall Study|Adverse Event|6|||
145989571|NCT02413346|526475171|FG001|Overall Study|Adverse Event|6|||
145989572|NCT02413346|526475170|FG000|Overall Study|Withdrawal by Subject|30|||
145989573|NCT02413346|526475171|FG001|Overall Study|Withdrawal by Subject|40|||
145989574|NCT02413346|526475170|FG000|Overall Study|Lost to Follow-up|17|||
145989575|NCT02413346|526475171|FG001|Overall Study|Lost to Follow-up|21|||
145989576|NCT02413346|526475170|FG000|Overall Study|Protocol Violation|2|||
145989577|NCT02413346|526475171|FG001|Overall Study|Protocol Violation|0|||
145989578|NCT02413346|526475170|FG000|Overall Study|Other Miscellaneous Reasons|4|||
145989579|NCT02413346|526475171|FG001|Overall Study|Other Miscellaneous Reasons|3|||
145989580|NCT02539394|526475172|FG000|Overall Study|Protocol Violation|1|||
145989581|NCT02539394|526475173|FG001|Overall Study|Protocol Violation|3|||
145989582|NCT02539394|526475172|FG000|Overall Study|Lost to Follow-up|1|||
145989583|NCT02539394|526475173|FG001|Overall Study|Lost to Follow-up|2|||
145989584|NCT02539394|526475172|FG000|Overall Study|Incomplete dataset|6|||
145989585|NCT02539394|526475173|FG001|Overall Study|Incomplete dataset|6|||
145989586|NCT03425188|526475176|FG000|Overall Study|Withdrawal by Subject|1|||
145989587|NCT01316900|526475179|FG000|Overall Study|Adverse Event|10|||
145989588|NCT01316900|526475180|FG001|Overall Study|Adverse Event|10|||
145989589|NCT01316900|526475181|FG002|Overall Study|Adverse Event|15|||
145989590|NCT01316900|526475182|FG003|Overall Study|Adverse Event|9|||
145989591|NCT01316900|526475179|FG000|Overall Study|Lack of Efficacy|17|||
145989592|NCT01316900|526475180|FG001|Overall Study|Lack of Efficacy|9|||
145989593|NCT01316900|526475181|FG002|Overall Study|Lack of Efficacy|5|||
145989594|NCT01316900|526475182|FG003|Overall Study|Lack of Efficacy|7|||
145989595|NCT01316900|526475179|FG000|Overall Study|Protocol Violation|7|||
145989596|NCT01316900|526475180|FG001|Overall Study|Protocol Violation|1|||
145989597|NCT01316900|526475181|FG002|Overall Study|Protocol Violation|4|||
146245969|NCT02008916|527414124|FG001|Week 16 - 156|Lost to Follow-up|0|||
145989598|NCT01316900|526475182|FG003|Overall Study|Protocol Violation|0|||
145989599|NCT01316900|526475179|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
145989600|NCT01316900|526475180|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
145989601|NCT01316900|526475181|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
145989602|NCT01316900|526475182|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
145989603|NCT01316900|526475179|FG000|Overall Study|Lost to Follow-up|1|||
145989604|NCT01316900|526475180|FG001|Overall Study|Lost to Follow-up|0|||
145989605|NCT01316900|526475181|FG002|Overall Study|Lost to Follow-up|1|||
145989606|NCT01316900|526475182|FG003|Overall Study|Lost to Follow-up|1|||
145989607|NCT01316900|526475179|FG000|Overall Study|Withdrawal by Subject|7|||
145989608|NCT01316900|526475180|FG001|Overall Study|Withdrawal by Subject|8|||
145989609|NCT01316900|526475181|FG002|Overall Study|Withdrawal by Subject|6|||
145989610|NCT01316900|526475182|FG003|Overall Study|Withdrawal by Subject|9|||
145989611|NCT00562861|526475183|FG000|Overall Study|Adverse Event|1|||
145989612|NCT00562861|526475184|FG001|Overall Study|Adverse Event|1|||
145989613|NCT00562861|526475183|FG000|Overall Study|Lack of Efficacy|5|||
145989614|NCT00562861|526475184|FG001|Overall Study|Lack of Efficacy|5|||
145989615|NCT00562861|526475183|FG000|Overall Study|noncompliance, moved|7|||
145989616|NCT00562861|526475184|FG001|Overall Study|noncompliance, moved|2|||
145989617|NCT00562861|526475183|FG000|Overall Study|Lost to Follow-up|7|||
145989618|NCT00562861|526475184|FG001|Overall Study|Lost to Follow-up|3|||
145989619|NCT05626686|526475185|FG000|Overall Study|Protocol Violation|3|||
145989620|NCT05626686|526475185|FG000|Overall Study|Withdrawal by Subject|3|||
145989621|NCT00289900|526475187|FG000|Overall Study|Adverse Event|28|||
145989622|NCT00289900|526475188|FG001|Overall Study|Adverse Event|40|||
145989623|NCT00289900|526475189|FG002|Overall Study|Adverse Event|13|||
145989624|NCT00289900|526475190|FG003|Overall Study|Adverse Event|19|||
145989625|NCT00289900|526475191|FG004|Overall Study|Adverse Event|20|||
145989626|NCT00289900|526475192|FG005|Overall Study|Adverse Event|33|||
145989627|NCT00289900|526475187|FG000|Overall Study|Lost to Follow-up|7|||
145989628|NCT00289900|526475188|FG001|Overall Study|Lost to Follow-up|7|||
145989629|NCT00289900|526475189|FG002|Overall Study|Lost to Follow-up|8|||
145989630|NCT00289900|526475190|FG003|Overall Study|Lost to Follow-up|8|||
145989631|NCT00289900|526475191|FG004|Overall Study|Lost to Follow-up|4|||
146245970|NCT02008916|527414125|FG002|Week 16 - 156|Lost to Follow-up|0|||
146245971|NCT02008916|527414123|FG000|Week 16 - 156|Lack of Efficacy|3|||
146245972|NCT02008916|527414124|FG001|Week 16 - 156|Lack of Efficacy|5|||
146245973|NCT02008916|527414125|FG002|Week 16 - 156|Lack of Efficacy|2|||
146245974|NCT02008916|527414123|FG000|Week 16 - 156|Pregnancy|0|||
145989632|NCT00289900|526475192|FG005|Overall Study|Lost to Follow-up|8|||
145989633|NCT00289900|526475187|FG000|Overall Study|Participant had flushing|18|||
145989634|NCT00289900|526475188|FG001|Overall Study|Participant had flushing|42|||
145989635|NCT00289900|526475189|FG002|Overall Study|Participant had flushing|1|||
145989636|NCT00289900|526475190|FG003|Overall Study|Participant had flushing|2|||
145989637|NCT00289900|526475191|FG004|Overall Study|Participant had flushing|0|||
145989638|NCT00289900|526475192|FG005|Overall Study|Participant had flushing|4|||
145989639|NCT00289900|526475187|FG000|Overall Study|Other|0|||
145989640|NCT00289900|526475188|FG001|Overall Study|Other|0|||
145989641|NCT00289900|526475189|FG002|Overall Study|Other|0|||
145989642|NCT00289900|526475190|FG003|Overall Study|Other|5|||
145989643|NCT00289900|526475191|FG004|Overall Study|Other|1|||
145989644|NCT00289900|526475192|FG005|Overall Study|Other|0|||
145989645|NCT00289900|526475187|FG000|Overall Study|Participant moved|1|||
145989646|NCT00289900|526475188|FG001|Overall Study|Participant moved|0|||
145989647|NCT00289900|526475189|FG002|Overall Study|Participant moved|0|||
145989648|NCT00289900|526475190|FG003|Overall Study|Participant moved|1|||
145989649|NCT00289900|526475191|FG004|Overall Study|Participant moved|1|||
145989650|NCT00289900|526475192|FG005|Overall Study|Participant moved|1|||
145989651|NCT00289900|526475187|FG000|Overall Study|Withdrawal by Subject|10|||
145989652|NCT00289900|526475188|FG001|Overall Study|Withdrawal by Subject|21|||
145989653|NCT00289900|526475189|FG002|Overall Study|Withdrawal by Subject|8|||
145989654|NCT00289900|526475190|FG003|Overall Study|Withdrawal by Subject|18|||
145989655|NCT00289900|526475191|FG004|Overall Study|Withdrawal by Subject|12|||
145989656|NCT00289900|526475192|FG005|Overall Study|Withdrawal by Subject|11|||
145989657|NCT00289900|526475187|FG000|Overall Study|Protocol Violation|3|||
146245975|NCT02008916|527414124|FG001|Week 16 - 156|Pregnancy|1|||
146245976|NCT02008916|527414125|FG002|Week 16 - 156|Pregnancy|0|||
145989658|NCT00289900|526475188|FG001|Overall Study|Protocol Violation|9|||
145989659|NCT00289900|526475189|FG002|Overall Study|Protocol Violation|2|||
145989660|NCT00289900|526475190|FG003|Overall Study|Protocol Violation|6|||
145989661|NCT00289900|526475191|FG004|Overall Study|Protocol Violation|7|||
145989662|NCT00289900|526475192|FG005|Overall Study|Protocol Violation|4|||
145989663|NCT00289900|526475187|FG000|Overall Study|site terminated|1|||
146245977|NCT02008916|527414123|FG000|Week 16 - 156|Physician Decision|0|||
145989664|NCT00289900|526475188|FG001|Overall Study|site terminated|0|||
146245978|NCT02008916|527414124|FG001|Week 16 - 156|Physician Decision|1|||
146245979|NCT02008916|527414125|FG002|Week 16 - 156|Physician Decision|0|||
146245980|NCT01528605|527414126|FG000|Overall Study|Lost to Follow-up|1|||
145989665|NCT00289900|526475189|FG002|Overall Study|site terminated|1|||
145989666|NCT00289900|526475190|FG003|Overall Study|site terminated|0|||
145989667|NCT00289900|526475191|FG004|Overall Study|site terminated|0|||
145989668|NCT00289900|526475192|FG005|Overall Study|site terminated|0|||
145989669|NCT00289900|526475187|FG000|Overall Study|Not treated|0|||
145989670|NCT00289900|526475188|FG001|Overall Study|Not treated|1|||
145989671|NCT00289900|526475189|FG002|Overall Study|Not treated|0|||
145989672|NCT00289900|526475190|FG003|Overall Study|Not treated|0|||
145989673|NCT00289900|526475191|FG004|Overall Study|Not treated|0|||
145989674|NCT00289900|526475192|FG005|Overall Study|Not treated|0|||
145989675|NCT01152385|526475193|FG000|Overall Study|Withdrawal by Subject|3|||
145989676|NCT01152385|526475194|FG001|Overall Study|Withdrawal by Subject|1|||
145989677|NCT01152385|526475195|FG002|Overall Study|Withdrawal by Subject|1|||
145989678|NCT01152385|526475196|FG003|Overall Study|Withdrawal by Subject|1|||
145989679|NCT01152385|526475193|FG000|Overall Study|Protocol Violation|0|||
145989680|NCT01152385|526475194|FG001|Overall Study|Protocol Violation|0|||
145989681|NCT01152385|526475195|FG002|Overall Study|Protocol Violation|0|||
145989682|NCT01152385|526475196|FG003|Overall Study|Protocol Violation|1|||
145989683|NCT01152385|526475193|FG000|Overall Study|Adverse Event|1|||
145989684|NCT01152385|526475194|FG001|Overall Study|Adverse Event|1|||
145989685|NCT01152385|526475195|FG002|Overall Study|Adverse Event|0|||
145989686|NCT01152385|526475196|FG003|Overall Study|Adverse Event|0|||
145989687|NCT01152385|526475193|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145989688|NCT01152385|526475194|FG001|Overall Study|Study-specific withdrawal criteria|1|||
145989689|NCT01152385|526475195|FG002|Overall Study|Study-specific withdrawal criteria|2|||
145989690|NCT01152385|526475196|FG003|Overall Study|Study-specific withdrawal criteria|0|||
145989691|NCT01152385|526475193|FG000|Overall Study|Other|4|||
145989692|NCT01152385|526475194|FG001|Overall Study|Other|3|||
145989693|NCT01152385|526475195|FG002|Overall Study|Other|2|||
145989694|NCT01152385|526475196|FG003|Overall Study|Other|3|||
145989695|NCT02656173|526475197|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
145989696|NCT02656173|526475198|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
145989697|NCT02656173|526475197|FG000|Overall Study|Adverse Event|7|||
145989698|NCT02656173|526475198|FG001|Overall Study|Adverse Event|5|||
145989699|NCT02656173|526475197|FG000|Overall Study|Withdrawal by Subject|1|||
145989700|NCT02656173|526475198|FG001|Overall Study|Withdrawal by Subject|3|||
145989701|NCT02656173|526475197|FG000|Overall Study|Protocol Violation|0|||
145989702|NCT02656173|526475198|FG001|Overall Study|Protocol Violation|1|||
145989703|NCT02656173|526475197|FG000|Overall Study|Miscellaneous|2|||
145989704|NCT02656173|526475198|FG001|Overall Study|Miscellaneous|0|||
145989705|NCT03449147|526475199|FG000|52-week Treatment Period|Death|0|||
145989706|NCT03449147|526475200|FG001|52-week Treatment Period|Death|1|||
145989707|NCT03449147|526475201|FG002|52-week Treatment Period|Death|0|||
145989708|NCT03449147|526475199|FG000|52-week Treatment Period|Lost to Follow-up|6|||
145989709|NCT03449147|526475200|FG001|52-week Treatment Period|Lost to Follow-up|2|||
145989710|NCT03449147|526475201|FG002|52-week Treatment Period|Lost to Follow-up|5|||
145989711|NCT03449147|526475199|FG000|52-week Treatment Period|Other|0|||
145989712|NCT03449147|526475200|FG001|52-week Treatment Period|Other|1|||
145989713|NCT03449147|526475201|FG002|52-week Treatment Period|Other|2|||
145989714|NCT03449147|526475199|FG000|52-week Treatment Period|Physician Decision|1|||
145989715|NCT03449147|526475200|FG001|52-week Treatment Period|Physician Decision|0|||
145989716|NCT03449147|526475201|FG002|52-week Treatment Period|Physician Decision|3|||
145989717|NCT03449147|526475199|FG000|52-week Treatment Period|Screen Failure|1|||
145989718|NCT03449147|526475200|FG001|52-week Treatment Period|Screen Failure|2|||
145989719|NCT03449147|526475201|FG002|52-week Treatment Period|Screen Failure|0|||
145989720|NCT03449147|526475199|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
145989721|NCT03449147|526475200|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
145989722|NCT03449147|526475201|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
145989723|NCT03449147|526475199|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
145989724|NCT03449147|526475200|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
145989725|NCT03449147|526475201|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
145989726|NCT03449147|526475199|FG000|12-Week Off-Treatment Durability Period|Other|0|||
145989727|NCT03449147|526475200|FG001|12-Week Off-Treatment Durability Period|Other|1|||
145989728|NCT03449147|526475201|FG002|12-Week Off-Treatment Durability Period|Other|0|||
145989729|NCT00992394|526475202|FG000|Overall Study|Lack of Efficacy|6|||
145989730|NCT00992394|526475203|FG001|Overall Study|Lack of Efficacy|3|||
145989731|NCT00992394|526475202|FG000|Overall Study|Adverse Event|4|||
145989732|NCT00992394|526475203|FG001|Overall Study|Adverse Event|5|||
145989733|NCT00992394|526475202|FG000|Overall Study|Withdrawal by Subject|8|||
145989734|NCT00992394|526475203|FG001|Overall Study|Withdrawal by Subject|2|||
145989735|NCT00992394|526475202|FG000|Overall Study|Physician Decision|1|||
145989736|NCT00992394|526475203|FG001|Overall Study|Physician Decision|0|||
145989737|NCT00992394|526475202|FG000|Overall Study|Protocol Violation|2|||
145989738|NCT00992394|526475203|FG001|Overall Study|Protocol Violation|4|||
145989739|NCT00992394|526475202|FG000|Overall Study|Lost to Follow-up|2|||
145989740|NCT00992394|526475203|FG001|Overall Study|Lost to Follow-up|0|||
145989741|NCT00992394|526475202|FG000|Overall Study|Other event|1|||
145989742|NCT00992394|526475203|FG001|Overall Study|Other event|0|||
145989743|NCT00974233|526475207|FG000|Induction Chemoimmunotherapy|Death|2|||
145989744|NCT00974233|526475207|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
145989745|NCT00974233|526475207|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
145989746|NCT00974233|526475207|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
145989747|NCT00974233|526475207|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
145989748|NCT00974233|526475207|FG000|Maintenance Lenalidomide|Adverse Event|8|||
145989749|NCT02113878|526476715|FG000|Overall Study|Adverse Event|1|||
145989750|NCT02113878|526476716|FG001|Overall Study|Adverse Event|0|||
145989751|NCT02113878|526476715|FG000|Overall Study|Withdrawal by Subject|1|||
145989752|NCT02113878|526476716|FG001|Overall Study|Withdrawal by Subject|0|||
145989753|NCT02113878|526476715|FG000|Overall Study|patient non-compliance|1|||
145989754|NCT02113878|526476716|FG001|Overall Study|patient non-compliance|0|||
145989755|NCT01251965|526476717|FG000|Overall Study|Participant/physician decision|1|||
145989756|NCT01251965|526476718|FG001|Overall Study|Participant/physician decision|2|||
145989757|NCT01251965|526476719|FG002|Overall Study|Participant/physician decision|0|||
145989758|NCT01251965|526476717|FG000|Overall Study|Death|0|||
145989759|NCT01251965|526476718|FG001|Overall Study|Death|0|||
145989760|NCT01251965|526476719|FG002|Overall Study|Death|11|||
145989761|NCT00530257|526476720|FG000|Overall Study|Lost to Follow-up|1|||
145989762|NCT05401409|526476723|FG000|Overall Study|Lost to Follow-up|1|||
145989763|NCT05401409|526476724|FG001|Overall Study|Lost to Follow-up|0|||
145989764|NCT02371889|526476725|FG000|Overall Study|Adverse medication effect|11|||
145989765|NCT02371889|526476726|FG001|Overall Study|Adverse medication effect|2|||
145989766|NCT02371889|526476725|FG000|Overall Study|Lost to Follow-up|6|||
145989767|NCT02371889|526476726|FG001|Overall Study|Lost to Follow-up|5|||
145989768|NCT02371889|526476725|FG000|Overall Study|Personal time constraints|2|||
145989769|NCT02371889|526476726|FG001|Overall Study|Personal time constraints|4|||
145989770|NCT02371889|526476725|FG000|Overall Study|Lack of Efficacy|0|||
145989771|NCT02371889|526476726|FG001|Overall Study|Lack of Efficacy|2|||
145989772|NCT02371889|526476725|FG000|Overall Study|Relapse|0|||
145989773|NCT02371889|526476726|FG001|Overall Study|Relapse|1|||
145989774|NCT06844812|526476727|FG000|Overall Study|Lost to Follow-up|5|||
145989775|NCT06844812|526476727|FG000|Overall Study|stigmatization concerns|2|||
145989776|NCT06844812|526476727|FG000|Overall Study|medication refusal|2|||
145989777|NCT06844812|526476727|FG000|Overall Study|concerns about possible side effects|2|||
145989778|NCT06844812|526476727|FG000|Overall Study|wanting to seek another specialist opinion|2|||
145989779|NCT06844812|526476727|FG000|Overall Study|side effects (dizziness)|1|||
145989780|NCT05520333|526476728|FG000|Overall Study|Lost to Follow-up|3|||
145989781|NCT05520333|526476729|FG001|Overall Study|Lost to Follow-up|6|||
145989782|NCT02410200|526476730|FG000|Overall Study|Adverse Event|2|||
145989783|NCT00203242|526476751|FG000|Overall Study|Lost to Follow-up|1|||
145989784|NCT00866775|526476752|FG000|Overall Study|Adverse Event|5|||
145989785|NCT00866775|526476753|FG001|Overall Study|Adverse Event|19|||
145989786|NCT00866775|526476752|FG000|Overall Study|Death|1|||
145989787|NCT00866775|526476753|FG001|Overall Study|Death|0|||
145989788|NCT00866775|526476752|FG000|Overall Study|Lost to Follow-up|0|||
145989789|NCT00866775|526476753|FG001|Overall Study|Lost to Follow-up|4|||
145989790|NCT00866775|526476752|FG000|Overall Study|Physician Decision|0|||
145989791|NCT00866775|526476753|FG001|Overall Study|Physician Decision|3|||
145989792|NCT00866775|526476752|FG000|Overall Study|Protocol Violation|3|||
145989793|NCT00866775|526476753|FG001|Overall Study|Protocol Violation|4|||
145989794|NCT00866775|526476752|FG000|Overall Study|Withdrawal by Subject|4|||
145989795|NCT00866775|526476753|FG001|Overall Study|Withdrawal by Subject|4|||
145989796|NCT00866775|526476752|FG000|Overall Study|met exit criteria|23|||
145989797|NCT00866775|526476753|FG001|Overall Study|met exit criteria|17|||
145989798|NCT00866775|526476752|FG000|Overall Study|discontinued due to communication error|0|||
145989799|NCT00866775|526476753|FG001|Overall Study|discontinued due to communication error|1|||
145989800|NCT01500135|526476754|FG000|Overall Study|Withdrawal of Consent|4|||
145989801|NCT01500135|526476755|FG001|Overall Study|Withdrawal of Consent|0|||
145989802|NCT01500135|526476754|FG000|Overall Study|Lost to Follow-up|6|||
145989803|NCT01500135|526476755|FG001|Overall Study|Lost to Follow-up|4|||
145989804|NCT01500135|526476754|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
145989805|NCT01500135|526476755|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
145989806|NCT01500135|526476754|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
145989807|NCT01500135|526476755|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
145989808|NCT01500135|526476754|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
145989809|NCT01500135|526476755|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
145989810|NCT01500135|526476754|FG000|Overall Study|Participant was a Safety Concern|1|||
145989811|NCT01500135|526476755|FG001|Overall Study|Participant was a Safety Concern|0|||
145989812|NCT01500135|526476754|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
145989813|NCT01500135|526476755|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
145989814|NCT00912509|526476756|FG000|Overall Study|Lost to Follow-up|1|||
145989815|NCT00912509|526476757|FG001|Overall Study|Lost to Follow-up|0|||
145989816|NCT00912509|526476756|FG000|Overall Study|Lack of Efficacy|4|||
145989817|NCT00912509|526476757|FG001|Overall Study|Lack of Efficacy|3|||
145989818|NCT05538728|526476758|FG000|Overall Study|Withdrawal by Subject|1|||
145989819|NCT05538728|526476759|FG001|Overall Study|Withdrawal by Subject|1|||
145989820|NCT01050218|526476760|FG000|Overall Study|Adverse Event|37|||
145989821|NCT01050218|526476760|FG000|Overall Study|Lack of Efficacy|8|||
145989822|NCT01050218|526476760|FG000|Overall Study|Protocol Violation|3|||
145989823|NCT01050218|526476760|FG000|Overall Study|Withdrawal by Subject|18|||
145989824|NCT01050218|526476760|FG000|Overall Study|Discontinued by sponsor|18|||
145989825|NCT01050218|526476760|FG000|Overall Study|Compliance|2|||
145989826|NCT01050218|526476760|FG000|Overall Study|Failed to return|7|||
145989827|NCT01050218|526476760|FG000|Overall Study|Serious Adverse Event|1|||
145989828|NCT01050218|526476760|FG000|Overall Study|Family emergency|1|||
145989829|NCT01772693|526476761|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
145989830|NCT01772693|526476762|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
145989831|NCT01772693|526476761|FG000|Overall Study|Withdrawal by Subject|2|||
145989832|NCT01772693|526476762|FG001|Overall Study|Withdrawal by Subject|0|||
145989833|NCT01772693|526476761|FG000|Overall Study|Alternative Treatment|2|||
145989834|NCT01772693|526476762|FG001|Overall Study|Alternative Treatment|0|||
145989835|NCT00889005|526476771|FG000|Overall Study|Lost to Follow-up|4|||
145989836|NCT00889005|526476772|FG001|Overall Study|Lost to Follow-up|2|||
145989837|NCT00889005|526476771|FG000|Overall Study|Withdrawal by Subject|4|||
145989838|NCT00889005|526476772|FG001|Overall Study|Withdrawal by Subject|0|||
145989839|NCT00756314|526476776|FG000|Overall Study|Lost to Follow-up|2|||
145989840|NCT00756314|526476777|FG001|Overall Study|Lost to Follow-up|59|||
145989841|NCT02605967|526476779|FG000|Overall Study|subject / guardian decision|1|||
145989842|NCT02605967|526476780|FG001|Overall Study|subject / guardian decision|2|||
145989843|NCT02605967|526476779|FG000|Overall Study|Physician Decision|10|||
145989844|NCT02605967|526476780|FG001|Overall Study|Physician Decision|1|||
145989845|NCT02605967|526476779|FG000|Overall Study|Death|4|||
145989846|NCT02605967|526476780|FG001|Overall Study|Death|2|||
145989847|NCT02605967|526476779|FG000|Overall Study|Adverse Event|1|||
145989848|NCT02605967|526476780|FG001|Overall Study|Adverse Event|0|||
145989849|NCT02605967|526476779|FG000|Overall Study|progressive disease|66|||
145989850|NCT02605967|526476780|FG001|Overall Study|progressive disease|35|||
145989851|NCT01903720|526476781|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
145989852|NCT01903720|526476781|FG000|Overall Study|Adverse Event|1|||
145989853|NCT01903720|526476781|FG000|Overall Study|Rescinding of informed consent|2|||
145989854|NCT01903720|526476781|FG000|Overall Study|Lost to Follow-up|2|||
145989855|NCT01903720|526476781|FG000|Overall Study|Treatment with alternative drug|1|||
145989856|NCT00692237|526476784|FG000|Overall Study|Withdrawal by Subject|1|||
145989857|NCT00692237|526476785|FG001|Overall Study|Withdrawal by Subject|3|||
145989858|NCT00692237|526476784|FG000|Overall Study|Adverse Event|0|||
145989859|NCT00692237|526476785|FG001|Overall Study|Adverse Event|1|||
145989860|NCT02244957|526476786|FG000|Overall Study|Lack of Efficacy|1|||
145989861|NCT02244957|526476787|FG001|Overall Study|Lack of Efficacy|0|||
145989862|NCT01347086|526476790|FG000|Overall Study|failed screening visit|0|||
145989863|NCT01347086|526476791|FG001|Overall Study|failed screening visit|0|||
145989864|NCT01347086|526476792|FG002|Overall Study|failed screening visit|1|||
145989865|NCT01347086|526476793|FG003|Overall Study|failed screening visit|0|||
145989866|NCT01347086|526476794|FG004|Overall Study|failed screening visit|0|||
145989867|NCT01347086|526476795|FG005|Overall Study|failed screening visit|0|||
145989868|NCT01347086|526476796|FG006|Overall Study|failed screening visit|1|||
145989869|NCT01347086|526476797|FG007|Overall Study|failed screening visit|1|||
145989870|NCT01347086|526476798|FG008|Overall Study|failed screening visit|0|||
145989871|NCT01347086|526476799|FG009|Overall Study|failed screening visit|1|||
145989872|NCT02624687|526476801|FG000|Overall Study|Withdrawal by Subject|1|||
145989873|NCT02624687|526476802|FG001|Overall Study|Withdrawal by Subject|1|||
145989874|NCT02624687|526476801|FG000|Overall Study|medical leave from work|0|||
145989875|NCT02624687|526476802|FG001|Overall Study|medical leave from work|1|||
145989876|NCT03111108|526476803|FG000|Overall Study|Death|0|||
145989877|NCT03111108|526476804|FG001|Overall Study|Death|1|||
145989878|NCT03111108|526476803|FG000|Overall Study|Withdrawal by Subject|1|||
145989879|NCT03111108|526476804|FG001|Overall Study|Withdrawal by Subject|0|||
145989880|NCT01853280|526476805|FG000|Overall Study|Lack of Efficacy|2|||
145989881|NCT01853280|526476806|FG001|Overall Study|Lack of Efficacy|2|||
145989882|NCT01853280|526476805|FG000|Overall Study|Lost to Follow-up|0|||
145989883|NCT01853280|526476806|FG001|Overall Study|Lost to Follow-up|1|||
145989884|NCT01853280|526476805|FG000|Overall Study|Physician Decision|0|||
145989885|NCT01853280|526476806|FG001|Overall Study|Physician Decision|1|||
145989886|NCT01853280|526476805|FG000|Overall Study|Withdrawal by Subject|0|||
145989887|NCT01853280|526476806|FG001|Overall Study|Withdrawal by Subject|1|||
145989888|NCT01853280|526476805|FG000|Overall Study|Ineligible|0|||
145989889|NCT01853280|526476806|FG001|Overall Study|Ineligible|1|||
145989890|NCT00104884|526476807|FG000|Overall Study|Disease progression|4|||
145989891|NCT03032484|526476808|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
145989892|NCT03032484|526476809|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
145989893|NCT03032484|526476808|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
145989894|NCT03032484|526476809|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
145989895|NCT01689649|526476810|FG000|Overall Study|Lack of Efficacy|3|||
146297869|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145989896|NCT01689649|526476810|FG000|Overall Study|Non-compliance|11|||
145989897|NCT01689649|526476810|FG000|Overall Study|Protocol Violation|3|||
145989898|NCT01689649|526476810|FG000|Overall Study|Lost to Follow-up|5|||
145989899|NCT03760081|526476824|FG000|Overall Study|Miscellaneous|0|||
145989900|NCT03760081|526476825|FG001|Overall Study|Miscellaneous|1|||
145989901|NCT03760081|526476824|FG000|Overall Study|Progressive Disease|5|||
145989902|NCT03760081|526476825|FG001|Overall Study|Progressive Disease|10|||
145989903|NCT03760081|526476824|FG000|Overall Study|Death|1|||
145989904|NCT03760081|526476825|FG001|Overall Study|Death|1|||
145989905|NCT01725282|526476826|FG000|Overall Study|Adverse Event|1|||
145989906|NCT01725282|526476827|FG001|Overall Study|Adverse Event|3|||
145989907|NCT01725282|526476828|FG002|Overall Study|Adverse Event|6|||
145989908|NCT01725282|526476829|FG003|Overall Study|Adverse Event|4|||
145989909|NCT01725282|526476826|FG000|Overall Study|Exacerbation of Target Disease|1|||
145989910|NCT01725282|526476827|FG001|Overall Study|Exacerbation of Target Disease|0|||
145989911|NCT01725282|526476828|FG002|Overall Study|Exacerbation of Target Disease|0|||
145989912|NCT01725282|526476829|FG003|Overall Study|Exacerbation of Target Disease|1|||
145989913|NCT01725282|526476826|FG000|Overall Study|Met Exclusion Criteria|0|||
145989914|NCT01725282|526476827|FG001|Overall Study|Met Exclusion Criteria|0|||
145989915|NCT01725282|526476828|FG002|Overall Study|Met Exclusion Criteria|1|||
145989916|NCT01725282|526476829|FG003|Overall Study|Met Exclusion Criteria|0|||
145989917|NCT01725282|526476826|FG000|Overall Study|Study Site Withdrawal|0|||
145989918|NCT01725282|526476827|FG001|Overall Study|Study Site Withdrawal|1|||
145989919|NCT01725282|526476828|FG002|Overall Study|Study Site Withdrawal|0|||
145989920|NCT01725282|526476829|FG003|Overall Study|Study Site Withdrawal|0|||
145989921|NCT01725282|526476826|FG000|Overall Study|Withdrawal by Subject|0|||
145989922|NCT01725282|526476827|FG001|Overall Study|Withdrawal by Subject|0|||
145989923|NCT01725282|526476828|FG002|Overall Study|Withdrawal by Subject|1|||
145989924|NCT01725282|526476829|FG003|Overall Study|Withdrawal by Subject|1|||
145989925|NCT01725282|526476826|FG000|Overall Study|Lack of Efficacy|0|||
145989926|NCT01725282|526476827|FG001|Overall Study|Lack of Efficacy|1|||
145989927|NCT01725282|526476828|FG002|Overall Study|Lack of Efficacy|0|||
145989928|NCT01725282|526476829|FG003|Overall Study|Lack of Efficacy|1|||
145989929|NCT04064567|526476830|FG000|Overall Study|Lost to Follow-up|23|||
145989930|NCT04064567|526476831|FG001|Overall Study|Lost to Follow-up|22|||
145989931|NCT04064567|526476830|FG000|Overall Study|Withdrawal by Subject|0|||
145989932|NCT04064567|526476831|FG001|Overall Study|Withdrawal by Subject|1|||
145989933|NCT04064567|526476830|FG000|Overall Study|Reincarcerated|7|||
145989934|NCT04064567|526476831|FG001|Overall Study|Reincarcerated|10|||
145989935|NCT04064567|526476830|FG000|Overall Study|Moved out of U.S.|0|||
145989936|NCT04064567|526476831|FG001|Overall Study|Moved out of U.S.|1|||
145989937|NCT05524948|526476837|FG000|Overall Study|Withdrawal by Subject|1|||
145989938|NCT05524948|526476838|FG001|Overall Study|Withdrawal by Subject|0|||
145989939|NCT05524948|526476837|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
145989940|NCT05524948|526476838|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
145989941|NCT02758626|526476841|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
145989942|NCT02758626|526476842|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
145989943|NCT02758626|526476841|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
145989944|NCT02758626|526476842|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
145989945|NCT02758626|526476841|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
145989946|NCT02758626|526476842|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
145989947|NCT02758626|526476841|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
145989948|NCT02758626|526476842|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
145989949|NCT02739828|526476843|FG000|Overall Study|Adverse Event|1|||
145989950|NCT02739828|526476843|FG000|Overall Study|Lost to Follow-up|4|||
145989951|NCT01682720|526476851|FG000|Overall Study|Randomized but Not Treated|0|||
145989952|NCT01682720|526476852|FG001|Overall Study|Randomized but Not Treated|1|||
145989953|NCT01682720|526476853|FG002|Overall Study|Randomized but Not Treated|1|||
145989954|NCT01682720|526476854|FG003|Overall Study|Randomized but Not Treated|0|||
146245981|NCT01528605|527414127|FG001|Overall Study|Lost to Follow-up|0|||
146245982|NCT01528605|527414128|FG002|Overall Study|Lost to Follow-up|1|||
146245983|NCT01528605|527414129|FG003|Overall Study|Lost to Follow-up|1|||
146245984|NCT01528605|527414130|FG004|Overall Study|Lost to Follow-up|0|||
146245985|NCT01528605|527414131|FG005|Overall Study|Lost to Follow-up|0|||
146245986|NCT01528605|527414126|FG000|Overall Study|Death|1|||
145989955|NCT01682720|526476851|FG000|Overall Study|Terminated by Sponsor|83|||
145989956|NCT01682720|526476852|FG001|Overall Study|Terminated by Sponsor|0|||
145989957|NCT01682720|526476853|FG002|Overall Study|Terminated by Sponsor|0|||
145989958|NCT01682720|526476854|FG003|Overall Study|Terminated by Sponsor|0|||
145989959|NCT01682720|526476851|FG000|Overall Study|Efficacy Failure|0|||
145989960|NCT01682720|526476852|FG001|Overall Study|Efficacy Failure|3|||
145989961|NCT01682720|526476853|FG002|Overall Study|Efficacy Failure|3|||
145989962|NCT01682720|526476854|FG003|Overall Study|Efficacy Failure|30|||
145989963|NCT01682720|526476851|FG000|Overall Study|Lost to Follow-up|1|||
145989964|NCT01682720|526476852|FG001|Overall Study|Lost to Follow-up|1|||
146245987|NCT01528605|527414127|FG001|Overall Study|Death|0|||
146245988|NCT01528605|527414128|FG002|Overall Study|Death|0|||
146245989|NCT01528605|527414129|FG003|Overall Study|Death|0|||
145989965|NCT01682720|526476853|FG002|Overall Study|Lost to Follow-up|0|||
145989966|NCT01682720|526476854|FG003|Overall Study|Lost to Follow-up|6|||
145989967|NCT01682720|526476851|FG000|Overall Study|Subject Withdrew Consent|0|||
145989968|NCT01682720|526476852|FG001|Overall Study|Subject Withdrew Consent|0|||
145989969|NCT01682720|526476853|FG002|Overall Study|Subject Withdrew Consent|2|||
145989970|NCT01682720|526476854|FG003|Overall Study|Subject Withdrew Consent|2|||
145989971|NCT01682720|526476851|FG000|Overall Study|Adverse Event|1|||
145989972|NCT01682720|526476852|FG001|Overall Study|Adverse Event|0|||
145989973|NCT01682720|526476853|FG002|Overall Study|Adverse Event|1|||
145989974|NCT01682720|526476854|FG003|Overall Study|Adverse Event|1|||
145989975|NCT04204902|526476857|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
145989976|NCT04204902|526476858|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
145989977|NCT02202577|526476859|FG000|Overall Study|Lost to Follow-up|6|||
145989978|NCT02202577|526476860|FG001|Overall Study|Lost to Follow-up|16|||
145989979|NCT02202577|526476859|FG000|Overall Study|Protocol Violation|7|||
145989980|NCT02202577|526476860|FG001|Overall Study|Protocol Violation|3|||
145989981|NCT01618708|526476861|FG000|Overall Study|Adverse Event|10|||
145989982|NCT01618708|526476862|FG001|Overall Study|Adverse Event|10|||
145989983|NCT01618708|526476861|FG000|Overall Study|Lost to Follow-up|3|||
145989984|NCT01618708|526476862|FG001|Overall Study|Lost to Follow-up|3|||
145989985|NCT01618708|526476861|FG000|Overall Study|Withdrawal by Subject|17|||
145989986|NCT01618708|526476862|FG001|Overall Study|Withdrawal by Subject|22|||
145989987|NCT01618708|526476861|FG000|Overall Study|Lack of Efficacy|8|||
145989988|NCT01618708|526476862|FG001|Overall Study|Lack of Efficacy|8|||
145989989|NCT01618708|526476861|FG000|Overall Study|Technical problems|2|||
145989990|NCT01618708|526476862|FG001|Overall Study|Technical problems|0|||
145989991|NCT01618708|526476861|FG000|Overall Study|Other than specified above|1|||
145989992|NCT01618708|526476862|FG001|Overall Study|Other than specified above|1|||
145989993|NCT01618708|526476861|FG000|Overall Study|Randomized but not treated|3|||
145989994|NCT01618708|526476862|FG001|Overall Study|Randomized but not treated|2|||
145989995|NCT00489476|526476866|FG000|Overall Study|Lost to Follow-up|0|||
145989996|NCT00489476|526476867|FG001|Overall Study|Lost to Follow-up|1|||
145989997|NCT00489476|526476868|FG002|Overall Study|Lost to Follow-up|0|||
145989998|NCT00489476|526476869|FG003|Overall Study|Lost to Follow-up|0|||
145989999|NCT02757963|526476878|FG000|Overall Study|Adverse Event|3|||
145990000|NCT02757963|526476878|FG000|Overall Study|Reached Stopping Criteria|1054|||
145990001|NCT02757963|526476878|FG000|Overall Study|Lost to Follow-up|5|||
145990002|NCT02757963|526476878|FG000|Overall Study|Physician Decision|1|||
145990003|NCT02757963|526476878|FG000|Overall Study|Withdrawal by Subject|34|||
145990004|NCT00655356|526476879|FG000|Overall Study|Withdrawal by Subject|3|||
145990005|NCT00655356|526476880|FG001|Overall Study|Withdrawal by Subject|4|||
145990006|NCT00655356|526476879|FG000|Overall Study|Sponsor Request|10|||
145990007|NCT00655356|526476880|FG001|Overall Study|Sponsor Request|4|||
145990008|NCT00655356|526476879|FG000|Overall Study|Adverse Event|1|||
145990009|NCT00655356|526476880|FG001|Overall Study|Adverse Event|1|||
145990010|NCT00655356|526476879|FG000|Overall Study|Protocol Violation|2|||
145990011|NCT00655356|526476880|FG001|Overall Study|Protocol Violation|1|||
145990012|NCT00655356|526476879|FG000|Overall Study|Other Reason|1|||
145990013|NCT00655356|526476880|FG001|Overall Study|Other Reason|0|||
145990014|NCT01044459|526476881|FG000|Overall Study|Withdrawal by Subject|21|||
145990015|NCT01044459|526476882|FG001|Overall Study|Withdrawal by Subject|28|||
145990016|NCT01044459|526476881|FG000|Overall Study|Terminated by Sponsor|22|||
145990017|NCT01044459|526476882|FG001|Overall Study|Terminated by Sponsor|21|||
145990018|NCT01044459|526476881|FG000|Overall Study|Adverse Event|22|||
145990019|NCT01044459|526476882|FG001|Overall Study|Adverse Event|20|||
145990020|NCT01044459|526476881|FG000|Overall Study|Lack of Efficacy|23|||
145990021|NCT01044459|526476882|FG001|Overall Study|Lack of Efficacy|12|||
145990022|NCT01044459|526476881|FG000|Overall Study|Protocol Violation|11|||
145990023|NCT01044459|526476882|FG001|Overall Study|Protocol Violation|16|||
145990024|NCT01044459|526476881|FG000|Overall Study|Other Reason|7|||
145990025|NCT01044459|526476882|FG001|Overall Study|Other Reason|14|||
145990026|NCT01044459|526476881|FG000|Overall Study|COPD exacerbation|9|||
145990027|NCT01044459|526476882|FG001|Overall Study|COPD exacerbation|8|||
145990028|NCT01044459|526476881|FG000|Overall Study|Lost to Follow-up|18|||
145990029|NCT01044459|526476882|FG001|Overall Study|Lost to Follow-up|12|||
145990030|NCT04105725|526476883|FG000|Primary Intervention|Lost to Follow-up|0|||
145990031|NCT04105725|526476884|FG001|Primary Intervention|Lost to Follow-up|2|||
145990032|NCT04105725|526476883|FG000|Primary Intervention|Withdrawal by Subject|0|||
145990033|NCT04105725|526476884|FG001|Primary Intervention|Withdrawal by Subject|1|||
145990034|NCT05346640|526476885|FG000|Overall Study|Lack of Efficacy|2|||
145990035|NCT05346640|526476885|FG000|Overall Study|Lost to Follow-up|14|||
146245990|NCT01528605|527414130|FG004|Overall Study|Death|0|||
145990036|NCT05346640|526476885|FG000|Overall Study|Protocol Violation|4|||
145990037|NCT05346640|526476885|FG000|Overall Study|Withdrawal by Subject|2|||
145990038|NCT05346640|526476885|FG000|Overall Study|Physiological Complications|3|||
145990039|NCT05346640|526476885|FG000|Overall Study|Other Reason|3|||
145990040|NCT04634331|526476886|FG000|Overall Study|Withdrawal by Subject|2|||
145990041|NCT04634331|526476887|FG001|Overall Study|Withdrawal by Subject|2|||
145990042|NCT00507507|526476888|FG000|Treatment Period|Lost to Follow-up|0|||
146245991|NCT01528605|527414131|FG005|Overall Study|Death|0|||
146245992|NCT01681511|527414132|FG000|Overall Study|No Treatment Received|1|||
146245993|NCT01681511|527414133|FG001|Overall Study|No Treatment Received|3|||
146245994|NCT01681511|527414132|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
146245995|NCT01681511|527414133|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
146245996|NCT01681511|527414132|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
146245997|NCT01681511|527414133|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
146245998|NCT01681511|527414132|FG000|Overall Study|No Daily Urine Sample Collected|0|||
145990043|NCT00507507|526476889|FG001|Treatment Period|Lost to Follow-up|2|||
145990044|NCT00507507|526476888|FG000|Treatment Period|Physician Decision|4|||
145990045|NCT00507507|526476889|FG001|Treatment Period|Physician Decision|1|||
145990046|NCT00507507|526476888|FG000|Treatment Period|Protocol Violation|1|||
145990047|NCT00507507|526476889|FG001|Treatment Period|Protocol Violation|2|||
145990048|NCT00507507|526476888|FG000|Treatment Period|Adverse Event|1|||
145990049|NCT00507507|526476889|FG001|Treatment Period|Adverse Event|1|||
145990050|NCT00507507|526476888|FG000|Treatment Period|Withdrawal by Subject|46|||
145990051|NCT00507507|526476889|FG001|Treatment Period|Withdrawal by Subject|47|||
145990052|NCT00507507|526476888|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
145990053|NCT00507507|526476889|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
145990054|NCT00507507|526476888|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
145990055|NCT00507507|526476889|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
145990056|NCT00507507|526476888|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
145990057|NCT00507507|526476889|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
145990058|NCT02916433|526476890|FG000|Overall Study|Withdrawal by Subject|1|||
145990059|NCT02916433|526476891|FG001|Overall Study|Withdrawal by Subject|0|||
145990060|NCT02916433|526476890|FG000|Overall Study|Physician Decision|1|||
145990061|NCT02916433|526476891|FG001|Overall Study|Physician Decision|0|||
145990062|NCT01694771|526476892|FG000|Overall Study|Adverse Event|18|||
145990063|NCT01694771|526476893|FG001|Overall Study|Adverse Event|16|||
145990064|NCT01694771|526476892|FG000|Overall Study|Lack of Efficacy|1|||
145990065|NCT01694771|526476893|FG001|Overall Study|Lack of Efficacy|0|||
145990066|NCT01694771|526476892|FG000|Overall Study|Non compliance protocol|7|||
145990067|NCT01694771|526476893|FG001|Overall Study|Non compliance protocol|6|||
145990068|NCT01694771|526476892|FG000|Overall Study|Lost to Follow-up|2|||
145990069|NCT01694771|526476893|FG001|Overall Study|Lost to Follow-up|3|||
145990070|NCT01694771|526476892|FG000|Overall Study|Consent withdrawn|7|||
145990071|NCT01694771|526476893|FG001|Overall Study|Consent withdrawn|9|||
145990072|NCT01694771|526476892|FG000|Overall Study|Other reasons|5|||
145990073|NCT01694771|526476893|FG001|Overall Study|Other reasons|6|||
145990074|NCT03927846|526476896|FG000|Overall Study|Lost to Follow-up|10|||
145990075|NCT03927846|526476897|FG001|Overall Study|Lost to Follow-up|11|||
145990076|NCT03878069|526476898|FG000|Overall Study|Death|0|||
145990077|NCT03878069|526476899|FG001|Overall Study|Death|1|||
145990078|NCT03878069|526476900|FG002|Overall Study|Death|0|||
145990079|NCT01197300|526478131|FG000|Overall Study|Lost to Follow-up|0|||
145990080|NCT01197300|526478132|FG001|Overall Study|Lost to Follow-up|1|||
145990081|NCT01197300|526478131|FG000|Overall Study|Protocol Violation|0|||
145990082|NCT01197300|526478132|FG001|Overall Study|Protocol Violation|1|||
145990083|NCT04744831|526478133|FG000|Overall Study|Progressive Disease|31|||
145990084|NCT04744831|526478134|FG001|Overall Study|Progressive Disease|27|||
145990085|NCT04744831|526478135|FG002|Overall Study|Progressive Disease|25|||
145990086|NCT04744831|526478133|FG000|Overall Study|Adverse Event|3|||
145990087|NCT04744831|526478134|FG001|Overall Study|Adverse Event|3|||
146245999|NCT01681511|527414133|FG001|Overall Study|No Daily Urine Sample Collected|1|||
145990088|NCT04744831|526478135|FG002|Overall Study|Adverse Event|3|||
145990089|NCT04744831|526478133|FG000|Overall Study|Clinical Progression|3|||
145990090|NCT04744831|526478134|FG001|Overall Study|Clinical Progression|2|||
145990091|NCT04744831|526478135|FG002|Overall Study|Clinical Progression|5|||
145990092|NCT04744831|526478133|FG000|Overall Study|Other|0|||
145990093|NCT04744831|526478134|FG001|Overall Study|Other|2|||
145990094|NCT04744831|526478135|FG002|Overall Study|Other|1|||
145990095|NCT04744831|526478133|FG000|Overall Study|Death|0|||
145990096|NCT04744831|526478134|FG001|Overall Study|Death|2|||
145990097|NCT04744831|526478135|FG002|Overall Study|Death|1|||
145990098|NCT00590317|526478140|FG000|Overall Study|Lack of Efficacy|1|||
145990099|NCT00590317|526478141|FG001|Overall Study|Lack of Efficacy|5|||
145990100|NCT03443401|526478148|FG000|Overall Study|Lost to Follow-up|13|||
145990101|NCT03443401|526478148|FG000|Overall Study|Influential outlier|1|||
145990102|NCT02363283|526478149|FG000|Overall Study|Withdrawal by Subject|1|||
145990103|NCT02363283|526478149|FG000|Overall Study|Not eligible due to transaminitis|1|||
145990104|NCT04616196|526478156|FG000|Overall Study|Progressive Disease|3|||
145990105|NCT04616196|526478157|FG001|Overall Study|Progressive Disease|0|||
146246000|NCT01681511|527414132|FG000|Overall Study|No post-catheter sample collected|11|||
146246001|NCT01681511|527414133|FG001|Overall Study|No post-catheter sample collected|4|||
146246002|NCT01156675|527414134|FG000|Overall Study|Death|5|||
145990106|NCT04616196|526478158|FG002|Overall Study|Progressive Disease|4|||
145990107|NCT04616196|526478159|FG003|Overall Study|Progressive Disease|1|||
145990108|NCT04616196|526478156|FG000|Overall Study|Death|2|||
145990109|NCT04616196|526478157|FG001|Overall Study|Death|4|||
145990110|NCT04616196|526478158|FG002|Overall Study|Death|1|||
145990111|NCT04616196|526478159|FG003|Overall Study|Death|0|||
145990112|NCT04616196|526478156|FG000|Overall Study|Withdrawal by Subject|0|||
145990113|NCT04616196|526478157|FG001|Overall Study|Withdrawal by Subject|2|||
145990114|NCT04616196|526478158|FG002|Overall Study|Withdrawal by Subject|0|||
145990115|NCT04616196|526478159|FG003|Overall Study|Withdrawal by Subject|0|||
145990116|NCT04616196|526478156|FG000|Overall Study|Lost to Follow-up|1|||
145990117|NCT04616196|526478157|FG001|Overall Study|Lost to Follow-up|0|||
146246003|NCT01156675|527414135|FG001|Overall Study|Death|3|||
145990118|NCT04616196|526478158|FG002|Overall Study|Lost to Follow-up|0|||
145990119|NCT04616196|526478159|FG003|Overall Study|Lost to Follow-up|0|||
145990120|NCT04616196|526478156|FG000|Overall Study|Sponsor request|2|||
145990121|NCT04616196|526478157|FG001|Overall Study|Sponsor request|1|||
145990122|NCT04616196|526478158|FG002|Overall Study|Sponsor request|1|||
145990123|NCT04616196|526478159|FG003|Overall Study|Sponsor request|2|||
145990124|NCT01394185|526478160|FG000|Overall Study|Withdrawal by Subject|2|||
145990125|NCT01394185|526478161|FG001|Overall Study|Withdrawal by Subject|0|||
145990126|NCT01394185|526478162|FG002|Overall Study|Withdrawal by Subject|0|||
145990127|NCT01394185|526478163|FG003|Overall Study|Withdrawal by Subject|0|||
145990128|NCT01394185|526478164|FG004|Overall Study|Withdrawal by Subject|1|||
145990129|NCT01394185|526478165|FG005|Overall Study|Withdrawal by Subject|0|||
145990130|NCT01394185|526478160|FG000|Overall Study|Change in protocol|3|||
145990131|NCT01394185|526478161|FG001|Overall Study|Change in protocol|0|||
145990132|NCT01394185|526478162|FG002|Overall Study|Change in protocol|0|||
145990133|NCT01394185|526478163|FG003|Overall Study|Change in protocol|0|||
145990134|NCT01394185|526478164|FG004|Overall Study|Change in protocol|3|||
145990135|NCT01394185|526478165|FG005|Overall Study|Change in protocol|0|||
145990136|NCT01394185|526478160|FG000|Overall Study|Protocol Violation|1|||
145990137|NCT01394185|526478161|FG001|Overall Study|Protocol Violation|0|||
145990138|NCT01394185|526478162|FG002|Overall Study|Protocol Violation|0|||
145990139|NCT01394185|526478163|FG003|Overall Study|Protocol Violation|1|||
145990140|NCT01394185|526478164|FG004|Overall Study|Protocol Violation|0|||
145990141|NCT01394185|526478165|FG005|Overall Study|Protocol Violation|1|||
145990142|NCT01681849|526478171|FG000|Overall Study|Protocol Violation|2|||
145990143|NCT01681849|526478172|FG001|Overall Study|Protocol Violation|0|||
145990144|NCT01681849|526478173|FG002|Overall Study|Protocol Violation|0|||
145990145|NCT01681849|526478171|FG000|Overall Study|Withdrawal by Subject|3|||
145990146|NCT01681849|526478172|FG001|Overall Study|Withdrawal by Subject|5|||
145990147|NCT01681849|526478173|FG002|Overall Study|Withdrawal by Subject|33|||
145990148|NCT01681849|526478171|FG000|Overall Study|Lost to Follow-up|3|||
145990149|NCT01681849|526478172|FG001|Overall Study|Lost to Follow-up|2|||
145990150|NCT01681849|526478173|FG002|Overall Study|Lost to Follow-up|6|||
145990151|NCT04525183|526478176|FG000|Overall Study|Withdrawal by Subject|0|||
145990152|NCT04525183|526478177|FG001|Overall Study|Withdrawal by Subject|0|||
145990153|NCT04525183|526478178|FG002|Overall Study|Withdrawal by Subject|3|||
145990154|NCT04525183|526478176|FG000|Overall Study|Study non-compliance|0|||
145990155|NCT04525183|526478177|FG001|Overall Study|Study non-compliance|0|||
145990156|NCT04525183|526478178|FG002|Overall Study|Study non-compliance|1|||
145990157|NCT04525183|526478176|FG000|Overall Study|Recurrent disease before starting on study|0|||
145990158|NCT04525183|526478177|FG001|Overall Study|Recurrent disease before starting on study|0|||
145990159|NCT04525183|526478178|FG002|Overall Study|Recurrent disease before starting on study|1|||
145990160|NCT01166646|526478179|FG000|Overall Study|Protocol Violation|0|||
145990161|NCT01166646|526478180|FG001|Overall Study|Protocol Violation|1|||
145990162|NCT01166646|526478179|FG000|Overall Study|Adverse Event|1|||
145990163|NCT01166646|526478180|FG001|Overall Study|Adverse Event|0|||
145990164|NCT03777020|526478181|FG000|Overall Study|Withdrawal by Subject|4|||
145990165|NCT03777020|526478182|FG001|Overall Study|Withdrawal by Subject|4|||
145990166|NCT03777020|526478181|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
145990167|NCT03777020|526478182|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
146246004|NCT01156675|527414136|FG002|Overall Study|Death|0|||
146246005|NCT01156675|527414134|FG000|Overall Study|No data|29|||
146246006|NCT01156675|527414135|FG001|Overall Study|No data|22|||
146246007|NCT01156675|527414136|FG002|Overall Study|No data|2|||
145990168|NCT03460704|526478183|FG000|Overall Study|Withdrawal by Subject|11|||
146246008|NCT02432274|527414150|FG000|Overall Study|Death|2|||
146246009|NCT02432274|527414151|FG001|Overall Study|Death|6|||
145990169|NCT03460704|526478184|FG001|Overall Study|Withdrawal by Subject|14|||
145990170|NCT03460704|526478183|FG000|Overall Study|Study terminated by the Sponsor|29|||
145990171|NCT03460704|526478184|FG001|Overall Study|Study terminated by the Sponsor|19|||
145990172|NCT03460704|526478183|FG000|Overall Study|Adverse Event|10|||
145990173|NCT03460704|526478184|FG001|Overall Study|Adverse Event|5|||
145990174|NCT03460704|526478183|FG000|Overall Study|Death|3|||
145990175|NCT03460704|526478184|FG001|Overall Study|Death|2|||
145990176|NCT03460704|526478183|FG000|Overall Study|Non-Compliance with Study Drug|3|||
146246010|NCT02432274|527414152|FG002|Overall Study|Death|7|||
146246011|NCT02432274|527414153|FG003|Overall Study|Death|0|||
146246012|NCT02432274|527414154|FG004|Overall Study|Death|27|||
146246013|NCT02432274|527414155|FG005|Overall Study|Death|7|||
145990177|NCT03460704|526478184|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145990178|NCT03460704|526478183|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146246014|NCT02432274|527414156|FG006|Overall Study|Death|9|||
146246015|NCT02432274|527414157|FG007|Overall Study|Death|14|||
146246016|NCT02432274|527414150|FG000|Overall Study|Withdrawal of Consent|0|||
146246017|NCT02432274|527414151|FG001|Overall Study|Withdrawal of Consent|0|||
146246018|NCT02432274|527414152|FG002|Overall Study|Withdrawal of Consent|0|||
146246019|NCT02432274|527414153|FG003|Overall Study|Withdrawal of Consent|0|||
146246020|NCT02432274|527414154|FG004|Overall Study|Withdrawal of Consent|2|||
146246021|NCT02432274|527414155|FG005|Overall Study|Withdrawal of Consent|0|||
146246022|NCT02432274|527414156|FG006|Overall Study|Withdrawal of Consent|1|||
145990179|NCT03460704|526478184|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
145990180|NCT03460704|526478183|FG000|Overall Study|Other|2|||
145990181|NCT03460704|526478184|FG001|Overall Study|Other|1|||
145990182|NCT04126174|526478185|FG000|Overall Study|Lost to Follow-up|3|||
145990183|NCT04126174|526478186|FG001|Overall Study|Lost to Follow-up|3|||
145990184|NCT04439903|526478199|FG000|Overall Study|Withdrawal by Subject|2|||
145990185|NCT04439903|526478199|FG000|Overall Study|Screen Failure|1|||
145990186|NCT02899754|526478200|FG000|Overall Study|Lost to Follow-up|7|||
145990187|NCT02899754|526478201|FG001|Overall Study|Lost to Follow-up|9|||
145990188|NCT04818229|526478202|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
145990189|NCT04818229|526478203|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
145990190|NCT04818229|526478204|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
145990191|NCT04818229|526478202|FG000|Overall Study|Adverse Event|3|||
145990192|NCT04818229|526478203|FG001|Overall Study|Adverse Event|1|||
145990193|NCT04818229|526478204|FG002|Overall Study|Adverse Event|1|||
145990194|NCT04818229|526478202|FG000|Overall Study|Withdrawal by Subject|0|||
145990195|NCT04818229|526478203|FG001|Overall Study|Withdrawal by Subject|0|||
145990196|NCT04818229|526478204|FG002|Overall Study|Withdrawal by Subject|2|||
145990197|NCT04818229|526478202|FG000|Overall Study|Lost to Follow-up|0|||
145990198|NCT04818229|526478203|FG001|Overall Study|Lost to Follow-up|0|||
145990199|NCT04818229|526478204|FG002|Overall Study|Lost to Follow-up|1|||
145990200|NCT03769116|526478211|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
145990201|NCT03769116|526478212|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
145990202|NCT03769116|526478211|FG000|Part 3 - Open Label|Physician Decision|1|||
145990203|NCT03769116|526478212|FG001|Part 3 - Open Label|Physician Decision|0|||
145990204|NCT03769116|526478211|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
145990205|NCT03769116|526478212|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
145990206|NCT02181413|526478215|FG000|Overall Study|Withdrawal by Subject|45|||
145990207|NCT02181413|526478216|FG001|Overall Study|Withdrawal by Subject|61|||
145990208|NCT02181413|526478215|FG000|Overall Study|Reason Not Specified|2|||
145990209|NCT02181413|526478216|FG001|Overall Study|Reason Not Specified|5|||
145990210|NCT02181413|526478215|FG000|Overall Study|Lost to Follow-up|8|||
145990211|NCT02181413|526478216|FG001|Overall Study|Lost to Follow-up|7|||
145990212|NCT04003142|526478218|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
145990213|NCT04003142|526478219|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
145990214|NCT04003142|526478220|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
145990215|NCT04003142|526478221|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
145990216|NCT04003142|526478222|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
145990217|NCT04003142|526478218|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
145990218|NCT04003142|526478219|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
145990219|NCT04003142|526478220|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
145990220|NCT04003142|526478221|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
145990221|NCT04003142|526478222|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
145990222|NCT04003142|526478218|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
145990223|NCT04003142|526478219|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
145990224|NCT04003142|526478220|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145990225|NCT04003142|526478221|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145990226|NCT04003142|526478222|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145990227|NCT04003142|526478218|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
145990228|NCT04003142|526478219|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
145990229|NCT04003142|526478220|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
145990230|NCT04003142|526478221|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
145990231|NCT04003142|526478222|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
145990232|NCT04003142|526478218|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
145990233|NCT04003142|526478219|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
145990234|NCT04003142|526478220|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
145990235|NCT04003142|526478221|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
145990236|NCT04003142|526478222|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
145990237|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
145990238|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
145990239|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
146246023|NCT02432274|527414157|FG007|Overall Study|Withdrawal of Consent|2|||
146246024|NCT00090519|527414158|FG000|Overall Study|Adverse Event|5|||
145990240|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
145990241|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
145990242|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Death|0|||
145990243|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Death|0|||
145990244|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Death|0|||
145990245|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Death|0|||
145990246|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Death|1|||
145990247|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
145990248|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
145990249|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
145990250|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
145990251|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
145990252|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
145990253|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
145990254|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
145990255|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
145990256|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
145990257|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
145990258|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
145990259|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
145990260|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
145990261|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
145990262|NCT04003142|526478218|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
145990263|NCT04003142|526478219|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
145990264|NCT04003142|526478220|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
145990265|NCT04003142|526478221|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
145990266|NCT04003142|526478222|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
145990267|NCT03382873|526478223|FG000|Overall Study|Lost to Follow-up|9|||
145990268|NCT03382873|526478224|FG001|Overall Study|Lost to Follow-up|10|||
145990269|NCT03382873|526478223|FG000|Overall Study|Withdrawal by Subject|6|||
145990270|NCT03382873|526478224|FG001|Overall Study|Withdrawal by Subject|11|||
145990271|NCT03382873|526478223|FG000|Overall Study|Visit not completed due to pandemic|16|||
145990272|NCT03382873|526478224|FG001|Overall Study|Visit not completed due to pandemic|41|||
145990273|NCT04755231|526478230|FG000|Overall Study|Lost to Follow-up|5|||
145990274|NCT04755231|526478230|FG000|Overall Study|Withdrawal by Subject|5|||
145990275|NCT04754399|526478231|FG000|Overall Study|Adverse Event|5|||
145990276|NCT04754399|526478231|FG000|Overall Study|Withdrawal by Subject|6|||
145990277|NCT00025233|526478234|FG000|Overall Study|Ineligible: wrong cell type|1|||
145990278|NCT00025233|526478234|FG000|Overall Study|Ineligible: wrong primary|1|||
145990279|NCT00025233|526478234|FG000|Overall Study|Ineligible: improper prior treatment|1|||
145990280|NCT00025233|526478234|FG000|Overall Study|Never treated|1|||
145990281|NCT01720602|526478235|FG000|Overall Study|Adverse Event|3|||
145990282|NCT01720602|526478235|FG000|Overall Study|Progressive disease on therapy|2|||
145990283|NCT00834587|526478241|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145990284|NCT00834587|526478242|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145990285|NCT00176254|526478243|FG000|Overall Study|Lost to Follow-up|1|||
145990286|NCT02536339|526478245|FG000|Overall Study|Death|20|||
145990287|NCT02536339|526478245|FG000|Overall Study|Withdrawal by Subject|3|||
145990288|NCT02536339|526478245|FG000|Overall Study|Lost to Follow-up|2|||
145990289|NCT02536339|526478245|FG000|Overall Study|Treatment discontinued|2|||
145990290|NCT02536339|526478245|FG000|Overall Study|Physician Decision|1|||
145990291|NCT02037984|526478247|FG000|Overall Study|Lack of Efficacy|0|||
145990292|NCT02037984|526478248|FG001|Overall Study|Lack of Efficacy|0|||
145990293|NCT02037984|526478249|FG002|Overall Study|Lack of Efficacy|3|||
145990294|NCT02037984|526478250|FG003|Overall Study|Lack of Efficacy|10|||
146091498|NCT02537574|526856835|FG002|Overall Study|Withdrawal by Subject|29|||
146246025|NCT00090519|527414159|FG001|Overall Study|Adverse Event|4|||
146246026|NCT00090519|527414158|FG000|Overall Study|Death|9|||
145990295|NCT02037984|526478251|FG004|Overall Study|Lack of Efficacy|2|||
145990296|NCT02037984|526478252|FG005|Overall Study|Lack of Efficacy|2|||
145990297|NCT02037984|526478253|FG006|Overall Study|Lack of Efficacy|4|||
145990298|NCT02037984|526478254|FG007|Overall Study|Lack of Efficacy|3|||
145990299|NCT02037984|526478247|FG000|Overall Study|Lost to Follow-up|1|||
145990300|NCT02037984|526478248|FG001|Overall Study|Lost to Follow-up|0|||
145990301|NCT02037984|526478249|FG002|Overall Study|Lost to Follow-up|3|||
145990302|NCT02037984|526478250|FG003|Overall Study|Lost to Follow-up|5|||
145990303|NCT02037984|526478251|FG004|Overall Study|Lost to Follow-up|2|||
145990304|NCT02037984|526478252|FG005|Overall Study|Lost to Follow-up|2|||
145990305|NCT02037984|526478253|FG006|Overall Study|Lost to Follow-up|2|||
145990306|NCT02037984|526478254|FG007|Overall Study|Lost to Follow-up|4|||
145990307|NCT02037984|526478247|FG000|Overall Study|Physician Decision|0|||
145990308|NCT02037984|526478248|FG001|Overall Study|Physician Decision|0|||
145990309|NCT02037984|526478249|FG002|Overall Study|Physician Decision|0|||
145990310|NCT02037984|526478250|FG003|Overall Study|Physician Decision|0|||
145990311|NCT02037984|526478251|FG004|Overall Study|Physician Decision|0|||
145990312|NCT02037984|526478252|FG005|Overall Study|Physician Decision|0|||
146246027|NCT00090519|527414159|FG001|Overall Study|Death|9|||
145990313|NCT02037984|526478253|FG006|Overall Study|Physician Decision|1|||
145990314|NCT02037984|526478254|FG007|Overall Study|Physician Decision|0|||
145990315|NCT02037984|526478247|FG000|Overall Study|Protocol Violation|0|||
145990316|NCT02037984|526478248|FG001|Overall Study|Protocol Violation|0|||
145990317|NCT02037984|526478249|FG002|Overall Study|Protocol Violation|0|||
145990318|NCT02037984|526478250|FG003|Overall Study|Protocol Violation|0|||
145990319|NCT02037984|526478251|FG004|Overall Study|Protocol Violation|0|||
145990320|NCT02037984|526478252|FG005|Overall Study|Protocol Violation|1|||
145990321|NCT02037984|526478253|FG006|Overall Study|Protocol Violation|2|||
145990322|NCT02037984|526478254|FG007|Overall Study|Protocol Violation|0|||
145990323|NCT02037984|526478247|FG000|Overall Study|Technical Problems|0|||
145990324|NCT02037984|526478248|FG001|Overall Study|Technical Problems|0|||
145990325|NCT02037984|526478249|FG002|Overall Study|Technical Problems|3|||
145990326|NCT02037984|526478250|FG003|Overall Study|Technical Problems|3|||
145990327|NCT02037984|526478251|FG004|Overall Study|Technical Problems|2|||
145990328|NCT02037984|526478252|FG005|Overall Study|Technical Problems|3|||
145990329|NCT02037984|526478253|FG006|Overall Study|Technical Problems|4|||
145990330|NCT02037984|526478254|FG007|Overall Study|Technical Problems|2|||
145990331|NCT02037984|526478247|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146246028|NCT00090519|527414158|FG000|Overall Study|Lost to Follow-up|26|||
145990332|NCT02037984|526478248|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145990333|NCT02037984|526478249|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
145990334|NCT02037984|526478250|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
145990335|NCT02037984|526478251|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
145990336|NCT02037984|526478252|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
145990337|NCT02037984|526478253|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
145990338|NCT02037984|526478254|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
145990339|NCT02037984|526478247|FG000|Overall Study|Withdrawal by Subject|0|||
145990340|NCT02037984|526478248|FG001|Overall Study|Withdrawal by Subject|0|||
145990341|NCT02037984|526478249|FG002|Overall Study|Withdrawal by Subject|0|||
145990342|NCT02037984|526478250|FG003|Overall Study|Withdrawal by Subject|1|||
145990343|NCT02037984|526478251|FG004|Overall Study|Withdrawal by Subject|1|||
145990344|NCT02037984|526478252|FG005|Overall Study|Withdrawal by Subject|3|||
145990345|NCT02037984|526478253|FG006|Overall Study|Withdrawal by Subject|0|||
145990346|NCT02037984|526478254|FG007|Overall Study|Withdrawal by Subject|1|||
145990347|NCT01691092|526478255|FG000|Overall Study|Lost to Follow-up|10|||
145990348|NCT01691092|526478255|FG000|Overall Study|Physician Decision|4|||
145990349|NCT01691092|526478255|FG000|Overall Study|Withdrawal by Subject|3|||
145990350|NCT01691092|526478255|FG000|Overall Study|non-compliance|3|||
145990351|NCT01691092|526478255|FG000|Overall Study|used for different study|2|||
145990352|NCT01691092|526478255|FG000|Overall Study|screen fail|19|||
145990353|NCT00561821|526478258|FG000|Overall Study|Not treated|0|||
145990354|NCT00561821|526478259|FG001|Overall Study|Not treated|0|||
145990355|NCT00561821|526478260|FG002|Overall Study|Not treated|1|||
145990356|NCT00561821|526478261|FG003|Overall Study|Not treated|0|||
145990357|NCT00561821|526478258|FG000|Overall Study|Withdrawal by Subject|0|||
145990358|NCT00561821|526478259|FG001|Overall Study|Withdrawal by Subject|1|||
145990359|NCT00561821|526478260|FG002|Overall Study|Withdrawal by Subject|0|||
145990360|NCT00561821|526478261|FG003|Overall Study|Withdrawal by Subject|2|||
145990361|NCT00561821|526478258|FG000|Overall Study|Reasons not related to trial|2|||
145990362|NCT00561821|526478259|FG001|Overall Study|Reasons not related to trial|1|||
145990363|NCT00561821|526478260|FG002|Overall Study|Reasons not related to trial|0|||
145990364|NCT00561821|526478261|FG003|Overall Study|Reasons not related to trial|0|||
145990365|NCT00561821|526478258|FG000|Overall Study|Other (reason not specified)|1|||
145990366|NCT00561821|526478259|FG001|Overall Study|Other (reason not specified)|1|||
145990367|NCT00561821|526478260|FG002|Overall Study|Other (reason not specified)|0|||
145990368|NCT00561821|526478261|FG003|Overall Study|Other (reason not specified)|0|||
145990369|NCT00561821|526478258|FG000|Overall Study|Adverse Event|2|||
145990370|NCT00561821|526478259|FG001|Overall Study|Adverse Event|3|||
145990371|NCT00561821|526478260|FG002|Overall Study|Adverse Event|1|||
145990372|NCT00561821|526478261|FG003|Overall Study|Adverse Event|1|||
145990373|NCT01657942|526478262|FG000|Overall Study|Alternative Treatment|7|||
145990374|NCT01657942|526478262|FG000|Overall Study|Lost to Follow-up|1|||
145990375|NCT00581100|526479759|FG000|Overall Study|Death|1|||
145990376|NCT00581100|526479760|FG001|Overall Study|Death|0|||
145990377|NCT00581100|526479759|FG000|Overall Study|Adverse Event|2|||
145990378|NCT00581100|526479760|FG001|Overall Study|Adverse Event|1|||
145990379|NCT00581100|526479759|FG000|Overall Study|Withdrawal by Subject|1|||
145990380|NCT00581100|526479760|FG001|Overall Study|Withdrawal by Subject|4|||
145990381|NCT00581100|526479759|FG000|Overall Study|Other|3|||
145990382|NCT00581100|526479760|FG001|Overall Study|Other|0|||
145990383|NCT02904265|526479761|FG000|Overall Study|Physician Decision|1|||
145990384|NCT02904265|526479762|FG001|Overall Study|Physician Decision|2|||
145990385|NCT02579759|526479763|FG000|Overall Study|Protocol Violation|2|||
145990386|NCT02579759|526479764|FG001|Overall Study|Protocol Violation|0|||
145990387|NCT02579759|526479765|FG002|Overall Study|Protocol Violation|0|||
145990388|NCT02579759|526479763|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
145990389|NCT02579759|526479764|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
145990390|NCT02579759|526479765|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
145990391|NCT02579759|526479763|FG000|Overall Study|BfArM hold|13|||
145990392|NCT02579759|526479764|FG001|Overall Study|BfArM hold|12|||
145990393|NCT02579759|526479765|FG002|Overall Study|BfArM hold|12|||
145990394|NCT02579759|526479763|FG000|Overall Study|Sponsor stopped Dose 2|0|||
145990395|NCT02579759|526479764|FG001|Overall Study|Sponsor stopped Dose 2|41|||
145990396|NCT02579759|526479765|FG002|Overall Study|Sponsor stopped Dose 2|0|||
145990397|NCT02579759|526479763|FG000|Overall Study|Non compliance|0|||
145990398|NCT02579759|526479764|FG001|Overall Study|Non compliance|1|||
145990399|NCT02579759|526479765|FG002|Overall Study|Non compliance|0|||
145990400|NCT02579759|526479763|FG000|Overall Study|Pregnancy|0|||
145990401|NCT02579759|526479764|FG001|Overall Study|Pregnancy|1|||
145990402|NCT02579759|526479765|FG002|Overall Study|Pregnancy|0|||
145990403|NCT02579759|526479763|FG000|Overall Study|Inclusion/exclusion criteria|0|||
145990404|NCT02579759|526479764|FG001|Overall Study|Inclusion/exclusion criteria|0|||
145990405|NCT02579759|526479765|FG002|Overall Study|Inclusion/exclusion criteria|1|||
145990406|NCT02579759|526479763|FG000|Overall Study|Adverse Event|4|||
145990407|NCT02579759|526479764|FG001|Overall Study|Adverse Event|3|||
145990408|NCT02579759|526479765|FG002|Overall Study|Adverse Event|1|||
145990409|NCT02579759|526479763|FG000|Overall Study|Withdrawal by Subject|3|||
145990410|NCT02579759|526479764|FG001|Overall Study|Withdrawal by Subject|3|||
145990411|NCT02579759|526479765|FG002|Overall Study|Withdrawal by Subject|5|||
145990412|NCT02579759|526479763|FG000|Overall Study|Lost to Follow-up|2|||
145990413|NCT02579759|526479764|FG001|Overall Study|Lost to Follow-up|2|||
145990414|NCT02579759|526479765|FG002|Overall Study|Lost to Follow-up|2|||
145990415|NCT00003907|526479775|FG000|Overall Study|Adverse Event|2|||
145990416|NCT00003907|526479776|FG001|Overall Study|Adverse Event|11|||
145990417|NCT00003907|526479775|FG000|Overall Study|Death|2|||
145990418|NCT00003907|526479776|FG001|Overall Study|Death|0|||
145990419|NCT00003907|526479775|FG000|Overall Study|Withdrawal by Subject|1|||
145990420|NCT00003907|526479776|FG001|Overall Study|Withdrawal by Subject|3|||
145990421|NCT00003907|526479775|FG000|Overall Study|Progressive disease|4|||
145990422|NCT00003907|526479776|FG001|Overall Study|Progressive disease|4|||
145990423|NCT00003907|526479775|FG000|Overall Study|Complicating disease|1|||
145990424|NCT00003907|526479776|FG001|Overall Study|Complicating disease|0|||
145990425|NCT00003907|526479775|FG000|Overall Study|Other|1|||
145990426|NCT00003907|526479776|FG001|Overall Study|Other|3|||
145990427|NCT00003907|526479775|FG000|Overall Study|ineligible or not treated|2|||
145990428|NCT00003907|526479776|FG001|Overall Study|ineligible or not treated|2|||
145990429|NCT02336555|526479777|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145990430|NCT02336555|526479778|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145990431|NCT02336555|526479777|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
145990432|NCT02336555|526479778|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
145990433|NCT02336555|526479777|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
145990434|NCT02336555|526479778|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
145990435|NCT00993473|526479779|FG000|Overall Study|Adverse Event|0|||
145990436|NCT00993473|526479780|FG001|Overall Study|Adverse Event|2|||
145990437|NCT00993473|526479779|FG000|Overall Study|Protocol Violation|1|||
145990438|NCT00993473|526479780|FG001|Overall Study|Protocol Violation|2|||
145990439|NCT00993473|526479779|FG000|Overall Study|Lost to Follow-up|1|||
145990440|NCT00993473|526479780|FG001|Overall Study|Lost to Follow-up|0|||
145990441|NCT00993473|526479779|FG000|Overall Study|Withdrawal by Subject|1|||
145990442|NCT00993473|526479780|FG001|Overall Study|Withdrawal by Subject|5|||
145990443|NCT00993473|526479779|FG000|Overall Study|Technical problem with CGM device|0|||
145990444|NCT00993473|526479780|FG001|Overall Study|Technical problem with CGM device|1|||
145990445|NCT00993473|526479779|FG000|Overall Study|Family event|1|||
145990446|NCT00993473|526479780|FG001|Overall Study|Family event|0|||
145990447|NCT03682367|526479791|FG000|Overall Study|Protocol Violation|2|||
145990448|NCT03682367|526479792|FG001|Overall Study|Protocol Violation|1|||
145990449|NCT03682367|526479791|FG000|Overall Study|Closed Study Early|0|||
145990450|NCT03682367|526479792|FG001|Overall Study|Closed Study Early|3|||
145990451|NCT03707821|526479793|FG000|Overall Study|Protocol Violation|0|||
145990452|NCT03707821|526479794|FG001|Overall Study|Protocol Violation|1|||
145990453|NCT03707821|526479793|FG000|Overall Study|Unsatisfactory Visual Response|1|||
145990454|NCT03707821|526479794|FG001|Overall Study|Unsatisfactory Visual Response|0|||
145990455|NCT03707821|526479793|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
145990456|NCT03707821|526479794|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
145990457|NCT00770679|526479797|FG000|Overall Study|Lost to Follow-up|3|||
145990458|NCT00770679|526479797|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
145990459|NCT00129974|526479798|FG000|Overall Study|Other|1|||
145990460|NCT00414609|526479799|FG000|Core Study|Adverse Event|9|||
145990461|NCT00414609|526479800|FG001|Core Study|Adverse Event|11|||
145990462|NCT00414609|526479801|FG002|Core Study|Adverse Event|0|||
145990463|NCT00414609|526479799|FG000|Core Study|Abnormal laboratory values|0|||
145990464|NCT00414609|526479800|FG001|Core Study|Abnormal laboratory values|1|||
145990465|NCT00414609|526479801|FG002|Core Study|Abnormal laboratory values|0|||
145990466|NCT00414609|526479799|FG000|Core Study|Abnormal test procedure results|1|||
145990467|NCT00414609|526479800|FG001|Core Study|Abnormal test procedure results|1|||
145990468|NCT00414609|526479801|FG002|Core Study|Abnormal test procedure results|0|||
145990469|NCT00414609|526479799|FG000|Core Study|Protocol deviation|0|||
145990470|NCT00414609|526479800|FG001|Core Study|Protocol deviation|1|||
145990471|NCT00414609|526479801|FG002|Core Study|Protocol deviation|0|||
145990472|NCT00414609|526479799|FG000|Core Study|Patient withdrew consent|10|||
145990473|NCT00414609|526479800|FG001|Core Study|Patient withdrew consent|11|||
145990474|NCT00414609|526479801|FG002|Core Study|Patient withdrew consent|0|||
145990475|NCT00414609|526479799|FG000|Core Study|Lost to Follow-up|7|||
145990476|NCT00414609|526479800|FG001|Core Study|Lost to Follow-up|4|||
145990477|NCT00414609|526479801|FG002|Core Study|Lost to Follow-up|0|||
145990478|NCT00414609|526479799|FG000|Core Study|Administrative problems|0|||
145990479|NCT00414609|526479800|FG001|Core Study|Administrative problems|2|||
145990480|NCT00414609|526479801|FG002|Core Study|Administrative problems|0|||
145990481|NCT00414609|526479799|FG000|Core Study|Death|7|||
145990482|NCT00414609|526479800|FG001|Core Study|Death|14|||
145990483|NCT00414609|526479801|FG002|Core Study|Death|0|||
145990484|NCT00414609|526479799|FG000|Extension Study|Adverse Event|0|||
145990485|NCT00414609|526479800|FG001|Extension Study|Adverse Event|0|||
145990486|NCT00414609|526479801|FG002|Extension Study|Adverse Event|14|||
145990487|NCT00414609|526479799|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
145990488|NCT00414609|526479800|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
145990489|NCT00414609|526479801|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
145990490|NCT00414609|526479799|FG000|Extension Study|Withdrawal by Subject|0|||
145990491|NCT00414609|526479800|FG001|Extension Study|Withdrawal by Subject|0|||
145990492|NCT00414609|526479801|FG002|Extension Study|Withdrawal by Subject|13|||
145990493|NCT00414609|526479799|FG000|Extension Study|Lost to Follow-up|0|||
145990494|NCT00414609|526479800|FG001|Extension Study|Lost to Follow-up|0|||
145990495|NCT00414609|526479801|FG002|Extension Study|Lost to Follow-up|10|||
145990496|NCT00414609|526479799|FG000|Extension Study|Administrative problems|0|||
145990497|NCT00414609|526479800|FG001|Extension Study|Administrative problems|0|||
145990498|NCT00414609|526479801|FG002|Extension Study|Administrative problems|1|||
145990499|NCT00414609|526479799|FG000|Extension Study|Death|0|||
145990500|NCT00414609|526479800|FG001|Extension Study|Death|0|||
145990501|NCT00414609|526479801|FG002|Extension Study|Death|17|||
145990502|NCT00266032|526479807|FG000|Treatment|Adverse Event|42|||
145990503|NCT00266032|526479808|FG001|Treatment|Adverse Event|26|||
145990504|NCT00266032|526479809|FG002|Treatment|Adverse Event|10|||
145990505|NCT00266032|526479807|FG000|Treatment|Lost to Follow-up|19|||
145990506|NCT00266032|526479808|FG001|Treatment|Lost to Follow-up|4|||
145990507|NCT00266032|526479809|FG002|Treatment|Lost to Follow-up|2|||
145990508|NCT00266032|526479807|FG000|Treatment|Pregnancy|3|||
145990509|NCT00266032|526479808|FG001|Treatment|Pregnancy|2|||
145990510|NCT00266032|526479809|FG002|Treatment|Pregnancy|2|||
145990511|NCT00266032|526479807|FG000|Treatment|Protocol Violation|6|||
145990512|NCT00266032|526479808|FG001|Treatment|Protocol Violation|14|||
145990513|NCT00266032|526479809|FG002|Treatment|Protocol Violation|13|||
145990514|NCT00266032|526479807|FG000|Treatment|Withdrawal by Subject|28|||
145990515|NCT00266032|526479808|FG001|Treatment|Withdrawal by Subject|13|||
145990516|NCT00266032|526479809|FG002|Treatment|Withdrawal by Subject|12|||
145990517|NCT00266032|526479807|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
145990518|NCT00266032|526479808|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
145990519|NCT00266032|526479809|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
145990520|NCT00266032|526479807|FG000|Open-label Safety Extension|Adverse Event|5|||
145990521|NCT00266032|526479808|FG001|Open-label Safety Extension|Adverse Event|0|||
145990522|NCT00266032|526479809|FG002|Open-label Safety Extension|Adverse Event|4|||
145990523|NCT00266032|526479807|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
145990524|NCT00266032|526479808|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
145990525|NCT00266032|526479809|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
145990526|NCT00266032|526479807|FG000|Open-label Safety Extension|Pregnancy|4|||
145990527|NCT00266032|526479808|FG001|Open-label Safety Extension|Pregnancy|1|||
145990528|NCT00266032|526479809|FG002|Open-label Safety Extension|Pregnancy|2|||
145990529|NCT00266032|526479807|FG000|Open-label Safety Extension|Protocol Violation|1|||
145990530|NCT00266032|526479808|FG001|Open-label Safety Extension|Protocol Violation|3|||
145990531|NCT00266032|526479809|FG002|Open-label Safety Extension|Protocol Violation|2|||
145990532|NCT00266032|526479807|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
146091499|NCT02537574|526856833|FG000|Overall Study|Lack of Efficacy|14|||
146091500|NCT02537574|526856834|FG001|Overall Study|Lack of Efficacy|16|||
146246029|NCT00090519|527414159|FG001|Overall Study|Lost to Follow-up|29|||
145990533|NCT00266032|526479808|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
145990534|NCT00266032|526479809|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
145990535|NCT00266032|526479807|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
145990536|NCT00266032|526479808|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
145990537|NCT00266032|526479809|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
146091501|NCT02537574|526856835|FG002|Overall Study|Lack of Efficacy|15|||
146246030|NCT00090519|527414158|FG000|Overall Study|Withdrawal by Subject|28|||
145990538|NCT00124657|526479810|FG000|Overall Study|Toxicity|0|||
145990539|NCT00124657|526479811|FG001|Overall Study|Toxicity|0|||
146246031|NCT00090519|527414159|FG001|Overall Study|Withdrawal by Subject|29|||
146246032|NCT00090519|527414158|FG000|Overall Study|Physician Decision|2|||
146246033|NCT00090519|527414159|FG001|Overall Study|Physician Decision|3|||
146246034|NCT00090519|527414158|FG000|Overall Study|Sponsor Decision|3|||
146246035|NCT00090519|527414159|FG001|Overall Study|Sponsor Decision|1|||
146246036|NCT00116649|527414160|FG000|Overall Study|Adverse Event|20|||
145990540|NCT00124657|526479812|FG002|Overall Study|Toxicity|1|||
145990541|NCT00124657|526479810|FG000|Overall Study|Non-compliance|1|||
146246037|NCT00116649|527414160|FG000|Overall Study|Lack of Efficacy|1|||
146246038|NCT00116649|527414160|FG000|Overall Study|Lost to Follow-up|32|||
146246039|NCT00116649|527414160|FG000|Overall Study|Withdrawal by Subject|68|||
145990542|NCT00124657|526479811|FG001|Overall Study|Non-compliance|0|||
145990543|NCT00124657|526479812|FG002|Overall Study|Non-compliance|4|||
145990544|NCT00124657|526479810|FG000|Overall Study|Progressive disease|14|||
145990545|NCT00124657|526479811|FG001|Overall Study|Progressive disease|5|||
145990546|NCT00124657|526479812|FG002|Overall Study|Progressive disease|27|||
145990547|NCT00124657|526479810|FG000|Overall Study|Intercurrent illness|1|||
145990548|NCT00124657|526479811|FG001|Overall Study|Intercurrent illness|0|||
145990549|NCT00124657|526479812|FG002|Overall Study|Intercurrent illness|0|||
145990550|NCT00814983|526479817|FG000|Overall Study|Screen failure|1|||
145990551|NCT00814983|526479818|FG001|Overall Study|Screen failure|0|||
145990552|NCT00814983|526479817|FG000|Overall Study|Withdrawal by Subject|1|||
145990553|NCT00814983|526479818|FG001|Overall Study|Withdrawal by Subject|0|||
145990554|NCT00814983|526479817|FG000|Overall Study|Graft failure|1|||
145990555|NCT00814983|526479818|FG001|Overall Study|Graft failure|0|||
145990556|NCT01475825|526479819|FG000|Overall Study|Adverse Event|41|||
145990557|NCT01475825|526479820|FG001|Overall Study|Adverse Event|15|||
145990558|NCT01475825|526479821|FG002|Overall Study|Adverse Event|27|||
145990559|NCT01475825|526479822|FG003|Overall Study|Adverse Event|11|||
145990560|NCT01475825|526479819|FG000|Overall Study|Death|1|||
145990561|NCT01475825|526479820|FG001|Overall Study|Death|0|||
145990562|NCT01475825|526479821|FG002|Overall Study|Death|1|||
145990563|NCT01475825|526479822|FG003|Overall Study|Death|0|||
145990564|NCT01475825|526479819|FG000|Overall Study|Lack of Efficacy|0|||
145990565|NCT01475825|526479820|FG001|Overall Study|Lack of Efficacy|0|||
145990566|NCT01475825|526479821|FG002|Overall Study|Lack of Efficacy|1|||
145990567|NCT01475825|526479822|FG003|Overall Study|Lack of Efficacy|0|||
145990568|NCT01475825|526479819|FG000|Overall Study|Lost to Follow-up|0|||
145990569|NCT01475825|526479820|FG001|Overall Study|Lost to Follow-up|0|||
145990570|NCT01475825|526479821|FG002|Overall Study|Lost to Follow-up|3|||
145990571|NCT01475825|526479822|FG003|Overall Study|Lost to Follow-up|1|||
145990572|NCT01475825|526479819|FG000|Overall Study|Non-compliance with Study Drug|1|||
145990573|NCT01475825|526479820|FG001|Overall Study|Non-compliance with Study Drug|2|||
145990574|NCT01475825|526479821|FG002|Overall Study|Non-compliance with Study Drug|4|||
145990575|NCT01475825|526479822|FG003|Overall Study|Non-compliance with Study Drug|0|||
145990576|NCT01475825|526479819|FG000|Overall Study|Other: Not available|0|||
145990577|NCT01475825|526479820|FG001|Overall Study|Other: Not available|0|||
145990578|NCT01475825|526479821|FG002|Overall Study|Other: Not available|2|||
145990579|NCT01475825|526479822|FG003|Overall Study|Other: Not available|0|||
145990580|NCT01475825|526479819|FG000|Overall Study|Protocol Violation|1|||
145990581|NCT01475825|526479820|FG001|Overall Study|Protocol Violation|0|||
145990582|NCT01475825|526479821|FG002|Overall Study|Protocol Violation|0|||
145990583|NCT01475825|526479822|FG003|Overall Study|Protocol Violation|0|||
145990584|NCT01475825|526479819|FG000|Overall Study|Physician Decision|0|||
145990585|NCT01475825|526479820|FG001|Overall Study|Physician Decision|1|||
145990586|NCT01475825|526479821|FG002|Overall Study|Physician Decision|0|||
145990587|NCT01475825|526479822|FG003|Overall Study|Physician Decision|0|||
145990588|NCT01475825|526479819|FG000|Overall Study|Withdrawal by Subject|8|||
145990589|NCT01475825|526479820|FG001|Overall Study|Withdrawal by Subject|3|||
145990590|NCT01475825|526479821|FG002|Overall Study|Withdrawal by Subject|11|||
145990591|NCT01475825|526479822|FG003|Overall Study|Withdrawal by Subject|7|||
145990592|NCT01475825|526479819|FG000|Overall Study|Did not enter OLC|15|||
145990593|NCT01475825|526479820|FG001|Overall Study|Did not enter OLC|11|||
145990594|NCT01475825|526479821|FG002|Overall Study|Did not enter OLC|15|||
145990595|NCT01475825|526479822|FG003|Overall Study|Did not enter OLC|11|||
145990596|NCT04157738|526479823|FG000|Overall Study|Moved out of state|0|||
145990597|NCT04157738|526479824|FG001|Overall Study|Moved out of state|2|||
145990598|NCT04157738|526479823|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
145990599|NCT04157738|526479824|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
145990600|NCT00160563|526479825|FG000|Overall Study|Adverse Event|1|||
145990601|NCT00160563|526479826|FG001|Overall Study|Adverse Event|1|||
145990602|NCT00160563|526479827|FG002|Overall Study|Adverse Event|1|||
145990603|NCT00160563|526479825|FG000|Overall Study|Lost to Follow-up|1|||
145990604|NCT00160563|526479826|FG001|Overall Study|Lost to Follow-up|1|||
145990605|NCT00160563|526479827|FG002|Overall Study|Lost to Follow-up|2|||
145990606|NCT00160563|526479825|FG000|Overall Study|Protocol Violation|0|||
146246040|NCT00116649|527414160|FG000|Overall Study|Local Skin Reaction|9|||
146246041|NCT00116649|527414160|FG000|Overall Study|Various Reasons|18|||
145990607|NCT00160563|526479826|FG001|Overall Study|Protocol Violation|0|||
146246042|NCT00116649|527414160|FG000|Overall Study|Protocol Specified|7|||
146246043|NCT02161146|527414161|FG000|Overall Study|Adverse Event|1|||
146246044|NCT02161146|527414162|FG001|Overall Study|Adverse Event|1|||
146246045|NCT02161146|527414163|FG002|Overall Study|Adverse Event|0|||
146246046|NCT02161146|527414164|FG003|Overall Study|Adverse Event|1|||
146246047|NCT02161146|527414165|FG004|Overall Study|Adverse Event|0|||
146246048|NCT02161146|527414161|FG000|Overall Study|Lost to Follow-up|0|||
146246049|NCT02161146|527414162|FG001|Overall Study|Lost to Follow-up|1|||
146246050|NCT02161146|527414163|FG002|Overall Study|Lost to Follow-up|0|||
146246051|NCT02161146|527414164|FG003|Overall Study|Lost to Follow-up|0|||
146246052|NCT02161146|527414165|FG004|Overall Study|Lost to Follow-up|0|||
146246053|NCT02161146|527414161|FG000|Overall Study|Personal Reasons|0|||
146246054|NCT02161146|527414162|FG001|Overall Study|Personal Reasons|1|||
146246055|NCT02161146|527414163|FG002|Overall Study|Personal Reasons|0|||
146246056|NCT02161146|527414164|FG003|Overall Study|Personal Reasons|2|||
146246057|NCT02161146|527414165|FG004|Overall Study|Personal Reasons|1|||
146246058|NCT02161146|527414161|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145990608|NCT00160563|526479827|FG002|Overall Study|Protocol Violation|3|||
145990609|NCT00160563|526479825|FG000|Overall Study|Withdrawal by Subject|1|||
145990610|NCT00160563|526479826|FG001|Overall Study|Withdrawal by Subject|2|||
145990611|NCT00160563|526479827|FG002|Overall Study|Withdrawal by Subject|3|||
145990612|NCT00160563|526479825|FG000|Overall Study|Other (listed in the study report)|48|||
145990613|NCT00160563|526479826|FG001|Overall Study|Other (listed in the study report)|40|||
145990614|NCT00160563|526479827|FG002|Overall Study|Other (listed in the study report)|81|||
145990615|NCT00160563|526479825|FG000|Overall Study|Missing reason|0|||
145990616|NCT00160563|526479826|FG001|Overall Study|Missing reason|1|||
145990617|NCT00160563|526479827|FG002|Overall Study|Missing reason|0|||
145990618|NCT03766906|526479832|FG000|Overall Study|Withdrawal by Subject|6|||
145990619|NCT01514357|526479833|FG000|Overall Study|Screen failure|2|||
145990620|NCT01514357|526479834|FG001|Overall Study|Screen failure|0|||
145990621|NCT01514357|526479833|FG000|Overall Study|Withdrawal by Subject|2|||
145990622|NCT01514357|526479834|FG001|Overall Study|Withdrawal by Subject|0|||
145990623|NCT00752219|526479835|FG000|Overall Study|Clinical failure|0|||
145990624|NCT00752219|526479836|FG001|Overall Study|Clinical failure|1|||
145990625|NCT00752219|526479835|FG000|Overall Study|Adverse Event|5|||
145990626|NCT00752219|526479836|FG001|Overall Study|Adverse Event|3|||
145990627|NCT00752219|526479835|FG000|Overall Study|Protocol deviation|1|||
145990628|NCT00752219|526479836|FG001|Overall Study|Protocol deviation|0|||
145990629|NCT00752219|526479835|FG000|Overall Study|Lost to Follow-up|1|||
145990630|NCT00752219|526479836|FG001|Overall Study|Lost to Follow-up|2|||
145990631|NCT00752219|526479835|FG000|Overall Study|Randomized but not treated|1|||
145990632|NCT00752219|526479836|FG001|Overall Study|Randomized but not treated|0|||
145990633|NCT00752219|526479835|FG000|Overall Study|Other|3|||
145990634|NCT00752219|526479836|FG001|Overall Study|Other|0|||
145990635|NCT04691115|526479839|FG000|Overall Study|Withdrawal by Subject|0|||
145990636|NCT04691115|526479840|FG001|Overall Study|Withdrawal by Subject|0|||
145990637|NCT04691115|526479841|FG002|Overall Study|Withdrawal by Subject|0|||
145990638|NCT04691115|526479842|FG003|Overall Study|Withdrawal by Subject|0|||
145990639|NCT04691115|526479843|FG004|Overall Study|Withdrawal by Subject|0|||
145990640|NCT04691115|526479844|FG005|Overall Study|Withdrawal by Subject|1|||
145990641|NCT04691115|526479845|FG006|Overall Study|Withdrawal by Subject|0|||
145990642|NCT04691115|526479846|FG007|Overall Study|Withdrawal by Subject|0|||
145990643|NCT04691115|526479847|FG008|Overall Study|Withdrawal by Subject|0|||
145990644|NCT04691115|526479848|FG009|Overall Study|Withdrawal by Subject|0|||
145990645|NCT04691115|526479849|FG010|Overall Study|Withdrawal by Subject|0|||
145990646|NCT04691115|526479850|FG011|Overall Study|Withdrawal by Subject|0|||
145990647|NCT04691115|526479851|FG012|Overall Study|Withdrawal by Subject|0|||
145990648|NCT04691115|526479852|FG013|Overall Study|Withdrawal by Subject|0|||
145990649|NCT01047540|526479858|FG000|Overall Study|Protocol Violation|1|||
145990650|NCT01047540|526479859|FG001|Overall Study|Protocol Violation|0|||
145990651|NCT01047540|526479860|FG002|Overall Study|Protocol Violation|0|||
145990652|NCT01047540|526479861|FG003|Overall Study|Protocol Violation|0|||
145990653|NCT01047540|526479862|FG004|Overall Study|Protocol Violation|0|||
145990654|NCT01047540|526479858|FG000|Overall Study|Lost to Follow-up|1|||
145990655|NCT01047540|526479859|FG001|Overall Study|Lost to Follow-up|0|||
145990656|NCT01047540|526479860|FG002|Overall Study|Lost to Follow-up|0|||
145990657|NCT01047540|526479861|FG003|Overall Study|Lost to Follow-up|0|||
146091502|NCT02537574|526856833|FG000|Overall Study|Duplicate Patient|1|||
146246059|NCT02161146|527414162|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146246060|NCT02161146|527414163|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146246061|NCT02161146|527414164|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146246062|NCT02161146|527414165|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145990658|NCT01047540|526479862|FG004|Overall Study|Lost to Follow-up|0|||
145990659|NCT01047540|526479858|FG000|Overall Study|Withdrawal by Subject|1|||
145990660|NCT01047540|526479859|FG001|Overall Study|Withdrawal by Subject|0|||
145990661|NCT01047540|526479860|FG002|Overall Study|Withdrawal by Subject|3|||
145990662|NCT01047540|526479861|FG003|Overall Study|Withdrawal by Subject|0|||
145990663|NCT01047540|526479862|FG004|Overall Study|Withdrawal by Subject|1|||
145990664|NCT01047540|526479858|FG000|Overall Study|Pregnancy|1|||
145990665|NCT01047540|526479859|FG001|Overall Study|Pregnancy|0|||
145990666|NCT01047540|526479860|FG002|Overall Study|Pregnancy|0|||
145990667|NCT01047540|526479861|FG003|Overall Study|Pregnancy|0|||
145990668|NCT01047540|526479862|FG004|Overall Study|Pregnancy|0|||
145990669|NCT01047540|526479858|FG000|Overall Study|Adverse Event|1|||
145990670|NCT01047540|526479859|FG001|Overall Study|Adverse Event|0|||
146246063|NCT00845520|527414166|FG000|Overall Study|Death|1|||
146246064|NCT00845520|527414167|FG001|Overall Study|Death|2|||
146246065|NCT00845520|527414168|FG002|Overall Study|Death|0|||
146246066|NCT00845520|527414166|FG000|Overall Study|Lost to Follow-up|1|||
145990671|NCT01047540|526479860|FG002|Overall Study|Adverse Event|0|||
145990672|NCT01047540|526479861|FG003|Overall Study|Adverse Event|0|||
145990673|NCT01047540|526479862|FG004|Overall Study|Adverse Event|0|||
145990674|NCT01437189|526479868|FG000|Overall Study|Adverse Event|3|||
145990675|NCT01437189|526479868|FG000|Overall Study|Lack of Efficacy|4|||
145990676|NCT01437189|526479868|FG000|Overall Study|Withdrawal by Subject|8|||
145990677|NCT04576481|526479873|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
145990678|NCT04576481|526479874|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
145990679|NCT04576481|526479875|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
145990680|NCT04576481|526479876|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
145990681|NCT05261490|526479879|FG000|Overall Study|Other|1|||
145990682|NCT05261490|526479880|FG001|Overall Study|Other|0|||
145990683|NCT05261490|526479881|FG002|Overall Study|Other|0|||
145990684|NCT05261490|526479879|FG000|Overall Study|Study Terminated by Sponsor|1|||
145990685|NCT05261490|526479880|FG001|Overall Study|Study Terminated by Sponsor|1|||
145990686|NCT05261490|526479881|FG002|Overall Study|Study Terminated by Sponsor|4|||
145990687|NCT05261490|526479879|FG000|Overall Study|Death|1|||
145990688|NCT05261490|526479880|FG001|Overall Study|Death|2|||
145990689|NCT05261490|526479881|FG002|Overall Study|Death|0|||
145990690|NCT00456365|526479889|FG000|Overall Study|Lost to Follow-up|1|||
145990691|NCT00456365|526479890|FG001|Overall Study|Lost to Follow-up|3|||
145990692|NCT00456365|526479889|FG000|Overall Study|Withdrawal by Subject|4|||
145990693|NCT00456365|526479890|FG001|Overall Study|Withdrawal by Subject|7|||
145990694|NCT00456365|526479889|FG000|Overall Study|Pregnancy|1|||
145990695|NCT00456365|526479890|FG001|Overall Study|Pregnancy|1|||
145990696|NCT00456365|526479889|FG000|Overall Study|oncologic diagnosis|1|||
145990697|NCT00456365|526479890|FG001|Overall Study|oncologic diagnosis|1|||
145990698|NCT06091956|526479891|FG000|Overall Study|Withdrawal by Subject|1|||
145990699|NCT06091956|526479891|FG000|Overall Study|Complicating Disease|1|||
145990700|NCT03760068|526479897|FG000|Overall Study|Withdrawal by Subject|7|||
145990701|NCT03760068|526479898|FG001|Overall Study|Withdrawal by Subject|8|||
145990702|NCT03760068|526479897|FG000|Overall Study|Adverse Event|1|||
145990703|NCT03760068|526479898|FG001|Overall Study|Adverse Event|2|||
145990704|NCT03760068|526479897|FG000|Overall Study|Administrative Decision by Sponsor|0|||
145990705|NCT03760068|526479898|FG001|Overall Study|Administrative Decision by Sponsor|2|||
145990706|NCT03760068|526479897|FG000|Overall Study|Physician Decision|1|||
145990707|NCT03760068|526479898|FG001|Overall Study|Physician Decision|2|||
145990708|NCT03760068|526479897|FG000|Overall Study|Lost to Follow-up|4|||
145990709|NCT03760068|526479898|FG001|Overall Study|Lost to Follow-up|9|||
145990710|NCT03760068|526479897|FG000|Overall Study|Subject Moved Out of State|1|||
145990711|NCT03760068|526479898|FG001|Overall Study|Subject Moved Out of State|0|||
145990712|NCT01767857|526479903|FG000|Overall Study|Adverse Event|27|||
145990713|NCT01767857|526479904|FG001|Overall Study|Adverse Event|7|||
145990714|NCT01767857|526479903|FG000|Overall Study|Death|28|||
145990715|NCT01767857|526479904|FG001|Overall Study|Death|13|||
145990716|NCT01767857|526479903|FG000|Overall Study|Lack of Efficacy|299|||
145990717|NCT01767857|526479904|FG001|Overall Study|Lack of Efficacy|151|||
145990718|NCT01767857|526479903|FG000|Overall Study|Lost to Follow-up|1|||
145990719|NCT01767857|526479904|FG001|Overall Study|Lost to Follow-up|1|||
145990720|NCT01767857|526479903|FG000|Overall Study|Withdrawal by Subject|38|||
145990721|NCT01767857|526479904|FG001|Overall Study|Withdrawal by Subject|18|||
145990722|NCT01767857|526479903|FG000|Overall Study|Physician Decision|17|||
145990723|NCT01767857|526479904|FG001|Overall Study|Physician Decision|10|||
145990724|NCT01767857|526479903|FG000|Overall Study|Protocol Terminated|1|||
145990725|NCT01767857|526479904|FG001|Overall Study|Protocol Terminated|0|||
145990726|NCT01767857|526479903|FG000|Overall Study|Randomized But Never Treated|19|||
146091503|NCT02537574|526856834|FG001|Overall Study|Duplicate Patient|0|||
146246067|NCT00845520|527414167|FG001|Overall Study|Lost to Follow-up|0|||
146246068|NCT00845520|527414168|FG002|Overall Study|Lost to Follow-up|0|||
145990727|NCT01767857|526479904|FG001|Overall Study|Randomized But Never Treated|13|||
145990728|NCT01421459|526479905|FG000|Overall Study|Adverse Event|6|||
145990729|NCT01421459|526479906|FG001|Overall Study|Adverse Event|10|||
145990730|NCT01421459|526479905|FG000|Overall Study|Death|1|||
145990731|NCT01421459|526479906|FG001|Overall Study|Death|1|||
145990732|NCT01421459|526479905|FG000|Overall Study|Lack of Efficacy|1|||
145990733|NCT01421459|526479906|FG001|Overall Study|Lack of Efficacy|2|||
145990734|NCT01421459|526479905|FG000|Overall Study|Lost to Follow-up|8|||
146246069|NCT00845520|527414166|FG000|Overall Study|Adverse Event|0|||
146246070|NCT00845520|527414167|FG001|Overall Study|Adverse Event|0|||
145990735|NCT01421459|526479906|FG001|Overall Study|Lost to Follow-up|9|||
145990736|NCT01421459|526479905|FG000|Overall Study|Physician Decision|9|||
145990737|NCT01421459|526479906|FG001|Overall Study|Physician Decision|9|||
145990738|NCT01421459|526479905|FG000|Overall Study|Protocol Violation|8|||
145990739|NCT01421459|526479906|FG001|Overall Study|Protocol Violation|5|||
145990740|NCT01421459|526479905|FG000|Overall Study|Withdrawal by Subject|12|||
145990741|NCT01421459|526479906|FG001|Overall Study|Withdrawal by Subject|16|||
145990742|NCT03289741|526479917|FG000|Overall Study|Adverse Event|1|||
145990743|NCT03289741|526479918|FG001|Overall Study|Adverse Event|1|||
145990744|NCT03289741|526479917|FG000|Overall Study|Physician Decision|2|||
145990745|NCT03289741|526479918|FG001|Overall Study|Physician Decision|2|||
145990746|NCT03289741|526479917|FG000|Overall Study|Withdrawal by Subject|1|||
145990747|NCT03289741|526479918|FG001|Overall Study|Withdrawal by Subject|0|||
145990748|NCT04129398|526481459|FG000|Overall Study|Physician Decision|2|||
145990749|NCT04280783|526481460|FG000|Overall Study|Family issues unrelated to the study.|1|||
145990750|NCT04280783|526481461|FG001|Overall Study|Family issues unrelated to the study.|0|||
145990751|NCT04280783|526481460|FG000|Overall Study|Withdrawal by Subject|0|||
145990752|NCT04280783|526481461|FG001|Overall Study|Withdrawal by Subject|1|||
145990753|NCT04110145|526481462|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145990754|NCT04110145|526481463|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145990755|NCT04110145|526481464|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145990756|NCT04110145|526481465|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
145990757|NCT04110145|526481466|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145990758|NCT00980044|526481467|FG000|Overall Study|Withdrawal by Subject|5|||
145990759|NCT00980044|526481468|FG001|Overall Study|Withdrawal by Subject|7|||
145990760|NCT00980044|526481469|FG002|Overall Study|Withdrawal by Subject|3|||
145990761|NCT00980044|526481467|FG000|Overall Study|Protocol Violation|0|||
145990762|NCT00980044|526481468|FG001|Overall Study|Protocol Violation|0|||
145990763|NCT00980044|526481469|FG002|Overall Study|Protocol Violation|2|||
145990764|NCT00185614|526481470|FG000|Inter-treatment Period|Physician Decision|1|||
145990765|NCT00185614|526481470|FG000|Inter-treatment Period|Relapse|2|||
145990766|NCT00185614|526481470|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
145990767|NCT03257657|526481471|FG000|Overall Study|Lost to Follow-up|0|||
145990768|NCT03257657|526481472|FG001|Overall Study|Lost to Follow-up|3|||
145990769|NCT03257657|526481471|FG000|Overall Study|Withdrawn|0|||
145990770|NCT03257657|526481472|FG001|Overall Study|Withdrawn|1|||
145990771|NCT03257657|526481471|FG000|Overall Study|Noted not eligible right after enrolled|0|||
145990772|NCT03257657|526481472|FG001|Overall Study|Noted not eligible right after enrolled|1|||
145990773|NCT00137449|526481473|FG000|Overall Study|Disease Progression|8|||
145990774|NCT00137449|526481474|FG001|Overall Study|Disease Progression|13|||
145990775|NCT00137449|526481473|FG000|Overall Study|Death|4|||
145990776|NCT00137449|526481474|FG001|Overall Study|Death|3|||
145990777|NCT00137449|526481473|FG000|Overall Study|Adverse Event|3|||
145990778|NCT00137449|526481474|FG001|Overall Study|Adverse Event|1|||
145990779|NCT00137449|526481473|FG000|Overall Study|Withdrawal by Subject|1|||
145990780|NCT00137449|526481474|FG001|Overall Study|Withdrawal by Subject|1|||
145990781|NCT02263547|526481481|FG000|Overall Study|Adverse Event|1|||
145990782|NCT02263547|526481481|FG000|Overall Study|Lost to Follow-up|2|||
145990783|NCT00836901|526481484|FG000|First Intervention|Withdrawal by Subject|1|||
145990784|NCT00836901|526481485|FG001|First Intervention|Withdrawal by Subject|0|||
145990785|NCT00830336|526481486|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
145990786|NCT00830336|526481487|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
145990787|NCT00867334|526481488|FG000|Overall Study|Withdrawal by Subject|0|||
145990788|NCT00867334|526481489|FG001|Overall Study|Withdrawal by Subject|1|||
146246071|NCT00845520|527414168|FG002|Overall Study|Adverse Event|1|||
146246072|NCT02613403|527414169|FG000|Overall Study|Lost to Follow-up|0|||
145990789|NCT00867334|526481488|FG000|Overall Study|Withdrawal by Subject|1|||
145990790|NCT00867334|526481489|FG001|Overall Study|Withdrawal by Subject|0|||
145990791|NCT00867334|526481488|FG000|Overall Study|Withdrawal by Subject|1|||
145990792|NCT00867334|526481489|FG001|Overall Study|Withdrawal by Subject|0|||
145990793|NCT01148771|526481492|FG000|Washout Period|Withdrawal by Subject|0|||
145990794|NCT01148771|526481493|FG001|Washout Period|Withdrawal by Subject|1|||
145990795|NCT01229111|526481498|FG000|Overall Study|Death|1|||
145990796|NCT03464461|526481500|FG000|Overall Study|exclusionary medication given ,|1|||
145990797|NCT03464461|526481501|FG001|Overall Study|exclusionary medication given ,|2|||
145990798|NCT03464461|526481502|FG002|Overall Study|exclusionary medication given ,|0|||
145990799|NCT03464461|526481500|FG000|Overall Study|Physician Decision|0|||
145990800|NCT03464461|526481501|FG001|Overall Study|Physician Decision|1|||
145990801|NCT03464461|526481502|FG002|Overall Study|Physician Decision|0|||
145990802|NCT05463952|526481503|FG000|Treatment|Progressive disease|4|||
145990803|NCT05463952|526481503|FG000|Treatment|Ongoing|2|||
145990804|NCT02096354|526481507|FG000|Overall Study|Physician Decision|4|||
145990805|NCT02096354|526481508|FG001|Overall Study|Physician Decision|5|||
145990806|NCT02096354|526481509|FG002|Overall Study|Physician Decision|0|||
145990807|NCT02096354|526481507|FG000|Overall Study|Withdrawal by Subject|3|||
146246073|NCT02613403|527414170|FG001|Overall Study|Lost to Follow-up|1|||
146246074|NCT02613403|527414171|FG002|Overall Study|Lost to Follow-up|0|||
146246075|NCT02613403|527414172|FG003|Overall Study|Lost to Follow-up|0|||
146246076|NCT02613403|527414173|FG004|Overall Study|Lost to Follow-up|0|||
146246077|NCT02613403|527414169|FG000|Overall Study|Withdrawal by Subject|2|||
146246078|NCT02613403|527414170|FG001|Overall Study|Withdrawal by Subject|0|||
146246079|NCT02613403|527414171|FG002|Overall Study|Withdrawal by Subject|0|||
146246080|NCT02613403|527414172|FG003|Overall Study|Withdrawal by Subject|0|||
146246081|NCT02613403|527414173|FG004|Overall Study|Withdrawal by Subject|0|||
146246082|NCT02807857|527414174|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
146246083|NCT02807857|527414174|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
146246084|NCT02807857|527414174|FG000|Follow-Up Set|Withdrawal by Subject|8|||
146246085|NCT02807857|527414174|FG000|Follow-Up Set|Lost to Follow-up|7|||
146246086|NCT02807857|527414174|FG000|Follow-Up Set|Physician Decision|6|||
146246087|NCT02807857|527414174|FG000|Follow-Up Set|Adverse Event|3|||
146246088|NCT02807857|527414174|FG000|Follow-Up Set|Death|27|||
146246089|NCT02807857|527414174|FG000|Follow-Up Set|Relocation|2|||
146246090|NCT00800176|527414175|FG000|Overall Study|Adverse Event|2|||
146246091|NCT00800176|527414176|FG001|Overall Study|Adverse Event|1|||
146246092|NCT00800176|527414177|FG002|Overall Study|Adverse Event|0|||
146246093|NCT00800176|527414178|FG003|Overall Study|Adverse Event|2|||
146246094|NCT00800176|527414179|FG004|Overall Study|Adverse Event|1|||
146246095|NCT00800176|527414180|FG005|Overall Study|Adverse Event|1|||
146246096|NCT00800176|527414175|FG000|Overall Study|Refused treatment|3|||
146246097|NCT00800176|527414176|FG001|Overall Study|Refused treatment|2|||
146246098|NCT00800176|527414177|FG002|Overall Study|Refused treatment|0|||
146246099|NCT00800176|527414178|FG003|Overall Study|Refused treatment|0|||
146246100|NCT00800176|527414179|FG004|Overall Study|Refused treatment|1|||
146246101|NCT00800176|527414180|FG005|Overall Study|Refused treatment|4|||
146246102|NCT00800176|527414175|FG000|Overall Study|Failure to return|3|||
146246103|NCT00800176|527414176|FG001|Overall Study|Failure to return|3|||
146246104|NCT00800176|527414177|FG002|Overall Study|Failure to return|0|||
146246105|NCT00800176|527414178|FG003|Overall Study|Failure to return|2|||
146246106|NCT00800176|527414179|FG004|Overall Study|Failure to return|0|||
146246107|NCT00800176|527414180|FG005|Overall Study|Failure to return|0|||
146246108|NCT00800176|527414175|FG000|Overall Study|Other|1|||
146246109|NCT00800176|527414176|FG001|Overall Study|Other|0|||
146246110|NCT00800176|527414177|FG002|Overall Study|Other|0|||
145990808|NCT02096354|526481508|FG001|Overall Study|Withdrawal by Subject|1|||
145990809|NCT02096354|526481509|FG002|Overall Study|Withdrawal by Subject|0|||
145990810|NCT02096354|526481507|FG000|Overall Study|Adverse Event|7|||
145990811|NCT02096354|526481508|FG001|Overall Study|Adverse Event|4|||
145990812|NCT02096354|526481509|FG002|Overall Study|Adverse Event|0|||
145990813|NCT02096354|526481507|FG000|Overall Study|Ineligible|0|||
145990814|NCT02096354|526481508|FG001|Overall Study|Ineligible|0|||
145990815|NCT02096354|526481509|FG002|Overall Study|Ineligible|11|||
145990816|NCT03579719|526481512|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
145990817|NCT00069953|526481513|FG000|Overall Study|Protocol Violation|2|||
145990818|NCT01646216|526481514|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
145990819|NCT01646216|526481515|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
145990820|NCT01646216|526481514|FG000|Overall Study|Did not complete training|0|||
145990821|NCT01646216|526481515|FG001|Overall Study|Did not complete training|2|||
145990822|NCT01646216|526481514|FG000|Overall Study|Investigator decision|1|||
145990823|NCT01646216|526481515|FG001|Overall Study|Investigator decision|1|||
145990824|NCT00113373|526481518|FG000|Overall Study|Ineligible: wrong primary|1|||
145990825|NCT00113373|526481518|FG000|Overall Study|Ineligible: second primary|1|||
145990826|NCT00113373|526481518|FG000|Overall Study|Never Treated|1|||
145990827|NCT02395627|526481519|FG000|Overall Study|Withdrawal by Subject|0|||
145990828|NCT02395627|526481520|FG001|Overall Study|Withdrawal by Subject|2|||
145990829|NCT02395627|526481521|FG002|Overall Study|Withdrawal by Subject|0|||
145990830|NCT02395627|526481519|FG000|Overall Study|Did not receive pembrolizumab|3|||
145990831|NCT02395627|526481520|FG001|Overall Study|Did not receive pembrolizumab|1|||
145990832|NCT02395627|526481521|FG002|Overall Study|Did not receive pembrolizumab|0|||
145990833|NCT03253627|526481522|FG000|Overall Study|Lost to Follow-up|1|||
145990834|NCT03253627|526481523|FG001|Overall Study|Lost to Follow-up|2|||
145990835|NCT03253627|526481522|FG000|Overall Study|Withdrawal by Subject|0|||
145990836|NCT03253627|526481523|FG001|Overall Study|Withdrawal by Subject|2|||
146246111|NCT00800176|527414178|FG003|Overall Study|Other|0|||
145990837|NCT03253627|526481522|FG000|Overall Study|Inability to complete MRI|1|||
145990838|NCT03253627|526481523|FG001|Overall Study|Inability to complete MRI|0|||
145990839|NCT03829683|526481524|FG000|Overall Study|Lost to Follow-up|1|||
145990840|NCT03829683|526481525|FG001|Overall Study|Lost to Follow-up|0|||
145990841|NCT03829683|526481524|FG000|Overall Study|Physician Decision|3|||
145990842|NCT03829683|526481525|FG001|Overall Study|Physician Decision|1|||
145990843|NCT03829683|526481524|FG000|Overall Study|Withdrawal by Subject|0|||
146246112|NCT00800176|527414179|FG004|Overall Study|Other|2|||
146246113|NCT00800176|527414180|FG005|Overall Study|Other|0|||
146246114|NCT01240590|527414183|FG000|Phase I|Refused further treatment|0|||
146246115|NCT01240590|527414184|FG001|Phase I|Refused further treatment|0|||
146246116|NCT01240590|527414185|FG002|Phase I|Refused further treatment|3|||
145990844|NCT03829683|526481525|FG001|Overall Study|Withdrawal by Subject|1|||
146246117|NCT01240590|527414186|FG003|Phase I|Refused further treatment|0|||
146246118|NCT01240590|527414187|FG004|Phase I|Refused further treatment|0|||
146246119|NCT01240590|527414183|FG000|Phase II|Refused further treatment|0|||
146246120|NCT01240590|527414184|FG001|Phase II|Refused further treatment|0|||
146246121|NCT01240590|527414185|FG002|Phase II|Refused further treatment|0|||
145990845|NCT03829683|526481524|FG000|Overall Study|Discharge from hospital|1|||
145990846|NCT03829683|526481525|FG001|Overall Study|Discharge from hospital|0|||
145990847|NCT03163667|526481526|FG000|Overall Study|Death|15|||
145990848|NCT03163667|526481527|FG001|Overall Study|Death|27|||
145990849|NCT03163667|526481526|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
145990850|NCT03163667|526481527|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
145990851|NCT00979407|526481528|FG000|Overall Study|Withdrawal by Subject|3|||
145990852|NCT00979407|526481529|FG001|Overall Study|Withdrawal by Subject|4|||
145990853|NCT00979407|526481528|FG000|Overall Study|Lost to Follow-up|3|||
145990854|NCT00979407|526481529|FG001|Overall Study|Lost to Follow-up|3|||
145990855|NCT02420314|526481530|FG000|Overall Study|Withdrawal by Subject|1|||
145990856|NCT02420314|526481530|FG000|Overall Study|Protocol Violation|1|||
145990857|NCT05430919|526481531|FG000|Overall Study|Protocol Violation|0|||
145990858|NCT05430919|526481532|FG001|Overall Study|Protocol Violation|0|||
145990859|NCT05430919|526481533|FG002|Overall Study|Protocol Violation|1|||
145990860|NCT05430919|526481534|FG003|Overall Study|Protocol Violation|0|||
145990861|NCT05430919|526481531|FG000|Overall Study|Lost to Follow-up|0|||
145990862|NCT05430919|526481532|FG001|Overall Study|Lost to Follow-up|1|||
145990863|NCT05430919|526481533|FG002|Overall Study|Lost to Follow-up|0|||
145990864|NCT05430919|526481534|FG003|Overall Study|Lost to Follow-up|0|||
145990865|NCT05430919|526481531|FG000|Overall Study|Withdrawal by Subject|3|||
145990866|NCT05430919|526481532|FG001|Overall Study|Withdrawal by Subject|0|||
145990867|NCT05430919|526481533|FG002|Overall Study|Withdrawal by Subject|0|||
145990868|NCT05430919|526481534|FG003|Overall Study|Withdrawal by Subject|1|||
145990869|NCT01335685|526481538|FG000|Overall Study|Study Terminated by Sponsor|2|||
145990870|NCT01335685|526481539|FG001|Overall Study|Study Terminated by Sponsor|1|||
145990871|NCT01335685|526481540|FG002|Overall Study|Study Terminated by Sponsor|1|||
145990872|NCT01335685|526481541|FG003|Overall Study|Study Terminated by Sponsor|10|||
145990873|NCT01335685|526481542|FG004|Overall Study|Study Terminated by Sponsor|0|||
145990874|NCT01335685|526481543|FG005|Overall Study|Study Terminated by Sponsor|4|||
145990875|NCT01335685|526481544|FG006|Overall Study|Study Terminated by Sponsor|2|||
145990876|NCT01335685|526481545|FG007|Overall Study|Study Terminated by Sponsor|3|||
145990877|NCT01335685|526481538|FG000|Overall Study|Withdrawal by Subject|1|||
145990878|NCT01335685|526481539|FG001|Overall Study|Withdrawal by Subject|0|||
145990879|NCT01335685|526481540|FG002|Overall Study|Withdrawal by Subject|0|||
145990880|NCT01335685|526481541|FG003|Overall Study|Withdrawal by Subject|1|||
145990881|NCT01335685|526481542|FG004|Overall Study|Withdrawal by Subject|0|||
145990882|NCT01335685|526481543|FG005|Overall Study|Withdrawal by Subject|0|||
145990883|NCT01335685|526481544|FG006|Overall Study|Withdrawal by Subject|0|||
145990884|NCT01335685|526481545|FG007|Overall Study|Withdrawal by Subject|0|||
145990885|NCT01335685|526481538|FG000|Overall Study|Reason not Specified|0|||
145990886|NCT01335685|526481539|FG001|Overall Study|Reason not Specified|0|||
145990887|NCT01335685|526481540|FG002|Overall Study|Reason not Specified|1|||
145990888|NCT01335685|526481541|FG003|Overall Study|Reason not Specified|0|||
146246122|NCT01240590|527414186|FG003|Phase II|Refused further treatment|2|||
146246123|NCT01240590|527414187|FG004|Phase II|Refused further treatment|1|||
146246124|NCT01075152|527414189|FG000|Overall Study|Withdrawal by Subject|1|||
146246125|NCT01075152|527414190|FG001|Overall Study|Withdrawal by Subject|0|||
145990889|NCT01335685|526481542|FG004|Overall Study|Reason not Specified|0|||
145990890|NCT01335685|526481543|FG005|Overall Study|Reason not Specified|1|||
145990891|NCT01335685|526481544|FG006|Overall Study|Reason not Specified|0|||
145990892|NCT01335685|526481545|FG007|Overall Study|Reason not Specified|0|||
145990893|NCT00855166|526481546|FG000|Overall Study|Adverse Event|0|||
145990894|NCT00855166|526481547|FG001|Overall Study|Adverse Event|2|||
145990895|NCT00855166|526481546|FG000|Overall Study|Death|0|||
145990896|NCT00855166|526481547|FG001|Overall Study|Death|1|||
145990897|NCT00855166|526481546|FG000|Overall Study|Withdrawal by Subject|1|||
145990898|NCT00855166|526481547|FG001|Overall Study|Withdrawal by Subject|4|||
145990899|NCT00855166|526481546|FG000|Overall Study|Poor/non-compliance|2|||
145990900|NCT00855166|526481547|FG001|Overall Study|Poor/non-compliance|0|||
145990901|NCT00855166|526481546|FG000|Overall Study|Administrative reasons by sponsor|1|||
146091504|NCT02537574|526856835|FG002|Overall Study|Duplicate Patient|0|||
146091505|NCT02537574|526856833|FG000|Overall Study|Patient not Stable|0|||
146246126|NCT01079949|527414191|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
145990902|NCT00855166|526481547|FG001|Overall Study|Administrative reasons by sponsor|0|||
145990903|NCT00855166|526481546|FG000|Overall Study|Subject no longer meets study criteria|1|||
145990904|NCT00855166|526481547|FG001|Overall Study|Subject no longer meets study criteria|1|||
145990905|NCT00803049|526481548|FG000|Overall Study|Adverse Event|21|||
145990906|NCT00803049|526481549|FG001|Overall Study|Adverse Event|33|||
146246127|NCT01079949|527414192|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
145990907|NCT00803049|526481550|FG002|Overall Study|Adverse Event|13|||
145990908|NCT00803049|526481551|FG003|Overall Study|Adverse Event|27|||
145990909|NCT00803049|526481548|FG000|Overall Study|Lack of Efficacy|10|||
145990910|NCT00803049|526481549|FG001|Overall Study|Lack of Efficacy|19|||
145990911|NCT00803049|526481550|FG002|Overall Study|Lack of Efficacy|6|||
145990912|NCT00803049|526481551|FG003|Overall Study|Lack of Efficacy|13|||
145990913|NCT00803049|526481548|FG000|Overall Study|Lost to Follow-up|0|||
145990914|NCT00803049|526481549|FG001|Overall Study|Lost to Follow-up|2|||
145990915|NCT00803049|526481550|FG002|Overall Study|Lost to Follow-up|0|||
145990916|NCT00803049|526481551|FG003|Overall Study|Lost to Follow-up|3|||
145990917|NCT00803049|526481548|FG000|Overall Study|Death|2|||
145990918|NCT00803049|526481549|FG001|Overall Study|Death|1|||
145990919|NCT00803049|526481550|FG002|Overall Study|Death|0|||
145990920|NCT00803049|526481551|FG003|Overall Study|Death|2|||
145990921|NCT00803049|526481548|FG000|Overall Study|Progressive Disease|6|||
145990922|NCT00803049|526481549|FG001|Overall Study|Progressive Disease|10|||
145990923|NCT00803049|526481550|FG002|Overall Study|Progressive Disease|6|||
145990924|NCT00803049|526481551|FG003|Overall Study|Progressive Disease|6|||
145990925|NCT00803049|526481548|FG000|Overall Study|Withdrawal by Subject|19|||
145990926|NCT00803049|526481549|FG001|Overall Study|Withdrawal by Subject|43|||
145990927|NCT00803049|526481550|FG002|Overall Study|Withdrawal by Subject|16|||
145990928|NCT00803049|526481551|FG003|Overall Study|Withdrawal by Subject|44|||
145990929|NCT00803049|526481548|FG000|Overall Study|Protocol Violation|0|||
145990930|NCT00803049|526481549|FG001|Overall Study|Protocol Violation|1|||
145990931|NCT00803049|526481550|FG002|Overall Study|Protocol Violation|1|||
145990932|NCT00803049|526481551|FG003|Overall Study|Protocol Violation|0|||
145990933|NCT00803049|526481548|FG000|Overall Study|Randomized and Not Treated|0|||
145990934|NCT00803049|526481549|FG001|Overall Study|Randomized and Not Treated|0|||
145990935|NCT00803049|526481550|FG002|Overall Study|Randomized and Not Treated|0|||
145990936|NCT00803049|526481551|FG003|Overall Study|Randomized and Not Treated|2|||
145990937|NCT00803049|526481548|FG000|Overall Study|Other than Specified Above|3|||
145990938|NCT00803049|526481549|FG001|Overall Study|Other than Specified Above|9|||
145990939|NCT00803049|526481550|FG002|Overall Study|Other than Specified Above|2|||
145990940|NCT00803049|526481551|FG003|Overall Study|Other than Specified Above|5|||
145990941|NCT01422382|526481552|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
145990942|NCT04082364|526481555|FG000|Overall Study|Death|23|||
145990943|NCT04082364|526481556|FG001|Overall Study|Death|1|||
145990944|NCT04082364|526481557|FG002|Overall Study|Death|1|||
145990945|NCT04082364|526481558|FG003|Overall Study|Death|2|||
145990946|NCT04082364|526481559|FG004|Overall Study|Death|1|||
145990947|NCT04082364|526481555|FG000|Overall Study|Lost to Follow-up|1|||
145990948|NCT04082364|526481556|FG001|Overall Study|Lost to Follow-up|0|||
145990949|NCT04082364|526481557|FG002|Overall Study|Lost to Follow-up|0|||
145990950|NCT04082364|526481558|FG003|Overall Study|Lost to Follow-up|0|||
145990951|NCT04082364|526481559|FG004|Overall Study|Lost to Follow-up|1|||
145990952|NCT04082364|526481555|FG000|Overall Study|Physician Decision|1|||
145990953|NCT04082364|526481556|FG001|Overall Study|Physician Decision|1|||
145990954|NCT04082364|526481557|FG002|Overall Study|Physician Decision|0|||
145990955|NCT04082364|526481558|FG003|Overall Study|Physician Decision|2|||
145990956|NCT04082364|526481559|FG004|Overall Study|Physician Decision|1|||
145990957|NCT04082364|526481555|FG000|Overall Study|Withdrawal by Subject|1|||
145990958|NCT04082364|526481556|FG001|Overall Study|Withdrawal by Subject|1|||
145990959|NCT04082364|526481557|FG002|Overall Study|Withdrawal by Subject|0|||
145990960|NCT04082364|526481558|FG003|Overall Study|Withdrawal by Subject|0|||
145990961|NCT04082364|526481559|FG004|Overall Study|Withdrawal by Subject|1|||
145990962|NCT04082364|526481555|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
145990963|NCT04082364|526481556|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
145990964|NCT04082364|526481557|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
145990965|NCT04082364|526481558|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
145990966|NCT04082364|526481559|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
145990967|NCT04082364|526481555|FG000|Overall Study|Disease progression|0|||
145990968|NCT04082364|526481556|FG001|Overall Study|Disease progression|0|||
146246128|NCT01079949|527414191|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
145990969|NCT04082364|526481557|FG002|Overall Study|Disease progression|0|||
145990970|NCT04082364|526481558|FG003|Overall Study|Disease progression|1|||
145990971|NCT04082364|526481559|FG004|Overall Study|Disease progression|0|||
145990972|NCT03186378|526481560|FG000|Overall Study|Lost to Follow-up|1|||
145990973|NCT03186378|526481561|FG001|Overall Study|Lost to Follow-up|0|||
145990974|NCT02514746|526481562|FG000|Overall Study|Chronically Ill|1|||
145990975|NCT02514746|526481563|FG001|Overall Study|Chronically Ill|2|||
145990976|NCT02514746|526481562|FG000|Overall Study|Physician Decision|4|||
145990977|NCT02514746|526481563|FG001|Overall Study|Physician Decision|2|||
145990978|NCT02514746|526481562|FG000|Overall Study|Withdrawal by Subject|12|||
145990979|NCT02514746|526481563|FG001|Overall Study|Withdrawal by Subject|10|||
145990980|NCT02514746|526481562|FG000|Overall Study|Other|5|||
145990981|NCT02514746|526481563|FG001|Overall Study|Other|1|||
145990982|NCT04042311|526481564|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
145990983|NCT04042311|526481564|FG000|Overall Study|Unable to tolerate|4|||
145990984|NCT04042311|526481564|FG000|Overall Study|Concurrent illness|2|||
146246129|NCT01079949|527414192|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
146246130|NCT01079949|527414191|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
146246131|NCT01079949|527414192|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
145990985|NCT04042311|526481564|FG000|Overall Study|Adverse Event|2|||
145990986|NCT04042311|526481564|FG000|Overall Study|No longer meeting inclusion criteria|2|||
145990987|NCT04042311|526481564|FG000|Overall Study|No reason given|1|||
145990988|NCT04042311|526481564|FG000|Overall Study|Withdrawal by Subject|4|||
145990989|NCT05021224|526481565|FG000|Overall Study|Did not complete all survey items|4|||
145990990|NCT05021224|526481566|FG001|Overall Study|Did not complete all survey items|1|||
145990991|NCT05021224|526481567|FG002|Overall Study|Did not complete all survey items|0|||
145990992|NCT05021224|526481568|FG003|Overall Study|Did not complete all survey items|2|||
145990993|NCT03996395|526481569|FG000|Overall Study|Lost to Follow-up|4|||
145990994|NCT03996395|526481569|FG000|Overall Study|Withdrawal by Subject|1|||
145990995|NCT03996395|526481569|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
145990996|NCT05375929|526481570|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
145990997|NCT05375929|526481571|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145990998|NCT05375929|526481572|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145990999|NCT05375929|526481573|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145991000|NCT05375929|526481570|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145991001|NCT05375929|526481571|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145991002|NCT05375929|526481572|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145991003|NCT05375929|526481573|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145991004|NCT05375929|526481570|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
145991005|NCT05375929|526481571|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
145991006|NCT05375929|526481572|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
145991007|NCT05375929|526481573|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
145991008|NCT05375929|526481570|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145991009|NCT05375929|526481571|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
145991010|NCT05375929|526481572|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145991011|NCT05375929|526481573|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145991012|NCT05375929|526481570|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
145991013|NCT05375929|526481571|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145991014|NCT05375929|526481572|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145991015|NCT05375929|526481573|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145991016|NCT05375929|526481570|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145991017|NCT05375929|526481571|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
145991018|NCT05375929|526481572|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145991019|NCT05375929|526481573|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145991020|NCT05375929|526481570|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145991021|NCT05375929|526481571|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145991022|NCT05375929|526481572|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145991023|NCT05375929|526481573|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
145991024|NCT05375929|526481570|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145991025|NCT05375929|526481571|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145991026|NCT05375929|526481572|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
145991027|NCT05375929|526481573|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145991028|NCT05375929|526481570|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145991029|NCT05375929|526481571|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145991030|NCT05375929|526481572|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
145991031|NCT05375929|526481573|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145991032|NCT05375929|526481570|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145991033|NCT05375929|526481571|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145991034|NCT05375929|526481572|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
145991035|NCT05375929|526481573|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145991036|NCT03973489|526481574|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
145991037|NCT03973489|526481575|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991038|NCT03973489|526481576|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991039|NCT03973489|526481577|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991040|NCT03973489|526481578|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
145991041|NCT03973489|526481579|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991042|NCT03973489|526481580|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991043|NCT03973489|526481581|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145991044|NCT03973489|526481574|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145991045|NCT03973489|526481575|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
146246132|NCT01079949|527414191|FG000|Overall Study|Randomized but not treated|1|||
146246133|NCT01079949|527414192|FG001|Overall Study|Randomized but not treated|0|||
145991046|NCT03973489|526481576|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145991047|NCT03973489|526481577|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
145991048|NCT03973489|526481578|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
145991049|NCT03973489|526481579|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145991050|NCT03973489|526481580|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145991051|NCT03973489|526481581|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145991052|NCT03973489|526481574|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991053|NCT03973489|526481575|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991054|NCT03973489|526481576|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991055|NCT03973489|526481577|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991056|NCT03973489|526481578|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
145991057|NCT03973489|526481579|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991058|NCT03973489|526481580|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
145991059|NCT03973489|526481581|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
145991060|NCT03973489|526481574|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
145991061|NCT03973489|526481575|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991062|NCT03973489|526481576|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991063|NCT03973489|526481577|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
145991064|NCT03973489|526481578|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991065|NCT03973489|526481579|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991066|NCT03973489|526481580|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991067|NCT03973489|526481581|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145991068|NCT03973489|526481574|FG000|Second Intervention (1 Day)|Adverse Event|0|||
145991069|NCT03973489|526481575|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145991070|NCT03973489|526481576|FG002|Second Intervention (1 Day)|Adverse Event|0|||
145991071|NCT03973489|526481577|FG003|Second Intervention (1 Day)|Adverse Event|1|||
145991072|NCT03973489|526481578|FG004|Second Intervention (1 Day)|Adverse Event|0|||
145991073|NCT03973489|526481579|FG005|Second Intervention (1 Day)|Adverse Event|0|||
145991074|NCT03973489|526481580|FG006|Second Intervention (1 Day)|Adverse Event|0|||
145991075|NCT03973489|526481581|FG007|Second Intervention (1 Day)|Adverse Event|0|||
145991076|NCT03301415|526481582|FG000|Overall Study|Lost to Follow-up|2|||
145991077|NCT03301415|526481582|FG000|Overall Study|Unable to comply with visit schedule|2|||
145991078|NCT03247673|526481583|FG000|Overall Study|Withdrawal by Subject|1|||
145991079|NCT03247673|526481584|FG001|Overall Study|Withdrawal by Subject|0|||
145991080|NCT03247673|526481585|FG002|Overall Study|Withdrawal by Subject|3|||
145991081|NCT03247673|526481583|FG000|Overall Study|Lost to Follow-up|0|||
145991082|NCT03247673|526481584|FG001|Overall Study|Lost to Follow-up|0|||
145991083|NCT03247673|526481585|FG002|Overall Study|Lost to Follow-up|1|||
145991084|NCT02184442|526481586|FG000|Overall Study|Death|61|||
145991085|NCT02184442|526481587|FG001|Overall Study|Death|65|||
145991086|NCT02184442|526481586|FG000|Overall Study|Withdrawal by Subject|3|||
145991087|NCT02184442|526481587|FG001|Overall Study|Withdrawal by Subject|11|||
145991088|NCT04091438|526481588|FG000|Treatment Period 1 (1 Day)|Other|1|||
145991089|NCT04091438|526481589|FG001|Treatment Period 1 (1 Day)|Other|0|||
145991090|NCT04091438|526481588|FG000|Washout Period (1 Day)|Protocol deviation|0|||
145991091|NCT04091438|526481589|FG001|Washout Period (1 Day)|Protocol deviation|1|||
145991092|NCT04091438|526481588|FG000|Washout Period (1 Day)|Other|0|||
145991093|NCT04091438|526481589|FG001|Washout Period (1 Day)|Other|1|||
145991094|NCT02691494|526481594|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
145991095|NCT02691494|526481595|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
145991096|NCT02691494|526481596|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
145991097|NCT02691494|526481594|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145991098|NCT02691494|526481595|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145991099|NCT02691494|526481596|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
145991100|NCT02691494|526481594|FG000|Post-Treatment Follow-Up Period|Other|2|||
145991101|NCT02691494|526481595|FG001|Post-Treatment Follow-Up Period|Other|1|||
145991102|NCT02691494|526481596|FG002|Post-Treatment Follow-Up Period|Other|1|||
146091506|NCT02537574|526856834|FG001|Overall Study|Patient not Stable|1|||
146091507|NCT02537574|526856835|FG002|Overall Study|Patient not Stable|0|||
146091508|NCT02537574|526856833|FG000|Overall Study|Incarceration|0|||
146091509|NCT02537574|526856834|FG001|Overall Study|Incarceration|1|||
146246134|NCT02144285|527414193|FG000|Overall Study|Withdrawal by Subject|0|||
146246135|NCT02144285|527414194|FG001|Overall Study|Withdrawal by Subject|0|||
146246136|NCT02144285|527414195|FG002|Overall Study|Withdrawal by Subject|0|||
146246137|NCT02144285|527414196|FG003|Overall Study|Withdrawal by Subject|0|||
146246138|NCT02144285|527414197|FG004|Overall Study|Withdrawal by Subject|1|||
146246139|NCT02144285|527414198|FG005|Overall Study|Withdrawal by Subject|0|||
146246140|NCT02144285|527414199|FG006|Overall Study|Withdrawal by Subject|0|||
146246141|NCT02144285|527414200|FG007|Overall Study|Withdrawal by Subject|0|||
146246142|NCT02144285|527414201|FG008|Overall Study|Withdrawal by Subject|0|||
146246143|NCT02144285|527414202|FG009|Overall Study|Withdrawal by Subject|0|||
146246144|NCT01529632|527414203|FG000|Overall Study|Administrative problem|2|||
145991103|NCT02691494|526481594|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
145991104|NCT02691494|526481595|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
145991105|NCT02691494|526481596|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
145991106|NCT02691494|526481594|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145991107|NCT02691494|526481595|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
145991108|NCT02691494|526481596|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
145991109|NCT02657356|526482514|FG000|Overall Study|Death|1|||
145991110|NCT02657356|526482515|FG001|Overall Study|Death|0|||
145991111|NCT02657356|526482514|FG000|Overall Study|Withdrawal by Subject|5|||
145991112|NCT02657356|526482515|FG001|Overall Study|Withdrawal by Subject|6|||
145991113|NCT02657356|526482514|FG000|Overall Study|Terminated by Sponsor|8|||
145991114|NCT02657356|526482515|FG001|Overall Study|Terminated by Sponsor|5|||
145991115|NCT02657356|526482514|FG000|Overall Study|Rolled over to EAP study|6|||
145991116|NCT02657356|526482515|FG001|Overall Study|Rolled over to EAP study|4|||
145991117|NCT03379870|526482516|FG000|Overall Study|Lost to Follow-up|1|||
145991118|NCT03379870|526482517|FG001|Overall Study|Lost to Follow-up|0|||
145991119|NCT03379870|526482516|FG000|Overall Study|Protocol Violation|1|||
145991120|NCT03379870|526482517|FG001|Overall Study|Protocol Violation|1|||
145991121|NCT02471144|526482518|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
145991122|NCT02471144|526482519|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
145991123|NCT02471144|526482520|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
146091510|NCT02537574|526856835|FG002|Overall Study|Incarceration|0|||
146091511|NCT02537574|526856833|FG000|Overall Study|Failed Naloxone Challenge|0|||
146091512|NCT02537574|526856834|FG001|Overall Study|Failed Naloxone Challenge|1|||
146091513|NCT02537574|526856835|FG002|Overall Study|Failed Naloxone Challenge|0|||
146091514|NCT02537574|526856833|FG000|Overall Study|Transportation Issues|0|||
146091515|NCT02537574|526856834|FG001|Overall Study|Transportation Issues|0|||
146091516|NCT02537574|526856835|FG002|Overall Study|Transportation Issues|1|||
146091517|NCT02537574|526856833|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
146091518|NCT02537574|526856834|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
146091519|NCT02537574|526856835|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
146091520|NCT02537574|526856833|FG000|Overall Study|Noncompliance with Protocol|0|||
146091521|NCT02537574|526856834|FG001|Overall Study|Noncompliance with Protocol|0|||
146091522|NCT02537574|526856835|FG002|Overall Study|Noncompliance with Protocol|1|||
146091523|NCT02663687|526856836|FG000|Overall Study|Adverse Event|1|||
146091524|NCT02663687|526856837|FG001|Overall Study|Adverse Event|0|||
146091525|NCT02663687|526856838|FG002|Overall Study|Adverse Event|0|||
146091526|NCT02663687|526856839|FG003|Overall Study|Adverse Event|0|||
146091527|NCT02663687|526856840|FG004|Overall Study|Adverse Event|0|||
146091528|NCT02663687|526856836|FG000|Overall Study|Other|1|||
146091529|NCT02663687|526856837|FG001|Overall Study|Other|0|||
146091530|NCT02663687|526856838|FG002|Overall Study|Other|1|||
146091531|NCT02663687|526856839|FG003|Overall Study|Other|0|||
146091532|NCT02663687|526856840|FG004|Overall Study|Other|0|||
146091533|NCT01151098|526856841|FG000|Overall Study|Adverse Event|82|||
146091534|NCT01151098|526856841|FG000|Overall Study|Lost to Follow-up|6|||
146091535|NCT01151098|526856841|FG000|Overall Study|Lack of Efficacy|15|||
146091536|NCT01151098|526856841|FG000|Overall Study|Protocol Violation|1|||
146091537|NCT01151098|526856841|FG000|Overall Study|Miscellaneous|13|||
146091538|NCT03343067|526856844|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
146091539|NCT03343067|526856845|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
146091540|NCT03343067|526856846|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
146091541|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
146091542|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
146091543|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
146091544|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
146091545|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146091546|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
146091547|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146091548|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
146091549|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
146091550|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
146091551|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
146091552|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
145991124|NCT02471144|526482521|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
145991125|NCT02471144|526482522|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
145991126|NCT02471144|526482523|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
145991127|NCT02471144|526482524|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
146091553|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146091554|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
146091555|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146091556|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
146091557|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Program Termination|3|||
145991128|NCT02471144|526482525|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
145991129|NCT02471144|526482526|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
145991130|NCT02471144|526482527|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
145991131|NCT02471144|526482528|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
145991132|NCT02471144|526482518|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991133|NCT02471144|526482519|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991134|NCT02471144|526482520|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991135|NCT02471144|526482521|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
145991136|NCT02471144|526482522|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991137|NCT02471144|526482523|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991138|NCT02471144|526482524|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991139|NCT02471144|526482525|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991140|NCT02471144|526482526|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991141|NCT02471144|526482527|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991142|NCT02471144|526482528|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145991143|NCT02471144|526482518|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991144|NCT02471144|526482519|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991145|NCT02471144|526482520|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
145991146|NCT02471144|526482521|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991147|NCT02471144|526482522|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991148|NCT02471144|526482523|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991149|NCT02471144|526482524|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991150|NCT02471144|526482525|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991151|NCT02471144|526482526|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991152|NCT02471144|526482527|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991153|NCT02471144|526482528|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145991154|NCT02471144|526482518|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
145991155|NCT02471144|526482519|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
145991156|NCT02471144|526482520|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991157|NCT02471144|526482521|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991158|NCT02471144|526482522|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991159|NCT02471144|526482523|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991160|NCT02471144|526482524|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991161|NCT02471144|526482525|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991162|NCT02471144|526482526|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991163|NCT02471144|526482527|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991164|NCT02471144|526482528|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145991165|NCT02471144|526482518|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991166|NCT02471144|526482519|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991167|NCT02471144|526482520|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991168|NCT02471144|526482521|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991169|NCT02471144|526482522|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145991170|NCT02471144|526482523|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991171|NCT02471144|526482524|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145991172|NCT02471144|526482525|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991173|NCT02471144|526482526|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145991174|NCT02471144|526482527|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991175|NCT02471144|526482528|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145991176|NCT02471144|526482518|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991177|NCT02471144|526482519|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991178|NCT02471144|526482520|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991179|NCT02471144|526482521|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991180|NCT02471144|526482522|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991181|NCT02471144|526482523|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
145991182|NCT02471144|526482524|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991183|NCT02471144|526482525|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991184|NCT02471144|526482526|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
145991185|NCT02471144|526482527|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991186|NCT02471144|526482528|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145991187|NCT02471144|526482518|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991188|NCT02471144|526482519|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991189|NCT02471144|526482520|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146297870|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145991190|NCT02471144|526482521|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991191|NCT02471144|526482522|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991192|NCT02471144|526482523|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146297871|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
145991193|NCT02471144|526482524|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991194|NCT02471144|526482525|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
146246145|NCT01529632|527414204|FG001|Overall Study|Administrative problem|1|||
146246146|NCT01529632|527414203|FG000|Overall Study|Protocol Violation|0|||
146246147|NCT01529632|527414204|FG001|Overall Study|Protocol Violation|1|||
146246148|NCT01529632|527414203|FG000|Overall Study|Adverse Event|1|||
146246149|NCT01529632|527414204|FG001|Overall Study|Adverse Event|1|||
146246150|NCT00452452|527414205|FG000|Overall Study|Protocol Violation|0|||
145991195|NCT02471144|526482526|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
145991196|NCT02471144|526482527|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991197|NCT02471144|526482528|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145991198|NCT02471144|526482518|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991199|NCT02471144|526482519|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991200|NCT02471144|526482520|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991201|NCT02471144|526482521|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991202|NCT02471144|526482522|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991203|NCT02471144|526482523|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991204|NCT02471144|526482524|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991205|NCT02471144|526482525|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
145991206|NCT02471144|526482526|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
145991207|NCT02471144|526482527|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991208|NCT02471144|526482528|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145991209|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991210|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991211|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991212|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991213|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991214|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991215|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991216|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991217|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145991218|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
145991219|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
145991220|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
146091558|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Program Termination|0|||
146091559|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Program Termination|1|||
146091560|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Program Termination|1|||
146091561|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
146091562|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146091563|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146091564|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
146091565|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
146091566|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
146091567|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
146091568|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
146091569|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
146091570|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
146091571|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
146091572|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
146091573|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146091574|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
146091575|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146091576|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
146091577|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
146091578|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
146091579|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
146091580|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
146091581|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146091582|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
146091583|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146091584|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
146091585|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
146091586|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
146091587|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
146246151|NCT00452452|527414206|FG001|Overall Study|Protocol Violation|0|||
146091588|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
146246152|NCT00452452|527414207|FG002|Overall Study|Protocol Violation|1|||
146246153|NCT00452452|527414205|FG000|Overall Study|Withdrawal by Subject|1|||
145991221|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991222|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991223|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991224|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991225|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991226|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991227|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991228|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991229|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
145991230|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145991231|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991232|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991233|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991234|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991235|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991236|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991237|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991238|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991239|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991240|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145991241|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
145991242|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991243|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991244|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991245|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991246|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991247|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991248|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991249|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991250|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145991251|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
145991252|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
145991253|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991254|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991255|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991256|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991257|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991258|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991259|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991260|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991261|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991262|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
145991263|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145991264|NCT02471144|526482518|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991265|NCT02471144|526482519|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991266|NCT02471144|526482520|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991267|NCT02471144|526482521|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991268|NCT02471144|526482522|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991269|NCT02471144|526482523|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991270|NCT02471144|526482524|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991271|NCT02471144|526482525|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991272|NCT02471144|526482526|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145991273|NCT02471144|526482527|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
145991274|NCT02471144|526482528|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
145991275|NCT03058952|526482531|FG000|Overall Study|Adverse Event|1|||
145991276|NCT03058952|526482532|FG001|Overall Study|Adverse Event|0|||
145991277|NCT03058952|526482531|FG000|Overall Study|Lost to Follow-up|15|||
145991278|NCT03058952|526482532|FG001|Overall Study|Lost to Follow-up|15|||
145991279|NCT03058952|526482531|FG000|Overall Study|Withdrawal by Subject|7|||
145991280|NCT03058952|526482532|FG001|Overall Study|Withdrawal by Subject|11|||
145991281|NCT05654181|526482533|FG000|Overall Study|Adverse Event|1|||
145991282|NCT05654181|526482534|FG001|Overall Study|Adverse Event|0|||
145991283|NCT05654181|526482535|FG002|Overall Study|Adverse Event|0|||
145991284|NCT05654181|526482536|FG003|Overall Study|Adverse Event|0|||
145991285|NCT05654181|526482537|FG004|Overall Study|Adverse Event|0|||
145991286|NCT05654181|526482538|FG005|Overall Study|Adverse Event|0|||
145991287|NCT05654181|526482539|FG006|Overall Study|Adverse Event|0|||
145991288|NCT05654181|526482540|FG007|Overall Study|Adverse Event|1|||
145991289|NCT05654181|526482541|FG008|Overall Study|Adverse Event|0|||
145991290|NCT05654181|526482542|FG009|Overall Study|Adverse Event|0|||
145991291|NCT05654181|526482533|FG000|Overall Study|Withdrawal by Subject|0|||
145991292|NCT05654181|526482534|FG001|Overall Study|Withdrawal by Subject|0|||
145991293|NCT05654181|526482535|FG002|Overall Study|Withdrawal by Subject|0|||
145991294|NCT05654181|526482536|FG003|Overall Study|Withdrawal by Subject|0|||
145991295|NCT05654181|526482537|FG004|Overall Study|Withdrawal by Subject|0|||
145991296|NCT05654181|526482538|FG005|Overall Study|Withdrawal by Subject|0|||
145991297|NCT05654181|526482539|FG006|Overall Study|Withdrawal by Subject|0|||
145991298|NCT05654181|526482540|FG007|Overall Study|Withdrawal by Subject|1|||
145991299|NCT05654181|526482541|FG008|Overall Study|Withdrawal by Subject|0|||
145991300|NCT05654181|526482542|FG009|Overall Study|Withdrawal by Subject|0|||
145991301|NCT05654181|526482533|FG000|Overall Study|Other|0|||
145991302|NCT05654181|526482534|FG001|Overall Study|Other|0|||
145991303|NCT05654181|526482535|FG002|Overall Study|Other|0|||
145991304|NCT05654181|526482536|FG003|Overall Study|Other|0|||
145991305|NCT05654181|526482537|FG004|Overall Study|Other|1|||
145991306|NCT05654181|526482538|FG005|Overall Study|Other|1|||
145991307|NCT05654181|526482539|FG006|Overall Study|Other|0|||
145991308|NCT05654181|526482540|FG007|Overall Study|Other|0|||
145991309|NCT05654181|526482541|FG008|Overall Study|Other|0|||
145991310|NCT05654181|526482542|FG009|Overall Study|Other|0|||
145991311|NCT04101331|526482543|FG000|Overall Study|Adverse Event|9|||
145991312|NCT04101331|526482543|FG000|Overall Study|Disease progression|82|||
145991313|NCT04101331|526482543|FG000|Overall Study|Withdrawal by Subject|1|||
145991314|NCT04101331|526482543|FG000|Overall Study|Investigator decision|6|||
145991315|NCT04101331|526482543|FG000|Overall Study|Death|6|||
145991316|NCT04101331|526482543|FG000|Overall Study|Allogenic transplant|1|||
145991317|NCT02254291|526482544|FG000|Overall Study|Withdrawal by Subject|0|||
145991318|NCT02254291|526482545|FG001|Overall Study|Withdrawal by Subject|3|||
145991319|NCT02254291|526482546|FG002|Overall Study|Withdrawal by Subject|1|||
145991320|NCT02254291|526482544|FG000|Overall Study|Missing follow-up information|0|||
145991321|NCT02254291|526482545|FG001|Overall Study|Missing follow-up information|0|||
145991322|NCT02254291|526482546|FG002|Overall Study|Missing follow-up information|1|||
146246154|NCT00452452|527414206|FG001|Overall Study|Withdrawal by Subject|0|||
145991323|NCT00833703|526482557|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
145991324|NCT00833703|526482558|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
145991325|NCT01557569|526482561|FG000|Overall Study|Adverse Event|2|||
145991326|NCT01557569|526482562|FG001|Overall Study|Adverse Event|0|||
145991327|NCT01557569|526482561|FG000|Overall Study|high blood pressure|0|||
145991328|NCT01557569|526482562|FG001|Overall Study|high blood pressure|1|||
145991329|NCT01557569|526482561|FG000|Overall Study|Withdrawal by Subject|3|||
145991330|NCT01557569|526482562|FG001|Overall Study|Withdrawal by Subject|5|||
145991331|NCT01557569|526482561|FG000|Overall Study|noncompliance with rules of residential|0|||
145991332|NCT01557569|526482562|FG001|Overall Study|noncompliance with rules of residential|1|||
145991333|NCT00267488|526482563|FG000|Overall Study|Sponsor Terminated Study|9|||
145991334|NCT00267488|526482563|FG000|Overall Study|Protocol Violation|1|||
145991335|NCT00267488|526482563|FG000|Overall Study|Other (Disease Progression)|1|||
145991336|NCT02254460|526482564|FG000|Overall Study|Adverse Event|1|||
145991337|NCT02254460|526482565|FG001|Overall Study|Adverse Event|0|||
145991338|NCT01149460|526482570|FG000|Overall Study|Withdrawal by Subject|0|||
145991339|NCT01149460|526482571|FG001|Overall Study|Withdrawal by Subject|2|||
145991340|NCT01904279|526482577|FG000|Overall Study|Lack of Efficacy|2|||
145991341|NCT01904279|526482578|FG001|Overall Study|Lack of Efficacy|3|||
145991342|NCT01904279|526482577|FG000|Overall Study|Withdrawal by Subject|1|||
145991343|NCT01904279|526482578|FG001|Overall Study|Withdrawal by Subject|0|||
145991344|NCT02801578|526482586|FG000|Overall Study|Adverse Event|2|||
145991345|NCT01356940|526482592|FG000|First Intervention (28 Days)|Adverse Event|1|||
145991346|NCT01356940|526482593|FG001|First Intervention (28 Days)|Adverse Event|0|||
145991347|NCT01356940|526482592|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
145991348|NCT01356940|526482593|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
145991349|NCT00668642|526482594|FG000|First Off-cycle|Cancer progression|1|||
145991350|NCT00668642|526482595|FG001|First Off-cycle|Cancer progression|0|||
145991351|NCT00668642|526482594|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
145991352|NCT00668642|526482595|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
145991353|NCT03412591|526482596|FG000|Overall Study|Withdrawal by Subject|1|||
145991354|NCT03412591|526482597|FG001|Overall Study|Withdrawal by Subject|8|||
145991355|NCT03412591|526482596|FG000|Overall Study|Adverse Event|0|||
145991356|NCT03412591|526482597|FG001|Overall Study|Adverse Event|1|||
145991357|NCT02272985|526482598|FG000|Overall Study|Withdrawal by Subject|1|||
145991358|NCT02272985|526482598|FG000|Overall Study|hip fracture|1|||
145991359|NCT02272985|526482598|FG000|Overall Study|kidney transplantation|1|||
145991360|NCT00505687|526482599|FG000|Overall Study|Important protocol violation|2|||
145991361|NCT00505687|526482599|FG000|Overall Study|Lack of Efficacy|15|||
145991362|NCT00505687|526482599|FG000|Overall Study|Adverse Event|48|||
145991363|NCT00505687|526482599|FG000|Overall Study|Subject withdrew consent|15|||
145991364|NCT00505687|526482599|FG000|Overall Study|Lost to Follow-up|1|||
145991365|NCT00505687|526482599|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
145991366|NCT00505687|526482599|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
145991367|NCT00505687|526482599|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
145991368|NCT00505687|526482599|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
145991369|NCT00505687|526482599|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
145991370|NCT00505687|526482599|FG000|Overall Study|Other: Disease Progression|1|||
146246155|NCT00452452|527414207|FG002|Overall Study|Withdrawal by Subject|0|||
146246156|NCT00452452|527414205|FG000|Overall Study|Lost to Follow-up|1|||
146246157|NCT00452452|527414206|FG001|Overall Study|Lost to Follow-up|0|||
146246158|NCT00452452|527414207|FG002|Overall Study|Lost to Follow-up|0|||
146246159|NCT05184062|527414208|FG000|Overall Study|Lost to Follow-up|5|||
146246160|NCT05184062|527414209|FG001|Overall Study|Lost to Follow-up|1|||
145991371|NCT00505687|526482599|FG000|Overall Study|Other: As Per Sponsor|8|||
145991372|NCT01935947|526482600|FG000|Overall Study|Adverse Event|0|||
145991373|NCT01935947|526482601|FG001|Overall Study|Adverse Event|2|||
145991374|NCT01935947|526482602|FG002|Overall Study|Adverse Event|0|||
145991375|NCT01935947|526482600|FG000|Overall Study|Diease Progression|2|||
145991376|NCT01935947|526482601|FG001|Overall Study|Diease Progression|2|||
145991377|NCT01935947|526482602|FG002|Overall Study|Diease Progression|2|||
145991378|NCT01935947|526482600|FG000|Overall Study|Death|1|||
145991379|NCT01935947|526482601|FG001|Overall Study|Death|0|||
145991380|NCT01935947|526482602|FG002|Overall Study|Death|0|||
145991381|NCT00425555|526482605|FG000|Overall Study|Withdrawal by Subject|11|||
145991382|NCT00425555|526482606|FG001|Overall Study|Withdrawal by Subject|8|||
145991383|NCT00425555|526482605|FG000|Overall Study|Lost to Follow-up|0|||
145991384|NCT00425555|526482606|FG001|Overall Study|Lost to Follow-up|1|||
145991385|NCT00425555|526482605|FG000|Overall Study|Administrative problems|3|||
145991386|NCT00425555|526482606|FG001|Overall Study|Administrative problems|0|||
145991387|NCT00425555|526482605|FG000|Overall Study|Death|1|||
145991388|NCT00425555|526482606|FG001|Overall Study|Death|2|||
145991389|NCT00425555|526482605|FG000|Overall Study|New cancer therapy|2|||
145991390|NCT00425555|526482606|FG001|Overall Study|New cancer therapy|1|||
145991391|NCT00425555|526482605|FG000|Overall Study|Disease progression|36|||
145991392|NCT00425555|526482606|FG001|Overall Study|Disease progression|33|||
145991393|NCT00425555|526482605|FG000|Overall Study|Adverse Event|25|||
145991394|NCT00425555|526482606|FG001|Overall Study|Adverse Event|15|||
145991395|NCT00425555|526482605|FG000|Overall Study|Protocol Violation|1|||
145991396|NCT00425555|526482606|FG001|Overall Study|Protocol Violation|0|||
145991397|NCT04102514|526482607|FG000|Overall Study|Death|3|||
145991398|NCT04102514|526482608|FG001|Overall Study|Death|0|||
145991399|NCT04102514|526482609|FG002|Overall Study|Death|0|||
145991400|NCT04102514|526482610|FG003|Overall Study|Death|0|||
145991401|NCT04102514|526482607|FG000|Overall Study|Lost to Follow-up|0|||
145991402|NCT04102514|526482608|FG001|Overall Study|Lost to Follow-up|0|||
145991403|NCT04102514|526482609|FG002|Overall Study|Lost to Follow-up|3|||
145991404|NCT04102514|526482610|FG003|Overall Study|Lost to Follow-up|0|||
145991405|NCT04102514|526482607|FG000|Overall Study|Physician Decision|0|||
146091589|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146091590|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146091591|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
146091592|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
146091593|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146091594|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146091595|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
146091596|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
146091597|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146091598|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146091599|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
146091600|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
146091601|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146091602|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146091603|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
146246161|NCT05184062|527414208|FG000|Overall Study|Withdrawal by Subject|1|||
146246162|NCT05184062|527414209|FG001|Overall Study|Withdrawal by Subject|0|||
146246163|NCT00747149|527415610|FG000|Overall Study|Adverse Event|0|||
146246164|NCT00747149|527415611|FG001|Overall Study|Adverse Event|15|||
145991406|NCT04102514|526482608|FG001|Overall Study|Physician Decision|0|||
145991407|NCT04102514|526482609|FG002|Overall Study|Physician Decision|1|||
145991408|NCT04102514|526482610|FG003|Overall Study|Physician Decision|0|||
145991409|NCT04102514|526482607|FG000|Overall Study|Withdrawal by Subject|7|||
146246165|NCT00747149|527415610|FG000|Overall Study|Lost to Follow-up|0|||
146246166|NCT00747149|527415611|FG001|Overall Study|Lost to Follow-up|10|||
146246167|NCT00747149|527415610|FG000|Overall Study|Withdrawal by Subject|0|||
145991410|NCT04102514|526482608|FG001|Overall Study|Withdrawal by Subject|13|||
145991411|NCT04102514|526482609|FG002|Overall Study|Withdrawal by Subject|7|||
145991412|NCT04102514|526482610|FG003|Overall Study|Withdrawal by Subject|14|||
145991413|NCT04102514|526482607|FG000|Overall Study|Moved to longterm care facility|6|||
145991414|NCT04102514|526482608|FG001|Overall Study|Moved to longterm care facility|0|||
145991415|NCT04102514|526482609|FG002|Overall Study|Moved to longterm care facility|4|||
145991416|NCT04102514|526482610|FG003|Overall Study|Moved to longterm care facility|0|||
145991417|NCT03268499|526482611|FG000|Overall Study|Withdrawal by Subject|2|||
145991418|NCT03268499|526482612|FG001|Overall Study|Withdrawal by Subject|1|||
145991419|NCT03533491|526482617|FG000|Overall Study|Lost to Follow-up|2|||
145991420|NCT05071027|526482625|FG000|Overall Study|Lost to Follow-up|1|||
145991421|NCT05071027|526482626|FG001|Overall Study|Lost to Follow-up|4|||
145991422|NCT00595075|526482632|FG000|Overall Study|Withdrawal by Subject|1|||
145991423|NCT00595075|526482633|FG001|Overall Study|Withdrawal by Subject|0|||
145991424|NCT03249558|526482635|FG000|Overall Study|Lost to Follow-up|2|||
145991425|NCT03249558|526482636|FG001|Overall Study|Lost to Follow-up|1|||
145991426|NCT03249558|526482637|FG002|Overall Study|Lost to Follow-up|4|||
145991427|NCT03249558|526482635|FG000|Overall Study|Physician Decision|1|||
145991428|NCT03249558|526482636|FG001|Overall Study|Physician Decision|0|||
145991429|NCT03249558|526482637|FG002|Overall Study|Physician Decision|0|||
145991430|NCT03249558|526482635|FG000|Overall Study|Withdrawal by Subject|6|||
145991431|NCT03249558|526482636|FG001|Overall Study|Withdrawal by Subject|5|||
145991432|NCT03249558|526482637|FG002|Overall Study|Withdrawal by Subject|7|||
145991433|NCT03249558|526482635|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
145991434|NCT03249558|526482636|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
145991435|NCT03249558|526482637|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
145991436|NCT03249558|526482635|FG000|Overall Study|Protocol Violation|1|||
145991437|NCT03249558|526482636|FG001|Overall Study|Protocol Violation|1|||
145991438|NCT03249558|526482637|FG002|Overall Study|Protocol Violation|2|||
145991439|NCT00908141|526482638|FG000|Overall Study|Withdrawal by Subject|0|||
145991440|NCT00908141|526482639|FG001|Overall Study|Withdrawal by Subject|1|||
145991441|NCT01444781|526484400|FG000|Overall Study|Lost to Follow-up|0|||
145991442|NCT01444781|526484401|FG001|Overall Study|Lost to Follow-up|3|||
145991443|NCT01444781|526484402|FG002|Overall Study|Lost to Follow-up|1|||
145991444|NCT01444781|526484400|FG000|Overall Study|Withdrawal by Subject|3|||
145991445|NCT01444781|526484401|FG001|Overall Study|Withdrawal by Subject|1|||
145991446|NCT01444781|526484402|FG002|Overall Study|Withdrawal by Subject|2|||
145991447|NCT02489279|526484403|FG000|Overall Study|Lost to Follow-up|12|||
145991448|NCT02489279|526484404|FG001|Overall Study|Lost to Follow-up|10|||
145991449|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
145991450|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
145991451|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
145991452|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
145991453|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
145991454|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
145991455|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
145991456|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
145991457|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
145991458|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
145991459|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
145991460|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
145991461|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
145991462|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
145991463|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
145991464|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
145991465|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
145991466|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
145991467|NCT01432444|526484405|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
145991468|NCT01432444|526484406|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
145991469|NCT01432444|526484407|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
145991470|NCT01432444|526484405|FG000|Treatment Phase|Lost to Follow-up|0|||
145991471|NCT01432444|526484406|FG001|Treatment Phase|Lost to Follow-up|33|||
145991472|NCT01432444|526484407|FG002|Treatment Phase|Lost to Follow-up|0|||
145991473|NCT01432444|526484405|FG000|Treatment Phase|Adverse Event|0|||
145991474|NCT01432444|526484406|FG001|Treatment Phase|Adverse Event|37|||
145991475|NCT01432444|526484407|FG002|Treatment Phase|Adverse Event|0|||
145991476|NCT01432444|526484405|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
145991477|NCT01432444|526484406|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
145991478|NCT01432444|526484407|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
145991479|NCT01432444|526484405|FG000|Treatment Phase|Physician Decision|0|||
145991480|NCT01432444|526484406|FG001|Treatment Phase|Physician Decision|5|||
145991481|NCT01432444|526484407|FG002|Treatment Phase|Physician Decision|0|||
145991482|NCT01432444|526484405|FG000|Treatment Phase|Withdrawal by Subject|0|||
145991483|NCT01432444|526484406|FG001|Treatment Phase|Withdrawal by Subject|41|||
145991484|NCT01432444|526484407|FG002|Treatment Phase|Withdrawal by Subject|0|||
145991485|NCT01432444|526484405|FG000|Treatment Phase|Protocol Deviation|0|||
145991486|NCT01432444|526484406|FG001|Treatment Phase|Protocol Deviation|3|||
145991487|NCT01432444|526484407|FG002|Treatment Phase|Protocol Deviation|0|||
145991488|NCT01432444|526484405|FG000|Treatment Phase|Lack of Efficacy|0|||
145991489|NCT01432444|526484406|FG001|Treatment Phase|Lack of Efficacy|10|||
145991490|NCT01432444|526484407|FG002|Treatment Phase|Lack of Efficacy|0|||
145991491|NCT01432444|526484405|FG000|Extension Phase|Lost to Follow-up|0|||
145991492|NCT01432444|526484406|FG001|Extension Phase|Lost to Follow-up|0|||
145991493|NCT01432444|526484407|FG002|Extension Phase|Lost to Follow-up|17|||
145991494|NCT01432444|526484405|FG000|Extension Phase|Adverse Event|0|||
145991495|NCT01432444|526484406|FG001|Extension Phase|Adverse Event|0|||
145991496|NCT01432444|526484407|FG002|Extension Phase|Adverse Event|10|||
145991497|NCT01432444|526484405|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
145991498|NCT01432444|526484406|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
145991499|NCT01432444|526484407|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
145991500|NCT01432444|526484405|FG000|Extension Phase|Met Withdrawal Criteria|0|||
145991501|NCT01432444|526484406|FG001|Extension Phase|Met Withdrawal Criteria|0|||
145991502|NCT01432444|526484407|FG002|Extension Phase|Met Withdrawal Criteria|144|||
145991503|NCT01432444|526484405|FG000|Extension Phase|Physician Decision|0|||
145991504|NCT01432444|526484406|FG001|Extension Phase|Physician Decision|0|||
145991505|NCT01432444|526484407|FG002|Extension Phase|Physician Decision|1|||
145991506|NCT01432444|526484405|FG000|Extension Phase|Withdrawal by Subject|0|||
145991507|NCT01432444|526484406|FG001|Extension Phase|Withdrawal by Subject|0|||
145991508|NCT01432444|526484407|FG002|Extension Phase|Withdrawal by Subject|13|||
145991509|NCT03283241|526484408|FG000|Overall Study|Adverse Event|4|||
145991510|NCT03283241|526484409|FG001|Overall Study|Adverse Event|1|||
145991511|NCT03283241|526484408|FG000|Overall Study|Withdrawal by Subject|0|||
145991512|NCT03283241|526484409|FG001|Overall Study|Withdrawal by Subject|1|||
145991513|NCT03283241|526484408|FG000|Overall Study|Subject relocated to Finland|0|||
145991514|NCT03283241|526484409|FG001|Overall Study|Subject relocated to Finland|1|||
145991515|NCT00666263|526484412|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
145991516|NCT00666263|526484413|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
146091604|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
146091605|NCT03739840|526856847|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146091606|NCT03739840|526856848|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146091607|NCT03739840|526856849|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
146091608|NCT03739840|526856850|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
146091609|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
146091610|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146091611|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146297872|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146091612|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
146091613|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146091614|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146091615|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
146091616|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
146091617|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
146091618|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146091619|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146091620|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
146091621|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146091622|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
146091623|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146091624|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
146091625|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146091626|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
146091627|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146091628|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
146091629|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146091630|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146091631|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
146091632|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
146091633|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146091634|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146091635|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
145991517|NCT00666263|526484412|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
145991518|NCT00666263|526484413|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
145991519|NCT00666263|526484412|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
145991520|NCT00666263|526484413|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
145991521|NCT02439957|526484414|FG000|Overall Study|Study Terminated|3|||
145991522|NCT02439957|526484415|FG001|Overall Study|Study Terminated|3|||
145991523|NCT00586157|526484416|FG000|First Intervention|Worsening behavior|1|||
145991524|NCT00586157|526484417|FG001|First Intervention|Worsening behavior|0|||
145991525|NCT00586157|526484416|FG000|Second Intervention|Withdrawal by Subject|1|||
145991526|NCT00586157|526484417|FG001|Second Intervention|Withdrawal by Subject|0|||
145991527|NCT00586157|526484416|FG000|Second Intervention|Worsening behavior|1|||
145991528|NCT00586157|526484417|FG001|Second Intervention|Worsening behavior|0|||
145991529|NCT00586157|526484416|FG000|Second Intervention|Adverse Event|0|||
145991530|NCT00586157|526484417|FG001|Second Intervention|Adverse Event|1|||
145991531|NCT02014467|526484419|FG000|Overall Study|Adverse Event|4|||
145991532|NCT02014467|526484420|FG001|Overall Study|Adverse Event|0|||
145991533|NCT02014467|526484419|FG000|Overall Study|Protocol Violation|3|||
145991534|NCT02014467|526484420|FG001|Overall Study|Protocol Violation|0|||
145991535|NCT02014467|526484419|FG000|Overall Study|Physician Decision|2|||
145991536|NCT02014467|526484420|FG001|Overall Study|Physician Decision|3|||
145991537|NCT02014467|526484419|FG000|Overall Study|Withdrawal by Subject|16|||
145991538|NCT02014467|526484420|FG001|Overall Study|Withdrawal by Subject|4|||
145991539|NCT01230060|526484421|FG000|Overall Study|Withdrawal by Subject|1|||
145991540|NCT03802916|526484422|FG000|Overall Study|Adverse Event|0|||
145991541|NCT03802916|526484423|FG001|Overall Study|Adverse Event|1|||
145991542|NCT03802916|526484422|FG000|Overall Study|Withdrawal by Subject|0|||
145991543|NCT03802916|526484423|FG001|Overall Study|Withdrawal by Subject|1|||
145991544|NCT00480532|526484426|FG000|Overall Study|Withdrawal by Subject|2|||
145991545|NCT00480532|526484427|FG001|Overall Study|Withdrawal by Subject|4|||
145991546|NCT00480532|526484428|FG002|Overall Study|Withdrawal by Subject|3|||
145991547|NCT00480532|526484429|FG003|Overall Study|Withdrawal by Subject|1|||
145991548|NCT00480532|526484426|FG000|Overall Study|Protocol Violation|0|||
145991549|NCT00480532|526484427|FG001|Overall Study|Protocol Violation|0|||
145991550|NCT00480532|526484428|FG002|Overall Study|Protocol Violation|1|||
145991551|NCT00480532|526484429|FG003|Overall Study|Protocol Violation|0|||
145991552|NCT00831389|526484430|FG000|Overall Study|Withdrawal by Subject|0|||
145991553|NCT00831389|526484431|FG001|Overall Study|Withdrawal by Subject|1|||
145991554|NCT00278161|526484433|FG000|Overall Study|Death|11|||
145991555|NCT01817777|526484434|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
145991556|NCT01817777|526484435|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
145991557|NCT01817777|526484436|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
145991558|NCT01817777|526484434|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
145991559|NCT01817777|526484435|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
145991560|NCT01817777|526484436|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
145991561|NCT01817777|526484434|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
145991562|NCT01817777|526484435|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
145991563|NCT01817777|526484436|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
145991564|NCT01817777|526484434|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
145991565|NCT01817777|526484435|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
145991566|NCT01817777|526484436|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
145991567|NCT01817777|526484434|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
145991568|NCT01817777|526484435|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
145991569|NCT01817777|526484436|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
145991570|NCT00443456|526484437|FG000|Overall Study|Adverse Event|16|||
145991571|NCT00443456|526484437|FG000|Overall Study|Move|1|||
145991572|NCT00443456|526484437|FG000|Overall Study|Withdrawal by Subject|1|||
145991573|NCT03242434|526484438|FG000|Overall Study|Death|0|||
145991574|NCT03242434|526484439|FG001|Overall Study|Death|2|||
145991575|NCT02157610|526484440|FG000|Overall Study|Death|4|||
145991576|NCT02157610|526484441|FG001|Overall Study|Death|4|||
145991577|NCT01592747|526484442|FG000|Overall Study|Loss of Therapeutic Response|107|||
145991578|NCT01592747|526484443|FG001|Overall Study|Loss of Therapeutic Response|108|||
145991579|NCT01592747|526484444|FG002|Overall Study|Loss of Therapeutic Response|100|||
145991580|NCT01592747|526484442|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
145991581|NCT01592747|526484443|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
145991582|NCT01592747|526484444|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
145991583|NCT01592747|526484442|FG000|Overall Study|Adverse Event|1|||
145991584|NCT01592747|526484443|FG001|Overall Study|Adverse Event|0|||
145991585|NCT01592747|526484444|FG002|Overall Study|Adverse Event|0|||
145991586|NCT01592747|526484442|FG000|Overall Study|Protocol Violation|4|||
145991587|NCT01592747|526484443|FG001|Overall Study|Protocol Violation|0|||
145991588|NCT01592747|526484444|FG002|Overall Study|Protocol Violation|4|||
145991589|NCT01592747|526484442|FG000|Overall Study|Lack of Efficacy|0|||
145991590|NCT01592747|526484443|FG001|Overall Study|Lack of Efficacy|1|||
145991591|NCT01592747|526484444|FG002|Overall Study|Lack of Efficacy|0|||
145991592|NCT01592747|526484442|FG000|Overall Study|Withdrawal by Subject|2|||
145991593|NCT01592747|526484443|FG001|Overall Study|Withdrawal by Subject|0|||
145991594|NCT01592747|526484444|FG002|Overall Study|Withdrawal by Subject|2|||
145991595|NCT01592747|526484442|FG000|Overall Study|Lost to Follow-up|1|||
145991596|NCT01592747|526484443|FG001|Overall Study|Lost to Follow-up|0|||
145991597|NCT01592747|526484444|FG002|Overall Study|Lost to Follow-up|1|||
146246168|NCT00747149|527415611|FG001|Overall Study|Withdrawal by Subject|6|||
146246169|NCT00747149|527415610|FG000|Overall Study|Did not receive treatment|0|||
146246170|NCT00747149|527415611|FG001|Overall Study|Did not receive treatment|1|||
146246171|NCT00747149|527415610|FG000|Overall Study|Incorrect enrollment|0|||
146246172|NCT00747149|527415611|FG001|Overall Study|Incorrect enrollment|6|||
146246173|NCT00747149|527415610|FG000|Overall Study|Severe non-compliance to protocol|0|||
145991598|NCT01592747|526484442|FG000|Overall Study|Other Reasons|1|||
145991599|NCT01592747|526484443|FG001|Overall Study|Other Reasons|1|||
145991600|NCT01592747|526484444|FG002|Overall Study|Other Reasons|0|||
145991601|NCT00619918|526484445|FG000|Overall Study|Withdrawal by Subject|4|||
145991602|NCT00619918|526484446|FG001|Overall Study|Withdrawal by Subject|3|||
145991603|NCT00619918|526484445|FG000|Overall Study|Physician Decision|2|||
145991604|NCT00619918|526484446|FG001|Overall Study|Physician Decision|4|||
145991605|NCT00619918|526484445|FG000|Overall Study|Transfer to outside facility|3|||
145991606|NCT00619918|526484446|FG001|Overall Study|Transfer to outside facility|3|||
145991607|NCT00619918|526484445|FG000|Overall Study|Left before receiving first dose|7|||
145991608|NCT00619918|526484446|FG001|Overall Study|Left before receiving first dose|6|||
145991609|NCT00619918|526484445|FG000|Overall Study|ICU admission|4|||
145991610|NCT00619918|526484446|FG001|Overall Study|ICU admission|6|||
145991611|NCT04661839|526484449|FG000|Overall Study|Not Treated|0|||
145991612|NCT04661839|526484450|FG001|Overall Study|Not Treated|0|||
145991613|NCT04661839|526484451|FG002|Overall Study|Not Treated|1|||
145991614|NCT04661839|526484452|FG003|Overall Study|Not Treated|0|||
145991615|NCT04661839|526484449|FG000|Overall Study|Lost to Follow-up|1|||
145991616|NCT04661839|526484450|FG001|Overall Study|Lost to Follow-up|0|||
145991617|NCT04661839|526484451|FG002|Overall Study|Lost to Follow-up|0|||
145991618|NCT04661839|526484452|FG003|Overall Study|Lost to Follow-up|1|||
145991619|NCT01946880|526484453|FG000|Overall Study|Lost to Follow-up|1|||
145991620|NCT01946880|526484454|FG001|Overall Study|Lost to Follow-up|0|||
145991621|NCT01946880|526484453|FG000|Overall Study|Physician Decision|1|||
145991622|NCT01946880|526484454|FG001|Overall Study|Physician Decision|1|||
145991623|NCT01946880|526484453|FG000|Overall Study|Withdrawal by Subject|3|||
145991624|NCT01946880|526484454|FG001|Overall Study|Withdrawal by Subject|2|||
145991625|NCT01946880|526484453|FG000|Overall Study|Met Primary Endpoint|1|||
145991626|NCT01946880|526484454|FG001|Overall Study|Met Primary Endpoint|0|||
145991627|NCT01946880|526484453|FG000|Overall Study|Personal and Family Issues|1|||
145991628|NCT01946880|526484454|FG001|Overall Study|Personal and Family Issues|0|||
145991629|NCT02951819|526484458|FG000|Overall Study|Death|9|||
145991630|NCT02951819|526484459|FG001|Overall Study|Death|7|||
145991631|NCT02951819|526484458|FG000|Overall Study|Withdrawal by Subject|3|||
145991632|NCT02951819|526484459|FG001|Overall Study|Withdrawal by Subject|0|||
145991633|NCT02951819|526484458|FG000|Overall Study|Adverse Event|1|||
145991634|NCT02951819|526484459|FG001|Overall Study|Adverse Event|0|||
145991635|NCT02951819|526484458|FG000|Overall Study|Lack of Efficacy|4|||
145991636|NCT02951819|526484459|FG001|Overall Study|Lack of Efficacy|0|||
145991637|NCT02951819|526484458|FG000|Overall Study|Lost to Follow-up|1|||
145991638|NCT02951819|526484459|FG001|Overall Study|Lost to Follow-up|0|||
145991639|NCT02951819|526484458|FG000|Overall Study|Progressive Disease|1|||
145991640|NCT02951819|526484459|FG001|Overall Study|Progressive Disease|0|||
145991641|NCT02951819|526484458|FG000|Overall Study|Other|9|||
145991642|NCT02951819|526484459|FG001|Overall Study|Other|0|||
145991643|NCT03715829|526484460|FG000|Dose Ranging Period|Adverse Event|2|||
145991644|NCT03715829|526484461|FG001|Dose Ranging Period|Adverse Event|4|||
145991645|NCT03715829|526484462|FG002|Dose Ranging Period|Adverse Event|5|||
145991646|NCT03715829|526484463|FG003|Dose Ranging Period|Adverse Event|2|||
145991647|NCT03715829|526484464|FG004|Dose Ranging Period|Adverse Event|3|||
145991648|NCT03715829|526484465|FG005|Dose Ranging Period|Adverse Event|3|||
145991649|NCT03715829|526484466|FG006|Dose Ranging Period|Adverse Event|0|||
145991650|NCT03715829|526484467|FG007|Dose Ranging Period|Adverse Event|0|||
145991651|NCT03715829|526484468|FG008|Dose Ranging Period|Adverse Event|0|||
145991652|NCT03715829|526484469|FG009|Dose Ranging Period|Adverse Event|0|||
145991653|NCT03715829|526484470|FG010|Dose Ranging Period|Adverse Event|0|||
145991654|NCT03715829|526484460|FG000|Dose Ranging Period|Lack of Efficacy|0|||
145991655|NCT03715829|526484461|FG001|Dose Ranging Period|Lack of Efficacy|1|||
145991656|NCT03715829|526484462|FG002|Dose Ranging Period|Lack of Efficacy|0|||
145991657|NCT03715829|526484463|FG003|Dose Ranging Period|Lack of Efficacy|1|||
145991658|NCT03715829|526484464|FG004|Dose Ranging Period|Lack of Efficacy|0|||
145991659|NCT03715829|526484465|FG005|Dose Ranging Period|Lack of Efficacy|0|||
145991660|NCT03715829|526484466|FG006|Dose Ranging Period|Lack of Efficacy|0|||
145991661|NCT03715829|526484467|FG007|Dose Ranging Period|Lack of Efficacy|0|||
145991662|NCT03715829|526484468|FG008|Dose Ranging Period|Lack of Efficacy|0|||
145991663|NCT03715829|526484469|FG009|Dose Ranging Period|Lack of Efficacy|0|||
145991664|NCT03715829|526484470|FG010|Dose Ranging Period|Lack of Efficacy|0|||
145991665|NCT03715829|526484460|FG000|Dose Ranging Period|Lost to Follow-up|2|||
145991666|NCT03715829|526484461|FG001|Dose Ranging Period|Lost to Follow-up|0|||
145991667|NCT03715829|526484462|FG002|Dose Ranging Period|Lost to Follow-up|1|||
145991668|NCT03715829|526484463|FG003|Dose Ranging Period|Lost to Follow-up|1|||
145991669|NCT03715829|526484464|FG004|Dose Ranging Period|Lost to Follow-up|1|||
145991670|NCT03715829|526484465|FG005|Dose Ranging Period|Lost to Follow-up|2|||
145991671|NCT03715829|526484466|FG006|Dose Ranging Period|Lost to Follow-up|0|||
145991672|NCT03715829|526484467|FG007|Dose Ranging Period|Lost to Follow-up|0|||
145991673|NCT03715829|526484468|FG008|Dose Ranging Period|Lost to Follow-up|0|||
145991674|NCT03715829|526484469|FG009|Dose Ranging Period|Lost to Follow-up|0|||
145991675|NCT03715829|526484470|FG010|Dose Ranging Period|Lost to Follow-up|0|||
145991676|NCT03715829|526484460|FG000|Dose Ranging Period|Protocol Violation|0|||
145991677|NCT03715829|526484461|FG001|Dose Ranging Period|Protocol Violation|0|||
145991678|NCT03715829|526484462|FG002|Dose Ranging Period|Protocol Violation|0|||
145991679|NCT03715829|526484463|FG003|Dose Ranging Period|Protocol Violation|1|||
145991680|NCT03715829|526484464|FG004|Dose Ranging Period|Protocol Violation|0|||
145991681|NCT03715829|526484465|FG005|Dose Ranging Period|Protocol Violation|0|||
145991682|NCT03715829|526484466|FG006|Dose Ranging Period|Protocol Violation|0|||
145991683|NCT03715829|526484467|FG007|Dose Ranging Period|Protocol Violation|0|||
145991684|NCT03715829|526484468|FG008|Dose Ranging Period|Protocol Violation|0|||
145991685|NCT03715829|526484469|FG009|Dose Ranging Period|Protocol Violation|0|||
145991686|NCT03715829|526484470|FG010|Dose Ranging Period|Protocol Violation|0|||
145991687|NCT03715829|526484460|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
145991688|NCT03715829|526484461|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
145991689|NCT03715829|526484462|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
145991690|NCT03715829|526484463|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
145991691|NCT03715829|526484464|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
145991692|NCT03715829|526484465|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
145991693|NCT03715829|526484466|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
145991694|NCT03715829|526484467|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
145991695|NCT03715829|526484468|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
145991696|NCT03715829|526484469|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
145991697|NCT03715829|526484470|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
145991698|NCT03715829|526484460|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991699|NCT03715829|526484461|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991700|NCT03715829|526484462|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
145991701|NCT03715829|526484463|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991702|NCT03715829|526484464|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991703|NCT03715829|526484465|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991704|NCT03715829|526484466|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991705|NCT03715829|526484467|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991706|NCT03715829|526484468|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991707|NCT03715829|526484469|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991708|NCT03715829|526484470|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145991709|NCT03715829|526484460|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991710|NCT03715829|526484461|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991711|NCT03715829|526484462|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
145991712|NCT03715829|526484463|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991713|NCT03715829|526484464|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
145991714|NCT03715829|526484465|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991715|NCT03715829|526484466|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991716|NCT03715829|526484467|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991717|NCT03715829|526484468|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991718|NCT03715829|526484469|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991719|NCT03715829|526484470|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145991720|NCT03715829|526484460|FG000|Dose Ranging Period|Other|0|||
145991721|NCT03715829|526484461|FG001|Dose Ranging Period|Other|0|||
145991722|NCT03715829|526484462|FG002|Dose Ranging Period|Other|2|||
145991723|NCT03715829|526484463|FG003|Dose Ranging Period|Other|0|||
145991724|NCT03715829|526484464|FG004|Dose Ranging Period|Other|0|||
145991725|NCT03715829|526484465|FG005|Dose Ranging Period|Other|3|||
145991726|NCT03715829|526484466|FG006|Dose Ranging Period|Other|0|||
145991727|NCT03715829|526484467|FG007|Dose Ranging Period|Other|0|||
145991728|NCT03715829|526484468|FG008|Dose Ranging Period|Other|0|||
145991729|NCT03715829|526484469|FG009|Dose Ranging Period|Other|0|||
145991730|NCT03715829|526484470|FG010|Dose Ranging Period|Other|0|||
145991731|NCT03715829|526484460|FG000|Extension Period|Adverse Event|0|||
145991732|NCT03715829|526484461|FG001|Extension Period|Adverse Event|0|||
145991733|NCT03715829|526484462|FG002|Extension Period|Adverse Event|0|||
145991734|NCT03715829|526484463|FG003|Extension Period|Adverse Event|0|||
145991735|NCT03715829|526484464|FG004|Extension Period|Adverse Event|0|||
145991736|NCT03715829|526484465|FG005|Extension Period|Adverse Event|0|||
145991737|NCT03715829|526484466|FG006|Extension Period|Adverse Event|3|||
145991738|NCT03715829|526484467|FG007|Extension Period|Adverse Event|1|||
145991739|NCT03715829|526484468|FG008|Extension Period|Adverse Event|6|||
145991740|NCT03715829|526484469|FG009|Extension Period|Adverse Event|0|||
145991741|NCT03715829|526484470|FG010|Extension Period|Adverse Event|0|||
145991742|NCT03715829|526484460|FG000|Extension Period|Lack of Efficacy|0|||
145991743|NCT03715829|526484461|FG001|Extension Period|Lack of Efficacy|0|||
145991744|NCT03715829|526484462|FG002|Extension Period|Lack of Efficacy|0|||
145991745|NCT03715829|526484463|FG003|Extension Period|Lack of Efficacy|0|||
145991746|NCT03715829|526484464|FG004|Extension Period|Lack of Efficacy|0|||
145991747|NCT03715829|526484465|FG005|Extension Period|Lack of Efficacy|0|||
145991748|NCT03715829|526484466|FG006|Extension Period|Lack of Efficacy|1|||
145991749|NCT03715829|526484467|FG007|Extension Period|Lack of Efficacy|9|||
145991750|NCT03715829|526484468|FG008|Extension Period|Lack of Efficacy|2|||
145991751|NCT03715829|526484469|FG009|Extension Period|Lack of Efficacy|0|||
145991752|NCT03715829|526484470|FG010|Extension Period|Lack of Efficacy|0|||
145991753|NCT03715829|526484460|FG000|Extension Period|Lost to Follow-up|0|||
145991754|NCT03715829|526484461|FG001|Extension Period|Lost to Follow-up|0|||
145991755|NCT03715829|526484462|FG002|Extension Period|Lost to Follow-up|0|||
145991756|NCT03715829|526484463|FG003|Extension Period|Lost to Follow-up|0|||
145991757|NCT03715829|526484464|FG004|Extension Period|Lost to Follow-up|0|||
145991758|NCT03715829|526484465|FG005|Extension Period|Lost to Follow-up|0|||
145991759|NCT03715829|526484466|FG006|Extension Period|Lost to Follow-up|0|||
145991760|NCT03715829|526484467|FG007|Extension Period|Lost to Follow-up|0|||
145991761|NCT03715829|526484468|FG008|Extension Period|Lost to Follow-up|2|||
145991762|NCT03715829|526484469|FG009|Extension Period|Lost to Follow-up|0|||
145991763|NCT03715829|526484470|FG010|Extension Period|Lost to Follow-up|0|||
145991764|NCT03715829|526484460|FG000|Extension Period|Protocol Violation|0|||
145991765|NCT03715829|526484461|FG001|Extension Period|Protocol Violation|0|||
145991766|NCT03715829|526484462|FG002|Extension Period|Protocol Violation|0|||
145991767|NCT03715829|526484463|FG003|Extension Period|Protocol Violation|0|||
145991768|NCT03715829|526484464|FG004|Extension Period|Protocol Violation|0|||
145991769|NCT03715829|526484465|FG005|Extension Period|Protocol Violation|0|||
145991770|NCT03715829|526484466|FG006|Extension Period|Protocol Violation|0|||
145991771|NCT03715829|526484467|FG007|Extension Period|Protocol Violation|0|||
145991772|NCT03715829|526484468|FG008|Extension Period|Protocol Violation|1|||
145991773|NCT03715829|526484469|FG009|Extension Period|Protocol Violation|0|||
145991774|NCT03715829|526484470|FG010|Extension Period|Protocol Violation|0|||
145991775|NCT03715829|526484460|FG000|Extension Period|Withdrawal by Subject|0|||
145991776|NCT03715829|526484461|FG001|Extension Period|Withdrawal by Subject|0|||
145991777|NCT03715829|526484462|FG002|Extension Period|Withdrawal by Subject|0|||
145991778|NCT03715829|526484463|FG003|Extension Period|Withdrawal by Subject|0|||
145991779|NCT03715829|526484464|FG004|Extension Period|Withdrawal by Subject|0|||
145991780|NCT03715829|526484465|FG005|Extension Period|Withdrawal by Subject|0|||
145991781|NCT03715829|526484466|FG006|Extension Period|Withdrawal by Subject|3|||
145991782|NCT03715829|526484467|FG007|Extension Period|Withdrawal by Subject|3|||
145991783|NCT03715829|526484468|FG008|Extension Period|Withdrawal by Subject|12|||
145991784|NCT03715829|526484469|FG009|Extension Period|Withdrawal by Subject|3|||
145991785|NCT03715829|526484470|FG010|Extension Period|Withdrawal by Subject|0|||
145991786|NCT03715829|526484460|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991787|NCT03715829|526484461|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991788|NCT03715829|526484462|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991789|NCT03715829|526484463|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991790|NCT03715829|526484464|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991791|NCT03715829|526484465|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991792|NCT03715829|526484466|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991793|NCT03715829|526484467|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
145991794|NCT03715829|526484468|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
145991795|NCT03715829|526484469|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991796|NCT03715829|526484470|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
145991797|NCT03715829|526484460|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991798|NCT03715829|526484461|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991799|NCT03715829|526484462|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991800|NCT03715829|526484463|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991801|NCT03715829|526484464|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991802|NCT03715829|526484465|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991803|NCT03715829|526484466|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
146246174|NCT00747149|527415611|FG001|Overall Study|Severe non-compliance to protocol|1|||
146246175|NCT00747149|527415610|FG000|Overall Study|Not reported|1|||
145991804|NCT03715829|526484467|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991805|NCT03715829|526484468|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
145991806|NCT03715829|526484469|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
145991807|NCT03715829|526484470|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
146246176|NCT00747149|527415611|FG001|Overall Study|Not reported|4|||
146246177|NCT03840200|527415612|FG000|Overall Study|Death|6|||
146246178|NCT03840200|527415613|FG001|Overall Study|Death|3|||
146246179|NCT03840200|527415614|FG002|Overall Study|Death|6|||
146246180|NCT03840200|527415615|FG003|Overall Study|Death|10|||
145991808|NCT03715829|526484460|FG000|Extension Period|Other|0|||
145991809|NCT03715829|526484461|FG001|Extension Period|Other|0|||
145991810|NCT03715829|526484462|FG002|Extension Period|Other|0|||
145991811|NCT03715829|526484463|FG003|Extension Period|Other|0|||
145991812|NCT03715829|526484464|FG004|Extension Period|Other|0|||
145991813|NCT03715829|526484465|FG005|Extension Period|Other|0|||
145991814|NCT03715829|526484466|FG006|Extension Period|Other|1|||
145991815|NCT03715829|526484467|FG007|Extension Period|Other|2|||
145991816|NCT03715829|526484468|FG008|Extension Period|Other|4|||
145991817|NCT03715829|526484469|FG009|Extension Period|Other|0|||
145991818|NCT03715829|526484470|FG010|Extension Period|Other|0|||
145991819|NCT03647137|526484471|FG000|Overall Study|Scan Limitation|2|||
145991820|NCT03647137|526484472|FG001|Overall Study|Scan Limitation|1|||
145991821|NCT03647137|526484473|FG002|Overall Study|Scan Limitation|1|||
145991822|NCT03647137|526484474|FG003|Overall Study|Scan Limitation|2|||
145991823|NCT01443026|526484475|FG000|Overall Study|Physician Decision|1|||
145991824|NCT01443026|526484476|FG001|Overall Study|Physician Decision|0|||
145991825|NCT01443026|526484475|FG000|Overall Study|Death|0|||
145991826|NCT01443026|526484476|FG001|Overall Study|Death|1|||
145991827|NCT01443026|526484475|FG000|Overall Study|Withdrawal by Subject|0|||
145991828|NCT01443026|526484476|FG001|Overall Study|Withdrawal by Subject|3|||
145991829|NCT01443026|526484475|FG000|Overall Study|Lost to Follow-up|2|||
145991830|NCT01443026|526484476|FG001|Overall Study|Lost to Follow-up|1|||
145991831|NCT00581919|526484477|FG000|Overall Study|Adverse Event|8|||
145991832|NCT00581919|526484477|FG000|Overall Study|Death|1|||
145991833|NCT00581919|526484477|FG000|Overall Study|Disease Progression|10|||
145991834|NCT00581919|526484477|FG000|Overall Study|Physician Decision|1|||
145991835|NCT00581919|526484477|FG000|Overall Study|Other Complicating Disease|1|||
145991836|NCT00581919|526484477|FG000|Overall Study|Started Non-Protocol Therapy|2|||
145991837|NCT00581919|526484477|FG000|Overall Study|Withdrawal by Subject|1|||
145991838|NCT02034565|526484478|FG000|Overall Study|Adverse Event|1|||
145991839|NCT02034565|526484479|FG001|Overall Study|Adverse Event|0|||
145991840|NCT01813357|526484486|FG000|Overall Study|Lost to Follow-up|5|||
146091636|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
146091637|NCT03739840|526856847|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146091638|NCT03739840|526856848|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146091639|NCT03739840|526856849|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
146246181|NCT03840200|527415612|FG000|Overall Study|Reason Not Specified|2|||
146246182|NCT03840200|527415613|FG001|Overall Study|Reason Not Specified|2|||
146246183|NCT03840200|527415614|FG002|Overall Study|Reason Not Specified|1|||
146246184|NCT03840200|527415615|FG003|Overall Study|Reason Not Specified|15|||
146246185|NCT03840200|527415612|FG000|Overall Study|Physician Decision|0|||
146246186|NCT03840200|527415613|FG001|Overall Study|Physician Decision|0|||
146246187|NCT03840200|527415614|FG002|Overall Study|Physician Decision|0|||
146246188|NCT03840200|527415615|FG003|Overall Study|Physician Decision|2|||
146246189|NCT03840200|527415612|FG000|Overall Study|Progressive Disease|0|||
146246190|NCT03840200|527415613|FG001|Overall Study|Progressive Disease|0|||
146246191|NCT03840200|527415614|FG002|Overall Study|Progressive Disease|0|||
146246192|NCT03840200|527415615|FG003|Overall Study|Progressive Disease|1|||
146246193|NCT03840200|527415612|FG000|Overall Study|Withdrawal by Subject|0|||
146246194|NCT03840200|527415613|FG001|Overall Study|Withdrawal by Subject|1|||
146246195|NCT03840200|527415614|FG002|Overall Study|Withdrawal by Subject|0|||
146246196|NCT03840200|527415615|FG003|Overall Study|Withdrawal by Subject|2|||
146246197|NCT05006703|527415618|FG000|Overall Study|Withdrawal by Subject|1|||
146246198|NCT05006703|527415619|FG001|Overall Study|Withdrawal by Subject|0|||
146246199|NCT05006703|527415618|FG000|Overall Study|Lost to Follow-up|13|||
146246200|NCT05006703|527415619|FG001|Overall Study|Lost to Follow-up|5|||
146246201|NCT04620733|527415620|FG000|Overall Study|Adverse Event|4|||
146246202|NCT04620733|527415621|FG001|Overall Study|Adverse Event|3|||
146246203|NCT04620733|527415620|FG000|Overall Study|Withdrawal by Subject|2|||
146246204|NCT04620733|527415621|FG001|Overall Study|Withdrawal by Subject|5|||
146246205|NCT04620733|527415620|FG000|Overall Study|Lost to Follow-up|1|||
146246206|NCT04620733|527415621|FG001|Overall Study|Lost to Follow-up|1|||
146246207|NCT04620733|527415620|FG000|Overall Study|Protocol Deviation|1|||
146246208|NCT04620733|527415621|FG001|Overall Study|Protocol Deviation|1|||
146246209|NCT04620733|527415620|FG000|Overall Study|Reason Not Specified|0|||
146246210|NCT04620733|527415621|FG001|Overall Study|Reason Not Specified|1|||
146246211|NCT02196259|527415626|FG000|Overall Study|Researcher choice|0|||
146246212|NCT02196259|527415627|FG001|Overall Study|Researcher choice|0|||
145991841|NCT01813357|526484487|FG001|Overall Study|Lost to Follow-up|6|||
145991842|NCT03773562|526484488|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
145991843|NCT03773562|526484488|FG000|Overall Study|Lost to Follow-up|10|||
145991844|NCT03773562|526484488|FG000|Overall Study|Withdrawal by Subject|1|||
146246213|NCT02196259|527415628|FG002|Overall Study|Researcher choice|1|||
146246214|NCT02196259|527415626|FG000|Overall Study|Partial data analysis|0|||
146246215|NCT02196259|527415627|FG001|Overall Study|Partial data analysis|3|||
145991845|NCT03131479|526484489|FG000|Overall Study|Adverse Event|0|||
145991846|NCT03131479|526484490|FG001|Overall Study|Adverse Event|0|||
146246216|NCT02196259|527415628|FG002|Overall Study|Partial data analysis|0|||
145991847|NCT03131479|526484491|FG002|Overall Study|Adverse Event|1|||
145991848|NCT03131479|526484492|FG003|Overall Study|Adverse Event|1|||
145991849|NCT03131479|526484493|FG004|Overall Study|Adverse Event|0|||
145991850|NCT03131479|526484489|FG000|Overall Study|Subject/Guardian Decision|0|||
145991851|NCT03131479|526484490|FG001|Overall Study|Subject/Guardian Decision|0|||
145991852|NCT03131479|526484491|FG002|Overall Study|Subject/Guardian Decision|0|||
145991853|NCT03131479|526484492|FG003|Overall Study|Subject/Guardian Decision|1|||
145991854|NCT03131479|526484493|FG004|Overall Study|Subject/Guardian Decision|0|||
145991855|NCT01272219|526484494|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
145991856|NCT01272219|526484495|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
145991857|NCT01272219|526484496|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
145991858|NCT01272219|526484497|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
145991859|NCT01272219|526484498|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
145991860|NCT01272219|526484499|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
145991861|NCT01272219|526484494|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
145991862|NCT01272219|526484495|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
145991863|NCT01272219|526484496|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
145991864|NCT01272219|526484497|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
145991865|NCT01272219|526484498|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
145991866|NCT01272219|526484499|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
145991867|NCT01272219|526484494|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
145991868|NCT01272219|526484495|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
145991869|NCT01272219|526484496|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
145991870|NCT01272219|526484497|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
146246217|NCT00264576|527415629|FG000|Overall Study|Lost to Follow-up|1|||
146246218|NCT00264576|527415630|FG001|Overall Study|Lost to Follow-up|1|||
146246219|NCT02659059|527415633|FG000|Overall Study|Other reasons|6|||
146246220|NCT02659059|527415634|FG001|Overall Study|Other reasons|1|||
146246221|NCT02659059|527415633|FG000|Overall Study|Disease Progression|143|||
146246222|NCT02659059|527415634|FG001|Overall Study|Disease Progression|16|||
145991871|NCT01272219|526484498|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
145991872|NCT01272219|526484499|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
145991873|NCT01272219|526484494|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
145991874|NCT01272219|526484495|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
145991875|NCT01272219|526484496|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
145991876|NCT01272219|526484497|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
145991877|NCT01272219|526484498|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
145991878|NCT01272219|526484499|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
145991879|NCT01272219|526484494|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
145991880|NCT01272219|526484495|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
145991881|NCT01272219|526484496|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
145991882|NCT01272219|526484497|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
145991883|NCT01272219|526484498|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
145991884|NCT01272219|526484499|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
145991885|NCT01272219|526484494|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145991886|NCT01272219|526484495|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
145991887|NCT01272219|526484496|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
145991888|NCT01272219|526484497|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
145991889|NCT01272219|526484498|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145991890|NCT01272219|526484499|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145991891|NCT01272219|526484494|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145991892|NCT01272219|526484495|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145991893|NCT01272219|526484496|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145991894|NCT01272219|526484497|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
145991895|NCT01272219|526484498|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145991896|NCT01272219|526484499|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145991897|NCT01272219|526484494|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145991898|NCT01272219|526484495|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
145991899|NCT01272219|526484496|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145991900|NCT01272219|526484497|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
145991901|NCT01272219|526484498|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145991902|NCT01272219|526484499|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145991903|NCT01272219|526484494|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145991904|NCT01272219|526484495|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
145991905|NCT01272219|526484496|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
146091640|NCT03739840|526856850|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
146246223|NCT02659059|527415633|FG000|Overall Study|Study Drug toxicity|56|||
146246224|NCT02659059|527415634|FG001|Overall Study|Study Drug toxicity|9|||
146246225|NCT02659059|527415633|FG000|Overall Study|Death|3|||
146246226|NCT02659059|527415634|FG001|Overall Study|Death|1|||
145991906|NCT01272219|526484497|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
145991907|NCT01272219|526484498|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145991908|NCT01272219|526484499|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145991909|NCT01272219|526484494|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145991910|NCT01272219|526484495|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
145991911|NCT01272219|526484496|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
145991912|NCT01272219|526484497|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
145991913|NCT01272219|526484498|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145991914|NCT01272219|526484499|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145991915|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
146246227|NCT02659059|527415633|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
145991916|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
145991917|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
145991918|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
145991919|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
145991920|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
145991921|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145991922|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145991923|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145991924|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145991925|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
145991926|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
145991927|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145991928|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145991929|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145991930|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145991931|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
145991932|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
145991933|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145991934|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145991935|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145991936|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145991937|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
145991938|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
145991939|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
145991940|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
145991941|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
145991942|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
145991943|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
145991944|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
145991945|NCT01272219|526484494|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
145991946|NCT01272219|526484495|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
145991947|NCT01272219|526484496|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
145991948|NCT01272219|526484497|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
145991949|NCT01272219|526484498|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
145991950|NCT01272219|526484499|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
145991951|NCT01491919|526484500|FG000|Overall Study|Insufficient PK sampling|1|||
145991952|NCT01491919|526484501|FG001|Overall Study|Insufficient PK sampling|2|||
145991953|NCT01491919|526484502|FG002|Overall Study|Insufficient PK sampling|1|||
145991954|NCT04003389|526484503|FG000|Overall Study|Adverse Event|27|||
145991955|NCT04003389|526484504|FG001|Overall Study|Adverse Event|34|||
145991956|NCT04003389|526484505|FG002|Overall Study|Adverse Event|28|||
146246228|NCT02659059|527415634|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
146246229|NCT02659059|527415633|FG000|Overall Study|Participant request to discontinue study treatment|5|||
146246230|NCT02659059|527415634|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146246231|NCT02659059|527415633|FG000|Overall Study|Participant withdrew consent|6|||
146246232|NCT02659059|527415634|FG001|Overall Study|Participant withdrew consent|1|||
146246233|NCT00092456|527415640|FG000|Overall Study|Adverse Event|0|||
146246234|NCT00092456|527415641|FG001|Overall Study|Adverse Event|0|||
146246235|NCT00092456|527415642|FG002|Overall Study|Adverse Event|1|||
146246236|NCT00092456|527415643|FG003|Overall Study|Adverse Event|1|||
145991957|NCT04003389|526484503|FG000|Overall Study|Lost to Follow-up|39|||
145991958|NCT04003389|526484504|FG001|Overall Study|Lost to Follow-up|30|||
145991959|NCT04003389|526484505|FG002|Overall Study|Lost to Follow-up|33|||
145991960|NCT04003389|526484503|FG000|Overall Study|Protocol Violation|1|||
145991961|NCT04003389|526484504|FG001|Overall Study|Protocol Violation|6|||
146246237|NCT00092456|527415640|FG000|Overall Study|Lost to Follow-up|2|||
146297873|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145991962|NCT04003389|526484505|FG002|Overall Study|Protocol Violation|5|||
146246238|NCT00092456|527415641|FG001|Overall Study|Lost to Follow-up|2|||
146246239|NCT00092456|527415642|FG002|Overall Study|Lost to Follow-up|1|||
146246240|NCT00092456|527415643|FG003|Overall Study|Lost to Follow-up|2|||
146246241|NCT00092456|527415640|FG000|Overall Study|Protocol Violation|5|||
146246242|NCT00092456|527415641|FG001|Overall Study|Protocol Violation|7|||
146246243|NCT00092456|527415642|FG002|Overall Study|Protocol Violation|8|||
146246244|NCT00092456|527415643|FG003|Overall Study|Protocol Violation|6|||
146246245|NCT00092456|527415640|FG000|Overall Study|Withdrawal by Subject|13|||
146246246|NCT00092456|527415641|FG001|Overall Study|Withdrawal by Subject|5|||
146246247|NCT00092456|527415642|FG002|Overall Study|Withdrawal by Subject|16|||
146246248|NCT00092456|527415643|FG003|Overall Study|Withdrawal by Subject|6|||
146246249|NCT00092456|527415640|FG000|Overall Study|Moved|1|||
146246250|NCT00092456|527415641|FG001|Overall Study|Moved|1|||
146246251|NCT00092456|527415642|FG002|Overall Study|Moved|0|||
146246252|NCT00092456|527415643|FG003|Overall Study|Moved|1|||
146246253|NCT00092456|527415640|FG000|Overall Study|Other|4|||
146246254|NCT00092456|527415641|FG001|Overall Study|Other|2|||
146246255|NCT00092456|527415642|FG002|Overall Study|Other|3|||
145991963|NCT04003389|526484503|FG000|Overall Study|Withdrawal by Subject|119|||
145991964|NCT04003389|526484504|FG001|Overall Study|Withdrawal by Subject|79|||
145991965|NCT04003389|526484505|FG002|Overall Study|Withdrawal by Subject|85|||
145991966|NCT04003389|526484503|FG000|Overall Study|Miscellaneous|14|||
145991967|NCT04003389|526484504|FG001|Overall Study|Miscellaneous|11|||
145991968|NCT04003389|526484505|FG002|Overall Study|Miscellaneous|14|||
145991969|NCT04003389|526484503|FG000|Overall Study|Participant did not receive study drug|1|||
145991970|NCT04003389|526484504|FG001|Overall Study|Participant did not receive study drug|0|||
145991971|NCT04003389|526484505|FG002|Overall Study|Participant did not receive study drug|0|||
145991972|NCT04806373|526484511|FG000|Overall Study|Withdrawal by Subject|1|||
145991973|NCT04806373|526484512|FG001|Overall Study|Withdrawal by Subject|1|||
145991974|NCT05810597|526484513|FG000|Period 1|Adverse Event|2|||
145991975|NCT05810597|526484514|FG001|Period 1|Adverse Event|0|||
145991976|NCT05810597|526484513|FG000|Period 1|Physician Decision|1|||
145991977|NCT05810597|526484514|FG001|Period 1|Physician Decision|0|||
145991978|NCT02061085|526484519|FG000|Overall Study|Adverse Event|8|||
145991979|NCT04903093|526484520|FG000|Overall Study|Withdrawal by Subject|0|||
145991980|NCT04903093|526484521|FG001|Overall Study|Withdrawal by Subject|0|||
145991981|NCT04903093|526484522|FG002|Overall Study|Withdrawal by Subject|0|||
145991982|NCT04903093|526484523|FG003|Overall Study|Withdrawal by Subject|1|||
145991983|NCT04903093|526484524|FG004|Overall Study|Withdrawal by Subject|0|||
145991984|NCT04903093|526484525|FG005|Overall Study|Withdrawal by Subject|0|||
145991985|NCT03204812|526484535|FG000|Overall Study|Adverse Event|3|||
145991986|NCT02412436|526484536|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
145991987|NCT02412436|526484536|FG000|Overall Study|Lost to Follow-up|6|||
145991988|NCT02412436|526484536|FG000|Overall Study|Unable to get to clinic|3|||
145991989|NCT02412436|526484536|FG000|Overall Study|Death|1|||
145991990|NCT02412436|526484536|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
145991991|NCT00392288|526484537|FG000|Overall Study|Adverse Event|17|||
145991992|NCT00392288|526484538|FG001|Overall Study|Adverse Event|7|||
146246256|NCT00092456|527415643|FG003|Overall Study|Other|0|||
146246257|NCT04783389|527415644|FG000|Overall Study|Withdrawal by Subject|2|||
146246258|NCT04783389|527415645|FG001|Overall Study|Withdrawal by Subject|0|||
146246259|NCT04783389|527415646|FG002|Overall Study|Withdrawal by Subject|0|||
146246260|NCT04783389|527415644|FG000|Overall Study|Termination of Study by Sponsor|10|||
146246261|NCT04783389|527415645|FG001|Overall Study|Termination of Study by Sponsor|12|||
146246262|NCT04783389|527415646|FG002|Overall Study|Termination of Study by Sponsor|14|||
146246263|NCT00451906|527415647|FG000|Overall Study|Adverse Event|515|||
146246264|NCT00451906|527415647|FG000|Overall Study|Lost to Follow-up|31|||
146246265|NCT00451906|527415647|FG000|Overall Study|Withdrawal by Subject|111|||
146246266|NCT00451906|527415647|FG000|Overall Study|Protocol Violation|21|||
146246267|NCT00451906|527415647|FG000|Overall Study|Progressive disease|1328|||
145991993|NCT00392288|526484539|FG002|Overall Study|Adverse Event|8|||
145991994|NCT00392288|526484537|FG000|Overall Study|Lack of Efficacy|8|||
145991995|NCT00392288|526484538|FG001|Overall Study|Lack of Efficacy|5|||
145991996|NCT00392288|526484539|FG002|Overall Study|Lack of Efficacy|3|||
145991997|NCT00392288|526484537|FG000|Overall Study|Protocol Violation|1|||
145991998|NCT00392288|526484538|FG001|Overall Study|Protocol Violation|3|||
145991999|NCT00392288|526484539|FG002|Overall Study|Protocol Violation|1|||
145992000|NCT00392288|526484537|FG000|Overall Study|Lost to Follow-up|1|||
145992001|NCT00392288|526484538|FG001|Overall Study|Lost to Follow-up|1|||
145992002|NCT00392288|526484539|FG002|Overall Study|Lost to Follow-up|1|||
146246268|NCT00451906|527415647|FG000|Overall Study|Termination of the study|108|||
146246269|NCT00451906|527415647|FG000|Overall Study|Other Reasons|121|||
146246270|NCT00451906|527415647|FG000|Overall Study|Did not complete final visit|4|||
146246271|NCT02121808|527415649|FG000|Overall Study|Technical problem|3|||
145992003|NCT00392288|526484537|FG000|Overall Study|Withdrawal by Subject|1|||
145992004|NCT00392288|526484538|FG001|Overall Study|Withdrawal by Subject|0|||
146246272|NCT02164578|527415654|FG000|Treatment Period|Withdrawal by Subject|3|||
146246273|NCT02164578|527415655|FG001|Treatment Period|Withdrawal by Subject|3|||
146246274|NCT02164578|527415654|FG000|Treatment Period|Adverse Event|13|||
146246275|NCT02164578|527415655|FG001|Treatment Period|Adverse Event|6|||
146246276|NCT02164578|527415654|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
146246277|NCT02164578|527415655|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
146246278|NCT02164578|527415654|FG000|Treatment Period|Protocol Violation|0|||
146246279|NCT02164578|527415655|FG001|Treatment Period|Protocol Violation|2|||
146246280|NCT02164578|527415654|FG000|Extension Period|Withdrawal by Subject|2|||
146246281|NCT02164578|527415655|FG001|Extension Period|Withdrawal by Subject|0|||
146246282|NCT02164578|527415654|FG000|Extension Period|Adverse Event|4|||
146246283|NCT02164578|527415655|FG001|Extension Period|Adverse Event|0|||
146246284|NCT02164578|527415654|FG000|Extension Period|Expiry of study medication|1|||
146246285|NCT02164578|527415655|FG001|Extension Period|Expiry of study medication|0|||
146246286|NCT02164578|527415654|FG000|Extension Period|Protocol Violation|0|||
146246287|NCT02164578|527415655|FG001|Extension Period|Protocol Violation|1|||
146246288|NCT03924193|527415656|FG000|Overall Study|Adverse Event|10|||
145992005|NCT00392288|526484539|FG002|Overall Study|Withdrawal by Subject|2|||
145992006|NCT00392288|526484537|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
145992007|NCT00392288|526484538|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
145992008|NCT00392288|526484539|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
145992009|NCT00392288|526484537|FG000|Overall Study|Other|3|||
145992010|NCT00392288|526484538|FG001|Overall Study|Other|4|||
145992011|NCT00392288|526484539|FG002|Overall Study|Other|1|||
145992012|NCT02544763|526484540|FG000|Overall Study|Adverse Event|8|||
145992013|NCT02544763|526484541|FG001|Overall Study|Adverse Event|8|||
145992014|NCT02544763|526484542|FG002|Overall Study|Adverse Event|0|||
145992015|NCT02544763|526484540|FG000|Overall Study|Withdrawn by parent/guardian|1|||
145992016|NCT02544763|526484541|FG001|Overall Study|Withdrawn by parent/guardian|1|||
145992017|NCT02544763|526484542|FG002|Overall Study|Withdrawn by parent/guardian|1|||
145992018|NCT02544763|526484540|FG000|Overall Study|Met withdrawal criteria|0|||
145992019|NCT02544763|526484541|FG001|Overall Study|Met withdrawal criteria|2|||
145992020|NCT02544763|526484542|FG002|Overall Study|Met withdrawal criteria|0|||
145992021|NCT02544763|526484540|FG000|Overall Study|Physician Decision|0|||
145992022|NCT02544763|526484541|FG001|Overall Study|Physician Decision|1|||
145992023|NCT02544763|526484542|FG002|Overall Study|Physician Decision|0|||
145992024|NCT02544763|526484540|FG000|Overall Study|Difficulties taking IMP|1|||
145992025|NCT02544763|526484541|FG001|Overall Study|Difficulties taking IMP|0|||
145992026|NCT02544763|526484542|FG002|Overall Study|Difficulties taking IMP|0|||
145992027|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
145992028|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145992029|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145992030|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145992031|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145992032|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
145992033|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145992034|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145992035|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145992036|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145992037|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
145992038|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145992039|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145992040|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145992041|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145992042|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
145992043|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145992044|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145992045|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145992046|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145992047|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
145992048|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145992049|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145992050|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145992051|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145992052|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
146246289|NCT03924193|527415657|FG001|Overall Study|Adverse Event|0|||
146246290|NCT03924193|527415658|FG002|Overall Study|Adverse Event|10|||
146297874|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145992053|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145992054|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145992055|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145992056|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145992057|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
145992058|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145992059|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145992060|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145992061|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145992062|NCT01111552|526484543|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
145992063|NCT01111552|526484544|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145992064|NCT01111552|526484545|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145992065|NCT01111552|526484546|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145992066|NCT01111552|526484547|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145992067|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145992068|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145992069|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145992070|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
145992071|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145992072|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
145992073|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145992074|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
145992075|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
145992076|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145992077|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145992078|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
145992079|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145992080|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145992081|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145992082|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145992083|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
145992084|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145992085|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145992086|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145992087|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145992088|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
145992089|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145992090|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145992091|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145992092|NCT01111552|526484543|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145992093|NCT01111552|526484544|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145992094|NCT01111552|526484545|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
145992095|NCT01111552|526484546|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145992096|NCT01111552|526484547|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145992097|NCT01027351|526484549|FG000|Overall Study|Withdrawal by Subject|1|||
145992098|NCT01027351|526484550|FG001|Overall Study|Withdrawal by Subject|0|||
145992099|NCT01027351|526484551|FG002|Overall Study|Withdrawal by Subject|1|||
145992100|NCT01027351|526484552|FG003|Overall Study|Withdrawal by Subject|0|||
145992101|NCT01027351|526484553|FG004|Overall Study|Withdrawal by Subject|3|||
145992102|NCT01027351|526484554|FG005|Overall Study|Withdrawal by Subject|5|||
145992103|NCT01027351|526484549|FG000|Overall Study|Lost to Follow-up|1|||
145992104|NCT01027351|526484550|FG001|Overall Study|Lost to Follow-up|1|||
145992105|NCT01027351|526484551|FG002|Overall Study|Lost to Follow-up|0|||
145992106|NCT01027351|526484552|FG003|Overall Study|Lost to Follow-up|1|||
145992107|NCT01027351|526484553|FG004|Overall Study|Lost to Follow-up|6|||
145992108|NCT01027351|526484554|FG005|Overall Study|Lost to Follow-up|0|||
145992109|NCT01027351|526484549|FG000|Overall Study|Inappropriate enrollment|0|||
145992110|NCT01027351|526484550|FG001|Overall Study|Inappropriate enrollment|0|||
145992111|NCT01027351|526484551|FG002|Overall Study|Inappropriate enrollment|0|||
145992112|NCT01027351|526484552|FG003|Overall Study|Inappropriate enrollment|0|||
145992113|NCT01027351|526484553|FG004|Overall Study|Inappropriate enrollment|1|||
146091641|NCT00116168|526856851|FG000|Overall Study|Lost to Follow-up|6|||
146091642|NCT00116168|526856852|FG001|Overall Study|Lost to Follow-up|5|||
146246291|NCT03924193|527415656|FG000|Overall Study|Withdrawal by Subject|5|||
145992114|NCT01027351|526484554|FG005|Overall Study|Inappropriate enrollment|0|||
145992115|NCT01027351|526484549|FG000|Overall Study|Protocol Violation|1|||
146091643|NCT00116168|526856853|FG002|Overall Study|Lost to Follow-up|0|||
146091644|NCT00116168|526856854|FG003|Overall Study|Lost to Follow-up|0|||
146246292|NCT03924193|527415657|FG001|Overall Study|Withdrawal by Subject|10|||
145992116|NCT01027351|526484550|FG001|Overall Study|Protocol Violation|0|||
145992117|NCT01027351|526484551|FG002|Overall Study|Protocol Violation|0|||
146091645|NCT01323946|526856855|FG000|Overall Study|Lost to Follow-up|0|||
146091646|NCT01323946|526856856|FG001|Overall Study|Lost to Follow-up|1|||
146246293|NCT03924193|527415658|FG002|Overall Study|Withdrawal by Subject|2|||
146246294|NCT00647699|527415659|FG000|Overall Study|Lost to Follow-up|5|||
146246295|NCT00647699|527415660|FG001|Overall Study|Lost to Follow-up|4|||
146246296|NCT00647699|527415659|FG000|Overall Study|Withdrawal by Subject|3|||
146246297|NCT00647699|527415660|FG001|Overall Study|Withdrawal by Subject|8|||
146246298|NCT03029585|527415661|FG000|Overall Study|Death|1|||
146246299|NCT03029585|527415662|FG001|Overall Study|Death|1|||
146246300|NCT03029585|527415661|FG000|Overall Study|Withdrawal by Subject|1|||
146246301|NCT03029585|527415662|FG001|Overall Study|Withdrawal by Subject|0|||
146246302|NCT02165202|527415663|FG000|Oral Phase|Refused further participation|5|||
146246303|NCT02165202|527415664|FG001|Oral Phase|Refused further participation|1|||
146246304|NCT02165202|527415663|FG000|Oral Phase|Study product Related Toxicity|1|||
146246305|NCT02165202|527415664|FG001|Oral Phase|Study product Related Toxicity|0|||
146246306|NCT02165202|527415663|FG000|Oral Phase|Unable to contact Participant|1|||
146246307|NCT02165202|527415664|FG001|Oral Phase|Unable to contact Participant|1|||
146246308|NCT02165202|527415663|FG000|Oral Phase|Clinical reasons|1|||
146246309|NCT02165202|527415664|FG001|Oral Phase|Clinical reasons|0|||
146246310|NCT02165202|527415663|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
146091647|NCT01323946|526856857|FG002|Overall Study|Lost to Follow-up|0|||
146091648|NCT01323946|526856855|FG000|Overall Study|Parents refused the last blood draw|1|||
146246311|NCT02165202|527415664|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
146246312|NCT02165202|527415663|FG000|Oral Phase|CMC advised termination|1|||
146246313|NCT02165202|527415664|FG001|Oral Phase|CMC advised termination|0|||
145992118|NCT01027351|526484552|FG003|Overall Study|Protocol Violation|1|||
145992119|NCT01027351|526484553|FG004|Overall Study|Protocol Violation|1|||
145992120|NCT01027351|526484554|FG005|Overall Study|Protocol Violation|0|||
145992121|NCT04650893|526484555|FG000|Overall Study|Lost to Follow-up|11|||
145992122|NCT04650893|526484556|FG001|Overall Study|Lost to Follow-up|10|||
145992123|NCT04650893|526484557|FG002|Overall Study|Lost to Follow-up|11|||
145992124|NCT04090749|526484560|FG000|Open Label Pilot|Lost to Follow-up|1|||
145992125|NCT04090749|526484561|FG001|Open Label Pilot|Lost to Follow-up|0|||
145992126|NCT04090749|526484562|FG002|Open Label Pilot|Lost to Follow-up|0|||
145992127|NCT04090749|526484560|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
145992128|NCT04090749|526484561|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
145992129|NCT04090749|526484562|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
145992130|NCT04090749|526484560|FG000|Pilot Trial|Lost to Follow-up|0|||
145992131|NCT04090749|526484561|FG001|Pilot Trial|Lost to Follow-up|1|||
145992132|NCT04090749|526484562|FG002|Pilot Trial|Lost to Follow-up|1|||
145992133|NCT02528305|526484563|FG000|Overall Study|Withdrawal by Subject|1|||
145992134|NCT02528305|526484563|FG000|Overall Study|Adverse Event|1|||
145992135|NCT02528305|526484563|FG000|Overall Study|Physician Decision|1|||
145992136|NCT03768336|526486170|FG000|Overall Study|Lost to Follow-up|3|||
145992137|NCT03768336|526486171|FG001|Overall Study|Lost to Follow-up|2|||
145992138|NCT03768336|526486170|FG000|Overall Study|Became Ineligible|2|||
145992139|NCT03768336|526486171|FG001|Overall Study|Became Ineligible|0|||
145992140|NCT03768336|526486170|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
145992141|NCT03768336|526486171|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
145992142|NCT03768336|526486170|FG000|Overall Study|Missed final survey (post-treatment|0|||
145992143|NCT03768336|526486171|FG001|Overall Study|Missed final survey (post-treatment|1|||
145992144|NCT06790303|526486172|FG000|Overall Study|Study Terminated by sponsor|4|||
145992145|NCT06790303|526486172|FG000|Overall Study|Death|4|||
145992146|NCT00500331|526486175|FG000|Overall Study|Adverse Event|0|||
145992147|NCT00500331|526486176|FG001|Overall Study|Adverse Event|2|||
145992148|NCT00500331|526486177|FG002|Overall Study|Adverse Event|0|||
145992149|NCT00500331|526486178|FG003|Overall Study|Adverse Event|1|||
145992150|NCT00500331|526486179|FG004|Overall Study|Adverse Event|2|||
145992151|NCT00500331|526486180|FG005|Overall Study|Adverse Event|2|||
145992152|NCT00500331|526486181|FG006|Overall Study|Adverse Event|0|||
145992153|NCT00500331|526486175|FG000|Overall Study|Lost to Follow-up|1|||
145992154|NCT00500331|526486176|FG001|Overall Study|Lost to Follow-up|1|||
145992155|NCT00500331|526486177|FG002|Overall Study|Lost to Follow-up|1|||
145992156|NCT00500331|526486178|FG003|Overall Study|Lost to Follow-up|2|||
145992157|NCT00500331|526486179|FG004|Overall Study|Lost to Follow-up|1|||
145992158|NCT00500331|526486180|FG005|Overall Study|Lost to Follow-up|0|||
145992159|NCT00500331|526486181|FG006|Overall Study|Lost to Follow-up|0|||
145992160|NCT00500331|526486175|FG000|Overall Study|Protocol Violation|3|||
146246314|NCT02165202|527415663|FG000|Oral Phase|Relocated, no follow-up planned|1|||
146246315|NCT02165202|527415664|FG001|Oral Phase|Relocated, no follow-up planned|0|||
146246316|NCT02165202|527415663|FG000|Oral Phase|Abnormal EKG|0|||
146246317|NCT02165202|527415664|FG001|Oral Phase|Abnormal EKG|1|||
145992161|NCT00500331|526486176|FG001|Overall Study|Protocol Violation|1|||
146246318|NCT02165202|527415663|FG000|Injection Phase|Abnormal Lab Value|5|||
146246319|NCT02165202|527415664|FG001|Injection Phase|Abnormal Lab Value|1|||
145992162|NCT00500331|526486177|FG002|Overall Study|Protocol Violation|1|||
145992163|NCT00500331|526486178|FG003|Overall Study|Protocol Violation|0|||
145992164|NCT00500331|526486179|FG004|Overall Study|Protocol Violation|1|||
145992165|NCT00500331|526486180|FG005|Overall Study|Protocol Violation|1|||
145992166|NCT00500331|526486181|FG006|Overall Study|Protocol Violation|1|||
146246320|NCT02165202|527415663|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
146246321|NCT02165202|527415664|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
146246322|NCT02165202|527415663|FG000|Injection Phase|Unable to attend within Visit Window|1|||
146246323|NCT02165202|527415664|FG001|Injection Phase|Unable to attend within Visit Window|0|||
146246324|NCT02165202|527415663|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
146246325|NCT02165202|527415664|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
146246326|NCT02165202|527415663|FG000|Injection Phase|End of Study|2|||
146246327|NCT02165202|527415664|FG001|Injection Phase|End of Study|1|||
146246328|NCT02165202|527415663|FG000|Injection Phase|Study Product related Toxicity|1|||
146246329|NCT02165202|527415664|FG001|Injection Phase|Study Product related Toxicity|0|||
146246330|NCT02165202|527415663|FG000|Injection Phase|No longer interested|0|||
146246331|NCT02165202|527415664|FG001|Injection Phase|No longer interested|1|||
146246332|NCT02165202|527415663|FG000|Injection Phase|Participant unwilling to comply|1|||
146246333|NCT02165202|527415664|FG001|Injection Phase|Participant unwilling to comply|0|||
146246334|NCT01975701|527415672|FG000|Overall Study|Lost to Follow-up|1|||
146246335|NCT01975701|527415672|FG000|Overall Study|Death|23|||
146246336|NCT01975701|527415672|FG000|Overall Study|Physician Decision|1|||
146246337|NCT02753075|527415673|FG000|Overall Study|Adverse Event|2|||
146246338|NCT02753075|527415674|FG001|Overall Study|Adverse Event|1|||
146246339|NCT02753075|527415675|FG002|Overall Study|Adverse Event|0|||
146246340|NCT02753075|527415673|FG000|Overall Study|Lost to Follow-up|2|||
146246341|NCT02753075|527415674|FG001|Overall Study|Lost to Follow-up|0|||
146246342|NCT02753075|527415675|FG002|Overall Study|Lost to Follow-up|0|||
146246343|NCT02753075|527415673|FG000|Overall Study|Withdrawal of Consent|1|||
146246344|NCT02753075|527415674|FG001|Overall Study|Withdrawal of Consent|1|||
146246345|NCT02753075|527415675|FG002|Overall Study|Withdrawal of Consent|3|||
146246346|NCT02753075|527415673|FG000|Overall Study|Physician Decision|3|||
146246347|NCT02753075|527415674|FG001|Overall Study|Physician Decision|1|||
146246348|NCT02753075|527415675|FG002|Overall Study|Physician Decision|0|||
145992167|NCT00500331|526486175|FG000|Overall Study|Withdrawal by Subject|4|||
145992168|NCT00500331|526486176|FG001|Overall Study|Withdrawal by Subject|0|||
145992169|NCT00500331|526486177|FG002|Overall Study|Withdrawal by Subject|1|||
145992170|NCT00500331|526486178|FG003|Overall Study|Withdrawal by Subject|5|||
145992171|NCT00500331|526486179|FG004|Overall Study|Withdrawal by Subject|0|||
145992172|NCT00500331|526486180|FG005|Overall Study|Withdrawal by Subject|1|||
145992173|NCT00500331|526486181|FG006|Overall Study|Withdrawal by Subject|1|||
145992174|NCT00500331|526486175|FG000|Overall Study|Lack of Efficacy|3|||
145992175|NCT00500331|526486176|FG001|Overall Study|Lack of Efficacy|1|||
145992176|NCT00500331|526486177|FG002|Overall Study|Lack of Efficacy|0|||
145992177|NCT00500331|526486178|FG003|Overall Study|Lack of Efficacy|0|||
145992178|NCT00500331|526486179|FG004|Overall Study|Lack of Efficacy|0|||
145992179|NCT00500331|526486180|FG005|Overall Study|Lack of Efficacy|0|||
145992180|NCT00500331|526486181|FG006|Overall Study|Lack of Efficacy|0|||
145992181|NCT00500331|526486175|FG000|Overall Study|Liver function test abnormality|0|||
145992182|NCT00500331|526486176|FG001|Overall Study|Liver function test abnormality|0|||
145992183|NCT00500331|526486177|FG002|Overall Study|Liver function test abnormality|1|||
145992184|NCT00500331|526486178|FG003|Overall Study|Liver function test abnormality|0|||
145992185|NCT00500331|526486179|FG004|Overall Study|Liver function test abnormality|0|||
145992186|NCT00500331|526486180|FG005|Overall Study|Liver function test abnormality|0|||
145992187|NCT00500331|526486181|FG006|Overall Study|Liver function test abnormality|0|||
145992188|NCT00500331|526486175|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
145992189|NCT00500331|526486176|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
145992190|NCT00500331|526486177|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
145992191|NCT00500331|526486178|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
145992192|NCT00500331|526486179|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
145992193|NCT00500331|526486180|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
145992194|NCT00500331|526486181|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
145992195|NCT00500331|526486175|FG000|Overall Study|Didn't return for continuation of study|1|||
145992196|NCT00500331|526486176|FG001|Overall Study|Didn't return for continuation of study|0|||
145992197|NCT00500331|526486177|FG002|Overall Study|Didn't return for continuation of study|0|||
145992198|NCT00500331|526486178|FG003|Overall Study|Didn't return for continuation of study|0|||
145992199|NCT00500331|526486179|FG004|Overall Study|Didn't return for continuation of study|0|||
145992200|NCT00500331|526486180|FG005|Overall Study|Didn't return for continuation of study|0|||
145992201|NCT00500331|526486181|FG006|Overall Study|Didn't return for continuation of study|0|||
145992202|NCT00500331|526486175|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
145992203|NCT00500331|526486176|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
146246349|NCT02152384|527415678|FG000|Period 1|Withdrawal by Subject|0|||
146246350|NCT02152384|527415679|FG001|Period 1|Withdrawal by Subject|1|||
146246351|NCT02152384|527415678|FG000|Period 1|Adverse Event|1|||
146246352|NCT02152384|527415679|FG001|Period 1|Adverse Event|1|||
146246353|NCT00603798|527415682|FG000|Overall Study|Adverse Event|4|||
145992204|NCT00500331|526486177|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
145992205|NCT00500331|526486178|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
146246354|NCT00603798|527415683|FG001|Overall Study|Adverse Event|2|||
146246355|NCT00603798|527415684|FG002|Overall Study|Adverse Event|1|||
146246356|NCT00603798|527415682|FG000|Overall Study|Withdrawal by Subject|4|||
146246357|NCT00603798|527415683|FG001|Overall Study|Withdrawal by Subject|3|||
146246358|NCT00603798|527415684|FG002|Overall Study|Withdrawal by Subject|4|||
146246359|NCT00603798|527415682|FG000|Overall Study|Lost to Follow-up|1|||
145992206|NCT00500331|526486179|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
145992207|NCT00500331|526486180|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
145992208|NCT00500331|526486181|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
145992209|NCT00500331|526486175|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
145992210|NCT00500331|526486176|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
145992211|NCT00500331|526486177|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
145992212|NCT00500331|526486178|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
145992213|NCT00500331|526486179|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
145992214|NCT00500331|526486180|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
145992215|NCT00500331|526486181|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
145992216|NCT00500331|526486175|FG000|Overall Study|Participant was randomized by mistake|1|||
145992217|NCT00500331|526486176|FG001|Overall Study|Participant was randomized by mistake|0|||
145992218|NCT00500331|526486177|FG002|Overall Study|Participant was randomized by mistake|0|||
145992219|NCT00500331|526486178|FG003|Overall Study|Participant was randomized by mistake|0|||
145992220|NCT00500331|526486179|FG004|Overall Study|Participant was randomized by mistake|0|||
145992221|NCT00500331|526486180|FG005|Overall Study|Participant was randomized by mistake|0|||
145992222|NCT00500331|526486181|FG006|Overall Study|Participant was randomized by mistake|0|||
145992223|NCT00500331|526486175|FG000|Overall Study|Diabetologist nurse in the study|0|||
145992224|NCT00500331|526486176|FG001|Overall Study|Diabetologist nurse in the study|0|||
145992225|NCT00500331|526486177|FG002|Overall Study|Diabetologist nurse in the study|1|||
145992226|NCT00500331|526486178|FG003|Overall Study|Diabetologist nurse in the study|0|||
145992227|NCT00500331|526486179|FG004|Overall Study|Diabetologist nurse in the study|0|||
145992228|NCT00500331|526486180|FG005|Overall Study|Diabetologist nurse in the study|0|||
145992229|NCT00500331|526486181|FG006|Overall Study|Diabetologist nurse in the study|0|||
145992230|NCT00500331|526486175|FG000|Overall Study|State ban of biological samples export|0|||
145992231|NCT00500331|526486176|FG001|Overall Study|State ban of biological samples export|0|||
145992232|NCT00500331|526486177|FG002|Overall Study|State ban of biological samples export|0|||
145992233|NCT00500331|526486178|FG003|Overall Study|State ban of biological samples export|1|||
145992234|NCT00500331|526486179|FG004|Overall Study|State ban of biological samples export|0|||
145992235|NCT00500331|526486180|FG005|Overall Study|State ban of biological samples export|0|||
146297875|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146297876|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
146297877|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
146297878|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146297879|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146297880|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146246360|NCT00603798|527415683|FG001|Overall Study|Lost to Follow-up|0|||
146246361|NCT00603798|527415684|FG002|Overall Study|Lost to Follow-up|1|||
146297881|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145992236|NCT00500331|526486181|FG006|Overall Study|State ban of biological samples export|0|||
145992237|NCT00500331|526486175|FG000|Overall Study|Protocol violated|0|||
145992238|NCT00500331|526486176|FG001|Overall Study|Protocol violated|0|||
145992239|NCT00500331|526486177|FG002|Overall Study|Protocol violated|0|||
145992240|NCT00500331|526486178|FG003|Overall Study|Protocol violated|1|||
145992241|NCT00500331|526486179|FG004|Overall Study|Protocol violated|0|||
145992242|NCT00500331|526486180|FG005|Overall Study|Protocol violated|0|||
145992243|NCT00500331|526486181|FG006|Overall Study|Protocol violated|0|||
145992244|NCT03345550|526486182|FG000|Overall Study|Withdrawal by Subject|1|||
145992245|NCT03345550|526486183|FG001|Overall Study|Withdrawal by Subject|0|||
145992246|NCT03345550|526486182|FG000|Overall Study|Lost to Follow-up|4|||
145992247|NCT03345550|526486183|FG001|Overall Study|Lost to Follow-up|5|||
145992248|NCT03033784|526486187|FG000|Overall Study|Anxiety related to MRI scanner|0|||
145992249|NCT03033784|526486188|FG001|Overall Study|Anxiety related to MRI scanner|1|||
145992250|NCT03033784|526486189|FG002|Overall Study|Anxiety related to MRI scanner|0|||
145992251|NCT03033784|526486190|FG003|Overall Study|Anxiety related to MRI scanner|0|||
145992252|NCT03033784|526486191|FG004|Overall Study|Anxiety related to MRI scanner|0|||
145992253|NCT03033784|526486192|FG005|Overall Study|Anxiety related to MRI scanner|0|||
145992254|NCT03033784|526486193|FG006|Overall Study|Anxiety related to MRI scanner|0|||
145992255|NCT03033784|526486194|FG007|Overall Study|Anxiety related to MRI scanner|0|||
145992256|NCT03033784|526486195|FG008|Overall Study|Anxiety related to MRI scanner|0|||
145992257|NCT03033784|526486196|FG009|Overall Study|Anxiety related to MRI scanner|0|||
145992258|NCT03033784|526486197|FG010|Overall Study|Anxiety related to MRI scanner|0|||
146297882|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
146297883|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
145992259|NCT03033784|526486198|FG011|Overall Study|Anxiety related to MRI scanner|0|||
145992260|NCT03033784|526486199|FG012|Overall Study|Anxiety related to MRI scanner|0|||
145992261|NCT03033784|526486187|FG000|Overall Study|Withdrawal by Subject|0|||
145992262|NCT03033784|526486188|FG001|Overall Study|Withdrawal by Subject|0|||
145992263|NCT03033784|526486189|FG002|Overall Study|Withdrawal by Subject|0|||
145992264|NCT03033784|526486190|FG003|Overall Study|Withdrawal by Subject|0|||
145992265|NCT03033784|526486191|FG004|Overall Study|Withdrawal by Subject|0|||
145992266|NCT03033784|526486192|FG005|Overall Study|Withdrawal by Subject|0|||
145992267|NCT03033784|526486193|FG006|Overall Study|Withdrawal by Subject|0|||
145992268|NCT03033784|526486194|FG007|Overall Study|Withdrawal by Subject|0|||
145992269|NCT03033784|526486195|FG008|Overall Study|Withdrawal by Subject|0|||
145992270|NCT03033784|526486196|FG009|Overall Study|Withdrawal by Subject|0|||
145992271|NCT03033784|526486197|FG010|Overall Study|Withdrawal by Subject|0|||
145992272|NCT03033784|526486198|FG011|Overall Study|Withdrawal by Subject|0|||
145992273|NCT03033784|526486199|FG012|Overall Study|Withdrawal by Subject|2|||
145992274|NCT02374255|526486200|FG000|Overall Study|Withdrawal by Subject|2|||
145992275|NCT02374255|526486201|FG001|Overall Study|Withdrawal by Subject|0|||
145992276|NCT02374255|526486202|FG002|Overall Study|Withdrawal by Subject|0|||
145992277|NCT02374255|526486203|FG003|Overall Study|Withdrawal by Subject|0|||
145992278|NCT03332056|526486204|FG000|Overall Study|Incomplete questionnaires|8|||
145992279|NCT03332056|526486205|FG001|Overall Study|Incomplete questionnaires|9|||
146246362|NCT00603798|527415682|FG000|Overall Study|Non-compliance with study procedures|0|||
145992280|NCT03332056|526486204|FG000|Overall Study|Passed stone prior to surgery date|1|||
145992281|NCT03332056|526486205|FG001|Overall Study|Passed stone prior to surgery date|0|||
145992282|NCT03332056|526486204|FG000|Overall Study|Did not require a ureteral stent|0|||
145992283|NCT03332056|526486205|FG001|Overall Study|Did not require a ureteral stent|1|||
145992284|NCT02093520|526486206|FG000|Overall Study|Not treated|6|||
145992285|NCT02093520|526486207|FG001|Overall Study|Not treated|22|||
145992286|NCT03014089|526486208|FG000|Overall Study|Withdrawal by Subject|0|||
145992287|NCT03014089|526486209|FG001|Overall Study|Withdrawal by Subject|1|||
145992288|NCT03014089|526486210|FG002|Overall Study|Withdrawal by Subject|1|||
145992289|NCT03014089|526486211|FG003|Overall Study|Withdrawal by Subject|1|||
145992290|NCT03014089|526486208|FG000|Overall Study|Lost to Follow-up|1|||
145992291|NCT03014089|526486209|FG001|Overall Study|Lost to Follow-up|0|||
145992292|NCT03014089|526486210|FG002|Overall Study|Lost to Follow-up|0|||
145992293|NCT03014089|526486211|FG003|Overall Study|Lost to Follow-up|0|||
145992294|NCT03014089|526486208|FG000|Overall Study|Adverse Event|1|||
145992295|NCT03014089|526486209|FG001|Overall Study|Adverse Event|0|||
145992296|NCT03014089|526486210|FG002|Overall Study|Adverse Event|1|||
145992297|NCT03014089|526486211|FG003|Overall Study|Adverse Event|0|||
145992298|NCT00851084|526486212|FG000|Overall Study|Randomized but not treated|1|||
145992299|NCT00851084|526486213|FG001|Overall Study|Randomized but not treated|0|||
145992300|NCT00851084|526486212|FG000|Overall Study|Adverse Event|26|||
145992301|NCT00851084|526486213|FG001|Overall Study|Adverse Event|36|||
145992302|NCT00851084|526486212|FG000|Overall Study|Disease progression|52|||
145992303|NCT00851084|526486213|FG001|Overall Study|Disease progression|47|||
145992304|NCT00851084|526486212|FG000|Overall Study|Poor compliance to protocol|1|||
145992305|NCT00851084|526486213|FG001|Overall Study|Poor compliance to protocol|1|||
145992306|NCT00851084|526486212|FG000|Overall Study|Physician Decision|13|||
145992307|NCT00851084|526486213|FG001|Overall Study|Physician Decision|14|||
145992308|NCT00851084|526486212|FG000|Overall Study|Consent withdrawn|0|||
145992309|NCT00851084|526486213|FG001|Overall Study|Consent withdrawn|2|||
145992310|NCT00851084|526486212|FG000|Overall Study|Withdrawal by Subject|11|||
145992311|NCT00851084|526486213|FG001|Overall Study|Withdrawal by Subject|12|||
145992312|NCT00851084|526486212|FG000|Overall Study|Metastatic surgery|6|||
145992313|NCT00851084|526486213|FG001|Overall Study|Metastatic surgery|6|||
145992314|NCT00851084|526486212|FG000|Overall Study|Other|7|||
145992315|NCT00851084|526486213|FG001|Overall Study|Other|1|||
145992316|NCT00321932|526486214|FG000|Overall Study|Death|3|||
145992317|NCT00321932|526486215|FG001|Overall Study|Death|6|||
145992318|NCT00321932|526486214|FG000|Overall Study|Withdrawal by Subject|3|||
145992319|NCT00321932|526486215|FG001|Overall Study|Withdrawal by Subject|6|||
145992320|NCT00321932|526486214|FG000|Overall Study|Early relapse|2|||
145992321|NCT00321932|526486215|FG001|Overall Study|Early relapse|8|||
145992322|NCT00321932|526486214|FG000|Overall Study|Missing data|2|||
145992323|NCT00321932|526486215|FG001|Overall Study|Missing data|1|||
145992324|NCT00734032|526486216|FG000|Overall Study|Adverse Event|0|||
145992325|NCT00734032|526486217|FG001|Overall Study|Adverse Event|1|||
145992326|NCT00734032|526486218|FG002|Overall Study|Adverse Event|0|||
145992327|NCT00734032|526486219|FG003|Overall Study|Adverse Event|0|||
145992328|NCT02367885|526486224|FG000|Overall Study|Lost to Follow-up|1|||
145992329|NCT02367885|526486225|FG001|Overall Study|Lost to Follow-up|0|||
145992330|NCT02367885|526486226|FG002|Overall Study|Lost to Follow-up|0|||
145992331|NCT02367885|526486224|FG000|Overall Study|Withdrawal by Subject|1|||
145992332|NCT02367885|526486225|FG001|Overall Study|Withdrawal by Subject|0|||
145992333|NCT02367885|526486226|FG002|Overall Study|Withdrawal by Subject|0|||
145992334|NCT01602484|526486227|FG000|Overall Study|Airway issues unrelated to study|0|||
145992335|NCT01602484|526486228|FG001|Overall Study|Airway issues unrelated to study|1|||
145992336|NCT01378195|526486229|FG000|Overall Study|Lost to Follow-up|29|||
145992337|NCT01378195|526486230|FG001|Overall Study|Lost to Follow-up|18|||
145992338|NCT03427619|526486231|FG000|Overall Study|Physician Decision|3|||
145992339|NCT03427619|526486231|FG000|Overall Study|Withdrawal by Subject|4|||
145992340|NCT03427619|526486231|FG000|Overall Study|Lost to Follow-up|5|||
145992341|NCT03427619|526486231|FG000|Overall Study|Administrative|4|||
145992342|NCT03427619|526486231|FG000|Overall Study|Other|2|||
145992343|NCT03427619|526486231|FG000|Overall Study|Unknown or Missing Completion Status|48|||
145992344|NCT05763381|526486237|FG000|Overall Study|Lost to Follow-up|2|||
145992345|NCT05763381|526486238|FG001|Overall Study|Lost to Follow-up|3|||
145992346|NCT05763381|526486237|FG000|Overall Study|Withdrawal by Subject|1|||
145992347|NCT05763381|526486238|FG001|Overall Study|Withdrawal by Subject|2|||
145992348|NCT03787615|526486242|FG000|Overall Study|Withdrawal by Subject|2|||
145992349|NCT03787615|526486242|FG000|Overall Study|Lost to Follow-up|2|||
145992350|NCT02697448|526486244|FG000|Overall Study|Protocol Violation|2|||
145992351|NCT02697448|526486245|FG001|Overall Study|Protocol Violation|4|||
145992352|NCT02697448|526486244|FG000|Overall Study|Clinical concerns during ablation|1|||
145992353|NCT02697448|526486245|FG001|Overall Study|Clinical concerns during ablation|1|||
145992354|NCT02697448|526486244|FG000|Overall Study|No data collected|2|||
145992355|NCT02697448|526486245|FG001|Overall Study|No data collected|0|||
145992356|NCT05418426|526486247|FG000|Overall Study|Adverse Event|0|||
145992357|NCT05418426|526486248|FG001|Overall Study|Adverse Event|1|||
145992358|NCT05418426|526486249|FG002|Overall Study|Adverse Event|0|||
145992359|NCT05418426|526486247|FG000|Overall Study|Withdrawal by Subject|0|||
145992360|NCT05418426|526486248|FG001|Overall Study|Withdrawal by Subject|1|||
145992361|NCT05418426|526486249|FG002|Overall Study|Withdrawal by Subject|0|||
145992362|NCT05418426|526486247|FG000|Overall Study|Protocol Violation|0|||
146246363|NCT00603798|527415683|FG001|Overall Study|Non-compliance with study procedures|1|||
146246364|NCT00603798|527415684|FG002|Overall Study|Non-compliance with study procedures|0|||
146246365|NCT00603798|527415682|FG000|Overall Study|Not due to AE|1|||
145992363|NCT05418426|526486248|FG001|Overall Study|Protocol Violation|0|||
145992364|NCT05418426|526486249|FG002|Overall Study|Protocol Violation|1|||
145992365|NCT01674062|526486250|FG000|Overall Study|Insufficient Therapeutic Response|56|||
145992366|NCT01674062|526486251|FG001|Overall Study|Insufficient Therapeutic Response|26|||
145992367|NCT01674062|526486250|FG000|Overall Study|Other|8|||
145992368|NCT01674062|526486251|FG001|Overall Study|Other|1|||
145992369|NCT01674062|526486250|FG000|Overall Study|Adverse Event|1|||
145992370|NCT01674062|526486251|FG001|Overall Study|Adverse Event|1|||
145992371|NCT01674062|526486250|FG000|Overall Study|Death|0|||
145992372|NCT01674062|526486251|FG001|Overall Study|Death|1|||
145992373|NCT01674062|526486250|FG000|Overall Study|Programming Error|1|||
145992374|NCT01674062|526486251|FG001|Overall Study|Programming Error|0|||
145992375|NCT04620668|526486252|FG000|Overall Study|Withdrawal by Subject|2|||
145992376|NCT04620668|526486253|FG001|Overall Study|Withdrawal by Subject|0|||
145992377|NCT04620668|526486252|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
145992378|NCT04620668|526486253|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
145992379|NCT04620668|526486252|FG000|Overall Study|Removed before analysis: missing data|2|||
145992380|NCT04620668|526486253|FG001|Overall Study|Removed before analysis: missing data|0|||
145992381|NCT04620668|526486252|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
145992382|NCT04620668|526486253|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
145992383|NCT04620668|526486252|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
145992384|NCT04620668|526486253|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
145992385|NCT02655601|526486254|FG000|Overall Study|Adverse Event|0|||
145992386|NCT02655601|526486255|FG001|Overall Study|Adverse Event|0|||
145992387|NCT02655601|526486256|FG002|Overall Study|Adverse Event|0|||
145992388|NCT02655601|526486257|FG003|Overall Study|Adverse Event|1|||
145992389|NCT02655601|526486258|FG004|Overall Study|Adverse Event|1|||
145992390|NCT02655601|526486259|FG005|Overall Study|Adverse Event|0|||
145992391|NCT02655601|526486254|FG000|Overall Study|Physician Decision|0|||
145992392|NCT02655601|526486255|FG001|Overall Study|Physician Decision|0|||
145992393|NCT02655601|526486256|FG002|Overall Study|Physician Decision|0|||
145992394|NCT02655601|526486257|FG003|Overall Study|Physician Decision|0|||
146246366|NCT00603798|527415683|FG001|Overall Study|Not due to AE|1|||
146246367|NCT00603798|527415684|FG002|Overall Study|Not due to AE|4|||
145992395|NCT02655601|526486258|FG004|Overall Study|Physician Decision|1|||
145992396|NCT02655601|526486259|FG005|Overall Study|Physician Decision|1|||
145992397|NCT02655601|526486254|FG000|Overall Study|Withdrawal by Subject|0|||
145992398|NCT02655601|526486255|FG001|Overall Study|Withdrawal by Subject|0|||
145992399|NCT02655601|526486256|FG002|Overall Study|Withdrawal by Subject|0|||
145992400|NCT02655601|526486257|FG003|Overall Study|Withdrawal by Subject|0|||
145992401|NCT02655601|526486258|FG004|Overall Study|Withdrawal by Subject|4|||
145992402|NCT02655601|526486259|FG005|Overall Study|Withdrawal by Subject|8|||
145992403|NCT02655601|526486254|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
146246368|NCT04361617|527415688|FG000|Overall Study|Withdrawal by Subject|0|||
146246369|NCT04361617|527415689|FG001|Overall Study|Withdrawal by Subject|1|||
145992404|NCT02655601|526486255|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145992405|NCT02655601|526486256|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145992406|NCT02655601|526486257|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145992407|NCT02655601|526486258|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145992408|NCT02655601|526486259|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145992409|NCT00829868|526486260|FG000|Washout|Physician Decision|1|||
145992410|NCT00829868|526486261|FG001|Washout|Physician Decision|0|||
145992411|NCT01969409|526486262|FG000|Overall Study|Death|2|||
145992412|NCT01969409|526486263|FG001|Overall Study|Death|2|||
145992413|NCT01969409|526486262|FG000|Overall Study|Transplant|1|||
145992414|NCT01969409|526486263|FG001|Overall Study|Transplant|1|||
145992415|NCT01969409|526486262|FG000|Overall Study|Withdrawal by Subject|0|||
145992416|NCT01969409|526486263|FG001|Overall Study|Withdrawal by Subject|1|||
145992417|NCT02799043|526486264|FG000|Overall Study|Adverse Event|0|||
145992418|NCT02799043|526486265|FG001|Overall Study|Adverse Event|1|||
145992419|NCT02799043|526486264|FG000|Overall Study|Death|1|||
145992420|NCT02799043|526486265|FG001|Overall Study|Death|1|||
145992421|NCT02799043|526486264|FG000|Overall Study|Lost to Follow-up|3|||
145992422|NCT02799043|526486265|FG001|Overall Study|Lost to Follow-up|6|||
145992423|NCT02799043|526486264|FG000|Overall Study|Withdrawal by Subject|4|||
145992424|NCT02799043|526486265|FG001|Overall Study|Withdrawal by Subject|4|||
145992425|NCT02799043|526486264|FG000|Overall Study|Moved to different country|0|||
145992426|NCT02799043|526486265|FG001|Overall Study|Moved to different country|1|||
145992427|NCT02799043|526486264|FG000|Overall Study|Trial Screen Failure|1|||
145992428|NCT02799043|526486265|FG001|Overall Study|Trial Screen Failure|0|||
145992429|NCT02799043|526486264|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
145992430|NCT02799043|526486265|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
145992431|NCT01554904|526486266|FG000|Overall Study|Withdrawal by Subject|3|||
145992432|NCT01554904|526486266|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
145992433|NCT01051661|526486269|FG000|Overall Study|Adverse Event|1|||
145992434|NCT01051661|526486270|FG001|Overall Study|Adverse Event|1|||
145992435|NCT01051661|526486271|FG002|Overall Study|Adverse Event|1|||
145992436|NCT01051661|526486272|FG003|Overall Study|Adverse Event|1|||
145992437|NCT01051661|526486273|FG004|Overall Study|Adverse Event|0|||
145992438|NCT01051661|526486274|FG005|Overall Study|Adverse Event|0|||
145992439|NCT01051661|526486269|FG000|Overall Study|Lost to Follow-up|13|||
145992440|NCT01051661|526486270|FG001|Overall Study|Lost to Follow-up|22|||
145992441|NCT01051661|526486271|FG002|Overall Study|Lost to Follow-up|15|||
145992442|NCT01051661|526486272|FG003|Overall Study|Lost to Follow-up|17|||
145992443|NCT01051661|526486273|FG004|Overall Study|Lost to Follow-up|10|||
145992444|NCT01051661|526486274|FG005|Overall Study|Lost to Follow-up|24|||
145992445|NCT01051661|526486269|FG000|Overall Study|Migrated/moved from study area|1|||
145992446|NCT01051661|526486270|FG001|Overall Study|Migrated/moved from study area|6|||
145992447|NCT01051661|526486271|FG002|Overall Study|Migrated/moved from study area|6|||
145992448|NCT01051661|526486272|FG003|Overall Study|Migrated/moved from study area|8|||
145992449|NCT01051661|526486273|FG004|Overall Study|Migrated/moved from study area|7|||
145992450|NCT01051661|526486274|FG005|Overall Study|Migrated/moved from study area|3|||
145992451|NCT01051661|526486269|FG000|Overall Study|Refused blood sampling|0|||
145992452|NCT01051661|526486270|FG001|Overall Study|Refused blood sampling|0|||
145992453|NCT01051661|526486271|FG002|Overall Study|Refused blood sampling|0|||
145992454|NCT01051661|526486272|FG003|Overall Study|Refused blood sampling|0|||
145992455|NCT01051661|526486273|FG004|Overall Study|Refused blood sampling|0|||
145992456|NCT01051661|526486274|FG005|Overall Study|Refused blood sampling|1|||
145992457|NCT01051661|526486269|FG000|Overall Study|Data not reliable|1|||
145992458|NCT01051661|526486270|FG001|Overall Study|Data not reliable|0|||
145992459|NCT01051661|526486271|FG002|Overall Study|Data not reliable|0|||
145992460|NCT01051661|526486272|FG003|Overall Study|Data not reliable|0|||
145992461|NCT01051661|526486273|FG004|Overall Study|Data not reliable|0|||
145992462|NCT01051661|526486274|FG005|Overall Study|Data not reliable|1|||
145992463|NCT01051661|526486269|FG000|Overall Study|Unable to attend visit(s)|2|||
145992464|NCT01051661|526486270|FG001|Overall Study|Unable to attend visit(s)|4|||
145992465|NCT01051661|526486271|FG002|Overall Study|Unable to attend visit(s)|2|||
145992466|NCT01051661|526486272|FG003|Overall Study|Unable to attend visit(s)|1|||
145992467|NCT01051661|526486273|FG004|Overall Study|Unable to attend visit(s)|3|||
145992468|NCT01051661|526486274|FG005|Overall Study|Unable to attend visit(s)|2|||
145992469|NCT01051661|526486269|FG000|Overall Study|Consent not received from both parents|0|||
145992470|NCT01051661|526486270|FG001|Overall Study|Consent not received from both parents|0|||
145992471|NCT01051661|526486271|FG002|Overall Study|Consent not received from both parents|0|||
145992472|NCT01051661|526486272|FG003|Overall Study|Consent not received from both parents|0|||
145992473|NCT01051661|526486273|FG004|Overall Study|Consent not received from both parents|0|||
145992474|NCT01051661|526486274|FG005|Overall Study|Consent not received from both parents|1|||
145992475|NCT01051661|526486269|FG000|Overall Study|Failure to comply with protocol|0|||
145992476|NCT01051661|526486270|FG001|Overall Study|Failure to comply with protocol|0|||
145992477|NCT01051661|526486271|FG002|Overall Study|Failure to comply with protocol|2|||
146246370|NCT02005484|527415691|FG000|Overall Study|Death|1|||
146246371|NCT02005484|527415691|FG000|Overall Study|Disease progression|1|||
146246372|NCT02005484|527415691|FG000|Overall Study|Changed to a Different Study|1|||
146246373|NCT02005484|527415691|FG000|Overall Study|Sponsor decision|1|||
146246374|NCT02584257|527415697|FG000|Period 1|Withdrawal by Subject|0|||
146246375|NCT02584257|527415698|FG001|Period 1|Withdrawal by Subject|0|||
146246376|NCT02584257|527415699|FG002|Period 1|Withdrawal by Subject|0|||
146246377|NCT02584257|527415700|FG003|Period 1|Withdrawal by Subject|0|||
146246378|NCT02584257|527415701|FG004|Period 1|Withdrawal by Subject|0|||
146246379|NCT02584257|527415702|FG005|Period 1|Withdrawal by Subject|0|||
146246380|NCT02584257|527415703|FG006|Period 1|Withdrawal by Subject|1|||
145992478|NCT01051661|526486272|FG003|Overall Study|Failure to comply with protocol|0|||
145992479|NCT01051661|526486273|FG004|Overall Study|Failure to comply with protocol|0|||
145992480|NCT01051661|526486274|FG005|Overall Study|Failure to comply with protocol|0|||
145992481|NCT01051661|526486269|FG000|Overall Study|Subject lost legal representation|0|||
145992482|NCT01051661|526486270|FG001|Overall Study|Subject lost legal representation|0|||
145992483|NCT01051661|526486271|FG002|Overall Study|Subject lost legal representation|0|||
145992484|NCT01051661|526486272|FG003|Overall Study|Subject lost legal representation|0|||
145992485|NCT01051661|526486273|FG004|Overall Study|Subject lost legal representation|1|||
145992486|NCT01051661|526486274|FG005|Overall Study|Subject lost legal representation|0|||
145992487|NCT01051661|526486269|FG000|Overall Study|Protocol Violation|0|||
145992488|NCT01051661|526486270|FG001|Overall Study|Protocol Violation|0|||
145992489|NCT01051661|526486271|FG002|Overall Study|Protocol Violation|0|||
146246381|NCT02584257|527415704|FG007|Period 1|Withdrawal by Subject|0|||
146246382|NCT02584257|527415705|FG008|Period 1|Withdrawal by Subject|0|||
145992490|NCT01051661|526486272|FG003|Overall Study|Protocol Violation|1|||
145992491|NCT01051661|526486273|FG004|Overall Study|Protocol Violation|2|||
145992492|NCT01051661|526486274|FG005|Overall Study|Protocol Violation|1|||
145992493|NCT01051661|526486269|FG000|Overall Study|Withdrawal by Subject|16|||
145992494|NCT01051661|526486270|FG001|Overall Study|Withdrawal by Subject|30|||
145992495|NCT01051661|526486271|FG002|Overall Study|Withdrawal by Subject|13|||
145992496|NCT01051661|526486272|FG003|Overall Study|Withdrawal by Subject|28|||
145992497|NCT01051661|526486273|FG004|Overall Study|Withdrawal by Subject|12|||
145992498|NCT01051661|526486274|FG005|Overall Study|Withdrawal by Subject|34|||
145992499|NCT01916226|526486275|FG000|Overall Study|Adverse Event|1|||
145992500|NCT01916226|526486276|FG001|Overall Study|Adverse Event|0|||
145992501|NCT01916226|526486277|FG002|Overall Study|Adverse Event|1|||
145992502|NCT01916226|526486278|FG003|Overall Study|Adverse Event|1|||
145992503|NCT01916226|526486275|FG000|Overall Study|Lack of Efficacy|0|||
145992504|NCT01916226|526486276|FG001|Overall Study|Lack of Efficacy|0|||
145992505|NCT01916226|526486277|FG002|Overall Study|Lack of Efficacy|2|||
145992506|NCT01916226|526486278|FG003|Overall Study|Lack of Efficacy|1|||
145992507|NCT01916226|526486275|FG000|Overall Study|Protocol Violation|0|||
145992508|NCT01916226|526486276|FG001|Overall Study|Protocol Violation|1|||
145992509|NCT01916226|526486277|FG002|Overall Study|Protocol Violation|0|||
145992510|NCT01916226|526486278|FG003|Overall Study|Protocol Violation|1|||
145992511|NCT01916226|526486275|FG000|Overall Study|Physician Decision|0|||
145992512|NCT01916226|526486276|FG001|Overall Study|Physician Decision|0|||
145992513|NCT01916226|526486277|FG002|Overall Study|Physician Decision|0|||
145992514|NCT01916226|526486278|FG003|Overall Study|Physician Decision|1|||
145992515|NCT00680914|526486281|FG000|Overall Study|Consent withdrawal|6|||
145992516|NCT00680914|526486282|FG001|Overall Study|Consent withdrawal|3|||
145992517|NCT00680914|526486281|FG000|Overall Study|Lost to Follow-up|4|||
145992518|NCT00680914|526486282|FG001|Overall Study|Lost to Follow-up|0|||
145992519|NCT00680914|526486281|FG000|Overall Study|serious adverse event (SAE)|0|||
145992520|NCT00680914|526486282|FG001|Overall Study|serious adverse event (SAE)|1|||
145992521|NCT01848457|526486283|FG000|Overall Study|Death|1|||
146246383|NCT02584257|527415697|FG000|Period 2|Physician Decision|1|||
145992522|NCT01848457|526486284|FG001|Overall Study|Death|0|||
145992523|NCT01848457|526486285|FG002|Overall Study|Death|0|||
145992524|NCT01848457|526486286|FG003|Overall Study|Death|0|||
145992525|NCT00421408|526486287|FG000|Overall Study|Lost to Follow-up|30|||
145992526|NCT00421408|526486288|FG001|Overall Study|Lost to Follow-up|20|||
145992527|NCT00421408|526486287|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
145992528|NCT00421408|526486288|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
145992529|NCT00787800|526486291|FG000|Overall Study|Withdrawal by Subject|3|||
145992530|NCT00787800|526486292|FG001|Overall Study|Withdrawal by Subject|5|||
145992531|NCT00787800|526486291|FG000|Overall Study|Death|0|||
145992532|NCT00787800|526486292|FG001|Overall Study|Death|2|||
145992533|NCT04309500|526486296|FG000|Overall Study|Lost to Follow-up|1|||
145992534|NCT04309500|526486297|FG001|Overall Study|Lost to Follow-up|0|||
146246384|NCT02584257|527415698|FG001|Period 2|Physician Decision|0|||
145992535|NCT04309500|526486298|FG002|Overall Study|Lost to Follow-up|0|||
145992536|NCT04309500|526486299|FG003|Overall Study|Lost to Follow-up|0|||
145992537|NCT00913835|526486301|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
145992538|NCT00913835|526486302|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
146246385|NCT02584257|527415699|FG002|Period 2|Physician Decision|0|||
146246386|NCT02584257|527415700|FG003|Period 2|Physician Decision|0|||
145992539|NCT00913835|526486301|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
145992540|NCT00913835|526486302|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
145992541|NCT00913835|526486301|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
145992542|NCT00913835|526486302|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
145992543|NCT00913835|526486301|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
145992544|NCT00913835|526486302|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
145992545|NCT00913835|526486301|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
146091649|NCT01323946|526856856|FG001|Overall Study|Parents refused the last blood draw|0|||
145992546|NCT00913835|526486302|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
145992547|NCT00773461|526486303|FG000|Overall Study|Adverse Event|1|||
145992548|NCT00773461|526486304|FG001|Overall Study|Adverse Event|3|||
145992549|NCT00773461|526486303|FG000|Overall Study|Withdrawal by Subject|4|||
145992550|NCT00773461|526486304|FG001|Overall Study|Withdrawal by Subject|1|||
145992551|NCT00637156|526486307|FG000|Overall Study|Withdrawal by Subject|0|||
145992552|NCT00637156|526486308|FG001|Overall Study|Withdrawal by Subject|7|||
145992553|NCT00637156|526486307|FG000|Overall Study|Death|0|||
145992554|NCT00637156|526486308|FG001|Overall Study|Death|1|||
145992555|NCT00637156|526486307|FG000|Overall Study|Lost to Follow-up|10|||
145992556|NCT00637156|526486308|FG001|Overall Study|Lost to Follow-up|16|||
145992557|NCT00461812|526486309|FG000|Overall Study|study terminated|10|||
145992558|NCT01308788|526486310|FG000|2-year Treatment|medication change by treating physician|4|||
145992559|NCT01308788|526486311|FG001|2-year Treatment|medication change by treating physician|11|||
145992560|NCT00322218|526486312|FG000|Overall Study|Death|3|||
145992561|NCT00322218|526486313|FG001|Overall Study|Death|6|||
145992562|NCT03193437|526486320|FG000|Overall Study|Adverse Event|4|||
145992563|NCT03193437|526486320|FG000|Overall Study|Withdrawal by Subject|2|||
145992564|NCT03193437|526486320|FG000|Overall Study|Disease Progression|2|||
145992565|NCT02414841|526486323|FG000|Overall Study|Withdrawal by Subject|7|||
145992566|NCT02414841|526486324|FG001|Overall Study|Withdrawal by Subject|5|||
145992567|NCT02414841|526486323|FG000|Overall Study|Lost to Follow-up|13|||
145992568|NCT02414841|526486324|FG001|Overall Study|Lost to Follow-up|6|||
145992569|NCT02414841|526486323|FG000|Overall Study|Death|17|||
145992570|NCT02414841|526486324|FG001|Overall Study|Death|14|||
145992571|NCT02414841|526486323|FG000|Overall Study|Received a Kidney Transplant|13|||
145992572|NCT02414841|526486324|FG001|Overall Study|Received a Kidney Transplant|4|||
145992573|NCT02414841|526486323|FG000|Overall Study|Randomized But Not Treated|6|||
145992574|NCT02414841|526486324|FG001|Overall Study|Randomized But Not Treated|4|||
145992575|NCT03941093|526486334|FG000|Overall Study|Protocol Violation|0|||
145992576|NCT03941093|526486335|FG001|Overall Study|Protocol Violation|1|||
145992577|NCT03941093|526486334|FG000|Overall Study|Withdrawal by Subject|9|||
145992578|NCT03941093|526486335|FG001|Overall Study|Withdrawal by Subject|6|||
145992579|NCT02301897|526488162|FG000|Treatment Course 1|Non-Compliance|0|||
145992580|NCT02301897|526488163|FG001|Treatment Course 1|Non-Compliance|0|||
145992581|NCT02301897|526488164|FG002|Treatment Course 1|Non-Compliance|1|||
145992582|NCT02301897|526488162|FG000|Treatment Course 1|Adverse Event|1|||
145992583|NCT02301897|526488163|FG001|Treatment Course 1|Adverse Event|1|||
145992584|NCT02301897|526488164|FG002|Treatment Course 1|Adverse Event|0|||
145992585|NCT02301897|526488162|FG000|Treatment Course 1|Lost to Follow-up|1|||
145992586|NCT02301897|526488163|FG001|Treatment Course 1|Lost to Follow-up|2|||
145992587|NCT02301897|526488164|FG002|Treatment Course 1|Lost to Follow-up|1|||
145992588|NCT02301897|526488162|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
145992589|NCT02301897|526488163|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
145992590|NCT02301897|526488164|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
145992591|NCT02301897|526488162|FG000|Treatment Course 1|Withdrawal by Subject|0|||
145992592|NCT02301897|526488163|FG001|Treatment Course 1|Withdrawal by Subject|0|||
145992593|NCT02301897|526488164|FG002|Treatment Course 1|Withdrawal by Subject|2|||
145992594|NCT02301897|526488162|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
145992595|NCT02301897|526488163|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
145992596|NCT02301897|526488164|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
145992597|NCT02301897|526488162|FG000|Treatment Course 2|Lost to Follow-up|0|||
145992598|NCT02301897|526488163|FG001|Treatment Course 2|Lost to Follow-up|2|||
145992599|NCT02301897|526488164|FG002|Treatment Course 2|Lost to Follow-up|0|||
145992600|NCT02301897|526488162|FG000|Treatment Course 2|Pregnancy|0|||
145992601|NCT02301897|526488163|FG001|Treatment Course 2|Pregnancy|1|||
145992602|NCT02301897|526488164|FG002|Treatment Course 2|Pregnancy|1|||
145992603|NCT02301897|526488162|FG000|Treatment Course 2|Withdrawal by Subject|0|||
145992604|NCT02301897|526488163|FG001|Treatment Course 2|Withdrawal by Subject|2|||
145992605|NCT02301897|526488164|FG002|Treatment Course 2|Withdrawal by Subject|0|||
145992606|NCT02301897|526488162|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
145992607|NCT02301897|526488163|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
145992608|NCT02301897|526488164|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
145992609|NCT00337168|526488165|FG000|Overall Study|Death|5|||
145992610|NCT00337168|526488165|FG000|Overall Study|Not protocol specified|2|||
145992611|NCT00337168|526488165|FG000|Overall Study|Did not start therapy|1|||
146091650|NCT01323946|526856857|FG002|Overall Study|Parents refused the last blood draw|0|||
146091651|NCT01323946|526856855|FG000|Overall Study|Withdrawal by Subject|2|||
145992612|NCT01225952|526488166|FG000|Overall Study|Lost to Follow-up|1|||
145992613|NCT01225952|526488167|FG001|Overall Study|Lost to Follow-up|0|||
145992614|NCT01225952|526488168|FG002|Overall Study|Lost to Follow-up|0|||
145992615|NCT01225952|526488166|FG000|Overall Study|Study Eye Explanted|0|||
145992616|NCT01225952|526488167|FG001|Overall Study|Study Eye Explanted|0|||
145992617|NCT01225952|526488168|FG002|Overall Study|Study Eye Explanted|1|||
145992618|NCT01225952|526488166|FG000|Overall Study|Withdrawal by Subject|4|||
145992619|NCT01225952|526488167|FG001|Overall Study|Withdrawal by Subject|4|||
145992620|NCT01225952|526488168|FG002|Overall Study|Withdrawal by Subject|5|||
145992621|NCT01225952|526488166|FG000|Overall Study|Surgical complications|1|||
145992622|NCT01225952|526488167|FG001|Overall Study|Surgical complications|0|||
145992623|NCT01225952|526488168|FG002|Overall Study|Surgical complications|0|||
145992624|NCT01217892|526488172|FG000|Overall Study|Adverse Event|1|||
145992625|NCT01217892|526488173|FG001|Overall Study|Adverse Event|1|||
145992626|NCT01217892|526488174|FG002|Overall Study|Adverse Event|1|||
145992627|NCT01217892|526488175|FG003|Overall Study|Adverse Event|0|||
145992628|NCT01217892|526488172|FG000|Overall Study|Withdrawal by Subject|0|||
145992629|NCT01217892|526488173|FG001|Overall Study|Withdrawal by Subject|2|||
145992630|NCT01217892|526488174|FG002|Overall Study|Withdrawal by Subject|1|||
145992631|NCT01217892|526488175|FG003|Overall Study|Withdrawal by Subject|0|||
145992632|NCT01217892|526488172|FG000|Overall Study|Lab value|1|||
145992633|NCT01217892|526488173|FG001|Overall Study|Lab value|0|||
145992634|NCT01217892|526488174|FG002|Overall Study|Lab value|1|||
145992635|NCT01217892|526488175|FG003|Overall Study|Lab value|0|||
145992636|NCT01217892|526488172|FG000|Overall Study|Subject no longer meets study criteria|5|||
145992637|NCT01217892|526488173|FG001|Overall Study|Subject no longer meets study criteria|2|||
145992638|NCT01217892|526488174|FG002|Overall Study|Subject no longer meets study criteria|4|||
145992639|NCT01217892|526488175|FG003|Overall Study|Subject no longer meets study criteria|8|||
145992640|NCT01217892|526488172|FG000|Overall Study|Incorrect enrollment|0|||
145992641|NCT01217892|526488173|FG001|Overall Study|Incorrect enrollment|1|||
145992642|NCT01217892|526488174|FG002|Overall Study|Incorrect enrollment|1|||
145992643|NCT01217892|526488175|FG003|Overall Study|Incorrect enrollment|0|||
145992644|NCT01217892|526488172|FG000|Overall Study|Poor/Non-Compliance|0|||
145992645|NCT01217892|526488173|FG001|Overall Study|Poor/Non-Compliance|0|||
145992646|NCT01217892|526488174|FG002|Overall Study|Poor/Non-Compliance|1|||
145992647|NCT01217892|526488175|FG003|Overall Study|Poor/Non-Compliance|0|||
145992648|NCT01052779|526488176|FG000|Overall Study|Adverse Event|1|||
145992649|NCT01052779|526488177|FG001|Overall Study|Adverse Event|4|||
145992650|NCT01052779|526488176|FG000|Overall Study|Withdrawal by Subject|1|||
145992651|NCT01052779|526488177|FG001|Overall Study|Withdrawal by Subject|2|||
145992652|NCT01052779|526488176|FG000|Overall Study|Other-Protocol Violation|1|||
145992653|NCT01052779|526488177|FG001|Overall Study|Other-Protocol Violation|1|||
145992654|NCT01052779|526488176|FG000|Overall Study|Other-Surgery|0|||
145992655|NCT01052779|526488177|FG001|Overall Study|Other-Surgery|2|||
145992656|NCT01052779|526488176|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
145992657|NCT01052779|526488177|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
145992658|NCT03663582|526488178|FG000|Overall Study|Physician Decision|1|||
145992659|NCT02853136|526488179|FG000|Wash-out|Adverse Event|0|||
145992660|NCT02853136|526488180|FG001|Wash-out|Adverse Event|0|||
145992661|NCT02853136|526488181|FG002|Wash-out|Adverse Event|0|||
145992662|NCT02853136|526488182|FG003|Wash-out|Adverse Event|1|||
145992663|NCT00841815|526488183|FG000|Washout|Withdrawal by Subject|0|||
145992664|NCT00841815|526488184|FG001|Washout|Withdrawal by Subject|1|||
145992665|NCT03729609|526488185|FG000|Overall Study|Protocol Violation|1|||
145992666|NCT03412929|526488190|FG000|Overall Study|Protocol Violation|3|||
145992667|NCT00605189|526488191|FG000|Overall Study|Adverse Event|1|||
145992668|NCT00605189|526488192|FG001|Overall Study|Adverse Event|0|||
145992669|NCT00605189|526488193|FG002|Overall Study|Adverse Event|0|||
145992670|NCT00605189|526488191|FG000|Overall Study|Other|2|||
145992671|NCT00605189|526488192|FG001|Overall Study|Other|2|||
145992672|NCT00605189|526488193|FG002|Overall Study|Other|0|||
145992673|NCT03685149|526488194|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
145992674|NCT03685149|526488195|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
145992675|NCT03685149|526488194|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146246387|NCT02584257|527415701|FG004|Period 2|Physician Decision|0|||
145992676|NCT03685149|526488195|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145992677|NCT03685149|526488194|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
145992678|NCT03685149|526488195|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
145992679|NCT01922895|526488197|FG000|Overall Study|Death|0|||
145992680|NCT01922895|526488198|FG001|Overall Study|Death|1|||
145992681|NCT01922895|526488197|FG000|Overall Study|Withdrawal by Subject|1|||
145992682|NCT01922895|526488198|FG001|Overall Study|Withdrawal by Subject|2|||
145992683|NCT01922895|526488197|FG000|Overall Study|Lost to Follow-up|5|||
145992684|NCT01922895|526488198|FG001|Overall Study|Lost to Follow-up|11|||
145992685|NCT05142306|526488201|FG000|Overall Study|Withdrawal by Subject|0|||
145992686|NCT05142306|526488202|FG001|Overall Study|Withdrawal by Subject|0|||
145992687|NCT05142306|526488203|FG002|Overall Study|Withdrawal by Subject|1|||
145992688|NCT04079920|526488204|FG000|Overall Study|Adverse event, not related to study drug|2|||
145992689|NCT04079920|526488204|FG000|Overall Study|Adverse event related to study drug|10|||
145992690|NCT04079920|526488204|FG000|Overall Study|Death|2|||
145992691|NCT04079920|526488204|FG000|Overall Study|Lost to Follow-up|22|||
145992692|NCT04079920|526488204|FG000|Overall Study|Physician Decision|1|||
145992693|NCT04079920|526488204|FG000|Overall Study|Withdrawal by Subject|11|||
145992694|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
145992695|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
146246388|NCT02584257|527415702|FG005|Period 2|Physician Decision|0|||
146246389|NCT02584257|527415703|FG006|Period 2|Physician Decision|0|||
146246390|NCT02584257|527415704|FG007|Period 2|Physician Decision|0|||
145992696|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
145992697|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
145992698|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
145992699|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
145992700|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
145992701|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
145992702|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
145992703|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
145992704|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145992705|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145992706|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
145992707|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
145992708|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
145992709|NCT05014919|526488207|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
145992710|NCT05014919|526488208|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
145992711|NCT05014919|526488209|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
145992712|NCT05014919|526488207|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
145992713|NCT05014919|526488208|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
145992714|NCT05014919|526488209|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
145992715|NCT05014919|526488207|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145992716|NCT05014919|526488208|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
145992717|NCT05014919|526488209|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
145992718|NCT05305651|526488210|FG000|Overall Study|Death|1|||
145992719|NCT05305651|526488210|FG000|Overall Study|Withdrawal by Subject|4|||
145992720|NCT05305651|526488210|FG000|Overall Study|Lost to Follow-up|4|||
145992721|NCT00522379|526488211|FG000|Overall Study|Adverse Event|12|||
145992722|NCT00522379|526488212|FG001|Overall Study|Adverse Event|15|||
145992723|NCT00522379|526488213|FG002|Overall Study|Adverse Event|12|||
145992724|NCT00522379|526488214|FG003|Overall Study|Adverse Event|5|||
145992725|NCT00522379|526488215|FG004|Overall Study|Adverse Event|17|||
145992726|NCT00522379|526488211|FG000|Overall Study|Lack of Efficacy|3|||
145992727|NCT00522379|526488212|FG001|Overall Study|Lack of Efficacy|0|||
145992728|NCT00522379|526488213|FG002|Overall Study|Lack of Efficacy|2|||
145992729|NCT00522379|526488214|FG003|Overall Study|Lack of Efficacy|2|||
145992730|NCT00522379|526488215|FG004|Overall Study|Lack of Efficacy|7|||
145992731|NCT00522379|526488211|FG000|Overall Study|Withdrawal by Subject|2|||
145992732|NCT00522379|526488212|FG001|Overall Study|Withdrawal by Subject|3|||
145992733|NCT00522379|526488213|FG002|Overall Study|Withdrawal by Subject|1|||
145992734|NCT00522379|526488214|FG003|Overall Study|Withdrawal by Subject|2|||
145992735|NCT00522379|526488215|FG004|Overall Study|Withdrawal by Subject|0|||
145992736|NCT00522379|526488211|FG000|Overall Study|Protocol Violation|1|||
145992737|NCT00522379|526488212|FG001|Overall Study|Protocol Violation|1|||
145992738|NCT00522379|526488213|FG002|Overall Study|Protocol Violation|2|||
145992739|NCT00522379|526488214|FG003|Overall Study|Protocol Violation|0|||
145992740|NCT00522379|526488215|FG004|Overall Study|Protocol Violation|0|||
145992741|NCT00522379|526488211|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
145992742|NCT00522379|526488212|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
145992743|NCT00522379|526488213|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
145992744|NCT00522379|526488214|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
145992745|NCT00522379|526488215|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
145992746|NCT00522379|526488211|FG000|Overall Study|Lost to Follow-up|1|||
145992747|NCT00522379|526488212|FG001|Overall Study|Lost to Follow-up|0|||
145992748|NCT00522379|526488213|FG002|Overall Study|Lost to Follow-up|4|||
145992749|NCT00522379|526488214|FG003|Overall Study|Lost to Follow-up|2|||
145992750|NCT00522379|526488215|FG004|Overall Study|Lost to Follow-up|2|||
145992751|NCT00522379|526488211|FG000|Overall Study|Randomization error|0|||
145992752|NCT00522379|526488212|FG001|Overall Study|Randomization error|0|||
145992753|NCT00522379|526488213|FG002|Overall Study|Randomization error|0|||
145992754|NCT00522379|526488214|FG003|Overall Study|Randomization error|0|||
145992755|NCT00522379|526488215|FG004|Overall Study|Randomization error|1|||
145992756|NCT00522379|526488211|FG000|Overall Study|Dispensing error|1|||
145992757|NCT00522379|526488212|FG001|Overall Study|Dispensing error|0|||
145992758|NCT00522379|526488213|FG002|Overall Study|Dispensing error|0|||
146246391|NCT02584257|527415705|FG008|Period 2|Physician Decision|0|||
145992759|NCT00522379|526488214|FG003|Overall Study|Dispensing error|1|||
145992760|NCT00522379|526488215|FG004|Overall Study|Dispensing error|0|||
145992761|NCT00522379|526488211|FG000|Overall Study|Subject Moved|1|||
145992762|NCT00522379|526488212|FG001|Overall Study|Subject Moved|1|||
145992763|NCT00522379|526488213|FG002|Overall Study|Subject Moved|0|||
145992764|NCT00522379|526488214|FG003|Overall Study|Subject Moved|0|||
145992765|NCT00522379|526488215|FG004|Overall Study|Subject Moved|0|||
145992766|NCT00522379|526488211|FG000|Overall Study|Sponsor Request|0|||
145992767|NCT00522379|526488212|FG001|Overall Study|Sponsor Request|1|||
145992768|NCT00522379|526488213|FG002|Overall Study|Sponsor Request|0|||
145992769|NCT00522379|526488214|FG003|Overall Study|Sponsor Request|0|||
145992770|NCT00522379|526488215|FG004|Overall Study|Sponsor Request|0|||
145992771|NCT00522379|526488211|FG000|Overall Study|Family Problem|0|||
145992772|NCT00522379|526488212|FG001|Overall Study|Family Problem|0|||
145992773|NCT00522379|526488213|FG002|Overall Study|Family Problem|1|||
145992774|NCT00522379|526488214|FG003|Overall Study|Family Problem|0|||
145992775|NCT00522379|526488215|FG004|Overall Study|Family Problem|0|||
145992776|NCT00522379|526488211|FG000|Overall Study|Site Closed|0|||
145992777|NCT00522379|526488212|FG001|Overall Study|Site Closed|0|||
145992778|NCT00522379|526488213|FG002|Overall Study|Site Closed|0|||
145992779|NCT00522379|526488214|FG003|Overall Study|Site Closed|1|||
145992780|NCT00522379|526488215|FG004|Overall Study|Site Closed|0|||
145992781|NCT00522379|526488211|FG000|Overall Study|Subject Withdrawal|0|||
145992782|NCT00522379|526488212|FG001|Overall Study|Subject Withdrawal|0|||
145992783|NCT00522379|526488213|FG002|Overall Study|Subject Withdrawal|0|||
145992784|NCT00522379|526488214|FG003|Overall Study|Subject Withdrawal|1|||
145992785|NCT00522379|526488215|FG004|Overall Study|Subject Withdrawal|0|||
145992786|NCT00967499|526488216|FG000|Overall Study|Adverse Event|0|||
145992787|NCT00967499|526488217|FG001|Overall Study|Adverse Event|1|||
145992788|NCT00967499|526488216|FG000|Overall Study|Protocol Violation|1|||
145992789|NCT00967499|526488217|FG001|Overall Study|Protocol Violation|0|||
145992790|NCT00967499|526488216|FG000|Overall Study|Sponsor Decision|1|||
145992791|NCT00967499|526488217|FG001|Overall Study|Sponsor Decision|0|||
145992792|NCT00967499|526488216|FG000|Overall Study|Randomized but not treated|63|||
145992793|NCT00967499|526488217|FG001|Overall Study|Randomized but not treated|59|||
145992794|NCT02298946|526488221|FG000|Overall Study|Did not receive treatment|2|||
145992795|NCT02298946|526488222|FG001|Overall Study|Did not receive treatment|0|||
145992796|NCT02298946|526488221|FG000|Overall Study|Unevaluable|2|||
145992797|NCT02298946|526488222|FG001|Overall Study|Unevaluable|1|||
145992798|NCT00050011|526488223|FG000|Overall Study|Adverse Event|41|||
145992799|NCT00050011|526488224|FG001|Overall Study|Adverse Event|46|||
145992800|NCT00050011|526488223|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145992801|NCT00050011|526488224|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145992802|NCT00050011|526488223|FG000|Overall Study|Abnormal test procedure results|0|||
145992803|NCT00050011|526488224|FG001|Overall Study|Abnormal test procedure results|1|||
145992804|NCT00050011|526488223|FG000|Overall Study|Lack of Efficacy|16|||
145992805|NCT00050011|526488224|FG001|Overall Study|Lack of Efficacy|21|||
145992806|NCT00050011|526488223|FG000|Overall Study|Participant condition no longer required|1|||
145992807|NCT00050011|526488224|FG001|Overall Study|Participant condition no longer required|0|||
145992808|NCT00050011|526488223|FG000|Overall Study|Protocol Violation|4|||
145992809|NCT00050011|526488224|FG001|Overall Study|Protocol Violation|10|||
145992810|NCT00050011|526488223|FG000|Overall Study|Withdrawal by Subject|34|||
145992811|NCT00050011|526488224|FG001|Overall Study|Withdrawal by Subject|26|||
145992812|NCT00050011|526488223|FG000|Overall Study|Lost to Follow-up|7|||
145992813|NCT00050011|526488224|FG001|Overall Study|Lost to Follow-up|9|||
145992814|NCT00050011|526488223|FG000|Overall Study|Administrative problems|10|||
145992815|NCT00050011|526488224|FG001|Overall Study|Administrative problems|6|||
145992816|NCT00050011|526488223|FG000|Overall Study|Death|7|||
145992817|NCT00050011|526488224|FG001|Overall Study|Death|4|||
145992818|NCT00050011|526488223|FG000|Overall Study|Unknown - Reason is missing|0|||
145992819|NCT00050011|526488224|FG001|Overall Study|Unknown - Reason is missing|2|||
145992820|NCT05535972|526488225|FG000|Overall Study|Withdrawal by Subject|31|||
145992821|NCT05535972|526488225|FG000|Overall Study|Lost to Follow-up|5|||
145992822|NCT05535972|526488225|FG000|Overall Study|Adverse Event|6|||
145992823|NCT05535972|526488225|FG000|Overall Study|Protocol Deviation|2|||
145992824|NCT04197583|526488228|FG000|Overall Study|Study Stent Replacement|34|||
145992825|NCT04197583|526488229|FG001|Overall Study|Study Stent Replacement|8|||
145992826|NCT04197583|526488228|FG000|Overall Study|Lost to Follow-up|14|||
145992827|NCT04197583|526488229|FG001|Overall Study|Lost to Follow-up|3|||
145992828|NCT04197583|526488228|FG000|Overall Study|Death|3|||
145992829|NCT04197583|526488229|FG001|Overall Study|Death|0|||
145992830|NCT04197583|526488228|FG000|Overall Study|Physician Decision|1|||
145992831|NCT04197583|526488229|FG001|Overall Study|Physician Decision|0|||
145992832|NCT04197583|526488228|FG000|Overall Study|Withdrawal by Subject|1|||
145992833|NCT04197583|526488229|FG001|Overall Study|Withdrawal by Subject|1|||
145992834|NCT04197583|526488228|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
145992835|NCT04197583|526488229|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
145992836|NCT04197583|526488228|FG000|Overall Study|Screen Failure|0|||
145992837|NCT04197583|526488229|FG001|Overall Study|Screen Failure|20|||
145992838|NCT04629196|526488230|FG000|Overall Study|Subject discontinued study drug|1|||
145992839|NCT04629196|526488231|FG001|Overall Study|Subject discontinued study drug|0|||
145992840|NCT04629196|526488230|FG000|Overall Study|Subject study drug dosing increased|1|||
145992841|NCT04629196|526488231|FG001|Overall Study|Subject study drug dosing increased|1|||
145992842|NCT04629196|526488230|FG000|Overall Study|Withdrawal by Subject|1|||
145992843|NCT04629196|526488231|FG001|Overall Study|Withdrawal by Subject|2|||
145992844|NCT01450631|526488235|FG000|Overall Study|Lost to Follow-up|2|||
145992845|NCT01450631|526488236|FG001|Overall Study|Lost to Follow-up|4|||
145992846|NCT01450631|526488235|FG000|Overall Study|Withdrawal by Subject|1|||
145992847|NCT01450631|526488236|FG001|Overall Study|Withdrawal by Subject|0|||
145992848|NCT00323622|526488239|FG000|Overall Study|Other|30|||
145992849|NCT00323622|526488240|FG001|Overall Study|Other|91|||
145992850|NCT00323622|526488241|FG002|Overall Study|Other|4|||
145992851|NCT00323622|526488242|FG003|Overall Study|Other|12|||
145992852|NCT00323622|526488243|FG004|Overall Study|Other|32|||
145992853|NCT00323622|526488244|FG005|Overall Study|Other|74|||
145992854|NCT00323622|526488245|FG006|Overall Study|Other|5|||
145992855|NCT00323622|526488246|FG007|Overall Study|Other|13|||
145992856|NCT00323622|526488239|FG000|Overall Study|Death|1|||
145992857|NCT00323622|526488240|FG001|Overall Study|Death|1|||
145992858|NCT00323622|526488241|FG002|Overall Study|Death|0|||
145992859|NCT00323622|526488242|FG003|Overall Study|Death|0|||
145992860|NCT00323622|526488243|FG004|Overall Study|Death|7|||
145992861|NCT00323622|526488244|FG005|Overall Study|Death|0|||
145992862|NCT00323622|526488245|FG006|Overall Study|Death|0|||
145992863|NCT00323622|526488246|FG007|Overall Study|Death|2|||
145992864|NCT00835354|526488247|FG000|First Intervention|Adverse Event|0|||
145992865|NCT00835354|526488248|FG001|First Intervention|Adverse Event|1|||
145992866|NCT01385995|526488253|FG000|Period 1, 2 Months|Physician Decision|1|||
145992867|NCT01385995|526488254|FG001|Period 1, 2 Months|Physician Decision|0|||
145992868|NCT00112385|526488255|FG000|Overall Study|Lost to Follow-up|1|||
145992869|NCT00112385|526488256|FG001|Overall Study|Lost to Follow-up|0|||
145992870|NCT00112385|526488255|FG000|Overall Study|Withdrawal by Subject|0|||
145992871|NCT00112385|526488256|FG001|Overall Study|Withdrawal by Subject|1|||
145992872|NCT00835172|526488272|FG000|Washout|Protocol Violation|0|||
145992873|NCT00835172|526488273|FG001|Washout|Protocol Violation|1|||
145992874|NCT02613507|526488275|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
145992875|NCT02613507|526488276|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
145992876|NCT02613507|526488275|FG000|Pre-Treamtent|Participant withdrew consent|0|||
145992877|NCT02613507|526488276|FG001|Pre-Treamtent|Participant withdrew consent|4|||
145992878|NCT02613507|526488275|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
145992879|NCT02613507|526488276|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
145992880|NCT02613507|526488275|FG000|Treatment|Not reported|3|||
145992881|NCT02613507|526488276|FG001|Treatment|Not reported|0|||
145992882|NCT02613507|526488275|FG000|Treatment|Other reasons|8|||
145992883|NCT02613507|526488276|FG001|Treatment|Other reasons|0|||
145992884|NCT02613507|526488275|FG000|Treatment|Participant no longer meets criteria|3|||
145992885|NCT02613507|526488276|FG001|Treatment|Participant no longer meets criteria|0|||
145992886|NCT02613507|526488275|FG000|Treatment|Maximum clinical benefit|5|||
145992887|NCT02613507|526488276|FG001|Treatment|Maximum clinical benefit|10|||
145992888|NCT02613507|526488275|FG000|Treatment|Lost to Follow-up|1|||
145992889|NCT02613507|526488276|FG001|Treatment|Lost to Follow-up|0|||
145992890|NCT02613507|526488275|FG000|Treatment|Participant withdrew consent|0|||
145992891|NCT02613507|526488276|FG001|Treatment|Participant withdrew consent|2|||
145992892|NCT02613507|526488275|FG000|Treatment|Participant request to discontinue study treatment|13|||
145992893|NCT02613507|526488276|FG001|Treatment|Participant request to discontinue study treatment|17|||
145992894|NCT02613507|526488275|FG000|Treatment|Adverse event unrelated to study drug|20|||
145992895|NCT02613507|526488276|FG001|Treatment|Adverse event unrelated to study drug|3|||
146091652|NCT01323946|526856856|FG001|Overall Study|Withdrawal by Subject|2|||
146091653|NCT01323946|526856857|FG002|Overall Study|Withdrawal by Subject|0|||
146091654|NCT02962765|526856860|FG000|Overall Study|Protocol Violation|9|||
146091655|NCT02962765|526856860|FG000|Overall Study|Withdrawal by Subject|3|||
146091656|NCT02962765|526856860|FG000|Overall Study|Lost to Follow-up|1|||
146091657|NCT02962765|526856860|FG000|Overall Study|Death|1|||
146091658|NCT02962765|526856860|FG000|Overall Study|Limited access to study medication|3|||
146091659|NCT00750880|526856865|FG000|Overall Study|Adverse Event|76|||
146091660|NCT00750880|526856865|FG000|Overall Study|Death|4|||
146091661|NCT00750880|526856865|FG000|Overall Study|Lack of Efficacy|46|||
145992896|NCT02613507|526488275|FG000|Treatment|Death|2|||
145992897|NCT02613507|526488276|FG001|Treatment|Death|0|||
145992898|NCT02613507|526488275|FG000|Treatment|Study drug toxicity|19|||
145992899|NCT02613507|526488276|FG001|Treatment|Study drug toxicity|14|||
145992900|NCT02613507|526488275|FG000|Treatment|Disease progression|263|||
145992901|NCT02613507|526488276|FG001|Treatment|Disease progression|110|||
145992902|NCT03648372|526488293|FG000|Overall Study|Withdrawal by Subject|2|||
145992903|NCT03648372|526488294|FG001|Overall Study|Withdrawal by Subject|0|||
145992904|NCT03648372|526488295|FG002|Overall Study|Withdrawal by Subject|0|||
145992905|NCT03648372|526488296|FG003|Overall Study|Withdrawal by Subject|0|||
146246392|NCT02584257|527415697|FG000|Period 2|Adverse Event|0|||
146246393|NCT02584257|527415698|FG001|Period 2|Adverse Event|1|||
146246394|NCT02584257|527415699|FG002|Period 2|Adverse Event|0|||
146246395|NCT02584257|527415700|FG003|Period 2|Adverse Event|0|||
146246396|NCT02584257|527415701|FG004|Period 2|Adverse Event|0|||
146246397|NCT02584257|527415702|FG005|Period 2|Adverse Event|0|||
146246398|NCT02584257|527415703|FG006|Period 2|Adverse Event|0|||
146246399|NCT02584257|527415704|FG007|Period 2|Adverse Event|0|||
146246400|NCT02584257|527415705|FG008|Period 2|Adverse Event|0|||
146246401|NCT02137785|527415706|FG000|Overall Study|Lost to Follow-up|1|||
146246402|NCT02137785|527415707|FG001|Overall Study|Lost to Follow-up|0|||
146246403|NCT02137785|527415706|FG000|Overall Study|Withdrawal by Subject|1|||
146246404|NCT02137785|527415707|FG001|Overall Study|Withdrawal by Subject|4|||
146246405|NCT02137785|527415706|FG000|Overall Study|subject moved out of state|1|||
146246406|NCT02137785|527415707|FG001|Overall Study|subject moved out of state|0|||
146246407|NCT01670877|527415708|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146246408|NCT01670877|527415709|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
146246409|NCT01670877|527415710|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146246410|NCT01670877|527415711|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146246411|NCT01670877|527415712|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146246412|NCT01670877|527415713|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
146246413|NCT01670877|527415708|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146246414|NCT01670877|527415709|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146246415|NCT01670877|527415710|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
146246416|NCT01670877|527415711|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146246417|NCT01670877|527415712|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146246418|NCT01670877|527415713|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
146246419|NCT01670877|527415708|FG000|Part I and Part 2|Grade 2 vomiting|0|||
146246420|NCT01670877|527415709|FG001|Part I and Part 2|Grade 2 vomiting|0|||
146246421|NCT01670877|527415710|FG002|Part I and Part 2|Grade 2 vomiting|0|||
146246422|NCT01670877|527415711|FG003|Part I and Part 2|Grade 2 vomiting|1|||
146246423|NCT01670877|527415712|FG004|Part I and Part 2|Grade 2 vomiting|0|||
146246424|NCT01670877|527415713|FG005|Part I and Part 2|Grade 2 vomiting|0|||
146246425|NCT01670877|527415708|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146246426|NCT01670877|527415709|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146246427|NCT01670877|527415710|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145992906|NCT03648372|526488297|FG004|Overall Study|Withdrawal by Subject|0|||
145992907|NCT03648372|526488298|FG005|Overall Study|Withdrawal by Subject|1|||
145992908|NCT03648372|526488299|FG006|Overall Study|Withdrawal by Subject|2|||
145992909|NCT03648372|526488300|FG007|Overall Study|Withdrawal by Subject|0|||
145992910|NCT03648372|526488301|FG008|Overall Study|Withdrawal by Subject|0|||
145992911|NCT03648372|526488302|FG009|Overall Study|Withdrawal by Subject|0|||
145992912|NCT03648372|526488303|FG010|Overall Study|Withdrawal by Subject|2|||
145992913|NCT03648372|526488304|FG011|Overall Study|Withdrawal by Subject|0|||
145992914|NCT03648372|526488305|FG012|Overall Study|Withdrawal by Subject|2|||
145992915|NCT03648372|526488306|FG013|Overall Study|Withdrawal by Subject|0|||
145992916|NCT03648372|526488307|FG014|Overall Study|Withdrawal by Subject|0|||
145992917|NCT03648372|526488308|FG015|Overall Study|Withdrawal by Subject|0|||
145992918|NCT03648372|526488309|FG016|Overall Study|Withdrawal by Subject|1|||
145992919|NCT03648372|526488310|FG017|Overall Study|Withdrawal by Subject|0|||
145992920|NCT03648372|526488311|FG018|Overall Study|Withdrawal by Subject|0|||
145992921|NCT03648372|526488312|FG019|Overall Study|Withdrawal by Subject|0|||
145992922|NCT03648372|526488313|FG020|Overall Study|Withdrawal by Subject|0|||
145992923|NCT03648372|526488293|FG000|Overall Study|Progressive Disease|2|||
145992924|NCT03648372|526488294|FG001|Overall Study|Progressive Disease|3|||
145992925|NCT03648372|526488295|FG002|Overall Study|Progressive Disease|4|||
145992926|NCT03648372|526488296|FG003|Overall Study|Progressive Disease|3|||
145992927|NCT03648372|526488297|FG004|Overall Study|Progressive Disease|2|||
145992928|NCT03648372|526488298|FG005|Overall Study|Progressive Disease|2|||
145992929|NCT03648372|526488299|FG006|Overall Study|Progressive Disease|3|||
145992930|NCT03648372|526488300|FG007|Overall Study|Progressive Disease|3|||
145992931|NCT03648372|526488301|FG008|Overall Study|Progressive Disease|5|||
145992932|NCT03648372|526488302|FG009|Overall Study|Progressive Disease|5|||
145992933|NCT03648372|526488303|FG010|Overall Study|Progressive Disease|2|||
146246428|NCT01670877|527415711|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
146246429|NCT01670877|527415712|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146246430|NCT01670877|527415713|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
146246431|NCT01670877|527415708|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145992934|NCT03648372|526488304|FG011|Overall Study|Progressive Disease|3|||
145992935|NCT03648372|526488305|FG012|Overall Study|Progressive Disease|3|||
145992936|NCT03648372|526488306|FG013|Overall Study|Progressive Disease|3|||
145992937|NCT03648372|526488307|FG014|Overall Study|Progressive Disease|6|||
145992938|NCT03648372|526488308|FG015|Overall Study|Progressive Disease|0|||
145992939|NCT03648372|526488309|FG016|Overall Study|Progressive Disease|0|||
145992940|NCT03648372|526488310|FG017|Overall Study|Progressive Disease|0|||
145992941|NCT03648372|526488311|FG018|Overall Study|Progressive Disease|0|||
145992942|NCT03648372|526488312|FG019|Overall Study|Progressive Disease|0|||
145992943|NCT03648372|526488313|FG020|Overall Study|Progressive Disease|0|||
145992944|NCT03648372|526488293|FG000|Overall Study|Other|0|||
145992945|NCT03648372|526488294|FG001|Overall Study|Other|0|||
145992946|NCT03648372|526488295|FG002|Overall Study|Other|0|||
145992947|NCT03648372|526488296|FG003|Overall Study|Other|0|||
145992948|NCT03648372|526488297|FG004|Overall Study|Other|1|||
145992949|NCT03648372|526488298|FG005|Overall Study|Other|0|||
145992950|NCT03648372|526488299|FG006|Overall Study|Other|0|||
145992951|NCT03648372|526488300|FG007|Overall Study|Other|0|||
145992952|NCT03648372|526488301|FG008|Overall Study|Other|0|||
145992953|NCT03648372|526488302|FG009|Overall Study|Other|0|||
145992954|NCT03648372|526488303|FG010|Overall Study|Other|1|||
145992955|NCT03648372|526488304|FG011|Overall Study|Other|2|||
145992956|NCT03648372|526488305|FG012|Overall Study|Other|1|||
145992957|NCT03648372|526488306|FG013|Overall Study|Other|3|||
145992958|NCT03648372|526488307|FG014|Overall Study|Other|0|||
145992959|NCT03648372|526488308|FG015|Overall Study|Other|5|||
145992960|NCT03648372|526488309|FG016|Overall Study|Other|1|||
145992961|NCT03648372|526488310|FG017|Overall Study|Other|5|||
145992962|NCT03648372|526488311|FG018|Overall Study|Other|0|||
145992963|NCT03648372|526488312|FG019|Overall Study|Other|1|||
145992964|NCT03648372|526488313|FG020|Overall Study|Other|0|||
145992965|NCT03648372|526488293|FG000|Overall Study|Lost to Follow-up|0|||
145992966|NCT03648372|526488294|FG001|Overall Study|Lost to Follow-up|0|||
145992967|NCT03648372|526488295|FG002|Overall Study|Lost to Follow-up|0|||
145992968|NCT03648372|526488296|FG003|Overall Study|Lost to Follow-up|0|||
145992969|NCT03648372|526488297|FG004|Overall Study|Lost to Follow-up|0|||
145992970|NCT03648372|526488298|FG005|Overall Study|Lost to Follow-up|0|||
145992971|NCT03648372|526488299|FG006|Overall Study|Lost to Follow-up|0|||
145992972|NCT03648372|526488300|FG007|Overall Study|Lost to Follow-up|0|||
145992973|NCT03648372|526488301|FG008|Overall Study|Lost to Follow-up|0|||
145992974|NCT03648372|526488302|FG009|Overall Study|Lost to Follow-up|0|||
145992975|NCT03648372|526488303|FG010|Overall Study|Lost to Follow-up|0|||
145992976|NCT03648372|526488304|FG011|Overall Study|Lost to Follow-up|0|||
145992977|NCT03648372|526488305|FG012|Overall Study|Lost to Follow-up|0|||
145992978|NCT03648372|526488306|FG013|Overall Study|Lost to Follow-up|1|||
145992979|NCT03648372|526488307|FG014|Overall Study|Lost to Follow-up|0|||
145992980|NCT03648372|526488308|FG015|Overall Study|Lost to Follow-up|1|||
145992981|NCT03648372|526488309|FG016|Overall Study|Lost to Follow-up|0|||
145992982|NCT03648372|526488310|FG017|Overall Study|Lost to Follow-up|1|||
145992983|NCT03648372|526488311|FG018|Overall Study|Lost to Follow-up|0|||
145992984|NCT03648372|526488312|FG019|Overall Study|Lost to Follow-up|0|||
145992985|NCT03648372|526488313|FG020|Overall Study|Lost to Follow-up|0|||
145992986|NCT03648372|526488293|FG000|Overall Study|Start of a New Systemic Treatment|0|||
145992987|NCT03648372|526488294|FG001|Overall Study|Start of a New Systemic Treatment|0|||
145992988|NCT03648372|526488295|FG002|Overall Study|Start of a New Systemic Treatment|0|||
145992989|NCT03648372|526488296|FG003|Overall Study|Start of a New Systemic Treatment|0|||
145992990|NCT03648372|526488297|FG004|Overall Study|Start of a New Systemic Treatment|0|||
145992991|NCT03648372|526488298|FG005|Overall Study|Start of a New Systemic Treatment|0|||
145992992|NCT03648372|526488299|FG006|Overall Study|Start of a New Systemic Treatment|0|||
145992993|NCT03648372|526488300|FG007|Overall Study|Start of a New Systemic Treatment|2|||
145992994|NCT03648372|526488301|FG008|Overall Study|Start of a New Systemic Treatment|0|||
145992995|NCT03648372|526488302|FG009|Overall Study|Start of a New Systemic Treatment|0|||
145992996|NCT03648372|526488303|FG010|Overall Study|Start of a New Systemic Treatment|1|||
145992997|NCT03648372|526488304|FG011|Overall Study|Start of a New Systemic Treatment|0|||
145992998|NCT03648372|526488305|FG012|Overall Study|Start of a New Systemic Treatment|0|||
145992999|NCT03648372|526488306|FG013|Overall Study|Start of a New Systemic Treatment|0|||
145993000|NCT03648372|526488307|FG014|Overall Study|Start of a New Systemic Treatment|0|||
145993001|NCT03648372|526488308|FG015|Overall Study|Start of a New Systemic Treatment|0|||
145993002|NCT03648372|526488309|FG016|Overall Study|Start of a New Systemic Treatment|0|||
145993003|NCT03648372|526488310|FG017|Overall Study|Start of a New Systemic Treatment|0|||
145993004|NCT03648372|526488311|FG018|Overall Study|Start of a New Systemic Treatment|0|||
145993005|NCT03648372|526488312|FG019|Overall Study|Start of a New Systemic Treatment|0|||
145993006|NCT03648372|526488313|FG020|Overall Study|Start of a New Systemic Treatment|0|||
145993007|NCT04191135|526488314|FG000|Induction Treatment|Not Treated|2|||
145993008|NCT04191135|526488315|FG001|Induction Treatment|Not Treated|0|||
145993009|NCT04191135|526488316|FG002|Induction Treatment|Not Treated|0|||
145993010|NCT04191135|526488314|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
145993011|NCT04191135|526488315|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
145993012|NCT04191135|526488316|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
145993013|NCT04191135|526488314|FG000|Induction Treatment|Adverse Event|25|||
145993014|NCT04191135|526488315|FG001|Induction Treatment|Adverse Event|0|||
145993015|NCT04191135|526488316|FG002|Induction Treatment|Adverse Event|0|||
145993016|NCT04191135|526488314|FG000|Induction Treatment|Clinical Progression|8|||
145993017|NCT04191135|526488315|FG001|Induction Treatment|Clinical Progression|0|||
145993018|NCT04191135|526488316|FG002|Induction Treatment|Clinical Progression|0|||
145993019|NCT04191135|526488314|FG000|Induction Treatment|Excluded Medication|1|||
145993020|NCT04191135|526488315|FG001|Induction Treatment|Excluded Medication|0|||
145993021|NCT04191135|526488316|FG002|Induction Treatment|Excluded Medication|0|||
145993022|NCT04191135|526488314|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
145993023|NCT04191135|526488315|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
145993024|NCT04191135|526488316|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
145993025|NCT04191135|526488314|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
145993026|NCT04191135|526488315|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
145993027|NCT04191135|526488316|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
145993028|NCT04191135|526488314|FG000|Induction Treatment|Physician Decision|2|||
145993029|NCT04191135|526488315|FG001|Induction Treatment|Physician Decision|0|||
145993030|NCT04191135|526488316|FG002|Induction Treatment|Physician Decision|0|||
145993031|NCT04191135|526488314|FG000|Induction Treatment|Progressive Disease|135|||
145993032|NCT04191135|526488315|FG001|Induction Treatment|Progressive Disease|0|||
145993033|NCT04191135|526488316|FG002|Induction Treatment|Progressive Disease|0|||
145993034|NCT04191135|526488314|FG000|Induction Treatment|Protocol Violation|10|||
145993035|NCT04191135|526488315|FG001|Induction Treatment|Protocol Violation|0|||
145993036|NCT04191135|526488316|FG002|Induction Treatment|Protocol Violation|0|||
145993037|NCT04191135|526488314|FG000|Induction Treatment|Withdrawal by Subject|4|||
145993038|NCT04191135|526488315|FG001|Induction Treatment|Withdrawal by Subject|0|||
145993039|NCT04191135|526488316|FG002|Induction Treatment|Withdrawal by Subject|0|||
145993040|NCT04191135|526488314|FG000|Randomized Treatment|Death|0|||
145993041|NCT04191135|526488315|FG001|Randomized Treatment|Death|50|||
145993042|NCT04191135|526488316|FG002|Randomized Treatment|Death|54|||
145993043|NCT04191135|526488314|FG000|Randomized Treatment|Lost to Follow-up|0|||
145993044|NCT04191135|526488315|FG001|Randomized Treatment|Lost to Follow-up|0|||
145993045|NCT04191135|526488316|FG002|Randomized Treatment|Lost to Follow-up|1|||
145993046|NCT04191135|526488314|FG000|Randomized Treatment|Withdrawal by Subject|0|||
145993047|NCT04191135|526488315|FG001|Randomized Treatment|Withdrawal by Subject|2|||
145993048|NCT04191135|526488316|FG002|Randomized Treatment|Withdrawal by Subject|0|||
145993049|NCT04191135|526488314|FG000|Randomized Treatment|Ongoing in Trial|0|||
145993050|NCT04191135|526488315|FG001|Randomized Treatment|Ongoing in Trial|83|||
145993051|NCT04191135|526488316|FG002|Randomized Treatment|Ongoing in Trial|81|||
145993052|NCT03514134|526489660|FG000|Overall Study|Lost to Follow-up|0|||
145993053|NCT03514134|526489661|FG001|Overall Study|Lost to Follow-up|1|||
145993054|NCT00003645|526489662|FG000|Overall Study|Death|4|||
145993055|NCT00003645|526489663|FG001|Overall Study|Death|1|||
145993056|NCT00003645|526489662|FG000|Overall Study|Lost to Follow-up|7|||
145993057|NCT00003645|526489663|FG001|Overall Study|Lost to Follow-up|8|||
145993058|NCT00003645|526489662|FG000|Overall Study|Withdrawal by Subject|1|||
145993059|NCT00003645|526489663|FG001|Overall Study|Withdrawal by Subject|3|||
145993060|NCT00363298|526489674|FG000|First Study Week|Lack of Efficacy|6|||
145993061|NCT00363298|526489675|FG001|First Study Week|Lack of Efficacy|5|||
145993062|NCT00363298|526489674|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
145993063|NCT00363298|526489675|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
145993064|NCT03360344|526489680|FG000|Overall Study|Withdrawal by Subject|0|||
145993065|NCT03360344|526489681|FG001|Overall Study|Withdrawal by Subject|1|||
145993066|NCT03360344|526489682|FG002|Overall Study|Withdrawal by Subject|1|||
145993067|NCT00133705|526489687|FG000|Overall Study|Withdrawal by Subject|2|||
145993068|NCT00133705|526489688|FG001|Overall Study|Withdrawal by Subject|3|||
145993069|NCT00959049|526489689|FG000|Overall Study|Adverse Event|1|||
145993070|NCT00959049|526489690|FG001|Overall Study|Adverse Event|0|||
145993071|NCT00959049|526489691|FG002|Overall Study|Adverse Event|0|||
145993072|NCT00959049|526489692|FG003|Overall Study|Adverse Event|0|||
145993073|NCT00959049|526489693|FG004|Overall Study|Adverse Event|0|||
145993074|NCT00959049|526489694|FG005|Overall Study|Adverse Event|0|||
145993075|NCT00959049|526489689|FG000|Overall Study|Lost to Follow-up|17|||
145993076|NCT00959049|526489690|FG001|Overall Study|Lost to Follow-up|5|||
145993077|NCT00959049|526489691|FG002|Overall Study|Lost to Follow-up|1|||
145993078|NCT00959049|526489692|FG003|Overall Study|Lost to Follow-up|10|||
145993079|NCT00959049|526489693|FG004|Overall Study|Lost to Follow-up|9|||
145993080|NCT00959049|526489694|FG005|Overall Study|Lost to Follow-up|1|||
145993081|NCT00959049|526489689|FG000|Overall Study|Contraindicated medication|0|||
145993082|NCT00959049|526489690|FG001|Overall Study|Contraindicated medication|0|||
145993083|NCT00959049|526489691|FG002|Overall Study|Contraindicated medication|0|||
145993084|NCT00959049|526489692|FG003|Overall Study|Contraindicated medication|1|||
145993085|NCT00959049|526489693|FG004|Overall Study|Contraindicated medication|0|||
145993086|NCT00959049|526489694|FG005|Overall Study|Contraindicated medication|0|||
145993087|NCT00959049|526489689|FG000|Overall Study|Withdrawal by Subject|0|||
145993088|NCT00959049|526489690|FG001|Overall Study|Withdrawal by Subject|2|||
145993089|NCT00959049|526489691|FG002|Overall Study|Withdrawal by Subject|0|||
145993090|NCT00959049|526489692|FG003|Overall Study|Withdrawal by Subject|0|||
145993091|NCT00959049|526489693|FG004|Overall Study|Withdrawal by Subject|0|||
145993092|NCT00959049|526489694|FG005|Overall Study|Withdrawal by Subject|0|||
145993093|NCT01892189|526489699|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
145993094|NCT01892189|526489700|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
146246432|NCT01670877|527415709|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146246433|NCT01670877|527415710|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146246434|NCT01670877|527415711|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
146246435|NCT01670877|527415712|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146246436|NCT01670877|527415713|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
146246437|NCT00417885|527415714|FG000|Overall Study|Adverse Event|1|||
146246438|NCT00417885|527415714|FG000|Overall Study|Objective Progression or Relapse|3|||
146246439|NCT00417885|527415714|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
146246440|NCT02309892|527415715|FG000|Overall Study|Physician Decision|1|||
146246441|NCT02309892|527415716|FG001|Overall Study|Physician Decision|0|||
146246442|NCT02309892|527415717|FG002|Overall Study|Physician Decision|0|||
146246443|NCT02309892|527415718|FG003|Overall Study|Physician Decision|0|||
146246444|NCT02309892|527415719|FG004|Overall Study|Physician Decision|0|||
146246445|NCT02309892|527415720|FG005|Overall Study|Physician Decision|0|||
145993095|NCT01892189|526489701|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
145993096|NCT01892189|526489702|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
145993097|NCT01892189|526489703|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
145993098|NCT01892189|526489704|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
145993099|NCT01892189|526489705|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
145993100|NCT01892189|526489706|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
145993101|NCT01892189|526489707|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
145993102|NCT01892189|526489699|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145993103|NCT01892189|526489700|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145993104|NCT01892189|526489701|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
145993105|NCT01892189|526489702|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145993106|NCT01892189|526489703|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145993107|NCT01892189|526489704|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145993108|NCT01892189|526489705|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145993109|NCT01892189|526489706|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145993110|NCT01892189|526489707|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145993111|NCT01892189|526489699|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993112|NCT01892189|526489700|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993113|NCT01892189|526489701|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993114|NCT01892189|526489702|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993115|NCT01892189|526489703|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993116|NCT01892189|526489704|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
145993117|NCT01892189|526489705|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993118|NCT01892189|526489706|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993119|NCT01892189|526489707|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145993120|NCT01992757|526489710|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
145993121|NCT03440411|526489711|FG000|Overall Study|Adverse Event|0|||
145993122|NCT03440411|526489712|FG001|Overall Study|Adverse Event|0|||
145993123|NCT03440411|526489713|FG002|Overall Study|Adverse Event|1|||
145993124|NCT03440411|526489714|FG003|Overall Study|Adverse Event|0|||
145993125|NCT03440411|526489711|FG000|Overall Study|PD|2|||
145993126|NCT03440411|526489712|FG001|Overall Study|PD|1|||
145993127|NCT03440411|526489713|FG002|Overall Study|PD|1|||
145993128|NCT03440411|526489714|FG003|Overall Study|PD|1|||
145993129|NCT03440411|526489711|FG000|Overall Study|Withdrawal by Subject|1|||
145993130|NCT03440411|526489712|FG001|Overall Study|Withdrawal by Subject|0|||
145993131|NCT03440411|526489713|FG002|Overall Study|Withdrawal by Subject|0|||
145993132|NCT03440411|526489714|FG003|Overall Study|Withdrawal by Subject|0|||
145993133|NCT03440411|526489711|FG000|Overall Study|Closed study by sponsor|0|||
145993134|NCT03440411|526489712|FG001|Overall Study|Closed study by sponsor|0|||
145993135|NCT03440411|526489713|FG002|Overall Study|Closed study by sponsor|0|||
145993136|NCT03440411|526489714|FG003|Overall Study|Closed study by sponsor|1|||
145993137|NCT01344356|526489715|FG000|Overall Study|Physician Decision|0|||
145993138|NCT01344356|526489716|FG001|Overall Study|Physician Decision|3|||
145993139|NCT01344356|526489715|FG000|Overall Study|Lost to Follow-up|0|||
145993140|NCT01344356|526489716|FG001|Overall Study|Lost to Follow-up|6|||
145993141|NCT00095576|526489717|FG000|Overall Study|Adverse Event|5|||
145993142|NCT00095576|526489718|FG001|Overall Study|Adverse Event|3|||
146246446|NCT02309892|527415721|FG006|Overall Study|Physician Decision|0|||
146297884|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146297885|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145993143|NCT00095576|526489717|FG000|Overall Study|Lost to Follow-up|233|||
145993144|NCT00095576|526489718|FG001|Overall Study|Lost to Follow-up|229|||
145993145|NCT00095576|526489717|FG000|Overall Study|Protocol Violation|1|||
145993146|NCT00095576|526489718|FG001|Overall Study|Protocol Violation|0|||
145993147|NCT00095576|526489717|FG000|Overall Study|Withdrawal by Subject|34|||
145993148|NCT00095576|526489718|FG001|Overall Study|Withdrawal by Subject|47|||
145993149|NCT00095576|526489717|FG000|Overall Study|Option to switch to a rollover study|1097|||
145993150|NCT00095576|526489718|FG001|Overall Study|Option to switch to a rollover study|1099|||
145993151|NCT00095576|526489717|FG000|Overall Study|Site terminated|75|||
146246447|NCT02309892|527415715|FG000|Overall Study|Adverse Event|1|||
146246448|NCT02309892|527415716|FG001|Overall Study|Adverse Event|0|||
146246449|NCT02309892|527415717|FG002|Overall Study|Adverse Event|1|||
146246450|NCT02309892|527415718|FG003|Overall Study|Adverse Event|0|||
145993152|NCT00095576|526489718|FG001|Overall Study|Site terminated|67|||
145993153|NCT00095576|526489717|FG000|Overall Study|Subject moved|30|||
145993154|NCT00095576|526489718|FG001|Overall Study|Subject moved|36|||
145993155|NCT00856557|526489719|FG000|Overall Study|No patients with contextual flags|12|||
145993156|NCT00856557|526489720|FG001|Overall Study|No patients with contextual flags|16|||
145993157|NCT03673176|526489721|FG000|Overall Study|Death prior to intervention|1|||
145993158|NCT03673176|526489721|FG000|Overall Study|Death following intervention|3|||
145993159|NCT03673176|526489721|FG000|Overall Study|Withdrawal by Subject|1|||
145993160|NCT02378480|526489722|FG000|Overall Study|Physician Decision|1|||
145993161|NCT02378480|526489723|FG001|Overall Study|Physician Decision|1|||
145993162|NCT02378480|526489722|FG000|Overall Study|Death|1|||
145993163|NCT02378480|526489723|FG001|Overall Study|Death|2|||
145993164|NCT02378480|526489722|FG000|Overall Study|Randomized, but Not Treated|6|||
145993165|NCT02378480|526489723|FG001|Overall Study|Randomized, but Not Treated|4|||
145993166|NCT02378480|526489722|FG000|Overall Study|Adverse Event|0|||
145993167|NCT02378480|526489723|FG001|Overall Study|Adverse Event|1|||
145993168|NCT02378480|526489722|FG000|Overall Study|Missed EOT/PTE Visit|1|||
145993169|NCT02378480|526489723|FG001|Overall Study|Missed EOT/PTE Visit|2|||
145993170|NCT02378480|526489722|FG000|Overall Study|Withdrawal by Subject|9|||
145993171|NCT02378480|526489723|FG001|Overall Study|Withdrawal by Subject|4|||
145993172|NCT02378480|526489722|FG000|Overall Study|Lost to Follow-up|10|||
145993173|NCT02378480|526489723|FG001|Overall Study|Lost to Follow-up|18|||
145993174|NCT01285102|526489725|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
145993175|NCT04507763|526489726|FG000|Overall Study|Participants did not meet entrance criteria|201|||
145993176|NCT01905540|526489727|FG000|Period 3|Other|1|||
145993177|NCT01905540|526489728|FG001|Period 3|Other|0|||
145993178|NCT01905540|526489729|FG002|Period 3|Other|1|||
145993179|NCT01905540|526489730|FG003|Period 3|Other|1|||
145993180|NCT03847519|526489731|FG000|Overall Study|Death|5|||
145993181|NCT03847519|526489732|FG001|Overall Study|Death|8|||
145993182|NCT03847519|526489733|FG002|Overall Study|Death|1|||
145993183|NCT03847519|526489731|FG000|Overall Study|Lost to Follow-up|1|||
145993184|NCT03847519|526489732|FG001|Overall Study|Lost to Follow-up|2|||
145993185|NCT03847519|526489733|FG002|Overall Study|Lost to Follow-up|0|||
145993186|NCT03847519|526489731|FG000|Overall Study|Study Terminated by Sponsor|0|||
145993187|NCT03847519|526489732|FG001|Overall Study|Study Terminated by Sponsor|3|||
145993188|NCT03847519|526489733|FG002|Overall Study|Study Terminated by Sponsor|2|||
145993189|NCT02743962|526489734|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
145993190|NCT02743962|526489735|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
145993191|NCT00725985|526489739|FG000|ITP- Treatment Disposition|Adverse Event|20|||
145993192|NCT00725985|526489740|FG001|ITP- Treatment Disposition|Adverse Event|10|||
145993193|NCT00725985|526489741|FG002|ITP- Treatment Disposition|Adverse Event|5|||
145993194|NCT00725985|526489742|FG003|ITP- Treatment Disposition|Adverse Event|0|||
145993195|NCT00725985|526489743|FG004|ITP- Treatment Disposition|Adverse Event|0|||
145993196|NCT00725985|526489744|FG005|ITP- Treatment Disposition|Adverse Event|0|||
145993197|NCT00725985|526489745|FG006|ITP- Treatment Disposition|Adverse Event|0|||
145993198|NCT00725985|526489746|FG007|ITP- Treatment Disposition|Adverse Event|0|||
145993199|NCT00725985|526489747|FG008|ITP- Treatment Disposition|Adverse Event|0|||
145993200|NCT00725985|526489748|FG009|ITP- Treatment Disposition|Adverse Event|0|||
145993201|NCT00725985|526489749|FG010|ITP- Treatment Disposition|Adverse Event|0|||
145993202|NCT00725985|526489750|FG011|ITP- Treatment Disposition|Adverse Event|0|||
145993203|NCT00725985|526489739|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993204|NCT00725985|526489740|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993205|NCT00725985|526489741|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
145993206|NCT00725985|526489742|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993207|NCT00725985|526489743|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
146091662|NCT00750880|526856865|FG000|Overall Study|Lost to Follow-up|10|||
146246451|NCT02309892|527415719|FG004|Overall Study|Adverse Event|0|||
146246452|NCT02309892|527415720|FG005|Overall Study|Adverse Event|0|||
146246453|NCT02309892|527415721|FG006|Overall Study|Adverse Event|0|||
146246454|NCT02309892|527415715|FG000|Overall Study|Progressive Disease|0|||
146246455|NCT02309892|527415716|FG001|Overall Study|Progressive Disease|1|||
146297886|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145993208|NCT00725985|526489744|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993209|NCT00725985|526489745|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993210|NCT00725985|526489746|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993211|NCT00725985|526489747|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993212|NCT00725985|526489748|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993213|NCT00725985|526489749|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
145993214|NCT00725985|526489750|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
146091663|NCT00750880|526856865|FG000|Overall Study|Protocol Violation|15|||
146246456|NCT02309892|527415717|FG002|Overall Study|Progressive Disease|0|||
146246457|NCT02309892|527415718|FG003|Overall Study|Progressive Disease|0|||
146091664|NCT00750880|526856865|FG000|Overall Study|Withdrawal by Subject|33|||
145993215|NCT00725985|526489739|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
145993216|NCT00725985|526489740|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
145993217|NCT00725985|526489741|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
145993218|NCT00725985|526489742|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
145993219|NCT00725985|526489743|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
145993220|NCT00725985|526489744|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
145993221|NCT00725985|526489745|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
145993222|NCT00725985|526489746|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
145993223|NCT00725985|526489747|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
145993224|NCT00725985|526489748|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
145993225|NCT00725985|526489749|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
145993226|NCT00725985|526489750|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
145993227|NCT00725985|526489739|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
145993228|NCT00725985|526489740|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
145993229|NCT00725985|526489741|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
145993230|NCT00725985|526489742|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
145993231|NCT00725985|526489743|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
145993232|NCT00725985|526489744|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
145993233|NCT00725985|526489745|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
145993234|NCT00725985|526489746|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
145993235|NCT00725985|526489747|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
145993236|NCT00725985|526489748|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
145993237|NCT00725985|526489749|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
145993238|NCT00725985|526489750|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
145993239|NCT00725985|526489739|FG000|ITP- Treatment Disposition|Other|50|||
145993240|NCT00725985|526489740|FG001|ITP- Treatment Disposition|Other|38|||
145993241|NCT00725985|526489741|FG002|ITP- Treatment Disposition|Other|24|||
145993242|NCT00725985|526489742|FG003|ITP- Treatment Disposition|Other|0|||
145993243|NCT00725985|526489743|FG004|ITP- Treatment Disposition|Other|0|||
145993244|NCT00725985|526489744|FG005|ITP- Treatment Disposition|Other|0|||
145993245|NCT00725985|526489745|FG006|ITP- Treatment Disposition|Other|0|||
145993246|NCT00725985|526489746|FG007|ITP- Treatment Disposition|Other|0|||
145993247|NCT00725985|526489747|FG008|ITP- Treatment Disposition|Other|0|||
145993248|NCT00725985|526489748|FG009|ITP- Treatment Disposition|Other|0|||
145993249|NCT00725985|526489749|FG010|ITP- Treatment Disposition|Other|0|||
145993250|NCT00725985|526489750|FG011|ITP- Treatment Disposition|Other|0|||
145993251|NCT00725985|526489739|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993252|NCT00725985|526489740|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993253|NCT00725985|526489741|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993254|NCT00725985|526489742|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
145993255|NCT00725985|526489743|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
145993256|NCT00725985|526489744|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
145993257|NCT00725985|526489745|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993258|NCT00725985|526489746|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993259|NCT00725985|526489747|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993260|NCT00725985|526489748|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993261|NCT00725985|526489749|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993262|NCT00725985|526489750|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145993263|NCT00725985|526489739|FG000|OLMP (Up to 96 Weeks)|Death|0|||
145993264|NCT00725985|526489740|FG001|OLMP (Up to 96 Weeks)|Death|0|||
145993265|NCT00725985|526489741|FG002|OLMP (Up to 96 Weeks)|Death|0|||
145993266|NCT00725985|526489742|FG003|OLMP (Up to 96 Weeks)|Death|0|||
145993267|NCT00725985|526489743|FG004|OLMP (Up to 96 Weeks)|Death|1|||
145993268|NCT00725985|526489744|FG005|OLMP (Up to 96 Weeks)|Death|0|||
145993269|NCT00725985|526489745|FG006|OLMP (Up to 96 Weeks)|Death|0|||
145993270|NCT00725985|526489746|FG007|OLMP (Up to 96 Weeks)|Death|0|||
145993271|NCT00725985|526489747|FG008|OLMP (Up to 96 Weeks)|Death|0|||
145993272|NCT00725985|526489748|FG009|OLMP (Up to 96 Weeks)|Death|0|||
145993273|NCT00725985|526489749|FG010|OLMP (Up to 96 Weeks)|Death|0|||
145993274|NCT00725985|526489750|FG011|OLMP (Up to 96 Weeks)|Death|0|||
145993275|NCT00725985|526489739|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993276|NCT00725985|526489740|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146091665|NCT00750880|526856865|FG000|Overall Study|Physician Decision|20|||
145993277|NCT00725985|526489741|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993278|NCT00725985|526489742|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
145993279|NCT00725985|526489743|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993280|NCT00725985|526489744|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993281|NCT00725985|526489745|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993282|NCT00725985|526489746|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993283|NCT00725985|526489747|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993284|NCT00725985|526489748|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993285|NCT00725985|526489749|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
146091666|NCT00750880|526856865|FG000|Overall Study|Administrative|11|||
145993286|NCT00725985|526489750|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145993287|NCT00725985|526489739|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993288|NCT00725985|526489740|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993289|NCT00725985|526489741|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993290|NCT00725985|526489742|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993291|NCT00725985|526489743|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993292|NCT00725985|526489744|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
145993293|NCT00725985|526489745|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993294|NCT00725985|526489746|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993295|NCT00725985|526489747|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993296|NCT00725985|526489748|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993297|NCT00725985|526489749|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993298|NCT00725985|526489750|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
145993299|NCT00725985|526489739|FG000|OLMP (Up to 96 Weeks)|Other|0|||
145993300|NCT00725985|526489740|FG001|OLMP (Up to 96 Weeks)|Other|0|||
145993301|NCT00725985|526489741|FG002|OLMP (Up to 96 Weeks)|Other|0|||
145993302|NCT00725985|526489742|FG003|OLMP (Up to 96 Weeks)|Other|15|||
145993303|NCT00725985|526489743|FG004|OLMP (Up to 96 Weeks)|Other|20|||
145993304|NCT00725985|526489744|FG005|OLMP (Up to 96 Weeks)|Other|44|||
145993305|NCT00725985|526489745|FG006|OLMP (Up to 96 Weeks)|Other|0|||
145993306|NCT00725985|526489746|FG007|OLMP (Up to 96 Weeks)|Other|0|||
145993307|NCT00725985|526489747|FG008|OLMP (Up to 96 Weeks)|Other|0|||
145993308|NCT00725985|526489748|FG009|OLMP (Up to 96 Weeks)|Other|0|||
145993309|NCT00725985|526489749|FG010|OLMP (Up to 96 Weeks)|Other|0|||
145993310|NCT00725985|526489750|FG011|OLMP (Up to 96 Weeks)|Other|0|||
145993311|NCT00725985|526489739|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993312|NCT00725985|526489740|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993313|NCT00725985|526489741|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993314|NCT00725985|526489742|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993315|NCT00725985|526489743|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993316|NCT00725985|526489744|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993317|NCT00725985|526489745|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993318|NCT00725985|526489746|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
145993319|NCT00725985|526489747|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993320|NCT00725985|526489748|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993321|NCT00725985|526489749|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993322|NCT00725985|526489750|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145993323|NCT00725985|526489739|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993324|NCT00725985|526489740|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993325|NCT00725985|526489741|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993326|NCT00725985|526489742|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993327|NCT00725985|526489743|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993328|NCT00725985|526489744|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993329|NCT00725985|526489745|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993330|NCT00725985|526489746|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993331|NCT00725985|526489747|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
145993332|NCT00725985|526489748|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993333|NCT00725985|526489749|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993334|NCT00725985|526489750|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145993335|NCT00725985|526489739|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993336|NCT00725985|526489740|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993337|NCT00725985|526489741|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993338|NCT00725985|526489742|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993339|NCT00725985|526489743|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993340|NCT00725985|526489744|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993341|NCT00725985|526489745|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
145993342|NCT00725985|526489746|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
145993343|NCT00725985|526489747|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
145993344|NCT00725985|526489748|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993345|NCT00725985|526489749|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993346|NCT00725985|526489750|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145993347|NCT00725985|526489739|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993348|NCT00725985|526489740|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993349|NCT00725985|526489741|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993350|NCT00725985|526489742|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993351|NCT00725985|526489743|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993352|NCT00725985|526489744|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993353|NCT00725985|526489745|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993354|NCT00725985|526489746|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993355|NCT00725985|526489747|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145993356|NCT00725985|526489748|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
145993357|NCT00725985|526489749|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
145993358|NCT00725985|526489750|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
145993359|NCT03931330|526489752|FG000|Overall Study|Physician Decision|1|||
145993360|NCT01381679|526489755|FG000|Overall Study|Adverse Event|3|||
145993361|NCT01381679|526489755|FG000|Overall Study|Lost to Follow-up|885|||
145993362|NCT02743221|526489757|FG000|Overall Study|Progressive disease|29|||
145993363|NCT02743221|526489758|FG001|Overall Study|Progressive disease|38|||
145993364|NCT02743221|526489757|FG000|Overall Study|Adverse Event|17|||
145993365|NCT02743221|526489758|FG001|Overall Study|Adverse Event|14|||
145993366|NCT02743221|526489757|FG000|Overall Study|non medical reason|8|||
145993367|NCT02743221|526489758|FG001|Overall Study|non medical reason|2|||
145993368|NCT02743221|526489757|FG000|Overall Study|Physician Decision|2|||
145993369|NCT02743221|526489758|FG001|Overall Study|Physician Decision|5|||
145993370|NCT02743221|526489757|FG000|Overall Study|Patient not eligible, not treated|0|||
145993371|NCT02743221|526489758|FG001|Overall Study|Patient not eligible, not treated|1|||
145993372|NCT02609503|526489760|FG000|Overall Study|Adverse Event|1|||
145993373|NCT02609503|526489760|FG000|Overall Study|Death|1|||
145993374|NCT02609503|526489760|FG000|Overall Study|Withdrawal by Subject|1|||
145993375|NCT02609503|526489760|FG000|Overall Study|Disease progression|1|||
145993376|NCT02457065|526489766|FG000|Overall Study|Lost to Follow-up|9|||
145993377|NCT02457065|526489767|FG001|Overall Study|Lost to Follow-up|11|||
145993378|NCT04642079|526489770|FG000|Overall Study|Lost to Follow-up|2|||
145993379|NCT04642079|526489771|FG001|Overall Study|Lost to Follow-up|5|||
145993380|NCT04642079|526489772|FG002|Overall Study|Lost to Follow-up|2|||
145993381|NCT04642079|526489773|FG003|Overall Study|Lost to Follow-up|0|||
145993382|NCT04642079|526489770|FG000|Overall Study|Withdrawal by Subject|0|||
145993383|NCT04642079|526489771|FG001|Overall Study|Withdrawal by Subject|4|||
145993384|NCT04642079|526489772|FG002|Overall Study|Withdrawal by Subject|1|||
145993385|NCT04642079|526489773|FG003|Overall Study|Withdrawal by Subject|2|||
145993386|NCT04642079|526489770|FG000|Overall Study|Other|0|||
145993387|NCT04642079|526489771|FG001|Overall Study|Other|0|||
145993388|NCT04642079|526489772|FG002|Overall Study|Other|0|||
145993389|NCT04642079|526489773|FG003|Overall Study|Other|1|||
145993390|NCT04642079|526489770|FG000|Overall Study|No longer met eligibility criteria|1|||
145993391|NCT04642079|526489771|FG001|Overall Study|No longer met eligibility criteria|0|||
145993392|NCT04642079|526489772|FG002|Overall Study|No longer met eligibility criteria|1|||
145993393|NCT04642079|526489773|FG003|Overall Study|No longer met eligibility criteria|1|||
145993394|NCT05360784|526489775|FG000|Overall Study|Discontinued|25|||
145993395|NCT05360784|526489776|FG001|Overall Study|Discontinued|11|||
145993396|NCT02796651|526489777|FG000|Overall Study|Adverse Event|6|||
145993397|NCT02796651|526489777|FG000|Overall Study|Lost to Follow-up|1|||
145993398|NCT02796651|526489777|FG000|Overall Study|Withdrawal by Subject|4|||
145993399|NCT02796651|526489777|FG000|Overall Study|Protocol Violation|4|||
145993400|NCT02796651|526489777|FG000|Overall Study|Lack of Efficacy|1|||
145993401|NCT02796651|526489777|FG000|Overall Study|Other|10|||
145993402|NCT02251041|526489781|FG000|Overall Study|Did not receive intervention|15|||
145993403|NCT02251041|526489782|FG001|Overall Study|Did not receive intervention|4|||
145993404|NCT04918771|526489783|FG000|Overall Study|Withdrawal by Subject|4|||
145993405|NCT04918771|526489784|FG001|Overall Study|Withdrawal by Subject|5|||
145993406|NCT04918771|526489783|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
145993407|NCT04918771|526489784|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
145993408|NCT02971163|526489785|FG000|Overall Study|Lost to Follow-up|4|||
145993409|NCT02971163|526489786|FG001|Overall Study|Lost to Follow-up|2|||
145993410|NCT02940223|526489795|FG000|Overall Study|Failed Requirement|2|||
145993411|NCT02940223|526489796|FG001|Overall Study|Failed Requirement|0|||
145993412|NCT00526799|526489797|FG000|Overall Study|Withdrawal by Subject|1|||
145993413|NCT00526799|526489798|FG001|Overall Study|Withdrawal by Subject|0|||
145993414|NCT00526799|526489797|FG000|Overall Study|Intercurrent Complicating Disease|0|||
145993415|NCT00526799|526489798|FG001|Overall Study|Intercurrent Complicating Disease|1|||
145993416|NCT02871219|526489810|FG000|Overall Study|Adverse Event|15|||
145993417|NCT02871219|526489810|FG000|Overall Study|Death|3|||
145993418|NCT02871219|526489810|FG000|Overall Study|Progression|3|||
146091667|NCT02169284|526856866|FG000|Overall Study|Physician Decision|0|||
145993419|NCT02871219|526489810|FG000|Overall Study|Infections|7|||
145993420|NCT02871219|526489810|FG000|Overall Study|Infusion Related|4|||
145993421|NCT04134936|526489811|FG000|Overall Study|Adverse Event|3|||
145993422|NCT04134936|526489812|FG001|Overall Study|Adverse Event|2|||
145993423|NCT04134936|526489811|FG000|Overall Study|Withdrawal by Subject|2|||
145993424|NCT04134936|526489812|FG001|Overall Study|Withdrawal by Subject|3|||
145993425|NCT04134936|526489811|FG000|Overall Study|Physician Decision|0|||
146091668|NCT02169284|526856867|FG001|Overall Study|Physician Decision|1|||
145993426|NCT04134936|526489812|FG001|Overall Study|Physician Decision|1|||
145993427|NCT04134936|526489811|FG000|Overall Study|Progressive disease, joined another trial|1|||
145993428|NCT04134936|526489812|FG001|Overall Study|Progressive disease, joined another trial|0|||
145993429|NCT04134936|526489811|FG000|Overall Study|Progressive disease|1|||
145993430|NCT04134936|526489812|FG001|Overall Study|Progressive disease|0|||
145993431|NCT03518060|526489813|FG000|Overall Study|Death|1|||
145993432|NCT03518060|526489813|FG000|Overall Study|Poor adherence|1|||
145993433|NCT03518060|526489813|FG000|Overall Study|Withdrawal of informed consent|2|||
145993434|NCT03518060|526489813|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
145993435|NCT03518060|526489813|FG000|Overall Study|Physician Decision|7|||
145993436|NCT03518060|526489813|FG000|Overall Study|Adverse drug reactions|23|||
145993437|NCT03518060|526489813|FG000|Overall Study|Withdrawal by Subject|25|||
145993438|NCT03518060|526489813|FG000|Overall Study|Lost to Follow-up|13|||
145993439|NCT02097225|526489815|FG000|Dose Level 4|Adverse Event|0|||
145993440|NCT02097225|526489816|FG001|Dose Level 4|Adverse Event|0|||
145993441|NCT02097225|526489817|FG002|Dose Level 4|Adverse Event|0|||
145993442|NCT02097225|526489818|FG003|Dose Level 4|Adverse Event|0|||
145993443|NCT02097225|526489819|FG004|Dose Level 4|Adverse Event|1|||
145993444|NCT01852214|526489821|FG000|Period 1|Adverse Event|1|||
145993445|NCT01852214|526489822|FG001|Period 1|Adverse Event|2|||
145993446|NCT01852214|526489821|FG000|Period 1|Withdrawal by Subject|0|||
145993447|NCT01852214|526489822|FG001|Period 1|Withdrawal by Subject|1|||
145993448|NCT01852214|526489821|FG000|Washout Period|Withdrawal by Subject|0|||
145993449|NCT01852214|526489822|FG001|Washout Period|Withdrawal by Subject|1|||
145993450|NCT02679274|526489823|FG000|Overall Study|Withdrawal by Subject|1|||
145993451|NCT02679274|526489824|FG001|Overall Study|Withdrawal by Subject|0|||
145993452|NCT04976855|526489825|FG000|Part I|Withdrawal by Subject|0|||
145993453|NCT04976855|526489826|FG001|Part I|Withdrawal by Subject|1|||
145993454|NCT04976855|526489827|FG002|Part I|Withdrawal by Subject|0|||
145993455|NCT04976855|526489828|FG003|Part I|Withdrawal by Subject|0|||
145993456|NCT04976855|526489829|FG004|Part I|Withdrawal by Subject|0|||
145993457|NCT04976855|526489830|FG005|Part I|Withdrawal by Subject|0|||
145993458|NCT04976855|526489831|FG006|Part I|Withdrawal by Subject|0|||
145993459|NCT04976855|526489825|FG000|Part II|Adverse Event|0|||
145993460|NCT04976855|526489826|FG001|Part II|Adverse Event|0|||
145993461|NCT04976855|526489827|FG002|Part II|Adverse Event|0|||
145993462|NCT04976855|526489828|FG003|Part II|Adverse Event|1|||
145993463|NCT04976855|526489829|FG004|Part II|Adverse Event|0|||
145993464|NCT04976855|526489830|FG005|Part II|Adverse Event|0|||
145993465|NCT04976855|526489831|FG006|Part II|Adverse Event|0|||
145993466|NCT04976855|526489825|FG000|Part II|Withdrawal by Subject|0|||
145993467|NCT04976855|526489826|FG001|Part II|Withdrawal by Subject|0|||
145993468|NCT04976855|526489827|FG002|Part II|Withdrawal by Subject|0|||
145993469|NCT04976855|526489828|FG003|Part II|Withdrawal by Subject|0|||
145993470|NCT04976855|526489829|FG004|Part II|Withdrawal by Subject|1|||
145993471|NCT04976855|526489830|FG005|Part II|Withdrawal by Subject|0|||
145993472|NCT04976855|526489831|FG006|Part II|Withdrawal by Subject|0|||
145993473|NCT04976855|526489825|FG000|Part II|Lost to Follow-up|0|||
145993474|NCT04976855|526489826|FG001|Part II|Lost to Follow-up|0|||
145993475|NCT04976855|526489827|FG002|Part II|Lost to Follow-up|0|||
145993476|NCT04976855|526489828|FG003|Part II|Lost to Follow-up|0|||
145993477|NCT04976855|526489829|FG004|Part II|Lost to Follow-up|0|||
145993478|NCT04976855|526489830|FG005|Part II|Lost to Follow-up|1|||
145993479|NCT04976855|526489831|FG006|Part II|Lost to Follow-up|0|||
145993480|NCT05487378|526489832|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
145993481|NCT05487378|526489833|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
145993482|NCT05487378|526489832|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
145993483|NCT05487378|526489833|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
145993484|NCT00791648|526491102|FG000|Overall Study|Physician Decision|0|||
145993485|NCT00791648|526491103|FG001|Overall Study|Physician Decision|1|||
145993486|NCT00791648|526491102|FG000|Overall Study|Withdrawal by Subject|0|||
145993487|NCT00791648|526491103|FG001|Overall Study|Withdrawal by Subject|1|||
145993488|NCT01373281|526491105|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
145993489|NCT01373281|526491106|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
145993490|NCT01373281|526491105|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
146246458|NCT02309892|527415719|FG004|Overall Study|Progressive Disease|1|||
146246459|NCT02309892|527415720|FG005|Overall Study|Progressive Disease|0|||
146246460|NCT02309892|527415721|FG006|Overall Study|Progressive Disease|0|||
146246461|NCT02309892|527415715|FG000|Overall Study|Death|0|||
146246462|NCT02309892|527415716|FG001|Overall Study|Death|0|||
146246463|NCT02309892|527415717|FG002|Overall Study|Death|0|||
146246464|NCT02309892|527415718|FG003|Overall Study|Death|0|||
145993491|NCT01373281|526491106|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
145993492|NCT01373281|526491105|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
145993493|NCT01373281|526491106|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
145993494|NCT01373281|526491105|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
146246465|NCT02309892|527415719|FG004|Overall Study|Death|0|||
145993495|NCT01373281|526491106|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
145993496|NCT01373281|526491105|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
145993497|NCT01373281|526491106|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
145993498|NCT01373281|526491105|FG000|Surveillance Expansion Period|Protocol Violation|9|||
145993499|NCT01373281|526491106|FG001|Surveillance Expansion Period|Protocol Violation|1|||
145993500|NCT01373281|526491105|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
145993501|NCT01373281|526491106|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
145993502|NCT01373281|526491105|FG000|Surveillance Expansion Period|Serious adverse event|3|||
146246466|NCT02309892|527415720|FG005|Overall Study|Death|1|||
145993503|NCT01373281|526491106|FG001|Surveillance Expansion Period|Serious adverse event|4|||
145993504|NCT03502681|526491109|FG000|Overall Study|Adverse Event|1|||
145993505|NCT03502681|526491110|FG001|Overall Study|Adverse Event|1|||
145993506|NCT03502681|526491109|FG000|Overall Study|Disease Progression|2|||
145993507|NCT03502681|526491110|FG001|Overall Study|Disease Progression|1|||
145993508|NCT00488293|526491111|FG000|Overall Study|Lost to Follow-up|28|||
145993509|NCT00488293|526491112|FG001|Overall Study|Lost to Follow-up|25|||
145993510|NCT00488293|526491111|FG000|Overall Study|Withdrawal by Subject|5|||
145993511|NCT00488293|526491112|FG001|Overall Study|Withdrawal by Subject|3|||
145993512|NCT00488293|526491111|FG000|Overall Study|Death|2|||
145993513|NCT00488293|526491112|FG001|Overall Study|Death|1|||
145993514|NCT00488293|526491111|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
145993515|NCT00488293|526491112|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
145993516|NCT00939185|526491113|FG000|Overall Study|Adverse Event|3|||
145993517|NCT00939185|526491113|FG000|Overall Study|Lack of Efficacy|1|||
145993518|NCT00939185|526491113|FG000|Overall Study|Lost to Follow-up|6|||
145993519|NCT00939185|526491113|FG000|Overall Study|Other|3|||
145993520|NCT00939185|526491113|FG000|Overall Study|Withdrawal by Subject|2|||
145993521|NCT00939185|526491113|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
145993522|NCT03552029|526491114|FG000|Overall Study|Death|3|||
145993523|NCT03552029|526491115|FG001|Overall Study|Death|0|||
145993524|NCT03552029|526491114|FG000|Overall Study|Adverse Event|1|||
145993525|NCT03552029|526491115|FG001|Overall Study|Adverse Event|0|||
145993526|NCT03552029|526491114|FG000|Overall Study|Lack of Efficacy|0|||
145993527|NCT03552029|526491115|FG001|Overall Study|Lack of Efficacy|2|||
145993528|NCT03552029|526491114|FG000|Overall Study|Physician Decision|0|||
145993529|NCT03552029|526491115|FG001|Overall Study|Physician Decision|1|||
145993530|NCT03552029|526491114|FG000|Overall Study|Study terminated by Sponsor|0|||
145993531|NCT03552029|526491115|FG001|Overall Study|Study terminated by Sponsor|1|||
145993532|NCT03552029|526491114|FG000|Overall Study|Other|0|||
145993533|NCT03552029|526491115|FG001|Overall Study|Other|2|||
145993534|NCT03468998|526491117|FG000|Overall Study|Withdrawal by Subject|1|||
145993535|NCT03468998|526491118|FG001|Overall Study|Withdrawal by Subject|1|||
145993536|NCT03468998|526491119|FG002|Overall Study|Withdrawal by Subject|0|||
145993537|NCT03468998|526491120|FG003|Overall Study|Withdrawal by Subject|4|||
145993538|NCT03468998|526491121|FG004|Overall Study|Withdrawal by Subject|1|||
145993539|NCT03468998|526491122|FG005|Overall Study|Withdrawal by Subject|0|||
145993540|NCT00836706|526491123|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
145993541|NCT00836706|526491124|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
145993542|NCT02989857|526491125|FG000|Randomization Phase|Not Treated|3|||
145993543|NCT02989857|526491126|FG001|Randomization Phase|Not Treated|2|||
145993544|NCT02989857|526491127|FG002|Randomization Phase|Not Treated|0|||
145993545|NCT00633126|526491130|FG000|Overall Study|Did not receive full dose|1|||
145993546|NCT00688740|526491134|FG000|Overall Study|Adverse Event|45|||
145993547|NCT00688740|526491135|FG001|Overall Study|Adverse Event|8|||
145993548|NCT00688740|526491134|FG000|Overall Study|Death|2|||
145993549|NCT00688740|526491135|FG001|Overall Study|Death|2|||
145993550|NCT00688740|526491134|FG000|Overall Study|Lost to Follow-up|0|||
145993551|NCT00688740|526491135|FG001|Overall Study|Lost to Follow-up|1|||
145993552|NCT00688740|526491134|FG000|Overall Study|Consent Withdrawn|17|||
145993553|NCT00688740|526491135|FG001|Overall Study|Consent Withdrawn|17|||
145993554|NCT00688740|526491134|FG000|Overall Study|Breast Cancer Relapse|1|||
145993555|NCT00688740|526491135|FG001|Overall Study|Breast Cancer Relapse|4|||
145993556|NCT00688740|526491134|FG000|Overall Study|Violation of Inclusion Criteria|1|||
145993557|NCT00688740|526491135|FG001|Overall Study|Violation of Inclusion Criteria|3|||
145993558|NCT00567502|526491140|FG000|Overall Study|Lost to Follow-up|91|||
145993559|NCT00567502|526491141|FG001|Overall Study|Lost to Follow-up|14|||
145993560|NCT00567502|526491142|FG002|Overall Study|Lost to Follow-up|351|||
145993561|NCT00567502|526491143|FG003|Overall Study|Lost to Follow-up|2|||
145993562|NCT00567502|526491140|FG000|Overall Study|Death|65|||
145993563|NCT00567502|526491141|FG001|Overall Study|Death|16|||
145993564|NCT00567502|526491142|FG002|Overall Study|Death|360|||
146246467|NCT02309892|527415721|FG006|Overall Study|Death|0|||
145993565|NCT00567502|526491143|FG003|Overall Study|Death|5|||
145993566|NCT00567502|526491140|FG000|Overall Study|Other|64|||
145993567|NCT00567502|526491141|FG001|Overall Study|Other|2|||
145993568|NCT00567502|526491142|FG002|Overall Study|Other|134|||
145993569|NCT00567502|526491143|FG003|Overall Study|Other|6|||
145993570|NCT00567502|526491140|FG000|Overall Study|Participant request|12|||
145993571|NCT00567502|526491141|FG001|Overall Study|Participant request|1|||
145993572|NCT00567502|526491142|FG002|Overall Study|Participant request|33|||
145993573|NCT00567502|526491143|FG003|Overall Study|Participant request|1|||
145993574|NCT00567502|526491140|FG000|Overall Study|Sponsor request|9|||
145993575|NCT00567502|526491141|FG001|Overall Study|Sponsor request|0|||
145993576|NCT00567502|526491142|FG002|Overall Study|Sponsor request|30|||
145993577|NCT00567502|526491143|FG003|Overall Study|Sponsor request|1|||
145993578|NCT00567502|526491140|FG000|Overall Study|Never Initiated Treatment|0|||
145993579|NCT00567502|526491141|FG001|Overall Study|Never Initiated Treatment|0|||
145993580|NCT00567502|526491142|FG002|Overall Study|Never Initiated Treatment|0|||
146091669|NCT03583073|526856868|FG000|Overall Study|Lost to Follow-up|8|||
145993581|NCT00567502|526491143|FG003|Overall Study|Never Initiated Treatment|72|||
145993582|NCT00557440|526491155|FG000|Treatment Period 1|Adverse Event|0|||
145993583|NCT00557440|526491156|FG001|Treatment Period 1|Adverse Event|0|||
145993584|NCT00557440|526491157|FG002|Treatment Period 1|Adverse Event|1|||
145993585|NCT03524157|526491158|FG000|Overall Study|cytology not readable|0|||
145993586|NCT03524157|526491159|FG001|Overall Study|cytology not readable|0|||
145993587|NCT03524157|526491160|FG002|Overall Study|cytology not readable|1|||
145993588|NCT03322566|526491161|FG000|Overall Study|Death|34|||
145993589|NCT03322566|526491162|FG001|Overall Study|Death|35|||
145993590|NCT03322566|526491163|FG002|Overall Study|Death|23|||
145993591|NCT03322566|526491161|FG000|Overall Study|Physician Decision|6|||
146091670|NCT03583073|526856869|FG001|Overall Study|Lost to Follow-up|12|||
146091671|NCT05323656|526856873|FG000|Overall Study|Still On-Treatment|6|||
146091672|NCT05323656|526856874|FG001|Overall Study|Still On-Treatment|6|||
146091673|NCT05323656|526856873|FG000|Overall Study|Progressive Disease|15|||
146091674|NCT05323656|526856874|FG001|Overall Study|Progressive Disease|14|||
146091675|NCT05323656|526856873|FG000|Overall Study|Adverse Event|2|||
146091676|NCT05323656|526856874|FG001|Overall Study|Adverse Event|3|||
146091677|NCT05323656|526856873|FG000|Overall Study|Death|1|||
146091678|NCT05323656|526856874|FG001|Overall Study|Death|2|||
146091679|NCT05323656|526856873|FG000|Overall Study|Withdrawal by Subject|1|||
146091680|NCT05323656|526856874|FG001|Overall Study|Withdrawal by Subject|0|||
146091681|NCT05323656|526856873|FG000|Overall Study|Clinical disease progression|0|||
146091682|NCT05323656|526856874|FG001|Overall Study|Clinical disease progression|1|||
146091683|NCT05323656|526856873|FG000|Overall Study|Patient and Investigator decision|1|||
146091684|NCT05323656|526856874|FG001|Overall Study|Patient and Investigator decision|0|||
146091685|NCT05323656|526856873|FG000|Overall Study|Physician Decision|0|||
146091686|NCT05323656|526856874|FG001|Overall Study|Physician Decision|1|||
146091687|NCT02495233|526856877|FG000|Overall Study|Miscellaneous|0|||
146091688|NCT02495233|526856878|FG001|Overall Study|Miscellaneous|1|||
146091689|NCT03880461|526856880|FG000|Overall Study|Determined ineligible after enrollment|45|||
146091690|NCT03880461|526856881|FG001|Overall Study|Determined ineligible after enrollment|44|||
146091691|NCT03880461|526856880|FG000|Overall Study|No weight measurement after enrollment|24|||
146091692|NCT03880461|526856881|FG001|Overall Study|No weight measurement after enrollment|17|||
146091693|NCT01115803|526856887|FG000|Overall Study|Withdrawal by Subject|0|||
146091694|NCT01115803|526856888|FG001|Overall Study|Withdrawal by Subject|0|||
146091695|NCT01115803|526856889|FG002|Overall Study|Withdrawal by Subject|0|||
146091696|NCT01115803|526856890|FG003|Overall Study|Withdrawal by Subject|0|||
146091697|NCT01115803|526856891|FG004|Overall Study|Withdrawal by Subject|0|||
146091698|NCT01115803|526856892|FG005|Overall Study|Withdrawal by Subject|0|||
146091699|NCT01115803|526856893|FG006|Overall Study|Withdrawal by Subject|1|||
146091700|NCT01115803|526856887|FG000|Overall Study|Lost to Follow-up|0|||
146091701|NCT01115803|526856888|FG001|Overall Study|Lost to Follow-up|0|||
146091702|NCT01115803|526856889|FG002|Overall Study|Lost to Follow-up|1|||
146091703|NCT01115803|526856890|FG003|Overall Study|Lost to Follow-up|0|||
146091704|NCT01115803|526856891|FG004|Overall Study|Lost to Follow-up|0|||
146091705|NCT01115803|526856892|FG005|Overall Study|Lost to Follow-up|0|||
146091706|NCT01115803|526856893|FG006|Overall Study|Lost to Follow-up|0|||
146091707|NCT01115803|526856887|FG000|Overall Study|Progressive Disease during Cycle1|0|||
146091708|NCT01115803|526856888|FG001|Overall Study|Progressive Disease during Cycle1|0|||
146091709|NCT01115803|526856889|FG002|Overall Study|Progressive Disease during Cycle1|0|||
146091710|NCT01115803|526856890|FG003|Overall Study|Progressive Disease during Cycle1|0|||
146091711|NCT01115803|526856891|FG004|Overall Study|Progressive Disease during Cycle1|0|||
146091712|NCT01115803|526856892|FG005|Overall Study|Progressive Disease during Cycle1|0|||
146091713|NCT01115803|526856893|FG006|Overall Study|Progressive Disease during Cycle1|1|||
146091714|NCT00450385|526856894|FG000|Overall Study|Death|3|||
146091715|NCT00450385|526856894|FG000|Overall Study|Protocol Violation|1|||
146091716|NCT00450385|526856894|FG000|Overall Study|Withdrawal by Subject|2|||
146091717|NCT00450385|526856894|FG000|Overall Study|Lack of Efficacy|2|||
146091718|NCT00450385|526856894|FG000|Overall Study|Adverse Event|1|||
146091719|NCT00450385|526856894|FG000|Overall Study|Physician Decision|1|||
146091720|NCT00450385|526856894|FG000|Overall Study|Other|3|||
146091721|NCT03533686|526856895|FG000|Overall Study|Withdrawal by Subject|1|||
146091722|NCT03533686|526856896|FG001|Overall Study|Withdrawal by Subject|0|||
145993592|NCT03322566|526491162|FG001|Overall Study|Physician Decision|7|||
145993593|NCT03322566|526491163|FG002|Overall Study|Physician Decision|2|||
145993594|NCT03322566|526491161|FG000|Overall Study|Withdrawal by Subject|4|||
145993595|NCT03322566|526491162|FG001|Overall Study|Withdrawal by Subject|3|||
146091723|NCT03533686|526856897|FG002|Overall Study|Withdrawal by Subject|0|||
146091724|NCT03533686|526856898|FG003|Overall Study|Withdrawal by Subject|3|||
146091725|NCT03533686|526856899|FG004|Overall Study|Withdrawal by Subject|5|||
146091726|NCT03533686|526856900|FG005|Overall Study|Withdrawal by Subject|1|||
146091727|NCT03533686|526856895|FG000|Overall Study|Lost to Follow-up|0|||
146091728|NCT03533686|526856896|FG001|Overall Study|Lost to Follow-up|1|||
146091729|NCT03533686|526856897|FG002|Overall Study|Lost to Follow-up|0|||
145993596|NCT03322566|526491163|FG002|Overall Study|Withdrawal by Subject|6|||
145993597|NCT03322566|526491161|FG000|Overall Study|Lost to Follow-up|0|||
145993598|NCT03322566|526491162|FG001|Overall Study|Lost to Follow-up|0|||
145993599|NCT03322566|526491163|FG002|Overall Study|Lost to Follow-up|1|||
145993600|NCT03322566|526491161|FG000|Overall Study|Study terminated by sponsor|1|||
145993601|NCT03322566|526491162|FG001|Overall Study|Study terminated by sponsor|0|||
145993602|NCT03322566|526491163|FG002|Overall Study|Study terminated by sponsor|1|||
145993603|NCT04023487|526491166|FG000|Overall Study|Lost to Follow-up|5|||
145993604|NCT04023487|526491167|FG001|Overall Study|Lost to Follow-up|4|||
145993605|NCT04023487|526491166|FG000|Overall Study|Pregnancy|1|||
145993606|NCT04023487|526491167|FG001|Overall Study|Pregnancy|2|||
145993607|NCT04023487|526491166|FG000|Overall Study|Withdrawal by Subject|4|||
145993608|NCT04023487|526491167|FG001|Overall Study|Withdrawal by Subject|5|||
145993609|NCT04023487|526491166|FG000|Overall Study|Partially completed testing|8|||
145993610|NCT04023487|526491167|FG001|Overall Study|Partially completed testing|4|||
145993611|NCT05473715|526491170|FG000|Overall Study|Trial terminate|2|||
145993612|NCT05473715|526491171|FG001|Overall Study|Trial terminate|1|||
145993613|NCT02592863|526491172|FG000|Overall Study|Withdrawal by Subject|2|||
145993614|NCT02592863|526491173|FG001|Overall Study|Withdrawal by Subject|2|||
145993615|NCT02592863|526491172|FG000|Overall Study|Lost to Follow-up|1|||
145993616|NCT02592863|526491173|FG001|Overall Study|Lost to Follow-up|1|||
145993617|NCT03528902|526491176|FG000|Overall Study|Adverse Event|1|||
145993618|NCT03528902|526491177|FG001|Overall Study|Adverse Event|0|||
145993619|NCT03411044|526491178|FG000|Overall Study|Death|30|||
145993620|NCT03411044|526491178|FG000|Overall Study|Withdrawal by Subject|48|||
145993621|NCT03411044|526491178|FG000|Overall Study|Lost to Follow-up|78|||
145993622|NCT03411044|526491178|FG000|Overall Study|Adverse Event|30|||
145993623|NCT03411044|526491178|FG000|Overall Study|Missing status|4|||
145993624|NCT00023595|526491185|FG000|5 Year Follow up|Lost to Follow-up|2|||
145993625|NCT00023595|526491186|FG001|5 Year Follow up|Lost to Follow-up|2|||
145993626|NCT00023595|526491187|FG002|5 Year Follow up|Lost to Follow-up|1|||
145993627|NCT00023595|526491188|FG003|5 Year Follow up|Lost to Follow-up|7|||
145993628|NCT00023595|526491189|FG004|5 Year Follow up|Lost to Follow-up|3|||
145993629|NCT00023595|526491185|FG000|10 Year Follow up|Lost to Follow-up|12|||
145993630|NCT00023595|526491186|FG001|10 Year Follow up|Lost to Follow-up|10|||
145993631|NCT00023595|526491187|FG002|10 Year Follow up|Lost to Follow-up|3|||
145993632|NCT00023595|526491188|FG003|10 Year Follow up|Lost to Follow-up|0|||
145993633|NCT00023595|526491189|FG004|10 Year Follow up|Lost to Follow-up|0|||
145993634|NCT05889468|526491190|FG000|Overall Study|Lost to Follow-up|9|||
145993635|NCT05889468|526491191|FG001|Overall Study|Lost to Follow-up|2|||
145993636|NCT05889468|526491190|FG000|Overall Study|Withdrawal by Subject|2|||
145993637|NCT05889468|526491191|FG001|Overall Study|Withdrawal by Subject|2|||
145993638|NCT03900650|526491196|FG000|Overall Study|Withdrawal by Subject|1|||
145993639|NCT03900650|526491197|FG001|Overall Study|Withdrawal by Subject|1|||
145993640|NCT03900650|526491198|FG002|Overall Study|Withdrawal by Subject|0|||
145993641|NCT03900650|526491199|FG003|Overall Study|Withdrawal by Subject|0|||
145993642|NCT03900650|526491196|FG000|Overall Study|Withdrawn by staff|1|||
145993643|NCT03900650|526491197|FG001|Overall Study|Withdrawn by staff|0|||
145993644|NCT03900650|526491198|FG002|Overall Study|Withdrawn by staff|0|||
145993645|NCT03900650|526491199|FG003|Overall Study|Withdrawn by staff|0|||
145993646|NCT02014376|526491202|FG000|Overall Study|Adverse Event|1|||
145993647|NCT02014376|526491203|FG001|Overall Study|Adverse Event|1|||
145993648|NCT02014376|526491204|FG002|Overall Study|Adverse Event|0|||
145993649|NCT02014376|526491202|FG000|Overall Study|Lost to Follow-up|2|||
145993650|NCT02014376|526491203|FG001|Overall Study|Lost to Follow-up|0|||
145993651|NCT02014376|526491204|FG002|Overall Study|Lost to Follow-up|0|||
145993652|NCT00721110|526491209|FG000|Overall Study|Ultram use|1|||
145993653|NCT00721110|526491210|FG001|Overall Study|Ultram use|0|||
145993654|NCT00721110|526491211|FG002|Overall Study|Ultram use|0|||
145993655|NCT00721110|526491212|FG003|Overall Study|Ultram use|0|||
145993656|NCT00721110|526491209|FG000|Overall Study|vertical incision|0|||
145993657|NCT00721110|526491210|FG001|Overall Study|vertical incision|0|||
145993658|NCT00721110|526491211|FG002|Overall Study|vertical incision|1|||
145993659|NCT00721110|526491212|FG003|Overall Study|vertical incision|0|||
145993660|NCT02226653|526491219|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
145993661|NCT02226653|526491220|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
145993662|NCT02226653|526491219|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
145993663|NCT02226653|526491220|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
145993664|NCT00209131|526491228|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
145993665|NCT00209131|526491229|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
145993666|NCT03034044|526491230|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
145993667|NCT00462826|526492984|FG000|Overall Study|Ineligible - second primary|1|||
145993668|NCT00462826|526492984|FG000|Overall Study|Ineligible - wrong cell type|1|||
145993669|NCT00462826|526492984|FG000|Overall Study|Ineligible - wrong primary|2|||
145993670|NCT00462826|526492984|FG000|Overall Study|Never treated|1|||
145993671|NCT01397253|526492985|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
145993672|NCT01397253|526492986|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
145993673|NCT03436732|526492987|FG000|Overall Study|Not treated-enrolled in different study|1|||
145993674|NCT03436732|526492988|FG001|Overall Study|Not treated-enrolled in different study|0|||
146246468|NCT01584648|527415722|FG000|Overall Study|Death|136|||
146246469|NCT01584648|527415723|FG001|Overall Study|Death|146|||
146246470|NCT01584648|527415722|FG000|Overall Study|Lost to Follow-up|9|||
145993675|NCT03436732|526492987|FG000|Overall Study|Off study after cycle 1|1|||
145993676|NCT03436732|526492988|FG001|Overall Study|Off study after cycle 1|0|||
145993677|NCT03436732|526492987|FG000|Overall Study|Adverse Event|2|||
145993678|NCT03436732|526492988|FG001|Overall Study|Adverse Event|0|||
145993679|NCT03436732|526492987|FG000|Overall Study|Death|0|||
145993680|NCT03436732|526492988|FG001|Overall Study|Death|1|||
145993681|NCT03243084|526492992|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
145993682|NCT03243084|526492993|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
145993683|NCT00863304|526492996|FG000|Overall Study|Adverse Event|10|||
145993684|NCT00863304|526492997|FG001|Overall Study|Adverse Event|4|||
145993685|NCT00863304|526492998|FG002|Overall Study|Adverse Event|14|||
145993686|NCT00863304|526492999|FG003|Overall Study|Adverse Event|16|||
145993687|NCT00863304|526492996|FG000|Overall Study|Lost to Follow-up|1|||
145993688|NCT00863304|526492997|FG001|Overall Study|Lost to Follow-up|5|||
145993689|NCT00863304|526492998|FG002|Overall Study|Lost to Follow-up|4|||
145993690|NCT00863304|526492999|FG003|Overall Study|Lost to Follow-up|2|||
145993691|NCT00863304|526492996|FG000|Overall Study|Lack of Efficacy|57|||
145993692|NCT00863304|526492997|FG001|Overall Study|Lack of Efficacy|26|||
145993693|NCT00863304|526492998|FG002|Overall Study|Lack of Efficacy|30|||
145993694|NCT00863304|526492999|FG003|Overall Study|Lack of Efficacy|28|||
145993695|NCT00863304|526492996|FG000|Overall Study|Withdrawal by Subject|19|||
145993696|NCT00863304|526492997|FG001|Overall Study|Withdrawal by Subject|14|||
145993697|NCT00863304|526492998|FG002|Overall Study|Withdrawal by Subject|20|||
145993698|NCT00863304|526492999|FG003|Overall Study|Withdrawal by Subject|18|||
145993699|NCT00863304|526492996|FG000|Overall Study|Other|1|||
145993700|NCT00863304|526492997|FG001|Overall Study|Other|0|||
145993701|NCT00863304|526492998|FG002|Overall Study|Other|0|||
145993702|NCT00863304|526492999|FG003|Overall Study|Other|1|||
145993703|NCT00863304|526492996|FG000|Overall Study|Protocol Violation|2|||
145993704|NCT00863304|526492997|FG001|Overall Study|Protocol Violation|6|||
145993705|NCT00863304|526492998|FG002|Overall Study|Protocol Violation|2|||
145993706|NCT00863304|526492999|FG003|Overall Study|Protocol Violation|0|||
145993707|NCT00863304|526492996|FG000|Overall Study|Randomized, but not Treated|3|||
145993708|NCT00863304|526492997|FG001|Overall Study|Randomized, but not Treated|1|||
145993709|NCT00863304|526492998|FG002|Overall Study|Randomized, but not Treated|4|||
145993710|NCT00863304|526492999|FG003|Overall Study|Randomized, but not Treated|1|||
145993711|NCT00863304|526492996|FG000|Overall Study|Entered extension study|101|||
145993712|NCT00863304|526492997|FG001|Overall Study|Entered extension study|129|||
145993713|NCT00863304|526492998|FG002|Overall Study|Entered extension study|113|||
145993714|NCT00863304|526492999|FG003|Overall Study|Entered extension study|125|||
145993715|NCT02327169|526493000|FG000|Overall Study|Progressive Disease|1|||
145993716|NCT02327169|526493001|FG001|Overall Study|Progressive Disease|3|||
145993717|NCT02327169|526493002|FG002|Overall Study|Progressive Disease|4|||
145993718|NCT02327169|526493003|FG003|Overall Study|Progressive Disease|3|||
145993719|NCT02327169|526493004|FG004|Overall Study|Progressive Disease|4|||
145993720|NCT02327169|526493005|FG005|Overall Study|Progressive Disease|3|||
145993721|NCT02327169|526493006|FG006|Overall Study|Progressive Disease|3|||
145993722|NCT02327169|526493007|FG007|Overall Study|Progressive Disease|3|||
145993723|NCT02327169|526493008|FG008|Overall Study|Progressive Disease|4|||
145993724|NCT02327169|526493009|FG009|Overall Study|Progressive Disease|4|||
145993725|NCT02327169|526493010|FG010|Overall Study|Progressive Disease|4|||
145993726|NCT02327169|526493011|FG011|Overall Study|Progressive Disease|3|||
145993727|NCT02327169|526493012|FG012|Overall Study|Progressive Disease|1|||
145993728|NCT02327169|526493013|FG013|Overall Study|Progressive Disease|3|||
145993729|NCT02327169|526493014|FG014|Overall Study|Progressive Disease|3|||
145993730|NCT02327169|526493000|FG000|Overall Study|Adverse Event|2|||
145993731|NCT02327169|526493001|FG001|Overall Study|Adverse Event|0|||
145993732|NCT02327169|526493002|FG002|Overall Study|Adverse Event|1|||
145993733|NCT02327169|526493003|FG003|Overall Study|Adverse Event|0|||
145993734|NCT02327169|526493004|FG004|Overall Study|Adverse Event|1|||
145993735|NCT02327169|526493005|FG005|Overall Study|Adverse Event|0|||
145993736|NCT02327169|526493006|FG006|Overall Study|Adverse Event|0|||
145993737|NCT02327169|526493007|FG007|Overall Study|Adverse Event|0|||
145993738|NCT02327169|526493008|FG008|Overall Study|Adverse Event|0|||
145993739|NCT02327169|526493009|FG009|Overall Study|Adverse Event|2|||
146091730|NCT03533686|526856898|FG003|Overall Study|Lost to Follow-up|0|||
146091731|NCT03533686|526856899|FG004|Overall Study|Lost to Follow-up|2|||
146091732|NCT03533686|526856900|FG005|Overall Study|Lost to Follow-up|0|||
145993740|NCT02327169|526493010|FG010|Overall Study|Adverse Event|0|||
145993741|NCT02327169|526493011|FG011|Overall Study|Adverse Event|3|||
145993742|NCT02327169|526493012|FG012|Overall Study|Adverse Event|0|||
145993743|NCT02327169|526493013|FG013|Overall Study|Adverse Event|2|||
145993744|NCT02327169|526493014|FG014|Overall Study|Adverse Event|1|||
146091733|NCT03533686|526856895|FG000|Overall Study|Screen Failure|0|||
145993745|NCT02327169|526493000|FG000|Overall Study|Symptomatic Deterioration|0|||
145993746|NCT02327169|526493001|FG001|Overall Study|Symptomatic Deterioration|0|||
145993747|NCT02327169|526493002|FG002|Overall Study|Symptomatic Deterioration|1|||
146091734|NCT03533686|526856896|FG001|Overall Study|Screen Failure|0|||
146091735|NCT03533686|526856897|FG002|Overall Study|Screen Failure|0|||
146091736|NCT03533686|526856898|FG003|Overall Study|Screen Failure|2|||
146091737|NCT03533686|526856899|FG004|Overall Study|Screen Failure|0|||
146246471|NCT01584648|527415723|FG001|Overall Study|Lost to Follow-up|9|||
145993748|NCT02327169|526493003|FG003|Overall Study|Symptomatic Deterioration|0|||
145993749|NCT02327169|526493004|FG004|Overall Study|Symptomatic Deterioration|1|||
145993750|NCT02327169|526493005|FG005|Overall Study|Symptomatic Deterioration|1|||
145993751|NCT02327169|526493006|FG006|Overall Study|Symptomatic Deterioration|0|||
145993752|NCT02327169|526493007|FG007|Overall Study|Symptomatic Deterioration|0|||
145993753|NCT02327169|526493008|FG008|Overall Study|Symptomatic Deterioration|2|||
145993754|NCT02327169|526493009|FG009|Overall Study|Symptomatic Deterioration|1|||
145993755|NCT02327169|526493010|FG010|Overall Study|Symptomatic Deterioration|0|||
145993756|NCT02327169|526493011|FG011|Overall Study|Symptomatic Deterioration|0|||
145993757|NCT02327169|526493012|FG012|Overall Study|Symptomatic Deterioration|0|||
145993758|NCT02327169|526493013|FG013|Overall Study|Symptomatic Deterioration|2|||
145993759|NCT02327169|526493014|FG014|Overall Study|Symptomatic Deterioration|1|||
145993760|NCT02327169|526493000|FG000|Overall Study|Reason Not Specified|0|||
145993761|NCT02327169|526493001|FG001|Overall Study|Reason Not Specified|0|||
145993762|NCT02327169|526493002|FG002|Overall Study|Reason Not Specified|1|||
145993763|NCT02327169|526493003|FG003|Overall Study|Reason Not Specified|0|||
145993764|NCT02327169|526493004|FG004|Overall Study|Reason Not Specified|0|||
145993765|NCT02327169|526493005|FG005|Overall Study|Reason Not Specified|0|||
145993766|NCT02327169|526493006|FG006|Overall Study|Reason Not Specified|0|||
145993767|NCT02327169|526493007|FG007|Overall Study|Reason Not Specified|0|||
145993768|NCT02327169|526493008|FG008|Overall Study|Reason Not Specified|0|||
145993769|NCT02327169|526493009|FG009|Overall Study|Reason Not Specified|1|||
145993770|NCT02327169|526493010|FG010|Overall Study|Reason Not Specified|2|||
145993771|NCT02327169|526493011|FG011|Overall Study|Reason Not Specified|1|||
145993772|NCT02327169|526493012|FG012|Overall Study|Reason Not Specified|0|||
145993773|NCT02327169|526493013|FG013|Overall Study|Reason Not Specified|0|||
145993774|NCT02327169|526493014|FG014|Overall Study|Reason Not Specified|2|||
145993775|NCT02327169|526493000|FG000|Overall Study|Withdrawal by Subject|1|||
145993776|NCT02327169|526493001|FG001|Overall Study|Withdrawal by Subject|0|||
145993777|NCT02327169|526493002|FG002|Overall Study|Withdrawal by Subject|0|||
145993778|NCT02327169|526493003|FG003|Overall Study|Withdrawal by Subject|0|||
145993779|NCT02327169|526493004|FG004|Overall Study|Withdrawal by Subject|1|||
145993780|NCT02327169|526493005|FG005|Overall Study|Withdrawal by Subject|0|||
145993781|NCT02327169|526493006|FG006|Overall Study|Withdrawal by Subject|0|||
145993782|NCT02327169|526493007|FG007|Overall Study|Withdrawal by Subject|1|||
145993783|NCT02327169|526493008|FG008|Overall Study|Withdrawal by Subject|0|||
145993784|NCT02327169|526493009|FG009|Overall Study|Withdrawal by Subject|0|||
145993785|NCT02327169|526493010|FG010|Overall Study|Withdrawal by Subject|0|||
145993786|NCT02327169|526493011|FG011|Overall Study|Withdrawal by Subject|0|||
145993787|NCT02327169|526493012|FG012|Overall Study|Withdrawal by Subject|0|||
145993788|NCT02327169|526493013|FG013|Overall Study|Withdrawal by Subject|0|||
145993789|NCT02327169|526493014|FG014|Overall Study|Withdrawal by Subject|3|||
145993790|NCT02327169|526493000|FG000|Overall Study|Lost to Follow-up|0|||
145993791|NCT02327169|526493001|FG001|Overall Study|Lost to Follow-up|0|||
145993792|NCT02327169|526493002|FG002|Overall Study|Lost to Follow-up|0|||
145993793|NCT02327169|526493003|FG003|Overall Study|Lost to Follow-up|0|||
145993794|NCT02327169|526493004|FG004|Overall Study|Lost to Follow-up|1|||
145993795|NCT02327169|526493005|FG005|Overall Study|Lost to Follow-up|0|||
145993796|NCT02327169|526493006|FG006|Overall Study|Lost to Follow-up|0|||
145993797|NCT02327169|526493007|FG007|Overall Study|Lost to Follow-up|0|||
145993798|NCT02327169|526493008|FG008|Overall Study|Lost to Follow-up|0|||
145993799|NCT02327169|526493009|FG009|Overall Study|Lost to Follow-up|0|||
145993800|NCT02327169|526493010|FG010|Overall Study|Lost to Follow-up|0|||
145993801|NCT02327169|526493011|FG011|Overall Study|Lost to Follow-up|0|||
145993802|NCT02327169|526493012|FG012|Overall Study|Lost to Follow-up|0|||
145993803|NCT02327169|526493013|FG013|Overall Study|Lost to Follow-up|0|||
145993804|NCT02327169|526493014|FG014|Overall Study|Lost to Follow-up|0|||
145993805|NCT03766399|526493015|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993806|NCT03766399|526493016|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993807|NCT03766399|526493017|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993808|NCT03766399|526493018|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993809|NCT03766399|526493019|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993810|NCT03766399|526493020|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146091738|NCT03533686|526856900|FG005|Overall Study|Screen Failure|0|||
145993811|NCT03766399|526493021|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993812|NCT03766399|526493022|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146091739|NCT00136604|526856901|FG000|Overall Study|Lost to Follow-up|1|||
145993813|NCT03766399|526493023|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993814|NCT03766399|526493024|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
146091740|NCT00136604|526856902|FG001|Overall Study|Lost to Follow-up|0|||
145993815|NCT03766399|526493025|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993816|NCT03766399|526493026|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993817|NCT03766399|526493027|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993818|NCT03766399|526493028|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
145993819|NCT03766399|526493029|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993820|NCT03766399|526493030|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993821|NCT03766399|526493031|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993822|NCT03766399|526493032|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145993823|NCT05030766|526493033|FG000|Phase 1 Participants|Lost to Follow-up|12|||
145993824|NCT05030766|526493034|FG001|Phase 1 Participants|Lost to Follow-up|22|||
145993825|NCT05030766|526493035|FG002|Phase 1 Participants|Lost to Follow-up|0|||
145993826|NCT05030766|526493036|FG003|Phase 1 Participants|Lost to Follow-up|0|||
145993827|NCT05030766|526493033|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
145993828|NCT05030766|526493034|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
145993829|NCT05030766|526493035|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
145993830|NCT05030766|526493036|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
145993831|NCT05030766|526493033|FG000|Phase 2 Participants|Lost to Follow-up|0|||
145993832|NCT05030766|526493034|FG001|Phase 2 Participants|Lost to Follow-up|0|||
145993833|NCT05030766|526493035|FG002|Phase 2 Participants|Lost to Follow-up|6|||
145993834|NCT05030766|526493036|FG003|Phase 2 Participants|Lost to Follow-up|2|||
145993835|NCT00645658|526493037|FG000|Overall Study|Withdrawal by Subject|1|||
145993836|NCT00645658|526493038|FG001|Overall Study|Withdrawal by Subject|0|||
145993837|NCT00645658|526493037|FG000|Overall Study|Did not complete all assesments|0|||
145993838|NCT00645658|526493038|FG001|Overall Study|Did not complete all assesments|2|||
145993839|NCT03895372|526493041|FG000|Investigational Treatment Period|Adverse Event|1|||
145993840|NCT03895372|526493042|FG001|Investigational Treatment Period|Adverse Event|0|||
145993841|NCT03895372|526493043|FG002|Investigational Treatment Period|Adverse Event|0|||
145993842|NCT03895372|526493044|FG003|Investigational Treatment Period|Adverse Event|0|||
145993843|NCT03895372|526493045|FG004|Investigational Treatment Period|Adverse Event|0|||
145993844|NCT03895372|526493046|FG005|Investigational Treatment Period|Adverse Event|0|||
145993845|NCT03895372|526493047|FG006|Investigational Treatment Period|Adverse Event|4|||
145993846|NCT03895372|526493048|FG007|Investigational Treatment Period|Adverse Event|3|||
145993847|NCT03895372|526493041|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
145993848|NCT03895372|526493042|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
145993849|NCT03895372|526493043|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
145993850|NCT03895372|526493044|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
145993851|NCT03895372|526493045|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
145993852|NCT03895372|526493046|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
145993853|NCT03895372|526493047|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
145993854|NCT03895372|526493048|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
145993855|NCT03895372|526493041|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
145993856|NCT03895372|526493042|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
145993857|NCT03895372|526493043|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
145993858|NCT03895372|526493044|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
145993859|NCT03895372|526493045|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
145993860|NCT03895372|526493046|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
145993861|NCT03895372|526493047|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
145993862|NCT03895372|526493048|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
145993863|NCT03895372|526493041|FG000|Investigational Treatment Period|Other|0|||
145993864|NCT03895372|526493042|FG001|Investigational Treatment Period|Other|0|||
145993865|NCT03895372|526493043|FG002|Investigational Treatment Period|Other|0|||
145993866|NCT03895372|526493044|FG003|Investigational Treatment Period|Other|0|||
145993867|NCT03895372|526493045|FG004|Investigational Treatment Period|Other|0|||
145993868|NCT03895372|526493046|FG005|Investigational Treatment Period|Other|1|||
145993869|NCT03895372|526493047|FG006|Investigational Treatment Period|Other|0|||
145993870|NCT03895372|526493048|FG007|Investigational Treatment Period|Other|2|||
145993871|NCT03895372|526493041|FG000|Investigational Treatment Period|Protocol Violation|0|||
145993872|NCT03895372|526493042|FG001|Investigational Treatment Period|Protocol Violation|0|||
145993873|NCT03895372|526493043|FG002|Investigational Treatment Period|Protocol Violation|0|||
145993874|NCT03895372|526493044|FG003|Investigational Treatment Period|Protocol Violation|1|||
145993875|NCT03895372|526493045|FG004|Investigational Treatment Period|Protocol Violation|0|||
145993876|NCT03895372|526493046|FG005|Investigational Treatment Period|Protocol Violation|0|||
145993877|NCT03895372|526493047|FG006|Investigational Treatment Period|Protocol Violation|0|||
145993878|NCT03895372|526493048|FG007|Investigational Treatment Period|Protocol Violation|0|||
145993879|NCT03895372|526493041|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
145993880|NCT03895372|526493042|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
145993881|NCT03895372|526493043|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
145993882|NCT03895372|526493044|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
146091741|NCT00136604|526856903|FG002|Overall Study|Lost to Follow-up|0|||
145993883|NCT03895372|526493045|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
145993884|NCT03895372|526493046|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
145993885|NCT03895372|526493047|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
145993886|NCT03895372|526493048|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
145993887|NCT03895372|526493041|FG000|Extension Treatment Period|Adverse Event|0|||
145993888|NCT03895372|526493042|FG001|Extension Treatment Period|Adverse Event|1|||
145993889|NCT03895372|526493043|FG002|Extension Treatment Period|Adverse Event|0|||
145993890|NCT03895372|526493044|FG003|Extension Treatment Period|Adverse Event|1|||
145993891|NCT03895372|526493045|FG004|Extension Treatment Period|Adverse Event|0|||
145993892|NCT03895372|526493046|FG005|Extension Treatment Period|Adverse Event|0|||
145993893|NCT03895372|526493047|FG006|Extension Treatment Period|Adverse Event|3|||
145993894|NCT03895372|526493048|FG007|Extension Treatment Period|Adverse Event|3|||
145993895|NCT03895372|526493041|FG000|Extension Treatment Period|Other|1|||
145993896|NCT03895372|526493042|FG001|Extension Treatment Period|Other|3|||
145993897|NCT03895372|526493043|FG002|Extension Treatment Period|Other|0|||
145993898|NCT03895372|526493044|FG003|Extension Treatment Period|Other|0|||
145993899|NCT03895372|526493045|FG004|Extension Treatment Period|Other|1|||
145993900|NCT03895372|526493046|FG005|Extension Treatment Period|Other|0|||
145993901|NCT03895372|526493047|FG006|Extension Treatment Period|Other|0|||
145993902|NCT03895372|526493048|FG007|Extension Treatment Period|Other|2|||
145993903|NCT03895372|526493041|FG000|Extension Treatment Period|Pregnancy|0|||
145993904|NCT03895372|526493042|FG001|Extension Treatment Period|Pregnancy|0|||
145993905|NCT03895372|526493043|FG002|Extension Treatment Period|Pregnancy|0|||
145993906|NCT03895372|526493044|FG003|Extension Treatment Period|Pregnancy|0|||
145993907|NCT03895372|526493045|FG004|Extension Treatment Period|Pregnancy|1|||
145993908|NCT03895372|526493046|FG005|Extension Treatment Period|Pregnancy|0|||
145993909|NCT03895372|526493047|FG006|Extension Treatment Period|Pregnancy|0|||
145993910|NCT03895372|526493048|FG007|Extension Treatment Period|Pregnancy|0|||
145993911|NCT03895372|526493041|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
145993912|NCT03895372|526493042|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
145993913|NCT03895372|526493043|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
145993914|NCT03895372|526493044|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
145993915|NCT03895372|526493045|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
145993916|NCT03895372|526493046|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
145993917|NCT03895372|526493047|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
145993918|NCT03895372|526493048|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
145993919|NCT03559530|526493049|FG000|Overall Study|non-location of medical records|44|||
145993920|NCT03559530|526493050|FG001|Overall Study|non-location of medical records|0|||
145993921|NCT03559530|526493049|FG000|Overall Study|culture results not considered for treat|29|||
145993922|NCT03559530|526493050|FG001|Overall Study|culture results not considered for treat|0|||
145993923|NCT03559530|526493049|FG000|Overall Study|duplicate cases|8|||
145993924|NCT03559530|526493050|FG001|Overall Study|duplicate cases|0|||
145993925|NCT03559530|526493049|FG000|Overall Study|other species of Acinetobacte|7|||
145993926|NCT03559530|526493050|FG001|Overall Study|other species of Acinetobacte|0|||
145993927|NCT03559530|526493049|FG000|Overall Study|contamination / colonization|3|||
145993928|NCT03559530|526493050|FG001|Overall Study|contamination / colonization|0|||
145993929|NCT01309230|526493053|FG000|Overall Study|Withdrawal by Subject|0|||
145993930|NCT01309230|526493054|FG001|Overall Study|Withdrawal by Subject|2|||
145993931|NCT01309230|526493053|FG000|Overall Study|Observation arm closed|0|||
145993932|NCT01309230|526493054|FG001|Overall Study|Observation arm closed|2|||
145993933|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
145993934|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993935|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993936|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993937|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993938|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993939|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145993940|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
145993941|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
145993942|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
145993943|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
145993944|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
145993945|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
145993946|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
145993947|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
145993948|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
145993949|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
145993950|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
145993951|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
145993952|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
145993953|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
145993954|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
145993955|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
145993956|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
145993957|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
145993958|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
146246472|NCT01584648|527415722|FG000|Overall Study|Investigator discretion|3|||
146246473|NCT01584648|527415723|FG001|Overall Study|Investigator discretion|2|||
146246474|NCT01584648|527415722|FG000|Overall Study|Withdrew consent|13|||
146246475|NCT01584648|527415723|FG001|Overall Study|Withdrew consent|4|||
146246476|NCT01584648|527415722|FG000|Overall Study|Study closed/terminated|50|||
146246477|NCT01584648|527415723|FG001|Overall Study|Study closed/terminated|23|||
146246478|NCT01584648|527415722|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
146246479|NCT01584648|527415723|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
146246480|NCT02009332|527415726|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146246481|NCT02009332|527415727|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
146246482|NCT02009332|527415728|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146246483|NCT02009332|527415729|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146246484|NCT02009332|527415730|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146246485|NCT02009332|527415731|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
146246486|NCT02009332|527415726|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146246487|NCT02009332|527415727|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146246488|NCT02009332|527415728|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146246489|NCT02009332|527415729|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146246490|NCT02009332|527415730|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
146246491|NCT02009332|527415731|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
146246492|NCT02009332|527415726|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146246493|NCT02009332|527415727|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146246494|NCT02009332|527415728|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146246495|NCT02009332|527415729|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146246496|NCT02009332|527415730|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
146246497|NCT02009332|527415731|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
146246498|NCT01912599|527415733|FG000|Overall Study|Withdrawal by Subject|0|||
145993959|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
145993960|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
145993961|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
145993962|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
145993963|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
145993964|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
145993965|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
145993966|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
145993967|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
145993968|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
145993969|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
145993970|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
145993971|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
145993972|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
145993973|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
145993974|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
145993975|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
145993976|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993977|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993978|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993979|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993980|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993981|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145993982|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145993983|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
145993984|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145993985|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145993986|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
146246499|NCT01912599|527415734|FG001|Overall Study|Withdrawal by Subject|1|||
146246500|NCT03449979|527415741|FG000|Overall Study|Technical difficulty|0|||
146246501|NCT03449979|527415742|FG001|Overall Study|Technical difficulty|0|||
146246502|NCT03449979|527415743|FG002|Overall Study|Technical difficulty|0|||
146246503|NCT03449979|527415744|FG003|Overall Study|Technical difficulty|1|||
146246504|NCT00068107|527415745|FG000|Overall Study|end-stage renal disease|6|||
146246505|NCT00068107|527415745|FG000|Overall Study|Death|2|||
146246506|NCT00068107|527415745|FG000|Overall Study|Withdrawal by Subject|1|||
146246507|NCT03288506|527415746|FG000|Overall Study|Withdrawal by Subject|52|||
145993987|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145993988|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145993989|NCT01362790|526493057|FG000|Pilot Phase & Phase 2|Death on study|0|||
145993990|NCT01362790|526493058|FG001|Pilot Phase & Phase 2|Death on study|0|||
145993991|NCT01362790|526493059|FG002|Pilot Phase & Phase 2|Death on study|0|||
145993992|NCT01362790|526493060|FG003|Pilot Phase & Phase 2|Death on study|1|||
145993993|NCT01362790|526493061|FG004|Pilot Phase & Phase 2|Death on study|0|||
145993994|NCT01362790|526493062|FG005|Pilot Phase & Phase 2|Death on study|0|||
145993995|NCT01362790|526493063|FG006|Pilot Phase & Phase 2|Death on study|0|||
145993996|NCT01362790|526493057|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
145993997|NCT01362790|526493058|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
145993998|NCT01362790|526493059|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
145993999|NCT01362790|526493060|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
145994000|NCT01362790|526493061|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
145994001|NCT01362790|526493062|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
145994002|NCT01362790|526493063|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
145994003|NCT01362790|526493057|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994004|NCT01362790|526493058|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994005|NCT01362790|526493059|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994006|NCT01362790|526493060|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994007|NCT01362790|526493061|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
145994008|NCT01362790|526493062|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994009|NCT01362790|526493063|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145994010|NCT01362790|526493057|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
145994011|NCT01362790|526493058|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
145994012|NCT01362790|526493059|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
145994013|NCT01362790|526493060|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
145994014|NCT01362790|526493061|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
145994015|NCT01362790|526493062|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
145994016|NCT01362790|526493063|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
145994017|NCT00635050|526493067|FG000|Overall Study|Withdrawal by Subject|1|||
145994018|NCT00759395|526493068|FG000|Overall Study|Adverse Event|1|||
145994019|NCT00759395|526493069|FG001|Overall Study|Adverse Event|0|||
145994020|NCT00759395|526493068|FG000|Overall Study|Withdrawal by Subject|1|||
145994021|NCT00759395|526493069|FG001|Overall Study|Withdrawal by Subject|0|||
145994022|NCT00759395|526493068|FG000|Overall Study|Lack of Efficacy|0|||
145994023|NCT00759395|526493069|FG001|Overall Study|Lack of Efficacy|2|||
145994024|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
145994025|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
145994026|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
145994027|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
145994028|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
145994029|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
145994030|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
145994031|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
145994032|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
145994033|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
145994034|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
145994035|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
145994036|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
145994037|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
145994038|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
145994039|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
145994040|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
145994041|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
145994042|NCT00086515|526493074|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
145994043|NCT00086515|526493075|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
145994044|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
145994045|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
145994046|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
145994047|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
145994048|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
145994049|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
145994050|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
146091742|NCT00136604|526856904|FG003|Overall Study|Lost to Follow-up|0|||
145994051|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
145994052|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
145994053|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
145994054|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
146091743|NCT00136604|526856905|FG004|Overall Study|Lost to Follow-up|1|||
146091744|NCT00136604|526856901|FG000|Overall Study|Migrated/moved from study area|0|||
145994055|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
145994056|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
145994057|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
145994058|NCT00086515|526493074|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
145994059|NCT00086515|526493075|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
145994060|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
145994061|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
145994062|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
145994063|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
145994064|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
145994065|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
145994066|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
145994067|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
145994068|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
145994069|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
145994070|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
145994071|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
145994072|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
145994073|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
145994074|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
145994075|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
145994076|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
145994077|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
145994078|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
145994079|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
145994080|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
145994081|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
145994082|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
145994083|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
145994084|NCT00086515|526493074|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
145994085|NCT00086515|526493075|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
145994086|NCT01435356|526493076|FG000|Overall Study|Adverse Event|2|||
145994087|NCT01435356|526493077|FG001|Overall Study|Adverse Event|0|||
145994088|NCT01435356|526493076|FG000|Overall Study|Disease progression/recurrence|17|||
145994089|NCT01435356|526493077|FG001|Overall Study|Disease progression/recurrence|10|||
145994090|NCT01435356|526493076|FG000|Overall Study|Protocol Violation|0|||
145994091|NCT01435356|526493077|FG001|Overall Study|Protocol Violation|1|||
145994092|NCT01435356|526493076|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
145994093|NCT01435356|526493077|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
145994094|NCT01435356|526493076|FG000|Overall Study|Withdrawal by Subject|1|||
145994095|NCT01435356|526493077|FG001|Overall Study|Withdrawal by Subject|1|||
145994096|NCT01435356|526493076|FG000|Overall Study|Facial palsy|1|||
145994097|NCT01435356|526493077|FG001|Overall Study|Facial palsy|0|||
145994098|NCT01435356|526493076|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
145994099|NCT01435356|526493077|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
145994100|NCT01435356|526493076|FG000|Overall Study|Physician Decision|1|||
145994101|NCT01435356|526493077|FG001|Overall Study|Physician Decision|0|||
145994102|NCT01435356|526493076|FG000|Overall Study|Patient decision|3|||
145994103|NCT01435356|526493077|FG001|Overall Study|Patient decision|0|||
145994104|NCT01435356|526493076|FG000|Overall Study|Patient moved to another city|1|||
145994105|NCT01435356|526493077|FG001|Overall Study|Patient moved to another city|1|||
145994106|NCT00437073|526493078|FG000|Overall Study|Sponsor Terminated Study|1|||
145994107|NCT00437073|526493079|FG001|Overall Study|Sponsor Terminated Study|0|||
145994108|NCT00437073|526493078|FG000|Overall Study|Physician Decision|0|||
145994109|NCT00437073|526493079|FG001|Overall Study|Physician Decision|1|||
145994110|NCT03485157|526493080|FG000|Double Blind Phase|Lost to Follow-up|4|||
145994111|NCT03485157|526493081|FG001|Double Blind Phase|Lost to Follow-up|4|||
145994112|NCT03485157|526493080|FG000|Double Blind Phase|Adverse Event|2|||
145994113|NCT03485157|526493081|FG001|Double Blind Phase|Adverse Event|1|||
145994114|NCT03485157|526493080|FG000|Double Blind Phase|Withdrawal by Subject|6|||
145994115|NCT03485157|526493081|FG001|Double Blind Phase|Withdrawal by Subject|9|||
145994116|NCT03485157|526493080|FG000|Double Blind Phase|Removal by PI|3|||
145994117|NCT03485157|526493081|FG001|Double Blind Phase|Removal by PI|7|||
145994118|NCT03485157|526493080|FG000|Open Label Phase|Lost to Follow-up|1|||
145994119|NCT03485157|526493081|FG001|Open Label Phase|Lost to Follow-up|2|||
145994120|NCT03485157|526493080|FG000|Open Label Phase|Adverse Event|0|||
146091745|NCT00136604|526856902|FG001|Overall Study|Migrated/moved from study area|1|||
145994121|NCT03485157|526493081|FG001|Open Label Phase|Adverse Event|1|||
145994122|NCT03485157|526493080|FG000|Open Label Phase|Withdrawal by Subject|1|||
145994123|NCT03485157|526493081|FG001|Open Label Phase|Withdrawal by Subject|2|||
145994124|NCT03485157|526493080|FG000|Open Label Phase|Removal by PI|2|||
146091746|NCT00136604|526856903|FG002|Overall Study|Migrated/moved from study area|0|||
145994125|NCT03485157|526493081|FG001|Open Label Phase|Removal by PI|0|||
145994126|NCT05205616|526493082|FG000|Overall Study|Lost to Follow-up|4|||
145994127|NCT05205616|526493083|FG001|Overall Study|Lost to Follow-up|4|||
145994128|NCT04875533|526493084|FG000|Overall Study|Adverse Event|6|||
145994129|NCT04875533|526493085|FG001|Overall Study|Adverse Event|4|||
145994130|NCT04875533|526493084|FG000|Overall Study|Protocol Violation|4|||
145994131|NCT04875533|526493085|FG001|Overall Study|Protocol Violation|0|||
145994132|NCT04875533|526493084|FG000|Overall Study|Withdrawal by Subject|8|||
145994133|NCT04875533|526493085|FG001|Overall Study|Withdrawal by Subject|5|||
145994134|NCT04875533|526493084|FG000|Overall Study|No longer meets eligibility criteria|1|||
145994135|NCT04875533|526493085|FG001|Overall Study|No longer meets eligibility criteria|0|||
145994136|NCT04875533|526493084|FG000|Overall Study|Other|0|||
145994137|NCT04875533|526493085|FG001|Overall Study|Other|2|||
145994138|NCT01849276|526493088|FG000|Followed for Survival for 5 Years|Death|1|||
145994139|NCT01849276|526493088|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
145994140|NCT00539500|526493089|FG000|Overall Study|Disease Progression|1|||
145994141|NCT00539500|526493089|FG000|Overall Study|Lost to Follow-up|2|||
145994142|NCT02011542|526493091|FG000|Overall Study|Physician Decision|1|||
145994143|NCT01299961|526493092|FG000|Overall Study|Adverse Event|3|||
145994144|NCT01299961|526493092|FG000|Overall Study|Lack of Efficacy|2|||
145994145|NCT01299961|526493092|FG000|Overall Study|Lost to Follow-up|1|||
145994146|NCT00663260|526493094|FG000|Overall Study|Lack of Efficacy|2|||
145994147|NCT00663260|526493095|FG001|Overall Study|Lack of Efficacy|0|||
145994148|NCT00663260|526493096|FG002|Overall Study|Lack of Efficacy|0|||
145994149|NCT00663260|526493094|FG000|Overall Study|Adverse Event|12|||
145994150|NCT00663260|526493095|FG001|Overall Study|Adverse Event|7|||
145994151|NCT00663260|526493096|FG002|Overall Study|Adverse Event|6|||
145994152|NCT00663260|526493094|FG000|Overall Study|Withdrawal by Subject|3|||
145994153|NCT00663260|526493095|FG001|Overall Study|Withdrawal by Subject|1|||
145994154|NCT00663260|526493096|FG002|Overall Study|Withdrawal by Subject|6|||
145994155|NCT00663260|526493094|FG000|Overall Study|Death|1|||
145994156|NCT00663260|526493095|FG001|Overall Study|Death|0|||
145994157|NCT00663260|526493096|FG002|Overall Study|Death|1|||
145994158|NCT00663260|526493094|FG000|Overall Study|Lost to Follow-up|0|||
145994159|NCT00663260|526493095|FG001|Overall Study|Lost to Follow-up|1|||
145994160|NCT00663260|526493096|FG002|Overall Study|Lost to Follow-up|0|||
145994161|NCT00663260|526493094|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
145994162|NCT00663260|526493095|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
145994163|NCT00663260|526493096|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
145994164|NCT00980798|526493097|FG000|Overall Study|Adverse Event|7|||
145994165|NCT00980798|526493098|FG001|Overall Study|Adverse Event|36|||
145994166|NCT00980798|526493097|FG000|Overall Study|Lack of Efficacy|16|||
145994167|NCT00980798|526493098|FG001|Overall Study|Lack of Efficacy|5|||
145994168|NCT00980798|526493097|FG000|Overall Study|Lost to Follow-up|0|||
145994169|NCT00980798|526493098|FG001|Overall Study|Lost to Follow-up|1|||
145994170|NCT00980798|526493097|FG000|Overall Study|Physician Decision|2|||
145994171|NCT00980798|526493098|FG001|Overall Study|Physician Decision|1|||
145994172|NCT00980798|526493097|FG000|Overall Study|Withdrawal by Subject|8|||
145994173|NCT00980798|526493098|FG001|Overall Study|Withdrawal by Subject|11|||
145994174|NCT00980798|526493097|FG000|Overall Study|Other|0|||
145994175|NCT00980798|526493098|FG001|Overall Study|Other|1|||
145994176|NCT02607722|526493099|FG000|Overall Study|No data reliability|1|||
145994177|NCT02607722|526493099|FG000|Overall Study|no patient visit|18|||
145994178|NCT02607722|526493099|FG000|Overall Study|missing info in CRF|13|||
145994179|NCT02607722|526493099|FG000|Overall Study|Withdrawal by Subject|616|||
145994180|NCT02607722|526493099|FG000|Overall Study|Lost to Follow-up|312|||
145994181|NCT02607722|526493099|FG000|Overall Study|Improved|22|||
145994182|NCT02607722|526493099|FG000|Overall Study|Lack of Efficacy|316|||
145994183|NCT02607722|526493099|FG000|Overall Study|Adverse Event|2553|||
145994184|NCT02607722|526493099|FG000|Overall Study|Not treated|1|||
145994185|NCT02607722|526493099|FG000|Overall Study|No CRF collected|138|||
145994186|NCT02607722|526493099|FG000|Overall Study|without CRF|4225|||
145994187|NCT02607722|526493099|FG000|Overall Study|Physician Decision|367|||
145994188|NCT02135133|526493100|FG000|Overall Study|Adverse Event|10|||
145994189|NCT02135133|526493100|FG000|Overall Study|regulatory mandate|5|||
145994190|NCT05081843|526493101|FG000|Overall Study|Lost to Follow-up|135|||
145994191|NCT05081843|526493102|FG001|Overall Study|Lost to Follow-up|145|||
145994192|NCT02402647|526493103|FG000|Overall Study|Lost to Follow-up|13|||
145994193|NCT02402647|526493104|FG001|Overall Study|Lost to Follow-up|7|||
145994194|NCT02402647|526493103|FG000|Overall Study|Protocol Violation|1|||
145994195|NCT02402647|526493104|FG001|Overall Study|Protocol Violation|1|||
145994196|NCT02402647|526493103|FG000|Overall Study|scheduled and timed out|2|||
145994197|NCT02402647|526493104|FG001|Overall Study|scheduled and timed out|1|||
145994198|NCT02402647|526493103|FG000|Overall Study|medical illness|2|||
145994199|NCT02402647|526493104|FG001|Overall Study|medical illness|4|||
145994200|NCT02402647|526493103|FG000|Overall Study|Moved|2|||
145994201|NCT02402647|526493104|FG001|Overall Study|Moved|0|||
145994202|NCT02402647|526493103|FG000|Overall Study|loved one illness|1|||
145994203|NCT02402647|526493104|FG001|Overall Study|loved one illness|0|||
145994204|NCT02402647|526493103|FG000|Overall Study|deceased preexisting condition|2|||
145994205|NCT02402647|526493104|FG001|Overall Study|deceased preexisting condition|0|||
145994206|NCT02402647|526493103|FG000|Overall Study|Other|2|||
145994207|NCT02402647|526493104|FG001|Overall Study|Other|1|||
145994208|NCT03211416|526493110|FG000|Overall Study|Adverse Event|7|||
145994209|NCT03211416|526493110|FG000|Overall Study|Lack of Efficacy|2|||
145994210|NCT03211416|526493110|FG000|Overall Study|Physician Decision|1|||
145994211|NCT03709472|526493114|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
145994212|NCT03709472|526493115|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
145994213|NCT03709472|526493114|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
145994214|NCT03709472|526493115|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
145994215|NCT03559556|526493116|FG000|Overall Study|Withdrawal by Subject|1|||
145994216|NCT02496000|526493120|FG000|Overall Study|Withdrawal by Subject|1|||
145994217|NCT02496000|526493121|FG001|Overall Study|Withdrawal by Subject|2|||
145994218|NCT02496000|526493122|FG002|Overall Study|Withdrawal by Subject|0|||
145994219|NCT02496000|526493120|FG000|Overall Study|Lost to Follow-up|1|||
145994220|NCT02496000|526493121|FG001|Overall Study|Lost to Follow-up|0|||
145994221|NCT02496000|526493122|FG002|Overall Study|Lost to Follow-up|1|||
145994222|NCT02496000|526493120|FG000|Overall Study|Protocol Violation|0|||
145994223|NCT02496000|526493121|FG001|Overall Study|Protocol Violation|0|||
145994224|NCT02496000|526493122|FG002|Overall Study|Protocol Violation|1|||
145994225|NCT02496000|526493120|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
146246508|NCT02644122|527415750|FG000|Overall Study|Withdrawal by Subject|1|||
146246509|NCT00805441|527415753|FG000|Overall Study|Adverse Event|5|||
146246510|NCT00805441|527415754|FG001|Overall Study|Adverse Event|2|||
146246511|NCT00805441|527415753|FG000|Overall Study|Lack of Efficacy|0|||
146246512|NCT00805441|527415754|FG001|Overall Study|Lack of Efficacy|2|||
146246513|NCT00805441|527415753|FG000|Overall Study|Protocol Violation|4|||
146246514|NCT00805441|527415754|FG001|Overall Study|Protocol Violation|8|||
146246515|NCT00805441|527415753|FG000|Overall Study|Lost to Follow-up|10|||
146246516|NCT00805441|527415754|FG001|Overall Study|Lost to Follow-up|13|||
146246517|NCT00805441|527415753|FG000|Overall Study|Withdrawal by Subject|15|||
146246518|NCT00805441|527415754|FG001|Overall Study|Withdrawal by Subject|9|||
146246519|NCT00805441|527415753|FG000|Overall Study|Physician Decision|0|||
146246520|NCT00805441|527415754|FG001|Overall Study|Physician Decision|1|||
146246521|NCT00805441|527415753|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
146246522|NCT00805441|527415754|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
146246523|NCT02935894|527415756|FG000|Overall Study|Subject dismissed|1|||
146246524|NCT03786471|527415759|FG000|Overall Study|Death|254|||
146246525|NCT03786471|527415760|FG001|Overall Study|Death|223|||
146246526|NCT03786471|527415761|FG002|Overall Study|Death|37|||
146246527|NCT03786471|527415759|FG000|Overall Study|Lost to Follow-up|63|||
146246528|NCT03786471|527415760|FG001|Overall Study|Lost to Follow-up|50|||
146246529|NCT03786471|527415761|FG002|Overall Study|Lost to Follow-up|15|||
146246530|NCT03786471|527415759|FG000|Overall Study|Withdrawal by Subject|99|||
146246531|NCT03786471|527415760|FG001|Overall Study|Withdrawal by Subject|81|||
146246532|NCT03786471|527415761|FG002|Overall Study|Withdrawal by Subject|11|||
146246533|NCT05487300|527417585|FG000|Overall Study|Withdrawal by Subject|1|||
146246534|NCT05487300|527417586|FG001|Overall Study|Withdrawal by Subject|0|||
146246535|NCT03141177|527417587|FG000|Overall Study|Death|62|||
146246536|NCT03141177|527417588|FG001|Overall Study|Death|13|||
146246537|NCT03141177|527417589|FG002|Overall Study|Death|84|||
146246538|NCT03141177|527417587|FG000|Overall Study|Participant withdrew consent|9|||
146246539|NCT03141177|527417588|FG001|Overall Study|Participant withdrew consent|2|||
146246540|NCT03141177|527417589|FG002|Overall Study|Participant withdrew consent|13|||
146246541|NCT03141177|527417587|FG000|Overall Study|Not reported|1|||
146246542|NCT03141177|527417588|FG001|Overall Study|Not reported|0|||
146246543|NCT03141177|527417589|FG002|Overall Study|Not reported|1|||
146246544|NCT03141177|527417587|FG000|Overall Study|Lost to Follow-up|2|||
146246545|NCT03141177|527417588|FG001|Overall Study|Lost to Follow-up|1|||
146246546|NCT03141177|527417589|FG002|Overall Study|Lost to Follow-up|1|||
146246547|NCT03141177|527417587|FG000|Overall Study|Other reasons|4|||
146246548|NCT03141177|527417588|FG001|Overall Study|Other reasons|0|||
146246549|NCT03141177|527417589|FG002|Overall Study|Other reasons|11|||
146246550|NCT03141177|527417587|FG000|Overall Study|Participants did not start treatment period|3|||
146246551|NCT03141177|527417588|FG001|Overall Study|Participants did not start treatment period|0|||
146246552|NCT03141177|527417589|FG002|Overall Study|Participants did not start treatment period|8|||
146246553|NCT03976102|527417595|FG000|Overall Study|Withdrawal by Subject|4|||
146246554|NCT03976102|527417596|FG001|Overall Study|Withdrawal by Subject|4|||
146246555|NCT03976102|527417595|FG000|Overall Study|Adverse Event|2|||
146246556|NCT03976102|527417596|FG001|Overall Study|Adverse Event|4|||
146246557|NCT03976102|527417595|FG000|Overall Study|Not related to Covid-19|9|||
146246558|NCT03976102|527417596|FG001|Overall Study|Not related to Covid-19|13|||
146246559|NCT03976102|527417595|FG000|Overall Study|Lost to Follow-up|0|||
146246560|NCT03976102|527417596|FG001|Overall Study|Lost to Follow-up|2|||
146246561|NCT03976102|527417595|FG000|Overall Study|Death|3|||
146246562|NCT03976102|527417596|FG001|Overall Study|Death|2|||
146246563|NCT03976102|527417595|FG000|Overall Study|Physician Decision|1|||
146246564|NCT03976102|527417596|FG001|Overall Study|Physician Decision|1|||
145994226|NCT02496000|526493121|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
145994227|NCT02496000|526493122|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
145994228|NCT02496000|526493120|FG000|Overall Study|undetermined|0|||
145994229|NCT02496000|526493121|FG001|Overall Study|undetermined|1|||
145994230|NCT02496000|526493122|FG002|Overall Study|undetermined|0|||
145994231|NCT02255656|526493123|FG000|Overall Study|Adverse Event|11|||
145994232|NCT02255656|526493123|FG000|Overall Study|Poor compliance to protocol|3|||
145994233|NCT02255656|526493123|FG000|Overall Study|Lost to Follow-up|30|||
145994234|NCT02255656|526493123|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
145994235|NCT02255656|526493123|FG000|Overall Study|Other|126|||
145994236|NCT01969058|526493124|FG000|Overall Study|Withdrawal by Subject|2|||
145994237|NCT01969058|526493125|FG001|Overall Study|Withdrawal by Subject|0|||
145994238|NCT01969058|526493124|FG000|Overall Study|Adverse Event|1|||
145994239|NCT01969058|526493125|FG001|Overall Study|Adverse Event|0|||
145994240|NCT02038036|526493133|FG000|Core Study|Adverse Event|7|||
145994241|NCT02038036|526493134|FG001|Core Study|Adverse Event|7|||
145994242|NCT02038036|526493133|FG000|Core Study|Death|1|||
145994243|NCT02038036|526493134|FG001|Core Study|Death|1|||
145994244|NCT02038036|526493133|FG000|Core Study|Disease progression|2|||
145994245|NCT02038036|526493134|FG001|Core Study|Disease progression|2|||
145994246|NCT02038036|526493133|FG000|Core Study|Lost to Follow-up|0|||
145994247|NCT02038036|526493134|FG001|Core Study|Lost to Follow-up|1|||
145994248|NCT02038036|526493133|FG000|Core Study|Physician Decision|2|||
145994249|NCT02038036|526493134|FG001|Core Study|Physician Decision|1|||
145994250|NCT02038036|526493133|FG000|Core Study|Subject/guardian decision|0|||
145994251|NCT02038036|526493134|FG001|Core Study|Subject/guardian decision|1|||
145994252|NCT02038036|526493133|FG000|Core Study|Withdrawal by Subject|3|||
145994253|NCT02038036|526493134|FG001|Core Study|Withdrawal by Subject|1|||
145994254|NCT02038036|526493133|FG000|Crossover Period|Withdrawal by Subject|0|||
145994255|NCT02038036|526493134|FG001|Crossover Period|Withdrawal by Subject|3|||
145994256|NCT02038036|526493133|FG000|Crossover Period|Adverse Event|0|||
145994257|NCT02038036|526493134|FG001|Crossover Period|Adverse Event|9|||
145994258|NCT02038036|526493133|FG000|Crossover Period|Death|0|||
145994259|NCT02038036|526493134|FG001|Crossover Period|Death|2|||
145994260|NCT02038036|526493133|FG000|Crossover Period|Disease progression|0|||
145994261|NCT02038036|526493134|FG001|Crossover Period|Disease progression|3|||
145994262|NCT02038036|526493133|FG000|Crossover Period|Lost to Follow-up|0|||
145994263|NCT02038036|526493134|FG001|Crossover Period|Lost to Follow-up|1|||
145994264|NCT02038036|526493133|FG000|Crossover Period|Physician Decision|0|||
145994265|NCT02038036|526493134|FG001|Crossover Period|Physician Decision|2|||
145994266|NCT00964678|526493142|FG000|Overall Study|Physician Decision|4|||
145994267|NCT03359395|526493143|FG000|First Intervention A / B|Withdrawal by Subject|1|||
145994268|NCT03359395|526493144|FG001|First Intervention A / B|Withdrawal by Subject|0|||
145994269|NCT03359395|526493143|FG000|First Intervention A / B|Lost to Follow-up|2|||
145994270|NCT03359395|526493144|FG001|First Intervention A / B|Lost to Follow-up|3|||
145994271|NCT03359395|526493143|FG000|Second Intervention B/A|Exclusion criteria|0|||
145994272|NCT03359395|526493144|FG001|Second Intervention B/A|Exclusion criteria|1|||
145994273|NCT03359395|526493143|FG000|Second Intervention B/A|Lost to Follow-up|3|||
145994274|NCT03359395|526493144|FG001|Second Intervention B/A|Lost to Follow-up|2|||
145994275|NCT03977155|526494336|FG000|Overall Study|Adverse Event|3|||
145994276|NCT03977155|526494337|FG001|Overall Study|Adverse Event|0|||
145994277|NCT03977155|526494338|FG002|Overall Study|Adverse Event|0|||
145994278|NCT03977155|526494336|FG000|Overall Study|Lost to Follow-up|0|||
145994279|NCT03977155|526494337|FG001|Overall Study|Lost to Follow-up|1|||
145994280|NCT03977155|526494338|FG002|Overall Study|Lost to Follow-up|0|||
145994281|NCT03977155|526494336|FG000|Overall Study|Withdrawal by Subject|1|||
145994282|NCT03977155|526494337|FG001|Overall Study|Withdrawal by Subject|1|||
145994283|NCT03977155|526494338|FG002|Overall Study|Withdrawal by Subject|2|||
145994284|NCT03977155|526494336|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
145994285|NCT03977155|526494337|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
145994286|NCT03977155|526494338|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
145994287|NCT00936936|526494339|FG000|Overall Study|Adverse Event|7|||
145994288|NCT00936936|526494340|FG001|Overall Study|Adverse Event|1|||
145994289|NCT00936936|526494339|FG000|Overall Study|Disease Progression|2|||
145994290|NCT00936936|526494340|FG001|Overall Study|Disease Progression|2|||
145994291|NCT00936936|526494339|FG000|Overall Study|Unrelated|3|||
145994292|NCT00936936|526494340|FG001|Overall Study|Unrelated|1|||
145994293|NCT02278003|526494341|FG000|Overall Study|Withdrawal by Subject|11|||
145994294|NCT02278003|526494342|FG001|Overall Study|Withdrawal by Subject|0|||
145994295|NCT02278003|526494341|FG000|Overall Study|Not Treated|1|||
145994296|NCT02278003|526494342|FG001|Overall Study|Not Treated|0|||
145994297|NCT02278003|526494341|FG000|Overall Study|Recognition task improperly completed|7|||
145994298|NCT02278003|526494342|FG001|Overall Study|Recognition task improperly completed|0|||
145994299|NCT02296476|526494343|FG000|Overall Study|Disease Progression|6|||
145994300|NCT02296476|526494344|FG001|Overall Study|Disease Progression|4|||
145994301|NCT02296476|526494345|FG002|Overall Study|Disease Progression|2|||
145994302|NCT03440385|526494347|FG000|Overall Study|Other Reason|4|||
145994303|NCT03440385|526494348|FG001|Overall Study|Other Reason|1|||
145994304|NCT03440385|526494347|FG000|Overall Study|Site Closed|1|||
145994305|NCT03440385|526494348|FG001|Overall Study|Site Closed|0|||
145994306|NCT03440385|526494347|FG000|Overall Study|Lost to Follow-up|2|||
145994307|NCT03440385|526494348|FG001|Overall Study|Lost to Follow-up|0|||
145994308|NCT03440385|526494347|FG000|Overall Study|Withdrawal by Subject|12|||
145994309|NCT03440385|526494348|FG001|Overall Study|Withdrawal by Subject|6|||
145994310|NCT03440385|526494347|FG000|Overall Study|Lack of Efficacy|9|||
145994311|NCT03440385|526494348|FG001|Overall Study|Lack of Efficacy|2|||
145994312|NCT03440385|526494347|FG000|Overall Study|Adverse Event|15|||
145994313|NCT03440385|526494348|FG001|Overall Study|Adverse Event|11|||
145994314|NCT00730327|526494350|FG000|Overall Study|Lost to Follow-up|14|||
145994315|NCT00730327|526494351|FG001|Overall Study|Lost to Follow-up|16|||
145994316|NCT00730327|526494350|FG000|Overall Study|Adverse Event|8|||
145994317|NCT00730327|526494351|FG001|Overall Study|Adverse Event|1|||
145994318|NCT00730327|526494350|FG000|Overall Study|Withdrawal by Subject|3|||
145994319|NCT00730327|526494351|FG001|Overall Study|Withdrawal by Subject|13|||
145994320|NCT00730327|526494350|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
145994321|NCT00730327|526494351|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
145994322|NCT02332928|526494357|FG000|Overall Study|Withdrawal by Subject|0|||
145994323|NCT02332928|526494358|FG001|Overall Study|Withdrawal by Subject|2|||
145994324|NCT02332928|526494357|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
145994325|NCT02332928|526494358|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
145994326|NCT04484857|526494364|FG000|Overall Study|Adverse Event|2|||
145994327|NCT04484857|526494364|FG000|Overall Study|Death|10|||
145994328|NCT04484857|526494364|FG000|Overall Study|Withdrawal by Subject|3|||
145994329|NCT04484857|526494364|FG000|Overall Study|Transferred/Relocation|5|||
145994330|NCT04484857|526494364|FG000|Overall Study|Kidney Transplant|7|||
145994331|NCT04484857|526494364|FG000|Overall Study|Other than specified|4|||
145994332|NCT04484857|526494364|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
145994333|NCT02095106|526494372|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
145994334|NCT02095106|526494373|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
145994335|NCT01182350|526494374|FG000|Overall Study|Adverse Event|5|||
145994336|NCT01182350|526494375|FG001|Overall Study|Adverse Event|0|||
145994337|NCT01182350|526494376|FG002|Overall Study|Adverse Event|0|||
145994338|NCT01182350|526494377|FG003|Overall Study|Adverse Event|0|||
145994339|NCT01182350|526494378|FG004|Overall Study|Adverse Event|0|||
145994340|NCT01182350|526494374|FG000|Overall Study|Disease Progression|15|||
145994341|NCT01182350|526494375|FG001|Overall Study|Disease Progression|12|||
145994342|NCT01182350|526494376|FG002|Overall Study|Disease Progression|0|||
145994343|NCT01182350|526494377|FG003|Overall Study|Disease Progression|1|||
145994344|NCT01182350|526494378|FG004|Overall Study|Disease Progression|0|||
145994345|NCT01182350|526494374|FG000|Overall Study|Death|0|||
145994346|NCT01182350|526494375|FG001|Overall Study|Death|1|||
145994347|NCT01182350|526494376|FG002|Overall Study|Death|1|||
145994348|NCT01182350|526494377|FG003|Overall Study|Death|0|||
145994349|NCT01182350|526494378|FG004|Overall Study|Death|0|||
145994350|NCT01182350|526494374|FG000|Overall Study|Withdrawal by Subject|3|||
145994351|NCT01182350|526494375|FG001|Overall Study|Withdrawal by Subject|1|||
145994352|NCT01182350|526494376|FG002|Overall Study|Withdrawal by Subject|0|||
145994353|NCT01182350|526494377|FG003|Overall Study|Withdrawal by Subject|1|||
145994354|NCT01182350|526494378|FG004|Overall Study|Withdrawal by Subject|0|||
145994355|NCT01182350|526494374|FG000|Overall Study|Alternative Therapy|2|||
145994356|NCT01182350|526494375|FG001|Overall Study|Alternative Therapy|0|||
145994357|NCT01182350|526494376|FG002|Overall Study|Alternative Therapy|1|||
145994358|NCT01182350|526494377|FG003|Overall Study|Alternative Therapy|0|||
145994359|NCT01182350|526494378|FG004|Overall Study|Alternative Therapy|0|||
145994360|NCT01182350|526494374|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
145994361|NCT01182350|526494375|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
145994362|NCT01182350|526494376|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
145994363|NCT01182350|526494377|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
145994364|NCT01182350|526494378|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
145994365|NCT01182350|526494374|FG000|Overall Study|Unevaluable for Biopsy|0|||
145994366|NCT01182350|526494375|FG001|Overall Study|Unevaluable for Biopsy|0|||
146297887|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
146297888|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145994367|NCT01182350|526494376|FG002|Overall Study|Unevaluable for Biopsy|0|||
145994368|NCT01182350|526494377|FG003|Overall Study|Unevaluable for Biopsy|0|||
145994369|NCT01182350|526494378|FG004|Overall Study|Unevaluable for Biopsy|3|||
145994370|NCT02919618|526494381|FG000|Overall Study|Death|1|||
145994371|NCT04770285|526494383|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
145994372|NCT04770285|526494384|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
145994373|NCT04770285|526494383|FG000|Overall Study|Lack of Efficacy|0|||
145994374|NCT04770285|526494384|FG001|Overall Study|Lack of Efficacy|1|||
145994375|NCT04770285|526494383|FG000|Overall Study|Lost to Follow-up|11|||
145994376|NCT04770285|526494384|FG001|Overall Study|Lost to Follow-up|8|||
145994377|NCT04770285|526494383|FG000|Overall Study|Protocol Deviation|6|||
145994378|NCT04770285|526494384|FG001|Overall Study|Protocol Deviation|6|||
145994379|NCT04770285|526494383|FG000|Overall Study|Technical Problem|0|||
145994380|NCT04770285|526494384|FG001|Overall Study|Technical Problem|1|||
145994381|NCT04770285|526494383|FG000|Overall Study|Withdrawal by Subject|9|||
145994382|NCT04770285|526494384|FG001|Overall Study|Withdrawal by Subject|8|||
145994383|NCT04770285|526494383|FG000|Overall Study|Reason Not Specified|0|||
145994384|NCT04770285|526494384|FG001|Overall Study|Reason Not Specified|1|||
145994385|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
145994386|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
145994387|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
145994388|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
145994389|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
145994390|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
145994391|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
145994392|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
145994393|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
145994394|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
145994395|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
145994396|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
145994397|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
145994398|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
145994399|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
145994400|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
145994401|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
145994402|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
145994403|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
145994404|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
145994405|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
145994406|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
145994407|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
145994408|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
145994409|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
145994410|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
145994411|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
145994412|NCT03093415|526494385|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
145994413|NCT03093415|526494386|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
145994414|NCT03093415|526494387|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
145994415|NCT03093415|526494385|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
145994416|NCT03093415|526494386|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
145994417|NCT03093415|526494387|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
145994418|NCT01646827|526494388|FG000|Overall Study|Lost to Follow-up|0|||
145994419|NCT01646827|526494389|FG001|Overall Study|Lost to Follow-up|3|||
145994420|NCT01646827|526494388|FG000|Overall Study|Physician Decision|1|||
145994421|NCT01646827|526494389|FG001|Overall Study|Physician Decision|2|||
145994422|NCT01646827|526494388|FG000|Overall Study|Withdrawal by Subject|1|||
145994423|NCT01646827|526494389|FG001|Overall Study|Withdrawal by Subject|0|||
145994424|NCT01472185|526494394|FG000|Overall Study|Randomized but Not Treated|0|||
145994425|NCT01472185|526494395|FG001|Overall Study|Randomized but Not Treated|1|||
145994426|NCT01472185|526494394|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
145994427|NCT01472185|526494395|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
145994428|NCT01472185|526494394|FG000|Overall Study|Hyperglycemia|5|||
145994429|NCT01472185|526494395|FG001|Overall Study|Hyperglycemia|2|||
145994430|NCT01472185|526494394|FG000|Overall Study|Investigator's Discretion|3|||
145994431|NCT01472185|526494395|FG001|Overall Study|Investigator's Discretion|1|||
145994432|NCT01472185|526494394|FG000|Overall Study|Lost to Follow-up|4|||
145994433|NCT01472185|526494395|FG001|Overall Study|Lost to Follow-up|1|||
145994434|NCT01472185|526494394|FG000|Overall Study|Protocol Violation|5|||
145994435|NCT01472185|526494395|FG001|Overall Study|Protocol Violation|1|||
145994436|NCT01472185|526494394|FG000|Overall Study|Subject Noncompliance|8|||
145994437|NCT01472185|526494395|FG001|Overall Study|Subject Noncompliance|15|||
145994438|NCT01472185|526494394|FG000|Overall Study|Subject Withdrew Consent|6|||
145994439|NCT01472185|526494395|FG001|Overall Study|Subject Withdrew Consent|3|||
146091747|NCT00136604|526856904|FG003|Overall Study|Migrated/moved from study area|0|||
146091748|NCT00136604|526856905|FG004|Overall Study|Migrated/moved from study area|0|||
146091749|NCT02017171|526856906|FG000|Overall Study|Death|10|||
146091750|NCT02017171|526856907|FG001|Overall Study|Death|4|||
145994440|NCT00427700|526494396|FG000|Overall Study|Lost to Follow-up|2|||
145994441|NCT00427700|526494397|FG001|Overall Study|Lost to Follow-up|5|||
145994442|NCT00427700|526494396|FG000|Overall Study|no induction of menses|1|||
145994443|NCT00427700|526494397|FG001|Overall Study|no induction of menses|4|||
145994444|NCT00427700|526494396|FG000|Overall Study|Pregnancy|0|||
145994445|NCT00427700|526494397|FG001|Overall Study|Pregnancy|2|||
145994446|NCT00815633|526494398|FG000|Overall Study|study terminated|1|||
145994447|NCT03038087|526494399|FG000|Overall Study|lost data|1|||
145994448|NCT02657343|526494404|FG000|Overall Study|Death|0|||
145994449|NCT02657343|526494405|FG001|Overall Study|Death|2|||
145994450|NCT02657343|526494406|FG002|Overall Study|Death|0|||
145994451|NCT02657343|526494407|FG003|Overall Study|Death|0|||
145994452|NCT02657343|526494408|FG004|Overall Study|Death|0|||
145994453|NCT02657343|526494409|FG005|Overall Study|Death|0|||
145994454|NCT02657343|526494404|FG000|Overall Study|Patient went to hospice|1|||
145994455|NCT02657343|526494405|FG001|Overall Study|Patient went to hospice|0|||
145994456|NCT02657343|526494406|FG002|Overall Study|Patient went to hospice|0|||
145994457|NCT02657343|526494407|FG003|Overall Study|Patient went to hospice|0|||
145994458|NCT02657343|526494408|FG004|Overall Study|Patient went to hospice|0|||
145994459|NCT02657343|526494409|FG005|Overall Study|Patient went to hospice|0|||
145994460|NCT02657343|526494404|FG000|Overall Study|Withdrawal by Subject|0|||
145994461|NCT02657343|526494405|FG001|Overall Study|Withdrawal by Subject|0|||
145994462|NCT02657343|526494406|FG002|Overall Study|Withdrawal by Subject|0|||
145994463|NCT02657343|526494407|FG003|Overall Study|Withdrawal by Subject|0|||
145994464|NCT02657343|526494408|FG004|Overall Study|Withdrawal by Subject|1|||
145994465|NCT02657343|526494409|FG005|Overall Study|Withdrawal by Subject|0|||
145994466|NCT02904096|526494410|FG000|Overall Study|Adverse Event|1|||
145994467|NCT02904096|526494411|FG001|Overall Study|Adverse Event|0|||
145994468|NCT02904096|526494410|FG000|Overall Study|Withdrawal by Subject|4|||
145994469|NCT02904096|526494411|FG001|Overall Study|Withdrawal by Subject|3|||
145994470|NCT02904096|526494410|FG000|Overall Study|Lost to Follow-up|10|||
145994471|NCT02904096|526494411|FG001|Overall Study|Lost to Follow-up|17|||
145994472|NCT02904096|526494410|FG000|Overall Study|Non-compliant|3|||
145994473|NCT02904096|526494411|FG001|Overall Study|Non-compliant|1|||
145994474|NCT02904096|526494410|FG000|Overall Study|Sponsor instructed|1|||
145994475|NCT02904096|526494411|FG001|Overall Study|Sponsor instructed|0|||
145994476|NCT01979185|526494415|FG000|Period 2|Other|0|||
145994477|NCT01979185|526494416|FG001|Period 2|Other|1|||
145994478|NCT03238196|526494417|FG000|Overall Study|Adverse Event|3|||
145994479|NCT03238196|526494418|FG001|Overall Study|Adverse Event|0|||
145994480|NCT03238196|526494419|FG002|Overall Study|Adverse Event|2|||
145994481|NCT03238196|526494420|FG003|Overall Study|Adverse Event|2|||
145994482|NCT03238196|526494417|FG000|Overall Study|Withdrawal by Subject|4|||
145994483|NCT03238196|526494418|FG001|Overall Study|Withdrawal by Subject|1|||
145994484|NCT03238196|526494419|FG002|Overall Study|Withdrawal by Subject|1|||
145994485|NCT03238196|526494420|FG003|Overall Study|Withdrawal by Subject|0|||
145994486|NCT03238196|526494417|FG000|Overall Study|Disease progression|14|||
145994487|NCT03238196|526494418|FG001|Overall Study|Disease progression|2|||
145994488|NCT03238196|526494419|FG002|Overall Study|Disease progression|3|||
145994489|NCT03238196|526494420|FG003|Overall Study|Disease progression|2|||
145994490|NCT03238196|526494417|FG000|Overall Study|Still on treatment|1|||
145994491|NCT03238196|526494418|FG001|Overall Study|Still on treatment|0|||
145994492|NCT03238196|526494419|FG002|Overall Study|Still on treatment|0|||
145994493|NCT03238196|526494420|FG003|Overall Study|Still on treatment|0|||
145994494|NCT00847730|526494421|FG000|Overall Study|Multiple interruptions in therapy|8|||
145994495|NCT01877278|526494429|FG000|Overall Study|Lost to Follow-up|3|||
145994496|NCT01877278|526494430|FG001|Overall Study|Lost to Follow-up|3|||
145994497|NCT04727151|526494431|FG000|Overall Study|Death|0|||
145994498|NCT04727151|526494432|FG001|Overall Study|Death|0|||
145994499|NCT04727151|526494433|FG002|Overall Study|Death|0|||
145994500|NCT04727151|526494434|FG003|Overall Study|Death|0|||
145994501|NCT04727151|526494435|FG004|Overall Study|Death|3|||
146091751|NCT02017171|526856906|FG000|Overall Study|Withdrawal by Subject|23|||
145994502|NCT04727151|526494431|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145994503|NCT04727151|526494432|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145994504|NCT04727151|526494433|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
146091752|NCT02017171|526856907|FG001|Overall Study|Withdrawal by Subject|17|||
145994505|NCT04727151|526494434|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145994506|NCT04727151|526494435|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
145994507|NCT03510715|526494436|FG000|Overall Study|Adverse Event|1|||
145994508|NCT03510715|526494437|FG001|Overall Study|Adverse Event|0|||
145994509|NCT05318287|526494439|FG000|Overall Study|Lost to Follow-up|8|||
145994510|NCT04144517|526494442|FG000|Overall Study|Physician Decision|0|||
145994511|NCT04144517|526494443|FG001|Overall Study|Physician Decision|1|||
145994512|NCT04144517|526494442|FG000|Overall Study|Other|2|||
146246565|NCT05066230|527417599|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
145994513|NCT04144517|526494443|FG001|Overall Study|Other|2|||
145994514|NCT04144517|526494442|FG000|Overall Study|Death|6|||
145994515|NCT04144517|526494443|FG001|Overall Study|Death|3|||
145994516|NCT02757768|526494447|FG000|Overall Study|Randomized Never Received Study Drug|3|||
145994517|NCT02757768|526494448|FG001|Overall Study|Randomized Never Received Study Drug|4|||
145994518|NCT02757768|526494447|FG000|Overall Study|Adverse Event|5|||
145994519|NCT02757768|526494448|FG001|Overall Study|Adverse Event|3|||
145994520|NCT02757768|526494447|FG000|Overall Study|Lack of Efficacy|2|||
145994521|NCT02757768|526494448|FG001|Overall Study|Lack of Efficacy|1|||
145994522|NCT02757768|526494447|FG000|Overall Study|Lost to Follow-up|1|||
145994523|NCT02757768|526494448|FG001|Overall Study|Lost to Follow-up|0|||
145994524|NCT02757768|526494447|FG000|Overall Study|Protocol Deviation|2|||
145994525|NCT02757768|526494448|FG001|Overall Study|Protocol Deviation|9|||
145994526|NCT02757768|526494447|FG000|Overall Study|Withdrawal by Subject|16|||
145994527|NCT02757768|526494448|FG001|Overall Study|Withdrawal by Subject|9|||
145994528|NCT02757768|526494447|FG000|Overall Study|Miscellaneous|4|||
145994529|NCT02757768|526494448|FG001|Overall Study|Miscellaneous|2|||
145994530|NCT02495883|526494455|FG000|Overall Study|Excessive head motion|1|||
145994531|NCT02495883|526494456|FG001|Overall Study|Excessive head motion|0|||
145994532|NCT03557502|526494457|FG000|Protocol 2|Withdrawal by Subject|1|||
145994533|NCT03557502|526494458|FG001|Protocol 2|Withdrawal by Subject|1|||
145994534|NCT03557502|526494457|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
145994535|NCT03557502|526494458|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
145994536|NCT03164356|526494460|FG000|Overall Study|Lost to Follow-up|1|||
145994537|NCT03164356|526494461|FG001|Overall Study|Lost to Follow-up|1|||
145994538|NCT03164356|526494462|FG002|Overall Study|Lost to Follow-up|2|||
145994539|NCT03164356|526494463|FG003|Overall Study|Lost to Follow-up|1|||
145994540|NCT03164356|526494460|FG000|Overall Study|Physician Decision|0|||
145994541|NCT03164356|526494461|FG001|Overall Study|Physician Decision|0|||
145994542|NCT03164356|526494462|FG002|Overall Study|Physician Decision|3|||
145994543|NCT03164356|526494463|FG003|Overall Study|Physician Decision|0|||
145994544|NCT03164356|526494460|FG000|Overall Study|Protocol Violation|2|||
145994545|NCT03164356|526494461|FG001|Overall Study|Protocol Violation|1|||
145994546|NCT03164356|526494462|FG002|Overall Study|Protocol Violation|0|||
145994547|NCT03164356|526494463|FG003|Overall Study|Protocol Violation|0|||
145994548|NCT03164356|526494460|FG000|Overall Study|Withdrawal by Subject|1|||
145994549|NCT03164356|526494461|FG001|Overall Study|Withdrawal by Subject|0|||
145994550|NCT03164356|526494462|FG002|Overall Study|Withdrawal by Subject|0|||
145994551|NCT03164356|526494463|FG003|Overall Study|Withdrawal by Subject|0|||
145994552|NCT03164356|526494460|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
145994553|NCT03164356|526494461|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
145994554|NCT03164356|526494462|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
145994555|NCT03164356|526494463|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
145994556|NCT03164356|526494460|FG000|Overall Study|Subject Incarcerated|0|||
145994557|NCT03164356|526494461|FG001|Overall Study|Subject Incarcerated|1|||
145994558|NCT03164356|526494462|FG002|Overall Study|Subject Incarcerated|0|||
145994559|NCT03164356|526494463|FG003|Overall Study|Subject Incarcerated|0|||
145994560|NCT03164356|526494460|FG000|Overall Study|Prosthetist unable to participate|0|||
145994561|NCT03164356|526494461|FG001|Overall Study|Prosthetist unable to participate|2|||
145994562|NCT03164356|526494462|FG002|Overall Study|Prosthetist unable to participate|1|||
145994563|NCT03164356|526494463|FG003|Overall Study|Prosthetist unable to participate|0|||
145994564|NCT02520154|526494470|FG000|Overall Study|Death|1|||
145994565|NCT02520154|526494470|FG000|Overall Study|Withdrawal by Subject|2|||
145994566|NCT02520154|526494470|FG000|Overall Study|Physician Decision|2|||
145994567|NCT05943990|526494474|FG000|Overall Study|Study Terminated by Sponsor|0|||
145994568|NCT05943990|526494475|FG001|Overall Study|Study Terminated by Sponsor|0|||
145994569|NCT05943990|526494476|FG002|Overall Study|Study Terminated by Sponsor|1|||
145994570|NCT04976777|526496688|FG000|Overall Study|COVID-19 Infection|1|||
145994571|NCT04976777|526496689|FG001|Overall Study|COVID-19 Infection|0|||
145994572|NCT00442702|526496690|FG000|Titration Period|Adverse Event|2|||
145994573|NCT00442702|526496691|FG001|Titration Period|Adverse Event|0|||
145994574|NCT00442702|526496690|FG000|Titration Period|Death|3|||
145994575|NCT00442702|526496691|FG001|Titration Period|Death|2|||
145994576|NCT00442702|526496690|FG000|Titration Period|Insufficient Therapeutic Response|1|||
145994577|NCT00442702|526496691|FG001|Titration Period|Insufficient Therapeutic Response|0|||
145994578|NCT00442702|526496690|FG000|Titration Period|Refused Treatment|4|||
145994579|NCT00442702|526496691|FG001|Titration Period|Refused Treatment|1|||
145994580|NCT00442702|526496690|FG000|Titration Period|Failure to return|1|||
145994581|NCT00442702|526496691|FG001|Titration Period|Failure to return|0|||
145994582|NCT00442702|526496690|FG000|Titration Period|Hospitalized in another hospital|1|||
145994583|NCT00442702|526496691|FG001|Titration Period|Hospitalized in another hospital|0|||
145994584|NCT00442702|526496690|FG000|Evaluation Period|Adverse Event|1|||
145994585|NCT00442702|526496691|FG001|Evaluation Period|Adverse Event|0|||
145994586|NCT00442702|526496690|FG000|Evaluation Period|Death|1|||
145994587|NCT00442702|526496691|FG001|Evaluation Period|Death|1|||
145994588|NCT00442702|526496690|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
145994589|NCT00442702|526496691|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
145994590|NCT00442702|526496690|FG000|Evaluation Period|Refused treatment|1|||
145994591|NCT00442702|526496691|FG001|Evaluation Period|Refused treatment|1|||
146297889|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
146297890|NCT02038920|527606027|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146297891|NCT02038920|527606028|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146297892|NCT02038920|527606029|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146297893|NCT02038920|527606030|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146297894|NCT02038920|527606031|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
146297895|NCT02038920|527606032|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
146297896|NCT02383589|527606034|FG000|Treatment Period|Adverse Event|1|||
146297897|NCT02383589|527606035|FG001|Treatment Period|Adverse Event|3|||
146297898|NCT02383589|527606034|FG000|Treatment Period|Lost to Follow-up|0|||
146297899|NCT02383589|527606035|FG001|Treatment Period|Lost to Follow-up|1|||
146297900|NCT02383589|527606034|FG000|Treatment Period|Withdrawal by Subject|0|||
146297901|NCT02383589|527606035|FG001|Treatment Period|Withdrawal by Subject|5|||
146297902|NCT02383589|527606034|FG000|Treatment Period|Non-compliance with study drug|0|||
146297903|NCT02383589|527606035|FG001|Treatment Period|Non-compliance with study drug|1|||
146297904|NCT02383589|527606034|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
146297905|NCT02383589|527606035|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
146297906|NCT02383589|527606034|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
146297907|NCT02383589|527606035|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
146297908|NCT02383589|527606034|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
146297909|NCT02383589|527606035|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
146297910|NCT00866697|527606036|FG000|Overall Study|Study closed/terminated|156|||
146297911|NCT00866697|527606037|FG001|Overall Study|Study closed/terminated|138|||
146297912|NCT00866697|527606036|FG000|Overall Study|Lost to Follow-up|22|||
146297913|NCT00866697|527606037|FG001|Overall Study|Lost to Follow-up|28|||
146297914|NCT00866697|527606036|FG000|Overall Study|Physician Decision|3|||
146297915|NCT00866697|527606037|FG001|Overall Study|Physician Decision|5|||
146297916|NCT00866697|527606036|FG000|Overall Study|Withdrawal by Subject|33|||
146297917|NCT00866697|527606037|FG001|Overall Study|Withdrawal by Subject|57|||
146297918|NCT02906787|527606041|FG000|Overall Study|Withdrawal by Subject|12|||
146297919|NCT02906787|527606042|FG001|Overall Study|Withdrawal by Subject|10|||
146297920|NCT02906787|527606041|FG000|Overall Study|Missed|24|||
146297921|NCT02906787|527606042|FG001|Overall Study|Missed|22|||
146297922|NCT04275297|527606043|FG000|Overall Study|Lost to Follow-up|1|||
146297923|NCT04275297|527606044|FG001|Overall Study|Lost to Follow-up|1|||
146297924|NCT00447382|527606047|FG000|Overall Study|Adverse Event|1|||
146297925|NCT00447382|527606048|FG001|Overall Study|Adverse Event|1|||
146297926|NCT00447382|527606047|FG000|Overall Study|Lack of Efficacy|1|||
146297927|NCT00447382|527606048|FG001|Overall Study|Lack of Efficacy|0|||
146297928|NCT00447382|527606047|FG000|Overall Study|Protocol Violation|2|||
146297929|NCT00447382|527606048|FG001|Overall Study|Protocol Violation|0|||
146297930|NCT00447382|527606047|FG000|Overall Study|Unclassified|2|||
145994592|NCT00442702|526496690|FG000|Evaluation Period|Renal transplant|0|||
145994593|NCT00442702|526496691|FG001|Evaluation Period|Renal transplant|1|||
145994594|NCT00442702|526496690|FG000|Evaluation Period|Failure to return|1|||
145994595|NCT00442702|526496691|FG001|Evaluation Period|Failure to return|0|||
145994596|NCT00442702|526496690|FG000|Evaluation Period|Site closure|0|||
145994597|NCT00442702|526496691|FG001|Evaluation Period|Site closure|1|||
145994598|NCT04123704|526496702|FG000|Overall Study|Disease progression|2|||
145994599|NCT01425814|526496708|FG000|Period 1|Stability criteria not fulfilled|0|||
145994600|NCT01425814|526496709|FG001|Period 1|Stability criteria not fulfilled|1|||
145994601|NCT01425814|526496710|FG002|Period 1|Stability criteria not fulfilled|0|||
145994602|NCT01425814|526496711|FG003|Period 1|Stability criteria not fulfilled|0|||
145994603|NCT01425814|526496712|FG004|Period 1|Stability criteria not fulfilled|0|||
145994604|NCT01425814|526496713|FG005|Period 1|Stability criteria not fulfilled|0|||
145994605|NCT01425814|526496708|FG000|Period 2|Stability criteria not fulfilled|0|||
145994606|NCT01425814|526496709|FG001|Period 2|Stability criteria not fulfilled|1|||
145994607|NCT01425814|526496710|FG002|Period 2|Stability criteria not fulfilled|0|||
145994608|NCT01425814|526496711|FG003|Period 2|Stability criteria not fulfilled|0|||
145994609|NCT01425814|526496712|FG004|Period 2|Stability criteria not fulfilled|0|||
145994610|NCT01425814|526496713|FG005|Period 2|Stability criteria not fulfilled|0|||
145994611|NCT01425814|526496708|FG000|Period 3|Adverse Event|0|||
145994612|NCT01425814|526496709|FG001|Period 3|Adverse Event|0|||
145994613|NCT01425814|526496710|FG002|Period 3|Adverse Event|0|||
145994614|NCT01425814|526496711|FG003|Period 3|Adverse Event|0|||
145994615|NCT01425814|526496712|FG004|Period 3|Adverse Event|0|||
145994616|NCT01425814|526496713|FG005|Period 3|Adverse Event|1|||
145994617|NCT01425814|526496708|FG000|Period 4|Adverse Event|1|||
145994618|NCT01425814|526496709|FG001|Period 4|Adverse Event|0|||
145994619|NCT01425814|526496710|FG002|Period 4|Adverse Event|1|||
145994620|NCT01425814|526496711|FG003|Period 4|Adverse Event|0|||
145994621|NCT01425814|526496712|FG004|Period 4|Adverse Event|0|||
145994622|NCT01425814|526496713|FG005|Period 4|Adverse Event|0|||
145994623|NCT01425814|526496708|FG000|Period 5|Stability criteria not fulfilled|0|||
145994624|NCT01425814|526496709|FG001|Period 5|Stability criteria not fulfilled|0|||
145994625|NCT01425814|526496710|FG002|Period 5|Stability criteria not fulfilled|1|||
146297931|NCT00447382|527606048|FG001|Overall Study|Unclassified|5|||
145994626|NCT01425814|526496711|FG003|Period 5|Stability criteria not fulfilled|0|||
145994627|NCT01425814|526496712|FG004|Period 5|Stability criteria not fulfilled|0|||
145994628|NCT01425814|526496713|FG005|Period 5|Stability criteria not fulfilled|1|||
145994629|NCT02546323|526496717|FG000|Overall Study|Withdrawal by Subject|36|||
145994630|NCT02546323|526496718|FG001|Overall Study|Withdrawal by Subject|33|||
145994631|NCT02546323|526496717|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
145994632|NCT02546323|526496718|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
145994633|NCT02546323|526496717|FG000|Overall Study|Adverse Event|17|||
145994634|NCT02546323|526496718|FG001|Overall Study|Adverse Event|11|||
145994635|NCT02546323|526496717|FG000|Overall Study|Patient Specific Reasons|1|||
145994636|NCT02546323|526496718|FG001|Overall Study|Patient Specific Reasons|2|||
145994637|NCT02546323|526496717|FG000|Overall Study|Lost to Follow-up|2|||
145994638|NCT02546323|526496718|FG001|Overall Study|Lost to Follow-up|3|||
145994639|NCT02546323|526496717|FG000|Overall Study|Non-compliance with Study Drug|2|||
145994640|NCT02546323|526496718|FG001|Overall Study|Non-compliance with Study Drug|2|||
145994641|NCT02546323|526496717|FG000|Overall Study|Met Withdrawal Criteria|2|||
145994642|NCT02546323|526496718|FG001|Overall Study|Met Withdrawal Criteria|14|||
145994643|NCT04476784|526496719|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
145994644|NCT04476784|526496720|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
145994645|NCT00478257|526496721|FG000|Overall Study|Withdrawal by Subject|8|||
145994646|NCT00478257|526496722|FG001|Overall Study|Withdrawal by Subject|3|||
145994647|NCT01055028|526496724|FG000|Screening|Screen Failure|1|||
146091753|NCT02017171|526856906|FG000|Overall Study|Lost to Follow-up|21|||
146091754|NCT02017171|526856907|FG001|Overall Study|Lost to Follow-up|20|||
146091755|NCT02017171|526856906|FG000|Overall Study|ESKD|6|||
145994648|NCT01055028|526496725|FG001|Screening|Screen Failure|1|||
145994649|NCT01055028|526496724|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
145994650|NCT01055028|526496725|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
145994651|NCT01055028|526496724|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
145994652|NCT01055028|526496725|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
145994653|NCT01055028|526496724|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
145994654|NCT01055028|526496725|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
145994655|NCT06582732|526496726|FG000|Initial Study Period|Adverse Event|0|||
146091756|NCT02017171|526856907|FG001|Overall Study|ESKD|2|||
146091757|NCT02017171|526856906|FG000|Overall Study|Miscellaneous|2|||
146091758|NCT02017171|526856907|FG001|Overall Study|Miscellaneous|3|||
146091759|NCT01562873|526856908|FG000|Overall Study|Disease Progression per RECIST|10|||
146091760|NCT01562873|526856909|FG001|Overall Study|Disease Progression per RECIST|0|||
146091761|NCT01562873|526856908|FG000|Overall Study|Adverse Event|1|||
146091762|NCT01562873|526856909|FG001|Overall Study|Adverse Event|0|||
146091763|NCT01562873|526856908|FG000|Overall Study|Clinical Disease Progression|9|||
146091764|NCT01562873|526856909|FG001|Overall Study|Clinical Disease Progression|0|||
146091765|NCT01562873|526856908|FG000|Overall Study|Clinical PD and adverse event|1|||
146091766|NCT01562873|526856909|FG001|Overall Study|Clinical PD and adverse event|0|||
146091767|NCT02536833|526856910|FG000|Overall Study|Discontinued Before Treatment|0|||
146091768|NCT02536833|526856911|FG001|Overall Study|Discontinued Before Treatment|0|||
146091769|NCT02536833|526856912|FG002|Overall Study|Discontinued Before Treatment|1|||
146091770|NCT02536833|526856913|FG003|Overall Study|Discontinued Before Treatment|2|||
146091771|NCT02536833|526856910|FG000|Overall Study|Adverse Event|1|||
146091772|NCT02536833|526856911|FG001|Overall Study|Adverse Event|3|||
146091773|NCT02536833|526856912|FG002|Overall Study|Adverse Event|4|||
146091774|NCT02536833|526856913|FG003|Overall Study|Adverse Event|1|||
146091775|NCT02536833|526856910|FG000|Overall Study|Lost to Follow-up|2|||
146091776|NCT02536833|526856911|FG001|Overall Study|Lost to Follow-up|1|||
146091777|NCT02536833|526856912|FG002|Overall Study|Lost to Follow-up|2|||
146091778|NCT02536833|526856913|FG003|Overall Study|Lost to Follow-up|2|||
146091779|NCT02536833|526856910|FG000|Overall Study|Physician Decision|0|||
146091780|NCT02536833|526856911|FG001|Overall Study|Physician Decision|0|||
146091781|NCT02536833|526856912|FG002|Overall Study|Physician Decision|0|||
146091782|NCT02536833|526856913|FG003|Overall Study|Physician Decision|1|||
146091783|NCT02536833|526856910|FG000|Overall Study|Site Terminated by Sponsor|2|||
146091784|NCT02536833|526856911|FG001|Overall Study|Site Terminated by Sponsor|2|||
146091785|NCT02536833|526856912|FG002|Overall Study|Site Terminated by Sponsor|2|||
146091786|NCT02536833|526856913|FG003|Overall Study|Site Terminated by Sponsor|2|||
146091787|NCT02536833|526856910|FG000|Overall Study|Subject Non-Compliance|0|||
146091788|NCT02536833|526856911|FG001|Overall Study|Subject Non-Compliance|1|||
146091789|NCT02536833|526856912|FG002|Overall Study|Subject Non-Compliance|1|||
146091790|NCT02536833|526856913|FG003|Overall Study|Subject Non-Compliance|0|||
146091791|NCT02536833|526856910|FG000|Overall Study|Withdrawal by Subject|4|||
146091792|NCT02536833|526856911|FG001|Overall Study|Withdrawal by Subject|3|||
146091793|NCT02536833|526856912|FG002|Overall Study|Withdrawal by Subject|5|||
146091794|NCT02536833|526856913|FG003|Overall Study|Withdrawal by Subject|11|||
146091795|NCT03370289|526856914|FG000|Overall Study|Screen Failure|1|||
146091796|NCT03370289|526856914|FG000|Overall Study|Sample Size Sufficient|4|||
146091797|NCT02220998|526856916|FG000|Overall Study|Randomized but Never Treated|1|||
146246566|NCT05066230|527417600|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
146246567|NCT05066230|527417599|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
146246568|NCT05066230|527417600|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
146246569|NCT05066230|527417599|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
146246570|NCT05066230|527417600|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
146246571|NCT05066230|527417599|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
146246572|NCT05066230|527417600|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
146246573|NCT05066230|527417599|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
146246574|NCT05066230|527417600|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
146246575|NCT05066230|527417599|FG000|After Week 48|Adverse Event|1|||
146246576|NCT05066230|527417600|FG001|After Week 48|Adverse Event|0|||
146246577|NCT05066230|527417599|FG000|After Week 48|Non-compliance with study schedule|1|||
146246578|NCT05066230|527417600|FG001|After Week 48|Non-compliance with study schedule|0|||
146246579|NCT05066230|527417599|FG000|After Week 48|Withdrawal by Subject|0|||
146246580|NCT05066230|527417600|FG001|After Week 48|Withdrawal by Subject|1|||
146246581|NCT05066230|527417599|FG000|After Week 48|Lost to Follow-up|3|||
146246582|NCT05066230|527417600|FG001|After Week 48|Lost to Follow-up|3|||
146246583|NCT05066230|527417599|FG000|After Week 48|Sponsor Request|115|||
146246584|NCT05066230|527417600|FG001|After Week 48|Sponsor Request|111|||
146246585|NCT03072238|527417601|FG000|Overall Study|Withdrawal by Subject|44|||
146246586|NCT03072238|527417602|FG001|Overall Study|Withdrawal by Subject|64|||
146091798|NCT02220998|526856917|FG001|Overall Study|Randomized but Never Treated|2|||
146091799|NCT02220998|526856916|FG000|Overall Study|Death|2|||
146091800|NCT02220998|526856917|FG001|Overall Study|Death|0|||
146091801|NCT02220998|526856916|FG000|Overall Study|Lack of Efficacy|0|||
146091802|NCT02220998|526856917|FG001|Overall Study|Lack of Efficacy|5|||
146091803|NCT02220998|526856916|FG000|Overall Study|Lost to Follow-up|4|||
146091804|NCT02220998|526856917|FG001|Overall Study|Lost to Follow-up|4|||
146091805|NCT02764190|526856918|FG000|Overall Study|Lost to Follow-up|17|||
146091806|NCT02764190|526856919|FG001|Overall Study|Lost to Follow-up|13|||
146091807|NCT02140775|526856921|FG000|Overall Study|Withdrawal by Subject|30|||
146091808|NCT02140775|526856922|FG001|Overall Study|Withdrawal by Subject|7|||
146091809|NCT02280473|526856926|FG000|Overall Study|Adverse Event|1|||
146091810|NCT02280473|526856927|FG001|Overall Study|Adverse Event|1|||
146091811|NCT02280473|526856926|FG000|Overall Study|Lack of Efficacy|0|||
146091812|NCT02280473|526856927|FG001|Overall Study|Lack of Efficacy|1|||
146091813|NCT02280473|526856926|FG000|Overall Study|Lost to Follow-up|0|||
146091814|NCT02280473|526856927|FG001|Overall Study|Lost to Follow-up|1|||
146091815|NCT04223232|526856932|FG000|Overall Study|Withdrawal by Subject|1|||
146091816|NCT05281601|526856940|FG000|Overall Study|Physician Decision|2|||
146091817|NCT05281601|526856941|FG001|Overall Study|Physician Decision|0|||
146091818|NCT05281601|526856940|FG000|Overall Study|Lost to Follow-up|2|||
146091819|NCT05281601|526856941|FG001|Overall Study|Lost to Follow-up|0|||
146091820|NCT05281601|526856940|FG000|Overall Study|Death|1|||
146091821|NCT05281601|526856941|FG001|Overall Study|Death|0|||
146091822|NCT05281601|526856940|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146091823|NCT05281601|526856941|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146091824|NCT00901927|526856942|FG000|Overall Study|Lack of Efficacy|1|||
146091825|NCT00901927|526856942|FG000|Overall Study|Protocol Violation|3|||
146091826|NCT00901927|526856942|FG000|Overall Study|Withdrawal by Subject|2|||
146091827|NCT03172910|526858422|FG000|Overall Study|Adverse Event|0|||
146091828|NCT03172910|526858423|FG001|Overall Study|Adverse Event|0|||
146091829|NCT03172910|526858424|FG002|Overall Study|Adverse Event|0|||
146091830|NCT03172910|526858425|FG003|Overall Study|Adverse Event|0|||
146091831|NCT03172910|526858426|FG004|Overall Study|Adverse Event|1|||
146091832|NCT00451451|526858435|FG000|Overall Study|Adverse Event|11|||
146091833|NCT00451451|526858436|FG001|Overall Study|Adverse Event|21|||
146091834|NCT00451451|526858437|FG002|Overall Study|Adverse Event|26|||
146091835|NCT00451451|526858438|FG003|Overall Study|Adverse Event|10|||
146091836|NCT00451451|526858435|FG000|Overall Study|Lost to Follow-up|11|||
146091837|NCT00451451|526858436|FG001|Overall Study|Lost to Follow-up|9|||
146091838|NCT00451451|526858437|FG002|Overall Study|Lost to Follow-up|8|||
146091839|NCT00451451|526858438|FG003|Overall Study|Lost to Follow-up|11|||
146246587|NCT03072238|527417601|FG000|Overall Study|Lost to Follow-up|14|||
146091840|NCT00451451|526858435|FG000|Overall Study|Consent Withdrawn|14|||
146091841|NCT00451451|526858436|FG001|Overall Study|Consent Withdrawn|9|||
146091842|NCT00451451|526858437|FG002|Overall Study|Consent Withdrawn|17|||
146091843|NCT00451451|526858438|FG003|Overall Study|Consent Withdrawn|17|||
146091844|NCT00451451|526858435|FG000|Overall Study|Investigator Decision|6|||
146091845|NCT00451451|526858436|FG001|Overall Study|Investigator Decision|2|||
146091846|NCT00451451|526858437|FG002|Overall Study|Investigator Decision|1|||
146091847|NCT00451451|526858438|FG003|Overall Study|Investigator Decision|2|||
146091848|NCT00451451|526858435|FG000|Overall Study|Subject Non-Compliance|8|||
146091849|NCT00451451|526858436|FG001|Overall Study|Subject Non-Compliance|4|||
146091850|NCT00451451|526858437|FG002|Overall Study|Subject Non-Compliance|3|||
146091851|NCT00451451|526858438|FG003|Overall Study|Subject Non-Compliance|3|||
146091852|NCT00451451|526858435|FG000|Overall Study|Death|1|||
145994656|NCT06582732|526496727|FG001|Initial Study Period|Adverse Event|0|||
145994657|NCT06582732|526496728|FG002|Initial Study Period|Adverse Event|0|||
145994658|NCT06582732|526496729|FG003|Initial Study Period|Adverse Event|2|||
145994659|NCT06582732|526496730|FG004|Initial Study Period|Adverse Event|0|||
145994660|NCT06582732|526496731|FG005|Initial Study Period|Adverse Event|0|||
145994661|NCT06582732|526496732|FG006|Initial Study Period|Adverse Event|0|||
145994662|NCT06582732|526496726|FG000|Initial Study Period|Death|1|||
145994663|NCT06582732|526496727|FG001|Initial Study Period|Death|0|||
145994664|NCT06582732|526496728|FG002|Initial Study Period|Death|0|||
145994665|NCT06582732|526496729|FG003|Initial Study Period|Death|0|||
145994666|NCT06582732|526496730|FG004|Initial Study Period|Death|1|||
145994667|NCT06582732|526496731|FG005|Initial Study Period|Death|0|||
145994668|NCT06582732|526496732|FG006|Initial Study Period|Death|0|||
145994669|NCT06582732|526496726|FG000|Initial Study Period|Lost to Follow-up|0|||
145994670|NCT06582732|526496727|FG001|Initial Study Period|Lost to Follow-up|0|||
145994671|NCT06582732|526496728|FG002|Initial Study Period|Lost to Follow-up|2|||
145994672|NCT06582732|526496729|FG003|Initial Study Period|Lost to Follow-up|0|||
145994673|NCT06582732|526496730|FG004|Initial Study Period|Lost to Follow-up|0|||
145994674|NCT06582732|526496731|FG005|Initial Study Period|Lost to Follow-up|0|||
145994675|NCT06582732|526496732|FG006|Initial Study Period|Lost to Follow-up|0|||
145994676|NCT06582732|526496726|FG000|Initial Study Period|Withdrawal by Subject|0|||
145994677|NCT06582732|526496727|FG001|Initial Study Period|Withdrawal by Subject|1|||
145994678|NCT06582732|526496728|FG002|Initial Study Period|Withdrawal by Subject|0|||
145994679|NCT06582732|526496729|FG003|Initial Study Period|Withdrawal by Subject|1|||
145994680|NCT06582732|526496730|FG004|Initial Study Period|Withdrawal by Subject|3|||
145994681|NCT06582732|526496731|FG005|Initial Study Period|Withdrawal by Subject|1|||
145994682|NCT06582732|526496732|FG006|Initial Study Period|Withdrawal by Subject|2|||
145994683|NCT06582732|526496726|FG000|Initial Study Period|Moved Away|0|||
145994684|NCT06582732|526496727|FG001|Initial Study Period|Moved Away|0|||
145994685|NCT06582732|526496728|FG002|Initial Study Period|Moved Away|0|||
145994686|NCT06582732|526496729|FG003|Initial Study Period|Moved Away|0|||
145994687|NCT06582732|526496730|FG004|Initial Study Period|Moved Away|1|||
145994688|NCT06582732|526496731|FG005|Initial Study Period|Moved Away|0|||
145994689|NCT06582732|526496732|FG006|Initial Study Period|Moved Away|0|||
145994690|NCT03605693|526496733|FG000|Overall Study|Lost to Follow-up|4|||
145994691|NCT03605693|526496734|FG001|Overall Study|Lost to Follow-up|0|||
145994692|NCT03605693|526496733|FG000|Overall Study|Physician Decision|1|||
145994693|NCT03605693|526496734|FG001|Overall Study|Physician Decision|0|||
145994694|NCT05134649|526496737|FG000|Overall Study|Lost to Follow-up|12|||
145994695|NCT05134649|526496737|FG000|Overall Study|Withdrawal by Subject|14|||
145994696|NCT05134649|526496737|FG000|Overall Study|Pregnancy|1|||
145994697|NCT05134649|526496737|FG000|Overall Study|Other, not specified|3|||
145994698|NCT01605097|526496740|FG000|Overall Study|Protocol Violation|1|||
145994699|NCT02038647|526496741|FG000|Overall Study|Progressive Disease|50|||
145994700|NCT02038647|526496742|FG001|Overall Study|Progressive Disease|59|||
145994701|NCT02038647|526496741|FG000|Overall Study|Adverse Event|18|||
145994702|NCT02038647|526496742|FG001|Overall Study|Adverse Event|10|||
145994703|NCT02038647|526496741|FG000|Overall Study|Symptomatic Deterioration|7|||
145994704|NCT02038647|526496742|FG001|Overall Study|Symptomatic Deterioration|7|||
145994705|NCT02038647|526496741|FG000|Overall Study|Withdrawal by Subject|5|||
145994706|NCT02038647|526496742|FG001|Overall Study|Withdrawal by Subject|2|||
145994707|NCT02038647|526496741|FG000|Overall Study|Not Reported|0|||
145994708|NCT02038647|526496742|FG001|Overall Study|Not Reported|1|||
145994709|NCT02038647|526496741|FG000|Overall Study|Ongoing at Datacut|9|||
145994710|NCT02038647|526496742|FG001|Overall Study|Ongoing at Datacut|10|||
145994711|NCT03078868|526496743|FG000|Overall Study|Physician Decision|3|||
145994712|NCT03038620|526496744|FG000|Overall Study|Lost to Follow-up|18|||
145994713|NCT03038620|526496745|FG001|Overall Study|Lost to Follow-up|23|||
145994714|NCT03038620|526496744|FG000|Overall Study|Withdrawal by Subject|0|||
145994715|NCT03038620|526496745|FG001|Overall Study|Withdrawal by Subject|15|||
145994716|NCT03038620|526496744|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
145994717|NCT03038620|526496745|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
145994718|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Adverse Event|3|||
145994719|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Adverse Event|0|||
145994720|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Adverse Event|0|||
145994721|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
145994722|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
145994723|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
145994724|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
145994725|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
145994726|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
145994727|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
145994728|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
145994729|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
145994730|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
145994731|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
145994732|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
145994733|NCT04380142|526496746|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
145994734|NCT04380142|526496747|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
145994735|NCT04380142|526496748|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
145994736|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145994737|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145994738|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Adverse Event|14|||
145994739|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
145994740|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
145994741|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
145994742|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145994743|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
145994744|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
145994745|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
145994746|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
145994747|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
145994748|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
145994749|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
145994750|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
145994751|NCT04380142|526496746|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
145994752|NCT04380142|526496747|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
145994753|NCT04380142|526496748|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
145994754|NCT02106832|526496755|FG000|Overall Study|Adverse Event|1|||
145994755|NCT02106832|526496756|FG001|Overall Study|Adverse Event|2|||
145994756|NCT02106832|526496757|FG002|Overall Study|Adverse Event|3|||
145994757|NCT02106832|526496758|FG003|Overall Study|Adverse Event|0|||
145994758|NCT02106832|526496755|FG000|Overall Study|Death|4|||
145994759|NCT02106832|526496756|FG001|Overall Study|Death|4|||
145994760|NCT02106832|526496757|FG002|Overall Study|Death|1|||
145994761|NCT02106832|526496758|FG003|Overall Study|Death|4|||
145994762|NCT02106832|526496755|FG000|Overall Study|Deterioration of general conditions|0|||
145994763|NCT02106832|526496756|FG001|Overall Study|Deterioration of general conditions|0|||
145994764|NCT02106832|526496757|FG002|Overall Study|Deterioration of general conditions|1|||
145994765|NCT02106832|526496758|FG003|Overall Study|Deterioration of general conditions|0|||
145994766|NCT02106832|526496755|FG000|Overall Study|Lost to Follow-up|0|||
145994767|NCT02106832|526496756|FG001|Overall Study|Lost to Follow-up|1|||
145994768|NCT02106832|526496757|FG002|Overall Study|Lost to Follow-up|1|||
145994769|NCT02106832|526496758|FG003|Overall Study|Lost to Follow-up|3|||
145994770|NCT02106832|526496755|FG000|Overall Study|Physician Decision|1|||
145994771|NCT02106832|526496756|FG001|Overall Study|Physician Decision|0|||
145994772|NCT02106832|526496757|FG002|Overall Study|Physician Decision|0|||
145994773|NCT02106832|526496758|FG003|Overall Study|Physician Decision|0|||
145994774|NCT02106832|526496755|FG000|Overall Study|Protocol Violation|0|||
145994775|NCT02106832|526496756|FG001|Overall Study|Protocol Violation|0|||
145994776|NCT02106832|526496757|FG002|Overall Study|Protocol Violation|0|||
145994777|NCT02106832|526496758|FG003|Overall Study|Protocol Violation|1|||
145994778|NCT02106832|526496755|FG000|Overall Study|Withdrawal by Subject|17|||
145994779|NCT02106832|526496756|FG001|Overall Study|Withdrawal by Subject|17|||
145994780|NCT02106832|526496757|FG002|Overall Study|Withdrawal by Subject|10|||
145994781|NCT02106832|526496758|FG003|Overall Study|Withdrawal by Subject|7|||
145994782|NCT02106832|526496755|FG000|Overall Study|Technical problems|0|||
145994783|NCT02106832|526496756|FG001|Overall Study|Technical problems|1|||
145994784|NCT02106832|526496757|FG002|Overall Study|Technical problems|0|||
145994785|NCT02106832|526496758|FG003|Overall Study|Technical problems|0|||
145994786|NCT01968980|526496779|FG000|Overall Study|Death|0|||
145994787|NCT01968980|526496780|FG001|Overall Study|Death|1|||
145994788|NCT01968980|526496779|FG000|Overall Study|Adverse Event|1|||
145994789|NCT01968980|526496780|FG001|Overall Study|Adverse Event|3|||
145994790|NCT01968980|526496779|FG000|Overall Study|Does not meet entry criteria|1|||
145994791|NCT01968980|526496780|FG001|Overall Study|Does not meet entry criteria|3|||
145994792|NCT01968980|526496779|FG000|Overall Study|Withdrawal by Subject|13|||
145994793|NCT01968980|526496780|FG001|Overall Study|Withdrawal by Subject|5|||
145994794|NCT01968980|526496779|FG000|Overall Study|Other unspecified|1|||
145994795|NCT01968980|526496780|FG001|Overall Study|Other unspecified|2|||
145994796|NCT00265122|526496781|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145994797|NCT00265122|526496782|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145994798|NCT00265122|526496783|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
145994799|NCT00265122|526496784|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
145994800|NCT00265122|526496785|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145994801|NCT00265122|526496786|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
146091853|NCT00451451|526858436|FG001|Overall Study|Death|0|||
145994802|NCT00265122|526496781|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
145994803|NCT00265122|526496782|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145994804|NCT00265122|526496783|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145994805|NCT00265122|526496784|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
145994806|NCT00265122|526496785|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145994807|NCT00265122|526496786|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145994808|NCT00265122|526496781|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145994809|NCT00265122|526496782|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
145994810|NCT00265122|526496783|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
145994811|NCT00265122|526496784|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
145994812|NCT00265122|526496785|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145994813|NCT00265122|526496786|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145994814|NCT00265122|526496781|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
145994815|NCT00265122|526496782|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
145994816|NCT00265122|526496783|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
145994817|NCT00265122|526496784|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
145994818|NCT00265122|526496785|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
145994819|NCT00265122|526496786|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
145994820|NCT00265122|526496781|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
145994821|NCT00265122|526496782|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
145994822|NCT00265122|526496783|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
145994823|NCT00265122|526496784|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
145994824|NCT00265122|526496785|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
145994825|NCT00265122|526496786|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
145994826|NCT00265122|526496781|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
145994827|NCT00265122|526496782|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145994828|NCT00265122|526496783|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
145994829|NCT00265122|526496784|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
145994830|NCT00265122|526496785|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145994831|NCT00265122|526496786|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145994832|NCT04716894|526496787|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
145994833|NCT04716894|526496787|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
145994834|NCT00982280|526496808|FG000|Observation Period|Not eligible to be dosed|19|||
145994835|NCT00982280|526496808|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
145994836|NCT00982280|526496808|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
145994837|NCT00982280|526496808|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
145994838|NCT00982280|526496808|FG000|Maintenance Period|Adverse Event|1|||
145994839|NCT01506726|526496814|FG000|Overall Study|Adverse Event|1|||
145994840|NCT01506726|526496815|FG001|Overall Study|Adverse Event|2|||
145994841|NCT02231580|526496816|FG000|Overall Study|Adverse Event|5|||
145994842|NCT02231580|526496817|FG001|Overall Study|Adverse Event|0|||
145994843|NCT04724837|526496818|FG000|Overall Study|Other|4|||
145994844|NCT04724837|526496819|FG001|Overall Study|Other|16|||
145994845|NCT04724837|526496820|FG002|Overall Study|Other|0|||
145994846|NCT04724837|526496818|FG000|Overall Study|Withdrawal by Subject|2|||
145994847|NCT04724837|526496819|FG001|Overall Study|Withdrawal by Subject|9|||
145994848|NCT04724837|526496820|FG002|Overall Study|Withdrawal by Subject|9|||
145994849|NCT04724837|526496818|FG000|Overall Study|Adverse Event|2|||
145994850|NCT04724837|526496819|FG001|Overall Study|Adverse Event|7|||
145994851|NCT04724837|526496820|FG002|Overall Study|Adverse Event|4|||
145994852|NCT04724837|526496818|FG000|Overall Study|Lost to Follow-up|0|||
145994853|NCT04724837|526496819|FG001|Overall Study|Lost to Follow-up|1|||
145994854|NCT04724837|526496820|FG002|Overall Study|Lost to Follow-up|3|||
145994855|NCT04724837|526496818|FG000|Overall Study|Physician Decision|1|||
145994856|NCT04724837|526496819|FG001|Overall Study|Physician Decision|2|||
145994857|NCT04724837|526496820|FG002|Overall Study|Physician Decision|0|||
145994858|NCT04724837|526496818|FG000|Overall Study|Death|0|||
145994859|NCT04724837|526496819|FG001|Overall Study|Death|0|||
145994860|NCT04724837|526496820|FG002|Overall Study|Death|1|||
145994861|NCT04724837|526496818|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145994862|NCT04724837|526496819|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
145994863|NCT04724837|526496820|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
145994864|NCT04724837|526496818|FG000|Overall Study|Study Terminated by Sponsor|0|||
145994865|NCT04724837|526496819|FG001|Overall Study|Study Terminated by Sponsor|1|||
145994866|NCT04724837|526496820|FG002|Overall Study|Study Terminated by Sponsor|0|||
145994867|NCT03620981|526496821|FG000|Overall Study|Adverse Event|14|||
145994868|NCT03620981|526496822|FG001|Overall Study|Adverse Event|38|||
146091854|NCT00451451|526858437|FG002|Overall Study|Death|0|||
146246588|NCT03072238|527417602|FG001|Overall Study|Lost to Follow-up|5|||
145994869|NCT03620981|526496823|FG002|Overall Study|Adverse Event|25|||
145994870|NCT03620981|526496821|FG000|Overall Study|Lack of Efficacy|2|||
146246589|NCT03072238|527417601|FG000|Overall Study|Physician Decision|4|||
145994871|NCT03620981|526496822|FG001|Overall Study|Lack of Efficacy|1|||
145994872|NCT03620981|526496823|FG002|Overall Study|Lack of Efficacy|1|||
145994873|NCT03620981|526496821|FG000|Overall Study|Physician Decision|7|||
145994874|NCT03620981|526496822|FG001|Overall Study|Physician Decision|4|||
145994875|NCT03620981|526496823|FG002|Overall Study|Physician Decision|4|||
145994876|NCT03620981|526496821|FG000|Overall Study|Protocol Violation|1|||
145994877|NCT03620981|526496822|FG001|Overall Study|Protocol Violation|2|||
145994878|NCT03620981|526496823|FG002|Overall Study|Protocol Violation|1|||
145994879|NCT03620981|526496821|FG000|Overall Study|Withdrawal by Legal Representative|2|||
145994880|NCT03620981|526496822|FG001|Overall Study|Withdrawal by Legal Representative|1|||
145994881|NCT03620981|526496823|FG002|Overall Study|Withdrawal by Legal Representative|1|||
145994882|NCT03620981|526496821|FG000|Overall Study|Withdrawal by Care Giver|2|||
145994883|NCT03620981|526496822|FG001|Overall Study|Withdrawal by Care Giver|0|||
145994884|NCT03620981|526496823|FG002|Overall Study|Withdrawal by Care Giver|1|||
145994885|NCT03620981|526496821|FG000|Overall Study|Non-compliance with Study Drug|1|||
145994886|NCT03620981|526496822|FG001|Overall Study|Non-compliance with Study Drug|1|||
145994887|NCT03620981|526496823|FG002|Overall Study|Non-compliance with Study Drug|0|||
145994888|NCT04347538|526496824|FG000|Overall Study|Lost to Follow-up|4|||
145994889|NCT04347538|526496825|FG001|Overall Study|Lost to Follow-up|5|||
145994890|NCT04347538|526496826|FG002|Overall Study|Lost to Follow-up|7|||
145994891|NCT02259231|526496827|FG000|Overall Study|Adverse Event|1|||
145994892|NCT02259231|526496828|FG001|Overall Study|Adverse Event|1|||
145994893|NCT02259231|526496829|FG002|Overall Study|Adverse Event|2|||
145994894|NCT02259231|526496830|FG003|Overall Study|Adverse Event|0|||
145994895|NCT02259231|526496831|FG004|Overall Study|Adverse Event|0|||
145994896|NCT02259231|526496832|FG005|Overall Study|Adverse Event|0|||
145994897|NCT02259231|526496833|FG006|Overall Study|Adverse Event|0|||
145994898|NCT02259231|526496827|FG000|Overall Study|Progressive Disease|4|||
145994899|NCT02259231|526496828|FG001|Overall Study|Progressive Disease|5|||
145994900|NCT02259231|526496829|FG002|Overall Study|Progressive Disease|4|||
145994901|NCT02259231|526496830|FG003|Overall Study|Progressive Disease|5|||
145994902|NCT02259231|526496831|FG004|Overall Study|Progressive Disease|4|||
145994903|NCT02259231|526496832|FG005|Overall Study|Progressive Disease|5|||
145994904|NCT02259231|526496833|FG006|Overall Study|Progressive Disease|4|||
145994905|NCT02259231|526496827|FG000|Overall Study|Sponsor termination of study|1|||
145994906|NCT02259231|526496828|FG001|Overall Study|Sponsor termination of study|0|||
145994907|NCT02259231|526496829|FG002|Overall Study|Sponsor termination of study|0|||
145994908|NCT02259231|526496830|FG003|Overall Study|Sponsor termination of study|1|||
145994909|NCT02259231|526496831|FG004|Overall Study|Sponsor termination of study|2|||
145994910|NCT02259231|526496832|FG005|Overall Study|Sponsor termination of study|1|||
145994911|NCT02259231|526496833|FG006|Overall Study|Sponsor termination of study|1|||
145994912|NCT04562090|526496834|FG000|Overall Study|Withdrawal by Subject|3|||
145994913|NCT04562090|526496835|FG001|Overall Study|Withdrawal by Subject|4|||
145994914|NCT04562090|526496834|FG000|Overall Study|Protocol Violation|2|||
145994915|NCT04562090|526496835|FG001|Overall Study|Protocol Violation|0|||
145994916|NCT04562090|526496834|FG000|Overall Study|Lack of Efficacy|0|||
145994917|NCT04562090|526496835|FG001|Overall Study|Lack of Efficacy|1|||
145994918|NCT04562090|526496834|FG000|Overall Study|Adverse Event|1|||
145994919|NCT04562090|526496835|FG001|Overall Study|Adverse Event|4|||
145994920|NCT04562090|526496834|FG000|Overall Study|Miscellaneous|0|||
145994921|NCT04562090|526496835|FG001|Overall Study|Miscellaneous|3|||
145994922|NCT04938427|526496836|FG000|Overall Study|Adverse Event|5|||
145994923|NCT04938427|526496837|FG001|Overall Study|Adverse Event|19|||
145994924|NCT04938427|526496836|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145994925|NCT04938427|526496837|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145994926|NCT04938427|526496836|FG000|Overall Study|Withdrawal by Subject|1|||
145994927|NCT04938427|526496837|FG001|Overall Study|Withdrawal by Subject|0|||
145994928|NCT04938427|526496836|FG000|Overall Study|Reason Not Specified|2|||
145994929|NCT04938427|526496837|FG001|Overall Study|Reason Not Specified|1|||
145994930|NCT03633058|526496846|FG000|Overall Study|Adverse Event|0|||
145994931|NCT03633058|526496847|FG001|Overall Study|Adverse Event|0|||
146091855|NCT00451451|526858438|FG003|Overall Study|Death|1|||
146091856|NCT00451451|526858435|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
146091857|NCT00451451|526858436|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
146246590|NCT03072238|527417602|FG001|Overall Study|Physician Decision|6|||
145994932|NCT03633058|526496848|FG002|Overall Study|Adverse Event|1|||
145994933|NCT03633058|526496849|FG003|Overall Study|Adverse Event|0|||
145994934|NCT03312543|526496852|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
145994935|NCT03312543|526496853|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
145994936|NCT03312543|526496852|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
145994937|NCT03312543|526496853|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
145994938|NCT03312543|526496852|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
145994939|NCT03312543|526496853|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
145994940|NCT03312543|526496852|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
145994941|NCT03312543|526496853|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
145994942|NCT03312543|526496852|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
146091858|NCT00451451|526858437|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
146246591|NCT03072238|527417601|FG000|Overall Study|Death|351|||
146297932|NCT04600336|527606055|FG000|Initial Treatment|Withdrawal by Subject|1|||
146297933|NCT04600336|527606056|FG001|Initial Treatment|Withdrawal by Subject|2|||
146297934|NCT04600336|527606057|FG002|Initial Treatment|Withdrawal by Subject|0|||
146297935|NCT04600336|527606058|FG003|Initial Treatment|Withdrawal by Subject|0|||
146297936|NCT04600336|527606055|FG000|Initial Treatment|Adverse Event|0|||
146297937|NCT04600336|527606056|FG001|Initial Treatment|Adverse Event|2|||
146297938|NCT04600336|527606057|FG002|Initial Treatment|Adverse Event|0|||
146297939|NCT04600336|527606058|FG003|Initial Treatment|Adverse Event|0|||
146297940|NCT04600336|527606055|FG000|Initial Treatment|Other complicating disease|0|||
146297941|NCT04600336|527606056|FG001|Initial Treatment|Other complicating disease|0|||
146297942|NCT04600336|527606057|FG002|Initial Treatment|Other complicating disease|1|||
146297943|NCT04600336|527606058|FG003|Initial Treatment|Other complicating disease|0|||
146297944|NCT04600336|527606055|FG000|Crossover Treatment|Withdrawal by Subject|0|||
146297945|NCT04600336|527606056|FG001|Crossover Treatment|Withdrawal by Subject|0|||
146297946|NCT04600336|527606057|FG002|Crossover Treatment|Withdrawal by Subject|2|||
146297947|NCT04600336|527606058|FG003|Crossover Treatment|Withdrawal by Subject|1|||
146297948|NCT04600336|527606055|FG000|Crossover Treatment|Adverse Event|0|||
146297949|NCT04600336|527606056|FG001|Crossover Treatment|Adverse Event|0|||
146297950|NCT04600336|527606057|FG002|Crossover Treatment|Adverse Event|1|||
146297951|NCT04600336|527606058|FG003|Crossover Treatment|Adverse Event|1|||
146297952|NCT04739800|527606059|FG000|Overall Study|Adverse Event|2|||
146297953|NCT04739800|527606060|FG001|Overall Study|Adverse Event|1|||
146297954|NCT04739800|527606061|FG002|Overall Study|Adverse Event|4|||
146297955|NCT04739800|527606062|FG003|Overall Study|Adverse Event|5|||
146297956|NCT04739800|527606059|FG000|Overall Study|Never Treated|2|||
146297957|NCT04739800|527606060|FG001|Overall Study|Never Treated|0|||
146297958|NCT04739800|527606061|FG002|Overall Study|Never Treated|1|||
146297959|NCT04739800|527606062|FG003|Overall Study|Never Treated|1|||
146297960|NCT04739800|527606059|FG000|Overall Study|On Treatment|5|||
146297961|NCT04739800|527606060|FG001|Overall Study|On Treatment|9|||
146297962|NCT04739800|527606061|FG002|Overall Study|On Treatment|9|||
146297963|NCT04739800|527606062|FG003|Overall Study|On Treatment|9|||
146297964|NCT04739800|527606059|FG000|Overall Study|Symptomatic Deterioration|1|||
146297965|NCT04739800|527606060|FG001|Overall Study|Symptomatic Deterioration|1|||
146297966|NCT04739800|527606061|FG002|Overall Study|Symptomatic Deterioration|3|||
146297967|NCT04739800|527606062|FG003|Overall Study|Symptomatic Deterioration|0|||
146297968|NCT04739800|527606059|FG000|Overall Study|Withdrawal by Subject|1|||
146297969|NCT04739800|527606060|FG001|Overall Study|Withdrawal by Subject|2|||
146297970|NCT04739800|527606061|FG002|Overall Study|Withdrawal by Subject|1|||
146297971|NCT04739800|527606062|FG003|Overall Study|Withdrawal by Subject|3|||
146297972|NCT04739800|527606059|FG000|Overall Study|Other Reason|1|||
146297973|NCT04739800|527606060|FG001|Overall Study|Other Reason|3|||
146297974|NCT04739800|527606061|FG002|Overall Study|Other Reason|5|||
146297975|NCT04739800|527606062|FG003|Overall Study|Other Reason|4|||
146297976|NCT04225806|527606063|FG000|Overall Study|Trial termination|15|||
146297977|NCT02408861|527606066|FG000|Overall Study|Death|0|||
146297978|NCT02408861|527606067|FG001|Overall Study|Death|3|||
146297979|NCT02408861|527606068|FG002|Overall Study|Death|1|||
146297980|NCT02408861|527606069|FG003|Overall Study|Death|2|||
146297981|NCT02408861|527606070|FG004|Overall Study|Death|4|||
146297982|NCT02408861|527606071|FG005|Overall Study|Death|1|||
146297983|NCT02408861|527606072|FG006|Overall Study|Death|0|||
146297984|NCT02408861|527606066|FG000|Overall Study|Lost to Follow-up|0|||
146297985|NCT02408861|527606067|FG001|Overall Study|Lost to Follow-up|0|||
146297986|NCT02408861|527606068|FG002|Overall Study|Lost to Follow-up|1|||
146297987|NCT02408861|527606069|FG003|Overall Study|Lost to Follow-up|1|||
146297988|NCT02408861|527606070|FG004|Overall Study|Lost to Follow-up|4|||
146297989|NCT02408861|527606071|FG005|Overall Study|Lost to Follow-up|2|||
145994943|NCT03312543|526496853|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
146297990|NCT02408861|527606072|FG006|Overall Study|Lost to Follow-up|1|||
146297991|NCT02408861|527606066|FG000|Overall Study|Disease Progression|0|||
146297992|NCT02408861|527606067|FG001|Overall Study|Disease Progression|0|||
146297993|NCT02408861|527606068|FG002|Overall Study|Disease Progression|1|||
146297994|NCT02408861|527606069|FG003|Overall Study|Disease Progression|0|||
146297995|NCT02408861|527606070|FG004|Overall Study|Disease Progression|3|||
146297996|NCT02408861|527606071|FG005|Overall Study|Disease Progression|1|||
145994944|NCT03312543|526496852|FG000|Regression (Week 12 to Week 24)|Death|0|||
145994945|NCT03312543|526496853|FG001|Regression (Week 12 to Week 24)|Death|1|||
146297997|NCT02408861|527606072|FG006|Overall Study|Disease Progression|1|||
146297998|NCT02408861|527606066|FG000|Overall Study|Adverse Event|1|||
146297999|NCT02408861|527606067|FG001|Overall Study|Adverse Event|0|||
146298000|NCT02408861|527606068|FG002|Overall Study|Adverse Event|1|||
146298001|NCT02408861|527606069|FG003|Overall Study|Adverse Event|0|||
146298002|NCT02408861|527606070|FG004|Overall Study|Adverse Event|2|||
146298003|NCT02408861|527606071|FG005|Overall Study|Adverse Event|0|||
146298004|NCT02408861|527606072|FG006|Overall Study|Adverse Event|0|||
146298005|NCT02408861|527606066|FG000|Overall Study|Physician Decision|1|||
146298006|NCT02408861|527606067|FG001|Overall Study|Physician Decision|1|||
146298007|NCT02408861|527606068|FG002|Overall Study|Physician Decision|1|||
145994946|NCT04507269|526496854|FG000|Overall Study|Withdrawal by Subject|1|||
145994947|NCT04507269|526496855|FG001|Overall Study|Withdrawal by Subject|1|||
145994948|NCT04507269|526496856|FG002|Overall Study|Withdrawal by Subject|0|||
145994949|NCT04507269|526496857|FG003|Overall Study|Withdrawal by Subject|0|||
145994950|NCT04507269|526496858|FG004|Overall Study|Withdrawal by Subject|0|||
145994951|NCT04507269|526496859|FG005|Overall Study|Withdrawal by Subject|0|||
145994952|NCT04507269|526496854|FG000|Overall Study|Lost to Follow-up|0|||
145994953|NCT04507269|526496855|FG001|Overall Study|Lost to Follow-up|0|||
145994954|NCT04507269|526496856|FG002|Overall Study|Lost to Follow-up|0|||
145994955|NCT04507269|526496857|FG003|Overall Study|Lost to Follow-up|0|||
145994956|NCT04507269|526496858|FG004|Overall Study|Lost to Follow-up|1|||
145994957|NCT04507269|526496859|FG005|Overall Study|Lost to Follow-up|0|||
145994958|NCT05852340|526496860|FG000|Period 5|Not completing the meal|0|||
145994959|NCT05852340|526496861|FG001|Period 5|Not completing the meal|1|||
145994960|NCT05852340|526496862|FG002|Period 5|Not completing the meal|0|||
145994961|NCT05852340|526496863|FG003|Period 5|Not completing the meal|0|||
145994962|NCT05852340|526496860|FG000|Period 5|Adverse Event|0|||
145994963|NCT05852340|526496861|FG001|Period 5|Adverse Event|0|||
145994964|NCT05852340|526496862|FG002|Period 5|Adverse Event|0|||
145994965|NCT05852340|526496863|FG003|Period 5|Adverse Event|1|||
145994966|NCT01722669|526496866|FG000|Overall Study|Withdrawal by Subject|0|||
145994967|NCT01722669|526496867|FG001|Overall Study|Withdrawal by Subject|0|||
145994968|NCT01722669|526496868|FG002|Overall Study|Withdrawal by Subject|0|||
145994969|NCT01722669|526496869|FG003|Overall Study|Withdrawal by Subject|0|||
145994970|NCT01722669|526496870|FG004|Overall Study|Withdrawal by Subject|0|||
145994971|NCT01722669|526496871|FG005|Overall Study|Withdrawal by Subject|2|||
145994972|NCT02420717|526496872|FG000|Overall Study|Did not receive all study medication|2|||
145994973|NCT02420717|526496873|FG001|Overall Study|Did not receive all study medication|0|||
145994974|NCT02420717|526496874|FG002|Overall Study|Did not receive all study medication|0|||
145994975|NCT04116489|526496875|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
145994976|NCT04116489|526496875|FG000|Overall Study|Withdrawal by Subject|1|||
145994977|NCT03781570|526496876|FG000|Overall Study|Technical Issues (equipment failure)|31|||
145994978|NCT03781570|526496876|FG000|Overall Study|Withdrawal by Subject|7|||
145994979|NCT03781570|526496876|FG000|Overall Study|Physical Constraints|11|||
145994980|NCT01107496|526496877|FG000|Overall Study|Adverse Event|1|||
145994981|NCT01107496|526496878|FG001|Overall Study|Adverse Event|0|||
145994982|NCT01107496|526496877|FG000|Overall Study|Lack of Efficacy|1|||
145994983|NCT01107496|526496878|FG001|Overall Study|Lack of Efficacy|0|||
145994984|NCT01107496|526496877|FG000|Overall Study|Protocol Violation|0|||
145994985|NCT01107496|526496878|FG001|Overall Study|Protocol Violation|1|||
145994986|NCT01107496|526496877|FG000|Overall Study|Lost to Follow-up|0|||
145994987|NCT01107496|526496878|FG001|Overall Study|Lost to Follow-up|1|||
145994988|NCT01346592|526496879|FG000|Overall Study|Lost to Follow-up|62|||
145994989|NCT01346592|526496880|FG001|Overall Study|Lost to Follow-up|29|||
145994990|NCT01346592|526496881|FG002|Overall Study|Lost to Follow-up|29|||
145994991|NCT01346592|526496879|FG000|Overall Study|Protocol Violation|2|||
145994992|NCT01346592|526496880|FG001|Overall Study|Protocol Violation|1|||
145994993|NCT01346592|526496881|FG002|Overall Study|Protocol Violation|0|||
145994994|NCT01346592|526496879|FG000|Overall Study|Death|1|||
145994995|NCT01346592|526496880|FG001|Overall Study|Death|3|||
145994996|NCT01346592|526496881|FG002|Overall Study|Death|4|||
145994997|NCT01346592|526496879|FG000|Overall Study|Adverse Event|0|||
145994998|NCT01346592|526496880|FG001|Overall Study|Adverse Event|1|||
145994999|NCT01346592|526496881|FG002|Overall Study|Adverse Event|0|||
145995000|NCT01346592|526496879|FG000|Overall Study|Withdrawal by Subject|77|||
145995001|NCT01346592|526496880|FG001|Overall Study|Withdrawal by Subject|51|||
145995002|NCT01346592|526496881|FG002|Overall Study|Withdrawal by Subject|38|||
145995003|NCT01346592|526496879|FG000|Overall Study|Inappropriate enrollment|3|||
145995004|NCT01346592|526496880|FG001|Overall Study|Inappropriate enrollment|1|||
145995005|NCT01346592|526496881|FG002|Overall Study|Inappropriate enrollment|1|||
145995006|NCT01346592|526496879|FG000|Overall Study|Administrative reason|1|||
145995007|NCT01346592|526496880|FG001|Overall Study|Administrative reason|0|||
145995008|NCT01346592|526496881|FG002|Overall Study|Administrative reason|0|||
145995009|NCT01346592|526496879|FG000|Overall Study|Unable to Classify|7|||
145995010|NCT01346592|526496880|FG001|Overall Study|Unable to Classify|3|||
145995011|NCT01346592|526496881|FG002|Overall Study|Unable to Classify|6|||
145995012|NCT02457793|526496882|FG000|Overall Study|Reason not specified|0|||
145995013|NCT02457793|526496883|FG001|Overall Study|Reason not specified|0|||
145995014|NCT02457793|526496884|FG002|Overall Study|Reason not specified|0|||
145995015|NCT02457793|526496885|FG003|Overall Study|Reason not specified|1|||
145995016|NCT02457793|526496886|FG004|Overall Study|Reason not specified|1|||
145995017|NCT02457793|526496887|FG005|Overall Study|Reason not specified|1|||
145995018|NCT02457793|526496882|FG000|Overall Study|Withdrawal by Subject|0|||
145995019|NCT02457793|526496883|FG001|Overall Study|Withdrawal by Subject|4|||
145995020|NCT02457793|526496884|FG002|Overall Study|Withdrawal by Subject|2|||
145995021|NCT02457793|526496885|FG003|Overall Study|Withdrawal by Subject|2|||
145995022|NCT02457793|526496886|FG004|Overall Study|Withdrawal by Subject|2|||
145995023|NCT02457793|526496887|FG005|Overall Study|Withdrawal by Subject|2|||
145995024|NCT02457793|526496882|FG000|Overall Study|Adverse Event|0|||
145995025|NCT02457793|526496883|FG001|Overall Study|Adverse Event|0|||
145995026|NCT02457793|526496884|FG002|Overall Study|Adverse Event|0|||
145995027|NCT02457793|526496885|FG003|Overall Study|Adverse Event|1|||
145995028|NCT02457793|526496886|FG004|Overall Study|Adverse Event|0|||
145995029|NCT02457793|526496887|FG005|Overall Study|Adverse Event|0|||
145995030|NCT02457793|526496882|FG000|Overall Study|Physician Decision|1|||
145995031|NCT02457793|526496883|FG001|Overall Study|Physician Decision|0|||
145995032|NCT02457793|526496884|FG002|Overall Study|Physician Decision|1|||
145995033|NCT02457793|526496885|FG003|Overall Study|Physician Decision|1|||
145995034|NCT02457793|526496886|FG004|Overall Study|Physician Decision|1|||
145995035|NCT02457793|526496887|FG005|Overall Study|Physician Decision|3|||
145995036|NCT03814044|526496892|FG000|Overall Study|Protocol deviation|1|||
145995037|NCT00835367|526496904|FG000|Washout|Adverse Event|2|||
145995038|NCT00835367|526496905|FG001|Washout|Adverse Event|0|||
145995039|NCT00835367|526496904|FG000|Washout|Withdrawal by Subject|1|||
145995040|NCT00835367|526496905|FG001|Washout|Withdrawal by Subject|0|||
145995041|NCT00835367|526496904|FG000|Second Intervention|Adverse Event|1|||
145995042|NCT00835367|526496905|FG001|Second Intervention|Adverse Event|1|||
145995043|NCT05929326|526496906|FG000|Overall Study|unqualified sample|2|||
145995044|NCT05929326|526496907|FG001|Overall Study|unqualified sample|3|||
145995045|NCT05929326|526496908|FG002|Overall Study|unqualified sample|7|||
145995046|NCT04890509|526496909|FG000|Overall Study|Death|4|||
145995047|NCT04890509|526496910|FG001|Overall Study|Death|4|||
145995048|NCT02552225|526498511|FG000|Overall Study|Withdrawal by Subject|1|||
145995049|NCT02552225|526498512|FG001|Overall Study|Withdrawal by Subject|0|||
145995050|NCT03122184|526498513|FG000|Overall Study|Lost to Follow-up|4|||
145995051|NCT03122184|526498514|FG001|Overall Study|Lost to Follow-up|6|||
145995052|NCT03122184|526498513|FG000|Overall Study|Withdrawal by Subject|3|||
145995053|NCT03122184|526498514|FG001|Overall Study|Withdrawal by Subject|0|||
145995054|NCT03122184|526498513|FG000|Overall Study|Terminated due to cognitive problem|1|||
145995055|NCT03122184|526498514|FG001|Overall Study|Terminated due to cognitive problem|0|||
145995056|NCT01168596|526498515|FG000|Overall Study|Withdrawal by Subject|3|||
145995057|NCT01168596|526498516|FG001|Overall Study|Withdrawal by Subject|1|||
145995058|NCT02297516|526498519|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
145995059|NCT02297516|526498520|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
145995060|NCT02297516|526498519|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
145995061|NCT02297516|526498520|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
145995062|NCT02297516|526498519|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
145995063|NCT02297516|526498520|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
145995064|NCT00710593|526498521|FG000|Overall Study|Incarceration|1|||
145995065|NCT00710593|526498522|FG001|Overall Study|Incarceration|0|||
145995066|NCT00710593|526498521|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
145995067|NCT00710593|526498522|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
145995068|NCT00710593|526498521|FG000|Overall Study|Lost to Follow-up|3|||
145995069|NCT00710593|526498522|FG001|Overall Study|Lost to Follow-up|1|||
145995070|NCT00710593|526498521|FG000|Overall Study|Moved out of area|1|||
145995071|NCT00710593|526498522|FG001|Overall Study|Moved out of area|0|||
145995072|NCT00710593|526498521|FG000|Overall Study|Failure to adhere or complete study eval|1|||
145995073|NCT00710593|526498522|FG001|Overall Study|Failure to adhere or complete study eval|1|||
145995074|NCT00710593|526498521|FG000|Overall Study|Protocol Violation|1|||
145995075|NCT00710593|526498522|FG001|Overall Study|Protocol Violation|1|||
145995076|NCT00710593|526498521|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
145995077|NCT00710593|526498522|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
145995078|NCT04490278|526498523|FG000|Overall Study|Lost to Follow-up|6|||
145995079|NCT00366457|526498526|FG000|Overall Study|never began study therapy|2|||
146246592|NCT03072238|527417602|FG001|Overall Study|Death|318|||
146246593|NCT03072238|527417601|FG000|Overall Study|Progressive Disease|3|||
146246594|NCT03072238|527417602|FG001|Overall Study|Progressive Disease|4|||
145995080|NCT02829996|526498527|FG000|Overall Study|Withdrawal by Subject|1|||
145995081|NCT02829996|526498528|FG001|Overall Study|Withdrawal by Subject|0|||
145995082|NCT02829996|526498529|FG002|Overall Study|Withdrawal by Subject|0|||
145995083|NCT02829996|526498530|FG003|Overall Study|Withdrawal by Subject|0|||
146246595|NCT03072238|527417601|FG000|Overall Study|Reason Not Specified|138|||
146246596|NCT03072238|527417602|FG001|Overall Study|Reason Not Specified|150|||
145995084|NCT02829996|526498531|FG004|Overall Study|Withdrawal by Subject|0|||
145995085|NCT00189423|526498532|FG000|Overall Study|Death|746|||
145995086|NCT00189423|526498533|FG001|Overall Study|Death|747|||
145995087|NCT00189423|526498532|FG000|Overall Study|Withdrawal by Subject|9|||
145995088|NCT00189423|526498533|FG001|Overall Study|Withdrawal by Subject|9|||
146091859|NCT00451451|526858438|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
145995089|NCT00189423|526498532|FG000|Overall Study|Lost to Follow-up|10|||
145995090|NCT00189423|526498533|FG001|Overall Study|Lost to Follow-up|10|||
145995091|NCT01497197|526498534|FG000|Overall Study|Lost to Follow-up|1|||
145995092|NCT01497197|526498535|FG001|Overall Study|Lost to Follow-up|0|||
145995093|NCT01497197|526498534|FG000|Overall Study|Protocol Violation|0|||
146246597|NCT01562275|527417608|FG000|Stage 1|Adverse Event|0|||
145995094|NCT01497197|526498535|FG001|Overall Study|Protocol Violation|2|||
145995095|NCT01497197|526498534|FG000|Overall Study|Withdrawal by Subject|2|||
145995096|NCT01497197|526498535|FG001|Overall Study|Withdrawal by Subject|1|||
145995097|NCT01497197|526498534|FG000|Overall Study|Excessive/lack of response to treatment|1|||
145995098|NCT01497197|526498535|FG001|Overall Study|Excessive/lack of response to treatment|0|||
145995099|NCT01497197|526498534|FG000|Overall Study|Risk of OHSS|1|||
145995100|NCT01497197|526498535|FG001|Overall Study|Risk of OHSS|0|||
145995101|NCT01497197|526498534|FG000|Overall Study|No oocytes retrieved|3|||
145995102|NCT01497197|526498535|FG001|Overall Study|No oocytes retrieved|2|||
145995103|NCT01497197|526498534|FG000|Overall Study|No fertilisation|6|||
145995104|NCT01497197|526498535|FG001|Overall Study|No fertilisation|5|||
145995105|NCT01497197|526498534|FG000|Overall Study|Intention to freeze all embryos|0|||
145995106|NCT01497197|526498535|FG001|Overall Study|Intention to freeze all embryos|1|||
145995107|NCT01497197|526498534|FG000|Overall Study|All embryos discarded|0|||
145995108|NCT01497197|526498535|FG001|Overall Study|All embryos discarded|3|||
145995109|NCT01497197|526498534|FG000|Overall Study|Other|3|||
145995110|NCT01497197|526498535|FG001|Overall Study|Other|1|||
145995111|NCT00565747|526498540|FG000|Overall Study|No embryo transfer|67|||
145995112|NCT00565747|526498541|FG001|Overall Study|No embryo transfer|73|||
145995113|NCT00183248|526498542|FG000|Overall Study|Lost to Follow-up|0|||
145995114|NCT00183248|526498543|FG001|Overall Study|Lost to Follow-up|1|||
145995115|NCT00183248|526498542|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
145995116|NCT00183248|526498543|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
145995117|NCT04734210|526498546|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
145995118|NCT04734210|526498547|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
145995119|NCT04734210|526498548|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
145995120|NCT04734210|526498546|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
145995121|NCT04734210|526498547|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
145995122|NCT04734210|526498548|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
145995123|NCT04734210|526498546|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
145995124|NCT04734210|526498547|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
145995125|NCT04734210|526498548|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
145995126|NCT04734210|526498546|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
145995127|NCT04734210|526498547|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
145995128|NCT04734210|526498548|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
145995129|NCT02684461|526498549|FG000|Overall Study|Adverse Event|1|||
145995130|NCT02684461|526498550|FG001|Overall Study|Adverse Event|0|||
145995131|NCT02684461|526498551|FG002|Overall Study|Adverse Event|0|||
145995132|NCT02684461|526498549|FG000|Overall Study|Lack of Efficacy|1|||
145995133|NCT02684461|526498550|FG001|Overall Study|Lack of Efficacy|2|||
145995134|NCT02684461|526498551|FG002|Overall Study|Lack of Efficacy|0|||
145995135|NCT02390076|526498552|FG000|Overall Study|Lost to Follow-up|2|||
145995136|NCT02390076|526498553|FG001|Overall Study|Lost to Follow-up|1|||
145995137|NCT02390076|526498554|FG002|Overall Study|Lost to Follow-up|4|||
145995138|NCT01206517|526498557|FG000|Overall Study|Withdrawal by Subject|0|||
145995139|NCT01206517|526498558|FG001|Overall Study|Withdrawal by Subject|0|||
145995140|NCT01206517|526498559|FG002|Overall Study|Withdrawal by Subject|2|||
145995141|NCT01206517|526498560|FG003|Overall Study|Withdrawal by Subject|0|||
145995142|NCT01206517|526498561|FG004|Overall Study|Withdrawal by Subject|1|||
145995143|NCT01206517|526498562|FG005|Overall Study|Withdrawal by Subject|0|||
145995144|NCT03493958|526498563|FG000|Overall Study|Withdrawal by Subject|6|||
145995145|NCT03493958|526498563|FG000|Overall Study|Lost to Follow-up|7|||
145995146|NCT03493958|526498563|FG000|Overall Study|Did not complete all required study procedures|2|||
145995147|NCT01029535|526498564|FG000|Overall Study|Lost to Follow-up|24|||
145995148|NCT01029535|526498564|FG000|Overall Study|Protocol Violation|2|||
145995149|NCT01029535|526498564|FG000|Overall Study|Participant Withdrew Consent|2|||
145995150|NCT01029535|526498564|FG000|Overall Study|Adverse Event|1|||
145995151|NCT01029535|526498564|FG000|Overall Study|Use of Another Treatment|1|||
145995152|NCT01029535|526498564|FG000|Overall Study|Death|1|||
145995153|NCT01358734|526498567|FG000|Overall Study|Adverse Event|4|||
145995154|NCT01358734|526498568|FG001|Overall Study|Adverse Event|7|||
145995155|NCT01358734|526498569|FG002|Overall Study|Adverse Event|3|||
145995156|NCT01358734|526498567|FG000|Overall Study|Lack of Efficacy|0|||
145995157|NCT01358734|526498568|FG001|Overall Study|Lack of Efficacy|1|||
145995158|NCT01358734|526498569|FG002|Overall Study|Lack of Efficacy|3|||
146298008|NCT02408861|527606069|FG003|Overall Study|Physician Decision|0|||
145995159|NCT01358734|526498567|FG000|Overall Study|Withdrawal by Subject|1|||
145995160|NCT01358734|526498568|FG001|Overall Study|Withdrawal by Subject|6|||
145995161|NCT01358734|526498569|FG002|Overall Study|Withdrawal by Subject|3|||
145995162|NCT01358734|526498567|FG000|Overall Study|Death|3|||
145995163|NCT01358734|526498568|FG001|Overall Study|Death|7|||
146298009|NCT02408861|527606070|FG004|Overall Study|Physician Decision|0|||
146298010|NCT02408861|527606071|FG005|Overall Study|Physician Decision|1|||
145995164|NCT01358734|526498569|FG002|Overall Study|Death|2|||
145995165|NCT01358734|526498567|FG000|Overall Study|Progressive Disease|5|||
145995166|NCT01358734|526498568|FG001|Overall Study|Progressive Disease|13|||
145995167|NCT01358734|526498569|FG002|Overall Study|Progressive Disease|16|||
145995168|NCT01358734|526498567|FG000|Overall Study|Non-compliance with study drug|0|||
145995169|NCT01358734|526498568|FG001|Overall Study|Non-compliance with study drug|0|||
145995170|NCT01358734|526498569|FG002|Overall Study|Non-compliance with study drug|1|||
145995171|NCT01358734|526498567|FG000|Overall Study|Other|2|||
145995172|NCT01358734|526498568|FG001|Overall Study|Other|5|||
145995173|NCT01358734|526498569|FG002|Overall Study|Other|4|||
145995174|NCT01358734|526498567|FG000|Overall Study|Protocol Violation|0|||
145995175|NCT01358734|526498568|FG001|Overall Study|Protocol Violation|0|||
145995176|NCT01358734|526498569|FG002|Overall Study|Protocol Violation|2|||
145995177|NCT01822925|526498570|FG000|Overall Study|Adverse Event|1|||
145995178|NCT01822925|526498571|FG001|Overall Study|Adverse Event|1|||
145995179|NCT01822925|526498572|FG002|Overall Study|Adverse Event|1|||
145995180|NCT01822925|526498573|FG003|Overall Study|Adverse Event|1|||
145995181|NCT01822925|526498570|FG000|Overall Study|Lost to Follow-up|0|||
145995182|NCT01822925|526498571|FG001|Overall Study|Lost to Follow-up|1|||
145995183|NCT01822925|526498572|FG002|Overall Study|Lost to Follow-up|0|||
145995184|NCT01822925|526498573|FG003|Overall Study|Lost to Follow-up|0|||
145995185|NCT01822925|526498570|FG000|Overall Study|Protocol Violation|1|||
145995186|NCT01822925|526498571|FG001|Overall Study|Protocol Violation|0|||
145995187|NCT01822925|526498572|FG002|Overall Study|Protocol Violation|0|||
145995188|NCT01822925|526498573|FG003|Overall Study|Protocol Violation|1|||
146298011|NCT02408861|527606072|FG006|Overall Study|Physician Decision|0|||
146298012|NCT02408861|527606066|FG000|Overall Study|Protocol Violation|1|||
146298013|NCT02408861|527606067|FG001|Overall Study|Protocol Violation|0|||
146298014|NCT02408861|527606068|FG002|Overall Study|Protocol Violation|0|||
146298015|NCT02408861|527606069|FG003|Overall Study|Protocol Violation|0|||
146298016|NCT02408861|527606070|FG004|Overall Study|Protocol Violation|0|||
146298017|NCT02408861|527606071|FG005|Overall Study|Protocol Violation|0|||
146298018|NCT02408861|527606072|FG006|Overall Study|Protocol Violation|0|||
146298019|NCT02408861|527606066|FG000|Overall Study|Withdrawal by Subject|0|||
146298020|NCT02408861|527606067|FG001|Overall Study|Withdrawal by Subject|0|||
146298021|NCT02408861|527606068|FG002|Overall Study|Withdrawal by Subject|0|||
146298022|NCT02408861|527606069|FG003|Overall Study|Withdrawal by Subject|0|||
146298023|NCT02408861|527606070|FG004|Overall Study|Withdrawal by Subject|1|||
146298024|NCT02408861|527606071|FG005|Overall Study|Withdrawal by Subject|1|||
146298025|NCT02408861|527606072|FG006|Overall Study|Withdrawal by Subject|0|||
146298026|NCT02408861|527606066|FG000|Overall Study|Other Treatment|0|||
146298027|NCT02408861|527606067|FG001|Overall Study|Other Treatment|0|||
146298028|NCT02408861|527606068|FG002|Overall Study|Other Treatment|0|||
146298029|NCT02408861|527606069|FG003|Overall Study|Other Treatment|0|||
146298030|NCT02408861|527606070|FG004|Overall Study|Other Treatment|0|||
146298031|NCT02408861|527606071|FG005|Overall Study|Other Treatment|1|||
146298032|NCT02408861|527606072|FG006|Overall Study|Other Treatment|1|||
146298033|NCT04091451|527606073|FG000|Overall Study|Adverse Event|15|||
146298034|NCT04091451|527606074|FG001|Overall Study|Adverse Event|10|||
146298035|NCT04091451|527606073|FG000|Overall Study|Lost to Follow-up|8|||
146298036|NCT04091451|527606074|FG001|Overall Study|Lost to Follow-up|8|||
146298037|NCT04091451|527606073|FG000|Overall Study|Protocol Violation|5|||
146298038|NCT04091451|527606074|FG001|Overall Study|Protocol Violation|4|||
146298039|NCT04091451|527606073|FG000|Overall Study|Withdrawal by Subject|21|||
146298040|NCT04091451|527606074|FG001|Overall Study|Withdrawal by Subject|27|||
146298041|NCT04091451|527606073|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
146298042|NCT04091451|527606074|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
146298043|NCT04091451|527606073|FG000|Overall Study|Migrated/moved from the study area|3|||
145995189|NCT01822925|526498570|FG000|Overall Study|Withdrawal by Subject|2|||
146298044|NCT04091451|527606074|FG001|Overall Study|Migrated/moved from the study area|5|||
146298045|NCT04091451|527606073|FG000|Overall Study|Suspected HZ episode|1|||
146298046|NCT04091451|527606074|FG001|Overall Study|Suspected HZ episode|0|||
146298047|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
146298048|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
146298049|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
146298050|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
146298051|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
145995190|NCT01822925|526498571|FG001|Overall Study|Withdrawal by Subject|0|||
145995191|NCT01822925|526498572|FG002|Overall Study|Withdrawal by Subject|2|||
145995192|NCT01822925|526498573|FG003|Overall Study|Withdrawal by Subject|2|||
145995193|NCT01822925|526498570|FG000|Overall Study|Taking prohibited medication|2|||
145995194|NCT01822925|526498571|FG001|Overall Study|Taking prohibited medication|0|||
145995195|NCT01822925|526498572|FG002|Overall Study|Taking prohibited medication|0|||
145995196|NCT01822925|526498573|FG003|Overall Study|Taking prohibited medication|1|||
145995197|NCT00553254|526498578|FG000|Overall Study|Death|3|||
145995198|NCT00553254|526498579|FG001|Overall Study|Death|6|||
145995199|NCT00553254|526498580|FG002|Overall Study|Death|25|||
145995200|NCT00553254|526498578|FG000|Overall Study|Lost to Follow-up|0|||
145995201|NCT00553254|526498579|FG001|Overall Study|Lost to Follow-up|0|||
145995202|NCT00553254|526498580|FG002|Overall Study|Lost to Follow-up|2|||
145995203|NCT00553254|526498578|FG000|Overall Study|Withdrawal by Subject|2|||
145995204|NCT00553254|526498579|FG001|Overall Study|Withdrawal by Subject|0|||
145995205|NCT00553254|526498580|FG002|Overall Study|Withdrawal by Subject|2|||
145995206|NCT00553254|526498578|FG000|Overall Study|Study terminated by Sponsor|0|||
145995207|NCT00553254|526498579|FG001|Overall Study|Study terminated by Sponsor|0|||
145995208|NCT00553254|526498580|FG002|Overall Study|Study terminated by Sponsor|1|||
145995209|NCT00553254|526498578|FG000|Overall Study|Other|1|||
145995210|NCT00553254|526498579|FG001|Overall Study|Other|0|||
145995211|NCT00553254|526498580|FG002|Overall Study|Other|13|||
145995212|NCT02314923|526498583|FG000|Overall Study|Death|0|||
145995213|NCT02314923|526498584|FG001|Overall Study|Death|0|||
145995214|NCT02314923|526498585|FG002|Overall Study|Death|0|||
145995215|NCT02314923|526498586|FG003|Overall Study|Death|1|||
145995216|NCT02314923|526498587|FG004|Overall Study|Death|0|||
145995217|NCT02314923|526498588|FG005|Overall Study|Death|0|||
145995218|NCT02314923|526498589|FG006|Overall Study|Death|0|||
145995219|NCT02314923|526498590|FG007|Overall Study|Death|0|||
145995220|NCT02314923|526498591|FG008|Overall Study|Death|0|||
145995221|NCT02314923|526498592|FG009|Overall Study|Death|0|||
145995222|NCT02314923|526498583|FG000|Overall Study|Lost to Follow-up|2|||
145995223|NCT02314923|526498584|FG001|Overall Study|Lost to Follow-up|3|||
145995224|NCT02314923|526498585|FG002|Overall Study|Lost to Follow-up|1|||
145995225|NCT02314923|526498586|FG003|Overall Study|Lost to Follow-up|0|||
145995226|NCT02314923|526498587|FG004|Overall Study|Lost to Follow-up|0|||
145995227|NCT02314923|526498588|FG005|Overall Study|Lost to Follow-up|0|||
145995228|NCT02314923|526498589|FG006|Overall Study|Lost to Follow-up|3|||
145995229|NCT02314923|526498590|FG007|Overall Study|Lost to Follow-up|4|||
145995230|NCT02314923|526498591|FG008|Overall Study|Lost to Follow-up|2|||
145995231|NCT02314923|526498592|FG009|Overall Study|Lost to Follow-up|0|||
145995232|NCT02314923|526498583|FG000|Overall Study|Withdrawal by Subject|0|||
145995233|NCT02314923|526498584|FG001|Overall Study|Withdrawal by Subject|0|||
145995234|NCT02314923|526498585|FG002|Overall Study|Withdrawal by Subject|1|||
145995235|NCT02314923|526498586|FG003|Overall Study|Withdrawal by Subject|0|||
145995236|NCT02314923|526498587|FG004|Overall Study|Withdrawal by Subject|1|||
145995237|NCT02314923|526498588|FG005|Overall Study|Withdrawal by Subject|0|||
145995238|NCT02314923|526498589|FG006|Overall Study|Withdrawal by Subject|1|||
145995239|NCT02314923|526498590|FG007|Overall Study|Withdrawal by Subject|0|||
145995240|NCT02314923|526498591|FG008|Overall Study|Withdrawal by Subject|0|||
145995241|NCT02314923|526498592|FG009|Overall Study|Withdrawal by Subject|0|||
145995242|NCT02314923|526498583|FG000|Overall Study|Physician Decision|0|||
145995243|NCT02314923|526498584|FG001|Overall Study|Physician Decision|1|||
145995244|NCT02314923|526498585|FG002|Overall Study|Physician Decision|0|||
145995245|NCT02314923|526498586|FG003|Overall Study|Physician Decision|0|||
145995246|NCT02314923|526498587|FG004|Overall Study|Physician Decision|0|||
145995247|NCT02314923|526498588|FG005|Overall Study|Physician Decision|0|||
145995248|NCT02314923|526498589|FG006|Overall Study|Physician Decision|0|||
145995249|NCT02314923|526498590|FG007|Overall Study|Physician Decision|0|||
145995250|NCT02314923|526498591|FG008|Overall Study|Physician Decision|0|||
145995251|NCT02314923|526498592|FG009|Overall Study|Physician Decision|0|||
145995252|NCT02314923|526498583|FG000|Overall Study|Participant unavailable|0|||
145995253|NCT02314923|526498584|FG001|Overall Study|Participant unavailable|0|||
145995254|NCT02314923|526498585|FG002|Overall Study|Participant unavailable|0|||
145995255|NCT02314923|526498586|FG003|Overall Study|Participant unavailable|0|||
145995256|NCT02314923|526498587|FG004|Overall Study|Participant unavailable|0|||
145995257|NCT02314923|526498588|FG005|Overall Study|Participant unavailable|1|||
146298052|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
146298053|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
146298054|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
145995258|NCT02314923|526498589|FG006|Overall Study|Participant unavailable|0|||
145995259|NCT02314923|526498590|FG007|Overall Study|Participant unavailable|0|||
145995260|NCT02314923|526498591|FG008|Overall Study|Participant unavailable|0|||
145995261|NCT02314923|526498592|FG009|Overall Study|Participant unavailable|0|||
145995262|NCT02314923|526498583|FG000|Overall Study|Screen failure|0|||
145995263|NCT02314923|526498584|FG001|Overall Study|Screen failure|0|||
145995264|NCT02314923|526498585|FG002|Overall Study|Screen failure|0|||
145995265|NCT02314923|526498586|FG003|Overall Study|Screen failure|0|||
145995266|NCT02314923|526498587|FG004|Overall Study|Screen failure|0|||
145995267|NCT02314923|526498588|FG005|Overall Study|Screen failure|0|||
145995268|NCT02314923|526498589|FG006|Overall Study|Screen failure|1|||
145995269|NCT02314923|526498590|FG007|Overall Study|Screen failure|0|||
145995270|NCT02314923|526498591|FG008|Overall Study|Screen failure|0|||
145995271|NCT02314923|526498592|FG009|Overall Study|Screen failure|0|||
145995272|NCT02314923|526498583|FG000|Overall Study|Participant relocation|1|||
145995273|NCT02314923|526498584|FG001|Overall Study|Participant relocation|0|||
145995274|NCT02314923|526498585|FG002|Overall Study|Participant relocation|0|||
145995275|NCT02314923|526498586|FG003|Overall Study|Participant relocation|0|||
145995276|NCT02314923|526498587|FG004|Overall Study|Participant relocation|0|||
145995277|NCT02314923|526498588|FG005|Overall Study|Participant relocation|0|||
145995278|NCT02314923|526498589|FG006|Overall Study|Participant relocation|0|||
145995279|NCT02314923|526498590|FG007|Overall Study|Participant relocation|1|||
145995280|NCT02314923|526498591|FG008|Overall Study|Participant relocation|0|||
145995281|NCT02314923|526498592|FG009|Overall Study|Participant relocation|0|||
145995282|NCT03232567|526498594|FG000|Overall Study|Withdrawal by Subject|0|||
145995283|NCT03232567|526498595|FG001|Overall Study|Withdrawal by Subject|1|||
145995284|NCT03232567|526498596|FG002|Overall Study|Withdrawal by Subject|0|||
145995285|NCT03232567|526498597|FG003|Overall Study|Withdrawal by Subject|0|||
145995286|NCT01153516|526498598|FG000|Overall Study|Both subjects refused surgery|2|||
145995287|NCT01153516|526498599|FG001|Overall Study|Both subjects refused surgery|0|||
145995288|NCT05837481|526498600|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
145995289|NCT05837481|526498601|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
145995290|NCT04581395|526498602|FG000|Overall Study|Protocol Violation|4|||
145995291|NCT04581395|526498603|FG001|Overall Study|Protocol Violation|3|||
145995292|NCT04581395|526498604|FG002|Overall Study|Protocol Violation|2|||
145995293|NCT04581395|526498602|FG000|Overall Study|Physician Decision|0|||
145995294|NCT04581395|526498603|FG001|Overall Study|Physician Decision|1|||
145995295|NCT04581395|526498604|FG002|Overall Study|Physician Decision|0|||
145995296|NCT00071032|526498609|FG000|Overall Study|Lost to Follow-up|1|||
145995297|NCT00071032|526498610|FG001|Overall Study|Lost to Follow-up|1|||
145995298|NCT00071032|526498609|FG000|Overall Study|Withdrawal by Subject|8|||
145995299|NCT00071032|526498610|FG001|Overall Study|Withdrawal by Subject|6|||
145995300|NCT00071032|526498609|FG000|Overall Study|Missing Primary Outcome|0|||
145995301|NCT00071032|526498610|FG001|Overall Study|Missing Primary Outcome|1|||
145995302|NCT05852470|526498612|FG000|Overall Study|Withdrawal by Subject|0|||
145995303|NCT05852470|526498613|FG001|Overall Study|Withdrawal by Subject|1|||
145995304|NCT06071104|526498614|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
145995305|NCT01903863|526498615|FG000|Overall Study|Physician Decision|2|||
145995306|NCT01903863|526498616|FG001|Overall Study|Physician Decision|0|||
145995307|NCT03636022|526498619|FG000|Overall Study|Withdrawal by Subject|1|||
145995308|NCT03636022|526498620|FG001|Overall Study|Withdrawal by Subject|3|||
145995309|NCT05185453|526498632|FG000|Overall Study|Lost to Follow-up|13|||
145995310|NCT05185453|526498633|FG001|Overall Study|Lost to Follow-up|3|||
145995311|NCT03537508|526498646|FG000|Overall Study|Adverse Event|2|||
145995312|NCT03537508|526498647|FG001|Overall Study|Adverse Event|1|||
145995313|NCT03537508|526498646|FG000|Overall Study|Protocol Violation|65|||
145995314|NCT03537508|526498647|FG001|Overall Study|Protocol Violation|48|||
145995315|NCT03537508|526498646|FG000|Overall Study|Lost to Follow-up|86|||
145995316|NCT03537508|526498647|FG001|Overall Study|Lost to Follow-up|60|||
145995317|NCT03537508|526498646|FG000|Overall Study|Withdrawal by parent/guardian|263|||
145995318|NCT03537508|526498647|FG001|Overall Study|Withdrawal by parent/guardian|149|||
145995319|NCT01972659|526498648|FG000|Overall Study|Protocol Violation|2|||
145995320|NCT01972659|526498649|FG001|Overall Study|Protocol Violation|2|||
145995321|NCT01972659|526498648|FG000|Overall Study|problems realted to acceleromyograph|2|||
145995322|NCT01972659|526498649|FG001|Overall Study|problems realted to acceleromyograph|1|||
145995323|NCT04569084|526498653|FG000|Overall Study|Adverse Event|10|||
145995324|NCT04569084|526498654|FG001|Overall Study|Adverse Event|14|||
145995325|NCT04569084|526498653|FG000|Overall Study|Death|2|||
145995326|NCT04569084|526498654|FG001|Overall Study|Death|3|||
145995327|NCT04569084|526498653|FG000|Overall Study|Lost to Follow-up|1|||
145995328|NCT04569084|526498654|FG001|Overall Study|Lost to Follow-up|1|||
145995329|NCT04569084|526498653|FG000|Overall Study|Physician Decision|3|||
145995330|NCT04569084|526498654|FG001|Overall Study|Physician Decision|3|||
145995331|NCT04569084|526498653|FG000|Overall Study|Protocol Violation|2|||
145995332|NCT04569084|526498654|FG001|Overall Study|Protocol Violation|1|||
145995333|NCT04569084|526498653|FG000|Overall Study|Withdrawal by Subject|20|||
145995334|NCT04569084|526498654|FG001|Overall Study|Withdrawal by Subject|21|||
146246598|NCT01562275|527417609|FG001|Stage 1|Adverse Event|0|||
146246599|NCT01562275|527417610|FG002|Stage 1|Adverse Event|0|||
146246600|NCT01562275|527417611|FG003|Stage 1|Adverse Event|1|||
146246601|NCT01562275|527417612|FG004|Stage 1|Adverse Event|1|||
146246602|NCT01562275|527417613|FG005|Stage 1|Adverse Event|0|||
146246603|NCT01562275|527417614|FG006|Stage 1|Adverse Event|0|||
146246604|NCT01562275|527417615|FG007|Stage 1|Adverse Event|0|||
146246605|NCT01562275|527417616|FG008|Stage 1|Adverse Event|0|||
146246606|NCT01562275|527417617|FG009|Stage 1|Adverse Event|1|||
146246607|NCT01562275|527417618|FG010|Stage 1|Adverse Event|0|||
146246608|NCT01562275|527417619|FG011|Stage 1|Adverse Event|0|||
146246609|NCT01562275|527417620|FG012|Stage 1|Adverse Event|0|||
146246610|NCT01562275|527417608|FG000|Stage 1|Death|1|||
146246611|NCT01562275|527417609|FG001|Stage 1|Death|0|||
145995335|NCT04569084|526498653|FG000|Overall Study|Study terminated by sponsor|26|||
146246612|NCT01562275|527417610|FG002|Stage 1|Death|0|||
145995336|NCT04569084|526498654|FG001|Overall Study|Study terminated by sponsor|23|||
145995337|NCT04569084|526498653|FG000|Overall Study|Other|3|||
145995338|NCT04569084|526498654|FG001|Overall Study|Other|5|||
145995339|NCT03274466|526498655|FG000|Overall Study|Withdrawal by Subject|7|||
145995340|NCT03274466|526498656|FG001|Overall Study|Withdrawal by Subject|3|||
145995341|NCT03274466|526498655|FG000|Overall Study|Protocol Specified Withdrawal|5|||
145995342|NCT03274466|526498656|FG001|Overall Study|Protocol Specified Withdrawal|11|||
145995343|NCT03274466|526498655|FG000|Overall Study|Lost to Follow-up|5|||
145995344|NCT03274466|526498656|FG001|Overall Study|Lost to Follow-up|7|||
145995345|NCT03274466|526498655|FG000|Overall Study|Subject Non-compliance|0|||
145995346|NCT03274466|526498656|FG001|Overall Study|Subject Non-compliance|1|||
145995347|NCT03274466|526498655|FG000|Overall Study|Adverse Event|3|||
145995348|NCT03274466|526498656|FG001|Overall Study|Adverse Event|3|||
145995349|NCT03274466|526498655|FG000|Overall Study|Physician Decision|0|||
145995350|NCT03274466|526498656|FG001|Overall Study|Physician Decision|1|||
145995351|NCT03274466|526498655|FG000|Overall Study|Protocol Violation|3|||
145995352|NCT03274466|526498656|FG001|Overall Study|Protocol Violation|3|||
145995353|NCT06022107|526498657|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
145995354|NCT06022107|526498657|FG000|Overall Study|Dropped out of study for higher level of care|1|||
145995355|NCT06022107|526498657|FG000|Overall Study|Lost to Follow-up|2|||
145995364|NCT02333799|526500671|FG000|Treatment Period|Withdrawal by Subject|1|||
145995365|NCT02333799|526500671|FG000|Treatment Period|Death|6|||
145995366|NCT02333799|526500671|FG000|6 Month Follow Up Period|Physician Decision|1|||
145995367|NCT02333799|526500671|FG000|6 Month Follow Up Period|Death|1|||
145995368|NCT02333799|526500671|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
145995369|NCT02333799|526500671|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
145995370|NCT05484895|526500672|FG000|Overall Study|Lost to Follow-up|63|||
145995371|NCT05484895|526500673|FG001|Overall Study|Lost to Follow-up|64|||
145995372|NCT03396445|526500674|FG000|Treatment Period|Death|2|||
145995373|NCT03396445|526500675|FG001|Treatment Period|Death|2|||
145995374|NCT03396445|526500676|FG002|Treatment Period|Death|1|||
145995375|NCT03396445|526500677|FG003|Treatment Period|Death|1|||
145995376|NCT03396445|526500678|FG004|Treatment Period|Death|3|||
145995377|NCT03396445|526500679|FG005|Treatment Period|Death|2|||
145995378|NCT03396445|526500680|FG006|Treatment Period|Death|5|||
145995379|NCT03396445|526500681|FG007|Treatment Period|Death|3|||
145995380|NCT03396445|526500682|FG008|Treatment Period|Death|3|||
145995381|NCT03396445|526500683|FG009|Treatment Period|Death|3|||
145995382|NCT03396445|526500684|FG010|Treatment Period|Death|7|||
145995383|NCT03396445|526500685|FG011|Treatment Period|Death|12|||
145995384|NCT03396445|526500686|FG012|Treatment Period|Death|28|||
145995385|NCT03396445|526500687|FG013|Treatment Period|Death|14|||
145995386|NCT03396445|526500688|FG014|Treatment Period|Death|10|||
145995387|NCT03396445|526500689|FG015|Treatment Period|Death|8|||
145995388|NCT03396445|526500690|FG016|Treatment Period|Death|18|||
145995389|NCT03396445|526500691|FG017|Treatment Period|Death|0|||
145995390|NCT03396445|526500692|FG018|Treatment Period|Death|0|||
145995391|NCT03396445|526500693|FG019|Treatment Period|Death|0|||
145995392|NCT03396445|526500694|FG020|Treatment Period|Death|0|||
145995393|NCT03396445|526500695|FG021|Treatment Period|Death|0|||
145995394|NCT03396445|526500696|FG022|Treatment Period|Death|0|||
145995395|NCT03396445|526500697|FG023|Treatment Period|Death|0|||
145995396|NCT03396445|526500698|FG024|Treatment Period|Death|0|||
145995397|NCT03396445|526500699|FG025|Treatment Period|Death|0|||
145995398|NCT03396445|526500674|FG000|Treatment Period|Lost to Follow-up|0|||
145995399|NCT03396445|526500675|FG001|Treatment Period|Lost to Follow-up|0|||
145995400|NCT03396445|526500676|FG002|Treatment Period|Lost to Follow-up|0|||
145995401|NCT03396445|526500677|FG003|Treatment Period|Lost to Follow-up|0|||
145995402|NCT03396445|526500678|FG004|Treatment Period|Lost to Follow-up|0|||
145995403|NCT03396445|526500679|FG005|Treatment Period|Lost to Follow-up|0|||
145995404|NCT03396445|526500680|FG006|Treatment Period|Lost to Follow-up|0|||
145995405|NCT03396445|526500681|FG007|Treatment Period|Lost to Follow-up|0|||
145995406|NCT03396445|526500682|FG008|Treatment Period|Lost to Follow-up|0|||
145995407|NCT03396445|526500683|FG009|Treatment Period|Lost to Follow-up|0|||
145995408|NCT03396445|526500684|FG010|Treatment Period|Lost to Follow-up|0|||
145995409|NCT03396445|526500685|FG011|Treatment Period|Lost to Follow-up|0|||
145995410|NCT03396445|526500686|FG012|Treatment Period|Lost to Follow-up|1|||
145995411|NCT03396445|526500687|FG013|Treatment Period|Lost to Follow-up|0|||
145995412|NCT03396445|526500688|FG014|Treatment Period|Lost to Follow-up|1|||
145995413|NCT03396445|526500689|FG015|Treatment Period|Lost to Follow-up|0|||
145995414|NCT03396445|526500690|FG016|Treatment Period|Lost to Follow-up|0|||
145995415|NCT03396445|526500691|FG017|Treatment Period|Lost to Follow-up|0|||
145995416|NCT03396445|526500692|FG018|Treatment Period|Lost to Follow-up|0|||
145995417|NCT03396445|526500693|FG019|Treatment Period|Lost to Follow-up|0|||
145995418|NCT03396445|526500694|FG020|Treatment Period|Lost to Follow-up|0|||
145995419|NCT03396445|526500695|FG021|Treatment Period|Lost to Follow-up|0|||
145995420|NCT03396445|526500696|FG022|Treatment Period|Lost to Follow-up|0|||
145995421|NCT03396445|526500697|FG023|Treatment Period|Lost to Follow-up|0|||
145995422|NCT03396445|526500698|FG024|Treatment Period|Lost to Follow-up|0|||
145995423|NCT03396445|526500699|FG025|Treatment Period|Lost to Follow-up|0|||
146246613|NCT01562275|527417611|FG003|Stage 1|Death|0|||
146246614|NCT01562275|527417612|FG004|Stage 1|Death|0|||
146246615|NCT01562275|527417613|FG005|Stage 1|Death|0|||
146246616|NCT01562275|527417614|FG006|Stage 1|Death|0|||
146246617|NCT01562275|527417615|FG007|Stage 1|Death|0|||
146246618|NCT01562275|527417616|FG008|Stage 1|Death|0|||
146246619|NCT01562275|527417617|FG009|Stage 1|Death|0|||
146246620|NCT01562275|527417618|FG010|Stage 1|Death|0|||
146246621|NCT01562275|527417619|FG011|Stage 1|Death|0|||
146246622|NCT01562275|527417620|FG012|Stage 1|Death|0|||
145995424|NCT03396445|526500674|FG000|Treatment Period|Physician Decision|0|||
145995425|NCT03396445|526500675|FG001|Treatment Period|Physician Decision|0|||
145995426|NCT03396445|526500676|FG002|Treatment Period|Physician Decision|0|||
145995427|NCT03396445|526500677|FG003|Treatment Period|Physician Decision|0|||
145995428|NCT03396445|526500678|FG004|Treatment Period|Physician Decision|1|||
145995429|NCT03396445|526500679|FG005|Treatment Period|Physician Decision|0|||
145995430|NCT03396445|526500680|FG006|Treatment Period|Physician Decision|0|||
145995431|NCT03396445|526500681|FG007|Treatment Period|Physician Decision|0|||
145995432|NCT03396445|526500682|FG008|Treatment Period|Physician Decision|0|||
145995433|NCT03396445|526500683|FG009|Treatment Period|Physician Decision|1|||
145995434|NCT03396445|526500684|FG010|Treatment Period|Physician Decision|0|||
145995435|NCT03396445|526500685|FG011|Treatment Period|Physician Decision|0|||
145995436|NCT03396445|526500686|FG012|Treatment Period|Physician Decision|0|||
145995437|NCT03396445|526500687|FG013|Treatment Period|Physician Decision|0|||
145995438|NCT03396445|526500688|FG014|Treatment Period|Physician Decision|0|||
145995439|NCT03396445|526500689|FG015|Treatment Period|Physician Decision|0|||
145995440|NCT03396445|526500690|FG016|Treatment Period|Physician Decision|0|||
145995441|NCT03396445|526500691|FG017|Treatment Period|Physician Decision|0|||
145995442|NCT03396445|526500692|FG018|Treatment Period|Physician Decision|0|||
145995443|NCT03396445|526500693|FG019|Treatment Period|Physician Decision|0|||
145995444|NCT03396445|526500694|FG020|Treatment Period|Physician Decision|0|||
145995445|NCT03396445|526500695|FG021|Treatment Period|Physician Decision|0|||
145995446|NCT03396445|526500696|FG022|Treatment Period|Physician Decision|0|||
145995447|NCT03396445|526500697|FG023|Treatment Period|Physician Decision|0|||
145995448|NCT03396445|526500698|FG024|Treatment Period|Physician Decision|0|||
145995449|NCT03396445|526500699|FG025|Treatment Period|Physician Decision|0|||
145995450|NCT03396445|526500674|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995451|NCT03396445|526500675|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995452|NCT03396445|526500676|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995453|NCT03396445|526500677|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995454|NCT03396445|526500678|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995455|NCT03396445|526500679|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995456|NCT03396445|526500680|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995457|NCT03396445|526500681|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995458|NCT03396445|526500682|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995459|NCT03396445|526500683|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995460|NCT03396445|526500684|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995461|NCT03396445|526500685|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995462|NCT03396445|526500686|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
145995463|NCT03396445|526500687|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995464|NCT03396445|526500688|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
145995465|NCT03396445|526500689|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995466|NCT03396445|526500690|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995467|NCT03396445|526500691|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995468|NCT03396445|526500692|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995469|NCT03396445|526500693|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
146246623|NCT01562275|527417608|FG000|Stage 1|Non Compliance|0|||
146246624|NCT01562275|527417609|FG001|Stage 1|Non Compliance|0|||
146246625|NCT01562275|527417610|FG002|Stage 1|Non Compliance|1|||
146091860|NCT00122278|526858439|FG000|Overall Study|Lost to Follow-up|2|||
146246626|NCT01562275|527417611|FG003|Stage 1|Non Compliance|0|||
146246627|NCT01562275|527417612|FG004|Stage 1|Non Compliance|0|||
146246628|NCT01562275|527417613|FG005|Stage 1|Non Compliance|0|||
146246629|NCT01562275|527417614|FG006|Stage 1|Non Compliance|0|||
146246630|NCT01562275|527417615|FG007|Stage 1|Non Compliance|0|||
145995470|NCT03396445|526500694|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995471|NCT03396445|526500695|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995472|NCT03396445|526500696|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995473|NCT03396445|526500697|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995474|NCT03396445|526500698|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995475|NCT03396445|526500699|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145995476|NCT03396445|526500674|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
145995477|NCT03396445|526500675|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
145995478|NCT03396445|526500676|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
145995479|NCT03396445|526500677|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
145995480|NCT03396445|526500678|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
145995481|NCT03396445|526500679|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995482|NCT03396445|526500680|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
145995483|NCT03396445|526500681|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995484|NCT03396445|526500682|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995485|NCT03396445|526500683|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995486|NCT03396445|526500684|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995487|NCT03396445|526500685|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995488|NCT03396445|526500686|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995489|NCT03396445|526500687|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995490|NCT03396445|526500688|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995491|NCT03396445|526500689|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995492|NCT03396445|526500690|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995493|NCT03396445|526500691|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995494|NCT03396445|526500692|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995495|NCT03396445|526500693|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995496|NCT03396445|526500694|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995497|NCT03396445|526500695|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995498|NCT03396445|526500696|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995499|NCT03396445|526500697|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995500|NCT03396445|526500698|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995501|NCT03396445|526500699|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145995502|NCT03396445|526500674|FG000|Treatment Period|Withdrawal by Subject|0|||
145995503|NCT03396445|526500675|FG001|Treatment Period|Withdrawal by Subject|0|||
145995504|NCT03396445|526500676|FG002|Treatment Period|Withdrawal by Subject|0|||
145995505|NCT03396445|526500677|FG003|Treatment Period|Withdrawal by Subject|0|||
145995506|NCT03396445|526500678|FG004|Treatment Period|Withdrawal by Subject|0|||
145995507|NCT03396445|526500679|FG005|Treatment Period|Withdrawal by Subject|0|||
145995508|NCT03396445|526500680|FG006|Treatment Period|Withdrawal by Subject|0|||
145995509|NCT03396445|526500681|FG007|Treatment Period|Withdrawal by Subject|0|||
145995510|NCT03396445|526500682|FG008|Treatment Period|Withdrawal by Subject|0|||
145995511|NCT03396445|526500683|FG009|Treatment Period|Withdrawal by Subject|0|||
145995512|NCT03396445|526500684|FG010|Treatment Period|Withdrawal by Subject|0|||
145995513|NCT03396445|526500685|FG011|Treatment Period|Withdrawal by Subject|0|||
145995514|NCT03396445|526500686|FG012|Treatment Period|Withdrawal by Subject|0|||
145995515|NCT03396445|526500687|FG013|Treatment Period|Withdrawal by Subject|0|||
145995516|NCT03396445|526500688|FG014|Treatment Period|Withdrawal by Subject|1|||
145995517|NCT03396445|526500689|FG015|Treatment Period|Withdrawal by Subject|0|||
146091861|NCT00122278|526858440|FG001|Overall Study|Lost to Follow-up|0|||
146091862|NCT01002482|526858441|FG000|Overall Study|Withdrawal by Subject|14|||
146091863|NCT01002482|526858442|FG001|Overall Study|Withdrawal by Subject|21|||
146091864|NCT01002482|526858441|FG000|Overall Study|Included twice|1|||
146091865|NCT01002482|526858442|FG001|Overall Study|Included twice|0|||
146091866|NCT01865084|526858443|FG000|Double Blind Period (DB)|Adverse Event|2|||
146091867|NCT01865084|526858444|FG001|Double Blind Period (DB)|Adverse Event|2|||
146091868|NCT01865084|526858445|FG002|Double Blind Period (DB)|Adverse Event|1|||
146091869|NCT01865084|526858443|FG000|Double Blind Period (DB)|Protocol Violation|0|||
146298055|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
145995518|NCT03396445|526500690|FG016|Treatment Period|Withdrawal by Subject|1|||
145995519|NCT03396445|526500691|FG017|Treatment Period|Withdrawal by Subject|0|||
145995520|NCT03396445|526500692|FG018|Treatment Period|Withdrawal by Subject|0|||
145995521|NCT03396445|526500693|FG019|Treatment Period|Withdrawal by Subject|0|||
145995522|NCT03396445|526500694|FG020|Treatment Period|Withdrawal by Subject|0|||
145995523|NCT03396445|526500695|FG021|Treatment Period|Withdrawal by Subject|0|||
145995524|NCT03396445|526500696|FG022|Treatment Period|Withdrawal by Subject|0|||
145995525|NCT03396445|526500697|FG023|Treatment Period|Withdrawal by Subject|0|||
145995526|NCT03396445|526500698|FG024|Treatment Period|Withdrawal by Subject|0|||
145995527|NCT03396445|526500699|FG025|Treatment Period|Withdrawal by Subject|0|||
145995528|NCT03396445|526500674|FG000|Switch-over Period|Death|0|||
145995529|NCT03396445|526500675|FG001|Switch-over Period|Death|0|||
145995530|NCT03396445|526500676|FG002|Switch-over Period|Death|0|||
145995531|NCT03396445|526500677|FG003|Switch-over Period|Death|0|||
145995532|NCT03396445|526500678|FG004|Switch-over Period|Death|0|||
145995533|NCT03396445|526500679|FG005|Switch-over Period|Death|0|||
145995534|NCT03396445|526500680|FG006|Switch-over Period|Death|0|||
145995535|NCT03396445|526500681|FG007|Switch-over Period|Death|0|||
145995536|NCT03396445|526500682|FG008|Switch-over Period|Death|0|||
145995537|NCT03396445|526500683|FG009|Switch-over Period|Death|0|||
145995538|NCT03396445|526500684|FG010|Switch-over Period|Death|0|||
145995539|NCT03396445|526500685|FG011|Switch-over Period|Death|0|||
145995540|NCT03396445|526500686|FG012|Switch-over Period|Death|0|||
145995541|NCT03396445|526500687|FG013|Switch-over Period|Death|0|||
145995542|NCT03396445|526500688|FG014|Switch-over Period|Death|0|||
145995543|NCT03396445|526500689|FG015|Switch-over Period|Death|0|||
145995544|NCT03396445|526500690|FG016|Switch-over Period|Death|0|||
145995545|NCT03396445|526500691|FG017|Switch-over Period|Death|0|||
145995546|NCT03396445|526500692|FG018|Switch-over Period|Death|1|||
145995547|NCT03396445|526500693|FG019|Switch-over Period|Death|2|||
145995548|NCT03396445|526500694|FG020|Switch-over Period|Death|2|||
145995549|NCT03396445|526500695|FG021|Switch-over Period|Death|1|||
145995550|NCT03396445|526500696|FG022|Switch-over Period|Death|2|||
145995551|NCT03396445|526500697|FG023|Switch-over Period|Death|0|||
145995552|NCT03396445|526500698|FG024|Switch-over Period|Death|1|||
145995553|NCT03396445|526500699|FG025|Switch-over Period|Death|6|||
145995554|NCT03396445|526500674|FG000|Switch-over Period|Lost to Follow-up|0|||
145995555|NCT03396445|526500675|FG001|Switch-over Period|Lost to Follow-up|0|||
145995556|NCT03396445|526500676|FG002|Switch-over Period|Lost to Follow-up|0|||
145995557|NCT03396445|526500677|FG003|Switch-over Period|Lost to Follow-up|0|||
145995558|NCT03396445|526500678|FG004|Switch-over Period|Lost to Follow-up|0|||
145995559|NCT03396445|526500679|FG005|Switch-over Period|Lost to Follow-up|0|||
145995560|NCT03396445|526500680|FG006|Switch-over Period|Lost to Follow-up|0|||
145995561|NCT03396445|526500681|FG007|Switch-over Period|Lost to Follow-up|0|||
145995562|NCT03396445|526500682|FG008|Switch-over Period|Lost to Follow-up|0|||
145995563|NCT03396445|526500683|FG009|Switch-over Period|Lost to Follow-up|0|||
145995564|NCT03396445|526500684|FG010|Switch-over Period|Lost to Follow-up|0|||
145995565|NCT03396445|526500685|FG011|Switch-over Period|Lost to Follow-up|0|||
145995566|NCT03396445|526500686|FG012|Switch-over Period|Lost to Follow-up|0|||
145995567|NCT03396445|526500687|FG013|Switch-over Period|Lost to Follow-up|0|||
145995568|NCT03396445|526500688|FG014|Switch-over Period|Lost to Follow-up|0|||
145995569|NCT03396445|526500689|FG015|Switch-over Period|Lost to Follow-up|0|||
145995570|NCT03396445|526500690|FG016|Switch-over Period|Lost to Follow-up|0|||
145995571|NCT03396445|526500691|FG017|Switch-over Period|Lost to Follow-up|0|||
145995572|NCT03396445|526500692|FG018|Switch-over Period|Lost to Follow-up|0|||
145995573|NCT03396445|526500693|FG019|Switch-over Period|Lost to Follow-up|0|||
145995574|NCT03396445|526500694|FG020|Switch-over Period|Lost to Follow-up|0|||
145995575|NCT03396445|526500695|FG021|Switch-over Period|Lost to Follow-up|0|||
145995576|NCT03396445|526500696|FG022|Switch-over Period|Lost to Follow-up|0|||
145995577|NCT03396445|526500697|FG023|Switch-over Period|Lost to Follow-up|1|||
145995578|NCT03396445|526500698|FG024|Switch-over Period|Lost to Follow-up|0|||
145995579|NCT03396445|526500699|FG025|Switch-over Period|Lost to Follow-up|0|||
145995580|NCT00876447|526500703|FG000|Overall Study|Other miscellaneous reasons|3|||
145995581|NCT00876447|526500704|FG001|Overall Study|Other miscellaneous reasons|8|||
145995582|NCT00876447|526500703|FG000|Overall Study|Site closure|19|||
145995583|NCT00876447|526500704|FG001|Overall Study|Site closure|14|||
145995584|NCT00876447|526500703|FG000|Overall Study|Protocol Violation|9|||
145995585|NCT00876447|526500704|FG001|Overall Study|Protocol Violation|3|||
145995586|NCT00876447|526500703|FG000|Overall Study|Personal reasons|30|||
145995587|NCT00876447|526500704|FG001|Overall Study|Personal reasons|28|||
145995588|NCT00876447|526500703|FG000|Overall Study|Lost to Follow-up|6|||
145995589|NCT00876447|526500704|FG001|Overall Study|Lost to Follow-up|15|||
145995590|NCT00876447|526500703|FG000|Overall Study|Pregnancy|4|||
145995591|NCT00876447|526500704|FG001|Overall Study|Pregnancy|2|||
145995592|NCT00876447|526500703|FG000|Overall Study|Lack of Efficacy|5|||
145995593|NCT00876447|526500704|FG001|Overall Study|Lack of Efficacy|3|||
145995594|NCT00876447|526500703|FG000|Overall Study|Adverse Event|4|||
145995595|NCT00876447|526500704|FG001|Overall Study|Adverse Event|8|||
145995596|NCT02538614|526500705|FG000|Overall Study|Progressive Disease|2|||
145995597|NCT04507204|526500716|FG000|Overall Study|Adverse Event|8|||
145995598|NCT04507204|526500717|FG001|Overall Study|Adverse Event|13|||
145995599|NCT04507204|526500716|FG000|Overall Study|Death|0|||
145995600|NCT04507204|526500717|FG001|Overall Study|Death|1|||
145995601|NCT04507204|526500716|FG000|Overall Study|Lost to Follow-up|15|||
145995602|NCT04507204|526500717|FG001|Overall Study|Lost to Follow-up|14|||
145995603|NCT04507204|526500716|FG000|Overall Study|Poor Compliance with Protocol|2|||
145995604|NCT04507204|526500717|FG001|Overall Study|Poor Compliance with Protocol|4|||
145995605|NCT04507204|526500716|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
145995606|NCT04507204|526500717|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
145995607|NCT04507204|526500716|FG000|Overall Study|Withdrawal of Patient Consent|21|||
145995608|NCT04507204|526500717|FG001|Overall Study|Withdrawal of Patient Consent|13|||
145995609|NCT03580044|526500718|FG000|Overall Study|Death|2|||
145995610|NCT03580044|526500719|FG001|Overall Study|Death|1|||
145995611|NCT03580044|526500718|FG000|Overall Study|Withdrawal by Subject|1|||
145995612|NCT03580044|526500719|FG001|Overall Study|Withdrawal by Subject|1|||
145995613|NCT00904371|526500725|FG000|Overall Study|Adverse Event|2|||
146246631|NCT01562275|527417616|FG008|Stage 1|Non Compliance|0|||
146246632|NCT01562275|527417617|FG009|Stage 1|Non Compliance|0|||
146246633|NCT01562275|527417618|FG010|Stage 1|Non Compliance|0|||
146246634|NCT01562275|527417619|FG011|Stage 1|Non Compliance|0|||
146246635|NCT01562275|527417620|FG012|Stage 1|Non Compliance|0|||
146246636|NCT01562275|527417608|FG000|Stage 1|Physician Decision|0|||
146246637|NCT01562275|527417609|FG001|Stage 1|Physician Decision|0|||
146246638|NCT01562275|527417610|FG002|Stage 1|Physician Decision|0|||
146246639|NCT01562275|527417611|FG003|Stage 1|Physician Decision|0|||
146246640|NCT01562275|527417612|FG004|Stage 1|Physician Decision|1|||
146246641|NCT01562275|527417613|FG005|Stage 1|Physician Decision|0|||
146246642|NCT01562275|527417614|FG006|Stage 1|Physician Decision|1|||
146246643|NCT01562275|527417615|FG007|Stage 1|Physician Decision|0|||
146246644|NCT01562275|527417616|FG008|Stage 1|Physician Decision|1|||
146246645|NCT01562275|527417617|FG009|Stage 1|Physician Decision|0|||
146246646|NCT01562275|527417618|FG010|Stage 1|Physician Decision|0|||
146246647|NCT01562275|527417619|FG011|Stage 1|Physician Decision|0|||
146246648|NCT01562275|527417620|FG012|Stage 1|Physician Decision|0|||
146246649|NCT01562275|527417608|FG000|Stage 1|Progression of Disease|2|||
146246650|NCT01562275|527417609|FG001|Stage 1|Progression of Disease|6|||
146246651|NCT01562275|527417610|FG002|Stage 1|Progression of Disease|2|||
146246652|NCT01562275|527417611|FG003|Stage 1|Progression of Disease|1|||
146246653|NCT01562275|527417612|FG004|Stage 1|Progression of Disease|2|||
145995614|NCT00904371|526500725|FG000|Overall Study|Lost to Follow-up|4|||
145995615|NCT00904371|526500725|FG000|Overall Study|Discontinued at target blood pressure|2|||
145995616|NCT00904371|526500725|FG000|Overall Study|Continued with Tritace|1|||
145995617|NCT02300233|526500737|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
145995618|NCT02300233|526500738|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145995619|NCT02300233|526500739|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
145995620|NCT02300233|526500737|FG000|Overall Study|Withdrawal by Subject|1|||
145995621|NCT02300233|526500738|FG001|Overall Study|Withdrawal by Subject|0|||
145995622|NCT02300233|526500739|FG002|Overall Study|Withdrawal by Subject|3|||
145995623|NCT02300233|526500737|FG000|Overall Study|Investigator Judgement|0|||
145995624|NCT02300233|526500738|FG001|Overall Study|Investigator Judgement|0|||
145995625|NCT02300233|526500739|FG002|Overall Study|Investigator Judgement|1|||
145995626|NCT02300233|526500737|FG000|Overall Study|Reason Not Specified|0|||
145995627|NCT02300233|526500738|FG001|Overall Study|Reason Not Specified|0|||
145995628|NCT02300233|526500739|FG002|Overall Study|Reason Not Specified|5|||
145995629|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145995630|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
145995631|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145995632|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145995633|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
146246654|NCT01562275|527417613|FG005|Stage 1|Progression of Disease|4|||
146246655|NCT01562275|527417614|FG006|Stage 1|Progression of Disease|1|||
146246656|NCT01562275|527417615|FG007|Stage 1|Progression of Disease|7|||
145995634|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
145995635|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146246657|NCT01562275|527417616|FG008|Stage 1|Progression of Disease|2|||
146246658|NCT01562275|527417617|FG009|Stage 1|Progression of Disease|5|||
145995636|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
146246659|NCT01562275|527417618|FG010|Stage 1|Progression of Disease|3|||
146246660|NCT01562275|527417619|FG011|Stage 1|Progression of Disease|0|||
146246661|NCT01562275|527417620|FG012|Stage 1|Progression of Disease|0|||
145995637|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
145995638|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
146246662|NCT01562275|527417608|FG000|Stage 1|Withdrawal by Subject|0|||
145995639|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
146246663|NCT01562275|527417609|FG001|Stage 1|Withdrawal by Subject|1|||
146246664|NCT01562275|527417610|FG002|Stage 1|Withdrawal by Subject|0|||
146246665|NCT01562275|527417611|FG003|Stage 1|Withdrawal by Subject|2|||
145995640|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145995641|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145995642|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145995643|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145995644|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145995645|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
145995646|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
145995647|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
145995648|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
145995649|NCT02836249|526500740|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
145995650|NCT02836249|526500741|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145995651|NCT02836249|526500742|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145995652|NCT02836249|526500743|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145995653|NCT02836249|526500740|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145995654|NCT02836249|526500741|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145995655|NCT02836249|526500742|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
145995656|NCT02836249|526500743|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
145995657|NCT02836249|526500740|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145995658|NCT02836249|526500741|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145995659|NCT02836249|526500742|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
145995660|NCT02836249|526500743|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
145995661|NCT02836249|526500740|FG000|Open-Label TAF Treatment Phase|Death|0|||
145995662|NCT02836249|526500741|FG001|Open-Label TAF Treatment Phase|Death|0|||
145995663|NCT02836249|526500742|FG002|Open-Label TAF Treatment Phase|Death|1|||
145995664|NCT02836249|526500743|FG003|Open-Label TAF Treatment Phase|Death|0|||
145995665|NCT02836249|526500740|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145995666|NCT02836249|526500741|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145995667|NCT02836249|526500742|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
145995668|NCT02836249|526500743|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145995669|NCT02836249|526500740|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
145995670|NCT02836249|526500741|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
145995671|NCT02836249|526500742|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
145995672|NCT02836249|526500743|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
145995673|NCT04752566|526500744|FG000|Overall Study|Protocol Violation|0|||
145995674|NCT04752566|526500745|FG001|Overall Study|Protocol Violation|1|||
145995675|NCT04752566|526500744|FG000|Overall Study|Death|1|||
145995676|NCT04752566|526500745|FG001|Overall Study|Death|0|||
145995677|NCT04752566|526500744|FG000|Overall Study|Adverse Event|1|||
145995678|NCT04752566|526500745|FG001|Overall Study|Adverse Event|0|||
145995679|NCT04752566|526500744|FG000|Overall Study|Withdrawal by Subject|2|||
145995680|NCT04752566|526500745|FG001|Overall Study|Withdrawal by Subject|0|||
145995681|NCT04752566|526500744|FG000|Overall Study|Physician Decision|1|||
145995682|NCT04752566|526500745|FG001|Overall Study|Physician Decision|1|||
145995683|NCT03331354|526500746|FG000|Overall Study|Withdrawal by Subject|1|||
145995684|NCT03331354|526500747|FG001|Overall Study|Withdrawal by Subject|3|||
145995685|NCT03331354|526500746|FG000|Overall Study|Lost to Follow-up|3|||
145995686|NCT03331354|526500747|FG001|Overall Study|Lost to Follow-up|3|||
145995687|NCT03331354|526500746|FG000|Overall Study|Found employment before initiated active intervention|0|||
145995688|NCT03331354|526500747|FG001|Overall Study|Found employment before initiated active intervention|4|||
145995689|NCT00928668|526500748|FG000|Overall Study|Adverse Event|1|||
145995690|NCT00928668|526500749|FG001|Overall Study|Adverse Event|0|||
145995691|NCT00928668|526500750|FG002|Overall Study|Adverse Event|0|||
145995692|NCT00928668|526500751|FG003|Overall Study|Adverse Event|0|||
145995693|NCT00928668|526500752|FG004|Overall Study|Adverse Event|0|||
145995694|NCT00928668|526500748|FG000|Overall Study|Protocol Violation|0|||
145995695|NCT00928668|526500749|FG001|Overall Study|Protocol Violation|0|||
145995696|NCT00928668|526500750|FG002|Overall Study|Protocol Violation|0|||
145995697|NCT00928668|526500751|FG003|Overall Study|Protocol Violation|0|||
145995698|NCT00928668|526500752|FG004|Overall Study|Protocol Violation|1|||
145995699|NCT00928668|526500748|FG000|Overall Study|Withdrawal by Subject|0|||
145995700|NCT00928668|526500749|FG001|Overall Study|Withdrawal by Subject|1|||
145995701|NCT00928668|526500750|FG002|Overall Study|Withdrawal by Subject|1|||
146298056|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
145995702|NCT00928668|526500751|FG003|Overall Study|Withdrawal by Subject|0|||
145995703|NCT00928668|526500752|FG004|Overall Study|Withdrawal by Subject|0|||
145995704|NCT00928668|526500748|FG000|Overall Study|Other reasons not listed above|0|||
145995705|NCT00928668|526500749|FG001|Overall Study|Other reasons not listed above|0|||
145995706|NCT00928668|526500750|FG002|Overall Study|Other reasons not listed above|0|||
145995707|NCT00928668|526500751|FG003|Overall Study|Other reasons not listed above|1|||
145995708|NCT00928668|526500752|FG004|Overall Study|Other reasons not listed above|0|||
145995709|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
145995710|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
146298057|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
146246666|NCT01562275|527417612|FG004|Stage 1|Withdrawal by Subject|0|||
146246667|NCT01562275|527417613|FG005|Stage 1|Withdrawal by Subject|0|||
146246668|NCT01562275|527417614|FG006|Stage 1|Withdrawal by Subject|1|||
146246669|NCT01562275|527417615|FG007|Stage 1|Withdrawal by Subject|0|||
146246670|NCT01562275|527417616|FG008|Stage 1|Withdrawal by Subject|0|||
146246671|NCT01562275|527417617|FG009|Stage 1|Withdrawal by Subject|1|||
146246672|NCT01562275|527417618|FG010|Stage 1|Withdrawal by Subject|0|||
146246673|NCT01562275|527417619|FG011|Stage 1|Withdrawal by Subject|0|||
146246674|NCT01562275|527417620|FG012|Stage 1|Withdrawal by Subject|0|||
146246675|NCT01562275|527417608|FG000|Stage 2|Death|0|||
146246676|NCT01562275|527417609|FG001|Stage 2|Death|0|||
146246677|NCT01562275|527417610|FG002|Stage 2|Death|0|||
146246678|NCT01562275|527417611|FG003|Stage 2|Death|0|||
146246679|NCT01562275|527417612|FG004|Stage 2|Death|0|||
146246680|NCT01562275|527417613|FG005|Stage 2|Death|0|||
146246681|NCT01562275|527417614|FG006|Stage 2|Death|0|||
146246682|NCT01562275|527417615|FG007|Stage 2|Death|0|||
146246683|NCT01562275|527417616|FG008|Stage 2|Death|0|||
146246684|NCT01562275|527417617|FG009|Stage 2|Death|0|||
146246685|NCT01562275|527417618|FG010|Stage 2|Death|0|||
146246686|NCT01562275|527417619|FG011|Stage 2|Death|2|||
146246687|NCT01562275|527417620|FG012|Stage 2|Death|1|||
146246688|NCT01562275|527417608|FG000|Stage 2|Progression of Disease|0|||
146246689|NCT01562275|527417609|FG001|Stage 2|Progression of Disease|0|||
145995711|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
145995712|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
145995713|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145995714|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
145995715|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145995716|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145995717|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
145995718|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
145995719|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
145995720|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
145995721|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
145995722|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
145995723|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
145995724|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
145995725|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
145995726|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
145995727|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
145995728|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
145995729|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
145995730|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
145995731|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
145995732|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
146246690|NCT01562275|527417610|FG002|Stage 2|Progression of Disease|0|||
146246691|NCT01562275|527417611|FG003|Stage 2|Progression of Disease|0|||
146246692|NCT01562275|527417612|FG004|Stage 2|Progression of Disease|0|||
146246693|NCT01562275|527417613|FG005|Stage 2|Progression of Disease|0|||
146298058|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
145995733|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
145995734|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
145995735|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
145995736|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
145995737|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
145995738|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
145995739|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
145995740|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
145995741|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
145995742|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
145995743|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
145995744|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
145995745|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
145995746|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
145995747|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
145995748|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
145995749|NCT04392154|526500753|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145995750|NCT04392154|526500754|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
146246694|NCT01562275|527417614|FG006|Stage 2|Progression of Disease|0|||
146246695|NCT01562275|527417615|FG007|Stage 2|Progression of Disease|0|||
146246696|NCT01562275|527417616|FG008|Stage 2|Progression of Disease|0|||
146246697|NCT01562275|527417617|FG009|Stage 2|Progression of Disease|0|||
146246698|NCT01562275|527417618|FG010|Stage 2|Progression of Disease|0|||
146246699|NCT01562275|527417619|FG011|Stage 2|Progression of Disease|12|||
145995751|NCT04392154|526500755|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145995752|NCT04392154|526500756|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145995753|NCT04392154|526500753|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145995754|NCT04392154|526500754|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145995755|NCT04392154|526500755|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145995756|NCT04392154|526500756|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
145995757|NCT04392154|526500753|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145995758|NCT04392154|526500754|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145995759|NCT04392154|526500755|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
145995760|NCT04392154|526500756|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145995761|NCT04392154|526500753|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145995762|NCT04392154|526500754|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145995763|NCT04392154|526500755|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145995764|NCT04392154|526500756|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
145995765|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995766|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
145995767|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995768|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
145995769|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
145995770|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
145995771|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
145995772|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995773|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995774|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995775|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995776|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995777|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995778|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995779|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995780|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145995781|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
145995782|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
145995783|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
145995784|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
145995785|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
145995786|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
145995787|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
145995788|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
145995789|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
145995790|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
145995791|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
145995792|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
145995793|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
145995794|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
145995795|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
145995796|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
145995797|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
145995798|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
145995799|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995800|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995801|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995802|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995803|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995804|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995805|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995806|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995807|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995808|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995809|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995810|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995811|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995812|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145995813|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
145995814|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995815|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
145995816|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145995817|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145995818|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145995819|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145995820|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995821|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995822|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995823|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995824|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995825|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995826|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995827|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995828|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145995829|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995830|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995831|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995832|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
145995833|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995834|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995835|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
145995836|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995837|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995838|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995839|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995840|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995841|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995842|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995843|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995844|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145995845|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995846|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995847|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
145995848|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995849|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995850|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995851|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995852|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995853|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995854|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995855|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995856|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995857|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995858|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995859|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995860|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145995861|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145995862|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145995863|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145995864|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995865|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995866|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995867|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995868|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995869|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995870|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995871|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995872|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995873|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995874|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995875|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995876|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145995877|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
145995878|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
145995879|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
145995880|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
146091870|NCT01865084|526858444|FG001|Double Blind Period (DB)|Protocol Violation|0|||
146091871|NCT01865084|526858445|FG002|Double Blind Period (DB)|Protocol Violation|1|||
146091872|NCT01865084|526858443|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
146246700|NCT01562275|527417620|FG012|Stage 2|Progression of Disease|4|||
146246701|NCT01863368|527417621|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
146246702|NCT01863368|527417622|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
146246703|NCT01863368|527417621|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
145995881|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
145995882|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
145995883|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
145995884|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
145995885|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
145995886|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
145995887|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
145995888|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
145995889|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
145995890|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
145995891|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
145995892|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
145995893|NCT02958865|526500757|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995894|NCT02958865|526500758|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995895|NCT02958865|526500759|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995896|NCT02958865|526500760|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995897|NCT02958865|526500761|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
145995898|NCT02958865|526500762|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995899|NCT02958865|526500763|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995900|NCT02958865|526500764|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995901|NCT02958865|526500765|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995902|NCT02958865|526500766|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995903|NCT02958865|526500767|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995904|NCT02958865|526500768|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995905|NCT02958865|526500769|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995906|NCT02958865|526500770|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995907|NCT02958865|526500771|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995908|NCT02958865|526500772|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145995909|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995910|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995911|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995912|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995913|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995914|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995915|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995916|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145995917|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145995918|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
145995919|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145995920|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145995921|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
145995922|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145995923|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145995924|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
145995925|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995926|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995927|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995928|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995929|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995930|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995931|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995932|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
146246704|NCT01863368|527417622|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
146246705|NCT01863368|527417621|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
146246706|NCT01863368|527417622|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
145995933|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
145995934|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
145995935|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995936|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
145995937|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995938|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
145995939|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145995940|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
145995941|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995942|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995943|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995944|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995945|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995946|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995947|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995948|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995949|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995950|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
145995951|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995952|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995953|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995954|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995955|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145995956|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
145995957|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995958|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995959|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995960|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995961|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995962|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995963|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995964|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995965|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995966|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995967|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145995968|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
145995969|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
145995970|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
145995971|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
145995972|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
145995973|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
145995974|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
145995975|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
145995976|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
145995977|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
145995978|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
145995979|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
145995980|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
145995981|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
145995982|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
145995983|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
145995984|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
145995985|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
145995986|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
145995987|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
145995988|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
145995989|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995990|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995991|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995992|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995993|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995994|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995995|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995996|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995997|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995998|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145995999|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145996000|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145996001|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145996002|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
145996003|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
146246707|NCT01863368|527417621|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
146091873|NCT01865084|526858444|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
146246708|NCT01863368|527417622|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
146246709|NCT01863368|527417621|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
146246710|NCT01863368|527417622|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
146246711|NCT01863368|527417621|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
145996004|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145996005|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996006|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996007|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996008|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996009|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996010|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996011|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996012|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996013|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996014|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996015|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996016|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996017|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996018|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
145996019|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996020|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145996021|NCT02958865|526500757|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996022|NCT02958865|526500758|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996023|NCT02958865|526500759|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996024|NCT02958865|526500760|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996025|NCT02958865|526500761|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996026|NCT02958865|526500762|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996027|NCT02958865|526500763|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996028|NCT02958865|526500764|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996029|NCT02958865|526500765|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996030|NCT02958865|526500766|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
145996031|NCT02958865|526500767|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996032|NCT02958865|526500768|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996033|NCT02958865|526500769|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996034|NCT02958865|526500770|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996035|NCT02958865|526500771|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996036|NCT02958865|526500772|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145996037|NCT01767987|526500773|FG000|Overall Study|Physician Decision|4|||
145996038|NCT01767987|526500774|FG001|Overall Study|Physician Decision|1|||
145996039|NCT00654355|526500781|FG000|Overall Study|Lost to Follow-up|2|||
145996040|NCT00654355|526500782|FG001|Overall Study|Lost to Follow-up|2|||
145996041|NCT05805150|526500787|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
145996042|NCT05805150|526500788|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
145996043|NCT02284893|526500789|FG000|26 Week (Short Term)|Adverse Event|1|||
145996044|NCT02284893|526500790|FG001|26 Week (Short Term)|Adverse Event|9|||
145996045|NCT02284893|526500789|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
145996046|NCT02284893|526500790|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
145996047|NCT02284893|526500789|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
145996048|NCT02284893|526500790|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
145996049|NCT02284893|526500789|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
145996050|NCT02284893|526500790|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
145996051|NCT02284893|526500789|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
145996052|NCT02284893|526500790|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
145996053|NCT02284893|526500789|FG000|26 Week (Short Term)|Other|1|||
145996054|NCT02284893|526500790|FG001|26 Week (Short Term)|Other|1|||
145996055|NCT02284893|526500789|FG000|52 Week (Long Term)|Adverse Event|3|||
145996056|NCT02284893|526500790|FG001|52 Week (Long Term)|Adverse Event|1|||
145996057|NCT02284893|526500789|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
145996058|NCT02284893|526500790|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
145996059|NCT02284893|526500789|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
145996060|NCT02284893|526500790|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
145996061|NCT02284893|526500789|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
145996062|NCT02284893|526500790|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
145996063|NCT02284893|526500789|FG000|52 Week (Long Term)|Non-Compliance|2|||
145996064|NCT02284893|526500790|FG001|52 Week (Long Term)|Non-Compliance|3|||
145996065|NCT02757430|526500791|FG000|Overall Study|Physician Decision|6|||
146246712|NCT01863368|527417622|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
146246713|NCT00515112|527417624|FG000|Overall Study|Death|0|||
146246714|NCT00515112|527417625|FG001|Overall Study|Death|1|||
146246715|NCT00515112|527417624|FG000|Overall Study|The study was terminated|3|||
146246716|NCT00515112|527417625|FG001|Overall Study|The study was terminated|2|||
146246717|NCT00307489|527417628|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
146246718|NCT00307489|527417629|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
145996066|NCT02757430|526500791|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
145996067|NCT02757430|526500791|FG000|Overall Study|No informed consent|1|||
145996068|NCT02757430|526500791|FG000|Overall Study|No procedure performed|2|||
145996069|NCT01983111|526500794|FG000|Overall Study|Withdrawal by Subject|8|||
145996070|NCT01983111|526500795|FG001|Overall Study|Withdrawal by Subject|6|||
145996071|NCT01983111|526500794|FG000|Overall Study|Adverse Event|4|||
145996072|NCT01983111|526500795|FG001|Overall Study|Adverse Event|0|||
145996073|NCT01983111|526500794|FG000|Overall Study|Protocol Violation|0|||
145996074|NCT01983111|526500795|FG001|Overall Study|Protocol Violation|1|||
145996075|NCT00855335|526500796|FG000|Overall Study|Lost to Follow-up|0|||
145996076|NCT00855335|526500797|FG001|Overall Study|Lost to Follow-up|0|||
145996077|NCT00855335|526500798|FG002|Overall Study|Lost to Follow-up|3|||
145996078|NCT00855335|526500799|FG003|Overall Study|Lost to Follow-up|1|||
145996079|NCT00855335|526500800|FG004|Overall Study|Lost to Follow-up|0|||
145996080|NCT00855335|526500796|FG000|Overall Study|Withdrawal by Subject|0|||
145996081|NCT00855335|526500797|FG001|Overall Study|Withdrawal by Subject|0|||
145996082|NCT00855335|526500798|FG002|Overall Study|Withdrawal by Subject|0|||
145996083|NCT00855335|526500799|FG003|Overall Study|Withdrawal by Subject|1|||
145996084|NCT00855335|526500800|FG004|Overall Study|Withdrawal by Subject|0|||
145996085|NCT00855335|526500796|FG000|Overall Study|Adverse Event|2|||
145996086|NCT00855335|526500797|FG001|Overall Study|Adverse Event|0|||
145996087|NCT00855335|526500798|FG002|Overall Study|Adverse Event|0|||
145996088|NCT00855335|526500799|FG003|Overall Study|Adverse Event|0|||
145996089|NCT00855335|526500800|FG004|Overall Study|Adverse Event|0|||
145996090|NCT00855335|526500796|FG000|Overall Study|Physician Decision|1|||
145996091|NCT00855335|526500797|FG001|Overall Study|Physician Decision|1|||
145996092|NCT00855335|526500798|FG002|Overall Study|Physician Decision|0|||
145996093|NCT00855335|526500799|FG003|Overall Study|Physician Decision|0|||
145996094|NCT00855335|526500800|FG004|Overall Study|Physician Decision|0|||
145996095|NCT00855335|526500796|FG000|Overall Study|Other|2|||
145996096|NCT00855335|526500797|FG001|Overall Study|Other|1|||
145996097|NCT00855335|526500798|FG002|Overall Study|Other|2|||
145996098|NCT00855335|526500799|FG003|Overall Study|Other|5|||
145996099|NCT00855335|526500800|FG004|Overall Study|Other|1|||
145996100|NCT02526290|526500801|FG000|Overall Study|Adverse Event|3|||
145996101|NCT02526290|526500801|FG000|Overall Study|Withdrawal by Subject|4|||
145996102|NCT02526290|526500801|FG000|Overall Study|Physician Decision|1|||
145996103|NCT02082977|526500802|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
145996104|NCT02082977|526500803|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
145996105|NCT02082977|526500804|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
145996106|NCT02082977|526500805|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
145996107|NCT02082977|526500806|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
145996108|NCT02082977|526500807|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
145996109|NCT02082977|526500808|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
145996110|NCT02082977|526500809|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
145996111|NCT02082977|526500810|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
145996112|NCT02082977|526500811|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
145996113|NCT02082977|526500802|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996114|NCT02082977|526500803|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996115|NCT02082977|526500804|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996116|NCT02082977|526500805|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996117|NCT02082977|526500806|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996118|NCT02082977|526500807|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996119|NCT02082977|526500808|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996120|NCT02082977|526500809|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
145996121|NCT02082977|526500810|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
146246719|NCT00307489|527417628|FG000|Baseline Through Week 48|Physician Decision|1|||
145996122|NCT02082977|526500811|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145996123|NCT02082977|526500802|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146246720|NCT00307489|527417629|FG001|Baseline Through Week 48|Physician Decision|0|||
145996124|NCT02082977|526500803|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996125|NCT02082977|526500804|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996126|NCT02082977|526500805|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
146246721|NCT00307489|527417628|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
146246722|NCT00307489|527417629|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
145996127|NCT02082977|526500806|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996128|NCT02082977|526500807|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
145996129|NCT02082977|526500808|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996130|NCT02082977|526500809|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996131|NCT02082977|526500810|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996132|NCT02082977|526500811|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145996133|NCT02082977|526500802|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145996134|NCT02082977|526500803|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145996135|NCT02082977|526500804|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145996136|NCT02082977|526500805|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145996137|NCT02082977|526500806|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145996138|NCT02082977|526500807|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145996139|NCT02082977|526500808|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
145996140|NCT02082977|526500809|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145996141|NCT02082977|526500810|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
145996142|NCT02082977|526500811|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145996143|NCT02082977|526500802|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996144|NCT02082977|526500803|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996145|NCT02082977|526500804|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996146|NCT02082977|526500805|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996147|NCT02082977|526500806|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996148|NCT02082977|526500807|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996149|NCT02082977|526500808|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996150|NCT02082977|526500809|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
145996151|NCT02082977|526500810|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
146246723|NCT00307489|527417628|FG000|Week 48 Through Week 168|Adverse Event|1|||
146246724|NCT00307489|527417629|FG001|Week 48 Through Week 168|Adverse Event|0|||
146246725|NCT00307489|527417628|FG000|Week 48 Through Week 168|Physician Decision|1|||
146246726|NCT00307489|527417629|FG001|Week 48 Through Week 168|Physician Decision|0|||
146246727|NCT00307489|527417628|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
146246728|NCT00307489|527417629|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
146246729|NCT00307489|527417628|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
146246730|NCT00307489|527417629|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
146246731|NCT00307489|527417628|FG000|Week 48 Through Week 168|Death|0|||
146246732|NCT00307489|527417629|FG001|Week 48 Through Week 168|Death|1|||
146246733|NCT00307489|527417628|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
146246734|NCT00307489|527417629|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
146246735|NCT00307489|527417628|FG000|Week 48 Through Week 168|Seroconversion|1|||
145996152|NCT02082977|526500811|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145996153|NCT00049543|526500815|FG000|Overall Study|still on treatment|2|||
145996154|NCT00049543|526500816|FG001|Overall Study|still on treatment|9|||
145996155|NCT00105066|526500817|FG000|Overall Study|Adverse Event|2|||
145996156|NCT00105066|526500818|FG001|Overall Study|Adverse Event|5|||
145996157|NCT00787150|526500819|FG000|Overall Study|Adverse Event|4|||
145996158|NCT00787150|526500820|FG001|Overall Study|Adverse Event|4|||
145996159|NCT00787150|526500821|FG002|Overall Study|Adverse Event|4|||
145996160|NCT00787150|526500819|FG000|Overall Study|Physician Decision|1|||
145996161|NCT00787150|526500820|FG001|Overall Study|Physician Decision|2|||
145996162|NCT00787150|526500821|FG002|Overall Study|Physician Decision|1|||
145996163|NCT00787150|526500819|FG000|Overall Study|Withdrawal by Subject|2|||
145996164|NCT00787150|526500820|FG001|Overall Study|Withdrawal by Subject|1|||
145996165|NCT00787150|526500821|FG002|Overall Study|Withdrawal by Subject|0|||
145996166|NCT00787150|526500819|FG000|Overall Study|Dosing incorrect study durg|2|||
145996167|NCT00787150|526500820|FG001|Overall Study|Dosing incorrect study durg|0|||
145996168|NCT00787150|526500821|FG002|Overall Study|Dosing incorrect study durg|0|||
145996169|NCT04079738|526500828|FG000|Study Treatment|Death|1|||
145996170|NCT04079738|526500829|FG001|Study Treatment|Death|0|||
145996171|NCT04079738|526500830|FG002|Study Treatment|Death|0|||
145996172|NCT04079738|526500831|FG003|Study Treatment|Death|0|||
145996173|NCT04079738|526500828|FG000|Study Treatment|Adverse Event|2|||
145996174|NCT04079738|526500829|FG001|Study Treatment|Adverse Event|0|||
145996175|NCT04079738|526500830|FG002|Study Treatment|Adverse Event|0|||
145996176|NCT04079738|526500831|FG003|Study Treatment|Adverse Event|0|||
145996177|NCT04079738|526500828|FG000|Study Treatment|withdrawal before treatment|1|||
145996178|NCT04079738|526500829|FG001|Study Treatment|withdrawal before treatment|0|||
145996179|NCT04079738|526500830|FG002|Study Treatment|withdrawal before treatment|0|||
145996180|NCT04079738|526500831|FG003|Study Treatment|withdrawal before treatment|0|||
145996181|NCT04079738|526500828|FG000|Study Treatment|symptomatic deterioration|2|||
145996182|NCT04079738|526500829|FG001|Study Treatment|symptomatic deterioration|0|||
145996183|NCT04079738|526500830|FG002|Study Treatment|symptomatic deterioration|0|||
145996184|NCT04079738|526500831|FG003|Study Treatment|symptomatic deterioration|0|||
145996185|NCT04079738|526500828|FG000|Study Treatment|Disease Progression|1|||
145996186|NCT04079738|526500829|FG001|Study Treatment|Disease Progression|0|||
145996187|NCT04079738|526500830|FG002|Study Treatment|Disease Progression|0|||
145996188|NCT04079738|526500831|FG003|Study Treatment|Disease Progression|0|||
145996189|NCT04079738|526500828|FG000|Study Treatment|withdrawal after treatment|1|||
145996190|NCT04079738|526500829|FG001|Study Treatment|withdrawal after treatment|0|||
145996191|NCT04079738|526500830|FG002|Study Treatment|withdrawal after treatment|0|||
145996192|NCT04079738|526500831|FG003|Study Treatment|withdrawal after treatment|0|||
145996193|NCT04079738|526500828|FG000|Follow up|Withdrawal by Subject|3|||
145996194|NCT04079738|526500829|FG001|Follow up|Withdrawal by Subject|0|||
145996195|NCT04079738|526500830|FG002|Follow up|Withdrawal by Subject|0|||
145996196|NCT04079738|526500831|FG003|Follow up|Withdrawal by Subject|0|||
145996197|NCT04079738|526500828|FG000|Follow up|Death|5|||
145996198|NCT04079738|526500829|FG001|Follow up|Death|0|||
145996199|NCT04079738|526500830|FG002|Follow up|Death|0|||
145996200|NCT04079738|526500831|FG003|Follow up|Death|0|||
145996201|NCT03448393|526500834|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996202|NCT03448393|526500835|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996203|NCT03448393|526500836|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
145996204|NCT03448393|526500837|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996205|NCT03448393|526500838|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996206|NCT03448393|526500839|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996207|NCT03448393|526500840|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996208|NCT03448393|526500841|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145996209|NCT03448393|526500842|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
145996210|NCT03448393|526500834|FG000|Dose Expansion|Not treated - screen failure|0|||
145996211|NCT03448393|526500835|FG001|Dose Expansion|Not treated - screen failure|0|||
145996212|NCT03448393|526500836|FG002|Dose Expansion|Not treated - screen failure|0|||
145996213|NCT03448393|526500837|FG003|Dose Expansion|Not treated - screen failure|0|||
145996214|NCT03448393|526500838|FG004|Dose Expansion|Not treated - screen failure|0|||
145996215|NCT03448393|526500839|FG005|Dose Expansion|Not treated - screen failure|0|||
145996216|NCT03448393|526500840|FG006|Dose Expansion|Not treated - screen failure|0|||
145996217|NCT03448393|526500841|FG007|Dose Expansion|Not treated - screen failure|0|||
145996218|NCT03448393|526500842|FG008|Dose Expansion|Not treated - screen failure|7|||
145996219|NCT01587196|526500843|FG000|Overall Study|Lost to Follow-up|50|||
145996220|NCT01587196|526500843|FG000|Overall Study|Withdrawal by Subject|4|||
145996221|NCT00642759|526500844|FG000|Overall Study|Protocol Violation|1|||
145996222|NCT00643279|526500849|FG000|Overall Study|Death|13|||
145996223|NCT00643279|526500850|FG001|Overall Study|Death|11|||
145996224|NCT00643279|526500849|FG000|Overall Study|Withdrawal by Subject|3|||
145996225|NCT00643279|526500850|FG001|Overall Study|Withdrawal by Subject|0|||
145996226|NCT00643279|526500849|FG000|Overall Study|Lost to Follow-up|0|||
145996227|NCT00643279|526500850|FG001|Overall Study|Lost to Follow-up|1|||
145996228|NCT00643279|526500849|FG000|Overall Study|Physician Decision|0|||
145996229|NCT00643279|526500850|FG001|Overall Study|Physician Decision|1|||
145996230|NCT03612570|526500851|FG000|Overall Study|Lost to Follow-up|1|||
145996231|NCT05715827|526500859|FG000|Overall Study|Physician Decision|0|||
145996232|NCT05715827|526500860|FG001|Overall Study|Physician Decision|1|||
145996233|NCT05715827|526500859|FG000|Overall Study|console communication error|0|||
145996234|NCT05715827|526500860|FG001|Overall Study|console communication error|1|||
145996235|NCT04795531|526502746|FG000|Overall Study|Withdrawal by Subject|4|||
145996236|NCT04795531|526502747|FG001|Overall Study|Withdrawal by Subject|4|||
145996237|NCT04795531|526502746|FG000|Overall Study|Lost to Follow-up|0|||
145996238|NCT04795531|526502747|FG001|Overall Study|Lost to Follow-up|1|||
145996239|NCT04795531|526502746|FG000|Overall Study|Physician Decision|0|||
145996240|NCT04795531|526502747|FG001|Overall Study|Physician Decision|2|||
145996241|NCT04795531|526502746|FG000|Overall Study|Death|2|||
145996242|NCT04795531|526502747|FG001|Overall Study|Death|1|||
145996243|NCT04887831|526502748|FG000|Overall Study|Death|26|||
145996244|NCT04887831|526502749|FG001|Overall Study|Death|26|||
145996245|NCT04887831|526502748|FG000|Overall Study|Lost to Follow-up|0|||
145996246|NCT04887831|526502749|FG001|Overall Study|Lost to Follow-up|1|||
145996247|NCT04887831|526502748|FG000|Overall Study|Withdrawal by Subject|2|||
145996248|NCT04887831|526502749|FG001|Overall Study|Withdrawal by Subject|1|||
145996249|NCT04887831|526502748|FG000|Overall Study|Study Terminated by Sponsor|18|||
145996250|NCT04887831|526502749|FG001|Overall Study|Study Terminated by Sponsor|17|||
145996251|NCT04887831|526502748|FG000|Overall Study|Other|1|||
145996252|NCT04887831|526502749|FG001|Overall Study|Other|0|||
145996253|NCT04622592|526502750|FG000|Overall Study|Death|0|||
145996254|NCT04622592|526502751|FG001|Overall Study|Death|0|||
145996255|NCT04622592|526502752|FG002|Overall Study|Death|1|||
145996256|NCT04622592|526502753|FG003|Overall Study|Death|0|||
145996257|NCT04622592|526502754|FG004|Overall Study|Death|0|||
145996258|NCT04622592|526502755|FG005|Overall Study|Death|0|||
145996259|NCT04622592|526502756|FG006|Overall Study|Death|0|||
145996260|NCT04622592|526502757|FG007|Overall Study|Death|1|||
145996261|NCT04622592|526502750|FG000|Overall Study|Lost to Follow-up|0|||
145996262|NCT04622592|526502751|FG001|Overall Study|Lost to Follow-up|0|||
145996263|NCT04622592|526502752|FG002|Overall Study|Lost to Follow-up|0|||
145996264|NCT04622592|526502753|FG003|Overall Study|Lost to Follow-up|3|||
145996265|NCT04622592|526502754|FG004|Overall Study|Lost to Follow-up|1|||
145996266|NCT04622592|526502755|FG005|Overall Study|Lost to Follow-up|0|||
145996267|NCT04622592|526502756|FG006|Overall Study|Lost to Follow-up|2|||
145996268|NCT04622592|526502757|FG007|Overall Study|Lost to Follow-up|2|||
145996269|NCT04622592|526502750|FG000|Overall Study|Physician Decision|0|||
145996270|NCT04622592|526502751|FG001|Overall Study|Physician Decision|0|||
146246736|NCT00307489|527417629|FG001|Week 48 Through Week 168|Seroconversion|0|||
146246737|NCT00304278|527417631|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
146246738|NCT00304278|527417631|FG000|Overall Study|PT had medical condition preventing TX|1|||
146246739|NCT04025762|527417634|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
146246740|NCT04025762|527417635|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
146246741|NCT01286311|527417637|FG000|Overall Study|Physician did not want outreach sent|14|||
146246742|NCT01286311|527417638|FG001|Overall Study|Physician did not want outreach sent|0|||
146246743|NCT01381549|527417641|FG000|Overall Study|Ineligible: No organisms isolated|0|||
146246744|NCT01381549|527417642|FG001|Overall Study|Ineligible: No organisms isolated|0|||
146246745|NCT01381549|527417643|FG002|Overall Study|Ineligible: No organisms isolated|1|||
146246746|NCT02981953|527417644|FG000|Overall Study|Death|9|||
146246747|NCT02981953|527417644|FG000|Overall Study|Withdrawal by Subject|1|||
146246748|NCT02981953|527417644|FG000|Overall Study|Withdrawal to non-compliance|1|||
146246749|NCT02889900|527417645|FG000|Overall Study|Adverse Event|11|||
146246750|NCT02889900|527417645|FG000|Overall Study|Condition under investigation worsened|32|||
146246751|NCT02889900|527417645|FG000|Overall Study|Other|5|||
145996271|NCT04622592|526502752|FG002|Overall Study|Physician Decision|0|||
145996272|NCT04622592|526502753|FG003|Overall Study|Physician Decision|0|||
145996273|NCT04622592|526502754|FG004|Overall Study|Physician Decision|1|||
145996274|NCT04622592|526502755|FG005|Overall Study|Physician Decision|0|||
145996275|NCT04622592|526502756|FG006|Overall Study|Physician Decision|0|||
145996276|NCT04622592|526502757|FG007|Overall Study|Physician Decision|0|||
145996277|NCT04622592|526502750|FG000|Overall Study|Withdrawal by Subject|1|||
145996278|NCT04622592|526502751|FG001|Overall Study|Withdrawal by Subject|0|||
145996279|NCT04622592|526502752|FG002|Overall Study|Withdrawal by Subject|2|||
145996280|NCT04622592|526502753|FG003|Overall Study|Withdrawal by Subject|0|||
145996281|NCT04622592|526502754|FG004|Overall Study|Withdrawal by Subject|0|||
145996282|NCT04622592|526502755|FG005|Overall Study|Withdrawal by Subject|0|||
145996283|NCT04622592|526502756|FG006|Overall Study|Withdrawal by Subject|1|||
145996284|NCT04622592|526502757|FG007|Overall Study|Withdrawal by Subject|4|||
145996285|NCT04622592|526502750|FG000|Overall Study|Other than specified above|0|||
145996286|NCT04622592|526502751|FG001|Overall Study|Other than specified above|0|||
145996287|NCT04622592|526502752|FG002|Overall Study|Other than specified above|1|||
145996288|NCT04622592|526502753|FG003|Overall Study|Other than specified above|0|||
145996289|NCT04622592|526502754|FG004|Overall Study|Other than specified above|0|||
145996290|NCT04622592|526502755|FG005|Overall Study|Other than specified above|0|||
145996291|NCT04622592|526502756|FG006|Overall Study|Other than specified above|0|||
145996292|NCT04622592|526502757|FG007|Overall Study|Other than specified above|0|||
145996293|NCT01664624|526502758|FG000|Overall Study|Adverse Event|0|||
145996294|NCT01664624|526502759|FG001|Overall Study|Adverse Event|1|||
145996295|NCT01664624|526502760|FG002|Overall Study|Adverse Event|0|||
145996296|NCT01664624|526502761|FG003|Overall Study|Adverse Event|0|||
145996297|NCT01517984|526502767|FG000|Overall Study|Lost to Follow-up|0|||
145996298|NCT01517984|526502768|FG001|Overall Study|Lost to Follow-up|1|||
145996299|NCT01517984|526502769|FG002|Overall Study|Lost to Follow-up|0|||
145996300|NCT01517984|526502770|FG003|Overall Study|Lost to Follow-up|0|||
145996301|NCT01517984|526502767|FG000|Overall Study|Withdrawal by Subject|1|||
145996302|NCT01517984|526502768|FG001|Overall Study|Withdrawal by Subject|8|||
145996303|NCT01517984|526502769|FG002|Overall Study|Withdrawal by Subject|4|||
145996304|NCT01517984|526502770|FG003|Overall Study|Withdrawal by Subject|1|||
145996305|NCT01517984|526502767|FG000|Overall Study|Screen Failure|4|||
145996306|NCT01517984|526502768|FG001|Overall Study|Screen Failure|0|||
145996307|NCT01517984|526502769|FG002|Overall Study|Screen Failure|0|||
145996308|NCT01517984|526502770|FG003|Overall Study|Screen Failure|0|||
145996309|NCT01517984|526502767|FG000|Overall Study|Ineligible for randomization|0|||
145996310|NCT01517984|526502768|FG001|Overall Study|Ineligible for randomization|14|||
145996311|NCT01517984|526502769|FG002|Overall Study|Ineligible for randomization|0|||
145996312|NCT01517984|526502770|FG003|Overall Study|Ineligible for randomization|0|||
145996313|NCT04903288|526502772|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
145996314|NCT04903288|526502772|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
145996315|NCT04903288|526502772|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
145996316|NCT04903288|526502772|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
145996317|NCT00573768|526502773|FG000|Overall Study|Adverse Event|1|||
145996318|NCT00573768|526502774|FG001|Overall Study|Adverse Event|1|||
145996319|NCT00573768|526502775|FG002|Overall Study|Adverse Event|2|||
145996320|NCT00573768|526502773|FG000|Overall Study|Protocol Violation|1|||
145996321|NCT00573768|526502774|FG001|Overall Study|Protocol Violation|0|||
145996322|NCT00573768|526502775|FG002|Overall Study|Protocol Violation|1|||
145996323|NCT00573768|526502773|FG000|Overall Study|Withdrawal by Subject|0|||
145996324|NCT00573768|526502774|FG001|Overall Study|Withdrawal by Subject|1|||
145996325|NCT00573768|526502775|FG002|Overall Study|Withdrawal by Subject|0|||
145996326|NCT00573768|526502773|FG000|Overall Study|Lost to Follow-up|0|||
145996327|NCT00573768|526502774|FG001|Overall Study|Lost to Follow-up|0|||
146246752|NCT02889900|527417645|FG000|Overall Study|Withdrawal by Subject|7|||
146246753|NCT02889900|527417645|FG000|Overall Study|Not treated|2|||
145996328|NCT00573768|526502775|FG002|Overall Study|Lost to Follow-up|1|||
145996329|NCT00583219|526502780|FG000|Phase 2|Withdrawal by Subject|1|||
145996330|NCT04617860|526502781|FG000|Overall Study|Adverse Event|0|||
145996331|NCT04617860|526502782|FG001|Overall Study|Adverse Event|2|||
145996332|NCT04617860|526502783|FG002|Overall Study|Adverse Event|2|||
145996333|NCT04617860|526502781|FG000|Overall Study|Withdrawal by Subject|0|||
145996334|NCT04617860|526502782|FG001|Overall Study|Withdrawal by Subject|0|||
145996335|NCT04617860|526502783|FG002|Overall Study|Withdrawal by Subject|2|||
145996336|NCT04617860|526502781|FG000|Overall Study|Physician Decision|0|||
145996337|NCT04617860|526502782|FG001|Overall Study|Physician Decision|1|||
145996338|NCT04617860|526502783|FG002|Overall Study|Physician Decision|0|||
145996339|NCT04617860|526502781|FG000|Overall Study|Sponsor Decision|0|||
145996340|NCT04617860|526502782|FG001|Overall Study|Sponsor Decision|3|||
145996341|NCT04617860|526502783|FG002|Overall Study|Sponsor Decision|1|||
145996342|NCT04617860|526502781|FG000|Overall Study|Termination of Study by Sponsor|8|||
145996343|NCT04617860|526502782|FG001|Overall Study|Termination of Study by Sponsor|4|||
145996344|NCT04617860|526502783|FG002|Overall Study|Termination of Study by Sponsor|13|||
145996345|NCT03898180|526502784|FG000|Overall Study|Death|178|||
145996346|NCT03898180|526502785|FG001|Overall Study|Death|173|||
145996347|NCT03898180|526502784|FG000|Overall Study|Physician Decision|1|||
145996348|NCT03898180|526502785|FG001|Overall Study|Physician Decision|0|||
145996349|NCT03898180|526502784|FG000|Overall Study|Sponsor Decision|3|||
145996350|NCT03898180|526502785|FG001|Overall Study|Sponsor Decision|0|||
145996351|NCT03898180|526502784|FG000|Overall Study|Lost to Follow-up|1|||
145996352|NCT03898180|526502785|FG001|Overall Study|Lost to Follow-up|0|||
145996353|NCT03898180|526502784|FG000|Overall Study|Withdrawal by Subject|5|||
145996354|NCT03898180|526502785|FG001|Overall Study|Withdrawal by Subject|4|||
145996355|NCT02507934|526502786|FG000|Overall Study|Lost to Follow-up|2|||
145996356|NCT02507934|526502787|FG001|Overall Study|Lost to Follow-up|0|||
145996357|NCT02507934|526502786|FG000|Overall Study|Withdrawal by Subject|2|||
145996358|NCT02507934|526502787|FG001|Overall Study|Withdrawal by Subject|0|||
145996359|NCT01559935|526502788|FG000|Car Phase|Toxicity|4|||
145996360|NCT01559935|526502788|FG000|Car Phase|Death|1|||
145996361|NCT01559935|526502788|FG000|Car Phase|Lack of Efficacy|2|||
145996362|NCT01559935|526502788|FG000|Car Phase|Lost to Follow-up|1|||
145996363|NCT01559935|526502788|FG000|Car Phase|Physician Decision|1|||
145996364|NCT01559935|526502788|FG000|Car Phase|Withdrawal by Subject|2|||
145996365|NCT01559935|526502788|FG000|Car Phase|Per protocol|1|||
145996366|NCT01559935|526502788|FG000|Car Phase|Insurance|1|||
145996367|NCT01559935|526502788|FG000|Car Phase|non-compliance|1|||
145996368|NCT01559935|526502788|FG000|BiRD Phase|Toxicity|1|||
145996369|NCT01559935|526502788|FG000|BiRD Phase|Lack of Efficacy|1|||
145996370|NCT01559935|526502788|FG000|BiRD Phase|Withdrawal by Subject|2|||
145996371|NCT01559935|526502788|FG000|Maintenance Phase|Remains on study|28|||
145996372|NCT01559935|526502788|FG000|Maintenance Phase|Toxicity|1|||
145996373|NCT01559935|526502788|FG000|Maintenance Phase|Lack of Efficacy|18|||
145996374|NCT01559935|526502788|FG000|Maintenance Phase|Withdrawal by Subject|5|||
145996375|NCT01559935|526502788|FG000|Maintenance Phase|Non-compliance|2|||
145996376|NCT02661815|526502789|FG000|Overall Study|Withdrawal by Subject|1|||
145996377|NCT02661815|526502790|FG001|Overall Study|Withdrawal by Subject|0|||
145996378|NCT02661815|526502791|FG002|Overall Study|Withdrawal by Subject|0|||
145996379|NCT02661815|526502792|FG003|Overall Study|Withdrawal by Subject|0|||
145996380|NCT02706392|526502804|FG000|Overall Study|Death|1|||
145996381|NCT02706392|526502805|FG001|Overall Study|Death|0|||
145996382|NCT02706392|526502806|FG002|Overall Study|Death|2|||
145996383|NCT02706392|526502807|FG003|Overall Study|Death|2|||
145996384|NCT02706392|526502808|FG004|Overall Study|Death|5|||
145996385|NCT02706392|526502809|FG005|Overall Study|Death|2|||
145996386|NCT01467466|526502813|FG000|Overall Study|Withdrawal by Subject|15|||
145996387|NCT01467466|526502814|FG001|Overall Study|Withdrawal by Subject|18|||
145996388|NCT01467466|526502815|FG002|Overall Study|Withdrawal by Subject|13|||
145996389|NCT01467466|526502816|FG003|Overall Study|Withdrawal by Subject|11|||
145996390|NCT01467466|526502813|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
145996391|NCT01467466|526502814|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
146298059|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
146298060|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
145996392|NCT01467466|526502815|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
145996393|NCT01467466|526502816|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
145996394|NCT01467466|526502813|FG000|Overall Study|Procedure Cancelled|46|||
145996395|NCT01467466|526502814|FG001|Overall Study|Procedure Cancelled|45|||
145996396|NCT01467466|526502815|FG002|Overall Study|Procedure Cancelled|25|||
145996397|NCT01467466|526502816|FG003|Overall Study|Procedure Cancelled|29|||
145996398|NCT01467466|526502813|FG000|Overall Study|No Endpoint Blood Draw|38|||
145996399|NCT01467466|526502814|FG001|Overall Study|No Endpoint Blood Draw|32|||
145996400|NCT01467466|526502815|FG002|Overall Study|No Endpoint Blood Draw|51|||
145996401|NCT01467466|526502816|FG003|Overall Study|No Endpoint Blood Draw|43|||
145996402|NCT03261505|526502817|FG000|Overall Study|Withdrawal by Subject|2|||
145996403|NCT03261505|526502818|FG001|Overall Study|Withdrawal by Subject|3|||
145996404|NCT03261505|526502819|FG002|Overall Study|Withdrawal by Subject|4|||
145996405|NCT03261505|526502820|FG003|Overall Study|Withdrawal by Subject|3|||
145996406|NCT03261505|526502817|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145996407|NCT03261505|526502818|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145996408|NCT03261505|526502819|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
145996409|NCT03261505|526502820|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145996410|NCT03261505|526502817|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145996411|NCT03261505|526502818|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145996412|NCT03261505|526502819|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
145996413|NCT03261505|526502820|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145996414|NCT03261505|526502817|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
145996415|NCT03261505|526502818|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145996416|NCT03261505|526502819|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145996417|NCT03261505|526502820|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145996418|NCT03773484|526502825|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
145996419|NCT05552859|526502826|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
145996420|NCT05552859|526502827|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
145996421|NCT04251533|526502828|FG000|Overall Study|Progressive disease|33|||
145996422|NCT04251533|526502829|FG001|Overall Study|Progressive disease|29|||
145996423|NCT04251533|526502830|FG002|Overall Study|Progressive disease|22|||
145996424|NCT04251533|526502828|FG000|Overall Study|Death|5|||
145996425|NCT04251533|526502829|FG001|Overall Study|Death|1|||
145996426|NCT04251533|526502830|FG002|Overall Study|Death|3|||
145996427|NCT04251533|526502828|FG000|Overall Study|Physician Decision|3|||
145996428|NCT04251533|526502829|FG001|Overall Study|Physician Decision|2|||
145996429|NCT04251533|526502830|FG002|Overall Study|Physician Decision|4|||
145996430|NCT04251533|526502828|FG000|Overall Study|Participant decision|1|||
145996431|NCT04251533|526502829|FG001|Overall Study|Participant decision|3|||
145996432|NCT04251533|526502830|FG002|Overall Study|Participant decision|1|||
145996433|NCT04251533|526502828|FG000|Overall Study|Adverse Event|2|||
145996434|NCT04251533|526502829|FG001|Overall Study|Adverse Event|1|||
145996435|NCT04251533|526502830|FG002|Overall Study|Adverse Event|1|||
145996436|NCT00210132|526502833|FG000|Overall Study|Protocol Violation|1|||
145996437|NCT00210132|526502834|FG001|Overall Study|Protocol Violation|4|||
145996438|NCT02711202|526502835|FG000|Overall Study|Adverse Event|3|||
145996439|NCT02711202|526502836|FG001|Overall Study|Adverse Event|0|||
145996440|NCT02711202|526502835|FG000|Overall Study|graft loss|1|||
145996441|NCT02711202|526502836|FG001|Overall Study|graft loss|0|||
145996442|NCT00432965|526502837|FG000|Overall Study|Lost to Follow-up|22|||
145996443|NCT00432965|526502838|FG001|Overall Study|Lost to Follow-up|19|||
145996444|NCT00432965|526502837|FG000|Overall Study|Withdrawal by Subject|13|||
145996445|NCT00432965|526502838|FG001|Overall Study|Withdrawal by Subject|13|||
145996446|NCT00432965|526502837|FG000|Overall Study|Physician Decision|14|||
145996447|NCT00432965|526502838|FG001|Overall Study|Physician Decision|13|||
145996448|NCT00432965|526502837|FG000|Overall Study|Lack of Efficacy|8|||
145996449|NCT00432965|526502838|FG001|Overall Study|Lack of Efficacy|13|||
145996450|NCT00432965|526502837|FG000|Overall Study|Non-compliance|7|||
145996451|NCT00432965|526502838|FG001|Overall Study|Non-compliance|0|||
145996452|NCT00432965|526502837|FG000|Overall Study|Adverse Event|22|||
145996453|NCT00432965|526502838|FG001|Overall Study|Adverse Event|19|||
145996454|NCT00432965|526502837|FG000|Overall Study|Death|3|||
145996455|NCT00432965|526502838|FG001|Overall Study|Death|4|||
145996456|NCT00432965|526502837|FG000|Overall Study|Exclusionary Methods|1|||
145996457|NCT00432965|526502838|FG001|Overall Study|Exclusionary Methods|2|||
145996458|NCT00432965|526502837|FG000|Overall Study|Incomplete Data|4|||
145996459|NCT00432965|526502838|FG001|Overall Study|Incomplete Data|3|||
146091874|NCT01865084|526858445|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
146091875|NCT01865084|526858443|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
146091876|NCT01865084|526858444|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
146091877|NCT01865084|526858445|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
146091878|NCT01865084|526858443|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
146091879|NCT01865084|526858444|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
146091880|NCT01865084|526858445|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
146091881|NCT01865084|526858443|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
146091882|NCT01865084|526858444|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
146091883|NCT01865084|526858445|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
146298061|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
145996460|NCT01889251|526502839|FG000|Overall Study|Adverse Event|1|||
146091884|NCT01865084|526858443|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
145996461|NCT01889251|526502840|FG001|Overall Study|Adverse Event|0|||
145996462|NCT01344226|526502843|FG000|Overall Study|Protocol Violation|2|||
145996463|NCT01344226|526502843|FG000|Overall Study|Withdrawal by Subject|3|||
145996464|NCT01344226|526502843|FG000|Overall Study|Lack of Efficacy|3|||
145996465|NCT03138564|526502844|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
145996466|NCT03138564|526502845|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
145996467|NCT03138564|526502844|FG000|Overall Study|Lost to Follow-up|16|||
145996468|NCT03138564|526502845|FG001|Overall Study|Lost to Follow-up|2|||
145996469|NCT03138564|526502844|FG000|Overall Study|Withdrawal by Subject|48|||
145996470|NCT03138564|526502845|FG001|Overall Study|Withdrawal by Subject|4|||
145996471|NCT03138564|526502844|FG000|Overall Study|No longer met eligibility criteria|2|||
145996472|NCT03138564|526502845|FG001|Overall Study|No longer met eligibility criteria|0|||
145996473|NCT03138564|526502844|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
145996474|NCT03138564|526502845|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
145996475|NCT03138564|526502844|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
145996476|NCT03138564|526502845|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
145996477|NCT03138564|526502844|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
145996478|NCT03138564|526502845|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
145996479|NCT03138564|526502844|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
145996480|NCT03138564|526502845|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
145996481|NCT03330847|526502847|FG000|Overall Study|Patients ongoing study|62|||
145996482|NCT03330847|526502848|FG001|Overall Study|Patients ongoing study|65|||
145996483|NCT03330847|526502849|FG002|Overall Study|Patients ongoing study|15|||
145996484|NCT05211596|526502852|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
145996485|NCT05211596|526502852|FG000|Baseline to 6 Months|Death|1|||
145996486|NCT05211596|526502852|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
145996487|NCT05211596|526502852|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
145996488|NCT04846868|526502853|FG000|Overall Study|Adverse Event|12|||
145996489|NCT04846868|526502854|FG001|Overall Study|Adverse Event|11|||
145996490|NCT04846868|526502853|FG000|Overall Study|Protocol deviation|6|||
145996491|NCT04846868|526502854|FG001|Overall Study|Protocol deviation|2|||
145996492|NCT04846868|526502853|FG000|Overall Study|Perceived lack of efficacy|3|||
145996493|NCT04846868|526502854|FG001|Overall Study|Perceived lack of efficacy|2|||
145996494|NCT04846868|526502853|FG000|Overall Study|Change of residence|2|||
145996495|NCT04846868|526502854|FG001|Overall Study|Change of residence|3|||
145996496|NCT04846868|526502853|FG000|Overall Study|Burden of study procedures|1|||
145996497|NCT04846868|526502854|FG001|Overall Study|Burden of study procedures|1|||
145996498|NCT04846868|526502853|FG000|Overall Study|No reason available|2|||
145996499|NCT04846868|526502854|FG001|Overall Study|No reason available|5|||
145996500|NCT04846868|526502853|FG000|Overall Study|Other reason listed|20|||
145996501|NCT04846868|526502854|FG001|Overall Study|Other reason listed|10|||
145996502|NCT04846868|526502853|FG000|Overall Study|Not treated|0|||
145996503|NCT04846868|526502854|FG001|Overall Study|Not treated|1|||
145996504|NCT04116853|526502855|FG000|Overall Study|Adverse Event|1|||
145996505|NCT04116853|526502856|FG001|Overall Study|Adverse Event|3|||
145996506|NCT04116853|526502855|FG000|Overall Study|Lost to Follow-up|2|||
145996507|NCT04116853|526502856|FG001|Overall Study|Lost to Follow-up|0|||
145996508|NCT04116853|526502855|FG000|Overall Study|Incarceration|0|||
145996509|NCT04116853|526502856|FG001|Overall Study|Incarceration|1|||
145996510|NCT04116853|526502855|FG000|Overall Study|Pregnancy|1|||
145996511|NCT04116853|526502856|FG001|Overall Study|Pregnancy|1|||
145996512|NCT04116853|526502855|FG000|Overall Study|Began Other Weight Loss program|4|||
145996513|NCT04116853|526502856|FG001|Overall Study|Began Other Weight Loss program|8|||
145996514|NCT04116853|526502855|FG000|Overall Study|Began Anti-Obesity Medication|3|||
145996515|NCT04116853|526502856|FG001|Overall Study|Began Anti-Obesity Medication|3|||
145996516|NCT04116853|526502855|FG000|Overall Study|Protocol Violation|0|||
145996517|NCT04116853|526502856|FG001|Overall Study|Protocol Violation|1|||
145996518|NCT05212168|526502857|FG000|Overall Study|Lost to Follow-up|0|||
145996519|NCT05212168|526502858|FG001|Overall Study|Lost to Follow-up|3|||
145996520|NCT05212168|526502857|FG000|Overall Study|Study terminated by sponsor|30|||
145996521|NCT05212168|526502858|FG001|Overall Study|Study terminated by sponsor|27|||
145996522|NCT05212168|526502857|FG000|Overall Study|Other|4|||
145996523|NCT05212168|526502858|FG001|Overall Study|Other|7|||
145996524|NCT00618787|526502860|FG000|Overall Study|Adverse Event|0|||
145996525|NCT00618787|526502861|FG001|Overall Study|Adverse Event|1|||
145996526|NCT00618787|526502860|FG000|Overall Study|Withdrawal by Subject|2|||
145996527|NCT00618787|526502861|FG001|Overall Study|Withdrawal by Subject|1|||
145996528|NCT00618787|526502860|FG000|Overall Study|Lost to Follow-up|1|||
145996529|NCT00618787|526502861|FG001|Overall Study|Lost to Follow-up|0|||
145996530|NCT01107886|526502862|FG000|Overall Study|Lost to Follow-up|15|||
145996531|NCT01107886|526502863|FG001|Overall Study|Lost to Follow-up|13|||
145996532|NCT01107886|526502862|FG000|Overall Study|Withdrawal by Subject|180|||
145996533|NCT01107886|526502863|FG001|Overall Study|Withdrawal by Subject|196|||
145996534|NCT01107886|526502862|FG000|Overall Study|Administrative withdrawal of consent|7|||
145996535|NCT01107886|526502863|FG001|Overall Study|Administrative withdrawal of consent|5|||
145996536|NCT01994876|526502864|FG000|Test Period 1|Withdrawal by Subject|0|||
145996537|NCT01994876|526502865|FG001|Test Period 1|Withdrawal by Subject|1|||
145996538|NCT01994876|526502864|FG000|Test Period 1|Adverse Event|0|||
145996539|NCT01994876|526502865|FG001|Test Period 1|Adverse Event|1|||
145996540|NCT01994876|526502864|FG000|Test Period 2|Adverse Event|1|||
145996541|NCT01994876|526502865|FG001|Test Period 2|Adverse Event|0|||
145996542|NCT01994876|526502864|FG000|Test Period 2|Protocol Violation|0|||
145996543|NCT01994876|526502865|FG001|Test Period 2|Protocol Violation|1|||
145996544|NCT01346176|526502866|FG000|Recruited|Protocol Violation|1|||
145996545|NCT01346176|526502867|FG001|Recruited|Protocol Violation|0|||
145996546|NCT01346176|526502868|FG002|Recruited|Protocol Violation|0|||
145996547|NCT01346176|526502866|FG000|Completed Advance Directive|Death|3|||
145996548|NCT01346176|526502867|FG001|Completed Advance Directive|Death|2|||
145996549|NCT01346176|526502868|FG002|Completed Advance Directive|Death|2|||
145996550|NCT01346176|526502866|FG000|Completed Advance Directive|Became Ineligible|3|||
145996551|NCT01346176|526502867|FG001|Completed Advance Directive|Became Ineligible|0|||
145996552|NCT01346176|526502868|FG002|Completed Advance Directive|Became Ineligible|1|||
145996553|NCT01346176|526502866|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
145996554|NCT01346176|526502867|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
145996555|NCT01346176|526502868|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
145996556|NCT01346176|526502866|FG000|Completed Satisfaction Survey|Death|3|||
145996557|NCT01346176|526502867|FG001|Completed Satisfaction Survey|Death|0|||
145996558|NCT01346176|526502868|FG002|Completed Satisfaction Survey|Death|2|||
145996559|NCT01346176|526502866|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
145996560|NCT01346176|526502867|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
145996561|NCT01346176|526502868|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
145996562|NCT05819398|526502869|FG000|Overall Study|Withdrawal by Subject|11|||
145996563|NCT05819398|526502870|FG001|Overall Study|Withdrawal by Subject|7|||
145996564|NCT05819398|526502871|FG002|Overall Study|Withdrawal by Subject|6|||
145996565|NCT05819398|526502872|FG003|Overall Study|Withdrawal by Subject|6|||
145996566|NCT05819398|526502869|FG000|Overall Study|Lost to Follow-up|0|||
145996567|NCT05819398|526502870|FG001|Overall Study|Lost to Follow-up|2|||
145996568|NCT05819398|526502871|FG002|Overall Study|Lost to Follow-up|0|||
145996569|NCT05819398|526502872|FG003|Overall Study|Lost to Follow-up|1|||
145996570|NCT05819398|526502869|FG000|Overall Study|Adverse Event|1|||
145996571|NCT05819398|526502870|FG001|Overall Study|Adverse Event|3|||
145996572|NCT05819398|526502871|FG002|Overall Study|Adverse Event|4|||
145996573|NCT05819398|526502872|FG003|Overall Study|Adverse Event|5|||
145996574|NCT05819398|526502869|FG000|Overall Study|Other than listed|0|||
145996575|NCT05819398|526502870|FG001|Overall Study|Other than listed|2|||
145996576|NCT05819398|526502871|FG002|Overall Study|Other than listed|2|||
145996577|NCT05819398|526502872|FG003|Overall Study|Other than listed|0|||
145996578|NCT05819398|526502869|FG000|Overall Study|Lack of Efficacy|0|||
145996579|NCT05819398|526502870|FG001|Overall Study|Lack of Efficacy|1|||
145996580|NCT05819398|526502871|FG002|Overall Study|Lack of Efficacy|0|||
145996581|NCT05819398|526502872|FG003|Overall Study|Lack of Efficacy|0|||
145996582|NCT05819398|526502869|FG000|Overall Study|Study terminated by sponsor|20|||
145996583|NCT05819398|526502870|FG001|Overall Study|Study terminated by sponsor|18|||
145996584|NCT05819398|526502871|FG002|Overall Study|Study terminated by sponsor|20|||
145996585|NCT05819398|526502872|FG003|Overall Study|Study terminated by sponsor|22|||
145996586|NCT04522973|526502873|FG000|Overall Study|Lost to Follow-up|4|||
145996587|NCT04522973|526502873|FG000|Overall Study|Could not adhere to study schedule|1|||
145996588|NCT01649869|526502874|FG000|Overall Study|Family member illness|1|||
145996589|NCT01649869|526502875|FG001|Overall Study|Family member illness|0|||
145996590|NCT01649869|526502874|FG000|Overall Study|Required treatment outside protocol|1|||
145996591|NCT01649869|526502875|FG001|Overall Study|Required treatment outside protocol|0|||
145996592|NCT01649869|526502874|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
145996593|NCT01649869|526502875|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
145996594|NCT02776735|526502876|FG000|Overall Study|Adverse Event|0|||
145996595|NCT02776735|526502877|FG001|Overall Study|Adverse Event|0|||
145996596|NCT02776735|526502878|FG002|Overall Study|Adverse Event|0|||
145996597|NCT02776735|526502879|FG003|Overall Study|Adverse Event|1|||
145996598|NCT02776735|526502880|FG004|Overall Study|Adverse Event|0|||
145996599|NCT02776735|526502881|FG005|Overall Study|Adverse Event|1|||
145996600|NCT02776735|526502876|FG000|Overall Study|Lost to Follow-up|0|||
145996601|NCT02776735|526502877|FG001|Overall Study|Lost to Follow-up|0|||
145996602|NCT02776735|526502878|FG002|Overall Study|Lost to Follow-up|0|||
145996603|NCT02776735|526502879|FG003|Overall Study|Lost to Follow-up|1|||
146246754|NCT00813709|527417656|FG000|Double Blind Period|Adverse Event|4|||
145996604|NCT02776735|526502880|FG004|Overall Study|Lost to Follow-up|0|||
145996605|NCT02776735|526502881|FG005|Overall Study|Lost to Follow-up|0|||
145996606|NCT02776735|526502876|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145996607|NCT02776735|526502877|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145996608|NCT02776735|526502878|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145996609|NCT02776735|526502879|FG003|Overall Study|Withdrawal by parent/guardian|2|||
145996610|NCT02776735|526502880|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145996611|NCT02776735|526502881|FG005|Overall Study|Withdrawal by parent/guardian|0|||
146246755|NCT00813709|527417657|FG001|Double Blind Period|Adverse Event|1|||
145996612|NCT02776735|526502876|FG000|Overall Study|Withdrawal by Subject|1|||
145996613|NCT02776735|526502877|FG001|Overall Study|Withdrawal by Subject|0|||
145996614|NCT02776735|526502878|FG002|Overall Study|Withdrawal by Subject|0|||
145996615|NCT02776735|526502879|FG003|Overall Study|Withdrawal by Subject|0|||
145996616|NCT02776735|526502880|FG004|Overall Study|Withdrawal by Subject|0|||
145996617|NCT02776735|526502881|FG005|Overall Study|Withdrawal by Subject|1|||
145996618|NCT02776735|526502876|FG000|Overall Study|Other|0|||
145996619|NCT02776735|526502877|FG001|Overall Study|Other|0|||
145996620|NCT02776735|526502878|FG002|Overall Study|Other|3|||
145996621|NCT02776735|526502879|FG003|Overall Study|Other|0|||
145996622|NCT02776735|526502880|FG004|Overall Study|Other|0|||
145996623|NCT02776735|526502881|FG005|Overall Study|Other|0|||
145996624|NCT05847686|526504895|FG000|Overall Study|Withdrawal by Subject|3|||
145996625|NCT03716830|526504896|FG000|Overall Study|Withdrawal by Subject|2|||
145996626|NCT03716830|526504897|FG001|Overall Study|Withdrawal by Subject|2|||
145996627|NCT03716830|526504898|FG002|Overall Study|Withdrawal by Subject|6|||
145996628|NCT03716830|526504899|FG003|Overall Study|Withdrawal by Subject|5|||
145996629|NCT03716830|526504896|FG000|Overall Study|Adverse Event|1|||
145996630|NCT03716830|526504897|FG001|Overall Study|Adverse Event|2|||
145996631|NCT03716830|526504898|FG002|Overall Study|Adverse Event|0|||
145996632|NCT03716830|526504899|FG003|Overall Study|Adverse Event|1|||
145996633|NCT03716830|526504896|FG000|Overall Study|Lost to Follow-up|1|||
145996634|NCT03716830|526504897|FG001|Overall Study|Lost to Follow-up|1|||
145996635|NCT03716830|526504898|FG002|Overall Study|Lost to Follow-up|0|||
145996636|NCT03716830|526504899|FG003|Overall Study|Lost to Follow-up|0|||
145996637|NCT03309202|526504902|FG000|Overall Study|Lost to Follow-up|1|||
145996638|NCT03309202|526504903|FG001|Overall Study|Lost to Follow-up|0|||
146246756|NCT00813709|527417658|FG002|Double Blind Period|Adverse Event|4|||
146246757|NCT00813709|527417659|FG003|Double Blind Period|Adverse Event|0|||
146246758|NCT00813709|527417660|FG004|Double Blind Period|Adverse Event|0|||
146246759|NCT00813709|527417661|FG005|Double Blind Period|Adverse Event|0|||
146246760|NCT00813709|527417656|FG000|Double Blind Period|Lost to Follow-up|3|||
146246761|NCT00813709|527417657|FG001|Double Blind Period|Lost to Follow-up|2|||
146246762|NCT00813709|527417658|FG002|Double Blind Period|Lost to Follow-up|2|||
146246763|NCT00813709|527417659|FG003|Double Blind Period|Lost to Follow-up|0|||
146246764|NCT00813709|527417660|FG004|Double Blind Period|Lost to Follow-up|0|||
146246765|NCT00813709|527417661|FG005|Double Blind Period|Lost to Follow-up|0|||
146246766|NCT00813709|527417656|FG000|Double Blind Period|Switched to open label phase|9|||
146246767|NCT00813709|527417657|FG001|Double Blind Period|Switched to open label phase|26|||
146246768|NCT00813709|527417658|FG002|Double Blind Period|Switched to open label phase|18|||
146246769|NCT00813709|527417659|FG003|Double Blind Period|Switched to open label phase|0|||
146246770|NCT00813709|527417660|FG004|Double Blind Period|Switched to open label phase|0|||
146246771|NCT00813709|527417661|FG005|Double Blind Period|Switched to open label phase|0|||
146246772|NCT00813709|527417656|FG000|Double Blind Period|Randomized but not treated|1|||
146246773|NCT00813709|527417657|FG001|Double Blind Period|Randomized but not treated|3|||
146246774|NCT00813709|527417658|FG002|Double Blind Period|Randomized but not treated|1|||
146246775|NCT00813709|527417659|FG003|Double Blind Period|Randomized but not treated|0|||
146246776|NCT00813709|527417660|FG004|Double Blind Period|Randomized but not treated|0|||
146246777|NCT00813709|527417661|FG005|Double Blind Period|Randomized but not treated|0|||
145996639|NCT03309202|526504904|FG002|Overall Study|Lost to Follow-up|0|||
145996640|NCT03309202|526504905|FG003|Overall Study|Lost to Follow-up|0|||
145996641|NCT01209767|526504906|FG000|Overall Study|Withdrawal by Subject|1|||
145996642|NCT01209767|526504906|FG000|Overall Study|Lost to Follow-up|3|||
145996643|NCT01702298|526504907|FG000|Overall Study|Withdrawal by Subject|1|||
145996644|NCT03502200|526504918|FG000|Overall Study|Adverse Event|1|||
145996645|NCT03502200|526504919|FG001|Overall Study|Adverse Event|0|||
145996646|NCT03502200|526504918|FG000|Overall Study|Lost to Follow-up|36|||
145996647|NCT03502200|526504919|FG001|Overall Study|Lost to Follow-up|38|||
145996648|NCT03502200|526504918|FG000|Overall Study|Study Team Decision|1|||
145996649|NCT03502200|526504919|FG001|Overall Study|Study Team Decision|1|||
146091885|NCT01865084|526858444|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
146091886|NCT01865084|526858445|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
146246778|NCT00813709|527417656|FG000|Double Blind Period|Other|14|||
146246779|NCT00813709|527417657|FG001|Double Blind Period|Other|9|||
146246780|NCT00813709|527417658|FG002|Double Blind Period|Other|6|||
146246781|NCT00813709|527417659|FG003|Double Blind Period|Other|0|||
145996650|NCT03502200|526504918|FG000|Overall Study|Withdrawal by Subject|5|||
145996651|NCT03502200|526504919|FG001|Overall Study|Withdrawal by Subject|7|||
145996652|NCT03502200|526504918|FG000|Overall Study|Death|0|||
145996653|NCT03502200|526504919|FG001|Overall Study|Death|2|||
146246782|NCT00813709|527417660|FG004|Double Blind Period|Other|0|||
146246783|NCT00813709|527417661|FG005|Double Blind Period|Other|0|||
146298062|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
145996654|NCT04138056|526504925|FG000|Primary Study|Lost to Follow-up|3|||
145996655|NCT04138056|526504926|FG001|Primary Study|Lost to Follow-up|4|||
145996656|NCT04138056|526504927|FG002|Primary Study|Lost to Follow-up|1|||
145996657|NCT04138056|526504928|FG003|Primary Study|Lost to Follow-up|1|||
146246784|NCT00813709|527417656|FG000|Open Label Period|Adverse Event|0|||
145996658|NCT04138056|526504929|FG004|Primary Study|Lost to Follow-up|4|||
145996659|NCT04138056|526504925|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
145996660|NCT04138056|526504926|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
145996661|NCT04138056|526504927|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
145996662|NCT04138056|526504928|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
145996663|NCT04138056|526504929|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
145996664|NCT04138056|526504925|FG000|Extension Study|Lost to Follow-up|1|||
145996665|NCT04138056|526504926|FG001|Extension Study|Lost to Follow-up|2|||
145996666|NCT04138056|526504927|FG002|Extension Study|Lost to Follow-up|1|||
145996667|NCT04138056|526504928|FG003|Extension Study|Lost to Follow-up|0|||
145996668|NCT04138056|526504929|FG004|Extension Study|Lost to Follow-up|1|||
145996669|NCT01276106|526504936|FG000|Overall Study|Adverse Event|3|||
145996670|NCT01276106|526504937|FG001|Overall Study|Adverse Event|3|||
145996671|NCT01276106|526504938|FG002|Overall Study|Adverse Event|11|||
145996672|NCT01276106|526504939|FG003|Overall Study|Adverse Event|3|||
145996673|NCT01276106|526504936|FG000|Overall Study|Withdrawal by Subject|6|||
145996674|NCT01276106|526504937|FG001|Overall Study|Withdrawal by Subject|3|||
145996675|NCT01276106|526504938|FG002|Overall Study|Withdrawal by Subject|1|||
145996676|NCT01276106|526504939|FG003|Overall Study|Withdrawal by Subject|6|||
145996677|NCT01276106|526504936|FG000|Overall Study|Lack of Efficacy|0|||
145996678|NCT01276106|526504937|FG001|Overall Study|Lack of Efficacy|1|||
145996679|NCT01276106|526504938|FG002|Overall Study|Lack of Efficacy|0|||
145996680|NCT01276106|526504939|FG003|Overall Study|Lack of Efficacy|1|||
145996681|NCT01276106|526504936|FG000|Overall Study|Lost to Follow-up|2|||
145996682|NCT01276106|526504937|FG001|Overall Study|Lost to Follow-up|1|||
145996683|NCT01276106|526504938|FG002|Overall Study|Lost to Follow-up|1|||
145996684|NCT01276106|526504939|FG003|Overall Study|Lost to Follow-up|0|||
145996685|NCT01276106|526504936|FG000|Overall Study|Physician Decision|0|||
145996686|NCT01276106|526504937|FG001|Overall Study|Physician Decision|0|||
145996687|NCT01276106|526504938|FG002|Overall Study|Physician Decision|1|||
145996688|NCT01276106|526504939|FG003|Overall Study|Physician Decision|1|||
145996689|NCT01276106|526504936|FG000|Overall Study|Protocol Violation|1|||
145996690|NCT01276106|526504937|FG001|Overall Study|Protocol Violation|1|||
145996691|NCT01276106|526504938|FG002|Overall Study|Protocol Violation|0|||
145996692|NCT01276106|526504939|FG003|Overall Study|Protocol Violation|2|||
145996693|NCT01276106|526504936|FG000|Overall Study|Insufficient therapeutic effects|0|||
145996694|NCT01276106|526504937|FG001|Overall Study|Insufficient therapeutic effects|0|||
145996695|NCT01276106|526504938|FG002|Overall Study|Insufficient therapeutic effects|2|||
145996696|NCT01276106|526504939|FG003|Overall Study|Insufficient therapeutic effects|0|||
145996697|NCT01242514|526504942|FG000|Overall Study|e.g., project closure|1042|||
145996698|NCT01242514|526504943|FG001|Overall Study|e.g., project closure|305|||
145996699|NCT01242514|526504944|FG002|Overall Study|e.g., project closure|171|||
145996700|NCT01242514|526504942|FG000|Overall Study|Subject decision|33|||
145996701|NCT01242514|526504943|FG001|Overall Study|Subject decision|8|||
145996702|NCT01242514|526504944|FG002|Overall Study|Subject decision|2|||
145996703|NCT01242514|526504942|FG000|Overall Study|Severe non-compliance to protocol|5|||
145996704|NCT01242514|526504943|FG001|Overall Study|Severe non-compliance to protocol|2|||
145996705|NCT01242514|526504944|FG002|Overall Study|Severe non-compliance to protocol|1|||
145996706|NCT01242514|526504942|FG000|Overall Study|Lack of therapeutic response|99|||
145996707|NCT01242514|526504943|FG001|Overall Study|Lack of therapeutic response|16|||
145996708|NCT01242514|526504944|FG002|Overall Study|Lack of therapeutic response|10|||
145996709|NCT01242514|526504942|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
145996710|NCT01242514|526504943|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
145996711|NCT01242514|526504944|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
145996712|NCT01242514|526504942|FG000|Overall Study|Lost to Follow-up|14|||
145996713|NCT01242514|526504943|FG001|Overall Study|Lost to Follow-up|5|||
145996714|NCT01242514|526504944|FG002|Overall Study|Lost to Follow-up|4|||
145996715|NCT01242514|526504942|FG000|Overall Study|Adverse Event|129|||
145996716|NCT01242514|526504943|FG001|Overall Study|Adverse Event|18|||
145996717|NCT01242514|526504944|FG002|Overall Study|Adverse Event|19|||
145996718|NCT00862940|526504946|FG000|Overall Study|Adverse Event|15|||
145996719|NCT00862940|526504947|FG001|Overall Study|Adverse Event|12|||
145996720|NCT00862940|526504946|FG000|Overall Study|Lack of Efficacy|1|||
145996721|NCT00862940|526504947|FG001|Overall Study|Lack of Efficacy|3|||
145996722|NCT00862940|526504946|FG000|Overall Study|Protocol Violation|2|||
145996723|NCT00862940|526504947|FG001|Overall Study|Protocol Violation|5|||
145996724|NCT00862940|526504946|FG000|Overall Study|Withdrawal by Subject|4|||
145996725|NCT00862940|526504947|FG001|Overall Study|Withdrawal by Subject|6|||
145996726|NCT00862940|526504946|FG000|Overall Study|Non-compliance|4|||
146091887|NCT01865084|526858443|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
146091888|NCT01865084|526858444|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
145996727|NCT00862940|526504947|FG001|Overall Study|Non-compliance|0|||
145996728|NCT00862940|526504946|FG000|Overall Study|Lost to Follow-up|0|||
145996729|NCT00862940|526504947|FG001|Overall Study|Lost to Follow-up|1|||
145996730|NCT00862940|526504946|FG000|Overall Study|Administrative or other reason(s)|4|||
145996731|NCT00862940|526504947|FG001|Overall Study|Administrative or other reason(s)|3|||
145996732|NCT00879398|526504948|FG000|Overall Study|Visit Stop|399|||
145996733|NCT00879398|526504948|FG000|Overall Study|Lack of Efficacy|64|||
145996734|NCT00879398|526504948|FG000|Overall Study|Adverse Event|41|||
145996735|NCT00879398|526504948|FG000|Overall Study|Other Reasons|171|||
145996736|NCT01121757|526504950|FG000|First Drug|Death|1|||
145996737|NCT01121757|526504951|FG001|First Drug|Death|0|||
145996738|NCT01121757|526504950|FG000|First Drug|Disease Progression|0|||
145996739|NCT01121757|526504951|FG001|First Drug|Disease Progression|2|||
145996740|NCT01121757|526504950|FG000|Combination|Physician Decision|0|||
145996741|NCT01121757|526504951|FG001|Combination|Physician Decision|1|||
145996742|NCT01121757|526504950|FG000|Combination|Disease Progression|2|||
145996743|NCT01121757|526504951|FG001|Combination|Disease Progression|0|||
145996744|NCT01380080|526504970|FG000|Overall Study|Death|36|||
145996745|NCT01380080|526504971|FG001|Overall Study|Death|44|||
145996746|NCT01380080|526504970|FG000|Overall Study|Site is closing|28|||
145996747|NCT01380080|526504971|FG001|Overall Study|Site is closing|31|||
145996748|NCT01380080|526504970|FG000|Overall Study|Not able to get to clinic|7|||
145996749|NCT01380080|526504971|FG001|Overall Study|Not able to get to clinic|1|||
145996750|NCT01380080|526504970|FG000|Overall Study|Not willing to adhere to requirements|6|||
145996751|NCT01380080|526504971|FG001|Overall Study|Not willing to adhere to requirements|2|||
145996752|NCT01380080|526504970|FG000|Overall Study|Withdrawal by Subject|5|||
145996753|NCT01380080|526504971|FG001|Overall Study|Withdrawal by Subject|2|||
145996754|NCT01380080|526504970|FG000|Overall Study|Lost to Follow-up|3|||
145996755|NCT01380080|526504971|FG001|Overall Study|Lost to Follow-up|3|||
145996756|NCT05901636|526504972|FG000|Overall Study|Lost to Follow-up|0|||
145996757|NCT05901636|526504973|FG001|Overall Study|Lost to Follow-up|1|||
145996758|NCT05901636|526504974|FG002|Overall Study|Lost to Follow-up|0|||
145996759|NCT05901636|526504975|FG003|Overall Study|Lost to Follow-up|1|||
145996760|NCT05901636|526504976|FG004|Overall Study|Lost to Follow-up|1|||
145996761|NCT05901636|526504977|FG005|Overall Study|Lost to Follow-up|3|||
145996762|NCT05901636|526504978|FG006|Overall Study|Lost to Follow-up|1|||
145996763|NCT05901636|526504972|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
145996764|NCT05901636|526504973|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
145996765|NCT05901636|526504974|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
145996766|NCT05901636|526504975|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
145996767|NCT05901636|526504976|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
145996768|NCT05901636|526504977|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
145996769|NCT05901636|526504978|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
145996770|NCT05901636|526504972|FG000|Overall Study|Withdrawal by Subject|1|||
145996771|NCT05901636|526504973|FG001|Overall Study|Withdrawal by Subject|1|||
145996772|NCT05901636|526504974|FG002|Overall Study|Withdrawal by Subject|0|||
145996773|NCT05901636|526504975|FG003|Overall Study|Withdrawal by Subject|0|||
145996774|NCT05901636|526504976|FG004|Overall Study|Withdrawal by Subject|1|||
145996775|NCT05901636|526504977|FG005|Overall Study|Withdrawal by Subject|1|||
145996776|NCT05901636|526504978|FG006|Overall Study|Withdrawal by Subject|0|||
145996777|NCT05901636|526504972|FG000|Overall Study|Other|0|||
145996778|NCT05901636|526504973|FG001|Overall Study|Other|0|||
145996779|NCT05901636|526504974|FG002|Overall Study|Other|1|||
145996780|NCT05901636|526504975|FG003|Overall Study|Other|1|||
145996781|NCT05901636|526504976|FG004|Overall Study|Other|0|||
145996782|NCT05901636|526504977|FG005|Overall Study|Other|0|||
145996783|NCT05901636|526504978|FG006|Overall Study|Other|0|||
145996784|NCT02303821|526504979|FG000|Overall Study|Withdrawal by Subject|0|||
145996785|NCT02303821|526504980|FG001|Overall Study|Withdrawal by Subject|0|||
145996786|NCT02303821|526504981|FG002|Overall Study|Withdrawal by Subject|0|||
145996787|NCT02303821|526504982|FG003|Overall Study|Withdrawal by Subject|0|||
145996788|NCT02303821|526504983|FG004|Overall Study|Withdrawal by Subject|0|||
145996789|NCT02303821|526504984|FG005|Overall Study|Withdrawal by Subject|0|||
145996790|NCT02303821|526504985|FG006|Overall Study|Withdrawal by Subject|0|||
145996791|NCT02303821|526504986|FG007|Overall Study|Withdrawal by Subject|2|||
145996792|NCT02303821|526504979|FG000|Overall Study|Death|0|||
146298063|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
145996793|NCT02303821|526504980|FG001|Overall Study|Death|2|||
145996794|NCT02303821|526504981|FG002|Overall Study|Death|0|||
145996795|NCT02303821|526504982|FG003|Overall Study|Death|0|||
145996796|NCT02303821|526504983|FG004|Overall Study|Death|0|||
145996797|NCT02303821|526504984|FG005|Overall Study|Death|3|||
145996798|NCT02303821|526504985|FG006|Overall Study|Death|41|||
145996799|NCT02303821|526504986|FG007|Overall Study|Death|29|||
145996800|NCT02303821|526504979|FG000|Overall Study|Lost to Follow-up|0|||
145996801|NCT02303821|526504980|FG001|Overall Study|Lost to Follow-up|0|||
145996802|NCT02303821|526504981|FG002|Overall Study|Lost to Follow-up|0|||
145996803|NCT02303821|526504982|FG003|Overall Study|Lost to Follow-up|0|||
145996804|NCT02303821|526504983|FG004|Overall Study|Lost to Follow-up|0|||
145996805|NCT02303821|526504984|FG005|Overall Study|Lost to Follow-up|0|||
145996806|NCT02303821|526504985|FG006|Overall Study|Lost to Follow-up|1|||
145996807|NCT02303821|526504986|FG007|Overall Study|Lost to Follow-up|0|||
145996808|NCT02303821|526504979|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996809|NCT02303821|526504980|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996810|NCT02303821|526504981|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996811|NCT02303821|526504982|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996812|NCT02303821|526504983|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996813|NCT02303821|526504984|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996814|NCT02303821|526504985|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
145996815|NCT02303821|526504986|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145996816|NCT02303821|526504979|FG000|Overall Study|Decision by sponsor|0|||
145996817|NCT02303821|526504980|FG001|Overall Study|Decision by sponsor|0|||
145996818|NCT02303821|526504981|FG002|Overall Study|Decision by sponsor|0|||
145996819|NCT02303821|526504982|FG003|Overall Study|Decision by sponsor|0|||
145996820|NCT02303821|526504983|FG004|Overall Study|Decision by sponsor|0|||
145996821|NCT02303821|526504984|FG005|Overall Study|Decision by sponsor|1|||
145996822|NCT02303821|526504985|FG006|Overall Study|Decision by sponsor|0|||
145996823|NCT02303821|526504986|FG007|Overall Study|Decision by sponsor|0|||
145996824|NCT02303821|526504979|FG000|Overall Study|Protocol-specified criteria|0|||
145996825|NCT02303821|526504980|FG001|Overall Study|Protocol-specified criteria|1|||
145996826|NCT02303821|526504981|FG002|Overall Study|Protocol-specified criteria|0|||
145996827|NCT02303821|526504982|FG003|Overall Study|Protocol-specified criteria|0|||
145996828|NCT02303821|526504983|FG004|Overall Study|Protocol-specified criteria|0|||
145996829|NCT02303821|526504984|FG005|Overall Study|Protocol-specified criteria|1|||
145996830|NCT02303821|526504985|FG006|Overall Study|Protocol-specified criteria|0|||
145996831|NCT02303821|526504986|FG007|Overall Study|Protocol-specified criteria|0|||
145996832|NCT04583618|526504992|FG000|Overall Study|Adverse Event|0|||
145996833|NCT04583618|526504993|FG001|Overall Study|Adverse Event|0|||
145996834|NCT04583618|526504994|FG002|Overall Study|Adverse Event|1|||
145996835|NCT04583618|526504995|FG003|Overall Study|Adverse Event|0|||
145996836|NCT04583618|526504996|FG004|Overall Study|Adverse Event|0|||
145996837|NCT04583618|526504992|FG000|Overall Study|Protocol deviation|1|||
145996838|NCT04583618|526504993|FG001|Overall Study|Protocol deviation|1|||
145996839|NCT04583618|526504994|FG002|Overall Study|Protocol deviation|1|||
145996840|NCT04583618|526504995|FG003|Overall Study|Protocol deviation|0|||
145996841|NCT04583618|526504996|FG004|Overall Study|Protocol deviation|0|||
145996842|NCT04583618|526504992|FG000|Overall Study|Withdrawal by Subject|2|||
145996843|NCT04583618|526504993|FG001|Overall Study|Withdrawal by Subject|1|||
145996844|NCT04583618|526504994|FG002|Overall Study|Withdrawal by Subject|3|||
145996845|NCT04583618|526504995|FG003|Overall Study|Withdrawal by Subject|1|||
145996846|NCT04583618|526504996|FG004|Overall Study|Withdrawal by Subject|1|||
145996847|NCT04583618|526504992|FG000|Overall Study|Lost to Follow-up|0|||
145996848|NCT04583618|526504993|FG001|Overall Study|Lost to Follow-up|1|||
145996849|NCT04583618|526504994|FG002|Overall Study|Lost to Follow-up|3|||
145996850|NCT04583618|526504995|FG003|Overall Study|Lost to Follow-up|1|||
145996851|NCT04583618|526504996|FG004|Overall Study|Lost to Follow-up|1|||
145996852|NCT02302222|526505007|FG000|Overall Study|Physician Decision|0|||
145996853|NCT02302222|526505008|FG001|Overall Study|Physician Decision|4|||
145996854|NCT02302222|526505007|FG000|Overall Study|Lost to Follow-up|1|||
145996855|NCT02302222|526505008|FG001|Overall Study|Lost to Follow-up|0|||
145996856|NCT02302222|526505007|FG000|Overall Study|Treatment discontinued before day 5|0|||
145996857|NCT02302222|526505008|FG001|Overall Study|Treatment discontinued before day 5|1|||
145996858|NCT02302222|526505007|FG000|Overall Study|Withdrawn prior to any treatment|0|||
145996859|NCT02302222|526505008|FG001|Overall Study|Withdrawn prior to any treatment|1|||
145996860|NCT03193801|526505009|FG000|Overall Study|Physician Decision|2|||
145996861|NCT03193801|526505009|FG000|Overall Study|Withdrawal by Subject|1|||
145996862|NCT03909971|526505010|FG000|Overall Study|Participant transition to rollover study|26|||
145996863|NCT03909971|526505011|FG001|Overall Study|Participant transition to rollover study|9|||
145996864|NCT03909971|526505010|FG000|Overall Study|Global Deterioration of Health Status|2|||
145996865|NCT03909971|526505011|FG001|Overall Study|Global Deterioration of Health Status|2|||
145996866|NCT03909971|526505010|FG000|Overall Study|Progressive Disease|28|||
145996867|NCT03909971|526505011|FG001|Overall Study|Progressive Disease|21|||
145996868|NCT03909971|526505010|FG000|Overall Study|Death|6|||
145996869|NCT03909971|526505011|FG001|Overall Study|Death|6|||
145996870|NCT03909971|526505010|FG000|Overall Study|Adverse Event|1|||
145996871|NCT03909971|526505011|FG001|Overall Study|Adverse Event|2|||
145996872|NCT03909971|526505010|FG000|Overall Study|Withdrawal by Subject|2|||
145996873|NCT03909971|526505011|FG001|Overall Study|Withdrawal by Subject|1|||
145996874|NCT03909971|526505010|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
145996875|NCT03909971|526505011|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
145996876|NCT03909971|526505010|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
145996877|NCT03909971|526505011|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
145996878|NCT05177354|526505012|FG000|Implant to 30-day Visit|Physician Decision|1|||
145996879|NCT05177354|526505012|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
145996880|NCT05177354|526505012|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
145996881|NCT05177354|526505012|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
145996882|NCT03734536|526505013|FG000|Overall Study|Withdrew Consent|1|||
145996883|NCT03734536|526505014|FG001|Overall Study|Withdrew Consent|5|||
145996884|NCT03734536|526505013|FG000|Overall Study|Lost to Follow-up|10|||
145996885|NCT03734536|526505014|FG001|Overall Study|Lost to Follow-up|7|||
145996886|NCT06028464|526505018|FG000|Washout|Positive drug test.|1|||
145996887|NCT03189719|526505019|FG000|Overall Study|Death|325|||
145996888|NCT03189719|526505020|FG001|Overall Study|Death|361|||
145996889|NCT03189719|526505019|FG000|Overall Study|Physician Decision|1|||
145996890|NCT03189719|526505020|FG001|Overall Study|Physician Decision|0|||
145996891|NCT03189719|526505019|FG000|Overall Study|Sponsor Decision|40|||
145996892|NCT03189719|526505020|FG001|Overall Study|Sponsor Decision|12|||
145996893|NCT03189719|526505019|FG000|Overall Study|Withdrawal by Subject|7|||
145996894|NCT03189719|526505020|FG001|Overall Study|Withdrawal by Subject|3|||
145996895|NCT02769481|526505021|FG000|Overall Study|Protocol Violation|1|||
145996896|NCT02769481|526505022|FG001|Overall Study|Protocol Violation|0|||
145996897|NCT02769481|526505021|FG000|Overall Study|Adverse Event|3|||
145996898|NCT02769481|526505022|FG001|Overall Study|Adverse Event|6|||
145996899|NCT02769481|526505021|FG000|Overall Study|Entry Criteria Not Met|1|||
145996900|NCT02769481|526505022|FG001|Overall Study|Entry Criteria Not Met|2|||
145996901|NCT02769481|526505021|FG000|Overall Study|Withdrawal by Subject|14|||
145996902|NCT02769481|526505022|FG001|Overall Study|Withdrawal by Subject|16|||
145996903|NCT02769481|526505021|FG000|Overall Study|Lost to Follow-up|9|||
145996904|NCT02769481|526505022|FG001|Overall Study|Lost to Follow-up|9|||
145996905|NCT02769481|526505021|FG000|Overall Study|Physician Decision|0|||
145996906|NCT02769481|526505022|FG001|Overall Study|Physician Decision|1|||
145996907|NCT02769481|526505021|FG000|Overall Study|Terminated by Sponsor|1|||
145996908|NCT02769481|526505022|FG001|Overall Study|Terminated by Sponsor|0|||
145996909|NCT02769481|526505021|FG000|Overall Study|Death|0|||
145996910|NCT02769481|526505022|FG001|Overall Study|Death|1|||
145996911|NCT02769481|526505021|FG000|Overall Study|Undefined|4|||
145996912|NCT02769481|526505022|FG001|Overall Study|Undefined|1|||
145996913|NCT06272383|526505023|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
145996914|NCT06272383|526505024|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
145996915|NCT04398706|526505025|FG000|Overall Study|Adverse Event|0|||
145996916|NCT04398706|526505026|FG001|Overall Study|Adverse Event|0|||
145996917|NCT04398706|526505027|FG002|Overall Study|Adverse Event|0|||
145996918|NCT04398706|526505028|FG003|Overall Study|Adverse Event|0|||
145996919|NCT04398706|526505029|FG004|Overall Study|Adverse Event|0|||
145996920|NCT04398706|526505030|FG005|Overall Study|Adverse Event|1|||
145996921|NCT04398706|526505031|FG006|Overall Study|Adverse Event|1|||
145996922|NCT04398706|526505032|FG007|Overall Study|Adverse Event|0|||
145996923|NCT04398706|526505025|FG000|Overall Study|Lost to Follow-up|0|||
145996924|NCT04398706|526505026|FG001|Overall Study|Lost to Follow-up|1|||
145996925|NCT04398706|526505027|FG002|Overall Study|Lost to Follow-up|2|||
145996926|NCT04398706|526505028|FG003|Overall Study|Lost to Follow-up|1|||
145996927|NCT04398706|526505029|FG004|Overall Study|Lost to Follow-up|6|||
145996928|NCT04398706|526505030|FG005|Overall Study|Lost to Follow-up|3|||
145996929|NCT04398706|526505031|FG006|Overall Study|Lost to Follow-up|8|||
145996930|NCT04398706|526505032|FG007|Overall Study|Lost to Follow-up|2|||
145996931|NCT04398706|526505025|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145996932|NCT04398706|526505026|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145996933|NCT04398706|526505027|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145996934|NCT04398706|526505028|FG003|Overall Study|Withdrawal by parent/guardian|2|||
145996935|NCT04398706|526505029|FG004|Overall Study|Withdrawal by parent/guardian|19|||
145996936|NCT04398706|526505030|FG005|Overall Study|Withdrawal by parent/guardian|23|||
145996937|NCT04398706|526505031|FG006|Overall Study|Withdrawal by parent/guardian|13|||
145996938|NCT04398706|526505032|FG007|Overall Study|Withdrawal by parent/guardian|11|||
145996939|NCT04398706|526505025|FG000|Overall Study|Protocol deviation|0|||
145996940|NCT04398706|526505026|FG001|Overall Study|Protocol deviation|1|||
145996941|NCT04398706|526505027|FG002|Overall Study|Protocol deviation|0|||
145996942|NCT04398706|526505028|FG003|Overall Study|Protocol deviation|0|||
145996943|NCT04398706|526505029|FG004|Overall Study|Protocol deviation|6|||
145996944|NCT04398706|526505030|FG005|Overall Study|Protocol deviation|4|||
145996945|NCT04398706|526505031|FG006|Overall Study|Protocol deviation|6|||
145996946|NCT04398706|526505032|FG007|Overall Study|Protocol deviation|3|||
145996947|NCT05489328|526506583|FG000|Overall Study|Lost to Follow-up|0|||
145996948|NCT05489328|526506584|FG001|Overall Study|Lost to Follow-up|0|||
145996949|NCT05489328|526506585|FG002|Overall Study|Lost to Follow-up|1|||
145996950|NCT05489328|526506586|FG003|Overall Study|Lost to Follow-up|0|||
145996951|NCT05489328|526506587|FG004|Overall Study|Lost to Follow-up|2|||
145996952|NCT05489328|526506588|FG005|Overall Study|Lost to Follow-up|0|||
145996953|NCT05489328|526506589|FG006|Overall Study|Lost to Follow-up|0|||
145996954|NCT05489328|526506590|FG007|Overall Study|Lost to Follow-up|1|||
145996955|NCT05489328|526506591|FG008|Overall Study|Lost to Follow-up|0|||
145996956|NCT05489328|526506583|FG000|Overall Study|Withdrawal by Subject|0|||
145996957|NCT05489328|526506584|FG001|Overall Study|Withdrawal by Subject|0|||
145996958|NCT05489328|526506585|FG002|Overall Study|Withdrawal by Subject|0|||
145996959|NCT05489328|526506586|FG003|Overall Study|Withdrawal by Subject|0|||
145996960|NCT05489328|526506587|FG004|Overall Study|Withdrawal by Subject|0|||
145996961|NCT05489328|526506588|FG005|Overall Study|Withdrawal by Subject|0|||
145996962|NCT05489328|526506589|FG006|Overall Study|Withdrawal by Subject|1|||
145996963|NCT05489328|526506590|FG007|Overall Study|Withdrawal by Subject|1|||
145996964|NCT05489328|526506591|FG008|Overall Study|Withdrawal by Subject|0|||
145996965|NCT05489328|526506583|FG000|Overall Study|Other|0|||
145996966|NCT05489328|526506584|FG001|Overall Study|Other|0|||
145996967|NCT05489328|526506585|FG002|Overall Study|Other|0|||
145996968|NCT05489328|526506586|FG003|Overall Study|Other|0|||
145996969|NCT05489328|526506587|FG004|Overall Study|Other|0|||
145996970|NCT05489328|526506588|FG005|Overall Study|Other|0|||
145996971|NCT05489328|526506589|FG006|Overall Study|Other|0|||
145996972|NCT05489328|526506590|FG007|Overall Study|Other|1|||
145996973|NCT05489328|526506591|FG008|Overall Study|Other|1|||
145996974|NCT01083602|526506592|FG000|Overall Study|Adverse Event|11|||
145996975|NCT01083602|526506592|FG000|Overall Study|New Cancer Therapy|2|||
145996976|NCT01083602|526506592|FG000|Overall Study|Death|1|||
145996977|NCT01083602|526506592|FG000|Overall Study|Withdrawal by Subject|5|||
145996978|NCT01083602|526506592|FG000|Overall Study|Lack of Efficacy|36|||
145996979|NCT01657370|526506593|FG000|Overall Study|Withdrawal by Subject|0|||
145996980|NCT01657370|526506594|FG001|Overall Study|Withdrawal by Subject|0|||
145996981|NCT01657370|526506595|FG002|Overall Study|Withdrawal by Subject|1|||
145996982|NCT01657370|526506596|FG003|Overall Study|Withdrawal by Subject|0|||
145996983|NCT01657370|526506597|FG004|Overall Study|Withdrawal by Subject|0|||
145996984|NCT01657370|526506598|FG005|Overall Study|Withdrawal by Subject|1|||
145996985|NCT01657370|526506593|FG000|Overall Study|Physician Decision|2|||
145996986|NCT01657370|526506594|FG001|Overall Study|Physician Decision|3|||
145996987|NCT01657370|526506595|FG002|Overall Study|Physician Decision|1|||
145996988|NCT01657370|526506596|FG003|Overall Study|Physician Decision|2|||
145996989|NCT01657370|526506597|FG004|Overall Study|Physician Decision|5|||
145996990|NCT01657370|526506598|FG005|Overall Study|Physician Decision|0|||
145996991|NCT01657370|526506593|FG000|Overall Study|Lack of Qualifying Event|1|||
145996992|NCT01657370|526506594|FG001|Overall Study|Lack of Qualifying Event|0|||
145996993|NCT01657370|526506595|FG002|Overall Study|Lack of Qualifying Event|3|||
145996994|NCT01657370|526506596|FG003|Overall Study|Lack of Qualifying Event|2|||
145996995|NCT01657370|526506597|FG004|Overall Study|Lack of Qualifying Event|1|||
145996996|NCT01657370|526506598|FG005|Overall Study|Lack of Qualifying Event|2|||
145996997|NCT01657370|526506593|FG000|Overall Study|Adverse Event|0|||
145996998|NCT01657370|526506594|FG001|Overall Study|Adverse Event|0|||
145996999|NCT01657370|526506595|FG002|Overall Study|Adverse Event|0|||
145997000|NCT01657370|526506596|FG003|Overall Study|Adverse Event|0|||
145997001|NCT01657370|526506597|FG004|Overall Study|Adverse Event|1|||
145997002|NCT01657370|526506598|FG005|Overall Study|Adverse Event|0|||
145997003|NCT01657370|526506593|FG000|Overall Study|Protocol Violation|1|||
145997004|NCT01657370|526506594|FG001|Overall Study|Protocol Violation|1|||
145997005|NCT01657370|526506595|FG002|Overall Study|Protocol Violation|1|||
145997006|NCT01657370|526506596|FG003|Overall Study|Protocol Violation|1|||
145997007|NCT01657370|526506597|FG004|Overall Study|Protocol Violation|0|||
145997008|NCT01657370|526506598|FG005|Overall Study|Protocol Violation|0|||
145997009|NCT01657370|526506593|FG000|Overall Study|Lost to Follow-up|2|||
145997010|NCT01657370|526506594|FG001|Overall Study|Lost to Follow-up|0|||
145997011|NCT01657370|526506595|FG002|Overall Study|Lost to Follow-up|1|||
145997012|NCT01657370|526506596|FG003|Overall Study|Lost to Follow-up|0|||
145997013|NCT01657370|526506597|FG004|Overall Study|Lost to Follow-up|0|||
145997014|NCT01657370|526506598|FG005|Overall Study|Lost to Follow-up|1|||
145997015|NCT03021486|526506599|FG000|Overall Study|Withdrawal by Subject|1|||
145997016|NCT03021486|526506600|FG001|Overall Study|Withdrawal by Subject|1|||
145997017|NCT03021486|526506601|FG002|Overall Study|Withdrawal by Subject|3|||
145997018|NCT03021486|526506599|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
145997019|NCT03021486|526506600|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
145997020|NCT03021486|526506601|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
145997021|NCT04043286|526506602|FG000|Overall Study|Withdrawal by Subject|2|||
145997022|NCT04043286|526506603|FG001|Overall Study|Withdrawal by Subject|2|||
145997023|NCT03698279|526506604|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145997024|NCT03698279|526506605|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145997025|NCT03698279|526506606|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145997026|NCT03698279|526506607|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145997027|NCT03698279|526506608|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145997028|NCT03698279|526506609|FG005|Overall Study|Withdrawal by parent/guardian|0|||
145997029|NCT03698279|526506604|FG000|Overall Study|Protocol deviation|1|||
145997030|NCT03698279|526506605|FG001|Overall Study|Protocol deviation|0|||
145997031|NCT03698279|526506606|FG002|Overall Study|Protocol deviation|1|||
145997032|NCT03698279|526506607|FG003|Overall Study|Protocol deviation|0|||
145997033|NCT03698279|526506608|FG004|Overall Study|Protocol deviation|0|||
145997034|NCT03698279|526506609|FG005|Overall Study|Protocol deviation|0|||
145997035|NCT03698279|526506604|FG000|Overall Study|Withdrawal by Subject|0|||
145997036|NCT03698279|526506605|FG001|Overall Study|Withdrawal by Subject|0|||
145997037|NCT03698279|526506606|FG002|Overall Study|Withdrawal by Subject|1|||
145997038|NCT03698279|526506607|FG003|Overall Study|Withdrawal by Subject|0|||
145997039|NCT03698279|526506608|FG004|Overall Study|Withdrawal by Subject|0|||
145997040|NCT03698279|526506609|FG005|Overall Study|Withdrawal by Subject|0|||
145997041|NCT03698279|526506604|FG000|Overall Study|Lost to Follow-up|3|||
145997042|NCT03698279|526506605|FG001|Overall Study|Lost to Follow-up|1|||
145997043|NCT03698279|526506606|FG002|Overall Study|Lost to Follow-up|4|||
145997044|NCT03698279|526506607|FG003|Overall Study|Lost to Follow-up|5|||
145997045|NCT03698279|526506608|FG004|Overall Study|Lost to Follow-up|0|||
145997046|NCT03698279|526506609|FG005|Overall Study|Lost to Follow-up|0|||
145997047|NCT00415636|526506610|FG000|Overall Study|Symptomatic deterioration|1|||
145997048|NCT00415636|526506611|FG001|Overall Study|Symptomatic deterioration|0|||
145997049|NCT00415636|526506612|FG002|Overall Study|Symptomatic deterioration|1|||
145997050|NCT00415636|526506613|FG003|Overall Study|Symptomatic deterioration|2|||
145997051|NCT00415636|526506614|FG004|Overall Study|Symptomatic deterioration|0|||
145997052|NCT00415636|526506615|FG005|Overall Study|Symptomatic deterioration|1|||
145997053|NCT00415636|526506610|FG000|Overall Study|Adverse Event|0|||
145997054|NCT00415636|526506611|FG001|Overall Study|Adverse Event|0|||
145997055|NCT00415636|526506612|FG002|Overall Study|Adverse Event|0|||
145997056|NCT00415636|526506613|FG003|Overall Study|Adverse Event|1|||
145997057|NCT00415636|526506614|FG004|Overall Study|Adverse Event|1|||
145997058|NCT00415636|526506615|FG005|Overall Study|Adverse Event|0|||
145997059|NCT00415636|526506610|FG000|Overall Study|Withdrawal by Subject|0|||
145997060|NCT00415636|526506611|FG001|Overall Study|Withdrawal by Subject|0|||
145997061|NCT00415636|526506612|FG002|Overall Study|Withdrawal by Subject|0|||
145997062|NCT00415636|526506613|FG003|Overall Study|Withdrawal by Subject|0|||
145997063|NCT00415636|526506614|FG004|Overall Study|Withdrawal by Subject|1|||
145997064|NCT00415636|526506615|FG005|Overall Study|Withdrawal by Subject|0|||
145997065|NCT00415636|526506610|FG000|Overall Study|Disease progression|0|||
145997066|NCT00415636|526506611|FG001|Overall Study|Disease progression|0|||
145997067|NCT00415636|526506612|FG002|Overall Study|Disease progression|0|||
145997068|NCT00415636|526506613|FG003|Overall Study|Disease progression|3|||
145997069|NCT00415636|526506614|FG004|Overall Study|Disease progression|0|||
145997070|NCT00415636|526506615|FG005|Overall Study|Disease progression|1|||
145997071|NCT01263119|526506616|FG000|Period 1|Protocol Violation|2|||
145997072|NCT01263119|526506616|FG000|Period 2|Adverse Event|2|||
145997073|NCT02138825|526506617|FG000|Main Study Treatment|Adverse Event|11|||
145997074|NCT02138825|526506618|FG001|Main Study Treatment|Adverse Event|3|||
145997075|NCT02138825|526506617|FG000|Main Study Treatment|Death|1|||
145997076|NCT02138825|526506618|FG001|Main Study Treatment|Death|2|||
145997077|NCT02138825|526506617|FG000|Main Study Treatment|Protocol Violation|2|||
145997078|NCT02138825|526506618|FG001|Main Study Treatment|Protocol Violation|2|||
145997079|NCT02138825|526506617|FG000|Main Study Treatment|Sponsor decision|12|||
145997080|NCT02138825|526506618|FG001|Main Study Treatment|Sponsor decision|18|||
145997081|NCT02138825|526506617|FG000|Main Study Treatment|Study terminated by sponsor|10|||
145997082|NCT02138825|526506618|FG001|Main Study Treatment|Study terminated by sponsor|9|||
145997083|NCT02138825|526506617|FG000|Main Study Treatment|Withdrawal by Subject|3|||
145997084|NCT02138825|526506618|FG001|Main Study Treatment|Withdrawal by Subject|1|||
145997085|NCT02138825|526506617|FG000|Main Study Treatment|Medical decision|1|||
145997086|NCT02138825|526506618|FG001|Main Study Treatment|Medical decision|0|||
145997087|NCT02138825|526506617|FG000|Long-term Extension|Study termination by sponsor|32|||
145997088|NCT02138825|526506618|FG001|Long-term Extension|Study termination by sponsor|38|||
145997089|NCT02138825|526506617|FG000|Safety Follow-up|Adverse Event|4|||
145997090|NCT02138825|526506618|FG001|Safety Follow-up|Adverse Event|3|||
145997091|NCT02138825|526506617|FG000|Safety Follow-up|Death|11|||
145997092|NCT02138825|526506618|FG001|Safety Follow-up|Death|5|||
145997093|NCT02138825|526506617|FG000|Safety Follow-up|Withdrawal by Subject|5|||
145997094|NCT02138825|526506618|FG001|Safety Follow-up|Withdrawal by Subject|3|||
145997095|NCT02138825|526506617|FG000|Safety Follow-up|clinic worsening|1|||
145997096|NCT02138825|526506618|FG001|Safety Follow-up|clinic worsening|0|||
145997097|NCT02138825|526506617|FG000|Safety Follow-up|withdrawal by PI|1|||
145997098|NCT02138825|526506618|FG001|Safety Follow-up|withdrawal by PI|0|||
145997099|NCT02138825|526506617|FG000|Safety Follow-up|logistical difficulties|0|||
145997100|NCT02138825|526506618|FG001|Safety Follow-up|logistical difficulties|1|||
145997101|NCT02138825|526506617|FG000|Safety Follow-up|progressive disease|0|||
145997102|NCT02138825|526506618|FG001|Safety Follow-up|progressive disease|2|||
145997103|NCT02138825|526506617|FG000|Safety Follow-up|too unwell to attend the visit|0|||
145997104|NCT02138825|526506618|FG001|Safety Follow-up|too unwell to attend the visit|1|||
145997105|NCT02138825|526506617|FG000|Safety Follow-up|treatment unblinded|0|||
145997106|NCT02138825|526506618|FG001|Safety Follow-up|treatment unblinded|1|||
145997107|NCT02138825|526506617|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
145997108|NCT02138825|526506618|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
145997109|NCT05201807|526506621|FG000|Overall Study|Adverse Event|1|||
145997110|NCT05201807|526506621|FG000|Overall Study|COVID-19 Related|1|||
145997111|NCT02367456|526506627|FG000|Overall Study|Death|8|||
145997112|NCT02367456|526506628|FG001|Overall Study|Death|24|||
145997113|NCT02367456|526506629|FG002|Overall Study|Death|17|||
145997114|NCT02367456|526506627|FG000|Overall Study|Lost to Follow-up|1|||
145997115|NCT02367456|526506628|FG001|Overall Study|Lost to Follow-up|3|||
145997116|NCT02367456|526506629|FG002|Overall Study|Lost to Follow-up|1|||
145997117|NCT02367456|526506627|FG000|Overall Study|Other reason|3|||
145997118|NCT02367456|526506628|FG001|Overall Study|Other reason|3|||
145997119|NCT02367456|526506629|FG002|Overall Study|Other reason|9|||
145997120|NCT02367456|526506627|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
145997121|NCT02367456|526506628|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
145997122|NCT02367456|526506629|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
145997123|NCT02862574|526506630|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145997124|NCT02862574|526506631|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145997125|NCT02862574|526506632|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145997126|NCT02862574|526506630|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
145997127|NCT02862574|526506631|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
145997128|NCT02862574|526506632|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
145997129|NCT02862574|526506630|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
145997130|NCT02862574|526506631|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
145997131|NCT02862574|526506632|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
145997132|NCT04573972|526506633|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
145997133|NCT04573972|526506634|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
145997134|NCT00976456|526506635|FG000|Overall Study|Adverse Event|17|||
145997135|NCT00976456|526506636|FG001|Overall Study|Adverse Event|22|||
145997136|NCT00976456|526506635|FG000|Overall Study|Death|7|||
145997137|NCT00976456|526506636|FG001|Overall Study|Death|9|||
145997138|NCT00976456|526506635|FG000|Overall Study|Lack of Efficacy|5|||
145997139|NCT00976456|526506636|FG001|Overall Study|Lack of Efficacy|2|||
145997140|NCT00976456|526506635|FG000|Overall Study|Withdrawal by Subject|3|||
145997141|NCT00976456|526506636|FG001|Overall Study|Withdrawal by Subject|1|||
145997142|NCT00976456|526506635|FG000|Overall Study|screening failure, unknown|11|||
145997143|NCT00976456|526506636|FG001|Overall Study|screening failure, unknown|4|||
145997144|NCT02090764|526506637|FG000|Overall Study|Adverse Event|1|||
145997145|NCT02090764|526506638|FG001|Overall Study|Adverse Event|3|||
145997146|NCT02090764|526506637|FG000|Overall Study|Lack of Efficacy|0|||
145997147|NCT02090764|526506638|FG001|Overall Study|Lack of Efficacy|13|||
145997148|NCT02090764|526506637|FG000|Overall Study|Withdrawal by Subject|2|||
145997149|NCT02090764|526506638|FG001|Overall Study|Withdrawal by Subject|1|||
145997150|NCT02090764|526506637|FG000|Overall Study|Intercurrent illness and other|1|||
145997151|NCT02090764|526506638|FG001|Overall Study|Intercurrent illness and other|1|||
145997152|NCT02090764|526506637|FG000|Overall Study|Lost to Follow-up|2|||
145997153|NCT02090764|526506638|FG001|Overall Study|Lost to Follow-up|2|||
145997154|NCT02037529|526506639|FG000|Overall Study|Withdrawal by Subject|1|||
145997155|NCT02037529|526506640|FG001|Overall Study|Withdrawal by Subject|3|||
145997156|NCT02037529|526506639|FG000|Overall Study|Adverse Event|0|||
145997157|NCT02037529|526506640|FG001|Overall Study|Adverse Event|1|||
145997158|NCT02131766|526506641|FG000|Overall Study|Withdrawal by Subject|4|||
145997159|NCT00718315|526506643|FG000|Overall Study|Adverse Event|1|||
145997160|NCT00718315|526506644|FG001|Overall Study|Adverse Event|2|||
145997161|NCT00718315|526506645|FG002|Overall Study|Adverse Event|3|||
145997162|NCT00718315|526506643|FG000|Overall Study|Death|6|||
145997163|NCT00718315|526506644|FG001|Overall Study|Death|6|||
145997164|NCT00718315|526506645|FG002|Overall Study|Death|5|||
145997165|NCT00718315|526506643|FG000|Overall Study|Lost to Follow-up|2|||
145997166|NCT00718315|526506644|FG001|Overall Study|Lost to Follow-up|3|||
145997167|NCT00718315|526506645|FG002|Overall Study|Lost to Follow-up|4|||
145997168|NCT00718315|526506643|FG000|Overall Study|Protocol Violation|5|||
145997169|NCT00718315|526506644|FG001|Overall Study|Protocol Violation|5|||
145997170|NCT00718315|526506645|FG002|Overall Study|Protocol Violation|3|||
145997171|NCT00718315|526506643|FG000|Overall Study|Erlotinib dose decreased|4|||
145997172|NCT00718315|526506644|FG001|Overall Study|Erlotinib dose decreased|3|||
145997173|NCT00718315|526506645|FG002|Overall Study|Erlotinib dose decreased|1|||
145997174|NCT00718315|526506643|FG000|Overall Study|Use of Minocyclin|1|||
145997175|NCT00718315|526506644|FG001|Overall Study|Use of Minocyclin|1|||
145997176|NCT00718315|526506645|FG002|Overall Study|Use of Minocyclin|1|||
145997177|NCT00718315|526506643|FG000|Overall Study|Disease progression|0|||
145997178|NCT00718315|526506644|FG001|Overall Study|Disease progression|1|||
145997179|NCT00718315|526506645|FG002|Overall Study|Disease progression|1|||
145997180|NCT00718315|526506643|FG000|Overall Study|Other|0|||
145997181|NCT00718315|526506644|FG001|Overall Study|Other|0|||
145997182|NCT00718315|526506645|FG002|Overall Study|Other|1|||
145997183|NCT00718315|526506643|FG000|Overall Study|Use of ATB and Corticoids|0|||
145997184|NCT00718315|526506644|FG001|Overall Study|Use of ATB and Corticoids|1|||
145997185|NCT00718315|526506645|FG002|Overall Study|Use of ATB and Corticoids|2|||
145997186|NCT00806585|526506646|FG000|Overall Study|Study terminated by Sponsor|0|||
145997187|NCT00806585|526506647|FG001|Overall Study|Study terminated by Sponsor|0|||
145997188|NCT00806585|526506648|FG002|Overall Study|Study terminated by Sponsor|1|||
145997189|NCT00806585|526506649|FG003|Overall Study|Study terminated by Sponsor|2|||
145997190|NCT00806585|526506650|FG004|Overall Study|Study terminated by Sponsor|0|||
145997191|NCT00806585|526506646|FG000|Overall Study|Protocol Violation|3|||
145997192|NCT00806585|526506647|FG001|Overall Study|Protocol Violation|1|||
145997193|NCT00806585|526506648|FG002|Overall Study|Protocol Violation|2|||
145997194|NCT00806585|526506649|FG003|Overall Study|Protocol Violation|0|||
145997195|NCT00806585|526506650|FG004|Overall Study|Protocol Violation|0|||
145997196|NCT00806585|526506646|FG000|Overall Study|Physician Decision|0|||
145997197|NCT00806585|526506647|FG001|Overall Study|Physician Decision|2|||
145997198|NCT00806585|526506648|FG002|Overall Study|Physician Decision|3|||
145997199|NCT00806585|526506649|FG003|Overall Study|Physician Decision|0|||
145997200|NCT00806585|526506650|FG004|Overall Study|Physician Decision|1|||
145997201|NCT00806585|526506646|FG000|Overall Study|Lost to Follow-up|2|||
145997202|NCT00806585|526506647|FG001|Overall Study|Lost to Follow-up|1|||
145997203|NCT00806585|526506648|FG002|Overall Study|Lost to Follow-up|2|||
145997204|NCT00806585|526506649|FG003|Overall Study|Lost to Follow-up|2|||
145997205|NCT00806585|526506650|FG004|Overall Study|Lost to Follow-up|5|||
145997206|NCT00806585|526506646|FG000|Overall Study|Lack of Efficacy|1|||
145997207|NCT00806585|526506647|FG001|Overall Study|Lack of Efficacy|0|||
145997208|NCT00806585|526506648|FG002|Overall Study|Lack of Efficacy|0|||
145997209|NCT00806585|526506649|FG003|Overall Study|Lack of Efficacy|0|||
145997210|NCT00806585|526506650|FG004|Overall Study|Lack of Efficacy|0|||
145997211|NCT00806585|526506646|FG000|Overall Study|Adverse Event|1|||
145997212|NCT00806585|526506647|FG001|Overall Study|Adverse Event|5|||
145997213|NCT00806585|526506648|FG002|Overall Study|Adverse Event|3|||
145997214|NCT00806585|526506649|FG003|Overall Study|Adverse Event|4|||
145997215|NCT00806585|526506650|FG004|Overall Study|Adverse Event|2|||
145997216|NCT00806585|526506646|FG000|Overall Study|Withdrawal by Subject|10|||
145997217|NCT00806585|526506647|FG001|Overall Study|Withdrawal by Subject|8|||
145997218|NCT00806585|526506648|FG002|Overall Study|Withdrawal by Subject|9|||
145997219|NCT00806585|526506649|FG003|Overall Study|Withdrawal by Subject|3|||
145997220|NCT00806585|526506650|FG004|Overall Study|Withdrawal by Subject|11|||
145997221|NCT00806585|526506646|FG000|Overall Study|Completion status unknown|15|||
145997222|NCT00806585|526506647|FG001|Overall Study|Completion status unknown|14|||
145997223|NCT00806585|526506648|FG002|Overall Study|Completion status unknown|12|||
145997224|NCT00806585|526506649|FG003|Overall Study|Completion status unknown|4|||
145997225|NCT00806585|526506650|FG004|Overall Study|Completion status unknown|12|||
145997226|NCT00673920|526506658|FG000|Baseline up to Week 48|Withdrew consent|1|||
145997227|NCT00673920|526506659|FG001|Baseline up to Week 48|Withdrew consent|0|||
145997228|NCT00673920|526506660|FG002|Baseline up to Week 48|Withdrew consent|2|||
145997229|NCT00673920|526506661|FG003|Baseline up to Week 48|Withdrew consent|0|||
145997230|NCT00673920|526506662|FG004|Baseline up to Week 48|Withdrew consent|0|||
145997231|NCT00673920|526506663|FG005|Baseline up to Week 48|Withdrew consent|0|||
145997232|NCT00673920|526506664|FG006|Baseline up to Week 48|Withdrew consent|0|||
145997233|NCT00673920|526506665|FG007|Baseline up to Week 48|Withdrew consent|0|||
145997234|NCT00673920|526506658|FG000|Baseline up to Week 48|Refused treatment|1|||
145997235|NCT00673920|526506659|FG001|Baseline up to Week 48|Refused treatment|0|||
145997236|NCT00673920|526506660|FG002|Baseline up to Week 48|Refused treatment|0|||
145997237|NCT00673920|526506661|FG003|Baseline up to Week 48|Refused treatment|0|||
145997238|NCT00673920|526506662|FG004|Baseline up to Week 48|Refused treatment|0|||
145997239|NCT00673920|526506663|FG005|Baseline up to Week 48|Refused treatment|0|||
145997240|NCT00673920|526506664|FG006|Baseline up to Week 48|Refused treatment|0|||
145997241|NCT00673920|526506665|FG007|Baseline up to Week 48|Refused treatment|0|||
145997242|NCT00673920|526506658|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
145997243|NCT00673920|526506659|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
145997244|NCT00673920|526506660|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997245|NCT00673920|526506661|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997246|NCT00673920|526506662|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997247|NCT00673920|526506663|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997248|NCT00673920|526506664|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997249|NCT00673920|526506665|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
145997250|NCT00673920|526506658|FG000|Baseline up to Week 48|Protocol Violation|0|||
145997251|NCT00673920|526506659|FG001|Baseline up to Week 48|Protocol Violation|0|||
145997252|NCT00673920|526506660|FG002|Baseline up to Week 48|Protocol Violation|1|||
145997253|NCT00673920|526506661|FG003|Baseline up to Week 48|Protocol Violation|0|||
145997254|NCT00673920|526506662|FG004|Baseline up to Week 48|Protocol Violation|0|||
145997255|NCT00673920|526506663|FG005|Baseline up to Week 48|Protocol Violation|0|||
145997256|NCT00673920|526506664|FG006|Baseline up to Week 48|Protocol Violation|0|||
145997257|NCT00673920|526506665|FG007|Baseline up to Week 48|Protocol Violation|0|||
145997258|NCT00673920|526506658|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997259|NCT00673920|526506659|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997260|NCT00673920|526506660|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
145997261|NCT00673920|526506661|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997262|NCT00673920|526506662|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
146246785|NCT00813709|527417657|FG001|Open Label Period|Adverse Event|0|||
146246786|NCT00813709|527417658|FG002|Open Label Period|Adverse Event|0|||
146246787|NCT00813709|527417659|FG003|Open Label Period|Adverse Event|5|||
146246788|NCT00813709|527417660|FG004|Open Label Period|Adverse Event|4|||
146246789|NCT00813709|527417661|FG005|Open Label Period|Adverse Event|3|||
146246790|NCT00813709|527417656|FG000|Open Label Period|Lack of Efficacy|0|||
145997263|NCT00673920|526506663|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997264|NCT00673920|526506664|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997265|NCT00673920|526506665|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145997266|NCT00673920|526506658|FG000|Baseline up to Week 48|Administrative/Other|0|||
145997267|NCT00673920|526506659|FG001|Baseline up to Week 48|Administrative/Other|1|||
145997268|NCT00673920|526506660|FG002|Baseline up to Week 48|Administrative/Other|2|||
145997269|NCT00673920|526506661|FG003|Baseline up to Week 48|Administrative/Other|0|||
145997270|NCT00673920|526506662|FG004|Baseline up to Week 48|Administrative/Other|0|||
145997271|NCT00673920|526506663|FG005|Baseline up to Week 48|Administrative/Other|0|||
145997272|NCT00673920|526506664|FG006|Baseline up to Week 48|Administrative/Other|0|||
145997273|NCT00673920|526506665|FG007|Baseline up to Week 48|Administrative/Other|0|||
145997274|NCT00673920|526506658|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997275|NCT00673920|526506659|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
145997276|NCT00673920|526506660|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
145997277|NCT00673920|526506661|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997278|NCT00673920|526506662|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997279|NCT00673920|526506663|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997280|NCT00673920|526506664|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997281|NCT00673920|526506665|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145997282|NCT00673920|526506658|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997283|NCT00673920|526506659|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997284|NCT00673920|526506660|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997285|NCT00673920|526506661|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997286|NCT00673920|526506662|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997287|NCT00673920|526506663|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997288|NCT00673920|526506664|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
145997289|NCT00673920|526506665|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145997290|NCT00673920|526506658|FG000|Week 24 to Week 48|Failure to return|0|||
145997291|NCT00673920|526506659|FG001|Week 24 to Week 48|Failure to return|0|||
145997292|NCT00673920|526506660|FG002|Week 24 to Week 48|Failure to return|0|||
145997293|NCT00673920|526506661|FG003|Week 24 to Week 48|Failure to return|0|||
145997294|NCT00673920|526506662|FG004|Week 24 to Week 48|Failure to return|0|||
145997295|NCT00673920|526506663|FG005|Week 24 to Week 48|Failure to return|1|||
145997296|NCT00673920|526506664|FG006|Week 24 to Week 48|Failure to return|0|||
145997297|NCT00673920|526506665|FG007|Week 24 to Week 48|Failure to return|0|||
145997298|NCT00673920|526506658|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997299|NCT00673920|526506659|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997300|NCT00673920|526506660|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997301|NCT00673920|526506661|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997302|NCT00673920|526506662|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997303|NCT00673920|526506663|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
145997304|NCT00673920|526506664|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997305|NCT00673920|526506665|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
145997306|NCT00673920|526506658|FG000|Week 24 to Week 48|Death|0|||
145997307|NCT00673920|526506659|FG001|Week 24 to Week 48|Death|0|||
145997308|NCT00673920|526506660|FG002|Week 24 to Week 48|Death|0|||
145997309|NCT00673920|526506661|FG003|Week 24 to Week 48|Death|0|||
145997310|NCT00673920|526506662|FG004|Week 24 to Week 48|Death|0|||
145997311|NCT00673920|526506663|FG005|Week 24 to Week 48|Death|1|||
145997312|NCT00673920|526506664|FG006|Week 24 to Week 48|Death|0|||
145997313|NCT00673920|526506665|FG007|Week 24 to Week 48|Death|0|||
145997314|NCT00673920|526506658|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
145997315|NCT00673920|526506659|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
145997316|NCT00673920|526506660|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
145997317|NCT00673920|526506661|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
145997318|NCT00673920|526506662|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
145997319|NCT00673920|526506663|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
145997320|NCT00673920|526506664|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
145997321|NCT00673920|526506665|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
145997322|NCT00833690|526506669|FG000|Overall Study|Withdrawal by Subject|1|||
145997323|NCT00833690|526506670|FG001|Overall Study|Withdrawal by Subject|0|||
145997324|NCT00833690|526506671|FG002|Overall Study|Withdrawal by Subject|0|||
145997325|NCT00833690|526506669|FG000|Overall Study|Discontinued study drug|3|||
145997326|NCT00833690|526506670|FG001|Overall Study|Discontinued study drug|2|||
145997327|NCT00833690|526506671|FG002|Overall Study|Discontinued study drug|0|||
145997328|NCT04562116|526506677|FG000|Overall Study|Lost to Follow-up|1|||
145997329|NCT04562116|526506677|FG000|Overall Study|Withdrawal by Subject|3|||
145997330|NCT01143402|526506684|FG000|Overall Study|Rapid clinical decline|1|||
145997331|NCT01143402|526506685|FG001|Overall Study|Rapid clinical decline|1|||
145997332|NCT01143402|526506686|FG002|Overall Study|Rapid clinical decline|0|||
145997333|NCT01143402|526506684|FG000|Overall Study|Not Treated|0|||
145997334|NCT01143402|526506685|FG001|Overall Study|Not Treated|0|||
145997335|NCT01143402|526506686|FG002|Overall Study|Not Treated|1|||
145997336|NCT04462471|526506687|FG000|Overall Study|Adverse Event|0|||
145997337|NCT04462471|526506688|FG001|Overall Study|Adverse Event|1|||
145997338|NCT04462471|526506689|FG002|Overall Study|Adverse Event|0|||
145997339|NCT04462471|526506690|FG003|Overall Study|Adverse Event|0|||
145997340|NCT04462471|526506687|FG000|Overall Study|Disease progression|1|||
145997341|NCT04462471|526506688|FG001|Overall Study|Disease progression|0|||
145997342|NCT04462471|526506689|FG002|Overall Study|Disease progression|0|||
145997343|NCT04462471|526506690|FG003|Overall Study|Disease progression|0|||
145997344|NCT03097289|526506691|FG000|Overall Study|Adverse Event|1|||
145997345|NCT03097289|526506691|FG000|Overall Study|Equipment failure|2|||
145997346|NCT03097289|526506691|FG000|Overall Study|Collected platelet product unusable|3|||
145997347|NCT00397540|526506695|FG000|Overall Study|short follow-up duration < 12 months|1|||
145997348|NCT00397540|526506696|FG001|Overall Study|short follow-up duration < 12 months|0|||
145997349|NCT00619866|526506697|FG000|Weeks 1 - 12|Adverse Event|0|||
145997350|NCT00619866|526506698|FG001|Weeks 1 - 12|Adverse Event|1|||
145997351|NCT00619866|526506699|FG002|Weeks 1 - 12|Adverse Event|2|||
145997352|NCT00619866|526506700|FG003|Weeks 1 - 12|Adverse Event|0|||
145997353|NCT00619866|526506701|FG004|Weeks 1 - 12|Adverse Event|0|||
145997354|NCT00619866|526506697|FG000|Weeks 1 - 12|Non-compliance|0|||
145997355|NCT00619866|526506698|FG001|Weeks 1 - 12|Non-compliance|0|||
145997356|NCT00619866|526506699|FG002|Weeks 1 - 12|Non-compliance|1|||
145997357|NCT00619866|526506700|FG003|Weeks 1 - 12|Non-compliance|0|||
145997358|NCT00619866|526506701|FG004|Weeks 1 - 12|Non-compliance|0|||
145997359|NCT00619866|526506697|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
145997360|NCT00619866|526506698|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
145997361|NCT00619866|526506699|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
145997362|NCT00619866|526506700|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
146091889|NCT01865084|526858445|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
146091890|NCT01865084|526858443|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
146091891|NCT01865084|526858444|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
146091892|NCT01865084|526858445|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
146091893|NCT02247531|526858449|FG000|Overall Study|Adverse Event|3|||
146091894|NCT02247531|526858450|FG001|Overall Study|Adverse Event|4|||
146091895|NCT02247531|526858451|FG002|Overall Study|Adverse Event|9|||
146091896|NCT02247531|526858449|FG000|Overall Study|Death|8|||
146091897|NCT02247531|526858450|FG001|Overall Study|Death|9|||
146091898|NCT02247531|526858451|FG002|Overall Study|Death|5|||
146091899|NCT02247531|526858449|FG000|Overall Study|Lost to Follow-up|1|||
146091900|NCT02247531|526858450|FG001|Overall Study|Lost to Follow-up|8|||
146091901|NCT02247531|526858451|FG002|Overall Study|Lost to Follow-up|3|||
146091902|NCT02247531|526858449|FG000|Overall Study|Non-compliance|2|||
146091903|NCT02247531|526858450|FG001|Overall Study|Non-compliance|2|||
146091904|NCT02247531|526858451|FG002|Overall Study|Non-compliance|0|||
146091905|NCT02247531|526858449|FG000|Overall Study|Withdrawal by Subject|26|||
146091906|NCT02247531|526858450|FG001|Overall Study|Withdrawal by Subject|31|||
146091907|NCT02247531|526858451|FG002|Overall Study|Withdrawal by Subject|25|||
145997363|NCT00619866|526506701|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
145997364|NCT00619866|526506697|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
145997365|NCT00619866|526506698|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
145997366|NCT00619866|526506699|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
145997367|NCT00619866|526506700|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
145997368|NCT00619866|526506701|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
145997369|NCT00619866|526506697|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
145997370|NCT00619866|526506698|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
145997371|NCT00619866|526506699|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
145997372|NCT00619866|526506700|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
145997373|NCT00619866|526506701|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
146091908|NCT02247531|526858449|FG000|Overall Study|Study Terminated by Sponsor|64|||
146091909|NCT02247531|526858450|FG001|Overall Study|Study Terminated by Sponsor|66|||
145997374|NCT00619866|526506697|FG000|Weeks 1 - 12|Sponsor Decision|0|||
145997375|NCT00619866|526506698|FG001|Weeks 1 - 12|Sponsor Decision|1|||
145997376|NCT00619866|526506699|FG002|Weeks 1 - 12|Sponsor Decision|0|||
145997377|NCT00619866|526506700|FG003|Weeks 1 - 12|Sponsor Decision|0|||
146091910|NCT02247531|526858451|FG002|Overall Study|Study Terminated by Sponsor|62|||
145997378|NCT00619866|526506701|FG004|Weeks 1 - 12|Sponsor Decision|0|||
145997379|NCT00619866|526506697|FG000|Weeks 13 - 24|Adverse Event|0|||
145997380|NCT00619866|526506698|FG001|Weeks 13 - 24|Adverse Event|0|||
145997381|NCT00619866|526506699|FG002|Weeks 13 - 24|Adverse Event|2|||
145997382|NCT00619866|526506700|FG003|Weeks 13 - 24|Adverse Event|1|||
146091911|NCT02247531|526858449|FG000|Overall Study|Physician Decision|0|||
146091912|NCT02247531|526858450|FG001|Overall Study|Physician Decision|2|||
145997383|NCT00619866|526506701|FG004|Weeks 13 - 24|Adverse Event|0|||
145997384|NCT00619866|526506697|FG000|Weeks 13 - 24|Protocol Deviation|0|||
145997385|NCT00619866|526506698|FG001|Weeks 13 - 24|Protocol Deviation|0|||
145997386|NCT00619866|526506699|FG002|Weeks 13 - 24|Protocol Deviation|0|||
145997387|NCT00619866|526506700|FG003|Weeks 13 - 24|Protocol Deviation|1|||
145997388|NCT00619866|526506701|FG004|Weeks 13 - 24|Protocol Deviation|0|||
145997389|NCT00619866|526506697|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
145997390|NCT00619866|526506698|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
145997391|NCT00619866|526506699|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
145997392|NCT00619866|526506700|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
145997393|NCT00619866|526506701|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
145997394|NCT00619866|526506697|FG000|Weeks 13 - 24|Non-compliance|0|||
145997395|NCT00619866|526506698|FG001|Weeks 13 - 24|Non-compliance|1|||
145997396|NCT00619866|526506699|FG002|Weeks 13 - 24|Non-compliance|1|||
145997397|NCT00619866|526506700|FG003|Weeks 13 - 24|Non-compliance|0|||
145997398|NCT00619866|526506701|FG004|Weeks 13 - 24|Non-compliance|0|||
145997399|NCT00619866|526506697|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
145997400|NCT00619866|526506698|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
145997401|NCT00619866|526506699|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
145997402|NCT00619866|526506700|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
145997403|NCT00619866|526506701|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
145997404|NCT01656161|526506702|FG000|Overall Study|Death|3|||
145997405|NCT01656161|526506702|FG000|Overall Study|Adverse Event|2|||
145997406|NCT01656161|526506702|FG000|Overall Study|Protocol Violation|1|||
145997407|NCT01656161|526506702|FG000|Overall Study|Withdrawal by Subject|1|||
145997408|NCT00776230|526506706|FG000|Overall Study|Lost to Follow-up|2|||
145997409|NCT00776230|526506707|FG001|Overall Study|Lost to Follow-up|1|||
145997410|NCT00776230|526506708|FG002|Overall Study|Lost to Follow-up|5|||
145997411|NCT00776230|526506706|FG000|Overall Study|Not vaccinated at Day 0|1|||
145997412|NCT00776230|526506707|FG001|Overall Study|Not vaccinated at Day 0|0|||
145997413|NCT00776230|526506708|FG002|Overall Study|Not vaccinated at Day 0|0|||
145997414|NCT00776230|526506706|FG000|Overall Study|Withdrawal by Subject|0|||
145997415|NCT00776230|526506707|FG001|Overall Study|Withdrawal by Subject|1|||
145997416|NCT00776230|526506708|FG002|Overall Study|Withdrawal by Subject|0|||
145997417|NCT00776230|526506706|FG000|Overall Study|Subject missed Visit 4|0|||
145997418|NCT00776230|526506707|FG001|Overall Study|Subject missed Visit 4|1|||
145997419|NCT00776230|526506708|FG002|Overall Study|Subject missed Visit 4|0|||
145997420|NCT01215851|526506709|FG000|Treatment Period|Adverse Event|1|||
145997421|NCT01215851|526506710|FG001|Treatment Period|Adverse Event|1|||
145997422|NCT01215851|526506711|FG002|Treatment Period|Adverse Event|1|||
145997423|NCT01215851|526506712|FG003|Treatment Period|Adverse Event|3|||
145997424|NCT01215851|526506713|FG004|Treatment Period|Adverse Event|0|||
145997425|NCT01215851|526506714|FG005|Treatment Period|Adverse Event|1|||
145997426|NCT01215851|526506709|FG000|Follow up Period|Lost to Follow-up|0|||
145997427|NCT01215851|526506710|FG001|Follow up Period|Lost to Follow-up|0|||
145997428|NCT01215851|526506711|FG002|Follow up Period|Lost to Follow-up|0|||
145997429|NCT01215851|526506712|FG003|Follow up Period|Lost to Follow-up|0|||
145997430|NCT01215851|526506713|FG004|Follow up Period|Lost to Follow-up|0|||
145997431|NCT01215851|526506714|FG005|Follow up Period|Lost to Follow-up|1|||
145997432|NCT03510273|526506717|FG000|Overall Study|Withdrawal by Subject|2|||
145997433|NCT03510273|526506717|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
146091913|NCT02247531|526858451|FG002|Overall Study|Physician Decision|2|||
146091914|NCT02247531|526858449|FG000|Overall Study|Unspecified Reason|2|||
146091915|NCT02247531|526858450|FG001|Overall Study|Unspecified Reason|3|||
146091916|NCT02247531|526858451|FG002|Overall Study|Unspecified Reason|4|||
146091917|NCT02423109|526858456|FG000|Lens 1|Adverse Event|1|||
146091918|NCT02423109|526858457|FG001|Lens 1|Adverse Event|0|||
146091919|NCT03468985|526858458|FG000|Overall Study|Adverse Event|0|||
146091920|NCT03468985|526858459|FG001|Overall Study|Adverse Event|2|||
146091921|NCT03468985|526858460|FG002|Overall Study|Adverse Event|0|||
146091922|NCT03468985|526858461|FG003|Overall Study|Adverse Event|0|||
146091923|NCT03468985|526858458|FG000|Overall Study|Withdrawal by Subject|0|||
146091924|NCT03468985|526858459|FG001|Overall Study|Withdrawal by Subject|0|||
146091925|NCT03468985|526858460|FG002|Overall Study|Withdrawal by Subject|0|||
146091926|NCT03468985|526858461|FG003|Overall Study|Withdrawal by Subject|1|||
146091927|NCT04060862|526858462|FG000|Overall Study|Symptomatic Deterioration|1|||
146091928|NCT04060862|526858462|FG000|Overall Study|Un-specified|6|||
146091929|NCT04060862|526858462|FG000|Overall Study|Progressive disease|12|||
146091930|NCT04060862|526858462|FG000|Overall Study|Physician Decision|1|||
146091931|NCT01243671|526858463|FG000|Overall Study|Adverse Event|3|||
145997434|NCT03510273|526506717|FG000|Overall Study|Moved away from study area|4|||
145997435|NCT02589938|526506718|FG000|Overall Study|Withdrawal by Subject|11|||
145997436|NCT02589938|526506719|FG001|Overall Study|Withdrawal by Subject|5|||
145997437|NCT02589938|526506720|FG002|Overall Study|Withdrawal by Subject|6|||
145997438|NCT02589938|526506718|FG000|Overall Study|Lost to Follow-up|3|||
145997439|NCT02589938|526506719|FG001|Overall Study|Lost to Follow-up|3|||
145997440|NCT02589938|526506720|FG002|Overall Study|Lost to Follow-up|3|||
146091932|NCT01243671|526858463|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
145997441|NCT02589938|526506718|FG000|Overall Study|Death|1|||
145997442|NCT02589938|526506719|FG001|Overall Study|Death|0|||
145997443|NCT02589938|526506720|FG002|Overall Study|Death|1|||
145997444|NCT02589938|526506718|FG000|Overall Study|Protocol Violation|6|||
145997445|NCT02589938|526506719|FG001|Overall Study|Protocol Violation|2|||
145997446|NCT02589938|526506720|FG002|Overall Study|Protocol Violation|3|||
146091933|NCT01243671|526858463|FG000|Overall Study|Other|1|||
145997447|NCT02589938|526506718|FG000|Overall Study|Physician Decision|1|||
145997448|NCT02589938|526506719|FG001|Overall Study|Physician Decision|0|||
145997449|NCT02589938|526506720|FG002|Overall Study|Physician Decision|0|||
145997450|NCT02589938|526506718|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
145997451|NCT02589938|526506719|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
145997452|NCT02589938|526506720|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
145997453|NCT00485173|526506721|FG000|Overall Study|Death|4|||
145997454|NCT00485173|526506722|FG001|Overall Study|Death|3|||
145997455|NCT00485173|526506721|FG000|Overall Study|Lost to Follow-up|32|||
145997456|NCT00485173|526506722|FG001|Overall Study|Lost to Follow-up|61|||
145997457|NCT00829244|526506723|FG000|Overall Study|Adverse Event|1|||
145997458|NCT00829244|526506724|FG001|Overall Study|Adverse Event|3|||
145997459|NCT00829244|526506723|FG000|Overall Study|Protocol Violation|1|||
145997460|NCT00829244|526506724|FG001|Overall Study|Protocol Violation|0|||
145997461|NCT00829244|526506723|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
145997462|NCT00829244|526506724|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
145997463|NCT00829244|526506723|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
145997464|NCT00829244|526506724|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
145997465|NCT00829244|526506723|FG000|Overall Study|No fertilization|2|||
145997466|NCT00829244|526506724|FG001|Overall Study|No fertilization|2|||
145997467|NCT00829244|526506723|FG000|Overall Study|All embryos discarded|0|||
145997468|NCT00829244|526506724|FG001|Overall Study|All embryos discarded|3|||
145997469|NCT00829244|526506723|FG000|Overall Study|No embryo cleavage|0|||
145997470|NCT00829244|526506724|FG001|Overall Study|No embryo cleavage|2|||
145997471|NCT04222673|526506725|FG000|Overall Study|Lost to Follow-up|5|||
145997472|NCT03213509|526506729|FG000|Overall Study|Did not consent for verbal autopsy|4|||
145997473|NCT03213509|526506730|FG001|Overall Study|Did not consent for verbal autopsy|5|||
145997474|NCT02297412|526506731|FG000|Overall Study|Canceled|1|||
145997475|NCT02297412|526506732|FG001|Overall Study|Canceled|1|||
145997476|NCT01323192|526508274|FG000|Overall Study|Adverse Event|6|||
145997477|NCT01323192|526508275|FG001|Overall Study|Adverse Event|1|||
145997478|NCT01323192|526508274|FG000|Overall Study|Withdrawal by Subject|3|||
145997479|NCT01323192|526508275|FG001|Overall Study|Withdrawal by Subject|1|||
145997480|NCT01323192|526508274|FG000|Overall Study|Noncompliance with study medication|0|||
145997481|NCT01323192|526508275|FG001|Overall Study|Noncompliance with study medication|3|||
145997482|NCT01323192|526508274|FG000|Overall Study|Nonmedical reasons|0|||
145997483|NCT01323192|526508275|FG001|Overall Study|Nonmedical reasons|1|||
145997484|NCT02276040|526508281|FG000|Overall Study|Physician Decision|15|||
145997485|NCT02835690|526508282|FG000|Overall Study|Death|12|||
145997486|NCT02835690|526508283|FG001|Overall Study|Death|11|||
145997487|NCT02835690|526508284|FG002|Overall Study|Death|13|||
145997488|NCT02835690|526508282|FG000|Overall Study|Transferred to Extension Study|2|||
145997489|NCT02835690|526508283|FG001|Overall Study|Transferred to Extension Study|2|||
145997490|NCT02835690|526508284|FG002|Overall Study|Transferred to Extension Study|1|||
145997491|NCT02835690|526508282|FG000|Overall Study|Did Not Continue on Extension Study|0|||
145997492|NCT02835690|526508283|FG001|Overall Study|Did Not Continue on Extension Study|0|||
145997493|NCT02835690|526508284|FG002|Overall Study|Did Not Continue on Extension Study|1|||
145997494|NCT02835690|526508282|FG000|Overall Study|Not Treated|0|||
145997495|NCT02835690|526508283|FG001|Overall Study|Not Treated|2|||
145997496|NCT02835690|526508284|FG002|Overall Study|Not Treated|0|||
145997497|NCT03674281|526508285|FG000|Overall Study|screen failure|2|||
145997498|NCT03674281|526508286|FG001|Overall Study|screen failure|0|||
145997499|NCT03674281|526508287|FG002|Overall Study|screen failure|0|||
145997500|NCT03674281|526508285|FG000|Overall Study|Withdrawal by Subject|1|||
145997501|NCT03674281|526508286|FG001|Overall Study|Withdrawal by Subject|3|||
145997502|NCT03674281|526508287|FG002|Overall Study|Withdrawal by Subject|3|||
145997503|NCT00582907|526508288|FG000|1st Course|Withdrawal by Subject|1|||
145997504|NCT00582907|526508289|FG001|1st Course|Withdrawal by Subject|0|||
145997505|NCT00582907|526508290|FG002|1st Course|Withdrawal by Subject|0|||
145997506|NCT00582907|526508291|FG003|1st Course|Withdrawal by Subject|0|||
145997507|NCT00582907|526508288|FG000|1st Course|Lost to Follow-up|0|||
145997508|NCT00582907|526508289|FG001|1st Course|Lost to Follow-up|0|||
145997509|NCT00582907|526508290|FG002|1st Course|Lost to Follow-up|0|||
145997510|NCT00582907|526508291|FG003|1st Course|Lost to Follow-up|1|||
145997511|NCT00582907|526508288|FG000|2nd Course|Lack of Efficacy|1|||
145997512|NCT00582907|526508289|FG001|2nd Course|Lack of Efficacy|0|||
145997513|NCT00582907|526508290|FG002|2nd Course|Lack of Efficacy|0|||
145997514|NCT00582907|526508291|FG003|2nd Course|Lack of Efficacy|0|||
145997515|NCT01441960|526508292|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
145997516|NCT01441960|526508293|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
145997517|NCT01441960|526508292|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
145997518|NCT01441960|526508293|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
145997519|NCT01441960|526508292|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
145997520|NCT01441960|526508293|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
145997521|NCT00069641|526508299|FG000|Overall Study|Death|1|||
145997522|NCT00069641|526508300|FG001|Overall Study|Death|0|||
145997523|NCT00069641|526508301|FG002|Overall Study|Death|1|||
145997524|NCT03186638|526508302|FG000|Overall Study|Withdrawal by Subject|4|||
145997525|NCT03186638|526508303|FG001|Overall Study|Withdrawal by Subject|4|||
145997526|NCT03186638|526508302|FG000|Overall Study|Withdrawn due to medical problem|3|||
145997527|NCT03186638|526508303|FG001|Overall Study|Withdrawn due to medical problem|2|||
145997528|NCT03186638|526508302|FG000|Overall Study|Lost to Follow-up|1|||
145997529|NCT03186638|526508303|FG001|Overall Study|Lost to Follow-up|0|||
145997530|NCT02239926|526508304|FG000|Overall Study|Withdrawal by Subject|0|||
145997531|NCT02239926|526508305|FG001|Overall Study|Withdrawal by Subject|1|||
145997532|NCT05067335|526508310|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
145997533|NCT05067335|526508311|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
145997534|NCT05067335|526508312|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
145997535|NCT05067335|526508313|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
145997536|NCT05067335|526508310|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
145997537|NCT05067335|526508311|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
145997538|NCT05067335|526508312|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
145997539|NCT05067335|526508313|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
145997540|NCT05067335|526508310|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
145997541|NCT05067335|526508311|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
145997542|NCT05067335|526508312|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
145997543|NCT05067335|526508313|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
145997544|NCT05067335|526508310|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
145997545|NCT05067335|526508311|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145997546|NCT05067335|526508312|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145997547|NCT05067335|526508313|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145997548|NCT05067335|526508310|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145997549|NCT05067335|526508311|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
145997550|NCT05067335|526508312|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145997551|NCT05067335|526508313|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145997552|NCT05067335|526508310|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
145997553|NCT05067335|526508311|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
145997554|NCT05067335|526508312|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
145997555|NCT05067335|526508313|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
145997556|NCT05067335|526508310|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145997557|NCT05067335|526508311|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145997558|NCT05067335|526508312|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
145997559|NCT05067335|526508313|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145997560|NCT05067335|526508310|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145997561|NCT05067335|526508311|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145997562|NCT05067335|526508312|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145997563|NCT05067335|526508313|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
145997564|NCT05067335|526508310|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145997565|NCT05067335|526508311|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145997566|NCT05067335|526508312|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
145997567|NCT05067335|526508313|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145997568|NCT05067335|526508310|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145997569|NCT05067335|526508311|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145997570|NCT05067335|526508312|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
145997571|NCT05067335|526508313|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145997572|NCT02234362|526508314|FG000|Overall Study|Not eligible after first screening visit|17|||
145997573|NCT02234362|526508314|FG000|Overall Study|Lost to Follow-up|6|||
145997574|NCT02234362|526508314|FG000|Overall Study|Withdrawal by Subject|3|||
145997575|NCT00261833|526508322|FG000|Overall Study|Death|1|||
145997576|NCT00261833|526508323|FG001|Overall Study|Death|3|||
145997577|NCT00261833|526508322|FG000|Overall Study|Adverse Event|1|||
146091934|NCT05342532|526858467|FG000|Overall Study|Adverse Event|5|||
146091935|NCT05342532|526858468|FG001|Overall Study|Adverse Event|20|||
146091936|NCT05342532|526858467|FG000|Overall Study|Lost to Follow-up|10|||
146091937|NCT05342532|526858468|FG001|Overall Study|Lost to Follow-up|15|||
146091938|NCT02675231|526858469|FG000|Overall Study|Withdrawal by Subject|2|||
146246791|NCT00813709|527417657|FG001|Open Label Period|Lack of Efficacy|0|||
145997578|NCT00261833|526508323|FG001|Overall Study|Adverse Event|4|||
145997579|NCT00261833|526508322|FG000|Overall Study|Withdrawal by Subject|5|||
146091939|NCT02675231|526858470|FG001|Overall Study|Withdrawal by Subject|4|||
145997580|NCT00261833|526508323|FG001|Overall Study|Withdrawal by Subject|7|||
145997581|NCT00261833|526508322|FG000|Overall Study|Protocol Violation|0|||
145997582|NCT00261833|526508323|FG001|Overall Study|Protocol Violation|1|||
145997583|NCT00261833|526508322|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
145997584|NCT00261833|526508323|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
145997585|NCT00261833|526508322|FG000|Overall Study|Lung transplantation|1|||
145997586|NCT00261833|526508323|FG001|Overall Study|Lung transplantation|1|||
145997587|NCT00261833|526508322|FG000|Overall Study|Missing reason|1|||
145997588|NCT00261833|526508323|FG001|Overall Study|Missing reason|0|||
145997589|NCT00261833|526508322|FG000|Overall Study|Not interested in being participant|0|||
145997590|NCT00261833|526508323|FG001|Overall Study|Not interested in being participant|1|||
145997591|NCT00402987|526508326|FG000|Overall Study|Lack of Efficacy|0|||
145997592|NCT00402987|526508327|FG001|Overall Study|Lack of Efficacy|0|||
145997593|NCT00402987|526508328|FG002|Overall Study|Lack of Efficacy|1|||
145997594|NCT00402987|526508329|FG003|Overall Study|Lack of Efficacy|0|||
145997595|NCT02434081|526508330|FG000|Overall Study|Death (never started treatment)|2|||
145997596|NCT02434081|526508330|FG000|Overall Study|Death|2|||
145997597|NCT02434081|526508330|FG000|Overall Study|Progression|20|||
145997598|NCT02434081|526508330|FG000|Overall Study|Adverse Event|20|||
145997599|NCT02434081|526508330|FG000|Overall Study|Physician Decision|2|||
145997600|NCT02434081|526508330|FG000|Overall Study|Withdrawal by Subject|1|||
145997601|NCT02434081|526508330|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
145997602|NCT00419744|526508331|FG000|Overall Study|Adverse Event|39|||
145997603|NCT00419744|526508332|FG001|Overall Study|Adverse Event|40|||
145997604|NCT00419744|526508333|FG002|Overall Study|Adverse Event|50|||
145997605|NCT00419744|526508331|FG000|Overall Study|Withdrawal by Subject|45|||
145997606|NCT00419744|526508332|FG001|Overall Study|Withdrawal by Subject|49|||
145997607|NCT00419744|526508333|FG002|Overall Study|Withdrawal by Subject|52|||
145997608|NCT00419744|526508331|FG000|Overall Study|Lost to Follow-up|8|||
145997609|NCT00419744|526508332|FG001|Overall Study|Lost to Follow-up|10|||
145997610|NCT00419744|526508333|FG002|Overall Study|Lost to Follow-up|6|||
145997611|NCT00419744|526508331|FG000|Overall Study|Protocol Violation|4|||
145997612|NCT00419744|526508332|FG001|Overall Study|Protocol Violation|7|||
145997613|NCT00419744|526508333|FG002|Overall Study|Protocol Violation|8|||
145997614|NCT00419744|526508331|FG000|Overall Study|Randomized in error|9|||
145997615|NCT00419744|526508332|FG001|Overall Study|Randomized in error|6|||
145997616|NCT00419744|526508333|FG002|Overall Study|Randomized in error|7|||
145997617|NCT00419744|526508331|FG000|Overall Study|Moving out of state|2|||
145997618|NCT00419744|526508332|FG001|Overall Study|Moving out of state|0|||
145997619|NCT00419744|526508333|FG002|Overall Study|Moving out of state|1|||
145997620|NCT00419744|526508331|FG000|Overall Study|Physician Decision|10|||
145997621|NCT00419744|526508332|FG001|Overall Study|Physician Decision|5|||
145997622|NCT00419744|526508333|FG002|Overall Study|Physician Decision|6|||
145997623|NCT00419744|526508331|FG000|Overall Study|Spirometry mouthpiece issues|0|||
145997624|NCT00419744|526508332|FG001|Overall Study|Spirometry mouthpiece issues|1|||
145997625|NCT00419744|526508333|FG002|Overall Study|Spirometry mouthpiece issues|2|||
145997626|NCT00419744|526508331|FG000|Overall Study|Incorrect medication kit dispensed|0|||
145997627|NCT00419744|526508332|FG001|Overall Study|Incorrect medication kit dispensed|0|||
145997628|NCT00419744|526508333|FG002|Overall Study|Incorrect medication kit dispensed|1|||
145997629|NCT01668004|526508334|FG000|Overall Study|Adverse Event|7|||
145997630|NCT01668004|526508334|FG000|Overall Study|Withdrawal by Subject|2|||
145997631|NCT01668004|526508334|FG000|Overall Study|Lost to Follow-up|5|||
145997632|NCT01668004|526508334|FG000|Overall Study|Lack of Efficacy|9|||
145997633|NCT01668004|526508334|FG000|Overall Study|Non-compliance with treatment|2|||
145997634|NCT01500317|526508341|FG000|Overall Study|Withdrawal by Subject|3|||
145997635|NCT01500317|526508342|FG001|Overall Study|Withdrawal by Subject|2|||
145997636|NCT01500317|526508343|FG002|Overall Study|Withdrawal by Subject|0|||
145997637|NCT04856527|526508345|FG000|Overall Study|Unable to complete experimental task|2|||
145997638|NCT04856527|526508346|FG001|Overall Study|Unable to complete experimental task|0|||
145997639|NCT01463527|526508349|FG000|Overall Study|Protocol Violation|1|||
145997640|NCT01463527|526508350|FG001|Overall Study|Protocol Violation|1|||
145997641|NCT01463527|526508349|FG000|Overall Study|Crying >20% of sedation|5|||
145997642|NCT01463527|526508350|FG001|Overall Study|Crying >20% of sedation|6|||
146246792|NCT00813709|527417658|FG002|Open Label Period|Lack of Efficacy|0|||
146246793|NCT00813709|527417659|FG003|Open Label Period|Lack of Efficacy|3|||
145997643|NCT01493414|526508353|FG000|Overall Study|Adverse Event|405|||
145997644|NCT01493414|526508353|FG000|Overall Study|Disease progression|204|||
145997645|NCT01493414|526508353|FG000|Overall Study|Death|101|||
145997646|NCT01493414|526508353|FG000|Overall Study|Physician Decision|93|||
145997647|NCT01493414|526508353|FG000|Overall Study|Withdrawal by Subject|79|||
145997648|NCT01493414|526508353|FG000|Overall Study|Protocol deviation|27|||
145997649|NCT01493414|526508353|FG000|Overall Study|Administrative problems|25|||
145997650|NCT01493414|526508353|FG000|Overall Study|Lost to Follow-up|16|||
145997651|NCT03746015|526508356|FG000|Overall Study|Withdrawal of Consent|1|||
145997652|NCT03746015|526508357|FG001|Overall Study|Withdrawal of Consent|0|||
145997653|NCT03746015|526508358|FG002|Overall Study|Withdrawal of Consent|0|||
146091940|NCT02675231|526858471|FG002|Overall Study|Withdrawal by Subject|2|||
145997654|NCT05448950|526508359|FG000|Overall Study|Death|2|||
145997655|NCT05448950|526508359|FG000|Overall Study|Withdrawal by Subject|1|||
145997656|NCT05448950|526508359|FG000|Overall Study|AVG abandoned|4|||
145997657|NCT02303262|526508360|FG000|Overall Study|Withdrawal by Subject|2|||
145997658|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Adverse Event|6|||
145997659|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Adverse Event|15|||
145997660|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Adverse Event|0|||
145997661|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Death|0|||
145997662|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Death|2|||
145997663|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Death|0|||
145997664|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
145997665|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
145997666|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
145997667|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
145997668|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
145997669|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
145997670|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Physician Decision|1|||
145997671|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Physician Decision|1|||
145997672|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Physician Decision|0|||
145997673|NCT02921256|526508361|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
145997674|NCT02921256|526508362|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
145997675|NCT02921256|526508363|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
145997676|NCT02921256|526508361|FG000|Arm Ib v Arm III|Adverse Event|9|||
145997677|NCT02921256|526508362|FG001|Arm Ib v Arm III|Adverse Event|0|||
145997678|NCT02921256|526508363|FG002|Arm Ib v Arm III|Adverse Event|4|||
145997679|NCT02921256|526508361|FG000|Arm Ib v Arm III|Death|1|||
145997680|NCT02921256|526508362|FG001|Arm Ib v Arm III|Death|0|||
145997681|NCT02921256|526508363|FG002|Arm Ib v Arm III|Death|1|||
145997682|NCT02921256|526508361|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
145997683|NCT02921256|526508362|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
145997684|NCT02921256|526508363|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
145997685|NCT02921256|526508361|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
145997686|NCT02921256|526508362|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
145997687|NCT02921256|526508363|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
145997688|NCT02921256|526508361|FG000|Arm Ib v Arm III|Physician Decision|4|||
145997689|NCT02921256|526508362|FG001|Arm Ib v Arm III|Physician Decision|0|||
145997690|NCT02921256|526508363|FG002|Arm Ib v Arm III|Physician Decision|1|||
145997691|NCT02921256|526508361|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
145997692|NCT02921256|526508362|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
145997693|NCT02921256|526508363|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
145997694|NCT01728246|526508365|FG000|Overall Study|Participant needed rescue medication|1|||
145997695|NCT01728246|526508366|FG001|Overall Study|Participant needed rescue medication|5|||
145997696|NCT01728246|526508365|FG000|Overall Study|Protocol Violation|1|||
145997697|NCT01728246|526508366|FG001|Overall Study|Protocol Violation|0|||
145997698|NCT01728246|526508365|FG000|Overall Study|Withdrawal by Subject|2|||
145997699|NCT01728246|526508366|FG001|Overall Study|Withdrawal by Subject|3|||
145997700|NCT01728246|526508365|FG000|Overall Study|Lost to Follow-up|23|||
145997701|NCT01728246|526508366|FG001|Overall Study|Lost to Follow-up|22|||
145997702|NCT01728246|526508365|FG000|Overall Study|Lack of Efficacy|1|||
145997703|NCT01728246|526508366|FG001|Overall Study|Lack of Efficacy|1|||
145997704|NCT01728246|526508365|FG000|Overall Study|Adverse Event|8|||
145997705|NCT01728246|526508366|FG001|Overall Study|Adverse Event|5|||
145997706|NCT01959932|526508367|FG000|Overall Study|Withdrawal by Subject|1|||
145997707|NCT01959932|526508368|FG001|Overall Study|Withdrawal by Subject|0|||
145997708|NCT01959932|526508369|FG002|Overall Study|Withdrawal by Subject|0|||
145997709|NCT00016354|526508374|FG000|Overall Study|Lack of Efficacy|0|||
145997710|NCT00016354|526508375|FG001|Overall Study|Lack of Efficacy|0|||
145997711|NCT00016354|526508376|FG002|Overall Study|Lack of Efficacy|0|||
145997712|NCT00016354|526508377|FG003|Overall Study|Lack of Efficacy|0|||
145997713|NCT00016354|526508378|FG004|Overall Study|Lack of Efficacy|0|||
145997714|NCT00016354|526508379|FG005|Overall Study|Lack of Efficacy|0|||
145997715|NCT00016354|526508380|FG006|Overall Study|Lack of Efficacy|0|||
145997716|NCT00016354|526508381|FG007|Overall Study|Lack of Efficacy|1|||
145997717|NCT03110562|526508382|FG000|Initial Treatment Period|Disease Progression|1|||
145997718|NCT03110562|526508383|FG001|Initial Treatment Period|Disease Progression|1|||
145997719|NCT03110562|526508384|FG002|Initial Treatment Period|Disease Progression|0|||
145997720|NCT03110562|526508385|FG003|Initial Treatment Period|Disease Progression|0|||
145997721|NCT03110562|526508382|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
145997722|NCT03110562|526508383|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
145997723|NCT03110562|526508384|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
145997724|NCT03110562|526508385|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
145997725|NCT03110562|526508382|FG000|Initial Treatment Period|Adverse Event|1|||
145997726|NCT03110562|526508383|FG001|Initial Treatment Period|Adverse Event|0|||
145997727|NCT03110562|526508384|FG002|Initial Treatment Period|Adverse Event|0|||
145997728|NCT03110562|526508385|FG003|Initial Treatment Period|Adverse Event|0|||
145997729|NCT03110562|526508382|FG000|Initial Treatment Period|Death|74|||
145997730|NCT03110562|526508383|FG001|Initial Treatment Period|Death|82|||
146246794|NCT00813709|527417660|FG004|Open Label Period|Lack of Efficacy|1|||
146246795|NCT00813709|527417661|FG005|Open Label Period|Lack of Efficacy|1|||
146246796|NCT00813709|527417656|FG000|Open Label Period|Randomized but not treated|0|||
146246797|NCT00813709|527417657|FG001|Open Label Period|Randomized but not treated|0|||
146246798|NCT00813709|527417658|FG002|Open Label Period|Randomized but not treated|0|||
146246799|NCT00813709|527417659|FG003|Open Label Period|Randomized but not treated|1|||
145997731|NCT03110562|526508384|FG002|Initial Treatment Period|Death|0|||
146246800|NCT00813709|527417660|FG004|Open Label Period|Randomized but not treated|0|||
146246801|NCT00813709|527417661|FG005|Open Label Period|Randomized but not treated|1|||
146246802|NCT00813709|527417656|FG000|Open Label Period|Other|0|||
146246803|NCT00813709|527417657|FG001|Open Label Period|Other|0|||
146246804|NCT00813709|527417658|FG002|Open Label Period|Other|0|||
146246805|NCT00813709|527417659|FG003|Open Label Period|Other|11|||
146246806|NCT00813709|527417660|FG004|Open Label Period|Other|5|||
146246807|NCT00813709|527417661|FG005|Open Label Period|Other|6|||
146246808|NCT00759681|527417662|FG000|Overall Study|Death|2|||
146246809|NCT00759681|527417663|FG001|Overall Study|Death|5|||
146246810|NCT00759681|527417662|FG000|Overall Study|Lost to Follow-up|8|||
146246811|NCT00759681|527417663|FG001|Overall Study|Lost to Follow-up|5|||
146246812|NCT03146845|527417665|FG000|Overall Study|Reference ulcer healed|1|||
146246813|NCT03146845|527417666|FG001|Overall Study|Reference ulcer healed|0|||
146246814|NCT03146845|527417665|FG000|Overall Study|Physician Decision|1|||
146246815|NCT03146845|527417666|FG001|Overall Study|Physician Decision|0|||
146246816|NCT03146845|527417665|FG000|Overall Study|Adverse Event|1|||
146246817|NCT03146845|527417666|FG001|Overall Study|Adverse Event|0|||
146246818|NCT03146845|527417665|FG000|Overall Study|Withdrawal by Subject|2|||
146246819|NCT03146845|527417666|FG001|Overall Study|Withdrawal by Subject|0|||
146246820|NCT03146845|527417665|FG000|Overall Study|Noncompliance|0|||
145997732|NCT03110562|526508385|FG003|Initial Treatment Period|Death|0|||
145997733|NCT03110562|526508382|FG000|Initial Treatment Period|Lost to Follow-up|13|||
145997734|NCT03110562|526508383|FG001|Initial Treatment Period|Lost to Follow-up|8|||
145997735|NCT03110562|526508384|FG002|Initial Treatment Period|Lost to Follow-up|0|||
145997736|NCT03110562|526508385|FG003|Initial Treatment Period|Lost to Follow-up|0|||
145997737|NCT03110562|526508382|FG000|Initial Treatment Period|Protocol Deviation|1|||
145997738|NCT03110562|526508383|FG001|Initial Treatment Period|Protocol Deviation|0|||
145997739|NCT03110562|526508384|FG002|Initial Treatment Period|Protocol Deviation|0|||
145997740|NCT03110562|526508385|FG003|Initial Treatment Period|Protocol Deviation|0|||
145997741|NCT03110562|526508382|FG000|Initial Treatment Period|Physician Decision|2|||
145997742|NCT03110562|526508383|FG001|Initial Treatment Period|Physician Decision|1|||
145997743|NCT03110562|526508384|FG002|Initial Treatment Period|Physician Decision|0|||
145997744|NCT03110562|526508385|FG003|Initial Treatment Period|Physician Decision|0|||
145997745|NCT03110562|526508382|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
145997746|NCT03110562|526508383|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
145997747|NCT03110562|526508384|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
145997748|NCT03110562|526508385|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
145997749|NCT03110562|526508382|FG000|Initial Treatment Period|Other|5|||
145997750|NCT03110562|526508383|FG001|Initial Treatment Period|Other|4|||
145997751|NCT03110562|526508384|FG002|Initial Treatment Period|Other|0|||
145997752|NCT03110562|526508385|FG003|Initial Treatment Period|Other|0|||
145997753|NCT03110562|526508382|FG000|Initial Treatment Period|Randomized but never treated|0|||
145997754|NCT03110562|526508383|FG001|Initial Treatment Period|Randomized but never treated|3|||
145997755|NCT03110562|526508384|FG002|Initial Treatment Period|Randomized but never treated|0|||
145997756|NCT03110562|526508385|FG003|Initial Treatment Period|Randomized but never treated|0|||
145997757|NCT03110562|526508382|FG000|Crossover Period|Disease Progression|0|||
145997758|NCT03110562|526508383|FG001|Crossover Period|Disease Progression|0|||
145997759|NCT03110562|526508384|FG002|Crossover Period|Disease Progression|1|||
145997760|NCT03110562|526508385|FG003|Crossover Period|Disease Progression|0|||
145997761|NCT03110562|526508382|FG000|Crossover Period|Withdrawal by Subject|0|||
145997762|NCT03110562|526508383|FG001|Crossover Period|Withdrawal by Subject|0|||
145997763|NCT03110562|526508384|FG002|Crossover Period|Withdrawal by Subject|8|||
145997764|NCT03110562|526508385|FG003|Crossover Period|Withdrawal by Subject|6|||
145997765|NCT03110562|526508382|FG000|Crossover Period|Death|0|||
145997766|NCT03110562|526508383|FG001|Crossover Period|Death|0|||
145997767|NCT03110562|526508384|FG002|Crossover Period|Death|37|||
146091941|NCT02675231|526858469|FG000|Overall Study|Lost to Follow-up|3|||
146246821|NCT03146845|527417666|FG001|Overall Study|Noncompliance|1|||
146246822|NCT03146845|527417665|FG000|Overall Study|Protocol Violation|0|||
146246823|NCT03146845|527417666|FG001|Overall Study|Protocol Violation|2|||
146246824|NCT03146845|527417665|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
146246825|NCT03146845|527417666|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
145997768|NCT03110562|526508385|FG003|Crossover Period|Death|3|||
145997769|NCT03110562|526508382|FG000|Crossover Period|Lost to Follow-up|0|||
145997770|NCT03110562|526508383|FG001|Crossover Period|Lost to Follow-up|0|||
146246826|NCT02721147|527417669|FG000|Overall Study|Lost to Follow-up|2|||
145997771|NCT03110562|526508384|FG002|Crossover Period|Lost to Follow-up|0|||
145997772|NCT03110562|526508385|FG003|Crossover Period|Lost to Follow-up|1|||
145997773|NCT03110562|526508382|FG000|Crossover Period|Other|0|||
145997774|NCT03110562|526508383|FG001|Crossover Period|Other|0|||
145997775|NCT03110562|526508384|FG002|Crossover Period|Other|1|||
145997776|NCT03110562|526508385|FG003|Crossover Period|Other|1|||
145997777|NCT03110562|526508382|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
145997778|NCT03110562|526508383|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
145997779|NCT03110562|526508384|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
145997780|NCT03110562|526508385|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
145997781|NCT03012880|526508389|FG000|Overall Study|Withdrawal by Subject|1|||
145997782|NCT03012880|526508390|FG001|Overall Study|Withdrawal by Subject|0|||
145997783|NCT03012880|526508389|FG000|Overall Study|Ineligible|1|||
145997784|NCT03012880|526508390|FG001|Overall Study|Ineligible|0|||
145997785|NCT01355627|526508391|FG000|Overall Study|Request By the Patient to Discontinue|5|||
145997786|NCT01355627|526508392|FG001|Overall Study|Request By the Patient to Discontinue|7|||
145997787|NCT01355627|526508391|FG000|Overall Study|Lost to Follow-up|8|||
145997788|NCT01355627|526508392|FG001|Overall Study|Lost to Follow-up|7|||
145997789|NCT01355627|526508391|FG000|Overall Study|Fatal Adverse Event|19|||
145997790|NCT01355627|526508392|FG001|Overall Study|Fatal Adverse Event|23|||
145997791|NCT01355627|526508391|FG000|Overall Study|Other|1|||
145997792|NCT01355627|526508392|FG001|Overall Study|Other|1|||
145997793|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
145997794|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
145997795|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
145997796|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
145997797|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
145997798|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
145997799|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
145997800|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
145997801|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
145997802|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
145997803|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
145997804|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
145997805|NCT04532749|526508393|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
145997806|NCT04532749|526508394|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
145997807|NCT04532749|526508393|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
145997808|NCT04532749|526508394|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
145997809|NCT04532749|526508393|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
145997810|NCT04532749|526508394|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
145997811|NCT04532749|526508393|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
145997812|NCT04532749|526508394|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
145997813|NCT04756531|526508395|FG000|Overall Study|Adverse Event|0|||
145997814|NCT04756531|526508396|FG001|Overall Study|Adverse Event|0|||
145997815|NCT04756531|526508397|FG002|Overall Study|Adverse Event|0|||
145997816|NCT04756531|526508398|FG003|Overall Study|Adverse Event|0|||
145997817|NCT04756531|526508399|FG004|Overall Study|Adverse Event|1|||
145997818|NCT04756531|526508400|FG005|Overall Study|Adverse Event|0|||
145997819|NCT04756531|526508401|FG006|Overall Study|Adverse Event|0|||
145997820|NCT04756531|526508402|FG007|Overall Study|Adverse Event|0|||
145997821|NCT04756531|526508403|FG008|Overall Study|Adverse Event|0|||
145997822|NCT04756531|526508404|FG009|Overall Study|Adverse Event|0|||
145997823|NCT04756531|526508405|FG010|Overall Study|Adverse Event|0|||
145997824|NCT04756531|526508406|FG011|Overall Study|Adverse Event|0|||
145997825|NCT04756531|526508407|FG012|Overall Study|Adverse Event|0|||
145997826|NCT04756531|526508408|FG013|Overall Study|Adverse Event|0|||
145997827|NCT04756531|526508409|FG014|Overall Study|Adverse Event|0|||
145997828|NCT04756531|526508410|FG015|Overall Study|Adverse Event|0|||
145997829|NCT04756531|526508411|FG016|Overall Study|Adverse Event|0|||
145997830|NCT04756531|526508412|FG017|Overall Study|Adverse Event|0|||
145997831|NCT04756531|526508395|FG000|Overall Study|Withdrawal by Subject|0|||
145997832|NCT04756531|526508396|FG001|Overall Study|Withdrawal by Subject|0|||
145997833|NCT04756531|526508397|FG002|Overall Study|Withdrawal by Subject|0|||
145997834|NCT04756531|526508398|FG003|Overall Study|Withdrawal by Subject|0|||
145997835|NCT04756531|526508399|FG004|Overall Study|Withdrawal by Subject|0|||
145997836|NCT04756531|526508400|FG005|Overall Study|Withdrawal by Subject|0|||
145997837|NCT04756531|526508401|FG006|Overall Study|Withdrawal by Subject|1|||
145997838|NCT04756531|526508402|FG007|Overall Study|Withdrawal by Subject|0|||
145997839|NCT04756531|526508403|FG008|Overall Study|Withdrawal by Subject|0|||
145997840|NCT04756531|526508404|FG009|Overall Study|Withdrawal by Subject|0|||
145997841|NCT04756531|526508405|FG010|Overall Study|Withdrawal by Subject|0|||
145997842|NCT04756531|526508406|FG011|Overall Study|Withdrawal by Subject|0|||
145997843|NCT04756531|526508407|FG012|Overall Study|Withdrawal by Subject|0|||
145997844|NCT04756531|526508408|FG013|Overall Study|Withdrawal by Subject|0|||
146246827|NCT02721147|527417670|FG001|Overall Study|Lost to Follow-up|0|||
146246828|NCT02721147|527417671|FG002|Overall Study|Lost to Follow-up|0|||
146246829|NCT01722097|527417673|FG000|Overall Study|Patient sheets not returned|6|||
146246830|NCT01722097|527417674|FG001|Overall Study|Patient sheets not returned|5|||
146246831|NCT01757288|527417677|FG000|Overall Study|Consent withdrawal|0|||
145997845|NCT04756531|526508409|FG014|Overall Study|Withdrawal by Subject|0|||
145997846|NCT04756531|526508410|FG015|Overall Study|Withdrawal by Subject|0|||
145997847|NCT04756531|526508411|FG016|Overall Study|Withdrawal by Subject|0|||
145997848|NCT04756531|526508412|FG017|Overall Study|Withdrawal by Subject|0|||
145997849|NCT05239221|526508416|FG000|Overall Study|Adverse Event|0|||
145997850|NCT05239221|526508417|FG001|Overall Study|Adverse Event|0|||
145997851|NCT05239221|526508418|FG002|Overall Study|Adverse Event|0|||
145997852|NCT05239221|526508419|FG003|Overall Study|Adverse Event|0|||
145997853|NCT05239221|526508420|FG004|Overall Study|Adverse Event|0|||
145997854|NCT05239221|526508421|FG005|Overall Study|Adverse Event|0|||
145997855|NCT05239221|526508422|FG006|Overall Study|Adverse Event|1|||
145997856|NCT05239221|526508423|FG007|Overall Study|Adverse Event|0|||
145997857|NCT05239221|526508424|FG008|Overall Study|Adverse Event|0|||
145997858|NCT05239221|526508425|FG009|Overall Study|Adverse Event|0|||
145997859|NCT05239221|526508426|FG010|Overall Study|Adverse Event|1|||
145997860|NCT05239221|526508427|FG011|Overall Study|Adverse Event|1|||
145997861|NCT05239221|526508428|FG012|Overall Study|Adverse Event|0|||
145997862|NCT05239221|526508429|FG013|Overall Study|Adverse Event|0|||
145997863|NCT05239221|526508430|FG014|Overall Study|Adverse Event|0|||
145997864|NCT05239221|526508431|FG015|Overall Study|Adverse Event|0|||
145997865|NCT05239221|526508416|FG000|Overall Study|Withdrawal by Subject|0|||
145997866|NCT05239221|526508417|FG001|Overall Study|Withdrawal by Subject|0|||
145997867|NCT05239221|526508418|FG002|Overall Study|Withdrawal by Subject|0|||
145997868|NCT05239221|526508419|FG003|Overall Study|Withdrawal by Subject|0|||
145997869|NCT05239221|526508420|FG004|Overall Study|Withdrawal by Subject|0|||
145997870|NCT05239221|526508421|FG005|Overall Study|Withdrawal by Subject|0|||
145997871|NCT05239221|526508422|FG006|Overall Study|Withdrawal by Subject|0|||
145997872|NCT05239221|526508423|FG007|Overall Study|Withdrawal by Subject|0|||
145997873|NCT05239221|526508424|FG008|Overall Study|Withdrawal by Subject|0|||
145997874|NCT05239221|526508425|FG009|Overall Study|Withdrawal by Subject|0|||
145997875|NCT05239221|526508426|FG010|Overall Study|Withdrawal by Subject|1|||
145997876|NCT05239221|526508427|FG011|Overall Study|Withdrawal by Subject|0|||
145997877|NCT05239221|526508428|FG012|Overall Study|Withdrawal by Subject|0|||
145997878|NCT05239221|526508429|FG013|Overall Study|Withdrawal by Subject|0|||
145997879|NCT05239221|526508430|FG014|Overall Study|Withdrawal by Subject|0|||
145997880|NCT05239221|526508431|FG015|Overall Study|Withdrawal by Subject|1|||
145997881|NCT02581930|526508432|FG000|Overall Study|Withdrawal by Subject|1|||
145997882|NCT02581930|526508432|FG000|Overall Study|patient declined further treatment|1|||
145997883|NCT01400412|526508433|FG000|Overall Study|Lost to Follow-up|4|||
145997884|NCT01400412|526508434|FG001|Overall Study|Lost to Follow-up|7|||
145997885|NCT01400412|526508433|FG000|Overall Study|Withdrawal by Subject|3|||
145997886|NCT01400412|526508434|FG001|Overall Study|Withdrawal by Subject|4|||
145997887|NCT01400412|526508433|FG000|Overall Study|Unable to complete|3|||
145997888|NCT01400412|526508434|FG001|Overall Study|Unable to complete|3|||
145997889|NCT01400412|526508433|FG000|Overall Study|Never started study treatment|0|||
145997890|NCT01400412|526508434|FG001|Overall Study|Never started study treatment|3|||
145997891|NCT04696146|526510213|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
145997892|NCT04696146|526510214|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
145997893|NCT04696146|526510213|FG000|Overall Study|Off hours issue with product|1|||
145997894|NCT04696146|526510214|FG001|Overall Study|Off hours issue with product|0|||
145997895|NCT01334918|526510219|FG000|Overall Study|Did not receive study drug|6|||
145997896|NCT01334918|526510220|FG001|Overall Study|Did not receive study drug|0|||
145997897|NCT01334918|526510219|FG000|Overall Study|Adverse Event|2|||
145997898|NCT01334918|526510220|FG001|Overall Study|Adverse Event|0|||
145997899|NCT01334918|526510219|FG000|Overall Study|Withdrawal by Subject|0|||
145997900|NCT01334918|526510220|FG001|Overall Study|Withdrawal by Subject|1|||
145997901|NCT01897493|526510221|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
146246832|NCT01757288|527417678|FG001|Overall Study|Consent withdrawal|4|||
145997902|NCT00805389|526510222|FG000|Overall Study|Adverse Event|0|||
145997903|NCT00805389|526510223|FG001|Overall Study|Adverse Event|0|||
145997904|NCT00805389|526510224|FG002|Overall Study|Adverse Event|1|||
145997905|NCT00805389|526510225|FG003|Overall Study|Adverse Event|2|||
145997906|NCT00805389|526510226|FG004|Overall Study|Adverse Event|0|||
145997907|NCT00805389|526510222|FG000|Overall Study|Lost to Follow-up|4|||
145997908|NCT00805389|526510223|FG001|Overall Study|Lost to Follow-up|3|||
145997909|NCT00805389|526510224|FG002|Overall Study|Lost to Follow-up|6|||
145997910|NCT00805389|526510225|FG003|Overall Study|Lost to Follow-up|10|||
145997911|NCT00805389|526510226|FG004|Overall Study|Lost to Follow-up|9|||
145997912|NCT00805389|526510222|FG000|Overall Study|Protocol Violation|0|||
145997913|NCT00805389|526510223|FG001|Overall Study|Protocol Violation|0|||
145997914|NCT00805389|526510224|FG002|Overall Study|Protocol Violation|1|||
145997915|NCT00805389|526510225|FG003|Overall Study|Protocol Violation|0|||
145997916|NCT00805389|526510226|FG004|Overall Study|Protocol Violation|0|||
145997917|NCT00805389|526510222|FG000|Overall Study|Withdrawal by Subject|3|||
145997918|NCT00805389|526510223|FG001|Overall Study|Withdrawal by Subject|2|||
145997919|NCT00805389|526510224|FG002|Overall Study|Withdrawal by Subject|4|||
145997920|NCT00805389|526510225|FG003|Overall Study|Withdrawal by Subject|5|||
145997921|NCT00805389|526510226|FG004|Overall Study|Withdrawal by Subject|4|||
145997922|NCT04388826|526510227|FG000|Overall Study|Lost to Follow-up|3|||
145997923|NCT04388826|526510228|FG001|Overall Study|Lost to Follow-up|2|||
145997924|NCT04388826|526510227|FG000|Overall Study|Adverse Event|1|||
145997925|NCT04388826|526510228|FG001|Overall Study|Adverse Event|0|||
145997926|NCT04047446|526510229|FG000|Overall Study|Physician Decision|1|||
145997927|NCT04047446|526510230|FG001|Overall Study|Physician Decision|0|||
145997928|NCT00329420|526510231|FG000|Re-induction Phase|Lack of Efficacy|0|||
145997929|NCT00329420|526510232|FG001|Re-induction Phase|Lack of Efficacy|1|||
145997930|NCT00329420|526510233|FG002|Re-induction Phase|Lack of Efficacy|0|||
145997931|NCT00329420|526510231|FG000|Re-induction Phase|Withdrawal of Consent|0|||
145997932|NCT00329420|526510232|FG001|Re-induction Phase|Withdrawal of Consent|0|||
145997933|NCT00329420|526510233|FG002|Re-induction Phase|Withdrawal of Consent|1|||
145997934|NCT00329420|526510231|FG000|Re-induction Phase|Did not respond to re-induction|6|||
145997935|NCT00329420|526510232|FG001|Re-induction Phase|Did not respond to re-induction|5|||
145997936|NCT00329420|526510233|FG002|Re-induction Phase|Did not respond to re-induction|7|||
145997937|NCT00329420|526510231|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
145997938|NCT00329420|526510232|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
145997939|NCT00329420|526510233|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
145997940|NCT00329420|526510231|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
145997941|NCT00329420|526510232|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
145997942|NCT00329420|526510233|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
145997943|NCT00329420|526510231|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
145997944|NCT00329420|526510232|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
145997945|NCT00329420|526510233|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
145997946|NCT03386773|526510235|FG000|Overall Study|Lost to Follow-up|24|||
145997947|NCT03386773|526510236|FG001|Overall Study|Lost to Follow-up|33|||
145997948|NCT03386773|526510235|FG000|Overall Study|Withdrawal by Subject|3|||
145997949|NCT03386773|526510236|FG001|Overall Study|Withdrawal by Subject|2|||
145997950|NCT03983421|526510237|FG000|Overall Study|Lost to Follow-up|1|||
145997951|NCT03639610|526510238|FG000|Overall Study|Adverse Event|7|||
145997952|NCT03639610|526510239|FG001|Overall Study|Adverse Event|1|||
145997953|NCT03639610|526510240|FG002|Overall Study|Adverse Event|0|||
145997954|NCT03639610|526510238|FG000|Overall Study|Physician Decision|3|||
145997955|NCT03639610|526510239|FG001|Overall Study|Physician Decision|1|||
145997956|NCT03639610|526510240|FG002|Overall Study|Physician Decision|0|||
145997957|NCT03639610|526510238|FG000|Overall Study|Disease progression|8|||
145997958|NCT03639610|526510239|FG001|Overall Study|Disease progression|5|||
145997959|NCT03639610|526510240|FG002|Overall Study|Disease progression|3|||
145997960|NCT03639610|526510238|FG000|Overall Study|Study terminated by sponsor|2|||
145997961|NCT03639610|526510239|FG001|Overall Study|Study terminated by sponsor|1|||
145997962|NCT03639610|526510240|FG002|Overall Study|Study terminated by sponsor|1|||
145997963|NCT03639610|526510238|FG000|Overall Study|Patient request to stop treatment|1|||
145997964|NCT03639610|526510239|FG001|Overall Study|Patient request to stop treatment|2|||
145997965|NCT03639610|526510240|FG002|Overall Study|Patient request to stop treatment|0|||
145997966|NCT00892008|526510243|FG000|Overall Study|Death|5|||
145997967|NCT00892008|526510243|FG000|Overall Study|Lack of Efficacy|3|||
145997968|NCT00892008|526510243|FG000|Overall Study|Lost to Follow-up|142|||
145997969|NCT00892008|526510243|FG000|Overall Study|Other|378|||
145997970|NCT00892008|526510243|FG000|Overall Study|Adverse Event|37|||
145997971|NCT02410772|526510245|FG000|Overall Study|Death|3|||
145997972|NCT02410772|526510246|FG001|Overall Study|Death|4|||
146091942|NCT02675231|526858470|FG001|Overall Study|Lost to Follow-up|4|||
146091943|NCT02675231|526858471|FG002|Overall Study|Lost to Follow-up|3|||
145997973|NCT02410772|526510247|FG002|Overall Study|Death|8|||
145997974|NCT02410772|526510245|FG000|Overall Study|Lost to Follow-up|31|||
145997975|NCT02410772|526510246|FG001|Overall Study|Lost to Follow-up|23|||
145997976|NCT02410772|526510247|FG002|Overall Study|Lost to Follow-up|22|||
145997977|NCT02410772|526510245|FG000|Overall Study|Pregnancy|8|||
145997978|NCT02410772|526510246|FG001|Overall Study|Pregnancy|4|||
145997979|NCT02410772|526510247|FG002|Overall Study|Pregnancy|5|||
145997980|NCT02410772|526510245|FG000|Overall Study|Protocol Violation|8|||
145997981|NCT02410772|526510246|FG001|Overall Study|Protocol Violation|8|||
145997982|NCT02410772|526510247|FG002|Overall Study|Protocol Violation|4|||
145997983|NCT02410772|526510245|FG000|Overall Study|Baseline Drug Resistance|49|||
145997984|NCT02410772|526510246|FG001|Overall Study|Baseline Drug Resistance|40|||
145997985|NCT02410772|526510247|FG002|Overall Study|Baseline Drug Resistance|51|||
145997986|NCT02410772|526510245|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
145997987|NCT02410772|526510246|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
145997988|NCT02410772|526510247|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
146091944|NCT02652767|526858472|FG000|Overall Study|Death|2|||
145997989|NCT02410772|526510245|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
145997990|NCT02410772|526510246|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
145997991|NCT02410772|526510247|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
145997992|NCT02724839|526510250|FG000|Overall Study|Withdrawal by Subject|1|||
145997993|NCT02724839|526510251|FG001|Overall Study|Withdrawal by Subject|1|||
145997994|NCT02724839|526510252|FG002|Overall Study|Withdrawal by Subject|0|||
145997995|NCT02724839|526510250|FG000|Overall Study|Lost to Follow-up|0|||
145997996|NCT02724839|526510251|FG001|Overall Study|Lost to Follow-up|3|||
145997997|NCT02724839|526510252|FG002|Overall Study|Lost to Follow-up|2|||
145997998|NCT02724839|526510250|FG000|Overall Study|Physician Decision|0|||
145997999|NCT02724839|526510251|FG001|Overall Study|Physician Decision|0|||
145998000|NCT02724839|526510252|FG002|Overall Study|Physician Decision|3|||
145998001|NCT01645176|526510254|FG000|Overall Study|Lack of Efficacy|4|||
145998002|NCT01645176|526510254|FG000|Overall Study|did not complete final MRI|1|||
145998003|NCT05878067|526510255|FG000|Overall Study|Lost to Follow-up|2|||
145998004|NCT00949533|526510258|FG000|Overall Study|Lost to Follow-up|0|||
145998005|NCT00949533|526510259|FG001|Overall Study|Lost to Follow-up|1|||
145998006|NCT01198587|526510262|FG000|Overall Study|Lost to Follow-up|8|||
145998007|NCT01198587|526510263|FG001|Overall Study|Lost to Follow-up|0|||
145998008|NCT01198587|526510264|FG002|Overall Study|Lost to Follow-up|9|||
145998009|NCT01198587|526510265|FG003|Overall Study|Lost to Follow-up|0|||
145998010|NCT01493089|526510266|FG000|Overall Study|Protocol Violation|2|||
145998011|NCT01493089|526510267|FG001|Overall Study|Protocol Violation|2|||
145998012|NCT01493089|526510266|FG000|Overall Study|Withdrawal by Subject|1|||
145998013|NCT01493089|526510267|FG001|Overall Study|Withdrawal by Subject|0|||
145998014|NCT01493089|526510266|FG000|Overall Study|Physician Decision|0|||
145998015|NCT01493089|526510267|FG001|Overall Study|Physician Decision|1|||
145998016|NCT01959529|526510268|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
145998017|NCT01959529|526510269|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
145998018|NCT01959529|526510268|FG000|Overall Study|Lost to Follow-up|4|||
145998019|NCT01959529|526510269|FG001|Overall Study|Lost to Follow-up|1|||
145998020|NCT01959529|526510268|FG000|Overall Study|Other|70|||
145998021|NCT01959529|526510269|FG001|Overall Study|Other|68|||
145998022|NCT01959529|526510268|FG000|Overall Study|Hypoglycaemia|1|||
145998023|NCT01959529|526510269|FG001|Overall Study|Hypoglycaemia|1|||
145998024|NCT01959529|526510268|FG000|Overall Study|Lack of glycaemic control|1|||
145998025|NCT01959529|526510269|FG001|Overall Study|Lack of glycaemic control|1|||
145998026|NCT00560417|526510270|FG000|Overall Study|Adverse Event|3|||
145998027|NCT00560417|526510271|FG001|Overall Study|Adverse Event|2|||
145998028|NCT00560417|526510270|FG000|Overall Study|Entry Criteria Not Met|1|||
145998029|NCT00560417|526510271|FG001|Overall Study|Entry Criteria Not Met|0|||
145998030|NCT00560417|526510270|FG000|Overall Study|Lost to Follow-up|0|||
145998031|NCT00560417|526510271|FG001|Overall Study|Lost to Follow-up|1|||
145998032|NCT00560417|526510270|FG000|Overall Study|Physician Decision|2|||
145998033|NCT00560417|526510271|FG001|Overall Study|Physician Decision|6|||
145998034|NCT00560417|526510270|FG000|Overall Study|Protocol Violation|6|||
145998035|NCT00560417|526510271|FG001|Overall Study|Protocol Violation|5|||
145998036|NCT00560417|526510270|FG000|Overall Study|Sponsor Decision|2|||
145998037|NCT00560417|526510271|FG001|Overall Study|Sponsor Decision|0|||
145998038|NCT00560417|526510270|FG000|Overall Study|Withdrawal by Subject|3|||
145998039|NCT00560417|526510271|FG001|Overall Study|Withdrawal by Subject|3|||
145998040|NCT01870869|526510274|FG000|Overall Study|Implanted with nonstudy device|1|||
145998041|NCT01870869|526510275|FG001|Overall Study|Implanted with nonstudy device|3|||
145998042|NCT01870869|526510276|FG002|Overall Study|Implanted with nonstudy device|14|||
145998043|NCT01870869|526510277|FG003|Overall Study|Implanted with nonstudy device|4|||
145998044|NCT01870869|526510274|FG000|Overall Study|Death|0|||
145998045|NCT01870869|526510275|FG001|Overall Study|Death|0|||
145998046|NCT01870869|526510276|FG002|Overall Study|Death|7|||
145998047|NCT01870869|526510277|FG003|Overall Study|Death|1|||
145998048|NCT01870869|526510274|FG000|Overall Study|Subject choice|6|||
145998049|NCT01870869|526510275|FG001|Overall Study|Subject choice|2|||
145998050|NCT01870869|526510276|FG002|Overall Study|Subject choice|22|||
145998051|NCT01870869|526510277|FG003|Overall Study|Subject choice|8|||
145998052|NCT01870869|526510274|FG000|Overall Study|Lost to Follow-up|10|||
146091945|NCT02652767|526858472|FG000|Overall Study|Lost to Follow-up|1|||
146091946|NCT02652767|526858472|FG000|Overall Study|Withdrawal by Subject|1|||
146091947|NCT00887744|526858481|FG000|Overall Study|Adverse Event|3|||
145998053|NCT01870869|526510275|FG001|Overall Study|Lost to Follow-up|2|||
145998054|NCT01870869|526510276|FG002|Overall Study|Lost to Follow-up|25|||
145998055|NCT01870869|526510277|FG003|Overall Study|Lost to Follow-up|3|||
145998056|NCT01870869|526510274|FG000|Overall Study|Reason not Specified|1|||
145998057|NCT01870869|526510275|FG001|Overall Study|Reason not Specified|2|||
145998058|NCT01870869|526510276|FG002|Overall Study|Reason not Specified|20|||
145998059|NCT01870869|526510277|FG003|Overall Study|Reason not Specified|4|||
145998060|NCT01870869|526510274|FG000|Overall Study|Not evaluable|10|||
145998061|NCT01870869|526510275|FG001|Overall Study|Not evaluable|5|||
145998062|NCT01870869|526510276|FG002|Overall Study|Not evaluable|42|||
145998063|NCT01870869|526510277|FG003|Overall Study|Not evaluable|10|||
146091948|NCT00887744|526858481|FG000|Overall Study|Death|1|||
146246833|NCT01757288|527417679|FG002|Overall Study|Consent withdrawal|4|||
146246834|NCT01757288|527417677|FG000|Overall Study|Patient off study, IRB hold.|0|||
146246835|NCT01757288|527417678|FG001|Overall Study|Patient off study, IRB hold.|0|||
145998064|NCT00557193|526510278|FG000|Induction|Adverse Event|2|||
145998065|NCT00557193|526510279|FG001|Induction|Adverse Event|0|||
145998066|NCT00557193|526510280|FG002|Induction|Adverse Event|0|||
145998067|NCT00557193|526510281|FG003|Induction|Adverse Event|0|||
145998068|NCT00557193|526510282|FG004|Induction|Adverse Event|0|||
145998069|NCT00557193|526510283|FG005|Induction|Adverse Event|0|||
145998070|NCT00557193|526510278|FG000|Induction|Death|6|||
145998071|NCT00557193|526510279|FG001|Induction|Death|0|||
145998072|NCT00557193|526510280|FG002|Induction|Death|0|||
145998073|NCT00557193|526510281|FG003|Induction|Death|0|||
145998074|NCT00557193|526510282|FG004|Induction|Death|0|||
145998075|NCT00557193|526510283|FG005|Induction|Death|0|||
145998076|NCT00557193|526510278|FG000|Induction|Physician Decision|3|||
145998077|NCT00557193|526510279|FG001|Induction|Physician Decision|0|||
145998078|NCT00557193|526510280|FG002|Induction|Physician Decision|0|||
145998079|NCT00557193|526510281|FG003|Induction|Physician Decision|0|||
145998080|NCT00557193|526510282|FG004|Induction|Physician Decision|0|||
145998081|NCT00557193|526510283|FG005|Induction|Physician Decision|0|||
145998082|NCT00557193|526510278|FG000|Induction|Withdrawal by Subject|1|||
145998083|NCT00557193|526510279|FG001|Induction|Withdrawal by Subject|0|||
145998084|NCT00557193|526510280|FG002|Induction|Withdrawal by Subject|0|||
145998085|NCT00557193|526510281|FG003|Induction|Withdrawal by Subject|0|||
145998086|NCT00557193|526510282|FG004|Induction|Withdrawal by Subject|0|||
145998087|NCT00557193|526510283|FG005|Induction|Withdrawal by Subject|0|||
145998088|NCT00557193|526510278|FG000|Induction|Refusal of Further Protocol Therapy|2|||
145998089|NCT00557193|526510279|FG001|Induction|Refusal of Further Protocol Therapy|0|||
145998090|NCT00557193|526510280|FG002|Induction|Refusal of Further Protocol Therapy|0|||
145998091|NCT00557193|526510281|FG003|Induction|Refusal of Further Protocol Therapy|0|||
145998092|NCT00557193|526510282|FG004|Induction|Refusal of Further Protocol Therapy|0|||
145998093|NCT00557193|526510283|FG005|Induction|Refusal of Further Protocol Therapy|0|||
145998094|NCT00557193|526510278|FG000|Induction|Ineligible|8|||
145998095|NCT00557193|526510279|FG001|Induction|Ineligible|0|||
145998096|NCT00557193|526510280|FG002|Induction|Ineligible|0|||
145998097|NCT00557193|526510281|FG003|Induction|Ineligible|0|||
145998098|NCT00557193|526510282|FG004|Induction|Ineligible|0|||
145998099|NCT00557193|526510283|FG005|Induction|Ineligible|0|||
145998100|NCT00557193|526510278|FG000|Induction|Inevaluable for post Induction|2|||
145998101|NCT00557193|526510279|FG001|Induction|Inevaluable for post Induction|0|||
145998102|NCT00557193|526510280|FG002|Induction|Inevaluable for post Induction|0|||
145998103|NCT00557193|526510281|FG003|Induction|Inevaluable for post Induction|0|||
145998104|NCT00557193|526510282|FG004|Induction|Inevaluable for post Induction|0|||
145998105|NCT00557193|526510283|FG005|Induction|Inevaluable for post Induction|0|||
145998106|NCT00557193|526510278|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
145998107|NCT00557193|526510279|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145998108|NCT00557193|526510280|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145998109|NCT00557193|526510281|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145998110|NCT00557193|526510282|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145998111|NCT00557193|526510283|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145998112|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145998113|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
145998114|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
145998115|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
145998116|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145998117|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
145998118|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
145998119|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
146246836|NCT01757288|527417679|FG002|Overall Study|Patient off study, IRB hold.|1|||
146246837|NCT01757288|527417677|FG000|Overall Study|Patient death prior to starting treatment|0|||
146246838|NCT01757288|527417678|FG001|Overall Study|Patient death prior to starting treatment|0|||
145998120|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
145998121|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
145998122|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
145998123|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
145998124|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
145998125|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
145998126|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
145998127|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
145998128|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
145998129|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
145998130|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
146091949|NCT00887744|526858481|FG000|Overall Study|Lost to Follow-up|3|||
146091950|NCT00887744|526858481|FG000|Overall Study|Withdrawal by Subject|18|||
146091951|NCT00887744|526858481|FG000|Overall Study|Various reasons|9|||
146091952|NCT01610271|526858482|FG000|Overall Study|Surgery not complete|0|||
146091953|NCT01610271|526858483|FG001|Overall Study|Surgery not complete|1|||
146091954|NCT01610271|526858482|FG000|Overall Study|Prosthesis not implanted|2|||
146091955|NCT01610271|526858483|FG001|Overall Study|Prosthesis not implanted|3|||
146091956|NCT02961218|526858485|FG000|Overall Study|Lost to Follow-up|0|||
146091957|NCT02961218|526858486|FG001|Overall Study|Lost to Follow-up|2|||
146091958|NCT02961218|526858485|FG000|Overall Study|Physician Decision|0|||
146091959|NCT02961218|526858486|FG001|Overall Study|Physician Decision|2|||
146091960|NCT02961218|526858485|FG000|Overall Study|Subject/Guardian Decision|3|||
146091961|NCT02961218|526858486|FG001|Overall Study|Subject/Guardian Decision|1|||
146246839|NCT01757288|527417679|FG002|Overall Study|Patient death prior to starting treatment|1|||
146246840|NCT01757288|527417677|FG000|Overall Study|Wrong medication administered|0|||
146246841|NCT01757288|527417678|FG001|Overall Study|Wrong medication administered|1|||
146246842|NCT01757288|527417679|FG002|Overall Study|Wrong medication administered|0|||
146246843|NCT01757288|527417677|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
146246844|NCT01757288|527417678|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
146246845|NCT01757288|527417679|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
145998131|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
145998132|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
145998133|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
145998134|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
145998135|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
145998136|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
145998137|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
145998138|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
145998139|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
145998140|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
145998141|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
145998142|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145998143|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145998144|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
145998145|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145998146|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145998147|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145998148|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145998149|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145998150|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
145998151|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145998152|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145998153|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145998154|NCT00557193|526510278|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145998155|NCT00557193|526510279|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145998156|NCT00557193|526510280|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
145998157|NCT00557193|526510281|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145998158|NCT00557193|526510282|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145998159|NCT00557193|526510283|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
145998160|NCT00622726|526510284|FG000|March, 2008 to August, 2010|Death|5|||
145998161|NCT00622726|526510285|FG001|March, 2008 to August, 2010|Death|2|||
145998162|NCT00622726|526510284|FG000|August, 2010 to April, 2013|Death|1|||
145998163|NCT00622726|526510285|FG001|August, 2010 to April, 2013|Death|5|||
145998164|NCT01948427|526510286|FG000|Overall Study|Serious Adverse Event|3|||
145998165|NCT01948427|526510287|FG001|Overall Study|Serious Adverse Event|0|||
145998166|NCT01948427|526510288|FG002|Overall Study|Serious Adverse Event|0|||
145998167|NCT01948427|526510289|FG003|Overall Study|Serious Adverse Event|0|||
145998168|NCT01948427|526510290|FG004|Overall Study|Serious Adverse Event|1|||
145998169|NCT01948427|526510286|FG000|Overall Study|Investigator Request|0|||
145998170|NCT01948427|526510287|FG001|Overall Study|Investigator Request|8|||
145998171|NCT01948427|526510288|FG002|Overall Study|Investigator Request|0|||
145998172|NCT01948427|526510289|FG003|Overall Study|Investigator Request|0|||
145998173|NCT01948427|526510290|FG004|Overall Study|Investigator Request|6|||
145998174|NCT01948427|526510286|FG000|Overall Study|Lost to Follow-up|1|||
145998175|NCT01948427|526510287|FG001|Overall Study|Lost to Follow-up|0|||
146091962|NCT01462227|526858487|FG000|Second Assignment|Lost to Follow-up|1|||
145998176|NCT01948427|526510288|FG002|Overall Study|Lost to Follow-up|0|||
145998177|NCT01948427|526510289|FG003|Overall Study|Lost to Follow-up|0|||
146091963|NCT01462227|526858488|FG001|Second Assignment|Lost to Follow-up|0|||
145998178|NCT01948427|526510290|FG004|Overall Study|Lost to Follow-up|4|||
145998179|NCT01948427|526510286|FG000|Overall Study|Withdrawal by Subject|2|||
145998180|NCT01948427|526510287|FG001|Overall Study|Withdrawal by Subject|0|||
145998181|NCT01948427|526510288|FG002|Overall Study|Withdrawal by Subject|0|||
145998182|NCT01948427|526510289|FG003|Overall Study|Withdrawal by Subject|0|||
145998183|NCT01948427|526510290|FG004|Overall Study|Withdrawal by Subject|1|||
145998184|NCT01948427|526510286|FG000|Overall Study|Other, Not Specified|1|||
145998185|NCT01948427|526510287|FG001|Overall Study|Other, Not Specified|9|||
145998186|NCT01948427|526510288|FG002|Overall Study|Other, Not Specified|0|||
145998187|NCT01948427|526510289|FG003|Overall Study|Other, Not Specified|0|||
145998188|NCT01948427|526510290|FG004|Overall Study|Other, Not Specified|2|||
145998189|NCT02448381|526510292|FG000|Overall Study|Adverse Event|2|||
145998190|NCT02448381|526510293|FG001|Overall Study|Adverse Event|0|||
146091964|NCT01462227|526858489|FG002|Second Assignment|Lost to Follow-up|0|||
146091965|NCT01462227|526858490|FG003|Second Assignment|Lost to Follow-up|0|||
146091966|NCT01462227|526858487|FG000|Second Assignment|Protocol Violation|0|||
146091967|NCT01462227|526858488|FG001|Second Assignment|Protocol Violation|1|||
146091968|NCT01462227|526858489|FG002|Second Assignment|Protocol Violation|1|||
146091969|NCT01462227|526858490|FG003|Second Assignment|Protocol Violation|0|||
146091970|NCT00591266|526858491|FG000|Overall Study|Adverse Event|2|||
146091971|NCT00591266|526858492|FG001|Overall Study|Adverse Event|2|||
146091972|NCT00591266|526858493|FG002|Overall Study|Adverse Event|3|||
146091973|NCT00591266|526858491|FG000|Overall Study|Lost to Follow-up|0|||
146091974|NCT00591266|526858492|FG001|Overall Study|Lost to Follow-up|1|||
146091975|NCT00591266|526858493|FG002|Overall Study|Lost to Follow-up|0|||
146091976|NCT00591266|526858491|FG000|Overall Study|Protocol Violation|0|||
146091977|NCT00591266|526858492|FG001|Overall Study|Protocol Violation|0|||
146091978|NCT00591266|526858493|FG002|Overall Study|Protocol Violation|1|||
146091979|NCT00591266|526858491|FG000|Overall Study|Withdrawal by Subject|6|||
146091980|NCT00591266|526858492|FG001|Overall Study|Withdrawal by Subject|2|||
146091981|NCT00591266|526858493|FG002|Overall Study|Withdrawal by Subject|5|||
146091982|NCT00591266|526858491|FG000|Overall Study|Lack of Efficacy|0|||
146246846|NCT01757288|527417677|FG000|Overall Study|Not meeting protocol constraints|0|||
146246847|NCT01757288|527417678|FG001|Overall Study|Not meeting protocol constraints|1|||
146246848|NCT01757288|527417679|FG002|Overall Study|Not meeting protocol constraints|1|||
146091983|NCT00591266|526858492|FG001|Overall Study|Lack of Efficacy|2|||
146091984|NCT00591266|526858493|FG002|Overall Study|Lack of Efficacy|0|||
146091985|NCT00591266|526858491|FG000|Overall Study|Other|1|||
146091986|NCT00591266|526858492|FG001|Overall Study|Other|4|||
146091987|NCT00591266|526858493|FG002|Overall Study|Other|5|||
146091988|NCT00586846|526858494|FG000|Overall Study|Physician Decision|1|||
146091989|NCT00586846|526858494|FG000|Overall Study|Death|1|||
146091990|NCT00586846|526858494|FG000|Overall Study|Evaluable for Toxicity Only|4|||
146091991|NCT05298306|526858497|FG000|Overall Study|Physician Decision|0|||
146091992|NCT05298306|526858498|FG001|Overall Study|Physician Decision|0|||
146091993|NCT05298306|526858499|FG002|Overall Study|Physician Decision|0|||
146091994|NCT05298306|526858500|FG003|Overall Study|Physician Decision|1|||
146091995|NCT05298306|526858501|FG004|Overall Study|Physician Decision|0|||
146091996|NCT05298306|526858502|FG005|Overall Study|Physician Decision|0|||
146091997|NCT01178073|526858503|FG000|Overall Study|Adverse Event|34|||
146091998|NCT01178073|526858504|FG001|Overall Study|Adverse Event|27|||
146091999|NCT01178073|526858505|FG002|Overall Study|Adverse Event|24|||
146092000|NCT01178073|526858503|FG000|Overall Study|Protocol Violation|1|||
146092001|NCT01178073|526858504|FG001|Overall Study|Protocol Violation|1|||
146092002|NCT01178073|526858505|FG002|Overall Study|Protocol Violation|1|||
146092003|NCT01178073|526858503|FG000|Overall Study|Lost to Follow-up|2|||
146092004|NCT01178073|526858504|FG001|Overall Study|Lost to Follow-up|0|||
146092005|NCT01178073|526858505|FG002|Overall Study|Lost to Follow-up|3|||
146092006|NCT01178073|526858503|FG000|Overall Study|Physician Decision|14|||
146092007|NCT01178073|526858504|FG001|Overall Study|Physician Decision|10|||
146092008|NCT01178073|526858505|FG002|Overall Study|Physician Decision|10|||
146092009|NCT01178073|526858503|FG000|Overall Study|Withdrawal by Subject|10|||
146092010|NCT01178073|526858504|FG001|Overall Study|Withdrawal by Subject|6|||
146092011|NCT01178073|526858505|FG002|Overall Study|Withdrawal by Subject|8|||
146092012|NCT01178073|526858503|FG000|Overall Study|Missing Completion Status|1|||
146092013|NCT01178073|526858504|FG001|Overall Study|Missing Completion Status|0|||
146092014|NCT01178073|526858505|FG002|Overall Study|Missing Completion Status|0|||
146092015|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
146246849|NCT01757288|527417677|FG000|Overall Study|Multiple missed appointments|0|||
146246850|NCT01757288|527417678|FG001|Overall Study|Multiple missed appointments|1|||
145998191|NCT02448381|526510292|FG000|Overall Study|Lost to Follow-up|16|||
146092016|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
146092017|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
146092018|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
146092019|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
145998192|NCT02448381|526510293|FG001|Overall Study|Lost to Follow-up|9|||
146092020|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
145998193|NCT02448381|526510292|FG000|Overall Study|Physician Decision|1|||
145998194|NCT02448381|526510293|FG001|Overall Study|Physician Decision|1|||
145998195|NCT02448381|526510292|FG000|Overall Study|Pregnancy|1|||
145998196|NCT02448381|526510293|FG001|Overall Study|Pregnancy|0|||
145998197|NCT02448381|526510292|FG000|Overall Study|Withdrawal by Subject|13|||
145998198|NCT02448381|526510293|FG001|Overall Study|Withdrawal by Subject|9|||
145998199|NCT02448381|526510292|FG000|Overall Study|Noncompliance with Study Procedures|2|||
145998200|NCT02448381|526510293|FG001|Overall Study|Noncompliance with Study Procedures|0|||
145998201|NCT00335829|526510296|FG000|Overall Study|Withdrawal by Subject|1|||
145998202|NCT00335829|526510296|FG000|Overall Study|Lost to Follow-up|1|||
145998203|NCT00335829|526510296|FG000|Overall Study|Adverse Event|1|||
145998204|NCT00854360|526510297|FG000|Overall Study|Adverse Event|0|||
145998205|NCT00854360|526510298|FG001|Overall Study|Adverse Event|1|||
145998206|NCT00854360|526510299|FG002|Overall Study|Adverse Event|2|||
145998207|NCT00854360|526510300|FG003|Overall Study|Adverse Event|6|||
145998208|NCT00854360|526510297|FG000|Overall Study|Withdrawal by Subject|0|||
145998209|NCT00854360|526510298|FG001|Overall Study|Withdrawal by Subject|0|||
145998210|NCT00854360|526510299|FG002|Overall Study|Withdrawal by Subject|0|||
145998211|NCT00854360|526510300|FG003|Overall Study|Withdrawal by Subject|1|||
145998212|NCT00854360|526510297|FG000|Overall Study|Pregnancy|0|||
145998213|NCT00854360|526510298|FG001|Overall Study|Pregnancy|1|||
145998214|NCT00854360|526510299|FG002|Overall Study|Pregnancy|0|||
145998215|NCT00854360|526510300|FG003|Overall Study|Pregnancy|0|||
145998216|NCT00854360|526510297|FG000|Overall Study|Lack of Efficacy|2|||
145998217|NCT00854360|526510298|FG001|Overall Study|Lack of Efficacy|1|||
145998218|NCT00854360|526510299|FG002|Overall Study|Lack of Efficacy|0|||
145998219|NCT00854360|526510300|FG003|Overall Study|Lack of Efficacy|0|||
145998220|NCT00854360|526510297|FG000|Overall Study|Other|0|||
145998221|NCT00854360|526510298|FG001|Overall Study|Other|0|||
145998222|NCT00854360|526510299|FG002|Overall Study|Other|0|||
145998223|NCT00854360|526510300|FG003|Overall Study|Other|3|||
145998224|NCT00754572|526510301|FG000|Overall Study|Adverse Event|19|||
145998225|NCT00754572|526510301|FG000|Overall Study|Other|39|||
145998226|NCT00754572|526510301|FG000|Overall Study|Protocol Violation|3|||
145998227|NCT00754572|526510301|FG000|Overall Study|Withdrawal by Subject|3|||
145998228|NCT00754572|526510301|FG000|Overall Study|Lack of Efficacy|2|||
145998229|NCT00754572|526510301|FG000|Overall Study|Death|1|||
145998230|NCT00754572|526510301|FG000|Overall Study|Administrative Reason|3|||
145998231|NCT00754572|526510301|FG000|Overall Study|Lost to Follow-up|1|||
145998232|NCT01170663|526510302|FG000|Overall Study|Lost to Follow-up|3|||
145998233|NCT01170663|526510303|FG001|Overall Study|Lost to Follow-up|9|||
145998234|NCT01170663|526510302|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
145998235|NCT01170663|526510303|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
145998236|NCT02006927|526510306|FG000|Overall Study|Adverse Event|2|||
145998237|NCT02006927|526510306|FG000|Overall Study|Withdrawal by Subject|1|||
145998238|NCT02735200|526510309|FG000|Overall Study|Lost to Follow-up|0|||
145998239|NCT02735200|526510310|FG001|Overall Study|Lost to Follow-up|5|||
145998240|NCT02735200|526510309|FG000|Overall Study|Withdrawal by Subject|8|||
145998241|NCT02735200|526510310|FG001|Overall Study|Withdrawal by Subject|0|||
145998242|NCT02746809|526510311|FG000|Enrollment|Inclusion Exclusion not met|9|||
145998243|NCT02746809|526510311|FG000|Enrollment|Withdrawal by Subject|1|||
145998244|NCT02746809|526510311|FG000|Enrollment|Expected Enrollment Met|2|||
145998245|NCT02746809|526510311|FG000|Procedure|Death|1|||
145998246|NCT02746809|526510311|FG000|1-Month|Death|5|||
145998247|NCT02746809|526510311|FG000|6-Month|Death|2|||
145998248|NCT02746809|526510311|FG000|6-Month|Withdrawal by Subject|1|||
145998249|NCT02746809|526510311|FG000|12-Month|Death|3|||
145998250|NCT02746809|526510311|FG000|12-Month|Withdrawal by Subject|2|||
145998251|NCT02746809|526510311|FG000|24-Month|Death|1|||
145998252|NCT02746809|526510311|FG000|24-Month|Withdrawal by Subject|1|||
145998253|NCT02746809|526510311|FG000|36-Month|Death|8|||
145998254|NCT02746809|526510311|FG000|36-Month|Withdrawal by Subject|1|||
145998255|NCT02746809|526510311|FG000|48-Month|Death|7|||
145998256|NCT02746809|526510311|FG000|48-Month|Withdrawal by Subject|1|||
145998257|NCT02746809|526510311|FG000|60-Month|Death|1|||
146092021|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
145998258|NCT02746809|526510311|FG000|60-Month|Lost to Follow-up|2|||
145998259|NCT01164007|526510314|FG000|Overall Study|Adverse Event|5|||
145998260|NCT01164007|526510314|FG000|Overall Study|Progression of Disease|30|||
145998261|NCT01164007|526510314|FG000|Overall Study|Protocol Violation|1|||
145998262|NCT01164007|526510314|FG000|Overall Study|Withdrawal by Subject|1|||
145998263|NCT01164007|526510314|FG000|Overall Study|Medical Decision|3|||
145998264|NCT00894387|526510315|FG000|Overall Study|Adverse Event|44|||
145998265|NCT00894387|526510316|FG001|Overall Study|Adverse Event|45|||
145998266|NCT00894387|526510315|FG000|Overall Study|Abnormal Laboratory values|2|||
145998267|NCT00894387|526510316|FG001|Overall Study|Abnormal Laboratory values|2|||
145998268|NCT00894387|526510315|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145998269|NCT00894387|526510316|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145998270|NCT00894387|526510315|FG000|Overall Study|Lost to Follow-up|3|||
145998271|NCT00894387|526510316|FG001|Overall Study|Lost to Follow-up|5|||
145998272|NCT00894387|526510315|FG000|Overall Study|Administrative problems|2|||
145998273|NCT00894387|526510316|FG001|Overall Study|Administrative problems|2|||
145998274|NCT00894387|526510315|FG000|Overall Study|Death|77|||
145998275|NCT00894387|526510316|FG001|Overall Study|Death|76|||
145998276|NCT00894387|526510315|FG000|Overall Study|Protocol Deviation|4|||
145998277|NCT00894387|526510316|FG001|Overall Study|Protocol Deviation|0|||
145998278|NCT00894387|526510315|FG000|Overall Study|Patient's request|25|||
145998279|NCT00894387|526510316|FG001|Overall Study|Patient's request|30|||
145998280|NCT00894387|526510315|FG000|Overall Study|Other (Missing)|5|||
145998281|NCT00894387|526510316|FG001|Overall Study|Other (Missing)|3|||
145998282|NCT00894387|526510315|FG000|Overall Study|Mis-randomized|13|||
145998283|NCT00894387|526510316|FG001|Overall Study|Mis-randomized|9|||
145998284|NCT00894387|526510315|FG000|Overall Study|GCP non-compliance|0|||
145998285|NCT00894387|526510316|FG001|Overall Study|GCP non-compliance|2|||
145998286|NCT00744861|526510317|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
145998287|NCT00744861|526510318|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
145998288|NCT00744861|526510319|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
145998289|NCT00744861|526510320|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
145998290|NCT00744861|526510317|FG000|Feasibility Stage 1|Pregnancy|0|||
145998291|NCT00744861|526510318|FG001|Feasibility Stage 1|Pregnancy|1|||
145998292|NCT00744861|526510319|FG002|Feasibility Stage 1|Pregnancy|0|||
145998293|NCT00744861|526510320|FG003|Feasibility Stage 1|Pregnancy|0|||
145998294|NCT00744861|526510317|FG000|Pivotal Stage 2|Adverse Event|0|||
145998295|NCT00744861|526510318|FG001|Pivotal Stage 2|Adverse Event|0|||
145998296|NCT00744861|526510319|FG002|Pivotal Stage 2|Adverse Event|6|||
145998297|NCT00744861|526510320|FG003|Pivotal Stage 2|Adverse Event|11|||
145998298|NCT00744861|526510317|FG000|Pivotal Stage 2|Death|0|||
145998299|NCT00744861|526510318|FG001|Pivotal Stage 2|Death|0|||
145998300|NCT00744861|526510319|FG002|Pivotal Stage 2|Death|0|||
145998301|NCT00744861|526510320|FG003|Pivotal Stage 2|Death|1|||
145998302|NCT00744861|526510317|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
145998303|NCT00744861|526510318|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
145998304|NCT00744861|526510319|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
145998305|NCT00744861|526510320|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
145998306|NCT00744861|526510317|FG000|Pivotal Stage 2|Physician Decision|0|||
145998307|NCT00744861|526510318|FG001|Pivotal Stage 2|Physician Decision|0|||
145998308|NCT00744861|526510319|FG002|Pivotal Stage 2|Physician Decision|3|||
145998309|NCT00744861|526510320|FG003|Pivotal Stage 2|Physician Decision|1|||
145998310|NCT00744861|526510317|FG000|Pivotal Stage 2|Protocol Violation|0|||
145998311|NCT00744861|526510318|FG001|Pivotal Stage 2|Protocol Violation|0|||
145998312|NCT00744861|526510319|FG002|Pivotal Stage 2|Protocol Violation|0|||
145998313|NCT00744861|526510320|FG003|Pivotal Stage 2|Protocol Violation|1|||
145998314|NCT00744861|526510317|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
145998315|NCT00744861|526510318|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
145998316|NCT00744861|526510319|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
145998317|NCT00744861|526510320|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
145998318|NCT00744861|526510317|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
145998319|NCT00744861|526510318|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
145998320|NCT00744861|526510319|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
145998321|NCT00744861|526510320|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
145998322|NCT02493764|526510321|FG000|Overall Study|Adverse Event|2|||
145998323|NCT02493764|526510322|FG001|Overall Study|Adverse Event|2|||
145998324|NCT02493764|526510321|FG000|Overall Study|Death|44|||
145998325|NCT02493764|526510322|FG001|Overall Study|Death|58|||
145998326|NCT02493764|526510321|FG000|Overall Study|Lost to Follow-up|2|||
145998327|NCT02493764|526510322|FG001|Overall Study|Lost to Follow-up|1|||
145998328|NCT02493764|526510321|FG000|Overall Study|Protocol Violation|6|||
145998329|NCT02493764|526510322|FG001|Overall Study|Protocol Violation|7|||
145998330|NCT02493764|526510321|FG000|Overall Study|Physician Decision|1|||
146092022|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
146246851|NCT01757288|527417679|FG002|Overall Study|Multiple missed appointments|0|||
146246852|NCT01757288|527417677|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
146246853|NCT01757288|527417678|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
146246854|NCT01757288|527417679|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
146246855|NCT01757288|527417677|FG000|Overall Study|>2 weeks treatment break|0|||
145998331|NCT02493764|526510322|FG001|Overall Study|Physician Decision|1|||
145998332|NCT02493764|526510321|FG000|Overall Study|Participant moved|17|||
145998333|NCT02493764|526510322|FG001|Overall Study|Participant moved|5|||
145998334|NCT02493764|526510321|FG000|Overall Study|Withdrawal parent/guardian|0|||
145998335|NCT02493764|526510322|FG001|Overall Study|Withdrawal parent/guardian|1|||
145998336|NCT02493764|526510321|FG000|Overall Study|Withdrawal by Subject|11|||
145998337|NCT02493764|526510322|FG001|Overall Study|Withdrawal by Subject|7|||
145998338|NCT01561976|526510323|FG000|Period 1|Adverse Event|0|||
145998339|NCT01561976|526510324|FG001|Period 1|Adverse Event|0|||
145998340|NCT01561976|526510325|FG002|Period 1|Adverse Event|1|||
145998341|NCT01561976|526510326|FG003|Period 1|Adverse Event|0|||
145998342|NCT01561976|526510327|FG004|Period 1|Adverse Event|0|||
145998343|NCT01561976|526510328|FG005|Period 1|Adverse Event|0|||
145998344|NCT01561976|526510323|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
145998345|NCT01561976|526510324|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
145998346|NCT01561976|526510325|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
145998347|NCT01561976|526510326|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
145998348|NCT01561976|526510327|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
145998349|NCT01561976|526510328|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
145998350|NCT01561976|526510323|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145998351|NCT01561976|526510324|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145998352|NCT01561976|526510325|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145998353|NCT01561976|526510326|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145998354|NCT01561976|526510327|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145998355|NCT01561976|526510328|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145998356|NCT01561976|526510323|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
145998357|NCT01561976|526510324|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
145998358|NCT01561976|526510325|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
145998359|NCT01561976|526510326|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
145998360|NCT01561976|526510327|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
145998361|NCT01561976|526510328|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
145998362|NCT01977222|526510331|FG000|Overall Study|Withdrawal by Subject|1|||
145998363|NCT04165824|526510332|FG000|Overall Study|Adverse Event|23|||
145998364|NCT04165824|526510332|FG000|Overall Study|Physician Decision|1|||
145998365|NCT04165824|526510332|FG000|Overall Study|Withdrawal by Subject|17|||
145998366|NCT04165824|526510332|FG000|Overall Study|Other|5|||
145998367|NCT04403919|526510333|FG000|Overall Study|Lost to Follow-up|0|||
145998368|NCT04403919|526510334|FG001|Overall Study|Lost to Follow-up|0|||
145998369|NCT04403919|526510335|FG002|Overall Study|Lost to Follow-up|0|||
145998370|NCT04403919|526510336|FG003|Overall Study|Lost to Follow-up|1|||
145998371|NCT01038323|526510337|FG000|Overall Study|Withdrawal by Subject|3|||
145998372|NCT01038323|526510338|FG001|Overall Study|Withdrawal by Subject|2|||
145998373|NCT01038323|526510339|FG002|Overall Study|Withdrawal by Subject|4|||
145998374|NCT05643495|526510346|FG000|Overall Study|Adverse Event|0|||
145998375|NCT05643495|526510347|FG001|Overall Study|Adverse Event|1|||
145998376|NCT05643495|526510346|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145998377|NCT05643495|526510347|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
145998378|NCT02257528|526510348|FG000|Overall Study|Never received study treatment|1|||
145998379|NCT04237584|526510349|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
145998380|NCT04237584|526510350|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
145998381|NCT04237584|526510351|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
145998382|NCT04237584|526510352|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
146092023|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
146092024|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146092025|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146092026|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
146092027|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
146092028|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
146092029|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
146092030|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
146092031|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146092032|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
146092033|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146092034|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
146092035|NCT01226043|526858517|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
146092036|NCT01226043|526858518|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
146092037|NCT01226043|526858519|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
146092038|NCT01226043|526858520|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
146092039|NCT01226043|526858517|FG000|6-week Re-randomization Phase|Adverse Event|0|||
146092040|NCT01226043|526858518|FG001|6-week Re-randomization Phase|Adverse Event|0|||
146092041|NCT01226043|526858519|FG002|6-week Re-randomization Phase|Adverse Event|1|||
146092042|NCT01226043|526858520|FG003|6-week Re-randomization Phase|Adverse Event|1|||
146092043|NCT01226043|526858517|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
146092044|NCT01226043|526858518|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
146092045|NCT01226043|526858519|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
146092046|NCT01226043|526858520|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
146092047|NCT01226043|526858517|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
146092048|NCT01226043|526858518|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
145998383|NCT04237584|526510349|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145998384|NCT04237584|526510350|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145998385|NCT04237584|526510351|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
146092049|NCT01226043|526858519|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
145998386|NCT04237584|526510352|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145998387|NCT04237584|526510349|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145998388|NCT04237584|526510350|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145998389|NCT04237584|526510351|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
145998390|NCT04237584|526510352|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145998391|NCT04237584|526510349|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
145998392|NCT04237584|526510350|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
145998393|NCT04237584|526510351|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
145998394|NCT04237584|526510352|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
145998395|NCT04237584|526510349|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145998396|NCT04237584|526510350|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145998397|NCT04237584|526510351|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
145998398|NCT04237584|526510352|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145998399|NCT00529633|526511443|FG000|Overall Study|Withdrawal by Subject|1|||
145998400|NCT00529633|526511444|FG001|Overall Study|Withdrawal by Subject|1|||
145998401|NCT02777086|526511450|FG000|Overall Study|Lost to Follow-up|96|||
145998402|NCT02777086|526511451|FG001|Overall Study|Lost to Follow-up|99|||
145998403|NCT01133665|526511452|FG000|Overall Study|Physician Decision|2|||
145998404|NCT01819272|526511453|FG000|Overall Study|Adverse Event|1|||
145998405|NCT01819272|526511454|FG001|Overall Study|Adverse Event|0|||
145998406|NCT01819272|526511455|FG002|Overall Study|Adverse Event|0|||
145998407|NCT01819272|526511456|FG003|Overall Study|Adverse Event|2|||
145998408|NCT01819272|526511457|FG004|Overall Study|Adverse Event|0|||
145998409|NCT01819272|526511458|FG005|Overall Study|Adverse Event|0|||
145998410|NCT01819272|526511453|FG000|Overall Study|Lost to Follow-up|3|||
145998411|NCT01819272|526511454|FG001|Overall Study|Lost to Follow-up|0|||
145998412|NCT01819272|526511455|FG002|Overall Study|Lost to Follow-up|1|||
145998413|NCT01819272|526511456|FG003|Overall Study|Lost to Follow-up|0|||
145998414|NCT01819272|526511457|FG004|Overall Study|Lost to Follow-up|0|||
145998415|NCT01819272|526511458|FG005|Overall Study|Lost to Follow-up|3|||
146246856|NCT01757288|527417678|FG001|Overall Study|>2 weeks treatment break|0|||
146246857|NCT01757288|527417679|FG002|Overall Study|>2 weeks treatment break|1|||
146246858|NCT02825550|527417680|FG000|Overall Study|Physician Decision|1|||
146246859|NCT00042939|527417681|FG000|Overall Study|Adverse Event|6|||
146246860|NCT00042939|527417682|FG001|Overall Study|Adverse Event|7|||
146246861|NCT00042939|527417681|FG000|Overall Study|Death|3|||
146246862|NCT00042939|527417682|FG001|Overall Study|Death|2|||
146246863|NCT00042939|527417681|FG000|Overall Study|Withdrawal by Subject|3|||
146246864|NCT00042939|527417682|FG001|Overall Study|Withdrawal by Subject|4|||
146246865|NCT00042939|527417681|FG000|Overall Study|Other disease|1|||
146246866|NCT00042939|527417682|FG001|Overall Study|Other disease|0|||
146246867|NCT00042939|527417681|FG000|Overall Study|Ineligible|2|||
146246868|NCT00042939|527417682|FG001|Overall Study|Ineligible|2|||
146246869|NCT00042939|527417681|FG000|Overall Study|Deterioration of health|3|||
146246870|NCT00042939|527417682|FG001|Overall Study|Deterioration of health|4|||
146246871|NCT00042939|527417681|FG000|Overall Study|QOL diminished|1|||
146246872|NCT00042939|527417682|FG001|Overall Study|QOL diminished|0|||
146246873|NCT00042939|527417681|FG000|Overall Study|Rising ca 19-9|1|||
146246874|NCT00042939|527417682|FG001|Overall Study|Rising ca 19-9|0|||
146246875|NCT00042939|527417681|FG000|Overall Study|Patient non-compliance|1|||
146246876|NCT00042939|527417682|FG001|Overall Study|Patient non-compliance|0|||
146246877|NCT00042939|527417681|FG000|Overall Study|Still on treatment|1|||
145998416|NCT01819272|526511453|FG000|Overall Study|Protocol Violation|0|||
146246878|NCT00042939|527417682|FG001|Overall Study|Still on treatment|0|||
145998417|NCT01819272|526511454|FG001|Overall Study|Protocol Violation|0|||
145998418|NCT01819272|526511455|FG002|Overall Study|Protocol Violation|0|||
145998419|NCT01819272|526511456|FG003|Overall Study|Protocol Violation|1|||
145998420|NCT01819272|526511457|FG004|Overall Study|Protocol Violation|2|||
145998421|NCT01819272|526511458|FG005|Overall Study|Protocol Violation|3|||
145998422|NCT01819272|526511453|FG000|Overall Study|Physician Decision|0|||
146246879|NCT00042939|527417681|FG000|Overall Study|Treatment break > 4 weeks|0|||
145998423|NCT01819272|526511454|FG001|Overall Study|Physician Decision|1|||
145998424|NCT01819272|526511455|FG002|Overall Study|Physician Decision|0|||
146246880|NCT00042939|527417682|FG001|Overall Study|Treatment break > 4 weeks|1|||
145998425|NCT01819272|526511456|FG003|Overall Study|Physician Decision|0|||
145998426|NCT01819272|526511457|FG004|Overall Study|Physician Decision|0|||
145998427|NCT01819272|526511458|FG005|Overall Study|Physician Decision|0|||
146246881|NCT00042939|527417681|FG000|Overall Study|Did not start treatment|2|||
146246882|NCT00042939|527417682|FG001|Overall Study|Did not start treatment|1|||
145998428|NCT01819272|526511453|FG000|Overall Study|Withdrawal of Consent|0|||
145998429|NCT01819272|526511454|FG001|Overall Study|Withdrawal of Consent|1|||
145998430|NCT01819272|526511455|FG002|Overall Study|Withdrawal of Consent|2|||
146246883|NCT00795639|527417683|FG000|Overall Study|Death|1|||
146246884|NCT00795639|527417684|FG001|Overall Study|Death|6|||
146246885|NCT00795639|527417683|FG000|Overall Study|Withdrawal by Subject|1|||
146246886|NCT00795639|527417684|FG001|Overall Study|Withdrawal by Subject|3|||
146246887|NCT00795639|527417683|FG000|Overall Study|Pregnancy|1|||
146246888|NCT00795639|527417684|FG001|Overall Study|Pregnancy|0|||
146246889|NCT00795639|527417683|FG000|Overall Study|Adverse Event|5|||
146246890|NCT00795639|527417684|FG001|Overall Study|Adverse Event|2|||
146246891|NCT00795639|527417683|FG000|Overall Study|Other|0|||
146246892|NCT00795639|527417684|FG001|Overall Study|Other|2|||
146246893|NCT00795639|527417683|FG000|Overall Study|Terminated by sponsor|13|||
146246894|NCT00795639|527417684|FG001|Overall Study|Terminated by sponsor|12|||
146246895|NCT00795639|527417683|FG000|Overall Study|Randomized and not treated|0|||
146246896|NCT00795639|527417684|FG001|Overall Study|Randomized and not treated|1|||
146246897|NCT03349476|527417685|FG000|Overall Study|Physician Decision|3|||
146246898|NCT00248794|527417686|FG000|Overall Study|Lost to Follow-up|6|||
146246899|NCT00248794|527417687|FG001|Overall Study|Lost to Follow-up|8|||
146246900|NCT00248794|527417688|FG002|Overall Study|Lost to Follow-up|3|||
146246901|NCT01762345|527417691|FG000|Overall Study|Adverse Event|5|||
146246902|NCT01762345|527417691|FG000|Overall Study|Protocol Violation|2|||
146246903|NCT00244751|527417692|FG000|Overall Study|Adverse Event|7|||
146246904|NCT00244751|527417693|FG001|Overall Study|Adverse Event|7|||
145998431|NCT01819272|526511456|FG003|Overall Study|Withdrawal of Consent|1|||
145998432|NCT01819272|526511457|FG004|Overall Study|Withdrawal of Consent|0|||
145998433|NCT01819272|526511458|FG005|Overall Study|Withdrawal of Consent|1|||
145998434|NCT01819272|526511453|FG000|Overall Study|Loss of Glucose Control|2|||
145998435|NCT01819272|526511454|FG001|Overall Study|Loss of Glucose Control|1|||
145998436|NCT01819272|526511455|FG002|Overall Study|Loss of Glucose Control|0|||
145998437|NCT01819272|526511456|FG003|Overall Study|Loss of Glucose Control|1|||
146246905|NCT00244751|527417694|FG002|Overall Study|Adverse Event|5|||
146246906|NCT00244751|527417692|FG000|Overall Study|Lost to Follow-up|0|||
146246907|NCT00244751|527417693|FG001|Overall Study|Lost to Follow-up|1|||
146246908|NCT00244751|527417694|FG002|Overall Study|Lost to Follow-up|0|||
146246909|NCT00244751|527417692|FG000|Overall Study|Protocol Violation|1|||
146246910|NCT00244751|527417693|FG001|Overall Study|Protocol Violation|0|||
146246911|NCT00244751|527417694|FG002|Overall Study|Protocol Violation|1|||
146246912|NCT00244751|527417692|FG000|Overall Study|Withdrawal by Subject|7|||
146246913|NCT00244751|527417693|FG001|Overall Study|Withdrawal by Subject|5|||
146246914|NCT00244751|527417694|FG002|Overall Study|Withdrawal by Subject|3|||
146246915|NCT00244751|527417692|FG000|Overall Study|Elevated liver enzymes|1|||
145998438|NCT01819272|526511457|FG004|Overall Study|Loss of Glucose Control|2|||
145998439|NCT01819272|526511458|FG005|Overall Study|Loss of Glucose Control|0|||
145998440|NCT01276704|526511459|FG000|Overall Study|Lost to Follow-up|2|||
145998441|NCT01276704|526511460|FG001|Overall Study|Lost to Follow-up|3|||
146246916|NCT00244751|527417693|FG001|Overall Study|Elevated liver enzymes|0|||
146246917|NCT00244751|527417694|FG002|Overall Study|Elevated liver enzymes|0|||
146246918|NCT00244751|527417692|FG000|Overall Study|Lack of compliance with protocol|0|||
146246919|NCT00244751|527417693|FG001|Overall Study|Lack of compliance with protocol|1|||
146246920|NCT00244751|527417694|FG002|Overall Study|Lack of compliance with protocol|0|||
146246921|NCT00244751|527417692|FG000|Overall Study|Safety reasons|0|||
146246922|NCT00244751|527417693|FG001|Overall Study|Safety reasons|1|||
146246923|NCT00244751|527417694|FG002|Overall Study|Safety reasons|0|||
146246924|NCT00244751|527417692|FG000|Overall Study|Participant randomized by mistake|0|||
146246925|NCT00244751|527417693|FG001|Overall Study|Participant randomized by mistake|0|||
146246926|NCT00244751|527417694|FG002|Overall Study|Participant randomized by mistake|1|||
145998442|NCT01276704|526511459|FG000|Overall Study|Non-compliant|2|||
145998443|NCT01276704|526511460|FG001|Overall Study|Non-compliant|2|||
145998444|NCT01276704|526511459|FG000|Overall Study|Withdrawal by Subject|7|||
146246927|NCT00761267|527417699|FG000|Overall Study|Death|1|||
146246928|NCT00761267|527417700|FG001|Overall Study|Death|2|||
146246929|NCT00761267|527417701|FG002|Overall Study|Death|5|||
146246930|NCT00761267|527417699|FG000|Overall Study|Lost to Follow-up|0|||
146246931|NCT00761267|527417700|FG001|Overall Study|Lost to Follow-up|0|||
146246932|NCT00761267|527417701|FG002|Overall Study|Lost to Follow-up|1|||
146246933|NCT00761267|527417699|FG000|Overall Study|Randomized but not treated|1|||
146246934|NCT00761267|527417700|FG001|Overall Study|Randomized but not treated|1|||
146246935|NCT00761267|527417701|FG002|Overall Study|Randomized but not treated|0|||
146246936|NCT00761267|527417699|FG000|Overall Study|Withdrawal by Subject|0|||
146246937|NCT00761267|527417700|FG001|Overall Study|Withdrawal by Subject|1|||
146246938|NCT00761267|527417701|FG002|Overall Study|Withdrawal by Subject|0|||
145998445|NCT01276704|526511460|FG001|Overall Study|Withdrawal by Subject|1|||
146246939|NCT01777932|527417702|FG000|Overall Study|Disease progression|136|||
146246940|NCT01777932|527417702|FG000|Overall Study|Death|3|||
145998446|NCT01276704|526511459|FG000|Overall Study|Physician Decision|3|||
146246941|NCT01777932|527417702|FG000|Overall Study|Adverse Event|34|||
146246942|NCT01777932|527417702|FG000|Overall Study|Lost to Follow-up|3|||
146246943|NCT01777932|527417702|FG000|Overall Study|Investigator decision|10|||
145998447|NCT01276704|526511460|FG001|Overall Study|Physician Decision|5|||
146298064|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
146246944|NCT01777932|527417702|FG000|Overall Study|Reimbursement limit|9|||
146246945|NCT01777932|527417702|FG000|Overall Study|Patient refused further treatment|10|||
146298065|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
145998448|NCT01359956|526511461|FG000|Overall Study|Death|58|||
146246946|NCT01419184|527417706|FG000|Overall Study|Site data not available|3|||
145998449|NCT01359956|526511462|FG001|Overall Study|Death|60|||
145998450|NCT01359956|526511463|FG002|Overall Study|Death|66|||
145998451|NCT01359956|526511464|FG003|Overall Study|Death|57|||
145998452|NCT01359956|526511461|FG000|Overall Study|Lost to Follow-up|3|||
145998453|NCT01359956|526511462|FG001|Overall Study|Lost to Follow-up|4|||
145998454|NCT01359956|526511463|FG002|Overall Study|Lost to Follow-up|1|||
145998455|NCT01359956|526511464|FG003|Overall Study|Lost to Follow-up|1|||
145998456|NCT01784029|526511465|FG000|Overall Study|Lost to Follow-up|19|||
145998457|NCT01784029|526511466|FG001|Overall Study|Lost to Follow-up|20|||
145998458|NCT01784029|526511467|FG002|Overall Study|Lost to Follow-up|22|||
145998459|NCT00370292|526511468|FG000|Overall Study|Disease Progression|4|||
145998460|NCT00370292|526511468|FG000|Overall Study|Adverse Event|7|||
145998461|NCT00370292|526511468|FG000|Overall Study|Physician Decision|2|||
145998462|NCT00276419|526511469|FG000|First Intervention|Adverse Event|1|||
145998463|NCT00276419|526511470|FG001|First Intervention|Adverse Event|0|||
145998464|NCT00276419|526511469|FG000|First Intervention|Withdrawal by Subject|0|||
145998465|NCT00276419|526511470|FG001|First Intervention|Withdrawal by Subject|2|||
145998466|NCT02704208|526511471|FG000|Overall Study|Lost to Follow-up|42|||
145998467|NCT02704208|526511472|FG001|Overall Study|Lost to Follow-up|37|||
145998468|NCT03801525|526511473|FG000|Overall Study|Adverse Event|17|||
145998469|NCT03801525|526511474|FG001|Overall Study|Adverse Event|1|||
145998470|NCT03801525|526511475|FG002|Overall Study|Adverse Event|0|||
145998471|NCT03801525|526511473|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
145998472|NCT03801525|526511474|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
145998473|NCT03801525|526511475|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
145998474|NCT03801525|526511473|FG000|Overall Study|Death|29|||
145998475|NCT03801525|526511474|FG001|Overall Study|Death|1|||
145998476|NCT03801525|526511475|FG002|Overall Study|Death|4|||
145998477|NCT03801525|526511473|FG000|Overall Study|Disease Progression|6|||
145998478|NCT03801525|526511474|FG001|Overall Study|Disease Progression|0|||
145998479|NCT03801525|526511475|FG002|Overall Study|Disease Progression|1|||
145998480|NCT03801525|526511473|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
145998481|NCT03801525|526511474|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
145998482|NCT03801525|526511475|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
145998483|NCT03801525|526511473|FG000|Overall Study|Investigator Decision|18|||
145998484|NCT03801525|526511474|FG001|Overall Study|Investigator Decision|1|||
145998485|NCT03801525|526511475|FG002|Overall Study|Investigator Decision|0|||
145998486|NCT03801525|526511473|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
145998487|NCT03801525|526511474|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
145998488|NCT03801525|526511475|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
145998489|NCT03801525|526511473|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
145998490|NCT03801525|526511474|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
145998491|NCT03801525|526511475|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
145998492|NCT03801525|526511473|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
145998493|NCT03801525|526511474|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
145998494|NCT03801525|526511475|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
145998495|NCT03801525|526511473|FG000|Overall Study|Withdrawal of Subject Consent|38|||
145998496|NCT03801525|526511474|FG001|Overall Study|Withdrawal of Subject Consent|2|||
145998497|NCT03801525|526511475|FG002|Overall Study|Withdrawal of Subject Consent|1|||
145998498|NCT03801525|526511473|FG000|Overall Study|Reason not Specified|4|||
145998499|NCT03801525|526511474|FG001|Overall Study|Reason not Specified|0|||
145998500|NCT03801525|526511475|FG002|Overall Study|Reason not Specified|4|||
145998501|NCT03545672|526511478|FG000|Overall Study|Uncertain diagnosis|2|||
145998502|NCT03545672|526511479|FG001|Overall Study|Uncertain diagnosis|1|||
145998503|NCT03545672|526511478|FG000|Overall Study|Protocol Violation|2|||
145998504|NCT03545672|526511479|FG001|Overall Study|Protocol Violation|2|||
145998505|NCT01628913|526511480|FG000|Overall Study|Adverse Event|12|||
145998506|NCT01628913|526511481|FG001|Overall Study|Adverse Event|5|||
145998507|NCT01628913|526511480|FG000|Overall Study|Disease Progression|11|||
146246947|NCT01419184|527417707|FG001|Overall Study|Site data not available|2|||
146246948|NCT01419184|527417706|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
146246949|NCT01419184|527417707|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
146246950|NCT01419184|527417706|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
146246951|NCT01419184|527417707|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
146246952|NCT01419184|527417706|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
145998508|NCT01628913|526511481|FG001|Overall Study|Disease Progression|14|||
145998509|NCT01628913|526511480|FG000|Overall Study|Protocol Violation|1|||
145998510|NCT01628913|526511481|FG001|Overall Study|Protocol Violation|0|||
145998511|NCT01628913|526511480|FG000|Overall Study|Death|1|||
146246953|NCT01419184|527417707|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
145998512|NCT01628913|526511481|FG001|Overall Study|Death|0|||
145998513|NCT01628913|526511480|FG000|Overall Study|study terminated by Sponsor|4|||
145998514|NCT01628913|526511481|FG001|Overall Study|study terminated by Sponsor|9|||
145998515|NCT01628913|526511480|FG000|Overall Study|Withdrawal by Subject|1|||
145998516|NCT01628913|526511481|FG001|Overall Study|Withdrawal by Subject|0|||
145998517|NCT01628913|526511480|FG000|Overall Study|Physician Decision|1|||
145998518|NCT01628913|526511481|FG001|Overall Study|Physician Decision|3|||
145998519|NCT00560508|526511483|FG000|12 Week Double-blind Period|Adverse Event|3|||
145998520|NCT00560508|526511484|FG001|12 Week Double-blind Period|Adverse Event|2|||
145998521|NCT00560508|526511483|FG000|12 Week Double-blind Period|Protocol Violation|1|||
145998522|NCT00560508|526511484|FG001|12 Week Double-blind Period|Protocol Violation|0|||
145998523|NCT00560508|526511483|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
145998524|NCT00560508|526511484|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
145998525|NCT00560508|526511483|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
145998526|NCT00560508|526511484|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
145998527|NCT00560508|526511483|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
145998528|NCT00560508|526511484|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
145998529|NCT00560508|526511483|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
145998530|NCT00560508|526511484|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
145998531|NCT00560508|526511483|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
145998532|NCT00560508|526511484|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
145998533|NCT02164864|526511485|FG000|Overall Study|Trial disease worsening|7|||
145998534|NCT02164864|526511486|FG001|Overall Study|Trial disease worsening|5|||
145998535|NCT02164864|526511487|FG002|Overall Study|Trial disease worsening|1|||
145998536|NCT02164864|526511485|FG000|Overall Study|Other pre-existing disease worsening|6|||
145998537|NCT02164864|526511486|FG001|Overall Study|Other pre-existing disease worsening|4|||
145998538|NCT02164864|526511487|FG002|Overall Study|Other pre-existing disease worsening|9|||
145998539|NCT02164864|526511485|FG000|Overall Study|Other Adverse Event (AE)|52|||
145998540|NCT02164864|526511486|FG001|Overall Study|Other Adverse Event (AE)|32|||
145998541|NCT02164864|526511487|FG002|Overall Study|Other Adverse Event (AE)|49|||
145998542|NCT02164864|526511485|FG000|Overall Study|Protocol Violation|2|||
145998543|NCT02164864|526511486|FG001|Overall Study|Protocol Violation|4|||
145998544|NCT02164864|526511487|FG002|Overall Study|Protocol Violation|1|||
145998545|NCT02164864|526511485|FG000|Overall Study|Lost to Follow-up|4|||
145998546|NCT02164864|526511486|FG001|Overall Study|Lost to Follow-up|3|||
145998547|NCT02164864|526511487|FG002|Overall Study|Lost to Follow-up|2|||
145998548|NCT02164864|526511485|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
145998549|NCT02164864|526511486|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
145998550|NCT02164864|526511487|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
145998551|NCT02164864|526511485|FG000|Overall Study|Other than stated|3|||
145998552|NCT02164864|526511486|FG001|Overall Study|Other than stated|4|||
145998553|NCT02164864|526511487|FG002|Overall Study|Other than stated|14|||
145998554|NCT00652834|526511488|FG000|Overall Study|Withdrawal by Subject|3|||
145998555|NCT00652834|526511488|FG000|Overall Study|Lost to Follow-up|2|||
145998556|NCT03984825|526511489|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
145998557|NCT03984825|526511489|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
145998558|NCT03984825|526511489|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
145998559|NCT02569853|526511490|FG000|Overall Study|Adverse Event|2|||
145998560|NCT02569853|526511491|FG001|Overall Study|Adverse Event|0|||
145998561|NCT02569853|526511490|FG000|Overall Study|Withdrawal by Subject|3|||
145998562|NCT02569853|526511491|FG001|Overall Study|Withdrawal by Subject|2|||
145998563|NCT02569853|526511490|FG000|Overall Study|Lost to Follow-up|3|||
145998564|NCT02569853|526511491|FG001|Overall Study|Lost to Follow-up|3|||
145998565|NCT02569853|526511490|FG000|Overall Study|Protocol Violation|1|||
145998566|NCT02569853|526511491|FG001|Overall Study|Protocol Violation|1|||
145998567|NCT02569853|526511490|FG000|Overall Study|Did not experience migraine attack|10|||
145998568|NCT02569853|526511491|FG001|Overall Study|Did not experience migraine attack|7|||
145998569|NCT02569853|526511490|FG000|Overall Study|Physician Decision|1|||
145998570|NCT02569853|526511491|FG001|Overall Study|Physician Decision|1|||
145998571|NCT02271880|526511493|FG000|Overall Study|Premature discontinuation of study|3|||
145998572|NCT02271880|526511494|FG001|Overall Study|Premature discontinuation of study|4|||
145998573|NCT00474903|526511495|FG000|Overall Study|Protocol Violation|1|||
145998574|NCT00474903|526511496|FG001|Overall Study|Protocol Violation|5|||
145998575|NCT00474903|526511497|FG002|Overall Study|Protocol Violation|2|||
145998576|NCT01612676|526511501|FG000|Overall Study|Adverse Event|2|||
145998577|NCT01612676|526511502|FG001|Overall Study|Adverse Event|3|||
145998578|NCT01612676|526511503|FG002|Overall Study|Adverse Event|1|||
145998579|NCT01612676|526511504|FG003|Overall Study|Adverse Event|3|||
145998580|NCT01612676|526511501|FG000|Overall Study|Protocol Violation|0|||
145998581|NCT01612676|526511502|FG001|Overall Study|Protocol Violation|1|||
145998582|NCT01612676|526511503|FG002|Overall Study|Protocol Violation|0|||
145998583|NCT01612676|526511504|FG003|Overall Study|Protocol Violation|0|||
145998584|NCT04846231|526511511|FG000|Overall Study|Lost to Follow-up|1|||
145998585|NCT04846231|526511512|FG001|Overall Study|Lost to Follow-up|0|||
145998586|NCT04846231|526511513|FG002|Overall Study|Lost to Follow-up|0|||
145998587|NCT04846231|526511514|FG003|Overall Study|Lost to Follow-up|0|||
145998588|NCT04846231|526511515|FG004|Overall Study|Lost to Follow-up|0|||
145998589|NCT04846231|526511516|FG005|Overall Study|Lost to Follow-up|0|||
145998590|NCT04846231|526511517|FG006|Overall Study|Lost to Follow-up|0|||
145998591|NCT04846231|526511518|FG007|Overall Study|Lost to Follow-up|1|||
145998592|NCT04846231|526511511|FG000|Overall Study|Withdrawal by Subject|0|||
145998593|NCT04846231|526511512|FG001|Overall Study|Withdrawal by Subject|1|||
145998594|NCT04846231|526511513|FG002|Overall Study|Withdrawal by Subject|2|||
145998595|NCT04846231|526511514|FG003|Overall Study|Withdrawal by Subject|1|||
145998596|NCT04846231|526511515|FG004|Overall Study|Withdrawal by Subject|0|||
145998597|NCT04846231|526511516|FG005|Overall Study|Withdrawal by Subject|0|||
145998598|NCT04846231|526511517|FG006|Overall Study|Withdrawal by Subject|0|||
145998599|NCT04846231|526511518|FG007|Overall Study|Withdrawal by Subject|0|||
145998600|NCT04846231|526511511|FG000|Overall Study|Protocol Violation|0|||
145998601|NCT04846231|526511512|FG001|Overall Study|Protocol Violation|1|||
145998602|NCT04846231|526511513|FG002|Overall Study|Protocol Violation|0|||
145998603|NCT04846231|526511514|FG003|Overall Study|Protocol Violation|0|||
145998604|NCT04846231|526511515|FG004|Overall Study|Protocol Violation|0|||
145998605|NCT04846231|526511516|FG005|Overall Study|Protocol Violation|0|||
145998606|NCT04846231|526511517|FG006|Overall Study|Protocol Violation|0|||
145998607|NCT04846231|526511518|FG007|Overall Study|Protocol Violation|0|||
145998608|NCT04846231|526511511|FG000|Overall Study|Adverse Event|0|||
145998609|NCT04846231|526511512|FG001|Overall Study|Adverse Event|0|||
145998610|NCT04846231|526511513|FG002|Overall Study|Adverse Event|0|||
145998611|NCT04846231|526511514|FG003|Overall Study|Adverse Event|0|||
145998612|NCT04846231|526511515|FG004|Overall Study|Adverse Event|0|||
145998613|NCT04846231|526511516|FG005|Overall Study|Adverse Event|0|||
145998614|NCT04846231|526511517|FG006|Overall Study|Adverse Event|1|||
145998615|NCT04846231|526511518|FG007|Overall Study|Adverse Event|1|||
145998616|NCT02980107|526511519|FG000|Overall Study|Withdrawal by Subject|51|||
145998617|NCT02980107|526511520|FG001|Overall Study|Withdrawal by Subject|62|||
145998618|NCT04064905|526511523|FG000|Overall Study|Lost to Follow-up|0|||
145998619|NCT04064905|526511524|FG001|Overall Study|Lost to Follow-up|3|||
145998620|NCT04064905|526511525|FG002|Overall Study|Lost to Follow-up|1|||
145998621|NCT04064905|526511526|FG003|Overall Study|Lost to Follow-up|4|||
145998622|NCT04064905|526511527|FG004|Overall Study|Lost to Follow-up|2|||
145998623|NCT00404248|526511531|FG000|Overall Study|pts declining status|0|||
145998624|NCT00404248|526511532|FG001|Overall Study|pts declining status|1|||
145998625|NCT00404248|526511533|FG002|Overall Study|pts declining status|0|||
145998626|NCT00404248|526511534|FG003|Overall Study|pts declining status|0|||
145998627|NCT00404248|526511535|FG004|Overall Study|pts declining status|0|||
145998628|NCT00404248|526511536|FG005|Overall Study|pts declining status|0|||
145998629|NCT00404248|526511537|FG006|Overall Study|pts declining status|0|||
145998630|NCT00404248|526511538|FG007|Overall Study|pts declining status|0|||
145998631|NCT00404248|526511539|FG008|Overall Study|pts declining status|0|||
145998632|NCT00789555|526511540|FG000|Overall Study|Protocol Amendment|78|||
145998633|NCT00789555|526511541|FG001|Overall Study|Protocol Amendment|76|||
145998634|NCT00789555|526511542|FG002|Overall Study|Protocol Amendment|80|||
145998635|NCT00789555|526511540|FG000|Overall Study|Adverse Event|17|||
145998636|NCT00789555|526511541|FG001|Overall Study|Adverse Event|7|||
145998637|NCT00789555|526511542|FG002|Overall Study|Adverse Event|10|||
145998638|NCT00789555|526511540|FG000|Overall Study|Lost to Follow-up|9|||
145998639|NCT00789555|526511541|FG001|Overall Study|Lost to Follow-up|10|||
145998640|NCT00789555|526511542|FG002|Overall Study|Lost to Follow-up|18|||
145998641|NCT00789555|526511540|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
145998642|NCT00789555|526511541|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
145998643|NCT00789555|526511542|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
145998644|NCT00789555|526511540|FG000|Overall Study|Treatment failure|11|||
145998645|NCT00789555|526511541|FG001|Overall Study|Treatment failure|8|||
145998646|NCT00789555|526511542|FG002|Overall Study|Treatment failure|12|||
145998647|NCT00789555|526511540|FG000|Overall Study|Protocol Violation|6|||
145998648|NCT00789555|526511541|FG001|Overall Study|Protocol Violation|9|||
145998649|NCT00789555|526511542|FG002|Overall Study|Protocol Violation|13|||
145998650|NCT00698841|526511543|FG000|Overall Study|Withdrawal by Subject|2|||
145998651|NCT00698841|526511543|FG000|Overall Study|Adverse Event|3|||
145998652|NCT00698841|526511543|FG000|Overall Study|Disease progression|7|||
145998653|NCT00698841|526511543|FG000|Overall Study|Failure to meet eligibility criteria|2|||
145998654|NCT00698841|526511543|FG000|Overall Study|Study drug toxicity|2|||
145998655|NCT00698841|526511543|FG000|Overall Study|Other|2|||
145998656|NCT04646005|526511544|FG000|Overall Study|Adverse Event|1|||
145998657|NCT04646005|526511544|FG000|Overall Study|Progressive Disease|71|||
145998658|NCT04646005|526511544|FG000|Overall Study|Death|20|||
145998659|NCT04646005|526511544|FG000|Overall Study|Withdrawal by Subject|12|||
145998660|NCT04646005|526511544|FG000|Overall Study|Sponsor Request|9|||
145998661|NCT05788991|526511545|FG000|Overall Study|Not treated with study medication|1|||
145998662|NCT05788991|526511546|FG001|Overall Study|Not treated with study medication|3|||
145998663|NCT05788991|526511545|FG000|Overall Study|Withdrawal by Subject|1|||
145998664|NCT05788991|526511546|FG001|Overall Study|Withdrawal by Subject|0|||
145998665|NCT05788991|526511545|FG000|Overall Study|Lack of Efficacy|0|||
145998666|NCT05788991|526511546|FG001|Overall Study|Lack of Efficacy|1|||
145998667|NCT05788991|526511545|FG000|Overall Study|Protocol Violation|1|||
145998668|NCT05788991|526511546|FG001|Overall Study|Protocol Violation|2|||
145998669|NCT04464473|526511547|FG000|Overall Study|New piercing could not be removed for scanning|0|||
145998670|NCT04464473|526511548|FG001|Overall Study|New piercing could not be removed for scanning|0|||
145998671|NCT04464473|526511549|FG002|Overall Study|New piercing could not be removed for scanning|0|||
145998672|NCT04464473|526511550|FG003|Overall Study|New piercing could not be removed for scanning|1|||
145998673|NCT04464473|526511551|FG004|Overall Study|New piercing could not be removed for scanning|0|||
145998674|NCT04464473|526511552|FG005|Overall Study|New piercing could not be removed for scanning|0|||
145998675|NCT04464473|526511547|FG000|Overall Study|Adverse Event|0|||
145998676|NCT04464473|526511548|FG001|Overall Study|Adverse Event|0|||
145998677|NCT04464473|526511549|FG002|Overall Study|Adverse Event|0|||
146246954|NCT01419184|527417706|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
146246955|NCT01419184|527417707|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
146246956|NCT01419184|527417706|FG000|Overall Study|Participant randomized, not treated|1|||
146246957|NCT01419184|527417707|FG001|Overall Study|Participant randomized, not treated|0|||
146246958|NCT03031782|527417710|FG000|Treatment Period 1|Lack of Efficacy|3|||
146246959|NCT03031782|527417711|FG001|Treatment Period 1|Lack of Efficacy|0|||
146246960|NCT03031782|527417712|FG002|Treatment Period 1|Lack of Efficacy|0|||
146246961|NCT03031782|527417713|FG003|Treatment Period 1|Lack of Efficacy|0|||
146246962|NCT03031782|527417714|FG004|Treatment Period 1|Lack of Efficacy|0|||
146246963|NCT03031782|527417710|FG000|Treatment Period 2|Physician Decision|0|||
146246964|NCT03031782|527417711|FG001|Treatment Period 2|Physician Decision|1|||
146246965|NCT03031782|527417712|FG002|Treatment Period 2|Physician Decision|0|||
146246966|NCT03031782|527417713|FG003|Treatment Period 2|Physician Decision|0|||
146246967|NCT03031782|527417714|FG004|Treatment Period 2|Physician Decision|3|||
146246968|NCT03031782|527417710|FG000|Treatment Period 2|Lack of Efficacy|0|||
146246969|NCT03031782|527417711|FG001|Treatment Period 2|Lack of Efficacy|1|||
146246970|NCT03031782|527417712|FG002|Treatment Period 2|Lack of Efficacy|0|||
146246971|NCT03031782|527417713|FG003|Treatment Period 2|Lack of Efficacy|0|||
146246972|NCT03031782|527417714|FG004|Treatment Period 2|Lack of Efficacy|1|||
146246973|NCT03031782|527417710|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146246974|NCT03031782|527417711|FG001|Treatment Period 2|Withdrawal by Subject|3|||
146246975|NCT03031782|527417712|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146246976|NCT03031782|527417713|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146246977|NCT03031782|527417714|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146246978|NCT03031782|527417710|FG000|Treatment Period 2|Adverse Event|0|||
146246979|NCT03031782|527417711|FG001|Treatment Period 2|Adverse Event|1|||
146246980|NCT03031782|527417712|FG002|Treatment Period 2|Adverse Event|2|||
146246981|NCT03031782|527417713|FG003|Treatment Period 2|Adverse Event|0|||
146246982|NCT03031782|527417714|FG004|Treatment Period 2|Adverse Event|0|||
145998678|NCT04464473|526511550|FG003|Overall Study|Adverse Event|1|||
145998679|NCT04464473|526511551|FG004|Overall Study|Adverse Event|0|||
145998680|NCT04464473|526511552|FG005|Overall Study|Adverse Event|0|||
145998681|NCT04464473|526511547|FG000|Overall Study|Lost to Follow-up|0|||
145998682|NCT04464473|526511548|FG001|Overall Study|Lost to Follow-up|0|||
145998683|NCT04464473|526511549|FG002|Overall Study|Lost to Follow-up|0|||
145998684|NCT04464473|526511550|FG003|Overall Study|Lost to Follow-up|1|||
145998685|NCT04464473|526511551|FG004|Overall Study|Lost to Follow-up|0|||
145998686|NCT04464473|526511552|FG005|Overall Study|Lost to Follow-up|0|||
145998687|NCT03802396|526511553|FG000|Overall Study|Withdrawal by Subject|2|||
145998688|NCT03802396|526511554|FG001|Overall Study|Withdrawal by Subject|0|||
145998689|NCT03802396|526511553|FG000|Overall Study|Surgery Cancelled|1|||
145998690|NCT03802396|526511554|FG001|Overall Study|Surgery Cancelled|0|||
145998691|NCT01576783|526512698|FG000|Overall Study|Change in Medical Care|1|||
145998692|NCT01576783|526512699|FG001|Overall Study|Change in Medical Care|0|||
145998693|NCT01576783|526512698|FG000|Overall Study|Lost to Follow-up|14|||
145998694|NCT01576783|526512699|FG001|Overall Study|Lost to Follow-up|16|||
145998695|NCT01576783|526512698|FG000|Overall Study|Withdrawal by Subject|5|||
145998696|NCT01576783|526512699|FG001|Overall Study|Withdrawal by Subject|1|||
145998697|NCT01732536|526512702|FG000|Overall Study|Withdrawal by Subject|1|||
145998698|NCT01732536|526512703|FG001|Overall Study|Withdrawal by Subject|1|||
145998699|NCT05111145|526512706|FG000|Overall Study|Commercial drug is available for participant|76|||
145998700|NCT05111145|526512706|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
145998701|NCT03728933|526512709|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145998702|NCT03728933|526512710|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145998703|NCT03728933|526512711|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145998704|NCT03728933|526512709|FG000|Overall Study|Withdrawal by Subject|0|||
145998705|NCT03728933|526512710|FG001|Overall Study|Withdrawal by Subject|0|||
145998706|NCT03728933|526512711|FG002|Overall Study|Withdrawal by Subject|1|||
145998707|NCT03728933|526512709|FG000|Overall Study|Lost to Follow-up|0|||
145998708|NCT03728933|526512710|FG001|Overall Study|Lost to Follow-up|1|||
145998709|NCT03728933|526512711|FG002|Overall Study|Lost to Follow-up|0|||
146246983|NCT03031782|527417710|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146246984|NCT03031782|527417711|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146246985|NCT03031782|527417712|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146246986|NCT03031782|527417713|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146246987|NCT03031782|527417714|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146246988|NCT00424476|527417717|FG000|Overall Study|Withdrawal by Subject|7|||
145998710|NCT03728933|526512709|FG000|Overall Study|Adverse Event|1|||
145998711|NCT03728933|526512710|FG001|Overall Study|Adverse Event|0|||
145998712|NCT03728933|526512711|FG002|Overall Study|Adverse Event|0|||
145998713|NCT01146613|526512712|FG000|Overall Study|Lost to Follow-up|3|||
145998714|NCT01146613|526512713|FG001|Overall Study|Lost to Follow-up|8|||
145998715|NCT01146613|526512712|FG000|Overall Study|Lack of Efficacy|0|||
145998716|NCT01146613|526512713|FG001|Overall Study|Lack of Efficacy|1|||
145998717|NCT01146613|526512712|FG000|Overall Study|Death|1|||
145998718|NCT01146613|526512713|FG001|Overall Study|Death|0|||
145998719|NCT01146613|526512712|FG000|Overall Study|Physician Decision|1|||
145998720|NCT01146613|526512713|FG001|Overall Study|Physician Decision|0|||
145998721|NCT01146613|526512712|FG000|Overall Study|Withdrawal by Subject|0|||
145998722|NCT01146613|526512713|FG001|Overall Study|Withdrawal by Subject|3|||
145998723|NCT01146613|526512712|FG000|Overall Study|schedule conflict|1|||
145998724|NCT01146613|526512713|FG001|Overall Study|schedule conflict|0|||
145998725|NCT01146613|526512712|FG000|Overall Study|Outpatient detox|1|||
145998726|NCT01146613|526512713|FG001|Overall Study|Outpatient detox|0|||
145998727|NCT00320606|526512714|FG000|Overall Study|Adverse Event|1|||
145998728|NCT00320606|526512714|FG000|Overall Study|Protocol Violation|1|||
145998729|NCT00320606|526512714|FG000|Overall Study|Withdrawal by Subject|1|||
145998730|NCT00399529|526512717|FG000|Overall Study|Off Study Prior to Treatment|2|||
145998731|NCT00742625|526512718|FG000|Remission Induction|Progression|6|||
145998732|NCT00742625|526512718|FG000|Remission Induction|Failed induction|8|||
145998733|NCT00742625|526512718|FG000|Remission Induction|Adverse Event|3|||
145998734|NCT00742625|526512718|FG000|Remission Induction|Death|10|||
145998735|NCT00742625|526512718|FG000|Remission Induction|Refusal|5|||
145998736|NCT00742625|526512718|FG000|Remission Induction|Non protocol treatment|17|||
145998737|NCT00742625|526512718|FG000|Remission Induction|Other, not specified|5|||
145998738|NCT00742625|526512718|FG000|Consolidation|Progression|5|||
145998739|NCT00742625|526512718|FG000|Consolidation|Adverse Event|1|||
145998740|NCT00742625|526512718|FG000|Consolidation|Death|1|||
145998741|NCT00742625|526512718|FG000|Consolidation|Refused|1|||
145998742|NCT00742625|526512718|FG000|Consolidation|Non protocol therapy|13|||
145998743|NCT02519842|526512722|FG000|Base Study: Cycle 1|Screening Failure|1|||
145998744|NCT02519842|526512723|FG001|Base Study: Cycle 1|Screening Failure|1|||
145998745|NCT02519842|526512724|FG002|Base Study: Cycle 1|Screening Failure|0|||
145998746|NCT02519842|526512722|FG000|Base Study: Cycle 1|Adverse Event|1|||
145998747|NCT02519842|526512723|FG001|Base Study: Cycle 1|Adverse Event|0|||
145998748|NCT02519842|526512724|FG002|Base Study: Cycle 1|Adverse Event|0|||
145998749|NCT02519842|526512722|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
145998750|NCT02519842|526512723|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
145998751|NCT02519842|526512724|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
145998752|NCT02519842|526512722|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
145998753|NCT02519842|526512723|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
145998754|NCT02519842|526512724|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
145998755|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
145998756|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
145998757|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
145998758|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
145998759|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
145998760|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
145998761|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145998762|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145998763|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
146092050|NCT01226043|526858520|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
146246989|NCT00424476|527417718|FG001|Overall Study|Withdrawal by Subject|6|||
146246990|NCT00424476|527417719|FG002|Overall Study|Withdrawal by Subject|3|||
146246991|NCT00424476|527417717|FG000|Overall Study|Adverse Event|19|||
146246992|NCT00424476|527417718|FG001|Overall Study|Adverse Event|16|||
146246993|NCT00424476|527417719|FG002|Overall Study|Adverse Event|15|||
146246994|NCT00424476|527417717|FG000|Overall Study|Lack of Efficacy|16|||
145998764|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
145998765|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
145998766|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
145998767|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Death|0|||
145998768|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Death|0|||
145998769|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Death|1|||
145998770|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
145998771|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
145998772|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
145998773|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
146246995|NCT00424476|527417718|FG001|Overall Study|Lack of Efficacy|12|||
145998774|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
145998775|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
145998776|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
145998777|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
145998778|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
145998779|NCT02519842|526512722|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
145998780|NCT02519842|526512723|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
145998781|NCT02519842|526512724|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
145998782|NCT02115321|526512725|FG000|Overall Study|Death|1|||
145998783|NCT02115321|526512726|FG001|Overall Study|Death|0|||
145998784|NCT01816295|526512728|FG000|Double Blind Phase|Adverse Event|11|||
145998785|NCT01816295|526512729|FG001|Double Blind Phase|Adverse Event|8|||
145998786|NCT01816295|526512728|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
145998787|NCT01816295|526512729|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
145998788|NCT01816295|526512728|FG000|Double Blind Phase|Lost to Follow-up|3|||
145998789|NCT01816295|526512729|FG001|Double Blind Phase|Lost to Follow-up|5|||
145998790|NCT01816295|526512728|FG000|Double Blind Phase|Physician Decision|2|||
145998791|NCT01816295|526512729|FG001|Double Blind Phase|Physician Decision|2|||
145998792|NCT01816295|526512728|FG000|Double Blind Phase|Protocol Violation|17|||
145998793|NCT01816295|526512729|FG001|Double Blind Phase|Protocol Violation|11|||
145998794|NCT01816295|526512728|FG000|Double Blind Phase|Sponsor Decision|8|||
145998795|NCT01816295|526512729|FG001|Double Blind Phase|Sponsor Decision|8|||
145998796|NCT01816295|526512728|FG000|Double Blind Phase|Withdrawal by Subject|22|||
145998797|NCT01816295|526512729|FG001|Double Blind Phase|Withdrawal by Subject|20|||
145998798|NCT01816295|526512728|FG000|OLE Phase|Adverse Event|17|||
145998799|NCT01816295|526512729|FG001|OLE Phase|Adverse Event|15|||
145998800|NCT01816295|526512728|FG000|OLE Phase|Death|1|||
145998801|NCT01816295|526512729|FG001|OLE Phase|Death|0|||
145998802|NCT01816295|526512728|FG000|OLE Phase|Entry Criteria Not Met|3|||
145998803|NCT01816295|526512729|FG001|OLE Phase|Entry Criteria Not Met|5|||
145998804|NCT01816295|526512728|FG000|OLE Phase|Lost to Follow-up|5|||
145998805|NCT01816295|526512729|FG001|OLE Phase|Lost to Follow-up|5|||
145998806|NCT01816295|526512728|FG000|OLE Phase|Physician Decision|3|||
145998807|NCT01816295|526512729|FG001|OLE Phase|Physician Decision|1|||
145998808|NCT01816295|526512728|FG000|OLE Phase|Protocol Violation|4|||
145998809|NCT01816295|526512729|FG001|OLE Phase|Protocol Violation|4|||
145998810|NCT01816295|526512728|FG000|OLE Phase|Sponsor Decision|7|||
145998811|NCT01816295|526512729|FG001|OLE Phase|Sponsor Decision|9|||
145998812|NCT01816295|526512728|FG000|OLE Phase|Withdrawal by Subject|10|||
145998813|NCT01816295|526512729|FG001|OLE Phase|Withdrawal by Subject|10|||
145998814|NCT01816295|526512728|FG000|OLE Phase|Lack of Efficacy|3|||
145998815|NCT01816295|526512729|FG001|OLE Phase|Lack of Efficacy|7|||
145998816|NCT01156844|526512732|FG000|Overall Study|Adverse Event|0|||
145998817|NCT01156844|526512733|FG001|Overall Study|Adverse Event|0|||
145998818|NCT01156844|526512734|FG002|Overall Study|Adverse Event|1|||
145998819|NCT01156844|526512735|FG003|Overall Study|Adverse Event|1|||
145998820|NCT01156844|526512732|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145998821|NCT01156844|526512733|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145998822|NCT01156844|526512734|FG002|Overall Study|Abnormal test procedure result(s)|2|||
145998823|NCT01156844|526512735|FG003|Overall Study|Abnormal test procedure result(s)|2|||
145998824|NCT01156844|526512732|FG000|Overall Study|Withdrawal by Subject|0|||
145998825|NCT01156844|526512733|FG001|Overall Study|Withdrawal by Subject|0|||
145998826|NCT01156844|526512734|FG002|Overall Study|Withdrawal by Subject|2|||
145998827|NCT01156844|526512735|FG003|Overall Study|Withdrawal by Subject|2|||
145998828|NCT01156844|526512732|FG000|Overall Study|Lost to Follow-up|0|||
145998829|NCT01156844|526512733|FG001|Overall Study|Lost to Follow-up|0|||
145998830|NCT01156844|526512734|FG002|Overall Study|Lost to Follow-up|1|||
145998831|NCT01156844|526512735|FG003|Overall Study|Lost to Follow-up|0|||
145998832|NCT01156844|526512732|FG000|Overall Study|Administrative problems|0|||
145998833|NCT01156844|526512733|FG001|Overall Study|Administrative problems|1|||
145998834|NCT01156844|526512734|FG002|Overall Study|Administrative problems|0|||
145998835|NCT01156844|526512735|FG003|Overall Study|Administrative problems|1|||
145998836|NCT01156844|526512732|FG000|Overall Study|Protocol deviation|2|||
146246996|NCT00424476|527417719|FG002|Overall Study|Lack of Efficacy|12|||
146246997|NCT00424476|527417717|FG000|Overall Study|Lack of Compliance|1|||
146246998|NCT00424476|527417718|FG001|Overall Study|Lack of Compliance|1|||
146246999|NCT00424476|527417719|FG002|Overall Study|Lack of Compliance|1|||
145998837|NCT01156844|526512733|FG001|Overall Study|Protocol deviation|0|||
145998838|NCT01156844|526512734|FG002|Overall Study|Protocol deviation|0|||
145998839|NCT01156844|526512735|FG003|Overall Study|Protocol deviation|0|||
145998840|NCT00945659|526512736|FG000|Overall Study|Lost to Follow-up|7|||
145998841|NCT00945659|526512737|FG001|Overall Study|Lost to Follow-up|20|||
145998842|NCT00945659|526512738|FG002|Overall Study|Lost to Follow-up|17|||
145998843|NCT04067011|526512739|FG000|Overall Study|Not Treated|8|||
145998844|NCT04067011|526512740|FG001|Overall Study|Not Treated|7|||
146247000|NCT00424476|527417717|FG000|Overall Study|Lost to Follow-up|4|||
146247001|NCT00424476|527417718|FG001|Overall Study|Lost to Follow-up|6|||
145998845|NCT04067011|526512741|FG002|Overall Study|Not Treated|5|||
145998846|NCT04067011|526512739|FG000|Overall Study|Adverse Event|2|||
145998847|NCT04067011|526512740|FG001|Overall Study|Adverse Event|1|||
145998848|NCT04067011|526512741|FG002|Overall Study|Adverse Event|0|||
145998849|NCT04067011|526512739|FG000|Overall Study|Withdrawal by Subject|6|||
145998850|NCT04067011|526512740|FG001|Overall Study|Withdrawal by Subject|2|||
145998851|NCT04067011|526512741|FG002|Overall Study|Withdrawal by Subject|1|||
145998852|NCT04067011|526512739|FG000|Overall Study|Lost to Follow-up|0|||
145998853|NCT04067011|526512740|FG001|Overall Study|Lost to Follow-up|0|||
145998854|NCT04067011|526512741|FG002|Overall Study|Lost to Follow-up|1|||
145998855|NCT04067011|526512739|FG000|Overall Study|Physician Decision|1|||
145998856|NCT04067011|526512740|FG001|Overall Study|Physician Decision|1|||
145998857|NCT04067011|526512741|FG002|Overall Study|Physician Decision|0|||
145998858|NCT04067011|526512739|FG000|Overall Study|Other Reasons|2|||
145998859|NCT04067011|526512740|FG001|Overall Study|Other Reasons|0|||
145998860|NCT04067011|526512741|FG002|Overall Study|Other Reasons|1|||
145998861|NCT04067011|526512739|FG000|Overall Study|Missing|0|||
145998862|NCT04067011|526512740|FG001|Overall Study|Missing|2|||
145998863|NCT04067011|526512741|FG002|Overall Study|Missing|0|||
145998864|NCT05209386|526512742|FG000|Overall Study|Withdrawal by Subject|8|||
145998865|NCT05209386|526512742|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
145998866|NCT05200845|526512744|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
145998867|NCT05200845|526512745|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
145998868|NCT05200845|526512746|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
145998869|NCT05200845|526512747|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
145998870|NCT05200845|526512744|FG000|Overall Study|Withdrawal by Subject|0|||
145998871|NCT05200845|526512745|FG001|Overall Study|Withdrawal by Subject|1|||
145998872|NCT05200845|526512746|FG002|Overall Study|Withdrawal by Subject|1|||
145998873|NCT05200845|526512747|FG003|Overall Study|Withdrawal by Subject|0|||
145998874|NCT02412670|526512748|FG000|Overall Study|Adverse Event|4|||
145998875|NCT02412670|526512749|FG001|Overall Study|Adverse Event|1|||
145998876|NCT02412670|526512748|FG000|Overall Study|Physician Decision|1|||
145998877|NCT02412670|526512749|FG001|Overall Study|Physician Decision|0|||
145998878|NCT02412670|526512748|FG000|Overall Study|Withdrawal by Subject|1|||
145998879|NCT02412670|526512749|FG001|Overall Study|Withdrawal by Subject|0|||
145998880|NCT02412670|526512748|FG000|Overall Study|Ineligible|1|||
145998881|NCT02412670|526512749|FG001|Overall Study|Ineligible|0|||
145998882|NCT00565409|526512752|FG000|Period 1 Open Label|Adverse Event|17|||
145998883|NCT00565409|526512753|FG001|Period 1 Open Label|Adverse Event|0|||
145998884|NCT00565409|526512754|FG002|Period 1 Open Label|Adverse Event|0|||
145998885|NCT00565409|526512755|FG003|Period 1 Open Label|Adverse Event|0|||
145998886|NCT00565409|526512752|FG000|Period 1 Open Label|Death|2|||
145998887|NCT00565409|526512753|FG001|Period 1 Open Label|Death|0|||
145998888|NCT00565409|526512754|FG002|Period 1 Open Label|Death|0|||
145998889|NCT00565409|526512755|FG003|Period 1 Open Label|Death|0|||
145998890|NCT00565409|526512752|FG000|Period 1 Open Label|Lost to Follow-up|1|||
145998891|NCT00565409|526512753|FG001|Period 1 Open Label|Lost to Follow-up|0|||
145998892|NCT00565409|526512754|FG002|Period 1 Open Label|Lost to Follow-up|0|||
145998893|NCT00565409|526512755|FG003|Period 1 Open Label|Lost to Follow-up|0|||
145998894|NCT00565409|526512752|FG000|Period 1 Open Label|Other|21|||
145998895|NCT00565409|526512753|FG001|Period 1 Open Label|Other|0|||
145998896|NCT00565409|526512754|FG002|Period 1 Open Label|Other|0|||
145998897|NCT00565409|526512755|FG003|Period 1 Open Label|Other|0|||
145998898|NCT00565409|526512752|FG000|Period 1 Open Label|Protocol Violation|14|||
145998899|NCT00565409|526512753|FG001|Period 1 Open Label|Protocol Violation|0|||
145998900|NCT00565409|526512754|FG002|Period 1 Open Label|Protocol Violation|0|||
145998901|NCT00565409|526512755|FG003|Period 1 Open Label|Protocol Violation|0|||
145998902|NCT00565409|526512752|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
145998903|NCT00565409|526512753|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145998904|NCT00565409|526512754|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145998905|NCT00565409|526512755|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145998906|NCT00565409|526512752|FG000|Period 1 Open Label|no conclusion of participation record|1|||
145998907|NCT00565409|526512753|FG001|Period 1 Open Label|no conclusion of participation record|0|||
145998908|NCT00565409|526512754|FG002|Period 1 Open Label|no conclusion of participation record|0|||
146247002|NCT00424476|527417719|FG002|Overall Study|Lost to Follow-up|3|||
146247003|NCT00424476|527417717|FG000|Overall Study|Protocol Violation|7|||
146247004|NCT00424476|527417718|FG001|Overall Study|Protocol Violation|2|||
146247005|NCT00424476|527417719|FG002|Overall Study|Protocol Violation|3|||
146247006|NCT00424476|527417717|FG000|Overall Study|Physician Decision|3|||
146247007|NCT00424476|527417718|FG001|Overall Study|Physician Decision|2|||
146247008|NCT00424476|527417719|FG002|Overall Study|Physician Decision|3|||
146247009|NCT00424476|527417717|FG000|Overall Study|Other|4|||
146298066|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
145998909|NCT00565409|526512755|FG003|Period 1 Open Label|no conclusion of participation record|0|||
145998910|NCT00565409|526512752|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
146247010|NCT00424476|527417718|FG001|Overall Study|Other|3|||
146247011|NCT00424476|527417719|FG002|Overall Study|Other|9|||
146247012|NCT03979040|527417720|FG000|Overall Study|Withdrawal by Subject|24|||
146247013|NCT03979040|527417721|FG001|Overall Study|Withdrawal by Subject|32|||
146247014|NCT03979040|527417720|FG000|Overall Study|randomized but never started treatment|32|||
146247015|NCT03979040|527417721|FG001|Overall Study|randomized but never started treatment|39|||
146247016|NCT03979040|527417720|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
145998911|NCT00565409|526512753|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
145998912|NCT00565409|526512754|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
145998913|NCT00565409|526512755|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
145998914|NCT00565409|526512752|FG000|Period 2 Double-Blind|Adverse Event|0|||
145998915|NCT00565409|526512753|FG001|Period 2 Double-Blind|Adverse Event|7|||
145998916|NCT00565409|526512754|FG002|Period 2 Double-Blind|Adverse Event|4|||
145998917|NCT00565409|526512755|FG003|Period 2 Double-Blind|Adverse Event|5|||
145998918|NCT00565409|526512752|FG000|Period 2 Double-Blind|Death|0|||
145998919|NCT00565409|526512753|FG001|Period 2 Double-Blind|Death|2|||
145998920|NCT00565409|526512754|FG002|Period 2 Double-Blind|Death|0|||
145998921|NCT00565409|526512755|FG003|Period 2 Double-Blind|Death|0|||
145998922|NCT00565409|526512752|FG000|Period 2 Double-Blind|Protocol Violation|0|||
145998923|NCT00565409|526512753|FG001|Period 2 Double-Blind|Protocol Violation|4|||
145998924|NCT00565409|526512754|FG002|Period 2 Double-Blind|Protocol Violation|6|||
145998925|NCT00565409|526512755|FG003|Period 2 Double-Blind|Protocol Violation|2|||
145998926|NCT00565409|526512752|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
145998927|NCT00565409|526512753|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
145998928|NCT00565409|526512754|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
145998929|NCT00565409|526512755|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
145998930|NCT00565409|526512752|FG000|Period 2 Double-Blind|Other|0|||
145998931|NCT00565409|526512753|FG001|Period 2 Double-Blind|Other|4|||
145998932|NCT00565409|526512754|FG002|Period 2 Double-Blind|Other|5|||
145998933|NCT00565409|526512755|FG003|Period 2 Double-Blind|Other|9|||
145998934|NCT00565409|526512752|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
145998935|NCT00565409|526512753|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
145998936|NCT00565409|526512754|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
145998937|NCT00565409|526512755|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
145998938|NCT01448616|526512757|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
145998939|NCT01448616|526512758|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145998940|NCT01448616|526512759|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145998941|NCT01448616|526512760|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145998942|NCT01448616|526512757|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
145998943|NCT01448616|526512758|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145998944|NCT01448616|526512759|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145998945|NCT01448616|526512760|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145998946|NCT01448616|526512757|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
145998947|NCT01448616|526512758|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
145998948|NCT01448616|526512759|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
145998949|NCT01448616|526512760|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
145998950|NCT01448616|526512757|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
145998951|NCT01448616|526512758|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
145998952|NCT01448616|526512759|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
146092051|NCT01226043|526858517|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
146092052|NCT01226043|526858518|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
146092053|NCT01226043|526858519|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
146092054|NCT01226043|526858520|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
146092055|NCT01226043|526858517|FG000|6-week Re-randomization Phase|Physician Decision|0|||
146092056|NCT01226043|526858518|FG001|6-week Re-randomization Phase|Physician Decision|0|||
146092057|NCT01226043|526858519|FG002|6-week Re-randomization Phase|Physician Decision|3|||
146092058|NCT01226043|526858520|FG003|6-week Re-randomization Phase|Physician Decision|2|||
146092059|NCT01226043|526858517|FG000|6-week Re-randomization Phase|completed in error|0|||
146092060|NCT01226043|526858518|FG001|6-week Re-randomization Phase|completed in error|0|||
146092061|NCT01226043|526858519|FG002|6-week Re-randomization Phase|completed in error|0|||
146092062|NCT01226043|526858520|FG003|6-week Re-randomization Phase|completed in error|1|||
146092063|NCT01226043|526858517|FG000|30-week Observational Phase|Adverse Event|0|||
146092064|NCT01226043|526858518|FG001|30-week Observational Phase|Adverse Event|0|||
146092065|NCT01226043|526858519|FG002|30-week Observational Phase|Adverse Event|1|||
146247017|NCT03979040|527417721|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
146247018|NCT03541369|527417724|FG000|Overall Study|Death|0|||
145998953|NCT01448616|526512760|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
145998954|NCT01448616|526512757|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
145998955|NCT01448616|526512758|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
145998956|NCT01448616|526512759|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
146092066|NCT01226043|526858520|FG003|30-week Observational Phase|Adverse Event|1|||
146092067|NCT01226043|526858517|FG000|30-week Observational Phase|Protocol Violation|0|||
145998957|NCT01448616|526512760|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
145998958|NCT02943473|526512761|FG000|Overall Study|enrolled but not dosed|1|||
145998959|NCT02943473|526512761|FG000|Overall Study|screen failure|1|||
145998960|NCT02943473|526512761|FG000|Overall Study|Physician Decision|4|||
145998961|NCT01567722|526512768|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
145998962|NCT01567722|526512769|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
145998963|NCT01567722|526512770|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
145998964|NCT01567722|526512768|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
145998965|NCT01567722|526512769|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
145998966|NCT01567722|526512770|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
146247019|NCT03541369|527417725|FG001|Overall Study|Death|0|||
145998967|NCT01567722|526512768|FG000|Overall Study|Protocol closure by the OCG|2|||
145998968|NCT01567722|526512769|FG001|Overall Study|Protocol closure by the OCG|0|||
145998969|NCT01567722|526512770|FG002|Overall Study|Protocol closure by the OCG|0|||
145998970|NCT01567722|526512768|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
145998971|NCT01567722|526512769|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
145998972|NCT01567722|526512770|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
145998973|NCT00431964|526512773|FG000|Overall Study|Adverse Event|1|||
145998974|NCT00431964|526512774|FG001|Overall Study|Adverse Event|0|||
145998975|NCT00431964|526512773|FG000|Overall Study|Lost to Follow-up|1|||
145998976|NCT00431964|526512774|FG001|Overall Study|Lost to Follow-up|2|||
145998977|NCT00431964|526512773|FG000|Overall Study|Physician Decision|2|||
145998978|NCT00431964|526512774|FG001|Overall Study|Physician Decision|2|||
145998979|NCT00431964|526512773|FG000|Overall Study|Withdrawal by Subject|2|||
145998980|NCT00431964|526512774|FG001|Overall Study|Withdrawal by Subject|1|||
145998981|NCT00431964|526512773|FG000|Overall Study|Parental Consent Withdrawn|0|||
145998982|NCT00431964|526512774|FG001|Overall Study|Parental Consent Withdrawn|2|||
145998983|NCT00431964|526512773|FG000|Overall Study|Due to Unstable Health|0|||
145998984|NCT00431964|526512774|FG001|Overall Study|Due to Unstable Health|1|||
145998985|NCT02170064|526512775|FG000|Overall Study|Withdrawal by Subject|5|||
145998986|NCT02170064|526512776|FG001|Overall Study|Withdrawal by Subject|1|||
145998987|NCT02170064|526512777|FG002|Overall Study|Withdrawal by Subject|1|||
145998988|NCT02170064|526512775|FG000|Overall Study|Physician Decision|1|||
145998989|NCT02170064|526512776|FG001|Overall Study|Physician Decision|1|||
145998990|NCT02170064|526512777|FG002|Overall Study|Physician Decision|0|||
145998991|NCT03323164|526512778|FG000|Overall Study|Poor quality imaging/scans|2|||
145998992|NCT03323164|526512779|FG001|Overall Study|Poor quality imaging/scans|2|||
145998993|NCT04211363|526512780|FG000|Overall Study|Adverse Event|5|||
145998994|NCT04211363|526512781|FG001|Overall Study|Adverse Event|2|||
145998995|NCT04211363|526512780|FG000|Overall Study|Physician Decision|0|||
145998996|NCT04211363|526512781|FG001|Overall Study|Physician Decision|1|||
145998997|NCT04211363|526512780|FG000|Overall Study|Protocol Violation|1|||
145998998|NCT04211363|526512781|FG001|Overall Study|Protocol Violation|0|||
145998999|NCT04211363|526512780|FG000|Overall Study|Pregnancy|1|||
145999000|NCT04211363|526512781|FG001|Overall Study|Pregnancy|0|||
145999001|NCT04211363|526512780|FG000|Overall Study|Lost to Follow-up|12|||
145999002|NCT04211363|526512781|FG001|Overall Study|Lost to Follow-up|4|||
145999003|NCT04211363|526512780|FG000|Overall Study|Withdrawal by Subject|11|||
145999004|NCT04211363|526512781|FG001|Overall Study|Withdrawal by Subject|11|||
145999005|NCT04211363|526512780|FG000|Overall Study|Other|1|||
145999006|NCT04211363|526512781|FG001|Overall Study|Other|2|||
145999007|NCT03961308|526512786|FG000|Overall Study|Withdrawal by Subject|1|||
145999008|NCT03961308|526512787|FG001|Overall Study|Withdrawal by Subject|0|||
146247020|NCT03541369|527417726|FG002|Overall Study|Death|0|||
146247021|NCT03541369|527417727|FG003|Overall Study|Death|0|||
145999009|NCT03961308|526512786|FG000|Overall Study|Other|1|||
145999010|NCT03961308|526512787|FG001|Overall Study|Other|0|||
145999011|NCT03961308|526512786|FG000|Overall Study|Lost to Follow-up|0|||
145999012|NCT03961308|526512787|FG001|Overall Study|Lost to Follow-up|1|||
145999013|NCT03961308|526512786|FG000|Overall Study|Adverse Event|0|||
146247022|NCT03541369|527417728|FG004|Overall Study|Death|1|||
146247023|NCT03541369|527417729|FG005|Overall Study|Death|1|||
146247024|NCT03541369|527417730|FG006|Overall Study|Death|0|||
145999014|NCT03961308|526512787|FG001|Overall Study|Adverse Event|1|||
145999015|NCT00659425|526512790|FG000|Overall Study|Disease progression|1|||
145999016|NCT00659425|526512791|FG001|Overall Study|Disease progression|0|||
145999017|NCT00659425|526512792|FG002|Overall Study|Disease progression|0|||
146247025|NCT03541369|527417731|FG007|Overall Study|Death|2|||
146247026|NCT03541369|527417732|FG008|Overall Study|Death|1|||
145999018|NCT00659425|526512793|FG003|Overall Study|Disease progression|1|||
145999019|NCT00659425|526512794|FG004|Overall Study|Disease progression|0|||
145999020|NCT00659425|526512795|FG005|Overall Study|Disease progression|2|||
145999021|NCT00659425|526512796|FG006|Overall Study|Disease progression|4|||
146247027|NCT03541369|527417733|FG009|Overall Study|Death|2|||
146247028|NCT03541369|527417734|FG010|Overall Study|Death|1|||
146247029|NCT03541369|527417735|FG011|Overall Study|Death|0|||
146247030|NCT03541369|527417736|FG012|Overall Study|Death|2|||
146247031|NCT03541369|527417737|FG013|Overall Study|Death|1|||
146247032|NCT03541369|527417738|FG014|Overall Study|Death|1|||
146247033|NCT03541369|527417739|FG015|Overall Study|Death|1|||
146247034|NCT03541369|527417740|FG016|Overall Study|Death|0|||
146247035|NCT03541369|527417741|FG017|Overall Study|Death|1|||
146247036|NCT03541369|527417724|FG000|Overall Study|Decision by sponsor|0|||
146247037|NCT03541369|527417725|FG001|Overall Study|Decision by sponsor|0|||
146247038|NCT03541369|527417726|FG002|Overall Study|Decision by sponsor|0|||
146247039|NCT03541369|527417727|FG003|Overall Study|Decision by sponsor|1|||
146247040|NCT03541369|527417728|FG004|Overall Study|Decision by sponsor|0|||
146247041|NCT03541369|527417729|FG005|Overall Study|Decision by sponsor|2|||
146247042|NCT03541369|527417730|FG006|Overall Study|Decision by sponsor|0|||
146247043|NCT03541369|527417731|FG007|Overall Study|Decision by sponsor|1|||
146247044|NCT03541369|527417732|FG008|Overall Study|Decision by sponsor|2|||
146247045|NCT03541369|527417733|FG009|Overall Study|Decision by sponsor|0|||
146247046|NCT03541369|527417734|FG010|Overall Study|Decision by sponsor|0|||
146247047|NCT03541369|527417735|FG011|Overall Study|Decision by sponsor|0|||
146247048|NCT03541369|527417736|FG012|Overall Study|Decision by sponsor|2|||
146247049|NCT03541369|527417737|FG013|Overall Study|Decision by sponsor|2|||
146247050|NCT03541369|527417738|FG014|Overall Study|Decision by sponsor|0|||
146247051|NCT03541369|527417739|FG015|Overall Study|Decision by sponsor|1|||
146247052|NCT03541369|527417740|FG016|Overall Study|Decision by sponsor|1|||
146247053|NCT03541369|527417741|FG017|Overall Study|Decision by sponsor|1|||
146247054|NCT03541369|527417724|FG000|Overall Study|Withdrawal by Subject|0|||
146247055|NCT03541369|527417725|FG001|Overall Study|Withdrawal by Subject|0|||
145999022|NCT00659425|526512797|FG007|Overall Study|Disease progression|3|||
145999023|NCT00659425|526512798|FG008|Overall Study|Disease progression|5|||
145999024|NCT00659425|526512799|FG009|Overall Study|Disease progression|3|||
145999025|NCT00659425|526512790|FG000|Overall Study|Death|0|||
145999026|NCT00659425|526512791|FG001|Overall Study|Death|0|||
145999027|NCT00659425|526512792|FG002|Overall Study|Death|0|||
145999028|NCT00659425|526512793|FG003|Overall Study|Death|1|||
145999029|NCT00659425|526512794|FG004|Overall Study|Death|0|||
145999030|NCT00659425|526512795|FG005|Overall Study|Death|0|||
145999031|NCT00659425|526512796|FG006|Overall Study|Death|1|||
145999032|NCT00659425|526512797|FG007|Overall Study|Death|0|||
145999033|NCT00659425|526512798|FG008|Overall Study|Death|0|||
145999034|NCT00659425|526512799|FG009|Overall Study|Death|0|||
145999035|NCT00659425|526512790|FG000|Overall Study|Adverse Event|0|||
145999036|NCT00659425|526512791|FG001|Overall Study|Adverse Event|0|||
145999037|NCT00659425|526512792|FG002|Overall Study|Adverse Event|0|||
145999038|NCT00659425|526512793|FG003|Overall Study|Adverse Event|0|||
145999039|NCT00659425|526512794|FG004|Overall Study|Adverse Event|0|||
145999040|NCT00659425|526512795|FG005|Overall Study|Adverse Event|1|||
145999041|NCT00659425|526512796|FG006|Overall Study|Adverse Event|0|||
145999042|NCT00659425|526512797|FG007|Overall Study|Adverse Event|3|||
145999043|NCT00659425|526512798|FG008|Overall Study|Adverse Event|1|||
145999044|NCT00659425|526512799|FG009|Overall Study|Adverse Event|4|||
145999045|NCT00659425|526512790|FG000|Overall Study|Investigator Discretion|0|||
145999046|NCT00659425|526512791|FG001|Overall Study|Investigator Discretion|0|||
145999047|NCT00659425|526512792|FG002|Overall Study|Investigator Discretion|0|||
145999048|NCT00659425|526512793|FG003|Overall Study|Investigator Discretion|0|||
145999049|NCT00659425|526512794|FG004|Overall Study|Investigator Discretion|0|||
145999050|NCT00659425|526512795|FG005|Overall Study|Investigator Discretion|1|||
145999051|NCT00659425|526512796|FG006|Overall Study|Investigator Discretion|0|||
145999052|NCT00659425|526512797|FG007|Overall Study|Investigator Discretion|3|||
146092068|NCT01226043|526858518|FG001|30-week Observational Phase|Protocol Violation|0|||
146247056|NCT03541369|527417726|FG002|Overall Study|Withdrawal by Subject|0|||
145999053|NCT00659425|526512798|FG008|Overall Study|Investigator Discretion|0|||
145999054|NCT00659425|526512799|FG009|Overall Study|Investigator Discretion|0|||
145999055|NCT00659425|526512790|FG000|Overall Study|Other|0|||
145999056|NCT00659425|526512791|FG001|Overall Study|Other|1|||
146247057|NCT03541369|527417727|FG003|Overall Study|Withdrawal by Subject|0|||
146247058|NCT03541369|527417728|FG004|Overall Study|Withdrawal by Subject|0|||
145999057|NCT00659425|526512792|FG002|Overall Study|Other|1|||
145999058|NCT00659425|526512793|FG003|Overall Study|Other|2|||
146092069|NCT01226043|526858519|FG002|30-week Observational Phase|Protocol Violation|0|||
146247059|NCT03541369|527417729|FG005|Overall Study|Withdrawal by Subject|0|||
146247060|NCT03541369|527417730|FG006|Overall Study|Withdrawal by Subject|1|||
146247061|NCT03541369|527417731|FG007|Overall Study|Withdrawal by Subject|0|||
146247062|NCT03541369|527417732|FG008|Overall Study|Withdrawal by Subject|0|||
146247063|NCT03541369|527417733|FG009|Overall Study|Withdrawal by Subject|0|||
145999059|NCT00659425|526512794|FG004|Overall Study|Other|4|||
145999060|NCT00659425|526512795|FG005|Overall Study|Other|0|||
145999061|NCT00659425|526512796|FG006|Overall Study|Other|3|||
145999062|NCT00659425|526512797|FG007|Overall Study|Other|2|||
145999063|NCT00659425|526512798|FG008|Overall Study|Other|0|||
145999064|NCT00659425|526512799|FG009|Overall Study|Other|6|||
145999065|NCT03358030|526512800|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
146247064|NCT03541369|527417734|FG010|Overall Study|Withdrawal by Subject|0|||
145999066|NCT03358030|526512801|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
145999067|NCT03358030|526512802|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
145999068|NCT03358030|526512803|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
145999069|NCT03358030|526512800|FG000|Overall Study|Ineligibility|0|||
145999070|NCT03358030|526512801|FG001|Overall Study|Ineligibility|0|||
145999071|NCT03358030|526512802|FG002|Overall Study|Ineligibility|0|||
145999072|NCT03358030|526512803|FG003|Overall Study|Ineligibility|2|||
145999073|NCT03358030|526512800|FG000|Overall Study|Voluntary Withdrawal|1|||
145999074|NCT03358030|526512801|FG001|Overall Study|Voluntary Withdrawal|1|||
145999075|NCT03358030|526512802|FG002|Overall Study|Voluntary Withdrawal|3|||
145999076|NCT03358030|526512803|FG003|Overall Study|Voluntary Withdrawal|1|||
145999077|NCT03358030|526512800|FG000|Overall Study|Other|0|||
145999078|NCT03358030|526512801|FG001|Overall Study|Other|0|||
145999079|NCT03358030|526512802|FG002|Overall Study|Other|1|||
145999080|NCT03358030|526512803|FG003|Overall Study|Other|0|||
145999081|NCT03342560|526512804|FG000|Overall Study|Lost to Follow-up|2|||
145999082|NCT02604511|526512805|FG000|Overall Study|Adverse Event|3|||
145999083|NCT02604511|526512805|FG000|Overall Study|Disease Progression|4|||
145999084|NCT02604511|526512805|FG000|Overall Study|Withdrawal by Subject|3|||
145999085|NCT02604511|526512805|FG000|Overall Study|Participant ineligible|1|||
145999086|NCT02604511|526512805|FG000|Overall Study|Intercurrent illness|1|||
145999087|NCT03770286|526512806|FG000|Overall Study|Lost to Follow-up|6|||
145999088|NCT03770286|526512807|FG001|Overall Study|Lost to Follow-up|4|||
145999089|NCT03770286|526512808|FG002|Overall Study|Lost to Follow-up|3|||
145999090|NCT03770286|526512806|FG000|Overall Study|Protocol Violation|1|||
145999091|NCT03770286|526512807|FG001|Overall Study|Protocol Violation|0|||
145999092|NCT03770286|526512808|FG002|Overall Study|Protocol Violation|2|||
145999093|NCT01729039|526512811|FG000|Overall Study|disqualified|2|||
145999094|NCT01729039|526512812|FG001|Overall Study|disqualified|5|||
145999095|NCT01729039|526512811|FG000|Overall Study|Withdrawal by Subject|8|||
145999096|NCT01729039|526512812|FG001|Overall Study|Withdrawal by Subject|7|||
145999097|NCT02661672|526512817|FG000|Overall Study|Lost to Follow-up|1|||
145999098|NCT02661672|526512817|FG000|Overall Study|Death|4|||
145999099|NCT02114177|526514634|FG000|Overall Study|Lost to Follow-up|1|||
145999100|NCT02114177|526514635|FG001|Overall Study|Lost to Follow-up|2|||
145999101|NCT02114177|526514634|FG000|Overall Study|Withdrawal by Subject|6|||
145999102|NCT02114177|526514635|FG001|Overall Study|Withdrawal by Subject|1|||
145999103|NCT02114177|526514634|FG000|Overall Study|Other|2|||
145999104|NCT02114177|526514635|FG001|Overall Study|Other|1|||
145999105|NCT01770743|526514636|FG000|Overall Study|Adverse Event|1|||
145999106|NCT01770743|526514637|FG001|Overall Study|Adverse Event|0|||
145999107|NCT01770743|526514638|FG002|Overall Study|Adverse Event|0|||
145999108|NCT01770743|526514639|FG003|Overall Study|Adverse Event|0|||
145999109|NCT01770743|526514640|FG004|Overall Study|Adverse Event|0|||
145999110|NCT01770743|526514636|FG000|Overall Study|Withdrawal by Subject|0|||
145999111|NCT01770743|526514637|FG001|Overall Study|Withdrawal by Subject|0|||
145999112|NCT01770743|526514638|FG002|Overall Study|Withdrawal by Subject|1|||
145999113|NCT01770743|526514639|FG003|Overall Study|Withdrawal by Subject|1|||
145999114|NCT01770743|526514640|FG004|Overall Study|Withdrawal by Subject|1|||
145999115|NCT01770743|526514636|FG000|Overall Study|Lost to Follow-up|0|||
145999116|NCT01770743|526514637|FG001|Overall Study|Lost to Follow-up|2|||
145999117|NCT01770743|526514638|FG002|Overall Study|Lost to Follow-up|0|||
145999118|NCT01770743|526514639|FG003|Overall Study|Lost to Follow-up|0|||
145999119|NCT01770743|526514640|FG004|Overall Study|Lost to Follow-up|1|||
145999120|NCT01770743|526514636|FG000|Overall Study|Sponsor Terminated Subject|1|||
145999121|NCT01770743|526514637|FG001|Overall Study|Sponsor Terminated Subject|0|||
145999122|NCT01770743|526514638|FG002|Overall Study|Sponsor Terminated Subject|0|||
145999123|NCT01770743|526514639|FG003|Overall Study|Sponsor Terminated Subject|1|||
145999124|NCT01770743|526514640|FG004|Overall Study|Sponsor Terminated Subject|0|||
145999125|NCT01770743|526514636|FG000|Overall Study|Moving Out of State|0|||
145999126|NCT01770743|526514637|FG001|Overall Study|Moving Out of State|1|||
145999127|NCT01770743|526514638|FG002|Overall Study|Moving Out of State|0|||
145999128|NCT01770743|526514639|FG003|Overall Study|Moving Out of State|0|||
146298067|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
146298068|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
145999129|NCT01770743|526514640|FG004|Overall Study|Moving Out of State|0|||
146298069|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
145999130|NCT01585025|526514641|FG000|Overall Study|Withdrawal by Subject|0|||
145999131|NCT01585025|526514642|FG001|Overall Study|Withdrawal by Subject|3|||
145999132|NCT01585025|526514643|FG002|Overall Study|Withdrawal by Subject|4|||
145999133|NCT02336815|526514644|FG000|Overall Study|Disease Progression|45|||
146298070|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
145999134|NCT02336815|526514645|FG001|Overall Study|Disease Progression|70|||
145999135|NCT02336815|526514644|FG000|Overall Study|Adverse Event|18|||
145999136|NCT02336815|526514645|FG001|Overall Study|Adverse Event|39|||
145999137|NCT02336815|526514644|FG000|Overall Study|Physician Decision|11|||
145999138|NCT02336815|526514645|FG001|Overall Study|Physician Decision|4|||
145999139|NCT02336815|526514644|FG000|Overall Study|Withdrawal by Subject|3|||
145999140|NCT02336815|526514645|FG001|Overall Study|Withdrawal by Subject|2|||
145999141|NCT02336815|526514644|FG000|Overall Study|Lost to Follow-up|1|||
145999142|NCT02336815|526514645|FG001|Overall Study|Lost to Follow-up|3|||
145999143|NCT02336815|526514644|FG000|Overall Study|Other|1|||
145999144|NCT02336815|526514645|FG001|Overall Study|Other|5|||
145999145|NCT00952705|526514646|FG000|Overall Study|Lost to Follow-up|24|||
145999146|NCT00952705|526514647|FG001|Overall Study|Lost to Follow-up|8|||
145999147|NCT00952705|526514648|FG002|Overall Study|Lost to Follow-up|9|||
145999148|NCT00952705|526514646|FG000|Overall Study|Withdrawal by Subject|2|||
145999149|NCT00952705|526514647|FG001|Overall Study|Withdrawal by Subject|1|||
145999150|NCT00952705|526514648|FG002|Overall Study|Withdrawal by Subject|1|||
145999151|NCT00952705|526514646|FG000|Overall Study|Death|2|||
145999152|NCT00952705|526514647|FG001|Overall Study|Death|0|||
145999153|NCT00952705|526514648|FG002|Overall Study|Death|0|||
145999154|NCT00952705|526514646|FG000|Overall Study|Incarcerated post dose|5|||
145999155|NCT00952705|526514647|FG001|Overall Study|Incarcerated post dose|0|||
145999156|NCT00952705|526514648|FG002|Overall Study|Incarcerated post dose|0|||
145999157|NCT00952705|526514646|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
145999158|NCT00952705|526514647|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
145999159|NCT00952705|526514648|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
145999160|NCT02986074|526514649|FG000|First Trial Period|Adverse Event|1|||
145999161|NCT02986074|526514650|FG001|First Trial Period|Adverse Event|0|||
145999162|NCT02986074|526514651|FG002|First Trial Period|Adverse Event|0|||
145999163|NCT02986074|526514652|FG003|First Trial Period|Adverse Event|0|||
145999164|NCT02986074|526514649|FG000|Follow up Period|system explant|0|||
145999165|NCT02986074|526514650|FG001|Follow up Period|system explant|0|||
145999166|NCT02986074|526514651|FG002|Follow up Period|system explant|1|||
145999167|NCT02986074|526514652|FG003|Follow up Period|system explant|2|||
145999168|NCT02986074|526514649|FG000|Follow up Period|Physician Decision|0|||
145999169|NCT02986074|526514650|FG001|Follow up Period|Physician Decision|0|||
145999170|NCT02986074|526514651|FG002|Follow up Period|Physician Decision|0|||
145999171|NCT02986074|526514652|FG003|Follow up Period|Physician Decision|1|||
145999172|NCT02415556|526514653|FG000|Overall Study|Adverse Event|3|||
145999173|NCT02415556|526514654|FG001|Overall Study|Adverse Event|4|||
145999174|NCT02415556|526514655|FG002|Overall Study|Adverse Event|2|||
145999175|NCT02415556|526514656|FG003|Overall Study|Adverse Event|4|||
145999176|NCT02415556|526514653|FG000|Overall Study|Lost to Follow-up|4|||
145999177|NCT02415556|526514654|FG001|Overall Study|Lost to Follow-up|5|||
145999178|NCT02415556|526514655|FG002|Overall Study|Lost to Follow-up|4|||
145999179|NCT02415556|526514656|FG003|Overall Study|Lost to Follow-up|1|||
145999180|NCT02415556|526514653|FG000|Overall Study|Withdrawal by Subject|13|||
145999181|NCT02415556|526514654|FG001|Overall Study|Withdrawal by Subject|4|||
145999182|NCT02415556|526514655|FG002|Overall Study|Withdrawal by Subject|14|||
145999183|NCT02415556|526514656|FG003|Overall Study|Withdrawal by Subject|12|||
145999184|NCT02415556|526514653|FG000|Overall Study|Physician Decision|1|||
145999185|NCT02415556|526514654|FG001|Overall Study|Physician Decision|3|||
145999186|NCT02415556|526514655|FG002|Overall Study|Physician Decision|1|||
145999187|NCT02415556|526514656|FG003|Overall Study|Physician Decision|2|||
145999188|NCT02415556|526514653|FG000|Overall Study|Censored - study completion|4|||
145999189|NCT02415556|526514654|FG001|Overall Study|Censored - study completion|5|||
145999190|NCT02415556|526514655|FG002|Overall Study|Censored - study completion|1|||
145999191|NCT02415556|526514656|FG003|Overall Study|Censored - study completion|0|||
145999192|NCT02415556|526514653|FG000|Overall Study|Family-related issues|0|||
145999193|NCT02415556|526514654|FG001|Overall Study|Family-related issues|0|||
145999194|NCT02415556|526514655|FG002|Overall Study|Family-related issues|0|||
145999195|NCT02415556|526514656|FG003|Overall Study|Family-related issues|1|||
145999196|NCT00399035|526514659|FG000|Overall Study|Death|289|||
145999197|NCT00399035|526514660|FG001|Overall Study|Death|141|||
145999198|NCT00399035|526514661|FG002|Overall Study|Death|234|||
145999199|NCT00399035|526514659|FG000|Overall Study|Lost to Follow-up|2|||
145999200|NCT00399035|526514660|FG001|Overall Study|Lost to Follow-up|1|||
145999201|NCT00399035|526514661|FG002|Overall Study|Lost to Follow-up|5|||
145999202|NCT00399035|526514659|FG000|Overall Study|Withdrawal by Subject|19|||
145999203|NCT00399035|526514660|FG001|Overall Study|Withdrawal by Subject|15|||
145999204|NCT00399035|526514661|FG002|Overall Study|Withdrawal by Subject|12|||
145999205|NCT00399035|526514659|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
145999206|NCT00399035|526514660|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
145999207|NCT00399035|526514661|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
145999208|NCT00399035|526514659|FG000|Overall Study|Severe non-compliance with protocol|2|||
145999209|NCT00399035|526514660|FG001|Overall Study|Severe non-compliance with protocol|1|||
145999210|NCT00399035|526514661|FG002|Overall Study|Severe non-compliance with protocol|0|||
145999211|NCT02949011|526514664|FG000|Overall Study|Adverse Event|6|||
145999212|NCT02949011|526514665|FG001|Overall Study|Adverse Event|7|||
145999213|NCT02949011|526514666|FG002|Overall Study|Adverse Event|3|||
145999214|NCT02949011|526514664|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145999215|NCT02949011|526514665|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145999216|NCT02949011|526514666|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
145999217|NCT02949011|526514664|FG000|Overall Study|Protocol Deviation|5|||
145999218|NCT02949011|526514665|FG001|Overall Study|Protocol Deviation|3|||
145999219|NCT02949011|526514666|FG002|Overall Study|Protocol Deviation|3|||
145999220|NCT02949011|526514664|FG000|Overall Study|Lack of Efficacy|0|||
145999221|NCT02949011|526514665|FG001|Overall Study|Lack of Efficacy|2|||
145999222|NCT02949011|526514666|FG002|Overall Study|Lack of Efficacy|0|||
145999223|NCT02949011|526514664|FG000|Overall Study|Withdrawal by Subject|13|||
145999224|NCT02949011|526514665|FG001|Overall Study|Withdrawal by Subject|13|||
145999225|NCT02949011|526514666|FG002|Overall Study|Withdrawal by Subject|21|||
145999226|NCT02949011|526514664|FG000|Overall Study|Lost to Follow-up|7|||
145999227|NCT02949011|526514665|FG001|Overall Study|Lost to Follow-up|5|||
145999228|NCT02949011|526514666|FG002|Overall Study|Lost to Follow-up|5|||
145999229|NCT02949011|526514664|FG000|Overall Study|Death|0|||
145999230|NCT02949011|526514665|FG001|Overall Study|Death|0|||
145999231|NCT02949011|526514666|FG002|Overall Study|Death|1|||
145999232|NCT02949011|526514664|FG000|Overall Study|Miscellaneous|2|||
145999233|NCT02949011|526514665|FG001|Overall Study|Miscellaneous|4|||
145999234|NCT02949011|526514666|FG002|Overall Study|Miscellaneous|6|||
145999235|NCT01213082|526514667|FG000|Overall Study|Lost to Follow-up|6|||
145999236|NCT01213082|526514668|FG001|Overall Study|Lost to Follow-up|7|||
145999237|NCT01213082|526514669|FG002|Overall Study|Lost to Follow-up|4|||
145999238|NCT01213082|526514667|FG000|Overall Study|Physician Decision|0|||
145999239|NCT01213082|526514668|FG001|Overall Study|Physician Decision|0|||
145999240|NCT01213082|526514669|FG002|Overall Study|Physician Decision|1|||
145999241|NCT01627691|526514673|FG000|Overall Study|Death|11|||
145999242|NCT01627691|526514673|FG000|Overall Study|Lost to Follow-up|3|||
145999243|NCT01627691|526514673|FG000|Overall Study|Withdrawal by Subject|1|||
145999244|NCT01627691|526514673|FG000|Overall Study|Missed the visit|3|||
145999245|NCT02639390|526514674|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
145999246|NCT02639390|526514675|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
145999247|NCT03218917|526514676|FG000|Overall Study|Adverse Event|3|||
145999248|NCT03218917|526514677|FG001|Overall Study|Adverse Event|3|||
145999249|NCT03218917|526514678|FG002|Overall Study|Adverse Event|2|||
145999250|NCT03218917|526514676|FG000|Overall Study|Subject withdrew consent|2|||
145999251|NCT03218917|526514677|FG001|Overall Study|Subject withdrew consent|4|||
145999252|NCT03218917|526514678|FG002|Overall Study|Subject withdrew consent|10|||
145999253|NCT03218917|526514676|FG000|Overall Study|Physician Decision|0|||
145999254|NCT03218917|526514677|FG001|Overall Study|Physician Decision|1|||
145999255|NCT03218917|526514678|FG002|Overall Study|Physician Decision|1|||
145999256|NCT03218917|526514676|FG000|Overall Study|Lost to Follow-up|1|||
145999257|NCT03218917|526514677|FG001|Overall Study|Lost to Follow-up|0|||
145999258|NCT03218917|526514678|FG002|Overall Study|Lost to Follow-up|0|||
145999259|NCT03218917|526514676|FG000|Overall Study|Reason Missing|0|||
145999260|NCT03218917|526514677|FG001|Overall Study|Reason Missing|2|||
145999261|NCT03218917|526514678|FG002|Overall Study|Reason Missing|0|||
145999262|NCT03218917|526514676|FG000|Overall Study|Death|0|||
145999263|NCT03218917|526514677|FG001|Overall Study|Death|1|||
145999264|NCT03218917|526514678|FG002|Overall Study|Death|0|||
145999265|NCT03218917|526514676|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145999266|NCT03218917|526514677|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145999267|NCT03218917|526514678|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145999268|NCT01908140|526514679|FG000|Overall Study|Other or Progressive Disease|5|||
145999269|NCT01908140|526514680|FG001|Overall Study|Other or Progressive Disease|12|||
145999270|NCT01908140|526514679|FG000|Overall Study|Lack of Efficacy|7|||
145999271|NCT01908140|526514680|FG001|Overall Study|Lack of Efficacy|5|||
145999272|NCT01908140|526514679|FG000|Overall Study|Withdrawal by Subject|23|||
145999273|NCT01908140|526514680|FG001|Overall Study|Withdrawal by Subject|24|||
145999274|NCT01908140|526514679|FG000|Overall Study|Lost to Follow-up|1|||
145999275|NCT01908140|526514680|FG001|Overall Study|Lost to Follow-up|6|||
146247065|NCT03541369|527417735|FG011|Overall Study|Withdrawal by Subject|1|||
146247066|NCT03541369|527417736|FG012|Overall Study|Withdrawal by Subject|0|||
146247067|NCT03541369|527417737|FG013|Overall Study|Withdrawal by Subject|0|||
145999276|NCT01908140|526514679|FG000|Overall Study|Protocol Violation|8|||
145999277|NCT01908140|526514680|FG001|Overall Study|Protocol Violation|9|||
146247068|NCT03541369|527417738|FG014|Overall Study|Withdrawal by Subject|3|||
146247069|NCT03541369|527417739|FG015|Overall Study|Withdrawal by Subject|0|||
146247070|NCT03541369|527417740|FG016|Overall Study|Withdrawal by Subject|4|||
145999278|NCT01908140|526514679|FG000|Overall Study|Adverse Event|22|||
145999279|NCT01908140|526514680|FG001|Overall Study|Adverse Event|23|||
145999280|NCT01307449|526514681|FG000|Overall Study|Adverse Event|1|||
145999281|NCT01307449|526514682|FG001|Overall Study|Adverse Event|0|||
145999282|NCT01307449|526514683|FG002|Overall Study|Adverse Event|0|||
145999283|NCT01307449|526514684|FG003|Overall Study|Adverse Event|0|||
145999284|NCT00698828|526514687|FG000|Overall Study|Adverse Event|3|||
145999285|NCT00698828|526514688|FG001|Overall Study|Adverse Event|4|||
145999286|NCT00698828|526514689|FG002|Overall Study|Adverse Event|4|||
145999287|NCT00698828|526514687|FG000|Overall Study|Death|0|||
145999288|NCT00698828|526514688|FG001|Overall Study|Death|0|||
146247071|NCT03541369|527417741|FG017|Overall Study|Withdrawal by Subject|2|||
145999289|NCT00698828|526514689|FG002|Overall Study|Death|1|||
145999290|NCT00698828|526514687|FG000|Overall Study|Exacerbation of COPD|1|||
145999291|NCT00698828|526514688|FG001|Overall Study|Exacerbation of COPD|3|||
145999292|NCT00698828|526514689|FG002|Overall Study|Exacerbation of COPD|0|||
145999293|NCT00698828|526514687|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
145999294|NCT00698828|526514688|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
145999295|NCT00698828|526514689|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
145999296|NCT00698828|526514687|FG000|Overall Study|Investigator/Sponsor decision|1|||
145999297|NCT00698828|526514688|FG001|Overall Study|Investigator/Sponsor decision|0|||
145999298|NCT00698828|526514689|FG002|Overall Study|Investigator/Sponsor decision|2|||
145999299|NCT00698828|526514687|FG000|Overall Study|Lost to Follow-up|1|||
145999300|NCT00698828|526514688|FG001|Overall Study|Lost to Follow-up|1|||
145999301|NCT00698828|526514689|FG002|Overall Study|Lost to Follow-up|0|||
145999302|NCT00698828|526514687|FG000|Overall Study|Withdrew consent|0|||
145999303|NCT00698828|526514688|FG001|Overall Study|Withdrew consent|7|||
145999304|NCT00698828|526514689|FG002|Overall Study|Withdrew consent|4|||
145999305|NCT00698828|526514687|FG000|Overall Study|Withdrew consent (not treated)|2|||
145999306|NCT00698828|526514688|FG001|Overall Study|Withdrew consent (not treated)|0|||
145999307|NCT00698828|526514689|FG002|Overall Study|Withdrew consent (not treated)|0|||
145999308|NCT02013609|526514690|FG000|Overall Study|Withdrawal by Subject|9|||
145999309|NCT02013609|526514690|FG000|Overall Study|Lost to Follow-up|3|||
145999310|NCT02013609|526514690|FG000|Overall Study|Adverse Event|3|||
145999311|NCT02013609|526514690|FG000|Overall Study|Met Withdrawal Criteria|3|||
145999312|NCT01119287|526514691|FG000|Overall Study|Patient Decision, not related to AE|0|||
145999313|NCT01119287|526514692|FG001|Overall Study|Patient Decision, not related to AE|0|||
145999314|NCT01119287|526514693|FG002|Overall Study|Patient Decision, not related to AE|2|||
145999315|NCT01119287|526514694|FG003|Overall Study|Patient Decision, not related to AE|2|||
145999316|NCT01119287|526514695|FG004|Overall Study|Patient Decision, not related to AE|1|||
145999317|NCT01119287|526514696|FG005|Overall Study|Patient Decision, not related to AE|0|||
145999318|NCT01076010|526514697|FG000|Overall Study|Death|15|||
145999319|NCT01076010|526514698|FG001|Overall Study|Death|1|||
145999320|NCT01076010|526514699|FG002|Overall Study|Death|0|||
145999321|NCT01076010|526514697|FG000|Overall Study|Adverse Event|7|||
145999322|NCT01076010|526514698|FG001|Overall Study|Adverse Event|2|||
145999323|NCT01076010|526514699|FG002|Overall Study|Adverse Event|0|||
145999324|NCT01076010|526514697|FG000|Overall Study|Progressive disease|90|||
145999325|NCT01076010|526514698|FG001|Overall Study|Progressive disease|30|||
145999326|NCT01076010|526514699|FG002|Overall Study|Progressive disease|1|||
145999327|NCT01076010|526514697|FG000|Overall Study|Lack of Efficacy|4|||
145999328|NCT01076010|526514698|FG001|Overall Study|Lack of Efficacy|0|||
145999329|NCT01076010|526514699|FG002|Overall Study|Lack of Efficacy|0|||
145999330|NCT01076010|526514697|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
145999331|NCT01076010|526514698|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
145999332|NCT01076010|526514699|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
145999333|NCT01076010|526514697|FG000|Overall Study|Significant Surgical Procedure|0|||
145999334|NCT01076010|526514698|FG001|Overall Study|Significant Surgical Procedure|1|||
145999335|NCT01076010|526514699|FG002|Overall Study|Significant Surgical Procedure|0|||
145999336|NCT01076010|526514697|FG000|Overall Study|Protocol Violation|0|||
145999337|NCT01076010|526514698|FG001|Overall Study|Protocol Violation|1|||
145999338|NCT01076010|526514699|FG002|Overall Study|Protocol Violation|0|||
145999339|NCT01076010|526514697|FG000|Overall Study|Noncompliance|1|||
145999340|NCT01076010|526514698|FG001|Overall Study|Noncompliance|1|||
145999341|NCT01076010|526514699|FG002|Overall Study|Noncompliance|0|||
145999342|NCT01076010|526514697|FG000|Overall Study|Withdrawal by Subject|3|||
145999343|NCT01076010|526514698|FG001|Overall Study|Withdrawal by Subject|0|||
145999344|NCT01076010|526514699|FG002|Overall Study|Withdrawal by Subject|1|||
145999345|NCT01076010|526514697|FG000|Overall Study|Other|5|||
145999346|NCT01076010|526514698|FG001|Overall Study|Other|2|||
145999347|NCT01076010|526514699|FG002|Overall Study|Other|0|||
145999348|NCT02284191|526514703|FG000|Overall Study|Withdrawal by Subject|1|||
145999349|NCT02284191|526514704|FG001|Overall Study|Withdrawal by Subject|3|||
145999350|NCT02284191|526514703|FG000|Overall Study|Lost to Follow-up|1|||
145999351|NCT02284191|526514704|FG001|Overall Study|Lost to Follow-up|0|||
145999352|NCT02257684|526514707|FG000|Overall Study|Adverse Event|2|||
145999353|NCT02257684|526514707|FG000|Overall Study|Lack of Efficacy|1|||
145999354|NCT02257684|526514707|FG000|Overall Study|Sponsor's Decision|1|||
145999355|NCT01570387|526514708|FG000|Overall Study|Adverse Event|1|||
145999356|NCT01570387|526514709|FG001|Overall Study|Adverse Event|0|||
145999357|NCT01570387|526514710|FG002|Overall Study|Adverse Event|0|||
145999358|NCT01570387|526514711|FG003|Overall Study|Adverse Event|0|||
145999359|NCT01570387|526514708|FG000|Overall Study|Death|0|||
145999360|NCT01570387|526514709|FG001|Overall Study|Death|0|||
145999361|NCT01570387|526514710|FG002|Overall Study|Death|0|||
145999362|NCT01570387|526514711|FG003|Overall Study|Death|1|||
145999363|NCT01570387|526514708|FG000|Overall Study|Withdrawal by Subject|0|||
145999364|NCT01570387|526514709|FG001|Overall Study|Withdrawal by Subject|0|||
145999365|NCT01570387|526514710|FG002|Overall Study|Withdrawal by Subject|0|||
145999366|NCT01570387|526514711|FG003|Overall Study|Withdrawal by Subject|1|||
145999367|NCT01823289|526514713|FG000|Overall Study|Lost to Follow-up|5|||
145999368|NCT01823289|526514713|FG000|Overall Study|Adverse Event|5|||
145999369|NCT01823289|526514713|FG000|Overall Study|Lack of Efficacy|1|||
145999370|NCT01823289|526514713|FG000|Overall Study|Physician Decision|9|||
145999371|NCT01823289|526514713|FG000|Overall Study|Administered contraindicated medicine|1|||
145999372|NCT01823289|526514713|FG000|Overall Study|Transaminase increased more than 3 times|1|||
145999373|NCT01823289|526514713|FG000|Overall Study|Drug affected efficacy and safety|1|||
145999374|NCT01823289|526514713|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
145999375|NCT00654732|526514714|FG000|Overall Study|Adverse Event|4|||
145999376|NCT00654732|526514715|FG001|Overall Study|Adverse Event|6|||
145999377|NCT01734902|526514720|FG000|Overall Study|Other than listed|0|||
145999378|NCT01734902|526514721|FG001|Overall Study|Other than listed|2|||
145999379|NCT00060944|526514724|FG000|Overall Study|Adverse Event|12|||
145999380|NCT00060944|526514725|FG001|Overall Study|Adverse Event|10|||
145999381|NCT00060944|526514724|FG000|Overall Study|Death|2|||
145999382|NCT00060944|526514725|FG001|Overall Study|Death|3|||
145999383|NCT00060944|526514724|FG000|Overall Study|Withdrawal by Subject|18|||
145999384|NCT00060944|526514725|FG001|Overall Study|Withdrawal by Subject|5|||
145999385|NCT00060944|526514724|FG000|Overall Study|Disease Progression|93|||
145999386|NCT00060944|526514725|FG001|Overall Study|Disease Progression|94|||
145999387|NCT00060944|526514724|FG000|Overall Study|Lost to Follow-up|1|||
145999388|NCT00060944|526514725|FG001|Overall Study|Lost to Follow-up|0|||
145999389|NCT00060944|526514724|FG000|Overall Study|Subject Ineligible To Continue|2|||
145999390|NCT00060944|526514725|FG001|Overall Study|Subject Ineligible To Continue|1|||
145999391|NCT00060944|526514724|FG000|Overall Study|Treatment Switch|0|||
145999392|NCT00060944|526514725|FG001|Overall Study|Treatment Switch|13|||
145999393|NCT00060944|526514724|FG000|Overall Study|Other|2|||
145999394|NCT00060944|526514725|FG001|Overall Study|Other|4|||
145999395|NCT00060944|526514724|FG000|Overall Study|randomized but not treated|6|||
145999396|NCT00060944|526514725|FG001|Overall Study|randomized but not treated|4|||
145999397|NCT02359903|526514730|FG000|Overall Study|Adverse Event|0|||
145999398|NCT02359903|526514731|FG001|Overall Study|Adverse Event|2|||
145999399|NCT03383666|526514732|FG000|Overall Study|Withdrawal by Subject|2|||
145999400|NCT03383666|526514732|FG000|Overall Study|Lost to Follow-up|2|||
145999401|NCT02536664|526514733|FG000|Overall Study|Inadequate completion of documentation|2|||
145999402|NCT02536664|526514734|FG001|Overall Study|Inadequate completion of documentation|4|||
145999403|NCT02536664|526514733|FG000|Overall Study|Progression|13|||
145999404|NCT02536664|526514734|FG001|Overall Study|Progression|18|||
145999405|NCT02536664|526514733|FG000|Overall Study|Death due to lymphoma|2|||
145999406|NCT02536664|526514734|FG001|Overall Study|Death due to lymphoma|1|||
145999407|NCT02536664|526514733|FG000|Overall Study|Death due to other reason|3|||
145999408|NCT02536664|526514734|FG001|Overall Study|Death due to other reason|2|||
145999409|NCT02536664|526514733|FG000|Overall Study|Intolerability|8|||
145999410|NCT02536664|526514734|FG001|Overall Study|Intolerability|6|||
145999411|NCT02536664|526514733|FG000|Overall Study|Withdrawal by Subject|8|||
145999412|NCT02536664|526514734|FG001|Overall Study|Withdrawal by Subject|5|||
145999413|NCT02536664|526514733|FG000|Overall Study|Other|18|||
145999414|NCT02536664|526514734|FG001|Overall Study|Other|24|||
145999415|NCT02536664|526514733|FG000|Overall Study|Missing|53|||
145999416|NCT02536664|526514734|FG001|Overall Study|Missing|20|||
145999417|NCT03507127|526514742|FG000|Overall Study|Withdrawal by Subject|1|||
145999418|NCT03507127|526514743|FG001|Overall Study|Withdrawal by Subject|0|||
145999419|NCT03507127|526514742|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
145999420|NCT03507127|526514743|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
145999421|NCT00746811|526514748|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
145999422|NCT00746811|526514749|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
145999423|NCT02505425|526514753|FG000|Overall Study|Lost to Follow-up|41|||
145999424|NCT02505425|526514754|FG001|Overall Study|Lost to Follow-up|61|||
145999425|NCT02505425|526514755|FG002|Overall Study|Lost to Follow-up|31|||
145999426|NCT02505425|526514756|FG003|Overall Study|Lost to Follow-up|19|||
145999427|NCT02505425|526514753|FG000|Overall Study|Withdrawal by Subject|39|||
145999428|NCT02505425|526514754|FG001|Overall Study|Withdrawal by Subject|9|||
145999429|NCT02505425|526514755|FG002|Overall Study|Withdrawal by Subject|19|||
145999430|NCT02505425|526514756|FG003|Overall Study|Withdrawal by Subject|7|||
145999431|NCT02505425|526514753|FG000|Overall Study|Death|8|||
146092070|NCT01226043|526858520|FG003|30-week Observational Phase|Protocol Violation|1|||
145999432|NCT02505425|526514754|FG001|Overall Study|Death|12|||
145999433|NCT02505425|526514755|FG002|Overall Study|Death|0|||
145999434|NCT02505425|526514756|FG003|Overall Study|Death|0|||
145999435|NCT02031302|526514757|FG000|Overall Study|Death|115|||
145999436|NCT02031302|526514758|FG001|Overall Study|Death|0|||
145999437|NCT02031302|526514757|FG000|Overall Study|Not treated with study valve system|18|||
146247072|NCT03541369|527417724|FG000|Overall Study|Lost to Follow-up|0|||
146092071|NCT01226043|526858517|FG000|30-week Observational Phase|Lost to Follow-up|0|||
146247073|NCT03541369|527417725|FG001|Overall Study|Lost to Follow-up|0|||
145999438|NCT02031302|526514758|FG001|Overall Study|Not treated with study valve system|0|||
145999439|NCT02031302|526514757|FG000|Overall Study|Missed Follow Up|27|||
145999440|NCT02031302|526514758|FG001|Overall Study|Missed Follow Up|0|||
145999441|NCT02031302|526514757|FG000|Overall Study|Lost to Follow-up|4|||
145999442|NCT02031302|526514758|FG001|Overall Study|Lost to Follow-up|0|||
145999443|NCT02293551|526514765|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
145999444|NCT02293551|526514766|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
145999445|NCT02293551|526514767|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
145999446|NCT02293551|526514768|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
145999447|NCT02293551|526514769|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
145999448|NCT02293551|526514770|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
145999449|NCT02293551|526514765|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
145999450|NCT02293551|526514766|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
145999451|NCT02293551|526514767|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
145999452|NCT02293551|526514768|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
145999453|NCT02293551|526514769|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
145999454|NCT02293551|526514770|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
145999455|NCT02293551|526514765|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
145999456|NCT02293551|526514766|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
145999457|NCT02293551|526514767|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
145999458|NCT02293551|526514768|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
145999459|NCT02293551|526514769|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
145999460|NCT02293551|526514770|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
145999461|NCT02936323|526514771|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999462|NCT02936323|526514772|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145999463|NCT02936323|526514773|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999464|NCT02936323|526514774|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145999465|NCT02936323|526514775|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145999466|NCT02936323|526514776|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145999467|NCT02936323|526514777|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999468|NCT02936323|526514778|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999469|NCT02936323|526514779|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999470|NCT02936323|526514780|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145999471|NCT02936323|526514771|FG000|Phase 1 Dose Escalation|Death|2|||
145999472|NCT02936323|526514772|FG001|Phase 1 Dose Escalation|Death|1|||
145999473|NCT02936323|526514773|FG002|Phase 1 Dose Escalation|Death|3|||
145999474|NCT02936323|526514774|FG003|Phase 1 Dose Escalation|Death|1|||
145999475|NCT02936323|526514775|FG004|Phase 1 Dose Escalation|Death|2|||
145999476|NCT02936323|526514776|FG005|Phase 1 Dose Escalation|Death|3|||
145999477|NCT02936323|526514777|FG006|Phase 1 Dose Escalation|Death|3|||
145999478|NCT02936323|526514778|FG007|Phase 1 Dose Escalation|Death|0|||
145999479|NCT02936323|526514779|FG008|Phase 1 Dose Escalation|Death|0|||
145999480|NCT02936323|526514780|FG009|Phase 1 Dose Escalation|Death|0|||
145999481|NCT02936323|526514771|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999482|NCT02936323|526514772|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999483|NCT02936323|526514773|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999484|NCT02936323|526514774|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999485|NCT02936323|526514775|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999486|NCT02936323|526514776|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
145999487|NCT02936323|526514777|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999488|NCT02936323|526514778|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999489|NCT02936323|526514779|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999490|NCT02936323|526514780|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145999491|NCT02936323|526514771|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999492|NCT02936323|526514772|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999493|NCT02936323|526514773|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999494|NCT02936323|526514774|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999495|NCT02936323|526514775|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999496|NCT02936323|526514776|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999497|NCT02936323|526514777|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145999498|NCT02936323|526514778|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
145999499|NCT02936323|526514779|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
145999500|NCT02936323|526514780|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
145999501|NCT02936323|526514771|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
145999502|NCT02936323|526514772|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
145999503|NCT02936323|526514773|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
145999504|NCT02936323|526514774|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
145999505|NCT02936323|526514775|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
145999506|NCT02936323|526514776|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
145999507|NCT02936323|526514777|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
145999508|NCT02936323|526514778|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
145999509|NCT02936323|526514779|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
146247074|NCT03541369|527417726|FG002|Overall Study|Lost to Follow-up|0|||
146247075|NCT03541369|527417727|FG003|Overall Study|Lost to Follow-up|0|||
146247076|NCT03541369|527417728|FG004|Overall Study|Lost to Follow-up|1|||
146247077|NCT03541369|527417729|FG005|Overall Study|Lost to Follow-up|0|||
145999510|NCT02936323|526514780|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
145999511|NCT02936323|526514771|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999512|NCT02936323|526514772|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999513|NCT02936323|526514773|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999514|NCT02936323|526514774|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999515|NCT02936323|526514775|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999516|NCT02936323|526514776|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999517|NCT02936323|526514777|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999518|NCT02936323|526514778|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
145999519|NCT02936323|526514779|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
145999520|NCT02936323|526514780|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145999521|NCT02936323|526514771|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999522|NCT02936323|526514772|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999523|NCT02936323|526514773|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999524|NCT02936323|526514774|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999525|NCT02936323|526514775|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999526|NCT02936323|526514776|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999527|NCT02936323|526514777|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999528|NCT02936323|526514778|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999529|NCT02936323|526514779|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145999530|NCT02936323|526514780|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
146247078|NCT03541369|527417730|FG006|Overall Study|Lost to Follow-up|0|||
146247079|NCT03541369|527417731|FG007|Overall Study|Lost to Follow-up|0|||
146247080|NCT03541369|527417732|FG008|Overall Study|Lost to Follow-up|1|||
146247081|NCT03541369|527417733|FG009|Overall Study|Lost to Follow-up|0|||
146247082|NCT03541369|527417734|FG010|Overall Study|Lost to Follow-up|0|||
146247083|NCT03541369|527417735|FG011|Overall Study|Lost to Follow-up|0|||
146247084|NCT03541369|527417736|FG012|Overall Study|Lost to Follow-up|1|||
146247085|NCT03541369|527417737|FG013|Overall Study|Lost to Follow-up|0|||
146247086|NCT03541369|527417738|FG014|Overall Study|Lost to Follow-up|0|||
146247087|NCT03541369|527417739|FG015|Overall Study|Lost to Follow-up|0|||
146247088|NCT03541369|527417740|FG016|Overall Study|Lost to Follow-up|0|||
146247089|NCT03541369|527417741|FG017|Overall Study|Lost to Follow-up|0|||
146247090|NCT02279732|527417744|FG000|Overall Study|Death|23|||
146247091|NCT02279732|527417745|FG001|Overall Study|Death|20|||
146247092|NCT02279732|527417744|FG000|Overall Study|Disease Progression|13|||
146247093|NCT02279732|527417745|FG001|Overall Study|Disease Progression|3|||
146247094|NCT02279732|527417744|FG000|Overall Study|Withdrawal by Subject|2|||
146247095|NCT02279732|527417745|FG001|Overall Study|Withdrawal by Subject|7|||
146247096|NCT02279732|527417744|FG000|Overall Study|Adverse Event|1|||
146247097|NCT02279732|527417745|FG001|Overall Study|Adverse Event|2|||
146247098|NCT02279732|527417744|FG000|Overall Study|Administrative Reason By Sponsor|0|||
146247099|NCT02279732|527417745|FG001|Overall Study|Administrative Reason By Sponsor|2|||
146247100|NCT02279732|527417744|FG000|Overall Study|Study Drug Toxicity|2|||
146247101|NCT02279732|527417745|FG001|Overall Study|Study Drug Toxicity|0|||
146247102|NCT02279732|527417744|FG000|Overall Study|Lost to Follow-up|0|||
146247103|NCT02279732|527417745|FG001|Overall Study|Lost to Follow-up|1|||
146247104|NCT02279732|527417744|FG000|Overall Study|Maximum Clinical Benefit|1|||
146247105|NCT02279732|527417745|FG001|Overall Study|Maximum Clinical Benefit|0|||
146247106|NCT02279732|527417744|FG000|Overall Study|Subject Requested to Discontinue|0|||
146247107|NCT02279732|527417745|FG001|Overall Study|Subject Requested to Discontinue|1|||
146247108|NCT02279732|527417744|FG000|Overall Study|Other|53|||
146247109|NCT02279732|527417745|FG001|Overall Study|Other|67|||
146247110|NCT02279732|527417744|FG000|Overall Study|Other|3|||
146247111|NCT02279732|527417745|FG001|Overall Study|Other|3|||
146247112|NCT03072862|527417749|FG000|Overall Study|Withdrawal by Subject|4|||
146247113|NCT03072862|527417749|FG000|Overall Study|Lost to Follow-up|6|||
146298071|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
145999531|NCT02936323|526514771|FG000|Phase 2a Dose Expansion|Death|0|||
146247114|NCT03072862|527417749|FG000|Overall Study|Protocol Violation|4|||
146247115|NCT03072862|527417749|FG000|Overall Study|Physician Decision|2|||
146247116|NCT03072862|527417749|FG000|Overall Study|Death|1|||
146247117|NCT03072862|527417749|FG000|Overall Study|Adverse Event|1|||
146247118|NCT02513667|527417750|FG000|Overall Study|Withdrawal by Subject|0|||
146247119|NCT02513667|527417751|FG001|Overall Study|Withdrawal by Subject|1|||
146247120|NCT03347396|527417752|FG000|Part A (26 Weeks)|Adverse Event|1|||
146298072|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
146298073|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
146247121|NCT03347396|527417753|FG001|Part A (26 Weeks)|Adverse Event|0|||
146247122|NCT03347396|527417752|FG000|Part A (26 Weeks)|Death|0|||
146247123|NCT03347396|527417753|FG001|Part A (26 Weeks)|Death|1|||
146247124|NCT03347396|527417752|FG000|Part B (149 Weeks)|Adverse Event|1|||
146247125|NCT03347396|527417753|FG001|Part B (149 Weeks)|Adverse Event|1|||
146247126|NCT03347396|527417752|FG000|Part B (149 Weeks)|Death|1|||
146247127|NCT03347396|527417753|FG001|Part B (149 Weeks)|Death|0|||
146247128|NCT01670526|527417758|FG000|Overall Study|Withdrawal by Subject|3|||
145999532|NCT02936323|526514772|FG001|Phase 2a Dose Expansion|Death|0|||
145999533|NCT02936323|526514773|FG002|Phase 2a Dose Expansion|Death|0|||
145999534|NCT02936323|526514774|FG003|Phase 2a Dose Expansion|Death|0|||
145999535|NCT02936323|526514775|FG004|Phase 2a Dose Expansion|Death|0|||
145999536|NCT02936323|526514776|FG005|Phase 2a Dose Expansion|Death|0|||
145999537|NCT02936323|526514777|FG006|Phase 2a Dose Expansion|Death|0|||
145999538|NCT02936323|526514778|FG007|Phase 2a Dose Expansion|Death|4|||
145999539|NCT02936323|526514779|FG008|Phase 2a Dose Expansion|Death|8|||
145999540|NCT02936323|526514780|FG009|Phase 2a Dose Expansion|Death|10|||
145999541|NCT02781558|526514781|FG000|Overall Study|Lost to Follow-up|2|||
145999542|NCT02781558|526514782|FG001|Overall Study|Lost to Follow-up|2|||
145999543|NCT02781558|526514781|FG000|Overall Study|Adverse Event|1|||
145999544|NCT02781558|526514782|FG001|Overall Study|Adverse Event|0|||
145999545|NCT00545779|526514785|FG000|Overall Study|Violation of selection criteria at entry|8|||
145999546|NCT00545779|526514785|FG000|Overall Study|Other protocol violation|1|||
145999547|NCT00545779|526514785|FG000|Overall Study|Did not cooperate|7|||
145999548|NCT00545779|526514785|FG000|Overall Study|Withdrawal by Subject|20|||
145999549|NCT00545779|526514785|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
145999550|NCT00545779|526514785|FG000|Overall Study|Failure to return|3|||
145999551|NCT01542788|526514786|FG000|Overall Study|Randomized but Not Treated|2|||
145999552|NCT01542788|526514787|FG001|Overall Study|Randomized but Not Treated|0|||
145999553|NCT01542788|526514786|FG000|Overall Study|Lack of Efficacy|41|||
145999554|NCT01542788|526514787|FG001|Overall Study|Lack of Efficacy|71|||
145999555|NCT01542788|526514786|FG000|Overall Study|Lost to Follow-up|5|||
145999556|NCT01542788|526514787|FG001|Overall Study|Lost to Follow-up|0|||
145999557|NCT01542788|526514786|FG000|Overall Study|Death|3|||
145999558|NCT01542788|526514787|FG001|Overall Study|Death|0|||
145999559|NCT01542788|526514786|FG000|Overall Study|Protocol Violation|2|||
145999560|NCT01542788|526514787|FG001|Overall Study|Protocol Violation|0|||
145999561|NCT01542788|526514786|FG000|Overall Study|Physician Decision|1|||
145999562|NCT01542788|526514787|FG001|Overall Study|Physician Decision|0|||
145999563|NCT01542788|526514786|FG000|Overall Study|Withdrawal by Subject|1|||
145999564|NCT01542788|526514787|FG001|Overall Study|Withdrawal by Subject|0|||
145999565|NCT00542178|526514790|FG000|Overall Study|did not complete year 4 follow-up|75|||
145999566|NCT00542178|526514791|FG001|Overall Study|did not complete year 4 follow-up|80|||
145999567|NCT00542178|526514792|FG002|Overall Study|did not complete year 4 follow-up|74|||
145999568|NCT00542178|526514793|FG003|Overall Study|did not complete year 4 follow-up|62|||
145999569|NCT00542178|526514794|FG004|Overall Study|did not complete year 4 follow-up|64|||
145999570|NCT00542178|526514795|FG005|Overall Study|did not complete year 4 follow-up|89|||
145999571|NCT00542178|526514796|FG006|Overall Study|did not complete year 4 follow-up|87|||
145999572|NCT00542178|526514797|FG007|Overall Study|did not complete year 4 follow-up|85|||
145999573|NCT02611037|526514798|FG000|Overall Study|Withdrawal prior to treatment|2|||
145999574|NCT02611037|526514799|FG001|Overall Study|Withdrawal prior to treatment|0|||
145999575|NCT05270863|526514802|FG000|Visit 2 First Intervention|Randomization error|0|||
145999576|NCT05270863|526514803|FG001|Visit 2 First Intervention|Randomization error|0|||
145999577|NCT05270863|526514804|FG002|Visit 2 First Intervention|Randomization error|0|||
145999578|NCT05270863|526514805|FG003|Visit 2 First Intervention|Randomization error|1|||
145999579|NCT05270863|526514806|FG004|Visit 2 First Intervention|Randomization error|0|||
145999580|NCT05270863|526514807|FG005|Visit 2 First Intervention|Randomization error|0|||
145999581|NCT05270863|526514802|FG000|First Washout|Withdrawal by Subject|0|||
146247129|NCT01670526|527417759|FG001|Overall Study|Withdrawal by Subject|1|||
146247130|NCT01670526|527417758|FG000|Overall Study|Lost to Follow-up|9|||
145999582|NCT05270863|526514803|FG001|First Washout|Withdrawal by Subject|0|||
145999583|NCT05270863|526514804|FG002|First Washout|Withdrawal by Subject|0|||
145999584|NCT05270863|526514805|FG003|First Washout|Withdrawal by Subject|0|||
145999585|NCT05270863|526514806|FG004|First Washout|Withdrawal by Subject|1|||
145999586|NCT05270863|526514807|FG005|First Washout|Withdrawal by Subject|1|||
145999587|NCT05270863|526514802|FG000|First Washout|Lost to Follow-up|0|||
145999588|NCT05270863|526514803|FG001|First Washout|Lost to Follow-up|0|||
145999589|NCT05270863|526514804|FG002|First Washout|Lost to Follow-up|0|||
145999590|NCT05270863|526514805|FG003|First Washout|Lost to Follow-up|0|||
145999591|NCT05270863|526514806|FG004|First Washout|Lost to Follow-up|0|||
146247131|NCT01670526|527417759|FG001|Overall Study|Lost to Follow-up|5|||
145999592|NCT05270863|526514807|FG005|First Washout|Lost to Follow-up|1|||
146247132|NCT03659136|527417766|FG000|Overall Study|Not treated|2|||
146247133|NCT03659136|527417767|FG001|Overall Study|Not treated|0|||
146247134|NCT03659136|527417766|FG000|Overall Study|Covid-19 related|1|||
145999593|NCT05270863|526514802|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
145999594|NCT05270863|526514803|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
145999595|NCT05270863|526514804|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
145999596|NCT05270863|526514805|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
146092072|NCT01226043|526858518|FG001|30-week Observational Phase|Lost to Follow-up|0|||
146247135|NCT03659136|527417767|FG001|Overall Study|Covid-19 related|1|||
145999597|NCT05270863|526514806|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
145999598|NCT05270863|526514807|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
145999599|NCT05270863|526514802|FG000|Second Washout|Withdrawal by Subject|1|||
145999600|NCT05270863|526514803|FG001|Second Washout|Withdrawal by Subject|1|||
145999601|NCT05270863|526514804|FG002|Second Washout|Withdrawal by Subject|0|||
145999602|NCT05270863|526514805|FG003|Second Washout|Withdrawal by Subject|0|||
145999603|NCT05270863|526514806|FG004|Second Washout|Withdrawal by Subject|0|||
145999604|NCT05270863|526514807|FG005|Second Washout|Withdrawal by Subject|0|||
145999605|NCT05270863|526514802|FG000|Second Washout|Lost to Follow-up|0|||
145999606|NCT05270863|526514803|FG001|Second Washout|Lost to Follow-up|0|||
145999607|NCT05270863|526514804|FG002|Second Washout|Lost to Follow-up|0|||
145999608|NCT05270863|526514805|FG003|Second Washout|Lost to Follow-up|1|||
145999609|NCT05270863|526514806|FG004|Second Washout|Lost to Follow-up|0|||
145999610|NCT05270863|526514807|FG005|Second Washout|Lost to Follow-up|0|||
145999611|NCT04712669|526514808|FG000|Double Blind Phase|Adverse Event|4|||
145999612|NCT04712669|526514809|FG001|Double Blind Phase|Adverse Event|4|||
145999613|NCT04712669|526514810|FG002|Double Blind Phase|Adverse Event|3|||
145999614|NCT04712669|526514811|FG003|Double Blind Phase|Adverse Event|0|||
145999615|NCT04712669|526514812|FG004|Double Blind Phase|Adverse Event|0|||
145999616|NCT04712669|526514813|FG005|Double Blind Phase|Adverse Event|0|||
145999617|NCT04712669|526514814|FG006|Double Blind Phase|Adverse Event|0|||
145999618|NCT04712669|526514815|FG007|Double Blind Phase|Adverse Event|0|||
145999619|NCT04712669|526514808|FG000|Double Blind Phase|Physician Decision|1|||
145999620|NCT04712669|526514809|FG001|Double Blind Phase|Physician Decision|0|||
145999621|NCT04712669|526514810|FG002|Double Blind Phase|Physician Decision|0|||
145999622|NCT04712669|526514811|FG003|Double Blind Phase|Physician Decision|0|||
145999623|NCT04712669|526514812|FG004|Double Blind Phase|Physician Decision|0|||
145999624|NCT04712669|526514813|FG005|Double Blind Phase|Physician Decision|0|||
146092073|NCT01226043|526858519|FG002|30-week Observational Phase|Lost to Follow-up|2|||
146092074|NCT01226043|526858520|FG003|30-week Observational Phase|Lost to Follow-up|2|||
146092075|NCT01226043|526858517|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
146092076|NCT01226043|526858518|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
146092077|NCT01226043|526858519|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
146092078|NCT01226043|526858520|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
146092079|NCT01226043|526858517|FG000|30-week Observational Phase|Physician Decision|0|||
146092080|NCT01226043|526858518|FG001|30-week Observational Phase|Physician Decision|0|||
146092081|NCT01226043|526858519|FG002|30-week Observational Phase|Physician Decision|2|||
146092082|NCT01226043|526858520|FG003|30-week Observational Phase|Physician Decision|2|||
146092083|NCT01702571|526858521|FG000|Overall Study|Death|1067|||
146092084|NCT01702571|526858522|FG001|Overall Study|Death|76|||
146092085|NCT01702571|526858521|FG000|Overall Study|Lost to Follow-up|144|||
146092086|NCT01702571|526858522|FG001|Overall Study|Lost to Follow-up|10|||
146092087|NCT01702571|526858521|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
146092088|NCT01702571|526858522|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
146092089|NCT01702571|526858521|FG000|Overall Study|Investigator Decision|5|||
146092090|NCT01702571|526858522|FG001|Overall Study|Investigator Decision|0|||
146092091|NCT01702571|526858521|FG000|Overall Study|Not Classifiable|1|||
146092092|NCT01702571|526858522|FG001|Overall Study|Not Classifiable|0|||
146092093|NCT01702571|526858521|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
146092094|NCT01702571|526858522|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
146092095|NCT01702571|526858521|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
146092096|NCT01702571|526858522|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
146092097|NCT01702571|526858521|FG000|Overall Study|Progressive Disease|3|||
146092098|NCT01702571|526858522|FG001|Overall Study|Progressive Disease|0|||
146092099|NCT01702571|526858521|FG000|Overall Study|Protocol Violation|2|||
146092100|NCT01702571|526858522|FG001|Overall Study|Protocol Violation|0|||
146092101|NCT01702571|526858521|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
146092102|NCT01702571|526858522|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
146247136|NCT03659136|527417766|FG000|Overall Study|Withdrawal by Subject|1|||
146247137|NCT03659136|527417767|FG001|Overall Study|Withdrawal by Subject|6|||
146247138|NCT03659136|527417766|FG000|Overall Study|Adverse Event|4|||
146092103|NCT01702571|526858521|FG000|Overall Study|Termination By Sponsor|4|||
146247139|NCT03659136|527417767|FG001|Overall Study|Adverse Event|6|||
145999625|NCT04712669|526514814|FG006|Double Blind Phase|Physician Decision|0|||
145999626|NCT04712669|526514815|FG007|Double Blind Phase|Physician Decision|0|||
145999627|NCT04712669|526514808|FG000|Double Blind Phase|Withdrawal by Subject|3|||
145999628|NCT04712669|526514809|FG001|Double Blind Phase|Withdrawal by Subject|6|||
145999629|NCT04712669|526514810|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145999630|NCT04712669|526514811|FG003|Double Blind Phase|Withdrawal by Subject|0|||
146092104|NCT01702571|526858522|FG001|Overall Study|Termination By Sponsor|0|||
146092105|NCT01702571|526858521|FG000|Overall Study|Withdrawal by Subject|177|||
146092106|NCT01702571|526858522|FG001|Overall Study|Withdrawal by Subject|29|||
146092107|NCT00910988|526858523|FG000|Overall Study|Lost to Follow-up|2|||
146092108|NCT00910988|526858524|FG001|Overall Study|Lost to Follow-up|4|||
146092109|NCT00910988|526858525|FG002|Overall Study|Lost to Follow-up|3|||
146247140|NCT03659136|527417766|FG000|Overall Study|Progressive disease|37|||
146247141|NCT03659136|527417767|FG001|Overall Study|Progressive disease|31|||
146247142|NCT03659136|527417766|FG000|Overall Study|Study closure|2|||
146247143|NCT03659136|527417767|FG001|Overall Study|Study closure|2|||
146247144|NCT03659136|527417766|FG000|Overall Study|Sponsor decision/recommendation|3|||
146247145|NCT03659136|527417767|FG001|Overall Study|Sponsor decision/recommendation|2|||
146247146|NCT03659136|527417766|FG000|Overall Study|Switched to other drug/therapy|2|||
146247147|NCT03659136|527417767|FG001|Overall Study|Switched to other drug/therapy|2|||
145999631|NCT04712669|526514812|FG004|Double Blind Phase|Withdrawal by Subject|0|||
146247148|NCT03659136|527417766|FG000|Overall Study|Lack of clinical benefit|0|||
146247149|NCT03659136|527417767|FG001|Overall Study|Lack of clinical benefit|1|||
146247150|NCT04425252|527419774|FG000|Overall Study|Withdrawal by Subject|2|||
146247151|NCT04425252|527419775|FG001|Overall Study|Withdrawal by Subject|1|||
146247152|NCT04425252|527419774|FG000|Overall Study|Lost to Follow-up|1|||
146247153|NCT04425252|527419775|FG001|Overall Study|Lost to Follow-up|0|||
146247154|NCT04425252|527419774|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
146247155|NCT04425252|527419775|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
145999632|NCT04712669|526514813|FG005|Double Blind Phase|Withdrawal by Subject|0|||
145999633|NCT04712669|526514814|FG006|Double Blind Phase|Withdrawal by Subject|0|||
145999634|NCT04712669|526514815|FG007|Double Blind Phase|Withdrawal by Subject|0|||
145999635|NCT04712669|526514808|FG000|Double Blind Phase|Termination by Sponsor|0|||
145999636|NCT04712669|526514809|FG001|Double Blind Phase|Termination by Sponsor|0|||
145999637|NCT04712669|526514810|FG002|Double Blind Phase|Termination by Sponsor|1|||
145999638|NCT04712669|526514811|FG003|Double Blind Phase|Termination by Sponsor|0|||
145999639|NCT04712669|526514812|FG004|Double Blind Phase|Termination by Sponsor|0|||
145999640|NCT04712669|526514813|FG005|Double Blind Phase|Termination by Sponsor|0|||
145999641|NCT04712669|526514814|FG006|Double Blind Phase|Termination by Sponsor|0|||
145999642|NCT04712669|526514815|FG007|Double Blind Phase|Termination by Sponsor|0|||
145999643|NCT04712669|526514808|FG000|Open Label Phase|Adverse Event|0|||
145999644|NCT04712669|526514809|FG001|Open Label Phase|Adverse Event|0|||
145999645|NCT04712669|526514810|FG002|Open Label Phase|Adverse Event|0|||
145999646|NCT04712669|526514811|FG003|Open Label Phase|Adverse Event|1|||
145999647|NCT04712669|526514812|FG004|Open Label Phase|Adverse Event|1|||
145999648|NCT04712669|526514813|FG005|Open Label Phase|Adverse Event|3|||
145999649|NCT04712669|526514814|FG006|Open Label Phase|Adverse Event|1|||
145999650|NCT04712669|526514815|FG007|Open Label Phase|Adverse Event|2|||
145999651|NCT04712669|526514808|FG000|Open Label Phase|Death|0|||
145999652|NCT04712669|526514809|FG001|Open Label Phase|Death|0|||
145999653|NCT04712669|526514810|FG002|Open Label Phase|Death|0|||
145999654|NCT04712669|526514811|FG003|Open Label Phase|Death|1|||
145999655|NCT04712669|526514812|FG004|Open Label Phase|Death|0|||
145999656|NCT04712669|526514813|FG005|Open Label Phase|Death|0|||
145999657|NCT04712669|526514814|FG006|Open Label Phase|Death|0|||
145999658|NCT04712669|526514815|FG007|Open Label Phase|Death|0|||
145999659|NCT04712669|526514808|FG000|Open Label Phase|Lack of Efficacy|0|||
145999660|NCT04712669|526514809|FG001|Open Label Phase|Lack of Efficacy|0|||
145999661|NCT04712669|526514810|FG002|Open Label Phase|Lack of Efficacy|0|||
145999662|NCT04712669|526514811|FG003|Open Label Phase|Lack of Efficacy|0|||
145999663|NCT04712669|526514812|FG004|Open Label Phase|Lack of Efficacy|1|||
145999664|NCT04712669|526514813|FG005|Open Label Phase|Lack of Efficacy|0|||
145999665|NCT04712669|526514814|FG006|Open Label Phase|Lack of Efficacy|0|||
145999666|NCT04712669|526514815|FG007|Open Label Phase|Lack of Efficacy|0|||
145999667|NCT04712669|526514808|FG000|Open Label Phase|Lost to Follow-up|0|||
145999668|NCT04712669|526514809|FG001|Open Label Phase|Lost to Follow-up|0|||
145999669|NCT04712669|526514810|FG002|Open Label Phase|Lost to Follow-up|0|||
145999670|NCT04712669|526514811|FG003|Open Label Phase|Lost to Follow-up|0|||
145999671|NCT04712669|526514812|FG004|Open Label Phase|Lost to Follow-up|0|||
145999672|NCT04712669|526514813|FG005|Open Label Phase|Lost to Follow-up|0|||
145999673|NCT04712669|526514814|FG006|Open Label Phase|Lost to Follow-up|1|||
145999674|NCT04712669|526514815|FG007|Open Label Phase|Lost to Follow-up|1|||
145999675|NCT04712669|526514808|FG000|Open Label Phase|Physician Decision|0|||
145999676|NCT04712669|526514809|FG001|Open Label Phase|Physician Decision|0|||
145999677|NCT04712669|526514810|FG002|Open Label Phase|Physician Decision|0|||
145999678|NCT04712669|526514811|FG003|Open Label Phase|Physician Decision|1|||
145999679|NCT04712669|526514812|FG004|Open Label Phase|Physician Decision|0|||
145999680|NCT04712669|526514813|FG005|Open Label Phase|Physician Decision|0|||
145999681|NCT04712669|526514814|FG006|Open Label Phase|Physician Decision|0|||
145999682|NCT04712669|526514815|FG007|Open Label Phase|Physician Decision|0|||
146247156|NCT01215253|527419776|FG000|Overall Study|Withdrawal by Subject|57|||
146247157|NCT01215253|527419777|FG001|Overall Study|Withdrawal by Subject|35|||
146247158|NCT01215253|527419776|FG000|Overall Study|Physician Decision|9|||
145999683|NCT04712669|526514808|FG000|Open Label Phase|Withdrawal by Subject|0|||
145999684|NCT04712669|526514809|FG001|Open Label Phase|Withdrawal by Subject|0|||
145999685|NCT04712669|526514810|FG002|Open Label Phase|Withdrawal by Subject|0|||
145999686|NCT04712669|526514811|FG003|Open Label Phase|Withdrawal by Subject|1|||
145999687|NCT04712669|526514812|FG004|Open Label Phase|Withdrawal by Subject|5|||
145999688|NCT04712669|526514813|FG005|Open Label Phase|Withdrawal by Subject|5|||
146247159|NCT01215253|527419777|FG001|Overall Study|Physician Decision|12|||
146247160|NCT01215253|527419776|FG000|Overall Study|Lost to Follow-up|6|||
146247161|NCT01215253|527419777|FG001|Overall Study|Lost to Follow-up|4|||
146247162|NCT01215253|527419776|FG000|Overall Study|Other|14|||
146247163|NCT01215253|527419777|FG001|Overall Study|Other|12|||
146247164|NCT03761849|527419778|FG000|Overall Study|transferred to OpenLabelExtension|35|||
146247165|NCT03761849|527419779|FG001|Overall Study|transferred to OpenLabelExtension|34|||
146247166|NCT03761849|527419780|FG002|Overall Study|transferred to OpenLabelExtension|36|||
145999689|NCT04712669|526514814|FG006|Open Label Phase|Withdrawal by Subject|0|||
145999690|NCT04712669|526514815|FG007|Open Label Phase|Withdrawal by Subject|4|||
145999691|NCT04712669|526514808|FG000|Open Label Phase|Termination by Sponsor|0|||
145999692|NCT04712669|526514809|FG001|Open Label Phase|Termination by Sponsor|0|||
146247167|NCT03761849|527419781|FG003|Overall Study|transferred to OpenLabelExtension|0|||
145999693|NCT04712669|526514810|FG002|Open Label Phase|Termination by Sponsor|0|||
145999694|NCT04712669|526514811|FG003|Open Label Phase|Termination by Sponsor|11|||
145999695|NCT04712669|526514812|FG004|Open Label Phase|Termination by Sponsor|9|||
145999696|NCT04712669|526514813|FG005|Open Label Phase|Termination by Sponsor|14|||
145999697|NCT04712669|526514814|FG006|Open Label Phase|Termination by Sponsor|0|||
145999698|NCT04712669|526514815|FG007|Open Label Phase|Termination by Sponsor|14|||
145999699|NCT04577404|526514816|FG000|Overall Study|Adverse Event|31|||
145999700|NCT04577404|526514816|FG000|Overall Study|Death|1|||
145999701|NCT04577404|526514816|FG000|Overall Study|Lack of Efficacy|3|||
145999702|NCT04577404|526514816|FG000|Overall Study|Physician Decision|7|||
145999703|NCT04577404|526514816|FG000|Overall Study|Withdrawal by Subject|21|||
145999704|NCT04577404|526514816|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
145999705|NCT02561962|526514826|FG000|Overall Study|Withdrawal by Subject|1|||
145999706|NCT02561962|526514827|FG001|Overall Study|Withdrawal by Subject|0|||
145999707|NCT02561962|526514828|FG002|Overall Study|Withdrawal by Subject|0|||
145999708|NCT02561962|526514829|FG003|Overall Study|Withdrawal by Subject|0|||
145999709|NCT02561962|526514830|FG004|Overall Study|Withdrawal by Subject|1|||
145999710|NCT02561962|526514831|FG005|Overall Study|Withdrawal by Subject|1|||
145999711|NCT02561962|526514832|FG006|Overall Study|Withdrawal by Subject|2|||
145999712|NCT02561962|526514833|FG007|Overall Study|Withdrawal by Subject|1|||
145999713|NCT02561962|526514834|FG008|Overall Study|Withdrawal by Subject|0|||
145999714|NCT02561962|526514826|FG000|Overall Study|Decision by sponsor|0|||
145999715|NCT02561962|526514827|FG001|Overall Study|Decision by sponsor|0|||
145999716|NCT02561962|526514828|FG002|Overall Study|Decision by sponsor|0|||
145999717|NCT02561962|526514829|FG003|Overall Study|Decision by sponsor|0|||
145999718|NCT02561962|526514830|FG004|Overall Study|Decision by sponsor|1|||
145999719|NCT02561962|526514831|FG005|Overall Study|Decision by sponsor|1|||
145999720|NCT02561962|526514832|FG006|Overall Study|Decision by sponsor|0|||
145999721|NCT02561962|526514833|FG007|Overall Study|Decision by sponsor|3|||
145999722|NCT02561962|526514834|FG008|Overall Study|Decision by sponsor|0|||
145999723|NCT02561962|526514826|FG000|Overall Study|Lost to Follow-up|0|||
145999724|NCT02561962|526514827|FG001|Overall Study|Lost to Follow-up|0|||
145999725|NCT02561962|526514828|FG002|Overall Study|Lost to Follow-up|0|||
145999726|NCT02561962|526514829|FG003|Overall Study|Lost to Follow-up|0|||
145999727|NCT02561962|526514830|FG004|Overall Study|Lost to Follow-up|0|||
145999728|NCT02561962|526514831|FG005|Overall Study|Lost to Follow-up|1|||
145999729|NCT02561962|526514832|FG006|Overall Study|Lost to Follow-up|0|||
145999730|NCT02561962|526514833|FG007|Overall Study|Lost to Follow-up|0|||
145999731|NCT02561962|526514834|FG008|Overall Study|Lost to Follow-up|0|||
145999732|NCT03586973|526514835|FG000|Overall Study|Death|15|||
145999733|NCT03586973|526514836|FG001|Overall Study|Death|8|||
145999734|NCT03586973|526514835|FG000|Overall Study|Site Terminated by Sponsor|3|||
145999735|NCT03586973|526514836|FG001|Overall Study|Site Terminated by Sponsor|6|||
145999736|NCT03586973|526514835|FG000|Overall Study|Withdrawal by Subject|1|||
145999737|NCT03586973|526514836|FG001|Overall Study|Withdrawal by Subject|0|||
145999738|NCT03586973|526514835|FG000|Overall Study|Lost to Follow-up|1|||
145999739|NCT03586973|526514836|FG001|Overall Study|Lost to Follow-up|0|||
145999740|NCT01150357|526514837|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
145999741|NCT01150357|526514838|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
145999742|NCT01150357|526514839|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
146247168|NCT03761849|527419782|FG004|Overall Study|transferred to OpenLabelExtension|0|||
146247169|NCT03761849|527419783|FG005|Overall Study|transferred to OpenLabelExtension|0|||
146247170|NCT03761849|527419778|FG000|Overall Study|Adverse Event|1|||
146247171|NCT03761849|527419779|FG001|Overall Study|Adverse Event|0|||
146247172|NCT03761849|527419780|FG002|Overall Study|Adverse Event|0|||
145999743|NCT01150357|526514837|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
145999744|NCT01150357|526514838|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
145999745|NCT01150357|526514839|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
145999746|NCT01150357|526514837|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
145999747|NCT01150357|526514838|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
145999748|NCT01150357|526514839|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
146247173|NCT03761849|527419781|FG003|Overall Study|Adverse Event|0|||
146092110|NCT00910988|526858526|FG003|Overall Study|Lost to Follow-up|0|||
146092111|NCT01977937|526858529|FG000|Overall Study|Withdrawal by Subject|2|||
145999749|NCT01150357|526514837|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
145999750|NCT01150357|526514838|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
145999751|NCT01150357|526514839|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
145999752|NCT01150357|526514837|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
145999753|NCT01150357|526514838|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
145999754|NCT01150357|526514839|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
145999755|NCT01150357|526514837|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
145999756|NCT01150357|526514838|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
145999757|NCT01150357|526514839|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
145999758|NCT01150357|526514837|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
145999759|NCT01150357|526514838|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
145999760|NCT01150357|526514839|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
145999761|NCT00269113|526516403|FG000|Overall Study|Adverse Event|14|||
145999762|NCT00269113|526516404|FG001|Overall Study|Adverse Event|7|||
145999763|NCT00269113|526516403|FG000|Overall Study|Lack of Efficacy|35|||
145999764|NCT00269113|526516404|FG001|Overall Study|Lack of Efficacy|18|||
145999765|NCT00269113|526516403|FG000|Overall Study|Early Improvement|2|||
145999766|NCT00269113|526516404|FG001|Overall Study|Early Improvement|0|||
145999767|NCT00269113|526516403|FG000|Overall Study|Withdrawal by Subject|0|||
145999768|NCT00269113|526516404|FG001|Overall Study|Withdrawal by Subject|2|||
145999769|NCT00269113|526516403|FG000|Overall Study|Death|6|||
145999770|NCT00269113|526516404|FG001|Overall Study|Death|2|||
145999771|NCT00269113|526516403|FG000|Overall Study|Lost to Follow-up|2|||
145999772|NCT00269113|526516404|FG001|Overall Study|Lost to Follow-up|1|||
145999773|NCT00269113|526516403|FG000|Overall Study|Protocol Violation|15|||
145999774|NCT00269113|526516404|FG001|Overall Study|Protocol Violation|5|||
146092112|NCT01977937|526858530|FG001|Overall Study|Withdrawal by Subject|1|||
146092113|NCT01977937|526858529|FG000|Overall Study|Adverse Event|1|||
146092114|NCT01977937|526858530|FG001|Overall Study|Adverse Event|0|||
146092115|NCT01977937|526858529|FG000|Overall Study|Physician Decision|0|||
146092116|NCT01977937|526858530|FG001|Overall Study|Physician Decision|1|||
146092117|NCT03004443|526858531|FG000|Overall Study|Pregnancy|0|||
146092118|NCT03004443|526858532|FG001|Overall Study|Pregnancy|1|||
146092119|NCT00828854|526858536|FG000|Overall Study|Disease Progression|17|||
146092120|NCT00828854|526858536|FG000|Overall Study|Adverse Event|9|||
146092121|NCT00828854|526858536|FG000|Overall Study|Reason not Specified|1|||
146092122|NCT00915356|526858537|FG000|Overall Study|Withdrawal by Subject|1|||
146092123|NCT00915356|526858538|FG001|Overall Study|Withdrawal by Subject|0|||
146092124|NCT00915356|526858539|FG002|Overall Study|Withdrawal by Subject|0|||
146092125|NCT00915356|526858540|FG003|Overall Study|Withdrawal by Subject|0|||
146092126|NCT00915356|526858541|FG004|Overall Study|Withdrawal by Subject|0|||
146092127|NCT00191646|526858544|FG000|Overall Study|Toxicity|26|||
146092128|NCT00191646|526858545|FG001|Overall Study|Toxicity|37|||
146092129|NCT00191646|526858544|FG000|Overall Study|Disease Progression|5|||
146092130|NCT00191646|526858545|FG001|Overall Study|Disease Progression|6|||
146092131|NCT00191646|526858544|FG000|Overall Study|Physician Decision|20|||
146092132|NCT00191646|526858545|FG001|Overall Study|Physician Decision|11|||
146092133|NCT00191646|526858544|FG000|Overall Study|Withdrawal by Subject|58|||
146092134|NCT00191646|526858545|FG001|Overall Study|Withdrawal by Subject|39|||
146092135|NCT00191646|526858544|FG000|Overall Study|Protocol Violation|5|||
146092136|NCT00191646|526858545|FG001|Overall Study|Protocol Violation|7|||
146092137|NCT00191646|526858544|FG000|Overall Study|Death|6|||
146092138|NCT00191646|526858545|FG001|Overall Study|Death|8|||
146092139|NCT00191646|526858544|FG000|Overall Study|Other|33|||
146092140|NCT00191646|526858545|FG001|Overall Study|Other|34|||
146092141|NCT00191646|526858544|FG000|Overall Study|Missing Data|18|||
146092142|NCT00191646|526858545|FG001|Overall Study|Missing Data|11|||
146092143|NCT03194490|526858552|FG000|Overall Study|Lost to Follow-up|1|||
146092144|NCT03194490|526858553|FG001|Overall Study|Lost to Follow-up|3|||
146092145|NCT03194490|526858552|FG000|Overall Study|participant developed specific neck pain|1|||
146298074|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
146092146|NCT03194490|526858553|FG001|Overall Study|participant developed specific neck pain|0|||
146092147|NCT01505647|526858554|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
146092148|NCT01505647|526858555|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
146092149|NCT01505647|526858554|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
146092150|NCT01505647|526858555|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
146092151|NCT01505647|526858554|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
146092152|NCT01505647|526858555|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
146092153|NCT01505647|526858554|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
146092154|NCT01505647|526858555|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
146092155|NCT01505647|526858554|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
146092156|NCT01505647|526858555|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
146092157|NCT01574079|526858556|FG000|Overall Study|Physician Decision|0|||
145999775|NCT00269113|526516403|FG000|Overall Study|Other|0|||
146092158|NCT01574079|526858557|FG001|Overall Study|Physician Decision|2|||
145999776|NCT00269113|526516404|FG001|Overall Study|Other|2|||
145999777|NCT00503984|526516405|FG000|Overall Study|Protocol Violation|0|||
145999778|NCT00503984|526516406|FG001|Overall Study|Protocol Violation|1|||
145999779|NCT00503984|526516407|FG002|Overall Study|Protocol Violation|0|||
145999780|NCT00503984|526516408|FG003|Overall Study|Protocol Violation|0|||
145999781|NCT00503984|526516409|FG004|Overall Study|Protocol Violation|0|||
145999782|NCT00503984|526516410|FG005|Overall Study|Protocol Violation|0|||
145999783|NCT00503984|526516405|FG000|Overall Study|Adverse Event|0|||
145999784|NCT00503984|526516406|FG001|Overall Study|Adverse Event|1|||
145999785|NCT00503984|526516407|FG002|Overall Study|Adverse Event|0|||
145999786|NCT00503984|526516408|FG003|Overall Study|Adverse Event|0|||
145999787|NCT00503984|526516409|FG004|Overall Study|Adverse Event|0|||
145999788|NCT00503984|526516410|FG005|Overall Study|Adverse Event|0|||
145999789|NCT00503984|526516405|FG000|Overall Study|Death|0|||
145999790|NCT00503984|526516406|FG001|Overall Study|Death|0|||
145999791|NCT00503984|526516407|FG002|Overall Study|Death|0|||
145999792|NCT00503984|526516408|FG003|Overall Study|Death|0|||
145999793|NCT00503984|526516409|FG004|Overall Study|Death|1|||
145999794|NCT00503984|526516410|FG005|Overall Study|Death|0|||
145999795|NCT02122380|526516413|FG000|First Intervention (30 Days)|Adverse Event|1|||
145999796|NCT02122380|526516414|FG001|First Intervention (30 Days)|Adverse Event|0|||
145999797|NCT02122380|526516413|FG000|First Intervention (30 Days)|Physician Decision|0|||
145999798|NCT02122380|526516414|FG001|First Intervention (30 Days)|Physician Decision|1|||
145999799|NCT02122380|526516413|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
145999800|NCT02122380|526516414|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
145999801|NCT02122380|526516413|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
145999802|NCT02122380|526516414|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
145999803|NCT02122380|526516413|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
145999804|NCT02122380|526516414|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
145999805|NCT00140140|526516416|FG000|Overall Study|Unacceptable toxicity|1|||
145999806|NCT00140140|526516417|FG001|Overall Study|Unacceptable toxicity|1|||
145999807|NCT00140140|526516418|FG002|Overall Study|Unacceptable toxicity|2|||
145999808|NCT00140140|526516416|FG000|Overall Study|Physician Decision|1|||
145999809|NCT00140140|526516417|FG001|Overall Study|Physician Decision|1|||
145999810|NCT00140140|526516418|FG002|Overall Study|Physician Decision|0|||
145999811|NCT03376516|526516419|FG000|Overall Study|Not treated|1|||
145999812|NCT03376516|526516419|FG000|Overall Study|Consent withdrawn|1|||
145999813|NCT01581684|526516420|FG000|Overall Study|Other reason not defined|0|||
145999814|NCT01581684|526516421|FG001|Overall Study|Other reason not defined|0|||
145999815|NCT01581684|526516422|FG002|Overall Study|Other reason not defined|0|||
146247174|NCT03761849|527419782|FG004|Overall Study|Adverse Event|2|||
146247175|NCT03761849|527419783|FG005|Overall Study|Adverse Event|3|||
146247176|NCT03761849|527419778|FG000|Overall Study|Withdrawal by Subject|0|||
146247177|NCT03761849|527419779|FG001|Overall Study|Withdrawal by Subject|0|||
145999816|NCT01581684|526516423|FG003|Overall Study|Other reason not defined|0|||
145999817|NCT01581684|526516424|FG004|Overall Study|Other reason not defined|0|||
145999818|NCT01581684|526516425|FG005|Overall Study|Other reason not defined|0|||
145999819|NCT01581684|526516426|FG006|Overall Study|Other reason not defined|0|||
145999820|NCT01581684|526516427|FG007|Overall Study|Other reason not defined|0|||
145999821|NCT01581684|526516428|FG008|Overall Study|Other reason not defined|1|||
145999822|NCT01581684|526516429|FG009|Overall Study|Other reason not defined|0|||
145999823|NCT00598650|526516430|FG000|Overall Study|Withdrawal by Subject|3|||
145999824|NCT00598650|526516430|FG000|Overall Study|Adverse Event|18|||
145999825|NCT00598650|526516430|FG000|Overall Study|No treatment for 3 weeks|1|||
145999826|NCT00598650|526516430|FG000|Overall Study|Not eligible|1|||
145999827|NCT00598650|526516430|FG000|Overall Study|Prohibited Concomitant Medication|2|||
145999828|NCT00598650|526516430|FG000|Overall Study|Physician Decision|2|||
145999829|NCT01128569|526516431|FG000|Washout Period 1|Adverse Event|0|||
145999830|NCT01128569|526516432|FG001|Washout Period 1|Adverse Event|0|||
145999831|NCT01128569|526516433|FG002|Washout Period 1|Adverse Event|1|||
145999832|NCT01128569|526516434|FG003|Washout Period 1|Adverse Event|0|||
145999833|NCT01128569|526516435|FG004|Washout Period 1|Adverse Event|0|||
145999834|NCT01128569|526516436|FG005|Washout Period 1|Adverse Event|0|||
145999835|NCT01128569|526516431|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145999836|NCT01128569|526516432|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145999837|NCT01128569|526516433|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146247178|NCT03761849|527419780|FG002|Overall Study|Withdrawal by Subject|0|||
146247179|NCT03761849|527419781|FG003|Overall Study|Withdrawal by Subject|41|||
145999838|NCT01128569|526516434|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145999839|NCT01128569|526516435|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145999840|NCT01128569|526516436|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145999841|NCT03338400|526516437|FG000|Overall Study|Lost to Follow-up|1|||
145999842|NCT03338400|526516438|FG001|Overall Study|Lost to Follow-up|2|||
145999843|NCT01865487|526516442|FG000|Overall Study|Lost to Follow-up|0|||
145999844|NCT01865487|526516443|FG001|Overall Study|Lost to Follow-up|0|||
145999845|NCT01865487|526516444|FG002|Overall Study|Lost to Follow-up|0|||
146092159|NCT01574079|526858556|FG000|Overall Study|Lost to Follow-up|1|||
145999846|NCT01865487|526516445|FG003|Overall Study|Lost to Follow-up|1|||
145999847|NCT01865487|526516446|FG004|Overall Study|Lost to Follow-up|0|||
145999848|NCT01865487|526516447|FG005|Overall Study|Lost to Follow-up|0|||
145999849|NCT01865487|526516448|FG006|Overall Study|Lost to Follow-up|1|||
145999850|NCT01865487|526516449|FG007|Overall Study|Lost to Follow-up|0|||
145999851|NCT01865487|526516450|FG008|Overall Study|Lost to Follow-up|0|||
145999852|NCT01865487|526516451|FG009|Overall Study|Lost to Follow-up|0|||
145999853|NCT01865487|526516442|FG000|Overall Study|Withdrawal by Subject|0|||
145999854|NCT01865487|526516443|FG001|Overall Study|Withdrawal by Subject|0|||
145999855|NCT01865487|526516444|FG002|Overall Study|Withdrawal by Subject|0|||
145999856|NCT01865487|526516445|FG003|Overall Study|Withdrawal by Subject|0|||
145999857|NCT01865487|526516446|FG004|Overall Study|Withdrawal by Subject|1|||
145999858|NCT01865487|526516447|FG005|Overall Study|Withdrawal by Subject|0|||
145999859|NCT01865487|526516448|FG006|Overall Study|Withdrawal by Subject|0|||
145999860|NCT01865487|526516449|FG007|Overall Study|Withdrawal by Subject|0|||
145999861|NCT01865487|526516450|FG008|Overall Study|Withdrawal by Subject|0|||
145999862|NCT01865487|526516451|FG009|Overall Study|Withdrawal by Subject|0|||
145999863|NCT01531998|526516456|FG000|Overall Study|Withdrawal by Subject|3|||
145999864|NCT00107276|526516462|FG000|Overall Study|Progression|46|||
145999865|NCT00107276|526516462|FG000|Overall Study|Adverse Event|6|||
145999866|NCT00107276|526516462|FG000|Overall Study|M.D. decision|2|||
145999867|NCT00107276|526516462|FG000|Overall Study|Patient refusal|1|||
145999868|NCT00107276|526516462|FG000|Overall Study|Death|1|||
145999869|NCT00107276|526516462|FG000|Overall Study|Ineligible|16|||
146247180|NCT03761849|527419782|FG004|Overall Study|Withdrawal by Subject|43|||
146247181|NCT03761849|527419783|FG005|Overall Study|Withdrawal by Subject|35|||
146247182|NCT03761849|527419778|FG000|Overall Study|Lost to Follow-up|0|||
146247183|NCT03761849|527419779|FG001|Overall Study|Lost to Follow-up|1|||
146247184|NCT03761849|527419780|FG002|Overall Study|Lost to Follow-up|0|||
146247185|NCT03761849|527419781|FG003|Overall Study|Lost to Follow-up|2|||
146247186|NCT03761849|527419782|FG004|Overall Study|Lost to Follow-up|4|||
146247187|NCT03761849|527419783|FG005|Overall Study|Lost to Follow-up|5|||
146247188|NCT03761849|527419778|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
146247189|NCT03761849|527419779|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
146247190|NCT03761849|527419780|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
146247191|NCT03761849|527419781|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
146247192|NCT03761849|527419782|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
146247193|NCT03761849|527419783|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
146247194|NCT03761849|527419778|FG000|Overall Study|Physician Decision|0|||
146247195|NCT03761849|527419779|FG001|Overall Study|Physician Decision|0|||
146247196|NCT03761849|527419780|FG002|Overall Study|Physician Decision|0|||
146247197|NCT03761849|527419781|FG003|Overall Study|Physician Decision|1|||
146247198|NCT03761849|527419782|FG004|Overall Study|Physician Decision|4|||
146247199|NCT03761849|527419783|FG005|Overall Study|Physician Decision|4|||
146247200|NCT03761849|527419778|FG000|Overall Study|Death|0|||
146247201|NCT03761849|527419779|FG001|Overall Study|Death|0|||
146247202|NCT03761849|527419780|FG002|Overall Study|Death|0|||
146247203|NCT03761849|527419781|FG003|Overall Study|Death|1|||
146247204|NCT03761849|527419782|FG004|Overall Study|Death|1|||
146247205|NCT03761849|527419783|FG005|Overall Study|Death|3|||
146247206|NCT03761849|527419778|FG000|Overall Study|Protocol Violation|0|||
146247207|NCT03761849|527419779|FG001|Overall Study|Protocol Violation|0|||
146247208|NCT03761849|527419780|FG002|Overall Study|Protocol Violation|0|||
146247209|NCT03761849|527419781|FG003|Overall Study|Protocol Violation|2|||
146247210|NCT03761849|527419782|FG004|Overall Study|Protocol Violation|2|||
146247211|NCT03761849|527419783|FG005|Overall Study|Protocol Violation|1|||
146247212|NCT03761849|527419778|FG000|Overall Study|Participant could not come to site|0|||
146247213|NCT03761849|527419779|FG001|Overall Study|Participant could not come to site|0|||
146247214|NCT03761849|527419780|FG002|Overall Study|Participant could not come to site|0|||
146247215|NCT03761849|527419781|FG003|Overall Study|Participant could not come to site|0|||
146247216|NCT03761849|527419782|FG004|Overall Study|Participant could not come to site|1|||
146247217|NCT03761849|527419783|FG005|Overall Study|Participant could not come to site|0|||
146247218|NCT03761849|527419778|FG000|Overall Study|SF- safety Finding|0|||
146247219|NCT03761849|527419779|FG001|Overall Study|SF- safety Finding|0|||
146247220|NCT03761849|527419780|FG002|Overall Study|SF- safety Finding|0|||
146247221|NCT03761849|527419781|FG003|Overall Study|SF- safety Finding|0|||
146247222|NCT03761849|527419782|FG004|Overall Study|SF- safety Finding|0|||
146247223|NCT03761849|527419783|FG005|Overall Study|SF- safety Finding|1|||
146247224|NCT03761849|527419778|FG000|Overall Study|Patient did not attend visit|0|||
146247225|NCT03761849|527419779|FG001|Overall Study|Patient did not attend visit|0|||
145999918|NCT03179761|526516471|FG000|Overall Study|Death|2|||
145999919|NCT03179761|526516472|FG001|Overall Study|Death|5|||
145999920|NCT03179761|526516471|FG000|Overall Study|Lost to Follow-up|2|||
145999921|NCT03179761|526516472|FG001|Overall Study|Lost to Follow-up|2|||
145999922|NCT03179761|526516471|FG000|Overall Study|Protocol Violation|1|||
145999923|NCT03179761|526516472|FG001|Overall Study|Protocol Violation|0|||
145999924|NCT03179761|526516471|FG000|Overall Study|Withdrawal by Subject|1|||
145999925|NCT03179761|526516472|FG001|Overall Study|Withdrawal by Subject|4|||
146092160|NCT01574079|526858557|FG001|Overall Study|Lost to Follow-up|0|||
145999926|NCT03179761|526516471|FG000|Overall Study|Investigator Request|0|||
145999927|NCT03179761|526516472|FG001|Overall Study|Investigator Request|2|||
145999928|NCT04661033|526516473|FG000|Overall Study|Adverse Event|0|||
145999929|NCT04661033|526516474|FG001|Overall Study|Adverse Event|0|||
145999930|NCT04661033|526516475|FG002|Overall Study|Adverse Event|1|||
145999931|NCT04661033|526516476|FG003|Overall Study|Adverse Event|0|||
145999932|NCT04661033|526516473|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
145999933|NCT04661033|526516474|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145999934|NCT04661033|526516475|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145999935|NCT04661033|526516476|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145999936|NCT04661033|526516473|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
145999937|NCT04661033|526516474|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
145999938|NCT04661033|526516475|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
145999939|NCT04661033|526516476|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
145999940|NCT04661033|526516473|FG000|Overall Study|Early discontinuation as per PI|1|||
145999941|NCT04661033|526516474|FG001|Overall Study|Early discontinuation as per PI|0|||
145999942|NCT04661033|526516475|FG002|Overall Study|Early discontinuation as per PI|0|||
145999943|NCT04661033|526516476|FG003|Overall Study|Early discontinuation as per PI|0|||
145999944|NCT03440008|526516479|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
145999945|NCT03440008|526516480|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
145999946|NCT03440008|526516479|FG000|Overall Study|Withdrawal by Subject|1|||
145999947|NCT03440008|526516480|FG001|Overall Study|Withdrawal by Subject|0|||
145999948|NCT03498716|526516488|FG000|Overall Study|Withdrawal by Subject|88|||
145999949|NCT03498716|526516489|FG001|Overall Study|Withdrawal by Subject|73|||
145999950|NCT03498716|526516488|FG000|Overall Study|Study Terminated By Sponsor|933|||
145999951|NCT03498716|526516489|FG001|Overall Study|Study Terminated By Sponsor|927|||
145999952|NCT03498716|526516488|FG000|Overall Study|Lost to Follow-up|15|||
145999953|NCT03498716|526516489|FG001|Overall Study|Lost to Follow-up|26|||
145999954|NCT03498716|526516488|FG000|Overall Study|Disease Relapse|0|||
145999955|NCT03498716|526516489|FG001|Overall Study|Disease Relapse|1|||
145999956|NCT03498716|526516488|FG000|Overall Study|Death|58|||
145999957|NCT03498716|526516489|FG001|Overall Study|Death|72|||
145999958|NCT03498716|526516488|FG000|Overall Study|Physician Decision|4|||
145999959|NCT03498716|526516489|FG001|Overall Study|Physician Decision|2|||
145999960|NCT03139448|526516493|FG000|Overall Study|Lack of Efficacy|6|||
145999961|NCT03139448|526516494|FG001|Overall Study|Lack of Efficacy|7|||
145999962|NCT03139448|526516493|FG000|Overall Study|Location of procedure changed|2|||
145999963|NCT03139448|526516494|FG001|Overall Study|Location of procedure changed|8|||
145999964|NCT03139448|526516493|FG000|Overall Study|Withdrawal by Subject|3|||
145999965|NCT03139448|526516494|FG001|Overall Study|Withdrawal by Subject|6|||
145999966|NCT03139448|526516493|FG000|Overall Study|Screen fail|1|||
145999967|NCT03139448|526516494|FG001|Overall Study|Screen fail|3|||
145999968|NCT03139448|526516493|FG000|Overall Study|Physician Decision|0|||
145999969|NCT03139448|526516494|FG001|Overall Study|Physician Decision|2|||
145999970|NCT00760552|526516495|FG000|Overall Study|Death|2|||
145999971|NCT00760552|526516496|FG001|Overall Study|Death|0|||
145999972|NCT00760552|526516495|FG000|Overall Study|Lost to Follow-up|11|||
145999973|NCT00760552|526516496|FG001|Overall Study|Lost to Follow-up|10|||
146247226|NCT03761849|527419780|FG002|Overall Study|Patient did not attend visit|0|||
146247227|NCT03761849|527419781|FG003|Overall Study|Patient did not attend visit|0|||
146247228|NCT03761849|527419782|FG004|Overall Study|Patient did not attend visit|0|||
146247229|NCT03761849|527419783|FG005|Overall Study|Patient did not attend visit|1|||
146247230|NCT01131325|527419784|FG000|Overall Study|Adverse Event|1|||
146247231|NCT01131325|527419784|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
146247232|NCT03840993|527419785|FG000|Overall Study|Adverse Event|1|||
146247233|NCT03840993|527419786|FG001|Overall Study|Adverse Event|0|||
146247234|NCT03840993|527419785|FG000|Overall Study|Lost to Follow-up|4|||
146247235|NCT03840993|527419786|FG001|Overall Study|Lost to Follow-up|0|||
146247236|NCT03840993|527419785|FG000|Overall Study|Physician Decision|0|||
146247237|NCT03840993|527419786|FG001|Overall Study|Physician Decision|1|||
146247238|NCT03840993|527419785|FG000|Overall Study|Pregnancy|0|||
146247239|NCT03840993|527419786|FG001|Overall Study|Pregnancy|1|||
146247240|NCT03840993|527419785|FG000|Overall Study|Withdrawal by Subject|1|||
146247241|NCT03840993|527419786|FG001|Overall Study|Withdrawal by Subject|3|||
146247242|NCT03840993|527419785|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
146247243|NCT03840993|527419786|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
146247244|NCT04271254|527419787|FG000|Overall Study|Withdrawal by Subject|3|||
146247245|NCT00473512|527419788|FG000|Period 1 (Phase 1)|Adverse Event|0|||
146247246|NCT00473512|527419789|FG001|Period 1 (Phase 1)|Adverse Event|0|||
146247247|NCT00473512|527419790|FG002|Period 1 (Phase 1)|Adverse Event|0|||
145999996|NCT01736917|526516506|FG000|Overall Study|Adverse Event|1|||
145999997|NCT01736917|526516506|FG000|Overall Study|Protocol Violation|10|||
145999998|NCT01911260|526516509|FG000|Supplementation Period|transference or evasion of school|7|||
145999999|NCT01911260|526516510|FG001|Supplementation Period|transference or evasion of school|9|||
146000000|NCT01911260|526516511|FG002|Supplementation Period|transference or evasion of school|7|||
146000001|NCT01911260|526516512|FG003|Supplementation Period|transference or evasion of school|6|||
146000002|NCT01911260|526516509|FG000|Supplementation Period|Adverse Event|2|||
146000003|NCT01911260|526516510|FG001|Supplementation Period|Adverse Event|0|||
146000004|NCT01911260|526516511|FG002|Supplementation Period|Adverse Event|1|||
146000005|NCT01911260|526516512|FG003|Supplementation Period|Adverse Event|0|||
146000006|NCT01911260|526516509|FG000|Supplementation Period|refused to receive supplement|1|||
146000007|NCT01911260|526516510|FG001|Supplementation Period|refused to receive supplement|0|||
146000008|NCT01911260|526516511|FG002|Supplementation Period|refused to receive supplement|1|||
146000009|NCT01911260|526516512|FG003|Supplementation Period|refused to receive supplement|0|||
146000010|NCT01911260|526516509|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
146000011|NCT01911260|526516510|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
146000012|NCT01911260|526516511|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
146000013|NCT01911260|526516512|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
146000014|NCT01911260|526516509|FG000|Follow-up Period|transference or evasion of school|13|||
146000015|NCT01911260|526516510|FG001|Follow-up Period|transference or evasion of school|20|||
146000016|NCT01911260|526516511|FG002|Follow-up Period|transference or evasion of school|15|||
146000017|NCT01911260|526516512|FG003|Follow-up Period|transference or evasion of school|12|||
146000018|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
146000019|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
146000020|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
146000021|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Death|0|||
146000022|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Death|0|||
146000023|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Death|1|||
146000024|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
146000025|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
146000026|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
146000027|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
146000028|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
146000029|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
146000030|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
146000031|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
146000032|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
146000033|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Graft loss|0|||
146000034|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Graft loss|0|||
146000035|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Graft loss|7|||
146000036|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
146000037|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
146000038|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
146000039|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
146000040|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
146000041|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
146000042|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
146000043|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
146000044|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
146000045|NCT00956293|526516513|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
146000046|NCT00956293|526516514|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
146000047|NCT00956293|526516515|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
146000048|NCT00956293|526516513|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
146000049|NCT00956293|526516514|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
146000050|NCT00956293|526516515|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
146000051|NCT00956293|526516513|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
146000052|NCT00956293|526516514|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
146000053|NCT00956293|526516515|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
146000054|NCT00956293|526516513|FG000|Main Period (Randomization)|Adverse Event|0|||
146000055|NCT00956293|526516514|FG001|Main Period (Randomization)|Adverse Event|15|||
146000056|NCT00956293|526516515|FG002|Main Period (Randomization)|Adverse Event|0|||
146000057|NCT00956293|526516513|FG000|Follow-up Period|Follow-up period was terminated.|20|||
146000058|NCT00956293|526516514|FG001|Follow-up Period|Follow-up period was terminated.|32|||
146000059|NCT00956293|526516515|FG002|Follow-up Period|Follow-up period was terminated.|0|||
146000060|NCT01240863|526516518|FG000|Open-label Titration Period|Adverse Event|47|||
146000061|NCT01240863|526516519|FG001|Open-label Titration Period|Adverse Event|0|||
146000062|NCT01240863|526516520|FG002|Open-label Titration Period|Adverse Event|0|||
146000063|NCT01240863|526516518|FG000|Open-label Titration Period|Lack of Efficacy|19|||
146000064|NCT01240863|526516519|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146000065|NCT01240863|526516520|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146000066|NCT01240863|526516518|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
146000067|NCT01240863|526516519|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146000068|NCT01240863|526516520|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146000069|NCT01240863|526516518|FG000|Open-label Titration Period|Protocol Violation|7|||
146000070|NCT01240863|526516519|FG001|Open-label Titration Period|Protocol Violation|0|||
146000071|NCT01240863|526516520|FG002|Open-label Titration Period|Protocol Violation|0|||
146000072|NCT01240863|526516518|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
146000073|NCT01240863|526516519|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
146000074|NCT01240863|526516520|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
146000075|NCT01240863|526516518|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
146000076|NCT01240863|526516519|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
146000077|NCT01240863|526516520|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
146000078|NCT01240863|526516518|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
146000079|NCT01240863|526516519|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
146000080|NCT01240863|526516520|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
146000081|NCT01240863|526516518|FG000|Open-label Titration Period|Other|7|||
146000082|NCT01240863|526516519|FG001|Open-label Titration Period|Other|0|||
146000083|NCT01240863|526516520|FG002|Open-label Titration Period|Other|0|||
146000084|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
146000085|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
146000086|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
146000087|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146000088|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
146000089|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
146000090|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146000091|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
146000092|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
146000093|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146000094|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
146000095|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
146000096|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
146000097|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
146000098|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
146000099|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
146000100|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
146000101|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
146000102|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
146000103|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
146000104|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
146000105|NCT01240863|526516518|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
146000106|NCT01240863|526516519|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
146000107|NCT01240863|526516520|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
146000108|NCT01816984|526516522|FG000|Overall Study|declining health status|1|||
146000109|NCT05899829|526516523|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
146000110|NCT05899829|526516524|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
146000111|NCT05899829|526516523|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
146000112|NCT05899829|526516524|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
146000113|NCT00636181|526516529|FG000|Overall Study|Withdrawal by Subject|8|||
146000114|NCT00636181|526516530|FG001|Overall Study|Withdrawal by Subject|6|||
146000115|NCT00636181|526516531|FG002|Overall Study|Withdrawal by Subject|10|||
146000116|NCT04549454|526516534|FG000|T1 to T2|Lost to Follow-up|22|||
146000117|NCT04549454|526516535|FG001|T1 to T2|Lost to Follow-up|26|||
146000118|NCT04549454|526516534|FG000|T1 to T3|Lost to Follow-up|31|||
146000119|NCT04549454|526516535|FG001|T1 to T3|Lost to Follow-up|36|||
146000120|NCT00867035|526516541|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
146000121|NCT00867035|526516542|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
146000122|NCT00867035|526516541|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
146000123|NCT00867035|526516542|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
146000124|NCT05076045|526516544|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
146000125|NCT05076045|526516545|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
146000126|NCT02993263|526516556|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
146000127|NCT01405196|526516559|FG000|Overall Study|Study Terminated by Sponsor|0|||
146000128|NCT01405196|526516560|FG001|Overall Study|Study Terminated by Sponsor|0|||
146000129|NCT01405196|526516561|FG002|Overall Study|Study Terminated by Sponsor|9|||
146000130|NCT01405196|526516562|FG003|Overall Study|Study Terminated by Sponsor|0|||
146000131|NCT01405196|526516559|FG000|Overall Study|Other|2|||
146000132|NCT01405196|526516560|FG001|Overall Study|Other|2|||
146000133|NCT01405196|526516561|FG002|Overall Study|Other|5|||
146000134|NCT01405196|526516562|FG003|Overall Study|Other|0|||
146247248|NCT00473512|527419791|FG003|Period 1 (Phase 1)|Adverse Event|5|||
146247249|NCT00473512|527419792|FG004|Period 1 (Phase 1)|Adverse Event|0|||
146000135|NCT01405196|526516559|FG000|Overall Study|Withdrawal by Subject|4|||
146000136|NCT01405196|526516560|FG001|Overall Study|Withdrawal by Subject|6|||
146000137|NCT01405196|526516561|FG002|Overall Study|Withdrawal by Subject|3|||
146000138|NCT01405196|526516562|FG003|Overall Study|Withdrawal by Subject|6|||
146000139|NCT01405196|526516559|FG000|Overall Study|Adverse Event|2|||
146000140|NCT01405196|526516560|FG001|Overall Study|Adverse Event|2|||
146000141|NCT01405196|526516561|FG002|Overall Study|Adverse Event|0|||
146000142|NCT01405196|526516562|FG003|Overall Study|Adverse Event|2|||
146000143|NCT01405196|526516559|FG000|Overall Study|Death|1|||
146000144|NCT01405196|526516560|FG001|Overall Study|Death|0|||
146000145|NCT01405196|526516561|FG002|Overall Study|Death|3|||
146000146|NCT01405196|526516562|FG003|Overall Study|Death|0|||
146000147|NCT01405196|526516559|FG000|Overall Study|Lost to Follow-up|2|||
146000148|NCT01405196|526516560|FG001|Overall Study|Lost to Follow-up|2|||
146000149|NCT01405196|526516561|FG002|Overall Study|Lost to Follow-up|3|||
146000150|NCT01405196|526516562|FG003|Overall Study|Lost to Follow-up|1|||
146000151|NCT04704193|526516563|FG000|Overall Study|Withdrawal by Subject|1|||
146000152|NCT00829998|526516566|FG000|Washout|Adverse Event|0|||
146000153|NCT00829998|526516567|FG001|Washout|Adverse Event|1|||
146000154|NCT02735421|526518582|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
146000155|NCT02735421|526518582|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
146000156|NCT02735421|526518582|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
146000157|NCT02735421|526518582|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
146000158|NCT02735421|526518582|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
146092161|NCT00406718|526858558|FG000|Overall Study|Withdrawal by Subject|2|||
146092162|NCT00406718|526858559|FG001|Overall Study|Withdrawal by Subject|9|||
146092163|NCT00406718|526858560|FG002|Overall Study|Withdrawal by Subject|4|||
146092164|NCT00406718|526858558|FG000|Overall Study|Lost to Follow-up|2|||
146092165|NCT00406718|526858559|FG001|Overall Study|Lost to Follow-up|5|||
146092166|NCT00406718|526858560|FG002|Overall Study|Lost to Follow-up|4|||
146092167|NCT03640559|526858561|FG000|Overall Study|Physician Decision|1|||
146092168|NCT03640559|526858562|FG001|Overall Study|Physician Decision|1|||
146092169|NCT03640559|526858561|FG000|Overall Study|Withdrawal by Subject|1|||
146092170|NCT03640559|526858562|FG001|Overall Study|Withdrawal by Subject|0|||
146092171|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
146092172|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
146092173|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
146092174|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
146092175|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
146092176|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
146092177|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
146092178|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
146092179|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
146247250|NCT00473512|527419788|FG000|Period 1 (Phase 1)|Death|0|||
146000159|NCT02735421|526518582|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
146000160|NCT02735421|526518582|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
146000161|NCT00652743|526518585|FG000|Months 12-18|Lost to Follow-up|1|||
146000162|NCT00652743|526518586|FG001|Months 12-18|Lost to Follow-up|2|||
146000163|NCT00652743|526518587|FG002|Months 12-18|Lost to Follow-up|7|||
146000164|NCT00652743|526518585|FG000|Months 24-30|Other|5|||
146000165|NCT00652743|526518586|FG001|Months 24-30|Other|1|||
146000166|NCT00652743|526518587|FG002|Months 24-30|Other|11|||
146000167|NCT00652743|526518585|FG000|Months 36-42|Serious Adverse Events|0|||
146000168|NCT00652743|526518586|FG001|Months 36-42|Serious Adverse Events|1|||
146000169|NCT00652743|526518587|FG002|Months 36-42|Serious Adverse Events|1|||
146000170|NCT00652743|526518585|FG000|Months 36-42|Withdrawal by Subject|1|||
146000171|NCT00652743|526518586|FG001|Months 36-42|Withdrawal by Subject|1|||
146000172|NCT00652743|526518587|FG002|Months 36-42|Withdrawal by Subject|0|||
146247251|NCT00473512|527419789|FG001|Period 1 (Phase 1)|Death|0|||
146247252|NCT00473512|527419790|FG002|Period 1 (Phase 1)|Death|0|||
146247253|NCT00473512|527419791|FG003|Period 1 (Phase 1)|Death|1|||
146247254|NCT00473512|527419792|FG004|Period 1 (Phase 1)|Death|0|||
146247255|NCT00473512|527419788|FG000|Period 1 (Phase 1)|Disease Progression|1|||
146000173|NCT00652743|526518585|FG000|Months 36-42|Lost to Follow-up|0|||
146000174|NCT00652743|526518586|FG001|Months 36-42|Lost to Follow-up|1|||
146000175|NCT00652743|526518587|FG002|Months 36-42|Lost to Follow-up|0|||
146000176|NCT00652743|526518585|FG000|Months 36-42|Migrated/moved from study area|1|||
146000177|NCT00652743|526518586|FG001|Months 36-42|Migrated/moved from study area|0|||
146247256|NCT00473512|527419789|FG001|Period 1 (Phase 1)|Disease Progression|1|||
146000178|NCT00652743|526518587|FG002|Months 36-42|Migrated/moved from study area|0|||
146000179|NCT00652743|526518585|FG000|Months 36-42|Other|4|||
146000180|NCT00652743|526518586|FG001|Months 36-42|Other|2|||
146000181|NCT00652743|526518587|FG002|Months 36-42|Other|8|||
146000182|NCT01246960|526518592|FG000|Overall Study|Lost to Follow-up|3|||
146000183|NCT01246960|526518593|FG001|Overall Study|Lost to Follow-up|1|||
146000184|NCT01246960|526518592|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
146000185|NCT01246960|526518593|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
146000186|NCT00639457|526518594|FG000|Overall Study|Withdrawal by Subject|2|||
146000187|NCT00639457|526518595|FG001|Overall Study|Withdrawal by Subject|3|||
146000188|NCT03235050|526518596|FG000|Overall Study|Adverse Event|0|||
146000189|NCT03235050|526518597|FG001|Overall Study|Adverse Event|0|||
146000190|NCT03235050|526518598|FG002|Overall Study|Adverse Event|1|||
146000191|NCT03235050|526518599|FG003|Overall Study|Adverse Event|4|||
146000192|NCT03235050|526518600|FG004|Overall Study|Adverse Event|1|||
146000193|NCT03235050|526518596|FG000|Overall Study|Death|0|||
146000194|NCT03235050|526518597|FG001|Overall Study|Death|0|||
146000195|NCT03235050|526518598|FG002|Overall Study|Death|0|||
146000196|NCT03235050|526518599|FG003|Overall Study|Death|2|||
146000197|NCT03235050|526518600|FG004|Overall Study|Death|1|||
146000198|NCT03235050|526518596|FG000|Overall Study|Lost to Follow-up|1|||
146000199|NCT03235050|526518597|FG001|Overall Study|Lost to Follow-up|2|||
146000200|NCT03235050|526518598|FG002|Overall Study|Lost to Follow-up|1|||
146000201|NCT03235050|526518599|FG003|Overall Study|Lost to Follow-up|2|||
146092180|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
146092181|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
146092182|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
146092183|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
146092184|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146092185|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
146092186|NCT01436162|526858563|FG000|Single-blind Lead-in Phase|Other|107|||
146092187|NCT01436162|526858564|FG001|Single-blind Lead-in Phase|Other|0|||
146092188|NCT01436162|526858565|FG002|Single-blind Lead-in Phase|Other|0|||
146092189|NCT01436162|526858563|FG000|Randomized Phase|Adverse Event|1|||
146092190|NCT01436162|526858564|FG001|Randomized Phase|Adverse Event|5|||
146092191|NCT01436162|526858565|FG002|Randomized Phase|Adverse Event|6|||
146092192|NCT01436162|526858563|FG000|Randomized Phase|Protocol Violation|4|||
146092193|NCT01436162|526858564|FG001|Randomized Phase|Protocol Violation|4|||
146092194|NCT01436162|526858565|FG002|Randomized Phase|Protocol Violation|2|||
146092195|NCT01436162|526858563|FG000|Randomized Phase|Withdrawal by Subject|16|||
146092196|NCT01436162|526858564|FG001|Randomized Phase|Withdrawal by Subject|9|||
146092197|NCT01436162|526858565|FG002|Randomized Phase|Withdrawal by Subject|8|||
146092198|NCT01436162|526858563|FG000|Randomized Phase|Lost to Follow-up|17|||
146092199|NCT01436162|526858564|FG001|Randomized Phase|Lost to Follow-up|5|||
146092200|NCT01436162|526858565|FG002|Randomized Phase|Lost to Follow-up|4|||
146092201|NCT01436162|526858563|FG000|Randomized Phase|Lack of Efficacy|0|||
146092202|NCT01436162|526858564|FG001|Randomized Phase|Lack of Efficacy|1|||
146092203|NCT01436162|526858565|FG002|Randomized Phase|Lack of Efficacy|1|||
146092204|NCT01436162|526858563|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
146092205|NCT01436162|526858564|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
146092206|NCT01436162|526858565|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
146092207|NCT01436162|526858563|FG000|Randomized Phase|Other|2|||
146092208|NCT01436162|526858564|FG001|Randomized Phase|Other|5|||
146092209|NCT01436162|526858565|FG002|Randomized Phase|Other|4|||
146092210|NCT01888003|526858566|FG000|Overall Study|Study Terminated|5|||
146092211|NCT01888003|526858567|FG001|Overall Study|Study Terminated|6|||
146092212|NCT01888003|526858568|FG002|Overall Study|Study Terminated|40|||
146092213|NCT03187756|526858569|FG000|Overall Study|Termination of study|4|||
146092214|NCT01931202|526858573|FG000|Overall Study|Withdrawal by Subject|0|||
146092215|NCT01931202|526858574|FG001|Overall Study|Withdrawal by Subject|0|||
146092216|NCT01931202|526858575|FG002|Overall Study|Withdrawal by Subject|2|||
146092217|NCT01931202|526858573|FG000|Overall Study|Lost to Follow-up|0|||
146092218|NCT01931202|526858574|FG001|Overall Study|Lost to Follow-up|5|||
146092219|NCT01931202|526858575|FG002|Overall Study|Lost to Follow-up|2|||
146092220|NCT04597918|526858578|FG000|Overall Study|Withdrawal by Subject|6|||
146092221|NCT04597918|526858578|FG000|Overall Study|Lost to Follow-up|3|||
146092222|NCT04597918|526858578|FG000|Overall Study|Death|1|||
146000202|NCT03235050|526518600|FG004|Overall Study|Lost to Follow-up|0|||
146000203|NCT03235050|526518596|FG000|Overall Study|Withdrawal by Subject|3|||
146000204|NCT03235050|526518597|FG001|Overall Study|Withdrawal by Subject|2|||
146000205|NCT03235050|526518598|FG002|Overall Study|Withdrawal by Subject|2|||
146092223|NCT01876810|526858579|FG000|Overall Study|Physician Decision|0|||
146092224|NCT01876810|526858580|FG001|Overall Study|Physician Decision|1|||
146092225|NCT05140382|526858583|FG000|Overall Study|Death|3|||
146092226|NCT05140382|526858584|FG001|Overall Study|Death|0|||
146000206|NCT03235050|526518599|FG003|Overall Study|Withdrawal by Subject|5|||
146000207|NCT03235050|526518600|FG004|Overall Study|Withdrawal by Subject|7|||
146092227|NCT05140382|526858585|FG002|Overall Study|Death|0|||
146092228|NCT05140382|526858583|FG000|Overall Study|Investigator decision|1|||
146092229|NCT05140382|526858584|FG001|Overall Study|Investigator decision|0|||
146092230|NCT05140382|526858585|FG002|Overall Study|Investigator decision|0|||
146092231|NCT05140382|526858583|FG000|Overall Study|Other|4|||
146092232|NCT05140382|526858584|FG001|Overall Study|Other|0|||
146000208|NCT03235050|526518596|FG000|Overall Study|Other reasons|0|||
146000209|NCT03235050|526518597|FG001|Overall Study|Other reasons|1|||
146092233|NCT05140382|526858585|FG002|Overall Study|Other|1|||
146092234|NCT05140382|526858583|FG000|Overall Study|Progressive disease|20|||
146092235|NCT05140382|526858584|FG001|Overall Study|Progressive disease|1|||
146092236|NCT05140382|526858585|FG002|Overall Study|Progressive disease|12|||
146092237|NCT05140382|526858583|FG000|Overall Study|Subjective disease progression|2|||
146092238|NCT05140382|526858584|FG001|Overall Study|Subjective disease progression|1|||
146092239|NCT05140382|526858585|FG002|Overall Study|Subjective disease progression|0|||
146092240|NCT05140382|526858583|FG000|Overall Study|Unknown at data cut-off|0|||
146092241|NCT05140382|526858584|FG001|Overall Study|Unknown at data cut-off|0|||
146092242|NCT05140382|526858585|FG002|Overall Study|Unknown at data cut-off|1|||
146092243|NCT05140382|526858583|FG000|Overall Study|Withdrawal by Subject|1|||
146092244|NCT05140382|526858584|FG001|Overall Study|Withdrawal by Subject|0|||
146092245|NCT05140382|526858585|FG002|Overall Study|Withdrawal by Subject|4|||
146092246|NCT05140382|526858583|FG000|Overall Study|Withdrawal of consent|0|||
146092247|NCT05140382|526858584|FG001|Overall Study|Withdrawal of consent|0|||
146092248|NCT05140382|526858585|FG002|Overall Study|Withdrawal of consent|1|||
146092249|NCT01442038|526860242|FG000|Overall Study|Death|35|||
146092250|NCT01442038|526860243|FG001|Overall Study|Death|29|||
146092251|NCT01442038|526860242|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
146092252|NCT01442038|526860243|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
146092253|NCT01442038|526860242|FG000|Overall Study|Participant Withdrew Consent|137|||
146092254|NCT01442038|526860243|FG001|Overall Study|Participant Withdrew Consent|102|||
146092255|NCT01442038|526860242|FG000|Overall Study|Lost to Follow-up|37|||
146092256|NCT01442038|526860243|FG001|Overall Study|Lost to Follow-up|51|||
146092257|NCT01442038|526860242|FG000|Overall Study|Adverse Event|26|||
146092258|NCT01442038|526860243|FG001|Overall Study|Adverse Event|15|||
146092259|NCT01442038|526860242|FG000|Overall Study|Protocol Deviation|9|||
146092260|NCT01442038|526860243|FG001|Overall Study|Protocol Deviation|20|||
146092261|NCT01442038|526860242|FG000|Overall Study|Investigator's Discretion|13|||
146092262|NCT01442038|526860243|FG001|Overall Study|Investigator's Discretion|16|||
146092263|NCT01442038|526860242|FG000|Overall Study|Study Terminated By Sponsor|2|||
146092264|NCT01442038|526860243|FG001|Overall Study|Study Terminated By Sponsor|3|||
146092265|NCT00089284|526860244|FG000|Overall Study|Adverse event before starting treatment|0|||
146092266|NCT00089284|526860245|FG001|Overall Study|Adverse event before starting treatment|0|||
146092267|NCT00089284|526860246|FG002|Overall Study|Adverse event before starting treatment|0|||
146092268|NCT00089284|526860247|FG003|Overall Study|Adverse event before starting treatment|0|||
146092269|NCT00089284|526860248|FG004|Overall Study|Adverse event before starting treatment|0|||
146092270|NCT00089284|526860249|FG005|Overall Study|Adverse event before starting treatment|0|||
146092271|NCT00089284|526860250|FG006|Overall Study|Adverse event before starting treatment|1|||
146092272|NCT02428608|526860252|FG000|Overall Study|Pregnancy|2|||
146000210|NCT03235050|526518598|FG002|Overall Study|Other reasons|0|||
146000211|NCT03235050|526518599|FG003|Overall Study|Other reasons|1|||
146000212|NCT03235050|526518600|FG004|Overall Study|Other reasons|2|||
146000213|NCT01621178|526518602|FG000|Overall Study|Adverse Event|5|||
146000214|NCT01621178|526518603|FG001|Overall Study|Adverse Event|2|||
146000215|NCT01621178|526518604|FG002|Overall Study|Adverse Event|8|||
146000216|NCT01621178|526518602|FG000|Overall Study|Death|6|||
146000217|NCT01621178|526518603|FG001|Overall Study|Death|7|||
146000218|NCT01621178|526518604|FG002|Overall Study|Death|2|||
146000219|NCT01621178|526518602|FG000|Overall Study|Lost to Follow-up|1|||
146000220|NCT01621178|526518603|FG001|Overall Study|Lost to Follow-up|2|||
146000221|NCT01621178|526518604|FG002|Overall Study|Lost to Follow-up|1|||
146000222|NCT01621178|526518602|FG000|Overall Study|Withdrawal by Subject|14|||
146000223|NCT01621178|526518603|FG001|Overall Study|Withdrawal by Subject|17|||
146000224|NCT01621178|526518604|FG002|Overall Study|Withdrawal by Subject|18|||
146000225|NCT01621178|526518602|FG000|Overall Study|Physician Decision|5|||
146000226|NCT01621178|526518603|FG001|Overall Study|Physician Decision|2|||
146000227|NCT01621178|526518604|FG002|Overall Study|Physician Decision|7|||
146000228|NCT02896257|526518605|FG000|Providers|Without eligible patients|21|||
146000229|NCT02896257|526518606|FG001|Providers|Without eligible patients|28|||
146000230|NCT02896257|526518605|FG000|Patients|PFT entry criteria not met|43|||
146000231|NCT02896257|526518606|FG001|Patients|PFT entry criteria not met|50|||
146000232|NCT02896257|526518605|FG000|Patients|No capacity to review|8|||
146000233|NCT02896257|526518606|FG001|Patients|No capacity to review|11|||
146000234|NCT02896257|526518605|FG000|Patients|Appointment rescheduled/cancelled|5|||
146000235|NCT02896257|526518606|FG001|Patients|Appointment rescheduled/cancelled|7|||
146000236|NCT02896257|526518605|FG000|Patients|PCP not assigned a clinic|4|||
146000237|NCT02896257|526518606|FG001|Patients|PCP not assigned a clinic|0|||
146000238|NCT02896257|526518605|FG000|Patients|No history of COPD|0|||
146000239|NCT02896257|526518606|FG001|Patients|No history of COPD|1|||
146000240|NCT02896257|526518605|FG000|Patients|Deceased between review and index date|0|||
146000241|NCT02896257|526518606|FG001|Patients|Deceased between review and index date|1|||
146092273|NCT02428608|526860252|FG000|Overall Study|Lost to Follow-up|37|||
146092274|NCT02428608|526860252|FG000|Overall Study|Withdrawal by Subject|2|||
146092275|NCT02428608|526860252|FG000|Overall Study|scheduling conflicts|15|||
146000242|NCT02896257|526518605|FG000|Patients|No ICS Rx upon review|1|||
146000243|NCT02896257|526518606|FG001|Patients|No ICS Rx upon review|1|||
146000244|NCT02896257|526518605|FG000|Patients|Protocol Violation|2|||
146000245|NCT02896257|526518606|FG001|Patients|Protocol Violation|1|||
146000246|NCT02896257|526518605|FG000|Patients|Hospice care|0|||
146000247|NCT02896257|526518606|FG001|Patients|Hospice care|1|||
146000248|NCT00492557|526518608|FG000|Overall Study|Subject request|12|||
146000249|NCT00492557|526518609|FG001|Overall Study|Subject request|11|||
146000250|NCT00492557|526518608|FG000|Overall Study|Protocol Violation|7|||
146000251|NCT00492557|526518609|FG001|Overall Study|Protocol Violation|8|||
146000252|NCT00492557|526518608|FG000|Overall Study|Other|2|||
146000253|NCT00492557|526518609|FG001|Overall Study|Other|2|||
146000254|NCT00492557|526518608|FG000|Overall Study|Death|1|||
146000255|NCT00492557|526518609|FG001|Overall Study|Death|1|||
146000256|NCT00492557|526518608|FG000|Overall Study|Adverse Event|1|||
146000257|NCT00492557|526518609|FG001|Overall Study|Adverse Event|0|||
146000258|NCT00492557|526518608|FG000|Overall Study|Failed to return|1|||
146000259|NCT00492557|526518609|FG001|Overall Study|Failed to return|0|||
146000260|NCT00492557|526518608|FG000|Overall Study|Lost to Follow-up|0|||
146000261|NCT00492557|526518609|FG001|Overall Study|Lost to Follow-up|1|||
146000262|NCT04778592|526518614|FG000|Overall Study|Adverse Event|1|||
146000263|NCT04778592|526518615|FG001|Overall Study|Adverse Event|2|||
146000264|NCT04778592|526518614|FG000|Overall Study|Withdrawal by Subject|1|||
146000265|NCT04778592|526518615|FG001|Overall Study|Withdrawal by Subject|2|||
146000266|NCT03423121|526518616|FG000|Overall Study|Lost to Follow-up|2|||
146000267|NCT03423121|526518617|FG001|Overall Study|Lost to Follow-up|6|||
146000268|NCT03423121|526518616|FG000|Overall Study|Adverse Event|1|||
146000269|NCT03423121|526518617|FG001|Overall Study|Adverse Event|0|||
146000270|NCT01192126|526518618|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
146000271|NCT01192126|526518619|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
146000272|NCT01192126|526518618|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
146000273|NCT01192126|526518619|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
146000274|NCT01354223|526518620|FG000|Overall Study|Withdrawal by Subject|3|||
146000275|NCT01354223|526518621|FG001|Overall Study|Withdrawal by Subject|1|||
146000276|NCT04102007|526518625|FG000|Overall Study|Adverse Event|4|||
146000277|NCT04102007|526518625|FG000|Overall Study|Lost to Follow-up|3|||
146000278|NCT04102007|526518625|FG000|Overall Study|Withdrawal by Subject|12|||
146000279|NCT04102007|526518625|FG000|Overall Study|Eligibility Violation|5|||
146092276|NCT02428608|526860252|FG000|Overall Study|moved away|10|||
146092277|NCT02428608|526860252|FG000|Overall Study|Death|1|||
146092278|NCT02428608|526860252|FG000|Overall Study|various|16|||
146092279|NCT01092507|526860253|FG000|Overall Study|Withdrawal by Subject|2|||
146092280|NCT01092507|526860254|FG001|Overall Study|Withdrawal by Subject|0|||
146247257|NCT00473512|527419790|FG002|Period 1 (Phase 1)|Disease Progression|0|||
146247258|NCT00473512|527419791|FG003|Period 1 (Phase 1)|Disease Progression|10|||
146247259|NCT00473512|527419792|FG004|Period 1 (Phase 1)|Disease Progression|1|||
146247260|NCT00473512|527419788|FG000|Period 1 (Phase 1)|Other|0|||
146247261|NCT00473512|527419789|FG001|Period 1 (Phase 1)|Other|0|||
146247262|NCT00473512|527419790|FG002|Period 1 (Phase 1)|Other|0|||
146247263|NCT00473512|527419791|FG003|Period 1 (Phase 1)|Other|1|||
146247264|NCT00473512|527419792|FG004|Period 1 (Phase 1)|Other|0|||
146092289|NCT01251744|526860257|FG000|Overall Study|Lost to Follow-up|1|||
146092290|NCT01251744|526860258|FG001|Overall Study|Lost to Follow-up|0|||
146092291|NCT01068652|526860259|FG000|Overall Study|Adverse Event|4|||
146092292|NCT01068652|526860260|FG001|Overall Study|Adverse Event|0|||
146000280|NCT04102007|526518625|FG000|Overall Study|Lack of Efficacy|6|||
146000281|NCT04102007|526518625|FG000|Overall Study|Protocol Deviation|5|||
146000282|NCT04102007|526518625|FG000|Overall Study|Protocol Compliance|1|||
146000283|NCT04102007|526518625|FG000|Overall Study|Withdrew Treatment|2|||
146000284|NCT04102007|526518625|FG000|Overall Study|Pregnancy|1|||
146000285|NCT05173974|526518626|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146092293|NCT01068652|526860259|FG000|Overall Study|Lack of Efficacy|0|||
146092294|NCT01068652|526860260|FG001|Overall Study|Lack of Efficacy|2|||
146092295|NCT01068652|526860259|FG000|Overall Study|Lost to Follow-up|2|||
146092296|NCT01068652|526860260|FG001|Overall Study|Lost to Follow-up|1|||
146092297|NCT01068652|526860259|FG000|Overall Study|Protocol Violation|3|||
146092298|NCT01068652|526860260|FG001|Overall Study|Protocol Violation|6|||
146092299|NCT01068652|526860259|FG000|Overall Study|Withdrawal criteria|1|||
146092300|NCT01068652|526860260|FG001|Overall Study|Withdrawal criteria|2|||
146000286|NCT05173974|526518627|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146000287|NCT05173974|526518628|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
146092301|NCT01068652|526860259|FG000|Overall Study|Patient was not eligible|1|||
146000288|NCT05173974|526518629|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
146000289|NCT05173974|526518626|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146000290|NCT05173974|526518627|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
146000291|NCT05173974|526518628|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146092302|NCT01068652|526860260|FG001|Overall Study|Patient was not eligible|0|||
146092303|NCT01068652|526860259|FG000|Overall Study|Unclassified|7|||
146092304|NCT01068652|526860260|FG001|Overall Study|Unclassified|4|||
146092305|NCT02147184|526860261|FG000|Overall Study|Lost to Follow-up|28|||
146092306|NCT02147184|526860262|FG001|Overall Study|Lost to Follow-up|15|||
146092307|NCT02147184|526860261|FG000|Overall Study|Study Burden|11|||
146092308|NCT02147184|526860262|FG001|Overall Study|Study Burden|7|||
146092309|NCT02147184|526860261|FG000|Overall Study|Pregnancy|6|||
146092310|NCT02147184|526860262|FG001|Overall Study|Pregnancy|0|||
146092311|NCT02147184|526860261|FG000|Overall Study|Moved out of state|3|||
146092312|NCT02147184|526860262|FG001|Overall Study|Moved out of state|3|||
146092313|NCT02147184|526860261|FG000|Overall Study|Physician Decision|0|||
146092314|NCT02147184|526860262|FG001|Overall Study|Physician Decision|2|||
146092315|NCT02147184|526860261|FG000|Overall Study|Other|1|||
146092316|NCT02147184|526860262|FG001|Overall Study|Other|0|||
146092317|NCT00417482|526860267|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
146092318|NCT00417482|526860268|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
146092319|NCT00417482|526860269|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
146092320|NCT00417482|526860267|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
146092321|NCT00417482|526860268|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
146092322|NCT00417482|526860269|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
146092323|NCT00417482|526860267|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
146092324|NCT00417482|526860268|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
146092325|NCT00417482|526860269|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
146092326|NCT00417482|526860267|FG000|Phase B 1st 16 Weeks|Death|1|||
146092327|NCT00417482|526860268|FG001|Phase B 1st 16 Weeks|Death|0|||
146092328|NCT00417482|526860269|FG002|Phase B 1st 16 Weeks|Death|0|||
146092329|NCT00417482|526860267|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
146092330|NCT00417482|526860268|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
146092331|NCT00417482|526860269|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
146092332|NCT00417482|526860267|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
146092333|NCT00417482|526860268|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
146092334|NCT00417482|526860269|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
146092335|NCT00417482|526860267|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
146092336|NCT00417482|526860268|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
146092337|NCT00417482|526860269|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
146092338|NCT00417482|526860267|FG000|Phase B 2nd 16 Weeks|Death|1|||
146092339|NCT00417482|526860268|FG001|Phase B 2nd 16 Weeks|Death|1|||
146092340|NCT00417482|526860269|FG002|Phase B 2nd 16 Weeks|Death|0|||
146092341|NCT06400979|526860270|FG000|Overall Study|Lost to Follow-up|29|||
146092342|NCT06400979|526860270|FG000|Overall Study|Withdrawal by Subject|1|||
146092343|NCT00117286|526860273|FG000|Overall Study|Adverse Event|12|||
146000292|NCT05173974|526518629|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
146000293|NCT03289143|526518630|FG000|Overall Study|Caregiver Unavailability|1|||
146000294|NCT03289143|526518631|FG001|Overall Study|Caregiver Unavailability|1|||
146000295|NCT03289143|526518632|FG002|Overall Study|Caregiver Unavailability|0|||
146000296|NCT03289143|526518633|FG003|Overall Study|Caregiver Unavailability|0|||
146000297|NCT03289143|526518630|FG000|Overall Study|Research Department Closure|0|||
146000298|NCT03289143|526518631|FG001|Overall Study|Research Department Closure|0|||
146000299|NCT03289143|526518632|FG002|Overall Study|Research Department Closure|1|||
146000300|NCT03289143|526518633|FG003|Overall Study|Research Department Closure|0|||
146000301|NCT03289143|526518630|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146000302|NCT03289143|526518631|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146000303|NCT03289143|526518632|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
146000304|NCT03289143|526518633|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
146000305|NCT03289143|526518630|FG000|Overall Study|Medical Monitor Decision|1|||
146000306|NCT03289143|526518631|FG001|Overall Study|Medical Monitor Decision|0|||
146000307|NCT03289143|526518632|FG002|Overall Study|Medical Monitor Decision|0|||
146000308|NCT03289143|526518633|FG003|Overall Study|Medical Monitor Decision|0|||
146000309|NCT03289143|526518630|FG000|Overall Study|Participant Non-Compliance|0|||
146000310|NCT03289143|526518631|FG001|Overall Study|Participant Non-Compliance|0|||
146000311|NCT03289143|526518632|FG002|Overall Study|Participant Non-Compliance|1|||
146000312|NCT03289143|526518633|FG003|Overall Study|Participant Non-Compliance|0|||
146000313|NCT03289143|526518630|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146000314|NCT03289143|526518631|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146092344|NCT00117286|526860274|FG001|Overall Study|Adverse Event|6|||
146000315|NCT03289143|526518632|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
146000316|NCT03289143|526518633|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
146092345|NCT00117286|526860273|FG000|Overall Study|Lost to Follow-up|2|||
146092346|NCT00117286|526860274|FG001|Overall Study|Lost to Follow-up|0|||
146092347|NCT00117286|526860273|FG000|Overall Study|Protocol Violation|3|||
146092348|NCT00117286|526860274|FG001|Overall Study|Protocol Violation|3|||
146092349|NCT00117286|526860273|FG000|Overall Study|Withdrawal by Subject|6|||
146092350|NCT00117286|526860274|FG001|Overall Study|Withdrawal by Subject|2|||
146000317|NCT03289143|526518630|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146000318|NCT03289143|526518631|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146092351|NCT00117286|526860273|FG000|Overall Study|Physician Decision|3|||
146092352|NCT00117286|526860274|FG001|Overall Study|Physician Decision|7|||
146092353|NCT00117286|526860273|FG000|Overall Study|Lack of Efficacy|2|||
146247265|NCT00473512|527419788|FG000|Period 2 (Phase 2)|Adverse Event|0|||
146247266|NCT00473512|527419789|FG001|Period 2 (Phase 2)|Adverse Event|0|||
146247267|NCT00473512|527419790|FG002|Period 2 (Phase 2)|Adverse Event|0|||
146247268|NCT00473512|527419791|FG003|Period 2 (Phase 2)|Adverse Event|1|||
146247269|NCT00473512|527419792|FG004|Period 2 (Phase 2)|Adverse Event|0|||
146247270|NCT00473512|527419788|FG000|Period 2 (Phase 2)|Death|0|||
146247271|NCT00473512|527419789|FG001|Period 2 (Phase 2)|Death|0|||
146247272|NCT00473512|527419790|FG002|Period 2 (Phase 2)|Death|0|||
146247273|NCT00473512|527419791|FG003|Period 2 (Phase 2)|Death|1|||
146247274|NCT00473512|527419792|FG004|Period 2 (Phase 2)|Death|1|||
146000319|NCT03289143|526518632|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
146247275|NCT00473512|527419788|FG000|Period 2 (Phase 2)|Disease Progression|0|||
146247276|NCT00473512|527419789|FG001|Period 2 (Phase 2)|Disease Progression|2|||
146247277|NCT00473512|527419790|FG002|Period 2 (Phase 2)|Disease Progression|2|||
146247278|NCT00473512|527419791|FG003|Period 2 (Phase 2)|Disease Progression|17|||
146247279|NCT00473512|527419792|FG004|Period 2 (Phase 2)|Disease Progression|1|||
146247280|NCT00473512|527419788|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146247281|NCT00473512|527419789|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146247282|NCT00473512|527419790|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146247283|NCT00473512|527419791|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
146247284|NCT00473512|527419792|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
146247285|NCT00473512|527419788|FG000|Period 2 (Phase 2)|Other|1|||
146247286|NCT00473512|527419789|FG001|Period 2 (Phase 2)|Other|0|||
146247287|NCT00473512|527419790|FG002|Period 2 (Phase 2)|Other|0|||
146247288|NCT00473512|527419791|FG003|Period 2 (Phase 2)|Other|3|||
146247289|NCT00473512|527419792|FG004|Period 2 (Phase 2)|Other|0|||
146247290|NCT00267956|527419797|FG000|Controlled Period|Adverse Event|4|||
146247291|NCT00267956|527419798|FG001|Controlled Period|Adverse Event|1|||
146247292|NCT00267956|527419799|FG002|Controlled Period|Adverse Event|0|||
146247293|NCT00267956|527419800|FG003|Controlled Period|Adverse Event|0|||
146247294|NCT00267956|527419797|FG000|Controlled Period|Lack of Efficacy|4|||
146247295|NCT00267956|527419798|FG001|Controlled Period|Lack of Efficacy|2|||
146247296|NCT00267956|527419799|FG002|Controlled Period|Lack of Efficacy|0|||
146247297|NCT00267956|527419800|FG003|Controlled Period|Lack of Efficacy|0|||
146247298|NCT00267956|527419797|FG000|Controlled Period|Lost to Follow-up|2|||
146247299|NCT00267956|527419798|FG001|Controlled Period|Lost to Follow-up|0|||
146247300|NCT00267956|527419799|FG002|Controlled Period|Lost to Follow-up|0|||
146247301|NCT00267956|527419800|FG003|Controlled Period|Lost to Follow-up|0|||
146247302|NCT00267956|527419797|FG000|Controlled Period|Withdrew consent|3|||
146247303|NCT00267956|527419798|FG001|Controlled Period|Withdrew consent|1|||
146247304|NCT00267956|527419799|FG002|Controlled Period|Withdrew consent|0|||
146247305|NCT00267956|527419800|FG003|Controlled Period|Withdrew consent|0|||
146247306|NCT00267956|527419797|FG000|After Controlled Period|Adverse Event|0|||
146247307|NCT00267956|527419798|FG001|After Controlled Period|Adverse Event|0|||
146247308|NCT00267956|527419799|FG002|After Controlled Period|Adverse Event|2|||
146247309|NCT00267956|527419800|FG003|After Controlled Period|Adverse Event|1|||
146247310|NCT00267956|527419797|FG000|After Controlled Period|Lack of Efficacy|0|||
146247311|NCT00267956|527419798|FG001|After Controlled Period|Lack of Efficacy|0|||
146247312|NCT00267956|527419799|FG002|After Controlled Period|Lack of Efficacy|1|||
146247313|NCT00267956|527419800|FG003|After Controlled Period|Lack of Efficacy|1|||
146247314|NCT00267956|527419797|FG000|After Controlled Period|Lost to Follow-up|0|||
146247315|NCT00267956|527419798|FG001|After Controlled Period|Lost to Follow-up|0|||
146247316|NCT00267956|527419799|FG002|After Controlled Period|Lost to Follow-up|1|||
146247317|NCT00267956|527419800|FG003|After Controlled Period|Lost to Follow-up|0|||
146247318|NCT00267956|527419797|FG000|After Controlled Period|Withdrew consent|0|||
146247319|NCT00267956|527419798|FG001|After Controlled Period|Withdrew consent|0|||
146247320|NCT00267956|527419799|FG002|After Controlled Period|Withdrew consent|1|||
146247321|NCT00267956|527419800|FG003|After Controlled Period|Withdrew consent|0|||
146247322|NCT01263223|527419801|FG000|Period 2|Withdrawal by Subject|0|||
146000320|NCT03289143|526518633|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
146000321|NCT03289143|526518630|FG000|Overall Study|Caregiver Passed Away|1|||
146247323|NCT01263223|527419802|FG001|Period 2|Withdrawal by Subject|1|||
146247324|NCT01263223|527419801|FG000|7-day Follow-up|Withdrawal by Subject|0|||
146247325|NCT01263223|527419802|FG001|7-day Follow-up|Withdrawal by Subject|1|||
146247326|NCT01263223|527419801|FG000|7-day Follow-up|Lost to Follow-up|1|||
146247327|NCT01263223|527419802|FG001|7-day Follow-up|Lost to Follow-up|0|||
146247328|NCT02246647|527419803|FG000|Overall Study|Withdrawal by Subject|1|||
146247329|NCT02246647|527419804|FG001|Overall Study|Withdrawal by Subject|1|||
146247330|NCT01113541|527419808|FG000|Overall Study|Withdrawal by Subject|1|||
146247331|NCT01113541|527419808|FG000|Overall Study|Protocol Violation|1|||
146247332|NCT01113541|527419808|FG000|Overall Study|Study Terminated by Sponsor|7|||
146247333|NCT01113541|527419808|FG000|Overall Study|Adverse Event|4|||
146247334|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
146247335|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
146000322|NCT03289143|526518631|FG001|Overall Study|Caregiver Passed Away|0|||
146247336|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
146000323|NCT03289143|526518632|FG002|Overall Study|Caregiver Passed Away|0|||
146000324|NCT03289143|526518633|FG003|Overall Study|Caregiver Passed Away|0|||
146000325|NCT03289143|526518630|FG000|Overall Study|Physician Decision|0|||
146000326|NCT03289143|526518631|FG001|Overall Study|Physician Decision|2|||
146000327|NCT03289143|526518632|FG002|Overall Study|Physician Decision|2|||
146000328|NCT03289143|526518633|FG003|Overall Study|Physician Decision|2|||
146000329|NCT03289143|526518630|FG000|Overall Study|Protocol Deviation|2|||
146000330|NCT03289143|526518631|FG001|Overall Study|Protocol Deviation|1|||
146000331|NCT03289143|526518632|FG002|Overall Study|Protocol Deviation|3|||
146000332|NCT03289143|526518633|FG003|Overall Study|Protocol Deviation|1|||
146000333|NCT03289143|526518630|FG000|Overall Study|Study Terminated By Sponsor|101|||
146000334|NCT03289143|526518631|FG001|Overall Study|Study Terminated By Sponsor|75|||
146000335|NCT03289143|526518632|FG002|Overall Study|Study Terminated By Sponsor|100|||
146000336|NCT03289143|526518633|FG003|Overall Study|Study Terminated By Sponsor|69|||
146000337|NCT03289143|526518630|FG000|Overall Study|Withdrawal by Subject|14|||
146000338|NCT03289143|526518631|FG001|Overall Study|Withdrawal by Subject|6|||
146000339|NCT03289143|526518632|FG002|Overall Study|Withdrawal by Subject|14|||
146000340|NCT03289143|526518633|FG003|Overall Study|Withdrawal by Subject|12|||
146000341|NCT03289143|526518630|FG000|Overall Study|Adverse Event|10|||
146000342|NCT03289143|526518631|FG001|Overall Study|Adverse Event|7|||
146000343|NCT03289143|526518632|FG002|Overall Study|Adverse Event|6|||
146000344|NCT03289143|526518633|FG003|Overall Study|Adverse Event|5|||
146000345|NCT03289143|526518630|FG000|Overall Study|Death|2|||
146000346|NCT03289143|526518631|FG001|Overall Study|Death|0|||
146000347|NCT03289143|526518632|FG002|Overall Study|Death|2|||
146000348|NCT03289143|526518633|FG003|Overall Study|Death|1|||
146000349|NCT03289143|526518630|FG000|Overall Study|Lost to Follow-up|2|||
146000350|NCT03289143|526518631|FG001|Overall Study|Lost to Follow-up|1|||
146000351|NCT03289143|526518632|FG002|Overall Study|Lost to Follow-up|1|||
146000352|NCT03289143|526518633|FG003|Overall Study|Lost to Follow-up|0|||
146000353|NCT03289143|526518630|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
146000354|NCT03289143|526518631|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
146000355|NCT03289143|526518632|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
146000356|NCT03289143|526518633|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
146000357|NCT03289143|526518630|FG000|Overall Study|Withdrawal by Caregiver|0|||
146000358|NCT03289143|526518631|FG001|Overall Study|Withdrawal by Caregiver|1|||
146000359|NCT03289143|526518632|FG002|Overall Study|Withdrawal by Caregiver|0|||
146000360|NCT03289143|526518633|FG003|Overall Study|Withdrawal by Caregiver|0|||
146000361|NCT03289143|526518630|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146000362|NCT03289143|526518631|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146000363|NCT03289143|526518632|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
146000364|NCT03289143|526518633|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
146000365|NCT03289143|526518630|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146000366|NCT03289143|526518631|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146000367|NCT03289143|526518632|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
146000368|NCT03289143|526518633|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
146000369|NCT00730756|526518634|FG000|Overall Study|Adverse Event|2|||
146000370|NCT00730756|526518635|FG001|Overall Study|Adverse Event|0|||
146000371|NCT00730756|526518634|FG000|Overall Study|Lack of Efficacy|1|||
146000372|NCT00730756|526518635|FG001|Overall Study|Lack of Efficacy|1|||
146000373|NCT00730756|526518634|FG000|Overall Study|Protocol Deviation|1|||
146000374|NCT00730756|526518635|FG001|Overall Study|Protocol Deviation|2|||
146000375|NCT00730756|526518634|FG000|Overall Study|Lost to Follow-up|0|||
146000376|NCT00730756|526518635|FG001|Overall Study|Lost to Follow-up|1|||
146000377|NCT00730756|526518634|FG000|Overall Study|Withdrew Consent|0|||
146000378|NCT00730756|526518635|FG001|Overall Study|Withdrew Consent|1|||
146000379|NCT00948688|526518636|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
146000380|NCT00948688|526518637|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
146000381|NCT00948688|526518636|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
146000382|NCT00948688|526518637|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
146000383|NCT00948688|526518636|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
146000384|NCT00948688|526518637|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
146000385|NCT00524121|526518640|FG000|Overall Study|Disease progression|6|||
146000386|NCT00524121|526518640|FG000|Overall Study|Adverse Event|4|||
146000387|NCT00524121|526518640|FG000|Overall Study|Patient refused|2|||
146000388|NCT00524121|526518640|FG000|Overall Study|Other|1|||
146000389|NCT00524121|526518640|FG000|Overall Study|Death|1|||
146000390|NCT00524121|526518640|FG000|Overall Study|Not treated (became ineligible)|4|||
146000391|NCT00524121|526518640|FG000|Overall Study|Not treated (changed mind)|1|||
146000392|NCT01840943|526518641|FG000|Overall Study|Withdrawal by Subject|5|||
146000393|NCT01840943|526518642|FG001|Overall Study|Withdrawal by Subject|6|||
146000394|NCT01840943|526518641|FG000|Overall Study|Physician Decision|4|||
146000395|NCT01840943|526518642|FG001|Overall Study|Physician Decision|2|||
146000396|NCT01840943|526518641|FG000|Overall Study|Lost to Follow-up|4|||
146000397|NCT01840943|526518642|FG001|Overall Study|Lost to Follow-up|4|||
146000398|NCT01446874|526518643|FG000|Overall Study|Not eligible|1|||
146000399|NCT01446874|526518644|FG001|Overall Study|Not eligible|0|||
146000400|NCT01446874|526518645|FG002|Overall Study|Not eligible|0|||
146000401|NCT01446874|526518643|FG000|Overall Study|No surgery/No qualifying surgery|1|||
146000402|NCT01446874|526518644|FG001|Overall Study|No surgery/No qualifying surgery|0|||
146000403|NCT01446874|526518645|FG002|Overall Study|No surgery/No qualifying surgery|12|||
146000404|NCT01446874|526518643|FG000|Overall Study|Non-compliance|0|||
146000405|NCT01446874|526518644|FG001|Overall Study|Non-compliance|4|||
146000406|NCT01446874|526518645|FG002|Overall Study|Non-compliance|0|||
146000407|NCT01446874|526518643|FG000|Overall Study|Antibiotics for pre-op infection|0|||
146000408|NCT01446874|526518644|FG001|Overall Study|Antibiotics for pre-op infection|0|||
146000409|NCT01446874|526518645|FG002|Overall Study|Antibiotics for pre-op infection|2|||
146000410|NCT01446874|526518643|FG000|Overall Study|Withdrawal by Subject|0|||
146000411|NCT01446874|526518644|FG001|Overall Study|Withdrawal by Subject|0|||
146000412|NCT01446874|526518645|FG002|Overall Study|Withdrawal by Subject|4|||
146000413|NCT01135992|526518646|FG000|Overall Study|Adverse Event|1|||
146000414|NCT01135992|526518646|FG000|Overall Study|Lack of Efficacy|1|||
146000415|NCT01135992|526518646|FG000|Overall Study|Protocol Violation|2|||
146000416|NCT01135992|526518646|FG000|Overall Study|Withdrawal criteria|10|||
146000417|NCT01135992|526518646|FG000|Overall Study|Unclassified|7|||
146000418|NCT01977898|526518647|FG000|Overall Study|Non functioning catheter|1|||
146000419|NCT01977898|526518648|FG001|Overall Study|Non functioning catheter|1|||
146000420|NCT01049373|526518654|FG000|Overall Study|Protocol Violation|9|||
146000421|NCT01049373|526518655|FG001|Overall Study|Protocol Violation|9|||
146000422|NCT01049373|526518654|FG000|Overall Study|Withdrawal by Subject|8|||
146000423|NCT01049373|526518655|FG001|Overall Study|Withdrawal by Subject|5|||
146000424|NCT01049373|526518654|FG000|Overall Study|Adverse Event|3|||
146000425|NCT01049373|526518655|FG001|Overall Study|Adverse Event|3|||
146000426|NCT01049373|526518654|FG000|Overall Study|Lost to Follow-up|9|||
146000427|NCT01049373|526518655|FG001|Overall Study|Lost to Follow-up|4|||
146000428|NCT01049373|526518654|FG000|Overall Study|no evaluable study values|9|||
146000429|NCT01049373|526518655|FG001|Overall Study|no evaluable study values|21|||
146000430|NCT01049373|526518654|FG000|Overall Study|Other|1|||
146000431|NCT01049373|526518655|FG001|Overall Study|Other|1|||
146000432|NCT01049373|526518654|FG000|Overall Study|Non-cooperation|0|||
146000433|NCT01049373|526518655|FG001|Overall Study|Non-cooperation|1|||
146000434|NCT01693367|526518656|FG000|Overall Study|Withdrawal by Subject|1|||
146000435|NCT01693367|526518657|FG001|Overall Study|Withdrawal by Subject|1|||
146000436|NCT01693367|526518656|FG000|Overall Study|Physician Decision|0|||
146000437|NCT01693367|526518657|FG001|Overall Study|Physician Decision|1|||
146000438|NCT03610048|526518658|FG000|Overall Study|Study terminated by sponsor|84|||
146000439|NCT03610048|526518658|FG000|Overall Study|Adverse Event|32|||
146000440|NCT03610048|526518658|FG000|Overall Study|Withdrawal by Subject|31|||
146000441|NCT03610048|526518658|FG000|Overall Study|Lost to Follow-up|8|||
146000442|NCT03610048|526518658|FG000|Overall Study|Other|4|||
146000443|NCT03610048|526518658|FG000|Overall Study|Physician Decision|1|||
146000444|NCT03610048|526518658|FG000|Overall Study|Pregnancy|1|||
146000445|NCT01155050|526518659|FG000|Overall Study|Lost to Follow-up|15|||
146000446|NCT01155050|526518660|FG001|Overall Study|Lost to Follow-up|20|||
146000447|NCT01155050|526518661|FG002|Overall Study|Lost to Follow-up|19|||
146000448|NCT01155050|526518662|FG003|Overall Study|Lost to Follow-up|22|||
146000449|NCT02136914|526518663|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
146000450|NCT02136914|526518664|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
146000451|NCT02136914|526518663|FG000|Overall Study|Withdrawal by Subject|3|||
146000452|NCT02136914|526518664|FG001|Overall Study|Withdrawal by Subject|10|||
146000453|NCT02136914|526518663|FG000|Overall Study|Subject Unwilling to Proceed|7|||
146000454|NCT02136914|526518664|FG001|Overall Study|Subject Unwilling to Proceed|2|||
146000455|NCT02136914|526518663|FG000|Overall Study|Lost to Follow-up|1|||
146000456|NCT02136914|526518664|FG001|Overall Study|Lost to Follow-up|1|||
146000457|NCT02136914|526518663|FG000|Overall Study|Did Not Receive Study Drug|2|||
146000458|NCT02136914|526518664|FG001|Overall Study|Did Not Receive Study Drug|0|||
146000459|NCT02136914|526518663|FG000|Overall Study|Lack of Efficacy|1|||
146000460|NCT02136914|526518664|FG001|Overall Study|Lack of Efficacy|0|||
146000461|NCT02136914|526518663|FG000|Overall Study|Death|0|||
146000462|NCT02136914|526518664|FG001|Overall Study|Death|1|||
146000463|NCT00329030|526518667|FG000|Overall Study|Withdrawal by Subject|1|||
146000464|NCT00329030|526518668|FG001|Overall Study|Withdrawal by Subject|3|||
146000465|NCT00329030|526518667|FG000|Overall Study|Progressive Disease|6|||
146000466|NCT00329030|526518668|FG001|Overall Study|Progressive Disease|2|||
146000467|NCT00329030|526518667|FG000|Overall Study|Ineligible Pathology|1|||
146000468|NCT00329030|526518668|FG001|Overall Study|Ineligible Pathology|1|||
146000469|NCT00325143|526518669|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
146000470|NCT00325143|526518669|FG000|Overall Study|Migrated/moved from study area|1|||
146000471|NCT00325143|526518669|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
146000472|NCT00325143|526518669|FG000|Overall Study|Withdrawal by Subject|8|||
146000473|NCT02286895|526518670|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
146000474|NCT02286895|526518671|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
146000475|NCT02286895|526518670|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
146247337|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
146000476|NCT02286895|526518671|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
146000477|NCT02286895|526518670|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
146000478|NCT02286895|526518671|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
146000479|NCT03036852|526518672|FG000|Overall Study|Death|2|||
146000480|NCT03036852|526518672|FG000|Overall Study|Lack of Efficacy|2|||
146000481|NCT03036852|526518672|FG000|Overall Study|Adverse Event|1|||
146000482|NCT03036852|526518672|FG000|Overall Study|Lost to Follow-up|1|||
146000483|NCT01541371|526518679|FG000|Overall Study|Withdrawal by Subject|14|||
146000484|NCT01541371|526518679|FG000|Overall Study|Lost to Follow-up|21|||
146000485|NCT01541371|526518679|FG000|Overall Study|Adverse Event|15|||
146000486|NCT01541371|526518679|FG000|Overall Study|Lack of Efficacy|12|||
146000487|NCT01541371|526518679|FG000|Overall Study|Protocol Violation|6|||
146000488|NCT01541371|526518679|FG000|Overall Study|Study medication non-compliance|3|||
146000489|NCT01541371|526518679|FG000|Overall Study|Other|6|||
146000490|NCT02441218|526518680|FG000|Overall Study|Death|503|||
146000491|NCT02441218|526518681|FG001|Overall Study|Death|553|||
146000492|NCT02441218|526518680|FG000|Overall Study|Withdrawal by Subject|73|||
146000493|NCT02441218|526518681|FG001|Overall Study|Withdrawal by Subject|58|||
146000494|NCT02441218|526518680|FG000|Overall Study|Lost to Follow-up|2|||
146000495|NCT02441218|526518681|FG001|Overall Study|Lost to Follow-up|1|||
146000496|NCT00163189|526518684|FG000|Overall Study|Other|6|||
146000497|NCT00163189|526518684|FG000|Overall Study|Lost to Follow-up|1|||
146000498|NCT00163189|526518684|FG000|Overall Study|Protocol Violation|2|||
146000499|NCT00163189|526518684|FG000|Overall Study|Death|3|||
146000500|NCT00163189|526518684|FG000|Overall Study|Adverse Event|6|||
146000501|NCT00163189|526518684|FG000|Overall Study|Lack of Efficacy|7|||
146000502|NCT00163189|526518684|FG000|Overall Study|Study terminated by sponsor|11|||
146000503|NCT00163189|526518684|FG000|Overall Study|Withdrawal by Subject|11|||
146000504|NCT00163189|526518684|FG000|Overall Study|Did not meet continuation criterion|16|||
146000505|NCT02154061|526518685|FG000|Overall Study|Pregnancy|1|||
146000506|NCT02154061|526518686|FG001|Overall Study|Pregnancy|0|||
146000507|NCT02154061|526518685|FG000|Overall Study|enrolled but not vaccinated|1|||
146000508|NCT02154061|526518686|FG001|Overall Study|enrolled but not vaccinated|0|||
146000509|NCT03435380|526518687|FG000|Overall Study|Death|1|||
146000510|NCT03435380|526518688|FG001|Overall Study|Death|2|||
146000511|NCT03435380|526518689|FG002|Overall Study|Death|1|||
146000512|NCT03435380|526518687|FG000|Overall Study|Lost to Follow-up|12|||
146000513|NCT03435380|526518688|FG001|Overall Study|Lost to Follow-up|8|||
146000514|NCT03435380|526518689|FG002|Overall Study|Lost to Follow-up|6|||
146000515|NCT03435380|526518687|FG000|Overall Study|Physician Decision|1|||
146000516|NCT03435380|526518688|FG001|Overall Study|Physician Decision|0|||
146000517|NCT03435380|526518689|FG002|Overall Study|Physician Decision|0|||
146000518|NCT03435380|526518687|FG000|Overall Study|Withdrawal by Subject|0|||
146000519|NCT03435380|526518688|FG001|Overall Study|Withdrawal by Subject|1|||
146000520|NCT03435380|526518689|FG002|Overall Study|Withdrawal by Subject|1|||
146000521|NCT03435380|526518687|FG000|Overall Study|Ineligible|0|||
146000522|NCT03435380|526518688|FG001|Overall Study|Ineligible|1|||
146000523|NCT03435380|526518689|FG002|Overall Study|Ineligible|1|||
146000524|NCT01936831|526518690|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000525|NCT01936831|526518691|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000526|NCT01936831|526518692|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000527|NCT01936831|526518693|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000528|NCT01936831|526518694|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000529|NCT01936831|526518695|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
146000530|NCT01936831|526518696|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000531|NCT01936831|526518697|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000532|NCT01936831|526518698|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
146000533|NCT02431325|526518699|FG000|Overall Study|Adverse Event|3|||
146000534|NCT02431325|526518700|FG001|Overall Study|Adverse Event|0|||
146000535|NCT02431325|526518699|FG000|Overall Study|Lost to Follow-up|0|||
146000536|NCT02431325|526518700|FG001|Overall Study|Lost to Follow-up|1|||
146247338|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
146247339|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
146247340|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
146000537|NCT02431325|526518699|FG000|Overall Study|Withdrawal by Subject|1|||
146247341|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
146247342|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146247343|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146000538|NCT02431325|526518700|FG001|Overall Study|Withdrawal by Subject|2|||
146000539|NCT02431325|526518699|FG000|Overall Study|Declined to take study medication|1|||
146000540|NCT02431325|526518700|FG001|Overall Study|Declined to take study medication|0|||
146000541|NCT02431325|526518699|FG000|Overall Study|Withdrew before starting study medication|1|||
146298075|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
146000542|NCT02431325|526518700|FG001|Overall Study|Withdrew before starting study medication|0|||
146000543|NCT02431325|526518699|FG000|Overall Study|Placebo shortage|2|||
146000544|NCT02431325|526518700|FG001|Overall Study|Placebo shortage|0|||
146000545|NCT01534481|526518704|FG000|Overall Study|Lost to Follow-up|29|||
146000546|NCT01534481|526518705|FG001|Overall Study|Lost to Follow-up|24|||
146000547|NCT01534481|526518704|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
146000548|NCT01534481|526518705|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
146000549|NCT01130337|526518706|FG000|Overall Study|Withdrawal by Subject|3|||
146000550|NCT01130337|526518706|FG000|Overall Study|Principal investigator decision|1|||
146000551|NCT01130337|526518706|FG000|Overall Study|Death|1|||
146000552|NCT01130337|526518706|FG000|Overall Study|Disease progression|1|||
146000553|NCT01130337|526518706|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
146000554|NCT01130337|526518706|FG000|Overall Study|Surgical resection (R2)|1|||
146000555|NCT05525910|526518707|FG000|Period 4|Per sponsor due to study timelines|0|||
146000556|NCT05525910|526518708|FG001|Period 4|Per sponsor due to study timelines|0|||
146000557|NCT05525910|526518709|FG002|Period 4|Per sponsor due to study timelines|1|||
146000558|NCT05525910|526518710|FG003|Period 4|Per sponsor due to study timelines|1|||
146000559|NCT05525910|526518711|FG004|Period 4|Per sponsor due to study timelines|1|||
146000560|NCT03886493|526518712|FG000|Overall Study|Adverse Event|1|||
146000561|NCT00181844|526518714|FG000|Signed Consent|Withdrawal by Subject|5|||
146000562|NCT00181844|526518714|FG000|Signed Consent|Did not meet entrance criteria|7|||
146000563|NCT00181844|526518714|FG000|Exposed to Study Medication|Adverse Event|10|||
146000564|NCT00181844|526518714|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
146000565|NCT00181844|526518714|FG000|Exposed to Study Medication|Non-compliance|2|||
146000566|NCT00181844|526518714|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
146000567|NCT00181844|526518714|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
146000568|NCT01987557|526518724|FG000|Overall Study|Protocol Violation|1|||
146000569|NCT01987557|526518725|FG001|Overall Study|Protocol Violation|0|||
146000570|NCT01987557|526518726|FG002|Overall Study|Protocol Violation|1|||
146000571|NCT01987557|526518724|FG000|Overall Study|Withdrawal by Subject|2|||
146000572|NCT01987557|526518725|FG001|Overall Study|Withdrawal by Subject|1|||
146000573|NCT01987557|526518726|FG002|Overall Study|Withdrawal by Subject|2|||
146000574|NCT01987557|526518724|FG000|Overall Study|Adverse Event|0|||
146000575|NCT01987557|526518725|FG001|Overall Study|Adverse Event|2|||
146000576|NCT01987557|526518726|FG002|Overall Study|Adverse Event|0|||
146000577|NCT01880957|526518727|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
146000578|NCT01880957|526518728|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
146000579|NCT01880957|526518727|FG000|Overall Study|Lost to Follow-up|11|||
146000580|NCT01880957|526518728|FG001|Overall Study|Lost to Follow-up|0|||
146000581|NCT01880957|526518727|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
146000582|NCT01880957|526518728|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
146000583|NCT01854528|526518729|FG000|Overall Study|Adverse Event|0|||
146000584|NCT01854528|526518730|FG001|Overall Study|Adverse Event|4|||
146000585|NCT01854528|526518729|FG000|Overall Study|Withdrawal by Subject|0|||
146000586|NCT01854528|526518730|FG001|Overall Study|Withdrawal by Subject|2|||
146000587|NCT01854528|526518729|FG000|Overall Study|Virologic Failure|0|||
146000588|NCT01854528|526518730|FG001|Overall Study|Virologic Failure|9|||
146000589|NCT00518180|526518731|FG000|Overall Study|Withdrawal by Subject|29|||
146000590|NCT00518180|526518732|FG001|Overall Study|Withdrawal by Subject|30|||
146000591|NCT00518180|526518733|FG002|Overall Study|Withdrawal by Subject|42|||
146000592|NCT00518180|526518731|FG000|Overall Study|Lost to Follow-up|30|||
146000593|NCT00518180|526518732|FG001|Overall Study|Lost to Follow-up|28|||
146000594|NCT00518180|526518733|FG002|Overall Study|Lost to Follow-up|34|||
146000595|NCT00518180|526518731|FG000|Overall Study|Administrative reason|0|||
146000596|NCT00518180|526518732|FG001|Overall Study|Administrative reason|2|||
146000597|NCT00518180|526518733|FG002|Overall Study|Administrative reason|2|||
146000598|NCT00518180|526518731|FG000|Overall Study|Protocol Violation|5|||
146000599|NCT00518180|526518732|FG001|Overall Study|Protocol Violation|7|||
146000600|NCT00518180|526518733|FG002|Overall Study|Protocol Violation|4|||
146000601|NCT00518180|526518731|FG000|Overall Study|Unable to classify|0|||
146000602|NCT00518180|526518732|FG001|Overall Study|Unable to classify|2|||
146000603|NCT00518180|526518733|FG002|Overall Study|Unable to classify|0|||
146000604|NCT00518180|526518731|FG000|Overall Study|Adverse Event|1|||
146000605|NCT00518180|526518732|FG001|Overall Study|Adverse Event|0|||
146000606|NCT00518180|526518733|FG002|Overall Study|Adverse Event|0|||
146000607|NCT02951780|526518734|FG000|Period 1|Adverse Event|0|||
146000608|NCT02951780|526518735|FG001|Period 1|Adverse Event|0|||
146000609|NCT02951780|526518736|FG002|Period 1|Adverse Event|0|||
146000610|NCT02951780|526518737|FG003|Period 1|Adverse Event|1|||
146000611|NCT02951780|526518738|FG004|Period 1|Adverse Event|0|||
146000612|NCT02951780|526518739|FG005|Period 1|Adverse Event|0|||
146000613|NCT02951780|526518740|FG006|Period 1|Adverse Event|0|||
146000614|NCT02951780|526518741|FG007|Period 1|Adverse Event|0|||
146000615|NCT02951780|526518742|FG008|Period 1|Adverse Event|0|||
146000616|NCT02951780|526518734|FG000|Period 1|Scheduling Conflicts|0|||
146000617|NCT02951780|526518735|FG001|Period 1|Scheduling Conflicts|0|||
146000618|NCT02951780|526518736|FG002|Period 1|Scheduling Conflicts|0|||
146000619|NCT02951780|526518737|FG003|Period 1|Scheduling Conflicts|0|||
146000620|NCT02951780|526518738|FG004|Period 1|Scheduling Conflicts|0|||
146000621|NCT02951780|526518739|FG005|Period 1|Scheduling Conflicts|0|||
146000622|NCT02951780|526518740|FG006|Period 1|Scheduling Conflicts|0|||
146000623|NCT02951780|526518741|FG007|Period 1|Scheduling Conflicts|1|||
146000624|NCT02951780|526518742|FG008|Period 1|Scheduling Conflicts|0|||
146000625|NCT02951780|526518734|FG000|Period 2|Scheduling Conflicts|0|||
146000626|NCT02951780|526518735|FG001|Period 2|Scheduling Conflicts|0|||
146000627|NCT02951780|526518736|FG002|Period 2|Scheduling Conflicts|0|||
146000628|NCT02951780|526518737|FG003|Period 2|Scheduling Conflicts|0|||
146000629|NCT02951780|526518738|FG004|Period 2|Scheduling Conflicts|0|||
146000630|NCT02951780|526518739|FG005|Period 2|Scheduling Conflicts|0|||
146000631|NCT02951780|526518740|FG006|Period 2|Scheduling Conflicts|0|||
146000632|NCT02951780|526518741|FG007|Period 2|Scheduling Conflicts|1|||
146000633|NCT02951780|526518742|FG008|Period 2|Scheduling Conflicts|0|||
146000634|NCT02289469|526518745|FG000|Overall Study|Unable to match a control|6|||
146000635|NCT02289469|526518746|FG001|Overall Study|Unable to match a control|0|||
146000636|NCT03508050|526518747|FG000|Overall Study|Pleural adhesions|1|||
146000637|NCT03508050|526518748|FG001|Overall Study|Pleural adhesions|0|||
146000638|NCT03508050|526518747|FG000|Overall Study|Mucus plug|1|||
146000639|NCT03508050|526518748|FG001|Overall Study|Mucus plug|0|||
146000640|NCT03508050|526518747|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
146000641|NCT03508050|526518748|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
146000642|NCT03508050|526518747|FG000|Overall Study|Sustained desaturation|0|||
146000643|NCT03508050|526518748|FG001|Overall Study|Sustained desaturation|1|||
146000644|NCT01082614|526518749|FG000|Overall Study|Adverse Event|1|||
146000645|NCT01082614|526518750|FG001|Overall Study|Adverse Event|4|||
146000646|NCT01082614|526518749|FG000|Overall Study|Equipment Malfunction|0|||
146000647|NCT01082614|526518750|FG001|Overall Study|Equipment Malfunction|1|||
146000648|NCT01082614|526518749|FG000|Overall Study|Physician Decision|2|||
146000649|NCT01082614|526518750|FG001|Overall Study|Physician Decision|0|||
146000650|NCT03710889|526518755|FG000|Overall Study|Adverse Event|2|||
146000651|NCT03710889|526518755|FG000|Overall Study|Protocol Deviation|1|||
146000652|NCT04881760|526518756|FG000|Overall Study|Adverse Event|0|||
146000653|NCT04881760|526518757|FG001|Overall Study|Adverse Event|1|||
146000654|NCT04881760|526518758|FG002|Overall Study|Adverse Event|1|||
146000655|NCT04881760|526518759|FG003|Overall Study|Adverse Event|0|||
146000656|NCT04881760|526518760|FG004|Overall Study|Adverse Event|1|||
146000657|NCT04881760|526518761|FG005|Overall Study|Adverse Event|1|||
146000658|NCT04881760|526518762|FG006|Overall Study|Adverse Event|2|||
146000659|NCT04881760|526518756|FG000|Overall Study|Death|0|||
146000660|NCT04881760|526518757|FG001|Overall Study|Death|0|||
146000661|NCT04881760|526518758|FG002|Overall Study|Death|0|||
146000662|NCT04881760|526518759|FG003|Overall Study|Death|1|||
146000663|NCT04881760|526518760|FG004|Overall Study|Death|0|||
146000664|NCT04881760|526518761|FG005|Overall Study|Death|0|||
146000665|NCT04881760|526518762|FG006|Overall Study|Death|0|||
146000666|NCT04881760|526518756|FG000|Overall Study|Lost to Follow-up|5|||
146000667|NCT04881760|526518757|FG001|Overall Study|Lost to Follow-up|7|||
146000668|NCT04881760|526518758|FG002|Overall Study|Lost to Follow-up|5|||
146000669|NCT04881760|526518759|FG003|Overall Study|Lost to Follow-up|1|||
146000670|NCT04881760|526518760|FG004|Overall Study|Lost to Follow-up|2|||
146000671|NCT04881760|526518761|FG005|Overall Study|Lost to Follow-up|4|||
146000672|NCT04881760|526518762|FG006|Overall Study|Lost to Follow-up|4|||
146000673|NCT04881760|526518756|FG000|Overall Study|Withdrawal by Subject|13|||
146000674|NCT04881760|526518757|FG001|Overall Study|Withdrawal by Subject|1|||
146000675|NCT04881760|526518758|FG002|Overall Study|Withdrawal by Subject|1|||
146000676|NCT04881760|526518759|FG003|Overall Study|Withdrawal by Subject|4|||
146000677|NCT04881760|526518760|FG004|Overall Study|Withdrawal by Subject|2|||
146000678|NCT04881760|526518761|FG005|Overall Study|Withdrawal by Subject|1|||
146000679|NCT04881760|526518762|FG006|Overall Study|Withdrawal by Subject|2|||
146000680|NCT04881760|526518756|FG000|Overall Study|Randomized but Never Treated|0|||
146000681|NCT04881760|526518757|FG001|Overall Study|Randomized but Never Treated|0|||
146000682|NCT04881760|526518758|FG002|Overall Study|Randomized but Never Treated|0|||
146000683|NCT04881760|526518759|FG003|Overall Study|Randomized but Never Treated|1|||
146000684|NCT04881760|526518760|FG004|Overall Study|Randomized but Never Treated|0|||
146000685|NCT04881760|526518761|FG005|Overall Study|Randomized but Never Treated|0|||
146000686|NCT04881760|526518762|FG006|Overall Study|Randomized but Never Treated|0|||
146000687|NCT04881760|526518756|FG000|Overall Study|Inadvertent Enrollment|2|||
146000688|NCT04881760|526518757|FG001|Overall Study|Inadvertent Enrollment|0|||
146000689|NCT04881760|526518758|FG002|Overall Study|Inadvertent Enrollment|0|||
146000690|NCT04881760|526518759|FG003|Overall Study|Inadvertent Enrollment|0|||
146000691|NCT04881760|526518760|FG004|Overall Study|Inadvertent Enrollment|0|||
146000692|NCT04881760|526518761|FG005|Overall Study|Inadvertent Enrollment|0|||
146000693|NCT04881760|526518762|FG006|Overall Study|Inadvertent Enrollment|0|||
146000694|NCT04881760|526518756|FG000|Overall Study|Site Closure|0|||
146000695|NCT04881760|526518757|FG001|Overall Study|Site Closure|0|||
146000696|NCT04881760|526518758|FG002|Overall Study|Site Closure|0|||
146000697|NCT04881760|526518759|FG003|Overall Study|Site Closure|1|||
146000698|NCT04881760|526518760|FG004|Overall Study|Site Closure|0|||
146000699|NCT04881760|526518761|FG005|Overall Study|Site Closure|0|||
146000700|NCT04881760|526518762|FG006|Overall Study|Site Closure|0|||
146000701|NCT01538199|526518763|FG000|Overall Study|Lost to Follow-up|1|||
146000702|NCT01538199|526518764|FG001|Overall Study|Lost to Follow-up|2|||
146000703|NCT01538199|526518765|FG002|Overall Study|Lost to Follow-up|1|||
146000704|NCT01538199|526518766|FG003|Overall Study|Lost to Follow-up|0|||
146000705|NCT01538199|526518763|FG000|Overall Study|participant did not have time|1|||
146000706|NCT01538199|526518764|FG001|Overall Study|participant did not have time|0|||
146000707|NCT01538199|526518765|FG002|Overall Study|participant did not have time|0|||
146000708|NCT01538199|526518766|FG003|Overall Study|participant did not have time|2|||
146000709|NCT01538199|526518763|FG000|Overall Study|Lack of Efficacy|0|||
146000710|NCT01538199|526518764|FG001|Overall Study|Lack of Efficacy|1|||
146000711|NCT01538199|526518765|FG002|Overall Study|Lack of Efficacy|0|||
146000712|NCT01538199|526518766|FG003|Overall Study|Lack of Efficacy|0|||
146000713|NCT02081586|526518767|FG000|Overall Study|Lost to Follow-up|0|||
146000714|NCT02081586|526518768|FG001|Overall Study|Lost to Follow-up|1|||
146000715|NCT02081586|526518769|FG002|Overall Study|Lost to Follow-up|0|||
146000716|NCT02081586|526518770|FG003|Overall Study|Lost to Follow-up|1|||
146000717|NCT02081586|526518767|FG000|Overall Study|Head injury not related to study|0|||
146000718|NCT02081586|526518768|FG001|Overall Study|Head injury not related to study|0|||
146000719|NCT02081586|526518769|FG002|Overall Study|Head injury not related to study|1|||
146000720|NCT02081586|526518770|FG003|Overall Study|Head injury not related to study|0|||
146000721|NCT01492426|526520168|FG000|Treatment|Death|0|||
146000722|NCT01492426|526520169|FG001|Treatment|Death|1|||
146000723|NCT01492426|526520168|FG000|Treatment|Other|1|||
146000724|NCT01492426|526520169|FG001|Treatment|Other|0|||
146000725|NCT01492426|526520168|FG000|Treatment|Adverse Event|25|||
146000726|NCT01492426|526520169|FG001|Treatment|Adverse Event|25|||
146000727|NCT01492426|526520168|FG000|Treatment|Lack of Efficacy|38|||
146000728|NCT01492426|526520169|FG001|Treatment|Lack of Efficacy|5|||
146000729|NCT01492426|526520168|FG000|Treatment|Participant withdrew consent|1|||
146000730|NCT01492426|526520169|FG001|Treatment|Participant withdrew consent|2|||
146000731|NCT01492426|526520168|FG000|Treatment|Poor compliance/noncompliance|1|||
146000732|NCT01492426|526520169|FG001|Treatment|Poor compliance/noncompliance|0|||
146000733|NCT01492426|526520168|FG000|Treatment|Subject requested discontinue study drug|7|||
146000734|NCT01492426|526520169|FG001|Treatment|Subject requested discontinue study drug|3|||
146000735|NCT01492426|526520168|FG000|Treatment|Lost to Follow-up|9|||
146000736|NCT01492426|526520169|FG001|Treatment|Lost to Follow-up|4|||
146000737|NCT01492426|526520168|FG000|Treatment|Participant does not meet study criteria|1|||
146000738|NCT01492426|526520169|FG001|Treatment|Participant does not meet study criteria|0|||
146000739|NCT01492426|526520168|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
146000740|NCT01492426|526520169|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
146000741|NCT01492426|526520168|FG000|Follow-Up|Death|1|||
146000742|NCT01492426|526520169|FG001|Follow-Up|Death|0|||
146000743|NCT01492426|526520168|FG000|Follow-Up|Other|4|||
146000744|NCT01492426|526520169|FG001|Follow-Up|Other|2|||
146000745|NCT01492426|526520168|FG000|Follow-Up|Participant Withdrew Consent|6|||
146000746|NCT01492426|526520169|FG001|Follow-Up|Participant Withdrew Consent|1|||
146000747|NCT01492426|526520168|FG000|Follow-Up|Lost to Follow-up|12|||
146000748|NCT01492426|526520169|FG001|Follow-Up|Lost to Follow-up|6|||
146000749|NCT03549338|526520170|FG000|Overall Study|Progressive Disease|1|||
146000750|NCT03549338|526520171|FG001|Overall Study|Progressive Disease|0|||
146000751|NCT03549338|526520172|FG002|Overall Study|Progressive Disease|0|||
146000752|NCT03549338|526520170|FG000|Overall Study|Clinical Progression|0|||
146000753|NCT03549338|526520171|FG001|Overall Study|Clinical Progression|1|||
146000754|NCT03549338|526520172|FG002|Overall Study|Clinical Progression|0|||
146000755|NCT01173679|526520173|FG000|Overall Study|Death|1|||
146000756|NCT02026011|526520174|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
146000757|NCT02026011|526520175|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
146000758|NCT02026011|526520174|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
146000759|NCT02026011|526520175|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
146000760|NCT02026011|526520174|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
146000761|NCT02026011|526520175|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
146000762|NCT02026011|526520174|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
146000763|NCT02026011|526520175|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
146000764|NCT05010070|526520176|FG000|Overall Study|Lost to Follow-up|1|||
146000765|NCT05010070|526520176|FG000|Overall Study|Withdrawal by Subject|1|||
146000766|NCT00939107|526520177|FG000|Overall Study|Lost to Follow-up|14|||
146000767|NCT00939107|526520178|FG001|Overall Study|Lost to Follow-up|12|||
146000768|NCT00529243|526520179|FG000|Overall Study|Adverse Event|1|||
146000769|NCT00529243|526520179|FG000|Overall Study|Death|1|||
146000770|NCT00529243|526520179|FG000|Overall Study|Relocated|1|||
146000771|NCT00105534|526520182|FG000|Overall Study|Adverse Event|2|||
146000772|NCT00105534|526520183|FG001|Overall Study|Adverse Event|5|||
146000773|NCT00105534|526520182|FG000|Overall Study|Protocol Violation|1|||
146000774|NCT00105534|526520183|FG001|Overall Study|Protocol Violation|4|||
146000775|NCT00105534|526520182|FG000|Overall Study|Withdrawal by Subject|6|||
146000776|NCT00105534|526520183|FG001|Overall Study|Withdrawal by Subject|6|||
146000777|NCT00105534|526520182|FG000|Overall Study|Lost to Follow-up|5|||
146000778|NCT00105534|526520183|FG001|Overall Study|Lost to Follow-up|1|||
146000779|NCT00105534|526520182|FG000|Overall Study|Lack of Efficacy|7|||
146000780|NCT00105534|526520183|FG001|Overall Study|Lack of Efficacy|15|||
146247344|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
146247345|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
146000781|NCT00105534|526520182|FG000|Overall Study|Treatment unmasked|1|||
146000782|NCT00105534|526520183|FG001|Overall Study|Treatment unmasked|0|||
146000783|NCT00105534|526520182|FG000|Overall Study|Other Reason|0|||
146000784|NCT00105534|526520183|FG001|Overall Study|Other Reason|2|||
146000785|NCT02935192|526520184|FG000|Overall Study|Withdrawal by Subject|8|||
146000786|NCT02935192|526520185|FG001|Overall Study|Withdrawal by Subject|4|||
146000787|NCT02465931|526520186|FG000|Overall Study|Lost to Follow-up|9|||
146000788|NCT02465931|526520187|FG001|Overall Study|Lost to Follow-up|11|||
146000789|NCT02465931|526520186|FG000|Overall Study|Protocol Violation|1|||
146000790|NCT02465931|526520187|FG001|Overall Study|Protocol Violation|0|||
146000791|NCT02465931|526520186|FG000|Overall Study|Withdrawal by Subject|1|||
146000792|NCT02465931|526520187|FG001|Overall Study|Withdrawal by Subject|0|||
146000793|NCT03423602|526520188|FG000|Overall Study|Death|1|||
146000794|NCT03423602|526520188|FG000|Overall Study|Lost to Follow-up|6|||
146000795|NCT03423602|526520188|FG000|Overall Study|Protocol Violation|1|||
146000796|NCT03423602|526520188|FG000|Overall Study|Withdrawal by Subject|4|||
146000797|NCT01126190|526520189|FG000|Double-Blind Phase|Death|0|||
146000798|NCT01126190|526520190|FG001|Double-Blind Phase|Death|1|||
146000799|NCT01126190|526520191|FG002|Double-Blind Phase|Death|0|||
146000800|NCT01126190|526520189|FG000|Double-Blind Phase|Adverse Event|1|||
146000801|NCT01126190|526520190|FG001|Double-Blind Phase|Adverse Event|2|||
146000802|NCT01126190|526520191|FG002|Double-Blind Phase|Adverse Event|0|||
146000803|NCT01126190|526520189|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146000804|NCT01126190|526520190|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
146000805|NCT01126190|526520191|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146000806|NCT01126190|526520189|FG000|Double-Blind Phase|Request of Investigator|1|||
146000807|NCT01126190|526520190|FG001|Double-Blind Phase|Request of Investigator|0|||
146000808|NCT01126190|526520191|FG002|Double-Blind Phase|Request of Investigator|0|||
146000809|NCT01126190|526520189|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
146000810|NCT01126190|526520190|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
146000811|NCT01126190|526520191|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
146000812|NCT01126190|526520189|FG000|Double-Blind Phase|Non-compliance|1|||
146000813|NCT01126190|526520190|FG001|Double-Blind Phase|Non-compliance|0|||
146000814|NCT01126190|526520191|FG002|Double-Blind Phase|Non-compliance|0|||
146000815|NCT01126190|526520189|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146000816|NCT01126190|526520190|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146000817|NCT01126190|526520191|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146000818|NCT01126190|526520189|FG000|Open-Label Phase|Death|0|||
146000819|NCT01126190|526520190|FG001|Open-Label Phase|Death|0|||
146000820|NCT01126190|526520191|FG002|Open-Label Phase|Death|1|||
146000821|NCT01126190|526520189|FG000|Open-Label Phase|Adverse Event|0|||
146000822|NCT01126190|526520190|FG001|Open-Label Phase|Adverse Event|0|||
146000823|NCT01126190|526520191|FG002|Open-Label Phase|Adverse Event|4|||
146000824|NCT01126190|526520189|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146000825|NCT01126190|526520190|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146000826|NCT01126190|526520191|FG002|Open-Label Phase|Withdrawal by Subject|6|||
146092354|NCT00117286|526860274|FG001|Overall Study|Lack of Efficacy|1|||
146247346|NCT01494467|527419815|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
146247347|NCT01494467|527419816|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
146247348|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
146247349|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
146247350|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
146247351|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
146247352|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
146247353|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
146247354|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
146092355|NCT00117286|526860273|FG000|Overall Study|Research site closing|0|||
146092356|NCT00117286|526860274|FG001|Overall Study|Research site closing|2|||
146092357|NCT01272661|526860275|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
146092358|NCT01272661|526860276|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
146092359|NCT01272661|526860277|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
146092360|NCT01367119|526860278|FG000|Overall Study|Adverse Event|1|||
146092361|NCT01367119|526860279|FG001|Overall Study|Adverse Event|0|||
146092362|NCT01367119|526860278|FG000|Overall Study|Withdrawal by Subject|1|||
146000827|NCT01114737|526520192|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
146000828|NCT01114737|526520193|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
146000829|NCT01114737|526520192|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
146000830|NCT01114737|526520193|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
146000831|NCT01114737|526520192|FG000|Randomized Treatment Period|Pregnancy|1|||
146000832|NCT01114737|526520193|FG001|Randomized Treatment Period|Pregnancy|0|||
146000833|NCT01114737|526520192|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
146000834|NCT01114737|526520193|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
146000835|NCT01114737|526520192|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
146000836|NCT01114737|526520193|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146000837|NCT01114737|526520192|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
146000838|NCT01114737|526520193|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
146000839|NCT02660229|526520197|FG000|Overall Study|Adverse Event|2|||
146000840|NCT02660229|526520198|FG001|Overall Study|Adverse Event|0|||
146000841|NCT02660229|526520197|FG000|Overall Study|Withdrawal by Subject|0|||
146000842|NCT02660229|526520198|FG001|Overall Study|Withdrawal by Subject|1|||
146000843|NCT01466491|526520199|FG000|Overall Study|Protocol Violation|0|||
146000844|NCT01466491|526520200|FG001|Overall Study|Protocol Violation|3|||
146000845|NCT01466491|526520201|FG002|Overall Study|Protocol Violation|2|||
146000846|NCT01466491|526520202|FG003|Overall Study|Protocol Violation|0|||
146000847|NCT01466491|526520199|FG000|Overall Study|Missing Data|0|||
146000848|NCT01466491|526520200|FG001|Overall Study|Missing Data|0|||
146000849|NCT01466491|526520201|FG002|Overall Study|Missing Data|1|||
146000850|NCT01466491|526520202|FG003|Overall Study|Missing Data|0|||
146000851|NCT02727322|526520203|FG000|Overall Study|Withdrawal by Subject|1|||
146000852|NCT02727322|526520204|FG001|Overall Study|Withdrawal by Subject|1|||
146000853|NCT02727322|526520203|FG000|Overall Study|Protocol Violation|1|||
146000854|NCT02727322|526520204|FG001|Overall Study|Protocol Violation|0|||
146000855|NCT02852967|526520205|FG000|Overall Study|Adverse Event|3|||
146000856|NCT02852967|526520206|FG001|Overall Study|Adverse Event|1|||
146000857|NCT02852967|526520207|FG002|Overall Study|Adverse Event|0|||
146000858|NCT02852967|526520208|FG003|Overall Study|Adverse Event|1|||
146000859|NCT02852967|526520209|FG004|Overall Study|Adverse Event|0|||
146000860|NCT02852967|526520205|FG000|Overall Study|Death|1|||
146000861|NCT02852967|526520206|FG001|Overall Study|Death|0|||
146000862|NCT02852967|526520207|FG002|Overall Study|Death|0|||
146000863|NCT02852967|526520208|FG003|Overall Study|Death|0|||
146000864|NCT02852967|526520209|FG004|Overall Study|Death|0|||
146000865|NCT02852967|526520205|FG000|Overall Study|Lost to Follow-up|1|||
146000866|NCT02852967|526520206|FG001|Overall Study|Lost to Follow-up|2|||
146000867|NCT02852967|526520207|FG002|Overall Study|Lost to Follow-up|3|||
146000868|NCT02852967|526520208|FG003|Overall Study|Lost to Follow-up|4|||
146000869|NCT02852967|526520209|FG004|Overall Study|Lost to Follow-up|4|||
146000870|NCT02852967|526520205|FG000|Overall Study|Withdrawal by Subject|6|||
146000871|NCT02852967|526520206|FG001|Overall Study|Withdrawal by Subject|12|||
146000872|NCT02852967|526520207|FG002|Overall Study|Withdrawal by Subject|7|||
146000873|NCT02852967|526520208|FG003|Overall Study|Withdrawal by Subject|10|||
146000874|NCT02852967|526520209|FG004|Overall Study|Withdrawal by Subject|10|||
146000875|NCT02852967|526520205|FG000|Overall Study|SAE|0|||
146000876|NCT02852967|526520206|FG001|Overall Study|SAE|0|||
146000877|NCT02852967|526520207|FG002|Overall Study|SAE|0|||
146000878|NCT02852967|526520208|FG003|Overall Study|SAE|3|||
146000879|NCT02852967|526520209|FG004|Overall Study|SAE|0|||
146000880|NCT02852967|526520205|FG000|Overall Study|Elevated Liver Enzymes|2|||
146000881|NCT02852967|526520206|FG001|Overall Study|Elevated Liver Enzymes|0|||
146298076|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
146298077|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
146298078|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
146298079|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
146298080|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
146298081|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
146000882|NCT02852967|526520207|FG002|Overall Study|Elevated Liver Enzymes|0|||
146000883|NCT02852967|526520208|FG003|Overall Study|Elevated Liver Enzymes|2|||
146000884|NCT02852967|526520209|FG004|Overall Study|Elevated Liver Enzymes|2|||
146000885|NCT02852967|526520205|FG000|Overall Study|Physician Decision|0|||
146000886|NCT02852967|526520206|FG001|Overall Study|Physician Decision|0|||
146000887|NCT02852967|526520207|FG002|Overall Study|Physician Decision|0|||
146000888|NCT02852967|526520208|FG003|Overall Study|Physician Decision|1|||
146000889|NCT02852967|526520209|FG004|Overall Study|Physician Decision|0|||
146000890|NCT02852967|526520205|FG000|Overall Study|Lack of Efficacy|0|||
146000891|NCT02852967|526520206|FG001|Overall Study|Lack of Efficacy|1|||
146000892|NCT02852967|526520207|FG002|Overall Study|Lack of Efficacy|0|||
146000893|NCT02852967|526520208|FG003|Overall Study|Lack of Efficacy|0|||
146000894|NCT02852967|526520209|FG004|Overall Study|Lack of Efficacy|0|||
146000895|NCT02852967|526520205|FG000|Overall Study|Non-compliance|0|||
146000896|NCT02852967|526520206|FG001|Overall Study|Non-compliance|0|||
146000897|NCT02852967|526520207|FG002|Overall Study|Non-compliance|1|||
146092363|NCT01367119|526860279|FG001|Overall Study|Withdrawal by Subject|1|||
146092364|NCT03953183|526860280|FG000|Overall Study|Physician Decision|0|||
146000898|NCT02852967|526520208|FG003|Overall Study|Non-compliance|1|||
146000899|NCT02852967|526520209|FG004|Overall Study|Non-compliance|0|||
146000900|NCT02852967|526520205|FG000|Overall Study|Dispensing Drug Violation|0|||
146000901|NCT02852967|526520206|FG001|Overall Study|Dispensing Drug Violation|0|||
146247355|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
146247356|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
146000902|NCT02852967|526520207|FG002|Overall Study|Dispensing Drug Violation|1|||
146000903|NCT02852967|526520208|FG003|Overall Study|Dispensing Drug Violation|0|||
146000904|NCT02852967|526520209|FG004|Overall Study|Dispensing Drug Violation|0|||
146000905|NCT02852967|526520205|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
146000906|NCT02852967|526520206|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
146000907|NCT02852967|526520207|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
146000908|NCT02852967|526520208|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
146000909|NCT02852967|526520209|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
146000910|NCT01123148|526520210|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
146000911|NCT01123148|526520210|FG000|Overall Study|Didn't meet milestone criteria|1|||
146000912|NCT03046446|526520211|FG000|Overall Study|Lack of Efficacy|7|||
146000913|NCT03046446|526520211|FG000|Overall Study|Adverse Event|6|||
146000914|NCT03046446|526520211|FG000|Overall Study|Lost to Follow-up|3|||
146000915|NCT03046446|526520211|FG000|Overall Study|Withdrawal by Subject|14|||
146000916|NCT03046446|526520211|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
146000917|NCT03046446|526520211|FG000|Overall Study|Disease Progression (see caveats)|25|||
146000918|NCT03046446|526520211|FG000|Overall Study|Non OA related knee surgery|1|||
146000919|NCT02808897|526520212|FG000|Overall Study|Lost to Follow-up|9|||
146000920|NCT02808897|526520213|FG001|Overall Study|Lost to Follow-up|11|||
146000921|NCT01496287|526520214|FG000|Overall Study|Lost to Follow-up|1|||
146000922|NCT01496287|526520214|FG000|Overall Study|Incomplete anesthesia|5|||
146000923|NCT03012334|526520215|FG000|Period 1|Withdrawal by Subject|0|||
146000924|NCT03012334|526520216|FG001|Period 1|Withdrawal by Subject|0|||
146000925|NCT03012334|526520217|FG002|Period 1|Withdrawal by Subject|0|||
146000926|NCT03012334|526520218|FG003|Period 1|Withdrawal by Subject|0|||
146000927|NCT03012334|526520219|FG004|Period 1|Withdrawal by Subject|0|||
146000928|NCT03012334|526520220|FG005|Period 1|Withdrawal by Subject|0|||
146000929|NCT03012334|526520221|FG006|Period 1|Withdrawal by Subject|0|||
146000930|NCT03012334|526520222|FG007|Period 1|Withdrawal by Subject|0|||
146000931|NCT03012334|526520223|FG008|Period 1|Withdrawal by Subject|0|||
146000932|NCT03012334|526520224|FG009|Period 1|Withdrawal by Subject|1|||
146000933|NCT03012334|526520215|FG000|Period 2|Withdrawal by Subject|0|||
146000934|NCT03012334|526520216|FG001|Period 2|Withdrawal by Subject|1|||
146000935|NCT03012334|526520217|FG002|Period 2|Withdrawal by Subject|0|||
146000936|NCT03012334|526520218|FG003|Period 2|Withdrawal by Subject|0|||
146000937|NCT03012334|526520219|FG004|Period 2|Withdrawal by Subject|0|||
146000938|NCT03012334|526520220|FG005|Period 2|Withdrawal by Subject|0|||
146000939|NCT03012334|526520221|FG006|Period 2|Withdrawal by Subject|0|||
146000940|NCT03012334|526520222|FG007|Period 2|Withdrawal by Subject|0|||
146000941|NCT03012334|526520223|FG008|Period 2|Withdrawal by Subject|0|||
146000942|NCT03012334|526520224|FG009|Period 2|Withdrawal by Subject|0|||
146000943|NCT03012334|526520215|FG000|Period 2|Protocol Violation|0|||
146000944|NCT03012334|526520216|FG001|Period 2|Protocol Violation|0|||
146000945|NCT03012334|526520217|FG002|Period 2|Protocol Violation|1|||
146000946|NCT03012334|526520218|FG003|Period 2|Protocol Violation|0|||
146000947|NCT03012334|526520219|FG004|Period 2|Protocol Violation|0|||
146000948|NCT03012334|526520220|FG005|Period 2|Protocol Violation|0|||
146000949|NCT03012334|526520221|FG006|Period 2|Protocol Violation|0|||
146000950|NCT03012334|526520222|FG007|Period 2|Protocol Violation|1|||
146000951|NCT03012334|526520223|FG008|Period 2|Protocol Violation|0|||
146000952|NCT03012334|526520224|FG009|Period 2|Protocol Violation|0|||
146000953|NCT03012334|526520215|FG000|Period 4|Non-Compliance|0|||
146000954|NCT03012334|526520216|FG001|Period 4|Non-Compliance|0|||
146000955|NCT03012334|526520217|FG002|Period 4|Non-Compliance|0|||
146000956|NCT03012334|526520218|FG003|Period 4|Non-Compliance|0|||
146247357|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
146000957|NCT03012334|526520219|FG004|Period 4|Non-Compliance|0|||
146000958|NCT03012334|526520220|FG005|Period 4|Non-Compliance|0|||
146000959|NCT03012334|526520221|FG006|Period 4|Non-Compliance|1|||
146000960|NCT03012334|526520222|FG007|Period 4|Non-Compliance|0|||
146000961|NCT03012334|526520223|FG008|Period 4|Non-Compliance|0|||
146000962|NCT03012334|526520224|FG009|Period 4|Non-Compliance|0|||
146000963|NCT03012334|526520215|FG000|Period 4|Adverse Event|0|||
146000964|NCT03012334|526520216|FG001|Period 4|Adverse Event|0|||
146000965|NCT03012334|526520217|FG002|Period 4|Adverse Event|0|||
146000966|NCT03012334|526520218|FG003|Period 4|Adverse Event|0|||
146000967|NCT03012334|526520219|FG004|Period 4|Adverse Event|0|||
146000968|NCT03012334|526520220|FG005|Period 4|Adverse Event|0|||
146000969|NCT03012334|526520221|FG006|Period 4|Adverse Event|0|||
146247358|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
146000970|NCT03012334|526520222|FG007|Period 4|Adverse Event|0|||
146000971|NCT03012334|526520223|FG008|Period 4|Adverse Event|1|||
146000972|NCT03012334|526520224|FG009|Period 4|Adverse Event|0|||
146000973|NCT01823107|526520225|FG000|Overall Study|Withdrawal by Subject|1|||
146000974|NCT00256126|526520226|FG000|Overall Study|Adverse Event|1|||
146000975|NCT00256126|526520227|FG001|Overall Study|Adverse Event|0|||
146000976|NCT00256126|526520226|FG000|Overall Study|Other|1|||
146247359|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
146247360|NCT01494467|527419815|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
146247361|NCT01494467|527419816|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
146247362|NCT03386344|527419819|FG000|Overall Study|Adverse Event|6|||
146247363|NCT03386344|527419820|FG001|Overall Study|Adverse Event|3|||
146247364|NCT03386344|527419821|FG002|Overall Study|Adverse Event|1|||
146247365|NCT03386344|527419819|FG000|Overall Study|Poor Compliance to Protocol|0|||
146247366|NCT03386344|527419820|FG001|Overall Study|Poor Compliance to Protocol|1|||
146247367|NCT03386344|527419821|FG002|Overall Study|Poor Compliance to Protocol|0|||
146247368|NCT03386344|527419819|FG000|Overall Study|Study Terminated by Sponsor|101|||
146247369|NCT03386344|527419820|FG001|Overall Study|Study Terminated by Sponsor|102|||
146247370|NCT03386344|527419821|FG002|Overall Study|Study Terminated by Sponsor|106|||
146247371|NCT03386344|527419819|FG000|Overall Study|Lost to Follow-up|3|||
146247372|NCT03386344|527419820|FG001|Overall Study|Lost to Follow-up|2|||
146247373|NCT03386344|527419821|FG002|Overall Study|Lost to Follow-up|1|||
146247374|NCT03386344|527419819|FG000|Overall Study|At the Participant's own Request|7|||
146247375|NCT03386344|527419820|FG001|Overall Study|At the Participant's own Request|7|||
146000977|NCT00256126|526520227|FG001|Overall Study|Other|2|||
146000978|NCT00800735|526520228|FG000|Overall Study|Administrative/Other|2|||
146000979|NCT00800735|526520228|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146000980|NCT00800735|526520228|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
146000981|NCT00800735|526520228|FG000|Overall Study|Withdrew Consent|3|||
146000982|NCT02133573|526520234|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
146000983|NCT02133573|526520235|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
146000984|NCT02133573|526520234|FG000|Overall Study|Child Deaths|3|||
146000985|NCT02133573|526520235|FG001|Overall Study|Child Deaths|5|||
146000986|NCT02133573|526520234|FG000|Overall Study|Child Declined Follow Ups|2|||
146000987|NCT02133573|526520235|FG001|Overall Study|Child Declined Follow Ups|1|||
146000988|NCT02133573|526520234|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
146000989|NCT02133573|526520235|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
146000990|NCT00454116|526520237|FG000|Overall Study|Adverse Event|5|||
146000991|NCT00454116|526520238|FG001|Overall Study|Adverse Event|11|||
146000992|NCT00454116|526520239|FG002|Overall Study|Adverse Event|9|||
146000993|NCT00454116|526520237|FG000|Overall Study|Condition under investigation worsened|17|||
146000994|NCT00454116|526520238|FG001|Overall Study|Condition under investigation worsened|13|||
146000995|NCT00454116|526520239|FG002|Overall Study|Condition under investigation worsened|18|||
146000996|NCT00454116|526520237|FG000|Overall Study|Withdrawal by Subject|3|||
146000997|NCT00454116|526520238|FG001|Overall Study|Withdrawal by Subject|3|||
146000998|NCT00454116|526520239|FG002|Overall Study|Withdrawal by Subject|1|||
146000999|NCT00454116|526520237|FG000|Overall Study|Other|2|||
146001000|NCT00454116|526520238|FG001|Overall Study|Other|2|||
146001001|NCT00454116|526520239|FG002|Overall Study|Other|0|||
146001002|NCT01917318|526520242|FG000|First Treatment|Withdrawal by Subject|0|||
146001003|NCT01917318|526520243|FG001|First Treatment|Withdrawal by Subject|1|||
146001004|NCT01008618|526520244|FG000|Period 1 (Titration Period)|Physician Decision|2|||
146001005|NCT01008618|526520245|FG001|Period 1 (Titration Period)|Physician Decision|0|||
146001006|NCT01008618|526520246|FG002|Period 1 (Titration Period)|Physician Decision|0|||
146001007|NCT01008618|526520244|FG000|Period 1 (Titration Period)|Adverse Event|33|||
146001008|NCT01008618|526520245|FG001|Period 1 (Titration Period)|Adverse Event|0|||
146001009|NCT01008618|526520246|FG002|Period 1 (Titration Period)|Adverse Event|0|||
146001010|NCT01008618|526520244|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
146001011|NCT01008618|526520245|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146001012|NCT01008618|526520246|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146001013|NCT01008618|526520244|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
146001014|NCT01008618|526520245|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146001015|NCT01008618|526520246|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146001016|NCT01008618|526520244|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
146001017|NCT01008618|526520245|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
146001018|NCT01008618|526520246|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
146001019|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
146001020|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
146001021|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
146001022|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
146001023|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
146001024|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146001025|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
146001026|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
146001027|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
146001028|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146092365|NCT03953183|526860281|FG001|Overall Study|Physician Decision|1|||
146247376|NCT03386344|527419821|FG002|Overall Study|At the Participant's own Request|8|||
146247377|NCT03386344|527419819|FG000|Overall Study|Reason not Specified|0|||
146001029|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146001030|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
146001031|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146001032|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146001033|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
146001034|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
146001035|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
146001036|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
146001037|NCT01008618|526520244|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
146001038|NCT01008618|526520245|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
146001039|NCT01008618|526520246|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
146001040|NCT02581891|526520248|FG000|Overall Study|Adverse Event|4|||
146001041|NCT02581891|526520249|FG001|Overall Study|Adverse Event|6|||
146001042|NCT02581891|526520248|FG000|Overall Study|Death|3|||
146001043|NCT02581891|526520249|FG001|Overall Study|Death|4|||
146001044|NCT02581891|526520248|FG000|Overall Study|Lost to Follow-up|1|||
146001045|NCT02581891|526520249|FG001|Overall Study|Lost to Follow-up|2|||
146001046|NCT02581891|526520248|FG000|Overall Study|Physician Decision|0|||
146001047|NCT02581891|526520249|FG001|Overall Study|Physician Decision|1|||
146001048|NCT02581891|526520248|FG000|Overall Study|Withdrawal by Subject|4|||
146001049|NCT02581891|526520249|FG001|Overall Study|Withdrawal by Subject|5|||
146001050|NCT02581891|526520248|FG000|Overall Study|Other Reasons|3|||
146001051|NCT02581891|526520249|FG001|Overall Study|Other Reasons|1|||
146001052|NCT02581891|526520248|FG000|Overall Study|Discontinued during followup|1|||
146001053|NCT02581891|526520249|FG001|Overall Study|Discontinued during followup|0|||
146001054|NCT02927795|526520250|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
146001055|NCT02927795|526520250|FG000|Overall Study|Not Treated|4|||
146247378|NCT03386344|527419820|FG001|Overall Study|Reason not Specified|1|||
146247379|NCT03386344|527419821|FG002|Overall Study|Reason not Specified|0|||
146247380|NCT01280721|527419824|FG000|Overall Study|Adverse Event|4|||
146247381|NCT01280721|527419824|FG000|Overall Study|Physician Decision|3|||
146247382|NCT01280721|527419824|FG000|Overall Study|Withdrawal by Subject|6|||
146247383|NCT01280721|527419824|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
146247384|NCT01280721|527419824|FG000|Overall Study|No tolerability for the lowest dose|2|||
146247385|NCT01180400|527419825|FG000|Overall Study|Withdrawal by Subject|5|||
146247386|NCT01180400|527419826|FG001|Overall Study|Withdrawal by Subject|6|||
146247387|NCT01180400|527419825|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146247388|NCT01180400|527419826|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
146247389|NCT01180400|527419825|FG000|Overall Study|Adverse Event|12|||
146247390|NCT01180400|527419826|FG001|Overall Study|Adverse Event|10|||
146247391|NCT01180400|527419825|FG000|Overall Study|Severe non-compliance to protocol|1|||
146247392|NCT01180400|527419826|FG001|Overall Study|Severe non-compliance to protocol|2|||
146247393|NCT01180400|527419825|FG000|Overall Study|Condition under investigation worsened|2|||
146247394|NCT01180400|527419826|FG001|Overall Study|Condition under investigation worsened|1|||
146247395|NCT01180400|527419825|FG000|Overall Study|Lack of Efficacy|2|||
146247396|NCT01180400|527419826|FG001|Overall Study|Lack of Efficacy|0|||
146247397|NCT01180400|527419825|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146247398|NCT01180400|527419826|FG001|Overall Study|Study-specific withdrawal criteria|2|||
146247399|NCT01180400|527419825|FG000|Overall Study|Lost to Follow-up|2|||
146247400|NCT01180400|527419826|FG001|Overall Study|Lost to Follow-up|3|||
146247401|NCT01180400|527419825|FG000|Overall Study|Other|0|||
146247402|NCT01180400|527419826|FG001|Overall Study|Other|1|||
146247403|NCT01182285|527419828|FG000|First Intervention Week 1-10|Disease progression|1|||
146247404|NCT01182285|527419829|FG001|First Intervention Week 1-10|Disease progression|0|||
146001056|NCT01832727|526520254|FG000|Overall Study|Adverse Event|4|||
146001057|NCT01832727|526520255|FG001|Overall Study|Adverse Event|6|||
146001058|NCT01832727|526520256|FG002|Overall Study|Adverse Event|1|||
146001059|NCT01832727|526520257|FG003|Overall Study|Adverse Event|0|||
146001060|NCT01832727|526520258|FG004|Overall Study|Adverse Event|1|||
146247405|NCT01182285|527419830|FG002|First Intervention Week 1-10|Disease progression|0|||
146247406|NCT01182285|527419828|FG000|First Intervention Week 1-10|Adverse Event|1|||
146247407|NCT01182285|527419829|FG001|First Intervention Week 1-10|Adverse Event|0|||
146247408|NCT01182285|527419830|FG002|First Intervention Week 1-10|Adverse Event|0|||
146247409|NCT01182285|527419828|FG000|First Intervention Week 1-10|Non-compliance|1|||
146247410|NCT01182285|527419829|FG001|First Intervention Week 1-10|Non-compliance|0|||
146001061|NCT01832727|526520259|FG005|Overall Study|Adverse Event|1|||
146001062|NCT01832727|526520260|FG006|Overall Study|Adverse Event|2|||
146001063|NCT01832727|526520261|FG007|Overall Study|Adverse Event|1|||
146001064|NCT01832727|526520262|FG008|Overall Study|Adverse Event|9|||
146001065|NCT01832727|526520254|FG000|Overall Study|Disease progression|3|||
146001066|NCT01832727|526520255|FG001|Overall Study|Disease progression|0|||
146001067|NCT01832727|526520256|FG002|Overall Study|Disease progression|2|||
146001068|NCT01832727|526520257|FG003|Overall Study|Disease progression|1|||
146001069|NCT01832727|526520258|FG004|Overall Study|Disease progression|3|||
146001070|NCT01832727|526520259|FG005|Overall Study|Disease progression|3|||
146001071|NCT01832727|526520260|FG006|Overall Study|Disease progression|6|||
146001072|NCT01832727|526520261|FG007|Overall Study|Disease progression|2|||
146001073|NCT01832727|526520262|FG008|Overall Study|Disease progression|7|||
146001074|NCT01832727|526520254|FG000|Overall Study|Lost to Follow-up|0|||
146001075|NCT01832727|526520255|FG001|Overall Study|Lost to Follow-up|0|||
146001076|NCT01832727|526520256|FG002|Overall Study|Lost to Follow-up|0|||
146247411|NCT01182285|527419830|FG002|First Intervention Week 1-10|Non-compliance|0|||
146247412|NCT01182285|527419828|FG000|Third Intervention Week 11-52|Disease Progression|0|||
146247413|NCT01182285|527419829|FG001|Third Intervention Week 11-52|Disease Progression|0|||
146247414|NCT01182285|527419830|FG002|Third Intervention Week 11-52|Disease Progression|6|||
146247415|NCT01182285|527419828|FG000|Third Intervention Week 11-52|Other|0|||
146247416|NCT01182285|527419829|FG001|Third Intervention Week 11-52|Other|0|||
146247417|NCT01182285|527419830|FG002|Third Intervention Week 11-52|Other|2|||
146247418|NCT03209492|527419831|FG000|Overall Study|Case Report Forms Uncollected|5|||
146247419|NCT01525875|527419832|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146247420|NCT01525875|527419833|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
146247421|NCT01525875|527419832|FG000|Open-label Period|Lost to Follow-up|0|||
146247422|NCT01525875|527419833|FG001|Open-label Period|Lost to Follow-up|2|||
146247423|NCT00700999|527419834|FG000|Overall Study|Lost to Follow-up|7|||
146247424|NCT00700999|527419835|FG001|Overall Study|Lost to Follow-up|7|||
146247425|NCT00700999|527419834|FG000|Overall Study|Excluded - did not meet study criteria|0|||
146001077|NCT01832727|526520257|FG003|Overall Study|Lost to Follow-up|1|||
146001078|NCT01832727|526520258|FG004|Overall Study|Lost to Follow-up|0|||
146001079|NCT01832727|526520259|FG005|Overall Study|Lost to Follow-up|0|||
146001080|NCT01832727|526520260|FG006|Overall Study|Lost to Follow-up|0|||
146001081|NCT01832727|526520261|FG007|Overall Study|Lost to Follow-up|0|||
146001082|NCT01832727|526520262|FG008|Overall Study|Lost to Follow-up|0|||
146001083|NCT01832727|526520254|FG000|Overall Study|Physician Decision|1|||
146001084|NCT01832727|526520255|FG001|Overall Study|Physician Decision|0|||
146001085|NCT01832727|526520256|FG002|Overall Study|Physician Decision|0|||
146001086|NCT01832727|526520257|FG003|Overall Study|Physician Decision|1|||
146001087|NCT01832727|526520258|FG004|Overall Study|Physician Decision|0|||
146001088|NCT01832727|526520259|FG005|Overall Study|Physician Decision|1|||
146001089|NCT01832727|526520260|FG006|Overall Study|Physician Decision|0|||
146001090|NCT01832727|526520261|FG007|Overall Study|Physician Decision|0|||
146001091|NCT01832727|526520262|FG008|Overall Study|Physician Decision|0|||
146001092|NCT01832727|526520254|FG000|Overall Study|Withdrawal by Subject|1|||
146001093|NCT01832727|526520255|FG001|Overall Study|Withdrawal by Subject|1|||
146001094|NCT01832727|526520256|FG002|Overall Study|Withdrawal by Subject|0|||
146001095|NCT01832727|526520257|FG003|Overall Study|Withdrawal by Subject|1|||
146001096|NCT01832727|526520258|FG004|Overall Study|Withdrawal by Subject|0|||
146001097|NCT01832727|526520259|FG005|Overall Study|Withdrawal by Subject|1|||
146001098|NCT01832727|526520260|FG006|Overall Study|Withdrawal by Subject|0|||
146001099|NCT01832727|526520261|FG007|Overall Study|Withdrawal by Subject|2|||
146001100|NCT01832727|526520262|FG008|Overall Study|Withdrawal by Subject|1|||
146001101|NCT01832727|526520254|FG000|Overall Study|Study terminated by sponsor|0|||
146001102|NCT01832727|526520255|FG001|Overall Study|Study terminated by sponsor|0|||
146001103|NCT01832727|526520256|FG002|Overall Study|Study terminated by sponsor|0|||
146001104|NCT01832727|526520257|FG003|Overall Study|Study terminated by sponsor|0|||
146001105|NCT01832727|526520258|FG004|Overall Study|Study terminated by sponsor|0|||
146001106|NCT01832727|526520259|FG005|Overall Study|Study terminated by sponsor|0|||
146001107|NCT01832727|526520260|FG006|Overall Study|Study terminated by sponsor|0|||
146001108|NCT01832727|526520261|FG007|Overall Study|Study terminated by sponsor|1|||
146001109|NCT01832727|526520262|FG008|Overall Study|Study terminated by sponsor|1|||
146001110|NCT03434834|526520263|FG000|Overall Study|unable to swallow OCT probe|16|||
146001111|NCT01812057|526520271|FG000|Overall Study|Protocol Violation|1|||
146001112|NCT01812057|526520272|FG001|Overall Study|Protocol Violation|0|||
146001113|NCT01812057|526520271|FG000|Overall Study|Physician Decision|1|||
146247426|NCT00700999|527419835|FG001|Overall Study|Excluded - did not meet study criteria|1|||
146247427|NCT00700999|527419834|FG000|Overall Study|Withdrawal by Subject|8|||
146247428|NCT00700999|527419835|FG001|Overall Study|Withdrawal by Subject|1|||
146247429|NCT02379078|527419836|FG000|Overall Study|Lost to Follow-up|33|||
146001114|NCT01812057|526520272|FG001|Overall Study|Physician Decision|0|||
146001115|NCT01657305|526520276|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
146001116|NCT01657305|526520276|FG000|Overall Study|Withdrawal by Subject|4|||
146001117|NCT01657305|526520276|FG000|Overall Study|Adverse Event|1|||
146001118|NCT01657305|526520276|FG000|Overall Study|Lost to Follow-up|1|||
146001119|NCT01657305|526520276|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
146001120|NCT01133847|526520281|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
146001121|NCT01133847|526520282|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
146001122|NCT01133847|526520283|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
146001123|NCT01133847|526520281|FG000|Follow-Up Phase|Lost to Follow-up|1|||
146001124|NCT01133847|526520282|FG001|Follow-Up Phase|Lost to Follow-up|3|||
146247430|NCT02379078|527419837|FG001|Overall Study|Lost to Follow-up|30|||
146247431|NCT02379078|527419836|FG000|Overall Study|Withdrawal by Subject|6|||
146247432|NCT02379078|527419837|FG001|Overall Study|Withdrawal by Subject|5|||
146001125|NCT01133847|526520283|FG002|Follow-Up Phase|Lost to Follow-up|7|||
146001126|NCT02961244|526520287|FG000|Overall Study|Protocol Violation|0|||
146001127|NCT02961244|526520288|FG001|Overall Study|Protocol Violation|1|||
146001128|NCT02961244|526520287|FG000|Overall Study|Withdrawal by Subject|1|||
146001129|NCT02961244|526520288|FG001|Overall Study|Withdrawal by Subject|2|||
146001130|NCT02961244|526520287|FG000|Overall Study|Surgery plan change after study approval|0|||
146001131|NCT02961244|526520288|FG001|Overall Study|Surgery plan change after study approval|2|||
146001132|NCT02961244|526520287|FG000|Overall Study|Lost to Follow-up|0|||
146247433|NCT03481725|527419838|FG000|Overall Study|Withdrawal by Subject|1|||
146247434|NCT03481725|527419839|FG001|Overall Study|Withdrawal by Subject|0|||
146247435|NCT01133678|527419840|FG000|Overall Study|Death|1|||
146247436|NCT01133678|527419841|FG001|Overall Study|Death|1|||
146247437|NCT00879710|527419848|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
146247438|NCT00879710|527419849|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
146247439|NCT00879710|527419850|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
146247440|NCT00879710|527419851|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
146247441|NCT00879710|527419848|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
146247442|NCT00879710|527419849|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
146247443|NCT00879710|527419850|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
146001133|NCT02961244|526520288|FG001|Overall Study|Lost to Follow-up|2|||
146001134|NCT02961244|526520287|FG000|Overall Study|İnadequate data|0|||
146001135|NCT02961244|526520288|FG001|Overall Study|İnadequate data|2|||
146001136|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
146001137|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
146001138|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
146001139|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
146001140|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
146247444|NCT00879710|527419851|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
146247445|NCT01864200|527419852|FG000|Overall Study|Lost to Follow-up|1|||
146247446|NCT01864200|527419853|FG001|Overall Study|Lost to Follow-up|3|||
146247447|NCT01864200|527419852|FG000|Overall Study|Protocol Violation|1|||
146247448|NCT01864200|527419853|FG001|Overall Study|Protocol Violation|0|||
146247449|NCT02514824|527419861|FG000|Overall Study|Withdrawal by Subject|1|||
146247450|NCT02514824|527419862|FG001|Overall Study|Withdrawal by Subject|0|||
146247451|NCT02514824|527419863|FG002|Overall Study|Withdrawal by Subject|0|||
146247452|NCT02514824|527419864|FG003|Overall Study|Withdrawal by Subject|0|||
146247453|NCT02514824|527419861|FG000|Overall Study|Dose-Limiting Toxicity|0|||
146247454|NCT02514824|527419862|FG001|Overall Study|Dose-Limiting Toxicity|1|||
146247455|NCT02514824|527419863|FG002|Overall Study|Dose-Limiting Toxicity|0|||
146247456|NCT02514824|527419864|FG003|Overall Study|Dose-Limiting Toxicity|0|||
146247457|NCT02170207|527419867|FG000|Overall Study|Case report forms unavailable|5|||
146247458|NCT03122860|527419868|FG000|Overall Study|Discontinued Before Treatment|1|||
146247459|NCT03122860|527419869|FG001|Overall Study|Discontinued Before Treatment|1|||
146247460|NCT03122860|527419870|FG002|Overall Study|Discontinued Before Treatment|2|||
146247461|NCT03122860|527419871|FG003|Overall Study|Discontinued Before Treatment|0|||
146247462|NCT03122860|527419872|FG004|Overall Study|Discontinued Before Treatment|1|||
146247463|NCT03122860|527419873|FG005|Overall Study|Discontinued Before Treatment|0|||
146247464|NCT03122860|527419868|FG000|Overall Study|Adverse Event|1|||
146247465|NCT03122860|527419869|FG001|Overall Study|Adverse Event|0|||
146247466|NCT03122860|527419870|FG002|Overall Study|Adverse Event|1|||
146247467|NCT03122860|527419871|FG003|Overall Study|Adverse Event|1|||
146247468|NCT03122860|527419872|FG004|Overall Study|Adverse Event|0|||
146247469|NCT03122860|527419873|FG005|Overall Study|Adverse Event|0|||
146001141|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
146001142|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
146001143|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
146247470|NCT03122860|527419868|FG000|Overall Study|Lost to Follow-up|5|||
146247471|NCT03122860|527419869|FG001|Overall Study|Lost to Follow-up|2|||
146247472|NCT03122860|527419870|FG002|Overall Study|Lost to Follow-up|3|||
146247473|NCT03122860|527419871|FG003|Overall Study|Lost to Follow-up|3|||
146247474|NCT03122860|527419872|FG004|Overall Study|Lost to Follow-up|5|||
146247475|NCT03122860|527419873|FG005|Overall Study|Lost to Follow-up|4|||
146247476|NCT03122860|527419868|FG000|Overall Study|Subject Non-Compliance|0|||
146247477|NCT03122860|527419869|FG001|Overall Study|Subject Non-Compliance|0|||
146298082|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
146001144|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
146001145|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
146247478|NCT03122860|527419870|FG002|Overall Study|Subject Non-Compliance|1|||
146247479|NCT03122860|527419871|FG003|Overall Study|Subject Non-Compliance|0|||
146247480|NCT03122860|527419872|FG004|Overall Study|Subject Non-Compliance|0|||
146247481|NCT03122860|527419873|FG005|Overall Study|Subject Non-Compliance|0|||
146247482|NCT03122860|527419868|FG000|Overall Study|Withdrawal by Subject|3|||
146001146|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
146001147|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
146001148|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
146001149|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
146001150|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
146001151|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
146001152|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
146001153|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
146001154|NCT03789292|526520289|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
146001155|NCT03789292|526520290|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
146001156|NCT03789292|526520291|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
146001157|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
146001158|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
146001159|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
146001160|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
146001161|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
146001162|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
146001163|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
146001164|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
146001165|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
146001166|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
146001167|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
146001168|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
146001169|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
146001170|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
146001171|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
146001172|NCT03789292|526520289|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
146001173|NCT03789292|526520290|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
146001174|NCT03789292|526520291|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
146001175|NCT00967616|526520292|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
146001176|NCT00967616|526520293|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
146001177|NCT00967616|526520292|FG000|Overall Study|Death|0|||
146001178|NCT00967616|526520293|FG001|Overall Study|Death|3|||
146001179|NCT00967616|526520292|FG000|Overall Study|Withdrawal by Subject|8|||
146001180|NCT00967616|526520293|FG001|Overall Study|Withdrawal by Subject|4|||
146001181|NCT00967616|526520292|FG000|Overall Study|Progressive Disease|31|||
146001182|NCT00967616|526520293|FG001|Overall Study|Progressive Disease|18|||
146001183|NCT00967616|526520292|FG000|Overall Study|Other|8|||
146001184|NCT00967616|526520293|FG001|Overall Study|Other|8|||
146001185|NCT00967616|526520292|FG000|Overall Study|Protocol Violation|1|||
146001186|NCT00967616|526520293|FG001|Overall Study|Protocol Violation|0|||
146001187|NCT01696643|526520294|FG000|Overall Study|Adverse Event|15|||
146001188|NCT01696643|526520295|FG001|Overall Study|Adverse Event|7|||
146001189|NCT01696643|526520294|FG000|Overall Study|Death|1|||
146001190|NCT01696643|526520295|FG001|Overall Study|Death|2|||
146001191|NCT01696643|526520294|FG000|Overall Study|Lack of Efficacy|3|||
146001192|NCT01696643|526520295|FG001|Overall Study|Lack of Efficacy|0|||
146001193|NCT01696643|526520294|FG000|Overall Study|Lost to Follow-up|67|||
146001194|NCT01696643|526520295|FG001|Overall Study|Lost to Follow-up|67|||
146001195|NCT01696643|526520294|FG000|Overall Study|Physician Decision|3|||
146001196|NCT01696643|526520295|FG001|Overall Study|Physician Decision|2|||
146001197|NCT01696643|526520294|FG000|Overall Study|Pregnancy|0|||
146001198|NCT01696643|526520295|FG001|Overall Study|Pregnancy|1|||
146001199|NCT01696643|526520294|FG000|Overall Study|Protocol Violation|7|||
146001200|NCT01696643|526520295|FG001|Overall Study|Protocol Violation|7|||
146001201|NCT01696643|526520294|FG000|Overall Study|Study Terminated by Sponsor|286|||
146001202|NCT01696643|526520295|FG001|Overall Study|Study Terminated by Sponsor|294|||
146001203|NCT01696643|526520294|FG000|Overall Study|Withdrawal by Subject|142|||
146001204|NCT01696643|526520295|FG001|Overall Study|Withdrawal by Subject|149|||
146001205|NCT01696643|526520294|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
146001206|NCT01696643|526520295|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
146001207|NCT01696643|526520294|FG000|Overall Study|Site Error|2|||
146001208|NCT01696643|526520295|FG001|Overall Study|Site Error|1|||
146001209|NCT01696643|526520294|FG000|Overall Study|Participant Incarcerated|0|||
146001210|NCT01696643|526520295|FG001|Overall Study|Participant Incarcerated|1|||
146001211|NCT01696643|526520294|FG000|Overall Study|Medical Monitor Decision|0|||
146001212|NCT01696643|526520295|FG001|Overall Study|Medical Monitor Decision|2|||
146001213|NCT01696643|526520294|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
146001214|NCT01696643|526520295|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
146001215|NCT00575666|526520296|FG000|Overall Study|Withdrawal by Subject|3|||
146001216|NCT00575666|526520297|FG001|Overall Study|Withdrawal by Subject|2|||
146001217|NCT00575666|526520296|FG000|Overall Study|Physician Decision|1|||
146001218|NCT00575666|526520297|FG001|Overall Study|Physician Decision|1|||
146001219|NCT00508482|526520298|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
146001220|NCT00508482|526520299|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
146001221|NCT00508482|526520300|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
146001222|NCT00508482|526520298|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
146001223|NCT00508482|526520299|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
146001224|NCT00508482|526520300|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
146001225|NCT00508482|526520298|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
146001226|NCT00508482|526520299|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
146001227|NCT00508482|526520300|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
146001228|NCT02850978|526520303|FG000|Overall Study|Uncollectable CRF|27|||
146001229|NCT02850978|526520303|FG000|Overall Study|No visit since the first visit|35|||
146001230|NCT02850978|526520303|FG000|Overall Study|Adverse Event|81|||
146001231|NCT02850978|526520303|FG000|Overall Study|Lack of Efficacy|40|||
146001232|NCT02850978|526520303|FG000|Overall Study|Improvement in condition|34|||
146001233|NCT02850978|526520303|FG000|Overall Study|Lost to Follow-up|121|||
146001234|NCT02850978|526520303|FG000|Overall Study|Reason not listed|88|||
146001235|NCT00421148|526520304|FG000|Overall Study|Lost to Follow-up|0|||
146001236|NCT00421148|526520305|FG001|Overall Study|Lost to Follow-up|0|||
146001237|NCT00421148|526520306|FG002|Overall Study|Lost to Follow-up|0|||
146001238|NCT00421148|526520307|FG003|Overall Study|Lost to Follow-up|0|||
146001239|NCT00421148|526520308|FG004|Overall Study|Lost to Follow-up|0|||
146001240|NCT00421148|526520309|FG005|Overall Study|Lost to Follow-up|0|||
146001241|NCT00421148|526520310|FG006|Overall Study|Lost to Follow-up|0|||
146001242|NCT00421148|526520311|FG007|Overall Study|Lost to Follow-up|0|||
146001243|NCT00421148|526520312|FG008|Overall Study|Lost to Follow-up|0|||
146001244|NCT00421148|526520313|FG009|Overall Study|Lost to Follow-up|0|||
146001245|NCT00421148|526520314|FG010|Overall Study|Lost to Follow-up|0|||
146001246|NCT00421148|526520315|FG011|Overall Study|Lost to Follow-up|0|||
146001247|NCT00421148|526520316|FG012|Overall Study|Lost to Follow-up|0|||
146001248|NCT00421148|526520317|FG013|Overall Study|Lost to Follow-up|0|||
146001249|NCT00421148|526520318|FG014|Overall Study|Lost to Follow-up|0|||
146001250|NCT00421148|526520319|FG015|Overall Study|Lost to Follow-up|0|||
146001251|NCT00421148|526520320|FG016|Overall Study|Lost to Follow-up|0|||
146001252|NCT00421148|526520321|FG017|Overall Study|Lost to Follow-up|1|||
146001253|NCT00421148|526520322|FG018|Overall Study|Lost to Follow-up|0|||
146001254|NCT00421148|526520323|FG019|Overall Study|Lost to Follow-up|0|||
146001255|NCT00421148|526520304|FG000|Overall Study|Withdrawal by Subject|0|||
146001256|NCT00421148|526520305|FG001|Overall Study|Withdrawal by Subject|0|||
146001257|NCT00421148|526520306|FG002|Overall Study|Withdrawal by Subject|0|||
146001258|NCT00421148|526520307|FG003|Overall Study|Withdrawal by Subject|0|||
146001259|NCT00421148|526520308|FG004|Overall Study|Withdrawal by Subject|0|||
146001260|NCT00421148|526520309|FG005|Overall Study|Withdrawal by Subject|0|||
146001261|NCT00421148|526520310|FG006|Overall Study|Withdrawal by Subject|0|||
146001262|NCT00421148|526520311|FG007|Overall Study|Withdrawal by Subject|0|||
146001263|NCT00421148|526520312|FG008|Overall Study|Withdrawal by Subject|0|||
146001264|NCT00421148|526520313|FG009|Overall Study|Withdrawal by Subject|0|||
146001265|NCT00421148|526520314|FG010|Overall Study|Withdrawal by Subject|0|||
146001266|NCT00421148|526520315|FG011|Overall Study|Withdrawal by Subject|0|||
146001267|NCT00421148|526520316|FG012|Overall Study|Withdrawal by Subject|0|||
146001268|NCT00421148|526520317|FG013|Overall Study|Withdrawal by Subject|0|||
146001269|NCT00421148|526520318|FG014|Overall Study|Withdrawal by Subject|0|||
146001270|NCT00421148|526520319|FG015|Overall Study|Withdrawal by Subject|0|||
146001271|NCT00421148|526520320|FG016|Overall Study|Withdrawal by Subject|0|||
146001272|NCT00421148|526520321|FG017|Overall Study|Withdrawal by Subject|1|||
146001273|NCT00421148|526520322|FG018|Overall Study|Withdrawal by Subject|0|||
146001274|NCT00421148|526520323|FG019|Overall Study|Withdrawal by Subject|0|||
146001275|NCT00421148|526520304|FG000|Overall Study|Protocol Violation|0|||
146001276|NCT00421148|526520305|FG001|Overall Study|Protocol Violation|0|||
146001277|NCT00421148|526520306|FG002|Overall Study|Protocol Violation|0|||
146001278|NCT00421148|526520307|FG003|Overall Study|Protocol Violation|0|||
146001279|NCT00421148|526520308|FG004|Overall Study|Protocol Violation|0|||
146001280|NCT00421148|526520309|FG005|Overall Study|Protocol Violation|1|||
146001281|NCT00421148|526520310|FG006|Overall Study|Protocol Violation|0|||
146001282|NCT00421148|526520311|FG007|Overall Study|Protocol Violation|0|||
146001283|NCT00421148|526520312|FG008|Overall Study|Protocol Violation|0|||
146001284|NCT00421148|526520313|FG009|Overall Study|Protocol Violation|0|||
146001285|NCT00421148|526520314|FG010|Overall Study|Protocol Violation|0|||
146001286|NCT00421148|526520315|FG011|Overall Study|Protocol Violation|0|||
146001287|NCT00421148|526520316|FG012|Overall Study|Protocol Violation|0|||
146001288|NCT00421148|526520317|FG013|Overall Study|Protocol Violation|0|||
146001289|NCT00421148|526520318|FG014|Overall Study|Protocol Violation|0|||
146001290|NCT00421148|526520319|FG015|Overall Study|Protocol Violation|0|||
146001291|NCT00421148|526520320|FG016|Overall Study|Protocol Violation|0|||
146001292|NCT00421148|526520321|FG017|Overall Study|Protocol Violation|0|||
146001293|NCT00421148|526520322|FG018|Overall Study|Protocol Violation|1|||
146001294|NCT00421148|526520323|FG019|Overall Study|Protocol Violation|0|||
146001295|NCT00570713|526520324|FG000|Overall Study|Adverse Event|16|||
146001296|NCT00570713|526520325|FG001|Overall Study|Adverse Event|9|||
146001297|NCT00570713|526520324|FG000|Overall Study|Death|7|||
146001298|NCT00570713|526520325|FG001|Overall Study|Death|7|||
146001299|NCT00570713|526520324|FG000|Overall Study|Lack of Efficacy|40|||
146001300|NCT00570713|526520325|FG001|Overall Study|Lack of Efficacy|49|||
146001301|NCT00570713|526520324|FG000|Overall Study|Physician Decision|2|||
146001302|NCT00570713|526520325|FG001|Overall Study|Physician Decision|2|||
146001303|NCT00570713|526520324|FG000|Overall Study|Withdrawal by Subject|3|||
146001304|NCT00570713|526520325|FG001|Overall Study|Withdrawal by Subject|3|||
146001305|NCT00570713|526520324|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
146001306|NCT00570713|526520325|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
146001307|NCT01822665|526520326|FG000|Overall Study|Adverse Event|3|||
146001308|NCT01822665|526520326|FG000|Overall Study|Other Reason|5|||
146001309|NCT02121509|526520327|FG000|Washout Period (35 Days)|Adverse Event|1|||
146001310|NCT02121509|526520328|FG001|Washout Period (35 Days)|Adverse Event|1|||
146001311|NCT02121509|526520329|FG002|Washout Period (35 Days)|Adverse Event|0|||
146001312|NCT02121509|526520330|FG003|Washout Period (35 Days)|Adverse Event|0|||
146001313|NCT02121509|526520327|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
146001314|NCT02121509|526520328|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
146001315|NCT02121509|526520329|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
146001316|NCT02121509|526520330|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
146001317|NCT02121509|526520327|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
146001318|NCT02121509|526520328|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146001319|NCT02121509|526520329|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146001320|NCT02121509|526520330|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
146001321|NCT01978145|526522012|FG000|Treatment Period 1|Adverse Event|1|||
146001322|NCT01978145|526522013|FG001|Treatment Period 1|Adverse Event|9|||
146001323|NCT01978145|526522012|FG000|Treatment Period 1|Physician Decision|1|||
146001324|NCT01978145|526522013|FG001|Treatment Period 1|Physician Decision|0|||
146001325|NCT01978145|526522012|FG000|Treatment Period 1|Withdrawal by Subject|5|||
146001326|NCT01978145|526522013|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146001327|NCT01978145|526522012|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
146001328|NCT01978145|526522013|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
146001329|NCT01978145|526522012|FG000|Washout Period 1|Adverse Event|0|||
146001330|NCT01978145|526522013|FG001|Washout Period 1|Adverse Event|1|||
146001331|NCT01978145|526522012|FG000|Washout Period 1|Withdrawal by Subject|1|||
146001332|NCT01978145|526522013|FG001|Washout Period 1|Withdrawal by Subject|1|||
146001333|NCT01978145|526522012|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
146001334|NCT01978145|526522013|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
146001335|NCT01978145|526522012|FG000|Treatment Period 2|Adverse Event|3|||
146001336|NCT01978145|526522013|FG001|Treatment Period 2|Adverse Event|3|||
146001337|NCT01978145|526522012|FG000|Treatment Period 2|Protocol Violation|0|||
146001338|NCT01978145|526522013|FG001|Treatment Period 2|Protocol Violation|1|||
146001339|NCT01978145|526522012|FG000|Treatment Period 2|Lost to Follow-up|1|||
146001340|NCT01978145|526522013|FG001|Treatment Period 2|Lost to Follow-up|1|||
146001341|NCT01978145|526522012|FG000|Treatment Period 2|Withdrawal by Subject|7|||
146001342|NCT01978145|526522013|FG001|Treatment Period 2|Withdrawal by Subject|4|||
146001343|NCT01978145|526522012|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
146001344|NCT01978145|526522013|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
146001345|NCT00322049|526522014|FG000|Overall Study|Moved out of area|0|||
146001346|NCT00322049|526522015|FG001|Overall Study|Moved out of area|0|||
146001347|NCT00322049|526522016|FG002|Overall Study|Moved out of area|0|||
146001348|NCT00322049|526522017|FG003|Overall Study|Moved out of area|1|||
146001349|NCT00322049|526522014|FG000|Overall Study|Infected with Dengue during study|0|||
146001350|NCT00322049|526522015|FG001|Overall Study|Infected with Dengue during study|1|||
146247483|NCT03122860|527419869|FG001|Overall Study|Withdrawal by Subject|2|||
146001351|NCT00322049|526522016|FG002|Overall Study|Infected with Dengue during study|0|||
146001352|NCT00322049|526522017|FG003|Overall Study|Infected with Dengue during study|0|||
146001353|NCT01250054|526522018|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
146001354|NCT01250054|526522019|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
146001355|NCT00755807|526522024|FG000|Acute Phase|Adverse Event|16|||
146001356|NCT00755807|526522025|FG001|Acute Phase|Adverse Event|5|||
146001357|NCT00755807|526522024|FG000|Acute Phase|Protocol Violation|1|||
146001358|NCT00755807|526522025|FG001|Acute Phase|Protocol Violation|3|||
146001359|NCT00755807|526522024|FG000|Acute Phase|Withdrawal by Subject|1|||
146001360|NCT00755807|526522025|FG001|Acute Phase|Withdrawal by Subject|2|||
146001361|NCT00755807|526522024|FG000|Acute Phase|Lack of Efficacy|0|||
146001362|NCT00755807|526522025|FG001|Acute Phase|Lack of Efficacy|1|||
146001363|NCT00755807|526522024|FG000|Acute Phase|Physician Decision|0|||
146001364|NCT00755807|526522025|FG001|Acute Phase|Physician Decision|1|||
146001365|NCT00755807|526522024|FG000|Open-label Extension Phase|Adverse Event|7|||
146001366|NCT00755807|526522025|FG001|Open-label Extension Phase|Adverse Event|7|||
146001367|NCT00755807|526522024|FG000|Open-label Extension Phase|Protocol Violation|5|||
146001368|NCT00755807|526522025|FG001|Open-label Extension Phase|Protocol Violation|2|||
146001369|NCT00755807|526522024|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
146001370|NCT00755807|526522025|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
146001371|NCT00755807|526522024|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
146001372|NCT00755807|526522025|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
146001373|NCT00755807|526522024|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
146001374|NCT00755807|526522025|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
146001375|NCT00755807|526522024|FG000|Open-label Extension Phase|Sponsor Decision|0|||
146001376|NCT00755807|526522025|FG001|Open-label Extension Phase|Sponsor Decision|1|||
146001377|NCT02921789|526522033|FG000|Overall Study|Adverse Event|0|||
146001378|NCT02921789|526522034|FG001|Overall Study|Adverse Event|1|||
146001379|NCT02921789|526522033|FG000|Overall Study|Lost to Follow-up|1|||
146001380|NCT02921789|526522034|FG001|Overall Study|Lost to Follow-up|0|||
146001381|NCT02921789|526522033|FG000|Overall Study|Protocol Deviation|2|||
146001382|NCT02921789|526522034|FG001|Overall Study|Protocol Deviation|0|||
146001383|NCT02921789|526522033|FG000|Overall Study|Withdrawal by Subject|2|||
146001384|NCT02921789|526522034|FG001|Overall Study|Withdrawal by Subject|1|||
146001385|NCT02921789|526522033|FG000|Overall Study|Miscellaneous|3|||
146001386|NCT02921789|526522034|FG001|Overall Study|Miscellaneous|2|||
146001387|NCT04099277|526522035|FG000|Overall Study|Physician Decision|1|||
146001388|NCT04099277|526522035|FG000|Overall Study|Withdrawal by Subject|1|||
146001389|NCT00305877|526522036|FG000|Overall Study|Lack of Efficacy|6|||
146001390|NCT00305877|526522037|FG001|Overall Study|Lack of Efficacy|9|||
146001391|NCT00305877|526522036|FG000|Overall Study|Adverse Event|9|||
146001392|NCT00305877|526522037|FG001|Overall Study|Adverse Event|14|||
146001393|NCT00305877|526522036|FG000|Overall Study|Death|0|||
146001394|NCT00305877|526522037|FG001|Overall Study|Death|1|||
146001395|NCT00305877|526522036|FG000|Overall Study|Withdrawal by Subject|4|||
146001396|NCT00305877|526522037|FG001|Overall Study|Withdrawal by Subject|2|||
146001397|NCT00305877|526522036|FG000|Overall Study|Physician Decision|1|||
146001398|NCT00305877|526522037|FG001|Overall Study|Physician Decision|1|||
146001399|NCT00305877|526522036|FG000|Overall Study|Never start treatment|2|||
146001400|NCT00305877|526522037|FG001|Overall Study|Never start treatment|5|||
146001401|NCT00305877|526522036|FG000|Overall Study|Ineligible|2|||
146001402|NCT00305877|526522037|FG001|Overall Study|Ineligible|1|||
146001403|NCT00305877|526522036|FG000|Overall Study|Transportation issue with daily RT|0|||
146001404|NCT00305877|526522037|FG001|Overall Study|Transportation issue with daily RT|1|||
146001405|NCT02580877|526522038|FG000|Overall Study|Withdrawal by Subject|1|||
146001406|NCT02580877|526522039|FG001|Overall Study|Withdrawal by Subject|3|||
146001407|NCT02580877|526522038|FG000|Overall Study|Adverse Event|0|||
146001408|NCT02580877|526522039|FG001|Overall Study|Adverse Event|1|||
146001409|NCT02903823|526522040|FG000|Overall Study|Physician Decision|5|||
146001410|NCT02903823|526522040|FG000|Overall Study|Could not advance catheter|1|||
146001411|NCT02903823|526522040|FG000|Overall Study|Catheter dislodgement|1|||
146001412|NCT00355030|526522047|FG000|Study Period 1 Treatment|Adverse Event|1|||
146001413|NCT00355030|526522048|FG001|Study Period 1 Treatment|Adverse Event|1|||
146001414|NCT00355030|526522047|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
146001415|NCT00355030|526522048|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
146001416|NCT00355030|526522047|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
146001417|NCT00355030|526522048|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
146001418|NCT00355030|526522047|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
146001419|NCT00355030|526522048|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
146001420|NCT00355030|526522047|FG000|Study Period 1 Treatment|Physician Decision|0|||
146001421|NCT00355030|526522048|FG001|Study Period 1 Treatment|Physician Decision|1|||
146001422|NCT00355030|526522047|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
146001423|NCT00355030|526522048|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
146001424|NCT00355030|526522047|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
146001425|NCT00355030|526522048|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
146001426|NCT00355030|526522047|FG000|Study Period 1 Treatment|Other|2|||
146001427|NCT00355030|526522048|FG001|Study Period 1 Treatment|Other|6|||
146001428|NCT00355030|526522047|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
146001429|NCT00355030|526522048|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
146001430|NCT00355030|526522047|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
146001431|NCT00355030|526522048|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
146001432|NCT00339040|526522049|FG000|Stage I|Not able to attend clinic|1|||
146001433|NCT00339040|526522050|FG001|Stage I|Not able to attend clinic|0|||
146001434|NCT00339040|526522049|FG000|Stage I|Protocol Violation|1|||
146001435|NCT00339040|526522050|FG001|Stage I|Protocol Violation|1|||
146001436|NCT00339040|526522049|FG000|Stage II|Lost to Follow-up|3|||
146001437|NCT00339040|526522050|FG001|Stage II|Lost to Follow-up|0|||
146001438|NCT00339040|526522049|FG000|Stage II|Withdrawal by Subject|1|||
146001439|NCT00339040|526522050|FG001|Stage II|Withdrawal by Subject|2|||
146001440|NCT00339040|526522049|FG000|Stage II|Protocol Violation|3|||
146001441|NCT00339040|526522050|FG001|Stage II|Protocol Violation|0|||
146001442|NCT00339040|526522049|FG000|Stage II|Not able to attend clinic|1|||
146001443|NCT00339040|526522050|FG001|Stage II|Not able to attend clinic|0|||
146001444|NCT00339040|526522049|FG000|Stage II|Site closing|2|||
146001445|NCT00339040|526522050|FG001|Stage II|Site closing|0|||
146001446|NCT00690794|526522051|FG000|Overall Study|Adverse Event|12|||
146001447|NCT00690794|526522052|FG001|Overall Study|Adverse Event|10|||
146001448|NCT00690794|526522051|FG000|Overall Study|Lost to Follow-up|1|||
146001449|NCT00690794|526522052|FG001|Overall Study|Lost to Follow-up|4|||
146001450|NCT00690794|526522051|FG000|Overall Study|Withdrawal by Subject|0|||
146001451|NCT00690794|526522052|FG001|Overall Study|Withdrawal by Subject|9|||
146001452|NCT00690794|526522051|FG000|Overall Study|Protocol Violation|6|||
146001453|NCT00690794|526522052|FG001|Overall Study|Protocol Violation|7|||
146001454|NCT00690794|526522051|FG000|Overall Study|Noncompliance|1|||
146001455|NCT00690794|526522052|FG001|Overall Study|Noncompliance|2|||
146001456|NCT00690794|526522051|FG000|Overall Study|Other not specified|1|||
146001457|NCT00690794|526522052|FG001|Overall Study|Other not specified|3|||
146001458|NCT02808429|526522055|FG000|Overall Study|Lost to Follow-up|1|||
146001459|NCT02808429|526522056|FG001|Overall Study|Lost to Follow-up|0|||
146001460|NCT02808429|526522057|FG002|Overall Study|Lost to Follow-up|0|||
146001461|NCT02808429|526522055|FG000|Overall Study|Protocol Violation|0|||
146001462|NCT02808429|526522056|FG001|Overall Study|Protocol Violation|1|||
146001463|NCT02808429|526522057|FG002|Overall Study|Protocol Violation|0|||
146001464|NCT02808429|526522055|FG000|Overall Study|Premature study termination by sponsor|2|||
146001465|NCT02808429|526522056|FG001|Overall Study|Premature study termination by sponsor|0|||
146001466|NCT02808429|526522057|FG002|Overall Study|Premature study termination by sponsor|1|||
146001467|NCT02808429|526522055|FG000|Overall Study|Relocation|0|||
146001468|NCT02808429|526522056|FG001|Overall Study|Relocation|0|||
146001469|NCT02808429|526522057|FG002|Overall Study|Relocation|1|||
146001470|NCT01788943|526522058|FG000|Overall Study|Withdrawal by Subject|1|||
146001471|NCT01788943|526522059|FG001|Overall Study|Withdrawal by Subject|0|||
146001472|NCT04436744|526522066|FG000|Overall Study|Adverse Event|1|||
146001473|NCT04436744|526522067|FG001|Overall Study|Adverse Event|1|||
146001474|NCT04436744|526522066|FG000|Overall Study|Death|1|||
146001475|NCT04436744|526522067|FG001|Overall Study|Death|0|||
146001476|NCT04436744|526522066|FG000|Overall Study|Lost to Follow-up|0|||
146001477|NCT04436744|526522067|FG001|Overall Study|Lost to Follow-up|2|||
146001478|NCT04436744|526522066|FG000|Overall Study|Physician Decision|0|||
146001479|NCT04436744|526522067|FG001|Overall Study|Physician Decision|1|||
146001480|NCT04436744|526522066|FG000|Overall Study|Progressive Disease|0|||
146001481|NCT04436744|526522067|FG001|Overall Study|Progressive Disease|4|||
146001482|NCT04436744|526522066|FG000|Overall Study|Protocol Deviation|1|||
146001483|NCT04436744|526522067|FG001|Overall Study|Protocol Deviation|1|||
146001484|NCT04436744|526522066|FG000|Overall Study|Withdrawal by Subject|1|||
146001485|NCT04436744|526522067|FG001|Overall Study|Withdrawal by Subject|2|||
146001486|NCT01378117|526522068|FG000|Overall Study|withdrawal|2|||
146001487|NCT01378117|526522069|FG001|Overall Study|withdrawal|1|||
146001488|NCT01378117|526522070|FG002|Overall Study|withdrawal|2|||
146001489|NCT01378117|526522068|FG000|Overall Study|discharged before med given|2|||
146001490|NCT01378117|526522069|FG001|Overall Study|discharged before med given|0|||
146001491|NCT01378117|526522070|FG002|Overall Study|discharged before med given|1|||
146001492|NCT01374425|526522072|FG000|Overall Study|Radiographic Disease Progression|86|||
146001493|NCT01374425|526522073|FG001|Overall Study|Radiographic Disease Progression|81|||
146001494|NCT01374425|526522072|FG000|Overall Study|Clinical Disease Progression|9|||
146001495|NCT01374425|526522073|FG001|Overall Study|Clinical Disease Progression|6|||
146001496|NCT01374425|526522072|FG000|Overall Study|Adverse Event|29|||
146001497|NCT01374425|526522073|FG001|Overall Study|Adverse Event|18|||
146001498|NCT01374425|526522072|FG000|Overall Study|Death (Progression of Disease)|1|||
146001499|NCT01374425|526522073|FG001|Overall Study|Death (Progression of Disease)|0|||
146001500|NCT01374425|526522072|FG000|Overall Study|Death (Adverse Event)|2|||
146001501|NCT01374425|526522073|FG001|Overall Study|Death (Adverse Event)|4|||
146001502|NCT01374425|526522072|FG000|Overall Study|Withdrawal by Subject|6|||
146247484|NCT03122860|527419870|FG002|Overall Study|Withdrawal by Subject|5|||
146001503|NCT01374425|526522073|FG001|Overall Study|Withdrawal by Subject|7|||
146247485|NCT03122860|527419871|FG003|Overall Study|Withdrawal by Subject|7|||
146247486|NCT03122860|527419872|FG004|Overall Study|Withdrawal by Subject|9|||
146001504|NCT01374425|526522072|FG000|Overall Study|Refused Treatment|10|||
146247487|NCT03122860|527419873|FG005|Overall Study|Withdrawal by Subject|8|||
146001505|NCT01374425|526522073|FG001|Overall Study|Refused Treatment|24|||
146001506|NCT01374425|526522072|FG000|Overall Study|Protocol Violation|2|||
146001507|NCT01374425|526522073|FG001|Overall Study|Protocol Violation|3|||
146001508|NCT01374425|526522072|FG000|Overall Study|Sponsor Decision|0|||
146001509|NCT01374425|526522073|FG001|Overall Study|Sponsor Decision|1|||
146001510|NCT01374425|526522072|FG000|Overall Study|Lost to Follow-up|2|||
146001511|NCT01374425|526522073|FG001|Overall Study|Lost to Follow-up|1|||
146001512|NCT01374425|526522072|FG000|Overall Study|Other|41|||
146001513|NCT01374425|526522073|FG001|Overall Study|Other|43|||
146001514|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
146001515|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
146001516|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
146001517|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
146001518|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
146001519|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
146001520|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
146001521|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
146001522|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
146001523|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
146001524|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
146001525|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
146001526|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
146001527|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
146001528|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
146001529|NCT00546481|526522074|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
146001530|NCT00546481|526522075|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
146001531|NCT00546481|526522076|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
146001532|NCT00546481|526522074|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
146001533|NCT00546481|526522075|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
146001534|NCT00546481|526522076|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
146001535|NCT00546481|526522074|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
146001536|NCT00546481|526522075|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
146001537|NCT00546481|526522076|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
146001538|NCT00546481|526522074|FG000|Maintenance Phase (CERA)|Other Reason|0|||
146001539|NCT00546481|526522075|FG001|Maintenance Phase (CERA)|Other Reason|0|||
146001540|NCT00546481|526522076|FG002|Maintenance Phase (CERA)|Other Reason|1|||
146001541|NCT00950651|526522079|FG000|Overall Study|Adverse Event|17|||
146001542|NCT00950651|526522080|FG001|Overall Study|Adverse Event|20|||
146001543|NCT00950651|526522079|FG000|Overall Study|Death|1|||
146001544|NCT00950651|526522080|FG001|Overall Study|Death|0|||
146001545|NCT00950651|526522079|FG000|Overall Study|Lack of Efficacy|2|||
146001546|NCT00950651|526522080|FG001|Overall Study|Lack of Efficacy|2|||
146001547|NCT00950651|526522079|FG000|Overall Study|Protocol Violation|3|||
146001548|NCT00950651|526522080|FG001|Overall Study|Protocol Violation|4|||
146001549|NCT00950651|526522079|FG000|Overall Study|Withdrawal by Subject|8|||
146001550|NCT00950651|526522080|FG001|Overall Study|Withdrawal by Subject|9|||
146001551|NCT02761642|526522081|FG000|Overall Study|Did not Receive Study Treatment|3|||
146001552|NCT02761642|526522081|FG000|Overall Study|Adverse Event|13|||
146001553|NCT02761642|526522081|FG000|Overall Study|Withdrawal by Subject|2|||
146001554|NCT02761642|526522081|FG000|Overall Study|Non-compliant|7|||
146001555|NCT02761642|526522081|FG000|Overall Study|Death|3|||
146001556|NCT02761642|526522081|FG000|Overall Study|Lack of Efficacy|20|||
146001557|NCT02761642|526522081|FG000|Overall Study|Physician Decision|1|||
146001558|NCT02761642|526522081|FG000|Overall Study|Reason Unspecified|21|||
146001559|NCT03783780|526522082|FG000|Overall Study|Withdrawn prior to completion|1|||
146001560|NCT02765399|526522090|FG000|Overall Study|Nausea|1|||
146001561|NCT02765399|526522091|FG001|Overall Study|Nausea|0|||
146001562|NCT00120627|526522098|FG000|Overall Study|Withdrawal by Subject|5|||
146001563|NCT00120627|526522099|FG001|Overall Study|Withdrawal by Subject|5|||
146001564|NCT04016714|526522100|FG000|Overall Study|Death|1|||
146001565|NCT04016714|526522101|FG001|Overall Study|Death|0|||
146001566|NCT04016714|526522100|FG000|Overall Study|Lost to Follow-up|3|||
146001567|NCT04016714|526522101|FG001|Overall Study|Lost to Follow-up|1|||
146001568|NCT04016714|526522100|FG000|Overall Study|Physician Decision|3|||
146001569|NCT04016714|526522101|FG001|Overall Study|Physician Decision|3|||
146001570|NCT04016714|526522100|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
146001571|NCT04016714|526522101|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
146001572|NCT01677988|526522106|FG000|Overall Study|Lack of Efficacy|2|||
146001573|NCT00271544|526522110|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
146001574|NCT00271544|526522110|FG000|Overall Study|Model 4196 lead not attempted|9|||
146001575|NCT00271544|526522110|FG000|Overall Study|Implant not attempted|4|||
146001576|NCT04540367|526522111|FG000|Overall Study|Withdrawal by Subject|0|||
146001577|NCT04540367|526522112|FG001|Overall Study|Withdrawal by Subject|0|||
146001578|NCT04540367|526522113|FG002|Overall Study|Withdrawal by Subject|0|||
146001579|NCT04540367|526522114|FG003|Overall Study|Withdrawal by Subject|2|||
146001580|NCT04540367|526522111|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
146001581|NCT04540367|526522112|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
146001582|NCT04540367|526522113|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
146001583|NCT04540367|526522114|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
146001584|NCT04540367|526522111|FG000|Overall Study|Adverse Event|0|||
146001585|NCT04540367|526522112|FG001|Overall Study|Adverse Event|0|||
146001586|NCT04540367|526522113|FG002|Overall Study|Adverse Event|1|||
146001587|NCT04540367|526522114|FG003|Overall Study|Adverse Event|1|||
146001588|NCT00907621|526522118|FG000|Overall Study|Lost to Follow-up|6|||
146001589|NCT00907621|526522119|FG001|Overall Study|Lost to Follow-up|3|||
146001590|NCT00907621|526522118|FG000|Overall Study|intercurrent febrile illness|1|||
146001591|NCT00907621|526522119|FG001|Overall Study|intercurrent febrile illness|1|||
146001592|NCT00902330|526522124|FG000|Overall Study|Too overwhelmed by treatment|2|||
146001593|NCT00902330|526522125|FG001|Overall Study|Too overwhelmed by treatment|5|||
146001594|NCT00902330|526522124|FG000|Overall Study|Adverse Event|1|||
146001595|NCT00902330|526522125|FG001|Overall Study|Adverse Event|0|||
146001596|NCT00902330|526522124|FG000|Overall Study|No post baseline data|1|||
146001597|NCT00902330|526522125|FG001|Overall Study|No post baseline data|0|||
146001598|NCT00165789|526522126|FG000|Overall Study|Adverse Event|0|||
146001599|NCT00165789|526522127|FG001|Overall Study|Adverse Event|3|||
146001600|NCT00165789|526522128|FG002|Overall Study|Adverse Event|0|||
146001601|NCT00165789|526522129|FG003|Overall Study|Adverse Event|12|||
146001602|NCT00165789|526522126|FG000|Overall Study|Withdrawal by Subject|0|||
146001603|NCT00165789|526522127|FG001|Overall Study|Withdrawal by Subject|1|||
146001604|NCT00165789|526522128|FG002|Overall Study|Withdrawal by Subject|1|||
146001605|NCT00165789|526522129|FG003|Overall Study|Withdrawal by Subject|2|||
146001606|NCT01816048|526522130|FG000|Overall Study|Adverse Event|1|||
146001607|NCT01816048|526522130|FG000|Overall Study|Death|1|||
146001608|NCT01816048|526522130|FG000|Overall Study|Withdrawal by Subject|1|||
146001609|NCT01816048|526522130|FG000|Overall Study|Disease Progression|3|||
146001610|NCT04290624|526522131|FG000|Overall Study|Adverse Event|1|||
146001611|NCT04290624|526522132|FG001|Overall Study|Adverse Event|0|||
146001612|NCT01847443|526522133|FG000|Study Period 1|Withdrawal by Subject|0|||
146001613|NCT01847443|526522134|FG001|Study Period 1|Withdrawal by Subject|1|||
146001614|NCT01847443|526522135|FG002|Study Period 1|Withdrawal by Subject|0|||
146001615|NCT01847443|526522136|FG003|Study Period 1|Withdrawal by Subject|0|||
146001616|NCT01847443|526522133|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
146001617|NCT01847443|526522134|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
146001618|NCT01847443|526522135|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
146001619|NCT01847443|526522136|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
146001620|NCT01847443|526522133|FG000|Washout Period Before Study Period 2|Other reason|1|||
146001621|NCT01847443|526522134|FG001|Washout Period Before Study Period 2|Other reason|0|||
146001622|NCT01847443|526522135|FG002|Washout Period Before Study Period 2|Other reason|0|||
146001623|NCT01847443|526522136|FG003|Washout Period Before Study Period 2|Other reason|0|||
146001624|NCT01847443|526522133|FG000|Washout Period Before Study Period 3|Other reason|1|||
146001625|NCT01847443|526522134|FG001|Washout Period Before Study Period 3|Other reason|0|||
146001626|NCT01847443|526522135|FG002|Washout Period Before Study Period 3|Other reason|0|||
146001627|NCT01847443|526522136|FG003|Washout Period Before Study Period 3|Other reason|0|||
146001628|NCT01847443|526522133|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
146001629|NCT01847443|526522134|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146001630|NCT01847443|526522135|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146001631|NCT01847443|526522136|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
146001632|NCT01847443|526522133|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
146001633|NCT01847443|526522134|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
146001634|NCT01847443|526522135|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
146001635|NCT01847443|526522136|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
146001636|NCT03571971|526522137|FG000|Overall Study|Lost to Follow-up|2|||
146001637|NCT03571971|526522138|FG001|Overall Study|Lost to Follow-up|2|||
146001638|NCT03571971|526522137|FG000|Overall Study|Protocol Violation|2|||
146001639|NCT03571971|526522138|FG001|Overall Study|Protocol Violation|3|||
146001640|NCT03571971|526522137|FG000|Overall Study|Withdrawal by Subject|2|||
146001641|NCT03571971|526522138|FG001|Overall Study|Withdrawal by Subject|0|||
146001642|NCT03571971|526522137|FG000|Overall Study|Incomplete primary outcome data|2|||
146001643|NCT03571971|526522138|FG001|Overall Study|Incomplete primary outcome data|0|||
146001644|NCT04067492|526522139|FG000|Overall Study|Lost to Follow-up|0|||
146001645|NCT04067492|526522140|FG001|Overall Study|Lost to Follow-up|0|||
146001646|NCT04067492|526522141|FG002|Overall Study|Lost to Follow-up|0|||
146001647|NCT04067492|526522142|FG003|Overall Study|Lost to Follow-up|0|||
146001648|NCT04067492|526522143|FG004|Overall Study|Lost to Follow-up|0|||
146001649|NCT04067492|526522144|FG005|Overall Study|Lost to Follow-up|1|||
146001650|NCT04067492|526522139|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146001651|NCT04067492|526522140|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
146001652|NCT04067492|526522141|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146001653|NCT04067492|526522142|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146001654|NCT04067492|526522143|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146001655|NCT04067492|526522144|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
146001656|NCT04067492|526522139|FG000|Overall Study|COVID-19 epidemiological situation|0|||
146001657|NCT04067492|526522140|FG001|Overall Study|COVID-19 epidemiological situation|0|||
146247488|NCT01138657|527419874|FG000|Overall Study|Adverse Event|3|||
146001658|NCT04067492|526522141|FG002|Overall Study|COVID-19 epidemiological situation|0|||
146001659|NCT04067492|526522142|FG003|Overall Study|COVID-19 epidemiological situation|1|||
146001660|NCT04067492|526522143|FG004|Overall Study|COVID-19 epidemiological situation|0|||
146001661|NCT04067492|526522144|FG005|Overall Study|COVID-19 epidemiological situation|0|||
146001662|NCT03950856|526522152|FG000|Overall Study|Death|1|||
146001663|NCT03950856|526522153|FG001|Overall Study|Death|2|||
146001664|NCT03950856|526522154|FG002|Overall Study|Death|0|||
146001665|NCT03950856|526522155|FG003|Overall Study|Death|0|||
146001666|NCT03950856|526522152|FG000|Overall Study|Lost to Follow-up|5|||
146001667|NCT03950856|526522153|FG001|Overall Study|Lost to Follow-up|6|||
146001668|NCT03950856|526522154|FG002|Overall Study|Lost to Follow-up|8|||
146001669|NCT03950856|526522155|FG003|Overall Study|Lost to Follow-up|2|||
146001670|NCT03950856|526522152|FG000|Overall Study|Protocol Violation|2|||
146001671|NCT03950856|526522153|FG001|Overall Study|Protocol Violation|0|||
146001672|NCT03950856|526522154|FG002|Overall Study|Protocol Violation|0|||
146001673|NCT03950856|526522155|FG003|Overall Study|Protocol Violation|1|||
146001674|NCT03950856|526522152|FG000|Overall Study|Withdrawal by Subject|4|||
146001675|NCT03950856|526522153|FG001|Overall Study|Withdrawal by Subject|1|||
146001676|NCT03950856|526522154|FG002|Overall Study|Withdrawal by Subject|3|||
146001677|NCT03950856|526522155|FG003|Overall Study|Withdrawal by Subject|1|||
146001678|NCT03950856|526522152|FG000|Overall Study|Unable to phone|7|||
146001679|NCT03950856|526522153|FG001|Overall Study|Unable to phone|6|||
146001680|NCT03950856|526522154|FG002|Overall Study|Unable to phone|7|||
146001681|NCT03950856|526522155|FG003|Overall Study|Unable to phone|2|||
146001682|NCT00656370|526522156|FG000|Overall Study|Screen Failures|7|||
146001683|NCT00656370|526522156|FG000|Overall Study|Alternates|3|||
146001684|NCT03402841|526522162|FG000|Overall Study|Withdrawal by Subject|3|||
146001685|NCT03402841|526522162|FG000|Overall Study|Lost to Follow-up|2|||
146001686|NCT03402841|526522162|FG000|Overall Study|Death|146|||
146001687|NCT03984188|526522165|FG000|Overall Study|Death|2|||
146001688|NCT03984188|526522166|FG001|Overall Study|Death|4|||
146001689|NCT03984188|526522165|FG000|Overall Study|Physician Decision|0|||
146001690|NCT03984188|526522166|FG001|Overall Study|Physician Decision|2|||
146001691|NCT03984188|526522165|FG000|Overall Study|Lost to Follow-up|3|||
146001692|NCT03984188|526522166|FG001|Overall Study|Lost to Follow-up|2|||
146001693|NCT03984188|526522165|FG000|Overall Study|Withdrawal by Subject|6|||
146001694|NCT03984188|526522166|FG001|Overall Study|Withdrawal by Subject|0|||
146001695|NCT03384875|526522167|FG000|Overall Study|Death|1|||
146001696|NCT03384875|526522168|FG001|Overall Study|Death|1|||
146001697|NCT03384875|526522169|FG002|Overall Study|Death|0|||
146001698|NCT03384875|526522167|FG000|Overall Study|Reason not provided|1|||
146001699|NCT03384875|526522168|FG001|Overall Study|Reason not provided|0|||
146001700|NCT03384875|526522169|FG002|Overall Study|Reason not provided|0|||
146056138|NCT03452540|526721105|FG000|Overall Study|Withdrawal by Subject|1|||
146056139|NCT03452540|526721105|FG000|Overall Study|Other SAE and AE|2|||
146247489|NCT01138657|527419875|FG001|Overall Study|Adverse Event|10|||
146247490|NCT01138657|527419874|FG000|Overall Study|Lack of Efficacy|2|||
146247491|NCT01138657|527419875|FG001|Overall Study|Lack of Efficacy|1|||
146247492|NCT01138657|527419874|FG000|Overall Study|Lost to Follow-up|0|||
146247493|NCT01138657|527419875|FG001|Overall Study|Lost to Follow-up|3|||
146247494|NCT01138657|527419874|FG000|Overall Study|Miscellaneous Reasons|3|||
146056140|NCT01582061|526721106|FG000|Overall Study|Lack of Efficacy|3|||
146056141|NCT01582061|526721107|FG001|Overall Study|Lack of Efficacy|23|||
146247495|NCT01138657|527419875|FG001|Overall Study|Miscellaneous Reasons|4|||
146247496|NCT02159352|527419876|FG000|Overall Study|Adverse Event|3|||
146247497|NCT02159352|527419877|FG001|Overall Study|Adverse Event|1|||
146298083|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
146056142|NCT01582061|526721106|FG000|Overall Study|Adverse Event|12|||
146056143|NCT01582061|526721107|FG001|Overall Study|Adverse Event|8|||
146056144|NCT01582061|526721106|FG000|Overall Study|Withdrawal by Subject|10|||
146056145|NCT01582061|526721107|FG001|Overall Study|Withdrawal by Subject|4|||
146056146|NCT01582061|526721106|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146056147|NCT01582061|526721107|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146056148|NCT01582061|526721106|FG000|Overall Study|Death|0|||
146056149|NCT01582061|526721107|FG001|Overall Study|Death|1|||
146056150|NCT01582061|526721106|FG000|Overall Study|condition no longer requires study drug|1|||
146298084|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
146056151|NCT01582061|526721107|FG001|Overall Study|condition no longer requires study drug|0|||
146056152|NCT01582061|526721106|FG000|Overall Study|Lost to Follow-up|1|||
146056153|NCT01582061|526721107|FG001|Overall Study|Lost to Follow-up|0|||
146056154|NCT04664153|526721110|FG000|Overall Study|Lack of Efficacy|0|||
146056155|NCT04664153|526721111|FG001|Overall Study|Lack of Efficacy|0|||
146056156|NCT04664153|526721112|FG002|Overall Study|Lack of Efficacy|1|||
146056157|NCT04664153|526721113|FG003|Overall Study|Lack of Efficacy|0|||
146247498|NCT02159352|527419876|FG000|Overall Study|Withdrawal by Subject|0|||
146056158|NCT04664153|526721110|FG000|Overall Study|Physician Decision|0|||
146056159|NCT04664153|526721111|FG001|Overall Study|Physician Decision|0|||
146056160|NCT04664153|526721112|FG002|Overall Study|Physician Decision|1|||
146056161|NCT04664153|526721113|FG003|Overall Study|Physician Decision|0|||
146247499|NCT02159352|527419877|FG001|Overall Study|Withdrawal by Subject|1|||
146001701|NCT00272792|526524162|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
146001702|NCT00272792|526524163|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
146001703|NCT00272792|526524162|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
146001704|NCT00272792|526524163|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
146001705|NCT00272792|526524162|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
146001706|NCT00272792|526524163|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
146001707|NCT00272792|526524162|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
146001708|NCT00272792|526524163|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
146001709|NCT01047007|526524166|FG000|Overall Study|Adverse Event|0|||
146001710|NCT01047007|526524167|FG001|Overall Study|Adverse Event|2|||
146001711|NCT01047007|526524168|FG002|Overall Study|Adverse Event|1|||
146001712|NCT01047007|526524169|FG003|Overall Study|Adverse Event|0|||
146001713|NCT01047007|526524166|FG000|Overall Study|Progressive Disease|2|||
146001714|NCT01047007|526524167|FG001|Overall Study|Progressive Disease|4|||
146001715|NCT01047007|526524168|FG002|Overall Study|Progressive Disease|1|||
146001716|NCT01047007|526524169|FG003|Overall Study|Progressive Disease|0|||
146001717|NCT03759600|526524178|FG000|Overall Study|Adverse Event|2|||
146001718|NCT03759600|526524178|FG000|Overall Study|Progressive Disease|15|||
146001719|NCT03759600|526524178|FG000|Overall Study|Site Terminated by Sponsor|3|||
146001720|NCT03257358|526524179|FG000|Overall Study|Adverse Event|25|||
146001721|NCT03257358|526524180|FG001|Overall Study|Adverse Event|12|||
146001722|NCT03257358|526524179|FG000|Overall Study|Lack of Efficacy|1|||
146001723|NCT03257358|526524180|FG001|Overall Study|Lack of Efficacy|1|||
146001724|NCT03257358|526524179|FG000|Overall Study|Lost to Follow-up|12|||
146001725|NCT03257358|526524180|FG001|Overall Study|Lost to Follow-up|4|||
146001726|NCT03257358|526524179|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
146001727|NCT03257358|526524180|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
146001728|NCT03257358|526524179|FG000|Overall Study|Physician Decision|2|||
146001729|NCT03257358|526524180|FG001|Overall Study|Physician Decision|2|||
146001730|NCT03257358|526524179|FG000|Overall Study|Protocol Violation|5|||
146001731|NCT03257358|526524180|FG001|Overall Study|Protocol Violation|3|||
146001732|NCT03257358|526524179|FG000|Overall Study|Technical problems|4|||
146001733|NCT03257358|526524180|FG001|Overall Study|Technical problems|1|||
146001734|NCT03257358|526524179|FG000|Overall Study|Withdrawal by Subject|8|||
146001735|NCT03257358|526524180|FG001|Overall Study|Withdrawal by Subject|3|||
146001736|NCT03257358|526524179|FG000|Overall Study|Withdrawal of informed consent|9|||
146001737|NCT03257358|526524180|FG001|Overall Study|Withdrawal of informed consent|5|||
146001738|NCT03257358|526524179|FG000|Overall Study|New therapy for study indication|1|||
146001739|NCT03257358|526524180|FG001|Overall Study|New therapy for study indication|0|||
146001740|NCT03257358|526524179|FG000|Overall Study|No longer requires treatment|0|||
146001741|NCT03257358|526524180|FG001|Overall Study|No longer requires treatment|1|||
146001742|NCT01248793|526524181|FG000|Overall Study|Lost to Follow-up|0|||
146001743|NCT01248793|526524182|FG001|Overall Study|Lost to Follow-up|1|||
146001744|NCT01248793|526524181|FG000|Overall Study|Adverse Event|1|||
146001745|NCT01248793|526524182|FG001|Overall Study|Adverse Event|1|||
146001746|NCT01248793|526524181|FG000|Overall Study|Protocol Violation|0|||
146001747|NCT01248793|526524182|FG001|Overall Study|Protocol Violation|1|||
146001748|NCT01248793|526524181|FG000|Overall Study|Withdrawal by Subject|3|||
146001749|NCT01248793|526524182|FG001|Overall Study|Withdrawal by Subject|3|||
146001750|NCT02332187|526524183|FG000|Overall Study|Withdrawal by Subject|2|||
146001751|NCT02332187|526524184|FG001|Overall Study|Withdrawal by Subject|2|||
146001752|NCT02332187|526524183|FG000|Overall Study|Adverse Event|0|||
146001753|NCT02332187|526524184|FG001|Overall Study|Adverse Event|1|||
146001754|NCT01747915|526524185|FG000|Overall Study|Other|1|||
146001755|NCT01747915|526524186|FG001|Overall Study|Other|1|||
146001756|NCT01747915|526524187|FG002|Overall Study|Other|1|||
146001757|NCT01747915|526524185|FG000|Overall Study|Adverse Event|8|||
146001758|NCT01747915|526524186|FG001|Overall Study|Adverse Event|5|||
146001759|NCT01747915|526524187|FG002|Overall Study|Adverse Event|2|||
146001760|NCT01747915|526524185|FG000|Overall Study|Death|0|||
146001761|NCT01747915|526524186|FG001|Overall Study|Death|0|||
146001762|NCT01747915|526524187|FG002|Overall Study|Death|1|||
146001763|NCT01747915|526524185|FG000|Overall Study|Lack of Efficacy|0|||
146298085|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
146001764|NCT01747915|526524186|FG001|Overall Study|Lack of Efficacy|1|||
146001765|NCT01747915|526524187|FG002|Overall Study|Lack of Efficacy|0|||
146001766|NCT01747915|526524185|FG000|Overall Study|Lost to Follow-up|1|||
146001767|NCT01747915|526524186|FG001|Overall Study|Lost to Follow-up|0|||
146001768|NCT01747915|526524187|FG002|Overall Study|Lost to Follow-up|0|||
146001769|NCT01747915|526524185|FG000|Overall Study|Withdrawal by Subject|4|||
146001770|NCT01747915|526524186|FG001|Overall Study|Withdrawal by Subject|4|||
146001771|NCT01747915|526524187|FG002|Overall Study|Withdrawal by Subject|1|||
146001772|NCT01747915|526524185|FG000|Overall Study|Protocol Violation|1|||
146001773|NCT01747915|526524186|FG001|Overall Study|Protocol Violation|0|||
146001774|NCT01747915|526524187|FG002|Overall Study|Protocol Violation|0|||
146001775|NCT01747915|526524185|FG000|Overall Study|Pregnancy|0|||
146001776|NCT01747915|526524186|FG001|Overall Study|Pregnancy|0|||
146001777|NCT01747915|526524187|FG002|Overall Study|Pregnancy|1|||
146001778|NCT02391311|526524190|FG000|Overall Study|Lost to Follow-up|2|||
146001779|NCT02391311|526524191|FG001|Overall Study|Lost to Follow-up|1|||
146001780|NCT02391311|526524190|FG000|Overall Study|deemed ineligible after baseline|1|||
146001781|NCT02391311|526524191|FG001|Overall Study|deemed ineligible after baseline|1|||
146001782|NCT03183063|526524192|FG000|Overall Study|Withdrawal by Subject|2|||
146001783|NCT03183063|526524193|FG001|Overall Study|Withdrawal by Subject|0|||
146001784|NCT03183063|526524194|FG002|Overall Study|Withdrawal by Subject|0|||
146001785|NCT03183063|526524192|FG000|Overall Study|Physician Decision|3|||
146001786|NCT03183063|526524193|FG001|Overall Study|Physician Decision|4|||
146001787|NCT03183063|526524194|FG002|Overall Study|Physician Decision|4|||
146001788|NCT00688467|526524195|FG000|Treatment Period 1|Adverse Event|2|||
146001789|NCT00688467|526524196|FG001|Treatment Period 1|Adverse Event|1|||
146001790|NCT00688467|526524195|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
146001791|NCT00688467|526524196|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
146001792|NCT00688467|526524195|FG000|Treatment Period 2|Protocol Violation|0|||
146001793|NCT00688467|526524196|FG001|Treatment Period 2|Protocol Violation|1|||
146001794|NCT00688467|526524195|FG000|Treatment Period 2|Adverse Event|0|||
146001795|NCT00688467|526524196|FG001|Treatment Period 2|Adverse Event|1|||
146001796|NCT01073293|526524201|FG000|Overall Study|Lost to Follow-up|0|||
146001797|NCT01073293|526524202|FG001|Overall Study|Lost to Follow-up|1|||
146001798|NCT01073293|526524201|FG000|Overall Study|Withdrawal by Subject|5|||
146001799|NCT01073293|526524202|FG001|Overall Study|Withdrawal by Subject|10|||
146001800|NCT00305448|526524203|FG000|Overall Study|Protocol Violation|0|||
146001801|NCT00305448|526524204|FG001|Overall Study|Protocol Violation|1|||
146001802|NCT00305448|526524205|FG002|Overall Study|Protocol Violation|0|||
146001803|NCT00305448|526524203|FG000|Overall Study|Withdrawal by Subject|2|||
146001804|NCT00305448|526524204|FG001|Overall Study|Withdrawal by Subject|0|||
146001805|NCT00305448|526524205|FG002|Overall Study|Withdrawal by Subject|1|||
146001806|NCT00305448|526524203|FG000|Overall Study|Adverse Event|1|||
146001807|NCT00305448|526524204|FG001|Overall Study|Adverse Event|0|||
146001808|NCT00305448|526524205|FG002|Overall Study|Adverse Event|1|||
146001809|NCT00305448|526524203|FG000|Overall Study|Disease Progression|27|||
146001810|NCT00305448|526524204|FG001|Overall Study|Disease Progression|31|||
146001811|NCT00305448|526524205|FG002|Overall Study|Disease Progression|28|||
146001812|NCT00305448|526524203|FG000|Overall Study|Subjective Disease Progression|1|||
146001813|NCT00305448|526524204|FG001|Overall Study|Subjective Disease Progression|2|||
146001814|NCT00305448|526524205|FG002|Overall Study|Subjective Disease Progression|2|||
146001815|NCT00305448|526524203|FG000|Overall Study|Tumor Marker Elevation|0|||
146001816|NCT00305448|526524204|FG001|Overall Study|Tumor Marker Elevation|0|||
146001817|NCT00305448|526524205|FG002|Overall Study|Tumor Marker Elevation|1|||
146001818|NCT00077974|526524206|FG000|Overall Study|Adverse Event|22|||
146001819|NCT00077974|526524206|FG000|Overall Study|Protocol Violation|1|||
146001820|NCT00077974|526524206|FG000|Overall Study|Withdrawal by Subject|3|||
146001821|NCT00077974|526524206|FG000|Overall Study|Lack of Efficacy|76|||
146001822|NCT00077974|526524206|FG000|Overall Study|Decision of Sponsor|2|||
146001823|NCT01343888|526524207|FG000|Overall Study|Adverse Event|12|||
146001824|NCT01343888|526524208|FG001|Overall Study|Adverse Event|22|||
146001825|NCT01343888|526524209|FG002|Overall Study|Adverse Event|5|||
146001826|NCT01343888|526524207|FG000|Overall Study|Lack of Efficacy|9|||
146001827|NCT01343888|526524208|FG001|Overall Study|Lack of Efficacy|9|||
146001828|NCT01343888|526524209|FG002|Overall Study|Lack of Efficacy|13|||
146001829|NCT01343888|526524207|FG000|Overall Study|Lost to Follow-up|0|||
146001830|NCT01343888|526524208|FG001|Overall Study|Lost to Follow-up|2|||
146001831|NCT01343888|526524209|FG002|Overall Study|Lost to Follow-up|1|||
146001832|NCT01343888|526524207|FG000|Overall Study|Protocol Violation|0|||
146001833|NCT01343888|526524208|FG001|Overall Study|Protocol Violation|2|||
146001834|NCT01343888|526524209|FG002|Overall Study|Protocol Violation|0|||
146001835|NCT01343888|526524207|FG000|Overall Study|Withdrawal by Subject|4|||
146001836|NCT01343888|526524208|FG001|Overall Study|Withdrawal by Subject|4|||
146001837|NCT01343888|526524209|FG002|Overall Study|Withdrawal by Subject|2|||
146001838|NCT01343888|526524207|FG000|Overall Study|other than stated above|0|||
146001839|NCT01343888|526524208|FG001|Overall Study|other than stated above|0|||
146001840|NCT01343888|526524209|FG002|Overall Study|other than stated above|1|||
146001841|NCT04108273|526524221|FG000|Overall Study|COVID Pandemic|1|||
146092366|NCT03953183|526860280|FG000|Overall Study|Withdrawal by Subject|0|||
146001842|NCT04108273|526524222|FG001|Overall Study|COVID Pandemic|0|||
146001843|NCT00506142|526524223|FG000|Overall Study|Adverse Event|8|||
146001844|NCT00506142|526524224|FG001|Overall Study|Adverse Event|7|||
146001845|NCT00506142|526524223|FG000|Overall Study|Lack of Efficacy|21|||
146001846|NCT00506142|526524224|FG001|Overall Study|Lack of Efficacy|7|||
146001847|NCT00506142|526524223|FG000|Overall Study|Withdrawal by Subject|4|||
146001848|NCT00506142|526524224|FG001|Overall Study|Withdrawal by Subject|5|||
146001849|NCT00506142|526524223|FG000|Overall Study|Physician Decision|1|||
146001850|NCT00506142|526524224|FG001|Overall Study|Physician Decision|0|||
146001851|NCT00506142|526524223|FG000|Overall Study|New health condition|1|||
146001852|NCT00506142|526524224|FG001|Overall Study|New health condition|0|||
146001853|NCT03500211|526524229|FG000|Overall Study|Withdrawal by Subject|1|||
146001854|NCT03500211|526524230|FG001|Overall Study|Withdrawal by Subject|1|||
146001855|NCT04460183|526524231|FG000|Overall Study|Lost to Follow-up|3|||
146001856|NCT04460183|526524232|FG001|Overall Study|Lost to Follow-up|1|||
146001857|NCT04460183|526524231|FG000|Overall Study|Withdrawal by Subject|1|||
146001858|NCT04460183|526524232|FG001|Overall Study|Withdrawal by Subject|0|||
146001859|NCT00487981|526524233|FG000|Overall Study|Hypothyroidism diagnosis|1|||
146001860|NCT03848416|526524235|FG000|Overall Study|Withdrawal by Subject|1|||
146001861|NCT03848416|526524236|FG001|Overall Study|Withdrawal by Subject|0|||
146001862|NCT03848416|526524237|FG002|Overall Study|Withdrawal by Subject|0|||
146001863|NCT03848416|526524235|FG000|Overall Study|Death|0|||
146001864|NCT03848416|526524236|FG001|Overall Study|Death|0|||
146001865|NCT03848416|526524237|FG002|Overall Study|Death|1|||
146001866|NCT00856609|526524245|FG000|Overall Study|Adverse Event|1|||
146001867|NCT00856609|526524246|FG001|Overall Study|Adverse Event|0|||
146001868|NCT00783432|526524247|FG000|Overall Study|Adverse Event|22|||
146001869|NCT00783432|526524248|FG001|Overall Study|Adverse Event|17|||
146001870|NCT00783432|526524247|FG000|Overall Study|Lack of Efficacy|20|||
146001871|NCT00783432|526524248|FG001|Overall Study|Lack of Efficacy|21|||
146001872|NCT00783432|526524247|FG000|Overall Study|Lost to Follow-up|11|||
146001873|NCT00783432|526524248|FG001|Overall Study|Lost to Follow-up|6|||
146001874|NCT00783432|526524247|FG000|Overall Study|Withdrawal by Subject|23|||
146001875|NCT00783432|526524248|FG001|Overall Study|Withdrawal by Subject|20|||
146001876|NCT00783432|526524247|FG000|Overall Study|subject moved|3|||
146001877|NCT00783432|526524248|FG001|Overall Study|subject moved|5|||
146001878|NCT00783432|526524247|FG000|Overall Study|Protocol Violation|6|||
146001879|NCT00783432|526524248|FG001|Overall Study|Protocol Violation|9|||
146001880|NCT01436110|526524249|FG000|Overall Study|Lack of Efficacy|23|||
146001881|NCT01436110|526524250|FG001|Overall Study|Lack of Efficacy|14|||
146001882|NCT01436110|526524251|FG002|Overall Study|Lack of Efficacy|9|||
146001883|NCT01436110|526524249|FG000|Overall Study|Withdrawal by Subject|6|||
146001884|NCT01436110|526524250|FG001|Overall Study|Withdrawal by Subject|8|||
146001885|NCT01436110|526524251|FG002|Overall Study|Withdrawal by Subject|4|||
146001886|NCT01436110|526524249|FG000|Overall Study|Adverse Event|2|||
146001887|NCT01436110|526524250|FG001|Overall Study|Adverse Event|1|||
146001888|NCT01436110|526524251|FG002|Overall Study|Adverse Event|2|||
146001889|NCT01436110|526524249|FG000|Overall Study|Physician Decision|3|||
146001890|NCT01436110|526524250|FG001|Overall Study|Physician Decision|1|||
146001891|NCT01436110|526524251|FG002|Overall Study|Physician Decision|1|||
146001892|NCT01436110|526524249|FG000|Overall Study|Lost to Follow-up|1|||
146001893|NCT01436110|526524250|FG001|Overall Study|Lost to Follow-up|1|||
146001894|NCT01436110|526524251|FG002|Overall Study|Lost to Follow-up|3|||
146001895|NCT01436110|526524249|FG000|Overall Study|Protocol Violation|3|||
146001896|NCT01436110|526524250|FG001|Overall Study|Protocol Violation|1|||
146001897|NCT01436110|526524251|FG002|Overall Study|Protocol Violation|1|||
146001898|NCT01436110|526524249|FG000|Overall Study|Did Not Receive Trial Medication|1|||
146001899|NCT01436110|526524250|FG001|Overall Study|Did Not Receive Trial Medication|0|||
146001900|NCT01436110|526524251|FG002|Overall Study|Did Not Receive Trial Medication|3|||
146001901|NCT03273907|526524252|FG000|Overall Study|Death|1|||
146001902|NCT03273907|526524252|FG000|Overall Study|Lost to Follow-up|4|||
146001903|NCT03273907|526524252|FG000|Overall Study|Withdrawal by Subject|2|||
146001904|NCT03273907|526524252|FG000|Overall Study|COVID 19|2|||
146001905|NCT01088503|526524253|FG000|Overall Study|Withdrawal by Subject|118|||
146001906|NCT01088503|526524254|FG001|Overall Study|Withdrawal by Subject|327|||
146001907|NCT01088503|526524255|FG002|Overall Study|Withdrawal by Subject|10|||
146001908|NCT01088503|526524253|FG000|Overall Study|Death|64|||
146001909|NCT01088503|526524254|FG001|Overall Study|Death|358|||
146001910|NCT01088503|526524255|FG002|Overall Study|Death|7|||
146001911|NCT00110214|526524256|FG000|Overall Study|Never started treatment|21|||
146001912|NCT00110214|526524257|FG001|Overall Study|Never started treatment|20|||
146001913|NCT00110214|526524256|FG000|Overall Study|Disease progression or death|260|||
146001914|NCT00110214|526524257|FG001|Overall Study|Disease progression or death|151|||
146001915|NCT00110214|526524256|FG000|Overall Study|Adverse Event|115|||
146001916|NCT00110214|526524257|FG001|Overall Study|Adverse Event|192|||
146001917|NCT00110214|526524256|FG000|Overall Study|Refused further treatment|52|||
146001918|NCT00110214|526524257|FG001|Overall Study|Refused further treatment|65|||
146001919|NCT00110214|526524256|FG000|Overall Study|Other (not specified)|61|||
146001920|NCT00110214|526524257|FG001|Overall Study|Other (not specified)|75|||
146001921|NCT01847092|526524258|FG000|Overall Study|Adverse Event|12|||
146092367|NCT03953183|526860281|FG001|Overall Study|Withdrawal by Subject|1|||
146092368|NCT02314143|526860284|FG000|Overall Study|Adverse Event|0|||
146092369|NCT02314143|526860285|FG001|Overall Study|Adverse Event|6|||
146001922|NCT01847092|526524259|FG001|Overall Study|Adverse Event|3|||
146001923|NCT01847092|526524258|FG000|Overall Study|Withdrawal by Subject|5|||
146001924|NCT01847092|526524259|FG001|Overall Study|Withdrawal by Subject|5|||
146001925|NCT01847092|526524258|FG000|Overall Study|Protocol Specified|8|||
146001926|NCT01847092|526524259|FG001|Overall Study|Protocol Specified|0|||
146001927|NCT01847092|526524258|FG000|Overall Study|Physician Decision|1|||
146001928|NCT01847092|526524259|FG001|Overall Study|Physician Decision|1|||
146001929|NCT01847092|526524258|FG000|Overall Study|Protocol Violation|0|||
146001930|NCT01847092|526524259|FG001|Overall Study|Protocol Violation|2|||
146001931|NCT03604497|526524261|FG000|Overall Study|Protocol Violation|52|||
146001932|NCT00811954|526524262|FG000|Overall Study|Death|10|||
146001933|NCT00811954|526524263|FG001|Overall Study|Death|6|||
146001934|NCT00811954|526524264|FG002|Overall Study|Death|13|||
146001935|NCT00811954|526524262|FG000|Overall Study|Lost to Follow-up|29|||
146001936|NCT00811954|526524263|FG001|Overall Study|Lost to Follow-up|23|||
146001937|NCT00811954|526524264|FG002|Overall Study|Lost to Follow-up|34|||
146001938|NCT00811954|526524262|FG000|Overall Study|Not able to get to clinic|28|||
146001939|NCT00811954|526524263|FG001|Overall Study|Not able to get to clinic|35|||
146001940|NCT00811954|526524264|FG002|Overall Study|Not able to get to clinic|30|||
146001941|NCT00811954|526524262|FG000|Overall Study|Not willing to adhere to requirements|12|||
146001942|NCT00811954|526524263|FG001|Overall Study|Not willing to adhere to requirements|2|||
146001943|NCT00811954|526524264|FG002|Overall Study|Not willing to adhere to requirements|16|||
146001944|NCT00811954|526524262|FG000|Overall Study|Withdraw consent prior study completion|4|||
146001945|NCT00811954|526524263|FG001|Overall Study|Withdraw consent prior study completion|6|||
146001946|NCT00811954|526524264|FG002|Overall Study|Withdraw consent prior study completion|5|||
146001947|NCT00811954|526524262|FG000|Overall Study|Site Closure|4|||
146001948|NCT00811954|526524263|FG001|Overall Study|Site Closure|0|||
146001949|NCT00811954|526524264|FG002|Overall Study|Site Closure|1|||
146001950|NCT00811954|526524262|FG000|Overall Study|Severe Debilitation|2|||
146001951|NCT00811954|526524263|FG001|Overall Study|Severe Debilitation|0|||
146001952|NCT00811954|526524264|FG002|Overall Study|Severe Debilitation|1|||
146001953|NCT00811954|526524262|FG000|Overall Study|Complete Protocol: No follow-up|0|||
146001954|NCT00811954|526524263|FG001|Overall Study|Complete Protocol: No follow-up|0|||
146001955|NCT00811954|526524264|FG002|Overall Study|Complete Protocol: No follow-up|1|||
146001956|NCT01016067|526524265|FG000|Overall Study|Lost to Follow-up|1|||
146001957|NCT01016067|526524266|FG001|Overall Study|Lost to Follow-up|2|||
146001958|NCT01016067|526524265|FG000|Overall Study|Physician Decision|1|||
146001959|NCT01016067|526524266|FG001|Overall Study|Physician Decision|1|||
146001960|NCT01016067|526524265|FG000|Overall Study|Withdrew due to Relocation|0|||
146001961|NCT01016067|526524266|FG001|Overall Study|Withdrew due to Relocation|1|||
146001962|NCT00186628|526524268|FG000|Overall Study|Death|2|||
146001963|NCT00186628|526524268|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
146001964|NCT01331681|526524270|FG000|Overall Study|Adverse Event|10|||
146001965|NCT01331681|526524271|FG001|Overall Study|Adverse Event|13|||
146001966|NCT01331681|526524272|FG002|Overall Study|Adverse Event|10|||
146001967|NCT01331681|526524270|FG000|Overall Study|Death|6|||
146001968|NCT01331681|526524271|FG001|Overall Study|Death|6|||
146001969|NCT01331681|526524272|FG002|Overall Study|Death|2|||
146001970|NCT01331681|526524270|FG000|Overall Study|Lack of Efficacy|0|||
146001971|NCT01331681|526524271|FG001|Overall Study|Lack of Efficacy|1|||
146001972|NCT01331681|526524272|FG002|Overall Study|Lack of Efficacy|0|||
146001973|NCT01331681|526524270|FG000|Overall Study|Withdrawal by Subject|12|||
146001974|NCT01331681|526524271|FG001|Overall Study|Withdrawal by Subject|8|||
146001975|NCT01331681|526524272|FG002|Overall Study|Withdrawal by Subject|15|||
146001976|NCT01331681|526524270|FG000|Overall Study|Protocol Violation|1|||
146001977|NCT01331681|526524271|FG001|Overall Study|Protocol Violation|1|||
146001978|NCT01331681|526524272|FG002|Overall Study|Protocol Violation|0|||
146001979|NCT01331681|526524270|FG000|Overall Study|Lost to Follow-up|2|||
146001980|NCT01331681|526524271|FG001|Overall Study|Lost to Follow-up|4|||
146001981|NCT01331681|526524272|FG002|Overall Study|Lost to Follow-up|1|||
146001982|NCT01331681|526524270|FG000|Overall Study|Physician Decision|2|||
146001983|NCT01331681|526524271|FG001|Overall Study|Physician Decision|0|||
146001984|NCT01331681|526524272|FG002|Overall Study|Physician Decision|4|||
146001985|NCT01331681|526524270|FG000|Overall Study|Therapeutic procedure required|1|||
146001986|NCT01331681|526524271|FG001|Overall Study|Therapeutic procedure required|0|||
146001987|NCT01331681|526524272|FG002|Overall Study|Therapeutic procedure required|0|||
146001988|NCT01331681|526524270|FG000|Overall Study|Sponsor decision|1|||
146001989|NCT01331681|526524271|FG001|Overall Study|Sponsor decision|1|||
146001990|NCT01331681|526524272|FG002|Overall Study|Sponsor decision|0|||
146001991|NCT01331681|526524270|FG000|Overall Study|Switching to other therapy|0|||
146001992|NCT01331681|526524271|FG001|Overall Study|Switching to other therapy|0|||
146001993|NCT01331681|526524272|FG002|Overall Study|Switching to other therapy|1|||
146001994|NCT01331681|526524270|FG000|Overall Study|Not Received Study Treatment|0|||
146001995|NCT01331681|526524271|FG001|Overall Study|Not Received Study Treatment|0|||
146001996|NCT01331681|526524272|FG002|Overall Study|Not Received Study Treatment|2|||
146001997|NCT04828707|526524279|FG000|Overall Study|Lost to Follow-up|3|||
146001998|NCT04828707|526524280|FG001|Overall Study|Lost to Follow-up|2|||
146001999|NCT04828707|526524279|FG000|Overall Study|Withdrawal by Subject|2|||
146002000|NCT04828707|526524280|FG001|Overall Study|Withdrawal by Subject|1|||
146002001|NCT02394561|526524283|FG000|CORE Phase|Adverse Event|7|||
146002002|NCT02394561|526524284|FG001|CORE Phase|Adverse Event|9|||
146002003|NCT02394561|526524283|FG000|CORE Phase|Death|0|||
146002004|NCT02394561|526524284|FG001|CORE Phase|Death|1|||
146002005|NCT02394561|526524283|FG000|CORE Phase|Pregnancy|1|||
146002006|NCT02394561|526524284|FG001|CORE Phase|Pregnancy|0|||
146092370|NCT02314143|526860286|FG002|Overall Study|Adverse Event|4|||
146002007|NCT02394561|526524283|FG000|CORE Phase|Lost to Follow-up|1|||
146002008|NCT02394561|526524284|FG001|CORE Phase|Lost to Follow-up|0|||
146002009|NCT02394561|526524283|FG000|CORE Phase|Physician Decision|1|||
146002010|NCT02394561|526524284|FG001|CORE Phase|Physician Decision|1|||
146002011|NCT02394561|526524283|FG000|CORE Phase|Withdrawal by Subject|2|||
146002012|NCT02394561|526524284|FG001|CORE Phase|Withdrawal by Subject|2|||
146002013|NCT02394561|526524283|FG000|CORE Phase|Lack of Efficacy|1|||
146002014|NCT02394561|526524284|FG001|CORE Phase|Lack of Efficacy|6|||
146002015|NCT02394561|526524283|FG000|Extension Phase|Adverse Event|6|||
146002016|NCT02394561|526524284|FG001|Extension Phase|Adverse Event|1|||
146002017|NCT02394561|526524283|FG000|Extension Phase|Death|0|||
146002018|NCT02394561|526524284|FG001|Extension Phase|Death|1|||
146002019|NCT02394561|526524283|FG000|Extension Phase|Protocol Violation|1|||
146002020|NCT02394561|526524284|FG001|Extension Phase|Protocol Violation|0|||
146002021|NCT02394561|526524283|FG000|Extension Phase|Lost to Follow-up|1|||
146002022|NCT02394561|526524284|FG001|Extension Phase|Lost to Follow-up|0|||
146002023|NCT02394561|526524283|FG000|Extension Phase|Physician Decision|0|||
146002024|NCT02394561|526524284|FG001|Extension Phase|Physician Decision|2|||
146002025|NCT02394561|526524283|FG000|Extension Phase|Withdrawal by Subject|0|||
146002026|NCT02394561|526524284|FG001|Extension Phase|Withdrawal by Subject|5|||
146002027|NCT02394561|526524283|FG000|Extension Phase|Lack of Efficacy|3|||
146002028|NCT02394561|526524284|FG001|Extension Phase|Lack of Efficacy|3|||
146002029|NCT00501644|526524285|FG000|Overall Study|Adverse Event|4|||
146002030|NCT00501644|526524285|FG000|Overall Study|Withdrawal by Subject|1|||
146002031|NCT02553629|526524286|FG000|Overall Study|Logistic reasons|3|||
146002032|NCT02553629|526524287|FG001|Overall Study|Logistic reasons|6|||
146002033|NCT00696878|526524290|FG000|Overall Study|Adverse Event|8|||
146002034|NCT00696878|526524290|FG000|Overall Study|Withdrawal by Subject|87|||
146002035|NCT00696878|526524290|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
146002036|NCT00696878|526524290|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
146002037|NCT00696878|526524290|FG000|Overall Study|Trial stopped|32|||
146002038|NCT00696878|526524290|FG000|Overall Study|Other reason (not specified)|55|||
146002039|NCT02259114|526524295|FG000|Overall Study|Progressive Disease|14|||
146002040|NCT02259114|526524296|FG001|Overall Study|Progressive Disease|2|||
146002041|NCT02259114|526524297|FG002|Overall Study|Progressive Disease|10|||
146002042|NCT02259114|526524298|FG003|Overall Study|Progressive Disease|2|||
146002043|NCT02259114|526524299|FG004|Overall Study|Progressive Disease|5|||
146002044|NCT02259114|526524295|FG000|Overall Study|Adverse Event|2|||
146002045|NCT02259114|526524296|FG001|Overall Study|Adverse Event|1|||
146002046|NCT02259114|526524297|FG002|Overall Study|Adverse Event|0|||
146002047|NCT02259114|526524298|FG003|Overall Study|Adverse Event|0|||
146002048|NCT02259114|526524299|FG004|Overall Study|Adverse Event|1|||
146002049|NCT02259114|526524295|FG000|Overall Study|Death|3|||
146002050|NCT02259114|526524296|FG001|Overall Study|Death|0|||
146002051|NCT02259114|526524297|FG002|Overall Study|Death|1|||
146002052|NCT02259114|526524298|FG003|Overall Study|Death|0|||
146002053|NCT02259114|526524299|FG004|Overall Study|Death|0|||
146002054|NCT02259114|526524295|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146002055|NCT02259114|526524296|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146002056|NCT02259114|526524297|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
146002057|NCT02259114|526524298|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146002058|NCT02259114|526524299|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
146002059|NCT02259114|526524295|FG000|Overall Study|Withdrawal by Subject|0|||
146002060|NCT02259114|526524296|FG001|Overall Study|Withdrawal by Subject|0|||
146002061|NCT02259114|526524297|FG002|Overall Study|Withdrawal by Subject|1|||
146002062|NCT02259114|526524298|FG003|Overall Study|Withdrawal by Subject|1|||
146002063|NCT02259114|526524299|FG004|Overall Study|Withdrawal by Subject|0|||
146002064|NCT02259114|526524295|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
146002065|NCT02259114|526524296|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
146002066|NCT02259114|526524297|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146002067|NCT02259114|526524298|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146002068|NCT02259114|526524299|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
146002069|NCT02259114|526524295|FG000|Overall Study|Not Treated|1|||
146002070|NCT02259114|526524296|FG001|Overall Study|Not Treated|0|||
146002071|NCT02259114|526524297|FG002|Overall Study|Not Treated|0|||
146002072|NCT02259114|526524298|FG003|Overall Study|Not Treated|0|||
146002073|NCT02259114|526524299|FG004|Overall Study|Not Treated|0|||
146002074|NCT03937479|526524300|FG000|Overall Study|Adverse Event|2|||
146002075|NCT03937479|526524301|FG001|Overall Study|Adverse Event|3|||
146002076|NCT03937479|526524302|FG002|Overall Study|Adverse Event|0|||
146002077|NCT03937479|526524303|FG003|Overall Study|Adverse Event|0|||
146002078|NCT03937479|526524304|FG004|Overall Study|Adverse Event|1|||
146002079|NCT03937479|526524300|FG000|Overall Study|Withdrawal by Subject|3|||
146002080|NCT03937479|526524301|FG001|Overall Study|Withdrawal by Subject|5|||
146002081|NCT03937479|526524302|FG002|Overall Study|Withdrawal by Subject|2|||
146002082|NCT03937479|526524303|FG003|Overall Study|Withdrawal by Subject|2|||
146002083|NCT03937479|526524304|FG004|Overall Study|Withdrawal by Subject|1|||
146002084|NCT03937479|526524300|FG000|Overall Study|Protocol Violation|5|||
146247500|NCT00529529|527419882|FG000|Overall Study|Adverse Event|12|||
146247501|NCT00529529|527419883|FG001|Overall Study|Adverse Event|17|||
146247502|NCT00529529|527419884|FG002|Overall Study|Adverse Event|8|||
146247503|NCT00529529|527419882|FG000|Overall Study|Subject withdrew consent|12|||
146247504|NCT00529529|527419883|FG001|Overall Study|Subject withdrew consent|9|||
146247505|NCT00529529|527419884|FG002|Overall Study|Subject withdrew consent|12|||
146247506|NCT00529529|527419882|FG000|Overall Study|Protocol deviation|8|||
146247507|NCT00529529|527419883|FG001|Overall Study|Protocol deviation|12|||
146247508|NCT00529529|527419884|FG002|Overall Study|Protocol deviation|5|||
146002085|NCT03937479|526524301|FG001|Overall Study|Protocol Violation|6|||
146002086|NCT03937479|526524302|FG002|Overall Study|Protocol Violation|4|||
146002087|NCT03937479|526524303|FG003|Overall Study|Protocol Violation|3|||
146002088|NCT03937479|526524304|FG004|Overall Study|Protocol Violation|2|||
146002089|NCT03937479|526524300|FG000|Overall Study|Lost to Follow-up|0|||
146002090|NCT03937479|526524301|FG001|Overall Study|Lost to Follow-up|1|||
146002091|NCT03937479|526524302|FG002|Overall Study|Lost to Follow-up|0|||
146002092|NCT03937479|526524303|FG003|Overall Study|Lost to Follow-up|1|||
146002093|NCT03937479|526524304|FG004|Overall Study|Lost to Follow-up|0|||
146002094|NCT03937479|526524300|FG000|Overall Study|Physician Decision|0|||
146002095|NCT03937479|526524301|FG001|Overall Study|Physician Decision|0|||
146002096|NCT03937479|526524302|FG002|Overall Study|Physician Decision|1|||
146002097|NCT03937479|526524303|FG003|Overall Study|Physician Decision|0|||
146002098|NCT03937479|526524304|FG004|Overall Study|Physician Decision|1|||
146002099|NCT00940602|526524308|FG000|Overall Study|Administrative problems|1|||
146002100|NCT00940602|526524309|FG001|Overall Study|Administrative problems|1|||
146002101|NCT00940602|526524308|FG000|Overall Study|Patient/guardian decision|13|||
146002102|NCT00940602|526524309|FG001|Overall Study|Patient/guardian decision|28|||
146002103|NCT00940602|526524308|FG000|Overall Study|Physician Decision|8|||
146002104|NCT00940602|526524309|FG001|Overall Study|Physician Decision|5|||
146002105|NCT00940602|526524308|FG000|Overall Study|Pregnancy|1|||
146002106|NCT00940602|526524309|FG001|Overall Study|Pregnancy|0|||
146002107|NCT00940602|526524308|FG000|Overall Study|Protocol Deviation (untreated)|1|||
146002108|NCT00940602|526524309|FG001|Overall Study|Protocol Deviation (untreated)|0|||
146002109|NCT00940602|526524308|FG000|Overall Study|Disease progression|8|||
146002110|NCT00940602|526524309|FG001|Overall Study|Disease progression|2|||
146002111|NCT00940602|526524308|FG000|Overall Study|Death|38|||
146002112|NCT00940602|526524309|FG001|Overall Study|Death|19|||
146002113|NCT00940602|526524308|FG000|Overall Study|Lost to Follow-up|3|||
146002114|NCT00940602|526524309|FG001|Overall Study|Lost to Follow-up|1|||
146002115|NCT00940602|526524308|FG000|Overall Study|Patient withdrew consent|26|||
146002116|NCT00940602|526524309|FG001|Overall Study|Patient withdrew consent|13|||
146002117|NCT00940602|526524308|FG000|Overall Study|Adverse Event|7|||
146002118|NCT00940602|526524309|FG001|Overall Study|Adverse Event|2|||
146002119|NCT00940602|526524308|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
146002120|NCT00940602|526524309|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
146002121|NCT03768427|526524310|FG000|Overall Study|Death|0|||
146002122|NCT03768427|526524311|FG001|Overall Study|Death|0|||
146002123|NCT03768427|526524312|FG002|Overall Study|Death|1|||
146002124|NCT03768427|526524313|FG003|Overall Study|Death|0|||
146002125|NCT03768427|526524310|FG000|Overall Study|Lost to Follow-up|2|||
146002126|NCT03768427|526524311|FG001|Overall Study|Lost to Follow-up|0|||
146002127|NCT03768427|526524312|FG002|Overall Study|Lost to Follow-up|0|||
146002128|NCT03768427|526524313|FG003|Overall Study|Lost to Follow-up|0|||
146002129|NCT03768427|526524310|FG000|Overall Study|Physician Decision|3|||
146002130|NCT03768427|526524311|FG001|Overall Study|Physician Decision|2|||
146002131|NCT03768427|526524312|FG002|Overall Study|Physician Decision|4|||
146002132|NCT03768427|526524313|FG003|Overall Study|Physician Decision|4|||
146002133|NCT03768427|526524310|FG000|Overall Study|Withdrawal by Subject|7|||
146002134|NCT03768427|526524311|FG001|Overall Study|Withdrawal by Subject|2|||
146002135|NCT03768427|526524312|FG002|Overall Study|Withdrawal by Subject|6|||
146002136|NCT03768427|526524313|FG003|Overall Study|Withdrawal by Subject|7|||
146002137|NCT02756403|526524316|FG000|Overall Study|Unable to swallow medication|0|||
146002138|NCT02756403|526524317|FG001|Overall Study|Unable to swallow medication|1|||
146092371|NCT02314143|526860284|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
146092372|NCT02314143|526860285|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
146247509|NCT00529529|527419882|FG000|Overall Study|Lost to Follow-up|5|||
146247510|NCT00529529|527419883|FG001|Overall Study|Lost to Follow-up|3|||
146002139|NCT02756403|526524318|FG002|Overall Study|Unable to swallow medication|1|||
146002140|NCT02756403|526524319|FG003|Overall Study|Unable to swallow medication|1|||
146002141|NCT02756403|526524316|FG000|Overall Study|Did not complete Procedure|0|||
146247511|NCT00529529|527419884|FG002|Overall Study|Lost to Follow-up|1|||
146247512|NCT00529529|527419882|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146002142|NCT02756403|526524317|FG001|Overall Study|Did not complete Procedure|1|||
146002143|NCT02756403|526524318|FG002|Overall Study|Did not complete Procedure|0|||
146002144|NCT02756403|526524319|FG003|Overall Study|Did not complete Procedure|0|||
146002145|NCT02756403|526524316|FG000|Overall Study|Changed Mind About Procedure|0|||
146002146|NCT02756403|526524317|FG001|Overall Study|Changed Mind About Procedure|0|||
146002147|NCT02756403|526524318|FG002|Overall Study|Changed Mind About Procedure|1|||
146002148|NCT02756403|526524319|FG003|Overall Study|Changed Mind About Procedure|0|||
146002149|NCT02756403|526524316|FG000|Overall Study|Protocol Violation|0|||
146002150|NCT02756403|526524317|FG001|Overall Study|Protocol Violation|1|||
146002151|NCT02756403|526524318|FG002|Overall Study|Protocol Violation|0|||
146002152|NCT02756403|526524319|FG003|Overall Study|Protocol Violation|1|||
146002153|NCT01644643|526524320|FG000|Overall Study|Death|1|||
146002154|NCT01644643|526524321|FG001|Overall Study|Death|0|||
146002155|NCT01644643|526524322|FG002|Overall Study|Death|3|||
146002156|NCT01644643|526524323|FG003|Overall Study|Death|3|||
146002157|NCT01644643|526524320|FG000|Overall Study|Lost to Follow-up|0|||
146002158|NCT01644643|526524321|FG001|Overall Study|Lost to Follow-up|0|||
146002159|NCT01644643|526524322|FG002|Overall Study|Lost to Follow-up|0|||
146002160|NCT01644643|526524323|FG003|Overall Study|Lost to Follow-up|4|||
146002161|NCT01644643|526524320|FG000|Overall Study|Withdrawal by Subject|1|||
146002162|NCT01644643|526524321|FG001|Overall Study|Withdrawal by Subject|0|||
146002163|NCT01644643|526524322|FG002|Overall Study|Withdrawal by Subject|2|||
146002164|NCT01644643|526524323|FG003|Overall Study|Withdrawal by Subject|1|||
146002165|NCT01644643|526524320|FG000|Overall Study|Other Eligibility criteria|0|||
146002166|NCT01644643|526524321|FG001|Overall Study|Other Eligibility criteria|0|||
146002167|NCT01644643|526524322|FG002|Overall Study|Other Eligibility criteria|0|||
146002168|NCT01644643|526524323|FG003|Overall Study|Other Eligibility criteria|2|||
146002169|NCT00776789|526524326|FG000|Overall Study|Consent refusal|2|||
146002170|NCT00776789|526524327|FG001|Overall Study|Consent refusal|2|||
146002171|NCT00776789|526524326|FG000|Overall Study|Poor quality video|1|||
146002172|NCT00776789|526524327|FG001|Overall Study|Poor quality video|1|||
146002173|NCT03391882|526524331|FG000|Study Overall|Adverse Event|3|||
146002174|NCT03391882|526524332|FG001|Study Overall|Adverse Event|6|||
146002175|NCT03391882|526524333|FG002|Study Overall|Adverse Event|1|||
146002176|NCT03391882|526524334|FG003|Study Overall|Adverse Event|1|||
146002177|NCT03391882|526524335|FG004|Study Overall|Adverse Event|3|||
146002178|NCT03391882|526524336|FG005|Study Overall|Adverse Event|1|||
146002179|NCT03391882|526524331|FG000|Study Overall|Lack of Efficacy|13|||
146002180|NCT03391882|526524332|FG001|Study Overall|Lack of Efficacy|9|||
146002181|NCT03391882|526524333|FG002|Study Overall|Lack of Efficacy|0|||
146002182|NCT03391882|526524334|FG003|Study Overall|Lack of Efficacy|0|||
146002183|NCT03391882|526524335|FG004|Study Overall|Lack of Efficacy|0|||
146002184|NCT03391882|526524336|FG005|Study Overall|Lack of Efficacy|0|||
146002185|NCT03391882|526524331|FG000|Study Overall|Withdrawal by Subject|3|||
146002186|NCT03391882|526524332|FG001|Study Overall|Withdrawal by Subject|3|||
146002187|NCT03391882|526524333|FG002|Study Overall|Withdrawal by Subject|2|||
146002188|NCT03391882|526524334|FG003|Study Overall|Withdrawal by Subject|2|||
146002189|NCT03391882|526524335|FG004|Study Overall|Withdrawal by Subject|1|||
146002190|NCT03391882|526524336|FG005|Study Overall|Withdrawal by Subject|3|||
146002191|NCT03391882|526524331|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146002192|NCT03391882|526524332|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
146002193|NCT03391882|526524333|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146002194|NCT03391882|526524334|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146002195|NCT03391882|526524335|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146002196|NCT03391882|526524336|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
146002197|NCT03391882|526524331|FG000|Study Overall|Protocol Violation|1|||
146002198|NCT03391882|526524332|FG001|Study Overall|Protocol Violation|0|||
146002199|NCT03391882|526524333|FG002|Study Overall|Protocol Violation|0|||
146002200|NCT03391882|526524334|FG003|Study Overall|Protocol Violation|0|||
146002201|NCT03391882|526524335|FG004|Study Overall|Protocol Violation|0|||
146002202|NCT03391882|526524336|FG005|Study Overall|Protocol Violation|0|||
146002203|NCT03391882|526524331|FG000|Part A - Titration Phase|Adverse Event|3|||
146002204|NCT03391882|526524332|FG001|Part A - Titration Phase|Adverse Event|6|||
146002205|NCT03391882|526524333|FG002|Part A - Titration Phase|Adverse Event|0|||
146002206|NCT03391882|526524334|FG003|Part A - Titration Phase|Adverse Event|0|||
146002207|NCT03391882|526524335|FG004|Part A - Titration Phase|Adverse Event|0|||
146002208|NCT03391882|526524336|FG005|Part A - Titration Phase|Adverse Event|0|||
146002209|NCT03391882|526524331|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
146002210|NCT03391882|526524332|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
146002211|NCT03391882|526524333|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
146002212|NCT03391882|526524334|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
146002213|NCT03391882|526524335|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
146002214|NCT03391882|526524336|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
146002215|NCT03391882|526524331|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
146002216|NCT03391882|526524332|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
146002217|NCT03391882|526524333|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
146002218|NCT03391882|526524334|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
146002219|NCT03391882|526524335|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
146002220|NCT03391882|526524336|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
146002221|NCT03391882|526524331|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146002222|NCT03391882|526524332|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
146247513|NCT00529529|527419883|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146247514|NCT00529529|527419884|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146247515|NCT00529529|527419882|FG000|Overall Study|Death|2|||
146247516|NCT00529529|527419883|FG001|Overall Study|Death|0|||
146002223|NCT03391882|526524333|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146002224|NCT03391882|526524334|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146002225|NCT03391882|526524335|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146002226|NCT03391882|526524336|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
146002227|NCT03391882|526524331|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
146002228|NCT03391882|526524332|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
146002229|NCT03391882|526524333|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
146002230|NCT03391882|526524334|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
146002231|NCT03391882|526524335|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
146002232|NCT03391882|526524336|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
146002233|NCT03391882|526524331|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
146002234|NCT03391882|526524332|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
146002235|NCT03391882|526524333|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
146002236|NCT03391882|526524334|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
146002237|NCT03391882|526524335|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
146002238|NCT03391882|526524336|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
146002239|NCT03391882|526524331|FG000|Part B - Treatment Phase|Adverse Event|0|||
146002240|NCT03391882|526524332|FG001|Part B - Treatment Phase|Adverse Event|0|||
146002241|NCT03391882|526524333|FG002|Part B - Treatment Phase|Adverse Event|1|||
146002242|NCT03391882|526524334|FG003|Part B - Treatment Phase|Adverse Event|1|||
146002243|NCT03391882|526524335|FG004|Part B - Treatment Phase|Adverse Event|3|||
146002244|NCT03391882|526524336|FG005|Part B - Treatment Phase|Adverse Event|1|||
146002245|NCT03391882|526524331|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
146002246|NCT03391882|526524332|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
146002247|NCT03391882|526524333|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
146002248|NCT03391882|526524334|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
146002249|NCT03391882|526524335|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
146002250|NCT03391882|526524336|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
146002251|NCT00543985|526524337|FG000|Overall Study|Withdrawal by Subject|4|||
146002252|NCT01280968|526524338|FG000|Overall Study|Lost to Follow-up|8|||
146002253|NCT01280968|526524339|FG001|Overall Study|Lost to Follow-up|2|||
146002254|NCT01280968|526524338|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
146002255|NCT01280968|526524339|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
146002256|NCT01280968|526524338|FG000|Overall Study|Commuting Problems|2|||
146002257|NCT01280968|526524339|FG001|Overall Study|Commuting Problems|0|||
146002258|NCT01280968|526524338|FG000|Overall Study|Anxiety|2|||
146002259|NCT01280968|526524339|FG001|Overall Study|Anxiety|0|||
146002260|NCT01280968|526524338|FG000|Overall Study|Adverse Event|1|||
146002261|NCT01280968|526524339|FG001|Overall Study|Adverse Event|0|||
146002262|NCT01280968|526524338|FG000|Overall Study|Scheduling Conflicts|1|||
146002263|NCT01280968|526524339|FG001|Overall Study|Scheduling Conflicts|1|||
146002264|NCT01280968|526524338|FG000|Overall Study|Pre-existing Neurological Condition|1|||
146002265|NCT01280968|526524339|FG001|Overall Study|Pre-existing Neurological Condition|0|||
146002266|NCT01280968|526524338|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
146002267|NCT01280968|526524339|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
146002268|NCT00038948|526524340|FG000|Overall Study|Adverse Event|131|||
146002269|NCT00038948|526524341|FG001|Overall Study|Adverse Event|43|||
146002270|NCT00038948|526524340|FG000|Overall Study|Lost to Follow-up|4|||
146002271|NCT00038948|526524341|FG001|Overall Study|Lost to Follow-up|4|||
146002272|NCT00038948|526524340|FG000|Overall Study|Nonmedical event|5|||
146002273|NCT00038948|526524341|FG001|Overall Study|Nonmedical event|7|||
146002274|NCT00038948|526524340|FG000|Overall Study|Withdrawal by Subject|23|||
146002275|NCT00038948|526524341|FG001|Overall Study|Withdrawal by Subject|10|||
146002276|NCT00038948|526524340|FG000|Overall Study|Protocol Violation|3|||
146002277|NCT00038948|526524341|FG001|Overall Study|Protocol Violation|7|||
146002278|NCT00038948|526524340|FG000|Overall Study|Lack of Efficacy|3|||
146002279|NCT00038948|526524341|FG001|Overall Study|Lack of Efficacy|6|||
146002280|NCT02670473|526524342|FG000|Overall Study|Withdrawal by Subject|1|||
146002281|NCT01404234|526524343|FG000|Overall Study|Withdrawal by Subject|2|||
146002282|NCT01214837|526524344|FG000|Overall Study|Death|0|||
146002283|NCT01214837|526524345|FG001|Overall Study|Death|0|||
146002284|NCT01214837|526524346|FG002|Overall Study|Death|1|||
146092373|NCT02314143|526860286|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
146092374|NCT02314143|526860284|FG000|Overall Study|Physician Decision|2|||
146092375|NCT02314143|526860285|FG001|Overall Study|Physician Decision|1|||
146247517|NCT00529529|527419884|FG002|Overall Study|Death|0|||
146247518|NCT00529529|527419882|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146002285|NCT01214837|526524344|FG000|Overall Study|Adverse Event|1|||
146002286|NCT01214837|526524345|FG001|Overall Study|Adverse Event|2|||
146002287|NCT01214837|526524346|FG002|Overall Study|Adverse Event|1|||
146002288|NCT01214837|526524344|FG000|Overall Study|Withdrawal by Subject|27|||
146092376|NCT02314143|526860286|FG002|Overall Study|Physician Decision|0|||
146002289|NCT01214837|526524345|FG001|Overall Study|Withdrawal by Subject|36|||
146002290|NCT01214837|526524346|FG002|Overall Study|Withdrawal by Subject|28|||
146002291|NCT01214837|526524344|FG000|Overall Study|Lost to Follow-up|20|||
146002292|NCT01214837|526524345|FG001|Overall Study|Lost to Follow-up|15|||
146002293|NCT01214837|526524346|FG002|Overall Study|Lost to Follow-up|21|||
146002294|NCT01214837|526524344|FG000|Overall Study|Inappropriate Enrolment|0|||
146002295|NCT01214837|526524345|FG001|Overall Study|Inappropriate Enrolment|1|||
146002296|NCT01214837|526524346|FG002|Overall Study|Inappropriate Enrolment|2|||
146002297|NCT01214837|526524344|FG000|Overall Study|Administrative Reason|2|||
146002298|NCT01214837|526524345|FG001|Overall Study|Administrative Reason|6|||
146002299|NCT01214837|526524346|FG002|Overall Study|Administrative Reason|4|||
146002300|NCT01214837|526524344|FG000|Overall Study|Protocol Violation|3|||
146002301|NCT01214837|526524345|FG001|Overall Study|Protocol Violation|1|||
146002302|NCT01214837|526524346|FG002|Overall Study|Protocol Violation|5|||
146002303|NCT01214837|526524344|FG000|Overall Study|Unable to Classify|1|||
146002304|NCT01214837|526524345|FG001|Overall Study|Unable to Classify|3|||
146002305|NCT01214837|526524346|FG002|Overall Study|Unable to Classify|0|||
146002306|NCT03247829|526525866|FG000|Overall Study|Death|3|||
146002307|NCT03247829|526525867|FG001|Overall Study|Death|4|||
146002308|NCT03247829|526525866|FG000|Overall Study|Enter Hospice Care|1|||
146002309|NCT03247829|526525867|FG001|Overall Study|Enter Hospice Care|0|||
146002310|NCT03247829|526525866|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
146002311|NCT03247829|526525867|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
146002312|NCT03247829|526525866|FG000|Overall Study|LVAD Explant|1|||
146002313|NCT03247829|526525867|FG001|Overall Study|LVAD Explant|1|||
146002314|NCT03247829|526525866|FG000|Overall Study|Transplant|1|||
146002315|NCT03247829|526525867|FG001|Overall Study|Transplant|1|||
146002316|NCT00427011|526525868|FG000|Overall Study|Adverse Event|10|||
146002317|NCT00427011|526525868|FG000|Overall Study|Withdrawal by Subject|1|||
146002318|NCT00427011|526525868|FG000|Overall Study|Lack of Efficacy|2|||
146002319|NCT00427011|526525868|FG000|Overall Study|Other|12|||
146002320|NCT00288015|526525869|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
146002321|NCT00288015|526525869|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
146002322|NCT00288015|526525869|FG000|First Response Assessment|Withdrawal by Subject|1|||
146002323|NCT00288015|526525869|FG000|First Response Assessment|Death|1|||
146002324|NCT00288015|526525869|FG000|First Response Assessment|Physician Decision|2|||
146002325|NCT00288015|526525869|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
146002326|NCT00288015|526525869|FG000|Follow up for Survival x 2 Years|Death|13|||
146002327|NCT00288015|526525869|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
146002328|NCT00288015|526525869|FG000|Follow up for Survival x 2 Years|Other|9|||
146002329|NCT00443703|526525870|FG000|Overall Study|Never Treated|3|||
146002330|NCT00443703|526525871|FG001|Overall Study|Never Treated|1|||
146298086|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
146002331|NCT00443703|526525870|FG000|Overall Study|Adverse Event|7|||
146002332|NCT00443703|526525871|FG001|Overall Study|Adverse Event|3|||
146002333|NCT00443703|526525870|FG000|Overall Study|Lack of Efficacy|3|||
146002334|NCT00443703|526525871|FG001|Overall Study|Lack of Efficacy|1|||
146002335|NCT00443703|526525870|FG000|Overall Study|Lost to Follow-up|0|||
146002336|NCT00443703|526525871|FG001|Overall Study|Lost to Follow-up|4|||
146002337|NCT00443703|526525870|FG000|Overall Study|Physician Decision|4|||
146002338|NCT00443703|526525871|FG001|Overall Study|Physician Decision|2|||
146002339|NCT00443703|526525870|FG000|Overall Study|Protocol Violation|1|||
146002340|NCT00443703|526525871|FG001|Overall Study|Protocol Violation|1|||
146002341|NCT00443703|526525870|FG000|Overall Study|Withdrawal by Subject|9|||
146002342|NCT00443703|526525871|FG001|Overall Study|Withdrawal by Subject|6|||
146002343|NCT00443703|526525870|FG000|Overall Study|Progressive Disease|1|||
146002344|NCT00443703|526525871|FG001|Overall Study|Progressive Disease|0|||
146002345|NCT01669902|526525876|FG000|Overall Study|Adverse Event|11|||
146298087|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
146002346|NCT01669902|526525876|FG000|Overall Study|Lack of Efficacy|10|||
146002347|NCT01669902|526525876|FG000|Overall Study|Other|8|||
146002348|NCT00457392|526525877|FG000|Overall Study|Objective Progression or Relapse|229|||
146002349|NCT00457392|526525878|FG001|Overall Study|Objective Progression or Relapse|296|||
146002350|NCT00457392|526525877|FG000|Overall Study|Death|106|||
146002351|NCT00457392|526525878|FG001|Overall Study|Death|106|||
146002352|NCT00457392|526525877|FG000|Overall Study|Adverse Event|84|||
146002353|NCT00457392|526525878|FG001|Overall Study|Adverse Event|41|||
146002354|NCT00457392|526525877|FG000|Overall Study|Global Deterioration of Health Status|22|||
146002355|NCT00457392|526525878|FG001|Overall Study|Global Deterioration of Health Status|8|||
146002356|NCT00457392|526525877|FG000|Overall Study|Withdrawal by Subject|14|||
146002357|NCT00457392|526525878|FG001|Overall Study|Withdrawal by Subject|8|||
146002358|NCT00457392|526525877|FG000|Overall Study|Lost to Follow-up|6|||
146002359|NCT00457392|526525878|FG001|Overall Study|Lost to Follow-up|7|||
146002360|NCT00457392|526525877|FG000|Overall Study|Protocol Violation|4|||
146298088|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
146002361|NCT00457392|526525878|FG001|Overall Study|Protocol Violation|3|||
146002362|NCT00457392|526525877|FG000|Overall Study|Other|7|||
146002363|NCT00457392|526525878|FG001|Overall Study|Other|4|||
146002364|NCT00457392|526525877|FG000|Overall Study|Study Terminated by Sponsor|1|||
146002365|NCT00457392|526525878|FG001|Overall Study|Study Terminated by Sponsor|4|||
146002366|NCT00457392|526525877|FG000|Overall Study|Randomized, Not Treated|7|||
146002367|NCT00457392|526525878|FG001|Overall Study|Randomized, Not Treated|3|||
146002368|NCT00980148|526525879|FG000|Overall Study|Discharged from facility|89|||
146002369|NCT00980148|526525880|FG001|Overall Study|Discharged from facility|96|||
146002370|NCT00980148|526525879|FG000|Overall Study|Received other antichlamydia treatment|20|||
146002371|NCT00980148|526525880|FG001|Overall Study|Received other antichlamydia treatment|14|||
146002372|NCT00980148|526525879|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
146002373|NCT00980148|526525880|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
146002374|NCT00980148|526525879|FG000|Overall Study|Various other reasons|8|||
146002375|NCT00980148|526525880|FG001|Overall Study|Various other reasons|9|||
146002376|NCT01462929|526525881|FG000|Overall Study|Adverse Event|3|||
146002377|NCT01462929|526525882|FG001|Overall Study|Adverse Event|3|||
146002378|NCT01462929|526525883|FG002|Overall Study|Adverse Event|4|||
146002379|NCT01462929|526525881|FG000|Overall Study|Withdrawal by Subject|2|||
146002380|NCT01462929|526525882|FG001|Overall Study|Withdrawal by Subject|1|||
146002381|NCT01462929|526525883|FG002|Overall Study|Withdrawal by Subject|0|||
146002382|NCT01462929|526525881|FG000|Overall Study|Lack of Efficacy|0|||
146002383|NCT01462929|526525882|FG001|Overall Study|Lack of Efficacy|0|||
146002384|NCT01462929|526525883|FG002|Overall Study|Lack of Efficacy|1|||
146002385|NCT01309204|526525888|FG000|Overall Study|Adverse Event|48|||
146002386|NCT01309204|526525889|FG001|Overall Study|Adverse Event|58|||
146002387|NCT01309204|526525888|FG000|Overall Study|Lost to Follow-up|2|||
146002388|NCT01309204|526525889|FG001|Overall Study|Lost to Follow-up|2|||
146002389|NCT01309204|526525888|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
146002390|NCT01309204|526525889|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
146002391|NCT01309204|526525888|FG000|Overall Study|Inadequate control of IOP|4|||
146002392|NCT01309204|526525889|FG001|Overall Study|Inadequate control of IOP|4|||
146002393|NCT01309204|526525888|FG000|Overall Study|Other|4|||
146002394|NCT01309204|526525889|FG001|Overall Study|Other|1|||
146002395|NCT00925002|526525890|FG000|Overall Study|Other|1|||
146002396|NCT00925002|526525891|FG001|Overall Study|Other|4|||
146002397|NCT00925002|526525892|FG002|Overall Study|Other|0|||
146002398|NCT00925002|526525890|FG000|Overall Study|Death|1|||
146002399|NCT00925002|526525891|FG001|Overall Study|Death|1|||
146002400|NCT00925002|526525892|FG002|Overall Study|Death|5|||
146002401|NCT00925002|526525890|FG000|Overall Study|Adverse Event|3|||
146002402|NCT00925002|526525891|FG001|Overall Study|Adverse Event|1|||
146002403|NCT00925002|526525892|FG002|Overall Study|Adverse Event|2|||
146002404|NCT00925002|526525890|FG000|Overall Study|Participant withdrew consent|1|||
146002405|NCT00925002|526525891|FG001|Overall Study|Participant withdrew consent|3|||
146002406|NCT00925002|526525892|FG002|Overall Study|Participant withdrew consent|3|||
146002407|NCT00002766|526525893|FG000|Overall Study|Withdrawal by Subject|0|||
146002408|NCT00002766|526525894|FG001|Overall Study|Withdrawal by Subject|1|||
146002409|NCT00002766|526525893|FG000|Overall Study|Patient Not Treated|1|||
146002410|NCT00002766|526525894|FG001|Overall Study|Patient Not Treated|2|||
146002411|NCT00002766|526525893|FG000|Overall Study|Adverse Event|1|||
146002412|NCT00002766|526525894|FG001|Overall Study|Adverse Event|1|||
146002413|NCT00002766|526525893|FG000|Overall Study|Protocol Violation|1|||
146002414|NCT00002766|526525894|FG001|Overall Study|Protocol Violation|0|||
146002415|NCT00328172|526525897|FG000|Overall Study|Adverse Event|3|||
146002416|NCT00328172|526525898|FG001|Overall Study|Adverse Event|2|||
146002417|NCT00328172|526525899|FG002|Overall Study|Adverse Event|1|||
146002418|NCT00328172|526525900|FG003|Overall Study|Adverse Event|2|||
146002419|NCT00328172|526525901|FG004|Overall Study|Adverse Event|1|||
146002420|NCT00328172|526525897|FG000|Overall Study|Protocol Violation|0|||
146002421|NCT00328172|526525898|FG001|Overall Study|Protocol Violation|1|||
146002422|NCT00328172|526525899|FG002|Overall Study|Protocol Violation|1|||
146002423|NCT00328172|526525900|FG003|Overall Study|Protocol Violation|0|||
146002424|NCT00328172|526525901|FG004|Overall Study|Protocol Violation|0|||
146002425|NCT00328172|526525897|FG000|Overall Study|Lost to Follow-up|1|||
146002426|NCT00328172|526525898|FG001|Overall Study|Lost to Follow-up|1|||
146002427|NCT00328172|526525899|FG002|Overall Study|Lost to Follow-up|2|||
146002428|NCT00328172|526525900|FG003|Overall Study|Lost to Follow-up|1|||
146002429|NCT00328172|526525901|FG004|Overall Study|Lost to Follow-up|1|||
146002430|NCT00328172|526525897|FG000|Overall Study|Withdrawal by Subject|1|||
146002431|NCT00328172|526525898|FG001|Overall Study|Withdrawal by Subject|1|||
146002432|NCT00328172|526525899|FG002|Overall Study|Withdrawal by Subject|1|||
146002433|NCT00328172|526525900|FG003|Overall Study|Withdrawal by Subject|6|||
146002434|NCT00328172|526525901|FG004|Overall Study|Withdrawal by Subject|0|||
146002435|NCT00328172|526525897|FG000|Overall Study|Lack of Efficacy|14|||
146002436|NCT00328172|526525898|FG001|Overall Study|Lack of Efficacy|9|||
146002437|NCT00328172|526525899|FG002|Overall Study|Lack of Efficacy|4|||
146002438|NCT00328172|526525900|FG003|Overall Study|Lack of Efficacy|4|||
146002439|NCT00328172|526525901|FG004|Overall Study|Lack of Efficacy|3|||
146002440|NCT00328172|526525897|FG000|Overall Study|Other reason (not specified)|3|||
146002441|NCT00328172|526525898|FG001|Overall Study|Other reason (not specified)|0|||
146002442|NCT00328172|526525899|FG002|Overall Study|Other reason (not specified)|1|||
146002443|NCT00328172|526525900|FG003|Overall Study|Other reason (not specified)|0|||
146002444|NCT00328172|526525901|FG004|Overall Study|Other reason (not specified)|0|||
146002445|NCT00558636|526525902|FG000|Treatment|Adverse Event|9|||
146002446|NCT00558636|526525903|FG001|Treatment|Adverse Event|2|||
146002447|NCT00558636|526525902|FG000|Treatment|Withdrawal by Subject|2|||
146002448|NCT00558636|526525903|FG001|Treatment|Withdrawal by Subject|0|||
146002449|NCT00558636|526525902|FG000|Treatment|Premature termination of the study|35|||
146002450|NCT00558636|526525903|FG001|Treatment|Premature termination of the study|37|||
146002451|NCT00558636|526525902|FG000|Treatment|Disease progression|1|||
146002452|NCT00558636|526525903|FG001|Treatment|Disease progression|5|||
146002453|NCT00558636|526525902|FG000|Follow-up|Premature termination of the study|12|||
146002454|NCT00558636|526525903|FG001|Follow-up|Premature termination of the study|7|||
146002455|NCT01990742|526525904|FG000|Overall Study|Withdrawal by facility|407|||
146002456|NCT01990742|526525905|FG001|Overall Study|Withdrawal by facility|1083|||
146002457|NCT01990742|526525904|FG000|Overall Study|Facility closed|0|||
146002458|NCT01990742|526525905|FG001|Overall Study|Facility closed|270|||
146002459|NCT03443687|526525906|FG000|Overall Study|Lost to Follow-up|3|||
146002460|NCT03443687|526525907|FG001|Overall Study|Lost to Follow-up|5|||
146002461|NCT03443687|526525906|FG000|Overall Study|Withdrawal by Subject|1|||
146002462|NCT03443687|526525907|FG001|Overall Study|Withdrawal by Subject|0|||
146002463|NCT03443687|526525906|FG000|Overall Study|Discontinued intervention|1|||
146002464|NCT03443687|526525907|FG001|Overall Study|Discontinued intervention|1|||
146002465|NCT00658541|526525913|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146002466|NCT00658541|526525914|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146002467|NCT00658541|526525913|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146002468|NCT00658541|526525914|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146002469|NCT01063348|526525915|FG000|Overall Study|Lost to Follow-up|3|||
146002470|NCT01063348|526525916|FG001|Overall Study|Lost to Follow-up|10|||
146002471|NCT00269087|526525917|FG000|Overall Study|Adverse Event|20|||
146002472|NCT00269087|526525917|FG000|Overall Study|Withdrawal by Subject|1|||
146002473|NCT00269087|526525917|FG000|Overall Study|Exacerbation of COPD|13|||
146002474|NCT01188967|526525918|FG000|Overall Study|Withdrawal by Subject|1|||
146002475|NCT01188967|526525919|FG001|Overall Study|Withdrawal by Subject|1|||
146002476|NCT01188967|526525918|FG000|Overall Study|Physician Decision|1|||
146002477|NCT01188967|526525919|FG001|Overall Study|Physician Decision|1|||
146002478|NCT01188967|526525918|FG000|Overall Study|Lost to Follow-up|3|||
146002479|NCT01188967|526525919|FG001|Overall Study|Lost to Follow-up|2|||
146002480|NCT00523978|526525922|FG000|Overall Study|Withdrawal by Subject|3|||
146002481|NCT00523978|526525923|FG001|Overall Study|Withdrawal by Subject|7|||
146002482|NCT00523978|526525922|FG000|Overall Study|Screen Failures|5|||
146002483|NCT00523978|526525923|FG001|Overall Study|Screen Failures|1|||
146002484|NCT00523978|526525922|FG000|Overall Study|Death|1|||
146002485|NCT00523978|526525923|FG001|Overall Study|Death|0|||
146002486|NCT04577781|526525924|FG000|Overall Study|Adverse Event|2|||
146002487|NCT04577781|526525925|FG001|Overall Study|Adverse Event|2|||
146002488|NCT04577781|526525924|FG000|Overall Study|Physician Decision|1|||
146002489|NCT04577781|526525925|FG001|Overall Study|Physician Decision|0|||
146002490|NCT04103450|526525927|FG000|Overall Study|Adverse Event|4|||
146002491|NCT04103450|526525928|FG001|Overall Study|Adverse Event|2|||
146002492|NCT04103450|526525927|FG000|Overall Study|Lack of Efficacy|3|||
146002493|NCT04103450|526525928|FG001|Overall Study|Lack of Efficacy|0|||
146002494|NCT04103450|526525927|FG000|Overall Study|Withdrawal by Subject|5|||
146002495|NCT04103450|526525928|FG001|Overall Study|Withdrawal by Subject|3|||
146002496|NCT04103450|526525927|FG000|Overall Study|Lost to Follow-up|1|||
146002497|NCT04103450|526525928|FG001|Overall Study|Lost to Follow-up|2|||
146002498|NCT04103450|526525927|FG000|Overall Study|Physician Decision|1|||
146002499|NCT04103450|526525928|FG001|Overall Study|Physician Decision|2|||
146002500|NCT04103450|526525927|FG000|Overall Study|Protocol Violation|1|||
146002501|NCT04103450|526525928|FG001|Overall Study|Protocol Violation|0|||
146002502|NCT04103450|526525927|FG000|Overall Study|Other|1|||
146002503|NCT04103450|526525928|FG001|Overall Study|Other|1|||
146002504|NCT02712788|526525931|FG000|Overall Study|Physician Decision|1|||
146002505|NCT02712788|526525932|FG001|Overall Study|Physician Decision|0|||
146002506|NCT02712788|526525931|FG000|Overall Study|Protocol Violation|1|||
146002507|NCT02712788|526525932|FG001|Overall Study|Protocol Violation|0|||
146002508|NCT01463033|526525933|FG000|Overall Study|Lost to Follow-up|4|||
146002509|NCT01463033|526525934|FG001|Overall Study|Lost to Follow-up|4|||
146298089|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
146002510|NCT01463033|526525933|FG000|Overall Study|Death|3|||
146002511|NCT01463033|526525934|FG001|Overall Study|Death|2|||
146002512|NCT01368614|526525935|FG000|Screening Period|Screen Failure|58|||
146002513|NCT01368614|526525936|FG001|Screening Period|Screen Failure|0|||
146002514|NCT01368614|526525937|FG002|Screening Period|Screen Failure|0|||
146002515|NCT01368614|526525938|FG003|Screening Period|Screen Failure|0|||
146002516|NCT01368614|526525935|FG000|Study Period|Withdrawal by Subject|0|||
146002517|NCT01368614|526525936|FG001|Study Period|Withdrawal by Subject|1|||
146002518|NCT01368614|526525937|FG002|Study Period|Withdrawal by Subject|1|||
146002519|NCT01368614|526525938|FG003|Study Period|Withdrawal by Subject|3|||
146002520|NCT01368614|526525935|FG000|Study Period|Lost to Follow-up|0|||
146002521|NCT01368614|526525936|FG001|Study Period|Lost to Follow-up|0|||
146002522|NCT01368614|526525937|FG002|Study Period|Lost to Follow-up|1|||
146002523|NCT01368614|526525938|FG003|Study Period|Lost to Follow-up|0|||
146002524|NCT00244621|526525939|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146002525|NCT00244621|526525940|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146002526|NCT00244621|526525941|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146002527|NCT00244621|526525939|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146002528|NCT00244621|526525940|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146002529|NCT00244621|526525941|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146002530|NCT00244621|526525939|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146002531|NCT00244621|526525940|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
146002532|NCT00244621|526525941|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146002533|NCT00244621|526525939|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
146002534|NCT00244621|526525940|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
146002535|NCT00244621|526525941|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
146002536|NCT00244621|526525939|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146002537|NCT00244621|526525940|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
146002538|NCT00244621|526525941|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146002539|NCT00244621|526525939|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
146002540|NCT00244621|526525940|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146002541|NCT00244621|526525941|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146002542|NCT00244621|526525939|FG000|Open-label Treatment Period|Adverse Event|0|||
146002543|NCT00244621|526525940|FG001|Open-label Treatment Period|Adverse Event|0|||
146002544|NCT00244621|526525941|FG002|Open-label Treatment Period|Adverse Event|1|||
146002545|NCT00244621|526525939|FG000|Open-label Treatment Period|Moved abroad|0|||
146002546|NCT00244621|526525940|FG001|Open-label Treatment Period|Moved abroad|0|||
146002547|NCT00244621|526525941|FG002|Open-label Treatment Period|Moved abroad|1|||
146002548|NCT01847755|526525945|FG000|Overall Study|Adverse Event|2|||
146002549|NCT01847755|526525945|FG000|Overall Study|Withdrawal by Subject|2|||
146002550|NCT01847755|526525945|FG000|Overall Study|Physician Decision|1|||
146002551|NCT01193101|526525946|FG000|Overall Study|Adverse Event|0|||
146002552|NCT01193101|526525947|FG001|Overall Study|Adverse Event|1|||
146002553|NCT01193101|526525948|FG002|Overall Study|Adverse Event|1|||
146002554|NCT01193101|526525949|FG003|Overall Study|Adverse Event|3|||
146002555|NCT01193101|526525946|FG000|Overall Study|Lack of Efficacy|3|||
146002556|NCT01193101|526525947|FG001|Overall Study|Lack of Efficacy|1|||
146002557|NCT01193101|526525948|FG002|Overall Study|Lack of Efficacy|0|||
146002558|NCT01193101|526525949|FG003|Overall Study|Lack of Efficacy|8|||
146002559|NCT01193101|526525946|FG000|Overall Study|Withdrawal by Subject|2|||
146002560|NCT01193101|526525947|FG001|Overall Study|Withdrawal by Subject|4|||
146002561|NCT01193101|526525948|FG002|Overall Study|Withdrawal by Subject|1|||
146002562|NCT01193101|526525949|FG003|Overall Study|Withdrawal by Subject|1|||
146002563|NCT01193101|526525946|FG000|Overall Study|Administrative problems|0|||
146002564|NCT01193101|526525947|FG001|Overall Study|Administrative problems|0|||
146002565|NCT01193101|526525948|FG002|Overall Study|Administrative problems|1|||
146002566|NCT01193101|526525949|FG003|Overall Study|Administrative problems|0|||
146002567|NCT01193101|526525946|FG000|Overall Study|Abnormal test procedure results|0|||
146002568|NCT01193101|526525947|FG001|Overall Study|Abnormal test procedure results|1|||
146002569|NCT01193101|526525948|FG002|Overall Study|Abnormal test procedure results|0|||
146002570|NCT01193101|526525949|FG003|Overall Study|Abnormal test procedure results|0|||
146002571|NCT02347085|526525950|FG000|Overall Study|Adverse Event|2|||
146002572|NCT02347085|526525950|FG000|Overall Study|Lack of Efficacy|1|||
146002573|NCT02347085|526525950|FG000|Overall Study|Withdrawal by Subject|4|||
146002574|NCT02347085|526525950|FG000|Overall Study|Lost to Follow-up|1|||
146002575|NCT02347085|526525950|FG000|Overall Study|Protocol Criteria|2|||
146002576|NCT02271529|526525951|FG000|Overall Study|Withdrawal by Subject|1|||
146002577|NCT01904721|526525953|FG000|Overall Study|Other Reasons|0|||
146002578|NCT01904721|526525954|FG001|Overall Study|Other Reasons|0|||
146002579|NCT01904721|526525955|FG002|Overall Study|Other Reasons|1|||
146002580|NCT01904721|526525956|FG003|Overall Study|Other Reasons|1|||
146002581|NCT01904721|526525957|FG004|Overall Study|Other Reasons|2|||
146002582|NCT01904721|526525958|FG005|Overall Study|Other Reasons|2|||
146002583|NCT01904721|526525959|FG006|Overall Study|Other Reasons|2|||
146002584|NCT01904721|526525953|FG000|Overall Study|Personal Reasons|0|||
146002585|NCT01904721|526525954|FG001|Overall Study|Personal Reasons|0|||
146002586|NCT01904721|526525955|FG002|Overall Study|Personal Reasons|0|||
146002587|NCT01904721|526525956|FG003|Overall Study|Personal Reasons|0|||
146002588|NCT01904721|526525957|FG004|Overall Study|Personal Reasons|2|||
146002589|NCT01904721|526525958|FG005|Overall Study|Personal Reasons|3|||
146002590|NCT01904721|526525959|FG006|Overall Study|Personal Reasons|3|||
146002591|NCT01904721|526525953|FG000|Overall Study|Lost to Follow-up|0|||
146002592|NCT01904721|526525954|FG001|Overall Study|Lost to Follow-up|0|||
146002593|NCT01904721|526525955|FG002|Overall Study|Lost to Follow-up|0|||
146247519|NCT00529529|527419883|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146247520|NCT00529529|527419884|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146247521|NCT00529529|527419882|FG000|Overall Study|Administrative problems|1|||
146247522|NCT00529529|527419883|FG001|Overall Study|Administrative problems|0|||
146247523|NCT00529529|527419884|FG002|Overall Study|Administrative problems|3|||
146247524|NCT01000649|527419885|FG000|Overall Study|Adverse Event|5|||
146247525|NCT01000649|527419886|FG001|Overall Study|Adverse Event|1|||
146247526|NCT01000649|527419887|FG002|Overall Study|Adverse Event|2|||
146247527|NCT01000649|527419888|FG003|Overall Study|Adverse Event|4|||
146247528|NCT01000649|527419885|FG000|Overall Study|Lost to Follow-up|0|||
146247529|NCT01000649|527419886|FG001|Overall Study|Lost to Follow-up|2|||
146247530|NCT01000649|527419887|FG002|Overall Study|Lost to Follow-up|0|||
146247531|NCT01000649|527419888|FG003|Overall Study|Lost to Follow-up|2|||
146247532|NCT01916109|527419891|FG000|Overall Study|Withdrawal by Subject|1|||
146247533|NCT00103857|527419894|FG000|54-Week Base Study|Adverse Event|12|||
146247534|NCT00103857|527419895|FG001|54-Week Base Study|Adverse Event|9|||
146247535|NCT00103857|527419896|FG002|54-Week Base Study|Adverse Event|11|||
146247536|NCT00103857|527419897|FG003|54-Week Base Study|Adverse Event|6|||
146247537|NCT00103857|527419898|FG004|54-Week Base Study|Adverse Event|5|||
146247538|NCT00103857|527419899|FG005|54-Week Base Study|Adverse Event|11|||
146247539|NCT00103857|527419900|FG006|54-Week Base Study|Adverse Event|3|||
146247540|NCT00103857|527419894|FG000|54-Week Base Study|Death|0|||
146247541|NCT00103857|527419895|FG001|54-Week Base Study|Death|0|||
146247542|NCT00103857|527419896|FG002|54-Week Base Study|Death|0|||
146247543|NCT00103857|527419897|FG003|54-Week Base Study|Death|0|||
146247544|NCT00103857|527419898|FG004|54-Week Base Study|Death|1|||
146247545|NCT00103857|527419899|FG005|54-Week Base Study|Death|1|||
146247546|NCT00103857|527419900|FG006|54-Week Base Study|Death|0|||
146247547|NCT00103857|527419894|FG000|54-Week Base Study|Lack of Efficacy|11|||
146247548|NCT00103857|527419895|FG001|54-Week Base Study|Lack of Efficacy|14|||
146247549|NCT00103857|527419896|FG002|54-Week Base Study|Lack of Efficacy|8|||
146247550|NCT00103857|527419897|FG003|54-Week Base Study|Lack of Efficacy|4|||
146247551|NCT00103857|527419898|FG004|54-Week Base Study|Lack of Efficacy|3|||
146247552|NCT00103857|527419899|FG005|54-Week Base Study|Lack of Efficacy|14|||
146247553|NCT00103857|527419900|FG006|54-Week Base Study|Lack of Efficacy|19|||
146247554|NCT00103857|527419894|FG000|54-Week Base Study|Lost to Follow-up|5|||
146247555|NCT00103857|527419895|FG001|54-Week Base Study|Lost to Follow-up|4|||
146247556|NCT00103857|527419896|FG002|54-Week Base Study|Lost to Follow-up|7|||
146247557|NCT00103857|527419897|FG003|54-Week Base Study|Lost to Follow-up|5|||
146247558|NCT00103857|527419898|FG004|54-Week Base Study|Lost to Follow-up|10|||
146247559|NCT00103857|527419899|FG005|54-Week Base Study|Lost to Follow-up|9|||
146002594|NCT01904721|526525956|FG003|Overall Study|Lost to Follow-up|0|||
146002595|NCT01904721|526525957|FG004|Overall Study|Lost to Follow-up|1|||
146002596|NCT01904721|526525958|FG005|Overall Study|Lost to Follow-up|3|||
146002597|NCT01904721|526525959|FG006|Overall Study|Lost to Follow-up|1|||
146002598|NCT01904721|526525953|FG000|Overall Study|Lack of Efficacy|0|||
146002599|NCT01904721|526525954|FG001|Overall Study|Lack of Efficacy|0|||
146002600|NCT01904721|526525955|FG002|Overall Study|Lack of Efficacy|0|||
146002601|NCT01904721|526525956|FG003|Overall Study|Lack of Efficacy|0|||
146002602|NCT01904721|526525957|FG004|Overall Study|Lack of Efficacy|0|||
146002603|NCT01904721|526525958|FG005|Overall Study|Lack of Efficacy|0|||
146002604|NCT01904721|526525959|FG006|Overall Study|Lack of Efficacy|1|||
146002605|NCT01904721|526525953|FG000|Overall Study|Adverse Event|0|||
146002606|NCT01904721|526525954|FG001|Overall Study|Adverse Event|0|||
146002607|NCT01904721|526525955|FG002|Overall Study|Adverse Event|0|||
146002608|NCT01904721|526525956|FG003|Overall Study|Adverse Event|0|||
146002609|NCT01904721|526525957|FG004|Overall Study|Adverse Event|3|||
146002610|NCT01904721|526525958|FG005|Overall Study|Adverse Event|1|||
146002611|NCT01904721|526525959|FG006|Overall Study|Adverse Event|0|||
146002612|NCT01957865|526525960|FG000|Overall Study|Found HIV negative|0|||
146002613|NCT01957865|526525961|FG001|Overall Study|Found HIV negative|0|||
146002614|NCT01957865|526525962|FG002|Overall Study|Found HIV negative|1|||
146247560|NCT00103857|527419900|FG006|54-Week Base Study|Lost to Follow-up|3|||
146247561|NCT00103857|527419894|FG000|54-Week Base Study|Physician Decision|1|||
146247562|NCT00103857|527419895|FG001|54-Week Base Study|Physician Decision|1|||
146002615|NCT01957865|526525960|FG000|Overall Study|Lost to Follow-up|0|||
146002616|NCT01957865|526525961|FG001|Overall Study|Lost to Follow-up|2|||
146002617|NCT01957865|526525962|FG002|Overall Study|Lost to Follow-up|2|||
146247563|NCT00103857|527419896|FG002|54-Week Base Study|Physician Decision|0|||
146247564|NCT00103857|527419897|FG003|54-Week Base Study|Physician Decision|0|||
146247565|NCT00103857|527419898|FG004|54-Week Base Study|Physician Decision|1|||
146002618|NCT00811720|526525966|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
146002619|NCT00811720|526525967|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
146002620|NCT00811720|526525966|FG000|All Treated Patients|Adverse Event|20|||
146247566|NCT00103857|527419899|FG005|54-Week Base Study|Physician Decision|0|||
146247567|NCT00103857|527419900|FG006|54-Week Base Study|Physician Decision|0|||
146002621|NCT00811720|526525967|FG001|All Treated Patients|Adverse Event|62|||
146247568|NCT00103857|527419894|FG000|54-Week Base Study|Pregnancy|1|||
146247569|NCT00103857|527419895|FG001|54-Week Base Study|Pregnancy|0|||
146247570|NCT00103857|527419896|FG002|54-Week Base Study|Pregnancy|0|||
146247571|NCT00103857|527419897|FG003|54-Week Base Study|Pregnancy|0|||
146247572|NCT00103857|527419898|FG004|54-Week Base Study|Pregnancy|1|||
146247573|NCT00103857|527419899|FG005|54-Week Base Study|Pregnancy|0|||
146247574|NCT00103857|527419900|FG006|54-Week Base Study|Pregnancy|1|||
146247575|NCT00103857|527419894|FG000|54-Week Base Study|Protocol Violation|6|||
146247576|NCT00103857|527419895|FG001|54-Week Base Study|Protocol Violation|4|||
146247577|NCT00103857|527419896|FG002|54-Week Base Study|Protocol Violation|2|||
146247578|NCT00103857|527419897|FG003|54-Week Base Study|Protocol Violation|4|||
146247579|NCT00103857|527419898|FG004|54-Week Base Study|Protocol Violation|0|||
146247580|NCT00103857|527419899|FG005|54-Week Base Study|Protocol Violation|3|||
146247581|NCT00103857|527419900|FG006|54-Week Base Study|Protocol Violation|3|||
146247582|NCT00103857|527419894|FG000|54-Week Base Study|Withdrawal by Subject|17|||
146247583|NCT00103857|527419895|FG001|54-Week Base Study|Withdrawal by Subject|16|||
146247584|NCT00103857|527419896|FG002|54-Week Base Study|Withdrawal by Subject|16|||
146247585|NCT00103857|527419897|FG003|54-Week Base Study|Withdrawal by Subject|15|||
146247586|NCT00103857|527419898|FG004|54-Week Base Study|Withdrawal by Subject|10|||
146247587|NCT00103857|527419899|FG005|54-Week Base Study|Withdrawal by Subject|15|||
146247588|NCT00103857|527419900|FG006|54-Week Base Study|Withdrawal by Subject|4|||
146247589|NCT00103857|527419894|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
146247590|NCT00103857|527419895|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
146247591|NCT00103857|527419896|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
146247592|NCT00103857|527419897|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
146247593|NCT00103857|527419898|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
146247594|NCT00103857|527419899|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
146247595|NCT00103857|527419900|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
146247596|NCT00103857|527419894|FG000|54-Week Base Study|patient moved|0|||
146247597|NCT00103857|527419895|FG001|54-Week Base Study|patient moved|1|||
146247598|NCT00103857|527419896|FG002|54-Week Base Study|patient moved|1|||
146247599|NCT00103857|527419897|FG003|54-Week Base Study|patient moved|2|||
146247600|NCT00103857|527419898|FG004|54-Week Base Study|patient moved|3|||
146247601|NCT00103857|527419899|FG005|54-Week Base Study|patient moved|1|||
146247602|NCT00103857|527419900|FG006|54-Week Base Study|patient moved|0|||
146247603|NCT00103857|527419894|FG000|54-Week Base Study|non-compliance with study procedures|1|||
146247604|NCT00103857|527419895|FG001|54-Week Base Study|non-compliance with study procedures|2|||
146002622|NCT00811720|526525966|FG000|All Treated Patients|Lack of Efficacy|22|||
146002623|NCT00811720|526525967|FG001|All Treated Patients|Lack of Efficacy|18|||
146002624|NCT00811720|526525966|FG000|All Treated Patients|Non-compliance|0|||
146002625|NCT00811720|526525967|FG001|All Treated Patients|Non-compliance|14|||
146002626|NCT00811720|526525966|FG000|All Treated Patients|Protocol Violation|9|||
146002627|NCT00811720|526525967|FG001|All Treated Patients|Protocol Violation|16|||
146002628|NCT00811720|526525966|FG000|All Treated Patients|Withdrawal by Subject|28|||
146002629|NCT00811720|526525967|FG001|All Treated Patients|Withdrawal by Subject|34|||
146002630|NCT00811720|526525966|FG000|All Treated Patients|Lost to Follow-up|10|||
146002631|NCT00811720|526525967|FG001|All Treated Patients|Lost to Follow-up|16|||
146002632|NCT00811720|526525966|FG000|All Treated Patients|Other Reason|7|||
146002633|NCT00811720|526525967|FG001|All Treated Patients|Other Reason|4|||
146002634|NCT01077063|526525968|FG000|Overall Study|Adverse Event|3|||
146002635|NCT01077063|526525969|FG001|Overall Study|Adverse Event|0|||
146002636|NCT01077063|526525968|FG000|Overall Study|Death|1|||
146002637|NCT01077063|526525969|FG001|Overall Study|Death|1|||
146002638|NCT01077063|526525968|FG000|Overall Study|Withdrawal by Subject|0|||
146002639|NCT01077063|526525969|FG001|Overall Study|Withdrawal by Subject|2|||
146002640|NCT02750930|526525970|FG000|Overall Study|Study closed/terminated|8|||
146002641|NCT00553631|526525971|FG000|Overall Study|Withdrawal by Subject|0|||
146002642|NCT00553631|526525972|FG001|Overall Study|Withdrawal by Subject|1|||
146002643|NCT00553631|526525971|FG000|Overall Study|Lost to Follow-up|1|||
146002644|NCT00553631|526525972|FG001|Overall Study|Lost to Follow-up|0|||
146002645|NCT00527618|526525973|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
146002646|NCT00527618|526525974|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
146002647|NCT00527618|526525973|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
146002648|NCT00527618|526525974|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
146002649|NCT00527618|526525973|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
146002650|NCT00527618|526525974|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
146247605|NCT00103857|527419896|FG002|54-Week Base Study|non-compliance with study procedures|0|||
146247606|NCT00103857|527419897|FG003|54-Week Base Study|non-compliance with study procedures|0|||
146247607|NCT00103857|527419898|FG004|54-Week Base Study|non-compliance with study procedures|0|||
146247608|NCT00103857|527419899|FG005|54-Week Base Study|non-compliance with study procedures|2|||
146002651|NCT00527618|526525973|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
146247609|NCT00103857|527419900|FG006|54-Week Base Study|non-compliance with study procedures|0|||
146247610|NCT00103857|527419894|FG000|54-Week Base Study|patient incarcerated|0|||
146247611|NCT00103857|527419895|FG001|54-Week Base Study|patient incarcerated|0|||
146002652|NCT00527618|526525974|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
146002653|NCT00527618|526525973|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
146002654|NCT00527618|526525974|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
146002655|NCT00527618|526525973|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
146002656|NCT00527618|526525974|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
146002657|NCT01490918|526525975|FG000|Overall Study|Lost to Follow-up|2|||
146002658|NCT01490918|526525976|FG001|Overall Study|Lost to Follow-up|1|||
146002659|NCT01490918|526525977|FG002|Overall Study|Lost to Follow-up|0|||
146002660|NCT01490918|526525975|FG000|Overall Study|Withdrawal by Subject|7|||
146002661|NCT01490918|526525976|FG001|Overall Study|Withdrawal by Subject|8|||
146002662|NCT01490918|526525977|FG002|Overall Study|Withdrawal by Subject|3|||
146002663|NCT01490918|526525975|FG000|Overall Study|Adverse Event|0|||
146002664|NCT01490918|526525976|FG001|Overall Study|Adverse Event|0|||
146002665|NCT01490918|526525977|FG002|Overall Study|Adverse Event|1|||
146002666|NCT01490918|526525975|FG000|Overall Study|other cause|4|||
146002667|NCT01490918|526525976|FG001|Overall Study|other cause|5|||
146002668|NCT01490918|526525977|FG002|Overall Study|other cause|8|||
146002669|NCT00648037|526525980|FG000|Overall Study|Not Treated|1|||
146002670|NCT00648037|526525980|FG000|Overall Study|Withdrawal by Subject|1|||
146002671|NCT00648037|526525980|FG000|Overall Study|Adverse Event|11|||
146002672|NCT00648037|526525980|FG000|Overall Study|Relapse|2|||
146002673|NCT00648037|526525980|FG000|Overall Study|Other|1|||
146002674|NCT02967679|526525981|FG000|Overall Study|Adverse Event|1|||
146002675|NCT00114127|526525983|FG000|Overall Study|Adverse Event|2|||
146002676|NCT00114127|526525984|FG001|Overall Study|Adverse Event|1|||
146002677|NCT00114127|526525983|FG000|Overall Study|Lost to Follow-up|1|||
146002678|NCT00114127|526525984|FG001|Overall Study|Lost to Follow-up|0|||
146002679|NCT00114127|526525983|FG000|Overall Study|Withdrawal by Subject|1|||
146002680|NCT00114127|526525984|FG001|Overall Study|Withdrawal by Subject|3|||
146002681|NCT03188263|526525985|FG000|Overall Study|Withdrawal by Subject|3|||
146002682|NCT03188263|526525986|FG001|Overall Study|Withdrawal by Subject|0|||
146002683|NCT03188263|526525985|FG000|Overall Study|Physician Decision|1|||
146002684|NCT03188263|526525986|FG001|Overall Study|Physician Decision|0|||
146002685|NCT00881894|526525987|FG000|Overall Study|Consent withdrawn|0|||
146002686|NCT00881894|526525988|FG001|Overall Study|Consent withdrawn|1|||
146002687|NCT00881894|526525987|FG000|Overall Study|Other reasons for premature termination|1|||
146002688|NCT00881894|526525988|FG001|Overall Study|Other reasons for premature termination|2|||
146002689|NCT00469833|526525989|FG000|Overall Study|No IV access|2|||
146002690|NCT01253369|526525990|FG000|Overall Study|Adverse Event|4|||
146002691|NCT01253369|526525990|FG000|Overall Study|Withdrawal by Subject|2|||
146002692|NCT01253369|526525990|FG000|Overall Study|Death|1|||
146002693|NCT01253369|526525990|FG000|Overall Study|Progressive disease|23|||
146002694|NCT01253369|526525990|FG000|Overall Study|Not Evaluable|3|||
146002695|NCT01284959|526525992|FG000|Overall Study|Withdrawal by Subject|1|||
146002696|NCT01284959|526525993|FG001|Overall Study|Withdrawal by Subject|0|||
146002697|NCT01284959|526525994|FG002|Overall Study|Withdrawal by Subject|0|||
146002698|NCT01284959|526525992|FG000|Overall Study|Adverse Event|0|||
146002699|NCT01284959|526525993|FG001|Overall Study|Adverse Event|0|||
146002700|NCT01284959|526525994|FG002|Overall Study|Adverse Event|1|||
146002701|NCT00363311|526525995|FG000|Overall Study|Adverse Event|6|||
146247612|NCT00103857|527419896|FG002|54-Week Base Study|patient incarcerated|0|||
146002702|NCT00363311|526525996|FG001|Overall Study|Adverse Event|4|||
146002703|NCT00363311|526525995|FG000|Overall Study|Lost to Follow-up|3|||
146002704|NCT00363311|526525996|FG001|Overall Study|Lost to Follow-up|0|||
146002705|NCT00363311|526525995|FG000|Overall Study|Protocol Violation|1|||
146002706|NCT00363311|526525996|FG001|Overall Study|Protocol Violation|2|||
146002707|NCT00363311|526525995|FG000|Overall Study|Withdrawal by Subject|12|||
146002708|NCT00363311|526525996|FG001|Overall Study|Withdrawal by Subject|6|||
146002709|NCT00363311|526525995|FG000|Overall Study|Physician Decision|1|||
146002710|NCT00363311|526525996|FG001|Overall Study|Physician Decision|1|||
146002711|NCT00363311|526525995|FG000|Overall Study|Sponsor Terminated Study|2|||
146002712|NCT00363311|526525996|FG001|Overall Study|Sponsor Terminated Study|2|||
146002713|NCT00363311|526525995|FG000|Overall Study|Disease Progression|46|||
146002714|NCT00363311|526525996|FG001|Overall Study|Disease Progression|26|||
146002715|NCT00363311|526525995|FG000|Overall Study|Non-Compliance|1|||
146002716|NCT00363311|526525996|FG001|Overall Study|Non-Compliance|1|||
146002717|NCT00363311|526525995|FG000|Overall Study|Participant Refused Biopsy|1|||
146002718|NCT00363311|526525996|FG001|Overall Study|Participant Refused Biopsy|0|||
146002719|NCT00363311|526525995|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
146002720|NCT00363311|526525996|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
146247613|NCT00103857|527419897|FG003|54-Week Base Study|patient incarcerated|0|||
146002721|NCT00363311|526525995|FG000|Overall Study|Participant Opted for Treatment|1|||
146002722|NCT00363311|526525996|FG001|Overall Study|Participant Opted for Treatment|0|||
146002723|NCT00363311|526525995|FG000|Overall Study|Participant Moved to Another Country|1|||
146002724|NCT00363311|526525996|FG001|Overall Study|Participant Moved to Another Country|0|||
146247614|NCT00103857|527419898|FG004|54-Week Base Study|patient incarcerated|1|||
146002725|NCT00363311|526525995|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
146002726|NCT00363311|526525996|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
146002727|NCT00363311|526525995|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
146247615|NCT00103857|527419899|FG005|54-Week Base Study|patient incarcerated|1|||
146247616|NCT00103857|527419900|FG006|54-Week Base Study|patient incarcerated|0|||
146247617|NCT00103857|527419894|FG000|54-Week Base Study|laboratory reporting error|0|||
146247618|NCT00103857|527419895|FG001|54-Week Base Study|laboratory reporting error|0|||
146247619|NCT00103857|527419896|FG002|54-Week Base Study|laboratory reporting error|0|||
146247620|NCT00103857|527419897|FG003|54-Week Base Study|laboratory reporting error|0|||
146247621|NCT00103857|527419898|FG004|54-Week Base Study|laboratory reporting error|1|||
146247622|NCT00103857|527419899|FG005|54-Week Base Study|laboratory reporting error|0|||
146247623|NCT00103857|527419900|FG006|54-Week Base Study|laboratory reporting error|0|||
146247624|NCT00103857|527419894|FG000|54-Week Base Study|site error|0|||
146247625|NCT00103857|527419895|FG001|54-Week Base Study|site error|0|||
146247626|NCT00103857|527419896|FG002|54-Week Base Study|site error|0|||
146247627|NCT00103857|527419897|FG003|54-Week Base Study|site error|0|||
146247628|NCT00103857|527419898|FG004|54-Week Base Study|site error|0|||
146247629|NCT00103857|527419899|FG005|54-Week Base Study|site error|1|||
146247630|NCT00103857|527419900|FG006|54-Week Base Study|site error|0|||
146247631|NCT00103857|527419894|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
146002728|NCT00363311|526525996|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
146002729|NCT00363311|526525995|FG000|Overall Study|Participant Moved to Louisiana|0|||
146002730|NCT00363311|526525996|FG001|Overall Study|Participant Moved to Louisiana|1|||
146002731|NCT02103062|526526001|FG000|Overall Study|Adverse Event|1|||
146002732|NCT02103062|526526002|FG001|Overall Study|Adverse Event|2|||
146002733|NCT02103062|526526001|FG000|Overall Study|Progressive Disease|17|||
146002734|NCT02103062|526526002|FG001|Overall Study|Progressive Disease|20|||
146002735|NCT02103062|526526001|FG000|Overall Study|Death|0|||
146002736|NCT02103062|526526002|FG001|Overall Study|Death|1|||
146002737|NCT01182298|526526003|FG000|Overall Study|Lack of Efficacy|4|||
146002738|NCT01182298|526526003|FG000|Overall Study|Withdrawal by Subject|2|||
146002739|NCT00959907|526526007|FG000|Overall Study|Protocol Violation|0|||
146002740|NCT00959907|526526008|FG001|Overall Study|Protocol Violation|1|||
146002741|NCT00959907|526526007|FG000|Overall Study|Adverse Event|1|||
146002742|NCT00959907|526526008|FG001|Overall Study|Adverse Event|0|||
146002743|NCT00959907|526526007|FG000|Overall Study|Withdrawal by Subject|2|||
146002744|NCT00959907|526526008|FG001|Overall Study|Withdrawal by Subject|0|||
146002745|NCT03958331|526526009|FG000|Overall Study|Withdrawal by Subject|3|||
146002746|NCT03958331|526526010|FG001|Overall Study|Withdrawal by Subject|1|||
146002747|NCT03958331|526526011|FG002|Overall Study|Withdrawal by Subject|5|||
146002748|NCT03958331|526526009|FG000|Overall Study|Weaned from medicine|2|||
146002749|NCT03958331|526526010|FG001|Overall Study|Weaned from medicine|0|||
146002750|NCT03958331|526526011|FG002|Overall Study|Weaned from medicine|0|||
146002751|NCT03958331|526526009|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
146002752|NCT03958331|526526010|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
146002753|NCT03958331|526526011|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
146002754|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
146002755|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
146002756|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
146002757|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
146002758|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
146002759|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
146002760|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
146002761|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
146002762|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
146002763|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
146002764|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
146002765|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
146002766|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
146002767|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
146002768|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
146002769|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
146002770|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
146002771|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
146002772|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
146002773|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
146002774|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
146002775|NCT04021290|526526021|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
146002776|NCT04021290|526526022|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
146002777|NCT04021290|526526023|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
146002778|NCT04021290|526526021|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
146247632|NCT00103857|527419895|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
146002779|NCT04021290|526526022|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
146002780|NCT04021290|526526023|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
146002781|NCT04021290|526526021|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
146002782|NCT04021290|526526022|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
146002783|NCT04021290|526526023|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
146002784|NCT04021290|526526021|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
146002785|NCT04021290|526526022|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
146002786|NCT04021290|526526023|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
146002787|NCT04021290|526526021|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
146002788|NCT04021290|526526022|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
146002789|NCT04021290|526526023|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
146002790|NCT01174563|526526024|FG000|Overall Study|Progressive Disease|45|||
146002791|NCT01174563|526526024|FG000|Overall Study|Death|5|||
146002792|NCT01174563|526526024|FG000|Overall Study|Investigator's Discretion|5|||
146002793|NCT01174563|526526024|FG000|Overall Study|Participant Withdrew Consent|3|||
146002794|NCT01174563|526526024|FG000|Overall Study|Rash Adverse Event|1|||
146002795|NCT01174563|526526024|FG000|Overall Study|Sponsor's decision|1|||
146002796|NCT02015039|526526028|FG000|Overall Study|Not eligible|0|||
146002797|NCT02015039|526526029|FG001|Overall Study|Not eligible|1|||
146002798|NCT01088906|526526033|FG000|Overall Study|Inclusion error|1|||
146002799|NCT01088906|526526033|FG000|Overall Study|Did not receive study treatment|3|||
146002800|NCT01088906|526526033|FG000|Overall Study|Missing data|1|||
146002801|NCT00887159|526527762|FG000|Overall Study|Disease progression|6|||
146002802|NCT00887159|526527763|FG001|Overall Study|Disease progression|39|||
146002803|NCT00887159|526527764|FG002|Overall Study|Disease progression|33|||
146002804|NCT00887159|526527762|FG000|Overall Study|Adverse Event|3|||
146002805|NCT00887159|526527763|FG001|Overall Study|Adverse Event|4|||
146002806|NCT00887159|526527764|FG002|Overall Study|Adverse Event|17|||
146002807|NCT00887159|526527762|FG000|Overall Study|Death|2|||
146002808|NCT00887159|526527763|FG001|Overall Study|Death|2|||
146002809|NCT00887159|526527764|FG002|Overall Study|Death|0|||
146002810|NCT00887159|526527762|FG000|Overall Study|Withdrawal by Subject|4|||
146002811|NCT00887159|526527763|FG001|Overall Study|Withdrawal by Subject|4|||
146002812|NCT00887159|526527764|FG002|Overall Study|Withdrawal by Subject|2|||
146002813|NCT00887159|526527762|FG000|Overall Study|Alternative therapy|2|||
146002814|NCT00887159|526527763|FG001|Overall Study|Alternative therapy|0|||
146002815|NCT00887159|526527764|FG002|Overall Study|Alternative therapy|0|||
146002816|NCT00887159|526527762|FG000|Overall Study|Physician Decision|1|||
146002817|NCT00887159|526527763|FG001|Overall Study|Physician Decision|1|||
146002818|NCT00887159|526527764|FG002|Overall Study|Physician Decision|0|||
146002819|NCT00887159|526527762|FG000|Overall Study|Sympomatic deterioration|1|||
146002820|NCT00887159|526527763|FG001|Overall Study|Sympomatic deterioration|0|||
146002821|NCT00887159|526527764|FG002|Overall Study|Sympomatic deterioration|0|||
146002822|NCT00887159|526527762|FG000|Overall Study|Treatment delayed|1|||
146002823|NCT00887159|526527763|FG001|Overall Study|Treatment delayed|1|||
146002824|NCT00887159|526527764|FG002|Overall Study|Treatment delayed|0|||
146002825|NCT00887159|526527762|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
146002826|NCT00887159|526527763|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
146002827|NCT00887159|526527764|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
146298090|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
146298091|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
146298092|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
146298093|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
146298094|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
146298095|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
146298096|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
146298097|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
146298098|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
146002828|NCT00887159|526527762|FG000|Overall Study|Received more tx instead of observation|1|||
146002829|NCT00887159|526527763|FG001|Overall Study|Received more tx instead of observation|0|||
146002830|NCT00887159|526527764|FG002|Overall Study|Received more tx instead of observation|0|||
146002831|NCT00887159|526527762|FG000|Overall Study|Ineligible|5|||
146002832|NCT00887159|526527763|FG001|Overall Study|Ineligible|1|||
146002833|NCT00887159|526527764|FG002|Overall Study|Ineligible|0|||
146002834|NCT00887159|526527762|FG000|Overall Study|Never started assigned therapy|3|||
146002835|NCT00887159|526527763|FG001|Overall Study|Never started assigned therapy|3|||
146002836|NCT00887159|526527764|FG002|Overall Study|Never started assigned therapy|4|||
146002837|NCT06164691|526527769|FG000|Overall Study|Withdrawal by Subject|2|||
146002838|NCT06164691|526527770|FG001|Overall Study|Withdrawal by Subject|0|||
146002839|NCT06164691|526527771|FG002|Overall Study|Withdrawal by Subject|0|||
146002840|NCT00812955|526527772|FG000|Overall Study|Adverse Event|7|||
146002841|NCT00812955|526527773|FG001|Overall Study|Adverse Event|6|||
146002842|NCT00812955|526527774|FG002|Overall Study|Adverse Event|3|||
146002843|NCT00812955|526527775|FG003|Overall Study|Adverse Event|4|||
146002844|NCT00812955|526527772|FG000|Overall Study|Lost to Follow-up|2|||
146002845|NCT00812955|526527773|FG001|Overall Study|Lost to Follow-up|1|||
146002846|NCT00812955|526527774|FG002|Overall Study|Lost to Follow-up|1|||
146002847|NCT00812955|526527775|FG003|Overall Study|Lost to Follow-up|2|||
146002848|NCT00812955|526527772|FG000|Overall Study|Withdrawal by Subject|1|||
146002849|NCT00812955|526527773|FG001|Overall Study|Withdrawal by Subject|0|||
146002850|NCT00812955|526527774|FG002|Overall Study|Withdrawal by Subject|1|||
146002851|NCT00812955|526527775|FG003|Overall Study|Withdrawal by Subject|2|||
146002852|NCT00812955|526527772|FG000|Overall Study|randomized in error|0|||
146002853|NCT00812955|526527773|FG001|Overall Study|randomized in error|0|||
146002854|NCT00812955|526527774|FG002|Overall Study|randomized in error|1|||
146002855|NCT00812955|526527775|FG003|Overall Study|randomized in error|0|||
146002856|NCT01815424|526527777|FG000|Week 0 to 16|Adverse Event|1|||
146002857|NCT01815424|526527778|FG001|Week 0 to 16|Adverse Event|3|||
146002858|NCT01815424|526527779|FG002|Week 0 to 16|Adverse Event|3|||
146002859|NCT01815424|526527780|FG003|Week 0 to 16|Adverse Event|0|||
146002860|NCT01815424|526527781|FG004|Week 0 to 16|Adverse Event|0|||
146002861|NCT01815424|526527777|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
146002862|NCT01815424|526527778|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146002863|NCT01815424|526527779|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146002864|NCT01815424|526527780|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146002865|NCT01815424|526527781|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
146002866|NCT01815424|526527777|FG000|Week 0 to 16|Lost to Follow-up|0|||
146002867|NCT01815424|526527778|FG001|Week 0 to 16|Lost to Follow-up|1|||
146002868|NCT01815424|526527779|FG002|Week 0 to 16|Lost to Follow-up|0|||
146002869|NCT01815424|526527780|FG003|Week 0 to 16|Lost to Follow-up|0|||
146002870|NCT01815424|526527781|FG004|Week 0 to 16|Lost to Follow-up|0|||
146002871|NCT01815424|526527777|FG000|Week 0 to 16|Withdrawal by Subject|0|||
146002872|NCT01815424|526527778|FG001|Week 0 to 16|Withdrawal by Subject|0|||
146002873|NCT01815424|526527779|FG002|Week 0 to 16|Withdrawal by Subject|1|||
146002874|NCT01815424|526527780|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146002875|NCT01815424|526527781|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146002876|NCT01815424|526527777|FG000|Week 0 to 16|Other|1|||
146002877|NCT01815424|526527778|FG001|Week 0 to 16|Other|0|||
146002878|NCT01815424|526527779|FG002|Week 0 to 16|Other|3|||
146002879|NCT01815424|526527780|FG003|Week 0 to 16|Other|0|||
146002880|NCT01815424|526527781|FG004|Week 0 to 16|Other|0|||
146002881|NCT01815424|526527777|FG000|Week 0 to 16|Protocol Violation|1|||
146002882|NCT01815424|526527778|FG001|Week 0 to 16|Protocol Violation|0|||
146002883|NCT01815424|526527779|FG002|Week 0 to 16|Protocol Violation|0|||
146002884|NCT01815424|526527780|FG003|Week 0 to 16|Protocol Violation|0|||
146002885|NCT01815424|526527781|FG004|Week 0 to 16|Protocol Violation|0|||
146002886|NCT01815424|526527777|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
146002887|NCT01815424|526527778|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
146002888|NCT01815424|526527779|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
146002889|NCT01815424|526527780|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
146002890|NCT01815424|526527781|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
146002891|NCT01815424|526527777|FG000|Week 16 to 52|Other|0|||
146002892|NCT01815424|526527778|FG001|Week 16 to 52|Other|1|||
146002893|NCT01815424|526527779|FG002|Week 16 to 52|Other|0|||
146002894|NCT01815424|526527780|FG003|Week 16 to 52|Other|0|||
146002895|NCT01815424|526527781|FG004|Week 16 to 52|Other|0|||
146002896|NCT01815424|526527777|FG000|Week 16 to 52|Adverse Event|0|||
146002897|NCT01815424|526527778|FG001|Week 16 to 52|Adverse Event|0|||
146002898|NCT01815424|526527779|FG002|Week 16 to 52|Adverse Event|0|||
146002899|NCT01815424|526527780|FG003|Week 16 to 52|Adverse Event|0|||
146002900|NCT01815424|526527781|FG004|Week 16 to 52|Adverse Event|1|||
146002901|NCT01815424|526527777|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
146002902|NCT01815424|526527778|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
146002903|NCT01815424|526527779|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
146002904|NCT01815424|526527780|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
146002905|NCT01815424|526527781|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
146002906|NCT01815424|526527777|FG000|Week 16 to 52|Lost to Follow-up|0|||
146002907|NCT01815424|526527778|FG001|Week 16 to 52|Lost to Follow-up|2|||
146002908|NCT01815424|526527779|FG002|Week 16 to 52|Lost to Follow-up|0|||
146002909|NCT01815424|526527780|FG003|Week 16 to 52|Lost to Follow-up|2|||
146002910|NCT01815424|526527781|FG004|Week 16 to 52|Lost to Follow-up|1|||
146002911|NCT01815424|526527777|FG000|Week 16 to 52|Withdrawal by Subject|1|||
146002912|NCT01815424|526527778|FG001|Week 16 to 52|Withdrawal by Subject|2|||
146002913|NCT01815424|526527779|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146002914|NCT01815424|526527780|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146002915|NCT01815424|526527781|FG004|Week 16 to 52|Withdrawal by Subject|0|||
146002916|NCT04723355|526527782|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
146002917|NCT04723355|526527782|FG000|Overall Study|Errors in the informed consent form|2|||
146002918|NCT03374358|526527783|FG000|Overall Study|Withdrawal by Subject|0|||
146002919|NCT03374358|526527784|FG001|Overall Study|Withdrawal by Subject|2|||
146002920|NCT01127633|526527785|FG000|Overall Study|Adverse Event|74|||
146002921|NCT01127633|526527786|FG001|Overall Study|Adverse Event|73|||
146002922|NCT01127633|526527785|FG000|Overall Study|Death|40|||
146002923|NCT01127633|526527786|FG001|Overall Study|Death|43|||
146002924|NCT01127633|526527785|FG000|Overall Study|Lost to Follow-up|4|||
146002925|NCT01127633|526527786|FG001|Overall Study|Lost to Follow-up|0|||
146002926|NCT01127633|526527785|FG000|Overall Study|Parent/Caregiver Decision|246|||
146002927|NCT01127633|526527786|FG001|Overall Study|Parent/Caregiver Decision|228|||
146002928|NCT01127633|526527785|FG000|Overall Study|Physician Decision|60|||
146002929|NCT01127633|526527786|FG001|Overall Study|Physician Decision|45|||
146002930|NCT01127633|526527785|FG000|Overall Study|Withdrawal by Subject|57|||
146002931|NCT01127633|526527786|FG001|Overall Study|Withdrawal by Subject|72|||
146002932|NCT01127633|526527785|FG000|Overall Study|Sponsor Decision|163|||
146002933|NCT01127633|526527786|FG001|Overall Study|Sponsor Decision|195|||
146002934|NCT01127633|526527785|FG000|Overall Study|Protocol Violation|8|||
146002935|NCT01127633|526527786|FG001|Overall Study|Protocol Violation|16|||
146002936|NCT01127633|526527785|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
146002937|NCT01127633|526527786|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
146002938|NCT01127633|526527785|FG000|Overall Study|Not treated|1|||
146002939|NCT01127633|526527786|FG001|Overall Study|Not treated|0|||
146002940|NCT02805790|526527790|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
146002941|NCT02805790|526527791|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
146002942|NCT02329743|526527794|FG000|Overall Study|Adverse Event|1|||
146002943|NCT02329743|526527795|FG001|Overall Study|Adverse Event|1|||
146002944|NCT02329743|526527796|FG002|Overall Study|Adverse Event|3|||
146002945|NCT02329743|526527794|FG000|Overall Study|Lost to Follow-up|1|||
146002946|NCT02329743|526527795|FG001|Overall Study|Lost to Follow-up|0|||
146002947|NCT02329743|526527796|FG002|Overall Study|Lost to Follow-up|1|||
146002948|NCT02329743|526527794|FG000|Overall Study|Withdrawal by Subject|4|||
146002949|NCT02329743|526527795|FG001|Overall Study|Withdrawal by Subject|4|||
146002950|NCT02329743|526527796|FG002|Overall Study|Withdrawal by Subject|1|||
146002951|NCT02329743|526527794|FG000|Overall Study|Other|0|||
146002952|NCT02329743|526527795|FG001|Overall Study|Other|2|||
146002953|NCT02329743|526527796|FG002|Overall Study|Other|3|||
146002954|NCT00825994|526527801|FG000|Overall Study|Withdrawal by Subject|2|||
146002955|NCT00825994|526527801|FG000|Overall Study|Lost to Follow-up|1|||
146002956|NCT00825994|526527801|FG000|Overall Study|Protocol Violation|1|||
146002957|NCT00825994|526527801|FG000|Overall Study|Placebo Responder at V2|1|||
146002958|NCT00616642|526527804|FG000|Overall Study|Withdrawal by Subject|0|||
146002959|NCT00616642|526527805|FG001|Overall Study|Withdrawal by Subject|1|||
146002960|NCT01673646|526527809|FG000|Overall Study|Adverse Event|2|||
146002961|NCT01673646|526527810|FG001|Overall Study|Adverse Event|1|||
146002962|NCT01673646|526527811|FG002|Overall Study|Adverse Event|1|||
146002963|NCT01673646|526527809|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146002964|NCT01673646|526527810|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146002965|NCT01673646|526527811|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146002966|NCT01673646|526527809|FG000|Overall Study|Condition no longer requires study drug|0|||
146002967|NCT01673646|526527810|FG001|Overall Study|Condition no longer requires study drug|1|||
146002968|NCT01673646|526527811|FG002|Overall Study|Condition no longer requires study drug|0|||
146002969|NCT01673646|526527809|FG000|Overall Study|Withdrawal by Subject|0|||
146002970|NCT01673646|526527810|FG001|Overall Study|Withdrawal by Subject|2|||
146002971|NCT01673646|526527811|FG002|Overall Study|Withdrawal by Subject|2|||
146002972|NCT01673646|526527809|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
146002973|NCT01673646|526527810|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
146002974|NCT01673646|526527811|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
146002975|NCT01881009|526527812|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
146002976|NCT01881009|526527813|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
146002977|NCT05518461|526527815|FG000|Overall Study|Lost to Follow-up|25|||
146002978|NCT03326063|526527817|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
146002979|NCT03326063|526527818|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
146002980|NCT01876381|526527819|FG000|Overall Study|Lack of Efficacy|5|||
146002981|NCT01876381|526527819|FG000|Overall Study|Physician Decision|1|||
146002982|NCT01876381|526527819|FG000|Overall Study|Withdrawal by Subject|1|||
146002983|NCT00332696|526527820|FG000|Overall Study|Death|24|||
146002984|NCT00332696|526527821|FG001|Overall Study|Death|14|||
146002985|NCT00332696|526527820|FG000|Overall Study|Insufficient therapeutic effect|4|||
146002986|NCT00332696|526527821|FG001|Overall Study|Insufficient therapeutic effect|11|||
146002987|NCT00332696|526527820|FG000|Overall Study|Adverse Event|1|||
146002988|NCT00332696|526527821|FG001|Overall Study|Adverse Event|2|||
146002989|NCT00332696|526527820|FG000|Overall Study|Condition does not justify treatment|0|||
146002990|NCT00332696|526527821|FG001|Overall Study|Condition does not justify treatment|2|||
146002991|NCT00332696|526527820|FG000|Overall Study|Lost to Follow-up|0|||
146002992|NCT00332696|526527821|FG001|Overall Study|Lost to Follow-up|1|||
146002993|NCT00332696|526527820|FG000|Overall Study|Withdrawal by Subject|1|||
146002994|NCT00332696|526527821|FG001|Overall Study|Withdrawal by Subject|0|||
146002995|NCT00382174|526527822|FG000|Overall Study|Lost to Follow-up|1|||
146002996|NCT00382174|526527823|FG001|Overall Study|Lost to Follow-up|4|||
146002997|NCT00382174|526527824|FG002|Overall Study|Lost to Follow-up|5|||
146002998|NCT00382174|526527822|FG000|Overall Study|Adverse Event|1|||
146002999|NCT00382174|526527823|FG001|Overall Study|Adverse Event|4|||
146003000|NCT00382174|526527824|FG002|Overall Study|Adverse Event|5|||
146003001|NCT00382174|526527822|FG000|Overall Study|Withdrawal by Subject|1|||
146003002|NCT00382174|526527823|FG001|Overall Study|Withdrawal by Subject|4|||
146003003|NCT00382174|526527824|FG002|Overall Study|Withdrawal by Subject|5|||
146003004|NCT00382174|526527822|FG000|Overall Study|Non compliance|1|||
146003005|NCT00382174|526527823|FG001|Overall Study|Non compliance|0|||
146003006|NCT00382174|526527824|FG002|Overall Study|Non compliance|1|||
146003007|NCT00382174|526527822|FG000|Overall Study|Physician Decision|0|||
146003008|NCT00382174|526527823|FG001|Overall Study|Physician Decision|2|||
146003009|NCT00382174|526527824|FG002|Overall Study|Physician Decision|2|||
146003010|NCT00382174|526527822|FG000|Overall Study|Failed to meet criteria|0|||
146003011|NCT00382174|526527823|FG001|Overall Study|Failed to meet criteria|1|||
146003012|NCT00382174|526527824|FG002|Overall Study|Failed to meet criteria|1|||
146003013|NCT00382174|526527822|FG000|Overall Study|Wounds merged|0|||
146003014|NCT00382174|526527823|FG001|Overall Study|Wounds merged|2|||
146003015|NCT00382174|526527824|FG002|Overall Study|Wounds merged|2|||
146003016|NCT00461708|526527825|FG000|Overall Study|Adverse Event|17|||
146003017|NCT00461708|526527826|FG001|Overall Study|Adverse Event|7|||
146003018|NCT00461708|526527825|FG000|Overall Study|Lack of Efficacy|68|||
146003019|NCT00461708|526527826|FG001|Overall Study|Lack of Efficacy|20|||
146003020|NCT00461708|526527825|FG000|Overall Study|Physician Decision|10|||
146003021|NCT00461708|526527826|FG001|Overall Study|Physician Decision|4|||
146003022|NCT00461708|526527825|FG000|Overall Study|Withdrawal by Subject|8|||
146003023|NCT00461708|526527826|FG001|Overall Study|Withdrawal by Subject|2|||
146003024|NCT00461708|526527825|FG000|Overall Study|Other|4|||
146003025|NCT00461708|526527826|FG001|Overall Study|Other|4|||
146003026|NCT00461708|526527825|FG000|Overall Study|Death|8|||
146003027|NCT00461708|526527826|FG001|Overall Study|Death|1|||
146003028|NCT02750514|526527827|FG000|Track 1|Disease progression|20|||
146003029|NCT02750514|526527828|FG001|Track 1|Disease progression|1|||
146003030|NCT02750514|526527829|FG002|Track 1|Disease progression|0|||
146003031|NCT02750514|526527830|FG003|Track 1|Disease progression|1|||
146003032|NCT02750514|526527831|FG004|Track 1|Disease progression|0|||
146003033|NCT02750514|526527827|FG000|Track 1|Adverse event unrelated to study drug|1|||
146003034|NCT02750514|526527828|FG001|Track 1|Adverse event unrelated to study drug|0|||
146003035|NCT02750514|526527829|FG002|Track 1|Adverse event unrelated to study drug|0|||
146092377|NCT02314143|526860284|FG000|Overall Study|Withdrawal by Subject|1|||
146247633|NCT00103857|527419896|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
146247634|NCT00103857|527419897|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
146247635|NCT00103857|527419898|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
146247636|NCT00103857|527419899|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
146247637|NCT00103857|527419900|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
146247638|NCT00103857|527419894|FG000|50-Week Extension Study|Adverse Event|2|||
146247639|NCT00103857|527419895|FG001|50-Week Extension Study|Adverse Event|3|||
146247640|NCT00103857|527419896|FG002|50-Week Extension Study|Adverse Event|2|||
146247641|NCT00103857|527419897|FG003|50-Week Extension Study|Adverse Event|0|||
146247642|NCT00103857|527419898|FG004|50-Week Extension Study|Adverse Event|1|||
146247643|NCT00103857|527419899|FG005|50-Week Extension Study|Adverse Event|1|||
146247644|NCT00103857|527419900|FG006|50-Week Extension Study|Adverse Event|0|||
146247645|NCT00103857|527419894|FG000|50-Week Extension Study|Death|0|||
146247646|NCT00103857|527419895|FG001|50-Week Extension Study|Death|0|||
146247647|NCT00103857|527419896|FG002|50-Week Extension Study|Death|0|||
146247648|NCT00103857|527419897|FG003|50-Week Extension Study|Death|1|||
146247649|NCT00103857|527419898|FG004|50-Week Extension Study|Death|0|||
146247650|NCT00103857|527419899|FG005|50-Week Extension Study|Death|1|||
146247651|NCT00103857|527419900|FG006|50-Week Extension Study|Death|0|||
146247652|NCT00103857|527419894|FG000|50-Week Extension Study|Lack of Efficacy|26|||
146247653|NCT00103857|527419895|FG001|50-Week Extension Study|Lack of Efficacy|15|||
146247654|NCT00103857|527419896|FG002|50-Week Extension Study|Lack of Efficacy|13|||
146247655|NCT00103857|527419897|FG003|50-Week Extension Study|Lack of Efficacy|16|||
146247656|NCT00103857|527419898|FG004|50-Week Extension Study|Lack of Efficacy|8|||
146247657|NCT00103857|527419899|FG005|50-Week Extension Study|Lack of Efficacy|8|||
146247658|NCT00103857|527419900|FG006|50-Week Extension Study|Lack of Efficacy|0|||
146247659|NCT00103857|527419894|FG000|50-Week Extension Study|Lost to Follow-up|4|||
146247660|NCT00103857|527419895|FG001|50-Week Extension Study|Lost to Follow-up|0|||
146247661|NCT00103857|527419896|FG002|50-Week Extension Study|Lost to Follow-up|1|||
146247662|NCT00103857|527419897|FG003|50-Week Extension Study|Lost to Follow-up|4|||
146247663|NCT00103857|527419898|FG004|50-Week Extension Study|Lost to Follow-up|3|||
146003036|NCT02750514|526527830|FG003|Track 1|Adverse event unrelated to study drug|0|||
146247664|NCT00103857|527419899|FG005|50-Week Extension Study|Lost to Follow-up|3|||
146247665|NCT00103857|527419900|FG006|50-Week Extension Study|Lost to Follow-up|0|||
146247666|NCT00103857|527419894|FG000|50-Week Extension Study|Physician Decision|0|||
146003037|NCT02750514|526527831|FG004|Track 1|Adverse event unrelated to study drug|0|||
146003038|NCT02750514|526527827|FG000|Track 1|Study drug toxicity|4|||
146092378|NCT02314143|526860285|FG001|Overall Study|Withdrawal by Subject|0|||
146003039|NCT02750514|526527828|FG001|Track 1|Study drug toxicity|1|||
146298099|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
146298100|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
146003040|NCT02750514|526527829|FG002|Track 1|Study drug toxicity|0|||
146003041|NCT02750514|526527830|FG003|Track 1|Study drug toxicity|1|||
146003042|NCT02750514|526527831|FG004|Track 1|Study drug toxicity|0|||
146003043|NCT02750514|526527827|FG000|Track 1|Participant request to discontinue|1|||
146003044|NCT02750514|526527828|FG001|Track 1|Participant request to discontinue|0|||
146003045|NCT02750514|526527829|FG002|Track 1|Participant request to discontinue|0|||
146003046|NCT02750514|526527830|FG003|Track 1|Participant request to discontinue|0|||
146003047|NCT02750514|526527831|FG004|Track 1|Participant request to discontinue|0|||
146003048|NCT02750514|526527827|FG000|Track 1|Other reasons|1|||
146003049|NCT02750514|526527828|FG001|Track 1|Other reasons|0|||
146003050|NCT02750514|526527829|FG002|Track 1|Other reasons|0|||
146003051|NCT02750514|526527830|FG003|Track 1|Other reasons|0|||
146003052|NCT02750514|526527831|FG004|Track 1|Other reasons|0|||
146003053|NCT02750514|526527827|FG000|Track 2|Disease progression|4|||
146003054|NCT02750514|526527828|FG001|Track 2|Disease progression|5|||
146003055|NCT02750514|526527829|FG002|Track 2|Disease progression|2|||
146003056|NCT02750514|526527830|FG003|Track 2|Disease progression|5|||
146003057|NCT02750514|526527831|FG004|Track 2|Disease progression|0|||
146003058|NCT02750514|526527827|FG000|Track 2|Adverse event unrelated to study drug|1|||
146003059|NCT02750514|526527828|FG001|Track 2|Adverse event unrelated to study drug|0|||
146003060|NCT02750514|526527829|FG002|Track 2|Adverse event unrelated to study drug|0|||
146003061|NCT02750514|526527830|FG003|Track 2|Adverse event unrelated to study drug|0|||
146003062|NCT02750514|526527831|FG004|Track 2|Adverse event unrelated to study drug|0|||
146003063|NCT02750514|526527827|FG000|Track 2|Study drug toxicity|1|||
146003064|NCT02750514|526527828|FG001|Track 2|Study drug toxicity|2|||
146003065|NCT02750514|526527829|FG002|Track 2|Study drug toxicity|0|||
146003066|NCT02750514|526527830|FG003|Track 2|Study drug toxicity|2|||
146003067|NCT02750514|526527831|FG004|Track 2|Study drug toxicity|0|||
146003068|NCT02750514|526527827|FG000|Track 2|Participant withdrew consent|0|||
146003069|NCT02750514|526527828|FG001|Track 2|Participant withdrew consent|1|||
146003070|NCT02750514|526527829|FG002|Track 2|Participant withdrew consent|0|||
146003071|NCT02750514|526527830|FG003|Track 2|Participant withdrew consent|0|||
146003072|NCT02750514|526527831|FG004|Track 2|Participant withdrew consent|0|||
146003073|NCT02750514|526527827|FG000|Track 3|Disease progression|0|||
146003074|NCT02750514|526527828|FG001|Track 3|Disease progression|24|||
146003075|NCT02750514|526527829|FG002|Track 3|Disease progression|13|||
146003076|NCT02750514|526527830|FG003|Track 3|Disease progression|14|||
146003077|NCT02750514|526527831|FG004|Track 3|Disease progression|0|||
146003078|NCT02750514|526527827|FG000|Track 3|Adverse event unrelated to study drug|0|||
146003079|NCT02750514|526527828|FG001|Track 3|Adverse event unrelated to study drug|1|||
146003080|NCT02750514|526527829|FG002|Track 3|Adverse event unrelated to study drug|1|||
146003081|NCT02750514|526527830|FG003|Track 3|Adverse event unrelated to study drug|1|||
146003082|NCT02750514|526527831|FG004|Track 3|Adverse event unrelated to study drug|0|||
146003083|NCT02750514|526527827|FG000|Track 3|Study drug toxicity|0|||
146003084|NCT02750514|526527828|FG001|Track 3|Study drug toxicity|3|||
146003085|NCT02750514|526527829|FG002|Track 3|Study drug toxicity|0|||
146003086|NCT02750514|526527830|FG003|Track 3|Study drug toxicity|1|||
146003087|NCT02750514|526527831|FG004|Track 3|Study drug toxicity|0|||
146003088|NCT02750514|526527827|FG000|Track 3|Participant request to discontinue|0|||
146003089|NCT02750514|526527828|FG001|Track 3|Participant request to discontinue|2|||
146003090|NCT02750514|526527829|FG002|Track 3|Participant request to discontinue|0|||
146003091|NCT02750514|526527830|FG003|Track 3|Participant request to discontinue|0|||
146003092|NCT02750514|526527831|FG004|Track 3|Participant request to discontinue|0|||
146003093|NCT02750514|526527827|FG000|Track 3|Participant withdrew consent|0|||
146003094|NCT02750514|526527828|FG001|Track 3|Participant withdrew consent|3|||
146003095|NCT02750514|526527829|FG002|Track 3|Participant withdrew consent|1|||
146003096|NCT02750514|526527830|FG003|Track 3|Participant withdrew consent|0|||
146003097|NCT02750514|526527831|FG004|Track 3|Participant withdrew consent|0|||
146003098|NCT02750514|526527827|FG000|Track 3|Other reasons|0|||
146003099|NCT02750514|526527828|FG001|Track 3|Other reasons|3|||
146003100|NCT02750514|526527829|FG002|Track 3|Other reasons|0|||
146298101|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
146003101|NCT02750514|526527830|FG003|Track 3|Other reasons|0|||
146003102|NCT02750514|526527831|FG004|Track 3|Other reasons|0|||
146003103|NCT02750514|526527827|FG000|Track 4|Study drug toxicity|0|||
146003104|NCT02750514|526527828|FG001|Track 4|Study drug toxicity|6|||
146003105|NCT02750514|526527829|FG002|Track 4|Study drug toxicity|0|||
146298102|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
146003106|NCT02750514|526527830|FG003|Track 4|Study drug toxicity|5|||
146003107|NCT02750514|526527831|FG004|Track 4|Study drug toxicity|0|||
146298103|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
146298104|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
146003108|NCT02750514|526527827|FG000|Track 4|Participant request to discontinue|0|||
146003109|NCT02750514|526527828|FG001|Track 4|Participant request to discontinue|1|||
146003110|NCT02750514|526527829|FG002|Track 4|Participant request to discontinue|0|||
146003111|NCT02750514|526527830|FG003|Track 4|Participant request to discontinue|1|||
146003112|NCT02750514|526527831|FG004|Track 4|Participant request to discontinue|0|||
146003113|NCT02750514|526527827|FG000|Track 4|Participant withdrew consent|0|||
146003114|NCT02750514|526527828|FG001|Track 4|Participant withdrew consent|1|||
146003115|NCT02750514|526527829|FG002|Track 4|Participant withdrew consent|0|||
146003116|NCT02750514|526527830|FG003|Track 4|Participant withdrew consent|0|||
146003117|NCT02750514|526527831|FG004|Track 4|Participant withdrew consent|0|||
146003118|NCT02750514|526527827|FG000|Track 4|Other reasons|0|||
146003119|NCT02750514|526527828|FG001|Track 4|Other reasons|5|||
146003120|NCT02750514|526527829|FG002|Track 4|Other reasons|0|||
146003121|NCT02750514|526527830|FG003|Track 4|Other reasons|3|||
146003122|NCT02750514|526527831|FG004|Track 4|Other reasons|0|||
146003123|NCT02750514|526527827|FG000|Track 4|Disease progression|0|||
146003124|NCT02750514|526527828|FG001|Track 4|Disease progression|33|||
146003125|NCT02750514|526527829|FG002|Track 4|Disease progression|0|||
146003126|NCT02750514|526527830|FG003|Track 4|Disease progression|32|||
146003127|NCT02750514|526527831|FG004|Track 4|Disease progression|0|||
146003128|NCT02750514|526527827|FG000|Track 4|Adverse event unrelated to study drug|0|||
146003129|NCT02750514|526527828|FG001|Track 4|Adverse event unrelated to study drug|5|||
146003130|NCT02750514|526527829|FG002|Track 4|Adverse event unrelated to study drug|0|||
146003131|NCT02750514|526527830|FG003|Track 4|Adverse event unrelated to study drug|0|||
146003132|NCT02750514|526527831|FG004|Track 4|Adverse event unrelated to study drug|0|||
146003133|NCT02750514|526527827|FG000|Track 4|Death|0|||
146003134|NCT02750514|526527828|FG001|Track 4|Death|0|||
146003135|NCT02750514|526527829|FG002|Track 4|Death|0|||
146003136|NCT02750514|526527830|FG003|Track 4|Death|1|||
146003137|NCT02750514|526527831|FG004|Track 4|Death|0|||
146003138|NCT02750514|526527827|FG000|Track 5|Disease progression|0|||
146003139|NCT02750514|526527828|FG001|Track 5|Disease progression|0|||
146003140|NCT02750514|526527829|FG002|Track 5|Disease progression|0|||
146003141|NCT02750514|526527830|FG003|Track 5|Disease progression|0|||
146003142|NCT02750514|526527831|FG004|Track 5|Disease progression|34|||
146003143|NCT02750514|526527827|FG000|Track 5|Adverse event unrelated to study drug|0|||
146003144|NCT02750514|526527828|FG001|Track 5|Adverse event unrelated to study drug|0|||
146003145|NCT02750514|526527829|FG002|Track 5|Adverse event unrelated to study drug|0|||
146003146|NCT02750514|526527830|FG003|Track 5|Adverse event unrelated to study drug|0|||
146003147|NCT02750514|526527831|FG004|Track 5|Adverse event unrelated to study drug|2|||
146003148|NCT02750514|526527827|FG000|Track 5|Study drug toxicity|0|||
146003149|NCT02750514|526527828|FG001|Track 5|Study drug toxicity|0|||
146003150|NCT02750514|526527829|FG002|Track 5|Study drug toxicity|0|||
146003151|NCT02750514|526527830|FG003|Track 5|Study drug toxicity|0|||
146003152|NCT02750514|526527831|FG004|Track 5|Study drug toxicity|2|||
146003153|NCT02750514|526527827|FG000|Track 5|Participant request to discontinue|0|||
146003154|NCT02750514|526527828|FG001|Track 5|Participant request to discontinue|0|||
146003155|NCT02750514|526527829|FG002|Track 5|Participant request to discontinue|0|||
146003156|NCT02750514|526527830|FG003|Track 5|Participant request to discontinue|0|||
146003157|NCT02750514|526527831|FG004|Track 5|Participant request to discontinue|3|||
146003158|NCT02750514|526527827|FG000|Track 5|Other reasons|0|||
146003159|NCT02750514|526527828|FG001|Track 5|Other reasons|0|||
146003160|NCT02750514|526527829|FG002|Track 5|Other reasons|0|||
146003161|NCT02750514|526527830|FG003|Track 5|Other reasons|0|||
146003162|NCT02750514|526527831|FG004|Track 5|Other reasons|2|||
146003163|NCT01464879|526527832|FG000|Overall Study|Physician Decision|1|||
146003164|NCT01464879|526527832|FG000|Overall Study|Non-compliance|1|||
146003165|NCT02230189|526527833|FG000|Overall Study|Withdrawal by Subject|3|||
146003166|NCT02230189|526527834|FG001|Overall Study|Withdrawal by Subject|0|||
146003167|NCT02230189|526527835|FG002|Overall Study|Withdrawal by Subject|1|||
146003168|NCT02230189|526527833|FG000|Overall Study|Lost to Follow-up|1|||
146003169|NCT02230189|526527834|FG001|Overall Study|Lost to Follow-up|0|||
146247667|NCT00103857|527419895|FG001|50-Week Extension Study|Physician Decision|1|||
146247668|NCT00103857|527419896|FG002|50-Week Extension Study|Physician Decision|1|||
146247669|NCT00103857|527419897|FG003|50-Week Extension Study|Physician Decision|0|||
146003170|NCT02230189|526527835|FG002|Overall Study|Lost to Follow-up|0|||
146003171|NCT02230189|526527833|FG000|Overall Study|Physician Decision|1|||
146003172|NCT02230189|526527834|FG001|Overall Study|Physician Decision|0|||
146003173|NCT02230189|526527835|FG002|Overall Study|Physician Decision|0|||
146003174|NCT01824290|526527842|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
146003175|NCT01824290|526527843|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
146003176|NCT01824290|526527844|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
146003177|NCT01824290|526527845|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
146003178|NCT01824290|526527842|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
146003179|NCT01824290|526527843|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
146003180|NCT01824290|526527844|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
146003181|NCT01824290|526527845|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
146003182|NCT01824290|526527842|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
146003183|NCT01824290|526527843|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
146092379|NCT02314143|526860286|FG002|Overall Study|Withdrawal by Subject|1|||
146003184|NCT01824290|526527844|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
146003185|NCT01824290|526527845|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
146003186|NCT01824290|526527842|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
146003187|NCT01824290|526527843|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
146003188|NCT01824290|526527844|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
146003189|NCT01824290|526527845|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
146003190|NCT01824290|526527842|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
146003191|NCT01824290|526527843|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
146003192|NCT01824290|526527844|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
146003193|NCT01824290|526527845|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
146003194|NCT01824290|526527842|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
146003195|NCT01824290|526527843|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
146003196|NCT01824290|526527844|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
146003197|NCT01824290|526527845|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
146003198|NCT00800982|526527846|FG000|Overall Study|Lost to Follow-up|1|||
146003199|NCT00800982|526527847|FG001|Overall Study|Lost to Follow-up|2|||
146003200|NCT00800982|526527846|FG000|Overall Study|Withdrawal by Subject|0|||
146003201|NCT00800982|526527847|FG001|Overall Study|Withdrawal by Subject|1|||
146003202|NCT00800982|526527846|FG000|Overall Study|Patient moved out of state|1|||
146003203|NCT00800982|526527847|FG001|Overall Study|Patient moved out of state|0|||
146003204|NCT00699413|526527849|FG000|Overall Study|Withdrawal by Subject|0|||
146003205|NCT00699413|526527850|FG001|Overall Study|Withdrawal by Subject|2|||
146003206|NCT00699413|526527849|FG000|Overall Study|Study terminated by sponsor|4|||
146003207|NCT00699413|526527850|FG001|Overall Study|Study terminated by sponsor|2|||
146003208|NCT02779777|526527851|FG000|Overall Study|Disease Progression|1|||
146003209|NCT02779777|526527852|FG001|Overall Study|Disease Progression|0|||
146003210|NCT02779777|526527853|FG002|Overall Study|Disease Progression|0|||
146003211|NCT02779777|526527851|FG000|Overall Study|Adverse Event|3|||
146003212|NCT02779777|526527852|FG001|Overall Study|Adverse Event|1|||
146003213|NCT02779777|526527853|FG002|Overall Study|Adverse Event|0|||
146003214|NCT02779777|526527851|FG000|Overall Study|Physician Decision|9|||
146003215|NCT02779777|526527852|FG001|Overall Study|Physician Decision|0|||
146003216|NCT02779777|526527853|FG002|Overall Study|Physician Decision|1|||
146003217|NCT02779777|526527851|FG000|Overall Study|Withdrawal by Subject|1|||
146003218|NCT02779777|526527852|FG001|Overall Study|Withdrawal by Subject|0|||
146003219|NCT02779777|526527853|FG002|Overall Study|Withdrawal by Subject|0|||
146003220|NCT03289533|526527854|FG000|Overall Study|Death|12|||
146003221|NCT03289533|526527854|FG000|Overall Study|Terminated from study by sponsor|10|||
146003222|NCT00539240|526527855|FG000|Overall Study|Withdrawal by Subject|0|||
146003223|NCT00539240|526527856|FG001|Overall Study|Withdrawal by Subject|2|||
146003224|NCT00539240|526527857|FG002|Overall Study|Withdrawal by Subject|0|||
146003225|NCT00539240|526527855|FG000|Overall Study|Protocol Violation|1|||
146003226|NCT00539240|526527856|FG001|Overall Study|Protocol Violation|1|||
146003227|NCT00539240|526527857|FG002|Overall Study|Protocol Violation|4|||
146003228|NCT00539240|526527855|FG000|Overall Study|Lost to Follow-up|2|||
146003229|NCT00539240|526527856|FG001|Overall Study|Lost to Follow-up|3|||
146003230|NCT00539240|526527857|FG002|Overall Study|Lost to Follow-up|1|||
146003231|NCT00539240|526527855|FG000|Overall Study|Adverse Event|3|||
146003232|NCT00539240|526527856|FG001|Overall Study|Adverse Event|1|||
146003233|NCT00539240|526527857|FG002|Overall Study|Adverse Event|10|||
146003234|NCT01055613|526527858|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
146003235|NCT01055613|526527859|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146003236|NCT01055613|526527858|FG000|Overall Study|Unacceptable lens fit|1|||
146003237|NCT01055613|526527859|FG001|Overall Study|Unacceptable lens fit|0|||
146003238|NCT01055613|526527858|FG000|Overall Study|Discomfort|2|||
146003239|NCT01055613|526527859|FG001|Overall Study|Discomfort|1|||
146003240|NCT01055613|526527858|FG000|Overall Study|Lost to Follow-up|1|||
146003241|NCT01055613|526527859|FG001|Overall Study|Lost to Follow-up|1|||
146003242|NCT01055613|526527858|FG000|Overall Study|Protocol Violation|1|||
146003243|NCT01055613|526527859|FG001|Overall Study|Protocol Violation|1|||
146003244|NCT01055613|526527858|FG000|Overall Study|Subject Disinterest|1|||
146003245|NCT01055613|526527859|FG001|Overall Study|Subject Disinterest|1|||
146003246|NCT01595529|526527860|FG000|Overall Study|Adverse Event|2|||
146003247|NCT01595529|526527861|FG001|Overall Study|Adverse Event|0|||
146003248|NCT01595529|526527860|FG000|Overall Study|Subject Non-Compliant|2|||
146003249|NCT01595529|526527861|FG001|Overall Study|Subject Non-Compliant|0|||
146003250|NCT01595529|526527860|FG000|Overall Study|Lost to Follow-up|8|||
146003251|NCT01595529|526527861|FG001|Overall Study|Lost to Follow-up|14|||
146003252|NCT01595529|526527860|FG000|Overall Study|Protocol Violation|1|||
146003253|NCT01595529|526527861|FG001|Overall Study|Protocol Violation|2|||
146003254|NCT01595529|526527860|FG000|Overall Study|Physician Decision|1|||
146003255|NCT01595529|526527861|FG001|Overall Study|Physician Decision|0|||
146003256|NCT01595529|526527860|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
146092380|NCT00089674|526860288|FG000|Overall Study|Physician Decision|4|||
146092381|NCT00089674|526860289|FG001|Overall Study|Physician Decision|2|||
146247670|NCT00103857|527419898|FG004|50-Week Extension Study|Physician Decision|0|||
146003257|NCT01595529|526527861|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
146003258|NCT01595529|526527860|FG000|Overall Study|Administrative Decision|1|||
146003259|NCT01595529|526527861|FG001|Overall Study|Administrative Decision|0|||
146003260|NCT01595529|526527860|FG000|Overall Study|Entry Failure/Screening Failure|6|||
146003261|NCT01595529|526527861|FG001|Overall Study|Entry Failure/Screening Failure|1|||
146003262|NCT02629861|526527864|FG000|Overall Study|Adverse Event|7|||
146003263|NCT02629861|526527865|FG001|Overall Study|Adverse Event|5|||
146003264|NCT02629861|526527866|FG002|Overall Study|Adverse Event|4|||
146003265|NCT02629861|526527864|FG000|Overall Study|Withdrawal by Subject|5|||
146003266|NCT02629861|526527865|FG001|Overall Study|Withdrawal by Subject|8|||
146003267|NCT02629861|526527866|FG002|Overall Study|Withdrawal by Subject|13|||
146003268|NCT02629861|526527864|FG000|Overall Study|Protocol Violation|2|||
146003269|NCT02629861|526527865|FG001|Overall Study|Protocol Violation|3|||
146003270|NCT02629861|526527866|FG002|Overall Study|Protocol Violation|7|||
146003271|NCT02629861|526527864|FG000|Overall Study|Lost to Follow-up|12|||
146003272|NCT02629861|526527865|FG001|Overall Study|Lost to Follow-up|9|||
146003273|NCT02629861|526527866|FG002|Overall Study|Lost to Follow-up|4|||
146003274|NCT02629861|526527864|FG000|Overall Study|Other|1|||
146003275|NCT02629861|526527865|FG001|Overall Study|Other|1|||
146003276|NCT02629861|526527866|FG002|Overall Study|Other|0|||
146003277|NCT02629861|526527864|FG000|Overall Study|Pregnancy|2|||
146003278|NCT02629861|526527865|FG001|Overall Study|Pregnancy|1|||
146003279|NCT02629861|526527866|FG002|Overall Study|Pregnancy|0|||
146003280|NCT00730886|526527867|FG000|Overall Study|Lost to Follow-up|1|||
146003281|NCT00730886|526527868|FG001|Overall Study|Lost to Follow-up|0|||
146003282|NCT00730886|526527867|FG000|Overall Study|Physician Decision|1|||
146003283|NCT00730886|526527868|FG001|Overall Study|Physician Decision|0|||
146003284|NCT01991483|526527869|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
146003285|NCT01991483|526527870|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
146003286|NCT01991483|526527871|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
146003287|NCT01991483|526527872|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
146003288|NCT01991483|526527869|FG000|Dose Level 600 mg|Physician Decision|0|||
146003289|NCT01991483|526527870|FG001|Dose Level 600 mg|Physician Decision|0|||
146003290|NCT01991483|526527871|FG002|Dose Level 600 mg|Physician Decision|1|||
146003291|NCT01991483|526527872|FG003|Dose Level 600 mg|Physician Decision|0|||
146003292|NCT01991483|526527869|FG000|Dose Level 1000 mg|Protocol Violation|0|||
146003293|NCT01991483|526527870|FG001|Dose Level 1000 mg|Protocol Violation|0|||
146003294|NCT01991483|526527871|FG002|Dose Level 1000 mg|Protocol Violation|0|||
146003295|NCT01991483|526527872|FG003|Dose Level 1000 mg|Protocol Violation|1|||
146003296|NCT02030821|526527875|FG000|Overall Study|Physician Decision|2|||
146003297|NCT02030821|526527876|FG001|Overall Study|Physician Decision|2|||
146003298|NCT02030821|526527877|FG002|Overall Study|Physician Decision|5|||
146003299|NCT02030821|526527878|FG003|Overall Study|Physician Decision|2|||
146003300|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
146003301|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146003302|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146003303|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146003304|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146003305|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
146003306|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
146003307|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
146003308|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
146003309|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
146003310|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
146003311|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
146003312|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
146003313|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146003314|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146003315|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146003316|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146003317|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
146003318|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
146003319|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
146247671|NCT00103857|527419899|FG005|50-Week Extension Study|Physician Decision|0|||
146247672|NCT00103857|527419900|FG006|50-Week Extension Study|Physician Decision|0|||
146003320|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
146003321|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
146003322|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
146003323|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
146003324|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
146003325|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
146003326|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146003327|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146003328|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146003329|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
146003330|NCT00716274|526527880|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146003331|NCT00716274|526527881|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
146003332|NCT00716274|526527882|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146003333|NCT00716274|526527883|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146003334|NCT00716274|526527884|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146003335|NCT00716274|526527885|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
146003336|NCT00716274|526527880|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146003337|NCT00716274|526527881|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146003338|NCT00716274|526527882|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
146003339|NCT00716274|526527883|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146003340|NCT00716274|526527884|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146003341|NCT00716274|526527885|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
146003342|NCT00716274|526527880|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
146003343|NCT00716274|526527881|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
146003344|NCT00716274|526527882|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
146003345|NCT00716274|526527883|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
146003346|NCT00716274|526527884|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
146003347|NCT00716274|526527885|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
146003348|NCT00716274|526527880|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146003349|NCT00716274|526527881|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146003350|NCT00716274|526527882|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146003351|NCT00716274|526527883|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
146003352|NCT00716274|526527884|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
146003353|NCT00716274|526527885|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
146003354|NCT00716274|526527880|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
146003355|NCT00716274|526527881|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
146003356|NCT00716274|526527882|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
146003357|NCT00716274|526527883|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
146003358|NCT00716274|526527884|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
146003359|NCT00716274|526527885|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
146003360|NCT00444106|526527895|FG000|Overall Study|Lost to Follow-up|2|||
146003361|NCT00444106|526527896|FG001|Overall Study|Lost to Follow-up|1|||
146003362|NCT00444106|526527897|FG002|Overall Study|Lost to Follow-up|0|||
146003363|NCT00444106|526527895|FG000|Overall Study|Abnormal Test Procedure Results|0|||
146003364|NCT00444106|526527896|FG001|Overall Study|Abnormal Test Procedure Results|0|||
146003365|NCT00444106|526527897|FG002|Overall Study|Abnormal Test Procedure Results|1|||
146003366|NCT01634152|526527898|FG000|Overall Study|Adverse Event|2|||
146003367|NCT01634152|526527899|FG001|Overall Study|Adverse Event|0|||
146003368|NCT01634152|526527900|FG002|Overall Study|Adverse Event|2|||
146003369|NCT01634152|526527898|FG000|Overall Study|Consent withdrawn not due to AE|1|||
146003370|NCT01634152|526527899|FG001|Overall Study|Consent withdrawn not due to AE|0|||
146003371|NCT01634152|526527900|FG002|Overall Study|Consent withdrawn not due to AE|1|||
146003372|NCT01634152|526527898|FG000|Overall Study|Not treated|0|||
146003373|NCT01634152|526527899|FG001|Overall Study|Not treated|1|||
146003374|NCT01634152|526527900|FG002|Overall Study|Not treated|0|||
146003375|NCT01634152|526527898|FG000|Overall Study|Other reason not defined above|1|||
146003376|NCT01634152|526527899|FG001|Overall Study|Other reason not defined above|0|||
146003377|NCT01634152|526527900|FG002|Overall Study|Other reason not defined above|1|||
146003378|NCT01152437|526527901|FG000|Overall Study|Other Adverse Event|8|||
146003379|NCT01152437|526527902|FG001|Overall Study|Other Adverse Event|1|||
146003380|NCT01152437|526527903|FG002|Overall Study|Other Adverse Event|7|||
146003381|NCT01152437|526527901|FG000|Overall Study|Not treated|0|||
146092382|NCT00089674|526860288|FG000|Overall Study|Adverse Event|23|||
146092383|NCT00089674|526860289|FG001|Overall Study|Adverse Event|29|||
146092384|NCT00089674|526860288|FG000|Overall Study|Withdrawal by Subject|143|||
146092385|NCT00089674|526860289|FG001|Overall Study|Withdrawal by Subject|127|||
146092386|NCT00089674|526860288|FG000|Overall Study|Death|43|||
146092387|NCT00089674|526860289|FG001|Overall Study|Death|43|||
146092388|NCT00089674|526860288|FG000|Overall Study|Disease progression|21|||
146092389|NCT00089674|526860289|FG001|Overall Study|Disease progression|23|||
146003382|NCT01152437|526527902|FG001|Overall Study|Not treated|1|||
146003383|NCT01152437|526527903|FG002|Overall Study|Not treated|2|||
146003384|NCT01152437|526527901|FG000|Overall Study|Progressive disease|27|||
146003385|NCT01152437|526527902|FG001|Overall Study|Progressive disease|13|||
146003386|NCT01152437|526527903|FG002|Overall Study|Progressive disease|32|||
146003387|NCT01152437|526527901|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
146003388|NCT01152437|526527902|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
146092390|NCT00089674|526860288|FG000|Overall Study|Ineligibility determined|8|||
146003389|NCT01152437|526527903|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
146092391|NCT00089674|526860289|FG001|Overall Study|Ineligibility determined|10|||
146003390|NCT00279214|526527905|FG000|Overall Study|Physician Decision|3|||
146092392|NCT00089674|526860288|FG000|Overall Study|Lost to Follow-up|21|||
146003391|NCT00279214|526527906|FG001|Overall Study|Physician Decision|2|||
146003392|NCT01897532|526527908|FG000|Discontinuation From Treatment|Not Treated|7|||
146003393|NCT01897532|526527909|FG001|Discontinuation From Treatment|Not Treated|5|||
146003394|NCT01897532|526527908|FG000|Discontinuation From Treatment|Other reason than specified|196|||
146003395|NCT01897532|526527909|FG001|Discontinuation From Treatment|Other reason than specified|176|||
146003396|NCT01897532|526527908|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
146003397|NCT01897532|526527909|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
146003398|NCT01897532|526527908|FG000|Discontinuation From Treatment|Non compliance|24|||
146003399|NCT01897532|526527909|FG001|Discontinuation From Treatment|Non compliance|15|||
146003400|NCT01897532|526527908|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
146003401|NCT01897532|526527909|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
146003402|NCT01897532|526527908|FG000|Discontinuation From Trial|Not Treated|7|||
146003403|NCT01897532|526527909|FG001|Discontinuation From Trial|Not Treated|5|||
146003404|NCT01897532|526527908|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
146003405|NCT01897532|526527909|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
146003406|NCT00953706|526527912|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
146003407|NCT00953706|526527913|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
146003408|NCT00953706|526527914|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
146003409|NCT00953706|526527915|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
146003410|NCT00953706|526527912|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146003411|NCT00953706|526527913|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
146003412|NCT00953706|526527914|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146003413|NCT00953706|526527915|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
146003414|NCT00953706|526527912|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146003415|NCT00953706|526527913|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
146003416|NCT00953706|526527914|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146003417|NCT00953706|526527915|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
146003418|NCT00953706|526527912|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146003419|NCT00953706|526527913|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
146003420|NCT00953706|526527914|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146003421|NCT00953706|526527915|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
146003422|NCT00953706|526527912|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146003423|NCT00953706|526527913|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
146003424|NCT00953706|526527914|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146003425|NCT00953706|526527915|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
146003426|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146003427|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146003428|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
146003429|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
146003430|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146003431|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146003432|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
146003433|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
146003434|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146003435|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146003436|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
146003437|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
146003438|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
146003439|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
146003440|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
146003441|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
146003442|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
146003443|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
146003444|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
146003445|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
146003446|NCT00953706|526527912|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
146003447|NCT00953706|526527913|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
146003448|NCT00953706|526527914|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
146003449|NCT00953706|526527915|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
146003450|NCT00457626|526527916|FG000|Overall Study|Adverse Event|3|||
146003451|NCT00457626|526527916|FG000|Overall Study|Administrative Problems|2|||
146003452|NCT00457626|526527916|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
146003453|NCT01783444|526529555|FG000|Treatment Phase|Adverse Event|9|||
146003454|NCT01783444|526529556|FG001|Treatment Phase|Adverse Event|20|||
146003455|NCT01783444|526529557|FG002|Treatment Phase|Adverse Event|19|||
146003456|NCT01783444|526529555|FG000|Treatment Phase|Disease Progression|76|||
146003457|NCT01783444|526529556|FG001|Treatment Phase|Disease Progression|66|||
146003458|NCT01783444|526529557|FG002|Treatment Phase|Disease Progression|64|||
146003459|NCT01783444|526529555|FG000|Treatment Phase|Death|2|||
146003460|NCT01783444|526529556|FG001|Treatment Phase|Death|2|||
146003461|NCT01783444|526529557|FG002|Treatment Phase|Death|2|||
146003462|NCT01783444|526529555|FG000|Treatment Phase|Protocol Violation|1|||
146003463|NCT01783444|526529556|FG001|Treatment Phase|Protocol Violation|1|||
146003464|NCT01783444|526529557|FG002|Treatment Phase|Protocol Violation|2|||
146003465|NCT01783444|526529555|FG000|Treatment Phase|Withdrawal by Subject|6|||
146003466|NCT01783444|526529556|FG001|Treatment Phase|Withdrawal by Subject|8|||
146003467|NCT01783444|526529557|FG002|Treatment Phase|Withdrawal by Subject|9|||
146003468|NCT01783444|526529555|FG000|Treatment Phase|Administrative problems|2|||
146003469|NCT01783444|526529556|FG001|Treatment Phase|Administrative problems|0|||
146003470|NCT01783444|526529557|FG002|Treatment Phase|Administrative problems|1|||
146003471|NCT01783444|526529555|FG000|Treatment Phase|Physician Decision|8|||
146003472|NCT01783444|526529556|FG001|Treatment Phase|Physician Decision|6|||
146003473|NCT01783444|526529557|FG002|Treatment Phase|Physician Decision|5|||
146003474|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
146003475|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
146003476|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
146003477|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
146003478|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
146003479|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
146003480|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
146003481|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
146003482|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
146003483|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
146003484|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
146003485|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
146003486|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
146003487|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
146003488|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
146003489|NCT01783444|526529555|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
146003490|NCT01783444|526529556|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
146003491|NCT01783444|526529557|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
146003492|NCT00552071|526529558|FG000|Overall Study|Adverse Event|1|||
146003493|NCT00552071|526529559|FG001|Overall Study|Adverse Event|0|||
146003494|NCT00552071|526529558|FG000|Overall Study|Lack of Efficacy|1|||
146003495|NCT00552071|526529559|FG001|Overall Study|Lack of Efficacy|0|||
146003496|NCT00552071|526529558|FG000|Overall Study|Physician Decision|1|||
146003497|NCT00552071|526529559|FG001|Overall Study|Physician Decision|0|||
146003498|NCT00552071|526529558|FG000|Overall Study|Pregnancy|1|||
146003499|NCT00552071|526529559|FG001|Overall Study|Pregnancy|0|||
146003500|NCT00552071|526529558|FG000|Overall Study|Death|0|||
146003501|NCT00552071|526529559|FG001|Overall Study|Death|1|||
146003502|NCT00552071|526529558|FG000|Overall Study|Withdrawal by Subject|0|||
146003503|NCT00552071|526529559|FG001|Overall Study|Withdrawal by Subject|1|||
146003504|NCT00937495|526529564|FG000|Overall Study|Protocol Violation|2|||
146003505|NCT00441272|526529565|FG000|Overall Study|Study terminated prior to enrollment|25|||
146003506|NCT00441272|526529566|FG001|Overall Study|Study terminated prior to enrollment|25|||
146003507|NCT01856322|526529567|FG000|Overall Study|off study due to lack of accrual|0|||
146003508|NCT01856322|526529568|FG001|Overall Study|off study due to lack of accrual|0|||
146003509|NCT01856322|526529569|FG002|Overall Study|off study due to lack of accrual|3|||
146247673|NCT00103857|527419894|FG000|50-Week Extension Study|Pregnancy|0|||
146247674|NCT00103857|527419895|FG001|50-Week Extension Study|Pregnancy|0|||
146247675|NCT00103857|527419896|FG002|50-Week Extension Study|Pregnancy|1|||
146247676|NCT00103857|527419897|FG003|50-Week Extension Study|Pregnancy|0|||
146247677|NCT00103857|527419898|FG004|50-Week Extension Study|Pregnancy|1|||
146003510|NCT00954447|526529571|FG000|Overall Study|Adverse Event|33|||
146247678|NCT00103857|527419899|FG005|50-Week Extension Study|Pregnancy|0|||
146247679|NCT00103857|527419900|FG006|50-Week Extension Study|Pregnancy|0|||
146003511|NCT00954447|526529572|FG001|Overall Study|Adverse Event|25|||
146003512|NCT00954447|526529571|FG000|Overall Study|Lack of Efficacy|17|||
146003513|NCT00954447|526529572|FG001|Overall Study|Lack of Efficacy|3|||
146092393|NCT00089674|526860289|FG001|Overall Study|Lost to Follow-up|17|||
146003514|NCT00954447|526529571|FG000|Overall Study|Protocol Violation|5|||
146003515|NCT00954447|526529572|FG001|Overall Study|Protocol Violation|7|||
146003516|NCT00954447|526529571|FG000|Overall Study|Lost to Follow-up|8|||
146003517|NCT00954447|526529572|FG001|Overall Study|Lost to Follow-up|14|||
146247680|NCT00103857|527419894|FG000|50-Week Extension Study|Protocol Violation|1|||
146003518|NCT00954447|526529571|FG000|Overall Study|Withdrawal by Subject|26|||
146003519|NCT00954447|526529572|FG001|Overall Study|Withdrawal by Subject|21|||
146003520|NCT00954447|526529571|FG000|Overall Study|Other|21|||
146003521|NCT00954447|526529572|FG001|Overall Study|Other|18|||
146003522|NCT04592341|526529573|FG000|Overall Study|Physician Decision|5|||
146003523|NCT04592341|526529573|FG000|Overall Study|Study Terminated by Sponsor|5|||
146003524|NCT04592341|526529573|FG000|Overall Study|Withdrawal by Subject|53|||
146003525|NCT04592341|526529573|FG000|Overall Study|Lost to Follow-up|3|||
146247681|NCT00103857|527419895|FG001|50-Week Extension Study|Protocol Violation|1|||
146247682|NCT00103857|527419896|FG002|50-Week Extension Study|Protocol Violation|1|||
146247683|NCT00103857|527419897|FG003|50-Week Extension Study|Protocol Violation|2|||
146003526|NCT04592341|526529573|FG000|Overall Study|Death|1|||
146003527|NCT04592341|526529573|FG000|Overall Study|Adverse Event|5|||
146003528|NCT04592341|526529573|FG000|Overall Study|other|4|||
146003529|NCT00692003|526529574|FG000|Overall Study|Sponsor Decision|5|||
146003530|NCT00692003|526529575|FG001|Overall Study|Sponsor Decision|1|||
146003531|NCT01535287|526529576|FG000|Overall Study|drug not prepared in time|5|||
146003532|NCT01535287|526529577|FG001|Overall Study|drug not prepared in time|6|||
146003533|NCT00517699|526529580|FG000|Overall Study|Withdrawal by Subject|1|||
146003534|NCT00517699|526529580|FG000|Overall Study|Lack of Efficacy|1|||
146003535|NCT00517699|526529580|FG000|Overall Study|Administrative error|1|||
146003536|NCT00517699|526529580|FG000|Overall Study|Study terminated by Sponsor|2|||
146003537|NCT03341637|526529581|FG000|Overall Study|Lost to Follow-up|1|||
146003538|NCT03341637|526529582|FG001|Overall Study|Lost to Follow-up|0|||
146003539|NCT03341637|526529581|FG000|Overall Study|Withdrawal by Subject|3|||
146003540|NCT03341637|526529582|FG001|Overall Study|Withdrawal by Subject|3|||
146003541|NCT03341637|526529581|FG000|Overall Study|Reason not Specified|1|||
146003542|NCT03341637|526529582|FG001|Overall Study|Reason not Specified|1|||
146003543|NCT01639469|526529593|FG000|Overall Study|Death|4|||
146003544|NCT01639469|526529594|FG001|Overall Study|Death|2|||
146003545|NCT01639469|526529593|FG000|Overall Study|Lost to Follow-up|1|||
146003546|NCT01639469|526529594|FG001|Overall Study|Lost to Follow-up|1|||
146003547|NCT01119443|526529595|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
146003548|NCT01119443|526529596|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
146003549|NCT00420381|526529597|FG000|Overall Study|Protocol Violation|1|||
146003550|NCT01428219|526529598|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
146003551|NCT02071771|526529599|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
146003552|NCT02071771|526529600|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
146003553|NCT02071771|526529599|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
146003554|NCT02071771|526529600|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
146003555|NCT02078752|526529601|FG000|Overall Study|Death|0|||
146003556|NCT02078752|526529602|FG001|Overall Study|Death|3|||
146003557|NCT02078752|526529603|FG002|Overall Study|Death|0|||
146003558|NCT02078752|526529604|FG003|Overall Study|Death|0|||
146003559|NCT02078752|526529605|FG004|Overall Study|Death|0|||
146003560|NCT02078752|526529606|FG005|Overall Study|Death|1|||
146003561|NCT02078752|526529607|FG006|Overall Study|Death|0|||
146003562|NCT02078752|526529608|FG007|Overall Study|Death|1|||
146003563|NCT02078752|526529609|FG008|Overall Study|Death|0|||
146003564|NCT02078752|526529610|FG009|Overall Study|Death|4|||
146003565|NCT02078752|526529601|FG000|Overall Study|Lost to Follow-up|1|||
146003566|NCT02078752|526529602|FG001|Overall Study|Lost to Follow-up|0|||
146003567|NCT02078752|526529603|FG002|Overall Study|Lost to Follow-up|0|||
146003568|NCT02078752|526529604|FG003|Overall Study|Lost to Follow-up|1|||
146003569|NCT02078752|526529605|FG004|Overall Study|Lost to Follow-up|0|||
146003570|NCT02078752|526529606|FG005|Overall Study|Lost to Follow-up|0|||
146003571|NCT02078752|526529607|FG006|Overall Study|Lost to Follow-up|0|||
146003572|NCT02078752|526529608|FG007|Overall Study|Lost to Follow-up|0|||
146003573|NCT02078752|526529609|FG008|Overall Study|Lost to Follow-up|0|||
146003574|NCT02078752|526529610|FG009|Overall Study|Lost to Follow-up|0|||
146003575|NCT02078752|526529601|FG000|Overall Study|Withdrawal by Subject|1|||
146003576|NCT02078752|526529602|FG001|Overall Study|Withdrawal by Subject|1|||
146003577|NCT02078752|526529603|FG002|Overall Study|Withdrawal by Subject|1|||
146003578|NCT02078752|526529604|FG003|Overall Study|Withdrawal by Subject|1|||
146003579|NCT02078752|526529605|FG004|Overall Study|Withdrawal by Subject|0|||
146003580|NCT02078752|526529606|FG005|Overall Study|Withdrawal by Subject|3|||
146092394|NCT00089674|526860288|FG000|Overall Study|Noncompliance|7|||
146003581|NCT02078752|526529607|FG006|Overall Study|Withdrawal by Subject|2|||
146003582|NCT02078752|526529608|FG007|Overall Study|Withdrawal by Subject|1|||
146003583|NCT02078752|526529609|FG008|Overall Study|Withdrawal by Subject|0|||
146003584|NCT02078752|526529610|FG009|Overall Study|Withdrawal by Subject|1|||
146003585|NCT02078752|526529601|FG000|Overall Study|Other|0|||
146003586|NCT02078752|526529602|FG001|Overall Study|Other|3|||
146003587|NCT02078752|526529603|FG002|Overall Study|Other|0|||
146003588|NCT02078752|526529604|FG003|Overall Study|Other|0|||
146003589|NCT02078752|526529605|FG004|Overall Study|Other|1|||
146003590|NCT02078752|526529606|FG005|Overall Study|Other|0|||
146003591|NCT02078752|526529607|FG006|Overall Study|Other|0|||
146003592|NCT02078752|526529608|FG007|Overall Study|Other|1|||
146092395|NCT00089674|526860289|FG001|Overall Study|Noncompliance|3|||
146003593|NCT02078752|526529609|FG008|Overall Study|Other|0|||
146003594|NCT02078752|526529610|FG009|Overall Study|Other|0|||
146003595|NCT02078752|526529601|FG000|Overall Study|Study terminated by sponsor|0|||
146003596|NCT02078752|526529602|FG001|Overall Study|Study terminated by sponsor|0|||
146003597|NCT02078752|526529603|FG002|Overall Study|Study terminated by sponsor|0|||
146003598|NCT02078752|526529604|FG003|Overall Study|Study terminated by sponsor|0|||
146003599|NCT02078752|526529605|FG004|Overall Study|Study terminated by sponsor|0|||
146003600|NCT02078752|526529606|FG005|Overall Study|Study terminated by sponsor|0|||
146003601|NCT02078752|526529607|FG006|Overall Study|Study terminated by sponsor|0|||
146003602|NCT02078752|526529608|FG007|Overall Study|Study terminated by sponsor|0|||
146003603|NCT02078752|526529609|FG008|Overall Study|Study terminated by sponsor|0|||
146003604|NCT02078752|526529610|FG009|Overall Study|Study terminated by sponsor|5|||
146003605|NCT00775268|526529624|FG000|Baseline|Drug not synthesize dose|1|||
146003606|NCT00775268|526529625|FG001|Baseline|Drug not synthesize dose|0|||
146003607|NCT00775268|526529624|FG000|Baseline|Not treated-ineligible per CT|0|||
146003608|NCT00775268|526529625|FG001|Baseline|Not treated-ineligible per CT|1|||
146003609|NCT00775268|526529624|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
146003610|NCT00775268|526529625|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
146003611|NCT00775268|526529624|FG000|After Completion|Participant missed scan appointment|1|||
146003612|NCT00775268|526529625|FG001|After Completion|Participant missed scan appointment|0|||
146003613|NCT01194245|526529631|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
146003614|NCT01194245|526529632|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146003615|NCT01194245|526529633|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146003616|NCT01194245|526529634|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146003617|NCT01194245|526529635|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
146003618|NCT01194245|526529631|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
146003619|NCT01194245|526529632|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146003620|NCT01194245|526529633|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146003621|NCT01194245|526529634|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146003622|NCT01194245|526529635|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
146003623|NCT01194245|526529631|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
146003624|NCT01194245|526529632|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146003625|NCT01194245|526529633|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146003626|NCT01194245|526529634|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146003627|NCT01194245|526529635|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
146003628|NCT01194245|526529631|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
146003629|NCT01194245|526529632|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146003630|NCT01194245|526529633|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146003631|NCT01194245|526529634|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146003632|NCT01194245|526529635|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
146003633|NCT01194245|526529631|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146003634|NCT01194245|526529632|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146003635|NCT01194245|526529633|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146003636|NCT01194245|526529634|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146003637|NCT01194245|526529635|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146003638|NCT01194245|526529631|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146003639|NCT01194245|526529632|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146003640|NCT01194245|526529633|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146003641|NCT01194245|526529634|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146003642|NCT01194245|526529635|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
146003643|NCT03962855|526529636|FG000|Overall Study|Death|0|||
146003644|NCT03962855|526529637|FG001|Overall Study|Death|1|||
146003645|NCT03962855|526529636|FG000|Overall Study|Lost to Follow-up|0|||
146003646|NCT03962855|526529637|FG001|Overall Study|Lost to Follow-up|1|||
146003647|NCT03962855|526529636|FG000|Overall Study|Adverse Event|0|||
146003648|NCT03962855|526529637|FG001|Overall Study|Adverse Event|1|||
146298105|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
146298106|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
146298107|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
146298108|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
146003649|NCT03962855|526529636|FG000|Overall Study|Physician Decision|0|||
146003650|NCT03962855|526529637|FG001|Overall Study|Physician Decision|2|||
146003651|NCT02216526|526529641|FG000|Overall Study|Adverse Event|1|||
146298109|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
146298110|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
146003652|NCT02216526|526529642|FG001|Overall Study|Adverse Event|1|||
146003653|NCT02216526|526529643|FG002|Overall Study|Adverse Event|0|||
146003654|NCT02216526|526529641|FG000|Overall Study|Death|0|||
146003655|NCT02216526|526529642|FG001|Overall Study|Death|1|||
146003656|NCT02216526|526529643|FG002|Overall Study|Death|3|||
146003657|NCT02216526|526529641|FG000|Overall Study|Protocol Violation|2|||
146003658|NCT02216526|526529642|FG001|Overall Study|Protocol Violation|0|||
146003659|NCT02216526|526529643|FG002|Overall Study|Protocol Violation|2|||
146003660|NCT02216526|526529641|FG000|Overall Study|Hospitalization|2|||
146003661|NCT02216526|526529642|FG001|Overall Study|Hospitalization|1|||
146003662|NCT02216526|526529643|FG002|Overall Study|Hospitalization|3|||
146003663|NCT01882465|526529644|FG000|Period 1|Lens Discomfort|0|||
146003664|NCT01882465|526529645|FG001|Period 1|Lens Discomfort|0|||
146003665|NCT01882465|526529646|FG002|Period 1|Lens Discomfort|0|||
146003666|NCT01882465|526529647|FG003|Period 1|Lens Discomfort|1|||
146003667|NCT01882465|526529648|FG004|Period 1|Lens Discomfort|0|||
146003668|NCT01882465|526529649|FG005|Period 1|Lens Discomfort|0|||
146003669|NCT01882465|526529650|FG006|Period 1|Lens Discomfort|0|||
146003670|NCT01882465|526529644|FG000|Period 1|Withdrawal by Subject|0|||
146003671|NCT01882465|526529645|FG001|Period 1|Withdrawal by Subject|0|||
146003672|NCT01882465|526529646|FG002|Period 1|Withdrawal by Subject|0|||
146003673|NCT01882465|526529647|FG003|Period 1|Withdrawal by Subject|0|||
146003674|NCT01882465|526529648|FG004|Period 1|Withdrawal by Subject|0|||
146003675|NCT01882465|526529649|FG005|Period 1|Withdrawal by Subject|0|||
146003676|NCT01882465|526529650|FG006|Period 1|Withdrawal by Subject|1|||
146003677|NCT01882465|526529644|FG000|Period 2|Protocol Violation|0|||
146003678|NCT01882465|526529645|FG001|Period 2|Protocol Violation|0|||
146003679|NCT01882465|526529646|FG002|Period 2|Protocol Violation|0|||
146003680|NCT01882465|526529647|FG003|Period 2|Protocol Violation|0|||
146003681|NCT01882465|526529648|FG004|Period 2|Protocol Violation|1|||
146003682|NCT01882465|526529649|FG005|Period 2|Protocol Violation|0|||
146003683|NCT01882465|526529650|FG006|Period 2|Protocol Violation|0|||
146003684|NCT03824392|526529651|FG000|Overall Study|Adverse Event|1|||
146003685|NCT03824392|526529652|FG001|Overall Study|Adverse Event|0|||
146003686|NCT03824392|526529653|FG002|Overall Study|Adverse Event|0|||
146003687|NCT03824392|526529654|FG003|Overall Study|Adverse Event|0|||
146003688|NCT03824392|526529651|FG000|Overall Study|Investigator Decision|0|||
146003689|NCT03824392|526529652|FG001|Overall Study|Investigator Decision|1|||
146003690|NCT03824392|526529653|FG002|Overall Study|Investigator Decision|0|||
146003691|NCT03824392|526529654|FG003|Overall Study|Investigator Decision|0|||
146003692|NCT03824392|526529651|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
146003693|NCT03824392|526529652|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
146003694|NCT03824392|526529653|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
146003695|NCT03824392|526529654|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
146003696|NCT03894891|526529657|FG000|Overall Study|Withdrawal by Subject|1|||
146003697|NCT03894891|526529657|FG000|Overall Study|Completed protocol treatment per protocol|5|||
146003698|NCT00251693|526529664|FG000|Overall Study|Adverse Event|17|||
146003699|NCT00251693|526529665|FG001|Overall Study|Adverse Event|9|||
146003700|NCT00251693|526529666|FG002|Overall Study|Adverse Event|9|||
146003701|NCT00251693|526529664|FG000|Overall Study|Protocol Violation|2|||
146003702|NCT00251693|526529665|FG001|Overall Study|Protocol Violation|0|||
146003703|NCT00251693|526529666|FG002|Overall Study|Protocol Violation|2|||
146003704|NCT00251693|526529664|FG000|Overall Study|Lost to Follow-up|12|||
146003705|NCT00251693|526529665|FG001|Overall Study|Lost to Follow-up|7|||
146003706|NCT00251693|526529666|FG002|Overall Study|Lost to Follow-up|8|||
146003707|NCT00251693|526529664|FG000|Overall Study|Withdrawal by Subject|11|||
146003708|NCT00251693|526529665|FG001|Overall Study|Withdrawal by Subject|17|||
146003709|NCT00251693|526529666|FG002|Overall Study|Withdrawal by Subject|14|||
146003710|NCT00251693|526529664|FG000|Overall Study|Lack of Efficacy|0|||
146003711|NCT00251693|526529665|FG001|Overall Study|Lack of Efficacy|1|||
146003712|NCT00251693|526529666|FG002|Overall Study|Lack of Efficacy|0|||
146003713|NCT00251693|526529664|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
146003714|NCT00251693|526529665|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
146003715|NCT00251693|526529666|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
146003716|NCT00251693|526529664|FG000|Overall Study|Noncompliant|0|||
146003717|NCT00251693|526529665|FG001|Overall Study|Noncompliant|0|||
146003718|NCT00251693|526529666|FG002|Overall Study|Noncompliant|2|||
146003719|NCT00251693|526529664|FG000|Overall Study|Possible Barrett's esophagus|3|||
146003720|NCT00251693|526529665|FG001|Overall Study|Possible Barrett's esophagus|5|||
146247684|NCT00103857|527419898|FG004|50-Week Extension Study|Protocol Violation|0|||
146003721|NCT00251693|526529666|FG002|Overall Study|Possible Barrett's esophagus|2|||
146003722|NCT00251693|526529664|FG000|Overall Study|Subject request/subject unavailable|1|||
146003723|NCT00251693|526529665|FG001|Overall Study|Subject request/subject unavailable|2|||
146247685|NCT00103857|527419899|FG005|50-Week Extension Study|Protocol Violation|1|||
146003724|NCT00251693|526529666|FG002|Overall Study|Subject request/subject unavailable|0|||
146003725|NCT00251693|526529664|FG000|Overall Study|Abnormal laboratory findings|0|||
146003726|NCT00251693|526529665|FG001|Overall Study|Abnormal laboratory findings|0|||
146247686|NCT00103857|527419900|FG006|50-Week Extension Study|Protocol Violation|0|||
146003727|NCT00251693|526529666|FG002|Overall Study|Abnormal laboratory findings|1|||
146003728|NCT01030822|526529667|FG000|Overall Study|Moved/migrated from study area|6|||
146003729|NCT01030822|526529668|FG001|Overall Study|Moved/migrated from study area|7|||
146247687|NCT00103857|527419894|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
146247688|NCT00103857|527419895|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
146247689|NCT00103857|527419896|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
146003730|NCT01030822|526529669|FG002|Overall Study|Moved/migrated from study area|3|||
146003731|NCT01030822|526529667|FG000|Overall Study|Withdrawal by Subject|16|||
146003732|NCT01030822|526529668|FG001|Overall Study|Withdrawal by Subject|13|||
146003733|NCT01030822|526529669|FG002|Overall Study|Withdrawal by Subject|16|||
146003734|NCT01030822|526529667|FG000|Overall Study|Lost to Follow-up|9|||
146003735|NCT01030822|526529668|FG001|Overall Study|Lost to Follow-up|4|||
146003736|NCT01030822|526529669|FG002|Overall Study|Lost to Follow-up|7|||
146003737|NCT00401843|526529670|FG000|Overall Study|Achieved Complete Response|1|||
146003738|NCT00401843|526529671|FG001|Overall Study|Achieved Complete Response|5|||
146003739|NCT00401843|526529672|FG002|Overall Study|Achieved Complete Response|11|||
146003740|NCT00401843|526529670|FG000|Overall Study|Adverse Event|7|||
146003741|NCT00401843|526529671|FG001|Overall Study|Adverse Event|26|||
146003742|NCT00401843|526529672|FG002|Overall Study|Adverse Event|27|||
146003743|NCT00401843|526529670|FG000|Overall Study|Death|0|||
146003744|NCT00401843|526529671|FG001|Overall Study|Death|8|||
146003745|NCT00401843|526529672|FG002|Overall Study|Death|10|||
146003746|NCT00401843|526529670|FG000|Overall Study|Disease progression|10|||
146003747|NCT00401843|526529671|FG001|Overall Study|Disease progression|60|||
146003748|NCT00401843|526529672|FG002|Overall Study|Disease progression|49|||
146003749|NCT00401843|526529670|FG000|Overall Study|End of Study|1|||
146003750|NCT00401843|526529671|FG001|Overall Study|End of Study|1|||
146003751|NCT00401843|526529672|FG002|Overall Study|End of Study|2|||
146003752|NCT00401843|526529670|FG000|Overall Study|Lost to Follow-up|0|||
146003753|NCT00401843|526529671|FG001|Overall Study|Lost to Follow-up|0|||
146003754|NCT00401843|526529672|FG002|Overall Study|Lost to Follow-up|2|||
146003755|NCT00401843|526529670|FG000|Overall Study|Other Unspecified|0|||
146003756|NCT00401843|526529671|FG001|Overall Study|Other Unspecified|3|||
146003757|NCT00401843|526529672|FG002|Overall Study|Other Unspecified|5|||
146003758|NCT00401843|526529670|FG000|Overall Study|Physician Decision|0|||
146003759|NCT00401843|526529671|FG001|Overall Study|Physician Decision|16|||
146003760|NCT00401843|526529672|FG002|Overall Study|Physician Decision|10|||
146003761|NCT00401843|526529670|FG000|Overall Study|Protocol Violation|0|||
146003762|NCT00401843|526529671|FG001|Overall Study|Protocol Violation|0|||
146003763|NCT00401843|526529672|FG002|Overall Study|Protocol Violation|1|||
146003764|NCT00401843|526529670|FG000|Overall Study|Withdrawal by Subject|1|||
146003765|NCT00401843|526529671|FG001|Overall Study|Withdrawal by Subject|5|||
146003766|NCT00401843|526529672|FG002|Overall Study|Withdrawal by Subject|5|||
146003767|NCT00401843|526529670|FG000|Overall Study|Withdrawal of consent to study agent|1|||
146003768|NCT00401843|526529671|FG001|Overall Study|Withdrawal of consent to study agent|15|||
146003769|NCT00401843|526529672|FG002|Overall Study|Withdrawal of consent to study agent|17|||
146003770|NCT00401843|526529670|FG000|Overall Study|Randomized but not Treated|0|||
146003771|NCT00401843|526529671|FG001|Overall Study|Randomized but not Treated|2|||
146003772|NCT00401843|526529672|FG002|Overall Study|Randomized but not Treated|3|||
146003773|NCT00401843|526529670|FG000|Overall Study|Received incorrect treatment|0|||
146003774|NCT00401843|526529671|FG001|Overall Study|Received incorrect treatment|3|||
146003775|NCT00401843|526529672|FG002|Overall Study|Received incorrect treatment|0|||
146003776|NCT01932788|526529685|FG000|Overall Study|Protocol Violation|18|||
146003777|NCT01932788|526529686|FG001|Overall Study|Protocol Violation|0|||
146003778|NCT01932788|526529685|FG000|Overall Study|Lost to Follow-up|18|||
146003779|NCT01932788|526529686|FG001|Overall Study|Lost to Follow-up|46|||
146003780|NCT01932788|526529685|FG000|Overall Study|Lack of Efficacy|2|||
146003781|NCT01932788|526529686|FG001|Overall Study|Lack of Efficacy|0|||
146003782|NCT01932788|526529685|FG000|Overall Study|Withdrawal by Subject|0|||
146003783|NCT01932788|526529686|FG001|Overall Study|Withdrawal by Subject|5|||
146003784|NCT01171677|526529687|FG000|Overall Study|Withdrawal by Subject|0|||
146003785|NCT01171677|526529688|FG001|Overall Study|Withdrawal by Subject|3|||
146003786|NCT01171677|526529687|FG000|Overall Study|Adverse Event|1|||
146003787|NCT01171677|526529688|FG001|Overall Study|Adverse Event|0|||
146247690|NCT00103857|527419897|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
146247691|NCT00103857|527419898|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
146247692|NCT00103857|527419899|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
146003788|NCT01171677|526529687|FG000|Overall Study|completed <70% IntenSati classes|5|||
146003789|NCT01171677|526529688|FG001|Overall Study|completed <70% IntenSati classes|0|||
146003790|NCT04422431|526529693|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
146003791|NCT04422431|526529693|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
146003792|NCT04422431|526529693|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
146003793|NCT04422431|526529693|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
146003794|NCT04422431|526529693|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
146247693|NCT00103857|527419900|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
146003795|NCT04422431|526529693|FG000|Extension Period (48 Weeks)|Other than specified|2|||
146003796|NCT01085214|526529696|FG000|Overall Study|Alternate treatment required|1|||
146003797|NCT01900665|526529698|FG000|Placebo Controlled Period|Death|9|||
146003798|NCT01900665|526529699|FG001|Placebo Controlled Period|Death|16|||
146003799|NCT01900665|526529698|FG000|Placebo Controlled Period|Adverse Event|48|||
146003800|NCT01900665|526529699|FG001|Placebo Controlled Period|Adverse Event|39|||
146003801|NCT01900665|526529698|FG000|Placebo Controlled Period|Protocol Violation|1|||
146003802|NCT01900665|526529699|FG001|Placebo Controlled Period|Protocol Violation|7|||
146003803|NCT01900665|526529698|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
146003804|NCT01900665|526529699|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
146003805|NCT01900665|526529698|FG000|Placebo Controlled Period|Physician Decision|11|||
146003806|NCT01900665|526529699|FG001|Placebo Controlled Period|Physician Decision|7|||
146003807|NCT01900665|526529698|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
146003808|NCT01900665|526529699|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
146003809|NCT01900665|526529698|FG000|Placebo Controlled Period|Caregiver Decision|33|||
146003810|NCT01900665|526529699|FG001|Placebo Controlled Period|Caregiver Decision|41|||
146003811|NCT01900665|526529698|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
146003812|NCT01900665|526529699|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
146003813|NCT01900665|526529698|FG000|Open Label Period|Adverse Event|16|||
146003814|NCT01900665|526529699|FG001|Open Label Period|Adverse Event|20|||
146003815|NCT01900665|526529698|FG000|Open Label Period|Death|5|||
146003816|NCT01900665|526529699|FG001|Open Label Period|Death|6|||
146003817|NCT01900665|526529698|FG000|Open Label Period|Lost to Follow-up|1|||
146003818|NCT01900665|526529699|FG001|Open Label Period|Lost to Follow-up|1|||
146003819|NCT01900665|526529698|FG000|Open Label Period|Parent/Caregiver Decision|33|||
146003820|NCT01900665|526529699|FG001|Open Label Period|Parent/Caregiver Decision|34|||
146003821|NCT01900665|526529698|FG000|Open Label Period|Physician Decision|4|||
146003822|NCT01900665|526529699|FG001|Open Label Period|Physician Decision|4|||
146003823|NCT01900665|526529698|FG000|Open Label Period|Protocol Violation|0|||
146003824|NCT01900665|526529699|FG001|Open Label Period|Protocol Violation|1|||
146003825|NCT01900665|526529698|FG000|Open Label Period|Sponsor Decision|802|||
146003826|NCT01900665|526529699|FG001|Open Label Period|Sponsor Decision|765|||
146003827|NCT01900665|526529698|FG000|Open Label Period|Withdrawal by Subject|20|||
146003828|NCT01900665|526529699|FG001|Open Label Period|Withdrawal by Subject|28|||
146003829|NCT02317627|526529700|FG000|Overall Study|Withdrawal by Subject|0|||
146003830|NCT02317627|526529701|FG001|Overall Study|Withdrawal by Subject|1|||
146003831|NCT02317627|526529702|FG002|Overall Study|Withdrawal by Subject|1|||
146003832|NCT02317627|526529700|FG000|Overall Study|Lost to Follow-up|2|||
146003833|NCT02317627|526529701|FG001|Overall Study|Lost to Follow-up|0|||
146003834|NCT02317627|526529702|FG002|Overall Study|Lost to Follow-up|0|||
146003835|NCT02317627|526529700|FG000|Overall Study|Stopped by Investigator|0|||
146003836|NCT02317627|526529701|FG001|Overall Study|Stopped by Investigator|1|||
146003837|NCT02317627|526529702|FG002|Overall Study|Stopped by Investigator|0|||
146003838|NCT02317627|526529700|FG000|Overall Study|Adverse Event|0|||
146003839|NCT02317627|526529701|FG001|Overall Study|Adverse Event|2|||
146003840|NCT02317627|526529702|FG002|Overall Study|Adverse Event|3|||
146003841|NCT02317627|526529700|FG000|Overall Study|Non-compliance with study drug|0|||
146003842|NCT02317627|526529701|FG001|Overall Study|Non-compliance with study drug|1|||
146003843|NCT02317627|526529702|FG002|Overall Study|Non-compliance with study drug|0|||
146003844|NCT04749914|526529703|FG000|Period 1|Adverse Event|1|||
146003845|NCT04749914|526529704|FG001|Period 1|Adverse Event|0|||
146003846|NCT04749914|526529705|FG002|Period 1|Adverse Event|0|||
146003847|NCT04749914|526529706|FG003|Period 1|Adverse Event|0|||
146003848|NCT04749914|526529703|FG000|Period 1|Withdrawal by Subject|1|||
146003849|NCT04749914|526529704|FG001|Period 1|Withdrawal by Subject|0|||
146003850|NCT04749914|526529705|FG002|Period 1|Withdrawal by Subject|1|||
146003851|NCT04749914|526529706|FG003|Period 1|Withdrawal by Subject|0|||
146003852|NCT04046939|526529707|FG000|Primary Assessment Period|Adverse Event|1|||
146003853|NCT04046939|526529708|FG001|Primary Assessment Period|Adverse Event|0|||
146003854|NCT04046939|526529709|FG002|Primary Assessment Period|Adverse Event|0|||
146003855|NCT04046939|526529710|FG003|Primary Assessment Period|Adverse Event|0|||
146003856|NCT04046939|526529707|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
146003857|NCT04046939|526529708|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
146003858|NCT04046939|526529709|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
146003859|NCT04046939|526529710|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
146003860|NCT04046939|526529707|FG000|Primary Assessment Period|Physician Decision|0|||
146003861|NCT04046939|526529708|FG001|Primary Assessment Period|Physician Decision|0|||
146003862|NCT04046939|526529709|FG002|Primary Assessment Period|Physician Decision|1|||
146003863|NCT04046939|526529710|FG003|Primary Assessment Period|Physician Decision|0|||
146003864|NCT04046939|526529707|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
146003865|NCT04046939|526529708|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
146003866|NCT04046939|526529709|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
146003867|NCT04046939|526529710|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
146003868|NCT00403130|526529711|FG000|2 Years From Start of Treatment|Not Eligible|3|||
146003869|NCT00403130|526529711|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
146003870|NCT00403130|526529711|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
146003871|NCT00403130|526529711|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
146003872|NCT00806260|526529712|FG000|Period 1 (1 Day)|Adverse Event|0|||
146003873|NCT00806260|526529713|FG001|Period 1 (1 Day)|Adverse Event|0|||
146003874|NCT00806260|526529714|FG002|Period 1 (1 Day)|Adverse Event|0|||
146003875|NCT00806260|526529715|FG003|Period 1 (1 Day)|Adverse Event|0|||
146003876|NCT00806260|526529716|FG004|Period 1 (1 Day)|Adverse Event|3|||
146003877|NCT00806260|526529717|FG005|Period 1 (1 Day)|Adverse Event|0|||
146003878|NCT00806260|526529712|FG000|Period 2|Adverse Event|0|||
146003879|NCT00806260|526529713|FG001|Period 2|Adverse Event|0|||
146003880|NCT00806260|526529714|FG002|Period 2|Adverse Event|0|||
146003881|NCT00806260|526529715|FG003|Period 2|Adverse Event|1|||
146003882|NCT00806260|526529716|FG004|Period 2|Adverse Event|0|||
146003883|NCT00806260|526529717|FG005|Period 2|Adverse Event|0|||
146003884|NCT00806260|526529712|FG000|Period 2|Protocol Violation|1|||
146003885|NCT00806260|526529713|FG001|Period 2|Protocol Violation|0|||
146003886|NCT00806260|526529714|FG002|Period 2|Protocol Violation|1|||
146003887|NCT00806260|526529715|FG003|Period 2|Protocol Violation|0|||
146003888|NCT00806260|526529716|FG004|Period 2|Protocol Violation|0|||
146003889|NCT00806260|526529717|FG005|Period 2|Protocol Violation|0|||
146003890|NCT00806260|526529712|FG000|Period 2|Need to take concomitant medication|1|||
146003891|NCT00806260|526529713|FG001|Period 2|Need to take concomitant medication|0|||
146003892|NCT00806260|526529714|FG002|Period 2|Need to take concomitant medication|0|||
146003893|NCT00806260|526529715|FG003|Period 2|Need to take concomitant medication|0|||
146003894|NCT00806260|526529716|FG004|Period 2|Need to take concomitant medication|0|||
146003895|NCT00806260|526529717|FG005|Period 2|Need to take concomitant medication|0|||
146003896|NCT00806260|526529712|FG000|Period 2|sponsor request|0|||
146003897|NCT00806260|526529713|FG001|Period 2|sponsor request|0|||
146003898|NCT00806260|526529714|FG002|Period 2|sponsor request|1|||
146003899|NCT00806260|526529715|FG003|Period 2|sponsor request|1|||
146003900|NCT00806260|526529716|FG004|Period 2|sponsor request|0|||
146003901|NCT00806260|526529717|FG005|Period 2|sponsor request|0|||
146003902|NCT00806260|526529712|FG000|Period 3|Protocol Violation|0|||
146003903|NCT00806260|526529713|FG001|Period 3|Protocol Violation|1|||
146003904|NCT00806260|526529714|FG002|Period 3|Protocol Violation|1|||
146003905|NCT00806260|526529715|FG003|Period 3|Protocol Violation|0|||
146003906|NCT00806260|526529716|FG004|Period 3|Protocol Violation|0|||
146003907|NCT00806260|526529717|FG005|Period 3|Protocol Violation|0|||
146003908|NCT00806260|526529712|FG000|Period 3|Pregnancy|1|||
146003909|NCT00806260|526529713|FG001|Period 3|Pregnancy|0|||
146003910|NCT00806260|526529714|FG002|Period 3|Pregnancy|0|||
146003911|NCT00806260|526529715|FG003|Period 3|Pregnancy|0|||
146003912|NCT00806260|526529716|FG004|Period 3|Pregnancy|0|||
146003913|NCT00806260|526529717|FG005|Period 3|Pregnancy|0|||
146003914|NCT00237042|526529718|FG000|Treatment|Became ineligible post-randomization|0|||
146003915|NCT00237042|526529719|FG001|Treatment|Became ineligible post-randomization|1|||
146003916|NCT00237042|526529720|FG002|Treatment|Became ineligible post-randomization|16|||
146003917|NCT00237042|526529718|FG000|Treatment|Moved out of state|1|||
146003918|NCT00237042|526529719|FG001|Treatment|Moved out of state|1|||
146003919|NCT00237042|526529720|FG002|Treatment|Moved out of state|1|||
146003920|NCT00237042|526529718|FG000|Treatment|Completed no treatment|5|||
146003921|NCT00237042|526529719|FG001|Treatment|Completed no treatment|5|||
146003922|NCT00237042|526529720|FG002|Treatment|Completed no treatment|21|||
146003923|NCT00237042|526529718|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
146003924|NCT00237042|526529719|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
146003925|NCT00237042|526529720|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
146003926|NCT00237042|526529718|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
146003927|NCT00237042|526529719|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
146003928|NCT00237042|526529720|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
146003929|NCT01074931|526529725|FG000|Overall Study|Economic reasons|1|||
146003930|NCT01074931|526529725|FG000|Overall Study|Death|5|||
146003931|NCT03132467|526529726|FG000|Overall Study|Adverse Event|2|||
146003932|NCT03132467|526529726|FG000|Overall Study|Withdrawal by Subject|2|||
146247694|NCT00103857|527419894|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
146003933|NCT05414175|526529727|FG000|Overall Study|Withdrawal by Subject|1|||
146003934|NCT05414175|526529727|FG000|Overall Study|Other Reasons|1|||
146003935|NCT05223673|526529728|FG000|Overall Study|Protocol Violation|1|||
146003936|NCT05223673|526529728|FG000|Overall Study|Study termination|6|||
146003937|NCT00027560|526529729|FG000|Overall Study|Withdrawal by Subject|1|||
146003938|NCT03559270|526529731|FG000|Overall Study|Adverse Event|6|||
146003939|NCT03559270|526529732|FG001|Overall Study|Adverse Event|5|||
146003940|NCT03559270|526529733|FG002|Overall Study|Adverse Event|3|||
146003941|NCT03559270|526529734|FG003|Overall Study|Adverse Event|0|||
146003942|NCT03559270|526529731|FG000|Overall Study|Lack of Efficacy|34|||
146003943|NCT03559270|526529732|FG001|Overall Study|Lack of Efficacy|52|||
146003944|NCT03559270|526529733|FG002|Overall Study|Lack of Efficacy|37|||
146003945|NCT03559270|526529734|FG003|Overall Study|Lack of Efficacy|2|||
146003946|NCT03559270|526529731|FG000|Overall Study|Death|0|||
146003947|NCT03559270|526529732|FG001|Overall Study|Death|2|||
146003948|NCT03559270|526529733|FG002|Overall Study|Death|0|||
146003949|NCT03559270|526529734|FG003|Overall Study|Death|0|||
146003950|NCT03559270|526529731|FG000|Overall Study|Lost to Follow-up|16|||
146003951|NCT03559270|526529732|FG001|Overall Study|Lost to Follow-up|4|||
146003952|NCT03559270|526529733|FG002|Overall Study|Lost to Follow-up|12|||
146003953|NCT03559270|526529734|FG003|Overall Study|Lost to Follow-up|3|||
146092396|NCT00089674|526860288|FG000|Overall Study|Other|5|||
146092397|NCT00089674|526860289|FG001|Overall Study|Other|9|||
146003954|NCT03559270|526529731|FG000|Overall Study|Sponsor Decision|38|||
146003955|NCT03559270|526529732|FG001|Overall Study|Sponsor Decision|31|||
146003956|NCT03559270|526529733|FG002|Overall Study|Sponsor Decision|35|||
146003957|NCT03559270|526529734|FG003|Overall Study|Sponsor Decision|18|||
146003958|NCT03559270|526529731|FG000|Overall Study|Withdrawal by Subject|19|||
146003959|NCT03559270|526529732|FG001|Overall Study|Withdrawal by Subject|21|||
146003960|NCT03559270|526529733|FG002|Overall Study|Withdrawal by Subject|18|||
146003961|NCT03559270|526529734|FG003|Overall Study|Withdrawal by Subject|7|||
146003962|NCT03559270|526529731|FG000|Overall Study|Physician Decision|3|||
146003963|NCT03559270|526529732|FG001|Overall Study|Physician Decision|2|||
146003964|NCT03559270|526529733|FG002|Overall Study|Physician Decision|1|||
146003965|NCT03559270|526529734|FG003|Overall Study|Physician Decision|0|||
146003966|NCT03559270|526529731|FG000|Overall Study|Pregnancy|0|||
146003967|NCT03559270|526529732|FG001|Overall Study|Pregnancy|1|||
146003968|NCT03559270|526529733|FG002|Overall Study|Pregnancy|0|||
146003969|NCT03559270|526529734|FG003|Overall Study|Pregnancy|0|||
146003970|NCT03559270|526529731|FG000|Overall Study|Protocol Violation|1|||
146003971|NCT03559270|526529732|FG001|Overall Study|Protocol Violation|0|||
146003972|NCT03559270|526529733|FG002|Overall Study|Protocol Violation|2|||
146003973|NCT03559270|526529734|FG003|Overall Study|Protocol Violation|0|||
146003974|NCT04472650|526531402|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
146003975|NCT04472650|526531403|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
146003976|NCT02549989|526531406|FG000|Overall Study|Adverse Event|4|||
146003977|NCT02549989|526531406|FG000|Overall Study|Death|1|||
146003978|NCT02549989|526531406|FG000|Overall Study|Lack of Efficacy|19|||
146003979|NCT02549989|526531406|FG000|Overall Study|Withdrawal by Subject|3|||
146003980|NCT01333722|526531410|FG000|Overall Study|Lack of Efficacy|0|||
146003981|NCT01333722|526531411|FG001|Overall Study|Lack of Efficacy|2|||
146003982|NCT01333722|526531410|FG000|Overall Study|Withdrawal by Subject|0|||
146003983|NCT01333722|526531411|FG001|Overall Study|Withdrawal by Subject|1|||
146003984|NCT00784368|526531414|FG000|Overall Study|Physician Decision|0|||
146003985|NCT00784368|526531415|FG001|Overall Study|Physician Decision|0|||
146003986|NCT00784368|526531416|FG002|Overall Study|Physician Decision|6|||
146003987|NCT00784368|526531414|FG000|Overall Study|Lack of Efficacy|2|||
146003988|NCT00784368|526531415|FG001|Overall Study|Lack of Efficacy|0|||
146003989|NCT00784368|526531416|FG002|Overall Study|Lack of Efficacy|1|||
146003990|NCT00784368|526531414|FG000|Overall Study|Adverse Event|6|||
146003991|NCT00784368|526531415|FG001|Overall Study|Adverse Event|9|||
146003992|NCT00784368|526531416|FG002|Overall Study|Adverse Event|2|||
146003993|NCT00784368|526531414|FG000|Overall Study|Diagnosis of fever|0|||
146003994|NCT00784368|526531415|FG001|Overall Study|Diagnosis of fever|0|||
146003995|NCT00784368|526531416|FG002|Overall Study|Diagnosis of fever|1|||
146003996|NCT00784368|526531414|FG000|Overall Study|Worsening of complications|0|||
146003997|NCT00784368|526531415|FG001|Overall Study|Worsening of complications|0|||
146003998|NCT00784368|526531416|FG002|Overall Study|Worsening of complications|1|||
146003999|NCT00784368|526531414|FG000|Overall Study|Worsening of symptoms|0|||
146004000|NCT00784368|526531415|FG001|Overall Study|Worsening of symptoms|1|||
146004001|NCT00784368|526531416|FG002|Overall Study|Worsening of symptoms|0|||
146004002|NCT00784368|526531414|FG000|Overall Study|Withdrawal of informed consent|0|||
146004003|NCT00784368|526531415|FG001|Overall Study|Withdrawal of informed consent|1|||
146004004|NCT00784368|526531416|FG002|Overall Study|Withdrawal of informed consent|0|||
146004005|NCT04776161|526531419|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
146004006|NCT04776161|526531420|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
146004007|NCT04776161|526531421|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
146004008|NCT04776161|526531419|FG000|Overall Study|Withdrawal by Subject|1|||
146004009|NCT04776161|526531420|FG001|Overall Study|Withdrawal by Subject|0|||
146004010|NCT04776161|526531421|FG002|Overall Study|Withdrawal by Subject|1|||
146004011|NCT04776161|526531419|FG000|Overall Study|Adverse Event|0|||
146004012|NCT04776161|526531420|FG001|Overall Study|Adverse Event|1|||
146004013|NCT04776161|526531421|FG002|Overall Study|Adverse Event|1|||
146004014|NCT00342628|526531422|FG000|Overall Study|Withdrawal by Subject|19|||
146004015|NCT00342628|526531423|FG001|Overall Study|Withdrawal by Subject|19|||
146092398|NCT00089674|526860288|FG000|Overall Study|Requirement for alternative therapy|14|||
146004016|NCT00342628|526531424|FG002|Overall Study|Withdrawal by Subject|18|||
146004017|NCT00342628|526531422|FG000|Overall Study|Death|1|||
146092399|NCT00089674|526860289|FG001|Overall Study|Requirement for alternative therapy|4|||
146004018|NCT00342628|526531423|FG001|Overall Study|Death|1|||
146092400|NCT03963401|526860290|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
146092401|NCT03963401|526860291|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
146004019|NCT00342628|526531424|FG002|Overall Study|Death|0|||
146004020|NCT00342628|526531422|FG000|Overall Study|moved residence|0|||
146004021|NCT00342628|526531423|FG001|Overall Study|moved residence|1|||
146004022|NCT00342628|526531424|FG002|Overall Study|moved residence|1|||
146004023|NCT01334554|526531425|FG000|Overall Study|Adverse Event|4|||
146004024|NCT01334554|526531426|FG001|Overall Study|Adverse Event|2|||
146298111|NCT00217737|527606079|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
146298112|NCT00217737|527606080|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
146298113|NCT00217737|527606081|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
146298114|NCT00217737|527606082|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
146298115|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
146004025|NCT02393859|526531428|FG000|Overall Study|Decision by Sponsor|2|||
146004026|NCT02393859|526531429|FG001|Overall Study|Decision by Sponsor|4|||
146004027|NCT02393859|526531428|FG000|Overall Study|Withdrawal by Subject|11|||
146004028|NCT02393859|526531429|FG001|Overall Study|Withdrawal by Subject|6|||
146004029|NCT02393859|526531428|FG000|Overall Study|Death|27|||
146004030|NCT02393859|526531429|FG001|Overall Study|Death|10|||
146004031|NCT02393859|526531428|FG000|Overall Study|Lost to Follow-up|1|||
146004032|NCT02393859|526531429|FG001|Overall Study|Lost to Follow-up|1|||
146004033|NCT01944020|526531430|FG000|Overall Study|Withdrawal by Subject|5|||
146004034|NCT01944020|526531431|FG001|Overall Study|Withdrawal by Subject|0|||
146004035|NCT00661830|526531432|FG000|Overall Study|Death|37|||
146004036|NCT00661830|526531433|FG001|Overall Study|Death|33|||
146004037|NCT00661830|526531432|FG000|Overall Study|Lost to Follow-up|1|||
146004038|NCT00661830|526531433|FG001|Overall Study|Lost to Follow-up|3|||
146004039|NCT00661830|526531432|FG000|Overall Study|Withdrawal by Subject|1|||
146004040|NCT00661830|526531433|FG001|Overall Study|Withdrawal by Subject|1|||
146004041|NCT00661830|526531432|FG000|Overall Study|Other reason|1|||
146004042|NCT00661830|526531433|FG001|Overall Study|Other reason|5|||
146004043|NCT01979614|526531434|FG000|Overall Study|Adverse Event|1|||
146004044|NCT01979614|526531435|FG001|Overall Study|Adverse Event|1|||
146004045|NCT00938912|526531436|FG000|Overall Study|Withdrawal by Subject|28|||
146004046|NCT00938912|526531436|FG000|Overall Study|Lost to Follow-up|4|||
146004047|NCT00938912|526531436|FG000|Overall Study|Lack of Efficacy|43|||
146004048|NCT00938912|526531436|FG000|Overall Study|Adverse event, non-fatal|24|||
146004049|NCT00938912|526531436|FG000|Overall Study|Adverse event, fatal|1|||
146004050|NCT00938912|526531436|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
146004051|NCT00938912|526531436|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
146004052|NCT00938912|526531436|FG000|Overall Study|Participant needed prohibit medication|1|||
146004053|NCT00938912|526531436|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
146004054|NCT00938912|526531436|FG000|Overall Study|Did not meet Eligibility criteria|1|||
146004055|NCT00938912|526531436|FG000|Overall Study|Participant relocated not related to AE|1|||
146004056|NCT00938912|526531436|FG000|Overall Study|Participant moved to another city|1|||
146004057|NCT00938912|526531436|FG000|Overall Study|Participant experienced break through seizures|1|||
146004058|NCT00938912|526531436|FG000|Overall Study|No longer wished to participate in the study|1|||
146004059|NCT00938912|526531436|FG000|Overall Study|Protocol Deviation|2|||
146004060|NCT00803738|526531437|FG000|Overall Study|Adverse Event|3|||
146004061|NCT00803738|526531438|FG001|Overall Study|Adverse Event|5|||
146004062|NCT00803738|526531437|FG000|Overall Study|Lost to Follow-up|4|||
146004063|NCT00803738|526531438|FG001|Overall Study|Lost to Follow-up|4|||
146004064|NCT00803738|526531437|FG000|Overall Study|Protocol Violation|18|||
146004065|NCT00803738|526531438|FG001|Overall Study|Protocol Violation|10|||
146004066|NCT00803738|526531437|FG000|Overall Study|Withdrawal by Subject|1|||
146004067|NCT00803738|526531438|FG001|Overall Study|Withdrawal by Subject|4|||
146004068|NCT00803738|526531437|FG000|Overall Study|Lack of Efficacy|10|||
146004069|NCT00803738|526531438|FG001|Overall Study|Lack of Efficacy|16|||
146004070|NCT00803738|526531437|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
146004071|NCT00803738|526531438|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
146004072|NCT00803738|526531437|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
146004073|NCT00803738|526531438|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
146004074|NCT01048242|526531439|FG000|Overall Study|See study flow chart|4|||
146004075|NCT01048242|526531440|FG001|Overall Study|See study flow chart|2|||
146298116|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
146298117|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
146298118|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
146004076|NCT02897115|526531445|FG000|Overall Study|Early termination of study by sponsor|11|||
146004077|NCT02897115|526531446|FG001|Overall Study|Early termination of study by sponsor|8|||
146004078|NCT00856323|526531448|FG000|Overall Study|Withdrawal by Subject|2|||
146004079|NCT03432494|526531449|FG000|Overall Study|Death|1|||
146004080|NCT03432494|526531449|FG000|Overall Study|Noncompliance|1|||
146004081|NCT01244035|526531451|FG000|Part 1: Period 1|Adverse Event|0|||
146004082|NCT01244035|526531452|FG001|Part 1: Period 1|Adverse Event|0|||
146004083|NCT01244035|526531453|FG002|Part 1: Period 1|Adverse Event|0|||
146004084|NCT01244035|526531454|FG003|Part 1: Period 1|Adverse Event|0|||
146004085|NCT01244035|526531455|FG004|Part 1: Period 1|Adverse Event|0|||
146004086|NCT01244035|526531456|FG005|Part 1: Period 1|Adverse Event|1|||
146004087|NCT01244035|526531451|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
146004088|NCT01244035|526531452|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
146004089|NCT01244035|526531453|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
146004090|NCT01244035|526531454|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
146004091|NCT01244035|526531455|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
146004092|NCT01244035|526531456|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
146004093|NCT01244035|526531451|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146004094|NCT01244035|526531452|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
146004095|NCT01244035|526531453|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
146004096|NCT01244035|526531454|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
146004097|NCT01244035|526531455|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146004098|NCT01244035|526531456|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
146004099|NCT01244035|526531451|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146004100|NCT01244035|526531452|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146004101|NCT01244035|526531453|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
146004102|NCT01244035|526531454|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146004103|NCT01244035|526531455|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146004104|NCT01244035|526531456|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
146004105|NCT01244035|526531451|FG000|Part 1: Period 3|Adverse Event|0|||
146004106|NCT01244035|526531452|FG001|Part 1: Period 3|Adverse Event|0|||
146004107|NCT01244035|526531453|FG002|Part 1: Period 3|Adverse Event|0|||
146004108|NCT01244035|526531454|FG003|Part 1: Period 3|Adverse Event|0|||
146004109|NCT01244035|526531455|FG004|Part 1: Period 3|Adverse Event|0|||
146004110|NCT01244035|526531456|FG005|Part 1: Period 3|Adverse Event|1|||
146004111|NCT01244035|526531451|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
146004112|NCT01244035|526531452|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
146004113|NCT01244035|526531453|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
146004114|NCT01244035|526531454|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
146004115|NCT01244035|526531455|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
146004116|NCT01244035|526531456|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
146004117|NCT01244035|526531451|FG000|Part 1: Period 3|Protocol Deviation|0|||
146004118|NCT01244035|526531452|FG001|Part 1: Period 3|Protocol Deviation|1|||
146004119|NCT01244035|526531453|FG002|Part 1: Period 3|Protocol Deviation|0|||
146004120|NCT01244035|526531454|FG003|Part 1: Period 3|Protocol Deviation|0|||
146004121|NCT01244035|526531455|FG004|Part 1: Period 3|Protocol Deviation|0|||
146004122|NCT01244035|526531456|FG005|Part 1: Period 3|Protocol Deviation|0|||
146004123|NCT02383862|526531458|FG000|3 Month Follow up|Lost to Follow-up|23|||
146004124|NCT02383862|526531459|FG001|3 Month Follow up|Lost to Follow-up|21|||
146004125|NCT01833494|526531460|FG000|Overall Study|Adverse Event|24|||
146004126|NCT01833494|526531460|FG000|Overall Study|Physician Decision|6|||
146004127|NCT01833494|526531460|FG000|Overall Study|Withdrawal by Subject|6|||
146004128|NCT01833494|526531460|FG000|Overall Study|Decrease in serum phosphorus|4|||
146004129|NCT01833494|526531460|FG000|Overall Study|Decrease in serum calcium|4|||
146004130|NCT01833494|526531460|FG000|Overall Study|Increase in serum ferritin|1|||
146004131|NCT01694433|526531465|FG000|Overall Study|Adverse Event|7|||
146004132|NCT01694433|526531466|FG001|Overall Study|Adverse Event|0|||
146004133|NCT01694433|526531465|FG000|Overall Study|Physician Decision|1|||
146004134|NCT01694433|526531466|FG001|Overall Study|Physician Decision|0|||
146004135|NCT01694433|526531465|FG000|Overall Study|Withdrawal by Subject|3|||
146004136|NCT01694433|526531466|FG001|Overall Study|Withdrawal by Subject|4|||
146004137|NCT00374595|526531469|FG000|Overall Study|Death|23|||
146004138|NCT00374595|526531469|FG000|Overall Study|Withdrawal by Subject|39|||
146004139|NCT00374595|526531469|FG000|Overall Study|Lost to Follow-up|3|||
146004140|NCT00374595|526531469|FG000|Overall Study|too much time commitment|1|||
146004141|NCT00374595|526531469|FG000|Overall Study|transfer care to other clinical site|1|||
146004142|NCT00374595|526531469|FG000|Overall Study|relocation|3|||
146004143|NCT03745768|526531470|FG000|Overall Study|discontinued study|2|||
146004144|NCT03745768|526531471|FG001|Overall Study|discontinued study|0|||
146004145|NCT00443118|526531472|FG000|Overall Study|unknown primary outcome|3|||
146004146|NCT00443118|526531473|FG001|Overall Study|unknown primary outcome|1|||
146004147|NCT00443118|526531474|FG002|Overall Study|unknown primary outcome|0|||
146004148|NCT00443118|526531472|FG000|Overall Study|Withdrawal by Subject|1|||
146004149|NCT00443118|526531473|FG001|Overall Study|Withdrawal by Subject|0|||
146004150|NCT00443118|526531474|FG002|Overall Study|Withdrawal by Subject|0|||
146004151|NCT04512001|526531475|FG000|Week 0 to Week 24|Adverse Event|14|||
146004152|NCT04512001|526531476|FG001|Week 0 to Week 24|Adverse Event|10|||
146004153|NCT04512001|526531477|FG002|Week 0 to Week 24|Adverse Event|0|||
146004154|NCT04512001|526531478|FG003|Week 0 to Week 24|Adverse Event|0|||
146004155|NCT04512001|526531479|FG004|Week 0 to Week 24|Adverse Event|0|||
146092402|NCT03963401|526860292|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
146092403|NCT03963401|526860293|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
146004156|NCT04512001|526531475|FG000|Week 0 to Week 24|Death|0|||
146004157|NCT04512001|526531476|FG001|Week 0 to Week 24|Death|2|||
146004158|NCT04512001|526531477|FG002|Week 0 to Week 24|Death|0|||
146004159|NCT04512001|526531478|FG003|Week 0 to Week 24|Death|0|||
146004160|NCT04512001|526531479|FG004|Week 0 to Week 24|Death|0|||
146004161|NCT04512001|526531475|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
146004162|NCT04512001|526531476|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
146004163|NCT04512001|526531477|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
146004164|NCT04512001|526531478|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
146004165|NCT04512001|526531479|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
146004166|NCT04512001|526531475|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
146004167|NCT04512001|526531476|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
146004168|NCT04512001|526531477|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146004169|NCT04512001|526531478|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146004170|NCT04512001|526531479|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
146004171|NCT04512001|526531475|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
146004172|NCT04512001|526531476|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146004173|NCT04512001|526531477|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146004174|NCT04512001|526531478|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146004175|NCT04512001|526531479|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
146004176|NCT04512001|526531475|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146004177|NCT04512001|526531476|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
146004178|NCT04512001|526531477|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146004179|NCT04512001|526531478|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146004180|NCT04512001|526531479|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
146004181|NCT04512001|526531475|FG000|Week 24 to Week 63|Adverse Event|0|||
146004182|NCT04512001|526531476|FG001|Week 24 to Week 63|Adverse Event|0|||
146004183|NCT04512001|526531477|FG002|Week 24 to Week 63|Adverse Event|13|||
146004184|NCT04512001|526531478|FG003|Week 24 to Week 63|Adverse Event|8|||
146004185|NCT04512001|526531479|FG004|Week 24 to Week 63|Adverse Event|6|||
146004186|NCT04512001|526531475|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
146004187|NCT04512001|526531476|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
146004188|NCT04512001|526531477|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
146004189|NCT04512001|526531478|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
146004190|NCT04512001|526531479|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
146004191|NCT04512001|526531475|FG000|Week 24 to Week 63|Death|0|||
146004192|NCT04512001|526531476|FG001|Week 24 to Week 63|Death|0|||
146004193|NCT04512001|526531477|FG002|Week 24 to Week 63|Death|0|||
146004194|NCT04512001|526531478|FG003|Week 24 to Week 63|Death|1|||
146004195|NCT04512001|526531479|FG004|Week 24 to Week 63|Death|1|||
146004196|NCT04512001|526531475|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
146004197|NCT04512001|526531476|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
146004198|NCT04512001|526531477|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
146004199|NCT04512001|526531478|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
146004200|NCT04512001|526531479|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
146004201|NCT04512001|526531475|FG000|Week 24 to Week 63|Miscellaneous|0|||
146004202|NCT04512001|526531476|FG001|Week 24 to Week 63|Miscellaneous|0|||
146004203|NCT04512001|526531477|FG002|Week 24 to Week 63|Miscellaneous|3|||
146004204|NCT04512001|526531478|FG003|Week 24 to Week 63|Miscellaneous|2|||
146004205|NCT04512001|526531479|FG004|Week 24 to Week 63|Miscellaneous|1|||
146004206|NCT02776683|526531480|FG000|Pre-switch Period|Protocol Violation|1|||
146004207|NCT02776683|526531481|FG001|Pre-switch Period|Protocol Violation|0|||
146004208|NCT02776683|526531480|FG000|Pre-switch Period|Adverse Event|21|||
146004209|NCT02776683|526531481|FG001|Pre-switch Period|Adverse Event|0|||
146004210|NCT02776683|526531480|FG000|Pre-switch Period|Withdrawal by Subject|9|||
146004211|NCT02776683|526531481|FG001|Pre-switch Period|Withdrawal by Subject|0|||
146004212|NCT02776683|526531480|FG000|Pre-switch Period|Physician Decision|7|||
146004213|NCT02776683|526531481|FG001|Pre-switch Period|Physician Decision|0|||
146004214|NCT02776683|526531480|FG000|Pre-switch Period|Progressive disease|39|||
146004215|NCT02776683|526531481|FG001|Pre-switch Period|Progressive disease|0|||
146004216|NCT02776683|526531480|FG000|Pre-switch Period|Other than listed|3|||
146004217|NCT02776683|526531481|FG001|Pre-switch Period|Other than listed|0|||
146004218|NCT02776683|526531480|FG000|Post-switch Period|Adverse Event|0|||
146004219|NCT02776683|526531481|FG001|Post-switch Period|Adverse Event|3|||
146004220|NCT02776683|526531480|FG000|Post-switch Period|Withdrawal by Subject|0|||
146004221|NCT02776683|526531481|FG001|Post-switch Period|Withdrawal by Subject|2|||
146004222|NCT02776683|526531480|FG000|Post-switch Period|Physician Decision|0|||
146004223|NCT02776683|526531481|FG001|Post-switch Period|Physician Decision|3|||
146004224|NCT02776683|526531480|FG000|Post-switch Period|Progressive disease|0|||
146004225|NCT02776683|526531481|FG001|Post-switch Period|Progressive disease|20|||
146004226|NCT02776683|526531480|FG000|Post-switch Period|Other than listed|0|||
146004227|NCT02776683|526531481|FG001|Post-switch Period|Other than listed|15|||
146004228|NCT04232943|526531482|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
146004229|NCT04232943|526531483|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
146004230|NCT04232943|526531484|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
146004231|NCT04232943|526531482|FG000|Overall Study|Withdrawal by Subject|1|||
146004232|NCT04232943|526531483|FG001|Overall Study|Withdrawal by Subject|1|||
146004233|NCT04232943|526531484|FG002|Overall Study|Withdrawal by Subject|0|||
146247695|NCT00103857|527419895|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
146004234|NCT01664247|526531490|FG000|Overall Study|Adverse Event|5|||
146004235|NCT01664247|526531491|FG001|Overall Study|Adverse Event|3|||
146004236|NCT01664247|526531490|FG000|Overall Study|Protocol Violation|3|||
146004237|NCT01664247|526531491|FG001|Overall Study|Protocol Violation|5|||
146004238|NCT01664247|526531490|FG000|Overall Study|Withdrawal Criteria|1|||
146004239|NCT01664247|526531491|FG001|Overall Study|Withdrawal Criteria|4|||
146004240|NCT01664247|526531490|FG000|Overall Study|Unclassified|5|||
146004241|NCT01664247|526531491|FG001|Overall Study|Unclassified|29|||
146004242|NCT01023217|526531493|FG000|Overall Study|Withdrawal by Subject|1|||
146004243|NCT01023217|526531494|FG001|Overall Study|Withdrawal by Subject|0|||
146004244|NCT01106157|526531495|FG000|Overall Study|Withdrawal by Subject|1|||
146004245|NCT01106157|526531496|FG001|Overall Study|Withdrawal by Subject|0|||
146004246|NCT02298868|526531500|FG000|Overall Study|Adverse Event|1|||
146004247|NCT02298868|526531500|FG000|Overall Study|Death|1|||
146004248|NCT02298868|526531500|FG000|Overall Study|Patient underwent transplant|1|||
146004249|NCT01000506|526531501|FG000|Overall Study|Adverse Event|6|||
146004250|NCT01000506|526531502|FG001|Overall Study|Adverse Event|5|||
146004251|NCT01000506|526531503|FG002|Overall Study|Adverse Event|8|||
146004252|NCT01000506|526531504|FG003|Overall Study|Adverse Event|9|||
146004253|NCT01000506|526531501|FG000|Overall Study|Lack of Efficacy|8|||
146004254|NCT01000506|526531502|FG001|Overall Study|Lack of Efficacy|6|||
146004255|NCT01000506|526531503|FG002|Overall Study|Lack of Efficacy|4|||
146004256|NCT01000506|526531504|FG003|Overall Study|Lack of Efficacy|4|||
146004257|NCT01000506|526531501|FG000|Overall Study|Protocol Violation|1|||
146004258|NCT01000506|526531502|FG001|Overall Study|Protocol Violation|1|||
146004259|NCT01000506|526531503|FG002|Overall Study|Protocol Violation|0|||
146004260|NCT01000506|526531504|FG003|Overall Study|Protocol Violation|0|||
146004261|NCT01000506|526531501|FG000|Overall Study|Lost to Follow-up|1|||
146004262|NCT01000506|526531502|FG001|Overall Study|Lost to Follow-up|1|||
146004263|NCT01000506|526531503|FG002|Overall Study|Lost to Follow-up|4|||
146004264|NCT01000506|526531504|FG003|Overall Study|Lost to Follow-up|0|||
146004265|NCT01000506|526531501|FG000|Overall Study|Physician Decision|1|||
146004266|NCT01000506|526531502|FG001|Overall Study|Physician Decision|3|||
146004267|NCT01000506|526531503|FG002|Overall Study|Physician Decision|3|||
146004268|NCT01000506|526531504|FG003|Overall Study|Physician Decision|3|||
146004269|NCT01000506|526531501|FG000|Overall Study|Withdrawal by Subject|11|||
146004270|NCT01000506|526531502|FG001|Overall Study|Withdrawal by Subject|8|||
146004271|NCT01000506|526531503|FG002|Overall Study|Withdrawal by Subject|2|||
146004272|NCT01000506|526531504|FG003|Overall Study|Withdrawal by Subject|7|||
146004273|NCT03064074|526531505|FG000|Overall Study|Physician Decision|0|||
146004274|NCT03064074|526531506|FG001|Overall Study|Physician Decision|0|||
146004275|NCT03064074|526531507|FG002|Overall Study|Physician Decision|0|||
146004276|NCT03064074|526531508|FG003|Overall Study|Physician Decision|1|||
146004277|NCT02141672|526531509|FG000|Overall Study|Adverse Event|0|||
146004278|NCT02141672|526531510|FG001|Overall Study|Adverse Event|1|||
146004279|NCT02141672|526531511|FG002|Overall Study|Adverse Event|0|||
146004280|NCT02141672|526531509|FG000|Overall Study|Death|10|||
146004281|NCT02141672|526531510|FG001|Overall Study|Death|2|||
146004282|NCT02141672|526531511|FG002|Overall Study|Death|1|||
146004283|NCT02141672|526531509|FG000|Overall Study|Lack of Efficacy|0|||
146004284|NCT02141672|526531510|FG001|Overall Study|Lack of Efficacy|0|||
146004285|NCT02141672|526531511|FG002|Overall Study|Lack of Efficacy|2|||
146004286|NCT02141672|526531509|FG000|Overall Study|Lost to Follow-up|1|||
146004287|NCT02141672|526531510|FG001|Overall Study|Lost to Follow-up|1|||
146004288|NCT02141672|526531511|FG002|Overall Study|Lost to Follow-up|3|||
146004289|NCT02141672|526531509|FG000|Overall Study|Physician Decision|1|||
146004290|NCT02141672|526531510|FG001|Overall Study|Physician Decision|2|||
146004291|NCT02141672|526531511|FG002|Overall Study|Physician Decision|5|||
146004292|NCT02141672|526531509|FG000|Overall Study|Protocol Violation|0|||
146004293|NCT02141672|526531510|FG001|Overall Study|Protocol Violation|0|||
146004294|NCT02141672|526531511|FG002|Overall Study|Protocol Violation|1|||
146004295|NCT02141672|526531509|FG000|Overall Study|Withdrawal by Subject|3|||
146004296|NCT02141672|526531510|FG001|Overall Study|Withdrawal by Subject|2|||
146004297|NCT02141672|526531511|FG002|Overall Study|Withdrawal by Subject|5|||
146004298|NCT02141672|526531509|FG000|Overall Study|refused to follow-up|1|||
146004299|NCT02141672|526531510|FG001|Overall Study|refused to follow-up|0|||
146004300|NCT02141672|526531511|FG002|Overall Study|refused to follow-up|1|||
146004301|NCT01118780|526531512|FG000|Overall Study|Adverse Event|15|||
146004302|NCT01118780|526531513|FG001|Overall Study|Adverse Event|15|||
146004303|NCT01118780|526531512|FG000|Overall Study|Death|1|||
146004304|NCT01118780|526531513|FG001|Overall Study|Death|0|||
146004305|NCT01118780|526531512|FG000|Overall Study|Lack of Efficacy|2|||
146004306|NCT01118780|526531513|FG001|Overall Study|Lack of Efficacy|6|||
146004307|NCT01118780|526531512|FG000|Overall Study|Physician Decision|2|||
146004308|NCT01118780|526531513|FG001|Overall Study|Physician Decision|0|||
146004309|NCT01118780|526531512|FG000|Overall Study|Protocol Violation|3|||
146004310|NCT01118780|526531513|FG001|Overall Study|Protocol Violation|6|||
146004311|NCT01118780|526531512|FG000|Overall Study|Withdrawal by Subject|13|||
146004312|NCT01118780|526531513|FG001|Overall Study|Withdrawal by Subject|8|||
146004313|NCT00532844|526531516|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
146004314|NCT00532844|526531517|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
146004315|NCT00532844|526531516|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
146092404|NCT03963401|526860294|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
146004316|NCT00532844|526531517|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
146004317|NCT00532844|526531516|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
146004318|NCT00532844|526531517|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
146004319|NCT00532844|526531516|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
146004320|NCT00532844|526531517|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
146004321|NCT00532844|526531516|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
146004322|NCT00532844|526531517|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
146004323|NCT04389866|526531520|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
146004324|NCT04389866|526531521|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
146004325|NCT04940130|526531527|FG000|Overall Study|Travel|1|||
146004326|NCT04940130|526531528|FG001|Overall Study|Travel|0|||
146004327|NCT04940130|526531529|FG002|Overall Study|Travel|2|||
146004328|NCT04940130|526531527|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
146004329|NCT04940130|526531528|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
146004330|NCT04940130|526531529|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
146004331|NCT04940130|526531527|FG000|Overall Study|Adverse Event|0|||
146004332|NCT04940130|526531528|FG001|Overall Study|Adverse Event|0|||
146004333|NCT04940130|526531529|FG002|Overall Study|Adverse Event|2|||
146004334|NCT04940130|526531527|FG000|Overall Study|Disease progression/treatment failure|0|||
146004335|NCT04940130|526531528|FG001|Overall Study|Disease progression/treatment failure|0|||
146004336|NCT04940130|526531529|FG002|Overall Study|Disease progression/treatment failure|1|||
146004337|NCT04940130|526531527|FG000|Overall Study|Participant refusal|0|||
146004338|NCT04940130|526531528|FG001|Overall Study|Participant refusal|0|||
146004339|NCT04940130|526531529|FG002|Overall Study|Participant refusal|1|||
146004340|NCT02240121|526531532|FG000|Overall Study|Protocol Violation|1|||
146004341|NCT02240121|526531533|FG001|Overall Study|Protocol Violation|2|||
146004342|NCT02240121|526531532|FG000|Overall Study|Physician Decision|0|||
146004343|NCT02240121|526531533|FG001|Overall Study|Physician Decision|1|||
146004344|NCT02240121|526531532|FG000|Overall Study|Change in protocol interpretation|1|||
146004345|NCT02240121|526531533|FG001|Overall Study|Change in protocol interpretation|0|||
146004346|NCT02240121|526531532|FG000|Overall Study|Lack of Efficacy|2|||
146004347|NCT02240121|526531533|FG001|Overall Study|Lack of Efficacy|3|||
146004348|NCT02240121|526531532|FG000|Overall Study|Site closed|1|||
146004349|NCT02240121|526531533|FG001|Overall Study|Site closed|1|||
146004350|NCT02240121|526531532|FG000|Overall Study|Pregnancy|1|||
146004351|NCT02240121|526531533|FG001|Overall Study|Pregnancy|0|||
146004352|NCT02240121|526531532|FG000|Overall Study|Adverse Event|2|||
146004353|NCT02240121|526531533|FG001|Overall Study|Adverse Event|4|||
146004354|NCT02240121|526531532|FG000|Overall Study|Withdrawal by Subject|6|||
146004355|NCT02240121|526531533|FG001|Overall Study|Withdrawal by Subject|2|||
146004356|NCT02240121|526531532|FG000|Overall Study|Lost to Follow-up|3|||
146004357|NCT02240121|526531533|FG001|Overall Study|Lost to Follow-up|4|||
146004358|NCT02240121|526531532|FG000|Overall Study|Other than specified|1|||
146004359|NCT02240121|526531533|FG001|Overall Study|Other than specified|3|||
146004360|NCT01508910|526531535|FG000|Treatment|Death|2|||
146004361|NCT01508910|526531536|FG001|Treatment|Death|3|||
146004362|NCT01508910|526531537|FG002|Treatment|Death|2|||
146004363|NCT01508910|526531538|FG003|Treatment|Death|0|||
146004364|NCT01508910|526531535|FG000|Treatment|Lost to Follow-up|0|||
146004365|NCT01508910|526531536|FG001|Treatment|Lost to Follow-up|0|||
146004366|NCT01508910|526531537|FG002|Treatment|Lost to Follow-up|2|||
146004367|NCT01508910|526531538|FG003|Treatment|Lost to Follow-up|1|||
146004368|NCT01508910|526531535|FG000|Treatment|Withdrawal by Subject|0|||
146004369|NCT01508910|526531536|FG001|Treatment|Withdrawal by Subject|1|||
146004370|NCT01508910|526531537|FG002|Treatment|Withdrawal by Subject|6|||
146004371|NCT01508910|526531538|FG003|Treatment|Withdrawal by Subject|1|||
146004372|NCT01508910|526531535|FG000|Treatment|Sponsor Decision|0|||
146004373|NCT01508910|526531536|FG001|Treatment|Sponsor Decision|0|||
146004374|NCT01508910|526531537|FG002|Treatment|Sponsor Decision|0|||
146004375|NCT01508910|526531538|FG003|Treatment|Sponsor Decision|1|||
146004376|NCT00833027|526531540|FG000|Overall Study|Adverse Event|33|||
146298119|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
146004377|NCT00833027|526531540|FG000|Overall Study|Death|1|||
146004378|NCT00833027|526531540|FG000|Overall Study|Lack of Efficacy|12|||
146004379|NCT00833027|526531540|FG000|Overall Study|Lost to Follow-up|24|||
146004380|NCT00833027|526531540|FG000|Overall Study|Protocol Violation|115|||
146004381|NCT00833027|526531540|FG000|Overall Study|Withdrawal by Subject|16|||
146004382|NCT00833027|526531540|FG000|Overall Study|Missing|10|||
146004383|NCT03069716|526531543|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
146004384|NCT03069716|526531544|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
146298120|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
146004385|NCT03069716|526531545|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
146004386|NCT03069716|526531543|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
146004387|NCT03069716|526531544|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
146004388|NCT03069716|526531545|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
146004389|NCT03069716|526531543|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
146004390|NCT03069716|526531544|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146004391|NCT03069716|526531545|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146004392|NCT03069716|526531543|FG000|Randomized Treatment|Withdrawal by Subject|0|||
146004393|NCT03069716|526531544|FG001|Randomized Treatment|Withdrawal by Subject|2|||
146004394|NCT03069716|526531545|FG002|Randomized Treatment|Withdrawal by Subject|0|||
146004395|NCT03092479|526531546|FG000|Overall Study|Lost to Follow-up|3|||
146004396|NCT03092479|526531547|FG001|Overall Study|Lost to Follow-up|2|||
146004397|NCT03092479|526531546|FG000|Overall Study|Withdrawal by Subject|4|||
146004398|NCT03092479|526531547|FG001|Overall Study|Withdrawal by Subject|0|||
146004399|NCT03913130|526531550|FG000|Overall Study|Sponsor Decision|1|||
146004400|NCT05653700|526531551|FG000|Overall Study|Non Responders|9|||
146004401|NCT05653700|526531552|FG001|Overall Study|Non Responders|0|||
146004402|NCT01985022|526531568|FG000|Overall Study|Lost to Follow-up|0|||
146004403|NCT01985022|526531569|FG001|Overall Study|Lost to Follow-up|1|||
146004404|NCT01985022|526531568|FG000|Overall Study|Protocol Violation|0|||
146004405|NCT01985022|526531569|FG001|Overall Study|Protocol Violation|1|||
146004406|NCT01985022|526531568|FG000|Overall Study|Withdrawal by Subject|4|||
146004407|NCT01985022|526531569|FG001|Overall Study|Withdrawal by Subject|1|||
146004408|NCT04790279|526533064|FG000|Overall Study|Did not meet medication start criteria|27|||
146004409|NCT04790279|526533065|FG001|Overall Study|Did not meet medication start criteria|15|||
146004410|NCT04790279|526533064|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
146004411|NCT04790279|526533065|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
146004412|NCT04790279|526533064|FG000|Overall Study|Protocol Violation|8|||
146004413|NCT04790279|526533065|FG001|Overall Study|Protocol Violation|3|||
146004414|NCT04790279|526533064|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
146004415|NCT04790279|526533065|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
146004416|NCT00678288|526533077|FG000|Overall Study|Adverse Event|0|||
146004417|NCT00678288|526533078|FG001|Overall Study|Adverse Event|2|||
146004418|NCT00678288|526533077|FG000|Overall Study|Withdrawal by Subject|1|||
146004419|NCT00678288|526533078|FG001|Overall Study|Withdrawal by Subject|1|||
146004420|NCT00678288|526533077|FG000|Overall Study|Study terminated by the sponsor|2|||
146004421|NCT00678288|526533078|FG001|Overall Study|Study terminated by the sponsor|0|||
146004422|NCT00678288|526533077|FG000|Overall Study|Not compliant with study medication|0|||
146004423|NCT00678288|526533078|FG001|Overall Study|Not compliant with study medication|1|||
146004424|NCT00678288|526533077|FG000|Overall Study|Switch to commercial drug|0|||
146004425|NCT00678288|526533078|FG001|Overall Study|Switch to commercial drug|1|||
146004426|NCT00678288|526533077|FG000|Overall Study|Reason not reported|1|||
146004427|NCT00678288|526533078|FG001|Overall Study|Reason not reported|0|||
146004428|NCT00678288|526533077|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
146004429|NCT00678288|526533078|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
146004430|NCT02628444|526533081|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
146004431|NCT02628444|526533082|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004432|NCT02628444|526533083|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004433|NCT02628444|526533084|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004434|NCT02628444|526533085|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004435|NCT02628444|526533086|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004436|NCT02628444|526533087|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004437|NCT02628444|526533088|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004438|NCT02628444|526533089|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
146004439|NCT02628444|526533081|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004440|NCT02628444|526533082|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
146004441|NCT02628444|526533083|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
146004442|NCT02628444|526533084|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004443|NCT02628444|526533085|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004444|NCT02628444|526533086|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004445|NCT02628444|526533087|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004446|NCT02628444|526533088|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004447|NCT02628444|526533089|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
146004448|NCT02628444|526533081|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
146004449|NCT02628444|526533082|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
146004450|NCT02628444|526533083|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
146004451|NCT02628444|526533084|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004452|NCT02628444|526533085|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004453|NCT02628444|526533086|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004454|NCT02628444|526533087|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004455|NCT02628444|526533088|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146247696|NCT00103857|527419896|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
146004456|NCT02628444|526533089|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004457|NCT02628444|526533081|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
146004458|NCT02628444|526533082|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
146004459|NCT02628444|526533083|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
146004460|NCT02628444|526533084|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004461|NCT02628444|526533085|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004462|NCT02628444|526533086|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004463|NCT02628444|526533087|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004464|NCT02628444|526533088|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004465|NCT02628444|526533089|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
146004466|NCT02628444|526533081|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
146004467|NCT02628444|526533082|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
146004468|NCT02628444|526533083|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
146004469|NCT02628444|526533084|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004470|NCT02628444|526533085|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004471|NCT02628444|526533086|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004472|NCT02628444|526533087|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004473|NCT02628444|526533088|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004474|NCT02628444|526533089|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
146004475|NCT02628444|526533081|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004476|NCT02628444|526533082|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004477|NCT02628444|526533083|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004478|NCT02628444|526533084|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
146004479|NCT02628444|526533085|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004480|NCT02628444|526533086|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004481|NCT02628444|526533087|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004482|NCT02628444|526533088|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004483|NCT02628444|526533089|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
146004484|NCT02628444|526533081|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146004485|NCT02628444|526533082|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146004486|NCT02628444|526533083|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
146004487|NCT02628444|526533084|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146004488|NCT02628444|526533085|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146004489|NCT02628444|526533086|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
146004490|NCT02628444|526533087|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
146004491|NCT02628444|526533088|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
146004492|NCT02628444|526533089|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
146004493|NCT02628444|526533081|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004494|NCT02628444|526533082|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004495|NCT02628444|526533083|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
146004496|NCT02628444|526533084|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
146004497|NCT02628444|526533085|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
146004498|NCT02628444|526533086|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
146004499|NCT02628444|526533087|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
146004500|NCT02628444|526533088|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
146004501|NCT02628444|526533089|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
146004502|NCT02628444|526533081|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004503|NCT02628444|526533082|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004504|NCT02628444|526533083|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004505|NCT02628444|526533084|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004506|NCT02628444|526533085|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
146004507|NCT02628444|526533086|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004508|NCT02628444|526533087|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
146004509|NCT02628444|526533088|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
146004510|NCT02628444|526533089|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
146004511|NCT02628444|526533081|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146004512|NCT02628444|526533082|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146004513|NCT02628444|526533083|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
146004514|NCT02628444|526533084|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146092405|NCT03963401|526860295|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
146092406|NCT03963401|526860290|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146092407|NCT03963401|526860291|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146004515|NCT02628444|526533085|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146004516|NCT02628444|526533086|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
146004517|NCT02628444|526533087|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
146004518|NCT02628444|526533088|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
146004519|NCT02628444|526533089|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
146004520|NCT02079909|526533090|FG000|Overall Study|Adverse Event|23|||
146004521|NCT02079909|526533091|FG001|Overall Study|Adverse Event|23|||
146004522|NCT02079909|526533092|FG002|Overall Study|Adverse Event|7|||
146004523|NCT02079909|526533090|FG000|Overall Study|Withdrawal by Subject|9|||
146004524|NCT02079909|526533091|FG001|Overall Study|Withdrawal by Subject|17|||
146004525|NCT02079909|526533092|FG002|Overall Study|Withdrawal by Subject|4|||
146247697|NCT00103857|527419897|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
146004526|NCT02079909|526533090|FG000|Overall Study|Lost to Follow-up|2|||
146004527|NCT02079909|526533091|FG001|Overall Study|Lost to Follow-up|3|||
146004528|NCT02079909|526533092|FG002|Overall Study|Lost to Follow-up|1|||
146004529|NCT02079909|526533090|FG000|Overall Study|Death|2|||
146004530|NCT02079909|526533091|FG001|Overall Study|Death|2|||
146004531|NCT02079909|526533092|FG002|Overall Study|Death|0|||
146004532|NCT02079909|526533090|FG000|Overall Study|Lack of Efficacy|0|||
146004533|NCT02079909|526533091|FG001|Overall Study|Lack of Efficacy|0|||
146004534|NCT02079909|526533092|FG002|Overall Study|Lack of Efficacy|1|||
146004535|NCT02079909|526533090|FG000|Overall Study|Protocol Violation|0|||
146004536|NCT02079909|526533091|FG001|Overall Study|Protocol Violation|1|||
146004537|NCT02079909|526533092|FG002|Overall Study|Protocol Violation|1|||
146004538|NCT02079909|526533090|FG000|Overall Study|Physician Decision|0|||
146004539|NCT02079909|526533091|FG001|Overall Study|Physician Decision|1|||
146004540|NCT02079909|526533092|FG002|Overall Study|Physician Decision|1|||
146004541|NCT02079909|526533090|FG000|Overall Study|Relocation etc.|2|||
146004542|NCT02079909|526533091|FG001|Overall Study|Relocation etc.|2|||
146004543|NCT02079909|526533092|FG002|Overall Study|Relocation etc.|3|||
146004544|NCT00720356|526533095|FG000|Registration to Study|Determined to have methylated MGMT|67|||
146004545|NCT00720356|526533095|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146004546|NCT00720356|526533095|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
146004547|NCT00720356|526533095|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
146004548|NCT00720356|526533095|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
146004549|NCT00720356|526533095|FG000|Follow up Until Death|Withdrawal by Subject|1|||
146004550|NCT00720356|526533095|FG000|Follow up Until Death|Alive at last data collection|4|||
146004551|NCT02237001|526533098|FG000|Overall Study|Lost to Follow-up|2|||
146004552|NCT02237001|526533098|FG000|Overall Study|Withdrawal by Subject|1|||
146004553|NCT02237001|526533098|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
146004554|NCT02237001|526533098|FG000|Overall Study|Re-operation|4|||
146004555|NCT02237001|526533098|FG000|Overall Study|Incarceration|1|||
146247698|NCT00103857|527419898|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
146247699|NCT00103857|527419899|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
146247700|NCT00103857|527419900|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
146247701|NCT00103857|527419894|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
146247702|NCT00103857|527419895|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
146247703|NCT00103857|527419896|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
146247704|NCT00103857|527419897|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
146247705|NCT00103857|527419898|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
146247706|NCT00103857|527419899|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
146247707|NCT00103857|527419900|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
146247708|NCT00103857|527419894|FG000|50-Week Extension Study|patient moved|0|||
146247709|NCT00103857|527419895|FG001|50-Week Extension Study|patient moved|0|||
146247710|NCT00103857|527419896|FG002|50-Week Extension Study|patient moved|1|||
146247711|NCT00103857|527419897|FG003|50-Week Extension Study|patient moved|2|||
146247712|NCT00103857|527419898|FG004|50-Week Extension Study|patient moved|0|||
146247713|NCT00103857|527419899|FG005|50-Week Extension Study|patient moved|0|||
146247714|NCT00103857|527419900|FG006|50-Week Extension Study|patient moved|0|||
146247715|NCT00103857|527419894|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
146247716|NCT00103857|527419895|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
146247717|NCT00103857|527419896|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
146247718|NCT00103857|527419897|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
146247719|NCT00103857|527419898|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
146004556|NCT01713582|526533099|FG000|Overall Study|Disease progression|3|||
146004557|NCT01713582|526533100|FG001|Overall Study|Disease progression|3|||
146004558|NCT01713582|526533101|FG002|Overall Study|Disease progression|3|||
146004559|NCT01713582|526533102|FG003|Overall Study|Disease progression|2|||
146004560|NCT01713582|526533103|FG004|Overall Study|Disease progression|3|||
146004561|NCT01713582|526533104|FG005|Overall Study|Disease progression|3|||
146004562|NCT01713582|526533105|FG006|Overall Study|Disease progression|3|||
146004563|NCT01713582|526533106|FG007|Overall Study|Disease progression|3|||
146004564|NCT01713582|526533107|FG008|Overall Study|Disease progression|3|||
146004565|NCT01713582|526533108|FG009|Overall Study|Disease progression|11|||
146004566|NCT01713582|526533109|FG010|Overall Study|Disease progression|10|||
146004567|NCT01713582|526533110|FG011|Overall Study|Disease progression|5|||
146004568|NCT01713582|526533111|FG012|Overall Study|Disease progression|3|||
146004569|NCT01713582|526533112|FG013|Overall Study|Disease progression|3|||
146004570|NCT01713582|526533113|FG014|Overall Study|Disease progression|6|||
146004571|NCT01713582|526533114|FG015|Overall Study|Disease progression|6|||
146004572|NCT01713582|526533115|FG016|Overall Study|Disease progression|5|||
146004573|NCT01713582|526533116|FG017|Overall Study|Disease progression|2|||
146004574|NCT01713582|526533117|FG018|Overall Study|Disease progression|3|||
146004575|NCT01713582|526533118|FG019|Overall Study|Disease progression|5|||
146004576|NCT01713582|526533119|FG020|Overall Study|Disease progression|15|||
146004577|NCT01713582|526533099|FG000|Overall Study|Death|0|||
146004578|NCT01713582|526533100|FG001|Overall Study|Death|0|||
146004579|NCT01713582|526533101|FG002|Overall Study|Death|0|||
146004580|NCT01713582|526533102|FG003|Overall Study|Death|1|||
146004581|NCT01713582|526533103|FG004|Overall Study|Death|1|||
146004582|NCT01713582|526533104|FG005|Overall Study|Death|3|||
146004583|NCT01713582|526533105|FG006|Overall Study|Death|3|||
146004584|NCT01713582|526533106|FG007|Overall Study|Death|2|||
146004585|NCT01713582|526533107|FG008|Overall Study|Death|3|||
146004586|NCT01713582|526533108|FG009|Overall Study|Death|4|||
146004587|NCT01713582|526533109|FG010|Overall Study|Death|3|||
146004588|NCT01713582|526533110|FG011|Overall Study|Death|0|||
146004589|NCT01713582|526533111|FG012|Overall Study|Death|0|||
146004590|NCT01713582|526533112|FG013|Overall Study|Death|0|||
146004591|NCT01713582|526533113|FG014|Overall Study|Death|0|||
146004592|NCT01713582|526533114|FG015|Overall Study|Death|0|||
146004593|NCT01713582|526533115|FG016|Overall Study|Death|0|||
146004594|NCT01713582|526533116|FG017|Overall Study|Death|0|||
146004595|NCT01713582|526533117|FG018|Overall Study|Death|0|||
146004596|NCT01713582|526533118|FG019|Overall Study|Death|0|||
146004597|NCT01713582|526533119|FG020|Overall Study|Death|0|||
146004598|NCT01713582|526533099|FG000|Overall Study|Adverse event-related|0|||
146004599|NCT01713582|526533100|FG001|Overall Study|Adverse event-related|0|||
146004600|NCT01713582|526533101|FG002|Overall Study|Adverse event-related|0|||
146004601|NCT01713582|526533102|FG003|Overall Study|Adverse event-related|0|||
146004602|NCT01713582|526533103|FG004|Overall Study|Adverse event-related|0|||
146004603|NCT01713582|526533104|FG005|Overall Study|Adverse event-related|0|||
146004604|NCT01713582|526533105|FG006|Overall Study|Adverse event-related|0|||
146004605|NCT01713582|526533106|FG007|Overall Study|Adverse event-related|0|||
146004606|NCT01713582|526533107|FG008|Overall Study|Adverse event-related|0|||
146004607|NCT01713582|526533108|FG009|Overall Study|Adverse event-related|1|||
146004608|NCT01713582|526533109|FG010|Overall Study|Adverse event-related|1|||
146004609|NCT01713582|526533110|FG011|Overall Study|Adverse event-related|0|||
146004610|NCT01713582|526533111|FG012|Overall Study|Adverse event-related|0|||
146004611|NCT01713582|526533112|FG013|Overall Study|Adverse event-related|0|||
146004612|NCT01713582|526533113|FG014|Overall Study|Adverse event-related|0|||
146004613|NCT01713582|526533114|FG015|Overall Study|Adverse event-related|0|||
146004614|NCT01713582|526533115|FG016|Overall Study|Adverse event-related|0|||
146004615|NCT01713582|526533116|FG017|Overall Study|Adverse event-related|0|||
146004616|NCT01713582|526533117|FG018|Overall Study|Adverse event-related|1|||
146004617|NCT01713582|526533118|FG019|Overall Study|Adverse event-related|0|||
146004618|NCT01713582|526533119|FG020|Overall Study|Adverse event-related|0|||
146004619|NCT01713582|526533099|FG000|Overall Study|Adverse event-unrelated|0|||
146004620|NCT01713582|526533100|FG001|Overall Study|Adverse event-unrelated|0|||
146004621|NCT01713582|526533101|FG002|Overall Study|Adverse event-unrelated|0|||
146004622|NCT01713582|526533102|FG003|Overall Study|Adverse event-unrelated|0|||
146247720|NCT00103857|527419899|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
146247721|NCT00103857|527419900|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
146247722|NCT00103857|527419894|FG000|50-Week Extension Study|reason unspecified|0|||
146247723|NCT00103857|527419895|FG001|50-Week Extension Study|reason unspecified|0|||
146247724|NCT00103857|527419896|FG002|50-Week Extension Study|reason unspecified|0|||
146247725|NCT00103857|527419897|FG003|50-Week Extension Study|reason unspecified|0|||
146004623|NCT01713582|526533103|FG004|Overall Study|Adverse event-unrelated|0|||
146004624|NCT01713582|526533104|FG005|Overall Study|Adverse event-unrelated|1|||
146004625|NCT01713582|526533105|FG006|Overall Study|Adverse event-unrelated|1|||
146004626|NCT01713582|526533106|FG007|Overall Study|Adverse event-unrelated|1|||
146004627|NCT01713582|526533107|FG008|Overall Study|Adverse event-unrelated|0|||
146004628|NCT01713582|526533108|FG009|Overall Study|Adverse event-unrelated|0|||
146004629|NCT01713582|526533109|FG010|Overall Study|Adverse event-unrelated|0|||
146004630|NCT01713582|526533110|FG011|Overall Study|Adverse event-unrelated|0|||
146004631|NCT01713582|526533111|FG012|Overall Study|Adverse event-unrelated|0|||
146004632|NCT01713582|526533112|FG013|Overall Study|Adverse event-unrelated|1|||
146004633|NCT01713582|526533113|FG014|Overall Study|Adverse event-unrelated|1|||
146004634|NCT01713582|526533114|FG015|Overall Study|Adverse event-unrelated|0|||
146004635|NCT01713582|526533115|FG016|Overall Study|Adverse event-unrelated|0|||
146004636|NCT01713582|526533116|FG017|Overall Study|Adverse event-unrelated|0|||
146004637|NCT01713582|526533117|FG018|Overall Study|Adverse event-unrelated|0|||
146004638|NCT01713582|526533118|FG019|Overall Study|Adverse event-unrelated|0|||
146004639|NCT01713582|526533119|FG020|Overall Study|Adverse event-unrelated|0|||
146004640|NCT01713582|526533099|FG000|Overall Study|Withdrawal of consent|0|||
146004641|NCT01713582|526533100|FG001|Overall Study|Withdrawal of consent|0|||
146004642|NCT01713582|526533101|FG002|Overall Study|Withdrawal of consent|1|||
146004643|NCT01713582|526533102|FG003|Overall Study|Withdrawal of consent|0|||
146004644|NCT01713582|526533103|FG004|Overall Study|Withdrawal of consent|0|||
146004645|NCT01713582|526533104|FG005|Overall Study|Withdrawal of consent|1|||
146004646|NCT01713582|526533105|FG006|Overall Study|Withdrawal of consent|0|||
146004647|NCT01713582|526533106|FG007|Overall Study|Withdrawal of consent|0|||
146004648|NCT01713582|526533107|FG008|Overall Study|Withdrawal of consent|0|||
146004649|NCT01713582|526533108|FG009|Overall Study|Withdrawal of consent|1|||
146004650|NCT01713582|526533109|FG010|Overall Study|Withdrawal of consent|0|||
146004651|NCT01713582|526533110|FG011|Overall Study|Withdrawal of consent|0|||
146004652|NCT01713582|526533111|FG012|Overall Study|Withdrawal of consent|0|||
146004653|NCT01713582|526533112|FG013|Overall Study|Withdrawal of consent|0|||
146004654|NCT01713582|526533113|FG014|Overall Study|Withdrawal of consent|0|||
146004655|NCT01713582|526533114|FG015|Overall Study|Withdrawal of consent|0|||
146004656|NCT01713582|526533115|FG016|Overall Study|Withdrawal of consent|0|||
146004657|NCT01713582|526533116|FG017|Overall Study|Withdrawal of consent|0|||
146004658|NCT01713582|526533117|FG018|Overall Study|Withdrawal of consent|1|||
146004659|NCT01713582|526533118|FG019|Overall Study|Withdrawal of consent|0|||
146004660|NCT01713582|526533119|FG020|Overall Study|Withdrawal of consent|0|||
146004661|NCT01713582|526533099|FG000|Overall Study|Lack of Efficacy|0|||
146004662|NCT01713582|526533100|FG001|Overall Study|Lack of Efficacy|0|||
146004663|NCT01713582|526533101|FG002|Overall Study|Lack of Efficacy|0|||
146004664|NCT01713582|526533102|FG003|Overall Study|Lack of Efficacy|0|||
146004665|NCT01713582|526533103|FG004|Overall Study|Lack of Efficacy|0|||
146004666|NCT01713582|526533104|FG005|Overall Study|Lack of Efficacy|0|||
146004667|NCT01713582|526533105|FG006|Overall Study|Lack of Efficacy|0|||
146004668|NCT01713582|526533106|FG007|Overall Study|Lack of Efficacy|0|||
146004669|NCT01713582|526533107|FG008|Overall Study|Lack of Efficacy|0|||
146004670|NCT01713582|526533108|FG009|Overall Study|Lack of Efficacy|1|||
146004671|NCT01713582|526533109|FG010|Overall Study|Lack of Efficacy|2|||
146004672|NCT01713582|526533110|FG011|Overall Study|Lack of Efficacy|0|||
146004673|NCT01713582|526533111|FG012|Overall Study|Lack of Efficacy|0|||
146004674|NCT01713582|526533112|FG013|Overall Study|Lack of Efficacy|0|||
146004675|NCT01713582|526533113|FG014|Overall Study|Lack of Efficacy|0|||
146004676|NCT01713582|526533114|FG015|Overall Study|Lack of Efficacy|0|||
146004677|NCT01713582|526533115|FG016|Overall Study|Lack of Efficacy|0|||
146004678|NCT01713582|526533116|FG017|Overall Study|Lack of Efficacy|0|||
146004679|NCT01713582|526533117|FG018|Overall Study|Lack of Efficacy|0|||
146004680|NCT01713582|526533118|FG019|Overall Study|Lack of Efficacy|0|||
146004681|NCT01713582|526533119|FG020|Overall Study|Lack of Efficacy|0|||
146004682|NCT01713582|526533099|FG000|Overall Study|Withdrawal by Subject|0|||
146004683|NCT01713582|526533100|FG001|Overall Study|Withdrawal by Subject|0|||
146004684|NCT01713582|526533101|FG002|Overall Study|Withdrawal by Subject|0|||
146004685|NCT01713582|526533102|FG003|Overall Study|Withdrawal by Subject|0|||
146004686|NCT01713582|526533103|FG004|Overall Study|Withdrawal by Subject|0|||
146004687|NCT01713582|526533104|FG005|Overall Study|Withdrawal by Subject|0|||
146004688|NCT01713582|526533105|FG006|Overall Study|Withdrawal by Subject|0|||
146004689|NCT01713582|526533106|FG007|Overall Study|Withdrawal by Subject|0|||
146004690|NCT01713582|526533107|FG008|Overall Study|Withdrawal by Subject|0|||
146004691|NCT01713582|526533108|FG009|Overall Study|Withdrawal by Subject|0|||
146004692|NCT01713582|526533109|FG010|Overall Study|Withdrawal by Subject|0|||
146004693|NCT01713582|526533110|FG011|Overall Study|Withdrawal by Subject|0|||
146004694|NCT01713582|526533111|FG012|Overall Study|Withdrawal by Subject|0|||
146004695|NCT01713582|526533112|FG013|Overall Study|Withdrawal by Subject|0|||
146004696|NCT01713582|526533113|FG014|Overall Study|Withdrawal by Subject|0|||
146004697|NCT01713582|526533114|FG015|Overall Study|Withdrawal by Subject|0|||
146004698|NCT01713582|526533115|FG016|Overall Study|Withdrawal by Subject|0|||
146004699|NCT01713582|526533116|FG017|Overall Study|Withdrawal by Subject|1|||
146247726|NCT00103857|527419898|FG004|50-Week Extension Study|reason unspecified|1|||
146004700|NCT01713582|526533117|FG018|Overall Study|Withdrawal by Subject|0|||
146004701|NCT01713582|526533118|FG019|Overall Study|Withdrawal by Subject|0|||
146004702|NCT01713582|526533119|FG020|Overall Study|Withdrawal by Subject|0|||
146004703|NCT01713582|526533099|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
146004704|NCT01713582|526533100|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
146004705|NCT01713582|526533101|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
146004706|NCT01713582|526533102|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
146004707|NCT01713582|526533103|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
146004708|NCT01713582|526533104|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
146004709|NCT01713582|526533105|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
146004710|NCT01713582|526533106|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
146004711|NCT01713582|526533107|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
146004712|NCT01713582|526533108|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
146004713|NCT01713582|526533109|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
146298121|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
146298122|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
146298123|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Study suspension|0|||
146298124|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Study suspension|45|||
146298125|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Study suspension|0|||
146004714|NCT01713582|526533110|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
146004715|NCT01713582|526533111|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
146004716|NCT01713582|526533112|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
146004717|NCT01713582|526533113|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
146004718|NCT01713582|526533114|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
146004719|NCT01713582|526533115|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
146004720|NCT01713582|526533116|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
146004721|NCT01713582|526533117|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
146004722|NCT01713582|526533118|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
146004723|NCT01713582|526533119|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
146004724|NCT01713582|526533099|FG000|Overall Study|Disease progression and adverse event|0|||
146004725|NCT01713582|526533100|FG001|Overall Study|Disease progression and adverse event|0|||
146004726|NCT01713582|526533101|FG002|Overall Study|Disease progression and adverse event|0|||
146004727|NCT01713582|526533102|FG003|Overall Study|Disease progression and adverse event|0|||
146004728|NCT01713582|526533103|FG004|Overall Study|Disease progression and adverse event|0|||
146004729|NCT01713582|526533104|FG005|Overall Study|Disease progression and adverse event|0|||
146004730|NCT01713582|526533105|FG006|Overall Study|Disease progression and adverse event|0|||
146004731|NCT01713582|526533106|FG007|Overall Study|Disease progression and adverse event|0|||
146004732|NCT01713582|526533107|FG008|Overall Study|Disease progression and adverse event|0|||
146004733|NCT01713582|526533108|FG009|Overall Study|Disease progression and adverse event|0|||
146004734|NCT01713582|526533109|FG010|Overall Study|Disease progression and adverse event|0|||
146004735|NCT01713582|526533110|FG011|Overall Study|Disease progression and adverse event|0|||
146004736|NCT01713582|526533111|FG012|Overall Study|Disease progression and adverse event|0|||
146004737|NCT01713582|526533112|FG013|Overall Study|Disease progression and adverse event|0|||
146004738|NCT01713582|526533113|FG014|Overall Study|Disease progression and adverse event|0|||
146004739|NCT01713582|526533114|FG015|Overall Study|Disease progression and adverse event|0|||
146004740|NCT01713582|526533115|FG016|Overall Study|Disease progression and adverse event|1|||
146004741|NCT01713582|526533116|FG017|Overall Study|Disease progression and adverse event|0|||
146004742|NCT01713582|526533117|FG018|Overall Study|Disease progression and adverse event|0|||
146004743|NCT01713582|526533118|FG019|Overall Study|Disease progression and adverse event|0|||
146004744|NCT01713582|526533119|FG020|Overall Study|Disease progression and adverse event|0|||
146004745|NCT03427814|526533122|FG000|Overall Study|Withdrawal by Subject|4|||
146004746|NCT03427814|526533123|FG001|Overall Study|Withdrawal by Subject|4|||
146004747|NCT03427814|526533122|FG000|Overall Study|Lost to Follow-up|0|||
146004748|NCT03427814|526533123|FG001|Overall Study|Lost to Follow-up|2|||
146004749|NCT03427814|526533122|FG000|Overall Study|Death|42|||
146004750|NCT03427814|526533123|FG001|Overall Study|Death|31|||
146004751|NCT03427814|526533122|FG000|Overall Study|Sponsor's Decision|1|||
146004752|NCT03427814|526533123|FG001|Overall Study|Sponsor's Decision|0|||
146004753|NCT03427814|526533122|FG000|Overall Study|Investigator's Decision|1|||
146004754|NCT03427814|526533123|FG001|Overall Study|Investigator's Decision|2|||
146004755|NCT03427814|526533122|FG000|Overall Study|Disease progression|1|||
146004756|NCT03427814|526533123|FG001|Overall Study|Disease progression|0|||
146004757|NCT03427814|526533122|FG000|Overall Study|Treatment Completed|0|||
146004758|NCT03427814|526533123|FG001|Overall Study|Treatment Completed|1|||
146004759|NCT03427814|526533122|FG000|Overall Study|Sponsor's Decision to End study|21|||
146004760|NCT03427814|526533123|FG001|Overall Study|Sponsor's Decision to End study|25|||
146004761|NCT03427814|526533122|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
146004762|NCT03427814|526533123|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
146004763|NCT03846427|526533124|FG000|Overall Study|Death|13|||
146004764|NCT03846427|526533124|FG000|Overall Study|Withdrawal by Subject|3|||
146004765|NCT03846427|526533124|FG000|Overall Study|Physician Decision|1|||
146004766|NCT00488514|526533125|FG000|Overall Study|Adverse Event|41|||
146004767|NCT00488514|526533125|FG000|Overall Study|Lost to Follow-up|44|||
146004768|NCT00488514|526533125|FG000|Overall Study|Protocol Violation|32|||
146004769|NCT00488514|526533125|FG000|Overall Study|Withdrawal by Subject|106|||
146004770|NCT00488514|526533125|FG000|Overall Study|Lack of Efficacy|28|||
146004771|NCT00488514|526533125|FG000|Overall Study|Did not meet criteria for treatment|30|||
146004772|NCT00488514|526533125|FG000|Overall Study|Postive drug screen|1|||
146004773|NCT00488514|526533125|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
146004774|NCT00488514|526533125|FG000|Overall Study|Investigator decision|1|||
146004775|NCT00488514|526533125|FG000|Overall Study|Participant had too few migraines|5|||
146004776|NCT00488514|526533125|FG000|Overall Study|Increase in number of migraines|2|||
146004777|NCT00488514|526533125|FG000|Overall Study|Increased use of concomitant medication|1|||
146004778|NCT04971967|526533130|FG000|Overall Study|Lost to Follow-up|6|||
146004779|NCT04971967|526533131|FG001|Overall Study|Lost to Follow-up|7|||
146004780|NCT01475721|526533134|FG000|Overall Study|Death|3|||
146004781|NCT01475721|526533135|FG001|Overall Study|Death|6|||
146004782|NCT01475721|526533134|FG000|Overall Study|Withdrawal by Subject|8|||
146004783|NCT01475721|526533135|FG001|Overall Study|Withdrawal by Subject|8|||
146004784|NCT02364037|526533136|FG000|Overall Study|Withdrawal by Subject|7|||
146004785|NCT02364037|526533137|FG001|Overall Study|Withdrawal by Subject|4|||
146004786|NCT02364037|526533136|FG000|Overall Study|Lost to Follow-up|37|||
146004787|NCT02364037|526533137|FG001|Overall Study|Lost to Follow-up|49|||
146004788|NCT01772550|526533138|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
146004789|NCT01772550|526533139|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
146004790|NCT01772550|526533140|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
146004791|NCT01772550|526533138|FG000|Overall Study|Adverse Event|0|||
146004792|NCT01772550|526533139|FG001|Overall Study|Adverse Event|0|||
146004793|NCT01772550|526533140|FG002|Overall Study|Adverse Event|1|||
146004794|NCT00559104|526533141|FG000|Overall Study|Lack of Efficacy|9|||
146004795|NCT00559104|526533142|FG001|Overall Study|Lack of Efficacy|0|||
146004796|NCT00387088|526533143|FG000|Overall Study|Adverse Event|143|||
146004797|NCT00387088|526533144|FG001|Overall Study|Adverse Event|156|||
146004798|NCT00387088|526533143|FG000|Overall Study|Protocol Violation|47|||
146004799|NCT00387088|526533144|FG001|Overall Study|Protocol Violation|35|||
146004800|NCT00387088|526533143|FG000|Overall Study|Withdrawal by Subject|20|||
146004801|NCT00387088|526533144|FG001|Overall Study|Withdrawal by Subject|35|||
146004802|NCT00387088|526533143|FG000|Overall Study|Lack of Efficacy|28|||
146004803|NCT00387088|526533144|FG001|Overall Study|Lack of Efficacy|67|||
146004804|NCT00387088|526533143|FG000|Overall Study|Lost to Follow-up|22|||
146004805|NCT00387088|526533144|FG001|Overall Study|Lost to Follow-up|28|||
146004806|NCT00387088|526533143|FG000|Overall Study|Other|58|||
146004807|NCT00387088|526533144|FG001|Overall Study|Other|52|||
146004808|NCT00856635|526533149|FG000|Overall Study|Lost to Follow-up|2|||
146004809|NCT00856635|526533150|FG001|Overall Study|Lost to Follow-up|5|||
146004810|NCT00856635|526533149|FG000|Overall Study|Pregnancy|1|||
146004811|NCT00856635|526533150|FG001|Overall Study|Pregnancy|0|||
146004812|NCT00856635|526533149|FG000|Overall Study|Withdrawal by Subject|3|||
146004813|NCT00856635|526533150|FG001|Overall Study|Withdrawal by Subject|1|||
146004814|NCT00856635|526533149|FG000|Overall Study|Serious Adverse Event|1|||
146004815|NCT00856635|526533150|FG001|Overall Study|Serious Adverse Event|0|||
146004816|NCT00856635|526533149|FG000|Overall Study|Other|1|||
146004817|NCT00856635|526533150|FG001|Overall Study|Other|0|||
146004818|NCT00856635|526533149|FG000|Overall Study|Discontinued at Randomization|2|||
146004819|NCT00856635|526533150|FG001|Overall Study|Discontinued at Randomization|2|||
146004820|NCT00347932|526533151|FG000|Overall Study|Adverse Event|4|||
146004821|NCT00347932|526533152|FG001|Overall Study|Adverse Event|5|||
146004822|NCT00347932|526533151|FG000|Overall Study|Lack of Efficacy|3|||
146004823|NCT00347932|526533152|FG001|Overall Study|Lack of Efficacy|14|||
146004824|NCT00347932|526533151|FG000|Overall Study|Lost to Follow-up|10|||
146004825|NCT00347932|526533152|FG001|Overall Study|Lost to Follow-up|9|||
146004826|NCT00347932|526533151|FG000|Overall Study|Withdrawal by Subject|10|||
146004827|NCT00347932|526533152|FG001|Overall Study|Withdrawal by Subject|16|||
146004828|NCT00347932|526533151|FG000|Overall Study|Did not meet inclusion criteria|4|||
146004829|NCT00347932|526533152|FG001|Overall Study|Did not meet inclusion criteria|8|||
146004830|NCT00400517|526533153|FG000|Overall Study|Withdrawal by Subject|1|||
146004831|NCT00400517|526533153|FG000|Overall Study|Physician Decision|1|||
146004832|NCT02457247|526533156|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
146004833|NCT02457247|526533157|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
146004834|NCT02457247|526533158|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
146004835|NCT02457247|526533159|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
146004836|NCT02457247|526533156|FG000|Period 1|Significant Protocol Deviation|1|||
146004837|NCT02457247|526533157|FG001|Period 1|Significant Protocol Deviation|1|||
146004838|NCT02457247|526533158|FG002|Period 1|Significant Protocol Deviation|0|||
146004839|NCT02457247|526533159|FG003|Period 1|Significant Protocol Deviation|0|||
146092408|NCT03963401|526860292|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
146004840|NCT02457247|526533156|FG000|Period 1|Voluntary Withdrawal|1|||
146004841|NCT02457247|526533157|FG001|Period 1|Voluntary Withdrawal|0|||
146004842|NCT02457247|526533158|FG002|Period 1|Voluntary Withdrawal|0|||
146004843|NCT02457247|526533159|FG003|Period 1|Voluntary Withdrawal|0|||
146004844|NCT02457247|526533156|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
146004845|NCT02457247|526533157|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
146004846|NCT02457247|526533158|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
146004847|NCT02457247|526533159|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
146004848|NCT02457247|526533156|FG000|Period 2|Significant Protocol Deviation|1|||
146004849|NCT02457247|526533157|FG001|Period 2|Significant Protocol Deviation|0|||
146004850|NCT02457247|526533158|FG002|Period 2|Significant Protocol Deviation|0|||
146004851|NCT02457247|526533159|FG003|Period 2|Significant Protocol Deviation|0|||
146004852|NCT02457247|526533156|FG000|Period 2|Lost to Follow-up|0|||
146004853|NCT02457247|526533157|FG001|Period 2|Lost to Follow-up|1|||
146004854|NCT02457247|526533158|FG002|Period 2|Lost to Follow-up|0|||
146004855|NCT02457247|526533159|FG003|Period 2|Lost to Follow-up|0|||
146004856|NCT02457247|526533156|FG000|Period 2|Voluntary Withdrawal|1|||
146004857|NCT02457247|526533157|FG001|Period 2|Voluntary Withdrawal|1|||
146004858|NCT02457247|526533158|FG002|Period 2|Voluntary Withdrawal|0|||
146004859|NCT02457247|526533159|FG003|Period 2|Voluntary Withdrawal|0|||
146004860|NCT02954887|526533160|FG000|Overall Study|Withdrawal by Subject|3|||
146004861|NCT02954887|526533160|FG000|Overall Study|Lack of Efficacy|3|||
146004862|NCT02954887|526533160|FG000|Overall Study|Other|1|||
146004863|NCT01061385|526533161|FG000|Overall Study|Lost to Follow-up|1|||
146004864|NCT01061385|526533162|FG001|Overall Study|Lost to Follow-up|0|||
146004865|NCT01061385|526533161|FG000|Overall Study|subject decision not related to AE|0|||
146004866|NCT01061385|526533162|FG001|Overall Study|subject decision not related to AE|1|||
146004867|NCT02803203|526533163|FG000|Overall Study|Adverse Event|4|||
146004868|NCT02803203|526533163|FG000|Overall Study|Death|4|||
146004869|NCT02803203|526533163|FG000|Overall Study|Progressive disease|29|||
146004870|NCT02803203|526533163|FG000|Overall Study|Withdrawal by Subject|8|||
146004871|NCT02803203|526533163|FG000|Overall Study|Complete resection of target disease|2|||
146004872|NCT02803203|526533163|FG000|Overall Study|Switched to commercial Osi|1|||
146004873|NCT02803203|526533163|FG000|Overall Study|Participant moved away|1|||
146004874|NCT02655887|526533170|FG000|Overall Study|Lost to Follow-up|3|||
146004875|NCT02655887|526533170|FG000|Overall Study|Death|4|||
146004876|NCT02655887|526533170|FG000|Overall Study|Withdrawal by Subject|3|||
146004877|NCT02655887|526533170|FG000|Overall Study|Missed 12-month follow-up visit|4|||
146004878|NCT00600067|526533183|FG000|Overall Study|Adverse Event|0|||
146004879|NCT00600067|526533184|FG001|Overall Study|Adverse Event|1|||
146004880|NCT00600067|526533183|FG000|Overall Study|Lost to Follow-up|2|||
146004881|NCT00600067|526533184|FG001|Overall Study|Lost to Follow-up|3|||
146004882|NCT00600067|526533183|FG000|Overall Study|protocol non-compliance|0|||
146004883|NCT00600067|526533184|FG001|Overall Study|protocol non-compliance|3|||
146004884|NCT00600067|526533183|FG000|Overall Study|Lack of Efficacy|1|||
146004885|NCT00600067|526533184|FG001|Overall Study|Lack of Efficacy|0|||
146004886|NCT04571060|526533190|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
146004887|NCT04571060|526533191|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
146004888|NCT04571060|526533190|FG000|Overall Study|Never treated migraine|47|||
146004889|NCT04571060|526533191|FG001|Overall Study|Never treated migraine|36|||
146004890|NCT04571060|526533190|FG000|Overall Study|Protocol Violation|4|||
146004891|NCT04571060|526533191|FG001|Overall Study|Protocol Violation|2|||
146004892|NCT04571060|526533190|FG000|Overall Study|Withdrawal by Subject|6|||
146004893|NCT04571060|526533191|FG001|Overall Study|Withdrawal by Subject|2|||
146004894|NCT04571060|526533190|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
146004895|NCT04571060|526533191|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
146004896|NCT01220401|526533195|FG000|Overall Study|Withdrawal by Subject|2|||
146004897|NCT01220401|526533195|FG000|Overall Study|Protocol Violation|1|||
146004898|NCT01070979|526533196|FG000|Overall Study|Adverse Event|2|||
146004899|NCT01070979|526533197|FG001|Overall Study|Adverse Event|3|||
146004900|NCT01070979|526533198|FG002|Overall Study|Adverse Event|3|||
146004901|NCT01070979|526533196|FG000|Overall Study|Lost to Follow-up|2|||
146004902|NCT01070979|526533197|FG001|Overall Study|Lost to Follow-up|1|||
146004903|NCT01070979|526533198|FG002|Overall Study|Lost to Follow-up|1|||
146004904|NCT01070979|526533196|FG000|Overall Study|Protocol Violation|0|||
146004905|NCT01070979|526533197|FG001|Overall Study|Protocol Violation|2|||
146004906|NCT01070979|526533198|FG002|Overall Study|Protocol Violation|6|||
146004907|NCT01070979|526533196|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
146004908|NCT01070979|526533197|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
146004909|NCT01070979|526533198|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
146004910|NCT01070979|526533196|FG000|Overall Study|Withdrawal by Subject|3|||
146004911|NCT01070979|526533197|FG001|Overall Study|Withdrawal by Subject|1|||
146004912|NCT01070979|526533198|FG002|Overall Study|Withdrawal by Subject|1|||
146004913|NCT01070979|526533196|FG000|Overall Study|No study drug taken|0|||
146004914|NCT01070979|526533197|FG001|Overall Study|No study drug taken|1|||
146004915|NCT01070979|526533198|FG002|Overall Study|No study drug taken|0|||
146004916|NCT00142792|526533199|FG000|Overall Study|Death|0|||
146004917|NCT00142792|526533200|FG001|Overall Study|Death|0|||
146004918|NCT00142792|526533201|FG002|Overall Study|Death|1|||
146004919|NCT00142792|526533199|FG000|Overall Study|Withdrawal by Subject|3|||
146004920|NCT00142792|526533200|FG001|Overall Study|Withdrawal by Subject|2|||
146004921|NCT00142792|526533201|FG002|Overall Study|Withdrawal by Subject|3|||
146004922|NCT00142792|526533199|FG000|Overall Study|Lost to Follow-up|8|||
146004923|NCT00142792|526533200|FG001|Overall Study|Lost to Follow-up|11|||
146004924|NCT00142792|526533201|FG002|Overall Study|Lost to Follow-up|7|||
146004925|NCT00142792|526533199|FG000|Overall Study|No category|1|||
146004926|NCT00142792|526533200|FG001|Overall Study|No category|2|||
146004927|NCT00142792|526533201|FG002|Overall Study|No category|1|||
146004928|NCT04819113|526533202|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146004929|NCT04819113|526533202|FG000|Overall Study|Lost to Follow-up|1|||
146004930|NCT04819113|526533202|FG000|Overall Study|Withdrawn before vaccination|2|||
146004931|NCT00437268|526533203|FG000|Overall Study|Adverse Event|1|||
146004932|NCT00437268|526533204|FG001|Overall Study|Adverse Event|1|||
146004933|NCT00437268|526533203|FG000|Overall Study|Withdrawal by Subject|2|||
146004934|NCT00437268|526533204|FG001|Overall Study|Withdrawal by Subject|2|||
146004935|NCT00437268|526533203|FG000|Overall Study|Progressive disease|9|||
146004936|NCT00437268|526533204|FG001|Overall Study|Progressive disease|9|||
146004937|NCT00437268|526533203|FG000|Overall Study|Physician Decision|1|||
146004938|NCT00437268|526533204|FG001|Overall Study|Physician Decision|0|||
146004939|NCT00437268|526533203|FG000|Overall Study|Death|0|||
146004940|NCT00437268|526533204|FG001|Overall Study|Death|1|||
146004941|NCT00444925|526533209|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
146004942|NCT00444925|526533210|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
146004943|NCT00444925|526533211|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
146004944|NCT00444925|526533209|FG000|Double-blind Treatment Period|Death|2|||
146004945|NCT00444925|526533210|FG001|Double-blind Treatment Period|Death|0|||
146004946|NCT00444925|526533211|FG002|Double-blind Treatment Period|Death|0|||
146004947|NCT00444925|526533209|FG000|Double-blind Treatment Period|Adverse Event|6|||
146004948|NCT00444925|526533210|FG001|Double-blind Treatment Period|Adverse Event|28|||
146004949|NCT00444925|526533211|FG002|Double-blind Treatment Period|Adverse Event|44|||
146004950|NCT00444925|526533209|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
146004951|NCT00444925|526533210|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
146004952|NCT00444925|526533211|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
146004953|NCT00444925|526533209|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
146004954|NCT00444925|526533210|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
146004955|NCT00444925|526533211|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
146004956|NCT00444925|526533209|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
146004957|NCT00444925|526533210|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
146004958|NCT00444925|526533211|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
146004959|NCT00444925|526533209|FG000|Double-blind Treatment Period|Other|7|||
146004960|NCT00444925|526533210|FG001|Double-blind Treatment Period|Other|7|||
146004961|NCT00444925|526533211|FG002|Double-blind Treatment Period|Other|12|||
146004962|NCT01342094|526533214|FG000|Overall Study|Adverse Event|5|||
146004963|NCT01342094|526533215|FG001|Overall Study|Adverse Event|0|||
146004964|NCT01342094|526533214|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146004965|NCT01342094|526533215|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146004966|NCT01342094|526533214|FG000|Overall Study|Withdrawal by Subject|0|||
146004967|NCT01342094|526533215|FG001|Overall Study|Withdrawal by Subject|2|||
146004968|NCT02806414|526533216|FG000|Overall Study|Lost to Follow-up|2|||
146004969|NCT02573948|526533227|FG000|Longitudinal Cohort|Death|9|||
146004970|NCT02573948|526533227|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
146004971|NCT02573948|526533227|FG000|Longitudinal Cohort|Incarcerated|25|||
146004972|NCT01673126|526533228|FG000|Overall Study|change of diagnosis|4|||
146004973|NCT01673126|526533229|FG001|Overall Study|change of diagnosis|3|||
146004974|NCT01913327|526533234|FG000|Overall Study|Withdrawal by Subject|0|||
146004975|NCT01913327|526533235|FG001|Overall Study|Withdrawal by Subject|1|||
146004976|NCT00628446|526534914|FG000|Overall Study|Lost to Follow-up|3|||
146004977|NCT00628446|526534914|FG000|Overall Study|Withdrawal by Subject|1|||
146004978|NCT00628446|526534914|FG000|Overall Study|Protocol Violation|3|||
146004979|NCT00756275|526534915|FG000|Overall Study|Lost to Follow-up|25|||
146004980|NCT00756275|526534916|FG001|Overall Study|Lost to Follow-up|21|||
146004981|NCT00756275|526534915|FG000|Overall Study|Withdrawal by Subject|4|||
146004982|NCT00756275|526534916|FG001|Overall Study|Withdrawal by Subject|7|||
146004983|NCT00551031|526534917|FG000|Overall Study|Adverse Event|0|||
146004984|NCT00551031|526534918|FG001|Overall Study|Adverse Event|1|||
146004985|NCT00551031|526534919|FG002|Overall Study|Adverse Event|0|||
146004986|NCT00551031|526534920|FG003|Overall Study|Adverse Event|0|||
146004987|NCT00551031|526534921|FG004|Overall Study|Adverse Event|0|||
146004988|NCT00551031|526534917|FG000|Overall Study|Protocol Violation|1|||
146004989|NCT00551031|526534918|FG001|Overall Study|Protocol Violation|1|||
146004990|NCT00551031|526534919|FG002|Overall Study|Protocol Violation|0|||
146004991|NCT00551031|526534920|FG003|Overall Study|Protocol Violation|0|||
146004992|NCT00551031|526534921|FG004|Overall Study|Protocol Violation|0|||
146004993|NCT00551031|526534917|FG000|Overall Study|Lost to Follow-up|0|||
146004994|NCT00551031|526534918|FG001|Overall Study|Lost to Follow-up|1|||
146004995|NCT00551031|526534919|FG002|Overall Study|Lost to Follow-up|0|||
146004996|NCT00551031|526534920|FG003|Overall Study|Lost to Follow-up|1|||
146004997|NCT00551031|526534921|FG004|Overall Study|Lost to Follow-up|1|||
146004998|NCT00551031|526534917|FG000|Overall Study|Withdrawal by Subject|0|||
146004999|NCT00551031|526534918|FG001|Overall Study|Withdrawal by Subject|4|||
146005000|NCT00551031|526534919|FG002|Overall Study|Withdrawal by Subject|1|||
146005001|NCT00551031|526534920|FG003|Overall Study|Withdrawal by Subject|2|||
146005002|NCT00551031|526534921|FG004|Overall Study|Withdrawal by Subject|0|||
146005003|NCT00551031|526534917|FG000|Overall Study|Serious Adverse Event|0|||
146005004|NCT00551031|526534918|FG001|Overall Study|Serious Adverse Event|2|||
146005005|NCT00551031|526534919|FG002|Overall Study|Serious Adverse Event|1|||
146005006|NCT00551031|526534920|FG003|Overall Study|Serious Adverse Event|0|||
146005007|NCT00551031|526534921|FG004|Overall Study|Serious Adverse Event|0|||
146005008|NCT00551031|526534917|FG000|Overall Study|Did not receive vaccine|1|||
146005009|NCT00551031|526534918|FG001|Overall Study|Did not receive vaccine|2|||
146005010|NCT00551031|526534919|FG002|Overall Study|Did not receive vaccine|0|||
146005011|NCT00551031|526534920|FG003|Overall Study|Did not receive vaccine|0|||
146005012|NCT00551031|526534921|FG004|Overall Study|Did not receive vaccine|0|||
146005013|NCT00682929|526534926|FG000|Overall Study|Adverse Event|4|||
146005014|NCT00682929|526534927|FG001|Overall Study|Adverse Event|1|||
146005015|NCT00682929|526534928|FG002|Overall Study|Adverse Event|1|||
146005016|NCT00682929|526534926|FG000|Overall Study|Withdrawal by Subject|1|||
146005017|NCT00682929|526534927|FG001|Overall Study|Withdrawal by Subject|2|||
146005018|NCT00682929|526534928|FG002|Overall Study|Withdrawal by Subject|1|||
146005019|NCT00682929|526534926|FG000|Overall Study|dosing compliance < 80%|0|||
146005020|NCT00682929|526534927|FG001|Overall Study|dosing compliance < 80%|2|||
146005021|NCT00682929|526534928|FG002|Overall Study|dosing compliance < 80%|0|||
146005022|NCT00682929|526534926|FG000|Overall Study|lag in DEA renewal|1|||
146005023|NCT00682929|526534927|FG001|Overall Study|lag in DEA renewal|0|||
146005024|NCT00682929|526534928|FG002|Overall Study|lag in DEA renewal|0|||
146005025|NCT00456755|526534933|FG000|Overall Study|Lost to Follow-up|2|||
146005026|NCT00456755|526534934|FG001|Overall Study|Lost to Follow-up|1|||
146005027|NCT04072835|526534939|FG000|Overall Study|Overall trial ended|603|||
146005028|NCT04072835|526534939|FG000|Overall Study|Ablation|97|||
146005029|NCT04072835|526534939|FG000|Overall Study|Withdrawal of consent|66|||
146005030|NCT04072835|526534939|FG000|Overall Study|Physician Decision|50|||
146005031|NCT04072835|526534939|FG000|Overall Study|Lost to Follow-up|39|||
146005032|NCT04072835|526534939|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
146005033|NCT04072835|526534939|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
146005034|NCT04072835|526534939|FG000|Overall Study|Adverse Event|25|||
146005035|NCT04072835|526534939|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
146005036|NCT04072835|526534939|FG000|Overall Study|Death|11|||
146005037|NCT04072835|526534939|FG000|Overall Study|Participant felt the drug did not work|8|||
146005038|NCT04072835|526534939|FG000|Overall Study|Participant tolerability|5|||
146005039|NCT04072835|526534939|FG000|Overall Study|Missing|5|||
146005040|NCT04072835|526534939|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
146005041|NCT04072835|526534939|FG000|Overall Study|Pregnancy|3|||
146005042|NCT00399568|526534940|FG000|Overall Study|Adverse Event|1|||
146005043|NCT00399568|526534941|FG001|Overall Study|Adverse Event|2|||
146005044|NCT00399568|526534940|FG000|Overall Study|Withdrawal by Subject|7|||
146005045|NCT00399568|526534941|FG001|Overall Study|Withdrawal by Subject|3|||
146005046|NCT00399568|526534940|FG000|Overall Study|Protocol non-compliance|2|||
146005047|NCT00399568|526534941|FG001|Overall Study|Protocol non-compliance|2|||
146005048|NCT00399568|526534940|FG000|Overall Study|Lost to Follow-up|2|||
146005049|NCT00399568|526534941|FG001|Overall Study|Lost to Follow-up|2|||
146005050|NCT00841776|526534944|FG000|Overall Study|Lack of Efficacy|0|||
146005051|NCT00841776|526534945|FG001|Overall Study|Lack of Efficacy|1|||
146005052|NCT00841776|526534944|FG000|Overall Study|Lost to Follow-up|2|||
146005053|NCT00841776|526534945|FG001|Overall Study|Lost to Follow-up|1|||
146005054|NCT00841776|526534944|FG000|Overall Study|Withdrawal by Subject|0|||
146005055|NCT00841776|526534945|FG001|Overall Study|Withdrawal by Subject|1|||
146005056|NCT02477527|526534946|FG000|Overall Study|Lost to Follow-up|2|||
146005057|NCT02477527|526534946|FG000|Overall Study|Withdrawal by Subject|1|||
146005058|NCT02477527|526534946|FG000|Overall Study|Screen Failure|3|||
146005059|NCT04567524|526534947|FG000|Overall Study|Adverse Event|1|||
146005060|NCT04567524|526534948|FG001|Overall Study|Adverse Event|1|||
146005061|NCT04567524|526534949|FG002|Overall Study|Adverse Event|0|||
146005062|NCT04567524|526534950|FG003|Overall Study|Adverse Event|0|||
146005063|NCT04567524|526534947|FG000|Overall Study|Withdrawal by Subject|2|||
146005064|NCT04567524|526534948|FG001|Overall Study|Withdrawal by Subject|0|||
146005065|NCT04567524|526534949|FG002|Overall Study|Withdrawal by Subject|0|||
146005066|NCT04567524|526534950|FG003|Overall Study|Withdrawal by Subject|1|||
146005067|NCT01147393|526534951|FG000|Dose Level 1|Dose limiting Toxicity|2|||
146005068|NCT01147393|526534951|FG000|Dose Level -1|Dose Limited Toxicity|1|||
146005069|NCT00592631|526534956|FG000|Overall Study|Lost to Follow-up|0|||
146005070|NCT00592631|526534957|FG001|Overall Study|Lost to Follow-up|2|||
146005071|NCT03688919|526534958|FG000|Overall Study|Lost to Follow-up|2|||
146005072|NCT03688919|526534959|FG001|Overall Study|Lost to Follow-up|1|||
146005073|NCT03688919|526534958|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
146005074|NCT03688919|526534959|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
146005075|NCT03389308|526534962|FG000|Overall Study|Withdrawal by Subject|5|||
146005076|NCT03389308|526534962|FG000|Overall Study|Lost to Follow-up|3|||
146005077|NCT03389308|526534962|FG000|Overall Study|Adverse Event|2|||
146005078|NCT03389308|526534962|FG000|Overall Study|Sponsor Request|2|||
146247727|NCT00103857|527419899|FG005|50-Week Extension Study|reason unspecified|0|||
146005079|NCT03198767|526534966|FG000|Overall Study|Protocol Violation|0|||
146005080|NCT03198767|526534967|FG001|Overall Study|Protocol Violation|0|||
146005081|NCT03198767|526534968|FG002|Overall Study|Protocol Violation|0|||
146247728|NCT00103857|527419900|FG006|50-Week Extension Study|reason unspecified|0|||
146247729|NCT01856569|527419901|FG000|Overall Study|Other|1|||
146247730|NCT01856569|527419901|FG000|Overall Study|Changed Site/Structure|1|||
146247731|NCT01856569|527419901|FG000|Overall Study|Lost to Follow-up|3|||
146247732|NCT01856569|527419901|FG000|Overall Study|Did not met inclusion criteria|8|||
146247733|NCT00696241|527419902|FG000|Overall Study|Adverse Event|11|||
146247734|NCT00696241|527419903|FG001|Overall Study|Adverse Event|3|||
146247735|NCT00696241|527419904|FG002|Overall Study|Adverse Event|6|||
146247736|NCT00696241|527419905|FG003|Overall Study|Adverse Event|4|||
146247737|NCT00696241|527419906|FG004|Overall Study|Adverse Event|5|||
146247738|NCT00696241|527419902|FG000|Overall Study|Protocol Violation|1|||
146247739|NCT00696241|527419903|FG001|Overall Study|Protocol Violation|1|||
146247740|NCT00696241|527419904|FG002|Overall Study|Protocol Violation|2|||
146247741|NCT00696241|527419905|FG003|Overall Study|Protocol Violation|0|||
146247742|NCT00696241|527419906|FG004|Overall Study|Protocol Violation|3|||
146247743|NCT00696241|527419902|FG000|Overall Study|Lost to Follow-up|1|||
146247744|NCT00696241|527419903|FG001|Overall Study|Lost to Follow-up|4|||
146247745|NCT00696241|527419904|FG002|Overall Study|Lost to Follow-up|1|||
146247746|NCT00696241|527419905|FG003|Overall Study|Lost to Follow-up|2|||
146247747|NCT00696241|527419906|FG004|Overall Study|Lost to Follow-up|0|||
146247748|NCT00696241|527419902|FG000|Overall Study|Withdrawal by Subject|4|||
146247749|NCT00696241|527419903|FG001|Overall Study|Withdrawal by Subject|8|||
146247750|NCT00696241|527419904|FG002|Overall Study|Withdrawal by Subject|6|||
146247751|NCT00696241|527419905|FG003|Overall Study|Withdrawal by Subject|1|||
146247752|NCT00696241|527419906|FG004|Overall Study|Withdrawal by Subject|0|||
146247753|NCT00696241|527419902|FG000|Overall Study|Lack of Efficacy|1|||
146247754|NCT00696241|527419903|FG001|Overall Study|Lack of Efficacy|5|||
146247755|NCT00696241|527419904|FG002|Overall Study|Lack of Efficacy|4|||
146247756|NCT00696241|527419905|FG003|Overall Study|Lack of Efficacy|5|||
146247757|NCT00696241|527419906|FG004|Overall Study|Lack of Efficacy|3|||
146247758|NCT00696241|527419902|FG000|Overall Study|Other|6|||
146247759|NCT00696241|527419903|FG001|Overall Study|Other|1|||
146005082|NCT03198767|526534969|FG003|Overall Study|Protocol Violation|6|||
146005083|NCT03198767|526534970|FG004|Overall Study|Protocol Violation|0|||
146005084|NCT03198767|526534971|FG005|Overall Study|Protocol Violation|0|||
146005085|NCT03198767|526534972|FG006|Overall Study|Protocol Violation|0|||
146005086|NCT00570323|526534973|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
146005087|NCT00570323|526534974|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
146005088|NCT00570323|526534973|FG000|Started Treatment After Randomization|Protocol Violation|1|||
146005089|NCT00570323|526534974|FG001|Started Treatment After Randomization|Protocol Violation|0|||
146005090|NCT00570323|526534973|FG000|Started Treatment After Randomization|Physician Decision|1|||
146005091|NCT00570323|526534974|FG001|Started Treatment After Randomization|Physician Decision|0|||
146005092|NCT00570323|526534973|FG000|Complete Study After Start|Lost to Follow-up|0|||
146005093|NCT00570323|526534974|FG001|Complete Study After Start|Lost to Follow-up|1|||
146005094|NCT00570323|526534973|FG000|Complete Study After Start|Withdrawal by Subject|2|||
146005095|NCT00570323|526534974|FG001|Complete Study After Start|Withdrawal by Subject|0|||
146005096|NCT00570323|526534973|FG000|Complete Study After Start|Physician Decision|1|||
146005097|NCT00570323|526534974|FG001|Complete Study After Start|Physician Decision|0|||
146005098|NCT02639247|526534977|FG000|Overall Study|Lost to Follow-up|2|||
146005099|NCT02639247|526534978|FG001|Overall Study|Lost to Follow-up|1|||
146005100|NCT02639247|526534977|FG000|Overall Study|Death|2|||
146005101|NCT02639247|526534978|FG001|Overall Study|Death|0|||
146005102|NCT02639247|526534977|FG000|Overall Study|Withdrew Consent|0|||
146005103|NCT02639247|526534978|FG001|Overall Study|Withdrew Consent|1|||
146247760|NCT00696241|527419904|FG002|Overall Study|Other|5|||
146247761|NCT00696241|527419905|FG003|Overall Study|Other|2|||
146005104|NCT02639247|526534977|FG000|Overall Study|Protocol Violation|1|||
146005105|NCT02639247|526534978|FG001|Overall Study|Protocol Violation|0|||
146005106|NCT02651116|526534980|FG000|Overall Study|Adverse Event|0|||
146005107|NCT02651116|526534981|FG001|Overall Study|Adverse Event|1|||
146005108|NCT02651116|526534980|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
146247762|NCT00696241|527419906|FG004|Overall Study|Other|1|||
146247763|NCT03065400|527419907|FG000|Overall Study|Adverse Event|1|||
146247764|NCT03065400|527419907|FG000|Overall Study|Physician Decision|3|||
146247765|NCT03065400|527419907|FG000|Overall Study|Withdrawal by Subject|1|||
146005109|NCT02651116|526534981|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
146005110|NCT00041470|526534989|FG000|Overall Study|Loss of Funding|38|||
146005111|NCT00739310|526534990|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
146247766|NCT03065400|527419907|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
146247767|NCT00392197|527419910|FG000|Overall Study|Adverse Event|4|||
146247768|NCT00392197|527419911|FG001|Overall Study|Adverse Event|12|||
146005112|NCT00739310|526534990|FG000|Overall Study|Withdrawal by Subject|1|||
146005113|NCT00739310|526534990|FG000|Overall Study|Lost to Follow-up|2|||
146005114|NCT01459666|526534991|FG000|Overall Study|PI left institution|5|||
146005115|NCT01459666|526534992|FG001|Overall Study|PI left institution|4|||
146005116|NCT00533429|526534993|FG000|Overall Study|Adverse Event|3|||
146005117|NCT00533429|526534994|FG001|Overall Study|Adverse Event|1|||
146005118|NCT00533429|526534993|FG000|Overall Study|Death|1|||
146005119|NCT00533429|526534994|FG001|Overall Study|Death|0|||
146005120|NCT00533429|526534993|FG000|Overall Study|Withdrawal by Subject|2|||
146005121|NCT00533429|526534994|FG001|Overall Study|Withdrawal by Subject|0|||
146005122|NCT00533429|526534993|FG000|Overall Study|Progressive Disease|12|||
146005123|NCT00533429|526534994|FG001|Overall Study|Progressive Disease|13|||
146005124|NCT00533429|526534993|FG000|Overall Study|Symptomatic deterioration|1|||
146005125|NCT00533429|526534994|FG001|Overall Study|Symptomatic deterioration|2|||
146005126|NCT00920556|526534995|FG000|Overall Study|Adverse Event|16|||
146005127|NCT00920556|526534995|FG000|Overall Study|Physician Decision|7|||
146005128|NCT00920556|526534995|FG000|Overall Study|Withdrawal by Subject|1|||
146005129|NCT01299389|526534996|FG000|Double-blind|Adverse Event|45|||
146005130|NCT01299389|526534997|FG001|Double-blind|Adverse Event|27|||
146005131|NCT01299389|526534998|FG002|Double-blind|Adverse Event|0|||
146005132|NCT01299389|526534999|FG003|Double-blind|Adverse Event|0|||
146005133|NCT01299389|526534996|FG000|Double-blind|Lack of Efficacy|45|||
146005134|NCT01299389|526534997|FG001|Double-blind|Lack of Efficacy|21|||
146005135|NCT01299389|526534998|FG002|Double-blind|Lack of Efficacy|0|||
146005136|NCT01299389|526534999|FG003|Double-blind|Lack of Efficacy|0|||
146005137|NCT01299389|526534996|FG000|Double-blind|Lost to Follow-up|2|||
146005138|NCT01299389|526534997|FG001|Double-blind|Lost to Follow-up|1|||
146005139|NCT01299389|526534998|FG002|Double-blind|Lost to Follow-up|0|||
146005140|NCT01299389|526534999|FG003|Double-blind|Lost to Follow-up|0|||
146005141|NCT01299389|526534996|FG000|Double-blind|Withdrawal by Subject|16|||
146005142|NCT01299389|526534997|FG001|Double-blind|Withdrawal by Subject|13|||
146005143|NCT01299389|526534998|FG002|Double-blind|Withdrawal by Subject|0|||
146005144|NCT01299389|526534999|FG003|Double-blind|Withdrawal by Subject|0|||
146005145|NCT01299389|526534996|FG000|Double-blind|Other|1|||
146005146|NCT01299389|526534997|FG001|Double-blind|Other|1|||
146005147|NCT01299389|526534998|FG002|Double-blind|Other|0|||
146005148|NCT01299389|526534999|FG003|Double-blind|Other|0|||
146005149|NCT01299389|526534996|FG000|Double-blind|"fail to meet study population criteria"|0|||
146005150|NCT01299389|526534997|FG001|Double-blind|"fail to meet study population criteria"|1|||
146005151|NCT01299389|526534998|FG002|Double-blind|"fail to meet study population criteria"|0|||
146005152|NCT01299389|526534999|FG003|Double-blind|"fail to meet study population criteria"|0|||
146005153|NCT01299389|526534996|FG000|Post-observational|Other|0|||
146005154|NCT01299389|526534997|FG001|Post-observational|Other|0|||
146005155|NCT01299389|526534998|FG002|Post-observational|Other|12|||
146005156|NCT01299389|526534999|FG003|Post-observational|Other|6|||
146005157|NCT04245709|526535000|FG000|Overall Study|Adverse Event|13|||
146005158|NCT04245709|526535000|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
146005159|NCT03637491|526535001|FG000|Overall Study|Death|9|||
146005160|NCT03637491|526535002|FG001|Overall Study|Death|9|||
146005161|NCT03637491|526535003|FG002|Overall Study|Death|5|||
146005162|NCT03637491|526535004|FG003|Overall Study|Death|3|||
146005163|NCT03637491|526535001|FG000|Overall Study|Lost to Follow-up|0|||
146005164|NCT03637491|526535002|FG001|Overall Study|Lost to Follow-up|1|||
146005165|NCT03637491|526535003|FG002|Overall Study|Lost to Follow-up|0|||
146005166|NCT03637491|526535004|FG003|Overall Study|Lost to Follow-up|1|||
146005167|NCT03637491|526535001|FG000|Overall Study|Study Terminated By Sponsor|0|||
146005168|NCT03637491|526535002|FG001|Overall Study|Study Terminated By Sponsor|2|||
146005169|NCT03637491|526535003|FG002|Overall Study|Study Terminated By Sponsor|1|||
146005170|NCT03637491|526535004|FG003|Overall Study|Study Terminated By Sponsor|0|||
146005171|NCT03637491|526535001|FG000|Overall Study|Withdrawal by Subject|1|||
146005172|NCT03637491|526535002|FG001|Overall Study|Withdrawal by Subject|0|||
146005173|NCT03637491|526535003|FG002|Overall Study|Withdrawal by Subject|1|||
146005174|NCT03637491|526535004|FG003|Overall Study|Withdrawal by Subject|2|||
146005175|NCT02185534|526535007|FG000|First Period|Withdrawal by Subject|0|||
146005176|NCT02185534|526535008|FG001|First Period|Withdrawal by Subject|0|||
146005177|NCT02185534|526535009|FG002|First Period|Withdrawal by Subject|0|||
146005178|NCT02185534|526535010|FG003|First Period|Withdrawal by Subject|1|||
146005179|NCT02185534|526535011|FG004|First Period|Withdrawal by Subject|0|||
146005180|NCT02185534|526535012|FG005|First Period|Withdrawal by Subject|0|||
146005181|NCT02185534|526535007|FG000|First Washout Period|Withdrawal by Subject|1|||
146005182|NCT02185534|526535008|FG001|First Washout Period|Withdrawal by Subject|0|||
146005183|NCT02185534|526535009|FG002|First Washout Period|Withdrawal by Subject|0|||
146005184|NCT02185534|526535010|FG003|First Washout Period|Withdrawal by Subject|0|||
146005185|NCT02185534|526535011|FG004|First Washout Period|Withdrawal by Subject|1|||
146005186|NCT02185534|526535012|FG005|First Washout Period|Withdrawal by Subject|0|||
146005187|NCT02185534|526535007|FG000|First Washout Period|Protocol Violation|0|||
146005188|NCT02185534|526535008|FG001|First Washout Period|Protocol Violation|0|||
146005189|NCT02185534|526535009|FG002|First Washout Period|Protocol Violation|0|||
146005190|NCT02185534|526535010|FG003|First Washout Period|Protocol Violation|0|||
146005191|NCT02185534|526535011|FG004|First Washout Period|Protocol Violation|0|||
146005192|NCT02185534|526535012|FG005|First Washout Period|Protocol Violation|1|||
146005193|NCT02948582|526535013|FG000|Washout Period 1|Adverse Event|0|||
146005194|NCT02948582|526535014|FG001|Washout Period 1|Adverse Event|2|||
146005195|NCT02948582|526535015|FG002|Washout Period 1|Adverse Event|0|||
146005196|NCT02948582|526535016|FG003|Washout Period 1|Adverse Event|0|||
146005197|NCT02948582|526535017|FG004|Washout Period 1|Adverse Event|0|||
146005198|NCT02948582|526535018|FG005|Washout Period 1|Adverse Event|0|||
146005199|NCT02948582|526535013|FG000|Washout Period 1|Protocol Violation|0|||
146005200|NCT02948582|526535014|FG001|Washout Period 1|Protocol Violation|0|||
146005201|NCT02948582|526535015|FG002|Washout Period 1|Protocol Violation|0|||
146005202|NCT02948582|526535016|FG003|Washout Period 1|Protocol Violation|0|||
146005203|NCT02948582|526535017|FG004|Washout Period 1|Protocol Violation|0|||
146005204|NCT02948582|526535018|FG005|Washout Period 1|Protocol Violation|1|||
146005205|NCT02948582|526535013|FG000|Washout Period 2|Adverse Event|0|||
146005206|NCT02948582|526535014|FG001|Washout Period 2|Adverse Event|1|||
146005207|NCT02948582|526535015|FG002|Washout Period 2|Adverse Event|0|||
146005208|NCT02948582|526535016|FG003|Washout Period 2|Adverse Event|0|||
146005209|NCT02948582|526535017|FG004|Washout Period 2|Adverse Event|0|||
146005210|NCT02948582|526535018|FG005|Washout Period 2|Adverse Event|0|||
146005211|NCT02948582|526535013|FG000|Washout Period 2|personal reasons|0|||
146005212|NCT02948582|526535014|FG001|Washout Period 2|personal reasons|0|||
146005213|NCT02948582|526535015|FG002|Washout Period 2|personal reasons|0|||
146005214|NCT02948582|526535016|FG003|Washout Period 2|personal reasons|1|||
146005215|NCT02948582|526535017|FG004|Washout Period 2|personal reasons|0|||
146005216|NCT02948582|526535018|FG005|Washout Period 2|personal reasons|0|||
146005217|NCT02948582|526535013|FG000|Washout Period 4|Adverse Event|1|||
146005218|NCT02948582|526535014|FG001|Washout Period 4|Adverse Event|0|||
146005219|NCT02948582|526535015|FG002|Washout Period 4|Adverse Event|1|||
146005220|NCT02948582|526535016|FG003|Washout Period 4|Adverse Event|0|||
146005221|NCT02948582|526535017|FG004|Washout Period 4|Adverse Event|0|||
146005222|NCT02948582|526535018|FG005|Washout Period 4|Adverse Event|0|||
146005223|NCT04419467|526535021|FG000|Overall Study|Not treated with IP|0|||
146005224|NCT04419467|526535022|FG001|Overall Study|Not treated with IP|0|||
146005225|NCT04419467|526535023|FG002|Overall Study|Not treated with IP|2|||
146005226|NCT04419467|526535021|FG000|Overall Study|Adverse Event|0|||
146005227|NCT04419467|526535022|FG001|Overall Study|Adverse Event|2|||
146005228|NCT04419467|526535023|FG002|Overall Study|Adverse Event|0|||
146005229|NCT04419467|526535021|FG000|Overall Study|Death|1|||
146005230|NCT04419467|526535022|FG001|Overall Study|Death|0|||
146005231|NCT04419467|526535023|FG002|Overall Study|Death|0|||
146005232|NCT04419467|526535021|FG000|Overall Study|Lost to Follow-up|0|||
146005233|NCT04419467|526535022|FG001|Overall Study|Lost to Follow-up|1|||
146005234|NCT04419467|526535023|FG002|Overall Study|Lost to Follow-up|2|||
146005235|NCT04419467|526535021|FG000|Overall Study|Withdrawal by Subject|0|||
146005236|NCT04419467|526535022|FG001|Overall Study|Withdrawal by Subject|0|||
146005237|NCT04419467|526535023|FG002|Overall Study|Withdrawal by Subject|4|||
146005238|NCT04419467|526535021|FG000|Overall Study|Pandemic related|0|||
146005239|NCT04419467|526535022|FG001|Overall Study|Pandemic related|0|||
146005240|NCT04419467|526535023|FG002|Overall Study|Pandemic related|1|||
146005241|NCT04419467|526535021|FG000|Overall Study|Reason not known|1|||
146005242|NCT04419467|526535022|FG001|Overall Study|Reason not known|0|||
146005243|NCT04419467|526535023|FG002|Overall Study|Reason not known|0|||
146005244|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146005245|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146005246|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146005247|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
146005248|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
146005249|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
146092409|NCT03963401|526860293|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
146092410|NCT03963401|526860294|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146092411|NCT03963401|526860295|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
146092412|NCT03963401|526860290|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
146247769|NCT00392197|527419910|FG000|Overall Study|Lack of Efficacy|3|||
146247770|NCT00392197|527419911|FG001|Overall Study|Lack of Efficacy|4|||
146005250|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146005251|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
146005252|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
146005253|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146005254|NCT01925768|526535024|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
146005255|NCT01925768|526535025|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
146005256|NCT01925768|526535024|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
146005257|NCT01925768|526535025|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
146005258|NCT01925768|526535024|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
146005259|NCT01925768|526535025|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
146005260|NCT01925768|526535024|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
146005261|NCT01925768|526535025|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
146005262|NCT01925768|526535024|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
146005263|NCT01925768|526535025|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
146005264|NCT01925768|526535024|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
146005265|NCT01925768|526535025|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
146005266|NCT00087698|526535038|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
146005267|NCT00087698|526535038|FG000|Overall Study|Death from Other Causes|3|||
146005268|NCT00087698|526535038|FG000|Overall Study|Adverse Event|4|||
146005269|NCT00087698|526535038|FG000|Overall Study|Withdrawal by Subject|4|||
146005270|NCT00087698|526535038|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
146005271|NCT00087698|526535038|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
146005272|NCT00087698|526535038|FG000|Overall Study|Clinical Relapse|1|||
146005273|NCT00087698|526535038|FG000|Overall Study|Death from Study Disease|2|||
146005274|NCT00087698|526535038|FG000|Overall Study|Death from Study Drug Toxicity|2|||
146247771|NCT00392197|527419910|FG000|Overall Study|Lost to Follow-up|0|||
146247772|NCT00392197|527419911|FG001|Overall Study|Lost to Follow-up|1|||
146247773|NCT00392197|527419910|FG000|Overall Study|Physician Decision|3|||
146247774|NCT00392197|527419911|FG001|Overall Study|Physician Decision|2|||
146247775|NCT00392197|527419910|FG000|Overall Study|Protocol Violation|7|||
146247776|NCT00392197|527419911|FG001|Overall Study|Protocol Violation|5|||
146247777|NCT00392197|527419910|FG000|Overall Study|Withdrawal by Subject|4|||
146247778|NCT00392197|527419911|FG001|Overall Study|Withdrawal by Subject|6|||
146247779|NCT01970527|527419913|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
146247780|NCT01970527|527419914|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
146247781|NCT01970527|527419913|FG000|Treatment|Disease progression|0|||
146247782|NCT01970527|527419914|FG001|Treatment|Disease progression|1|||
146247783|NCT01970527|527419913|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
146247784|NCT01970527|527419914|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
146247785|NCT01970527|527419913|FG000|Treatment|Death|0|||
146247786|NCT01970527|527419914|FG001|Treatment|Death|1|||
146247787|NCT01970527|527419913|FG000|Follow-up Clinic Visit|Disease progression|1|||
146247788|NCT01970527|527419914|FG001|Follow-up Clinic Visit|Disease progression|1|||
146247789|NCT01970527|527419913|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
146247790|NCT01970527|527419914|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
146247791|NCT01970527|527419913|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
146247792|NCT01970527|527419914|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
146247793|NCT03060525|527419915|FG000|Overall Study|moved out of state|1|||
146247794|NCT03060525|527419916|FG001|Overall Study|moved out of state|1|||
146247795|NCT03060525|527419917|FG002|Overall Study|moved out of state|1|||
146247796|NCT03060525|527419918|FG003|Overall Study|moved out of state|1|||
146247797|NCT03060525|527419915|FG000|Overall Study|unable to meet time commitment required of study|2|||
146247798|NCT03060525|527419916|FG001|Overall Study|unable to meet time commitment required of study|3|||
146247799|NCT03060525|527419917|FG002|Overall Study|unable to meet time commitment required of study|3|||
146247800|NCT03060525|527419918|FG003|Overall Study|unable to meet time commitment required of study|1|||
146247801|NCT03060525|527419915|FG000|Overall Study|no longer interested in doing intervention|0|||
146247802|NCT03060525|527419916|FG001|Overall Study|no longer interested in doing intervention|0|||
146247803|NCT03060525|527419917|FG002|Overall Study|no longer interested in doing intervention|0|||
146247804|NCT03060525|527419918|FG003|Overall Study|no longer interested in doing intervention|1|||
146247805|NCT02147093|527419919|FG000|Period 1|Lost to Follow-up|0|||
146247806|NCT02147093|527419920|FG001|Period 1|Lost to Follow-up|1|||
146005275|NCT00087698|526535038|FG000|Overall Study|Protocol Violation|1|||
146005276|NCT03943290|526535042|FG000|Overall Study|Sponsor Terminated Study|6|||
146005277|NCT03943290|526535043|FG001|Overall Study|Sponsor Terminated Study|1|||
146005278|NCT03943290|526535044|FG002|Overall Study|Sponsor Terminated Study|11|||
146005279|NCT03943290|526535045|FG003|Overall Study|Sponsor Terminated Study|6|||
146005280|NCT03943290|526535046|FG004|Overall Study|Sponsor Terminated Study|7|||
146005281|NCT03943290|526535047|FG005|Overall Study|Sponsor Terminated Study|6|||
146005282|NCT03943290|526535048|FG006|Overall Study|Sponsor Terminated Study|6|||
146247807|NCT02147093|527419919|FG000|Period 2|Protocol Violation|2|||
146247808|NCT02147093|527419920|FG001|Period 2|Protocol Violation|0|||
146247809|NCT02189759|527419926|FG000|Overall Study|Lost to Follow-up|0|||
146247810|NCT02189759|527419927|FG001|Overall Study|Lost to Follow-up|0|||
146247811|NCT02189759|527419928|FG002|Overall Study|Lost to Follow-up|2|||
146247812|NCT02189759|527419929|FG003|Overall Study|Lost to Follow-up|5|||
146247813|NCT01147471|527419930|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
146247814|NCT01147471|527419931|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
146247815|NCT01147471|527419930|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
146247816|NCT01147471|527419931|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
146247817|NCT01147471|527419930|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
146247818|NCT01147471|527419931|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
146005283|NCT03943290|526535049|FG007|Overall Study|Sponsor Terminated Study|7|||
146005284|NCT03943290|526535050|FG008|Overall Study|Sponsor Terminated Study|8|||
146005285|NCT03943290|526535042|FG000|Overall Study|Lost to Follow-up|1|||
146005286|NCT03943290|526535043|FG001|Overall Study|Lost to Follow-up|0|||
146005287|NCT03943290|526535044|FG002|Overall Study|Lost to Follow-up|1|||
146005288|NCT03943290|526535045|FG003|Overall Study|Lost to Follow-up|0|||
146005289|NCT03943290|526535046|FG004|Overall Study|Lost to Follow-up|0|||
146005290|NCT03943290|526535047|FG005|Overall Study|Lost to Follow-up|0|||
146005291|NCT03943290|526535048|FG006|Overall Study|Lost to Follow-up|0|||
146005292|NCT03943290|526535049|FG007|Overall Study|Lost to Follow-up|1|||
146005293|NCT03943290|526535050|FG008|Overall Study|Lost to Follow-up|0|||
146005294|NCT03943290|526535042|FG000|Overall Study|Withdrawal by Subject|0|||
146005295|NCT03943290|526535043|FG001|Overall Study|Withdrawal by Subject|0|||
146005296|NCT03943290|526535044|FG002|Overall Study|Withdrawal by Subject|1|||
146005297|NCT03943290|526535045|FG003|Overall Study|Withdrawal by Subject|0|||
146005298|NCT03943290|526535046|FG004|Overall Study|Withdrawal by Subject|0|||
146005299|NCT03943290|526535047|FG005|Overall Study|Withdrawal by Subject|0|||
146005300|NCT03943290|526535048|FG006|Overall Study|Withdrawal by Subject|0|||
146005301|NCT03943290|526535049|FG007|Overall Study|Withdrawal by Subject|0|||
146005302|NCT03943290|526535050|FG008|Overall Study|Withdrawal by Subject|0|||
146005303|NCT04179305|526535054|FG000|Overall Study|Death|1|||
146005304|NCT04179305|526535055|FG001|Overall Study|Death|1|||
146005305|NCT04179305|526535056|FG002|Overall Study|Death|0|||
146005306|NCT04179305|526535057|FG003|Overall Study|Death|0|||
146005307|NCT04179305|526535054|FG000|Overall Study|Lost to Follow-up|1|||
146005308|NCT04179305|526535055|FG001|Overall Study|Lost to Follow-up|1|||
146005309|NCT04179305|526535056|FG002|Overall Study|Lost to Follow-up|0|||
146005310|NCT04179305|526535057|FG003|Overall Study|Lost to Follow-up|0|||
146005311|NCT04179305|526535054|FG000|Overall Study|Withdrawal by Subject|0|||
146005312|NCT04179305|526535055|FG001|Overall Study|Withdrawal by Subject|1|||
146005313|NCT04179305|526535056|FG002|Overall Study|Withdrawal by Subject|0|||
146005314|NCT04179305|526535057|FG003|Overall Study|Withdrawal by Subject|0|||
146005315|NCT04179305|526535054|FG000|Overall Study|Did not have scan|1|||
146005316|NCT04179305|526535055|FG001|Overall Study|Did not have scan|0|||
146005317|NCT04179305|526535056|FG002|Overall Study|Did not have scan|0|||
146005318|NCT04179305|526535057|FG003|Overall Study|Did not have scan|0|||
146005319|NCT04179305|526535054|FG000|Overall Study|In hospice care|3|||
146005320|NCT04179305|526535055|FG001|Overall Study|In hospice care|0|||
146005321|NCT04179305|526535056|FG002|Overall Study|In hospice care|0|||
146005322|NCT04179305|526535057|FG003|Overall Study|In hospice care|0|||
146005323|NCT03192137|526535060|FG000|Overall Study|Adverse Event|10|||
146005324|NCT03192137|526535061|FG001|Overall Study|Adverse Event|11|||
146005325|NCT03192137|526535060|FG000|Overall Study|Physician Decision|1|||
146005326|NCT03192137|526535061|FG001|Overall Study|Physician Decision|0|||
146005327|NCT03192137|526535060|FG000|Overall Study|Lack of Efficacy|20|||
146005328|NCT03192137|526535061|FG001|Overall Study|Lack of Efficacy|37|||
146005329|NCT03192137|526535060|FG000|Overall Study|Withdrawal by Subject|3|||
146005330|NCT03192137|526535061|FG001|Overall Study|Withdrawal by Subject|3|||
146005331|NCT03192137|526535060|FG000|Overall Study|Protocol Violation|4|||
146005332|NCT03192137|526535061|FG001|Overall Study|Protocol Violation|3|||
146005333|NCT03192137|526535060|FG000|Overall Study|Surgery Cancelled|4|||
146005334|NCT03192137|526535061|FG001|Overall Study|Surgery Cancelled|1|||
146005335|NCT03192137|526535060|FG000|Overall Study|Other - Various Administrative Reasons|8|||
146005336|NCT03192137|526535061|FG001|Overall Study|Other - Various Administrative Reasons|3|||
146005337|NCT02737501|526535064|FG000|Randomized Phase|Died|41|||
146005338|NCT02737501|526535065|FG001|Randomized Phase|Died|29|||
146005339|NCT02737501|526535066|FG002|Randomized Phase|Died|0|||
146005340|NCT02737501|526535064|FG000|Randomized Phase|Withdrawal by Subject|16|||
146005341|NCT02737501|526535065|FG001|Randomized Phase|Withdrawal by Subject|6|||
146005342|NCT02737501|526535066|FG002|Randomized Phase|Withdrawal by Subject|0|||
146005343|NCT02737501|526535064|FG000|Randomized Phase|Lost to Follow-up|0|||
146005344|NCT02737501|526535065|FG001|Randomized Phase|Lost to Follow-up|1|||
146005345|NCT02737501|526535066|FG002|Randomized Phase|Lost to Follow-up|0|||
146005346|NCT02737501|526535064|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
146005347|NCT02737501|526535065|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
146005348|NCT02737501|526535066|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
146005349|NCT02737501|526535064|FG000|Randomized Phase|Reason not Specified|1|||
146005350|NCT02737501|526535065|FG001|Randomized Phase|Reason not Specified|1|||
146005351|NCT02737501|526535066|FG002|Randomized Phase|Reason not Specified|0|||
146005352|NCT02737501|526535064|FG000|Randomized Phase|Never Treated|1|||
146005353|NCT02737501|526535065|FG001|Randomized Phase|Never Treated|1|||
146005354|NCT02737501|526535066|FG002|Randomized Phase|Never Treated|0|||
146005355|NCT02737501|526535064|FG000|Crossover Phase|Died|0|||
146005356|NCT02737501|526535065|FG001|Crossover Phase|Died|0|||
146005357|NCT02737501|526535066|FG002|Crossover Phase|Died|22|||
146005358|NCT02737501|526535064|FG000|Crossover Phase|Withdrew Consent|0|||
146005359|NCT02737501|526535065|FG001|Crossover Phase|Withdrew Consent|0|||
146005360|NCT02737501|526535066|FG002|Crossover Phase|Withdrew Consent|9|||
146005361|NCT02737501|526535064|FG000|Crossover Phase|Physician Decision|0|||
146005362|NCT02737501|526535065|FG001|Crossover Phase|Physician Decision|0|||
146005363|NCT02737501|526535066|FG002|Crossover Phase|Physician Decision|1|||
146005364|NCT02737501|526535064|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
146005365|NCT02737501|526535065|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
146005366|NCT02737501|526535066|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
146005367|NCT01261975|526535067|FG000|Overall Study|Surgical complication|1|||
146005368|NCT00810277|526537104|FG000|Overall Study|Adverse Event|1|||
146005369|NCT00532129|526537107|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
146005370|NCT00532129|526537107|FG000|Treatment Period|Physician Decision|15|||
146005371|NCT00532129|526537107|FG000|Treatment Period|Disease progression|3|||
146005372|NCT00532129|526537107|FG000|Treatment Period|Protocol Violation|1|||
146005373|NCT00532129|526537107|FG000|Treatment Period|Other|5|||
146005374|NCT00532129|526537107|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
146005375|NCT00532129|526537107|FG000|Follow-up Period|Disease progression|57|||
146005376|NCT00532129|526537107|FG000|Follow-up Period|Lost to Follow-up|1|||
146005377|NCT00532129|526537107|FG000|Follow-up Period|Other|6|||
146005378|NCT04551898|526537108|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
146005379|NCT04551898|526537109|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
146005380|NCT04551898|526537110|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
146005381|NCT04551898|526537111|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
146005382|NCT04551898|526537108|FG000|Overall Study|Withdrawal by Subject|5|||
146005383|NCT04551898|526537109|FG001|Overall Study|Withdrawal by Subject|1|||
146005384|NCT04551898|526537110|FG002|Overall Study|Withdrawal by Subject|2|||
146005385|NCT04551898|526537111|FG003|Overall Study|Withdrawal by Subject|2|||
146005386|NCT04551898|526537108|FG000|Overall Study|Lost to Follow-up|2|||
146005387|NCT04551898|526537109|FG001|Overall Study|Lost to Follow-up|1|||
146005388|NCT04551898|526537110|FG002|Overall Study|Lost to Follow-up|2|||
146005389|NCT04551898|526537111|FG003|Overall Study|Lost to Follow-up|2|||
146005390|NCT04551898|526537108|FG000|Overall Study|Death|1|||
146005391|NCT04551898|526537109|FG001|Overall Study|Death|0|||
146005392|NCT04551898|526537110|FG002|Overall Study|Death|0|||
146005393|NCT04551898|526537111|FG003|Overall Study|Death|0|||
146005394|NCT04551898|526537108|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146005395|NCT04551898|526537109|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146005396|NCT04551898|526537110|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
146005397|NCT04551898|526537111|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
146005398|NCT01336712|526537114|FG000|Overall Study|Death|2|||
146005399|NCT01336712|526537114|FG000|Overall Study|Lack of Efficacy|1|||
146005400|NCT04263766|526537123|FG000|Overall Study|Withdrawal by Subject|6|||
146005401|NCT04263766|526537124|FG001|Overall Study|Withdrawal by Subject|4|||
146005402|NCT04263766|526537123|FG000|Overall Study|Lack of Efficacy|1|||
146005403|NCT04263766|526537124|FG001|Overall Study|Lack of Efficacy|3|||
146005404|NCT01891396|526537126|FG000|Overall Study|Withdrawal by Subject|4|||
146005405|NCT01891396|526537127|FG001|Overall Study|Withdrawal by Subject|4|||
146005406|NCT01891396|526537128|FG002|Overall Study|Withdrawal by Subject|3|||
146005407|NCT01891396|526537126|FG000|Overall Study|Lost to Follow-up|0|||
146005408|NCT01891396|526537127|FG001|Overall Study|Lost to Follow-up|1|||
146005409|NCT01891396|526537128|FG002|Overall Study|Lost to Follow-up|0|||
146005410|NCT03462758|526537129|FG000|Overall Study|Chose no or other method of contraception|20|||
146005411|NCT03462758|526537130|FG001|Overall Study|Chose no or other method of contraception|23|||
146005412|NCT03462758|526537129|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
146005413|NCT03462758|526537130|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
146005414|NCT03462758|526537129|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
146005415|NCT03462758|526537130|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
146005416|NCT03462758|526537129|FG000|Overall Study|Medical contraindication|2|||
146005417|NCT03462758|526537130|FG001|Overall Study|Medical contraindication|2|||
146005418|NCT03462758|526537129|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
146005419|NCT03462758|526537130|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
146005420|NCT02820844|526537132|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
146005421|NCT02820844|526537133|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
146005422|NCT02820844|526537134|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146005423|NCT02820844|526537135|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146247819|NCT01147471|527419930|FG000|3 Month Follow Up|Lost to Follow-up|1|||
146247820|NCT01147471|527419931|FG001|3 Month Follow Up|Lost to Follow-up|1|||
146247821|NCT01147471|527419930|FG000|3 Month Follow Up|Physician Decision|0|||
146005424|NCT02820844|526537136|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146005425|NCT02820844|526537137|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
146005426|NCT02820844|526537132|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
146005427|NCT02820844|526537133|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
146092413|NCT03963401|526860291|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146092414|NCT03963401|526860292|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146092415|NCT03963401|526860293|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
146005428|NCT02820844|526537134|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146005429|NCT02820844|526537135|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146247822|NCT01147471|527419931|FG001|3 Month Follow Up|Physician Decision|1|||
146005430|NCT02820844|526537136|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146005431|NCT02820844|526537137|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
146005432|NCT02820844|526537132|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146005433|NCT02820844|526537133|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
146005434|NCT02820844|526537134|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146005435|NCT02820844|526537135|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146005436|NCT02820844|526537136|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146005437|NCT02820844|526537137|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
146005438|NCT02820844|526537132|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
146005439|NCT02820844|526537133|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
146005440|NCT02820844|526537134|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146005441|NCT02820844|526537135|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146005442|NCT02820844|526537136|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146005443|NCT02820844|526537137|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
146005444|NCT02820844|526537132|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
146005445|NCT02820844|526537133|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146005446|NCT02820844|526537134|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146005447|NCT02820844|526537135|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146005448|NCT02820844|526537136|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146005449|NCT02820844|526537137|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
146005450|NCT02820844|526537132|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146005451|NCT02820844|526537133|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146005452|NCT02820844|526537134|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
146005453|NCT02820844|526537135|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
146005454|NCT02820844|526537136|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146005455|NCT02820844|526537137|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
146005456|NCT02820844|526537132|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146005457|NCT02820844|526537133|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146005458|NCT02820844|526537134|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
146005459|NCT02820844|526537135|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146092416|NCT03963401|526860294|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
146092417|NCT03963401|526860295|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
146005460|NCT02820844|526537136|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146005461|NCT02820844|526537137|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
146005462|NCT02820844|526537132|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005463|NCT02820844|526537133|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005464|NCT02820844|526537134|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
146005465|NCT02820844|526537135|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
146005466|NCT02820844|526537136|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005467|NCT02820844|526537137|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005468|NCT02820844|526537132|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146005469|NCT02820844|526537133|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146005470|NCT02820844|526537134|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146005471|NCT02820844|526537135|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146005472|NCT02820844|526537136|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
146005473|NCT02820844|526537137|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
146005474|NCT02820844|526537132|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005475|NCT02820844|526537133|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146247823|NCT01147471|527419930|FG000|6 Month Follow Up|Lost to Follow-up|4|||
146247824|NCT01147471|527419931|FG001|6 Month Follow Up|Lost to Follow-up|2|||
146247825|NCT03890484|527419937|FG000|Overall Study|Lost to Follow-up|1|||
146247826|NCT03890484|527419938|FG001|Overall Study|Lost to Follow-up|1|||
146247827|NCT00518206|527419939|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
146247828|NCT00518206|527419940|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
146005476|NCT02820844|526537134|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146092418|NCT03963401|526860290|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146092419|NCT03963401|526860291|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
146092420|NCT03963401|526860292|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146247829|NCT00518206|527419939|FG000|Overall Study|Withdrawal by Subject|2|||
146247830|NCT00518206|527419940|FG001|Overall Study|Withdrawal by Subject|0|||
146247831|NCT00518206|527419939|FG000|Overall Study|Drug Supply Issue|1|||
146247832|NCT00518206|527419940|FG001|Overall Study|Drug Supply Issue|0|||
146005477|NCT02820844|526537135|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146092421|NCT03963401|526860293|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146247833|NCT00518206|527419939|FG000|Overall Study|Reason Unknown|1|||
146005478|NCT02820844|526537136|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
146005479|NCT02820844|526537137|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
146005480|NCT02266147|526537138|FG000|PART 1: Dose Escalation|Physician Decision|0|||
146005481|NCT02266147|526537139|FG001|PART 1: Dose Escalation|Physician Decision|0|||
146005482|NCT02266147|526537140|FG002|PART 1: Dose Escalation|Physician Decision|1|||
146005483|NCT02266147|526537141|FG003|PART 1: Dose Escalation|Physician Decision|0|||
146005484|NCT02266147|526537138|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
146005485|NCT02266147|526537139|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
146005486|NCT02266147|526537140|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
146005487|NCT02266147|526537141|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
146005488|NCT02266147|526537138|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
146005489|NCT02266147|526537139|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
146005490|NCT02266147|526537140|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
146005491|NCT02266147|526537141|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
146005492|NCT02266147|526537138|FG000|PART 1: Dose Escalation|Other|1|||
146005493|NCT02266147|526537139|FG001|PART 1: Dose Escalation|Other|1|||
146005494|NCT02266147|526537140|FG002|PART 1: Dose Escalation|Other|0|||
146005495|NCT02266147|526537141|FG003|PART 1: Dose Escalation|Other|0|||
146005496|NCT02266147|526537138|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
146005497|NCT02266147|526537139|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
146005498|NCT02266147|526537140|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
146005499|NCT02266147|526537141|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
146005500|NCT02266147|526537138|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
146005501|NCT02266147|526537139|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
146005502|NCT02266147|526537140|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
146005503|NCT02266147|526537141|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
146005504|NCT00573391|526537142|FG000|Overall Study|study stopped|2|||
146005505|NCT00573391|526537143|FG001|Overall Study|study stopped|2|||
146005506|NCT00573391|526537142|FG000|Overall Study|Death|1|||
146005507|NCT00573391|526537143|FG001|Overall Study|Death|0|||
146005508|NCT00413660|526537144|FG000|Up To Week 12|Adverse Event|1|||
146005509|NCT00413660|526537145|FG001|Up To Week 12|Adverse Event|3|||
146005510|NCT00413660|526537146|FG002|Up To Week 12|Adverse Event|1|||
146005511|NCT00413660|526537147|FG003|Up To Week 12|Adverse Event|4|||
146005512|NCT00413660|526537148|FG004|Up To Week 12|Adverse Event|6|||
146005513|NCT00413660|526537149|FG005|Up To Week 12|Adverse Event|4|||
146005514|NCT00413660|526537150|FG006|Up To Week 12|Adverse Event|1|||
146005515|NCT00413660|526537151|FG007|Up To Week 12|Adverse Event|0|||
146005516|NCT00413660|526537152|FG008|Up To Week 12|Adverse Event|0|||
146005517|NCT00413660|526537153|FG009|Up To Week 12|Adverse Event|0|||
146005518|NCT00413660|526537154|FG010|Up To Week 12|Adverse Event|0|||
146005519|NCT00413660|526537144|FG000|Up To Week 12|Lack of Efficacy|2|||
146005520|NCT00413660|526537145|FG001|Up To Week 12|Lack of Efficacy|0|||
146005521|NCT00413660|526537146|FG002|Up To Week 12|Lack of Efficacy|0|||
146005522|NCT00413660|526537147|FG003|Up To Week 12|Lack of Efficacy|0|||
146005523|NCT00413660|526537148|FG004|Up To Week 12|Lack of Efficacy|0|||
146005524|NCT00413660|526537149|FG005|Up To Week 12|Lack of Efficacy|0|||
146005525|NCT00413660|526537150|FG006|Up To Week 12|Lack of Efficacy|5|||
146005526|NCT00413660|526537151|FG007|Up To Week 12|Lack of Efficacy|0|||
146005527|NCT00413660|526537152|FG008|Up To Week 12|Lack of Efficacy|0|||
146005528|NCT00413660|526537153|FG009|Up To Week 12|Lack of Efficacy|0|||
146005529|NCT00413660|526537154|FG010|Up To Week 12|Lack of Efficacy|0|||
146005530|NCT00413660|526537144|FG000|Up To Week 12|Lost to Follow-up|0|||
146005531|NCT00413660|526537145|FG001|Up To Week 12|Lost to Follow-up|1|||
146005532|NCT00413660|526537146|FG002|Up To Week 12|Lost to Follow-up|0|||
146005533|NCT00413660|526537147|FG003|Up To Week 12|Lost to Follow-up|0|||
146005534|NCT00413660|526537148|FG004|Up To Week 12|Lost to Follow-up|1|||
146005535|NCT00413660|526537149|FG005|Up To Week 12|Lost to Follow-up|0|||
146005536|NCT00413660|526537150|FG006|Up To Week 12|Lost to Follow-up|0|||
146005537|NCT00413660|526537151|FG007|Up To Week 12|Lost to Follow-up|0|||
146005538|NCT00413660|526537152|FG008|Up To Week 12|Lost to Follow-up|0|||
146005539|NCT00413660|526537153|FG009|Up To Week 12|Lost to Follow-up|0|||
146005540|NCT00413660|526537154|FG010|Up To Week 12|Lost to Follow-up|0|||
146005541|NCT00413660|526537144|FG000|Up To Week 12|Withdrawal by Subject|0|||
146005542|NCT00413660|526537145|FG001|Up To Week 12|Withdrawal by Subject|2|||
146005543|NCT00413660|526537146|FG002|Up To Week 12|Withdrawal by Subject|0|||
146005544|NCT00413660|526537147|FG003|Up To Week 12|Withdrawal by Subject|2|||
146005545|NCT00413660|526537148|FG004|Up To Week 12|Withdrawal by Subject|0|||
146005546|NCT00413660|526537149|FG005|Up To Week 12|Withdrawal by Subject|2|||
146005547|NCT00413660|526537150|FG006|Up To Week 12|Withdrawal by Subject|2|||
146005548|NCT00413660|526537151|FG007|Up To Week 12|Withdrawal by Subject|0|||
146005549|NCT00413660|526537152|FG008|Up To Week 12|Withdrawal by Subject|0|||
146005550|NCT00413660|526537153|FG009|Up To Week 12|Withdrawal by Subject|0|||
146005551|NCT00413660|526537154|FG010|Up To Week 12|Withdrawal by Subject|0|||
146005552|NCT00413660|526537144|FG000|Up To Week 12|Randomized, Not Treated|1|||
146005553|NCT00413660|526537145|FG001|Up To Week 12|Randomized, Not Treated|0|||
146005554|NCT00413660|526537146|FG002|Up To Week 12|Randomized, Not Treated|0|||
146005555|NCT00413660|526537147|FG003|Up To Week 12|Randomized, Not Treated|1|||
146005556|NCT00413660|526537148|FG004|Up To Week 12|Randomized, Not Treated|0|||
146005557|NCT00413660|526537149|FG005|Up To Week 12|Randomized, Not Treated|0|||
146005558|NCT00413660|526537150|FG006|Up To Week 12|Randomized, Not Treated|0|||
146005559|NCT00413660|526537151|FG007|Up To Week 12|Randomized, Not Treated|0|||
146005560|NCT00413660|526537152|FG008|Up To Week 12|Randomized, Not Treated|0|||
146005561|NCT00413660|526537153|FG009|Up To Week 12|Randomized, Not Treated|0|||
146005562|NCT00413660|526537154|FG010|Up To Week 12|Randomized, Not Treated|0|||
146005563|NCT00413660|526537144|FG000|Up To Week 12|Other|3|||
146005564|NCT00413660|526537145|FG001|Up To Week 12|Other|1|||
146005565|NCT00413660|526537146|FG002|Up To Week 12|Other|6|||
146005566|NCT00413660|526537147|FG003|Up To Week 12|Other|1|||
146005567|NCT00413660|526537148|FG004|Up To Week 12|Other|2|||
146005568|NCT00413660|526537149|FG005|Up To Week 12|Other|4|||
146005569|NCT00413660|526537150|FG006|Up To Week 12|Other|3|||
146005570|NCT00413660|526537151|FG007|Up To Week 12|Other|0|||
146005571|NCT00413660|526537152|FG008|Up To Week 12|Other|0|||
146005572|NCT00413660|526537153|FG009|Up To Week 12|Other|0|||
146005573|NCT00413660|526537154|FG010|Up To Week 12|Other|0|||
146005574|NCT00413660|526537144|FG000|Post Week 12|Adverse Event|2|||
146005575|NCT00413660|526537145|FG001|Post Week 12|Adverse Event|0|||
146005576|NCT00413660|526537146|FG002|Post Week 12|Adverse Event|2|||
146005577|NCT00413660|526537147|FG003|Post Week 12|Adverse Event|1|||
146005578|NCT00413660|526537148|FG004|Post Week 12|Adverse Event|4|||
146005579|NCT00413660|526537149|FG005|Post Week 12|Adverse Event|2|||
146005580|NCT00413660|526537150|FG006|Post Week 12|Adverse Event|2|||
146005581|NCT00413660|526537151|FG007|Post Week 12|Adverse Event|0|||
146005582|NCT00413660|526537152|FG008|Post Week 12|Adverse Event|0|||
146005583|NCT00413660|526537153|FG009|Post Week 12|Adverse Event|0|||
146005584|NCT00413660|526537154|FG010|Post Week 12|Adverse Event|0|||
146005585|NCT00413660|526537144|FG000|Post Week 12|Lack of Efficacy|0|||
146005586|NCT00413660|526537145|FG001|Post Week 12|Lack of Efficacy|0|||
146005587|NCT00413660|526537146|FG002|Post Week 12|Lack of Efficacy|1|||
146005588|NCT00413660|526537147|FG003|Post Week 12|Lack of Efficacy|0|||
146005589|NCT00413660|526537148|FG004|Post Week 12|Lack of Efficacy|0|||
146005590|NCT00413660|526537149|FG005|Post Week 12|Lack of Efficacy|0|||
146005591|NCT00413660|526537150|FG006|Post Week 12|Lack of Efficacy|0|||
146005592|NCT00413660|526537151|FG007|Post Week 12|Lack of Efficacy|0|||
146005593|NCT00413660|526537152|FG008|Post Week 12|Lack of Efficacy|0|||
146005594|NCT00413660|526537153|FG009|Post Week 12|Lack of Efficacy|1|||
146005595|NCT00413660|526537154|FG010|Post Week 12|Lack of Efficacy|0|||
146005596|NCT00413660|526537144|FG000|Post Week 12|Lost to Follow-up|0|||
146005597|NCT00413660|526537145|FG001|Post Week 12|Lost to Follow-up|1|||
146005598|NCT00413660|526537146|FG002|Post Week 12|Lost to Follow-up|1|||
146005599|NCT00413660|526537147|FG003|Post Week 12|Lost to Follow-up|0|||
146005600|NCT00413660|526537148|FG004|Post Week 12|Lost to Follow-up|0|||
146005601|NCT00413660|526537149|FG005|Post Week 12|Lost to Follow-up|0|||
146005602|NCT00413660|526537150|FG006|Post Week 12|Lost to Follow-up|0|||
146005603|NCT00413660|526537151|FG007|Post Week 12|Lost to Follow-up|0|||
146005604|NCT00413660|526537152|FG008|Post Week 12|Lost to Follow-up|0|||
146005605|NCT00413660|526537153|FG009|Post Week 12|Lost to Follow-up|0|||
146005606|NCT00413660|526537154|FG010|Post Week 12|Lost to Follow-up|0|||
146005607|NCT00413660|526537144|FG000|Post Week 12|Withdrawal by Subject|0|||
146005608|NCT00413660|526537145|FG001|Post Week 12|Withdrawal by Subject|1|||
146005609|NCT00413660|526537146|FG002|Post Week 12|Withdrawal by Subject|1|||
146005610|NCT00413660|526537147|FG003|Post Week 12|Withdrawal by Subject|0|||
146005611|NCT00413660|526537148|FG004|Post Week 12|Withdrawal by Subject|1|||
146005612|NCT00413660|526537149|FG005|Post Week 12|Withdrawal by Subject|0|||
146005613|NCT00413660|526537150|FG006|Post Week 12|Withdrawal by Subject|0|||
146005614|NCT00413660|526537151|FG007|Post Week 12|Withdrawal by Subject|0|||
146005615|NCT00413660|526537152|FG008|Post Week 12|Withdrawal by Subject|0|||
146005616|NCT00413660|526537153|FG009|Post Week 12|Withdrawal by Subject|0|||
146005617|NCT00413660|526537154|FG010|Post Week 12|Withdrawal by Subject|1|||
146005618|NCT00413660|526537144|FG000|Post Week 12|Other|1|||
146005619|NCT00413660|526537145|FG001|Post Week 12|Other|2|||
146005620|NCT00413660|526537146|FG002|Post Week 12|Other|3|||
146005621|NCT00413660|526537147|FG003|Post Week 12|Other|0|||
146005622|NCT00413660|526537148|FG004|Post Week 12|Other|1|||
146005623|NCT00413660|526537149|FG005|Post Week 12|Other|1|||
146005624|NCT00413660|526537150|FG006|Post Week 12|Other|1|||
146005625|NCT00413660|526537151|FG007|Post Week 12|Other|0|||
146005626|NCT00413660|526537152|FG008|Post Week 12|Other|0|||
146005627|NCT00413660|526537153|FG009|Post Week 12|Other|0|||
146005628|NCT00413660|526537154|FG010|Post Week 12|Other|0|||
146005629|NCT03896477|526537157|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
146005630|NCT03896477|526537158|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
146005631|NCT03896477|526537159|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
146005632|NCT03896477|526537157|FG000|Overall Study|Parent Requested Withdrawal|8|||
146005633|NCT03896477|526537158|FG001|Overall Study|Parent Requested Withdrawal|12|||
146247834|NCT00518206|527419940|FG001|Overall Study|Reason Unknown|0|||
146247835|NCT00518206|527419939|FG000|Overall Study|Completion Status Unknown|1|||
146247836|NCT00518206|527419940|FG001|Overall Study|Completion Status Unknown|0|||
146247837|NCT01294644|527419941|FG000|Overall Study|Adverse Event|2|||
146247838|NCT01294644|527419942|FG001|Overall Study|Adverse Event|0|||
146247839|NCT01294644|527419943|FG002|Overall Study|Adverse Event|1|||
146247840|NCT01294644|527419941|FG000|Overall Study|Withdrawal by Subject|3|||
146247841|NCT01294644|527419942|FG001|Overall Study|Withdrawal by Subject|7|||
146247842|NCT01294644|527419943|FG002|Overall Study|Withdrawal by Subject|4|||
146247843|NCT01294644|527419941|FG000|Overall Study|Lost to Follow-up|3|||
146247844|NCT01294644|527419942|FG001|Overall Study|Lost to Follow-up|2|||
146247845|NCT01294644|527419943|FG002|Overall Study|Lost to Follow-up|5|||
146247846|NCT01294644|527419941|FG000|Overall Study|Miscellaneous Reason|2|||
146247847|NCT01294644|527419942|FG001|Overall Study|Miscellaneous Reason|1|||
146247848|NCT01294644|527419943|FG002|Overall Study|Miscellaneous Reason|4|||
146247849|NCT02188459|527419944|FG000|Overall Study|Lost to Follow-up|3|||
146247850|NCT02188459|527419945|FG001|Overall Study|Lost to Follow-up|4|||
146247851|NCT02188459|527419944|FG000|Overall Study|Early Termination|0|||
146247852|NCT02188459|527419945|FG001|Overall Study|Early Termination|3|||
146247853|NCT02548585|527419946|FG000|Overall Study|Withdrawal by Subject|0|||
146247854|NCT02548585|527419947|FG001|Overall Study|Withdrawal by Subject|0|||
146247855|NCT02548585|527419948|FG002|Overall Study|Withdrawal by Subject|0|||
146247856|NCT02548585|527419949|FG003|Overall Study|Withdrawal by Subject|0|||
146247857|NCT02548585|527419950|FG004|Overall Study|Withdrawal by Subject|0|||
146247858|NCT02548585|527419951|FG005|Overall Study|Withdrawal by Subject|1|||
146247859|NCT02548585|527419952|FG006|Overall Study|Withdrawal by Subject|0|||
146247860|NCT02548585|527419946|FG000|Overall Study|Lost to Follow-up|1|||
146247861|NCT02548585|527419947|FG001|Overall Study|Lost to Follow-up|0|||
146247862|NCT02548585|527419948|FG002|Overall Study|Lost to Follow-up|0|||
146247863|NCT02548585|527419949|FG003|Overall Study|Lost to Follow-up|0|||
146247864|NCT02548585|527419950|FG004|Overall Study|Lost to Follow-up|0|||
146247865|NCT02548585|527419951|FG005|Overall Study|Lost to Follow-up|0|||
146247866|NCT02548585|527419952|FG006|Overall Study|Lost to Follow-up|0|||
146247867|NCT02548585|527419946|FG000|Overall Study|Other|1|||
146247868|NCT02548585|527419947|FG001|Overall Study|Other|0|||
146247869|NCT02548585|527419948|FG002|Overall Study|Other|0|||
146247870|NCT02548585|527419949|FG003|Overall Study|Other|2|||
146247871|NCT02548585|527419950|FG004|Overall Study|Other|3|||
146298126|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Study suspension|0|||
146005634|NCT03896477|526537159|FG002|Overall Study|Parent Requested Withdrawal|9|||
146005635|NCT03896477|526537157|FG000|Overall Study|Adverse Event|0|||
146005636|NCT03896477|526537158|FG001|Overall Study|Adverse Event|0|||
146005637|NCT03896477|526537159|FG002|Overall Study|Adverse Event|1|||
146005638|NCT03896477|526537157|FG000|Overall Study|Death|1|||
146005639|NCT03896477|526537158|FG001|Overall Study|Death|0|||
146005640|NCT03896477|526537159|FG002|Overall Study|Death|0|||
146005641|NCT03896477|526537157|FG000|Overall Study|Other|5|||
146005642|NCT03896477|526537158|FG001|Overall Study|Other|6|||
146005643|NCT03896477|526537159|FG002|Overall Study|Other|7|||
146005644|NCT03896477|526537157|FG000|Overall Study|Lost to Follow-up|2|||
146005645|NCT03896477|526537158|FG001|Overall Study|Lost to Follow-up|1|||
146005646|NCT03896477|526537159|FG002|Overall Study|Lost to Follow-up|1|||
146005647|NCT01791517|526537160|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
146005648|NCT01791517|526537161|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
146005649|NCT01791517|526537162|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
146005650|NCT01791517|526537163|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
146005651|NCT01791517|526537164|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
146005652|NCT01791517|526537165|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
146005653|NCT01791517|526537166|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
146005654|NCT01791517|526537167|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
146005655|NCT01791517|526537168|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
146005656|NCT01791517|526537169|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
146005657|NCT01791517|526537170|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
146005658|NCT01791517|526537171|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
146005659|NCT01791517|526537160|FG000|Phase I: Period 1|Adverse Event|0|||
146298127|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
146005660|NCT01791517|526537161|FG001|Phase I: Period 1|Adverse Event|0|||
146005661|NCT01791517|526537162|FG002|Phase I: Period 1|Adverse Event|1|||
146005662|NCT01791517|526537163|FG003|Phase I: Period 1|Adverse Event|1|||
146092422|NCT03963401|526860294|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146005663|NCT01791517|526537164|FG004|Phase I: Period 1|Adverse Event|0|||
146005664|NCT01791517|526537165|FG005|Phase I: Period 1|Adverse Event|0|||
146247872|NCT02548585|527419951|FG005|Overall Study|Other|0|||
146247873|NCT02548585|527419952|FG006|Overall Study|Other|1|||
146247874|NCT02548585|527419946|FG000|Overall Study|Randomized but not treated|0|||
146247875|NCT02548585|527419947|FG001|Overall Study|Randomized but not treated|0|||
146247876|NCT02548585|527419948|FG002|Overall Study|Randomized but not treated|0|||
146247877|NCT02548585|527419949|FG003|Overall Study|Randomized but not treated|0|||
146247878|NCT02548585|527419950|FG004|Overall Study|Randomized but not treated|0|||
146247879|NCT02548585|527419951|FG005|Overall Study|Randomized but not treated|1|||
146247880|NCT02548585|527419952|FG006|Overall Study|Randomized but not treated|0|||
146247881|NCT02612285|527419953|FG000|Overall Study|Withdrawal by Subject|1|||
146247882|NCT00853957|527419958|FG000|Overall Study|Adverse Event|9|||
146247883|NCT00853957|527419959|FG001|Overall Study|Adverse Event|3|||
146247884|NCT00853957|527419958|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146247885|NCT00853957|527419959|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146247886|NCT00853957|527419958|FG000|Overall Study|Subject withdrew consent|4|||
146247887|NCT00853957|527419959|FG001|Overall Study|Subject withdrew consent|5|||
146247888|NCT00853957|527419958|FG000|Overall Study|Lost to Follow-up|1|||
146247889|NCT00853957|527419959|FG001|Overall Study|Lost to Follow-up|6|||
146247890|NCT00853957|527419958|FG000|Overall Study|Protocol deviation|0|||
146247891|NCT00853957|527419959|FG001|Overall Study|Protocol deviation|3|||
146247892|NCT02942771|527419960|FG000|Overall Study|Adverse Event|1|||
146247893|NCT02942771|527419961|FG001|Overall Study|Adverse Event|0|||
146247894|NCT02942771|527419962|FG002|Overall Study|Adverse Event|0|||
146247895|NCT02942771|527419963|FG003|Overall Study|Adverse Event|0|||
146247896|NCT02942771|527419964|FG004|Overall Study|Adverse Event|2|||
146247897|NCT02942771|527419960|FG000|Overall Study|Lost to Follow-up|1|||
146247898|NCT02942771|527419961|FG001|Overall Study|Lost to Follow-up|0|||
146247899|NCT02942771|527419962|FG002|Overall Study|Lost to Follow-up|0|||
146247900|NCT02942771|527419963|FG003|Overall Study|Lost to Follow-up|0|||
146005665|NCT01791517|526537166|FG006|Phase I: Period 1|Adverse Event|0|||
146005666|NCT01791517|526537167|FG007|Phase I: Period 1|Adverse Event|0|||
146005667|NCT01791517|526537168|FG008|Phase I: Period 1|Adverse Event|0|||
146005668|NCT01791517|526537169|FG009|Phase I: Period 1|Adverse Event|0|||
146005669|NCT01791517|526537170|FG010|Phase I: Period 1|Adverse Event|0|||
146005670|NCT01791517|526537171|FG011|Phase I: Period 1|Adverse Event|0|||
146005671|NCT01791517|526537160|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
146005672|NCT01791517|526537161|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005673|NCT01791517|526537162|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005674|NCT01791517|526537163|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005675|NCT01791517|526537164|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005676|NCT01791517|526537165|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005677|NCT01791517|526537166|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005678|NCT01791517|526537167|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005679|NCT01791517|526537168|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005680|NCT01791517|526537169|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005681|NCT01791517|526537170|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005682|NCT01791517|526537171|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
146005683|NCT01791517|526537160|FG000|Phase I: Period 1|Protocol Violation|0|||
146005684|NCT01791517|526537161|FG001|Phase I: Period 1|Protocol Violation|1|||
146005685|NCT01791517|526537162|FG002|Phase I: Period 1|Protocol Violation|0|||
146005686|NCT01791517|526537163|FG003|Phase I: Period 1|Protocol Violation|0|||
146005687|NCT01791517|526537164|FG004|Phase I: Period 1|Protocol Violation|0|||
146005688|NCT01791517|526537165|FG005|Phase I: Period 1|Protocol Violation|0|||
146005689|NCT01791517|526537166|FG006|Phase I: Period 1|Protocol Violation|0|||
146005690|NCT01791517|526537167|FG007|Phase I: Period 1|Protocol Violation|0|||
146005691|NCT01791517|526537168|FG008|Phase I: Period 1|Protocol Violation|0|||
146005692|NCT01791517|526537169|FG009|Phase I: Period 1|Protocol Violation|0|||
146005693|NCT01791517|526537170|FG010|Phase I: Period 1|Protocol Violation|0|||
146005694|NCT01791517|526537171|FG011|Phase I: Period 1|Protocol Violation|0|||
146005695|NCT01791517|526537160|FG000|Phase I: Period 1|Lost to Follow-up|0|||
146005696|NCT01791517|526537161|FG001|Phase I: Period 1|Lost to Follow-up|0|||
146005697|NCT01791517|526537162|FG002|Phase I: Period 1|Lost to Follow-up|0|||
146005698|NCT01791517|526537163|FG003|Phase I: Period 1|Lost to Follow-up|1|||
146005699|NCT01791517|526537164|FG004|Phase I: Period 1|Lost to Follow-up|0|||
146005700|NCT01791517|526537165|FG005|Phase I: Period 1|Lost to Follow-up|0|||
146247901|NCT02942771|527419964|FG004|Overall Study|Lost to Follow-up|0|||
146247902|NCT02942771|527419960|FG000|Overall Study|Withdrawal by Subject|1|||
146247903|NCT02942771|527419961|FG001|Overall Study|Withdrawal by Subject|0|||
146247904|NCT02942771|527419962|FG002|Overall Study|Withdrawal by Subject|0|||
146005701|NCT01791517|526537166|FG006|Phase I: Period 1|Lost to Follow-up|1|||
146005702|NCT01791517|526537167|FG007|Phase I: Period 1|Lost to Follow-up|0|||
146247905|NCT02942771|527419963|FG003|Overall Study|Withdrawal by Subject|0|||
146005703|NCT01791517|526537168|FG008|Phase I: Period 1|Lost to Follow-up|1|||
146005704|NCT01791517|526537169|FG009|Phase I: Period 1|Lost to Follow-up|1|||
146005705|NCT01791517|526537170|FG010|Phase I: Period 1|Lost to Follow-up|0|||
146005706|NCT01791517|526537171|FG011|Phase I: Period 1|Lost to Follow-up|0|||
146247906|NCT02942771|527419964|FG004|Overall Study|Withdrawal by Subject|2|||
146247907|NCT04919499|527419965|FG000|Overall Study|Adverse Event|0|||
146247908|NCT04919499|527419966|FG001|Overall Study|Adverse Event|0|||
146247909|NCT04919499|527419967|FG002|Overall Study|Adverse Event|0|||
146005707|NCT01791517|526537160|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
146247910|NCT04919499|527419968|FG003|Overall Study|Adverse Event|0|||
146247911|NCT04919499|527419969|FG004|Overall Study|Adverse Event|2|||
146298128|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
146298129|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
146298130|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
146298131|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Death|2|||
146298132|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Death|3|||
146298133|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Death|0|||
146298134|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Death|0|||
146298135|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
146298136|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
146298137|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
146298138|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
146298139|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
146005708|NCT01791517|526537161|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005709|NCT01791517|526537162|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005710|NCT01791517|526537163|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005711|NCT01791517|526537164|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
146298140|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
146005712|NCT01791517|526537165|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005713|NCT01791517|526537166|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005714|NCT01791517|526537167|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005715|NCT01791517|526537168|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005716|NCT01791517|526537169|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005717|NCT01791517|526537170|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
146005718|NCT01791517|526537171|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
146005719|NCT01791517|526537160|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
146005720|NCT01791517|526537161|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005721|NCT01791517|526537162|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005722|NCT01791517|526537163|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005723|NCT01791517|526537164|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005724|NCT01791517|526537165|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005725|NCT01791517|526537166|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005726|NCT01791517|526537167|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005727|NCT01791517|526537168|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005728|NCT01791517|526537169|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005729|NCT01791517|526537170|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005730|NCT01791517|526537171|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
146005731|NCT01791517|526537160|FG000|Phase I: Period 2|Protocol Violation|0|||
146005732|NCT01791517|526537161|FG001|Phase I: Period 2|Protocol Violation|0|||
146005733|NCT01791517|526537162|FG002|Phase I: Period 2|Protocol Violation|0|||
146005734|NCT01791517|526537163|FG003|Phase I: Period 2|Protocol Violation|1|||
146005735|NCT01791517|526537164|FG004|Phase I: Period 2|Protocol Violation|0|||
146005736|NCT01791517|526537165|FG005|Phase I: Period 2|Protocol Violation|0|||
146005737|NCT01791517|526537166|FG006|Phase I: Period 2|Protocol Violation|0|||
146005738|NCT01791517|526537167|FG007|Phase I: Period 2|Protocol Violation|0|||
146005739|NCT01791517|526537168|FG008|Phase I: Period 2|Protocol Violation|0|||
146005740|NCT01791517|526537169|FG009|Phase I: Period 2|Protocol Violation|0|||
146005741|NCT01791517|526537170|FG010|Phase I: Period 2|Protocol Violation|0|||
146005742|NCT01791517|526537171|FG011|Phase I: Period 2|Protocol Violation|0|||
146005743|NCT01791517|526537160|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
146005744|NCT01791517|526537161|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
146005745|NCT01791517|526537162|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
146005746|NCT01791517|526537163|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
146005747|NCT01791517|526537164|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
146005748|NCT01791517|526537165|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
146005749|NCT01791517|526537166|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
146005750|NCT01791517|526537167|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
146005751|NCT01791517|526537168|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
146005752|NCT01791517|526537169|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
146005753|NCT01791517|526537170|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
146005754|NCT01791517|526537171|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
146005755|NCT01791517|526537160|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005756|NCT01791517|526537161|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005757|NCT01791517|526537162|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005758|NCT01791517|526537163|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005759|NCT01791517|526537164|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146298141|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
146005760|NCT01791517|526537165|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146298142|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
146005761|NCT01791517|526537166|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005762|NCT01791517|526537167|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005763|NCT01791517|526537168|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005764|NCT01791517|526537169|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005765|NCT01791517|526537170|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
146005766|NCT01791517|526537171|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
146005767|NCT01791517|526537160|FG000|Phase I: Period 2|Lens Discomfort|0|||
146005768|NCT01791517|526537161|FG001|Phase I: Period 2|Lens Discomfort|0|||
146005769|NCT01791517|526537162|FG002|Phase I: Period 2|Lens Discomfort|0|||
146005770|NCT01791517|526537163|FG003|Phase I: Period 2|Lens Discomfort|0|||
146005771|NCT01791517|526537164|FG004|Phase I: Period 2|Lens Discomfort|0|||
146005772|NCT01791517|526537165|FG005|Phase I: Period 2|Lens Discomfort|1|||
146005773|NCT01791517|526537166|FG006|Phase I: Period 2|Lens Discomfort|0|||
146005774|NCT01791517|526537167|FG007|Phase I: Period 2|Lens Discomfort|0|||
146005775|NCT01791517|526537168|FG008|Phase I: Period 2|Lens Discomfort|0|||
146005776|NCT01791517|526537169|FG009|Phase I: Period 2|Lens Discomfort|0|||
146005777|NCT01791517|526537170|FG010|Phase I: Period 2|Lens Discomfort|0|||
146005778|NCT01791517|526537171|FG011|Phase I: Period 2|Lens Discomfort|0|||
146005779|NCT01791517|526537160|FG000|Phase I: Period 2|Lost to Follow-up|0|||
146005780|NCT01791517|526537161|FG001|Phase I: Period 2|Lost to Follow-up|3|||
146005781|NCT01791517|526537162|FG002|Phase I: Period 2|Lost to Follow-up|2|||
146005782|NCT01791517|526537163|FG003|Phase I: Period 2|Lost to Follow-up|0|||
146005783|NCT01791517|526537164|FG004|Phase I: Period 2|Lost to Follow-up|0|||
146005784|NCT01791517|526537165|FG005|Phase I: Period 2|Lost to Follow-up|0|||
146005785|NCT01791517|526537166|FG006|Phase I: Period 2|Lost to Follow-up|0|||
146005786|NCT01791517|526537167|FG007|Phase I: Period 2|Lost to Follow-up|0|||
146005787|NCT01791517|526537168|FG008|Phase I: Period 2|Lost to Follow-up|0|||
146005788|NCT01791517|526537169|FG009|Phase I: Period 2|Lost to Follow-up|0|||
146092423|NCT03963401|526860295|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
146092424|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
146092425|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
146247912|NCT04919499|527419965|FG000|Overall Study|Not treated|0|||
146005789|NCT01791517|526537170|FG010|Phase I: Period 2|Lost to Follow-up|0|||
146005790|NCT01791517|526537171|FG011|Phase I: Period 2|Lost to Follow-up|0|||
146005791|NCT01791517|526537160|FG000|Phase I: Period 3|Lens Discomfort|0|||
146005792|NCT01791517|526537161|FG001|Phase I: Period 3|Lens Discomfort|0|||
146005793|NCT01791517|526537162|FG002|Phase I: Period 3|Lens Discomfort|0|||
146005794|NCT01791517|526537163|FG003|Phase I: Period 3|Lens Discomfort|0|||
146005795|NCT01791517|526537164|FG004|Phase I: Period 3|Lens Discomfort|0|||
146005796|NCT01791517|526537165|FG005|Phase I: Period 3|Lens Discomfort|0|||
146005797|NCT01791517|526537166|FG006|Phase I: Period 3|Lens Discomfort|0|||
146005798|NCT01791517|526537167|FG007|Phase I: Period 3|Lens Discomfort|0|||
146005799|NCT01791517|526537168|FG008|Phase I: Period 3|Lens Discomfort|0|||
146005800|NCT01791517|526537169|FG009|Phase I: Period 3|Lens Discomfort|0|||
146005801|NCT01791517|526537170|FG010|Phase I: Period 3|Lens Discomfort|0|||
146005802|NCT01791517|526537171|FG011|Phase I: Period 3|Lens Discomfort|1|||
146005803|NCT01791517|526537160|FG000|Phase I: Period 3|Lost to Follow-up|0|||
146005804|NCT01791517|526537161|FG001|Phase I: Period 3|Lost to Follow-up|1|||
146005805|NCT01791517|526537162|FG002|Phase I: Period 3|Lost to Follow-up|0|||
146005806|NCT01791517|526537163|FG003|Phase I: Period 3|Lost to Follow-up|0|||
146005807|NCT01791517|526537164|FG004|Phase I: Period 3|Lost to Follow-up|1|||
146005808|NCT01791517|526537165|FG005|Phase I: Period 3|Lost to Follow-up|0|||
146005809|NCT01791517|526537166|FG006|Phase I: Period 3|Lost to Follow-up|0|||
146005810|NCT01791517|526537167|FG007|Phase I: Period 3|Lost to Follow-up|0|||
146005811|NCT01791517|526537168|FG008|Phase I: Period 3|Lost to Follow-up|0|||
146005812|NCT01791517|526537169|FG009|Phase I: Period 3|Lost to Follow-up|0|||
146005813|NCT01791517|526537170|FG010|Phase I: Period 3|Lost to Follow-up|0|||
146005814|NCT01791517|526537171|FG011|Phase I: Period 3|Lost to Follow-up|0|||
146005815|NCT01791517|526537160|FG000|Phase I: Period 3|Adverse Event|0|||
146005816|NCT01791517|526537161|FG001|Phase I: Period 3|Adverse Event|0|||
146005817|NCT01791517|526537162|FG002|Phase I: Period 3|Adverse Event|0|||
146005818|NCT01791517|526537163|FG003|Phase I: Period 3|Adverse Event|1|||
146005819|NCT01791517|526537164|FG004|Phase I: Period 3|Adverse Event|0|||
146005820|NCT01791517|526537165|FG005|Phase I: Period 3|Adverse Event|0|||
146247913|NCT04919499|527419966|FG001|Overall Study|Not treated|0|||
146247914|NCT04919499|527419967|FG002|Overall Study|Not treated|0|||
146247915|NCT04919499|527419968|FG003|Overall Study|Not treated|1|||
146247916|NCT04919499|527419969|FG004|Overall Study|Not treated|0|||
146247917|NCT04914897|527421532|FG000|Overall Study|Withdrawal by Subject|3|||
146247918|NCT04914897|527421533|FG001|Overall Study|Withdrawal by Subject|1|||
146247919|NCT04914897|527421534|FG002|Overall Study|Withdrawal by Subject|1|||
146247920|NCT04914897|527421535|FG003|Overall Study|Withdrawal by Subject|1|||
146005821|NCT01791517|526537166|FG006|Phase I: Period 3|Adverse Event|0|||
146005822|NCT01791517|526537167|FG007|Phase I: Period 3|Adverse Event|0|||
146005823|NCT01791517|526537168|FG008|Phase I: Period 3|Adverse Event|0|||
146005824|NCT01791517|526537169|FG009|Phase I: Period 3|Adverse Event|0|||
146005825|NCT01791517|526537170|FG010|Phase I: Period 3|Adverse Event|0|||
146005826|NCT01791517|526537171|FG011|Phase I: Period 3|Adverse Event|0|||
146005827|NCT01791517|526537160|FG000|Phase II|Lost to Follow-up|1|||
146005828|NCT01791517|526537161|FG001|Phase II|Lost to Follow-up|0|||
146005829|NCT01791517|526537162|FG002|Phase II|Lost to Follow-up|1|||
146247921|NCT04914897|527421532|FG000|Overall Study|Poor compliance to protocol|0|||
146005830|NCT01791517|526537163|FG003|Phase II|Lost to Follow-up|0|||
146005831|NCT01791517|526537164|FG004|Phase II|Lost to Follow-up|1|||
146005832|NCT01791517|526537165|FG005|Phase II|Lost to Follow-up|2|||
146005833|NCT01791517|526537166|FG006|Phase II|Lost to Follow-up|0|||
146005834|NCT01791517|526537167|FG007|Phase II|Lost to Follow-up|1|||
146005835|NCT01791517|526537168|FG008|Phase II|Lost to Follow-up|1|||
146005836|NCT01791517|526537169|FG009|Phase II|Lost to Follow-up|1|||
146005837|NCT01791517|526537170|FG010|Phase II|Lost to Follow-up|0|||
146005838|NCT01791517|526537171|FG011|Phase II|Lost to Follow-up|0|||
146005839|NCT01791517|526537160|FG000|Phase II|Withdrawal by Subject|1|||
146005840|NCT01791517|526537161|FG001|Phase II|Withdrawal by Subject|0|||
146005841|NCT01791517|526537162|FG002|Phase II|Withdrawal by Subject|0|||
146005842|NCT01791517|526537163|FG003|Phase II|Withdrawal by Subject|0|||
146005843|NCT01791517|526537164|FG004|Phase II|Withdrawal by Subject|0|||
146005844|NCT01791517|526537165|FG005|Phase II|Withdrawal by Subject|2|||
146005845|NCT01791517|526537166|FG006|Phase II|Withdrawal by Subject|0|||
146005846|NCT01791517|526537167|FG007|Phase II|Withdrawal by Subject|1|||
146005847|NCT01791517|526537168|FG008|Phase II|Withdrawal by Subject|0|||
146005848|NCT01791517|526537169|FG009|Phase II|Withdrawal by Subject|0|||
146005849|NCT01791517|526537170|FG010|Phase II|Withdrawal by Subject|1|||
146005850|NCT01791517|526537171|FG011|Phase II|Withdrawal by Subject|0|||
146005851|NCT01791517|526537160|FG000|Phase II|Lack of Efficacy|0|||
146005852|NCT01791517|526537161|FG001|Phase II|Lack of Efficacy|0|||
146005853|NCT01791517|526537162|FG002|Phase II|Lack of Efficacy|0|||
146005854|NCT01791517|526537163|FG003|Phase II|Lack of Efficacy|0|||
146005855|NCT01791517|526537164|FG004|Phase II|Lack of Efficacy|1|||
146005856|NCT01791517|526537165|FG005|Phase II|Lack of Efficacy|0|||
146005857|NCT01791517|526537166|FG006|Phase II|Lack of Efficacy|0|||
146005858|NCT01791517|526537167|FG007|Phase II|Lack of Efficacy|0|||
146005859|NCT01791517|526537168|FG008|Phase II|Lack of Efficacy|0|||
146005860|NCT01791517|526537169|FG009|Phase II|Lack of Efficacy|0|||
146005861|NCT01791517|526537170|FG010|Phase II|Lack of Efficacy|0|||
146005862|NCT01791517|526537171|FG011|Phase II|Lack of Efficacy|0|||
146005863|NCT01791517|526537160|FG000|Phase II|Adverse Event|0|||
146005864|NCT01791517|526537161|FG001|Phase II|Adverse Event|0|||
146005865|NCT01791517|526537162|FG002|Phase II|Adverse Event|0|||
146005866|NCT01791517|526537163|FG003|Phase II|Adverse Event|0|||
146005867|NCT01791517|526537164|FG004|Phase II|Adverse Event|0|||
146005868|NCT01791517|526537165|FG005|Phase II|Adverse Event|0|||
146005869|NCT01791517|526537166|FG006|Phase II|Adverse Event|2|||
146005870|NCT01791517|526537167|FG007|Phase II|Adverse Event|1|||
146005871|NCT01791517|526537168|FG008|Phase II|Adverse Event|0|||
146005872|NCT01791517|526537169|FG009|Phase II|Adverse Event|1|||
146005873|NCT01791517|526537170|FG010|Phase II|Adverse Event|0|||
146005874|NCT01791517|526537171|FG011|Phase II|Adverse Event|0|||
146005875|NCT01791517|526537160|FG000|Phase II|Lens Handling Difficulties|0|||
146005876|NCT01791517|526537161|FG001|Phase II|Lens Handling Difficulties|0|||
146005877|NCT01791517|526537162|FG002|Phase II|Lens Handling Difficulties|0|||
146005878|NCT01791517|526537163|FG003|Phase II|Lens Handling Difficulties|0|||
146005879|NCT01791517|526537164|FG004|Phase II|Lens Handling Difficulties|0|||
146005880|NCT01791517|526537165|FG005|Phase II|Lens Handling Difficulties|0|||
146005881|NCT01791517|526537166|FG006|Phase II|Lens Handling Difficulties|0|||
146005882|NCT01791517|526537167|FG007|Phase II|Lens Handling Difficulties|0|||
146005883|NCT01791517|526537168|FG008|Phase II|Lens Handling Difficulties|1|||
146005884|NCT01791517|526537169|FG009|Phase II|Lens Handling Difficulties|0|||
146247922|NCT04914897|527421533|FG001|Overall Study|Poor compliance to protocol|0|||
146005885|NCT01791517|526537170|FG010|Phase II|Lens Handling Difficulties|0|||
146005886|NCT01791517|526537171|FG011|Phase II|Lens Handling Difficulties|0|||
146005887|NCT01791517|526537160|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
146005888|NCT01791517|526537161|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
146005889|NCT01791517|526537162|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
146005890|NCT01791517|526537163|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
146005891|NCT01791517|526537164|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
146005892|NCT01791517|526537165|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
146005893|NCT01791517|526537166|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
146005894|NCT01791517|526537167|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
146005895|NCT01791517|526537168|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
146005896|NCT01791517|526537169|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
146005897|NCT01791517|526537170|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
146092426|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
146247923|NCT04914897|527421534|FG002|Overall Study|Poor compliance to protocol|1|||
146005898|NCT01791517|526537171|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
146005899|NCT01791517|526537160|FG000|Phase II|Pre-Existing Ocular Issue|0|||
146005900|NCT01791517|526537161|FG001|Phase II|Pre-Existing Ocular Issue|0|||
146005901|NCT01791517|526537162|FG002|Phase II|Pre-Existing Ocular Issue|0|||
146005902|NCT01791517|526537163|FG003|Phase II|Pre-Existing Ocular Issue|0|||
146005903|NCT01791517|526537164|FG004|Phase II|Pre-Existing Ocular Issue|0|||
146005904|NCT01791517|526537165|FG005|Phase II|Pre-Existing Ocular Issue|0|||
146005905|NCT01791517|526537166|FG006|Phase II|Pre-Existing Ocular Issue|0|||
146005906|NCT01791517|526537167|FG007|Phase II|Pre-Existing Ocular Issue|0|||
146005907|NCT01791517|526537168|FG008|Phase II|Pre-Existing Ocular Issue|0|||
146005908|NCT01791517|526537169|FG009|Phase II|Pre-Existing Ocular Issue|0|||
146005909|NCT01791517|526537170|FG010|Phase II|Pre-Existing Ocular Issue|0|||
146005910|NCT01791517|526537171|FG011|Phase II|Pre-Existing Ocular Issue|1|||
146005911|NCT00589797|526537172|FG000|Overall Study|Death|1|||
146005912|NCT00589797|526537173|FG001|Overall Study|Death|0|||
146005913|NCT00589797|526537172|FG000|Overall Study|Lost to Follow-up|12|||
146005914|NCT00589797|526537173|FG001|Overall Study|Lost to Follow-up|9|||
146005915|NCT00589797|526537172|FG000|Overall Study|Physician Decision|8|||
146005916|NCT00589797|526537173|FG001|Overall Study|Physician Decision|3|||
146005917|NCT00589797|526537172|FG000|Overall Study|Withdrawal by Subject|6|||
146005918|NCT00589797|526537173|FG001|Overall Study|Withdrawal by Subject|5|||
146005919|NCT00589797|526537172|FG000|Overall Study|Non-Randomized Training Subjects|46|||
146005920|NCT00589797|526537173|FG001|Overall Study|Non-Randomized Training Subjects|6|||
146005921|NCT03230318|526537178|FG000|Overall Study|Radiographic disease progression|72|||
146005922|NCT03230318|526537179|FG001|Overall Study|Radiographic disease progression|19|||
146005923|NCT03230318|526537178|FG000|Overall Study|Clinical progression|17|||
146005924|NCT03230318|526537179|FG001|Overall Study|Clinical progression|7|||
146005925|NCT03230318|526537178|FG000|Overall Study|Adverse Event|5|||
146005926|NCT03230318|526537179|FG001|Overall Study|Adverse Event|3|||
146005927|NCT03230318|526537178|FG000|Overall Study|Physician Decision|2|||
146005928|NCT03230318|526537179|FG001|Overall Study|Physician Decision|3|||
146005929|NCT03230318|526537178|FG000|Overall Study|Death|3|||
146005930|NCT03230318|526537179|FG001|Overall Study|Death|2|||
146005931|NCT03230318|526537178|FG000|Overall Study|Lost to Follow-up|1|||
146005932|NCT03230318|526537179|FG001|Overall Study|Lost to Follow-up|0|||
146005933|NCT03230318|526537178|FG000|Overall Study|Withdrawal by Subject|1|||
146005934|NCT03230318|526537179|FG001|Overall Study|Withdrawal by Subject|3|||
146005935|NCT03230318|526537178|FG000|Overall Study|Other|3|||
146005936|NCT03230318|526537179|FG001|Overall Study|Other|7|||
146005937|NCT04011735|526537181|FG000|Overall Study|Withdrawal by Subject|1|||
146005938|NCT04011735|526537182|FG001|Overall Study|Withdrawal by Subject|0|||
146005939|NCT04011735|526537183|FG002|Overall Study|Withdrawal by Subject|1|||
146005940|NCT04011735|526537181|FG000|Overall Study|Met exclusion criteria after study entry|0|||
146005941|NCT04011735|526537182|FG001|Overall Study|Met exclusion criteria after study entry|1|||
146005942|NCT04011735|526537183|FG002|Overall Study|Met exclusion criteria after study entry|0|||
146005943|NCT01492088|526537189|FG000|Overall Study|Withdrawal by Patient|0|||
146005944|NCT01492088|526537190|FG001|Overall Study|Withdrawal by Patient|2|||
146005945|NCT01492088|526537191|FG002|Overall Study|Withdrawal by Patient|0|||
146005946|NCT01492088|526537189|FG000|Overall Study|Death|1|||
146005947|NCT01492088|526537190|FG001|Overall Study|Death|6|||
146005948|NCT01492088|526537191|FG002|Overall Study|Death|2|||
146005949|NCT01492088|526537189|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
146005950|NCT01492088|526537190|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
146005951|NCT01492088|526537191|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
146005952|NCT01492088|526537189|FG000|Overall Study|Alive at Last Follow-up|0|||
146005953|NCT01492088|526537190|FG001|Overall Study|Alive at Last Follow-up|6|||
146005954|NCT01492088|526537191|FG002|Overall Study|Alive at Last Follow-up|11|||
146005955|NCT02379052|526537192|FG000|Overall Study|Protocol Violation|0|||
146005956|NCT02379052|526537193|FG001|Overall Study|Protocol Violation|1|||
146005957|NCT02379052|526537192|FG000|Overall Study|Adverse Event|0|||
146005958|NCT02379052|526537193|FG001|Overall Study|Adverse Event|1|||
146005959|NCT02379052|526537192|FG000|Overall Study|Physician Decision|1|||
146005960|NCT02379052|526537193|FG001|Overall Study|Physician Decision|1|||
146005961|NCT02379052|526537192|FG000|Overall Study|Withdrawal by Subject|2|||
146005962|NCT02379052|526537193|FG001|Overall Study|Withdrawal by Subject|0|||
146005963|NCT02379052|526537192|FG000|Overall Study|Lost to Follow-up|2|||
146005964|NCT02379052|526537193|FG001|Overall Study|Lost to Follow-up|1|||
146005965|NCT02379052|526537192|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
146005966|NCT02379052|526537193|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
146005967|NCT02379052|526537192|FG000|Overall Study|Subject was Incarcerated|0|||
146005968|NCT02379052|526537193|FG001|Overall Study|Subject was Incarcerated|1|||
146005969|NCT00127855|526537194|FG000|Primary Vaccination Course|Adverse Event|0|||
146005970|NCT00127855|526537195|FG001|Primary Vaccination Course|Adverse Event|0|||
146005971|NCT00127855|526537196|FG002|Primary Vaccination Course|Adverse Event|1|||
146005972|NCT00127855|526537197|FG003|Primary Vaccination Course|Adverse Event|0|||
146005973|NCT00127855|526537198|FG004|Primary Vaccination Course|Adverse Event|0|||
146005974|NCT00127855|526537194|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
146005975|NCT00127855|526537195|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
146005976|NCT00127855|526537196|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
146005977|NCT00127855|526537197|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
146005978|NCT00127855|526537198|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
146005979|NCT00127855|526537194|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
146005980|NCT00127855|526537195|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
146005981|NCT00127855|526537196|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
146005982|NCT00127855|526537197|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
146005983|NCT00127855|526537198|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
146005984|NCT00127855|526537194|FG000|Primary Vaccination Course|Other|0|||
146005985|NCT00127855|526537195|FG001|Primary Vaccination Course|Other|0|||
146005986|NCT00127855|526537196|FG002|Primary Vaccination Course|Other|0|||
146005987|NCT00127855|526537197|FG003|Primary Vaccination Course|Other|0|||
146005988|NCT00127855|526537198|FG004|Primary Vaccination Course|Other|1|||
146005989|NCT02343302|526537199|FG000|Overall Study|Physician Decision|1|||
146005990|NCT02343302|526537200|FG001|Overall Study|Physician Decision|1|||
146005991|NCT01887717|526537201|FG000|Overall Study|Withdrawal by Subject|1|||
146005992|NCT01887717|526537202|FG001|Overall Study|Withdrawal by Subject|7|||
146005993|NCT01887717|526537201|FG000|Overall Study|Physician Decision|0|||
146005994|NCT01887717|526537202|FG001|Overall Study|Physician Decision|2|||
146005995|NCT01887717|526537201|FG000|Overall Study|Administrative reasons|5|||
146005996|NCT01887717|526537202|FG001|Overall Study|Administrative reasons|2|||
146005997|NCT02834819|526537205|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
146005998|NCT02834819|526537206|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
146005999|NCT00889707|526537210|FG000|Overall Study|Adverse Event|1|||
146006000|NCT00889707|526537211|FG001|Overall Study|Adverse Event|0|||
146006001|NCT00889707|526537210|FG000|Overall Study|Withdrawal by Subject|4|||
146006002|NCT00889707|526537211|FG001|Overall Study|Withdrawal by Subject|3|||
146247924|NCT04914897|527421535|FG003|Overall Study|Poor compliance to protocol|0|||
146006003|NCT00889707|526537210|FG000|Overall Study|Lost to Follow-up|0|||
146247925|NCT04914897|527421532|FG000|Overall Study|Progressive disease|5|||
146247926|NCT04914897|527421533|FG001|Overall Study|Progressive disease|14|||
146247927|NCT04914897|527421534|FG002|Overall Study|Progressive disease|30|||
146247928|NCT04914897|527421535|FG003|Overall Study|Progressive disease|21|||
146247929|NCT04914897|527421532|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
146247930|NCT04914897|527421533|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
146247931|NCT04914897|527421534|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
146247932|NCT04914897|527421535|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
146247933|NCT04914897|527421532|FG000|Overall Study|Other|1|||
146247934|NCT04914897|527421533|FG001|Overall Study|Other|0|||
146247935|NCT04914897|527421534|FG002|Overall Study|Other|0|||
146247936|NCT04914897|527421535|FG003|Overall Study|Other|1|||
146247937|NCT03020914|527421536|FG000|Overall Study|Surgery Cancelled|1|||
146006004|NCT00889707|526537211|FG001|Overall Study|Lost to Follow-up|2|||
146006005|NCT00889707|526537210|FG000|Overall Study|Lack of Efficacy|2|||
146006006|NCT00889707|526537211|FG001|Overall Study|Lack of Efficacy|5|||
146006007|NCT03465722|526537212|FG000|Overall Study|Withdrawal by Subject|21|||
146247938|NCT03020914|527421537|FG001|Overall Study|Surgery Cancelled|0|||
146247939|NCT01416285|527421540|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
146247940|NCT01416285|527421541|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
146006008|NCT03465722|526537213|FG001|Overall Study|Withdrawal by Subject|14|||
146006009|NCT03465722|526537212|FG000|Overall Study|Death|89|||
146006010|NCT03465722|526537213|FG001|Overall Study|Death|87|||
146006011|NCT03465722|526537212|FG000|Overall Study|Lost to Follow-up|5|||
146006012|NCT03465722|526537213|FG001|Overall Study|Lost to Follow-up|3|||
146006013|NCT03465722|526537212|FG000|Overall Study|Administrative/Other|33|||
146006014|NCT03465722|526537213|FG001|Overall Study|Administrative/Other|32|||
146006015|NCT03465722|526537212|FG000|Overall Study|Not treated|1|||
146006016|NCT03465722|526537213|FG001|Overall Study|Not treated|2|||
146006017|NCT03465722|526537212|FG000|Overall Study|Sponsor decision|91|||
146006018|NCT03465722|526537213|FG001|Overall Study|Sponsor decision|98|||
146006019|NCT02041299|526537217|FG000|Overall Study|Adverse Event|9|||
146006020|NCT02041299|526537218|FG001|Overall Study|Adverse Event|3|||
146006021|NCT02041299|526537217|FG000|Overall Study|Lost to Follow-up|4|||
146247941|NCT01005602|527421542|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
146006022|NCT02041299|526537218|FG001|Overall Study|Lost to Follow-up|1|||
146006023|NCT02041299|526537217|FG000|Overall Study|Physician Decision|1|||
146006024|NCT02041299|526537218|FG001|Overall Study|Physician Decision|1|||
146006025|NCT02041299|526537217|FG000|Overall Study|Withdrawal by Subject|13|||
146247942|NCT01005602|527421543|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
146247943|NCT01248715|527421544|FG000|Overall Study|Not influenza positive|501|||
146006026|NCT02041299|526537218|FG001|Overall Study|Withdrawal by Subject|7|||
146247944|NCT01248715|527421545|FG001|Overall Study|Not influenza positive|510|||
146247945|NCT01919489|527421549|FG000|Overall Study|Rejected the need of injections|4|||
146006027|NCT02041299|526537217|FG000|Overall Study|Protocol Violation|11|||
146006028|NCT02041299|526537218|FG001|Overall Study|Protocol Violation|4|||
146006029|NCT02041299|526537217|FG000|Overall Study|Termination of the study|7|||
146006030|NCT02041299|526537218|FG001|Overall Study|Termination of the study|3|||
146006031|NCT02041299|526537217|FG000|Overall Study|Required bone marrow transplant|0|||
146006032|NCT02041299|526537218|FG001|Overall Study|Required bone marrow transplant|1|||
146006033|NCT02041299|526537217|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
146247946|NCT01919489|527421550|FG001|Overall Study|Rejected the need of injections|7|||
146247947|NCT01919489|527421549|FG000|Overall Study|Adverse Event|10|||
146247948|NCT01919489|527421550|FG001|Overall Study|Adverse Event|0|||
146247949|NCT01919489|527421549|FG000|Overall Study|Hospital readmission|2|||
146247950|NCT01919489|527421550|FG001|Overall Study|Hospital readmission|9|||
146247951|NCT01919489|527421549|FG000|Overall Study|Death|2|||
146247952|NCT01919489|527421550|FG001|Overall Study|Death|1|||
146247953|NCT01919489|527421549|FG000|Overall Study|Lost to Follow-up|38|||
146006034|NCT02041299|526537218|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
146006035|NCT02389465|526537219|FG000|Overall Study|Lost to Follow-up|1|||
146006036|NCT02389465|526537220|FG001|Overall Study|Lost to Follow-up|3|||
146006037|NCT02389465|526537221|FG002|Overall Study|Lost to Follow-up|3|||
146006038|NCT02389465|526537222|FG003|Overall Study|Lost to Follow-up|0|||
146006039|NCT02389465|526537219|FG000|Overall Study|Physician Decision|0|||
146006040|NCT02389465|526537220|FG001|Overall Study|Physician Decision|0|||
146006041|NCT02389465|526537221|FG002|Overall Study|Physician Decision|0|||
146006042|NCT02389465|526537222|FG003|Overall Study|Physician Decision|1|||
146006043|NCT02389465|526537219|FG000|Overall Study|Withdrawal by Subject|0|||
146006044|NCT02389465|526537220|FG001|Overall Study|Withdrawal by Subject|1|||
146006045|NCT02389465|526537221|FG002|Overall Study|Withdrawal by Subject|2|||
146006046|NCT02389465|526537222|FG003|Overall Study|Withdrawal by Subject|2|||
146006047|NCT01635998|526537223|FG000|Overall Study|Death|1|||
146006048|NCT01635998|526537224|FG001|Overall Study|Death|1|||
146006049|NCT01635998|526537223|FG000|Overall Study|Lost to Follow-up|2|||
146006050|NCT01635998|526537224|FG001|Overall Study|Lost to Follow-up|1|||
146006051|NCT01635998|526537223|FG000|Overall Study|Withdrawal by Subject|1|||
146006052|NCT01635998|526537224|FG001|Overall Study|Withdrawal by Subject|5|||
146006053|NCT00846846|526537225|FG000|Overall Study|Death|56|||
146006054|NCT00846846|526537225|FG000|Overall Study|Withdrawal by Subject|19|||
146006055|NCT00003631|526537226|FG000|Overall Study|Patient not treated|1|||
146006056|NCT00003631|526537227|FG001|Overall Study|Patient not treated|0|||
146006057|NCT00003631|526537228|FG002|Overall Study|Patient not treated|1|||
146006058|NCT00003631|526537226|FG000|Overall Study|Protocol Violation|1|||
146006059|NCT00003631|526537227|FG001|Overall Study|Protocol Violation|0|||
146006060|NCT00003631|526537228|FG002|Overall Study|Protocol Violation|0|||
146006061|NCT00003631|526537226|FG000|Overall Study|Adverse Event|1|||
146006062|NCT00003631|526537227|FG001|Overall Study|Adverse Event|1|||
146006063|NCT00003631|526537228|FG002|Overall Study|Adverse Event|5|||
146006064|NCT00003631|526537226|FG000|Overall Study|Death|0|||
146006065|NCT00003631|526537227|FG001|Overall Study|Death|0|||
146006066|NCT00003631|526537228|FG002|Overall Study|Death|1|||
146006067|NCT00003631|526537226|FG000|Overall Study|Evaluable for toxicity only|0|||
146006068|NCT00003631|526537227|FG001|Overall Study|Evaluable for toxicity only|0|||
146006069|NCT00003631|526537228|FG002|Overall Study|Evaluable for toxicity only|2|||
146006070|NCT04339413|526537229|FG000|Overall Study|Reason Not Specified|2|||
146006071|NCT04339413|526537230|FG001|Overall Study|Reason Not Specified|7|||
146006072|NCT04339413|526537229|FG000|Overall Study|Study Terminated by Sponsor|30|||
146006073|NCT04339413|526537230|FG001|Overall Study|Study Terminated by Sponsor|33|||
146006074|NCT04339413|526537229|FG000|Overall Study|Progressive Disease|9|||
146006075|NCT04339413|526537230|FG001|Overall Study|Progressive Disease|6|||
146006076|NCT04339413|526537229|FG000|Overall Study|Withdrawal by Subject|9|||
146006077|NCT04339413|526537230|FG001|Overall Study|Withdrawal by Subject|10|||
146006078|NCT04339413|526537229|FG000|Overall Study|Physician Decision|3|||
146006079|NCT04339413|526537230|FG001|Overall Study|Physician Decision|1|||
146006080|NCT04339413|526537229|FG000|Overall Study|Death|2|||
146006081|NCT04339413|526537230|FG001|Overall Study|Death|0|||
146006082|NCT04339413|526537229|FG000|Overall Study|Adverse Event|3|||
146006083|NCT04339413|526537230|FG001|Overall Study|Adverse Event|0|||
146006084|NCT00442416|526537233|FG000|Overall Study|Adverse Event|4|||
146006085|NCT00442416|526537234|FG001|Overall Study|Adverse Event|1|||
146006086|NCT00442416|526537233|FG000|Overall Study|Death|1|||
146006087|NCT00442416|526537234|FG001|Overall Study|Death|0|||
146006088|NCT00442416|526537233|FG000|Overall Study|Lack of Efficacy|2|||
146006089|NCT00442416|526537234|FG001|Overall Study|Lack of Efficacy|0|||
146006090|NCT00442416|526537233|FG000|Overall Study|Protocol Violation|2|||
146006091|NCT00442416|526537234|FG001|Overall Study|Protocol Violation|3|||
146006092|NCT00442416|526537233|FG000|Overall Study|Withdrew consent|1|||
146006093|NCT00442416|526537234|FG001|Overall Study|Withdrew consent|2|||
146006094|NCT00442416|526537233|FG000|Overall Study|Administrative/Other|27|||
146006095|NCT00442416|526537234|FG001|Overall Study|Administrative/Other|33|||
146006096|NCT01853462|526537237|FG000|Overall Study|Withdrawal by Subject|1|||
146006097|NCT01853462|526537238|FG001|Overall Study|Withdrawal by Subject|1|||
146006098|NCT00955474|526537240|FG000|Overall Study|Physician Decision|7|||
146092427|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
146247954|NCT01919489|527421550|FG001|Overall Study|Lost to Follow-up|27|||
146247955|NCT00828139|527421551|FG000|Overall Study|Adverse Event|8|||
146247956|NCT00828139|527421552|FG001|Overall Study|Adverse Event|1|||
146006099|NCT00955474|526537241|FG001|Overall Study|Physician Decision|5|||
146006100|NCT04068922|526537244|FG000|Overall Study|Lost to Follow-up|5|||
146006101|NCT04068922|526537244|FG000|Overall Study|Withdrawal by Subject|7|||
146006102|NCT04068922|526537244|FG000|Overall Study|Adverse Event|1|||
146006103|NCT03542266|526537245|FG000|Treatment Phase|Withdrawal by Subject|1|||
146006104|NCT03542266|526537245|FG000|Treatment Phase|Adverse Event|1|||
146006105|NCT03542266|526537245|FG000|Treatment Phase|PD|1|||
146006106|NCT00625586|526537246|FG000|Overall Study|Adverse Event|1|||
146006107|NCT00625586|526537246|FG000|Overall Study|Progressive disease|1|||
146006108|NCT00657267|526537259|FG000|Overall Study|Progressive disease|45|||
146006109|NCT00657267|526537259|FG000|Overall Study|Adverse Event|9|||
146006110|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Death|2|||
146006111|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
146006112|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
146006113|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Physician Decision|1|||
146006114|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
146006115|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
146006116|NCT00786422|526537260|FG000|Rivaroxaban Treatment|Adverse Event|2|||
146006117|NCT00786422|526537260|FG000|Follow-up Period|Death|1|||
146006118|NCT00786422|526537260|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
146006119|NCT03484429|526537261|FG000|Overall Study|Withdrawal by Subject|1|||
146006120|NCT03484429|526537262|FG001|Overall Study|Withdrawal by Subject|0|||
146006121|NCT03484429|526537261|FG000|Overall Study|Adverse Event|2|||
146006122|NCT03484429|526537262|FG001|Overall Study|Adverse Event|0|||
146006123|NCT04466384|526537263|FG000|First Phase|Protocol Violation|1|||
146006124|NCT04466384|526537264|FG001|First Phase|Protocol Violation|0|||
146006125|NCT04466384|526537263|FG000|First Phase|Missing data|1|||
146006126|NCT04466384|526537264|FG001|First Phase|Missing data|0|||
146006127|NCT04466384|526537263|FG000|Cross Over Phase|Physician Decision|1|||
146006128|NCT04466384|526537264|FG001|Cross Over Phase|Physician Decision|0|||
146006129|NCT04466384|526537263|FG000|Cross Over Phase|Withdrawal by Subject|0|||
146006130|NCT04466384|526537264|FG001|Cross Over Phase|Withdrawal by Subject|1|||
146006131|NCT02268383|526537265|FG000|Overall Study|Death|12|||
146006132|NCT02268383|526537265|FG000|Overall Study|Lost to Follow-up|2|||
146006133|NCT02268383|526537265|FG000|Overall Study|Withdrawal by Subject|9|||
146006134|NCT02268383|526537265|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
146006135|NCT02268383|526537265|FG000|Overall Study|Protocol deviation|3|||
146006136|NCT02268383|526537265|FG000|Overall Study|Sponsor decision|22|||
146006137|NCT02268383|526537265|FG000|Overall Study|Not reported|12|||
146006138|NCT04162470|526537266|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
146006139|NCT03718325|526538903|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
146006140|NCT03718325|526538904|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
146006141|NCT03718325|526538905|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
146006142|NCT03718325|526538903|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
146006143|NCT03718325|526538904|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
146006144|NCT03718325|526538905|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
146006145|NCT03145064|526538906|FG000|Overall Study|Death|24|||
146006146|NCT03145064|526538906|FG000|Overall Study|Lost to Follow-up|3|||
146006147|NCT03145064|526538906|FG000|Overall Study|Withdrawal by Subject|6|||
146006148|NCT03145064|526538906|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
146006149|NCT03145064|526538906|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
146006150|NCT01396187|526538907|FG000|Overall Study|Adverse Event|0|||
146006151|NCT01396187|526538908|FG001|Overall Study|Adverse Event|1|||
146006152|NCT01396187|526538909|FG002|Overall Study|Adverse Event|0|||
146006153|NCT01396187|526538910|FG003|Overall Study|Adverse Event|0|||
146006154|NCT01396187|526538911|FG004|Overall Study|Adverse Event|0|||
146006155|NCT01396187|526538907|FG000|Overall Study|Withdrawal by Subject|0|||
146006156|NCT01396187|526538908|FG001|Overall Study|Withdrawal by Subject|1|||
146006157|NCT01396187|526538909|FG002|Overall Study|Withdrawal by Subject|1|||
146006158|NCT01396187|526538910|FG003|Overall Study|Withdrawal by Subject|0|||
146006159|NCT01396187|526538911|FG004|Overall Study|Withdrawal by Subject|0|||
146006160|NCT01396187|526538907|FG000|Overall Study|Other|1|||
146006161|NCT01396187|526538908|FG001|Overall Study|Other|1|||
146006162|NCT01396187|526538909|FG002|Overall Study|Other|0|||
146006163|NCT01396187|526538910|FG003|Overall Study|Other|0|||
146006164|NCT01396187|526538911|FG004|Overall Study|Other|1|||
146006165|NCT01898286|526538912|FG000|Overall Study|Withdrawal by Subject|1|||
146006166|NCT01898286|526538912|FG000|Overall Study|Protocol Violation|1|||
146006167|NCT01898286|526538912|FG000|Overall Study|Lost to Follow-up|1|||
146006168|NCT02257242|526538913|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
146006169|NCT02257242|526538914|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006170|NCT02257242|526538915|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006171|NCT02257242|526538916|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006172|NCT02257242|526538917|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146247957|NCT00828139|527421553|FG002|Overall Study|Adverse Event|10|||
146247958|NCT00828139|527421554|FG003|Overall Study|Adverse Event|5|||
146247959|NCT00828139|527421551|FG000|Overall Study|Death|2|||
146006173|NCT02257242|526538918|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006174|NCT02257242|526538919|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006175|NCT02257242|526538920|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006176|NCT02257242|526538921|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
146006177|NCT02964273|526538926|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
146006178|NCT02964273|526538927|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146006179|NCT02964273|526538928|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146006180|NCT02964273|526538929|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
146006181|NCT02964273|526538926|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146006182|NCT02964273|526538927|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
146006183|NCT02964273|526538928|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146006184|NCT02964273|526538929|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
146006185|NCT02964273|526538926|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
146006186|NCT02964273|526538927|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
146006187|NCT02964273|526538928|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
146006188|NCT02964273|526538929|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
146006189|NCT02964273|526538926|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146006190|NCT02964273|526538927|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146006191|NCT02964273|526538928|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
146006192|NCT02964273|526538929|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
146006193|NCT02964273|526538926|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
146006194|NCT02964273|526538927|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
146006195|NCT02964273|526538928|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
146006196|NCT02964273|526538929|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
146006197|NCT02964273|526538926|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
146006198|NCT02964273|526538927|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
146006199|NCT02964273|526538928|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
146006200|NCT02964273|526538929|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
146006201|NCT01453036|526538930|FG000|Overall Study|Lost to Follow-up|26|||
146006202|NCT01453036|526538931|FG001|Overall Study|Lost to Follow-up|115|||
146006203|NCT01453036|526538932|FG002|Overall Study|Lost to Follow-up|31|||
146006204|NCT04245449|526538934|FG000|Overall Study|COVID shutdown|7|||
146006205|NCT03073525|526538935|FG000|Overall Study|Withdrawal by Subject|0|||
146006206|NCT03073525|526538936|FG001|Overall Study|Withdrawal by Subject|0|||
146006207|NCT03073525|526538937|FG002|Overall Study|Withdrawal by Subject|3|||
146006208|NCT01976299|526538938|FG000|Overall Study|Withdrawal by Subject|3|||
146006209|NCT01976299|526538939|FG001|Overall Study|Withdrawal by Subject|1|||
146006210|NCT01976299|526538938|FG000|Overall Study|Death|4|||
146006211|NCT01976299|526538939|FG001|Overall Study|Death|2|||
146006212|NCT01976299|526538938|FG000|Overall Study|Lost to Follow-up|7|||
146006213|NCT01976299|526538939|FG001|Overall Study|Lost to Follow-up|1|||
146006214|NCT01976299|526538938|FG000|Overall Study|See clarification above in comments|9|||
146006215|NCT01976299|526538939|FG001|Overall Study|See clarification above in comments|2|||
146006216|NCT03692403|526538940|FG000|Overall Study|Withdrawal by Subject|1|||
146006217|NCT03692403|526538941|FG001|Overall Study|Withdrawal by Subject|0|||
146006218|NCT03692403|526538942|FG002|Overall Study|Withdrawal by Subject|1|||
146006219|NCT03692403|526538943|FG003|Overall Study|Withdrawal by Subject|0|||
146006220|NCT03692403|526538940|FG000|Overall Study|Adverse Event|0|||
146006221|NCT03692403|526538941|FG001|Overall Study|Adverse Event|0|||
146006222|NCT03692403|526538942|FG002|Overall Study|Adverse Event|0|||
146006223|NCT03692403|526538943|FG003|Overall Study|Adverse Event|1|||
146006224|NCT03692403|526538940|FG000|Overall Study|Pregnancy|0|||
146006225|NCT03692403|526538941|FG001|Overall Study|Pregnancy|1|||
146006226|NCT03692403|526538942|FG002|Overall Study|Pregnancy|0|||
146006227|NCT03692403|526538943|FG003|Overall Study|Pregnancy|0|||
146006228|NCT03692403|526538940|FG000|Overall Study|Other|0|||
146006229|NCT03692403|526538941|FG001|Overall Study|Other|0|||
146006230|NCT03692403|526538942|FG002|Overall Study|Other|1|||
146006231|NCT03692403|526538943|FG003|Overall Study|Other|0|||
146247960|NCT00828139|527421552|FG001|Overall Study|Death|1|||
146006232|NCT02848092|526538945|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
146006233|NCT02848092|526538946|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
146006234|NCT02848092|526538945|FG000|1-month Post-training Follow-up|Adverse Event|2|||
146006235|NCT02848092|526538946|FG001|1-month Post-training Follow-up|Adverse Event|1|||
146092428|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
146247961|NCT00828139|527421553|FG002|Overall Study|Death|0|||
146247962|NCT00828139|527421554|FG003|Overall Study|Death|2|||
146006236|NCT02848092|526538945|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
146006237|NCT02848092|526538946|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
146006238|NCT02848092|526538945|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
146006239|NCT02848092|526538946|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
146006240|NCT02848092|526538945|FG000|1-month Post-training Follow-up|fatigue|0|||
146006241|NCT02848092|526538946|FG001|1-month Post-training Follow-up|fatigue|1|||
146006242|NCT02848092|526538945|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
146006243|NCT02848092|526538946|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
146006244|NCT02848092|526538945|FG000|6-month Post-training Follow-up|Adverse Event|1|||
146006245|NCT02848092|526538946|FG001|6-month Post-training Follow-up|Adverse Event|1|||
146006246|NCT02848092|526538945|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
146006247|NCT02848092|526538946|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
146006248|NCT02848092|526538945|FG000|6-month Post-training Follow-up|frustrated with task|1|||
146006249|NCT02848092|526538946|FG001|6-month Post-training Follow-up|frustrated with task|0|||
146006250|NCT02848092|526538945|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
146006251|NCT02848092|526538946|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
146006252|NCT02848092|526538945|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
146006253|NCT02848092|526538946|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
146006254|NCT01665911|526538949|FG000|Overall Study|Protocol Violation|4|||
146006255|NCT01665911|526538949|FG000|Overall Study|Withdrawal by Subject|1|||
146006256|NCT01665911|526538949|FG000|Overall Study|Adverse Event|1|||
146006257|NCT01645735|526538954|FG000|Overall Study|Physician Decision|2|||
146006258|NCT01645735|526538955|FG001|Overall Study|Physician Decision|0|||
146006259|NCT01645735|526538954|FG000|Overall Study|Withdrawal by Subject|1|||
146006260|NCT01645735|526538955|FG001|Overall Study|Withdrawal by Subject|0|||
146006261|NCT01645735|526538954|FG000|Overall Study|Protocol Violation|1|||
146006262|NCT01645735|526538955|FG001|Overall Study|Protocol Violation|0|||
146006263|NCT01645735|526538954|FG000|Overall Study|Adverse Event|0|||
146006264|NCT01645735|526538955|FG001|Overall Study|Adverse Event|1|||
146006265|NCT04908683|526538960|FG000|Overall Study|Failure to meet continuation criteria|34|||
146006266|NCT04908683|526538961|FG001|Overall Study|Failure to meet continuation criteria|22|||
146006267|NCT04908683|526538960|FG000|Overall Study|Initiated prohibited medication|3|||
146006268|NCT04908683|526538961|FG001|Overall Study|Initiated prohibited medication|0|||
146006269|NCT04908683|526538960|FG000|Overall Study|Randomized by mistake|1|||
146006270|NCT04908683|526538961|FG001|Overall Study|Randomized by mistake|0|||
146006271|NCT04908683|526538960|FG000|Overall Study|Lost to Follow-up|679|||
146006272|NCT04908683|526538961|FG001|Overall Study|Lost to Follow-up|341|||
146006273|NCT04908683|526538960|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
146006274|NCT04908683|526538961|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
146006275|NCT04908683|526538960|FG000|Overall Study|Physician Decision|44|||
146006276|NCT04908683|526538961|FG001|Overall Study|Physician Decision|35|||
146006277|NCT04908683|526538960|FG000|Overall Study|Technical problems|12|||
146006278|NCT04908683|526538961|FG001|Overall Study|Technical problems|9|||
146006279|NCT04908683|526538960|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
146006280|NCT04908683|526538961|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
146006281|NCT04908683|526538960|FG000|Overall Study|Protocol Violation|2|||
146006282|NCT04908683|526538961|FG001|Overall Study|Protocol Violation|0|||
146006283|NCT04908683|526538960|FG000|Overall Study|Withdrawal by Subject|1188|||
146006284|NCT04908683|526538961|FG001|Overall Study|Withdrawal by Subject|570|||
146006285|NCT04908683|526538960|FG000|Overall Study|Site Closure by Sponsor|6|||
146006286|NCT04908683|526538961|FG001|Overall Study|Site Closure by Sponsor|3|||
146006287|NCT04908683|526538960|FG000|Overall Study|Adverse Event|21|||
146006288|NCT04908683|526538961|FG001|Overall Study|Adverse Event|11|||
146006289|NCT04908683|526538960|FG000|Overall Study|Death|101|||
146006290|NCT04908683|526538961|FG001|Overall Study|Death|61|||
146006291|NCT04908683|526538960|FG000|Overall Study|Sponsor's decision|14398|||
146006292|NCT04908683|526538961|FG001|Overall Study|Sponsor's decision|7205|||
146006293|NCT04908683|526538960|FG000|Overall Study|Other|92|||
146006294|NCT04908683|526538961|FG001|Overall Study|Other|50|||
146006295|NCT04908683|526538960|FG000|Overall Study|Randomized not vaccinated|108|||
146006296|NCT04908683|526538961|FG001|Overall Study|Randomized not vaccinated|52|||
146006297|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
146006298|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
146006299|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
146006300|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
146006301|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
146006302|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
146006303|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
146006304|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
146006305|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
146006306|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
146006307|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
146006308|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
146006309|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
146006310|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
146006311|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
146006312|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
146006313|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
146006314|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
146006315|NCT02831855|526538962|FG000|Open Label Phase (24 Weeks)|Other|4|||
146006316|NCT02831855|526538963|FG001|Open Label Phase (24 Weeks)|Other|0|||
146006317|NCT02831855|526538964|FG002|Open Label Phase (24 Weeks)|Other|0|||
146006318|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
146006319|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
146006320|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
146006321|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Death|0|||
146006322|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Death|0|||
146006323|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Death|2|||
146006324|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
146006325|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
146006326|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
146006327|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
146006328|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
146006329|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
146006330|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
146006331|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
146006332|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
146006333|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Other|0|||
146006334|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Other|2|||
146006335|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Other|5|||
146006336|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
146006337|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
146006338|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
146006339|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
146006340|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
146006341|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
146006342|NCT02831855|526538962|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
146006343|NCT02831855|526538963|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
146006344|NCT02831855|526538964|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
146006345|NCT02817594|526538968|FG000|Overall Study|Withdrawal by Subject|1|||
146006346|NCT02817594|526538968|FG000|Overall Study|Other|1|||
146006347|NCT02817594|526538968|FG000|Overall Study|Did Not Receive Treatment|1|||
146006348|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
146006349|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
146006350|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
146006351|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
146006352|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
146006353|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
146006354|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
146006355|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
146006356|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
146006357|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
146006358|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
146006359|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
146006360|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
146006361|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
146006362|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
146006363|NCT01057693|526538970|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
146006364|NCT01057693|526538971|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
146006365|NCT01057693|526538972|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
146006366|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
146006367|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
146006368|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
146298143|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
146006369|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
146006370|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
146006371|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
146298144|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
146298145|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
146298146|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
146298147|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
146006372|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
146006373|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
146006374|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
146006375|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
146006376|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
146006377|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
146006378|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
146006379|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
146006380|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
146006381|NCT01057693|526538970|FG000|Between Single-Blind and Double-Blind|Other|6|||
146006382|NCT01057693|526538971|FG001|Between Single-Blind and Double-Blind|Other|0|||
146006383|NCT01057693|526538972|FG002|Between Single-Blind and Double-Blind|Other|0|||
146006384|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
146006385|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
146006386|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
146006387|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
146298148|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
146298149|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
146006388|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
146006389|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
146006390|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
146006391|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
146006392|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
146006393|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
146006394|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
146006395|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
146006396|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
146006397|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
146006398|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
146006399|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
146006400|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
146006401|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
146006402|NCT01057693|526538970|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
146006403|NCT01057693|526538971|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
146006404|NCT01057693|526538972|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
146006405|NCT02236572|526538973|FG000|Overall Study|Withdrawal by Subject|1|||
146006406|NCT02236572|526538973|FG000|Overall Study|Protocol Violation|1|||
146006407|NCT02236572|526538973|FG000|Overall Study|Lost to Follow-up|1|||
146006408|NCT02413996|526538974|FG000|Overall Study|not comfortable with the intervention|9|||
146006409|NCT02413996|526538975|FG001|Overall Study|not comfortable with the intervention|2|||
146006410|NCT00090779|526538976|FG000|Step 1|Withdrawal by Subject|4|||
146006411|NCT00090779|526538977|FG001|Step 1|Withdrawal by Subject|2|||
146006412|NCT00090779|526538976|FG000|Step 1|Lost to Follow-up|3|||
146006413|NCT00090779|526538977|FG001|Step 1|Lost to Follow-up|2|||
146006414|NCT00090779|526538976|FG000|Step 1|Death|0|||
146092429|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
146298150|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
146298151|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
146298152|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
146298153|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
146298154|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
146298155|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
146298156|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
146298157|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
146298158|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
146298159|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
146298160|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
146298161|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
146298162|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
146298163|NCT00217737|527606079|FG000|Step 2 Randomization/Registration|Other|1|||
146298164|NCT00217737|527606080|FG001|Step 2 Randomization/Registration|Other|2|||
146298165|NCT00217737|527606081|FG002|Step 2 Randomization/Registration|Other|0|||
146298166|NCT00217737|527606082|FG003|Step 2 Randomization/Registration|Other|0|||
146006415|NCT00090779|526538977|FG001|Step 1|Death|2|||
146006416|NCT00090779|526538976|FG000|Step 1|Physician Decision|1|||
146006417|NCT00090779|526538977|FG001|Step 1|Physician Decision|0|||
146006418|NCT00090779|526538976|FG000|Step 1|Pregnancy|1|||
146006419|NCT00090779|526538977|FG001|Step 1|Pregnancy|0|||
146247963|NCT00828139|527421551|FG000|Overall Study|Refusal unrelated to toxicity|3|||
146247964|NCT00828139|527421552|FG001|Overall Study|Refusal unrelated to toxicity|4|||
146247965|NCT00828139|527421553|FG002|Overall Study|Refusal unrelated to toxicity|5|||
146006420|NCT00090779|526538976|FG000|Step 1|Non-compliance to study requirements|0|||
146006421|NCT00090779|526538977|FG001|Step 1|Non-compliance to study requirements|1|||
146006422|NCT00090779|526538976|FG000|Step 1|Subject relocated|2|||
146006423|NCT00090779|526538977|FG001|Step 1|Subject relocated|8|||
146006424|NCT00090779|526538976|FG000|Step 2|Off study per study closure|6|||
146006425|NCT00090779|526538977|FG001|Step 2|Off study per study closure|16|||
146006426|NCT00090779|526538976|FG000|Step 2|Subject relocated|0|||
146006427|NCT00090779|526538977|FG001|Step 2|Subject relocated|1|||
146006428|NCT00090779|526538976|FG000|Step 2|Non-compliance to study requirements|0|||
146006429|NCT00090779|526538977|FG001|Step 2|Non-compliance to study requirements|1|||
146006430|NCT00090779|526538976|FG000|Step 3|Initiation of ART and off extended study|3|||
146006431|NCT00090779|526538977|FG001|Step 3|Initiation of ART and off extended study|2|||
146006432|NCT00090779|526538976|FG000|Step 3|Off extended study due to study closure|4|||
146006433|NCT00090779|526538977|FG001|Step 3|Off extended study due to study closure|3|||
146006434|NCT00590967|526538981|FG000|Overall Study|Withdrawal by Subject|1|||
146006435|NCT00590967|526538982|FG001|Overall Study|Withdrawal by Subject|1|||
146006436|NCT00590967|526538981|FG000|Overall Study|Ineligible|1|||
146006437|NCT00590967|526538982|FG001|Overall Study|Ineligible|0|||
146006438|NCT00590967|526538981|FG000|Overall Study|Poor performance status|0|||
146006439|NCT00590967|526538982|FG001|Overall Study|Poor performance status|1|||
146006440|NCT00590967|526538981|FG000|Overall Study|Non-compliant|0|||
146006441|NCT00590967|526538982|FG001|Overall Study|Non-compliant|2|||
146006442|NCT00590967|526538981|FG000|Overall Study|Did not sign consent form|0|||
146006443|NCT00590967|526538982|FG001|Overall Study|Did not sign consent form|1|||
146006444|NCT00590967|526538981|FG000|Overall Study|Did not receive chemo per protocol|1|||
146006445|NCT00590967|526538982|FG001|Overall Study|Did not receive chemo per protocol|0|||
146006446|NCT01881789|526538983|FG000|Overall Study|Withdrawal by Subject|0|||
146006447|NCT01881789|526538984|FG001|Overall Study|Withdrawal by Subject|2|||
146006448|NCT01881789|526538985|FG002|Overall Study|Withdrawal by Subject|1|||
146006449|NCT01881789|526538986|FG003|Overall Study|Withdrawal by Subject|0|||
146006450|NCT01881789|526538987|FG004|Overall Study|Withdrawal by Subject|1|||
146006451|NCT01881789|526538988|FG005|Overall Study|Withdrawal by Subject|1|||
146006452|NCT01881789|526538983|FG000|Overall Study|Study Terminated by Sponsor|0|||
146006453|NCT01881789|526538984|FG001|Overall Study|Study Terminated by Sponsor|0|||
146006454|NCT01881789|526538985|FG002|Overall Study|Study Terminated by Sponsor|0|||
146006455|NCT01881789|526538986|FG003|Overall Study|Study Terminated by Sponsor|0|||
146006456|NCT01881789|526538987|FG004|Overall Study|Study Terminated by Sponsor|0|||
146006457|NCT01881789|526538988|FG005|Overall Study|Study Terminated by Sponsor|1|||
146006458|NCT01881789|526538983|FG000|Overall Study|Other|3|||
146006459|NCT01881789|526538984|FG001|Overall Study|Other|5|||
146006460|NCT01881789|526538985|FG002|Overall Study|Other|2|||
146006461|NCT01881789|526538986|FG003|Overall Study|Other|3|||
146006462|NCT01881789|526538987|FG004|Overall Study|Other|1|||
146006463|NCT01881789|526538988|FG005|Overall Study|Other|1|||
146006464|NCT00003869|526538989|FG000|Overall Study|Adverse Event|14|||
146006465|NCT00003869|526538990|FG001|Overall Study|Adverse Event|3|||
146006466|NCT00003869|526538989|FG000|Overall Study|Withdrawal by Subject|21|||
146006467|NCT00003869|526538990|FG001|Overall Study|Withdrawal by Subject|3|||
146006468|NCT00003869|526538989|FG000|Overall Study|Death|1|||
146006469|NCT00003869|526538990|FG001|Overall Study|Death|2|||
146006470|NCT00003869|526538989|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
146006471|NCT00003869|526538990|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
146006472|NCT01964378|526538991|FG000|Overall Study|Disc. due to death before first dosing|0|||
146006473|NCT01964378|526538992|FG001|Overall Study|Disc. due to death before first dosing|1|||
146006474|NCT01964378|526538991|FG000|Overall Study|Disc. due to AE before first dosing|1|||
146006475|NCT01964378|526538992|FG001|Overall Study|Disc. due to AE before first dosing|0|||
146006476|NCT01964378|526538991|FG000|Overall Study|Death|3|||
146006477|NCT01964378|526538992|FG001|Overall Study|Death|2|||
146247966|NCT00828139|527421554|FG003|Overall Study|Refusal unrelated to toxicity|3|||
146247967|NCT00828139|527421551|FG000|Overall Study|Disease Progression|24|||
146006478|NCT01964378|526538991|FG000|Overall Study|Adverse Event|12|||
146006479|NCT01964378|526538992|FG001|Overall Study|Adverse Event|5|||
146006480|NCT01964378|526538991|FG000|Overall Study|Lack of Efficacy|0|||
146006481|NCT01964378|526538992|FG001|Overall Study|Lack of Efficacy|1|||
146006482|NCT01964378|526538991|FG000|Overall Study|Protocol Violation|0|||
146006483|NCT01964378|526538992|FG001|Overall Study|Protocol Violation|1|||
146006484|NCT01964378|526538991|FG000|Overall Study|Lost to Follow-up|0|||
146006485|NCT01964378|526538992|FG001|Overall Study|Lost to Follow-up|1|||
146006486|NCT01964378|526538991|FG000|Overall Study|Withdrawal by Subject|7|||
146006487|NCT01964378|526538992|FG001|Overall Study|Withdrawal by Subject|5|||
146006488|NCT01964378|526538991|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
146247968|NCT00828139|527421552|FG001|Overall Study|Disease Progression|33|||
146006489|NCT01964378|526538992|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
146247969|NCT00828139|527421553|FG002|Overall Study|Disease Progression|35|||
146006490|NCT01964378|526538991|FG000|Overall Study|Other|1|||
146006491|NCT01964378|526538992|FG001|Overall Study|Other|2|||
146247970|NCT00828139|527421554|FG003|Overall Study|Disease Progression|39|||
146247971|NCT00828139|527421551|FG000|Overall Study|Other|4|||
146247972|NCT00828139|527421552|FG001|Overall Study|Other|2|||
146006492|NCT00326599|526538993|FG000|Overall Study|Withdrawal by Subject|1|||
146006493|NCT00326599|526538994|FG001|Overall Study|Withdrawal by Subject|0|||
146006494|NCT00326599|526538995|FG002|Overall Study|Withdrawal by Subject|5|||
146006495|NCT00326599|526538996|FG003|Overall Study|Withdrawal by Subject|2|||
146006496|NCT00326599|526538993|FG000|Overall Study|Adverse Event|1|||
146006497|NCT00326599|526538994|FG001|Overall Study|Adverse Event|0|||
146006498|NCT00326599|526538995|FG002|Overall Study|Adverse Event|32|||
146006499|NCT00326599|526538996|FG003|Overall Study|Adverse Event|3|||
146006500|NCT00326599|526538993|FG000|Overall Study|Disease Progression|3|||
146006501|NCT00326599|526538994|FG001|Overall Study|Disease Progression|1|||
146006502|NCT00326599|526538995|FG002|Overall Study|Disease Progression|13|||
146006503|NCT00326599|526538996|FG003|Overall Study|Disease Progression|11|||
146006504|NCT00326599|526538993|FG000|Overall Study|Alternate Treatment|1|||
146006505|NCT00326599|526538994|FG001|Overall Study|Alternate Treatment|0|||
146006506|NCT00326599|526538995|FG002|Overall Study|Alternate Treatment|0|||
146006507|NCT00326599|526538996|FG003|Overall Study|Alternate Treatment|0|||
146006508|NCT00326599|526538993|FG000|Overall Study|Death|0|||
146006509|NCT00326599|526538994|FG001|Overall Study|Death|0|||
146006510|NCT00326599|526538995|FG002|Overall Study|Death|1|||
146006511|NCT00326599|526538996|FG003|Overall Study|Death|2|||
146006512|NCT00326599|526538993|FG000|Overall Study|Other Unspecified Reason|0|||
146006513|NCT00326599|526538994|FG001|Overall Study|Other Unspecified Reason|0|||
146006514|NCT00326599|526538995|FG002|Overall Study|Other Unspecified Reason|2|||
146006515|NCT00326599|526538996|FG003|Overall Study|Other Unspecified Reason|1|||
146006516|NCT03386435|526538997|FG000|Overall Study|Protocol Violation|5|||
146006517|NCT03386435|526538998|FG001|Overall Study|Protocol Violation|7|||
146006518|NCT01162473|526539004|FG000|Overall Study|Adverse Event|2|||
146006519|NCT01162473|526539005|FG001|Overall Study|Adverse Event|1|||
146006520|NCT01162473|526539004|FG000|Overall Study|Withdrawal by Subject|0|||
146006521|NCT01162473|526539005|FG001|Overall Study|Withdrawal by Subject|4|||
146006522|NCT02382991|526539009|FG000|Overall Study|Adverse Event|1|||
146006523|NCT02382991|526539010|FG001|Overall Study|Adverse Event|2|||
146006524|NCT02382991|526539009|FG000|Overall Study|Lost to Follow-up|1|||
146006525|NCT02382991|526539010|FG001|Overall Study|Lost to Follow-up|0|||
146006526|NCT02382991|526539009|FG000|Overall Study|Withdrawal by Subject|0|||
146006527|NCT02382991|526539010|FG001|Overall Study|Withdrawal by Subject|1|||
146006528|NCT00943761|526539012|FG000|Overall Study|Lost to Follow-up|2|||
146006529|NCT00943761|526539013|FG001|Overall Study|Lost to Follow-up|0|||
146006530|NCT00943761|526539012|FG000|Overall Study|Withdrawal by Subject|2|||
146006531|NCT00943761|526539013|FG001|Overall Study|Withdrawal by Subject|1|||
146006532|NCT03382912|526539014|FG000|Overall Study|Physician Decision|0|||
146006533|NCT03382912|526539015|FG001|Overall Study|Physician Decision|1|||
146006534|NCT03382912|526539014|FG000|Overall Study|Sponsor Decision|6|||
146006535|NCT03382912|526539015|FG001|Overall Study|Sponsor Decision|6|||
146006536|NCT03382912|526539014|FG000|Overall Study|Withdrawal by Subject|0|||
146006537|NCT03382912|526539015|FG001|Overall Study|Withdrawal by Subject|5|||
146006538|NCT04570384|526539016|FG000|Overall Study|Adverse Event|2|||
146006539|NCT04570384|526539017|FG001|Overall Study|Adverse Event|1|||
146006540|NCT04570384|526539016|FG000|Overall Study|Death|2|||
146006541|NCT04570384|526539017|FG001|Overall Study|Death|5|||
146006542|NCT04570384|526539016|FG000|Overall Study|Lost to Follow-up|1|||
146006543|NCT04570384|526539017|FG001|Overall Study|Lost to Follow-up|0|||
146006544|NCT04570384|526539016|FG000|Overall Study|Other|1|||
146006545|NCT04570384|526539017|FG001|Overall Study|Other|0|||
146006546|NCT04570384|526539016|FG000|Overall Study|Protocol Violation|0|||
146006547|NCT04570384|526539017|FG001|Overall Study|Protocol Violation|1|||
146006548|NCT04570384|526539016|FG000|Overall Study|Sponsor Decision|1|||
146006549|NCT04570384|526539017|FG001|Overall Study|Sponsor Decision|0|||
146006550|NCT04570384|526539016|FG000|Overall Study|Withdrawal by Subject|4|||
146006551|NCT04570384|526539017|FG001|Overall Study|Withdrawal by Subject|2|||
146247973|NCT00828139|527421553|FG002|Overall Study|Other|5|||
146006552|NCT00326001|526539018|FG000|Overall Study|Adverse Event|4|||
146006553|NCT00326001|526539019|FG001|Overall Study|Adverse Event|5|||
146006554|NCT00326001|526539018|FG000|Overall Study|Physician Decision|3|||
146006555|NCT00326001|526539019|FG001|Overall Study|Physician Decision|3|||
146006556|NCT05005273|526539020|FG000|Overall Study|Study Terminated|1|||
146006557|NCT05005273|526539021|FG001|Overall Study|Study Terminated|0|||
146247974|NCT00828139|527421554|FG003|Overall Study|Other|2|||
146006558|NCT03265145|526539022|FG000|Overall Study|Protocol Violation|2|||
146006559|NCT03265145|526539023|FG001|Overall Study|Protocol Violation|0|||
146006560|NCT03265145|526539022|FG000|Overall Study|Adverse Event|1|||
146006561|NCT03265145|526539023|FG001|Overall Study|Adverse Event|0|||
146006562|NCT03265145|526539022|FG000|Overall Study|Withdrawal by Subject|23|||
146006563|NCT03265145|526539023|FG001|Overall Study|Withdrawal by Subject|19|||
146006564|NCT03265145|526539022|FG000|Overall Study|Death|12|||
146247975|NCT01714947|527421555|FG000|Part B|Progressive Disease|3|||
146247976|NCT04751929|527421556|FG000|Overall Study|Withdrawal by Subject|2|||
146247977|NCT04751929|527421557|FG001|Overall Study|Withdrawal by Subject|0|||
146247978|NCT04751929|527421558|FG002|Overall Study|Withdrawal by Subject|0|||
146247979|NCT04751929|527421559|FG003|Overall Study|Withdrawal by Subject|0|||
146247980|NCT04751929|527421556|FG000|Overall Study|Rising PSA|0|||
146247981|NCT04751929|527421557|FG001|Overall Study|Rising PSA|1|||
146247982|NCT04751929|527421558|FG002|Overall Study|Rising PSA|0|||
146247983|NCT04751929|527421559|FG003|Overall Study|Rising PSA|0|||
146247984|NCT04751929|527421556|FG000|Overall Study|Adverse Event|1|||
146006565|NCT03265145|526539023|FG001|Overall Study|Death|12|||
146006566|NCT03265145|526539022|FG000|Overall Study|Lost to Follow-up|13|||
146006567|NCT03265145|526539023|FG001|Overall Study|Lost to Follow-up|9|||
146006568|NCT03265145|526539022|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
146006569|NCT03265145|526539023|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
146006570|NCT03265145|526539022|FG000|Overall Study|Switched back to previous medication|1|||
146006571|NCT03265145|526539023|FG001|Overall Study|Switched back to previous medication|0|||
146006572|NCT03265145|526539022|FG000|Overall Study|Did not want to take medication|1|||
146006573|NCT03265145|526539023|FG001|Overall Study|Did not want to take medication|0|||
146006574|NCT03265145|526539022|FG000|Overall Study|Subject could not afford medication|0|||
146006575|NCT03265145|526539023|FG001|Overall Study|Subject could not afford medication|1|||
146006576|NCT03265145|526539022|FG000|Overall Study|Site closed|2|||
146006577|NCT03265145|526539023|FG001|Overall Study|Site closed|3|||
146006578|NCT03265145|526539022|FG000|Overall Study|Incorrectly randomized|16|||
146006579|NCT03265145|526539023|FG001|Overall Study|Incorrectly randomized|6|||
146006580|NCT03265145|526539022|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
146006581|NCT03265145|526539023|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
146006582|NCT03265145|526539022|FG000|Overall Study|Physician Decision|0|||
146006583|NCT03265145|526539023|FG001|Overall Study|Physician Decision|3|||
146006584|NCT03265145|526539022|FG000|Overall Study|Subject transferred to another facility|0|||
146006585|NCT03265145|526539023|FG001|Overall Study|Subject transferred to another facility|1|||
146006586|NCT04409834|526539024|FG000|Overall Study|Death|55|||
146006587|NCT04409834|526539025|FG001|Overall Study|Death|62|||
146006588|NCT02112656|526539026|FG000|Overall Study|Death|78|||
146006589|NCT02112656|526539027|FG001|Overall Study|Death|82|||
146006590|NCT02112656|526539026|FG000|Overall Study|Withdrawal by Subject|9|||
146006591|NCT02112656|526539027|FG001|Overall Study|Withdrawal by Subject|11|||
146006592|NCT02112656|526539026|FG000|Overall Study|Lost to Follow-up|2|||
146006593|NCT02112656|526539027|FG001|Overall Study|Lost to Follow-up|4|||
146247985|NCT04751929|527421557|FG001|Overall Study|Adverse Event|2|||
146247986|NCT04751929|527421558|FG002|Overall Study|Adverse Event|0|||
146247987|NCT04751929|527421559|FG003|Overall Study|Adverse Event|0|||
146247988|NCT04751929|527421556|FG000|Overall Study|Progressive Disease|3|||
146247989|NCT04751929|527421557|FG001|Overall Study|Progressive Disease|4|||
146247990|NCT04751929|527421558|FG002|Overall Study|Progressive Disease|4|||
146247991|NCT04751929|527421559|FG003|Overall Study|Progressive Disease|0|||
146247992|NCT04751929|527421556|FG000|Overall Study|Death|1|||
146247993|NCT04751929|527421557|FG001|Overall Study|Death|1|||
146247994|NCT04751929|527421558|FG002|Overall Study|Death|0|||
146247995|NCT04751929|527421559|FG003|Overall Study|Death|0|||
146247996|NCT01123356|527421560|FG000|Overall Study|Adverse Event|2|||
146247997|NCT01123356|527421560|FG000|Overall Study|Lack of Efficacy|4|||
146247998|NCT01123356|527421560|FG000|Overall Study|Withdrawal by Subject|1|||
146247999|NCT00376259|527421563|FG000|Overall Study|Sponsor request - study termination|21|||
146248000|NCT00376259|527421564|FG001|Overall Study|Sponsor request - study termination|21|||
146248001|NCT00376259|527421563|FG000|Overall Study|Patient request|1|||
146248002|NCT00376259|527421564|FG001|Overall Study|Patient request|0|||
146248003|NCT00930644|527421565|FG000|Overall Study|Withdrawal by Subject|4|||
146006594|NCT02112656|526539026|FG000|Overall Study|Noncompliance|1|||
146006595|NCT02112656|526539027|FG001|Overall Study|Noncompliance|2|||
146248004|NCT00930644|527421565|FG000|Overall Study|Physician Decision|2|||
146006596|NCT04749745|526539028|FG000|Overall Study|Withdrawal by Subject|1|||
146248005|NCT00930644|527421565|FG000|Overall Study|Death|1|||
146248006|NCT00930644|527421565|FG000|Overall Study|Adverse Event|16|||
146248007|NCT01877720|527421566|FG000|Overall Study|Adverse Event|1|||
146298167|NCT04890054|527607834|FG000|Overall Study|Lost to Follow-up|202|||
146006597|NCT04749745|526539029|FG001|Overall Study|Withdrawal by Subject|0|||
146248008|NCT01877720|527421567|FG001|Overall Study|Adverse Event|0|||
146248009|NCT02068352|527421570|FG000|Overall Study|Lost to Follow-up|0|||
146248010|NCT02068352|527421571|FG001|Overall Study|Lost to Follow-up|2|||
146248011|NCT02068352|527421572|FG002|Overall Study|Lost to Follow-up|0|||
146248012|NCT02068352|527421570|FG000|Overall Study|Adverse Event|4|||
146248013|NCT02068352|527421571|FG001|Overall Study|Adverse Event|2|||
146006598|NCT01365455|526539034|FG000|Induction Period|Adverse Event|5|||
146248014|NCT02068352|527421572|FG002|Overall Study|Adverse Event|7|||
146248015|NCT02068352|527421570|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
146248016|NCT02068352|527421571|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
146298168|NCT04890054|527607835|FG001|Overall Study|Lost to Follow-up|219|||
146006599|NCT01365455|526539035|FG001|Induction Period|Adverse Event|3|||
146006600|NCT01365455|526539036|FG002|Induction Period|Adverse Event|4|||
146006601|NCT01365455|526539037|FG003|Induction Period|Adverse Event|0|||
146006602|NCT01365455|526539038|FG004|Induction Period|Adverse Event|0|||
146006603|NCT01365455|526539034|FG000|Induction Period|Lack of Efficacy|1|||
146006604|NCT01365455|526539035|FG001|Induction Period|Lack of Efficacy|1|||
146006605|NCT01365455|526539036|FG002|Induction Period|Lack of Efficacy|0|||
146006606|NCT01365455|526539037|FG003|Induction Period|Lack of Efficacy|0|||
146006607|NCT01365455|526539038|FG004|Induction Period|Lack of Efficacy|0|||
146006608|NCT01365455|526539034|FG000|Induction Period|Pregnancy|0|||
146006609|NCT01365455|526539035|FG001|Induction Period|Pregnancy|1|||
146006610|NCT01365455|526539036|FG002|Induction Period|Pregnancy|0|||
146006611|NCT01365455|526539037|FG003|Induction Period|Pregnancy|0|||
146006612|NCT01365455|526539038|FG004|Induction Period|Pregnancy|0|||
146006613|NCT01365455|526539034|FG000|Induction Period|Protocol deviation|0|||
146006614|NCT01365455|526539035|FG001|Induction Period|Protocol deviation|1|||
146006615|NCT01365455|526539036|FG002|Induction Period|Protocol deviation|1|||
146006616|NCT01365455|526539037|FG003|Induction Period|Protocol deviation|0|||
146006617|NCT01365455|526539038|FG004|Induction Period|Protocol deviation|0|||
146006618|NCT01365455|526539034|FG000|Induction Period|Subject/guardian decision|9|||
146006619|NCT01365455|526539035|FG001|Induction Period|Subject/guardian decision|1|||
146006620|NCT01365455|526539036|FG002|Induction Period|Subject/guardian decision|8|||
146006621|NCT01365455|526539037|FG003|Induction Period|Subject/guardian decision|0|||
146006622|NCT01365455|526539038|FG004|Induction Period|Subject/guardian decision|0|||
146006623|NCT01365455|526539034|FG000|Induction Period|Lost to Follow-up|0|||
146006624|NCT01365455|526539035|FG001|Induction Period|Lost to Follow-up|0|||
146006625|NCT01365455|526539036|FG002|Induction Period|Lost to Follow-up|3|||
146006626|NCT01365455|526539037|FG003|Induction Period|Lost to Follow-up|0|||
146006627|NCT01365455|526539038|FG004|Induction Period|Lost to Follow-up|0|||
146006628|NCT01365455|526539034|FG000|Maintenance Period|Adverse Event|12|||
146006629|NCT01365455|526539035|FG001|Maintenance Period|Adverse Event|5|||
146006630|NCT01365455|526539036|FG002|Maintenance Period|Adverse Event|1|||
146006631|NCT01365455|526539037|FG003|Maintenance Period|Adverse Event|2|||
146006632|NCT01365455|526539038|FG004|Maintenance Period|Adverse Event|4|||
146006633|NCT01365455|526539034|FG000|Maintenance Period|Lack of Efficacy|10|||
146006634|NCT01365455|526539035|FG001|Maintenance Period|Lack of Efficacy|2|||
146006635|NCT01365455|526539036|FG002|Maintenance Period|Lack of Efficacy|0|||
146006636|NCT01365455|526539037|FG003|Maintenance Period|Lack of Efficacy|2|||
146006637|NCT01365455|526539038|FG004|Maintenance Period|Lack of Efficacy|2|||
146006638|NCT01365455|526539034|FG000|Maintenance Period|Lost to Follow-up|2|||
146006639|NCT01365455|526539035|FG001|Maintenance Period|Lost to Follow-up|4|||
146006640|NCT01365455|526539036|FG002|Maintenance Period|Lost to Follow-up|0|||
146006641|NCT01365455|526539037|FG003|Maintenance Period|Lost to Follow-up|0|||
146006642|NCT01365455|526539038|FG004|Maintenance Period|Lost to Follow-up|3|||
146006643|NCT01365455|526539034|FG000|Maintenance Period|Non-compliance with study treatment|0|||
146006644|NCT01365455|526539035|FG001|Maintenance Period|Non-compliance with study treatment|0|||
146006645|NCT01365455|526539036|FG002|Maintenance Period|Non-compliance with study treatment|0|||
146006646|NCT01365455|526539037|FG003|Maintenance Period|Non-compliance with study treatment|1|||
146006647|NCT01365455|526539038|FG004|Maintenance Period|Non-compliance with study treatment|0|||
146006648|NCT01365455|526539034|FG000|Maintenance Period|Physician Decision|0|||
146006649|NCT01365455|526539035|FG001|Maintenance Period|Physician Decision|1|||
146006650|NCT01365455|526539036|FG002|Maintenance Period|Physician Decision|0|||
146006651|NCT01365455|526539037|FG003|Maintenance Period|Physician Decision|0|||
146006652|NCT01365455|526539038|FG004|Maintenance Period|Physician Decision|1|||
146006653|NCT01365455|526539034|FG000|Maintenance Period|Pregnancy|0|||
146006654|NCT01365455|526539035|FG001|Maintenance Period|Pregnancy|4|||
146006655|NCT01365455|526539036|FG002|Maintenance Period|Pregnancy|0|||
146006656|NCT01365455|526539037|FG003|Maintenance Period|Pregnancy|0|||
146006657|NCT01365455|526539038|FG004|Maintenance Period|Pregnancy|2|||
146006658|NCT01365455|526539034|FG000|Maintenance Period|Protocol deviation|1|||
146006659|NCT01365455|526539035|FG001|Maintenance Period|Protocol deviation|1|||
146006660|NCT01365455|526539036|FG002|Maintenance Period|Protocol deviation|0|||
146006661|NCT01365455|526539037|FG003|Maintenance Period|Protocol deviation|0|||
146006662|NCT01365455|526539038|FG004|Maintenance Period|Protocol deviation|0|||
146006663|NCT01365455|526539034|FG000|Maintenance Period|Subject/guardian decision|4|||
146006664|NCT01365455|526539035|FG001|Maintenance Period|Subject/guardian decision|6|||
146006665|NCT01365455|526539036|FG002|Maintenance Period|Subject/guardian decision|2|||
146006666|NCT01365455|526539037|FG003|Maintenance Period|Subject/guardian decision|4|||
146006667|NCT01365455|526539038|FG004|Maintenance Period|Subject/guardian decision|1|||
146006668|NCT03965403|526539039|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
146006669|NCT01349673|526540167|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
146006670|NCT01349673|526540167|FG000|Overall Study|No Longer Qualified For Study|1|||
146006671|NCT01349673|526540167|FG000|Overall Study|Site Closure|10|||
146006672|NCT01349673|526540167|FG000|Overall Study|Withdrawal by Subject|21|||
146006673|NCT01349673|526540167|FG000|Overall Study|Lost to Follow-up|6|||
146006674|NCT01349673|526540167|FG000|Overall Study|Adverse Event|17|||
146006675|NCT01349673|526540167|FG000|Overall Study|Study Terminated By Sponsor|50|||
146006676|NCT01349673|526540167|FG000|Overall Study|Lack of Efficacy|8|||
146006677|NCT01724216|526540170|FG000|Overall Study|Scan was not completed|1|||
146006678|NCT00564733|526540171|FG000|Overall Study|Withdrawal by Subject|4|||
146006679|NCT00564733|526540171|FG000|Overall Study|Ineligible|5|||
146006680|NCT01484496|526540174|FG000|Period 1|Protocol Violation|3|||
146006681|NCT01484496|526540175|FG001|Period 1|Protocol Violation|4|||
146006682|NCT01484496|526540176|FG002|Period 1|Protocol Violation|0|||
146006683|NCT01484496|526540177|FG003|Period 1|Protocol Violation|0|||
146006684|NCT01484496|526540174|FG000|Period 1|Physician Decision|5|||
146006685|NCT01484496|526540175|FG001|Period 1|Physician Decision|1|||
146006686|NCT01484496|526540176|FG002|Period 1|Physician Decision|0|||
146006687|NCT01484496|526540177|FG003|Period 1|Physician Decision|0|||
146006688|NCT01484496|526540174|FG000|Period 1|Lack of Efficacy|10|||
146006689|NCT01484496|526540175|FG001|Period 1|Lack of Efficacy|15|||
146006690|NCT01484496|526540176|FG002|Period 1|Lack of Efficacy|0|||
146006691|NCT01484496|526540177|FG003|Period 1|Lack of Efficacy|0|||
146006692|NCT01484496|526540174|FG000|Period 1|Adverse Event|25|||
146006693|NCT01484496|526540175|FG001|Period 1|Adverse Event|40|||
146006694|NCT01484496|526540176|FG002|Period 1|Adverse Event|0|||
146006695|NCT01484496|526540177|FG003|Period 1|Adverse Event|0|||
146006696|NCT01484496|526540174|FG000|Period 1|Withdrawal by Subject|15|||
146006697|NCT01484496|526540175|FG001|Period 1|Withdrawal by Subject|12|||
146006698|NCT01484496|526540176|FG002|Period 1|Withdrawal by Subject|0|||
146006699|NCT01484496|526540177|FG003|Period 1|Withdrawal by Subject|0|||
146006700|NCT01484496|526540174|FG000|Period 1|Lost to Follow-up|2|||
146006701|NCT01484496|526540175|FG001|Period 1|Lost to Follow-up|6|||
146006702|NCT01484496|526540176|FG002|Period 1|Lost to Follow-up|0|||
146006703|NCT01484496|526540177|FG003|Period 1|Lost to Follow-up|0|||
146006704|NCT01484496|526540174|FG000|Period 1|Positive Pregnancy|1|||
146006705|NCT01484496|526540175|FG001|Period 1|Positive Pregnancy|6|||
146006706|NCT01484496|526540176|FG002|Period 1|Positive Pregnancy|0|||
146006707|NCT01484496|526540177|FG003|Period 1|Positive Pregnancy|0|||
146006708|NCT01484496|526540174|FG000|Period 1|Treatment Failure|3|||
146006709|NCT01484496|526540175|FG001|Period 1|Treatment Failure|6|||
146006710|NCT01484496|526540176|FG002|Period 1|Treatment Failure|0|||
146006711|NCT01484496|526540177|FG003|Period 1|Treatment Failure|0|||
146006712|NCT01484496|526540174|FG000|Period 1|Lack of Compliance|2|||
146006713|NCT01484496|526540175|FG001|Period 1|Lack of Compliance|1|||
146006714|NCT01484496|526540176|FG002|Period 1|Lack of Compliance|0|||
146006715|NCT01484496|526540177|FG003|Period 1|Lack of Compliance|0|||
146006716|NCT01484496|526540174|FG000|Period 1|Unable to Visit Site|0|||
146006717|NCT01484496|526540175|FG001|Period 1|Unable to Visit Site|2|||
146006718|NCT01484496|526540176|FG002|Period 1|Unable to Visit Site|0|||
146006719|NCT01484496|526540177|FG003|Period 1|Unable to Visit Site|0|||
146006720|NCT01484496|526540174|FG000|Period 2|Lack of Efficacy|0|||
146006721|NCT01484496|526540175|FG001|Period 2|Lack of Efficacy|0|||
146006722|NCT01484496|526540176|FG002|Period 2|Lack of Efficacy|1|||
146006723|NCT01484496|526540177|FG003|Period 2|Lack of Efficacy|3|||
146006724|NCT01484496|526540174|FG000|Period 2|Adverse Event|0|||
146006725|NCT01484496|526540175|FG001|Period 2|Adverse Event|0|||
146006726|NCT01484496|526540176|FG002|Period 2|Adverse Event|5|||
146006727|NCT01484496|526540177|FG003|Period 2|Adverse Event|13|||
146006728|NCT01484496|526540174|FG000|Period 2|Other|0|||
146006729|NCT01484496|526540175|FG001|Period 2|Other|0|||
146006730|NCT01484496|526540176|FG002|Period 2|Other|9|||
146006731|NCT01484496|526540177|FG003|Period 2|Other|6|||
146006732|NCT00506779|526540178|FG000|Overall Study|Withdrawal by Subject|1|||
146006733|NCT00506779|526540179|FG001|Overall Study|Withdrawal by Subject|0|||
146006734|NCT00506779|526540180|FG002|Overall Study|Withdrawal by Subject|1|||
146006735|NCT00506779|526540181|FG003|Overall Study|Withdrawal by Subject|0|||
146006736|NCT00506779|526540178|FG000|Overall Study|Adverse Event|0|||
146248017|NCT02068352|527421572|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
146248018|NCT02068352|527421570|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
146006737|NCT00506779|526540179|FG001|Overall Study|Adverse Event|1|||
146006738|NCT00506779|526540180|FG002|Overall Study|Adverse Event|1|||
146092430|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
146006739|NCT00506779|526540181|FG003|Overall Study|Adverse Event|1|||
146006740|NCT01456130|526540183|FG000|Overall Study|Adverse Event|4|||
146006741|NCT01456130|526540183|FG000|Overall Study|Voluntary Withdrawal|1|||
146006742|NCT01456130|526540183|FG000|Overall Study|Lack of Efficacy|4|||
146006743|NCT01456130|526540183|FG000|Overall Study|Other|1|||
146006744|NCT02688192|526540184|FG000|Overall Study|Lost to Follow-up|11|||
146248019|NCT02068352|527421571|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
146006745|NCT02688192|526540185|FG001|Overall Study|Lost to Follow-up|5|||
146006746|NCT02688192|526540184|FG000|Overall Study|Physician Decision|1|||
146006747|NCT02688192|526540185|FG001|Overall Study|Physician Decision|0|||
146006748|NCT00075764|526540186|FG000|Overall Study|Adverse Event|5|||
146006749|NCT00075764|526540187|FG001|Overall Study|Adverse Event|12|||
146006750|NCT00075764|526540186|FG000|Overall Study|Death|4|||
146006751|NCT00075764|526540187|FG001|Overall Study|Death|8|||
146298169|NCT02113579|527607839|FG000|Overall Study|Adverse Event|1|||
146298170|NCT02113579|527607840|FG001|Overall Study|Adverse Event|0|||
146006752|NCT00075764|526540186|FG000|Overall Study|Withdrawal by Subject|28|||
146006753|NCT00075764|526540187|FG001|Overall Study|Withdrawal by Subject|18|||
146006754|NCT00075764|526540186|FG000|Overall Study|Progression|269|||
146006755|NCT00075764|526540187|FG001|Overall Study|Progression|274|||
146006756|NCT00075764|526540186|FG000|Overall Study|Still on treatment|8|||
146006757|NCT00075764|526540187|FG001|Overall Study|Still on treatment|15|||
146006758|NCT00075764|526540186|FG000|Overall Study|Delinquent|4|||
146006759|NCT00075764|526540187|FG001|Overall Study|Delinquent|2|||
146006760|NCT00075764|526540186|FG000|Overall Study|Not protocol specified|27|||
146006761|NCT00075764|526540187|FG001|Overall Study|Not protocol specified|19|||
146006762|NCT00075764|526540186|FG000|Overall Study|Under review|0|||
146006763|NCT00075764|526540187|FG001|Overall Study|Under review|1|||
146006764|NCT02010593|526540188|FG000|Overall Study|Lost to Follow-up|1|||
146006765|NCT02010593|526540189|FG001|Overall Study|Lost to Follow-up|0|||
146006766|NCT02010593|526540188|FG000|Overall Study|Physician Decision|1|||
146006767|NCT02010593|526540189|FG001|Overall Study|Physician Decision|0|||
146006768|NCT02010593|526540188|FG000|Overall Study|Unable to adhere to visit schedule|0|||
146006769|NCT02010593|526540189|FG001|Overall Study|Unable to adhere to visit schedule|2|||
146006770|NCT01773967|526540190|FG000|Overall Study|Lost to Follow-up|15|||
146006771|NCT01773967|526540191|FG001|Overall Study|Lost to Follow-up|13|||
146006772|NCT01135459|526540192|FG000|Overall Study|Adverse Event|8|||
146006773|NCT01135459|526540193|FG001|Overall Study|Adverse Event|10|||
146006774|NCT01135459|526540192|FG000|Overall Study|Lack of Efficacy|3|||
146006775|NCT01135459|526540193|FG001|Overall Study|Lack of Efficacy|1|||
146006776|NCT01135459|526540192|FG000|Overall Study|Withdrawal by Subject|2|||
146006777|NCT01135459|526540193|FG001|Overall Study|Withdrawal by Subject|3|||
146006778|NCT01135459|526540192|FG000|Overall Study|Protocol Violation|5|||
146006779|NCT01135459|526540193|FG001|Overall Study|Protocol Violation|3|||
146006780|NCT01135459|526540192|FG000|Overall Study|Lost to Follow-up|2|||
146006781|NCT01135459|526540193|FG001|Overall Study|Lost to Follow-up|1|||
146006782|NCT01135459|526540192|FG000|Overall Study|Non-compliance to study procedures|0|||
146006783|NCT01135459|526540193|FG001|Overall Study|Non-compliance to study procedures|1|||
146006784|NCT01135459|526540192|FG000|Overall Study|Other than specified|1|||
146006785|NCT01135459|526540193|FG001|Overall Study|Other than specified|1|||
146006786|NCT00709319|526540194|FG000|Overall Study|Death|4|||
146006787|NCT00709319|526540194|FG000|Overall Study|Withdrawal by Subject|2|||
146006788|NCT04860869|526540204|FG000|Overall Study|Withdrawal by Subject|1|||
146006789|NCT04860869|526540205|FG001|Overall Study|Withdrawal by Subject|0|||
146006790|NCT01151020|526540206|FG000|Overall Study|Death|25|||
146006791|NCT01151020|526540206|FG000|Overall Study|Conversion to open repair|1|||
146006792|NCT01151020|526540206|FG000|Overall Study|Lost to Follow-up|4|||
146006793|NCT01151020|526540206|FG000|Overall Study|Withdrawal by Subject|22|||
146006794|NCT01151020|526540206|FG000|Overall Study|Patients did not receive the device|2|||
146006795|NCT03606486|526540207|FG000|Overall Study|Unable to collect sample|5|||
146006796|NCT01737762|526540216|FG000|Overall Study|Adverse Event|2|||
146006797|NCT01737762|526540217|FG001|Overall Study|Adverse Event|2|||
146006798|NCT01737762|526540216|FG000|Overall Study|Lost to Follow-up|1|||
146006799|NCT01737762|526540217|FG001|Overall Study|Lost to Follow-up|0|||
146006800|NCT01737762|526540216|FG000|Overall Study|Withdrawal by Subject|2|||
146006801|NCT01737762|526540217|FG001|Overall Study|Withdrawal by Subject|2|||
146006802|NCT01737762|526540216|FG000|Overall Study|Progressive disease|1|||
146006803|NCT01737762|526540217|FG001|Overall Study|Progressive disease|2|||
146006804|NCT01737762|526540216|FG000|Overall Study|Physician Decision|1|||
146006805|NCT01737762|526540217|FG001|Overall Study|Physician Decision|1|||
146006806|NCT01737762|526540216|FG000|Overall Study|Moved from area|2|||
146006807|NCT01737762|526540217|FG001|Overall Study|Moved from area|1|||
146006808|NCT01737762|526540216|FG000|Overall Study|Trial termination|11|||
146006809|NCT01737762|526540217|FG001|Overall Study|Trial termination|9|||
146006810|NCT00503425|526540218|FG000|Overall Study|Participant files lost|6|||
146006811|NCT00503425|526540218|FG000|Overall Study|Adverse Event|5|||
146006812|NCT00503425|526540218|FG000|Overall Study|Lack of Efficacy|25|||
146006813|NCT00503425|526540218|FG000|Overall Study|Withdrawal by Subject|8|||
146298171|NCT02113579|527607839|FG000|Overall Study|Withdrawal by Subject|3|||
146006814|NCT00503425|526540218|FG000|Overall Study|Lost to Follow-up|3|||
146006815|NCT00503425|526540218|FG000|Overall Study|Death|3|||
146006816|NCT00503425|526540218|FG000|Overall Study|Missing Data/Unknown|4|||
146006817|NCT02148263|526540219|FG000|Overall Study|Withdrawal by Subject|3|||
146006818|NCT02148263|526540220|FG001|Overall Study|Withdrawal by Subject|2|||
146006819|NCT03364231|526540221|FG000|Overall Study|Adverse Event|1|||
146006820|NCT03364231|526540222|FG001|Overall Study|Adverse Event|4|||
146006821|NCT03364231|526540221|FG000|Overall Study|Death|1|||
146006822|NCT03364231|526540222|FG001|Overall Study|Death|0|||
146006823|NCT03364231|526540221|FG000|Overall Study|Investigator Decision|2|||
146006824|NCT03364231|526540222|FG001|Overall Study|Investigator Decision|2|||
146006825|NCT03364231|526540221|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
146006826|NCT03364231|526540222|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
146298172|NCT02113579|527607840|FG001|Overall Study|Withdrawal by Subject|2|||
146248020|NCT02068352|527421572|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
146248021|NCT02068352|527421570|FG000|Overall Study|Protocol Deviation|0|||
146248022|NCT02068352|527421571|FG001|Overall Study|Protocol Deviation|0|||
146248023|NCT02068352|527421572|FG002|Overall Study|Protocol Deviation|1|||
146006827|NCT03364231|526540221|FG000|Overall Study|Withdrawal of Subject Consent|1|||
146006828|NCT03364231|526540222|FG001|Overall Study|Withdrawal of Subject Consent|0|||
146006829|NCT03364231|526540221|FG000|Overall Study|Reason Not Specified|1|||
146006830|NCT03364231|526540222|FG001|Overall Study|Reason Not Specified|0|||
146006831|NCT03364231|526540221|FG000|Overall Study|Disease Progression|0|||
146006832|NCT03364231|526540222|FG001|Overall Study|Disease Progression|6|||
146006833|NCT02503085|526540223|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
146006834|NCT02503085|526540224|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
146006835|NCT02503085|526540225|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
146006836|NCT02503085|526540226|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
146006837|NCT03328832|526540228|FG000|Overall Study|Lost to Follow-up|0|||
146006838|NCT03328832|526540229|FG001|Overall Study|Lost to Follow-up|1|||
146006839|NCT02012218|526540232|FG000|Overall Study|Withdrawal by Subject|1|||
146006840|NCT02012218|526540233|FG001|Overall Study|Withdrawal by Subject|0|||
146006841|NCT02012218|526540234|FG002|Overall Study|Withdrawal by Subject|1|||
146006842|NCT02012218|526540235|FG003|Overall Study|Withdrawal by Subject|1|||
146006843|NCT02012218|526540236|FG004|Overall Study|Withdrawal by Subject|1|||
146006844|NCT02012218|526540232|FG000|Overall Study|Adverse Event|1|||
146006845|NCT02012218|526540233|FG001|Overall Study|Adverse Event|0|||
146006846|NCT02012218|526540234|FG002|Overall Study|Adverse Event|0|||
146006847|NCT02012218|526540235|FG003|Overall Study|Adverse Event|1|||
146006848|NCT02012218|526540236|FG004|Overall Study|Adverse Event|0|||
146006849|NCT02012218|526540232|FG000|Overall Study|Lost to Follow-up|0|||
146006850|NCT02012218|526540233|FG001|Overall Study|Lost to Follow-up|1|||
146006851|NCT02012218|526540234|FG002|Overall Study|Lost to Follow-up|1|||
146006852|NCT02012218|526540235|FG003|Overall Study|Lost to Follow-up|0|||
146006853|NCT02012218|526540236|FG004|Overall Study|Lost to Follow-up|0|||
146006854|NCT02012218|526540232|FG000|Overall Study|Protocol Specified|1|||
146006855|NCT02012218|526540233|FG001|Overall Study|Protocol Specified|0|||
146006856|NCT02012218|526540234|FG002|Overall Study|Protocol Specified|0|||
146006857|NCT02012218|526540235|FG003|Overall Study|Protocol Specified|0|||
146006858|NCT02012218|526540236|FG004|Overall Study|Protocol Specified|0|||
146006859|NCT02012218|526540232|FG000|Overall Study|Protocol Deviation|1|||
146006860|NCT02012218|526540233|FG001|Overall Study|Protocol Deviation|0|||
146006861|NCT02012218|526540234|FG002|Overall Study|Protocol Deviation|0|||
146006862|NCT02012218|526540235|FG003|Overall Study|Protocol Deviation|0|||
146006863|NCT02012218|526540236|FG004|Overall Study|Protocol Deviation|0|||
146006864|NCT04872569|526540237|FG000|Overall Study|Withdrawal by Subject|2|||
146006865|NCT04417257|526540240|FG000|Pilot Phase 2|Adverse Event|2|||
146006866|NCT04417257|526540241|FG001|Pilot Phase 2|Adverse Event|0|||
146006867|NCT04417257|526540240|FG000|Pilot Phase 2|Death|14|||
146006868|NCT04417257|526540241|FG001|Pilot Phase 2|Death|11|||
146006869|NCT04417257|526540240|FG000|Pilot Phase 2|Lost to Follow-up|3|||
146006870|NCT04417257|526540241|FG001|Pilot Phase 2|Lost to Follow-up|5|||
146006871|NCT04417257|526540240|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
146006872|NCT04417257|526540241|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
146006873|NCT04417257|526540240|FG000|Pilot Phase 2|Hepatic impairment|1|||
146006874|NCT04417257|526540241|FG001|Pilot Phase 2|Hepatic impairment|0|||
146006875|NCT04417257|526540240|FG000|Pilot Phase 2|Unblinding|1|||
146006876|NCT04417257|526540241|FG001|Pilot Phase 2|Unblinding|0|||
146006877|NCT04417257|526540240|FG000|Pilot Phase 2|All other|0|||
146006878|NCT04417257|526540241|FG001|Pilot Phase 2|All other|2|||
146006879|NCT04417257|526540240|FG000|Phase 3 Extension|Death|3|||
146006880|NCT04417257|526540241|FG001|Phase 3 Extension|Death|1|||
146006881|NCT04417257|526540240|FG000|Phase 3 Extension|Lost to Follow-up|4|||
146006882|NCT04417257|526540241|FG001|Phase 3 Extension|Lost to Follow-up|2|||
146006883|NCT04417257|526540240|FG000|Phase 3 Extension|Patient withdrawal|2|||
146006884|NCT04417257|526540241|FG001|Phase 3 Extension|Patient withdrawal|2|||
146006885|NCT04417257|526540240|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
146006886|NCT04417257|526540241|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
146006887|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
146006888|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
146006889|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146006890|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146006891|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
146248024|NCT01129011|527421578|FG000|Overall Study|Adverse Event|20|||
146006892|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
146006893|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
146006894|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146006895|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146248025|NCT01129011|527421579|FG001|Overall Study|Adverse Event|30|||
146248026|NCT01129011|527421578|FG000|Overall Study|Withdrawal by Subject|24|||
146248027|NCT01129011|527421579|FG001|Overall Study|Withdrawal by Subject|8|||
146006896|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
146006897|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
146006898|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
146006899|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146006900|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146006901|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
146006902|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146006903|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
146006904|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146006905|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146006906|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
146006907|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
146006908|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
146006909|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146006910|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146006911|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
146006912|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146006913|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
146006914|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146006915|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146006916|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
146006917|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
146006918|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146006919|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146006920|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146006921|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
146006922|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
146006923|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146006924|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146006925|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146006926|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
146006927|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
146006928|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146006929|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146006930|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146006931|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
146006932|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146006933|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
146006934|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146006935|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146006936|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
146006937|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
146006938|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146006939|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146006940|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146006941|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
146006942|NCT04951622|526540242|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146006943|NCT04951622|526540243|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
146006944|NCT04951622|526540244|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146006945|NCT04951622|526540245|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146006946|NCT04951622|526540246|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
146006947|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146006948|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146006949|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
146248028|NCT01129011|527421578|FG000|Overall Study|Lost to Follow-up|6|||
146248029|NCT01129011|527421579|FG001|Overall Study|Lost to Follow-up|7|||
146248030|NCT01129011|527421578|FG000|Overall Study|Duodenal Ulcer|2|||
146248031|NCT01129011|527421579|FG001|Overall Study|Duodenal Ulcer|8|||
146248032|NCT01129011|527421578|FG000|Overall Study|misc|7|||
146248033|NCT01129011|527421579|FG001|Overall Study|misc|4|||
146248034|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146248035|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146006950|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
146248036|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146248037|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146248038|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146298173|NCT02113579|527607839|FG000|Overall Study|Lost to Follow-up|6|||
146006951|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
146006952|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146006953|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146006954|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
146006955|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
146006956|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
146006957|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
146248039|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146248040|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146248041|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
146006958|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
146006959|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
146006960|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
146006961|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
146006962|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146006963|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146006964|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
146006965|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
146006966|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
146006967|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146006968|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146006969|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
146006970|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146006971|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
146006972|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146006973|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146006974|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
146006975|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
146006976|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
146006977|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
146006978|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
146006979|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
146006980|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
146006981|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
146006982|NCT04951622|526540242|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146006983|NCT04951622|526540243|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146006984|NCT04951622|526540244|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146006985|NCT04951622|526540245|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
146006986|NCT04951622|526540246|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
146006987|NCT02708680|526540248|FG000|Overall Study|Withdrawal by Subject|4|||
146006988|NCT02708680|526540249|FG001|Overall Study|Withdrawal by Subject|12|||
146006989|NCT02708680|526540250|FG002|Overall Study|Withdrawal by Subject|12|||
146006990|NCT02708680|526540248|FG000|Overall Study|Death|4|||
146006991|NCT02708680|526540249|FG001|Overall Study|Death|19|||
146006992|NCT02708680|526540250|FG002|Overall Study|Death|21|||
146006993|NCT02708680|526540248|FG000|Overall Study|Lost to Follow-up|0|||
146006994|NCT02708680|526540249|FG001|Overall Study|Lost to Follow-up|3|||
146006995|NCT02708680|526540250|FG002|Overall Study|Lost to Follow-up|3|||
146006996|NCT02708680|526540248|FG000|Overall Study|Study Terminated By Sponsor|0|||
146006997|NCT02708680|526540249|FG001|Overall Study|Study Terminated By Sponsor|5|||
146006998|NCT02708680|526540250|FG002|Overall Study|Study Terminated By Sponsor|4|||
146006999|NCT02708680|526540248|FG000|Overall Study|Other than Specified|0|||
146007000|NCT02708680|526540249|FG001|Overall Study|Other than Specified|0|||
146007001|NCT02708680|526540250|FG002|Overall Study|Other than Specified|1|||
146007002|NCT02708680|526540248|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
146007003|NCT02708680|526540249|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
146007004|NCT02708680|526540250|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
146007005|NCT01342926|526540251|FG000|Overall Study|Adverse Event|5|||
146007006|NCT01342926|526540252|FG001|Overall Study|Adverse Event|8|||
146007007|NCT01342926|526540253|FG002|Overall Study|Adverse Event|10|||
146007008|NCT01342926|526540254|FG003|Overall Study|Adverse Event|7|||
146248042|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
146007009|NCT01342926|526540251|FG000|Overall Study|Lost to Follow-up|0|||
146007010|NCT01342926|526540252|FG001|Overall Study|Lost to Follow-up|1|||
146007011|NCT01342926|526540253|FG002|Overall Study|Lost to Follow-up|1|||
146248043|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
146248044|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146248045|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146248046|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146248047|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146248048|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
146248049|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146248050|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146248051|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146248052|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146248053|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146298174|NCT02113579|527607840|FG001|Overall Study|Lost to Follow-up|2|||
146298175|NCT03808688|527607841|FG000|Overall Study|Adverse Event|13|||
146298176|NCT03808688|527607842|FG001|Overall Study|Adverse Event|17|||
146298177|NCT03808688|527607841|FG000|Overall Study|Lack of Efficacy|2|||
146298178|NCT03808688|527607842|FG001|Overall Study|Lack of Efficacy|0|||
146298179|NCT03808688|527607841|FG000|Overall Study|Lost to Follow-up|0|||
146298180|NCT03808688|527607842|FG001|Overall Study|Lost to Follow-up|2|||
146298181|NCT03808688|527607841|FG000|Overall Study|Withdrawal by Subject|1|||
146298182|NCT03808688|527607842|FG001|Overall Study|Withdrawal by Subject|0|||
146298183|NCT03808688|527607841|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
146298184|NCT03808688|527607842|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
146298185|NCT03808688|527607841|FG000|Overall Study|IOP Too High|1|||
146298186|NCT03808688|527607842|FG001|Overall Study|IOP Too High|1|||
146298187|NCT03808688|527607841|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
146298188|NCT03808688|527607842|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
146298189|NCT03808688|527607841|FG000|Overall Study|Visit Out of Window|0|||
146298190|NCT03808688|527607842|FG001|Overall Study|Visit Out of Window|1|||
146298191|NCT03808688|527607841|FG000|Overall Study|Medication Non-Compliance|0|||
146298192|NCT03808688|527607842|FG001|Overall Study|Medication Non-Compliance|1|||
146298193|NCT01940354|527607856|FG000|Overall Study|Withdrawal by Subject|4|||
146298194|NCT01940354|527607857|FG001|Overall Study|Withdrawal by Subject|2|||
146298195|NCT03872453|527607858|FG000|Overall Study|Adverse Event|1|||
146298196|NCT03872453|527607859|FG001|Overall Study|Adverse Event|1|||
146298197|NCT03872453|527607860|FG002|Overall Study|Adverse Event|0|||
146298198|NCT03872453|527607861|FG003|Overall Study|Adverse Event|0|||
146007012|NCT01342926|526540254|FG003|Overall Study|Lost to Follow-up|0|||
146007013|NCT01342926|526540251|FG000|Overall Study|Investigator Discretion|2|||
146007014|NCT01342926|526540252|FG001|Overall Study|Investigator Discretion|2|||
146007015|NCT01342926|526540253|FG002|Overall Study|Investigator Discretion|0|||
146007016|NCT01342926|526540254|FG003|Overall Study|Investigator Discretion|0|||
146007017|NCT01342926|526540251|FG000|Overall Study|Withdrawal by Subject|2|||
146007018|NCT01342926|526540252|FG001|Overall Study|Withdrawal by Subject|4|||
146298199|NCT03872453|527607858|FG000|Overall Study|Lost to Follow-up|8|||
146007019|NCT01342926|526540253|FG002|Overall Study|Withdrawal by Subject|3|||
146007020|NCT01342926|526540254|FG003|Overall Study|Withdrawal by Subject|5|||
146007021|NCT03960684|526540257|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
146007022|NCT02151786|526540258|FG000|Overall Study|Unavailability of Case Report Form|26|||
146007023|NCT02151786|526540258|FG000|Overall Study|Outside the Contract Period|1|||
146007024|NCT02151786|526540258|FG000|Overall Study|Randomized, not Treated|1|||
146007025|NCT02151786|526540258|FG000|Overall Study|Unavailability of Information|8|||
146007026|NCT03761056|526540262|FG000|Overall Study|Death|8|||
146007027|NCT03761056|526540262|FG000|Overall Study|Enrolled but never treated|2|||
146007028|NCT03761056|526540262|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
146007029|NCT03761056|526540262|FG000|Overall Study|Investigator decision|1|||
146007030|NCT03941483|526540265|FG000|Overall Study|Miscellaneous|2|||
146007031|NCT03941483|526540266|FG001|Overall Study|Miscellaneous|3|||
146007032|NCT03941483|526540267|FG002|Overall Study|Miscellaneous|0|||
146007033|NCT03941483|526540265|FG000|Overall Study|Study Terminated by Sponsor|1|||
146298200|NCT03872453|527607859|FG001|Overall Study|Lost to Follow-up|7|||
146298201|NCT03872453|527607860|FG002|Overall Study|Lost to Follow-up|4|||
146007034|NCT03941483|526540266|FG001|Overall Study|Study Terminated by Sponsor|0|||
146248054|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146298202|NCT03872453|527607861|FG003|Overall Study|Lost to Follow-up|4|||
146007035|NCT03941483|526540267|FG002|Overall Study|Study Terminated by Sponsor|0|||
146007036|NCT03941483|526540265|FG000|Overall Study|Withdrawal by Subject|1|||
146007037|NCT03941483|526540266|FG001|Overall Study|Withdrawal by Subject|4|||
146007038|NCT03941483|526540267|FG002|Overall Study|Withdrawal by Subject|1|||
146007039|NCT03941483|526540265|FG000|Overall Study|Lost to Follow-up|2|||
146298203|NCT03872453|527607858|FG000|Overall Study|Never Treated Migraine|19|||
146298204|NCT03872453|527607859|FG001|Overall Study|Never Treated Migraine|17|||
146298205|NCT03872453|527607860|FG002|Overall Study|Never Treated Migraine|13|||
146298206|NCT03872453|527607861|FG003|Overall Study|Never Treated Migraine|12|||
146298207|NCT03872453|527607858|FG000|Overall Study|Pregnancy|1|||
146298208|NCT03872453|527607859|FG001|Overall Study|Pregnancy|0|||
146007040|NCT03941483|526540266|FG001|Overall Study|Lost to Follow-up|1|||
146007041|NCT03941483|526540267|FG002|Overall Study|Lost to Follow-up|8|||
146007042|NCT03941483|526540265|FG000|Overall Study|Death|3|||
146007043|NCT03941483|526540266|FG001|Overall Study|Death|2|||
146007044|NCT03941483|526540267|FG002|Overall Study|Death|6|||
146007045|NCT02685826|526540269|FG000|Overall Study|Adverse Event|2|||
146007046|NCT02685826|526540270|FG001|Overall Study|Adverse Event|0|||
146007047|NCT02685826|526540271|FG002|Overall Study|Adverse Event|1|||
146007048|NCT02685826|526540269|FG000|Overall Study|Progressive Disease|2|||
146007049|NCT02685826|526540270|FG001|Overall Study|Progressive Disease|1|||
146007050|NCT02685826|526540271|FG002|Overall Study|Progressive Disease|0|||
146007051|NCT02685826|526540269|FG000|Overall Study|Withdrawal by Subject|2|||
146007052|NCT02685826|526540270|FG001|Overall Study|Withdrawal by Subject|0|||
146007053|NCT02685826|526540271|FG002|Overall Study|Withdrawal by Subject|0|||
146007054|NCT02685826|526540269|FG000|Overall Study|Full Clinical Hold by FDA|19|||
146007055|NCT02685826|526540270|FG001|Overall Study|Full Clinical Hold by FDA|9|||
146007056|NCT02685826|526540271|FG002|Overall Study|Full Clinical Hold by FDA|20|||
146007057|NCT03154476|526540272|FG000|Overall Study|Lost to Follow-up|4|||
146007058|NCT03154476|526540273|FG001|Overall Study|Lost to Follow-up|4|||
146007059|NCT01444430|526540274|FG000|Overall Study|Withdrawal by Subject|53|||
146007060|NCT01444430|526540275|FG001|Overall Study|Withdrawal by Subject|72|||
146248055|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248056|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
146248057|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248058|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248059|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248060|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248061|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146248062|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
146248063|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
146248064|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
146248065|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146248066|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146248067|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146248068|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146248069|NCT03745651|527421580|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
146248070|NCT03745651|527421581|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
146248071|NCT03745651|527421582|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
146248072|NCT03745651|527421583|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146248073|NCT03745651|527421584|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146248074|NCT03745651|527421585|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146248075|NCT03745651|527421586|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
146248076|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248077|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248078|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248079|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248080|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248081|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
146248082|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146248083|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146248084|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146248085|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146248086|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146248087|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146248088|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
146248089|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
146248090|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146248091|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146248092|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146248093|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
146007061|NCT01444430|526540274|FG000|Overall Study|Death|6|||
146248094|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
146248095|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
146007062|NCT01444430|526540275|FG001|Overall Study|Death|8|||
146007063|NCT01444430|526540274|FG000|Overall Study|Lost to Follow-up|2|||
146007064|NCT01444430|526540275|FG001|Overall Study|Lost to Follow-up|0|||
146007065|NCT01444430|526540274|FG000|Overall Study|CRF termination module not completed.|0|||
146007066|NCT01444430|526540275|FG001|Overall Study|CRF termination module not completed.|1|||
146007067|NCT03816176|526540276|FG000|Overall Study|Miscellaneous|5|||
146007068|NCT03816176|526540276|FG000|Overall Study|Lack of Efficacy|4|||
146007069|NCT03816176|526540276|FG000|Overall Study|Adverse Event|3|||
146007070|NCT04267926|526541626|FG000|Overall Study|abnormal labs. No longer eligible|0|||
146007071|NCT04267926|526541627|FG001|Overall Study|abnormal labs. No longer eligible|0|||
146007072|NCT04267926|526541628|FG002|Overall Study|abnormal labs. No longer eligible|1|||
146007073|NCT04267926|526541626|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
146007074|NCT04267926|526541627|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
146007075|NCT04267926|526541628|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
146007076|NCT02489318|526541631|FG000|Randomized|Withdrawal by Subject|0|||
146007077|NCT02489318|526541632|FG001|Randomized|Withdrawal by Subject|1|||
146007078|NCT02489318|526541631|FG000|Treated|Adverse Event|19|||
146007079|NCT02489318|526541632|FG001|Treated|Adverse Event|62|||
146007080|NCT02489318|526541631|FG000|Treated|Death|13|||
146007081|NCT02489318|526541632|FG001|Treated|Death|11|||
146007082|NCT02489318|526541631|FG000|Treated|Physician Decision|4|||
146007083|NCT02489318|526541632|FG001|Treated|Physician Decision|6|||
146007084|NCT02489318|526541631|FG000|Treated|Protocol Violation|1|||
146007085|NCT02489318|526541632|FG001|Treated|Protocol Violation|2|||
146007086|NCT02489318|526541631|FG000|Treated|Withdrawal by Subject|37|||
146007087|NCT02489318|526541632|FG001|Treated|Withdrawal by Subject|36|||
146007088|NCT02489318|526541631|FG000|Treated|Other: Progressive Disease|245|||
146007089|NCT02489318|526541632|FG001|Treated|Other: Progressive Disease|138|||
146007090|NCT02489318|526541631|FG000|Treated|Other|0|||
146007091|NCT02489318|526541632|FG001|Treated|Other|2|||
146007092|NCT02489318|526541631|FG000|Treated|Ongoing|0|||
146007093|NCT02489318|526541632|FG001|Treated|Ongoing|267|||
146007094|NCT01306643|526541633|FG000|Overall Study|Adverse Event|5|||
146007095|NCT01306643|526541633|FG000|Overall Study|Disease Progression|7|||
146007096|NCT01306643|526541633|FG000|Overall Study|Other: Change in Eligibility Status|1|||
146007097|NCT02479880|526541636|FG000|Overall Study|Study Terminated by Sponsor|13|||
146007098|NCT02479880|526541637|FG001|Overall Study|Study Terminated by Sponsor|12|||
146007099|NCT02479880|526541636|FG000|Overall Study|Pregnancy|0|||
146007100|NCT02479880|526541637|FG001|Overall Study|Pregnancy|1|||
146007101|NCT00355368|526541638|FG000|Overall Study|Protocol Violation|8|||
146007102|NCT00355368|526541639|FG001|Overall Study|Protocol Violation|7|||
146007103|NCT00355368|526541638|FG000|Overall Study|cardiac arrest prior to intubation|2|||
146007104|NCT00355368|526541639|FG001|Overall Study|cardiac arrest prior to intubation|2|||
146007105|NCT03801928|526541640|FG000|Overall Study|Adverse Event|1|||
146007106|NCT03801928|526541641|FG001|Overall Study|Adverse Event|0|||
146007107|NCT03801928|526541642|FG002|Overall Study|Adverse Event|1|||
146007108|NCT03801928|526541643|FG003|Overall Study|Adverse Event|2|||
146007109|NCT03801928|526541644|FG004|Overall Study|Adverse Event|0|||
146007110|NCT03801928|526541645|FG005|Overall Study|Adverse Event|2|||
146007111|NCT03801928|526541640|FG000|Overall Study|Lack of Efficacy|0|||
146007112|NCT03801928|526541641|FG001|Overall Study|Lack of Efficacy|0|||
146007113|NCT03801928|526541642|FG002|Overall Study|Lack of Efficacy|1|||
146007114|NCT03801928|526541643|FG003|Overall Study|Lack of Efficacy|0|||
146007115|NCT03801928|526541644|FG004|Overall Study|Lack of Efficacy|0|||
146007116|NCT03801928|526541645|FG005|Overall Study|Lack of Efficacy|0|||
146007117|NCT03801928|526541640|FG000|Overall Study|Lost to Follow-up|5|||
146007118|NCT03801928|526541641|FG001|Overall Study|Lost to Follow-up|1|||
146007119|NCT03801928|526541642|FG002|Overall Study|Lost to Follow-up|1|||
146007120|NCT03801928|526541643|FG003|Overall Study|Lost to Follow-up|4|||
146007121|NCT03801928|526541644|FG004|Overall Study|Lost to Follow-up|4|||
146007122|NCT03801928|526541645|FG005|Overall Study|Lost to Follow-up|2|||
146007123|NCT03801928|526541640|FG000|Overall Study|Withdrawal by Subject|0|||
146007124|NCT03801928|526541641|FG001|Overall Study|Withdrawal by Subject|0|||
146007125|NCT03801928|526541642|FG002|Overall Study|Withdrawal by Subject|2|||
146007126|NCT03801928|526541643|FG003|Overall Study|Withdrawal by Subject|1|||
146007127|NCT03801928|526541644|FG004|Overall Study|Withdrawal by Subject|0|||
146007128|NCT03801928|526541645|FG005|Overall Study|Withdrawal by Subject|0|||
146007129|NCT03801928|526541640|FG000|Overall Study|Other|0|||
146007130|NCT03801928|526541641|FG001|Overall Study|Other|2|||
146007131|NCT03801928|526541642|FG002|Overall Study|Other|0|||
146007132|NCT03801928|526541643|FG003|Overall Study|Other|1|||
146007133|NCT03801928|526541644|FG004|Overall Study|Other|0|||
146007134|NCT03801928|526541645|FG005|Overall Study|Other|1|||
146007135|NCT02370368|526541648|FG000|Overall Study|Adverse Event|1|||
146007136|NCT02370368|526541649|FG001|Overall Study|Adverse Event|2|||
146007137|NCT02370368|526541648|FG000|Overall Study|Withdrawal by Subject|5|||
146007138|NCT02370368|526541649|FG001|Overall Study|Withdrawal by Subject|4|||
146007139|NCT03369665|526541650|FG000|Overall Study|Adverse Event|3|||
146007140|NCT03369665|526541650|FG000|Overall Study|Lost to Follow-up|7|||
146007141|NCT03369665|526541650|FG000|Overall Study|Withdrawal by Subject|15|||
146007142|NCT03369665|526541650|FG000|Overall Study|Progression Disease|2|||
146007143|NCT03369665|526541650|FG000|Overall Study|Not classified|3|||
146007144|NCT05197049|526541651|FG000|Overall Study|Death|0|||
146007145|NCT05197049|526541652|FG001|Overall Study|Death|1|||
146007146|NCT05197049|526541653|FG002|Overall Study|Death|0|||
146007147|NCT05197049|526541651|FG000|Overall Study|Lost to Follow-up|3|||
146007148|NCT05197049|526541652|FG001|Overall Study|Lost to Follow-up|1|||
146007149|NCT05197049|526541653|FG002|Overall Study|Lost to Follow-up|0|||
146007150|NCT05197049|526541651|FG000|Overall Study|Withdrawal by Subject|15|||
146007151|NCT05197049|526541652|FG001|Overall Study|Withdrawal by Subject|3|||
146007152|NCT05197049|526541653|FG002|Overall Study|Withdrawal by Subject|1|||
146007153|NCT05197049|526541651|FG000|Overall Study|GCP non-compliance|1|||
146007154|NCT05197049|526541652|FG001|Overall Study|GCP non-compliance|2|||
146007155|NCT05197049|526541653|FG002|Overall Study|GCP non-compliance|0|||
146007156|NCT00579553|526541654|FG000|Overall Study|Lost to Follow-up|16|||
146007157|NCT00579553|526541655|FG001|Overall Study|Lost to Follow-up|13|||
146007158|NCT03748641|526541656|FG000|Overall Study|Ongoing|155|||
146007159|NCT03748641|526541657|FG001|Overall Study|Ongoing|148|||
146007160|NCT03748641|526541658|FG002|Overall Study|Ongoing|66|||
146007161|NCT03748641|526541659|FG003|Overall Study|Ongoing|79|||
146007162|NCT03748641|526541660|FG004|Overall Study|Ongoing|84|||
146007163|NCT03748641|526541656|FG000|Overall Study|Death|54|||
146007164|NCT03748641|526541657|FG001|Overall Study|Death|59|||
146007165|NCT03748641|526541658|FG002|Overall Study|Death|51|||
146007166|NCT03748641|526541659|FG003|Overall Study|Death|42|||
146007167|NCT03748641|526541660|FG004|Overall Study|Death|9|||
146007168|NCT03748641|526541656|FG000|Overall Study|Lost to Follow-up|0|||
146007169|NCT03748641|526541657|FG001|Overall Study|Lost to Follow-up|2|||
146007170|NCT03748641|526541658|FG002|Overall Study|Lost to Follow-up|1|||
146007171|NCT03748641|526541659|FG003|Overall Study|Lost to Follow-up|0|||
146007172|NCT03748641|526541660|FG004|Overall Study|Lost to Follow-up|0|||
146007173|NCT03748641|526541656|FG000|Overall Study|Withdrawal by Subject|3|||
146007174|NCT03748641|526541657|FG001|Overall Study|Withdrawal by Subject|2|||
146007175|NCT03748641|526541658|FG002|Overall Study|Withdrawal by Subject|5|||
146007176|NCT03748641|526541659|FG003|Overall Study|Withdrawal by Subject|3|||
146007177|NCT03748641|526541660|FG004|Overall Study|Withdrawal by Subject|2|||
146007178|NCT04834726|526541661|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
146007179|NCT04834726|526541662|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
146007180|NCT04834726|526541663|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
146007181|NCT04834726|526541664|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
146007182|NCT04834726|526541665|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
146007183|NCT04834726|526541666|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
146007184|NCT04834726|526541667|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
146007185|NCT04834726|526541668|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
146007186|NCT04834726|526541669|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
146007187|NCT01144416|526541681|FG000|Intervention Period|Adverse Event|5|||
146007188|NCT01144416|526541682|FG001|Intervention Period|Adverse Event|6|||
146007189|NCT01144416|526541681|FG000|Intervention Period|Insufficient ovarian response|11|||
146007190|NCT01144416|526541682|FG001|Intervention Period|Insufficient ovarian response|17|||
146007191|NCT01144416|526541681|FG000|Intervention Period|Risk of OHSS|0|||
146007192|NCT01144416|526541682|FG001|Intervention Period|Risk of OHSS|1|||
146007193|NCT01144416|526541681|FG000|Intervention Period|Too high ovarian response|4|||
146007194|NCT01144416|526541682|FG001|Intervention Period|Too high ovarian response|2|||
146007195|NCT01144416|526541681|FG000|Intervention Period|No/too few/bad oocytes|7|||
146007196|NCT01144416|526541682|FG001|Intervention Period|No/too few/bad oocytes|5|||
146007197|NCT01144416|526541681|FG000|Intervention Period|No or abnormal fertilization|25|||
146007198|NCT01144416|526541682|FG001|Intervention Period|No or abnormal fertilization|10|||
146007199|NCT01144416|526541681|FG000|Intervention Period|No/too few/bad quality embryos|3|||
146007200|NCT01144416|526541682|FG001|Intervention Period|No/too few/bad quality embryos|3|||
146007201|NCT01144416|526541681|FG000|Intervention Period|Other|7|||
146007202|NCT01144416|526541682|FG001|Intervention Period|Other|5|||
146007203|NCT00124072|526541683|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
146007204|NCT00124072|526541684|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
146007205|NCT00124072|526541685|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
146007206|NCT00124072|526541686|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
146007207|NCT00124072|526541683|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
146007208|NCT00124072|526541684|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
146007209|NCT00124072|526541685|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
146248096|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
146248097|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146007210|NCT00124072|526541686|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
146007211|NCT00124072|526541683|FG000|Overall Study|Death|499|||
146007212|NCT00124072|526541684|FG001|Overall Study|Death|484|||
146007213|NCT00124072|526541685|FG002|Overall Study|Death|471|||
146007214|NCT00124072|526541686|FG003|Overall Study|Death|480|||
146007215|NCT02534883|526541687|FG000|Overall Study|Early Termination|8|||
146007216|NCT02534883|526541688|FG001|Overall Study|Early Termination|3|||
146007217|NCT00714948|526541697|FG000|Overall Study|Adverse Event|2|||
146007218|NCT03390504|526541700|FG000|Overall Study|Lost to Follow-up|2|||
146248098|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146007219|NCT03390504|526541701|FG001|Overall Study|Lost to Follow-up|4|||
146007220|NCT03390504|526541702|FG002|Overall Study|Lost to Follow-up|0|||
146007221|NCT03390504|526541703|FG003|Overall Study|Lost to Follow-up|1|||
146007222|NCT03390504|526541700|FG000|Overall Study|Withdrawal by Subject|3|||
146007223|NCT03390504|526541701|FG001|Overall Study|Withdrawal by Subject|15|||
146007224|NCT03390504|526541702|FG002|Overall Study|Withdrawal by Subject|5|||
146007225|NCT03390504|526541703|FG003|Overall Study|Withdrawal by Subject|2|||
146007226|NCT03390504|526541700|FG000|Overall Study|Other|1|||
146007227|NCT03390504|526541701|FG001|Overall Study|Other|2|||
146007228|NCT03390504|526541702|FG002|Overall Study|Other|2|||
146007229|NCT03390504|526541703|FG003|Overall Study|Other|6|||
146007230|NCT00980538|526541704|FG000|Overall Study|Lost to Follow-up|20|||
146007231|NCT00980538|526541704|FG000|Overall Study|Sponsor's Decision|4|||
146007232|NCT00980538|526541704|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
146007233|NCT00980538|526541704|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
146007234|NCT00980538|526541704|FG000|Overall Study|Switch to Commercially Available Medication|25|||
146007235|NCT00980538|526541704|FG000|Overall Study|Participant Non-Compliant|9|||
146007236|NCT00980538|526541704|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
146007237|NCT00980538|526541704|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
146007238|NCT00980538|526541704|FG000|Overall Study|Other|60|||
146007239|NCT00980538|526541704|FG000|Overall Study|Other|1|||
146007240|NCT01544348|526541705|FG000|Overall Study|Lost to Follow-up|1|||
146007241|NCT01544348|526541706|FG001|Overall Study|Lost to Follow-up|0|||
146007242|NCT01544348|526541707|FG002|Overall Study|Lost to Follow-up|0|||
146007243|NCT01544348|526541708|FG003|Overall Study|Lost to Follow-up|0|||
146007244|NCT01544348|526541709|FG004|Overall Study|Lost to Follow-up|0|||
146007245|NCT01544348|526541710|FG005|Overall Study|Lost to Follow-up|0|||
146007246|NCT01544348|526541711|FG006|Overall Study|Lost to Follow-up|1|||
146007247|NCT01544348|526541712|FG007|Overall Study|Lost to Follow-up|0|||
146007248|NCT01544348|526541705|FG000|Overall Study|Withdrawal by Subject|1|||
146007249|NCT01544348|526541706|FG001|Overall Study|Withdrawal by Subject|0|||
146007250|NCT01544348|526541707|FG002|Overall Study|Withdrawal by Subject|0|||
146007251|NCT01544348|526541708|FG003|Overall Study|Withdrawal by Subject|0|||
146007252|NCT01544348|526541709|FG004|Overall Study|Withdrawal by Subject|1|||
146007253|NCT01544348|526541710|FG005|Overall Study|Withdrawal by Subject|2|||
146007254|NCT01544348|526541711|FG006|Overall Study|Withdrawal by Subject|1|||
146007255|NCT01544348|526541712|FG007|Overall Study|Withdrawal by Subject|0|||
146007256|NCT01544348|526541705|FG000|Overall Study|Physician Decision|0|||
146007257|NCT01544348|526541706|FG001|Overall Study|Physician Decision|0|||
146007258|NCT01544348|526541707|FG002|Overall Study|Physician Decision|0|||
146007259|NCT01544348|526541708|FG003|Overall Study|Physician Decision|0|||
146007260|NCT01544348|526541709|FG004|Overall Study|Physician Decision|0|||
146007261|NCT01544348|526541710|FG005|Overall Study|Physician Decision|1|||
146007262|NCT01544348|526541711|FG006|Overall Study|Physician Decision|0|||
146007263|NCT01544348|526541712|FG007|Overall Study|Physician Decision|0|||
146007264|NCT01445847|526541713|FG000|Overall Study|Protocol Violation|13|||
146007265|NCT01445847|526541714|FG001|Overall Study|Protocol Violation|14|||
146007266|NCT01445847|526541713|FG000|Overall Study|Missed Data|1|||
146007267|NCT01445847|526541714|FG001|Overall Study|Missed Data|0|||
146007268|NCT00707993|526541715|FG000|Overall Study|Adverse Event|16|||
146007269|NCT00707993|526541716|FG001|Overall Study|Adverse Event|20|||
146007270|NCT00707993|526541715|FG000|Overall Study|Protocol Violation|4|||
146007271|NCT00707993|526541716|FG001|Overall Study|Protocol Violation|7|||
146007272|NCT00707993|526541715|FG000|Overall Study|Lost to Follow-up|0|||
146007273|NCT00707993|526541716|FG001|Overall Study|Lost to Follow-up|4|||
146092431|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146092432|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
146248099|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146248100|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
146298209|NCT03872453|527607860|FG002|Overall Study|Pregnancy|0|||
146007274|NCT00707993|526541715|FG000|Overall Study|Withdrawal by Subject|12|||
146092433|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146092434|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146092435|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
146007275|NCT00707993|526541716|FG001|Overall Study|Withdrawal by Subject|16|||
146007276|NCT00707993|526541715|FG000|Overall Study|Hyperglycemic Rescue|55|||
146007277|NCT00707993|526541716|FG001|Overall Study|Hyperglycemic Rescue|47|||
146007278|NCT00707993|526541715|FG000|Overall Study|Other|2|||
146007279|NCT00707993|526541716|FG001|Overall Study|Other|0|||
146007280|NCT03654274|526541720|FG000|Overall Study|Adverse Event|19|||
146007281|NCT03654274|526541721|FG001|Overall Study|Adverse Event|23|||
146007282|NCT03654274|526541722|FG002|Overall Study|Adverse Event|24|||
146007283|NCT03654274|526541720|FG000|Overall Study|Protocol Deviation|0|||
146007284|NCT03654274|526541721|FG001|Overall Study|Protocol Deviation|2|||
146007285|NCT03654274|526541722|FG002|Overall Study|Protocol Deviation|0|||
146007286|NCT03654274|526541720|FG000|Overall Study|Lost to Follow-up|8|||
146007287|NCT03654274|526541721|FG001|Overall Study|Lost to Follow-up|6|||
146007288|NCT03654274|526541722|FG002|Overall Study|Lost to Follow-up|5|||
146007289|NCT03654274|526541720|FG000|Overall Study|Withdrawal by Subject|46|||
146007290|NCT03654274|526541721|FG001|Overall Study|Withdrawal by Subject|25|||
146007291|NCT03654274|526541722|FG002|Overall Study|Withdrawal by Subject|33|||
146007292|NCT03654274|526541720|FG000|Overall Study|Lack of Efficacy|4|||
146007293|NCT03654274|526541721|FG001|Overall Study|Lack of Efficacy|5|||
146007294|NCT03654274|526541722|FG002|Overall Study|Lack of Efficacy|7|||
146007295|NCT03654274|526541720|FG000|Overall Study|Pregnancy|2|||
146007296|NCT03654274|526541721|FG001|Overall Study|Pregnancy|2|||
146007297|NCT03654274|526541722|FG002|Overall Study|Pregnancy|1|||
146007298|NCT03654274|526541720|FG000|Overall Study|Other|27|||
146007299|NCT03654274|526541721|FG001|Overall Study|Other|29|||
146007300|NCT03654274|526541722|FG002|Overall Study|Other|32|||
146007301|NCT03654274|526541720|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
146007302|NCT03654274|526541721|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
146007303|NCT03654274|526541722|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
146007304|NCT01102491|526541725|FG000|Overall Study|Protocol Violation|11|||
146007305|NCT01102491|526541726|FG001|Overall Study|Protocol Violation|12|||
146007306|NCT01265992|526541727|FG000|Overall Study|Lost to Follow-up|1|||
146007307|NCT01265992|526541727|FG000|Overall Study|Withdrawal by Subject|1|||
146007308|NCT01265992|526541727|FG000|Overall Study|Adverse Event|1|||
146007309|NCT01265992|526541727|FG000|Overall Study|Administrative reasons|2|||
146007310|NCT01265992|526541727|FG000|Overall Study|Stopped treatment|3|||
146007311|NCT01265992|526541727|FG000|Overall Study|Did not receive treatment|1|||
146007312|NCT01837680|526541728|FG000|Overall Study|Lost to Follow-up|2|||
146007313|NCT01837680|526541729|FG001|Overall Study|Lost to Follow-up|2|||
146007314|NCT01837680|526541728|FG000|Overall Study|lack of insurance|0|||
146007315|NCT01837680|526541729|FG001|Overall Study|lack of insurance|2|||
146007316|NCT01837680|526541728|FG000|Overall Study|allergic reaction|6|||
146092436|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146248101|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146248102|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
146248103|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
146248104|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146248105|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146248106|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146248107|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
146248108|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146248109|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
146248110|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
146248111|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248112|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248113|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248114|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248115|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248116|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
146248117|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146248118|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146248119|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146248120|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146248121|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
146248122|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
146248123|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
146248124|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
146248125|NCT03745651|527421580|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146248126|NCT03745651|527421581|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146248127|NCT03745651|527421582|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146248128|NCT03745651|527421583|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146248129|NCT03745651|527421584|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146248130|NCT03745651|527421585|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
146248131|NCT03745651|527421586|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
146248132|NCT04175834|527421587|FG000|Overall Study|Withdrawal by Subject|1|||
146248133|NCT04175834|527421588|FG001|Overall Study|Withdrawal by Subject|0|||
146248134|NCT02542696|527421593|FG000|Overall Study|Adverse Event|167|||
146248135|NCT02542696|527421593|FG000|Overall Study|Lack of Efficacy|26|||
146248136|NCT02542696|527421593|FG000|Overall Study|Lost to Follow-up|6|||
146248137|NCT02542696|527421593|FG000|Overall Study|Withdrawal by Subject|104|||
146248138|NCT02542696|527421593|FG000|Overall Study|Protocol Violation|5|||
146248139|NCT02542696|527421593|FG000|Overall Study|Death|8|||
146007317|NCT01837680|526541729|FG001|Overall Study|allergic reaction|0|||
146007318|NCT01837680|526541728|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
146007319|NCT01837680|526541729|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
146007320|NCT03008070|526541730|FG000|Overall Study|Adverse Event|3|||
146007321|NCT03008070|526541731|FG001|Overall Study|Adverse Event|3|||
146007322|NCT03008070|526541732|FG002|Overall Study|Adverse Event|3|||
146007323|NCT03008070|526541730|FG000|Overall Study|Lost to Follow-up|1|||
146007324|NCT03008070|526541731|FG001|Overall Study|Lost to Follow-up|1|||
146007325|NCT03008070|526541732|FG002|Overall Study|Lost to Follow-up|0|||
146007326|NCT03008070|526541730|FG000|Overall Study|Non compliance|0|||
146007327|NCT03008070|526541731|FG001|Overall Study|Non compliance|1|||
146007328|NCT03008070|526541732|FG002|Overall Study|Non compliance|1|||
146007329|NCT03008070|526541730|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
146007330|NCT03008070|526541731|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
146007331|NCT03008070|526541732|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
146007332|NCT03008070|526541730|FG000|Overall Study|Withdrawal by Subject|2|||
146007333|NCT03008070|526541731|FG001|Overall Study|Withdrawal by Subject|0|||
146007334|NCT03008070|526541732|FG002|Overall Study|Withdrawal by Subject|1|||
146007335|NCT03008070|526541730|FG000|Overall Study|Use of prohibited drug|0|||
146007336|NCT03008070|526541731|FG001|Overall Study|Use of prohibited drug|0|||
146007337|NCT03008070|526541732|FG002|Overall Study|Use of prohibited drug|2|||
146007338|NCT03533660|526541736|FG000|Overall Study|Withdrawal by Subject|2|||
146007339|NCT03533660|526541737|FG001|Overall Study|Withdrawal by Subject|2|||
146007340|NCT03533660|526541736|FG000|Overall Study|Death|2|||
146007341|NCT03533660|526541737|FG001|Overall Study|Death|4|||
146007342|NCT03533660|526541736|FG000|Overall Study|Adverse Event|0|||
146007343|NCT03533660|526541737|FG001|Overall Study|Adverse Event|2|||
146007344|NCT00996658|526541738|FG000|Overall Study|Adverse Event|2|||
146007345|NCT00996658|526541739|FG001|Overall Study|Adverse Event|5|||
146007346|NCT00996658|526541738|FG000|Overall Study|Protocol Violation|0|||
146007347|NCT00996658|526541739|FG001|Overall Study|Protocol Violation|1|||
146007348|NCT00996658|526541738|FG000|Overall Study|Lost to Follow-up|2|||
146007349|NCT00996658|526541739|FG001|Overall Study|Lost to Follow-up|5|||
146007350|NCT00996658|526541738|FG000|Overall Study|Non-compliance issues|3|||
146007351|NCT00996658|526541739|FG001|Overall Study|Non-compliance issues|3|||
146007352|NCT00996658|526541738|FG000|Overall Study|Other|9|||
146007353|NCT00996658|526541739|FG001|Overall Study|Other|7|||
146007354|NCT04487080|526541749|FG000|Overall Study|Withdrawal by Subject|19|||
146007355|NCT04487080|526541750|FG001|Overall Study|Withdrawal by Subject|18|||
146007356|NCT04487080|526541751|FG002|Overall Study|Withdrawal by Subject|13|||
146248140|NCT02542696|527421593|FG000|Overall Study|DECREASED OFF TIME|1|||
146007357|NCT04487080|526541749|FG000|Overall Study|Lost to Follow-up|3|||
146007358|NCT04487080|526541750|FG001|Overall Study|Lost to Follow-up|1|||
146007359|NCT04487080|526541751|FG002|Overall Study|Lost to Follow-up|0|||
146007360|NCT04487080|526541749|FG000|Overall Study|Ongoing|313|||
146007361|NCT04487080|526541750|FG001|Overall Study|Ongoing|297|||
146007362|NCT04487080|526541751|FG002|Overall Study|Ongoing|149|||
146007363|NCT02842086|526541752|FG000|Overall Study|Randomized but Never Treated|6|||
146007364|NCT02842086|526541753|FG001|Overall Study|Randomized but Never Treated|6|||
146007365|NCT02842086|526541752|FG000|Overall Study|Still in Double-Blind Phase|7|||
146007366|NCT02842086|526541753|FG001|Overall Study|Still in Double-Blind Phase|3|||
146007367|NCT02842086|526541752|FG000|Overall Study|Adverse Event|18|||
146007368|NCT02842086|526541753|FG001|Overall Study|Adverse Event|20|||
146007369|NCT02842086|526541752|FG000|Overall Study|Death|3|||
146007370|NCT02842086|526541753|FG001|Overall Study|Death|3|||
146007371|NCT02842086|526541752|FG000|Overall Study|Investigator's Discretion|9|||
146007372|NCT02842086|526541753|FG001|Overall Study|Investigator's Discretion|13|||
146007373|NCT02842086|526541752|FG000|Overall Study|Non-Compliance with Study Drug|9|||
146007374|NCT02842086|526541753|FG001|Overall Study|Non-Compliance with Study Drug|8|||
146248141|NCT02542696|527421593|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
146248142|NCT02542696|527421593|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
146007375|NCT02842086|526541752|FG000|Overall Study|Protocol Violation|8|||
146007376|NCT02842086|526541753|FG001|Overall Study|Protocol Violation|4|||
146248143|NCT02542696|527421593|FG000|Overall Study|MEDICAL HISTORY|1|||
146007377|NCT02842086|526541752|FG000|Overall Study|Withdrew Consent|205|||
146007378|NCT02842086|526541753|FG001|Overall Study|Withdrew Consent|194|||
146007379|NCT02842086|526541752|FG000|Overall Study|Lost to Follow-up|274|||
146007380|NCT02842086|526541753|FG001|Overall Study|Lost to Follow-up|236|||
146007381|NCT02842086|526541752|FG000|Overall Study|HIV-1 Infection|5|||
146282346|NCT01879722|527546471|FG002|Overall Study|Voluntary Withdrawal|0|||
146007382|NCT02842086|526541753|FG001|Overall Study|HIV-1 Infection|6|||
146007383|NCT03451851|526541754|FG000|PCP: Week 0 -16|Adverse Event|1|||
146007384|NCT03451851|526541755|FG001|PCP: Week 0 -16|Adverse Event|0|||
146007385|NCT03451851|526541756|FG002|PCP: Week 0 -16|Adverse Event|0|||
146007386|NCT03451851|526541757|FG003|PCP: Week 0 -16|Adverse Event|0|||
146007387|NCT03451851|526541758|FG004|PCP: Week 0 -16|Adverse Event|0|||
146007388|NCT03451851|526541759|FG005|PCP: Week 0 -16|Adverse Event|0|||
146007389|NCT03451851|526541760|FG006|PCP: Week 0 -16|Adverse Event|1|||
146007390|NCT03451851|526541761|FG007|PCP: Week 0 -16|Adverse Event|0|||
146007391|NCT03451851|526541754|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007392|NCT03451851|526541755|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007393|NCT03451851|526541756|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
146007394|NCT03451851|526541757|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007395|NCT03451851|526541758|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007396|NCT03451851|526541759|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007397|NCT03451851|526541760|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007398|NCT03451851|526541761|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
146007399|NCT03451851|526541754|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007400|NCT03451851|526541755|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007401|NCT03451851|526541756|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
146007402|NCT03451851|526541757|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007403|NCT03451851|526541758|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007404|NCT03451851|526541759|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007405|NCT03451851|526541760|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007406|NCT03451851|526541761|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
146007407|NCT03451851|526541754|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007408|NCT03451851|526541755|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007409|NCT03451851|526541756|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007410|NCT03451851|526541757|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007411|NCT03451851|526541758|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
146007412|NCT03451851|526541759|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
146007413|NCT03451851|526541760|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007414|NCT03451851|526541761|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
146007415|NCT03451851|526541754|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007416|NCT03451851|526541755|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007417|NCT03451851|526541756|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007418|NCT03451851|526541757|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007419|NCT03451851|526541758|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
146007420|NCT03451851|526541759|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007421|NCT03451851|526541760|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007422|NCT03451851|526541761|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
146007423|NCT03451851|526541754|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007424|NCT03451851|526541755|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007425|NCT03451851|526541756|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007426|NCT03451851|526541757|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007427|NCT03451851|526541758|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
146007428|NCT03451851|526541759|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007429|NCT03451851|526541760|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007430|NCT03451851|526541761|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
146007431|NCT03581292|526541762|FG000|Overall Study|Physician Decision|9|||
146007432|NCT03581292|526541763|FG001|Overall Study|Physician Decision|5|||
146007433|NCT03581292|526541762|FG000|Overall Study|Withdrawal by Subject|3|||
146007434|NCT03581292|526541763|FG001|Overall Study|Withdrawal by Subject|0|||
146007435|NCT03581292|526541762|FG000|Overall Study|Withdrawal before Therapy Start|1|||
146007436|NCT03581292|526541763|FG001|Overall Study|Withdrawal before Therapy Start|0|||
146007437|NCT07214935|526541764|FG000|Overall Study|Adverse Event|1|||
146248144|NCT02542696|527421593|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
146248145|NCT02542696|527421593|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
146248146|NCT02542696|527421593|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
146248147|NCT02542696|527421593|FG000|Overall Study|SPONSOR DECISION|3|||
146248148|NCT02542696|527421593|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
146248149|NCT02542696|527421593|FG000|Overall Study|SUBJECT DECISION|2|||
146248150|NCT02410278|527421594|FG000|Run-in Period|Adverse Event|5|||
146007438|NCT07214935|526541765|FG001|Overall Study|Adverse Event|1|||
146007439|NCT07214935|526541766|FG002|Overall Study|Adverse Event|1|||
146007440|NCT07214935|526541767|FG003|Overall Study|Adverse Event|0|||
146007441|NCT07214935|526541764|FG000|Overall Study|Lost to Follow-up|0|||
146007442|NCT07214935|526541765|FG001|Overall Study|Lost to Follow-up|1|||
146007443|NCT07214935|526541766|FG002|Overall Study|Lost to Follow-up|0|||
146007444|NCT07214935|526541767|FG003|Overall Study|Lost to Follow-up|0|||
146007445|NCT07214935|526541764|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
146007446|NCT07214935|526541765|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146007447|NCT07214935|526541766|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146007448|NCT07214935|526541767|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
146248151|NCT02410278|527421595|FG001|Run-in Period|Adverse Event|0|||
146248152|NCT02410278|527421596|FG002|Run-in Period|Adverse Event|0|||
146248153|NCT02410278|527421594|FG000|Run-in Period|GSRS Threshold Not Met|30|||
146248154|NCT02410278|527421595|FG001|Run-in Period|GSRS Threshold Not Met|0|||
146248155|NCT02410278|527421596|FG002|Run-in Period|GSRS Threshold Not Met|0|||
146248156|NCT02410278|527421594|FG000|Run-in Period|Lost to Follow-up|1|||
146248157|NCT02410278|527421595|FG001|Run-in Period|Lost to Follow-up|0|||
146248158|NCT02410278|527421596|FG002|Run-in Period|Lost to Follow-up|0|||
146248159|NCT02410278|527421594|FG000|Run-in Period|Withdrawal by Subject|1|||
146248160|NCT02410278|527421595|FG001|Run-in Period|Withdrawal by Subject|0|||
146248161|NCT02410278|527421596|FG002|Run-in Period|Withdrawal by Subject|0|||
146248162|NCT02410278|527421594|FG000|Run-in Period|Pregnancy|1|||
146248163|NCT02410278|527421595|FG001|Run-in Period|Pregnancy|0|||
146248164|NCT02410278|527421596|FG002|Run-in Period|Pregnancy|0|||
146248165|NCT02410278|527421594|FG000|Study Treatment Period|Adverse Event|0|||
146007449|NCT07214935|526541764|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
146007450|NCT07214935|526541765|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
146007451|NCT07214935|526541766|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
146092437|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146092438|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
146092439|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146092440|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146092441|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
146092442|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
146092443|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146092444|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146092445|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146092446|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146092447|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
146092448|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
146092449|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146092450|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
146092451|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
146092452|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146092453|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
146092454|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
146092455|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146092456|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146092457|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146092458|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146092459|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
146092460|NCT03963401|526860290|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
146092461|NCT03963401|526860291|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
146092462|NCT03963401|526860292|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
146092463|NCT03963401|526860293|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
146092464|NCT03963401|526860294|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
146248166|NCT02410278|527421595|FG001|Study Treatment Period|Adverse Event|6|||
146007452|NCT07214935|526541767|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
146007453|NCT00972023|526543231|FG000|Overall Study|Withdrawal by Subject|1|||
146007454|NCT02595879|526543232|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
146007455|NCT02595879|526543233|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
146007456|NCT01650831|526543234|FG000|Overall Study|Screen failure|1|||
146007457|NCT02522429|526543235|FG000|Overall Study|Lost to Follow-up|8|||
146007458|NCT02522429|526543235|FG000|Overall Study|Adverse Event|2|||
146007459|NCT02522429|526543235|FG000|Overall Study|Death|1|||
146007460|NCT02522429|526543235|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
146007461|NCT00600106|526543236|FG000|Overall Study|Withdrawal by Subject|1|||
146007462|NCT00600106|526543237|FG001|Overall Study|Withdrawal by Subject|1|||
146007463|NCT05554146|526543240|FG000|Overall Study|Adverse Event|0|||
146007464|NCT05554146|526543241|FG001|Overall Study|Adverse Event|1|||
146007465|NCT05554146|526543242|FG002|Overall Study|Adverse Event|0|||
146092465|NCT03963401|526860295|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
146248167|NCT02410278|527421596|FG002|Study Treatment Period|Adverse Event|3|||
146248168|NCT02410278|527421594|FG000|Study Treatment Period|Physician Decision|0|||
146007466|NCT05554146|526543243|FG003|Overall Study|Adverse Event|0|||
146007467|NCT05554146|526543240|FG000|Overall Study|Protocol Violation|0|||
146248169|NCT02410278|527421595|FG001|Study Treatment Period|Physician Decision|0|||
146248170|NCT02410278|527421596|FG002|Study Treatment Period|Physician Decision|1|||
146248171|NCT02410278|527421594|FG000|Study Treatment Period|Withdrawal by Subject|0|||
146007468|NCT05554146|526543241|FG001|Overall Study|Protocol Violation|1|||
146007469|NCT05554146|526543242|FG002|Overall Study|Protocol Violation|0|||
146007470|NCT05554146|526543243|FG003|Overall Study|Protocol Violation|0|||
146007471|NCT05554146|526543240|FG000|Overall Study|No longer interested in participating|0|||
146007472|NCT05554146|526543241|FG001|Overall Study|No longer interested in participating|0|||
146007473|NCT05554146|526543242|FG002|Overall Study|No longer interested in participating|1|||
146007474|NCT05554146|526543243|FG003|Overall Study|No longer interested in participating|0|||
146007475|NCT05554146|526543240|FG000|Overall Study|Lost to Follow-up|1|||
146007476|NCT05554146|526543241|FG001|Overall Study|Lost to Follow-up|0|||
146007477|NCT05554146|526543242|FG002|Overall Study|Lost to Follow-up|0|||
146007478|NCT05554146|526543243|FG003|Overall Study|Lost to Follow-up|0|||
146007479|NCT04988295|526543244|FG000|Overall Study|Withdrawal by Subject|9|||
146007480|NCT04988295|526543245|FG001|Overall Study|Withdrawal by Subject|29|||
146007481|NCT04988295|526543246|FG002|Overall Study|Withdrawal by Subject|6|||
146007482|NCT04988295|526543247|FG003|Overall Study|Withdrawal by Subject|0|||
146007483|NCT04988295|526543244|FG000|Overall Study|Lost to Follow-up|1|||
146007484|NCT04988295|526543245|FG001|Overall Study|Lost to Follow-up|0|||
146007485|NCT04988295|526543246|FG002|Overall Study|Lost to Follow-up|0|||
146007486|NCT04988295|526543247|FG003|Overall Study|Lost to Follow-up|0|||
146007487|NCT04988295|526543244|FG000|Overall Study|Study participation ongoing|186|||
146007488|NCT04988295|526543245|FG001|Overall Study|Study participation ongoing|169|||
146007489|NCT04988295|526543246|FG002|Overall Study|Study participation ongoing|99|||
146007490|NCT04988295|526543247|FG003|Overall Study|Study participation ongoing|119|||
146007491|NCT01273038|526543254|FG000|Second Intervention (14 Days)|Adverse Event|0|||
146007492|NCT01273038|526543255|FG001|Second Intervention (14 Days)|Adverse Event|1|||
146007493|NCT01273038|526543254|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146007494|NCT01273038|526543255|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146007495|NCT02197572|526543260|FG000|Overall Study|Progressive Disease|28|||
146007496|NCT02197572|526543260|FG000|Overall Study|Withdrawal by Subject|9|||
146007497|NCT02197572|526543260|FG000|Overall Study|Adverse Event|3|||
146007498|NCT02197572|526543260|FG000|Overall Study|Reason Not Specified|4|||
146007499|NCT01465386|526543262|FG000|Overall Study|Lack of Efficacy|3|||
146007500|NCT01465386|526543262|FG000|Overall Study|Adverse Event|1|||
146007501|NCT01279044|526543265|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
146007502|NCT01279044|526543266|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
146007503|NCT01279044|526543267|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
146007504|NCT01279044|526543265|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
146007505|NCT01279044|526543266|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
146007506|NCT01279044|526543267|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
146007507|NCT01279044|526543265|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
146007508|NCT01279044|526543266|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
146007509|NCT01279044|526543267|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
146007510|NCT01408277|526543271|FG000|Overall Study|Adverse Event|3|||
146007511|NCT01408277|526543272|FG001|Overall Study|Adverse Event|4|||
146007512|NCT01408277|526543271|FG000|Overall Study|Lost to Follow-up|1|||
146007513|NCT01408277|526543272|FG001|Overall Study|Lost to Follow-up|0|||
146007514|NCT01408277|526543271|FG000|Overall Study|Withdrawal by Subject|2|||
146007515|NCT01408277|526543272|FG001|Overall Study|Withdrawal by Subject|0|||
146007516|NCT01408277|526543271|FG000|Overall Study|Protocol Violation|2|||
146007517|NCT01408277|526543272|FG001|Overall Study|Protocol Violation|0|||
146007518|NCT02840253|526543273|FG000|Overall Study|Unsuccessful block|4|||
146007519|NCT03783962|526543274|FG000|Overall Study|Lost to Follow-up|3|||
146007520|NCT03783962|526543275|FG001|Overall Study|Lost to Follow-up|6|||
146007521|NCT03783962|526543274|FG000|Overall Study|Protocol Violation|0|||
146007522|NCT03783962|526543275|FG001|Overall Study|Protocol Violation|1|||
146007523|NCT03458325|526543276|FG000|Overall Study|Withdrawal by Subject|1|||
146007524|NCT02763059|526543279|FG000|Overall Study|Lost to Follow-up|4|||
146007525|NCT02763059|526543280|FG001|Overall Study|Lost to Follow-up|1|||
146248172|NCT02410278|527421595|FG001|Study Treatment Period|Withdrawal by Subject|1|||
146248173|NCT02410278|527421596|FG002|Study Treatment Period|Withdrawal by Subject|0|||
146248174|NCT02410278|527421594|FG000|Study Treatment Period|Other|0|||
146248175|NCT02410278|527421595|FG001|Study Treatment Period|Other|3|||
146248176|NCT02410278|527421596|FG002|Study Treatment Period|Other|0|||
146007526|NCT02763059|526543281|FG002|Overall Study|Lost to Follow-up|6|||
146007527|NCT02763059|526543279|FG000|Overall Study|Withdrawal by Subject|1|||
146007528|NCT02763059|526543280|FG001|Overall Study|Withdrawal by Subject|0|||
146007529|NCT02763059|526543281|FG002|Overall Study|Withdrawal by Subject|3|||
146007530|NCT00175916|526543282|FG000|Overall Study|Death|19|||
146007531|NCT00175916|526543282|FG000|Overall Study|Adverse Event|81|||
146007532|NCT00175916|526543282|FG000|Overall Study|Lack of Efficacy|354|||
146007533|NCT00175916|526543282|FG000|Overall Study|Lost to Follow-up|17|||
146007534|NCT00175916|526543282|FG000|Overall Study|Subject Choice|98|||
146007535|NCT00175916|526543282|FG000|Overall Study|Lack of compliance|8|||
146007536|NCT00175916|526543282|FG000|Overall Study|Patient cannot record seizures|1|||
146007537|NCT00175916|526543282|FG000|Overall Study|Sponsor decision|17|||
146007538|NCT00175916|526543282|FG000|Overall Study|Vigabatrin intake|1|||
146248177|NCT02410278|527421594|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
146007539|NCT00175916|526543282|FG000|Overall Study|Suicidal behaviour|1|||
146007540|NCT00175916|526543282|FG000|Overall Study|Withdrawal by Subject|1|||
146007541|NCT00175916|526543282|FG000|Overall Study|Seizure - free|4|||
146007542|NCT00175916|526543282|FG000|Overall Study|Administrative reason|1|||
146007543|NCT00175916|526543282|FG000|Overall Study|Pregnancy|1|||
146007544|NCT00175916|526543282|FG000|Overall Study|Patient's request|2|||
146007545|NCT00175916|526543282|FG000|Overall Study|Treating physiciant's choice|1|||
146007546|NCT00175916|526543282|FG000|Overall Study|Moved overseas|1|||
146007547|NCT00175916|526543282|FG000|Overall Study|Loss of job and economic burden|1|||
146007548|NCT00175916|526543282|FG000|Overall Study|Site was closed|9|||
146007549|NCT00175916|526543282|FG000|Overall Study|Patient went to prison|1|||
146007550|NCT04024436|526543283|FG000|Overall Study|Death|10|||
146007551|NCT04024436|526543284|FG001|Overall Study|Death|14|||
146007552|NCT04024436|526543285|FG002|Overall Study|Death|2|||
146007553|NCT04024436|526543286|FG003|Overall Study|Death|7|||
146007554|NCT04024436|526543283|FG000|Overall Study|Loss to follow up|1|||
146007555|NCT04024436|526543284|FG001|Overall Study|Loss to follow up|0|||
146007556|NCT04024436|526543285|FG002|Overall Study|Loss to follow up|0|||
146007557|NCT04024436|526543286|FG003|Overall Study|Loss to follow up|1|||
146007558|NCT04024436|526543283|FG000|Overall Study|Withdrawal of consent|2|||
146007559|NCT04024436|526543284|FG001|Overall Study|Withdrawal of consent|0|||
146007560|NCT04024436|526543285|FG002|Overall Study|Withdrawal of consent|0|||
146007561|NCT04024436|526543286|FG003|Overall Study|Withdrawal of consent|1|||
146007562|NCT04024436|526543283|FG000|Overall Study|Study termination by sponsor|4|||
146007563|NCT04024436|526543284|FG001|Overall Study|Study termination by sponsor|6|||
146007564|NCT04024436|526543285|FG002|Overall Study|Study termination by sponsor|2|||
146007565|NCT04024436|526543286|FG003|Overall Study|Study termination by sponsor|11|||
146007566|NCT04024436|526543283|FG000|Overall Study|Reason Not Specified|0|||
146007567|NCT04024436|526543284|FG001|Overall Study|Reason Not Specified|1|||
146007568|NCT04024436|526543285|FG002|Overall Study|Reason Not Specified|0|||
146007569|NCT04024436|526543286|FG003|Overall Study|Reason Not Specified|2|||
146007570|NCT00540592|526543287|FG000|Overall Study|Adverse Event|0|||
146007571|NCT00540592|526543288|FG001|Overall Study|Adverse Event|1|||
146007572|NCT00540592|526543289|FG002|Overall Study|Adverse Event|0|||
146007573|NCT00540592|526543290|FG003|Overall Study|Adverse Event|0|||
146007574|NCT00540592|526543291|FG004|Overall Study|Adverse Event|1|||
146007575|NCT00540592|526543292|FG005|Overall Study|Adverse Event|0|||
146007576|NCT00540592|526543293|FG006|Overall Study|Adverse Event|0|||
146007577|NCT00540592|526543294|FG007|Overall Study|Adverse Event|1|||
146007578|NCT00540592|526543295|FG008|Overall Study|Adverse Event|1|||
146007579|NCT00540592|526543296|FG009|Overall Study|Adverse Event|2|||
146007580|NCT00540592|526543287|FG000|Overall Study|Lost to Follow-up|2|||
146007581|NCT00540592|526543288|FG001|Overall Study|Lost to Follow-up|0|||
146007582|NCT00540592|526543289|FG002|Overall Study|Lost to Follow-up|0|||
146007583|NCT00540592|526543290|FG003|Overall Study|Lost to Follow-up|0|||
146007584|NCT00540592|526543291|FG004|Overall Study|Lost to Follow-up|0|||
146007585|NCT00540592|526543292|FG005|Overall Study|Lost to Follow-up|0|||
146007586|NCT00540592|526543293|FG006|Overall Study|Lost to Follow-up|0|||
146007587|NCT00540592|526543294|FG007|Overall Study|Lost to Follow-up|0|||
146007588|NCT00540592|526543295|FG008|Overall Study|Lost to Follow-up|0|||
146007589|NCT00540592|526543296|FG009|Overall Study|Lost to Follow-up|0|||
146007590|NCT00540592|526543287|FG000|Overall Study|Withdrawal by Subject|0|||
146007591|NCT00540592|526543288|FG001|Overall Study|Withdrawal by Subject|0|||
146007592|NCT00540592|526543289|FG002|Overall Study|Withdrawal by Subject|1|||
146007593|NCT00540592|526543290|FG003|Overall Study|Withdrawal by Subject|1|||
146007594|NCT00540592|526543291|FG004|Overall Study|Withdrawal by Subject|0|||
146007595|NCT00540592|526543292|FG005|Overall Study|Withdrawal by Subject|0|||
146007596|NCT00540592|526543293|FG006|Overall Study|Withdrawal by Subject|0|||
146007597|NCT00540592|526543294|FG007|Overall Study|Withdrawal by Subject|0|||
146007598|NCT00540592|526543295|FG008|Overall Study|Withdrawal by Subject|0|||
146007599|NCT00540592|526543296|FG009|Overall Study|Withdrawal by Subject|0|||
146007600|NCT03901963|526543300|FG000|Overall Study|Lost to Follow-up|1|||
146007601|NCT03901963|526543301|FG001|Overall Study|Lost to Follow-up|1|||
146007602|NCT03901963|526543300|FG000|Overall Study|Physician Decision|1|||
146007603|NCT03901963|526543301|FG001|Overall Study|Physician Decision|2|||
146007604|NCT03901963|526543300|FG000|Overall Study|Protocol Violation|1|||
146007605|NCT03901963|526543301|FG001|Overall Study|Protocol Violation|1|||
146007606|NCT03901963|526543300|FG000|Overall Study|Withdrawal by Subject|4|||
146007607|NCT03901963|526543301|FG001|Overall Study|Withdrawal by Subject|11|||
146007608|NCT03901963|526543300|FG000|Overall Study|Ongoing|84|||
146007609|NCT03901963|526543301|FG001|Overall Study|Ongoing|73|||
146007610|NCT03901963|526543300|FG000|Overall Study|Randomized but not treated|3|||
146007611|NCT03901963|526543301|FG001|Overall Study|Randomized but not treated|3|||
146007612|NCT01206140|526543302|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
146007613|NCT01206140|526543303|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
146007614|NCT01803880|526543304|FG000|Overall Study|Adverse Event|1|||
146007615|NCT01803880|526543305|FG001|Overall Study|Adverse Event|0|||
146007616|NCT01803880|526543306|FG002|Overall Study|Adverse Event|0|||
146007617|NCT01803880|526543304|FG000|Overall Study|Withdrawal by Subject|1|||
146007618|NCT01803880|526543305|FG001|Overall Study|Withdrawal by Subject|1|||
146007619|NCT01803880|526543306|FG002|Overall Study|Withdrawal by Subject|4|||
146007620|NCT01803880|526543304|FG000|Overall Study|Physician Decision|0|||
146007621|NCT01803880|526543305|FG001|Overall Study|Physician Decision|0|||
146007622|NCT01803880|526543306|FG002|Overall Study|Physician Decision|1|||
146007623|NCT01803880|526543304|FG000|Overall Study|Unable to return for follow-up visits|0|||
146007624|NCT01803880|526543305|FG001|Overall Study|Unable to return for follow-up visits|1|||
146007625|NCT01803880|526543306|FG002|Overall Study|Unable to return for follow-up visits|2|||
146007626|NCT01803880|526543304|FG000|Overall Study|Lost to Follow-up|1|||
146007627|NCT01803880|526543305|FG001|Overall Study|Lost to Follow-up|2|||
146007628|NCT01803880|526543306|FG002|Overall Study|Lost to Follow-up|3|||
146007629|NCT01803880|526543304|FG000|Overall Study|Protocol Violation|1|||
146007630|NCT01803880|526543305|FG001|Overall Study|Protocol Violation|0|||
146007631|NCT01803880|526543306|FG002|Overall Study|Protocol Violation|0|||
146007632|NCT01803880|526543304|FG000|Overall Study|Early study termination|0|||
146007633|NCT01803880|526543305|FG001|Overall Study|Early study termination|6|||
146007634|NCT01803880|526543306|FG002|Overall Study|Early study termination|5|||
146007635|NCT01803880|526543304|FG000|Overall Study|Incomplete data entry by sites|2|||
146007636|NCT01803880|526543305|FG001|Overall Study|Incomplete data entry by sites|0|||
146007637|NCT01803880|526543306|FG002|Overall Study|Incomplete data entry by sites|0|||
146007638|NCT01766037|526543307|FG000|Overall Study|Adverse Event|1|||
146007639|NCT01766037|526543308|FG001|Overall Study|Adverse Event|0|||
146007640|NCT01766037|526543307|FG000|Overall Study|Lack of Efficacy|1|||
146007641|NCT01766037|526543308|FG001|Overall Study|Lack of Efficacy|0|||
146007642|NCT01766037|526543307|FG000|Overall Study|Lost to Follow-up|0|||
146007643|NCT01766037|526543308|FG001|Overall Study|Lost to Follow-up|10|||
146007644|NCT01766037|526543307|FG000|Overall Study|Physician Decision|0|||
146007645|NCT01766037|526543308|FG001|Overall Study|Physician Decision|1|||
146007646|NCT01766037|526543307|FG000|Overall Study|Withdrawal by Subject|18|||
146007647|NCT01766037|526543308|FG001|Overall Study|Withdrawal by Subject|16|||
146007648|NCT01766037|526543307|FG000|Overall Study|Moved from area|5|||
146007649|NCT01766037|526543308|FG001|Overall Study|Moved from area|0|||
146007650|NCT01766037|526543307|FG000|Overall Study|medical - unrelated|1|||
146007651|NCT01766037|526543308|FG001|Overall Study|medical - unrelated|2|||
146007652|NCT01766037|526543307|FG000|Overall Study|nausea / discomfort|3|||
146007653|NCT01766037|526543308|FG001|Overall Study|nausea / discomfort|0|||
146007654|NCT05384834|526543311|FG000|Overall Study|Lost to Follow-up|43|||
146007655|NCT05384834|526543311|FG000|Overall Study|Withdrawal by Subject|5|||
146007656|NCT01775553|526543312|FG000|Overall Study|Adverse Event|1|||
146007657|NCT01775553|526543312|FG000|Overall Study|Disease Progression|12|||
146007658|NCT03810014|526543320|FG000|Overall Study|Pregnancy|2|||
146007659|NCT03810014|526543321|FG001|Overall Study|Pregnancy|2|||
146007660|NCT03810014|526543322|FG002|Overall Study|Pregnancy|0|||
146007661|NCT03810014|526543323|FG003|Overall Study|Pregnancy|2|||
146007662|NCT00886769|526543325|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146007663|NCT00886769|526543326|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
146007664|NCT00414076|526543327|FG000|Overall Study|Progression|1|||
146007665|NCT00414076|526543328|FG001|Overall Study|Progression|2|||
146007666|NCT00414076|526543327|FG000|Overall Study|Withdrawal by Subject|1|||
146007667|NCT00414076|526543328|FG001|Overall Study|Withdrawal by Subject|3|||
146007668|NCT00414076|526543327|FG000|Overall Study|Adverse Event|1|||
146007669|NCT00414076|526543328|FG001|Overall Study|Adverse Event|0|||
146007670|NCT00778336|526543329|FG000|Index Procedure-Discharge|Death|6|||
146007671|NCT00778336|526543330|FG001|Index Procedure-Discharge|Death|3|||
146007672|NCT00778336|526543331|FG002|Index Procedure-Discharge|Death|2|||
146007673|NCT00778336|526543332|FG003|Index Procedure-Discharge|Death|0|||
146007674|NCT00778336|526543329|FG000|3 Month Follow Up|Lost to Follow-up|15|||
146007675|NCT00778336|526543330|FG001|3 Month Follow Up|Lost to Follow-up|20|||
146007676|NCT00778336|526543331|FG002|3 Month Follow Up|Lost to Follow-up|3|||
146007677|NCT00778336|526543332|FG003|3 Month Follow Up|Lost to Follow-up|0|||
146007678|NCT00778336|526543329|FG000|3 Month Follow Up|Death|8|||
146007679|NCT00778336|526543330|FG001|3 Month Follow Up|Death|3|||
146007680|NCT00778336|526543331|FG002|3 Month Follow Up|Death|2|||
146007681|NCT00778336|526543332|FG003|3 Month Follow Up|Death|0|||
146007682|NCT04108208|526543333|FG000|Overall Study|Withdrawal by Subject|2|||
146007683|NCT04108208|526543334|FG001|Overall Study|Withdrawal by Subject|6|||
146007684|NCT04108208|526543333|FG000|Overall Study|other-ongoing|20|||
146007685|NCT04108208|526543334|FG001|Overall Study|other-ongoing|40|||
146007686|NCT04108208|526543333|FG000|Overall Study|Death|1|||
146007687|NCT04108208|526543334|FG001|Overall Study|Death|4|||
146007688|NCT04108208|526543333|FG000|Overall Study|Lost to Follow-up|2|||
146007689|NCT04108208|526543334|FG001|Overall Study|Lost to Follow-up|0|||
146007690|NCT03670355|526543335|FG000|Overall Study|Adverse Event|1|||
146007691|NCT03670355|526543336|FG001|Overall Study|Adverse Event|0|||
146007692|NCT03670355|526543335|FG000|Overall Study|Unable to comply with study procedures|0|||
146007693|NCT03670355|526543336|FG001|Overall Study|Unable to comply with study procedures|1|||
146007694|NCT03670355|526543335|FG000|Overall Study|Participant refused|0|||
146007695|NCT03670355|526543336|FG001|Overall Study|Participant refused|1|||
146092466|NCT01982331|526860296|FG000|Received Vaccination 2|Adverse Event|1|||
146092467|NCT01982331|526860297|FG001|Received Vaccination 2|Adverse Event|2|||
146092468|NCT01982331|526860296|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146092469|NCT01982331|526860297|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
146092470|NCT01982331|526860296|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
146092471|NCT01982331|526860297|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
146092472|NCT01528215|526860298|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
146092473|NCT01528215|526860299|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
146092474|NCT01528215|526860298|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
146007696|NCT03517436|526543337|FG000|Overall Study|Death|3|||
146007697|NCT03517436|526543337|FG000|Overall Study|Withdrawal by Subject|4|||
146007698|NCT03517436|526543337|FG000|Overall Study|Did not receive study valve.|1|||
146007699|NCT04181827|526543338|FG000|Overall Study|Ongoing|124|||
146007700|NCT04181827|526543339|FG001|Overall Study|Ongoing|157|||
146007701|NCT04181827|526543338|FG000|Overall Study|Death|82|||
146007702|NCT04181827|526543339|FG001|Overall Study|Death|50|||
146007703|NCT04181827|526543338|FG000|Overall Study|Lost to Follow-up|0|||
146007704|NCT04181827|526543339|FG001|Overall Study|Lost to Follow-up|1|||
146007705|NCT04181827|526543338|FG000|Overall Study|Withdrawal by Subject|5|||
146007706|NCT04181827|526543339|FG001|Overall Study|Withdrawal by Subject|0|||
146007707|NCT04587869|526543340|FG000|Overall Study|Death|1|||
146007708|NCT04587869|526543341|FG001|Overall Study|Death|0|||
146007709|NCT04587869|526543340|FG000|Overall Study|Lost to Follow-up|27|||
146007710|NCT04587869|526543341|FG001|Overall Study|Lost to Follow-up|34|||
146007711|NCT04587869|526543340|FG000|Overall Study|Grant Termination|13|||
146007712|NCT04587869|526543341|FG001|Overall Study|Grant Termination|25|||
146007713|NCT04587869|526543340|FG000|Overall Study|too busy|2|||
146007714|NCT04587869|526543341|FG001|Overall Study|too busy|0|||
146007715|NCT04587869|526543340|FG000|Overall Study|Withdrawal by Subject|2|||
146007716|NCT04587869|526543341|FG001|Overall Study|Withdrawal by Subject|2|||
146007717|NCT04587869|526543340|FG000|Overall Study|Other|1|||
146007718|NCT04587869|526543341|FG001|Overall Study|Other|0|||
146007719|NCT04538664|526543347|FG000|Overall Study|Withdrawal by Subject|5|||
146007720|NCT04538664|526543348|FG001|Overall Study|Withdrawal by Subject|9|||
146007721|NCT04538664|526543347|FG000|Overall Study|Lost to Follow-up|2|||
146007722|NCT04538664|526543348|FG001|Overall Study|Lost to Follow-up|1|||
146007723|NCT04538664|526543347|FG000|Overall Study|Ongoing|106|||
146007724|NCT04538664|526543348|FG001|Overall Study|Ongoing|115|||
146007725|NCT03929913|526543349|FG000|Overall Study|Death|4|||
146007726|NCT03929913|526543349|FG000|Overall Study|Lost to Follow-up|1|||
146007727|NCT03929913|526543349|FG000|Overall Study|Failed Procedure|2|||
146007728|NCT00642707|526543350|FG000|Overall Study|Adverse Event|0|||
146007729|NCT00642707|526543351|FG001|Overall Study|Adverse Event|0|||
146007730|NCT00642707|526543352|FG002|Overall Study|Adverse Event|0|||
146007731|NCT00642707|526543353|FG003|Overall Study|Adverse Event|2|||
146007732|NCT00642707|526543350|FG000|Overall Study|Withdrawal by Subject|1|||
146007733|NCT00642707|526543351|FG001|Overall Study|Withdrawal by Subject|0|||
146007734|NCT00642707|526543352|FG002|Overall Study|Withdrawal by Subject|0|||
146007735|NCT00642707|526543353|FG003|Overall Study|Withdrawal by Subject|0|||
146007736|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
146007737|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
146007738|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
146007739|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007740|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007741|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007742|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007743|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007744|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007745|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007746|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007747|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007748|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146092475|NCT01528215|526860299|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
146092476|NCT01528215|526860298|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
146092477|NCT01528215|526860299|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
146092478|NCT01528215|526860298|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
146007749|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007750|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007751|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
146007752|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146007753|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
146007754|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007755|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007756|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007757|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007758|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007759|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007760|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007761|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007762|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007763|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007764|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007765|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007766|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007767|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
146007768|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007769|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007770|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007771|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
146007772|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007773|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007774|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007775|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007776|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007777|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007778|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007779|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007780|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007781|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007782|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007783|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
146007784|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007785|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007786|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
146007787|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007788|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007789|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007790|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007791|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007792|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007793|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007794|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007795|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007796|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007797|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007798|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007799|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
146007800|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007801|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007802|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007803|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
146007804|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007805|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007806|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007807|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007808|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007809|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007810|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007811|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007812|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007813|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007814|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007815|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
146007816|NCT02891226|526543354|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007817|NCT02891226|526543355|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146248178|NCT02410278|527421595|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
146248179|NCT02410278|527421596|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
146007818|NCT02891226|526543356|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007819|NCT02891226|526543357|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
146007820|NCT02891226|526543358|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007821|NCT02891226|526543359|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007822|NCT02891226|526543360|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007823|NCT02891226|526543361|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007824|NCT02891226|526543362|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007825|NCT02891226|526543363|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007826|NCT02891226|526543364|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007827|NCT02891226|526543365|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146248180|NCT03693989|527421597|FG000|Overall Study|Protocol Violation|3|||
146007828|NCT02891226|526543366|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007829|NCT02891226|526543367|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007830|NCT02891226|526543368|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007831|NCT02891226|526543369|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
146007832|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007833|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007834|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007835|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007836|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007837|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007838|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
146007839|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
146007840|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
146007841|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
146007842|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007843|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007844|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146248181|NCT03693989|527421598|FG001|Overall Study|Protocol Violation|4|||
146248182|NCT01190436|527421599|FG000|Overall Study|Lost to Follow-up|35|||
146248183|NCT01190436|527421599|FG000|Overall Study|Other|4|||
146248184|NCT00113529|527421600|FG000|Overall Study|Adverse Event|4|||
146248185|NCT00113529|527421600|FG000|Overall Study|Lack of Efficacy|20|||
146248186|NCT00113529|527421600|FG000|Overall Study|Decision of sponsor|6|||
146248187|NCT00113529|527421600|FG000|Overall Study|Withdrawal by Subject|4|||
146248188|NCT00648895|527421601|FG000|Overall Study|Lack of Efficacy|0|||
146248189|NCT00648895|527421602|FG001|Overall Study|Lack of Efficacy|1|||
146248190|NCT01077284|527421603|FG000|Overall Study|Adverse Event|2|||
146248191|NCT01077284|527421604|FG001|Overall Study|Adverse Event|0|||
146248192|NCT01077284|527421605|FG002|Overall Study|Adverse Event|1|||
146248193|NCT01077284|527421603|FG000|Overall Study|Lost to Follow-up|1|||
146248194|NCT01077284|527421604|FG001|Overall Study|Lost to Follow-up|2|||
146248195|NCT01077284|527421605|FG002|Overall Study|Lost to Follow-up|0|||
146248196|NCT01077284|527421603|FG000|Overall Study|Withdrawal by Subject|2|||
146248197|NCT01077284|527421604|FG001|Overall Study|Withdrawal by Subject|3|||
146248198|NCT01077284|527421605|FG002|Overall Study|Withdrawal by Subject|1|||
146248199|NCT01077284|527421603|FG000|Overall Study|Other|0|||
146248200|NCT01077284|527421604|FG001|Overall Study|Other|0|||
146248201|NCT01077284|527421605|FG002|Overall Study|Other|1|||
146248202|NCT04626128|527421606|FG000|Overall Study|Withdrawal by Subject|0|||
146248203|NCT04626128|527421607|FG001|Overall Study|Withdrawal by Subject|1|||
146248204|NCT04626128|527421608|FG002|Overall Study|Withdrawal by Subject|0|||
146248205|NCT04626128|527421609|FG003|Overall Study|Withdrawal by Subject|0|||
146248206|NCT00841321|527421610|FG000|Overall Study|Lost to Follow-up|1|||
146248207|NCT00841321|527421611|FG001|Overall Study|Lost to Follow-up|1|||
146248208|NCT00841321|527421610|FG000|Overall Study|Adverse Event|0|||
146248209|NCT00841321|527421611|FG001|Overall Study|Adverse Event|2|||
146248210|NCT02632747|527421614|FG000|Wash-out Period|Adverse Event|1|||
146248211|NCT02632747|527421615|FG001|Wash-out Period|Adverse Event|0|||
146248212|NCT00379210|527421616|FG000|Overall Study|Withdrawal by Subject|10|||
146248213|NCT00379210|527421617|FG001|Overall Study|Withdrawal by Subject|7|||
146248214|NCT03444155|527421618|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
146248215|NCT03444155|527421619|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
146248216|NCT01894620|527421620|FG000|Overall Study|Withdrawal by Subject|0|||
146248217|NCT01894620|527421621|FG001|Overall Study|Withdrawal by Subject|1|||
146248218|NCT02877680|527421622|FG000|Overall Study|Lost to Follow-up|1|||
146248219|NCT02877680|527421623|FG001|Overall Study|Lost to Follow-up|1|||
146248220|NCT02077374|527421624|FG000|Overall Study|Withdrawal by Subject|0|||
146248221|NCT02077374|527421625|FG001|Overall Study|Withdrawal by Subject|1|||
146248222|NCT02077374|527421624|FG000|Overall Study|Protocol Violation|0|||
146248223|NCT02077374|527421625|FG001|Overall Study|Protocol Violation|1|||
146248224|NCT03875729|527421626|FG000|Overall Study|Adverse Event|0|||
146248225|NCT03875729|527421627|FG001|Overall Study|Adverse Event|5|||
146248226|NCT03875729|527421626|FG000|Overall Study|Withdrawal by Subject|8|||
146248227|NCT03875729|527421627|FG001|Overall Study|Withdrawal by Subject|11|||
146248228|NCT03875729|527421626|FG000|Overall Study|Pregnancy|0|||
146248229|NCT03875729|527421627|FG001|Overall Study|Pregnancy|1|||
146248230|NCT03875729|527421626|FG000|Overall Study|Lost to Follow-up|0|||
146248231|NCT03875729|527421627|FG001|Overall Study|Lost to Follow-up|5|||
146248232|NCT03875729|527421626|FG000|Overall Study|Personal reasons|2|||
146248233|NCT03875729|527421627|FG001|Overall Study|Personal reasons|0|||
146248234|NCT04085614|527421630|FG000|Overall Study|Protocol Violation|9|||
146248235|NCT04085614|527421631|FG001|Overall Study|Protocol Violation|6|||
146248236|NCT05265247|527421632|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
146248237|NCT05265247|527421633|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
146298210|NCT03872453|527607861|FG003|Overall Study|Pregnancy|0|||
146007845|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007846|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146298211|NCT03872453|527607858|FG000|Overall Study|Protocol Deviation|2|||
146007847|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
146007848|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007849|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007850|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007851|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007852|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007853|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
146007854|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007855|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007856|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007857|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
146007858|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007859|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007860|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007861|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007862|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007863|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
146007864|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007865|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007866|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007867|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007868|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007869|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007870|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
146007871|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
146007872|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
146007873|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
146007874|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007875|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007876|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007877|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007878|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007879|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
146007880|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007881|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007882|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007883|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007884|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
146007885|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007886|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007887|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007888|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007889|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007890|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007891|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007892|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007893|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007894|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007895|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
146007896|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007897|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007898|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007899|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007900|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146056162|NCT04664153|526721110|FG000|Overall Study|Withdrawal by Subject|3|||
146056163|NCT04664153|526721111|FG001|Overall Study|Withdrawal by Subject|2|||
146056164|NCT04664153|526721112|FG002|Overall Study|Withdrawal by Subject|1|||
146056165|NCT04664153|526721113|FG003|Overall Study|Withdrawal by Subject|2|||
146056166|NCT04664153|526721110|FG000|Overall Study|Other|0|||
146056167|NCT04664153|526721111|FG001|Overall Study|Other|1|||
146056168|NCT04664153|526721112|FG002|Overall Study|Other|0|||
146056169|NCT04664153|526721113|FG003|Overall Study|Other|0|||
146056170|NCT04664153|526721110|FG000|Overall Study|Adverse Event|4|||
146056171|NCT04664153|526721111|FG001|Overall Study|Adverse Event|0|||
146056172|NCT04664153|526721112|FG002|Overall Study|Adverse Event|1|||
146056173|NCT04664153|526721113|FG003|Overall Study|Adverse Event|0|||
146056174|NCT01045460|526721114|FG000|Overall Study|Physician Decision|3|||
146056175|NCT01045460|526721115|FG001|Overall Study|Physician Decision|2|||
146298212|NCT03872453|527607859|FG001|Overall Study|Protocol Deviation|0|||
146298213|NCT03872453|527607860|FG002|Overall Study|Protocol Deviation|0|||
146298214|NCT03872453|527607861|FG003|Overall Study|Protocol Deviation|2|||
146298215|NCT03872453|527607858|FG000|Overall Study|Withdrawal by Subject|0|||
146298216|NCT03872453|527607859|FG001|Overall Study|Withdrawal by Subject|1|||
146298217|NCT03872453|527607860|FG002|Overall Study|Withdrawal by Subject|2|||
146298218|NCT03872453|527607861|FG003|Overall Study|Withdrawal by Subject|0|||
146298219|NCT03872453|527607858|FG000|Overall Study|Other Than Specified|1|||
146298220|NCT03872453|527607859|FG001|Overall Study|Other Than Specified|0|||
146298221|NCT03872453|527607860|FG002|Overall Study|Other Than Specified|0|||
146298222|NCT03872453|527607861|FG003|Overall Study|Other Than Specified|0|||
146298223|NCT03756350|527607862|FG000|Overall Study|Lost to Follow-up|1|||
146298224|NCT01096342|527607865|FG000|Overall Study|Protocol Violation|1|||
146298225|NCT00929656|527607866|FG000|Overall Study|Lost to Follow-up|0|||
146298226|NCT00929656|527607867|FG001|Overall Study|Lost to Follow-up|1|||
146298227|NCT03308942|527607868|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
146298228|NCT03308942|527607869|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
146298229|NCT03308942|527607870|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
146298230|NCT03308942|527607871|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
146298231|NCT03308942|527607872|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
146298232|NCT03308942|527607868|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
146298233|NCT03308942|527607869|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
146298234|NCT03308942|527607870|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
146298235|NCT03308942|527607871|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
146298236|NCT03308942|527607872|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
146298237|NCT03308942|527607868|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146298238|NCT03308942|527607869|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
146298239|NCT03308942|527607870|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146298240|NCT03308942|527607871|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146298241|NCT03308942|527607872|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
146298242|NCT03308942|527607868|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
146298243|NCT03308942|527607869|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
146298244|NCT03308942|527607870|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146298245|NCT03308942|527607871|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146298246|NCT03308942|527607872|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
146298247|NCT03308942|527607868|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146298248|NCT03308942|527607869|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146298249|NCT03308942|527607870|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146007901|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007902|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
146007903|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007904|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007905|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007906|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007907|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007908|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007909|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007910|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007911|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
146007912|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007913|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007914|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007915|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007916|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007917|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007918|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007919|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146007920|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146007921|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
146007922|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007923|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007924|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007925|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007926|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007927|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
146007928|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146056176|NCT01045460|526721114|FG000|Overall Study|Lost to Follow-up|0|||
146007929|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007930|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007931|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007932|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007933|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007934|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007935|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
146007936|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007937|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007938|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007939|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007940|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007941|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007942|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007943|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
146007944|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007945|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007946|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007947|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007948|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007949|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007950|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007951|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007952|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
146007953|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007954|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007955|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007956|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007957|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007958|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007959|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
146007960|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007961|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007962|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007963|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007964|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007965|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007966|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007967|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007968|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007969|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
146007970|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007971|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007972|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007973|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007974|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007975|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
146007976|NCT02891226|526543354|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007977|NCT02891226|526543355|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007978|NCT02891226|526543356|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007979|NCT02891226|526543357|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007980|NCT02891226|526543358|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007981|NCT02891226|526543359|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007982|NCT02891226|526543360|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007983|NCT02891226|526543361|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007984|NCT02891226|526543362|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007985|NCT02891226|526543363|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
146007986|NCT02891226|526543364|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007987|NCT02891226|526543365|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007988|NCT02891226|526543366|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007989|NCT02891226|526543367|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007990|NCT02891226|526543368|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007991|NCT02891226|526543369|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
146007992|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007993|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007994|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007995|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007996|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007997|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007998|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146007999|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008000|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008001|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008002|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
146008003|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008004|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008005|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008006|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008007|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
146008008|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008009|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008010|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008011|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008012|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008013|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008014|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008015|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008016|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008017|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008018|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
146008019|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008020|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008021|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008022|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008023|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
146008024|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008025|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008026|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008027|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008028|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008029|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008030|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008031|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008032|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008033|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008034|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
146008035|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146092479|NCT01528215|526860299|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
146092480|NCT03497676|526860305|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146092481|NCT03497676|526860306|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
146092482|NCT03497676|526860307|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146092483|NCT03497676|526860308|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
146092484|NCT03497676|526860305|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
146092485|NCT03497676|526860306|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
146092486|NCT03497676|526860307|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
146092487|NCT03497676|526860308|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
146092488|NCT03497676|526860305|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
146092489|NCT03497676|526860306|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
146248238|NCT05265247|527421632|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
146248239|NCT05265247|527421633|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
146248240|NCT05265247|527421632|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
146248241|NCT05265247|527421633|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
146248242|NCT01029925|527421634|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
146248243|NCT01029925|527421634|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
146248244|NCT01029925|527421634|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
146248245|NCT02399449|527421635|FG000|Overall Study|Withdrawal by Subject|3|||
146248246|NCT02399449|527421636|FG001|Overall Study|Withdrawal by Subject|9|||
146248247|NCT02399449|527421635|FG000|Overall Study|Physician Decision|0|||
146248248|NCT02399449|527421636|FG001|Overall Study|Physician Decision|1|||
146008036|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008037|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008038|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008039|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
146008040|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008041|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008042|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008043|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008044|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008045|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008046|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008047|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008048|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008049|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008050|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
146008051|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008052|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008053|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008054|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008055|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
146008056|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008057|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008058|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008059|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008060|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008061|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008062|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008063|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008064|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008065|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008066|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
146008067|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008068|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008069|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008070|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008071|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
146008072|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008073|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008074|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008075|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008076|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008077|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008078|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008079|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008080|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008081|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008082|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
146008083|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008084|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008085|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008086|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008087|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
146008088|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008089|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008090|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008091|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008092|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008093|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008094|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008095|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008096|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008097|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008098|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
146056177|NCT01045460|526721115|FG001|Overall Study|Lost to Follow-up|1|||
146008099|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008100|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008101|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008102|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008103|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
146008104|NCT02891226|526543354|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008105|NCT02891226|526543355|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008106|NCT02891226|526543356|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008107|NCT02891226|526543357|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008108|NCT02891226|526543358|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008109|NCT02891226|526543359|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008110|NCT02891226|526543360|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008111|NCT02891226|526543361|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008112|NCT02891226|526543362|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008113|NCT02891226|526543363|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008114|NCT02891226|526543364|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
146008115|NCT02891226|526543365|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008116|NCT02891226|526543366|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008117|NCT02891226|526543367|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008118|NCT02891226|526543368|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008119|NCT02891226|526543369|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
146008120|NCT02891226|526543354|FG000|Follow-up Period|Withdrawal by Subject|0|||
146008121|NCT02891226|526543355|FG001|Follow-up Period|Withdrawal by Subject|0|||
146008122|NCT02891226|526543356|FG002|Follow-up Period|Withdrawal by Subject|0|||
146008123|NCT02891226|526543357|FG003|Follow-up Period|Withdrawal by Subject|0|||
146008124|NCT02891226|526543358|FG004|Follow-up Period|Withdrawal by Subject|0|||
146008125|NCT02891226|526543359|FG005|Follow-up Period|Withdrawal by Subject|0|||
146008126|NCT02891226|526543360|FG006|Follow-up Period|Withdrawal by Subject|0|||
146008127|NCT02891226|526543361|FG007|Follow-up Period|Withdrawal by Subject|0|||
146008128|NCT02891226|526543362|FG008|Follow-up Period|Withdrawal by Subject|0|||
146008129|NCT02891226|526543363|FG009|Follow-up Period|Withdrawal by Subject|0|||
146008130|NCT02891226|526543364|FG010|Follow-up Period|Withdrawal by Subject|0|||
146008131|NCT02891226|526543365|FG011|Follow-up Period|Withdrawal by Subject|1|||
146008132|NCT02891226|526543366|FG012|Follow-up Period|Withdrawal by Subject|0|||
146008133|NCT02891226|526543367|FG013|Follow-up Period|Withdrawal by Subject|0|||
146008134|NCT02891226|526543368|FG014|Follow-up Period|Withdrawal by Subject|1|||
146008135|NCT02891226|526543369|FG015|Follow-up Period|Withdrawal by Subject|1|||
146008136|NCT03381287|526543373|FG000|Overall Study|Withdrawal by Subject|0|||
146008137|NCT03381287|526543374|FG001|Overall Study|Withdrawal by Subject|1|||
146008138|NCT03381287|526543375|FG002|Overall Study|Withdrawal by Subject|0|||
146008139|NCT03381287|526543376|FG003|Overall Study|Withdrawal by Subject|0|||
146008140|NCT03381287|526543373|FG000|Overall Study|Adverse Event|0|||
146008141|NCT03381287|526543374|FG001|Overall Study|Adverse Event|0|||
146008142|NCT03381287|526543375|FG002|Overall Study|Adverse Event|0|||
146008143|NCT03381287|526543376|FG003|Overall Study|Adverse Event|1|||
146008144|NCT03381287|526543373|FG000|Overall Study|Physician Decision|0|||
146008145|NCT03381287|526543374|FG001|Overall Study|Physician Decision|0|||
146008146|NCT03381287|526543375|FG002|Overall Study|Physician Decision|0|||
146008147|NCT03381287|526543376|FG003|Overall Study|Physician Decision|1|||
146008148|NCT02454530|526543379|FG000|Overall Study|Other|8|||
146008149|NCT02454530|526543380|FG001|Overall Study|Other|13|||
146008150|NCT02454530|526543379|FG000|Overall Study|Missing information|56|||
146008151|NCT02454530|526543380|FG001|Overall Study|Missing information|69|||
146008152|NCT02454530|526543379|FG000|Overall Study|Death|2|||
146008153|NCT02454530|526543380|FG001|Overall Study|Death|41|||
146008154|NCT02454530|526543379|FG000|Overall Study|Lost to Follow-up|4|||
146008155|NCT02454530|526543380|FG001|Overall Study|Lost to Follow-up|4|||
146008156|NCT02137070|526543381|FG000|Overall Study|Adverse Event|12|||
146008157|NCT02137070|526543382|FG001|Overall Study|Adverse Event|3|||
146008158|NCT02137070|526543381|FG000|Overall Study|Death|2|||
146008159|NCT02137070|526543382|FG001|Overall Study|Death|0|||
146008160|NCT02137070|526543381|FG000|Overall Study|Lost to Follow-up|24|||
146008161|NCT02137070|526543382|FG001|Overall Study|Lost to Follow-up|9|||
146008162|NCT02137070|526543381|FG000|Overall Study|Physician Decision|0|||
146008163|NCT02137070|526543382|FG001|Overall Study|Physician Decision|1|||
146008164|NCT02137070|526543381|FG000|Overall Study|Protocol Violation|18|||
146008165|NCT02137070|526543382|FG001|Overall Study|Protocol Violation|4|||
146008166|NCT02137070|526543381|FG000|Overall Study|Withdrawal by Subject|18|||
146008167|NCT02137070|526543382|FG001|Overall Study|Withdrawal by Subject|1|||
146008168|NCT04609553|526544825|FG000|Overall Study|Lost to Follow-up|27|||
146008169|NCT04609553|526544826|FG001|Overall Study|Lost to Follow-up|31|||
146008170|NCT04609553|526544827|FG002|Overall Study|Lost to Follow-up|24|||
146008171|NCT04609553|526544825|FG000|Overall Study|Discontinued|12|||
146008172|NCT04609553|526544826|FG001|Overall Study|Discontinued|10|||
146008173|NCT04609553|526544827|FG002|Overall Study|Discontinued|9|||
146008174|NCT01147965|526544831|FG000|Overall Study|Progressive Disease|3|||
146008175|NCT01147965|526544832|FG001|Overall Study|Progressive Disease|3|||
146008176|NCT01147965|526544833|FG002|Overall Study|Progressive Disease|5|||
146008177|NCT01147965|526544834|FG003|Overall Study|Progressive Disease|9|||
146008178|NCT01147965|526544835|FG004|Overall Study|Progressive Disease|5|||
146008179|NCT01147965|526544836|FG005|Overall Study|Progressive Disease|5|||
146008180|NCT01147965|526544831|FG000|Overall Study|Death|0|||
146008181|NCT01147965|526544832|FG001|Overall Study|Death|0|||
146008182|NCT01147965|526544833|FG002|Overall Study|Death|1|||
146008183|NCT01147965|526544834|FG003|Overall Study|Death|1|||
146008184|NCT01147965|526544835|FG004|Overall Study|Death|0|||
146008185|NCT01147965|526544836|FG005|Overall Study|Death|2|||
146008186|NCT01147965|526544831|FG000|Overall Study|Withdrawal by Subject|0|||
146008187|NCT01147965|526544832|FG001|Overall Study|Withdrawal by Subject|0|||
146008188|NCT01147965|526544833|FG002|Overall Study|Withdrawal by Subject|1|||
146008189|NCT01147965|526544834|FG003|Overall Study|Withdrawal by Subject|1|||
146008190|NCT01147965|526544835|FG004|Overall Study|Withdrawal by Subject|0|||
146008191|NCT01147965|526544836|FG005|Overall Study|Withdrawal by Subject|0|||
146008192|NCT01147965|526544831|FG000|Overall Study|Administration Of Alternative Therapy|0|||
146008193|NCT01147965|526544832|FG001|Overall Study|Administration Of Alternative Therapy|0|||
146008194|NCT01147965|526544833|FG002|Overall Study|Administration Of Alternative Therapy|0|||
146008195|NCT01147965|526544834|FG003|Overall Study|Administration Of Alternative Therapy|0|||
146008196|NCT01147965|526544835|FG004|Overall Study|Administration Of Alternative Therapy|0|||
146008197|NCT01147965|526544836|FG005|Overall Study|Administration Of Alternative Therapy|1|||
146008198|NCT01147965|526544831|FG000|Overall Study|Other|0|||
146008199|NCT01147965|526544832|FG001|Overall Study|Other|0|||
146008200|NCT01147965|526544833|FG002|Overall Study|Other|0|||
146008201|NCT01147965|526544834|FG003|Overall Study|Other|3|||
146008202|NCT01147965|526544835|FG004|Overall Study|Other|1|||
146008203|NCT01147965|526544836|FG005|Overall Study|Other|0|||
146008204|NCT01169337|526544839|FG000|Overall Study|Lack of Efficacy|5|||
146008205|NCT01169337|526544840|FG001|Overall Study|Lack of Efficacy|7|||
146008206|NCT01169337|526544841|FG002|Overall Study|Lack of Efficacy|0|||
146008207|NCT01169337|526544839|FG000|Overall Study|Adverse Event|12|||
146008208|NCT01169337|526544840|FG001|Overall Study|Adverse Event|18|||
146008209|NCT01169337|526544841|FG002|Overall Study|Adverse Event|0|||
146008210|NCT01169337|526544839|FG000|Overall Study|Death|2|||
146008211|NCT01169337|526544840|FG001|Overall Study|Death|0|||
146008212|NCT01169337|526544841|FG002|Overall Study|Death|0|||
146008213|NCT01169337|526544839|FG000|Overall Study|Withdrawal by Subject|11|||
146008214|NCT01169337|526544840|FG001|Overall Study|Withdrawal by Subject|11|||
146008215|NCT01169337|526544841|FG002|Overall Study|Withdrawal by Subject|6|||
146008216|NCT01169337|526544839|FG000|Overall Study|Noncompliance|2|||
146008217|NCT01169337|526544840|FG001|Overall Study|Noncompliance|0|||
146008218|NCT01169337|526544841|FG002|Overall Study|Noncompliance|0|||
146008219|NCT01169337|526544839|FG000|Overall Study|Other complicating disease|1|||
146008220|NCT01169337|526544840|FG001|Overall Study|Other complicating disease|1|||
146008221|NCT01169337|526544841|FG002|Overall Study|Other complicating disease|0|||
146008222|NCT01169337|526544839|FG000|Overall Study|Physician Decision|1|||
146008223|NCT01169337|526544840|FG001|Overall Study|Physician Decision|5|||
146008224|NCT01169337|526544841|FG002|Overall Study|Physician Decision|0|||
146008225|NCT01169337|526544839|FG000|Overall Study|Alternative therapy|0|||
146248249|NCT02516202|527421637|FG000|Overall Study|Withdrawal by Subject|1|||
146248250|NCT02516202|527421638|FG001|Overall Study|Withdrawal by Subject|0|||
146248251|NCT02516202|527421639|FG002|Overall Study|Withdrawal by Subject|1|||
146248252|NCT02516202|527421637|FG000|Overall Study|Lost to Follow-up|1|||
146248253|NCT02516202|527421638|FG001|Overall Study|Lost to Follow-up|1|||
146248254|NCT02516202|527421639|FG002|Overall Study|Lost to Follow-up|1|||
146248255|NCT02516202|527421637|FG000|Overall Study|Stopped Follow-up|0|||
146248256|NCT02516202|527421638|FG001|Overall Study|Stopped Follow-up|0|||
146248257|NCT02516202|527421639|FG002|Overall Study|Stopped Follow-up|1|||
146298250|NCT03308942|527607871|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
146008226|NCT01169337|526544840|FG001|Overall Study|Alternative therapy|2|||
146008227|NCT01169337|526544841|FG002|Overall Study|Alternative therapy|0|||
146008228|NCT01169337|526544839|FG000|Overall Study|Changed hospital|0|||
146008229|NCT01169337|526544840|FG001|Overall Study|Changed hospital|1|||
146008230|NCT01169337|526544841|FG002|Overall Study|Changed hospital|0|||
146248258|NCT01020435|527421642|FG000|Overall Study|Lost to Follow-up|0|||
146008231|NCT01169337|526544839|FG000|Overall Study|Never started treatment|0|||
146008232|NCT01169337|526544840|FG001|Overall Study|Never started treatment|2|||
146008233|NCT01169337|526544841|FG002|Overall Study|Never started treatment|0|||
146008234|NCT01169337|526544839|FG000|Overall Study|Reason not reported|1|||
146008235|NCT01169337|526544840|FG001|Overall Study|Reason not reported|0|||
146008236|NCT01169337|526544841|FG002|Overall Study|Reason not reported|0|||
146008237|NCT01169337|526544839|FG000|Overall Study|Continuing lenalidomide|9|||
146092490|NCT03497676|526860307|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
146248259|NCT01020435|527421643|FG001|Overall Study|Lost to Follow-up|1|||
146008238|NCT01169337|526544840|FG001|Overall Study|Continuing lenalidomide|43|||
146008239|NCT01169337|526544841|FG002|Overall Study|Continuing lenalidomide|0|||
146008240|NCT01134614|526544842|FG000|Overall Study|Still on treatment as of March 2013|21|||
146008241|NCT01134614|526544843|FG001|Overall Study|Still on treatment as of March 2013|13|||
146008242|NCT01134614|526544842|FG000|Overall Study|Progressive disease|60|||
146008243|NCT01134614|526544843|FG001|Overall Study|Progressive disease|54|||
146008244|NCT01134614|526544842|FG000|Overall Study|Adverse Event|26|||
146008245|NCT01134614|526544843|FG001|Overall Study|Adverse Event|39|||
146008246|NCT01134614|526544842|FG000|Overall Study|Death|5|||
146008247|NCT01134614|526544843|FG001|Overall Study|Death|8|||
146008248|NCT01134614|526544842|FG000|Overall Study|Withdrawal by Subject|3|||
146008249|NCT01134614|526544843|FG001|Overall Study|Withdrawal by Subject|2|||
146008250|NCT01134614|526544842|FG000|Overall Study|Alternative therapy|2|||
146008251|NCT01134614|526544843|FG001|Overall Study|Alternative therapy|0|||
146008252|NCT01134614|526544842|FG000|Overall Study|Complicating disease|2|||
146008253|NCT01134614|526544843|FG001|Overall Study|Complicating disease|1|||
146008254|NCT01134614|526544842|FG000|Overall Study|Physician's decision|0|||
146008255|NCT01134614|526544843|FG001|Overall Study|Physician's decision|1|||
146008256|NCT01134614|526544842|FG000|Overall Study|Never started treatment|4|||
146008257|NCT01134614|526544843|FG001|Overall Study|Never started treatment|1|||
146008258|NCT01134614|526544842|FG000|Overall Study|Pt received tx not allowed on study|0|||
146008259|NCT01134614|526544843|FG001|Overall Study|Pt received tx not allowed on study|1|||
146008260|NCT01134614|526544842|FG000|Overall Study|Symptomatic deterioration|0|||
146008261|NCT01134614|526544843|FG001|Overall Study|Symptomatic deterioration|1|||
146008262|NCT01134614|526544842|FG000|Overall Study|Patient in hospice care|0|||
146008263|NCT01134614|526544843|FG001|Overall Study|Patient in hospice care|1|||
146008264|NCT02168101|526544845|FG000|Overall Study|Death|2|||
146008265|NCT02168101|526544846|FG001|Overall Study|Death|2|||
146008266|NCT02168101|526544847|FG002|Overall Study|Death|1|||
146008267|NCT05507567|526544848|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
146008268|NCT05507567|526544849|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
146008269|NCT05507567|526544850|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
146008270|NCT05507567|526544848|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
146008271|NCT05507567|526544849|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
146008272|NCT05507567|526544850|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
146008273|NCT05507567|526544848|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
146008274|NCT05507567|526544849|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
146008275|NCT05507567|526544850|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
146008276|NCT05507567|526544848|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
146008277|NCT05507567|526544849|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
146008278|NCT05507567|526544850|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
146008279|NCT01722994|526544853|FG000|Overall Study|Missing data|25|||
146008280|NCT01722994|526544854|FG001|Overall Study|Missing data|17|||
146008281|NCT05226598|526544859|FG000|Overall Study|Death|186|||
146008282|NCT05226598|526544860|FG001|Overall Study|Death|191|||
146008283|NCT05226598|526544859|FG000|Overall Study|Withdrawal by Subject|6|||
146008284|NCT05226598|526544860|FG001|Overall Study|Withdrawal by Subject|6|||
146008285|NCT05226598|526544859|FG000|Overall Study|Ongoing|174|||
146008286|NCT05226598|526544860|FG001|Overall Study|Ongoing|176|||
146008287|NCT02959463|526544861|FG000|Overall Study|Adverse Event|1|||
146008288|NCT02959463|526544862|FG001|Overall Study|Adverse Event|1|||
146008289|NCT02959463|526544861|FG000|Overall Study|Death|1|||
146092491|NCT03497676|526860308|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
146092492|NCT03497676|526860305|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146248260|NCT02707952|527421644|FG000|Overall Study|Adverse Event|1|||
146248261|NCT02707952|527421645|FG001|Overall Study|Adverse Event|0|||
146248262|NCT02707952|527421646|FG002|Overall Study|Adverse Event|0|||
146248263|NCT02707952|527421647|FG003|Overall Study|Adverse Event|0|||
146248264|NCT02707952|527421644|FG000|Overall Study|Lost to Follow-up|1|||
146248265|NCT02707952|527421645|FG001|Overall Study|Lost to Follow-up|0|||
146248266|NCT02707952|527421646|FG002|Overall Study|Lost to Follow-up|0|||
146248267|NCT02707952|527421647|FG003|Overall Study|Lost to Follow-up|0|||
146008290|NCT02959463|526544862|FG001|Overall Study|Death|0|||
146008291|NCT02959463|526544861|FG000|Overall Study|Withdrawal by Subject|1|||
146008292|NCT02959463|526544862|FG001|Overall Study|Withdrawal by Subject|0|||
146008293|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
146008294|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
146008295|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
146008296|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
146092493|NCT03497676|526860306|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
146248268|NCT02707952|527421644|FG000|Overall Study|Withdrawal by Subject|0|||
146248269|NCT02707952|527421645|FG001|Overall Study|Withdrawal by Subject|1|||
146008297|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
146008298|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
146008299|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
146008300|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
146008301|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
146008302|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
146008303|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
146008304|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
146008305|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
146008306|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
146008307|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
146008308|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
146008309|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
146008310|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
146008311|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
146008312|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
146008313|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
146008314|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
146008315|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
146008316|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
146008317|NCT01672879|526544863|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
146008318|NCT01672879|526544864|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
146008319|NCT01672879|526544865|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
146008320|NCT01672879|526544863|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
146008321|NCT01672879|526544864|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
146008322|NCT01672879|526544865|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
146008323|NCT01672879|526544863|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
146008324|NCT01672879|526544864|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
146008325|NCT01672879|526544865|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
146008326|NCT01672879|526544863|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
146008327|NCT01672879|526544864|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
146008328|NCT01672879|526544865|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
146008329|NCT01672879|526544863|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
146008330|NCT01672879|526544864|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
146008331|NCT01672879|526544865|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
146008332|NCT03951766|526544870|FG000|Treatment Phase|Lost to Follow-up|1|||
146008333|NCT03951766|526544870|FG000|Follow-up Phase|Lost to Follow-up|10|||
146008334|NCT01871545|526544871|FG000|Overall Study|Death|2|||
146008335|NCT01871545|526544872|FG001|Overall Study|Death|0|||
146008336|NCT01871545|526544871|FG000|Overall Study|Lack of Efficacy|11|||
146008337|NCT01871545|526544872|FG001|Overall Study|Lack of Efficacy|2|||
146008338|NCT01871545|526544871|FG000|Overall Study|Physician Decision|4|||
146008339|NCT01871545|526544872|FG001|Overall Study|Physician Decision|0|||
146008340|NCT01871545|526544871|FG000|Overall Study|Withdrawal by Subject|0|||
146008341|NCT01871545|526544872|FG001|Overall Study|Withdrawal by Subject|1|||
146092494|NCT03497676|526860307|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146092495|NCT03497676|526860308|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
146092496|NCT03497676|526860305|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146092497|NCT03497676|526860306|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146092498|NCT03497676|526860307|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
146092499|NCT03497676|526860308|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
146092500|NCT03497676|526860305|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146092501|NCT03497676|526860306|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146092502|NCT03497676|526860307|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
146092503|NCT03497676|526860308|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
146092504|NCT03497676|526860305|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146092505|NCT03497676|526860306|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146092506|NCT03497676|526860307|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
146008342|NCT01523743|526544873|FG000|Period 1|Adverse Event|1|||
146092507|NCT03497676|526860308|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
146248270|NCT02707952|527421646|FG002|Overall Study|Withdrawal by Subject|2|||
146248271|NCT02707952|527421647|FG003|Overall Study|Withdrawal by Subject|0|||
146248272|NCT00871715|527421648|FG000|Overall Study|Withdrawal by Subject|6|||
146248273|NCT00871715|527421649|FG001|Overall Study|Withdrawal by Subject|10|||
146008343|NCT01523743|526544874|FG001|Period 1|Adverse Event|0|||
146008344|NCT01523743|526544873|FG000|Period 1|Withdrawal by Subject|6|||
146008345|NCT01523743|526544874|FG001|Period 1|Withdrawal by Subject|2|||
146008346|NCT01523743|526544873|FG000|Period 1|Lost to Follow-up|1|||
146008347|NCT01523743|526544874|FG001|Period 1|Lost to Follow-up|0|||
146008348|NCT01523743|526544873|FG000|Period 1|Lack of Efficacy|1|||
146008349|NCT01523743|526544874|FG001|Period 1|Lack of Efficacy|0|||
146008350|NCT01523743|526544873|FG000|Period 1|Felt unable to empty bladder|1|||
146008351|NCT01523743|526544874|FG001|Period 1|Felt unable to empty bladder|0|||
146008352|NCT01523743|526544873|FG000|Period 2|Withdrawal by Subject|0|||
146008353|NCT01523743|526544874|FG001|Period 2|Withdrawal by Subject|2|||
146008354|NCT01523743|526544873|FG000|Period 2|Adverse Event|1|||
146008355|NCT01523743|526544874|FG001|Period 2|Adverse Event|0|||
146008356|NCT05710640|526544877|FG000|Overall Study|Physician Decision|0|||
146008357|NCT05710640|526544878|FG001|Overall Study|Physician Decision|1|||
146008358|NCT05710640|526544877|FG000|Overall Study|Withdrawal by Subject|1|||
146008359|NCT05710640|526544878|FG001|Overall Study|Withdrawal by Subject|0|||
146008360|NCT05710640|526544877|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
146008361|NCT05710640|526544878|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
146008362|NCT04188509|526544879|FG000|Overall Study|Adverse Event|2|||
146008363|NCT04188509|526544879|FG000|Overall Study|Lost to Follow-up|1|||
146008364|NCT04188509|526544879|FG000|Overall Study|Withdrawal of Consent|1|||
146008365|NCT04188509|526544879|FG000|Overall Study|Discretion of Investigator|1|||
146008366|NCT04188509|526544879|FG000|Overall Study|Noncompliance|3|||
146008367|NCT04188509|526544879|FG000|Overall Study|Sponsor Decision|127|||
146008368|NCT04188509|526544879|FG000|Overall Study|Other|2|||
146008369|NCT04158375|526544880|FG000|Overall Study|Withdrawal by Subject|0|||
146008370|NCT04158375|526544881|FG001|Overall Study|Withdrawal by Subject|3|||
146092508|NCT03497676|526860305|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146092509|NCT03497676|526860306|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146248274|NCT00871715|527421650|FG002|Overall Study|Withdrawal by Subject|15|||
146248275|NCT00871715|527421648|FG000|Overall Study|Physician Decision|6|||
146248276|NCT00871715|527421649|FG001|Overall Study|Physician Decision|0|||
146248277|NCT00871715|527421650|FG002|Overall Study|Physician Decision|2|||
146248278|NCT00871715|527421648|FG000|Overall Study|Lost to Follow-up|3|||
146248279|NCT00871715|527421649|FG001|Overall Study|Lost to Follow-up|6|||
146248280|NCT00871715|527421650|FG002|Overall Study|Lost to Follow-up|9|||
146248281|NCT01794689|527421651|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
146248282|NCT01794689|527421652|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
146248283|NCT01794689|527421653|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
146248284|NCT01794689|527421654|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
146248285|NCT01794689|527421651|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
146248286|NCT01794689|527421652|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
146248287|NCT01794689|527421653|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
146248288|NCT01794689|527421654|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
146248289|NCT01794689|527421651|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
146248290|NCT01794689|527421652|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
146248291|NCT01794689|527421653|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
146248292|NCT01794689|527421654|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
146248293|NCT01794689|527421651|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
146248294|NCT01794689|527421652|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
146248295|NCT01794689|527421653|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
146248296|NCT01794689|527421654|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
146248297|NCT01697956|527421655|FG000|Overall Study|Protocol Violation|1|||
146248298|NCT01697956|527421656|FG001|Overall Study|Protocol Violation|1|||
146248299|NCT01964547|527421657|FG000|Overall Study|Adverse Event|8|||
146248300|NCT01964547|527421658|FG001|Overall Study|Adverse Event|2|||
146248301|NCT01964547|527421657|FG000|Overall Study|Withdrawal by Subject|4|||
146248302|NCT01964547|527421658|FG001|Overall Study|Withdrawal by Subject|7|||
146248303|NCT01964547|527421657|FG000|Overall Study|Lost to Follow-up|0|||
146248304|NCT01964547|527421658|FG001|Overall Study|Lost to Follow-up|1|||
146248305|NCT01964547|527421657|FG000|Overall Study|Withdrawal by Investigator|0|||
146248306|NCT01964547|527421658|FG001|Overall Study|Withdrawal by Investigator|1|||
146008371|NCT04158375|526544882|FG002|Overall Study|Withdrawal by Subject|0|||
146008372|NCT04847843|526544883|FG000|Overall Study|Scheduling Conflicts|6|||
146008373|NCT04847843|526544884|FG001|Overall Study|Scheduling Conflicts|9|||
146008374|NCT04847843|526544883|FG000|Overall Study|Withdrawal by Subject|1|||
146008375|NCT04847843|526544884|FG001|Overall Study|Withdrawal by Subject|0|||
146008376|NCT04847843|526544883|FG000|Overall Study|Lost to Follow-up|1|||
146008377|NCT04847843|526544884|FG001|Overall Study|Lost to Follow-up|1|||
146008378|NCT04847843|526544883|FG000|Overall Study|Pregnancy|0|||
146008379|NCT04847843|526544884|FG001|Overall Study|Pregnancy|2|||
146008380|NCT04847843|526544883|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
146092510|NCT03497676|526860307|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
146008381|NCT04847843|526544884|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
146092511|NCT03497676|526860308|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
146248307|NCT01115309|527421659|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
146248308|NCT01115309|527421659|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
146248309|NCT01115309|527421659|FG000|Long-term Follow-up|Lost to Follow-up|6|||
146248310|NCT05700851|527421660|FG000|Overall Study|Received a kidney transplant|1|||
146092512|NCT00237185|526860309|FG000|Core|Adverse Event|3|||
146092513|NCT00237185|526860310|FG001|Core|Adverse Event|4|||
146092514|NCT00237185|526860309|FG000|Core|Abnormal laboratory value|0|||
146092515|NCT00237185|526860310|FG001|Core|Abnormal laboratory value|4|||
146092516|NCT00237185|526860309|FG000|Core|Abnormal test procedure results|1|||
146092517|NCT00237185|526860310|FG001|Core|Abnormal test procedure results|0|||
146092518|NCT00237185|526860309|FG000|Core|Lack of Efficacy|30|||
146008382|NCT02734004|526544885|FG000|Overall Study|Death|36|||
146008383|NCT02734004|526544886|FG001|Overall Study|Death|24|||
146008384|NCT02734004|526544887|FG002|Overall Study|Death|26|||
146008385|NCT02734004|526544888|FG003|Overall Study|Death|35|||
146008386|NCT02734004|526544889|FG004|Overall Study|Death|13|||
146008387|NCT02734004|526544890|FG005|Overall Study|Death|17|||
146008388|NCT02734004|526544891|FG006|Overall Study|Death|20|||
146008389|NCT02734004|526544885|FG000|Overall Study|Lost to Follow-up|1|||
146008390|NCT02734004|526544886|FG001|Overall Study|Lost to Follow-up|1|||
146008391|NCT02734004|526544887|FG002|Overall Study|Lost to Follow-up|0|||
146008392|NCT02734004|526544888|FG003|Overall Study|Lost to Follow-up|0|||
146008393|NCT02734004|526544889|FG004|Overall Study|Lost to Follow-up|1|||
146008394|NCT02734004|526544890|FG005|Overall Study|Lost to Follow-up|0|||
146008395|NCT02734004|526544891|FG006|Overall Study|Lost to Follow-up|0|||
146008396|NCT02734004|526544885|FG000|Overall Study|Withdrawal by Subject|3|||
146008397|NCT02734004|526544886|FG001|Overall Study|Withdrawal by Subject|1|||
146008398|NCT02734004|526544887|FG002|Overall Study|Withdrawal by Subject|1|||
146008399|NCT02734004|526544888|FG003|Overall Study|Withdrawal by Subject|1|||
146008400|NCT02734004|526544889|FG004|Overall Study|Withdrawal by Subject|3|||
146008401|NCT02734004|526544890|FG005|Overall Study|Withdrawal by Subject|0|||
146008402|NCT02734004|526544891|FG006|Overall Study|Withdrawal by Subject|2|||
146008403|NCT02734004|526544885|FG000|Overall Study|Other|0|||
146008404|NCT02734004|526544886|FG001|Overall Study|Other|8|||
146008405|NCT02734004|526544887|FG002|Overall Study|Other|7|||
146008406|NCT02734004|526544888|FG003|Overall Study|Other|4|||
146008407|NCT02734004|526544889|FG004|Overall Study|Other|34|||
146008408|NCT02734004|526544890|FG005|Overall Study|Other|14|||
146008409|NCT02734004|526544891|FG006|Overall Study|Other|10|||
146008410|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
146008411|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
146008412|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
146008413|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
146008414|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
146008415|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
146008416|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
146008417|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
146008418|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
146008419|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
146008420|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
146008421|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
146008422|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
146008423|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
146008424|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
146008425|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
146008426|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
146008427|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
146008428|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
146008429|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
146008430|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
146092519|NCT00237185|526860310|FG001|Core|Lack of Efficacy|23|||
146092520|NCT00237185|526860309|FG000|Core|Protocol Violation|1|||
146092521|NCT00237185|526860310|FG001|Core|Protocol Violation|1|||
146092522|NCT00237185|526860309|FG000|Core|Withdrawal by Subject|4|||
146092523|NCT00237185|526860310|FG001|Core|Withdrawal by Subject|4|||
146092524|NCT00237185|526860309|FG000|Core|Administrative problems|0|||
146092525|NCT00237185|526860310|FG001|Core|Administrative problems|1|||
146008431|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
146008432|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
146008433|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
146008434|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Other|6|||
146008435|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Other|0|||
146008436|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Other|0|||
146092526|NCT00237185|526860309|FG000|Core|Death|4|||
146092527|NCT00237185|526860310|FG001|Core|Death|0|||
146092528|NCT00237185|526860309|FG000|Core|Determined ineligible post randomization|1|||
146092529|NCT00237185|526860310|FG001|Core|Determined ineligible post randomization|0|||
146298251|NCT03308942|527607872|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
146298252|NCT03308942|527607868|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146298253|NCT03308942|527607869|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146298254|NCT03308942|527607870|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146298255|NCT03308942|527607871|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
146298256|NCT03308942|527607872|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
146298257|NCT03308942|527607868|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146298258|NCT03308942|527607869|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146298259|NCT03308942|527607870|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146298260|NCT03308942|527607871|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
146298261|NCT03308942|527607872|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
146298262|NCT01131351|527607873|FG000|Overall Study|Adverse Event|0|||
146298263|NCT01131351|527607874|FG001|Overall Study|Adverse Event|2|||
146298264|NCT01131351|527607873|FG000|Overall Study|Protocol Deviation|0|||
146298265|NCT01131351|527607874|FG001|Overall Study|Protocol Deviation|1|||
146298266|NCT04147234|527607877|FG000|Overall Study|Clinical deterioration|0|||
146298267|NCT04147234|527607878|FG001|Overall Study|Clinical deterioration|0|||
146298268|NCT04147234|527607879|FG002|Overall Study|Clinical deterioration|1|||
146008437|NCT05615220|526544892|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
146008438|NCT05615220|526544893|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
146008439|NCT05615220|526544894|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
146008440|NCT05615220|526544892|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
146008441|NCT05615220|526544893|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
146008442|NCT05615220|526544894|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
146008443|NCT05615220|526544892|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
146008444|NCT05615220|526544893|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
146008445|NCT05615220|526544894|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
146008446|NCT05615220|526544892|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
146008447|NCT05615220|526544893|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
146008448|NCT05615220|526544894|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
146008449|NCT05615220|526544892|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
146008450|NCT05615220|526544893|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
146008451|NCT05615220|526544894|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
146008452|NCT05615220|526544892|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
146008453|NCT05615220|526544893|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
146008454|NCT05615220|526544894|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
146008455|NCT01152788|526544896|FG000|Overall Study|Withdrawal by Subject|0|||
146008456|NCT01152788|526544897|FG001|Overall Study|Withdrawal by Subject|3|||
146248311|NCT05700851|527421660|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
146248312|NCT05700851|527421660|FG000|Overall Study|Withdrawal by Subject|1|||
146248313|NCT03246724|527421661|FG000|Overall Study|Withdrawal by Subject|5|||
146248314|NCT03246724|527421662|FG001|Overall Study|Withdrawal by Subject|2|||
146248315|NCT03246724|527421663|FG002|Overall Study|Withdrawal by Subject|4|||
146248316|NCT03246724|527421664|FG003|Overall Study|Withdrawal by Subject|2|||
146248317|NCT03246724|527421661|FG000|Overall Study|Ineligible on day of surgery|7|||
146248318|NCT03246724|527421662|FG001|Overall Study|Ineligible on day of surgery|2|||
146248319|NCT03246724|527421663|FG002|Overall Study|Ineligible on day of surgery|0|||
146248320|NCT03246724|527421664|FG003|Overall Study|Ineligible on day of surgery|3|||
146248321|NCT03246724|527421661|FG000|Overall Study|Study completed before surgical date|2|||
146248322|NCT03246724|527421662|FG001|Overall Study|Study completed before surgical date|1|||
146248323|NCT03246724|527421663|FG002|Overall Study|Study completed before surgical date|8|||
146248324|NCT03246724|527421664|FG003|Overall Study|Study completed before surgical date|1|||
146248325|NCT03246724|527421661|FG000|Overall Study|Transferred to other arm|0|||
146248326|NCT03246724|527421662|FG001|Overall Study|Transferred to other arm|0|||
146248327|NCT03246724|527421663|FG002|Overall Study|Transferred to other arm|1|||
146248328|NCT03246724|527421664|FG003|Overall Study|Transferred to other arm|0|||
146248329|NCT03246724|527421661|FG000|Overall Study|Unable to obtain medication timely|0|||
146248330|NCT03246724|527421662|FG001|Overall Study|Unable to obtain medication timely|2|||
146248331|NCT03246724|527421663|FG002|Overall Study|Unable to obtain medication timely|2|||
146248332|NCT03246724|527421664|FG003|Overall Study|Unable to obtain medication timely|1|||
146248333|NCT03246724|527421661|FG000|Overall Study|Re-consented to participate|0|||
146248334|NCT03246724|527421662|FG001|Overall Study|Re-consented to participate|0|||
146248335|NCT03246724|527421663|FG002|Overall Study|Re-consented to participate|0|||
146248336|NCT03246724|527421664|FG003|Overall Study|Re-consented to participate|1|||
146248337|NCT02978716|527421665|FG000|Overall Study|Death|25|||
146298269|NCT04147234|527607880|FG003|Overall Study|Clinical deterioration|0|||
146008457|NCT01152788|526544896|FG000|Overall Study|No treatment|0|||
146248338|NCT02978716|527421666|FG001|Overall Study|Death|13|||
146248339|NCT02978716|527421667|FG002|Overall Study|Death|20|||
146248340|NCT02978716|527421665|FG000|Overall Study|Lost to Follow-up|0|||
146008458|NCT01152788|526544897|FG001|Overall Study|No treatment|1|||
146008459|NCT01282866|526544904|FG000|Overall Study|Adverse Event|1|||
146008460|NCT01541865|526544906|FG000|Overall Study|Lost to Follow-up|11|||
146008461|NCT01541865|526544906|FG000|Overall Study|Withdrawal by Subject|9|||
146008462|NCT01541865|526544906|FG000|Overall Study|Adverse Event|1|||
146008463|NCT01541865|526544906|FG000|Overall Study|Protocol Violation|1|||
146008464|NCT01393899|526544910|FG000|Overall Study|Study terminated by sponsor|1|||
146008465|NCT01393899|526544911|FG001|Overall Study|Study terminated by sponsor|0|||
146008466|NCT01393899|526544912|FG002|Overall Study|Study terminated by sponsor|1|||
146008467|NCT01393899|526544910|FG000|Overall Study|Other|1|||
146008468|NCT01393899|526544911|FG001|Overall Study|Other|0|||
146008469|NCT01393899|526544912|FG002|Overall Study|Other|0|||
146008470|NCT01393899|526544910|FG000|Overall Study|Withdrawal by Subject|2|||
146008471|NCT01393899|526544911|FG001|Overall Study|Withdrawal by Subject|2|||
146008472|NCT01393899|526544912|FG002|Overall Study|Withdrawal by Subject|1|||
146008473|NCT01393899|526544910|FG000|Overall Study|Lost to Follow-up|0|||
146008474|NCT01393899|526544911|FG001|Overall Study|Lost to Follow-up|0|||
146008475|NCT01393899|526544912|FG002|Overall Study|Lost to Follow-up|1|||
146008476|NCT01393899|526544910|FG000|Overall Study|Does not meet entrance criteria|1|||
146008477|NCT01393899|526544911|FG001|Overall Study|Does not meet entrance criteria|0|||
146008478|NCT01393899|526544912|FG002|Overall Study|Does not meet entrance criteria|1|||
146008479|NCT01393899|526544910|FG000|Overall Study|Lack of Efficacy|26|||
146008480|NCT01393899|526544911|FG001|Overall Study|Lack of Efficacy|21|||
146008481|NCT01393899|526544912|FG002|Overall Study|Lack of Efficacy|16|||
146008482|NCT01393899|526544910|FG000|Overall Study|Adverse Event|1|||
146008483|NCT01393899|526544911|FG001|Overall Study|Adverse Event|5|||
146008484|NCT01393899|526544912|FG002|Overall Study|Adverse Event|3|||
146008485|NCT00049257|526544915|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
146008486|NCT00049257|526544915|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
146008487|NCT00049257|526544915|FG000|Carboplatin, Paclitaxel|Death|2|||
146008488|NCT00049257|526544915|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
146008489|NCT04721158|526544916|FG000|Overall Study|Lost to Follow-up|4|||
146008490|NCT04721158|526544916|FG000|Overall Study|Device did not connect|1|||
146008491|NCT00132301|526544917|FG000|Overall Study|Death|7|||
146008492|NCT00132301|526544918|FG001|Overall Study|Death|6|||
146008493|NCT00132301|526544917|FG000|Overall Study|Withdrawal by Subject|5|||
146008494|NCT00132301|526544918|FG001|Overall Study|Withdrawal by Subject|2|||
146008495|NCT00132301|526544917|FG000|Overall Study|Physician Decision|1|||
146008496|NCT00132301|526544918|FG001|Overall Study|Physician Decision|1|||
146008497|NCT00132301|526544917|FG000|Overall Study|Lost to Follow-up|5|||
146008498|NCT00132301|526544918|FG001|Overall Study|Lost to Follow-up|3|||
146008499|NCT00132301|526544917|FG000|Overall Study|Other|1|||
146008500|NCT00132301|526544918|FG001|Overall Study|Other|1|||
146008501|NCT00132301|526544917|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
146008502|NCT00132301|526544918|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
146008503|NCT01890265|526544923|FG000|Overall Study|Other (Unspecified reason)|0|||
146008504|NCT01890265|526544924|FG001|Overall Study|Other (Unspecified reason)|1|||
146008505|NCT01890265|526544925|FG002|Overall Study|Other (Unspecified reason)|0|||
146008506|NCT01890265|526544926|FG003|Overall Study|Other (Unspecified reason)|0|||
146008507|NCT01890265|526544927|FG004|Overall Study|Other (Unspecified reason)|0|||
146008508|NCT01890265|526544928|FG005|Overall Study|Other (Unspecified reason)|0|||
146008509|NCT01890265|526544923|FG000|Overall Study|Progressive disease|6|||
146008510|NCT01890265|526544924|FG001|Overall Study|Progressive disease|6|||
146008511|NCT01890265|526544925|FG002|Overall Study|Progressive disease|0|||
146008512|NCT01890265|526544926|FG003|Overall Study|Progressive disease|0|||
146008513|NCT01890265|526544927|FG004|Overall Study|Progressive disease|0|||
146008514|NCT01890265|526544928|FG005|Overall Study|Progressive disease|0|||
146008515|NCT01890265|526544923|FG000|Overall Study|Adverse Event|2|||
146008516|NCT01890265|526544924|FG001|Overall Study|Adverse Event|1|||
146008517|NCT01890265|526544925|FG002|Overall Study|Adverse Event|0|||
146008518|NCT01890265|526544926|FG003|Overall Study|Adverse Event|0|||
146008519|NCT01890265|526544927|FG004|Overall Study|Adverse Event|0|||
146008520|NCT01890265|526544928|FG005|Overall Study|Adverse Event|0|||
146008521|NCT01890265|526544923|FG000|Overall Study|Death|2|||
146008522|NCT01890265|526544924|FG001|Overall Study|Death|3|||
146008523|NCT01890265|526544925|FG002|Overall Study|Death|1|||
146008524|NCT01890265|526544926|FG003|Overall Study|Death|0|||
146008525|NCT01890265|526544927|FG004|Overall Study|Death|0|||
146008526|NCT01890265|526544928|FG005|Overall Study|Death|0|||
146008527|NCT01890265|526544923|FG000|Overall Study|Withdrawal by Subject|0|||
146008528|NCT01890265|526544924|FG001|Overall Study|Withdrawal by Subject|2|||
146008529|NCT01890265|526544925|FG002|Overall Study|Withdrawal by Subject|3|||
146008530|NCT01890265|526544926|FG003|Overall Study|Withdrawal by Subject|0|||
146008531|NCT01890265|526544927|FG004|Overall Study|Withdrawal by Subject|2|||
146008532|NCT01890265|526544928|FG005|Overall Study|Withdrawal by Subject|0|||
146008533|NCT03462719|526544936|FG000|Overall Study|Withdrawal by Subject|4|||
146008534|NCT03462719|526544937|FG001|Overall Study|Withdrawal by Subject|3|||
146008535|NCT03462719|526544936|FG000|Overall Study|Ongoing|87|||
146008536|NCT03462719|526544937|FG001|Overall Study|Ongoing|72|||
146298270|NCT04147234|527607881|FG004|Overall Study|Clinical deterioration|0|||
146298271|NCT04147234|527607882|FG005|Overall Study|Clinical deterioration|0|||
146298272|NCT04147234|527607883|FG006|Overall Study|Clinical deterioration|0|||
146298273|NCT04147234|527607877|FG000|Overall Study|Withdrawal by Subject|0|||
146298274|NCT04147234|527607878|FG001|Overall Study|Withdrawal by Subject|1|||
146298275|NCT04147234|527607879|FG002|Overall Study|Withdrawal by Subject|1|||
146298276|NCT04147234|527607880|FG003|Overall Study|Withdrawal by Subject|0|||
146298277|NCT04147234|527607881|FG004|Overall Study|Withdrawal by Subject|0|||
146298278|NCT04147234|527607882|FG005|Overall Study|Withdrawal by Subject|0|||
146298279|NCT04147234|527607883|FG006|Overall Study|Withdrawal by Subject|0|||
146298280|NCT04147234|527607877|FG000|Overall Study|Clinical disease progression|1|||
146298281|NCT04147234|527607878|FG001|Overall Study|Clinical disease progression|3|||
146298282|NCT04147234|527607879|FG002|Overall Study|Clinical disease progression|1|||
146298283|NCT04147234|527607880|FG003|Overall Study|Clinical disease progression|1|||
146298284|NCT04147234|527607881|FG004|Overall Study|Clinical disease progression|0|||
146298285|NCT04147234|527607882|FG005|Overall Study|Clinical disease progression|1|||
146298286|NCT04147234|527607883|FG006|Overall Study|Clinical disease progression|0|||
146298287|NCT04147234|527607877|FG000|Overall Study|Objective disease progression|6|||
146298288|NCT04147234|527607878|FG001|Overall Study|Objective disease progression|4|||
146298289|NCT04147234|527607879|FG002|Overall Study|Objective disease progression|3|||
146298290|NCT04147234|527607880|FG003|Overall Study|Objective disease progression|3|||
146298291|NCT04147234|527607881|FG004|Overall Study|Objective disease progression|5|||
146298292|NCT04147234|527607882|FG005|Overall Study|Objective disease progression|2|||
146298293|NCT04147234|527607883|FG006|Overall Study|Objective disease progression|3|||
146298294|NCT04147234|527607877|FG000|Overall Study|Adverse Event|0|||
146298295|NCT04147234|527607878|FG001|Overall Study|Adverse Event|0|||
146298296|NCT04147234|527607879|FG002|Overall Study|Adverse Event|0|||
146298297|NCT04147234|527607880|FG003|Overall Study|Adverse Event|0|||
146298298|NCT04147234|527607881|FG004|Overall Study|Adverse Event|1|||
146298299|NCT04147234|527607882|FG005|Overall Study|Adverse Event|0|||
146298300|NCT04147234|527607883|FG006|Overall Study|Adverse Event|0|||
146298301|NCT01524133|527607888|FG000|Treatment Phase|Withdrawal by Subject|13|||
146298302|NCT01524133|527607889|FG001|Treatment Phase|Withdrawal by Subject|28|||
146298303|NCT01524133|527607890|FG002|Treatment Phase|Withdrawal by Subject|31|||
146298304|NCT01524133|527607888|FG000|Treatment Phase|Physician Decision|6|||
146298305|NCT01524133|527607889|FG001|Treatment Phase|Physician Decision|3|||
146298306|NCT01524133|527607890|FG002|Treatment Phase|Physician Decision|3|||
146298307|NCT01524133|527607888|FG000|Treatment Phase|Lost to Follow-up|0|||
146298308|NCT01524133|527607889|FG001|Treatment Phase|Lost to Follow-up|1|||
146298309|NCT01524133|527607890|FG002|Treatment Phase|Lost to Follow-up|2|||
146298310|NCT01524133|527607888|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
146298311|NCT01524133|527607889|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
146298312|NCT01524133|527607890|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
146298313|NCT01524133|527607888|FG000|Overall Study 52 Weeks|Physician Decision|1|||
146298314|NCT01524133|527607889|FG001|Overall Study 52 Weeks|Physician Decision|0|||
146298315|NCT01524133|527607890|FG002|Overall Study 52 Weeks|Physician Decision|2|||
146298316|NCT01524133|527607888|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
146008537|NCT01402869|526544940|FG000|Overall Study|Required Tooth Extraction|0|||
146008538|NCT01402869|526544941|FG001|Overall Study|Required Tooth Extraction|0|||
146008539|NCT01402869|526544942|FG002|Overall Study|Required Tooth Extraction|1|||
146008540|NCT00100802|526544946|FG000|Overall Study|Adverse Event|9|||
146008541|NCT00100802|526544946|FG000|Overall Study|Death|1|||
146008542|NCT00100802|526544946|FG000|Overall Study|Lack of Efficacy|47|||
146008543|NCT00100802|526544946|FG000|Overall Study|Physician Decision|5|||
146008544|NCT00100802|526544946|FG000|Overall Study|Protocol Violation|1|||
146008545|NCT00100802|526544946|FG000|Overall Study|Withdrawal by Subject|5|||
146008546|NCT00100802|526544946|FG000|Overall Study|Ineligible|12|||
146008547|NCT00325130|526544978|FG000|Overall Study|Lost to Follow-up|6|||
146298317|NCT01524133|527607889|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
146298318|NCT01524133|527607890|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
146298319|NCT05104476|527607891|FG000|Overall Study|Randomized But Not Treated|1|||
146298320|NCT05104476|527607892|FG001|Overall Study|Randomized But Not Treated|2|||
146008548|NCT00325130|526544979|FG001|Overall Study|Lost to Follow-up|14|||
146008549|NCT00325130|526544978|FG000|Overall Study|Withdrawal by Subject|12|||
146008550|NCT00325130|526544979|FG001|Overall Study|Withdrawal by Subject|14|||
146008551|NCT00325130|526544978|FG000|Overall Study|Protocol Deviation|0|||
146008552|NCT00325130|526544979|FG001|Overall Study|Protocol Deviation|1|||
146092530|NCT00237185|526860309|FG000|Extension|Adverse Event|1|||
146298321|NCT05104476|527607891|FG000|Overall Study|Adverse Event|2|||
146298322|NCT05104476|527607892|FG001|Overall Study|Adverse Event|2|||
146298323|NCT05104476|527607891|FG000|Overall Study|Withdrawal by Subject|3|||
146298324|NCT05104476|527607892|FG001|Overall Study|Withdrawal by Subject|3|||
146298325|NCT05104476|527607891|FG000|Overall Study|Other Than Specified|0|||
146298326|NCT05104476|527607892|FG001|Overall Study|Other Than Specified|3|||
146298327|NCT04606771|527607893|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
146008553|NCT00325130|526544978|FG000|Overall Study|Moved|0|||
146008554|NCT00325130|526544979|FG001|Overall Study|Moved|1|||
146008555|NCT00325130|526544978|FG000|Overall Study|Patient Discontinued for Other|1|||
146008556|NCT00325130|526544979|FG001|Overall Study|Patient Discontinued for Other|0|||
146008557|NCT00928187|526544981|FG000|Overall Study|Death|1|||
146008558|NCT00928187|526544982|FG001|Overall Study|Death|2|||
146008559|NCT00928187|526544983|FG002|Overall Study|Death|3|||
146008560|NCT00928187|526544981|FG000|Overall Study|Lost to Follow-up|1|||
146008561|NCT00928187|526544982|FG001|Overall Study|Lost to Follow-up|2|||
146008562|NCT00928187|526544983|FG002|Overall Study|Lost to Follow-up|1|||
146008563|NCT00928187|526544981|FG000|Overall Study|Withdrawal by Subject|0|||
146008564|NCT00928187|526544982|FG001|Overall Study|Withdrawal by Subject|1|||
146008565|NCT00928187|526544983|FG002|Overall Study|Withdrawal by Subject|1|||
146008566|NCT00928187|526544981|FG000|Overall Study|Protocol Violation|0|||
146008567|NCT00928187|526544982|FG001|Overall Study|Protocol Violation|1|||
146008568|NCT00928187|526544983|FG002|Overall Study|Protocol Violation|0|||
146008569|NCT02524145|526544987|FG000|Overall Study|Withdrawal by Subject|2|||
146008570|NCT02524145|526544988|FG001|Overall Study|Withdrawal by Subject|2|||
146008571|NCT02524145|526544989|FG002|Overall Study|Withdrawal by Subject|3|||
146008572|NCT01142388|526546201|FG000|Overall Study|Lack of Efficacy|21|||
146008573|NCT01142388|526546202|FG001|Overall Study|Lack of Efficacy|31|||
146008574|NCT01142388|526546201|FG000|Overall Study|Adverse Event|9|||
146008575|NCT01142388|526546202|FG001|Overall Study|Adverse Event|5|||
146008576|NCT01142388|526546201|FG000|Overall Study|Death|3|||
146008577|NCT01142388|526546202|FG001|Overall Study|Death|2|||
146008578|NCT01142388|526546201|FG000|Overall Study|Withdrawal by Subject|5|||
146008579|NCT01142388|526546202|FG001|Overall Study|Withdrawal by Subject|3|||
146008580|NCT01142388|526546201|FG000|Overall Study|Alternative therapy|1|||
146008581|NCT01142388|526546202|FG001|Overall Study|Alternative therapy|0|||
146008582|NCT01142388|526546201|FG000|Overall Study|Other complications|0|||
146008583|NCT01142388|526546202|FG001|Overall Study|Other complications|2|||
146008584|NCT01142388|526546201|FG000|Overall Study|Other|1|||
146008585|NCT01142388|526546202|FG001|Overall Study|Other|1|||
146008586|NCT01142388|526546201|FG000|Overall Study|Never started therapy|7|||
146008587|NCT01142388|526546202|FG001|Overall Study|Never started therapy|3|||
146008588|NCT05730725|526546205|FG000|Overall Study|Withdrawal by Subject|3|||
146008589|NCT05730725|526546206|FG001|Overall Study|Withdrawal by Subject|0|||
146008590|NCT05730725|526546207|FG002|Overall Study|Withdrawal by Subject|0|||
146008591|NCT05730725|526546208|FG003|Overall Study|Withdrawal by Subject|1|||
146008592|NCT05730725|526546205|FG000|Overall Study|Not Reported|1|||
146008593|NCT05730725|526546206|FG001|Overall Study|Not Reported|1|||
146008594|NCT05730725|526546207|FG002|Overall Study|Not Reported|1|||
146008595|NCT05730725|526546208|FG003|Overall Study|Not Reported|1|||
146008596|NCT05265728|526546209|FG000|Overall Study|Adverse Event|1|||
146008597|NCT05265728|526546209|FG000|Overall Study|Study Terminated by Sponsor|5|||
146008598|NCT05265728|526546209|FG000|Overall Study|Withdrawal by Subject|2|||
146008599|NCT03687957|526546210|FG000|Overall Study|Withdrawal by Subject|0|||
146008600|NCT03687957|526546211|FG001|Overall Study|Withdrawal by Subject|0|||
146008601|NCT03687957|526546212|FG002|Overall Study|Withdrawal by Subject|0|||
146008602|NCT03687957|526546213|FG003|Overall Study|Withdrawal by Subject|2|||
146008603|NCT03687957|526546214|FG004|Overall Study|Withdrawal by Subject|0|||
146008604|NCT03687957|526546215|FG005|Overall Study|Withdrawal by Subject|0|||
146008605|NCT03687957|526546216|FG006|Overall Study|Withdrawal by Subject|3|||
146008606|NCT03687957|526546217|FG007|Overall Study|Withdrawal by Subject|1|||
146008607|NCT03687957|526546218|FG008|Overall Study|Withdrawal by Subject|1|||
146008608|NCT03687957|526546219|FG009|Overall Study|Withdrawal by Subject|0|||
146008609|NCT03687957|526546210|FG000|Overall Study|Disease progression|0|||
146008610|NCT03687957|526546211|FG001|Overall Study|Disease progression|1|||
146008611|NCT03687957|526546212|FG002|Overall Study|Disease progression|1|||
146008612|NCT03687957|526546213|FG003|Overall Study|Disease progression|2|||
146008613|NCT03687957|526546214|FG004|Overall Study|Disease progression|2|||
146008614|NCT03687957|526546215|FG005|Overall Study|Disease progression|0|||
146008615|NCT03687957|526546216|FG006|Overall Study|Disease progression|2|||
146008616|NCT03687957|526546217|FG007|Overall Study|Disease progression|1|||
146008617|NCT03687957|526546218|FG008|Overall Study|Disease progression|0|||
146008618|NCT03687957|526546219|FG009|Overall Study|Disease progression|0|||
146008619|NCT03687957|526546210|FG000|Overall Study|Physician Decision|0|||
146008620|NCT03687957|526546211|FG001|Overall Study|Physician Decision|0|||
146008621|NCT03687957|526546212|FG002|Overall Study|Physician Decision|0|||
146008622|NCT03687957|526546213|FG003|Overall Study|Physician Decision|2|||
146008623|NCT03687957|526546214|FG004|Overall Study|Physician Decision|1|||
146008624|NCT03687957|526546215|FG005|Overall Study|Physician Decision|0|||
146008625|NCT03687957|526546216|FG006|Overall Study|Physician Decision|1|||
146008626|NCT03687957|526546217|FG007|Overall Study|Physician Decision|0|||
146008627|NCT03687957|526546218|FG008|Overall Study|Physician Decision|0|||
146008628|NCT03687957|526546219|FG009|Overall Study|Physician Decision|0|||
146008629|NCT03687957|526546210|FG000|Overall Study|New malignancy|0|||
146008630|NCT03687957|526546211|FG001|Overall Study|New malignancy|0|||
146008631|NCT03687957|526546212|FG002|Overall Study|New malignancy|0|||
146008632|NCT03687957|526546213|FG003|Overall Study|New malignancy|0|||
146092531|NCT00237185|526860310|FG001|Extension|Adverse Event|0|||
146092532|NCT00237185|526860309|FG000|Extension|Abnormal laboratory value|0|||
146092533|NCT00237185|526860310|FG001|Extension|Abnormal laboratory value|1|||
146092534|NCT00237185|526860309|FG000|Extension|Lack of Efficacy|9|||
146092535|NCT00237185|526860310|FG001|Extension|Lack of Efficacy|14|||
146092536|NCT00237185|526860309|FG000|Extension|Condition no longer required study drug|0|||
146092537|NCT00237185|526860310|FG001|Extension|Condition no longer required study drug|1|||
146092538|NCT00237185|526860309|FG000|Extension|Withdrawal by Subject|3|||
146092539|NCT00237185|526860310|FG001|Extension|Withdrawal by Subject|2|||
146092540|NCT00237185|526860309|FG000|Extension|Lost to Follow-up|1|||
146092541|NCT00237185|526860310|FG001|Extension|Lost to Follow-up|0|||
146092542|NCT00237185|526860309|FG000|Extension|Administrative problems|1|||
146092543|NCT00237185|526860310|FG001|Extension|Administrative problems|0|||
146092544|NCT00237185|526860309|FG000|Extension|Death|1|||
146092545|NCT00237185|526860310|FG001|Extension|Death|1|||
146092546|NCT02204007|526860311|FG000|Overall Study|Surgery Canceled|1|||
146092547|NCT02204007|526860312|FG001|Overall Study|Surgery Canceled|1|||
146092548|NCT05211284|526860316|FG000|Overall Study|Study Terminated|3|||
146092549|NCT05211284|526860317|FG001|Overall Study|Study Terminated|1|||
146092550|NCT03911843|526860322|FG000|Overall Study|Adverse Event|2|||
146092551|NCT03911843|526860323|FG001|Overall Study|Adverse Event|0|||
146092552|NCT03911843|526860322|FG000|Overall Study|Protocol Violation|2|||
146092553|NCT03911843|526860323|FG001|Overall Study|Protocol Violation|0|||
146092554|NCT03911843|526860322|FG000|Overall Study|Lost to Follow-up|0|||
146092555|NCT03911843|526860323|FG001|Overall Study|Lost to Follow-up|1|||
146092556|NCT02819518|526860324|FG000|Overall Study|Death|9|||
146092557|NCT02819518|526860325|FG001|Overall Study|Death|12|||
146092558|NCT02819518|526860326|FG002|Overall Study|Death|9|||
146092559|NCT02819518|526860327|FG003|Overall Study|Death|475|||
146092560|NCT02819518|526860328|FG004|Overall Study|Death|244|||
146092561|NCT02819518|526860324|FG000|Overall Study|Withdrawal by Subject|0|||
146092562|NCT02819518|526860325|FG001|Overall Study|Withdrawal by Subject|0|||
146092563|NCT02819518|526860326|FG002|Overall Study|Withdrawal by Subject|0|||
146092564|NCT02819518|526860327|FG003|Overall Study|Withdrawal by Subject|25|||
146248341|NCT02978716|527421666|FG001|Overall Study|Lost to Follow-up|0|||
146248342|NCT02978716|527421667|FG002|Overall Study|Lost to Follow-up|1|||
146248343|NCT02978716|527421665|FG000|Overall Study|Withdrawal by Subject|6|||
146248344|NCT02978716|527421666|FG001|Overall Study|Withdrawal by Subject|4|||
146248345|NCT02978716|527421667|FG002|Overall Study|Withdrawal by Subject|5|||
146008633|NCT03687957|526546214|FG004|Overall Study|New malignancy|1|||
146008634|NCT03687957|526546215|FG005|Overall Study|New malignancy|0|||
146008635|NCT03687957|526546216|FG006|Overall Study|New malignancy|0|||
146008636|NCT03687957|526546217|FG007|Overall Study|New malignancy|0|||
146008637|NCT03687957|526546218|FG008|Overall Study|New malignancy|0|||
146008638|NCT03687957|526546219|FG009|Overall Study|New malignancy|0|||
146008639|NCT03687957|526546210|FG000|Overall Study|Adverse Event|0|||
146008640|NCT03687957|526546211|FG001|Overall Study|Adverse Event|0|||
146008641|NCT03687957|526546212|FG002|Overall Study|Adverse Event|0|||
146008642|NCT03687957|526546213|FG003|Overall Study|Adverse Event|0|||
146008643|NCT03687957|526546214|FG004|Overall Study|Adverse Event|0|||
146008644|NCT03687957|526546215|FG005|Overall Study|Adverse Event|2|||
146008645|NCT03687957|526546216|FG006|Overall Study|Adverse Event|0|||
146008646|NCT03687957|526546217|FG007|Overall Study|Adverse Event|3|||
146008647|NCT03687957|526546218|FG008|Overall Study|Adverse Event|0|||
146248346|NCT02978716|527421665|FG000|Overall Study|Sponsor terminated|2|||
146248347|NCT02978716|527421666|FG001|Overall Study|Sponsor terminated|13|||
146248348|NCT02978716|527421667|FG002|Overall Study|Sponsor terminated|9|||
146248349|NCT02978716|527421665|FG000|Overall Study|Other|1|||
146008648|NCT03687957|526546219|FG009|Overall Study|Adverse Event|0|||
146248350|NCT02978716|527421666|FG001|Overall Study|Other|3|||
146248351|NCT02978716|527421667|FG002|Overall Study|Other|0|||
146248352|NCT00589628|527421668|FG000|Overall Study|Lost to Follow-up|0|||
146248353|NCT00589628|527421669|FG001|Overall Study|Lost to Follow-up|1|||
146092565|NCT02819518|526860328|FG004|Overall Study|Withdrawal by Subject|8|||
146248354|NCT00689351|527421673|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
146248355|NCT00689351|527421674|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
146092566|NCT02819518|526860324|FG000|Overall Study|Lost to Follow-up|0|||
146092567|NCT02819518|526860325|FG001|Overall Study|Lost to Follow-up|0|||
146092568|NCT02819518|526860326|FG002|Overall Study|Lost to Follow-up|0|||
146092569|NCT02819518|526860327|FG003|Overall Study|Lost to Follow-up|0|||
146092570|NCT02819518|526860328|FG004|Overall Study|Lost to Follow-up|1|||
146092571|NCT02819518|526860324|FG000|Overall Study|Sponsor Decision|1|||
146092572|NCT02819518|526860325|FG001|Overall Study|Sponsor Decision|1|||
146248356|NCT00689351|527421673|FG000|Infant Series of Dosing|Adverse Event|1|||
146248357|NCT00689351|527421674|FG001|Infant Series of Dosing|Adverse Event|0|||
146008649|NCT03687957|526546210|FG000|Overall Study|Patient went on hospice|0|||
146008650|NCT03687957|526546211|FG001|Overall Study|Patient went on hospice|0|||
146008651|NCT03687957|526546212|FG002|Overall Study|Patient went on hospice|0|||
146008652|NCT03687957|526546213|FG003|Overall Study|Patient went on hospice|0|||
146092573|NCT02819518|526860326|FG002|Overall Study|Sponsor Decision|0|||
146248358|NCT00689351|527421673|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
146248359|NCT00689351|527421674|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
146248360|NCT00689351|527421673|FG000|After Infant Series|Parent/legal guardian request|1|||
146248361|NCT00689351|527421674|FG001|After Infant Series|Parent/legal guardian request|0|||
146248362|NCT03075878|527421675|FG000|Overall Study|Physician Decision|1|||
146248363|NCT01986348|527421676|FG000|Overall Study|Death|8|||
146248364|NCT01986348|527421677|FG001|Overall Study|Death|22|||
146248365|NCT01986348|527421678|FG002|Overall Study|Death|10|||
146248366|NCT01986348|527421679|FG003|Overall Study|Death|21|||
146248367|NCT01986348|527421676|FG000|Overall Study|Lost to Follow-up|0|||
146248368|NCT01986348|527421677|FG001|Overall Study|Lost to Follow-up|0|||
146248369|NCT01986348|527421678|FG002|Overall Study|Lost to Follow-up|0|||
146248370|NCT01986348|527421679|FG003|Overall Study|Lost to Follow-up|2|||
146248371|NCT01986348|527421676|FG000|Overall Study|Physician Decision|0|||
146248372|NCT01986348|527421677|FG001|Overall Study|Physician Decision|0|||
146248373|NCT01986348|527421678|FG002|Overall Study|Physician Decision|0|||
146248374|NCT01986348|527421679|FG003|Overall Study|Physician Decision|1|||
146248375|NCT01986348|527421676|FG000|Overall Study|Progressive Disease|0|||
146248376|NCT01986348|527421677|FG001|Overall Study|Progressive Disease|0|||
146248377|NCT01986348|527421678|FG002|Overall Study|Progressive Disease|2|||
146248378|NCT01986348|527421679|FG003|Overall Study|Progressive Disease|0|||
146248379|NCT01986348|527421676|FG000|Overall Study|Withdrawal by Participant|0|||
146248380|NCT01986348|527421677|FG001|Overall Study|Withdrawal by Participant|1|||
146248381|NCT01986348|527421678|FG002|Overall Study|Withdrawal by Participant|2|||
146248382|NCT01986348|527421679|FG003|Overall Study|Withdrawal by Participant|1|||
146248383|NCT01986348|527421676|FG000|Overall Study|Study Terminated by Sponsor|0|||
146248384|NCT01986348|527421677|FG001|Overall Study|Study Terminated by Sponsor|0|||
146248385|NCT01986348|527421678|FG002|Overall Study|Study Terminated by Sponsor|0|||
146248386|NCT01986348|527421679|FG003|Overall Study|Study Terminated by Sponsor|3|||
146248387|NCT01986348|527421676|FG000|Overall Study|Other-unspecified|0|||
146248388|NCT01986348|527421677|FG001|Overall Study|Other-unspecified|1|||
146248389|NCT01986348|527421678|FG002|Overall Study|Other-unspecified|0|||
146248390|NCT01986348|527421679|FG003|Overall Study|Other-unspecified|2|||
146248391|NCT02158806|527421680|FG000|Overall Study|Death|2|||
146248392|NCT02158806|527421681|FG001|Overall Study|Death|0|||
146248393|NCT02158806|527421680|FG000|Overall Study|Withdrawal by Subject|2|||
146248394|NCT02158806|527421681|FG001|Overall Study|Withdrawal by Subject|0|||
146248395|NCT02158806|527421680|FG000|Overall Study|Lost to Follow-up|0|||
146248396|NCT02158806|527421681|FG001|Overall Study|Lost to Follow-up|3|||
146248397|NCT02158806|527421680|FG000|Overall Study|Moved out of area|0|||
146248398|NCT02158806|527421681|FG001|Overall Study|Moved out of area|1|||
146248399|NCT02158806|527421680|FG000|Overall Study|Transferred to palliative care|0|||
146248400|NCT02158806|527421681|FG001|Overall Study|Transferred to palliative care|1|||
146248401|NCT01898299|527421682|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
146248402|NCT01898299|527421683|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
146248403|NCT00760877|527423486|FG000|Overall Study|Protocol Violation|1|||
146248404|NCT00760877|527423487|FG001|Overall Study|Protocol Violation|0|||
146248405|NCT00760877|527423486|FG000|Overall Study|Non-compliance with protocol treatment|2|||
146248406|NCT00760877|527423487|FG001|Overall Study|Non-compliance with protocol treatment|1|||
146248407|NCT00760877|527423486|FG000|Overall Study|Pregnancy|1|||
146248408|NCT00760877|527423487|FG001|Overall Study|Pregnancy|4|||
146248409|NCT00760877|527423486|FG000|Overall Study|Death|2|||
146248410|NCT00760877|527423487|FG001|Overall Study|Death|1|||
146248411|NCT00760877|527423486|FG000|Overall Study|Withdrawal by Subject|7|||
146008653|NCT03687957|526546214|FG004|Overall Study|Patient went on hospice|0|||
146008654|NCT03687957|526546215|FG005|Overall Study|Patient went on hospice|0|||
146008655|NCT03687957|526546216|FG006|Overall Study|Patient went on hospice|1|||
146008656|NCT03687957|526546217|FG007|Overall Study|Patient went on hospice|0|||
146248412|NCT00760877|527423487|FG001|Overall Study|Withdrawal by Subject|3|||
146248413|NCT00760877|527423486|FG000|Overall Study|Adverse Event|19|||
146248414|NCT00760877|527423487|FG001|Overall Study|Adverse Event|12|||
146248415|NCT00760877|527423486|FG000|Overall Study|Participant diagnosed with AML|0|||
146248416|NCT00760877|527423487|FG001|Overall Study|Participant diagnosed with AML|1|||
146248417|NCT00760877|527423486|FG000|Overall Study|Participant not eligible to cross-over|0|||
146248418|NCT00760877|527423487|FG001|Overall Study|Participant not eligible to cross-over|1|||
146248419|NCT00760877|527423486|FG000|Overall Study|Physician Decision|1|||
146248420|NCT00760877|527423487|FG001|Overall Study|Physician Decision|2|||
146248421|NCT00760877|527423486|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
146248422|NCT00760877|527423487|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
146248423|NCT00760877|527423486|FG000|Overall Study|Treatment failure|1|||
146248424|NCT00760877|527423487|FG001|Overall Study|Treatment failure|0|||
146248425|NCT00711555|527423490|FG000|Overall Study|Adverse Event|3|||
146248426|NCT04820023|527423497|FG000|Overall Study|Death|0|||
146248427|NCT04820023|527423498|FG001|Overall Study|Death|0|||
146248428|NCT04820023|527423499|FG002|Overall Study|Death|0|||
146298328|NCT04606771|527607894|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
146248429|NCT04820023|527423500|FG003|Overall Study|Death|0|||
146248430|NCT04820023|527423501|FG004|Overall Study|Death|0|||
146008657|NCT03687957|526546218|FG008|Overall Study|Patient went on hospice|0|||
146008658|NCT03687957|526546219|FG009|Overall Study|Patient went on hospice|0|||
146008659|NCT03687957|526546210|FG000|Overall Study|Death|0|||
146298329|NCT04606771|527607893|FG000|Overall Study|Death|5|||
146298330|NCT04606771|527607894|FG001|Overall Study|Death|6|||
146298331|NCT04606771|527607893|FG000|Overall Study|Wrong randomisation|0|||
146298332|NCT04606771|527607894|FG001|Overall Study|Wrong randomisation|1|||
146298333|NCT01423812|527607898|FG000|Overall Study|Lost to Follow-up|2|||
146298334|NCT01423812|527607899|FG001|Overall Study|Lost to Follow-up|2|||
146298335|NCT01423812|527607898|FG000|Overall Study|Withdrawal by Subject|1|||
146298336|NCT01423812|527607899|FG001|Overall Study|Withdrawal by Subject|2|||
146298337|NCT03155373|527607900|FG000|Overall Study|No longer required surgery|1|||
146298338|NCT03155373|527607900|FG000|Overall Study|Protocol Violation|1|||
146298339|NCT03155373|527607900|FG000|Overall Study|Death|2|||
146298340|NCT03155373|527607900|FG000|Overall Study|Withdrawal by Subject|3|||
146298341|NCT01214187|527607901|FG000|Overall Study|Adverse Event|6|||
146298342|NCT01214187|527607902|FG001|Overall Study|Adverse Event|2|||
146298343|NCT01214187|527607901|FG000|Overall Study|Death|1|||
146298344|NCT01214187|527607902|FG001|Overall Study|Death|1|||
146298345|NCT01214187|527607901|FG000|Overall Study|Withdrawal by Subject|0|||
146298346|NCT01214187|527607902|FG001|Overall Study|Withdrawal by Subject|3|||
146298347|NCT01233869|527607903|FG000|Initial Treatment Period (24 Months)|Death|1|||
146298348|NCT01233869|527607904|FG001|Initial Treatment Period (24 Months)|Death|0|||
146008660|NCT03687957|526546211|FG001|Overall Study|Death|0|||
146008661|NCT03687957|526546212|FG002|Overall Study|Death|0|||
146008662|NCT03687957|526546213|FG003|Overall Study|Death|0|||
146008663|NCT03687957|526546214|FG004|Overall Study|Death|0|||
146008664|NCT03687957|526546215|FG005|Overall Study|Death|0|||
146008665|NCT03687957|526546216|FG006|Overall Study|Death|0|||
146008666|NCT03687957|526546217|FG007|Overall Study|Death|1|||
146008667|NCT03687957|526546218|FG008|Overall Study|Death|0|||
146248431|NCT04820023|527423502|FG005|Overall Study|Death|0|||
146248432|NCT04820023|527423503|FG006|Overall Study|Death|1|||
146248433|NCT04820023|527423504|FG007|Overall Study|Death|0|||
146248434|NCT04820023|527423505|FG008|Overall Study|Death|1|||
146248435|NCT04820023|527423497|FG000|Overall Study|Withdrawal by Subject|1|||
146248436|NCT04820023|527423498|FG001|Overall Study|Withdrawal by Subject|2|||
146248437|NCT04820023|527423499|FG002|Overall Study|Withdrawal by Subject|2|||
146248438|NCT04820023|527423500|FG003|Overall Study|Withdrawal by Subject|1|||
146248439|NCT04820023|527423501|FG004|Overall Study|Withdrawal by Subject|4|||
146248440|NCT04820023|527423502|FG005|Overall Study|Withdrawal by Subject|3|||
146248441|NCT04820023|527423503|FG006|Overall Study|Withdrawal by Subject|3|||
146248442|NCT04820023|527423504|FG007|Overall Study|Withdrawal by Subject|6|||
146248443|NCT04820023|527423505|FG008|Overall Study|Withdrawal by Subject|5|||
146248444|NCT04820023|527423497|FG000|Overall Study|Progressive Disease|3|||
146248445|NCT04820023|527423498|FG001|Overall Study|Progressive Disease|0|||
146248446|NCT04820023|527423499|FG002|Overall Study|Progressive Disease|2|||
146248447|NCT04820023|527423500|FG003|Overall Study|Progressive Disease|2|||
146248448|NCT04820023|527423501|FG004|Overall Study|Progressive Disease|2|||
146248449|NCT04820023|527423502|FG005|Overall Study|Progressive Disease|0|||
146248450|NCT04820023|527423503|FG006|Overall Study|Progressive Disease|1|||
146248451|NCT04820023|527423504|FG007|Overall Study|Progressive Disease|1|||
146248452|NCT04820023|527423505|FG008|Overall Study|Progressive Disease|0|||
146248453|NCT04820023|527423497|FG000|Overall Study|New anti-cancer therapy|0|||
146248454|NCT04820023|527423498|FG001|Overall Study|New anti-cancer therapy|0|||
146248455|NCT04820023|527423499|FG002|Overall Study|New anti-cancer therapy|0|||
146248456|NCT04820023|527423500|FG003|Overall Study|New anti-cancer therapy|0|||
146248457|NCT04820023|527423501|FG004|Overall Study|New anti-cancer therapy|2|||
146248458|NCT04820023|527423502|FG005|Overall Study|New anti-cancer therapy|0|||
146248459|NCT04820023|527423503|FG006|Overall Study|New anti-cancer therapy|0|||
146248460|NCT04820023|527423504|FG007|Overall Study|New anti-cancer therapy|0|||
146298349|NCT01233869|527607905|FG002|Initial Treatment Period (24 Months)|Death|0|||
146298350|NCT01233869|527607906|FG003|Initial Treatment Period (24 Months)|Death|0|||
146008668|NCT03687957|526546219|FG009|Overall Study|Death|0|||
146008669|NCT03584152|526546222|FG000|Overall Study|Discontinued intervention|7|||
146008670|NCT03584152|526546223|FG001|Overall Study|Discontinued intervention|4|||
146008671|NCT03052608|526546225|FG000|Treatment Phase|Adverse Event|10|||
146248461|NCT04820023|527423505|FG008|Overall Study|New anti-cancer therapy|0|||
146248462|NCT04820023|527423497|FG000|Overall Study|Other|0|||
146248463|NCT04820023|527423498|FG001|Overall Study|Other|1|||
146248464|NCT04820023|527423499|FG002|Overall Study|Other|0|||
146248465|NCT04820023|527423500|FG003|Overall Study|Other|0|||
146008672|NCT03052608|526546226|FG001|Treatment Phase|Adverse Event|12|||
146248466|NCT04820023|527423501|FG004|Overall Study|Other|0|||
146248467|NCT04820023|527423502|FG005|Overall Study|Other|0|||
146248468|NCT04820023|527423503|FG006|Overall Study|Other|0|||
146248469|NCT04820023|527423504|FG007|Overall Study|Other|2|||
146298351|NCT01233869|527607903|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
146298352|NCT01233869|527607904|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
146298353|NCT01233869|527607905|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
146298354|NCT01233869|527607906|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
146298355|NCT01233869|527607903|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
146298356|NCT01233869|527607904|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
146298357|NCT01233869|527607905|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
146298358|NCT01233869|527607906|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
146298359|NCT01233869|527607903|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146298360|NCT01233869|527607904|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146298361|NCT01233869|527607905|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
146298362|NCT01233869|527607906|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
146298363|NCT01233869|527607903|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
146298364|NCT01233869|527607904|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
146298365|NCT01233869|527607905|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
146298366|NCT01233869|527607906|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
146008673|NCT03052608|526546225|FG000|Treatment Phase|Death|6|||
146298367|NCT01233869|527607903|FG000|Extended Treatment Period (46 Months)|Other|3|||
146298368|NCT01233869|527607904|FG001|Extended Treatment Period (46 Months)|Other|0|||
146298369|NCT01233869|527607905|FG002|Extended Treatment Period (46 Months)|Other|0|||
146298370|NCT01233869|527607906|FG003|Extended Treatment Period (46 Months)|Other|3|||
146298371|NCT01233869|527607903|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
146298372|NCT01233869|527607904|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
146298373|NCT01233869|527607905|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
146298374|NCT01233869|527607906|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
146298375|NCT04464265|527607908|FG000|Overall Study|Physician Decision|2|||
146298376|NCT01438151|527607912|FG000|Overall Study|study terminated|8|||
146298377|NCT02459769|527607916|FG000|Overall Study|Withdrawal by Subject|7|||
146298378|NCT02459769|527607917|FG001|Overall Study|Withdrawal by Subject|4|||
146298379|NCT02459769|527607918|FG002|Overall Study|Withdrawal by Subject|8|||
146298380|NCT02459769|527607919|FG003|Overall Study|Withdrawal by Subject|5|||
146298381|NCT02459769|527607916|FG000|Overall Study|Lost to Follow-up|1|||
146298382|NCT02459769|527607917|FG001|Overall Study|Lost to Follow-up|0|||
146298383|NCT02459769|527607918|FG002|Overall Study|Lost to Follow-up|1|||
146298384|NCT02459769|527607919|FG003|Overall Study|Lost to Follow-up|0|||
146298385|NCT02378220|527607920|FG000|Overall Study|Death|6|||
146298386|NCT02378220|527607921|FG001|Overall Study|Death|1|||
146298387|NCT00312221|527607922|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
146298388|NCT00312221|527607923|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
146298389|NCT00312221|527607924|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
146298390|NCT00312221|527607925|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
146298391|NCT00312221|527607922|FG000|Open-label Run-in Period|Adverse Event|74|||
146298392|NCT00312221|527607923|FG001|Open-label Run-in Period|Adverse Event|0|||
146298393|NCT00312221|527607924|FG002|Open-label Run-in Period|Adverse Event|0|||
146298394|NCT00312221|527607925|FG003|Open-label Run-in Period|Adverse Event|0|||
146298395|NCT00312221|527607922|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
146298396|NCT00312221|527607923|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
146298397|NCT00312221|527607924|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
146298398|NCT00312221|527607925|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
146298399|NCT00312221|527607922|FG000|Open-label Run-in Period|Administrative|42|||
146298400|NCT00312221|527607923|FG001|Open-label Run-in Period|Administrative|0|||
146298401|NCT00312221|527607924|FG002|Open-label Run-in Period|Administrative|0|||
146298402|NCT00312221|527607925|FG003|Open-label Run-in Period|Administrative|0|||
146298403|NCT00312221|527607922|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
146298404|NCT00312221|527607923|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
146298405|NCT00312221|527607924|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
146298406|NCT00312221|527607925|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
146298407|NCT00312221|527607922|FG000|Open-label Run-in Period|Did not qualify|5|||
146298408|NCT00312221|527607923|FG001|Open-label Run-in Period|Did not qualify|0|||
146298409|NCT00312221|527607924|FG002|Open-label Run-in Period|Did not qualify|0|||
146298410|NCT00312221|527607925|FG003|Open-label Run-in Period|Did not qualify|0|||
146298411|NCT00312221|527607922|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146298412|NCT00312221|527607923|FG001|Double-blind Phase|Withdrawal by Subject|6|||
146008674|NCT03052608|526546226|FG001|Treatment Phase|Death|4|||
146008675|NCT03052608|526546225|FG000|Treatment Phase|Withdrawal by Subject|4|||
146008676|NCT03052608|526546226|FG001|Treatment Phase|Withdrawal by Subject|12|||
146008677|NCT03052608|526546225|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
146008678|NCT03052608|526546226|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
146008679|NCT03052608|526546225|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
146298413|NCT00312221|527607924|FG002|Double-blind Phase|Withdrawal by Subject|8|||
146298414|NCT00312221|527607925|FG003|Double-blind Phase|Withdrawal by Subject|7|||
146298415|NCT00312221|527607922|FG000|Double-blind Phase|Adverse Event|0|||
146298416|NCT00312221|527607923|FG001|Double-blind Phase|Adverse Event|10|||
146298417|NCT00312221|527607924|FG002|Double-blind Phase|Adverse Event|19|||
146298418|NCT00312221|527607925|FG003|Double-blind Phase|Adverse Event|18|||
146092574|NCT02819518|526860327|FG003|Overall Study|Sponsor Decision|34|||
146092575|NCT02819518|526860328|FG004|Overall Study|Sponsor Decision|17|||
146092576|NCT02819518|526860324|FG000|Overall Study|Transferred to extension study|1|||
146092577|NCT02819518|526860325|FG001|Overall Study|Transferred to extension study|1|||
146092578|NCT02819518|526860326|FG002|Overall Study|Transferred to extension study|1|||
146092579|NCT02819518|526860327|FG003|Overall Study|Transferred to extension study|32|||
146092580|NCT02819518|526860328|FG004|Overall Study|Transferred to extension study|11|||
146092581|NCT00880165|526860329|FG000|Overall Study|Withdrawal by Subject|27|||
146092582|NCT00880165|526860330|FG001|Overall Study|Withdrawal by Subject|23|||
146092583|NCT00880165|526860329|FG000|Overall Study|Not diagnosed with OSA|14|||
146092584|NCT00880165|526860330|FG001|Overall Study|Not diagnosed with OSA|8|||
146092585|NCT00880165|526860329|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
146092586|NCT00880165|526860330|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
146092587|NCT00880165|526860329|FG000|Overall Study|Lost to follow|9|||
146092588|NCT00880165|526860330|FG001|Overall Study|Lost to follow|15|||
146092589|NCT01907100|526860331|FG000|Overall Study|PD based on modified RECIST criteria|31|||
146092590|NCT01907100|526860332|FG001|Overall Study|PD based on modified RECIST criteria|32|||
146092591|NCT01907100|526860333|FG002|Overall Study|PD based on modified RECIST criteria|95|||
146092592|NCT01907100|526860334|FG003|Overall Study|PD based on modified RECIST criteria|92|||
146092593|NCT01907100|526860331|FG000|Overall Study|Withdrawal by Subject|2|||
146092594|NCT01907100|526860332|FG001|Overall Study|Withdrawal by Subject|5|||
146092595|NCT01907100|526860333|FG002|Overall Study|Withdrawal by Subject|10|||
146092596|NCT01907100|526860334|FG003|Overall Study|Withdrawal by Subject|13|||
146092597|NCT01907100|526860331|FG000|Overall Study|Protocol Violation|0|||
146092598|NCT01907100|526860332|FG001|Overall Study|Protocol Violation|0|||
146092599|NCT01907100|526860333|FG002|Overall Study|Protocol Violation|1|||
146092600|NCT01907100|526860334|FG003|Overall Study|Protocol Violation|1|||
146092601|NCT01907100|526860331|FG000|Overall Study|Lost to Follow-up|0|||
146092602|NCT01907100|526860332|FG001|Overall Study|Lost to Follow-up|0|||
146092603|NCT01907100|526860333|FG002|Overall Study|Lost to Follow-up|0|||
146092604|NCT01907100|526860334|FG003|Overall Study|Lost to Follow-up|1|||
146092605|NCT01907100|526860331|FG000|Overall Study|Not treated|2|||
146092606|NCT01907100|526860332|FG001|Overall Study|Not treated|0|||
146092607|NCT01907100|526860333|FG002|Overall Study|Not treated|1|||
146092608|NCT01907100|526860334|FG003|Overall Study|Not treated|2|||
146092609|NCT01907100|526860331|FG000|Overall Study|Other than reasons specified|1|||
146092610|NCT01907100|526860332|FG001|Overall Study|Other than reasons specified|0|||
146092611|NCT01907100|526860333|FG002|Overall Study|Other than reasons specified|10|||
146092612|NCT01907100|526860334|FG003|Overall Study|Other than reasons specified|6|||
146092613|NCT01907100|526860331|FG000|Overall Study|Adverse event (AE)|6|||
146092614|NCT01907100|526860332|FG001|Overall Study|Adverse event (AE)|3|||
146092615|NCT01907100|526860333|FG002|Overall Study|Adverse event (AE)|22|||
146092616|NCT01907100|526860334|FG003|Overall Study|Adverse event (AE)|23|||
146092617|NCT01907100|526860331|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
146092618|NCT01907100|526860332|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
146092619|NCT01907100|526860333|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
146092620|NCT01907100|526860334|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
146092621|NCT01758289|526860335|FG000|Overall Study|Premature Study Termination|44|||
146008680|NCT03052608|526546226|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
146008681|NCT03052608|526546225|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
146008682|NCT03052608|526546226|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
146008683|NCT03052608|526546225|FG000|Treatment Phase|Ongoing|103|||
146008684|NCT03052608|526546226|FG001|Treatment Phase|Ongoing|31|||
146008685|NCT03052608|526546225|FG000|Long-Term Follow-up Phase|Death|23|||
146008686|NCT03052608|526546226|FG001|Long-Term Follow-up Phase|Death|28|||
146008687|NCT03052608|526546225|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
146008688|NCT03052608|526546226|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
146008689|NCT03052608|526546225|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
146008690|NCT03052608|526546226|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
146008691|NCT03052608|526546225|FG000|Long-Term Follow-up Phase|Ongoing|122|||
146008692|NCT03052608|526546226|FG001|Long-Term Follow-up Phase|Ongoing|99|||
146008693|NCT04667949|526546227|FG000|Overall Study|Adverse Event|0|||
146008694|NCT04667949|526546228|FG001|Overall Study|Adverse Event|2|||
146008695|NCT04667949|526546227|FG000|Overall Study|Lost to Follow-up|0|||
146008696|NCT04667949|526546228|FG001|Overall Study|Lost to Follow-up|1|||
146008697|NCT04667949|526546227|FG000|Overall Study|Physician Decision|0|||
146008698|NCT04667949|526546228|FG001|Overall Study|Physician Decision|2|||
146008699|NCT04667949|526546227|FG000|Overall Study|Subject decision|1|||
146092622|NCT01758289|526860335|FG000|Overall Study|Adverse Event|9|||
146092623|NCT00667602|526860338|FG000|Overall Study|Withdrawal by Subject|4|||
146008700|NCT04667949|526546228|FG001|Overall Study|Subject decision|7|||
146008701|NCT02213926|526546229|FG000|Overall Study|Death|59|||
146092624|NCT00667602|526860339|FG001|Overall Study|Withdrawal by Subject|9|||
146092625|NCT00667602|526860340|FG002|Overall Study|Withdrawal by Subject|10|||
146092626|NCT00667602|526860338|FG000|Overall Study|Lost to Follow-up|4|||
146008702|NCT02213926|526546229|FG000|Overall Study|Withdrawal by Subject|10|||
146008703|NCT02213926|526546229|FG000|Overall Study|study terminated by sponsor|51|||
146008704|NCT02213926|526546229|FG000|Overall Study|Lost to Follow-up|3|||
146008705|NCT02213926|526546229|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
146008706|NCT05887908|526546230|FG000|Overall Study|Adverse Event|6|||
146008707|NCT05887908|526546231|FG001|Overall Study|Adverse Event|1|||
146008708|NCT05887908|526546232|FG002|Overall Study|Adverse Event|1|||
146008709|NCT05887908|526546230|FG000|Overall Study|Physician Decision|4|||
146008710|NCT05887908|526546231|FG001|Overall Study|Physician Decision|1|||
146008711|NCT05887908|526546232|FG002|Overall Study|Physician Decision|0|||
146008712|NCT05887908|526546230|FG000|Overall Study|Withdrawal by Subject|3|||
146008713|NCT05887908|526546231|FG001|Overall Study|Withdrawal by Subject|2|||
146008714|NCT05887908|526546232|FG002|Overall Study|Withdrawal by Subject|3|||
146008715|NCT05887908|526546230|FG000|Overall Study|Ineligibility after the start of the study|4|||
146008716|NCT05887908|526546231|FG001|Overall Study|Ineligibility after the start of the study|1|||
146008717|NCT05887908|526546232|FG002|Overall Study|Ineligibility after the start of the study|0|||
146008718|NCT05887908|526546230|FG000|Overall Study|Subject non-compliance|4|||
146008719|NCT05887908|526546231|FG001|Overall Study|Subject non-compliance|0|||
146008720|NCT05887908|526546232|FG002|Overall Study|Subject non-compliance|4|||
146008721|NCT05887908|526546230|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
146008722|NCT05887908|526546231|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
146008723|NCT05887908|526546232|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
146008724|NCT05887908|526546230|FG000|Overall Study|Pregnancy|0|||
146008725|NCT05887908|526546231|FG001|Overall Study|Pregnancy|1|||
146008726|NCT05887908|526546232|FG002|Overall Study|Pregnancy|0|||
146008727|NCT05887908|526546230|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
146008728|NCT05887908|526546231|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
146092627|NCT00667602|526860339|FG001|Overall Study|Lost to Follow-up|5|||
146092628|NCT00667602|526860340|FG002|Overall Study|Lost to Follow-up|6|||
146298419|NCT00312221|527607922|FG000|Double-blind Phase|Lost to Follow-up|0|||
146298420|NCT00312221|527607923|FG001|Double-blind Phase|Lost to Follow-up|0|||
146298421|NCT00312221|527607924|FG002|Double-blind Phase|Lost to Follow-up|2|||
146298422|NCT00312221|527607925|FG003|Double-blind Phase|Lost to Follow-up|2|||
146298423|NCT00312221|527607922|FG000|Double-blind Phase|Administrative|0|||
146298424|NCT00312221|527607923|FG001|Double-blind Phase|Administrative|26|||
146298425|NCT00312221|527607924|FG002|Double-blind Phase|Administrative|37|||
146298426|NCT00312221|527607925|FG003|Double-blind Phase|Administrative|33|||
146298427|NCT00312221|527607922|FG000|Double-blind Phase|Lack of Efficacy|0|||
146298428|NCT00312221|527607923|FG001|Double-blind Phase|Lack of Efficacy|17|||
146298429|NCT00312221|527607924|FG002|Double-blind Phase|Lack of Efficacy|6|||
146298430|NCT00312221|527607925|FG003|Double-blind Phase|Lack of Efficacy|10|||
146298431|NCT02060721|527607926|FG000|Overall Study|Lost to Follow-up|1|||
146298432|NCT02060721|527607926|FG000|Overall Study|Physician Decision|2|||
146298433|NCT02060721|527607926|FG000|Overall Study|Death|14|||
146298434|NCT02060721|527607926|FG000|Overall Study|Withdrawal by Subject|2|||
146298435|NCT02060721|527607926|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
146298436|NCT00866723|527607927|FG000|Overall Study|Withdrawal by Subject|1|||
146298437|NCT00866723|527607927|FG000|Overall Study|Disease Progression|4|||
146298438|NCT04178967|527607928|FG000|Induction Period|Adverse Event|4|||
146298439|NCT04178967|527607929|FG001|Induction Period|Adverse Event|6|||
146298440|NCT04178967|527607930|FG002|Induction Period|Adverse Event|0|||
146298441|NCT04178967|527607931|FG003|Induction Period|Adverse Event|0|||
146298442|NCT04178967|527607932|FG004|Induction Period|Adverse Event|0|||
146298443|NCT04178967|527607933|FG005|Induction Period|Adverse Event|0|||
146298444|NCT04178967|527607934|FG006|Induction Period|Adverse Event|0|||
146298445|NCT04178967|527607935|FG007|Induction Period|Adverse Event|0|||
146298446|NCT04178967|527607936|FG008|Induction Period|Adverse Event|0|||
146298447|NCT04178967|527607937|FG009|Induction Period|Adverse Event|0|||
146298448|NCT04178967|527607938|FG010|Induction Period|Adverse Event|0|||
146298449|NCT04178967|527607928|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
146298450|NCT04178967|527607929|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
146298451|NCT04178967|527607930|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
146298452|NCT04178967|527607931|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
146298453|NCT04178967|527607932|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
146298454|NCT04178967|527607933|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
146298455|NCT04178967|527607934|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
146298456|NCT04178967|527607935|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
146298457|NCT04178967|527607936|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
146298458|NCT04178967|527607937|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
146298459|NCT04178967|527607938|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
146298460|NCT04178967|527607928|FG000|Induction Period|Lack of Efficacy|4|||
146298461|NCT04178967|527607929|FG001|Induction Period|Lack of Efficacy|1|||
146298462|NCT04178967|527607930|FG002|Induction Period|Lack of Efficacy|0|||
146298463|NCT04178967|527607931|FG003|Induction Period|Lack of Efficacy|0|||
146298464|NCT04178967|527607932|FG004|Induction Period|Lack of Efficacy|0|||
146298465|NCT04178967|527607933|FG005|Induction Period|Lack of Efficacy|0|||
146298466|NCT04178967|527607934|FG006|Induction Period|Lack of Efficacy|0|||
146298467|NCT04178967|527607935|FG007|Induction Period|Lack of Efficacy|0|||
146298468|NCT04178967|527607936|FG008|Induction Period|Lack of Efficacy|0|||
146298469|NCT04178967|527607937|FG009|Induction Period|Lack of Efficacy|0|||
146298470|NCT04178967|527607938|FG010|Induction Period|Lack of Efficacy|0|||
146298471|NCT04178967|527607928|FG000|Induction Period|Protocol Violation|0|||
146298472|NCT04178967|527607929|FG001|Induction Period|Protocol Violation|6|||
146008729|NCT05887908|526546232|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
146008730|NCT05887908|526546230|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
146056178|NCT01045460|526721114|FG000|Overall Study|Lack of Efficacy|3|||
146248470|NCT04820023|527423505|FG008|Overall Study|Other|0|||
146248471|NCT01020487|527423506|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
146248472|NCT01020487|527423507|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
146248473|NCT01020487|527423508|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
146248474|NCT01020487|527423506|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
146248475|NCT01020487|527423507|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
146248476|NCT01020487|527423508|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
146248477|NCT01020487|527423506|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
146248478|NCT01020487|527423507|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
146248479|NCT01020487|527423508|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
146248480|NCT01020487|527423506|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
146248481|NCT01020487|527423507|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
146248482|NCT01020487|527423508|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
146248483|NCT01020487|527423506|FG000|Part 2 Open-label Period|Adverse Event|0|||
146248484|NCT01020487|527423507|FG001|Part 2 Open-label Period|Adverse Event|4|||
146248485|NCT01020487|527423508|FG002|Part 2 Open-label Period|Adverse Event|1|||
146248486|NCT04049578|527423509|FG000|Overall Study|Physician Decision|1|||
146248487|NCT02400749|527423510|FG000|Week 0 -16|Withdrawal by Subject|5|||
146248488|NCT02400749|527423511|FG001|Week 0 -16|Withdrawal by Subject|5|||
146248489|NCT02400749|527423510|FG000|Week 0 -16|Adverse Event|3|||
146248490|NCT02400749|527423511|FG001|Week 0 -16|Adverse Event|1|||
146248491|NCT02400749|527423510|FG000|Week 0 -16|Lost to Follow-up|2|||
146248492|NCT02400749|527423511|FG001|Week 0 -16|Lost to Follow-up|0|||
146248493|NCT02400749|527423510|FG000|Week 0 -16|Protocol Violation|1|||
146248494|NCT02400749|527423511|FG001|Week 0 -16|Protocol Violation|0|||
146248495|NCT02400749|527423510|FG000|Week 17 - 32|Withdrawal by Subject|3|||
146248496|NCT02400749|527423511|FG001|Week 17 - 32|Withdrawal by Subject|2|||
146248497|NCT02400749|527423510|FG000|Week 17 - 32|Adverse Event|2|||
146248498|NCT02400749|527423511|FG001|Week 17 - 32|Adverse Event|1|||
146248499|NCT01945593|527423514|FG000|Overall Study|Adverse Event|0|||
146248500|NCT01945593|527423515|FG001|Overall Study|Adverse Event|0|||
146248501|NCT01945593|527423516|FG002|Overall Study|Adverse Event|0|||
146248502|NCT01945593|527423517|FG003|Overall Study|Adverse Event|5|||
146248503|NCT01945593|527423514|FG000|Overall Study|Physician Decision|0|||
146248504|NCT01945593|527423515|FG001|Overall Study|Physician Decision|0|||
146248505|NCT01945593|527423516|FG002|Overall Study|Physician Decision|1|||
146248506|NCT01945593|527423517|FG003|Overall Study|Physician Decision|1|||
146248507|NCT01945593|527423514|FG000|Overall Study|Withdrawal by Subject|0|||
146248508|NCT01945593|527423515|FG001|Overall Study|Withdrawal by Subject|2|||
146248509|NCT01945593|527423516|FG002|Overall Study|Withdrawal by Subject|0|||
146248510|NCT01945593|527423517|FG003|Overall Study|Withdrawal by Subject|4|||
146248511|NCT01945593|527423514|FG000|Overall Study|Protocol Violation|0|||
146248512|NCT01945593|527423515|FG001|Overall Study|Protocol Violation|2|||
146248513|NCT01945593|527423516|FG002|Overall Study|Protocol Violation|1|||
146248514|NCT01945593|527423517|FG003|Overall Study|Protocol Violation|3|||
146248515|NCT01945593|527423514|FG000|Overall Study|Death|0|||
146248516|NCT01945593|527423515|FG001|Overall Study|Death|0|||
146248517|NCT01945593|527423516|FG002|Overall Study|Death|1|||
146248518|NCT01945593|527423517|FG003|Overall Study|Death|0|||
146248519|NCT01945593|527423514|FG000|Overall Study|Other: Terminated|0|||
146248520|NCT01945593|527423515|FG001|Overall Study|Other: Terminated|0|||
146248521|NCT01945593|527423516|FG002|Overall Study|Other: Terminated|0|||
146248522|NCT01945593|527423517|FG003|Overall Study|Other: Terminated|1|||
146248523|NCT01945593|527423514|FG000|Overall Study|Other: Surgical Procedure|0|||
146248524|NCT01945593|527423515|FG001|Overall Study|Other: Surgical Procedure|2|||
146248525|NCT01945593|527423516|FG002|Overall Study|Other: Surgical Procedure|0|||
146248526|NCT01945593|527423517|FG003|Overall Study|Other: Surgical Procedure|6|||
146298473|NCT04178967|527607930|FG002|Induction Period|Protocol Violation|0|||
146248527|NCT01945593|527423514|FG000|Overall Study|Other: Screen Failure|0|||
146248528|NCT01945593|527423515|FG001|Overall Study|Other: Screen Failure|2|||
146248529|NCT01945593|527423516|FG002|Overall Study|Other: Screen Failure|0|||
146248530|NCT01945593|527423517|FG003|Overall Study|Other: Screen Failure|0|||
146248531|NCT00228813|527423518|FG000|Overall Study|Death|4|||
146248532|NCT00507429|527423519|FG000|Treatment Phase|Disease Progression|12|||
146248533|NCT00507429|527423520|FG001|Treatment Phase|Disease Progression|5|||
146248534|NCT00507429|527423519|FG000|Treatment Phase|Adverse Event|12|||
146248535|NCT00507429|527423520|FG001|Treatment Phase|Adverse Event|5|||
146248536|NCT00507429|527423519|FG000|Treatment Phase|Withdrawal by Subject|3|||
146248537|NCT00507429|527423520|FG001|Treatment Phase|Withdrawal by Subject|3|||
146008731|NCT05887908|526546231|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
146008732|NCT05887908|526546232|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
146008733|NCT05887908|526546230|FG000|Overall Study|Other Reason|3|||
146008734|NCT05887908|526546231|FG001|Overall Study|Other Reason|3|||
146008735|NCT05887908|526546232|FG002|Overall Study|Other Reason|3|||
146008736|NCT02630693|526546233|FG000|Overall Study|No receive treatment|0|||
146008737|NCT02630693|526546234|FG001|Overall Study|No receive treatment|1|||
146008738|NCT04423939|526546235|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
146008739|NCT04423939|526546236|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
146008740|NCT04423939|526546235|FG000|Overall Study|Death|3|||
146008741|NCT04423939|526546236|FG001|Overall Study|Death|0|||
146008742|NCT04423939|526546235|FG000|Overall Study|Withdrawal by Subject|3|||
146008743|NCT04423939|526546236|FG001|Overall Study|Withdrawal by Subject|0|||
146008744|NCT04423939|526546235|FG000|Overall Study|Caregiver to patient who died|0|||
146008745|NCT04423939|526546236|FG001|Overall Study|Caregiver to patient who died|3|||
146008746|NCT04423939|526546235|FG000|Overall Study|Caregiver to patient who withdrew|0|||
146008747|NCT04423939|526546236|FG001|Overall Study|Caregiver to patient who withdrew|3|||
146008748|NCT05338710|526546237|FG000|Overall Study|Withdrawal by Subject|3|||
146008749|NCT04503551|526546238|FG000|Overall Study|Withdrawal by Subject|5|||
146008750|NCT04503551|526546239|FG001|Overall Study|Withdrawal by Subject|3|||
146008751|NCT04503551|526546238|FG000|Overall Study|Physician Decision|1|||
146008752|NCT04503551|526546239|FG001|Overall Study|Physician Decision|0|||
146008753|NCT04503551|526546238|FG000|Overall Study|Death|0|||
146008754|NCT04503551|526546239|FG001|Overall Study|Death|1|||
146008755|NCT04503551|526546238|FG000|Overall Study|Lost to Follow-up|1|||
146008756|NCT04503551|526546239|FG001|Overall Study|Lost to Follow-up|2|||
146008757|NCT04503551|526546238|FG000|Overall Study|Ongoing at Week 52|99|||
146008758|NCT04503551|526546239|FG001|Overall Study|Ongoing at Week 52|62|||
146008759|NCT01272037|526546251|FG000|Overall Study|Death|25|||
146008760|NCT01272037|526546252|FG001|Overall Study|Death|28|||
146008761|NCT01272037|526546251|FG000|Overall Study|Adverse Event|12|||
146008762|NCT01272037|526546252|FG001|Overall Study|Adverse Event|7|||
146008763|NCT01272037|526546251|FG000|Overall Study|Withdrawal by Subject|175|||
146008764|NCT01272037|526546252|FG001|Overall Study|Withdrawal by Subject|93|||
146008765|NCT01272037|526546251|FG000|Overall Study|Disease progression|70|||
146008766|NCT01272037|526546252|FG001|Overall Study|Disease progression|111|||
146008767|NCT01272037|526546251|FG000|Overall Study|Other reason|42|||
146008768|NCT01272037|526546252|FG001|Overall Study|Other reason|41|||
146008769|NCT01272037|526546251|FG000|Overall Study|Delinquent data|24|||
146008770|NCT01272037|526546252|FG001|Overall Study|Delinquent data|19|||
146008771|NCT01272037|526546251|FG000|Overall Study|Reason under review|33|||
146008772|NCT01272037|526546252|FG001|Overall Study|Reason under review|29|||
146008773|NCT01272037|526546251|FG000|Overall Study|On treatment|626|||
146008774|NCT01272037|526546252|FG001|Overall Study|On treatment|632|||
146008775|NCT04585269|526546253|FG000|Intervention|Withdrawal by Subject|9|||
146008776|NCT04585269|526546254|FG001|Intervention|Withdrawal by Subject|0|||
146008777|NCT04585269|526546253|FG000|Intervention|Unable to schedule|15|||
146008778|NCT04585269|526546254|FG001|Intervention|Unable to schedule|0|||
146008779|NCT04585269|526546253|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
146008780|NCT04585269|526546254|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
146008781|NCT04585269|526546253|FG000|FU Time 2 (3 months)|Death|2|||
146008782|NCT04585269|526546254|FG001|FU Time 2 (3 months)|Death|2|||
146008783|NCT04585269|526546253|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
146008784|NCT04585269|526546254|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
146008785|NCT04585269|526546253|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
146008786|NCT04585269|526546254|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
146008787|NCT04585269|526546253|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
146248538|NCT00507429|527423519|FG000|Treatment Phase|Physician Decision|4|||
146008788|NCT04585269|526546254|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
146008789|NCT04585269|526546253|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
146008790|NCT04585269|526546254|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
146248539|NCT00507429|527423520|FG001|Treatment Phase|Physician Decision|2|||
146008791|NCT04585269|526546253|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
146008792|NCT04585269|526546254|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
146008793|NCT04271540|526546256|FG000|Overall Study|Lost to Follow-up|1|||
146008794|NCT04271540|526546256|FG000|Overall Study|Screen Fail|5|||
146008795|NCT03307785|526546257|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
146008796|NCT03307785|526546258|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008797|NCT03307785|526546259|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008798|NCT03307785|526546260|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008799|NCT03307785|526546261|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008800|NCT03307785|526546262|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008801|NCT03307785|526546263|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008802|NCT03307785|526546264|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008803|NCT03307785|526546265|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008804|NCT03307785|526546266|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008805|NCT03307785|526546267|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008806|NCT03307785|526546268|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008807|NCT03307785|526546269|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
146008808|NCT03307785|526546257|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
146008809|NCT03307785|526546258|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
146008810|NCT03307785|526546259|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008811|NCT03307785|526546260|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008812|NCT03307785|526546261|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008813|NCT03307785|526546262|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008814|NCT03307785|526546263|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008815|NCT03307785|526546264|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008816|NCT03307785|526546265|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008817|NCT03307785|526546266|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008818|NCT03307785|526546267|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008819|NCT03307785|526546268|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008820|NCT03307785|526546269|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
146008821|NCT03307785|526546257|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
146008822|NCT03307785|526546258|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
146008823|NCT03307785|526546259|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008824|NCT03307785|526546260|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008825|NCT03307785|526546261|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008826|NCT03307785|526546262|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008827|NCT03307785|526546263|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008828|NCT03307785|526546264|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008829|NCT03307785|526546265|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008830|NCT03307785|526546266|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008831|NCT03307785|526546267|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008832|NCT03307785|526546268|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008833|NCT03307785|526546269|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
146008834|NCT03307785|526546257|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
146008835|NCT03307785|526546258|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
146008836|NCT03307785|526546259|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008837|NCT03307785|526546260|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008838|NCT03307785|526546261|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008839|NCT03307785|526546262|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008840|NCT03307785|526546263|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008841|NCT03307785|526546264|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008842|NCT03307785|526546265|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008843|NCT03307785|526546266|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008844|NCT03307785|526546267|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008845|NCT03307785|526546268|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008846|NCT03307785|526546269|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
146008847|NCT03307785|526546257|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008848|NCT03307785|526546258|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008849|NCT03307785|526546259|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
146008850|NCT03307785|526546260|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008851|NCT03307785|526546261|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008852|NCT03307785|526546262|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008853|NCT03307785|526546263|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008854|NCT03307785|526546264|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008855|NCT03307785|526546265|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008856|NCT03307785|526546266|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008857|NCT03307785|526546267|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008858|NCT03307785|526546268|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008859|NCT03307785|526546269|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
146008860|NCT03307785|526546257|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
146056179|NCT01045460|526721115|FG001|Overall Study|Lack of Efficacy|0|||
146056180|NCT00097500|526721116|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
146056181|NCT00097500|526721117|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
146056182|NCT00097500|526721116|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
146056183|NCT00097500|526721117|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
146008861|NCT03307785|526546258|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008862|NCT03307785|526546259|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
146008863|NCT03307785|526546260|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008864|NCT03307785|526546261|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008865|NCT03307785|526546262|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008866|NCT03307785|526546263|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008867|NCT03307785|526546264|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008868|NCT03307785|526546265|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008869|NCT03307785|526546266|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008870|NCT03307785|526546267|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008871|NCT03307785|526546268|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008872|NCT03307785|526546269|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
146008873|NCT03307785|526546257|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008874|NCT03307785|526546258|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008875|NCT03307785|526546259|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
146008876|NCT03307785|526546260|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008877|NCT03307785|526546261|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008878|NCT03307785|526546262|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008879|NCT03307785|526546263|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008880|NCT03307785|526546264|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008881|NCT03307785|526546265|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008882|NCT03307785|526546266|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008883|NCT03307785|526546267|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008884|NCT03307785|526546268|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008885|NCT03307785|526546269|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
146008886|NCT03307785|526546257|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008887|NCT03307785|526546258|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008888|NCT03307785|526546259|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
146008889|NCT03307785|526546260|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008890|NCT03307785|526546261|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008891|NCT03307785|526546262|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008892|NCT03307785|526546263|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008893|NCT03307785|526546264|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008894|NCT03307785|526546265|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008895|NCT03307785|526546266|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008896|NCT03307785|526546267|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008897|NCT03307785|526546268|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008898|NCT03307785|526546269|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
146008899|NCT03307785|526546257|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008900|NCT03307785|526546258|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008901|NCT03307785|526546259|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
146008902|NCT03307785|526546260|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008903|NCT03307785|526546261|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008904|NCT03307785|526546262|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008905|NCT03307785|526546263|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008906|NCT03307785|526546264|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008907|NCT03307785|526546265|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008908|NCT03307785|526546266|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008909|NCT03307785|526546267|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008910|NCT03307785|526546268|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008911|NCT03307785|526546269|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
146008912|NCT03307785|526546257|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008913|NCT03307785|526546258|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008914|NCT03307785|526546259|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008915|NCT03307785|526546260|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
146008916|NCT03307785|526546261|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
146092629|NCT00667602|526860338|FG000|Overall Study|Administrative reason|0|||
146092630|NCT00667602|526860339|FG001|Overall Study|Administrative reason|0|||
146092631|NCT00667602|526860340|FG002|Overall Study|Administrative reason|2|||
146092632|NCT00667602|526860338|FG000|Overall Study|Protocol Violation|0|||
146092633|NCT00667602|526860339|FG001|Overall Study|Protocol Violation|1|||
146092634|NCT00667602|526860340|FG002|Overall Study|Protocol Violation|0|||
146092635|NCT02750943|526860348|FG000|Overall Study|Lost to Follow-up|1|||
146092636|NCT02750943|526860349|FG001|Overall Study|Lost to Follow-up|2|||
146008917|NCT03307785|526546262|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008918|NCT03307785|526546263|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008919|NCT03307785|526546264|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008920|NCT03307785|526546265|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008921|NCT03307785|526546266|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008922|NCT03307785|526546267|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146248540|NCT00507429|527423519|FG000|Treatment Phase|Other|6|||
146248541|NCT00507429|527423520|FG001|Treatment Phase|Other|3|||
146248542|NCT00507429|527423519|FG000|Maintenance Phase|Progressive Disease|14|||
146248543|NCT00507429|527423520|FG001|Maintenance Phase|Progressive Disease|0|||
146008923|NCT03307785|526546268|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008924|NCT03307785|526546269|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
146008925|NCT03307785|526546257|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008926|NCT03307785|526546258|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
146248544|NCT01437540|527423521|FG000|Overall Study|Not listed below|7|||
146248545|NCT01437540|527423522|FG001|Overall Study|Not listed below|6|||
146248546|NCT01437540|527423521|FG000|Overall Study|COPD exacerbation|13|||
146248547|NCT01437540|527423522|FG001|Overall Study|COPD exacerbation|3|||
146248548|NCT01437540|527423521|FG000|Overall Study|Lost to Follow-up|3|||
146248549|NCT01437540|527423522|FG001|Overall Study|Lost to Follow-up|5|||
146248550|NCT01437540|527423521|FG000|Overall Study|Lack of Efficacy|23|||
146248551|NCT01437540|527423522|FG001|Overall Study|Lack of Efficacy|11|||
146248552|NCT01437540|527423521|FG000|Overall Study|Protocol Violation|24|||
146248553|NCT01437540|527423522|FG001|Overall Study|Protocol Violation|12|||
146248554|NCT01437540|527423521|FG000|Overall Study|Adverse Event|26|||
146248555|NCT01437540|527423522|FG001|Overall Study|Adverse Event|13|||
146248556|NCT01437540|527423521|FG000|Overall Study|Withdrawal by Subject|31|||
146248557|NCT01437540|527423522|FG001|Overall Study|Withdrawal by Subject|15|||
146248558|NCT00608959|527423528|FG000|Part 1|Did not meet eligibility criteria|1|||
146248559|NCT03884478|527423530|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
146248560|NCT03884478|527423531|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
146248561|NCT03884478|527423532|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
146248562|NCT03884478|527423530|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
146248563|NCT03884478|527423531|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
146248564|NCT03884478|527423532|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
146248565|NCT03884478|527423530|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
146248566|NCT03884478|527423531|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
146248567|NCT03884478|527423532|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
146248568|NCT03884478|527423530|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
146248569|NCT03884478|527423531|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
146248570|NCT03884478|527423532|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
146008927|NCT03307785|526546259|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008928|NCT03307785|526546260|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
146008929|NCT03307785|526546261|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
146008930|NCT03307785|526546262|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008931|NCT03307785|526546263|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008932|NCT03307785|526546264|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008933|NCT03307785|526546265|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008934|NCT03307785|526546266|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008935|NCT03307785|526546267|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008936|NCT03307785|526546268|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008937|NCT03307785|526546269|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
146008938|NCT03307785|526546257|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008939|NCT03307785|526546258|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008940|NCT03307785|526546259|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008941|NCT03307785|526546260|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
146008942|NCT03307785|526546261|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008943|NCT03307785|526546262|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008944|NCT03307785|526546263|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008945|NCT03307785|526546264|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008946|NCT03307785|526546265|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146248571|NCT02213094|527423533|FG000|Overall Study|Adverse Event|1|||
146248572|NCT02213094|527423534|FG001|Overall Study|Adverse Event|0|||
146248573|NCT01807234|527423535|FG000|Overall Study|Lost to Follow-up|2|||
146008947|NCT03307785|526546266|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146248574|NCT01807234|527423536|FG001|Overall Study|Lost to Follow-up|5|||
146248575|NCT01807234|527423537|FG002|Overall Study|Lost to Follow-up|1|||
146008948|NCT03307785|526546267|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146248576|NCT01807234|527423538|FG003|Overall Study|Lost to Follow-up|1|||
146092637|NCT02750943|526860348|FG000|Overall Study|Withdrawal by Subject|5|||
146008949|NCT03307785|526546268|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008950|NCT03307785|526546269|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
146008951|NCT03307785|526546257|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008952|NCT03307785|526546258|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008953|NCT03307785|526546259|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008954|NCT03307785|526546260|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008955|NCT03307785|526546261|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
146008956|NCT03307785|526546262|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008957|NCT03307785|526546263|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008958|NCT03307785|526546264|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008959|NCT03307785|526546265|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008960|NCT03307785|526546266|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008961|NCT03307785|526546267|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008962|NCT03307785|526546268|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008963|NCT03307785|526546269|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
146008964|NCT03307785|526546257|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008965|NCT03307785|526546258|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008966|NCT03307785|526546259|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008967|NCT03307785|526546260|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008968|NCT03307785|526546261|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008969|NCT03307785|526546262|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
146008970|NCT03307785|526546263|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008971|NCT03307785|526546264|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008972|NCT03307785|526546265|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008973|NCT03307785|526546266|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008974|NCT03307785|526546267|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008975|NCT03307785|526546268|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008976|NCT03307785|526546269|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
146008977|NCT03307785|526546257|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008978|NCT03307785|526546258|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008979|NCT03307785|526546259|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008980|NCT03307785|526546260|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008981|NCT03307785|526546261|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008982|NCT03307785|526546262|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
146008983|NCT03307785|526546263|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008984|NCT03307785|526546264|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008985|NCT03307785|526546265|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008986|NCT03307785|526546266|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008987|NCT03307785|526546267|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008988|NCT03307785|526546268|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008989|NCT03307785|526546269|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
146008990|NCT03307785|526546257|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008991|NCT03307785|526546258|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008992|NCT03307785|526546259|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008993|NCT03307785|526546260|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008994|NCT03307785|526546261|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008995|NCT03307785|526546262|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
146008996|NCT03307785|526546263|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008997|NCT03307785|526546264|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008998|NCT03307785|526546265|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146008999|NCT03307785|526546266|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146009000|NCT03307785|526546267|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146009001|NCT03307785|526546268|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146009002|NCT03307785|526546269|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
146009003|NCT03307785|526546257|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009004|NCT03307785|526546258|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009005|NCT03307785|526546259|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009006|NCT03307785|526546260|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009007|NCT03307785|526546261|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009008|NCT03307785|526546262|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
146009009|NCT03307785|526546263|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009010|NCT03307785|526546264|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146298474|NCT04178967|527607931|FG003|Induction Period|Protocol Violation|0|||
146298475|NCT04178967|527607932|FG004|Induction Period|Protocol Violation|0|||
146298476|NCT04178967|527607933|FG005|Induction Period|Protocol Violation|0|||
146298477|NCT04178967|527607934|FG006|Induction Period|Protocol Violation|0|||
146298478|NCT04178967|527607935|FG007|Induction Period|Protocol Violation|0|||
146298479|NCT04178967|527607936|FG008|Induction Period|Protocol Violation|0|||
146298480|NCT04178967|527607937|FG009|Induction Period|Protocol Violation|0|||
146298481|NCT04178967|527607938|FG010|Induction Period|Protocol Violation|0|||
146298482|NCT04178967|527607928|FG000|Induction Period|Withdrawal by Subject|6|||
146298483|NCT04178967|527607929|FG001|Induction Period|Withdrawal by Subject|4|||
146009011|NCT03307785|526546265|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009012|NCT03307785|526546266|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009013|NCT03307785|526546267|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009014|NCT03307785|526546268|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009015|NCT03307785|526546269|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
146009016|NCT03307785|526546257|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009017|NCT03307785|526546258|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146248577|NCT01807234|527423539|FG004|Overall Study|Lost to Follow-up|1|||
146248578|NCT01807234|527423540|FG005|Overall Study|Lost to Follow-up|2|||
146248579|NCT01807234|527423535|FG000|Overall Study|Withdrawal by Subject|3|||
146248580|NCT01807234|527423536|FG001|Overall Study|Withdrawal by Subject|1|||
146248581|NCT01807234|527423537|FG002|Overall Study|Withdrawal by Subject|1|||
146248582|NCT01807234|527423538|FG003|Overall Study|Withdrawal by Subject|1|||
146248583|NCT01807234|527423539|FG004|Overall Study|Withdrawal by Subject|2|||
146248584|NCT01807234|527423540|FG005|Overall Study|Withdrawal by Subject|1|||
146248585|NCT01807234|527423535|FG000|Overall Study|Lack of Efficacy|0|||
146248586|NCT01807234|527423536|FG001|Overall Study|Lack of Efficacy|0|||
146248587|NCT01807234|527423537|FG002|Overall Study|Lack of Efficacy|0|||
146248588|NCT01807234|527423538|FG003|Overall Study|Lack of Efficacy|0|||
146248589|NCT01807234|527423539|FG004|Overall Study|Lack of Efficacy|1|||
146248590|NCT01807234|527423540|FG005|Overall Study|Lack of Efficacy|1|||
146248591|NCT01074229|527423541|FG000|Overall Study|Lost to Follow-up|1|||
146248592|NCT01074229|527423542|FG001|Overall Study|Lost to Follow-up|0|||
146248593|NCT01074229|527423543|FG002|Overall Study|Lost to Follow-up|0|||
146248594|NCT01074229|527423541|FG000|Overall Study|Change to open surgical procedure|1|||
146248595|NCT01074229|527423542|FG001|Overall Study|Change to open surgical procedure|3|||
146248596|NCT01074229|527423543|FG002|Overall Study|Change to open surgical procedure|4|||
146248597|NCT02163499|527423544|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
146248598|NCT02163499|527423544|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
146248599|NCT02163499|527423544|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
146248600|NCT02163499|527423544|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
146248601|NCT02163499|527423544|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
146248602|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
146248603|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
146248604|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
146248605|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
146248606|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
146248607|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
146248608|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
146248609|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
146248610|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
146248611|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Death|8|||
146248612|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
146248613|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
146248614|NCT02163499|527423544|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
146248615|NCT01540474|527423545|FG000|Vaccination Period|Lost to Follow-up|0|||
146248616|NCT01540474|527423546|FG001|Vaccination Period|Lost to Follow-up|1|||
146248617|NCT01540474|527423547|FG002|Vaccination Period|Lost to Follow-up|0|||
146248618|NCT01540474|527423548|FG003|Vaccination Period|Lost to Follow-up|0|||
146248619|NCT00857311|527423549|FG000|Overall Study|Lost to Follow-up|1|||
146248620|NCT00857311|527423550|FG001|Overall Study|Lost to Follow-up|0|||
146248621|NCT00857311|527423551|FG002|Overall Study|Lost to Follow-up|0|||
146248622|NCT00857311|527423552|FG003|Overall Study|Lost to Follow-up|0|||
146248623|NCT01587703|527423553|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
146248624|NCT01587703|527423554|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248625|NCT01587703|527423555|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248626|NCT01587703|527423556|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248627|NCT01587703|527423557|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248628|NCT01587703|527423558|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248629|NCT01587703|527423559|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146298484|NCT04178967|527607930|FG002|Induction Period|Withdrawal by Subject|0|||
146298485|NCT04178967|527607931|FG003|Induction Period|Withdrawal by Subject|0|||
146298486|NCT04178967|527607932|FG004|Induction Period|Withdrawal by Subject|0|||
146298487|NCT04178967|527607933|FG005|Induction Period|Withdrawal by Subject|0|||
146298488|NCT04178967|527607934|FG006|Induction Period|Withdrawal by Subject|0|||
146298489|NCT04178967|527607935|FG007|Induction Period|Withdrawal by Subject|0|||
146298490|NCT04178967|527607936|FG008|Induction Period|Withdrawal by Subject|0|||
146298491|NCT04178967|527607937|FG009|Induction Period|Withdrawal by Subject|0|||
146298492|NCT04178967|527607938|FG010|Induction Period|Withdrawal by Subject|0|||
146298493|NCT04178967|527607928|FG000|Induction Period|Lost to Follow-up|2|||
146298494|NCT04178967|527607929|FG001|Induction Period|Lost to Follow-up|0|||
146298495|NCT04178967|527607930|FG002|Induction Period|Lost to Follow-up|0|||
146298496|NCT04178967|527607931|FG003|Induction Period|Lost to Follow-up|0|||
146298497|NCT04178967|527607932|FG004|Induction Period|Lost to Follow-up|0|||
146298498|NCT04178967|527607933|FG005|Induction Period|Lost to Follow-up|0|||
146298499|NCT04178967|527607934|FG006|Induction Period|Lost to Follow-up|0|||
146298500|NCT04178967|527607935|FG007|Induction Period|Lost to Follow-up|0|||
146298501|NCT04178967|527607936|FG008|Induction Period|Lost to Follow-up|0|||
146298502|NCT04178967|527607937|FG009|Induction Period|Lost to Follow-up|0|||
146298503|NCT04178967|527607938|FG010|Induction Period|Lost to Follow-up|0|||
146298504|NCT04178967|527607928|FG000|Induction Period|Participant Missed Study Visits|0|||
146298505|NCT04178967|527607929|FG001|Induction Period|Participant Missed Study Visits|1|||
146298506|NCT04178967|527607930|FG002|Induction Period|Participant Missed Study Visits|0|||
146298507|NCT04178967|527607931|FG003|Induction Period|Participant Missed Study Visits|0|||
146298508|NCT04178967|527607932|FG004|Induction Period|Participant Missed Study Visits|0|||
146298509|NCT04178967|527607933|FG005|Induction Period|Participant Missed Study Visits|0|||
146298510|NCT04178967|527607934|FG006|Induction Period|Participant Missed Study Visits|0|||
146298511|NCT04178967|527607935|FG007|Induction Period|Participant Missed Study Visits|0|||
146298512|NCT04178967|527607936|FG008|Induction Period|Participant Missed Study Visits|0|||
146298513|NCT04178967|527607937|FG009|Induction Period|Participant Missed Study Visits|0|||
146298514|NCT04178967|527607938|FG010|Induction Period|Participant Missed Study Visits|0|||
146298515|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298516|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
146009018|NCT03307785|526546259|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146248630|NCT01587703|527423560|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248631|NCT01587703|527423561|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248632|NCT01587703|527423562|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248633|NCT01587703|527423563|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248634|NCT01587703|527423564|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248635|NCT01587703|527423565|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248636|NCT01587703|527423566|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248637|NCT01587703|527423567|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248638|NCT01587703|527423568|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248639|NCT01587703|527423569|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248640|NCT01587703|527423570|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248641|NCT01587703|527423571|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
146248642|NCT01587703|527423553|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248643|NCT01587703|527423554|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248644|NCT01587703|527423555|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248645|NCT01587703|527423556|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248646|NCT01587703|527423557|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248647|NCT01587703|527423558|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
146248648|NCT01587703|527423559|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248649|NCT01587703|527423560|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
146248650|NCT01587703|527423561|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248651|NCT01587703|527423562|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248652|NCT01587703|527423563|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248653|NCT01587703|527423564|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248654|NCT01587703|527423565|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248655|NCT01587703|527423566|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248656|NCT01587703|527423567|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248657|NCT01587703|527423568|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248658|NCT01587703|527423569|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146298517|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298518|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298519|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298520|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
146298521|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
146298522|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
146009019|NCT03307785|526546260|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009020|NCT03307785|526546261|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009021|NCT03307785|526546262|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
146009022|NCT03307785|526546263|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009023|NCT03307785|526546264|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009024|NCT03307785|526546265|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009025|NCT03307785|526546266|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009026|NCT03307785|526546267|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009027|NCT03307785|526546268|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009028|NCT03307785|526546269|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
146009029|NCT03307785|526546257|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009030|NCT03307785|526546258|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009031|NCT03307785|526546259|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009032|NCT03307785|526546260|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009033|NCT03307785|526546261|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009034|NCT03307785|526546262|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009035|NCT03307785|526546263|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
146009036|NCT03307785|526546264|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009037|NCT03307785|526546265|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009038|NCT03307785|526546266|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009039|NCT03307785|526546267|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009040|NCT03307785|526546268|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009041|NCT03307785|526546269|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
146009042|NCT03307785|526546257|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009043|NCT03307785|526546258|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009044|NCT03307785|526546259|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009045|NCT03307785|526546260|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009046|NCT03307785|526546261|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009047|NCT03307785|526546262|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009048|NCT03307785|526546263|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
146009049|NCT03307785|526546264|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009050|NCT03307785|526546265|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146092638|NCT02750943|526860349|FG001|Overall Study|Withdrawal by Subject|7|||
146092639|NCT00395538|526860350|FG000|Overall Study|Did not re-consent to revised protocol|1|||
146092640|NCT00395538|526860351|FG001|Overall Study|Did not re-consent to revised protocol|10|||
146092641|NCT00395538|526860352|FG002|Overall Study|Did not re-consent to revised protocol|0|||
146092642|NCT00395538|526860350|FG000|Overall Study|FDA partial hold on PTH|0|||
146092643|NCT00395538|526860351|FG001|Overall Study|FDA partial hold on PTH|0|||
146092644|NCT00395538|526860352|FG002|Overall Study|FDA partial hold on PTH|11|||
146092645|NCT00395538|526860350|FG000|Overall Study|Failed screening|0|||
146092646|NCT00395538|526860351|FG001|Overall Study|Failed screening|0|||
146092647|NCT00395538|526860352|FG002|Overall Study|Failed screening|4|||
146092648|NCT00395538|526860350|FG000|Overall Study|Switch to Natpara|0|||
146092649|NCT00395538|526860351|FG001|Overall Study|Switch to Natpara|0|||
146092650|NCT00395538|526860352|FG002|Overall Study|Switch to Natpara|3|||
146092651|NCT00395538|526860350|FG000|Overall Study|Adverse Event|1|||
146092652|NCT00395538|526860351|FG001|Overall Study|Adverse Event|0|||
146092653|NCT00395538|526860352|FG002|Overall Study|Adverse Event|2|||
146092654|NCT00395538|526860350|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
146092655|NCT00395538|526860351|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
146092656|NCT00395538|526860352|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
146092657|NCT00395538|526860350|FG000|Overall Study|Non-compliance with study protocol|0|||
146092658|NCT00395538|526860351|FG001|Overall Study|Non-compliance with study protocol|1|||
146092659|NCT00395538|526860352|FG002|Overall Study|Non-compliance with study protocol|0|||
146092660|NCT00395538|526860350|FG000|Overall Study|PTH resistance|0|||
146092661|NCT00395538|526860351|FG001|Overall Study|PTH resistance|0|||
146092662|NCT00395538|526860352|FG002|Overall Study|PTH resistance|1|||
146092663|NCT00395538|526860350|FG000|Overall Study|Pregnancy|1|||
146092664|NCT00395538|526860351|FG001|Overall Study|Pregnancy|0|||
146092665|NCT00395538|526860352|FG002|Overall Study|Pregnancy|0|||
146092666|NCT00395538|526860350|FG000|Overall Study|Partial recovery of parathyroid function|0|||
146092667|NCT00395538|526860351|FG001|Overall Study|Partial recovery of parathyroid function|0|||
146092668|NCT00395538|526860352|FG002|Overall Study|Partial recovery of parathyroid function|1|||
146092669|NCT00395538|526860350|FG000|Overall Study|Participant elected to discontinue|0|||
146092670|NCT00395538|526860351|FG001|Overall Study|Participant elected to discontinue|0|||
146092671|NCT00395538|526860352|FG002|Overall Study|Participant elected to discontinue|1|||
146092672|NCT01857583|526860353|FG000|Overall Study|Adverse Event|0|||
146092673|NCT01857583|526860354|FG001|Overall Study|Adverse Event|0|||
146092674|NCT01857583|526860355|FG002|Overall Study|Adverse Event|1|||
146009051|NCT03307785|526546266|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009052|NCT03307785|526546267|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009053|NCT03307785|526546268|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009054|NCT03307785|526546269|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
146009055|NCT03307785|526546257|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146248659|NCT01587703|527423570|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248660|NCT01587703|527423571|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
146248661|NCT01587703|527423553|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248662|NCT01587703|527423554|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248663|NCT01587703|527423555|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248664|NCT01587703|527423556|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248665|NCT01587703|527423557|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248666|NCT01587703|527423558|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248667|NCT01587703|527423559|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
146248668|NCT01587703|527423560|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248669|NCT01587703|527423561|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248670|NCT01587703|527423562|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248671|NCT01587703|527423563|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248672|NCT01587703|527423564|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248673|NCT01587703|527423565|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248674|NCT01587703|527423566|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248675|NCT01587703|527423567|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248676|NCT01587703|527423568|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248677|NCT01587703|527423569|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248678|NCT01587703|527423570|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248679|NCT01587703|527423571|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
146248680|NCT01587703|527423553|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
146248681|NCT01587703|527423554|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
146248682|NCT01587703|527423555|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
146248683|NCT01587703|527423556|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
146248684|NCT01587703|527423557|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
146248685|NCT01587703|527423558|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
146248686|NCT01587703|527423559|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
146248687|NCT01587703|527423560|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
146248688|NCT01587703|527423561|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248689|NCT01587703|527423562|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248690|NCT01587703|527423563|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248691|NCT01587703|527423564|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248692|NCT01587703|527423565|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248693|NCT01587703|527423566|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248694|NCT01587703|527423567|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248695|NCT01587703|527423568|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248696|NCT01587703|527423569|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248697|NCT01587703|527423570|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248698|NCT01587703|527423571|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
146248699|NCT01587703|527423553|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248700|NCT01587703|527423554|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248701|NCT01587703|527423555|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248702|NCT01587703|527423556|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248703|NCT01587703|527423557|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248704|NCT01587703|527423558|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248705|NCT01587703|527423559|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248706|NCT01587703|527423560|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248707|NCT01587703|527423561|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
146248708|NCT01587703|527423562|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
146248709|NCT01587703|527423563|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
146248710|NCT01587703|527423564|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248711|NCT01587703|527423565|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248712|NCT01587703|527423566|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248713|NCT01587703|527423567|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248714|NCT01587703|527423568|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248715|NCT01587703|527423569|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146009056|NCT03307785|526546258|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009057|NCT03307785|526546259|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146298523|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
146009058|NCT03307785|526546260|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009059|NCT03307785|526546261|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146092675|NCT01857583|526860356|FG003|Overall Study|Adverse Event|1|||
146009060|NCT03307785|526546262|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009061|NCT03307785|526546263|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009062|NCT03307785|526546264|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
146009063|NCT03307785|526546265|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009064|NCT03307785|526546266|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009065|NCT03307785|526546267|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009066|NCT03307785|526546268|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009067|NCT03307785|526546269|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
146009068|NCT03307785|526546257|FG000|PACT Phase: Up to 19 Months|Death|0|||
146009069|NCT03307785|526546258|FG001|PACT Phase: Up to 19 Months|Death|0|||
146009070|NCT03307785|526546259|FG002|PACT Phase: Up to 19 Months|Death|0|||
146009071|NCT03307785|526546260|FG003|PACT Phase: Up to 19 Months|Death|0|||
146009072|NCT03307785|526546261|FG004|PACT Phase: Up to 19 Months|Death|0|||
146009073|NCT03307785|526546262|FG005|PACT Phase: Up to 19 Months|Death|0|||
146009074|NCT03307785|526546263|FG006|PACT Phase: Up to 19 Months|Death|0|||
146009075|NCT03307785|526546264|FG007|PACT Phase: Up to 19 Months|Death|0|||
146009076|NCT03307785|526546265|FG008|PACT Phase: Up to 19 Months|Death|0|||
146009077|NCT03307785|526546266|FG009|PACT Phase: Up to 19 Months|Death|0|||
146009078|NCT03307785|526546267|FG010|PACT Phase: Up to 19 Months|Death|0|||
146009079|NCT03307785|526546268|FG011|PACT Phase: Up to 19 Months|Death|0|||
146009080|NCT03307785|526546269|FG012|PACT Phase: Up to 19 Months|Death|1|||
146009081|NCT05526521|526546273|FG000|Overall Study|Withdrawal by Subject|0|||
146009082|NCT05526521|526546274|FG001|Overall Study|Withdrawal by Subject|1|||
146009083|NCT05526521|526546275|FG002|Overall Study|Withdrawal by Subject|0|||
146009084|NCT05526521|526546276|FG003|Overall Study|Withdrawal by Subject|0|||
146009085|NCT03919929|526546277|FG000|Overall Study|Withdrawal by Subject|0|||
146009086|NCT03919929|526546278|FG001|Overall Study|Withdrawal by Subject|4|||
146009087|NCT03919929|526546277|FG000|Overall Study|Screen Failure|0|||
146009088|NCT03919929|526546278|FG001|Overall Study|Screen Failure|5|||
146009089|NCT01671956|526546281|FG000|Overall Study|Disease progression|0|||
146009090|NCT01671956|526546282|FG001|Overall Study|Disease progression|1|||
146009091|NCT01671956|526546281|FG000|Overall Study|Withdrawal by Subject|1|||
146009092|NCT01671956|526546282|FG001|Overall Study|Withdrawal by Subject|1|||
146009093|NCT01671956|526546281|FG000|Overall Study|Adverse Event|1|||
146009094|NCT01671956|526546282|FG001|Overall Study|Adverse Event|0|||
146009095|NCT04266912|526546294|FG000|Overall Study|Withdrawal by Subject|1|||
146009096|NCT04266912|526546295|FG001|Overall Study|Withdrawal by Subject|0|||
146009097|NCT04266912|526546296|FG002|Overall Study|Withdrawal by Subject|0|||
146009098|NCT04266912|526546297|FG003|Overall Study|Withdrawal by Subject|0|||
146009099|NCT04266912|526546294|FG000|Overall Study|Progression|6|||
146009100|NCT04266912|526546295|FG001|Overall Study|Progression|6|||
146009101|NCT04266912|526546296|FG002|Overall Study|Progression|0|||
146009102|NCT04266912|526546297|FG003|Overall Study|Progression|10|||
146009103|NCT00620373|526546851|FG000|Overall Study|Unverified cancer status|33|||
146009104|NCT01897727|526546852|FG000|Overall Study|Exclusion: central sleep apnea|0|||
146009105|NCT01897727|526546853|FG001|Overall Study|Exclusion: central sleep apnea|1|||
146009106|NCT01061723|526546854|FG000|Overall Study|Adverse Event|0|||
146009107|NCT01061723|526546855|FG001|Overall Study|Adverse Event|2|||
146009108|NCT01061723|526546856|FG002|Overall Study|Adverse Event|5|||
146009109|NCT01061723|526546857|FG003|Overall Study|Adverse Event|5|||
146009110|NCT01061723|526546858|FG004|Overall Study|Adverse Event|2|||
146009111|NCT01061723|526546859|FG005|Overall Study|Adverse Event|6|||
146009112|NCT01061723|526546854|FG000|Overall Study|Lack of Efficacy|2|||
146009113|NCT01061723|526546855|FG001|Overall Study|Lack of Efficacy|3|||
146009114|NCT01061723|526546856|FG002|Overall Study|Lack of Efficacy|4|||
146009115|NCT01061723|526546857|FG003|Overall Study|Lack of Efficacy|2|||
146009116|NCT01061723|526546858|FG004|Overall Study|Lack of Efficacy|1|||
146009117|NCT01061723|526546859|FG005|Overall Study|Lack of Efficacy|1|||
146009118|NCT01061723|526546854|FG000|Overall Study|Randomized but not treated|0|||
146009119|NCT01061723|526546855|FG001|Overall Study|Randomized but not treated|0|||
146009120|NCT01061723|526546856|FG002|Overall Study|Randomized but not treated|0|||
146009121|NCT01061723|526546857|FG003|Overall Study|Randomized but not treated|0|||
146009122|NCT01061723|526546858|FG004|Overall Study|Randomized but not treated|0|||
146009123|NCT01061723|526546859|FG005|Overall Study|Randomized but not treated|1|||
146009124|NCT01061723|526546854|FG000|Overall Study|Other than specified above|2|||
146009125|NCT01061723|526546855|FG001|Overall Study|Other than specified above|1|||
146009126|NCT01061723|526546856|FG002|Overall Study|Other than specified above|1|||
146009127|NCT01061723|526546857|FG003|Overall Study|Other than specified above|1|||
146009128|NCT01061723|526546858|FG004|Overall Study|Other than specified above|0|||
146009129|NCT01061723|526546859|FG005|Overall Study|Other than specified above|1|||
146009130|NCT00293813|526546860|FG000|Overall Study|Physician Decision|0|||
146009131|NCT00293813|526546861|FG001|Overall Study|Physician Decision|1|||
146009132|NCT00293813|526546862|FG002|Overall Study|Physician Decision|0|||
146009133|NCT00293813|526546860|FG000|Overall Study|Adverse Event|3|||
146009134|NCT00293813|526546861|FG001|Overall Study|Adverse Event|1|||
146009135|NCT00293813|526546862|FG002|Overall Study|Adverse Event|1|||
146009136|NCT00293813|526546860|FG000|Overall Study|Withdrawal by Subject|7|||
146092676|NCT01857583|526860353|FG000|Overall Study|Death|0|||
146092677|NCT01857583|526860354|FG001|Overall Study|Death|1|||
146092678|NCT01857583|526860355|FG002|Overall Study|Death|1|||
146092679|NCT01857583|526860356|FG003|Overall Study|Death|0|||
146092680|NCT01857583|526860353|FG000|Overall Study|Physician Decision|0|||
146092681|NCT01857583|526860354|FG001|Overall Study|Physician Decision|0|||
146092682|NCT01857583|526860355|FG002|Overall Study|Physician Decision|0|||
146092683|NCT01857583|526860356|FG003|Overall Study|Physician Decision|1|||
146298524|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298525|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
146298526|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298527|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298528|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298529|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298530|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298531|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
146298532|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298533|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298534|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298535|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298536|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
146298537|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298538|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298539|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298540|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
146298541|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298542|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146009137|NCT00293813|526546861|FG001|Overall Study|Withdrawal by Subject|4|||
146009138|NCT00293813|526546862|FG002|Overall Study|Withdrawal by Subject|4|||
146009139|NCT00293813|526546860|FG000|Overall Study|Lost to Follow-up|3|||
146009140|NCT00293813|526546861|FG001|Overall Study|Lost to Follow-up|2|||
146009141|NCT00293813|526546862|FG002|Overall Study|Lost to Follow-up|3|||
146009142|NCT00293813|526546860|FG000|Overall Study|Noncompliance|0|||
146009143|NCT00293813|526546861|FG001|Overall Study|Noncompliance|1|||
146009144|NCT00293813|526546862|FG002|Overall Study|Noncompliance|0|||
146009145|NCT00460655|526546867|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
146009146|NCT00460655|526546868|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146009147|NCT00460655|526546869|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146092684|NCT01857583|526860353|FG000|Overall Study|Withdrawal by Subject|1|||
146092685|NCT01857583|526860354|FG001|Overall Study|Withdrawal by Subject|0|||
146092686|NCT01857583|526860355|FG002|Overall Study|Withdrawal by Subject|1|||
146092687|NCT01857583|526860356|FG003|Overall Study|Withdrawal by Subject|2|||
146092688|NCT02211638|526860357|FG000|Overall Study|Case Report Forms Uncollected|291|||
146092689|NCT02211638|526860357|FG000|Overall Study|Protocol Violation|692|||
146092690|NCT04382755|526860358|FG000|Overall Study|Withdrawal by Subject|1|||
146092691|NCT04382755|526860359|FG001|Overall Study|Withdrawal by Subject|0|||
146092692|NCT04382755|526860358|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
146092693|NCT04382755|526860359|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
146092694|NCT04382755|526860358|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
146092695|NCT04382755|526860359|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
146092696|NCT04041700|526860364|FG000|Overall Study|Pregnancy|1|||
146092697|NCT04041700|526860364|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
146092698|NCT02775903|526860365|FG000|Overall Study|Death|7|||
146092699|NCT02775903|526860366|FG001|Overall Study|Death|11|||
146092700|NCT02775903|526860367|FG002|Overall Study|Death|12|||
146092701|NCT02775903|526860368|FG003|Overall Study|Death|11|||
146092702|NCT02775903|526860365|FG000|Overall Study|Adverse Event|0|||
146092703|NCT02775903|526860366|FG001|Overall Study|Adverse Event|1|||
146092704|NCT02775903|526860367|FG002|Overall Study|Adverse Event|12|||
146092705|NCT02775903|526860368|FG003|Overall Study|Adverse Event|3|||
146092706|NCT02775903|526860365|FG000|Overall Study|Progressive disease|15|||
146092707|NCT02775903|526860366|FG001|Overall Study|Progressive disease|14|||
146092708|NCT02775903|526860367|FG002|Overall Study|Progressive disease|30|||
146092709|NCT02775903|526860368|FG003|Overall Study|Progressive disease|20|||
146092710|NCT02775903|526860365|FG000|Overall Study|Lack of Efficacy|2|||
146092711|NCT02775903|526860366|FG001|Overall Study|Lack of Efficacy|2|||
146092712|NCT02775903|526860367|FG002|Overall Study|Lack of Efficacy|2|||
146092713|NCT02775903|526860368|FG003|Overall Study|Lack of Efficacy|6|||
146092714|NCT02775903|526860365|FG000|Overall Study|Withdrawal by Subject|7|||
146092715|NCT02775903|526860366|FG001|Overall Study|Withdrawal by Subject|5|||
146092716|NCT02775903|526860367|FG002|Overall Study|Withdrawal by Subject|5|||
146092717|NCT02775903|526860368|FG003|Overall Study|Withdrawal by Subject|8|||
146009148|NCT00460655|526546870|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146009149|NCT00460655|526546867|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
146009150|NCT00460655|526546868|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146009151|NCT00460655|526546869|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146009152|NCT00460655|526546870|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146009153|NCT00460655|526546867|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146009154|NCT00460655|526546868|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
146009155|NCT00460655|526546869|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146009156|NCT00460655|526546870|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
146009157|NCT00460655|526546867|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146009158|NCT00460655|526546868|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146248716|NCT01587703|527423570|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248717|NCT01587703|527423571|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
146248718|NCT01587703|527423553|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248719|NCT01587703|527423554|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248720|NCT01587703|527423555|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248721|NCT01587703|527423556|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248722|NCT01587703|527423557|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248723|NCT01587703|527423558|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248724|NCT01587703|527423559|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248725|NCT01587703|527423560|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248726|NCT01587703|527423561|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
146248727|NCT01587703|527423562|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248728|NCT01587703|527423563|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
146248729|NCT01587703|527423564|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248730|NCT01587703|527423565|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248731|NCT01587703|527423566|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248732|NCT01587703|527423567|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248733|NCT01587703|527423568|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248734|NCT01587703|527423569|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248735|NCT01587703|527423570|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248736|NCT01587703|527423571|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
146248737|NCT01587703|527423553|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248738|NCT01587703|527423554|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248739|NCT01587703|527423555|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248740|NCT01587703|527423556|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248741|NCT01587703|527423557|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248742|NCT01587703|527423558|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248743|NCT01587703|527423559|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248744|NCT01587703|527423560|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248745|NCT01587703|527423561|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248746|NCT01587703|527423562|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
146248747|NCT01587703|527423563|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
146248748|NCT01587703|527423564|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248749|NCT01587703|527423565|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248750|NCT01587703|527423566|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248751|NCT01587703|527423567|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248752|NCT01587703|527423568|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248753|NCT01587703|527423569|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248754|NCT01587703|527423570|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248755|NCT01587703|527423571|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
146248756|NCT01587703|527423553|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146009159|NCT00460655|526546869|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
146009160|NCT00460655|526546870|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
146009161|NCT00460655|526546867|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146009162|NCT00460655|526546868|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146009163|NCT00460655|526546869|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
146009164|NCT00460655|526546870|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
146009165|NCT00460655|526546867|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146009166|NCT00460655|526546868|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146248757|NCT01587703|527423554|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248758|NCT01587703|527423555|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146009167|NCT00460655|526546869|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
146009168|NCT00460655|526546870|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
146009169|NCT00910910|526546871|FG000|Overall Study|Adverse Event|63|||
146298543|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298544|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298545|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298546|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298547|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
146298548|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298549|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
146009170|NCT00910910|526546872|FG001|Overall Study|Adverse Event|35|||
146009171|NCT00910910|526546871|FG000|Overall Study|PD without histologic change|27|||
146009172|NCT00910910|526546872|FG001|Overall Study|PD without histologic change|23|||
146009173|NCT00910910|526546871|FG000|Overall Study|PD with histologic change|0|||
146009174|NCT00910910|526546872|FG001|Overall Study|PD with histologic change|2|||
146009175|NCT00910910|526546871|FG000|Overall Study|Withdrawal by Subject|7|||
146009176|NCT00910910|526546872|FG001|Overall Study|Withdrawal by Subject|5|||
146009177|NCT00910910|526546871|FG000|Overall Study|Lost to Follow-up|2|||
146009178|NCT00910910|526546872|FG001|Overall Study|Lost to Follow-up|2|||
146009179|NCT00910910|526546871|FG000|Overall Study|Death|9|||
146009180|NCT00910910|526546872|FG001|Overall Study|Death|3|||
146248759|NCT01587703|527423556|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248760|NCT01587703|527423557|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248761|NCT01587703|527423558|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248762|NCT01587703|527423559|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248763|NCT01587703|527423560|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248764|NCT01587703|527423561|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
146248765|NCT01587703|527423562|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248766|NCT01587703|527423563|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248767|NCT01587703|527423564|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248768|NCT01587703|527423565|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248769|NCT01587703|527423566|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248770|NCT01587703|527423567|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248771|NCT01587703|527423568|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248772|NCT01587703|527423569|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248773|NCT01587703|527423570|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146248774|NCT01587703|527423571|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
146009181|NCT00910910|526546871|FG000|Overall Study|Protocol Violation|2|||
146009182|NCT00910910|526546872|FG001|Overall Study|Protocol Violation|2|||
146009183|NCT00910910|526546871|FG000|Overall Study|Completed 13 cycles of treatment|0|||
146009184|NCT00910910|526546872|FG001|Overall Study|Completed 13 cycles of treatment|118|||
146009185|NCT00910910|526546871|FG000|Overall Study|Other|114|||
146009186|NCT00910910|526546872|FG001|Overall Study|Other|32|||
146009187|NCT00910910|526546871|FG000|Overall Study|Untreated before cycle 1|1|||
146009188|NCT00910910|526546872|FG001|Overall Study|Untreated before cycle 1|2|||
146009189|NCT01973231|526546873|FG000|Overall Study|Protocol Violation|1|||
146009190|NCT01973231|526546874|FG001|Overall Study|Protocol Violation|1|||
146009191|NCT01973231|526546873|FG000|Overall Study|Lost to Follow-up|1|||
146009192|NCT01973231|526546874|FG001|Overall Study|Lost to Follow-up|1|||
146009193|NCT01973231|526546873|FG000|Overall Study|unclassified|2|||
146009194|NCT01973231|526546874|FG001|Overall Study|unclassified|1|||
146009195|NCT01973231|526546873|FG000|Overall Study|Withdrawal by Subject|7|||
146009196|NCT01973231|526546874|FG001|Overall Study|Withdrawal by Subject|9|||
146009197|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
146009198|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
146009199|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009200|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009201|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009202|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009203|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009204|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009205|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009206|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
146009207|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
146009208|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
146009209|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009210|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009211|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009212|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009213|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146092718|NCT02775903|526860365|FG000|Overall Study|Other reasons|7|||
146298550|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298551|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
146009214|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009215|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009216|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
146009217|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
146009218|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009219|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009220|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009221|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009222|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009223|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009224|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009225|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009226|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
146009227|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
146009228|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
146009229|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009230|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009231|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009232|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009233|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009234|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009235|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146248775|NCT01587703|527423553|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248776|NCT01587703|527423554|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248777|NCT01587703|527423555|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248778|NCT01587703|527423556|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248779|NCT01587703|527423557|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248780|NCT01587703|527423558|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248781|NCT01587703|527423559|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248782|NCT01587703|527423560|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248783|NCT01587703|527423561|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248784|NCT01587703|527423562|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248785|NCT01587703|527423563|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248786|NCT01587703|527423564|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248787|NCT01587703|527423565|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248788|NCT01587703|527423566|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248789|NCT01587703|527423567|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248790|NCT01587703|527423568|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248791|NCT01587703|527423569|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248792|NCT01587703|527423570|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
146248793|NCT01587703|527423571|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
146248794|NCT01587703|527423553|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248795|NCT01587703|527423554|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248796|NCT01587703|527423555|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248797|NCT01587703|527423556|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248798|NCT01587703|527423557|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248799|NCT01587703|527423558|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248800|NCT01587703|527423559|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248801|NCT01587703|527423560|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248802|NCT01587703|527423561|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248803|NCT01587703|527423562|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248804|NCT01587703|527423563|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248805|NCT01587703|527423564|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248806|NCT01587703|527423565|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248807|NCT01587703|527423566|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248808|NCT01587703|527423567|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248809|NCT01587703|527423568|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248810|NCT01587703|527423569|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
146248811|NCT01587703|527423570|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
146248812|NCT01587703|527423571|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
146248813|NCT01587703|527423553|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248814|NCT01587703|527423554|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248815|NCT01587703|527423555|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248816|NCT01587703|527423556|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248817|NCT01587703|527423557|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248818|NCT01587703|527423558|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248819|NCT01587703|527423559|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248820|NCT01587703|527423560|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248821|NCT01587703|527423561|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248822|NCT01587703|527423562|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248823|NCT01587703|527423563|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248824|NCT01587703|527423564|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248825|NCT01587703|527423565|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248826|NCT01587703|527423566|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248827|NCT01587703|527423567|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248828|NCT01587703|527423568|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
146248829|NCT01587703|527423569|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248830|NCT01587703|527423570|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248831|NCT01587703|527423571|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
146248832|NCT01587703|527423553|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248833|NCT01587703|527423554|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248834|NCT01587703|527423555|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248835|NCT01587703|527423556|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248836|NCT01587703|527423557|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248837|NCT01587703|527423558|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248838|NCT01587703|527423559|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248839|NCT01587703|527423560|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248840|NCT01587703|527423561|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248841|NCT01587703|527423562|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248842|NCT01587703|527423563|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248843|NCT01587703|527423564|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
146248844|NCT01587703|527423565|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248845|NCT01587703|527423566|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248846|NCT01587703|527423567|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
146248847|NCT01587703|527423568|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248848|NCT01587703|527423569|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248849|NCT01587703|527423570|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248850|NCT01587703|527423571|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
146248851|NCT01587703|527423553|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248852|NCT01587703|527423554|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248853|NCT01587703|527423555|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248854|NCT01587703|527423556|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248855|NCT01587703|527423557|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248856|NCT01587703|527423558|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248857|NCT01587703|527423559|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248858|NCT01587703|527423560|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248859|NCT01587703|527423561|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248860|NCT01587703|527423562|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248861|NCT01587703|527423563|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248862|NCT01587703|527423564|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
146248863|NCT01587703|527423565|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
146248864|NCT01587703|527423566|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
146248865|NCT01587703|527423567|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
146248866|NCT01587703|527423568|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
146248867|NCT01587703|527423569|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
146248868|NCT01587703|527423570|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146298552|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298553|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
146248869|NCT01587703|527423571|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
146248870|NCT01587703|527423553|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248871|NCT01587703|527423554|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248872|NCT01587703|527423555|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248873|NCT01587703|527423556|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248874|NCT01587703|527423557|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248875|NCT01587703|527423558|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248876|NCT01587703|527423559|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248877|NCT01587703|527423560|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248878|NCT01587703|527423561|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248879|NCT01587703|527423562|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
146298554|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
146009236|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
146009237|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009238|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
146009239|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009240|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009241|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009242|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009243|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009244|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009245|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009246|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
146009247|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
146009248|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
146009249|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009250|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009251|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009252|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009253|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009254|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009255|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009256|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
146009257|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
146009258|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
146009259|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009260|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009261|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009262|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009263|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009264|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009265|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009266|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
146009267|NCT01194219|526546876|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
146009268|NCT01194219|526546877|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
146009269|NCT01194219|526546878|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009270|NCT01194219|526546879|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009271|NCT01194219|526546880|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146298555|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298556|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298557|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298558|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
146298559|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298560|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146009272|NCT01194219|526546881|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009273|NCT01194219|526546882|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009274|NCT01194219|526546883|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009275|NCT01194219|526546884|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009276|NCT01194219|526546885|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
146009277|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009278|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009279|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
146009280|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
146009281|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009282|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009283|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009284|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009285|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009286|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
146009287|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009288|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009289|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
146009290|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
146009291|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009292|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009293|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009294|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009295|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009296|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
146009297|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146092719|NCT02775903|526860366|FG001|Overall Study|Other reasons|8|||
146298561|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298562|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298563|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
146298564|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
146298565|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298566|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
146298567|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298568|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298569|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
146298570|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146298571|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146298572|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146298573|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146298574|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146298575|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
146298576|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
146298577|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
146298578|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146298579|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146298580|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
146298581|NCT04178967|527607928|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298582|NCT04178967|527607929|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298583|NCT04178967|527607930|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298584|NCT04178967|527607931|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
146298585|NCT04178967|527607932|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298586|NCT04178967|527607933|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
146298587|NCT04178967|527607934|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
146298588|NCT04178967|527607935|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
146009298|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009299|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
146009300|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
146009301|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009302|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009303|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009304|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009305|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009306|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
146009307|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009308|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009309|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
146009310|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
146009311|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009312|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009313|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009314|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009315|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009316|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
146009317|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009318|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009319|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
146009320|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009321|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009322|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009323|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009324|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009325|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009326|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
146009327|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009328|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009329|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009330|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
146009331|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009332|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009333|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009334|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009335|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146248880|NCT01587703|527423563|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248881|NCT01587703|527423564|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
146248882|NCT01587703|527423565|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
146248883|NCT01587703|527423566|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
146248884|NCT01587703|527423567|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
146248885|NCT01587703|527423568|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
146248886|NCT01587703|527423569|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
146248887|NCT01587703|527423570|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248888|NCT01587703|527423571|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
146248889|NCT01587703|527423553|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248890|NCT01587703|527423554|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248891|NCT01587703|527423555|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248892|NCT01587703|527423556|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146009336|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
146009337|NCT01194219|526546876|FG000|Maintenance Phase Weeks16-32|Other|0|||
146009338|NCT01194219|526546877|FG001|Maintenance Phase Weeks16-32|Other|0|||
146009339|NCT01194219|526546878|FG002|Maintenance Phase Weeks16-32|Other|2|||
146009340|NCT01194219|526546879|FG003|Maintenance Phase Weeks16-32|Other|1|||
146009341|NCT01194219|526546880|FG004|Maintenance Phase Weeks16-32|Other|0|||
146009342|NCT01194219|526546881|FG005|Maintenance Phase Weeks16-32|Other|0|||
146009343|NCT01194219|526546882|FG006|Maintenance Phase Weeks16-32|Other|0|||
146009344|NCT01194219|526546883|FG007|Maintenance Phase Weeks16-32|Other|0|||
146009345|NCT01194219|526546884|FG008|Maintenance Phase Weeks16-32|Other|0|||
146009346|NCT01194219|526546885|FG009|Maintenance Phase Weeks16-32|Other|0|||
146009347|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009348|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009349|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009350|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009351|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009352|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
146009353|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
146009354|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
146009355|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009356|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
146009357|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009358|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009359|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009360|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009361|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
146009362|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
146009363|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
146009364|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
146009365|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009366|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
146009367|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009368|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009369|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009370|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009371|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
146009372|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009373|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
146009374|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009375|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009376|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
146009377|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009378|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009379|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146092720|NCT02775903|526860367|FG002|Overall Study|Other reasons|2|||
146092721|NCT02775903|526860368|FG003|Overall Study|Other reasons|12|||
146092722|NCT00458536|526860371|FG000|Overall Study|Disease progression prior to treatment|7|||
146092723|NCT00458536|526860371|FG000|Overall Study|Unable to make vaccine|3|||
146248893|NCT01587703|527423557|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248894|NCT01587703|527423558|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248895|NCT01587703|527423559|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146009380|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009381|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
146009382|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009383|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
146009384|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
146009385|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009386|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
146009387|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009388|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009389|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009390|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146248896|NCT01587703|527423560|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248897|NCT01587703|527423561|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248898|NCT01587703|527423562|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248899|NCT01587703|527423563|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248900|NCT01587703|527423564|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
146248901|NCT01587703|527423565|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248902|NCT01587703|527423566|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248903|NCT01587703|527423567|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248904|NCT01587703|527423568|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248905|NCT01587703|527423569|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248906|NCT01587703|527423570|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248907|NCT01587703|527423571|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
146248908|NCT01012999|527423573|FG000|Overall Study|Protocol Violation|1|||
146248909|NCT01322347|527423574|FG000|Overall Study|Adverse Event|7|||
146248910|NCT01322347|527423575|FG001|Overall Study|Adverse Event|2|||
146248911|NCT01322347|527423574|FG000|Overall Study|Death|5|||
146248912|NCT01322347|527423575|FG001|Overall Study|Death|3|||
146248913|NCT01322347|527423574|FG000|Overall Study|Physician Decision|2|||
146248914|NCT01322347|527423575|FG001|Overall Study|Physician Decision|1|||
146248915|NCT01322347|527423574|FG000|Overall Study|Protocol Violation|5|||
146248916|NCT01322347|527423575|FG001|Overall Study|Protocol Violation|2|||
146248917|NCT01322347|527423574|FG000|Overall Study|Withdrawal by Subject|1|||
146248918|NCT01322347|527423575|FG001|Overall Study|Withdrawal by Subject|4|||
146248919|NCT01322347|527423574|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
146248920|NCT01322347|527423575|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
146248921|NCT01322347|527423574|FG000|Overall Study|blood transfusion|5|||
146248922|NCT01322347|527423575|FG001|Overall Study|blood transfusion|5|||
146248923|NCT01322347|527423574|FG000|Overall Study|sponsor decision|1|||
146248924|NCT01322347|527423575|FG001|Overall Study|sponsor decision|3|||
146248925|NCT01322347|527423574|FG000|Overall Study|ineligible|6|||
146248926|NCT01322347|527423575|FG001|Overall Study|ineligible|3|||
146248927|NCT01322347|527423574|FG000|Overall Study|kidney transplant|3|||
146248928|NCT01322347|527423575|FG001|Overall Study|kidney transplant|1|||
146248929|NCT01322347|527423574|FG000|Overall Study|study drug withheld > 12 wks|0|||
146248930|NCT01322347|527423575|FG001|Overall Study|study drug withheld > 12 wks|1|||
146248931|NCT01322347|527423574|FG000|Overall Study|moved/changed dialysis|2|||
146248932|NCT01322347|527423575|FG001|Overall Study|moved/changed dialysis|4|||
146248933|NCT04883541|527423576|FG000|Overall Study|Not attending regular yoga class|16|||
146248934|NCT04883541|527423577|FG001|Overall Study|Not attending regular yoga class|0|||
146248935|NCT04883541|527423576|FG000|Overall Study|Not attending the pregnancy school|0|||
146248936|NCT04883541|527423577|FG001|Overall Study|Not attending the pregnancy school|9|||
146248937|NCT01369147|527423578|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
146248938|NCT01369147|527423579|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
146248939|NCT01369147|527423580|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
146248940|NCT02823574|527423581|FG000|Randomization|Disease Progression|0|||
146248941|NCT02823574|527423582|FG001|Randomization|Disease Progression|0|||
146248942|NCT02823574|527423583|FG002|Randomization|Disease Progression|1|||
146248943|NCT02823574|527423584|FG003|Randomization|Disease Progression|0|||
146248944|NCT02823574|527423581|FG000|Randomization|AE unrelated to Study Drug|1|||
146248945|NCT02823574|527423582|FG001|Randomization|AE unrelated to Study Drug|0|||
146248946|NCT02823574|527423583|FG002|Randomization|AE unrelated to Study Drug|0|||
146248947|NCT02823574|527423584|FG003|Randomization|AE unrelated to Study Drug|0|||
146248948|NCT02823574|527423581|FG000|Treatment Period|Poor/Non Compliance|1|||
146248949|NCT02823574|527423582|FG001|Treatment Period|Poor/Non Compliance|0|||
146248950|NCT02823574|527423583|FG002|Treatment Period|Poor/Non Compliance|0|||
146248951|NCT02823574|527423584|FG003|Treatment Period|Poor/Non Compliance|1|||
146248952|NCT02823574|527423581|FG000|Treatment Period|Maximum Clinical Benefit|8|||
146248953|NCT02823574|527423582|FG001|Treatment Period|Maximum Clinical Benefit|4|||
146248954|NCT02823574|527423583|FG002|Treatment Period|Maximum Clinical Benefit|7|||
146248955|NCT02823574|527423584|FG003|Treatment Period|Maximum Clinical Benefit|1|||
146248956|NCT02823574|527423581|FG000|Treatment Period|Lost to Follow-up|1|||
146298589|NCT04178967|527607936|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298590|NCT04178967|527607937|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298591|NCT04178967|527607938|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
146298592|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
146009391|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
146009392|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
146298593|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298594|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298595|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298596|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298597|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298598|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298599|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298600|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
146298601|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
146298602|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
146298603|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298604|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298605|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298606|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298607|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298608|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298609|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298610|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146298611|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
146298612|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
146298613|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
146298614|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298615|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298616|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298617|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298618|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298619|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298620|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298621|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298622|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298623|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
146298624|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146298625|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298626|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298627|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298628|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298629|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298630|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298631|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298632|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146298633|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
146298634|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
146298635|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146298636|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298637|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298638|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298639|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146009393|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
146009394|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009395|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009396|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
146009397|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009398|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146298640|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298641|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298642|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298643|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298644|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146009399|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009400|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009401|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009402|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009403|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009404|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
146009405|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009406|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
146009407|NCT01194219|526546876|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009408|NCT01194219|526546877|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009409|NCT01194219|526546878|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009410|NCT01194219|526546879|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009411|NCT01194219|526546880|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009412|NCT01194219|526546881|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009413|NCT01194219|526546882|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
146009414|NCT01194219|526546883|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009415|NCT01194219|526546884|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009416|NCT01194219|526546885|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
146009417|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009418|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009419|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009420|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009421|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009422|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009423|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009424|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
146009425|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
146009426|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
146009427|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009428|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009429|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009430|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009431|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009432|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009433|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009434|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
146009435|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
146009436|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
146009437|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009438|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009439|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009440|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146248957|NCT02823574|527423582|FG001|Treatment Period|Lost to Follow-up|1|||
146248958|NCT02823574|527423583|FG002|Treatment Period|Lost to Follow-up|0|||
146248959|NCT02823574|527423584|FG003|Treatment Period|Lost to Follow-up|0|||
146248960|NCT02823574|527423581|FG000|Treatment Period|Participant withdrew consent|4|||
146248961|NCT02823574|527423582|FG001|Treatment Period|Participant withdrew consent|0|||
146248962|NCT02823574|527423583|FG002|Treatment Period|Participant withdrew consent|0|||
146248963|NCT02823574|527423584|FG003|Treatment Period|Participant withdrew consent|1|||
146248964|NCT02823574|527423581|FG000|Treatment Period|Participant request to discontinue|5|||
146248965|NCT02823574|527423582|FG001|Treatment Period|Participant request to discontinue|0|||
146248966|NCT02823574|527423583|FG002|Treatment Period|Participant request to discontinue|3|||
146248967|NCT02823574|527423584|FG003|Treatment Period|Participant request to discontinue|2|||
146248968|NCT02823574|527423581|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
146248969|NCT02823574|527423582|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
146248970|NCT02823574|527423583|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
146248971|NCT02823574|527423584|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
146248972|NCT02823574|527423581|FG000|Treatment Period|Study Drug Toxicity|11|||
146248973|NCT02823574|527423582|FG001|Treatment Period|Study Drug Toxicity|2|||
146248974|NCT02823574|527423583|FG002|Treatment Period|Study Drug Toxicity|14|||
146248975|NCT02823574|527423584|FG003|Treatment Period|Study Drug Toxicity|4|||
146009441|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009442|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146248976|NCT02823574|527423581|FG000|Treatment Period|Disease Progression|113|||
146248977|NCT02823574|527423582|FG001|Treatment Period|Disease Progression|64|||
146248978|NCT02823574|527423583|FG002|Treatment Period|Disease Progression|82|||
146248979|NCT02823574|527423584|FG003|Treatment Period|Disease Progression|43|||
146009443|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009444|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
146009445|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
146298645|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
146248980|NCT02823574|527423581|FG000|Treatment Period|Other reasons|5|||
146248981|NCT02823574|527423582|FG001|Treatment Period|Other reasons|9|||
146248982|NCT02823574|527423583|FG002|Treatment Period|Other reasons|3|||
146248983|NCT02823574|527423584|FG003|Treatment Period|Other reasons|6|||
146248984|NCT02823574|527423581|FG000|Treatment Period|Participant no longer meets study criteria|0|||
146248985|NCT02823574|527423582|FG001|Treatment Period|Participant no longer meets study criteria|0|||
146248986|NCT02823574|527423583|FG002|Treatment Period|Participant no longer meets study criteria|1|||
146248987|NCT02823574|527423584|FG003|Treatment Period|Participant no longer meets study criteria|0|||
146248988|NCT02823574|527423581|FG000|Treatment Period|Death|0|||
146248989|NCT02823574|527423582|FG001|Treatment Period|Death|0|||
146248990|NCT02823574|527423583|FG002|Treatment Period|Death|3|||
146248991|NCT02823574|527423584|FG003|Treatment Period|Death|1|||
146248992|NCT00590759|527423585|FG000|Overall Study|Death|52|||
146248993|NCT00590759|527423585|FG000|Overall Study|Lost to Follow-up|28|||
146248994|NCT02991118|527423586|FG000|Overall Study|Death|3|||
146248995|NCT02991118|527423587|FG001|Overall Study|Death|8|||
146248996|NCT02991118|527423586|FG000|Overall Study|Protocol Violation|0|||
146248997|NCT02991118|527423587|FG001|Overall Study|Protocol Violation|3|||
146248998|NCT02991118|527423586|FG000|Overall Study|Physician Decision|0|||
146248999|NCT02991118|527423587|FG001|Overall Study|Physician Decision|1|||
146249000|NCT02991118|527423586|FG000|Overall Study|Moved out of the country|0|||
146249001|NCT02991118|527423587|FG001|Overall Study|Moved out of the country|1|||
146249002|NCT02991118|527423586|FG000|Overall Study|Adverse Event|2|||
146249003|NCT02991118|527423587|FG001|Overall Study|Adverse Event|2|||
146249004|NCT02991118|527423586|FG000|Overall Study|Withdrawal by Subject|1|||
146249005|NCT02991118|527423587|FG001|Overall Study|Withdrawal by Subject|7|||
146249006|NCT02991118|527423586|FG000|Overall Study|Could not attend study visits|0|||
146249007|NCT02991118|527423587|FG001|Overall Study|Could not attend study visits|1|||
146249008|NCT02991118|527423586|FG000|Overall Study|Lost to Follow-up|1|||
146249009|NCT02991118|527423587|FG001|Overall Study|Lost to Follow-up|9|||
146249010|NCT00963924|527423592|FG000|Overall Study|Adverse Event|1|||
146249011|NCT00963924|527423593|FG001|Overall Study|Adverse Event|0|||
146249012|NCT00963924|527423592|FG000|Overall Study|Withdrawal by Subject|0|||
146249013|NCT00963924|527423593|FG001|Overall Study|Withdrawal by Subject|1|||
146249014|NCT00963924|527423592|FG000|Overall Study|Changed antipsychotic|0|||
146249015|NCT00963924|527423593|FG001|Overall Study|Changed antipsychotic|1|||
146249016|NCT00963924|527423592|FG000|Overall Study|Lost to Follow-up|0|||
146249017|NCT00963924|527423593|FG001|Overall Study|Lost to Follow-up|1|||
146249018|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
146249019|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
146249020|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
146249021|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
146249022|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
146249023|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Adverse Event|0|||
146249024|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Adverse Event|1|||
146249025|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Adverse Event|1|||
146249026|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Adverse Event|0|||
146249027|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Adverse Event|0|||
146298646|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
146298647|NCT04178967|527607928|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298648|NCT04178967|527607929|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298649|NCT04178967|527607930|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298650|NCT04178967|527607931|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298651|NCT04178967|527607932|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298652|NCT04178967|527607933|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298653|NCT04178967|527607934|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298654|NCT04178967|527607935|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298655|NCT04178967|527607936|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146298656|NCT04178967|527607937|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
146298657|NCT04178967|527607938|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
146249028|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
146249029|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146249030|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146249031|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146249032|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
146009446|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
146009447|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009448|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009449|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146249033|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Physician Decision|1|||
146249034|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Physician Decision|0|||
146249035|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Physician Decision|0|||
146249036|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Physician Decision|0|||
146298658|NCT00628251|527607942|FG000|Randomised Part|Withdrawal by Subject|0|||
146298659|NCT00628251|527607943|FG001|Randomised Part|Withdrawal by Subject|0|||
146298660|NCT00628251|527607944|FG002|Randomised Part|Withdrawal by Subject|1|||
146298661|NCT00628251|527607942|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
146298662|NCT00628251|527607943|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
146298663|NCT00628251|527607944|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
146298664|NCT00628251|527607942|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
146298665|NCT00628251|527607943|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
146298666|NCT00628251|527607944|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
146298667|NCT00628251|527607942|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
146298668|NCT00628251|527607943|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
146298669|NCT00628251|527607944|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
146298670|NCT00628251|527607942|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
146298671|NCT00628251|527607943|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
146298672|NCT00628251|527607944|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
146298673|NCT00628251|527607942|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
146298674|NCT00628251|527607943|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
146298675|NCT00628251|527607944|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
146298676|NCT01251120|527607946|FG000|Overall Study|Lack of Efficacy|0|||
146298677|NCT01251120|527607947|FG001|Overall Study|Lack of Efficacy|1|||
146298678|NCT01822522|527607948|FG000|Overall Study|Adverse Event|1|||
146298679|NCT01822522|527607949|FG001|Overall Study|Adverse Event|1|||
146298680|NCT01822522|527607950|FG002|Overall Study|Adverse Event|1|||
146298681|NCT01822522|527607951|FG003|Overall Study|Adverse Event|0|||
146298682|NCT01822522|527607952|FG004|Overall Study|Adverse Event|0|||
146298683|NCT01822522|527607953|FG005|Overall Study|Adverse Event|1|||
146298684|NCT01822522|527607948|FG000|Overall Study|Death|3|||
146298685|NCT01822522|527607949|FG001|Overall Study|Death|0|||
146298686|NCT01822522|527607950|FG002|Overall Study|Death|2|||
146298687|NCT01822522|527607951|FG003|Overall Study|Death|0|||
146298688|NCT01822522|527607952|FG004|Overall Study|Death|0|||
146298689|NCT01822522|527607953|FG005|Overall Study|Death|0|||
146298690|NCT01822522|527607948|FG000|Overall Study|Lost to Follow-up|0|||
146298691|NCT01822522|527607949|FG001|Overall Study|Lost to Follow-up|0|||
146298692|NCT01822522|527607950|FG002|Overall Study|Lost to Follow-up|1|||
146298693|NCT01822522|527607951|FG003|Overall Study|Lost to Follow-up|1|||
146298694|NCT01822522|527607952|FG004|Overall Study|Lost to Follow-up|0|||
146298695|NCT01822522|527607953|FG005|Overall Study|Lost to Follow-up|1|||
146298696|NCT01822522|527607948|FG000|Overall Study|Withdrawal by Subject|0|||
146298697|NCT01822522|527607949|FG001|Overall Study|Withdrawal by Subject|0|||
146298698|NCT01822522|527607950|FG002|Overall Study|Withdrawal by Subject|0|||
146298699|NCT01822522|527607951|FG003|Overall Study|Withdrawal by Subject|1|||
146298700|NCT01822522|527607952|FG004|Overall Study|Withdrawal by Subject|0|||
146298701|NCT01822522|527607953|FG005|Overall Study|Withdrawal by Subject|0|||
146298702|NCT01822522|527607948|FG000|Overall Study|Lack of Efficacy|0|||
146298703|NCT01822522|527607949|FG001|Overall Study|Lack of Efficacy|0|||
146298704|NCT01822522|527607950|FG002|Overall Study|Lack of Efficacy|0|||
146298705|NCT01822522|527607951|FG003|Overall Study|Lack of Efficacy|0|||
146298706|NCT01822522|527607952|FG004|Overall Study|Lack of Efficacy|0|||
146298707|NCT01822522|527607953|FG005|Overall Study|Lack of Efficacy|2|||
146298708|NCT01807923|527607954|FG000|Overall Study|Adverse Event|2|||
146298709|NCT01807923|527607955|FG001|Overall Study|Adverse Event|1|||
146298710|NCT01807923|527607956|FG002|Overall Study|Adverse Event|2|||
146298711|NCT01807923|527607954|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
146298712|NCT01807923|527607955|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
146298713|NCT01807923|527607956|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
146298714|NCT01807923|527607954|FG000|Overall Study|Physician Decision|0|||
146298715|NCT01807923|527607955|FG001|Overall Study|Physician Decision|0|||
146298716|NCT01807923|527607956|FG002|Overall Study|Physician Decision|1|||
146298717|NCT01807923|527607954|FG000|Overall Study|Not Eligible (Genotype)|0|||
146298718|NCT01807923|527607955|FG001|Overall Study|Not Eligible (Genotype)|0|||
146298719|NCT01807923|527607956|FG002|Overall Study|Not Eligible (Genotype)|1|||
146298720|NCT01807923|527607954|FG000|Overall Study|Randomized But Not Treated|3|||
146298721|NCT01807923|527607955|FG001|Overall Study|Randomized But Not Treated|2|||
146298722|NCT01807923|527607956|FG002|Overall Study|Randomized But Not Treated|5|||
146298723|NCT02558231|527607958|FG000|Overall Study|Death|4|||
146092724|NCT00458536|526860371|FG000|Overall Study|No measurable disease after surgery|2|||
146092725|NCT00458536|526860371|FG000|Overall Study|Did not have renal cell carcinoma|2|||
146092726|NCT00458536|526860371|FG000|Overall Study|Patient did not have surgery|1|||
146092727|NCT00458536|526860371|FG000|Overall Study|Ineligible due to toxicity|1|||
146298724|NCT02558231|527607959|FG001|Overall Study|Death|12|||
146298725|NCT02558231|527607958|FG000|Overall Study|Lost to Follow-up|7|||
146298726|NCT02558231|527607959|FG001|Overall Study|Lost to Follow-up|4|||
146298727|NCT02558231|527607958|FG000|Overall Study|Withdrawal by Subject|7|||
146298728|NCT02558231|527607959|FG001|Overall Study|Withdrawal by Subject|4|||
146092728|NCT00458536|526860371|FG000|Overall Study|Withdrawal by Subject|1|||
146092729|NCT00458536|526860371|FG000|Overall Study|Progressive disease during treatment|2|||
146092730|NCT00285207|526860374|FG000|Overall Study|Lost to Follow-up|3|||
146092731|NCT00285207|526860375|FG001|Overall Study|Lost to Follow-up|2|||
146092732|NCT00285207|526860374|FG000|Overall Study|Withdrawal by Subject|5|||
146092733|NCT00285207|526860375|FG001|Overall Study|Withdrawal by Subject|2|||
146092734|NCT00285207|526860374|FG000|Overall Study|Pregnancy|1|||
146092735|NCT00285207|526860375|FG001|Overall Study|Pregnancy|1|||
146092736|NCT00285207|526860374|FG000|Overall Study|non-compliance|0|||
146092737|NCT00285207|526860375|FG001|Overall Study|non-compliance|1|||
146092738|NCT04571515|526860377|FG000|Overall Study|Physician Decision|0|||
146092739|NCT04571515|526860378|FG001|Overall Study|Physician Decision|0|||
146092740|NCT04571515|526860379|FG002|Overall Study|Physician Decision|0|||
146092741|NCT04571515|526860380|FG003|Overall Study|Physician Decision|0|||
146092742|NCT04571515|526860381|FG004|Overall Study|Physician Decision|1|||
146092743|NCT04571515|526860377|FG000|Overall Study|Withdrawal by Subject|0|||
146092744|NCT04571515|526860378|FG001|Overall Study|Withdrawal by Subject|0|||
146092745|NCT04571515|526860379|FG002|Overall Study|Withdrawal by Subject|0|||
146092746|NCT04571515|526860380|FG003|Overall Study|Withdrawal by Subject|0|||
146092747|NCT04571515|526860381|FG004|Overall Study|Withdrawal by Subject|1|||
146092748|NCT04571515|526860377|FG000|Overall Study|insufficient pain|1|||
146092749|NCT04571515|526860378|FG001|Overall Study|insufficient pain|0|||
146092750|NCT04571515|526860379|FG002|Overall Study|insufficient pain|0|||
146092751|NCT04571515|526860380|FG003|Overall Study|insufficient pain|0|||
146092752|NCT04571515|526860381|FG004|Overall Study|insufficient pain|1|||
146092753|NCT01659658|526861641|FG000|Overall Study|Withdrawal by Patient|18|||
146092754|NCT01659658|526861642|FG001|Overall Study|Withdrawal by Patient|4|||
146092755|NCT01659658|526861643|FG002|Overall Study|Withdrawal by Patient|2|||
146092756|NCT01659658|526861644|FG003|Overall Study|Withdrawal by Patient|0|||
146092757|NCT01659658|526861645|FG004|Overall Study|Withdrawal by Patient|11|||
146092758|NCT01659658|526861641|FG000|Overall Study|Study Terminated by Sponsor|9|||
146092759|NCT01659658|526861642|FG001|Overall Study|Study Terminated by Sponsor|7|||
146092760|NCT01659658|526861643|FG002|Overall Study|Study Terminated by Sponsor|0|||
146092761|NCT01659658|526861644|FG003|Overall Study|Study Terminated by Sponsor|1|||
146092762|NCT01659658|526861645|FG004|Overall Study|Study Terminated by Sponsor|4|||
146092763|NCT01659658|526861641|FG000|Overall Study|Reason not Specified|61|||
146092764|NCT01659658|526861642|FG001|Overall Study|Reason not Specified|15|||
146092765|NCT01659658|526861643|FG002|Overall Study|Reason not Specified|8|||
146092766|NCT01659658|526861644|FG003|Overall Study|Reason not Specified|1|||
146092767|NCT01659658|526861645|FG004|Overall Study|Reason not Specified|34|||
146092768|NCT01659658|526861641|FG000|Overall Study|Lost to Follow-up|2|||
146092769|NCT01659658|526861642|FG001|Overall Study|Lost to Follow-up|0|||
146092770|NCT01659658|526861643|FG002|Overall Study|Lost to Follow-up|0|||
146092771|NCT01659658|526861644|FG003|Overall Study|Lost to Follow-up|0|||
146092772|NCT01659658|526861645|FG004|Overall Study|Lost to Follow-up|0|||
146092773|NCT01927341|526861647|FG000|Phase 1b|Lost to Follow-up|1|||
146092774|NCT01927341|526861648|FG001|Phase 1b|Lost to Follow-up|0|||
146092775|NCT01927341|526861649|FG002|Phase 1b|Lost to Follow-up|0|||
146092776|NCT01927341|526861650|FG003|Phase 1b|Lost to Follow-up|0|||
146092777|NCT01927341|526861651|FG004|Phase 1b|Lost to Follow-up|0|||
146092778|NCT01927341|526861647|FG000|Phase 1b|Death|2|||
146092779|NCT01927341|526861648|FG001|Phase 1b|Death|0|||
146092780|NCT01927341|526861649|FG002|Phase 1b|Death|0|||
146249037|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Physician Decision|0|||
146092781|NCT01927341|526861650|FG003|Phase 1b|Death|0|||
146092782|NCT01927341|526861651|FG004|Phase 1b|Death|0|||
146092783|NCT01927341|526861647|FG000|Phase 1b|Follow-up completed|7|||
146092784|NCT01927341|526861648|FG001|Phase 1b|Follow-up completed|0|||
146092785|NCT01927341|526861649|FG002|Phase 1b|Follow-up completed|0|||
146092786|NCT01927341|526861650|FG003|Phase 1b|Follow-up completed|0|||
146092787|NCT01927341|526861651|FG004|Phase 1b|Follow-up completed|0|||
146092788|NCT01927341|526861647|FG000|Phase 2|Lost to Follow-up|0|||
146092789|NCT01927341|526861648|FG001|Phase 2|Lost to Follow-up|1|||
146092790|NCT01927341|526861649|FG002|Phase 2|Lost to Follow-up|0|||
146092791|NCT01927341|526861650|FG003|Phase 2|Lost to Follow-up|0|||
146092792|NCT01927341|526861651|FG004|Phase 2|Lost to Follow-up|0|||
146092793|NCT01927341|526861647|FG000|Phase 2|Participant withdrew consent|0|||
146092794|NCT01927341|526861648|FG001|Phase 2|Participant withdrew consent|2|||
146092795|NCT01927341|526861649|FG002|Phase 2|Participant withdrew consent|1|||
146092796|NCT01927341|526861650|FG003|Phase 2|Participant withdrew consent|2|||
146092797|NCT01927341|526861651|FG004|Phase 2|Participant withdrew consent|3|||
146092798|NCT01927341|526861647|FG000|Phase 2|Death|0|||
146092799|NCT01927341|526861648|FG001|Phase 2|Death|4|||
146092800|NCT01927341|526861649|FG002|Phase 2|Death|0|||
146092801|NCT01927341|526861650|FG003|Phase 2|Death|3|||
146092802|NCT01927341|526861651|FG004|Phase 2|Death|2|||
146092803|NCT01927341|526861647|FG000|Phase 2|New cancer therapy|0|||
146092804|NCT01927341|526861648|FG001|Phase 2|New cancer therapy|1|||
146092805|NCT01927341|526861649|FG002|Phase 2|New cancer therapy|0|||
146092806|NCT01927341|526861650|FG003|Phase 2|New cancer therapy|4|||
146092807|NCT01927341|526861651|FG004|Phase 2|New cancer therapy|1|||
146249038|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
146249039|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
146249040|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
146249041|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
146249042|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
146249043|NCT00446095|527423594|FG000|Phase II (8 Weeks)|Ongoing|0|||
146249044|NCT00446095|527423595|FG001|Phase II (8 Weeks)|Ongoing|0|||
146249045|NCT00446095|527423596|FG002|Phase II (8 Weeks)|Ongoing|1|||
146009450|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009451|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009452|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009453|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009454|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
146009455|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
146009456|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
146009457|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
146009458|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
146009459|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
146009460|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
146009461|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
146009462|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
146009463|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
146009464|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
146009465|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
146009466|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
146009467|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009468|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009469|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009470|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009471|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009472|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009473|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009474|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
146009475|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
146009476|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
146009477|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009478|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009479|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009480|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009481|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009482|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009483|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009484|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009485|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
146009486|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
146009487|NCT01194219|526546876|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009488|NCT01194219|526546877|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009489|NCT01194219|526546878|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009490|NCT01194219|526546879|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009491|NCT01194219|526546880|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009492|NCT01194219|526546881|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009493|NCT01194219|526546882|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009494|NCT01194219|526546883|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
146009495|NCT01194219|526546884|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
146009496|NCT01194219|526546885|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
146009497|NCT01081951|526546886|FG000|Overall Study|Death|54|||
146009498|NCT01081951|526546887|FG001|Overall Study|Death|47|||
146009499|NCT01081951|526546886|FG000|Overall Study|Withdrawal by Subject|2|||
146009500|NCT01081951|526546887|FG001|Overall Study|Withdrawal by Subject|6|||
146009501|NCT01081951|526546886|FG000|Overall Study|Allocated treatment but did not take it|0|||
146009502|NCT01081951|526546887|FG001|Overall Study|Allocated treatment but did not take it|1|||
146009503|NCT01081951|526546886|FG000|Overall Study|Lost to Follow-up|0|||
146009504|NCT01081951|526546887|FG001|Overall Study|Lost to Follow-up|1|||
146009505|NCT03726658|526546891|FG000|Overall Study|Lost to Follow-up|0|||
146009506|NCT03726658|526546892|FG001|Overall Study|Lost to Follow-up|0|||
146009507|NCT03726658|526546893|FG002|Overall Study|Lost to Follow-up|2|||
146009508|NCT03726658|526546894|FG003|Overall Study|Lost to Follow-up|0|||
146009509|NCT03726658|526546895|FG004|Overall Study|Lost to Follow-up|0|||
146009510|NCT03726658|526546896|FG005|Overall Study|Lost to Follow-up|1|||
146092808|NCT01927341|526861647|FG000|Phase 2|Disease progression|0|||
146249046|NCT00446095|527423597|FG003|Phase II (8 Weeks)|Ongoing|0|||
146009511|NCT03726658|526546897|FG006|Overall Study|Lost to Follow-up|1|||
146009512|NCT03726658|526546891|FG000|Overall Study|Withdrawal by Subject|1|||
146249047|NCT00446095|527423598|FG004|Phase II (8 Weeks)|Ongoing|0|||
146249048|NCT00446095|527423594|FG000|Phase I (28 Days)|Adverse Event|0|||
146249049|NCT00446095|527423595|FG001|Phase I (28 Days)|Adverse Event|0|||
146249050|NCT00446095|527423596|FG002|Phase I (28 Days)|Adverse Event|0|||
146249051|NCT00446095|527423597|FG003|Phase I (28 Days)|Adverse Event|1|||
146249052|NCT00446095|527423598|FG004|Phase I (28 Days)|Adverse Event|0|||
146249053|NCT00446095|527423594|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
146249054|NCT00446095|527423595|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
146249055|NCT00446095|527423596|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
146249056|NCT00446095|527423597|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
146249057|NCT00446095|527423598|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
146249058|NCT00657709|527423599|FG000|Overall Study|AE or Death|7|||
146249059|NCT00657709|527423600|FG001|Overall Study|AE or Death|7|||
146249060|NCT00657709|527423601|FG002|Overall Study|AE or Death|6|||
146249061|NCT00657709|527423602|FG003|Overall Study|AE or Death|7|||
146249062|NCT00657709|527423603|FG004|Overall Study|AE or Death|1|||
146249063|NCT00657709|527423599|FG000|Overall Study|Withdrawal by Subject|7|||
146249064|NCT00657709|527423600|FG001|Overall Study|Withdrawal by Subject|15|||
146249065|NCT00657709|527423601|FG002|Overall Study|Withdrawal by Subject|15|||
146249066|NCT00657709|527423602|FG003|Overall Study|Withdrawal by Subject|5|||
146249067|NCT00657709|527423603|FG004|Overall Study|Withdrawal by Subject|9|||
146249068|NCT00657709|527423599|FG000|Overall Study|Lost to Follow-up|9|||
146249069|NCT00657709|527423600|FG001|Overall Study|Lost to Follow-up|9|||
146249070|NCT00657709|527423601|FG002|Overall Study|Lost to Follow-up|7|||
146249071|NCT00657709|527423602|FG003|Overall Study|Lost to Follow-up|1|||
146249072|NCT00657709|527423603|FG004|Overall Study|Lost to Follow-up|21|||
146249073|NCT00657709|527423599|FG000|Overall Study|Protocol Violation|0|||
146249074|NCT00657709|527423600|FG001|Overall Study|Protocol Violation|2|||
146249075|NCT00657709|527423601|FG002|Overall Study|Protocol Violation|0|||
146249076|NCT00657709|527423602|FG003|Overall Study|Protocol Violation|1|||
146249077|NCT00657709|527423603|FG004|Overall Study|Protocol Violation|2|||
146249078|NCT00886834|527423604|FG000|Overall Study|Protocol Violation|0|||
146249079|NCT00886834|527423605|FG001|Overall Study|Protocol Violation|3|||
146249080|NCT02574286|527423606|FG000|Overall Study|Adverse Event|3|||
146249081|NCT02574286|527423606|FG000|Overall Study|Withdrawal by Subject|2|||
146249082|NCT02959866|527423607|FG000|Overall Study|Withdrawal by Subject|1|||
146249083|NCT00952523|527423608|FG000|Overall Study|Withdrawal by Subject|7|||
146249084|NCT03150589|527423609|FG000|Overall Study|Withdrawal by Subject|16|||
146249085|NCT03150589|527423610|FG001|Overall Study|Withdrawal by Subject|9|||
146249086|NCT03150589|527423609|FG000|Overall Study|Adverse Event|7|||
146249087|NCT03150589|527423610|FG001|Overall Study|Adverse Event|6|||
146249088|NCT03150589|527423609|FG000|Overall Study|Protocol Violation|4|||
146249089|NCT03150589|527423610|FG001|Overall Study|Protocol Violation|3|||
146249090|NCT03150589|527423609|FG000|Overall Study|Lost to Follow-up|3|||
146249091|NCT03150589|527423610|FG001|Overall Study|Lost to Follow-up|3|||
146249092|NCT03150589|527423609|FG000|Overall Study|Death|2|||
146249093|NCT03150589|527423610|FG001|Overall Study|Death|3|||
146249094|NCT03150589|527423609|FG000|Overall Study|IP non-compliance and other reasons|12|||
146249095|NCT03150589|527423610|FG001|Overall Study|IP non-compliance and other reasons|3|||
146249096|NCT01405508|527423611|FG000|Overall Study|AE, non-serious non-fatal|1|||
146249097|NCT01405508|527423612|FG001|Overall Study|AE, non-serious non-fatal|1|||
146009513|NCT03726658|526546892|FG001|Overall Study|Withdrawal by Subject|0|||
146249098|NCT01405508|527423613|FG002|Overall Study|AE, non-serious non-fatal|0|||
146249099|NCT01405508|527423614|FG003|Overall Study|AE, non-serious non-fatal|0|||
146249100|NCT00476957|527423619|FG000|Overall Study|Lost to Follow-up|176|||
146249101|NCT00476957|527423620|FG001|Overall Study|Lost to Follow-up|193|||
146249102|NCT00346398|527423621|FG000|Overall Study|Lost to Follow-up|3|||
146249103|NCT00346398|527423622|FG001|Overall Study|Lost to Follow-up|0|||
146249104|NCT00346398|527423621|FG000|Overall Study|Withdrawal by Subject|0|||
146249105|NCT00346398|527423622|FG001|Overall Study|Withdrawal by Subject|2|||
146249106|NCT02607956|527423623|FG000|Double-Blinded Phase|Withdrew Consent|17|||
146249107|NCT02607956|527423624|FG001|Double-Blinded Phase|Withdrew Consent|19|||
146249108|NCT02607956|527423625|FG002|Double-Blinded Phase|Withdrew Consent|0|||
146249109|NCT02607956|527423626|FG003|Double-Blinded Phase|Withdrew Consent|0|||
146249110|NCT02607956|527423623|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
146249111|NCT02607956|527423624|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
146249112|NCT02607956|527423625|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
146249113|NCT02607956|527423626|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
146249114|NCT02607956|527423623|FG000|Double-Blinded Phase|Randomized but never treated|7|||
146009514|NCT03726658|526546893|FG002|Overall Study|Withdrawal by Subject|0|||
146249115|NCT02607956|527423624|FG001|Double-Blinded Phase|Randomized but never treated|5|||
146249116|NCT02607956|527423625|FG002|Double-Blinded Phase|Randomized but never treated|0|||
146249117|NCT02607956|527423626|FG003|Double-Blinded Phase|Randomized but never treated|0|||
146249118|NCT02607956|527423623|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
146249119|NCT02607956|527423624|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
146249120|NCT02607956|527423625|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
146009515|NCT03726658|526546894|FG003|Overall Study|Withdrawal by Subject|0|||
146009516|NCT03726658|526546895|FG004|Overall Study|Withdrawal by Subject|6|||
146009517|NCT03726658|526546896|FG005|Overall Study|Withdrawal by Subject|4|||
146009518|NCT03726658|526546897|FG006|Overall Study|Withdrawal by Subject|2|||
146009519|NCT03726658|526546891|FG000|Overall Study|Pregnancy|0|||
146009520|NCT03726658|526546892|FG001|Overall Study|Pregnancy|0|||
146009521|NCT03726658|526546893|FG002|Overall Study|Pregnancy|0|||
146009522|NCT03726658|526546894|FG003|Overall Study|Pregnancy|0|||
146249121|NCT02607956|527423626|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
146249122|NCT02607956|527423623|FG000|Double-Blinded Phase|Death|4|||
146249123|NCT02607956|527423624|FG001|Double-Blinded Phase|Death|4|||
146249124|NCT02607956|527423625|FG002|Double-Blinded Phase|Death|0|||
146249125|NCT02607956|527423626|FG003|Double-Blinded Phase|Death|0|||
146249126|NCT02607956|527423623|FG000|Double-Blinded Phase|Adverse Event|4|||
146249127|NCT02607956|527423624|FG001|Double-Blinded Phase|Adverse Event|3|||
146249128|NCT02607956|527423625|FG002|Double-Blinded Phase|Adverse Event|0|||
146249129|NCT02607956|527423626|FG003|Double-Blinded Phase|Adverse Event|0|||
146249130|NCT02607956|527423623|FG000|Double-Blinded Phase|Protocol Violation|3|||
146249131|NCT02607956|527423624|FG001|Double-Blinded Phase|Protocol Violation|1|||
146249132|NCT02607956|527423625|FG002|Double-Blinded Phase|Protocol Violation|0|||
146249133|NCT02607956|527423626|FG003|Double-Blinded Phase|Protocol Violation|0|||
146249134|NCT02607956|527423623|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146249135|NCT02607956|527423624|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
146249136|NCT02607956|527423625|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146249137|NCT02607956|527423626|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
146249138|NCT02607956|527423623|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
146249139|NCT02607956|527423624|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
146249140|NCT02607956|527423625|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
146249141|NCT02607956|527423626|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
146249142|NCT02607956|527423623|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146249143|NCT02607956|527423624|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146249144|NCT02607956|527423625|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
146249145|NCT02607956|527423626|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
146249146|NCT02607956|527423623|FG000|Open-Label Extension Phase|Death|0|||
146249147|NCT02607956|527423624|FG001|Open-Label Extension Phase|Death|0|||
146249148|NCT02607956|527423625|FG002|Open-Label Extension Phase|Death|1|||
146249149|NCT02607956|527423626|FG003|Open-Label Extension Phase|Death|3|||
146249150|NCT02607956|527423623|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
146009523|NCT03726658|526546895|FG004|Overall Study|Pregnancy|0|||
146009524|NCT03726658|526546896|FG005|Overall Study|Pregnancy|0|||
146009525|NCT03726658|526546897|FG006|Overall Study|Pregnancy|1|||
146009526|NCT03726658|526546891|FG000|Overall Study|Not Reported|0|||
146009527|NCT03726658|526546892|FG001|Overall Study|Not Reported|0|||
146009528|NCT03726658|526546893|FG002|Overall Study|Not Reported|0|||
146009529|NCT03726658|526546894|FG003|Overall Study|Not Reported|0|||
146009530|NCT03726658|526546895|FG004|Overall Study|Not Reported|0|||
146009531|NCT03726658|526546896|FG005|Overall Study|Not Reported|0|||
146009532|NCT03726658|526546897|FG006|Overall Study|Not Reported|1|||
146009533|NCT00412958|526546898|FG000|Overall Study|Withdrawal by Subject|3|||
146009534|NCT00412958|526546899|FG001|Overall Study|Withdrawal by Subject|0|||
146009535|NCT00412958|526546900|FG002|Overall Study|Withdrawal by Subject|0|||
146009536|NCT00412958|526546901|FG003|Overall Study|Withdrawal by Subject|1|||
146009537|NCT00412958|526546898|FG000|Overall Study|Adverse Event|0|||
146009538|NCT00412958|526546899|FG001|Overall Study|Adverse Event|1|||
146009539|NCT00412958|526546900|FG002|Overall Study|Adverse Event|0|||
146009540|NCT00412958|526546901|FG003|Overall Study|Adverse Event|0|||
146009541|NCT00412958|526546898|FG000|Overall Study|Lost to Follow-up|0|||
146009542|NCT00412958|526546899|FG001|Overall Study|Lost to Follow-up|1|||
146009543|NCT00412958|526546900|FG002|Overall Study|Lost to Follow-up|0|||
146249151|NCT02607956|527423624|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146249152|NCT02607956|527423625|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
146009544|NCT00412958|526546901|FG003|Overall Study|Lost to Follow-up|0|||
146249153|NCT02607956|527423626|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
146249154|NCT02607956|527423623|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146249155|NCT02607956|527423624|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146249156|NCT02607956|527423625|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
146249157|NCT02607956|527423626|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
146249158|NCT02607956|527423623|FG000|Open-Label Extension Phase|Protocol Violation|0|||
146249159|NCT02607956|527423624|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146009545|NCT00412958|526546898|FG000|Overall Study|Death|0|||
146009546|NCT00412958|526546899|FG001|Overall Study|Death|1|||
146009547|NCT00412958|526546900|FG002|Overall Study|Death|0|||
146009548|NCT00412958|526546901|FG003|Overall Study|Death|0|||
146009549|NCT00412958|526546898|FG000|Overall Study|Transport issue|0|||
146249160|NCT02607956|527423625|FG002|Open-Label Extension Phase|Protocol Violation|0|||
146249161|NCT02607956|527423626|FG003|Open-Label Extension Phase|Protocol Violation|2|||
146249162|NCT02607956|527423623|FG000|Open-Label Extension Phase|Pregnancy|0|||
146249163|NCT02607956|527423624|FG001|Open-Label Extension Phase|Pregnancy|0|||
146249164|NCT02607956|527423625|FG002|Open-Label Extension Phase|Pregnancy|0|||
146249165|NCT02607956|527423626|FG003|Open-Label Extension Phase|Pregnancy|1|||
146249166|NCT02006641|527423628|FG000|Overall Study|Withdrawal before treatment|2|||
146249167|NCT02006641|527423629|FG001|Overall Study|Withdrawal before treatment|5|||
146249168|NCT02006641|527423630|FG002|Overall Study|Withdrawal before treatment|3|||
146249169|NCT02006641|527423628|FG000|Overall Study|Adverse Event|15|||
146249170|NCT02006641|527423629|FG001|Overall Study|Adverse Event|11|||
146249171|NCT02006641|527423630|FG002|Overall Study|Adverse Event|15|||
146249172|NCT02006641|527423628|FG000|Overall Study|Protocol Violation|0|||
146249173|NCT02006641|527423629|FG001|Overall Study|Protocol Violation|2|||
146249174|NCT02006641|527423630|FG002|Overall Study|Protocol Violation|2|||
146249175|NCT02006641|527423628|FG000|Overall Study|Lost to Follow-up|0|||
146249176|NCT02006641|527423629|FG001|Overall Study|Lost to Follow-up|1|||
146249177|NCT02006641|527423630|FG002|Overall Study|Lost to Follow-up|0|||
146249178|NCT02006641|527423628|FG000|Overall Study|Withdrawal by Subject|7|||
146249179|NCT02006641|527423629|FG001|Overall Study|Withdrawal by Subject|12|||
146249180|NCT02006641|527423630|FG002|Overall Study|Withdrawal by Subject|11|||
146249181|NCT02006641|527423628|FG000|Overall Study|Other reason: patient didn't show up|1|||
146249182|NCT02006641|527423629|FG001|Overall Study|Other reason: patient didn't show up|0|||
146249183|NCT02006641|527423630|FG002|Overall Study|Other reason: patient didn't show up|0|||
146249184|NCT02006641|527423628|FG000|Overall Study|Other reason:patient didn't want to come|0|||
146249185|NCT02006641|527423629|FG001|Overall Study|Other reason:patient didn't want to come|0|||
146249186|NCT02006641|527423630|FG002|Overall Study|Other reason:patient didn't want to come|1|||
146249187|NCT02006641|527423628|FG000|Overall Study|Other reason: patient has moved|1|||
146249188|NCT02006641|527423629|FG001|Overall Study|Other reason: patient has moved|0|||
146249189|NCT02006641|527423630|FG002|Overall Study|Other reason: patient has moved|1|||
146249190|NCT02006641|527423628|FG000|Overall Study|Other reason: caregiver in hospital|0|||
146249191|NCT02006641|527423629|FG001|Overall Study|Other reason: caregiver in hospital|1|||
146249192|NCT02006641|527423630|FG002|Overall Study|Other reason: caregiver in hospital|0|||
146249193|NCT02006641|527423628|FG000|Overall Study|Other reason: patient's wife has died|0|||
146249194|NCT02006641|527423629|FG001|Overall Study|Other reason: patient's wife has died|0|||
146249195|NCT02006641|527423630|FG002|Overall Study|Other reason: patient's wife has died|1|||
146249196|NCT02006641|527423628|FG000|Overall Study|Other reason: hospitalisation|0|||
146249197|NCT02006641|527423629|FG001|Overall Study|Other reason: hospitalisation|1|||
146249198|NCT02006641|527423630|FG002|Overall Study|Other reason: hospitalisation|0|||
146249199|NCT02006641|527423628|FG000|Overall Study|Other reason: caregiver impossibility|0|||
146009550|NCT00412958|526546899|FG001|Overall Study|Transport issue|1|||
146009551|NCT00412958|526546900|FG002|Overall Study|Transport issue|0|||
146009552|NCT00412958|526546901|FG003|Overall Study|Transport issue|0|||
146009553|NCT00980460|526546902|FG000|Overall Study|Death|0|||
146249200|NCT02006641|527423629|FG001|Overall Study|Other reason: caregiver impossibility|0|||
146009554|NCT00980460|526546903|FG001|Overall Study|Death|0|||
146009555|NCT00980460|526546904|FG002|Overall Study|Death|1|||
146009556|NCT00980460|526546905|FG003|Overall Study|Death|2|||
146249201|NCT02006641|527423630|FG002|Overall Study|Other reason: caregiver impossibility|1|||
146249202|NCT02006641|527423628|FG000|Overall Study|Other reason: protocol non-compliance|0|||
146249203|NCT02006641|527423629|FG001|Overall Study|Other reason: protocol non-compliance|0|||
146249204|NCT02006641|527423630|FG002|Overall Study|Other reason: protocol non-compliance|1|||
146249205|NCT02132195|527423631|FG000|Initial Assignment|Relapsed|14|||
146249206|NCT02132195|527423632|FG001|Initial Assignment|Relapsed|0|||
146249207|NCT02132195|527423633|FG002|Initial Assignment|Relapsed|0|||
146249208|NCT02132195|527423631|FG000|Rescue Therapy|Relapsed|0|||
146009557|NCT00980460|526546906|FG004|Overall Study|Death|1|||
146009558|NCT00980460|526546902|FG000|Overall Study|Lack of Efficacy|0|||
146009559|NCT00980460|526546903|FG001|Overall Study|Lack of Efficacy|0|||
146009560|NCT00980460|526546904|FG002|Overall Study|Lack of Efficacy|10|||
146009561|NCT00980460|526546905|FG003|Overall Study|Lack of Efficacy|6|||
146009562|NCT00980460|526546906|FG004|Overall Study|Lack of Efficacy|8|||
146009563|NCT00980460|526546902|FG000|Overall Study|Lost to Follow-up|0|||
146009564|NCT00980460|526546903|FG001|Overall Study|Lost to Follow-up|0|||
146009565|NCT00980460|526546904|FG002|Overall Study|Lost to Follow-up|0|||
146009566|NCT00980460|526546905|FG003|Overall Study|Lost to Follow-up|1|||
146009567|NCT00980460|526546906|FG004|Overall Study|Lost to Follow-up|0|||
146009568|NCT00980460|526546902|FG000|Overall Study|Physician Decision|0|||
146009569|NCT00980460|526546903|FG001|Overall Study|Physician Decision|0|||
146009570|NCT00980460|526546904|FG002|Overall Study|Physician Decision|11|||
146009571|NCT00980460|526546905|FG003|Overall Study|Physician Decision|5|||
146009572|NCT00980460|526546906|FG004|Overall Study|Physician Decision|3|||
146009573|NCT00980460|526546902|FG000|Overall Study|Withdrawal by Subject|0|||
146249209|NCT02132195|527423632|FG001|Rescue Therapy|Relapsed|0|||
146249210|NCT02132195|527423633|FG002|Rescue Therapy|Relapsed|7|||
146009574|NCT00980460|526546903|FG001|Overall Study|Withdrawal by Subject|0|||
146009575|NCT00980460|526546904|FG002|Overall Study|Withdrawal by Subject|1|||
146009576|NCT00980460|526546905|FG003|Overall Study|Withdrawal by Subject|0|||
146249211|NCT02132195|527423631|FG000|Rescue Therapy|Physician Decision|0|||
146249212|NCT02132195|527423632|FG001|Rescue Therapy|Physician Decision|0|||
146249213|NCT02132195|527423633|FG002|Rescue Therapy|Physician Decision|1|||
146249214|NCT02132195|527423631|FG000|Rescue Therapy|Withdrawal by Subject|0|||
146249215|NCT02132195|527423632|FG001|Rescue Therapy|Withdrawal by Subject|0|||
146249216|NCT02132195|527423633|FG002|Rescue Therapy|Withdrawal by Subject|1|||
146249217|NCT02132195|527423631|FG000|Rescue Therapy|Adverse Event|0|||
146249218|NCT02132195|527423632|FG001|Rescue Therapy|Adverse Event|0|||
146249219|NCT02132195|527423633|FG002|Rescue Therapy|Adverse Event|2|||
146249220|NCT01287832|527423634|FG000|Overall Study|Adverse Event|1|||
146249221|NCT01287832|527423635|FG001|Overall Study|Adverse Event|0|||
146249222|NCT01287832|527423634|FG000|Overall Study|Death|0|||
146249223|NCT01287832|527423635|FG001|Overall Study|Death|1|||
146249224|NCT04749797|527423636|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
146249225|NCT04749797|527423637|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
146249226|NCT04749797|527423638|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
146249227|NCT00537914|527423639|FG000|Overall Study|Death|1|||
146249228|NCT00537914|527423639|FG000|Overall Study|Adverse Event|7|||
146249229|NCT00537914|527423639|FG000|Overall Study|Treatment failure|10|||
146249230|NCT00537914|527423639|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
146249231|NCT00537914|527423639|FG000|Overall Study|Lost to Follow-up|19|||
146249232|NCT00537914|527423639|FG000|Overall Study|Withdrawal of informed consent|59|||
146249233|NCT02312258|527423640|FG000|Overall Study|Lost to Follow-up|8|||
146249234|NCT02312258|527423641|FG001|Overall Study|Lost to Follow-up|8|||
146249235|NCT02312258|527423640|FG000|Overall Study|Withdrawal by Patient|49|||
146249236|NCT02312258|527423641|FG001|Overall Study|Withdrawal by Patient|76|||
146249237|NCT02312258|527423640|FG000|Overall Study|Reason not Specified|107|||
146249238|NCT02312258|527423641|FG001|Overall Study|Reason not Specified|159|||
146249239|NCT02312258|527423640|FG000|Overall Study|Missing|2|||
146249240|NCT02312258|527423641|FG001|Overall Study|Missing|1|||
146249241|NCT02312258|527423640|FG000|Overall Study|Death|115|||
146249242|NCT02312258|527423641|FG001|Overall Study|Death|181|||
146249243|NCT01766206|527423642|FG000|Overall Study|Withdrawal by Subject|22|||
146249244|NCT01766206|527423642|FG000|Overall Study|Lost to Follow-up|10|||
146249245|NCT01766206|527423642|FG000|Overall Study|Inappropriate enrollment|18|||
146249246|NCT01766206|527423642|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
146249247|NCT01662505|527423643|FG000|Overall Study|Progressive disease|6|||
146249248|NCT01662505|527423644|FG001|Overall Study|Progressive disease|1|||
146249249|NCT01662505|527423645|FG002|Overall Study|Progressive disease|5|||
146249250|NCT01662505|527423643|FG000|Overall Study|Refused cont. medication|0|||
146249251|NCT01662505|527423644|FG001|Overall Study|Refused cont. medication|0|||
146249252|NCT01662505|527423645|FG002|Overall Study|Refused cont. medication|1|||
146249253|NCT01662505|527423643|FG000|Overall Study|Not specified above|1|||
146249254|NCT01662505|527423644|FG001|Overall Study|Not specified above|3|||
146249255|NCT01662505|527423645|FG002|Overall Study|Not specified above|2|||
146249256|NCT01313663|527423646|FG000|Overall Study|Study Closed/Terminated|2|||
146249257|NCT01313663|527423647|FG001|Overall Study|Study Closed/Terminated|4|||
146249258|NCT01313663|527423646|FG000|Overall Study|Lost to Follow-up|0|||
146249259|NCT01313663|527423647|FG001|Overall Study|Lost to Follow-up|1|||
146249260|NCT01313663|527423646|FG000|Overall Study|Physician Decision|0|||
146249261|NCT01313663|527423647|FG001|Overall Study|Physician Decision|2|||
146249262|NCT01313663|527423646|FG000|Overall Study|Withdrawal by Subject|2|||
146249263|NCT01313663|527423647|FG001|Overall Study|Withdrawal by Subject|1|||
146249264|NCT02340806|527423651|FG000|Overall Study|Protocol Violation|2|||
146249265|NCT02340806|527423652|FG001|Overall Study|Protocol Violation|0|||
146249266|NCT02340806|527423651|FG000|Overall Study|epidural catheter replaced|2|||
146249267|NCT02340806|527423652|FG001|Overall Study|epidural catheter replaced|1|||
146249268|NCT02340806|527423651|FG000|Overall Study|history of chronic pain medication|1|||
146249269|NCT02340806|527423652|FG001|Overall Study|history of chronic pain medication|0|||
146249270|NCT02340806|527423651|FG000|Overall Study|re-dose < 90 min of CSE|1|||
146249271|NCT02340806|527423652|FG001|Overall Study|re-dose < 90 min of CSE|3|||
146298729|NCT02558231|527607958|FG000|Overall Study|Physician Decision|7|||
146298730|NCT02558231|527607959|FG001|Overall Study|Physician Decision|5|||
146249272|NCT01186809|527423653|FG000|Overall Study|Death|30|||
146009577|NCT00980460|526546906|FG004|Overall Study|Withdrawal by Subject|0|||
146249273|NCT04895085|527423654|FG000|Overall Study|Death|1|||
146249274|NCT04895085|527423654|FG000|Overall Study|Withdrawal by Subject|1|||
146249275|NCT04895085|527423654|FG000|Overall Study|No longer eligible: Moved from area|1|||
146249276|NCT05379400|527425191|FG000|Overall Study|Lost to Follow-up|1|||
146249277|NCT05379400|527425192|FG001|Overall Study|Lost to Follow-up|1|||
146249278|NCT01922102|527425193|FG000|Overall Study|Withdrawal by Subject|7|||
146249279|NCT01922102|527425194|FG001|Overall Study|Withdrawal by Subject|3|||
146249280|NCT01922102|527425195|FG002|Overall Study|Withdrawal by Subject|7|||
146249281|NCT01922102|527425193|FG000|Overall Study|Physician Decision|0|||
146249282|NCT01922102|527425194|FG001|Overall Study|Physician Decision|2|||
146249283|NCT01922102|527425195|FG002|Overall Study|Physician Decision|1|||
146009578|NCT00980460|526546902|FG000|Overall Study|Ineligible|0|||
146249284|NCT01922102|527425193|FG000|Overall Study|Adverse Event|1|||
146249285|NCT01922102|527425194|FG001|Overall Study|Adverse Event|2|||
146249286|NCT01922102|527425195|FG002|Overall Study|Adverse Event|0|||
146249287|NCT01922102|527425193|FG000|Overall Study|Lost to Follow-up|1|||
146249288|NCT01922102|527425194|FG001|Overall Study|Lost to Follow-up|0|||
146249289|NCT01922102|527425195|FG002|Overall Study|Lost to Follow-up|0|||
146249290|NCT01922102|527425193|FG000|Overall Study|Administrative problems|0|||
146249291|NCT01922102|527425194|FG001|Overall Study|Administrative problems|2|||
146249292|NCT01922102|527425195|FG002|Overall Study|Administrative problems|0|||
146249293|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
146249294|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
146249295|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
146249296|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
146249297|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
146249298|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
146249299|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
146249300|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
146249301|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
146249302|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
146249303|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
146249304|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
146249305|NCT01345253|527425200|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
146249306|NCT01345253|527425201|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
146249307|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
146249308|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
146249309|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
146249310|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
146249311|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
146249312|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
146249313|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
146249314|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
146249315|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
146249316|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
146249317|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
146298731|NCT02558231|527607958|FG000|Overall Study|Sponsor Decision|0|||
146298732|NCT02558231|527607959|FG001|Overall Study|Sponsor Decision|1|||
146298733|NCT00995007|527607960|FG000|Overall Study|Withdrew consent|1|||
146298734|NCT00995007|527607961|FG001|Overall Study|Withdrew consent|0|||
146009579|NCT00980460|526546903|FG001|Overall Study|Ineligible|2|||
146009580|NCT00980460|526546904|FG002|Overall Study|Ineligible|3|||
146009581|NCT00980460|526546905|FG003|Overall Study|Ineligible|1|||
146009582|NCT00980460|526546906|FG004|Overall Study|Ineligible|4|||
146009583|NCT00980460|526546902|FG000|Overall Study|Refusal of further therapy|0|||
146009584|NCT00980460|526546903|FG001|Overall Study|Refusal of further therapy|2|||
146009585|NCT00980460|526546904|FG002|Overall Study|Refusal of further therapy|3|||
146009586|NCT00980460|526546905|FG003|Overall Study|Refusal of further therapy|2|||
146009587|NCT00980460|526546906|FG004|Overall Study|Refusal of further therapy|0|||
146009588|NCT00980460|526546902|FG000|Overall Study|No therapy within 42 days of resection|0|||
146009589|NCT00980460|526546903|FG001|Overall Study|No therapy within 42 days of resection|0|||
146009590|NCT00980460|526546904|FG002|Overall Study|No therapy within 42 days of resection|3|||
146009591|NCT00980460|526546905|FG003|Overall Study|No therapy within 42 days of resection|1|||
146009592|NCT00980460|526546906|FG004|Overall Study|No therapy within 42 days of resection|0|||
146009593|NCT00980460|526546902|FG000|Overall Study|No transplant by protocol timepoints|0|||
146009594|NCT00980460|526546903|FG001|Overall Study|No transplant by protocol timepoints|0|||
146009595|NCT00980460|526546904|FG002|Overall Study|No transplant by protocol timepoints|3|||
146009596|NCT00980460|526546905|FG003|Overall Study|No transplant by protocol timepoints|0|||
146009597|NCT00980460|526546906|FG004|Overall Study|No transplant by protocol timepoints|0|||
146009598|NCT05696444|526546907|FG000|Treatment|Physician Decision|0|||
146009599|NCT05696444|526546908|FG001|Treatment|Physician Decision|1|||
146009600|NCT05696444|526546909|FG002|Treatment|Physician Decision|0|||
146009601|NCT05696444|526546907|FG000|30 Days|Death|1|||
146009602|NCT05696444|526546908|FG001|30 Days|Death|1|||
146009603|NCT05696444|526546909|FG002|30 Days|Death|0|||
146009604|NCT05696444|526546907|FG000|30 Days|Missed Visit|1|||
146009605|NCT05696444|526546908|FG001|30 Days|Missed Visit|1|||
146009606|NCT05696444|526546909|FG002|30 Days|Missed Visit|1|||
146009607|NCT05200572|526546910|FG000|Overall Study|Withdrawal by Subject|14|||
146298735|NCT00995007|527607960|FG000|Overall Study|Refused further treatment|8|||
146298736|NCT00995007|527607961|FG001|Overall Study|Refused further treatment|2|||
146298737|NCT00995007|527607960|FG000|Overall Study|Toxicity|8|||
146009608|NCT00316706|526548428|FG000|Overall Study|Lost to Follow-up|38|||
146009609|NCT00316706|526548429|FG001|Overall Study|Lost to Follow-up|48|||
146009610|NCT00283803|526548435|FG000|Overall Study|Physician Decision|9|||
146009611|NCT00283803|526548435|FG000|Overall Study|Withdrawal by Subject|4|||
146009612|NCT01127607|526548436|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
146009613|NCT01127607|526548437|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
146009614|NCT01127607|526548436|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
146009615|NCT01127607|526548437|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
146009616|NCT03640325|526548438|FG000|Overall Study|Withdrawal by Subject|4|||
146009617|NCT03640325|526548439|FG001|Overall Study|Withdrawal by Subject|1|||
146249318|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
146249319|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
146249320|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
146249321|NCT01345253|527425200|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
146249322|NCT01345253|527425201|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
146249323|NCT05361304|527425204|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
146249324|NCT05361304|527425205|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
146009618|NCT03640325|526548440|FG002|Overall Study|Withdrawal by Subject|0|||
146249325|NCT05361304|527425204|FG000|Overall Study|COVID-19 Related|1|||
146249326|NCT05361304|527425205|FG001|Overall Study|COVID-19 Related|2|||
146249327|NCT05361304|527425204|FG000|Overall Study|Withdrawal by Subject|1|||
146249328|NCT05361304|527425205|FG001|Overall Study|Withdrawal by Subject|0|||
146249329|NCT00476151|527425206|FG000|Overall Study|Adverse Event|0|||
146249330|NCT00476151|527425207|FG001|Overall Study|Adverse Event|2|||
146249331|NCT00476151|527425206|FG000|Overall Study|Protocol Violation|1|||
146249332|NCT00476151|527425207|FG001|Overall Study|Protocol Violation|3|||
146249333|NCT00476151|527425206|FG000|Overall Study|Withdrawal by Subject|2|||
146249334|NCT00476151|527425207|FG001|Overall Study|Withdrawal by Subject|0|||
146249335|NCT00476151|527425206|FG000|Overall Study|Physician Decision|0|||
146249336|NCT00476151|527425207|FG001|Overall Study|Physician Decision|2|||
146249337|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
146249338|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
146249339|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
146249340|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
146249341|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
146249342|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
146249343|NCT03557307|527425211|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
146249344|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
146249345|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Death|3|||
146249346|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
146249347|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
146249348|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
146249349|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
146249350|NCT03557307|527425211|FG000|Period 2: Maintenance Phase|other|3|||
146249351|NCT04239911|527425214|FG000|Overall Study|Lost to Follow-up|2|||
146249352|NCT04239911|527425215|FG001|Overall Study|Lost to Follow-up|1|||
146249353|NCT03456856|527425216|FG000|Overall Study|Lost to Follow-up|2|||
146249354|NCT03456856|527425216|FG000|Overall Study|Withdrawal by Subject|1|||
146249355|NCT03262389|527425219|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
146249356|NCT03262389|527425219|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
146249357|NCT03262389|527425219|FG000|Overall Study|opted out of PET/MR|1|||
146249358|NCT01052272|527425220|FG000|Overall Study|Death|0|||
146249359|NCT01052272|527425221|FG001|Overall Study|Death|0|||
146249360|NCT01052272|527425222|FG002|Overall Study|Death|1|||
146249361|NCT01052272|527425223|FG003|Overall Study|Death|1|||
146249362|NCT01052272|527425220|FG000|Overall Study|Physician Decision|0|||
146249363|NCT01052272|527425221|FG001|Overall Study|Physician Decision|1|||
146249364|NCT01052272|527425222|FG002|Overall Study|Physician Decision|0|||
146249365|NCT01052272|527425223|FG003|Overall Study|Physician Decision|0|||
146249366|NCT01052272|527425220|FG000|Overall Study|patient refuses follow-up|5|||
146249367|NCT01052272|527425221|FG001|Overall Study|patient refuses follow-up|4|||
146249368|NCT01052272|527425222|FG002|Overall Study|patient refuses follow-up|2|||
146249369|NCT01052272|527425223|FG003|Overall Study|patient refuses follow-up|4|||
146009619|NCT03640325|526548438|FG000|Overall Study|Lost to Follow-up|4|||
146009620|NCT03640325|526548439|FG001|Overall Study|Lost to Follow-up|5|||
146009621|NCT03640325|526548440|FG002|Overall Study|Lost to Follow-up|21|||
146249370|NCT01052272|527425220|FG000|Overall Study|Withdrawal by Subject|0|||
146249371|NCT01052272|527425221|FG001|Overall Study|Withdrawal by Subject|2|||
146249372|NCT01052272|527425222|FG002|Overall Study|Withdrawal by Subject|3|||
146009622|NCT03640325|526548438|FG000|Overall Study|Death|5|||
146009623|NCT03640325|526548439|FG001|Overall Study|Death|5|||
146249373|NCT01052272|527425223|FG003|Overall Study|Withdrawal by Subject|2|||
146249374|NCT01052272|527425220|FG000|Overall Study|placed in long-term care|0|||
146249375|NCT01052272|527425221|FG001|Overall Study|placed in long-term care|0|||
146249376|NCT01052272|527425222|FG002|Overall Study|placed in long-term care|1|||
146249377|NCT01052272|527425223|FG003|Overall Study|placed in long-term care|0|||
146249378|NCT01052272|527425220|FG000|Overall Study|decline in health|0|||
146249379|NCT01052272|527425221|FG001|Overall Study|decline in health|0|||
146249380|NCT01052272|527425222|FG002|Overall Study|decline in health|1|||
146249381|NCT01052272|527425223|FG003|Overall Study|decline in health|0|||
146249382|NCT00096278|527425226|FG000|Overall Study|No follow-up data|15|||
146249383|NCT00096278|527425227|FG001|Overall Study|No follow-up data|18|||
146249384|NCT00096278|527425226|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
146249385|NCT00096278|527425227|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
146249386|NCT02105688|527425228|FG000|Part A: Double-Blind|Adverse Event|1|||
146249387|NCT02105688|527425229|FG001|Part A: Double-Blind|Adverse Event|0|||
146249388|NCT02105688|527425228|FG000|Part A: Double-Blind|Death|0|||
146249389|NCT02105688|527425229|FG001|Part A: Double-Blind|Death|1|||
146249390|NCT02105688|527425228|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
146249391|NCT02105688|527425229|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
146249392|NCT02105688|527425228|FG000|Part A: Double-Blind|Physician Decision|0|||
146249393|NCT02105688|527425229|FG001|Part A: Double-Blind|Physician Decision|1|||
146249394|NCT02105688|527425228|FG000|Part A: Double-Blind|Status Unknown|0|||
146249395|NCT02105688|527425229|FG001|Part A: Double-Blind|Status Unknown|2|||
146249396|NCT02105688|527425228|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
146249397|NCT02105688|527425229|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
146249398|NCT02105688|527425228|FG000|Part B: Observational Follow-up|Death|2|||
146249399|NCT02105688|527425229|FG001|Part B: Observational Follow-up|Death|1|||
146249400|NCT02105688|527425228|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
146249401|NCT02105688|527425229|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
146249402|NCT02105688|527425228|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
146249403|NCT02105688|527425229|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
146249404|NCT02105688|527425228|FG000|Part B: Observational Follow-up|Physician Decision|3|||
146249405|NCT02105688|527425229|FG001|Part B: Observational Follow-up|Physician Decision|1|||
146249406|NCT04908488|527425232|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
146249407|NCT04908488|527425233|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
146249408|NCT04908488|527425232|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
146249409|NCT04908488|527425233|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
146249410|NCT01107912|527425235|FG000|Period 1|Adverse Event|0|||
146249411|NCT01107912|527425236|FG001|Period 1|Adverse Event|0|||
146249412|NCT01107912|527425237|FG002|Period 1|Adverse Event|0|||
146249413|NCT01107912|527425238|FG003|Period 1|Adverse Event|0|||
146249414|NCT01107912|527425239|FG004|Period 1|Adverse Event|2|||
146249415|NCT01107912|527425240|FG005|Period 1|Adverse Event|0|||
146249416|NCT01107912|527425235|FG000|Period 1|Physician Decision|0|||
146249417|NCT01107912|527425236|FG001|Period 1|Physician Decision|0|||
146249418|NCT01107912|527425237|FG002|Period 1|Physician Decision|0|||
146249419|NCT01107912|527425238|FG003|Period 1|Physician Decision|0|||
146249420|NCT01107912|527425239|FG004|Period 1|Physician Decision|1|||
146249421|NCT01107912|527425240|FG005|Period 1|Physician Decision|0|||
146249422|NCT01107912|527425235|FG000|Period 1|Withdrawal by Subject|1|||
146249423|NCT01107912|527425236|FG001|Period 1|Withdrawal by Subject|0|||
146249424|NCT01107912|527425237|FG002|Period 1|Withdrawal by Subject|0|||
146249425|NCT01107912|527425238|FG003|Period 1|Withdrawal by Subject|0|||
146249426|NCT01107912|527425239|FG004|Period 1|Withdrawal by Subject|0|||
146249427|NCT01107912|527425240|FG005|Period 1|Withdrawal by Subject|0|||
146249428|NCT01107912|527425235|FG000|Period 2|Physician Decision|0|||
146249429|NCT01107912|527425236|FG001|Period 2|Physician Decision|0|||
146249430|NCT01107912|527425237|FG002|Period 2|Physician Decision|1|||
146009624|NCT03640325|526548440|FG002|Overall Study|Death|0|||
146009625|NCT03493451|526548441|FG000|Overall Study|Death|11|||
146009626|NCT03493451|526548442|FG001|Overall Study|Death|26|||
146009627|NCT03493451|526548443|FG002|Overall Study|Death|3|||
146009628|NCT03493451|526548441|FG000|Overall Study|Lost to Follow-up|1|||
146009629|NCT03493451|526548442|FG001|Overall Study|Lost to Follow-up|4|||
146009630|NCT03493451|526548443|FG002|Overall Study|Lost to Follow-up|1|||
146009631|NCT03493451|526548441|FG000|Overall Study|Withdrawal by Subject|1|||
146009632|NCT03493451|526548442|FG001|Overall Study|Withdrawal by Subject|1|||
146249431|NCT01107912|527425238|FG003|Period 2|Physician Decision|0|||
146249432|NCT01107912|527425239|FG004|Period 2|Physician Decision|0|||
146249433|NCT01107912|527425240|FG005|Period 2|Physician Decision|0|||
146249434|NCT01107912|527425235|FG000|Period 3|Adverse Event|0|||
146009633|NCT03493451|526548443|FG002|Overall Study|Withdrawal by Subject|2|||
146009634|NCT03493451|526548441|FG000|Overall Study|Progressive Disease|1|||
146249435|NCT01107912|527425236|FG001|Period 3|Adverse Event|1|||
146249436|NCT01107912|527425237|FG002|Period 3|Adverse Event|1|||
146249437|NCT01107912|527425238|FG003|Period 3|Adverse Event|0|||
146249438|NCT01107912|527425239|FG004|Period 3|Adverse Event|0|||
146249439|NCT01107912|527425240|FG005|Period 3|Adverse Event|0|||
146249440|NCT01107912|527425235|FG000|Period 3|Withdrawal by Subject|0|||
146249441|NCT01107912|527425236|FG001|Period 3|Withdrawal by Subject|0|||
146249442|NCT01107912|527425237|FG002|Period 3|Withdrawal by Subject|0|||
146249443|NCT01107912|527425238|FG003|Period 3|Withdrawal by Subject|1|||
146249444|NCT01107912|527425239|FG004|Period 3|Withdrawal by Subject|0|||
146249445|NCT01107912|527425240|FG005|Period 3|Withdrawal by Subject|0|||
146298738|NCT00995007|527607961|FG001|Overall Study|Toxicity|0|||
146009635|NCT03493451|526548442|FG001|Overall Study|Progressive Disease|0|||
146009636|NCT03493451|526548443|FG002|Overall Study|Progressive Disease|0|||
146009637|NCT03493451|526548441|FG000|Overall Study|Transferred to long term extension study|8|||
146009638|NCT03493451|526548442|FG001|Overall Study|Transferred to long term extension study|13|||
146009639|NCT03493451|526548443|FG002|Overall Study|Transferred to long term extension study|5|||
146249446|NCT00595959|527425245|FG000|Overall Study|Withdrawal by Subject|1|||
146249447|NCT00595959|527425245|FG000|Overall Study|Lost to Follow-up|1|||
146249448|NCT02764320|527425248|FG000|Overall Study|Withdrawal by Subject|35|||
146249449|NCT02764320|527425249|FG001|Overall Study|Withdrawal by Subject|38|||
146249450|NCT02764320|527425248|FG000|Overall Study|Protocol Violation|11|||
146249451|NCT02764320|527425249|FG001|Overall Study|Protocol Violation|6|||
146249452|NCT02764320|527425248|FG000|Overall Study|Adverse Event|2|||
146249453|NCT02764320|527425249|FG001|Overall Study|Adverse Event|0|||
146249454|NCT02764320|527425248|FG000|Overall Study|Health Issues unable to continue|2|||
146249455|NCT02764320|527425249|FG001|Overall Study|Health Issues unable to continue|0|||
146249456|NCT02764320|527425248|FG000|Overall Study|Did not meet inclusion criteria|1|||
146249457|NCT02764320|527425249|FG001|Overall Study|Did not meet inclusion criteria|0|||
146249458|NCT02764320|527425248|FG000|Overall Study|Subject moved|0|||
146249459|NCT02764320|527425249|FG001|Overall Study|Subject moved|2|||
146249460|NCT02764320|527425248|FG000|Overall Study|Overused medication unavailable|0|||
146249461|NCT02764320|527425249|FG001|Overall Study|Overused medication unavailable|1|||
146249462|NCT02764320|527425248|FG000|Overall Study|Seeking care outside site|0|||
146249463|NCT02764320|527425249|FG001|Overall Study|Seeking care outside site|1|||
146249464|NCT02764320|527425248|FG000|Overall Study|Technology barriers|0|||
146249465|NCT02764320|527425249|FG001|Overall Study|Technology barriers|1|||
146249466|NCT00753896|527425250|FG000|Overall Study|Adverse Event|4|||
146249467|NCT00753896|527425250|FG000|Overall Study|Death|1|||
146249468|NCT00753896|527425250|FG000|Overall Study|Lost to Follow-up|2|||
146249469|NCT00753896|527425250|FG000|Overall Study|Protocol Violation|1|||
146249470|NCT00753896|527425250|FG000|Overall Study|Withdrawal by Subject|4|||
146249471|NCT00753896|527425250|FG000|Overall Study|Entry Criteria Not Met|4|||
146249472|NCT01280656|527425251|FG000|Overall Study|Adverse Event|1|||
146249473|NCT01280656|527425252|FG001|Overall Study|Adverse Event|14|||
146249474|NCT01280656|527425253|FG002|Overall Study|Adverse Event|13|||
146249475|NCT01280656|527425251|FG000|Overall Study|Lack of Efficacy|1|||
146249476|NCT01280656|527425252|FG001|Overall Study|Lack of Efficacy|22|||
146249477|NCT01280656|527425253|FG002|Overall Study|Lack of Efficacy|38|||
146249478|NCT01280656|527425251|FG000|Overall Study|Treatment shortening (RGT)|0|||
146249479|NCT01280656|527425252|FG001|Overall Study|Treatment shortening (RGT)|4|||
146249480|NCT01280656|527425253|FG002|Overall Study|Treatment shortening (RGT)|5|||
146249481|NCT01280656|527425251|FG000|Overall Study|Other|1|||
146009640|NCT01133756|526548447|FG000|Overall Study|Adverse Event|1|||
146009641|NCT01133756|526548448|FG001|Overall Study|Adverse Event|2|||
146009642|NCT01133756|526548449|FG002|Overall Study|Adverse Event|1|||
146009643|NCT01133756|526548447|FG000|Overall Study|Investigator Decision|1|||
146009644|NCT01133756|526548448|FG001|Overall Study|Investigator Decision|0|||
146009645|NCT01133756|526548449|FG002|Overall Study|Investigator Decision|0|||
146009646|NCT01133756|526548447|FG000|Overall Study|Withdrawal by Subject|0|||
146009647|NCT01133756|526548448|FG001|Overall Study|Withdrawal by Subject|1|||
146009648|NCT01133756|526548449|FG002|Overall Study|Withdrawal by Subject|0|||
146009649|NCT01133756|526548447|FG000|Overall Study|Progression of Disease|0|||
146009650|NCT01133756|526548448|FG001|Overall Study|Progression of Disease|0|||
146009651|NCT01133756|526548449|FG002|Overall Study|Progression of Disease|1|||
146009652|NCT01566149|526548450|FG000|Overall Study|Adverse Event|0|||
146009653|NCT01566149|526548451|FG001|Overall Study|Adverse Event|1|||
146009654|NCT01566149|526548450|FG000|Overall Study|Non-compliance with study medication|2|||
146009655|NCT01566149|526548451|FG001|Overall Study|Non-compliance with study medication|0|||
146009656|NCT01566149|526548450|FG000|Overall Study|Protocol Violation|0|||
146009657|NCT01566149|526548451|FG001|Overall Study|Protocol Violation|1|||
146009658|NCT01566149|526548450|FG000|Overall Study|Withdrawal by Subject|1|||
146009659|NCT01566149|526548451|FG001|Overall Study|Withdrawal by Subject|0|||
146009660|NCT03941873|526548465|FG000|Overall Study|Death|0|||
146009661|NCT03941873|526548466|FG001|Overall Study|Death|12|||
146009662|NCT03941873|526548467|FG002|Overall Study|Death|2|||
146009663|NCT03941873|526548468|FG003|Overall Study|Death|53|||
146009664|NCT03941873|526548465|FG000|Overall Study|Withdrawal by Subject|1|||
146009665|NCT03941873|526548466|FG001|Overall Study|Withdrawal by Subject|1|||
146249482|NCT01280656|527425252|FG001|Overall Study|Other|7|||
146009666|NCT03941873|526548467|FG002|Overall Study|Withdrawal by Subject|0|||
146249483|NCT01280656|527425253|FG002|Overall Study|Other|7|||
146249484|NCT03529942|527425254|FG000|Overall Study|Withdrawal by Subject|13|||
146249485|NCT03529942|527425254|FG000|Overall Study|Physician Decision|1|||
146249486|NCT03529942|527425254|FG000|Overall Study|Lost to Follow-up|7|||
146249487|NCT03529942|527425254|FG000|Overall Study|Needle inserted but no drug administered|1|||
146249488|NCT03529942|527425254|FG000|Overall Study|Personal reasons|1|||
146249489|NCT00409747|527425257|FG000|Overall Study|Withdrawal by Subject|1|||
146249490|NCT00636168|527425258|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
146249491|NCT00636168|527425259|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
146249492|NCT00636168|527425258|FG000|Randomized to Study Drug|Adverse Event|1|||
146249493|NCT00636168|527425259|FG001|Randomized to Study Drug|Adverse Event|0|||
146249494|NCT00636168|527425258|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
146249495|NCT00636168|527425259|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
146249496|NCT00636168|527425258|FG000|Treated With Study Drug|Recurrence of disease|135|||
146249497|NCT00636168|527425259|FG001|Treated With Study Drug|Recurrence of disease|282|||
146249498|NCT00636168|527425258|FG000|Treated With Study Drug|Adverse Event|250|||
146249499|NCT00636168|527425259|FG001|Treated With Study Drug|Adverse Event|22|||
146249500|NCT00636168|527425258|FG000|Treated With Study Drug|Participant withdrew consent|16|||
146249501|NCT00636168|527425259|FG001|Treated With Study Drug|Participant withdrew consent|21|||
146249502|NCT00636168|527425258|FG000|Treated With Study Drug|Poor/non-compliance|1|||
146249503|NCT00636168|527425259|FG001|Treated With Study Drug|Poor/non-compliance|3|||
146249504|NCT00636168|527425258|FG000|Treated With Study Drug|Death|3|||
146249505|NCT00636168|527425259|FG001|Treated With Study Drug|Death|0|||
146249506|NCT00636168|527425258|FG000|Treated With Study Drug|Pregnancy|1|||
146249507|NCT00636168|527425259|FG001|Treated With Study Drug|Pregnancy|0|||
146249508|NCT00636168|527425258|FG000|Treated With Study Drug|No longer meets study criteria|1|||
146249509|NCT00636168|527425259|FG001|Treated With Study Drug|No longer meets study criteria|0|||
146249510|NCT00636168|527425258|FG000|Treated With Study Drug|Other reason|1|||
146249511|NCT00636168|527425259|FG001|Treated With Study Drug|Other reason|3|||
146249512|NCT00636168|527425258|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
146249513|NCT00636168|527425259|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
146249514|NCT00636168|527425258|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
146249515|NCT00636168|527425259|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
146249516|NCT00636168|527425258|FG000|Long Term Follow-Up|Death|8|||
146249517|NCT00636168|527425259|FG001|Long Term Follow-Up|Death|9|||
146249518|NCT00632736|527425260|FG000|Overall Study|Adverse Event|104|||
146249519|NCT00632736|527425260|FG000|Overall Study|Lost to Follow-up|15|||
146298739|NCT03933397|527607962|FG000|Overall Study|No emergency department visit|65|||
146298740|NCT03933397|527607963|FG001|Overall Study|No emergency department visit|71|||
146298741|NCT03933397|527607962|FG000|Overall Study|Missed emergency department visit|25|||
146298742|NCT03933397|527607963|FG001|Overall Study|Missed emergency department visit|30|||
146298743|NCT03933397|527607962|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
146009667|NCT03941873|526548468|FG003|Overall Study|Withdrawal by Subject|5|||
146009668|NCT03941873|526548465|FG000|Overall Study|Lost to Follow-up|1|||
146009669|NCT03941873|526548466|FG001|Overall Study|Lost to Follow-up|2|||
146009670|NCT03941873|526548467|FG002|Overall Study|Lost to Follow-up|0|||
146009671|NCT03941873|526548468|FG003|Overall Study|Lost to Follow-up|0|||
146009672|NCT03941873|526548465|FG000|Overall Study|Sponsor Decision|0|||
146009673|NCT03941873|526548466|FG001|Overall Study|Sponsor Decision|6|||
146009674|NCT03941873|526548467|FG002|Overall Study|Sponsor Decision|0|||
146009675|NCT03941873|526548468|FG003|Overall Study|Sponsor Decision|15|||
146009676|NCT03276728|526548469|FG000|Overall Study|Lost to Follow-up|0|||
146009677|NCT03276728|526548470|FG001|Overall Study|Lost to Follow-up|0|||
146009678|NCT03276728|526548471|FG002|Overall Study|Lost to Follow-up|2|||
146009679|NCT03276728|526548472|FG003|Overall Study|Lost to Follow-up|2|||
146009680|NCT03276728|526548473|FG004|Overall Study|Lost to Follow-up|0|||
146009681|NCT03276728|526548474|FG005|Overall Study|Lost to Follow-up|0|||
146009682|NCT03276728|526548475|FG006|Overall Study|Lost to Follow-up|0|||
146009683|NCT03276728|526548476|FG007|Overall Study|Lost to Follow-up|0|||
146009684|NCT03276728|526548469|FG000|Overall Study|Withdrawal by Subject|0|||
146009685|NCT03276728|526548470|FG001|Overall Study|Withdrawal by Subject|0|||
146009686|NCT03276728|526548471|FG002|Overall Study|Withdrawal by Subject|0|||
146009687|NCT03276728|526548472|FG003|Overall Study|Withdrawal by Subject|3|||
146009688|NCT03276728|526548473|FG004|Overall Study|Withdrawal by Subject|0|||
146009689|NCT03276728|526548474|FG005|Overall Study|Withdrawal by Subject|0|||
146009690|NCT03276728|526548475|FG006|Overall Study|Withdrawal by Subject|0|||
146009691|NCT03276728|526548476|FG007|Overall Study|Withdrawal by Subject|0|||
146009692|NCT03276728|526548469|FG000|Overall Study|Decision by sponsor|0|||
146009693|NCT03276728|526548470|FG001|Overall Study|Decision by sponsor|0|||
146009694|NCT03276728|526548471|FG002|Overall Study|Decision by sponsor|0|||
146009695|NCT03276728|526548472|FG003|Overall Study|Decision by sponsor|0|||
146009696|NCT03276728|526548473|FG004|Overall Study|Decision by sponsor|1|||
146009697|NCT03276728|526548474|FG005|Overall Study|Decision by sponsor|0|||
146009698|NCT03276728|526548475|FG006|Overall Study|Decision by sponsor|2|||
146009699|NCT03276728|526548476|FG007|Overall Study|Decision by sponsor|1|||
146009700|NCT01234480|526548479|FG000|Overall Study|Pregnancy|88|||
146009701|NCT01234480|526548479|FG000|Overall Study|>36/Normal History|50|||
146009702|NCT01234480|526548479|FG000|Overall Study|Age|3|||
146009703|NCT01234480|526548479|FG000|Overall Study|HPV Vaccine History|28|||
146249520|NCT00632736|527425260|FG000|Overall Study|Protocol Violation|14|||
146249521|NCT00632736|527425260|FG000|Overall Study|Withdrawal by Subject|99|||
146249522|NCT00632736|527425260|FG000|Overall Study|Lack of Efficacy|5|||
146249523|NCT00632736|527425260|FG000|Overall Study|Sponsor terminated study|5|||
146249524|NCT00632736|527425260|FG000|Overall Study|Non-compliance|10|||
146092809|NCT01927341|526861648|FG001|Phase 2|Disease progression|1|||
146092810|NCT01927341|526861649|FG002|Phase 2|Disease progression|1|||
146092811|NCT01927341|526861650|FG003|Phase 2|Disease progression|1|||
146092812|NCT01927341|526861651|FG004|Phase 2|Disease progression|0|||
146092813|NCT01927341|526861647|FG000|Phase 2|Follow-up completed|0|||
146092814|NCT01927341|526861648|FG001|Phase 2|Follow-up completed|6|||
146092815|NCT01927341|526861649|FG002|Phase 2|Follow-up completed|3|||
146092816|NCT01927341|526861650|FG003|Phase 2|Follow-up completed|5|||
146092817|NCT01927341|526861651|FG004|Phase 2|Follow-up completed|2|||
146092818|NCT01397201|526861652|FG000|Overall Study|Not treated|0|||
146092819|NCT01397201|526861653|FG001|Overall Study|Not treated|0|||
146092820|NCT01397201|526861654|FG002|Overall Study|Not treated|1|||
146092821|NCT01397201|526861655|FG003|Overall Study|Not treated|0|||
146092822|NCT01397201|526861656|FG004|Overall Study|Not treated|0|||
146092823|NCT01397201|526861652|FG000|Overall Study|Not yet defined|3|||
146092824|NCT01397201|526861653|FG001|Overall Study|Not yet defined|6|||
146092825|NCT01397201|526861654|FG002|Overall Study|Not yet defined|5|||
146092826|NCT01397201|526861655|FG003|Overall Study|Not yet defined|5|||
146092827|NCT01397201|526861656|FG004|Overall Study|Not yet defined|4|||
146092828|NCT01397201|526861652|FG000|Overall Study|Adverse Event|2|||
146092829|NCT01397201|526861653|FG001|Overall Study|Adverse Event|0|||
146092830|NCT01397201|526861654|FG002|Overall Study|Adverse Event|0|||
146092831|NCT01397201|526861655|FG003|Overall Study|Adverse Event|0|||
146092832|NCT01397201|526861656|FG004|Overall Study|Adverse Event|0|||
146092833|NCT03956056|526861657|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
146092834|NCT03956056|526861657|FG000|Overall Study|Lack of Efficacy|1|||
146092835|NCT01298531|526861660|FG000|Overall Study|Lack of Efficacy|0|||
146092836|NCT01298531|526861661|FG001|Overall Study|Lack of Efficacy|1|||
146092837|NCT01298531|526861660|FG000|Overall Study|Lost to Follow-up|2|||
146092838|NCT01298531|526861661|FG001|Overall Study|Lost to Follow-up|0|||
146092839|NCT01298531|526861660|FG000|Overall Study|Protocol Violation|1|||
146092840|NCT01298531|526861661|FG001|Overall Study|Protocol Violation|1|||
146092841|NCT01298531|526861660|FG000|Overall Study|Adverse Event|4|||
146092842|NCT01298531|526861661|FG001|Overall Study|Adverse Event|3|||
146092843|NCT01298531|526861660|FG000|Overall Study|Does not meet entrance criteria|0|||
146092844|NCT01298531|526861661|FG001|Overall Study|Does not meet entrance criteria|1|||
146092845|NCT01298531|526861660|FG000|Overall Study|Other|2|||
146092846|NCT01298531|526861661|FG001|Overall Study|Other|1|||
146092847|NCT03646643|526861662|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
146092848|NCT03646643|526861663|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
146092849|NCT03646643|526861662|FG000|Overall Study|Lost to Follow-up|0|||
146092850|NCT03646643|526861663|FG001|Overall Study|Lost to Follow-up|1|||
146092851|NCT04629508|526861666|FG000|Overall Study|Adverse Event|1|||
146092852|NCT04629508|526861666|FG000|Overall Study|Death|2|||
146092853|NCT04629508|526861666|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
146092854|NCT04073368|526861671|FG000|Overall Study|Adverse Event|2|||
146092855|NCT04073368|526861672|FG001|Overall Study|Adverse Event|0|||
146092856|NCT04073368|526861673|FG002|Overall Study|Adverse Event|1|||
146092857|NCT04073368|526861674|FG003|Overall Study|Adverse Event|1|||
146092858|NCT04073368|526861671|FG000|Overall Study|Withdrawal by Subject|2|||
146092859|NCT04073368|526861672|FG001|Overall Study|Withdrawal by Subject|2|||
146249525|NCT00632736|527425260|FG000|Overall Study|Other|16|||
146249526|NCT03015220|527425261|FG000|Overall Study|Withdrawal by Subject|3|||
146249527|NCT03015220|527425262|FG001|Overall Study|Withdrawal by Subject|2|||
146249528|NCT03015220|527425263|FG002|Overall Study|Withdrawal by Subject|2|||
146249529|NCT03015220|527425264|FG003|Overall Study|Withdrawal by Subject|2|||
146249530|NCT03015220|527425261|FG000|Overall Study|Lost to Follow-up|0|||
146249531|NCT03015220|527425262|FG001|Overall Study|Lost to Follow-up|0|||
146249532|NCT03015220|527425263|FG002|Overall Study|Lost to Follow-up|1|||
146249533|NCT03015220|527425264|FG003|Overall Study|Lost to Follow-up|0|||
146249534|NCT02291549|527425265|FG000|Overall Study|Lost to Follow-up|1|||
146332886|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146092860|NCT04073368|526861673|FG002|Overall Study|Withdrawal by Subject|1|||
146092861|NCT04073368|526861674|FG003|Overall Study|Withdrawal by Subject|1|||
146092862|NCT04073368|526861671|FG000|Overall Study|Lost to Follow-up|1|||
146092863|NCT04073368|526861672|FG001|Overall Study|Lost to Follow-up|1|||
146092864|NCT04073368|526861673|FG002|Overall Study|Lost to Follow-up|1|||
146092865|NCT04073368|526861674|FG003|Overall Study|Lost to Follow-up|0|||
146092866|NCT04073368|526861671|FG000|Overall Study|Protocol Violation|0|||
146249535|NCT02291549|527425266|FG001|Overall Study|Lost to Follow-up|0|||
146249536|NCT02291549|527425265|FG000|Overall Study|Withdrawal by Subject|0|||
146092867|NCT04073368|526861672|FG001|Overall Study|Protocol Violation|1|||
146092868|NCT04073368|526861673|FG002|Overall Study|Protocol Violation|0|||
146092869|NCT04073368|526861674|FG003|Overall Study|Protocol Violation|0|||
146092870|NCT04073368|526861671|FG000|Overall Study|Subject noncompliance|7|||
146092871|NCT04073368|526861672|FG001|Overall Study|Subject noncompliance|4|||
146249537|NCT02291549|527425266|FG001|Overall Study|Withdrawal by Subject|1|||
146249538|NCT01468597|527425268|FG000|Overall Study|Found ineligible|17|||
146249539|NCT01468597|527425268|FG000|Overall Study|concomitant valves|12|||
146298744|NCT03933397|527607963|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
146298745|NCT03933397|527607962|FG000|Overall Study|Withdrawal by Subject|1|||
146298746|NCT03933397|527607963|FG001|Overall Study|Withdrawal by Subject|0|||
146298747|NCT03933397|527607962|FG000|Overall Study|Physician Decision|1|||
146298748|NCT03933397|527607963|FG001|Overall Study|Physician Decision|1|||
146009704|NCT01234480|526548479|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
146009705|NCT01234480|526548479|FG000|Overall Study|Hysterectomy|2|||
146009706|NCT01234480|526548479|FG000|Overall Study|Hysterectomy post enrollment|1|||
146009707|NCT01234480|526548479|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
146009708|NCT01234480|526548479|FG000|Overall Study|Informed Consent Form Violation|30|||
146009709|NCT01234480|526548479|FG000|Overall Study|Incorrect Visit|3|||
146009710|NCT01234480|526548479|FG000|Overall Study|No Florida Lab License|20|||
146009711|NCT01234480|526548479|FG000|Overall Study|Out of Window|42|||
146009712|NCT01234480|526548479|FG000|Overall Study|Sample Processing/Storage|92|||
146009713|NCT01234480|526548479|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
146009714|NCT01234480|526548479|FG000|Overall Study|Site/Subject non-compliance|44|||
146009715|NCT01234480|526548479|FG000|Overall Study|Missing Sample|9|||
146009716|NCT02982772|526548480|FG000|Intervention|Lost to Follow-up|19|||
146009717|NCT02982772|526548481|FG001|Intervention|Lost to Follow-up|13|||
146009718|NCT02982772|526548480|FG000|1M Follow-Up|Lost to Follow-up|21|||
146009719|NCT02982772|526548481|FG001|1M Follow-Up|Lost to Follow-up|18|||
146009720|NCT02982772|526548480|FG000|3M Follow-Up|Lost to Follow-up|17|||
146009721|NCT02982772|526548481|FG001|3M Follow-Up|Lost to Follow-up|11|||
146009722|NCT02982772|526548480|FG000|6M Follow-Up|Lost to Follow-up|11|||
146009723|NCT02982772|526548481|FG001|6M Follow-Up|Lost to Follow-up|9|||
146009724|NCT02982772|526548480|FG000|12M Follow-Up|Lost to Follow-up|11|||
146009725|NCT02982772|526548481|FG001|12M Follow-Up|Lost to Follow-up|5|||
146009726|NCT02974140|526548482|FG000|Overall Study|Adverse Event|2|||
146009727|NCT02974140|526548482|FG000|Overall Study|Lost to Follow-up|1|||
146009728|NCT02974140|526548482|FG000|Overall Study|Study Terminated by Sponsor|36|||
146009729|NCT00617084|526548483|FG000|Overall Study|Withdrawal by Subject|5|||
146009730|NCT00617084|526548484|FG001|Overall Study|Withdrawal by Subject|7|||
146009731|NCT00617084|526548483|FG000|Overall Study|Missed 12 Months visit|16|||
146009732|NCT00617084|526548484|FG001|Overall Study|Missed 12 Months visit|19|||
146009733|NCT03370419|526548485|FG000|Overall Study|Lost to Follow-up|16|||
146009734|NCT01693250|526548496|FG000|Overall Study|Lost to Follow-up|2|||
146009735|NCT01693250|526548497|FG001|Overall Study|Lost to Follow-up|2|||
146009736|NCT02297815|526548502|FG000|Overall Study|Lost to Follow-up|236|||
146009737|NCT02297815|526548503|FG001|Overall Study|Lost to Follow-up|140|||
146009738|NCT03650413|526548504|FG000|Overall Study|Adverse Event|1|||
146009739|NCT03650413|526548504|FG000|Overall Study|Lack of Efficacy|17|||
146009740|NCT03650413|526548504|FG000|Overall Study|Other|9|||
146009741|NCT03650413|526548504|FG000|Overall Study|Physician Decision|2|||
146009742|NCT03650413|526548504|FG000|Overall Study|Study Terminated By Sponsor|16|||
146009743|NCT03650413|526548504|FG000|Overall Study|Withdrawal by Subject|16|||
146009744|NCT00310375|526548505|FG000|Primary Reporting Phase|Adverse Event|28|||
146009745|NCT00310375|526548506|FG001|Primary Reporting Phase|Adverse Event|22|||
146009746|NCT00310375|526548507|FG002|Primary Reporting Phase|Adverse Event|0|||
146009747|NCT00310375|526548505|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
146009748|NCT00310375|526548506|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
146009749|NCT00310375|526548507|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
146009750|NCT00310375|526548505|FG000|Primary Reporting Phase|Pregnancy|2|||
146009751|NCT00310375|526548506|FG001|Primary Reporting Phase|Pregnancy|2|||
146009752|NCT00310375|526548507|FG002|Primary Reporting Phase|Pregnancy|0|||
146009753|NCT00310375|526548505|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
146009754|NCT00310375|526548506|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
146009755|NCT00310375|526548507|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
146009756|NCT00310375|526548505|FG000|Primary Reporting Phase|Protocol Violation|8|||
146009757|NCT00310375|526548506|FG001|Primary Reporting Phase|Protocol Violation|5|||
146009758|NCT00310375|526548507|FG002|Primary Reporting Phase|Protocol Violation|0|||
146009759|NCT00310375|526548505|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
146009760|NCT00310375|526548506|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
146092872|NCT04073368|526861673|FG002|Overall Study|Subject noncompliance|0|||
146092873|NCT04073368|526861674|FG003|Overall Study|Subject noncompliance|0|||
146009761|NCT00310375|526548507|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
146009762|NCT00310375|526548505|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
146009763|NCT00310375|526548506|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
146009764|NCT00310375|526548507|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
146009765|NCT00310375|526548505|FG000|Primary Reporting Phase|Physician Decision|5|||
146009766|NCT00310375|526548506|FG001|Primary Reporting Phase|Physician Decision|3|||
146009767|NCT00310375|526548507|FG002|Primary Reporting Phase|Physician Decision|0|||
146009768|NCT00310375|526548505|FG000|Primary Reporting Phase|Request of the sponsor|2|||
146009769|NCT00310375|526548506|FG001|Primary Reporting Phase|Request of the sponsor|2|||
146092874|NCT00145600|526861675|FG000|Overall Study|Death|1|||
146298749|NCT03933397|527607962|FG000|Overall Study|missing pain score|1|||
146009770|NCT00310375|526548507|FG002|Primary Reporting Phase|Request of the sponsor|0|||
146009771|NCT00310375|526548505|FG000|Primary Reporting Phase|Failed to return|1|||
146249540|NCT01468597|527425268|FG000|Overall Study|off-pump CABG|1|||
146249541|NCT01468597|527425268|FG000|Overall Study|no platelet function data|5|||
146249542|NCT04447287|527425269|FG000|Period 1: Run-in Period|Adverse Event|3|||
146249543|NCT04447287|527425270|FG001|Period 1: Run-in Period|Adverse Event|0|||
146249544|NCT04447287|527425271|FG002|Period 1: Run-in Period|Adverse Event|0|||
146249545|NCT04447287|527425269|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
146249546|NCT04447287|527425270|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
146249547|NCT04447287|527425271|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
146249548|NCT04447287|527425269|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
146249549|NCT04447287|527425270|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
146249550|NCT04447287|527425271|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
146249551|NCT00912964|527425272|FG000|Overall Study|Eligibility criterion not met|1|||
146249552|NCT00912964|527425273|FG001|Overall Study|Eligibility criterion not met|1|||
146249553|NCT00912964|527425274|FG002|Overall Study|Eligibility criterion not met|0|||
146249554|NCT00912964|527425272|FG000|Overall Study|Adverse Event|15|||
146249555|NCT00912964|527425273|FG001|Overall Study|Adverse Event|18|||
146249556|NCT00912964|527425274|FG002|Overall Study|Adverse Event|12|||
146249557|NCT00912964|527425272|FG000|Overall Study|Lack of Efficacy|11|||
146249558|NCT00912964|527425273|FG001|Overall Study|Lack of Efficacy|4|||
146249559|NCT00912964|527425274|FG002|Overall Study|Lack of Efficacy|3|||
146249560|NCT00912964|527425272|FG000|Overall Study|Withdrawal by Subject|20|||
146249561|NCT00912964|527425273|FG001|Overall Study|Withdrawal by Subject|12|||
146249562|NCT00912964|527425274|FG002|Overall Study|Withdrawal by Subject|18|||
146249563|NCT00912964|527425272|FG000|Overall Study|Lost to Follow-up|4|||
146249564|NCT00912964|527425273|FG001|Overall Study|Lost to Follow-up|3|||
146249565|NCT00912964|527425274|FG002|Overall Study|Lost to Follow-up|3|||
146249566|NCT00912964|527425272|FG000|Overall Study|Protocol Violation|5|||
146249567|NCT00912964|527425273|FG001|Overall Study|Protocol Violation|3|||
146249568|NCT00912964|527425274|FG002|Overall Study|Protocol Violation|8|||
146249569|NCT00912964|527425272|FG000|Overall Study|Taking exclusionary medications|7|||
146249570|NCT00912964|527425273|FG001|Overall Study|Taking exclusionary medications|4|||
146249571|NCT00912964|527425274|FG002|Overall Study|Taking exclusionary medications|8|||
146249572|NCT00912964|527425272|FG000|Overall Study|Medical History|1|||
146249573|NCT00912964|527425273|FG001|Overall Study|Medical History|0|||
146249574|NCT00912964|527425274|FG002|Overall Study|Medical History|0|||
146249575|NCT00912964|527425272|FG000|Overall Study|Non-compliance with study procedures|2|||
146249576|NCT00912964|527425273|FG001|Overall Study|Non-compliance with study procedures|0|||
146249577|NCT00912964|527425274|FG002|Overall Study|Non-compliance with study procedures|0|||
146249578|NCT00912964|527425272|FG000|Overall Study|Violation of exclusion criterion|0|||
146249579|NCT00912964|527425273|FG001|Overall Study|Violation of exclusion criterion|0|||
146249580|NCT00912964|527425274|FG002|Overall Study|Violation of exclusion criterion|2|||
146249581|NCT00912964|527425272|FG000|Overall Study|Randomized but never received study drug|0|||
146249582|NCT00912964|527425273|FG001|Overall Study|Randomized but never received study drug|1|||
146249583|NCT00912964|527425274|FG002|Overall Study|Randomized but never received study drug|0|||
146249584|NCT00655824|527425277|FG000|Overall Study|Adverse Event|3|||
146249585|NCT00655824|527425277|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
146249586|NCT00655824|527425277|FG000|Overall Study|Protocol Violation|1|||
146249587|NCT00655824|527425277|FG000|Overall Study|Withdrawal by Subject|4|||
146249588|NCT00655824|527425277|FG000|Overall Study|Deterioration of Trial Disease|2|||
146249589|NCT00960206|527425278|FG000|Overall Study|Death|7|||
146249590|NCT00960206|527425279|FG001|Overall Study|Death|4|||
146249591|NCT00960206|527425280|FG002|Overall Study|Death|1|||
146249592|NCT00960206|527425278|FG000|Overall Study|Unwilling/Unable to return|1|||
146249593|NCT00960206|527425279|FG001|Overall Study|Unwilling/Unable to return|2|||
146249594|NCT00960206|527425280|FG002|Overall Study|Unwilling/Unable to return|0|||
146249595|NCT00960206|527425278|FG000|Overall Study|Lost to Follow-up|8|||
146249596|NCT00960206|527425279|FG001|Overall Study|Lost to Follow-up|14|||
146249597|NCT00960206|527425280|FG002|Overall Study|Lost to Follow-up|8|||
146249598|NCT00960206|527425278|FG000|Overall Study|Withdrawal by Subject|2|||
146249599|NCT00960206|527425279|FG001|Overall Study|Withdrawal by Subject|4|||
146249600|NCT00960206|527425280|FG002|Overall Study|Withdrawal by Subject|0|||
146249601|NCT00960206|527425278|FG000|Overall Study|Revision of study component|2|||
146249602|NCT00960206|527425279|FG001|Overall Study|Revision of study component|2|||
146249603|NCT00960206|527425280|FG002|Overall Study|Revision of study component|2|||
146249604|NCT00960206|527425278|FG000|Overall Study|Missing 10 year data|20|||
146249605|NCT00960206|527425279|FG001|Overall Study|Missing 10 year data|1|||
146249606|NCT00960206|527425280|FG002|Overall Study|Missing 10 year data|1|||
146249607|NCT02470806|527425287|FG000|Overall Study|Lost to Follow-up|1|||
146249608|NCT02470806|527425288|FG001|Overall Study|Lost to Follow-up|1|||
146249609|NCT02470806|527425287|FG000|Overall Study|Adverse Event|5|||
146249610|NCT02470806|527425288|FG001|Overall Study|Adverse Event|2|||
146249611|NCT02470806|527425287|FG000|Overall Study|Protocol Violation|4|||
146249612|NCT02470806|527425288|FG001|Overall Study|Protocol Violation|11|||
146249613|NCT02470806|527425287|FG000|Overall Study|Physician Decision|0|||
146009772|NCT00310375|526548506|FG001|Primary Reporting Phase|Failed to return|3|||
146009773|NCT00310375|526548507|FG002|Primary Reporting Phase|Failed to return|0|||
146009774|NCT00310375|526548505|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
146009775|NCT00310375|526548506|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
146009776|NCT00310375|526548507|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
146009777|NCT00310375|526548505|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
146009778|NCT00310375|526548506|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
146009779|NCT00310375|526548507|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
146009780|NCT00310375|526548505|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
146009781|NCT00310375|526548506|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
146009782|NCT00310375|526548507|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
146009783|NCT00310375|526548505|FG000|Primary Reporting Phase|Site closure|3|||
146009784|NCT00310375|526548506|FG001|Primary Reporting Phase|Site closure|0|||
146009785|NCT00310375|526548507|FG002|Primary Reporting Phase|Site closure|0|||
146009786|NCT00310375|526548505|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
146009787|NCT00310375|526548506|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
146009788|NCT00310375|526548507|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
146009789|NCT00310375|526548505|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
146009790|NCT00310375|526548506|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
146009791|NCT00310375|526548507|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
146009792|NCT00310375|526548505|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
146009793|NCT00310375|526548506|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
146009794|NCT00310375|526548507|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
146009795|NCT00310375|526548505|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
146009796|NCT00310375|526548506|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
146009797|NCT00310375|526548507|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
146009798|NCT01318135|526548508|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146009799|NCT01318135|526548509|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009800|NCT01318135|526548510|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009801|NCT01318135|526548511|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009802|NCT01318135|526548512|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009803|NCT01318135|526548513|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009804|NCT01318135|526548514|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009805|NCT01318135|526548515|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146009806|NCT01318135|526548508|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
146009807|NCT01318135|526548509|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009808|NCT01318135|526548510|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009809|NCT01318135|526548511|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009810|NCT01318135|526548512|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146249614|NCT02470806|527425288|FG001|Overall Study|Physician Decision|3|||
146249615|NCT02470806|527425287|FG000|Overall Study|Withdrawal by Subject|3|||
146249616|NCT02470806|527425288|FG001|Overall Study|Withdrawal by Subject|10|||
146249617|NCT02470806|527425287|FG000|Overall Study|Lack of Efficacy|5|||
146249618|NCT02470806|527425288|FG001|Overall Study|Lack of Efficacy|15|||
146249619|NCT03032198|527425289|FG000|Overall Study|Screen Fail|1|||
146249620|NCT00866619|527425290|FG000|Overall Study|Adverse Event|112|||
146249621|NCT00866619|527425291|FG001|Overall Study|Adverse Event|106|||
146249622|NCT00866619|527425292|FG002|Overall Study|Adverse Event|47|||
146249623|NCT00866619|527425293|FG003|Overall Study|Adverse Event|44|||
146009811|NCT01318135|526548513|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009812|NCT01318135|526548514|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009813|NCT01318135|526548515|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
146009814|NCT01318135|526548508|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
146009815|NCT01318135|526548509|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
146009816|NCT01318135|526548510|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
146009817|NCT01318135|526548511|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
146009818|NCT01318135|526548512|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
146009819|NCT01318135|526548513|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
146009820|NCT01318135|526548514|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
146249624|NCT00866619|527425290|FG000|Overall Study|Protocol Violation|2|||
146249625|NCT00866619|527425291|FG001|Overall Study|Protocol Violation|39|||
146249626|NCT00866619|527425292|FG002|Overall Study|Protocol Violation|2|||
146249627|NCT00866619|527425293|FG003|Overall Study|Protocol Violation|17|||
146249628|NCT00866619|527425290|FG000|Overall Study|Withdrawal by Subject|587|||
146249629|NCT00866619|527425291|FG001|Overall Study|Withdrawal by Subject|295|||
146249630|NCT00866619|527425292|FG002|Overall Study|Withdrawal by Subject|272|||
146249631|NCT00866619|527425293|FG003|Overall Study|Withdrawal by Subject|144|||
146249632|NCT00866619|527425290|FG000|Overall Study|Lost to Follow-up|1145|||
146249633|NCT00866619|527425291|FG001|Overall Study|Lost to Follow-up|830|||
146249634|NCT00866619|527425292|FG002|Overall Study|Lost to Follow-up|568|||
146249635|NCT00866619|527425293|FG003|Overall Study|Lost to Follow-up|425|||
146249636|NCT02892019|527425295|FG000|Overall Study|randomized but not treated|0|||
146249637|NCT02892019|527425296|FG001|Overall Study|randomized but not treated|1|||
146249638|NCT02892019|527425295|FG000|Overall Study|Withdrawal by Subject|0|||
146249639|NCT02892019|527425296|FG001|Overall Study|Withdrawal by Subject|1|||
146249640|NCT02892019|527425295|FG000|Overall Study|Adverse Event|1|||
146249641|NCT02892019|527425296|FG001|Overall Study|Adverse Event|1|||
146249642|NCT01229176|527425297|FG000|Overall Study|Withdrawal by Subject|0|||
146249643|NCT01229176|527425298|FG001|Overall Study|Withdrawal by Subject|0|||
146249644|NCT01229176|527425299|FG002|Overall Study|Withdrawal by Subject|0|||
146249645|NCT01229176|527425300|FG003|Overall Study|Withdrawal by Subject|1|||
146249646|NCT01229176|527425301|FG004|Overall Study|Withdrawal by Subject|1|||
146249647|NCT01229176|527425302|FG005|Overall Study|Withdrawal by Subject|1|||
146249648|NCT01229176|527425303|FG006|Overall Study|Withdrawal by Subject|0|||
146249649|NCT01229176|527425304|FG007|Overall Study|Withdrawal by Subject|1|||
146249650|NCT01229176|527425297|FG000|Overall Study|Lost to Follow-up|0|||
146249651|NCT01229176|527425298|FG001|Overall Study|Lost to Follow-up|3|||
146249652|NCT01229176|527425299|FG002|Overall Study|Lost to Follow-up|0|||
146249653|NCT01229176|527425300|FG003|Overall Study|Lost to Follow-up|0|||
146249654|NCT01229176|527425301|FG004|Overall Study|Lost to Follow-up|1|||
146249655|NCT01229176|527425302|FG005|Overall Study|Lost to Follow-up|1|||
146249656|NCT01229176|527425303|FG006|Overall Study|Lost to Follow-up|0|||
146249657|NCT01229176|527425304|FG007|Overall Study|Lost to Follow-up|2|||
146249658|NCT01661972|527425305|FG000|Overall Study|Adverse Event|1|||
146249659|NCT01661972|527425306|FG001|Overall Study|Adverse Event|2|||
146249660|NCT01661972|527425305|FG000|Overall Study|Death during Treatment period|1|||
146249661|NCT01661972|527425306|FG001|Overall Study|Death during Treatment period|1|||
146249662|NCT01661972|527425305|FG000|Overall Study|Withdrawal by Subject|0|||
146249663|NCT01661972|527425306|FG001|Overall Study|Withdrawal by Subject|1|||
146249664|NCT01159600|527425308|FG000|Overall Study|Not treated|0|||
146249665|NCT01159600|527425309|FG001|Overall Study|Not treated|0|||
146249666|NCT01159600|527425310|FG002|Overall Study|Not treated|1|||
146249667|NCT01159600|527425311|FG003|Overall Study|Not treated|0|||
146249668|NCT01159600|527425312|FG004|Overall Study|Not treated|0|||
146249669|NCT01159600|527425313|FG005|Overall Study|Not treated|1|||
146249670|NCT01159600|527425314|FG006|Overall Study|Not treated|2|||
146249671|NCT01159600|527425315|FG007|Overall Study|Not treated|2|||
146249672|NCT01159600|527425308|FG000|Overall Study|Adverse Event|7|||
146249673|NCT01159600|527425309|FG001|Overall Study|Adverse Event|2|||
146249674|NCT01159600|527425310|FG002|Overall Study|Adverse Event|5|||
146249675|NCT01159600|527425311|FG003|Overall Study|Adverse Event|1|||
146249676|NCT01159600|527425312|FG004|Overall Study|Adverse Event|8|||
146249677|NCT01159600|527425313|FG005|Overall Study|Adverse Event|6|||
146249678|NCT01159600|527425314|FG006|Overall Study|Adverse Event|7|||
146249679|NCT01159600|527425315|FG007|Overall Study|Adverse Event|5|||
146249680|NCT01159600|527425308|FG000|Overall Study|Lack of Efficacy|0|||
146249681|NCT01159600|527425309|FG001|Overall Study|Lack of Efficacy|0|||
146249682|NCT01159600|527425310|FG002|Overall Study|Lack of Efficacy|0|||
146249683|NCT01159600|527425311|FG003|Overall Study|Lack of Efficacy|0|||
146249684|NCT01159600|527425312|FG004|Overall Study|Lack of Efficacy|2|||
146249685|NCT01159600|527425313|FG005|Overall Study|Lack of Efficacy|0|||
146249686|NCT01159600|527425314|FG006|Overall Study|Lack of Efficacy|0|||
146249687|NCT01159600|527425315|FG007|Overall Study|Lack of Efficacy|1|||
146249688|NCT01159600|527425308|FG000|Overall Study|Non compliant with protocol|2|||
146249689|NCT01159600|527425309|FG001|Overall Study|Non compliant with protocol|1|||
146249690|NCT01159600|527425310|FG002|Overall Study|Non compliant with protocol|0|||
146092875|NCT00145600|526861676|FG001|Overall Study|Death|2|||
146249691|NCT01159600|527425311|FG003|Overall Study|Non compliant with protocol|0|||
146249692|NCT01159600|527425312|FG004|Overall Study|Non compliant with protocol|2|||
146249693|NCT01159600|527425313|FG005|Overall Study|Non compliant with protocol|0|||
146249694|NCT01159600|527425314|FG006|Overall Study|Non compliant with protocol|2|||
146249695|NCT01159600|527425315|FG007|Overall Study|Non compliant with protocol|0|||
146249696|NCT01159600|527425308|FG000|Overall Study|Lost to Follow-up|2|||
146249697|NCT01159600|527425309|FG001|Overall Study|Lost to Follow-up|3|||
146249698|NCT01159600|527425310|FG002|Overall Study|Lost to Follow-up|4|||
146249699|NCT01159600|527425311|FG003|Overall Study|Lost to Follow-up|3|||
146249700|NCT01159600|527425312|FG004|Overall Study|Lost to Follow-up|3|||
146249701|NCT01159600|527425313|FG005|Overall Study|Lost to Follow-up|0|||
146249702|NCT01159600|527425314|FG006|Overall Study|Lost to Follow-up|3|||
146249703|NCT01159600|527425315|FG007|Overall Study|Lost to Follow-up|2|||
146249704|NCT01159600|527425308|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
146249705|NCT01159600|527425309|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
146249706|NCT01159600|527425310|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
146249707|NCT01159600|527425311|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
146249708|NCT01159600|527425312|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
146298750|NCT03933397|527607963|FG001|Overall Study|missing pain score|1|||
146249709|NCT01159600|527425313|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
146249710|NCT01159600|527425314|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
146249711|NCT01159600|527425315|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
146249712|NCT01159600|527425308|FG000|Overall Study|Other reason not defined above|3|||
146249713|NCT01159600|527425309|FG001|Overall Study|Other reason not defined above|0|||
146249714|NCT01159600|527425310|FG002|Overall Study|Other reason not defined above|4|||
146249715|NCT01159600|527425311|FG003|Overall Study|Other reason not defined above|2|||
146249716|NCT01159600|527425312|FG004|Overall Study|Other reason not defined above|5|||
146249717|NCT01159600|527425313|FG005|Overall Study|Other reason not defined above|7|||
146249718|NCT01159600|527425314|FG006|Overall Study|Other reason not defined above|3|||
146249719|NCT01159600|527425315|FG007|Overall Study|Other reason not defined above|3|||
146249720|NCT00946998|527426722|FG000|Overall Study|Exited prior to first outcome assessment|5|||
146249721|NCT00946998|527426723|FG001|Overall Study|Exited prior to first outcome assessment|3|||
146249722|NCT01279447|527426732|FG000|Overall Study|Lost to Follow-up|3|||
146249723|NCT01279447|527426733|FG001|Overall Study|Lost to Follow-up|1|||
146249724|NCT00538629|527426739|FG000|Overall Study|At subject's request|1|||
146249725|NCT00538629|527426739|FG000|Overall Study|Adverse Event|2|||
146249726|NCT00538629|527426739|FG000|Overall Study|Lack of Efficacy|12|||
146249727|NCT00538629|527426739|FG000|Overall Study|Lost to Follow-up|6|||
146249728|NCT00538629|527426739|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
146249729|NCT00555620|527426745|FG000|Overall Study|Death|0|||
146249730|NCT00555620|527426746|FG001|Overall Study|Death|1|||
146249731|NCT00555620|527426747|FG002|Overall Study|Death|0|||
146249732|NCT00555620|527426748|FG003|Overall Study|Death|0|||
146249733|NCT00555620|527426749|FG004|Overall Study|Death|0|||
146249734|NCT00555620|527426750|FG005|Overall Study|Death|1|||
146249735|NCT00555620|527426745|FG000|Overall Study|Study terminated by sponsor|0|||
146249736|NCT00555620|527426746|FG001|Overall Study|Study terminated by sponsor|0|||
146249737|NCT00555620|527426747|FG002|Overall Study|Study terminated by sponsor|1|||
146249738|NCT00555620|527426748|FG003|Overall Study|Study terminated by sponsor|0|||
146249739|NCT00555620|527426749|FG004|Overall Study|Study terminated by sponsor|0|||
146249740|NCT00555620|527426750|FG005|Overall Study|Study terminated by sponsor|0|||
146249741|NCT00555620|527426745|FG000|Overall Study|Adverse Event|0|||
146249742|NCT00555620|527426746|FG001|Overall Study|Adverse Event|0|||
146249743|NCT00555620|527426747|FG002|Overall Study|Adverse Event|1|||
146249744|NCT00555620|527426748|FG003|Overall Study|Adverse Event|5|||
146249745|NCT00555620|527426749|FG004|Overall Study|Adverse Event|0|||
146249746|NCT00555620|527426750|FG005|Overall Study|Adverse Event|1|||
146249747|NCT00555620|527426745|FG000|Overall Study|Objective progression or relapse|6|||
146249748|NCT00555620|527426746|FG001|Overall Study|Objective progression or relapse|5|||
146249749|NCT00555620|527426747|FG002|Overall Study|Objective progression or relapse|12|||
146249750|NCT00555620|527426748|FG003|Overall Study|Objective progression or relapse|17|||
146249751|NCT00555620|527426749|FG004|Overall Study|Objective progression or relapse|3|||
146249752|NCT00555620|527426750|FG005|Overall Study|Objective progression or relapse|16|||
146249753|NCT00555620|527426745|FG000|Overall Study|Participant refused treatment|0|||
146249754|NCT00555620|527426746|FG001|Overall Study|Participant refused treatment|1|||
146249755|NCT00555620|527426747|FG002|Overall Study|Participant refused treatment|1|||
146249756|NCT00555620|527426748|FG003|Overall Study|Participant refused treatment|0|||
146249757|NCT00555620|527426749|FG004|Overall Study|Participant refused treatment|0|||
146249758|NCT00555620|527426750|FG005|Overall Study|Participant refused treatment|1|||
146249759|NCT00555620|527426745|FG000|Overall Study|Other|0|||
146249760|NCT00555620|527426746|FG001|Overall Study|Other|0|||
146298751|NCT03933397|527607962|FG000|Overall Study|Confirmed COVID-19|1|||
146298752|NCT03933397|527607963|FG001|Overall Study|Confirmed COVID-19|2|||
146298753|NCT02066051|527607968|FG000|Overall Study|Subject developed active GVHD|1|||
146298754|NCT01237340|527607973|FG000|Overall Study|Adverse Event|3|||
146298755|NCT01237340|527607973|FG000|Overall Study|Withdrawal by Subject|1|||
146298756|NCT01237340|527607973|FG000|Overall Study|Early termination of the trial|36|||
146249761|NCT00555620|527426747|FG002|Overall Study|Other|0|||
146249762|NCT00555620|527426748|FG003|Overall Study|Other|1|||
146249763|NCT00555620|527426749|FG004|Overall Study|Other|0|||
146249764|NCT00555620|527426750|FG005|Overall Study|Other|3|||
146249765|NCT05203822|527426751|FG000|Overall Study|Adverse Event|1|||
146249766|NCT05203822|527426751|FG000|Overall Study|Withdrawal by Subject|1|||
146249767|NCT03320941|527426755|FG000|Overall Study|subject/guardian decision|0|||
146249768|NCT03320941|527426756|FG001|Overall Study|subject/guardian decision|0|||
146249769|NCT03320941|527426757|FG002|Overall Study|subject/guardian decision|0|||
146249770|NCT03320941|527426758|FG003|Overall Study|subject/guardian decision|1|||
146249771|NCT03320941|527426759|FG004|Overall Study|subject/guardian decision|0|||
146249772|NCT00447499|527426760|FG000|Overall Study|Adverse Event|1|||
146249773|NCT00447499|527426760|FG000|Overall Study|Patient Decision|4|||
146249774|NCT00447499|527426760|FG000|Overall Study|Sponsor Decision|1|||
146249775|NCT00447499|527426760|FG000|Overall Study|Physician Decision|1|||
146249776|NCT01767376|527426762|FG000|Overall Study|Lost to Follow-up|3|||
146249777|NCT01767376|527426763|FG001|Overall Study|Lost to Follow-up|2|||
146298757|NCT01610687|527607974|FG000|Overall Study|Lack of Efficacy|26|||
146249778|NCT01767376|527426764|FG002|Overall Study|Lost to Follow-up|0|||
146249779|NCT01767376|527426762|FG000|Overall Study|Withdrawal by Subject|1|||
146249780|NCT01767376|527426763|FG001|Overall Study|Withdrawal by Subject|1|||
146249781|NCT01767376|527426764|FG002|Overall Study|Withdrawal by Subject|0|||
146249782|NCT00946088|527426765|FG000|Overall Study|Withdrawal by Subject|0|||
146249783|NCT00946088|527426766|FG001|Overall Study|Withdrawal by Subject|1|||
146249784|NCT03184519|527426768|FG000|Overall Study|Lost to Follow-up|6|||
146249785|NCT03184519|527426768|FG000|Overall Study|Physician Decision|21|||
146249786|NCT00584909|527426769|FG000|Overall Study|Adverse Event|4|||
146249787|NCT03345407|527426770|FG000|Overall Study|Withdrawal by Subject|11|||
146249788|NCT03345407|527426771|FG001|Overall Study|Withdrawal by Subject|1|||
146249789|NCT03345407|527426772|FG002|Overall Study|Withdrawal by Subject|5|||
146249790|NCT03345407|527426773|FG003|Overall Study|Withdrawal by Subject|6|||
146249791|NCT03345407|527426774|FG004|Overall Study|Withdrawal by Subject|3|||
146249792|NCT03345407|527426775|FG005|Overall Study|Withdrawal by Subject|6|||
146249793|NCT03345407|527426776|FG006|Overall Study|Withdrawal by Subject|16|||
146249794|NCT03345407|527426770|FG000|Overall Study|Physician Decision|3|||
146249795|NCT03345407|527426771|FG001|Overall Study|Physician Decision|1|||
146249796|NCT03345407|527426772|FG002|Overall Study|Physician Decision|0|||
146249797|NCT03345407|527426773|FG003|Overall Study|Physician Decision|0|||
146249798|NCT03345407|527426774|FG004|Overall Study|Physician Decision|1|||
146249799|NCT03345407|527426775|FG005|Overall Study|Physician Decision|2|||
146249800|NCT03345407|527426776|FG006|Overall Study|Physician Decision|3|||
146249801|NCT03345407|527426770|FG000|Overall Study|Lost to Follow-up|2|||
146249802|NCT03345407|527426771|FG001|Overall Study|Lost to Follow-up|0|||
146249803|NCT03345407|527426772|FG002|Overall Study|Lost to Follow-up|1|||
146249804|NCT03345407|527426773|FG003|Overall Study|Lost to Follow-up|0|||
146249805|NCT03345407|527426774|FG004|Overall Study|Lost to Follow-up|1|||
146249806|NCT03345407|527426775|FG005|Overall Study|Lost to Follow-up|2|||
146249807|NCT03345407|527426776|FG006|Overall Study|Lost to Follow-up|3|||
146249808|NCT03345407|527426770|FG000|Overall Study|Protocol-defined stopping criteria|9|||
146249809|NCT03345407|527426771|FG001|Overall Study|Protocol-defined stopping criteria|0|||
146249810|NCT03345407|527426772|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146249811|NCT03345407|527426773|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146249812|NCT03345407|527426774|FG004|Overall Study|Protocol-defined stopping criteria|2|||
146249813|NCT03345407|527426775|FG005|Overall Study|Protocol-defined stopping criteria|1|||
146249814|NCT03345407|527426776|FG006|Overall Study|Protocol-defined stopping criteria|1|||
146249815|NCT03345407|527426770|FG000|Overall Study|Protocol Violation|2|||
146249816|NCT03345407|527426771|FG001|Overall Study|Protocol Violation|0|||
146249817|NCT03345407|527426772|FG002|Overall Study|Protocol Violation|0|||
146249818|NCT03345407|527426773|FG003|Overall Study|Protocol Violation|0|||
146249819|NCT03345407|527426774|FG004|Overall Study|Protocol Violation|1|||
146249820|NCT03345407|527426775|FG005|Overall Study|Protocol Violation|0|||
146249821|NCT03345407|527426776|FG006|Overall Study|Protocol Violation|3|||
146249822|NCT03345407|527426770|FG000|Overall Study|Lack of Efficacy|1|||
146249823|NCT03345407|527426771|FG001|Overall Study|Lack of Efficacy|1|||
146249824|NCT03345407|527426772|FG002|Overall Study|Lack of Efficacy|1|||
146249825|NCT03345407|527426773|FG003|Overall Study|Lack of Efficacy|1|||
146249826|NCT03345407|527426774|FG004|Overall Study|Lack of Efficacy|1|||
146249827|NCT03345407|527426775|FG005|Overall Study|Lack of Efficacy|0|||
146249828|NCT03345407|527426776|FG006|Overall Study|Lack of Efficacy|3|||
146249829|NCT03345407|527426770|FG000|Overall Study|Adverse Event|4|||
146249830|NCT03345407|527426771|FG001|Overall Study|Adverse Event|0|||
146249831|NCT03345407|527426772|FG002|Overall Study|Adverse Event|5|||
146249832|NCT03345407|527426773|FG003|Overall Study|Adverse Event|4|||
146249833|NCT03345407|527426774|FG004|Overall Study|Adverse Event|6|||
146249834|NCT03345407|527426775|FG005|Overall Study|Adverse Event|5|||
146249835|NCT03345407|527426776|FG006|Overall Study|Adverse Event|16|||
146249836|NCT02092909|527426779|FG000|Overall Study|Adverse Event|0|||
146249837|NCT02092909|527426780|FG001|Overall Study|Adverse Event|0|||
146249838|NCT02092909|527426781|FG002|Overall Study|Adverse Event|4|||
146249839|NCT02092909|527426782|FG003|Overall Study|Adverse Event|2|||
146249840|NCT02092909|527426779|FG000|Overall Study|Lack of Efficacy|0|||
146249841|NCT02092909|527426780|FG001|Overall Study|Lack of Efficacy|2|||
146249842|NCT02092909|527426781|FG002|Overall Study|Lack of Efficacy|1|||
146249843|NCT02092909|527426782|FG003|Overall Study|Lack of Efficacy|0|||
146249844|NCT02092909|527426779|FG000|Overall Study|Withdrawal by Subject|0|||
146249845|NCT02092909|527426780|FG001|Overall Study|Withdrawal by Subject|0|||
146249846|NCT02092909|527426781|FG002|Overall Study|Withdrawal by Subject|2|||
146249847|NCT02092909|527426782|FG003|Overall Study|Withdrawal by Subject|1|||
146249848|NCT02092909|527426779|FG000|Overall Study|Study terminated by Sponsor|0|||
146249849|NCT02092909|527426780|FG001|Overall Study|Study terminated by Sponsor|0|||
146249850|NCT02092909|527426781|FG002|Overall Study|Study terminated by Sponsor|0|||
146249851|NCT02092909|527426782|FG003|Overall Study|Study terminated by Sponsor|2|||
146249852|NCT02092909|527426779|FG000|Overall Study|Miscellaneous|1|||
146249853|NCT02092909|527426780|FG001|Overall Study|Miscellaneous|1|||
146249854|NCT02092909|527426781|FG002|Overall Study|Miscellaneous|2|||
146249855|NCT02092909|527426782|FG003|Overall Study|Miscellaneous|1|||
146298758|NCT01610687|527607974|FG000|Overall Study|Adverse Event|18|||
146298759|NCT01610687|527607974|FG000|Overall Study|Moved out of area|6|||
146298760|NCT01610687|527607974|FG000|Overall Study|Withdrawal by Subject|7|||
146298761|NCT01610687|527607974|FG000|Overall Study|Lost to Follow-up|4|||
146298762|NCT01610687|527607974|FG000|Overall Study|Symptom control without study medication|2|||
146298763|NCT01610687|527607974|FG000|Overall Study|Unable to make journey|1|||
146298764|NCT01610687|527607974|FG000|Overall Study|Death|1|||
146298765|NCT01610687|527607974|FG000|Overall Study|Cannabis affecting job|1|||
146298766|NCT01610687|527607974|FG000|Overall Study|Felt more alter without study medication|1|||
146298767|NCT03836807|527607975|FG000|Overall Study|Physician Decision|1|||
146298768|NCT03836807|527607976|FG001|Overall Study|Physician Decision|0|||
146298769|NCT00685685|527607977|FG000|Washout Period of 7 Days|Adverse Event|2|||
146298770|NCT00685685|527607978|FG001|Washout Period of 7 Days|Adverse Event|0|||
146298771|NCT00685685|527607977|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
146298772|NCT00685685|527607978|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146298773|NCT04029116|527607979|FG000|Overall Study|Adverse Event|0|||
146298774|NCT04029116|527607980|FG001|Overall Study|Adverse Event|2|||
146298775|NCT04029116|527607979|FG000|Overall Study|Lost to Follow-up|3|||
146298776|NCT04029116|527607980|FG001|Overall Study|Lost to Follow-up|5|||
146298777|NCT04029116|527607979|FG000|Overall Study|Physician Decision|2|||
146298778|NCT04029116|527607980|FG001|Overall Study|Physician Decision|0|||
146298779|NCT04029116|527607979|FG000|Overall Study|Pregnancy|1|||
146298780|NCT04029116|527607980|FG001|Overall Study|Pregnancy|2|||
146298781|NCT04029116|527607979|FG000|Overall Study|Withdrawal by Subject|4|||
146298782|NCT04029116|527607980|FG001|Overall Study|Withdrawal by Subject|6|||
146298783|NCT04029116|527607979|FG000|Overall Study|Other|2|||
146298784|NCT04029116|527607980|FG001|Overall Study|Other|1|||
146298785|NCT01272947|527607981|FG000|Overall Study|Abnormal Laboratory Value|2|||
146009821|NCT01318135|526548515|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
146009822|NCT01318135|526548508|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
146009823|NCT01318135|526548509|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
146009824|NCT01318135|526548510|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
146009825|NCT01318135|526548511|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
146009826|NCT01318135|526548512|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
146009827|NCT01318135|526548513|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
146009828|NCT01318135|526548514|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
146009829|NCT01318135|526548515|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
146009830|NCT01318135|526548508|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146009831|NCT01318135|526548509|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146009832|NCT01318135|526548510|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146009833|NCT01318135|526548511|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146009834|NCT01318135|526548512|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146009835|NCT01318135|526548513|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146009836|NCT01318135|526548514|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146009837|NCT01318135|526548515|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146009838|NCT01318135|526548508|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
146009839|NCT01318135|526548509|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
146009840|NCT01318135|526548510|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146009841|NCT01318135|526548511|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
146009842|NCT01318135|526548512|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146009843|NCT01318135|526548513|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146009844|NCT01318135|526548514|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146009845|NCT01318135|526548515|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146009846|NCT01318135|526548508|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009847|NCT01318135|526548509|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146298786|NCT01272947|527607982|FG001|Overall Study|Abnormal Laboratory Value|2|||
146009848|NCT01318135|526548510|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009849|NCT01318135|526548511|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009850|NCT01318135|526548512|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009851|NCT01318135|526548513|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009852|NCT01318135|526548514|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
146009853|NCT01318135|526548515|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
146298787|NCT02019420|527607985|FG000|Overall Study|Did not receive study drug|2|||
146009854|NCT01071954|526548517|FG000|Overall Study|Noncompliance|4|||
146298788|NCT02019420|527607986|FG001|Overall Study|Did not receive study drug|2|||
146298789|NCT02019420|527607985|FG000|Overall Study|Withdrawal by Subject|1|||
146298790|NCT02019420|527607986|FG001|Overall Study|Withdrawal by Subject|3|||
146298791|NCT02019420|527607985|FG000|Overall Study|At request of sponsor or investigator|0|||
146298792|NCT02019420|527607986|FG001|Overall Study|At request of sponsor or investigator|1|||
146298793|NCT02019420|527607985|FG000|Overall Study|Death|104|||
146298794|NCT02019420|527607986|FG001|Overall Study|Death|99|||
146298795|NCT02019420|527607985|FG000|Overall Study|Transferred to other care facility|1|||
146298796|NCT02019420|527607986|FG001|Overall Study|Transferred to other care facility|1|||
146298797|NCT02469896|527607987|FG000|Overall Study|Withdrawal by Subject|2|||
146298798|NCT02469896|527607988|FG001|Overall Study|Withdrawal by Subject|0|||
146298799|NCT02401412|527607989|FG000|Overall Study|Lost to Follow-up|1|||
146092876|NCT00145600|526861677|FG002|Overall Study|Death|2|||
146092877|NCT00145600|526861678|FG003|Overall Study|Death|6|||
146092878|NCT00145600|526861675|FG000|Overall Study|Ineligible|3|||
146092879|NCT00145600|526861676|FG001|Overall Study|Ineligible|0|||
146092880|NCT00145600|526861677|FG002|Overall Study|Ineligible|1|||
146092881|NCT00145600|526861678|FG003|Overall Study|Ineligible|5|||
146092882|NCT00145600|526861675|FG000|Overall Study|Lost to Follow-up|2|||
146092883|NCT00145600|526861676|FG001|Overall Study|Lost to Follow-up|6|||
146092884|NCT00145600|526861677|FG002|Overall Study|Lost to Follow-up|2|||
146092885|NCT00145600|526861678|FG003|Overall Study|Lost to Follow-up|4|||
146092886|NCT00145600|526861675|FG000|Overall Study|Noncompliance|1|||
146092887|NCT00145600|526861676|FG001|Overall Study|Noncompliance|0|||
146092888|NCT00145600|526861677|FG002|Overall Study|Noncompliance|0|||
146092889|NCT00145600|526861678|FG003|Overall Study|Noncompliance|0|||
146092890|NCT00145600|526861675|FG000|Overall Study|Withdrawal by Subject|1|||
146092891|NCT00145600|526861676|FG001|Overall Study|Withdrawal by Subject|2|||
146092892|NCT00145600|526861677|FG002|Overall Study|Withdrawal by Subject|0|||
146092893|NCT00145600|526861678|FG003|Overall Study|Withdrawal by Subject|1|||
146092894|NCT01229397|526861679|FG000|Overall Study|Withdrawal by Subject|3|||
146092895|NCT01229397|526861680|FG001|Overall Study|Withdrawal by Subject|3|||
146092896|NCT01229397|526861679|FG000|Overall Study|Lost to Follow-up|7|||
146092897|NCT01229397|526861680|FG001|Overall Study|Lost to Follow-up|6|||
146092898|NCT01229397|526861679|FG000|Overall Study|Migrated/moved from study area|1|||
146092899|NCT01229397|526861680|FG001|Overall Study|Migrated/moved from study area|0|||
146092900|NCT00608543|526861681|FG000|Overall Study|Adverse Event|4|||
146092901|NCT04087213|526861686|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
146092902|NCT04087213|526861686|FG000|In-Facility Introduction|Adverse Event|1|||
146092903|NCT04087213|526861686|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
146092904|NCT04087213|526861686|FG000|Assisted Evaluable Period|Personal reasons|3|||
146092905|NCT04087213|526861686|FG000|Transition Period B|Renal Transplantation|1|||
146092906|NCT01134315|526861688|FG000|Overall Study|Adverse Event|1|||
146092907|NCT01134315|526861689|FG001|Overall Study|Adverse Event|2|||
146092908|NCT01134315|526861688|FG000|Overall Study|Other Reason|8|||
146092909|NCT01134315|526861689|FG001|Overall Study|Other Reason|17|||
146092910|NCT02545075|526861692|FG000|Randomization|Lost to Follow-up|0|||
146092911|NCT02545075|526861693|FG001|Randomization|Lost to Follow-up|1|||
146092912|NCT02545075|526861692|FG000|Randomization|Withdrawal by Subject|0|||
146092913|NCT02545075|526861693|FG001|Randomization|Withdrawal by Subject|6|||
146092914|NCT02545075|526861692|FG000|Treatment|Disease progression|71|||
146092915|NCT02545075|526861693|FG001|Treatment|Disease progression|32|||
146092916|NCT02545075|526861692|FG000|Treatment|Participant dicontinued study treatment|7|||
146092917|NCT02545075|526861693|FG001|Treatment|Participant dicontinued study treatment|9|||
146092918|NCT02545075|526861692|FG000|Treatment|Withdrawal by Subject|1|||
146092919|NCT02545075|526861693|FG001|Treatment|Withdrawal by Subject|0|||
146092920|NCT02545075|526861692|FG000|Treatment|Adverse event not related to study drug|1|||
146092921|NCT02545075|526861693|FG001|Treatment|Adverse event not related to study drug|0|||
146092922|NCT02545075|526861692|FG000|Treatment|Death|1|||
146092923|NCT02545075|526861693|FG001|Treatment|Death|0|||
146092924|NCT02545075|526861692|FG000|Treatment|Participant drug toxicity|1|||
146092925|NCT02545075|526861693|FG001|Treatment|Participant drug toxicity|0|||
146092926|NCT02545075|526861692|FG000|Treatment|Completed treatment|40|||
146092927|NCT02545075|526861693|FG001|Treatment|Completed treatment|12|||
146298800|NCT02401412|527607990|FG001|Overall Study|Lost to Follow-up|0|||
146298801|NCT02401412|527607989|FG000|Overall Study|Discontinued Intervention|15|||
146298802|NCT02401412|527607990|FG001|Overall Study|Discontinued Intervention|21|||
146298803|NCT02401412|527607989|FG000|Overall Study|Withdrawal by Subject|4|||
146092928|NCT05246397|526861697|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
146092929|NCT00214500|526861705|FG000|Treatment Period|Adverse Event|1|||
146092930|NCT00214500|526861705|FG000|Extension Period|Withdrawal by Subject|2|||
146092931|NCT00147251|526861706|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
146092932|NCT00147251|526861707|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
146092933|NCT00751621|526861708|FG000|Overall Study|Adverse Event|1|||
146092934|NCT00751621|526861708|FG000|Overall Study|Withdrawal by Subject|1|||
146092935|NCT00751621|526861708|FG000|Overall Study|Subject moved to another country|1|||
146092936|NCT00751621|526861708|FG000|Overall Study|Poor adherence to asthma treatment|1|||
146092937|NCT02694523|526861714|FG000|Part A|Adverse Event|7|||
146092938|NCT02694523|526861715|FG001|Part A|Adverse Event|3|||
146092939|NCT02694523|526861716|FG002|Part A|Adverse Event|0|||
146092940|NCT02694523|526861717|FG003|Part A|Adverse Event|0|||
146092941|NCT02694523|526861718|FG004|Part A|Adverse Event|0|||
146092942|NCT02694523|526861719|FG005|Part A|Adverse Event|0|||
146092943|NCT02694523|526861720|FG006|Part A|Adverse Event|0|||
146092944|NCT02694523|526861714|FG000|Part A|Protocol Violation|1|||
146249856|NCT03436797|527426783|FG000|Main Study|Withdrawal by Subject|2|||
146249857|NCT03436797|527426783|FG000|Main Study|Adverse Event|4|||
146249858|NCT03436797|527426783|FG000|Main Study|Lost to Follow-up|1|||
146249859|NCT03436797|527426783|FG000|Main Study|Death|1|||
146249860|NCT03436797|527426783|FG000|Main Study|Non-Specific|2|||
146249861|NCT03436797|527426783|FG000|Extended Dosing|Patient decision|1|||
146249862|NCT02865083|527426784|FG000|Overall Study|Early Termination|3|||
146009855|NCT01071954|526548517|FG000|Overall Study|Adverse Event|1|||
146009856|NCT01071954|526548517|FG000|Overall Study|Withdrawal by Subject|11|||
146009857|NCT01071954|526548517|FG000|Overall Study|Requirement for Alternative Therapy|5|||
146009858|NCT01071954|526548517|FG000|Overall Study|Administrative Decision|5|||
146009859|NCT01071954|526548517|FG000|Overall Study|Protocol Specified Criteria|1|||
146009860|NCT03782064|526548521|FG000|Overall Study|Lack of Efficacy|2|||
146249863|NCT02865083|527426785|FG001|Overall Study|Early Termination|1|||
146009861|NCT03782064|526548521|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
146009862|NCT00363142|526548522|FG000|Overall Study|Adverse Event|2|||
146009863|NCT00363142|526548523|FG001|Overall Study|Adverse Event|0|||
146009864|NCT00363142|526548522|FG000|Overall Study|Lack of Efficacy|0|||
146009865|NCT00363142|526548523|FG001|Overall Study|Lack of Efficacy|1|||
146009866|NCT00363142|526548522|FG000|Overall Study|Lost to Follow-up|1|||
146009867|NCT00363142|526548523|FG001|Overall Study|Lost to Follow-up|0|||
146009868|NCT00363142|526548522|FG000|Overall Study|Non-compliance|1|||
146009869|NCT00363142|526548523|FG001|Overall Study|Non-compliance|1|||
146009870|NCT00363142|526548522|FG000|Overall Study|Withdrawal by Subject|3|||
146009871|NCT00363142|526548523|FG001|Overall Study|Withdrawal by Subject|1|||
146009872|NCT00049322|526548527|FG000|Overall Study|disease burden|0|||
146009873|NCT00049322|526548528|FG001|Overall Study|disease burden|3|||
146009874|NCT00049322|526548527|FG000|Overall Study|Adverse Event|1|||
146009875|NCT00049322|526548528|FG001|Overall Study|Adverse Event|0|||
146009876|NCT00049322|526548527|FG000|Overall Study|refused angio|0|||
146009877|NCT00049322|526548528|FG001|Overall Study|refused angio|3|||
146009878|NCT03994211|526548529|FG000|Core Phase|Adverse Event|0|||
146009879|NCT03994211|526548530|FG001|Core Phase|Adverse Event|1|||
146009880|NCT03994211|526548531|FG002|Core Phase|Adverse Event|0|||
146009881|NCT03994211|526548529|FG000|Extension Phase|Adverse Event|0|||
146009882|NCT03994211|526548530|FG001|Extension Phase|Adverse Event|0|||
146009883|NCT03994211|526548531|FG002|Extension Phase|Adverse Event|1|||
146009884|NCT03994211|526548529|FG000|Extension Phase|Physician Decision|0|||
146009885|NCT03994211|526548530|FG001|Extension Phase|Physician Decision|0|||
146009886|NCT03994211|526548531|FG002|Extension Phase|Physician Decision|1|||
146009887|NCT03994211|526548529|FG000|Extension Phase|Progressive Disease|0|||
146009888|NCT03994211|526548530|FG001|Extension Phase|Progressive Disease|0|||
146009889|NCT03994211|526548531|FG002|Extension Phase|Progressive Disease|20|||
146009890|NCT03994211|526548529|FG000|Extension Phase|Withdrawal by Subject|0|||
146009891|NCT03994211|526548530|FG001|Extension Phase|Withdrawal by Subject|0|||
146009892|NCT03994211|526548531|FG002|Extension Phase|Withdrawal by Subject|2|||
146009893|NCT02625220|526548532|FG000|Overall Study|Adverse Event|2|||
146009894|NCT02625220|526548532|FG000|Overall Study|Lost to Follow-up|2|||
146009895|NCT02625220|526548532|FG000|Overall Study|Protocol Violation|1|||
146009896|NCT02625220|526548532|FG000|Overall Study|Study discontinued at site|2|||
146009897|NCT01140867|526548533|FG000|Overall Study|Adverse Event|22|||
146009898|NCT01140867|526548533|FG000|Overall Study|Lack of Efficacy|3|||
146009899|NCT01140867|526548533|FG000|Overall Study|Lost to Follow-up|2|||
146009900|NCT01140867|526548533|FG000|Overall Study|Withdrawal by Subject|1|||
146009901|NCT01140867|526548533|FG000|Overall Study|Protocol Violation|1|||
146009902|NCT01140867|526548533|FG000|Overall Study|Uncooperative patient|2|||
146009903|NCT01140867|526548533|FG000|Overall Study|Medication Noncompliance|2|||
146009904|NCT01926444|526548534|FG000|Overall Study|Colonoscopy not performed|0|||
146009905|NCT01926444|526548535|FG001|Overall Study|Colonoscopy not performed|0|||
146009906|NCT01926444|526548536|FG002|Overall Study|Colonoscopy not performed|4|||
146009907|NCT01926444|526548537|FG003|Overall Study|Colonoscopy not performed|2|||
146009908|NCT01232127|526548539|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
146009909|NCT01232127|526548540|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
146009910|NCT01232127|526548541|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
146009911|NCT03035864|526548544|FG000|Treatment Period|Adverse Event|1|||
146009912|NCT03035864|526548545|FG001|Treatment Period|Adverse Event|0|||
146009913|NCT03035864|526548544|FG000|Treatment Period|Other|3|||
146009914|NCT03035864|526548545|FG001|Treatment Period|Other|1|||
146009915|NCT03035864|526548544|FG000|Follow-up Period|Adverse Event|1|||
146009916|NCT03035864|526548545|FG001|Follow-up Period|Adverse Event|0|||
146009917|NCT03035864|526548544|FG000|Follow-up Period|Lost to Follow-up|6|||
146009918|NCT03035864|526548545|FG001|Follow-up Period|Lost to Follow-up|2|||
146009919|NCT03035864|526548544|FG000|Follow-up Period|Physician Decision|1|||
146009920|NCT03035864|526548545|FG001|Follow-up Period|Physician Decision|0|||
146009921|NCT03035864|526548544|FG000|Follow-up Period|Other|3|||
146249864|NCT01358175|527426788|FG000|Overall Study|Death|1|||
146249865|NCT01358175|527426789|FG001|Overall Study|Death|0|||
146249866|NCT01358175|527426790|FG002|Overall Study|Death|1|||
146249867|NCT01358175|527426788|FG000|Overall Study|Withdrawal by Subject|9|||
146249868|NCT01358175|527426789|FG001|Overall Study|Withdrawal by Subject|5|||
146249869|NCT01358175|527426790|FG002|Overall Study|Withdrawal by Subject|10|||
146249870|NCT01358175|527426788|FG000|Overall Study|Technical issues|0|||
146249871|NCT01358175|527426789|FG001|Overall Study|Technical issues|1|||
146249872|NCT01358175|527426790|FG002|Overall Study|Technical issues|0|||
146249873|NCT01358175|527426788|FG000|Overall Study|Pregnancy|0|||
146249874|NCT01358175|527426789|FG001|Overall Study|Pregnancy|1|||
146249875|NCT01358175|527426790|FG002|Overall Study|Pregnancy|0|||
146009922|NCT03035864|526548545|FG001|Follow-up Period|Other|2|||
146009923|NCT02720523|526548546|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
146009924|NCT02720523|526548547|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
146009925|NCT02720523|526548548|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
146009926|NCT02720523|526548549|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
146009927|NCT02720523|526548550|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
146009928|NCT02720523|526548551|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
146009929|NCT02720523|526548552|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
146009930|NCT02720523|526548546|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
146009931|NCT02720523|526548547|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009932|NCT02720523|526548548|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009933|NCT02720523|526548549|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009934|NCT02720523|526548550|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009935|NCT02720523|526548551|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009936|NCT02720523|526548552|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
146009937|NCT02720523|526548546|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
146009938|NCT02720523|526548547|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009939|NCT02720523|526548548|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009940|NCT02720523|526548549|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009941|NCT02720523|526548550|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009942|NCT02720523|526548551|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009943|NCT02720523|526548552|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
146009944|NCT02720523|526548546|FG000|Period 1: Placebo-controlled Period|Other|0|||
146009945|NCT02720523|526548547|FG001|Period 1: Placebo-controlled Period|Other|0|||
146009946|NCT02720523|526548548|FG002|Period 1: Placebo-controlled Period|Other|1|||
146009947|NCT02720523|526548549|FG003|Period 1: Placebo-controlled Period|Other|1|||
146009948|NCT02720523|526548550|FG004|Period 1: Placebo-controlled Period|Other|0|||
146009949|NCT02720523|526548551|FG005|Period 1: Placebo-controlled Period|Other|0|||
146009950|NCT02720523|526548552|FG006|Period 1: Placebo-controlled Period|Other|0|||
146009951|NCT02720523|526548546|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
146009952|NCT02720523|526548547|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
146009953|NCT02720523|526548548|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
146009954|NCT02720523|526548549|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
146009955|NCT02720523|526548550|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
146009956|NCT02720523|526548551|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
146009957|NCT02720523|526548552|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
146009958|NCT02720523|526548546|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
146009959|NCT02720523|526548547|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
146009960|NCT02720523|526548548|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
146009961|NCT02720523|526548549|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
146009962|NCT02720523|526548550|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
146009963|NCT02720523|526548551|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
146009964|NCT02720523|526548552|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
146009965|NCT02720523|526548546|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146009966|NCT02720523|526548547|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146009967|NCT02720523|526548548|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146009968|NCT02720523|526548549|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
146009969|NCT02720523|526548550|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
146009970|NCT02720523|526548551|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
146009971|NCT02720523|526548552|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
146009972|NCT02720523|526548546|FG000|Period 2: Long-term Extension Period|Other|0|||
146009973|NCT02720523|526548547|FG001|Period 2: Long-term Extension Period|Other|0|||
146009974|NCT02720523|526548548|FG002|Period 2: Long-term Extension Period|Other|0|||
146009975|NCT02720523|526548549|FG003|Period 2: Long-term Extension Period|Other|0|||
146009976|NCT02720523|526548550|FG004|Period 2: Long-term Extension Period|Other|2|||
146009977|NCT02720523|526548551|FG005|Period 2: Long-term Extension Period|Other|0|||
146092945|NCT02694523|526861715|FG001|Part A|Protocol Violation|0|||
146092946|NCT02694523|526861716|FG002|Part A|Protocol Violation|0|||
146092947|NCT02694523|526861717|FG003|Part A|Protocol Violation|0|||
146249876|NCT01358175|527426788|FG000|Overall Study|Physician Decision|1|||
146249877|NCT01358175|527426789|FG001|Overall Study|Physician Decision|0|||
146249878|NCT01358175|527426790|FG002|Overall Study|Physician Decision|0|||
146092948|NCT02694523|526861718|FG004|Part A|Protocol Violation|0|||
146092949|NCT02694523|526861719|FG005|Part A|Protocol Violation|0|||
146092950|NCT02694523|526861720|FG006|Part A|Protocol Violation|0|||
146092951|NCT02694523|526861714|FG000|Part A|Lost to Follow-up|1|||
146092952|NCT02694523|526861715|FG001|Part A|Lost to Follow-up|2|||
146092953|NCT02694523|526861716|FG002|Part A|Lost to Follow-up|0|||
146092954|NCT02694523|526861717|FG003|Part A|Lost to Follow-up|0|||
146092955|NCT02694523|526861718|FG004|Part A|Lost to Follow-up|0|||
146092956|NCT02694523|526861719|FG005|Part A|Lost to Follow-up|0|||
146092957|NCT02694523|526861720|FG006|Part A|Lost to Follow-up|0|||
146092958|NCT02694523|526861714|FG000|Part A|Withdrawal by Subject|3|||
146092959|NCT02694523|526861715|FG001|Part A|Withdrawal by Subject|1|||
146092960|NCT02694523|526861716|FG002|Part A|Withdrawal by Subject|0|||
146092961|NCT02694523|526861717|FG003|Part A|Withdrawal by Subject|0|||
146092962|NCT02694523|526861718|FG004|Part A|Withdrawal by Subject|0|||
146092963|NCT02694523|526861719|FG005|Part A|Withdrawal by Subject|0|||
146092964|NCT02694523|526861720|FG006|Part A|Withdrawal by Subject|0|||
146092965|NCT02694523|526861714|FG000|Part A|Other|1|||
146092966|NCT02694523|526861715|FG001|Part A|Other|1|||
146092967|NCT02694523|526861716|FG002|Part A|Other|0|||
146092968|NCT02694523|526861717|FG003|Part A|Other|0|||
146092969|NCT02694523|526861718|FG004|Part A|Other|0|||
146092970|NCT02694523|526861719|FG005|Part A|Other|0|||
146092971|NCT02694523|526861720|FG006|Part A|Other|0|||
146092972|NCT02694523|526861714|FG000|Part B|Adverse Event|0|||
146092973|NCT02694523|526861715|FG001|Part B|Adverse Event|0|||
146092974|NCT02694523|526861716|FG002|Part B|Adverse Event|7|||
146092975|NCT02694523|526861717|FG003|Part B|Adverse Event|1|||
146092976|NCT02694523|526861718|FG004|Part B|Adverse Event|1|||
146092977|NCT02694523|526861719|FG005|Part B|Adverse Event|2|||
146092978|NCT02694523|526861720|FG006|Part B|Adverse Event|0|||
146092979|NCT02694523|526861714|FG000|Part B|Protocol Violation|0|||
146092980|NCT02694523|526861715|FG001|Part B|Protocol Violation|0|||
146092981|NCT02694523|526861716|FG002|Part B|Protocol Violation|1|||
146092982|NCT02694523|526861717|FG003|Part B|Protocol Violation|0|||
146092983|NCT02694523|526861718|FG004|Part B|Protocol Violation|0|||
146092984|NCT02694523|526861719|FG005|Part B|Protocol Violation|0|||
146092985|NCT02694523|526861720|FG006|Part B|Protocol Violation|0|||
146092986|NCT02694523|526861714|FG000|Part B|Lost to Follow-up|0|||
146092987|NCT02694523|526861715|FG001|Part B|Lost to Follow-up|0|||
146092988|NCT02694523|526861716|FG002|Part B|Lost to Follow-up|2|||
146092989|NCT02694523|526861717|FG003|Part B|Lost to Follow-up|3|||
146249879|NCT01358175|527426788|FG000|Overall Study|Non Compliance with Study Treatment|0|||
146249880|NCT01358175|527426789|FG001|Overall Study|Non Compliance with Study Treatment|1|||
146249881|NCT01358175|527426790|FG002|Overall Study|Non Compliance with Study Treatment|1|||
146249882|NCT01358175|527426788|FG000|Overall Study|Lost to Follow-up|1|||
146249883|NCT01358175|527426789|FG001|Overall Study|Lost to Follow-up|1|||
146249884|NCT01358175|527426790|FG002|Overall Study|Lost to Follow-up|3|||
146249885|NCT01358175|527426788|FG000|Overall Study|Lack of Efficacy|3|||
146249886|NCT01358175|527426789|FG001|Overall Study|Lack of Efficacy|8|||
146249887|NCT01358175|527426790|FG002|Overall Study|Lack of Efficacy|6|||
146249888|NCT01358175|527426788|FG000|Overall Study|Adverse Event|6|||
146249889|NCT01358175|527426789|FG001|Overall Study|Adverse Event|11|||
146249890|NCT01358175|527426790|FG002|Overall Study|Adverse Event|11|||
146249891|NCT05104242|527426791|FG000|Overall Study|Withdrawal by Subject|1|||
146249892|NCT05104242|527426792|FG001|Overall Study|Withdrawal by Subject|5|||
146249893|NCT05104242|527426791|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
146249894|NCT05104242|527426792|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
146249895|NCT02469155|527426797|FG000|Overall Study|Adverse Event|6|||
146249896|NCT02469155|527426798|FG001|Overall Study|Adverse Event|0|||
146249897|NCT02469155|527426799|FG002|Overall Study|Adverse Event|1|||
146092990|NCT02694523|526861718|FG004|Part B|Lost to Follow-up|2|||
146092991|NCT02694523|526861719|FG005|Part B|Lost to Follow-up|0|||
146092992|NCT02694523|526861720|FG006|Part B|Lost to Follow-up|1|||
146092993|NCT02694523|526861714|FG000|Part B|Withdrawal by Subject|0|||
146092994|NCT02694523|526861715|FG001|Part B|Withdrawal by Subject|0|||
146092995|NCT02694523|526861716|FG002|Part B|Withdrawal by Subject|9|||
146092996|NCT02694523|526861717|FG003|Part B|Withdrawal by Subject|0|||
146092997|NCT02694523|526861718|FG004|Part B|Withdrawal by Subject|1|||
146092998|NCT02694523|526861719|FG005|Part B|Withdrawal by Subject|3|||
146092999|NCT02694523|526861720|FG006|Part B|Withdrawal by Subject|0|||
146093000|NCT02694523|526861714|FG000|Part B|Other|0|||
146093001|NCT02694523|526861715|FG001|Part B|Other|0|||
146093002|NCT02694523|526861716|FG002|Part B|Other|1|||
146093003|NCT02694523|526861717|FG003|Part B|Other|0|||
146093004|NCT02694523|526861718|FG004|Part B|Other|0|||
146093005|NCT02694523|526861719|FG005|Part B|Other|0|||
146093006|NCT02694523|526861720|FG006|Part B|Other|1|||
146093007|NCT01086423|526861721|FG000|Overall Study|Protocol Violation|0|||
146093008|NCT01086423|526861722|FG001|Overall Study|Protocol Violation|0|||
146093009|NCT01086423|526861723|FG002|Overall Study|Protocol Violation|1|||
146249898|NCT02469155|527426800|FG003|Overall Study|Adverse Event|10|||
146249899|NCT02469155|527426797|FG000|Overall Study|Lack of Efficacy|13|||
146249900|NCT02469155|527426798|FG001|Overall Study|Lack of Efficacy|10|||
146298804|NCT02401412|527607990|FG001|Overall Study|Withdrawal by Subject|4|||
146298805|NCT02401412|527607989|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
146298806|NCT02401412|527607990|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
146298807|NCT02401412|527607989|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
146298808|NCT02401412|527607990|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
146298809|NCT00882310|527607995|FG000|Overall Study|Screen Failure|10|||
146298810|NCT00882310|527607995|FG000|Overall Study|Never received treatment|1|||
146298811|NCT00882310|527607995|FG000|Overall Study|Death|6|||
146298812|NCT00882310|527607995|FG000|Overall Study|Progression of disease|4|||
146298813|NCT00882310|527607995|FG000|Overall Study|Adverse Event|1|||
146298814|NCT01093625|527607996|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
146298815|NCT01093625|527607997|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
146298816|NCT01093625|527607996|FG000|2-Week Visit|Withdrawal by Subject|1|||
146298817|NCT01093625|527607997|FG001|2-Week Visit|Withdrawal by Subject|0|||
146298818|NCT01093625|527607996|FG000|1-Month Visit|Lost to Follow-up|2|||
146298819|NCT01093625|527607997|FG001|1-Month Visit|Lost to Follow-up|0|||
146298820|NCT01093625|527607996|FG000|3-Month Visit|Lost to Follow-up|2|||
146298821|NCT01093625|527607997|FG001|3-Month Visit|Lost to Follow-up|0|||
146298822|NCT01093625|527607996|FG000|6-Month Visit|Withdrawal by Subject|6|||
146298823|NCT01093625|527607997|FG001|6-Month Visit|Withdrawal by Subject|7|||
146298824|NCT01093625|527607996|FG000|6-Month Visit|Lost to Follow-up|2|||
146298825|NCT01093625|527607997|FG001|6-Month Visit|Lost to Follow-up|2|||
146298826|NCT01093625|527607996|FG000|1-Year Visit|Lost to Follow-up|5|||
146298827|NCT01093625|527607997|FG001|1-Year Visit|Lost to Follow-up|3|||
146298828|NCT04233164|527608000|FG000|Overall Study|Unable to obtain specimen|0|||
146298829|NCT04233164|527608001|FG001|Overall Study|Unable to obtain specimen|1|||
146298830|NCT01605253|527608004|FG000|Overall Study|Physician Decision|3|||
146298831|NCT01605253|527608005|FG001|Overall Study|Physician Decision|2|||
146298832|NCT01605253|527608004|FG000|Overall Study|Lost to Follow-up|3|||
146298833|NCT01605253|527608005|FG001|Overall Study|Lost to Follow-up|1|||
146298834|NCT00726622|527609923|FG000|Overall Study|Withdrawal by Subject|16|||
146298835|NCT00726622|527609924|FG001|Overall Study|Withdrawal by Subject|2|||
146298836|NCT00726622|527609923|FG000|Overall Study|Physician Decision|0|||
146298837|NCT00726622|527609924|FG001|Overall Study|Physician Decision|1|||
146298838|NCT00726622|527609923|FG000|Overall Study|Metastasis|2|||
146298839|NCT00726622|527609924|FG001|Overall Study|Metastasis|0|||
146298840|NCT01016964|527609931|FG000|Overall Study|Lost to Follow-up|3|||
146298841|NCT01016964|527609932|FG001|Overall Study|Lost to Follow-up|3|||
146298842|NCT00352885|527609933|FG000|Overall Study|Withdrawal by Subject|0|||
146298843|NCT00352885|527609934|FG001|Overall Study|Withdrawal by Subject|3|||
146298844|NCT00352885|527609933|FG000|Overall Study|Development of major depression|0|||
146298845|NCT00352885|527609934|FG001|Overall Study|Development of major depression|1|||
146298846|NCT00352885|527609933|FG000|Overall Study|Progression of metastatic melanoma|5|||
146298847|NCT00352885|527609934|FG001|Overall Study|Progression of metastatic melanoma|3|||
146298848|NCT00352885|527609933|FG000|Overall Study|Side effects of IL-2 administration|1|||
146298849|NCT00352885|527609934|FG001|Overall Study|Side effects of IL-2 administration|0|||
146298850|NCT03873493|527609935|FG000|Overall Study|Withdrawal by Subject|1|||
146298851|NCT03873493|527609935|FG000|Overall Study|Death|9|||
146298852|NCT03873493|527609935|FG000|Overall Study|Lost to Follow-up|1|||
146298853|NCT03873493|527609935|FG000|Overall Study|Study Terminated by Sponsor|1|||
146298854|NCT03873493|527609935|FG000|Overall Study|Other|2|||
146298855|NCT00440700|527609937|FG000|Overall Study|Withdrawal by Subject|8|||
146298856|NCT00440700|527609938|FG001|Overall Study|Withdrawal by Subject|8|||
146298857|NCT00440700|527609939|FG002|Overall Study|Withdrawal by Subject|4|||
146298858|NCT04906616|527609940|FG000|Overall Study|Divorce|3|||
146298859|NCT04906616|527609941|FG001|Overall Study|Divorce|2|||
146298860|NCT00385203|527609944|FG000|Overall Study|Adverse Event|5|||
146298861|NCT00385203|527609945|FG001|Overall Study|Adverse Event|4|||
146009978|NCT02720523|526548552|FG006|Period 2: Long-term Extension Period|Other|3|||
146009979|NCT00577707|526548557|FG000|Overall Study|Withdrawal by Subject|3|||
146009980|NCT03299244|526548558|FG000|Overall Study|Withdrawal by Subject|34|||
146009981|NCT03299244|526548559|FG001|Overall Study|Withdrawal by Subject|29|||
146009982|NCT03299244|526548558|FG000|Overall Study|Decision by Sponsor|4|||
146009983|NCT03299244|526548559|FG001|Overall Study|Decision by Sponsor|5|||
146298862|NCT00385203|527609944|FG000|Overall Study|Death|1|||
146298863|NCT00385203|527609945|FG001|Overall Study|Death|0|||
146298864|NCT00385203|527609944|FG000|Overall Study|Condition under investigation worsened|18|||
146298865|NCT00385203|527609945|FG001|Overall Study|Condition under investigation worsened|3|||
146298866|NCT00385203|527609944|FG000|Overall Study|Incorrect enrollment|2|||
146298867|NCT00385203|527609945|FG001|Overall Study|Incorrect enrollment|0|||
146298868|NCT00698451|527609954|FG000|Overall Study|Adverse Event|22|||
146298869|NCT00698451|527609954|FG000|Overall Study|Physician Decision|2|||
146298870|NCT00698451|527609954|FG000|Overall Study|Protocol Violation|6|||
146298871|NCT00698451|527609954|FG000|Overall Study|Withdrawal by Subject|6|||
146298872|NCT00698451|527609954|FG000|Overall Study|Disease progression|3|||
146298873|NCT00733304|527609957|FG000|Overall Study|Adverse Event|3|||
146009984|NCT03299244|526548558|FG000|Overall Study|Death|9|||
146009985|NCT03299244|526548559|FG001|Overall Study|Death|4|||
146009986|NCT03146663|526548560|FG000|Overall Study|Did not receive study treatment|1|||
146009987|NCT03146663|526548561|FG001|Overall Study|Did not receive study treatment|1|||
146009988|NCT03666988|526548562|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
146009989|NCT03666988|526548563|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
146009990|NCT03666988|526548564|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
146009991|NCT03666988|526548565|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
146009992|NCT03666988|526548566|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
146009993|NCT03666988|526548567|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
146009994|NCT03666988|526548562|FG000|Part 1 (Up to 28 Months)|Other|0|||
146009995|NCT03666988|526548563|FG001|Part 1 (Up to 28 Months)|Other|1|||
146009996|NCT03666988|526548564|FG002|Part 1 (Up to 28 Months)|Other|1|||
146009997|NCT03666988|526548565|FG003|Part 1 (Up to 28 Months)|Other|0|||
146009998|NCT03666988|526548566|FG004|Part 1 (Up to 28 Months)|Other|0|||
146009999|NCT03666988|526548567|FG005|Part 1 (Up to 28 Months)|Other|0|||
146010000|NCT03666988|526548562|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
146010001|NCT03666988|526548563|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
146010002|NCT03666988|526548564|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
146010003|NCT03666988|526548565|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
146010004|NCT03666988|526548566|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
146010005|NCT03666988|526548567|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
146010006|NCT03666988|526548562|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
146010007|NCT03666988|526548563|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
146010008|NCT03666988|526548564|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
146010009|NCT03666988|526548565|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
146010010|NCT03666988|526548566|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
146010011|NCT03666988|526548567|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
146010012|NCT03666988|526548562|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
146010013|NCT03666988|526548563|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146010014|NCT03666988|526548564|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146010015|NCT03666988|526548565|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146010016|NCT03666988|526548566|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146010017|NCT03666988|526548567|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
146010018|NCT05588440|526548574|FG000|Overall Study|Sponsor Decision|2|||
146010019|NCT05588440|526548575|FG001|Overall Study|Sponsor Decision|0|||
146010020|NCT05588440|526548576|FG002|Overall Study|Sponsor Decision|1|||
146010021|NCT05588440|526548574|FG000|Overall Study|Death|1|||
146010022|NCT05588440|526548575|FG001|Overall Study|Death|1|||
146010023|NCT05588440|526548576|FG002|Overall Study|Death|1|||
146010024|NCT05588440|526548574|FG000|Overall Study|Screen Fail|0|||
146010025|NCT05588440|526548575|FG001|Overall Study|Screen Fail|1|||
146010026|NCT05588440|526548576|FG002|Overall Study|Screen Fail|1|||
146010027|NCT05588440|526548574|FG000|Overall Study|Withdrawal by Subject|0|||
146010028|NCT05588440|526548575|FG001|Overall Study|Withdrawal by Subject|0|||
146010029|NCT05588440|526548576|FG002|Overall Study|Withdrawal by Subject|1|||
146010030|NCT02142803|526548577|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146010031|NCT02142803|526548578|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146010032|NCT02142803|526548579|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
146010033|NCT02142803|526548580|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
146010034|NCT01154452|526548581|FG000|Phase Ib|Not Treated|1|||
146010035|NCT01154452|526548582|FG001|Phase Ib|Not Treated|0|||
146010036|NCT01154452|526548583|FG002|Phase Ib|Not Treated|0|||
146010037|NCT01154452|526548584|FG003|Phase Ib|Not Treated|0|||
146010038|NCT01154452|526548581|FG000|Phase Ib|Adverse Event|2|||
146010039|NCT01154452|526548582|FG001|Phase Ib|Adverse Event|1|||
146010040|NCT01154452|526548583|FG002|Phase Ib|Adverse Event|0|||
146010041|NCT01154452|526548584|FG003|Phase Ib|Adverse Event|0|||
146010042|NCT01154452|526548581|FG000|Phase II|Withdrawal by Subject|0|||
146010043|NCT01154452|526548582|FG001|Phase II|Withdrawal by Subject|0|||
146010044|NCT01154452|526548583|FG002|Phase II|Withdrawal by Subject|1|||
146010045|NCT01154452|526548584|FG003|Phase II|Withdrawal by Subject|2|||
146010046|NCT01154452|526548581|FG000|Phase II|Adverse Event|0|||
146093010|NCT01086423|526861721|FG000|Overall Study|Migrated/moved from study area|2|||
146010047|NCT01154452|526548582|FG001|Phase II|Adverse Event|0|||
146010048|NCT01154452|526548583|FG002|Phase II|Adverse Event|4|||
146010049|NCT01154452|526548584|FG003|Phase II|Adverse Event|4|||
146010050|NCT03706430|526548585|FG000|Overall Study|No A-Line placed|5|||
146010051|NCT03706430|526548585|FG000|Overall Study|Subject had gel nail polish|1|||
146010052|NCT03706430|526548585|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
146010053|NCT03706430|526548585|FG000|Overall Study|Cancelled Case|6|||
146010054|NCT03706430|526548585|FG000|Overall Study|Physician Decision|2|||
146010055|NCT00145626|526548586|FG000|Overall Study|Did not have NK infusions|2|||
146010056|NCT00145626|526548586|FG000|Overall Study|Turned 2 years old before treatment|1|||
146010057|NCT00145626|526548586|FG000|Overall Study|Death|1|||
146010058|NCT00145626|526548586|FG000|Overall Study|Withdrawal by Subject|1|||
146010059|NCT01392573|526548587|FG000|Overall Study|Adverse Event|1|||
146010060|NCT01392573|526548588|FG001|Overall Study|Adverse Event|3|||
146010061|NCT01392573|526548587|FG000|Overall Study|Lack of Efficacy|1|||
146010062|NCT01392573|526548588|FG001|Overall Study|Lack of Efficacy|2|||
146010063|NCT01392573|526548587|FG000|Overall Study|Protocol Violation|0|||
146010064|NCT01392573|526548588|FG001|Overall Study|Protocol Violation|2|||
146010065|NCT01392573|526548587|FG000|Overall Study|Withdrawal Criteria|13|||
146010066|NCT01392573|526548588|FG001|Overall Study|Withdrawal Criteria|15|||
146010067|NCT01392573|526548587|FG000|Overall Study|Site closure|8|||
146010068|NCT01392573|526548588|FG001|Overall Study|Site closure|7|||
146010069|NCT01392573|526548587|FG000|Overall Study|Unclassified|9|||
146010070|NCT01392573|526548588|FG001|Overall Study|Unclassified|6|||
146010071|NCT00436436|526548589|FG000|Overall Study|Progression|4|||
146010072|NCT00436436|526548589|FG000|Overall Study|Adverse Event|2|||
146010073|NCT00436436|526548589|FG000|Overall Study|Death|6|||
146010074|NCT02709720|526548590|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
146010075|NCT02709720|526548590|FG000|Overall Study|Protocol Violation|1|||
146010076|NCT02709720|526548590|FG000|Overall Study|Not take study medication|1|||
146010077|NCT00200967|526548591|FG000|First Treatment Period|Withdrawal by Subject|5|||
146010078|NCT00200967|526548592|FG001|First Treatment Period|Withdrawal by Subject|1|||
146010079|NCT00200967|526548591|FG000|First Treatment Period|Pregnancy|1|||
146010080|NCT00200967|526548592|FG001|First Treatment Period|Pregnancy|0|||
146010081|NCT00200967|526548591|FG000|Wash-out Period|Lost to Follow-up|0|||
146010082|NCT00200967|526548592|FG001|Wash-out Period|Lost to Follow-up|1|||
146010083|NCT00200967|526548591|FG000|Second Treatment Period|Withdrawal by Subject|1|||
146010084|NCT00200967|526548592|FG001|Second Treatment Period|Withdrawal by Subject|2|||
146010085|NCT00200967|526548591|FG000|Run-out Period|Lost to Follow-up|1|||
146010086|NCT00200967|526548592|FG001|Run-out Period|Lost to Follow-up|0|||
146010087|NCT00662831|526550084|FG000|Overall Study|Death|4|||
146010088|NCT00662831|526550085|FG001|Overall Study|Death|1|||
146010089|NCT00662831|526550084|FG000|Overall Study|Lack of Efficacy|6|||
146010090|NCT00662831|526550085|FG001|Overall Study|Lack of Efficacy|6|||
146010091|NCT00662831|526550084|FG000|Overall Study|Lost to Follow-up|1|||
146010092|NCT00662831|526550085|FG001|Overall Study|Lost to Follow-up|0|||
146010093|NCT00662831|526550084|FG000|Overall Study|Withdrawal by Subject|2|||
146010094|NCT00662831|526550085|FG001|Overall Study|Withdrawal by Subject|1|||
146010095|NCT00662831|526550084|FG000|Overall Study|Other|62|||
146010096|NCT00662831|526550085|FG001|Overall Study|Other|31|||
146010097|NCT00662831|526550084|FG000|Overall Study|Protocol Violation|8|||
146010098|NCT00662831|526550085|FG001|Overall Study|Protocol Violation|4|||
146010099|NCT00662831|526550084|FG000|Overall Study|Adverse Event|23|||
146010100|NCT00662831|526550085|FG001|Overall Study|Adverse Event|16|||
146010101|NCT00294671|526550086|FG000|Overall Study|Lack of Efficacy|11|||
146010102|NCT00294671|526550087|FG001|Overall Study|Lack of Efficacy|23|||
146010103|NCT00294671|526550086|FG000|Overall Study|Liver transplant|7|||
146010104|NCT00294671|526550087|FG001|Overall Study|Liver transplant|9|||
146010105|NCT00294671|526550086|FG000|Overall Study|Drug related adverse event (AE)|4|||
146010106|NCT00294671|526550087|FG001|Overall Study|Drug related adverse event (AE)|2|||
146010107|NCT00294671|526550086|FG000|Overall Study|Non-drug related AE|3|||
146010108|NCT00294671|526550087|FG001|Overall Study|Non-drug related AE|2|||
146010109|NCT00294671|526550086|FG000|Overall Study|Lost to Follow-up|1|||
146010110|NCT00294671|526550087|FG001|Overall Study|Lost to Follow-up|3|||
146010111|NCT00294671|526550086|FG000|Overall Study|Non-compliance|1|||
146010112|NCT00294671|526550087|FG001|Overall Study|Non-compliance|0|||
146010113|NCT00294671|526550086|FG000|Overall Study|Death|0|||
146010114|NCT00294671|526550087|FG001|Overall Study|Death|1|||
146010115|NCT01734785|526550088|FG000|Open-Label Period|Adverse Event|0|||
146010116|NCT01734785|526550089|FG001|Open-Label Period|Adverse Event|0|||
146010117|NCT01734785|526550090|FG002|Open-Label Period|Adverse Event|0|||
146010118|NCT01734785|526550091|FG003|Open-Label Period|Adverse Event|9|||
146010119|NCT01734785|526550088|FG000|Open-Label Period|Lack of Efficacy|0|||
146010120|NCT01734785|526550089|FG001|Open-Label Period|Lack of Efficacy|0|||
146010121|NCT01734785|526550090|FG002|Open-Label Period|Lack of Efficacy|0|||
146010122|NCT01734785|526550091|FG003|Open-Label Period|Lack of Efficacy|1|||
146010123|NCT01734785|526550088|FG000|Open-Label Period|Protocol Violation|0|||
146010124|NCT01734785|526550089|FG001|Open-Label Period|Protocol Violation|0|||
146010125|NCT01734785|526550090|FG002|Open-Label Period|Protocol Violation|0|||
146010126|NCT01734785|526550091|FG003|Open-Label Period|Protocol Violation|13|||
146010127|NCT01734785|526550088|FG000|Open-Label Period|Lost to Follow-up|0|||
146010128|NCT01734785|526550089|FG001|Open-Label Period|Lost to Follow-up|0|||
146010129|NCT01734785|526550090|FG002|Open-Label Period|Lost to Follow-up|0|||
146010130|NCT01734785|526550091|FG003|Open-Label Period|Lost to Follow-up|14|||
146010131|NCT01734785|526550088|FG000|Open-Label Period|Withdrawal by Subject|0|||
146010132|NCT01734785|526550089|FG001|Open-Label Period|Withdrawal by Subject|0|||
146010133|NCT01734785|526550090|FG002|Open-Label Period|Withdrawal by Subject|0|||
146010134|NCT01734785|526550091|FG003|Open-Label Period|Withdrawal by Subject|12|||
146010135|NCT01734785|526550088|FG000|Open-Label Period|Other Reasons|0|||
146010136|NCT01734785|526550089|FG001|Open-Label Period|Other Reasons|0|||
146010137|NCT01734785|526550090|FG002|Open-Label Period|Other Reasons|0|||
146010138|NCT01734785|526550091|FG003|Open-Label Period|Other Reasons|224|||
146010139|NCT01734785|526550088|FG000|Double-Blind Period|Adverse Event|0|||
146298874|NCT00733304|527609958|FG001|Overall Study|Adverse Event|0|||
146298875|NCT00733304|527609959|FG002|Overall Study|Adverse Event|0|||
146298876|NCT00733304|527609957|FG000|Overall Study|Lack of Efficacy|0|||
146298877|NCT00733304|527609958|FG001|Overall Study|Lack of Efficacy|0|||
146298878|NCT00733304|527609959|FG002|Overall Study|Lack of Efficacy|2|||
146298879|NCT00733304|527609957|FG000|Overall Study|Lost to Follow-up|0|||
146298880|NCT00733304|527609958|FG001|Overall Study|Lost to Follow-up|1|||
146298881|NCT00733304|527609959|FG002|Overall Study|Lost to Follow-up|0|||
146298882|NCT00733304|527609957|FG000|Overall Study|Physician Decision|3|||
146298883|NCT00733304|527609958|FG001|Overall Study|Physician Decision|1|||
146298884|NCT00733304|527609959|FG002|Overall Study|Physician Decision|3|||
146298885|NCT00733304|527609957|FG000|Overall Study|Withdrawal by Subject|1|||
146298886|NCT00733304|527609958|FG001|Overall Study|Withdrawal by Subject|1|||
146298887|NCT00733304|527609959|FG002|Overall Study|Withdrawal by Subject|0|||
146298888|NCT01187550|527609960|FG000|Overall Study|Protocol Violation|3|||
146298889|NCT01187550|527609961|FG001|Overall Study|Protocol Violation|1|||
146298890|NCT01187550|527609960|FG000|Overall Study|Other|3|||
146298891|NCT01187550|527609961|FG001|Overall Study|Other|0|||
146298892|NCT01187550|527609960|FG000|Overall Study|Randomized but not treated|8|||
146298893|NCT01187550|527609961|FG001|Overall Study|Randomized but not treated|0|||
146298894|NCT02445755|527609971|FG000|Overall Study|Withdrawal by Subject|2|||
146298895|NCT02445755|527609971|FG000|Overall Study|Protocol Violation|6|||
146298896|NCT02445755|527609971|FG000|Overall Study|Screen Failure|5|||
146298897|NCT05352048|527609972|FG000|Overall Study|Lost to Follow-up|1|||
146298898|NCT05352048|527609972|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
146298899|NCT02308007|527609982|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
146298900|NCT02308007|527609983|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
146298901|NCT02308007|527609984|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
146298902|NCT02308007|527609982|FG000|Overall Study|Positive for STD at Baseline|7|||
146298903|NCT02308007|527609983|FG001|Overall Study|Positive for STD at Baseline|11|||
146298904|NCT02308007|527609984|FG002|Overall Study|Positive for STD at Baseline|7|||
146298905|NCT02308007|527609982|FG000|Overall Study|Lost to Follow-up|3|||
146298906|NCT02308007|527609983|FG001|Overall Study|Lost to Follow-up|0|||
146298907|NCT02308007|527609984|FG002|Overall Study|Lost to Follow-up|1|||
146298908|NCT00528567|527609990|FG000|Overall Study|Death|4|||
146298909|NCT00528567|527609991|FG001|Overall Study|Death|5|||
146298910|NCT00528567|527609990|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
146298911|NCT00528567|527609991|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
146298912|NCT00528567|527609990|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
146298913|NCT00528567|527609991|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
146298914|NCT00528567|527609990|FG000|Overall Study|Violation Criteria at Entry|3|||
146298915|NCT00528567|527609991|FG001|Overall Study|Violation Criteria at Entry|17|||
146298916|NCT00528567|527609990|FG000|Overall Study|Withdrew Consent|59|||
146298917|NCT00528567|527609991|FG001|Overall Study|Withdrew Consent|55|||
146298918|NCT00528567|527609990|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
146298919|NCT00528567|527609991|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
146298920|NCT00528567|527609990|FG000|Overall Study|Failure to Return|1|||
146298921|NCT00528567|527609991|FG001|Overall Study|Failure to Return|4|||
146298922|NCT00528567|527609990|FG000|Overall Study|Other Protocol Violation|5|||
146298923|NCT00528567|527609991|FG001|Overall Study|Other Protocol Violation|21|||
146298924|NCT00528567|527609990|FG000|Overall Study|Administrative/Other|22|||
146298925|NCT00528567|527609991|FG001|Overall Study|Administrative/Other|75|||
146298926|NCT03085758|527609996|FG000|Overall Study|Death|26|||
146298927|NCT03085758|527609997|FG001|Overall Study|Death|24|||
146298928|NCT03085758|527609998|FG002|Overall Study|Death|53|||
146298929|NCT03085758|527609996|FG000|Overall Study|Lost to Follow-up|1|||
146298930|NCT03085758|527609997|FG001|Overall Study|Lost to Follow-up|1|||
146298931|NCT03085758|527609998|FG002|Overall Study|Lost to Follow-up|1|||
146010140|NCT01734785|526550089|FG001|Double-Blind Period|Adverse Event|3|||
146010141|NCT01734785|526550090|FG002|Double-Blind Period|Adverse Event|2|||
146010142|NCT01734785|526550091|FG003|Double-Blind Period|Adverse Event|0|||
146010143|NCT01734785|526550088|FG000|Double-Blind Period|Lack of Efficacy|0|||
146010144|NCT01734785|526550089|FG001|Double-Blind Period|Lack of Efficacy|1|||
146298932|NCT03085758|527609996|FG000|Overall Study|Withdrawal by Subject|2|||
146010145|NCT01734785|526550090|FG002|Double-Blind Period|Lack of Efficacy|0|||
146010146|NCT01734785|526550091|FG003|Double-Blind Period|Lack of Efficacy|0|||
146093011|NCT01086423|526861722|FG001|Overall Study|Migrated/moved from study area|0|||
146298933|NCT03085758|527609997|FG001|Overall Study|Withdrawal by Subject|2|||
146298934|NCT03085758|527609998|FG002|Overall Study|Withdrawal by Subject|1|||
146298935|NCT03085758|527609996|FG000|Overall Study|Refusal to recall it up to day 90|0|||
146298936|NCT03085758|527609997|FG001|Overall Study|Refusal to recall it up to day 90|0|||
146298937|NCT03085758|527609998|FG002|Overall Study|Refusal to recall it up to day 90|1|||
146298938|NCT03085758|527609996|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
146298939|NCT03085758|527609997|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
146298940|NCT03085758|527609998|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
146010147|NCT01734785|526550088|FG000|Double-Blind Period|Protocol Violation|0|||
146010148|NCT01734785|526550089|FG001|Double-Blind Period|Protocol Violation|1|||
146010149|NCT01734785|526550090|FG002|Double-Blind Period|Protocol Violation|1|||
146010150|NCT01734785|526550091|FG003|Double-Blind Period|Protocol Violation|0|||
146010151|NCT01734785|526550088|FG000|Double-Blind Period|Lost to Follow-up|2|||
146010152|NCT01734785|526550089|FG001|Double-Blind Period|Lost to Follow-up|4|||
146010153|NCT01734785|526550090|FG002|Double-Blind Period|Lost to Follow-up|2|||
146010154|NCT01734785|526550091|FG003|Double-Blind Period|Lost to Follow-up|0|||
146010155|NCT01734785|526550088|FG000|Double-Blind Period|Withdrawal by Subject|2|||
146010156|NCT01734785|526550089|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146010157|NCT01734785|526550090|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146010158|NCT01734785|526550091|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146010159|NCT01734785|526550088|FG000|Double-Blind Period|Not treated|1|||
146010160|NCT01734785|526550089|FG001|Double-Blind Period|Not treated|0|||
146010161|NCT01734785|526550090|FG002|Double-Blind Period|Not treated|0|||
146010162|NCT01734785|526550091|FG003|Double-Blind Period|Not treated|0|||
146010163|NCT02013778|526550097|FG000|Overall Study|Death|4|||
146010164|NCT02013778|526550097|FG000|Overall Study|Withdrawal by Subject|1|||
146010165|NCT02013778|526550097|FG000|Overall Study|Physician Decision|1|||
146010166|NCT02013778|526550097|FG000|Overall Study|Adverse Event|1|||
146010167|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
146010168|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
146010169|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
146010170|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
146010171|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
146010172|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
146010173|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
146010174|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
146010175|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
146010176|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
146010177|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
146010178|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
146010179|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
146010180|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
146010181|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
146010182|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
146010183|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
146010184|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
146010185|NCT03308968|526550098|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
146010186|NCT03308968|526550099|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
146010187|NCT03308968|526550100|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
146010188|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
146010189|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
146010190|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
146010191|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
146010192|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
146010193|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
146010194|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
146010195|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
146010196|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
146010197|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
146010198|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
146010199|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
146010200|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
146010201|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
146010202|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
146010203|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
146010204|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
146010205|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
146010206|NCT03308968|526550098|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
146010207|NCT03308968|526550099|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
146010208|NCT03308968|526550100|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
146010209|NCT01961297|526550101|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
146010210|NCT01961297|526550102|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
146010211|NCT02482298|526550103|FG000|Overall Study|Withdrawal by Subject|2|||
146010212|NCT02482298|526550104|FG001|Overall Study|Withdrawal by Subject|1|||
146010213|NCT02482298|526550105|FG002|Overall Study|Withdrawal by Subject|2|||
146010214|NCT02482298|526550103|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
146010215|NCT02482298|526550104|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
146010216|NCT02482298|526550105|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
146010217|NCT02482298|526550103|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
146249901|NCT02469155|527426799|FG002|Overall Study|Lack of Efficacy|10|||
146010218|NCT02482298|526550104|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
146010219|NCT02482298|526550105|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
146010220|NCT02482298|526550103|FG000|Overall Study|Lost to Follow-up|0|||
146010221|NCT02482298|526550104|FG001|Overall Study|Lost to Follow-up|1|||
146010222|NCT02482298|526550105|FG002|Overall Study|Lost to Follow-up|0|||
146010223|NCT01582009|526550108|FG000|Overall Study|Withdrawal by Subject|1|||
146010224|NCT01582009|526550108|FG000|Overall Study|Physician Decision|1|||
146010225|NCT03050450|526550111|FG000|Overall Study|Physician Decision|1|||
146010226|NCT03050450|526550112|FG001|Overall Study|Physician Decision|0|||
146010227|NCT03050450|526550113|FG002|Overall Study|Physician Decision|0|||
146010228|NCT03050450|526550114|FG003|Overall Study|Physician Decision|0|||
146010229|NCT03050450|526550115|FG004|Overall Study|Physician Decision|0|||
146010230|NCT03592771|526550116|FG000|Overall Study|Adverse Event|2|||
146010231|NCT03592771|526550117|FG001|Overall Study|Adverse Event|0|||
146010232|NCT03592771|526550118|FG002|Overall Study|Adverse Event|1|||
146010233|NCT03592771|526550116|FG000|Overall Study|Death|0|||
146010234|NCT03592771|526550117|FG001|Overall Study|Death|1|||
146010235|NCT03592771|526550118|FG002|Overall Study|Death|1|||
146010236|NCT03592771|526550116|FG000|Overall Study|Lost to Follow-up|5|||
146010237|NCT03592771|526550117|FG001|Overall Study|Lost to Follow-up|11|||
146010238|NCT03592771|526550118|FG002|Overall Study|Lost to Follow-up|15|||
146010239|NCT03592771|526550116|FG000|Overall Study|Withdrawal by Subject|0|||
146010240|NCT03592771|526550117|FG001|Overall Study|Withdrawal by Subject|2|||
146010241|NCT03592771|526550118|FG002|Overall Study|Withdrawal by Subject|0|||
146010242|NCT00735553|526550119|FG000|Overall Study|Study prematurely terminated|77|||
146010243|NCT02705105|526550120|FG000|Treatment|Objective Disease Progression|1|||
146010244|NCT02705105|526550121|FG001|Treatment|Objective Disease Progression|50|||
146010245|NCT02705105|526550120|FG000|Treatment|Withdrawal by Subject|3|||
146010246|NCT02705105|526550121|FG001|Treatment|Withdrawal by Subject|5|||
146010247|NCT02705105|526550120|FG000|Treatment|Adverse Event|0|||
146010248|NCT02705105|526550121|FG001|Treatment|Adverse Event|17|||
146010249|NCT02705105|526550120|FG000|Treatment|Clinical Disease Progression|0|||
146010250|NCT02705105|526550121|FG001|Treatment|Clinical Disease Progression|32|||
146010251|NCT02705105|526550120|FG000|Treatment|Physician Decision|0|||
146010252|NCT02705105|526550121|FG001|Treatment|Physician Decision|3|||
146010253|NCT02705105|526550120|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
146010254|NCT02705105|526550121|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
146010255|NCT02705105|526550120|FG000|Follow-Up|Death|3|||
146010256|NCT02705105|526550121|FG001|Follow-Up|Death|68|||
146010257|NCT02705105|526550120|FG000|Follow-Up|Withdrawal by Subject|1|||
146010258|NCT02705105|526550121|FG001|Follow-Up|Withdrawal by Subject|14|||
146010259|NCT02705105|526550120|FG000|Follow-Up|Study Terminated|0|||
146010260|NCT02705105|526550121|FG001|Follow-Up|Study Terminated|26|||
146010261|NCT02705105|526550120|FG000|Follow-Up|Discontinued per Amendment 3|0|||
146010262|NCT02705105|526550121|FG001|Follow-Up|Discontinued per Amendment 3|2|||
146010263|NCT04556591|526550123|FG000|Overall Study|Lost to Follow-up|1|||
146010264|NCT04556591|526550124|FG001|Overall Study|Lost to Follow-up|0|||
146010265|NCT04556591|526550123|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
146010266|NCT04556591|526550124|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
146010267|NCT03332173|526550125|FG000|Overall Study|Death|7|||
146010268|NCT03332173|526550125|FG000|Overall Study|Withdrawal by Subject|6|||
146010269|NCT03332173|526550125|FG000|Overall Study|Lost to Follow-up|2|||
146010270|NCT03332173|526550125|FG000|Overall Study|Transferred to long-term extension study|29|||
146010271|NCT01485796|526550126|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
146010272|NCT01485796|526550126|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
146249902|NCT02469155|527426800|FG003|Overall Study|Lack of Efficacy|8|||
146249903|NCT02469155|527426797|FG000|Overall Study|Death|0|||
146249904|NCT02469155|527426798|FG001|Overall Study|Death|0|||
146249905|NCT02469155|527426799|FG002|Overall Study|Death|0|||
146249906|NCT02469155|527426800|FG003|Overall Study|Death|1|||
146249907|NCT02469155|527426797|FG000|Overall Study|Lost to Follow-up|5|||
146249908|NCT02469155|527426798|FG001|Overall Study|Lost to Follow-up|2|||
146249909|NCT02469155|527426799|FG002|Overall Study|Lost to Follow-up|7|||
146249910|NCT02469155|527426800|FG003|Overall Study|Lost to Follow-up|2|||
146249911|NCT02469155|527426797|FG000|Overall Study|Physician Decision|0|||
146249912|NCT02469155|527426798|FG001|Overall Study|Physician Decision|0|||
146249913|NCT02469155|527426799|FG002|Overall Study|Physician Decision|1|||
146249914|NCT02469155|527426800|FG003|Overall Study|Physician Decision|0|||
146010273|NCT01485796|526550126|FG000|Period 2: Epoch 2|Adverse Event|3|||
146010274|NCT01485796|526550126|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
146010275|NCT01485796|526550126|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
146010276|NCT01485796|526550126|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
146010277|NCT01485796|526550126|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
146010278|NCT01485796|526550126|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
146249915|NCT02469155|527426797|FG000|Overall Study|Withdrawal by Subject|34|||
146249916|NCT02469155|527426798|FG001|Overall Study|Withdrawal by Subject|30|||
146249917|NCT02469155|527426799|FG002|Overall Study|Withdrawal by Subject|20|||
146010279|NCT04830215|526550127|FG000|Overall Study|Adverse Event|6|||
146010280|NCT04830215|526550127|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
146010281|NCT04830215|526550127|FG000|Overall Study|Withdrawal by Subject|3|||
146010282|NCT04830215|526550127|FG000|Overall Study|Protocol Deviation|1|||
146010283|NCT00211172|526550130|FG000|Overall Study|Died or lost health plan eligibility|39|||
146010284|NCT00211172|526550131|FG001|Overall Study|Died or lost health plan eligibility|32|||
146010285|NCT00770562|526550134|FG000|Overall Study|Did not take treatment|1|||
146010286|NCT00770562|526550135|FG001|Overall Study|Did not take treatment|1|||
146010287|NCT01643408|526550136|FG000|Overall Study|Adverse Event|12|||
146010288|NCT01643408|526550136|FG000|Overall Study|Other|2|||
146010289|NCT00292045|526550140|FG000|Core Study (Through Week 13)|Adverse Event|1|||
146010290|NCT00292045|526550140|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
146010291|NCT04474197|526550141|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146010292|NCT04474197|526550142|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
146010293|NCT04474197|526550143|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146010294|NCT04474197|526550144|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
146010295|NCT00606411|526550145|FG000|Overall Study|Adverse Event|1|||
146010296|NCT00606411|526550146|FG001|Overall Study|Adverse Event|2|||
146010297|NCT00606411|526550145|FG000|Overall Study|Lack of Adherence|1|||
146010298|NCT00606411|526550146|FG001|Overall Study|Lack of Adherence|1|||
146010299|NCT00606411|526550145|FG000|Overall Study|Lack of Efficacy|1|||
146010300|NCT00606411|526550146|FG001|Overall Study|Lack of Efficacy|1|||
146010301|NCT00606411|526550145|FG000|Overall Study|Withdrawal by Subject|2|||
146010302|NCT00606411|526550146|FG001|Overall Study|Withdrawal by Subject|0|||
146010303|NCT00606411|526550145|FG000|Overall Study|Lost to Follow-up|1|||
146010304|NCT00606411|526550146|FG001|Overall Study|Lost to Follow-up|2|||
146010305|NCT00606411|526550145|FG000|Overall Study|Move out of state|0|||
146010306|NCT00606411|526550146|FG001|Overall Study|Move out of state|1|||
146010307|NCT00624468|526550148|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
146010308|NCT00624468|526550149|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
146010309|NCT00624468|526550150|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
146010310|NCT00624468|526550151|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
146010311|NCT00624468|526550148|FG000|Double-blind Period|Withdrew Prematurely|1|||
146010312|NCT00624468|526550149|FG001|Double-blind Period|Withdrew Prematurely|1|||
146010313|NCT00624468|526550150|FG002|Double-blind Period|Withdrew Prematurely|0|||
146010314|NCT00624468|526550151|FG003|Double-blind Period|Withdrew Prematurely|0|||
146010315|NCT00624468|526550148|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
146010316|NCT00624468|526550149|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
146010317|NCT00624468|526550150|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
146010318|NCT00624468|526550151|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
146010319|NCT00624468|526550148|FG000|Safety Follow-up (SFU) Period|Other|0|||
146010320|NCT00624468|526550149|FG001|Safety Follow-up (SFU) Period|Other|0|||
146010321|NCT00624468|526550150|FG002|Safety Follow-up (SFU) Period|Other|1|||
146010322|NCT00624468|526550151|FG003|Safety Follow-up (SFU) Period|Other|1|||
146010323|NCT00635349|526550153|FG000|Overall Study|Other|8|||
146010324|NCT00635349|526550154|FG001|Overall Study|Other|6|||
146010325|NCT00635349|526550153|FG000|Overall Study|Protocol Violation|18|||
146010326|NCT00635349|526550154|FG001|Overall Study|Protocol Violation|22|||
146010327|NCT00635349|526550153|FG000|Overall Study|Withdrawal by Subject|3|||
146010328|NCT00635349|526550154|FG001|Overall Study|Withdrawal by Subject|8|||
146010329|NCT00635349|526550153|FG000|Overall Study|Lost to Follow-up|4|||
146010330|NCT00635349|526550154|FG001|Overall Study|Lost to Follow-up|3|||
146010331|NCT00635349|526550153|FG000|Overall Study|Adverse Event|11|||
146010332|NCT00635349|526550154|FG001|Overall Study|Adverse Event|9|||
146010333|NCT02569476|526550157|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
146010334|NCT02569476|526550157|FG000|Overall Study|Death|33|||
146010335|NCT02569476|526550157|FG000|Overall Study|Withdrawal by Subject|9|||
146010336|NCT02569476|526550157|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
146010337|NCT02569476|526550157|FG000|Overall Study|Palliative care|1|||
146010338|NCT02569476|526550157|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
146010339|NCT02569476|526550157|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
146010340|NCT00703963|526550158|FG000|Overall Study|Withdrawal by Subject|7|||
146010341|NCT00703963|526550159|FG001|Overall Study|Withdrawal by Subject|13|||
146010342|NCT00703963|526550158|FG000|Overall Study|Physician Decision|0|||
146010343|NCT00703963|526550159|FG001|Overall Study|Physician Decision|1|||
146010344|NCT01340664|526550160|FG000|Overall Study|Adverse Event|0|||
146010345|NCT01340664|526550161|FG001|Overall Study|Adverse Event|1|||
146010346|NCT01340664|526550162|FG002|Overall Study|Adverse Event|7|||
146010347|NCT01340664|526550160|FG000|Overall Study|Lost to Follow-up|2|||
146010348|NCT01340664|526550161|FG001|Overall Study|Lost to Follow-up|0|||
146010349|NCT01340664|526550162|FG002|Overall Study|Lost to Follow-up|2|||
146010350|NCT01340664|526550160|FG000|Overall Study|Withdrawal by Subject|2|||
146010351|NCT01340664|526550161|FG001|Overall Study|Withdrawal by Subject|4|||
146010352|NCT01340664|526550162|FG002|Overall Study|Withdrawal by Subject|0|||
146010353|NCT01340664|526550160|FG000|Overall Study|Glycemic withdrawal criteria|2|||
146010354|NCT01340664|526550161|FG001|Overall Study|Glycemic withdrawal criteria|0|||
146010355|NCT01340664|526550162|FG002|Overall Study|Glycemic withdrawal criteria|0|||
146010356|NCT01340664|526550160|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
146010357|NCT01340664|526550161|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
146010358|NCT01340664|526550162|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
146010359|NCT01340664|526550160|FG000|Overall Study|Other|1|||
146010360|NCT01340664|526550161|FG001|Overall Study|Other|2|||
146010361|NCT01340664|526550162|FG002|Overall Study|Other|2|||
146010362|NCT02528942|526550168|FG000|Overall Study|Did not meet imaging criteria|9|||
146010363|NCT02528942|526550168|FG000|Overall Study|Lost to Follow-up|25|||
146010364|NCT04599803|526550169|FG000|Overall Study|Withdrawal by Subject|5|||
146010365|NCT04599803|526550169|FG000|Overall Study|Lost to Follow-up|26|||
146010366|NCT00881530|526550170|FG000|Overall Study|Adverse Event|5|||
146010367|NCT00881530|526550171|FG001|Overall Study|Adverse Event|1|||
146010368|NCT00881530|526550172|FG002|Overall Study|Adverse Event|1|||
146010369|NCT00881530|526550173|FG003|Overall Study|Adverse Event|4|||
146010370|NCT00881530|526550174|FG004|Overall Study|Adverse Event|10|||
146010371|NCT00881530|526550175|FG005|Overall Study|Adverse Event|2|||
146010372|NCT00881530|526550170|FG000|Overall Study|Lack of Efficacy|1|||
146010373|NCT00881530|526550171|FG001|Overall Study|Lack of Efficacy|0|||
146010374|NCT00881530|526550172|FG002|Overall Study|Lack of Efficacy|0|||
146010375|NCT00881530|526550173|FG003|Overall Study|Lack of Efficacy|0|||
146010376|NCT00881530|526550174|FG004|Overall Study|Lack of Efficacy|1|||
146010377|NCT00881530|526550175|FG005|Overall Study|Lack of Efficacy|1|||
146010378|NCT00881530|526550170|FG000|Overall Study|Not compliant with the protocol|0|||
146010379|NCT00881530|526550171|FG001|Overall Study|Not compliant with the protocol|0|||
146010380|NCT00881530|526550172|FG002|Overall Study|Not compliant with the protocol|0|||
146010381|NCT00881530|526550173|FG003|Overall Study|Not compliant with the protocol|0|||
146010382|NCT00881530|526550174|FG004|Overall Study|Not compliant with the protocol|2|||
146010383|NCT00881530|526550175|FG005|Overall Study|Not compliant with the protocol|0|||
146010384|NCT00881530|526550170|FG000|Overall Study|Lost to Follow-up|0|||
146010385|NCT00881530|526550171|FG001|Overall Study|Lost to Follow-up|1|||
146010386|NCT00881530|526550172|FG002|Overall Study|Lost to Follow-up|1|||
146010387|NCT00881530|526550173|FG003|Overall Study|Lost to Follow-up|3|||
146010388|NCT00881530|526550174|FG004|Overall Study|Lost to Follow-up|1|||
146010389|NCT00881530|526550175|FG005|Overall Study|Lost to Follow-up|0|||
146010390|NCT00881530|526550170|FG000|Overall Study|Refused to continue medication|7|||
146010391|NCT00881530|526550171|FG001|Overall Study|Refused to continue medication|2|||
146010392|NCT00881530|526550172|FG002|Overall Study|Refused to continue medication|1|||
146010393|NCT00881530|526550173|FG003|Overall Study|Refused to continue medication|2|||
146010394|NCT00881530|526550174|FG004|Overall Study|Refused to continue medication|0|||
146010395|NCT00881530|526550175|FG005|Overall Study|Refused to continue medication|0|||
146010396|NCT00881530|526550170|FG000|Overall Study|Other reason not defined above|1|||
146010397|NCT00881530|526550171|FG001|Overall Study|Other reason not defined above|1|||
146010398|NCT00881530|526550172|FG002|Overall Study|Other reason not defined above|2|||
146010399|NCT00881530|526550173|FG003|Overall Study|Other reason not defined above|0|||
146010400|NCT00881530|526550174|FG004|Overall Study|Other reason not defined above|0|||
146010401|NCT00881530|526550175|FG005|Overall Study|Other reason not defined above|2|||
146010402|NCT00763256|526550176|FG000|Overall Study|Didn't return for appointments|7|||
146249918|NCT02469155|527426800|FG003|Overall Study|Withdrawal by Subject|37|||
146249919|NCT02469155|527426797|FG000|Overall Study|Other|3|||
146249920|NCT02469155|527426798|FG001|Overall Study|Other|3|||
146249921|NCT02469155|527426799|FG002|Overall Study|Other|2|||
146249922|NCT02469155|527426800|FG003|Overall Study|Other|10|||
146249923|NCT02469155|527426797|FG000|Overall Study|Protocol Violation|0|||
146249924|NCT02469155|527426798|FG001|Overall Study|Protocol Violation|1|||
146249925|NCT02469155|527426799|FG002|Overall Study|Protocol Violation|0|||
146298941|NCT00631189|527609999|FG000|Initial Phase|Protocol Violation|347|||
146298942|NCT00631189|527610000|FG001|Initial Phase|Protocol Violation|0|||
146010403|NCT00763256|526550177|FG001|Overall Study|Didn't return for appointments|10|||
146010404|NCT01637584|526550178|FG000|Overall Study|Withdrawal by Subject|1|||
146010405|NCT01637584|526550179|FG001|Overall Study|Withdrawal by Subject|3|||
146010406|NCT04396795|526550180|FG000|Month 1|Lost to Follow-up|2|||
146010407|NCT04396795|526550181|FG001|Month 1|Lost to Follow-up|3|||
146010408|NCT04396795|526550180|FG000|Month 3|Lost to Follow-up|1|||
146010409|NCT04396795|526550181|FG001|Month 3|Lost to Follow-up|3|||
146010410|NCT04396795|526550180|FG000|Month 6|Lost to Follow-up|3|||
146249926|NCT02469155|527426800|FG003|Overall Study|Protocol Violation|1|||
146298943|NCT00631189|527610001|FG002|Initial Phase|Protocol Violation|0|||
146298944|NCT00631189|527610002|FG003|Initial Phase|Protocol Violation|0|||
146010411|NCT04396795|526550181|FG001|Month 6|Lost to Follow-up|3|||
146010412|NCT02366923|526550182|FG000|Overall Study|Withdrawal by Subject|1|||
146249927|NCT00901459|527426802|FG000|Overall Study|Withdrawal by Subject|6|||
146249928|NCT04765046|527426803|FG000|Overall Study|Screen Failure|2|||
146249929|NCT04765046|527426803|FG000|Overall Study|Withdrawal by Subject|4|||
146249930|NCT04765046|527426803|FG000|Overall Study|Physician Decision|4|||
146010413|NCT02366923|526550182|FG000|Overall Study|Positive Slit Lamp Findings|2|||
146010414|NCT02366923|526550182|FG000|Overall Study|High Astigmatism|3|||
146010415|NCT00995436|526550186|FG000|Overall Study|Withdrawal by Subject|2|||
146010416|NCT00995436|526550187|FG001|Overall Study|Withdrawal by Subject|5|||
146010417|NCT00995436|526550188|FG002|Overall Study|Withdrawal by Subject|0|||
146010418|NCT02725476|526550189|FG000|Overall Study|Physician Decision|2|||
146010419|NCT02725476|526550190|FG001|Overall Study|Physician Decision|0|||
146010420|NCT02725476|526550189|FG000|Overall Study|Adverse Event|1|||
146010421|NCT02725476|526550190|FG001|Overall Study|Adverse Event|1|||
146010422|NCT00289289|526550191|FG000|Overall Study|Withdrawal by Subject|5|||
146093012|NCT01086423|526861723|FG002|Overall Study|Migrated/moved from study area|4|||
146010423|NCT00289289|526550192|FG001|Overall Study|Withdrawal by Subject|3|||
146010424|NCT00289289|526550193|FG002|Overall Study|Withdrawal by Subject|15|||
146093013|NCT01086423|526861721|FG000|Overall Study|Adverse event, fatal|1|||
146093014|NCT01086423|526861722|FG001|Overall Study|Adverse event, fatal|1|||
146093015|NCT01086423|526861723|FG002|Overall Study|Adverse event, fatal|0|||
146093016|NCT01086423|526861721|FG000|Overall Study|Adverse event, non-fatal|2|||
146093017|NCT01086423|526861722|FG001|Overall Study|Adverse event, non-fatal|1|||
146093018|NCT01086423|526861723|FG002|Overall Study|Adverse event, non-fatal|0|||
146093019|NCT01086423|526861721|FG000|Overall Study|Withdrawal by Subject|5|||
146093020|NCT01086423|526861722|FG001|Overall Study|Withdrawal by Subject|1|||
146093021|NCT01086423|526861723|FG002|Overall Study|Withdrawal by Subject|3|||
146093022|NCT01086423|526861721|FG000|Overall Study|Lost to Follow-up|0|||
146093023|NCT01086423|526861722|FG001|Overall Study|Lost to Follow-up|0|||
146093024|NCT01086423|526861723|FG002|Overall Study|Lost to Follow-up|1|||
146093025|NCT00984568|526861725|FG000|Overall Study|Withdrawal by Subject|1|||
146093026|NCT00984568|526861726|FG001|Overall Study|Withdrawal by Subject|2|||
146093027|NCT00984568|526861725|FG000|Overall Study|Lack of Efficacy|2|||
146093028|NCT00984568|526861726|FG001|Overall Study|Lack of Efficacy|0|||
146093029|NCT00984568|526861725|FG000|Overall Study|Adverse Event|2|||
146093030|NCT00984568|526861726|FG001|Overall Study|Adverse Event|0|||
146093031|NCT00984568|526861725|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
146093032|NCT00984568|526861726|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
146093033|NCT00984568|526861725|FG000|Overall Study|Lost to Follow-up|0|||
146093034|NCT00984568|526861726|FG001|Overall Study|Lost to Follow-up|1|||
146093035|NCT00984568|526861725|FG000|Overall Study|Opportunistic Infection|1|||
146093036|NCT00984568|526861726|FG001|Overall Study|Opportunistic Infection|0|||
146093037|NCT00984568|526861725|FG000|Overall Study|Unknown Reason|1|||
146093038|NCT00984568|526861726|FG001|Overall Study|Unknown Reason|3|||
146093039|NCT04505540|526861727|FG000|Baseline|Protocol Violation|10|||
146093040|NCT04505540|526861727|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
146093041|NCT04505540|526861727|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
146093042|NCT04505540|526861727|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
146093043|NCT04505540|526861727|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
146093044|NCT04505540|526861727|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
146093045|NCT04505540|526861727|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
146093046|NCT04505540|526861727|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
146093047|NCT04505540|526861727|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
146093048|NCT04505540|526861727|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
146093049|NCT04505540|526861727|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
146093050|NCT04505540|526861727|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
146093051|NCT04505540|526861727|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
146093052|NCT02057393|526861728|FG000|Overall Study|Withdrawal by Subject|1|||
146093053|NCT02057393|526861728|FG000|Overall Study|Patient did not meet criteria|1|||
146093054|NCT03091777|526861729|FG000|Overall Study|Pregnancy|2|||
146093055|NCT03091777|526861730|FG001|Overall Study|Pregnancy|1|||
146093056|NCT03091777|526861731|FG002|Overall Study|Pregnancy|0|||
146093057|NCT03091777|526861729|FG000|Overall Study|Adverse Event|2|||
146093058|NCT03091777|526861730|FG001|Overall Study|Adverse Event|1|||
146093059|NCT03091777|526861731|FG002|Overall Study|Adverse Event|4|||
146093060|NCT03091777|526861729|FG000|Overall Study|Withdrawal by Subject|4|||
146093061|NCT03091777|526861730|FG001|Overall Study|Withdrawal by Subject|2|||
146093062|NCT03091777|526861731|FG002|Overall Study|Withdrawal by Subject|6|||
146249931|NCT04765046|527426803|FG000|Overall Study|Surgery Cancelled|8|||
146010425|NCT00289289|526550191|FG000|Overall Study|Lost to Follow-up|1|||
146010426|NCT00289289|526550192|FG001|Overall Study|Lost to Follow-up|0|||
146010427|NCT00289289|526550193|FG002|Overall Study|Lost to Follow-up|1|||
146093063|NCT03091777|526861729|FG000|Overall Study|Protocol Violation|2|||
146093064|NCT03091777|526861730|FG001|Overall Study|Protocol Violation|1|||
146093065|NCT03091777|526861731|FG002|Overall Study|Protocol Violation|1|||
146093066|NCT03091777|526861729|FG000|Overall Study|Lost to Follow-up|12|||
146093067|NCT03091777|526861730|FG001|Overall Study|Lost to Follow-up|14|||
146010428|NCT00289289|526550191|FG000|Overall Study|Death|4|||
146010429|NCT00289289|526550192|FG001|Overall Study|Death|2|||
146093068|NCT03091777|526861731|FG002|Overall Study|Lost to Follow-up|7|||
146010430|NCT00289289|526550193|FG002|Overall Study|Death|5|||
146010431|NCT00289289|526550191|FG000|Overall Study|No implant attempted|0|||
146010432|NCT00289289|526550192|FG001|Overall Study|No implant attempted|0|||
146010433|NCT00289289|526550193|FG002|Overall Study|No implant attempted|1|||
146010434|NCT00289289|526550191|FG000|Overall Study|Physician Decision|1|||
146010435|NCT00289289|526550192|FG001|Overall Study|Physician Decision|0|||
146010436|NCT00289289|526550193|FG002|Overall Study|Physician Decision|6|||
146010437|NCT00289289|526550191|FG000|Overall Study|Non-study device implanted|2|||
146010438|NCT00289289|526550192|FG001|Overall Study|Non-study device implanted|1|||
146010439|NCT00289289|526550193|FG002|Overall Study|Non-study device implanted|3|||
146010440|NCT00289289|526550191|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
146010441|NCT00289289|526550192|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
146010442|NCT00289289|526550193|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
146010443|NCT00289289|526550191|FG000|Overall Study|Other Exit Reason|6|||
146010444|NCT00289289|526550192|FG001|Overall Study|Other Exit Reason|4|||
146010445|NCT00289289|526550193|FG002|Overall Study|Other Exit Reason|12|||
146010446|NCT01445613|526550194|FG000|30-day Follow-up|Withdrawal by Subject|6|||
146010447|NCT01445613|526550194|FG000|30-day Follow-up|Physician Decision|3|||
146010448|NCT01445613|526550194|FG000|30-day Follow-up|Missed visit|23|||
146010449|NCT01445613|526550194|FG000|30-day Follow-up|Death|3|||
146010450|NCT01445613|526550194|FG000|1-year Follow-up|Withdrawal by Subject|12|||
146010451|NCT01445613|526550194|FG000|1-year Follow-up|Missed visit|29|||
146010452|NCT01445613|526550194|FG000|1-year Follow-up|Lost to Follow-up|2|||
146010453|NCT01445613|526550194|FG000|1-year Follow-up|Death|30|||
146010454|NCT01445613|526550194|FG000|1-year Follow-up|Physician Decision|2|||
146010455|NCT01445613|526550194|FG000|1-year Follow-up|Received a non-study stent|2|||
146010456|NCT02517398|526550211|FG000|Overall Study|Death|2|||
146010457|NCT02517398|526550212|FG001|Overall Study|Death|3|||
146010458|NCT02517398|526550213|FG002|Overall Study|Death|4|||
146010459|NCT02517398|526550214|FG003|Overall Study|Death|2|||
146010460|NCT02517398|526550215|FG004|Overall Study|Death|3|||
146010461|NCT02517398|526550216|FG005|Overall Study|Death|8|||
146010462|NCT02517398|526550217|FG006|Overall Study|Death|3|||
146010463|NCT02517398|526550218|FG007|Overall Study|Death|2|||
146010464|NCT02517398|526550219|FG008|Overall Study|Death|6|||
146010465|NCT02517398|526550220|FG009|Overall Study|Death|24|||
146010466|NCT02517398|526550221|FG010|Overall Study|Death|53|||
146010467|NCT02517398|526550222|FG011|Overall Study|Death|25|||
146010468|NCT02517398|526550223|FG012|Overall Study|Death|73|||
146010469|NCT02517398|526550224|FG013|Overall Study|Death|29|||
146010470|NCT02517398|526550225|FG014|Overall Study|Death|26|||
146010471|NCT02517398|526550226|FG015|Overall Study|Death|23|||
146010472|NCT02517398|526550227|FG016|Overall Study|Death|26|||
146010473|NCT02517398|526550228|FG017|Overall Study|Death|25|||
146249932|NCT04930263|527426807|FG000|Overall Study|Withdrawal by Subject|3|||
146249933|NCT04930263|527426808|FG001|Overall Study|Withdrawal by Subject|5|||
146249934|NCT01989156|527426809|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
146249935|NCT01989156|527426810|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146249936|NCT01989156|527426811|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
146249937|NCT01989156|527426809|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
146249938|NCT01989156|527426810|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
146249939|NCT01989156|527426811|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
146249940|NCT01989156|527426809|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
146249941|NCT01989156|527426810|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
146249942|NCT01989156|527426811|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
146249943|NCT01989156|527426809|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146249944|NCT01989156|527426810|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146249945|NCT01989156|527426811|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
146249946|NCT01989156|527426809|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
146249947|NCT01989156|527426810|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
146249948|NCT01989156|527426811|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
146298945|NCT00631189|527609999|FG000|Initial Phase|Withdrawal by Subject|4|||
146298946|NCT00631189|527610000|FG001|Initial Phase|Withdrawal by Subject|0|||
146010474|NCT02517398|526550229|FG018|Overall Study|Death|22|||
146010475|NCT02517398|526550230|FG019|Overall Study|Death|7|||
146010476|NCT02517398|526550231|FG020|Overall Study|Death|26|||
146010477|NCT02517398|526550232|FG021|Overall Study|Death|30|||
146010478|NCT02517398|526550233|FG022|Overall Study|Death|20|||
146010479|NCT02517398|526550211|FG000|Overall Study|Other|0|||
146010480|NCT02517398|526550212|FG001|Overall Study|Other|0|||
146010481|NCT02517398|526550213|FG002|Overall Study|Other|0|||
146010482|NCT02517398|526550214|FG003|Overall Study|Other|1|||
146298947|NCT00631189|527610001|FG002|Initial Phase|Withdrawal by Subject|0|||
146010483|NCT02517398|526550215|FG004|Overall Study|Other|0|||
146010484|NCT02517398|526550216|FG005|Overall Study|Other|0|||
146010485|NCT02517398|526550217|FG006|Overall Study|Other|0|||
146010486|NCT02517398|526550218|FG007|Overall Study|Other|0|||
146010487|NCT02517398|526550219|FG008|Overall Study|Other|0|||
146010488|NCT02517398|526550220|FG009|Overall Study|Other|1|||
146010489|NCT02517398|526550221|FG010|Overall Study|Other|0|||
146010490|NCT02517398|526550222|FG011|Overall Study|Other|0|||
146010491|NCT02517398|526550223|FG012|Overall Study|Other|0|||
146010492|NCT02517398|526550224|FG013|Overall Study|Other|1|||
146010493|NCT02517398|526550225|FG014|Overall Study|Other|0|||
146010494|NCT02517398|526550226|FG015|Overall Study|Other|1|||
146010495|NCT02517398|526550227|FG016|Overall Study|Other|1|||
146010496|NCT02517398|526550228|FG017|Overall Study|Other|0|||
146010497|NCT02517398|526550229|FG018|Overall Study|Other|0|||
146010498|NCT02517398|526550230|FG019|Overall Study|Other|1|||
146010499|NCT02517398|526550231|FG020|Overall Study|Other|0|||
146010500|NCT02517398|526550232|FG021|Overall Study|Other|0|||
146010501|NCT02517398|526550233|FG022|Overall Study|Other|0|||
146010502|NCT02517398|526550211|FG000|Overall Study|Lost to Follow-up|0|||
146010503|NCT02517398|526550212|FG001|Overall Study|Lost to Follow-up|0|||
146010504|NCT02517398|526550213|FG002|Overall Study|Lost to Follow-up|0|||
146010505|NCT02517398|526550214|FG003|Overall Study|Lost to Follow-up|0|||
146010506|NCT02517398|526550215|FG004|Overall Study|Lost to Follow-up|0|||
146010507|NCT02517398|526550216|FG005|Overall Study|Lost to Follow-up|0|||
146010508|NCT02517398|526550217|FG006|Overall Study|Lost to Follow-up|0|||
146010509|NCT02517398|526550218|FG007|Overall Study|Lost to Follow-up|0|||
146010510|NCT02517398|526550219|FG008|Overall Study|Lost to Follow-up|0|||
146010511|NCT02517398|526550220|FG009|Overall Study|Lost to Follow-up|1|||
146010512|NCT02517398|526550221|FG010|Overall Study|Lost to Follow-up|0|||
146010513|NCT02517398|526550222|FG011|Overall Study|Lost to Follow-up|2|||
146010514|NCT02517398|526550223|FG012|Overall Study|Lost to Follow-up|2|||
146010515|NCT02517398|526550224|FG013|Overall Study|Lost to Follow-up|0|||
146010516|NCT02517398|526550225|FG014|Overall Study|Lost to Follow-up|1|||
146010517|NCT02517398|526550226|FG015|Overall Study|Lost to Follow-up|1|||
146010518|NCT02517398|526550227|FG016|Overall Study|Lost to Follow-up|0|||
146010519|NCT02517398|526550228|FG017|Overall Study|Lost to Follow-up|3|||
146010520|NCT02517398|526550229|FG018|Overall Study|Lost to Follow-up|1|||
146010521|NCT02517398|526550230|FG019|Overall Study|Lost to Follow-up|0|||
146010522|NCT02517398|526550231|FG020|Overall Study|Lost to Follow-up|1|||
146010523|NCT02517398|526550232|FG021|Overall Study|Lost to Follow-up|0|||
146010524|NCT02517398|526550233|FG022|Overall Study|Lost to Follow-up|2|||
146010525|NCT02517398|526550211|FG000|Overall Study|Withdrew Consent|0|||
146010526|NCT02517398|526550212|FG001|Overall Study|Withdrew Consent|0|||
146010527|NCT02517398|526550213|FG002|Overall Study|Withdrew Consent|0|||
146010528|NCT02517398|526550214|FG003|Overall Study|Withdrew Consent|0|||
146010529|NCT02517398|526550215|FG004|Overall Study|Withdrew Consent|0|||
146010530|NCT02517398|526550216|FG005|Overall Study|Withdrew Consent|0|||
146010531|NCT02517398|526550217|FG006|Overall Study|Withdrew Consent|1|||
146010532|NCT02517398|526550218|FG007|Overall Study|Withdrew Consent|0|||
146010533|NCT02517398|526550219|FG008|Overall Study|Withdrew Consent|0|||
146010534|NCT02517398|526550220|FG009|Overall Study|Withdrew Consent|2|||
146010535|NCT02517398|526550221|FG010|Overall Study|Withdrew Consent|7|||
146010536|NCT02517398|526550222|FG011|Overall Study|Withdrew Consent|1|||
146010537|NCT02517398|526550223|FG012|Overall Study|Withdrew Consent|5|||
146010538|NCT02517398|526550224|FG013|Overall Study|Withdrew Consent|4|||
146010539|NCT02517398|526550225|FG014|Overall Study|Withdrew Consent|2|||
146010540|NCT02517398|526550226|FG015|Overall Study|Withdrew Consent|5|||
146010541|NCT02517398|526550227|FG016|Overall Study|Withdrew Consent|4|||
146010542|NCT02517398|526550228|FG017|Overall Study|Withdrew Consent|2|||
146010543|NCT02517398|526550229|FG018|Overall Study|Withdrew Consent|3|||
146010544|NCT02517398|526550230|FG019|Overall Study|Withdrew Consent|2|||
146010545|NCT02517398|526550231|FG020|Overall Study|Withdrew Consent|9|||
146010546|NCT02517398|526550232|FG021|Overall Study|Withdrew Consent|3|||
146010547|NCT02517398|526550233|FG022|Overall Study|Withdrew Consent|1|||
146010548|NCT02131662|526550234|FG000|Overall Study|Protocol Violation|1|||
146010549|NCT02131662|526550235|FG001|Overall Study|Protocol Violation|0|||
146010550|NCT02131662|526550236|FG002|Overall Study|Protocol Violation|0|||
146010551|NCT02131662|526550237|FG003|Overall Study|Protocol Violation|0|||
146010552|NCT02131662|526550238|FG004|Overall Study|Protocol Violation|0|||
146010553|NCT02131662|526550234|FG000|Overall Study|Other|2|||
146010554|NCT02131662|526550235|FG001|Overall Study|Other|4|||
146010555|NCT02131662|526550236|FG002|Overall Study|Other|3|||
146249949|NCT01989156|527426809|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
146249950|NCT01989156|527426810|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
146249951|NCT01989156|527426811|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
146010556|NCT02131662|526550237|FG003|Overall Study|Other|3|||
146010557|NCT02131662|526550238|FG004|Overall Study|Other|4|||
146010558|NCT02131662|526550234|FG000|Overall Study|Adverse Event|0|||
146010559|NCT02131662|526550235|FG001|Overall Study|Adverse Event|1|||
146010560|NCT02131662|526550236|FG002|Overall Study|Adverse Event|1|||
146010561|NCT02131662|526550237|FG003|Overall Study|Adverse Event|1|||
146010562|NCT02131662|526550238|FG004|Overall Study|Adverse Event|3|||
146010563|NCT02131662|526550234|FG000|Overall Study|Pregnancy|0|||
146010564|NCT02131662|526550235|FG001|Overall Study|Pregnancy|1|||
146010565|NCT02131662|526550236|FG002|Overall Study|Pregnancy|0|||
146010566|NCT02131662|526550237|FG003|Overall Study|Pregnancy|1|||
146010567|NCT02131662|526550238|FG004|Overall Study|Pregnancy|0|||
146010568|NCT02131662|526550234|FG000|Overall Study|Wish for pregnancy|0|||
146010569|NCT02131662|526550235|FG001|Overall Study|Wish for pregnancy|0|||
146010570|NCT02131662|526550236|FG002|Overall Study|Wish for pregnancy|0|||
146010571|NCT02131662|526550237|FG003|Overall Study|Wish for pregnancy|0|||
146010572|NCT02131662|526550238|FG004|Overall Study|Wish for pregnancy|1|||
146010573|NCT02131662|526550234|FG000|Overall Study|Lack of Efficacy|1|||
146010574|NCT02131662|526550235|FG001|Overall Study|Lack of Efficacy|0|||
146010575|NCT02131662|526550236|FG002|Overall Study|Lack of Efficacy|0|||
146010576|NCT02131662|526550237|FG003|Overall Study|Lack of Efficacy|0|||
146010577|NCT02131662|526550238|FG004|Overall Study|Lack of Efficacy|1|||
146010578|NCT02131662|526550234|FG000|Overall Study|Withdrawal by Subject|1|||
146010579|NCT02131662|526550235|FG001|Overall Study|Withdrawal by Subject|5|||
146010580|NCT02131662|526550236|FG002|Overall Study|Withdrawal by Subject|1|||
146010581|NCT02131662|526550237|FG003|Overall Study|Withdrawal by Subject|5|||
146010582|NCT02131662|526550238|FG004|Overall Study|Withdrawal by Subject|6|||
146010583|NCT02131662|526550234|FG000|Overall Study|Lost to Follow-up|1|||
146010584|NCT02131662|526550235|FG001|Overall Study|Lost to Follow-up|3|||
146010585|NCT02131662|526550236|FG002|Overall Study|Lost to Follow-up|0|||
146010586|NCT02131662|526550237|FG003|Overall Study|Lost to Follow-up|9|||
146010587|NCT02131662|526550238|FG004|Overall Study|Lost to Follow-up|0|||
146010588|NCT02131662|526550234|FG000|Overall Study|Not treated|2|||
146010589|NCT02131662|526550235|FG001|Overall Study|Not treated|0|||
146010590|NCT02131662|526550236|FG002|Overall Study|Not treated|2|||
146010591|NCT02131662|526550237|FG003|Overall Study|Not treated|2|||
146010592|NCT02131662|526550238|FG004|Overall Study|Not treated|3|||
146010593|NCT00130039|526550243|FG000|Overall Study|Withdrawal by Subject|15|||
146010594|NCT00130039|526550244|FG001|Overall Study|Withdrawal by Subject|11|||
146010595|NCT00130039|526550243|FG000|Overall Study|Lost to Follow-up|3|||
146010596|NCT00130039|526550244|FG001|Overall Study|Lost to Follow-up|1|||
146010597|NCT00130039|526550243|FG000|Overall Study|Adverse Event|4|||
146010598|NCT00130039|526550244|FG001|Overall Study|Adverse Event|2|||
146010599|NCT00130039|526550243|FG000|Overall Study|Physician Decision|3|||
146010600|NCT00130039|526550244|FG001|Overall Study|Physician Decision|0|||
146010601|NCT00130039|526550243|FG000|Overall Study|clinical events without follow up MRI|5|||
146010602|NCT00130039|526550244|FG001|Overall Study|clinical events without follow up MRI|4|||
146010603|NCT01928433|526550245|FG000|Overall Study|Adverse Event|5|||
146010604|NCT01928433|526550246|FG001|Overall Study|Adverse Event|2|||
146010605|NCT01928433|526550247|FG002|Overall Study|Adverse Event|5|||
146010606|NCT01928433|526550245|FG000|Overall Study|Protocol Violation|0|||
146010607|NCT01928433|526550246|FG001|Overall Study|Protocol Violation|0|||
146010608|NCT01928433|526550247|FG002|Overall Study|Protocol Violation|2|||
146010609|NCT01928433|526550245|FG000|Overall Study|Lack of Efficacy|5|||
146010610|NCT01928433|526550246|FG001|Overall Study|Lack of Efficacy|4|||
146010611|NCT01928433|526550247|FG002|Overall Study|Lack of Efficacy|4|||
146010612|NCT01928433|526550245|FG000|Overall Study|Withdrawal by Subject|0|||
146010613|NCT01928433|526550246|FG001|Overall Study|Withdrawal by Subject|4|||
146010614|NCT01928433|526550247|FG002|Overall Study|Withdrawal by Subject|0|||
146010615|NCT01928433|526550245|FG000|Overall Study|Negative screening urine culture|7|||
146010616|NCT01928433|526550246|FG001|Overall Study|Negative screening urine culture|6|||
146010617|NCT01928433|526550247|FG002|Overall Study|Negative screening urine culture|10|||
146010618|NCT01928433|526550245|FG000|Overall Study|Lost to Follow-up|0|||
146249952|NCT01989156|527426809|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
146249953|NCT01989156|527426810|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
146249954|NCT01989156|527426811|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
146249955|NCT01989156|527426809|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
146249956|NCT01989156|527426810|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
146249957|NCT01989156|527426811|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
146249958|NCT00850993|527426812|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
146249959|NCT00850993|527426813|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
146249960|NCT00850993|527426814|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
146249961|NCT00850993|527426815|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
146249962|NCT03839355|527426816|FG000|Overall Study|Withdrawal by Subject|1|||
146249963|NCT03839355|527426817|FG001|Overall Study|Withdrawal by Subject|0|||
146010619|NCT01928433|526550246|FG001|Overall Study|Lost to Follow-up|2|||
146010620|NCT01928433|526550247|FG002|Overall Study|Lost to Follow-up|3|||
146010621|NCT01928433|526550245|FG000|Overall Study|Other reasons|3|||
146010622|NCT01928433|526550246|FG001|Overall Study|Other reasons|3|||
146010623|NCT01928433|526550247|FG002|Overall Study|Other reasons|4|||
146249964|NCT04501614|527426824|FG000|Overall Study|Study Terminated by Sponsor|6|||
146249965|NCT04501614|527426825|FG001|Overall Study|Study Terminated by Sponsor|3|||
146010624|NCT01740687|526550248|FG000|Overall Study|Lost to Follow-up|11|||
146010625|NCT01740687|526550248|FG000|Overall Study|Withdrawal by Subject|2|||
146010626|NCT01740687|526550248|FG000|Overall Study|other reason|22|||
146010627|NCT01740687|526550248|FG000|Overall Study|treatment not received|2|||
146249966|NCT04501614|527426824|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
146093069|NCT03091777|526861729|FG000|Overall Study|Lack of Efficacy|0|||
146093070|NCT03091777|526861730|FG001|Overall Study|Lack of Efficacy|0|||
146093071|NCT03091777|526861731|FG002|Overall Study|Lack of Efficacy|5|||
146093072|NCT03091777|526861729|FG000|Overall Study|Noncompliance with study drug|2|||
146093073|NCT03091777|526861730|FG001|Overall Study|Noncompliance with study drug|3|||
146093074|NCT03091777|526861731|FG002|Overall Study|Noncompliance with study drug|1|||
146093075|NCT03091777|526861729|FG000|Overall Study|Physician Decision|1|||
146093076|NCT03091777|526861730|FG001|Overall Study|Physician Decision|0|||
146093077|NCT03091777|526861731|FG002|Overall Study|Physician Decision|1|||
146093078|NCT03091777|526861729|FG000|Overall Study|Abnormal Laboratory Value|7|||
146093079|NCT03091777|526861730|FG001|Overall Study|Abnormal Laboratory Value|11|||
146093080|NCT03091777|526861731|FG002|Overall Study|Abnormal Laboratory Value|12|||
146093081|NCT01437878|526861732|FG000|Overall Study|Withdrawal by Subject|1|||
146093082|NCT01437878|526861733|FG001|Overall Study|Withdrawal by Subject|0|||
146093083|NCT01070043|526861734|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
146093084|NCT01070043|526861735|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
146093085|NCT01070043|526861736|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
146093086|NCT01070043|526861734|FG000|Double-Blind Treatment|Adverse Event|0|||
146093087|NCT01070043|526861735|FG001|Double-Blind Treatment|Adverse Event|0|||
146093088|NCT01070043|526861736|FG002|Double-Blind Treatment|Adverse Event|2|||
146093089|NCT01476644|526861741|FG000|Overall Study|Death|5|||
146093090|NCT01476644|526861741|FG000|Overall Study|moved to another state|2|||
146093091|NCT01476644|526861741|FG000|Overall Study|Lost to Follow-up|19|||
146249967|NCT04501614|527426825|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
146249968|NCT02555397|527426826|FG000|Overall Study|Withdrawal by Subject|1|||
146249969|NCT02555397|527426827|FG001|Overall Study|Withdrawal by Subject|0|||
146010628|NCT01016132|526550250|FG000|Overall Study|Discomfort|1|||
146010629|NCT01198574|526550252|FG000|Overall Study|Resigned from schools|4|||
146010630|NCT01198574|526550253|FG001|Overall Study|Resigned from schools|1|||
146010631|NCT01198574|526550254|FG002|Overall Study|Resigned from schools|1|||
146010632|NCT01198574|526550255|FG003|Overall Study|Resigned from schools|4|||
146010633|NCT00556439|526550256|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
146010634|NCT00556439|526550257|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
146010635|NCT00556439|526550258|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
146010636|NCT00556439|526550259|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
146010637|NCT00556439|526550256|FG000|Study Entry to Week 12|Physician Decision|1|||
146010638|NCT00556439|526550257|FG001|Study Entry to Week 12|Physician Decision|0|||
146010639|NCT00556439|526550258|FG002|Study Entry to Week 12|Physician Decision|0|||
146010640|NCT00556439|526550259|FG003|Study Entry to Week 12|Physician Decision|0|||
146010641|NCT00556439|526550256|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
146010642|NCT00556439|526550257|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
146010643|NCT00556439|526550258|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
146010644|NCT00556439|526550259|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
146010645|NCT00556439|526550256|FG000|Study Entry to Week 12|Recurrent infection|1|||
146010646|NCT00556439|526550257|FG001|Study Entry to Week 12|Recurrent infection|0|||
146010647|NCT00556439|526550258|FG002|Study Entry to Week 12|Recurrent infection|0|||
146010648|NCT00556439|526550259|FG003|Study Entry to Week 12|Recurrent infection|0|||
146010649|NCT00556439|526550256|FG000|Study Entry to Week 12|Malignancy|0|||
146010650|NCT00556439|526550257|FG001|Study Entry to Week 12|Malignancy|0|||
146010651|NCT00556439|526550258|FG002|Study Entry to Week 12|Malignancy|1|||
146010652|NCT00556439|526550259|FG003|Study Entry to Week 12|Malignancy|0|||
146010653|NCT00556439|526550256|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
146010654|NCT00556439|526550257|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
146010655|NCT00556439|526550258|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
146010656|NCT00556439|526550259|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
146010657|NCT00556439|526550256|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
146010658|NCT00556439|526550257|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146010659|NCT00556439|526550258|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146010660|NCT00556439|526550259|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
146010661|NCT00556439|526550256|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
146249970|NCT02555397|527426828|FG002|Overall Study|Withdrawal by Subject|0|||
146249971|NCT02555397|527426829|FG003|Overall Study|Withdrawal by Subject|0|||
146010662|NCT00556439|526550257|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
146010663|NCT00556439|526550258|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
146010664|NCT00556439|526550259|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
146093092|NCT01476644|526861741|FG000|Overall Study|Withdrawal by Subject|13|||
146093093|NCT02393690|526861742|FG000|Overall Study|Ineligible|0|||
146093094|NCT02393690|526861743|FG001|Overall Study|Ineligible|1|||
146093095|NCT03488927|526861744|FG000|Overall Study|Withdrawal by Subject|44|||
146249972|NCT02555397|527426830|FG004|Overall Study|Withdrawal by Subject|0|||
146093096|NCT03488927|526861745|FG001|Overall Study|Withdrawal by Subject|118|||
146093097|NCT03488927|526861746|FG002|Overall Study|Withdrawal by Subject|217|||
146249973|NCT00237809|527426831|FG000|Overall Study|Lost to Follow-up|11|||
146010665|NCT00556439|526550256|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
146010666|NCT00556439|526550257|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
146010667|NCT00556439|526550258|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
146010668|NCT00556439|526550259|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
146010669|NCT02100423|526550260|FG000|Overall Study|Death|1|||
146010670|NCT02100423|526550260|FG000|Overall Study|Withdrawal by Subject|3|||
146010671|NCT02100423|526550260|FG000|Overall Study|Adverse Event|1|||
146010672|NCT02100423|526550260|FG000|Overall Study|Physician Decision|1|||
146010673|NCT05823974|526552267|FG000|Overall Study|Lost to Follow-up|0|||
146010674|NCT05823974|526552268|FG001|Overall Study|Lost to Follow-up|3|||
146010675|NCT05823974|526552269|FG002|Overall Study|Lost to Follow-up|1|||
146010676|NCT05823974|526552270|FG003|Overall Study|Lost to Follow-up|0|||
146010677|NCT05823974|526552271|FG004|Overall Study|Lost to Follow-up|1|||
146010678|NCT05823974|526552272|FG005|Overall Study|Lost to Follow-up|0|||
146010679|NCT05823974|526552273|FG006|Overall Study|Lost to Follow-up|1|||
146010680|NCT05823974|526552274|FG007|Overall Study|Lost to Follow-up|0|||
146010681|NCT05823974|526552275|FG008|Overall Study|Lost to Follow-up|0|||
146010682|NCT05823974|526552276|FG009|Overall Study|Lost to Follow-up|1|||
146010683|NCT05823974|526552277|FG010|Overall Study|Lost to Follow-up|1|||
146010684|NCT05823974|526552278|FG011|Overall Study|Lost to Follow-up|0|||
146010685|NCT05823974|526552279|FG012|Overall Study|Lost to Follow-up|1|||
146010686|NCT05823974|526552280|FG013|Overall Study|Lost to Follow-up|2|||
146010687|NCT05823974|526552281|FG014|Overall Study|Lost to Follow-up|1|||
146010688|NCT05823974|526552282|FG015|Overall Study|Lost to Follow-up|1|||
146010689|NCT05823974|526552283|FG016|Overall Study|Lost to Follow-up|1|||
146010690|NCT05823974|526552284|FG017|Overall Study|Lost to Follow-up|0|||
146010691|NCT05823974|526552285|FG018|Overall Study|Lost to Follow-up|0|||
146010692|NCT05823974|526552286|FG019|Overall Study|Lost to Follow-up|2|||
146010693|NCT05823974|526552287|FG020|Overall Study|Lost to Follow-up|0|||
146010694|NCT05823974|526552267|FG000|Overall Study|Physician Decision|0|||
146249974|NCT00237809|527426832|FG001|Overall Study|Lost to Follow-up|10|||
146010695|NCT05823974|526552268|FG001|Overall Study|Physician Decision|0|||
146010696|NCT05823974|526552269|FG002|Overall Study|Physician Decision|0|||
146010697|NCT05823974|526552270|FG003|Overall Study|Physician Decision|0|||
146010698|NCT05823974|526552271|FG004|Overall Study|Physician Decision|0|||
146010699|NCT05823974|526552272|FG005|Overall Study|Physician Decision|0|||
146010700|NCT05823974|526552273|FG006|Overall Study|Physician Decision|0|||
146010701|NCT05823974|526552274|FG007|Overall Study|Physician Decision|0|||
146010702|NCT05823974|526552275|FG008|Overall Study|Physician Decision|0|||
146010703|NCT05823974|526552276|FG009|Overall Study|Physician Decision|0|||
146010704|NCT05823974|526552277|FG010|Overall Study|Physician Decision|0|||
146010705|NCT05823974|526552278|FG011|Overall Study|Physician Decision|0|||
146010706|NCT05823974|526552279|FG012|Overall Study|Physician Decision|0|||
146010707|NCT05823974|526552280|FG013|Overall Study|Physician Decision|0|||
146010708|NCT05823974|526552281|FG014|Overall Study|Physician Decision|0|||
146010709|NCT05823974|526552282|FG015|Overall Study|Physician Decision|1|||
146010710|NCT05823974|526552283|FG016|Overall Study|Physician Decision|0|||
146010711|NCT05823974|526552284|FG017|Overall Study|Physician Decision|1|||
146010712|NCT05823974|526552285|FG018|Overall Study|Physician Decision|1|||
146010713|NCT05823974|526552286|FG019|Overall Study|Physician Decision|0|||
146010714|NCT05823974|526552287|FG020|Overall Study|Physician Decision|0|||
146010715|NCT05823974|526552267|FG000|Overall Study|Withdrawal by Subject|1|||
146010716|NCT05823974|526552268|FG001|Overall Study|Withdrawal by Subject|1|||
146010717|NCT05823974|526552269|FG002|Overall Study|Withdrawal by Subject|2|||
146010718|NCT05823974|526552270|FG003|Overall Study|Withdrawal by Subject|0|||
146010719|NCT05823974|526552271|FG004|Overall Study|Withdrawal by Subject|2|||
146010720|NCT05823974|526552272|FG005|Overall Study|Withdrawal by Subject|3|||
146010721|NCT05823974|526552273|FG006|Overall Study|Withdrawal by Subject|1|||
146010722|NCT05823974|526552274|FG007|Overall Study|Withdrawal by Subject|1|||
146010723|NCT05823974|526552275|FG008|Overall Study|Withdrawal by Subject|2|||
146249975|NCT00237809|527426833|FG002|Overall Study|Lost to Follow-up|9|||
146249976|NCT00237809|527426834|FG003|Overall Study|Lost to Follow-up|9|||
146010724|NCT05823974|526552276|FG009|Overall Study|Withdrawal by Subject|1|||
146010725|NCT05823974|526552277|FG010|Overall Study|Withdrawal by Subject|1|||
146010726|NCT05823974|526552278|FG011|Overall Study|Withdrawal by Subject|0|||
146093098|NCT00586066|526861747|FG000|Overall Study|Lost to Follow-up|6|||
146249977|NCT02138838|527426840|FG000|Overall Study|Study Closure|7|||
146010727|NCT05823974|526552279|FG012|Overall Study|Withdrawal by Subject|0|||
146010728|NCT05823974|526552280|FG013|Overall Study|Withdrawal by Subject|1|||
146010729|NCT05823974|526552281|FG014|Overall Study|Withdrawal by Subject|1|||
146010730|NCT05823974|526552282|FG015|Overall Study|Withdrawal by Subject|3|||
146093099|NCT00586066|526861748|FG001|Overall Study|Lost to Follow-up|3|||
146010731|NCT05823974|526552283|FG016|Overall Study|Withdrawal by Subject|0|||
146010732|NCT05823974|526552284|FG017|Overall Study|Withdrawal by Subject|2|||
146010733|NCT05823974|526552285|FG018|Overall Study|Withdrawal by Subject|2|||
146010734|NCT05823974|526552286|FG019|Overall Study|Withdrawal by Subject|0|||
146010735|NCT05823974|526552287|FG020|Overall Study|Withdrawal by Subject|1|||
146249978|NCT02138838|527426841|FG001|Overall Study|Study Closure|6|||
146249979|NCT02138838|527426840|FG000|Overall Study|Withdrawal by Subject|1|||
146249980|NCT02138838|527426841|FG001|Overall Study|Withdrawal by Subject|5|||
146010736|NCT05823974|526552267|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010737|NCT05823974|526552268|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010738|NCT05823974|526552269|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146010739|NCT05823974|526552270|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010740|NCT05823974|526552271|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010741|NCT05823974|526552272|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010742|NCT05823974|526552273|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010743|NCT05823974|526552274|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010744|NCT05823974|526552275|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010745|NCT05823974|526552276|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010746|NCT05823974|526552277|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010747|NCT05823974|526552278|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010748|NCT05823974|526552279|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010749|NCT05823974|526552280|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010750|NCT05823974|526552281|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146010751|NCT05823974|526552282|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010752|NCT05823974|526552283|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010753|NCT05823974|526552284|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010754|NCT05823974|526552285|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010755|NCT05823974|526552286|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010756|NCT05823974|526552287|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146010757|NCT05823974|526552267|FG000|Overall Study|Other|0|||
146010758|NCT05823974|526552268|FG001|Overall Study|Other|1|||
146010759|NCT05823974|526552269|FG002|Overall Study|Other|1|||
146010760|NCT05823974|526552270|FG003|Overall Study|Other|1|||
146010761|NCT05823974|526552271|FG004|Overall Study|Other|0|||
146010762|NCT05823974|526552272|FG005|Overall Study|Other|1|||
146010763|NCT05823974|526552273|FG006|Overall Study|Other|1|||
146010764|NCT05823974|526552274|FG007|Overall Study|Other|1|||
146010765|NCT05823974|526552275|FG008|Overall Study|Other|1|||
146010766|NCT05823974|526552276|FG009|Overall Study|Other|0|||
146010767|NCT05823974|526552277|FG010|Overall Study|Other|0|||
146010768|NCT05823974|526552278|FG011|Overall Study|Other|0|||
146010769|NCT05823974|526552279|FG012|Overall Study|Other|2|||
146010770|NCT05823974|526552280|FG013|Overall Study|Other|1|||
146010771|NCT05823974|526552281|FG014|Overall Study|Other|0|||
146010772|NCT05823974|526552282|FG015|Overall Study|Other|1|||
146010773|NCT05823974|526552283|FG016|Overall Study|Other|0|||
146010774|NCT05823974|526552284|FG017|Overall Study|Other|0|||
146010775|NCT05823974|526552285|FG018|Overall Study|Other|0|||
146010776|NCT05823974|526552286|FG019|Overall Study|Other|0|||
146010777|NCT05823974|526552287|FG020|Overall Study|Other|0|||
146010778|NCT01238991|526552292|FG000|Overall Study|Adverse Event|1|||
146010779|NCT01238991|526552293|FG001|Overall Study|Adverse Event|0|||
146010780|NCT01238991|526552294|FG002|Overall Study|Adverse Event|3|||
146010781|NCT01238991|526552295|FG003|Overall Study|Adverse Event|1|||
146010782|NCT01238991|526552296|FG004|Overall Study|Adverse Event|1|||
146010783|NCT01238991|526552297|FG005|Overall Study|Adverse Event|0|||
146010784|NCT01238991|526552298|FG006|Overall Study|Adverse Event|1|||
146010785|NCT01238991|526552299|FG007|Overall Study|Adverse Event|1|||
146010786|NCT01238991|526552300|FG008|Overall Study|Adverse Event|0|||
146010787|NCT01238991|526552301|FG009|Overall Study|Adverse Event|0|||
146010788|NCT01238991|526552292|FG000|Overall Study|Death|0|||
146010789|NCT01238991|526552293|FG001|Overall Study|Death|0|||
146010790|NCT01238991|526552294|FG002|Overall Study|Death|0|||
146010791|NCT01238991|526552295|FG003|Overall Study|Death|1|||
146010792|NCT01238991|526552296|FG004|Overall Study|Death|0|||
146010793|NCT01238991|526552297|FG005|Overall Study|Death|0|||
146010794|NCT01238991|526552298|FG006|Overall Study|Death|0|||
146010795|NCT01238991|526552299|FG007|Overall Study|Death|0|||
146010796|NCT01238991|526552300|FG008|Overall Study|Death|0|||
146010797|NCT01238991|526552301|FG009|Overall Study|Death|0|||
146010798|NCT01238991|526552292|FG000|Overall Study|Lack of Efficacy|0|||
146249981|NCT02367794|527426848|FG000|Overall Study|Death|252|||
146249982|NCT02367794|527426849|FG001|Overall Study|Death|245|||
146010799|NCT01238991|526552293|FG001|Overall Study|Lack of Efficacy|0|||
146010800|NCT01238991|526552294|FG002|Overall Study|Lack of Efficacy|1|||
146093100|NCT00586066|526861747|FG000|Overall Study|Lack of Efficacy|5|||
146010801|NCT01238991|526552295|FG003|Overall Study|Lack of Efficacy|0|||
146010802|NCT01238991|526552296|FG004|Overall Study|Lack of Efficacy|0|||
146010803|NCT01238991|526552297|FG005|Overall Study|Lack of Efficacy|0|||
146010804|NCT01238991|526552298|FG006|Overall Study|Lack of Efficacy|0|||
146010805|NCT01238991|526552299|FG007|Overall Study|Lack of Efficacy|0|||
146010806|NCT01238991|526552300|FG008|Overall Study|Lack of Efficacy|1|||
146249983|NCT02367794|527426850|FG002|Overall Study|Death|243|||
146249984|NCT02367794|527426848|FG000|Overall Study|Lost to Follow-up|1|||
146249985|NCT02367794|527426849|FG001|Overall Study|Lost to Follow-up|2|||
146010807|NCT01238991|526552301|FG009|Overall Study|Lack of Efficacy|0|||
146010808|NCT01238991|526552292|FG000|Overall Study|Withdrawal by Subject|0|||
146010809|NCT01238991|526552293|FG001|Overall Study|Withdrawal by Subject|0|||
146010810|NCT01238991|526552294|FG002|Overall Study|Withdrawal by Subject|1|||
146010811|NCT01238991|526552295|FG003|Overall Study|Withdrawal by Subject|0|||
146010812|NCT01238991|526552296|FG004|Overall Study|Withdrawal by Subject|0|||
146010813|NCT01238991|526552297|FG005|Overall Study|Withdrawal by Subject|0|||
146010814|NCT01238991|526552298|FG006|Overall Study|Withdrawal by Subject|0|||
146010815|NCT01238991|526552299|FG007|Overall Study|Withdrawal by Subject|0|||
146010816|NCT01238991|526552300|FG008|Overall Study|Withdrawal by Subject|0|||
146010817|NCT01238991|526552301|FG009|Overall Study|Withdrawal by Subject|0|||
146010818|NCT01238991|526552292|FG000|Overall Study|Study Terminated by Sponsor|0|||
146010819|NCT01238991|526552293|FG001|Overall Study|Study Terminated by Sponsor|0|||
146010820|NCT01238991|526552294|FG002|Overall Study|Study Terminated by Sponsor|0|||
146010821|NCT01238991|526552295|FG003|Overall Study|Study Terminated by Sponsor|0|||
146010822|NCT01238991|526552296|FG004|Overall Study|Study Terminated by Sponsor|1|||
146010823|NCT01238991|526552297|FG005|Overall Study|Study Terminated by Sponsor|0|||
146010824|NCT01238991|526552298|FG006|Overall Study|Study Terminated by Sponsor|7|||
146010825|NCT01238991|526552299|FG007|Overall Study|Study Terminated by Sponsor|4|||
146010826|NCT01238991|526552300|FG008|Overall Study|Study Terminated by Sponsor|2|||
146010827|NCT01238991|526552301|FG009|Overall Study|Study Terminated by Sponsor|2|||
146010828|NCT01238991|526552292|FG000|Overall Study|Caregiver's request|0|||
146010829|NCT01238991|526552293|FG001|Overall Study|Caregiver's request|0|||
146010830|NCT01238991|526552294|FG002|Overall Study|Caregiver's request|0|||
146010831|NCT01238991|526552295|FG003|Overall Study|Caregiver's request|0|||
146010832|NCT01238991|526552296|FG004|Overall Study|Caregiver's request|0|||
146010833|NCT01238991|526552297|FG005|Overall Study|Caregiver's request|0|||
146010834|NCT01238991|526552298|FG006|Overall Study|Caregiver's request|0|||
146010835|NCT01238991|526552299|FG007|Overall Study|Caregiver's request|0|||
146010836|NCT01238991|526552300|FG008|Overall Study|Caregiver's request|1|||
146010837|NCT01238991|526552301|FG009|Overall Study|Caregiver's request|0|||
146010838|NCT01238991|526552292|FG000|Overall Study|Admission to a nursing home|1|||
146010839|NCT01238991|526552293|FG001|Overall Study|Admission to a nursing home|0|||
146010840|NCT01238991|526552294|FG002|Overall Study|Admission to a nursing home|1|||
146010841|NCT01238991|526552295|FG003|Overall Study|Admission to a nursing home|0|||
146010842|NCT01238991|526552296|FG004|Overall Study|Admission to a nursing home|0|||
146010843|NCT01238991|526552297|FG005|Overall Study|Admission to a nursing home|0|||
146010844|NCT01238991|526552298|FG006|Overall Study|Admission to a nursing home|0|||
146010845|NCT01238991|526552299|FG007|Overall Study|Admission to a nursing home|0|||
146010846|NCT01238991|526552300|FG008|Overall Study|Admission to a nursing home|0|||
146010847|NCT01238991|526552301|FG009|Overall Study|Admission to a nursing home|0|||
146010848|NCT02222688|526552305|FG000|Overall Study|Withdrawal by Subject|0|||
146010849|NCT02222688|526552306|FG001|Overall Study|Withdrawal by Subject|0|||
146010850|NCT02222688|526552307|FG002|Overall Study|Withdrawal by Subject|0|||
146010851|NCT02222688|526552308|FG003|Overall Study|Withdrawal by Subject|2|||
146010852|NCT02222688|526552309|FG004|Overall Study|Withdrawal by Subject|1|||
146010853|NCT02222688|526552310|FG005|Overall Study|Withdrawal by Subject|0|||
146010854|NCT02222688|526552311|FG006|Overall Study|Withdrawal by Subject|1|||
146010855|NCT02222688|526552305|FG000|Overall Study|Disease progression|1|||
146010856|NCT02222688|526552306|FG001|Overall Study|Disease progression|0|||
146010857|NCT02222688|526552307|FG002|Overall Study|Disease progression|0|||
146010858|NCT02222688|526552308|FG003|Overall Study|Disease progression|0|||
146010859|NCT02222688|526552309|FG004|Overall Study|Disease progression|0|||
146010860|NCT02222688|526552310|FG005|Overall Study|Disease progression|0|||
146010861|NCT02222688|526552311|FG006|Overall Study|Disease progression|0|||
146010862|NCT03037476|526552321|FG000|Overall Study|Lost to Follow-up|63|||
146010863|NCT03037476|526552322|FG001|Overall Study|Lost to Follow-up|46|||
146010864|NCT02141633|526552323|FG000|Overall Study|Physician Decision|1|||
146010865|NCT02141633|526552324|FG001|Overall Study|Physician Decision|0|||
146249986|NCT02367794|527426850|FG002|Overall Study|Lost to Follow-up|2|||
146010866|NCT03053440|526552327|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
146010867|NCT03053440|526552328|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
146010868|NCT03053440|526552327|FG000|Overall Study|Death|18|||
146093101|NCT00586066|526861748|FG001|Overall Study|Lack of Efficacy|3|||
146093102|NCT00586066|526861747|FG000|Overall Study|Adverse Event|2|||
146093103|NCT00586066|526861748|FG001|Overall Study|Adverse Event|2|||
146010869|NCT03053440|526552328|FG001|Overall Study|Death|14|||
146010870|NCT03053440|526552327|FG000|Overall Study|Withdrawal by Subject|9|||
146010871|NCT03053440|526552328|FG001|Overall Study|Withdrawal by Subject|8|||
146010872|NCT03053440|526552327|FG000|Overall Study|Lost to Follow-up|1|||
146010873|NCT03053440|526552328|FG001|Overall Study|Lost to Follow-up|0|||
146010874|NCT03053440|526552327|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
146010875|NCT03053440|526552328|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
146010876|NCT03053440|526552327|FG000|Overall Study|Physician Decision|2|||
146010877|NCT03053440|526552328|FG001|Overall Study|Physician Decision|1|||
146010878|NCT03053440|526552327|FG000|Overall Study|Participant Randomized but died before dosing|1|||
146249987|NCT02367794|527426848|FG000|Overall Study|Physician Decision|0|||
146249988|NCT02367794|527426849|FG001|Overall Study|Physician Decision|5|||
146249989|NCT02367794|527426850|FG002|Overall Study|Physician Decision|3|||
146249990|NCT02367794|527426848|FG000|Overall Study|Protocol Violation|1|||
146249991|NCT02367794|527426849|FG001|Overall Study|Protocol Violation|0|||
146249992|NCT02367794|527426850|FG002|Overall Study|Protocol Violation|1|||
146249993|NCT02367794|527426848|FG000|Overall Study|Withdrawal by Subject|25|||
146249994|NCT02367794|527426849|FG001|Overall Study|Withdrawal by Subject|12|||
146249995|NCT02367794|527426850|FG002|Overall Study|Withdrawal by Subject|20|||
146249996|NCT02367794|527426848|FG000|Overall Study|Brain metastasis|1|||
146249997|NCT02367794|527426849|FG001|Overall Study|Brain metastasis|0|||
146249998|NCT02367794|527426850|FG002|Overall Study|Brain metastasis|0|||
146249999|NCT02367794|527426848|FG000|Overall Study|Randomized in error|0|||
146250000|NCT02367794|527426849|FG001|Overall Study|Randomized in error|0|||
146250001|NCT02367794|527426850|FG002|Overall Study|Randomized in error|1|||
146250002|NCT02367794|527426848|FG000|Overall Study|Patient unable to receive carboplatin|0|||
146250003|NCT02367794|527426849|FG001|Overall Study|Patient unable to receive carboplatin|0|||
146250004|NCT02367794|527426850|FG002|Overall Study|Patient unable to receive carboplatin|1|||
146250005|NCT02367794|527426848|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
146250006|NCT02367794|527426849|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
146250007|NCT02367794|527426850|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
146250008|NCT02367794|527426848|FG000|Overall Study|Adverse Event|0|||
146250009|NCT02367794|527426849|FG001|Overall Study|Adverse Event|0|||
146250010|NCT02367794|527426850|FG002|Overall Study|Adverse Event|2|||
146250011|NCT02367794|527426848|FG000|Overall Study|Study Terminated By Sponsor|0|||
146250012|NCT02367794|527426849|FG001|Overall Study|Study Terminated By Sponsor|1|||
146010879|NCT03053440|526552328|FG001|Overall Study|Participant Randomized but died before dosing|0|||
146010880|NCT01188551|526552329|FG000|Overall Study|Pharmacy issues|1|||
146010881|NCT01188551|526552330|FG001|Overall Study|Pharmacy issues|0|||
146010882|NCT01188551|526552331|FG002|Overall Study|Pharmacy issues|0|||
146010883|NCT01188551|526552332|FG003|Overall Study|Pharmacy issues|0|||
146010884|NCT00391053|526552333|FG000|Overall Study|Serious Adverse Events|1|||
146010885|NCT00391053|526552334|FG001|Overall Study|Serious Adverse Events|0|||
146010886|NCT00391053|526552335|FG002|Overall Study|Serious Adverse Events|1|||
146010887|NCT00391053|526552336|FG003|Overall Study|Serious Adverse Events|4|||
146010888|NCT00391053|526552333|FG000|Overall Study|Protocol Violation|2|||
146010889|NCT00391053|526552334|FG001|Overall Study|Protocol Violation|0|||
146010890|NCT00391053|526552335|FG002|Overall Study|Protocol Violation|0|||
146010891|NCT00391053|526552336|FG003|Overall Study|Protocol Violation|0|||
146010892|NCT00391053|526552333|FG000|Overall Study|Lost to Follow-up|1|||
146010893|NCT00391053|526552334|FG001|Overall Study|Lost to Follow-up|0|||
146010894|NCT00391053|526552335|FG002|Overall Study|Lost to Follow-up|0|||
146010895|NCT00391053|526552336|FG003|Overall Study|Lost to Follow-up|5|||
146010896|NCT00391053|526552333|FG000|Overall Study|Withdrawal by Subject|5|||
146010897|NCT00391053|526552334|FG001|Overall Study|Withdrawal by Subject|1|||
146010898|NCT00391053|526552335|FG002|Overall Study|Withdrawal by Subject|1|||
146010899|NCT00391053|526552336|FG003|Overall Study|Withdrawal by Subject|1|||
146010900|NCT00473889|526552338|FG000|Overall Study|Did not receive study medication|1|||
146010901|NCT00473889|526552339|FG001|Overall Study|Did not receive study medication|4|||
146010902|NCT00473889|526552338|FG000|Overall Study|Adverse Event|30|||
146010903|NCT00473889|526552339|FG001|Overall Study|Adverse Event|17|||
146010904|NCT00473889|526552338|FG000|Overall Study|Protocol Violation|4|||
146010905|NCT00473889|526552339|FG001|Overall Study|Protocol Violation|2|||
146010906|NCT00473889|526552338|FG000|Overall Study|Lack of Efficacy|28|||
146010907|NCT00473889|526552339|FG001|Overall Study|Lack of Efficacy|29|||
146010908|NCT00473889|526552338|FG000|Overall Study|Lost to Follow-up|2|||
146010909|NCT00473889|526552339|FG001|Overall Study|Lost to Follow-up|1|||
146010910|NCT00473889|526552338|FG000|Overall Study|Physician Decision|10|||
146010911|NCT00473889|526552339|FG001|Overall Study|Physician Decision|5|||
146010912|NCT00473889|526552338|FG000|Overall Study|Trial Terminated|3|||
146010913|NCT00473889|526552339|FG001|Overall Study|Trial Terminated|6|||
146010914|NCT00473889|526552338|FG000|Overall Study|Withdrawal by Subject|5|||
146010915|NCT00473889|526552339|FG001|Overall Study|Withdrawal by Subject|0|||
146010916|NCT02140970|526552340|FG000|Overall Study|Lost to Follow-up|1|||
146010917|NCT02140970|526552341|FG001|Overall Study|Lost to Follow-up|2|||
146010918|NCT02140970|526552340|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
146010919|NCT02140970|526552341|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
146010920|NCT02140970|526552340|FG000|Overall Study|Did not meet inclusion criteria|0|||
146010921|NCT02140970|526552341|FG001|Overall Study|Did not meet inclusion criteria|1|||
146010922|NCT01947283|526552342|FG000|Overall Study|Death|1|||
146010923|NCT01947283|526552343|FG001|Overall Study|Death|1|||
146010924|NCT01947283|526552344|FG002|Overall Study|Death|1|||
146010925|NCT01947283|526552345|FG003|Overall Study|Death|0|||
146010926|NCT01947283|526552346|FG004|Overall Study|Death|0|||
146250013|NCT02367794|527426850|FG002|Overall Study|Study Terminated By Sponsor|1|||
146250014|NCT02367794|527426848|FG000|Overall Study|Moved to Roll-Over Study|0|||
146250015|NCT02367794|527426849|FG001|Overall Study|Moved to Roll-Over Study|15|||
146250016|NCT02367794|527426850|FG002|Overall Study|Moved to Roll-Over Study|13|||
146250017|NCT02367794|527426848|FG000|Overall Study|Sponsor Request|60|||
146010927|NCT01947283|526552347|FG005|Overall Study|Death|0|||
146010928|NCT01947283|526552348|FG006|Overall Study|Death|0|||
146010929|NCT01947283|526552342|FG000|Overall Study|Lost to Follow-up|4|||
146010930|NCT01947283|526552343|FG001|Overall Study|Lost to Follow-up|6|||
146010931|NCT01947283|526552344|FG002|Overall Study|Lost to Follow-up|5|||
146010932|NCT01947283|526552345|FG003|Overall Study|Lost to Follow-up|5|||
146010933|NCT01947283|526552346|FG004|Overall Study|Lost to Follow-up|0|||
146010934|NCT01947283|526552347|FG005|Overall Study|Lost to Follow-up|2|||
146010935|NCT01947283|526552348|FG006|Overall Study|Lost to Follow-up|5|||
146010936|NCT01947283|526552342|FG000|Overall Study|Withdrawal by Subject|10|||
146010937|NCT01947283|526552343|FG001|Overall Study|Withdrawal by Subject|8|||
146010938|NCT01947283|526552344|FG002|Overall Study|Withdrawal by Subject|4|||
146010939|NCT01947283|526552345|FG003|Overall Study|Withdrawal by Subject|1|||
146010940|NCT01947283|526552346|FG004|Overall Study|Withdrawal by Subject|0|||
146010941|NCT01947283|526552347|FG005|Overall Study|Withdrawal by Subject|0|||
146010942|NCT01947283|526552348|FG006|Overall Study|Withdrawal by Subject|2|||
146010943|NCT01947283|526552342|FG000|Overall Study|No Clinical Recording|12|||
146010944|NCT01947283|526552343|FG001|Overall Study|No Clinical Recording|6|||
146010945|NCT01947283|526552344|FG002|Overall Study|No Clinical Recording|8|||
146010946|NCT01947283|526552345|FG003|Overall Study|No Clinical Recording|10|||
146010947|NCT01947283|526552346|FG004|Overall Study|No Clinical Recording|0|||
146010948|NCT01947283|526552347|FG005|Overall Study|No Clinical Recording|0|||
146010949|NCT01947283|526552348|FG006|Overall Study|No Clinical Recording|0|||
146010950|NCT01947283|526552342|FG000|Overall Study|Non-coding Clinical Recording language|0|||
146010951|NCT01947283|526552343|FG001|Overall Study|Non-coding Clinical Recording language|0|||
146010952|NCT01947283|526552344|FG002|Overall Study|Non-coding Clinical Recording language|0|||
146010953|NCT01947283|526552345|FG003|Overall Study|Non-coding Clinical Recording language|1|||
146010954|NCT01947283|526552346|FG004|Overall Study|Non-coding Clinical Recording language|0|||
146010955|NCT01947283|526552347|FG005|Overall Study|Non-coding Clinical Recording language|0|||
146010956|NCT01947283|526552348|FG006|Overall Study|Non-coding Clinical Recording language|0|||
146010957|NCT01947283|526552342|FG000|Overall Study|Missing Follow-up Assessment|2|||
146010958|NCT01947283|526552343|FG001|Overall Study|Missing Follow-up Assessment|2|||
146010959|NCT01947283|526552344|FG002|Overall Study|Missing Follow-up Assessment|3|||
146010960|NCT01947283|526552345|FG003|Overall Study|Missing Follow-up Assessment|0|||
146010961|NCT01947283|526552346|FG004|Overall Study|Missing Follow-up Assessment|0|||
146010962|NCT01947283|526552347|FG005|Overall Study|Missing Follow-up Assessment|2|||
146010963|NCT01947283|526552348|FG006|Overall Study|Missing Follow-up Assessment|0|||
146010964|NCT01947283|526552342|FG000|Overall Study|No patients were enrolled in study|0|||
146010965|NCT01947283|526552343|FG001|Overall Study|No patients were enrolled in study|0|||
146010966|NCT01947283|526552344|FG002|Overall Study|No patients were enrolled in study|0|||
146010967|NCT01947283|526552345|FG003|Overall Study|No patients were enrolled in study|0|||
146010968|NCT01947283|526552346|FG004|Overall Study|No patients were enrolled in study|0|||
146010969|NCT01947283|526552347|FG005|Overall Study|No patients were enrolled in study|3|||
146010970|NCT01947283|526552348|FG006|Overall Study|No patients were enrolled in study|1|||
146010971|NCT00430989|526552349|FG000|Overall Study|Lost to Follow-up|2|||
146010972|NCT00430989|526552350|FG001|Overall Study|Lost to Follow-up|3|||
146010973|NCT00430989|526552349|FG000|Overall Study|Withdrawal by Subject|15|||
146010974|NCT00430989|526552350|FG001|Overall Study|Withdrawal by Subject|14|||
146010975|NCT00430989|526552349|FG000|Overall Study|Protocol Violation|30|||
146010976|NCT00430989|526552350|FG001|Overall Study|Protocol Violation|37|||
146250018|NCT02367794|527426849|FG001|Overall Study|Sponsor Request|57|||
146010977|NCT00430989|526552349|FG000|Overall Study|Not eligible|13|||
146010978|NCT00430989|526552350|FG001|Overall Study|Not eligible|6|||
146010979|NCT03782259|526552351|FG000|Overall Study|Lost to Follow-up|1|||
146010980|NCT03782259|526552352|FG001|Overall Study|Lost to Follow-up|1|||
146010981|NCT03782259|526552351|FG000|Overall Study|Moved out of state|0|||
146010982|NCT03782259|526552352|FG001|Overall Study|Moved out of state|2|||
146010983|NCT03782259|526552351|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
146010984|NCT03782259|526552352|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
146010985|NCT03782259|526552351|FG000|Overall Study|Subject discontinued intervention|1|||
146010986|NCT03782259|526552352|FG001|Overall Study|Subject discontinued intervention|0|||
146010987|NCT05069597|526552353|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146010988|NCT05069597|526552354|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146010989|NCT01014767|526552355|FG000|Overall Study|PI left institution, data unavailable|12|||
146010990|NCT01014767|526552356|FG001|Overall Study|PI left institution, data unavailable|1|||
146010991|NCT01014767|526552357|FG002|Overall Study|PI left institution, data unavailable|4|||
146010992|NCT01014767|526552358|FG003|Overall Study|PI left institution, data unavailable|1|||
146010993|NCT02553928|526552362|FG000|Overall Study|Adverse Event|2|||
146010994|NCT02553928|526552363|FG001|Overall Study|Adverse Event|1|||
146010995|NCT02553928|526552362|FG000|Overall Study|Lost to Follow-up|0|||
146250019|NCT02367794|527426850|FG002|Overall Study|Sponsor Request|45|||
146250020|NCT02367794|527426848|FG000|Overall Study|Moved into PTAP Study|0|||
146250021|NCT02367794|527426849|FG001|Overall Study|Moved into PTAP Study|2|||
146093104|NCT00586066|526861747|FG000|Overall Study|Physician Decision|1|||
146010996|NCT02553928|526552363|FG001|Overall Study|Lost to Follow-up|1|||
146010997|NCT02553928|526552362|FG000|Overall Study|Administrative reason(s)|0|||
146010998|NCT02553928|526552363|FG001|Overall Study|Administrative reason(s)|1|||
146010999|NCT00131352|526552364|FG000|Initial Treatment Period|Adverse Event|1|||
146011000|NCT00131352|526552365|FG001|Initial Treatment Period|Adverse Event|3|||
146011001|NCT00131352|526552364|FG000|Initial Treatment Period|Non-compliant|1|||
146011002|NCT00131352|526552365|FG001|Initial Treatment Period|Non-compliant|2|||
146011003|NCT00131352|526552364|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
146011004|NCT00131352|526552365|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
146011005|NCT00131352|526552364|FG000|Initial Treatment Period|Lack of Efficacy|6|||
146011006|NCT00131352|526552365|FG001|Initial Treatment Period|Lack of Efficacy|4|||
146011007|NCT00131352|526552364|FG000|Initial Treatment Period|Other|0|||
146011008|NCT00131352|526552365|FG001|Initial Treatment Period|Other|2|||
146011009|NCT00131352|526552364|FG000|Repeat Treatment Period|Adverse Event|1|||
146011010|NCT00131352|526552365|FG001|Repeat Treatment Period|Adverse Event|0|||
146011011|NCT00131352|526552364|FG000|Repeat Treatment Period|Other|1|||
146011012|NCT00131352|526552365|FG001|Repeat Treatment Period|Other|0|||
146011013|NCT02526212|526552368|FG000|Overall Study|Incarceration|1|||
146011014|NCT02526212|526552369|FG001|Overall Study|Incarceration|0|||
146011015|NCT02526212|526552368|FG000|Overall Study|Lost to Follow-up|1|||
146011016|NCT02526212|526552369|FG001|Overall Study|Lost to Follow-up|0|||
146011017|NCT02526212|526552368|FG000|Overall Study|Death|0|||
146011018|NCT02526212|526552369|FG001|Overall Study|Death|1|||
146011019|NCT02443337|526552370|FG000|Overall Study|Adverse Event|0|||
146011020|NCT02443337|526552371|FG001|Overall Study|Adverse Event|1|||
146011021|NCT02443337|526552370|FG000|Overall Study|Clinical Progressive Disease|3|||
146011022|NCT02443337|526552371|FG001|Overall Study|Clinical Progressive Disease|0|||
146011023|NCT02443337|526552370|FG000|Overall Study|Withdrawal by Subject|2|||
146011024|NCT02443337|526552371|FG001|Overall Study|Withdrawal by Subject|1|||
146011025|NCT02096952|526552372|FG000|Overall Study|Adverse Event|1|||
146011026|NCT00040742|526552373|FG000|Overall Study|Death|0|||
146011027|NCT00040742|526552374|FG001|Overall Study|Death|0|||
146011028|NCT00040742|526552375|FG002|Overall Study|Death|1|||
146011029|NCT00040742|526552376|FG003|Overall Study|Death|0|||
146011030|NCT00040742|526552373|FG000|Overall Study|Adverse Event|15|||
146011031|NCT00040742|526552374|FG001|Overall Study|Adverse Event|16|||
146011032|NCT00040742|526552375|FG002|Overall Study|Adverse Event|21|||
146011033|NCT00040742|526552376|FG003|Overall Study|Adverse Event|9|||
146011034|NCT00040742|526552373|FG000|Overall Study|Withdrawal by Subject|7|||
146011035|NCT00040742|526552374|FG001|Overall Study|Withdrawal by Subject|15|||
146011036|NCT00040742|526552375|FG002|Overall Study|Withdrawal by Subject|10|||
146011037|NCT00040742|526552376|FG003|Overall Study|Withdrawal by Subject|13|||
146011038|NCT00040742|526552373|FG000|Overall Study|Chemotoxicity|4|||
146011039|NCT00040742|526552374|FG001|Overall Study|Chemotoxicity|3|||
146011040|NCT00040742|526552375|FG002|Overall Study|Chemotoxicity|5|||
146011041|NCT00040742|526552376|FG003|Overall Study|Chemotoxicity|2|||
146011042|NCT00040742|526552373|FG000|Overall Study|Incomplete Forms|6|||
146011043|NCT00040742|526552374|FG001|Overall Study|Incomplete Forms|10|||
146011044|NCT00040742|526552375|FG002|Overall Study|Incomplete Forms|4|||
146011045|NCT00040742|526552376|FG003|Overall Study|Incomplete Forms|5|||
146011046|NCT00040742|526552373|FG000|Overall Study|Other medical|7|||
146011047|NCT00040742|526552374|FG001|Overall Study|Other medical|5|||
146011048|NCT00040742|526552375|FG002|Overall Study|Other medical|5|||
146011049|NCT00040742|526552376|FG003|Overall Study|Other medical|5|||
146011050|NCT00988052|526552386|FG000|Overall Study|Missing|1|||
146011051|NCT00988052|526552387|FG001|Overall Study|Missing|0|||
146011052|NCT00988052|526552386|FG000|Overall Study|Teva requested subject withdrawal|3|||
146011053|NCT00988052|526552387|FG001|Overall Study|Teva requested subject withdrawal|1|||
146011054|NCT00988052|526552386|FG000|Overall Study|Death|1|||
146011055|NCT00988052|526552387|FG001|Overall Study|Death|3|||
146011056|NCT00988052|526552386|FG000|Overall Study|Protocol Violation|6|||
146011057|NCT00988052|526552387|FG001|Overall Study|Protocol Violation|5|||
146011058|NCT00988052|526552386|FG000|Overall Study|Pregnancy|6|||
146011059|NCT00988052|526552387|FG001|Overall Study|Pregnancy|6|||
146011060|NCT00988052|526552386|FG000|Overall Study|Lack of Efficacy|8|||
146011061|NCT00988052|526552387|FG001|Overall Study|Lack of Efficacy|7|||
146011062|NCT00988052|526552386|FG000|Overall Study|Lost to Follow-up|6|||
146011063|NCT00988052|526552387|FG001|Overall Study|Lost to Follow-up|11|||
146011064|NCT00988052|526552386|FG000|Overall Study|Physician Decision|27|||
146011065|NCT00988052|526552387|FG001|Overall Study|Physician Decision|28|||
146011066|NCT00988052|526552386|FG000|Overall Study|Adverse Event|35|||
146011067|NCT00988052|526552387|FG001|Overall Study|Adverse Event|28|||
146011068|NCT00988052|526552386|FG000|Overall Study|Withdrawal by Subject|90|||
146011069|NCT00988052|526552387|FG001|Overall Study|Withdrawal by Subject|91|||
146011070|NCT00988052|526552386|FG000|Overall Study|Study terminated by sponsor|240|||
146011071|NCT00988052|526552387|FG001|Overall Study|Study terminated by sponsor|236|||
146011072|NCT01434654|526552388|FG000|Overall Study|Withdrawal by Subject|1|||
146011073|NCT01434654|526552389|FG001|Overall Study|Withdrawal by Subject|0|||
146011074|NCT01434654|526552388|FG000|Overall Study|Lost to Follow-up|1|||
146011075|NCT01434654|526552389|FG001|Overall Study|Lost to Follow-up|0|||
146011076|NCT00645840|526552391|FG000|Overall Study|Protocol Violation|3|||
146011077|NCT00402324|526552392|FG000|Overall Study|Lost to Follow-up|11|||
146011078|NCT00402324|526552393|FG001|Overall Study|Lost to Follow-up|11|||
146011079|NCT00402324|526552392|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
146011080|NCT00402324|526552393|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
146011081|NCT00402324|526552392|FG000|Overall Study|Protocol Violation|8|||
146011082|NCT00402324|526552393|FG001|Overall Study|Protocol Violation|7|||
146011083|NCT00402324|526552392|FG000|Overall Study|Withdrawal by Subject|5|||
146011084|NCT00402324|526552393|FG001|Overall Study|Withdrawal by Subject|2|||
146011085|NCT00402324|526552392|FG000|Overall Study|Physician Decision|2|||
146011086|NCT00402324|526552393|FG001|Overall Study|Physician Decision|4|||
146011087|NCT00402324|526552392|FG000|Overall Study|Sponsor Decision|4|||
146011088|NCT00402324|526552393|FG001|Overall Study|Sponsor Decision|5|||
146011089|NCT00402324|526552392|FG000|Overall Study|Lack of Efficacy|1|||
146011090|NCT00402324|526552393|FG001|Overall Study|Lack of Efficacy|4|||
146011091|NCT00402324|526552392|FG000|Overall Study|Adverse Event|6|||
146011092|NCT00402324|526552393|FG001|Overall Study|Adverse Event|4|||
146011093|NCT00402324|526552392|FG000|Overall Study|Death|1|||
146011094|NCT00402324|526552393|FG001|Overall Study|Death|0|||
146011095|NCT01823198|526552394|FG000|Overall Study|Physician Decision|0|||
146011096|NCT01823198|526552395|FG001|Overall Study|Physician Decision|1|||
146011097|NCT01823198|526552396|FG002|Overall Study|Physician Decision|0|||
146011098|NCT01823198|526552397|FG003|Overall Study|Physician Decision|0|||
146011099|NCT01823198|526552398|FG004|Overall Study|Physician Decision|0|||
146011100|NCT01823198|526552399|FG005|Overall Study|Physician Decision|3|||
146011101|NCT01823198|526552400|FG006|Overall Study|Physician Decision|3|||
146011102|NCT01119066|526552401|FG000|Overall Study|Withdrawal by Subject|4|||
146011103|NCT01119066|526552402|FG001|Overall Study|Withdrawal by Subject|6|||
146011104|NCT01119066|526552403|FG002|Overall Study|Withdrawal by Subject|0|||
146011105|NCT01119066|526552404|FG003|Overall Study|Withdrawal by Subject|0|||
146011106|NCT01119066|526552401|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
146011107|NCT01119066|526552402|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
146011108|NCT01119066|526552403|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
146011109|NCT01119066|526552404|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
146011110|NCT01119066|526552401|FG000|Overall Study|Relapse identified before transplant|1|||
146011111|NCT01119066|526552402|FG001|Overall Study|Relapse identified before transplant|0|||
146011112|NCT01119066|526552403|FG002|Overall Study|Relapse identified before transplant|0|||
146011113|NCT01119066|526552404|FG003|Overall Study|Relapse identified before transplant|0|||
146011114|NCT01119066|526552401|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146011115|NCT01119066|526552402|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
146011116|NCT01119066|526552403|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146011117|NCT01119066|526552404|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
146011118|NCT01119066|526552401|FG000|Overall Study|Relapse identified before transplant|0|||
146011119|NCT01119066|526552402|FG001|Overall Study|Relapse identified before transplant|4|||
146011120|NCT01119066|526552403|FG002|Overall Study|Relapse identified before transplant|0|||
146011121|NCT01119066|526552404|FG003|Overall Study|Relapse identified before transplant|0|||
146011122|NCT02441101|526552405|FG000|Overall Study|Withdrawal by Subject|1|||
146011123|NCT02441101|526552406|FG001|Overall Study|Withdrawal by Subject|0|||
146011124|NCT02441101|526552405|FG000|Overall Study|Lost to Follow-up|1|||
146011125|NCT02441101|526552406|FG001|Overall Study|Lost to Follow-up|0|||
146011126|NCT02441101|526552405|FG000|Overall Study|PI relocated and study terminated|1|||
146011127|NCT02441101|526552406|FG001|Overall Study|PI relocated and study terminated|0|||
146011128|NCT03012828|526552407|FG000|Overall Study|Lost to Follow-up|1|||
146011129|NCT03012828|526552408|FG001|Overall Study|Lost to Follow-up|0|||
146011130|NCT03012828|526552409|FG002|Overall Study|Lost to Follow-up|1|||
146011131|NCT03012828|526552410|FG003|Overall Study|Lost to Follow-up|0|||
146011132|NCT03012828|526552411|FG004|Overall Study|Lost to Follow-up|1|||
146011133|NCT03012828|526552412|FG005|Overall Study|Lost to Follow-up|0|||
146011134|NCT03012828|526552407|FG000|Overall Study|Withdrawal by Subject|0|||
146011135|NCT03012828|526552408|FG001|Overall Study|Withdrawal by Subject|0|||
146011136|NCT03012828|526552409|FG002|Overall Study|Withdrawal by Subject|1|||
146011137|NCT03012828|526552410|FG003|Overall Study|Withdrawal by Subject|0|||
146250022|NCT02367794|527426850|FG002|Overall Study|Moved into PTAP Study|3|||
146011138|NCT03012828|526552411|FG004|Overall Study|Withdrawal by Subject|0|||
146011139|NCT03012828|526552412|FG005|Overall Study|Withdrawal by Subject|1|||
146011140|NCT03012828|526552407|FG000|Overall Study|Non-compliance with protocol|0|||
146011141|NCT03012828|526552408|FG001|Overall Study|Non-compliance with protocol|0|||
146011142|NCT03012828|526552409|FG002|Overall Study|Non-compliance with protocol|0|||
146011143|NCT03012828|526552410|FG003|Overall Study|Non-compliance with protocol|0|||
146011144|NCT03012828|526552411|FG004|Overall Study|Non-compliance with protocol|1|||
146250023|NCT02367794|527426848|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
146011145|NCT03012828|526552412|FG005|Overall Study|Non-compliance with protocol|0|||
146011146|NCT03012828|526552407|FG000|Overall Study|Delay to last visit would delay DBL|0|||
146011147|NCT03012828|526552408|FG001|Overall Study|Delay to last visit would delay DBL|0|||
146011148|NCT03012828|526552409|FG002|Overall Study|Delay to last visit would delay DBL|0|||
146011149|NCT03012828|526552410|FG003|Overall Study|Delay to last visit would delay DBL|0|||
146011150|NCT03012828|526552411|FG004|Overall Study|Delay to last visit would delay DBL|0|||
146011151|NCT03012828|526552412|FG005|Overall Study|Delay to last visit would delay DBL|1|||
146011152|NCT01509846|526552413|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
146011153|NCT01509846|526552414|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146011154|NCT01509846|526552415|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
146011155|NCT01509846|526552416|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
146011156|NCT01509846|526552417|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
146011157|NCT01509846|526552413|FG000|Received Vaccination 2|Illness|0|||
146011158|NCT01509846|526552414|FG001|Received Vaccination 2|Illness|0|||
146011159|NCT01509846|526552415|FG002|Received Vaccination 2|Illness|0|||
146011160|NCT01509846|526552416|FG003|Received Vaccination 2|Illness|0|||
146011161|NCT01509846|526552417|FG004|Received Vaccination 2|Illness|1|||
146011162|NCT01509846|526552413|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
146011163|NCT01509846|526552414|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
146011164|NCT01509846|526552415|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
146011165|NCT01509846|526552416|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
146011166|NCT01509846|526552417|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
146011167|NCT01509846|526552413|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
146011168|NCT01509846|526552414|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
146011169|NCT01509846|526552415|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
146011170|NCT01509846|526552416|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
146011171|NCT01509846|526552417|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
146011172|NCT01509846|526552413|FG000|Received Vaccination 3|Pregnancy|0|||
146011173|NCT01509846|526552414|FG001|Received Vaccination 3|Pregnancy|0|||
146011174|NCT01509846|526552415|FG002|Received Vaccination 3|Pregnancy|0|||
146011175|NCT01509846|526552416|FG003|Received Vaccination 3|Pregnancy|1|||
146011176|NCT01509846|526552417|FG004|Received Vaccination 3|Pregnancy|0|||
146011177|NCT01509846|526552413|FG000|Received Vaccination 3|Lost to Follow-up|0|||
146011178|NCT01509846|526552414|FG001|Received Vaccination 3|Lost to Follow-up|0|||
146011179|NCT01509846|526552415|FG002|Received Vaccination 3|Lost to Follow-up|1|||
146011180|NCT01509846|526552416|FG003|Received Vaccination 3|Lost to Follow-up|0|||
146011181|NCT01509846|526552417|FG004|Received Vaccination 3|Lost to Follow-up|0|||
146011182|NCT03900728|526552418|FG000|Overall Study|No text responses|0|||
146011183|NCT03900728|526552419|FG001|Overall Study|No text responses|0|||
146011184|NCT03900728|526552420|FG002|Overall Study|No text responses|4|||
146011185|NCT02544750|526552422|FG000|Overall Study|Physician Decision|3|||
146011186|NCT02544750|526552423|FG001|Overall Study|Physician Decision|1|||
146011187|NCT02544750|526552422|FG000|Overall Study|Other reasons|69|||
146011188|NCT02544750|526552423|FG001|Overall Study|Other reasons|39|||
146011189|NCT02544750|526552422|FG000|Overall Study|Met withdrawal criteria|2|||
146011190|NCT02544750|526552423|FG001|Overall Study|Met withdrawal criteria|2|||
146011191|NCT02544750|526552422|FG000|Overall Study|Transition To Commercial Product|1|||
146011192|NCT02544750|526552423|FG001|Overall Study|Transition To Commercial Product|0|||
146011193|NCT02544750|526552422|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
146011194|NCT02544750|526552423|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
146011195|NCT02544750|526552422|FG000|Overall Study|Adverse Event|8|||
146011196|NCT02544750|526552423|FG001|Overall Study|Adverse Event|10|||
146011197|NCT02544750|526552422|FG000|Overall Study|Withdrawal by Subject|10|||
146011198|NCT02544750|526552423|FG001|Overall Study|Withdrawal by Subject|4|||
146011199|NCT02544750|526552422|FG000|Overall Study|Lost to Follow-up|1|||
146011200|NCT02544750|526552423|FG001|Overall Study|Lost to Follow-up|0|||
146011201|NCT02484443|526552426|FG000|Overall Study|Lack of Efficacy|28|||
146011202|NCT02484443|526552426|FG000|Overall Study|Physician Decision|2|||
146011203|NCT02484443|526552426|FG000|Overall Study|Ineligible|2|||
146011204|NCT02969915|526552427|FG000|Overall Study|Death|104|||
146011205|NCT02969915|526552428|FG001|Overall Study|Death|125|||
146011206|NCT02969915|526552427|FG000|Overall Study|Lost to Follow-up|108|||
146011207|NCT02969915|526552428|FG001|Overall Study|Lost to Follow-up|112|||
146011208|NCT02969915|526552427|FG000|Overall Study|Censored due to COVID-19|481|||
146011209|NCT02969915|526552428|FG001|Overall Study|Censored due to COVID-19|471|||
146011210|NCT02595866|526552429|FG000|Overall Study|Adverse Event|2|||
146011211|NCT02595866|526552430|FG001|Overall Study|Adverse Event|5|||
146011212|NCT02595866|526552429|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
146011213|NCT02595866|526552430|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
146011214|NCT02595866|526552429|FG000|Overall Study|Death|0|||
146011215|NCT02595866|526552430|FG001|Overall Study|Death|1|||
146011216|NCT02595866|526552429|FG000|Overall Study|Incarceration|1|||
146011217|NCT02595866|526552430|FG001|Overall Study|Incarceration|0|||
146011218|NCT02595866|526552429|FG000|Overall Study|Lack of Efficacy|17|||
146011219|NCT02595866|526552430|FG001|Overall Study|Lack of Efficacy|7|||
146011220|NCT02595866|526552429|FG000|Overall Study|Physician Decision|4|||
146298948|NCT00631189|527610002|FG003|Initial Phase|Withdrawal by Subject|0|||
146298949|NCT00631189|527609999|FG000|Treatment Phase|Withdrawal by Subject|0|||
146298950|NCT00631189|527610000|FG001|Treatment Phase|Withdrawal by Subject|2|||
146298951|NCT00631189|527610001|FG002|Treatment Phase|Withdrawal by Subject|1|||
146298952|NCT00631189|527610002|FG003|Treatment Phase|Withdrawal by Subject|1|||
146298953|NCT00631189|527609999|FG000|Treatment Phase|Protocol Violation|0|||
146298954|NCT00631189|527610000|FG001|Treatment Phase|Protocol Violation|1|||
146298955|NCT00631189|527610001|FG002|Treatment Phase|Protocol Violation|6|||
146298956|NCT00631189|527610002|FG003|Treatment Phase|Protocol Violation|2|||
146298957|NCT00631189|527609999|FG000|Treatment Phase|Adverse Event|0|||
146298958|NCT00631189|527610000|FG001|Treatment Phase|Adverse Event|3|||
146298959|NCT00631189|527610001|FG002|Treatment Phase|Adverse Event|2|||
146298960|NCT00631189|527610002|FG003|Treatment Phase|Adverse Event|4|||
146298961|NCT00631189|527609999|FG000|Treatment Phase|Lost to Follow-up|0|||
146298962|NCT00631189|527610000|FG001|Treatment Phase|Lost to Follow-up|1|||
146298963|NCT00631189|527610001|FG002|Treatment Phase|Lost to Follow-up|0|||
146298964|NCT00631189|527610002|FG003|Treatment Phase|Lost to Follow-up|0|||
146011221|NCT02595866|526552430|FG001|Overall Study|Physician Decision|3|||
146011222|NCT02595866|526552429|FG000|Overall Study|Switched to Alternative Treatment|1|||
146011223|NCT02595866|526552430|FG001|Overall Study|Switched to Alternative Treatment|0|||
146011224|NCT02595866|526552429|FG000|Overall Study|Study Terminated|0|||
146011225|NCT02595866|526552430|FG001|Overall Study|Study Terminated|4|||
146011226|NCT02595866|526552429|FG000|Overall Study|Withdrawal by Subject|6|||
146011227|NCT02595866|526552430|FG001|Overall Study|Withdrawal by Subject|1|||
146011228|NCT02520388|526552431|FG000|Overall Study|Physician Decision|1|||
146011229|NCT02520388|526552432|FG001|Overall Study|Physician Decision|0|||
146011230|NCT02520388|526552431|FG000|Overall Study|Subject or parent/guardian request|0|||
146011231|NCT02520388|526552432|FG001|Overall Study|Subject or parent/guardian request|6|||
146011232|NCT02520388|526552431|FG000|Overall Study|Adverse Event|1|||
146011233|NCT02520388|526552432|FG001|Overall Study|Adverse Event|4|||
146011234|NCT02520388|526552431|FG000|Overall Study|Lost to Follow-up|3|||
146011235|NCT02520388|526552432|FG001|Overall Study|Lost to Follow-up|2|||
146011236|NCT02520388|526552431|FG000|Overall Study|Other (reason not defined)|4|||
146011237|NCT02520388|526552432|FG001|Overall Study|Other (reason not defined)|4|||
146011238|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
146011239|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
146011240|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
146011241|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
146011242|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
146011243|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
146011244|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
146011245|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
146011246|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
146011247|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
146011248|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146011249|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
146011250|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
146011251|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
146011252|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
146011253|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
146011254|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146011255|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
146011256|NCT03162796|526552435|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
146011257|NCT03162796|526552436|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
146011258|NCT03162796|526552437|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
146011259|NCT03162796|526552435|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
146011260|NCT03162796|526552436|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
146011261|NCT03162796|526552437|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
146011262|NCT03162796|526552435|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
146011263|NCT03162796|526552436|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
146011264|NCT03162796|526552437|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
146011265|NCT03162796|526552435|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
146298965|NCT00631189|527609999|FG000|Treatment Phase|Pregnancy|0|||
146298966|NCT00631189|527610000|FG001|Treatment Phase|Pregnancy|0|||
146298967|NCT00631189|527610001|FG002|Treatment Phase|Pregnancy|1|||
146298968|NCT00631189|527610002|FG003|Treatment Phase|Pregnancy|0|||
146298969|NCT00631189|527609999|FG000|Treatment Phase|patient did not take pravastatin|0|||
146298970|NCT00631189|527610000|FG001|Treatment Phase|patient did not take pravastatin|0|||
146298971|NCT00631189|527610001|FG002|Treatment Phase|patient did not take pravastatin|1|||
146011266|NCT03162796|526552436|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
146298972|NCT00631189|527610002|FG003|Treatment Phase|patient did not take pravastatin|0|||
146298973|NCT00974090|527610003|FG000|Period 1: Double Blind Period|Adverse Event|2|||
146011267|NCT03162796|526552437|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
146011268|NCT03162796|526552435|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
146011269|NCT03162796|526552436|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
146011270|NCT03162796|526552437|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
146011271|NCT02342288|526552438|FG000|Overall Study|no protocol anesthesiologist available|3|||
146011272|NCT02342288|526552439|FG001|Overall Study|no protocol anesthesiologist available|2|||
146011273|NCT02342288|526552438|FG000|Overall Study|anesthesia leak in system|1|||
146011274|NCT02342288|526552439|FG001|Overall Study|anesthesia leak in system|0|||
146011275|NCT02342288|526552438|FG000|Overall Study|Withdrawal by Subject|1|||
146011276|NCT02342288|526552439|FG001|Overall Study|Withdrawal by Subject|0|||
146011277|NCT02342288|526552438|FG000|Overall Study|coordinator contaminated with blood|0|||
146011278|NCT02342288|526552439|FG001|Overall Study|coordinator contaminated with blood|1|||
146011279|NCT02342288|526552438|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
146011280|NCT02342288|526552439|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
146011281|NCT02342288|526552438|FG000|Overall Study|coordinator not available|0|||
146011282|NCT02342288|526552439|FG001|Overall Study|coordinator not available|2|||
146011283|NCT02375373|526552440|FG000|Overall Study|Withdrawal by Subject|11|||
146011284|NCT00407602|526552441|FG000|Overall Study|Death - unrelated to device|1|||
146011285|NCT00407602|526552441|FG000|Overall Study|Device explanted|5|||
146011286|NCT00407602|526552441|FG000|Overall Study|Withdrawal by Subject|1|||
146011287|NCT00431444|526552444|FG000|Overall Study|Protocol Violation|1|||
146011288|NCT00431444|526552445|FG001|Overall Study|Protocol Violation|4|||
146011289|NCT00431444|526552444|FG000|Overall Study|Adverse Event|2|||
146011290|NCT00431444|526552445|FG001|Overall Study|Adverse Event|1|||
146011291|NCT00431444|526552444|FG000|Overall Study|Withdrawal by Subject|1|||
146011292|NCT00431444|526552445|FG001|Overall Study|Withdrawal by Subject|1|||
146011293|NCT00431444|526552444|FG000|Overall Study|Lost to Follow-up|1|||
146011294|NCT00431444|526552445|FG001|Overall Study|Lost to Follow-up|0|||
146011295|NCT00431444|526552444|FG000|Overall Study|Administrative Problems|0|||
146011296|NCT00431444|526552445|FG001|Overall Study|Administrative Problems|1|||
146011297|NCT03554018|526552446|FG000|Overall Study|Lost to Follow-up|3|||
146011298|NCT03554018|526552447|FG001|Overall Study|Lost to Follow-up|7|||
146011299|NCT03744910|526554560|FG000|Overall Study|Withdrew Consent|1|||
146011300|NCT03744910|526554561|FG001|Overall Study|Withdrew Consent|8|||
146011301|NCT03744910|526554560|FG000|Overall Study|Physician Decision|5|||
146011302|NCT03744910|526554561|FG001|Overall Study|Physician Decision|4|||
146011303|NCT03744910|526554560|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
146011304|NCT03744910|526554561|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
146011305|NCT03744910|526554560|FG000|Overall Study|Lost to Follow-up|0|||
146011306|NCT03744910|526554561|FG001|Overall Study|Lost to Follow-up|1|||
146011307|NCT03744910|526554560|FG000|Overall Study|Other-unspecified|4|||
146011308|NCT03744910|526554561|FG001|Overall Study|Other-unspecified|1|||
146011309|NCT02744612|526554562|FG000|Overall Study|Withdrawal by Subject|0|||
146011310|NCT02744612|526554563|FG001|Overall Study|Withdrawal by Subject|2|||
146011311|NCT02220855|526554565|FG000|Overall Study|Adverse Event|8|||
146011312|NCT02220855|526554565|FG000|Overall Study|Disease Progression|5|||
146011313|NCT02220855|526554565|FG000|Overall Study|Withdrawal by Subject|1|||
146011314|NCT03280303|526554566|FG000|Overall Study|Death|505|||
146011315|NCT03280303|526554566|FG000|Overall Study|Study terminated by sponsor|383|||
146011316|NCT03280303|526554566|FG000|Overall Study|Other|148|||
146011317|NCT03280303|526554566|FG000|Overall Study|No longer willing to participate in study|101|||
146011318|NCT03280303|526554566|FG000|Overall Study|Lost to follow up|39|||
146011319|NCT03280303|526554566|FG000|Overall Study|Adverse Event|20|||
146011320|NCT03419897|526554567|FG000|Overall Study|Death|180|||
146011321|NCT03419897|526554567|FG000|Overall Study|Lost to Follow-up|1|||
146011322|NCT03419897|526554567|FG000|Overall Study|Withdrawal by Subject|6|||
146011323|NCT03419897|526554567|FG000|Overall Study|Sponsor Decision|61|||
146011324|NCT03419897|526554567|FG000|Overall Study|Physician Decision|1|||
146011325|NCT01945216|526554570|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
146011326|NCT01945216|526554570|FG000|Overall Study|Protocol Violation|42|||
146093105|NCT00586066|526861748|FG001|Overall Study|Physician Decision|0|||
146011327|NCT01945216|526554570|FG000|Overall Study|CRF not assured by investigators|5|||
146011328|NCT01905943|526554574|FG000|Overall Study|Withdrawal of consent|90|||
146011329|NCT01905943|526554574|FG000|Overall Study|Lost to Follow-up|16|||
146093106|NCT00586066|526861747|FG000|Overall Study|Withdrawal of consent|4|||
146093107|NCT00586066|526861748|FG001|Overall Study|Withdrawal of consent|2|||
146093108|NCT02676466|526861749|FG000|Overall Study|Death|0|||
146011330|NCT01905943|526554574|FG000|Overall Study|Investigator discretion|7|||
146011331|NCT01905943|526554574|FG000|Overall Study|Death|186|||
146011332|NCT01905943|526554574|FG000|Overall Study|Adverse Event|3|||
146011333|NCT01905943|526554574|FG000|Overall Study|Other|12|||
146011334|NCT02574078|526554575|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011335|NCT02574078|526554576|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011336|NCT02574078|526554577|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146093109|NCT02676466|526861750|FG001|Overall Study|Death|2|||
146093110|NCT02676466|526861751|FG002|Overall Study|Death|1|||
146011337|NCT02574078|526554578|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011338|NCT02574078|526554579|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011339|NCT02574078|526554580|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146011340|NCT02574078|526554581|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
146011341|NCT02574078|526554582|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011342|NCT02574078|526554583|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146011343|NCT02574078|526554584|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011344|NCT02574078|526554585|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011345|NCT02574078|526554586|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011346|NCT02574078|526554587|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146011347|NCT02574078|526554575|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146011348|NCT02574078|526554576|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
146011349|NCT02574078|526554577|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
146011350|NCT02574078|526554578|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
146011351|NCT02574078|526554579|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
146011352|NCT02574078|526554580|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
146011353|NCT02574078|526554581|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
146011354|NCT02574078|526554582|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
146011355|NCT02574078|526554583|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
146011356|NCT02574078|526554584|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
146011357|NCT02574078|526554585|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
146011358|NCT02574078|526554586|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
146011359|NCT02574078|526554587|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
146011360|NCT02574078|526554575|FG000|Pre-Treatment Period|Other reasons|0|||
146011361|NCT02574078|526554576|FG001|Pre-Treatment Period|Other reasons|0|||
146011362|NCT02574078|526554577|FG002|Pre-Treatment Period|Other reasons|0|||
146011363|NCT02574078|526554578|FG003|Pre-Treatment Period|Other reasons|0|||
146011364|NCT02574078|526554579|FG004|Pre-Treatment Period|Other reasons|0|||
146011365|NCT02574078|526554580|FG005|Pre-Treatment Period|Other reasons|0|||
146011366|NCT02574078|526554581|FG006|Pre-Treatment Period|Other reasons|2|||
146011367|NCT02574078|526554582|FG007|Pre-Treatment Period|Other reasons|0|||
146011368|NCT02574078|526554583|FG008|Pre-Treatment Period|Other reasons|0|||
146011369|NCT02574078|526554584|FG009|Pre-Treatment Period|Other reasons|0|||
146011370|NCT02574078|526554585|FG010|Pre-Treatment Period|Other reasons|2|||
146011371|NCT02574078|526554586|FG011|Pre-Treatment Period|Other reasons|0|||
146011372|NCT02574078|526554587|FG012|Pre-Treatment Period|Other reasons|0|||
146011373|NCT02574078|526554575|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
146011374|NCT02574078|526554576|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
146011375|NCT02574078|526554577|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
146011376|NCT02574078|526554578|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
146011377|NCT02574078|526554579|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
146011378|NCT02574078|526554580|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
146011379|NCT02574078|526554581|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
146011380|NCT02574078|526554582|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
146011381|NCT02574078|526554583|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
146011382|NCT02574078|526554584|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
146011383|NCT02574078|526554585|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
146011384|NCT02574078|526554586|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
146011385|NCT02574078|526554587|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
146011386|NCT02574078|526554575|FG000|Treatment Period|Disease progression|6|||
146011387|NCT02574078|526554576|FG001|Treatment Period|Disease progression|4|||
146011388|NCT02574078|526554577|FG002|Treatment Period|Disease progression|7|||
146011389|NCT02574078|526554578|FG003|Treatment Period|Disease progression|18|||
146011390|NCT02574078|526554579|FG004|Treatment Period|Disease progression|16|||
146011391|NCT02574078|526554580|FG005|Treatment Period|Disease progression|26|||
146011392|NCT02574078|526554581|FG006|Treatment Period|Disease progression|5|||
146011393|NCT02574078|526554582|FG007|Treatment Period|Disease progression|9|||
146011394|NCT02574078|526554583|FG008|Treatment Period|Disease progression|8|||
146011395|NCT02574078|526554584|FG009|Treatment Period|Disease progression|5|||
146011396|NCT02574078|526554585|FG010|Treatment Period|Disease progression|20|||
146011397|NCT02574078|526554586|FG011|Treatment Period|Disease progression|29|||
146011398|NCT02574078|526554587|FG012|Treatment Period|Disease progression|2|||
146093111|NCT02676466|526861752|FG003|Overall Study|Death|0|||
146011399|NCT02574078|526554575|FG000|Treatment Period|Study drug toxicity|1|||
146011400|NCT02574078|526554576|FG001|Treatment Period|Study drug toxicity|1|||
146093112|NCT02676466|526861753|FG004|Overall Study|Death|0|||
146093113|NCT02676466|526861754|FG005|Overall Study|Death|0|||
146093114|NCT02676466|526861755|FG006|Overall Study|Death|0|||
146093115|NCT02676466|526861756|FG007|Overall Study|Death|0|||
146093116|NCT02676466|526861749|FG000|Overall Study|Withdrawal by Subject|4|||
146093117|NCT02676466|526861750|FG001|Overall Study|Withdrawal by Subject|3|||
146093118|NCT02676466|526861751|FG002|Overall Study|Withdrawal by Subject|1|||
146093119|NCT02676466|526861752|FG003|Overall Study|Withdrawal by Subject|0|||
146011401|NCT02574078|526554577|FG002|Treatment Period|Study drug toxicity|0|||
146011402|NCT02574078|526554578|FG003|Treatment Period|Study drug toxicity|5|||
146011403|NCT02574078|526554579|FG004|Treatment Period|Study drug toxicity|3|||
146011404|NCT02574078|526554580|FG005|Treatment Period|Study drug toxicity|1|||
146011405|NCT02574078|526554581|FG006|Treatment Period|Study drug toxicity|2|||
146011406|NCT02574078|526554582|FG007|Treatment Period|Study drug toxicity|0|||
146011407|NCT02574078|526554583|FG008|Treatment Period|Study drug toxicity|2|||
146011408|NCT02574078|526554584|FG009|Treatment Period|Study drug toxicity|1|||
146011409|NCT02574078|526554585|FG010|Treatment Period|Study drug toxicity|16|||
146011410|NCT02574078|526554586|FG011|Treatment Period|Study drug toxicity|2|||
146011411|NCT02574078|526554587|FG012|Treatment Period|Study drug toxicity|4|||
146011412|NCT02574078|526554575|FG000|Treatment Period|Death|2|||
146011413|NCT02574078|526554576|FG001|Treatment Period|Death|0|||
146011414|NCT02574078|526554577|FG002|Treatment Period|Death|0|||
146011415|NCT02574078|526554578|FG003|Treatment Period|Death|0|||
146011416|NCT02574078|526554579|FG004|Treatment Period|Death|1|||
146011417|NCT02574078|526554580|FG005|Treatment Period|Death|1|||
146011418|NCT02574078|526554581|FG006|Treatment Period|Death|1|||
146011419|NCT02574078|526554582|FG007|Treatment Period|Death|1|||
146011420|NCT02574078|526554583|FG008|Treatment Period|Death|7|||
146011421|NCT02574078|526554584|FG009|Treatment Period|Death|1|||
146011422|NCT02574078|526554585|FG010|Treatment Period|Death|0|||
146011423|NCT02574078|526554586|FG011|Treatment Period|Death|2|||
146011424|NCT02574078|526554587|FG012|Treatment Period|Death|1|||
146011425|NCT02574078|526554575|FG000|Treatment Period|Adverse event unrelated to drug|0|||
146011426|NCT02574078|526554576|FG001|Treatment Period|Adverse event unrelated to drug|0|||
146011427|NCT02574078|526554577|FG002|Treatment Period|Adverse event unrelated to drug|1|||
146011428|NCT02574078|526554578|FG003|Treatment Period|Adverse event unrelated to drug|0|||
146011429|NCT02574078|526554579|FG004|Treatment Period|Adverse event unrelated to drug|2|||
146011430|NCT02574078|526554580|FG005|Treatment Period|Adverse event unrelated to drug|3|||
146011431|NCT02574078|526554581|FG006|Treatment Period|Adverse event unrelated to drug|0|||
146011432|NCT02574078|526554582|FG007|Treatment Period|Adverse event unrelated to drug|0|||
146011433|NCT02574078|526554583|FG008|Treatment Period|Adverse event unrelated to drug|1|||
146011434|NCT02574078|526554584|FG009|Treatment Period|Adverse event unrelated to drug|2|||
146011435|NCT02574078|526554585|FG010|Treatment Period|Adverse event unrelated to drug|4|||
146011436|NCT02574078|526554586|FG011|Treatment Period|Adverse event unrelated to drug|1|||
146011437|NCT02574078|526554587|FG012|Treatment Period|Adverse event unrelated to drug|0|||
146011438|NCT02574078|526554575|FG000|Treatment Period|Administrative reason by Sponsor|0|||
146011439|NCT02574078|526554576|FG001|Treatment Period|Administrative reason by Sponsor|1|||
146011440|NCT02574078|526554577|FG002|Treatment Period|Administrative reason by Sponsor|0|||
146011441|NCT02574078|526554578|FG003|Treatment Period|Administrative reason by Sponsor|0|||
146011442|NCT02574078|526554579|FG004|Treatment Period|Administrative reason by Sponsor|0|||
146011443|NCT02574078|526554580|FG005|Treatment Period|Administrative reason by Sponsor|0|||
146011444|NCT02574078|526554581|FG006|Treatment Period|Administrative reason by Sponsor|1|||
146011445|NCT02574078|526554582|FG007|Treatment Period|Administrative reason by Sponsor|0|||
146011446|NCT02574078|526554583|FG008|Treatment Period|Administrative reason by Sponsor|0|||
146011447|NCT02574078|526554584|FG009|Treatment Period|Administrative reason by Sponsor|0|||
146011448|NCT02574078|526554585|FG010|Treatment Period|Administrative reason by Sponsor|0|||
146011449|NCT02574078|526554586|FG011|Treatment Period|Administrative reason by Sponsor|0|||
146011450|NCT02574078|526554587|FG012|Treatment Period|Administrative reason by Sponsor|3|||
146011451|NCT02574078|526554575|FG000|Treatment Period|Other reasons|1|||
146011452|NCT02574078|526554576|FG001|Treatment Period|Other reasons|0|||
146011453|NCT02574078|526554577|FG002|Treatment Period|Other reasons|1|||
146011454|NCT02574078|526554578|FG003|Treatment Period|Other reasons|3|||
146011455|NCT02574078|526554579|FG004|Treatment Period|Other reasons|3|||
146011456|NCT02574078|526554580|FG005|Treatment Period|Other reasons|1|||
146011457|NCT02574078|526554581|FG006|Treatment Period|Other reasons|2|||
146011458|NCT02574078|526554582|FG007|Treatment Period|Other reasons|1|||
146011459|NCT02574078|526554583|FG008|Treatment Period|Other reasons|3|||
146250024|NCT02367794|527426849|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
146250025|NCT02367794|527426850|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
146250026|NCT02367794|527426848|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
146250027|NCT02367794|527426849|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
146250028|NCT02367794|527426850|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
146250029|NCT02367794|527426848|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
146250030|NCT02367794|527426849|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
146250031|NCT02367794|527426850|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
146250032|NCT02367794|527426848|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
146250033|NCT02367794|527426849|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
146250034|NCT02367794|527426850|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
146011460|NCT02574078|526554584|FG009|Treatment Period|Other reasons|1|||
146011461|NCT02574078|526554585|FG010|Treatment Period|Other reasons|1|||
146011462|NCT02574078|526554586|FG011|Treatment Period|Other reasons|3|||
146011463|NCT02574078|526554587|FG012|Treatment Period|Other reasons|1|||
146093120|NCT02676466|526861753|FG004|Overall Study|Withdrawal by Subject|3|||
146011464|NCT02574078|526554575|FG000|Treatment Period|Participant request to stop drug|0|||
146011465|NCT02574078|526554576|FG001|Treatment Period|Participant request to stop drug|0|||
146011466|NCT02574078|526554577|FG002|Treatment Period|Participant request to stop drug|0|||
146011467|NCT02574078|526554578|FG003|Treatment Period|Participant request to stop drug|2|||
146011468|NCT02574078|526554579|FG004|Treatment Period|Participant request to stop drug|4|||
146011469|NCT02574078|526554580|FG005|Treatment Period|Participant request to stop drug|0|||
146011470|NCT02574078|526554581|FG006|Treatment Period|Participant request to stop drug|1|||
146011471|NCT02574078|526554582|FG007|Treatment Period|Participant request to stop drug|0|||
146011472|NCT02574078|526554583|FG008|Treatment Period|Participant request to stop drug|3|||
146011473|NCT02574078|526554584|FG009|Treatment Period|Participant request to stop drug|2|||
146011474|NCT02574078|526554585|FG010|Treatment Period|Participant request to stop drug|2|||
146011475|NCT02574078|526554586|FG011|Treatment Period|Participant request to stop drug|4|||
146011476|NCT02574078|526554587|FG012|Treatment Period|Participant request to stop drug|1|||
146011477|NCT02574078|526554575|FG000|Treatment Period|Participant withdrew consent|0|||
146011478|NCT02574078|526554576|FG001|Treatment Period|Participant withdrew consent|0|||
146011479|NCT02574078|526554577|FG002|Treatment Period|Participant withdrew consent|0|||
146011480|NCT02574078|526554578|FG003|Treatment Period|Participant withdrew consent|0|||
146011481|NCT02574078|526554579|FG004|Treatment Period|Participant withdrew consent|1|||
146011482|NCT02574078|526554580|FG005|Treatment Period|Participant withdrew consent|1|||
146011483|NCT02574078|526554581|FG006|Treatment Period|Participant withdrew consent|0|||
146093121|NCT02676466|526861754|FG005|Overall Study|Withdrawal by Subject|1|||
146093122|NCT02676466|526861755|FG006|Overall Study|Withdrawal by Subject|1|||
146093123|NCT02676466|526861756|FG007|Overall Study|Withdrawal by Subject|1|||
146093124|NCT00760084|526861757|FG000|Overall Study|Physician Decision|5|||
146093125|NCT00760084|526861757|FG000|Overall Study|Withdrawal by Subject|2|||
146093126|NCT00760084|526861757|FG000|Overall Study|Progressive Disease|3|||
146093127|NCT03552965|526861760|FG000|Overall Study|Death|1|||
146093128|NCT03552965|526861761|FG001|Overall Study|Death|1|||
146093129|NCT03552965|526861760|FG000|Overall Study|Lost to Follow-up|1|||
146093130|NCT03552965|526861761|FG001|Overall Study|Lost to Follow-up|1|||
146093131|NCT03552965|526861760|FG000|Overall Study|Physician Decision|1|||
146093132|NCT03552965|526861761|FG001|Overall Study|Physician Decision|1|||
146093133|NCT03552965|526861760|FG000|Overall Study|Withdrawal by Subject|0|||
146093134|NCT03552965|526861761|FG001|Overall Study|Withdrawal by Subject|2|||
146093135|NCT03552965|526861760|FG000|Overall Study|Continuation not in patient best interest|1|||
146093136|NCT03552965|526861761|FG001|Overall Study|Continuation not in patient best interest|0|||
146093137|NCT03552965|526861760|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
146093138|NCT03552965|526861761|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
146093139|NCT03120624|526861762|FG000|Overall Study|Withdrawal by Subject|0|||
146093140|NCT03120624|526861763|FG001|Overall Study|Withdrawal by Subject|1|||
146093141|NCT03120624|526861764|FG002|Overall Study|Withdrawal by Subject|0|||
146093142|NCT03120624|526861765|FG003|Overall Study|Withdrawal by Subject|0|||
146093143|NCT03120624|526861766|FG004|Overall Study|Withdrawal by Subject|0|||
146093144|NCT03120624|526861767|FG005|Overall Study|Withdrawal by Subject|0|||
146093145|NCT03120624|526861768|FG006|Overall Study|Withdrawal by Subject|0|||
146093146|NCT03120624|526861769|FG007|Overall Study|Withdrawal by Subject|0|||
146093147|NCT01104701|526863359|FG000|Overall Study|Withdrawal by Subject|0|||
146093148|NCT01104701|526863360|FG001|Overall Study|Withdrawal by Subject|1|||
146093149|NCT01104701|526863361|FG002|Overall Study|Withdrawal by Subject|2|||
146093150|NCT01104701|526863362|FG003|Overall Study|Withdrawal by Subject|1|||
146093151|NCT01104701|526863359|FG000|Overall Study|Adverse Event|0|||
146093152|NCT01104701|526863360|FG001|Overall Study|Adverse Event|0|||
146093153|NCT01104701|526863361|FG002|Overall Study|Adverse Event|0|||
146093154|NCT01104701|526863362|FG003|Overall Study|Adverse Event|1|||
146093155|NCT01104701|526863359|FG000|Overall Study|Physician Decision|0|||
146093156|NCT01104701|526863360|FG001|Overall Study|Physician Decision|2|||
146093157|NCT01104701|526863361|FG002|Overall Study|Physician Decision|0|||
146093158|NCT01104701|526863362|FG003|Overall Study|Physician Decision|0|||
146093159|NCT02171065|526863365|FG000|Overall Study|Withdrawal by Subject|1|||
146093160|NCT02171065|526863366|FG001|Overall Study|Withdrawal by Subject|0|||
146093161|NCT02171065|526863367|FG002|Overall Study|Withdrawal by Subject|0|||
146011484|NCT02574078|526554582|FG007|Treatment Period|Participant withdrew consent|1|||
146011485|NCT02574078|526554583|FG008|Treatment Period|Participant withdrew consent|0|||
146093162|NCT02171065|526863365|FG000|Overall Study|Lost to Follow-up|0|||
146093163|NCT02171065|526863366|FG001|Overall Study|Lost to Follow-up|0|||
146093164|NCT02171065|526863367|FG002|Overall Study|Lost to Follow-up|1|||
146093165|NCT00084838|526863368|FG000|Overall Study|Death|1|||
146093166|NCT00084838|526863368|FG000|Overall Study|Adverse Event|2|||
146093167|NCT00084838|526863368|FG000|Overall Study|Withdrawal by Subject|1|||
146093168|NCT00084838|526863368|FG000|Overall Study|Progressive Disease|4|||
146093169|NCT00084838|526863368|FG000|Overall Study|Pt Non-Compliance|1|||
146011486|NCT02574078|526554584|FG009|Treatment Period|Participant withdrew consent|2|||
146093170|NCT00084838|526863368|FG000|Overall Study|Ineligible|4|||
146093171|NCT00518687|526863369|FG000|Overall Study|Adverse Event|201|||
146298974|NCT00974090|527610004|FG001|Period 1: Double Blind Period|Adverse Event|1|||
146298975|NCT00974090|527610003|FG000|Period 1: Double Blind Period|Physician Decision|1|||
146298976|NCT00974090|527610004|FG001|Period 1: Double Blind Period|Physician Decision|0|||
146298977|NCT00974090|527610003|FG000|Period 2: Open-label Period|Adverse Event|4|||
146298978|NCT00974090|527610004|FG001|Period 2: Open-label Period|Adverse Event|6|||
146298979|NCT00974090|527610003|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
146298980|NCT00974090|527610004|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
146298981|NCT00974090|527610003|FG000|Period 2: Open-label Period|Physician Decision|0|||
146298982|NCT00974090|527610004|FG001|Period 2: Open-label Period|Physician Decision|3|||
146298983|NCT00974090|527610003|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
146298984|NCT00974090|527610004|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
146298985|NCT03189862|527610005|FG000|Overall Study|Withdrawal by Subject|1|||
146298986|NCT03189862|527610006|FG001|Overall Study|Withdrawal by Subject|0|||
146298987|NCT03189862|527610005|FG000|Overall Study|Lost to Follow-up|54|||
146298988|NCT03189862|527610006|FG001|Overall Study|Lost to Follow-up|62|||
146298989|NCT01122576|527610007|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
146298990|NCT01122576|527610008|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
146298991|NCT01122576|527610009|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
146298992|NCT01122576|527610007|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
146298993|NCT01122576|527610008|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
146298994|NCT01122576|527610009|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
146298995|NCT01122576|527610007|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
146298996|NCT01122576|527610008|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
146298997|NCT01122576|527610009|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
146298998|NCT05696236|527610010|FG000|Overall Study|Lost to Follow-up|1|||
146011487|NCT02574078|526554585|FG010|Treatment Period|Participant withdrew consent|1|||
146011488|NCT02574078|526554586|FG011|Treatment Period|Participant withdrew consent|4|||
146011489|NCT02574078|526554587|FG012|Treatment Period|Participant withdrew consent|1|||
146011490|NCT02574078|526554575|FG000|Treatment Period|Participant no longer meets criteria|0|||
146011491|NCT02574078|526554576|FG001|Treatment Period|Participant no longer meets criteria|0|||
146011492|NCT02574078|526554577|FG002|Treatment Period|Participant no longer meets criteria|0|||
146011493|NCT02574078|526554578|FG003|Treatment Period|Participant no longer meets criteria|0|||
146011494|NCT02574078|526554579|FG004|Treatment Period|Participant no longer meets criteria|1|||
146011495|NCT02574078|526554580|FG005|Treatment Period|Participant no longer meets criteria|0|||
146011496|NCT02574078|526554581|FG006|Treatment Period|Participant no longer meets criteria|0|||
146011497|NCT02574078|526554582|FG007|Treatment Period|Participant no longer meets criteria|0|||
146011498|NCT02574078|526554583|FG008|Treatment Period|Participant no longer meets criteria|0|||
146011499|NCT02574078|526554584|FG009|Treatment Period|Participant no longer meets criteria|1|||
146011500|NCT02574078|526554585|FG010|Treatment Period|Participant no longer meets criteria|1|||
146011501|NCT02574078|526554586|FG011|Treatment Period|Participant no longer meets criteria|1|||
146011502|NCT02574078|526554587|FG012|Treatment Period|Participant no longer meets criteria|0|||
146011503|NCT02574078|526554575|FG000|Treatment Period|Lost to Follow-up|0|||
146011504|NCT02574078|526554576|FG001|Treatment Period|Lost to Follow-up|0|||
146011505|NCT02574078|526554577|FG002|Treatment Period|Lost to Follow-up|0|||
146011506|NCT02574078|526554578|FG003|Treatment Period|Lost to Follow-up|0|||
146011507|NCT02574078|526554579|FG004|Treatment Period|Lost to Follow-up|0|||
146011508|NCT02574078|526554580|FG005|Treatment Period|Lost to Follow-up|0|||
146011509|NCT02574078|526554581|FG006|Treatment Period|Lost to Follow-up|0|||
146011510|NCT02574078|526554582|FG007|Treatment Period|Lost to Follow-up|0|||
146011511|NCT02574078|526554583|FG008|Treatment Period|Lost to Follow-up|0|||
146011512|NCT02574078|526554584|FG009|Treatment Period|Lost to Follow-up|1|||
146011513|NCT02574078|526554585|FG010|Treatment Period|Lost to Follow-up|0|||
146011514|NCT02574078|526554586|FG011|Treatment Period|Lost to Follow-up|1|||
146011515|NCT02574078|526554587|FG012|Treatment Period|Lost to Follow-up|0|||
146011516|NCT02574078|526554575|FG000|Treatment Period|Maximum clinical benefit|0|||
146011517|NCT02574078|526554576|FG001|Treatment Period|Maximum clinical benefit|0|||
146011518|NCT02574078|526554577|FG002|Treatment Period|Maximum clinical benefit|0|||
146011519|NCT02574078|526554578|FG003|Treatment Period|Maximum clinical benefit|0|||
146011520|NCT02574078|526554579|FG004|Treatment Period|Maximum clinical benefit|0|||
146011521|NCT02574078|526554580|FG005|Treatment Period|Maximum clinical benefit|0|||
146011522|NCT02574078|526554581|FG006|Treatment Period|Maximum clinical benefit|0|||
146011523|NCT02574078|526554582|FG007|Treatment Period|Maximum clinical benefit|0|||
146011524|NCT02574078|526554583|FG008|Treatment Period|Maximum clinical benefit|0|||
146011525|NCT02574078|526554584|FG009|Treatment Period|Maximum clinical benefit|1|||
146011526|NCT02574078|526554585|FG010|Treatment Period|Maximum clinical benefit|0|||
146011527|NCT02574078|526554586|FG011|Treatment Period|Maximum clinical benefit|0|||
146011528|NCT02574078|526554587|FG012|Treatment Period|Maximum clinical benefit|0|||
146011529|NCT05935878|526554588|FG000|Overall Study|Death|1|||
146011530|NCT05935878|526554589|FG001|Overall Study|Death|2|||
146011531|NCT05935878|526554588|FG000|Overall Study|Withdrawal by Subject|5|||
146011532|NCT05935878|526554589|FG001|Overall Study|Withdrawal by Subject|5|||
146298999|NCT05696236|527610011|FG001|Overall Study|Lost to Follow-up|0|||
146299000|NCT05696236|527610010|FG000|Overall Study|Later determined to not be eligible for participation|0|||
146299001|NCT05696236|527610011|FG001|Overall Study|Later determined to not be eligible for participation|1|||
146299002|NCT05696236|527610010|FG000|Overall Study|Withdrawal by Subject|2|||
146299003|NCT05696236|527610011|FG001|Overall Study|Withdrawal by Subject|2|||
146299004|NCT01829360|527610012|FG000|Overall Study|Protocol Violation|0|||
146299005|NCT01829360|527610013|FG001|Overall Study|Protocol Violation|0|||
146299006|NCT01829360|527610014|FG002|Overall Study|Protocol Violation|1|||
146299007|NCT01829360|527610015|FG003|Overall Study|Protocol Violation|0|||
146299008|NCT00578786|527610016|FG000|Overall Study|Adverse Event|27|||
146299009|NCT00578786|527610017|FG001|Overall Study|Adverse Event|37|||
146299010|NCT00578786|527610018|FG002|Overall Study|Adverse Event|17|||
146299011|NCT00578786|527610016|FG000|Overall Study|Lack of Efficacy|2|||
146299012|NCT00578786|527610017|FG001|Overall Study|Lack of Efficacy|5|||
146299013|NCT00578786|527610018|FG002|Overall Study|Lack of Efficacy|2|||
146299014|NCT00578786|527610016|FG000|Overall Study|Early Escape from Prior Study|2|||
146299015|NCT00578786|527610017|FG001|Overall Study|Early Escape from Prior Study|1|||
146299016|NCT00578786|527610018|FG002|Overall Study|Early Escape from Prior Study|2|||
146299017|NCT00578786|527610016|FG000|Overall Study|Withdrawal by Subject|7|||
146011533|NCT05935878|526554588|FG000|Overall Study|Revision of implant|1|||
146011534|NCT05935878|526554589|FG001|Overall Study|Revision of implant|1|||
146011535|NCT05935878|526554588|FG000|Overall Study|Mobile bearing dislocation|0|||
146011536|NCT05935878|526554589|FG001|Overall Study|Mobile bearing dislocation|1|||
146093172|NCT00518687|526863370|FG001|Overall Study|Adverse Event|177|||
146011537|NCT03107052|526554598|FG000|Overall Study|Adverse Event|6|||
146011538|NCT03107052|526554599|FG001|Overall Study|Adverse Event|1|||
146011539|NCT03107052|526554600|FG002|Overall Study|Adverse Event|2|||
146011540|NCT03107052|526554598|FG000|Overall Study|Withdrawal by Subject|9|||
146011541|NCT03107052|526554599|FG001|Overall Study|Withdrawal by Subject|5|||
146011542|NCT03107052|526554600|FG002|Overall Study|Withdrawal by Subject|8|||
146011543|NCT03107052|526554598|FG000|Overall Study|Protocol Violation|6|||
146011544|NCT03107052|526554599|FG001|Overall Study|Protocol Violation|0|||
146011545|NCT03107052|526554600|FG002|Overall Study|Protocol Violation|3|||
146011546|NCT03107052|526554598|FG000|Overall Study|Lost to Follow-up|4|||
146011547|NCT03107052|526554599|FG001|Overall Study|Lost to Follow-up|0|||
146011548|NCT03107052|526554600|FG002|Overall Study|Lost to Follow-up|1|||
146011549|NCT03107052|526554598|FG000|Overall Study|Lack of Efficacy|23|||
146011550|NCT03107052|526554599|FG001|Overall Study|Lack of Efficacy|7|||
146011551|NCT03107052|526554600|FG002|Overall Study|Lack of Efficacy|4|||
146011552|NCT03107052|526554598|FG000|Overall Study|Other than specified|4|||
146011553|NCT03107052|526554599|FG001|Overall Study|Other than specified|2|||
146011554|NCT03107052|526554600|FG002|Overall Study|Other than specified|0|||
146011555|NCT03107052|526554598|FG000|Overall Study|Study terminated due to futility|67|||
146011556|NCT03107052|526554599|FG001|Overall Study|Study terminated due to futility|31|||
146011557|NCT03107052|526554600|FG002|Overall Study|Study terminated due to futility|23|||
146011558|NCT00958360|526554601|FG000|Overall Study|Withdrawal by Subject|3|||
146011559|NCT00958360|526554602|FG001|Overall Study|Withdrawal by Subject|1|||
146011560|NCT00958360|526554601|FG000|Overall Study|Death|6|||
146011561|NCT00958360|526554602|FG001|Overall Study|Death|7|||
146011562|NCT00958360|526554601|FG000|Overall Study|Physician Decision|2|||
146011563|NCT00958360|526554602|FG001|Overall Study|Physician Decision|1|||
146011564|NCT00958360|526554601|FG000|Overall Study|Lost to Follow-up|0|||
146011565|NCT00958360|526554602|FG001|Overall Study|Lost to Follow-up|1|||
146011566|NCT03015363|526554603|FG000|Overall Study|Physician Decision|14|||
146011567|NCT03015363|526554603|FG000|Overall Study|Withdrawal by Subject|3|||
146011568|NCT00500357|526554604|FG000|Overall Study|Death|1|||
146011569|NCT02263326|526554605|FG000|Overall Study|Lost to Follow-up|1|||
146011570|NCT02263326|526554606|FG001|Overall Study|Lost to Follow-up|1|||
146011571|NCT00078806|526554607|FG000|Part 1A|Adverse Event|2|||
146011572|NCT00078806|526554608|FG001|Part 1A|Adverse Event|0|||
146093173|NCT00518687|526863369|FG000|Overall Study|Lost to Follow-up|144|||
146011573|NCT00078806|526554609|FG002|Part 1A|Adverse Event|0|||
146011574|NCT00078806|526554610|FG003|Part 1A|Adverse Event|0|||
146250035|NCT00882050|527426851|FG000|Overall Study|Physician Decision|1|||
146250036|NCT00882050|527426852|FG001|Overall Study|Physician Decision|0|||
146250037|NCT00882050|527426853|FG002|Overall Study|Physician Decision|0|||
146250038|NCT02010684|527426854|FG000|Overall Study|Lost to Follow-up|8|||
146250039|NCT02010684|527426855|FG001|Overall Study|Lost to Follow-up|18|||
146250040|NCT02010684|527426854|FG000|Overall Study|Withdrawal by Subject|4|||
146250041|NCT02010684|527426855|FG001|Overall Study|Withdrawal by Subject|5|||
146250042|NCT01884571|527426860|FG000|Overall Study|Adverse Event|1|||
146250043|NCT01884571|527426860|FG000|Overall Study|Death|2|||
146250044|NCT01884571|527426860|FG000|Overall Study|Withdrawal by Subject|2|||
146299018|NCT00578786|527610017|FG001|Overall Study|Withdrawal by Subject|8|||
146299019|NCT00578786|527610018|FG002|Overall Study|Withdrawal by Subject|5|||
146011575|NCT00078806|526554607|FG000|Part 1A|Lack of Efficacy|7|||
146011576|NCT00078806|526554608|FG001|Part 1A|Lack of Efficacy|0|||
146250045|NCT01884571|527426860|FG000|Overall Study|Disease progression|3|||
146250046|NCT00091572|527426861|FG000|Overall Study|Lost to Follow-up|1|||
146250047|NCT00091572|527426862|FG001|Overall Study|Lost to Follow-up|1|||
146093174|NCT00518687|526863370|FG001|Overall Study|Lost to Follow-up|155|||
146093175|NCT00518687|526863369|FG000|Overall Study|Physician Decision|42|||
146093176|NCT00518687|526863370|FG001|Overall Study|Physician Decision|48|||
146093177|NCT00518687|526863369|FG000|Overall Study|Progressive disease|2|||
146093178|NCT00518687|526863370|FG001|Overall Study|Progressive disease|2|||
146093179|NCT00518687|526863369|FG000|Overall Study|Protocol Violation|8|||
146093180|NCT00518687|526863370|FG001|Overall Study|Protocol Violation|10|||
146093181|NCT00518687|526863369|FG000|Overall Study|Study terminated by sponsor|930|||
146093182|NCT00518687|526863370|FG001|Overall Study|Study terminated by sponsor|918|||
146093183|NCT00518687|526863369|FG000|Overall Study|Withdrawal by Subject|110|||
146093184|NCT00518687|526863370|FG001|Overall Study|Withdrawal by Subject|110|||
146093185|NCT02598960|526863371|FG000|Treatment Period|Disease Progression|4|||
146093186|NCT02598960|526863372|FG001|Treatment Period|Disease Progression|4|||
146093187|NCT02598960|526863373|FG002|Treatment Period|Disease Progression|4|||
146093188|NCT02598960|526863374|FG003|Treatment Period|Disease Progression|6|||
146093189|NCT02598960|526863375|FG004|Treatment Period|Disease Progression|8|||
146093190|NCT02598960|526863376|FG005|Treatment Period|Disease Progression|2|||
146093191|NCT02598960|526863377|FG006|Treatment Period|Disease Progression|2|||
146093192|NCT02598960|526863378|FG007|Treatment Period|Disease Progression|3|||
146093193|NCT02598960|526863379|FG008|Treatment Period|Disease Progression|7|||
146093194|NCT02598960|526863380|FG009|Treatment Period|Disease Progression|9|||
146093195|NCT02598960|526863381|FG010|Treatment Period|Disease Progression|7|||
146093196|NCT02598960|526863382|FG011|Treatment Period|Disease Progression|143|||
146093197|NCT02598960|526863383|FG012|Treatment Period|Disease Progression|23|||
146093198|NCT02598960|526863371|FG000|Treatment Period|Study drug toxicity|0|||
146093199|NCT02598960|526863372|FG001|Treatment Period|Study drug toxicity|0|||
146093200|NCT02598960|526863373|FG002|Treatment Period|Study drug toxicity|0|||
146093201|NCT02598960|526863374|FG003|Treatment Period|Study drug toxicity|0|||
146093202|NCT02598960|526863375|FG004|Treatment Period|Study drug toxicity|0|||
146093203|NCT02598960|526863376|FG005|Treatment Period|Study drug toxicity|0|||
146093204|NCT02598960|526863377|FG006|Treatment Period|Study drug toxicity|0|||
146093205|NCT02598960|526863378|FG007|Treatment Period|Study drug toxicity|0|||
146093206|NCT02598960|526863379|FG008|Treatment Period|Study drug toxicity|0|||
146093207|NCT02598960|526863380|FG009|Treatment Period|Study drug toxicity|1|||
146093208|NCT02598960|526863381|FG010|Treatment Period|Study drug toxicity|0|||
146093209|NCT02598960|526863382|FG011|Treatment Period|Study drug toxicity|3|||
146093210|NCT02598960|526863383|FG012|Treatment Period|Study drug toxicity|0|||
146093211|NCT02598960|526863371|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
146093212|NCT02598960|526863372|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
146093213|NCT02598960|526863373|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
146011577|NCT00078806|526554609|FG002|Part 1A|Lack of Efficacy|0|||
146011578|NCT00078806|526554610|FG003|Part 1A|Lack of Efficacy|0|||
146011579|NCT00078806|526554607|FG000|Part 1A|Other|1|||
146011580|NCT00078806|526554608|FG001|Part 1A|Other|0|||
146011581|NCT00078806|526554609|FG002|Part 1A|Other|0|||
146011582|NCT00078806|526554610|FG003|Part 1A|Other|0|||
146011583|NCT00078806|526554607|FG000|Part 1B|Adverse Event|1|||
146011584|NCT00078806|526554608|FG001|Part 1B|Adverse Event|0|||
146011585|NCT00078806|526554609|FG002|Part 1B|Adverse Event|0|||
146011586|NCT00078806|526554610|FG003|Part 1B|Adverse Event|0|||
146011587|NCT00078806|526554607|FG000|Part 1B|Lack of Efficacy|7|||
146011588|NCT00078806|526554608|FG001|Part 1B|Lack of Efficacy|0|||
146011589|NCT00078806|526554609|FG002|Part 1B|Lack of Efficacy|0|||
146011590|NCT00078806|526554610|FG003|Part 1B|Lack of Efficacy|0|||
146011591|NCT00078806|526554607|FG000|Part 2|Adverse Event|0|||
146011592|NCT00078806|526554608|FG001|Part 2|Adverse Event|1|||
146093214|NCT02598960|526863374|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
146093215|NCT02598960|526863375|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
146299020|NCT00578786|527610016|FG000|Overall Study|Protocol Violation|0|||
146299021|NCT00578786|527610017|FG001|Overall Study|Protocol Violation|3|||
146011593|NCT00078806|526554609|FG002|Part 2|Adverse Event|0|||
146011594|NCT00078806|526554610|FG003|Part 2|Adverse Event|0|||
146011595|NCT01893411|526554613|FG000|Overall Study|Protocol Violation|1|||
146011596|NCT01893411|526554614|FG001|Overall Study|Protocol Violation|0|||
146011597|NCT01893411|526554615|FG002|Overall Study|Protocol Violation|0|||
146011598|NCT01893411|526554613|FG000|Overall Study|Physician Decision|1|||
146011599|NCT01893411|526554614|FG001|Overall Study|Physician Decision|1|||
146093216|NCT02598960|526863376|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
146093217|NCT02598960|526863377|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
146093218|NCT02598960|526863378|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
146093219|NCT02598960|526863379|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
146011600|NCT01893411|526554615|FG002|Overall Study|Physician Decision|2|||
146011601|NCT01893411|526554613|FG000|Overall Study|Lack of Efficacy|2|||
146011602|NCT01893411|526554614|FG001|Overall Study|Lack of Efficacy|1|||
146011603|NCT01893411|526554615|FG002|Overall Study|Lack of Efficacy|0|||
146093220|NCT02598960|526863380|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
146093221|NCT02598960|526863381|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
146093222|NCT02598960|526863382|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
146011604|NCT01893411|526554613|FG000|Overall Study|Other|3|||
146011605|NCT01893411|526554614|FG001|Overall Study|Other|1|||
146011606|NCT01893411|526554615|FG002|Overall Study|Other|3|||
146011607|NCT01893411|526554613|FG000|Overall Study|Adverse Event|1|||
146011608|NCT01893411|526554614|FG001|Overall Study|Adverse Event|0|||
146011609|NCT01893411|526554615|FG002|Overall Study|Adverse Event|0|||
146011610|NCT01893411|526554613|FG000|Overall Study|Withdrawal by Subject|7|||
146011611|NCT01893411|526554614|FG001|Overall Study|Withdrawal by Subject|4|||
146011612|NCT01893411|526554615|FG002|Overall Study|Withdrawal by Subject|3|||
146011613|NCT01893411|526554613|FG000|Overall Study|Lost to Follow-up|2|||
146011614|NCT01893411|526554614|FG001|Overall Study|Lost to Follow-up|0|||
146011615|NCT01893411|526554615|FG002|Overall Study|Lost to Follow-up|1|||
146011616|NCT02397915|526554616|FG000|Period 1|Protocol Violation|0|||
146011617|NCT02397915|526554617|FG001|Period 1|Protocol Violation|1|||
146011618|NCT02397915|526554618|FG002|Period 1|Protocol Violation|0|||
146011619|NCT02397915|526554619|FG003|Period 1|Protocol Violation|0|||
146011620|NCT02397915|526554616|FG000|Period 1|Physician Decision|1|||
146011621|NCT02397915|526554617|FG001|Period 1|Physician Decision|0|||
146011622|NCT02397915|526554618|FG002|Period 1|Physician Decision|0|||
146011623|NCT02397915|526554619|FG003|Period 1|Physician Decision|0|||
146011624|NCT00368745|526554620|FG000|Double-blind Treatment Period|Adverse Event|6|||
146011625|NCT00368745|526554621|FG001|Double-blind Treatment Period|Adverse Event|6|||
146011626|NCT00368745|526554620|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
146011627|NCT00368745|526554621|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
146011628|NCT00368745|526554620|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
146011629|NCT00368745|526554621|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146011630|NCT00368745|526554620|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
146011631|NCT00368745|526554621|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
146011632|NCT00368745|526554620|FG000|Double-blind Treatment Period|Other|7|||
146011633|NCT00368745|526554621|FG001|Double-blind Treatment Period|Other|6|||
146011634|NCT03292874|526554622|FG000|Overall Study|Due to pandemic|5|||
146011635|NCT00161616|526554623|FG000|Overall Study|Withdrawal by Subject|6|||
146011636|NCT00161616|526554624|FG001|Overall Study|Withdrawal by Subject|5|||
146011637|NCT00161616|526554623|FG000|Overall Study|Physician Decision|1|||
146011638|NCT00161616|526554624|FG001|Overall Study|Physician Decision|0|||
146011639|NCT00161616|526554623|FG000|Overall Study|Death|1|||
146011640|NCT00161616|526554624|FG001|Overall Study|Death|1|||
146011641|NCT00161616|526554623|FG000|Overall Study|Lost to Follow-up|17|||
146011642|NCT00161616|526554624|FG001|Overall Study|Lost to Follow-up|13|||
146011643|NCT00161616|526554623|FG000|Overall Study|Protocol deviation|1|||
146011644|NCT00161616|526554624|FG001|Overall Study|Protocol deviation|0|||
146011645|NCT00933608|526554626|FG000|Overall Study|Adverse Event|4|||
146011646|NCT00933608|526554627|FG001|Overall Study|Adverse Event|2|||
146011647|NCT00933608|526554626|FG000|Overall Study|Physician Decision|1|||
146011648|NCT00933608|526554627|FG001|Overall Study|Physician Decision|0|||
146011649|NCT02719691|526554630|FG000|Overall Study|Physician Decision|0|||
146011650|NCT02719691|526554631|FG001|Overall Study|Physician Decision|0|||
146011651|NCT02719691|526554632|FG002|Overall Study|Physician Decision|1|||
146011652|NCT02719691|526554633|FG003|Overall Study|Physician Decision|0|||
146011653|NCT02719691|526554634|FG004|Overall Study|Physician Decision|0|||
146011654|NCT02719691|526554635|FG005|Overall Study|Physician Decision|0|||
146011655|NCT02719691|526554636|FG006|Overall Study|Physician Decision|0|||
146011656|NCT02719691|526554630|FG000|Overall Study|Withdrawal by Subject|0|||
146011657|NCT02719691|526554631|FG001|Overall Study|Withdrawal by Subject|0|||
146011658|NCT02719691|526554632|FG002|Overall Study|Withdrawal by Subject|0|||
146011659|NCT02719691|526554633|FG003|Overall Study|Withdrawal by Subject|0|||
146011660|NCT02719691|526554634|FG004|Overall Study|Withdrawal by Subject|0|||
146011661|NCT02719691|526554635|FG005|Overall Study|Withdrawal by Subject|1|||
146011662|NCT02719691|526554636|FG006|Overall Study|Withdrawal by Subject|0|||
146011663|NCT00336284|526554637|FG000|Overall Study|Death|52|||
146011664|NCT00336284|526554638|FG001|Overall Study|Death|26|||
146250048|NCT00091572|527426861|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
146011665|NCT00336284|526554637|FG000|Overall Study|Lost to Follow-up|82|||
146011666|NCT00336284|526554638|FG001|Overall Study|Lost to Follow-up|61|||
146011667|NCT00336284|526554637|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
146011668|NCT00336284|526554638|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
146011669|NCT00861757|526554643|FG000|Overall Study|Adverse Event|1|||
146011670|NCT00861757|526554644|FG001|Overall Study|Adverse Event|5|||
146011671|NCT00861757|526554645|FG002|Overall Study|Adverse Event|7|||
146011672|NCT00861757|526554646|FG003|Overall Study|Adverse Event|2|||
146011673|NCT00861757|526554643|FG000|Overall Study|Entry Criteria Not Met|1|||
146011674|NCT00861757|526554644|FG001|Overall Study|Entry Criteria Not Met|2|||
146011675|NCT00861757|526554645|FG002|Overall Study|Entry Criteria Not Met|1|||
146011676|NCT00861757|526554646|FG003|Overall Study|Entry Criteria Not Met|1|||
146011677|NCT00861757|526554643|FG000|Overall Study|Lack of Efficacy|3|||
146011678|NCT00861757|526554644|FG001|Overall Study|Lack of Efficacy|1|||
146011679|NCT00861757|526554645|FG002|Overall Study|Lack of Efficacy|0|||
146250049|NCT00091572|527426862|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
146011680|NCT00861757|526554646|FG003|Overall Study|Lack of Efficacy|1|||
146011681|NCT00861757|526554643|FG000|Overall Study|Lost to Follow-up|1|||
146011682|NCT00861757|526554644|FG001|Overall Study|Lost to Follow-up|0|||
146011683|NCT00861757|526554645|FG002|Overall Study|Lost to Follow-up|1|||
146011684|NCT00861757|526554646|FG003|Overall Study|Lost to Follow-up|1|||
146011685|NCT00861757|526554643|FG000|Overall Study|Physician Decision|0|||
146011686|NCT00861757|526554644|FG001|Overall Study|Physician Decision|0|||
146011687|NCT00861757|526554645|FG002|Overall Study|Physician Decision|0|||
146011688|NCT00861757|526554646|FG003|Overall Study|Physician Decision|1|||
146011689|NCT00861757|526554643|FG000|Overall Study|Protocol Violation|2|||
146011690|NCT00861757|526554644|FG001|Overall Study|Protocol Violation|2|||
146011691|NCT00861757|526554645|FG002|Overall Study|Protocol Violation|4|||
146011692|NCT00861757|526554646|FG003|Overall Study|Protocol Violation|1|||
146011693|NCT00861757|526554643|FG000|Overall Study|Withdrawal by Subject|1|||
146011694|NCT00861757|526554644|FG001|Overall Study|Withdrawal by Subject|5|||
146011695|NCT00861757|526554645|FG002|Overall Study|Withdrawal by Subject|5|||
146011696|NCT00861757|526554646|FG003|Overall Study|Withdrawal by Subject|2|||
146011697|NCT01521923|526554650|FG000|Overall Study|AE, serious fatal|1|||
146011698|NCT01521923|526554651|FG001|Overall Study|AE, serious fatal|0|||
146011699|NCT01521923|526554652|FG002|Overall Study|AE, serious fatal|0|||
146011700|NCT01521923|526554653|FG003|Overall Study|AE, serious fatal|0|||
146011701|NCT01521923|526554650|FG000|Overall Study|SAE, non-fatal|0|||
146011702|NCT01521923|526554651|FG001|Overall Study|SAE, non-fatal|2|||
146011703|NCT01521923|526554652|FG002|Overall Study|SAE, non-fatal|2|||
146011704|NCT01521923|526554653|FG003|Overall Study|SAE, non-fatal|0|||
146011705|NCT01521923|526554650|FG000|Overall Study|AE, non-serious, non-fatal|1|||
146011706|NCT01521923|526554651|FG001|Overall Study|AE, non-serious, non-fatal|3|||
146011707|NCT01521923|526554652|FG002|Overall Study|AE, non-serious, non-fatal|6|||
146011708|NCT01521923|526554653|FG003|Overall Study|AE, non-serious, non-fatal|2|||
146011709|NCT01521923|526554650|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146011710|NCT01521923|526554651|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146011711|NCT01521923|526554652|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
146011712|NCT01521923|526554653|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
146011713|NCT01521923|526554650|FG000|Overall Study|Lack of Efficacy|1|||
146011714|NCT01521923|526554651|FG001|Overall Study|Lack of Efficacy|1|||
146011715|NCT01521923|526554652|FG002|Overall Study|Lack of Efficacy|0|||
146011716|NCT01521923|526554653|FG003|Overall Study|Lack of Efficacy|0|||
146011717|NCT01521923|526554650|FG000|Overall Study|Protocol Violation|0|||
146011718|NCT01521923|526554651|FG001|Overall Study|Protocol Violation|0|||
146011719|NCT01521923|526554652|FG002|Overall Study|Protocol Violation|1|||
146011720|NCT01521923|526554653|FG003|Overall Study|Protocol Violation|0|||
146011721|NCT01521923|526554650|FG000|Overall Study|Lost to Follow-up|1|||
146011722|NCT01521923|526554651|FG001|Overall Study|Lost to Follow-up|0|||
146011723|NCT01521923|526554652|FG002|Overall Study|Lost to Follow-up|2|||
146011724|NCT01521923|526554653|FG003|Overall Study|Lost to Follow-up|1|||
146011725|NCT01521923|526554650|FG000|Overall Study|Withdrawal by Subject|1|||
146011726|NCT01521923|526554651|FG001|Overall Study|Withdrawal by Subject|1|||
146011727|NCT01521923|526554652|FG002|Overall Study|Withdrawal by Subject|1|||
146011728|NCT01521923|526554653|FG003|Overall Study|Withdrawal by Subject|2|||
146011729|NCT01521923|526554650|FG000|Overall Study|Other|2|||
146011730|NCT01521923|526554651|FG001|Overall Study|Other|1|||
146011731|NCT01521923|526554652|FG002|Overall Study|Other|3|||
146011732|NCT01521923|526554653|FG003|Overall Study|Other|6|||
146011733|NCT01521923|526554650|FG000|Overall Study|AE, captured in Period 1|0|||
146011734|NCT01521923|526554651|FG001|Overall Study|AE, captured in Period 1|1|||
146011735|NCT01521923|526554652|FG002|Overall Study|AE, captured in Period 1|0|||
146011736|NCT01521923|526554653|FG003|Overall Study|AE, captured in Period 1|1|||
146011737|NCT02403817|526554656|FG000|Overall Study|Withdrawal by Subject|5|||
146011738|NCT02403817|526554657|FG001|Overall Study|Withdrawal by Subject|0|||
146011739|NCT04908384|526554663|FG000|Overall Study|Lost to Follow-up|4|||
146011740|NCT04908384|526554664|FG001|Overall Study|Lost to Follow-up|4|||
146011741|NCT04908384|526554665|FG002|Overall Study|Lost to Follow-up|0|||
146011742|NCT04908384|526554666|FG003|Overall Study|Lost to Follow-up|0|||
146011743|NCT05002985|526554667|FG000|Overall Study|Withdrawal by Subject|1|||
146011744|NCT00603941|526554671|FG000|Overall Study|Disease progression|6|||
146011745|NCT00603941|526554672|FG001|Overall Study|Disease progression|7|||
146011746|NCT00603941|526554673|FG002|Overall Study|Disease progression|1|||
146011747|NCT00603941|526554671|FG000|Overall Study|Adverse Event|1|||
146011748|NCT00603941|526554672|FG001|Overall Study|Adverse Event|0|||
146011749|NCT00603941|526554673|FG002|Overall Study|Adverse Event|1|||
146011750|NCT00603941|526554671|FG000|Overall Study|Physician Decision|0|||
146011751|NCT00603941|526554672|FG001|Overall Study|Physician Decision|1|||
146011752|NCT00603941|526554673|FG002|Overall Study|Physician Decision|0|||
146011753|NCT00603941|526554671|FG000|Overall Study|Withdrawal by Subject|0|||
146011754|NCT00603941|526554672|FG001|Overall Study|Withdrawal by Subject|2|||
146011755|NCT00603941|526554673|FG002|Overall Study|Withdrawal by Subject|0|||
146011756|NCT00833469|526554674|FG000|Overall Study|Withdrawal by Subject|1|||
146011757|NCT00833469|526554674|FG000|Overall Study|Lost to Follow-up|1|||
146011758|NCT01642901|526554675|FG000|12-month Follow-up|Withdrawal by Subject|1|||
146011759|NCT01642901|526554676|FG001|12-month Follow-up|Withdrawal by Subject|0|||
146011760|NCT02707965|526554677|FG000|Overall Study|Withdrawal by Subject|0|||
146011761|NCT02707965|526554678|FG001|Overall Study|Withdrawal by Subject|0|||
146011762|NCT02707965|526554679|FG002|Overall Study|Withdrawal by Subject|1|||
146011763|NCT02707965|526554680|FG003|Overall Study|Withdrawal by Subject|0|||
146011764|NCT02707965|526554681|FG004|Overall Study|Withdrawal by Subject|0|||
146011765|NCT02707965|526554682|FG005|Overall Study|Withdrawal by Subject|0|||
146011766|NCT02707965|526554683|FG006|Overall Study|Withdrawal by Subject|0|||
146011767|NCT02707965|526554684|FG007|Overall Study|Withdrawal by Subject|2|||
146011768|NCT02707965|526554685|FG008|Overall Study|Withdrawal by Subject|0|||
146011769|NCT02707965|526554686|FG009|Overall Study|Withdrawal by Subject|0|||
146011770|NCT02707965|526554687|FG010|Overall Study|Withdrawal by Subject|0|||
146011771|NCT02707965|526554688|FG011|Overall Study|Withdrawal by Subject|0|||
146011772|NCT02707965|526554689|FG012|Overall Study|Withdrawal by Subject|0|||
146011773|NCT02707965|526554690|FG013|Overall Study|Withdrawal by Subject|0|||
146011774|NCT02707965|526554691|FG014|Overall Study|Withdrawal by Subject|0|||
146011775|NCT02707965|526554692|FG015|Overall Study|Withdrawal by Subject|0|||
146011776|NCT02707965|526554677|FG000|Overall Study|PI decisions|0|||
146011777|NCT02707965|526554678|FG001|Overall Study|PI decisions|0|||
146011778|NCT02707965|526554679|FG002|Overall Study|PI decisions|0|||
146011779|NCT02707965|526554680|FG003|Overall Study|PI decisions|0|||
146011780|NCT02707965|526554681|FG004|Overall Study|PI decisions|0|||
146011781|NCT02707965|526554682|FG005|Overall Study|PI decisions|0|||
146011782|NCT02707965|526554683|FG006|Overall Study|PI decisions|0|||
146011783|NCT02707965|526554684|FG007|Overall Study|PI decisions|0|||
146011784|NCT02707965|526554685|FG008|Overall Study|PI decisions|0|||
146011785|NCT02707965|526554686|FG009|Overall Study|PI decisions|0|||
146011786|NCT02707965|526554687|FG010|Overall Study|PI decisions|0|||
146011787|NCT02707965|526554688|FG011|Overall Study|PI decisions|0|||
146011788|NCT02707965|526554689|FG012|Overall Study|PI decisions|0|||
146011789|NCT02707965|526554690|FG013|Overall Study|PI decisions|0|||
146011790|NCT02707965|526554691|FG014|Overall Study|PI decisions|2|||
146011791|NCT02707965|526554692|FG015|Overall Study|PI decisions|0|||
146011792|NCT02707965|526554677|FG000|Overall Study|Protocol deviation|1|||
146011793|NCT02707965|526554678|FG001|Overall Study|Protocol deviation|1|||
146011794|NCT02707965|526554679|FG002|Overall Study|Protocol deviation|0|||
146011795|NCT02707965|526554680|FG003|Overall Study|Protocol deviation|0|||
146011796|NCT02707965|526554681|FG004|Overall Study|Protocol deviation|0|||
146011797|NCT02707965|526554682|FG005|Overall Study|Protocol deviation|0|||
146011798|NCT02707965|526554683|FG006|Overall Study|Protocol deviation|0|||
146011799|NCT02707965|526554684|FG007|Overall Study|Protocol deviation|1|||
146011800|NCT02707965|526554685|FG008|Overall Study|Protocol deviation|0|||
146011801|NCT02707965|526554686|FG009|Overall Study|Protocol deviation|0|||
146011802|NCT02707965|526554687|FG010|Overall Study|Protocol deviation|0|||
146011803|NCT02707965|526554688|FG011|Overall Study|Protocol deviation|0|||
146011804|NCT02707965|526554689|FG012|Overall Study|Protocol deviation|0|||
146011805|NCT02707965|526554690|FG013|Overall Study|Protocol deviation|0|||
146011806|NCT02707965|526554691|FG014|Overall Study|Protocol deviation|0|||
146011807|NCT02707965|526554692|FG015|Overall Study|Protocol deviation|0|||
146011808|NCT02943070|526554693|FG000|Overall Study|Physician Decision|1|||
146011809|NCT02943070|526554693|FG000|Overall Study|Adverse Event|2|||
146011810|NCT02943070|526554693|FG000|Overall Study|Death|2|||
146011811|NCT02943070|526554693|FG000|Overall Study|Withdrawal by Subject|3|||
146011812|NCT02943070|526554693|FG000|Overall Study|Lost to Follow-up|4|||
146011813|NCT02943070|526554693|FG000|Overall Study|Retreatment or TURP|13|||
146011814|NCT02943070|526554693|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
146011815|NCT00570778|526554694|FG000|Overall Study|Protocol deviation|2|||
146011816|NCT00570778|526554695|FG001|Overall Study|Protocol deviation|1|||
146011817|NCT00570778|526554696|FG002|Overall Study|Protocol deviation|2|||
146011818|NCT00570778|526554697|FG003|Overall Study|Protocol deviation|2|||
146011819|NCT00570778|526554694|FG000|Overall Study|Adverse Event|0|||
146011820|NCT00570778|526554695|FG001|Overall Study|Adverse Event|1|||
146011821|NCT00570778|526554696|FG002|Overall Study|Adverse Event|4|||
146011822|NCT00570778|526554697|FG003|Overall Study|Adverse Event|1|||
146011823|NCT00570778|526554694|FG000|Overall Study|Subject withdrew consent|0|||
146011824|NCT00570778|526554695|FG001|Overall Study|Subject withdrew consent|1|||
146011825|NCT00570778|526554696|FG002|Overall Study|Subject withdrew consent|0|||
146011826|NCT00570778|526554697|FG003|Overall Study|Subject withdrew consent|1|||
146011827|NCT00570778|526554694|FG000|Overall Study|Abnormal test procedure|1|||
146011828|NCT00570778|526554695|FG001|Overall Study|Abnormal test procedure|0|||
146011829|NCT00570778|526554696|FG002|Overall Study|Abnormal test procedure|0|||
146011830|NCT00570778|526554697|FG003|Overall Study|Abnormal test procedure|0|||
146011831|NCT00570778|526554694|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146011832|NCT00570778|526554695|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146011833|NCT00570778|526554696|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146011834|NCT00570778|526554697|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146011835|NCT00570778|526554694|FG000|Overall Study|Lost to Follow-up|0|||
146011836|NCT00570778|526554695|FG001|Overall Study|Lost to Follow-up|0|||
146011837|NCT00570778|526554696|FG002|Overall Study|Lost to Follow-up|1|||
146011838|NCT00570778|526554697|FG003|Overall Study|Lost to Follow-up|0|||
146011839|NCT00570778|526554694|FG000|Overall Study|Subject no longer requires study drug|0|||
146011840|NCT00570778|526554695|FG001|Overall Study|Subject no longer requires study drug|1|||
146011841|NCT00570778|526554696|FG002|Overall Study|Subject no longer requires study drug|0|||
146011842|NCT00570778|526554697|FG003|Overall Study|Subject no longer requires study drug|0|||
146011843|NCT00711594|526554698|FG000|Overall Study|Progressive disease|2|||
146011844|NCT00711594|526554699|FG001|Overall Study|Progressive disease|2|||
146011845|NCT00711594|526554700|FG002|Overall Study|Progressive disease|6|||
146011846|NCT00711594|526554701|FG003|Overall Study|Progressive disease|44|||
146011847|NCT00711594|526554698|FG000|Overall Study|Other Adverse Event|1|||
146011848|NCT00711594|526554699|FG001|Overall Study|Other Adverse Event|0|||
146011849|NCT00711594|526554700|FG002|Overall Study|Other Adverse Event|0|||
146011850|NCT00711594|526554701|FG003|Overall Study|Other Adverse Event|16|||
146011851|NCT00711594|526554698|FG000|Overall Study|Withdrawal by Subject|0|||
146011852|NCT00711594|526554699|FG001|Overall Study|Withdrawal by Subject|1|||
146011853|NCT00711594|526554700|FG002|Overall Study|Withdrawal by Subject|0|||
146011854|NCT00711594|526554701|FG003|Overall Study|Withdrawal by Subject|2|||
146011855|NCT02446769|526554702|FG000|Screening Period|Screen Failure|11|||
146011856|NCT02446769|526554703|FG001|Screening Period|Screen Failure|0|||
146011857|NCT02446769|526554704|FG002|Screening Period|Screen Failure|0|||
146011858|NCT02446769|526554702|FG000|Study Period|Randomized in Error|0|||
146011859|NCT02446769|526554703|FG001|Study Period|Randomized in Error|2|||
146011860|NCT02446769|526554704|FG002|Study Period|Randomized in Error|0|||
146011861|NCT04482439|526554705|FG000|Overall Study|Lost to Follow-up|1|||
146011862|NCT04482439|526554705|FG000|Overall Study|Unrelated illness|1|||
146011863|NCT03072043|526554708|FG000|Overall Study|Death|0|||
146011864|NCT03072043|526554709|FG001|Overall Study|Death|0|||
146011865|NCT03072043|526554710|FG002|Overall Study|Death|3|||
146011866|NCT03072043|526554708|FG000|Overall Study|Adverse Event|0|||
146011867|NCT03072043|526554709|FG001|Overall Study|Adverse Event|0|||
146011868|NCT03072043|526554710|FG002|Overall Study|Adverse Event|2|||
146011869|NCT03072043|526554708|FG000|Overall Study|Withdrawal by Subject|0|||
146011870|NCT03072043|526554709|FG001|Overall Study|Withdrawal by Subject|0|||
146011871|NCT03072043|526554710|FG002|Overall Study|Withdrawal by Subject|4|||
146011872|NCT01277822|526554711|FG000|Overall Study|Adverse Event|2|||
146011873|NCT01277822|526554712|FG001|Overall Study|Adverse Event|1|||
146011874|NCT01277822|526554711|FG000|Overall Study|Withdrawal by Subject|6|||
146011875|NCT01277822|526554712|FG001|Overall Study|Withdrawal by Subject|7|||
146011876|NCT01277822|526554711|FG000|Overall Study|Physician Decision|1|||
146011877|NCT01277822|526554712|FG001|Overall Study|Physician Decision|1|||
146011878|NCT01277822|526554711|FG000|Overall Study|Protocol Violation|1|||
146011879|NCT01277822|526554712|FG001|Overall Study|Protocol Violation|0|||
146011880|NCT01277822|526554711|FG000|Overall Study|Lost to Follow-up|2|||
146011881|NCT01277822|526554712|FG001|Overall Study|Lost to Follow-up|1|||
146011882|NCT01277822|526554711|FG000|Overall Study|Contraindicated medication used|2|||
146011883|NCT01277822|526554712|FG001|Overall Study|Contraindicated medication used|1|||
146011884|NCT01277822|526554711|FG000|Overall Study|Participant moved|1|||
146011885|NCT01277822|526554712|FG001|Overall Study|Participant moved|0|||
146011886|NCT02923531|526554713|FG000|Overall Study|Adverse Event|4|||
146011887|NCT02923531|526554713|FG000|Overall Study|Clinical Deterioration|1|||
146011888|NCT02923531|526554713|FG000|Overall Study|Disease Progression|3|||
146011889|NCT02923531|526554713|FG000|Overall Study|Study Termination|1|||
146011890|NCT00997984|526554714|FG000|Overall Study|Adverse Event|1|||
146011891|NCT00997984|526554715|FG001|Overall Study|Adverse Event|8|||
146011892|NCT00997984|526554716|FG002|Overall Study|Adverse Event|8|||
146011893|NCT00997984|526554714|FG000|Overall Study|Protocol Violation|1|||
146011894|NCT00997984|526554715|FG001|Overall Study|Protocol Violation|3|||
146011895|NCT00997984|526554716|FG002|Overall Study|Protocol Violation|0|||
146011896|NCT00997984|526554714|FG000|Overall Study|Withdrawal by Subject|6|||
146011897|NCT00997984|526554715|FG001|Overall Study|Withdrawal by Subject|9|||
146011898|NCT00997984|526554716|FG002|Overall Study|Withdrawal by Subject|5|||
146011899|NCT00997984|526554714|FG000|Overall Study|Lost to Follow-up|8|||
146011900|NCT00997984|526554715|FG001|Overall Study|Lost to Follow-up|5|||
146250050|NCT00091572|527426861|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
146250051|NCT00091572|527426862|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
146250052|NCT00091572|527426861|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
146250053|NCT00091572|527426862|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
146250054|NCT00091572|527426861|FG000|Overall Study|Other Reason|6|||
146250055|NCT00091572|527426862|FG001|Overall Study|Other Reason|13|||
146299022|NCT00578786|527610018|FG002|Overall Study|Protocol Violation|1|||
146299023|NCT00578786|527610016|FG000|Overall Study|Physician Decision|1|||
146011901|NCT00997984|526554716|FG002|Overall Study|Lost to Follow-up|4|||
146011902|NCT00997984|526554714|FG000|Overall Study|Lack of Efficacy|20|||
146011903|NCT00997984|526554715|FG001|Overall Study|Lack of Efficacy|6|||
146011904|NCT00997984|526554716|FG002|Overall Study|Lack of Efficacy|3|||
146011905|NCT00997984|526554714|FG000|Overall Study|Met exclusion criteria|1|||
146250056|NCT00091572|527426861|FG000|Overall Study|Ongoing (still on treatment)|8|||
146011906|NCT00997984|526554715|FG001|Overall Study|Met exclusion criteria|0|||
146011907|NCT00997984|526554716|FG002|Overall Study|Met exclusion criteria|0|||
146011908|NCT00997984|526554714|FG000|Overall Study|non-compliance|0|||
146011909|NCT00997984|526554715|FG001|Overall Study|non-compliance|2|||
146011910|NCT00997984|526554716|FG002|Overall Study|non-compliance|3|||
146011911|NCT00997984|526554714|FG000|Overall Study|Wrong medication dispensed|0|||
146011912|NCT00997984|526554715|FG001|Overall Study|Wrong medication dispensed|1|||
146011913|NCT00997984|526554716|FG002|Overall Study|Wrong medication dispensed|0|||
146011914|NCT00997984|526554714|FG000|Overall Study|Suicidal ideation|0|||
146011915|NCT00997984|526554715|FG001|Overall Study|Suicidal ideation|0|||
146011916|NCT00997984|526554716|FG002|Overall Study|Suicidal ideation|1|||
146011917|NCT00997984|526554714|FG000|Overall Study|Work schedule|0|||
146011918|NCT00997984|526554715|FG001|Overall Study|Work schedule|0|||
146011919|NCT00997984|526554716|FG002|Overall Study|Work schedule|2|||
146011920|NCT02997865|526554718|FG000|Overall Study|Death|2|||
146011921|NCT02997865|526554719|FG001|Overall Study|Death|1|||
146011922|NCT02997865|526554718|FG000|Overall Study|Lost to Follow-up|6|||
146011923|NCT02997865|526554719|FG001|Overall Study|Lost to Follow-up|3|||
146011924|NCT02997865|526554718|FG000|Overall Study|Withdrawal by Subject|5|||
146011925|NCT02997865|526554719|FG001|Overall Study|Withdrawal by Subject|0|||
146011926|NCT00295646|526554722|FG000|Overall Study|Protocol Violation|18|||
146011927|NCT00295646|526554723|FG001|Overall Study|Protocol Violation|20|||
146011928|NCT00295646|526554724|FG002|Overall Study|Protocol Violation|20|||
146011929|NCT00295646|526554725|FG003|Overall Study|Protocol Violation|18|||
146011930|NCT00295646|526554722|FG000|Overall Study|Withdrawal by Subject|8|||
146011931|NCT00295646|526554723|FG001|Overall Study|Withdrawal by Subject|9|||
146011932|NCT00295646|526554724|FG002|Overall Study|Withdrawal by Subject|11|||
146011933|NCT00295646|526554725|FG003|Overall Study|Withdrawal by Subject|14|||
146011934|NCT00295646|526554722|FG000|Overall Study|Lost to Follow-up|0|||
146011935|NCT00295646|526554723|FG001|Overall Study|Lost to Follow-up|5|||
146011936|NCT00295646|526554724|FG002|Overall Study|Lost to Follow-up|1|||
146011937|NCT00295646|526554725|FG003|Overall Study|Lost to Follow-up|5|||
146011938|NCT00295646|526554722|FG000|Overall Study|Death|9|||
146011939|NCT00295646|526554723|FG001|Overall Study|Death|7|||
146011940|NCT00295646|526554724|FG002|Overall Study|Death|18|||
146011941|NCT00295646|526554725|FG003|Overall Study|Death|8|||
146011942|NCT02243371|526554730|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
146011943|NCT02243371|526554731|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
146011944|NCT02243371|526554730|FG000|Overall Study|Death (unrelated)|2|||
146011945|NCT02243371|526554731|FG001|Overall Study|Death (unrelated)|4|||
146011946|NCT02243371|526554730|FG000|Overall Study|Adverse Event (unrelated)|0|||
146011947|NCT02243371|526554731|FG001|Overall Study|Adverse Event (unrelated)|1|||
146011948|NCT02243371|526554730|FG000|Overall Study|Lack of Clinical Benefit|0|||
146011949|NCT02243371|526554731|FG001|Overall Study|Lack of Clinical Benefit|1|||
146011950|NCT02243371|526554730|FG000|Overall Study|Withdrawal by Subject|0|||
146011951|NCT02243371|526554731|FG001|Overall Study|Withdrawal by Subject|2|||
146011952|NCT01945996|526554732|FG000|Overall Study|Lost to Follow-up|3|||
146011953|NCT01945996|526554733|FG001|Overall Study|Lost to Follow-up|5|||
146011954|NCT00271856|526554735|FG000|Overall Study|Withdrawal by Subject|1|||
146011955|NCT00271856|526554736|FG001|Overall Study|Withdrawal by Subject|7|||
146011956|NCT00271856|526554735|FG000|Overall Study|Lost to Follow-up|10|||
146011957|NCT00271856|526554736|FG001|Overall Study|Lost to Follow-up|11|||
146011958|NCT04677543|526554737|FG000|Overall Study|Withdrawal by Subject|4|||
146011959|NCT04677543|526554738|FG001|Overall Study|Withdrawal by Subject|1|||
146011960|NCT04677543|526554737|FG000|Overall Study|Physician Decision|0|||
146011961|NCT04677543|526554738|FG001|Overall Study|Physician Decision|1|||
146011962|NCT04677543|526554737|FG000|Overall Study|Adverse Event|0|||
146011963|NCT04677543|526554738|FG001|Overall Study|Adverse Event|1|||
146011964|NCT00809926|526554740|FG000|Overall Study|Adverse Event|18|||
146011965|NCT00809926|526554741|FG001|Overall Study|Adverse Event|10|||
146011966|NCT00809926|526554740|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
146011967|NCT00809926|526554741|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146011968|NCT00809926|526554740|FG000|Overall Study|Patient withdrew consent|8|||
146011969|NCT00809926|526554741|FG001|Overall Study|Patient withdrew consent|6|||
146011970|NCT00809926|526554740|FG000|Overall Study|Lost to Follow-up|2|||
146011971|NCT00809926|526554741|FG001|Overall Study|Lost to Follow-up|1|||
146011972|NCT00809926|526554740|FG000|Overall Study|Administrative Problems|0|||
146011973|NCT00809926|526554741|FG001|Overall Study|Administrative Problems|1|||
146011974|NCT00809926|526554740|FG000|Overall Study|Protocol deviation|0|||
146011975|NCT00809926|526554741|FG001|Overall Study|Protocol deviation|2|||
146011976|NCT01963767|526554757|FG000|Overall Study|Withdrawal by Subject|4|||
146011977|NCT01963767|526554758|FG001|Overall Study|Withdrawal by Subject|2|||
146299024|NCT00578786|527610017|FG001|Overall Study|Physician Decision|0|||
146011978|NCT01963767|526554757|FG000|Overall Study|Adverse Event|2|||
146011979|NCT01963767|526554758|FG001|Overall Study|Adverse Event|0|||
146011980|NCT01082081|526554761|FG000|Overall Study|Lost to Follow-up|0|||
146011981|NCT01082081|526554762|FG001|Overall Study|Lost to Follow-up|0|||
146011982|NCT01082081|526554763|FG002|Overall Study|Lost to Follow-up|1|||
146011983|NCT01082081|526554761|FG000|Overall Study|Withdrawal by Subject|0|||
146299025|NCT00578786|527610018|FG002|Overall Study|Physician Decision|1|||
146299026|NCT00578786|527610016|FG000|Overall Study|Sponsor Decision|0|||
146299027|NCT00578786|527610017|FG001|Overall Study|Sponsor Decision|0|||
146299028|NCT00578786|527610018|FG002|Overall Study|Sponsor Decision|1|||
146299029|NCT00578786|527610016|FG000|Overall Study|Lost to Follow-up|0|||
146299030|NCT00578786|527610017|FG001|Overall Study|Lost to Follow-up|4|||
146299031|NCT00578786|527610018|FG002|Overall Study|Lost to Follow-up|0|||
146299032|NCT00578786|527610016|FG000|Overall Study|Pregnancy|0|||
146299033|NCT00578786|527610017|FG001|Overall Study|Pregnancy|1|||
146299034|NCT00578786|527610018|FG002|Overall Study|Pregnancy|0|||
146299035|NCT00578786|527610016|FG000|Overall Study|Not Otherwise Specified|0|||
146299036|NCT00578786|527610017|FG001|Overall Study|Not Otherwise Specified|4|||
146299037|NCT00578786|527610018|FG002|Overall Study|Not Otherwise Specified|1|||
146299038|NCT00578786|527610016|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
146299039|NCT00578786|527610017|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
146299040|NCT00578786|527610018|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
146299041|NCT05105789|527610019|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
146299042|NCT01271803|527610023|FG000|Overall Study|Progressive disease|0|||
146299043|NCT01271803|527610024|FG001|Overall Study|Progressive disease|0|||
146299044|NCT01271803|527610025|FG002|Overall Study|Progressive disease|2|||
146299045|NCT01271803|527610023|FG000|Overall Study|Death|53|||
146299046|NCT01271803|527610024|FG001|Overall Study|Death|34|||
146299047|NCT01271803|527610025|FG002|Overall Study|Death|0|||
146299048|NCT01271803|527610023|FG000|Overall Study|Withdrawal by Subject|1|||
146299049|NCT01271803|527610024|FG001|Overall Study|Withdrawal by Subject|5|||
146299050|NCT01271803|527610025|FG002|Overall Study|Withdrawal by Subject|0|||
146299051|NCT01271803|527610023|FG000|Overall Study|Lost to Follow-up|1|||
146299052|NCT01271803|527610024|FG001|Overall Study|Lost to Follow-up|0|||
146299053|NCT01271803|527610025|FG002|Overall Study|Lost to Follow-up|0|||
146299054|NCT00728481|527610026|FG000|Overall Study|Withdrawal by Subject|0|||
146299055|NCT00728481|527610027|FG001|Overall Study|Withdrawal by Subject|1|||
146299056|NCT00728481|527610026|FG000|Overall Study|Adverse Event|0|||
146299057|NCT00728481|527610027|FG001|Overall Study|Adverse Event|1|||
146299058|NCT00728481|527610026|FG000|Overall Study|Study medication non-compliance|0|||
146299059|NCT00728481|527610027|FG001|Overall Study|Study medication non-compliance|2|||
146299060|NCT00728481|527610026|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
146299061|NCT00728481|527610027|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
146299062|NCT02545322|527610028|FG000|Overall Study|Withdrawal by Subject|3|||
146299063|NCT00041067|527610029|FG000|Overall Study|Adverse Event|20|||
146299064|NCT00041067|527610029|FG000|Overall Study|Progression|19|||
146299065|NCT00041067|527610029|FG000|Overall Study|Patient refusal|12|||
146299066|NCT00041067|527610029|FG000|Overall Study|Other reasons|23|||
146299067|NCT00041067|527610029|FG000|Overall Study|Ineligible|2|||
146299068|NCT00778622|527610030|FG000|Overall Study|Adverse Event|5|||
146299069|NCT00778622|527610031|FG001|Overall Study|Adverse Event|4|||
146299070|NCT00778622|527610032|FG002|Overall Study|Adverse Event|7|||
146299071|NCT00778622|527610030|FG000|Overall Study|Withdrawal by Subject|4|||
146299072|NCT00778622|527610031|FG001|Overall Study|Withdrawal by Subject|5|||
146299073|NCT00778622|527610032|FG002|Overall Study|Withdrawal by Subject|5|||
146299074|NCT00778622|527610030|FG000|Overall Study|Lost to Follow-up|3|||
146299075|NCT00778622|527610031|FG001|Overall Study|Lost to Follow-up|3|||
146299076|NCT00778622|527610032|FG002|Overall Study|Lost to Follow-up|2|||
146299077|NCT00778622|527610030|FG000|Overall Study|Protocol Violation|0|||
146299078|NCT00778622|527610031|FG001|Overall Study|Protocol Violation|3|||
146299079|NCT00778622|527610032|FG002|Overall Study|Protocol Violation|0|||
146299080|NCT00778622|527610030|FG000|Overall Study|Lack of Efficacy|2|||
146299081|NCT00778622|527610031|FG001|Overall Study|Lack of Efficacy|0|||
146299082|NCT00778622|527610032|FG002|Overall Study|Lack of Efficacy|0|||
146011984|NCT01082081|526554762|FG001|Overall Study|Withdrawal by Subject|0|||
146011985|NCT01082081|526554763|FG002|Overall Study|Withdrawal by Subject|1|||
146011986|NCT01082081|526554761|FG000|Overall Study|Other Reason|0|||
146011987|NCT01082081|526554762|FG001|Overall Study|Other Reason|1|||
146299083|NCT00778622|527610030|FG000|Overall Study|immigration|1|||
146299084|NCT00778622|527610031|FG001|Overall Study|immigration|0|||
146299085|NCT00778622|527610032|FG002|Overall Study|immigration|0|||
146299086|NCT00778622|527610030|FG000|Overall Study|Other|1|||
146299087|NCT00778622|527610031|FG001|Overall Study|Other|0|||
146299088|NCT00778622|527610032|FG002|Overall Study|Other|1|||
146299089|NCT00890929|527610033|FG000|Overall Study|Death before treatment|2|||
146299090|NCT00890929|527610033|FG000|Overall Study|Withdrawal by Subject|3|||
146011988|NCT01082081|526554763|FG002|Overall Study|Other Reason|0|||
146299091|NCT00890929|527610033|FG000|Overall Study|Physician Decision|1|||
146299092|NCT02014740|527610034|FG000|Overall Study|Lost to Follow-up|4|||
146299093|NCT02014740|527610035|FG001|Overall Study|Lost to Follow-up|4|||
146299094|NCT02014740|527610034|FG000|Overall Study|Withdrawal by Subject|2|||
146299095|NCT02014740|527610035|FG001|Overall Study|Withdrawal by Subject|1|||
146299096|NCT02608879|527610036|FG000|Overall Study|Lost to Follow-up|1|||
146299097|NCT02608879|527610037|FG001|Overall Study|Lost to Follow-up|0|||
146299098|NCT02608879|527610038|FG002|Overall Study|Lost to Follow-up|0|||
146011989|NCT00670930|526554764|FG000|Overall Study|Adminstrative Problem|0|||
146011990|NCT00670930|526554765|FG001|Overall Study|Adminstrative Problem|1|||
146011991|NCT00670930|526554764|FG000|Overall Study|Lost to Follow-up|1|||
146011992|NCT00670930|526554765|FG001|Overall Study|Lost to Follow-up|0|||
146011993|NCT03159468|526554767|FG000|Overall Study|Withdrawal by Subject|0|||
146011994|NCT03159468|526554768|FG001|Overall Study|Withdrawal by Subject|0|||
146011995|NCT03159468|526554769|FG002|Overall Study|Withdrawal by Subject|3|||
146011996|NCT03159468|526554770|FG003|Overall Study|Withdrawal by Subject|0|||
146011997|NCT03159468|526554771|FG004|Overall Study|Withdrawal by Subject|0|||
146011998|NCT03159468|526554772|FG005|Overall Study|Withdrawal by Subject|0|||
146011999|NCT00854724|526556344|FG000|First Intervention|Withdrawal by Subject|1|||
146012000|NCT00854724|526556345|FG001|First Intervention|Withdrawal by Subject|1|||
146012001|NCT00854724|526556344|FG000|Washout|Protocol Violation|1|||
146012002|NCT00854724|526556345|FG001|Washout|Protocol Violation|0|||
146012003|NCT00854724|526556344|FG000|Washout|Withdrawal by Subject|0|||
146012004|NCT00854724|526556345|FG001|Washout|Withdrawal by Subject|1|||
146012005|NCT00854724|526556344|FG000|Second Intervention|Protocol Violation|1|||
146012006|NCT00854724|526556345|FG001|Second Intervention|Protocol Violation|0|||
146012007|NCT00854724|526556344|FG000|Second Intervention|Physician Decision|0|||
146012008|NCT00854724|526556345|FG001|Second Intervention|Physician Decision|1|||
146012009|NCT01498692|526556354|FG000|Overall Study|Death|4|||
146012010|NCT01498692|526556354|FG000|Overall Study|Withdrawal by Subject|1|||
146012011|NCT01498692|526556354|FG000|Overall Study|Missed 12-month visit|3|||
146012012|NCT04729972|526556355|FG000|Overall Study|Adverse Event|1|||
146012013|NCT00590122|526556356|FG000|Overall Study|swallowed oral dissolving dose|1|||
146012014|NCT00590122|526556357|FG001|Overall Study|swallowed oral dissolving dose|0|||
146012015|NCT01208324|526556358|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
146012016|NCT01208324|526556359|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
146012017|NCT01208324|526556360|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
146012018|NCT01208324|526556361|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
146012019|NCT01701362|526556362|FG000|Overall Study|Adverse events not related to study drug|1|||
146012020|NCT01701362|526556363|FG001|Overall Study|Adverse events not related to study drug|6|||
146012021|NCT01701362|526556362|FG000|Overall Study|Adverse events related to study drug|12|||
146012022|NCT01701362|526556363|FG001|Overall Study|Adverse events related to study drug|10|||
146012023|NCT01701362|526556362|FG000|Overall Study|Protocol Violation|5|||
146012024|NCT01701362|526556363|FG001|Overall Study|Protocol Violation|3|||
146012025|NCT01701362|526556362|FG000|Overall Study|No longer willing to participate|8|||
146012026|NCT01701362|526556363|FG001|Overall Study|No longer willing to participate|14|||
146012027|NCT01701362|526556362|FG000|Overall Study|Lost to Follow-up|6|||
146012028|NCT01701362|526556363|FG001|Overall Study|Lost to Follow-up|9|||
146012029|NCT01701362|526556362|FG000|Overall Study|Insufficient clinical response|6|||
146012030|NCT01701362|526556363|FG001|Overall Study|Insufficient clinical response|6|||
146012031|NCT01701362|526556362|FG000|Overall Study|Death|0|||
146012032|NCT01701362|526556363|FG001|Overall Study|Death|1|||
146012033|NCT01701362|526556362|FG000|Overall Study|Randomized but not treated|1|||
146012034|NCT01701362|526556363|FG001|Overall Study|Randomized but not treated|2|||
146012035|NCT01701362|526556362|FG000|Overall Study|Reasons other than those mentioned above|3|||
146012036|NCT01701362|526556363|FG001|Overall Study|Reasons other than those mentioned above|5|||
146012037|NCT00249808|526556364|FG000|Overall Study|Other|27|||
146012038|NCT00249808|526556364|FG000|Overall Study|Protocol Violation|3|||
146012039|NCT00249808|526556364|FG000|Overall Study|Lost to Follow-up|8|||
146012040|NCT00249808|526556364|FG000|Overall Study|Adverse Event|81|||
146012041|NCT00249808|526556364|FG000|Overall Study|Lack of Efficacy|52|||
146012042|NCT00249808|526556364|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
146012043|NCT03654040|526556365|FG000|Overall Study|Death|1|||
146012044|NCT03654040|526556366|FG001|Overall Study|Death|0|||
146012045|NCT03654040|526556365|FG000|Overall Study|Withdrawal by Subject|1|||
146012046|NCT03654040|526556366|FG001|Overall Study|Withdrawal by Subject|0|||
146012047|NCT03654040|526556365|FG000|Overall Study|Study terminated by sponsor|8|||
146012048|NCT03654040|526556366|FG001|Overall Study|Study terminated by sponsor|2|||
146012049|NCT03654040|526556365|FG000|Overall Study|Failure to initiate study therapy|2|||
146012050|NCT03654040|526556366|FG001|Overall Study|Failure to initiate study therapy|0|||
146012051|NCT03654040|526556365|FG000|Overall Study|Transplanted at another center|2|||
146012052|NCT03654040|526556366|FG001|Overall Study|Transplanted at another center|0|||
146012053|NCT03654040|526556365|FG000|Overall Study|Failure to meet eligibility criteria|14|||
146012054|NCT03654040|526556366|FG001|Overall Study|Failure to meet eligibility criteria|2|||
146012055|NCT03654040|526556365|FG000|Overall Study|No longer transplant candidate|1|||
146012056|NCT03654040|526556366|FG001|Overall Study|No longer transplant candidate|0|||
146012057|NCT03654040|526556365|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
146012058|NCT03654040|526556366|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
146012059|NCT03654040|526556365|FG000|Overall Study|Recipient ineligible|0|||
146012060|NCT03654040|526556366|FG001|Overall Study|Recipient ineligible|2|||
146012061|NCT03654040|526556365|FG000|Overall Study|Received deceased liver|0|||
146012062|NCT03654040|526556366|FG001|Overall Study|Received deceased liver|1|||
146012063|NCT01709110|526556367|FG000|Overall Study|Adverse Event|56|||
146012064|NCT01709110|526556368|FG001|Overall Study|Adverse Event|48|||
146012065|NCT01709110|526556367|FG000|Overall Study|Death|14|||
146012066|NCT01709110|526556368|FG001|Overall Study|Death|6|||
146012067|NCT01709110|526556367|FG000|Overall Study|Lost to Follow-up|7|||
146012068|NCT01709110|526556368|FG001|Overall Study|Lost to Follow-up|5|||
146012069|NCT01709110|526556367|FG000|Overall Study|Protocol Violation|4|||
146012070|NCT01709110|526556368|FG001|Overall Study|Protocol Violation|6|||
146012071|NCT01709110|526556367|FG000|Overall Study|Withdrawal by Subject|96|||
146012072|NCT01709110|526556368|FG001|Overall Study|Withdrawal by Subject|89|||
146012073|NCT01709110|526556367|FG000|Overall Study|Physician Decision|4|||
146012074|NCT01709110|526556368|FG001|Overall Study|Physician Decision|10|||
146012075|NCT01709110|526556367|FG000|Overall Study|Sponsor Decision|2|||
146012076|NCT01709110|526556368|FG001|Overall Study|Sponsor Decision|2|||
146012077|NCT01709110|526556367|FG000|Overall Study|Lack of Efficacy|1|||
146012078|NCT01709110|526556368|FG001|Overall Study|Lack of Efficacy|1|||
146012079|NCT01709110|526556367|FG000|Overall Study|Caregiver Decision|1|||
146012080|NCT01709110|526556368|FG001|Overall Study|Caregiver Decision|1|||
146012081|NCT00485758|526556378|FG000|Overall Study|Adverse Event|102|||
146012082|NCT00485758|526556379|FG001|Overall Study|Adverse Event|31|||
146012083|NCT00485758|526556378|FG000|Overall Study|Death|0|||
146012084|NCT00485758|526556379|FG001|Overall Study|Death|1|||
146012085|NCT00485758|526556378|FG000|Overall Study|Lost to Follow-up|5|||
146012086|NCT00485758|526556379|FG001|Overall Study|Lost to Follow-up|1|||
146012087|NCT00485758|526556378|FG000|Overall Study|Physician Decision|3|||
146012088|NCT00485758|526556379|FG001|Overall Study|Physician Decision|3|||
146012089|NCT00485758|526556378|FG000|Overall Study|Protocol Violation|11|||
146012090|NCT00485758|526556379|FG001|Overall Study|Protocol Violation|2|||
146012091|NCT00485758|526556378|FG000|Overall Study|Withdrawal by Subject|32|||
146012092|NCT00485758|526556379|FG001|Overall Study|Withdrawal by Subject|27|||
146012093|NCT00485758|526556378|FG000|Overall Study|Study Terminated by Sponsor|3|||
146012094|NCT00485758|526556379|FG001|Overall Study|Study Terminated by Sponsor|0|||
146012095|NCT04123093|526556380|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
146012096|NCT04123093|526556381|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
146012097|NCT04123093|526556380|FG000|Phase 2|Physician Decision|0|||
146012098|NCT04123093|526556381|FG001|Phase 2|Physician Decision|1|||
146012099|NCT04123093|526556380|FG000|Phase 2|Withdrawal by Subject|0|||
146012100|NCT04123093|526556381|FG001|Phase 2|Withdrawal by Subject|1|||
146012101|NCT00984165|526556382|FG000|Overall Study|Death on study|2|||
146012102|NCT00984165|526556383|FG001|Overall Study|Death on study|0|||
146012103|NCT00984165|526556384|FG002|Overall Study|Death on study|0|||
146012104|NCT00984165|526556385|FG003|Overall Study|Death on study|0|||
146012105|NCT00984165|526556382|FG000|Overall Study|Disease progression on study|5|||
146012106|NCT00984165|526556383|FG001|Overall Study|Disease progression on study|1|||
146012107|NCT00984165|526556384|FG002|Overall Study|Disease progression on study|0|||
146012108|NCT00984165|526556385|FG003|Overall Study|Disease progression on study|0|||
146012109|NCT00984165|526556382|FG000|Overall Study|Death of recipient|0|||
146012110|NCT00984165|526556383|FG001|Overall Study|Death of recipient|0|||
146012111|NCT00984165|526556384|FG002|Overall Study|Death of recipient|0|||
146012112|NCT00984165|526556385|FG003|Overall Study|Death of recipient|1|||
146012113|NCT00984165|526556382|FG000|Overall Study|New protocol|0|||
146012114|NCT00984165|526556383|FG001|Overall Study|New protocol|0|||
146012115|NCT00984165|526556384|FG002|Overall Study|New protocol|0|||
146012116|NCT00984165|526556385|FG003|Overall Study|New protocol|1|||
146012117|NCT00984165|526556382|FG000|Overall Study|P+/donor pair removed from protocol|0|||
146012118|NCT00984165|526556383|FG001|Overall Study|P+/donor pair removed from protocol|0|||
146012119|NCT00984165|526556384|FG002|Overall Study|P+/donor pair removed from protocol|0|||
146012120|NCT00984165|526556385|FG003|Overall Study|P+/donor pair removed from protocol|1|||
146012121|NCT00984165|526556382|FG000|Overall Study|removed with a pair recipient|0|||
146012122|NCT00984165|526556383|FG001|Overall Study|removed with a pair recipient|0|||
146012123|NCT00984165|526556384|FG002|Overall Study|removed with a pair recipient|0|||
146012124|NCT00984165|526556385|FG003|Overall Study|removed with a pair recipient|1|||
146012125|NCT00135330|526556386|FG000|Overall Study|Adverse Event|2|||
146012126|NCT00135330|526556387|FG001|Overall Study|Adverse Event|5|||
146012127|NCT00135330|526556388|FG002|Overall Study|Adverse Event|1|||
146012128|NCT00135330|526556386|FG000|Overall Study|Lost to Follow-up|0|||
146012129|NCT00135330|526556387|FG001|Overall Study|Lost to Follow-up|2|||
146012130|NCT00135330|526556388|FG002|Overall Study|Lost to Follow-up|3|||
146012131|NCT00135330|526556386|FG000|Overall Study|Physician Decision|1|||
146012132|NCT00135330|526556387|FG001|Overall Study|Physician Decision|1|||
146012133|NCT00135330|526556388|FG002|Overall Study|Physician Decision|0|||
146012134|NCT00135330|526556386|FG000|Overall Study|Protocol Violation|4|||
146012135|NCT00135330|526556387|FG001|Overall Study|Protocol Violation|3|||
146012136|NCT00135330|526556388|FG002|Overall Study|Protocol Violation|3|||
146012137|NCT00135330|526556386|FG000|Overall Study|Patient Decision|5|||
146012138|NCT00135330|526556387|FG001|Overall Study|Patient Decision|1|||
146012139|NCT00135330|526556388|FG002|Overall Study|Patient Decision|4|||
146012140|NCT00135330|526556386|FG000|Overall Study|Sponsor Decision|0|||
146012141|NCT00135330|526556387|FG001|Overall Study|Sponsor Decision|1|||
146012142|NCT00135330|526556388|FG002|Overall Study|Sponsor Decision|0|||
146012143|NCT02229825|526556395|FG000|Overall Study|Personal Reasons|0|||
146012144|NCT02229825|526556396|FG001|Overall Study|Personal Reasons|1|||
146012145|NCT02229825|526556395|FG000|Overall Study|Refused continuing medication|7|||
146012146|NCT02229825|526556396|FG001|Overall Study|Refused continuing medication|6|||
146299099|NCT02608879|527610036|FG000|Overall Study|Did not meet continuation criteria|0|||
146299100|NCT02608879|527610037|FG001|Overall Study|Did not meet continuation criteria|0|||
146299101|NCT02608879|527610038|FG002|Overall Study|Did not meet continuation criteria|3|||
146299102|NCT04201821|527610041|FG000|Overall Study|Withdrawal by Subject|2|||
146299103|NCT01130974|527610042|FG000|Overall Study|Protocol Violation|10|||
146012147|NCT02229825|526556395|FG000|Overall Study|Lost to Follow-up|1|||
146012148|NCT02229825|526556396|FG001|Overall Study|Lost to Follow-up|2|||
146012149|NCT02229825|526556395|FG000|Overall Study|Protocol Violation|1|||
146012150|NCT02229825|526556396|FG001|Overall Study|Protocol Violation|1|||
146012151|NCT02229825|526556395|FG000|Overall Study|Lack of Efficacy|4|||
146012152|NCT02229825|526556396|FG001|Overall Study|Lack of Efficacy|10|||
146012153|NCT02229825|526556395|FG000|Overall Study|Adverse Event|11|||
146012154|NCT02229825|526556396|FG001|Overall Study|Adverse Event|9|||
146012155|NCT02229825|526556395|FG000|Overall Study|Not treated|0|||
146012156|NCT02229825|526556396|FG001|Overall Study|Not treated|1|||
146012157|NCT01390298|526556401|FG000|Overall Study|Death|1|||
146012158|NCT01390298|526556401|FG000|Overall Study|long term ICU admission|1|||
146012159|NCT01390298|526556401|FG000|Overall Study|Withdrawal by Subject|14|||
146012160|NCT01390298|526556401|FG000|Overall Study|Lost to Follow-up|7|||
146012161|NCT01390298|526556401|FG000|Overall Study|Surgery cancelled|1|||
146012162|NCT03520920|526556410|FG000|Overall Study|Death|13|||
146012163|NCT03520920|526556411|FG001|Overall Study|Death|1|||
146012164|NCT03520920|526556412|FG002|Overall Study|Death|0|||
146012165|NCT03520920|526556410|FG000|Overall Study|Withdrawal by Subject|2|||
146012166|NCT03520920|526556411|FG001|Overall Study|Withdrawal by Subject|1|||
146012167|NCT03520920|526556412|FG002|Overall Study|Withdrawal by Subject|0|||
146012168|NCT03520920|526556410|FG000|Overall Study|Study Terminated by the Sponsor|5|||
146012169|NCT03520920|526556411|FG001|Overall Study|Study Terminated by the Sponsor|14|||
146012170|NCT03520920|526556412|FG002|Overall Study|Study Terminated by the Sponsor|5|||
146012171|NCT00405392|526556413|FG000|Overall Study|Adverse Event|15|||
146012172|NCT00405392|526556414|FG001|Overall Study|Adverse Event|14|||
146012173|NCT00405392|526556413|FG000|Overall Study|Did not meet Eligibility criteria|7|||
146012174|NCT00405392|526556414|FG001|Overall Study|Did not meet Eligibility criteria|2|||
146012175|NCT00405392|526556413|FG000|Overall Study|Withdrawal by Subject|4|||
146012176|NCT00405392|526556414|FG001|Overall Study|Withdrawal by Subject|3|||
146012177|NCT00405392|526556413|FG000|Overall Study|Lost to Follow-up|1|||
146012178|NCT00405392|526556414|FG001|Overall Study|Lost to Follow-up|2|||
146012179|NCT00405392|526556413|FG000|Overall Study|Data missing|2|||
146012180|NCT00405392|526556414|FG001|Overall Study|Data missing|0|||
146012181|NCT00405392|526556413|FG000|Overall Study|Non-compliance|0|||
146012182|NCT00405392|526556414|FG001|Overall Study|Non-compliance|1|||
146012183|NCT00405392|526556413|FG000|Overall Study|Other|1|||
146012184|NCT00405392|526556414|FG001|Overall Study|Other|5|||
146012185|NCT05420961|526556417|FG000|Overall Study|Withdrawal by Subject|2|||
146012186|NCT05420961|526556418|FG001|Overall Study|Withdrawal by Subject|1|||
146012187|NCT05420961|526556419|FG002|Overall Study|Withdrawal by Subject|1|||
146012188|NCT05420961|526556420|FG003|Overall Study|Withdrawal by Subject|0|||
146012189|NCT05420961|526556421|FG004|Overall Study|Withdrawal by Subject|0|||
146012190|NCT05420961|526556417|FG000|Overall Study|Lost to Follow-up|0|||
146012191|NCT05420961|526556418|FG001|Overall Study|Lost to Follow-up|0|||
146012192|NCT05420961|526556419|FG002|Overall Study|Lost to Follow-up|1|||
146012193|NCT05420961|526556420|FG003|Overall Study|Lost to Follow-up|0|||
146012194|NCT05420961|526556421|FG004|Overall Study|Lost to Follow-up|0|||
146012195|NCT05420961|526556417|FG000|Overall Study|Randomized by mistake without study treatment|0|||
146012196|NCT05420961|526556418|FG001|Overall Study|Randomized by mistake without study treatment|0|||
146012197|NCT05420961|526556419|FG002|Overall Study|Randomized by mistake without study treatment|1|||
146012198|NCT05420961|526556420|FG003|Overall Study|Randomized by mistake without study treatment|0|||
146299104|NCT01130974|527610043|FG001|Overall Study|Protocol Violation|10|||
146012199|NCT05420961|526556421|FG004|Overall Study|Randomized by mistake without study treatment|1|||
146012200|NCT00803361|526556422|FG000|Overall Study|Adverse Event|13|||
146012201|NCT00803361|526556423|FG001|Overall Study|Adverse Event|3|||
146012202|NCT00803361|526556422|FG000|Overall Study|Lack of Efficacy|4|||
146012203|NCT00803361|526556423|FG001|Overall Study|Lack of Efficacy|13|||
146012204|NCT00803361|526556422|FG000|Overall Study|Lost to Follow-up|1|||
146012205|NCT00803361|526556423|FG001|Overall Study|Lost to Follow-up|2|||
146012206|NCT00803361|526556422|FG000|Overall Study|Physician Decision|1|||
146012207|NCT00803361|526556423|FG001|Overall Study|Physician Decision|0|||
146012208|NCT00803361|526556422|FG000|Overall Study|Protocol Violation|2|||
146012209|NCT00803361|526556423|FG001|Overall Study|Protocol Violation|4|||
146012210|NCT00803361|526556422|FG000|Overall Study|Withdrawal by Subject|5|||
146012211|NCT00803361|526556423|FG001|Overall Study|Withdrawal by Subject|6|||
146012212|NCT01437111|526556427|FG000|Overall Study|Adverse Event|2|||
146012213|NCT01437111|526556427|FG000|Overall Study|Withdrawal by Subject|4|||
146012214|NCT01437111|526556427|FG000|Overall Study|Not reported|5|||
146012215|NCT01437111|526556427|FG000|Overall Study|Physician Decision|1|||
146012216|NCT01437111|526556427|FG000|Overall Study|Lost to Follow-up|5|||
146012217|NCT01437111|526556427|FG000|Overall Study|Protocol Violation|1|||
146012218|NCT02131311|526556428|FG000|Overall Study|Adverse Event|2|||
146012219|NCT02131311|526556428|FG000|Overall Study|Protocol Violation|1|||
146012220|NCT02131311|526556428|FG000|Overall Study|Lost to Follow-up|1|||
146012221|NCT02623205|526556432|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
146012222|NCT02623205|526556433|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
146012223|NCT02473471|526556434|FG000|Overall Study|poor oral hygiene|2|||
146012224|NCT02473471|526556434|FG000|Overall Study|Lost to Follow-up|1|||
146012225|NCT03082677|526556435|FG000|Overall Study|Not Treated|2|||
146012226|NCT01667133|526556436|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
146012227|NCT01667133|526556437|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
146012228|NCT01667133|526556438|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
146012229|NCT01667133|526556439|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
146012230|NCT01667133|526556440|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
146012231|NCT01667133|526556441|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
146012232|NCT01667133|526556442|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
146012233|NCT01667133|526556443|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
146012234|NCT01667133|526556444|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
146012235|NCT01667133|526556445|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
146012236|NCT01667133|526556446|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
146012237|NCT01667133|526556447|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
146012238|NCT01667133|526556436|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012239|NCT01667133|526556437|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012240|NCT01667133|526556438|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
146012241|NCT01667133|526556439|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012242|NCT01667133|526556440|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012243|NCT01667133|526556441|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012244|NCT01667133|526556442|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012245|NCT01667133|526556443|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012246|NCT01667133|526556444|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012247|NCT01667133|526556445|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012248|NCT01667133|526556446|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012249|NCT01667133|526556447|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
146012250|NCT01667133|526556436|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
146012251|NCT01667133|526556437|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
146012252|NCT01667133|526556438|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
146012253|NCT01667133|526556439|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
146012254|NCT01667133|526556440|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
146012255|NCT01667133|526556441|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
146012256|NCT01667133|526556442|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
146012257|NCT01667133|526556443|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
146012258|NCT01667133|526556444|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
146012259|NCT01667133|526556445|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
146012260|NCT01667133|526556446|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
146012261|NCT01667133|526556447|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
146012262|NCT01667133|526556436|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012263|NCT01667133|526556437|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012264|NCT01667133|526556438|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012265|NCT01667133|526556439|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
146012266|NCT01667133|526556440|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012267|NCT01667133|526556441|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012268|NCT01667133|526556442|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012269|NCT01667133|526556443|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012270|NCT01667133|526556444|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012271|NCT01667133|526556445|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012272|NCT01667133|526556446|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012273|NCT01667133|526556447|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
146012274|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
146012275|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
146012276|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
146012277|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
146012278|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
146012279|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
146012280|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
146012281|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
146012282|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
146012283|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
146012284|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
146012285|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
146012286|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012287|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012288|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012289|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012290|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012291|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012292|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012293|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012294|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012295|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
146012296|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012297|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
146012298|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
146012299|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
146012300|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
146012301|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
146012302|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
146012303|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
146012304|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
146012305|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
146012306|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
146012307|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
146012308|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
146012309|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
146012310|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012311|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012312|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012313|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012314|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012315|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012316|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012317|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012318|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012319|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
146012320|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012321|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
146012322|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Death|0|||
146012323|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Death|0|||
146012324|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Death|0|||
146012325|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Death|0|||
146012326|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Death|0|||
146012327|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Death|0|||
146012328|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Death|0|||
146012329|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Death|0|||
146012330|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Death|0|||
146012331|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Death|1|||
146012332|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Death|0|||
146012333|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Death|0|||
146012334|NCT01667133|526556436|FG000|Phase 2: Dose-expansion|Other|0|||
146012335|NCT01667133|526556437|FG001|Phase 2: Dose-expansion|Other|0|||
146012336|NCT01667133|526556438|FG002|Phase 2: Dose-expansion|Other|0|||
146012337|NCT01667133|526556439|FG003|Phase 2: Dose-expansion|Other|0|||
146012338|NCT01667133|526556440|FG004|Phase 2: Dose-expansion|Other|0|||
146012339|NCT01667133|526556441|FG005|Phase 2: Dose-expansion|Other|0|||
146012340|NCT01667133|526556442|FG006|Phase 2: Dose-expansion|Other|0|||
146012341|NCT01667133|526556443|FG007|Phase 2: Dose-expansion|Other|0|||
146012342|NCT01667133|526556444|FG008|Phase 2: Dose-expansion|Other|0|||
146012343|NCT01667133|526556445|FG009|Phase 2: Dose-expansion|Other|0|||
146012344|NCT01667133|526556446|FG010|Phase 2: Dose-expansion|Other|0|||
146012345|NCT01667133|526556447|FG011|Phase 2: Dose-expansion|Other|1|||
146012346|NCT00255723|526556454|FG000|Overall Study|Adverse Event|1|||
146093223|NCT02598960|526863383|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
146093224|NCT02598960|526863371|FG000|Treatment Period|participant request to discontinue|0|||
146012347|NCT00255723|526556455|FG001|Overall Study|Adverse Event|1|||
146012348|NCT00255723|526556454|FG000|Overall Study|Death|0|||
146012349|NCT00255723|526556455|FG001|Overall Study|Death|1|||
146012350|NCT00255723|526556454|FG000|Overall Study|Response Data Not Available|1|||
146012351|NCT00255723|526556455|FG001|Overall Study|Response Data Not Available|0|||
146012352|NCT03711370|526556457|FG000|Overall Study|Lost to Follow-up|16|||
146093225|NCT02598960|526863372|FG001|Treatment Period|participant request to discontinue|1|||
146012353|NCT03711370|526556458|FG001|Overall Study|Lost to Follow-up|10|||
146012354|NCT03711370|526556457|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
146012355|NCT03711370|526556458|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
146012356|NCT01169701|526556461|FG000|Overall Study|Lost to Follow-up|1|||
146012357|NCT01169701|526556462|FG001|Overall Study|Lost to Follow-up|1|||
146012358|NCT01169701|526556461|FG000|Overall Study|Withdrawal by Subject|1|||
146012359|NCT01169701|526556462|FG001|Overall Study|Withdrawal by Subject|3|||
146012360|NCT01169701|526556461|FG000|Overall Study|Adverse Event|1|||
146012361|NCT01169701|526556462|FG001|Overall Study|Adverse Event|2|||
146012362|NCT01169701|526556461|FG000|Overall Study|Exclusion criteria|2|||
146012363|NCT01169701|526556462|FG001|Overall Study|Exclusion criteria|0|||
146012364|NCT01169701|526556461|FG000|Overall Study|Death|0|||
146012365|NCT01169701|526556462|FG001|Overall Study|Death|1|||
146012366|NCT01169701|526556461|FG000|Overall Study|Administrative problems|0|||
146012367|NCT01169701|526556462|FG001|Overall Study|Administrative problems|1|||
146012368|NCT01169701|526556461|FG000|Overall Study|Serious adverse event|0|||
146012369|NCT01169701|526556462|FG001|Overall Study|Serious adverse event|1|||
146012370|NCT01169701|526556461|FG000|Overall Study|Sponsor decision|0|||
146012371|NCT01169701|526556462|FG001|Overall Study|Sponsor decision|1|||
146012372|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
146012373|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
146012374|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
146012375|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
146012376|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
146012377|NCT01536561|526556463|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
146012378|NCT00553436|526556464|FG000|Overall Study|Conversion to another procedure|1|||
146012379|NCT04188834|526556465|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
146012380|NCT01030952|526556466|FG000|Overall Study|Protocol Violation|0|||
146012381|NCT01030952|526556467|FG001|Overall Study|Protocol Violation|1|||
146012382|NCT01030952|526556466|FG000|Overall Study|Informed consent withdrawal|1|||
146012383|NCT01030952|526556467|FG001|Overall Study|Informed consent withdrawal|0|||
146012384|NCT01030952|526556466|FG000|Overall Study|Lost to Follow-up|0|||
146012385|NCT01030952|526556467|FG001|Overall Study|Lost to Follow-up|1|||
146012386|NCT01030952|526556466|FG000|Overall Study|Unexplained|1|||
146012387|NCT01030952|526556467|FG001|Overall Study|Unexplained|1|||
146012388|NCT02455336|526556470|FG000|Overall Study|Withdrawal by Subject|0|||
146012389|NCT02455336|526556471|FG001|Overall Study|Withdrawal by Subject|2|||
146012390|NCT02455336|526556470|FG000|Overall Study|Adverse Event|3|||
146012391|NCT02455336|526556471|FG001|Overall Study|Adverse Event|0|||
146012392|NCT02455336|526556470|FG000|Overall Study|Non-responder to treatment|2|||
146012393|NCT02455336|526556471|FG001|Overall Study|Non-responder to treatment|0|||
146012394|NCT00391430|526556472|FG000|Overall Study|Withdrawal by Subject|3|||
146012395|NCT00391430|526556473|FG001|Overall Study|Withdrawal by Subject|0|||
146012396|NCT00391430|526556474|FG002|Overall Study|Withdrawal by Subject|12|||
146012397|NCT02467192|526556475|FG000|Overall Study|Death|1|||
146012398|NCT02467192|526556475|FG000|Overall Study|revealed to have pneumonia before|2|||
146012399|NCT01603043|526556476|FG000|Overall Study|Study Futility|7|||
146012400|NCT01603043|526556477|FG001|Overall Study|Study Futility|3|||
146012401|NCT04532294|526556478|FG000|Overall Study|Withdrawal by Subject|0|||
146012402|NCT04532294|526556479|FG001|Overall Study|Withdrawal by Subject|0|||
146012403|NCT04532294|526556480|FG002|Overall Study|Withdrawal by Subject|1|||
146012404|NCT04532294|526556478|FG000|Overall Study|Participants Not Dosed|0|||
146012405|NCT04532294|526556479|FG001|Overall Study|Participants Not Dosed|0|||
146012406|NCT04532294|526556480|FG002|Overall Study|Participants Not Dosed|2|||
146012407|NCT03497039|526556484|FG000|Overall Study|Withdrawal by Subject|1|||
146012408|NCT03497039|526556485|FG001|Overall Study|Withdrawal by Subject|0|||
146012409|NCT03497039|526556484|FG000|Overall Study|Protocol Violation|0|||
146012410|NCT03497039|526556485|FG001|Overall Study|Protocol Violation|1|||
146012411|NCT01451749|526556489|FG000|Overall Study|Protocol Violation|14|||
146012412|NCT01451749|526556490|FG001|Overall Study|Protocol Violation|7|||
146012413|NCT01451749|526556489|FG000|Overall Study|Lost to Follow-up|15|||
146012414|NCT01451749|526556490|FG001|Overall Study|Lost to Follow-up|5|||
146012415|NCT01451749|526556489|FG000|Overall Study|Meet the exclusion criteria,and|1|||
146012416|NCT01451749|526556490|FG001|Overall Study|Meet the exclusion criteria,and|1|||
146012417|NCT01451749|526556489|FG000|Overall Study|Adverse Event|2|||
146012418|NCT01451749|526556490|FG001|Overall Study|Adverse Event|0|||
146012419|NCT01451749|526556489|FG000|Overall Study|Withdrawal by Subject|0|||
146012420|NCT01451749|526556490|FG001|Overall Study|Withdrawal by Subject|1|||
146012421|NCT02949024|526556491|FG000|Overall Study|Withdrawal by Subject|0|||
146012422|NCT02949024|526556492|FG001|Overall Study|Withdrawal by Subject|1|||
146012423|NCT01027650|526556493|FG000|Overall Study|Personal Reasons|0|||
146012424|NCT01027650|526556494|FG001|Overall Study|Personal Reasons|0|||
146012425|NCT01027650|526556495|FG002|Overall Study|Personal Reasons|0|||
146012426|NCT01027650|526556496|FG003|Overall Study|Personal Reasons|0|||
146012427|NCT01027650|526556497|FG004|Overall Study|Personal Reasons|2|||
146012428|NCT01027650|526556498|FG005|Overall Study|Personal Reasons|1|||
146012429|NCT01027650|526556499|FG006|Overall Study|Personal Reasons|0|||
146012430|NCT01027650|526556500|FG007|Overall Study|Personal Reasons|0|||
146012431|NCT01027650|526556493|FG000|Overall Study|Lost to Follow-up|0|||
146012432|NCT01027650|526556494|FG001|Overall Study|Lost to Follow-up|0|||
146012433|NCT01027650|526556495|FG002|Overall Study|Lost to Follow-up|0|||
146012434|NCT01027650|526556496|FG003|Overall Study|Lost to Follow-up|0|||
146299105|NCT01130974|527610042|FG000|Overall Study|Withdrawal by Subject|0|||
146299106|NCT01130974|527610043|FG001|Overall Study|Withdrawal by Subject|1|||
146299107|NCT01130974|527610042|FG000|Overall Study|Ineligibility criteria|5|||
146299108|NCT01130974|527610043|FG001|Overall Study|Ineligibility criteria|2|||
146299109|NCT01395316|527610044|FG000|Overall Study|Lost to Follow-up|2|||
146299110|NCT01395316|527610044|FG000|Overall Study|poor MRI quality|1|||
146299111|NCT03359590|527610046|FG000|First Intervention|Withdrawal by Subject|1|||
146299112|NCT03359590|527610047|FG001|First Intervention|Withdrawal by Subject|1|||
146299113|NCT03359590|527610046|FG000|First Intervention|Protocol Violation|0|||
146299114|NCT03359590|527610047|FG001|First Intervention|Protocol Violation|1|||
146299115|NCT06132425|527610048|FG000|Overall Study|Withdrawal by Subject|3|||
146299116|NCT06132425|527610049|FG001|Overall Study|Withdrawal by Subject|0|||
146299117|NCT06132425|527610048|FG000|Overall Study|Did not follow study instructions|0|||
146299118|NCT06132425|527610049|FG001|Overall Study|Did not follow study instructions|2|||
146299119|NCT06132425|527610048|FG000|Overall Study|Lost to Follow-up|3|||
146299120|NCT06132425|527610049|FG001|Overall Study|Lost to Follow-up|5|||
146299121|NCT04409353|527610050|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
146299122|NCT04409353|527610051|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
146299123|NCT04409353|527610052|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
146299124|NCT04409353|527610050|FG000|Overall Study|Lost to Follow-up|6|||
146299125|NCT04409353|527610051|FG001|Overall Study|Lost to Follow-up|8|||
146299126|NCT04409353|527610052|FG002|Overall Study|Lost to Follow-up|7|||
146299127|NCT04409353|527610050|FG000|Overall Study|Major surgery during participation window|4|||
146299128|NCT04409353|527610051|FG001|Overall Study|Major surgery during participation window|3|||
146299129|NCT04409353|527610052|FG002|Overall Study|Major surgery during participation window|3|||
146299130|NCT04409353|527610050|FG000|Overall Study|Life event occurred during participation window|3|||
146299131|NCT04409353|527610051|FG001|Overall Study|Life event occurred during participation window|2|||
146299132|NCT04409353|527610052|FG002|Overall Study|Life event occurred during participation window|4|||
146299133|NCT04409353|527610050|FG000|Overall Study|Lack of Efficacy|4|||
146299134|NCT04409353|527610051|FG001|Overall Study|Lack of Efficacy|1|||
146299135|NCT04409353|527610052|FG002|Overall Study|Lack of Efficacy|3|||
146299136|NCT04409353|527610050|FG000|Overall Study|Adverse Event|2|||
146299137|NCT04409353|527610051|FG001|Overall Study|Adverse Event|1|||
146299138|NCT04409353|527610052|FG002|Overall Study|Adverse Event|1|||
146299139|NCT04409353|527610050|FG000|Overall Study|Disease burden - unable to participate|0|||
146299140|NCT04409353|527610051|FG001|Overall Study|Disease burden - unable to participate|1|||
146299141|NCT04409353|527610052|FG002|Overall Study|Disease burden - unable to participate|1|||
146299142|NCT04409353|527610050|FG000|Overall Study|Intervention too complicated|1|||
146299143|NCT04409353|527610051|FG001|Overall Study|Intervention too complicated|0|||
146299144|NCT04409353|527610052|FG002|Overall Study|Intervention too complicated|1|||
146299145|NCT06308666|527610053|FG000|Overall Study|Withdrawal by Subject|1|||
146299146|NCT06308666|527610053|FG000|Overall Study|Protocol Violation|2|||
146012435|NCT01027650|526556497|FG004|Overall Study|Lost to Follow-up|0|||
146012436|NCT01027650|526556498|FG005|Overall Study|Lost to Follow-up|0|||
146012437|NCT01027650|526556499|FG006|Overall Study|Lost to Follow-up|1|||
146012438|NCT01027650|526556500|FG007|Overall Study|Lost to Follow-up|0|||
146012439|NCT01027650|526556493|FG000|Overall Study|Lack of Efficacy|0|||
146012440|NCT01027650|526556494|FG001|Overall Study|Lack of Efficacy|0|||
146012441|NCT01027650|526556495|FG002|Overall Study|Lack of Efficacy|0|||
146012442|NCT01027650|526556496|FG003|Overall Study|Lack of Efficacy|0|||
146012443|NCT01027650|526556497|FG004|Overall Study|Lack of Efficacy|0|||
146012444|NCT01027650|526556498|FG005|Overall Study|Lack of Efficacy|1|||
146012445|NCT01027650|526556499|FG006|Overall Study|Lack of Efficacy|0|||
146012446|NCT01027650|526556500|FG007|Overall Study|Lack of Efficacy|0|||
146012447|NCT00912782|526556501|FG000|Overall Study|Death|2|||
146012448|NCT00912782|526556502|FG001|Overall Study|Death|1|||
146012449|NCT00912782|526556501|FG000|Overall Study|Lost to Follow-up|0|||
146012450|NCT00912782|526556502|FG001|Overall Study|Lost to Follow-up|1|||
146012451|NCT00912782|526556501|FG000|Overall Study|Did not receive vascular access type|1|||
146012452|NCT00912782|526556502|FG001|Overall Study|Did not receive vascular access type|2|||
146012453|NCT00912782|526556501|FG000|Overall Study|Relocated before study completion|0|||
146299147|NCT02499770|527610056|FG000|Overall Study|Death|17|||
146299148|NCT02499770|527610057|FG001|Overall Study|Death|56|||
146299149|NCT02499770|527610056|FG000|Overall Study|Study completion|1|||
146299150|NCT02499770|527610057|FG001|Overall Study|Study completion|10|||
146299151|NCT02499770|527610056|FG000|Overall Study|Withdrawal by Subject|0|||
146299152|NCT02499770|527610057|FG001|Overall Study|Withdrawal by Subject|7|||
146299153|NCT02499770|527610056|FG000|Overall Study|Lost to Follow-up|0|||
146012454|NCT00912782|526556502|FG001|Overall Study|Relocated before study completion|1|||
146012455|NCT02712983|526558627|FG000|Treatment Phase|Adverse Event|3|||
146012456|NCT02712983|526558628|FG001|Treatment Phase|Adverse Event|1|||
146012457|NCT02712983|526558629|FG002|Treatment Phase|Adverse Event|1|||
146299154|NCT02499770|527610057|FG001|Overall Study|Lost to Follow-up|2|||
146299155|NCT02499770|527610056|FG000|Overall Study|Subject declined further treatment|1|||
146299156|NCT02499770|527610057|FG001|Overall Study|Subject declined further treatment|0|||
146012458|NCT02712983|526558630|FG003|Treatment Phase|Adverse Event|4|||
146012459|NCT02712983|526558631|FG004|Treatment Phase|Adverse Event|3|||
146012460|NCT02712983|526558632|FG005|Treatment Phase|Adverse Event|0|||
146012461|NCT02712983|526558633|FG006|Treatment Phase|Adverse Event|6|||
146012462|NCT02712983|526558634|FG007|Treatment Phase|Adverse Event|6|||
146012463|NCT02712983|526558635|FG008|Treatment Phase|Adverse Event|1|||
146012464|NCT02712983|526558627|FG000|Treatment Phase|Protocol Deviation|0|||
146012465|NCT02712983|526558628|FG001|Treatment Phase|Protocol Deviation|0|||
146012466|NCT02712983|526558629|FG002|Treatment Phase|Protocol Deviation|0|||
146012467|NCT02712983|526558630|FG003|Treatment Phase|Protocol Deviation|2|||
146012468|NCT02712983|526558631|FG004|Treatment Phase|Protocol Deviation|0|||
146012469|NCT02712983|526558632|FG005|Treatment Phase|Protocol Deviation|0|||
146012470|NCT02712983|526558633|FG006|Treatment Phase|Protocol Deviation|1|||
146012471|NCT02712983|526558634|FG007|Treatment Phase|Protocol Deviation|0|||
146012472|NCT02712983|526558635|FG008|Treatment Phase|Protocol Deviation|0|||
146012473|NCT02712983|526558627|FG000|Treatment Phase|Technical Problems|0|||
146012474|NCT02712983|526558628|FG001|Treatment Phase|Technical Problems|0|||
146093226|NCT02598960|526863373|FG002|Treatment Period|participant request to discontinue|0|||
146093227|NCT02598960|526863374|FG003|Treatment Period|participant request to discontinue|0|||
146093228|NCT02598960|526863375|FG004|Treatment Period|participant request to discontinue|1|||
146093229|NCT02598960|526863376|FG005|Treatment Period|participant request to discontinue|0|||
146093230|NCT02598960|526863377|FG006|Treatment Period|participant request to discontinue|0|||
146093231|NCT02598960|526863378|FG007|Treatment Period|participant request to discontinue|0|||
146093232|NCT02598960|526863379|FG008|Treatment Period|participant request to discontinue|0|||
146093233|NCT02598960|526863380|FG009|Treatment Period|participant request to discontinue|0|||
146093234|NCT02598960|526863381|FG010|Treatment Period|participant request to discontinue|1|||
146093235|NCT02598960|526863382|FG011|Treatment Period|participant request to discontinue|4|||
146012475|NCT02712983|526558629|FG002|Treatment Phase|Technical Problems|0|||
146012476|NCT02712983|526558630|FG003|Treatment Phase|Technical Problems|0|||
146012477|NCT02712983|526558631|FG004|Treatment Phase|Technical Problems|0|||
146012478|NCT02712983|526558632|FG005|Treatment Phase|Technical Problems|0|||
146093236|NCT02598960|526863383|FG012|Treatment Period|participant request to discontinue|0|||
146093237|NCT02598960|526863371|FG000|Treatment Period|participant withdrew consent|0|||
146012479|NCT02712983|526558633|FG006|Treatment Phase|Technical Problems|1|||
146012480|NCT02712983|526558634|FG007|Treatment Phase|Technical Problems|0|||
146012481|NCT02712983|526558635|FG008|Treatment Phase|Technical Problems|0|||
146012482|NCT02712983|526558627|FG000|Treatment Phase|Physician Decision|0|||
146012483|NCT02712983|526558628|FG001|Treatment Phase|Physician Decision|0|||
146012484|NCT02712983|526558629|FG002|Treatment Phase|Physician Decision|0|||
146012485|NCT02712983|526558630|FG003|Treatment Phase|Physician Decision|0|||
146012486|NCT02712983|526558631|FG004|Treatment Phase|Physician Decision|0|||
146012487|NCT02712983|526558632|FG005|Treatment Phase|Physician Decision|0|||
146012488|NCT02712983|526558633|FG006|Treatment Phase|Physician Decision|0|||
146012489|NCT02712983|526558634|FG007|Treatment Phase|Physician Decision|1|||
146012490|NCT02712983|526558635|FG008|Treatment Phase|Physician Decision|1|||
146012491|NCT02712983|526558627|FG000|Treatment Phase|Subject Decision|2|||
146012492|NCT02712983|526558628|FG001|Treatment Phase|Subject Decision|0|||
146012493|NCT02712983|526558629|FG002|Treatment Phase|Subject Decision|0|||
146012494|NCT02712983|526558630|FG003|Treatment Phase|Subject Decision|2|||
146012495|NCT02712983|526558631|FG004|Treatment Phase|Subject Decision|1|||
146012496|NCT02712983|526558632|FG005|Treatment Phase|Subject Decision|0|||
146012497|NCT02712983|526558633|FG006|Treatment Phase|Subject Decision|1|||
146012498|NCT02712983|526558634|FG007|Treatment Phase|Subject Decision|2|||
146093238|NCT02598960|526863372|FG001|Treatment Period|participant withdrew consent|0|||
146093239|NCT02598960|526863373|FG002|Treatment Period|participant withdrew consent|0|||
146093240|NCT02598960|526863374|FG003|Treatment Period|participant withdrew consent|0|||
146093241|NCT02598960|526863375|FG004|Treatment Period|participant withdrew consent|0|||
146093242|NCT02598960|526863376|FG005|Treatment Period|participant withdrew consent|0|||
146093243|NCT02598960|526863377|FG006|Treatment Period|participant withdrew consent|0|||
146093244|NCT02598960|526863378|FG007|Treatment Period|participant withdrew consent|0|||
146093245|NCT02598960|526863379|FG008|Treatment Period|participant withdrew consent|0|||
146093246|NCT02598960|526863380|FG009|Treatment Period|participant withdrew consent|0|||
146093247|NCT02598960|526863381|FG010|Treatment Period|participant withdrew consent|0|||
146012499|NCT02712983|526558635|FG008|Treatment Phase|Subject Decision|0|||
146012500|NCT02712983|526558627|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012501|NCT02712983|526558628|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146012502|NCT02712983|526558629|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012503|NCT02712983|526558630|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012504|NCT02712983|526558631|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012505|NCT02712983|526558632|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012506|NCT02712983|526558633|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146012507|NCT02712983|526558634|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
146093248|NCT02598960|526863382|FG011|Treatment Period|participant withdrew consent|3|||
146093249|NCT02598960|526863383|FG012|Treatment Period|participant withdrew consent|0|||
146299157|NCT02499770|527610056|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
146299158|NCT02499770|527610057|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
146012508|NCT02712983|526558635|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146012509|NCT02712983|526558627|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012510|NCT02712983|526558628|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012511|NCT02712983|526558629|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012512|NCT02712983|526558630|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
146012513|NCT02712983|526558631|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012514|NCT02712983|526558632|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012515|NCT02712983|526558633|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012516|NCT02712983|526558634|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146093250|NCT02598960|526863371|FG000|Treatment Period|No longer meets study criteria|0|||
146093251|NCT02598960|526863372|FG001|Treatment Period|No longer meets study criteria|0|||
146250057|NCT00091572|527426862|FG001|Overall Study|Ongoing (still on treatment)|12|||
146250058|NCT00091572|527426861|FG000|Overall Study|Major Protocol Violation|2|||
146250059|NCT00091572|527426862|FG001|Overall Study|Major Protocol Violation|0|||
146250060|NCT00091572|527426861|FG000|Overall Study|Toxicity (Related AE)|53|||
146250061|NCT00091572|527426862|FG001|Overall Study|Toxicity (Related AE)|9|||
146250062|NCT01199302|527426864|FG000|Overall Study|Adverse Event|1|||
146250063|NCT01199302|527426865|FG001|Overall Study|Adverse Event|1|||
146250064|NCT01199302|527426866|FG002|Overall Study|Adverse Event|2|||
146250065|NCT01199302|527426867|FG003|Overall Study|Adverse Event|0|||
146250066|NCT01199302|527426864|FG000|Overall Study|Withdrawal by Subject|2|||
146250067|NCT01199302|527426865|FG001|Overall Study|Withdrawal by Subject|2|||
146250068|NCT01199302|527426866|FG002|Overall Study|Withdrawal by Subject|3|||
146250069|NCT01199302|527426867|FG003|Overall Study|Withdrawal by Subject|0|||
146250070|NCT01199302|527426864|FG000|Overall Study|Disease Progression|3|||
146250071|NCT01199302|527426865|FG001|Overall Study|Disease Progression|4|||
146250072|NCT01199302|527426866|FG002|Overall Study|Disease Progression|4|||
146250073|NCT01199302|527426867|FG003|Overall Study|Disease Progression|2|||
146250074|NCT01199302|527426864|FG000|Overall Study|Study Termination|13|||
146250075|NCT01199302|527426865|FG001|Overall Study|Study Termination|8|||
146250076|NCT01199302|527426866|FG002|Overall Study|Study Termination|11|||
146250077|NCT01199302|527426867|FG003|Overall Study|Study Termination|9|||
146250078|NCT01199302|527426864|FG000|Overall Study|Lost to Follow-up|0|||
146250079|NCT01199302|527426865|FG001|Overall Study|Lost to Follow-up|1|||
146250080|NCT01199302|527426866|FG002|Overall Study|Lost to Follow-up|0|||
146250081|NCT01199302|527426867|FG003|Overall Study|Lost to Follow-up|0|||
146250082|NCT01199302|527426864|FG000|Overall Study|Other|1|||
146250083|NCT01199302|527426865|FG001|Overall Study|Other|0|||
146250084|NCT01199302|527426866|FG002|Overall Study|Other|0|||
146250085|NCT01199302|527426867|FG003|Overall Study|Other|0|||
146250086|NCT04433091|527426868|FG000|Overall Study|Lost to Follow-up|1|||
146250087|NCT04433091|527426869|FG001|Overall Study|Lost to Follow-up|0|||
146250088|NCT04433091|527426868|FG000|Overall Study|Withdrawn .|2|||
146250089|NCT04433091|527426869|FG001|Overall Study|Withdrawn .|4|||
146250090|NCT05356130|527428051|FG000|Overall Study|Withdrawal by Subject|0|||
146250091|NCT05356130|527428052|FG001|Overall Study|Withdrawal by Subject|0|||
146250092|NCT05356130|527428053|FG002|Overall Study|Withdrawal by Subject|3|||
146250093|NCT04851587|527428054|FG000|Overall Study|Lost to Follow-up|18|||
146250094|NCT02880293|527428055|FG000|Overall Study|Inevaluable|5|||
146250095|NCT02109172|527428059|FG000|Overall Study|Withdrawal by Subject|1|||
146250096|NCT02109172|527428060|FG001|Overall Study|Withdrawal by Subject|0|||
146250097|NCT02109172|527428061|FG002|Overall Study|Withdrawal by Subject|0|||
146250098|NCT02109172|527428062|FG003|Overall Study|Withdrawal by Subject|1|||
146250099|NCT02109172|527428063|FG004|Overall Study|Withdrawal by Subject|0|||
146250100|NCT02109172|527428064|FG005|Overall Study|Withdrawal by Subject|0|||
146250101|NCT02109172|527428059|FG000|Overall Study|Adverse Event|0|||
146250102|NCT02109172|527428060|FG001|Overall Study|Adverse Event|0|||
146299159|NCT02499770|527610056|FG000|Overall Study|Randomized but not enrolled|0|||
146250103|NCT02109172|527428061|FG002|Overall Study|Adverse Event|1|||
146250104|NCT02109172|527428062|FG003|Overall Study|Adverse Event|0|||
146250105|NCT02109172|527428063|FG004|Overall Study|Adverse Event|0|||
146250106|NCT02109172|527428064|FG005|Overall Study|Adverse Event|1|||
146250107|NCT02109172|527428059|FG000|Overall Study|Death|0|||
146250108|NCT02109172|527428060|FG001|Overall Study|Death|0|||
146250109|NCT02109172|527428061|FG002|Overall Study|Death|0|||
146250110|NCT02109172|527428062|FG003|Overall Study|Death|0|||
146250111|NCT02109172|527428063|FG004|Overall Study|Death|1|||
146250112|NCT02109172|527428064|FG005|Overall Study|Death|0|||
146250113|NCT03409276|527428065|FG000|Overall Study|Withdrawal by Subject|0|||
146250114|NCT03409276|527428066|FG001|Overall Study|Withdrawal by Subject|0|||
146250115|NCT03409276|527428067|FG002|Overall Study|Withdrawal by Subject|0|||
146250116|NCT03409276|527428068|FG003|Overall Study|Withdrawal by Subject|0|||
146250117|NCT03409276|527428069|FG004|Overall Study|Withdrawal by Subject|1|||
146250118|NCT03409276|527428065|FG000|Overall Study|Lost to Follow-up|0|||
146012517|NCT02712983|526558635|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
146012518|NCT02712983|526558627|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146012519|NCT02712983|526558628|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146012520|NCT02712983|526558629|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146012521|NCT02712983|526558630|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146012522|NCT02712983|526558631|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
146012523|NCT02712983|526558632|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
146012524|NCT02712983|526558633|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
146012525|NCT02712983|526558634|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
146012526|NCT02712983|526558635|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
146012527|NCT05360966|526558640|FG000|Overall Study|Adverse Event|5|||
146012528|NCT05360966|526558641|FG001|Overall Study|Adverse Event|5|||
146012529|NCT05360966|526558640|FG000|Overall Study|Withdrawal of Consent|5|||
146012530|NCT05360966|526558641|FG001|Overall Study|Withdrawal of Consent|3|||
146012531|NCT05360966|526558640|FG000|Overall Study|Noncompliance|2|||
146012532|NCT05360966|526558641|FG001|Overall Study|Noncompliance|1|||
146012533|NCT05360966|526558640|FG000|Overall Study|Lost to Follow-up|2|||
146012534|NCT05360966|526558641|FG001|Overall Study|Lost to Follow-up|3|||
146012535|NCT05360966|526558640|FG000|Overall Study|Protocol Deviation|2|||
146012536|NCT05360966|526558641|FG001|Overall Study|Protocol Deviation|1|||
146012537|NCT05360966|526558640|FG000|Overall Study|As specified in the Clinical Study Report|1|||
146012538|NCT05360966|526558641|FG001|Overall Study|As specified in the Clinical Study Report|3|||
146012539|NCT05258890|526558643|FG000|Overall Study|Patient withdrawal|6|||
146012540|NCT05258890|526558644|FG001|Overall Study|Patient withdrawal|7|||
146012541|NCT05258890|526558643|FG000|Overall Study|Patient lost to follow-up|10|||
146012542|NCT05258890|526558644|FG001|Overall Study|Patient lost to follow-up|3|||
146012543|NCT05258890|526558643|FG000|Overall Study|Social network member withdrawal|1|||
146012544|NCT05258890|526558644|FG001|Overall Study|Social network member withdrawal|0|||
146012545|NCT05258890|526558643|FG000|Overall Study|Social network member lost to follow-up|5|||
146012546|NCT05258890|526558644|FG001|Overall Study|Social network member lost to follow-up|0|||
146012547|NCT05959447|526558645|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
146012548|NCT05959447|526558646|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
146012549|NCT05959447|526558645|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
146012550|NCT05959447|526558646|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
146012551|NCT05959447|526558645|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
146012552|NCT05959447|526558646|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
146012553|NCT05959447|526558645|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
146012554|NCT05959447|526558646|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
146012555|NCT00566982|526558647|FG000|Overall Study|Adverse Event|6|||
146012556|NCT00566982|526558648|FG001|Overall Study|Adverse Event|48|||
146012557|NCT00566982|526558647|FG000|Overall Study|Withdrawal by Subject|1|||
146012558|NCT00566982|526558648|FG001|Overall Study|Withdrawal by Subject|14|||
146012559|NCT00566982|526558647|FG000|Overall Study|Protocol Violation|1|||
146012560|NCT00566982|526558648|FG001|Overall Study|Protocol Violation|4|||
146093252|NCT02598960|526863373|FG002|Treatment Period|No longer meets study criteria|0|||
146093253|NCT02598960|526863374|FG003|Treatment Period|No longer meets study criteria|0|||
146093254|NCT02598960|526863375|FG004|Treatment Period|No longer meets study criteria|0|||
146093255|NCT02598960|526863376|FG005|Treatment Period|No longer meets study criteria|0|||
146093256|NCT02598960|526863377|FG006|Treatment Period|No longer meets study criteria|0|||
146093257|NCT02598960|526863378|FG007|Treatment Period|No longer meets study criteria|0|||
146093258|NCT02598960|526863379|FG008|Treatment Period|No longer meets study criteria|0|||
146093259|NCT02598960|526863380|FG009|Treatment Period|No longer meets study criteria|0|||
146093260|NCT02598960|526863381|FG010|Treatment Period|No longer meets study criteria|0|||
146093261|NCT02598960|526863382|FG011|Treatment Period|No longer meets study criteria|1|||
146093262|NCT02598960|526863383|FG012|Treatment Period|No longer meets study criteria|0|||
146093263|NCT02598960|526863371|FG000|Treatment Period|Other Reasons|0|||
146093264|NCT02598960|526863372|FG001|Treatment Period|Other Reasons|0|||
146093265|NCT02598960|526863373|FG002|Treatment Period|Other Reasons|0|||
146093266|NCT02598960|526863374|FG003|Treatment Period|Other Reasons|0|||
146093267|NCT02598960|526863375|FG004|Treatment Period|Other Reasons|0|||
146093268|NCT02598960|526863376|FG005|Treatment Period|Other Reasons|0|||
146093269|NCT02598960|526863377|FG006|Treatment Period|Other Reasons|0|||
146093270|NCT02598960|526863378|FG007|Treatment Period|Other Reasons|0|||
146093271|NCT02598960|526863379|FG008|Treatment Period|Other Reasons|0|||
146093272|NCT02598960|526863380|FG009|Treatment Period|Other Reasons|0|||
146093273|NCT02598960|526863381|FG010|Treatment Period|Other Reasons|0|||
146093274|NCT02598960|526863382|FG011|Treatment Period|Other Reasons|0|||
146093275|NCT02598960|526863383|FG012|Treatment Period|Other Reasons|1|||
146093276|NCT02598960|526863371|FG000|Participants Entering Follow Up Period|Death|1|||
146093277|NCT02598960|526863372|FG001|Participants Entering Follow Up Period|Death|0|||
146093278|NCT02598960|526863373|FG002|Participants Entering Follow Up Period|Death|0|||
146250119|NCT03409276|527428066|FG001|Overall Study|Lost to Follow-up|0|||
146250120|NCT03409276|527428067|FG002|Overall Study|Lost to Follow-up|0|||
146012561|NCT00566982|526558647|FG000|Overall Study|Lost to Follow-up|0|||
146012562|NCT00566982|526558648|FG001|Overall Study|Lost to Follow-up|1|||
146012563|NCT00566982|526558647|FG000|Overall Study|Other-family problems & doctor's request|0|||
146012564|NCT00566982|526558648|FG001|Overall Study|Other-family problems & doctor's request|2|||
146012565|NCT00443872|526558651|FG000|Overall Study|Protocol Violation|7|||
146012566|NCT00443872|526558651|FG000|Overall Study|Lost to Follow-up|2|||
146012567|NCT00443872|526558651|FG000|Overall Study|Adverse Event|8|||
146012568|NCT02789345|526558652|FG000|Overall Study|Adverse Event|0|||
146012569|NCT02789345|526558653|FG001|Overall Study|Adverse Event|0|||
146012570|NCT02789345|526558654|FG002|Overall Study|Adverse Event|1|||
146012571|NCT02789345|526558652|FG000|Overall Study|Death|0|||
146012572|NCT02789345|526558653|FG001|Overall Study|Death|0|||
146012573|NCT02789345|526558654|FG002|Overall Study|Death|1|||
146012574|NCT02789345|526558652|FG000|Overall Study|Physician Decision|2|||
146012575|NCT02789345|526558653|FG001|Overall Study|Physician Decision|0|||
146012576|NCT02789345|526558654|FG002|Overall Study|Physician Decision|1|||
146012577|NCT02789345|526558652|FG000|Overall Study|Progressive Disease|1|||
146012578|NCT02789345|526558653|FG001|Overall Study|Progressive Disease|3|||
146012579|NCT02789345|526558654|FG002|Overall Study|Progressive Disease|14|||
146012580|NCT00700622|526558661|FG000|Overall Study|Adverse Event|4|||
146012581|NCT00700622|526558662|FG001|Overall Study|Adverse Event|0|||
146012582|NCT00700622|526558661|FG000|Overall Study|Lost to Follow-up|0|||
146012583|NCT00700622|526558662|FG001|Overall Study|Lost to Follow-up|1|||
146012584|NCT00700622|526558661|FG000|Overall Study|Physician Decision|2|||
146012585|NCT00700622|526558662|FG001|Overall Study|Physician Decision|1|||
146012586|NCT00700622|526558661|FG000|Overall Study|Protocol Violation|0|||
146012587|NCT00700622|526558662|FG001|Overall Study|Protocol Violation|1|||
146012588|NCT00700622|526558661|FG000|Overall Study|Withdrawal by Subject|4|||
146012589|NCT00700622|526558662|FG001|Overall Study|Withdrawal by Subject|1|||
146012590|NCT00700622|526558661|FG000|Overall Study|Other|3|||
146012591|NCT00700622|526558662|FG001|Overall Study|Other|1|||
146012592|NCT00383331|526558663|FG000|Overall Study|Protocol Violation|0|||
146012593|NCT00383331|526558664|FG001|Overall Study|Protocol Violation|1|||
146012594|NCT02253433|526558665|FG000|Overall Study|Unable to Contact|9|||
146012595|NCT02253433|526558666|FG001|Overall Study|Unable to Contact|16|||
146012596|NCT02253433|526558665|FG000|Overall Study|Death|1|||
146012597|NCT02253433|526558666|FG001|Overall Study|Death|1|||
146012598|NCT02253433|526558665|FG000|Overall Study|No Longer Interested|3|||
146012599|NCT02253433|526558666|FG001|Overall Study|No Longer Interested|15|||
146012600|NCT02253433|526558665|FG000|Overall Study|Out of Study Area|2|||
146012601|NCT02253433|526558666|FG001|Overall Study|Out of Study Area|7|||
146012602|NCT02253433|526558665|FG000|Overall Study|Uncomfortable with home visitors|0|||
146012603|NCT02253433|526558666|FG001|Overall Study|Uncomfortable with home visitors|3|||
146012604|NCT02253433|526558665|FG000|Overall Study|Unstable Housing/Homeless|0|||
146012605|NCT02253433|526558666|FG001|Overall Study|Unstable Housing/Homeless|7|||
146012606|NCT02253433|526558665|FG000|Overall Study|Too Busy|0|||
146012607|NCT02253433|526558666|FG001|Overall Study|Too Busy|4|||
146012608|NCT02253433|526558665|FG000|Overall Study|Medical or Other Concerns|1|||
146012609|NCT02253433|526558666|FG001|Overall Study|Medical or Other Concerns|2|||
146012610|NCT00372619|526558676|FG000|Overall Study|Ineligible|0|||
146012611|NCT00372619|526558677|FG001|Overall Study|Ineligible|0|||
146012612|NCT00372619|526558678|FG002|Overall Study|Ineligible|0|||
146012613|NCT00372619|526558679|FG003|Overall Study|Ineligible|0|||
146012614|NCT00372619|526558680|FG004|Overall Study|Ineligible|0|||
146012615|NCT00372619|526558681|FG005|Overall Study|Ineligible|2|||
146012616|NCT00372619|526558682|FG006|Overall Study|Ineligible|0|||
146012617|NCT00372619|526558676|FG000|Overall Study|Inevaluable|0|||
146012618|NCT00372619|526558677|FG001|Overall Study|Inevaluable|0|||
146012619|NCT00372619|526558678|FG002|Overall Study|Inevaluable|0|||
146012620|NCT00372619|526558679|FG003|Overall Study|Inevaluable|0|||
146012621|NCT00372619|526558680|FG004|Overall Study|Inevaluable|0|||
146012622|NCT00372619|526558681|FG005|Overall Study|Inevaluable|1|||
146012623|NCT00372619|526558682|FG006|Overall Study|Inevaluable|0|||
146012624|NCT00066222|526558683|FG000|Overall Study|No protocol treatment received|1|||
146012625|NCT01703091|526558695|FG000|Overall Study|Adverse Event|5|||
146250121|NCT03409276|527428068|FG003|Overall Study|Lost to Follow-up|2|||
146012626|NCT01703091|526558696|FG001|Overall Study|Adverse Event|3|||
146012627|NCT01703091|526558695|FG000|Overall Study|Physician Decision|2|||
146012628|NCT01703091|526558696|FG001|Overall Study|Physician Decision|1|||
146012629|NCT01703091|526558695|FG000|Overall Study|Withdrawal by Subject|1|||
146012630|NCT01703091|526558696|FG001|Overall Study|Withdrawal by Subject|0|||
146012631|NCT01703091|526558695|FG000|Overall Study|Sponsor Decision|1|||
146012632|NCT01703091|526558696|FG001|Overall Study|Sponsor Decision|0|||
146012633|NCT03902392|526558697|FG000|Overall Study|Lost to Follow-up|7|||
146012634|NCT03902392|526558698|FG001|Overall Study|Lost to Follow-up|7|||
146012635|NCT00244725|526558699|FG000|Overall Study|Lost to Follow-up|3|||
146012636|NCT00244725|526558700|FG001|Overall Study|Lost to Follow-up|4|||
146012637|NCT00244725|526558701|FG002|Overall Study|Lost to Follow-up|9|||
146012638|NCT00244725|526558702|FG003|Overall Study|Lost to Follow-up|2|||
146012639|NCT00244725|526558699|FG000|Overall Study|Withdrawal by Subject|9|||
146012640|NCT00244725|526558700|FG001|Overall Study|Withdrawal by Subject|7|||
146299160|NCT02499770|527610057|FG001|Overall Study|Randomized but not enrolled|1|||
146299161|NCT00671554|527610064|FG000|Overall Study|Disease progression|3|||
146299162|NCT04376060|527610065|FG000|Overall Study|Physician Decision|1|||
146299163|NCT00977574|527610066|FG000|Overall Study|Never Treated|4|||
146299164|NCT00977574|527610067|FG001|Overall Study|Never Treated|2|||
146299165|NCT00977574|527610068|FG002|Overall Study|Never Treated|4|||
146299166|NCT07052682|527610069|FG000|Overall Study|Withdrawal by Subject|4|||
146299167|NCT04667247|527610070|FG000|Overall Study|Withdrawal by Subject|0|||
146299168|NCT04667247|527610071|FG001|Overall Study|Withdrawal by Subject|1|||
146299169|NCT05460273|527610072|FG000|Overall Study|Death|43|||
146299170|NCT05460273|527610073|FG001|Overall Study|Death|9|||
146299171|NCT05460273|527610072|FG000|Overall Study|Lost to Follow-up|7|||
146299172|NCT05460273|527610073|FG001|Overall Study|Lost to Follow-up|0|||
146299173|NCT05460273|527610072|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
146299174|NCT05460273|527610073|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
146299175|NCT04124614|527610074|FG000|Placebo Run-in Period|Not Randomized|34|||
146299176|NCT04124614|527610075|FG001|Placebo Run-in Period|Not Randomized|0|||
146299177|NCT04124614|527610076|FG002|Placebo Run-in Period|Not Randomized|0|||
146299178|NCT04124614|527610074|FG000|Double Blind Treatment Period|Adverse Event|0|||
146299179|NCT04124614|527610075|FG001|Double Blind Treatment Period|Adverse Event|7|||
146299180|NCT04124614|527610076|FG002|Double Blind Treatment Period|Adverse Event|22|||
146299181|NCT04124614|527610074|FG000|Double Blind Treatment Period|Death|0|||
146299182|NCT04124614|527610075|FG001|Double Blind Treatment Period|Death|0|||
146299183|NCT04124614|527610076|FG002|Double Blind Treatment Period|Death|1|||
146299184|NCT04124614|527610074|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146299185|NCT04124614|527610075|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
146299186|NCT04124614|527610076|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
146299187|NCT04124614|527610074|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
146299188|NCT04124614|527610075|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
146299189|NCT04124614|527610076|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
146299190|NCT04124614|527610074|FG000|Double Blind Treatment Period|Physician Decision|0|||
146299191|NCT04124614|527610075|FG001|Double Blind Treatment Period|Physician Decision|0|||
146299192|NCT04124614|527610076|FG002|Double Blind Treatment Period|Physician Decision|3|||
146299193|NCT04124614|527610074|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
146012641|NCT00244725|526558701|FG002|Overall Study|Withdrawal by Subject|7|||
146012642|NCT00244725|526558702|FG003|Overall Study|Withdrawal by Subject|8|||
146012643|NCT00244725|526558699|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
146012644|NCT00244725|526558700|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
146012645|NCT00244725|526558701|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
146012646|NCT00244725|526558702|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
146012647|NCT00244725|526558699|FG000|Overall Study|Physician Decision|3|||
146012648|NCT00244725|526558700|FG001|Overall Study|Physician Decision|0|||
146012649|NCT00244725|526558701|FG002|Overall Study|Physician Decision|1|||
146012650|NCT00244725|526558702|FG003|Overall Study|Physician Decision|2|||
146012651|NCT00244725|526558699|FG000|Overall Study|Adverse Events|3|||
146012652|NCT00244725|526558700|FG001|Overall Study|Adverse Events|1|||
146012653|NCT00244725|526558701|FG002|Overall Study|Adverse Events|4|||
146012654|NCT00244725|526558702|FG003|Overall Study|Adverse Events|4|||
146012655|NCT00244725|526558699|FG000|Overall Study|Withdrwal by participant|1|||
146012656|NCT00244725|526558700|FG001|Overall Study|Withdrwal by participant|0|||
146012657|NCT00244725|526558701|FG002|Overall Study|Withdrwal by participant|0|||
146012658|NCT00244725|526558702|FG003|Overall Study|Withdrwal by participant|1|||
146012659|NCT00244725|526558699|FG000|Overall Study|Liver function test abnormality|2|||
146012660|NCT00244725|526558700|FG001|Overall Study|Liver function test abnormality|0|||
146012661|NCT00244725|526558701|FG002|Overall Study|Liver function test abnormality|0|||
146012662|NCT00244725|526558702|FG003|Overall Study|Liver function test abnormality|1|||
146012663|NCT00244725|526558699|FG000|Overall Study|Sponsor withdrew the participant|1|||
146012664|NCT00244725|526558700|FG001|Overall Study|Sponsor withdrew the participant|0|||
146012665|NCT00244725|526558701|FG002|Overall Study|Sponsor withdrew the participant|0|||
146299194|NCT04124614|527610075|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
146299195|NCT04124614|527610076|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
146299196|NCT04124614|527610074|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146012666|NCT00244725|526558702|FG003|Overall Study|Sponsor withdrew the participant|1|||
146012667|NCT00244725|526558699|FG000|Overall Study|Mediciation Error|0|||
146012668|NCT00244725|526558700|FG001|Overall Study|Mediciation Error|1|||
146012669|NCT00244725|526558701|FG002|Overall Study|Mediciation Error|0|||
146012670|NCT00244725|526558702|FG003|Overall Study|Mediciation Error|0|||
146299197|NCT04124614|527610075|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
146299198|NCT04124614|527610076|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
146012671|NCT00244725|526558699|FG000|Overall Study|Rehab Refused to allow participantion|0|||
146012672|NCT00244725|526558700|FG001|Overall Study|Rehab Refused to allow participantion|1|||
146012673|NCT00244725|526558701|FG002|Overall Study|Rehab Refused to allow participantion|0|||
146012674|NCT00244725|526558702|FG003|Overall Study|Rehab Refused to allow participantion|0|||
146012675|NCT00244725|526558699|FG000|Overall Study|Headache|0|||
146012676|NCT00244725|526558700|FG001|Overall Study|Headache|1|||
146012677|NCT00244725|526558701|FG002|Overall Study|Headache|0|||
146012678|NCT00244725|526558702|FG003|Overall Study|Headache|0|||
146012679|NCT00244725|526558699|FG000|Overall Study|Received prohibited medication|0|||
146012680|NCT00244725|526558700|FG001|Overall Study|Received prohibited medication|1|||
146012681|NCT00244725|526558701|FG002|Overall Study|Received prohibited medication|0|||
146012682|NCT00244725|526558702|FG003|Overall Study|Received prohibited medication|1|||
146012683|NCT00244725|526558699|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146012684|NCT00244725|526558700|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
146012685|NCT00244725|526558701|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146012686|NCT00244725|526558702|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
146012687|NCT00244725|526558699|FG000|Overall Study|Administrative reason|0|||
146012688|NCT00244725|526558700|FG001|Overall Study|Administrative reason|0|||
146012689|NCT00244725|526558701|FG002|Overall Study|Administrative reason|1|||
146012690|NCT00244725|526558702|FG003|Overall Study|Administrative reason|0|||
146012691|NCT00244725|526558699|FG000|Overall Study|Vomit|0|||
146012692|NCT00244725|526558700|FG001|Overall Study|Vomit|0|||
146012693|NCT00244725|526558701|FG002|Overall Study|Vomit|1|||
146012694|NCT00244725|526558702|FG003|Overall Study|Vomit|0|||
146012695|NCT00244725|526558699|FG000|Overall Study|Failed to follow-up|0|||
146012696|NCT00244725|526558700|FG001|Overall Study|Failed to follow-up|0|||
146012697|NCT00244725|526558701|FG002|Overall Study|Failed to follow-up|1|||
146012698|NCT00244725|526558702|FG003|Overall Study|Failed to follow-up|1|||
146012699|NCT03799952|526558703|FG000|Overall Study|Program was too easy, discontinued|1|||
146012700|NCT03799952|526558704|FG001|Overall Study|Program was too easy, discontinued|0|||
146012701|NCT03799952|526558703|FG000|Overall Study|Lost to Follow-up|0|||
146012702|NCT03799952|526558704|FG001|Overall Study|Lost to Follow-up|2|||
146012703|NCT03248167|526558705|FG000|Overall Study|Withdrawal by Subject|2|||
146012704|NCT03248167|526558706|FG001|Overall Study|Withdrawal by Subject|2|||
146012705|NCT03248167|526558705|FG000|Overall Study|Physician Decision|0|||
146012706|NCT03248167|526558706|FG001|Overall Study|Physician Decision|1|||
146012707|NCT03248167|526558705|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
146012708|NCT03248167|526558706|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
146012709|NCT03248167|526558705|FG000|Overall Study|Lost to Follow-up|1|||
146012710|NCT03248167|526558706|FG001|Overall Study|Lost to Follow-up|0|||
146012711|NCT02122146|526558707|FG000|Part 1: Dose Escalation|Death|0|||
146012712|NCT02122146|526558708|FG001|Part 1: Dose Escalation|Death|1|||
146012713|NCT02122146|526558709|FG002|Part 1: Dose Escalation|Death|1|||
146012714|NCT02122146|526558710|FG003|Part 1: Dose Escalation|Death|0|||
146012715|NCT02122146|526558711|FG004|Part 1: Dose Escalation|Death|0|||
146012716|NCT02122146|526558712|FG005|Part 1: Dose Escalation|Death|0|||
146012717|NCT02122146|526558713|FG006|Part 1: Dose Escalation|Death|0|||
146012718|NCT02122146|526558714|FG007|Part 1: Dose Escalation|Death|0|||
146012719|NCT02122146|526558707|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012720|NCT02122146|526558708|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012721|NCT02122146|526558709|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
146012722|NCT02122146|526558710|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012723|NCT02122146|526558711|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
146012724|NCT02122146|526558712|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012725|NCT02122146|526558713|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012726|NCT02122146|526558714|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
146012727|NCT02122146|526558707|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012728|NCT02122146|526558708|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012729|NCT02122146|526558709|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012730|NCT02122146|526558710|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146012731|NCT02122146|526558711|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012732|NCT02122146|526558712|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012733|NCT02122146|526558713|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012734|NCT02122146|526558714|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146012735|NCT02122146|526558707|FG000|Part 1: Dose Escalation|Other|1|||
146250122|NCT03409276|527428069|FG004|Overall Study|Lost to Follow-up|2|||
146250123|NCT04454125|527428074|FG000|Overall Study|Lost to Follow-up|0|||
146250124|NCT04454125|527428075|FG001|Overall Study|Lost to Follow-up|1|||
146250125|NCT03360071|527428079|FG000|Overall Study|Lost to Follow-up|1|||
146012736|NCT02122146|526558708|FG001|Part 1: Dose Escalation|Other|0|||
146250126|NCT03360071|527428080|FG001|Overall Study|Lost to Follow-up|0|||
146012737|NCT02122146|526558709|FG002|Part 1: Dose Escalation|Other|0|||
146012738|NCT02122146|526558710|FG003|Part 1: Dose Escalation|Other|0|||
146012739|NCT02122146|526558711|FG004|Part 1: Dose Escalation|Other|0|||
146012740|NCT02122146|526558712|FG005|Part 1: Dose Escalation|Other|1|||
146012741|NCT02122146|526558713|FG006|Part 1: Dose Escalation|Other|1|||
146012742|NCT02122146|526558714|FG007|Part 1: Dose Escalation|Other|2|||
146012743|NCT03472495|526558715|FG000|Overall Study|Treatment no longer indicated|1|||
146012744|NCT03472495|526558716|FG001|Overall Study|Treatment no longer indicated|2|||
146250127|NCT01193283|527428081|FG000|Overall Study|Death|1|||
146250128|NCT02256553|527428086|FG000|Period I|Adverse Event|5|||
146012745|NCT03472495|526558715|FG000|Overall Study|Physician Decision|0|||
146012746|NCT03472495|526558716|FG001|Overall Study|Physician Decision|2|||
146012747|NCT01001767|526558717|FG000|Overall Study|no baseline study performed|1|||
146012748|NCT01001767|526558718|FG001|Overall Study|no baseline study performed|0|||
146012749|NCT01001767|526558717|FG000|Overall Study|Protocol Violation|1|||
146012750|NCT01001767|526558718|FG001|Overall Study|Protocol Violation|0|||
146012751|NCT01001767|526558717|FG000|Overall Study|Lost to Follow-up|1|||
146012752|NCT01001767|526558718|FG001|Overall Study|Lost to Follow-up|0|||
146012753|NCT01001767|526558717|FG000|Overall Study|Physician Decision|1|||
146012754|NCT01001767|526558718|FG001|Overall Study|Physician Decision|0|||
146012755|NCT02584452|526558719|FG000|Overall Study|Physician Decision|1|||
146012756|NCT02584452|526558720|FG001|Overall Study|Physician Decision|1|||
146012757|NCT02584452|526558719|FG000|Overall Study|Lost to Follow-up|1|||
146012758|NCT02584452|526558720|FG001|Overall Study|Lost to Follow-up|1|||
146012759|NCT01107392|526558722|FG000|Overall Study|Adverse Event|2|||
146012760|NCT01107392|526558723|FG001|Overall Study|Adverse Event|0|||
146012761|NCT01107392|526558722|FG000|Overall Study|Personal Reasons|2|||
146012762|NCT01107392|526558723|FG001|Overall Study|Personal Reasons|3|||
146012763|NCT01107392|526558722|FG000|Overall Study|Administrative decision|1|||
146012764|NCT01107392|526558723|FG001|Overall Study|Administrative decision|0|||
146012765|NCT02689206|526558724|FG000|Overall Study|Adverse Event|0|||
146012766|NCT02689206|526558725|FG001|Overall Study|Adverse Event|0|||
146012767|NCT02689206|526558726|FG002|Overall Study|Adverse Event|1|||
146012768|NCT02689206|526558727|FG003|Overall Study|Adverse Event|0|||
146012769|NCT02689206|526558728|FG004|Overall Study|Adverse Event|2|||
146012770|NCT02689206|526558724|FG000|Overall Study|Protocol Violation|1|||
146012771|NCT02689206|526558725|FG001|Overall Study|Protocol Violation|0|||
146012772|NCT02689206|526558726|FG002|Overall Study|Protocol Violation|0|||
146012773|NCT02689206|526558727|FG003|Overall Study|Protocol Violation|1|||
146012774|NCT02689206|526558728|FG004|Overall Study|Protocol Violation|2|||
146012775|NCT02689206|526558724|FG000|Overall Study|Other: Reached stopping criteria|0|||
146012776|NCT02689206|526558725|FG001|Overall Study|Other: Reached stopping criteria|1|||
146012777|NCT02689206|526558726|FG002|Overall Study|Other: Reached stopping criteria|2|||
146012778|NCT02689206|526558727|FG003|Overall Study|Other: Reached stopping criteria|3|||
146012779|NCT02689206|526558728|FG004|Overall Study|Other: Reached stopping criteria|4|||
146012780|NCT02689206|526558724|FG000|Overall Study|Physician Decision|1|||
146012781|NCT02689206|526558725|FG001|Overall Study|Physician Decision|0|||
146012782|NCT02689206|526558726|FG002|Overall Study|Physician Decision|0|||
146093279|NCT02598960|526863374|FG003|Participants Entering Follow Up Period|Death|0|||
146093280|NCT02598960|526863375|FG004|Participants Entering Follow Up Period|Death|0|||
146093281|NCT02598960|526863376|FG005|Participants Entering Follow Up Period|Death|0|||
146093282|NCT02598960|526863377|FG006|Participants Entering Follow Up Period|Death|0|||
146093283|NCT02598960|526863378|FG007|Participants Entering Follow Up Period|Death|0|||
146093284|NCT02598960|526863379|FG008|Participants Entering Follow Up Period|Death|0|||
146093285|NCT02598960|526863380|FG009|Participants Entering Follow Up Period|Death|1|||
146093286|NCT02598960|526863381|FG010|Participants Entering Follow Up Period|Death|0|||
146093287|NCT02598960|526863382|FG011|Participants Entering Follow Up Period|Death|11|||
146093288|NCT02598960|526863383|FG012|Participants Entering Follow Up Period|Death|2|||
146093289|NCT02598960|526863371|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093290|NCT02598960|526863372|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093291|NCT02598960|526863373|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
146012783|NCT02689206|526558727|FG003|Overall Study|Physician Decision|0|||
146012784|NCT02689206|526558728|FG004|Overall Study|Physician Decision|0|||
146012785|NCT02689206|526558724|FG000|Overall Study|Withdrawal by Subject|1|||
146012786|NCT02689206|526558725|FG001|Overall Study|Withdrawal by Subject|0|||
146012787|NCT02689206|526558726|FG002|Overall Study|Withdrawal by Subject|1|||
146012788|NCT02689206|526558727|FG003|Overall Study|Withdrawal by Subject|0|||
146012789|NCT02689206|526558728|FG004|Overall Study|Withdrawal by Subject|0|||
146093292|NCT02598960|526863374|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093293|NCT02598960|526863375|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093294|NCT02598960|526863376|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
146012790|NCT00177294|526558729|FG000|Overall Study|Withdrawal by Subject|7|||
146012791|NCT00177294|526558730|FG001|Overall Study|Withdrawal by Subject|5|||
146012792|NCT02998671|526558731|FG000|Period 1|Study Terminated By Sponsor|2|||
146012793|NCT02998671|526558732|FG001|Period 1|Study Terminated By Sponsor|1|||
146012794|NCT02998671|526558733|FG002|Period 1|Study Terminated By Sponsor|0|||
146012795|NCT02998671|526558734|FG003|Period 1|Study Terminated By Sponsor|0|||
146012796|NCT02998671|526558735|FG004|Period 1|Study Terminated By Sponsor|1|||
146012797|NCT02998671|526558731|FG000|Period 1|Withdrawal by Subject|1|||
146012798|NCT02998671|526558732|FG001|Period 1|Withdrawal by Subject|2|||
146012799|NCT02998671|526558733|FG002|Period 1|Withdrawal by Subject|0|||
146012800|NCT02998671|526558734|FG003|Period 1|Withdrawal by Subject|0|||
146012801|NCT02998671|526558735|FG004|Period 1|Withdrawal by Subject|2|||
146012802|NCT02998671|526558731|FG000|Period 1|Pregnancy|1|||
146012803|NCT02998671|526558732|FG001|Period 1|Pregnancy|0|||
146012804|NCT02998671|526558733|FG002|Period 1|Pregnancy|0|||
146012805|NCT02998671|526558734|FG003|Period 1|Pregnancy|0|||
146012806|NCT02998671|526558735|FG004|Period 1|Pregnancy|0|||
146012807|NCT02998671|526558731|FG000|Period 1|Adverse Event|0|||
146012808|NCT02998671|526558732|FG001|Period 1|Adverse Event|0|||
146012809|NCT02998671|526558733|FG002|Period 1|Adverse Event|0|||
146012810|NCT02998671|526558734|FG003|Period 1|Adverse Event|0|||
146012811|NCT02998671|526558735|FG004|Period 1|Adverse Event|1|||
146012812|NCT02998671|526558731|FG000|Period 2|Adverse Event|0|||
146012813|NCT02998671|526558732|FG001|Period 2|Adverse Event|1|||
146012814|NCT02998671|526558733|FG002|Period 2|Adverse Event|0|||
146012815|NCT02998671|526558734|FG003|Period 2|Adverse Event|0|||
146012816|NCT02998671|526558735|FG004|Period 2|Adverse Event|0|||
146012817|NCT02998671|526558731|FG000|Period 2|Study Terminated By Sponsor|3|||
146012818|NCT02998671|526558732|FG001|Period 2|Study Terminated By Sponsor|5|||
146012819|NCT02998671|526558733|FG002|Period 2|Study Terminated By Sponsor|1|||
146012820|NCT02998671|526558734|FG003|Period 2|Study Terminated By Sponsor|3|||
146012821|NCT02998671|526558735|FG004|Period 2|Study Terminated By Sponsor|0|||
146012822|NCT02998671|526558731|FG000|Period 2|Withdrawal by Subject|0|||
146012823|NCT02998671|526558732|FG001|Period 2|Withdrawal by Subject|1|||
146012824|NCT02998671|526558733|FG002|Period 2|Withdrawal by Subject|0|||
146012825|NCT02998671|526558734|FG003|Period 2|Withdrawal by Subject|0|||
146012826|NCT02998671|526558735|FG004|Period 2|Withdrawal by Subject|0|||
146012827|NCT02998671|526558731|FG000|Period 2|Lost to Follow-up|0|||
146012828|NCT02998671|526558732|FG001|Period 2|Lost to Follow-up|0|||
146012829|NCT02998671|526558733|FG002|Period 2|Lost to Follow-up|0|||
146012830|NCT02998671|526558734|FG003|Period 2|Lost to Follow-up|1|||
146012831|NCT02998671|526558735|FG004|Period 2|Lost to Follow-up|0|||
146012832|NCT00191945|526558739|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
146012833|NCT00191945|526558740|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
146012834|NCT00191945|526558739|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
146012835|NCT00191945|526558740|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
146012836|NCT00191945|526558739|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
146012837|NCT00191945|526558740|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
146012838|NCT00191945|526558739|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
146012839|NCT00191945|526558740|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
146012840|NCT00958347|526558742|FG000|Overall Study|Death|43|||
146012841|NCT00958347|526558742|FG000|Overall Study|Withdrawal by Subject|23|||
146012842|NCT00958347|526558742|FG000|Overall Study|Lost to Follow-up|15|||
146012843|NCT00958347|526558742|FG000|Overall Study|revision/removal|10|||
146012844|NCT00958347|526558742|FG000|Overall Study|study termination|135|||
146012845|NCT03089047|526558743|FG000|Overall Study|Lost to Follow-up|1|||
146012846|NCT03089047|526558744|FG001|Overall Study|Lost to Follow-up|0|||
146012847|NCT03599518|526558745|FG000|Overall Study|Clinical progression|0|||
146012848|NCT03599518|526558746|FG001|Overall Study|Clinical progression|0|||
146012849|NCT03599518|526558747|FG002|Overall Study|Clinical progression|0|||
146012850|NCT03599518|526558748|FG003|Overall Study|Clinical progression|0|||
146012851|NCT03599518|526558749|FG004|Overall Study|Clinical progression|1|||
146012852|NCT03599518|526558745|FG000|Overall Study|Adverse Event|0|||
146012853|NCT03599518|526558746|FG001|Overall Study|Adverse Event|0|||
146012854|NCT03599518|526558747|FG002|Overall Study|Adverse Event|0|||
146012855|NCT03599518|526558748|FG003|Overall Study|Adverse Event|0|||
146012856|NCT03599518|526558749|FG004|Overall Study|Adverse Event|1|||
146012857|NCT03599518|526558745|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
146012858|NCT03599518|526558746|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
146012859|NCT03599518|526558747|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
146012860|NCT03599518|526558748|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
146012861|NCT03599518|526558749|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
146012862|NCT03599518|526558745|FG000|Overall Study|Participant withdrawal from study treatment|0|||
146012863|NCT03599518|526558746|FG001|Overall Study|Participant withdrawal from study treatment|0|||
146012864|NCT03599518|526558747|FG002|Overall Study|Participant withdrawal from study treatment|1|||
146012865|NCT03599518|526558748|FG003|Overall Study|Participant withdrawal from study treatment|0|||
146012866|NCT03599518|526558749|FG004|Overall Study|Participant withdrawal from study treatment|0|||
146012867|NCT00375505|526558750|FG000|Overall Study|Adverse Event|1|||
146012868|NCT00375505|526558751|FG001|Overall Study|Adverse Event|2|||
146012869|NCT00429182|526558754|FG000|Overall Study|Not evaluable, Disease Progression|2|||
146012870|NCT00429182|526558754|FG000|Overall Study|Not eligible|5|||
146012871|NCT00861692|526558756|FG000|Overall Study|Death|6|||
146012872|NCT03292640|526558757|FG000|Overall Study|Withdrawal by Subject|17|||
146012873|NCT03292640|526558758|FG001|Overall Study|Withdrawal by Subject|16|||
146012874|NCT03292640|526558757|FG000|Overall Study|Adverse Event|20|||
146012875|NCT03292640|526558758|FG001|Overall Study|Adverse Event|2|||
146012876|NCT03292640|526558757|FG000|Overall Study|Lost to Follow-up|24|||
146012877|NCT03292640|526558758|FG001|Overall Study|Lost to Follow-up|24|||
146012878|NCT05111002|526558763|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
146012879|NCT05111002|526558764|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
146012880|NCT05111002|526558763|FG000|Secondary Outcome|Lost to Follow-up|1|||
146012881|NCT05111002|526558764|FG001|Secondary Outcome|Lost to Follow-up|0|||
146012882|NCT04380753|526558765|FG000|Overall Study|Participants continuing study|4|||
146012883|NCT04380753|526558765|FG000|Overall Study|Death|2|||
146012884|NCT04776720|526558770|FG000|Overall Study|COVID Related|4|||
146012885|NCT04776720|526558771|FG001|Overall Study|COVID Related|2|||
146012886|NCT04776720|526558770|FG000|Overall Study|Adverse Event|2|||
146012887|NCT04776720|526558771|FG001|Overall Study|Adverse Event|0|||
146012888|NCT04776720|526558770|FG000|Overall Study|Serious Adverse Event|0|||
146012889|NCT04776720|526558771|FG001|Overall Study|Serious Adverse Event|1|||
146012890|NCT04776720|526558770|FG000|Overall Study|Too Busy|3|||
146012891|NCT04776720|526558771|FG001|Overall Study|Too Busy|1|||
146012892|NCT04776720|526558770|FG000|Overall Study|Lost to Follow-up|1|||
146012893|NCT04776720|526558771|FG001|Overall Study|Lost to Follow-up|2|||
146012894|NCT04776720|526558770|FG000|Overall Study|Family|2|||
146012895|NCT04776720|526558771|FG001|Overall Study|Family|2|||
146012896|NCT04776720|526558770|FG000|Overall Study|No remote technology access|0|||
146012897|NCT04776720|526558771|FG001|Overall Study|No remote technology access|1|||
146012898|NCT04776720|526558770|FG000|Overall Study|Withdrawal by Subject|1|||
146012899|NCT04776720|526558771|FG001|Overall Study|Withdrawal by Subject|0|||
146012900|NCT04776720|526558770|FG000|Overall Study|Cannot tolerate intervention|1|||
146012901|NCT04776720|526558771|FG001|Overall Study|Cannot tolerate intervention|0|||
146012902|NCT04776720|526558770|FG000|Overall Study|Incomplete outcome data|6|||
146012903|NCT04776720|526558771|FG001|Overall Study|Incomplete outcome data|1|||
146012904|NCT02712996|526558773|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
146012905|NCT02712996|526558774|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
146012906|NCT00972517|526558780|FG000|Overall Study|Adverse Event|0|||
146012907|NCT00972517|526558781|FG001|Overall Study|Adverse Event|0|||
146012908|NCT00972517|526558782|FG002|Overall Study|Adverse Event|0|||
146012909|NCT00972517|526558783|FG003|Overall Study|Adverse Event|1|||
146012910|NCT00972517|526558784|FG004|Overall Study|Adverse Event|0|||
146012911|NCT00972517|526558785|FG005|Overall Study|Adverse Event|0|||
146012912|NCT00972517|526558780|FG000|Overall Study|Withdrawal by Subject|0|||
146012913|NCT00972517|526558781|FG001|Overall Study|Withdrawal by Subject|1|||
146012914|NCT00972517|526558782|FG002|Overall Study|Withdrawal by Subject|0|||
146012915|NCT00972517|526558783|FG003|Overall Study|Withdrawal by Subject|2|||
146012916|NCT00972517|526558784|FG004|Overall Study|Withdrawal by Subject|1|||
146012917|NCT00972517|526558785|FG005|Overall Study|Withdrawal by Subject|0|||
146012918|NCT02311881|526558786|FG000|Overall Study|Did not meet the study criteria|2|||
146012919|NCT02311881|526558787|FG001|Overall Study|Did not meet the study criteria|2|||
146012920|NCT02311881|526558788|FG002|Overall Study|Did not meet the study criteria|0|||
146012921|NCT02311881|526558786|FG000|Overall Study|Adverse Event|7|||
146012922|NCT02311881|526558787|FG001|Overall Study|Adverse Event|15|||
146012923|NCT02311881|526558788|FG002|Overall Study|Adverse Event|8|||
146012924|NCT02311881|526558786|FG000|Overall Study|Lost to Follow-up|3|||
146012925|NCT02311881|526558787|FG001|Overall Study|Lost to Follow-up|3|||
146012926|NCT02311881|526558788|FG002|Overall Study|Lost to Follow-up|2|||
146012927|NCT02311881|526558786|FG000|Overall Study|Protocol Violation|1|||
146012928|NCT02311881|526558787|FG001|Overall Study|Protocol Violation|2|||
146012929|NCT02311881|526558788|FG002|Overall Study|Protocol Violation|3|||
146012930|NCT02311881|526558786|FG000|Overall Study|Withdrawal of consent|14|||
146012931|NCT02311881|526558787|FG001|Overall Study|Withdrawal of consent|16|||
146012932|NCT02311881|526558788|FG002|Overall Study|Withdrawal of consent|17|||
146012933|NCT02311881|526558786|FG000|Overall Study|Other|0|||
146012934|NCT02311881|526558787|FG001|Overall Study|Other|0|||
146012935|NCT02311881|526558788|FG002|Overall Study|Other|1|||
146012936|NCT02311881|526558786|FG000|Overall Study|Lack of Efficacy|1|||
146012937|NCT02311881|526558787|FG001|Overall Study|Lack of Efficacy|2|||
146012938|NCT02311881|526558788|FG002|Overall Study|Lack of Efficacy|0|||
146093295|NCT02598960|526863377|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093296|NCT02598960|526863378|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
146012939|NCT02311881|526558786|FG000|Overall Study|Subject has border line pregnancy test|1|||
146012940|NCT02311881|526558787|FG001|Overall Study|Subject has border line pregnancy test|0|||
146012941|NCT02311881|526558788|FG002|Overall Study|Subject has border line pregnancy test|0|||
146012942|NCT02311881|526558786|FG000|Overall Study|Withdrawal by Subject|3|||
146012943|NCT02311881|526558787|FG001|Overall Study|Withdrawal by Subject|1|||
146012944|NCT02311881|526558788|FG002|Overall Study|Withdrawal by Subject|4|||
146012945|NCT02311881|526558786|FG000|Overall Study|Sponsor Decision|1|||
146012946|NCT02311881|526558787|FG001|Overall Study|Sponsor Decision|1|||
146012947|NCT02311881|526558788|FG002|Overall Study|Sponsor Decision|1|||
146012948|NCT02311881|526558786|FG000|Overall Study|Protocol Deviation|1|||
146012949|NCT02311881|526558787|FG001|Overall Study|Protocol Deviation|0|||
146012950|NCT02311881|526558788|FG002|Overall Study|Protocol Deviation|0|||
146012951|NCT02311881|526558786|FG000|Overall Study|Non-Compliance|1|||
146012952|NCT02311881|526558787|FG001|Overall Study|Non-Compliance|0|||
146012953|NCT02311881|526558788|FG002|Overall Study|Non-Compliance|2|||
146012954|NCT02311881|526558786|FG000|Overall Study|Physician Decision|0|||
146012955|NCT02311881|526558787|FG001|Overall Study|Physician Decision|0|||
146299199|NCT04124614|527610074|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
146299200|NCT04124614|527610075|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
146299201|NCT04124614|527610076|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
146299202|NCT05749952|527610077|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
146299203|NCT06950879|527610078|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
146299204|NCT04313153|527611686|FG000|Overall Study|Adverse Event (includes Death)|14|||
146299205|NCT04313153|527611687|FG001|Overall Study|Adverse Event (includes Death)|19|||
146299206|NCT04313153|527611688|FG002|Overall Study|Adverse Event (includes Death)|10|||
146299207|NCT04313153|527611686|FG000|Overall Study|Physician Decision|4|||
146299208|NCT04313153|527611687|FG001|Overall Study|Physician Decision|2|||
146299209|NCT04313153|527611688|FG002|Overall Study|Physician Decision|1|||
146299210|NCT04313153|527611686|FG000|Overall Study|Withdrawal by Subject|7|||
146299211|NCT04313153|527611687|FG001|Overall Study|Withdrawal by Subject|6|||
146299212|NCT04313153|527611688|FG002|Overall Study|Withdrawal by Subject|2|||
146299213|NCT04313153|527611686|FG000|Overall Study|Lack of Efficacy|3|||
146299214|NCT04313153|527611687|FG001|Overall Study|Lack of Efficacy|3|||
146299215|NCT04313153|527611688|FG002|Overall Study|Lack of Efficacy|0|||
146299216|NCT04313153|527611686|FG000|Overall Study|Lost to Follow-up|1|||
146012956|NCT02311881|526558788|FG002|Overall Study|Physician Decision|1|||
146012957|NCT02311881|526558786|FG000|Overall Study|Medical Monitor Discretion|0|||
146012958|NCT02311881|526558787|FG001|Overall Study|Medical Monitor Discretion|0|||
146012959|NCT02311881|526558788|FG002|Overall Study|Medical Monitor Discretion|1|||
146012960|NCT02311881|526558786|FG000|Overall Study|Participant taking another medication|0|||
146012961|NCT02311881|526558787|FG001|Overall Study|Participant taking another medication|0|||
146012962|NCT02311881|526558788|FG002|Overall Study|Participant taking another medication|1|||
146012963|NCT02311881|526558786|FG000|Overall Study|Serious Adverse Event|0|||
146012964|NCT02311881|526558787|FG001|Overall Study|Serious Adverse Event|1|||
146012965|NCT02311881|526558788|FG002|Overall Study|Serious Adverse Event|0|||
146012966|NCT00790582|526558793|FG000|Overall Study|Death|14|||
146012967|NCT00790582|526558794|FG001|Overall Study|Death|32|||
146012968|NCT00790582|526558793|FG000|Overall Study|Physician Decision|7|||
146012969|NCT00790582|526558794|FG001|Overall Study|Physician Decision|1|||
146012970|NCT00790582|526558793|FG000|Overall Study|Lost to Follow-up|3|||
146012971|NCT00790582|526558794|FG001|Overall Study|Lost to Follow-up|3|||
146012972|NCT00790582|526558793|FG000|Overall Study|Withdrawal by Subject|7|||
146012973|NCT00790582|526558794|FG001|Overall Study|Withdrawal by Subject|51|||
146012974|NCT01597908|526558797|FG000|Randomized Phase|Death|217|||
146012975|NCT01597908|526558798|FG001|Randomized Phase|Death|238|||
146012976|NCT01597908|526558799|FG002|Randomized Phase|Death|0|||
146012977|NCT01597908|526558797|FG000|Randomized Phase|Sponsor Decision|93|||
146012978|NCT01597908|526558798|FG001|Randomized Phase|Sponsor Decision|39|||
146012979|NCT01597908|526558799|FG002|Randomized Phase|Sponsor Decision|0|||
146012980|NCT01597908|526558797|FG000|Randomized Phase|Lost to Follow-up|9|||
146012981|NCT01597908|526558798|FG001|Randomized Phase|Lost to Follow-up|16|||
146012982|NCT01597908|526558799|FG002|Randomized Phase|Lost to Follow-up|0|||
146012983|NCT01597908|526558797|FG000|Randomized Phase|Physician Decision|6|||
146012984|NCT01597908|526558798|FG001|Randomized Phase|Physician Decision|3|||
146012985|NCT01597908|526558799|FG002|Randomized Phase|Physician Decision|0|||
146012986|NCT01597908|526558797|FG000|Randomized Phase|Withdrawal by Subject|26|||
146012987|NCT01597908|526558798|FG001|Randomized Phase|Withdrawal by Subject|22|||
146012988|NCT01597908|526558799|FG002|Randomized Phase|Withdrawal by Subject|0|||
146012989|NCT01597908|526558797|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
146012990|NCT01597908|526558798|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
146012991|NCT01597908|526558799|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
146012992|NCT01597908|526558797|FG000|Crossover Phase|Death|0|||
146012993|NCT01597908|526558798|FG001|Crossover Phase|Death|0|||
146012994|NCT01597908|526558799|FG002|Crossover Phase|Death|11|||
146299217|NCT04313153|527611687|FG001|Overall Study|Lost to Follow-up|0|||
146299218|NCT04313153|527611688|FG002|Overall Study|Lost to Follow-up|2|||
146299219|NCT04313153|527611686|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
146299220|NCT04313153|527611687|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
146299221|NCT04313153|527611688|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
146299222|NCT04313153|527611686|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
146299223|NCT04313153|527611687|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
146012995|NCT01597908|526558797|FG000|Crossover Phase|Withdrawal by Subject|0|||
146012996|NCT01597908|526558798|FG001|Crossover Phase|Withdrawal by Subject|0|||
146012997|NCT01597908|526558799|FG002|Crossover Phase|Withdrawal by Subject|3|||
146012998|NCT01597908|526558797|FG000|Crossover Phase|Sponsor Decision|0|||
146012999|NCT01597908|526558798|FG001|Crossover Phase|Sponsor Decision|0|||
146013000|NCT01597908|526558799|FG002|Crossover Phase|Sponsor Decision|20|||
146013001|NCT01132651|526560643|FG000|Overall Study|Lost to Follow-up|1|||
146013002|NCT01132651|526560644|FG001|Overall Study|Lost to Follow-up|1|||
146013003|NCT00948857|526560645|FG000|Overall Study|Lost to Follow-up|1|||
146299224|NCT04313153|527611688|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
146013004|NCT00948857|526560646|FG001|Overall Study|Lost to Follow-up|0|||
146013005|NCT03430843|526560647|FG000|Overall Study|Death|233|||
146013006|NCT03430843|526560648|FG001|Overall Study|Death|233|||
146013007|NCT03430843|526560647|FG000|Overall Study|Sponsor Decision|17|||
146013008|NCT03430843|526560648|FG001|Overall Study|Sponsor Decision|6|||
146013009|NCT03430843|526560647|FG000|Overall Study|Withdrawal by Subject|5|||
146013010|NCT03430843|526560648|FG001|Overall Study|Withdrawal by Subject|14|||
146013011|NCT03430843|526560647|FG000|Overall Study|Lost to Follow-up|1|||
146013012|NCT03430843|526560648|FG001|Overall Study|Lost to Follow-up|3|||
146013013|NCT05396014|526560653|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
146013014|NCT05396014|526560654|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013015|NCT05396014|526560655|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013016|NCT05396014|526560656|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013017|NCT05396014|526560657|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013018|NCT05396014|526560658|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013019|NCT05396014|526560659|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013020|NCT05396014|526560660|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013021|NCT05396014|526560661|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013022|NCT05396014|526560662|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013023|NCT05396014|526560663|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013024|NCT05396014|526560664|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013025|NCT05396014|526560665|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013026|NCT05396014|526560666|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
146013027|NCT05396014|526560667|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013028|NCT05396014|526560668|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013029|NCT05396014|526560669|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013030|NCT05396014|526560670|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013031|NCT05396014|526560671|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013032|NCT05396014|526560672|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013033|NCT05396014|526560673|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013034|NCT05396014|526560674|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013035|NCT05396014|526560675|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013036|NCT05396014|526560676|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013037|NCT05396014|526560677|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013038|NCT05396014|526560678|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013039|NCT05396014|526560679|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
146013040|NCT05396014|526560680|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013041|NCT05396014|526560681|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013042|NCT05396014|526560682|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013043|NCT05396014|526560683|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013044|NCT05396014|526560684|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013045|NCT05396014|526560685|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013046|NCT05396014|526560686|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013047|NCT05396014|526560687|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013048|NCT05396014|526560688|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013049|NCT05396014|526560689|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013050|NCT05396014|526560690|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013051|NCT05396014|526560691|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013052|NCT05396014|526560692|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
146013053|NCT05396014|526560693|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013054|NCT05396014|526560694|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013055|NCT05396014|526560695|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
146013056|NCT05396014|526560653|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
146013057|NCT05396014|526560654|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013058|NCT05396014|526560655|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013059|NCT05396014|526560656|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013060|NCT05396014|526560657|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013061|NCT05396014|526560658|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013062|NCT05396014|526560659|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013063|NCT05396014|526560660|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013064|NCT05396014|526560661|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013065|NCT05396014|526560662|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013066|NCT05396014|526560663|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013067|NCT05396014|526560664|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013068|NCT05396014|526560665|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013069|NCT05396014|526560666|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
146013070|NCT05396014|526560667|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013071|NCT05396014|526560668|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013072|NCT05396014|526560669|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013073|NCT05396014|526560670|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013074|NCT05396014|526560671|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013075|NCT05396014|526560672|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013076|NCT05396014|526560673|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013077|NCT05396014|526560674|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013078|NCT05396014|526560675|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013079|NCT05396014|526560676|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013080|NCT05396014|526560677|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013081|NCT05396014|526560678|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013082|NCT05396014|526560679|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
146013083|NCT05396014|526560680|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013084|NCT05396014|526560681|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013085|NCT05396014|526560682|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013086|NCT05396014|526560683|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013087|NCT05396014|526560684|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013088|NCT05396014|526560685|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013089|NCT05396014|526560686|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013090|NCT05396014|526560687|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013091|NCT05396014|526560688|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013092|NCT05396014|526560689|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013093|NCT05396014|526560690|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013094|NCT05396014|526560691|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013095|NCT05396014|526560692|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
146013096|NCT05396014|526560693|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013097|NCT05396014|526560694|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013098|NCT05396014|526560695|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
146013099|NCT05396014|526560653|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146013100|NCT05396014|526560654|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013101|NCT05396014|526560655|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013102|NCT05396014|526560656|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013103|NCT05396014|526560657|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013104|NCT05396014|526560658|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013105|NCT05396014|526560659|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013106|NCT05396014|526560660|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013107|NCT05396014|526560661|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013108|NCT05396014|526560662|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013109|NCT05396014|526560663|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013110|NCT05396014|526560664|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013111|NCT05396014|526560665|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013112|NCT05396014|526560666|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146013113|NCT05396014|526560667|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013114|NCT05396014|526560668|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013115|NCT05396014|526560669|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013116|NCT05396014|526560670|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013117|NCT05396014|526560671|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013118|NCT05396014|526560672|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013119|NCT05396014|526560673|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013120|NCT05396014|526560674|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013121|NCT05396014|526560675|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013122|NCT05396014|526560676|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013123|NCT05396014|526560677|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013124|NCT05396014|526560678|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013125|NCT05396014|526560679|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
146250129|NCT02256553|527428086|FG000|Period I|Protocol Violation|1|||
146250130|NCT02256553|527428086|FG000|Period II|Adverse Event|1|||
146250131|NCT02256553|527428086|FG000|Period II|Subject Moved|1|||
146250132|NCT02256553|527428086|FG000|Period III|Adverse Event|3|||
146250133|NCT01951105|527428087|FG000|Overall Study|Adverse Event|0|||
146250134|NCT01951105|527428088|FG001|Overall Study|Adverse Event|5|||
146013126|NCT05396014|526560680|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013127|NCT05396014|526560681|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013128|NCT05396014|526560682|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013129|NCT05396014|526560683|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013130|NCT05396014|526560684|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013131|NCT05396014|526560685|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146250135|NCT01951105|527428089|FG002|Overall Study|Adverse Event|0|||
146250136|NCT01951105|527428087|FG000|Overall Study|Lost to Follow-up|0|||
146013132|NCT05396014|526560686|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013133|NCT05396014|526560687|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013134|NCT05396014|526560688|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013135|NCT05396014|526560689|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013136|NCT05396014|526560690|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013137|NCT05396014|526560691|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013138|NCT05396014|526560692|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
146013139|NCT05396014|526560693|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013140|NCT05396014|526560694|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013141|NCT05396014|526560695|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
146013142|NCT05396014|526560653|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013143|NCT05396014|526560654|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013144|NCT05396014|526560655|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013145|NCT05396014|526560656|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013146|NCT05396014|526560657|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013147|NCT05396014|526560658|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013148|NCT05396014|526560659|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013149|NCT05396014|526560660|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013150|NCT05396014|526560661|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013151|NCT05396014|526560662|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013152|NCT05396014|526560663|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013153|NCT05396014|526560664|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013154|NCT05396014|526560665|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013155|NCT05396014|526560666|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013156|NCT05396014|526560667|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013157|NCT05396014|526560668|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013158|NCT05396014|526560669|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013159|NCT05396014|526560670|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013160|NCT05396014|526560671|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013161|NCT05396014|526560672|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013162|NCT05396014|526560673|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013163|NCT05396014|526560674|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013164|NCT05396014|526560675|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013165|NCT05396014|526560676|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013166|NCT05396014|526560677|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013167|NCT05396014|526560678|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013168|NCT05396014|526560679|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
146013169|NCT05396014|526560680|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013170|NCT05396014|526560681|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013171|NCT05396014|526560682|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013172|NCT05396014|526560683|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013173|NCT05396014|526560684|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013174|NCT05396014|526560685|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013175|NCT05396014|526560686|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013176|NCT05396014|526560687|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013177|NCT05396014|526560688|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013178|NCT05396014|526560689|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013179|NCT05396014|526560690|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013180|NCT05396014|526560691|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013181|NCT05396014|526560692|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
146013182|NCT05396014|526560693|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013183|NCT05396014|526560694|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013184|NCT05396014|526560695|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
146013185|NCT05396014|526560653|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013186|NCT05396014|526560654|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013187|NCT05396014|526560655|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013188|NCT05396014|526560656|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013189|NCT05396014|526560657|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013190|NCT05396014|526560658|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013191|NCT05396014|526560659|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013192|NCT05396014|526560660|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013193|NCT05396014|526560661|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013194|NCT05396014|526560662|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013195|NCT05396014|526560663|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013196|NCT05396014|526560664|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013197|NCT05396014|526560665|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146093297|NCT02598960|526863379|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
146013198|NCT05396014|526560666|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013199|NCT05396014|526560667|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013200|NCT05396014|526560668|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013201|NCT05396014|526560669|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013202|NCT05396014|526560670|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013203|NCT05396014|526560671|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013204|NCT05396014|526560672|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013205|NCT05396014|526560673|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013206|NCT05396014|526560674|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013207|NCT05396014|526560675|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013208|NCT05396014|526560676|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013209|NCT05396014|526560677|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013210|NCT05396014|526560678|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013211|NCT05396014|526560679|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
146013212|NCT05396014|526560680|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013213|NCT05396014|526560681|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013214|NCT05396014|526560682|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013215|NCT05396014|526560683|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013216|NCT05396014|526560684|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013217|NCT05396014|526560685|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013218|NCT05396014|526560686|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013219|NCT05396014|526560687|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013220|NCT05396014|526560688|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013221|NCT05396014|526560689|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013222|NCT05396014|526560690|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013223|NCT05396014|526560691|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013224|NCT05396014|526560692|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013225|NCT05396014|526560693|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013226|NCT05396014|526560694|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013227|NCT05396014|526560695|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
146013228|NCT05396014|526560653|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013229|NCT05396014|526560654|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013230|NCT05396014|526560655|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013231|NCT05396014|526560656|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013232|NCT05396014|526560657|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013233|NCT05396014|526560658|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013234|NCT05396014|526560659|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013235|NCT05396014|526560660|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013236|NCT05396014|526560661|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013237|NCT05396014|526560662|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013238|NCT05396014|526560663|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013239|NCT05396014|526560664|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013240|NCT05396014|526560665|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013241|NCT05396014|526560666|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
146013242|NCT05396014|526560667|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013243|NCT05396014|526560668|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013244|NCT05396014|526560669|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013245|NCT05396014|526560670|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013246|NCT05396014|526560671|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013247|NCT05396014|526560672|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013248|NCT05396014|526560673|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013249|NCT05396014|526560674|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013250|NCT05396014|526560675|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013251|NCT05396014|526560676|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013252|NCT05396014|526560677|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013253|NCT05396014|526560678|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013254|NCT05396014|526560679|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013255|NCT05396014|526560680|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013256|NCT05396014|526560681|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146093298|NCT02598960|526863380|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093299|NCT02598960|526863381|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093300|NCT02598960|526863382|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
146013257|NCT05396014|526560682|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013258|NCT05396014|526560683|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013259|NCT05396014|526560684|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013260|NCT05396014|526560685|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013261|NCT05396014|526560686|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013262|NCT05396014|526560687|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013263|NCT05396014|526560688|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013264|NCT05396014|526560689|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013265|NCT05396014|526560690|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013266|NCT05396014|526560691|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013267|NCT05396014|526560692|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013268|NCT05396014|526560693|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013269|NCT05396014|526560694|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013270|NCT05396014|526560695|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
146013271|NCT05396014|526560653|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
146013272|NCT05396014|526560654|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013273|NCT05396014|526560655|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013274|NCT05396014|526560656|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013275|NCT05396014|526560657|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013276|NCT05396014|526560658|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013277|NCT05396014|526560659|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013278|NCT05396014|526560660|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013279|NCT05396014|526560661|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013280|NCT05396014|526560662|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013281|NCT05396014|526560663|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013282|NCT05396014|526560664|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013283|NCT05396014|526560665|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013284|NCT05396014|526560666|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
146013285|NCT05396014|526560667|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013286|NCT05396014|526560668|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013287|NCT05396014|526560669|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013288|NCT05396014|526560670|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013289|NCT05396014|526560671|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013290|NCT05396014|526560672|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013291|NCT05396014|526560673|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013292|NCT05396014|526560674|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013293|NCT05396014|526560675|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013294|NCT05396014|526560676|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013295|NCT05396014|526560677|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013296|NCT05396014|526560678|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013297|NCT05396014|526560679|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013298|NCT05396014|526560680|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013299|NCT05396014|526560681|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013300|NCT05396014|526560682|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013301|NCT05396014|526560683|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013302|NCT05396014|526560684|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013303|NCT05396014|526560685|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013304|NCT05396014|526560686|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013305|NCT05396014|526560687|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013306|NCT05396014|526560688|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013307|NCT05396014|526560689|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146093301|NCT02598960|526863383|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
146093302|NCT02598960|526863371|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
146093303|NCT02598960|526863372|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
146093304|NCT02598960|526863373|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
146093305|NCT02598960|526863374|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
146093306|NCT02598960|526863375|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
146093307|NCT02598960|526863376|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
146013308|NCT05396014|526560690|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013309|NCT05396014|526560691|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013310|NCT05396014|526560692|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
146013311|NCT05396014|526560693|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013312|NCT05396014|526560694|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146093308|NCT02598960|526863377|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
146250137|NCT01951105|527428088|FG001|Overall Study|Lost to Follow-up|1|||
146013313|NCT05396014|526560695|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
146013314|NCT05396014|526560653|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
146013315|NCT05396014|526560654|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013316|NCT05396014|526560655|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013317|NCT05396014|526560656|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013318|NCT05396014|526560657|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013319|NCT05396014|526560658|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013320|NCT05396014|526560659|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013321|NCT05396014|526560660|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013322|NCT05396014|526560661|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013323|NCT05396014|526560662|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013324|NCT05396014|526560663|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013325|NCT05396014|526560664|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013326|NCT05396014|526560665|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013327|NCT05396014|526560666|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013328|NCT05396014|526560667|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013329|NCT05396014|526560668|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013330|NCT05396014|526560669|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013331|NCT05396014|526560670|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013332|NCT05396014|526560671|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013333|NCT05396014|526560672|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013334|NCT05396014|526560673|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013335|NCT05396014|526560674|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013336|NCT05396014|526560675|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013337|NCT05396014|526560676|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013338|NCT05396014|526560677|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013339|NCT05396014|526560678|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013340|NCT05396014|526560679|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
146013341|NCT05396014|526560680|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013342|NCT05396014|526560681|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013343|NCT05396014|526560682|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013344|NCT05396014|526560683|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013345|NCT05396014|526560684|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013346|NCT05396014|526560685|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013347|NCT05396014|526560686|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013348|NCT05396014|526560687|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013349|NCT05396014|526560688|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013350|NCT05396014|526560689|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013351|NCT05396014|526560690|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013352|NCT05396014|526560691|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013353|NCT05396014|526560692|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013354|NCT05396014|526560693|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013355|NCT05396014|526560694|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013356|NCT05396014|526560695|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
146013357|NCT05396014|526560653|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013358|NCT05396014|526560654|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013359|NCT05396014|526560655|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013360|NCT05396014|526560656|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013361|NCT05396014|526560657|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013362|NCT05396014|526560658|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013363|NCT05396014|526560659|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013364|NCT05396014|526560660|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013365|NCT05396014|526560661|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013366|NCT05396014|526560662|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013367|NCT05396014|526560663|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013368|NCT05396014|526560664|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013369|NCT05396014|526560665|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013370|NCT05396014|526560666|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
146013371|NCT05396014|526560667|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013372|NCT05396014|526560668|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013373|NCT05396014|526560669|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146250138|NCT01951105|527428089|FG002|Overall Study|Lost to Follow-up|0|||
146250139|NCT01951105|527428087|FG000|Overall Study|Protocol Violation|1|||
146013374|NCT05396014|526560670|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013375|NCT05396014|526560671|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146250140|NCT01951105|527428088|FG001|Overall Study|Protocol Violation|1|||
146250141|NCT01951105|527428089|FG002|Overall Study|Protocol Violation|1|||
146250142|NCT01951105|527428087|FG000|Overall Study|Withdrawal by Subject|0|||
146013376|NCT05396014|526560672|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013377|NCT05396014|526560673|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013378|NCT05396014|526560674|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013379|NCT05396014|526560675|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013380|NCT05396014|526560676|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013381|NCT05396014|526560677|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013382|NCT05396014|526560678|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013383|NCT05396014|526560679|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013384|NCT05396014|526560680|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013385|NCT05396014|526560681|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013386|NCT05396014|526560682|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013387|NCT05396014|526560683|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013388|NCT05396014|526560684|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013389|NCT05396014|526560685|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013390|NCT05396014|526560686|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013391|NCT05396014|526560687|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013392|NCT05396014|526560688|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013393|NCT05396014|526560689|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013394|NCT05396014|526560690|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013395|NCT05396014|526560691|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013396|NCT05396014|526560692|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013397|NCT05396014|526560693|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013398|NCT05396014|526560694|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013399|NCT05396014|526560695|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
146013400|NCT05396014|526560653|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013401|NCT05396014|526560654|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013402|NCT05396014|526560655|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013403|NCT05396014|526560656|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146013404|NCT05396014|526560657|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013405|NCT05396014|526560658|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013406|NCT05396014|526560659|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013407|NCT05396014|526560660|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013408|NCT05396014|526560661|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146013409|NCT05396014|526560662|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013410|NCT05396014|526560663|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013411|NCT05396014|526560664|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013412|NCT05396014|526560665|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013413|NCT05396014|526560666|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013414|NCT05396014|526560667|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013415|NCT05396014|526560668|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013416|NCT05396014|526560669|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013417|NCT05396014|526560670|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013418|NCT05396014|526560671|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013419|NCT05396014|526560672|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013420|NCT05396014|526560673|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013421|NCT05396014|526560674|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013422|NCT05396014|526560675|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013423|NCT05396014|526560676|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013424|NCT05396014|526560677|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013425|NCT05396014|526560678|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146013426|NCT05396014|526560679|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013427|NCT05396014|526560680|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013428|NCT05396014|526560681|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013429|NCT05396014|526560682|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013430|NCT05396014|526560683|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013431|NCT05396014|526560684|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013432|NCT05396014|526560685|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013433|NCT05396014|526560686|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013434|NCT05396014|526560687|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013435|NCT05396014|526560688|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013436|NCT05396014|526560689|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013437|NCT05396014|526560690|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013438|NCT05396014|526560691|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146250143|NCT01951105|527428088|FG001|Overall Study|Withdrawal by Subject|3|||
146299225|NCT04313153|527611686|FG000|Overall Study|Change in Dialysis Modality|0|||
146299226|NCT04313153|527611687|FG001|Overall Study|Change in Dialysis Modality|1|||
146299227|NCT04313153|527611688|FG002|Overall Study|Change in Dialysis Modality|2|||
146299228|NCT04313153|527611686|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
146299229|NCT04313153|527611687|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
146299230|NCT04313153|527611688|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
146299231|NCT04313153|527611686|FG000|Overall Study|Other|5|||
146299232|NCT04313153|527611687|FG001|Overall Study|Other|3|||
146299233|NCT04313153|527611688|FG002|Overall Study|Other|2|||
146299234|NCT05586269|527611689|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
146299235|NCT05586269|527611690|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
146299236|NCT05586269|527611691|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
146299237|NCT05586269|527611692|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
146299238|NCT05586269|527611689|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
146299239|NCT05586269|527611690|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
146299240|NCT05586269|527611691|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
146299241|NCT05586269|527611692|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
146299242|NCT04752475|527611693|FG000|Overall Study|Withdrawal by Subject|1|||
146299243|NCT04752475|527611694|FG001|Overall Study|Withdrawal by Subject|1|||
146299244|NCT00523718|527611700|FG000|Overall Study|Withdrawal by Subject|1|||
146299245|NCT00523718|527611701|FG001|Overall Study|Withdrawal by Subject|0|||
146299246|NCT00523718|527611700|FG000|Overall Study|Protocol Violation|2|||
146299247|NCT00523718|527611701|FG001|Overall Study|Protocol Violation|0|||
146299248|NCT01310803|527611702|FG000|Overall Study|Subject terminated by Sponsor|1|||
146299249|NCT01310803|527611703|FG001|Overall Study|Subject terminated by Sponsor|0|||
146299250|NCT00332839|527611704|FG000|Core (Months 0 - 12)|Administrative problems|1|||
146299251|NCT00332839|527611705|FG001|Core (Months 0 - 12)|Administrative problems|1|||
146299252|NCT00332839|527611704|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
146299253|NCT00332839|527611705|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
146299254|NCT00332839|527611704|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
146299255|NCT00332839|527611705|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
146299256|NCT00332839|527611704|FG000|Core (Months 0 - 12)|Adverse Event|5|||
146299257|NCT00332839|527611705|FG001|Core (Months 0 - 12)|Adverse Event|15|||
146299258|NCT00332839|527611704|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
146299259|NCT00332839|527611705|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
146299260|NCT00332839|527611704|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
146299261|NCT00332839|527611705|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
146299262|NCT00332839|527611704|FG000|Follow-up (Months 12 - 60)|Death|1|||
146299263|NCT00332839|527611705|FG001|Follow-up (Months 12 - 60)|Death|1|||
146299264|NCT01436071|527611706|FG000|Overall Study|Adverse Event|1|||
146013439|NCT05396014|526560692|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
146013440|NCT05396014|526560693|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
146013441|NCT05396014|526560694|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
146013442|NCT05396014|526560695|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
146013443|NCT05396014|526560653|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013444|NCT05396014|526560654|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013445|NCT05396014|526560655|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013446|NCT05396014|526560656|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013447|NCT05396014|526560657|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013448|NCT05396014|526560658|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013449|NCT05396014|526560659|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013450|NCT05396014|526560660|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013451|NCT05396014|526560661|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146013452|NCT05396014|526560662|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013453|NCT05396014|526560663|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013454|NCT05396014|526560664|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013455|NCT05396014|526560665|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013456|NCT05396014|526560666|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146299265|NCT01436071|527611707|FG001|Overall Study|Adverse Event|0|||
146299266|NCT01436071|527611706|FG000|Overall Study|Lack of Efficacy|16|||
146299267|NCT01436071|527611707|FG001|Overall Study|Lack of Efficacy|7|||
146299268|NCT01436071|527611706|FG000|Overall Study|Protocol Violation|0|||
146299269|NCT01436071|527611707|FG001|Overall Study|Protocol Violation|1|||
146299270|NCT01436071|527611706|FG000|Overall Study|Lost to Follow-up|3|||
146299271|NCT01436071|527611707|FG001|Overall Study|Lost to Follow-up|1|||
146299272|NCT01436071|527611706|FG000|Overall Study|Physician Decision|1|||
146299273|NCT01436071|527611707|FG001|Overall Study|Physician Decision|0|||
146299274|NCT01436071|527611706|FG000|Overall Study|Withdrawal by Subject|2|||
146299275|NCT01436071|527611707|FG001|Overall Study|Withdrawal by Subject|2|||
146299276|NCT01436071|527611706|FG000|Overall Study|Did Not Receive Trial Medication|3|||
146299277|NCT01436071|527611707|FG001|Overall Study|Did Not Receive Trial Medication|3|||
146013457|NCT05396014|526560667|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013458|NCT05396014|526560668|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013459|NCT05396014|526560669|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013460|NCT05396014|526560670|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013461|NCT05396014|526560671|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013462|NCT05396014|526560672|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013463|NCT05396014|526560673|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013464|NCT05396014|526560674|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146093309|NCT02598960|526863378|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
146093310|NCT02598960|526863379|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
146093311|NCT02598960|526863380|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
146093312|NCT02598960|526863381|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
146093313|NCT02598960|526863382|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
146093314|NCT02598960|526863383|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
146093315|NCT02598960|526863371|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093316|NCT02598960|526863372|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093317|NCT02598960|526863373|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093318|NCT02598960|526863374|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093319|NCT02598960|526863375|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093320|NCT02598960|526863376|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093321|NCT02598960|526863377|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093322|NCT02598960|526863378|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093323|NCT02598960|526863379|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093324|NCT02598960|526863380|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093325|NCT02598960|526863381|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093326|NCT02598960|526863382|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
146093327|NCT02598960|526863383|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
146093328|NCT02598960|526863371|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
146093329|NCT02598960|526863372|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
146093330|NCT02598960|526863373|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
146093331|NCT02598960|526863374|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
146093332|NCT02598960|526863375|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
146093333|NCT02598960|526863376|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
146093334|NCT02598960|526863377|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
146093335|NCT02598960|526863378|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
146093336|NCT02598960|526863379|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
146093337|NCT02598960|526863380|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
146093338|NCT02598960|526863381|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
146093339|NCT02598960|526863382|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
146093340|NCT02598960|526863383|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
146093341|NCT01846104|526863384|FG000|Overall Study|Withdrawal by Subject|1|||
146093342|NCT00851630|526863385|FG000|Overall Study|Death|2|||
146093343|NCT00851630|526863386|FG001|Overall Study|Death|1|||
146093344|NCT00851630|526863385|FG000|Overall Study|Clinical failure|0|||
146093345|NCT00851630|526863386|FG001|Overall Study|Clinical failure|1|||
146093346|NCT00398411|526863387|FG000|Overall Study|Death|0|||
146093347|NCT00398411|526863388|FG001|Overall Study|Death|1|||
146093348|NCT01397162|526863389|FG000|Overall Study|Adverse Event|4|||
146093349|NCT01397162|526863390|FG001|Overall Study|Adverse Event|0|||
146093350|NCT01397162|526863391|FG002|Overall Study|Adverse Event|0|||
146093351|NCT01397162|526863392|FG003|Overall Study|Adverse Event|0|||
146093352|NCT01397162|526863393|FG004|Overall Study|Adverse Event|0|||
146093353|NCT01397162|526863389|FG000|Overall Study|Not yet defined|3|||
146093354|NCT01397162|526863390|FG001|Overall Study|Not yet defined|4|||
146093355|NCT01397162|526863391|FG002|Overall Study|Not yet defined|3|||
146093356|NCT01397162|526863392|FG003|Overall Study|Not yet defined|5|||
146093357|NCT01397162|526863393|FG004|Overall Study|Not yet defined|3|||
146093358|NCT00401531|526863396|FG000|Overall Study|Adverse Event|2|||
146093359|NCT00401531|526863397|FG001|Overall Study|Adverse Event|0|||
146093360|NCT00401531|526863396|FG000|Overall Study|Protocol Violation|3|||
146093361|NCT00401531|526863397|FG001|Overall Study|Protocol Violation|7|||
146093362|NCT00401531|526863396|FG000|Overall Study|Lost to Follow-up|1|||
146093363|NCT00401531|526863397|FG001|Overall Study|Lost to Follow-up|1|||
146013465|NCT05396014|526560675|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146013466|NCT05396014|526560676|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146093364|NCT00401531|526863396|FG000|Overall Study|Withdrawal by Subject|3|||
146013467|NCT05396014|526560677|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146093365|NCT00401531|526863397|FG001|Overall Study|Withdrawal by Subject|2|||
146013468|NCT05396014|526560678|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146093366|NCT01614600|526863398|FG000|Overall Study|Unacceptable fit|1|||
146093367|NCT01614600|526863398|FG000|Overall Study|Discomfort|1|||
146093368|NCT01614600|526863398|FG000|Overall Study|Unable to remove lens at the end of day|1|||
146093369|NCT01614600|526863398|FG000|Overall Study|Protocol deviation|1|||
146093370|NCT02437513|526863399|FG000|Overall Study|Withdrawal by Subject|2|||
146093371|NCT03347188|526863402|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
146093372|NCT03347188|526863403|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
146093373|NCT03347188|526863402|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
146013469|NCT05396014|526560679|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013470|NCT05396014|526560680|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013471|NCT05396014|526560681|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013472|NCT05396014|526560682|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013473|NCT05396014|526560683|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013474|NCT05396014|526560684|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013475|NCT05396014|526560685|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013476|NCT05396014|526560686|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013477|NCT05396014|526560687|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013478|NCT05396014|526560688|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
146013479|NCT05396014|526560689|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013480|NCT05396014|526560690|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013481|NCT05396014|526560691|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146093374|NCT03347188|526863403|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
146093375|NCT03347188|526863402|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
146093376|NCT03347188|526863403|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
146093377|NCT03347188|526863402|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
146093378|NCT03347188|526863403|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
146093379|NCT03347188|526863402|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
146250144|NCT01951105|527428089|FG002|Overall Study|Withdrawal by Subject|1|||
146250145|NCT02727998|527428090|FG000|Overall Study|Lost to Follow-up|3|||
146250146|NCT02727998|527428091|FG001|Overall Study|Lost to Follow-up|3|||
146250147|NCT02727998|527428090|FG000|Overall Study|Withdrawal by Subject|0|||
146250148|NCT02727998|527428091|FG001|Overall Study|Withdrawal by Subject|1|||
146250149|NCT05072795|527428092|FG000|Overall Study|Lost to Follow-up|5|||
146250150|NCT03651271|527428093|FG000|Overall Study|Death|4|||
146250151|NCT03651271|527428094|FG001|Overall Study|Death|37|||
146250152|NCT03651271|527428095|FG002|Overall Study|Death|0|||
146250153|NCT03651271|527428096|FG003|Overall Study|Death|2|||
146250154|NCT03651271|527428097|FG004|Overall Study|Death|6|||
146250155|NCT03651271|527428093|FG000|Overall Study|Lost to Follow-up|1|||
146250156|NCT03651271|527428094|FG001|Overall Study|Lost to Follow-up|5|||
146250157|NCT03651271|527428095|FG002|Overall Study|Lost to Follow-up|0|||
146250158|NCT03651271|527428096|FG003|Overall Study|Lost to Follow-up|1|||
146250159|NCT03651271|527428097|FG004|Overall Study|Lost to Follow-up|0|||
146250160|NCT03651271|527428093|FG000|Overall Study|Physician Decision|0|||
146250161|NCT03651271|527428094|FG001|Overall Study|Physician Decision|2|||
146250162|NCT03651271|527428095|FG002|Overall Study|Physician Decision|0|||
146250163|NCT03651271|527428096|FG003|Overall Study|Physician Decision|0|||
146250164|NCT03651271|527428097|FG004|Overall Study|Physician Decision|0|||
146250165|NCT03651271|527428093|FG000|Overall Study|Withdrawal by Subject|1|||
146250166|NCT03651271|527428094|FG001|Overall Study|Withdrawal by Subject|15|||
146250167|NCT03651271|527428095|FG002|Overall Study|Withdrawal by Subject|0|||
146250168|NCT03651271|527428096|FG003|Overall Study|Withdrawal by Subject|0|||
146250169|NCT03651271|527428097|FG004|Overall Study|Withdrawal by Subject|1|||
146250170|NCT03651271|527428093|FG000|Overall Study|Patient medically unable to continue|0|||
146250171|NCT03651271|527428094|FG001|Overall Study|Patient medically unable to continue|0|||
146250172|NCT03651271|527428095|FG002|Overall Study|Patient medically unable to continue|0|||
146250173|NCT03651271|527428096|FG003|Overall Study|Patient medically unable to continue|1|||
146250174|NCT03651271|527428097|FG004|Overall Study|Patient medically unable to continue|0|||
146250175|NCT00821093|527428098|FG000|Overall Study|Adverse Event|20|||
146250176|NCT00821093|527428099|FG001|Overall Study|Adverse Event|12|||
146250177|NCT00821093|527428098|FG000|Overall Study|Withdrawal by Subject|9|||
146250178|NCT00821093|527428099|FG001|Overall Study|Withdrawal by Subject|13|||
146013482|NCT05396014|526560692|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
146013483|NCT05396014|526560693|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146250179|NCT00821093|527428098|FG000|Overall Study|Lost to Follow-up|9|||
146250180|NCT00821093|527428099|FG001|Overall Study|Lost to Follow-up|3|||
146250181|NCT00821093|527428098|FG000|Overall Study|Protocol deviation|3|||
146250182|NCT00821093|527428099|FG001|Overall Study|Protocol deviation|6|||
146250183|NCT00821093|527428098|FG000|Overall Study|Abnormal laboratory value(s)|2|||
146250184|NCT00821093|527428099|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146250185|NCT00821093|527428098|FG000|Overall Study|Lack of Efficacy|2|||
146250186|NCT00821093|527428099|FG001|Overall Study|Lack of Efficacy|2|||
146250187|NCT00821093|527428098|FG000|Overall Study|Death|2|||
146250188|NCT00821093|527428099|FG001|Overall Study|Death|1|||
146250189|NCT00821093|527428098|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146250190|NCT00821093|527428099|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146250191|NCT00821093|527428098|FG000|Overall Study|Administrative problems|1|||
146250192|NCT00821093|527428099|FG001|Overall Study|Administrative problems|2|||
146250193|NCT01601821|527428102|FG000|Overall Study|Death|2|||
146250194|NCT01601821|527428103|FG001|Overall Study|Death|5|||
146250195|NCT01601821|527428102|FG000|Overall Study|Protocol Violation|2|||
146250196|NCT01601821|527428103|FG001|Overall Study|Protocol Violation|2|||
146250197|NCT01601821|527428102|FG000|Overall Study|Lost to Follow-up|6|||
146250198|NCT01601821|527428103|FG001|Overall Study|Lost to Follow-up|14|||
146250199|NCT01601821|527428102|FG000|Overall Study|Withdrawal by Subject|1|||
146250200|NCT01601821|527428103|FG001|Overall Study|Withdrawal by Subject|0|||
146250201|NCT01601821|527428102|FG000|Overall Study|Graft Loss|6|||
146250202|NCT01601821|527428103|FG001|Overall Study|Graft Loss|6|||
146250203|NCT01601821|527428102|FG000|Overall Study|Study Events|7|||
146250204|NCT01601821|527428103|FG001|Overall Study|Study Events|1|||
146250205|NCT01601821|527428102|FG000|Overall Study|Other|5|||
146250206|NCT01601821|527428103|FG001|Overall Study|Other|1|||
146250207|NCT01901302|527428107|FG000|Overall Study|Adverse Event|2|||
146250208|NCT01901302|527428108|FG001|Overall Study|Adverse Event|1|||
146250209|NCT01901302|527428107|FG000|Overall Study|Lack of Efficacy|0|||
146250210|NCT01901302|527428108|FG001|Overall Study|Lack of Efficacy|2|||
146250211|NCT01901302|527428107|FG000|Overall Study|Study Terminated by Sponsor|23|||
146250212|NCT01901302|527428108|FG001|Overall Study|Study Terminated by Sponsor|20|||
146250213|NCT01901302|527428107|FG000|Overall Study|Withdrawal by Subject|2|||
146250214|NCT01901302|527428108|FG001|Overall Study|Withdrawal by Subject|0|||
146250215|NCT01124916|527428109|FG000|Overall Study|Lost to Follow-up|3|||
146250216|NCT01124916|527428110|FG001|Overall Study|Lost to Follow-up|2|||
146250217|NCT02812706|527428121|FG000|Phase 1|Adverse Event|0|||
146250218|NCT02812706|527428122|FG001|Phase 1|Adverse Event|2|||
146250219|NCT02812706|527428123|FG002|Phase 1|Adverse Event|0|||
146250220|NCT02812706|527428121|FG000|Phase 1|Progressive disease|3|||
146250221|NCT02812706|527428122|FG001|Phase 1|Progressive disease|3|||
146250222|NCT02812706|527428123|FG002|Phase 1|Progressive disease|0|||
146250223|NCT02812706|527428121|FG000|Phase 2|Adverse Event|0|||
146250224|NCT02812706|527428122|FG001|Phase 2|Adverse Event|0|||
146250225|NCT02812706|527428123|FG002|Phase 2|Adverse Event|2|||
146250226|NCT02812706|527428121|FG000|Phase 2|Progressive disease|0|||
146250227|NCT02812706|527428122|FG001|Phase 2|Progressive disease|0|||
146250228|NCT02812706|527428123|FG002|Phase 2|Progressive disease|22|||
146250229|NCT02812706|527428121|FG000|Phase 2|Other-Unspecified|0|||
146250230|NCT02812706|527428122|FG001|Phase 2|Other-Unspecified|0|||
146250231|NCT02812706|527428123|FG002|Phase 2|Other-Unspecified|4|||
146250232|NCT00910871|527428129|FG000|Overall Study|Adverse Event|5|||
146250233|NCT00910871|527428129|FG000|Overall Study|Death|12|||
146250234|NCT00910871|527428129|FG000|Overall Study|Lost to Follow-up|8|||
146250235|NCT00910871|527428129|FG000|Overall Study|Protocol Violation|11|||
146013484|NCT05396014|526560694|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
146013485|NCT05396014|526560695|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
146013486|NCT05396014|526560653|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013487|NCT05396014|526560654|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013488|NCT05396014|526560655|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013489|NCT05396014|526560656|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013490|NCT05396014|526560657|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013491|NCT05396014|526560658|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013492|NCT05396014|526560659|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013493|NCT05396014|526560660|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013494|NCT05396014|526560661|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013495|NCT05396014|526560662|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013496|NCT05396014|526560663|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013497|NCT05396014|526560664|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146250236|NCT00910871|527428129|FG000|Overall Study|Withdrawal by Subject|12|||
146250237|NCT00910871|527428129|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
146250238|NCT00910871|527428129|FG000|Overall Study|Undefined|1|||
146250239|NCT04529941|527428133|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
146250240|NCT04529941|527428134|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
146250241|NCT01005914|527428135|FG000|Overall Study|Adverse Event|4|||
146250242|NCT01005914|527428135|FG000|Overall Study|Death|4|||
146250243|NCT01005914|527428135|FG000|Overall Study|Lack of Efficacy|1|||
146250244|NCT01005914|527428135|FG000|Overall Study|Withdrawal by Subject|1|||
146250245|NCT01240785|527428136|FG000|Overall Study|Lost to Follow-up|1|||
146250246|NCT01240785|527428137|FG001|Overall Study|Lost to Follow-up|0|||
146250247|NCT01240785|527428136|FG000|Overall Study|Protocol Violation|0|||
146250248|NCT01240785|527428137|FG001|Overall Study|Protocol Violation|3|||
146250249|NCT01755598|527428139|FG000|Overall Study|Other|109|||
146250250|NCT01755598|527428140|FG001|Overall Study|Other|109|||
146250251|NCT01755598|527428139|FG000|Overall Study|Lost to Follow-up|32|||
146299278|NCT03047551|527611710|FG000|Overall Study|Did not receive TAS|1|||
146299279|NCT03047551|527611711|FG001|Overall Study|Did not receive TAS|0|||
146299280|NCT03047551|527611710|FG000|Overall Study|Physician Decision|1|||
146299281|NCT03047551|527611711|FG001|Overall Study|Physician Decision|0|||
146299282|NCT03047551|527611710|FG000|Overall Study|Withdrawal by Subject|0|||
146299283|NCT03047551|527611711|FG001|Overall Study|Withdrawal by Subject|1|||
146299284|NCT03047551|527611710|FG000|Overall Study|Probe malfunction|0|||
146299285|NCT03047551|527611711|FG001|Overall Study|Probe malfunction|1|||
146299286|NCT03047551|527611710|FG000|Overall Study|Ineligible|0|||
146299287|NCT03047551|527611711|FG001|Overall Study|Ineligible|1|||
146299288|NCT00594516|527611712|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
146299289|NCT00594516|527611713|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
146299290|NCT00594516|527611714|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
146299291|NCT00594516|527611712|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
146299292|NCT00594516|527611713|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
146299293|NCT00594516|527611714|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
146299294|NCT00594516|527611712|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
146299295|NCT00594516|527611713|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
146299296|NCT00594516|527611714|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
146299297|NCT00594516|527611712|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
146299298|NCT00594516|527611713|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
146299299|NCT00594516|527611714|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
146299300|NCT00594516|527611712|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
146299301|NCT00594516|527611713|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
146299302|NCT00594516|527611714|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
146299303|NCT00594516|527611712|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
146299304|NCT00594516|527611713|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
146299305|NCT00594516|527611714|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
146299306|NCT00594516|527611712|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
146299307|NCT00594516|527611713|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
146299308|NCT00594516|527611714|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
146299309|NCT00594516|527611712|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
146299310|NCT00594516|527611713|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
146299311|NCT00594516|527611714|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
146299312|NCT00594516|527611712|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
146299313|NCT00594516|527611713|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
146299314|NCT00594516|527611714|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
146299315|NCT02462928|527611715|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
146299316|NCT02462928|527611716|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
146299317|NCT02462928|527611717|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
146299318|NCT02462928|527611715|FG000|Overall Study|Adverse Event|47|||
146299319|NCT02462928|527611716|FG001|Overall Study|Adverse Event|51|||
146299320|NCT02462928|527611717|FG002|Overall Study|Adverse Event|25|||
146299321|NCT02462928|527611715|FG000|Overall Study|Lack of Efficacy|3|||
146299322|NCT02462928|527611716|FG001|Overall Study|Lack of Efficacy|8|||
146299323|NCT02462928|527611717|FG002|Overall Study|Lack of Efficacy|3|||
146299324|NCT02462928|527611715|FG000|Overall Study|Lost to Follow-up|4|||
146299325|NCT02462928|527611716|FG001|Overall Study|Lost to Follow-up|4|||
146299326|NCT02462928|527611717|FG002|Overall Study|Lost to Follow-up|1|||
146299327|NCT02462928|527611715|FG000|Overall Study|Withdrawal by Patient|31|||
146299328|NCT02462928|527611716|FG001|Overall Study|Withdrawal by Patient|21|||
146299329|NCT02462928|527611717|FG002|Overall Study|Withdrawal by Patient|21|||
146299330|NCT02462928|527611715|FG000|Overall Study|Protocol Violation|0|||
146013498|NCT05396014|526560665|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013499|NCT05396014|526560666|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146013500|NCT05396014|526560667|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013501|NCT05396014|526560668|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013502|NCT05396014|526560669|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013503|NCT05396014|526560670|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013504|NCT05396014|526560671|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013505|NCT05396014|526560672|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013506|NCT05396014|526560673|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013507|NCT05396014|526560674|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013508|NCT05396014|526560675|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013509|NCT05396014|526560676|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146299331|NCT02462928|527611716|FG001|Overall Study|Protocol Violation|1|||
146299332|NCT02462928|527611717|FG002|Overall Study|Protocol Violation|0|||
146299333|NCT02462928|527611715|FG000|Overall Study|Reason not Specified|4|||
146299334|NCT02462928|527611716|FG001|Overall Study|Reason not Specified|6|||
146013510|NCT05396014|526560677|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013511|NCT05396014|526560678|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146299335|NCT02462928|527611717|FG002|Overall Study|Reason not Specified|5|||
146299336|NCT04641299|527611718|FG000|Overall Study|Adverse Event|0|||
146299337|NCT04641299|527611719|FG001|Overall Study|Adverse Event|0|||
146299338|NCT04641299|527611720|FG002|Overall Study|Adverse Event|2|||
146299339|NCT04641299|527611721|FG003|Overall Study|Adverse Event|0|||
146299340|NCT04641299|527611718|FG000|Overall Study|Lost to Follow-up|0|||
146299341|NCT04641299|527611719|FG001|Overall Study|Lost to Follow-up|1|||
146299342|NCT04641299|527611720|FG002|Overall Study|Lost to Follow-up|0|||
146299343|NCT04641299|527611721|FG003|Overall Study|Lost to Follow-up|0|||
146299344|NCT04641299|527611718|FG000|Overall Study|Withdrawal by Subject|1|||
146299345|NCT04641299|527611719|FG001|Overall Study|Withdrawal by Subject|0|||
146299346|NCT04641299|527611720|FG002|Overall Study|Withdrawal by Subject|0|||
146299347|NCT04641299|527611721|FG003|Overall Study|Withdrawal by Subject|0|||
146299348|NCT04641299|527611718|FG000|Overall Study|Reason not given|1|||
146299349|NCT04641299|527611719|FG001|Overall Study|Reason not given|0|||
146299350|NCT04641299|527611720|FG002|Overall Study|Reason not given|0|||
146299351|NCT04641299|527611721|FG003|Overall Study|Reason not given|0|||
146299352|NCT00702845|527611724|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
146299353|NCT00702845|527611725|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
146299354|NCT00702845|527611724|FG000|Overall Study|Too high ovarian response|5|||
146299355|NCT00702845|527611725|FG001|Overall Study|Too high ovarian response|1|||
146299356|NCT00702845|527611724|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
146299357|NCT00702845|527611725|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
146299358|NCT00702845|527611724|FG000|Overall Study|Insufficient ovarian response|1|||
146013512|NCT05396014|526560679|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146013513|NCT05396014|526560680|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013514|NCT05396014|526560681|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013515|NCT05396014|526560682|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013516|NCT05396014|526560683|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013517|NCT05396014|526560684|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013518|NCT05396014|526560685|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013519|NCT05396014|526560686|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013520|NCT05396014|526560687|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146013521|NCT05396014|526560688|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013522|NCT05396014|526560689|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013523|NCT05396014|526560690|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013524|NCT05396014|526560691|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013525|NCT05396014|526560692|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013526|NCT05396014|526560693|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013527|NCT05396014|526560694|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
146013528|NCT05396014|526560695|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
146013529|NCT05396014|526560653|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013530|NCT05396014|526560654|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013531|NCT05396014|526560655|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013532|NCT05396014|526560656|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013533|NCT05396014|526560657|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013534|NCT05396014|526560658|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013535|NCT05396014|526560659|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013536|NCT05396014|526560660|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013537|NCT05396014|526560661|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013538|NCT05396014|526560662|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013539|NCT05396014|526560663|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013540|NCT05396014|526560664|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013541|NCT05396014|526560665|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013542|NCT05396014|526560666|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013543|NCT05396014|526560667|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013544|NCT05396014|526560668|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013545|NCT05396014|526560669|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013546|NCT05396014|526560670|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013547|NCT05396014|526560671|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013548|NCT05396014|526560672|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013549|NCT05396014|526560673|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013550|NCT05396014|526560674|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146299359|NCT00702845|527611725|FG001|Overall Study|Insufficient ovarian response|0|||
146299360|NCT00702845|527611724|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
146299361|NCT00702845|527611725|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
146299362|NCT00702845|527611724|FG000|Overall Study|No or abnormal fertilization|4|||
146299363|NCT00702845|527611725|FG001|Overall Study|No or abnormal fertilization|2|||
146299364|NCT00702845|527611724|FG000|Overall Study|Patient's decision|2|||
146299365|NCT00702845|527611725|FG001|Overall Study|Patient's decision|1|||
146299366|NCT00702845|527611724|FG000|Overall Study|Not randomized|0|||
146299367|NCT00702845|527611725|FG001|Overall Study|Not randomized|1|||
146013551|NCT05396014|526560675|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013552|NCT05396014|526560676|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013553|NCT05396014|526560677|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013554|NCT05396014|526560678|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013555|NCT05396014|526560679|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
146013556|NCT05396014|526560680|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013557|NCT05396014|526560681|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013558|NCT05396014|526560682|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013559|NCT05396014|526560683|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013560|NCT05396014|526560684|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013561|NCT05396014|526560685|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013562|NCT05396014|526560686|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013563|NCT05396014|526560687|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013564|NCT05396014|526560688|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013565|NCT05396014|526560689|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013566|NCT05396014|526560690|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013567|NCT05396014|526560691|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013568|NCT05396014|526560692|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013569|NCT05396014|526560693|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013570|NCT05396014|526560694|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013571|NCT05396014|526560695|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
146013572|NCT03062280|526560696|FG000|Overall Study|Adverse Event|1|||
146013573|NCT03062280|526560696|FG000|Overall Study|Death|1|||
146013574|NCT03062280|526560696|FG000|Overall Study|Fertility Treatment|2|||
146013575|NCT03062280|526560696|FG000|Overall Study|Physician Decision|2|||
146013576|NCT03062280|526560696|FG000|Overall Study|Pregnancy|5|||
146013577|NCT03062280|526560696|FG000|Overall Study|Withdrawal by Subject|11|||
146013578|NCT04439539|526560697|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
146013579|NCT04439539|526560698|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
146013580|NCT04439539|526560699|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
146013581|NCT04439539|526560697|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
146013582|NCT04439539|526560698|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
146013583|NCT04439539|526560699|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
146013584|NCT04439539|526560697|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
146013585|NCT04439539|526560698|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
146013586|NCT04439539|526560699|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
146013587|NCT04551963|526560709|FG000|Overall Study|Physician Decision|1|||
146013588|NCT04551963|526560710|FG001|Overall Study|Physician Decision|1|||
146013589|NCT04551963|526560709|FG000|Overall Study|Death|1|||
146013590|NCT04551963|526560710|FG001|Overall Study|Death|0|||
146013591|NCT03379259|526560711|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
146013592|NCT03379259|526560712|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
146013593|NCT03379259|526560713|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
146013594|NCT03379259|526560714|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
146013595|NCT03379259|526560715|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
146013596|NCT03379259|526560716|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
146013597|NCT03379259|526560711|FG000|Overall Study|Death|0|||
146013598|NCT03379259|526560712|FG001|Overall Study|Death|1|||
146013599|NCT03379259|526560713|FG002|Overall Study|Death|2|||
146013600|NCT03379259|526560714|FG003|Overall Study|Death|1|||
146013601|NCT03379259|526560715|FG004|Overall Study|Death|4|||
146013602|NCT03379259|526560716|FG005|Overall Study|Death|2|||
146013603|NCT03379259|526560711|FG000|Overall Study|Withdrawal by Subject|0|||
146013604|NCT03379259|526560712|FG001|Overall Study|Withdrawal by Subject|0|||
146013605|NCT03379259|526560713|FG002|Overall Study|Withdrawal by Subject|1|||
146013606|NCT03379259|526560714|FG003|Overall Study|Withdrawal by Subject|0|||
146013607|NCT03379259|526560715|FG004|Overall Study|Withdrawal by Subject|2|||
146013608|NCT03379259|526560716|FG005|Overall Study|Withdrawal by Subject|0|||
146013609|NCT03379259|526560711|FG000|Overall Study|Study terminated by sponsor|0|||
146013610|NCT03379259|526560712|FG001|Overall Study|Study terminated by sponsor|0|||
146013611|NCT03379259|526560713|FG002|Overall Study|Study terminated by sponsor|0|||
146013612|NCT03379259|526560714|FG003|Overall Study|Study terminated by sponsor|1|||
146013613|NCT03379259|526560715|FG004|Overall Study|Study terminated by sponsor|1|||
146013614|NCT03379259|526560716|FG005|Overall Study|Study terminated by sponsor|4|||
146013615|NCT03379259|526560711|FG000|Overall Study|Disease progression|0|||
146013616|NCT03379259|526560712|FG001|Overall Study|Disease progression|0|||
146013617|NCT03379259|526560713|FG002|Overall Study|Disease progression|0|||
146013618|NCT03379259|526560714|FG003|Overall Study|Disease progression|1|||
146013619|NCT03379259|526560715|FG004|Overall Study|Disease progression|0|||
146013620|NCT03379259|526560716|FG005|Overall Study|Disease progression|1|||
146013621|NCT03379259|526560711|FG000|Overall Study|Lost to Follow-up|0|||
146013622|NCT03379259|526560712|FG001|Overall Study|Lost to Follow-up|0|||
146013623|NCT03379259|526560713|FG002|Overall Study|Lost to Follow-up|0|||
146013624|NCT03379259|526560714|FG003|Overall Study|Lost to Follow-up|0|||
146013625|NCT03379259|526560715|FG004|Overall Study|Lost to Follow-up|1|||
146013626|NCT03379259|526560716|FG005|Overall Study|Lost to Follow-up|0|||
146013627|NCT03379259|526560711|FG000|Overall Study|Deteriorating condition|0|||
146013628|NCT03379259|526560712|FG001|Overall Study|Deteriorating condition|0|||
146013629|NCT03379259|526560713|FG002|Overall Study|Deteriorating condition|0|||
146013630|NCT03379259|526560714|FG003|Overall Study|Deteriorating condition|0|||
146013631|NCT03379259|526560715|FG004|Overall Study|Deteriorating condition|1|||
146013632|NCT03379259|526560716|FG005|Overall Study|Deteriorating condition|0|||
146013633|NCT03850093|526560717|FG000|Overall Study|Withdrawal by Subject|1|||
146013634|NCT03850093|526560718|FG001|Overall Study|Withdrawal by Subject|0|||
146013635|NCT03850093|526560719|FG002|Overall Study|Withdrawal by Subject|2|||
146013636|NCT02836717|526560721|FG000|Test Phase|Lack of Efficacy|14|||
146013637|NCT02836717|526560722|FG001|Test Phase|Lack of Efficacy|8|||
146013638|NCT02836717|526560723|FG002|Test Phase|Lack of Efficacy|0|||
146013639|NCT02836717|526560721|FG000|Study Phase|Adverse Event|2|||
146013640|NCT02836717|526560722|FG001|Study Phase|Adverse Event|0|||
146013641|NCT02836717|526560723|FG002|Study Phase|Adverse Event|0|||
146013642|NCT02836717|526560721|FG000|Study Phase|Lack of Efficacy|8|||
146013643|NCT02836717|526560722|FG001|Study Phase|Lack of Efficacy|6|||
146013644|NCT02836717|526560723|FG002|Study Phase|Lack of Efficacy|1|||
146013645|NCT02836717|526560721|FG000|Study Phase|Withdrawal by Subject|1|||
146013646|NCT02836717|526560722|FG001|Study Phase|Withdrawal by Subject|0|||
146013647|NCT02836717|526560723|FG002|Study Phase|Withdrawal by Subject|0|||
146013648|NCT02836717|526560721|FG000|Study Phase|Death|1|||
146013649|NCT02836717|526560722|FG001|Study Phase|Death|0|||
146013650|NCT02836717|526560723|FG002|Study Phase|Death|0|||
146013651|NCT02836717|526560721|FG000|Study Phase|abdominal surgeries|2|||
146013652|NCT02836717|526560722|FG001|Study Phase|abdominal surgeries|1|||
146013653|NCT02836717|526560723|FG002|Study Phase|abdominal surgeries|0|||
146013654|NCT01309997|526560725|FG000|Overall Study|Adverse Event|1|||
146013655|NCT01309997|526560726|FG001|Overall Study|Adverse Event|0|||
146013656|NCT01309997|526560725|FG000|Overall Study|Death|1|||
146013657|NCT01309997|526560726|FG001|Overall Study|Death|3|||
146013658|NCT01309997|526560725|FG000|Overall Study|Lack of Efficacy|2|||
146013659|NCT01309997|526560726|FG001|Overall Study|Lack of Efficacy|2|||
146013660|NCT01309997|526560725|FG000|Overall Study|Withdrawal by Subject|1|||
146013661|NCT01309997|526560726|FG001|Overall Study|Withdrawal by Subject|1|||
146013662|NCT00282087|526560727|FG000|Overall Study|Death|1|||
146013663|NCT03226249|526560728|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
146013664|NCT03226249|526560728|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
146013665|NCT03226249|526560728|FG000|Survival Follow-up|Patients still in follow-up.|30|||
146013666|NCT01532921|526560731|FG000|Overall Study|Death|3|||
146013667|NCT01532921|526560731|FG000|Overall Study|Withdrawal by Subject|2|||
146013668|NCT01532921|526560731|FG000|Overall Study|Lost to Follow-up|3|||
146013669|NCT01532921|526560731|FG000|Overall Study|Physician Decision|7|||
146013670|NCT01532921|526560731|FG000|Overall Study|Device was explanted during procedure|1|||
146013671|NCT03462641|526560732|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
146013672|NCT03462641|526560733|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
146013673|NCT03462641|526560732|FG000|Visit 2|Withdrawal by Subject|0|||
146013674|NCT03462641|526560733|FG001|Visit 2|Withdrawal by Subject|1|||
146013675|NCT01804049|526560734|FG000|Overall Study|Adverse Event|2|||
146013676|NCT01804049|526560735|FG001|Overall Study|Adverse Event|10|||
146013677|NCT01804049|526560734|FG000|Overall Study|Lost to Follow-up|2|||
146013678|NCT01804049|526560735|FG001|Overall Study|Lost to Follow-up|1|||
146013679|NCT01804049|526560734|FG000|Overall Study|Decreased interest/personal|4|||
146013680|NCT01804049|526560735|FG001|Overall Study|Decreased interest/personal|5|||
146013681|NCT01804049|526560734|FG000|Overall Study|Other health concerns|2|||
146013682|NCT01804049|526560735|FG001|Overall Study|Other health concerns|7|||
146013683|NCT01804049|526560734|FG000|Overall Study|Moved out of area|0|||
146013684|NCT01804049|526560735|FG001|Overall Study|Moved out of area|7|||
146013685|NCT01804049|526560734|FG000|Overall Study|other MD recommended|1|||
146013686|NCT01804049|526560735|FG001|Overall Study|other MD recommended|1|||
146013687|NCT01804049|526560734|FG000|Overall Study|Enrollment in dual studies|0|||
146013688|NCT01804049|526560735|FG001|Overall Study|Enrollment in dual studies|1|||
146013689|NCT00070109|526560736|FG000|Overall Study|Death|1|||
146013690|NCT00070109|526560737|FG001|Overall Study|Death|1|||
146250252|NCT01755598|527428140|FG001|Overall Study|Lost to Follow-up|43|||
146250253|NCT01755598|527428139|FG000|Overall Study|Migrated/moved from study area|76|||
146013691|NCT00070109|526560738|FG002|Overall Study|Death|0|||
146013692|NCT00070109|526560739|FG003|Overall Study|Death|0|||
146013693|NCT00070109|526560740|FG004|Overall Study|Death|1|||
146013694|NCT00070109|526560736|FG000|Overall Study|Lack of Efficacy|6|||
146013695|NCT00070109|526560737|FG001|Overall Study|Lack of Efficacy|4|||
146013696|NCT00070109|526560738|FG002|Overall Study|Lack of Efficacy|5|||
146013697|NCT00070109|526560739|FG003|Overall Study|Lack of Efficacy|15|||
146013698|NCT00070109|526560740|FG004|Overall Study|Lack of Efficacy|5|||
146013699|NCT00070109|526560736|FG000|Overall Study|Physician Decision|1|||
146013700|NCT00070109|526560737|FG001|Overall Study|Physician Decision|0|||
146299368|NCT00928564|527611729|FG000|Overall Study|Lost to Follow-up|6|||
146299369|NCT00928564|527611730|FG001|Overall Study|Lost to Follow-up|0|||
146299370|NCT02973425|527611732|FG000|Overall Study|Lost to Follow-up|49|||
146299371|NCT02973425|527611733|FG001|Overall Study|Lost to Follow-up|53|||
146299372|NCT03503513|527611738|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
146299373|NCT03503513|527611738|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
146299374|NCT03503513|527611738|FG000|Overall Study|Physician Decision|3|||
146299375|NCT03503513|527611738|FG000|Overall Study|Withdrawal by Subject|2|||
146299376|NCT03503513|527611738|FG000|Overall Study|Lost to Follow-up|1|||
146299377|NCT03842163|527611739|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
146299378|NCT03842163|527611739|FG000|Overall Study|Scintigraphy was not performed|44|||
146299379|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
146299380|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
146299381|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
146299382|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
146299383|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
146299384|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
146299385|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
146299386|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
146299387|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
146299388|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
146299389|NCT03829241|527611740|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
146299390|NCT03829241|527611741|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
146299391|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
146299392|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
146299393|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
146299394|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
146299395|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
146299396|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
146299397|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
146299398|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
146299399|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
146299400|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
146299401|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
146299402|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
146299403|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
146299404|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
146299405|NCT03829241|527611740|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
146299406|NCT03829241|527611741|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
146299407|NCT03083847|527611742|FG000|Main|Physician Decision|0|||
146013701|NCT00070109|526560738|FG002|Overall Study|Physician Decision|0|||
146013702|NCT00070109|526560739|FG003|Overall Study|Physician Decision|0|||
146013703|NCT00070109|526560740|FG004|Overall Study|Physician Decision|0|||
146013704|NCT00070109|526560736|FG000|Overall Study|Withdrawal by Subject|0|||
146013705|NCT00070109|526560737|FG001|Overall Study|Withdrawal by Subject|1|||
146013706|NCT00070109|526560738|FG002|Overall Study|Withdrawal by Subject|1|||
146013707|NCT00070109|526560739|FG003|Overall Study|Withdrawal by Subject|0|||
146013708|NCT00070109|526560740|FG004|Overall Study|Withdrawal by Subject|0|||
146013709|NCT00070109|526560736|FG000|Overall Study|Adverse Event|0|||
146013710|NCT00070109|526560737|FG001|Overall Study|Adverse Event|0|||
146013711|NCT00070109|526560738|FG002|Overall Study|Adverse Event|2|||
146013712|NCT00070109|526560739|FG003|Overall Study|Adverse Event|4|||
146013713|NCT00070109|526560740|FG004|Overall Study|Adverse Event|2|||
146013714|NCT00070109|526560736|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
146013715|NCT00070109|526560737|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
146013716|NCT00070109|526560738|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
146013717|NCT00070109|526560739|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
146013718|NCT00070109|526560740|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
146013719|NCT00588237|526560746|FG000|Overall Study|Evaluable for toxicity only|3|||
146013720|NCT00588237|526560746|FG000|Overall Study|Patien not treated|1|||
146013721|NCT02201329|526560749|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
146013722|NCT02201329|526560749|FG000|Overall Study|Withdrawal by Subject|2|||
146013723|NCT01555073|526560750|FG000|Overall Study|Lost to Follow-up|1|||
146013724|NCT01555073|526560751|FG001|Overall Study|Lost to Follow-up|2|||
146013725|NCT01555073|526560752|FG002|Overall Study|Lost to Follow-up|0|||
146013726|NCT01555073|526560753|FG003|Overall Study|Lost to Follow-up|5|||
146093380|NCT03347188|526863403|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
146093381|NCT03347188|526863402|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
146299408|NCT03083847|527611743|FG001|Main|Physician Decision|0|||
146013727|NCT01262638|526560754|FG000|Overall Study|Adverse Event|3|||
146013728|NCT01262638|526560755|FG001|Overall Study|Adverse Event|4|||
146013729|NCT01262638|526560756|FG002|Overall Study|Adverse Event|3|||
146013730|NCT01262638|526560757|FG003|Overall Study|Adverse Event|4|||
146013731|NCT01262638|526560754|FG000|Overall Study|Protocol Violation|1|||
146013732|NCT01262638|526560755|FG001|Overall Study|Protocol Violation|0|||
146013733|NCT01262638|526560756|FG002|Overall Study|Protocol Violation|0|||
146013734|NCT01262638|526560757|FG003|Overall Study|Protocol Violation|1|||
146013735|NCT01262638|526560754|FG000|Overall Study|Withdrawal by Subject|2|||
146013736|NCT01262638|526560755|FG001|Overall Study|Withdrawal by Subject|1|||
146013737|NCT01262638|526560756|FG002|Overall Study|Withdrawal by Subject|0|||
146013738|NCT01262638|526560757|FG003|Overall Study|Withdrawal by Subject|1|||
146013739|NCT01262638|526560754|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146013740|NCT01262638|526560755|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146013741|NCT01262638|526560756|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
146013742|NCT01262638|526560757|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146013743|NCT01262638|526560754|FG000|Overall Study|Lost to Follow-up|1|||
146013744|NCT01262638|526560755|FG001|Overall Study|Lost to Follow-up|1|||
146013745|NCT01262638|526560756|FG002|Overall Study|Lost to Follow-up|1|||
146013746|NCT01262638|526560757|FG003|Overall Study|Lost to Follow-up|1|||
146013747|NCT01262638|526560754|FG000|Overall Study|Participant Went Out of Town|0|||
146013748|NCT01262638|526560755|FG001|Overall Study|Participant Went Out of Town|0|||
146013749|NCT01262638|526560756|FG002|Overall Study|Participant Went Out of Town|1|||
146013750|NCT01262638|526560757|FG003|Overall Study|Participant Went Out of Town|0|||
146013751|NCT01369199|526560758|FG000|Overall Study|Withdrawal by Subject|1|||
146013752|NCT01369199|526560758|FG000|Overall Study|Lost to Follow-up|2|||
146013753|NCT01970241|526560766|FG000|Overall Study|Withdrawal by Subject|2|||
146013754|NCT01970241|526560767|FG001|Overall Study|Withdrawal by Subject|0|||
146013755|NCT01970241|526560766|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
146013756|NCT01970241|526560767|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
146013757|NCT00851552|526560772|FG000|Overall Study|Death|2|||
146013758|NCT00851552|526560772|FG000|Overall Study|Adverse Event|1|||
146013759|NCT00851552|526560772|FG000|Overall Study|Disease Progression|4|||
146013760|NCT01479764|526560773|FG000|Randomized|Adverse Event|1|||
146013761|NCT01479764|526560774|FG001|Randomized|Adverse Event|1|||
146013762|NCT01479764|526560773|FG000|Randomized|Withdrawal by Subject|1|||
146013763|NCT01479764|526560774|FG001|Randomized|Withdrawal by Subject|0|||
146013764|NCT01479764|526560773|FG000|Treated|Lost to Follow-up|0|||
146013765|NCT01479764|526560774|FG001|Treated|Lost to Follow-up|2|||
146013766|NCT01916824|526560779|FG000|Overall Study|Lost to Follow-up|3|||
146013767|NCT01916824|526560780|FG001|Overall Study|Lost to Follow-up|6|||
146013768|NCT01916824|526560779|FG000|Overall Study|Physician Decision|2|||
146013769|NCT01916824|526560780|FG001|Overall Study|Physician Decision|0|||
146013770|NCT01916824|526560779|FG000|Overall Study|Withdrawal by Subject|2|||
146013771|NCT01916824|526560780|FG001|Overall Study|Withdrawal by Subject|3|||
146013772|NCT00771927|526560783|FG000|Overall Study|Adverse Event|100|||
146013773|NCT00771927|526560784|FG001|Overall Study|Adverse Event|105|||
146013774|NCT00771927|526560783|FG000|Overall Study|Lack of Efficacy|70|||
146013775|NCT00771927|526560784|FG001|Overall Study|Lack of Efficacy|42|||
146013776|NCT00771927|526560783|FG000|Overall Study|Lost to Follow-up|46|||
146013777|NCT00771927|526560784|FG001|Overall Study|Lost to Follow-up|46|||
146013778|NCT00771927|526560783|FG000|Overall Study|Withdrawal by Subject|16|||
146013779|NCT00771927|526560784|FG001|Overall Study|Withdrawal by Subject|17|||
146013780|NCT00771927|526560783|FG000|Overall Study|Other reason|23|||
146013781|NCT00771927|526560784|FG001|Overall Study|Other reason|27|||
146013782|NCT03835481|526560785|FG000|Double-blind Period|Other not stated below|0|||
146013783|NCT03835481|526560786|FG001|Double-blind Period|Other not stated below|0|||
146013784|NCT03835481|526560787|FG002|Double-blind Period|Other not stated below|0|||
146013785|NCT03835481|526560788|FG003|Double-blind Period|Other not stated below|1|||
146013786|NCT03835481|526560789|FG004|Double-blind Period|Other not stated below|1|||
146013787|NCT03835481|526560785|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
146013788|NCT03835481|526560786|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
146299409|NCT03083847|527611744|FG002|Main|Physician Decision|0|||
146013789|NCT03835481|526560787|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
146299410|NCT03083847|527611745|FG003|Main|Physician Decision|0|||
146299411|NCT03083847|527611746|FG004|Main|Physician Decision|0|||
146299412|NCT03083847|527611747|FG005|Main|Physician Decision|1|||
146013790|NCT03835481|526560788|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
146013791|NCT03835481|526560789|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
146013792|NCT03835481|526560785|FG000|Double-blind Period|Withdrawal by Subject|0|||
146013793|NCT03835481|526560786|FG001|Double-blind Period|Withdrawal by Subject|0|||
146013794|NCT03835481|526560787|FG002|Double-blind Period|Withdrawal by Subject|1|||
146013795|NCT03835481|526560788|FG003|Double-blind Period|Withdrawal by Subject|0|||
146013796|NCT03835481|526560789|FG004|Double-blind Period|Withdrawal by Subject|5|||
146013797|NCT03835481|526560785|FG000|Double-blind Period|Lost to Follow-up|0|||
146013798|NCT03835481|526560786|FG001|Double-blind Period|Lost to Follow-up|0|||
146013799|NCT03835481|526560787|FG002|Double-blind Period|Lost to Follow-up|0|||
146013800|NCT03835481|526560788|FG003|Double-blind Period|Lost to Follow-up|1|||
146013801|NCT03835481|526560789|FG004|Double-blind Period|Lost to Follow-up|0|||
146013802|NCT03835481|526560785|FG000|Double-blind Period|Protocol Violation|0|||
146013803|NCT03835481|526560786|FG001|Double-blind Period|Protocol Violation|2|||
146013804|NCT03835481|526560787|FG002|Double-blind Period|Protocol Violation|0|||
146013805|NCT03835481|526560788|FG003|Double-blind Period|Protocol Violation|1|||
146013806|NCT03835481|526560789|FG004|Double-blind Period|Protocol Violation|0|||
146013807|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
146013808|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
146013809|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
146013810|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
146013811|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
146013812|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
146013813|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
146013814|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
146013815|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
146013816|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
146013817|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146013818|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146013819|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
146013820|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
146013821|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
146013822|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
146013823|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
146013824|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
146013825|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
146013826|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
146013827|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146013828|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146013829|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146013830|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
146013831|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
146013832|NCT03835481|526560785|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
146013833|NCT03835481|526560786|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
146013834|NCT03835481|526560787|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
146013835|NCT03835481|526560788|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
146013836|NCT03835481|526560789|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
146013837|NCT02063984|526560793|FG000|Overall Study|Lost to Follow-up|6|||
146013838|NCT02063984|526560794|FG001|Overall Study|Lost to Follow-up|5|||
146013839|NCT02146131|526560798|FG000|Overall Study|Physician Decision|61|||
146013840|NCT02146131|526560799|FG001|Overall Study|Physician Decision|56|||
146013841|NCT02567799|526560800|FG000|Concurrent Chemoradiotherapy|Death|1|||
146013842|NCT02567799|526560801|FG001|Concurrent Chemoradiotherapy|Death|0|||
146013843|NCT02567799|526560802|FG002|Concurrent Chemoradiotherapy|Death|0|||
146013844|NCT02567799|526560800|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
146013845|NCT02567799|526560801|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
146013846|NCT02567799|526560802|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
146013847|NCT02567799|526560800|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
146013848|NCT02567799|526560801|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
146013849|NCT02567799|526560802|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
146013850|NCT02567799|526560800|FG000|Follow-up|Death|1|||
146013851|NCT02567799|526560801|FG001|Follow-up|Death|0|||
146013852|NCT02567799|526560802|FG002|Follow-up|Death|1|||
146013853|NCT02567799|526560800|FG000|Follow-up|Progressive Disease|1|||
146013854|NCT02567799|526560801|FG001|Follow-up|Progressive Disease|1|||
146013855|NCT02567799|526560802|FG002|Follow-up|Progressive Disease|3|||
146013856|NCT03335150|526560805|FG000|Overall Study|Withdrawal by Subject|10|||
146013857|NCT03335150|526560806|FG001|Overall Study|Withdrawal by Subject|4|||
146013858|NCT03335150|526560805|FG000|Overall Study|Adverse Event|0|||
146013859|NCT03335150|526560806|FG001|Overall Study|Adverse Event|1|||
146013860|NCT02218697|526560807|FG000|Overall Study|Adverse Event|0|||
146013861|NCT02218697|526560808|FG001|Overall Study|Adverse Event|2|||
146013862|NCT02218697|526560807|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
146013863|NCT02218697|526560808|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
146013864|NCT02218697|526560807|FG000|Overall Study|Withdrawal by Subject|2|||
146013865|NCT02218697|526560808|FG001|Overall Study|Withdrawal by Subject|3|||
146013866|NCT05356910|526560811|FG000|Overall Study|Lost to Follow-up|10|||
146013867|NCT05356910|526560812|FG001|Overall Study|Lost to Follow-up|19|||
146013868|NCT05356910|526560813|FG002|Overall Study|Lost to Follow-up|0|||
146013869|NCT05356910|526560814|FG003|Overall Study|Lost to Follow-up|0|||
146013870|NCT05356910|526560811|FG000|Overall Study|Withdrawal by Subject|4|||
146013871|NCT05356910|526560812|FG001|Overall Study|Withdrawal by Subject|2|||
146013872|NCT05356910|526560813|FG002|Overall Study|Withdrawal by Subject|0|||
146013873|NCT05356910|526560814|FG003|Overall Study|Withdrawal by Subject|0|||
146013874|NCT03306433|526560817|FG000|Overall Study|Lost to Follow-up|3|||
146013875|NCT03306433|526560817|FG000|Overall Study|Patient did not have teeth extracted|1|||
146013876|NCT03306433|526560817|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
146013877|NCT00819156|526560818|FG000|Overall Study|Adverse Event|1|||
146013878|NCT00819156|526560819|FG001|Overall Study|Adverse Event|4|||
146013879|NCT00819156|526560820|FG002|Overall Study|Adverse Event|2|||
146013880|NCT00819156|526560821|FG003|Overall Study|Adverse Event|1|||
146013881|NCT00819156|526560822|FG004|Overall Study|Adverse Event|2|||
146013882|NCT00819156|526560823|FG005|Overall Study|Adverse Event|3|||
146013883|NCT00819156|526560818|FG000|Overall Study|Withdrawal by Subject|0|||
146013884|NCT00819156|526560819|FG001|Overall Study|Withdrawal by Subject|3|||
146013885|NCT00819156|526560820|FG002|Overall Study|Withdrawal by Subject|2|||
146013886|NCT00819156|526560821|FG003|Overall Study|Withdrawal by Subject|0|||
146013887|NCT00819156|526560822|FG004|Overall Study|Withdrawal by Subject|1|||
146013888|NCT00819156|526560823|FG005|Overall Study|Withdrawal by Subject|0|||
146013889|NCT00819156|526560818|FG000|Overall Study|Protocol Violation|1|||
146013890|NCT00819156|526560819|FG001|Overall Study|Protocol Violation|0|||
146013891|NCT00819156|526560820|FG002|Overall Study|Protocol Violation|1|||
146013892|NCT00819156|526560821|FG003|Overall Study|Protocol Violation|0|||
146013893|NCT00819156|526560822|FG004|Overall Study|Protocol Violation|0|||
146013894|NCT00819156|526560823|FG005|Overall Study|Protocol Violation|1|||
146013895|NCT00819156|526560818|FG000|Overall Study|Lost to Follow-up|0|||
146013896|NCT00819156|526560819|FG001|Overall Study|Lost to Follow-up|1|||
146013897|NCT00819156|526560820|FG002|Overall Study|Lost to Follow-up|0|||
146013898|NCT00819156|526560821|FG003|Overall Study|Lost to Follow-up|0|||
146013899|NCT00819156|526560822|FG004|Overall Study|Lost to Follow-up|0|||
146013900|NCT00819156|526560823|FG005|Overall Study|Lost to Follow-up|2|||
146013901|NCT00819156|526560818|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
146013902|NCT00819156|526560819|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
146013903|NCT00819156|526560820|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146013904|NCT00819156|526560821|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146013905|NCT00819156|526560822|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
146013906|NCT00819156|526560823|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
146013907|NCT00819156|526560818|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
146013908|NCT00819156|526560819|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146013909|NCT00819156|526560820|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146013910|NCT00819156|526560821|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146013911|NCT00819156|526560822|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
146013912|NCT00819156|526560823|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
146013913|NCT00819156|526560818|FG000|Overall Study|Prostate-specific antigen progression|0|||
146013914|NCT00819156|526560819|FG001|Overall Study|Prostate-specific antigen progression|0|||
146013915|NCT00819156|526560820|FG002|Overall Study|Prostate-specific antigen progression|0|||
146013916|NCT00819156|526560821|FG003|Overall Study|Prostate-specific antigen progression|0|||
146013917|NCT00819156|526560822|FG004|Overall Study|Prostate-specific antigen progression|1|||
146013918|NCT00819156|526560823|FG005|Overall Study|Prostate-specific antigen progression|0|||
146013919|NCT00803595|526560824|FG000|Overall Study|Adverse Event|3|||
146013920|NCT00803595|526560825|FG001|Overall Study|Adverse Event|4|||
146013921|NCT00803595|526560826|FG002|Overall Study|Adverse Event|1|||
146013922|NCT00803595|526560824|FG000|Overall Study|Protocol Violation|7|||
146013923|NCT00803595|526560825|FG001|Overall Study|Protocol Violation|2|||
146013924|NCT00803595|526560826|FG002|Overall Study|Protocol Violation|12|||
146013925|NCT00803595|526560824|FG000|Overall Study|Withdrawal by Subject|5|||
146013926|NCT00803595|526560825|FG001|Overall Study|Withdrawal by Subject|2|||
146013927|NCT00803595|526560826|FG002|Overall Study|Withdrawal by Subject|3|||
146013928|NCT02195700|526560828|FG000|Overall Study|Protocol Violation|0|||
146013929|NCT02195700|526560829|FG001|Overall Study|Protocol Violation|2|||
146013930|NCT02195700|526560828|FG000|Overall Study|Noncompliance|1|||
146013931|NCT02195700|526560829|FG001|Overall Study|Noncompliance|0|||
146013932|NCT02195700|526560828|FG000|Overall Study|Adverse Event|1|||
146013933|NCT02195700|526560829|FG001|Overall Study|Adverse Event|2|||
146013934|NCT02195700|526560828|FG000|Overall Study|Withdrawal by Subject|3|||
146013935|NCT02195700|526560829|FG001|Overall Study|Withdrawal by Subject|2|||
146013936|NCT02195700|526560828|FG000|Overall Study|Lost to Follow-up|1|||
146013937|NCT02195700|526560829|FG001|Overall Study|Lost to Follow-up|1|||
146013938|NCT02931838|526560830|FG000|Overall Study|Reason not provided by investigator|1|||
146013939|NCT02931838|526560831|FG001|Overall Study|Reason not provided by investigator|0|||
146013940|NCT02931838|526560832|FG002|Overall Study|Reason not provided by investigator|1|||
146013941|NCT02931838|526560833|FG003|Overall Study|Reason not provided by investigator|0|||
146013942|NCT02931838|526560834|FG004|Overall Study|Reason not provided by investigator|0|||
146013943|NCT02931838|526560835|FG005|Overall Study|Reason not provided by investigator|0|||
146013944|NCT02931838|526560830|FG000|Overall Study|Poor/non-compliance|0|||
146013945|NCT02931838|526560831|FG001|Overall Study|Poor/non-compliance|0|||
146013946|NCT02931838|526560832|FG002|Overall Study|Poor/non-compliance|1|||
146013947|NCT02931838|526560833|FG003|Overall Study|Poor/non-compliance|0|||
146013948|NCT02931838|526560834|FG004|Overall Study|Poor/non-compliance|0|||
146013949|NCT02931838|526560835|FG005|Overall Study|Poor/non-compliance|0|||
146013950|NCT02931838|526560830|FG000|Overall Study|Lack of Efficacy|5|||
146013951|NCT02931838|526560831|FG001|Overall Study|Lack of Efficacy|4|||
146013952|NCT02931838|526560832|FG002|Overall Study|Lack of Efficacy|0|||
146013953|NCT02931838|526560833|FG003|Overall Study|Lack of Efficacy|0|||
146013954|NCT02931838|526560834|FG004|Overall Study|Lack of Efficacy|0|||
146013955|NCT02931838|526560835|FG005|Overall Study|Lack of Efficacy|1|||
146013956|NCT02931838|526560830|FG000|Overall Study|Lost to Follow-up|1|||
146013957|NCT02931838|526560831|FG001|Overall Study|Lost to Follow-up|0|||
146013958|NCT02931838|526560832|FG002|Overall Study|Lost to Follow-up|1|||
146013959|NCT02931838|526560833|FG003|Overall Study|Lost to Follow-up|1|||
146013960|NCT02931838|526560834|FG004|Overall Study|Lost to Follow-up|2|||
146013961|NCT02931838|526560835|FG005|Overall Study|Lost to Follow-up|0|||
146013962|NCT02931838|526560830|FG000|Overall Study|Subject request to discontinue treatment|4|||
146013963|NCT02931838|526560831|FG001|Overall Study|Subject request to discontinue treatment|3|||
146013964|NCT02931838|526560832|FG002|Overall Study|Subject request to discontinue treatment|3|||
146013965|NCT02931838|526560833|FG003|Overall Study|Subject request to discontinue treatment|0|||
146013966|NCT02931838|526560834|FG004|Overall Study|Subject request to discontinue treatment|1|||
146013967|NCT02931838|526560835|FG005|Overall Study|Subject request to discontinue treatment|0|||
146013968|NCT02931838|526560830|FG000|Overall Study|Withdrawal by Subject|1|||
146013969|NCT02931838|526560831|FG001|Overall Study|Withdrawal by Subject|2|||
146013970|NCT02931838|526560832|FG002|Overall Study|Withdrawal by Subject|0|||
146013971|NCT02931838|526560833|FG003|Overall Study|Withdrawal by Subject|1|||
146013972|NCT02931838|526560834|FG004|Overall Study|Withdrawal by Subject|0|||
146013973|NCT02931838|526560835|FG005|Overall Study|Withdrawal by Subject|0|||
146013974|NCT02931838|526560830|FG000|Overall Study|Adverse Event|2|||
146013975|NCT02931838|526560831|FG001|Overall Study|Adverse Event|1|||
146013976|NCT02931838|526560832|FG002|Overall Study|Adverse Event|2|||
146013977|NCT02931838|526560833|FG003|Overall Study|Adverse Event|1|||
146013978|NCT02931838|526560834|FG004|Overall Study|Adverse Event|3|||
146013979|NCT02931838|526560835|FG005|Overall Study|Adverse Event|1|||
146013980|NCT00104728|526560836|FG000|Overall Study|screen failures|19|||
146013981|NCT02709577|526560837|FG000|Overall Study|non-accommodating anatomy|0|||
146013982|NCT02709577|526560838|FG001|Overall Study|non-accommodating anatomy|1|||
146013983|NCT02709577|526560839|FG002|Overall Study|non-accommodating anatomy|0|||
146013984|NCT02709577|526560840|FG003|Overall Study|non-accommodating anatomy|0|||
146013985|NCT02709577|526560837|FG000|Overall Study|procedural complication|0|||
146013986|NCT02709577|526560838|FG001|Overall Study|procedural complication|1|||
146013987|NCT02709577|526560839|FG002|Overall Study|procedural complication|0|||
146013988|NCT02709577|526560840|FG003|Overall Study|procedural complication|0|||
146013989|NCT02709577|526560837|FG000|Overall Study|Withdrawal by Subject|2|||
146013990|NCT02709577|526560838|FG001|Overall Study|Withdrawal by Subject|3|||
146013991|NCT02709577|526560839|FG002|Overall Study|Withdrawal by Subject|2|||
146013992|NCT02709577|526560840|FG003|Overall Study|Withdrawal by Subject|0|||
146013993|NCT01042158|526560841|FG000|Overall Study|Physician Decision|1|||
146013994|NCT01575808|526560842|FG000|Overall Study|Death|2|||
146013995|NCT01575808|526560843|FG001|Overall Study|Death|0|||
146013996|NCT01575808|526560842|FG000|Overall Study|Withdrawal by Subject|1|||
146013997|NCT01575808|526560843|FG001|Overall Study|Withdrawal by Subject|0|||
146013998|NCT00064259|526562233|FG000|Overall Study|Adverse Event|1|||
146013999|NCT00064259|526562234|FG001|Overall Study|Adverse Event|0|||
146014000|NCT00064259|526562235|FG002|Overall Study|Adverse Event|0|||
146014001|NCT00064259|526562236|FG003|Overall Study|Adverse Event|1|||
146014002|NCT01519791|526562244|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
146014003|NCT01519791|526562245|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
146014004|NCT01519791|526562244|FG000|Overall Study|Protocol Violation|6|||
146014005|NCT01519791|526562245|FG001|Overall Study|Protocol Violation|19|||
146014006|NCT01519791|526562244|FG000|Overall Study|Other Reason|87|||
146014007|NCT01519791|526562245|FG001|Overall Study|Other Reason|222|||
146014008|NCT01519791|526562244|FG000|Overall Study|subjects randomized in error|2|||
146014009|NCT01519791|526562245|FG001|Overall Study|subjects randomized in error|0|||
146093382|NCT03347188|526863403|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
146014010|NCT01519791|526562244|FG000|Overall Study|Lack of Efficacy|16|||
146014011|NCT01519791|526562245|FG001|Overall Study|Lack of Efficacy|20|||
146014012|NCT01519791|526562244|FG000|Overall Study|SAE, non-fatal|6|||
146014013|NCT01519791|526562245|FG001|Overall Study|SAE, non-fatal|22|||
146014014|NCT01519791|526562244|FG000|Overall Study|AE, serious fatal|0|||
146250254|NCT01755598|527428140|FG001|Overall Study|Migrated/moved from study area|65|||
146014015|NCT01519791|526562245|FG001|Overall Study|AE, serious fatal|1|||
146014016|NCT01519791|526562244|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
146014017|NCT01519791|526562245|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
146014018|NCT01519791|526562244|FG000|Overall Study|AE, non-serious non-fatal|12|||
146014019|NCT01519791|526562245|FG001|Overall Study|AE, non-serious non-fatal|31|||
146299413|NCT03083847|527611748|FG006|Main|Physician Decision|0|||
146093383|NCT03347188|526863402|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
146093384|NCT03347188|526863403|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
146093385|NCT03347188|526863402|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
146093386|NCT03347188|526863403|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
146093387|NCT03403374|526863404|FG000|Overall Study|Lost to Follow-up|1|||
146093388|NCT04879225|526863405|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
146093389|NCT04879225|526863405|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
146093390|NCT00736957|526863408|FG000|Overall Study|Adverse Event|43|||
146093391|NCT00736957|526863408|FG000|Overall Study|Withdrawal by Subject|49|||
146093392|NCT00736957|526863408|FG000|Overall Study|violation of eligibility criteria|2|||
146093393|NCT00736957|526863408|FG000|Overall Study|did not attend hospital appointments|1|||
146093394|NCT00736957|526863408|FG000|Overall Study|not eligible for Treatment Period I|22|||
146093395|NCT00736957|526863408|FG000|Overall Study|Physician Decision|5|||
146093396|NCT01409434|526863409|FG000|Overall Study|Protocol Violation|4|||
146299414|NCT03083847|527611749|FG007|Main|Physician Decision|0|||
146014020|NCT01519791|526562244|FG000|Overall Study|Withdrawal by Subject|15|||
146014021|NCT01519791|526562245|FG001|Overall Study|Withdrawal by Subject|37|||
146014022|NCT01519791|526562244|FG000|Overall Study|Lost to Follow-up|6|||
146014023|NCT01519791|526562245|FG001|Overall Study|Lost to Follow-up|14|||
146014024|NCT03206970|526562248|FG000|Overall Study|Death|21|||
146014025|NCT03206970|526562248|FG000|Overall Study|Withdrawal by Subject|13|||
146014026|NCT03206970|526562248|FG000|Overall Study|Lost to Follow-up|3|||
146014027|NCT03206970|526562248|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
146014028|NCT03645421|526562249|FG000|Overall Study|Adverse Event|0|||
146014029|NCT03645421|526562250|FG001|Overall Study|Adverse Event|0|||
146014030|NCT03645421|526562251|FG002|Overall Study|Adverse Event|4|||
146014031|NCT03645421|526562252|FG003|Overall Study|Adverse Event|1|||
146014032|NCT03645421|526562249|FG000|Overall Study|Withdrawal by patient|0|||
146014033|NCT03645421|526562250|FG001|Overall Study|Withdrawal by patient|0|||
146014034|NCT03645421|526562251|FG002|Overall Study|Withdrawal by patient|0|||
146014035|NCT03645421|526562252|FG003|Overall Study|Withdrawal by patient|3|||
146014036|NCT03645421|526562249|FG000|Overall Study|Study specific withdrawal criteria|0|||
146014037|NCT03645421|526562250|FG001|Overall Study|Study specific withdrawal criteria|0|||
146014038|NCT03645421|526562251|FG002|Overall Study|Study specific withdrawal criteria|1|||
146014039|NCT03645421|526562252|FG003|Overall Study|Study specific withdrawal criteria|0|||
146014040|NCT00375427|526562253|FG000|Overall Study|Adverse Event|21|||
146014041|NCT00375427|526562254|FG001|Overall Study|Adverse Event|27|||
146014042|NCT00375427|526562253|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146014043|NCT00375427|526562254|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146014044|NCT00375427|526562253|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146014045|NCT00375427|526562254|FG001|Overall Study|Abnormal laboratory value(s)|2|||
146014046|NCT00375427|526562253|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146014047|NCT00375427|526562254|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146014048|NCT00375427|526562253|FG000|Overall Study|Patient no longer requires study drug|3|||
146014049|NCT00375427|526562254|FG001|Overall Study|Patient no longer requires study drug|7|||
146014050|NCT00375427|526562253|FG000|Overall Study|Protocol Violation|10|||
146014051|NCT00375427|526562254|FG001|Overall Study|Protocol Violation|8|||
146014052|NCT00375427|526562253|FG000|Overall Study|Withdrawal by Subject|9|||
146014053|NCT00375427|526562254|FG001|Overall Study|Withdrawal by Subject|13|||
146014054|NCT00375427|526562253|FG000|Overall Study|Lost to Follow-up|1|||
146014055|NCT00375427|526562254|FG001|Overall Study|Lost to Follow-up|1|||
146014056|NCT00375427|526562253|FG000|Overall Study|Administrative reasons|0|||
146014057|NCT00375427|526562254|FG001|Overall Study|Administrative reasons|1|||
146014058|NCT00375427|526562253|FG000|Overall Study|Death|11|||
146014059|NCT00375427|526562254|FG001|Overall Study|Death|10|||
146014060|NCT03636893|526562260|FG000|Overall Study|Death|0|||
146014061|NCT03636893|526562261|FG001|Overall Study|Death|1|||
146014062|NCT03636893|526562260|FG000|Overall Study|Protocol Violation|0|||
146014063|NCT03636893|526562261|FG001|Overall Study|Protocol Violation|3|||
146014064|NCT03636893|526562260|FG000|Overall Study|Withdrawal by Subject|1|||
146014065|NCT03636893|526562261|FG001|Overall Study|Withdrawal by Subject|2|||
146014066|NCT03636893|526562260|FG000|Overall Study|Refusal to surgery|4|||
146014067|NCT03636893|526562261|FG001|Overall Study|Refusal to surgery|3|||
146014068|NCT03636893|526562260|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
146014069|NCT03636893|526562261|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
146014070|NCT03636893|526562260|FG000|Overall Study|Adverse Event|1|||
146014071|NCT03636893|526562261|FG001|Overall Study|Adverse Event|1|||
146014072|NCT00224120|526562262|FG000|Overall Study|Adverse Event|10|||
146014073|NCT00224120|526562263|FG001|Overall Study|Adverse Event|4|||
146093397|NCT02213042|526863410|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
146093398|NCT02213042|526863411|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
146093399|NCT02213042|526863412|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
146093400|NCT02213042|526863410|FG000|Overall Study|Adverse Event|2|||
146093401|NCT02213042|526863411|FG001|Overall Study|Adverse Event|1|||
146250255|NCT01755598|527428139|FG000|Overall Study|Withdrawal by Subject|22|||
146014074|NCT00224120|526562262|FG000|Overall Study|Protocol Violation|1|||
146014075|NCT00224120|526562263|FG001|Overall Study|Protocol Violation|0|||
146014076|NCT00224120|526562262|FG000|Overall Study|Withdrawal by Subject|5|||
146014077|NCT00224120|526562263|FG001|Overall Study|Withdrawal by Subject|10|||
146014078|NCT00224120|526562262|FG000|Overall Study|Lack of Efficacy|0|||
146014079|NCT00224120|526562263|FG001|Overall Study|Lack of Efficacy|2|||
146014080|NCT00224120|526562262|FG000|Overall Study|Lost to Follow-up|2|||
146014081|NCT00224120|526562263|FG001|Overall Study|Lost to Follow-up|3|||
146014082|NCT00224120|526562262|FG000|Overall Study|Other|4|||
146014083|NCT00224120|526562263|FG001|Overall Study|Other|5|||
146014084|NCT04560816|526562264|FG000|Overall Study|Withdrawal by Subject|1|||
146014085|NCT04560816|526562265|FG001|Overall Study|Withdrawal by Subject|1|||
146014086|NCT04560816|526562266|FG002|Overall Study|Withdrawal by Subject|1|||
146014087|NCT04560816|526562267|FG003|Overall Study|Withdrawal by Subject|0|||
146014088|NCT04560816|526562268|FG004|Overall Study|Withdrawal by Subject|3|||
146014089|NCT04560816|526562269|FG005|Overall Study|Withdrawal by Subject|0|||
146014090|NCT04560816|526562264|FG000|Overall Study|Lost to Follow-up|1|||
146014091|NCT04560816|526562265|FG001|Overall Study|Lost to Follow-up|0|||
146014092|NCT04560816|526562266|FG002|Overall Study|Lost to Follow-up|0|||
146014093|NCT04560816|526562267|FG003|Overall Study|Lost to Follow-up|0|||
146014094|NCT04560816|526562268|FG004|Overall Study|Lost to Follow-up|0|||
146014095|NCT04560816|526562269|FG005|Overall Study|Lost to Follow-up|0|||
146014096|NCT04560816|526562264|FG000|Overall Study|Protocol Violation|1|||
146014097|NCT04560816|526562265|FG001|Overall Study|Protocol Violation|0|||
146014098|NCT04560816|526562266|FG002|Overall Study|Protocol Violation|0|||
146014099|NCT04560816|526562267|FG003|Overall Study|Protocol Violation|0|||
146014100|NCT04560816|526562268|FG004|Overall Study|Protocol Violation|0|||
146014101|NCT04560816|526562269|FG005|Overall Study|Protocol Violation|0|||
146014102|NCT00716482|526562277|FG000|Overall Study|Lost to Follow-up|6|||
146014103|NCT00716482|526562277|FG000|Overall Study|Inadequate acquisition or analysis|50|||
146014104|NCT00716482|526562277|FG000|Overall Study|no pathology obtained|10|||
146014105|NCT00716482|526562277|FG000|Overall Study|technical/machine error|28|||
146014106|NCT00716482|526562277|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
146014107|NCT03248531|526562278|FG000|Overall Study|Adverse Event|0|||
146014108|NCT03248531|526562279|FG001|Overall Study|Adverse Event|0|||
146014109|NCT03248531|526562280|FG002|Overall Study|Adverse Event|1|||
146014110|NCT03248531|526562278|FG000|Overall Study|Lost to Follow-up|1|||
146014111|NCT03248531|526562279|FG001|Overall Study|Lost to Follow-up|0|||
146014112|NCT03248531|526562280|FG002|Overall Study|Lost to Follow-up|5|||
146014113|NCT03248531|526562278|FG000|Overall Study|Withdrawal by Subject|3|||
146014114|NCT03248531|526562279|FG001|Overall Study|Withdrawal by Subject|3|||
146014115|NCT03248531|526562280|FG002|Overall Study|Withdrawal by Subject|2|||
146014116|NCT03248531|526562278|FG000|Overall Study|Sponsor Request|0|||
146014117|NCT03248531|526562279|FG001|Overall Study|Sponsor Request|2|||
146014118|NCT03248531|526562280|FG002|Overall Study|Sponsor Request|0|||
146014119|NCT04075513|526562281|FG000|Overall Study|Withdrawal by Subject|2|||
146250256|NCT01755598|527428140|FG001|Overall Study|Withdrawal by Subject|31|||
146250257|NCT01755598|527428139|FG000|Overall Study|Protocol Violation|7|||
146250258|NCT01755598|527428140|FG001|Overall Study|Protocol Violation|7|||
146250259|NCT01755598|527428139|FG000|Overall Study|Adverse Event|19|||
146250260|NCT01755598|527428140|FG001|Overall Study|Adverse Event|28|||
146250261|NCT02260154|527428149|FG000|Overall Study|Screening failure|2|||
146250262|NCT03547167|527428150|FG000|Overall Study|Withdrawal by Subject|34|||
146250263|NCT03547167|527428151|FG001|Overall Study|Withdrawal by Subject|12|||
146250264|NCT03547167|527428150|FG000|Overall Study|Screen Failure|0|||
146250265|NCT03547167|527428151|FG001|Overall Study|Screen Failure|1|||
146250266|NCT03547167|527428150|FG000|Overall Study|Lost to Follow-up|59|||
146250267|NCT03547167|527428151|FG001|Overall Study|Lost to Follow-up|15|||
146250268|NCT03547167|527428150|FG000|Overall Study|Death|4|||
146250269|NCT03547167|527428151|FG001|Overall Study|Death|2|||
146250270|NCT00736502|527428152|FG000|Overall Study|Adverse Event|22|||
146250271|NCT00736502|527428152|FG000|Overall Study|Lack of Efficacy|16|||
146014120|NCT04075513|526562282|FG001|Overall Study|Withdrawal by Subject|2|||
146014121|NCT04075513|526562281|FG000|Overall Study|Lack of Efficacy|1|||
146014122|NCT04075513|526562282|FG001|Overall Study|Lack of Efficacy|0|||
146014123|NCT04075513|526562281|FG000|Overall Study|Lost to Follow-up|4|||
146014124|NCT04075513|526562282|FG001|Overall Study|Lost to Follow-up|2|||
146014125|NCT04075513|526562281|FG000|Overall Study|Switch to insulin pump|1|||
146014126|NCT04075513|526562282|FG001|Overall Study|Switch to insulin pump|0|||
146014127|NCT02550288|526562283|FG000|Overall Study|Adverse Event|0|||
146014128|NCT02550288|526562284|FG001|Overall Study|Adverse Event|1|||
146014129|NCT02550288|526562285|FG002|Overall Study|Adverse Event|0|||
146014130|NCT02550288|526562286|FG003|Overall Study|Adverse Event|0|||
146250272|NCT00736502|527428152|FG000|Overall Study|Lost to Follow-up|27|||
146250273|NCT00645411|527428153|FG000|Overall Study|Adverse Event|0|||
146250274|NCT00645411|527428154|FG001|Overall Study|Adverse Event|0|||
146250275|NCT00645411|527428155|FG002|Overall Study|Adverse Event|0|||
146250276|NCT00645411|527428156|FG003|Overall Study|Adverse Event|2|||
146299415|NCT03083847|527611750|FG008|Main|Physician Decision|0|||
146299416|NCT03083847|527611751|FG009|Main|Physician Decision|0|||
146299417|NCT03083847|527611742|FG000|Main|Pregnancy|0|||
146299418|NCT03083847|527611743|FG001|Main|Pregnancy|0|||
146299419|NCT03083847|527611744|FG002|Main|Pregnancy|0|||
146299420|NCT03083847|527611745|FG003|Main|Pregnancy|0|||
146299421|NCT03083847|527611746|FG004|Main|Pregnancy|0|||
146299422|NCT03083847|527611747|FG005|Main|Pregnancy|0|||
146299423|NCT03083847|527611748|FG006|Main|Pregnancy|0|||
146299424|NCT03083847|527611749|FG007|Main|Pregnancy|1|||
146299425|NCT03083847|527611750|FG008|Main|Pregnancy|0|||
146299426|NCT03083847|527611751|FG009|Main|Pregnancy|0|||
146299427|NCT03083847|527611742|FG000|Main|Adverse Event|0|||
146299428|NCT03083847|527611743|FG001|Main|Adverse Event|0|||
146299429|NCT03083847|527611744|FG002|Main|Adverse Event|0|||
146299430|NCT03083847|527611745|FG003|Main|Adverse Event|0|||
146299431|NCT03083847|527611746|FG004|Main|Adverse Event|0|||
146299432|NCT03083847|527611747|FG005|Main|Adverse Event|0|||
146299433|NCT03083847|527611748|FG006|Main|Adverse Event|0|||
146299434|NCT03083847|527611749|FG007|Main|Adverse Event|2|||
146299435|NCT03083847|527611750|FG008|Main|Adverse Event|0|||
146299436|NCT03083847|527611751|FG009|Main|Adverse Event|0|||
146299437|NCT03083847|527611742|FG000|Main|Withdrawal by Subject|0|||
146299438|NCT03083847|527611743|FG001|Main|Withdrawal by Subject|0|||
146299439|NCT03083847|527611744|FG002|Main|Withdrawal by Subject|0|||
146299440|NCT03083847|527611745|FG003|Main|Withdrawal by Subject|0|||
146299441|NCT03083847|527611746|FG004|Main|Withdrawal by Subject|0|||
146299442|NCT03083847|527611747|FG005|Main|Withdrawal by Subject|0|||
146299443|NCT03083847|527611748|FG006|Main|Withdrawal by Subject|1|||
146299444|NCT03083847|527611749|FG007|Main|Withdrawal by Subject|1|||
146299445|NCT03083847|527611750|FG008|Main|Withdrawal by Subject|0|||
146299446|NCT03083847|527611751|FG009|Main|Withdrawal by Subject|0|||
146014131|NCT02550288|526562287|FG004|Overall Study|Adverse Event|0|||
146014132|NCT02550288|526562283|FG000|Overall Study|Physician Decision|0|||
146014133|NCT02550288|526562284|FG001|Overall Study|Physician Decision|0|||
146014134|NCT02550288|526562285|FG002|Overall Study|Physician Decision|0|||
146014135|NCT02550288|526562286|FG003|Overall Study|Physician Decision|1|||
146299447|NCT02224599|527611752|FG000|Overall Study|Physician Decision|1|||
146299448|NCT02224599|527611752|FG000|Overall Study|Progression of Disease|1|||
146299449|NCT00129623|527611753|FG000|Overall Study|Adverse Event|3|||
146299450|NCT00129623|527611754|FG001|Overall Study|Adverse Event|7|||
146299451|NCT00129623|527611753|FG000|Overall Study|Refused Treatment|5|||
146014136|NCT02550288|526562287|FG004|Overall Study|Physician Decision|0|||
146014137|NCT02550288|526562283|FG000|Overall Study|Protocol Violation|2|||
146014138|NCT02550288|526562284|FG001|Overall Study|Protocol Violation|2|||
146014139|NCT02550288|526562285|FG002|Overall Study|Protocol Violation|1|||
146014140|NCT02550288|526562286|FG003|Overall Study|Protocol Violation|0|||
146014141|NCT02550288|526562287|FG004|Overall Study|Protocol Violation|3|||
146014142|NCT02550288|526562283|FG000|Overall Study|Participant moved|0|||
146014143|NCT02550288|526562284|FG001|Overall Study|Participant moved|0|||
146014144|NCT02550288|526562285|FG002|Overall Study|Participant moved|0|||
146014145|NCT02550288|526562286|FG003|Overall Study|Participant moved|1|||
146014146|NCT02550288|526562287|FG004|Overall Study|Participant moved|0|||
146014147|NCT02550288|526562283|FG000|Overall Study|Withdrawal by Subject|0|||
146014148|NCT02550288|526562284|FG001|Overall Study|Withdrawal by Subject|0|||
146014149|NCT02550288|526562285|FG002|Overall Study|Withdrawal by Subject|0|||
146014150|NCT02550288|526562286|FG003|Overall Study|Withdrawal by Subject|1|||
146014151|NCT02550288|526562287|FG004|Overall Study|Withdrawal by Subject|0|||
146014152|NCT01524224|526562288|FG000|Overall Study|Progressive Disease|1|||
146014153|NCT01524224|526562289|FG001|Overall Study|Progressive Disease|0|||
146014154|NCT01524224|526562290|FG002|Overall Study|Progressive Disease|2|||
146014155|NCT01524224|526562291|FG003|Overall Study|Progressive Disease|1|||
146014156|NCT01524224|526562292|FG004|Overall Study|Progressive Disease|2|||
146014157|NCT01524224|526562293|FG005|Overall Study|Progressive Disease|1|||
146299452|NCT00129623|527611754|FG001|Overall Study|Refused Treatment|3|||
146299453|NCT00129623|527611753|FG000|Overall Study|Failure to Return|1|||
146299454|NCT00129623|527611754|FG001|Overall Study|Failure to Return|1|||
146299455|NCT00129623|527611753|FG000|Overall Study|Relocated job out of state|1|||
146299456|NCT00129623|527611754|FG001|Overall Study|Relocated job out of state|0|||
146299457|NCT00129623|527611753|FG000|Overall Study|Uncertainty to return|0|||
146299458|NCT00129623|527611754|FG001|Overall Study|Uncertainty to return|1|||
146299459|NCT00056862|527611759|FG000|Overall Study|Protocol Violation|1|||
146299460|NCT00056862|527611760|FG001|Overall Study|Protocol Violation|0|||
146014158|NCT01524224|526562294|FG006|Overall Study|Progressive Disease|1|||
146014159|NCT01524224|526562295|FG007|Overall Study|Progressive Disease|5|||
146014160|NCT01524224|526562288|FG000|Overall Study|Withdrawal by Subject|2|||
146014161|NCT01524224|526562289|FG001|Overall Study|Withdrawal by Subject|0|||
146093402|NCT02213042|526863412|FG002|Overall Study|Adverse Event|0|||
146299461|NCT01968070|527611761|FG000|Period 1|Withdrawal by Subject|0|||
146299462|NCT01968070|527611762|FG001|Period 1|Withdrawal by Subject|1|||
146299463|NCT01968070|527611763|FG002|Period 1|Withdrawal by Subject|0|||
146299464|NCT01968070|527611764|FG003|Period 1|Withdrawal by Subject|0|||
146299465|NCT01968070|527611765|FG004|Period 1|Withdrawal by Subject|0|||
146299466|NCT01968070|527611766|FG005|Period 1|Withdrawal by Subject|0|||
146299467|NCT01968070|527611767|FG006|Period 1|Withdrawal by Subject|1|||
146299468|NCT01968070|527611768|FG007|Period 1|Withdrawal by Subject|0|||
146299469|NCT01968070|527611769|FG008|Period 1|Withdrawal by Subject|0|||
146299470|NCT01968070|527611770|FG009|Period 1|Withdrawal by Subject|0|||
146299471|NCT01968070|527611771|FG010|Period 1|Withdrawal by Subject|0|||
146299472|NCT01968070|527611772|FG011|Period 1|Withdrawal by Subject|0|||
146299473|NCT01968070|527611773|FG012|Period 1|Withdrawal by Subject|0|||
146299474|NCT01968070|527611774|FG013|Period 1|Withdrawal by Subject|0|||
146299475|NCT01968070|527611775|FG014|Period 1|Withdrawal by Subject|0|||
146299476|NCT01968070|527611776|FG015|Period 1|Withdrawal by Subject|1|||
146299477|NCT01968070|527611777|FG016|Period 1|Withdrawal by Subject|0|||
146299478|NCT01968070|527611778|FG017|Period 1|Withdrawal by Subject|0|||
146299479|NCT01968070|527611761|FG000|Period 1|Protocol Violation|0|||
146299480|NCT01968070|527611762|FG001|Period 1|Protocol Violation|0|||
146299481|NCT01968070|527611763|FG002|Period 1|Protocol Violation|0|||
146299482|NCT01968070|527611764|FG003|Period 1|Protocol Violation|1|||
146299483|NCT01968070|527611765|FG004|Period 1|Protocol Violation|1|||
146299484|NCT01968070|527611766|FG005|Period 1|Protocol Violation|0|||
146299485|NCT01968070|527611767|FG006|Period 1|Protocol Violation|0|||
146299486|NCT01968070|527611768|FG007|Period 1|Protocol Violation|0|||
146299487|NCT01968070|527611769|FG008|Period 1|Protocol Violation|0|||
146014162|NCT01524224|526562290|FG002|Overall Study|Withdrawal by Subject|0|||
146014163|NCT01524224|526562291|FG003|Overall Study|Withdrawal by Subject|0|||
146014164|NCT01524224|526562292|FG004|Overall Study|Withdrawal by Subject|0|||
146014165|NCT01524224|526562293|FG005|Overall Study|Withdrawal by Subject|0|||
146014166|NCT01524224|526562294|FG006|Overall Study|Withdrawal by Subject|2|||
146014167|NCT01524224|526562295|FG007|Overall Study|Withdrawal by Subject|0|||
146014168|NCT01524224|526562288|FG000|Overall Study|Adverse Event|0|||
146014169|NCT01524224|526562289|FG001|Overall Study|Adverse Event|1|||
146014170|NCT01524224|526562290|FG002|Overall Study|Adverse Event|0|||
146014171|NCT01524224|526562291|FG003|Overall Study|Adverse Event|0|||
146014172|NCT01524224|526562292|FG004|Overall Study|Adverse Event|0|||
146014173|NCT01524224|526562293|FG005|Overall Study|Adverse Event|1|||
146014174|NCT01524224|526562294|FG006|Overall Study|Adverse Event|0|||
146014175|NCT01524224|526562295|FG007|Overall Study|Adverse Event|0|||
146014176|NCT01524224|526562288|FG000|Overall Study|Physician Decision|0|||
146014177|NCT01524224|526562289|FG001|Overall Study|Physician Decision|0|||
146014178|NCT01524224|526562290|FG002|Overall Study|Physician Decision|0|||
146014179|NCT01524224|526562291|FG003|Overall Study|Physician Decision|1|||
146014180|NCT01524224|526562292|FG004|Overall Study|Physician Decision|1|||
146014181|NCT01524224|526562293|FG005|Overall Study|Physician Decision|0|||
146014182|NCT01524224|526562294|FG006|Overall Study|Physician Decision|0|||
146014183|NCT01524224|526562295|FG007|Overall Study|Physician Decision|1|||
146014184|NCT01524224|526562288|FG000|Overall Study|Sponsor Decision|0|||
146014185|NCT01524224|526562289|FG001|Overall Study|Sponsor Decision|0|||
146014186|NCT01524224|526562290|FG002|Overall Study|Sponsor Decision|0|||
146014187|NCT01524224|526562291|FG003|Overall Study|Sponsor Decision|0|||
146014188|NCT01524224|526562292|FG004|Overall Study|Sponsor Decision|1|||
146014189|NCT01524224|526562293|FG005|Overall Study|Sponsor Decision|0|||
146014190|NCT01524224|526562294|FG006|Overall Study|Sponsor Decision|0|||
146014191|NCT01524224|526562295|FG007|Overall Study|Sponsor Decision|0|||
146014192|NCT03517371|526562298|FG000|Overall Study|Adverse Event|8|||
146014193|NCT03517371|526562299|FG001|Overall Study|Adverse Event|9|||
146093403|NCT02213042|526863410|FG000|Overall Study|Withdrawal by Subject|0|||
146093404|NCT02213042|526863411|FG001|Overall Study|Withdrawal by Subject|1|||
146093405|NCT02213042|526863412|FG002|Overall Study|Withdrawal by Subject|1|||
146093406|NCT02213042|526863410|FG000|Overall Study|Protocol Violation|1|||
146093407|NCT02213042|526863411|FG001|Overall Study|Protocol Violation|0|||
146014194|NCT03517371|526562298|FG000|Overall Study|Lost to Follow-up|1|||
146014195|NCT03517371|526562299|FG001|Overall Study|Lost to Follow-up|2|||
146014196|NCT03517371|526562298|FG000|Overall Study|Withdrawal by Subject|4|||
146093408|NCT02213042|526863412|FG002|Overall Study|Protocol Violation|0|||
146093409|NCT02213042|526863410|FG000|Overall Study|Investigator discretion|0|||
146093410|NCT02213042|526863411|FG001|Overall Study|Investigator discretion|0|||
146093411|NCT02213042|526863412|FG002|Overall Study|Investigator discretion|1|||
146093412|NCT04622735|526863413|FG000|Overall Study|Lost to Follow-up|1|||
146299488|NCT01968070|527611770|FG009|Period 1|Protocol Violation|0|||
146299489|NCT01968070|527611771|FG010|Period 1|Protocol Violation|0|||
146299490|NCT01968070|527611772|FG011|Period 1|Protocol Violation|0|||
146299491|NCT01968070|527611773|FG012|Period 1|Protocol Violation|0|||
146299492|NCT01968070|527611774|FG013|Period 1|Protocol Violation|0|||
146299493|NCT01968070|527611775|FG014|Period 1|Protocol Violation|0|||
146014197|NCT03517371|526562299|FG001|Overall Study|Withdrawal by Subject|4|||
146014198|NCT03517371|526562298|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
146014199|NCT03517371|526562299|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
146299494|NCT01968070|527611776|FG015|Period 1|Protocol Violation|0|||
146299495|NCT01968070|527611777|FG016|Period 1|Protocol Violation|0|||
146299496|NCT01968070|527611778|FG017|Period 1|Protocol Violation|0|||
146299497|NCT01968070|527611761|FG000|Period 1|Lost to Follow-up|0|||
146014200|NCT03517371|526562298|FG000|Overall Study|COVID restrictions|2|||
146014201|NCT03517371|526562299|FG001|Overall Study|COVID restrictions|0|||
146014202|NCT03517371|526562298|FG000|Overall Study|Receiving DBS Surgery|0|||
146014203|NCT03517371|526562299|FG001|Overall Study|Receiving DBS Surgery|1|||
146014204|NCT05411822|526562300|FG000|Overall Study|Withdrawal by Subject|2|||
146014205|NCT05411822|526562301|FG001|Overall Study|Withdrawal by Subject|1|||
146014206|NCT05312697|526562302|FG000|Overall Study|Sponsor Terminated Trial|2|||
146014207|NCT04283656|526562303|FG000|Overall Study|Adverse Event|1|||
146014208|NCT04283656|526562304|FG001|Overall Study|Adverse Event|0|||
146014209|NCT04283656|526562303|FG000|Overall Study|Lost to Follow-up|0|||
146014210|NCT04283656|526562304|FG001|Overall Study|Lost to Follow-up|1|||
146093413|NCT04622735|526863414|FG001|Overall Study|Lost to Follow-up|2|||
146093414|NCT04622735|526863415|FG002|Overall Study|Lost to Follow-up|1|||
146093415|NCT04622735|526863413|FG000|Overall Study|Adverse Event|0|||
146014211|NCT02318368|526562305|FG000|Overall Study|Withdrawal by Subject|2|||
146014212|NCT02318368|526562306|FG001|Overall Study|Withdrawal by Subject|0|||
146014213|NCT02318368|526562305|FG000|Overall Study|Study terminated by the sponsor|5|||
146014214|NCT02318368|526562306|FG001|Overall Study|Study terminated by the sponsor|2|||
146014215|NCT02318368|526562305|FG000|Overall Study|Death|0|||
146014216|NCT02318368|526562306|FG001|Overall Study|Death|1|||
146014217|NCT01901614|526562307|FG000|Overall Study|Adverse Event|0|||
146014218|NCT01901614|526562308|FG001|Overall Study|Adverse Event|1|||
146014219|NCT01901614|526562307|FG000|Overall Study|Lost to Follow-up|1|||
146014220|NCT01901614|526562308|FG001|Overall Study|Lost to Follow-up|0|||
146014221|NCT01901614|526562307|FG000|Overall Study|Screen Fail|1|||
146014222|NCT01901614|526562308|FG001|Overall Study|Screen Fail|0|||
146014223|NCT03629223|526562309|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
146014224|NCT03629223|526562310|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
146014225|NCT03629223|526562311|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
146014226|NCT03629223|526562312|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
146014227|NCT03629223|526562313|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
146014228|NCT03629223|526562314|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
146014229|NCT03629223|526562309|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146014230|NCT03629223|526562310|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146014231|NCT03629223|526562311|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146014232|NCT03629223|526562312|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
146014233|NCT03629223|526562313|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146014234|NCT03629223|526562314|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
146014235|NCT03629223|526562309|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146014236|NCT03629223|526562310|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
146014237|NCT03629223|526562311|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146014238|NCT03629223|526562312|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146014239|NCT03629223|526562313|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146014240|NCT03629223|526562314|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
146014241|NCT03629223|526562309|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146014242|NCT03629223|526562310|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
146014243|NCT03629223|526562311|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146014244|NCT03629223|526562312|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146014245|NCT03629223|526562313|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146014246|NCT03629223|526562314|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
146014247|NCT03629223|526562309|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
146014248|NCT03629223|526562310|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146014249|NCT03629223|526562311|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146014250|NCT03629223|526562312|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146014251|NCT03629223|526562313|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146014252|NCT03629223|526562314|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
146014253|NCT02674464|526562315|FG000|Overall Study|Death|10|||
146014254|NCT02674464|526562316|FG001|Overall Study|Death|21|||
146250277|NCT00645411|527428153|FG000|Overall Study|Withdrawal by Subject|2|||
146250278|NCT00645411|527428154|FG001|Overall Study|Withdrawal by Subject|1|||
146014255|NCT02674464|526562315|FG000|Overall Study|Withdrawal by Subject|24|||
146014256|NCT02674464|526562316|FG001|Overall Study|Withdrawal by Subject|44|||
146014257|NCT02674464|526562315|FG000|Overall Study|Lost to Follow-up|97|||
146014258|NCT02674464|526562316|FG001|Overall Study|Lost to Follow-up|92|||
146014259|NCT02674464|526562315|FG000|Overall Study|Outside survey window|6|||
146014260|NCT02674464|526562316|FG001|Overall Study|Outside survey window|3|||
146014261|NCT00783835|526562317|FG000|Overall Study|Adverse Event|3|||
146014262|NCT00783835|526562317|FG000|Overall Study|Medical Criteria|1|||
146014263|NCT00783835|526562317|FG000|Overall Study|Withdrawal by Subject|2|||
146014264|NCT00783835|526562317|FG000|Overall Study|Lost to Follow-up|1|||
146014265|NCT00783835|526562317|FG000|Overall Study|Participant not Adherent|3|||
146014266|NCT01071252|526562320|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
146014267|NCT01071252|526562321|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
146250279|NCT00645411|527428155|FG002|Overall Study|Withdrawal by Subject|19|||
146014268|NCT01071252|526562322|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
146014269|NCT01071252|526562323|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
146014270|NCT01071252|526562324|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
146014271|NCT01071252|526562320|FG000|Overall Study|Withdrawal by Subject|8|||
146014272|NCT01071252|526562321|FG001|Overall Study|Withdrawal by Subject|2|||
146014273|NCT01071252|526562322|FG002|Overall Study|Withdrawal by Subject|1|||
146014274|NCT01071252|526562323|FG003|Overall Study|Withdrawal by Subject|2|||
146014275|NCT01071252|526562324|FG004|Overall Study|Withdrawal by Subject|3|||
146014276|NCT01071252|526562320|FG000|Overall Study|administrative problems|1|||
146014277|NCT01071252|526562321|FG001|Overall Study|administrative problems|1|||
146014278|NCT01071252|526562322|FG002|Overall Study|administrative problems|0|||
146014279|NCT01071252|526562323|FG003|Overall Study|administrative problems|2|||
146014280|NCT01071252|526562324|FG004|Overall Study|administrative problems|1|||
146014281|NCT01071252|526562320|FG000|Overall Study|Lost to Follow-up|1|||
146014282|NCT01071252|526562321|FG001|Overall Study|Lost to Follow-up|0|||
146014283|NCT01071252|526562322|FG002|Overall Study|Lost to Follow-up|1|||
146014284|NCT01071252|526562323|FG003|Overall Study|Lost to Follow-up|2|||
146014285|NCT01071252|526562324|FG004|Overall Study|Lost to Follow-up|0|||
146014286|NCT01071252|526562320|FG000|Overall Study|Adverse Event|1|||
146014287|NCT01071252|526562321|FG001|Overall Study|Adverse Event|1|||
146014288|NCT01071252|526562322|FG002|Overall Study|Adverse Event|0|||
146014289|NCT01071252|526562323|FG003|Overall Study|Adverse Event|1|||
146014290|NCT01071252|526562324|FG004|Overall Study|Adverse Event|0|||
146014291|NCT01071252|526562320|FG000|Overall Study|Death|0|||
146014292|NCT01071252|526562321|FG001|Overall Study|Death|0|||
146014293|NCT01071252|526562322|FG002|Overall Study|Death|0|||
146014294|NCT01071252|526562323|FG003|Overall Study|Death|0|||
146014295|NCT01071252|526562324|FG004|Overall Study|Death|1|||
146014296|NCT01066104|526562325|FG000|Overall Study|Adverse Event|1|||
146014297|NCT01066104|526562326|FG001|Overall Study|Adverse Event|1|||
146014298|NCT01066104|526562325|FG000|Overall Study|Protocol Violation|1|||
146014299|NCT01066104|526562326|FG001|Overall Study|Protocol Violation|0|||
146014300|NCT04660552|526562327|FG000|Overall Study|Withdrawal by Subject|3|||
146014301|NCT04660552|526562328|FG001|Overall Study|Withdrawal by Subject|1|||
146014302|NCT00470262|526562329|FG000|Overall Study|Withdrawal by Subject|2|||
146014303|NCT00470262|526562330|FG001|Overall Study|Withdrawal by Subject|0|||
146014304|NCT04004221|526562331|FG000|Overall Study|Death|89|||
146014305|NCT04004221|526562331|FG000|Overall Study|Withdrawal by Subject|5|||
146014306|NCT04004221|526562331|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
146014307|NCT04004221|526562331|FG000|Overall Study|Sponsor Decision|9|||
146014308|NCT04004221|526562331|FG000|Overall Study|Participant refused to enter LTE|1|||
146014309|NCT02036580|526562334|FG000|Overall Study|Withdrawal by Subject|0|||
146014310|NCT02036580|526562335|FG001|Overall Study|Withdrawal by Subject|1|||
146014311|NCT02036580|526562336|FG002|Overall Study|Withdrawal by Subject|0|||
146014312|NCT02036580|526562334|FG000|Overall Study|Adverse Event|1|||
146014313|NCT02036580|526562335|FG001|Overall Study|Adverse Event|0|||
146014314|NCT02036580|526562336|FG002|Overall Study|Adverse Event|0|||
146014315|NCT00992056|526562337|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
146014316|NCT00992056|526562338|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
146014317|NCT00992056|526562337|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
146014318|NCT00992056|526562338|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
146014319|NCT02038946|526562339|FG000|Overall Study|Death|5|||
146014320|NCT02038946|526562339|FG000|Overall Study|Withdrawal by Subject|3|||
146014321|NCT02038946|526562339|FG000|Overall Study|Lost to Follow-up|2|||
146014322|NCT02038946|526562339|FG000|Overall Study|Other reasons|2|||
146014323|NCT01558596|526562342|FG000|Overall Study|Withdrawal by Subject|1|||
146014324|NCT01558596|526562343|FG001|Overall Study|Withdrawal by Subject|0|||
146014325|NCT01558596|526562342|FG000|Overall Study|surgery elsewhere or cancelled|1|||
146014326|NCT01558596|526562343|FG001|Overall Study|surgery elsewhere or cancelled|1|||
146014327|NCT01558596|526562342|FG000|Overall Study|Protocol Violation|1|||
146250280|NCT00645411|527428156|FG003|Overall Study|Withdrawal by Subject|21|||
146250281|NCT00645411|527428153|FG000|Overall Study|Lost to Follow-up|10|||
146250282|NCT00645411|527428154|FG001|Overall Study|Lost to Follow-up|5|||
146014328|NCT01558596|526562343|FG001|Overall Study|Protocol Violation|0|||
146014329|NCT01270880|526562346|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
146014330|NCT01221753|526562353|FG000|Overall Study|Adverse Event|1|||
146014331|NCT04552288|526562354|FG000|Overall Study|Death|3|||
146014332|NCT04552288|526562354|FG000|Overall Study|Lost to Follow-up|6|||
146014333|NCT04552288|526562354|FG000|Overall Study|Physician Decision|3|||
146014334|NCT04552288|526562354|FG000|Overall Study|Protocol Violation|9|||
146014335|NCT04552288|526562354|FG000|Overall Study|Withdrawal by Subject|6|||
146014336|NCT04552288|526562354|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
146014337|NCT01831466|526562355|FG000|Overall Study|Protocol Violation|1|||
146250283|NCT00645411|527428155|FG002|Overall Study|Lost to Follow-up|124|||
146014338|NCT01831466|526562356|FG001|Overall Study|Protocol Violation|1|||
146014339|NCT01831466|526562357|FG002|Overall Study|Protocol Violation|2|||
146250284|NCT00645411|527428156|FG003|Overall Study|Lost to Follow-up|75|||
146299498|NCT01968070|527611762|FG001|Period 1|Lost to Follow-up|0|||
146299499|NCT01968070|527611763|FG002|Period 1|Lost to Follow-up|0|||
146299500|NCT01968070|527611764|FG003|Period 1|Lost to Follow-up|1|||
146299501|NCT01968070|527611765|FG004|Period 1|Lost to Follow-up|0|||
146299502|NCT01968070|527611766|FG005|Period 1|Lost to Follow-up|0|||
146299503|NCT01968070|527611767|FG006|Period 1|Lost to Follow-up|0|||
146299504|NCT01968070|527611768|FG007|Period 1|Lost to Follow-up|0|||
146014340|NCT01831466|526562358|FG003|Overall Study|Protocol Violation|0|||
146014341|NCT01831466|526562359|FG004|Overall Study|Protocol Violation|0|||
146014342|NCT01831466|526562360|FG005|Overall Study|Protocol Violation|1|||
146014343|NCT01831466|526562361|FG006|Overall Study|Protocol Violation|0|||
146014344|NCT01831466|526562362|FG007|Overall Study|Protocol Violation|0|||
146014345|NCT01831466|526562363|FG008|Overall Study|Protocol Violation|0|||
146014346|NCT01831466|526562364|FG009|Overall Study|Protocol Violation|0|||
146014347|NCT01831466|526562365|FG010|Overall Study|Protocol Violation|0|||
146014348|NCT01831466|526562366|FG011|Overall Study|Protocol Violation|0|||
146014349|NCT01831466|526562355|FG000|Overall Study|Other|2|||
146014350|NCT01831466|526562356|FG001|Overall Study|Other|3|||
146014351|NCT01831466|526562357|FG002|Overall Study|Other|2|||
146014352|NCT01831466|526562358|FG003|Overall Study|Other|2|||
146014353|NCT01831466|526562359|FG004|Overall Study|Other|2|||
146014354|NCT01831466|526562360|FG005|Overall Study|Other|1|||
146014355|NCT01831466|526562361|FG006|Overall Study|Other|0|||
146014356|NCT01831466|526562362|FG007|Overall Study|Other|0|||
146014357|NCT01831466|526562363|FG008|Overall Study|Other|0|||
146014358|NCT01831466|526562364|FG009|Overall Study|Other|0|||
146014359|NCT01831466|526562365|FG010|Overall Study|Other|0|||
146014360|NCT01831466|526562366|FG011|Overall Study|Other|0|||
146014361|NCT01831466|526562355|FG000|Overall Study|Non-compliance with study treatment|2|||
146014362|NCT01831466|526562356|FG001|Overall Study|Non-compliance with study treatment|1|||
146014363|NCT01831466|526562357|FG002|Overall Study|Non-compliance with study treatment|1|||
146014364|NCT01831466|526562358|FG003|Overall Study|Non-compliance with study treatment|0|||
146014365|NCT01831466|526562359|FG004|Overall Study|Non-compliance with study treatment|0|||
146014366|NCT01831466|526562360|FG005|Overall Study|Non-compliance with study treatment|1|||
146014367|NCT01831466|526562361|FG006|Overall Study|Non-compliance with study treatment|0|||
146014368|NCT01831466|526562362|FG007|Overall Study|Non-compliance with study treatment|0|||
146014369|NCT01831466|526562363|FG008|Overall Study|Non-compliance with study treatment|0|||
146014370|NCT01831466|526562364|FG009|Overall Study|Non-compliance with study treatment|0|||
146014371|NCT01831466|526562365|FG010|Overall Study|Non-compliance with study treatment|0|||
146014372|NCT01831466|526562366|FG011|Overall Study|Non-compliance with study treatment|0|||
146014373|NCT01831466|526562355|FG000|Overall Study|Death|0|||
146014374|NCT01831466|526562356|FG001|Overall Study|Death|1|||
146014375|NCT01831466|526562357|FG002|Overall Study|Death|0|||
146014376|NCT01831466|526562358|FG003|Overall Study|Death|0|||
146014377|NCT01831466|526562359|FG004|Overall Study|Death|0|||
146014378|NCT01831466|526562360|FG005|Overall Study|Death|0|||
146014379|NCT01831466|526562361|FG006|Overall Study|Death|0|||
146014380|NCT01831466|526562362|FG007|Overall Study|Death|0|||
146014381|NCT01831466|526562363|FG008|Overall Study|Death|0|||
146014382|NCT01831466|526562364|FG009|Overall Study|Death|0|||
146014383|NCT01831466|526562365|FG010|Overall Study|Death|0|||
146014384|NCT01831466|526562366|FG011|Overall Study|Death|0|||
146014385|NCT01831466|526562355|FG000|Overall Study|Withdrawal by Subject|6|||
146014386|NCT01831466|526562356|FG001|Overall Study|Withdrawal by Subject|3|||
146014387|NCT01831466|526562357|FG002|Overall Study|Withdrawal by Subject|3|||
146014388|NCT01831466|526562358|FG003|Overall Study|Withdrawal by Subject|3|||
146014389|NCT01831466|526562359|FG004|Overall Study|Withdrawal by Subject|3|||
146014390|NCT01831466|526562360|FG005|Overall Study|Withdrawal by Subject|5|||
146014391|NCT01831466|526562361|FG006|Overall Study|Withdrawal by Subject|0|||
146014392|NCT01831466|526562362|FG007|Overall Study|Withdrawal by Subject|0|||
146014393|NCT01831466|526562363|FG008|Overall Study|Withdrawal by Subject|0|||
146014394|NCT01831466|526562364|FG009|Overall Study|Withdrawal by Subject|1|||
146014395|NCT01831466|526562365|FG010|Overall Study|Withdrawal by Subject|0|||
146014396|NCT01831466|526562366|FG011|Overall Study|Withdrawal by Subject|1|||
146014397|NCT01831466|526562355|FG000|Overall Study|Lost to Follow-up|0|||
146014398|NCT01831466|526562356|FG001|Overall Study|Lost to Follow-up|1|||
146014399|NCT01831466|526562357|FG002|Overall Study|Lost to Follow-up|4|||
146014400|NCT01831466|526562358|FG003|Overall Study|Lost to Follow-up|2|||
146014401|NCT01831466|526562359|FG004|Overall Study|Lost to Follow-up|0|||
146014402|NCT01831466|526562360|FG005|Overall Study|Lost to Follow-up|3|||
146299505|NCT01968070|527611769|FG008|Period 1|Lost to Follow-up|0|||
146014403|NCT01831466|526562361|FG006|Overall Study|Lost to Follow-up|0|||
146014404|NCT01831466|526562362|FG007|Overall Study|Lost to Follow-up|0|||
146014405|NCT01831466|526562363|FG008|Overall Study|Lost to Follow-up|0|||
146014406|NCT01831466|526562364|FG009|Overall Study|Lost to Follow-up|1|||
146014407|NCT01831466|526562365|FG010|Overall Study|Lost to Follow-up|0|||
146014408|NCT01831466|526562366|FG011|Overall Study|Lost to Follow-up|1|||
146014409|NCT01831466|526562355|FG000|Overall Study|Lack of Efficacy|5|||
146014410|NCT01831466|526562356|FG001|Overall Study|Lack of Efficacy|8|||
146299506|NCT01968070|527611770|FG009|Period 1|Lost to Follow-up|0|||
146299507|NCT01968070|527611771|FG010|Period 1|Lost to Follow-up|0|||
146299508|NCT01968070|527611772|FG011|Period 1|Lost to Follow-up|0|||
146299509|NCT01968070|527611773|FG012|Period 1|Lost to Follow-up|0|||
146299510|NCT01968070|527611774|FG013|Period 1|Lost to Follow-up|0|||
146299511|NCT01968070|527611775|FG014|Period 1|Lost to Follow-up|0|||
146299512|NCT01968070|527611776|FG015|Period 1|Lost to Follow-up|0|||
146299513|NCT01968070|527611777|FG016|Period 1|Lost to Follow-up|0|||
146299514|NCT01968070|527611778|FG017|Period 1|Lost to Follow-up|0|||
146299515|NCT01968070|527611761|FG000|Period 1|Adverse Event|0|||
146299516|NCT01968070|527611762|FG001|Period 1|Adverse Event|0|||
146299517|NCT01968070|527611763|FG002|Period 1|Adverse Event|0|||
146299518|NCT01968070|527611764|FG003|Period 1|Adverse Event|0|||
146299519|NCT01968070|527611765|FG004|Period 1|Adverse Event|0|||
146299520|NCT01968070|527611766|FG005|Period 1|Adverse Event|0|||
146299521|NCT01968070|527611767|FG006|Period 1|Adverse Event|1|||
146299522|NCT01968070|527611768|FG007|Period 1|Adverse Event|0|||
146299523|NCT01968070|527611769|FG008|Period 1|Adverse Event|0|||
146299524|NCT01968070|527611770|FG009|Period 1|Adverse Event|0|||
146299525|NCT01968070|527611771|FG010|Period 1|Adverse Event|0|||
146299526|NCT01968070|527611772|FG011|Period 1|Adverse Event|0|||
146299527|NCT01968070|527611773|FG012|Period 1|Adverse Event|0|||
146299528|NCT01968070|527611774|FG013|Period 1|Adverse Event|0|||
146299529|NCT01968070|527611775|FG014|Period 1|Adverse Event|0|||
146299530|NCT01968070|527611776|FG015|Period 1|Adverse Event|0|||
146299531|NCT01968070|527611777|FG016|Period 1|Adverse Event|0|||
146299532|NCT01968070|527611778|FG017|Period 1|Adverse Event|0|||
146299533|NCT01968070|527611761|FG000|Period 1|Physician Decision|0|||
146299534|NCT01968070|527611762|FG001|Period 1|Physician Decision|0|||
146299535|NCT01968070|527611763|FG002|Period 1|Physician Decision|0|||
146299536|NCT01968070|527611764|FG003|Period 1|Physician Decision|0|||
146299537|NCT01968070|527611765|FG004|Period 1|Physician Decision|0|||
146299538|NCT01968070|527611766|FG005|Period 1|Physician Decision|0|||
146014411|NCT01831466|526562357|FG002|Overall Study|Lack of Efficacy|7|||
146014412|NCT01831466|526562358|FG003|Overall Study|Lack of Efficacy|6|||
146014413|NCT01831466|526562359|FG004|Overall Study|Lack of Efficacy|9|||
146014414|NCT01831466|526562360|FG005|Overall Study|Lack of Efficacy|8|||
146014415|NCT01831466|526562361|FG006|Overall Study|Lack of Efficacy|1|||
146014416|NCT01831466|526562362|FG007|Overall Study|Lack of Efficacy|1|||
146014417|NCT01831466|526562363|FG008|Overall Study|Lack of Efficacy|2|||
146014418|NCT01831466|526562364|FG009|Overall Study|Lack of Efficacy|2|||
146014419|NCT01831466|526562365|FG010|Overall Study|Lack of Efficacy|2|||
146014420|NCT01831466|526562366|FG011|Overall Study|Lack of Efficacy|0|||
146014421|NCT01831466|526562355|FG000|Overall Study|Adverse Event|0|||
146014422|NCT01831466|526562356|FG001|Overall Study|Adverse Event|0|||
146014423|NCT01831466|526562357|FG002|Overall Study|Adverse Event|4|||
146014424|NCT01831466|526562358|FG003|Overall Study|Adverse Event|6|||
146014425|NCT01831466|526562359|FG004|Overall Study|Adverse Event|3|||
146014426|NCT01831466|526562360|FG005|Overall Study|Adverse Event|7|||
146014427|NCT01831466|526562361|FG006|Overall Study|Adverse Event|0|||
146014428|NCT01831466|526562362|FG007|Overall Study|Adverse Event|1|||
146014429|NCT01831466|526562363|FG008|Overall Study|Adverse Event|1|||
146014430|NCT01831466|526562364|FG009|Overall Study|Adverse Event|1|||
146014431|NCT01831466|526562365|FG010|Overall Study|Adverse Event|0|||
146014432|NCT01831466|526562366|FG011|Overall Study|Adverse Event|2|||
146014433|NCT02798315|526562367|FG000|Overall Study|Failure to return|1|||
146014434|NCT00005947|526562368|FG000|Overall Study|Death|54|||
146014435|NCT00005947|526562369|FG001|Overall Study|Death|40|||
146014436|NCT00005947|526562368|FG000|Overall Study|Patient Refused to Continue|2|||
146014437|NCT00005947|526562369|FG001|Overall Study|Patient Refused to Continue|1|||
146014438|NCT00005947|526562368|FG000|Overall Study|Site Closure|1|||
146014439|NCT00005947|526562369|FG001|Overall Study|Site Closure|0|||
146014440|NCT01059864|526562375|FG000|Open-Label Run-In Phase|Adverse Event|7|||
146014441|NCT01059864|526562376|FG001|Open-Label Run-In Phase|Adverse Event|0|||
146014442|NCT01059864|526562377|FG002|Open-Label Run-In Phase|Adverse Event|0|||
146014443|NCT01059864|526562375|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
146014444|NCT01059864|526562376|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
146014445|NCT01059864|526562377|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
146014446|NCT01059864|526562375|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
146014447|NCT01059864|526562376|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
146014448|NCT01059864|526562377|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
146014449|NCT01059864|526562375|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
146014450|NCT01059864|526562376|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
146014451|NCT01059864|526562377|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
146014452|NCT01059864|526562375|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
146014453|NCT01059864|526562376|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
146014454|NCT01059864|526562377|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
146093416|NCT04622735|526863414|FG001|Overall Study|Adverse Event|0|||
146299539|NCT01968070|527611767|FG006|Period 1|Physician Decision|0|||
146299540|NCT01968070|527611768|FG007|Period 1|Physician Decision|0|||
146299541|NCT01968070|527611769|FG008|Period 1|Physician Decision|0|||
146299542|NCT01968070|527611770|FG009|Period 1|Physician Decision|0|||
146093417|NCT04622735|526863415|FG002|Overall Study|Adverse Event|1|||
146093418|NCT04622735|526863413|FG000|Overall Study|Protocol Violation|1|||
146093419|NCT04622735|526863414|FG001|Overall Study|Protocol Violation|0|||
146093420|NCT04622735|526863415|FG002|Overall Study|Protocol Violation|0|||
146093421|NCT05314478|526863416|FG000|Overall Study|Physician Decision|1|||
146093422|NCT02007512|526863417|FG000|Double Blind Treatment Period|Adverse Event|4|||
146093423|NCT02007512|526863418|FG001|Double Blind Treatment Period|Adverse Event|6|||
146093424|NCT02007512|526863419|FG002|Double Blind Treatment Period|Adverse Event|2|||
146093425|NCT02007512|526863420|FG003|Double Blind Treatment Period|Adverse Event|2|||
146093426|NCT02007512|526863417|FG000|Double Blind Treatment Period|Death|1|||
146093427|NCT02007512|526863418|FG001|Double Blind Treatment Period|Death|0|||
146093428|NCT02007512|526863419|FG002|Double Blind Treatment Period|Death|0|||
146093429|NCT02007512|526863420|FG003|Double Blind Treatment Period|Death|0|||
146093430|NCT02007512|526863417|FG000|Double Blind Treatment Period|Disease progression|51|||
146093431|NCT02007512|526863418|FG001|Double Blind Treatment Period|Disease progression|50|||
146093432|NCT02007512|526863419|FG002|Double Blind Treatment Period|Disease progression|57|||
146093433|NCT02007512|526863420|FG003|Double Blind Treatment Period|Disease progression|52|||
146093434|NCT02007512|526863417|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
146093435|NCT02007512|526863418|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
146093436|NCT02007512|526863419|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
146250285|NCT00645411|527428153|FG000|Overall Study|Protocol Violation|1|||
146250286|NCT00645411|527428154|FG001|Overall Study|Protocol Violation|0|||
146250287|NCT00645411|527428155|FG002|Overall Study|Protocol Violation|1|||
146014455|NCT01059864|526562375|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146014456|NCT01059864|526562376|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146014457|NCT01059864|526562377|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
146014458|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Adverse Event|21|||
146014459|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Adverse Event|34|||
146014460|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Adverse Event|14|||
146014461|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Adverse Event|17|||
146014462|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Adverse Event|0|||
146014463|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
146014464|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
146014465|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
146014466|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
146014467|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
146014468|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
146014469|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
146014470|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
146014471|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
146014472|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
146014473|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Physician Decision|2|||
146014474|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Physician Decision|4|||
146014475|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Physician Decision|4|||
146093437|NCT02007512|526863420|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
146093438|NCT02007512|526863417|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146093439|NCT02007512|526863418|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146093440|NCT02007512|526863419|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146250288|NCT00645411|527428156|FG003|Overall Study|Protocol Violation|0|||
146250289|NCT00645411|527428153|FG000|Overall Study|Inappropriate enrollment|0|||
146250290|NCT00645411|527428154|FG001|Overall Study|Inappropriate enrollment|0|||
146250291|NCT00645411|527428155|FG002|Overall Study|Inappropriate enrollment|4|||
146250292|NCT00645411|527428156|FG003|Overall Study|Inappropriate enrollment|1|||
146250293|NCT00645411|527428153|FG000|Overall Study|Unable to classify|0|||
146250294|NCT00645411|527428154|FG001|Overall Study|Unable to classify|0|||
146250295|NCT00645411|527428155|FG002|Overall Study|Unable to classify|3|||
146250296|NCT00645411|527428156|FG003|Overall Study|Unable to classify|4|||
146250297|NCT01307800|527428157|FG000|Overall Study|Adverse Event|9|||
146250298|NCT01307800|527428158|FG001|Overall Study|Adverse Event|8|||
146250299|NCT01307800|527428159|FG002|Overall Study|Adverse Event|10|||
146250300|NCT01307800|527428160|FG003|Overall Study|Adverse Event|14|||
146014476|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Physician Decision|4|||
146014477|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Physician Decision|0|||
146093441|NCT02007512|526863420|FG003|Double Blind Treatment Period|Protocol Violation|1|||
146093442|NCT02007512|526863417|FG000|Double Blind Treatment Period|Other|2|||
146093443|NCT02007512|526863418|FG001|Double Blind Treatment Period|Other|1|||
146093444|NCT02007512|526863419|FG002|Double Blind Treatment Period|Other|1|||
146093445|NCT02007512|526863420|FG003|Double Blind Treatment Period|Other|2|||
146250301|NCT01307800|527428157|FG000|Overall Study|Entry Criteria Not Met|0|||
146014478|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
146014479|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
146250302|NCT01307800|527428158|FG001|Overall Study|Entry Criteria Not Met|0|||
146250303|NCT01307800|527428159|FG002|Overall Study|Entry Criteria Not Met|0|||
146250304|NCT01307800|527428160|FG003|Overall Study|Entry Criteria Not Met|2|||
146250305|NCT01307800|527428157|FG000|Overall Study|Lost to Follow-up|5|||
146014480|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
146014481|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
146014482|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
146014483|NCT00451958|526562378|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
146014484|NCT00451958|526562379|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
146014485|NCT00451958|526562380|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
146014486|NCT00451958|526562381|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
146014487|NCT00451958|526562382|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
146014488|NCT03110029|526562383|FG000|Overall Study|Withdrawal by Subject|1|||
146014489|NCT03110029|526562384|FG001|Overall Study|Withdrawal by Subject|1|||
146014490|NCT03281629|526562385|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
146014491|NCT03281629|526562386|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
146014492|NCT03281629|526562385|FG000|Overall Study|Death|0|||
146014493|NCT03281629|526562386|FG001|Overall Study|Death|1|||
146014494|NCT03281629|526562385|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
146014495|NCT03281629|526562386|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
146014496|NCT02175277|526562387|FG000|Overall Study|Protocol-specified Criteria|1|||
146014497|NCT02482428|526564033|FG000|Overall Study|Lost to Follow-up|4|||
146014498|NCT02482428|526564034|FG001|Overall Study|Lost to Follow-up|9|||
146014499|NCT02482428|526564035|FG002|Overall Study|Lost to Follow-up|1|||
146014500|NCT02482428|526564036|FG003|Overall Study|Lost to Follow-up|2|||
146014501|NCT02482428|526564037|FG004|Overall Study|Lost to Follow-up|4|||
146014502|NCT02482428|526564033|FG000|Overall Study|Physician Decision|0|||
146014503|NCT02482428|526564034|FG001|Overall Study|Physician Decision|0|||
146014504|NCT02482428|526564035|FG002|Overall Study|Physician Decision|0|||
146014505|NCT02482428|526564036|FG003|Overall Study|Physician Decision|0|||
146014506|NCT02482428|526564037|FG004|Overall Study|Physician Decision|1|||
146014507|NCT02482428|526564033|FG000|Overall Study|protocol deviation|1|||
146014508|NCT02482428|526564034|FG001|Overall Study|protocol deviation|1|||
146014509|NCT02482428|526564035|FG002|Overall Study|protocol deviation|0|||
146014510|NCT02482428|526564036|FG003|Overall Study|protocol deviation|0|||
146014511|NCT02482428|526564037|FG004|Overall Study|protocol deviation|0|||
146014512|NCT02482428|526564033|FG000|Overall Study|subject/guardian decision|4|||
146014513|NCT02482428|526564034|FG001|Overall Study|subject/guardian decision|2|||
146014514|NCT02482428|526564035|FG002|Overall Study|subject/guardian decision|0|||
146014515|NCT02482428|526564036|FG003|Overall Study|subject/guardian decision|0|||
146014516|NCT02482428|526564037|FG004|Overall Study|subject/guardian decision|2|||
146014517|NCT02547038|526564038|FG000|Overall Study|Lost to Follow-up|3|||
146014518|NCT02547038|526564039|FG001|Overall Study|Lost to Follow-up|2|||
146014519|NCT00516893|526564040|FG000|Overall Study|Lost to Follow-up|4|||
146014520|NCT00516893|526564040|FG000|Overall Study|Adverse Event|3|||
146014521|NCT00516893|526564040|FG000|Overall Study|Withdrawal by Subject|2|||
146014522|NCT00516893|526564040|FG000|Overall Study|Noncompliance|2|||
146014523|NCT00516893|526564040|FG000|Overall Study|Death|1|||
146014524|NCT00516893|526564040|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
146014525|NCT00516893|526564040|FG000|Overall Study|Relocated|1|||
146014526|NCT00516893|526564040|FG000|Overall Study|Pregnancy|1|||
146014527|NCT00516893|526564040|FG000|Overall Study|Received Medication From Another Study|1|||
146014528|NCT00301262|526564043|FG000|Double Blind Phase (DB)|Adverse Event|1|||
146014529|NCT00301262|526564044|FG001|Double Blind Phase (DB)|Adverse Event|0|||
146014530|NCT00301262|526564043|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
146014531|NCT00301262|526564044|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
146014532|NCT00301262|526564043|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
146014533|NCT00301262|526564044|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
146014534|NCT00301262|526564043|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
146014535|NCT00301262|526564044|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
146014536|NCT00301262|526564043|FG000|Double Blind Phase (DB)|Other|1|||
146014537|NCT00301262|526564044|FG001|Double Blind Phase (DB)|Other|4|||
146014538|NCT00301262|526564043|FG000|Open Label Phase (OL)|Adverse Event|1|||
146014539|NCT00301262|526564044|FG001|Open Label Phase (OL)|Adverse Event|0|||
146014540|NCT00301262|526564043|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
146250306|NCT01307800|527428158|FG001|Overall Study|Lost to Follow-up|6|||
146250307|NCT01307800|527428159|FG002|Overall Study|Lost to Follow-up|2|||
146014541|NCT00301262|526564044|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
146014542|NCT00301262|526564043|FG000|Open Label Phase (OL)|Other|2|||
146014543|NCT00301262|526564044|FG001|Open Label Phase (OL)|Other|0|||
146014544|NCT01443364|526564045|FG000|Overall Study|Lack of Efficacy|14|||
146014545|NCT01443364|526564045|FG000|Overall Study|Lost to Follow-up|3|||
146014546|NCT01443364|526564045|FG000|Overall Study|Withdrawal by Subject|5|||
146014547|NCT01443364|526564045|FG000|Overall Study|Other Reason|4|||
146014548|NCT01443364|526564045|FG000|Overall Study|SAE, non-fatal|6|||
146014549|NCT01443364|526564045|FG000|Overall Study|AE, non-serious non-fatal|8|||
146014550|NCT01443364|526564045|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146014551|NCT00623233|526564046|FG000|Overall Study|Adverse Event|10|||
146014552|NCT00623233|526564046|FG000|Overall Study|Physician Decision|10|||
146014553|NCT00623233|526564046|FG000|Overall Study|Lost to Follow-up|1|||
146250308|NCT01307800|527428160|FG003|Overall Study|Lost to Follow-up|8|||
146014554|NCT00623233|526564046|FG000|Overall Study|Withdrawal by Subject|3|||
146014555|NCT00559845|526564047|FG000|Overall Study|Withdrew Consent|1|||
146014556|NCT00559845|526564047|FG000|Overall Study|Disease Progression|1|||
146014557|NCT00559845|526564047|FG000|Overall Study|Adverse Event|3|||
146014558|NCT00559845|526564047|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
146014559|NCT00559845|526564047|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
146014560|NCT00459875|526564048|FG000|Overall Study|Ineligible participant|1|||
146014561|NCT00459875|526564048|FG000|Overall Study|Adverse Event|2|||
146093446|NCT02007512|526863417|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
146093447|NCT02007512|526863418|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
146093448|NCT02007512|526863419|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
146093449|NCT02007512|526863420|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
146093450|NCT02007512|526863417|FG000|Open Label Treatment Period|Adverse Event|1|||
146093451|NCT02007512|526863418|FG001|Open Label Treatment Period|Adverse Event|0|||
146093452|NCT02007512|526863419|FG002|Open Label Treatment Period|Adverse Event|0|||
146093453|NCT02007512|526863420|FG003|Open Label Treatment Period|Adverse Event|0|||
146093454|NCT02007512|526863417|FG000|Open Label Treatment Period|Other|1|||
146093455|NCT02007512|526863418|FG001|Open Label Treatment Period|Other|1|||
146093456|NCT02007512|526863419|FG002|Open Label Treatment Period|Other|0|||
146014562|NCT02150057|526564049|FG000|Overall Study|Lost to Follow-up|6|||
146014563|NCT02150057|526564050|FG001|Overall Study|Lost to Follow-up|4|||
146014564|NCT01558115|526564051|FG000|Overall Study|Withdrawal by Subject|3|||
146014565|NCT01558115|526564051|FG000|Overall Study|Study closed due to poor enrollment|4|||
146014566|NCT01696994|526564052|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
146014567|NCT01696994|526564053|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
146014568|NCT01696994|526564052|FG000|Overall Study|Died Before Randomization|1|||
146014569|NCT01696994|526564053|FG001|Overall Study|Died Before Randomization|2|||
146014570|NCT01696994|526564052|FG000|Overall Study|Died Before ASU (Control)|73|||
146014571|NCT01696994|526564053|FG001|Overall Study|Died Before ASU (Control)|0|||
146014572|NCT01696994|526564052|FG000|Overall Study|No Ovaries at Baseline|4807|||
146014573|NCT01696994|526564053|FG001|Overall Study|No Ovaries at Baseline|4851|||
146014574|NCT01696994|526564052|FG000|Overall Study|Refused ASU (Control)|311|||
146014575|NCT01696994|526564053|FG001|Overall Study|Refused ASU (Control)|0|||
146014576|NCT01696994|526564052|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
146014577|NCT01696994|526564053|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
146014578|NCT00576628|526564056|FG000|Overall Study|Adverse Event|11|||
146014579|NCT00576628|526564056|FG000|Overall Study|Death|2|||
146014580|NCT00576628|526564056|FG000|Overall Study|Failure to return|1|||
146014581|NCT00576628|526564056|FG000|Overall Study|Refused Treatment|8|||
146014582|NCT00576628|526564056|FG000|Overall Study|Pregnancy|1|||
146014583|NCT00576628|526564056|FG000|Overall Study|RBC transfusion|1|||
146014584|NCT00576628|526564056|FG000|Overall Study|Progression of Kidney Disease|1|||
146014585|NCT00576628|526564056|FG000|Overall Study|Progression of Renal Failure|1|||
146014586|NCT00576628|526564056|FG000|Overall Study|The patient move into other town|1|||
146014587|NCT00576628|526564056|FG000|Overall Study|Transplantation|1|||
146014588|NCT00576628|526564056|FG000|Overall Study|Dialysis|15|||
146014589|NCT02516982|526564057|FG000|Overall Study|Called in to antenatal appointment|32|||
146014590|NCT02516982|526564058|FG001|Overall Study|Called in to antenatal appointment|35|||
146014591|NCT02516982|526564059|FG002|Overall Study|Called in to antenatal appointment|0|||
146014592|NCT02516982|526564060|FG003|Overall Study|Called in to antenatal appointment|0|||
146014593|NCT02516982|526564057|FG000|Overall Study|Withdrawal by Subject|0|||
146014594|NCT02516982|526564058|FG001|Overall Study|Withdrawal by Subject|0|||
146014595|NCT02516982|526564059|FG002|Overall Study|Withdrawal by Subject|1|||
146014596|NCT02516982|526564060|FG003|Overall Study|Withdrawal by Subject|2|||
146014597|NCT02516982|526564057|FG000|Overall Study|Protocol Violation|0|||
146014598|NCT02516982|526564058|FG001|Overall Study|Protocol Violation|0|||
146014599|NCT02516982|526564059|FG002|Overall Study|Protocol Violation|1|||
146014600|NCT02516982|526564060|FG003|Overall Study|Protocol Violation|1|||
146014601|NCT02516982|526564057|FG000|Overall Study|Did not install the app|0|||
146014602|NCT02516982|526564058|FG001|Overall Study|Did not install the app|0|||
146014603|NCT02516982|526564059|FG002|Overall Study|Did not install the app|46|||
146014604|NCT02516982|526564060|FG003|Overall Study|Did not install the app|47|||
146014605|NCT01951586|526564067|FG000|Overall Study|Death|61|||
146014606|NCT01951586|526564068|FG001|Overall Study|Death|120|||
146014607|NCT01951586|526564067|FG000|Overall Study|Withdrawal by Subject|8|||
146014608|NCT01951586|526564068|FG001|Overall Study|Withdrawal by Subject|17|||
146014609|NCT01951586|526564067|FG000|Overall Study|Lost to Follow-up|0|||
146250309|NCT01307800|527428157|FG000|Overall Study|Perceived Lack of Efficacy|24|||
146014610|NCT01951586|526564068|FG001|Overall Study|Lost to Follow-up|1|||
146014611|NCT01951586|526564067|FG000|Overall Study|Sponsor Decision|9|||
146014612|NCT01951586|526564068|FG001|Overall Study|Sponsor Decision|10|||
146014613|NCT00962741|526564069|FG000|Overall Study|Failed to return|3|||
146014614|NCT00962741|526564069|FG000|Overall Study|Lost to Follow-up|2|||
146014615|NCT00962741|526564069|FG000|Overall Study|Withdrawal by Subject|1|||
146014616|NCT00962741|526564069|FG000|Overall Study|Lack of Efficacy|1|||
146093457|NCT02007512|526863420|FG003|Open Label Treatment Period|Other|0|||
146014617|NCT00962741|526564069|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
146014618|NCT02120781|526564070|FG000|Overall Study|Physician Decision|2|||
146014619|NCT02120781|526564071|FG001|Overall Study|Physician Decision|0|||
146014620|NCT02120781|526564070|FG000|Overall Study|Completion not documented|2|||
146014621|NCT02120781|526564071|FG001|Overall Study|Completion not documented|1|||
146014622|NCT00654745|526564076|FG000|Overall Study|Adverse Event|12|||
146014623|NCT00654745|526564076|FG000|Overall Study|Lost to Follow-up|7|||
146014624|NCT00654745|526564076|FG000|Overall Study|Protocol Violation|11|||
146014625|NCT00654745|526564076|FG000|Overall Study|Withdrawal by Subject|10|||
146014626|NCT00654745|526564076|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
146014627|NCT00748618|526564077|FG000|Overall Study|Adverse Event|1|||
146014628|NCT00748618|526564078|FG001|Overall Study|Adverse Event|0|||
146014629|NCT00466947|526564079|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
146014630|NCT00466947|526564080|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
146014631|NCT00466947|526564079|FG000|Study End Analysis Period|Adverse Event|35|||
146014632|NCT00466947|526564080|FG001|Study End Analysis Period|Adverse Event|43|||
146014633|NCT00466947|526564079|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
146014634|NCT00466947|526564080|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
146014635|NCT00466947|526564079|FG000|Study End Analysis Period|Physician Decision|29|||
146014636|NCT00466947|526564080|FG001|Study End Analysis Period|Physician Decision|29|||
146014637|NCT00466947|526564079|FG000|Study End Analysis Period|Protocol Violation|9|||
146014638|NCT00466947|526564080|FG001|Study End Analysis Period|Protocol Violation|17|||
146014639|NCT00466947|526564079|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
146014640|NCT00466947|526564080|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
146014641|NCT00466947|526564079|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
146014642|NCT00466947|526564080|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
146014643|NCT00466947|526564079|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
146014644|NCT00466947|526564080|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
146014645|NCT00466947|526564079|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
146014646|NCT00466947|526564080|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
146014647|NCT01995526|526564081|FG000|Overall Study|Physician Decision|1|||
146014648|NCT01977729|526564085|FG000|Overall Study|Study terminated|1|||
146014649|NCT03286543|526564086|FG000|Consented|Screen failure before randomization|2|||
146014650|NCT03286543|526564087|FG001|Consented|Screen failure before randomization|0|||
146014651|NCT03286543|526564088|FG002|Consented|Screen failure before randomization|0|||
146014652|NCT03286543|526564086|FG000|Consented|Screen failure before enrollment|4|||
146014653|NCT03286543|526564087|FG001|Consented|Screen failure before enrollment|0|||
146014654|NCT03286543|526564088|FG002|Consented|Screen failure before enrollment|0|||
146014655|NCT03286543|526564086|FG000|Consented|TKA cancelled after enrollment|1|||
146093458|NCT02007512|526863417|FG000|Open Label Treatment Period|Disease progression|23|||
146250310|NCT01307800|527428158|FG001|Overall Study|Perceived Lack of Efficacy|23|||
146250311|NCT01307800|527428159|FG002|Overall Study|Perceived Lack of Efficacy|20|||
146250312|NCT01307800|527428160|FG003|Overall Study|Perceived Lack of Efficacy|33|||
146250313|NCT01307800|527428157|FG000|Overall Study|Protocol Violation|0|||
146250314|NCT01307800|527428158|FG001|Overall Study|Protocol Violation|3|||
146250315|NCT01307800|527428159|FG002|Overall Study|Protocol Violation|4|||
146250316|NCT01307800|527428160|FG003|Overall Study|Protocol Violation|5|||
146250317|NCT01307800|527428157|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
146250318|NCT01307800|527428158|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
146250319|NCT01307800|527428159|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
146250320|NCT01307800|527428160|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
146250321|NCT01307800|527428157|FG000|Overall Study|Sponsor Decision|6|||
146250322|NCT01307800|527428158|FG001|Overall Study|Sponsor Decision|9|||
146250323|NCT01307800|527428159|FG002|Overall Study|Sponsor Decision|12|||
146250324|NCT01307800|527428160|FG003|Overall Study|Sponsor Decision|28|||
146250325|NCT01307800|527428157|FG000|Overall Study|Withdrawal by Subject|10|||
146250326|NCT01307800|527428158|FG001|Overall Study|Withdrawal by Subject|11|||
146250327|NCT01307800|527428159|FG002|Overall Study|Withdrawal by Subject|8|||
146250328|NCT01307800|527428160|FG003|Overall Study|Withdrawal by Subject|15|||
146250329|NCT01307800|527428157|FG000|Overall Study|Participant Moved|0|||
146014656|NCT03286543|526564087|FG001|Consented|TKA cancelled after enrollment|0|||
146014657|NCT03286543|526564088|FG002|Consented|TKA cancelled after enrollment|0|||
146014658|NCT03286543|526564086|FG000|Consented|Withdrawn from study|12|||
146014659|NCT03286543|526564087|FG001|Consented|Withdrawn from study|0|||
146014660|NCT03286543|526564088|FG002|Consented|Withdrawn from study|0|||
146014661|NCT03286543|526564086|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
146014662|NCT03286543|526564087|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
146014663|NCT03286543|526564088|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
146250330|NCT01307800|527428158|FG001|Overall Study|Participant Moved|2|||
146250331|NCT01307800|527428159|FG002|Overall Study|Participant Moved|1|||
146250332|NCT01307800|527428160|FG003|Overall Study|Participant Moved|3|||
146250333|NCT02674399|527428161|FG000|Overall Study|Lost to Follow-up|2|||
146250334|NCT02674399|527428162|FG001|Overall Study|Lost to Follow-up|0|||
146014664|NCT03286543|526564086|FG000|Study Enrollment|Withdrawn from study|0|||
146014665|NCT03286543|526564087|FG001|Study Enrollment|Withdrawn from study|6|||
146014666|NCT03286543|526564088|FG002|Study Enrollment|Withdrawn from study|6|||
146093459|NCT02007512|526863418|FG001|Open Label Treatment Period|Disease progression|11|||
146093460|NCT02007512|526863419|FG002|Open Label Treatment Period|Disease progression|0|||
146093461|NCT02007512|526863420|FG003|Open Label Treatment Period|Disease progression|0|||
146014667|NCT00104416|526564089|FG000|Double-Blind Phase|Adverse Event|2|||
146014668|NCT00104416|526564090|FG001|Double-Blind Phase|Adverse Event|1|||
146014669|NCT00104416|526564091|FG002|Double-Blind Phase|Adverse Event|0|||
146014670|NCT00104416|526564092|FG003|Double-Blind Phase|Adverse Event|0|||
146014671|NCT00104416|526564093|FG004|Double-Blind Phase|Adverse Event|0|||
146014672|NCT00104416|526564089|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146014673|NCT00104416|526564090|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146014674|NCT00104416|526564091|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146014675|NCT00104416|526564092|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146014676|NCT00104416|526564093|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146014677|NCT00104416|526564089|FG000|Double-Blind Phase|Protocol Violation|0|||
146014678|NCT00104416|526564090|FG001|Double-Blind Phase|Protocol Violation|1|||
146093462|NCT03026088|526863421|FG000|Overall Study|Study termination|20|||
146093463|NCT03960554|526863428|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
146093464|NCT03960554|526863429|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
146093465|NCT00736879|526863430|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146093466|NCT00736879|526863431|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146093467|NCT00736879|526863432|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146093468|NCT00736879|526863433|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
146093469|NCT00736879|526863430|FG000|Double Blind Treatment Period|Adverse Event|0|||
146093470|NCT00736879|526863431|FG001|Double Blind Treatment Period|Adverse Event|1|||
146093471|NCT00736879|526863432|FG002|Double Blind Treatment Period|Adverse Event|1|||
146014679|NCT00104416|526564091|FG002|Double-Blind Phase|Protocol Violation|0|||
146014680|NCT00104416|526564092|FG003|Double-Blind Phase|Protocol Violation|0|||
146014681|NCT00104416|526564093|FG004|Double-Blind Phase|Protocol Violation|0|||
146014682|NCT00104416|526564089|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
146014683|NCT00104416|526564090|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
146014684|NCT00104416|526564091|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146014685|NCT00104416|526564092|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146014686|NCT00104416|526564093|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146014687|NCT00104416|526564089|FG000|Double-Blind Phase|Pregnancy|1|||
146014688|NCT00104416|526564090|FG001|Double-Blind Phase|Pregnancy|0|||
146014689|NCT00104416|526564091|FG002|Double-Blind Phase|Pregnancy|0|||
146014690|NCT00104416|526564092|FG003|Double-Blind Phase|Pregnancy|0|||
146014691|NCT00104416|526564093|FG004|Double-Blind Phase|Pregnancy|0|||
146014692|NCT00104416|526564089|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
146014693|NCT00104416|526564090|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
146014694|NCT00104416|526564091|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
146014695|NCT00104416|526564092|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
146014696|NCT00104416|526564093|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
146014697|NCT00104416|526564089|FG000|Continuation Phase|Adverse Event|0|||
146014698|NCT00104416|526564090|FG001|Continuation Phase|Adverse Event|0|||
146014699|NCT00104416|526564091|FG002|Continuation Phase|Adverse Event|2|||
146014700|NCT00104416|526564092|FG003|Continuation Phase|Adverse Event|0|||
146014701|NCT00104416|526564093|FG004|Continuation Phase|Adverse Event|2|||
146014702|NCT00104416|526564089|FG000|Continuation Phase|Lost to Follow-up|0|||
146014703|NCT00104416|526564090|FG001|Continuation Phase|Lost to Follow-up|0|||
146014704|NCT00104416|526564091|FG002|Continuation Phase|Lost to Follow-up|1|||
146014705|NCT00104416|526564092|FG003|Continuation Phase|Lost to Follow-up|0|||
146014706|NCT00104416|526564093|FG004|Continuation Phase|Lost to Follow-up|1|||
146014707|NCT00104416|526564089|FG000|Continuation Phase|Withdrawal by Subject|0|||
146014708|NCT00104416|526564090|FG001|Continuation Phase|Withdrawal by Subject|0|||
146014709|NCT00104416|526564091|FG002|Continuation Phase|Withdrawal by Subject|2|||
146014710|NCT00104416|526564092|FG003|Continuation Phase|Withdrawal by Subject|1|||
146014711|NCT00104416|526564093|FG004|Continuation Phase|Withdrawal by Subject|1|||
146093472|NCT00736879|526863433|FG003|Double Blind Treatment Period|Adverse Event|0|||
146093473|NCT00736879|526863430|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
146093474|NCT00736879|526863431|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146093475|NCT00736879|526863432|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
146299543|NCT01968070|527611771|FG010|Period 1|Physician Decision|0|||
146014712|NCT00104416|526564089|FG000|Continuation Phase|Pregnancy|0|||
146014713|NCT00104416|526564090|FG001|Continuation Phase|Pregnancy|0|||
146014714|NCT00104416|526564091|FG002|Continuation Phase|Pregnancy|1|||
146014715|NCT00104416|526564092|FG003|Continuation Phase|Pregnancy|1|||
146014716|NCT00104416|526564093|FG004|Continuation Phase|Pregnancy|0|||
146014717|NCT00104416|526564089|FG000|Continuation Phase|Non-compliance|0|||
146014718|NCT00104416|526564090|FG001|Continuation Phase|Non-compliance|0|||
146014719|NCT00104416|526564091|FG002|Continuation Phase|Non-compliance|0|||
146014720|NCT00104416|526564092|FG003|Continuation Phase|Non-compliance|0|||
146014721|NCT00104416|526564093|FG004|Continuation Phase|Non-compliance|1|||
146014722|NCT00438360|526564094|FG000|Overall Study|Adverse Event|6|||
146014723|NCT00438360|526564095|FG001|Overall Study|Adverse Event|1|||
146014724|NCT00438360|526564094|FG000|Overall Study|Lack of Efficacy|42|||
146014725|NCT00438360|526564095|FG001|Overall Study|Lack of Efficacy|27|||
146014726|NCT00438360|526564094|FG000|Overall Study|Other|24|||
146014727|NCT00438360|526564095|FG001|Overall Study|Other|15|||
146014728|NCT00758069|526564097|FG000|Overall Study|Lack of Efficacy|0|||
146250335|NCT02255474|527428163|FG000|Overall Study|Lost to Follow-up|1|||
146014729|NCT00758069|526564098|FG001|Overall Study|Lack of Efficacy|0|||
146014730|NCT00758069|526564099|FG002|Overall Study|Lack of Efficacy|1|||
146014731|NCT00758069|526564097|FG000|Overall Study|Incorrect Study Drug|1|||
146014732|NCT00758069|526564098|FG001|Overall Study|Incorrect Study Drug|0|||
146014733|NCT00758069|526564099|FG002|Overall Study|Incorrect Study Drug|0|||
146014734|NCT02277691|526564100|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
146014735|NCT02277691|526564100|FG000|Overall Study|Voluntary Withdrawal|7|||
146014736|NCT02277691|526564100|FG000|Overall Study|Lack of Efficacy|5|||
146014737|NCT02277691|526564100|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
146014738|NCT01147250|526564103|FG000|Overall Study|Lost to Follow-up|14|||
146014739|NCT01147250|526564104|FG001|Overall Study|Lost to Follow-up|11|||
146014740|NCT01147250|526564103|FG000|Overall Study|Withdrawal by Subject|83|||
146014741|NCT01147250|526564104|FG001|Overall Study|Withdrawal by Subject|88|||
146014742|NCT01147250|526564103|FG000|Overall Study|Site termination by sponsor|13|||
146093476|NCT00736879|526863433|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
146250336|NCT02255474|527428164|FG001|Overall Study|Lost to Follow-up|1|||
146250337|NCT02255474|527428165|FG002|Overall Study|Lost to Follow-up|3|||
146250338|NCT02255474|527428163|FG000|Overall Study|Withdrawal by Subject|1|||
146250339|NCT02255474|527428164|FG001|Overall Study|Withdrawal by Subject|1|||
146250340|NCT02255474|527428165|FG002|Overall Study|Withdrawal by Subject|0|||
146250341|NCT04520256|527428171|FG000|Overall Study|Lost to Follow-up|6|||
146250342|NCT04520256|527428172|FG001|Overall Study|Lost to Follow-up|4|||
146250343|NCT04520256|527428173|FG002|Overall Study|Lost to Follow-up|2|||
146250344|NCT04520256|527428174|FG003|Overall Study|Lost to Follow-up|3|||
146250345|NCT04520256|527428175|FG004|Overall Study|Lost to Follow-up|6|||
146250346|NCT04520256|527428176|FG005|Overall Study|Lost to Follow-up|6|||
146250347|NCT04520256|527428177|FG006|Overall Study|Lost to Follow-up|4|||
146250348|NCT04520256|527428178|FG007|Overall Study|Lost to Follow-up|6|||
146250349|NCT04520256|527428179|FG008|Overall Study|Lost to Follow-up|1|||
146250350|NCT04520256|527428180|FG009|Overall Study|Lost to Follow-up|3|||
146250351|NCT04520256|527428181|FG010|Overall Study|Lost to Follow-up|3|||
146250352|NCT04520256|527428182|FG011|Overall Study|Lost to Follow-up|2|||
146250353|NCT04520256|527428183|FG012|Overall Study|Lost to Follow-up|5|||
146250354|NCT04520256|527428184|FG013|Overall Study|Lost to Follow-up|3|||
146250355|NCT04520256|527428185|FG014|Overall Study|Lost to Follow-up|3|||
146250356|NCT04520256|527428186|FG015|Overall Study|Lost to Follow-up|6|||
146250357|NCT04520256|527428187|FG016|Overall Study|Lost to Follow-up|6|||
146250358|NCT04520256|527428188|FG017|Overall Study|Lost to Follow-up|4|||
146250359|NCT04520256|527428189|FG018|Overall Study|Lost to Follow-up|3|||
146250360|NCT04520256|527428190|FG019|Overall Study|Lost to Follow-up|3|||
146250361|NCT04520256|527428191|FG020|Overall Study|Lost to Follow-up|7|||
146250362|NCT04520256|527428192|FG021|Overall Study|Lost to Follow-up|3|||
146250363|NCT04520256|527428193|FG022|Overall Study|Lost to Follow-up|3|||
146250364|NCT04520256|527428194|FG023|Overall Study|Lost to Follow-up|8|||
146250365|NCT04520256|527428195|FG024|Overall Study|Lost to Follow-up|5|||
146250366|NCT04520256|527428196|FG025|Overall Study|Lost to Follow-up|4|||
146250367|NCT04520256|527428197|FG026|Overall Study|Lost to Follow-up|3|||
146250368|NCT04520256|527428198|FG027|Overall Study|Lost to Follow-up|4|||
146250369|NCT04520256|527428199|FG028|Overall Study|Lost to Follow-up|3|||
146250370|NCT04520256|527428200|FG029|Overall Study|Lost to Follow-up|4|||
146250371|NCT04520256|527428201|FG030|Overall Study|Lost to Follow-up|4|||
146250372|NCT04520256|527428202|FG031|Overall Study|Lost to Follow-up|4|||
146250373|NCT01730118|527429184|FG000|Dose Escalation|Death on study|5|||
146250374|NCT01730118|527429185|FG001|Dose Escalation|Death on study|7|||
146250375|NCT01730118|527429186|FG002|Dose Escalation|Death on study|2|||
146250376|NCT01730118|527429187|FG003|Dose Escalation|Death on study|6|||
146250377|NCT01730118|527429188|FG004|Dose Escalation|Death on study|0|||
146250378|NCT01730118|527429189|FG005|Dose Escalation|Death on study|0|||
146250379|NCT01730118|527429190|FG006|Dose Escalation|Death on study|0|||
146014743|NCT01147250|526564104|FG001|Overall Study|Site termination by sponsor|5|||
146014744|NCT01147250|526564103|FG000|Overall Study|Other than specified|0|||
146014745|NCT01147250|526564104|FG001|Overall Study|Other than specified|1|||
146014746|NCT02684617|526564105|FG000|Overall Study|Adverse Event|1|||
146014747|NCT02684617|526564106|FG001|Overall Study|Adverse Event|0|||
146014748|NCT02684617|526564107|FG002|Overall Study|Adverse Event|1|||
146250380|NCT01730118|527429184|FG000|Dose Escalation|Died before treatment|0|||
146250381|NCT01730118|527429185|FG001|Dose Escalation|Died before treatment|0|||
146250382|NCT01730118|527429186|FG002|Dose Escalation|Died before treatment|0|||
146250383|NCT01730118|527429187|FG003|Dose Escalation|Died before treatment|0|||
146250384|NCT01730118|527429188|FG004|Dose Escalation|Died before treatment|0|||
146014749|NCT02684617|526564105|FG000|Overall Study|Death|8|||
146014750|NCT02684617|526564106|FG001|Overall Study|Death|16|||
146014751|NCT02684617|526564107|FG002|Overall Study|Death|28|||
146014752|NCT02684617|526564105|FG000|Overall Study|Withdrawal by Subject|2|||
146014753|NCT02684617|526564106|FG001|Overall Study|Withdrawal by Subject|0|||
146014754|NCT02684617|526564107|FG002|Overall Study|Withdrawal by Subject|4|||
146014755|NCT02684617|526564105|FG000|Overall Study|Screen Failure|1|||
146014756|NCT02684617|526564106|FG001|Overall Study|Screen Failure|0|||
146014757|NCT02684617|526564107|FG002|Overall Study|Screen Failure|2|||
146014758|NCT02684617|526564105|FG000|Overall Study|Study Terminated by Sponsor|6|||
146014759|NCT02684617|526564106|FG001|Overall Study|Study Terminated by Sponsor|1|||
146014760|NCT02684617|526564107|FG002|Overall Study|Study Terminated by Sponsor|5|||
146014761|NCT01164891|526564111|FG000|Overall Study|Disease Progression|5|||
146014762|NCT01164891|526564111|FG000|Overall Study|Adverse Event|1|||
146014763|NCT00441142|526564112|FG000|Overall Study|Adverse Event|2|||
146014764|NCT00441142|526564113|FG001|Overall Study|Adverse Event|3|||
146014765|NCT00441142|526564114|FG002|Overall Study|Adverse Event|3|||
146014766|NCT00441142|526564115|FG003|Overall Study|Adverse Event|22|||
146014767|NCT00441142|526564112|FG000|Overall Study|Lack of Efficacy|3|||
146014768|NCT00441142|526564113|FG001|Overall Study|Lack of Efficacy|3|||
146014769|NCT00441142|526564114|FG002|Overall Study|Lack of Efficacy|17|||
146014770|NCT00441142|526564115|FG003|Overall Study|Lack of Efficacy|32|||
146014771|NCT00441142|526564112|FG000|Overall Study|Withdrawal by Subject|0|||
146014772|NCT00441142|526564113|FG001|Overall Study|Withdrawal by Subject|0|||
146014773|NCT00441142|526564114|FG002|Overall Study|Withdrawal by Subject|2|||
146014774|NCT00441142|526564115|FG003|Overall Study|Withdrawal by Subject|10|||
146014775|NCT00441142|526564112|FG000|Overall Study|Patient still receiving active study tx|1|||
146014776|NCT00441142|526564113|FG001|Overall Study|Patient still receiving active study tx|0|||
146014777|NCT00441142|526564114|FG002|Overall Study|Patient still receiving active study tx|0|||
146014778|NCT00441142|526564115|FG003|Overall Study|Patient still receiving active study tx|2|||
146014779|NCT00441142|526564112|FG000|Overall Study|Physician Decision|0|||
146014780|NCT00441142|526564113|FG001|Overall Study|Physician Decision|1|||
146014781|NCT00441142|526564114|FG002|Overall Study|Physician Decision|0|||
146014782|NCT00441142|526564115|FG003|Overall Study|Physician Decision|1|||
146014783|NCT00441142|526564112|FG000|Overall Study|Death|0|||
146014784|NCT00441142|526564113|FG001|Overall Study|Death|0|||
146014785|NCT00441142|526564114|FG002|Overall Study|Death|0|||
146014786|NCT00441142|526564115|FG003|Overall Study|Death|1|||
146014787|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146014788|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
146014789|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146014790|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146014791|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146014792|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
146014793|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
146014794|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
146014795|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146014796|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146014797|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146014798|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146014799|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
146014800|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
146014801|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146014802|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146014803|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146014804|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146014805|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
146014806|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
146014807|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146299544|NCT01968070|527611772|FG011|Period 1|Physician Decision|1|||
146014808|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146014809|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146014810|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
146014811|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146014812|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
146014813|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146014814|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146014815|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146014816|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146014817|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
146014818|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
146299545|NCT01968070|527611773|FG012|Period 1|Physician Decision|0|||
146299546|NCT01968070|527611774|FG013|Period 1|Physician Decision|0|||
146299547|NCT01968070|527611775|FG014|Period 1|Physician Decision|0|||
146299548|NCT01968070|527611776|FG015|Period 1|Physician Decision|0|||
146299549|NCT01968070|527611777|FG016|Period 1|Physician Decision|0|||
146299550|NCT01968070|527611778|FG017|Period 1|Physician Decision|0|||
146299551|NCT01968070|527611761|FG000|Period 2|Withdrawal by Subject|0|||
146299552|NCT01968070|527611762|FG001|Period 2|Withdrawal by Subject|0|||
146299553|NCT01968070|527611763|FG002|Period 2|Withdrawal by Subject|0|||
146299554|NCT01968070|527611764|FG003|Period 2|Withdrawal by Subject|0|||
146299555|NCT01968070|527611765|FG004|Period 2|Withdrawal by Subject|1|||
146299556|NCT01968070|527611766|FG005|Period 2|Withdrawal by Subject|0|||
146299557|NCT01968070|527611767|FG006|Period 2|Withdrawal by Subject|0|||
146299558|NCT01968070|527611768|FG007|Period 2|Withdrawal by Subject|0|||
146299559|NCT01968070|527611769|FG008|Period 2|Withdrawal by Subject|0|||
146299560|NCT01968070|527611770|FG009|Period 2|Withdrawal by Subject|0|||
146299561|NCT01968070|527611771|FG010|Period 2|Withdrawal by Subject|0|||
146299562|NCT01968070|527611772|FG011|Period 2|Withdrawal by Subject|0|||
146299563|NCT01968070|527611773|FG012|Period 2|Withdrawal by Subject|0|||
146299564|NCT01968070|527611774|FG013|Period 2|Withdrawal by Subject|0|||
146299565|NCT01968070|527611775|FG014|Period 2|Withdrawal by Subject|0|||
146299566|NCT01968070|527611776|FG015|Period 2|Withdrawal by Subject|0|||
146299567|NCT01968070|527611777|FG016|Period 2|Withdrawal by Subject|0|||
146299568|NCT01968070|527611778|FG017|Period 2|Withdrawal by Subject|0|||
146299569|NCT00108069|527611781|FG000|Overall Study|Never rec'd study drug|0|||
146299570|NCT00108069|527611782|FG001|Overall Study|Never rec'd study drug|1|||
146299571|NCT00108069|527611781|FG000|Overall Study|Adverse Event|1|||
146299572|NCT00108069|527611782|FG001|Overall Study|Adverse Event|1|||
146299573|NCT00108069|527611781|FG000|Overall Study|Withdrawal by Subject|1|||
146299574|NCT00108069|527611782|FG001|Overall Study|Withdrawal by Subject|0|||
146299575|NCT00108069|527611781|FG000|Overall Study|Death|1|||
146299576|NCT00108069|527611782|FG001|Overall Study|Death|0|||
146299577|NCT00108069|527611781|FG000|Overall Study|Progessive disease|27|||
146299578|NCT00108069|527611782|FG001|Overall Study|Progessive disease|11|||
146299579|NCT01294150|527611785|FG000|Overall Study|Physician Decision|2|||
146299580|NCT01294150|527611786|FG001|Overall Study|Physician Decision|2|||
146299581|NCT03675776|527611787|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
146299582|NCT03675776|527611788|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
146299583|NCT03675776|527611789|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
146299584|NCT03675776|527611787|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146299585|NCT03675776|527611788|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146299586|NCT03675776|527611789|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146299587|NCT04513665|527611790|FG000|Overall Study|Adverse Event|2|||
146299588|NCT04513665|527611791|FG001|Overall Study|Adverse Event|0|||
146299589|NCT04513665|527611790|FG000|Overall Study|Lack of Efficacy|14|||
146299590|NCT04513665|527611791|FG001|Overall Study|Lack of Efficacy|0|||
146299591|NCT03684642|527611792|FG000|Overall Study|Adverse Event|6|||
146299592|NCT03684642|527611793|FG001|Overall Study|Adverse Event|15|||
146299593|NCT03684642|527611794|FG002|Overall Study|Adverse Event|11|||
146299594|NCT03684642|527611792|FG000|Overall Study|Withdrawal by Subject|35|||
146299595|NCT03684642|527611793|FG001|Overall Study|Withdrawal by Subject|53|||
146299596|NCT03684642|527611794|FG002|Overall Study|Withdrawal by Subject|23|||
146299597|NCT03684642|527611792|FG000|Overall Study|Lack of Efficacy|0|||
146299598|NCT03684642|527611793|FG001|Overall Study|Lack of Efficacy|0|||
146299599|NCT03684642|527611794|FG002|Overall Study|Lack of Efficacy|1|||
146299600|NCT03684642|527611792|FG000|Overall Study|Poor compliance to protocol|0|||
146299601|NCT03684642|527611793|FG001|Overall Study|Poor compliance to protocol|4|||
146093477|NCT00736879|526863430|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146093478|NCT00736879|526863431|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146093479|NCT00736879|526863432|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
146299602|NCT03684642|527611794|FG002|Overall Study|Poor compliance to protocol|1|||
146299603|NCT03684642|527611792|FG000|Overall Study|Other than specified|62|||
146299604|NCT03684642|527611793|FG001|Overall Study|Other than specified|60|||
146299605|NCT03684642|527611794|FG002|Overall Study|Other than specified|67|||
146299606|NCT03684642|527611792|FG000|Overall Study|Randomized and not treated|0|||
146299607|NCT03684642|527611793|FG001|Overall Study|Randomized and not treated|0|||
146093480|NCT00736879|526863433|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
146093481|NCT00736879|526863430|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
146299608|NCT03684642|527611794|FG002|Overall Study|Randomized and not treated|1|||
146299609|NCT03684642|527611792|FG000|Overall Study|Missing completion status but alive at last contact|0|||
146299610|NCT03684642|527611793|FG001|Overall Study|Missing completion status but alive at last contact|1|||
146299611|NCT03684642|527611794|FG002|Overall Study|Missing completion status but alive at last contact|2|||
146299612|NCT02742766|527611798|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299613|NCT02742766|527611799|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299614|NCT02742766|527611800|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299615|NCT02742766|527611801|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299616|NCT02742766|527611802|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146093482|NCT00736879|526863431|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
146093483|NCT00736879|526863432|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
146093484|NCT00736879|526863433|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
146093485|NCT00736879|526863430|FG000|Double Blind Treatment Period|No longer met criteria|0|||
146093486|NCT00736879|526863431|FG001|Double Blind Treatment Period|No longer met criteria|1|||
146093487|NCT00736879|526863432|FG002|Double Blind Treatment Period|No longer met criteria|0|||
146093488|NCT00736879|526863433|FG003|Double Blind Treatment Period|No longer met criteria|0|||
146093489|NCT00736879|526863430|FG000|Double Blind Treatment Period|non-specified|0|||
146093490|NCT00736879|526863431|FG001|Double Blind Treatment Period|non-specified|1|||
146093491|NCT00736879|526863432|FG002|Double Blind Treatment Period|non-specified|0|||
146093492|NCT00736879|526863433|FG003|Double Blind Treatment Period|non-specified|0|||
146093493|NCT00736879|526863430|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146093494|NCT00736879|526863431|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
146093495|NCT00736879|526863432|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146093496|NCT00736879|526863433|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
146093497|NCT00736879|526863430|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
146093498|NCT00736879|526863431|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
146093499|NCT00736879|526863432|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
146093500|NCT00736879|526863433|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
146093501|NCT02360111|526863434|FG000|Overall Study|Death|2|||
146093502|NCT00735254|526863438|FG000|Overall Study|Protocol Violation|1|||
146093503|NCT00735254|526863439|FG001|Overall Study|Protocol Violation|1|||
146093504|NCT00735254|526863440|FG002|Overall Study|Protocol Violation|1|||
146093505|NCT00735254|526863441|FG003|Overall Study|Protocol Violation|0|||
146093506|NCT00573248|526863443|FG000|Overall Study|scheduling conflicts|15|||
146093507|NCT00573248|526863444|FG001|Overall Study|scheduling conflicts|11|||
146093508|NCT02791594|526863447|FG000|Overall Study|Physician Decision|2|||
146093509|NCT03180684|526863450|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
146093510|NCT03180684|526863451|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
146093511|NCT03180684|526863450|FG000|Overall Study|Physician Decision|1|||
146093512|NCT03180684|526863451|FG001|Overall Study|Physician Decision|0|||
146093513|NCT03180684|526863450|FG000|Overall Study|Lost to Follow-up|1|||
146093514|NCT03180684|526863451|FG001|Overall Study|Lost to Follow-up|0|||
146093515|NCT03180684|526863450|FG000|Overall Study|Progressive Disease|1|||
146093516|NCT03180684|526863451|FG001|Overall Study|Progressive Disease|0|||
146093517|NCT04950166|526863452|FG000|Overall Study|Withdrawal by Subject|1|||
146093518|NCT05896748|526863453|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
146093519|NCT05896748|526863453|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
146093520|NCT05896748|526863453|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
146093521|NCT05896748|526863453|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
146093522|NCT05896748|526863453|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
146093523|NCT00857415|526863459|FG000|Overall Study|Image acquisition failure|2|||
146093524|NCT00857415|526863460|FG001|Overall Study|Image acquisition failure|0|||
146093525|NCT00857415|526863459|FG000|Overall Study|Invalid image or not imaged|3|||
146093526|NCT00857415|526863460|FG001|Overall Study|Invalid image or not imaged|0|||
146093527|NCT00857415|526863459|FG000|Overall Study|Subject still living at end of study|110|||
146093528|NCT00857415|526863460|FG001|Overall Study|Subject still living at end of study|0|||
146093529|NCT00857415|526863459|FG000|Overall Study|Deceased with no autopsy|2|||
146093530|NCT00857415|526863460|FG001|Overall Study|Deceased with no autopsy|0|||
146093531|NCT04508140|526863463|FG000|Overall Study|Adverse Event|2|||
146093532|NCT04508140|526863464|FG001|Overall Study|Adverse Event|2|||
146093533|NCT04508140|526863463|FG000|Overall Study|Withdrawal by Subject|0|||
146093534|NCT04508140|526863464|FG001|Overall Study|Withdrawal by Subject|2|||
146093535|NCT04508140|526863463|FG000|Overall Study|progressive disease|9|||
146093536|NCT04508140|526863464|FG001|Overall Study|progressive disease|3|||
146093537|NCT01130103|526863465|FG000|Randomized Treatment|Adverse Event|1|||
146093538|NCT01130103|526863466|FG001|Randomized Treatment|Adverse Event|1|||
146093539|NCT01130103|526863465|FG000|Randomized Treatment|Lost to Follow-up|1|||
146093540|NCT01130103|526863466|FG001|Randomized Treatment|Lost to Follow-up|0|||
146093541|NCT01130103|526863465|FG000|Randomized Treatment|Protocol Violation|3|||
146093542|NCT01130103|526863466|FG001|Randomized Treatment|Protocol Violation|2|||
146093543|NCT01130103|526863465|FG000|Randomized Treatment|Withdrawal by Subject|1|||
146093544|NCT01130103|526863466|FG001|Randomized Treatment|Withdrawal by Subject|2|||
146093545|NCT01130103|526863465|FG000|Maintenance Treatment|Lack of Efficacy|0|||
146093546|NCT01130103|526863466|FG001|Maintenance Treatment|Lack of Efficacy|1|||
146093547|NCT01130103|526863465|FG000|Maintenance Treatment|Lost to Follow-up|1|||
146093548|NCT01130103|526863466|FG001|Maintenance Treatment|Lost to Follow-up|1|||
146093549|NCT01130103|526863465|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
146093550|NCT01130103|526863466|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
146093551|NCT01822678|526863469|FG000|Overall Study|Withdrawal by Subject|5|||
146093552|NCT01822678|526863470|FG001|Overall Study|Withdrawal by Subject|4|||
146093553|NCT01822678|526863471|FG002|Overall Study|Withdrawal by Subject|4|||
146093554|NCT01822678|526863469|FG000|Overall Study|Adverse Event|4|||
146093555|NCT01822678|526863470|FG001|Overall Study|Adverse Event|3|||
146093556|NCT01822678|526863471|FG002|Overall Study|Adverse Event|1|||
146093557|NCT01822678|526863469|FG000|Overall Study|Lack of Efficacy|3|||
146093558|NCT01822678|526863470|FG001|Overall Study|Lack of Efficacy|6|||
146093559|NCT01822678|526863471|FG002|Overall Study|Lack of Efficacy|5|||
146093560|NCT01822678|526863469|FG000|Overall Study|Lost to Follow-up|0|||
146093561|NCT01822678|526863470|FG001|Overall Study|Lost to Follow-up|2|||
146093562|NCT01822678|526863471|FG002|Overall Study|Lost to Follow-up|1|||
146093563|NCT04795622|526863477|FG000|Overall Study|Adverse Event|1|||
146093564|NCT04795622|526863478|FG001|Overall Study|Adverse Event|0|||
146093565|NCT04795622|526863477|FG000|Overall Study|Withdrawal by Subject|3|||
146093566|NCT04795622|526863478|FG001|Overall Study|Withdrawal by Subject|3|||
146093567|NCT04795622|526863477|FG000|Overall Study|Protocol Violation|0|||
146093568|NCT04795622|526863478|FG001|Overall Study|Protocol Violation|2|||
146093569|NCT04795622|526863477|FG000|Overall Study|Lost to Follow-up|2|||
146093570|NCT04795622|526863478|FG001|Overall Study|Lost to Follow-up|3|||
146093571|NCT04795622|526863477|FG000|Overall Study|Other|7|||
146093572|NCT04795622|526863478|FG001|Overall Study|Other|8|||
146093573|NCT03309046|526863479|FG000|Overall Study|Withdrawal by Subject|4|||
146093574|NCT03309046|526863480|FG001|Overall Study|Withdrawal by Subject|17|||
146093575|NCT02059005|526863485|FG000|Overall Study|Death|1|||
146093576|NCT02059005|526863486|FG001|Overall Study|Death|3|||
146093577|NCT02059005|526863485|FG000|Overall Study|Lost to Follow-up|19|||
146093578|NCT02059005|526863486|FG001|Overall Study|Lost to Follow-up|19|||
146093579|NCT02059005|526863485|FG000|Overall Study|Incarceration|0|||
146093580|NCT02059005|526863486|FG001|Overall Study|Incarceration|1|||
146014819|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146014820|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146014821|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146014822|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
146014823|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146014824|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
146014825|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146014826|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146014827|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146014828|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
146014829|NCT03985943|526564116|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146014830|NCT03985943|526564117|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
146014831|NCT03985943|526564118|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146014832|NCT03985943|526564119|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146014833|NCT03985943|526564120|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146014834|NCT03985943|526564121|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
146014835|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146014836|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146014837|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
146014838|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146014839|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
146014840|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
146014841|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146014842|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146014843|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146014844|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146014845|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146014846|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
146014847|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
146014848|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
146014849|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
146014850|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
146014851|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
146014852|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
146014853|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146014854|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146014855|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146093581|NCT02059005|526863485|FG000|Overall Study|Inpatient|0|||
146093582|NCT02059005|526863486|FG001|Overall Study|Inpatient|1|||
146093583|NCT00908011|526863491|FG000|Overall Study|Withdrawal by Subject|2|||
146093584|NCT00908011|526863492|FG001|Overall Study|Withdrawal by Subject|2|||
146093585|NCT00739596|526863493|FG000|Overall Study|Adverse Event|12|||
146014856|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146014857|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146014858|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146014859|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146014860|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146014861|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
146014862|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146014863|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
146014864|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
146014865|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
146014866|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
146014867|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
146014868|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
146014869|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
146014870|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
146014871|NCT03985943|526564116|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
146014872|NCT03985943|526564117|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
146014873|NCT03985943|526564118|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
146014874|NCT03985943|526564119|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
146014875|NCT03985943|526564120|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
146014876|NCT03985943|526564121|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
146014877|NCT00338286|526564122|FG000|Overall Study|Withdrawal by Subject|50|||
146014878|NCT00338286|526564123|FG001|Overall Study|Withdrawal by Subject|54|||
146014879|NCT00338286|526564122|FG000|Overall Study|Lost to Follow-up|80|||
146014880|NCT00338286|526564123|FG001|Overall Study|Lost to Follow-up|66|||
146014881|NCT00338286|526564122|FG000|Overall Study|Other|103|||
146014882|NCT00338286|526564123|FG001|Overall Study|Other|93|||
146014883|NCT01265563|526564124|FG000|Overall Study|Withdrawal by Subject|0|||
146014884|NCT01265563|526564125|FG001|Overall Study|Withdrawal by Subject|1|||
146014885|NCT01265563|526564126|FG002|Overall Study|Withdrawal by Subject|1|||
146014886|NCT01265563|526564127|FG003|Overall Study|Withdrawal by Subject|0|||
146014887|NCT01265563|526564128|FG004|Overall Study|Withdrawal by Subject|2|||
146250385|NCT01730118|527429189|FG005|Dose Escalation|Died before treatment|0|||
146250386|NCT01730118|527429190|FG006|Dose Escalation|Died before treatment|1|||
146250387|NCT01730118|527429184|FG000|Dose Escalation|Chose to start a different treatment|1|||
146250388|NCT01730118|527429185|FG001|Dose Escalation|Chose to start a different treatment|0|||
146250389|NCT01730118|527429186|FG002|Dose Escalation|Chose to start a different treatment|0|||
146250390|NCT01730118|527429187|FG003|Dose Escalation|Chose to start a different treatment|0|||
146250391|NCT01730118|527429188|FG004|Dose Escalation|Chose to start a different treatment|0|||
146250392|NCT01730118|527429189|FG005|Dose Escalation|Chose to start a different treatment|0|||
146250393|NCT01730118|527429190|FG006|Dose Escalation|Chose to start a different treatment|0|||
146250394|NCT01730118|527429184|FG000|Dose Escalation|Withdrawal by Subject|0|||
146250395|NCT01730118|527429185|FG001|Dose Escalation|Withdrawal by Subject|0|||
146250396|NCT01730118|527429186|FG002|Dose Escalation|Withdrawal by Subject|1|||
146250397|NCT01730118|527429187|FG003|Dose Escalation|Withdrawal by Subject|0|||
146250398|NCT01730118|527429188|FG004|Dose Escalation|Withdrawal by Subject|0|||
146250399|NCT01730118|527429189|FG005|Dose Escalation|Withdrawal by Subject|0|||
146250400|NCT01730118|527429190|FG006|Dose Escalation|Withdrawal by Subject|0|||
146250401|NCT01730118|527429184|FG000|Dose Escalation|Disease progression prior to treatment|0|||
146250402|NCT01730118|527429185|FG001|Dose Escalation|Disease progression prior to treatment|0|||
146250403|NCT01730118|527429186|FG002|Dose Escalation|Disease progression prior to treatment|0|||
146250404|NCT01730118|527429187|FG003|Dose Escalation|Disease progression prior to treatment|0|||
146250405|NCT01730118|527429188|FG004|Dose Escalation|Disease progression prior to treatment|0|||
146250406|NCT01730118|527429189|FG005|Dose Escalation|Disease progression prior to treatment|0|||
146250407|NCT01730118|527429190|FG006|Dose Escalation|Disease progression prior to treatment|1|||
146250408|NCT01730118|527429184|FG000|Dose Expansion|Death|0|||
146250409|NCT01730118|527429185|FG001|Dose Expansion|Death|0|||
146250410|NCT01730118|527429186|FG002|Dose Expansion|Death|0|||
146250411|NCT01730118|527429187|FG003|Dose Expansion|Death|0|||
146250412|NCT01730118|527429188|FG004|Dose Expansion|Death|1|||
146250413|NCT01730118|527429189|FG005|Dose Expansion|Death|0|||
146250414|NCT01730118|527429190|FG006|Dose Expansion|Death|0|||
146250415|NCT01730118|527429184|FG000|Dose Expansion|Other medical condition|0|||
146250416|NCT01730118|527429185|FG001|Dose Expansion|Other medical condition|0|||
146250417|NCT01730118|527429186|FG002|Dose Expansion|Other medical condition|0|||
146250418|NCT01730118|527429187|FG003|Dose Expansion|Other medical condition|0|||
146250419|NCT01730118|527429188|FG004|Dose Expansion|Other medical condition|1|||
146014888|NCT00964002|526564133|FG000|Overall Study|Protocol Violation|8|||
146014889|NCT00976716|526564139|FG000|Overall Study|Adverse Event|1|||
146014890|NCT04222699|526564140|FG000|Overall Study|Lost to Follow-up|2|||
146093586|NCT00739596|526863494|FG001|Overall Study|Adverse Event|6|||
146014891|NCT03583359|526564146|FG000|Overall Study|Withdrawal by Subject|15|||
146014892|NCT03583359|526564147|FG001|Overall Study|Withdrawal by Subject|6|||
146014893|NCT03583359|526564146|FG000|Overall Study|Lost to Follow-up|12|||
146014894|NCT03583359|526564147|FG001|Overall Study|Lost to Follow-up|3|||
146014895|NCT03583359|526564146|FG000|Overall Study|Adverse Event|0|||
146014896|NCT03583359|526564147|FG001|Overall Study|Adverse Event|1|||
146014897|NCT03583359|526564146|FG000|Overall Study|Protocol Violation|0|||
146014898|NCT03583359|526564147|FG001|Overall Study|Protocol Violation|1|||
146014899|NCT03583359|526564146|FG000|Overall Study|Other|2|||
146014900|NCT03583359|526564147|FG001|Overall Study|Other|1|||
146014901|NCT00703846|526564153|FG000|Overall Study|Adverse Event|8|||
146014902|NCT00703846|526564153|FG000|Overall Study|Lost to Follow-up|55|||
146014903|NCT00703846|526564153|FG000|Overall Study|Lack of Efficacy|15|||
146014904|NCT00703846|526564153|FG000|Overall Study|Noncompliance with Study Treatment|2|||
146014905|NCT00703846|526564153|FG000|Overall Study|Withdrawal by Subject|40|||
146014906|NCT00703846|526564153|FG000|Overall Study|Death|1|||
146014907|NCT00703846|526564153|FG000|Overall Study|Other|14|||
146014908|NCT00703846|526564153|FG000|Overall Study|Did Not Receive Study Drug|2|||
146014909|NCT04601532|526564154|FG000|Overall Study|Lost to Follow-up|1|||
146014910|NCT04601532|526564155|FG001|Overall Study|Lost to Follow-up|2|||
146014911|NCT04601532|526564154|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
146014912|NCT04601532|526564155|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
146014913|NCT02566785|526564156|FG000|Overall Study|Lost to Follow-up|0|||
146014914|NCT02566785|526564157|FG001|Overall Study|Lost to Follow-up|2|||
146014915|NCT02566785|526564156|FG000|Overall Study|Worsening condition|1|||
146014916|NCT02566785|526564157|FG001|Overall Study|Worsening condition|1|||
146014917|NCT00837161|526564160|FG000|Overall Study|refused hysterectomy|2|||
146014918|NCT01659996|526564161|FG000|Overall Study|Protocol Violation|3|||
146014919|NCT01659996|526564162|FG001|Overall Study|Protocol Violation|3|||
146014920|NCT01659996|526564163|FG002|Overall Study|Protocol Violation|3|||
146014921|NCT01659996|526564161|FG000|Overall Study|Lost to Follow-up|1|||
146014922|NCT01659996|526564162|FG001|Overall Study|Lost to Follow-up|3|||
146014923|NCT01659996|526564163|FG002|Overall Study|Lost to Follow-up|2|||
146014924|NCT01659996|526564161|FG000|Overall Study|Adverse Event|0|||
146014925|NCT01659996|526564162|FG001|Overall Study|Adverse Event|0|||
146014926|NCT01659996|526564163|FG002|Overall Study|Adverse Event|1|||
146014927|NCT01659996|526564161|FG000|Overall Study|Withdrawal by Subject|4|||
146014928|NCT01659996|526564162|FG001|Overall Study|Withdrawal by Subject|1|||
146014929|NCT01659996|526564163|FG002|Overall Study|Withdrawal by Subject|5|||
146014930|NCT03206918|526564164|FG000|Overall Study|Death|11|||
146014931|NCT03206918|526564164|FG000|Overall Study|Withdrawal by Subject|5|||
146014932|NCT03206918|526564164|FG000|Overall Study|Study terminated by sponsor|12|||
146014933|NCT03206918|526564164|FG000|Overall Study|Lost to Follow-up|3|||
146014934|NCT03206918|526564164|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
146014935|NCT02701764|526564165|FG000|Overall Study|Lost to Follow-up|0|||
146014936|NCT02701764|526564166|FG001|Overall Study|Lost to Follow-up|1|||
146014937|NCT03823287|526564167|FG000|Overall Study|Withdrawal by Subject|25|||
146014938|NCT03823287|526564168|FG001|Overall Study|Withdrawal by Subject|17|||
146014939|NCT03823287|526564167|FG000|Overall Study|Death|13|||
146014940|NCT03823287|526564168|FG001|Overall Study|Death|7|||
146014941|NCT03823287|526564167|FG000|Overall Study|Lost to Follow-up|7|||
146014942|NCT03823287|526564168|FG001|Overall Study|Lost to Follow-up|8|||
146014943|NCT03823287|526564167|FG000|Overall Study|Adverse Event|6|||
146014944|NCT03823287|526564168|FG001|Overall Study|Adverse Event|8|||
146014945|NCT03823287|526564167|FG000|Overall Study|Physician Decision|5|||
146014946|NCT03823287|526564168|FG001|Overall Study|Physician Decision|2|||
146014947|NCT03823287|526564167|FG000|Overall Study|Lack of Efficacy|2|||
146014948|NCT03823287|526564168|FG001|Overall Study|Lack of Efficacy|0|||
146014949|NCT03823287|526564167|FG000|Overall Study|Other|2|||
146014950|NCT03823287|526564168|FG001|Overall Study|Other|4|||
146014951|NCT00782171|526566051|FG000|Overall Study|Lost to Follow-up|2|||
146014952|NCT00782171|526566052|FG001|Overall Study|Lost to Follow-up|2|||
146093587|NCT00739596|526863493|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
146093588|NCT00739596|526863494|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146014953|NCT00782171|526566051|FG000|Overall Study|Withdrawal by Subject|2|||
146014954|NCT00782171|526566052|FG001|Overall Study|Withdrawal by Subject|1|||
146014955|NCT00782171|526566051|FG000|Overall Study|complications|3|||
146093589|NCT00739596|526863493|FG000|Overall Study|Patient Withdrew Consent|8|||
146093590|NCT00739596|526863494|FG001|Overall Study|Patient Withdrew Consent|8|||
146014956|NCT00782171|526566052|FG001|Overall Study|complications|1|||
146014957|NCT00782171|526566051|FG000|Overall Study|others|7|||
146014958|NCT00782171|526566052|FG001|Overall Study|others|9|||
146014959|NCT00782171|526566051|FG000|Overall Study|not eligible|8|||
146014960|NCT00782171|526566052|FG001|Overall Study|not eligible|6|||
146014961|NCT03522246|526566055|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
146014962|NCT03522246|526566056|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
146014963|NCT03522246|526566057|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
146014964|NCT03522246|526566058|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
146014965|NCT03522246|526566059|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
146014966|NCT00489424|526566062|FG000|Overall Study|Adverse Event|3|||
146014967|NCT00489424|526566063|FG001|Overall Study|Adverse Event|3|||
146014968|NCT00489424|526566064|FG002|Overall Study|Adverse Event|4|||
146014969|NCT00489424|526566062|FG000|Overall Study|Lack of Efficacy|1|||
146014970|NCT00489424|526566063|FG001|Overall Study|Lack of Efficacy|0|||
146014971|NCT00489424|526566064|FG002|Overall Study|Lack of Efficacy|0|||
146014972|NCT00489424|526566062|FG000|Overall Study|Administrative problems|0|||
146014973|NCT00489424|526566063|FG001|Overall Study|Administrative problems|2|||
146014974|NCT00489424|526566064|FG002|Overall Study|Administrative problems|1|||
146014975|NCT01436656|526566065|FG000|Dose Escalation|Death|1|||
146014976|NCT01436656|526566066|FG001|Dose Escalation|Death|3|||
146014977|NCT01436656|526566067|FG002|Dose Escalation|Death|1|||
146014978|NCT01436656|526566068|FG003|Dose Escalation|Death|0|||
146014979|NCT01436656|526566069|FG004|Dose Escalation|Death|2|||
146014980|NCT01436656|526566070|FG005|Dose Escalation|Death|1|||
146014981|NCT01436656|526566071|FG006|Dose Escalation|Death|1|||
146014982|NCT01436656|526566072|FG007|Dose Escalation|Death|1|||
146014983|NCT01436656|526566073|FG008|Dose Escalation|Death|1|||
146014984|NCT01436656|526566074|FG009|Dose Escalation|Death|0|||
146014985|NCT01436656|526566075|FG010|Dose Escalation|Death|0|||
146014986|NCT01436656|526566076|FG011|Dose Escalation|Death|0|||
146014987|NCT01436656|526566077|FG012|Dose Escalation|Death|0|||
146014988|NCT01436656|526566078|FG013|Dose Escalation|Death|0|||
146014989|NCT01436656|526566079|FG014|Dose Escalation|Death|0|||
146014990|NCT01436656|526566080|FG015|Dose Escalation|Death|0|||
146014991|NCT01436656|526566081|FG016|Dose Escalation|Death|0|||
146014992|NCT01436656|526566082|FG017|Dose Escalation|Death|0|||
146014993|NCT01436656|526566065|FG000|Dose Escalation|Protocol Violation|0|||
146014994|NCT01436656|526566066|FG001|Dose Escalation|Protocol Violation|0|||
146014995|NCT01436656|526566067|FG002|Dose Escalation|Protocol Violation|0|||
146014996|NCT01436656|526566068|FG003|Dose Escalation|Protocol Violation|0|||
146014997|NCT01436656|526566069|FG004|Dose Escalation|Protocol Violation|0|||
146014998|NCT01436656|526566070|FG005|Dose Escalation|Protocol Violation|1|||
146014999|NCT01436656|526566071|FG006|Dose Escalation|Protocol Violation|0|||
146015000|NCT01436656|526566072|FG007|Dose Escalation|Protocol Violation|0|||
146015001|NCT01436656|526566073|FG008|Dose Escalation|Protocol Violation|0|||
146015002|NCT01436656|526566074|FG009|Dose Escalation|Protocol Violation|0|||
146015003|NCT01436656|526566075|FG010|Dose Escalation|Protocol Violation|0|||
146015004|NCT01436656|526566076|FG011|Dose Escalation|Protocol Violation|0|||
146015005|NCT01436656|526566077|FG012|Dose Escalation|Protocol Violation|0|||
146015006|NCT01436656|526566078|FG013|Dose Escalation|Protocol Violation|0|||
146015007|NCT01436656|526566079|FG014|Dose Escalation|Protocol Violation|0|||
146015008|NCT01436656|526566080|FG015|Dose Escalation|Protocol Violation|0|||
146015009|NCT01436656|526566081|FG016|Dose Escalation|Protocol Violation|0|||
146015010|NCT01436656|526566082|FG017|Dose Escalation|Protocol Violation|0|||
146015011|NCT01436656|526566065|FG000|Dose Escalation|Withdrawal by Subject|0|||
146015012|NCT01436656|526566066|FG001|Dose Escalation|Withdrawal by Subject|0|||
146015013|NCT01436656|526566067|FG002|Dose Escalation|Withdrawal by Subject|0|||
146015014|NCT01436656|526566068|FG003|Dose Escalation|Withdrawal by Subject|0|||
146015015|NCT01436656|526566069|FG004|Dose Escalation|Withdrawal by Subject|1|||
146015016|NCT01436656|526566070|FG005|Dose Escalation|Withdrawal by Subject|0|||
146015017|NCT01436656|526566071|FG006|Dose Escalation|Withdrawal by Subject|0|||
146015018|NCT01436656|526566072|FG007|Dose Escalation|Withdrawal by Subject|2|||
146015019|NCT01436656|526566073|FG008|Dose Escalation|Withdrawal by Subject|0|||
146015020|NCT01436656|526566074|FG009|Dose Escalation|Withdrawal by Subject|1|||
146015021|NCT01436656|526566075|FG010|Dose Escalation|Withdrawal by Subject|1|||
146015022|NCT01436656|526566076|FG011|Dose Escalation|Withdrawal by Subject|0|||
146015023|NCT01436656|526566077|FG012|Dose Escalation|Withdrawal by Subject|0|||
146015024|NCT01436656|526566078|FG013|Dose Escalation|Withdrawal by Subject|0|||
146015025|NCT01436656|526566079|FG014|Dose Escalation|Withdrawal by Subject|0|||
146015026|NCT01436656|526566080|FG015|Dose Escalation|Withdrawal by Subject|0|||
146015027|NCT01436656|526566081|FG016|Dose Escalation|Withdrawal by Subject|0|||
146015028|NCT01436656|526566082|FG017|Dose Escalation|Withdrawal by Subject|0|||
146015029|NCT01436656|526566065|FG000|Dose Escalation|Administrative problems|0|||
146015030|NCT01436656|526566066|FG001|Dose Escalation|Administrative problems|1|||
146015031|NCT01436656|526566067|FG002|Dose Escalation|Administrative problems|0|||
146015032|NCT01436656|526566068|FG003|Dose Escalation|Administrative problems|0|||
146015033|NCT01436656|526566069|FG004|Dose Escalation|Administrative problems|0|||
146015034|NCT01436656|526566070|FG005|Dose Escalation|Administrative problems|0|||
146015035|NCT01436656|526566071|FG006|Dose Escalation|Administrative problems|0|||
146015036|NCT01436656|526566072|FG007|Dose Escalation|Administrative problems|0|||
146015037|NCT01436656|526566073|FG008|Dose Escalation|Administrative problems|0|||
146015038|NCT01436656|526566074|FG009|Dose Escalation|Administrative problems|0|||
146015039|NCT01436656|526566075|FG010|Dose Escalation|Administrative problems|0|||
146015040|NCT01436656|526566076|FG011|Dose Escalation|Administrative problems|0|||
146015041|NCT01436656|526566077|FG012|Dose Escalation|Administrative problems|0|||
146015042|NCT01436656|526566078|FG013|Dose Escalation|Administrative problems|0|||
146299617|NCT02742766|527611803|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299618|NCT02742766|527611804|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299619|NCT02742766|527611805|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299620|NCT02742766|527611806|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299621|NCT02742766|527611807|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299622|NCT02742766|527611808|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299623|NCT02742766|527611809|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299624|NCT02742766|527611810|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299625|NCT02742766|527611811|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
146299626|NCT02742766|527611812|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299627|NCT02742766|527611813|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299628|NCT02742766|527611814|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299629|NCT02742766|527611815|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299630|NCT02742766|527611816|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
146299631|NCT02742766|527611798|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299632|NCT02742766|527611799|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299633|NCT02742766|527611800|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
146015043|NCT01436656|526566079|FG014|Dose Escalation|Administrative problems|0|||
146015044|NCT01436656|526566080|FG015|Dose Escalation|Administrative problems|0|||
146015045|NCT01436656|526566081|FG016|Dose Escalation|Administrative problems|0|||
146015046|NCT01436656|526566082|FG017|Dose Escalation|Administrative problems|0|||
146015047|NCT01436656|526566065|FG000|Dose Escalation|Lost to Follow-up|1|||
146015048|NCT01436656|526566066|FG001|Dose Escalation|Lost to Follow-up|0|||
146015049|NCT01436656|526566067|FG002|Dose Escalation|Lost to Follow-up|0|||
146015050|NCT01436656|526566068|FG003|Dose Escalation|Lost to Follow-up|0|||
146015051|NCT01436656|526566069|FG004|Dose Escalation|Lost to Follow-up|1|||
146015052|NCT01436656|526566070|FG005|Dose Escalation|Lost to Follow-up|0|||
146015053|NCT01436656|526566071|FG006|Dose Escalation|Lost to Follow-up|0|||
146015054|NCT01436656|526566072|FG007|Dose Escalation|Lost to Follow-up|0|||
146015055|NCT01436656|526566073|FG008|Dose Escalation|Lost to Follow-up|0|||
146015056|NCT01436656|526566074|FG009|Dose Escalation|Lost to Follow-up|0|||
146015057|NCT01436656|526566075|FG010|Dose Escalation|Lost to Follow-up|0|||
146015058|NCT01436656|526566076|FG011|Dose Escalation|Lost to Follow-up|0|||
146015059|NCT01436656|526566077|FG012|Dose Escalation|Lost to Follow-up|0|||
146015060|NCT01436656|526566078|FG013|Dose Escalation|Lost to Follow-up|0|||
146015061|NCT01436656|526566079|FG014|Dose Escalation|Lost to Follow-up|0|||
146015062|NCT01436656|526566080|FG015|Dose Escalation|Lost to Follow-up|0|||
146015063|NCT01436656|526566081|FG016|Dose Escalation|Lost to Follow-up|0|||
146015064|NCT01436656|526566082|FG017|Dose Escalation|Lost to Follow-up|0|||
146015065|NCT01436656|526566065|FG000|Dose Escalation|New anti-cancer therapy|1|||
146015066|NCT01436656|526566066|FG001|Dose Escalation|New anti-cancer therapy|0|||
146015067|NCT01436656|526566067|FG002|Dose Escalation|New anti-cancer therapy|0|||
146015068|NCT01436656|526566068|FG003|Dose Escalation|New anti-cancer therapy|0|||
146015069|NCT01436656|526566069|FG004|Dose Escalation|New anti-cancer therapy|0|||
146015070|NCT01436656|526566070|FG005|Dose Escalation|New anti-cancer therapy|0|||
146015071|NCT01436656|526566071|FG006|Dose Escalation|New anti-cancer therapy|0|||
146015072|NCT01436656|526566072|FG007|Dose Escalation|New anti-cancer therapy|0|||
146015073|NCT01436656|526566073|FG008|Dose Escalation|New anti-cancer therapy|1|||
146015074|NCT01436656|526566074|FG009|Dose Escalation|New anti-cancer therapy|1|||
146015075|NCT01436656|526566075|FG010|Dose Escalation|New anti-cancer therapy|0|||
146015076|NCT01436656|526566076|FG011|Dose Escalation|New anti-cancer therapy|0|||
146015077|NCT01436656|526566077|FG012|Dose Escalation|New anti-cancer therapy|0|||
146015078|NCT01436656|526566078|FG013|Dose Escalation|New anti-cancer therapy|0|||
146015079|NCT01436656|526566079|FG014|Dose Escalation|New anti-cancer therapy|0|||
146015080|NCT01436656|526566080|FG015|Dose Escalation|New anti-cancer therapy|0|||
146015081|NCT01436656|526566081|FG016|Dose Escalation|New anti-cancer therapy|0|||
146015082|NCT01436656|526566082|FG017|Dose Escalation|New anti-cancer therapy|0|||
146015083|NCT01436656|526566065|FG000|Dose Expansion|Adverse Event|0|||
146015084|NCT01436656|526566066|FG001|Dose Expansion|Adverse Event|0|||
146299634|NCT02742766|527611801|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299635|NCT02742766|527611802|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299636|NCT02742766|527611803|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
146015085|NCT01436656|526566067|FG002|Dose Expansion|Adverse Event|0|||
146015086|NCT01436656|526566068|FG003|Dose Expansion|Adverse Event|0|||
146015087|NCT01436656|526566069|FG004|Dose Expansion|Adverse Event|0|||
146015088|NCT01436656|526566070|FG005|Dose Expansion|Adverse Event|0|||
146015089|NCT01436656|526566071|FG006|Dose Expansion|Adverse Event|0|||
146015090|NCT01436656|526566072|FG007|Dose Expansion|Adverse Event|0|||
146299637|NCT02742766|527611804|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
146015091|NCT01436656|526566073|FG008|Dose Expansion|Adverse Event|0|||
146015092|NCT01436656|526566074|FG009|Dose Expansion|Adverse Event|0|||
146015093|NCT01436656|526566075|FG010|Dose Expansion|Adverse Event|0|||
146015094|NCT01436656|526566076|FG011|Dose Expansion|Adverse Event|1|||
146015095|NCT01436656|526566077|FG012|Dose Expansion|Adverse Event|0|||
146015096|NCT01436656|526566078|FG013|Dose Expansion|Adverse Event|0|||
146015097|NCT01436656|526566079|FG014|Dose Expansion|Adverse Event|0|||
146250420|NCT01730118|527429189|FG005|Dose Expansion|Other medical condition|0|||
146250421|NCT01730118|527429190|FG006|Dose Expansion|Other medical condition|0|||
146250422|NCT01730118|527429184|FG000|Dose Expansion|Withdrawal by Subject|0|||
146250423|NCT01730118|527429185|FG001|Dose Expansion|Withdrawal by Subject|0|||
146250424|NCT01730118|527429186|FG002|Dose Expansion|Withdrawal by Subject|0|||
146250425|NCT01730118|527429187|FG003|Dose Expansion|Withdrawal by Subject|0|||
146250426|NCT01730118|527429188|FG004|Dose Expansion|Withdrawal by Subject|1|||
146250427|NCT01730118|527429189|FG005|Dose Expansion|Withdrawal by Subject|0|||
146250428|NCT01730118|527429190|FG006|Dose Expansion|Withdrawal by Subject|0|||
146250429|NCT01730118|527429184|FG000|Dose Expansion|Disease progression|0|||
146250430|NCT01730118|527429185|FG001|Dose Expansion|Disease progression|0|||
146250431|NCT01730118|527429186|FG002|Dose Expansion|Disease progression|0|||
146250432|NCT01730118|527429187|FG003|Dose Expansion|Disease progression|0|||
146250433|NCT01730118|527429188|FG004|Dose Expansion|Disease progression|0|||
146015098|NCT01436656|526566080|FG015|Dose Expansion|Adverse Event|0|||
146015099|NCT01436656|526566081|FG016|Dose Expansion|Adverse Event|0|||
146015100|NCT01436656|526566082|FG017|Dose Expansion|Adverse Event|0|||
146015101|NCT01436656|526566065|FG000|Dose Expansion|Withdrawal by Subject|0|||
146015102|NCT01436656|526566066|FG001|Dose Expansion|Withdrawal by Subject|0|||
146015103|NCT01436656|526566067|FG002|Dose Expansion|Withdrawal by Subject|0|||
146015104|NCT01436656|526566068|FG003|Dose Expansion|Withdrawal by Subject|0|||
146015105|NCT01436656|526566069|FG004|Dose Expansion|Withdrawal by Subject|0|||
146015106|NCT01436656|526566070|FG005|Dose Expansion|Withdrawal by Subject|0|||
146015107|NCT01436656|526566071|FG006|Dose Expansion|Withdrawal by Subject|0|||
146015108|NCT01436656|526566072|FG007|Dose Expansion|Withdrawal by Subject|0|||
146015109|NCT01436656|526566073|FG008|Dose Expansion|Withdrawal by Subject|0|||
146015110|NCT01436656|526566074|FG009|Dose Expansion|Withdrawal by Subject|0|||
146015111|NCT01436656|526566075|FG010|Dose Expansion|Withdrawal by Subject|0|||
146015112|NCT01436656|526566076|FG011|Dose Expansion|Withdrawal by Subject|1|||
146015113|NCT01436656|526566077|FG012|Dose Expansion|Withdrawal by Subject|3|||
146015114|NCT01436656|526566078|FG013|Dose Expansion|Withdrawal by Subject|1|||
146015115|NCT01436656|526566079|FG014|Dose Expansion|Withdrawal by Subject|2|||
146015116|NCT01436656|526566080|FG015|Dose Expansion|Withdrawal by Subject|0|||
146015117|NCT01436656|526566081|FG016|Dose Expansion|Withdrawal by Subject|1|||
146015118|NCT01436656|526566082|FG017|Dose Expansion|Withdrawal by Subject|1|||
146015119|NCT01436656|526566065|FG000|Dose Expansion|Death|0|||
146015120|NCT01436656|526566066|FG001|Dose Expansion|Death|0|||
146015121|NCT01436656|526566067|FG002|Dose Expansion|Death|0|||
146015122|NCT01436656|526566068|FG003|Dose Expansion|Death|0|||
145939163|NCT02122770|526285848|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145939164|NCT02122770|526285849|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
145939165|NCT02122770|526285850|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145939166|NCT02122770|526285851|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145939167|NCT02122770|526285852|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145939168|NCT02122770|526285853|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145939169|NCT02122770|526285848|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
145939170|NCT02122770|526285849|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
146015123|NCT01436656|526566069|FG004|Dose Expansion|Death|0|||
146015124|NCT01436656|526566070|FG005|Dose Expansion|Death|0|||
146015125|NCT01436656|526566071|FG006|Dose Expansion|Death|0|||
146015126|NCT01436656|526566072|FG007|Dose Expansion|Death|0|||
146015127|NCT01436656|526566073|FG008|Dose Expansion|Death|0|||
146015128|NCT01436656|526566074|FG009|Dose Expansion|Death|0|||
146015129|NCT01436656|526566075|FG010|Dose Expansion|Death|0|||
146015130|NCT01436656|526566076|FG011|Dose Expansion|Death|0|||
146015131|NCT01436656|526566077|FG012|Dose Expansion|Death|1|||
146015132|NCT01436656|526566078|FG013|Dose Expansion|Death|0|||
146015133|NCT01436656|526566079|FG014|Dose Expansion|Death|3|||
146015134|NCT01436656|526566080|FG015|Dose Expansion|Death|0|||
146015135|NCT01436656|526566081|FG016|Dose Expansion|Death|3|||
146015136|NCT01436656|526566082|FG017|Dose Expansion|Death|3|||
146250434|NCT01730118|527429189|FG005|Dose Expansion|Disease progression|1|||
146250435|NCT01730118|527429190|FG006|Dose Expansion|Disease progression|0|||
146250436|NCT01730118|527429184|FG000|Dose Expansion|Inability to return|0|||
146250437|NCT01730118|527429185|FG001|Dose Expansion|Inability to return|0|||
146299638|NCT02742766|527611805|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299639|NCT02742766|527611806|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
146015137|NCT01436656|526566065|FG000|Dose Expansion|Lost to Follow-up|0|||
146015138|NCT01436656|526566066|FG001|Dose Expansion|Lost to Follow-up|0|||
146015139|NCT01436656|526566067|FG002|Dose Expansion|Lost to Follow-up|0|||
146015140|NCT01436656|526566068|FG003|Dose Expansion|Lost to Follow-up|0|||
146015141|NCT01436656|526566069|FG004|Dose Expansion|Lost to Follow-up|0|||
146015142|NCT01436656|526566070|FG005|Dose Expansion|Lost to Follow-up|0|||
146015143|NCT01436656|526566071|FG006|Dose Expansion|Lost to Follow-up|0|||
146015144|NCT01436656|526566072|FG007|Dose Expansion|Lost to Follow-up|0|||
146015145|NCT01436656|526566073|FG008|Dose Expansion|Lost to Follow-up|0|||
146015146|NCT01436656|526566074|FG009|Dose Expansion|Lost to Follow-up|0|||
146299640|NCT02742766|527611807|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299641|NCT02742766|527611808|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299642|NCT02742766|527611809|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299643|NCT02742766|527611810|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
146299644|NCT02742766|527611811|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
146299645|NCT02742766|527611812|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299646|NCT02742766|527611813|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
146299647|NCT02742766|527611814|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299648|NCT02742766|527611815|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299649|NCT02742766|527611816|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
146299650|NCT00999713|527611817|FG000|Overall Study|Physician Decision|2|||
146299651|NCT00999713|527611818|FG001|Overall Study|Physician Decision|0|||
146299652|NCT01840605|527611821|FG000|Overall Study|Adverse Event|0|||
146299653|NCT01840605|527611822|FG001|Overall Study|Adverse Event|1|||
146299654|NCT01840605|527611821|FG000|Overall Study|Physician Decision|2|||
146299655|NCT01840605|527611822|FG001|Overall Study|Physician Decision|1|||
146299656|NCT03739437|527611823|FG000|Overall Study|Lost to Follow-up|2|||
146299657|NCT03739437|527611824|FG001|Overall Study|Lost to Follow-up|5|||
146299658|NCT01351623|527611826|FG000|Overall Study|Protocol Violation|2|||
146299659|NCT01351623|527611826|FG000|Overall Study|Adverse Event|4|||
146299660|NCT01351623|527611826|FG000|Overall Study|Withdrawal by Subject|1|||
146299661|NCT01351623|527611826|FG000|Overall Study|Death|2|||
146299662|NCT05390580|527611834|FG000|Overall Study|Physician Decision|3|||
146299663|NCT05390580|527611835|FG001|Overall Study|Physician Decision|2|||
146299664|NCT04014361|527611836|FG000|Period 2|Physician Decision|0|||
146299665|NCT04014361|527611837|FG001|Period 2|Physician Decision|0|||
146299666|NCT04014361|527611838|FG002|Period 2|Physician Decision|0|||
146299667|NCT04014361|527611839|FG003|Period 2|Physician Decision|1|||
146299668|NCT04014361|527611840|FG004|Period 2|Physician Decision|0|||
146299669|NCT04014361|527611841|FG005|Period 2|Physician Decision|0|||
146299670|NCT04014361|527611842|FG006|Period 2|Physician Decision|0|||
146299671|NCT04014361|527611843|FG007|Period 2|Physician Decision|0|||
146299672|NCT01130051|527611845|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
146299673|NCT01130051|527611846|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
146299674|NCT01130051|527611845|FG000|Washout Period of 14 Days|Protocol Violation|1|||
146299675|NCT01130051|527611846|FG001|Washout Period of 14 Days|Protocol Violation|1|||
146299676|NCT01298518|527611849|FG000|Overall Study|Withdrawal by Subject|0|||
146299677|NCT01298518|527611850|FG001|Overall Study|Withdrawal by Subject|0|||
146299678|NCT01298518|527611851|FG002|Overall Study|Withdrawal by Subject|1|||
146299679|NCT03610165|527611852|FG000|Overall Study|Device didn't work|0|||
146299680|NCT03610165|527611853|FG001|Overall Study|Device didn't work|1|||
146299681|NCT02129205|527611854|FG000|Overall Study|Withdrawal by Subject|0|||
146299682|NCT02129205|527611855|FG001|Overall Study|Withdrawal by Subject|0|||
146299683|NCT02129205|527611856|FG002|Overall Study|Withdrawal by Subject|0|||
146299684|NCT02129205|527611857|FG003|Overall Study|Withdrawal by Subject|0|||
146299685|NCT02129205|527611858|FG004|Overall Study|Withdrawal by Subject|1|||
146299686|NCT02129205|527611859|FG005|Overall Study|Withdrawal by Subject|1|||
146299687|NCT02129205|527611860|FG006|Overall Study|Withdrawal by Subject|1|||
146299688|NCT02129205|527611861|FG007|Overall Study|Withdrawal by Subject|0|||
146299689|NCT02129205|527611862|FG008|Overall Study|Withdrawal by Subject|1|||
146299690|NCT02129205|527611863|FG009|Overall Study|Withdrawal by Subject|0|||
146299691|NCT02129205|527611854|FG000|Overall Study|Other|1|||
146299692|NCT02129205|527611855|FG001|Overall Study|Other|0|||
146299693|NCT02129205|527611856|FG002|Overall Study|Other|0|||
146299694|NCT02129205|527611857|FG003|Overall Study|Other|0|||
146299695|NCT02129205|527611858|FG004|Overall Study|Other|2|||
146299696|NCT02129205|527611859|FG005|Overall Study|Other|3|||
146299697|NCT02129205|527611860|FG006|Overall Study|Other|3|||
146299698|NCT02129205|527611861|FG007|Overall Study|Other|2|||
146299699|NCT02129205|527611862|FG008|Overall Study|Other|1|||
146299700|NCT02129205|527611863|FG009|Overall Study|Other|0|||
146299701|NCT04435782|527611867|FG000|Overall Study|Study terminated by sponsor|4|||
146299702|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
146299703|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
146299704|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
146299705|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
146299706|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
146299707|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
145939171|NCT02122770|526285850|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
146299708|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
146299709|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
146299710|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
145939172|NCT02122770|526285851|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
145939173|NCT02122770|526285852|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
146299711|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
146015147|NCT01436656|526566075|FG010|Dose Expansion|Lost to Follow-up|0|||
146015148|NCT01436656|526566076|FG011|Dose Expansion|Lost to Follow-up|0|||
146015149|NCT01436656|526566077|FG012|Dose Expansion|Lost to Follow-up|0|||
146015150|NCT01436656|526566078|FG013|Dose Expansion|Lost to Follow-up|0|||
146015151|NCT01436656|526566079|FG014|Dose Expansion|Lost to Follow-up|0|||
146015152|NCT01436656|526566080|FG015|Dose Expansion|Lost to Follow-up|0|||
146015153|NCT01436656|526566081|FG016|Dose Expansion|Lost to Follow-up|0|||
146015154|NCT01436656|526566082|FG017|Dose Expansion|Lost to Follow-up|3|||
146015155|NCT01436656|526566065|FG000|Dose Expansion|Disease progression|0|||
146015156|NCT01436656|526566066|FG001|Dose Expansion|Disease progression|0|||
146015157|NCT01436656|526566067|FG002|Dose Expansion|Disease progression|0|||
146015158|NCT01436656|526566068|FG003|Dose Expansion|Disease progression|0|||
146015159|NCT01436656|526566069|FG004|Dose Expansion|Disease progression|0|||
146015160|NCT01436656|526566070|FG005|Dose Expansion|Disease progression|0|||
146015161|NCT01436656|526566071|FG006|Dose Expansion|Disease progression|0|||
146015162|NCT01436656|526566072|FG007|Dose Expansion|Disease progression|0|||
146015163|NCT01436656|526566073|FG008|Dose Expansion|Disease progression|0|||
146015164|NCT01436656|526566074|FG009|Dose Expansion|Disease progression|0|||
146015165|NCT01436656|526566075|FG010|Dose Expansion|Disease progression|0|||
146015166|NCT01436656|526566076|FG011|Dose Expansion|Disease progression|3|||
146015167|NCT01436656|526566077|FG012|Dose Expansion|Disease progression|1|||
146015168|NCT01436656|526566078|FG013|Dose Expansion|Disease progression|0|||
146015169|NCT01436656|526566079|FG014|Dose Expansion|Disease progression|1|||
146015170|NCT01436656|526566080|FG015|Dose Expansion|Disease progression|0|||
146015171|NCT01436656|526566081|FG016|Dose Expansion|Disease progression|0|||
146015172|NCT01436656|526566082|FG017|Dose Expansion|Disease progression|1|||
146015173|NCT01436656|526566065|FG000|Dose Expansion|New cancer therapy|0|||
146015174|NCT01436656|526566066|FG001|Dose Expansion|New cancer therapy|0|||
146015175|NCT01436656|526566067|FG002|Dose Expansion|New cancer therapy|0|||
146015176|NCT01436656|526566068|FG003|Dose Expansion|New cancer therapy|0|||
146015177|NCT01436656|526566069|FG004|Dose Expansion|New cancer therapy|0|||
146015178|NCT01436656|526566070|FG005|Dose Expansion|New cancer therapy|0|||
146015179|NCT01436656|526566071|FG006|Dose Expansion|New cancer therapy|0|||
146015180|NCT01436656|526566072|FG007|Dose Expansion|New cancer therapy|0|||
146015181|NCT01436656|526566073|FG008|Dose Expansion|New cancer therapy|0|||
146015182|NCT01436656|526566074|FG009|Dose Expansion|New cancer therapy|0|||
146015183|NCT01436656|526566075|FG010|Dose Expansion|New cancer therapy|0|||
146015184|NCT01436656|526566076|FG011|Dose Expansion|New cancer therapy|1|||
146015185|NCT01436656|526566077|FG012|Dose Expansion|New cancer therapy|1|||
146015186|NCT01436656|526566078|FG013|Dose Expansion|New cancer therapy|0|||
146015187|NCT01436656|526566079|FG014|Dose Expansion|New cancer therapy|2|||
146015188|NCT01436656|526566080|FG015|Dose Expansion|New cancer therapy|0|||
146015189|NCT01436656|526566081|FG016|Dose Expansion|New cancer therapy|0|||
146015190|NCT01436656|526566082|FG017|Dose Expansion|New cancer therapy|0|||
145939174|NCT02122770|526285853|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
145939175|NCT02122770|526285848|FG000|Part B: Standard of Care|Adverse Event|0|||
145939176|NCT02122770|526285849|FG001|Part B: Standard of Care|Adverse Event|0|||
145939177|NCT02122770|526285850|FG002|Part B: Standard of Care|Adverse Event|0|||
145939178|NCT02122770|526285851|FG003|Part B: Standard of Care|Adverse Event|0|||
145939179|NCT02122770|526285852|FG004|Part B: Standard of Care|Adverse Event|4|||
145939180|NCT02122770|526285853|FG005|Part B: Standard of Care|Adverse Event|1|||
145939181|NCT02122770|526285848|FG000|Part B: Standard of Care|Other|0|||
145939182|NCT02122770|526285849|FG001|Part B: Standard of Care|Other|0|||
145939183|NCT02122770|526285850|FG002|Part B: Standard of Care|Other|0|||
145939184|NCT02122770|526285851|FG003|Part B: Standard of Care|Other|0|||
145939185|NCT02122770|526285852|FG004|Part B: Standard of Care|Other|0|||
145939186|NCT02122770|526285853|FG005|Part B: Standard of Care|Other|2|||
145939187|NCT02122770|526285848|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
145939188|NCT02122770|526285849|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
145939189|NCT02122770|526285850|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
145939190|NCT02122770|526285851|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
145939191|NCT02122770|526285852|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
145939192|NCT02122770|526285853|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
145939193|NCT02122770|526285848|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
145939194|NCT02122770|526285849|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
145939195|NCT02122770|526285850|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
145939196|NCT02122770|526285851|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
145939197|NCT02122770|526285852|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
145939198|NCT02122770|526285853|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
145939199|NCT02122770|526285848|FG000|Part B: Standard of Care|Progressive Disease|0|||
145939200|NCT02122770|526285849|FG001|Part B: Standard of Care|Progressive Disease|0|||
145939201|NCT02122770|526285850|FG002|Part B: Standard of Care|Progressive Disease|0|||
145939202|NCT02122770|526285851|FG003|Part B: Standard of Care|Progressive Disease|0|||
145939203|NCT02122770|526285852|FG004|Part B: Standard of Care|Progressive Disease|10|||
145939204|NCT02122770|526285853|FG005|Part B: Standard of Care|Progressive Disease|8|||
146015191|NCT00880269|526566083|FG000|Overall Study|Protocol Violation|1|||
146015192|NCT00880269|526566084|FG001|Overall Study|Protocol Violation|0|||
146015193|NCT00880269|526566083|FG000|Overall Study|Disease Progression|13|||
146015194|NCT00880269|526566084|FG001|Overall Study|Disease Progression|11|||
146015195|NCT00880269|526566083|FG000|Overall Study|New Cancer Therapy|1|||
146015196|NCT00880269|526566084|FG001|Overall Study|New Cancer Therapy|0|||
146015197|NCT00880269|526566083|FG000|Overall Study|Death|4|||
146015198|NCT00880269|526566084|FG001|Overall Study|Death|2|||
146015199|NCT00880269|526566083|FG000|Overall Study|Lost to Follow-up|0|||
146015200|NCT00880269|526566084|FG001|Overall Study|Lost to Follow-up|1|||
146015201|NCT00880269|526566083|FG000|Overall Study|Withdrawal by Subject|3|||
146015202|NCT00880269|526566084|FG001|Overall Study|Withdrawal by Subject|4|||
146015203|NCT00880269|526566083|FG000|Overall Study|Adverse Event|10|||
146015204|NCT00880269|526566084|FG001|Overall Study|Adverse Event|9|||
146015205|NCT04952597|526566088|FG000|Overall Study|Death|12|||
146015206|NCT04952597|526566089|FG001|Overall Study|Death|13|||
146015207|NCT04952597|526566090|FG002|Overall Study|Death|14|||
146015208|NCT04952597|526566088|FG000|Overall Study|Withdrawal by Subject|1|||
146015209|NCT04952597|526566089|FG001|Overall Study|Withdrawal by Subject|0|||
146015210|NCT04952597|526566090|FG002|Overall Study|Withdrawal by Subject|3|||
146015211|NCT04952597|526566088|FG000|Overall Study|Lost to Follow-up|0|||
146015212|NCT04952597|526566089|FG001|Overall Study|Lost to Follow-up|1|||
146015213|NCT04952597|526566090|FG002|Overall Study|Lost to Follow-up|1|||
146015214|NCT00022763|526566098|FG000|Overall Study|Adverse Event|1|||
146015215|NCT00022763|526566099|FG001|Overall Study|Adverse Event|2|||
146015216|NCT00022763|526566098|FG000|Overall Study|Injection Site Reactions|0|||
146015217|NCT00022763|526566099|FG001|Overall Study|Injection Site Reactions|2|||
146015218|NCT00022763|526566098|FG000|Overall Study|Death|0|||
146015219|NCT00022763|526566099|FG001|Overall Study|Death|1|||
146015220|NCT00022763|526566098|FG000|Overall Study|Lost to Follow-up|0|||
146015221|NCT00022763|526566099|FG001|Overall Study|Lost to Follow-up|3|||
146015222|NCT00022763|526566098|FG000|Overall Study|Withdrawal by Subject|4|||
146015223|NCT00022763|526566099|FG001|Overall Study|Withdrawal by Subject|7|||
146015224|NCT00022763|526566098|FG000|Overall Study|Insufficient Therapy|1|||
146015225|NCT00022763|526566099|FG001|Overall Study|Insufficient Therapy|0|||
146015226|NCT00022763|526566098|FG000|Overall Study|Admin|3|||
146015227|NCT00022763|526566099|FG001|Overall Study|Admin|2|||
146015228|NCT04908865|526566100|FG000|Overall Study|Adverse Event|2|||
146015229|NCT04908865|526566100|FG000|Overall Study|Lack of Efficacy|5|||
146015230|NCT04908865|526566100|FG000|Overall Study|Lost to Follow-up|1|||
146015231|NCT02141399|526566101|FG000|Overall Study|Adverse Event|158|||
146015232|NCT02141399|526566101|FG000|Overall Study|Lack of Efficacy|62|||
146015233|NCT02141399|526566101|FG000|Overall Study|Lost to Follow-up|151|||
146015234|NCT02141399|526566101|FG000|Overall Study|Non-compliance with study drug|18|||
146015235|NCT02141399|526566101|FG000|Overall Study|Other|45|||
146015236|NCT02141399|526566101|FG000|Overall Study|Physician Decision|17|||
146015237|NCT02141399|526566101|FG000|Overall Study|Pregnancy|3|||
146015238|NCT02141399|526566101|FG000|Overall Study|Protocol Violation|38|||
146015239|NCT02141399|526566101|FG000|Overall Study|Withdrawal by Subject|238|||
146015240|NCT02141399|526566101|FG000|Overall Study|Failure to meet eligibility criteria|14|||
146015241|NCT04445519|526566102|FG000|Overall Study|Due to adaptive design|3|||
146015242|NCT04445519|526566103|FG001|Overall Study|Due to adaptive design|0|||
146015243|NCT04445519|526566104|FG002|Overall Study|Due to adaptive design|0|||
146015244|NCT04445519|526566102|FG000|Overall Study|Lost to Follow-up|0|||
146015245|NCT04445519|526566103|FG001|Overall Study|Lost to Follow-up|1|||
146015246|NCT04445519|526566104|FG002|Overall Study|Lost to Follow-up|4|||
146015247|NCT04445519|526566102|FG000|Overall Study|Sponsor or IRB Decision|0|||
146015248|NCT04445519|526566103|FG001|Overall Study|Sponsor or IRB Decision|1|||
146015249|NCT04445519|526566104|FG002|Overall Study|Sponsor or IRB Decision|2|||
146093591|NCT00739596|526863493|FG000|Overall Study|Lost to Follow-up|0|||
146093592|NCT00739596|526863494|FG001|Overall Study|Lost to Follow-up|2|||
146093593|NCT00739596|526863493|FG000|Overall Study|Protocol Deviation|1|||
146015250|NCT04445519|526566102|FG000|Overall Study|Withdrawal by Subject|0|||
146015251|NCT04445519|526566103|FG001|Overall Study|Withdrawal by Subject|3|||
146093594|NCT00739596|526863494|FG001|Overall Study|Protocol Deviation|1|||
146015252|NCT04445519|526566104|FG002|Overall Study|Withdrawal by Subject|3|||
146015253|NCT04445519|526566102|FG000|Overall Study|Adverse Event|0|||
146015254|NCT04445519|526566103|FG001|Overall Study|Adverse Event|8|||
146015255|NCT04445519|526566104|FG002|Overall Study|Adverse Event|6|||
146015256|NCT04445519|526566102|FG000|Overall Study|Other Reason|0|||
146015257|NCT04445519|526566103|FG001|Overall Study|Other Reason|1|||
146015258|NCT04445519|526566104|FG002|Overall Study|Other Reason|1|||
146015259|NCT04445519|526566102|FG000|Overall Study|Protocol Violation|0|||
146015260|NCT04445519|526566103|FG001|Overall Study|Protocol Violation|0|||
146015261|NCT04445519|526566104|FG002|Overall Study|Protocol Violation|1|||
146015262|NCT01345929|526566105|FG000|Overall Study|Withdrawal by Subject|9|||
146015263|NCT01345929|526566106|FG001|Overall Study|Withdrawal by Subject|8|||
146093595|NCT02301988|526863498|FG000|Overall Study|Withdrawal by Subject|2|||
146015264|NCT01345929|526566105|FG000|Overall Study|Lost to Follow-up|9|||
146093596|NCT02301988|526863499|FG001|Overall Study|Withdrawal by Subject|1|||
146015265|NCT01345929|526566106|FG001|Overall Study|Lost to Follow-up|9|||
146015266|NCT01345929|526566105|FG000|Overall Study|Adverse Event|0|||
146015267|NCT01345929|526566106|FG001|Overall Study|Adverse Event|1|||
146015268|NCT01345929|526566105|FG000|Overall Study|Didn't meet eligibility criteria|2|||
146015269|NCT01345929|526566106|FG001|Overall Study|Didn't meet eligibility criteria|0|||
146015270|NCT01345929|526566105|FG000|Overall Study|40,000 CFU/ML|1|||
146015271|NCT01345929|526566106|FG001|Overall Study|40,000 CFU/ML|0|||
146015272|NCT01345929|526566105|FG000|Overall Study|Patient withdrawal|0|||
146015273|NCT01345929|526566106|FG001|Overall Study|Patient withdrawal|1|||
146015274|NCT02819297|526566111|FG000|Overall Study|Withdrawal by Subject|25|||
146015275|NCT02819297|526566112|FG001|Overall Study|Withdrawal by Subject|13|||
146015276|NCT02819297|526566111|FG000|Overall Study|Lost to Follow-up|12|||
146015277|NCT02819297|526566112|FG001|Overall Study|Lost to Follow-up|14|||
146015278|NCT02819297|526566111|FG000|Overall Study|Adverse Event|12|||
146015279|NCT02819297|526566112|FG001|Overall Study|Adverse Event|10|||
146015280|NCT02819297|526566111|FG000|Overall Study|Physician Decision|5|||
146015281|NCT02819297|526566112|FG001|Overall Study|Physician Decision|5|||
146015282|NCT02819297|526566111|FG000|Overall Study|Lack of Efficacy|5|||
146015283|NCT02819297|526566112|FG001|Overall Study|Lack of Efficacy|8|||
146015284|NCT02819297|526566111|FG000|Overall Study|Protocol Violation|1|||
146015285|NCT02819297|526566112|FG001|Overall Study|Protocol Violation|2|||
146015286|NCT02858440|526566113|FG000|Overall Study|Lost to Follow-up|3|||
146015287|NCT02858440|526566113|FG000|Overall Study|Protocol Violation|2|||
146015288|NCT02858440|526566113|FG000|Overall Study|Consent withdrawal|3|||
146015289|NCT02858440|526566113|FG000|Overall Study|Migrated/moved from study area|4|||
146015290|NCT01670279|526566114|FG000|Overall Study|Adverse Event|0|||
146015291|NCT01670279|526566115|FG001|Overall Study|Adverse Event|1|||
146015292|NCT01670279|526566116|FG002|Overall Study|Adverse Event|0|||
146015293|NCT01670279|526566117|FG003|Overall Study|Adverse Event|0|||
146015294|NCT01670279|526566114|FG000|Overall Study|Physician Decision|0|||
146015295|NCT01670279|526566115|FG001|Overall Study|Physician Decision|1|||
146015296|NCT01670279|526566116|FG002|Overall Study|Physician Decision|0|||
146015297|NCT01670279|526566117|FG003|Overall Study|Physician Decision|0|||
146015298|NCT01670279|526566114|FG000|Overall Study|Participant met withdrawal criteria|0|||
146015299|NCT01670279|526566115|FG001|Overall Study|Participant met withdrawal criteria|0|||
146015300|NCT01670279|526566116|FG002|Overall Study|Participant met withdrawal criteria|0|||
146015301|NCT01670279|526566117|FG003|Overall Study|Participant met withdrawal criteria|1|||
146015302|NCT01534351|526566120|FG000|Overall Study|Study Terminated Early|1|||
146015303|NCT01534351|526566121|FG001|Overall Study|Study Terminated Early|0|||
146015304|NCT01534351|526566122|FG002|Overall Study|Study Terminated Early|0|||
146015305|NCT02702609|526566123|FG000|Overall Study|Lost to Follow-up|8|||
146015306|NCT02702609|526566124|FG001|Overall Study|Lost to Follow-up|4|||
146015307|NCT02702609|526566123|FG000|Overall Study|Physician Decision|1|||
146015308|NCT02702609|526566124|FG001|Overall Study|Physician Decision|0|||
146015309|NCT00935493|526566125|FG000|Overall Study|Lost to Follow-up|1|||
146015310|NCT00935493|526566126|FG001|Overall Study|Lost to Follow-up|1|||
146015311|NCT00935493|526566127|FG002|Overall Study|Lost to Follow-up|1|||
146015312|NCT00935493|526566125|FG000|Overall Study|Treatment Discontinued|0|||
146015313|NCT00935493|526566126|FG001|Overall Study|Treatment Discontinued|1|||
146015314|NCT00935493|526566127|FG002|Overall Study|Treatment Discontinued|0|||
146015315|NCT04153981|526566128|FG000|Overall Study|Death|1|||
146015316|NCT04153981|526566128|FG000|Overall Study|Withdrawal by Subject|24|||
146015317|NCT04153981|526566128|FG000|Overall Study|Lost to Follow-up|1|||
146015318|NCT04153981|526566128|FG000|Overall Study|Physician Decision|1|||
146015319|NCT04153981|526566128|FG000|Overall Study|Due to Unavailable Glucometer|1|||
146015320|NCT04153981|526566128|FG000|Overall Study|Covid 19|52|||
146015321|NCT04153981|526566128|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
146015322|NCT04153981|526566128|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
146015323|NCT02027311|526566131|FG000|Overall Study|Protocol Violation|3|||
146015324|NCT02027311|526566132|FG001|Overall Study|Protocol Violation|2|||
146015325|NCT03928418|526566133|FG000|Overall Study|Lost to Follow-up|5|||
146015326|NCT03928418|526566134|FG001|Overall Study|Lost to Follow-up|3|||
146250438|NCT01730118|527429186|FG002|Dose Expansion|Inability to return|0|||
146250439|NCT01730118|527429187|FG003|Dose Expansion|Inability to return|0|||
146250440|NCT01730118|527429188|FG004|Dose Expansion|Inability to return|0|||
146250441|NCT01730118|527429189|FG005|Dose Expansion|Inability to return|1|||
146250442|NCT01730118|527429190|FG006|Dose Expansion|Inability to return|0|||
146250443|NCT01730118|527429184|FG000|Dose Expansion|Physician Decision|0|||
146250444|NCT01730118|527429185|FG001|Dose Expansion|Physician Decision|0|||
146015327|NCT03928418|526566135|FG002|Overall Study|Lost to Follow-up|5|||
146015328|NCT03928418|526566133|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
146015329|NCT03928418|526566134|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
146015330|NCT03928418|526566135|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
146015331|NCT02091362|526566145|FG000|Period 1|Protocol Violation|1|||
146015332|NCT02091362|526566146|FG001|Period 1|Protocol Violation|0|||
146015333|NCT02091362|526566145|FG000|Period 1|Withdrawal by Subject|2|||
146015334|NCT02091362|526566146|FG001|Period 1|Withdrawal by Subject|3|||
146015335|NCT02091362|526566145|FG000|Period 1|Lost to Follow-up|0|||
146015336|NCT02091362|526566146|FG001|Period 1|Lost to Follow-up|1|||
146015337|NCT02091362|526566145|FG000|Period 1|Adverse Event|2|||
146015338|NCT02091362|526566146|FG001|Period 1|Adverse Event|0|||
146015339|NCT02091362|526566145|FG000|Wash-out|Lost to Follow-up|1|||
146015340|NCT02091362|526566146|FG001|Wash-out|Lost to Follow-up|1|||
146015341|NCT02091362|526566145|FG000|Wash-out|Withdrawal by Subject|0|||
146015342|NCT02091362|526566146|FG001|Wash-out|Withdrawal by Subject|2|||
146015343|NCT02091362|526566145|FG000|Period 2|Adverse Event|1|||
146015344|NCT02091362|526566146|FG001|Period 2|Adverse Event|0|||
146015345|NCT02091362|526566145|FG000|Period 2|Lost to Follow-up|0|||
146015346|NCT02091362|526566146|FG001|Period 2|Lost to Follow-up|1|||
146015347|NCT02091362|526566145|FG000|Period 2|Withdrawal by Subject|1|||
146015348|NCT02091362|526566146|FG001|Period 2|Withdrawal by Subject|1|||
146015349|NCT00690430|526566147|FG000|Core Phase|Abnormal Laboratory value|0|||
146015350|NCT00690430|526566148|FG001|Core Phase|Abnormal Laboratory value|1|||
146015351|NCT00690430|526566149|FG002|Core Phase|Abnormal Laboratory value|0|||
146015352|NCT00690430|526566147|FG000|Core Phase|Adverse Event|5|||
146015353|NCT00690430|526566148|FG001|Core Phase|Adverse Event|1|||
146015354|NCT00690430|526566149|FG002|Core Phase|Adverse Event|0|||
146015355|NCT00690430|526566147|FG000|Core Phase|Death|0|||
146015356|NCT00690430|526566148|FG001|Core Phase|Death|2|||
146015357|NCT00690430|526566149|FG002|Core Phase|Death|0|||
146015358|NCT00690430|526566147|FG000|Core Phase|Protocol Violation|1|||
146015359|NCT00690430|526566148|FG001|Core Phase|Protocol Violation|0|||
146015360|NCT00690430|526566149|FG002|Core Phase|Protocol Violation|0|||
146015361|NCT00690430|526566147|FG000|Core Phase|Withdrawal by Subject|3|||
146015362|NCT00690430|526566148|FG001|Core Phase|Withdrawal by Subject|3|||
146015363|NCT00690430|526566149|FG002|Core Phase|Withdrawal by Subject|0|||
146015364|NCT00690430|526566147|FG000|Core Phase|Subject no longer requires study drug|1|||
146015365|NCT00690430|526566148|FG001|Core Phase|Subject no longer requires study drug|0|||
146015366|NCT00690430|526566149|FG002|Core Phase|Subject no longer requires study drug|0|||
146015367|NCT00690430|526566147|FG000|Core Phase|Lack of Efficacy|8|||
146015368|NCT00690430|526566148|FG001|Core Phase|Lack of Efficacy|10|||
146015369|NCT00690430|526566149|FG002|Core Phase|Lack of Efficacy|0|||
146015370|NCT00690430|526566147|FG000|Core Phase|Administrative Problems|0|||
146015371|NCT00690430|526566148|FG001|Core Phase|Administrative Problems|1|||
146015372|NCT00690430|526566149|FG002|Core Phase|Administrative Problems|0|||
146015373|NCT00690430|526566147|FG000|Core Phase|Early Termination|0|||
146015374|NCT00690430|526566148|FG001|Core Phase|Early Termination|5|||
146015375|NCT00690430|526566149|FG002|Core Phase|Early Termination|0|||
146015376|NCT00690430|526566147|FG000|Extension Phase|Lack of Efficacy|3|||
146015377|NCT00690430|526566148|FG001|Extension Phase|Lack of Efficacy|1|||
146015378|NCT00690430|526566149|FG002|Extension Phase|Lack of Efficacy|4|||
146015379|NCT00690430|526566147|FG000|Extension Phase|Abnormal Lab Values|1|||
146015380|NCT00690430|526566148|FG001|Extension Phase|Abnormal Lab Values|0|||
146015381|NCT00690430|526566149|FG002|Extension Phase|Abnormal Lab Values|0|||
146015382|NCT00690430|526566147|FG000|Extension Phase|Abnormal test procedure results|1|||
146015383|NCT00690430|526566148|FG001|Extension Phase|Abnormal test procedure results|0|||
146015384|NCT00690430|526566149|FG002|Extension Phase|Abnormal test procedure results|0|||
146015385|NCT00690430|526566147|FG000|Extension Phase|Administrative Problems|0|||
146015386|NCT00690430|526566148|FG001|Extension Phase|Administrative Problems|1|||
146015387|NCT00690430|526566149|FG002|Extension Phase|Administrative Problems|1|||
146015388|NCT00690430|526566147|FG000|Extension Phase|Adverse Event|2|||
146015389|NCT00690430|526566148|FG001|Extension Phase|Adverse Event|1|||
146015390|NCT00690430|526566149|FG002|Extension Phase|Adverse Event|2|||
146015391|NCT00690430|526566147|FG000|Extension Phase|Death|1|||
146015392|NCT00690430|526566148|FG001|Extension Phase|Death|1|||
146015393|NCT00690430|526566149|FG002|Extension Phase|Death|1|||
146015394|NCT00690430|526566147|FG000|Extension Phase|Withdrawal by Subject|0|||
146015395|NCT00690430|526566148|FG001|Extension Phase|Withdrawal by Subject|0|||
146015396|NCT00690430|526566149|FG002|Extension Phase|Withdrawal by Subject|2|||
146015397|NCT00690430|526566147|FG000|Extension Phase|Early Termination|10|||
146015398|NCT00690430|526566148|FG001|Extension Phase|Early Termination|1|||
146015399|NCT00690430|526566149|FG002|Extension Phase|Early Termination|3|||
146015400|NCT02125838|526566152|FG000|Overall Study|Lost to Follow-up|4|||
146015401|NCT02125838|526566153|FG001|Overall Study|Lost to Follow-up|4|||
146015402|NCT02565147|526566154|FG000|Overall Study|Withdrawal by Subject|5|||
146015403|NCT02565147|526566155|FG001|Overall Study|Withdrawal by Subject|1|||
146015404|NCT02565147|526566154|FG000|Overall Study|Lost to Follow-up|0|||
146015405|NCT02565147|526566155|FG001|Overall Study|Lost to Follow-up|1|||
146015406|NCT02565147|526566154|FG000|Overall Study|Death|1|||
146015407|NCT02565147|526566155|FG001|Overall Study|Death|1|||
146015408|NCT00787839|526566156|FG000|Overall Study|Failure to have the OGTT was most common|404|||
146015409|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
146015410|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
146015411|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
146015412|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
146015413|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Death|58|||
146250445|NCT01730118|527429186|FG002|Dose Expansion|Physician Decision|0|||
146250446|NCT01730118|527429187|FG003|Dose Expansion|Physician Decision|0|||
146250447|NCT01730118|527429188|FG004|Dose Expansion|Physician Decision|0|||
146250448|NCT01730118|527429189|FG005|Dose Expansion|Physician Decision|1|||
146250449|NCT01730118|527429190|FG006|Dose Expansion|Physician Decision|0|||
146250450|NCT00668746|527429193|FG000|Overall Study|Lost to Follow-up|2|||
146250451|NCT00668746|527429194|FG001|Overall Study|Lost to Follow-up|1|||
146250452|NCT03605745|527429196|FG000|Overall Study|Study was terminated for business reasons|47|||
146250453|NCT01183013|527429202|FG000|Overall Study|Adverse Event|6|||
146250454|NCT01183013|527429203|FG001|Overall Study|Adverse Event|8|||
146250455|NCT01183013|527429204|FG002|Overall Study|Adverse Event|5|||
146250456|NCT01183013|527429205|FG003|Overall Study|Adverse Event|5|||
146250457|NCT01183013|527429206|FG004|Overall Study|Adverse Event|10|||
146250458|NCT01183013|527429207|FG005|Overall Study|Adverse Event|10|||
146250459|NCT01183013|527429208|FG006|Overall Study|Adverse Event|6|||
146250460|NCT01183013|527429202|FG000|Overall Study|Lack of Efficacy|3|||
146250461|NCT01183013|527429203|FG001|Overall Study|Lack of Efficacy|2|||
146250462|NCT01183013|527429204|FG002|Overall Study|Lack of Efficacy|1|||
146250463|NCT01183013|527429205|FG003|Overall Study|Lack of Efficacy|2|||
146250464|NCT01183013|527429206|FG004|Overall Study|Lack of Efficacy|1|||
146250465|NCT01183013|527429207|FG005|Overall Study|Lack of Efficacy|2|||
146250466|NCT01183013|527429208|FG006|Overall Study|Lack of Efficacy|0|||
146250467|NCT01183013|527429202|FG000|Overall Study|Protocol Violation|5|||
146250468|NCT01183013|527429203|FG001|Overall Study|Protocol Violation|2|||
146250469|NCT01183013|527429204|FG002|Overall Study|Protocol Violation|4|||
146250470|NCT01183013|527429205|FG003|Overall Study|Protocol Violation|0|||
146250471|NCT01183013|527429206|FG004|Overall Study|Protocol Violation|4|||
146250472|NCT01183013|527429207|FG005|Overall Study|Protocol Violation|3|||
146250473|NCT01183013|527429208|FG006|Overall Study|Protocol Violation|3|||
146250474|NCT01183013|527429202|FG000|Overall Study|Lost to Follow-up|7|||
146250475|NCT01183013|527429203|FG001|Overall Study|Lost to Follow-up|3|||
146250476|NCT01183013|527429204|FG002|Overall Study|Lost to Follow-up|4|||
146250477|NCT01183013|527429205|FG003|Overall Study|Lost to Follow-up|3|||
146250478|NCT01183013|527429206|FG004|Overall Study|Lost to Follow-up|2|||
146250479|NCT01183013|527429207|FG005|Overall Study|Lost to Follow-up|6|||
146250480|NCT01183013|527429208|FG006|Overall Study|Lost to Follow-up|5|||
146250481|NCT01183013|527429202|FG000|Overall Study|Withdrawal by Subject|9|||
146250482|NCT01183013|527429203|FG001|Overall Study|Withdrawal by Subject|13|||
146250483|NCT01183013|527429204|FG002|Overall Study|Withdrawal by Subject|10|||
146250484|NCT01183013|527429205|FG003|Overall Study|Withdrawal by Subject|8|||
146250485|NCT01183013|527429206|FG004|Overall Study|Withdrawal by Subject|7|||
146250486|NCT01183013|527429207|FG005|Overall Study|Withdrawal by Subject|9|||
146250487|NCT01183013|527429208|FG006|Overall Study|Withdrawal by Subject|10|||
146250488|NCT01183013|527429202|FG000|Overall Study|Reasons other than stated above|15|||
146250489|NCT01183013|527429203|FG001|Overall Study|Reasons other than stated above|11|||
146250490|NCT01183013|527429204|FG002|Overall Study|Reasons other than stated above|17|||
146250491|NCT01183013|527429205|FG003|Overall Study|Reasons other than stated above|12|||
146250492|NCT01183013|527429206|FG004|Overall Study|Reasons other than stated above|12|||
146250493|NCT01183013|527429207|FG005|Overall Study|Reasons other than stated above|15|||
146250494|NCT01183013|527429208|FG006|Overall Study|Reasons other than stated above|13|||
146250495|NCT04739306|527429209|FG000|Main Study Period|Adverse Event|6|||
146250496|NCT04739306|527429210|FG001|Main Study Period|Adverse Event|7|||
146299712|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
146299713|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
146299714|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
146015414|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Death|65|||
146250497|NCT04739306|527429209|FG000|Main Study Period|Lost to Follow-up|4|||
146250498|NCT04739306|527429210|FG001|Main Study Period|Lost to Follow-up|6|||
146015415|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Adverse Event|28|||
146015416|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Adverse Event|40|||
146015417|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Disease Progression|22|||
146015418|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Disease Progression|35|||
146015419|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Other|25|||
146015420|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Other|33|||
146015421|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
146015422|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
146015423|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Noncompliance|8|||
146015424|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Noncompliance|8|||
146015425|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
146015426|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
146015427|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
146015428|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
146015429|NCT00286091|526566163|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
146015430|NCT00286091|526566164|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
146015431|NCT00286091|526566163|FG000|Open-label Treatment Phase|Physician Decision|24|||
146015432|NCT00286091|526566164|FG001|Open-label Treatment Phase|Physician Decision|21|||
146015433|NCT00286091|526566163|FG000|Open-label Treatment Phase|Adverse Event|5|||
146015434|NCT00286091|526566164|FG001|Open-label Treatment Phase|Adverse Event|16|||
146015435|NCT00286091|526566163|FG000|Open-label Treatment Phase|Other|11|||
146015436|NCT00286091|526566164|FG001|Open-label Treatment Phase|Other|11|||
146015437|NCT00286091|526566163|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
146015438|NCT00286091|526566164|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
146015439|NCT00286091|526566163|FG000|Open-label Treatment Phase|Death|10|||
146015440|NCT00286091|526566164|FG001|Open-label Treatment Phase|Death|7|||
146015441|NCT00286091|526566163|FG000|Open-label Treatment Phase|Disease Progression|9|||
146015442|NCT00286091|526566164|FG001|Open-label Treatment Phase|Disease Progression|3|||
146015443|NCT00286091|526566163|FG000|Open-label Treatment Phase|Noncompliance|3|||
146015444|NCT00286091|526566164|FG001|Open-label Treatment Phase|Noncompliance|1|||
146015445|NCT00286091|526566163|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
146015446|NCT00286091|526566164|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
146015447|NCT00286091|526566163|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
146015448|NCT00286091|526566164|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
146015449|NCT00286091|526566163|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
146015450|NCT00286091|526566164|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
146015451|NCT02936869|526566167|FG000|Overall Study|Lost to Follow-up|1|||
146015452|NCT02936869|526566168|FG001|Overall Study|Lost to Follow-up|3|||
146015453|NCT02936869|526566167|FG000|Overall Study|Death|0|||
146015454|NCT02936869|526566168|FG001|Overall Study|Death|1|||
146015455|NCT02936869|526566167|FG000|Overall Study|Legal Case|0|||
146015456|NCT02936869|526566168|FG001|Overall Study|Legal Case|1|||
146015457|NCT02936869|526566167|FG000|Overall Study|Protocol Violation|1|||
146015458|NCT02936869|526566168|FG001|Overall Study|Protocol Violation|0|||
146015459|NCT00335738|526566169|FG000|Overall Study|Physician Decision|6|||
146015460|NCT00335738|526566170|FG001|Overall Study|Physician Decision|0|||
146015461|NCT00335738|526566169|FG000|Overall Study|Withdrawal by Subject|2|||
146015462|NCT00335738|526566170|FG001|Overall Study|Withdrawal by Subject|0|||
146015463|NCT00335738|526566169|FG000|Overall Study|Ineligible|3|||
146015464|NCT00335738|526566170|FG001|Overall Study|Ineligible|4|||
146015465|NCT00506454|526566177|FG000|Overall Study|Withdrawal by Subject|1|||
146015466|NCT00506454|526566178|FG001|Overall Study|Withdrawal by Subject|1|||
146015467|NCT00902850|526566180|FG000|Overall Study|Physician Decision|2|||
146015468|NCT00902850|526566181|FG001|Overall Study|Physician Decision|2|||
146015469|NCT00260832|526566182|FG000|Overall Study|Adverse Event|26|||
146015470|NCT00260832|526566183|FG001|Overall Study|Adverse Event|19|||
146015471|NCT00260832|526566182|FG000|Overall Study|Progression|116|||
146015472|NCT00260832|526566183|FG001|Overall Study|Progression|96|||
146015473|NCT00260832|526566182|FG000|Overall Study|Withdrawal by Subject|15|||
146015474|NCT00260832|526566183|FG001|Overall Study|Withdrawal by Subject|17|||
146015475|NCT00260832|526566182|FG000|Overall Study|Physician Decision|15|||
146015476|NCT00260832|526566183|FG001|Overall Study|Physician Decision|9|||
146015477|NCT00260832|526566182|FG000|Overall Study|Death|43|||
146015478|NCT00260832|526566183|FG001|Overall Study|Death|62|||
146015479|NCT00260832|526566182|FG000|Overall Study|Other|10|||
146015480|NCT00260832|526566183|FG001|Overall Study|Other|7|||
146015481|NCT00260832|526566182|FG000|Overall Study|Protocol Violation|3|||
146015482|NCT00260832|526566183|FG001|Overall Study|Protocol Violation|1|||
146015483|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
146015484|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
146015485|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
146015486|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146015487|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146015488|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146015489|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
146015490|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
146015491|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146250499|NCT04739306|527429209|FG000|Main Study Period|Physician Decision|1|||
146250500|NCT04739306|527429210|FG001|Main Study Period|Physician Decision|1|||
146250501|NCT04739306|527429209|FG000|Main Study Period|Withdrawal by Subject|8|||
146015492|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146015493|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146015494|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146015495|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146015496|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
146015497|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
146015498|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
146015499|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
146093597|NCT02301988|526863498|FG000|Overall Study|Physician Decision|2|||
146250502|NCT04739306|527429210|FG001|Main Study Period|Withdrawal by Subject|6|||
146250503|NCT04739306|527429209|FG000|Main Study Period|Protocol Violation|0|||
146015500|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146015501|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146015502|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146015503|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
146015504|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146015505|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
146015506|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146015507|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146015508|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146015509|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146015510|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
146015511|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
146015512|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015513|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015514|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015515|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015516|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015517|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
146015518|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015519|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
146015520|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015521|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015522|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015523|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015524|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
146015525|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
146015526|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
146015527|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
146015528|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146015529|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146015530|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146015531|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
146015532|NCT03745638|526566184|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
146015533|NCT03745638|526566185|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
146015534|NCT03745638|526566186|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146015535|NCT03745638|526566187|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146015536|NCT03745638|526566188|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146015537|NCT03745638|526566189|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146015538|NCT03745638|526566190|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
146015539|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146015540|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146015541|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146015542|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146015543|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
146015544|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
146015545|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
146015546|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146015547|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146015548|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146015549|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
146015550|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
146015551|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146015552|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
146015553|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146015554|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146015555|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
146015556|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
146015557|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
146015558|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
146015559|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
146250504|NCT04739306|527429210|FG001|Main Study Period|Protocol Violation|1|||
146250505|NCT04739306|527429209|FG000|Main Study Period|War in Ukraine|1|||
146250506|NCT04739306|527429210|FG001|Main Study Period|War in Ukraine|1|||
146250507|NCT04175392|527429211|FG000|Overall Study|Withdrawal by Subject|3|||
146250508|NCT04175392|527429212|FG001|Overall Study|Withdrawal by Subject|2|||
146250509|NCT01613599|527429213|FG000|Overall Study|Death|9|||
146250510|NCT01613599|527429213|FG000|Overall Study|Lost to Follow-up|5|||
146015560|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146015561|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146015562|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146015563|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146015564|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
146015565|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
146015566|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
146015567|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015568|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015569|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015570|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015571|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015572|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
146015573|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
146015574|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146015575|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146015576|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
146015577|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
146015578|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
146015579|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
146015580|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
146015581|NCT03745638|526566184|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146015582|NCT03745638|526566185|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146015583|NCT03745638|526566186|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146015584|NCT03745638|526566187|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146015585|NCT03745638|526566188|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
146015586|NCT03745638|526566189|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
146015587|NCT03745638|526566190|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
146015588|NCT03098433|526566191|FG000|Overall Study|Withdrawal by Subject|10|||
146015589|NCT03604172|526566193|FG000|Overall Study|Lost to Follow-up|1|||
146015590|NCT03604172|526566194|FG001|Overall Study|Lost to Follow-up|2|||
146015591|NCT02676895|526566195|FG000|Overall Study|Administrative reason|1|||
146015592|NCT02676895|526566196|FG001|Overall Study|Administrative reason|0|||
146015593|NCT02676895|526566197|FG002|Overall Study|Administrative reason|0|||
146015594|NCT02676895|526566195|FG000|Overall Study|Protocol Violation|1|||
146015595|NCT02676895|526566196|FG001|Overall Study|Protocol Violation|0|||
146015596|NCT02676895|526566197|FG002|Overall Study|Protocol Violation|0|||
146015597|NCT02676895|526566195|FG000|Overall Study|Adverse Event|0|||
146015598|NCT02676895|526566196|FG001|Overall Study|Adverse Event|3|||
146015599|NCT02676895|526566197|FG002|Overall Study|Adverse Event|1|||
146015600|NCT02676895|526566195|FG000|Overall Study|Lost to Follow-up|0|||
146015601|NCT02676895|526566196|FG001|Overall Study|Lost to Follow-up|0|||
146015602|NCT02676895|526566197|FG002|Overall Study|Lost to Follow-up|1|||
146015603|NCT02676895|526566195|FG000|Overall Study|Withdrawal by Subject|0|||
146015604|NCT02676895|526566196|FG001|Overall Study|Withdrawal by Subject|0|||
146015605|NCT02676895|526566197|FG002|Overall Study|Withdrawal by Subject|1|||
146015606|NCT00182078|526566201|FG000|Overall Study|Withdrawal by Subject|1|||
146015607|NCT00182078|526566202|FG001|Overall Study|Withdrawal by Subject|0|||
146015608|NCT00395486|526566203|FG000|Overall Study|Adverse Event|1|||
146015609|NCT00395486|526566204|FG001|Overall Study|Adverse Event|2|||
146015610|NCT00395486|526566203|FG000|Overall Study|Withdrawal by Subject|5|||
146015611|NCT00395486|526566204|FG001|Overall Study|Withdrawal by Subject|2|||
146015612|NCT00395486|526566203|FG000|Overall Study|Lost to Follow-up|0|||
146015613|NCT00395486|526566204|FG001|Overall Study|Lost to Follow-up|1|||
146015614|NCT01814046|526566208|FG000|Drug Administration|Death due to complications of RSV|1|||
146015615|NCT01814046|526566209|FG001|Drug Administration|Death due to complications of RSV|0|||
146015616|NCT01814046|526566210|FG002|Drug Administration|Death due to complications of RSV|0|||
146015617|NCT00564902|526566211|FG000|Overall Study|Withdrawal by Subject|0|||
146015618|NCT00564902|526566212|FG001|Overall Study|Withdrawal by Subject|3|||
146015619|NCT00564902|526566213|FG002|Overall Study|Withdrawal by Subject|4|||
146015620|NCT00564902|526566211|FG000|Overall Study|Death|1|||
146015621|NCT00564902|526566212|FG001|Overall Study|Death|1|||
146250511|NCT01613599|527429213|FG000|Overall Study|Withdrawal by Subject|8|||
146250512|NCT01613599|527429213|FG000|Overall Study|Reason not specified|3|||
146015622|NCT00564902|526566213|FG002|Overall Study|Death|0|||
146015623|NCT02097719|526566217|FG000|Overall Study|Subject Withdrew Consent|1|||
146093598|NCT02301988|526863499|FG001|Overall Study|Physician Decision|2|||
146015624|NCT02097719|526566218|FG001|Overall Study|Subject Withdrew Consent|0|||
146015625|NCT02097719|526566217|FG000|Overall Study|Lost to Follow-up|0|||
146015626|NCT02097719|526566218|FG001|Overall Study|Lost to Follow-up|1|||
146015627|NCT02097719|526566217|FG000|Overall Study|Adverse Event|2|||
146015628|NCT02097719|526566218|FG001|Overall Study|Adverse Event|0|||
146015629|NCT01854775|526566221|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
146015630|NCT01854775|526566222|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
146015631|NCT01854775|526566223|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
146015632|NCT01854775|526566221|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
146015633|NCT01854775|526566222|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
146015634|NCT01854775|526566223|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
146015635|NCT01854775|526566221|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
146015636|NCT01854775|526566222|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
146015637|NCT01854775|526566223|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
146015638|NCT01854775|526566221|FG000|Extension Phase|Pregnancy|3|||
146015639|NCT01854775|526566222|FG001|Extension Phase|Pregnancy|0|||
146015640|NCT01854775|526566223|FG002|Extension Phase|Pregnancy|0|||
146015641|NCT01854775|526566221|FG000|Extension Phase|Investigator's Discretion|1|||
146015642|NCT01854775|526566222|FG001|Extension Phase|Investigator's Discretion|0|||
146015643|NCT01854775|526566223|FG002|Extension Phase|Investigator's Discretion|0|||
146015644|NCT01854775|526566221|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
146015645|NCT01854775|526566222|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
146015646|NCT01854775|526566223|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
146015647|NCT01854775|526566221|FG000|Extension Phase|Lost to Follow-up|2|||
146015648|NCT01854775|526566222|FG001|Extension Phase|Lost to Follow-up|0|||
146015649|NCT01854775|526566223|FG002|Extension Phase|Lost to Follow-up|0|||
146015650|NCT01854775|526566221|FG000|Extension Phase|Still on Study|32|||
146015651|NCT01854775|526566222|FG001|Extension Phase|Still on Study|47|||
146015652|NCT01854775|526566223|FG002|Extension Phase|Still on Study|18|||
146015653|NCT00984594|526566225|FG000|Overall Study|Lost to Follow-up|1|||
146015654|NCT00984594|526566226|FG001|Overall Study|Lost to Follow-up|0|||
146015655|NCT00984594|526566225|FG000|Overall Study|Withdrawal by Subject|0|||
146015656|NCT00984594|526566226|FG001|Overall Study|Withdrawal by Subject|1|||
146015657|NCT03135431|526566227|FG000|Overall Study|Study Surgeon not available|2|||
146015658|NCT03135431|526566228|FG001|Overall Study|Study Surgeon not available|0|||
146015659|NCT03122145|526566230|FG000|Overall Study|Concurrent respiratory disease|3|||
146015660|NCT03122145|526566231|FG001|Overall Study|Concurrent respiratory disease|0|||
146015661|NCT03108521|526566235|FG000|Overall Study|Lost to Follow-up|3|||
146015662|NCT03108521|526566236|FG001|Overall Study|Lost to Follow-up|0|||
146015663|NCT03108521|526566235|FG000|Overall Study|Lack of Efficacy|2|||
146015664|NCT03108521|526566236|FG001|Overall Study|Lack of Efficacy|0|||
146015665|NCT03108521|526566235|FG000|Overall Study|Physician Decision|4|||
146015666|NCT03108521|526566236|FG001|Overall Study|Physician Decision|0|||
146015667|NCT03108521|526566235|FG000|Overall Study|Adverse Event|3|||
146015668|NCT03108521|526566236|FG001|Overall Study|Adverse Event|0|||
146015669|NCT00375674|526566243|FG000|Overall Study|Other|26|||
146015670|NCT00375674|526566244|FG001|Overall Study|Other|18|||
146015671|NCT00375674|526566243|FG000|Overall Study|Death|67|||
146015672|NCT00375674|526566244|FG001|Overall Study|Death|76|||
146015673|NCT00375674|526566243|FG000|Overall Study|Participants refused further follow-up|31|||
146015674|NCT00375674|526566244|FG001|Overall Study|Participants refused further follow-up|30|||
146015675|NCT00375674|526566243|FG000|Overall Study|Lost to Follow-up|17|||
146015676|NCT00375674|526566244|FG001|Overall Study|Lost to Follow-up|15|||
146015677|NCT00375674|526566243|FG000|Overall Study|Enrolled but not treated|3|||
146015678|NCT00375674|526566244|FG001|Overall Study|Enrolled but not treated|2|||
146015679|NCT00875485|526568063|FG000|Challenge Dose Epoch|Pregnancy|1|||
146015680|NCT00875485|526568064|FG001|Challenge Dose Epoch|Pregnancy|0|||
146015681|NCT01271010|526568065|FG000|Overall Study|Reason not specified|11|||
146015682|NCT01271010|526568065|FG000|Overall Study|Start of new CLL therapy|1|||
146015683|NCT01271010|526568065|FG000|Overall Study|Protocol Violation|1|||
146015684|NCT01271010|526568065|FG000|Overall Study|Death|2|||
146015685|NCT01271010|526568065|FG000|Overall Study|Progression and relapse of disease|1|||
146015686|NCT01271010|526568065|FG000|Overall Study|Withdrawal by Subject|18|||
146015687|NCT01271010|526568065|FG000|Overall Study|Disease progression|27|||
146015688|NCT01631747|526568066|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
146015689|NCT01631747|526568067|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
146015690|NCT01631747|526568066|FG000|Live Birth|Pregnancy Termination|1|||
146015691|NCT01631747|526568067|FG001|Live Birth|Pregnancy Termination|0|||
146015692|NCT01631747|526568066|FG000|Live Birth|MIscarriage|2|||
146015693|NCT01631747|526568067|FG001|Live Birth|MIscarriage|0|||
146015694|NCT01631747|526568066|FG000|Live Birth|Stillbirth|1|||
146015695|NCT01631747|526568067|FG001|Live Birth|Stillbirth|1|||
146015696|NCT01631747|526568066|FG000|One Year Infant Outcomes|Patient Refused|13|||
146015697|NCT01631747|526568067|FG001|One Year Infant Outcomes|Patient Refused|9|||
146015698|NCT01456195|526568068|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146015699|NCT01456195|526568069|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
146015700|NCT01456195|526568070|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146015701|NCT01456195|526568068|FG000|Overall Study|Lost to Follow-up|3|||
146015702|NCT01456195|526568069|FG001|Overall Study|Lost to Follow-up|1|||
146015703|NCT01456195|526568070|FG002|Overall Study|Lost to Follow-up|3|||
146015704|NCT01456195|526568068|FG000|Overall Study|Voluntary Withdrawal|5|||
146015705|NCT01456195|526568069|FG001|Overall Study|Voluntary Withdrawal|3|||
146015706|NCT01456195|526568070|FG002|Overall Study|Voluntary Withdrawal|7|||
146015707|NCT01456195|526568068|FG000|Overall Study|Lack of Efficacy|0|||
146015708|NCT01456195|526568069|FG001|Overall Study|Lack of Efficacy|1|||
146015709|NCT01456195|526568070|FG002|Overall Study|Lack of Efficacy|0|||
146015710|NCT01456195|526568068|FG000|Overall Study|Other Reasons|2|||
146015711|NCT01456195|526568069|FG001|Overall Study|Other Reasons|1|||
146015712|NCT01456195|526568070|FG002|Overall Study|Other Reasons|3|||
146015713|NCT02109432|526568071|FG000|Overall Study|Withdrawal by Subject|1|||
146015714|NCT02908685|526568078|FG000|Part 1 OLE|Withdrawal by Subject|0|||
146015715|NCT02908685|526568079|FG001|Part 1 OLE|Withdrawal by Subject|0|||
146015716|NCT02908685|526568080|FG002|Part 1 OLE|Withdrawal by Subject|0|||
146015717|NCT02908685|526568081|FG003|Part 1 OLE|Withdrawal by Subject|0|||
146015718|NCT02908685|526568082|FG004|Part 1 OLE|Withdrawal by Subject|0|||
146015719|NCT02908685|526568083|FG005|Part 1 OLE|Withdrawal by Subject|0|||
146015720|NCT02908685|526568084|FG006|Part 1 OLE|Withdrawal by Subject|0|||
146015721|NCT02908685|526568085|FG007|Part 1 OLE|Withdrawal by Subject|0|||
146015722|NCT02908685|526568086|FG008|Part 1 OLE|Withdrawal by Subject|0|||
146015723|NCT02908685|526568087|FG009|Part 1 OLE|Withdrawal by Subject|0|||
146015724|NCT02908685|526568088|FG010|Part 1 OLE|Withdrawal by Subject|2|||
146015725|NCT02908685|526568089|FG011|Part 1 OLE|Withdrawal by Subject|1|||
146015726|NCT02908685|526568090|FG012|Part 1 OLE|Withdrawal by Subject|0|||
146015727|NCT02908685|526568091|FG013|Part 1 OLE|Withdrawal by Subject|0|||
146015728|NCT02908685|526568078|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015729|NCT02908685|526568079|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015730|NCT02908685|526568080|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015731|NCT02908685|526568081|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015732|NCT02908685|526568082|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015733|NCT02908685|526568083|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015734|NCT02908685|526568084|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015735|NCT02908685|526568085|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015736|NCT02908685|526568086|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015737|NCT02908685|526568087|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015738|NCT02908685|526568088|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015739|NCT02908685|526568089|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
146015740|NCT02908685|526568090|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
146015741|NCT02908685|526568091|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
146015742|NCT02908685|526568078|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015743|NCT02908685|526568079|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015744|NCT02908685|526568080|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015745|NCT02908685|526568081|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015746|NCT02908685|526568082|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015747|NCT02908685|526568083|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015748|NCT02908685|526568084|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015749|NCT02908685|526568085|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015750|NCT02908685|526568086|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015751|NCT02908685|526568087|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015752|NCT02908685|526568088|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015753|NCT02908685|526568089|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015754|NCT02908685|526568090|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
146015755|NCT02908685|526568091|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
146015756|NCT02908685|526568078|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015757|NCT02908685|526568079|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015758|NCT02908685|526568080|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015759|NCT02908685|526568081|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015760|NCT02908685|526568082|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015761|NCT02908685|526568083|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015762|NCT02908685|526568084|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015763|NCT02908685|526568085|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015764|NCT02908685|526568086|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015765|NCT02908685|526568087|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015766|NCT02908685|526568088|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015767|NCT02908685|526568089|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015768|NCT02908685|526568090|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
146015769|NCT02908685|526568091|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
146015770|NCT02908685|526568078|FG000|Part 2 OLE: > Month 24|Death|0|||
146015771|NCT02908685|526568079|FG001|Part 2 OLE: > Month 24|Death|0|||
146015772|NCT02908685|526568080|FG002|Part 2 OLE: > Month 24|Death|0|||
146015773|NCT02908685|526568081|FG003|Part 2 OLE: > Month 24|Death|0|||
146015774|NCT02908685|526568082|FG004|Part 2 OLE: > Month 24|Death|0|||
146015775|NCT02908685|526568083|FG005|Part 2 OLE: > Month 24|Death|0|||
146015776|NCT02908685|526568084|FG006|Part 2 OLE: > Month 24|Death|0|||
146015777|NCT02908685|526568085|FG007|Part 2 OLE: > Month 24|Death|0|||
146015778|NCT02908685|526568086|FG008|Part 2 OLE: > Month 24|Death|0|||
146015779|NCT02908685|526568087|FG009|Part 2 OLE: > Month 24|Death|0|||
146015780|NCT02908685|526568088|FG010|Part 2 OLE: > Month 24|Death|0|||
146015781|NCT02908685|526568089|FG011|Part 2 OLE: > Month 24|Death|0|||
146015782|NCT02908685|526568090|FG012|Part 2 OLE: > Month 24|Death|1|||
146015783|NCT02908685|526568091|FG013|Part 2 OLE: > Month 24|Death|0|||
146015784|NCT02908685|526568078|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
146015785|NCT02908685|526568079|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
146015786|NCT02908685|526568080|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
146015787|NCT02908685|526568081|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
146015788|NCT02908685|526568082|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
146015789|NCT02908685|526568083|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
146015790|NCT02908685|526568084|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
146015791|NCT02908685|526568085|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
146015792|NCT02908685|526568086|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
146015793|NCT02908685|526568087|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
146015794|NCT02908685|526568088|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
146015795|NCT02908685|526568089|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
146015796|NCT02908685|526568090|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
146015797|NCT02908685|526568091|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
146015798|NCT02908685|526568078|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015799|NCT02908685|526568079|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015800|NCT02908685|526568080|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015801|NCT02908685|526568081|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015802|NCT02908685|526568082|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015803|NCT02908685|526568083|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015804|NCT02908685|526568084|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015805|NCT02908685|526568085|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015806|NCT02908685|526568086|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146093599|NCT02301988|526863498|FG000|Overall Study|Unknown Reason|1|||
146250513|NCT02991456|527429214|FG000|Overall Study|Adverse Event|2|||
146250514|NCT02991456|527429215|FG001|Overall Study|Adverse Event|0|||
146250515|NCT02991456|527429214|FG000|Overall Study|Lost to Follow-up|0|||
146250516|NCT02991456|527429215|FG001|Overall Study|Lost to Follow-up|2|||
146250517|NCT02991456|527429214|FG000|Overall Study|Withdrawal by Subject|1|||
146250518|NCT02991456|527429215|FG001|Overall Study|Withdrawal by Subject|0|||
146250519|NCT03503188|527429216|FG000|Overall Study|Non eligible in the sub study|0|||
146250520|NCT03503188|527429217|FG001|Overall Study|Non eligible in the sub study|1|||
146250521|NCT01699178|527429218|FG000|Overall Study|Adverse Event|1|||
146250522|NCT01699178|527429219|FG001|Overall Study|Adverse Event|5|||
146250523|NCT01699178|527429218|FG000|Overall Study|Lost to Follow-up|1|||
146250524|NCT01699178|527429219|FG001|Overall Study|Lost to Follow-up|6|||
146250525|NCT01699178|527429218|FG000|Overall Study|Non-compliance with Study Drug|3|||
146250526|NCT01699178|527429219|FG001|Overall Study|Non-compliance with Study Drug|1|||
146250527|NCT01699178|527429218|FG000|Overall Study|Physician Decision|1|||
146250528|NCT01699178|527429219|FG001|Overall Study|Physician Decision|0|||
146250529|NCT01699178|527429218|FG000|Overall Study|Withdrawal by Subject|4|||
146250530|NCT01699178|527429219|FG001|Overall Study|Withdrawal by Subject|12|||
146250531|NCT01699178|527429218|FG000|Overall Study|Hematocrit >54%|1|||
146250532|NCT01699178|527429219|FG001|Overall Study|Hematocrit >54%|1|||
146250533|NCT01699178|527429218|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
146250534|NCT01699178|527429219|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
146250535|NCT01699178|527429218|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
146250536|NCT01699178|527429219|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
146250537|NCT00321555|527429220|FG000|Overall Study|Developed antibodies|1|||
146250538|NCT00321555|527429220|FG000|Overall Study|Switched to alternative treatment|3|||
146250539|NCT00321555|527429220|FG000|Overall Study|Physician Decision|1|||
146250540|NCT00321555|527429220|FG000|Overall Study|Disease progression on study|1|||
146250541|NCT02066389|527429222|FG000|Overall Study|Adverse Event|1|||
146250542|NCT02066389|527429223|FG001|Overall Study|Adverse Event|1|||
146250543|NCT02066389|527429224|FG002|Overall Study|Adverse Event|1|||
146015807|NCT02908685|526568087|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015808|NCT02908685|526568088|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015809|NCT02908685|526568089|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
146015810|NCT02908685|526568090|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
146015811|NCT02908685|526568091|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
146015812|NCT02954406|526568092|FG000|Overall Study|Adverse Event|0|||
146015813|NCT02954406|526568093|FG001|Overall Study|Adverse Event|1|||
146299715|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
146093600|NCT02301988|526863499|FG001|Overall Study|Unknown Reason|3|||
146093601|NCT02301988|526863498|FG000|Overall Study|Lack of Efficacy|3|||
146093602|NCT02301988|526863499|FG001|Overall Study|Lack of Efficacy|2|||
146093603|NCT02301988|526863498|FG000|Overall Study|Death|1|||
146093604|NCT02301988|526863499|FG001|Overall Study|Death|0|||
146093605|NCT02301988|526863498|FG000|Overall Study|Adverse Event|1|||
146093606|NCT02301988|526863499|FG001|Overall Study|Adverse Event|1|||
146093607|NCT02891161|526863500|FG000|Study Treatment|Disease Progression|2|||
146093608|NCT02891161|526863501|FG001|Study Treatment|Disease Progression|4|||
146093609|NCT02891161|526863500|FG000|Study Treatment|AE/Side Effects/Complications|1|||
146093610|NCT02891161|526863501|FG001|Study Treatment|AE/Side Effects/Complications|5|||
146093611|NCT02891161|526863500|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
146093612|NCT02891161|526863501|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
146093613|NCT02891161|526863500|FG000|Follow up|Death|4|||
146093614|NCT02891161|526863501|FG001|Follow up|Death|8|||
146093615|NCT02891161|526863500|FG000|Follow up|Refused to Follow up|0|||
146093616|NCT02891161|526863501|FG001|Follow up|Refused to Follow up|2|||
146093617|NCT02891161|526863500|FG000|Follow up|Symptomatic deterioration|0|||
146093618|NCT02891161|526863501|FG001|Follow up|Symptomatic deterioration|1|||
146093619|NCT02891161|526863500|FG000|Follow up|Study terminated|0|||
146093620|NCT02891161|526863501|FG001|Follow up|Study terminated|6|||
146093621|NCT04669535|526863502|FG000|Overall Study|Death|1|||
146093622|NCT04669535|526863503|FG001|Overall Study|Death|1|||
146093623|NCT04669535|526863504|FG002|Overall Study|Death|0|||
146093624|NCT04669535|526863505|FG003|Overall Study|Death|0|||
146093625|NCT05169567|526863507|FG000|Overall Study|On study treatment|116|||
146093626|NCT05169567|526863508|FG001|Overall Study|On study treatment|128|||
146093627|NCT05169567|526863507|FG000|Overall Study|Lost to Follow-up|1|||
146093628|NCT05169567|526863508|FG001|Overall Study|Lost to Follow-up|0|||
146093629|NCT05169567|526863507|FG000|Overall Study|Withdrawal by Subject|25|||
146093630|NCT05169567|526863508|FG001|Overall Study|Withdrawal by Subject|21|||
146093631|NCT05419908|526863509|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
146093632|NCT05419908|526863510|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
146093633|NCT05419908|526863509|FG000|Overall Study|Serious Adverse Event|0|||
146093634|NCT05419908|526863510|FG001|Overall Study|Serious Adverse Event|2|||
146093635|NCT05419908|526863509|FG000|Overall Study|Withdrawal by Subject|2|||
146093636|NCT05419908|526863510|FG001|Overall Study|Withdrawal by Subject|0|||
146093637|NCT05419908|526863509|FG000|Overall Study|Miscellaneous|1|||
146093638|NCT05419908|526863510|FG001|Overall Study|Miscellaneous|1|||
146093639|NCT05069259|526863514|FG000|Overall Study|Withdrawal by Subject|1|||
146093640|NCT05069259|526863514|FG000|Overall Study|Sponsor decision|1|||
146093641|NCT01828320|526863516|FG000|Overall Study|Lost to Follow-up|1|||
146093642|NCT01828320|526863517|FG001|Overall Study|Lost to Follow-up|3|||
146093643|NCT01828320|526863516|FG000|Overall Study|Withdrawal by Subject|7|||
146093644|NCT01828320|526863517|FG001|Overall Study|Withdrawal by Subject|2|||
146093645|NCT02160782|526864856|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
146093646|NCT02160782|526864857|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
146093647|NCT02160782|526864858|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
146093648|NCT02160782|526864859|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
146093649|NCT02160782|526864860|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
146093650|NCT02160782|526864856|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146093651|NCT02160782|526864857|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146093652|NCT02160782|526864858|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146093653|NCT02160782|526864859|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
146093654|NCT02160782|526864860|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
146093655|NCT02160782|526864856|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146093656|NCT02160782|526864857|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146093657|NCT02160782|526864858|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146093658|NCT02160782|526864859|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
146093659|NCT02160782|526864860|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
146093660|NCT02160782|526864856|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146093661|NCT02160782|526864857|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146093662|NCT02160782|526864858|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146093663|NCT02160782|526864859|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
146093664|NCT02160782|526864860|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
146093665|NCT02160782|526864856|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146093666|NCT02160782|526864857|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146093667|NCT02160782|526864858|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146299716|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
146015814|NCT02954406|526568094|FG002|Overall Study|Adverse Event|0|||
146015815|NCT02954406|526568095|FG003|Overall Study|Adverse Event|0|||
146015816|NCT02954406|526568096|FG004|Overall Study|Adverse Event|1|||
146015817|NCT02954406|526568097|FG005|Overall Study|Adverse Event|0|||
146015818|NCT02954406|526568098|FG006|Overall Study|Adverse Event|0|||
146015819|NCT02954406|526568099|FG007|Overall Study|Adverse Event|0|||
146015820|NCT02954406|526568100|FG008|Overall Study|Adverse Event|1|||
146015821|NCT02954406|526568101|FG009|Overall Study|Adverse Event|1|||
146015822|NCT02954406|526568102|FG010|Overall Study|Adverse Event|0|||
146015823|NCT02954406|526568092|FG000|Overall Study|Progressive Disease|3|||
146015824|NCT02954406|526568093|FG001|Overall Study|Progressive Disease|4|||
146015825|NCT02954406|526568094|FG002|Overall Study|Progressive Disease|3|||
146015826|NCT02954406|526568095|FG003|Overall Study|Progressive Disease|4|||
146015827|NCT02954406|526568096|FG004|Overall Study|Progressive Disease|3|||
146015828|NCT02954406|526568097|FG005|Overall Study|Progressive Disease|3|||
146015829|NCT02954406|526568098|FG006|Overall Study|Progressive Disease|2|||
146015830|NCT02954406|526568099|FG007|Overall Study|Progressive Disease|2|||
146015831|NCT02954406|526568100|FG008|Overall Study|Progressive Disease|1|||
146015832|NCT02954406|526568101|FG009|Overall Study|Progressive Disease|1|||
146015833|NCT02954406|526568102|FG010|Overall Study|Progressive Disease|0|||
146015834|NCT02954406|526568092|FG000|Overall Study|Symptomatic Deterioration|0|||
146015835|NCT02954406|526568093|FG001|Overall Study|Symptomatic Deterioration|1|||
146015836|NCT02954406|526568094|FG002|Overall Study|Symptomatic Deterioration|0|||
146015837|NCT02954406|526568095|FG003|Overall Study|Symptomatic Deterioration|0|||
146015838|NCT02954406|526568096|FG004|Overall Study|Symptomatic Deterioration|0|||
146015839|NCT02954406|526568097|FG005|Overall Study|Symptomatic Deterioration|0|||
146015840|NCT02954406|526568098|FG006|Overall Study|Symptomatic Deterioration|0|||
146015841|NCT02954406|526568099|FG007|Overall Study|Symptomatic Deterioration|0|||
146015842|NCT02954406|526568100|FG008|Overall Study|Symptomatic Deterioration|0|||
146015843|NCT02954406|526568101|FG009|Overall Study|Symptomatic Deterioration|0|||
146015844|NCT02954406|526568102|FG010|Overall Study|Symptomatic Deterioration|0|||
146015845|NCT02954406|526568092|FG000|Overall Study|Death|0|||
146015846|NCT02954406|526568093|FG001|Overall Study|Death|0|||
146015847|NCT02954406|526568094|FG002|Overall Study|Death|0|||
146015848|NCT02954406|526568095|FG003|Overall Study|Death|0|||
146015849|NCT02954406|526568096|FG004|Overall Study|Death|1|||
146015850|NCT02954406|526568097|FG005|Overall Study|Death|0|||
146015851|NCT02954406|526568098|FG006|Overall Study|Death|0|||
146015852|NCT02954406|526568099|FG007|Overall Study|Death|0|||
146015853|NCT02954406|526568100|FG008|Overall Study|Death|1|||
146015854|NCT02954406|526568101|FG009|Overall Study|Death|1|||
146015855|NCT02954406|526568102|FG010|Overall Study|Death|0|||
146015856|NCT02954406|526568092|FG000|Overall Study|Reason Not Specified|0|||
146015857|NCT02954406|526568093|FG001|Overall Study|Reason Not Specified|0|||
146015858|NCT02954406|526568094|FG002|Overall Study|Reason Not Specified|3|||
146015859|NCT02954406|526568095|FG003|Overall Study|Reason Not Specified|2|||
146015860|NCT02954406|526568096|FG004|Overall Study|Reason Not Specified|2|||
146015861|NCT02954406|526568097|FG005|Overall Study|Reason Not Specified|0|||
146015862|NCT02954406|526568098|FG006|Overall Study|Reason Not Specified|1|||
146015863|NCT02954406|526568099|FG007|Overall Study|Reason Not Specified|0|||
146015864|NCT02954406|526568100|FG008|Overall Study|Reason Not Specified|1|||
146015865|NCT02954406|526568101|FG009|Overall Study|Reason Not Specified|0|||
146015866|NCT02954406|526568102|FG010|Overall Study|Reason Not Specified|0|||
146015867|NCT04683029|526568109|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
146015868|NCT04683029|526568110|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146015869|NCT04683029|526568111|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146015870|NCT04683029|526568112|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
146015871|NCT04683029|526568109|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146015872|NCT04683029|526568110|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146093668|NCT02160782|526864859|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
146093669|NCT02160782|526864860|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
146093670|NCT02160782|526864856|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146093671|NCT02160782|526864857|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146250544|NCT02066389|527429225|FG003|Overall Study|Adverse Event|1|||
146015873|NCT04683029|526568111|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
146015874|NCT04683029|526568112|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
146015875|NCT04683029|526568109|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146015876|NCT04683029|526568110|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146015877|NCT04683029|526568111|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
146015878|NCT04683029|526568112|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
146015879|NCT04299308|526568113|FG000|Overall Study|Withdrawal by Subject|1|||
146015880|NCT04299308|526568114|FG001|Overall Study|Withdrawal by Subject|0|||
146015881|NCT04299308|526568113|FG000|Overall Study|issue with PET image (1)|1|||
146015882|NCT04299308|526568114|FG001|Overall Study|issue with PET image (1)|0|||
146015883|NCT00814580|526568115|FG000|Overall Study|Adverse Event|6|||
146015884|NCT00814580|526568116|FG001|Overall Study|Adverse Event|15|||
146015885|NCT00814580|526568115|FG000|Overall Study|Lack of Efficacy|18|||
146015886|NCT00814580|526568116|FG001|Overall Study|Lack of Efficacy|25|||
146015887|NCT00814580|526568115|FG000|Overall Study|Protocol Violation|2|||
146015888|NCT00814580|526568116|FG001|Overall Study|Protocol Violation|0|||
146015889|NCT00814580|526568115|FG000|Overall Study|Withdrawal by Subject|2|||
146015890|NCT00814580|526568116|FG001|Overall Study|Withdrawal by Subject|2|||
146015891|NCT00814580|526568115|FG000|Overall Study|Other|1|||
146015892|NCT00814580|526568116|FG001|Overall Study|Other|3|||
146015893|NCT00814580|526568115|FG000|Overall Study|Did Not Take Drug|2|||
146015894|NCT00814580|526568116|FG001|Overall Study|Did Not Take Drug|2|||
146015895|NCT02920528|526568121|FG000|Overall Study|Incomplete Data|1|||
146015896|NCT02920528|526568122|FG001|Overall Study|Incomplete Data|1|||
146015897|NCT02920528|526568123|FG002|Overall Study|Incomplete Data|1|||
146015898|NCT02920528|526568121|FG000|Overall Study|Adverse Event|0|||
146015899|NCT02920528|526568122|FG001|Overall Study|Adverse Event|0|||
146015900|NCT02920528|526568123|FG002|Overall Study|Adverse Event|3|||
146015901|NCT02920528|526568121|FG000|Overall Study|Did not meet inclusion criteria|2|||
146015902|NCT02920528|526568122|FG001|Overall Study|Did not meet inclusion criteria|0|||
146015903|NCT02920528|526568123|FG002|Overall Study|Did not meet inclusion criteria|1|||
146015904|NCT01340625|526568124|FG000|First Intervention|Adverse Event|1|||
146015905|NCT01340625|526568125|FG001|First Intervention|Adverse Event|0|||
146015906|NCT01340625|526568124|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
146015907|NCT01340625|526568125|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
146015908|NCT01986231|526568126|FG000|Overall Study|Adverse Event|1|||
146015909|NCT02003638|526568127|FG000|Overall Study|Withdrawal by Subject|1|||
146015910|NCT02003638|526568128|FG001|Overall Study|Withdrawal by Subject|0|||
146015911|NCT03249909|526568129|FG000|Overall Study|Withdrawal by Subject|3|||
146015912|NCT03249909|526568130|FG001|Overall Study|Withdrawal by Subject|0|||
146015913|NCT03249909|526568131|FG002|Overall Study|Withdrawal by Subject|0|||
146015914|NCT03249909|526568129|FG000|Overall Study|Adverse Event|3|||
146015915|NCT03249909|526568130|FG001|Overall Study|Adverse Event|0|||
146015916|NCT03249909|526568131|FG002|Overall Study|Adverse Event|0|||
146015917|NCT03249909|526568129|FG000|Overall Study|Lost to Follow-up|0|||
146015918|NCT03249909|526568130|FG001|Overall Study|Lost to Follow-up|1|||
146015919|NCT03249909|526568131|FG002|Overall Study|Lost to Follow-up|0|||
146015920|NCT00606034|526568132|FG000|Overall Study|incarceration|1|||
146015921|NCT05286658|526568134|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
146015922|NCT05286658|526568134|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
146015923|NCT00615719|526568135|FG000|Overall Study|Physician Decision|5|||
146015924|NCT03748706|526568136|FG000|Overall Study|Lost to Follow-up|1|||
146015925|NCT00842153|526568139|FG000|Overall Study|Adverse Event|0|||
146015926|NCT00842153|526568140|FG001|Overall Study|Adverse Event|1|||
146015927|NCT00842153|526568139|FG000|Overall Study|Lost to Follow-up|1|||
146015928|NCT00842153|526568140|FG001|Overall Study|Lost to Follow-up|2|||
146015929|NCT01355679|526568142|FG000|Overall Study|benign tumor types found at biopsy|2|||
146015930|NCT05319600|526568143|FG000|Overall Study|Withdrawal by Subject|1|||
146015931|NCT05319600|526568144|FG001|Overall Study|Withdrawal by Subject|0|||
146015932|NCT05319600|526568143|FG000|Overall Study|Lost to Follow-up|0|||
146015933|NCT05319600|526568144|FG001|Overall Study|Lost to Follow-up|4|||
146015934|NCT03423238|526568153|FG000|Overall Study|Lost to Follow-up|1|||
146015935|NCT03423238|526568154|FG001|Overall Study|Lost to Follow-up|0|||
146015936|NCT03423238|526568153|FG000|Overall Study|Withdrawal by Subject|1|||
146015937|NCT03423238|526568154|FG001|Overall Study|Withdrawal by Subject|0|||
146015938|NCT05141175|526568155|FG000|Overall Study|Withdrawal by Subject|1|||
146015939|NCT04470050|526568159|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146015940|NCT04470050|526568160|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146015941|NCT04470050|526568161|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146015942|NCT04470050|526568162|FG003|Double-blind Treatment Phase|Adverse Event|1|||
146015943|NCT04470050|526568163|FG004|Double-blind Treatment Phase|Adverse Event|0|||
146015944|NCT04470050|526568164|FG005|Double-blind Treatment Phase|Adverse Event|0|||
146250545|NCT02066389|527429226|FG004|Overall Study|Adverse Event|5|||
146250546|NCT02066389|527429227|FG005|Overall Study|Adverse Event|1|||
146015945|NCT04470050|526568165|FG006|Double-blind Treatment Phase|Adverse Event|0|||
146015946|NCT04470050|526568159|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015947|NCT04470050|526568160|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015948|NCT04470050|526568161|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015949|NCT04470050|526568162|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015950|NCT04470050|526568163|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
146015951|NCT04470050|526568164|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015952|NCT04470050|526568165|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
146015953|NCT04470050|526568159|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
146015954|NCT04470050|526568160|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
146015955|NCT04470050|526568161|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
146015956|NCT04470050|526568162|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146015957|NCT04470050|526568163|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
146250547|NCT02066389|527429222|FG000|Overall Study|Withdrawal by Subject|4|||
146250548|NCT02066389|527429223|FG001|Overall Study|Withdrawal by Subject|0|||
146250549|NCT02066389|527429224|FG002|Overall Study|Withdrawal by Subject|5|||
146250550|NCT02066389|527429225|FG003|Overall Study|Withdrawal by Subject|1|||
146250551|NCT02066389|527429226|FG004|Overall Study|Withdrawal by Subject|1|||
146250552|NCT02066389|527429227|FG005|Overall Study|Withdrawal by Subject|2|||
146250553|NCT02066389|527429222|FG000|Overall Study|Lost to Follow-up|0|||
146250554|NCT02066389|527429223|FG001|Overall Study|Lost to Follow-up|0|||
146250555|NCT02066389|527429224|FG002|Overall Study|Lost to Follow-up|0|||
146250556|NCT02066389|527429225|FG003|Overall Study|Lost to Follow-up|1|||
146250557|NCT02066389|527429226|FG004|Overall Study|Lost to Follow-up|1|||
146250558|NCT02066389|527429227|FG005|Overall Study|Lost to Follow-up|1|||
146250559|NCT02066389|527429222|FG000|Overall Study|Randomized in Error|0|||
146250560|NCT02066389|527429223|FG001|Overall Study|Randomized in Error|0|||
146250561|NCT02066389|527429224|FG002|Overall Study|Randomized in Error|0|||
146250562|NCT02066389|527429225|FG003|Overall Study|Randomized in Error|0|||
146250563|NCT02066389|527429226|FG004|Overall Study|Randomized in Error|0|||
146250564|NCT02066389|527429227|FG005|Overall Study|Randomized in Error|1|||
146250565|NCT04016415|527429230|FG000|Overall Study|Adverse Event|2|||
146250566|NCT04016415|527429231|FG001|Overall Study|Adverse Event|1|||
146250567|NCT04016415|527429230|FG000|Overall Study|Lost to Follow-up|6|||
146250568|NCT04016415|527429231|FG001|Overall Study|Lost to Follow-up|2|||
146250569|NCT04016415|527429230|FG000|Overall Study|Physician Decision|5|||
146250570|NCT04016415|527429231|FG001|Overall Study|Physician Decision|1|||
146250571|NCT04016415|527429230|FG000|Overall Study|Pregnancy|0|||
146250572|NCT04016415|527429231|FG001|Overall Study|Pregnancy|1|||
146250573|NCT04016415|527429230|FG000|Overall Study|Withdrawal by Subject|24|||
146250574|NCT04016415|527429231|FG001|Overall Study|Withdrawal by Subject|27|||
146250575|NCT04016415|527429230|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
146250576|NCT04016415|527429231|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
146250577|NCT03905512|527429237|FG000|Overall Study|Withdrawal by Subject|9|||
146250578|NCT03905512|527429238|FG001|Overall Study|Withdrawal by Subject|8|||
146250579|NCT03905512|527429237|FG000|Overall Study|Adverse Event|1|||
146250580|NCT03905512|527429238|FG001|Overall Study|Adverse Event|2|||
146250581|NCT03905512|527429237|FG000|Overall Study|Lost to Follow-up|4|||
146250582|NCT03905512|527429238|FG001|Overall Study|Lost to Follow-up|3|||
146250583|NCT03905512|527429237|FG000|Overall Study|Other than Specified|7|||
146250584|NCT03905512|527429238|FG001|Overall Study|Other than Specified|4|||
146250585|NCT00070317|527429243|FG000|Overall Study|Inevaluable (Never Treated)|1|||
146250586|NCT00070317|527429243|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
146250587|NCT00070317|527429243|FG000|Overall Study|Ineligible required test not done|1|||
146250588|NCT00070317|527429243|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
146250589|NCT00070317|527429243|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
146250590|NCT03560206|527429245|FG000|Overall Study|Lost to Follow-up|19|||
146250591|NCT03560206|527429246|FG001|Overall Study|Lost to Follow-up|11|||
146250592|NCT03560206|527429245|FG000|Overall Study|Withdrawal by Subject|2|||
146250593|NCT03560206|527429246|FG001|Overall Study|Withdrawal by Subject|4|||
146250594|NCT03560206|527429245|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
146250595|NCT03560206|527429246|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
146250596|NCT03560206|527429245|FG000|Overall Study|Busy schedule|14|||
146250597|NCT03560206|527429246|FG001|Overall Study|Busy schedule|2|||
146250598|NCT03560206|527429245|FG000|Overall Study|patients' new health condition such as cancer|10|||
146250599|NCT03560206|527429246|FG001|Overall Study|patients' new health condition such as cancer|1|||
146250600|NCT03987074|527429247|FG000|Overall Study|Withdrew Consent|1|||
146250601|NCT03987074|527429248|FG001|Overall Study|Withdrew Consent|1|||
146250602|NCT03987074|527429249|FG002|Overall Study|Withdrew Consent|0|||
146250603|NCT03987074|527429250|FG003|Overall Study|Withdrew Consent|2|||
146250604|NCT03987074|527429251|FG004|Overall Study|Withdrew Consent|1|||
146250605|NCT03987074|527429247|FG000|Overall Study|Adverse Event|2|||
146250606|NCT03987074|527429248|FG001|Overall Study|Adverse Event|1|||
146250607|NCT03987074|527429249|FG002|Overall Study|Adverse Event|0|||
146250608|NCT03987074|527429250|FG003|Overall Study|Adverse Event|0|||
146250609|NCT03987074|527429251|FG004|Overall Study|Adverse Event|1|||
146250610|NCT03987074|527429247|FG000|Overall Study|Lost to Follow-up|0|||
146250611|NCT03987074|527429248|FG001|Overall Study|Lost to Follow-up|0|||
146250612|NCT03987074|527429249|FG002|Overall Study|Lost to Follow-up|1|||
146250613|NCT03987074|527429250|FG003|Overall Study|Lost to Follow-up|1|||
146250614|NCT03987074|527429251|FG004|Overall Study|Lost to Follow-up|0|||
146250615|NCT03987074|527429247|FG000|Overall Study|Investigator's Discretion|0|||
146250616|NCT03987074|527429248|FG001|Overall Study|Investigator's Discretion|0|||
146250617|NCT03987074|527429249|FG002|Overall Study|Investigator's Discretion|0|||
146250618|NCT03987074|527429250|FG003|Overall Study|Investigator's Discretion|1|||
146250619|NCT03987074|527429251|FG004|Overall Study|Investigator's Discretion|0|||
146250620|NCT03100370|527429252|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146250621|NCT03100370|527429253|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146250622|NCT03100370|527429254|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146299717|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
146299718|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
146299719|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
146299720|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Early termination|0|||
146299721|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Early termination|0|||
146299722|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Early termination|34|||
146299723|NCT01493557|527613592|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
146299724|NCT01493557|527613593|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
146299725|NCT01493557|527613594|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
146299726|NCT01493557|527613592|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
146299727|NCT01493557|527613593|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
146299728|NCT01493557|527613594|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
146299729|NCT01493557|527613592|FG000|Randomized to Management Strategies|Other adverse event|8|||
146299730|NCT01493557|527613593|FG001|Randomized to Management Strategies|Other adverse event|5|||
146299731|NCT01493557|527613594|FG002|Randomized to Management Strategies|Other adverse event|0|||
146299732|NCT01493557|527613592|FG000|Randomized to Management Strategies|Protocol Violation|3|||
146299733|NCT01493557|527613593|FG001|Randomized to Management Strategies|Protocol Violation|0|||
146299734|NCT01493557|527613594|FG002|Randomized to Management Strategies|Protocol Violation|0|||
146299735|NCT01493557|527613592|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
146299736|NCT01493557|527613593|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
146299737|NCT01493557|527613594|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
146299738|NCT01493557|527613592|FG000|Randomized to Management Strategies|Other than stated above|1|||
146299739|NCT01493557|527613593|FG001|Randomized to Management Strategies|Other than stated above|3|||
146299740|NCT01493557|527613594|FG002|Randomized to Management Strategies|Other than stated above|0|||
146299741|NCT01493557|527613592|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
146299742|NCT01493557|527613593|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
146299743|NCT01493557|527613594|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
146299744|NCT01493557|527613592|FG000|Adding the Second Strategy|Other adverse event|1|||
146299745|NCT01493557|527613593|FG001|Adding the Second Strategy|Other adverse event|2|||
146299746|NCT01493557|527613594|FG002|Adding the Second Strategy|Other adverse event|0|||
146299747|NCT01493557|527613592|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
146299748|NCT01493557|527613593|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
146299749|NCT01493557|527613594|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
146015958|NCT04470050|526568164|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
146015959|NCT04470050|526568165|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
146015960|NCT01104545|526568166|FG000|Overall Study|Adverse Event|0|||
146015961|NCT01104545|526568167|FG001|Overall Study|Adverse Event|1|||
146015962|NCT01104545|526568168|FG002|Overall Study|Adverse Event|2|||
146015963|NCT03640507|526568169|FG000|Overall Study|Withdrawal by Subject|0|||
146015964|NCT03640507|526568170|FG001|Overall Study|Withdrawal by Subject|0|||
146015965|NCT03640507|526568171|FG002|Overall Study|Withdrawal by Subject|1|||
146015966|NCT03028129|526568174|FG000|Overall Study|Adverse Event|13|||
146015967|NCT03028129|526568175|FG001|Overall Study|Adverse Event|2|||
146015968|NCT03028129|526568174|FG000|Overall Study|Lost to Follow-up|50|||
146015969|NCT03028129|526568175|FG001|Overall Study|Lost to Follow-up|38|||
146015970|NCT03028129|526568174|FG000|Overall Study|Physician Decision|0|||
146015971|NCT03028129|526568175|FG001|Overall Study|Physician Decision|1|||
146015972|NCT03028129|526568174|FG000|Overall Study|Protocol Violation|1|||
146015973|NCT03028129|526568175|FG001|Overall Study|Protocol Violation|1|||
146015974|NCT03028129|526568174|FG000|Overall Study|Withdrawal by Subject|62|||
146015975|NCT03028129|526568175|FG001|Overall Study|Withdrawal by Subject|45|||
146015976|NCT00923351|526568176|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
146015977|NCT00923351|526568177|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
146015978|NCT00923351|526568178|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
146015979|NCT01076205|526568183|FG000|Overall Study|Adverse Drug Reaction|299|||
146015980|NCT01076205|526568183|FG000|Overall Study|Lack of Effectiveness|1423|||
146015981|NCT01076205|526568183|FG000|Overall Study|Other Reason|1075|||
146015982|NCT01076205|526568183|FG000|Overall Study|Unknown Reason|71|||
146015983|NCT01076205|526568183|FG000|Overall Study|Lost to Follow-up|3151|||
146015984|NCT02993822|526568189|FG000|Overall Study|Lack of Efficacy|1|||
146015985|NCT02993822|526568190|FG001|Overall Study|Lack of Efficacy|1|||
146015986|NCT02993822|526568191|FG002|Overall Study|Lack of Efficacy|0|||
146299750|NCT03335163|527613601|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
146015987|NCT02993822|526568192|FG003|Overall Study|Lack of Efficacy|0|||
146015988|NCT02993822|526568189|FG000|Overall Study|Protocol Violation|1|||
146015989|NCT02993822|526568190|FG001|Overall Study|Protocol Violation|0|||
146015990|NCT02993822|526568191|FG002|Overall Study|Protocol Violation|0|||
146015991|NCT02993822|526568192|FG003|Overall Study|Protocol Violation|0|||
146015992|NCT02993822|526568189|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
146015993|NCT02993822|526568190|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
146299751|NCT03335163|527613601|FG000|Overall Study|Withdrawal by Subject|18|||
146299752|NCT02020863|527613603|FG000|Overall Study|Discovery of Metastatic disease|4|||
146299753|NCT02020863|527613603|FG000|Overall Study|Team chose not to place an a line|1|||
146299754|NCT01920594|527613604|FG000|Overall Study|Adverse Event|4|||
146299755|NCT01920594|527613605|FG001|Overall Study|Adverse Event|2|||
146299756|NCT01920594|527613604|FG000|Overall Study|Lost to Follow-up|1|||
146299757|NCT01920594|527613605|FG001|Overall Study|Lost to Follow-up|0|||
146299758|NCT01920594|527613604|FG000|Overall Study|Recovery|2|||
146299759|NCT01920594|527613605|FG001|Overall Study|Recovery|0|||
146299760|NCT01920594|527613604|FG000|Overall Study|Investigator discretion|0|||
146299761|NCT01920594|527613605|FG001|Overall Study|Investigator discretion|1|||
146299762|NCT01448213|527613608|FG000|Overall Study|Lost to Follow-up|12|||
146299763|NCT01448213|527613609|FG001|Overall Study|Lost to Follow-up|10|||
146299764|NCT01448213|527613608|FG000|Overall Study|Adverse Event|4|||
146299765|NCT01448213|527613609|FG001|Overall Study|Adverse Event|10|||
146299766|NCT01448213|527613608|FG000|Overall Study|Protocol Violation|1|||
146299767|NCT01448213|527613609|FG001|Overall Study|Protocol Violation|2|||
146299768|NCT02012296|527613610|FG000|Overall Study|Lack of Efficacy|0|||
146299769|NCT02012296|527613611|FG001|Overall Study|Lack of Efficacy|0|||
146299770|NCT02012296|527613612|FG002|Overall Study|Lack of Efficacy|15|||
146299771|NCT02012296|527613610|FG000|Overall Study|Adverse Event|0|||
146299772|NCT02012296|527613611|FG001|Overall Study|Adverse Event|0|||
146299773|NCT02012296|527613612|FG002|Overall Study|Adverse Event|2|||
146299774|NCT02012296|527613610|FG000|Overall Study|Early study closure|0|||
146299775|NCT02012296|527613611|FG001|Overall Study|Early study closure|0|||
146299776|NCT02012296|527613612|FG002|Overall Study|Early study closure|5|||
146299777|NCT02012296|527613610|FG000|Overall Study|Protocol Violation|0|||
146299778|NCT02012296|527613611|FG001|Overall Study|Protocol Violation|1|||
146299779|NCT02012296|527613612|FG002|Overall Study|Protocol Violation|0|||
146299780|NCT03876171|527613613|FG000|Overall Study|Withdrawal by Subject|3|||
146299781|NCT03876171|527613614|FG001|Overall Study|Withdrawal by Subject|3|||
146299782|NCT03876171|527613613|FG000|Overall Study|Re-arrest|0|||
146299783|NCT03876171|527613614|FG001|Overall Study|Re-arrest|4|||
146299784|NCT01330914|527613615|FG000|Overall Study|Withdrawal by Subject|4|||
146299785|NCT01330914|527613615|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
146299786|NCT01170039|527613622|FG000|Overall Study|Withdrawal by Subject|5|||
146299787|NCT01170039|527613623|FG001|Overall Study|Withdrawal by Subject|3|||
146299788|NCT01170039|527613622|FG000|Overall Study|Lack of funding, drug not available|3|||
146299789|NCT01170039|527613623|FG001|Overall Study|Lack of funding, drug not available|3|||
146299790|NCT00908583|527613624|FG000|Phase 1|Withdrawal by Subject|1|||
146299791|NCT00908583|527613624|FG000|Phase 1|Adverse Event|4|||
146299792|NCT00908583|527613624|FG000|Phase 2|Physician Decision|1|||
146299793|NCT00908583|527613624|FG000|Phase 2|Adverse Event|1|||
146299794|NCT00908583|527613624|FG000|Phase 3|Adverse Event|2|||
146299795|NCT00908583|527613624|FG000|Phase 4|Adverse Event|1|||
146299796|NCT00908583|527613624|FG000|Phase 4|Physician Decision|1|||
146299797|NCT00908583|527613624|FG000|Phase 5|Adverse Event|3|||
146299798|NCT00993954|527613625|FG000|Overall Study|Protocol Violation|21|||
146299799|NCT00993954|527613626|FG001|Overall Study|Protocol Violation|2|||
146299800|NCT00860951|527613627|FG000|Overall Study|Withdrawal by Subject|2|||
146299801|NCT00860951|527613627|FG000|Overall Study|Lost to Follow-up|5|||
146299802|NCT00727649|527613628|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
146299803|NCT00727649|527613629|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
146299804|NCT00727649|527613628|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
146299805|NCT00727649|527613629|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
146299806|NCT00727649|527613628|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
146299807|NCT00727649|527613629|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
146299808|NCT00727649|527613628|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
146299809|NCT00727649|527613629|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
146299810|NCT00727649|527613628|FG000|Second Intervention (4-weeks)|Death|1|||
146015994|NCT02993822|526568191|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
146015995|NCT02993822|526568192|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
146015996|NCT02993822|526568189|FG000|Overall Study|Adverse Event|3|||
146015997|NCT02993822|526568190|FG001|Overall Study|Adverse Event|1|||
146015998|NCT02993822|526568191|FG002|Overall Study|Adverse Event|7|||
146299811|NCT00727649|527613629|FG001|Second Intervention (4-weeks)|Death|0|||
146299812|NCT00727649|527613628|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
146299813|NCT00727649|527613629|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
146299814|NCT00727649|527613628|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
146299815|NCT00727649|527613629|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
146299816|NCT02953639|527613632|FG000|Overall Study|Adverse Event|2|||
146299817|NCT02953639|527613633|FG001|Overall Study|Adverse Event|0|||
146299818|NCT02953639|527613634|FG002|Overall Study|Adverse Event|1|||
146299819|NCT02953639|527613632|FG000|Overall Study|Lost to Follow-up|8|||
146299820|NCT02953639|527613633|FG001|Overall Study|Lost to Follow-up|4|||
146015999|NCT02993822|526568192|FG003|Overall Study|Adverse Event|0|||
146299821|NCT02953639|527613634|FG002|Overall Study|Lost to Follow-up|3|||
146299822|NCT02953639|527613632|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146016000|NCT02993822|526568189|FG000|Overall Study|Withdrawal by Subject|4|||
146016001|NCT02993822|526568190|FG001|Overall Study|Withdrawal by Subject|2|||
146016002|NCT02993822|526568191|FG002|Overall Study|Withdrawal by Subject|2|||
146016003|NCT02993822|526568192|FG003|Overall Study|Withdrawal by Subject|3|||
146250623|NCT03100370|527429255|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146250624|NCT03100370|527429256|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146250625|NCT03100370|527429257|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146250626|NCT00508144|527429260|FG000|Overall Study|Not eligible|6|||
146250627|NCT00508144|527429260|FG000|Overall Study|Death|5|||
146250628|NCT01084772|527429262|FG000|Baseline|Withdrawal by Subject|7|||
146250629|NCT01084772|527429263|FG001|Baseline|Withdrawal by Subject|6|||
146250630|NCT01084772|527429262|FG000|3 Months|Death|1|||
146250631|NCT01084772|527429263|FG001|3 Months|Death|0|||
146250632|NCT01084772|527429262|FG000|3 Months|Study Termination|2|||
146250633|NCT01084772|527429263|FG001|3 Months|Study Termination|2|||
146250634|NCT01084772|527429262|FG000|1 Year|Withdrawal by Subject|0|||
146250635|NCT01084772|527429263|FG001|1 Year|Withdrawal by Subject|1|||
146250636|NCT01084772|527429262|FG000|1 Year|Lost to Follow-up|3|||
146250637|NCT01084772|527429263|FG001|1 Year|Lost to Follow-up|0|||
146250638|NCT01084772|527429262|FG000|1 Year|Study Termination|0|||
146250639|NCT01084772|527429263|FG001|1 Year|Study Termination|7|||
146250640|NCT01084772|527429262|FG000|2 Years|Withdrawal by Subject|1|||
146250641|NCT01084772|527429263|FG001|2 Years|Withdrawal by Subject|0|||
146250642|NCT01084772|527429262|FG000|2 Years|Lost to Follow-up|5|||
146250643|NCT01084772|527429263|FG001|2 Years|Lost to Follow-up|2|||
146250644|NCT01084772|527429262|FG000|2 Years|Study Termination|3|||
146250645|NCT01084772|527429263|FG001|2 Years|Study Termination|2|||
146250646|NCT02009865|527429265|FG000|Overall Study|Adverse Event|0|||
146250647|NCT02009865|527429266|FG001|Overall Study|Adverse Event|2|||
146250648|NCT02009865|527429265|FG000|Overall Study|Protocol Violation|0|||
146250649|NCT02009865|527429266|FG001|Overall Study|Protocol Violation|2|||
146250650|NCT02009865|527429265|FG000|Overall Study|Withdrawal by Subject|1|||
146250651|NCT02009865|527429266|FG001|Overall Study|Withdrawal by Subject|1|||
146250652|NCT01517282|527429267|FG000|Overall Study|Consent withdrawn|0|||
146250653|NCT01517282|527429268|FG001|Overall Study|Consent withdrawn|1|||
146250654|NCT01517282|527429269|FG002|Overall Study|Consent withdrawn|1|||
146250655|NCT01517282|527429270|FG003|Overall Study|Consent withdrawn|1|||
146250656|NCT01517282|527429267|FG000|Overall Study|Physician Decision|1|||
146250657|NCT01517282|527429268|FG001|Overall Study|Physician Decision|0|||
146250658|NCT01517282|527429269|FG002|Overall Study|Physician Decision|0|||
146250659|NCT01517282|527429270|FG003|Overall Study|Physician Decision|0|||
146250660|NCT00525915|527429271|FG000|Overall Study|Non-Compliance|0|||
146250661|NCT00525915|527429272|FG001|Overall Study|Non-Compliance|1|||
146250662|NCT00525915|527429271|FG000|Overall Study|Disease Progression|5|||
146250663|NCT00525915|527429272|FG001|Overall Study|Disease Progression|6|||
146250664|NCT00525915|527429271|FG000|Overall Study|Withdrawal by Subject|1|||
146250665|NCT00525915|527429272|FG001|Overall Study|Withdrawal by Subject|0|||
146250666|NCT00525915|527429271|FG000|Overall Study|Refused Surgery|1|||
146250667|NCT00525915|527429272|FG001|Overall Study|Refused Surgery|2|||
146250668|NCT00525915|527429271|FG000|Overall Study|Unrelated illness|1|||
146250669|NCT00525915|527429272|FG001|Overall Study|Unrelated illness|0|||
146250670|NCT02332889|527429280|FG000|Overall Study|Physician Decision|1|||
146250671|NCT02135445|527429284|FG000|Overall Study|Lost to Follow-up|1|||
146250672|NCT02135445|527429285|FG001|Overall Study|Lost to Follow-up|0|||
146250673|NCT02135445|527429284|FG000|Overall Study|Withdrawal by Subject|1|||
146250674|NCT02135445|527429285|FG001|Overall Study|Withdrawal by Subject|0|||
146250675|NCT04097535|527429288|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
146250676|NCT03070301|527429289|FG000|Overall Study|Progression of disease|16|||
146250677|NCT03070301|527429289|FG000|Overall Study|Physician Decision|3|||
146250678|NCT03070301|527429289|FG000|Overall Study|Withdrawal by Subject|1|||
146250679|NCT03556891|527429290|FG000|Initial Pivotal Study|Adverse Event|4|||
146016004|NCT02993822|526568189|FG000|Overall Study|Lost to Follow-up|1|||
146016005|NCT02993822|526568190|FG001|Overall Study|Lost to Follow-up|0|||
146250680|NCT03556891|527429290|FG000|Initial Pivotal Study|MRI Need|3|||
146250681|NCT03556891|527429290|FG000|Initial Pivotal Study|Device Failure|1|||
146250682|NCT03556891|527429290|FG000|Initial Pivotal Study|Death|1|||
146250683|NCT03556891|527429290|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
146250684|NCT03556891|527429290|FG000|Initial Pivotal Study|Missing at random|1|||
146250685|NCT03556891|527429290|FG000|Initial Pivotal Study|Missing due to COVID|1|||
146250686|NCT03556891|527429290|FG000|Initial Pivotal Study|Protocol Violation|1|||
146250687|NCT00489489|527430434|FG000|Overall Study|Not treated due to protocol violation|0|||
146250688|NCT00489489|527430435|FG001|Overall Study|Not treated due to protocol violation|1|||
146250689|NCT00489489|527430436|FG002|Overall Study|Not treated due to protocol violation|1|||
146250690|NCT00489489|527430434|FG000|Overall Study|Adverse Event|1|||
146250691|NCT00489489|527430435|FG001|Overall Study|Adverse Event|1|||
146250692|NCT00489489|527430436|FG002|Overall Study|Adverse Event|1|||
146250693|NCT00489489|527430434|FG000|Overall Study|Protocol Violation|1|||
146016006|NCT02993822|526568191|FG002|Overall Study|Lost to Follow-up|1|||
146016007|NCT02993822|526568192|FG003|Overall Study|Lost to Follow-up|0|||
146016008|NCT01939977|526568193|FG000|Overall Study|Adverse Event|4|||
146016009|NCT01939977|526568194|FG001|Overall Study|Adverse Event|3|||
146016010|NCT01939977|526568193|FG000|Overall Study|Lack of Efficacy|3|||
146016011|NCT01939977|526568194|FG001|Overall Study|Lack of Efficacy|0|||
146016012|NCT01939977|526568193|FG000|Overall Study|Physician Decision|1|||
146016013|NCT01939977|526568194|FG001|Overall Study|Physician Decision|1|||
146016014|NCT01939977|526568193|FG000|Overall Study|Withdrawal by Subject|0|||
146016015|NCT01939977|526568194|FG001|Overall Study|Withdrawal by Subject|2|||
146016016|NCT01939977|526568193|FG000|Overall Study|Did not meet inclusion criteria|1|||
146016017|NCT01939977|526568194|FG001|Overall Study|Did not meet inclusion criteria|0|||
146016018|NCT01939977|526568193|FG000|Overall Study|Did not receive study medication|0|||
146016019|NCT01939977|526568194|FG001|Overall Study|Did not receive study medication|1|||
146016020|NCT01696981|526568205|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
146016021|NCT01696981|526568206|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
146016022|NCT01696981|526568205|FG000|Overall Study|Died Before Randomization|3|||
146016023|NCT01696981|526568206|FG001|Overall Study|Died Before Randomization|8|||
146016024|NCT01696981|526568205|FG000|Overall Study|Died Before ASU (Control)|278|||
146016025|NCT01696981|526568206|FG001|Overall Study|Died Before ASU (Control)|0|||
146016026|NCT01696981|526568205|FG000|Overall Study|Refused ASU (Control)|920|||
146016027|NCT01696981|526568206|FG001|Overall Study|Refused ASU (Control)|0|||
146016028|NCT01696981|526568205|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
146016029|NCT01696981|526568206|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
146016030|NCT00851890|526568209|FG000|Overall Study|Lost to Follow-up|0|||
146016031|NCT00851890|526568210|FG001|Overall Study|Lost to Follow-up|1|||
146016032|NCT00851890|526568211|FG002|Overall Study|Lost to Follow-up|0|||
146016033|NCT00851890|526568212|FG003|Overall Study|Lost to Follow-up|1|||
146016034|NCT02597452|526568213|FG000|Overall Study|testing incomplete|30|||
146016035|NCT00281099|526568214|FG000|Overall Study|Death|46|||
146016036|NCT00281099|526568215|FG001|Overall Study|Death|57|||
146016037|NCT00281099|526568214|FG000|Overall Study|Lost to Follow-up|10|||
146016038|NCT00281099|526568215|FG001|Overall Study|Lost to Follow-up|19|||
146016039|NCT00281099|526568214|FG000|Overall Study|Withdrawal by Subject|65|||
146016040|NCT00281099|526568215|FG001|Overall Study|Withdrawal by Subject|70|||
146016041|NCT00281099|526568214|FG000|Overall Study|Physician Decision|79|||
146016042|NCT00281099|526568215|FG001|Overall Study|Physician Decision|72|||
146016043|NCT00281099|526568214|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
146016044|NCT00281099|526568215|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
146016045|NCT06899737|526568220|FG000|Overall Study|Lost to Follow-up|19|||
146016046|NCT06899737|526568221|FG001|Overall Study|Lost to Follow-up|7|||
146016047|NCT01170273|526568223|FG000|Overall Study|Lost to Follow-up|6|||
146016048|NCT01170273|526568224|FG001|Overall Study|Lost to Follow-up|8|||
146016049|NCT01170273|526568223|FG000|Overall Study|Protocol Violation|1|||
146016050|NCT01170273|526568224|FG001|Overall Study|Protocol Violation|0|||
146016051|NCT01170273|526568223|FG000|Overall Study|Death|1|||
146016052|NCT01170273|526568224|FG001|Overall Study|Death|0|||
146016053|NCT01170273|526568223|FG000|Overall Study|Adverse Event|0|||
146016054|NCT01170273|526568224|FG001|Overall Study|Adverse Event|1|||
146016055|NCT00334737|526568225|FG000|Hospital Phase|Death|1|||
146016056|NCT00334737|526568226|FG001|Hospital Phase|Death|2|||
146016057|NCT00334737|526568227|FG002|Hospital Phase|Death|3|||
146016058|NCT00334737|526568225|FG000|Hospital Phase|Withdrawal by Subject|0|||
146016059|NCT00334737|526568226|FG001|Hospital Phase|Withdrawal by Subject|0|||
146016060|NCT00334737|526568227|FG002|Hospital Phase|Withdrawal by Subject|1|||
146016061|NCT00334737|526568225|FG000|Hospital Phase|Did not receive study drug|1|||
146016062|NCT00334737|526568226|FG001|Hospital Phase|Did not receive study drug|0|||
146016063|NCT00334737|526568227|FG002|Hospital Phase|Did not receive study drug|0|||
146016064|NCT00334737|526568225|FG000|Follow up Phase|Lost to Follow-up|5|||
146016065|NCT00334737|526568226|FG001|Follow up Phase|Lost to Follow-up|3|||
146016066|NCT00334737|526568227|FG002|Follow up Phase|Lost to Follow-up|6|||
146016067|NCT02316353|526568228|FG000|Overall Study|Pregnancy|1|||
146016068|NCT02316353|526568229|FG001|Overall Study|Pregnancy|3|||
146016069|NCT02316353|526568228|FG000|Overall Study|Adverse Event|1|||
146016070|NCT02316353|526568229|FG001|Overall Study|Adverse Event|3|||
146093672|NCT02160782|526864858|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146016071|NCT02316353|526568228|FG000|Overall Study|Withdrawal by Subject|6|||
146016072|NCT02316353|526568229|FG001|Overall Study|Withdrawal by Subject|2|||
146093673|NCT02160782|526864859|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
146016073|NCT01691014|526569810|FG000|Overall Study|Premature Termination|1|||
146016074|NCT01691014|526569811|FG001|Overall Study|Premature Termination|6|||
146016075|NCT01691014|526569812|FG002|Overall Study|Premature Termination|0|||
146016076|NCT01691014|526569813|FG003|Overall Study|Premature Termination|3|||
146016077|NCT01691014|526569810|FG000|Overall Study|Other|0|||
146016078|NCT01691014|526569811|FG001|Overall Study|Other|0|||
146016079|NCT01691014|526569812|FG002|Overall Study|Other|2|||
146016080|NCT01691014|526569813|FG003|Overall Study|Other|0|||
146016081|NCT01691014|526569810|FG000|Overall Study|Withdrawal by Subject|0|||
146016082|NCT01691014|526569811|FG001|Overall Study|Withdrawal by Subject|1|||
146016083|NCT01691014|526569812|FG002|Overall Study|Withdrawal by Subject|1|||
146016084|NCT01691014|526569813|FG003|Overall Study|Withdrawal by Subject|1|||
146016085|NCT01691014|526569810|FG000|Overall Study|Adverse Event|0|||
146016086|NCT01691014|526569811|FG001|Overall Study|Adverse Event|5|||
146016087|NCT01691014|526569812|FG002|Overall Study|Adverse Event|1|||
146016088|NCT01691014|526569813|FG003|Overall Study|Adverse Event|1|||
146016089|NCT01691014|526569810|FG000|Overall Study|Lack of Efficacy|2|||
146016090|NCT01691014|526569811|FG001|Overall Study|Lack of Efficacy|3|||
146016091|NCT01691014|526569812|FG002|Overall Study|Lack of Efficacy|7|||
146016092|NCT01691014|526569813|FG003|Overall Study|Lack of Efficacy|0|||
146016093|NCT03372551|526569814|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
146016094|NCT03372551|526569815|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
146016095|NCT00066703|526569816|FG000|Overall Study|Adverse Event|80|||
146016096|NCT00066703|526569817|FG001|Overall Study|Adverse Event|111|||
146016097|NCT00066703|526569816|FG000|Overall Study|Death|3|||
146016098|NCT00066703|526569817|FG001|Overall Study|Death|0|||
146016099|NCT00066703|526569816|FG000|Overall Study|Lack of Efficacy|114|||
146016100|NCT00066703|526569817|FG001|Overall Study|Lack of Efficacy|69|||
146016101|NCT00066703|526569816|FG000|Overall Study|Lost to Follow-up|31|||
146016102|NCT00066703|526569817|FG001|Overall Study|Lost to Follow-up|28|||
146016103|NCT00066703|526569816|FG000|Overall Study|Withdrawal by Subject|38|||
146016104|NCT00066703|526569817|FG001|Overall Study|Withdrawal by Subject|63|||
146016105|NCT00066703|526569816|FG000|Overall Study|Treatment ongoing|346|||
146016106|NCT00066703|526569817|FG001|Overall Study|Treatment ongoing|311|||
146016107|NCT01696968|526569818|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
146016108|NCT01696968|526569819|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
146016109|NCT01696968|526569818|FG000|Overall Study|Died Before Randomization|3|||
146016110|NCT01696968|526569819|FG001|Overall Study|Died Before Randomization|8|||
146016111|NCT01696968|526569818|FG000|Overall Study|Died Before ASU (Control)|278|||
146016112|NCT01696968|526569819|FG001|Overall Study|Died Before ASU (Control)|0|||
146016113|NCT01696968|526569818|FG000|Overall Study|Refused ASU (Control)|920|||
146016114|NCT01696968|526569819|FG001|Overall Study|Refused ASU (Control)|0|||
146016115|NCT01696968|526569818|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
146016116|NCT01696968|526569819|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
146016117|NCT03727646|526569820|FG000|Overall Study|Adverse Event|1|||
146016118|NCT03727646|526569821|FG001|Overall Study|Adverse Event|0|||
146016119|NCT04753658|526569824|FG000|Overall Study|Progressive disease|7|||
146016120|NCT04753658|526569824|FG000|Overall Study|Other|7|||
146016121|NCT04753658|526569824|FG000|Overall Study|Adverse Event|1|||
146016122|NCT05659719|526569825|FG000|Overall Study|At sponsor's request|0|||
146016123|NCT05659719|526569826|FG001|Overall Study|At sponsor's request|0|||
146016124|NCT05659719|526569827|FG002|Overall Study|At sponsor's request|0|||
146016125|NCT05659719|526569828|FG003|Overall Study|At sponsor's request|95|||
146016126|NCT05659719|526569825|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146016127|NCT05659719|526569826|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146016128|NCT05659719|526569827|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
146016129|NCT05659719|526569828|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
146250694|NCT00489489|527430435|FG001|Overall Study|Protocol Violation|0|||
146250695|NCT00489489|527430436|FG002|Overall Study|Protocol Violation|1|||
146250696|NCT00489489|527430434|FG000|Overall Study|Progressive disease|0|||
146250697|NCT00489489|527430435|FG001|Overall Study|Progressive disease|1|||
146250698|NCT00489489|527430436|FG002|Overall Study|Progressive disease|0|||
146250699|NCT00489489|527430434|FG000|Overall Study|Participant did not wish to continue|1|||
146250700|NCT00489489|527430435|FG001|Overall Study|Participant did not wish to continue|1|||
146250701|NCT00489489|527430436|FG002|Overall Study|Participant did not wish to continue|0|||
146250702|NCT00489489|527430434|FG000|Overall Study|Other than above|0|||
146250703|NCT00489489|527430435|FG001|Overall Study|Other than above|1|||
146250704|NCT00489489|527430436|FG002|Overall Study|Other than above|0|||
146250705|NCT03978130|527430439|FG000|Overall Study|Lost to Follow-up|13|||
146250706|NCT03978130|527430440|FG001|Overall Study|Lost to Follow-up|14|||
146250707|NCT03978130|527430439|FG000|Overall Study|Withdrawal by Subject|12|||
146250708|NCT03978130|527430440|FG001|Overall Study|Withdrawal by Subject|2|||
146250709|NCT03978130|527430439|FG000|Overall Study|Adverse Event|2|||
146250710|NCT03978130|527430440|FG001|Overall Study|Adverse Event|1|||
146250711|NCT02136797|527430445|FG000|Overall Study|Not Treated|8|||
146016130|NCT05659719|526569825|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
146016131|NCT05659719|526569826|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
146016132|NCT05659719|526569827|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
146250712|NCT04523571|527430446|FG000|Received 2 Doses|Withdrawal by Subject|0|||
146250713|NCT04523571|527430447|FG001|Received 2 Doses|Withdrawal by Subject|0|||
146250714|NCT04523571|527430448|FG002|Received 2 Doses|Withdrawal by Subject|0|||
146016133|NCT05659719|526569828|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
146250715|NCT04523571|527430449|FG003|Received 2 Doses|Withdrawal by Subject|1|||
146250716|NCT04523571|527430450|FG004|Received 2 Doses|Withdrawal by Subject|1|||
146016134|NCT05659719|526569825|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146016135|NCT05659719|526569826|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146016136|NCT05659719|526569827|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
146016137|NCT05659719|526569828|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
146016138|NCT05659719|526569825|FG000|Overall Study|Lost to Follow-up|0|||
146016139|NCT05659719|526569826|FG001|Overall Study|Lost to Follow-up|0|||
146016140|NCT05659719|526569827|FG002|Overall Study|Lost to Follow-up|0|||
146016141|NCT05659719|526569828|FG003|Overall Study|Lost to Follow-up|2|||
146016142|NCT05659719|526569825|FG000|Overall Study|Moved to another observational study|0|||
146016143|NCT05659719|526569826|FG001|Overall Study|Moved to another observational study|0|||
146250717|NCT04523571|527430451|FG005|Received 2 Doses|Withdrawal by Subject|0|||
146250718|NCT04523571|527430446|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
146250719|NCT04523571|527430447|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146250720|NCT04523571|527430448|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
146016144|NCT05659719|526569827|FG002|Overall Study|Moved to another observational study|0|||
146016145|NCT05659719|526569828|FG003|Overall Study|Moved to another observational study|1|||
146016146|NCT05659719|526569825|FG000|Overall Study|The child was enrolled in an interventional study|0|||
146016147|NCT05659719|526569826|FG001|Overall Study|The child was enrolled in an interventional study|0|||
146016148|NCT05659719|526569827|FG002|Overall Study|The child was enrolled in an interventional study|0|||
146016149|NCT05659719|526569828|FG003|Overall Study|The child was enrolled in an interventional study|55|||
146016150|NCT05659719|526569825|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146016151|NCT05659719|526569826|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146016152|NCT05659719|526569827|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
146016153|NCT05659719|526569828|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
146016154|NCT05659719|526569825|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146016155|NCT05659719|526569826|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146016156|NCT05659719|526569827|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
146016157|NCT05659719|526569828|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
146016158|NCT05924165|526569835|FG000|Overall Study|Physician Decision|2|||
146016159|NCT05924165|526569836|FG001|Overall Study|Physician Decision|3|||
146016160|NCT01681186|526569837|FG000|Washout Period From Second Intervention|Adverse Event|0|||
146016161|NCT01681186|526569838|FG001|Washout Period From Second Intervention|Adverse Event|0|||
146016162|NCT01681186|526569839|FG002|Washout Period From Second Intervention|Adverse Event|0|||
146016163|NCT01681186|526569840|FG003|Washout Period From Second Intervention|Adverse Event|0|||
146016164|NCT01681186|526569841|FG004|Washout Period From Second Intervention|Adverse Event|0|||
146016165|NCT01681186|526569842|FG005|Washout Period From Second Intervention|Adverse Event|0|||
146016166|NCT01681186|526569843|FG006|Washout Period From Second Intervention|Adverse Event|1|||
146016167|NCT01681186|526569844|FG007|Washout Period From Second Intervention|Adverse Event|0|||
146016168|NCT01681186|526569837|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
146016169|NCT01681186|526569838|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
146016170|NCT01681186|526569839|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
146016171|NCT01681186|526569840|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
146016172|NCT01681186|526569841|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
146016173|NCT01681186|526569842|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
146016174|NCT01681186|526569843|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
146016175|NCT01681186|526569844|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
146016176|NCT01681186|526569837|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016177|NCT01681186|526569838|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016178|NCT01681186|526569839|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
146093674|NCT02160782|526864860|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
146250721|NCT04523571|527430449|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146250722|NCT04523571|527430450|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146250723|NCT04523571|527430451|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
146250724|NCT04523571|527430446|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146250725|NCT04523571|527430447|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146250726|NCT04523571|527430448|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146250727|NCT04523571|527430449|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146250728|NCT04523571|527430450|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
146250729|NCT04523571|527430451|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
146250730|NCT04523571|527430446|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146016179|NCT01681186|526569840|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016180|NCT01681186|526569841|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016181|NCT01681186|526569842|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016182|NCT01681186|526569843|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
146250731|NCT04523571|527430447|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146250732|NCT04523571|527430448|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146250733|NCT04523571|527430449|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
146250734|NCT04523571|527430450|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
146250735|NCT04523571|527430451|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
146250736|NCT04198428|527430452|FG000|Overall Study|Withdrawal by Subject|150|||
146250737|NCT04198428|527430453|FG001|Overall Study|Withdrawal by Subject|156|||
146250738|NCT03344458|527430456|FG000|Overall Study|Physician Decision|1|||
146250739|NCT03344458|527430456|FG000|Overall Study|Withdrawal by Subject|16|||
146250740|NCT03344458|527430456|FG000|Overall Study|Other reasons|10|||
146250741|NCT03344458|527430456|FG000|Overall Study|Lost to Follow-up|9|||
146250742|NCT03344458|527430456|FG000|Overall Study|Protocol Violation|3|||
146250743|NCT03696342|527430459|FG000|Overall Study|Lost to Follow-up|1|||
146250744|NCT03696342|527430460|FG001|Overall Study|Lost to Follow-up|0|||
146250745|NCT01816165|527430463|FG000|Overall Study|Adverse Event|1|||
146250746|NCT01816165|527430464|FG001|Overall Study|Adverse Event|0|||
146250747|NCT01816165|527430465|FG002|Overall Study|Adverse Event|0|||
146250748|NCT01816165|527430466|FG003|Overall Study|Adverse Event|0|||
146250749|NCT02409732|527430467|FG000|Overall Study|Withdrawal by Subject|4|||
146250750|NCT02409732|527430467|FG000|Overall Study|Lost to Follow-up|2|||
146250751|NCT03960437|527430469|FG000|Overall Study|Removed by PI|4|||
146250752|NCT03960437|527430469|FG000|Overall Study|Lost to Follow-up|2|||
146250753|NCT03960437|527430469|FG000|Overall Study|Withdrawal by Subject|1|||
146250754|NCT03960437|527430469|FG000|Overall Study|Death|2|||
146250755|NCT01838499|527430470|FG000|Overall Study|Protocol Violation|0|||
146250756|NCT01838499|527430471|FG001|Overall Study|Protocol Violation|1|||
146250757|NCT01838499|527430470|FG000|Overall Study|Lost to Follow-up|2|||
146250758|NCT01838499|527430471|FG001|Overall Study|Lost to Follow-up|4|||
146250759|NCT01838499|527430470|FG000|Overall Study|Lack of Efficacy|1|||
146250760|NCT01838499|527430471|FG001|Overall Study|Lack of Efficacy|2|||
146250761|NCT01838499|527430470|FG000|Overall Study|Adverse Event|2|||
146250762|NCT01838499|527430471|FG001|Overall Study|Adverse Event|1|||
146250763|NCT01838499|527430470|FG000|Overall Study|Withdrawal by Subject|19|||
146250764|NCT01838499|527430471|FG001|Overall Study|Withdrawal by Subject|9|||
146250765|NCT03614923|527430472|FG000|Overall Study|Withdrawal by Subject|2|||
146250766|NCT03614923|527430473|FG001|Overall Study|Withdrawal by Subject|1|||
146250767|NCT03614923|527430474|FG002|Overall Study|Withdrawal by Subject|1|||
146250768|NCT03614923|527430472|FG000|Overall Study|Adverse Event|0|||
146250769|NCT03614923|527430473|FG001|Overall Study|Adverse Event|2|||
146250770|NCT03614923|527430474|FG002|Overall Study|Adverse Event|1|||
146250771|NCT03614923|527430472|FG000|Overall Study|Lost to Follow-up|1|||
146250772|NCT03614923|527430473|FG001|Overall Study|Lost to Follow-up|0|||
146250773|NCT03614923|527430474|FG002|Overall Study|Lost to Follow-up|1|||
146250774|NCT03614923|527430472|FG000|Overall Study|Lack of Efficacy|2|||
146250775|NCT03614923|527430473|FG001|Overall Study|Lack of Efficacy|0|||
146250776|NCT03614923|527430474|FG002|Overall Study|Lack of Efficacy|1|||
146250777|NCT03614923|527430472|FG000|Overall Study|Non-compliance|0|||
146250778|NCT03614923|527430473|FG001|Overall Study|Non-compliance|1|||
146250779|NCT03614923|527430474|FG002|Overall Study|Non-compliance|0|||
146250780|NCT03614923|527430472|FG000|Overall Study|Other|0|||
146250781|NCT03614923|527430473|FG001|Overall Study|Other|1|||
146016183|NCT01681186|526569844|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
146016184|NCT01681186|526569837|FG000|Fourth Intervention|Protocol Violation|0|||
146016185|NCT01681186|526569838|FG001|Fourth Intervention|Protocol Violation|0|||
146250782|NCT03614923|527430474|FG002|Overall Study|Other|1|||
146250783|NCT01882088|527430475|FG000|Overall Study|Intolerance of esophageal manometry|1|||
146250784|NCT01882088|527430475|FG000|Overall Study|no possibility to place the catheter|1|||
146250785|NCT01882088|527430475|FG000|Overall Study|Protocol Violation|1|||
146250786|NCT01882088|527430475|FG000|Overall Study|inadequate pH-impedance tracings|2|||
146250787|NCT02030847|527430481|FG000|Overall Study|Death|10|||
146250788|NCT02030847|527430481|FG000|Overall Study|Disease Progression|15|||
146250789|NCT02030847|527430481|FG000|Overall Study|New Cancer Therapy|8|||
146250790|NCT02030847|527430481|FG000|Overall Study|Physician Decision|3|||
146250791|NCT02030847|527430481|FG000|Overall Study|Withdrawal by Subject|1|||
146250792|NCT00168805|527430482|FG000|Overall Study|Adverse Event|7|||
146250793|NCT00168805|527430483|FG001|Overall Study|Adverse Event|11|||
146250794|NCT00168805|527430484|FG002|Overall Study|Adverse Event|16|||
146250795|NCT00168805|527430482|FG000|Overall Study|Protocol Violation|12|||
146250796|NCT00168805|527430483|FG001|Overall Study|Protocol Violation|11|||
146250797|NCT00168805|527430484|FG002|Overall Study|Protocol Violation|8|||
146250798|NCT00168805|527430482|FG000|Overall Study|Lost to Follow-up|12|||
146250799|NCT00168805|527430483|FG001|Overall Study|Lost to Follow-up|17|||
146250800|NCT00168805|527430484|FG002|Overall Study|Lost to Follow-up|11|||
146250801|NCT00168805|527430482|FG000|Overall Study|Withdrawal by Subject|16|||
146016186|NCT01681186|526569839|FG002|Fourth Intervention|Protocol Violation|0|||
146016187|NCT01681186|526569840|FG003|Fourth Intervention|Protocol Violation|0|||
146016188|NCT01681186|526569841|FG004|Fourth Intervention|Protocol Violation|0|||
146016189|NCT01681186|526569842|FG005|Fourth Intervention|Protocol Violation|0|||
146016190|NCT01681186|526569843|FG006|Fourth Intervention|Protocol Violation|0|||
146016191|NCT01681186|526569844|FG007|Fourth Intervention|Protocol Violation|1|||
146016192|NCT05160415|526569845|FG000|Overall Study|Withdrawal by Subject|3|||
146016193|NCT02582814|526569852|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146016194|NCT02582814|526569853|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146016195|NCT02582814|526569852|FG000|Overall Study|Withdrawal by Subject|4|||
146016196|NCT02582814|526569853|FG001|Overall Study|Withdrawal by Subject|3|||
146016197|NCT02582814|526569852|FG000|Overall Study|Adverse Event|4|||
146016198|NCT02582814|526569853|FG001|Overall Study|Adverse Event|4|||
146016199|NCT04308239|526569858|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
146016200|NCT04308239|526569859|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
146016201|NCT04308239|526569858|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
146016202|NCT04308239|526569859|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
146016203|NCT04308239|526569858|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
146016204|NCT04308239|526569859|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
146016205|NCT04308239|526569858|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
146016206|NCT04308239|526569859|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
146016207|NCT04848220|526569862|FG000|Overall Study|Unable to proceed to study procedure|0|||
146016208|NCT04848220|526569863|FG001|Overall Study|Unable to proceed to study procedure|1|||
146016209|NCT04848220|526569864|FG002|Overall Study|Unable to proceed to study procedure|0|||
146016210|NCT04848220|526569862|FG000|Overall Study|Fractional flow not significant|0|||
146016211|NCT04848220|526569863|FG001|Overall Study|Fractional flow not significant|1|||
146016212|NCT04848220|526569864|FG002|Overall Study|Fractional flow not significant|0|||
146016213|NCT00316225|526569865|FG000|Overall Study|Adverse Event|2|||
146016214|NCT00316225|526569865|FG000|Overall Study|Physician Decision|3|||
146016215|NCT00316225|526569865|FG000|Overall Study|Progressive Disease|15|||
146016216|NCT00316225|526569865|FG000|Overall Study|Withdrawal by Subject|3|||
146016217|NCT00316225|526569865|FG000|Overall Study|Death|2|||
146016218|NCT01814878|526569866|FG000|Overall Study|Adverse Event|16|||
146016219|NCT01814878|526569867|FG001|Overall Study|Adverse Event|5|||
146016220|NCT01814878|526569866|FG000|Overall Study|Withdrawal by Subject|20|||
146016221|NCT01814878|526569867|FG001|Overall Study|Withdrawal by Subject|16|||
146016222|NCT01814878|526569866|FG000|Overall Study|Protocol Violation|5|||
146016223|NCT01814878|526569867|FG001|Overall Study|Protocol Violation|5|||
146016224|NCT01814878|526569866|FG000|Overall Study|Physician Decision|3|||
146016225|NCT01814878|526569867|FG001|Overall Study|Physician Decision|1|||
146016226|NCT01814878|526569866|FG000|Overall Study|Screening failure (drop-out)|0|||
146016227|NCT01814878|526569867|FG001|Overall Study|Screening failure (drop-out)|3|||
146016228|NCT01814878|526569866|FG000|Overall Study|Other|2|||
146016229|NCT01814878|526569867|FG001|Overall Study|Other|0|||
146016230|NCT03654404|526569868|FG000|Overall Study|Death|1|||
146016231|NCT03654404|526569868|FG000|Overall Study|Lost to Follow-up|2|||
146016232|NCT03654404|526569868|FG000|Overall Study|Withdrawal by Subject|5|||
146016233|NCT00878254|526569873|FG000|Overall Study|Physician Decision|1|||
146016234|NCT00878254|526569873|FG000|Overall Study|Death|1|||
146016235|NCT00878254|526569873|FG000|Overall Study|Withdrawal by Subject|1|||
146016236|NCT00194077|526569877|FG000|Overall Study|Lack of Efficacy|22|||
146016237|NCT00194077|526569878|FG001|Overall Study|Lack of Efficacy|29|||
146016238|NCT00194077|526569877|FG000|Overall Study|Study nonadherence|1|||
146016239|NCT00194077|526569878|FG001|Overall Study|Study nonadherence|0|||
146016240|NCT00194077|526569877|FG000|Overall Study|Withdrawal by Subject|1|||
146016241|NCT00194077|526569878|FG001|Overall Study|Withdrawal by Subject|1|||
146016242|NCT03470194|526569881|FG000|Overall Study|Lost to Follow-up|11|||
146016243|NCT03470194|526569882|FG001|Overall Study|Lost to Follow-up|17|||
146016244|NCT01822899|526569883|FG000|Overall Study|Adverse Event|6|||
146016245|NCT01822899|526569884|FG001|Overall Study|Adverse Event|5|||
146016246|NCT01822899|526569883|FG000|Overall Study|Lack of Efficacy|6|||
146016247|NCT01822899|526569884|FG001|Overall Study|Lack of Efficacy|3|||
146016248|NCT01822899|526569883|FG000|Overall Study|Protocol Violation|6|||
146016249|NCT01822899|526569884|FG001|Overall Study|Protocol Violation|3|||
146016250|NCT01822899|526569883|FG000|Overall Study|Lost to Follow-up|1|||
146016251|NCT01822899|526569884|FG001|Overall Study|Lost to Follow-up|0|||
146016252|NCT01822899|526569883|FG000|Overall Study|Withdrawal by Subject|5|||
146016253|NCT01822899|526569884|FG001|Overall Study|Withdrawal by Subject|7|||
146016254|NCT05332392|526569885|FG000|Overall Study|Did not meet inclusion criteria|25|||
146016255|NCT05332392|526569885|FG000|Overall Study|Principal Investigator's decision|17|||
146016256|NCT05332392|526569885|FG000|Overall Study|Adverse Event|1|||
146016257|NCT05332392|526569885|FG000|Overall Study|Subject's decision|1|||
146016258|NCT01268046|526569886|FG000|Overall Study|Withdrawal by Subject|1|||
146016259|NCT01268046|526569887|FG001|Overall Study|Withdrawal by Subject|0|||
146016260|NCT01268046|526569888|FG002|Overall Study|Withdrawal by Subject|0|||
146250802|NCT00168805|527430483|FG001|Overall Study|Withdrawal by Subject|18|||
146250803|NCT00168805|527430484|FG002|Overall Study|Withdrawal by Subject|21|||
146250804|NCT00168805|527430482|FG000|Overall Study|Other|24|||
146250805|NCT00168805|527430483|FG001|Overall Study|Other|21|||
146250806|NCT00168805|527430484|FG002|Overall Study|Other|22|||
146250807|NCT00168805|527430482|FG000|Treatment|Adverse Event|25|||
146250808|NCT00168805|527430483|FG001|Treatment|Adverse Event|26|||
146250809|NCT00168805|527430484|FG002|Treatment|Adverse Event|32|||
146250810|NCT00168805|527430482|FG000|Treatment|Protocol Violation|3|||
146250811|NCT00168805|527430483|FG001|Treatment|Protocol Violation|5|||
146250812|NCT00168805|527430484|FG002|Treatment|Protocol Violation|5|||
146250813|NCT00168805|527430482|FG000|Treatment|Withdrawal by Subject|3|||
146250814|NCT00168805|527430483|FG001|Treatment|Withdrawal by Subject|7|||
146250815|NCT00168805|527430484|FG002|Treatment|Withdrawal by Subject|8|||
146250816|NCT00168805|527430482|FG000|Treatment|Other|18|||
146250817|NCT00168805|527430483|FG001|Treatment|Other|18|||
146250818|NCT00168805|527430484|FG002|Treatment|Other|17|||
146250819|NCT02062827|527430490|FG000|Overall Study|Death|1|||
146250820|NCT02062827|527430491|FG001|Overall Study|Death|0|||
146016261|NCT01268046|526569889|FG003|Overall Study|Withdrawal by Subject|1|||
146016262|NCT01268046|526569886|FG000|Overall Study|Lost to Follow-up|0|||
146016263|NCT01268046|526569887|FG001|Overall Study|Lost to Follow-up|0|||
146016264|NCT01268046|526569888|FG002|Overall Study|Lost to Follow-up|1|||
146016265|NCT01268046|526569889|FG003|Overall Study|Lost to Follow-up|0|||
146016266|NCT02314156|526569891|FG000|Overall Study|Adverse Event|1|||
146016267|NCT02314156|526569892|FG001|Overall Study|Adverse Event|0|||
146016268|NCT02314156|526569891|FG000|Overall Study|Withdrawal by Subject|1|||
146016269|NCT02314156|526569892|FG001|Overall Study|Withdrawal by Subject|0|||
146016270|NCT01450696|526569893|FG000|Overall Study|Never Treated|1|||
146016271|NCT01450696|526569894|FG001|Overall Study|Never Treated|1|||
146016272|NCT01450696|526569893|FG000|Overall Study|Death|77|||
146016273|NCT01450696|526569894|FG001|Overall Study|Death|84|||
146016274|NCT01450696|526569893|FG000|Overall Study|Lost to Follow-up|3|||
146016275|NCT01450696|526569894|FG001|Overall Study|Lost to Follow-up|3|||
146016276|NCT01450696|526569893|FG000|Overall Study|Non-Compliance|1|||
146016277|NCT01450696|526569894|FG001|Overall Study|Non-Compliance|0|||
146016278|NCT01450696|526569893|FG000|Overall Study|Withdrawal by Subject|13|||
146016279|NCT01450696|526569894|FG001|Overall Study|Withdrawal by Subject|2|||
146016280|NCT01450696|526569893|FG000|Overall Study|Study Terminated by Sponsor|53|||
146016281|NCT01450696|526569894|FG001|Overall Study|Study Terminated by Sponsor|58|||
146016282|NCT03818607|526569895|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
146016283|NCT03818607|526569896|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
146016284|NCT03818607|526569895|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
146016285|NCT03818607|526569896|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
146016286|NCT03818607|526569895|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
146016287|NCT03818607|526569896|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
146016288|NCT05059301|526569899|FG000|Overall Study|Adverse Event|0|||
146016289|NCT05059301|526569900|FG001|Overall Study|Adverse Event|2|||
146016290|NCT05059301|526569901|FG002|Overall Study|Adverse Event|2|||
146016291|NCT05059301|526569899|FG000|Overall Study|Lost to Follow-up|2|||
146016292|NCT05059301|526569900|FG001|Overall Study|Lost to Follow-up|3|||
146016293|NCT05059301|526569901|FG002|Overall Study|Lost to Follow-up|3|||
146016294|NCT05730335|526569904|FG000|Overall Study|Lost to Follow-up|8|||
146016295|NCT05730335|526569904|FG000|Overall Study|Withdrawal by Subject|6|||
146016296|NCT01262560|526569919|FG000|Overall Study|Protocol Violation|0|||
146016297|NCT01262560|526569920|FG001|Overall Study|Protocol Violation|1|||
146016298|NCT01262560|526569921|FG002|Overall Study|Protocol Violation|2|||
146016299|NCT02443116|526569926|FG000|Part 1|Adverse Event|2|||
146016300|NCT02443116|526569927|FG001|Part 1|Adverse Event|3|||
146016301|NCT02443116|526569928|FG002|Part 1|Adverse Event|0|||
146016302|NCT02443116|526569929|FG003|Part 1|Adverse Event|0|||
146016303|NCT02443116|526569930|FG004|Part 1|Adverse Event|0|||
146093675|NCT02160782|526864856|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146016304|NCT02443116|526569931|FG005|Part 1|Adverse Event|0|||
146016305|NCT02443116|526569932|FG006|Part 1|Adverse Event|0|||
146016306|NCT02443116|526569933|FG007|Part 1|Adverse Event|0|||
146016307|NCT02443116|526569934|FG008|Part 1|Adverse Event|0|||
146016308|NCT02443116|526569926|FG000|Part 1|Withdrew informed consent|0|||
146016309|NCT02443116|526569927|FG001|Part 1|Withdrew informed consent|1|||
146250821|NCT02062827|527430492|FG002|Overall Study|Death|0|||
146250822|NCT02062827|527430493|FG003|Overall Study|Death|0|||
146250823|NCT02062827|527430494|FG004|Overall Study|Death|0|||
146250824|NCT02062827|527430495|FG005|Overall Study|Death|0|||
146016310|NCT02443116|526569928|FG002|Part 1|Withdrew informed consent|0|||
146016311|NCT02443116|526569929|FG003|Part 1|Withdrew informed consent|0|||
146016312|NCT02443116|526569930|FG004|Part 1|Withdrew informed consent|0|||
146250825|NCT02062827|527430496|FG006|Overall Study|Death|0|||
146250826|NCT02062827|527430497|FG007|Overall Study|Death|0|||
146250827|NCT02062827|527430490|FG000|Overall Study|Withdrawal by Subject|3|||
146250828|NCT02062827|527430491|FG001|Overall Study|Withdrawal by Subject|1|||
146250829|NCT02062827|527430492|FG002|Overall Study|Withdrawal by Subject|1|||
146250830|NCT02062827|527430493|FG003|Overall Study|Withdrawal by Subject|2|||
146250831|NCT02062827|527430494|FG004|Overall Study|Withdrawal by Subject|6|||
146016313|NCT02443116|526569931|FG005|Part 1|Withdrew informed consent|0|||
146016314|NCT02443116|526569932|FG006|Part 1|Withdrew informed consent|0|||
146016315|NCT02443116|526569933|FG007|Part 1|Withdrew informed consent|0|||
146016316|NCT02443116|526569934|FG008|Part 1|Withdrew informed consent|0|||
146016317|NCT02443116|526569926|FG000|Part 1|Lost to Follow-up|0|||
146016318|NCT02443116|526569927|FG001|Part 1|Lost to Follow-up|0|||
146016319|NCT02443116|526569928|FG002|Part 1|Lost to Follow-up|2|||
146016320|NCT02443116|526569929|FG003|Part 1|Lost to Follow-up|0|||
146016321|NCT02443116|526569930|FG004|Part 1|Lost to Follow-up|0|||
146016322|NCT02443116|526569931|FG005|Part 1|Lost to Follow-up|0|||
146016323|NCT02443116|526569932|FG006|Part 1|Lost to Follow-up|0|||
146016324|NCT02443116|526569933|FG007|Part 1|Lost to Follow-up|0|||
146016325|NCT02443116|526569934|FG008|Part 1|Lost to Follow-up|0|||
146016326|NCT02443116|526569926|FG000|Part 1|Participant moved out of state|0|||
146016327|NCT02443116|526569927|FG001|Part 1|Participant moved out of state|0|||
146016328|NCT02443116|526569928|FG002|Part 1|Participant moved out of state|1|||
146016329|NCT02443116|526569929|FG003|Part 1|Participant moved out of state|0|||
146016330|NCT02443116|526569930|FG004|Part 1|Participant moved out of state|0|||
146016331|NCT02443116|526569931|FG005|Part 1|Participant moved out of state|0|||
146016332|NCT02443116|526569932|FG006|Part 1|Participant moved out of state|0|||
146016333|NCT02443116|526569933|FG007|Part 1|Participant moved out of state|0|||
146016334|NCT02443116|526569934|FG008|Part 1|Participant moved out of state|0|||
146016335|NCT02443116|526569926|FG000|Part 1|Participant enrolled in another clinical trial|0|||
146016336|NCT02443116|526569927|FG001|Part 1|Participant enrolled in another clinical trial|0|||
146016337|NCT02443116|526569928|FG002|Part 1|Participant enrolled in another clinical trial|1|||
146016338|NCT02443116|526569929|FG003|Part 1|Participant enrolled in another clinical trial|0|||
146016339|NCT02443116|526569930|FG004|Part 1|Participant enrolled in another clinical trial|0|||
146016340|NCT02443116|526569931|FG005|Part 1|Participant enrolled in another clinical trial|0|||
146016341|NCT02443116|526569932|FG006|Part 1|Participant enrolled in another clinical trial|0|||
146016342|NCT02443116|526569933|FG007|Part 1|Participant enrolled in another clinical trial|0|||
146016343|NCT02443116|526569934|FG008|Part 1|Participant enrolled in another clinical trial|0|||
146016344|NCT02443116|526569926|FG000|Part 2|Adverse Event|0|||
146016345|NCT02443116|526569927|FG001|Part 2|Adverse Event|0|||
146016346|NCT02443116|526569928|FG002|Part 2|Adverse Event|0|||
146016347|NCT02443116|526569929|FG003|Part 2|Adverse Event|0|||
146016348|NCT02443116|526569930|FG004|Part 2|Adverse Event|1|||
146016349|NCT02443116|526569931|FG005|Part 2|Adverse Event|1|||
146016350|NCT02443116|526569932|FG006|Part 2|Adverse Event|2|||
146016351|NCT02443116|526569933|FG007|Part 2|Adverse Event|0|||
146016352|NCT02443116|526569934|FG008|Part 2|Adverse Event|0|||
146016353|NCT02443116|526569926|FG000|Part 2|Withdrew informed consent|0|||
146016354|NCT02443116|526569927|FG001|Part 2|Withdrew informed consent|0|||
146016355|NCT02443116|526569928|FG002|Part 2|Withdrew informed consent|0|||
146016356|NCT02443116|526569929|FG003|Part 2|Withdrew informed consent|0|||
146016357|NCT02443116|526569930|FG004|Part 2|Withdrew informed consent|0|||
146016358|NCT02443116|526569931|FG005|Part 2|Withdrew informed consent|1|||
146016359|NCT02443116|526569932|FG006|Part 2|Withdrew informed consent|1|||
146016360|NCT02443116|526569933|FG007|Part 2|Withdrew informed consent|0|||
146016361|NCT02443116|526569934|FG008|Part 2|Withdrew informed consent|0|||
146016362|NCT02443116|526569926|FG000|Part 2|Inability to comply with protocol|0|||
146016363|NCT02443116|526569927|FG001|Part 2|Inability to comply with protocol|0|||
146016364|NCT02443116|526569928|FG002|Part 2|Inability to comply with protocol|0|||
146016365|NCT02443116|526569929|FG003|Part 2|Inability to comply with protocol|1|||
146016366|NCT02443116|526569930|FG004|Part 2|Inability to comply with protocol|0|||
146016367|NCT02443116|526569931|FG005|Part 2|Inability to comply with protocol|0|||
146016368|NCT02443116|526569932|FG006|Part 2|Inability to comply with protocol|0|||
146016369|NCT02443116|526569933|FG007|Part 2|Inability to comply with protocol|0|||
146016370|NCT02443116|526569934|FG008|Part 2|Inability to comply with protocol|0|||
146016371|NCT02443116|526569926|FG000|Part 2|Lost to Follow-up|0|||
146016372|NCT02443116|526569927|FG001|Part 2|Lost to Follow-up|0|||
146016373|NCT02443116|526569928|FG002|Part 2|Lost to Follow-up|0|||
146016374|NCT02443116|526569929|FG003|Part 2|Lost to Follow-up|1|||
146016375|NCT02443116|526569930|FG004|Part 2|Lost to Follow-up|0|||
146016376|NCT02443116|526569931|FG005|Part 2|Lost to Follow-up|0|||
146016377|NCT02443116|526569932|FG006|Part 2|Lost to Follow-up|0|||
146016378|NCT02443116|526569933|FG007|Part 2|Lost to Follow-up|0|||
146016379|NCT02443116|526569934|FG008|Part 2|Lost to Follow-up|0|||
146016380|NCT02443116|526569926|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016381|NCT02443116|526569927|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016382|NCT02443116|526569928|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016383|NCT02443116|526569929|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016384|NCT02443116|526569930|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016385|NCT02443116|526569931|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
146250832|NCT02062827|527430495|FG005|Overall Study|Withdrawal by Subject|0|||
146016386|NCT02443116|526569932|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016387|NCT02443116|526569933|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016388|NCT02443116|526569934|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
146016389|NCT02443116|526569926|FG000|Part 3|Adverse Event|0|||
146016390|NCT02443116|526569927|FG001|Part 3|Adverse Event|0|||
146016391|NCT02443116|526569928|FG002|Part 3|Adverse Event|0|||
146016392|NCT02443116|526569929|FG003|Part 3|Adverse Event|0|||
146016393|NCT02443116|526569930|FG004|Part 3|Adverse Event|0|||
146016394|NCT02443116|526569931|FG005|Part 3|Adverse Event|0|||
146016395|NCT02443116|526569932|FG006|Part 3|Adverse Event|0|||
146016396|NCT02443116|526569933|FG007|Part 3|Adverse Event|0|||
146016397|NCT02443116|526569934|FG008|Part 3|Adverse Event|1|||
146016398|NCT02443116|526569926|FG000|Part 3|Withdrew informed consent|0|||
146016399|NCT02443116|526569927|FG001|Part 3|Withdrew informed consent|0|||
146016400|NCT02443116|526569928|FG002|Part 3|Withdrew informed consent|0|||
146016401|NCT02443116|526569929|FG003|Part 3|Withdrew informed consent|0|||
146016402|NCT02443116|526569930|FG004|Part 3|Withdrew informed consent|0|||
146016403|NCT02443116|526569931|FG005|Part 3|Withdrew informed consent|0|||
146016404|NCT02443116|526569932|FG006|Part 3|Withdrew informed consent|0|||
146016405|NCT02443116|526569933|FG007|Part 3|Withdrew informed consent|3|||
146016406|NCT02443116|526569934|FG008|Part 3|Withdrew informed consent|2|||
146016407|NCT02443116|526569926|FG000|Part 3|Lost to Follow-up|0|||
146016408|NCT02443116|526569927|FG001|Part 3|Lost to Follow-up|0|||
146016409|NCT02443116|526569928|FG002|Part 3|Lost to Follow-up|0|||
146016410|NCT02443116|526569929|FG003|Part 3|Lost to Follow-up|0|||
146016411|NCT02443116|526569930|FG004|Part 3|Lost to Follow-up|0|||
146016412|NCT02443116|526569931|FG005|Part 3|Lost to Follow-up|0|||
146016413|NCT02443116|526569932|FG006|Part 3|Lost to Follow-up|0|||
146016414|NCT02443116|526569933|FG007|Part 3|Lost to Follow-up|1|||
146016415|NCT02443116|526569934|FG008|Part 3|Lost to Follow-up|2|||
146016416|NCT04295759|526569935|FG000|Overall Study|Lack of Efficacy|9|||
146016417|NCT04295759|526569935|FG000|Overall Study|Death|1|||
146016418|NCT04295759|526569935|FG000|Overall Study|Withdrawal by Subject|2|||
146016419|NCT04295759|526569935|FG000|Overall Study|Deemed ineligible|1|||
146016420|NCT02470585|526569936|FG000|Overall Study|Death|224|||
146016421|NCT02470585|526569937|FG001|Overall Study|Death|227|||
146016422|NCT02470585|526569938|FG002|Overall Study|Death|199|||
146016423|NCT02470585|526569936|FG000|Overall Study|Withdrew consent|21|||
146016424|NCT02470585|526569937|FG001|Overall Study|Withdrew consent|22|||
146016425|NCT02470585|526569938|FG002|Overall Study|Withdrew consent|31|||
146016426|NCT02470585|526569936|FG000|Overall Study|Lost to Follow-up|8|||
146016427|NCT02470585|526569937|FG001|Overall Study|Lost to Follow-up|15|||
146016428|NCT02470585|526569938|FG002|Overall Study|Lost to Follow-up|13|||
146016429|NCT02470585|526569936|FG000|Overall Study|Sponsor discontinued study|117|||
146016430|NCT02470585|526569937|FG001|Overall Study|Sponsor discontinued study|110|||
146016431|NCT02470585|526569938|FG002|Overall Study|Sponsor discontinued study|122|||
146016432|NCT02470585|526569936|FG000|Overall Study|Other, not specified|5|||
146016433|NCT02470585|526569937|FG001|Overall Study|Other, not specified|7|||
146016434|NCT02470585|526569938|FG002|Overall Study|Other, not specified|14|||
146016435|NCT02470585|526569936|FG000|Overall Study|Missing due to site non-compliance|0|||
146016436|NCT02470585|526569937|FG001|Overall Study|Missing due to site non-compliance|2|||
146016437|NCT02470585|526569938|FG002|Overall Study|Missing due to site non-compliance|3|||
146016438|NCT00465972|526569939|FG000|Overall Study|Withdrawal by Subject|2|||
146016439|NCT00465972|526569940|FG001|Overall Study|Withdrawal by Subject|1|||
146016440|NCT00349349|526569941|FG000|Overall Study|Adverse Event|5|||
146016441|NCT00349349|526569942|FG001|Overall Study|Adverse Event|6|||
146016442|NCT00349349|526569943|FG002|Overall Study|Adverse Event|2|||
146016443|NCT00349349|526569941|FG000|Overall Study|Withdrawal by Subject|5|||
146016444|NCT00349349|526569942|FG001|Overall Study|Withdrawal by Subject|2|||
146016445|NCT00349349|526569943|FG002|Overall Study|Withdrawal by Subject|1|||
146016446|NCT00349349|526569941|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
146016447|NCT00349349|526569942|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
146016448|NCT00349349|526569943|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
146016449|NCT00349349|526569941|FG000|Overall Study|Death|13|||
146016450|NCT00349349|526569942|FG001|Overall Study|Death|10|||
146016451|NCT00349349|526569943|FG002|Overall Study|Death|1|||
146016452|NCT00349349|526569941|FG000|Overall Study|Other Treatment Selected|2|||
146016453|NCT00349349|526569942|FG001|Overall Study|Other Treatment Selected|0|||
146016454|NCT00349349|526569943|FG002|Overall Study|Other Treatment Selected|0|||
146016455|NCT00349349|526569941|FG000|Overall Study|Participant Reduced General Condition|0|||
146016456|NCT00349349|526569942|FG001|Overall Study|Participant Reduced General Condition|1|||
146016457|NCT00349349|526569943|FG002|Overall Study|Participant Reduced General Condition|0|||
146250833|NCT02062827|527430496|FG006|Overall Study|Withdrawal by Subject|5|||
146250834|NCT02062827|527430497|FG007|Overall Study|Withdrawal by Subject|0|||
146250835|NCT02062827|527430490|FG000|Overall Study|Screen Fail|0|||
146250836|NCT02062827|527430491|FG001|Overall Study|Screen Fail|0|||
146016458|NCT00349349|526569941|FG000|Overall Study|Physician Decision|1|||
146250837|NCT02062827|527430492|FG002|Overall Study|Screen Fail|0|||
146016459|NCT00349349|526569942|FG001|Overall Study|Physician Decision|2|||
146016460|NCT00349349|526569943|FG002|Overall Study|Physician Decision|1|||
146016461|NCT00349349|526569941|FG000|Overall Study|No Response|0|||
146016462|NCT00349349|526569942|FG001|Overall Study|No Response|3|||
146016463|NCT00349349|526569943|FG002|Overall Study|No Response|0|||
146016464|NCT00349349|526569941|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
146016465|NCT00349349|526569942|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
146016466|NCT00349349|526569943|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
146016467|NCT03028415|526569944|FG000|Overall Study|Lost to Follow-up|6|||
146016468|NCT03028415|526569945|FG001|Overall Study|Lost to Follow-up|3|||
146016469|NCT03028415|526569944|FG000|Overall Study|Withdrawal by Subject|1|||
146016470|NCT03028415|526569945|FG001|Overall Study|Withdrawal by Subject|0|||
146016471|NCT03028415|526569944|FG000|Overall Study|Discontinued due to COVID-19|1|||
146016472|NCT03028415|526569945|FG001|Overall Study|Discontinued due to COVID-19|0|||
146016473|NCT01108731|526569953|FG000|Overall Study|Withdrawal by Subject|1|||
146016474|NCT01108731|526569954|FG001|Overall Study|Withdrawal by Subject|1|||
146016475|NCT01108731|526569953|FG000|Overall Study|Adverse Event|3|||
146016476|NCT01108731|526569954|FG001|Overall Study|Adverse Event|3|||
146016477|NCT02095873|526569955|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146016478|NCT02095873|526569956|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146016479|NCT02095873|526569955|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
146016480|NCT02095873|526569956|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
146016481|NCT02095873|526569955|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
146016482|NCT02095873|526569956|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
146016483|NCT00792740|526569957|FG000|Overall Study|Disease Worsening|3|||
146016484|NCT00792740|526569958|FG001|Overall Study|Disease Worsening|2|||
146016485|NCT00792740|526569957|FG000|Overall Study|Personal Reason|1|||
146016486|NCT00792740|526569958|FG001|Overall Study|Personal Reason|0|||
146016487|NCT00792740|526569957|FG000|Overall Study|Adverse Event|1|||
146016488|NCT00792740|526569958|FG001|Overall Study|Adverse Event|3|||
146016489|NCT00792740|526569957|FG000|Overall Study|Patient's withdrawal of consent|0|||
146016490|NCT00792740|526569958|FG001|Overall Study|Patient's withdrawal of consent|1|||
146016491|NCT00792740|526569957|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
146016492|NCT00792740|526569958|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
146016493|NCT00792740|526569957|FG000|Overall Study|Other reasons|0|||
146016494|NCT00792740|526569958|FG001|Overall Study|Other reasons|1|||
146016495|NCT01063062|526569959|FG000|Overall Study|Patient withdrew consent|0|||
146016496|NCT01063062|526569960|FG001|Overall Study|Patient withdrew consent|1|||
146016497|NCT01063062|526569959|FG000|Overall Study|Adverse Event|2|||
146016498|NCT01063062|526569960|FG001|Overall Study|Adverse Event|4|||
146016499|NCT01063062|526569959|FG000|Overall Study|Protocol Violation|5|||
146016500|NCT01063062|526569960|FG001|Overall Study|Protocol Violation|4|||
146016501|NCT01063062|526569959|FG000|Overall Study|Investigator's request|1|||
146016502|NCT01063062|526569960|FG001|Overall Study|Investigator's request|0|||
146016503|NCT01063062|526569959|FG000|Overall Study|Lost to Follow-up|0|||
146016504|NCT01063062|526569960|FG001|Overall Study|Lost to Follow-up|2|||
146016505|NCT01063062|526569959|FG000|Overall Study|Miscellaneous reason|0|||
146016506|NCT01063062|526569960|FG001|Overall Study|Miscellaneous reason|1|||
146016507|NCT02015481|526569961|FG000|Overall Study|Death|1|||
146016508|NCT01352221|526569968|FG000|Double-blind Phase|Adverse Event|6|||
146016509|NCT01352221|526569969|FG001|Double-blind Phase|Adverse Event|4|||
146016510|NCT01352221|526569970|FG002|Double-blind Phase|Adverse Event|0|||
146016511|NCT01352221|526569971|FG003|Double-blind Phase|Adverse Event|0|||
146016512|NCT01352221|526569968|FG000|Double-blind Phase|Withdrawal by Subject|3|||
146016513|NCT01352221|526569969|FG001|Double-blind Phase|Withdrawal by Subject|5|||
146016514|NCT01352221|526569970|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146016515|NCT01352221|526569971|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146016516|NCT01352221|526569968|FG000|Double-blind Phase|Lost to Follow-up|0|||
146016517|NCT01352221|526569969|FG001|Double-blind Phase|Lost to Follow-up|1|||
146016518|NCT01352221|526569970|FG002|Double-blind Phase|Lost to Follow-up|0|||
146016519|NCT01352221|526569971|FG003|Double-blind Phase|Lost to Follow-up|0|||
146016520|NCT01352221|526569968|FG000|Double-blind Phase|Protocol Violation|0|||
146016521|NCT01352221|526569969|FG001|Double-blind Phase|Protocol Violation|1|||
146016522|NCT01352221|526569970|FG002|Double-blind Phase|Protocol Violation|0|||
146016523|NCT01352221|526569971|FG003|Double-blind Phase|Protocol Violation|0|||
146016524|NCT01352221|526569968|FG000|Open-label Phase|Physician Decision|0|||
146016525|NCT01352221|526569969|FG001|Open-label Phase|Physician Decision|0|||
146016526|NCT01352221|526569970|FG002|Open-label Phase|Physician Decision|2|||
146299823|NCT02953639|527613633|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146299824|NCT02953639|527613634|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146016527|NCT01352221|526569971|FG003|Open-label Phase|Physician Decision|1|||
146016528|NCT01352221|526569968|FG000|Open-label Phase|Pregnancy|0|||
146016529|NCT01352221|526569969|FG001|Open-label Phase|Pregnancy|0|||
146299825|NCT02953639|527613632|FG000|Overall Study|Multiple Reasons|1|||
146016530|NCT01352221|526569970|FG002|Open-label Phase|Pregnancy|1|||
146016531|NCT01352221|526569971|FG003|Open-label Phase|Pregnancy|0|||
146016532|NCT01352221|526569968|FG000|Open-label Phase|Adverse Event|0|||
146016533|NCT01352221|526569969|FG001|Open-label Phase|Adverse Event|0|||
146016534|NCT01352221|526569970|FG002|Open-label Phase|Adverse Event|8|||
146016535|NCT01352221|526569971|FG003|Open-label Phase|Adverse Event|4|||
146016536|NCT01352221|526569968|FG000|Open-label Phase|Withdrawal by Subject|0|||
146016537|NCT01352221|526569969|FG001|Open-label Phase|Withdrawal by Subject|0|||
146016538|NCT01352221|526569970|FG002|Open-label Phase|Withdrawal by Subject|1|||
146016539|NCT01352221|526569971|FG003|Open-label Phase|Withdrawal by Subject|6|||
146016540|NCT01352221|526569968|FG000|Open-label Phase|Worsening of IBD|0|||
146016541|NCT01352221|526569969|FG001|Open-label Phase|Worsening of IBD|0|||
146016542|NCT01352221|526569970|FG002|Open-label Phase|Worsening of IBD|1|||
146016543|NCT01352221|526569971|FG003|Open-label Phase|Worsening of IBD|0|||
146016544|NCT02016716|526569972|FG000|Overall Study|Withdrawal by Subject|5|||
146016545|NCT02016716|526569973|FG001|Overall Study|Withdrawal by Subject|5|||
146016546|NCT02016716|526569974|FG002|Overall Study|Withdrawal by Subject|5|||
146016547|NCT02016716|526569972|FG000|Overall Study|Protocol-specified Criteria|0|||
146016548|NCT02016716|526569973|FG001|Overall Study|Protocol-specified Criteria|1|||
146016549|NCT02016716|526569974|FG002|Overall Study|Protocol-specified Criteria|0|||
146016550|NCT02016716|526569972|FG000|Overall Study|Lost to Follow-up|1|||
146016551|NCT02016716|526569973|FG001|Overall Study|Lost to Follow-up|2|||
146016552|NCT02016716|526569974|FG002|Overall Study|Lost to Follow-up|1|||
146016553|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
146016554|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
146016555|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
146016556|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
146016557|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
146016558|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
146016559|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
146016560|NCT01673854|526569980|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
146016561|NCT01673854|526569980|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
146016562|NCT01673854|526569980|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
146016563|NCT01673854|526569980|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
146016564|NCT01673854|526569980|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
146016565|NCT05897242|526571874|FG000|Overall Study|Lost to Follow-up|6|||
146016566|NCT05897242|526571875|FG001|Overall Study|Lost to Follow-up|1|||
146016567|NCT05897242|526571874|FG000|Overall Study|Incomplete|1|||
146016568|NCT05897242|526571875|FG001|Overall Study|Incomplete|0|||
146016569|NCT05897242|526571874|FG000|Overall Study|Withdrawal by Subject|1|||
146016570|NCT05897242|526571875|FG001|Overall Study|Withdrawal by Subject|0|||
146016571|NCT00809835|526571876|FG000|Overall Study|Lost to Follow-up|7|||
146016572|NCT00809835|526571877|FG001|Overall Study|Lost to Follow-up|6|||
146016573|NCT00809835|526571878|FG002|Overall Study|Lost to Follow-up|10|||
146016574|NCT00809835|526571879|FG003|Overall Study|Lost to Follow-up|2|||
146016575|NCT00809835|526571876|FG000|Overall Study|Withdrawal by Subject|1|||
146016576|NCT00809835|526571877|FG001|Overall Study|Withdrawal by Subject|1|||
146016577|NCT00809835|526571878|FG002|Overall Study|Withdrawal by Subject|1|||
146016578|NCT00809835|526571879|FG003|Overall Study|Withdrawal by Subject|0|||
146016579|NCT03530995|526571883|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
146016580|NCT03530995|526571884|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
146016581|NCT03530995|526571883|FG000|Part 1 Period 3|Protocol Violation|1|||
146016582|NCT03530995|526571884|FG001|Part 1 Period 3|Protocol Violation|0|||
146016583|NCT03530995|526571883|FG000|Part 1 Period 4|Physician Decision|1|||
146016584|NCT03530995|526571884|FG001|Part 1 Period 4|Physician Decision|0|||
146016585|NCT03530995|526571883|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
146016586|NCT03530995|526571884|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
146016587|NCT02923830|526571889|FG000|Overall Study|Physician Decision|13|||
146016588|NCT02923830|526571890|FG001|Overall Study|Physician Decision|15|||
146016589|NCT01751906|526571891|FG000|Overall Study|Lost to Follow-up|151|||
146016590|NCT01751906|526571892|FG001|Overall Study|Lost to Follow-up|68|||
146016591|NCT01751906|526571891|FG000|Overall Study|Withdrawal by Subject|22|||
146016592|NCT01751906|526571892|FG001|Overall Study|Withdrawal by Subject|18|||
146016593|NCT01751906|526571891|FG000|Overall Study|Physician Decision|5|||
146016594|NCT01751906|526571892|FG001|Overall Study|Physician Decision|2|||
146016595|NCT01751906|526571891|FG000|Overall Study|Death|84|||
146016596|NCT01751906|526571892|FG001|Overall Study|Death|43|||
146016597|NCT01751906|526571891|FG000|Overall Study|Denied on premises for follow-up by law|1|||
146016598|NCT01751906|526571892|FG001|Overall Study|Denied on premises for follow-up by law|0|||
146016599|NCT02557100|526571901|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
146016600|NCT02557100|526571902|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
146016601|NCT02557100|526571903|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
146016602|NCT02557100|526571901|FG000|Single Blind Treatment Period|Death|0|||
146016603|NCT02557100|526571902|FG001|Single Blind Treatment Period|Death|1|||
146016604|NCT02557100|526571903|FG002|Single Blind Treatment Period|Death|0|||
146016605|NCT02557100|526571901|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
146299826|NCT02953639|527613633|FG001|Overall Study|Multiple Reasons|0|||
146299827|NCT02953639|527613634|FG002|Overall Study|Multiple Reasons|1|||
146299828|NCT02953639|527613632|FG000|Overall Study|Physician Decision|1|||
146299829|NCT02953639|527613633|FG001|Overall Study|Physician Decision|0|||
146299830|NCT02953639|527613634|FG002|Overall Study|Physician Decision|0|||
146299831|NCT02953639|527613632|FG000|Overall Study|Withdrawal by Subject|7|||
146299832|NCT02953639|527613633|FG001|Overall Study|Withdrawal by Subject|8|||
146299833|NCT02953639|527613634|FG002|Overall Study|Withdrawal by Subject|10|||
146299834|NCT02953639|527613632|FG000|Overall Study|Completed or Discontinued information is missing|1|||
146299835|NCT02953639|527613633|FG001|Overall Study|Completed or Discontinued information is missing|0|||
146299836|NCT02953639|527613634|FG002|Overall Study|Completed or Discontinued information is missing|0|||
146299837|NCT01830855|527613635|FG000|Overall Study|Other|7|||
146299838|NCT01830855|527613636|FG001|Overall Study|Other|1|||
146299839|NCT01830855|527613637|FG002|Overall Study|Other|4|||
146299840|NCT01830855|527613638|FG003|Overall Study|Other|4|||
146299841|NCT01830855|527613635|FG000|Overall Study|Medication error without associated AE|1|||
146299842|NCT01830855|527613636|FG001|Overall Study|Medication error without associated AE|0|||
146299843|NCT01830855|527613637|FG002|Overall Study|Medication error without associated AE|0|||
146299844|NCT01830855|527613638|FG003|Overall Study|Medication error without associated AE|1|||
146299845|NCT01830855|527613635|FG000|Overall Study|Pregnancy|3|||
146299846|NCT01830855|527613636|FG001|Overall Study|Pregnancy|1|||
146299847|NCT01830855|527613637|FG002|Overall Study|Pregnancy|2|||
146299848|NCT01830855|527613638|FG003|Overall Study|Pregnancy|1|||
146299849|NCT01830855|527613635|FG000|Overall Study|No longer meets eligibility criteria|11|||
146299850|NCT01830855|527613636|FG001|Overall Study|No longer meets eligibility criteria|2|||
146299851|NCT01830855|527613637|FG002|Overall Study|No longer meets eligibility criteria|3|||
146299852|NCT01830855|527613638|FG003|Overall Study|No longer meets eligibility criteria|5|||
146299853|NCT01830855|527613635|FG000|Overall Study|Adverse Event|11|||
146299854|NCT01830855|527613636|FG001|Overall Study|Adverse Event|5|||
146299855|NCT01830855|527613637|FG002|Overall Study|Adverse Event|6|||
146299856|NCT01830855|527613638|FG003|Overall Study|Adverse Event|3|||
146299857|NCT01830855|527613635|FG000|Overall Study|Protocol deviation|10|||
146299858|NCT01830855|527613636|FG001|Overall Study|Protocol deviation|5|||
146299859|NCT01830855|527613637|FG002|Overall Study|Protocol deviation|6|||
146299860|NCT01830855|527613638|FG003|Overall Study|Protocol deviation|6|||
146299861|NCT01830855|527613635|FG000|Overall Study|Withdrawal by Subject|33|||
146299862|NCT01830855|527613636|FG001|Overall Study|Withdrawal by Subject|14|||
146299863|NCT01830855|527613637|FG002|Overall Study|Withdrawal by Subject|10|||
146299864|NCT01830855|527613638|FG003|Overall Study|Withdrawal by Subject|12|||
146299865|NCT01830855|527613635|FG000|Overall Study|No longer willing to participate|32|||
146299866|NCT01830855|527613636|FG001|Overall Study|No longer willing to participate|13|||
146299867|NCT01830855|527613637|FG002|Overall Study|No longer willing to participate|12|||
146299868|NCT01830855|527613638|FG003|Overall Study|No longer willing to participate|17|||
146299869|NCT01830855|527613635|FG000|Overall Study|Lost to Follow-up|47|||
146299870|NCT01830855|527613636|FG001|Overall Study|Lost to Follow-up|20|||
146299871|NCT01830855|527613637|FG002|Overall Study|Lost to Follow-up|23|||
146299872|NCT01830855|527613638|FG003|Overall Study|Lost to Follow-up|33|||
146299873|NCT01667081|527613639|FG000|Overall Study|Death|43|||
146250838|NCT02062827|527430493|FG003|Overall Study|Screen Fail|0|||
146250839|NCT02062827|527430494|FG004|Overall Study|Screen Fail|0|||
146250840|NCT02062827|527430495|FG005|Overall Study|Screen Fail|0|||
146250841|NCT02062827|527430496|FG006|Overall Study|Screen Fail|0|||
146250842|NCT02062827|527430497|FG007|Overall Study|Screen Fail|8|||
146250843|NCT02604199|527430501|FG000|Overall Study|Pregnancy|0|||
146250844|NCT02604199|527430502|FG001|Overall Study|Pregnancy|0|||
146250845|NCT02604199|527430503|FG002|Overall Study|Pregnancy|0|||
146250846|NCT02604199|527430504|FG003|Overall Study|Pregnancy|1|||
146250847|NCT02604199|527430501|FG000|Overall Study|Study terminated by sponsor|0|||
146250848|NCT02604199|527430502|FG001|Overall Study|Study terminated by sponsor|2|||
146250849|NCT02604199|527430503|FG002|Overall Study|Study terminated by sponsor|0|||
146299874|NCT01667081|527613640|FG001|Overall Study|Death|3|||
146299875|NCT01667081|527613639|FG000|Overall Study|Lost to Follow-up|99|||
146299876|NCT01667081|527613640|FG001|Overall Study|Lost to Follow-up|48|||
146299877|NCT01667081|527613639|FG000|Overall Study|Physician Decision|16|||
146299878|NCT01667081|527613640|FG001|Overall Study|Physician Decision|2|||
146299879|NCT01667081|527613639|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
146299880|NCT01667081|527613640|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
146299881|NCT01667081|527613639|FG000|Overall Study|Withdrawal by Subject|90|||
146299882|NCT01667081|527613640|FG001|Overall Study|Withdrawal by Subject|35|||
146299883|NCT03034460|527613641|FG000|Overall Study|Adverse Event|0|||
146299884|NCT03034460|527613642|FG001|Overall Study|Adverse Event|1|||
146299885|NCT03034460|527613641|FG000|Overall Study|Withdrawal by Subject|2|||
146299886|NCT03034460|527613642|FG001|Overall Study|Withdrawal by Subject|2|||
146250850|NCT02604199|527430504|FG003|Overall Study|Study terminated by sponsor|2|||
146250851|NCT02604199|527430501|FG000|Overall Study|Withdrawal by Subject|0|||
146250852|NCT02604199|527430502|FG001|Overall Study|Withdrawal by Subject|1|||
146016606|NCT02557100|526571902|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
146016607|NCT02557100|526571903|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
146016608|NCT02557100|526571901|FG000|Single Blind Treatment Period|Adverse Event|0|||
146016609|NCT02557100|526571902|FG001|Single Blind Treatment Period|Adverse Event|1|||
146016610|NCT02557100|526571903|FG002|Single Blind Treatment Period|Adverse Event|0|||
146016611|NCT02557100|526571901|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
146016612|NCT02557100|526571902|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
146016613|NCT02557100|526571903|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
146016614|NCT02557100|526571901|FG000|Cumulative Abatacept Period|Other Reasons|0|||
146016615|NCT02557100|526571902|FG001|Cumulative Abatacept Period|Other Reasons|0|||
146016616|NCT02557100|526571903|FG002|Cumulative Abatacept Period|Other Reasons|1|||
146016617|NCT02557100|526571901|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
146016618|NCT02557100|526571902|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
146016619|NCT02557100|526571903|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
146016620|NCT02557100|526571901|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
146016621|NCT02557100|526571902|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
146016622|NCT02557100|526571903|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
146016623|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
146016624|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
146016625|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
146016626|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
146016627|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
146016628|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
146016629|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
146016630|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
146016631|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
146016632|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
146016633|NCT00510718|526571904|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
146016634|NCT00510718|526571905|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
146016635|NCT00394251|526571913|FG000|Overall Study|Adverse Event|7|||
146016636|NCT00394251|526571914|FG001|Overall Study|Adverse Event|5|||
146016637|NCT00394251|526571913|FG000|Overall Study|Unacceptable Toxicity|20|||
146016638|NCT00394251|526571914|FG001|Overall Study|Unacceptable Toxicity|18|||
146016639|NCT00394251|526571913|FG000|Overall Study|Physician Decision|1|||
146016640|NCT00394251|526571914|FG001|Overall Study|Physician Decision|1|||
146016641|NCT00394251|526571913|FG000|Overall Study|Protocol Violation|0|||
146016642|NCT00394251|526571914|FG001|Overall Study|Protocol Violation|1|||
146016643|NCT00394251|526571913|FG000|Overall Study|Withdrawal by Subject|7|||
146016644|NCT00394251|526571914|FG001|Overall Study|Withdrawal by Subject|11|||
146016645|NCT00394251|526571913|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
146016646|NCT00394251|526571914|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
146016647|NCT05791565|526571915|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
146016648|NCT05791565|526571916|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
146016649|NCT04644276|526571917|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
146016650|NCT04644276|526571918|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
146016651|NCT04644276|526571919|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
146016652|NCT02388165|526571920|FG000|Overall Study|Study terminated by sponsor|5|||
146016653|NCT02388165|526571921|FG001|Overall Study|Study terminated by sponsor|5|||
146016654|NCT02388165|526571920|FG000|Overall Study|Other|11|||
146016655|NCT02388165|526571921|FG001|Overall Study|Other|13|||
146016656|NCT02388165|526571920|FG000|Overall Study|No longer meet eligibility criteria|40|||
146016657|NCT02388165|526571921|FG001|Overall Study|No longer meet eligibility criteria|43|||
146016658|NCT02388165|526571920|FG000|Overall Study|Withdrawal of consent|31|||
146016659|NCT02388165|526571921|FG001|Overall Study|Withdrawal of consent|32|||
146016660|NCT02388165|526571920|FG000|Overall Study|Lost to Follow-up|19|||
146016661|NCT02388165|526571921|FG001|Overall Study|Lost to Follow-up|20|||
146016662|NCT02388165|526571920|FG000|Overall Study|Death|13|||
146016663|NCT02388165|526571921|FG001|Overall Study|Death|10|||
146016664|NCT02388165|526571920|FG000|Overall Study|Adverse Event|3|||
146016665|NCT02388165|526571921|FG001|Overall Study|Adverse Event|5|||
146016666|NCT02388165|526571920|FG000|Overall Study|Did not meet entrance criteria|5|||
146016667|NCT02388165|526571921|FG001|Overall Study|Did not meet entrance criteria|2|||
146016668|NCT00705250|526571922|FG000|Overall Study|Withdrawal by Subject|1|||
146016669|NCT00705250|526571922|FG000|Overall Study|Patient died in car accident|1|||
146016670|NCT01406938|526571923|FG000|Induction Period|Subject/guardian decision|6|||
146016671|NCT01406938|526571924|FG001|Induction Period|Subject/guardian decision|8|||
146016672|NCT01406938|526571925|FG002|Induction Period|Subject/guardian decision|0|||
146016673|NCT01406938|526571926|FG003|Induction Period|Subject/guardian decision|0|||
146016674|NCT01406938|526571927|FG004|Induction Period|Subject/guardian decision|0|||
146016675|NCT01406938|526571928|FG005|Induction Period|Subject/guardian decision|0|||
146250853|NCT02604199|527430503|FG002|Overall Study|Withdrawal by Subject|0|||
146250854|NCT02604199|527430504|FG003|Overall Study|Withdrawal by Subject|0|||
146250855|NCT02213458|527430510|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
146250856|NCT02213458|527430511|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
146250857|NCT02213458|527430510|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
146250858|NCT02213458|527430511|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
146250859|NCT02213458|527430510|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
146250860|NCT02213458|527430511|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
146250861|NCT02213458|527430510|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
146250862|NCT02213458|527430511|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
146250863|NCT02213458|527430510|FG000|Overall Study|Refused re-consent|6|||
146250864|NCT02213458|527430511|FG001|Overall Study|Refused re-consent|0|||
146250865|NCT02213458|527430510|FG000|Overall Study|Lost to Follow-up|2|||
146250866|NCT02213458|527430511|FG001|Overall Study|Lost to Follow-up|2|||
146250867|NCT02213458|527430510|FG000|Overall Study|Withdrawal by Subject|26|||
146250868|NCT02213458|527430511|FG001|Overall Study|Withdrawal by Subject|8|||
146250869|NCT01721109|527430513|FG000|Overall Study|Lack of Efficacy|1|||
146250870|NCT01721109|527430513|FG000|Overall Study|Non- Compliance with Study Drug|3|||
146250871|NCT01721109|527430513|FG000|Overall Study|Withdrew Consent|1|||
146250872|NCT01721109|527430513|FG000|Overall Study|Lost to Follow-up|2|||
146250873|NCT05740371|527430514|FG000|Overall Study|Death|1|||
146250874|NCT02561195|527430518|FG000|Vaccination 1 to 3|Adverse Event|4|||
146250875|NCT02561195|527430519|FG001|Vaccination 1 to 3|Adverse Event|5|||
146250876|NCT02561195|527430520|FG002|Vaccination 1 to 3|Adverse Event|0|||
146250877|NCT02561195|527430521|FG003|Vaccination 1 to 3|Adverse Event|3|||
146250878|NCT02561195|527430522|FG004|Vaccination 1 to 3|Adverse Event|4|||
146250879|NCT02561195|527430523|FG005|Vaccination 1 to 3|Adverse Event|0|||
146250880|NCT02561195|527430524|FG006|Vaccination 1 to 3|Adverse Event|0|||
146250881|NCT02561195|527430525|FG007|Vaccination 1 to 3|Adverse Event|0|||
146250882|NCT02561195|527430526|FG008|Vaccination 1 to 3|Adverse Event|0|||
146250883|NCT02561195|527430527|FG009|Vaccination 1 to 3|Adverse Event|0|||
146250884|NCT02561195|527430528|FG010|Vaccination 1 to 3|Adverse Event|0|||
146250885|NCT02561195|527430529|FG011|Vaccination 1 to 3|Adverse Event|0|||
146250886|NCT02561195|527430530|FG012|Vaccination 1 to 3|Adverse Event|0|||
146250887|NCT02561195|527430531|FG013|Vaccination 1 to 3|Adverse Event|0|||
146250888|NCT02561195|527430518|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
146250889|NCT02561195|527430519|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
146250890|NCT02561195|527430520|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
146250891|NCT02561195|527430521|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
146250892|NCT02561195|527430522|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
146250893|NCT02561195|527430523|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
146250894|NCT02561195|527430524|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
146250895|NCT02561195|527430525|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
146250896|NCT02561195|527430526|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
146250897|NCT02561195|527430527|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
146250898|NCT02561195|527430528|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
146250899|NCT02561195|527430529|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
146250900|NCT02561195|527430530|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
146250901|NCT02561195|527430531|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
146250902|NCT02561195|527430518|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250903|NCT02561195|527430519|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
146250904|NCT02561195|527430520|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250905|NCT02561195|527430521|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
146250906|NCT02561195|527430522|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
146250907|NCT02561195|527430523|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
146250908|NCT02561195|527430524|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250909|NCT02561195|527430525|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250910|NCT02561195|527430526|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250911|NCT02561195|527430527|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250912|NCT02561195|527430528|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250913|NCT02561195|527430529|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146016676|NCT01406938|526571923|FG000|Induction Period|Protocol deviation|1|||
146016677|NCT01406938|526571924|FG001|Induction Period|Protocol deviation|0|||
146016678|NCT01406938|526571925|FG002|Induction Period|Protocol deviation|0|||
146016679|NCT01406938|526571926|FG003|Induction Period|Protocol deviation|0|||
146250914|NCT02561195|527430530|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146250915|NCT02561195|527430531|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
146299887|NCT03034460|527613641|FG000|Overall Study|Personal Reasons|1|||
146299888|NCT03034460|527613642|FG001|Overall Study|Personal Reasons|0|||
146016680|NCT01406938|526571927|FG004|Induction Period|Protocol deviation|0|||
146250916|NCT02561195|527430518|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
146250917|NCT02561195|527430519|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
146250918|NCT02561195|527430520|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
146250919|NCT02561195|527430521|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
146250920|NCT02561195|527430522|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
146250921|NCT02561195|527430523|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
146250922|NCT02561195|527430524|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
146250923|NCT02561195|527430525|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
146250924|NCT02561195|527430526|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
146250925|NCT02561195|527430527|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
146250926|NCT02561195|527430528|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
146250927|NCT02561195|527430529|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
146250928|NCT02561195|527430530|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
146250929|NCT02561195|527430531|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
146250930|NCT02561195|527430518|FG000|Vaccination 1 to 3|Other|7|||
146250931|NCT02561195|527430519|FG001|Vaccination 1 to 3|Other|3|||
146250932|NCT02561195|527430520|FG002|Vaccination 1 to 3|Other|1|||
146250933|NCT02561195|527430521|FG003|Vaccination 1 to 3|Other|7|||
146250934|NCT02561195|527430522|FG004|Vaccination 1 to 3|Other|5|||
146250935|NCT02561195|527430523|FG005|Vaccination 1 to 3|Other|1|||
146250936|NCT02561195|527430524|FG006|Vaccination 1 to 3|Other|0|||
146250937|NCT02561195|527430525|FG007|Vaccination 1 to 3|Other|0|||
146250938|NCT02561195|527430526|FG008|Vaccination 1 to 3|Other|0|||
146250939|NCT02561195|527430527|FG009|Vaccination 1 to 3|Other|0|||
146250940|NCT02561195|527430528|FG010|Vaccination 1 to 3|Other|0|||
146250941|NCT02561195|527430529|FG011|Vaccination 1 to 3|Other|0|||
146250942|NCT02561195|527430530|FG012|Vaccination 1 to 3|Other|0|||
146250943|NCT02561195|527430531|FG013|Vaccination 1 to 3|Other|0|||
146250944|NCT02561195|527430518|FG000|Vaccination 1 to 3|Protocol Violation|1|||
146250945|NCT02561195|527430519|FG001|Vaccination 1 to 3|Protocol Violation|0|||
146250946|NCT02561195|527430520|FG002|Vaccination 1 to 3|Protocol Violation|1|||
146250947|NCT02561195|527430521|FG003|Vaccination 1 to 3|Protocol Violation|2|||
146250948|NCT02561195|527430522|FG004|Vaccination 1 to 3|Protocol Violation|5|||
146250949|NCT02561195|527430523|FG005|Vaccination 1 to 3|Protocol Violation|2|||
146250950|NCT02561195|527430524|FG006|Vaccination 1 to 3|Protocol Violation|0|||
146250951|NCT02561195|527430525|FG007|Vaccination 1 to 3|Protocol Violation|0|||
146250952|NCT02561195|527430526|FG008|Vaccination 1 to 3|Protocol Violation|0|||
146250953|NCT02561195|527430527|FG009|Vaccination 1 to 3|Protocol Violation|0|||
146250954|NCT02561195|527430528|FG010|Vaccination 1 to 3|Protocol Violation|0|||
146250955|NCT02561195|527430529|FG011|Vaccination 1 to 3|Protocol Violation|0|||
146250956|NCT02561195|527430530|FG012|Vaccination 1 to 3|Protocol Violation|0|||
146250957|NCT02561195|527430531|FG013|Vaccination 1 to 3|Protocol Violation|0|||
146250958|NCT02561195|527430518|FG000|Vaccination 1 to 3|Death|2|||
146250959|NCT02561195|527430519|FG001|Vaccination 1 to 3|Death|1|||
146250960|NCT02561195|527430520|FG002|Vaccination 1 to 3|Death|0|||
146250961|NCT02561195|527430521|FG003|Vaccination 1 to 3|Death|2|||
146250962|NCT02561195|527430522|FG004|Vaccination 1 to 3|Death|0|||
146250963|NCT02561195|527430523|FG005|Vaccination 1 to 3|Death|0|||
146250964|NCT02561195|527430524|FG006|Vaccination 1 to 3|Death|0|||
146250965|NCT02561195|527430525|FG007|Vaccination 1 to 3|Death|0|||
146250966|NCT02561195|527430526|FG008|Vaccination 1 to 3|Death|0|||
146016681|NCT01406938|526571928|FG005|Induction Period|Protocol deviation|0|||
146016682|NCT01406938|526571923|FG000|Induction Period|Adverse Event|8|||
146016683|NCT01406938|526571924|FG001|Induction Period|Adverse Event|9|||
146016684|NCT01406938|526571925|FG002|Induction Period|Adverse Event|0|||
146016685|NCT01406938|526571926|FG003|Induction Period|Adverse Event|0|||
146016686|NCT01406938|526571927|FG004|Induction Period|Adverse Event|0|||
146016687|NCT01406938|526571928|FG005|Induction Period|Adverse Event|0|||
146016688|NCT01406938|526571923|FG000|Induction Period|Lack of Efficacy|1|||
146016689|NCT01406938|526571924|FG001|Induction Period|Lack of Efficacy|0|||
146016690|NCT01406938|526571925|FG002|Induction Period|Lack of Efficacy|0|||
146016691|NCT01406938|526571926|FG003|Induction Period|Lack of Efficacy|0|||
146016692|NCT01406938|526571927|FG004|Induction Period|Lack of Efficacy|0|||
146016693|NCT01406938|526571928|FG005|Induction Period|Lack of Efficacy|0|||
146016694|NCT01406938|526571923|FG000|Induction Period|Lost to Follow-up|2|||
146016695|NCT01406938|526571924|FG001|Induction Period|Lost to Follow-up|3|||
146016696|NCT01406938|526571925|FG002|Induction Period|Lost to Follow-up|0|||
146016697|NCT01406938|526571926|FG003|Induction Period|Lost to Follow-up|0|||
146250967|NCT02561195|527430527|FG009|Vaccination 1 to 3|Death|0|||
146250968|NCT02561195|527430528|FG010|Vaccination 1 to 3|Death|0|||
146016698|NCT01406938|526571927|FG004|Induction Period|Lost to Follow-up|0|||
146016699|NCT01406938|526571928|FG005|Induction Period|Lost to Follow-up|0|||
146016700|NCT01406938|526571923|FG000|Maintenance Period|Adverse Event|0|||
146016701|NCT01406938|526571924|FG001|Maintenance Period|Adverse Event|0|||
146250969|NCT02561195|527430529|FG011|Vaccination 1 to 3|Death|0|||
146250970|NCT02561195|527430530|FG012|Vaccination 1 to 3|Death|0|||
146250971|NCT02561195|527430531|FG013|Vaccination 1 to 3|Death|0|||
146250972|NCT02561195|527430518|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
146250973|NCT02561195|527430519|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
146250974|NCT02561195|527430520|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
146250975|NCT02561195|527430521|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
146250976|NCT02561195|527430522|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
146250977|NCT02561195|527430523|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250978|NCT02561195|527430524|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250979|NCT02561195|527430525|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250980|NCT02561195|527430526|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250981|NCT02561195|527430527|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250982|NCT02561195|527430528|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250983|NCT02561195|527430529|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250984|NCT02561195|527430530|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250985|NCT02561195|527430531|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
146250986|NCT02561195|527430518|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
146250987|NCT02561195|527430519|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
146250988|NCT02561195|527430520|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
146250989|NCT02561195|527430521|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
146250990|NCT02561195|527430522|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
146250991|NCT02561195|527430523|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
146250992|NCT02561195|527430524|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
146250993|NCT02561195|527430525|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
146250994|NCT02561195|527430526|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
146250995|NCT02561195|527430527|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
146250996|NCT02561195|527430528|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
146250997|NCT02561195|527430529|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
146250998|NCT02561195|527430530|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
146250999|NCT02561195|527430531|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
146251000|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251001|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251002|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251003|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251004|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251005|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251006|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251007|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251008|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
146251009|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
146251010|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
146251011|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
146251012|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
146251013|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
146251014|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251015|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251016|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251017|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251018|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251019|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251020|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251021|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251022|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251023|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251024|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251025|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251026|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
146251027|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
146251028|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Death|0|||
146251029|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Death|0|||
146251030|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Death|0|||
146251031|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Death|0|||
146251032|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Death|0|||
146251033|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Death|0|||
146016702|NCT01406938|526571925|FG002|Maintenance Period|Adverse Event|2|||
146016703|NCT01406938|526571926|FG003|Maintenance Period|Adverse Event|8|||
146016704|NCT01406938|526571927|FG004|Maintenance Period|Adverse Event|4|||
146016705|NCT01406938|526571928|FG005|Maintenance Period|Adverse Event|2|||
146016706|NCT01406938|526571923|FG000|Maintenance Period|Death|0|||
146016707|NCT01406938|526571924|FG001|Maintenance Period|Death|0|||
146016708|NCT01406938|526571925|FG002|Maintenance Period|Death|0|||
146016709|NCT01406938|526571926|FG003|Maintenance Period|Death|0|||
146251034|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Death|0|||
146251035|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Death|0|||
146251036|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Death|0|||
146251037|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Death|1|||
146251038|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Death|0|||
146251039|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Death|0|||
146016710|NCT01406938|526571927|FG004|Maintenance Period|Death|1|||
146016711|NCT01406938|526571928|FG005|Maintenance Period|Death|0|||
146016712|NCT01406938|526571923|FG000|Maintenance Period|Subject/guardian decision|0|||
146016713|NCT01406938|526571924|FG001|Maintenance Period|Subject/guardian decision|0|||
146016714|NCT01406938|526571925|FG002|Maintenance Period|Subject/guardian decision|11|||
146016715|NCT01406938|526571926|FG003|Maintenance Period|Subject/guardian decision|7|||
146016716|NCT01406938|526571927|FG004|Maintenance Period|Subject/guardian decision|10|||
146016717|NCT01406938|526571928|FG005|Maintenance Period|Subject/guardian decision|7|||
146016718|NCT01406938|526571923|FG000|Maintenance Period|Protocol Violation|0|||
146016719|NCT01406938|526571924|FG001|Maintenance Period|Protocol Violation|0|||
146016720|NCT01406938|526571925|FG002|Maintenance Period|Protocol Violation|2|||
146016721|NCT01406938|526571926|FG003|Maintenance Period|Protocol Violation|2|||
146016722|NCT01406938|526571927|FG004|Maintenance Period|Protocol Violation|2|||
146016723|NCT01406938|526571928|FG005|Maintenance Period|Protocol Violation|2|||
146016724|NCT01406938|526571923|FG000|Maintenance Period|Pregnancy|0|||
146016725|NCT01406938|526571924|FG001|Maintenance Period|Pregnancy|0|||
146016726|NCT01406938|526571925|FG002|Maintenance Period|Pregnancy|0|||
146016727|NCT01406938|526571926|FG003|Maintenance Period|Pregnancy|0|||
146016728|NCT01406938|526571927|FG004|Maintenance Period|Pregnancy|1|||
146016729|NCT01406938|526571928|FG005|Maintenance Period|Pregnancy|0|||
146016730|NCT01406938|526571923|FG000|Maintenance Period|Lost to Follow-up|0|||
146016731|NCT01406938|526571924|FG001|Maintenance Period|Lost to Follow-up|0|||
146016732|NCT01406938|526571925|FG002|Maintenance Period|Lost to Follow-up|0|||
146016733|NCT01406938|526571926|FG003|Maintenance Period|Lost to Follow-up|0|||
146016734|NCT01406938|526571927|FG004|Maintenance Period|Lost to Follow-up|4|||
146016735|NCT01406938|526571928|FG005|Maintenance Period|Lost to Follow-up|0|||
146016736|NCT01406938|526571923|FG000|Maintenance Period|Lack of Efficacy|0|||
146016737|NCT01406938|526571924|FG001|Maintenance Period|Lack of Efficacy|0|||
146016738|NCT01406938|526571925|FG002|Maintenance Period|Lack of Efficacy|2|||
146016739|NCT01406938|526571926|FG003|Maintenance Period|Lack of Efficacy|1|||
146016740|NCT01406938|526571927|FG004|Maintenance Period|Lack of Efficacy|3|||
146016741|NCT01406938|526571928|FG005|Maintenance Period|Lack of Efficacy|5|||
146016742|NCT01406938|526571923|FG000|Follow up|Lack of Efficacy|3|||
146016743|NCT01406938|526571924|FG001|Follow up|Lack of Efficacy|2|||
146016744|NCT01406938|526571925|FG002|Follow up|Lack of Efficacy|1|||
146016745|NCT01406938|526571926|FG003|Follow up|Lack of Efficacy|0|||
146016746|NCT01406938|526571927|FG004|Follow up|Lack of Efficacy|0|||
146016747|NCT01406938|526571928|FG005|Follow up|Lack of Efficacy|0|||
146016748|NCT01406938|526571923|FG000|Follow up|Patient/guardian decision|4|||
146016749|NCT01406938|526571924|FG001|Follow up|Patient/guardian decision|2|||
146016750|NCT01406938|526571925|FG002|Follow up|Patient/guardian decision|4|||
146016751|NCT01406938|526571926|FG003|Follow up|Patient/guardian decision|2|||
146016752|NCT01406938|526571927|FG004|Follow up|Patient/guardian decision|4|||
146016753|NCT01406938|526571928|FG005|Follow up|Patient/guardian decision|1|||
146016754|NCT01406938|526571923|FG000|Follow up|Protocol Violation|0|||
146016755|NCT01406938|526571924|FG001|Follow up|Protocol Violation|0|||
146016756|NCT01406938|526571925|FG002|Follow up|Protocol Violation|1|||
146016757|NCT01406938|526571926|FG003|Follow up|Protocol Violation|0|||
146016758|NCT01406938|526571927|FG004|Follow up|Protocol Violation|0|||
146016759|NCT01406938|526571928|FG005|Follow up|Protocol Violation|0|||
146016760|NCT01406938|526571923|FG000|Follow up|Physician Decision|0|||
146016761|NCT01406938|526571924|FG001|Follow up|Physician Decision|0|||
146016762|NCT01406938|526571925|FG002|Follow up|Physician Decision|2|||
146016763|NCT01406938|526571926|FG003|Follow up|Physician Decision|0|||
146016764|NCT01406938|526571927|FG004|Follow up|Physician Decision|3|||
146016765|NCT01406938|526571928|FG005|Follow up|Physician Decision|1|||
146016766|NCT01406938|526571923|FG000|Follow up|Lost to Follow-up|1|||
146016767|NCT01406938|526571924|FG001|Follow up|Lost to Follow-up|1|||
146016768|NCT01406938|526571925|FG002|Follow up|Lost to Follow-up|0|||
146016769|NCT01406938|526571926|FG003|Follow up|Lost to Follow-up|1|||
146016770|NCT01406938|526571927|FG004|Follow up|Lost to Follow-up|2|||
146016771|NCT01406938|526571928|FG005|Follow up|Lost to Follow-up|1|||
146016772|NCT01576146|526571933|FG000|Extension Period 1|Adverse Event|2|||
146016773|NCT01576146|526571933|FG000|Extension Period 1|Death|2|||
146016774|NCT01576146|526571933|FG000|Extension Period 1|Physician Decision|2|||
146016775|NCT01576146|526571933|FG000|Extension Period 1|Withdrawal by Subject|1|||
146016776|NCT01576146|526571933|FG000|Extension Period 1|Lost to Follow-up|1|||
146016777|NCT01576146|526571933|FG000|Extension Period 1|Parathyroidectomy|1|||
146016778|NCT01576146|526571933|FG000|Extension Period 1|Renal Transplant|1|||
146016779|NCT01576146|526571933|FG000|Extension Period 2|Sponsor Decision|13|||
146016780|NCT01576146|526571933|FG000|Extension Period 2|Death|1|||
146016781|NCT01576146|526571933|FG000|Extension Period 2|Adverse Event|1|||
146016782|NCT01576146|526571933|FG000|Extension Period 2|Renal Transplant|1|||
146016783|NCT01576146|526571933|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
146016784|NCT01667224|526571936|FG000|Overall Study|Withdrawal by Subject|3|||
146016785|NCT01667224|526571937|FG001|Overall Study|Withdrawal by Subject|1|||
146016786|NCT01667224|526571936|FG000|Overall Study|Protocol Violation|1|||
146016787|NCT01667224|526571937|FG001|Overall Study|Protocol Violation|1|||
146016788|NCT01811485|526571940|FG000|Overall Study|Adverse Event|1|||
146016789|NCT01811485|526571941|FG001|Overall Study|Adverse Event|3|||
146016790|NCT01811485|526571942|FG002|Overall Study|Adverse Event|2|||
146016791|NCT01811485|526571940|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146016792|NCT01811485|526571941|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146016793|NCT01811485|526571942|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146251040|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Death|0|||
146251041|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Death|0|||
146251042|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251043|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251044|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251045|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251046|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251047|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251048|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146251049|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146251050|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251051|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
146251052|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
146251053|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146251054|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
146251055|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
146251056|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251057|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251058|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251059|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251060|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251061|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251062|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251063|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251064|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251065|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251066|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
146251067|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146251068|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146251069|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
146251070|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Other|0|||
146251071|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Other|0|||
146251072|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Other|0|||
146251073|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Other|0|||
146251074|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Other|0|||
146251075|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Other|0|||
146251076|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Other|0|||
146251077|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Other|0|||
146251078|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Other|0|||
146251079|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Other|0|||
146251080|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Other|2|||
146251081|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Other|2|||
146251082|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Other|1|||
146251083|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Other|0|||
146251084|NCT02561195|527430518|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251085|NCT02561195|527430519|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251086|NCT02561195|527430520|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251087|NCT02561195|527430521|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251088|NCT02561195|527430522|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251089|NCT02561195|527430523|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251090|NCT02561195|527430524|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146251091|NCT02561195|527430525|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251092|NCT02561195|527430526|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251093|NCT02561195|527430527|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251094|NCT02561195|527430528|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
146251095|NCT02561195|527430529|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146251096|NCT02561195|527430530|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
146251097|NCT02561195|527430531|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
146251098|NCT01885559|527430534|FG000|Overall Study|Lost to Follow-up|15|||
146251099|NCT01885559|527430535|FG001|Overall Study|Lost to Follow-up|16|||
146251100|NCT01885559|527430534|FG000|Overall Study|Less than full participation|9|||
146251101|NCT01885559|527430535|FG001|Overall Study|Less than full participation|19|||
146251102|NCT01885559|527430534|FG000|Overall Study|Protocol Violation|0|||
146251103|NCT01885559|527430535|FG001|Overall Study|Protocol Violation|1|||
146251104|NCT01867307|527430539|FG000|Overall Study|Protocol Violation|2|||
146251105|NCT01867307|527430540|FG001|Overall Study|Protocol Violation|0|||
146251106|NCT01867307|527430539|FG000|Overall Study|Other Adverse Event|1|||
146251107|NCT01867307|527430540|FG001|Overall Study|Other Adverse Event|3|||
146251108|NCT01634165|527430545|FG000|Period 2|Adverse Event|0|||
146251109|NCT01634165|527430546|FG001|Period 2|Adverse Event|1|||
146251110|NCT01634165|527430547|FG002|Period 2|Adverse Event|0|||
146251111|NCT01634165|527430548|FG003|Period 2|Adverse Event|0|||
146251112|NCT03820024|527430549|FG000|Overall Study|Physician Decision|1|||
146251113|NCT03820024|527430550|FG001|Overall Study|Physician Decision|2|||
146251114|NCT00676195|527431584|FG000|Overall Study|Lost to Follow-up|1|||
146251115|NCT00676195|527431584|FG000|Overall Study|Adverse Event|1|||
146251116|NCT00676195|527431584|FG000|Overall Study|Physician Decision|1|||
146251117|NCT05927753|527431587|FG000|Overall Study|Withdrawal by Subject|0|||
146251118|NCT05927753|527431588|FG001|Overall Study|Withdrawal by Subject|2|||
146251119|NCT05927753|527431587|FG000|Overall Study|Physician Decision|0|||
146251120|NCT05927753|527431588|FG001|Overall Study|Physician Decision|1|||
146251121|NCT02101554|527431591|FG000|Overall Study|Protocol Violation|0|||
146251122|NCT02101554|527431592|FG001|Overall Study|Protocol Violation|1|||
146251123|NCT02101554|527431593|FG002|Overall Study|Protocol Violation|0|||
146016794|NCT01811485|526571940|FG000|Overall Study|Administrative problems|1|||
146016795|NCT01811485|526571941|FG001|Overall Study|Administrative problems|0|||
146016796|NCT01811485|526571942|FG002|Overall Study|Administrative problems|0|||
146016797|NCT01811485|526571940|FG000|Overall Study|Protocol Deviation|0|||
146016798|NCT01811485|526571941|FG001|Overall Study|Protocol Deviation|1|||
146016799|NCT01811485|526571942|FG002|Overall Study|Protocol Deviation|0|||
146016800|NCT01545934|526571943|FG000|Overall Study|Withdrawal by Subject|4|||
146016801|NCT01545934|526571944|FG001|Overall Study|Withdrawal by Subject|3|||
146016802|NCT01545934|526571943|FG000|Overall Study|Lost to Follow-up|1|||
146016803|NCT01545934|526571944|FG001|Overall Study|Lost to Follow-up|0|||
146016804|NCT03299881|526571945|FG000|Overall Study|Study Termination|17|||
146016805|NCT03299881|526571946|FG001|Overall Study|Study Termination|13|||
146016806|NCT01474772|526571947|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
146016807|NCT01474772|526571948|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
146016808|NCT01474772|526571947|FG000|Period 1|AE not Related to Study Drug|1|||
146016809|NCT01474772|526571948|FG001|Period 1|AE not Related to Study Drug|0|||
146016810|NCT01474772|526571947|FG000|Period 1|Withdrawal by Subject|3|||
146016811|NCT01474772|526571948|FG001|Period 1|Withdrawal by Subject|1|||
146016812|NCT01474772|526571947|FG000|Period 1|Lost to Follow-up|1|||
146016813|NCT01474772|526571948|FG001|Period 1|Lost to Follow-up|0|||
146016814|NCT01474772|526571947|FG000|Period 1|Reason not Specified|1|||
146016815|NCT01474772|526571948|FG001|Period 1|Reason not Specified|1|||
146016816|NCT01474772|526571947|FG000|Washout|AE not Related to Study Drug|2|||
146016817|NCT01474772|526571948|FG001|Washout|AE not Related to Study Drug|0|||
146016818|NCT01474772|526571947|FG000|Washout|Withdrawal by Subject|1|||
146016819|NCT01474772|526571948|FG001|Washout|Withdrawal by Subject|0|||
146016820|NCT01474772|526571947|FG000|Washout|Lost to Follow-up|0|||
146016821|NCT01474772|526571948|FG001|Washout|Lost to Follow-up|1|||
146016822|NCT01474772|526571947|FG000|Washout|Reason not Specified|0|||
146016823|NCT01474772|526571948|FG001|Washout|Reason not Specified|1|||
146016824|NCT01474772|526571947|FG000|Period 2|Death|0|||
146016825|NCT01474772|526571948|FG001|Period 2|Death|1|||
146016826|NCT01474772|526571947|FG000|Period 2|AE Related to Study Drug|0|||
146016827|NCT01474772|526571948|FG001|Period 2|AE Related to Study Drug|1|||
146016828|NCT01474772|526571947|FG000|Period 2|AE not Related to Study Drug|4|||
146016829|NCT01474772|526571948|FG001|Period 2|AE not Related to Study Drug|1|||
146016830|NCT01474772|526571947|FG000|Period 2|Lack of Efficacy|1|||
146016831|NCT01474772|526571948|FG001|Period 2|Lack of Efficacy|0|||
146016832|NCT01474772|526571947|FG000|Period 2|Withdrawal by Subject|3|||
146016833|NCT01474772|526571948|FG001|Period 2|Withdrawal by Subject|4|||
146016834|NCT01474772|526571947|FG000|Period 2|Lost to Follow-up|1|||
146016835|NCT01474772|526571948|FG001|Period 2|Lost to Follow-up|1|||
146016836|NCT01474772|526571947|FG000|Period 2|Reason not Specified|0|||
146016837|NCT01474772|526571948|FG001|Period 2|Reason not Specified|2|||
146016838|NCT01474772|526571947|FG000|Follow-up|AE not Related to Study Drug|0|||
146251124|NCT02101554|527431591|FG000|Overall Study|Insufficient Clinical Response|0|||
146251125|NCT02101554|527431592|FG001|Overall Study|Insufficient Clinical Response|2|||
146251126|NCT02101554|527431593|FG002|Overall Study|Insufficient Clinical Response|0|||
146251127|NCT02101554|527431591|FG000|Overall Study|Adverse Event|2|||
146251128|NCT02101554|527431592|FG001|Overall Study|Adverse Event|1|||
146016839|NCT01474772|526571948|FG001|Follow-up|AE not Related to Study Drug|1|||
146016840|NCT03195660|526571949|FG000|Overall Study|The study was terminated|2|||
146016841|NCT03367403|526571950|FG000|Overall Study|Adverse Event|20|||
146016842|NCT03367403|526571951|FG001|Overall Study|Adverse Event|6|||
146016843|NCT03367403|526571952|FG002|Overall Study|Adverse Event|2|||
146016844|NCT03367403|526571950|FG000|Overall Study|Withdrawal by Subject|12|||
146251129|NCT02101554|527431593|FG002|Overall Study|Adverse Event|1|||
146251130|NCT02101554|527431591|FG000|Overall Study|Lost to Follow-up|0|||
146251131|NCT02101554|527431592|FG001|Overall Study|Lost to Follow-up|1|||
146016845|NCT03367403|526571951|FG001|Overall Study|Withdrawal by Subject|13|||
146016846|NCT03367403|526571952|FG002|Overall Study|Withdrawal by Subject|1|||
146016847|NCT03367403|526571950|FG000|Overall Study|Death|1|||
146016848|NCT03367403|526571951|FG001|Overall Study|Death|2|||
146016849|NCT03367403|526571952|FG002|Overall Study|Death|0|||
146016850|NCT03367403|526571950|FG000|Overall Study|Physician Decision|0|||
146016851|NCT03367403|526571951|FG001|Overall Study|Physician Decision|1|||
146016852|NCT03367403|526571952|FG002|Overall Study|Physician Decision|0|||
146016853|NCT03367403|526571950|FG000|Overall Study|Protocol Violation|1|||
146016854|NCT03367403|526571951|FG001|Overall Study|Protocol Violation|1|||
146016855|NCT03367403|526571952|FG002|Overall Study|Protocol Violation|0|||
146016856|NCT03367403|526571950|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146016857|NCT03367403|526571951|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
146016858|NCT03367403|526571952|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146016859|NCT03367403|526571950|FG000|Overall Study|COVID-19|3|||
146016860|NCT03367403|526571951|FG001|Overall Study|COVID-19|6|||
146016861|NCT03367403|526571952|FG002|Overall Study|COVID-19|0|||
146016862|NCT03367403|526571950|FG000|Overall Study|Abuse of Alcohol Intake|0|||
146016863|NCT03367403|526571951|FG001|Overall Study|Abuse of Alcohol Intake|1|||
146016864|NCT03367403|526571952|FG002|Overall Study|Abuse of Alcohol Intake|0|||
146016865|NCT03367403|526571950|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
146016866|NCT03367403|526571951|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
146016867|NCT03367403|526571952|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
146016868|NCT00759876|526571953|FG000|Overall Study|Sponsor terminated study early|36|||
146016869|NCT02846389|526571954|FG000|Overall Study|Withdrawal by Subject|1|||
146016870|NCT02846389|526571955|FG001|Overall Study|Withdrawal by Subject|1|||
146016871|NCT02321319|526571957|FG000|Overall Study|Product discontinued|5|||
146016872|NCT02249091|526571958|FG000|Overall Study|Lack of Efficacy|8|||
146016873|NCT02249091|526571959|FG001|Overall Study|Lack of Efficacy|3|||
146016874|NCT02249091|526571958|FG000|Overall Study|Physician Decision|4|||
146016875|NCT02249091|526571959|FG001|Overall Study|Physician Decision|1|||
146016876|NCT02249091|526571958|FG000|Overall Study|Withdrawal by Subject|2|||
146016877|NCT02249091|526571959|FG001|Overall Study|Withdrawal by Subject|2|||
146016878|NCT02249091|526571958|FG000|Overall Study|Death|3|||
146016879|NCT02249091|526571959|FG001|Overall Study|Death|4|||
146016880|NCT02249091|526571958|FG000|Overall Study|Adverse Event|1|||
146016881|NCT02249091|526571959|FG001|Overall Study|Adverse Event|0|||
146016882|NCT02249091|526571958|FG000|Overall Study|Stable disease with following SCT|0|||
146016883|NCT02249091|526571959|FG001|Overall Study|Stable disease with following SCT|1|||
146016884|NCT02249091|526571958|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
146016885|NCT02249091|526571959|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
146016886|NCT02249091|526571958|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
146016887|NCT02249091|526571959|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
146016888|NCT02249091|526571958|FG000|Overall Study|Refractory AML|1|||
146016889|NCT02249091|526571959|FG001|Overall Study|Refractory AML|1|||
146016890|NCT00853242|526571960|FG000|Overall Study|Adverse Event|0|||
146016891|NCT00853242|526571961|FG001|Overall Study|Adverse Event|1|||
146016892|NCT00853242|526571962|FG002|Overall Study|Adverse Event|1|||
146016893|NCT00853242|526571963|FG003|Overall Study|Adverse Event|0|||
146016894|NCT00853242|526571964|FG004|Overall Study|Adverse Event|3|||
146016895|NCT00853242|526571965|FG005|Overall Study|Adverse Event|1|||
146016896|NCT00853242|526571966|FG006|Overall Study|Adverse Event|1|||
146016897|NCT00853242|526571960|FG000|Overall Study|Noncompliant|0|||
146016898|NCT00853242|526571961|FG001|Overall Study|Noncompliant|0|||
146016899|NCT00853242|526571962|FG002|Overall Study|Noncompliant|0|||
146016900|NCT00853242|526571963|FG003|Overall Study|Noncompliant|0|||
146016901|NCT00853242|526571964|FG004|Overall Study|Noncompliant|1|||
146016902|NCT00853242|526571965|FG005|Overall Study|Noncompliant|0|||
146016903|NCT00853242|526571966|FG006|Overall Study|Noncompliant|0|||
146016904|NCT00853242|526571960|FG000|Overall Study|Withdrawal by Subject|1|||
146016905|NCT00853242|526571961|FG001|Overall Study|Withdrawal by Subject|2|||
146016906|NCT00853242|526571962|FG002|Overall Study|Withdrawal by Subject|0|||
146251132|NCT02101554|527431593|FG002|Overall Study|Lost to Follow-up|0|||
146251133|NCT02101554|527431591|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
146251134|NCT02101554|527431592|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
146016907|NCT00853242|526571963|FG003|Overall Study|Withdrawal by Subject|4|||
146016908|NCT00853242|526571964|FG004|Overall Study|Withdrawal by Subject|0|||
146251135|NCT02101554|527431593|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
146016909|NCT00853242|526571965|FG005|Overall Study|Withdrawal by Subject|0|||
146016910|NCT00853242|526571966|FG006|Overall Study|Withdrawal by Subject|2|||
146016911|NCT00853242|526571960|FG000|Overall Study|Other|2|||
146016912|NCT00853242|526571961|FG001|Overall Study|Other|0|||
146016913|NCT00853242|526571962|FG002|Overall Study|Other|2|||
146016914|NCT00853242|526571963|FG003|Overall Study|Other|0|||
146016915|NCT00853242|526571964|FG004|Overall Study|Other|0|||
146016916|NCT00853242|526571965|FG005|Overall Study|Other|1|||
146016917|NCT00853242|526571966|FG006|Overall Study|Other|2|||
146016918|NCT02957747|526571967|FG000|Overall Study|Withdrawal by Subject|0|||
146016919|NCT02957747|526571968|FG001|Overall Study|Withdrawal by Subject|3|||
146016920|NCT02957747|526571967|FG000|Overall Study|Lost to Follow-up|10|||
146016921|NCT02957747|526571968|FG001|Overall Study|Lost to Follow-up|5|||
146016922|NCT01035463|526571969|FG000|Overall Study|Adverse Event|0|||
146016923|NCT01035463|526571970|FG001|Overall Study|Adverse Event|0|||
146016924|NCT01035463|526571971|FG002|Overall Study|Adverse Event|4|||
146016925|NCT01035463|526571972|FG003|Overall Study|Adverse Event|1|||
146016926|NCT01035463|526571973|FG004|Overall Study|Adverse Event|5|||
146016927|NCT01035463|526571974|FG005|Overall Study|Adverse Event|7|||
146016928|NCT01035463|526571969|FG000|Overall Study|Withdrawal by Subject|0|||
146016929|NCT01035463|526571970|FG001|Overall Study|Withdrawal by Subject|2|||
146016930|NCT01035463|526571971|FG002|Overall Study|Withdrawal by Subject|1|||
146016931|NCT01035463|526571972|FG003|Overall Study|Withdrawal by Subject|0|||
146016932|NCT01035463|526571973|FG004|Overall Study|Withdrawal by Subject|1|||
146016933|NCT01035463|526571974|FG005|Overall Study|Withdrawal by Subject|4|||
146016934|NCT01035463|526571969|FG000|Overall Study|Disease progression|0|||
146016935|NCT01035463|526571970|FG001|Overall Study|Disease progression|0|||
146016936|NCT01035463|526571971|FG002|Overall Study|Disease progression|0|||
146016937|NCT01035463|526571972|FG003|Overall Study|Disease progression|0|||
146016938|NCT01035463|526571973|FG004|Overall Study|Disease progression|0|||
146016939|NCT01035463|526571974|FG005|Overall Study|Disease progression|3|||
146016940|NCT01035463|526571969|FG000|Overall Study|Other Malignancy|0|||
146016941|NCT01035463|526571970|FG001|Overall Study|Other Malignancy|0|||
146016942|NCT01035463|526571971|FG002|Overall Study|Other Malignancy|0|||
146016943|NCT01035463|526571972|FG003|Overall Study|Other Malignancy|0|||
146016944|NCT01035463|526571973|FG004|Overall Study|Other Malignancy|0|||
146016945|NCT01035463|526571974|FG005|Overall Study|Other Malignancy|2|||
146016946|NCT01035463|526571969|FG000|Overall Study|Other|0|||
146016947|NCT01035463|526571970|FG001|Overall Study|Other|0|||
146016948|NCT01035463|526571971|FG002|Overall Study|Other|0|||
146016949|NCT01035463|526571972|FG003|Overall Study|Other|1|||
146016950|NCT01035463|526571973|FG004|Overall Study|Other|0|||
146016951|NCT01035463|526571974|FG005|Overall Study|Other|2|||
146016952|NCT02516098|526571975|FG000|Period 1|Protocol Violation|1|||
146016953|NCT02516098|526571976|FG001|Period 1|Protocol Violation|0|||
146016954|NCT02516098|526571975|FG000|Washout After Period 1|Adverse Event|0|||
146016955|NCT02516098|526571976|FG001|Washout After Period 1|Adverse Event|1|||
146016956|NCT02516098|526571975|FG000|Period 2|Withdrawal by Subject|0|||
146016957|NCT02516098|526571976|FG001|Period 2|Withdrawal by Subject|1|||
146016958|NCT01734395|526571977|FG000|Overall Study|Other|65|||
146016959|NCT01734395|526571977|FG000|Overall Study|Lost to Follow-up|287|||
146016960|NCT01734395|526571977|FG000|Overall Study|Lack of Efficacy|5|||
146016961|NCT01734395|526571977|FG000|Overall Study|Adverse Event|40|||
146016962|NCT01734395|526571977|FG000|Overall Study|Withdrawal by Subject|10|||
146016963|NCT01734395|526571977|FG000|Overall Study|Missing the reasons for not completed|3|||
146016964|NCT01092780|526571978|FG000|Washout Period 1|Adverse Event|0|||
146016965|NCT01092780|526571979|FG001|Washout Period 1|Adverse Event|1|||
146016966|NCT01092780|526571980|FG002|Washout Period 1|Adverse Event|0|||
146016967|NCT01092780|526571981|FG003|Washout Period 1|Adverse Event|0|||
146016968|NCT01092780|526571978|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
146016969|NCT01092780|526571979|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
146016970|NCT01092780|526571980|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
146016971|NCT01092780|526571981|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
146016972|NCT01092780|526571978|FG000|Washout Period 2|Adverse Event|0|||
146016973|NCT01092780|526571979|FG001|Washout Period 2|Adverse Event|1|||
146016974|NCT01092780|526571980|FG002|Washout Period 2|Adverse Event|1|||
146016975|NCT01092780|526571981|FG003|Washout Period 2|Adverse Event|0|||
146016976|NCT01257230|526571982|FG000|Overall Study|Not Treated|0|||
146016977|NCT01257230|526571983|FG001|Overall Study|Not Treated|0|||
146016978|NCT01257230|526571984|FG002|Overall Study|Not Treated|1|||
146016979|NCT01257230|526571982|FG000|Overall Study|Adverse Event|2|||
146016980|NCT01257230|526571983|FG001|Overall Study|Adverse Event|0|||
146016981|NCT01257230|526571984|FG002|Overall Study|Adverse Event|0|||
146016982|NCT01257230|526571982|FG000|Overall Study|Lack of Efficacy|0|||
146016983|NCT01257230|526571983|FG001|Overall Study|Lack of Efficacy|1|||
146016984|NCT01257230|526571984|FG002|Overall Study|Lack of Efficacy|0|||
146016985|NCT01257230|526571982|FG000|Overall Study|Protocol Violation|3|||
146016986|NCT01257230|526571983|FG001|Overall Study|Protocol Violation|0|||
146016987|NCT01257230|526571984|FG002|Overall Study|Protocol Violation|1|||
146016988|NCT01257230|526571982|FG000|Overall Study|Withdrawal by Subject|0|||
146016989|NCT01257230|526571983|FG001|Overall Study|Withdrawal by Subject|4|||
146016990|NCT01257230|526571984|FG002|Overall Study|Withdrawal by Subject|1|||
146016991|NCT01257230|526571982|FG000|Overall Study|Other reason not defined above|1|||
146016992|NCT01257230|526571983|FG001|Overall Study|Other reason not defined above|5|||
146016993|NCT01257230|526571984|FG002|Overall Study|Other reason not defined above|3|||
146016994|NCT04026009|526571987|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146016995|NCT04026009|526571988|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146251136|NCT02011568|527431597|FG000|Overall Study|Withdrawal by Subject|8|||
146251137|NCT02011568|527431598|FG001|Overall Study|Withdrawal by Subject|10|||
146251138|NCT02011568|527431597|FG000|Overall Study|Physician Decision|1|||
146251139|NCT02011568|527431598|FG001|Overall Study|Physician Decision|3|||
146251140|NCT02069366|527431599|FG000|Overall Study|Lost to Follow-up|0|||
146251141|NCT02069366|527431600|FG001|Overall Study|Lost to Follow-up|0|||
146251142|NCT02069366|527431601|FG002|Overall Study|Lost to Follow-up|1|||
146251143|NCT02069366|527431602|FG003|Overall Study|Lost to Follow-up|0|||
146251144|NCT02069366|527431603|FG004|Overall Study|Lost to Follow-up|0|||
146251145|NCT02069366|527431604|FG005|Overall Study|Lost to Follow-up|2|||
146251146|NCT02069366|527431599|FG000|Overall Study|Protocol Violation|0|||
146251147|NCT02069366|527431600|FG001|Overall Study|Protocol Violation|0|||
146251148|NCT02069366|527431601|FG002|Overall Study|Protocol Violation|1|||
146251149|NCT02069366|527431602|FG003|Overall Study|Protocol Violation|0|||
146251150|NCT02069366|527431603|FG004|Overall Study|Protocol Violation|0|||
146251151|NCT02069366|527431604|FG005|Overall Study|Protocol Violation|0|||
146251152|NCT02069366|527431599|FG000|Overall Study|Withdrawal by Subject|1|||
146251153|NCT02069366|527431600|FG001|Overall Study|Withdrawal by Subject|0|||
146251154|NCT02069366|527431601|FG002|Overall Study|Withdrawal by Subject|1|||
146251155|NCT02069366|527431602|FG003|Overall Study|Withdrawal by Subject|2|||
146251156|NCT02069366|527431603|FG004|Overall Study|Withdrawal by Subject|0|||
146251157|NCT02069366|527431604|FG005|Overall Study|Withdrawal by Subject|0|||
146251158|NCT03314233|527431606|FG000|Overall Study|No longer eligible at time of delivery|1|||
146251159|NCT01797705|527431607|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
146251160|NCT01797705|527431607|FG000|Overall Study|Withdrawal by Subject|1|||
146251161|NCT01838447|527431608|FG000|Overall Study|Change in surgical plan|1|||
146251162|NCT01838447|527431609|FG001|Overall Study|Change in surgical plan|2|||
146251163|NCT01838447|527431608|FG000|Overall Study|Withdrawal by Subject|1|||
146251164|NCT01838447|527431609|FG001|Overall Study|Withdrawal by Subject|1|||
146251165|NCT01114217|527431610|FG000|Overall Study|Adverse Event|5|||
146251166|NCT01114217|527431611|FG001|Overall Study|Adverse Event|3|||
146251167|NCT01114217|527431610|FG000|Overall Study|Lost to Follow-up|17|||
146251168|NCT01114217|527431611|FG001|Overall Study|Lost to Follow-up|33|||
146251169|NCT01114217|527431610|FG000|Overall Study|Withdrawal by Subject|21|||
146251170|NCT01114217|527431611|FG001|Overall Study|Withdrawal by Subject|28|||
146251171|NCT01114217|527431610|FG000|Overall Study|Other-Clerical Error|3|||
146251172|NCT01114217|527431611|FG001|Overall Study|Other-Clerical Error|0|||
146251173|NCT01114217|527431610|FG000|Overall Study|Other-Early termination|6|||
146251174|NCT01114217|527431611|FG001|Overall Study|Other-Early termination|10|||
146251175|NCT01114217|527431610|FG000|Overall Study|Other-Procedure|1|||
146251176|NCT01114217|527431611|FG001|Overall Study|Other-Procedure|1|||
146251177|NCT01114217|527431610|FG000|Overall Study|Other-Pregnancy|2|||
146251178|NCT01114217|527431611|FG001|Overall Study|Other-Pregnancy|4|||
146251179|NCT01114217|527431610|FG000|Overall Study|Other-Protocol Violation|1|||
146251180|NCT01114217|527431611|FG001|Overall Study|Other-Protocol Violation|3|||
146251181|NCT01114217|527431610|FG000|Overall Study|Other-Lack of Efficacy|1|||
146251182|NCT01114217|527431611|FG001|Overall Study|Other-Lack of Efficacy|0|||
146251183|NCT01114217|527431610|FG000|Overall Study|Other-Non Compliance|2|||
146251184|NCT01114217|527431611|FG001|Overall Study|Other-Non Compliance|0|||
146016996|NCT04026009|526571989|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146016997|NCT04026009|526571990|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146016998|NCT04026009|526571991|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146016999|NCT04026009|526571987|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
146017000|NCT04026009|526571988|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
146017001|NCT04026009|526571989|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
146017002|NCT04026009|526571990|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
146017003|NCT04026009|526571991|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
146017004|NCT02466425|526571994|FG000|Overall Study|Adverse Event|3|||
146017005|NCT02466425|526571995|FG001|Overall Study|Adverse Event|11|||
146017006|NCT02466425|526571994|FG000|Overall Study|Lack of Efficacy|4|||
146017007|NCT02466425|526571995|FG001|Overall Study|Lack of Efficacy|1|||
146017008|NCT02466425|526571994|FG000|Overall Study|Lost to Follow-up|3|||
146017009|NCT02466425|526571995|FG001|Overall Study|Lost to Follow-up|0|||
146017010|NCT02466425|526571994|FG000|Overall Study|Protocol Violation|1|||
146017011|NCT02466425|526571995|FG001|Overall Study|Protocol Violation|0|||
146017012|NCT02466425|526571994|FG000|Overall Study|Withdrawal by Subject|0|||
146017013|NCT02466425|526571995|FG001|Overall Study|Withdrawal by Subject|1|||
146017014|NCT02466425|526571994|FG000|Overall Study|Other|1|||
146017015|NCT02466425|526571995|FG001|Overall Study|Other|3|||
146017016|NCT02466425|526571994|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146017017|NCT02466425|526571995|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146017018|NCT01721486|526572000|FG000|Overall Study|Protocol Violation|1|||
146017019|NCT01721486|526572001|FG001|Overall Study|Protocol Violation|0|||
146017020|NCT01721486|526572000|FG000|Overall Study|Physician Decision|0|||
146017021|NCT01721486|526572001|FG001|Overall Study|Physician Decision|1|||
146017022|NCT00582712|526572002|FG000|Overall Study|Adverse Event|1|||
146017023|NCT00582712|526572002|FG000|Overall Study|Lack of Efficacy|1|||
146017024|NCT00582712|526572002|FG000|Overall Study|Withdrawal by Subject|1|||
146017025|NCT00582712|526572002|FG000|Overall Study|Complicating disease requiring treatment|1|||
146017026|NCT01901289|526572003|FG000|Overall Study|Death|32|||
146017027|NCT01901289|526572003|FG000|Overall Study|Lost to Follow-up|16|||
146017028|NCT01901289|526572003|FG000|Overall Study|Withdrawal by Subject|35|||
146017029|NCT01901289|526572003|FG000|Overall Study|Other type of endpoint met|2|||
146017030|NCT01813058|526572005|FG000|Overall Study|Withdrawal by Subject|5|||
146017031|NCT01813058|526572006|FG001|Overall Study|Withdrawal by Subject|4|||
146017032|NCT03585764|526572007|FG000|Overall Study|Death|3|||
146017033|NCT03585764|526572008|FG001|Overall Study|Death|2|||
146017034|NCT03585764|526572009|FG002|Overall Study|Death|3|||
146017035|NCT03585764|526572010|FG003|Overall Study|Death|0|||
146017036|NCT03585764|526572007|FG000|Overall Study|Lost to Follow-up|0|||
146017037|NCT03585764|526572008|FG001|Overall Study|Lost to Follow-up|1|||
146017038|NCT03585764|526572009|FG002|Overall Study|Lost to Follow-up|0|||
146017039|NCT03585764|526572010|FG003|Overall Study|Lost to Follow-up|0|||
146017040|NCT03585764|526572007|FG000|Overall Study|Physician Decision|0|||
146017041|NCT03585764|526572008|FG001|Overall Study|Physician Decision|0|||
146017042|NCT03585764|526572009|FG002|Overall Study|Physician Decision|2|||
146017043|NCT03585764|526572010|FG003|Overall Study|Physician Decision|0|||
146017044|NCT01581021|526572011|FG000|Overall Study|Lost to Follow-up|4|||
146017045|NCT01581021|526572012|FG001|Overall Study|Lost to Follow-up|6|||
146017046|NCT01581021|526572011|FG000|Overall Study|More than 2 hooks in thoracic|3|||
146017047|NCT01581021|526572012|FG001|Overall Study|More than 2 hooks in thoracic|0|||
146017048|NCT01581021|526572011|FG000|Overall Study|Neuromuscular|2|||
146017049|NCT01581021|526572012|FG001|Overall Study|Neuromuscular|1|||
146017050|NCT01581021|526572011|FG000|Overall Study|Not Randomized|1|||
146017051|NCT01581021|526572012|FG001|Overall Study|Not Randomized|2|||
146017052|NCT01581021|526572011|FG000|Overall Study|Lenke 6 Classification|0|||
146017053|NCT01581021|526572012|FG001|Overall Study|Lenke 6 Classification|1|||
146017054|NCT01581021|526572011|FG000|Overall Study|Lack of Efficacy|0|||
146017055|NCT01581021|526572012|FG001|Overall Study|Lack of Efficacy|1|||
146017056|NCT03403361|526572013|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
146017057|NCT01932372|526572014|FG000|Overall Study|Not meeting eligibility criteria|33|||
146017058|NCT01932372|526572015|FG001|Overall Study|Not meeting eligibility criteria|179|||
146017059|NCT01917929|526572020|FG000|Overall Study|Death|8|||
146017060|NCT01917929|526572020|FG000|Overall Study|Lost to Follow-up|19|||
146017061|NCT01917929|526572020|FG000|Overall Study|Withdrawal by Subject|33|||
146017062|NCT01917929|526572020|FG000|Overall Study|Adverse Event|6|||
146017063|NCT01917929|526572020|FG000|Overall Study|Investigative Site Terminated|35|||
146017064|NCT01917929|526572020|FG000|Overall Study|Censored because study device not implanted|6|||
146017065|NCT01917929|526572020|FG000|Overall Study|Censored because surgery not performed|3|||
146017066|NCT01917929|526572020|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
146017067|NCT01917929|526572020|FG000|Overall Study|Sponsor terminated study|175|||
146017068|NCT00673231|526572021|FG000|Overall Study|Withdrawal by Subject|14|||
146017069|NCT00673231|526572022|FG001|Overall Study|Withdrawal by Subject|10|||
146017070|NCT00673231|526572023|FG002|Overall Study|Withdrawal by Subject|8|||
146017071|NCT00673231|526572024|FG003|Overall Study|Withdrawal by Subject|6|||
146017072|NCT00673231|526572021|FG000|Overall Study|Adverse Event|6|||
146017073|NCT00673231|526572022|FG001|Overall Study|Adverse Event|5|||
146017074|NCT00673231|526572023|FG002|Overall Study|Adverse Event|9|||
146017075|NCT00673231|526572024|FG003|Overall Study|Adverse Event|6|||
146017076|NCT00673231|526572021|FG000|Overall Study|Lost to Follow-up|1|||
146017077|NCT00673231|526572022|FG001|Overall Study|Lost to Follow-up|2|||
146017078|NCT00673231|526572023|FG002|Overall Study|Lost to Follow-up|1|||
146017079|NCT00673231|526572024|FG003|Overall Study|Lost to Follow-up|2|||
146017080|NCT00673231|526572021|FG000|Overall Study|Death|0|||
146017081|NCT00673231|526572022|FG001|Overall Study|Death|0|||
146017082|NCT00673231|526572023|FG002|Overall Study|Death|1|||
146017083|NCT00673231|526572024|FG003|Overall Study|Death|0|||
146251185|NCT01114217|527431610|FG000|Overall Study|Other-Physician Decision|1|||
146017084|NCT00673231|526572021|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
146017085|NCT00673231|526572022|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
146017086|NCT00673231|526572023|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
146017087|NCT00673231|526572024|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
146017088|NCT03594747|526572028|FG000|Overall Study|Death|78|||
146251186|NCT01114217|527431611|FG001|Overall Study|Other-Physician Decision|1|||
146017089|NCT03594747|526572029|FG001|Overall Study|Death|86|||
146017090|NCT03594747|526572030|FG002|Overall Study|Death|87|||
146017091|NCT03594747|526572028|FG000|Overall Study|Withdrawal by Subject|5|||
146017092|NCT03594747|526572029|FG001|Overall Study|Withdrawal by Subject|2|||
146017093|NCT03594747|526572030|FG002|Overall Study|Withdrawal by Subject|11|||
146017094|NCT03594747|526572028|FG000|Overall Study|Lost to Follow-up|4|||
146017095|NCT03594747|526572029|FG001|Overall Study|Lost to Follow-up|1|||
146017096|NCT03594747|526572030|FG002|Overall Study|Lost to Follow-up|1|||
146017097|NCT03594747|526572028|FG000|Overall Study|Physician Decision|0|||
146017098|NCT03594747|526572029|FG001|Overall Study|Physician Decision|1|||
146299889|NCT00295633|527613645|FG000|Overall Study|Lack of Efficacy|19|||
146299890|NCT00295633|527613646|FG001|Overall Study|Lack of Efficacy|7|||
146299891|NCT00295633|527613647|FG002|Overall Study|Lack of Efficacy|16|||
146299892|NCT00295633|527613645|FG000|Overall Study|Withdrawal of consent by subject|16|||
146299893|NCT00295633|527613646|FG001|Overall Study|Withdrawal of consent by subject|16|||
146299894|NCT00295633|527613647|FG002|Overall Study|Withdrawal of consent by subject|26|||
146299895|NCT00295633|527613645|FG000|Overall Study|Adverse Event|9|||
146299896|NCT00295633|527613646|FG001|Overall Study|Adverse Event|17|||
146299897|NCT00295633|527613647|FG002|Overall Study|Adverse Event|9|||
146299898|NCT00295633|527613645|FG000|Overall Study|Lost to Follow-up|6|||
146299899|NCT00295633|527613646|FG001|Overall Study|Lost to Follow-up|11|||
146299900|NCT00295633|527613647|FG002|Overall Study|Lost to Follow-up|7|||
146299901|NCT00295633|527613645|FG000|Overall Study|Physician Decision|9|||
146299902|NCT00295633|527613646|FG001|Overall Study|Physician Decision|10|||
146299903|NCT00295633|527613647|FG002|Overall Study|Physician Decision|8|||
146299904|NCT00295633|527613645|FG000|Overall Study|Poor/Noncompliance|2|||
146299905|NCT00295633|527613646|FG001|Overall Study|Poor/Noncompliance|2|||
146299906|NCT00295633|527613647|FG002|Overall Study|Poor/Noncompliance|6|||
146299907|NCT00295633|527613645|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146299908|NCT00295633|527613646|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
146299909|NCT00295633|527613647|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
146299910|NCT00295633|527613645|FG000|Overall Study|Death|1|||
146299911|NCT00295633|527613646|FG001|Overall Study|Death|1|||
146299912|NCT00295633|527613647|FG002|Overall Study|Death|0|||
146299913|NCT00295633|527613645|FG000|Overall Study|Administrative reason by sponsor|0|||
146299914|NCT00295633|527613646|FG001|Overall Study|Administrative reason by sponsor|0|||
146299915|NCT00295633|527613647|FG002|Overall Study|Administrative reason by sponsor|1|||
146299916|NCT02294682|527613648|FG000|Overall Study|Could not swallow pills|1|||
146299917|NCT02294682|527613649|FG001|Overall Study|Could not swallow pills|0|||
146299918|NCT01516970|527613650|FG000|Overall Study|Lost to Follow-up|7|||
146299919|NCT01516970|527613651|FG001|Overall Study|Lost to Follow-up|8|||
146299920|NCT01516970|527613650|FG000|Overall Study|Adverse Event|1|||
146299921|NCT01516970|527613651|FG001|Overall Study|Adverse Event|5|||
146299922|NCT01516970|527613650|FG000|Overall Study|Withdrawal by Subject|1|||
146299923|NCT01516970|527613651|FG001|Overall Study|Withdrawal by Subject|1|||
146299924|NCT01516970|527613650|FG000|Overall Study|Other|9|||
146299925|NCT01516970|527613651|FG001|Overall Study|Other|7|||
146299926|NCT00434421|527613652|FG000|Overall Study|Withdrawal by Subject|1|||
146299927|NCT00434421|527613652|FG000|Overall Study|Non-compliance with study treatment|1|||
146299928|NCT01205438|527613653|FG000|Overall Study|Adverse Event|19|||
146299929|NCT01205438|527613654|FG001|Overall Study|Adverse Event|17|||
146299930|NCT01205438|527613655|FG002|Overall Study|Adverse Event|24|||
146299931|NCT01205438|527613653|FG000|Overall Study|Death|1|||
146299932|NCT01205438|527613654|FG001|Overall Study|Death|1|||
146299933|NCT01205438|527613655|FG002|Overall Study|Death|3|||
146299934|NCT01205438|527613653|FG000|Overall Study|Entry Criteria Not Met|16|||
146299935|NCT01205438|527613654|FG001|Overall Study|Entry Criteria Not Met|15|||
146299936|NCT01205438|527613655|FG002|Overall Study|Entry Criteria Not Met|13|||
146299937|NCT01205438|527613653|FG000|Overall Study|Lack of Efficacy|14|||
146299938|NCT01205438|527613654|FG001|Overall Study|Lack of Efficacy|11|||
146299939|NCT01205438|527613655|FG002|Overall Study|Lack of Efficacy|14|||
146299940|NCT01205438|527613653|FG000|Overall Study|Lost to Follow-up|6|||
146299941|NCT01205438|527613654|FG001|Overall Study|Lost to Follow-up|7|||
146299942|NCT01205438|527613655|FG002|Overall Study|Lost to Follow-up|8|||
146299943|NCT01205438|527613653|FG000|Overall Study|Withdrawal by Subject|19|||
146299944|NCT01205438|527613654|FG001|Overall Study|Withdrawal by Subject|25|||
146299945|NCT01205438|527613655|FG002|Overall Study|Withdrawal by Subject|19|||
146299946|NCT01205438|527613653|FG000|Overall Study|Physician Decision|0|||
146299947|NCT01205438|527613654|FG001|Overall Study|Physician Decision|3|||
146299948|NCT01205438|527613655|FG002|Overall Study|Physician Decision|2|||
146299949|NCT01205438|527613653|FG000|Overall Study|Protocol Violation|2|||
146299950|NCT01205438|527613654|FG001|Overall Study|Protocol Violation|7|||
146299951|NCT01205438|527613655|FG002|Overall Study|Protocol Violation|4|||
146299952|NCT01205438|527613653|FG000|Overall Study|Sponsor Decision|0|||
146299953|NCT01205438|527613654|FG001|Overall Study|Sponsor Decision|1|||
146299954|NCT01205438|527613655|FG002|Overall Study|Sponsor Decision|1|||
146299955|NCT03823404|527613656|FG000|Overall Study|Lost to Follow-up|1|||
146299956|NCT03823404|527613657|FG001|Overall Study|Lost to Follow-up|2|||
146299957|NCT03823404|527613658|FG002|Overall Study|Lost to Follow-up|3|||
146299958|NCT03823404|527613656|FG000|Overall Study|Protocol Violation|2|||
146299959|NCT03823404|527613657|FG001|Overall Study|Protocol Violation|0|||
146299960|NCT03823404|527613658|FG002|Overall Study|Protocol Violation|2|||
146299961|NCT03823404|527613656|FG000|Overall Study|Adverse Event|35|||
146299962|NCT03823404|527613657|FG001|Overall Study|Adverse Event|38|||
146299963|NCT03823404|527613658|FG002|Overall Study|Adverse Event|8|||
146299964|NCT03823404|527613656|FG000|Overall Study|Withdrawal by Subject|38|||
146299965|NCT03823404|527613657|FG001|Overall Study|Withdrawal by Subject|40|||
146299966|NCT03823404|527613658|FG002|Overall Study|Withdrawal by Subject|35|||
146299967|NCT03823404|527613656|FG000|Overall Study|Death|4|||
146017099|NCT03594747|526572030|FG002|Overall Study|Physician Decision|0|||
146017100|NCT03594747|526572028|FG000|Overall Study|Sponsor decision|23|||
146017101|NCT03594747|526572029|FG001|Overall Study|Sponsor decision|17|||
146017102|NCT03594747|526572030|FG002|Overall Study|Sponsor decision|16|||
146017103|NCT03594747|526572028|FG000|Overall Study|Did not meet inclusion criteria|0|||
146017104|NCT03594747|526572029|FG001|Overall Study|Did not meet inclusion criteria|0|||
146017105|NCT03594747|526572030|FG002|Overall Study|Did not meet inclusion criteria|1|||
146017106|NCT03594747|526572028|FG000|Overall Study|Transfer to long term extension study|10|||
146017107|NCT03594747|526572029|FG001|Overall Study|Transfer to long term extension study|12|||
146017108|NCT03594747|526572030|FG002|Overall Study|Transfer to long term extension study|5|||
146017109|NCT02907216|526572031|FG000|Overall Study|No benefit to be obtained by continuing|0|||
146017110|NCT02907216|526572032|FG001|Overall Study|No benefit to be obtained by continuing|1|||
146017111|NCT02907216|526572031|FG000|Overall Study|Withdrawal by Subject|1|||
146017112|NCT02907216|526572032|FG001|Overall Study|Withdrawal by Subject|0|||
146017113|NCT02485639|526572038|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
146017114|NCT02485639|526572038|FG000|Overall Study|Early termination|4|||
146017115|NCT02485639|526572038|FG000|Overall Study|Withdrawal by Subject|4|||
146017116|NCT03479541|526572039|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
146017117|NCT03479541|526572040|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
146017118|NCT03479541|526572041|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
146017119|NCT03479541|526572042|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
146017120|NCT03479541|526572039|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
146017121|NCT03479541|526572040|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
146017122|NCT03479541|526572041|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
146017123|NCT03479541|526572042|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
146017124|NCT03479541|526572039|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
146017125|NCT03479541|526572040|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
146017126|NCT03479541|526572041|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
146017127|NCT03479541|526572042|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
146017128|NCT03479541|526572039|FG000|Home Monitoring|Lost to Follow-up|0|||
146017129|NCT03479541|526572040|FG001|Home Monitoring|Lost to Follow-up|0|||
146017130|NCT03479541|526572041|FG002|Home Monitoring|Lost to Follow-up|8|||
146017131|NCT03479541|526572042|FG003|Home Monitoring|Lost to Follow-up|12|||
146017132|NCT03479541|526572039|FG000|Home Monitoring|Withdrawal by Subject|0|||
146017133|NCT03479541|526572040|FG001|Home Monitoring|Withdrawal by Subject|0|||
146017134|NCT03479541|526572041|FG002|Home Monitoring|Withdrawal by Subject|17|||
146017135|NCT03479541|526572042|FG003|Home Monitoring|Withdrawal by Subject|30|||
146017136|NCT03479541|526572039|FG000|Home Monitoring|Early Termination - PI Decision|0|||
146017137|NCT03479541|526572040|FG001|Home Monitoring|Early Termination - PI Decision|0|||
146017138|NCT03479541|526572041|FG002|Home Monitoring|Early Termination - PI Decision|4|||
146017139|NCT03479541|526572042|FG003|Home Monitoring|Early Termination - PI Decision|6|||
146017140|NCT00107900|526572045|FG000|Overall Study|Adverse Event|3|||
146017141|NCT00107900|526572046|FG001|Overall Study|Adverse Event|2|||
146017142|NCT00107900|526572047|FG002|Overall Study|Adverse Event|10|||
146017143|NCT00107900|526572048|FG003|Overall Study|Adverse Event|3|||
146017144|NCT00107900|526572049|FG004|Overall Study|Adverse Event|5|||
146017145|NCT00107900|526572050|FG005|Overall Study|Adverse Event|3|||
146017146|NCT00107900|526572045|FG000|Overall Study|Death|0|||
146017147|NCT00107900|526572046|FG001|Overall Study|Death|0|||
146017148|NCT00107900|526572047|FG002|Overall Study|Death|0|||
146017149|NCT00107900|526572048|FG003|Overall Study|Death|0|||
146017150|NCT00107900|526572049|FG004|Overall Study|Death|1|||
146017151|NCT00107900|526572050|FG005|Overall Study|Death|0|||
146017152|NCT00107900|526572045|FG000|Overall Study|Lost to Follow-up|4|||
146017153|NCT00107900|526572046|FG001|Overall Study|Lost to Follow-up|1|||
146017154|NCT00107900|526572047|FG002|Overall Study|Lost to Follow-up|3|||
146017155|NCT00107900|526572048|FG003|Overall Study|Lost to Follow-up|2|||
146017156|NCT00107900|526572049|FG004|Overall Study|Lost to Follow-up|5|||
146017157|NCT00107900|526572050|FG005|Overall Study|Lost to Follow-up|5|||
146017158|NCT00107900|526572045|FG000|Overall Study|Protocol Violation|1|||
146017159|NCT00107900|526572046|FG001|Overall Study|Protocol Violation|0|||
146017160|NCT00107900|526572047|FG002|Overall Study|Protocol Violation|5|||
146017161|NCT00107900|526572048|FG003|Overall Study|Protocol Violation|5|||
146017162|NCT00107900|526572049|FG004|Overall Study|Protocol Violation|7|||
146017163|NCT00107900|526572050|FG005|Overall Study|Protocol Violation|0|||
146017164|NCT00107900|526572045|FG000|Overall Study|Withdrawal by Subject|1|||
146017165|NCT00107900|526572046|FG001|Overall Study|Withdrawal by Subject|0|||
146017166|NCT00107900|526572047|FG002|Overall Study|Withdrawal by Subject|5|||
146017167|NCT00107900|526572048|FG003|Overall Study|Withdrawal by Subject|0|||
146017168|NCT00107900|526572049|FG004|Overall Study|Withdrawal by Subject|1|||
146017169|NCT00107900|526572050|FG005|Overall Study|Withdrawal by Subject|1|||
146017170|NCT00107900|526572045|FG000|Overall Study|Administrative Reasons|1|||
146017171|NCT00107900|526572046|FG001|Overall Study|Administrative Reasons|0|||
146017172|NCT00107900|526572047|FG002|Overall Study|Administrative Reasons|2|||
146017173|NCT00107900|526572048|FG003|Overall Study|Administrative Reasons|2|||
146017174|NCT00107900|526572049|FG004|Overall Study|Administrative Reasons|2|||
146017175|NCT00107900|526572050|FG005|Overall Study|Administrative Reasons|0|||
146017176|NCT02147197|526572054|FG000|Overall Study|Adverse Event|1|||
146017177|NCT02147197|526572055|FG001|Overall Study|Adverse Event|0|||
146017178|NCT02147197|526572056|FG002|Overall Study|Adverse Event|0|||
146017179|NCT02147197|526572054|FG000|Overall Study|Withdrawal of Consent|4|||
146017180|NCT02147197|526572055|FG001|Overall Study|Withdrawal of Consent|3|||
146017181|NCT02147197|526572056|FG002|Overall Study|Withdrawal of Consent|2|||
146017182|NCT02147197|526572054|FG000|Overall Study|Lost to Follow-up|2|||
146017183|NCT02147197|526572055|FG001|Overall Study|Lost to Follow-up|3|||
146017184|NCT02147197|526572056|FG002|Overall Study|Lost to Follow-up|1|||
146017185|NCT02147197|526572054|FG000|Overall Study|Protocol Violation|1|||
146017186|NCT02147197|526572055|FG001|Overall Study|Protocol Violation|0|||
146017187|NCT02147197|526572056|FG002|Overall Study|Protocol Violation|3|||
146017188|NCT02147197|526572054|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146017189|NCT02147197|526572055|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146017190|NCT02147197|526572056|FG002|Overall Study|Other Miscellaneous Reasons|3|||
146017191|NCT00923975|526574329|FG000|Overall Study|Did not meet inclusion criteria|1|||
146017192|NCT01005316|526574332|FG000|Overall Study|Adverse Event|0|||
146017193|NCT01005316|526574333|FG001|Overall Study|Adverse Event|0|||
146017194|NCT01005316|526574334|FG002|Overall Study|Adverse Event|0|||
146017195|NCT01005316|526574335|FG003|Overall Study|Adverse Event|1|||
146017196|NCT01005316|526574332|FG000|Overall Study|Death|20|||
146017197|NCT01005316|526574333|FG001|Overall Study|Death|5|||
146017198|NCT01005316|526574334|FG002|Overall Study|Death|1|||
146017199|NCT01005316|526574335|FG003|Overall Study|Death|15|||
146017200|NCT01005316|526574332|FG000|Overall Study|Study Termination|5|||
146017201|NCT01005316|526574333|FG001|Overall Study|Study Termination|63|||
146017202|NCT01005316|526574334|FG002|Overall Study|Study Termination|9|||
146017203|NCT01005316|526574335|FG003|Overall Study|Study Termination|85|||
146017204|NCT01005316|526574332|FG000|Overall Study|Lost to Follow-up|1|||
146017205|NCT01005316|526574333|FG001|Overall Study|Lost to Follow-up|3|||
146017206|NCT01005316|526574334|FG002|Overall Study|Lost to Follow-up|0|||
146017207|NCT01005316|526574335|FG003|Overall Study|Lost to Follow-up|2|||
146017208|NCT01005316|526574332|FG000|Overall Study|Physician Decision|6|||
146017209|NCT01005316|526574333|FG001|Overall Study|Physician Decision|0|||
146017210|NCT01005316|526574334|FG002|Overall Study|Physician Decision|0|||
146017211|NCT01005316|526574335|FG003|Overall Study|Physician Decision|0|||
146017212|NCT01005316|526574332|FG000|Overall Study|Sponsor Decision|6|||
146017213|NCT01005316|526574333|FG001|Overall Study|Sponsor Decision|3|||
146017214|NCT01005316|526574334|FG002|Overall Study|Sponsor Decision|0|||
146017215|NCT01005316|526574335|FG003|Overall Study|Sponsor Decision|0|||
146017216|NCT01005316|526574332|FG000|Overall Study|Withdrawal by Subject|1|||
146017217|NCT01005316|526574333|FG001|Overall Study|Withdrawal by Subject|1|||
146017218|NCT01005316|526574334|FG002|Overall Study|Withdrawal by Subject|0|||
146017219|NCT01005316|526574335|FG003|Overall Study|Withdrawal by Subject|2|||
146017220|NCT01005316|526574332|FG000|Overall Study|Consented to Another Study|2|||
146017221|NCT01005316|526574333|FG001|Overall Study|Consented to Another Study|0|||
146017222|NCT01005316|526574334|FG002|Overall Study|Consented to Another Study|0|||
146017223|NCT01005316|526574335|FG003|Overall Study|Consented to Another Study|0|||
146017224|NCT01005316|526574332|FG000|Overall Study|Delisted|8|||
146017225|NCT01005316|526574333|FG001|Overall Study|Delisted|0|||
146017226|NCT01005316|526574334|FG002|Overall Study|Delisted|0|||
146017227|NCT01005316|526574335|FG003|Overall Study|Delisted|0|||
146017228|NCT01005316|526574332|FG000|Overall Study|Transferred Care|1|||
146017229|NCT01005316|526574333|FG001|Overall Study|Transferred Care|0|||
146017230|NCT01005316|526574334|FG002|Overall Study|Transferred Care|1|||
146017231|NCT01005316|526574335|FG003|Overall Study|Transferred Care|3|||
146017232|NCT01005316|526574332|FG000|Overall Study|Retransplanted|0|||
146017233|NCT01005316|526574333|FG001|Overall Study|Retransplanted|1|||
146017234|NCT01005316|526574334|FG002|Overall Study|Retransplanted|0|||
146017235|NCT01005316|526574335|FG003|Overall Study|Retransplanted|0|||
146017236|NCT00632827|526574336|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
146017237|NCT00632827|526574336|FG000|Overall Study|Death|2|||
146017238|NCT00632827|526574336|FG000|Overall Study|Adverse Event|5|||
146017239|NCT00632827|526574336|FG000|Overall Study|Lost to Follow-up|1|||
146017240|NCT01126268|526574344|FG000|Overall Study|Adverse Event|1|||
146017241|NCT01205061|526574345|FG000|Overall Study|Adverse Event|4|||
146299968|NCT03823404|527613657|FG001|Overall Study|Death|0|||
146299969|NCT03823404|527613658|FG002|Overall Study|Death|0|||
146017242|NCT01205061|526574345|FG000|Overall Study|Withdrawal by Subject|11|||
146017243|NCT01205061|526574345|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
146017244|NCT01205061|526574345|FG000|Overall Study|Lost to Follow-up|9|||
146017245|NCT01205061|526574345|FG000|Overall Study|Other|1|||
146017246|NCT00765037|526574346|FG000|Overall Study|Lost to Follow-up|5|||
146017247|NCT00765037|526574346|FG000|Overall Study|Adverse Event|1|||
146017248|NCT01988662|526574351|FG000|Overall Study|Subject/guardian decision|1|||
146017249|NCT01988662|526574352|FG001|Overall Study|Subject/guardian decision|1|||
146017250|NCT01988662|526574351|FG000|Overall Study|Adverse Event|3|||
146093676|NCT02160782|526864857|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146093677|NCT02160782|526864858|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146093678|NCT02160782|526864859|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
146093679|NCT02160782|526864860|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
146093680|NCT00891462|526864863|FG000|Overall Study|Withdrawal by Subject|9|||
146093681|NCT00891462|526864864|FG001|Overall Study|Withdrawal by Subject|6|||
146093682|NCT00891462|526864865|FG002|Overall Study|Withdrawal by Subject|7|||
146093683|NCT00891462|526864863|FG000|Overall Study|Adverse Event|7|||
146093684|NCT00891462|526864864|FG001|Overall Study|Adverse Event|8|||
146093685|NCT00891462|526864865|FG002|Overall Study|Adverse Event|7|||
146093686|NCT00891462|526864863|FG000|Overall Study|Lack of Efficacy|10|||
146093687|NCT00891462|526864864|FG001|Overall Study|Lack of Efficacy|5|||
146093688|NCT00891462|526864865|FG002|Overall Study|Lack of Efficacy|1|||
146093689|NCT00891462|526864863|FG000|Overall Study|COPD exacerbation|7|||
146093690|NCT00891462|526864864|FG001|Overall Study|COPD exacerbation|4|||
146093691|NCT00891462|526864865|FG002|Overall Study|COPD exacerbation|1|||
146093692|NCT00891462|526864863|FG000|Overall Study|Other Reason|2|||
146093693|NCT00891462|526864864|FG001|Overall Study|Other Reason|5|||
146093694|NCT00891462|526864865|FG002|Overall Study|Other Reason|3|||
146093695|NCT00891462|526864863|FG000|Overall Study|Protocol Violation|2|||
146093696|NCT00891462|526864864|FG001|Overall Study|Protocol Violation|1|||
146093697|NCT00891462|526864865|FG002|Overall Study|Protocol Violation|3|||
146251187|NCT01114217|527431610|FG000|Overall Study|Other-Sponsor Decision|10|||
146251188|NCT01114217|527431611|FG001|Overall Study|Other-Sponsor Decision|12|||
146251189|NCT01114217|527431610|FG000|Overall Study|Other-Study Termination|0|||
146251190|NCT01114217|527431611|FG001|Overall Study|Other-Study Termination|1|||
146251191|NCT01114217|527431610|FG000|Overall Study|Other-Study Withdrawn|1|||
146251192|NCT01114217|527431611|FG001|Overall Study|Other-Study Withdrawn|1|||
146251193|NCT01114217|527431610|FG000|Overall Study|Other-Site Stopped Communicating|2|||
146251194|NCT01114217|527431611|FG001|Overall Study|Other-Site Stopped Communicating|0|||
146251195|NCT01114217|527431610|FG000|Overall Study|Other-Lost to Follow-up|1|||
146251196|NCT01114217|527431611|FG001|Overall Study|Other-Lost to Follow-up|0|||
146251197|NCT01114217|527431610|FG000|Overall Study|Other-Withdrawal by Subject|1|||
146251198|NCT01114217|527431611|FG001|Overall Study|Other-Withdrawal by Subject|1|||
146251199|NCT06247488|527431612|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
146251200|NCT06247488|527431613|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146251201|NCT06247488|527431614|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146251202|NCT06247488|527431615|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146251203|NCT06247488|527431616|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146251204|NCT06247488|527431617|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
146093698|NCT00891462|526864863|FG000|Overall Study|Inclusion/exclusion criteria|0|||
146093699|NCT00891462|526864864|FG001|Overall Study|Inclusion/exclusion criteria|2|||
146093700|NCT00891462|526864865|FG002|Overall Study|Inclusion/exclusion criteria|2|||
146093701|NCT00891462|526864863|FG000|Overall Study|Lost to Follow-up|0|||
146093702|NCT00891462|526864864|FG001|Overall Study|Lost to Follow-up|2|||
146093703|NCT00891462|526864865|FG002|Overall Study|Lost to Follow-up|0|||
146093704|NCT00423722|526864869|FG000|Overall Study|Death|4|||
146093705|NCT00423722|526864870|FG001|Overall Study|Death|4|||
146093706|NCT00423722|526864869|FG000|Overall Study|Declined to participate|2|||
146093707|NCT00423722|526864870|FG001|Overall Study|Declined to participate|3|||
146251205|NCT06247488|527431612|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146251206|NCT06247488|527431613|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146251207|NCT06247488|527431614|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146251208|NCT06247488|527431615|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
146251209|NCT06247488|527431616|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146251210|NCT06247488|527431617|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
146251211|NCT06247488|527431612|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
146251212|NCT06247488|527431613|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146251213|NCT06247488|527431614|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146251214|NCT06247488|527431615|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146093708|NCT00423722|526864869|FG000|Overall Study|Unable to complete questionnaires|4|||
146093709|NCT00423722|526864870|FG001|Overall Study|Unable to complete questionnaires|4|||
146093710|NCT00423722|526864869|FG000|Overall Study|Withdrawal by Subject|4|||
146093711|NCT00423722|526864870|FG001|Overall Study|Withdrawal by Subject|2|||
146093712|NCT00215683|526864871|FG000|Overall Study|Adverse Event|15|||
146251215|NCT06247488|527431616|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146251216|NCT06247488|527431617|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
146251217|NCT06247488|527431612|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146251218|NCT06247488|527431613|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146251219|NCT06247488|527431614|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146251220|NCT06247488|527431615|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
146251221|NCT06247488|527431616|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146017251|NCT01988662|526574352|FG001|Overall Study|Adverse Event|1|||
146017252|NCT03425006|526574353|FG000|Overall Study|Withdrawal by Subject|1|||
146017253|NCT03425006|526574353|FG000|Overall Study|Physician Decision|1|||
146017254|NCT03425006|526574353|FG000|Overall Study|Death|1|||
146017255|NCT01177553|526574354|FG000|Overall Study|babies not yet 6 months of age|1|||
146017256|NCT01177553|526574355|FG001|Overall Study|babies not yet 6 months of age|0|||
146017257|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
146017258|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
146017259|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
146017260|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
146017261|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146017262|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146017263|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146017264|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146017265|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
146017266|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
146017267|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
146017268|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
146017269|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
146017270|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
146017271|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
146017272|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
146017273|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
146017274|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017275|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017276|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017277|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017278|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017279|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017280|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017281|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017282|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017283|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017284|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017285|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017286|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
146017287|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
146017288|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
146017289|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
146017290|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
146017291|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
146017292|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
146017293|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
146017294|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
146017295|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
146017296|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
146017297|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
146017298|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
146017299|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
146017300|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
146017301|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
146017302|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
146017303|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
146017304|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
146017305|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
146017306|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
146017307|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
146017308|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
146017309|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
146017310|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
146017311|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
146017312|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
146017313|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
146017314|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
146017315|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
146017316|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
146017317|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
146017318|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146017319|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
146017320|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
146017321|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017322|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017323|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146299970|NCT03823404|527613656|FG000|Overall Study|Other: Various reasons provided|5|||
146251222|NCT06247488|527431617|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
146299971|NCT03823404|527613657|FG001|Overall Study|Other: Various reasons provided|5|||
146299972|NCT03823404|527613658|FG002|Overall Study|Other: Various reasons provided|6|||
146299973|NCT00892177|527613663|FG000|Phase II|Ineligible|0|||
146299974|NCT00892177|527613664|FG001|Phase II|Ineligible|0|||
146299975|NCT00892177|527613665|FG002|Phase II|Ineligible|0|||
146299976|NCT00892177|527613666|FG003|Phase II|Ineligible|0|||
146299977|NCT00892177|527613667|FG004|Phase II|Ineligible|1|||
146299978|NCT00892177|527613668|FG005|Phase II|Ineligible|1|||
146299979|NCT00892177|527613663|FG000|Phase II|Withdrawal by Subject|0|||
146299980|NCT00892177|527613664|FG001|Phase II|Withdrawal by Subject|0|||
146299981|NCT00892177|527613665|FG002|Phase II|Withdrawal by Subject|0|||
146017324|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017325|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017326|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017327|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017328|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017329|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017330|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017331|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146017332|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
146017333|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
146017334|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
146017335|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
146017336|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017337|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017338|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017339|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017340|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017341|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017342|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017343|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017344|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017345|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017346|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
146017347|NCT03831191|526574366|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017348|NCT03831191|526574367|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017349|NCT03831191|526574368|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017350|NCT03831191|526574369|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
146017351|NCT03831191|526574370|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017352|NCT03831191|526574371|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017353|NCT03831191|526574372|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017354|NCT03831191|526574373|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017355|NCT03831191|526574374|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017356|NCT03831191|526574375|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017357|NCT03831191|526574376|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017358|NCT03831191|526574377|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017359|NCT03831191|526574378|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017360|NCT03831191|526574379|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017361|NCT03831191|526574380|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
146017362|NCT03831191|526574366|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146017363|NCT03831191|526574367|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146017364|NCT03831191|526574368|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146017365|NCT03831191|526574369|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
146017366|NCT03831191|526574370|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146017367|NCT03831191|526574371|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
146017368|NCT03831191|526574372|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
146017369|NCT03831191|526574373|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146251223|NCT06247488|527431612|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146251224|NCT06247488|527431613|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146251225|NCT06247488|527431614|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146251226|NCT06247488|527431615|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146251227|NCT06247488|527431616|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
146251228|NCT06247488|527431617|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
146251229|NCT06247488|527431612|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146299982|NCT00892177|527613666|FG003|Phase II|Withdrawal by Subject|0|||
146017370|NCT03831191|526574374|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
146299983|NCT00892177|527613667|FG004|Phase II|Withdrawal by Subject|4|||
146299984|NCT00892177|527613668|FG005|Phase II|Withdrawal by Subject|1|||
146299985|NCT00404066|527613674|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
146251230|NCT06247488|527431613|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146251231|NCT06247488|527431614|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146251232|NCT06247488|527431615|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146251233|NCT06247488|527431616|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
146251234|NCT06247488|527431617|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
146251235|NCT06247488|527431612|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146251236|NCT06247488|527431613|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146251237|NCT06247488|527431614|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146251238|NCT06247488|527431615|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146251239|NCT06247488|527431616|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
146251240|NCT06247488|527431617|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
146251241|NCT03785210|527431620|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
146251242|NCT03785210|527431621|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
146251243|NCT00460434|527431622|FG000|Overall Study|Lost to Follow-up|3|||
146251244|NCT00460434|527431623|FG001|Overall Study|Lost to Follow-up|7|||
146251245|NCT02722278|527431626|FG000|Overall Study|Withdrawal by Subject|5|||
146251246|NCT02722278|527431627|FG001|Overall Study|Withdrawal by Subject|3|||
146251247|NCT02722278|527431626|FG000|Overall Study|Adverse Event|4|||
146251248|NCT02722278|527431627|FG001|Overall Study|Adverse Event|1|||
146251249|NCT02722278|527431626|FG000|Overall Study|Lost to Follow-up|2|||
146251250|NCT02722278|527431627|FG001|Overall Study|Lost to Follow-up|0|||
146251251|NCT02722278|527431626|FG000|Overall Study|Protocol Violation|1|||
146251252|NCT02722278|527431627|FG001|Overall Study|Protocol Violation|0|||
146251253|NCT02722278|527431626|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
146251254|NCT02722278|527431627|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
146251255|NCT02722278|527431626|FG000|Overall Study|Subject declined after tx assignment|0|||
146251256|NCT02722278|527431627|FG001|Overall Study|Subject declined after tx assignment|1|||
146251257|NCT02722278|527431626|FG000|Overall Study|Site closure not study related|0|||
146251258|NCT02722278|527431627|FG001|Overall Study|Site closure not study related|1|||
146251259|NCT00561678|527431628|FG000|Overall Study|Withdrawal by Subject|4|||
146251260|NCT00561678|527431629|FG001|Overall Study|Withdrawal by Subject|3|||
146251261|NCT00561678|527431628|FG000|Overall Study|surgery cancelled|1|||
146251262|NCT00561678|527431629|FG001|Overall Study|surgery cancelled|1|||
146251263|NCT00561678|527431628|FG000|Overall Study|surgery rescheduled to different site|2|||
146251264|NCT00561678|527431629|FG001|Overall Study|surgery rescheduled to different site|2|||
146251265|NCT00561678|527431628|FG000|Overall Study|anesthesia provider refusal|1|||
146251266|NCT00561678|527431629|FG001|Overall Study|anesthesia provider refusal|0|||
146251267|NCT01103141|527431630|FG000|Overall Study|Death|0|||
146251268|NCT01103141|527431631|FG001|Overall Study|Death|1|||
146251269|NCT01103141|527431630|FG000|Overall Study|Lost to Follow-up|2|||
146251270|NCT01103141|527431631|FG001|Overall Study|Lost to Follow-up|1|||
146251271|NCT00422162|527431634|FG000|Overall Study|Adverse Event|11|||
146251272|NCT00422162|527431635|FG001|Overall Study|Adverse Event|9|||
146251273|NCT00422162|527431634|FG000|Overall Study|Lack of Efficacy|4|||
146251274|NCT00422162|527431635|FG001|Overall Study|Lack of Efficacy|10|||
146251275|NCT00422162|527431634|FG000|Overall Study|Withdrawal by Subject|7|||
146251276|NCT00422162|527431635|FG001|Overall Study|Withdrawal by Subject|6|||
146251277|NCT00422162|527431634|FG000|Overall Study|Lost to Follow-up|1|||
146251278|NCT00422162|527431635|FG001|Overall Study|Lost to Follow-up|2|||
146251279|NCT00422162|527431634|FG000|Overall Study|Non-Compliant with Protocol|1|||
146251280|NCT00422162|527431635|FG001|Overall Study|Non-Compliant with Protocol|1|||
146251281|NCT00422162|527431634|FG000|Overall Study|Other|0|||
146251282|NCT00422162|527431635|FG001|Overall Study|Other|1|||
146017371|NCT03831191|526574375|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146017372|NCT03831191|526574376|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
146017373|NCT03831191|526574377|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
146017374|NCT03831191|526574378|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146017375|NCT03831191|526574379|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
146017376|NCT03831191|526574380|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
146017377|NCT03831191|526574366|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017378|NCT03831191|526574367|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017379|NCT03831191|526574368|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017380|NCT03831191|526574369|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017381|NCT03831191|526574370|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017382|NCT03831191|526574371|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017383|NCT03831191|526574372|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017384|NCT03831191|526574373|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017385|NCT03831191|526574374|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017386|NCT03831191|526574375|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017387|NCT03831191|526574376|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017388|NCT03831191|526574377|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017389|NCT03831191|526574378|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017390|NCT03831191|526574379|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146017391|NCT03831191|526574380|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
146017392|NCT03831191|526574366|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017393|NCT03831191|526574367|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017394|NCT03831191|526574368|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017395|NCT03831191|526574369|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017396|NCT03831191|526574370|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017397|NCT03831191|526574371|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017398|NCT03831191|526574372|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017399|NCT03831191|526574373|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017400|NCT03831191|526574374|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017401|NCT03831191|526574375|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017402|NCT03831191|526574376|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017403|NCT03831191|526574377|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017404|NCT03831191|526574378|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017405|NCT03831191|526574379|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146017406|NCT03831191|526574380|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
146017407|NCT03070171|526574383|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
146017408|NCT03070171|526574384|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
146017409|NCT03070171|526574383|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
146017410|NCT03070171|526574384|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
146017411|NCT02300558|526574388|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
146017412|NCT02300558|526574388|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
146017413|NCT02300558|526574388|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
146017414|NCT02300558|526574388|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
146017415|NCT01471028|526574389|FG000|VTI-208|Adverse Event|39|||
146017416|NCT01471028|526574390|FG001|VTI-208|Adverse Event|41|||
146017417|NCT01471028|526574389|FG000|VTI-208|Withdrawal by Subject|0|||
146017418|NCT01471028|526574390|FG001|VTI-208|Withdrawal by Subject|2|||
146017419|NCT01471028|526574389|FG000|VTI-208|Lost to Follow-up|1|||
146017420|NCT01471028|526574390|FG001|VTI-208|Lost to Follow-up|1|||
146017421|NCT01471028|526574389|FG000|VTI-208E|Death|7|||
146017422|NCT01471028|526574390|FG001|VTI-208E|Death|10|||
146017423|NCT01471028|526574389|FG000|VTI-208E|Withdrawal by Subject|1|||
146017424|NCT01471028|526574390|FG001|VTI-208E|Withdrawal by Subject|0|||
146017425|NCT01471028|526574389|FG000|VTI-208E|Lost to Follow-up|0|||
146017426|NCT01471028|526574390|FG001|VTI-208E|Lost to Follow-up|2|||
146017427|NCT00695955|526574391|FG000|Cohort 1|Adverse Event|26|||
146017428|NCT00695955|526574391|FG000|Cohort 1|Protocol Violation|2|||
146017429|NCT00695955|526574391|FG000|Cohort 1|Lost to Follow-up|30|||
146017430|NCT00695955|526574391|FG000|Cohort 1|Withdrawal by Subject|25|||
146017431|NCT00695955|526574391|FG000|Cohort 1|Lack of Efficacy|3|||
146017432|NCT00695955|526574391|FG000|Cohort 1|Other|16|||
146017433|NCT00695955|526574391|FG000|Cohort 2|Adverse Event|24|||
146017434|NCT00695955|526574391|FG000|Cohort 2|Protocol Violation|5|||
146017435|NCT00695955|526574391|FG000|Cohort 2|Lost to Follow-up|38|||
146017436|NCT00695955|526574391|FG000|Cohort 2|Withdrawal by Subject|28|||
146017437|NCT00695955|526574391|FG000|Cohort 2|Lack of Efficacy|4|||
146017438|NCT00695955|526574391|FG000|Cohort 2|Other|5|||
146017439|NCT00610857|526574395|FG000|Overall Study|Not evaluable for response|2|||
146017440|NCT01626118|526574398|FG000|Overall Study|Lack of Efficacy|1|||
146017441|NCT01626118|526574399|FG001|Overall Study|Lack of Efficacy|0|||
146017442|NCT01626118|526574400|FG002|Overall Study|Lack of Efficacy|1|||
146017443|NCT01626118|526574401|FG003|Overall Study|Lack of Efficacy|3|||
146017444|NCT01626118|526574398|FG000|Overall Study|Lost to Follow-up|1|||
146017445|NCT01626118|526574399|FG001|Overall Study|Lost to Follow-up|0|||
146017446|NCT01626118|526574400|FG002|Overall Study|Lost to Follow-up|0|||
146017447|NCT01626118|526574401|FG003|Overall Study|Lost to Follow-up|0|||
146017448|NCT01626118|526574398|FG000|Overall Study|Adverse Event|0|||
146017449|NCT01626118|526574399|FG001|Overall Study|Adverse Event|1|||
146017450|NCT01626118|526574400|FG002|Overall Study|Adverse Event|1|||
146017451|NCT01626118|526574401|FG003|Overall Study|Adverse Event|0|||
146017452|NCT01626118|526574398|FG000|Overall Study|Investigator Decision|0|||
146017453|NCT01626118|526574399|FG001|Overall Study|Investigator Decision|1|||
146017454|NCT01626118|526574400|FG002|Overall Study|Investigator Decision|0|||
146017455|NCT01626118|526574401|FG003|Overall Study|Investigator Decision|0|||
146017456|NCT00888329|526574402|FG000|Overall Study|Physician Decision|6|||
146017457|NCT00888329|526574403|FG001|Overall Study|Physician Decision|9|||
146017458|NCT00002540|526574404|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
146017459|NCT00002540|526574405|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
146017460|NCT00002540|526574404|FG000|Overall Study|Died Before Randomization|2|||
146017461|NCT00002540|526574405|FG001|Overall Study|Died Before Randomization|6|||
146017462|NCT00002540|526574404|FG000|Overall Study|Died Before ASU (Control)|202|||
146017463|NCT00002540|526574405|FG001|Overall Study|Died Before ASU (Control)|0|||
146017464|NCT00002540|526574404|FG000|Overall Study|Refused ASU (Control)|597|||
146017465|NCT00002540|526574405|FG001|Overall Study|Refused ASU (Control)|0|||
146093713|NCT00215683|526864872|FG001|Overall Study|Adverse Event|16|||
146017466|NCT00002540|526574404|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
146017467|NCT00002540|526574405|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
146017468|NCT04826094|526574406|FG000|Overall Study|Lost to Follow-up|2|||
146017469|NCT04826094|526574407|FG001|Overall Study|Lost to Follow-up|1|||
146017470|NCT04826094|526574408|FG002|Overall Study|Lost to Follow-up|0|||
146017471|NCT04826094|526574409|FG003|Overall Study|Lost to Follow-up|0|||
146017472|NCT04826094|526574410|FG004|Overall Study|Lost to Follow-up|1|||
146017473|NCT04826094|526574411|FG005|Overall Study|Lost to Follow-up|3|||
146017474|NCT04826094|526574412|FG006|Overall Study|Lost to Follow-up|1|||
146017475|NCT04826094|526574413|FG007|Overall Study|Lost to Follow-up|1|||
146017476|NCT04826094|526574406|FG000|Overall Study|Participant withdrew consent|1|||
146017477|NCT04826094|526574407|FG001|Overall Study|Participant withdrew consent|0|||
146017478|NCT04826094|526574408|FG002|Overall Study|Participant withdrew consent|0|||
146017479|NCT04826094|526574409|FG003|Overall Study|Participant withdrew consent|1|||
146017480|NCT04826094|526574410|FG004|Overall Study|Participant withdrew consent|1|||
146017481|NCT04826094|526574411|FG005|Overall Study|Participant withdrew consent|1|||
146017482|NCT04826094|526574412|FG006|Overall Study|Participant withdrew consent|0|||
146017483|NCT04826094|526574413|FG007|Overall Study|Participant withdrew consent|1|||
146017484|NCT04826094|526574406|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
146017485|NCT04826094|526574407|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
146017486|NCT04826094|526574408|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
146017487|NCT04826094|526574409|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
146017488|NCT04826094|526574410|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
146017489|NCT04826094|526574411|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
146017490|NCT04826094|526574412|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
146017491|NCT04826094|526574413|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
146017492|NCT04826094|526574406|FG000|Overall Study|Withdrawn by Investigator|0|||
146017493|NCT04826094|526574407|FG001|Overall Study|Withdrawn by Investigator|0|||
146017494|NCT04826094|526574408|FG002|Overall Study|Withdrawn by Investigator|0|||
146017495|NCT04826094|526574409|FG003|Overall Study|Withdrawn by Investigator|0|||
146017496|NCT04826094|526574410|FG004|Overall Study|Withdrawn by Investigator|0|||
146017497|NCT04826094|526574411|FG005|Overall Study|Withdrawn by Investigator|1|||
146017498|NCT04826094|526574412|FG006|Overall Study|Withdrawn by Investigator|0|||
146017499|NCT04826094|526574413|FG007|Overall Study|Withdrawn by Investigator|1|||
146251283|NCT00422162|527431634|FG000|Overall Study|Didn't Receive Treatment|0|||
146251284|NCT00422162|527431635|FG001|Overall Study|Didn't Receive Treatment|1|||
146251285|NCT05274906|527431637|FG000|Overall Study|Withdrawal by Subject|2|||
146017500|NCT04826094|526574406|FG000|Overall Study|Other: Moved from area|1|||
146017501|NCT04826094|526574407|FG001|Overall Study|Other: Moved from area|1|||
146251286|NCT05274906|527431638|FG001|Overall Study|Withdrawal by Subject|1|||
146251287|NCT00848198|527431639|FG000|Overall Study|Incomplete Case Report Forms|15|||
146017502|NCT04826094|526574408|FG002|Overall Study|Other: Moved from area|1|||
146017503|NCT04826094|526574409|FG003|Overall Study|Other: Moved from area|0|||
146017504|NCT04826094|526574410|FG004|Overall Study|Other: Moved from area|0|||
146017505|NCT04826094|526574411|FG005|Overall Study|Other: Moved from area|0|||
146017506|NCT04826094|526574412|FG006|Overall Study|Other: Moved from area|0|||
146017507|NCT04826094|526574413|FG007|Overall Study|Other: Moved from area|0|||
146017508|NCT04826094|526574406|FG000|Overall Study|Other: Declined|0|||
146017509|NCT04826094|526574407|FG001|Overall Study|Other: Declined|0|||
146017510|NCT04826094|526574408|FG002|Overall Study|Other: Declined|0|||
146017511|NCT04826094|526574409|FG003|Overall Study|Other: Declined|0|||
146017512|NCT04826094|526574410|FG004|Overall Study|Other: Declined|1|||
146017513|NCT04826094|526574411|FG005|Overall Study|Other: Declined|0|||
146017514|NCT04826094|526574412|FG006|Overall Study|Other: Declined|0|||
146017515|NCT04826094|526574413|FG007|Overall Study|Other: Declined|0|||
146017516|NCT04826094|526574406|FG000|Overall Study|Other: Vaccine not administered|0|||
146017517|NCT04826094|526574407|FG001|Overall Study|Other: Vaccine not administered|0|||
146017518|NCT04826094|526574408|FG002|Overall Study|Other: Vaccine not administered|1|||
146017519|NCT04826094|526574409|FG003|Overall Study|Other: Vaccine not administered|0|||
146017520|NCT04826094|526574410|FG004|Overall Study|Other: Vaccine not administered|0|||
146251288|NCT03708744|527431640|FG000|Overall Study|Withdrawal by Subject|0|||
146251289|NCT03708744|527431641|FG001|Overall Study|Withdrawal by Subject|0|||
146251290|NCT03708744|527431642|FG002|Overall Study|Withdrawal by Subject|1|||
146251291|NCT03708744|527431643|FG003|Overall Study|Withdrawal by Subject|0|||
146251292|NCT00460577|527431644|FG000|Overall Study|Protocol Violation|2|||
146251293|NCT00460577|527431645|FG001|Overall Study|Protocol Violation|6|||
146251294|NCT04043806|527431646|FG000|Overall Study|Commercial drug is available for participants|13|||
146251295|NCT04043806|527431646|FG000|Overall Study|Physician Decision|2|||
146251296|NCT04043806|527431646|FG000|Overall Study|Other|12|||
146251297|NCT04043806|527431646|FG000|Overall Study|Adverse Event|2|||
146251298|NCT04043806|527431646|FG000|Overall Study|Lost to Follow-up|6|||
146017521|NCT04826094|526574411|FG005|Overall Study|Other: Vaccine not administered|1|||
146251299|NCT04043806|527431646|FG000|Overall Study|Other non-compliance|2|||
146251300|NCT04043806|527431646|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
146017522|NCT04826094|526574412|FG006|Overall Study|Other: Vaccine not administered|1|||
146017523|NCT04826094|526574413|FG007|Overall Study|Other: Vaccine not administered|3|||
146017524|NCT02151903|526574414|FG000|Overall Study|Withdrawal by Subject|1|||
146017525|NCT02151903|526574415|FG001|Overall Study|Withdrawal by Subject|0|||
146017526|NCT02151903|526574414|FG000|Overall Study|Progressive disease|2|||
146017527|NCT02151903|526574415|FG001|Overall Study|Progressive disease|1|||
146017528|NCT01864148|526574416|FG000|Overall Study|Other|2|||
146017529|NCT01864148|526574417|FG001|Overall Study|Other|1|||
146017530|NCT01864148|526574418|FG002|Overall Study|Other|1|||
146017531|NCT01864148|526574419|FG003|Overall Study|Other|3|||
146017532|NCT01864148|526574420|FG004|Overall Study|Other|1|||
146017533|NCT01864148|526574416|FG000|Overall Study|Death|0|||
146017534|NCT01864148|526574417|FG001|Overall Study|Death|0|||
146017535|NCT01864148|526574418|FG002|Overall Study|Death|0|||
146017536|NCT01864148|526574419|FG003|Overall Study|Death|1|||
146017537|NCT01864148|526574420|FG004|Overall Study|Death|0|||
146017538|NCT01864148|526574416|FG000|Overall Study|Investigator Decision|5|||
146017539|NCT01864148|526574417|FG001|Overall Study|Investigator Decision|0|||
146017540|NCT01864148|526574418|FG002|Overall Study|Investigator Decision|0|||
146017541|NCT01864148|526574419|FG003|Overall Study|Investigator Decision|4|||
146017542|NCT01864148|526574420|FG004|Overall Study|Investigator Decision|6|||
146017543|NCT01864148|526574416|FG000|Overall Study|Withdrawal by Subject|9|||
146017544|NCT01864148|526574417|FG001|Overall Study|Withdrawal by Subject|2|||
146017545|NCT01864148|526574418|FG002|Overall Study|Withdrawal by Subject|6|||
146017546|NCT01864148|526574419|FG003|Overall Study|Withdrawal by Subject|8|||
146017547|NCT01864148|526574420|FG004|Overall Study|Withdrawal by Subject|8|||
146017548|NCT01864148|526574416|FG000|Overall Study|Lost to Follow-up|0|||
146017549|NCT01864148|526574417|FG001|Overall Study|Lost to Follow-up|0|||
146017550|NCT01864148|526574418|FG002|Overall Study|Lost to Follow-up|0|||
146017551|NCT01864148|526574419|FG003|Overall Study|Lost to Follow-up|2|||
146017552|NCT01864148|526574420|FG004|Overall Study|Lost to Follow-up|1|||
146017553|NCT01864148|526574416|FG000|Overall Study|Adverse Event|4|||
146017554|NCT01864148|526574417|FG001|Overall Study|Adverse Event|2|||
146017555|NCT01864148|526574418|FG002|Overall Study|Adverse Event|4|||
146017556|NCT01864148|526574419|FG003|Overall Study|Adverse Event|7|||
146017557|NCT01864148|526574420|FG004|Overall Study|Adverse Event|7|||
146017558|NCT01864148|526574416|FG000|Overall Study|Not Dosed|0|||
146017559|NCT01864148|526574417|FG001|Overall Study|Not Dosed|0|||
146017560|NCT01864148|526574418|FG002|Overall Study|Not Dosed|0|||
146017561|NCT01864148|526574419|FG003|Overall Study|Not Dosed|1|||
146017562|NCT01864148|526574420|FG004|Overall Study|Not Dosed|0|||
146017563|NCT01500252|526574421|FG000|Overall Study|Death|4|||
146017564|NCT01500252|526574422|FG001|Overall Study|Death|2|||
146017565|NCT01500252|526574421|FG000|Overall Study|Lost to Follow-up|5|||
146017566|NCT01500252|526574422|FG001|Overall Study|Lost to Follow-up|4|||
146017567|NCT00778375|526574424|FG000|Overall Study|Ineligible|3|||
146017568|NCT03490292|526574425|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
146017569|NCT03490292|526574426|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
146017570|NCT03490292|526574425|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
146017571|NCT03490292|526574426|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
146017572|NCT03490292|526574425|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
146017573|NCT03490292|526574426|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
146017574|NCT03490292|526574425|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
146017575|NCT03490292|526574426|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
146017576|NCT03490292|526574425|FG000|1 Year Follow Up Post Last Dose|Death|1|||
146017577|NCT03490292|526574426|FG001|1 Year Follow Up Post Last Dose|Death|1|||
146017578|NCT01421303|526574427|FG000|Overall Study|Lost to Follow-up|13|||
146017579|NCT01421303|526574427|FG000|Overall Study|Non compliance with study procedure|1|||
146017580|NCT01421303|526574427|FG000|Overall Study|Other|7|||
146017581|NCT01421303|526574427|FG000|Overall Study|Withdrawal by Subject|1|||
146017582|NCT06003777|526574428|FG000|Period 1|Adverse Event|0|||
146017583|NCT06003777|526574429|FG001|Period 1|Adverse Event|0|||
146017584|NCT06003777|526574430|FG002|Period 1|Adverse Event|1|||
146093714|NCT00215683|526864873|FG002|Overall Study|Adverse Event|15|||
146093715|NCT00215683|526864871|FG000|Overall Study|Lack of Efficacy|5|||
146017585|NCT06003777|526574431|FG003|Period 1|Adverse Event|0|||
146017586|NCT06003777|526574432|FG004|Period 1|Adverse Event|0|||
146017587|NCT06003777|526574433|FG005|Period 1|Adverse Event|0|||
146017588|NCT06003777|526574434|FG006|Period 1|Adverse Event|0|||
146017589|NCT06003777|526574435|FG007|Period 1|Adverse Event|0|||
146017590|NCT06003777|526574436|FG008|Period 1|Adverse Event|0|||
146093716|NCT00215683|526864872|FG001|Overall Study|Lack of Efficacy|1|||
146093717|NCT00215683|526864873|FG002|Overall Study|Lack of Efficacy|2|||
146017591|NCT06003777|526574437|FG009|Period 1|Adverse Event|0|||
146017592|NCT06003777|526574438|FG010|Period 1|Adverse Event|0|||
146093718|NCT00215683|526864871|FG000|Overall Study|Lost to Follow-up|0|||
146017593|NCT06003777|526574439|FG011|Period 1|Adverse Event|0|||
146017594|NCT06003777|526574428|FG000|Period 1|Withdrawal by Subject|0|||
146017595|NCT06003777|526574429|FG001|Period 1|Withdrawal by Subject|0|||
146017596|NCT06003777|526574430|FG002|Period 1|Withdrawal by Subject|0|||
146093719|NCT00215683|526864872|FG001|Overall Study|Lost to Follow-up|2|||
146093720|NCT00215683|526864873|FG002|Overall Study|Lost to Follow-up|1|||
146093721|NCT00215683|526864871|FG000|Overall Study|Withdrawal by Subject|9|||
146093722|NCT00215683|526864872|FG001|Overall Study|Withdrawal by Subject|4|||
146093723|NCT00215683|526864873|FG002|Overall Study|Withdrawal by Subject|13|||
146093724|NCT00215683|526864871|FG000|Overall Study|Physician Decision|0|||
146093725|NCT00215683|526864872|FG001|Overall Study|Physician Decision|0|||
146093726|NCT00215683|526864873|FG002|Overall Study|Physician Decision|1|||
146093727|NCT00215683|526864871|FG000|Overall Study|Difficult to attend visits|0|||
146093728|NCT00215683|526864872|FG001|Overall Study|Difficult to attend visits|1|||
146093729|NCT00215683|526864873|FG002|Overall Study|Difficult to attend visits|0|||
146093730|NCT00215683|526864871|FG000|Overall Study|No study drug available|0|||
146093731|NCT00215683|526864872|FG001|Overall Study|No study drug available|1|||
146093732|NCT00215683|526864873|FG002|Overall Study|No study drug available|0|||
146093733|NCT00215683|526864871|FG000|Overall Study|Intermittent therapy required|0|||
146093734|NCT00215683|526864872|FG001|Overall Study|Intermittent therapy required|1|||
146093735|NCT00215683|526864873|FG002|Overall Study|Intermittent therapy required|0|||
146093736|NCT01083485|526864874|FG000|Overall Study|Adverse Event|0|||
146251301|NCT04043806|527431646|FG000|Overall Study|Never Dosed|1|||
146017597|NCT06003777|526574431|FG003|Period 1|Withdrawal by Subject|0|||
146017598|NCT06003777|526574432|FG004|Period 1|Withdrawal by Subject|1|||
146017599|NCT06003777|526574433|FG005|Period 1|Withdrawal by Subject|0|||
146017600|NCT06003777|526574434|FG006|Period 1|Withdrawal by Subject|0|||
146017601|NCT06003777|526574435|FG007|Period 1|Withdrawal by Subject|0|||
146017602|NCT06003777|526574436|FG008|Period 1|Withdrawal by Subject|0|||
146017603|NCT06003777|526574437|FG009|Period 1|Withdrawal by Subject|0|||
146017604|NCT06003777|526574438|FG010|Period 1|Withdrawal by Subject|0|||
146017605|NCT06003777|526574439|FG011|Period 1|Withdrawal by Subject|0|||
146017606|NCT06003777|526574428|FG000|Period 2|Withdrawal by Subject|0|||
146017607|NCT06003777|526574429|FG001|Period 2|Withdrawal by Subject|0|||
146017608|NCT06003777|526574430|FG002|Period 2|Withdrawal by Subject|0|||
146017609|NCT06003777|526574431|FG003|Period 2|Withdrawal by Subject|0|||
146017610|NCT06003777|526574432|FG004|Period 2|Withdrawal by Subject|0|||
146017611|NCT06003777|526574433|FG005|Period 2|Withdrawal by Subject|0|||
146017612|NCT06003777|526574434|FG006|Period 2|Withdrawal by Subject|0|||
146017613|NCT06003777|526574435|FG007|Period 2|Withdrawal by Subject|0|||
146017614|NCT06003777|526574436|FG008|Period 2|Withdrawal by Subject|1|||
146017615|NCT06003777|526574437|FG009|Period 2|Withdrawal by Subject|0|||
146017616|NCT06003777|526574438|FG010|Period 2|Withdrawal by Subject|0|||
146017617|NCT06003777|526574439|FG011|Period 2|Withdrawal by Subject|0|||
146017618|NCT06003777|526574428|FG000|Period 3|Adverse Event|0|||
146017619|NCT06003777|526574429|FG001|Period 3|Adverse Event|0|||
146017620|NCT06003777|526574430|FG002|Period 3|Adverse Event|0|||
146017621|NCT06003777|526574431|FG003|Period 3|Adverse Event|0|||
146017622|NCT06003777|526574432|FG004|Period 3|Adverse Event|0|||
146017623|NCT06003777|526574433|FG005|Period 3|Adverse Event|0|||
146017624|NCT06003777|526574434|FG006|Period 3|Adverse Event|1|||
146017625|NCT06003777|526574435|FG007|Period 3|Adverse Event|0|||
146017626|NCT06003777|526574436|FG008|Period 3|Adverse Event|0|||
146017627|NCT06003777|526574437|FG009|Period 3|Adverse Event|0|||
146017628|NCT06003777|526574438|FG010|Period 3|Adverse Event|0|||
146017629|NCT06003777|526574439|FG011|Period 3|Adverse Event|0|||
146017630|NCT06003777|526574428|FG000|Period 4|No longer met eligibility criteria|0|||
146093737|NCT01083485|526864875|FG001|Overall Study|Adverse Event|1|||
146093738|NCT01083485|526864874|FG000|Overall Study|Protocol Violation|1|||
146251302|NCT01622088|527431649|FG000|Overall Study|Adverse Event|20|||
146251303|NCT01622088|527431649|FG000|Overall Study|Lost to Follow-up|1|||
146251304|NCT01622088|527431649|FG000|Overall Study|Withdrawal by Subject|20|||
146251305|NCT01622088|527431649|FG000|Overall Study|Investigator Decision|1|||
146251306|NCT01622088|527431649|FG000|Overall Study|Death|53|||
146251307|NCT01622088|527431649|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
146251308|NCT03166215|527431650|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
146251309|NCT03166215|527431651|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
146251310|NCT03166215|527431652|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
146251311|NCT03166215|527431650|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
146251312|NCT03166215|527431651|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
146251313|NCT03166215|527431652|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
146251314|NCT04362176|527431655|FG000|Overall Study|Lost to Follow-up|5|||
146251315|NCT04362176|527431656|FG001|Overall Study|Lost to Follow-up|8|||
146251316|NCT04362176|527431655|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
146251317|NCT04362176|527431656|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
146251318|NCT00658632|527431658|FG000|Overall Study|Adverse Event|13|||
146017631|NCT06003777|526574429|FG001|Period 4|No longer met eligibility criteria|0|||
146017632|NCT06003777|526574430|FG002|Period 4|No longer met eligibility criteria|1|||
146017633|NCT06003777|526574431|FG003|Period 4|No longer met eligibility criteria|0|||
146017634|NCT06003777|526574432|FG004|Period 4|No longer met eligibility criteria|0|||
146017635|NCT06003777|526574433|FG005|Period 4|No longer met eligibility criteria|0|||
146017636|NCT06003777|526574434|FG006|Period 4|No longer met eligibility criteria|0|||
146017637|NCT06003777|526574435|FG007|Period 4|No longer met eligibility criteria|0|||
146093739|NCT01083485|526864875|FG001|Overall Study|Protocol Violation|0|||
146093740|NCT01083485|526864874|FG000|Overall Study|Withdrawal by Subject|5|||
146093741|NCT01083485|526864875|FG001|Overall Study|Withdrawal by Subject|2|||
146093742|NCT01083485|526864874|FG000|Overall Study|Other|1|||
146093743|NCT01083485|526864875|FG001|Overall Study|Other|0|||
146093744|NCT04493333|526864876|FG000|Overall Study|Withdrawal by Subject|1|||
146093745|NCT04493333|526864877|FG001|Overall Study|Withdrawal by Subject|1|||
146093746|NCT04493333|526864876|FG000|Overall Study|Ineligible|0|||
146093747|NCT04493333|526864877|FG001|Overall Study|Ineligible|1|||
146093748|NCT04493333|526864876|FG000|Overall Study|Noncompliance|2|||
146093749|NCT04493333|526864877|FG001|Overall Study|Noncompliance|1|||
146093750|NCT00674973|526864880|FG000|Overall Study|Insufficient Therapeutic Response|77|||
146093751|NCT00674973|526864881|FG001|Overall Study|Insufficient Therapeutic Response|72|||
146093752|NCT00674973|526864880|FG000|Overall Study|Refused Treatment|1|||
146093753|NCT00674973|526864881|FG001|Overall Study|Refused Treatment|5|||
146093754|NCT00674973|526864880|FG000|Overall Study|Failure to Return|1|||
146093755|NCT00674973|526864881|FG001|Overall Study|Failure to Return|0|||
146093756|NCT00674973|526864880|FG000|Overall Study|Adverse Event|2|||
146093757|NCT00674973|526864881|FG001|Overall Study|Adverse Event|9|||
146093758|NCT00674973|526864880|FG000|Overall Study|Death|19|||
146093759|NCT00674973|526864881|FG001|Overall Study|Death|15|||
146093760|NCT00674973|526864880|FG000|Overall Study|Protocol Violation|0|||
146093761|NCT00674973|526864881|FG001|Overall Study|Protocol Violation|1|||
146093762|NCT05036369|526864886|FG000|Overall Study|Run In non compliance|1|||
146093763|NCT05036369|526864887|FG001|Overall Study|Run In non compliance|2|||
146093764|NCT05036369|526864886|FG000|Overall Study|Change in eligibility criteria|0|||
146093765|NCT05036369|526864887|FG001|Overall Study|Change in eligibility criteria|1|||
146093766|NCT02095223|526864890|FG000|Overall Study|Withdrawal by Subject|1|||
146093767|NCT02095223|526864891|FG001|Overall Study|Withdrawal by Subject|0|||
146093768|NCT03906461|526864892|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
146093769|NCT03906461|526864892|FG000|Completed 12-month Follow-up|Missed Visit|6|||
146093770|NCT00426231|526864895|FG000|Overall Study|Withdrawal by Subject|9|||
146093771|NCT00426231|526864896|FG001|Overall Study|Withdrawal by Subject|12|||
146093772|NCT01795638|526864897|FG000|Overall Study|Death|0|||
146093773|NCT01795638|526864898|FG001|Overall Study|Death|3|||
146093774|NCT01795638|526864897|FG000|Overall Study|transferred to quaternary hospital|2|||
146093775|NCT01795638|526864898|FG001|Overall Study|transferred to quaternary hospital|3|||
146093776|NCT01795638|526864897|FG000|Overall Study|Protocol Violation|3|||
146093777|NCT01795638|526864898|FG001|Overall Study|Protocol Violation|0|||
146093778|NCT01795638|526864897|FG000|Overall Study|discharged from hospital|7|||
146093779|NCT01795638|526864898|FG001|Overall Study|discharged from hospital|5|||
146093780|NCT01795638|526864897|FG000|Overall Study|Withdrawal by Subject|1|||
146017638|NCT06003777|526574436|FG008|Period 4|No longer met eligibility criteria|0|||
146017639|NCT06003777|526574437|FG009|Period 4|No longer met eligibility criteria|0|||
146017640|NCT06003777|526574438|FG010|Period 4|No longer met eligibility criteria|0|||
146017641|NCT06003777|526574439|FG011|Period 4|No longer met eligibility criteria|0|||
146017642|NCT06003777|526574428|FG000|Period 4|Withdrawal by Subject|0|||
146017643|NCT06003777|526574429|FG001|Period 4|Withdrawal by Subject|1|||
146017644|NCT06003777|526574430|FG002|Period 4|Withdrawal by Subject|0|||
146017645|NCT06003777|526574431|FG003|Period 4|Withdrawal by Subject|0|||
146017646|NCT06003777|526574432|FG004|Period 4|Withdrawal by Subject|0|||
146017647|NCT06003777|526574433|FG005|Period 4|Withdrawal by Subject|0|||
146017648|NCT06003777|526574434|FG006|Period 4|Withdrawal by Subject|0|||
146017649|NCT06003777|526574435|FG007|Period 4|Withdrawal by Subject|0|||
146017650|NCT06003777|526574436|FG008|Period 4|Withdrawal by Subject|0|||
146017651|NCT06003777|526574437|FG009|Period 4|Withdrawal by Subject|0|||
146017652|NCT06003777|526574438|FG010|Period 4|Withdrawal by Subject|0|||
146017653|NCT06003777|526574439|FG011|Period 4|Withdrawal by Subject|0|||
146017654|NCT00904670|526574440|FG000|Open Label Phase|Withdrawal by Subject|2|||
146017655|NCT00904670|526574441|FG001|Open Label Phase|Withdrawal by Subject|0|||
146017656|NCT00904670|526574440|FG000|Open Label Phase|Adverse Event|2|||
146017657|NCT00904670|526574441|FG001|Open Label Phase|Adverse Event|0|||
146017658|NCT00904670|526574440|FG000|Open Label Phase|Lack of Efficacy|1|||
146017659|NCT00904670|526574441|FG001|Open Label Phase|Lack of Efficacy|0|||
146017660|NCT00904670|526574440|FG000|Open Label Phase|Lost to Follow-up|1|||
146017661|NCT00904670|526574441|FG001|Open Label Phase|Lost to Follow-up|0|||
146017662|NCT00054327|526574447|FG000|Overall Study|Engraftment failure|1|||
146093781|NCT01795638|526864898|FG001|Overall Study|Withdrawal by Subject|0|||
146017663|NCT00054327|526574448|FG001|Overall Study|Engraftment failure|0|||
146093782|NCT03061097|526864899|FG000|Overall Study|Withdrawal by Subject|0|||
146093783|NCT03061097|526864900|FG001|Overall Study|Withdrawal by Subject|3|||
146093784|NCT00595465|526864907|FG000|Overall Study|Adverse Event|4|||
146017664|NCT00054327|526574449|FG002|Overall Study|Engraftment failure|0|||
146017665|NCT00054327|526574450|FG003|Overall Study|Engraftment failure|0|||
146017666|NCT00054327|526574451|FG004|Overall Study|Engraftment failure|0|||
146093785|NCT00595465|526864908|FG001|Overall Study|Adverse Event|3|||
146093786|NCT00595465|526864909|FG002|Overall Study|Adverse Event|3|||
146093787|NCT00595465|526864907|FG000|Overall Study|Pregnancy|0|||
146017667|NCT00054327|526574452|FG005|Overall Study|Engraftment failure|0|||
146017668|NCT00613327|526574453|FG000|Overall Study|Adverse Event|38|||
146017669|NCT00613327|526574453|FG000|Overall Study|Lost to Follow-up|8|||
146017670|NCT00613327|526574453|FG000|Overall Study|Withdrawal by Subject|6|||
146017671|NCT00613327|526574453|FG000|Overall Study|Protocol Violation|2|||
146299986|NCT00404066|527613674|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
146299987|NCT01754857|527613675|FG000|Overall Study|Adverse Event|7|||
146299988|NCT01754857|527613675|FG000|Overall Study|Disease progression|3|||
146299989|NCT01754857|527613675|FG000|Overall Study|Physician Decision|2|||
146299990|NCT01754857|527613675|FG000|Overall Study|Withdrawal by Subject|3|||
146299991|NCT01754857|527613675|FG000|Overall Study|other complicating disease|1|||
146299992|NCT01754857|527613675|FG000|Overall Study|ineligible to continue onto maintenance|1|||
146299993|NCT01754857|527613675|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
146299994|NCT01754857|527613675|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
146017672|NCT00613327|526574453|FG000|Overall Study|Other|47|||
146017673|NCT00344318|526574454|FG000|Overall Study|Adverse Event|0|||
146017674|NCT00344318|526574455|FG001|Overall Study|Adverse Event|3|||
146017675|NCT00344318|526574456|FG002|Overall Study|Adverse Event|0|||
146017676|NCT00344318|526574457|FG003|Overall Study|Adverse Event|1|||
146017677|NCT00344318|526574454|FG000|Overall Study|Withdrawal by Subject|2|||
146017678|NCT00344318|526574455|FG001|Overall Study|Withdrawal by Subject|2|||
146017679|NCT00344318|526574456|FG002|Overall Study|Withdrawal by Subject|0|||
146017680|NCT00344318|526574457|FG003|Overall Study|Withdrawal by Subject|2|||
146017681|NCT00344318|526574454|FG000|Overall Study|Lost to Follow-up|2|||
146017682|NCT00344318|526574455|FG001|Overall Study|Lost to Follow-up|0|||
146017683|NCT00344318|526574456|FG002|Overall Study|Lost to Follow-up|1|||
146017684|NCT00344318|526574457|FG003|Overall Study|Lost to Follow-up|0|||
146017685|NCT01606176|526574461|FG000|Overall Study|Adverse Event|2|||
146017686|NCT01606176|526574462|FG001|Overall Study|Adverse Event|3|||
146017687|NCT01606176|526574461|FG000|Overall Study|Disease progression|1|||
146017688|NCT01606176|526574462|FG001|Overall Study|Disease progression|0|||
146017689|NCT01606176|526574461|FG000|Overall Study|Withdrawal by Subject|1|||
146017690|NCT01606176|526574462|FG001|Overall Study|Withdrawal by Subject|0|||
146017691|NCT00361231|526574464|FG000|Overall Study|Physician Decision|3|||
146017692|NCT00361231|526574464|FG000|Overall Study|Symptomatic deterioration|5|||
146017693|NCT00361231|526574464|FG000|Overall Study|Radiographic disease progression|16|||
146017694|NCT00361231|526574464|FG000|Overall Study|Withdrawal by Subject|4|||
146017695|NCT00361231|526574464|FG000|Overall Study|Adverse Event|6|||
146017696|NCT01814397|526574467|FG000|Overall Study|Adverse Event|7|||
146017697|NCT01814397|526574467|FG000|Overall Study|Withdrawal by Subject|7|||
146017698|NCT00244933|526574468|FG000|Overall Study|Not response evaluable|2|||
146017699|NCT04731298|526574469|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
146017700|NCT04731298|526574470|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
146017701|NCT01208961|526574471|FG000|High-Fat Period III|Protocol Violation|1|||
146017702|NCT01208961|526574472|FG001|High-Fat Period III|Protocol Violation|0|||
146017703|NCT03213938|526574473|FG000|Overall Study|Lost to Follow-up|4|||
146017704|NCT03213938|526574474|FG001|Overall Study|Lost to Follow-up|3|||
146017705|NCT03213938|526574473|FG000|Overall Study|Lack of Efficacy|1|||
146017706|NCT03213938|526574474|FG001|Overall Study|Lack of Efficacy|0|||
146017707|NCT03213938|526574473|FG000|Overall Study|Decline to participate|5|||
146017708|NCT03213938|526574474|FG001|Overall Study|Decline to participate|4|||
146017709|NCT03213938|526574473|FG000|Overall Study|Without reason|4|||
146017710|NCT03213938|526574474|FG001|Overall Study|Without reason|5|||
146017711|NCT02487654|526574476|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
146017712|NCT02487654|526574477|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
146017713|NCT02487654|526574476|FG000|Overall Study|Withdrawal by Subject|3|||
146017714|NCT02487654|526574477|FG001|Overall Study|Withdrawal by Subject|7|||
146017715|NCT04238481|526574478|FG000|Overall Study|Miscellaneous|0|||
146017716|NCT04238481|526574479|FG001|Overall Study|Miscellaneous|1|||
146017717|NCT04238481|526574480|FG002|Overall Study|Miscellaneous|0|||
146017718|NCT04238481|526574481|FG003|Overall Study|Miscellaneous|0|||
146017719|NCT02152371|526574482|FG000|Overall Study|Adverse Event|6|||
146017720|NCT02152371|526574483|FG001|Overall Study|Adverse Event|2|||
146017721|NCT02152371|526574482|FG000|Overall Study|Withdrawal by Subject|3|||
146017722|NCT02152371|526574483|FG001|Overall Study|Withdrawal by Subject|7|||
146017723|NCT02152371|526574482|FG000|Overall Study|Protocol Violation|2|||
146017724|NCT02152371|526574483|FG001|Overall Study|Protocol Violation|3|||
146017725|NCT02152371|526574482|FG000|Overall Study|Lost to Follow-up|1|||
146017726|NCT02152371|526574483|FG001|Overall Study|Lost to Follow-up|0|||
146017727|NCT02152371|526574482|FG000|Overall Study|Lack of Efficacy|0|||
146017728|NCT02152371|526574483|FG001|Overall Study|Lack of Efficacy|1|||
146017729|NCT02152371|526574482|FG000|Overall Study|Physician Decision|0|||
146017730|NCT02152371|526574483|FG001|Overall Study|Physician Decision|2|||
146017731|NCT02152371|526574482|FG000|Overall Study|Reason Not Given|0|||
146299995|NCT01399190|527613676|FG000|Overall Study|Not Eligible for Final Analysis|5|||
146017732|NCT02152371|526574483|FG001|Overall Study|Reason Not Given|1|||
146017733|NCT00350870|526574484|FG000|Overall Study|Withdrawal by Subject|21|||
146017734|NCT00350870|526574485|FG001|Overall Study|Withdrawal by Subject|17|||
146017735|NCT00350870|526574486|FG002|Overall Study|Withdrawal by Subject|15|||
146017736|NCT00350870|526574487|FG003|Overall Study|Withdrawal by Subject|14|||
146017737|NCT00350870|526574484|FG000|Overall Study|Physician Decision|1|||
146017738|NCT00350870|526574485|FG001|Overall Study|Physician Decision|0|||
146017739|NCT00350870|526574486|FG002|Overall Study|Physician Decision|1|||
146017740|NCT00350870|526574487|FG003|Overall Study|Physician Decision|1|||
146017741|NCT00349921|526574488|FG000|First Spinal Injection|Physician Decision|1|||
146017742|NCT00349921|526574489|FG001|First Spinal Injection|Physician Decision|0|||
146017743|NCT00349921|526574490|FG002|First Spinal Injection|Physician Decision|0|||
146017744|NCT00349921|526574491|FG003|First Spinal Injection|Physician Decision|0|||
146017745|NCT00349921|526574488|FG000|First Spinal Injection|Adverse Event|0|||
146017746|NCT00349921|526574489|FG001|First Spinal Injection|Adverse Event|0|||
146017747|NCT00349921|526574490|FG002|First Spinal Injection|Adverse Event|1|||
146017748|NCT00349921|526574491|FG003|First Spinal Injection|Adverse Event|0|||
146017749|NCT05285644|526574492|FG000|Overall Study|Adverse Event|3|||
146017750|NCT05285644|526574493|FG001|Overall Study|Adverse Event|3|||
146017751|NCT05285644|526574492|FG000|Overall Study|Withdrawal of Consent|2|||
146017752|NCT05285644|526574493|FG001|Overall Study|Withdrawal of Consent|5|||
146017753|NCT05285644|526574492|FG000|Overall Study|Noncompliance|0|||
146017754|NCT05285644|526574493|FG001|Overall Study|Noncompliance|4|||
146017755|NCT05285644|526574492|FG000|Overall Study|Lost to Follow-up|4|||
146017756|NCT05285644|526574493|FG001|Overall Study|Lost to Follow-up|6|||
146017757|NCT05285644|526574492|FG000|Overall Study|Disallowed Concurrent Medication|1|||
146017758|NCT05285644|526574493|FG001|Overall Study|Disallowed Concurrent Medication|1|||
146017759|NCT05285644|526574492|FG000|Overall Study|Investigator Decision|2|||
146017760|NCT05285644|526574493|FG001|Overall Study|Investigator Decision|0|||
146017761|NCT05285644|526574492|FG000|Overall Study|Protocol Deviation|1|||
146017762|NCT05285644|526574493|FG001|Overall Study|Protocol Deviation|0|||
146017763|NCT05285644|526574492|FG000|Overall Study|As specified in the Clinical Study Report|7|||
146017764|NCT05285644|526574493|FG001|Overall Study|As specified in the Clinical Study Report|3|||
146017765|NCT02952313|526574494|FG000|Primary Endpoint|Lost to Follow-up|4|||
146017766|NCT02952313|526574494|FG000|Primary Endpoint|Withdrawal by Subject|1|||
146017767|NCT02952313|526574494|FG000|Primary Endpoint|Lack of Efficacy|1|||
146017768|NCT02952313|526574494|FG000|Primary Endpoint|Missed visit|1|||
146017769|NCT02952313|526574494|FG000|Long-term Follow-up|Lost to Follow-up|12|||
146017770|NCT02952313|526574494|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
146017771|NCT02952313|526574494|FG000|Long-term Follow-up|Lack of Efficacy|6|||
146017772|NCT02952313|526574494|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
146017773|NCT02952313|526574494|FG000|Long-term Follow-up|Physician Decision|1|||
146017774|NCT02952313|526574494|FG000|Long-term Follow-up|Death|1|||
146017775|NCT04382586|526574495|FG000|Overall Study|Death|3|||
146017776|NCT04382586|526574496|FG001|Overall Study|Death|4|||
146017777|NCT04382586|526574495|FG000|Overall Study|Lost to Follow-up|11|||
146017778|NCT04382586|526574496|FG001|Overall Study|Lost to Follow-up|8|||
146017779|NCT04382586|526574495|FG000|Overall Study|Withdrawal by Subject|3|||
146017780|NCT04382586|526574496|FG001|Overall Study|Withdrawal by Subject|1|||
146017781|NCT04382586|526574495|FG000|Overall Study|Physician Decision|0|||
146017782|NCT04382586|526574496|FG001|Overall Study|Physician Decision|3|||
146017783|NCT00079391|526574497|FG000|Overall Study|Withdrawal by Subject|1|||
146017784|NCT00583752|526574498|FG000|Overall Study|Lost to Follow-up|5|||
146017785|NCT00583752|526574499|FG001|Overall Study|Lost to Follow-up|5|||
146017786|NCT00830375|526574500|FG000|Overall Study|Lost to Follow-up|1|||
146017787|NCT01700959|526574501|FG000|Overall Study|Adverse Event|0|||
146017788|NCT01700959|526574502|FG001|Overall Study|Adverse Event|1|||
146017789|NCT01700959|526574503|FG002|Overall Study|Adverse Event|1|||
146017790|NCT01700959|526574504|FG003|Overall Study|Adverse Event|2|||
146017791|NCT01700959|526574505|FG004|Overall Study|Adverse Event|0|||
146017792|NCT01700959|526574506|FG005|Overall Study|Adverse Event|2|||
146017793|NCT01700959|526574501|FG000|Overall Study|Withdrawal by Subject|15|||
146017794|NCT01700959|526574502|FG001|Overall Study|Withdrawal by Subject|9|||
146017795|NCT01700959|526574503|FG002|Overall Study|Withdrawal by Subject|12|||
146017796|NCT01700959|526574504|FG003|Overall Study|Withdrawal by Subject|11|||
146017797|NCT01700959|526574505|FG004|Overall Study|Withdrawal by Subject|8|||
146017798|NCT01700959|526574506|FG005|Overall Study|Withdrawal by Subject|12|||
146017799|NCT01700959|526574501|FG000|Overall Study|Ineligible|2|||
146093788|NCT00595465|526864908|FG001|Overall Study|Pregnancy|0|||
146093789|NCT00595465|526864909|FG002|Overall Study|Pregnancy|1|||
146093790|NCT00595465|526864907|FG000|Overall Study|Protocol Violation|2|||
146017800|NCT01700959|526574502|FG001|Overall Study|Ineligible|1|||
146017801|NCT01700959|526574503|FG002|Overall Study|Ineligible|2|||
146017802|NCT01700959|526574504|FG003|Overall Study|Ineligible|0|||
146017803|NCT01700959|526574505|FG004|Overall Study|Ineligible|0|||
146017804|NCT01700959|526574506|FG005|Overall Study|Ineligible|1|||
146017805|NCT01700959|526574501|FG000|Overall Study|Noncompliant|9|||
146017806|NCT01700959|526574502|FG001|Overall Study|Noncompliant|9|||
146017807|NCT01700959|526574503|FG002|Overall Study|Noncompliant|17|||
146093791|NCT00595465|526864908|FG001|Overall Study|Protocol Violation|1|||
146017808|NCT01700959|526574504|FG003|Overall Study|Noncompliant|18|||
146017809|NCT01700959|526574505|FG004|Overall Study|Noncompliant|15|||
146017810|NCT01700959|526574506|FG005|Overall Study|Noncompliant|9|||
146017811|NCT01700959|526574501|FG000|Overall Study|Side effects|1|||
146017812|NCT01700959|526574502|FG001|Overall Study|Side effects|4|||
146017813|NCT01700959|526574503|FG002|Overall Study|Side effects|8|||
146017814|NCT01700959|526574504|FG003|Overall Study|Side effects|4|||
146017815|NCT01700959|526574505|FG004|Overall Study|Side effects|4|||
146017816|NCT01700959|526574506|FG005|Overall Study|Side effects|1|||
146299996|NCT01399190|527613676|FG000|Overall Study|Adverse Event|8|||
146299997|NCT01399190|527613676|FG000|Overall Study|Participant's Request|5|||
146299998|NCT01399190|527613676|FG000|Overall Study|Physician Decision|2|||
146017817|NCT01331837|526574507|FG000|Overall Study|Death|30|||
146017818|NCT01331837|526574508|FG001|Overall Study|Death|34|||
146017819|NCT01331837|526574507|FG000|Overall Study|Lost to Follow-up|3|||
146017820|NCT01331837|526574508|FG001|Overall Study|Lost to Follow-up|1|||
146017821|NCT01331837|526574507|FG000|Overall Study|Info not recorded|10|||
146017822|NCT01331837|526574508|FG001|Overall Study|Info not recorded|16|||
146017823|NCT01331837|526574507|FG000|Overall Study|Withdrawal by Subject|13|||
146017824|NCT01331837|526574508|FG001|Overall Study|Withdrawal by Subject|16|||
146017825|NCT02640625|526577603|FG000|Overall Study|Adverse Event|1|||
146017826|NCT00511433|526577604|FG000|Overall Study|Adverse Event|5|||
146017827|NCT00511433|526577605|FG001|Overall Study|Adverse Event|0|||
146017828|NCT00511433|526577604|FG000|Overall Study|Other Reason|1|||
146017829|NCT00511433|526577605|FG001|Overall Study|Other Reason|1|||
146017830|NCT01380535|526577606|FG000|Overall Study|Adverse Event|3|||
146017831|NCT01380535|526577607|FG001|Overall Study|Adverse Event|3|||
146017832|NCT01380535|526577606|FG000|Overall Study|Death|3|||
146017833|NCT01380535|526577607|FG001|Overall Study|Death|0|||
146017834|NCT01380535|526577606|FG000|Overall Study|Study site closed|0|||
146017835|NCT01380535|526577607|FG001|Overall Study|Study site closed|5|||
146017836|NCT01380535|526577606|FG000|Overall Study|Withdrawal by Subject|1|||
146017837|NCT01380535|526577607|FG001|Overall Study|Withdrawal by Subject|2|||
146017838|NCT01380535|526577606|FG000|Overall Study|Protocol Violation|0|||
146017839|NCT01380535|526577607|FG001|Overall Study|Protocol Violation|2|||
146017840|NCT01380535|526577606|FG000|Overall Study|Lack of Efficacy|0|||
146017841|NCT01380535|526577607|FG001|Overall Study|Lack of Efficacy|3|||
146017842|NCT03100539|526577614|FG000|Overall Study|Lost to Follow-up|60|||
146017843|NCT03100539|526577615|FG001|Overall Study|Lost to Follow-up|54|||
146017844|NCT03100539|526577616|FG002|Overall Study|Lost to Follow-up|17|||
146017845|NCT03100539|526577614|FG000|Overall Study|Uncollected|8|||
146017846|NCT03100539|526577615|FG001|Overall Study|Uncollected|8|||
146017847|NCT03100539|526577616|FG002|Overall Study|Uncollected|0|||
146017848|NCT03100539|526577614|FG000|Overall Study|Ally Health|0|||
146017849|NCT03100539|526577615|FG001|Overall Study|Ally Health|0|||
146017850|NCT03100539|526577616|FG002|Overall Study|Ally Health|3|||
146017851|NCT03100539|526577614|FG000|Overall Study|Disinterest|0|||
146017852|NCT03100539|526577615|FG001|Overall Study|Disinterest|0|||
146017853|NCT03100539|526577616|FG002|Overall Study|Disinterest|22|||
146017854|NCT03100539|526577614|FG000|Overall Study|Veteran Health|0|||
146017855|NCT03100539|526577615|FG001|Overall Study|Veteran Health|0|||
146017856|NCT03100539|526577616|FG002|Overall Study|Veteran Health|8|||
146017857|NCT03100539|526577614|FG000|Overall Study|Moved|0|||
146017858|NCT03100539|526577615|FG001|Overall Study|Moved|0|||
146017859|NCT03100539|526577616|FG002|Overall Study|Moved|1|||
146017860|NCT03100539|526577614|FG000|Overall Study|Scheduling Conflicts|0|||
146017861|NCT03100539|526577615|FG001|Overall Study|Scheduling Conflicts|0|||
146017862|NCT03100539|526577616|FG002|Overall Study|Scheduling Conflicts|12|||
146017863|NCT02596958|526577620|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
146017864|NCT02596958|526577620|FG000|Overall Study|Cancer Progression|441|||
146017865|NCT02596958|526577620|FG000|Overall Study|Death From Cancer|112|||
146017866|NCT02596958|526577620|FG000|Overall Study|Death From Other Cause|33|||
146017867|NCT02596958|526577620|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
146017868|NCT02596958|526577620|FG000|Overall Study|Administrative Reasons/Other|231|||
146017869|NCT02596958|526577620|FG000|Overall Study|Lost to Follow-up|33|||
146017870|NCT02596958|526577620|FG000|Overall Study|Missing|32|||
146017871|NCT02596958|526577620|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
146017872|NCT03596047|526577621|FG000|Overall Study|Withdrawal by Subject|7|||
146017873|NCT03596047|526577622|FG001|Overall Study|Withdrawal by Subject|4|||
146017874|NCT03596047|526577621|FG000|Overall Study|Lost to Follow-up|0|||
146017875|NCT03596047|526577622|FG001|Overall Study|Lost to Follow-up|2|||
146017876|NCT02242435|526577627|FG000|Overall Study|Lost to Follow-up|3|||
146017877|NCT02242435|526577628|FG001|Overall Study|Lost to Follow-up|4|||
146017878|NCT02242435|526577627|FG000|Overall Study|Adverse Event|3|||
146017879|NCT02242435|526577628|FG001|Overall Study|Adverse Event|2|||
146017880|NCT02242435|526577627|FG000|Overall Study|Withdrawal by Subject|13|||
146017881|NCT02242435|526577628|FG001|Overall Study|Withdrawal by Subject|8|||
146017882|NCT02242435|526577627|FG000|Overall Study|Death|0|||
146017883|NCT02242435|526577628|FG001|Overall Study|Death|1|||
146017884|NCT02242435|526577627|FG000|Overall Study|Protocol Violation|1|||
146299999|NCT00059839|527613679|FG000|Overall Study|Death|1|||
146093792|NCT00595465|526864909|FG002|Overall Study|Protocol Violation|0|||
146093793|NCT00595465|526864907|FG000|Overall Study|Lost to Follow-up|0|||
146093794|NCT00595465|526864908|FG001|Overall Study|Lost to Follow-up|0|||
146093795|NCT00595465|526864909|FG002|Overall Study|Lost to Follow-up|2|||
146093796|NCT00595465|526864907|FG000|Overall Study|administrative reason|0|||
146093797|NCT00595465|526864908|FG001|Overall Study|administrative reason|0|||
146093798|NCT00595465|526864909|FG002|Overall Study|administrative reason|1|||
146093799|NCT00107783|526864910|FG000|Overall Study|Adverse Event|0|||
146093800|NCT00107783|526864911|FG001|Overall Study|Adverse Event|2|||
146093801|NCT00107783|526864910|FG000|Overall Study|Death|0|||
146093802|NCT00107783|526864911|FG001|Overall Study|Death|1|||
146093803|NCT00107783|526864910|FG000|Overall Study|Withdrawal by Subject|2|||
146093804|NCT00107783|526864911|FG001|Overall Study|Withdrawal by Subject|0|||
146093805|NCT00107783|526864910|FG000|Overall Study|Second hip replacement|1|||
146093806|NCT00107783|526864911|FG001|Overall Study|Second hip replacement|1|||
146093807|NCT00422097|526864912|FG000|Dose Level 2|Still on treatment|0|||
146093808|NCT00422097|526864913|FG001|Dose Level 2|Still on treatment|1|||
146093809|NCT00422097|526864914|FG002|Dose Level 2|Still on treatment|0|||
146093810|NCT00422097|526864915|FG003|Dose Level 2|Still on treatment|0|||
146093811|NCT00422097|526864916|FG004|Dose Level 2|Still on treatment|0|||
146093812|NCT00422097|526864917|FG005|Dose Level 2|Still on treatment|0|||
146093813|NCT00422097|526864918|FG006|Dose Level 2|Still on treatment|0|||
146093814|NCT00422097|526864919|FG007|Dose Level 2|Still on treatment|0|||
146093815|NCT02572388|526864920|FG000|Overall Study|Withdrawal by Subject|1|||
146093816|NCT02572388|526864921|FG001|Overall Study|Withdrawal by Subject|1|||
146093817|NCT02572388|526864922|FG002|Overall Study|Withdrawal by Subject|2|||
146093818|NCT02572388|526864923|FG003|Overall Study|Withdrawal by Subject|2|||
146093819|NCT02360995|526864924|FG000|Overall Study|Lost to Follow-up|2|||
146093820|NCT02360995|526864925|FG001|Overall Study|Lost to Follow-up|0|||
146093821|NCT02360995|526864926|FG002|Overall Study|Lost to Follow-up|2|||
146093822|NCT02360995|526864924|FG000|Overall Study|Withdrawal by Subject|0|||
146093823|NCT02360995|526864925|FG001|Overall Study|Withdrawal by Subject|1|||
146093824|NCT02360995|526864926|FG002|Overall Study|Withdrawal by Subject|0|||
146093825|NCT01051466|526864927|FG000|Overall Study|Adverse Event|1|||
146093826|NCT01051466|526864928|FG001|Overall Study|Adverse Event|0|||
146093827|NCT01051466|526864927|FG000|Overall Study|Lost to Follow-up|1|||
146093828|NCT01051466|526864928|FG001|Overall Study|Lost to Follow-up|1|||
146093829|NCT01051466|526864927|FG000|Overall Study|Withdrawal by Subject|5|||
146093830|NCT01051466|526864928|FG001|Overall Study|Withdrawal by Subject|1|||
146093831|NCT01051466|526864927|FG000|Overall Study|Entry Criteria Not Met|0|||
146093832|NCT01051466|526864928|FG001|Overall Study|Entry Criteria Not Met|3|||
146093833|NCT01051466|526864927|FG000|Overall Study|Physician Decision|1|||
146093834|NCT01051466|526864928|FG001|Overall Study|Physician Decision|0|||
146093835|NCT02231918|526864929|FG000|Overall Study|Withdrawal by Subject|0|||
146093836|NCT02231918|526864930|FG001|Overall Study|Withdrawal by Subject|1|||
146093837|NCT02231918|526864931|FG002|Overall Study|Withdrawal by Subject|0|||
146093838|NCT02231918|526864929|FG000|Overall Study|Adverse Event|0|||
146093839|NCT02231918|526864930|FG001|Overall Study|Adverse Event|0|||
146093840|NCT02231918|526864931|FG002|Overall Study|Adverse Event|1|||
146093841|NCT00331864|526864939|FG000|Overall Study|Adverse Event|30|||
146093842|NCT00331864|526864940|FG001|Overall Study|Adverse Event|1|||
146093843|NCT00331864|526864939|FG000|Overall Study|Lack of Efficacy|4|||
146093844|NCT00331864|526864940|FG001|Overall Study|Lack of Efficacy|0|||
146093845|NCT00331864|526864939|FG000|Overall Study|Protocol Violation|3|||
146093846|NCT00331864|526864940|FG001|Overall Study|Protocol Violation|0|||
146093847|NCT00331864|526864939|FG000|Overall Study|Withdrawal by Subject|10|||
146017885|NCT02242435|526577628|FG001|Overall Study|Protocol Violation|0|||
146017886|NCT02242435|526577627|FG000|Overall Study|Physician Decision|0|||
146017887|NCT02242435|526577628|FG001|Overall Study|Physician Decision|1|||
146017888|NCT01110330|526577631|FG000|Overall Study|Adverse Event|0|||
146017889|NCT01110330|526577632|FG001|Overall Study|Adverse Event|4|||
146017890|NCT01110330|526577633|FG002|Overall Study|Adverse Event|3|||
146017891|NCT01110330|526577631|FG000|Overall Study|Lack of Efficacy|3|||
146017892|NCT01110330|526577632|FG001|Overall Study|Lack of Efficacy|1|||
146017893|NCT01110330|526577633|FG002|Overall Study|Lack of Efficacy|1|||
146017894|NCT01110330|526577631|FG000|Overall Study|Lost to Follow-up|9|||
146017895|NCT01110330|526577632|FG001|Overall Study|Lost to Follow-up|10|||
146017896|NCT01110330|526577633|FG002|Overall Study|Lost to Follow-up|15|||
146017897|NCT01110330|526577631|FG000|Overall Study|Physician Decision|0|||
146093848|NCT00331864|526864940|FG001|Overall Study|Withdrawal by Subject|0|||
146093849|NCT00331864|526864939|FG000|Overall Study|Lost to Follow-up|4|||
146093850|NCT00331864|526864940|FG001|Overall Study|Lost to Follow-up|3|||
146093851|NCT00331864|526864939|FG000|Overall Study|Administrative Problems|1|||
146093852|NCT00331864|526864940|FG001|Overall Study|Administrative Problems|0|||
146093853|NCT00331864|526864939|FG000|Overall Study|Death|6|||
146093854|NCT00331864|526864940|FG001|Overall Study|Death|0|||
146093855|NCT02395666|526864941|FG000|Overall Study|Physician Decision|3|||
146093856|NCT02395666|526864942|FG001|Overall Study|Physician Decision|0|||
146093857|NCT02395666|526864941|FG000|Overall Study|Lost to Follow-up|1|||
146093858|NCT02395666|526864942|FG001|Overall Study|Lost to Follow-up|0|||
146017898|NCT01110330|526577632|FG001|Overall Study|Physician Decision|1|||
146017899|NCT01110330|526577633|FG002|Overall Study|Physician Decision|0|||
146017900|NCT01110330|526577631|FG000|Overall Study|Protocol Violation|2|||
146017901|NCT01110330|526577632|FG001|Overall Study|Protocol Violation|0|||
146017902|NCT01110330|526577633|FG002|Overall Study|Protocol Violation|4|||
146017903|NCT01110330|526577631|FG000|Overall Study|Withdrawal by Subject|0|||
146017904|NCT01110330|526577632|FG001|Overall Study|Withdrawal by Subject|6|||
146017905|NCT01110330|526577633|FG002|Overall Study|Withdrawal by Subject|2|||
146017906|NCT01110330|526577631|FG000|Overall Study|Other|1|||
146017907|NCT01110330|526577632|FG001|Overall Study|Other|1|||
146017908|NCT01110330|526577633|FG002|Overall Study|Other|1|||
146017911|NCT02513485|526577648|FG000|Overall Study|Adverse Event|1|||
146017912|NCT02513485|526577649|FG001|Overall Study|Adverse Event|0|||
146017913|NCT03350035|526577659|FG000|Overall Study|Lack of Efficacy|2|||
146017914|NCT03350035|526577660|FG001|Overall Study|Lack of Efficacy|0|||
146017915|NCT03350035|526577661|FG002|Overall Study|Lack of Efficacy|0|||
146017916|NCT03350035|526577659|FG000|Overall Study|Subject discharged to hospice|0|||
146017917|NCT03350035|526577660|FG001|Overall Study|Subject discharged to hospice|0|||
146017918|NCT03350035|526577661|FG002|Overall Study|Subject discharged to hospice|1|||
146017919|NCT04115748|526577667|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
146017920|NCT04115748|526577668|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
146017921|NCT04115748|526577669|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
146017922|NCT04115748|526577670|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
146017923|NCT04115748|526577671|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017924|NCT04115748|526577672|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017925|NCT04115748|526577673|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017926|NCT04115748|526577674|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017927|NCT04115748|526577675|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017928|NCT04115748|526577676|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
146017929|NCT04115748|526577667|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017930|NCT04115748|526577668|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017931|NCT04115748|526577669|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017932|NCT04115748|526577670|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
146017933|NCT04115748|526577671|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017934|NCT04115748|526577672|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017935|NCT04115748|526577673|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017936|NCT04115748|526577674|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017937|NCT04115748|526577675|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017938|NCT04115748|526577676|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
146017939|NCT04115748|526577667|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146017940|NCT04115748|526577668|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146017941|NCT04115748|526577669|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146017942|NCT04115748|526577670|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
146017943|NCT04115748|526577671|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
146017944|NCT04115748|526577672|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
146017945|NCT04115748|526577673|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146017946|NCT04115748|526577674|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146017947|NCT04115748|526577675|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
146017948|NCT04115748|526577676|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
146017949|NCT04115748|526577667|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017950|NCT04115748|526577668|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017951|NCT04115748|526577669|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017952|NCT04115748|526577670|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017953|NCT04115748|526577671|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017954|NCT04115748|526577672|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017955|NCT04115748|526577673|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017956|NCT04115748|526577674|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017957|NCT04115748|526577675|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
146017958|NCT04115748|526577676|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
146017959|NCT00713349|526577677|FG000|Overall Study|Protocol Violation|1|||
146017960|NCT03764631|526577678|FG000|Overall Study|Personal Reasons|3|||
146017961|NCT03764631|526577679|FG001|Overall Study|Personal Reasons|2|||
146093859|NCT02395666|526864941|FG000|Overall Study|Withdrawal by Subject|2|||
146093860|NCT02395666|526864942|FG001|Overall Study|Withdrawal by Subject|1|||
146093861|NCT02611960|526864943|FG000|Overall Study|Adverse Event|7|||
146093862|NCT02611960|526864944|FG001|Overall Study|Adverse Event|8|||
146093863|NCT02611960|526864943|FG000|Overall Study|Death|98|||
146093864|NCT02611960|526864944|FG001|Overall Study|Death|92|||
146093865|NCT02611960|526864943|FG000|Overall Study|Withdrawal by Subject|1|||
146300000|NCT00059839|527613680|FG001|Overall Study|Death|1|||
146093866|NCT02611960|526864944|FG001|Overall Study|Withdrawal by Subject|5|||
146093867|NCT02611960|526864943|FG000|Overall Study|Sponsor Decision|11|||
146093868|NCT02611960|526864944|FG001|Overall Study|Sponsor Decision|11|||
146093869|NCT00137631|526864945|FG000|Overall Study|Lost to Follow-up|37|||
146093870|NCT00137631|526864946|FG001|Overall Study|Lost to Follow-up|41|||
146093871|NCT00085709|526864948|FG000|Overall Study|Adverse Event|8|||
146093872|NCT00085709|526864949|FG001|Overall Study|Adverse Event|0|||
146093873|NCT00085709|526864948|FG000|Overall Study|Death|8|||
146093874|NCT00085709|526864949|FG001|Overall Study|Death|2|||
146093875|NCT00085709|526864948|FG000|Overall Study|Refusal unrelated to adverse events|1|||
146093876|NCT00085709|526864949|FG001|Overall Study|Refusal unrelated to adverse events|2|||
146093877|NCT00085709|526864948|FG000|Overall Study|Progression|3|||
146093878|NCT00085709|526864949|FG001|Overall Study|Progression|4|||
146093879|NCT00085709|526864948|FG000|Overall Study|Not protocol specified|12|||
146093880|NCT00085709|526864949|FG001|Overall Study|Not protocol specified|22|||
146093881|NCT00085709|526864948|FG000|Overall Study|Not eligible|19|||
146093882|NCT00085709|526864949|FG001|Overall Study|Not eligible|19|||
146093883|NCT00085709|526864948|FG000|Overall Study|Withdrawal by Subject|2|||
146093884|NCT00085709|526864949|FG001|Overall Study|Withdrawal by Subject|1|||
146093885|NCT00293215|526864950|FG000|Overall Study|Progressive disease|3|||
146093886|NCT00293215|526864951|FG001|Overall Study|Progressive disease|1|||
146093887|NCT00293215|526864950|FG000|Overall Study|Adverse Event|2|||
146093888|NCT00293215|526864951|FG001|Overall Study|Adverse Event|2|||
146093889|NCT04131556|526864952|FG000|Overall Study|Adverse Event|1|||
146093890|NCT04131556|526864952|FG000|Overall Study|Withdrawal by Subject|1|||
146093891|NCT01229371|526864955|FG000|Overall Study|Withdrawal by Subject|0|||
146093892|NCT01229371|526864956|FG001|Overall Study|Withdrawal by Subject|1|||
146093893|NCT01229371|526864957|FG002|Overall Study|Withdrawal by Subject|0|||
146093894|NCT01229371|526864958|FG003|Overall Study|Withdrawal by Subject|0|||
146093895|NCT03611010|526864959|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
146093896|NCT03611010|526864960|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146093897|NCT03611010|526864961|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146093898|NCT03611010|526864962|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
146093899|NCT00760214|526864965|FG000|Overall Study|Adverse Event|8|||
146093900|NCT00760214|526864966|FG001|Overall Study|Adverse Event|9|||
146093901|NCT00760214|526864967|FG002|Overall Study|Adverse Event|12|||
146093902|NCT00760214|526864965|FG000|Overall Study|Protocol Violation|3|||
146093903|NCT00760214|526864966|FG001|Overall Study|Protocol Violation|0|||
146093904|NCT00760214|526864967|FG002|Overall Study|Protocol Violation|3|||
146093905|NCT00760214|526864965|FG000|Overall Study|Lost to Follow-up|0|||
146017962|NCT03764631|526577678|FG000|Overall Study|Switching Therapy|3|||
146017963|NCT03764631|526577679|FG001|Overall Study|Switching Therapy|3|||
146017964|NCT03764631|526577678|FG000|Overall Study|Adverse Event|0|||
146017965|NCT03764631|526577679|FG001|Overall Study|Adverse Event|1|||
146017966|NCT03764631|526577678|FG000|Overall Study|Lost to Follow-up|33|||
146017967|NCT03764631|526577679|FG001|Overall Study|Lost to Follow-up|41|||
146017968|NCT03764631|526577678|FG000|Overall Study|No data as study site was closed|2|||
146017969|NCT03764631|526577679|FG001|Overall Study|No data as study site was closed|6|||
146017970|NCT01200407|526577680|FG000|Overall Study|Lost to Follow-up|56|||
146017971|NCT01200407|526577680|FG000|Overall Study|Adverse Event|3|||
146017972|NCT01200407|526577680|FG000|Overall Study|Withdrawal by Subject|4|||
146017973|NCT01200407|526577680|FG000|Overall Study|Other|19|||
146017974|NCT02974855|526577683|FG000|Overall Study|Adverse Event|0|||
146017975|NCT02974855|526577684|FG001|Overall Study|Adverse Event|1|||
146017976|NCT02974855|526577685|FG002|Overall Study|Adverse Event|0|||
146017977|NCT02974855|526577686|FG003|Overall Study|Adverse Event|1|||
146017978|NCT00633074|526577687|FG000|Overall Study|Adverse Event|1|||
146017979|NCT00633074|526577688|FG001|Overall Study|Adverse Event|0|||
146017980|NCT02752633|526577690|FG000|Overall Study|Withdrawal by Subject|1|||
146017981|NCT01843673|526577691|FG000|Overall Study|Lack of Efficacy|2|||
146017982|NCT01843673|526577691|FG000|Overall Study|Withdrawal by Subject|4|||
146017983|NCT03275246|526577692|FG000|Overall Study|Protocol Violation|5|||
146093906|NCT00760214|526864966|FG001|Overall Study|Lost to Follow-up|0|||
146093907|NCT00760214|526864967|FG002|Overall Study|Lost to Follow-up|1|||
146017984|NCT03275246|526577692|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
146017985|NCT00433966|526577695|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
146017986|NCT00433966|526577696|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
146093908|NCT00760214|526864965|FG000|Overall Study|Withdrawal by Subject|12|||
146017987|NCT00433966|526577697|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
146300001|NCT00059839|527613679|FG000|Overall Study|Lack of Efficacy|6|||
146093909|NCT00760214|526864966|FG001|Overall Study|Withdrawal by Subject|14|||
146093910|NCT00760214|526864967|FG002|Overall Study|Withdrawal by Subject|13|||
146093911|NCT00760214|526864965|FG000|Overall Study|Lack of Efficacy|3|||
146093912|NCT00760214|526864966|FG001|Overall Study|Lack of Efficacy|2|||
146093913|NCT00760214|526864967|FG002|Overall Study|Lack of Efficacy|4|||
146093914|NCT00760214|526864965|FG000|Overall Study|Pregnancy|0|||
146093915|NCT00760214|526864966|FG001|Overall Study|Pregnancy|0|||
146093916|NCT00760214|526864967|FG002|Overall Study|Pregnancy|1|||
146017988|NCT00433966|526577698|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
146017989|NCT00433966|526577695|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
146017990|NCT00433966|526577696|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
146017991|NCT00433966|526577697|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
146017992|NCT00433966|526577698|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
146017993|NCT00433966|526577695|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
146017994|NCT00433966|526577696|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
146017995|NCT00433966|526577697|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
146017996|NCT00433966|526577698|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
146017997|NCT00433966|526577695|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
146017998|NCT00433966|526577696|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
146017999|NCT00433966|526577697|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
146018000|NCT00433966|526577698|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
146018001|NCT00433966|526577695|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
146018002|NCT00433966|526577696|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
146018003|NCT00433966|526577697|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
146018004|NCT00433966|526577698|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
146018005|NCT02570152|526577699|FG000|Overall Study|Protocol Violation|2|||
146018006|NCT02570152|526577699|FG000|Overall Study|Migrated/moved from study area|13|||
146018007|NCT03497975|526577701|FG000|Overall Study|Withdrew Consent|34|||
146018008|NCT03497975|526577702|FG001|Overall Study|Withdrew Consent|35|||
146018009|NCT03497975|526577701|FG000|Overall Study|Lost to Follow-up|7|||
146018010|NCT03497975|526577702|FG001|Overall Study|Lost to Follow-up|7|||
146018011|NCT03497975|526577701|FG000|Overall Study|Physician Decision|4|||
146018012|NCT03497975|526577702|FG001|Overall Study|Physician Decision|5|||
146018013|NCT03497975|526577701|FG000|Overall Study|Discontinued|42|||
146018014|NCT03497975|526577702|FG001|Overall Study|Discontinued|39|||
146018015|NCT03497975|526577701|FG000|Overall Study|Reason Not Specified|15|||
146018016|NCT03497975|526577702|FG001|Overall Study|Reason Not Specified|14|||
146018017|NCT01296711|526577703|FG000|Overall Study|Adverse Event|3|||
146018018|NCT01296711|526577704|FG001|Overall Study|Adverse Event|1|||
146018019|NCT01296711|526577705|FG002|Overall Study|Adverse Event|4|||
146018020|NCT01296711|526577706|FG003|Overall Study|Adverse Event|3|||
146018021|NCT01296711|526577707|FG004|Overall Study|Adverse Event|1|||
146018022|NCT01296711|526577708|FG005|Overall Study|Adverse Event|6|||
146018023|NCT01296711|526577709|FG006|Overall Study|Adverse Event|11|||
146018024|NCT01296711|526577710|FG007|Overall Study|Adverse Event|3|||
146018025|NCT01296711|526577703|FG000|Overall Study|Lack of Efficacy|1|||
146018026|NCT01296711|526577704|FG001|Overall Study|Lack of Efficacy|4|||
146018027|NCT01296711|526577705|FG002|Overall Study|Lack of Efficacy|1|||
146018028|NCT01296711|526577706|FG003|Overall Study|Lack of Efficacy|1|||
146018029|NCT01296711|526577707|FG004|Overall Study|Lack of Efficacy|1|||
146018030|NCT01296711|526577708|FG005|Overall Study|Lack of Efficacy|0|||
146018031|NCT01296711|526577709|FG006|Overall Study|Lack of Efficacy|2|||
146018032|NCT01296711|526577710|FG007|Overall Study|Lack of Efficacy|3|||
146018033|NCT01296711|526577703|FG000|Overall Study|Lost to Follow-up|0|||
146018034|NCT01296711|526577704|FG001|Overall Study|Lost to Follow-up|0|||
146018035|NCT01296711|526577705|FG002|Overall Study|Lost to Follow-up|1|||
146018036|NCT01296711|526577706|FG003|Overall Study|Lost to Follow-up|1|||
146018037|NCT01296711|526577707|FG004|Overall Study|Lost to Follow-up|2|||
146018038|NCT01296711|526577708|FG005|Overall Study|Lost to Follow-up|0|||
146018039|NCT01296711|526577709|FG006|Overall Study|Lost to Follow-up|4|||
146018040|NCT01296711|526577710|FG007|Overall Study|Lost to Follow-up|2|||
146018041|NCT01296711|526577703|FG000|Overall Study|Protocol Violation|0|||
146018042|NCT01296711|526577704|FG001|Overall Study|Protocol Violation|0|||
146018043|NCT01296711|526577705|FG002|Overall Study|Protocol Violation|0|||
146018044|NCT01296711|526577706|FG003|Overall Study|Protocol Violation|1|||
146018045|NCT01296711|526577707|FG004|Overall Study|Protocol Violation|1|||
146018046|NCT01296711|526577708|FG005|Overall Study|Protocol Violation|0|||
146018047|NCT01296711|526577709|FG006|Overall Study|Protocol Violation|0|||
146018048|NCT01296711|526577710|FG007|Overall Study|Protocol Violation|0|||
146018049|NCT01296711|526577703|FG000|Overall Study|Withdrawal by Subject|4|||
146018050|NCT01296711|526577704|FG001|Overall Study|Withdrawal by Subject|2|||
146018051|NCT01296711|526577705|FG002|Overall Study|Withdrawal by Subject|2|||
146018052|NCT01296711|526577706|FG003|Overall Study|Withdrawal by Subject|1|||
146018053|NCT01296711|526577707|FG004|Overall Study|Withdrawal by Subject|1|||
146018054|NCT01296711|526577708|FG005|Overall Study|Withdrawal by Subject|1|||
146018055|NCT01296711|526577709|FG006|Overall Study|Withdrawal by Subject|2|||
146018056|NCT01296711|526577710|FG007|Overall Study|Withdrawal by Subject|1|||
146018057|NCT01296711|526577703|FG000|Overall Study|Study termination|8|||
146018058|NCT01296711|526577704|FG001|Overall Study|Study termination|1|||
146018059|NCT01296711|526577705|FG002|Overall Study|Study termination|5|||
146018060|NCT01296711|526577706|FG003|Overall Study|Study termination|4|||
146018061|NCT01296711|526577707|FG004|Overall Study|Study termination|4|||
146018062|NCT01296711|526577708|FG005|Overall Study|Study termination|4|||
146018063|NCT01296711|526577709|FG006|Overall Study|Study termination|8|||
146018064|NCT01296711|526577710|FG007|Overall Study|Study termination|10|||
146018065|NCT01296711|526577703|FG000|Overall Study|Continued elevated liver enzymes|0|||
146018066|NCT01296711|526577704|FG001|Overall Study|Continued elevated liver enzymes|0|||
146018067|NCT01296711|526577705|FG002|Overall Study|Continued elevated liver enzymes|0|||
146018068|NCT01296711|526577706|FG003|Overall Study|Continued elevated liver enzymes|1|||
146018069|NCT01296711|526577707|FG004|Overall Study|Continued elevated liver enzymes|0|||
146018070|NCT01296711|526577708|FG005|Overall Study|Continued elevated liver enzymes|0|||
146018071|NCT01296711|526577709|FG006|Overall Study|Continued elevated liver enzymes|0|||
146018072|NCT01296711|526577710|FG007|Overall Study|Continued elevated liver enzymes|0|||
146018073|NCT01296711|526577703|FG000|Overall Study|Methotrexate discontinued|0|||
146018074|NCT01296711|526577704|FG001|Overall Study|Methotrexate discontinued|0|||
146018075|NCT01296711|526577705|FG002|Overall Study|Methotrexate discontinued|0|||
146018076|NCT01296711|526577706|FG003|Overall Study|Methotrexate discontinued|1|||
146018077|NCT01296711|526577707|FG004|Overall Study|Methotrexate discontinued|0|||
146018078|NCT01296711|526577708|FG005|Overall Study|Methotrexate discontinued|0|||
146018079|NCT01296711|526577709|FG006|Overall Study|Methotrexate discontinued|0|||
146018080|NCT01296711|526577710|FG007|Overall Study|Methotrexate discontinued|0|||
146018081|NCT01296711|526577703|FG000|Overall Study|Investigator discretion|0|||
146018082|NCT01296711|526577704|FG001|Overall Study|Investigator discretion|0|||
146018083|NCT01296711|526577705|FG002|Overall Study|Investigator discretion|0|||
146018084|NCT01296711|526577706|FG003|Overall Study|Investigator discretion|0|||
146018085|NCT01296711|526577707|FG004|Overall Study|Investigator discretion|0|||
146018086|NCT01296711|526577708|FG005|Overall Study|Investigator discretion|0|||
146018087|NCT01296711|526577709|FG006|Overall Study|Investigator discretion|1|||
146018088|NCT01296711|526577710|FG007|Overall Study|Investigator discretion|0|||
146018089|NCT01296711|526577703|FG000|Overall Study|Other|0|||
146018090|NCT01296711|526577704|FG001|Overall Study|Other|0|||
146018091|NCT01296711|526577705|FG002|Overall Study|Other|0|||
146018092|NCT01296711|526577706|FG003|Overall Study|Other|0|||
146018093|NCT01296711|526577707|FG004|Overall Study|Other|0|||
146018094|NCT01296711|526577708|FG005|Overall Study|Other|0|||
146018095|NCT01296711|526577709|FG006|Overall Study|Other|1|||
146018096|NCT01296711|526577710|FG007|Overall Study|Other|0|||
146018097|NCT01296711|526577703|FG000|Overall Study|Required restricted steroid injections|0|||
146018098|NCT01296711|526577704|FG001|Overall Study|Required restricted steroid injections|0|||
146018099|NCT01296711|526577705|FG002|Overall Study|Required restricted steroid injections|0|||
146018100|NCT01296711|526577706|FG003|Overall Study|Required restricted steroid injections|0|||
146018101|NCT01296711|526577707|FG004|Overall Study|Required restricted steroid injections|0|||
146018102|NCT01296711|526577708|FG005|Overall Study|Required restricted steroid injections|0|||
146018103|NCT01296711|526577709|FG006|Overall Study|Required restricted steroid injections|1|||
146018104|NCT01296711|526577710|FG007|Overall Study|Required restricted steroid injections|0|||
146018105|NCT01296711|526577703|FG000|Overall Study|Ongoing missed appointments|0|||
146018106|NCT01296711|526577704|FG001|Overall Study|Ongoing missed appointments|0|||
146018107|NCT01296711|526577705|FG002|Overall Study|Ongoing missed appointments|0|||
146018108|NCT01296711|526577706|FG003|Overall Study|Ongoing missed appointments|0|||
146018109|NCT01296711|526577707|FG004|Overall Study|Ongoing missed appointments|0|||
146018110|NCT01296711|526577708|FG005|Overall Study|Ongoing missed appointments|0|||
146018111|NCT01296711|526577709|FG006|Overall Study|Ongoing missed appointments|1|||
146018112|NCT01296711|526577710|FG007|Overall Study|Ongoing missed appointments|0|||
146018113|NCT01296711|526577703|FG000|Overall Study|Failure to comply with visits|0|||
146018114|NCT01296711|526577704|FG001|Overall Study|Failure to comply with visits|0|||
146018115|NCT01296711|526577705|FG002|Overall Study|Failure to comply with visits|0|||
146018116|NCT01296711|526577706|FG003|Overall Study|Failure to comply with visits|0|||
146018117|NCT01296711|526577707|FG004|Overall Study|Failure to comply with visits|0|||
146018118|NCT01296711|526577708|FG005|Overall Study|Failure to comply with visits|0|||
146018119|NCT01296711|526577709|FG006|Overall Study|Failure to comply with visits|0|||
146018120|NCT01296711|526577710|FG007|Overall Study|Failure to comply with visits|1|||
146018121|NCT01296711|526577703|FG000|Overall Study|Patient decision due to transport|0|||
146018122|NCT01296711|526577704|FG001|Overall Study|Patient decision due to transport|0|||
146018123|NCT01296711|526577705|FG002|Overall Study|Patient decision due to transport|0|||
146018124|NCT01296711|526577706|FG003|Overall Study|Patient decision due to transport|0|||
146018125|NCT01296711|526577707|FG004|Overall Study|Patient decision due to transport|0|||
146018126|NCT01296711|526577708|FG005|Overall Study|Patient decision due to transport|0|||
146018127|NCT01296711|526577709|FG006|Overall Study|Patient decision due to transport|0|||
146018128|NCT01296711|526577710|FG007|Overall Study|Patient decision due to transport|1|||
146018129|NCT02120300|526577713|FG000|Overall Study|Enrolled but Never Treated|2|||
146300002|NCT00059839|527613680|FG001|Overall Study|Lack of Efficacy|5|||
146018130|NCT02120300|526577714|FG001|Overall Study|Enrolled but Never Treated|0|||
146018131|NCT02120300|526577715|FG002|Overall Study|Enrolled but Never Treated|0|||
146018132|NCT02120300|526577716|FG003|Overall Study|Enrolled but Never Treated|0|||
146018133|NCT02120300|526577713|FG000|Overall Study|Lack of Efficacy|0|||
146018134|NCT02120300|526577714|FG001|Overall Study|Lack of Efficacy|0|||
146018135|NCT02120300|526577715|FG002|Overall Study|Lack of Efficacy|0|||
146018136|NCT02120300|526577716|FG003|Overall Study|Lack of Efficacy|1|||
146018137|NCT02120300|526577713|FG000|Overall Study|Lost to Follow-up|1|||
146018138|NCT02120300|526577714|FG001|Overall Study|Lost to Follow-up|0|||
146018139|NCT02120300|526577715|FG002|Overall Study|Lost to Follow-up|0|||
146018140|NCT02120300|526577716|FG003|Overall Study|Lost to Follow-up|0|||
146018141|NCT00700882|526577719|FG000|Overall Study|Never received treatment|6|||
146018142|NCT00700882|526577719|FG000|Overall Study|Ineligible|2|||
146018143|NCT00700882|526577719|FG000|Overall Study|No KIT mutation|51|||
146018144|NCT01832493|526577723|FG000|Overall Study|Physician Decision|2|||
146018145|NCT01832493|526577723|FG000|Overall Study|Protocol Violation|4|||
146018146|NCT01832493|526577723|FG000|Overall Study|Unable to place LV lead|2|||
146018147|NCT01732510|526577724|FG000|Overall Study|Adverse Event|0|||
146018148|NCT01732510|526577725|FG001|Overall Study|Adverse Event|1|||
146018149|NCT01732510|526577726|FG002|Overall Study|Adverse Event|1|||
146018150|NCT01732510|526577727|FG003|Overall Study|Adverse Event|0|||
146018151|NCT01732510|526577728|FG004|Overall Study|Adverse Event|0|||
146018152|NCT01732510|526577729|FG005|Overall Study|Adverse Event|0|||
146018153|NCT01732510|526577730|FG006|Overall Study|Adverse Event|1|||
146018154|NCT01732510|526577724|FG000|Overall Study|Protocol Violation|0|||
146018155|NCT01732510|526577725|FG001|Overall Study|Protocol Violation|0|||
146018156|NCT01732510|526577726|FG002|Overall Study|Protocol Violation|0|||
146018157|NCT01732510|526577727|FG003|Overall Study|Protocol Violation|1|||
146018158|NCT01732510|526577728|FG004|Overall Study|Protocol Violation|0|||
146018159|NCT01732510|526577729|FG005|Overall Study|Protocol Violation|0|||
146018160|NCT01732510|526577730|FG006|Overall Study|Protocol Violation|0|||
146018161|NCT01732510|526577724|FG000|Overall Study|Withdrawal by Subject|1|||
146018162|NCT01732510|526577725|FG001|Overall Study|Withdrawal by Subject|3|||
146018163|NCT01732510|526577726|FG002|Overall Study|Withdrawal by Subject|2|||
146018164|NCT01732510|526577727|FG003|Overall Study|Withdrawal by Subject|1|||
146018165|NCT01732510|526577728|FG004|Overall Study|Withdrawal by Subject|5|||
146018166|NCT01732510|526577729|FG005|Overall Study|Withdrawal by Subject|0|||
146018167|NCT01732510|526577730|FG006|Overall Study|Withdrawal by Subject|1|||
146018168|NCT01732510|526577724|FG000|Overall Study|Lost to Follow-up|0|||
146018169|NCT01732510|526577725|FG001|Overall Study|Lost to Follow-up|0|||
146018170|NCT01732510|526577726|FG002|Overall Study|Lost to Follow-up|1|||
146018171|NCT01732510|526577727|FG003|Overall Study|Lost to Follow-up|1|||
146018172|NCT01732510|526577728|FG004|Overall Study|Lost to Follow-up|0|||
146018173|NCT01732510|526577729|FG005|Overall Study|Lost to Follow-up|1|||
146018174|NCT01732510|526577730|FG006|Overall Study|Lost to Follow-up|0|||
146018175|NCT01732510|526577724|FG000|Overall Study|Physician Decision|0|||
146018176|NCT01732510|526577725|FG001|Overall Study|Physician Decision|1|||
146018177|NCT01732510|526577726|FG002|Overall Study|Physician Decision|0|||
146018178|NCT01732510|526577727|FG003|Overall Study|Physician Decision|0|||
146018179|NCT01732510|526577728|FG004|Overall Study|Physician Decision|0|||
146018180|NCT01732510|526577729|FG005|Overall Study|Physician Decision|0|||
146018181|NCT01732510|526577730|FG006|Overall Study|Physician Decision|0|||
146018182|NCT01732510|526577724|FG000|Overall Study|Pregnancy|0|||
146018183|NCT01732510|526577725|FG001|Overall Study|Pregnancy|0|||
146018184|NCT01732510|526577726|FG002|Overall Study|Pregnancy|0|||
146018185|NCT01732510|526577727|FG003|Overall Study|Pregnancy|1|||
146018186|NCT01732510|526577728|FG004|Overall Study|Pregnancy|0|||
146018187|NCT01732510|526577729|FG005|Overall Study|Pregnancy|0|||
146018188|NCT01732510|526577730|FG006|Overall Study|Pregnancy|0|||
146018189|NCT01732510|526577724|FG000|Overall Study|Study Terminated By Sponsor|0|||
146018190|NCT01732510|526577725|FG001|Overall Study|Study Terminated By Sponsor|0|||
146018191|NCT01732510|526577726|FG002|Overall Study|Study Terminated By Sponsor|0|||
146018192|NCT01732510|526577727|FG003|Overall Study|Study Terminated By Sponsor|1|||
146018193|NCT01732510|526577728|FG004|Overall Study|Study Terminated By Sponsor|0|||
146018194|NCT01732510|526577729|FG005|Overall Study|Study Terminated By Sponsor|12|||
146018195|NCT01732510|526577730|FG006|Overall Study|Study Terminated By Sponsor|6|||
146018196|NCT00313144|526577731|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
146018197|NCT00313144|526577731|FG000|Overall Study|Death|7|||
146018198|NCT00313144|526577731|FG000|Overall Study|Lost to Follow-up|5|||
146018199|NCT00313144|526577731|FG000|Overall Study|Withdrawal by Subject|4|||
146018200|NCT00313144|526577731|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
146018201|NCT00313144|526577731|FG000|Overall Study|Physician Decision|4|||
146018202|NCT00313144|526577731|FG000|Overall Study|Adverse event - transient|5|||
146018203|NCT00313144|526577731|FG000|Overall Study|Liver transplant|1|||
146018204|NCT00313144|526577731|FG000|Overall Study|Insurance (homecare provider) change|1|||
146300003|NCT00059839|527613679|FG000|Overall Study|Lost to Follow-up|2|||
146018205|NCT00313144|526577731|FG000|Overall Study|Change to different product|1|||
146018206|NCT00313144|526577731|FG000|Overall Study|Due to termination of the study|66|||
146018207|NCT00656058|526577736|FG000|Overall Study|Withdrawal by Subject|2|||
146018208|NCT00656058|526577736|FG000|Overall Study|Withdrawal by Subject|4|||
146018209|NCT00404755|526577737|FG000|Phase I (Bupropion)|Adverse Event|3|||
146018210|NCT00404755|526577737|FG000|Phase I (Bupropion)|Other|1|||
146018211|NCT00404755|526577737|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
146018212|NCT05145322|526577740|FG000|Overall Study|Lost to Follow-up|4|||
146018213|NCT05145322|526577741|FG001|Overall Study|Lost to Follow-up|5|||
146300004|NCT00059839|527613680|FG001|Overall Study|Lost to Follow-up|0|||
146300005|NCT00059839|527613679|FG000|Overall Study|Physician Decision|1|||
146300006|NCT00059839|527613680|FG001|Overall Study|Physician Decision|2|||
146300007|NCT00059839|527613679|FG000|Overall Study|Withdrawal by Subject|1|||
146300008|NCT00059839|527613680|FG001|Overall Study|Withdrawal by Subject|6|||
146300009|NCT00059839|527613679|FG000|Overall Study|Ineligible|1|||
146300010|NCT00059839|527613680|FG001|Overall Study|Ineligible|3|||
146300011|NCT00596934|527613681|FG000|Overall Study|Protocol Violation|1|||
146300012|NCT00596934|527613681|FG000|Overall Study|Withdrawal by Subject|1|||
146300013|NCT02315898|527613682|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
146300014|NCT02315898|527613683|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
146300015|NCT02315898|527613684|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
146300016|NCT02315898|527613685|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
146300017|NCT03239483|527613686|FG000|Overall Study|Lost to Follow-up|1|||
146300018|NCT03239483|527613687|FG001|Overall Study|Lost to Follow-up|0|||
146300019|NCT03239483|527613686|FG000|Overall Study|Withdrawal by Subject|1|||
146300020|NCT03239483|527613687|FG001|Overall Study|Withdrawal by Subject|0|||
146300021|NCT01296035|527613688|FG000|Overall Study|Withdrawal by Subject|1|||
146300022|NCT05395104|527613697|FG000|Overall Study|Met Liver Stopping Criteria|1|||
146300023|NCT05395104|527613697|FG000|Overall Study|Withdrawal by Subject|1|||
146300024|NCT00381563|527613698|FG000|Overall Study|Withdrawal by Subject|5|||
146300025|NCT00381563|527613699|FG001|Overall Study|Withdrawal by Subject|5|||
146300026|NCT00381563|527613698|FG000|Overall Study|Lost to Follow-up|2|||
146300027|NCT00381563|527613699|FG001|Overall Study|Lost to Follow-up|0|||
146300028|NCT00381563|527613698|FG000|Overall Study|Protocol Violation|0|||
146300029|NCT00381563|527613699|FG001|Overall Study|Protocol Violation|1|||
146300030|NCT03974334|527613701|FG000|Overall Study|Lost to Follow-up|1|||
146300031|NCT00931944|527613702|FG000|Overall Study|Adverse Event|4|||
146300032|NCT00931944|527613702|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
146300033|NCT00931944|527613702|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
146300034|NCT00931944|527613702|FG000|Overall Study|Death|28|||
146300035|NCT00931944|527613702|FG000|Overall Study|Other|2|||
146300036|NCT01109173|527613703|FG000|Overall Study|Adverse Event|15|||
146300037|NCT01109173|527613704|FG001|Overall Study|Adverse Event|17|||
146300038|NCT01109173|527613705|FG002|Overall Study|Adverse Event|9|||
146300039|NCT01109173|527613706|FG003|Overall Study|Adverse Event|6|||
146300040|NCT01109173|527613703|FG000|Overall Study|Lost to Follow-up|0|||
146300041|NCT01109173|527613704|FG001|Overall Study|Lost to Follow-up|1|||
146300042|NCT01109173|527613705|FG002|Overall Study|Lost to Follow-up|0|||
146300043|NCT01109173|527613706|FG003|Overall Study|Lost to Follow-up|0|||
146300044|NCT01109173|527613703|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
146300045|NCT01109173|527613704|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
146300046|NCT01109173|527613705|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
146300047|NCT01109173|527613706|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
146300048|NCT01109173|527613703|FG000|Overall Study|Noncompliance|0|||
146300049|NCT01109173|527613704|FG001|Overall Study|Noncompliance|1|||
146018214|NCT06359028|526577742|FG000|Overall Study|Adverse Event|1|||
146018215|NCT06359028|526577743|FG001|Overall Study|Adverse Event|0|||
146018216|NCT06359028|526577742|FG000|Overall Study|Withdrawal by Subject|1|||
146018217|NCT06359028|526577743|FG001|Overall Study|Withdrawal by Subject|0|||
146018218|NCT04700540|526577744|FG000|Overall Study|Withdrawal by Subject|12|||
146018219|NCT04700540|526577745|FG001|Overall Study|Withdrawal by Subject|8|||
146018220|NCT04700540|526577744|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
146018221|NCT04700540|526577745|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
146018222|NCT02265536|526577747|FG000|Overall Study|Adverse Event|1|||
146018223|NCT02265536|526577748|FG001|Overall Study|Adverse Event|0|||
146018224|NCT02265536|526577749|FG002|Overall Study|Adverse Event|0|||
146018225|NCT02265536|526577750|FG003|Overall Study|Adverse Event|0|||
146018226|NCT02265536|526577751|FG004|Overall Study|Adverse Event|1|||
146018227|NCT02265536|526577752|FG005|Overall Study|Adverse Event|0|||
146018228|NCT02265536|526577747|FG000|Overall Study|Physician Decision|0|||
146018229|NCT02265536|526577748|FG001|Overall Study|Physician Decision|0|||
146018230|NCT02265536|526577749|FG002|Overall Study|Physician Decision|0|||
146018231|NCT02265536|526577750|FG003|Overall Study|Physician Decision|0|||
146300050|NCT01109173|527613705|FG002|Overall Study|Noncompliance|0|||
146300051|NCT01109173|527613706|FG003|Overall Study|Noncompliance|0|||
146300052|NCT01109173|527613703|FG000|Overall Study|Treatment Failure|25|||
146300053|NCT01109173|527613704|FG001|Overall Study|Treatment Failure|32|||
146300054|NCT01109173|527613705|FG002|Overall Study|Treatment Failure|69|||
146300055|NCT01109173|527613706|FG003|Overall Study|Treatment Failure|64|||
146300056|NCT01109173|527613703|FG000|Overall Study|Protocol Violation|4|||
146018232|NCT02265536|526577751|FG004|Overall Study|Physician Decision|2|||
146018233|NCT02265536|526577752|FG005|Overall Study|Physician Decision|0|||
146018234|NCT02265536|526577747|FG000|Overall Study|Withdrawal by Subject|0|||
146018235|NCT02265536|526577748|FG001|Overall Study|Withdrawal by Subject|3|||
146018236|NCT02265536|526577749|FG002|Overall Study|Withdrawal by Subject|0|||
146018237|NCT02265536|526577750|FG003|Overall Study|Withdrawal by Subject|0|||
146018238|NCT02265536|526577751|FG004|Overall Study|Withdrawal by Subject|0|||
146018239|NCT02265536|526577752|FG005|Overall Study|Withdrawal by Subject|0|||
146018240|NCT01252186|526577757|FG000|Overall Study|Adverse Event|9|||
146018241|NCT01252186|526577758|FG001|Overall Study|Adverse Event|6|||
146018242|NCT01252186|526577759|FG002|Overall Study|Adverse Event|8|||
146018243|NCT01252186|526577757|FG000|Overall Study|Withdrawal by Subject|2|||
146018244|NCT01252186|526577758|FG001|Overall Study|Withdrawal by Subject|5|||
146018245|NCT01252186|526577759|FG002|Overall Study|Withdrawal by Subject|2|||
146018246|NCT01252186|526577757|FG000|Overall Study|Physician Decision|0|||
146018247|NCT01252186|526577758|FG001|Overall Study|Physician Decision|0|||
146018248|NCT01252186|526577759|FG002|Overall Study|Physician Decision|1|||
146018249|NCT01252186|526577757|FG000|Overall Study|Non-compliance|0|||
146018250|NCT01252186|526577758|FG001|Overall Study|Non-compliance|3|||
146018251|NCT01252186|526577759|FG002|Overall Study|Non-compliance|4|||
146018252|NCT01252186|526577757|FG000|Overall Study|Protocol Violation|0|||
146018253|NCT01252186|526577758|FG001|Overall Study|Protocol Violation|0|||
146018254|NCT01252186|526577759|FG002|Overall Study|Protocol Violation|1|||
146018255|NCT01252186|526577757|FG000|Overall Study|Pregnancy|2|||
146018256|NCT01252186|526577758|FG001|Overall Study|Pregnancy|2|||
146093917|NCT00760214|526864965|FG000|Overall Study|Physician Decision|1|||
146093918|NCT00760214|526864966|FG001|Overall Study|Physician Decision|1|||
146093919|NCT00760214|526864967|FG002|Overall Study|Physician Decision|1|||
146093920|NCT00760214|526864965|FG000|Overall Study|Other|3|||
146093921|NCT00760214|526864966|FG001|Overall Study|Other|4|||
146093922|NCT00760214|526864967|FG002|Overall Study|Other|6|||
146093923|NCT01933217|526864973|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
146093924|NCT01933217|526864974|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
146093925|NCT01933217|526864973|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
146093926|NCT01933217|526864974|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
146093927|NCT03923738|526864977|FG000|Period 1|Adverse Event|1|||
146093928|NCT03923738|526864977|FG000|Period 1|Withdrawal by Subject|1|||
146093929|NCT03583164|526864980|FG000|Overall Study|Death in Main Phase|35|||
146093930|NCT03583164|526864980|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
146093931|NCT03583164|526864980|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
146093932|NCT03583164|526864980|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
146093933|NCT03583164|526864980|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
146093934|NCT03583164|526864980|FG000|Overall Study|Physician decision in Main Phase|1|||
146093935|NCT03583164|526864980|FG000|Overall Study|Physician decision in Extended Phase|2|||
146093936|NCT03583164|526864980|FG000|Overall Study|Death in Extended Phase|13|||
146093937|NCT03583164|526864980|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
146093938|NCT03583164|526864980|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
146093939|NCT03583164|526864980|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
146093940|NCT03583164|526864980|FG000|Overall Study|Treatment failure in Main Phase|2|||
146093941|NCT03583164|526864980|FG000|Overall Study|Treatment failure in Extended Phase|4|||
146093942|NCT03583164|526864980|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
146093943|NCT03583164|526864980|FG000|Overall Study|Other not specified reason in Main Phase|2|||
146093944|NCT01031381|526864981|FG000|Overall Study|Physician Decision|3|||
146093945|NCT01031381|526864981|FG000|Overall Study|Withdrawal by Subject|6|||
146093946|NCT01369615|526864992|FG000|Overall Study|Withdrawal by Subject|0|||
146093947|NCT01369615|526864993|FG001|Overall Study|Withdrawal by Subject|1|||
146093948|NCT01369615|526864992|FG000|Overall Study|Lost to Follow-up|0|||
146093949|NCT01369615|526864993|FG001|Overall Study|Lost to Follow-up|1|||
146093950|NCT04263454|526864994|FG000|Overall Study|Adverse Event|0|||
146093951|NCT04263454|526864995|FG001|Overall Study|Adverse Event|2|||
146093952|NCT04263454|526864994|FG000|Overall Study|Physician Decision|3|||
146093953|NCT04263454|526864995|FG001|Overall Study|Physician Decision|5|||
146093954|NCT04263454|526864994|FG000|Overall Study|Poor Data Quality|0|||
146093955|NCT04263454|526864995|FG001|Overall Study|Poor Data Quality|1|||
146093956|NCT00986479|526864997|FG000|Period 1|Improved mood|1|||
146093957|NCT00986479|526864998|FG001|Period 1|Improved mood|0|||
146093958|NCT00986479|526864997|FG000|Period 1|Administrative reasons|1|||
146093959|NCT00986479|526864998|FG001|Period 1|Administrative reasons|0|||
146093960|NCT01721070|526864999|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
146093961|NCT02035475|526865000|FG000|Overall Study|Withdrawal by Subject|4|||
146093962|NCT02035475|526865000|FG000|Overall Study|Physician Decision|1|||
146093963|NCT02035475|526865000|FG000|Overall Study|Equipment Error|1|||
146093964|NCT02047227|526865001|FG000|Overall Study|Adverse Event|2|||
146093965|NCT02047227|526865002|FG001|Overall Study|Adverse Event|4|||
146093966|NCT02047227|526865001|FG000|Overall Study|Lost to Follow-up|0|||
146018257|NCT01252186|526577759|FG002|Overall Study|Pregnancy|0|||
146018258|NCT01252186|526577757|FG000|Overall Study|Sponsor Request|2|||
146018259|NCT01252186|526577758|FG001|Overall Study|Sponsor Request|1|||
146018260|NCT01252186|526577759|FG002|Overall Study|Sponsor Request|0|||
146093967|NCT02047227|526865002|FG001|Overall Study|Lost to Follow-up|3|||
146018261|NCT01252186|526577757|FG000|Overall Study|Lost to Follow-up|10|||
146018262|NCT01252186|526577758|FG001|Overall Study|Lost to Follow-up|10|||
146018263|NCT01252186|526577759|FG002|Overall Study|Lost to Follow-up|11|||
146018264|NCT01252186|526577757|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
146018265|NCT01252186|526577758|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
146018266|NCT01252186|526577759|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
146018267|NCT02791516|526577760|FG000|Overall Study|Withdrawal by Subject|1|||
146018268|NCT02791516|526577761|FG001|Overall Study|Withdrawal by Subject|1|||
146018269|NCT02524275|526577762|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
146018270|NCT04283994|526577763|FG000|Overall Study|Death|11|||
146018271|NCT04283994|526577764|FG001|Overall Study|Death|20|||
146018272|NCT04283994|526577765|FG002|Overall Study|Death|11|||
146018273|NCT04283994|526577766|FG003|Overall Study|Death|0|||
146018274|NCT04283994|526577767|FG004|Overall Study|Death|0|||
146018275|NCT04283994|526577768|FG005|Overall Study|Death|0|||
146018276|NCT04283994|526577769|FG006|Overall Study|Death|0|||
146018277|NCT04283994|526577763|FG000|Overall Study|Withdrawal by Subject|16|||
146018278|NCT04283994|526577764|FG001|Overall Study|Withdrawal by Subject|4|||
146018279|NCT04283994|526577765|FG002|Overall Study|Withdrawal by Subject|6|||
146018280|NCT04283994|526577766|FG003|Overall Study|Withdrawal by Subject|1|||
146018281|NCT04283994|526577767|FG004|Overall Study|Withdrawal by Subject|0|||
146018282|NCT04283994|526577768|FG005|Overall Study|Withdrawal by Subject|1|||
146018283|NCT04283994|526577769|FG006|Overall Study|Withdrawal by Subject|0|||
146018284|NCT03763656|526577770|FG000|Overall Study|Physician Decision|1|||
146018285|NCT03763656|526577770|FG000|Overall Study|Protocol Violation|1|||
146018286|NCT03763656|526577770|FG000|Overall Study|Withdrawal by Subject|7|||
146018287|NCT03724981|526579356|FG000|First Device|Protocol Violation|1|||
146018288|NCT03724981|526579357|FG001|First Device|Protocol Violation|1|||
146018289|NCT00197145|526579359|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
146018290|NCT00197145|526579360|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
146018291|NCT00197145|526579359|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
146018292|NCT00197145|526579360|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
146018293|NCT00197145|526579359|FG000|Period 1: Randomized Treatment Phase|Other|2|||
146018294|NCT00197145|526579360|FG001|Period 1: Randomized Treatment Phase|Other|2|||
146018295|NCT00197145|526579359|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
146018296|NCT00197145|526579360|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
146093968|NCT02047227|526865001|FG000|Overall Study|Protocol Violation|1|||
146018297|NCT00197145|526579359|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
146018298|NCT00197145|526579360|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
146093969|NCT02047227|526865002|FG001|Overall Study|Protocol Violation|0|||
146093970|NCT02047227|526865001|FG000|Overall Study|Spontaneous pregnancy|1|||
146093971|NCT02047227|526865002|FG001|Overall Study|Spontaneous pregnancy|0|||
146093972|NCT02047227|526865001|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
146093973|NCT02047227|526865002|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
146093974|NCT02047227|526865001|FG000|Overall Study|No oocytes retrieved|21|||
146093975|NCT02047227|526865002|FG001|Overall Study|No oocytes retrieved|20|||
146093976|NCT02047227|526865001|FG000|Overall Study|No fertilization|61|||
146093977|NCT02047227|526865002|FG001|Overall Study|No fertilization|51|||
146093978|NCT02047227|526865001|FG000|Overall Study|Intention to freeze all embryos|1|||
146093979|NCT02047227|526865002|FG001|Overall Study|Intention to freeze all embryos|0|||
146093980|NCT02047227|526865001|FG000|Overall Study|All embryos discarded|12|||
146093981|NCT02047227|526865002|FG001|Overall Study|All embryos discarded|11|||
146093982|NCT02047227|526865001|FG000|Overall Study|Other|10|||
146093983|NCT02047227|526865002|FG001|Overall Study|Other|9|||
146093984|NCT01090973|526865009|FG000|Overall Study|Disease progression|1|||
146093985|NCT02567552|526865010|FG000|Overall Study|Adverse Event|0|||
146093986|NCT02567552|526865011|FG001|Overall Study|Adverse Event|1|||
146018299|NCT00197145|526579359|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
146018300|NCT00197145|526579360|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
146018301|NCT00197145|526579359|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
146018302|NCT00197145|526579360|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
146018303|NCT00197145|526579359|FG000|Period 2 : Open Label Phase|Other|1|||
146018304|NCT00197145|526579360|FG001|Period 2 : Open Label Phase|Other|0|||
146018305|NCT02370537|526579361|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
146018306|NCT02370537|526579362|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
146018307|NCT02370537|526579363|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
146018308|NCT02370537|526579361|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
146093987|NCT00171054|526865013|FG000|Overall Study|Protocol Violation|1|||
146093988|NCT00171054|526865014|FG001|Overall Study|Protocol Violation|2|||
146093989|NCT00171054|526865013|FG000|Overall Study|Patient withdrew consent|1|||
146018309|NCT02370537|526579362|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
146093990|NCT00171054|526865014|FG001|Overall Study|Patient withdrew consent|0|||
146018310|NCT02370537|526579363|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
146018311|NCT02370537|526579361|FG000|Part B|Not randomised to receive treatment|1|||
146018312|NCT02370537|526579362|FG001|Part B|Not randomised to receive treatment|2|||
146018313|NCT02370537|526579363|FG002|Part B|Not randomised to receive treatment|259|||
146018314|NCT02370537|526579361|FG000|Part B|Withdrawal by Subject|0|||
146018315|NCT02370537|526579362|FG001|Part B|Withdrawal by Subject|1|||
146018316|NCT02370537|526579363|FG002|Part B|Withdrawal by Subject|0|||
146018317|NCT00882583|526579366|FG000|Overall Study|Physician Decision|1|||
146018318|NCT00882583|526579367|FG001|Overall Study|Physician Decision|0|||
146018319|NCT00882583|526579366|FG000|Overall Study|Adverse Event|0|||
146018320|NCT00882583|526579367|FG001|Overall Study|Adverse Event|1|||
146018321|NCT02589665|526579368|FG000|Induction Period|Did not receive drug|0|||
146018322|NCT02589665|526579369|FG001|Induction Period|Did not receive drug|0|||
146018323|NCT02589665|526579370|FG002|Induction Period|Did not receive drug|0|||
146018324|NCT02589665|526579371|FG003|Induction Period|Did not receive drug|1|||
146018325|NCT02589665|526579372|FG004|Induction Period|Did not receive drug|0|||
146018326|NCT02589665|526579373|FG005|Induction Period|Did not receive drug|0|||
146018327|NCT02589665|526579374|FG006|Induction Period|Did not receive drug|0|||
146018328|NCT02589665|526579375|FG007|Induction Period|Did not receive drug|0|||
146018329|NCT02589665|526579376|FG008|Induction Period|Did not receive drug|0|||
146018330|NCT02589665|526579377|FG009|Induction Period|Did not receive drug|0|||
146018331|NCT02589665|526579368|FG000|Induction Period|Adverse Event|3|||
146018332|NCT02589665|526579369|FG001|Induction Period|Adverse Event|0|||
146018333|NCT02589665|526579370|FG002|Induction Period|Adverse Event|2|||
146018334|NCT02589665|526579371|FG003|Induction Period|Adverse Event|2|||
146018335|NCT02589665|526579372|FG004|Induction Period|Adverse Event|0|||
146018336|NCT02589665|526579373|FG005|Induction Period|Adverse Event|0|||
146018337|NCT02589665|526579374|FG006|Induction Period|Adverse Event|0|||
146018338|NCT02589665|526579375|FG007|Induction Period|Adverse Event|0|||
146018339|NCT02589665|526579376|FG008|Induction Period|Adverse Event|0|||
146018340|NCT02589665|526579377|FG009|Induction Period|Adverse Event|0|||
146018341|NCT02589665|526579368|FG000|Induction Period|Withdrawal by Subject|0|||
146018342|NCT02589665|526579369|FG001|Induction Period|Withdrawal by Subject|1|||
146018343|NCT02589665|526579370|FG002|Induction Period|Withdrawal by Subject|0|||
146018344|NCT02589665|526579371|FG003|Induction Period|Withdrawal by Subject|1|||
146018345|NCT02589665|526579372|FG004|Induction Period|Withdrawal by Subject|0|||
146018346|NCT02589665|526579373|FG005|Induction Period|Withdrawal by Subject|0|||
146018347|NCT02589665|526579374|FG006|Induction Period|Withdrawal by Subject|0|||
146018348|NCT02589665|526579375|FG007|Induction Period|Withdrawal by Subject|0|||
146018349|NCT02589665|526579376|FG008|Induction Period|Withdrawal by Subject|0|||
146018350|NCT02589665|526579377|FG009|Induction Period|Withdrawal by Subject|0|||
146018351|NCT02589665|526579368|FG000|Induction Period|Protocol Violation|0|||
146018352|NCT02589665|526579369|FG001|Induction Period|Protocol Violation|1|||
146018353|NCT02589665|526579370|FG002|Induction Period|Protocol Violation|0|||
146018354|NCT02589665|526579371|FG003|Induction Period|Protocol Violation|0|||
146018355|NCT02589665|526579372|FG004|Induction Period|Protocol Violation|0|||
146018356|NCT02589665|526579373|FG005|Induction Period|Protocol Violation|0|||
146018357|NCT02589665|526579374|FG006|Induction Period|Protocol Violation|0|||
146018358|NCT02589665|526579375|FG007|Induction Period|Protocol Violation|0|||
146018359|NCT02589665|526579376|FG008|Induction Period|Protocol Violation|0|||
146018360|NCT02589665|526579377|FG009|Induction Period|Protocol Violation|0|||
146018361|NCT02589665|526579368|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018362|NCT02589665|526579369|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018363|NCT02589665|526579370|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018364|NCT02589665|526579371|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018365|NCT02589665|526579372|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
146018366|NCT02589665|526579373|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
146018367|NCT02589665|526579374|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
146018368|NCT02589665|526579375|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018369|NCT02589665|526579376|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018370|NCT02589665|526579377|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018371|NCT02589665|526579368|FG000|Maintenance Period|Withdrawal by Subject|0|||
146018372|NCT02589665|526579369|FG001|Maintenance Period|Withdrawal by Subject|0|||
146018373|NCT02589665|526579370|FG002|Maintenance Period|Withdrawal by Subject|0|||
146018374|NCT02589665|526579371|FG003|Maintenance Period|Withdrawal by Subject|0|||
146018375|NCT02589665|526579372|FG004|Maintenance Period|Withdrawal by Subject|4|||
146018376|NCT02589665|526579373|FG005|Maintenance Period|Withdrawal by Subject|2|||
146018377|NCT02589665|526579374|FG006|Maintenance Period|Withdrawal by Subject|4|||
146018378|NCT02589665|526579375|FG007|Maintenance Period|Withdrawal by Subject|0|||
146018379|NCT02589665|526579376|FG008|Maintenance Period|Withdrawal by Subject|0|||
146018380|NCT02589665|526579377|FG009|Maintenance Period|Withdrawal by Subject|0|||
146018381|NCT02589665|526579368|FG000|Maintenance Period|Lack of Efficacy|0|||
146018382|NCT02589665|526579369|FG001|Maintenance Period|Lack of Efficacy|0|||
146018383|NCT02589665|526579370|FG002|Maintenance Period|Lack of Efficacy|0|||
146018384|NCT02589665|526579371|FG003|Maintenance Period|Lack of Efficacy|0|||
146093991|NCT00171054|526865013|FG000|Overall Study|Lost to Follow-up|0|||
146093992|NCT00171054|526865014|FG001|Overall Study|Lost to Follow-up|1|||
146093993|NCT00171054|526865013|FG000|Overall Study|Adverse Event|8|||
146018385|NCT02589665|526579372|FG004|Maintenance Period|Lack of Efficacy|2|||
146018386|NCT02589665|526579373|FG005|Maintenance Period|Lack of Efficacy|1|||
146018387|NCT02589665|526579374|FG006|Maintenance Period|Lack of Efficacy|0|||
146018388|NCT02589665|526579375|FG007|Maintenance Period|Lack of Efficacy|0|||
146018389|NCT02589665|526579376|FG008|Maintenance Period|Lack of Efficacy|0|||
146018390|NCT02589665|526579377|FG009|Maintenance Period|Lack of Efficacy|0|||
146018391|NCT02589665|526579368|FG000|Maintenance Period|Adverse Event|0|||
146018392|NCT02589665|526579369|FG001|Maintenance Period|Adverse Event|0|||
146018393|NCT02589665|526579370|FG002|Maintenance Period|Adverse Event|0|||
146018394|NCT02589665|526579371|FG003|Maintenance Period|Adverse Event|0|||
146018395|NCT02589665|526579372|FG004|Maintenance Period|Adverse Event|0|||
146018396|NCT02589665|526579373|FG005|Maintenance Period|Adverse Event|0|||
146018397|NCT02589665|526579374|FG006|Maintenance Period|Adverse Event|2|||
146018398|NCT02589665|526579375|FG007|Maintenance Period|Adverse Event|0|||
146018399|NCT02589665|526579376|FG008|Maintenance Period|Adverse Event|0|||
146018400|NCT02589665|526579377|FG009|Maintenance Period|Adverse Event|0|||
146018401|NCT02589665|526579368|FG000|Maintenance Period|Lost to Follow-up|0|||
146018402|NCT02589665|526579369|FG001|Maintenance Period|Lost to Follow-up|0|||
146018403|NCT02589665|526579370|FG002|Maintenance Period|Lost to Follow-up|0|||
146018404|NCT02589665|526579371|FG003|Maintenance Period|Lost to Follow-up|0|||
146018405|NCT02589665|526579372|FG004|Maintenance Period|Lost to Follow-up|0|||
146018406|NCT02589665|526579373|FG005|Maintenance Period|Lost to Follow-up|1|||
146018407|NCT02589665|526579374|FG006|Maintenance Period|Lost to Follow-up|0|||
146018408|NCT02589665|526579375|FG007|Maintenance Period|Lost to Follow-up|0|||
146018409|NCT02589665|526579376|FG008|Maintenance Period|Lost to Follow-up|0|||
146018410|NCT02589665|526579377|FG009|Maintenance Period|Lost to Follow-up|0|||
146018411|NCT02589665|526579368|FG000|Maintenance Period|Physician Decision|0|||
146018412|NCT02589665|526579369|FG001|Maintenance Period|Physician Decision|0|||
146018413|NCT02589665|526579370|FG002|Maintenance Period|Physician Decision|0|||
146018414|NCT02589665|526579371|FG003|Maintenance Period|Physician Decision|0|||
146018415|NCT02589665|526579372|FG004|Maintenance Period|Physician Decision|0|||
146018416|NCT02589665|526579373|FG005|Maintenance Period|Physician Decision|1|||
146018417|NCT02589665|526579374|FG006|Maintenance Period|Physician Decision|0|||
146018418|NCT02589665|526579375|FG007|Maintenance Period|Physician Decision|0|||
146018419|NCT02589665|526579376|FG008|Maintenance Period|Physician Decision|0|||
146018420|NCT02589665|526579377|FG009|Maintenance Period|Physician Decision|0|||
146018421|NCT02589665|526579368|FG000|Maintenance Period|Reason Not Collected|0|||
146018422|NCT02589665|526579369|FG001|Maintenance Period|Reason Not Collected|0|||
146018423|NCT02589665|526579370|FG002|Maintenance Period|Reason Not Collected|0|||
146018424|NCT02589665|526579371|FG003|Maintenance Period|Reason Not Collected|0|||
146018425|NCT02589665|526579372|FG004|Maintenance Period|Reason Not Collected|0|||
146018426|NCT02589665|526579373|FG005|Maintenance Period|Reason Not Collected|1|||
146018427|NCT02589665|526579374|FG006|Maintenance Period|Reason Not Collected|1|||
146018428|NCT02589665|526579375|FG007|Maintenance Period|Reason Not Collected|0|||
146018429|NCT02589665|526579376|FG008|Maintenance Period|Reason Not Collected|0|||
146018430|NCT02589665|526579377|FG009|Maintenance Period|Reason Not Collected|0|||
146018431|NCT02589665|526579368|FG000|Induction Extension Period|Adverse Event|0|||
146018432|NCT02589665|526579369|FG001|Induction Extension Period|Adverse Event|0|||
146018433|NCT02589665|526579370|FG002|Induction Extension Period|Adverse Event|0|||
146018434|NCT02589665|526579371|FG003|Induction Extension Period|Adverse Event|0|||
146018435|NCT02589665|526579372|FG004|Induction Extension Period|Adverse Event|0|||
146018436|NCT02589665|526579373|FG005|Induction Extension Period|Adverse Event|0|||
146018437|NCT02589665|526579374|FG006|Induction Extension Period|Adverse Event|0|||
146018438|NCT02589665|526579375|FG007|Induction Extension Period|Adverse Event|0|||
146018439|NCT02589665|526579376|FG008|Induction Extension Period|Adverse Event|4|||
146018440|NCT02589665|526579377|FG009|Induction Extension Period|Adverse Event|0|||
146018441|NCT02589665|526579368|FG000|Induction Extension Period|Lack of Efficacy|0|||
146018442|NCT02589665|526579369|FG001|Induction Extension Period|Lack of Efficacy|0|||
146018443|NCT02589665|526579370|FG002|Induction Extension Period|Lack of Efficacy|0|||
146018444|NCT02589665|526579371|FG003|Induction Extension Period|Lack of Efficacy|0|||
146018445|NCT02589665|526579372|FG004|Induction Extension Period|Lack of Efficacy|0|||
146018446|NCT02589665|526579373|FG005|Induction Extension Period|Lack of Efficacy|0|||
146018447|NCT02589665|526579374|FG006|Induction Extension Period|Lack of Efficacy|0|||
146018448|NCT02589665|526579375|FG007|Induction Extension Period|Lack of Efficacy|0|||
146093994|NCT00171054|526865014|FG001|Overall Study|Adverse Event|8|||
146093995|NCT00171054|526865013|FG000|Overall Study|Condition no longer required study drug|0|||
146018449|NCT02589665|526579376|FG008|Induction Extension Period|Lack of Efficacy|3|||
146018450|NCT02589665|526579377|FG009|Induction Extension Period|Lack of Efficacy|0|||
146018451|NCT02589665|526579368|FG000|Induction Extension Period|Withdrawal by Subject|0|||
146018452|NCT02589665|526579369|FG001|Induction Extension Period|Withdrawal by Subject|0|||
146018453|NCT02589665|526579370|FG002|Induction Extension Period|Withdrawal by Subject|0|||
146093996|NCT00171054|526865014|FG001|Overall Study|Condition no longer required study drug|1|||
146093997|NCT01074047|526865021|FG000|Treatment Phase|Adverse Event|89|||
146093998|NCT01074047|526865022|FG001|Treatment Phase|Adverse Event|66|||
146093999|NCT01074047|526865021|FG000|Treatment Phase|Disease Progression|16|||
146094000|NCT01074047|526865022|FG001|Treatment Phase|Disease Progression|21|||
146094001|NCT01074047|526865021|FG000|Treatment Phase|Withdrawal by Subject|27|||
146094002|NCT01074047|526865022|FG001|Treatment Phase|Withdrawal by Subject|48|||
146094003|NCT01074047|526865021|FG000|Treatment Phase|Death|53|||
146094004|NCT01074047|526865022|FG001|Treatment Phase|Death|58|||
146094005|NCT01074047|526865021|FG000|Treatment Phase|Lost to Follow-up|0|||
146094006|NCT01074047|526865022|FG001|Treatment Phase|Lost to Follow-up|1|||
146094007|NCT01074047|526865021|FG000|Treatment Phase|Protocol Violation|0|||
146094008|NCT01074047|526865022|FG001|Treatment Phase|Protocol Violation|1|||
146094009|NCT01074047|526865021|FG000|Treatment Phase|Miscellaneous|32|||
146094010|NCT01074047|526865022|FG001|Treatment Phase|Miscellaneous|39|||
146094011|NCT01074047|526865021|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
146094012|NCT01074047|526865022|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
146094013|NCT01074047|526865021|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
146094014|NCT01074047|526865022|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
146094015|NCT01074047|526865021|FG000|Survival Follow-Up Phase|Death|116|||
146094016|NCT01074047|526865022|FG001|Survival Follow-Up Phase|Death|124|||
146094017|NCT01074047|526865021|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
146094018|NCT01074047|526865022|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
146094019|NCT01074047|526865021|FG000|Extension Phase|Physician Decision|1|||
146094020|NCT01074047|526865022|FG001|Extension Phase|Physician Decision|0|||
146094021|NCT01074047|526865021|FG000|Extension Phase|Adverse Event|5|||
146094022|NCT01074047|526865022|FG001|Extension Phase|Adverse Event|0|||
146094023|NCT01074047|526865021|FG000|Extension Phase|Disease Progression|9|||
146094024|NCT01074047|526865022|FG001|Extension Phase|Disease Progression|0|||
146094025|NCT01074047|526865021|FG000|Extension Phase|Withdrawal by Subject|2|||
146094026|NCT01074047|526865022|FG001|Extension Phase|Withdrawal by Subject|0|||
146094027|NCT01074047|526865021|FG000|Extension Phase|Death|5|||
146094028|NCT01074047|526865022|FG001|Extension Phase|Death|0|||
146094029|NCT05108922|526866502|FG000|Overall Study|Adverse Event|2|||
146094030|NCT05108922|526866503|FG001|Overall Study|Adverse Event|3|||
146094031|NCT05108922|526866502|FG000|Overall Study|Lost to Follow-up|2|||
146094032|NCT05108922|526866503|FG001|Overall Study|Lost to Follow-up|1|||
146094033|NCT05108922|526866502|FG000|Overall Study|Inadvertent enrollment|0|||
146094034|NCT05108922|526866503|FG001|Overall Study|Inadvertent enrollment|1|||
146094035|NCT05108922|526866502|FG000|Overall Study|Physician Decision|2|||
146094036|NCT05108922|526866503|FG001|Overall Study|Physician Decision|3|||
146094037|NCT05108922|526866502|FG000|Overall Study|Protocol deviation|1|||
146094038|NCT05108922|526866503|FG001|Overall Study|Protocol deviation|0|||
146094039|NCT05108922|526866502|FG000|Overall Study|Screen failure|1|||
146094040|NCT05108922|526866503|FG001|Overall Study|Screen failure|0|||
146094041|NCT05108922|526866502|FG000|Overall Study|Withdrawal by Subject|11|||
146094042|NCT05108922|526866503|FG001|Overall Study|Withdrawal by Subject|8|||
146094043|NCT00810108|526866508|FG000|Overall Study|Withdrawal by Subject|1|||
146094044|NCT00810108|526866509|FG001|Overall Study|Withdrawal by Subject|0|||
146094045|NCT00761579|526866524|FG000|Overall Study|Adverse Event|10|||
146094046|NCT00761579|526866524|FG000|Overall Study|Death|2|||
146094047|NCT00761579|526866524|FG000|Overall Study|Lack of Efficacy|21|||
146094048|NCT00761579|526866524|FG000|Overall Study|Lost to Follow-up|16|||
146094049|NCT00761579|526866524|FG000|Overall Study|Pregnancy|1|||
146094050|NCT00761579|526866524|FG000|Overall Study|Withdrawal by Subject|34|||
146094051|NCT00761579|526866524|FG000|Overall Study|Lack of compliance|2|||
146094052|NCT00761579|526866524|FG000|Overall Study|Protocol deviation|1|||
146094053|NCT00761579|526866524|FG000|Overall Study|Drug overdose|1|||
146094054|NCT00761579|526866524|FG000|Overall Study|Aggravation of depression|1|||
146251319|NCT00658632|527431659|FG001|Overall Study|Adverse Event|11|||
146251320|NCT00658632|527431658|FG000|Overall Study|Lost to Follow-up|25|||
146251321|NCT00658632|527431659|FG001|Overall Study|Lost to Follow-up|23|||
146251322|NCT00658632|527431658|FG000|Overall Study|Withdrawal by Subject|10|||
146251323|NCT00658632|527431659|FG001|Overall Study|Withdrawal by Subject|7|||
146094055|NCT00761579|526866524|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
146094056|NCT00761579|526866524|FG000|Overall Study|Lost survey form|1|||
146094057|NCT00761579|526866524|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
146094058|NCT00950911|526866525|FG000|Overall Study|Adverse Event|0|||
146094059|NCT00950911|526866526|FG001|Overall Study|Adverse Event|2|||
146094060|NCT00950911|526866525|FG000|Overall Study|Death|4|||
146094061|NCT00950911|526866526|FG001|Overall Study|Death|6|||
146251324|NCT00658632|527431658|FG000|Overall Study|Lack of Efficacy|0|||
146251325|NCT00658632|527431659|FG001|Overall Study|Lack of Efficacy|1|||
146251326|NCT00658632|527431658|FG000|Overall Study|Withdrawal of consent|8|||
146094062|NCT00950911|526866525|FG000|Overall Study|Disease progression|2|||
146094063|NCT00950911|526866526|FG001|Overall Study|Disease progression|2|||
146094064|NCT00950911|526866525|FG000|Overall Study|Consent withdrawn|1|||
146094065|NCT00950911|526866526|FG001|Overall Study|Consent withdrawn|3|||
146094066|NCT00950911|526866525|FG000|Overall Study|Administrative decision|3|||
146300057|NCT01109173|527613704|FG001|Overall Study|Protocol Violation|5|||
146018454|NCT02589665|526579371|FG003|Induction Extension Period|Withdrawal by Subject|0|||
146018455|NCT02589665|526579372|FG004|Induction Extension Period|Withdrawal by Subject|0|||
146018456|NCT02589665|526579373|FG005|Induction Extension Period|Withdrawal by Subject|0|||
146018457|NCT02589665|526579374|FG006|Induction Extension Period|Withdrawal by Subject|0|||
146018458|NCT02589665|526579375|FG007|Induction Extension Period|Withdrawal by Subject|2|||
146018459|NCT02589665|526579376|FG008|Induction Extension Period|Withdrawal by Subject|3|||
146018460|NCT02589665|526579377|FG009|Induction Extension Period|Withdrawal by Subject|0|||
146018461|NCT02589665|526579368|FG000|Induction Extension Period|Physician Decision|0|||
146018462|NCT02589665|526579369|FG001|Induction Extension Period|Physician Decision|0|||
146018463|NCT02589665|526579370|FG002|Induction Extension Period|Physician Decision|0|||
146018464|NCT02589665|526579371|FG003|Induction Extension Period|Physician Decision|0|||
146018465|NCT02589665|526579372|FG004|Induction Extension Period|Physician Decision|0|||
146018466|NCT02589665|526579373|FG005|Induction Extension Period|Physician Decision|0|||
146018467|NCT02589665|526579374|FG006|Induction Extension Period|Physician Decision|0|||
146300058|NCT01109173|527613705|FG002|Overall Study|Protocol Violation|1|||
146300059|NCT01109173|527613706|FG003|Overall Study|Protocol Violation|2|||
146300060|NCT01109173|527613703|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
146300061|NCT01109173|527613704|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
146300062|NCT01109173|527613705|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
146300063|NCT01109173|527613706|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
146300064|NCT01109173|527613703|FG000|Overall Study|Not Specifiied|5|||
146300065|NCT01109173|527613704|FG001|Overall Study|Not Specifiied|4|||
146300066|NCT01109173|527613705|FG002|Overall Study|Not Specifiied|9|||
146300067|NCT01109173|527613706|FG003|Overall Study|Not Specifiied|14|||
146300068|NCT01132612|527613707|FG000|Overall Study|Death|0|||
146300069|NCT01132612|527613708|FG001|Overall Study|Death|0|||
146300070|NCT01132612|527613709|FG002|Overall Study|Death|1|||
146300071|NCT01132612|527613707|FG000|Overall Study|Protocol deviation|0|||
146300072|NCT01132612|527613708|FG001|Overall Study|Protocol deviation|0|||
146300073|NCT01132612|527613709|FG002|Overall Study|Protocol deviation|3|||
146300074|NCT01132612|527613707|FG000|Overall Study|Lost to Follow-up|2|||
146300075|NCT01132612|527613708|FG001|Overall Study|Lost to Follow-up|2|||
146300076|NCT01132612|527613709|FG002|Overall Study|Lost to Follow-up|7|||
146018468|NCT02589665|526579375|FG007|Induction Extension Period|Physician Decision|0|||
146018469|NCT02589665|526579376|FG008|Induction Extension Period|Physician Decision|1|||
146018470|NCT02589665|526579377|FG009|Induction Extension Period|Physician Decision|0|||
146018471|NCT02589665|526579368|FG000|Induction Extension Period|Reason Not Collected|0|||
146018472|NCT02589665|526579369|FG001|Induction Extension Period|Reason Not Collected|0|||
146018473|NCT02589665|526579370|FG002|Induction Extension Period|Reason Not Collected|0|||
146018474|NCT02589665|526579371|FG003|Induction Extension Period|Reason Not Collected|0|||
146018475|NCT02589665|526579372|FG004|Induction Extension Period|Reason Not Collected|0|||
146018476|NCT02589665|526579373|FG005|Induction Extension Period|Reason Not Collected|0|||
146018477|NCT02589665|526579374|FG006|Induction Extension Period|Reason Not Collected|0|||
146018478|NCT02589665|526579375|FG007|Induction Extension Period|Reason Not Collected|0|||
146018479|NCT02589665|526579376|FG008|Induction Extension Period|Reason Not Collected|1|||
146018480|NCT02589665|526579377|FG009|Induction Extension Period|Reason Not Collected|0|||
146018481|NCT02589665|526579368|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018482|NCT02589665|526579369|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018483|NCT02589665|526579370|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018484|NCT02589665|526579371|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018485|NCT02589665|526579372|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018486|NCT02589665|526579373|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018487|NCT02589665|526579374|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018488|NCT02589665|526579375|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018489|NCT02589665|526579376|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
146018490|NCT02589665|526579377|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
146018491|NCT02589665|526579368|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
146018492|NCT02589665|526579369|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
146018493|NCT02589665|526579370|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
146018494|NCT02589665|526579371|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
146018495|NCT02589665|526579372|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
146300077|NCT01132612|527613707|FG000|Overall Study|Adverse Event|5|||
146300078|NCT01132612|527613708|FG001|Overall Study|Adverse Event|2|||
146300079|NCT01132612|527613709|FG002|Overall Study|Adverse Event|15|||
146300080|NCT01132612|527613707|FG000|Overall Study|Withdrawal by Subject|5|||
146018496|NCT02589665|526579373|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
146300081|NCT01132612|527613708|FG001|Overall Study|Withdrawal by Subject|8|||
146300082|NCT01132612|527613709|FG002|Overall Study|Withdrawal by Subject|19|||
146300083|NCT01132612|527613707|FG000|Overall Study|Administrative problems|5|||
146251327|NCT00658632|527431659|FG001|Overall Study|Withdrawal of consent|14|||
146251328|NCT00658632|527431658|FG000|Overall Study|Pregnancy|1|||
146251329|NCT00658632|527431659|FG001|Overall Study|Pregnancy|1|||
146251330|NCT00658632|527431658|FG000|Overall Study|Other|7|||
146251331|NCT00658632|527431659|FG001|Overall Study|Other|8|||
146251332|NCT02632045|527431663|FG000|Overall Study|Withdrawal by Subject|1|||
146018497|NCT02589665|526579374|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
146018498|NCT02589665|526579375|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
146018499|NCT02589665|526579376|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
146018500|NCT02589665|526579377|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
146018501|NCT02589665|526579368|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
146018502|NCT02589665|526579369|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
146018503|NCT02589665|526579370|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
146018504|NCT02589665|526579371|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
146018505|NCT02589665|526579372|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
146018506|NCT02589665|526579373|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
146018507|NCT02589665|526579374|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
146018508|NCT02589665|526579375|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
146018509|NCT02589665|526579376|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
146018510|NCT02589665|526579377|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
146018511|NCT02589665|526579368|FG000|Maintenance Extension Period|Adverse Event|0|||
146018512|NCT02589665|526579369|FG001|Maintenance Extension Period|Adverse Event|0|||
146018513|NCT02589665|526579370|FG002|Maintenance Extension Period|Adverse Event|0|||
146018514|NCT02589665|526579371|FG003|Maintenance Extension Period|Adverse Event|0|||
146018515|NCT02589665|526579372|FG004|Maintenance Extension Period|Adverse Event|0|||
146018516|NCT02589665|526579373|FG005|Maintenance Extension Period|Adverse Event|0|||
146018517|NCT02589665|526579374|FG006|Maintenance Extension Period|Adverse Event|0|||
146018518|NCT02589665|526579375|FG007|Maintenance Extension Period|Adverse Event|0|||
146018519|NCT02589665|526579376|FG008|Maintenance Extension Period|Adverse Event|0|||
146018520|NCT02589665|526579377|FG009|Maintenance Extension Period|Adverse Event|2|||
146018521|NCT02589665|526579368|FG000|Maintenance Extension Period|Non-responder|0|||
146018522|NCT02589665|526579369|FG001|Maintenance Extension Period|Non-responder|0|||
146018523|NCT02589665|526579370|FG002|Maintenance Extension Period|Non-responder|0|||
146018524|NCT02589665|526579371|FG003|Maintenance Extension Period|Non-responder|0|||
146018525|NCT02589665|526579372|FG004|Maintenance Extension Period|Non-responder|0|||
146018526|NCT02589665|526579373|FG005|Maintenance Extension Period|Non-responder|0|||
146018527|NCT02589665|526579374|FG006|Maintenance Extension Period|Non-responder|0|||
146018528|NCT02589665|526579375|FG007|Maintenance Extension Period|Non-responder|0|||
146018529|NCT02589665|526579376|FG008|Maintenance Extension Period|Non-responder|0|||
146018530|NCT02589665|526579377|FG009|Maintenance Extension Period|Non-responder|1|||
146018531|NCT00176488|526579380|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
146018532|NCT00327015|526579381|FG000|Overall Study|Lack of Efficacy|18|||
146018533|NCT00327015|526579382|FG001|Overall Study|Lack of Efficacy|18|||
146018534|NCT00327015|526579383|FG002|Overall Study|Lack of Efficacy|35|||
146018535|NCT00327015|526579384|FG003|Overall Study|Lack of Efficacy|29|||
146018536|NCT00327015|526579381|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
146018537|NCT00327015|526579382|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
146018538|NCT00327015|526579383|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
146018539|NCT00327015|526579384|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
146018540|NCT00327015|526579381|FG000|Overall Study|Lost to Follow-up|22|||
146018541|NCT00327015|526579382|FG001|Overall Study|Lost to Follow-up|23|||
146018542|NCT00327015|526579383|FG002|Overall Study|Lost to Follow-up|29|||
146018543|NCT00327015|526579384|FG003|Overall Study|Lost to Follow-up|22|||
146018544|NCT00327015|526579381|FG000|Overall Study|Adverse Event|14|||
146018545|NCT00327015|526579382|FG001|Overall Study|Adverse Event|10|||
146018546|NCT00327015|526579383|FG002|Overall Study|Adverse Event|14|||
146018547|NCT00327015|526579384|FG003|Overall Study|Adverse Event|14|||
146018548|NCT00327015|526579381|FG000|Overall Study|Subject no longer meets study criteria|4|||
146018549|NCT00327015|526579382|FG001|Overall Study|Subject no longer meets study criteria|2|||
146018550|NCT00327015|526579383|FG002|Overall Study|Subject no longer meets study criteria|8|||
146018551|NCT00327015|526579384|FG003|Overall Study|Subject no longer meets study criteria|7|||
146018552|NCT00327015|526579381|FG000|Overall Study|Poor/Noncompliance|11|||
146018553|NCT00327015|526579382|FG001|Overall Study|Poor/Noncompliance|8|||
146018554|NCT00327015|526579383|FG002|Overall Study|Poor/Noncompliance|4|||
146018555|NCT00327015|526579384|FG003|Overall Study|Poor/Noncompliance|5|||
146018556|NCT00327015|526579381|FG000|Overall Study|Physician Decision|0|||
146018557|NCT00327015|526579382|FG001|Overall Study|Physician Decision|1|||
146018558|NCT00327015|526579383|FG002|Overall Study|Physician Decision|3|||
146018559|NCT00327015|526579384|FG003|Overall Study|Physician Decision|2|||
146018560|NCT00327015|526579381|FG000|Overall Study|Death|1|||
146018561|NCT00327015|526579382|FG001|Overall Study|Death|2|||
146251333|NCT02632045|527431664|FG001|Overall Study|Withdrawal by Subject|2|||
146251334|NCT05878522|527431665|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146300084|NCT01132612|527613708|FG001|Overall Study|Administrative problems|1|||
146300085|NCT01132612|527613709|FG002|Overall Study|Administrative problems|52|||
146300086|NCT01132612|527613707|FG000|Overall Study|Lack of Efficacy|23|||
146300087|NCT01132612|527613708|FG001|Overall Study|Lack of Efficacy|22|||
146300088|NCT01132612|527613709|FG002|Overall Study|Lack of Efficacy|73|||
146300089|NCT02252536|527613713|FG000|Overall Study|Lost to Follow-up|5|||
146300090|NCT02252536|527613714|FG001|Overall Study|Lost to Follow-up|3|||
146300091|NCT00006392|527613720|FG000|Overall Study|Ineligible|11|||
146300092|NCT00006392|527613721|FG001|Overall Study|Ineligible|3|||
146300093|NCT00006392|527613722|FG002|Overall Study|Ineligible|5|||
146300094|NCT00006392|527613723|FG003|Overall Study|Ineligible|5|||
146300095|NCT00006392|527613720|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
146300096|NCT00006392|527613721|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146300097|NCT00006392|527613722|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146300098|NCT00006392|527613723|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
146300099|NCT01186796|527613724|FG000|Overall Study|Adverse Event|3|||
146300100|NCT01186796|527613725|FG001|Overall Study|Adverse Event|0|||
146300101|NCT01186796|527613724|FG000|Overall Study|Withdrawal by Subject|1|||
146300102|NCT01186796|527613725|FG001|Overall Study|Withdrawal by Subject|1|||
146300103|NCT01186796|527613724|FG000|Overall Study|Protocol Violation|0|||
146300104|NCT01186796|527613725|FG001|Overall Study|Protocol Violation|1|||
146300105|NCT03838198|527613726|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146300106|NCT03838198|527613727|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146300107|NCT03838198|527613728|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
146300108|NCT03838198|527613729|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
146300109|NCT03838198|527613726|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
146300110|NCT03838198|527613727|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
146018562|NCT00327015|526579383|FG002|Overall Study|Death|2|||
146018563|NCT00327015|526579384|FG003|Overall Study|Death|3|||
146251335|NCT05878522|527431666|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251336|NCT05878522|527431667|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251337|NCT05878522|527431668|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251338|NCT05878522|527431669|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251339|NCT05878522|527431670|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251340|NCT05878522|527431671|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251341|NCT05878522|527431672|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251342|NCT05878522|527431673|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
146251343|NCT05878522|527431674|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251344|NCT05878522|527431675|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251345|NCT05878522|527431676|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
146251346|NCT05878522|527431665|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
146251347|NCT05878522|527431666|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251348|NCT05878522|527431667|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251349|NCT05878522|527431668|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251350|NCT05878522|527431669|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251351|NCT05878522|527431670|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251352|NCT05878522|527431671|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251353|NCT05878522|527431672|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251354|NCT05878522|527431673|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251355|NCT05878522|527431674|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
146251356|NCT05878522|527431675|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251357|NCT05878522|527431676|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
146251358|NCT05878522|527431665|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251359|NCT05878522|527431666|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
146251360|NCT05878522|527431667|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251361|NCT05878522|527431668|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
146251362|NCT05878522|527431669|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146300111|NCT03838198|527613728|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
146018564|NCT00327015|526579381|FG000|Overall Study|Pregnancy|0|||
146018565|NCT00327015|526579382|FG001|Overall Study|Pregnancy|2|||
146018566|NCT00327015|526579383|FG002|Overall Study|Pregnancy|1|||
146018567|NCT00327015|526579384|FG003|Overall Study|Pregnancy|1|||
146018568|NCT00327015|526579381|FG000|Overall Study|Administrative Reason by Sponsor|1|||
146018569|NCT00327015|526579382|FG001|Overall Study|Administrative Reason by Sponsor|2|||
146018570|NCT00327015|526579383|FG002|Overall Study|Administrative Reason by Sponsor|2|||
146251363|NCT05878522|527431670|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251364|NCT05878522|527431671|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251365|NCT05878522|527431672|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251366|NCT05878522|527431673|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146018571|NCT00327015|526579384|FG003|Overall Study|Administrative Reason by Sponsor|1|||
146018572|NCT02650804|526579385|FG000|Overall Study|Adverse Event|3|||
146018573|NCT02650804|526579386|FG001|Overall Study|Adverse Event|2|||
146018574|NCT02650804|526579385|FG000|Overall Study|Death|1|||
146018575|NCT02650804|526579386|FG001|Overall Study|Death|2|||
146018576|NCT02650804|526579385|FG000|Overall Study|Progressive Disease|7|||
146018577|NCT02650804|526579386|FG001|Overall Study|Progressive Disease|10|||
146018578|NCT02650804|526579385|FG000|Overall Study|Physician Decision|0|||
146018579|NCT02650804|526579386|FG001|Overall Study|Physician Decision|2|||
146018580|NCT02650804|526579385|FG000|Overall Study|Withdrawal by Subject|1|||
146018581|NCT02650804|526579386|FG001|Overall Study|Withdrawal by Subject|4|||
146018582|NCT02650804|526579385|FG000|Overall Study|Symptomatic deterioration|5|||
146018583|NCT02650804|526579386|FG001|Overall Study|Symptomatic deterioration|7|||
146018584|NCT02650804|526579385|FG000|Overall Study|Protocol Violation|0|||
146018585|NCT02650804|526579386|FG001|Overall Study|Protocol Violation|1|||
146018586|NCT01159171|526579387|FG000|Overall Study|Adverse Event|11|||
146018587|NCT01159171|526579387|FG000|Overall Study|Progression of Disease|28|||
146018588|NCT01159171|526579387|FG000|Overall Study|Protocol Violation|1|||
146018589|NCT01159171|526579387|FG000|Overall Study|Need for Surgery|5|||
146018590|NCT01159171|526579387|FG000|Overall Study|Medical Decision|4|||
146018591|NCT01159171|526579387|FG000|Overall Study|Death|1|||
146018592|NCT01892436|526579390|FG000|Overall Study|Withdrawal by Subject|8|||
146018593|NCT01892436|526579391|FG001|Overall Study|Withdrawal by Subject|15|||
146018594|NCT01892436|526579392|FG002|Overall Study|Withdrawal by Subject|4|||
146018595|NCT01892436|526579393|FG003|Overall Study|Withdrawal by Subject|4|||
146018596|NCT01892436|526579390|FG000|Overall Study|Death|1|||
146018597|NCT01892436|526579391|FG001|Overall Study|Death|1|||
146018598|NCT01892436|526579392|FG002|Overall Study|Death|0|||
146018599|NCT01892436|526579393|FG003|Overall Study|Death|0|||
146018600|NCT01892436|526579390|FG000|Overall Study|Physician Decision|2|||
146018601|NCT01892436|526579391|FG001|Overall Study|Physician Decision|1|||
146018602|NCT01892436|526579392|FG002|Overall Study|Physician Decision|0|||
146018603|NCT01892436|526579393|FG003|Overall Study|Physician Decision|1|||
146018604|NCT01892436|526579390|FG000|Overall Study|Pregnancy|0|||
146018605|NCT01892436|526579391|FG001|Overall Study|Pregnancy|2|||
146018606|NCT01892436|526579392|FG002|Overall Study|Pregnancy|1|||
146018607|NCT01892436|526579393|FG003|Overall Study|Pregnancy|0|||
146018608|NCT01892436|526579390|FG000|Overall Study|Technical problems|2|||
146018609|NCT01892436|526579391|FG001|Overall Study|Technical problems|1|||
146018610|NCT01892436|526579392|FG002|Overall Study|Technical problems|1|||
146018611|NCT01892436|526579393|FG003|Overall Study|Technical problems|1|||
146018612|NCT01892436|526579390|FG000|Overall Study|Lack of Efficacy|1|||
146018613|NCT01892436|526579391|FG001|Overall Study|Lack of Efficacy|2|||
146018614|NCT01892436|526579392|FG002|Overall Study|Lack of Efficacy|2|||
146018615|NCT01892436|526579393|FG003|Overall Study|Lack of Efficacy|2|||
146018616|NCT01892436|526579390|FG000|Overall Study|Lost to Follow-up|1|||
146018617|NCT01892436|526579391|FG001|Overall Study|Lost to Follow-up|1|||
146018618|NCT01892436|526579392|FG002|Overall Study|Lost to Follow-up|1|||
146018619|NCT01892436|526579393|FG003|Overall Study|Lost to Follow-up|3|||
146018620|NCT01892436|526579390|FG000|Overall Study|non-compliance with treatment|1|||
146018621|NCT01892436|526579391|FG001|Overall Study|non-compliance with treatment|0|||
146018622|NCT01892436|526579392|FG002|Overall Study|non-compliance with treatment|0|||
146018623|NCT01892436|526579393|FG003|Overall Study|non-compliance with treatment|0|||
146018624|NCT01892436|526579390|FG000|Overall Study|Adverse Event|7|||
146018625|NCT01892436|526579391|FG001|Overall Study|Adverse Event|6|||
146018626|NCT01892436|526579392|FG002|Overall Study|Adverse Event|2|||
146018627|NCT01892436|526579393|FG003|Overall Study|Adverse Event|3|||
146018628|NCT00837265|526579397|FG000|Pilot Phase|Withdrawal by Subject|0|||
146018629|NCT00837265|526579398|FG001|Pilot Phase|Withdrawal by Subject|2|||
146018630|NCT00837265|526579399|FG002|Pilot Phase|Withdrawal by Subject|3|||
146018631|NCT00837265|526579400|FG003|Pilot Phase|Withdrawal by Subject|2|||
146018632|NCT00837265|526579401|FG004|Pilot Phase|Withdrawal by Subject|0|||
146018633|NCT00837265|526579402|FG005|Pilot Phase|Withdrawal by Subject|0|||
146018634|NCT00837265|526579403|FG006|Pilot Phase|Withdrawal by Subject|0|||
146018635|NCT00837265|526579397|FG000|Pilot Phase|Decision of the investigator|2|||
146018636|NCT00837265|526579398|FG001|Pilot Phase|Decision of the investigator|1|||
146018637|NCT00837265|526579399|FG002|Pilot Phase|Decision of the investigator|0|||
146018638|NCT00837265|526579400|FG003|Pilot Phase|Decision of the investigator|0|||
146018639|NCT00837265|526579401|FG004|Pilot Phase|Decision of the investigator|0|||
146018640|NCT00837265|526579402|FG005|Pilot Phase|Decision of the investigator|0|||
146018641|NCT00837265|526579403|FG006|Pilot Phase|Decision of the investigator|0|||
146018642|NCT00837265|526579397|FG000|Pilot Phase|Adverse Event|1|||
146018643|NCT00837265|526579398|FG001|Pilot Phase|Adverse Event|0|||
146018644|NCT00837265|526579399|FG002|Pilot Phase|Adverse Event|0|||
146018645|NCT00837265|526579400|FG003|Pilot Phase|Adverse Event|0|||
146018646|NCT00837265|526579401|FG004|Pilot Phase|Adverse Event|0|||
146018647|NCT00837265|526579402|FG005|Pilot Phase|Adverse Event|0|||
146018648|NCT00837265|526579403|FG006|Pilot Phase|Adverse Event|0|||
146018649|NCT00837265|526579397|FG000|Pilot Phase|Disease progression|0|||
146018650|NCT00837265|526579398|FG001|Pilot Phase|Disease progression|0|||
146018651|NCT00837265|526579399|FG002|Pilot Phase|Disease progression|0|||
146018652|NCT00837265|526579400|FG003|Pilot Phase|Disease progression|1|||
146018653|NCT00837265|526579401|FG004|Pilot Phase|Disease progression|0|||
146018654|NCT00837265|526579402|FG005|Pilot Phase|Disease progression|0|||
146018655|NCT00837265|526579403|FG006|Pilot Phase|Disease progression|0|||
146018656|NCT00837265|526579397|FG000|Pilot Phase|Participant left the city|0|||
146018657|NCT00837265|526579398|FG001|Pilot Phase|Participant left the city|0|||
146018658|NCT00837265|526579399|FG002|Pilot Phase|Participant left the city|0|||
146018659|NCT00837265|526579400|FG003|Pilot Phase|Participant left the city|1|||
146018660|NCT00837265|526579401|FG004|Pilot Phase|Participant left the city|0|||
146018661|NCT00837265|526579402|FG005|Pilot Phase|Participant left the city|0|||
146018662|NCT00837265|526579403|FG006|Pilot Phase|Participant left the city|0|||
146018663|NCT00837265|526579397|FG000|Main Phase|Withdrawal by Subject|0|||
146018664|NCT00837265|526579398|FG001|Main Phase|Withdrawal by Subject|0|||
146018665|NCT00837265|526579399|FG002|Main Phase|Withdrawal by Subject|0|||
146018666|NCT00837265|526579400|FG003|Main Phase|Withdrawal by Subject|0|||
146018667|NCT00837265|526579401|FG004|Main Phase|Withdrawal by Subject|4|||
146018668|NCT00837265|526579402|FG005|Main Phase|Withdrawal by Subject|2|||
146018669|NCT00837265|526579403|FG006|Main Phase|Withdrawal by Subject|1|||
146018670|NCT00837265|526579397|FG000|Main Phase|Decision of the investigator|0|||
146018671|NCT00837265|526579398|FG001|Main Phase|Decision of the investigator|0|||
146018672|NCT00837265|526579399|FG002|Main Phase|Decision of the investigator|0|||
146018673|NCT00837265|526579400|FG003|Main Phase|Decision of the investigator|0|||
146018674|NCT00837265|526579401|FG004|Main Phase|Decision of the investigator|0|||
146018675|NCT00837265|526579402|FG005|Main Phase|Decision of the investigator|2|||
146018676|NCT00837265|526579403|FG006|Main Phase|Decision of the investigator|1|||
146018677|NCT00837265|526579397|FG000|Main Phase|Adverse Event|0|||
146018678|NCT00837265|526579398|FG001|Main Phase|Adverse Event|0|||
146018679|NCT00837265|526579399|FG002|Main Phase|Adverse Event|0|||
146018680|NCT00837265|526579400|FG003|Main Phase|Adverse Event|0|||
146018681|NCT00837265|526579401|FG004|Main Phase|Adverse Event|0|||
146018682|NCT00837265|526579402|FG005|Main Phase|Adverse Event|1|||
146018683|NCT00837265|526579403|FG006|Main Phase|Adverse Event|0|||
146018684|NCT00837265|526579397|FG000|Main Phase|Death|0|||
146018685|NCT00837265|526579398|FG001|Main Phase|Death|0|||
146018686|NCT00837265|526579399|FG002|Main Phase|Death|0|||
146018687|NCT00837265|526579400|FG003|Main Phase|Death|0|||
146018688|NCT00837265|526579401|FG004|Main Phase|Death|2|||
146018689|NCT00837265|526579402|FG005|Main Phase|Death|0|||
146018690|NCT00837265|526579403|FG006|Main Phase|Death|1|||
146018691|NCT00837265|526579397|FG000|Main Phase|Lost to Follow-up|0|||
146018692|NCT00837265|526579398|FG001|Main Phase|Lost to Follow-up|0|||
146018693|NCT00837265|526579399|FG002|Main Phase|Lost to Follow-up|0|||
146018694|NCT00837265|526579400|FG003|Main Phase|Lost to Follow-up|0|||
146018695|NCT00837265|526579401|FG004|Main Phase|Lost to Follow-up|1|||
146018696|NCT00837265|526579402|FG005|Main Phase|Lost to Follow-up|0|||
146018697|NCT00837265|526579403|FG006|Main Phase|Lost to Follow-up|0|||
146018698|NCT00837265|526579397|FG000|Main Phase|Principal investigator resignation|0|||
146018699|NCT00837265|526579398|FG001|Main Phase|Principal investigator resignation|0|||
146018700|NCT00837265|526579399|FG002|Main Phase|Principal investigator resignation|0|||
146018701|NCT00837265|526579400|FG003|Main Phase|Principal investigator resignation|0|||
146018702|NCT00837265|526579401|FG004|Main Phase|Principal investigator resignation|2|||
146018703|NCT00837265|526579402|FG005|Main Phase|Principal investigator resignation|0|||
146018704|NCT00837265|526579403|FG006|Main Phase|Principal investigator resignation|0|||
146018705|NCT00837265|526579397|FG000|Main Phase|Participant's personal reason|0|||
146018706|NCT00837265|526579398|FG001|Main Phase|Participant's personal reason|0|||
146018707|NCT00837265|526579399|FG002|Main Phase|Participant's personal reason|0|||
146018708|NCT00837265|526579400|FG003|Main Phase|Participant's personal reason|0|||
146018709|NCT00837265|526579401|FG004|Main Phase|Participant's personal reason|1|||
146018710|NCT00837265|526579402|FG005|Main Phase|Participant's personal reason|0|||
146018711|NCT00837265|526579403|FG006|Main Phase|Participant's personal reason|0|||
146018712|NCT02759107|526579405|FG000|Overall Study|Adverse Event|0|||
146018713|NCT02759107|526579406|FG001|Overall Study|Adverse Event|0|||
146018714|NCT02759107|526579407|FG002|Overall Study|Adverse Event|0|||
146018715|NCT02759107|526579408|FG003|Overall Study|Adverse Event|0|||
146018716|NCT02759107|526579409|FG004|Overall Study|Adverse Event|0|||
146018717|NCT02759107|526579410|FG005|Overall Study|Adverse Event|0|||
146018718|NCT02759107|526579411|FG006|Overall Study|Adverse Event|0|||
146018719|NCT02759107|526579412|FG007|Overall Study|Adverse Event|0|||
146018720|NCT02759107|526579413|FG008|Overall Study|Adverse Event|0|||
146018721|NCT02759107|526579414|FG009|Overall Study|Adverse Event|0|||
146018722|NCT02759107|526579415|FG010|Overall Study|Adverse Event|0|||
146018723|NCT02759107|526579416|FG011|Overall Study|Adverse Event|0|||
146018724|NCT02759107|526579417|FG012|Overall Study|Adverse Event|2|||
146018725|NCT02759107|526579418|FG013|Overall Study|Adverse Event|0|||
146018726|NCT02759107|526579419|FG014|Overall Study|Adverse Event|0|||
146018727|NCT02759107|526579420|FG015|Overall Study|Adverse Event|1|||
146018728|NCT02759107|526579421|FG016|Overall Study|Adverse Event|0|||
146018729|NCT02759107|526579422|FG017|Overall Study|Adverse Event|2|||
146018730|NCT02759107|526579405|FG000|Overall Study|Scheduling Conflict|0|||
146018731|NCT02759107|526579406|FG001|Overall Study|Scheduling Conflict|0|||
146018732|NCT02759107|526579407|FG002|Overall Study|Scheduling Conflict|0|||
146251367|NCT05878522|527431674|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251368|NCT05878522|527431675|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251369|NCT05878522|527431676|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
146251370|NCT05878522|527431665|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146094067|NCT00950911|526866526|FG001|Overall Study|Administrative decision|1|||
146094068|NCT00950911|526866525|FG000|Overall Study|Ineligibility determined|1|||
146094069|NCT00950911|526866526|FG001|Overall Study|Ineligibility determined|0|||
146094070|NCT00950911|526866525|FG000|Overall Study|Noncompliance|1|||
146094071|NCT00950911|526866526|FG001|Overall Study|Noncompliance|0|||
146094072|NCT00950911|526866525|FG000|Overall Study|Poor performance status|0|||
146094073|NCT00950911|526866526|FG001|Overall Study|Poor performance status|1|||
146094074|NCT02476422|526866527|FG000|Overall Study|Subject/guardian decision|0|||
146094075|NCT02476422|526866528|FG001|Overall Study|Subject/guardian decision|1|||
146094076|NCT01859143|526866529|FG000|Overall Study|Lost to Follow-up|2|||
146094077|NCT01859143|526866530|FG001|Overall Study|Lost to Follow-up|0|||
146251371|NCT05878522|527431666|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251372|NCT05878522|527431667|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146018733|NCT02759107|526579408|FG003|Overall Study|Scheduling Conflict|0|||
146018734|NCT02759107|526579409|FG004|Overall Study|Scheduling Conflict|0|||
146018735|NCT02759107|526579410|FG005|Overall Study|Scheduling Conflict|0|||
146018736|NCT02759107|526579411|FG006|Overall Study|Scheduling Conflict|0|||
146018737|NCT02759107|526579412|FG007|Overall Study|Scheduling Conflict|0|||
146018738|NCT02759107|526579413|FG008|Overall Study|Scheduling Conflict|0|||
146018739|NCT02759107|526579414|FG009|Overall Study|Scheduling Conflict|1|||
146018740|NCT02759107|526579415|FG010|Overall Study|Scheduling Conflict|0|||
146018741|NCT02759107|526579416|FG011|Overall Study|Scheduling Conflict|0|||
146018742|NCT02759107|526579417|FG012|Overall Study|Scheduling Conflict|0|||
146018743|NCT02759107|526579418|FG013|Overall Study|Scheduling Conflict|0|||
146018744|NCT02759107|526579419|FG014|Overall Study|Scheduling Conflict|0|||
146018745|NCT02759107|526579420|FG015|Overall Study|Scheduling Conflict|0|||
146018746|NCT02759107|526579421|FG016|Overall Study|Scheduling Conflict|0|||
146018747|NCT02759107|526579422|FG017|Overall Study|Scheduling Conflict|0|||
146018748|NCT00420004|526579423|FG000|Overall Study|Adverse Event|4|||
146018749|NCT00420004|526579424|FG001|Overall Study|Adverse Event|1|||
146018750|NCT00420004|526579425|FG002|Overall Study|Adverse Event|1|||
146018751|NCT00420004|526579423|FG000|Overall Study|Lack of Efficacy|5|||
146018752|NCT00420004|526579424|FG001|Overall Study|Lack of Efficacy|4|||
146018753|NCT00420004|526579425|FG002|Overall Study|Lack of Efficacy|1|||
146018754|NCT00420004|526579423|FG000|Overall Study|Lost to Follow-up|31|||
146018755|NCT00420004|526579424|FG001|Overall Study|Lost to Follow-up|12|||
146018756|NCT00420004|526579425|FG002|Overall Study|Lost to Follow-up|10|||
146018757|NCT00420004|526579423|FG000|Overall Study|Entry Criteria Not Met|0|||
146018758|NCT00420004|526579424|FG001|Overall Study|Entry Criteria Not Met|1|||
146018759|NCT00420004|526579425|FG002|Overall Study|Entry Criteria Not Met|0|||
146018760|NCT00420004|526579423|FG000|Overall Study|Physician Decision|14|||
146018761|NCT00420004|526579424|FG001|Overall Study|Physician Decision|4|||
146018762|NCT00420004|526579425|FG002|Overall Study|Physician Decision|2|||
146018763|NCT00420004|526579423|FG000|Overall Study|Protocol Violation|5|||
146018764|NCT00420004|526579424|FG001|Overall Study|Protocol Violation|4|||
146018765|NCT00420004|526579425|FG002|Overall Study|Protocol Violation|3|||
146018766|NCT00420004|526579423|FG000|Overall Study|Withdrawal by Subject|67|||
146018767|NCT00420004|526579424|FG001|Overall Study|Withdrawal by Subject|42|||
146018768|NCT00420004|526579425|FG002|Overall Study|Withdrawal by Subject|14|||
146018769|NCT00420004|526579423|FG000|Overall Study|Sponsor Decision|3|||
146018770|NCT00420004|526579424|FG001|Overall Study|Sponsor Decision|3|||
146018771|NCT00420004|526579425|FG002|Overall Study|Sponsor Decision|1|||
146018772|NCT03215758|526579428|FG000|Overall Study|Technical Problems|1|||
146018773|NCT03215758|526579429|FG001|Overall Study|Technical Problems|0|||
146018774|NCT03215758|526579428|FG000|Overall Study|Protocol deviation|0|||
146018775|NCT03215758|526579429|FG001|Overall Study|Protocol deviation|1|||
146018776|NCT03215758|526579428|FG000|Overall Study|Physician Decision|0|||
146094078|NCT02413372|526866534|FG000|Treatment|Lost to Follow-up|0|||
146251373|NCT05878522|527431668|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251374|NCT05878522|527431669|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
146251375|NCT05878522|527431670|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146018777|NCT03215758|526579429|FG001|Overall Study|Physician Decision|1|||
146094079|NCT02413372|526866535|FG001|Treatment|Lost to Follow-up|2|||
146094080|NCT02413372|526866536|FG002|Treatment|Lost to Follow-up|1|||
146251376|NCT05878522|527431671|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146018778|NCT03215758|526579428|FG000|Overall Study|Death|0|||
146018779|NCT03215758|526579429|FG001|Overall Study|Death|1|||
146018780|NCT03215758|526579428|FG000|Overall Study|Adverse Event|1|||
146018781|NCT03215758|526579429|FG001|Overall Study|Adverse Event|2|||
146018782|NCT03215758|526579428|FG000|Overall Study|Subject/Guardian Decision|3|||
146018783|NCT03215758|526579429|FG001|Overall Study|Subject/Guardian Decision|3|||
146018784|NCT03931382|526579436|FG000|Overall Study|Equipment malfunction|2|||
146018785|NCT03931382|526579437|FG001|Overall Study|Equipment malfunction|0|||
146018786|NCT03931382|526579438|FG002|Overall Study|Equipment malfunction|2|||
146018787|NCT03931382|526579436|FG000|Overall Study|Withdrawal by Subject|0|||
146018788|NCT03931382|526579437|FG001|Overall Study|Withdrawal by Subject|1|||
146018789|NCT03931382|526579438|FG002|Overall Study|Withdrawal by Subject|0|||
146018790|NCT01106651|526579444|FG000|Overall Study|Adverse Event|17|||
146018791|NCT01106651|526579445|FG001|Overall Study|Adverse Event|9|||
146018792|NCT01106651|526579446|FG002|Overall Study|Adverse Event|23|||
146018793|NCT01106651|526579444|FG000|Overall Study|Lost to Follow-up|8|||
146018794|NCT01106651|526579445|FG001|Overall Study|Lost to Follow-up|2|||
146018795|NCT01106651|526579446|FG002|Overall Study|Lost to Follow-up|6|||
146018796|NCT01106651|526579444|FG000|Overall Study|Physician Decision|4|||
146018797|NCT01106651|526579445|FG001|Overall Study|Physician Decision|3|||
146018798|NCT01106651|526579446|FG002|Overall Study|Physician Decision|1|||
146018799|NCT01106651|526579444|FG000|Overall Study|Protocol Violation|1|||
146018800|NCT01106651|526579445|FG001|Overall Study|Protocol Violation|2|||
146018801|NCT01106651|526579446|FG002|Overall Study|Protocol Violation|1|||
146018802|NCT01106651|526579444|FG000|Overall Study|Withdrawal by Subject|14|||
146018803|NCT01106651|526579445|FG001|Overall Study|Withdrawal by Subject|7|||
146018804|NCT01106651|526579446|FG002|Overall Study|Withdrawal by Subject|4|||
146018805|NCT01106651|526579444|FG000|Overall Study|Noncompliance with study drug|1|||
146018806|NCT01106651|526579445|FG001|Overall Study|Noncompliance with study drug|0|||
146018807|NCT01106651|526579446|FG002|Overall Study|Noncompliance with study drug|2|||
146018808|NCT01106651|526579444|FG000|Overall Study|Other|34|||
146018809|NCT01106651|526579445|FG001|Overall Study|Other|31|||
146018810|NCT01106651|526579446|FG002|Overall Study|Other|21|||
146018811|NCT01106651|526579444|FG000|Overall Study|Death|0|||
146018812|NCT01106651|526579445|FG001|Overall Study|Death|3|||
146018813|NCT01106651|526579446|FG002|Overall Study|Death|0|||
146018814|NCT03768089|526579447|FG000|Part A|Lost to Follow-up|0|||
146018815|NCT03768089|526579448|FG001|Part A|Lost to Follow-up|0|||
146018816|NCT03768089|526579449|FG002|Part A|Lost to Follow-up|0|||
146018817|NCT03768089|526579450|FG003|Part A|Lost to Follow-up|0|||
146018818|NCT03768089|526579451|FG004|Part A|Lost to Follow-up|1|||
146018819|NCT03768089|526579452|FG005|Part A|Lost to Follow-up|0|||
146018820|NCT03768089|526579453|FG006|Part A|Lost to Follow-up|0|||
146018821|NCT03768089|526579454|FG007|Part A|Lost to Follow-up|0|||
146018822|NCT03768089|526579455|FG008|Part A|Lost to Follow-up|0|||
146018823|NCT03768089|526579456|FG009|Part A|Lost to Follow-up|0|||
146018824|NCT03768089|526579457|FG010|Part A|Lost to Follow-up|0|||
146018825|NCT03768089|526579458|FG011|Part A|Lost to Follow-up|0|||
146018826|NCT03768089|526579459|FG012|Part A|Lost to Follow-up|0|||
146018827|NCT03768089|526579460|FG013|Part A|Lost to Follow-up|0|||
146018828|NCT03768089|526579461|FG014|Part A|Lost to Follow-up|0|||
146018829|NCT03768089|526579462|FG015|Part A|Lost to Follow-up|0|||
146018830|NCT03768089|526579463|FG016|Part A|Lost to Follow-up|0|||
146018831|NCT03768089|526579464|FG017|Part A|Lost to Follow-up|0|||
146018832|NCT03768089|526579447|FG000|Part C|Randomized, Never Dosed|0|||
146018833|NCT03768089|526579448|FG001|Part C|Randomized, Never Dosed|0|||
146018834|NCT03768089|526579449|FG002|Part C|Randomized, Never Dosed|0|||
146018835|NCT03768089|526579450|FG003|Part C|Randomized, Never Dosed|0|||
146018836|NCT03768089|526579451|FG004|Part C|Randomized, Never Dosed|0|||
146018837|NCT03768089|526579452|FG005|Part C|Randomized, Never Dosed|0|||
146018838|NCT03768089|526579453|FG006|Part C|Randomized, Never Dosed|0|||
146018839|NCT03768089|526579454|FG007|Part C|Randomized, Never Dosed|0|||
146018840|NCT03768089|526579455|FG008|Part C|Randomized, Never Dosed|0|||
146018841|NCT03768089|526579456|FG009|Part C|Randomized, Never Dosed|0|||
146018842|NCT03768089|526579457|FG010|Part C|Randomized, Never Dosed|0|||
146018843|NCT03768089|526579458|FG011|Part C|Randomized, Never Dosed|0|||
146018844|NCT03768089|526579459|FG012|Part C|Randomized, Never Dosed|0|||
146018845|NCT03768089|526579460|FG013|Part C|Randomized, Never Dosed|0|||
146018846|NCT03768089|526579461|FG014|Part C|Randomized, Never Dosed|1|||
146018847|NCT03768089|526579462|FG015|Part C|Randomized, Never Dosed|0|||
146018848|NCT03768089|526579463|FG016|Part C|Randomized, Never Dosed|0|||
146018849|NCT03768089|526579464|FG017|Part C|Randomized, Never Dosed|0|||
146018850|NCT04590404|526579467|FG000|Overall Study|Death|16|||
146018851|NCT04590404|526579468|FG001|Overall Study|Death|17|||
146018852|NCT04590404|526579467|FG000|Overall Study|Withdrawal by Subject|7|||
146251377|NCT05878522|527431672|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251378|NCT05878522|527431673|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146018853|NCT04590404|526579468|FG001|Overall Study|Withdrawal by Subject|2|||
146018854|NCT04154605|526579469|FG000|Overall Study|Procedure Canceled|1|||
146018855|NCT04154605|526579470|FG001|Overall Study|Procedure Canceled|1|||
146018856|NCT04154605|526579469|FG000|Overall Study|Missed follow up|1|||
146018857|NCT04154605|526579470|FG001|Overall Study|Missed follow up|1|||
146018858|NCT04154605|526579469|FG000|Overall Study|Withdrawal by Subject|1|||
146018859|NCT04154605|526579470|FG001|Overall Study|Withdrawal by Subject|0|||
146018860|NCT00675441|526579473|FG000|Overall Study|Withdrawal by Subject|2|||
146018861|NCT00675441|526579473|FG000|Overall Study|Death|1|||
146018862|NCT04154293|526579478|FG000|Overall Study|Withdrawal by Subject|2|||
146018863|NCT04154293|526579479|FG001|Overall Study|Withdrawal by Subject|3|||
146018864|NCT04154293|526579480|FG002|Overall Study|Withdrawal by Subject|1|||
146251379|NCT05878522|527431674|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251380|NCT05878522|527431675|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251381|NCT05878522|527431676|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
146251382|NCT00617708|527431680|FG000|Overall Study|Adverse Event|0|||
146251383|NCT00617708|527431681|FG001|Overall Study|Adverse Event|6|||
146251384|NCT00617708|527431682|FG002|Overall Study|Adverse Event|9|||
146251385|NCT00617708|527431680|FG000|Overall Study|Withdrawal by Subject|1|||
146251386|NCT00617708|527431681|FG001|Overall Study|Withdrawal by Subject|1|||
146251387|NCT00617708|527431682|FG002|Overall Study|Withdrawal by Subject|7|||
146251388|NCT00617708|527431680|FG000|Overall Study|Death|0|||
146251389|NCT00617708|527431681|FG001|Overall Study|Death|6|||
146251390|NCT00617708|527431682|FG002|Overall Study|Death|5|||
146251391|NCT00617708|527431680|FG000|Overall Study|Progression/Relapse|7|||
146251392|NCT00617708|527431681|FG001|Overall Study|Progression/Relapse|40|||
146251393|NCT00617708|527431682|FG002|Overall Study|Progression/Relapse|36|||
146251394|NCT00617708|527431680|FG000|Overall Study|Not protocol specified|1|||
146251395|NCT00617708|527431681|FG001|Overall Study|Not protocol specified|4|||
146251396|NCT00617708|527431682|FG002|Overall Study|Not protocol specified|2|||
146251397|NCT00617708|527431680|FG000|Overall Study|Not eligible|1|||
146251398|NCT00617708|527431681|FG001|Overall Study|Not eligible|3|||
146251399|NCT00617708|527431682|FG002|Overall Study|Not eligible|5|||
146251400|NCT05615870|527431683|FG000|Overall Study|Lost to Follow-up|10|||
146251401|NCT05615870|527431684|FG001|Overall Study|Lost to Follow-up|13|||
146251402|NCT05615870|527431683|FG000|Overall Study|Physician Decision|2|||
146251403|NCT05615870|527431684|FG001|Overall Study|Physician Decision|0|||
146251404|NCT05615870|527431683|FG000|Overall Study|Withdrawal by Subject|0|||
146251405|NCT05615870|527431684|FG001|Overall Study|Withdrawal by Subject|2|||
146251406|NCT05615870|527431683|FG000|Overall Study|Protocol Violation|0|||
146251407|NCT05615870|527431684|FG001|Overall Study|Protocol Violation|3|||
146251408|NCT05615870|527431683|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
146251409|NCT05615870|527431684|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
146251410|NCT05615870|527431683|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
146251411|NCT05615870|527431684|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
146251412|NCT05615870|527431683|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
146251413|NCT05615870|527431684|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
146251414|NCT02993926|527431690|FG000|Enantone Treatment Phase|Adverse Event|1|||
146251415|NCT02993926|527431691|FG001|Enantone Treatment Phase|Adverse Event|0|||
146251416|NCT02993926|527431692|FG002|Enantone Treatment Phase|Adverse Event|0|||
146251417|NCT02993926|527431690|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
146251418|NCT02993926|527431691|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
146251419|NCT02993926|527431692|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
146251420|NCT02993926|527431690|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
146251421|NCT02993926|527431691|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
146251422|NCT02993926|527431692|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
146251423|NCT02993926|527431690|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
146251424|NCT02993926|527431691|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
146251425|NCT02993926|527431692|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
146251426|NCT01760876|527431693|FG000|Overall Study|Non-cardiac death (head injury)|1|||
146251427|NCT01760876|527431693|FG000|Overall Study|Carcinoma of prostate|1|||
146251428|NCT01760876|527431693|FG000|Overall Study|Impaired renal function|1|||
146251429|NCT01760876|527431693|FG000|Overall Study|Major depression|1|||
146251430|NCT01760876|527431693|FG000|Overall Study|Very poor baseline OCT quality|2|||
146251431|NCT00732498|527431697|FG000|Overall Study|Ineligible|1|||
146251432|NCT00732498|527431697|FG000|Overall Study|Adverse Event|2|||
146251433|NCT00732498|527431697|FG000|Overall Study|Physician Decision|3|||
146251434|NCT03394508|527431698|FG000|Overall Study|Protocol Violation|0|||
146251435|NCT03394508|527431699|FG001|Overall Study|Protocol Violation|3|||
146251436|NCT03394508|527431698|FG000|Overall Study|Lost to Follow-up|1|||
146251437|NCT03394508|527431699|FG001|Overall Study|Lost to Follow-up|0|||
146251438|NCT00267865|527431700|FG000|Induction Treatment|Died before completing.|2|||
146251439|NCT00267865|527431700|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
146251440|NCT03122548|527431704|FG000|Overall Study|Death|2|||
146251441|NCT03122548|527431704|FG000|Overall Study|Progression - subject went into hospice|1|||
146251442|NCT03122548|527431704|FG000|Overall Study|Study Terminated by Sponsor|2|||
146251443|NCT02819141|527431705|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
146251444|NCT02819141|527431706|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
146251445|NCT00409006|527433315|FG000|Overall Study|Death|15|||
146251446|NCT00409006|527433316|FG001|Overall Study|Death|6|||
146251447|NCT00409006|527433315|FG000|Overall Study|Lost to Follow-up|1|||
146251448|NCT00409006|527433316|FG001|Overall Study|Lost to Follow-up|2|||
146251449|NCT00409006|527433315|FG000|Overall Study|Withdrawal by Subject|3|||
146251450|NCT00409006|527433316|FG001|Overall Study|Withdrawal by Subject|2|||
146251451|NCT00409006|527433315|FG000|Overall Study|Physician Decision|1|||
146300112|NCT03838198|527613729|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
146300113|NCT03606980|527613730|FG000|Overall Study|Lost to Follow-up|3|||
146300114|NCT03606980|527613731|FG001|Overall Study|Lost to Follow-up|2|||
146300115|NCT03606980|527613732|FG002|Overall Study|Lost to Follow-up|3|||
146300116|NCT03606980|527613730|FG000|Overall Study|Withdrawal by Subject|1|||
146300117|NCT03606980|527613731|FG001|Overall Study|Withdrawal by Subject|0|||
146300118|NCT03606980|527613732|FG002|Overall Study|Withdrawal by Subject|4|||
146300119|NCT03672461|527613736|FG000|Overall Study|COVID Related|4|||
146300120|NCT03672461|527613737|FG001|Overall Study|COVID Related|2|||
146300121|NCT03672461|527613736|FG000|Overall Study|Adverse Event|2|||
146300122|NCT03672461|527613737|FG001|Overall Study|Adverse Event|0|||
146300123|NCT03672461|527613736|FG000|Overall Study|Serious Adverse Event|0|||
146094081|NCT02413372|526866534|FG000|Treatment|Withdrawal by Subject|1|||
146094082|NCT02413372|526866535|FG001|Treatment|Withdrawal by Subject|0|||
146251452|NCT00409006|527433316|FG001|Overall Study|Physician Decision|2|||
146251453|NCT03050372|527433317|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
146251454|NCT03050372|527433318|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
146251455|NCT03050372|527433317|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
146251456|NCT03050372|527433318|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
146251457|NCT02123797|527433321|FG000|Baseline Intervention|Death|9|||
146251458|NCT02123797|527433322|FG001|Baseline Intervention|Death|16|||
146251459|NCT02123797|527433323|FG002|Baseline Intervention|Death|0|||
146251460|NCT02123797|527433324|FG003|Baseline Intervention|Death|0|||
146251461|NCT02123797|527433325|FG004|Baseline Intervention|Death|0|||
146300124|NCT03672461|527613737|FG001|Overall Study|Serious Adverse Event|1|||
146300125|NCT03672461|527613736|FG000|Overall Study|Too Busy|3|||
146094083|NCT02413372|526866536|FG002|Treatment|Withdrawal by Subject|0|||
146094084|NCT02413372|526866534|FG000|Follow-up|Lost to Follow-up|1|||
146094085|NCT02413372|526866535|FG001|Follow-up|Lost to Follow-up|1|||
146094086|NCT02413372|526866536|FG002|Follow-up|Lost to Follow-up|0|||
146094087|NCT02413372|526866534|FG000|Follow-up|Subject Withdrew Consent|1|||
146094088|NCT02413372|526866535|FG001|Follow-up|Subject Withdrew Consent|0|||
146300126|NCT03672461|527613737|FG001|Overall Study|Too Busy|1|||
146018865|NCT04154293|526579478|FG000|Overall Study|Physician Decision|0|||
146094089|NCT02413372|526866536|FG002|Follow-up|Subject Withdrew Consent|1|||
146094090|NCT02413372|526866534|FG000|Follow-up|Subject unable to return for visit|0|||
146094091|NCT02413372|526866535|FG001|Follow-up|Subject unable to return for visit|0|||
146094092|NCT02413372|526866536|FG002|Follow-up|Subject unable to return for visit|1|||
146094093|NCT04587271|526866539|FG000|Overall Study|Lost to Follow-up|2|||
146300127|NCT03672461|527613736|FG000|Overall Study|Lost to Follow-up|1|||
146300128|NCT03672461|527613737|FG001|Overall Study|Lost to Follow-up|2|||
146018866|NCT04154293|526579479|FG001|Overall Study|Physician Decision|0|||
146018867|NCT04154293|526579480|FG002|Overall Study|Physician Decision|1|||
146018868|NCT03703817|526579482|FG000|Overall Study|Not meeting eligibility criteria|7|||
146018869|NCT03703817|526579483|FG001|Overall Study|Not meeting eligibility criteria|4|||
146018870|NCT03194568|526579484|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
146018871|NCT03515551|526579487|FG000|Overall Study|Death|4|||
146018872|NCT03515551|526579488|FG001|Overall Study|Death|1|||
146018873|NCT03515551|526579489|FG002|Overall Study|Death|2|||
146018874|NCT03515551|526579490|FG003|Overall Study|Death|2|||
146018875|NCT03515551|526579491|FG004|Overall Study|Death|2|||
146018876|NCT03515551|526579492|FG005|Overall Study|Death|4|||
146018877|NCT03515551|526579493|FG006|Overall Study|Death|1|||
146018878|NCT03515551|526579487|FG000|Overall Study|Lost to Follow-up|0|||
146018879|NCT03515551|526579488|FG001|Overall Study|Lost to Follow-up|0|||
146018880|NCT03515551|526579489|FG002|Overall Study|Lost to Follow-up|1|||
146018881|NCT03515551|526579490|FG003|Overall Study|Lost to Follow-up|0|||
146018882|NCT03515551|526579491|FG004|Overall Study|Lost to Follow-up|0|||
146018883|NCT03515551|526579492|FG005|Overall Study|Lost to Follow-up|0|||
146018884|NCT03515551|526579493|FG006|Overall Study|Lost to Follow-up|0|||
146018885|NCT03515551|526579487|FG000|Overall Study|Withdrawal by Subject|0|||
146018886|NCT03515551|526579488|FG001|Overall Study|Withdrawal by Subject|1|||
146018887|NCT03515551|526579489|FG002|Overall Study|Withdrawal by Subject|0|||
146018888|NCT03515551|526579490|FG003|Overall Study|Withdrawal by Subject|0|||
146018889|NCT03515551|526579491|FG004|Overall Study|Withdrawal by Subject|0|||
146018890|NCT03515551|526579492|FG005|Overall Study|Withdrawal by Subject|0|||
146094094|NCT04587271|526866540|FG001|Overall Study|Lost to Follow-up|2|||
146094095|NCT04587271|526866541|FG002|Overall Study|Lost to Follow-up|0|||
146094096|NCT04587271|526866542|FG003|Overall Study|Lost to Follow-up|2|||
146251462|NCT02123797|527433321|FG000|Baseline Intervention|Withdrawal by Subject|2|||
146300129|NCT03672461|527613736|FG000|Overall Study|Family|2|||
146018891|NCT03515551|526579493|FG006|Overall Study|Withdrawal by Subject|1|||
146018892|NCT03515551|526579487|FG000|Overall Study|Study ended by sponsor|0|||
146018893|NCT03515551|526579488|FG001|Overall Study|Study ended by sponsor|0|||
146018894|NCT03515551|526579489|FG002|Overall Study|Study ended by sponsor|2|||
146018895|NCT03515551|526579490|FG003|Overall Study|Study ended by sponsor|1|||
146300130|NCT03672461|527613737|FG001|Overall Study|Family|2|||
146251463|NCT02123797|527433322|FG001|Baseline Intervention|Withdrawal by Subject|8|||
146251464|NCT02123797|527433323|FG002|Baseline Intervention|Withdrawal by Subject|0|||
146251465|NCT02123797|527433324|FG003|Baseline Intervention|Withdrawal by Subject|0|||
146251466|NCT02123797|527433325|FG004|Baseline Intervention|Withdrawal by Subject|0|||
146251467|NCT02123797|527433321|FG000|Baseline Intervention|Relocation|2|||
146251468|NCT02123797|527433322|FG001|Baseline Intervention|Relocation|0|||
146251469|NCT02123797|527433323|FG002|Baseline Intervention|Relocation|0|||
146251470|NCT02123797|527433324|FG003|Baseline Intervention|Relocation|0|||
146251471|NCT02123797|527433325|FG004|Baseline Intervention|Relocation|0|||
146251472|NCT02123797|527433321|FG000|Baseline Intervention|Out of window for initial survey|6|||
146251473|NCT02123797|527433322|FG001|Baseline Intervention|Out of window for initial survey|13|||
146251474|NCT02123797|527433323|FG002|Baseline Intervention|Out of window for initial survey|0|||
146251475|NCT02123797|527433324|FG003|Baseline Intervention|Out of window for initial survey|0|||
146251476|NCT02123797|527433325|FG004|Baseline Intervention|Out of window for initial survey|0|||
146251477|NCT02123797|527433321|FG000|Baseline Intervention|Lost to Follow-up|0|||
146251478|NCT02123797|527433322|FG001|Baseline Intervention|Lost to Follow-up|5|||
146251479|NCT02123797|527433323|FG002|Baseline Intervention|Lost to Follow-up|0|||
146251480|NCT02123797|527433324|FG003|Baseline Intervention|Lost to Follow-up|0|||
146251481|NCT02123797|527433325|FG004|Baseline Intervention|Lost to Follow-up|0|||
146251482|NCT02123797|527433321|FG000|Baseline Intervention|Other Disease|3|||
146251483|NCT02123797|527433322|FG001|Baseline Intervention|Other Disease|0|||
146251484|NCT02123797|527433323|FG002|Baseline Intervention|Other Disease|0|||
146251485|NCT02123797|527433324|FG003|Baseline Intervention|Other Disease|0|||
146251486|NCT02123797|527433325|FG004|Baseline Intervention|Other Disease|0|||
146251487|NCT02123797|527433321|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
146251488|NCT02123797|527433322|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
146251489|NCT02123797|527433323|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
146251490|NCT02123797|527433324|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
146251491|NCT02123797|527433325|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
146251492|NCT02123797|527433321|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
146251493|NCT02123797|527433322|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
146251494|NCT02123797|527433323|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
146251495|NCT02123797|527433324|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
146251496|NCT02123797|527433325|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146251497|NCT02123797|527433321|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
146251498|NCT02123797|527433322|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
146251499|NCT02123797|527433323|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146251500|NCT02123797|527433324|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146251501|NCT02123797|527433325|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146251502|NCT02123797|527433321|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
146251503|NCT02123797|527433322|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
146251504|NCT02123797|527433323|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
146251505|NCT02123797|527433324|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
146251506|NCT02123797|527433325|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
146251507|NCT02123797|527433321|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
146251508|NCT02123797|527433322|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
146251509|NCT02123797|527433323|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146251510|NCT02123797|527433324|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146251511|NCT02123797|527433325|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
146251512|NCT02123797|527433321|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
146251513|NCT02123797|527433322|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
146251514|NCT02123797|527433323|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
146251515|NCT02123797|527433324|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
146251516|NCT02123797|527433325|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
146251517|NCT02123797|527433321|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146251518|NCT02123797|527433322|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
146251519|NCT02123797|527433323|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
146251520|NCT02123797|527433324|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
146251521|NCT02123797|527433325|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
146300131|NCT03672461|527613736|FG000|Overall Study|No remote technology access|0|||
146300132|NCT03672461|527613737|FG001|Overall Study|No remote technology access|1|||
146018896|NCT03515551|526579491|FG004|Overall Study|Study ended by sponsor|3|||
146018897|NCT03515551|526579492|FG005|Overall Study|Study ended by sponsor|0|||
146251522|NCT02123797|527433321|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
146251523|NCT02123797|527433322|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
146251524|NCT02123797|527433323|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146251525|NCT02123797|527433324|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146251526|NCT02123797|527433325|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
146300133|NCT03672461|527613736|FG000|Overall Study|Withdrawal by Subject|1|||
146300134|NCT03672461|527613737|FG001|Overall Study|Withdrawal by Subject|0|||
146300135|NCT03672461|527613736|FG000|Overall Study|Cannot tolerate intervention|1|||
146300136|NCT03672461|527613737|FG001|Overall Study|Cannot tolerate intervention|0|||
146300137|NCT03672461|527613736|FG000|Overall Study|Incomplete outcome data|6|||
146300138|NCT03672461|527613737|FG001|Overall Study|Incomplete outcome data|1|||
146300139|NCT01798992|527615122|FG000|Overall Study|Administrative withdrawal|0|||
146300140|NCT01798992|527615123|FG001|Overall Study|Administrative withdrawal|1|||
146300141|NCT01798992|527615124|FG002|Overall Study|Administrative withdrawal|0|||
146300142|NCT01798992|527615125|FG003|Overall Study|Administrative withdrawal|1|||
146300143|NCT01798992|527615122|FG000|Overall Study|Lost to Follow-up|0|||
146300144|NCT01798992|527615123|FG001|Overall Study|Lost to Follow-up|1|||
146300145|NCT01798992|527615124|FG002|Overall Study|Lost to Follow-up|1|||
146300146|NCT01798992|527615125|FG003|Overall Study|Lost to Follow-up|0|||
146300147|NCT01798992|527615122|FG000|Overall Study|Insufficient biopsy tissue|0|||
146300148|NCT01798992|527615123|FG001|Overall Study|Insufficient biopsy tissue|0|||
146300149|NCT01798992|527615124|FG002|Overall Study|Insufficient biopsy tissue|1|||
146300150|NCT01798992|527615125|FG003|Overall Study|Insufficient biopsy tissue|0|||
146300151|NCT03631667|527615128|FG000|Overall Study|Withdrawal by Subject|3|||
146300152|NCT01674712|527615133|FG000|Overall Study|Adverse Event|5|||
146300153|NCT01674712|527615134|FG001|Overall Study|Adverse Event|6|||
146300154|NCT01674712|527615135|FG002|Overall Study|Adverse Event|3|||
146300155|NCT01674712|527615136|FG003|Overall Study|Adverse Event|4|||
146300156|NCT01674712|527615137|FG004|Overall Study|Adverse Event|6|||
146300157|NCT01674712|527615133|FG000|Overall Study|Lost to Follow-up|1|||
146300158|NCT01674712|527615134|FG001|Overall Study|Lost to Follow-up|0|||
146300159|NCT01674712|527615135|FG002|Overall Study|Lost to Follow-up|0|||
146300160|NCT01674712|527615136|FG003|Overall Study|Lost to Follow-up|0|||
146300161|NCT01674712|527615137|FG004|Overall Study|Lost to Follow-up|0|||
146300162|NCT01674712|527615133|FG000|Overall Study|Protocol Violation|2|||
146300163|NCT01674712|527615134|FG001|Overall Study|Protocol Violation|0|||
146300164|NCT01674712|527615135|FG002|Overall Study|Protocol Violation|0|||
146300165|NCT01674712|527615136|FG003|Overall Study|Protocol Violation|0|||
146300166|NCT01674712|527615137|FG004|Overall Study|Protocol Violation|0|||
146300167|NCT01674712|527615133|FG000|Overall Study|Withdrawal by Subject|2|||
146300168|NCT01674712|527615134|FG001|Overall Study|Withdrawal by Subject|2|||
146300169|NCT01674712|527615135|FG002|Overall Study|Withdrawal by Subject|5|||
146300170|NCT01674712|527615136|FG003|Overall Study|Withdrawal by Subject|4|||
146300171|NCT01674712|527615137|FG004|Overall Study|Withdrawal by Subject|3|||
146300172|NCT01674712|527615133|FG000|Overall Study|Administrative|0|||
146300173|NCT01674712|527615134|FG001|Overall Study|Administrative|1|||
146300174|NCT01674712|527615135|FG002|Overall Study|Administrative|0|||
146300175|NCT01674712|527615136|FG003|Overall Study|Administrative|0|||
146300176|NCT01674712|527615137|FG004|Overall Study|Administrative|1|||
146300177|NCT01674712|527615133|FG000|Overall Study|Lack of Efficacy|0|||
146300178|NCT01674712|527615134|FG001|Overall Study|Lack of Efficacy|0|||
146300179|NCT01674712|527615135|FG002|Overall Study|Lack of Efficacy|1|||
146300180|NCT01674712|527615136|FG003|Overall Study|Lack of Efficacy|0|||
146251527|NCT02123797|527433321|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
146251528|NCT02123797|527433322|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
146251529|NCT02123797|527433323|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
146251530|NCT02123797|527433324|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
146251531|NCT02123797|527433325|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
146251532|NCT05878990|527433328|FG000|Overall Study|Lost to Follow-up|7|||
146251533|NCT05878990|527433328|FG000|Overall Study|Withdrawal by Subject|1|||
146251534|NCT00396409|527433336|FG000|Period 1 - 2007|Adverse Event|0|||
146251535|NCT00396409|527433337|FG001|Period 1 - 2007|Adverse Event|1|||
146300181|NCT01674712|527615137|FG004|Overall Study|Lack of Efficacy|1|||
146300182|NCT01287364|527615141|FG000|Overall Study|Adverse Event|0|||
146300183|NCT01287364|527615142|FG001|Overall Study|Adverse Event|3|||
146300184|NCT01287364|527615141|FG000|Overall Study|Protocol Violation|5|||
146300185|NCT01287364|527615142|FG001|Overall Study|Protocol Violation|5|||
146018898|NCT03515551|526579493|FG006|Overall Study|Study ended by sponsor|3|||
146018899|NCT03515551|526579487|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146251536|NCT00396409|527433336|FG000|Period 1 - 2007|Lack of Efficacy|0|||
146018900|NCT03515551|526579488|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
146251537|NCT00396409|527433337|FG001|Period 1 - 2007|Lack of Efficacy|1|||
146251538|NCT00396409|527433336|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
146251539|NCT00396409|527433337|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
146251540|NCT00396409|527433336|FG000|Period 1 - 2007|Lost to Follow-up|2|||
146300186|NCT01287364|527615141|FG000|Overall Study|Other Reason|4|||
146300187|NCT01287364|527615142|FG001|Overall Study|Other Reason|2|||
146300188|NCT00770770|527615155|FG000|Overall Study|Lost to Follow-up|1|||
146300189|NCT00770770|527615156|FG001|Overall Study|Lost to Follow-up|0|||
146300190|NCT00770770|527615155|FG000|Overall Study|Withdrawal by Subject|1|||
146300191|NCT00770770|527615156|FG001|Overall Study|Withdrawal by Subject|0|||
146300192|NCT00770770|527615155|FG000|Overall Study|Death|0|||
146300193|NCT00770770|527615156|FG001|Overall Study|Death|1|||
146018901|NCT03515551|526579489|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146018902|NCT03515551|526579490|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146018903|NCT03515551|526579491|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146018904|NCT03515551|526579492|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146018905|NCT03515551|526579493|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
146018906|NCT00920387|526579500|FG000|Stage 1|Adverse Event|1|||
146018907|NCT00920387|526579501|FG001|Stage 1|Adverse Event|0|||
146018908|NCT00920387|526579502|FG002|Stage 1|Adverse Event|0|||
146018909|NCT02241733|526579513|FG000|Overall Study|Lost to Follow-up|9|||
146018910|NCT02241733|526579514|FG001|Overall Study|Lost to Follow-up|4|||
146018911|NCT02241733|526579513|FG000|Overall Study|Physician Decision|6|||
146018912|NCT02241733|526579514|FG001|Overall Study|Physician Decision|2|||
146018913|NCT02241733|526579513|FG000|Overall Study|Withdrawal by Subject|0|||
146018914|NCT02241733|526579514|FG001|Overall Study|Withdrawal by Subject|2|||
146018915|NCT02241733|526579513|FG000|Overall Study|Death|0|||
146018916|NCT02241733|526579514|FG001|Overall Study|Death|2|||
146018917|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
146018918|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
146018919|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
146018920|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
146018921|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
146018922|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
146018923|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
146018924|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
146018925|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
146018926|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
146018927|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
146018928|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
146018929|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
146018930|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
146018931|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
146018932|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
146018933|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146018934|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146018935|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
146018936|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
146018937|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
146018938|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146018939|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146018940|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
146018941|NCT01866111|526579515|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
146018942|NCT01866111|526579516|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
146018943|NCT01866111|526579517|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
146018944|NCT01866111|526579518|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
146018945|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
146018946|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
146018947|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
146018948|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
146018949|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
146018950|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
146018951|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
146018952|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
146018953|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
146018954|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
146018955|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
146018956|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
146018957|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
146018958|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
146018959|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
146018960|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
146018961|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Death|1|||
146018962|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Death|1|||
146018963|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Death|3|||
146018964|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Death|2|||
146018965|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
146018966|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
146018967|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
146018968|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
146018969|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
146018970|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
146018971|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
146018972|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
146018973|NCT01866111|526579515|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146018974|NCT01866111|526579516|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146018975|NCT01866111|526579517|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
146018976|NCT01866111|526579518|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
146018977|NCT00157196|526579519|FG000|Overall Study|Ongoing at data cut-off|9|||
146018978|NCT01439971|526579520|FG000|Overall Study|Required number in cohort dosed|0|||
146018979|NCT01439971|526579521|FG001|Overall Study|Required number in cohort dosed|1|||
146018980|NCT01439971|526579522|FG002|Overall Study|Required number in cohort dosed|2|||
146018981|NCT01439971|526579523|FG003|Overall Study|Required number in cohort dosed|0|||
146018982|NCT01439971|526579524|FG004|Overall Study|Required number in cohort dosed|1|||
146018983|NCT02628600|526579525|FG000|Overall Study|Death|2|||
146018984|NCT02628600|526579526|FG001|Overall Study|Death|1|||
146018985|NCT02628600|526579525|FG000|Overall Study|Adverse Event|3|||
146018986|NCT02628600|526579526|FG001|Overall Study|Adverse Event|20|||
146018987|NCT02628600|526579525|FG000|Overall Study|Protocol Violation|0|||
146018988|NCT02628600|526579526|FG001|Overall Study|Protocol Violation|1|||
146018989|NCT02628600|526579525|FG000|Overall Study|Lack of Efficacy|2|||
146018990|NCT02628600|526579526|FG001|Overall Study|Lack of Efficacy|0|||
146018991|NCT02628600|526579525|FG000|Overall Study|Withdrawal by Subject|13|||
146018992|NCT02628600|526579526|FG001|Overall Study|Withdrawal by Subject|8|||
146018993|NCT02628600|526579525|FG000|Overall Study|Lost to Follow-up|1|||
146018994|NCT02628600|526579526|FG001|Overall Study|Lost to Follow-up|0|||
146018995|NCT02628600|526579525|FG000|Overall Study|Physician Decision|2|||
146018996|NCT02628600|526579526|FG001|Overall Study|Physician Decision|2|||
146018997|NCT02628600|526579525|FG000|Overall Study|Other not specified|1|||
146018998|NCT02628600|526579526|FG001|Overall Study|Other not specified|0|||
146018999|NCT01221623|526579533|FG000|Overall Study|Withdrawal by Subject|19|||
146019000|NCT01221623|526579534|FG001|Overall Study|Withdrawal by Subject|8|||
146019001|NCT01221623|526579533|FG000|Overall Study|Lost to Follow-up|7|||
146019002|NCT01221623|526579534|FG001|Overall Study|Lost to Follow-up|1|||
146019003|NCT01221623|526579533|FG000|Overall Study|Adverse Event|6|||
146019004|NCT01221623|526579534|FG001|Overall Study|Adverse Event|3|||
146019005|NCT01221623|526579533|FG000|Overall Study|Death|1|||
146019006|NCT01221623|526579534|FG001|Overall Study|Death|0|||
146019007|NCT01221623|526579533|FG000|Overall Study|Other|5|||
146019008|NCT01221623|526579534|FG001|Overall Study|Other|2|||
146019009|NCT00780143|526579535|FG000|Overall Study|Progressive disease|1|||
146019010|NCT00780143|526579535|FG000|Overall Study|Toxicity|1|||
146019011|NCT00780143|526579535|FG000|Overall Study|Adverse Event|1|||
146019012|NCT04091581|526579536|FG000|Overall Study|Lost to Follow-up|0|||
146019013|NCT04091581|526579537|FG001|Overall Study|Lost to Follow-up|1|||
146019014|NCT02438384|526579538|FG000|Overall Study|Lost to Follow-up|8|||
146019015|NCT02438384|526579539|FG001|Overall Study|Lost to Follow-up|6|||
146019016|NCT02438384|526579540|FG002|Overall Study|Lost to Follow-up|4|||
146019017|NCT03315793|526579541|FG000|Overall Study|Adverse Event|4|||
146019018|NCT03315793|526579542|FG001|Overall Study|Adverse Event|2|||
146019019|NCT03315793|526579541|FG000|Overall Study|Protocol Deviation|1|||
146019020|NCT03315793|526579542|FG001|Overall Study|Protocol Deviation|0|||
146019021|NCT03315793|526579541|FG000|Overall Study|Difficult for regular visit|0|||
146019022|NCT03315793|526579542|FG001|Overall Study|Difficult for regular visit|1|||
146019023|NCT02578680|526580821|FG000|Overall Study|Death|329|||
146251541|NCT00396409|527433337|FG001|Period 1 - 2007|Lost to Follow-up|3|||
146251542|NCT00396409|527433336|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
146251543|NCT00396409|527433337|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
146251544|NCT00396409|527433336|FG000|Period 2 - 2008|Protocol Violation|1|||
146251545|NCT00396409|527433337|FG001|Period 2 - 2008|Protocol Violation|0|||
146251546|NCT00396409|527433336|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
146251547|NCT00396409|527433337|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
146251548|NCT00396409|527433336|FG000|Period 2 - 2008|Lost to Follow-up|3|||
146251549|NCT00396409|527433337|FG001|Period 2 - 2008|Lost to Follow-up|1|||
146251550|NCT00331799|527433338|FG000|Overall Study|Withdrawal by Subject|2|||
146251551|NCT00331799|527433338|FG000|Overall Study|Sedation|1|||
146019024|NCT02578680|526580822|FG001|Overall Study|Death|181|||
146019025|NCT02578680|526580821|FG000|Overall Study|Lost to Follow-up|3|||
146019026|NCT02578680|526580822|FG001|Overall Study|Lost to Follow-up|1|||
146019027|NCT02578680|526580821|FG000|Overall Study|Physician Decision|0|||
146019028|NCT02578680|526580822|FG001|Overall Study|Physician Decision|1|||
146019029|NCT02578680|526580821|FG000|Overall Study|Protocol Violation|1|||
146019030|NCT02578680|526580822|FG001|Overall Study|Protocol Violation|1|||
146019031|NCT02578680|526580821|FG000|Overall Study|Sponsor Decision|64|||
146019032|NCT02578680|526580822|FG001|Overall Study|Sponsor Decision|13|||
146019033|NCT02578680|526580821|FG000|Overall Study|Withdrawal by Subject|13|||
146251552|NCT02889809|527433339|FG000|Overall Study|Withdrawal by Subject|30|||
146251553|NCT02889809|527433340|FG001|Overall Study|Withdrawal by Subject|21|||
146251554|NCT02889809|527433339|FG000|Overall Study|Lost to Follow-up|1|||
146251555|NCT02889809|527433340|FG001|Overall Study|Lost to Follow-up|1|||
146251556|NCT02889809|527433339|FG000|Overall Study|Site Closed|12|||
146251557|NCT02889809|527433340|FG001|Overall Study|Site Closed|11|||
146251558|NCT04203199|527433343|FG000|First Intervention Period|Lost to Follow-up|0|||
146251559|NCT04203199|527433344|FG001|First Intervention Period|Lost to Follow-up|1|||
146251560|NCT04203199|527433343|FG000|Second Intervention Period|Medication change|1|||
146251561|NCT04203199|527433344|FG001|Second Intervention Period|Medication change|0|||
146251562|NCT01107353|527433353|FG000|Overall Study|Positive Drug Screen|1|||
146251563|NCT01107353|527433354|FG001|Overall Study|Positive Drug Screen|0|||
146251564|NCT03034772|527433355|FG000|Overall Study|Adverse Event|0|||
146251565|NCT03034772|527433356|FG001|Overall Study|Adverse Event|1|||
146251566|NCT03034772|527433355|FG000|Overall Study|Withdrawal by Subject|0|||
146251567|NCT03034772|527433356|FG001|Overall Study|Withdrawal by Subject|1|||
146251568|NCT01136733|527433357|FG000|Phase 1b|Adverse Event|0|||
146251569|NCT01136733|527433358|FG001|Phase 1b|Adverse Event|3|||
146251570|NCT01136733|527433359|FG002|Phase 1b|Adverse Event|1|||
146251571|NCT01136733|527433360|FG003|Phase 1b|Adverse Event|0|||
146251572|NCT01136733|527433361|FG004|Phase 1b|Adverse Event|0|||
146251573|NCT01136733|527433362|FG005|Phase 1b|Adverse Event|0|||
146251574|NCT01136733|527433363|FG006|Phase 1b|Adverse Event|0|||
146251575|NCT01136733|527433357|FG000|Phase 1b|Participant Choice|0|||
146251576|NCT01136733|527433358|FG001|Phase 1b|Participant Choice|0|||
146251577|NCT01136733|527433359|FG002|Phase 1b|Participant Choice|1|||
146251578|NCT01136733|527433360|FG003|Phase 1b|Participant Choice|0|||
146251579|NCT01136733|527433361|FG004|Phase 1b|Participant Choice|0|||
146251580|NCT01136733|527433362|FG005|Phase 1b|Participant Choice|0|||
146251581|NCT01136733|527433363|FG006|Phase 1b|Participant Choice|0|||
146251582|NCT01136733|527433357|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
146251583|NCT01136733|527433358|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
146251584|NCT01136733|527433359|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
146251585|NCT01136733|527433360|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
146251586|NCT01136733|527433361|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
146251587|NCT01136733|527433362|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
146251588|NCT01136733|527433363|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
146251589|NCT01136733|527433357|FG000|Phase 1b|Clinical Progression|1|||
146251590|NCT01136733|527433358|FG001|Phase 1b|Clinical Progression|1|||
146251591|NCT01136733|527433359|FG002|Phase 1b|Clinical Progression|0|||
146251592|NCT01136733|527433360|FG003|Phase 1b|Clinical Progression|0|||
146251593|NCT01136733|527433361|FG004|Phase 1b|Clinical Progression|0|||
146251594|NCT01136733|527433362|FG005|Phase 1b|Clinical Progression|0|||
146019034|NCT02578680|526580822|FG001|Overall Study|Withdrawal by Subject|9|||
146019035|NCT00306293|526580825|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
146019036|NCT00306293|526580826|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
146019037|NCT00306293|526580825|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
146019038|NCT00306293|526580826|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
146019039|NCT00306293|526580825|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
146019040|NCT00306293|526580826|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
146019041|NCT00306293|526580825|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
146019042|NCT00306293|526580826|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
146019043|NCT00306293|526580825|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
146019044|NCT00306293|526580826|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
146019045|NCT00306293|526580825|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
146019046|NCT00306293|526580826|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
146019047|NCT00306293|526580825|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
146251595|NCT01136733|527433363|FG006|Phase 1b|Clinical Progression|0|||
146251596|NCT01136733|527433357|FG000|Phase 2|Disease Progression|0|||
146251597|NCT01136733|527433358|FG001|Phase 2|Disease Progression|0|||
146251598|NCT01136733|527433359|FG002|Phase 2|Disease Progression|0|||
146251599|NCT01136733|527433360|FG003|Phase 2|Disease Progression|0|||
146251600|NCT01136733|527433361|FG004|Phase 2|Disease Progression|30|||
146251601|NCT01136733|527433362|FG005|Phase 2|Disease Progression|32|||
146251602|NCT01136733|527433363|FG006|Phase 2|Disease Progression|38|||
146251603|NCT01136733|527433357|FG000|Phase 2|Adverse Event|0|||
146251604|NCT01136733|527433358|FG001|Phase 2|Adverse Event|0|||
146251605|NCT01136733|527433359|FG002|Phase 2|Adverse Event|0|||
146251606|NCT01136733|527433360|FG003|Phase 2|Adverse Event|0|||
146251607|NCT01136733|527433361|FG004|Phase 2|Adverse Event|11|||
146251608|NCT01136733|527433362|FG005|Phase 2|Adverse Event|13|||
146251609|NCT01136733|527433363|FG006|Phase 2|Adverse Event|5|||
146251610|NCT01136733|527433357|FG000|Phase 2|Participant Choice|0|||
146251611|NCT01136733|527433358|FG001|Phase 2|Participant Choice|0|||
146251612|NCT01136733|527433359|FG002|Phase 2|Participant Choice|0|||
146251613|NCT01136733|527433360|FG003|Phase 2|Participant Choice|0|||
146019048|NCT00306293|526580826|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
146019049|NCT00306293|526580825|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
146300194|NCT00770770|527615155|FG000|Overall Study|Study Terminated|8|||
146300195|NCT00770770|527615156|FG001|Overall Study|Study Terminated|0|||
146300196|NCT05372653|527615158|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
146300197|NCT05372653|527615159|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
146300198|NCT05372653|527615158|FG000|Overall Study|Adverse Event|0|||
146300199|NCT05372653|527615159|FG001|Overall Study|Adverse Event|1|||
146300200|NCT00117507|527615160|FG000|Overall Study|Adverse Event|4|||
146300201|NCT00117507|527615160|FG000|Overall Study|Abnormal laboratory values|3|||
146019050|NCT00306293|526580826|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
146251614|NCT01136733|527433361|FG004|Phase 2|Participant Choice|3|||
146251615|NCT01136733|527433362|FG005|Phase 2|Participant Choice|0|||
146251616|NCT01136733|527433363|FG006|Phase 2|Participant Choice|1|||
146251617|NCT01136733|527433357|FG000|Phase 2|Administrative-Withdrew Consent|0|||
146251618|NCT01136733|527433358|FG001|Phase 2|Administrative-Withdrew Consent|0|||
146251619|NCT01136733|527433359|FG002|Phase 2|Administrative-Withdrew Consent|0|||
146251620|NCT01136733|527433360|FG003|Phase 2|Administrative-Withdrew Consent|0|||
146251621|NCT01136733|527433361|FG004|Phase 2|Administrative-Withdrew Consent|1|||
146251622|NCT01136733|527433362|FG005|Phase 2|Administrative-Withdrew Consent|0|||
146251623|NCT01136733|527433363|FG006|Phase 2|Administrative-Withdrew Consent|0|||
146251624|NCT01136733|527433357|FG000|Phase 2|Other|0|||
146251625|NCT01136733|527433358|FG001|Phase 2|Other|0|||
146251626|NCT01136733|527433359|FG002|Phase 2|Other|0|||
146251627|NCT01136733|527433360|FG003|Phase 2|Other|0|||
146251628|NCT01136733|527433361|FG004|Phase 2|Other|6|||
146251629|NCT01136733|527433362|FG005|Phase 2|Other|7|||
146251630|NCT01136733|527433363|FG006|Phase 2|Other|6|||
146251631|NCT01745380|527433364|FG000|Overall Study|Lost to Follow-up|1|||
146251632|NCT01745380|527433365|FG001|Overall Study|Lost to Follow-up|0|||
146251633|NCT01745380|527433364|FG000|Overall Study|Lack of Efficacy|0|||
146251634|NCT01745380|527433365|FG001|Overall Study|Lack of Efficacy|1|||
146251635|NCT02368691|527433366|FG000|Overall Study|Death|13|||
146251636|NCT02368691|527433366|FG000|Overall Study|Lack of Efficacy|15|||
146251637|NCT02368691|527433366|FG000|Overall Study|Physician Decision|4|||
146251638|NCT02660034|527433367|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
146251639|NCT02660034|527433368|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
146300202|NCT00117507|527615160|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146019051|NCT00185380|526580829|FG000|Overall Study|Adverse Event|41|||
146019052|NCT00185380|526580830|FG001|Overall Study|Adverse Event|43|||
146019053|NCT00185380|526580831|FG002|Overall Study|Adverse Event|48|||
146019054|NCT00185380|526580829|FG000|Overall Study|Lost to Follow-up|0|||
146019055|NCT00185380|526580830|FG001|Overall Study|Lost to Follow-up|4|||
146019056|NCT00185380|526580831|FG002|Overall Study|Lost to Follow-up|3|||
146019057|NCT00185380|526580829|FG000|Overall Study|Pregnancy|1|||
146019058|NCT00185380|526580830|FG001|Overall Study|Pregnancy|4|||
146019059|NCT00185380|526580831|FG002|Overall Study|Pregnancy|0|||
146019060|NCT00185380|526580829|FG000|Overall Study|Protocol Violation|2|||
146019061|NCT00185380|526580830|FG001|Overall Study|Protocol Violation|2|||
146019062|NCT00185380|526580831|FG002|Overall Study|Protocol Violation|1|||
146019063|NCT00185380|526580829|FG000|Overall Study|Withdrawal by Subject|1|||
146019064|NCT00185380|526580830|FG001|Overall Study|Withdrawal by Subject|2|||
146019065|NCT00185380|526580831|FG002|Overall Study|Withdrawal by Subject|0|||
146019066|NCT00185380|526580829|FG000|Overall Study|Failed insertion|1|||
146019067|NCT00185380|526580830|FG001|Overall Study|Failed insertion|1|||
146019068|NCT00185380|526580831|FG002|Overall Study|Failed insertion|2|||
146019069|NCT00185380|526580829|FG000|Overall Study|Planned pregnancy|9|||
146019070|NCT00185380|526580830|FG001|Overall Study|Planned pregnancy|12|||
146019071|NCT00185380|526580831|FG002|Overall Study|Planned pregnancy|12|||
146019072|NCT00185380|526580829|FG000|Overall Study|No need for contraception|3|||
146300203|NCT00117507|527615160|FG000|Overall Study|Patient withdrew consent|4|||
146300204|NCT00117507|527615160|FG000|Overall Study|Death|3|||
146019073|NCT00185380|526580830|FG001|Overall Study|No need for contraception|3|||
146251640|NCT02660034|527433369|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
146251641|NCT02660034|527433370|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
146251642|NCT02660034|527433371|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
146251643|NCT02660034|527433372|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
146251644|NCT02660034|527433373|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
146251645|NCT02660034|527433374|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
146251646|NCT02660034|527433375|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
146251647|NCT02660034|527433376|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
146251648|NCT02660034|527433377|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
146251649|NCT02660034|527433378|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
146251650|NCT02660034|527433379|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
146251651|NCT02660034|527433380|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
146300205|NCT00800436|527615161|FG000|Overall Study|Withdrawal by Subject|0|||
146019074|NCT00185380|526580831|FG002|Overall Study|No need for contraception|3|||
146019075|NCT00185380|526580829|FG000|Overall Study|Could not attend visits|2|||
146019076|NCT00185380|526580830|FG001|Overall Study|Could not attend visits|0|||
146019077|NCT00185380|526580831|FG002|Overall Study|Could not attend visits|4|||
146300206|NCT00800436|527615162|FG001|Overall Study|Withdrawal by Subject|0|||
146300207|NCT00800436|527615163|FG002|Overall Study|Withdrawal by Subject|1|||
146300208|NCT00800436|527615164|FG003|Overall Study|Withdrawal by Subject|1|||
146300209|NCT00800436|527615165|FG004|Overall Study|Withdrawal by Subject|0|||
146300210|NCT00800436|527615166|FG005|Overall Study|Withdrawal by Subject|0|||
146300211|NCT00800436|527615167|FG006|Overall Study|Withdrawal by Subject|0|||
146300212|NCT00711529|527615174|FG000|Overall Study|Protocol Violation|2|||
146300213|NCT00711529|527615175|FG001|Overall Study|Protocol Violation|0|||
146300214|NCT00711529|527615174|FG000|Overall Study|Withdrawal by Subject|2|||
146300215|NCT00711529|527615175|FG001|Overall Study|Withdrawal by Subject|6|||
146300216|NCT03740997|527615180|FG000|Overall Study|Withdrawal by Subject|1|||
146300217|NCT03740997|527615181|FG001|Overall Study|Withdrawal by Subject|0|||
146300218|NCT03740997|527615180|FG000|Overall Study|Participant was unable to complete study procedures|1|||
146300219|NCT03740997|527615181|FG001|Overall Study|Participant was unable to complete study procedures|0|||
146300220|NCT01003990|527615182|FG000|Overall Study|Adverse Event|8|||
146300221|NCT01003990|527615183|FG001|Overall Study|Adverse Event|5|||
146300222|NCT01003990|527615184|FG002|Overall Study|Adverse Event|11|||
146300223|NCT01003990|527615182|FG000|Overall Study|Death|0|||
146300224|NCT01003990|527615183|FG001|Overall Study|Death|8|||
146300225|NCT01003990|527615184|FG002|Overall Study|Death|1|||
146300226|NCT01003990|527615182|FG000|Overall Study|Lack of Efficacy|10|||
146300227|NCT01003990|527615183|FG001|Overall Study|Lack of Efficacy|2|||
146300228|NCT01003990|527615184|FG002|Overall Study|Lack of Efficacy|3|||
146300229|NCT01003990|527615182|FG000|Overall Study|Lost to Follow-up|30|||
146300230|NCT01003990|527615183|FG001|Overall Study|Lost to Follow-up|12|||
146300231|NCT01003990|527615184|FG002|Overall Study|Lost to Follow-up|7|||
146300232|NCT01003990|527615182|FG000|Overall Study|Reasons Not Identified|14|||
146300233|NCT01003990|527615183|FG001|Overall Study|Reasons Not Identified|13|||
146300234|NCT01003990|527615184|FG002|Overall Study|Reasons Not Identified|8|||
146300235|NCT01003990|527615182|FG000|Overall Study|Poor/Non-compliance|4|||
146300236|NCT01003990|527615183|FG001|Overall Study|Poor/Non-compliance|3|||
146300237|NCT01003990|527615184|FG002|Overall Study|Poor/Non-compliance|2|||
146300238|NCT01003990|527615182|FG000|Overall Study|Pregnancy|10|||
146300239|NCT01003990|527615183|FG001|Overall Study|Pregnancy|2|||
146300240|NCT01003990|527615184|FG002|Overall Study|Pregnancy|4|||
146300241|NCT01003990|527615182|FG000|Overall Study|No Longer Met Study Criteria|4|||
146300242|NCT01003990|527615183|FG001|Overall Study|No Longer Met Study Criteria|1|||
146300243|NCT01003990|527615184|FG002|Overall Study|No Longer Met Study Criteria|0|||
146300244|NCT01003990|527615182|FG000|Overall Study|Subject Withdrew Consent|12|||
146019078|NCT00185380|526580829|FG000|Overall Study|personal reason|6|||
146019079|NCT00185380|526580830|FG001|Overall Study|personal reason|1|||
146019080|NCT00185380|526580831|FG002|Overall Study|personal reason|1|||
146019081|NCT00733291|526580833|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
146019082|NCT00733291|526580834|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146019083|NCT00733291|526580835|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146019084|NCT00733291|526580836|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
146019085|NCT01089413|526580840|FG000|Overall Study|Lost to Follow-up|1|||
146019086|NCT01089413|526580840|FG000|Overall Study|Progressive Disease|93|||
146019087|NCT01089413|526580840|FG000|Overall Study|Participant Withdrew Consent|1|||
146019088|NCT01089413|526580840|FG000|Overall Study|Unacceptable Toxicity|12|||
146019089|NCT01089413|526580840|FG000|Overall Study|Death|10|||
146019090|NCT01089413|526580840|FG000|Overall Study|Metastasectomy|13|||
146019091|NCT01089413|526580840|FG000|Overall Study|Other|71|||
146019092|NCT02526524|526580841|FG000|Overall Study|Withdrawal by Subject|3|||
146019093|NCT02526524|526580842|FG001|Overall Study|Withdrawal by Subject|3|||
146019094|NCT02526524|526580843|FG002|Overall Study|Withdrawal by Subject|6|||
146019095|NCT02526524|526580844|FG003|Overall Study|Withdrawal by Subject|1|||
146019096|NCT02526524|526580845|FG004|Overall Study|Withdrawal by Subject|9|||
146019097|NCT02526524|526580846|FG005|Overall Study|Withdrawal by Subject|5|||
146019098|NCT02526524|526580841|FG000|Overall Study|Adverse Event|3|||
146019099|NCT02526524|526580842|FG001|Overall Study|Adverse Event|2|||
146019100|NCT02526524|526580843|FG002|Overall Study|Adverse Event|4|||
146019101|NCT02526524|526580844|FG003|Overall Study|Adverse Event|2|||
146019102|NCT02526524|526580845|FG004|Overall Study|Adverse Event|6|||
146019103|NCT02526524|526580846|FG005|Overall Study|Adverse Event|8|||
146019104|NCT02526524|526580841|FG000|Overall Study|Lost to Follow-up|2|||
146300245|NCT01003990|527615183|FG001|Overall Study|Subject Withdrew Consent|5|||
146300246|NCT01003990|527615184|FG002|Overall Study|Subject Withdrew Consent|7|||
146300247|NCT01829425|527615188|FG000|Overall Study|Withdrawal by Subject|4|||
146300248|NCT01829425|527615189|FG001|Overall Study|Withdrawal by Subject|3|||
146300249|NCT01829425|527615188|FG000|Overall Study|Lost to Follow-up|2|||
146300250|NCT01829425|527615189|FG001|Overall Study|Lost to Follow-up|1|||
146300251|NCT05211739|527615190|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
146300252|NCT05211739|527615191|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
146300253|NCT05211739|527615190|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
146019105|NCT02526524|526580842|FG001|Overall Study|Lost to Follow-up|3|||
146019106|NCT02526524|526580843|FG002|Overall Study|Lost to Follow-up|8|||
146019107|NCT02526524|526580844|FG003|Overall Study|Lost to Follow-up|1|||
146019108|NCT02526524|526580845|FG004|Overall Study|Lost to Follow-up|2|||
146019109|NCT02526524|526580846|FG005|Overall Study|Lost to Follow-up|5|||
146019110|NCT02526524|526580841|FG000|Overall Study|Protocol Violation|3|||
146019111|NCT02526524|526580842|FG001|Overall Study|Protocol Violation|1|||
146019112|NCT02526524|526580843|FG002|Overall Study|Protocol Violation|5|||
146019113|NCT02526524|526580844|FG003|Overall Study|Protocol Violation|3|||
146019114|NCT02526524|526580845|FG004|Overall Study|Protocol Violation|4|||
146251652|NCT02660034|527433367|FG000|Overall Study|Progressive Disease (Clinical)|7|||
146251653|NCT02660034|527433368|FG001|Overall Study|Progressive Disease (Clinical)|8|||
146251654|NCT02660034|527433369|FG002|Overall Study|Progressive Disease (Clinical)|3|||
146251655|NCT02660034|527433370|FG003|Overall Study|Progressive Disease (Clinical)|9|||
146251656|NCT02660034|527433371|FG004|Overall Study|Progressive Disease (Clinical)|3|||
146251657|NCT02660034|527433372|FG005|Overall Study|Progressive Disease (Clinical)|0|||
146251658|NCT02660034|527433373|FG006|Overall Study|Progressive Disease (Clinical)|0|||
146251659|NCT02660034|527433374|FG007|Overall Study|Progressive Disease (Clinical)|0|||
146251660|NCT02660034|527433375|FG008|Overall Study|Progressive Disease (Clinical)|0|||
146251661|NCT02660034|527433376|FG009|Overall Study|Progressive Disease (Clinical)|0|||
146251662|NCT02660034|527433377|FG010|Overall Study|Progressive Disease (Clinical)|0|||
146251663|NCT02660034|527433378|FG011|Overall Study|Progressive Disease (Clinical)|0|||
146251664|NCT02660034|527433379|FG012|Overall Study|Progressive Disease (Clinical)|0|||
146251665|NCT02660034|527433380|FG013|Overall Study|Progressive Disease (Clinical)|0|||
146251666|NCT02660034|527433367|FG000|Overall Study|Lost to Follow-up|0|||
146251667|NCT02660034|527433368|FG001|Overall Study|Lost to Follow-up|0|||
146251668|NCT02660034|527433369|FG002|Overall Study|Lost to Follow-up|1|||
146251669|NCT02660034|527433370|FG003|Overall Study|Lost to Follow-up|1|||
146251670|NCT02660034|527433371|FG004|Overall Study|Lost to Follow-up|0|||
146019115|NCT02526524|526580846|FG005|Overall Study|Protocol Violation|3|||
146019116|NCT02526524|526580841|FG000|Overall Study|Loss of Glucose Control|0|||
146019117|NCT02526524|526580842|FG001|Overall Study|Loss of Glucose Control|0|||
146019118|NCT02526524|526580843|FG002|Overall Study|Loss of Glucose Control|3|||
146019119|NCT02526524|526580844|FG003|Overall Study|Loss of Glucose Control|0|||
146019120|NCT02526524|526580845|FG004|Overall Study|Loss of Glucose Control|2|||
146019121|NCT02526524|526580846|FG005|Overall Study|Loss of Glucose Control|0|||
146019122|NCT02526524|526580841|FG000|Overall Study|Physician Decision|0|||
146019123|NCT02526524|526580842|FG001|Overall Study|Physician Decision|0|||
146019124|NCT02526524|526580843|FG002|Overall Study|Physician Decision|0|||
146019125|NCT02526524|526580844|FG003|Overall Study|Physician Decision|0|||
146019126|NCT02526524|526580845|FG004|Overall Study|Physician Decision|1|||
146019127|NCT02526524|526580846|FG005|Overall Study|Physician Decision|0|||
146019128|NCT02526524|526580841|FG000|Overall Study|Sponsor Decision|1|||
146019129|NCT02526524|526580842|FG001|Overall Study|Sponsor Decision|0|||
146019130|NCT02526524|526580843|FG002|Overall Study|Sponsor Decision|0|||
146019131|NCT02526524|526580844|FG003|Overall Study|Sponsor Decision|0|||
146019132|NCT02526524|526580845|FG004|Overall Study|Sponsor Decision|0|||
146019133|NCT02526524|526580846|FG005|Overall Study|Sponsor Decision|0|||
146019134|NCT00470093|526580851|FG000|Overall Study|Adverse Event|2|||
146019135|NCT00664560|526580852|FG000|Overall Study|Adverse Event|19|||
146019136|NCT00664560|526580853|FG001|Overall Study|Adverse Event|16|||
146019137|NCT00664560|526580854|FG002|Overall Study|Adverse Event|7|||
146019138|NCT00664560|526580852|FG000|Overall Study|Withdrawal by Subject|9|||
146019139|NCT00664560|526580853|FG001|Overall Study|Withdrawal by Subject|13|||
146019140|NCT00664560|526580854|FG002|Overall Study|Withdrawal by Subject|7|||
146019141|NCT00664560|526580852|FG000|Overall Study|Lost to Follow-up|0|||
146019142|NCT00664560|526580853|FG001|Overall Study|Lost to Follow-up|2|||
146019143|NCT00664560|526580854|FG002|Overall Study|Lost to Follow-up|0|||
146019144|NCT00664560|526580852|FG000|Overall Study|Other|11|||
146019145|NCT00664560|526580853|FG001|Overall Study|Other|4|||
146019146|NCT00664560|526580854|FG002|Overall Study|Other|5|||
146019147|NCT01610557|526580857|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146019148|NCT01610557|526580858|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
146019149|NCT01610557|526580859|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146019150|NCT01610557|526580860|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146019151|NCT01610557|526580861|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
146019152|NCT01610557|526580857|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146019153|NCT01610557|526580858|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146019154|NCT01610557|526580859|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146094097|NCT04587271|526866543|FG004|Overall Study|Lost to Follow-up|2|||
146251671|NCT02660034|527433372|FG005|Overall Study|Lost to Follow-up|0|||
146251672|NCT02660034|527433373|FG006|Overall Study|Lost to Follow-up|0|||
146251673|NCT02660034|527433374|FG007|Overall Study|Lost to Follow-up|0|||
146251674|NCT02660034|527433375|FG008|Overall Study|Lost to Follow-up|0|||
146251675|NCT02660034|527433376|FG009|Overall Study|Lost to Follow-up|1|||
146251676|NCT02660034|527433377|FG010|Overall Study|Lost to Follow-up|1|||
146251677|NCT02660034|527433378|FG011|Overall Study|Lost to Follow-up|1|||
146019155|NCT01610557|526580860|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
146019156|NCT01610557|526580861|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
146019157|NCT01289353|526580862|FG000|Overall Study|Lost to Follow-up|2|||
146251678|NCT02660034|527433379|FG012|Overall Study|Lost to Follow-up|0|||
146251679|NCT02660034|527433380|FG013|Overall Study|Lost to Follow-up|0|||
146251680|NCT02660034|527433367|FG000|Overall Study|Participant moved into special access scheme|1|||
146019158|NCT01549886|526580863|FG000|Overall Study|Sponsor's decision|2|||
146019159|NCT01549886|526580864|FG001|Overall Study|Sponsor's decision|3|||
146019160|NCT00473668|526580865|FG000|Overall Study|Withdrawal by Subject|0|||
146019161|NCT00473668|526580866|FG001|Overall Study|Withdrawal by Subject|2|||
146019162|NCT00473668|526580867|FG002|Overall Study|Withdrawal by Subject|0|||
146251681|NCT02660034|527433368|FG001|Overall Study|Participant moved into special access scheme|2|||
146251682|NCT02660034|527433369|FG002|Overall Study|Participant moved into special access scheme|0|||
146251683|NCT02660034|527433370|FG003|Overall Study|Participant moved into special access scheme|0|||
146251684|NCT02660034|527433371|FG004|Overall Study|Participant moved into special access scheme|0|||
146019163|NCT00473668|526580865|FG000|Overall Study|Migrated/moved from study area|3|||
146019164|NCT00473668|526580866|FG001|Overall Study|Migrated/moved from study area|2|||
146019165|NCT00473668|526580867|FG002|Overall Study|Migrated/moved from study area|0|||
146019166|NCT00473668|526580865|FG000|Overall Study|Lost to Follow-up|0|||
146019167|NCT00473668|526580866|FG001|Overall Study|Lost to Follow-up|4|||
146019168|NCT00473668|526580867|FG002|Overall Study|Lost to Follow-up|6|||
146019169|NCT00473668|526580865|FG000|Overall Study|Other|2|||
146251685|NCT02660034|527433372|FG005|Overall Study|Participant moved into special access scheme|0|||
146251686|NCT02660034|527433373|FG006|Overall Study|Participant moved into special access scheme|0|||
146251687|NCT02660034|527433374|FG007|Overall Study|Participant moved into special access scheme|0|||
146251688|NCT02660034|527433375|FG008|Overall Study|Participant moved into special access scheme|0|||
146251689|NCT02660034|527433376|FG009|Overall Study|Participant moved into special access scheme|0|||
146251690|NCT02660034|527433377|FG010|Overall Study|Participant moved into special access scheme|0|||
146251691|NCT02660034|527433378|FG011|Overall Study|Participant moved into special access scheme|0|||
146251692|NCT02660034|527433379|FG012|Overall Study|Participant moved into special access scheme|0|||
146251693|NCT02660034|527433380|FG013|Overall Study|Participant moved into special access scheme|0|||
146251694|NCT02660034|527433367|FG000|Overall Study|Adverse Event|1|||
146251695|NCT02660034|527433368|FG001|Overall Study|Adverse Event|0|||
146251696|NCT02660034|527433369|FG002|Overall Study|Adverse Event|0|||
146251697|NCT02660034|527433370|FG003|Overall Study|Adverse Event|0|||
146251698|NCT02660034|527433371|FG004|Overall Study|Adverse Event|0|||
146251699|NCT02660034|527433372|FG005|Overall Study|Adverse Event|0|||
146251700|NCT02660034|527433373|FG006|Overall Study|Adverse Event|0|||
146251701|NCT02660034|527433374|FG007|Overall Study|Adverse Event|0|||
146251702|NCT02660034|527433375|FG008|Overall Study|Adverse Event|0|||
146019170|NCT00473668|526580866|FG001|Overall Study|Other|3|||
146019171|NCT00473668|526580867|FG002|Overall Study|Other|4|||
146019172|NCT02039219|526580868|FG000|Treatment|Withdrawal by Subject|1|||
146019173|NCT02039219|526580869|FG001|Treatment|Withdrawal by Subject|0|||
146019174|NCT02039219|526580868|FG000|Treatment|Adverse Event|0|||
146019175|NCT02039219|526580869|FG001|Treatment|Adverse Event|1|||
146019176|NCT02039219|526580868|FG000|Treatment|Physician Decision|1|||
146019177|NCT02039219|526580869|FG001|Treatment|Physician Decision|0|||
146019178|NCT02039219|526580868|FG000|Treatment|Lost to Follow-up|0|||
146019179|NCT02039219|526580869|FG001|Treatment|Lost to Follow-up|1|||
146019180|NCT02039219|526580868|FG000|Treatment|Protocol Violation|1|||
146094098|NCT04587271|526866544|FG005|Overall Study|Lost to Follow-up|0|||
146094099|NCT04587271|526866539|FG000|Overall Study|Caregiver brought child to visits|0|||
146094100|NCT04587271|526866540|FG001|Overall Study|Caregiver brought child to visits|0|||
146094101|NCT04587271|526866541|FG002|Overall Study|Caregiver brought child to visits|0|||
146094102|NCT04587271|526866542|FG003|Overall Study|Caregiver brought child to visits|1|||
146094103|NCT04587271|526866543|FG004|Overall Study|Caregiver brought child to visits|0|||
146094104|NCT04587271|526866544|FG005|Overall Study|Caregiver brought child to visits|0|||
146094105|NCT02180165|526866545|FG000|Overall Study|Not Treated|0|||
146094106|NCT02180165|526866546|FG001|Overall Study|Not Treated|0|||
146094107|NCT02180165|526866547|FG002|Overall Study|Not Treated|1|||
146094108|NCT02180165|526866548|FG003|Overall Study|Not Treated|0|||
146019181|NCT02039219|526580869|FG001|Treatment|Protocol Violation|0|||
146094109|NCT02180165|526866545|FG000|Overall Study|Adverse Event|7|||
146094110|NCT02180165|526866546|FG001|Overall Study|Adverse Event|0|||
146251703|NCT02660034|527433376|FG009|Overall Study|Adverse Event|0|||
146251704|NCT02660034|527433377|FG010|Overall Study|Adverse Event|0|||
146251705|NCT02660034|527433378|FG011|Overall Study|Adverse Event|0|||
146251706|NCT02660034|527433379|FG012|Overall Study|Adverse Event|0|||
146251707|NCT02660034|527433380|FG013|Overall Study|Adverse Event|0|||
146251708|NCT02660034|527433367|FG000|Overall Study|Sponsor Decision|0|||
146251709|NCT02660034|527433368|FG001|Overall Study|Sponsor Decision|1|||
146251710|NCT02660034|527433369|FG002|Overall Study|Sponsor Decision|2|||
146019182|NCT02039219|526580868|FG000|Treatment|Death|1|||
146094111|NCT02180165|526866547|FG002|Overall Study|Adverse Event|18|||
146019183|NCT02039219|526580869|FG001|Treatment|Death|0|||
146019184|NCT02039219|526580868|FG000|Follow up|Adverse Event|0|||
146019185|NCT02039219|526580869|FG001|Follow up|Adverse Event|1|||
146019186|NCT02226562|526580870|FG000|Overall Study|Lost to Follow-up|0|||
146019187|NCT02226562|526580871|FG001|Overall Study|Lost to Follow-up|1|||
146019188|NCT04569136|526580872|FG000|Overall Study|Lost to Follow-up|2|||
146019189|NCT04569136|526580873|FG001|Overall Study|Lost to Follow-up|0|||
146019190|NCT04569136|526580874|FG002|Overall Study|Lost to Follow-up|1|||
146019191|NCT01466660|526580876|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
146019192|NCT01466660|526580877|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
146019193|NCT01466660|526580876|FG000|Overall Study|Worsening of underlying cancer disease|5|||
146019194|NCT01466660|526580877|FG001|Overall Study|Worsening of underlying cancer disease|2|||
146019195|NCT01466660|526580876|FG000|Overall Study|Other adverse event|19|||
146019196|NCT01466660|526580877|FG001|Overall Study|Other adverse event|18|||
146019197|NCT01466660|526580876|FG000|Overall Study|Protocol Violation|2|||
146019198|NCT01466660|526580877|FG001|Overall Study|Protocol Violation|1|||
146019199|NCT01466660|526580876|FG000|Overall Study|Refused continuation of trial medication|4|||
146019200|NCT01466660|526580877|FG001|Overall Study|Refused continuation of trial medication|3|||
146019201|NCT01466660|526580876|FG000|Overall Study|Other reason not defined above|10|||
146019202|NCT01466660|526580877|FG001|Overall Study|Other reason not defined above|8|||
146019203|NCT00129701|526580878|FG000|Overall Study|Withdrawal by Subject|33|||
146019204|NCT02750345|526580879|FG000|Intervention 1|Adverse Event|0|||
146019205|NCT02750345|526580880|FG001|Intervention 1|Adverse Event|0|||
146019206|NCT02750345|526580881|FG002|Intervention 1|Adverse Event|0|||
146019207|NCT02750345|526580882|FG003|Intervention 1|Adverse Event|0|||
146019208|NCT02750345|526580883|FG004|Intervention 1|Adverse Event|1|||
146019209|NCT02750345|526580884|FG005|Intervention 1|Adverse Event|0|||
146019210|NCT00006164|526580885|FG000|Overall Study|Withdrew or lost to follow-up|70|||
146019211|NCT00006164|526580886|FG001|Overall Study|Withdrew or lost to follow-up|81|||
146019212|NCT00223808|526580887|FG000|Overall Study|<5 hrs therapy before discharge|3|||
146019213|NCT00223808|526580888|FG001|Overall Study|<5 hrs therapy before discharge|5|||
146019214|NCT00223808|526580889|FG002|Overall Study|<5 hrs therapy before discharge|5|||
146019215|NCT00608023|526580890|FG000|Overall Study|Withdrawal by Subject|8|||
146019216|NCT00608023|526580891|FG001|Overall Study|Withdrawal by Subject|10|||
146019217|NCT00608023|526580892|FG002|Overall Study|Withdrawal by Subject|7|||
146019218|NCT00608023|526580890|FG000|Overall Study|Adverse Event|1|||
146019219|NCT00608023|526580891|FG001|Overall Study|Adverse Event|4|||
146019220|NCT00608023|526580892|FG002|Overall Study|Adverse Event|5|||
146019221|NCT00608023|526580890|FG000|Overall Study|Lost to Follow-up|2|||
146019222|NCT00608023|526580891|FG001|Overall Study|Lost to Follow-up|2|||
146019223|NCT00608023|526580892|FG002|Overall Study|Lost to Follow-up|1|||
146019224|NCT00608023|526580890|FG000|Overall Study|Protocol Violation|1|||
146019225|NCT00608023|526580891|FG001|Overall Study|Protocol Violation|3|||
146019226|NCT00608023|526580892|FG002|Overall Study|Protocol Violation|1|||
146019227|NCT00608023|526580890|FG000|Overall Study|Unknown reason|0|||
146019228|NCT00608023|526580891|FG001|Overall Study|Unknown reason|3|||
146019229|NCT00608023|526580892|FG002|Overall Study|Unknown reason|0|||
146019230|NCT01328535|526580893|FG000|Overall Study|Ineligible|1|||
146019231|NCT00758264|526580896|FG000|Active Phase|Withdrawal by Subject|0|||
146019232|NCT00758264|526580897|FG001|Active Phase|Withdrawal by Subject|0|||
146019233|NCT00758264|526580898|FG002|Active Phase|Withdrawal by Subject|1|||
146019234|NCT00758264|526580896|FG000|Active Phase|Lost to Follow-up|1|||
146019235|NCT00758264|526580897|FG001|Active Phase|Lost to Follow-up|0|||
146019236|NCT00758264|526580898|FG002|Active Phase|Lost to Follow-up|0|||
146019237|NCT00758264|526580896|FG000|Active Phase|Other|0|||
146019238|NCT00758264|526580897|FG001|Active Phase|Other|0|||
146019239|NCT00758264|526580898|FG002|Active Phase|Other|4|||
146019240|NCT03655054|526580899|FG000|Overall Study|Lost to Follow-up|1|||
146019241|NCT01054560|526580904|FG000|Overall Study|Death|10|||
146019242|NCT01054560|526580905|FG001|Overall Study|Death|21|||
146019243|NCT01054560|526580904|FG000|Overall Study|Lost to Follow-up|2|||
146019244|NCT01054560|526580905|FG001|Overall Study|Lost to Follow-up|5|||
146019245|NCT01054560|526580904|FG000|Overall Study|Withdrawal by Subject|0|||
146019246|NCT01054560|526580905|FG001|Overall Study|Withdrawal by Subject|2|||
146019247|NCT01054560|526580904|FG000|Overall Study|Physician Decision|1|||
146019248|NCT01054560|526580905|FG001|Overall Study|Physician Decision|0|||
146019249|NCT02135029|526580910|FG000|Overall Study|Adverse Event|2|||
146019250|NCT02135029|526580911|FG001|Overall Study|Adverse Event|2|||
146019251|NCT02135029|526580912|FG002|Overall Study|Adverse Event|2|||
146332887|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146019252|NCT02135029|526580910|FG000|Overall Study|Lost to Follow-up|0|||
146019253|NCT02135029|526580911|FG001|Overall Study|Lost to Follow-up|1|||
146019254|NCT02135029|526580912|FG002|Overall Study|Lost to Follow-up|0|||
146019255|NCT02135029|526580910|FG000|Overall Study|Withdrawal by Subject|2|||
146019256|NCT02135029|526580911|FG001|Overall Study|Withdrawal by Subject|0|||
146019257|NCT02135029|526580912|FG002|Overall Study|Withdrawal by Subject|1|||
146019258|NCT02135029|526580910|FG000|Overall Study|Other|0|||
146019259|NCT02135029|526580911|FG001|Overall Study|Other|1|||
146019260|NCT02135029|526580912|FG002|Overall Study|Other|0|||
146019261|NCT02135029|526580910|FG000|Overall Study|Death|0|||
146019262|NCT02135029|526580911|FG001|Overall Study|Death|1|||
146019263|NCT02135029|526580912|FG002|Overall Study|Death|0|||
146019264|NCT00712725|526580913|FG000|Overall Study|Adverse Event|1|||
146019265|NCT00712725|526580914|FG001|Overall Study|Adverse Event|0|||
146019266|NCT00712725|526580915|FG002|Overall Study|Adverse Event|0|||
146019267|NCT00712725|526580916|FG003|Overall Study|Adverse Event|1|||
146019268|NCT00712725|526580917|FG004|Overall Study|Adverse Event|0|||
146019269|NCT00712725|526580918|FG005|Overall Study|Adverse Event|0|||
146019270|NCT00712725|526580919|FG006|Overall Study|Adverse Event|0|||
146019271|NCT00712725|526580920|FG007|Overall Study|Adverse Event|0|||
146019272|NCT00712725|526580913|FG000|Overall Study|Lost to Follow-up|3|||
146019273|NCT00712725|526580914|FG001|Overall Study|Lost to Follow-up|2|||
146019274|NCT00712725|526580915|FG002|Overall Study|Lost to Follow-up|1|||
146019275|NCT00712725|526580916|FG003|Overall Study|Lost to Follow-up|1|||
146019276|NCT00712725|526580917|FG004|Overall Study|Lost to Follow-up|2|||
146019277|NCT00712725|526580918|FG005|Overall Study|Lost to Follow-up|2|||
146019278|NCT00712725|526580919|FG006|Overall Study|Lost to Follow-up|3|||
146019279|NCT00712725|526580920|FG007|Overall Study|Lost to Follow-up|1|||
146019280|NCT00712725|526580913|FG000|Overall Study|Physician Decision|2|||
146019281|NCT00712725|526580914|FG001|Overall Study|Physician Decision|0|||
146019282|NCT00712725|526580915|FG002|Overall Study|Physician Decision|0|||
146019283|NCT00712725|526580916|FG003|Overall Study|Physician Decision|0|||
146019284|NCT00712725|526580917|FG004|Overall Study|Physician Decision|1|||
146019285|NCT00712725|526580918|FG005|Overall Study|Physician Decision|0|||
146019286|NCT00712725|526580919|FG006|Overall Study|Physician Decision|2|||
146019287|NCT00712725|526580920|FG007|Overall Study|Physician Decision|0|||
146019288|NCT00712725|526580913|FG000|Overall Study|Pregnancy|0|||
146019289|NCT00712725|526580914|FG001|Overall Study|Pregnancy|1|||
146019290|NCT00712725|526580915|FG002|Overall Study|Pregnancy|0|||
146019291|NCT00712725|526580916|FG003|Overall Study|Pregnancy|0|||
146019292|NCT00712725|526580917|FG004|Overall Study|Pregnancy|1|||
146019293|NCT00712725|526580918|FG005|Overall Study|Pregnancy|0|||
146019294|NCT00712725|526580919|FG006|Overall Study|Pregnancy|2|||
146019295|NCT00712725|526580920|FG007|Overall Study|Pregnancy|0|||
146019296|NCT00712725|526580913|FG000|Overall Study|Protocol Violation|2|||
146019297|NCT00712725|526580914|FG001|Overall Study|Protocol Violation|0|||
146019298|NCT00712725|526580915|FG002|Overall Study|Protocol Violation|1|||
146019299|NCT00712725|526580916|FG003|Overall Study|Protocol Violation|3|||
146019300|NCT00712725|526580917|FG004|Overall Study|Protocol Violation|2|||
146019301|NCT00712725|526580918|FG005|Overall Study|Protocol Violation|0|||
146019302|NCT00712725|526580919|FG006|Overall Study|Protocol Violation|1|||
146019303|NCT00712725|526580920|FG007|Overall Study|Protocol Violation|1|||
146019304|NCT00712725|526580913|FG000|Overall Study|Withdrawal by Subject|2|||
146019305|NCT00712725|526580914|FG001|Overall Study|Withdrawal by Subject|1|||
146019306|NCT00712725|526580915|FG002|Overall Study|Withdrawal by Subject|1|||
146019307|NCT00712725|526580916|FG003|Overall Study|Withdrawal by Subject|2|||
146094112|NCT02180165|526866548|FG003|Overall Study|Adverse Event|3|||
146094113|NCT02180165|526866545|FG000|Overall Study|Lack of Efficacy|0|||
146094114|NCT02180165|526866546|FG001|Overall Study|Lack of Efficacy|1|||
146094115|NCT02180165|526866547|FG002|Overall Study|Lack of Efficacy|3|||
146094116|NCT02180165|526866548|FG003|Overall Study|Lack of Efficacy|2|||
146094117|NCT02180165|526866545|FG000|Overall Study|Physician Decision|1|||
146094118|NCT02180165|526866546|FG001|Overall Study|Physician Decision|0|||
146094119|NCT02180165|526866547|FG002|Overall Study|Physician Decision|5|||
146094120|NCT02180165|526866548|FG003|Overall Study|Physician Decision|0|||
146094121|NCT02180165|526866545|FG000|Overall Study|Withdrawal by Subject|3|||
146094122|NCT02180165|526866546|FG001|Overall Study|Withdrawal by Subject|0|||
146094123|NCT02180165|526866547|FG002|Overall Study|Withdrawal by Subject|2|||
146019308|NCT00712725|526580917|FG004|Overall Study|Withdrawal by Subject|1|||
146019309|NCT00712725|526580918|FG005|Overall Study|Withdrawal by Subject|1|||
146019310|NCT00712725|526580919|FG006|Overall Study|Withdrawal by Subject|1|||
146019311|NCT00712725|526580920|FG007|Overall Study|Withdrawal by Subject|2|||
146019312|NCT00712725|526580913|FG000|Overall Study|Lack of Qualifying Event|16|||
146019313|NCT00712725|526580914|FG001|Overall Study|Lack of Qualifying Event|2|||
146019314|NCT00712725|526580915|FG002|Overall Study|Lack of Qualifying Event|6|||
146019315|NCT00712725|526580916|FG003|Overall Study|Lack of Qualifying Event|8|||
146019316|NCT00712725|526580917|FG004|Overall Study|Lack of Qualifying Event|11|||
146094124|NCT02180165|526866548|FG003|Overall Study|Withdrawal by Subject|1|||
146332888|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
146019317|NCT00712725|526580918|FG005|Overall Study|Lack of Qualifying Event|13|||
146019318|NCT00712725|526580919|FG006|Overall Study|Lack of Qualifying Event|11|||
146019319|NCT00712725|526580920|FG007|Overall Study|Lack of Qualifying Event|6|||
146094125|NCT00723398|526866549|FG000|Overall Study|Withdrawal by Subject|2|||
146094126|NCT00723398|526866550|FG001|Overall Study|Withdrawal by Subject|6|||
146094127|NCT00723398|526866551|FG002|Overall Study|Withdrawal by Subject|4|||
146019320|NCT00712725|526580913|FG000|Overall Study|Protocol Specified Criteria|3|||
146019321|NCT00712725|526580914|FG001|Overall Study|Protocol Specified Criteria|0|||
146019322|NCT00712725|526580915|FG002|Overall Study|Protocol Specified Criteria|1|||
146019323|NCT00712725|526580916|FG003|Overall Study|Protocol Specified Criteria|2|||
146019324|NCT00712725|526580917|FG004|Overall Study|Protocol Specified Criteria|1|||
146019325|NCT00712725|526580918|FG005|Overall Study|Protocol Specified Criteria|0|||
146019326|NCT00712725|526580919|FG006|Overall Study|Protocol Specified Criteria|2|||
146019327|NCT00712725|526580920|FG007|Overall Study|Protocol Specified Criteria|1|||
146019328|NCT03466099|526580921|FG000|Overall Study|Adverse Event|1|||
146019329|NCT03466099|526580922|FG001|Overall Study|Adverse Event|1|||
146019330|NCT03466099|526580923|FG002|Overall Study|Adverse Event|1|||
146019331|NCT03466099|526580921|FG000|Overall Study|Withdrawal by Subject|2|||
146019332|NCT03466099|526580922|FG001|Overall Study|Withdrawal by Subject|3|||
146019333|NCT03466099|526580923|FG002|Overall Study|Withdrawal by Subject|1|||
146019334|NCT03466099|526580921|FG000|Overall Study|Use of rescue medication|8|||
146019335|NCT03466099|526580922|FG001|Overall Study|Use of rescue medication|9|||
146019336|NCT03466099|526580923|FG002|Overall Study|Use of rescue medication|13|||
146019337|NCT03466099|526580921|FG000|Overall Study|Rescued without meeting criteria|4|||
146019338|NCT03466099|526580922|FG001|Overall Study|Rescued without meeting criteria|1|||
146019339|NCT03466099|526580923|FG002|Overall Study|Rescued without meeting criteria|1|||
146019340|NCT03466099|526580921|FG000|Overall Study|Subject compliance|2|||
146019341|NCT03466099|526580922|FG001|Overall Study|Subject compliance|0|||
146019342|NCT03466099|526580923|FG002|Overall Study|Subject compliance|0|||
146019343|NCT03466099|526580921|FG000|Overall Study|Worsening disease|0|||
146019344|NCT03466099|526580922|FG001|Overall Study|Worsening disease|0|||
146019345|NCT03466099|526580923|FG002|Overall Study|Worsening disease|1|||
146019346|NCT03525600|526580926|FG000|Overall Study|Adverse Event|9|||
146019347|NCT03525600|526580927|FG001|Overall Study|Adverse Event|6|||
146019348|NCT03525600|526580928|FG002|Overall Study|Adverse Event|5|||
146019349|NCT03525600|526580929|FG003|Overall Study|Adverse Event|3|||
146019350|NCT03525600|526580926|FG000|Overall Study|Lost to Follow-up|2|||
146019351|NCT03525600|526580927|FG001|Overall Study|Lost to Follow-up|4|||
146019352|NCT03525600|526580928|FG002|Overall Study|Lost to Follow-up|4|||
146019353|NCT03525600|526580929|FG003|Overall Study|Lost to Follow-up|0|||
146019354|NCT03525600|526580926|FG000|Overall Study|Physician Decision|1|||
146019355|NCT03525600|526580927|FG001|Overall Study|Physician Decision|0|||
146019356|NCT03525600|526580928|FG002|Overall Study|Physician Decision|2|||
146019357|NCT03525600|526580929|FG003|Overall Study|Physician Decision|0|||
146019358|NCT03525600|526580926|FG000|Overall Study|Consent withdrawal|36|||
146019359|NCT03525600|526580927|FG001|Overall Study|Consent withdrawal|20|||
146019360|NCT03525600|526580928|FG002|Overall Study|Consent withdrawal|6|||
146019361|NCT03525600|526580929|FG003|Overall Study|Consent withdrawal|13|||
146019362|NCT03525600|526580926|FG000|Overall Study|Death|7|||
146019363|NCT03525600|526580927|FG001|Overall Study|Death|6|||
146019364|NCT03525600|526580928|FG002|Overall Study|Death|4|||
146019365|NCT03525600|526580929|FG003|Overall Study|Death|3|||
146019366|NCT03525600|526580926|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
146019367|NCT03525600|526580927|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
146019368|NCT03525600|526580928|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
146019369|NCT03525600|526580929|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
146019370|NCT03525600|526580926|FG000|Overall Study|Other|0|||
146019371|NCT03525600|526580927|FG001|Overall Study|Other|1|||
146019372|NCT03525600|526580928|FG002|Overall Study|Other|0|||
146019373|NCT03525600|526580929|FG003|Overall Study|Other|0|||
146019374|NCT01923363|526580932|FG000|Overall Study|Protocol Violation|1|||
146019375|NCT00290771|526580933|FG000|Overall Study|Disease progression|95|||
146019376|NCT00290771|526580934|FG001|Overall Study|Disease progression|73|||
146019377|NCT00290771|526580933|FG000|Overall Study|Death|11|||
146019378|NCT00290771|526580934|FG001|Overall Study|Death|10|||
146019379|NCT00290771|526580933|FG000|Overall Study|Adverse Event|12|||
146019380|NCT00290771|526580934|FG001|Overall Study|Adverse Event|6|||
146019381|NCT00290771|526580933|FG000|Overall Study|Withdrawal by Subject|5|||
146019382|NCT00290771|526580934|FG001|Overall Study|Withdrawal by Subject|6|||
146019383|NCT00290771|526580933|FG000|Overall Study|Administrative problems|2|||
146019384|NCT00290771|526580934|FG001|Overall Study|Administrative problems|1|||
146019385|NCT00290771|526580933|FG000|Overall Study|Protocol Violation|2|||
146019386|NCT00290771|526580934|FG001|Overall Study|Protocol Violation|0|||
146019387|NCT00290771|526580933|FG000|Overall Study|Lost to Follow-up|0|||
146019388|NCT00290771|526580934|FG001|Overall Study|Lost to Follow-up|1|||
146019389|NCT05129449|526580935|FG000|Overall Study|Protocol Violation|1|||
146019390|NCT01818258|526580939|FG000|Overall Study|Death|3|||
146019391|NCT01818258|526580940|FG001|Overall Study|Death|0|||
146019392|NCT01818258|526580939|FG000|Overall Study|Withdrawal by Subject|0|||
146019393|NCT01818258|526580940|FG001|Overall Study|Withdrawal by Subject|1|||
146019394|NCT01818258|526580939|FG000|Overall Study|Lost to Follow-up|0|||
146019395|NCT01818258|526580940|FG001|Overall Study|Lost to Follow-up|1|||
146019396|NCT01818258|526580939|FG000|Overall Study|Unable to Travel to Clinic|0|||
146019397|NCT01818258|526580940|FG001|Overall Study|Unable to Travel to Clinic|1|||
146019398|NCT02099344|526580943|FG000|Overall Study|Physician Decision|1|||
146019399|NCT02099344|526580944|FG001|Overall Study|Physician Decision|0|||
146019400|NCT03802630|526580947|FG000|Overall Study|Study terminated by sponsor|130|||
146019401|NCT03802630|526580948|FG001|Overall Study|Study terminated by sponsor|134|||
146019402|NCT03802630|526580947|FG000|Overall Study|Subject decision|16|||
146019403|NCT03802630|526580948|FG001|Overall Study|Subject decision|9|||
146019404|NCT03802630|526580947|FG000|Overall Study|Adverse Event|3|||
146019405|NCT03802630|526580948|FG001|Overall Study|Adverse Event|1|||
146019406|NCT03802630|526580947|FG000|Overall Study|Lost to Follow-up|2|||
146019407|NCT03802630|526580948|FG001|Overall Study|Lost to Follow-up|2|||
146019408|NCT03802630|526580947|FG000|Overall Study|Physician Decision|2|||
146019409|NCT03802630|526580948|FG001|Overall Study|Physician Decision|0|||
146019410|NCT03802630|526580947|FG000|Overall Study|Death|0|||
146019411|NCT03802630|526580948|FG001|Overall Study|Death|2|||
146019412|NCT00661726|526580949|FG000|Overall Study|Adverse Event|1|||
146019413|NCT02644096|526580950|FG000|Overall Study|Withdrawal by Subject|28|||
146019414|NCT02644096|526580951|FG001|Overall Study|Withdrawal by Subject|25|||
146019415|NCT00322452|526580952|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146019416|NCT00322452|526580953|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146019417|NCT00322452|526580952|FG000|Overall Study|Lost to Follow-up|5|||
146019418|NCT00322452|526580953|FG001|Overall Study|Lost to Follow-up|2|||
146019419|NCT00322452|526580952|FG000|Overall Study|Withdrawal by Subject|19|||
146019420|NCT00322452|526580953|FG001|Overall Study|Withdrawal by Subject|46|||
146019421|NCT00322452|526580952|FG000|Overall Study|Death|223|||
146019422|NCT00322452|526580953|FG001|Overall Study|Death|227|||
146019423|NCT00526656|526580954|FG000|Overall Study|Death|1|||
146019424|NCT00526656|526580954|FG000|Overall Study|Refused surgery|1|||
146019425|NCT03319953|526580955|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
146019426|NCT03319953|526580956|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146019427|NCT03319953|526580957|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146019428|NCT03319953|526580958|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
146019429|NCT03319953|526580955|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
146019430|NCT03319953|526580956|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
146019431|NCT03319953|526580957|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
146019432|NCT03319953|526580958|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
146019433|NCT01795495|526580960|FG000|Overall Study|Protocol Violation|1|||
146019434|NCT01795495|526580961|FG001|Overall Study|Protocol Violation|0|||
146019435|NCT01795495|526580962|FG002|Overall Study|Protocol Violation|1|||
146019436|NCT01795495|526580960|FG000|Overall Study|Physician Decision|0|||
146019437|NCT01795495|526580961|FG001|Overall Study|Physician Decision|0|||
146019438|NCT01795495|526580962|FG002|Overall Study|Physician Decision|1|||
146019439|NCT00790868|526582900|FG000|Overall Study|Withdrawal by Subject|4|||
146019440|NCT00790868|526582901|FG001|Overall Study|Withdrawal by Subject|5|||
146019441|NCT00790868|526582900|FG000|Overall Study|Lost to Follow-up|2|||
146019442|NCT00790868|526582901|FG001|Overall Study|Lost to Follow-up|12|||
146019443|NCT01579565|526582902|FG000|Randomized|Adverse Event|1|||
146019444|NCT01579565|526582903|FG001|Randomized|Adverse Event|3|||
146019445|NCT01579565|526582902|FG000|Randomized|Withdrawal by Subject|3|||
146019446|NCT01579565|526582903|FG001|Randomized|Withdrawal by Subject|0|||
146019447|NCT01579565|526582902|FG000|Randomized|inadequate preoperative pupil dilation|0|||
146019448|NCT01579565|526582903|FG001|Randomized|inadequate preoperative pupil dilation|1|||
146019449|NCT01579565|526582902|FG000|Randomized|prohibited preoperative eating|1|||
146019450|NCT01579565|526582903|FG001|Randomized|prohibited preoperative eating|0|||
146019451|NCT01579565|526582902|FG000|Randomized|prohibited preoperative medication|0|||
146019452|NCT01579565|526582903|FG001|Randomized|prohibited preoperative medication|1|||
146019453|NCT01579565|526582902|FG000|Treated|Physician Decision|0|||
146019454|NCT01579565|526582903|FG001|Treated|Physician Decision|1|||
146019455|NCT01579565|526582902|FG000|Treated|Lost to Follow-up|2|||
146019456|NCT01579565|526582903|FG001|Treated|Lost to Follow-up|1|||
146019457|NCT01579565|526582902|FG000|Treated|declined to return for final visit|0|||
146019458|NCT01579565|526582903|FG001|Treated|declined to return for final visit|1|||
146019459|NCT02791191|526582904|FG000|Overall Study|Adverse Event|2|||
146019460|NCT02791191|526582905|FG001|Overall Study|Adverse Event|4|||
146019461|NCT02791191|526582906|FG002|Overall Study|Adverse Event|5|||
146019462|NCT02791191|526582904|FG000|Overall Study|Lack of Efficacy|0|||
146019463|NCT02791191|526582905|FG001|Overall Study|Lack of Efficacy|1|||
146019464|NCT02791191|526582906|FG002|Overall Study|Lack of Efficacy|0|||
146019465|NCT02791191|526582904|FG000|Overall Study|Study Drug Non-Compliance|0|||
146019466|NCT02791191|526582905|FG001|Overall Study|Study Drug Non-Compliance|2|||
146019467|NCT02791191|526582906|FG002|Overall Study|Study Drug Non-Compliance|0|||
146019468|NCT02791191|526582904|FG000|Overall Study|Site Closed by Sponsor|1|||
146019469|NCT02791191|526582905|FG001|Overall Study|Site Closed by Sponsor|1|||
146019470|NCT02791191|526582906|FG002|Overall Study|Site Closed by Sponsor|3|||
146019471|NCT02791191|526582904|FG000|Overall Study|Progressive Disease|1|||
146019472|NCT02791191|526582905|FG001|Overall Study|Progressive Disease|0|||
146019473|NCT02791191|526582906|FG002|Overall Study|Progressive Disease|0|||
146019474|NCT02791191|526582904|FG000|Overall Study|Study Terminated by Sponsor|29|||
146019475|NCT02791191|526582905|FG001|Overall Study|Study Terminated by Sponsor|101|||
146019476|NCT02791191|526582906|FG002|Overall Study|Study Terminated by Sponsor|109|||
146019477|NCT02791191|526582904|FG000|Overall Study|Withdrawal by Subject|3|||
146019478|NCT02791191|526582905|FG001|Overall Study|Withdrawal by Subject|1|||
146019479|NCT02791191|526582906|FG002|Overall Study|Withdrawal by Subject|3|||
146019480|NCT02791191|526582904|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
146019481|NCT02791191|526582905|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
146019482|NCT02791191|526582906|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
146019483|NCT02290691|526582909|FG000|Overall Study|Noncompliance|0|||
146019484|NCT02290691|526582910|FG001|Overall Study|Noncompliance|1|||
146019485|NCT02290691|526582909|FG000|Overall Study|Withdrawal by Subject|1|||
146019486|NCT02290691|526582910|FG001|Overall Study|Withdrawal by Subject|1|||
146019487|NCT02290691|526582909|FG000|Overall Study|Lost to Follow-up|7|||
146019488|NCT02290691|526582910|FG001|Overall Study|Lost to Follow-up|7|||
146019489|NCT00978380|526582911|FG000|Overall Study|Protocol Violation|2|||
146019490|NCT00978380|526582911|FG000|Overall Study|Withdrawal criteria|9|||
146019491|NCT00978380|526582911|FG000|Overall Study|Unclassified|8|||
146019492|NCT02199314|526582912|FG000|Overall Study|Withdrawal by Subject|6|||
146019493|NCT02199314|526582912|FG000|Overall Study|Physician Decision|10|||
146019494|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Adverse Event|76|||
146019495|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Adverse Event|0|||
146094128|NCT00723398|526866552|FG003|Overall Study|Withdrawal by Subject|4|||
146251711|NCT02660034|527433370|FG003|Overall Study|Sponsor Decision|2|||
146251712|NCT02660034|527433371|FG004|Overall Study|Sponsor Decision|3|||
146251713|NCT02660034|527433372|FG005|Overall Study|Sponsor Decision|0|||
146251714|NCT02660034|527433373|FG006|Overall Study|Sponsor Decision|0|||
146251715|NCT02660034|527433374|FG007|Overall Study|Sponsor Decision|0|||
146251716|NCT02660034|527433375|FG008|Overall Study|Sponsor Decision|0|||
146251717|NCT02660034|527433376|FG009|Overall Study|Sponsor Decision|0|||
146251718|NCT02660034|527433377|FG010|Overall Study|Sponsor Decision|0|||
146251719|NCT02660034|527433378|FG011|Overall Study|Sponsor Decision|0|||
146251720|NCT02660034|527433379|FG012|Overall Study|Sponsor Decision|0|||
146251721|NCT02660034|527433380|FG013|Overall Study|Sponsor Decision|1|||
146251722|NCT02660034|527433367|FG000|Overall Study|Withdrawal by Subject|0|||
146251723|NCT02660034|527433368|FG001|Overall Study|Withdrawal by Subject|0|||
146251724|NCT02660034|527433369|FG002|Overall Study|Withdrawal by Subject|0|||
146251725|NCT02660034|527433370|FG003|Overall Study|Withdrawal by Subject|0|||
146251726|NCT02660034|527433371|FG004|Overall Study|Withdrawal by Subject|0|||
146251727|NCT02660034|527433372|FG005|Overall Study|Withdrawal by Subject|0|||
146251728|NCT02660034|527433373|FG006|Overall Study|Withdrawal by Subject|1|||
146251729|NCT02660034|527433374|FG007|Overall Study|Withdrawal by Subject|1|||
146251730|NCT02660034|527433375|FG008|Overall Study|Withdrawal by Subject|1|||
146251731|NCT02660034|527433376|FG009|Overall Study|Withdrawal by Subject|0|||
146251732|NCT02660034|527433377|FG010|Overall Study|Withdrawal by Subject|0|||
146251733|NCT02660034|527433378|FG011|Overall Study|Withdrawal by Subject|1|||
146251734|NCT02660034|527433379|FG012|Overall Study|Withdrawal by Subject|2|||
146251735|NCT02660034|527433380|FG013|Overall Study|Withdrawal by Subject|0|||
146251736|NCT02660034|527433367|FG000|Overall Study|Death|0|||
146251737|NCT02660034|527433368|FG001|Overall Study|Death|0|||
146251738|NCT02660034|527433369|FG002|Overall Study|Death|0|||
146251739|NCT02660034|527433370|FG003|Overall Study|Death|0|||
146251740|NCT02660034|527433371|FG004|Overall Study|Death|0|||
146251741|NCT02660034|527433372|FG005|Overall Study|Death|13|||
146251742|NCT02660034|527433373|FG006|Overall Study|Death|14|||
146251743|NCT02660034|527433374|FG007|Overall Study|Death|10|||
146251744|NCT02660034|527433375|FG008|Overall Study|Death|9|||
146251745|NCT02660034|527433376|FG009|Overall Study|Death|21|||
146251746|NCT02660034|527433377|FG010|Overall Study|Death|17|||
146251747|NCT02660034|527433378|FG011|Overall Study|Death|15|||
146251748|NCT02660034|527433379|FG012|Overall Study|Death|18|||
146251749|NCT02660034|527433380|FG013|Overall Study|Death|7|||
146251750|NCT02660034|527433367|FG000|Overall Study|Physician Decision|0|||
146251751|NCT02660034|527433368|FG001|Overall Study|Physician Decision|0|||
146251752|NCT02660034|527433369|FG002|Overall Study|Physician Decision|0|||
146251753|NCT02660034|527433370|FG003|Overall Study|Physician Decision|0|||
146251754|NCT02660034|527433371|FG004|Overall Study|Physician Decision|0|||
146251755|NCT02660034|527433372|FG005|Overall Study|Physician Decision|0|||
146251756|NCT02660034|527433373|FG006|Overall Study|Physician Decision|0|||
146251757|NCT02660034|527433374|FG007|Overall Study|Physician Decision|0|||
146251758|NCT02660034|527433375|FG008|Overall Study|Physician Decision|0|||
146251759|NCT02660034|527433376|FG009|Overall Study|Physician Decision|0|||
146251760|NCT02660034|527433377|FG010|Overall Study|Physician Decision|0|||
146251761|NCT02660034|527433378|FG011|Overall Study|Physician Decision|0|||
146251762|NCT02660034|527433379|FG012|Overall Study|Physician Decision|0|||
146251763|NCT02660034|527433380|FG013|Overall Study|Physician Decision|1|||
146251764|NCT02660034|527433367|FG000|Overall Study|Participants transferred to LTE|0|||
146251765|NCT02660034|527433368|FG001|Overall Study|Participants transferred to LTE|0|||
146251766|NCT02660034|527433369|FG002|Overall Study|Participants transferred to LTE|0|||
146251767|NCT02660034|527433370|FG003|Overall Study|Participants transferred to LTE|0|||
146251768|NCT02660034|527433371|FG004|Overall Study|Participants transferred to LTE|0|||
146251769|NCT02660034|527433372|FG005|Overall Study|Participants transferred to LTE|10|||
146251770|NCT02660034|527433373|FG006|Overall Study|Participants transferred to LTE|8|||
146251771|NCT02660034|527433374|FG007|Overall Study|Participants transferred to LTE|8|||
146251772|NCT02660034|527433375|FG008|Overall Study|Participants transferred to LTE|10|||
146019496|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Adverse Event|0|||
146019497|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Death|3|||
146019498|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Death|0|||
146019499|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Death|0|||
146019500|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
146019501|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
146019502|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
146019503|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Physician Decision|9|||
146019504|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Physician Decision|0|||
146019505|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Physician Decision|0|||
146019506|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
146019507|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
146019508|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
146019509|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Disease progression|45|||
146019510|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Disease progression|0|||
146019511|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Disease progression|0|||
146019512|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
146019513|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
146019514|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
146019515|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
146019516|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
146019517|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
146019518|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
146019519|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
146019520|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
146019521|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
146019522|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
146019523|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
146019524|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
146019525|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
146019526|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
146019527|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
146019528|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
146019529|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
146019530|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
146019531|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
146019532|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
146019533|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
146019534|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
146019535|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
146019536|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
146019537|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
146019538|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
146019539|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Promotor request|1|||
146019540|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Promotor request|0|||
146019541|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Promotor request|0|||
146019542|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
146019543|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
146019544|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
146019545|NCT01461928|526582913|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
146019546|NCT01461928|526582914|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
146019547|NCT01461928|526582915|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
146019548|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Death|3|||
146019549|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Death|0|||
146019550|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Death|0|||
146019551|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
146019552|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
146019553|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
146019554|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
146019555|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
146019556|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
146019557|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Diseases progression|91|||
146019558|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Diseases progression|0|||
146019559|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Diseases progression|0|||
146019560|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Adverse Event|70|||
146019561|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Adverse Event|0|||
146019562|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Adverse Event|0|||
146019563|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Physician Decision|9|||
146251773|NCT02660034|527433376|FG009|Overall Study|Participants transferred to LTE|1|||
146251774|NCT02660034|527433377|FG010|Overall Study|Participants transferred to LTE|2|||
146251775|NCT02660034|527433378|FG011|Overall Study|Participants transferred to LTE|4|||
146251776|NCT02660034|527433379|FG012|Overall Study|Participants transferred to LTE|1|||
146251777|NCT02660034|527433380|FG013|Overall Study|Participants transferred to LTE|1|||
146251778|NCT01403805|527433383|FG000|Overall Study|Withdrawal by Subject|0|||
146251779|NCT01403805|527433384|FG001|Overall Study|Withdrawal by Subject|4|||
146251780|NCT01403805|527433383|FG000|Overall Study|Lost to Follow-up|0|||
146251781|NCT01403805|527433384|FG001|Overall Study|Lost to Follow-up|2|||
146251782|NCT01403805|527433383|FG000|Overall Study|Death|0|||
146251783|NCT01403805|527433384|FG001|Overall Study|Death|1|||
146251784|NCT00147745|527433385|FG000|Overall Study|Withdrawal by Subject|1|||
146251785|NCT00147745|527433386|FG001|Overall Study|Withdrawal by Subject|0|||
146251786|NCT00147745|527433387|FG002|Overall Study|Withdrawal by Subject|0|||
146251787|NCT00316121|527433391|FG000|Overall Study|Death|1|||
146251788|NCT00316121|527433392|FG001|Overall Study|Death|0|||
146251789|NCT00316121|527433391|FG000|Overall Study|Lost to Follow-up|14|||
146251790|NCT00316121|527433392|FG001|Overall Study|Lost to Follow-up|8|||
146251791|NCT00316121|527433391|FG000|Overall Study|Withdrawal by Subject|2|||
146251792|NCT00316121|527433392|FG001|Overall Study|Withdrawal by Subject|0|||
146251793|NCT00316121|527433391|FG000|Overall Study|Reason is missing|1|||
146251794|NCT00316121|527433392|FG001|Overall Study|Reason is missing|0|||
146251795|NCT00316121|527433391|FG000|Overall Study|Subject relocated|1|||
146251796|NCT00316121|527433392|FG001|Overall Study|Subject relocated|1|||
146251797|NCT00316121|527433391|FG000|Overall Study|Subject refused to return|1|||
146251798|NCT00316121|527433392|FG001|Overall Study|Subject refused to return|0|||
146251799|NCT00316121|527433391|FG000|Overall Study|Subject no show for visit x 3|1|||
146251800|NCT00316121|527433392|FG001|Overall Study|Subject no show for visit x 3|0|||
146251801|NCT00316121|527433391|FG000|Overall Study|Subject did not have 24 month visit|1|||
146251802|NCT00316121|527433392|FG001|Overall Study|Subject did not have 24 month visit|0|||
146251803|NCT03045302|527433397|FG000|Overall Study|Pre-treatment adverse event|1|||
146251804|NCT00134056|527433398|FG000|Randomization|Not eligible for assigned treatment|22|||
146251805|NCT00134056|527433399|FG001|Randomization|Not eligible for assigned treatment|20|||
146251806|NCT00134056|527433398|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
146251807|NCT00134056|527433399|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
146251808|NCT00134056|527433398|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
146251809|NCT00134056|527433399|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
146251810|NCT00134056|527433398|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
146251811|NCT00134056|527433399|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
146251812|NCT00134056|527433398|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
146251813|NCT00134056|527433399|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
146251814|NCT00742560|527433401|FG000|Overall Study|Adverse Event|0|||
146251815|NCT00742560|527433402|FG001|Overall Study|Adverse Event|0|||
146251816|NCT00742560|527433403|FG002|Overall Study|Adverse Event|1|||
146251817|NCT00742560|527433404|FG003|Overall Study|Adverse Event|1|||
146251818|NCT00742560|527433405|FG004|Overall Study|Adverse Event|1|||
146251819|NCT00742560|527433401|FG000|Overall Study|Death|0|||
146251820|NCT00742560|527433402|FG001|Overall Study|Death|2|||
146251821|NCT00742560|527433403|FG002|Overall Study|Death|0|||
146300254|NCT05211739|527615191|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
146300255|NCT05211739|527615190|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
146300256|NCT05211739|527615191|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
146300257|NCT05211739|527615190|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
146300258|NCT05211739|527615191|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
146300259|NCT03681951|527615192|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
146300260|NCT03681951|527615193|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146300261|NCT03681951|527615194|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146251822|NCT00742560|527433404|FG003|Overall Study|Death|2|||
146251823|NCT00742560|527433405|FG004|Overall Study|Death|3|||
146251824|NCT00742560|527433401|FG000|Overall Study|Subject's Decision|1|||
146251825|NCT00742560|527433402|FG001|Overall Study|Subject's Decision|0|||
146251826|NCT00742560|527433403|FG002|Overall Study|Subject's Decision|2|||
146251827|NCT00742560|527433404|FG003|Overall Study|Subject's Decision|3|||
146251828|NCT00742560|527433405|FG004|Overall Study|Subject's Decision|3|||
146251829|NCT00742560|527433401|FG000|Overall Study|Investigator's Decision|0|||
146251830|NCT00742560|527433402|FG001|Overall Study|Investigator's Decision|0|||
146251831|NCT00742560|527433403|FG002|Overall Study|Investigator's Decision|4|||
146251832|NCT00742560|527433404|FG003|Overall Study|Investigator's Decision|1|||
146251833|NCT00742560|527433405|FG004|Overall Study|Investigator's Decision|0|||
146251834|NCT00742560|527433401|FG000|Overall Study|Disease Progression|1|||
146251835|NCT00742560|527433402|FG001|Overall Study|Disease Progression|0|||
146251836|NCT00742560|527433403|FG002|Overall Study|Disease Progression|5|||
146251837|NCT00742560|527433404|FG003|Overall Study|Disease Progression|17|||
146251838|NCT00742560|527433405|FG004|Overall Study|Disease Progression|16|||
146251839|NCT00742560|527433401|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
146251840|NCT00742560|527433402|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
146251841|NCT00742560|527433403|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
146251842|NCT00742560|527433404|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
146251843|NCT00742560|527433405|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
146251844|NCT00742560|527433401|FG000|Overall Study|Other|0|||
146251845|NCT00742560|527433402|FG001|Overall Study|Other|1|||
146251846|NCT00742560|527433403|FG002|Overall Study|Other|8|||
146251847|NCT00742560|527433404|FG003|Overall Study|Other|9|||
146251848|NCT00742560|527433405|FG004|Overall Study|Other|9|||
146251849|NCT00742560|527433401|FG000|Overall Study|MIssing|0|||
146251850|NCT00742560|527433402|FG001|Overall Study|MIssing|0|||
146251851|NCT00742560|527433403|FG002|Overall Study|MIssing|0|||
146251852|NCT00742560|527433404|FG003|Overall Study|MIssing|0|||
146251853|NCT00742560|527433405|FG004|Overall Study|MIssing|1|||
146251854|NCT01536795|527433406|FG000|Overall Study|Lost to Follow-up|0|||
146251855|NCT01536795|527433407|FG001|Overall Study|Lost to Follow-up|2|||
146251856|NCT01536795|527433406|FG000|Overall Study|Lack of Efficacy|1|||
146251857|NCT01536795|527433407|FG001|Overall Study|Lack of Efficacy|0|||
146251858|NCT04985604|527433408|FG000|Overall Study|Death|4|||
146251859|NCT04985604|527433409|FG001|Overall Study|Death|6|||
146251860|NCT04985604|527433408|FG000|Overall Study|Withdrawal by Subject|0|||
146251861|NCT04985604|527433409|FG001|Overall Study|Withdrawal by Subject|1|||
146251862|NCT04598776|527433410|FG000|Overall Study|Protocol Violation|5|||
146251863|NCT04598776|527433410|FG000|Overall Study|Physician Decision|4|||
146251864|NCT00348283|527433411|FG000|Induction|Adverse Event|0|||
146251865|NCT00348283|527433412|FG001|Induction|Adverse Event|2|||
146251866|NCT00348283|527433411|FG000|Induction|Protocol Violation|0|||
146251867|NCT00348283|527433412|FG001|Induction|Protocol Violation|4|||
146251868|NCT00348283|527433411|FG000|Double Blind|Adverse Event|2|||
146251869|NCT00348283|527433412|FG001|Double Blind|Adverse Event|5|||
146251870|NCT00348283|527433411|FG000|Double Blind|Withdrawal by Subject|1|||
146251871|NCT00348283|527433412|FG001|Double Blind|Withdrawal by Subject|1|||
146251872|NCT00348283|527433411|FG000|Double Blind|Protocol Violation|0|||
146251873|NCT00348283|527433412|FG001|Double Blind|Protocol Violation|1|||
146251874|NCT00348283|527433411|FG000|Double Blind|Lack of Efficacy|2|||
146251875|NCT00348283|527433412|FG001|Double Blind|Lack of Efficacy|2|||
146251876|NCT00348283|527433411|FG000|Double Blind|Pregnancy|0|||
146251877|NCT00348283|527433412|FG001|Double Blind|Pregnancy|1|||
146251878|NCT00348283|527433411|FG000|Open Label|Adverse Event|0|||
146251879|NCT00348283|527433412|FG001|Open Label|Adverse Event|8|||
146251880|NCT00348283|527433411|FG000|Open Label|Withdrawal by Subject|0|||
146251881|NCT00348283|527433412|FG001|Open Label|Withdrawal by Subject|4|||
146251882|NCT00348283|527433411|FG000|Open Label|Lost to Follow-up|0|||
146251883|NCT00348283|527433412|FG001|Open Label|Lost to Follow-up|1|||
146251884|NCT00348283|527433411|FG000|Open Label|Lack of Efficacy|0|||
146251885|NCT00348283|527433412|FG001|Open Label|Lack of Efficacy|13|||
146251886|NCT00348283|527433411|FG000|Open Label|Administrative reasons|0|||
146251887|NCT00348283|527433412|FG001|Open Label|Administrative reasons|5|||
146251888|NCT00348283|527433411|FG000|Open Label|Subject moved to the United States|0|||
146300262|NCT03681951|527615195|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146300263|NCT03681951|527615196|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146094129|NCT00723398|526866553|FG004|Overall Study|Withdrawal by Subject|4|||
146094130|NCT00723398|526866549|FG000|Overall Study|Protocol Violation|2|||
146251889|NCT00348283|527433412|FG001|Open Label|Subject moved to the United States|1|||
146251890|NCT00348283|527433411|FG000|Open Label|Pregnancy|0|||
146251891|NCT00348283|527433412|FG001|Open Label|Pregnancy|1|||
146251892|NCT00348283|527433411|FG000|Open Label|Sponsor decision|0|||
146251893|NCT00348283|527433412|FG001|Open Label|Sponsor decision|1|||
146251894|NCT02282761|527433415|FG000|Overall Study|Death|0|||
146251895|NCT02282761|527433416|FG001|Overall Study|Death|0|||
146251896|NCT02282761|527433417|FG002|Overall Study|Death|1|||
146251897|NCT02282761|527433415|FG000|Overall Study|Adverse Event|6|||
146251898|NCT02282761|527433416|FG001|Overall Study|Adverse Event|2|||
146251899|NCT02282761|527433417|FG002|Overall Study|Adverse Event|0|||
146251900|NCT02282761|527433415|FG000|Overall Study|Lack of Efficacy|11|||
146251901|NCT02282761|527433416|FG001|Overall Study|Lack of Efficacy|6|||
146251902|NCT02282761|527433417|FG002|Overall Study|Lack of Efficacy|17|||
146251903|NCT02282761|527433415|FG000|Overall Study|Lost to Follow-up|2|||
146251904|NCT02282761|527433416|FG001|Overall Study|Lost to Follow-up|2|||
146251905|NCT02282761|527433417|FG002|Overall Study|Lost to Follow-up|1|||
146251906|NCT02282761|527433415|FG000|Overall Study|Physician Decision|0|||
146251907|NCT02282761|527433416|FG001|Overall Study|Physician Decision|0|||
146251908|NCT02282761|527433417|FG002|Overall Study|Physician Decision|2|||
146251909|NCT02282761|527433415|FG000|Overall Study|Withdrawal by Subject|8|||
146251910|NCT02282761|527433416|FG001|Overall Study|Withdrawal by Subject|10|||
146251911|NCT02282761|527433417|FG002|Overall Study|Withdrawal by Subject|16|||
146251912|NCT02282761|527433415|FG000|Overall Study|Other|3|||
146251913|NCT02282761|527433416|FG001|Overall Study|Other|2|||
146251914|NCT02282761|527433417|FG002|Overall Study|Other|1|||
146251915|NCT06312566|527433421|FG000|Overall Study|Protocol Violation|0|||
146019564|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Physician Decision|0|||
146019565|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Physician Decision|0|||
146019566|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
146019567|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
146019568|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
146019569|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
146019570|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
146019571|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
146019572|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
146019573|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
146019574|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
146019575|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Not compliant|1|||
146019576|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Not compliant|0|||
146019577|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Not compliant|0|||
146019578|NCT01461928|526582913|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
146019579|NCT01461928|526582914|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
146019580|NCT01461928|526582915|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
146019581|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Adverse Event|0|||
146019582|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Adverse Event|2|||
146019583|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Adverse Event|0|||
146019584|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Death|0|||
146019585|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Death|10|||
146019586|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Death|8|||
146019587|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Physician Decision|0|||
146019588|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Physician Decision|0|||
146019589|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Physician Decision|4|||
146019590|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
146019591|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
146019592|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
146019593|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Moved to another town|0|||
146019594|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Moved to another town|1|||
146019595|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Moved to another town|0|||
146019596|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Disease progression|0|||
146019597|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Disease progression|0|||
146019598|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Disease progression|3|||
146019599|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
146019600|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
146019601|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
146019602|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
146019603|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
146019604|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
146019605|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
146019606|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
146019607|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
146019608|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
146019609|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
146019610|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
146019611|NCT01461928|526582913|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
146019612|NCT01461928|526582914|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
146251916|NCT06312566|527433422|FG001|Overall Study|Protocol Violation|1|||
146251917|NCT04551053|527433423|FG000|Overall Study|Death|10|||
146251918|NCT04551053|527433424|FG001|Overall Study|Death|9|||
146251919|NCT04551053|527433423|FG000|Overall Study|Lost to Follow-up|0|||
146251920|NCT04551053|527433424|FG001|Overall Study|Lost to Follow-up|2|||
146019613|NCT01461928|526582915|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
146019614|NCT03576066|526582916|FG000|Overall Study|Noncompliance with study drug|0|||
146019615|NCT03576066|526582917|FG001|Overall Study|Noncompliance with study drug|1|||
146019616|NCT00365105|526582918|FG000|Overall Study|Protocol Violation|5|||
146019617|NCT00365105|526582919|FG001|Overall Study|Protocol Violation|8|||
146019618|NCT00191724|526582922|FG000|Overall Study|Adverse Event|0|||
146094131|NCT00723398|526866550|FG001|Overall Study|Protocol Violation|1|||
146094132|NCT00723398|526866551|FG002|Overall Study|Protocol Violation|5|||
146094133|NCT00723398|526866552|FG003|Overall Study|Protocol Violation|0|||
146251921|NCT04551053|527433423|FG000|Overall Study|Study Terminated by Sponsor|57|||
146251922|NCT04551053|527433424|FG001|Overall Study|Study Terminated by Sponsor|65|||
146251923|NCT04551053|527433423|FG000|Overall Study|Withdrawal by Subject|12|||
146019619|NCT00191724|526582923|FG001|Overall Study|Adverse Event|0|||
146019620|NCT00191724|526582924|FG002|Overall Study|Adverse Event|1|||
146019621|NCT00191724|526582925|FG003|Overall Study|Adverse Event|0|||
146019622|NCT00191724|526582926|FG004|Overall Study|Adverse Event|0|||
146019623|NCT00191724|526582922|FG000|Overall Study|Lost to Follow-up|1|||
146251924|NCT04551053|527433424|FG001|Overall Study|Withdrawal by Subject|5|||
146251925|NCT04551053|527433423|FG000|Overall Study|Adverse Event|2|||
146251926|NCT04551053|527433424|FG001|Overall Study|Adverse Event|0|||
146251927|NCT04551053|527433423|FG000|Overall Study|Lack of Efficacy|2|||
146251928|NCT04551053|527433424|FG001|Overall Study|Lack of Efficacy|1|||
146251929|NCT04551053|527433423|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
146251930|NCT04551053|527433424|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
146251931|NCT04551053|527433423|FG000|Overall Study|Splenapendectomi|1|||
146251932|NCT04551053|527433424|FG001|Overall Study|Splenapendectomi|0|||
146251933|NCT04551053|527433423|FG000|Overall Study|Medical Decision|1|||
146251934|NCT04551053|527433424|FG001|Overall Study|Medical Decision|1|||
146251935|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
146251936|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
146251937|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
146251938|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
146251939|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
146251940|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
146251941|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
146251942|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
146251943|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
146251944|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
146251945|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
146251946|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
146251947|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
146251948|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
146251949|NCT02971683|527433425|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
146251950|NCT02971683|527433426|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
146251951|NCT02971683|527433425|FG000|Open-Label|Lost to Follow-up|1|||
146251952|NCT02971683|527433426|FG001|Open-Label|Lost to Follow-up|0|||
146251953|NCT02971683|527433425|FG000|Open-Label|Participants withdrew consent|0|||
146251954|NCT02971683|527433426|FG001|Open-Label|Participants withdrew consent|2|||
146251955|NCT02971683|527433425|FG000|Open-Label|Participant request to discontinue study treatment|1|||
146251956|NCT02971683|527433426|FG001|Open-Label|Participant request to discontinue study treatment|0|||
146251957|NCT02971683|527433425|FG000|Open-Label|Lack of Efficacy|2|||
146251958|NCT02971683|527433426|FG001|Open-Label|Lack of Efficacy|0|||
146251959|NCT02971683|527433425|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
146251960|NCT02971683|527433426|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
146251961|NCT02971683|527433425|FG000|Long-Term Open Label|Participant withdrew consent|1|||
146251962|NCT02971683|527433426|FG001|Long-Term Open Label|Participant withdrew consent|0|||
146251963|NCT02971683|527433425|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
146251964|NCT02971683|527433426|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
146251965|NCT02971683|527433425|FG000|Long-Term Open Label|Adverse Event|1|||
146251966|NCT02971683|527433426|FG001|Long-Term Open Label|Adverse Event|2|||
146251967|NCT02971683|527433425|FG000|Long-Term Open Label|Lack of Efficacy|1|||
146251968|NCT02971683|527433426|FG001|Long-Term Open Label|Lack of Efficacy|1|||
146251969|NCT03747575|527433432|FG000|Overall Study|Withdrawal by Subject|6|||
146251970|NCT03747575|527433433|FG001|Overall Study|Withdrawal by Subject|3|||
146251971|NCT03747575|527433432|FG000|Overall Study|Lost to Follow-up|3|||
146251972|NCT03747575|527433433|FG001|Overall Study|Lost to Follow-up|3|||
146251973|NCT03747575|527433432|FG000|Overall Study|Adverse Event|0|||
146300264|NCT03681951|527615197|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146300265|NCT03681951|527615198|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146300266|NCT03681951|527615199|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
146019624|NCT00191724|526582923|FG001|Overall Study|Lost to Follow-up|1|||
146300267|NCT03681951|527615192|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
146019625|NCT00191724|526582924|FG002|Overall Study|Lost to Follow-up|0|||
146019626|NCT00191724|526582925|FG003|Overall Study|Lost to Follow-up|2|||
146019627|NCT00191724|526582926|FG004|Overall Study|Lost to Follow-up|3|||
146019628|NCT00191724|526582922|FG000|Overall Study|Withdrawal by Subject|0|||
146019629|NCT00191724|526582923|FG001|Overall Study|Withdrawal by Subject|0|||
146019630|NCT00191724|526582924|FG002|Overall Study|Withdrawal by Subject|0|||
146019631|NCT00191724|526582925|FG003|Overall Study|Withdrawal by Subject|1|||
146019632|NCT00191724|526582926|FG004|Overall Study|Withdrawal by Subject|0|||
146019633|NCT06422364|526582927|FG000|Overall Study|Withdrawn due to study closure|0|||
146019634|NCT06422364|526582928|FG001|Overall Study|Withdrawn due to study closure|2|||
146019635|NCT05260073|526582930|FG000|Overall Study|Physician Decision|1|||
146094134|NCT00723398|526866553|FG004|Overall Study|Protocol Violation|0|||
146019636|NCT05260073|526582930|FG000|Overall Study|Withdrawal by Subject|6|||
146094135|NCT00723398|526866549|FG000|Overall Study|Physician Decision|2|||
146251974|NCT03747575|527433433|FG001|Overall Study|Adverse Event|1|||
146019637|NCT05260073|526582930|FG000|Overall Study|Lost to Follow-up|14|||
146019638|NCT03458910|526582931|FG000|Overall Study|Withdrawal by Subject|7|||
146019639|NCT03458910|526582932|FG001|Overall Study|Withdrawal by Subject|8|||
146019640|NCT03458910|526582933|FG002|Overall Study|Withdrawal by Subject|6|||
146019641|NCT03458910|526582934|FG003|Overall Study|Withdrawal by Subject|4|||
146019642|NCT03458910|526582931|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
146019643|NCT03458910|526582932|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
146019644|NCT03458910|526582933|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
146019645|NCT03458910|526582934|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
146019646|NCT06004895|526582935|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
146019647|NCT06004895|526582935|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
146019648|NCT01463696|526582944|FG000|Overall Study|Adverse Event|0|||
146019649|NCT01463696|526582945|FG001|Overall Study|Adverse Event|1|||
146019650|NCT01463696|526582946|FG002|Overall Study|Adverse Event|0|||
146019651|NCT01463696|526582947|FG003|Overall Study|Adverse Event|2|||
146019652|NCT01463696|526582948|FG004|Overall Study|Adverse Event|0|||
146019653|NCT01463696|526582949|FG005|Overall Study|Adverse Event|1|||
146019654|NCT01463696|526582950|FG006|Overall Study|Adverse Event|3|||
146019655|NCT01463696|526582951|FG007|Overall Study|Adverse Event|2|||
146019656|NCT01463696|526582944|FG000|Overall Study|Lost to Follow-up|0|||
146019657|NCT01463696|526582945|FG001|Overall Study|Lost to Follow-up|0|||
146019658|NCT01463696|526582946|FG002|Overall Study|Lost to Follow-up|1|||
146019659|NCT01463696|526582947|FG003|Overall Study|Lost to Follow-up|0|||
146019660|NCT01463696|526582948|FG004|Overall Study|Lost to Follow-up|0|||
146019661|NCT01463696|526582949|FG005|Overall Study|Lost to Follow-up|0|||
146019662|NCT01463696|526582950|FG006|Overall Study|Lost to Follow-up|0|||
146019663|NCT01463696|526582951|FG007|Overall Study|Lost to Follow-up|0|||
146019664|NCT01463696|526582944|FG000|Overall Study|Progressive Disease|0|||
146019665|NCT01463696|526582945|FG001|Overall Study|Progressive Disease|1|||
146019666|NCT01463696|526582946|FG002|Overall Study|Progressive Disease|0|||
146019667|NCT01463696|526582947|FG003|Overall Study|Progressive Disease|1|||
146019668|NCT01463696|526582948|FG004|Overall Study|Progressive Disease|0|||
146019669|NCT01463696|526582949|FG005|Overall Study|Progressive Disease|1|||
146019670|NCT01463696|526582950|FG006|Overall Study|Progressive Disease|4|||
146019671|NCT01463696|526582951|FG007|Overall Study|Progressive Disease|2|||
146019672|NCT01463696|526582944|FG000|Overall Study|Withdrawal by Subject|0|||
146019673|NCT01463696|526582945|FG001|Overall Study|Withdrawal by Subject|0|||
146019674|NCT01463696|526582946|FG002|Overall Study|Withdrawal by Subject|0|||
146019675|NCT01463696|526582947|FG003|Overall Study|Withdrawal by Subject|1|||
146019676|NCT01463696|526582948|FG004|Overall Study|Withdrawal by Subject|1|||
146019677|NCT01463696|526582949|FG005|Overall Study|Withdrawal by Subject|1|||
146019678|NCT01463696|526582950|FG006|Overall Study|Withdrawal by Subject|2|||
146019679|NCT01463696|526582951|FG007|Overall Study|Withdrawal by Subject|0|||
146019680|NCT01463696|526582944|FG000|Overall Study|Not Treated|0|||
146019681|NCT01463696|526582945|FG001|Overall Study|Not Treated|0|||
146019682|NCT01463696|526582946|FG002|Overall Study|Not Treated|0|||
146019683|NCT01463696|526582947|FG003|Overall Study|Not Treated|0|||
146019684|NCT01463696|526582948|FG004|Overall Study|Not Treated|0|||
146019685|NCT01463696|526582949|FG005|Overall Study|Not Treated|0|||
146019686|NCT01463696|526582950|FG006|Overall Study|Not Treated|1|||
146019687|NCT01463696|526582951|FG007|Overall Study|Not Treated|0|||
146019688|NCT00967694|526582953|FG000|Overall Study|Withdrawal by Subject|6|||
146019689|NCT00152477|526582956|FG000|Chemotherapy Period|Adverse Event|9|||
146019690|NCT00152477|526582957|FG001|Chemotherapy Period|Adverse Event|4|||
146019691|NCT00152477|526582958|FG002|Chemotherapy Period|Adverse Event|5|||
146019692|NCT00152477|526582956|FG000|Chemotherapy Period|Death|1|||
146019693|NCT00152477|526582957|FG001|Chemotherapy Period|Death|3|||
146019694|NCT00152477|526582958|FG002|Chemotherapy Period|Death|3|||
146019695|NCT00152477|526582956|FG000|Chemotherapy Period|Lack of Efficacy|4|||
146019696|NCT00152477|526582957|FG001|Chemotherapy Period|Lack of Efficacy|5|||
146019697|NCT00152477|526582958|FG002|Chemotherapy Period|Lack of Efficacy|6|||
146019698|NCT00152477|526582956|FG000|Chemotherapy Period|Lost to Follow-up|1|||
146019699|NCT00152477|526582957|FG001|Chemotherapy Period|Lost to Follow-up|0|||
146019700|NCT00152477|526582958|FG002|Chemotherapy Period|Lost to Follow-up|1|||
146019701|NCT00152477|526582956|FG000|Chemotherapy Period|Protocol Violation|1|||
146019702|NCT00152477|526582957|FG001|Chemotherapy Period|Protocol Violation|1|||
146019703|NCT00152477|526582958|FG002|Chemotherapy Period|Protocol Violation|0|||
146251975|NCT02924051|527433438|FG000|Overall Study|Withdrawal by Subject|1|||
146019704|NCT00152477|526582956|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
146019705|NCT00152477|526582957|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
146019706|NCT00152477|526582958|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
146019707|NCT00152477|526582956|FG000|Chemotherapy Period|Progression of Disease|6|||
146019708|NCT00152477|526582957|FG001|Chemotherapy Period|Progression of Disease|8|||
146019709|NCT00152477|526582958|FG002|Chemotherapy Period|Progression of Disease|4|||
146019710|NCT00152477|526582956|FG000|Chemotherapy Period|Investigator decision|0|||
146019711|NCT00152477|526582957|FG001|Chemotherapy Period|Investigator decision|0|||
146251976|NCT02924051|527433439|FG001|Overall Study|Withdrawal by Subject|9|||
146019712|NCT00152477|526582958|FG002|Chemotherapy Period|Investigator decision|1|||
146251977|NCT03689452|527433443|FG000|Overall Study|Lost to Follow-up|1|||
146019713|NCT00152477|526582956|FG000|Chemotherapy Period|Patient condition worsened|1|||
146019714|NCT00152477|526582957|FG001|Chemotherapy Period|Patient condition worsened|0|||
146019715|NCT00152477|526582958|FG002|Chemotherapy Period|Patient condition worsened|0|||
146019716|NCT00152477|526582956|FG000|Monotherapy Period|Adverse Event|1|||
146251978|NCT03689452|527433444|FG001|Overall Study|Lost to Follow-up|1|||
146251979|NCT02676778|527433445|FG000|Overall Study|Disease Progression|7|||
146251980|NCT02676778|527433446|FG001|Overall Study|Disease Progression|3|||
146251981|NCT02676778|527433447|FG002|Overall Study|Disease Progression|1|||
146251982|NCT02676778|527433445|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
146251983|NCT02676778|527433446|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
146251984|NCT02676778|527433447|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
146251985|NCT02676778|527433445|FG000|Overall Study|Withdrawal by Subject|3|||
146251986|NCT02676778|527433446|FG001|Overall Study|Withdrawal by Subject|2|||
146251987|NCT02676778|527433447|FG002|Overall Study|Withdrawal by Subject|0|||
146251988|NCT02676778|527433445|FG000|Overall Study|Other|4|||
146251989|NCT02676778|527433446|FG001|Overall Study|Other|3|||
146251990|NCT02676778|527433447|FG002|Overall Study|Other|0|||
146251991|NCT02676778|527433445|FG000|Overall Study|Adverse Event|2|||
146251992|NCT02676778|527433446|FG001|Overall Study|Adverse Event|3|||
146251993|NCT02676778|527433447|FG002|Overall Study|Adverse Event|0|||
146251994|NCT03214198|527433457|FG000|Overall Study|Case Report Forms Uncollected|18|||
146251995|NCT03214198|527433457|FG000|Overall Study|Protocol Deviation|18|||
146251996|NCT03686176|527433458|FG000|Overall Study|Procedure cancelled|1|||
146251997|NCT03686176|527433459|FG001|Overall Study|Procedure cancelled|0|||
146251998|NCT03686176|527433460|FG002|Overall Study|Procedure cancelled|0|||
146251999|NCT03686176|527433458|FG000|Overall Study|VR Malfunction|1|||
146252000|NCT03686176|527433459|FG001|Overall Study|VR Malfunction|0|||
146252001|NCT03686176|527433460|FG002|Overall Study|VR Malfunction|0|||
146252002|NCT04295499|527433465|FG000|Overall Study|moving out of state|1|||
146252003|NCT04295499|527433466|FG001|Overall Study|moving out of state|0|||
146252004|NCT04295499|527433465|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
146252005|NCT04295499|527433466|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
146252006|NCT00308113|527433469|FG000|Overall Study|Protocol closure|0|||
146252007|NCT00308113|527433470|FG001|Overall Study|Protocol closure|0|||
146252008|NCT00308113|527433471|FG002|Overall Study|Protocol closure|0|||
146252009|NCT00308113|527433472|FG003|Overall Study|Protocol closure|1|||
146252010|NCT04448561|527433473|FG000|Overall Study|Noncompliance|1|||
146252011|NCT04448561|527433474|FG001|Overall Study|Noncompliance|0|||
146252012|NCT04413149|527435248|FG000|Overall Study|Death|10|||
146252013|NCT04413149|527435249|FG001|Overall Study|Death|5|||
146252014|NCT04413149|527435248|FG000|Overall Study|Lung transplantation|1|||
146252015|NCT04413149|527435249|FG001|Overall Study|Lung transplantation|0|||
146252016|NCT02878590|527435252|FG000|Overall Study|Withdrawal by Subject|2|||
146252017|NCT02661490|527435253|FG000|Overall Study|Lost to Follow-up|0|||
146252018|NCT02661490|527435254|FG001|Overall Study|Lost to Follow-up|1|||
146252019|NCT02661490|527435255|FG002|Overall Study|Lost to Follow-up|0|||
146252020|NCT02661490|527435256|FG003|Overall Study|Lost to Follow-up|0|||
146252021|NCT02661490|527435257|FG004|Overall Study|Lost to Follow-up|2|||
146252022|NCT02661490|527435253|FG000|Overall Study|Withdrawal by Subject|2|||
146252023|NCT02661490|527435254|FG001|Overall Study|Withdrawal by Subject|0|||
146252024|NCT02661490|527435255|FG002|Overall Study|Withdrawal by Subject|2|||
146252025|NCT02661490|527435256|FG003|Overall Study|Withdrawal by Subject|0|||
146252026|NCT02661490|527435257|FG004|Overall Study|Withdrawal by Subject|0|||
146252027|NCT02661490|527435253|FG000|Overall Study|Death|1|||
146252028|NCT02661490|527435254|FG001|Overall Study|Death|1|||
146252029|NCT02661490|527435255|FG002|Overall Study|Death|0|||
146252030|NCT02661490|527435256|FG003|Overall Study|Death|1|||
146252031|NCT02661490|527435257|FG004|Overall Study|Death|0|||
146252032|NCT02661490|527435253|FG000|Overall Study|Reason not Specified|0|||
146252033|NCT02661490|527435254|FG001|Overall Study|Reason not Specified|0|||
146252034|NCT02661490|527435255|FG002|Overall Study|Reason not Specified|0|||
146252035|NCT02661490|527435256|FG003|Overall Study|Reason not Specified|0|||
146252036|NCT02661490|527435257|FG004|Overall Study|Reason not Specified|1|||
146252037|NCT03322514|527435258|FG000|Overall Study|Withdrawal by Subject|1|||
146252038|NCT03322514|527435259|FG001|Overall Study|Withdrawal by Subject|1|||
146252039|NCT01184859|527435260|FG000|Period 1: Single Dose|Insufficient urine production|0|||
146252040|NCT01184859|527435261|FG001|Period 1: Single Dose|Insufficient urine production|1|||
146252041|NCT01184859|527435262|FG002|Period 1: Single Dose|Insufficient urine production|0|||
146252042|NCT01184859|527435263|FG003|Period 1: Single Dose|Insufficient urine production|0|||
146252043|NCT01184859|527435264|FG004|Period 1: Single Dose|Insufficient urine production|0|||
146252044|NCT01184859|527435260|FG000|Period 1: Single Dose|Protocol Violation|0|||
146252045|NCT01184859|527435261|FG001|Period 1: Single Dose|Protocol Violation|1|||
146252046|NCT01184859|527435262|FG002|Period 1: Single Dose|Protocol Violation|0|||
146252047|NCT01184859|527435263|FG003|Period 1: Single Dose|Protocol Violation|0|||
146252048|NCT01184859|527435264|FG004|Period 1: Single Dose|Protocol Violation|0|||
146094136|NCT00723398|526866550|FG001|Overall Study|Physician Decision|2|||
146019717|NCT00152477|526582957|FG001|Monotherapy Period|Adverse Event|0|||
146019718|NCT00152477|526582958|FG002|Monotherapy Period|Adverse Event|5|||
146019719|NCT00152477|526582956|FG000|Monotherapy Period|Death|2|||
146019720|NCT00152477|526582957|FG001|Monotherapy Period|Death|0|||
146019721|NCT00152477|526582958|FG002|Monotherapy Period|Death|1|||
146019722|NCT00152477|526582956|FG000|Monotherapy Period|Lack of Efficacy|7|||
146019723|NCT00152477|526582957|FG001|Monotherapy Period|Lack of Efficacy|16|||
146019724|NCT00152477|526582958|FG002|Monotherapy Period|Lack of Efficacy|10|||
146019725|NCT00152477|526582956|FG000|Monotherapy Period|Protocol Violation|0|||
146019726|NCT00152477|526582957|FG001|Monotherapy Period|Protocol Violation|1|||
146019727|NCT00152477|526582958|FG002|Monotherapy Period|Protocol Violation|0|||
146019728|NCT00152477|526582956|FG000|Monotherapy Period|Withdrawal by Subject|0|||
146019729|NCT00152477|526582957|FG001|Monotherapy Period|Withdrawal by Subject|0|||
146019730|NCT00152477|526582958|FG002|Monotherapy Period|Withdrawal by Subject|4|||
146019731|NCT00152477|526582956|FG000|Monotherapy Period|Progression of Disease|5|||
146019732|NCT00152477|526582957|FG001|Monotherapy Period|Progression of Disease|11|||
146019733|NCT00152477|526582958|FG002|Monotherapy Period|Progression of Disease|12|||
146019734|NCT00152477|526582956|FG000|Monotherapy Period|Patient decision|0|||
146019735|NCT00152477|526582957|FG001|Monotherapy Period|Patient decision|1|||
146019736|NCT00152477|526582958|FG002|Monotherapy Period|Patient decision|1|||
146019737|NCT00152477|526582956|FG000|Monotherapy Period|Study personel decision|0|||
146019738|NCT00152477|526582957|FG001|Monotherapy Period|Study personel decision|0|||
146019739|NCT00152477|526582958|FG002|Monotherapy Period|Study personel decision|1|||
146019740|NCT00425698|526582959|FG000|Overall Study|Adverse Event|3|||
146019741|NCT00425698|526582960|FG001|Overall Study|Adverse Event|1|||
146019742|NCT00425698|526582959|FG000|Overall Study|Withdrawal by Subject|0|||
146019743|NCT00425698|526582960|FG001|Overall Study|Withdrawal by Subject|1|||
146019744|NCT03905265|526582968|FG000|Overall Study|Withdrawal by Subject|1|||
146019745|NCT03905265|526582969|FG001|Overall Study|Withdrawal by Subject|1|||
146019746|NCT03905265|526582970|FG002|Overall Study|Withdrawal by Subject|0|||
146094137|NCT00723398|526866551|FG002|Overall Study|Physician Decision|5|||
146094138|NCT00723398|526866552|FG003|Overall Study|Physician Decision|0|||
146094139|NCT00723398|526866553|FG004|Overall Study|Physician Decision|1|||
146019747|NCT03905265|526582971|FG003|Overall Study|Withdrawal by Subject|0|||
146019748|NCT00960011|526582972|FG000|Overall Study|Death|5|||
146019749|NCT00960011|526582973|FG001|Overall Study|Death|0|||
146019750|NCT00960011|526582972|FG000|Overall Study|Lost to Follow-up|6|||
146019751|NCT00960011|526582973|FG001|Overall Study|Lost to Follow-up|2|||
146094140|NCT00723398|526866549|FG000|Overall Study|Adverse Event|0|||
146094141|NCT00723398|526866550|FG001|Overall Study|Adverse Event|5|||
146252049|NCT01184859|527435260|FG000|Period 1: Single Dose|Adverse Event|0|||
146252050|NCT01184859|527435261|FG001|Period 1: Single Dose|Adverse Event|0|||
146252051|NCT01184859|527435262|FG002|Period 1: Single Dose|Adverse Event|0|||
146252052|NCT01184859|527435263|FG003|Period 1: Single Dose|Adverse Event|0|||
146252053|NCT01184859|527435264|FG004|Period 1: Single Dose|Adverse Event|1|||
146252054|NCT01184859|527435260|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146252055|NCT01184859|527435261|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146252056|NCT01184859|527435262|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146252057|NCT01184859|527435263|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
146252058|NCT01184859|527435264|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
146252059|NCT01184859|527435260|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
146252060|NCT01184859|527435261|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146252061|NCT01184859|527435262|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146252062|NCT01184859|527435263|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146252063|NCT01184859|527435264|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
146252064|NCT00961298|527435265|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
146252065|NCT00961298|527435265|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
146252066|NCT00961298|527435265|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
146252067|NCT00814632|527435266|FG000|Overall Study|Lack of Efficacy|2|||
146252068|NCT02186015|527435271|FG000|Overall Study|Physician Decision|1|||
146252069|NCT02186015|527435272|FG001|Overall Study|Physician Decision|0|||
146252070|NCT01837719|527435275|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
146252071|NCT01837719|527435275|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
146252072|NCT01703988|527435276|FG000|Overall Study|Investigator Judgment|0|||
146252073|NCT01703988|527435277|FG001|Overall Study|Investigator Judgment|0|||
146252074|NCT01703988|527435278|FG002|Overall Study|Investigator Judgment|0|||
146252075|NCT01703988|527435279|FG003|Overall Study|Investigator Judgment|1|||
146252076|NCT02995733|527435280|FG000|Overall Study|Study site closed|9|||
146252077|NCT02995733|527435281|FG001|Overall Study|Study site closed|10|||
146252078|NCT02995733|527435280|FG000|Overall Study|Death|3|||
146252079|NCT02995733|527435281|FG001|Overall Study|Death|4|||
146252080|NCT02995733|527435280|FG000|Overall Study|Withdrawal by Subject|6|||
146252081|NCT02995733|527435281|FG001|Overall Study|Withdrawal by Subject|2|||
146094142|NCT00723398|526866551|FG002|Overall Study|Adverse Event|3|||
146019752|NCT00889603|526582975|FG000|Overall Study|Adverse Event|7|||
146019753|NCT00889603|526582975|FG000|Overall Study|Death|3|||
146019754|NCT00889603|526582975|FG000|Overall Study|Lost to Follow-up|19|||
146019755|NCT00889603|526582975|FG000|Overall Study|No longer willing to participant in stud|4|||
146019756|NCT00889603|526582975|FG000|Overall Study|Other|4|||
146019757|NCT02231892|526582976|FG000|Overall Study|Lost to Follow-up|1|||
146019758|NCT02231892|526582977|FG001|Overall Study|Lost to Follow-up|0|||
146019759|NCT02231892|526582978|FG002|Overall Study|Lost to Follow-up|3|||
146019760|NCT02231892|526582976|FG000|Overall Study|Withdrawal by Subject|4|||
146019761|NCT02231892|526582977|FG001|Overall Study|Withdrawal by Subject|3|||
146019762|NCT02231892|526582978|FG002|Overall Study|Withdrawal by Subject|15|||
146019763|NCT02231892|526582976|FG000|Overall Study|Physician Decision|0|||
146019764|NCT02231892|526582977|FG001|Overall Study|Physician Decision|2|||
146019765|NCT02231892|526582978|FG002|Overall Study|Physician Decision|4|||
146019766|NCT02231892|526582976|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
146019767|NCT02231892|526582977|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
146019768|NCT02231892|526582978|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
146019769|NCT02231892|526582976|FG000|Overall Study|Participant motor threshold was >83%|0|||
146019770|NCT02231892|526582977|FG001|Overall Study|Participant motor threshold was >83%|0|||
146019771|NCT02231892|526582978|FG002|Overall Study|Participant motor threshold was >83%|9|||
146019772|NCT02231892|526582976|FG000|Overall Study|Could not find motor threshold|2|||
146019773|NCT02231892|526582977|FG001|Overall Study|Could not find motor threshold|0|||
146019774|NCT02231892|526582978|FG002|Overall Study|Could not find motor threshold|1|||
146019775|NCT02231892|526582976|FG000|Overall Study|Could not find reliable motor hotspot|0|||
146019776|NCT02231892|526582977|FG001|Overall Study|Could not find reliable motor hotspot|0|||
146019777|NCT02231892|526582978|FG002|Overall Study|Could not find reliable motor hotspot|1|||
146019778|NCT03832322|526582979|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
146019779|NCT03832322|526582980|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
146019780|NCT02186652|526582993|FG000|Overall Study|Lost to Follow-up|2|||
146019781|NCT02186652|526582994|FG001|Overall Study|Lost to Follow-up|0|||
146019782|NCT02901054|526582996|FG000|Overall Study|Physician Decision|1|||
146019783|NCT02901054|526582996|FG000|Overall Study|Withdrawal by Subject|3|||
146019784|NCT00616018|526583000|FG000|Overall Study|Protocol Violation|3|||
146019785|NCT03718884|526583001|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
146019786|NCT03718884|526583002|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
146019787|NCT03718884|526583001|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
146019788|NCT03718884|526583002|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
146019789|NCT02839720|526583004|FG000|Overall Study|Adverse Event|2|||
146019790|NCT02839720|526583004|FG000|Overall Study|Non-compliance|2|||
146019791|NCT02839720|526583004|FG000|Overall Study|Intercurrent Illness|1|||
146019792|NCT02839720|526583004|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
146019793|NCT05248997|526583007|FG000|Overall Study|Lost to Follow-up|1|||
146019794|NCT05248997|526583008|FG001|Overall Study|Lost to Follow-up|1|||
146019795|NCT05248997|526583007|FG000|Overall Study|Randomized but not treated|32|||
146252082|NCT02995733|527435280|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
146252083|NCT02995733|527435281|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
146252084|NCT02995733|527435280|FG000|Overall Study|Lost to Follow-up|48|||
146252085|NCT02995733|527435281|FG001|Overall Study|Lost to Follow-up|37|||
146252086|NCT02995733|527435280|FG000|Overall Study|Other|0|||
146252087|NCT02995733|527435281|FG001|Overall Study|Other|1|||
146252088|NCT02720198|527435282|FG000|Overall Study|Withdrawal by Subject|0|||
146252089|NCT02720198|527435283|FG001|Overall Study|Withdrawal by Subject|1|||
146252090|NCT00105521|527435286|FG000|Overall Study|Other|1|||
146252091|NCT00105521|527435287|FG001|Overall Study|Other|1|||
146252092|NCT00105521|527435288|FG002|Overall Study|Other|2|||
146252093|NCT00105521|527435289|FG003|Overall Study|Other|0|||
146252094|NCT00105521|527435286|FG000|Overall Study|Adverse Event|10|||
146252095|NCT00105521|527435287|FG001|Overall Study|Adverse Event|4|||
146252096|NCT00105521|527435288|FG002|Overall Study|Adverse Event|10|||
146252097|NCT00105521|527435289|FG003|Overall Study|Adverse Event|8|||
146252098|NCT00105521|527435286|FG000|Overall Study|Withdrawal by Subject|1|||
146019796|NCT05248997|526583008|FG001|Overall Study|Randomized but not treated|25|||
146019797|NCT01453205|526583009|FG000|Overall Study|Lost to Follow-up|3|||
146252099|NCT00105521|527435287|FG001|Overall Study|Withdrawal by Subject|0|||
146252100|NCT00105521|527435288|FG002|Overall Study|Withdrawal by Subject|1|||
146019798|NCT01453205|526583010|FG001|Overall Study|Lost to Follow-up|0|||
146019799|NCT01453205|526583011|FG002|Overall Study|Lost to Follow-up|1|||
146019800|NCT01453205|526583009|FG000|Overall Study|Withdrawal by Subject|8|||
146019801|NCT01453205|526583010|FG001|Overall Study|Withdrawal by Subject|3|||
146019802|NCT01453205|526583011|FG002|Overall Study|Withdrawal by Subject|0|||
146019803|NCT01453205|526583009|FG000|Overall Study|Death|24|||
146252101|NCT00105521|527435289|FG003|Overall Study|Withdrawal by Subject|4|||
146252102|NCT00105521|527435286|FG000|Overall Study|Lack of Efficacy|0|||
146252103|NCT00105521|527435287|FG001|Overall Study|Lack of Efficacy|0|||
146252104|NCT00105521|527435288|FG002|Overall Study|Lack of Efficacy|0|||
146252105|NCT00105521|527435289|FG003|Overall Study|Lack of Efficacy|1|||
146019804|NCT01453205|526583010|FG001|Overall Study|Death|22|||
146019805|NCT01453205|526583011|FG002|Overall Study|Death|18|||
146019806|NCT01453205|526583009|FG000|Overall Study|Other|45|||
146019807|NCT01453205|526583010|FG001|Overall Study|Other|27|||
146019808|NCT01453205|526583011|FG002|Overall Study|Other|35|||
146019809|NCT05593913|526583012|FG000|Overall Study|Insufficient image quality|39|||
146019810|NCT02602275|526583013|FG000|Day 1|Physician Decision|0|||
146019811|NCT02602275|526583014|FG001|Day 1|Physician Decision|1|||
146019812|NCT04113018|526583019|FG000|Overall Study|Death|2|||
146019813|NCT04113018|526583019|FG000|Overall Study|Lost to Follow-up|1|||
146019814|NCT04113018|526583019|FG000|Overall Study|Still On Study (on study treatment)|24|||
146019815|NCT04113018|526583019|FG000|Overall Study|Still On Study (in follow up)|12|||
146019816|NCT05005013|526583020|FG000|Overall Study|Withdrawal by Subject|5|||
146019817|NCT05005013|526583021|FG001|Overall Study|Withdrawal by Subject|1|||
146019818|NCT05005013|526583020|FG000|Overall Study|Lost to Follow-up|3|||
146019819|NCT05005013|526583021|FG001|Overall Study|Lost to Follow-up|1|||
146019820|NCT05005013|526583020|FG000|Overall Study|Ineligibility|1|||
146019821|NCT05005013|526583021|FG001|Overall Study|Ineligibility|1|||
146019822|NCT02059499|526583022|FG000|Upto Week 20|Lost to Follow-up|2|||
146019823|NCT02059499|526583023|FG001|Upto Week 20|Lost to Follow-up|6|||
146019824|NCT02059499|526583024|FG002|Upto Week 20|Lost to Follow-up|0|||
146019825|NCT02059499|526583022|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
146019826|NCT02059499|526583023|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
146019827|NCT02059499|526583024|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
146019828|NCT02059499|526583022|FG000|Upto Week 20|Withdrawal by Subject|1|||
146019829|NCT02059499|526583023|FG001|Upto Week 20|Withdrawal by Subject|1|||
146019830|NCT02059499|526583024|FG002|Upto Week 20|Withdrawal by Subject|0|||
146019831|NCT02059499|526583022|FG000|Upto Week 20|No treatment per protocol criteria|0|||
146019832|NCT02059499|526583023|FG001|Upto Week 20|No treatment per protocol criteria|0|||
146019833|NCT02059499|526583024|FG002|Upto Week 20|No treatment per protocol criteria|5|||
146019834|NCT02059499|526583022|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
146019835|NCT02059499|526583023|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
146019836|NCT02059499|526583024|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
146019837|NCT02059499|526583022|FG000|Post-week 20|Lost to Follow-up|0|||
146019838|NCT02059499|526583023|FG001|Post-week 20|Lost to Follow-up|2|||
146019839|NCT02059499|526583024|FG002|Post-week 20|Lost to Follow-up|0|||
146019840|NCT02059499|526583022|FG000|Post-week 20|Withdrawal by Subject|0|||
146019841|NCT02059499|526583023|FG001|Post-week 20|Withdrawal by Subject|1|||
146019842|NCT02059499|526583024|FG002|Post-week 20|Withdrawal by Subject|0|||
146019843|NCT02059499|526583022|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
146019844|NCT02059499|526583023|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
146019845|NCT02059499|526583024|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
146019846|NCT04210245|526583025|FG000|Overall Study|Adverse Event|0|||
146019847|NCT04210245|526583026|FG001|Overall Study|Adverse Event|3|||
146019848|NCT04210245|526583027|FG002|Overall Study|Adverse Event|6|||
146019849|NCT04210245|526583028|FG003|Overall Study|Adverse Event|0|||
146019850|NCT04210245|526583025|FG000|Overall Study|Withdrawal by Subject|0|||
146019851|NCT04210245|526583026|FG001|Overall Study|Withdrawal by Subject|1|||
146019852|NCT04210245|526583027|FG002|Overall Study|Withdrawal by Subject|4|||
146019853|NCT04210245|526583028|FG003|Overall Study|Withdrawal by Subject|4|||
146019854|NCT04210245|526583025|FG000|Overall Study|Lost to Follow-up|0|||
146019855|NCT04210245|526583026|FG001|Overall Study|Lost to Follow-up|1|||
146019856|NCT04210245|526583027|FG002|Overall Study|Lost to Follow-up|1|||
146019857|NCT04210245|526583028|FG003|Overall Study|Lost to Follow-up|1|||
146019858|NCT04210245|526583025|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146019859|NCT04210245|526583026|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146019860|NCT04210245|526583027|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
146019861|NCT04210245|526583028|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
146019862|NCT06099223|526583029|FG000|Overall Study|Preoperative surveys missed|0|||
146019863|NCT06099223|526583030|FG001|Overall Study|Preoperative surveys missed|1|||
146019864|NCT02248649|526583031|FG000|Overall Study|Death|7|||
146019865|NCT02248649|526583032|FG001|Overall Study|Death|11|||
146019866|NCT02248649|526583031|FG000|Overall Study|Lost to Follow-up|14|||
146019867|NCT02248649|526583032|FG001|Overall Study|Lost to Follow-up|10|||
146019868|NCT03255967|526583033|FG000|Overall Study|Adverse Event|26|||
146019869|NCT03255967|526583034|FG001|Overall Study|Adverse Event|30|||
146019870|NCT03255967|526583033|FG000|Overall Study|Withdrawal by Subject|6|||
146019871|NCT03255967|526583034|FG001|Overall Study|Withdrawal by Subject|6|||
146019872|NCT03255967|526583033|FG000|Overall Study|Schedule conflict|6|||
146019873|NCT03255967|526583034|FG001|Overall Study|Schedule conflict|4|||
146019874|NCT03255967|526583033|FG000|Overall Study|POA did not sign consent form|2|||
146019875|NCT03255967|526583034|FG001|Overall Study|POA did not sign consent form|0|||
146019876|NCT04621240|526583045|FG000|Overall Study|Withdrawal by Subject|36|||
146019877|NCT01202188|526583047|FG000|Overall Study|Protocol deviation|14|||
146019878|NCT01202188|526583048|FG001|Overall Study|Protocol deviation|8|||
146019879|NCT01202188|526583049|FG002|Overall Study|Protocol deviation|12|||
146019880|NCT01202188|526583050|FG003|Overall Study|Protocol deviation|10|||
146019881|NCT01202188|526583051|FG004|Overall Study|Protocol deviation|11|||
146019882|NCT01202188|526583047|FG000|Overall Study|Subject withdrew consent|12|||
146019883|NCT01202188|526583048|FG001|Overall Study|Subject withdrew consent|13|||
146019884|NCT01202188|526583049|FG002|Overall Study|Subject withdrew consent|22|||
146019885|NCT01202188|526583050|FG003|Overall Study|Subject withdrew consent|11|||
146019886|NCT01202188|526583051|FG004|Overall Study|Subject withdrew consent|13|||
146019887|NCT01202188|526583047|FG000|Overall Study|Adverse Event|5|||
146019888|NCT01202188|526583048|FG001|Overall Study|Adverse Event|23|||
146019889|NCT01202188|526583049|FG002|Overall Study|Adverse Event|13|||
146019890|NCT01202188|526583050|FG003|Overall Study|Adverse Event|10|||
146019891|NCT01202188|526583051|FG004|Overall Study|Adverse Event|10|||
146019892|NCT01202188|526583047|FG000|Overall Study|Administrative problems|3|||
146019893|NCT01202188|526583048|FG001|Overall Study|Administrative problems|2|||
146019894|NCT01202188|526583049|FG002|Overall Study|Administrative problems|1|||
146019895|NCT01202188|526583050|FG003|Overall Study|Administrative problems|1|||
146019896|NCT01202188|526583051|FG004|Overall Study|Administrative problems|2|||
146019897|NCT01202188|526583047|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146019898|NCT01202188|526583048|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146019899|NCT01202188|526583049|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146019900|NCT01202188|526583050|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
146019901|NCT01202188|526583051|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
146019902|NCT01202188|526583047|FG000|Overall Study|Lost to Follow-up|1|||
146019903|NCT01202188|526583048|FG001|Overall Study|Lost to Follow-up|1|||
146019904|NCT01202188|526583049|FG002|Overall Study|Lost to Follow-up|0|||
146252106|NCT00105521|527435286|FG000|Overall Study|Protocol Violation|3|||
146252107|NCT00105521|527435287|FG001|Overall Study|Protocol Violation|5|||
146252108|NCT00105521|527435288|FG002|Overall Study|Protocol Violation|4|||
146252109|NCT00105521|527435289|FG003|Overall Study|Protocol Violation|4|||
146252110|NCT00105521|527435286|FG000|Overall Study|Lost to Follow-up|0|||
146252111|NCT00105521|527435287|FG001|Overall Study|Lost to Follow-up|1|||
146252112|NCT00105521|527435288|FG002|Overall Study|Lost to Follow-up|0|||
146252113|NCT00105521|527435289|FG003|Overall Study|Lost to Follow-up|0|||
146252114|NCT00385697|527435290|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
146252115|NCT00385697|527435291|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
146252116|NCT00385697|527435292|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
146252117|NCT00385697|527435293|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
146252118|NCT00385697|527435294|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
146252119|NCT00385697|527435290|FG000|Open-label Segment 1|Lost to Follow-up|1|||
146252120|NCT00385697|527435291|FG001|Open-label Segment 1|Lost to Follow-up|0|||
146252121|NCT00385697|527435292|FG002|Open-label Segment 1|Lost to Follow-up|0|||
146252122|NCT00385697|527435293|FG003|Open-label Segment 1|Lost to Follow-up|0|||
146252123|NCT00385697|527435294|FG004|Open-label Segment 1|Lost to Follow-up|0|||
146252124|NCT00385697|527435290|FG000|Double-blind Segment 2|Adverse Event|0|||
146252125|NCT00385697|527435291|FG001|Double-blind Segment 2|Adverse Event|3|||
146252126|NCT00385697|527435292|FG002|Double-blind Segment 2|Adverse Event|1|||
146252127|NCT00385697|527435293|FG003|Double-blind Segment 2|Adverse Event|0|||
146252128|NCT00385697|527435294|FG004|Double-blind Segment 2|Adverse Event|0|||
146252129|NCT00385697|527435290|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
146252130|NCT00385697|527435291|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
146252131|NCT00385697|527435292|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
146252132|NCT00385697|527435293|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
146252133|NCT00385697|527435294|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
146252134|NCT00385697|527435290|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
146252135|NCT00385697|527435291|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
146252136|NCT00385697|527435292|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
146252137|NCT00385697|527435293|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
146252138|NCT00385697|527435294|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
146252139|NCT00385697|527435290|FG000|Double-blind Segment 2|Other|0|||
146252140|NCT00385697|527435291|FG001|Double-blind Segment 2|Other|2|||
146252141|NCT00385697|527435292|FG002|Double-blind Segment 2|Other|0|||
146252142|NCT00385697|527435293|FG003|Double-blind Segment 2|Other|0|||
146252143|NCT00385697|527435294|FG004|Double-blind Segment 2|Other|0|||
146252144|NCT00510783|527435297|FG000|Overall Study|Lost to Follow-up|29|||
146019905|NCT01202188|526583050|FG003|Overall Study|Lost to Follow-up|4|||
146019906|NCT01202188|526583051|FG004|Overall Study|Lost to Follow-up|1|||
146019907|NCT01202188|526583047|FG000|Overall Study|Death|1|||
146019908|NCT01202188|526583048|FG001|Overall Study|Death|1|||
146019909|NCT01202188|526583049|FG002|Overall Study|Death|1|||
146252145|NCT00510783|527435298|FG001|Overall Study|Lost to Follow-up|25|||
146252146|NCT00510783|527435297|FG000|Overall Study|Withdrawal by Subject|2|||
146252147|NCT00510783|527435298|FG001|Overall Study|Withdrawal by Subject|3|||
146252148|NCT00510783|527435297|FG000|Overall Study|Protocol Violation|0|||
146252149|NCT00510783|527435298|FG001|Overall Study|Protocol Violation|1|||
146252150|NCT00442559|527435299|FG000|Overall Study|Lost to Follow-up|32|||
146252151|NCT00442559|527435300|FG001|Overall Study|Lost to Follow-up|34|||
146252152|NCT00442559|527435299|FG000|Overall Study|Protocol Violation|1|||
146252153|NCT00442559|527435300|FG001|Overall Study|Protocol Violation|1|||
146252154|NCT00442559|527435299|FG000|Overall Study|Withdrawal by Subject|1|||
146252155|NCT00442559|527435300|FG001|Overall Study|Withdrawal by Subject|0|||
146252156|NCT02267746|527435308|FG000|Overall Study|Adverse Event|0|||
146252157|NCT02267746|527435309|FG001|Overall Study|Adverse Event|2|||
146252158|NCT02267746|527435310|FG002|Overall Study|Adverse Event|1|||
146252159|NCT02267746|527435308|FG000|Overall Study|Protocol Violation|8|||
146252160|NCT02267746|527435309|FG001|Overall Study|Protocol Violation|7|||
146252161|NCT02267746|527435310|FG002|Overall Study|Protocol Violation|3|||
146252162|NCT02267746|527435308|FG000|Overall Study|Lack of Efficacy|11|||
146252163|NCT02267746|527435309|FG001|Overall Study|Lack of Efficacy|11|||
146252164|NCT02267746|527435310|FG002|Overall Study|Lack of Efficacy|15|||
146252165|NCT02267746|527435308|FG000|Overall Study|Protocol Violation|1|||
146252166|NCT02267746|527435309|FG001|Overall Study|Protocol Violation|2|||
146252167|NCT02267746|527435310|FG002|Overall Study|Protocol Violation|1|||
146252168|NCT02267746|527435308|FG000|Overall Study|Miscellaneous|1|||
146252169|NCT02267746|527435309|FG001|Overall Study|Miscellaneous|0|||
146252170|NCT02267746|527435310|FG002|Overall Study|Miscellaneous|1|||
146252171|NCT01812837|527435311|FG000|Overall Study|Lost to Follow-up|1|||
146252172|NCT01812837|527435312|FG001|Overall Study|Lost to Follow-up|1|||
146252173|NCT01812837|527435313|FG002|Overall Study|Lost to Follow-up|0|||
146252174|NCT01812837|527435311|FG000|Overall Study|Protocol Violation|1|||
146252175|NCT01812837|527435312|FG001|Overall Study|Protocol Violation|0|||
146252176|NCT01812837|527435313|FG002|Overall Study|Protocol Violation|0|||
146252177|NCT05008224|527435318|FG000|Overall Study|Death|3|||
146252178|NCT05008224|527435318|FG000|Overall Study|Lost to Follow-up|2|||
146252179|NCT05008224|527435318|FG000|Overall Study|Did Not Continue on Extension Study|39|||
146252180|NCT05008224|527435318|FG000|Overall Study|Transferred to Extension Study|100|||
146252181|NCT05008224|527435318|FG000|Overall Study|Withdrawal by Subject|2|||
146252182|NCT05234632|527435319|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
146252183|NCT05234632|527435320|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
146252184|NCT05234632|527435319|FG000|Overall Study|Withdrawal by Subject|2|||
146252185|NCT05234632|527435320|FG001|Overall Study|Withdrawal by Subject|0|||
146252186|NCT05234632|527435319|FG000|Overall Study|Adverse Event|0|||
146252187|NCT05234632|527435320|FG001|Overall Study|Adverse Event|4|||
146252188|NCT05234632|527435319|FG000|Overall Study|Physician Decision|1|||
146252189|NCT05234632|527435320|FG001|Overall Study|Physician Decision|1|||
146252190|NCT05234632|527435319|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
146252191|NCT05234632|527435320|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
146252192|NCT05234632|527435319|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
146252193|NCT05234632|527435320|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
146252194|NCT04799587|527435321|FG000|Overall Study|Withdrawal by Subject|0|||
146252195|NCT04799587|527435322|FG001|Overall Study|Withdrawal by Subject|1|||
146252196|NCT00728884|527435323|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
146252197|NCT00728884|527435323|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
146252198|NCT05263492|527435324|FG000|Overall Study|Adverse Event|1|||
146252199|NCT05263492|527435324|FG000|Overall Study|Disease progression during active treatment|3|||
146252200|NCT03345420|527435327|FG000|Overall Study|Withdrawal by Subject|1|||
146252201|NCT05216835|527435328|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146252202|NCT05216835|527435329|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146252203|NCT05216835|527435330|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146252204|NCT05216835|527435331|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
146252205|NCT05216835|527435332|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
146252206|NCT05216835|527435333|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
146252207|NCT05216835|527435334|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
146252208|NCT05216835|527435335|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
146252209|NCT05216835|527435328|FG000|Overall Study|Death|0|||
146252210|NCT05216835|527435329|FG001|Overall Study|Death|0|||
146252211|NCT05216835|527435330|FG002|Overall Study|Death|0|||
146252212|NCT05216835|527435331|FG003|Overall Study|Death|1|||
146252213|NCT05216835|527435332|FG004|Overall Study|Death|1|||
146252214|NCT05216835|527435333|FG005|Overall Study|Death|1|||
146252215|NCT05216835|527435334|FG006|Overall Study|Death|1|||
146252216|NCT05216835|527435335|FG007|Overall Study|Death|1|||
146252217|NCT05216835|527435328|FG000|Overall Study|Physician Decision|0|||
146252218|NCT05216835|527435329|FG001|Overall Study|Physician Decision|0|||
146252219|NCT05216835|527435330|FG002|Overall Study|Physician Decision|0|||
146252220|NCT05216835|527435331|FG003|Overall Study|Physician Decision|0|||
146252221|NCT05216835|527435332|FG004|Overall Study|Physician Decision|0|||
146252222|NCT05216835|527435333|FG005|Overall Study|Physician Decision|1|||
146252223|NCT05216835|527435334|FG006|Overall Study|Physician Decision|1|||
146252224|NCT05216835|527435335|FG007|Overall Study|Physician Decision|0|||
146252225|NCT05216835|527435328|FG000|Overall Study|Study terminated by Sponsor|0|||
146252226|NCT05216835|527435329|FG001|Overall Study|Study terminated by Sponsor|0|||
146252227|NCT05216835|527435330|FG002|Overall Study|Study terminated by Sponsor|0|||
146019910|NCT01202188|526583050|FG003|Overall Study|Death|1|||
146019911|NCT01202188|526583051|FG004|Overall Study|Death|0|||
146019912|NCT01202188|526583047|FG000|Overall Study|Abnormal test procedure result (s)|0|||
146019913|NCT01202188|526583048|FG001|Overall Study|Abnormal test procedure result (s)|0|||
146019914|NCT01202188|526583049|FG002|Overall Study|Abnormal test procedure result (s)|2|||
146019915|NCT01202188|526583050|FG003|Overall Study|Abnormal test procedure result (s)|0|||
146019916|NCT01202188|526583051|FG004|Overall Study|Abnormal test procedure result (s)|0|||
146019917|NCT00487942|526583054|FG000|Overall Study|Adverse Event|1|||
146019918|NCT00487942|526583055|FG001|Overall Study|Adverse Event|1|||
146019919|NCT00487942|526583056|FG002|Overall Study|Adverse Event|1|||
146019920|NCT00487942|526583057|FG003|Overall Study|Adverse Event|1|||
146252228|NCT05216835|527435331|FG003|Overall Study|Study terminated by Sponsor|0|||
146252229|NCT05216835|527435332|FG004|Overall Study|Study terminated by Sponsor|0|||
146252230|NCT05216835|527435333|FG005|Overall Study|Study terminated by Sponsor|0|||
146252231|NCT05216835|527435334|FG006|Overall Study|Study terminated by Sponsor|0|||
146252232|NCT05216835|527435335|FG007|Overall Study|Study terminated by Sponsor|1|||
146252233|NCT05216835|527435328|FG000|Overall Study|Withdrawal by Subject|1|||
146252234|NCT05216835|527435329|FG001|Overall Study|Withdrawal by Subject|0|||
146252235|NCT05216835|527435330|FG002|Overall Study|Withdrawal by Subject|1|||
146252236|NCT05216835|527435331|FG003|Overall Study|Withdrawal by Subject|0|||
146252237|NCT05216835|527435332|FG004|Overall Study|Withdrawal by Subject|1|||
146252238|NCT05216835|527435333|FG005|Overall Study|Withdrawal by Subject|0|||
146252239|NCT05216835|527435334|FG006|Overall Study|Withdrawal by Subject|0|||
146252240|NCT05216835|527435335|FG007|Overall Study|Withdrawal by Subject|1|||
146252241|NCT05216835|527435328|FG000|Overall Study|Other|0|||
146252242|NCT05216835|527435329|FG001|Overall Study|Other|1|||
146252243|NCT05216835|527435330|FG002|Overall Study|Other|0|||
146252244|NCT05216835|527435331|FG003|Overall Study|Other|0|||
146252245|NCT05216835|527435332|FG004|Overall Study|Other|0|||
146252246|NCT05216835|527435333|FG005|Overall Study|Other|0|||
146252247|NCT05216835|527435334|FG006|Overall Study|Other|0|||
146252248|NCT05216835|527435335|FG007|Overall Study|Other|0|||
146252249|NCT05179603|527435336|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
146252250|NCT05179603|527435336|FG000|Overall Study|Withdrawal by Subject|1|||
146252251|NCT05179603|527435336|FG000|Overall Study|Progressive disease|4|||
146252252|NCT05179603|527435336|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
146252253|NCT03861078|527435337|FG000|Overall Study|COVID-19 shut down|4|||
146252254|NCT03861078|527435337|FG000|Overall Study|Lost to Follow-up|1|||
146019921|NCT00487942|526583054|FG000|Overall Study|Lost to Follow-up|1|||
146019922|NCT00487942|526583055|FG001|Overall Study|Lost to Follow-up|0|||
146019923|NCT00487942|526583056|FG002|Overall Study|Lost to Follow-up|0|||
146252255|NCT03861078|527435337|FG000|Overall Study|Protocol Violation|2|||
146252256|NCT03861078|527435337|FG000|Overall Study|lack of venous access|1|||
146252257|NCT01075815|527435338|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
146252258|NCT01075815|527435339|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
146252259|NCT01075815|527435338|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
146252260|NCT01075815|527435339|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
146252261|NCT01075815|527435338|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
146019924|NCT00487942|526583057|FG003|Overall Study|Lost to Follow-up|1|||
146019925|NCT00487942|526583054|FG000|Overall Study|Protocol Violation|1|||
146019926|NCT00487942|526583055|FG001|Overall Study|Protocol Violation|1|||
146019927|NCT00487942|526583056|FG002|Overall Study|Protocol Violation|0|||
146019928|NCT00487942|526583057|FG003|Overall Study|Protocol Violation|0|||
146019929|NCT00487942|526583054|FG000|Overall Study|Withdrawal by Subject|0|||
146019930|NCT00487942|526583055|FG001|Overall Study|Withdrawal by Subject|1|||
146019931|NCT00487942|526583056|FG002|Overall Study|Withdrawal by Subject|2|||
146019932|NCT00487942|526583057|FG003|Overall Study|Withdrawal by Subject|0|||
146252262|NCT01075815|527435339|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
146252263|NCT00596960|527435340|FG000|Overall Study|Death|1|||
146252264|NCT00596960|527435341|FG001|Overall Study|Death|2|||
146252265|NCT00596960|527435340|FG000|Overall Study|Lost to Follow-up|6|||
146019933|NCT00211757|526583058|FG000|Overall Study|Withdrawal by Subject|1|||
146019934|NCT00211757|526583059|FG001|Overall Study|Withdrawal by Subject|1|||
146019935|NCT00211757|526583058|FG000|Overall Study|Lack of Efficacy|0|||
146019936|NCT00211757|526583059|FG001|Overall Study|Lack of Efficacy|1|||
146019937|NCT01457014|526583063|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
146252266|NCT00596960|527435341|FG001|Overall Study|Lost to Follow-up|5|||
146252267|NCT00596960|527435340|FG000|Overall Study|Withdrawal by Subject|1|||
146252268|NCT00596960|527435341|FG001|Overall Study|Withdrawal by Subject|0|||
146252269|NCT00596960|527435340|FG000|Overall Study|Incarcerated|2|||
146252270|NCT00596960|527435341|FG001|Overall Study|Incarcerated|0|||
146252271|NCT00596960|527435340|FG000|Overall Study|Physician Decision|1|||
146252272|NCT00596960|527435341|FG001|Overall Study|Physician Decision|0|||
146252273|NCT00596960|527435340|FG000|Overall Study|Protocol Violation|0|||
146019938|NCT01457014|526583064|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
146094143|NCT00723398|526866552|FG003|Overall Study|Adverse Event|1|||
146252274|NCT00596960|527435341|FG001|Overall Study|Protocol Violation|1|||
146019939|NCT01457014|526583065|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
146019940|NCT01457014|526583066|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
146019941|NCT01457014|526583063|FG000|First Night|Withdrawal by Subject|3|||
146019942|NCT01457014|526583064|FG001|First Night|Withdrawal by Subject|0|||
146019943|NCT01457014|526583065|FG002|First Night|Withdrawal by Subject|0|||
146019944|NCT01457014|526583066|FG003|First Night|Withdrawal by Subject|0|||
146019945|NCT02461290|526583067|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
146019946|NCT02461290|526583067|FG000|Overall Study|Lost to Follow-up|3|||
146019947|NCT04027049|526583068|FG000|Overall Study|Withdrawn by family|1|||
146019948|NCT04027049|526583069|FG001|Overall Study|Withdrawn by family|0|||
146019949|NCT04027049|526583068|FG000|Overall Study|Participant safety|1|||
146019950|NCT04027049|526583069|FG001|Overall Study|Participant safety|0|||
146019951|NCT02650128|526583070|FG000|Overall Study|Death|2|||
146019952|NCT01537081|526584595|FG000|Overall Study|Adverse Event|5|||
146019953|NCT01537081|526584596|FG001|Overall Study|Adverse Event|2|||
146019954|NCT01537081|526584597|FG002|Overall Study|Adverse Event|2|||
146019955|NCT01537081|526584595|FG000|Overall Study|Lack of Efficacy|2|||
146019956|NCT01537081|526584596|FG001|Overall Study|Lack of Efficacy|1|||
146019957|NCT01537081|526584597|FG002|Overall Study|Lack of Efficacy|0|||
146019958|NCT01537081|526584595|FG000|Overall Study|Lost to Follow-up|17|||
146019959|NCT01537081|526584596|FG001|Overall Study|Lost to Follow-up|15|||
146019960|NCT01537081|526584597|FG002|Overall Study|Lost to Follow-up|9|||
146019961|NCT01537081|526584595|FG000|Overall Study|Protocol Violation|3|||
146019962|NCT01537081|526584596|FG001|Overall Study|Protocol Violation|2|||
146019963|NCT01537081|526584597|FG002|Overall Study|Protocol Violation|2|||
146019964|NCT01537081|526584595|FG000|Overall Study|Withdrawal by Subject|6|||
146019965|NCT01537081|526584596|FG001|Overall Study|Withdrawal by Subject|11|||
146019966|NCT01537081|526584597|FG002|Overall Study|Withdrawal by Subject|3|||
146019967|NCT01537081|526584595|FG000|Overall Study|Physician Decision|5|||
146019968|NCT01537081|526584596|FG001|Overall Study|Physician Decision|6|||
146019969|NCT01537081|526584597|FG002|Overall Study|Physician Decision|0|||
146019970|NCT01537081|526584595|FG000|Overall Study|Sponsor decision|0|||
146019971|NCT01537081|526584596|FG001|Overall Study|Sponsor decision|1|||
146019972|NCT01537081|526584597|FG002|Overall Study|Sponsor decision|0|||
146019973|NCT01537081|526584595|FG000|Overall Study|Assigned but never dosed|1|||
146019974|NCT01537081|526584596|FG001|Overall Study|Assigned but never dosed|0|||
146019975|NCT01537081|526584597|FG002|Overall Study|Assigned but never dosed|0|||
146019976|NCT00218634|526584605|FG000|Overall Study|Lost to Follow-up|8|||
146019977|NCT00218634|526584606|FG001|Overall Study|Lost to Follow-up|15|||
146019978|NCT00734604|526584607|FG000|Overall Study|Adverse Event|0|||
146019979|NCT00734604|526584608|FG001|Overall Study|Adverse Event|2|||
146019980|NCT00734604|526584609|FG002|Overall Study|Adverse Event|0|||
146019981|NCT00734604|526584610|FG003|Overall Study|Adverse Event|2|||
146019982|NCT00734604|526584611|FG004|Overall Study|Adverse Event|1|||
146019983|NCT00734604|526584612|FG005|Overall Study|Adverse Event|1|||
146019984|NCT00734604|526584607|FG000|Overall Study|Serious Adverse Event|1|||
146019985|NCT00734604|526584608|FG001|Overall Study|Serious Adverse Event|0|||
146252275|NCT00596960|527435340|FG000|Overall Study|No alcohol use data|0|||
146019986|NCT00734604|526584609|FG002|Overall Study|Serious Adverse Event|1|||
146019987|NCT00734604|526584610|FG003|Overall Study|Serious Adverse Event|2|||
146019988|NCT00734604|526584611|FG004|Overall Study|Serious Adverse Event|0|||
146019989|NCT00734604|526584612|FG005|Overall Study|Serious Adverse Event|1|||
146019990|NCT00734604|526584607|FG000|Overall Study|Lost to Follow-up|1|||
146019991|NCT00734604|526584608|FG001|Overall Study|Lost to Follow-up|2|||
146019992|NCT00734604|526584609|FG002|Overall Study|Lost to Follow-up|2|||
146019993|NCT00734604|526584610|FG003|Overall Study|Lost to Follow-up|4|||
146019994|NCT00734604|526584611|FG004|Overall Study|Lost to Follow-up|2|||
146019995|NCT00734604|526584612|FG005|Overall Study|Lost to Follow-up|3|||
146019996|NCT00734604|526584607|FG000|Overall Study|Physician Decision|0|||
146019997|NCT00734604|526584608|FG001|Overall Study|Physician Decision|1|||
146019998|NCT00734604|526584609|FG002|Overall Study|Physician Decision|1|||
146019999|NCT00734604|526584610|FG003|Overall Study|Physician Decision|0|||
146020000|NCT00734604|526584611|FG004|Overall Study|Physician Decision|0|||
146020001|NCT00734604|526584612|FG005|Overall Study|Physician Decision|0|||
146252276|NCT00596960|527435341|FG001|Overall Study|No alcohol use data|1|||
146020002|NCT00734604|526584607|FG000|Overall Study|Protocol Violation|0|||
146020003|NCT00734604|526584608|FG001|Overall Study|Protocol Violation|2|||
146020004|NCT00734604|526584609|FG002|Overall Study|Protocol Violation|0|||
146020005|NCT00734604|526584610|FG003|Overall Study|Protocol Violation|0|||
146020006|NCT00734604|526584611|FG004|Overall Study|Protocol Violation|1|||
146020007|NCT00734604|526584612|FG005|Overall Study|Protocol Violation|0|||
146020008|NCT00734604|526584607|FG000|Overall Study|Sponsor Decision|1|||
146020009|NCT00734604|526584608|FG001|Overall Study|Sponsor Decision|2|||
146020010|NCT00734604|526584609|FG002|Overall Study|Sponsor Decision|1|||
146020011|NCT00734604|526584610|FG003|Overall Study|Sponsor Decision|0|||
146020012|NCT00734604|526584611|FG004|Overall Study|Sponsor Decision|2|||
146020013|NCT00734604|526584612|FG005|Overall Study|Sponsor Decision|0|||
146020014|NCT00734604|526584607|FG000|Overall Study|Withdrawal by Subject|0|||
146252277|NCT02058992|527435342|FG000|Overall Study|Lost to Follow-up|4|||
146252278|NCT02058992|527435342|FG000|Overall Study|Protocol Violation|92|||
146020015|NCT00734604|526584608|FG001|Overall Study|Withdrawal by Subject|2|||
146020016|NCT00734604|526584609|FG002|Overall Study|Withdrawal by Subject|0|||
146020017|NCT00734604|526584610|FG003|Overall Study|Withdrawal by Subject|1|||
146020018|NCT00734604|526584611|FG004|Overall Study|Withdrawal by Subject|2|||
146020019|NCT00734604|526584612|FG005|Overall Study|Withdrawal by Subject|1|||
146020020|NCT00734604|526584607|FG000|Overall Study|Lack of Efficacy|0|||
146020021|NCT00734604|526584608|FG001|Overall Study|Lack of Efficacy|1|||
146020022|NCT00734604|526584609|FG002|Overall Study|Lack of Efficacy|1|||
146020023|NCT00734604|526584610|FG003|Overall Study|Lack of Efficacy|0|||
146020024|NCT00734604|526584611|FG004|Overall Study|Lack of Efficacy|0|||
146020025|NCT00734604|526584612|FG005|Overall Study|Lack of Efficacy|0|||
146020026|NCT01044745|526584613|FG000|Overall Study|Ineiligible|2|||
146020027|NCT00591149|526584620|FG000|Overall Study|Adverse Event|4|||
146020028|NCT00591149|526584620|FG000|Overall Study|Withdrawal by Subject|1|||
146020029|NCT02456636|526584621|FG000|Overall Study|Death|0|||
146020030|NCT02456636|526584622|FG001|Overall Study|Death|3|||
146020031|NCT02456636|526584623|FG002|Overall Study|Death|0|||
146020032|NCT02456636|526584621|FG000|Overall Study|Pregnancy|1|||
146020033|NCT02456636|526584622|FG001|Overall Study|Pregnancy|3|||
146020034|NCT02456636|526584623|FG002|Overall Study|Pregnancy|5|||
146020035|NCT02456636|526584621|FG000|Overall Study|Physician Decision|4|||
146020036|NCT02456636|526584622|FG001|Overall Study|Physician Decision|5|||
146020037|NCT02456636|526584623|FG002|Overall Study|Physician Decision|4|||
146020038|NCT02456636|526584621|FG000|Overall Study|Withdrawal by Subject|13|||
146020039|NCT02456636|526584622|FG001|Overall Study|Withdrawal by Subject|14|||
146020040|NCT02456636|526584623|FG002|Overall Study|Withdrawal by Subject|16|||
146020041|NCT02456636|526584621|FG000|Overall Study|Lost to Follow-up|50|||
146020042|NCT02456636|526584622|FG001|Overall Study|Lost to Follow-up|44|||
146020043|NCT02456636|526584623|FG002|Overall Study|Lost to Follow-up|50|||
146020044|NCT02379221|526584624|FG000|Overall Study|Lost to Follow-up|1|||
146020045|NCT02019108|526584625|FG000|Overall Study|Lost to Follow-up|5|||
146020046|NCT02019108|526584626|FG001|Overall Study|Lost to Follow-up|7|||
146020047|NCT00519376|526584629|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020048|NCT00519376|526584630|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020049|NCT00519376|526584631|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020050|NCT00519376|526584632|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020051|NCT00519376|526584633|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020052|NCT00519376|526584634|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020053|NCT00519376|526584635|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020054|NCT00519376|526584636|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020055|NCT00519376|526584637|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020056|NCT00519376|526584638|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020057|NCT00519376|526584639|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020058|NCT00519376|526584640|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020059|NCT00519376|526584641|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
146020060|NCT00519376|526584642|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020061|NCT00519376|526584643|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020062|NCT00519376|526584644|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
146020063|NCT00519376|526584629|FG000|Treatment Period 4|Lost to Follow-up|0|||
146020064|NCT00519376|526584630|FG001|Treatment Period 4|Lost to Follow-up|0|||
146020065|NCT00519376|526584631|FG002|Treatment Period 4|Lost to Follow-up|1|||
146020066|NCT00519376|526584632|FG003|Treatment Period 4|Lost to Follow-up|0|||
146020067|NCT00519376|526584633|FG004|Treatment Period 4|Lost to Follow-up|0|||
146020068|NCT00519376|526584634|FG005|Treatment Period 4|Lost to Follow-up|0|||
146020069|NCT00519376|526584635|FG006|Treatment Period 4|Lost to Follow-up|0|||
146020070|NCT00519376|526584636|FG007|Treatment Period 4|Lost to Follow-up|0|||
146020071|NCT00519376|526584637|FG008|Treatment Period 4|Lost to Follow-up|0|||
146020072|NCT00519376|526584638|FG009|Treatment Period 4|Lost to Follow-up|0|||
146020073|NCT00519376|526584639|FG010|Treatment Period 4|Lost to Follow-up|0|||
146020074|NCT00519376|526584640|FG011|Treatment Period 4|Lost to Follow-up|0|||
146020075|NCT00519376|526584641|FG012|Treatment Period 4|Lost to Follow-up|0|||
146020076|NCT00519376|526584642|FG013|Treatment Period 4|Lost to Follow-up|0|||
146094144|NCT00723398|526866553|FG004|Overall Study|Adverse Event|4|||
146094145|NCT00723398|526866549|FG000|Overall Study|Lost to Follow-up|0|||
146094146|NCT00723398|526866550|FG001|Overall Study|Lost to Follow-up|1|||
146020077|NCT00519376|526584643|FG014|Treatment Period 4|Lost to Follow-up|0|||
146020078|NCT00519376|526584644|FG015|Treatment Period 4|Lost to Follow-up|0|||
146020079|NCT05275010|526584652|FG000|Overall Study|Reason Not Specified|4|||
146020080|NCT05275010|526584653|FG001|Overall Study|Reason Not Specified|1|||
146020081|NCT05275010|526584652|FG000|Overall Study|Withdrawal by Subject|1|||
146094147|NCT00723398|526866551|FG002|Overall Study|Lost to Follow-up|0|||
146094148|NCT00723398|526866552|FG003|Overall Study|Lost to Follow-up|0|||
146094149|NCT00723398|526866553|FG004|Overall Study|Lost to Follow-up|0|||
146094150|NCT00267189|526866558|FG000|Overall Study|Patient withdrew consent|1|||
146252279|NCT02058992|527435342|FG000|Overall Study|CRF Uncollected|20|||
146252280|NCT00914732|527435346|FG000|Overall Study|Lost to Follow-up|6|||
146252281|NCT00914732|527435347|FG001|Overall Study|Lost to Follow-up|7|||
146252282|NCT00914732|527435348|FG002|Overall Study|Lost to Follow-up|9|||
146252283|NCT00914732|527435346|FG000|Overall Study|Withdrawal by Subject|3|||
146252284|NCT00914732|527435347|FG001|Overall Study|Withdrawal by Subject|0|||
146252285|NCT00914732|527435348|FG002|Overall Study|Withdrawal by Subject|2|||
146252286|NCT00914732|527435346|FG000|Overall Study|Adverse Event|1|||
146252287|NCT00914732|527435347|FG001|Overall Study|Adverse Event|0|||
146252288|NCT00914732|527435348|FG002|Overall Study|Adverse Event|0|||
146252289|NCT02130401|527435349|FG000|Overall Study|Poor enrollment|6|||
146252290|NCT03005106|527435350|FG000|Overall Study|Lost to Follow-up|16|||
146252291|NCT03005106|527435350|FG000|Overall Study|Adverse Event|1|||
146252292|NCT03005106|527435350|FG000|Overall Study|Physician Decision|1|||
146252293|NCT03005106|527435350|FG000|Overall Study|Death|2|||
146252294|NCT01855399|527435351|FG000|6 Month|Lost to Follow-up|12|||
146252295|NCT01855399|527435352|FG001|6 Month|Lost to Follow-up|9|||
146252296|NCT01855399|527435351|FG000|6 Month|Withdrawal by Subject|8|||
146252297|NCT01855399|527435352|FG001|6 Month|Withdrawal by Subject|6|||
146252298|NCT01855399|527435351|FG000|12 Month|Lost to Follow-up|7|||
146252299|NCT01855399|527435352|FG001|12 Month|Lost to Follow-up|11|||
146252300|NCT00321672|527435355|FG000|Overall Study|Withdrawal by Subject|5|||
146252301|NCT00321672|527435356|FG001|Overall Study|Withdrawal by Subject|1|||
146252302|NCT00321672|527435357|FG002|Overall Study|Withdrawal by Subject|2|||
146252303|NCT00321672|527435358|FG003|Overall Study|Withdrawal by Subject|0|||
146252304|NCT00321672|527435355|FG000|Overall Study|Noncompliance|1|||
146252305|NCT00321672|527435356|FG001|Overall Study|Noncompliance|2|||
146252306|NCT00321672|527435357|FG002|Overall Study|Noncompliance|1|||
146252307|NCT00321672|527435358|FG003|Overall Study|Noncompliance|0|||
146252308|NCT00321672|527435355|FG000|Overall Study|Adverse Event|1|||
146252309|NCT00321672|527435356|FG001|Overall Study|Adverse Event|1|||
146252310|NCT00321672|527435357|FG002|Overall Study|Adverse Event|0|||
146252311|NCT00321672|527435358|FG003|Overall Study|Adverse Event|0|||
146252312|NCT00321672|527435355|FG000|Overall Study|Lack of Efficacy|1|||
146252313|NCT00321672|527435356|FG001|Overall Study|Lack of Efficacy|1|||
146252314|NCT00321672|527435357|FG002|Overall Study|Lack of Efficacy|0|||
146252315|NCT00321672|527435358|FG003|Overall Study|Lack of Efficacy|0|||
146252316|NCT00321672|527435355|FG000|Overall Study|Lost to Follow-up|2|||
146252317|NCT00321672|527435356|FG001|Overall Study|Lost to Follow-up|0|||
146252318|NCT00321672|527435357|FG002|Overall Study|Lost to Follow-up|4|||
146252319|NCT00321672|527435358|FG003|Overall Study|Lost to Follow-up|2|||
146252320|NCT00321672|527435355|FG000|Overall Study|Death|1|||
146252321|NCT00321672|527435356|FG001|Overall Study|Death|0|||
146252322|NCT00321672|527435357|FG002|Overall Study|Death|0|||
146252323|NCT00321672|527435358|FG003|Overall Study|Death|0|||
146252324|NCT00321672|527435355|FG000|Overall Study|Too far to travel for visits|1|||
146252325|NCT00321672|527435356|FG001|Overall Study|Too far to travel for visits|0|||
146020082|NCT05275010|526584653|FG001|Overall Study|Withdrawal by Subject|0|||
146020083|NCT05275010|526584652|FG000|Overall Study|Lost to Follow-up|0|||
146020084|NCT05275010|526584653|FG001|Overall Study|Lost to Follow-up|1|||
146020085|NCT04484649|526584656|FG000|Overall Study|Lost to Follow-up|2|||
146020086|NCT04484649|526584657|FG001|Overall Study|Lost to Follow-up|1|||
146020087|NCT04484649|526584656|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
146020088|NCT04484649|526584657|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
146020089|NCT04417218|526584668|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
146020090|NCT04417218|526584669|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
146020091|NCT01082874|526584673|FG000|Overall Study|Lost to Follow-up|10|||
146020092|NCT01082874|526584674|FG001|Overall Study|Lost to Follow-up|10|||
146020093|NCT01082874|526584675|FG002|Overall Study|Lost to Follow-up|6|||
146020094|NCT01082874|526584676|FG003|Overall Study|Lost to Follow-up|10|||
146020095|NCT01082874|526584673|FG000|Overall Study|Withdrawal by Subject|1|||
146020096|NCT01082874|526584674|FG001|Overall Study|Withdrawal by Subject|2|||
146020097|NCT01082874|526584675|FG002|Overall Study|Withdrawal by Subject|5|||
146252326|NCT00321672|527435357|FG002|Overall Study|Too far to travel for visits|0|||
146252327|NCT00321672|527435358|FG003|Overall Study|Too far to travel for visits|0|||
146252328|NCT00321672|527435355|FG000|Overall Study|Incarcerated|0|||
146252329|NCT00321672|527435356|FG001|Overall Study|Incarcerated|0|||
146252330|NCT00321672|527435357|FG002|Overall Study|Incarcerated|2|||
146252331|NCT00321672|527435358|FG003|Overall Study|Incarcerated|0|||
146252332|NCT00321672|527435355|FG000|Overall Study|Moved out of state|0|||
146252333|NCT00321672|527435356|FG001|Overall Study|Moved out of state|1|||
146252334|NCT00321672|527435357|FG002|Overall Study|Moved out of state|1|||
146020098|NCT01082874|526584676|FG003|Overall Study|Withdrawal by Subject|3|||
146252335|NCT00321672|527435358|FG003|Overall Study|Moved out of state|0|||
146252336|NCT00321672|527435355|FG000|Overall Study|Protocol Violation|0|||
146252337|NCT00321672|527435356|FG001|Overall Study|Protocol Violation|0|||
146252338|NCT00321672|527435357|FG002|Overall Study|Protocol Violation|1|||
146252339|NCT00321672|527435358|FG003|Overall Study|Protocol Violation|0|||
146252340|NCT00321672|527435355|FG000|Overall Study|Diagnosis of testicular cancer|0|||
146020099|NCT03888235|526584680|FG000|Overall Study|Lost to Follow-up|1|||
146020100|NCT03888235|526584681|FG001|Overall Study|Lost to Follow-up|1|||
146020101|NCT03888235|526584682|FG002|Overall Study|Lost to Follow-up|0|||
146020102|NCT00939029|526584685|FG000|Overall Study|Withdrawal by Subject|3|||
146020103|NCT00939029|526584686|FG001|Overall Study|Withdrawal by Subject|7|||
146020104|NCT00939029|526584685|FG000|Overall Study|Lost to Follow-up|3|||
146020105|NCT00939029|526584686|FG001|Overall Study|Lost to Follow-up|4|||
146020106|NCT00939029|526584685|FG000|Overall Study|Adverse Event|0|||
146020107|NCT00939029|526584686|FG001|Overall Study|Adverse Event|1|||
146020108|NCT03305419|526584698|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020109|NCT03305419|526584699|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
146020110|NCT03305419|526584700|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020111|NCT03305419|526584701|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020112|NCT03305419|526584702|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020113|NCT03305419|526584703|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020114|NCT03305419|526584704|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020115|NCT03305419|526584705|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
146020116|NCT03305419|526584698|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
146020117|NCT03305419|526584699|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020118|NCT03305419|526584700|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020119|NCT03305419|526584701|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020120|NCT03305419|526584702|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020121|NCT03305419|526584703|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020122|NCT03305419|526584704|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020123|NCT03305419|526584705|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
146020124|NCT03305419|526584698|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
146020125|NCT03305419|526584699|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020126|NCT03305419|526584700|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020127|NCT03305419|526584701|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020128|NCT03305419|526584702|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020129|NCT03305419|526584703|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020130|NCT03305419|526584704|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020131|NCT03305419|526584705|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
146020132|NCT03305419|526584698|FG000|Part B (14 Days)|Adverse Event|0|||
146020133|NCT03305419|526584699|FG001|Part B (14 Days)|Adverse Event|0|||
146020134|NCT03305419|526584700|FG002|Part B (14 Days)|Adverse Event|0|||
146020135|NCT03305419|526584701|FG003|Part B (14 Days)|Adverse Event|0|||
146020136|NCT03305419|526584702|FG004|Part B (14 Days)|Adverse Event|1|||
146020137|NCT03305419|526584703|FG005|Part B (14 Days)|Adverse Event|2|||
146020138|NCT03305419|526584704|FG006|Part B (14 Days)|Adverse Event|4|||
146020139|NCT03305419|526584705|FG007|Part B (14 Days)|Adverse Event|0|||
146020140|NCT03305419|526584698|FG000|Part B (14 Days)|Physician Decision|0|||
146020141|NCT03305419|526584699|FG001|Part B (14 Days)|Physician Decision|0|||
146020142|NCT03305419|526584700|FG002|Part B (14 Days)|Physician Decision|0|||
146020143|NCT03305419|526584701|FG003|Part B (14 Days)|Physician Decision|0|||
146020144|NCT03305419|526584702|FG004|Part B (14 Days)|Physician Decision|2|||
146020145|NCT03305419|526584703|FG005|Part B (14 Days)|Physician Decision|8|||
146020146|NCT03305419|526584704|FG006|Part B (14 Days)|Physician Decision|1|||
146020147|NCT03305419|526584705|FG007|Part B (14 Days)|Physician Decision|0|||
146252341|NCT00321672|527435356|FG001|Overall Study|Diagnosis of testicular cancer|1|||
146252342|NCT00321672|527435357|FG002|Overall Study|Diagnosis of testicular cancer|0|||
146252343|NCT00321672|527435358|FG003|Overall Study|Diagnosis of testicular cancer|0|||
146252344|NCT00321672|527435355|FG000|Overall Study|Extensive travel required for new job|0|||
146252345|NCT00321672|527435356|FG001|Overall Study|Extensive travel required for new job|1|||
146020148|NCT00075946|526584706|FG000|Overall Study|Path ineligible: undetermined histology|0|||
146020149|NCT00075946|526584707|FG001|Overall Study|Path ineligible: undetermined histology|0|||
146020150|NCT00075946|526584708|FG002|Overall Study|Path ineligible: undetermined histology|0|||
146020151|NCT00075946|526584709|FG003|Overall Study|Path ineligible: undetermined histology|0|||
146020152|NCT00075946|526584710|FG004|Overall Study|Path ineligible: undetermined histology|6|||
146020153|NCT00075946|526584706|FG000|Overall Study|Did not achieve response after induction|0|||
146020154|NCT00075946|526584707|FG001|Overall Study|Did not achieve response after induction|0|||
146020155|NCT00075946|526584708|FG002|Overall Study|Did not achieve response after induction|0|||
146020156|NCT00075946|526584709|FG003|Overall Study|Did not achieve response after induction|0|||
146020157|NCT00075946|526584710|FG004|Overall Study|Did not achieve response after induction|182|||
146020158|NCT00075946|526584706|FG000|Overall Study|Incorrectly randomized (no response)|5|||
146020159|NCT00075946|526584707|FG001|Overall Study|Incorrectly randomized (no response)|5|||
146020160|NCT00075946|526584708|FG002|Overall Study|Incorrectly randomized (no response)|5|||
146020161|NCT00075946|526584709|FG003|Overall Study|Incorrectly randomized (no response)|1|||
146094151|NCT00267189|526866559|FG001|Overall Study|Patient withdrew consent|1|||
146020162|NCT00075946|526584710|FG004|Overall Study|Incorrectly randomized (no response)|0|||
146020163|NCT00075946|526584706|FG000|Overall Study|Adverse Event|2|||
146020164|NCT00075946|526584707|FG001|Overall Study|Adverse Event|10|||
146020165|NCT00075946|526584708|FG002|Overall Study|Adverse Event|0|||
146020166|NCT00075946|526584709|FG003|Overall Study|Adverse Event|2|||
146020167|NCT00075946|526584710|FG004|Overall Study|Adverse Event|0|||
146020168|NCT00075946|526584706|FG000|Overall Study|Death|0|||
146252346|NCT00321672|527435357|FG002|Overall Study|Extensive travel required for new job|0|||
146252347|NCT00321672|527435358|FG003|Overall Study|Extensive travel required for new job|0|||
146252348|NCT00512902|527435359|FG000|Overall Study|Adverse Event|7|||
146252349|NCT00512902|527435359|FG000|Overall Study|Lost to Follow-up|1|||
146252350|NCT03019289|527435360|FG000|Overall Study|Adverse Event|1|||
146252351|NCT03019289|527435361|FG001|Overall Study|Adverse Event|0|||
146252352|NCT03019289|527435362|FG002|Overall Study|Adverse Event|0|||
146252353|NCT03019289|527435363|FG003|Overall Study|Adverse Event|0|||
146252354|NCT03019289|527435364|FG004|Overall Study|Adverse Event|0|||
146252355|NCT03019289|527435365|FG005|Overall Study|Adverse Event|0|||
146252356|NCT03019289|527435366|FG006|Overall Study|Adverse Event|0|||
146252357|NCT03019289|527435367|FG007|Overall Study|Adverse Event|0|||
146252358|NCT03019289|527435368|FG008|Overall Study|Adverse Event|1|||
146252359|NCT03019289|527435360|FG000|Overall Study|Other|1|||
146252360|NCT03019289|527435361|FG001|Overall Study|Other|0|||
146252361|NCT03019289|527435362|FG002|Overall Study|Other|0|||
146252362|NCT03019289|527435363|FG003|Overall Study|Other|0|||
146252363|NCT03019289|527435364|FG004|Overall Study|Other|0|||
146252364|NCT03019289|527435365|FG005|Overall Study|Other|0|||
146252365|NCT03019289|527435366|FG006|Overall Study|Other|0|||
146252366|NCT03019289|527435367|FG007|Overall Study|Other|0|||
146252367|NCT03019289|527435368|FG008|Overall Study|Other|0|||
146252368|NCT00936065|527435369|FG000|Overall Study|Adverse Event|1|||
146252369|NCT00936065|527435370|FG001|Overall Study|Adverse Event|0|||
146252370|NCT00936065|527435371|FG002|Overall Study|Adverse Event|1|||
146252371|NCT00936065|527435369|FG000|Overall Study|Lack of Efficacy|1|||
146252372|NCT00936065|527435370|FG001|Overall Study|Lack of Efficacy|0|||
146252373|NCT00936065|527435371|FG002|Overall Study|Lack of Efficacy|1|||
146252374|NCT00936065|527435369|FG000|Overall Study|Lost to Follow-up|1|||
146252375|NCT00936065|527435370|FG001|Overall Study|Lost to Follow-up|0|||
146252376|NCT00936065|527435371|FG002|Overall Study|Lost to Follow-up|0|||
146252377|NCT00936065|527435369|FG000|Overall Study|Protocol Violation|1|||
146252378|NCT00936065|527435370|FG001|Overall Study|Protocol Violation|2|||
146252379|NCT00936065|527435371|FG002|Overall Study|Protocol Violation|1|||
146252380|NCT00936065|527435369|FG000|Overall Study|Withdrawal by Subject|0|||
146252381|NCT00936065|527435370|FG001|Overall Study|Withdrawal by Subject|2|||
146252382|NCT00936065|527435371|FG002|Overall Study|Withdrawal by Subject|4|||
146252383|NCT02389894|527435372|FG000|Overall Study|Death|4|||
146252384|NCT02389894|527435373|FG001|Overall Study|Death|5|||
146252385|NCT02389894|527435374|FG002|Overall Study|Death|3|||
146252386|NCT02389894|527435372|FG000|Overall Study|Withdrawal by Subject|2|||
146252387|NCT02389894|527435373|FG001|Overall Study|Withdrawal by Subject|4|||
146252388|NCT02389894|527435374|FG002|Overall Study|Withdrawal by Subject|5|||
146252389|NCT02389894|527435372|FG000|Overall Study|Lost to Follow-up|2|||
146252390|NCT02389894|527435373|FG001|Overall Study|Lost to Follow-up|1|||
146252391|NCT02389894|527435374|FG002|Overall Study|Lost to Follow-up|1|||
146252392|NCT01429285|527435377|FG000|Overall Study|Protocol Violation|9|||
146252393|NCT01429285|527435378|FG001|Overall Study|Protocol Violation|4|||
146252394|NCT01429285|527435377|FG000|Overall Study|Missing Data|5|||
146252395|NCT01429285|527435378|FG001|Overall Study|Missing Data|3|||
146252396|NCT01429285|527435377|FG000|Overall Study|Erroneously Enrolled Twice|8|||
146020169|NCT00075946|526584707|FG001|Overall Study|Death|1|||
146094152|NCT00267189|526866558|FG000|Overall Study|Death|1|||
146094153|NCT00267189|526866559|FG001|Overall Study|Death|0|||
146020170|NCT00075946|526584708|FG002|Overall Study|Death|0|||
146020171|NCT00075946|526584709|FG003|Overall Study|Death|0|||
146252397|NCT01429285|527435378|FG001|Overall Study|Erroneously Enrolled Twice|2|||
146252398|NCT01549951|527435379|FG000|Overall Study|Adverse Event|15|||
146252399|NCT01549951|527435379|FG000|Overall Study|Withdrawal by Subject|2|||
146252400|NCT01549951|527435379|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146252401|NCT01549951|527435379|FG000|Overall Study|Progressive disease|29|||
146252402|NCT01549951|527435379|FG000|Overall Study|Symptomatic deterioration|1|||
146252403|NCT01549951|527435379|FG000|Overall Study|Other|2|||
146252404|NCT00738400|527435380|FG000|Overall Study|Adverse Event|3|||
146252405|NCT00738400|527435381|FG001|Overall Study|Adverse Event|1|||
146252406|NCT00738400|527435380|FG000|Overall Study|Withdrawal by Subject|0|||
146020172|NCT00075946|526584710|FG004|Overall Study|Death|0|||
146094154|NCT00267189|526866558|FG000|Overall Study|Missing|3|||
146252407|NCT00738400|527435381|FG001|Overall Study|Withdrawal by Subject|1|||
146252408|NCT00738400|527435380|FG000|Overall Study|Lack of Efficacy|0|||
146252409|NCT00738400|527435381|FG001|Overall Study|Lack of Efficacy|1|||
146252410|NCT00738400|527435380|FG000|Overall Study|Lost to Follow-up|0|||
146252411|NCT00738400|527435381|FG001|Overall Study|Lost to Follow-up|3|||
146252412|NCT00738400|527435380|FG000|Overall Study|Protocol Violation|1|||
146252413|NCT00738400|527435381|FG001|Overall Study|Protocol Violation|0|||
146252414|NCT00738400|527435380|FG000|Overall Study|Non-compliant with study medication|0|||
146020173|NCT00075946|526584706|FG000|Overall Study|Withdrawal by Subject|23|||
146020174|NCT00075946|526584707|FG001|Overall Study|Withdrawal by Subject|58|||
146020175|NCT00075946|526584708|FG002|Overall Study|Withdrawal by Subject|4|||
146020176|NCT00075946|526584709|FG003|Overall Study|Withdrawal by Subject|9|||
146020177|NCT00075946|526584710|FG004|Overall Study|Withdrawal by Subject|0|||
146020178|NCT00075946|526584706|FG000|Overall Study|Alternative therapy|16|||
146020179|NCT00075946|526584707|FG001|Overall Study|Alternative therapy|2|||
146020180|NCT00075946|526584708|FG002|Overall Study|Alternative therapy|5|||
146020181|NCT00075946|526584709|FG003|Overall Study|Alternative therapy|0|||
146020182|NCT00075946|526584710|FG004|Overall Study|Alternative therapy|0|||
146020183|NCT00075946|526584706|FG000|Overall Study|Other complicating disease|7|||
146020184|NCT00075946|526584707|FG001|Overall Study|Other complicating disease|13|||
146020185|NCT00075946|526584708|FG002|Overall Study|Other complicating disease|1|||
146020186|NCT00075946|526584709|FG003|Overall Study|Other complicating disease|4|||
146020187|NCT00075946|526584710|FG004|Overall Study|Other complicating disease|0|||
146020188|NCT00075946|526584706|FG000|Overall Study|No response to retreatment|23|||
146020189|NCT00075946|526584707|FG001|Overall Study|No response to retreatment|0|||
146020190|NCT00075946|526584708|FG002|Overall Study|No response to retreatment|2|||
146020191|NCT00075946|526584709|FG003|Overall Study|No response to retreatment|0|||
146020192|NCT00075946|526584710|FG004|Overall Study|No response to retreatment|0|||
146020193|NCT00075946|526584706|FG000|Overall Study|Time to progression less than 6 months|15|||
146020194|NCT00075946|526584707|FG001|Overall Study|Time to progression less than 6 months|30|||
146020195|NCT00075946|526584708|FG002|Overall Study|Time to progression less than 6 months|8|||
146020196|NCT00075946|526584709|FG003|Overall Study|Time to progression less than 6 months|3|||
146020197|NCT00075946|526584710|FG004|Overall Study|Time to progression less than 6 months|0|||
146020198|NCT00075946|526584706|FG000|Overall Study|Other|57|||
146020199|NCT00075946|526584707|FG001|Overall Study|Other|32|||
146020200|NCT00075946|526584708|FG002|Overall Study|Other|3|||
146020201|NCT00075946|526584709|FG003|Overall Study|Other|11|||
146020202|NCT00075946|526584710|FG004|Overall Study|Other|0|||
146020203|NCT02210689|526584711|FG000|Overall Study|Withdrawal by Subject|7|||
146020204|NCT02210689|526584712|FG001|Overall Study|Withdrawal by Subject|4|||
146020205|NCT02210689|526584713|FG002|Overall Study|Withdrawal by Subject|2|||
146020206|NCT02210689|526584711|FG000|Overall Study|Adverse Event|0|||
146020207|NCT02210689|526584712|FG001|Overall Study|Adverse Event|1|||
146020208|NCT02210689|526584713|FG002|Overall Study|Adverse Event|0|||
146020209|NCT02210689|526584711|FG000|Overall Study|Protocol Violation|1|||
146020210|NCT02210689|526584712|FG001|Overall Study|Protocol Violation|0|||
146020211|NCT02210689|526584713|FG002|Overall Study|Protocol Violation|0|||
146020212|NCT02210689|526584711|FG000|Overall Study|Lost to Follow-up|11|||
146020213|NCT02210689|526584712|FG001|Overall Study|Lost to Follow-up|9|||
146020214|NCT02210689|526584713|FG002|Overall Study|Lost to Follow-up|5|||
146020215|NCT02210689|526584711|FG000|Overall Study|Pregnancy|0|||
146020216|NCT02210689|526584712|FG001|Overall Study|Pregnancy|1|||
146020217|NCT02210689|526584713|FG002|Overall Study|Pregnancy|0|||
146020218|NCT02210689|526584711|FG000|Overall Study|Lack of Efficacy|0|||
146020219|NCT02210689|526584712|FG001|Overall Study|Lack of Efficacy|1|||
146020220|NCT02210689|526584713|FG002|Overall Study|Lack of Efficacy|5|||
146020221|NCT02210689|526584711|FG000|Overall Study|Prohibited medication|2|||
146020222|NCT02210689|526584712|FG001|Overall Study|Prohibited medication|8|||
146020223|NCT02210689|526584713|FG002|Overall Study|Prohibited medication|1|||
146020224|NCT02210689|526584711|FG000|Overall Study|Negative Nugent score at baseline|6|||
146020225|NCT02210689|526584712|FG001|Overall Study|Negative Nugent score at baseline|2|||
146020226|NCT02210689|526584713|FG002|Overall Study|Negative Nugent score at baseline|2|||
146020227|NCT02210689|526584711|FG000|Overall Study|Other|25|||
146020228|NCT02210689|526584712|FG001|Overall Study|Other|21|||
146020229|NCT02210689|526584713|FG002|Overall Study|Other|8|||
146252415|NCT00738400|527435381|FG001|Overall Study|Non-compliant with study medication|1|||
146252416|NCT01052714|527435388|FG000|Overall Study|Adverse Event|6|||
146252417|NCT01052714|527435389|FG001|Overall Study|Adverse Event|3|||
146252418|NCT01052714|527435390|FG002|Overall Study|Adverse Event|0|||
146252419|NCT01052714|527435388|FG000|Overall Study|Death|1|||
146020230|NCT00503776|526584714|FG000|Overall Study|Withdrawal by Subject|1|||
146020231|NCT00503776|526584715|FG001|Overall Study|Withdrawal by Subject|0|||
146020232|NCT00503776|526584716|FG002|Overall Study|Withdrawal by Subject|1|||
146020233|NCT00503776|526584717|FG003|Overall Study|Withdrawal by Subject|1|||
146020234|NCT00503776|526584714|FG000|Overall Study|Physician Decision|0|||
146020235|NCT00503776|526584715|FG001|Overall Study|Physician Decision|0|||
146020236|NCT00503776|526584716|FG002|Overall Study|Physician Decision|1|||
146020237|NCT00503776|526584717|FG003|Overall Study|Physician Decision|1|||
146020238|NCT02247011|526584720|FG000|Overall Study|Poor quality of radiological results|125|||
146020239|NCT02649218|526584725|FG000|Overall Study|Adverse Event|8|||
146020240|NCT02649218|526584725|FG000|Overall Study|Lack of Efficacy|8|||
146252420|NCT01052714|527435389|FG001|Overall Study|Death|2|||
146020241|NCT02649218|526584725|FG000|Overall Study|Pregnancy|3|||
146252421|NCT01052714|527435390|FG002|Overall Study|Death|0|||
146020242|NCT02649218|526584725|FG000|Overall Study|Protocol Violation|3|||
146020243|NCT02649218|526584725|FG000|Overall Study|Physician Decision|1|||
146020244|NCT02649218|526584725|FG000|Overall Study|Withdrawal by Subject|2|||
146020245|NCT04470908|526584728|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
146020246|NCT01301066|526584732|FG000|Overall Study|Lost to Follow-up|5|||
146020247|NCT01301066|526584733|FG001|Overall Study|Lost to Follow-up|11|||
146020248|NCT01301066|526584732|FG000|Overall Study|Protocol Violation|8|||
146020249|NCT01301066|526584733|FG001|Overall Study|Protocol Violation|7|||
146020250|NCT01301066|526584732|FG000|Overall Study|Withdrawal by Subject|4|||
146020251|NCT01301066|526584733|FG001|Overall Study|Withdrawal by Subject|9|||
146020252|NCT01301066|526584732|FG000|Overall Study|Adverse Event|6|||
146020253|NCT01301066|526584733|FG001|Overall Study|Adverse Event|6|||
146020254|NCT01301066|526584732|FG000|Overall Study|Sponsor Decision|2|||
146020255|NCT01301066|526584733|FG001|Overall Study|Sponsor Decision|1|||
146020256|NCT01301066|526584732|FG000|Overall Study|Physician Decision|0|||
146020257|NCT01301066|526584733|FG001|Overall Study|Physician Decision|1|||
146020258|NCT01301066|526584732|FG000|Overall Study|Other|2|||
146020259|NCT01301066|526584733|FG001|Overall Study|Other|0|||
146020260|NCT01974206|526584734|FG000|Overall Study|Did Not Take Study Drug|0|||
146020261|NCT01974206|526584735|FG001|Overall Study|Did Not Take Study Drug|1|||
146020262|NCT01974206|526584734|FG000|Overall Study|Physician Decision|1|||
146020263|NCT01974206|526584735|FG001|Overall Study|Physician Decision|0|||
146020264|NCT01974206|526584734|FG000|Overall Study|Withdrawal by Subject|3|||
146020265|NCT01974206|526584735|FG001|Overall Study|Withdrawal by Subject|0|||
146020266|NCT01974206|526584734|FG000|Overall Study|Lost to Follow-up|1|||
146020267|NCT01974206|526584735|FG001|Overall Study|Lost to Follow-up|0|||
146020268|NCT01974206|526584734|FG000|Overall Study|Death|1|||
146020269|NCT01974206|526584735|FG001|Overall Study|Death|0|||
146020270|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
146020271|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146020272|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146020273|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146020274|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146020275|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
146020276|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
146020277|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
146020278|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146020279|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146020280|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146020281|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
146020282|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
146020283|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
146020284|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146020285|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146020286|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146020287|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
146020288|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
146020289|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
146020290|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146020291|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146020292|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146020293|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
146020294|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
146020295|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
146094155|NCT00267189|526866559|FG001|Overall Study|Missing|0|||
146020296|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146094156|NCT04137224|526866561|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
146094157|NCT04137224|526866562|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
146094158|NCT04137224|526866561|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
146094159|NCT04137224|526866562|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
146094160|NCT04137224|526866561|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
146252422|NCT01052714|527435388|FG000|Overall Study|Lost to Follow-up|2|||
146020297|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146020298|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146020299|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
146020300|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
146020301|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146020302|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146020303|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146020304|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146020305|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
146020306|NCT03989349|526584738|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
146020307|NCT03989349|526584739|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
146020308|NCT03989349|526584740|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146020309|NCT03989349|526584741|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146020310|NCT03989349|526584742|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146020311|NCT03989349|526584743|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
146020312|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146020313|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146020314|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
146020315|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
146020316|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146020317|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
146020318|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146020319|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146020320|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146020321|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
146020322|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
146020323|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
146020324|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146020325|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146020326|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
146020327|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
146020328|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
146020329|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
146020330|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146020331|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146020332|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146020333|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146020334|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
146020335|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146020336|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146020337|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146020338|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146020339|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146020340|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146020341|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146020342|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
146020343|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
146020344|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
146020345|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
146020346|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
146020347|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
146020348|NCT03989349|526584738|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146020349|NCT03989349|526584739|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146020350|NCT03989349|526584740|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146020351|NCT03989349|526584741|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
146020352|NCT03989349|526584742|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146020353|NCT03989349|526584743|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
146020354|NCT01802580|526584746|FG000|Overall Study|Physician Decision|1|||
146020355|NCT01802580|526584747|FG001|Overall Study|Physician Decision|0|||
146020356|NCT01802580|526584746|FG000|Overall Study|Protocol Violation|2|||
146020357|NCT01802580|526584747|FG001|Overall Study|Protocol Violation|0|||
146020358|NCT01802580|526584746|FG000|Overall Study|Withdrawal by Subject|5|||
146020359|NCT01802580|526584747|FG001|Overall Study|Withdrawal by Subject|6|||
146020360|NCT01802580|526584746|FG000|Overall Study|Other|1|||
146020361|NCT01802580|526584747|FG001|Overall Study|Other|3|||
146020362|NCT01802580|526584746|FG000|Overall Study|Lack of Efficacy|0|||
146020363|NCT01802580|526584747|FG001|Overall Study|Lack of Efficacy|2|||
146020364|NCT00778258|526584748|FG000|Overall Study|Adverse Event|1|||
146020365|NCT00778258|526584749|FG001|Overall Study|Adverse Event|0|||
146020366|NCT00778258|526584750|FG002|Overall Study|Adverse Event|0|||
146020367|NCT00778258|526584751|FG003|Overall Study|Adverse Event|0|||
146020368|NCT00778258|526584752|FG004|Overall Study|Adverse Event|0|||
146020369|NCT00778258|526584753|FG005|Overall Study|Adverse Event|1|||
146252423|NCT01052714|527435389|FG001|Overall Study|Lost to Follow-up|3|||
146252424|NCT01052714|527435390|FG002|Overall Study|Lost to Follow-up|0|||
146252425|NCT01052714|527435388|FG000|Overall Study|Physician Decision|9|||
146252426|NCT01052714|527435389|FG001|Overall Study|Physician Decision|9|||
146252427|NCT01052714|527435390|FG002|Overall Study|Physician Decision|1|||
146252428|NCT01052714|527435388|FG000|Overall Study|Withdrawal by Subject|7|||
146252429|NCT01052714|527435389|FG001|Overall Study|Withdrawal by Subject|12|||
146252430|NCT01052714|527435390|FG002|Overall Study|Withdrawal by Subject|1|||
146252431|NCT00990314|527435391|FG000|Overall Study|Death|2|||
146252432|NCT00990314|527435391|FG000|Overall Study|Adverse Event|2|||
146252433|NCT00990314|527435391|FG000|Overall Study|Withdrawal by Subject|3|||
146252434|NCT00990314|527435391|FG000|Overall Study|Non-Compliance|1|||
146252435|NCT00990314|527435391|FG000|Overall Study|Physician Decision|3|||
146020370|NCT00778258|526584754|FG006|Overall Study|Adverse Event|0|||
146020371|NCT00778258|526584755|FG007|Overall Study|Adverse Event|0|||
146020372|NCT00778258|526584756|FG008|Overall Study|Adverse Event|0|||
146020373|NCT00778258|526584748|FG000|Overall Study|Lost to Follow-up|0|||
146020374|NCT00778258|526584749|FG001|Overall Study|Lost to Follow-up|0|||
146020375|NCT00778258|526584750|FG002|Overall Study|Lost to Follow-up|2|||
146020376|NCT00778258|526584751|FG003|Overall Study|Lost to Follow-up|0|||
146020377|NCT00778258|526584752|FG004|Overall Study|Lost to Follow-up|0|||
146020378|NCT00778258|526584753|FG005|Overall Study|Lost to Follow-up|3|||
146020379|NCT00778258|526584754|FG006|Overall Study|Lost to Follow-up|2|||
146020380|NCT00778258|526584755|FG007|Overall Study|Lost to Follow-up|2|||
146020381|NCT00778258|526584756|FG008|Overall Study|Lost to Follow-up|0|||
146020382|NCT00778258|526584748|FG000|Overall Study|Withdrawal by Subject|6|||
146020383|NCT00778258|526584749|FG001|Overall Study|Withdrawal by Subject|2|||
146020384|NCT00778258|526584750|FG002|Overall Study|Withdrawal by Subject|8|||
146020385|NCT00778258|526584751|FG003|Overall Study|Withdrawal by Subject|2|||
146020386|NCT00778258|526584752|FG004|Overall Study|Withdrawal by Subject|0|||
146020387|NCT00778258|526584753|FG005|Overall Study|Withdrawal by Subject|6|||
146020388|NCT00778258|526584754|FG006|Overall Study|Withdrawal by Subject|12|||
146020389|NCT00778258|526584755|FG007|Overall Study|Withdrawal by Subject|12|||
146020390|NCT00778258|526584756|FG008|Overall Study|Withdrawal by Subject|4|||
146020391|NCT00778258|526584748|FG000|Overall Study|New Contraindication|0|||
146020392|NCT00778258|526584749|FG001|Overall Study|New Contraindication|0|||
146020393|NCT00778258|526584750|FG002|Overall Study|New Contraindication|0|||
146020394|NCT00778258|526584751|FG003|Overall Study|New Contraindication|0|||
146020395|NCT00778258|526584752|FG004|Overall Study|New Contraindication|0|||
146020396|NCT00778258|526584753|FG005|Overall Study|New Contraindication|0|||
146020397|NCT00778258|526584754|FG006|Overall Study|New Contraindication|0|||
146020398|NCT00778258|526584755|FG007|Overall Study|New Contraindication|1|||
146020399|NCT00778258|526584756|FG008|Overall Study|New Contraindication|0|||
146020400|NCT00778258|526584748|FG000|Overall Study|Non-compliance|0|||
146020401|NCT00778258|526584749|FG001|Overall Study|Non-compliance|0|||
146020402|NCT00778258|526584750|FG002|Overall Study|Non-compliance|0|||
146020403|NCT00778258|526584751|FG003|Overall Study|Non-compliance|1|||
146020404|NCT00778258|526584752|FG004|Overall Study|Non-compliance|0|||
146020405|NCT00778258|526584753|FG005|Overall Study|Non-compliance|0|||
146020406|NCT00778258|526584754|FG006|Overall Study|Non-compliance|0|||
146020407|NCT00778258|526584755|FG007|Overall Study|Non-compliance|0|||
146020408|NCT00778258|526584756|FG008|Overall Study|Non-compliance|0|||
146020409|NCT00778258|526584748|FG000|Overall Study|Other|0|||
146252436|NCT00990314|527435391|FG000|Overall Study|Lack of Efficacy|1|||
146252437|NCT01288729|527435401|FG000|Overall Study|Withdrawal by Subject|1|||
146252438|NCT01288729|527435402|FG001|Overall Study|Withdrawal by Subject|0|||
146252439|NCT02514577|527436862|FG000|Overall Study|Lost to Follow-up|6|||
146020410|NCT00778258|526584749|FG001|Overall Study|Other|0|||
146020411|NCT00778258|526584750|FG002|Overall Study|Other|0|||
146020412|NCT00778258|526584751|FG003|Overall Study|Other|0|||
146020413|NCT00778258|526584752|FG004|Overall Study|Other|0|||
146020414|NCT00778258|526584753|FG005|Overall Study|Other|0|||
146020415|NCT00778258|526584754|FG006|Overall Study|Other|1|||
146020416|NCT00778258|526584755|FG007|Overall Study|Other|0|||
146020417|NCT00778258|526584756|FG008|Overall Study|Other|0|||
146020418|NCT02438683|526584757|FG000|Overall Study|Adverse Event|1|||
146252440|NCT02514577|527436863|FG001|Overall Study|Lost to Follow-up|6|||
146252441|NCT02514577|527436862|FG000|Overall Study|Protocol Violation|1|||
146252442|NCT02514577|527436863|FG001|Overall Study|Protocol Violation|0|||
146020419|NCT02438683|526584758|FG001|Overall Study|Adverse Event|0|||
146020420|NCT02438683|526584759|FG002|Overall Study|Adverse Event|0|||
146020421|NCT02438683|526584760|FG003|Overall Study|Adverse Event|0|||
146020422|NCT02438683|526584761|FG004|Overall Study|Adverse Event|0|||
146020423|NCT02438683|526584762|FG005|Overall Study|Adverse Event|0|||
146252443|NCT02514577|527436862|FG000|Overall Study|Withdrawal by Subject|6|||
146020424|NCT02867813|526586632|FG000|Overall Study|Withdrawal by Subject|57|||
146020425|NCT02867813|526586633|FG001|Overall Study|Withdrawal by Subject|56|||
146020426|NCT02867813|526586632|FG000|Overall Study|Decision by Sponsor|7|||
146020427|NCT02867813|526586633|FG001|Overall Study|Decision by Sponsor|7|||
146020428|NCT02867813|526586632|FG000|Overall Study|Lost to Follow-up|91|||
146252444|NCT02514577|527436863|FG001|Overall Study|Withdrawal by Subject|6|||
146252445|NCT02514577|527436862|FG000|Overall Study|Adverse Event|1|||
146252446|NCT02514577|527436863|FG001|Overall Study|Adverse Event|1|||
146252447|NCT02388932|527436864|FG000|Overall Study|Death|1|||
146020429|NCT02867813|526586633|FG001|Overall Study|Lost to Follow-up|78|||
146020430|NCT02867813|526586632|FG000|Overall Study|Missing|2|||
146020431|NCT02867813|526586633|FG001|Overall Study|Missing|1|||
146020432|NCT02867813|526586632|FG000|Overall Study|Death|294|||
146252448|NCT00627523|527436866|FG000|Overall Study|Lack of Efficacy|1|||
146252449|NCT00627523|527436867|FG001|Overall Study|Lack of Efficacy|0|||
146252450|NCT00627523|527436866|FG000|Overall Study|Withdrawal by Subject|0|||
146252451|NCT00627523|527436867|FG001|Overall Study|Withdrawal by Subject|2|||
146252452|NCT00627523|527436866|FG000|Overall Study|Other|1|||
146252453|NCT00627523|527436867|FG001|Overall Study|Other|0|||
146252454|NCT01038128|527436874|FG000|Overall Study|Lack of Efficacy|1|||
146252455|NCT01038128|527436874|FG000|Overall Study|Lost to Follow-up|1|||
146252456|NCT01038128|527436874|FG000|Overall Study|Withdrawal by Subject|2|||
146252457|NCT01234675|527436881|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
146252458|NCT01234675|527436882|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146252459|NCT01234675|527436881|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146252460|NCT01234675|527436882|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146252461|NCT01753323|527436883|FG000|Overall Study|Lack of Efficacy|0|||
146252462|NCT01753323|527436884|FG001|Overall Study|Lack of Efficacy|0|||
146252463|NCT01753323|527436885|FG002|Overall Study|Lack of Efficacy|8|||
146252464|NCT01753323|527436883|FG000|Overall Study|Protocol deviation|1|||
146252465|NCT01753323|527436884|FG001|Overall Study|Protocol deviation|0|||
146252466|NCT01753323|527436885|FG002|Overall Study|Protocol deviation|0|||
146252467|NCT01753323|527436883|FG000|Overall Study|Adverse Event|0|||
146252468|NCT01753323|527436884|FG001|Overall Study|Adverse Event|0|||
146252469|NCT01753323|527436885|FG002|Overall Study|Adverse Event|1|||
146252470|NCT01870999|527436887|FG000|Overall Study|Adverse Event|0|||
146252471|NCT01870999|527436888|FG001|Overall Study|Adverse Event|4|||
146252472|NCT01870999|527436889|FG002|Overall Study|Adverse Event|1|||
146252473|NCT01870999|527436887|FG000|Overall Study|Subject met withdrawal criteria|3|||
146252474|NCT01870999|527436888|FG001|Overall Study|Subject met withdrawal criteria|2|||
146252475|NCT01870999|527436889|FG002|Overall Study|Subject met withdrawal criteria|0|||
146252476|NCT01870999|527436887|FG000|Overall Study|Subject withdrawn by Investigator|1|||
146252477|NCT01870999|527436888|FG001|Overall Study|Subject withdrawn by Investigator|0|||
146252478|NCT01870999|527436889|FG002|Overall Study|Subject withdrawn by Investigator|0|||
146252479|NCT01870999|527436887|FG000|Overall Study|Withdrawal by Subject|0|||
146020433|NCT02867813|526586633|FG001|Overall Study|Death|268|||
146020434|NCT02013206|526586634|FG000|Overall Study|Progressive disease (PD)|14|||
146020435|NCT02013206|526586635|FG001|Overall Study|Progressive disease (PD)|17|||
146020436|NCT02013206|526586634|FG000|Overall Study|Symptomatic deterioration|3|||
146020437|NCT02013206|526586635|FG001|Overall Study|Symptomatic deterioration|1|||
146020438|NCT02013206|526586634|FG000|Overall Study|Adverse Event|1|||
146020439|NCT02013206|526586635|FG001|Overall Study|Adverse Event|0|||
146020440|NCT02013206|526586634|FG000|Overall Study|Patient refusal|2|||
146020441|NCT02013206|526586635|FG001|Overall Study|Patient refusal|0|||
146020442|NCT02013206|526586634|FG000|Overall Study|Patient non-compliance|1|||
146020443|NCT02013206|526586635|FG001|Overall Study|Patient non-compliance|0|||
146020444|NCT02013206|526586634|FG000|Overall Study|Death|1|||
146020445|NCT02013206|526586635|FG001|Overall Study|Death|2|||
146252480|NCT01870999|527436888|FG001|Overall Study|Withdrawal by Subject|2|||
146252481|NCT01870999|527436889|FG002|Overall Study|Withdrawal by Subject|5|||
146252482|NCT01870999|527436887|FG000|Overall Study|Protocol Violation|0|||
146252483|NCT01870999|527436888|FG001|Overall Study|Protocol Violation|0|||
146252484|NCT01870999|527436889|FG002|Overall Study|Protocol Violation|1|||
146020446|NCT02013206|526586634|FG000|Overall Study|Other reasons off treatment|5|||
146020447|NCT02013206|526586635|FG001|Overall Study|Other reasons off treatment|2|||
146094161|NCT04137224|526866562|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
146094162|NCT01225887|526866563|FG000|Overall Study|Ineligible:required test not done|2|||
146094163|NCT01225887|526866563|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
146252485|NCT00116584|527436900|FG000|Overall Study|Withdrawal by Subject|1|||
146252486|NCT00116584|527436901|FG001|Overall Study|Withdrawal by Subject|0|||
146252487|NCT00116584|527436900|FG000|Overall Study|Protocol Violation|1|||
146252488|NCT00116584|527436901|FG001|Overall Study|Protocol Violation|1|||
146020448|NCT01952665|526586636|FG000|Overall Study|Physician Decision|3|||
146020449|NCT01952665|526586637|FG001|Overall Study|Physician Decision|2|||
146094164|NCT01225887|526866563|FG000|Overall Study|Ineligible:inadequate pathology|2|||
146252489|NCT02798861|527436904|FG000|Overall Study|Lost to Follow-up|22|||
146252490|NCT02798861|527436904|FG000|Overall Study|Withdrawal by Subject|1|||
146252491|NCT01533181|527436905|FG000|Overall Study|Disease progression pre-active treatment|0|||
146252492|NCT01533181|527436906|FG001|Overall Study|Disease progression pre-active treatment|1|||
146020450|NCT01952665|526586636|FG000|Overall Study|Lost to Follow-up|1|||
146020451|NCT01952665|526586637|FG001|Overall Study|Lost to Follow-up|2|||
146020452|NCT01952665|526586636|FG000|Overall Study|Adverse Event|2|||
146020453|NCT01952665|526586637|FG001|Overall Study|Adverse Event|1|||
146020454|NCT01952665|526586636|FG000|Overall Study|Protocol Violation|0|||
146020455|NCT01952665|526586637|FG001|Overall Study|Protocol Violation|1|||
146020456|NCT01463111|526586640|FG000|Overall Study|Withdrawal by Subject|2|||
146020457|NCT01463111|526586640|FG000|Overall Study|Lost to Follow-up|5|||
146020458|NCT01463111|526586640|FG000|Overall Study|Physician Decision|2|||
146020459|NCT01559259|526586645|FG000|Overall Study|Withdrawal by Subject|0|||
146020460|NCT01559259|526586646|FG001|Overall Study|Withdrawal by Subject|0|||
146020461|NCT01559259|526586647|FG002|Overall Study|Withdrawal by Subject|0|||
146020462|NCT01559259|526586648|FG003|Overall Study|Withdrawal by Subject|1|||
146020463|NCT01559259|526586649|FG004|Overall Study|Withdrawal by Subject|0|||
146020464|NCT01559259|526586645|FG000|Overall Study|Adverse Event|0|||
146020465|NCT01559259|526586646|FG001|Overall Study|Adverse Event|1|||
146020466|NCT01559259|526586647|FG002|Overall Study|Adverse Event|1|||
146020467|NCT01559259|526586648|FG003|Overall Study|Adverse Event|0|||
146020468|NCT01559259|526586649|FG004|Overall Study|Adverse Event|0|||
146020469|NCT01995669|526586650|FG000|Overall Study|Progression|2|||
146020470|NCT01995669|526586651|FG001|Overall Study|Progression|1|||
146020471|NCT01995669|526586652|FG002|Overall Study|Progression|1|||
146020472|NCT01995669|526586653|FG003|Overall Study|Progression|13|||
146020473|NCT01995669|526586650|FG000|Overall Study|Adverse Event|0|||
146020474|NCT01995669|526586651|FG001|Overall Study|Adverse Event|0|||
146020475|NCT01995669|526586652|FG002|Overall Study|Adverse Event|0|||
146020476|NCT01995669|526586653|FG003|Overall Study|Adverse Event|3|||
146020477|NCT01995669|526586650|FG000|Overall Study|Death|0|||
146020478|NCT01995669|526586651|FG001|Overall Study|Death|0|||
146020479|NCT01995669|526586652|FG002|Overall Study|Death|0|||
146020480|NCT01995669|526586653|FG003|Overall Study|Death|6|||
146020481|NCT01995669|526586650|FG000|Overall Study|Withdrawal by Subject|0|||
146020482|NCT01995669|526586651|FG001|Overall Study|Withdrawal by Subject|0|||
146020483|NCT01995669|526586652|FG002|Overall Study|Withdrawal by Subject|0|||
146020484|NCT01995669|526586653|FG003|Overall Study|Withdrawal by Subject|6|||
146020485|NCT01995669|526586650|FG000|Overall Study|Insurance Expired|0|||
146020486|NCT01995669|526586651|FG001|Overall Study|Insurance Expired|0|||
146020487|NCT01995669|526586652|FG002|Overall Study|Insurance Expired|0|||
146020488|NCT01995669|526586653|FG003|Overall Study|Insurance Expired|1|||
146020489|NCT05425732|526586654|FG000|Overall Study|Death|4|||
146020490|NCT05425732|526586655|FG001|Overall Study|Death|2|||
146020491|NCT05425732|526586656|FG002|Overall Study|Death|0|||
146020492|NCT05425732|526586657|FG003|Overall Study|Death|0|||
146020493|NCT05425732|526586654|FG000|Overall Study|Lost to Follow-up|10|||
146020494|NCT05425732|526586655|FG001|Overall Study|Lost to Follow-up|15|||
146020495|NCT05425732|526586656|FG002|Overall Study|Lost to Follow-up|5|||
146020496|NCT05425732|526586657|FG003|Overall Study|Lost to Follow-up|3|||
146020497|NCT05425732|526586654|FG000|Overall Study|Physician Decision|0|||
146020498|NCT05425732|526586655|FG001|Overall Study|Physician Decision|2|||
146020499|NCT05425732|526586656|FG002|Overall Study|Physician Decision|0|||
146020500|NCT05425732|526586657|FG003|Overall Study|Physician Decision|0|||
146020501|NCT05425732|526586654|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146020502|NCT05425732|526586655|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
146020503|NCT05425732|526586656|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146020504|NCT05425732|526586657|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146020505|NCT05425732|526586654|FG000|Overall Study|Withdrawal by Subject|4|||
146020506|NCT05425732|526586655|FG001|Overall Study|Withdrawal by Subject|8|||
146020507|NCT05425732|526586656|FG002|Overall Study|Withdrawal by Subject|1|||
146020508|NCT05425732|526586657|FG003|Overall Study|Withdrawal by Subject|1|||
146020509|NCT05425732|526586654|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
146020510|NCT05425732|526586655|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146020511|NCT05425732|526586656|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146020512|NCT05425732|526586657|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
146020513|NCT00539513|526586659|FG000|Overall Study|Withdrawal by Subject|2|||
146020514|NCT00539513|526586660|FG001|Overall Study|Withdrawal by Subject|1|||
146020515|NCT00539513|526586659|FG000|Overall Study|Lost to Follow-up|0|||
146020516|NCT00539513|526586660|FG001|Overall Study|Lost to Follow-up|1|||
146020517|NCT01328041|526586661|FG000|Overall Study|Adverse Event|7|||
146020518|NCT01328041|526586661|FG000|Overall Study|Lack of Efficacy|27|||
146020519|NCT01328041|526586661|FG000|Overall Study|Protocol Violation|7|||
146020520|NCT01328041|526586661|FG000|Overall Study|Lost to Follow-up|7|||
146020521|NCT01328041|526586661|FG000|Overall Study|Physician Decision|2|||
146020522|NCT01328041|526586661|FG000|Overall Study|Withdrawal by Subject|7|||
146020523|NCT00711113|526586662|FG000|Overall Study|Lost to Follow-up|9|||
146020524|NCT00711113|526586662|FG000|Overall Study|Implant lost|2|||
146020525|NCT02688088|526586668|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146020526|NCT02688088|526586669|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
146020527|NCT02688088|526586670|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146020528|NCT02688088|526586671|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146020529|NCT02688088|526586672|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
146020530|NCT02688088|526586668|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146020531|NCT02688088|526586669|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
146020532|NCT02688088|526586670|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146020533|NCT02688088|526586671|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146020534|NCT02688088|526586672|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
146020535|NCT02688088|526586668|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146020536|NCT02688088|526586669|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
146020537|NCT02688088|526586670|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146020538|NCT02688088|526586671|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146020539|NCT02688088|526586672|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
146020540|NCT02688088|526586668|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146020541|NCT02688088|526586669|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
146020542|NCT02688088|526586670|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146020543|NCT02688088|526586671|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146020544|NCT02688088|526586672|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
146020545|NCT02688088|526586668|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146020546|NCT02688088|526586669|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146020547|NCT02688088|526586670|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
146020548|NCT02688088|526586671|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146020549|NCT02688088|526586672|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
146020550|NCT02688088|526586668|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146020551|NCT02688088|526586669|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146020552|NCT02688088|526586670|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
146020553|NCT02688088|526586671|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146020554|NCT02688088|526586672|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
146020555|NCT02688088|526586668|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146020556|NCT02688088|526586669|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146020557|NCT02688088|526586670|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146020558|NCT02688088|526586671|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
146020559|NCT02688088|526586672|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
146020560|NCT02688088|526586668|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146020561|NCT02688088|526586669|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146020562|NCT02688088|526586670|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146020563|NCT02688088|526586671|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
146020564|NCT02688088|526586672|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
146020565|NCT02688088|526586668|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146020566|NCT02688088|526586669|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146020567|NCT02688088|526586670|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146020568|NCT02688088|526586671|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
146020569|NCT02688088|526586672|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
146020570|NCT01231321|526586675|FG000|Overall Study|Adverse Event|3|||
146020571|NCT01231321|526586675|FG000|Overall Study|Lack of Efficacy|2|||
146020572|NCT04021524|526586676|FG000|Overall Study|Change in surgical intervention|0|||
146020573|NCT04021524|526586677|FG001|Overall Study|Change in surgical intervention|1|||
146020574|NCT00730041|526586681|FG000|Overall Study|Lost to Follow-up|0|||
146020575|NCT00730041|526586682|FG001|Overall Study|Lost to Follow-up|2|||
146020576|NCT02301546|526586683|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
146020577|NCT02301546|526586684|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
146020578|NCT02301546|526586683|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
146020579|NCT02301546|526586684|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
146020580|NCT02301546|526586683|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
146020581|NCT02301546|526586684|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
146020582|NCT02301546|526586683|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
146020583|NCT02301546|526586684|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
146020584|NCT02301546|526586683|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
146020585|NCT02301546|526586684|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
146020586|NCT02301546|526586683|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
146020587|NCT02301546|526586684|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
146020588|NCT02301546|526586683|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
146020589|NCT02301546|526586684|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
146020590|NCT01801436|526586687|FG000|Overall Study|Withdrawal by Subject|3|||
146020591|NCT01801436|526586687|FG000|Overall Study|Adverse Event|2|||
146020592|NCT01801436|526586687|FG000|Overall Study|Progressive disease|4|||
146020593|NCT02447250|526586690|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
146020594|NCT02447250|526586690|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
146094165|NCT00566501|526866564|FG000|Overall Study|Adverse Event|68|||
146020595|NCT02447250|526586690|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
146020596|NCT03632993|526586691|FG000|Overall Study|Withdrawal by Subject|1|||
146020597|NCT03632993|526586692|FG001|Overall Study|Withdrawal by Subject|0|||
146020598|NCT03632993|526586693|FG002|Overall Study|Withdrawal by Subject|0|||
146020599|NCT03632993|526586694|FG003|Overall Study|Withdrawal by Subject|0|||
146020600|NCT03632993|526586695|FG004|Overall Study|Withdrawal by Subject|0|||
146020601|NCT03632993|526586696|FG005|Overall Study|Withdrawal by Subject|0|||
146020602|NCT03632993|526586697|FG006|Overall Study|Withdrawal by Subject|0|||
146020603|NCT03632993|526586698|FG007|Overall Study|Withdrawal by Subject|0|||
146020604|NCT03632993|526586699|FG008|Overall Study|Withdrawal by Subject|0|||
146020605|NCT03632993|526586700|FG009|Overall Study|Withdrawal by Subject|1|||
146020606|NCT03632993|526586691|FG000|Overall Study|Protocol Non-compliance|0|||
146020607|NCT03632993|526586692|FG001|Overall Study|Protocol Non-compliance|1|||
146020608|NCT03632993|526586693|FG002|Overall Study|Protocol Non-compliance|0|||
146020609|NCT03632993|526586694|FG003|Overall Study|Protocol Non-compliance|0|||
146020610|NCT03632993|526586695|FG004|Overall Study|Protocol Non-compliance|0|||
146020611|NCT03632993|526586696|FG005|Overall Study|Protocol Non-compliance|0|||
146020612|NCT03632993|526586697|FG006|Overall Study|Protocol Non-compliance|0|||
146020613|NCT03632993|526586698|FG007|Overall Study|Protocol Non-compliance|0|||
146020614|NCT03632993|526586699|FG008|Overall Study|Protocol Non-compliance|0|||
146020615|NCT03632993|526586700|FG009|Overall Study|Protocol Non-compliance|0|||
146020616|NCT03632993|526586691|FG000|Overall Study|Lost to Follow-up|0|||
146020617|NCT03632993|526586692|FG001|Overall Study|Lost to Follow-up|0|||
146020618|NCT03632993|526586693|FG002|Overall Study|Lost to Follow-up|0|||
146020619|NCT03632993|526586694|FG003|Overall Study|Lost to Follow-up|0|||
146020620|NCT03632993|526586695|FG004|Overall Study|Lost to Follow-up|0|||
146020621|NCT03632993|526586696|FG005|Overall Study|Lost to Follow-up|1|||
146020622|NCT03632993|526586697|FG006|Overall Study|Lost to Follow-up|0|||
146020623|NCT03632993|526586698|FG007|Overall Study|Lost to Follow-up|1|||
146020624|NCT03632993|526586699|FG008|Overall Study|Lost to Follow-up|0|||
146020625|NCT03632993|526586700|FG009|Overall Study|Lost to Follow-up|0|||
146020626|NCT03632993|526586691|FG000|Overall Study|Adverse Event|0|||
146020627|NCT03632993|526586692|FG001|Overall Study|Adverse Event|0|||
146020628|NCT03632993|526586693|FG002|Overall Study|Adverse Event|0|||
146020629|NCT03632993|526586694|FG003|Overall Study|Adverse Event|0|||
146020630|NCT03632993|526586695|FG004|Overall Study|Adverse Event|0|||
146020631|NCT03632993|526586696|FG005|Overall Study|Adverse Event|1|||
146020632|NCT03632993|526586697|FG006|Overall Study|Adverse Event|0|||
146020633|NCT03632993|526586698|FG007|Overall Study|Adverse Event|1|||
146020634|NCT03632993|526586699|FG008|Overall Study|Adverse Event|0|||
146020635|NCT03632993|526586700|FG009|Overall Study|Adverse Event|0|||
146020636|NCT00920218|526586701|FG000|Overall Study|Serious Adverse Event|2|||
146020637|NCT00920218|526586702|FG001|Overall Study|Serious Adverse Event|0|||
146020638|NCT00920218|526586703|FG002|Overall Study|Serious Adverse Event|2|||
146020639|NCT00920218|526586704|FG003|Overall Study|Serious Adverse Event|1|||
146020640|NCT00920218|526586701|FG000|Overall Study|Withdrawal by Subject|0|||
146020641|NCT00920218|526586702|FG001|Overall Study|Withdrawal by Subject|3|||
146020642|NCT00920218|526586703|FG002|Overall Study|Withdrawal by Subject|2|||
146020643|NCT00920218|526586704|FG003|Overall Study|Withdrawal by Subject|0|||
146020644|NCT00920218|526586701|FG000|Overall Study|Migrated/moved from study area|0|||
146020645|NCT00920218|526586702|FG001|Overall Study|Migrated/moved from study area|0|||
146020646|NCT00920218|526586703|FG002|Overall Study|Migrated/moved from study area|1|||
146020647|NCT00920218|526586704|FG003|Overall Study|Migrated/moved from study area|0|||
146020648|NCT00920218|526586701|FG000|Overall Study|Lost to Follow-up|0|||
146020649|NCT00920218|526586702|FG001|Overall Study|Lost to Follow-up|1|||
146020650|NCT00920218|526586703|FG002|Overall Study|Lost to Follow-up|0|||
146020651|NCT00920218|526586704|FG003|Overall Study|Lost to Follow-up|3|||
146020652|NCT00920218|526586701|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
146020653|NCT00920218|526586702|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
146020654|NCT00920218|526586703|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
146020655|NCT00920218|526586704|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
146020656|NCT00920218|526586701|FG000|Overall Study|Other|0|||
146020657|NCT00920218|526586702|FG001|Overall Study|Other|0|||
146020658|NCT00920218|526586703|FG002|Overall Study|Other|1|||
146020659|NCT00920218|526586704|FG003|Overall Study|Other|0|||
146020660|NCT00873041|526586705|FG000|Core Study|Adverse Event|2|||
146020661|NCT00873041|526586706|FG001|Core Study|Adverse Event|3|||
146020662|NCT00873041|526586707|FG002|Core Study|Adverse Event|1|||
146020663|NCT00873041|526586705|FG000|Core Study|Withdrawal by Subject|1|||
146020664|NCT00873041|526586706|FG001|Core Study|Withdrawal by Subject|2|||
146020665|NCT00873041|526586707|FG002|Core Study|Withdrawal by Subject|2|||
146020666|NCT00873041|526586705|FG000|Core Study|Lost to Follow-up|3|||
146020667|NCT00873041|526586706|FG001|Core Study|Lost to Follow-up|1|||
146020668|NCT00873041|526586707|FG002|Core Study|Lost to Follow-up|0|||
146020669|NCT00873041|526586705|FG000|Core Study|Abnormal laboratory value|0|||
146020670|NCT00873041|526586706|FG001|Core Study|Abnormal laboratory value|0|||
146020671|NCT00873041|526586707|FG002|Core Study|Abnormal laboratory value|1|||
146020672|NCT00873041|526586705|FG000|Core Study|Protocol deviation|1|||
146020673|NCT00873041|526586706|FG001|Core Study|Protocol deviation|0|||
146020674|NCT00873041|526586707|FG002|Core Study|Protocol deviation|1|||
146020675|NCT00873041|526586705|FG000|Extension Study|Adverse Event|1|||
146020676|NCT00873041|526586706|FG001|Extension Study|Adverse Event|0|||
146020677|NCT00873041|526586707|FG002|Extension Study|Adverse Event|1|||
146020678|NCT00873041|526586705|FG000|Extension Study|Administrative reasons|0|||
146020679|NCT00873041|526586706|FG001|Extension Study|Administrative reasons|0|||
146020680|NCT00873041|526586707|FG002|Extension Study|Administrative reasons|1|||
146020681|NCT00313313|526586708|FG000|Overall Study|Lack of Efficacy|14|||
146020682|NCT00313313|526586709|FG001|Overall Study|Lack of Efficacy|9|||
146020683|NCT00313313|526586710|FG002|Overall Study|Lack of Efficacy|20|||
146020684|NCT00313313|526586708|FG000|Overall Study|Withdrawal of consent by subject|18|||
146020685|NCT00313313|526586709|FG001|Overall Study|Withdrawal of consent by subject|17|||
146020686|NCT00313313|526586710|FG002|Overall Study|Withdrawal of consent by subject|31|||
146020687|NCT00313313|526586708|FG000|Overall Study|Lost to Follow-up|10|||
146020688|NCT00313313|526586709|FG001|Overall Study|Lost to Follow-up|7|||
146020689|NCT00313313|526586710|FG002|Overall Study|Lost to Follow-up|9|||
146020690|NCT00313313|526586708|FG000|Overall Study|Adverse Event|15|||
146020691|NCT00313313|526586709|FG001|Overall Study|Adverse Event|16|||
146020692|NCT00313313|526586710|FG002|Overall Study|Adverse Event|12|||
146020693|NCT00313313|526586708|FG000|Overall Study|Physician Decision|2|||
146020694|NCT00313313|526586709|FG001|Overall Study|Physician Decision|6|||
146020695|NCT00313313|526586710|FG002|Overall Study|Physician Decision|4|||
146020696|NCT00313313|526586708|FG000|Overall Study|Poor/Noncompliance|3|||
146020697|NCT00313313|526586709|FG001|Overall Study|Poor/Noncompliance|6|||
146020698|NCT00313313|526586710|FG002|Overall Study|Poor/Noncompliance|2|||
146020699|NCT00313313|526586708|FG000|Overall Study|Pregnancy|1|||
146020700|NCT00313313|526586709|FG001|Overall Study|Pregnancy|2|||
146020701|NCT00313313|526586710|FG002|Overall Study|Pregnancy|0|||
146020702|NCT00313313|526586708|FG000|Overall Study|Death|0|||
146020703|NCT00313313|526586709|FG001|Overall Study|Death|0|||
146020704|NCT00313313|526586710|FG002|Overall Study|Death|2|||
146020705|NCT00313313|526586708|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146020706|NCT00313313|526586709|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
146020707|NCT00313313|526586710|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
146020708|NCT00368836|526586714|FG000|Phase II|Screen Failure|1|||
146020709|NCT00368836|526586714|FG000|Phase II|Withdrawal by Subject|1|||
146020710|NCT00368836|526586714|FG000|Phase II|unable to collect blood and/or breath|17|||
146020711|NCT00368836|526586714|FG000|Phase II|Protocol Violation|2|||
146020712|NCT01345591|526586723|FG000|Overall Study|Lost to Follow-up|1|||
146020713|NCT00090142|526586724|FG000|Treatment Period I|Lost to Follow-up|1|||
146020714|NCT00090142|526586725|FG001|Treatment Period I|Lost to Follow-up|2|||
146020715|NCT00090142|526586724|FG000|Treatment Period I|Protocol Violation|2|||
146020716|NCT00090142|526586725|FG001|Treatment Period I|Protocol Violation|0|||
146020717|NCT00090142|526586724|FG000|Treatment Period I|Withdrawal by Subject|2|||
146020718|NCT00090142|526586725|FG001|Treatment Period I|Withdrawal by Subject|0|||
146020719|NCT00090142|526586724|FG000|Treatment Period I|Other|0|||
146020720|NCT00090142|526586725|FG001|Treatment Period I|Other|1|||
146020721|NCT00090142|526586724|FG000|Treatment Period II|Other|1|||
146020722|NCT00090142|526586725|FG001|Treatment Period II|Other|0|||
146020723|NCT02442310|526586726|FG000|Overall Study|Adverse Event|2|||
146020724|NCT02442310|526586726|FG000|Overall Study|Withdrawal by Subject|1|||
146020725|NCT01126437|526586727|FG000|Overall Study|Not treated|11|||
146020726|NCT01126437|526586728|FG001|Overall Study|Not treated|18|||
146020727|NCT01126437|526586729|FG002|Overall Study|Not treated|19|||
146020728|NCT01126437|526586727|FG000|Overall Study|Sites with data irregularities/fraud|6|||
146020729|NCT01126437|526586728|FG001|Overall Study|Sites with data irregularities/fraud|6|||
146020730|NCT01126437|526586729|FG002|Overall Study|Sites with data irregularities/fraud|7|||
146020731|NCT01126437|526586727|FG000|Overall Study|Adverse Event|602|||
146020732|NCT01126437|526586728|FG001|Overall Study|Adverse Event|606|||
146020733|NCT01126437|526586729|FG002|Overall Study|Adverse Event|635|||
146252493|NCT01533181|527436905|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
146020734|NCT01126437|526586727|FG000|Overall Study|Lack of Efficacy|65|||
146020735|NCT01126437|526586728|FG001|Overall Study|Lack of Efficacy|60|||
146252494|NCT01533181|527436906|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
146252495|NCT04879823|527436914|FG000|Overall Study|Physician Decision|3|||
146020736|NCT01126437|526586729|FG002|Overall Study|Lack of Efficacy|59|||
146020737|NCT01126437|526586727|FG000|Overall Study|Protocol Violation|64|||
146020738|NCT01126437|526586728|FG001|Overall Study|Protocol Violation|66|||
146020739|NCT01126437|526586729|FG002|Overall Study|Protocol Violation|41|||
146020740|NCT01126437|526586727|FG000|Overall Study|Lost to Follow-up|52|||
146020741|NCT01126437|526586728|FG001|Overall Study|Lost to Follow-up|63|||
146252496|NCT04879823|527436915|FG001|Overall Study|Physician Decision|1|||
146020742|NCT01126437|526586729|FG002|Overall Study|Lost to Follow-up|55|||
146020743|NCT01126437|526586727|FG000|Overall Study|Withdrawal by Subject|331|||
146020744|NCT01126437|526586728|FG001|Overall Study|Withdrawal by Subject|335|||
146020745|NCT01126437|526586729|FG002|Overall Study|Withdrawal by Subject|319|||
146020746|NCT01126437|526586727|FG000|Overall Study|Other reason not specified|210|||
146020747|NCT01126437|526586728|FG001|Overall Study|Other reason not specified|176|||
146020748|NCT01126437|526586729|FG002|Overall Study|Other reason not specified|178|||
146020749|NCT00006046|526586735|FG000|Overall Study|Adverse Event|3|||
146020750|NCT00006046|526586736|FG001|Overall Study|Adverse Event|0|||
146020751|NCT00006046|526586737|FG002|Overall Study|Adverse Event|0|||
146020752|NCT00006046|526586738|FG003|Overall Study|Adverse Event|0|||
146020753|NCT00006046|526586739|FG004|Overall Study|Adverse Event|0|||
146020754|NCT00006046|526586735|FG000|Overall Study|Disease Progression|2|||
146020755|NCT00006046|526586736|FG001|Overall Study|Disease Progression|0|||
146020756|NCT00006046|526586737|FG002|Overall Study|Disease Progression|0|||
146020757|NCT00006046|526586738|FG003|Overall Study|Disease Progression|0|||
146020758|NCT00006046|526586739|FG004|Overall Study|Disease Progression|0|||
146020759|NCT00596154|526586740|FG000|Overall Study|Not Evaluable|2|||
146020760|NCT01846663|526586741|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
146020761|NCT01846663|526586742|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
146020762|NCT01846663|526586741|FG000|Overall Study|Withdrawal by Subject|1|||
146020763|NCT01846663|526586742|FG001|Overall Study|Withdrawal by Subject|0|||
146020764|NCT01846663|526586741|FG000|Overall Study|Adverse Event|1|||
146020765|NCT01846663|526586742|FG001|Overall Study|Adverse Event|2|||
146020766|NCT01535599|526586760|FG000|Overall Study|Adverse Event|6|||
146020767|NCT01535599|526586761|FG001|Overall Study|Adverse Event|15|||
146020768|NCT01535599|526586760|FG000|Overall Study|Lost to Follow-up|3|||
146020769|NCT01535599|526586761|FG001|Overall Study|Lost to Follow-up|4|||
146020770|NCT01535599|526586760|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
146020771|NCT01535599|526586761|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
146020772|NCT01535599|526586760|FG000|Overall Study|Treatment Failure|33|||
146020773|NCT01535599|526586761|FG001|Overall Study|Treatment Failure|66|||
146020774|NCT01535599|526586760|FG000|Overall Study|BL Culture + for Group A Strep|0|||
146020775|NCT01535599|526586761|FG001|Overall Study|BL Culture + for Group A Strep|1|||
146020776|NCT01535599|526586760|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
146020777|NCT01535599|526586761|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
146020778|NCT01535599|526586760|FG000|Overall Study|Randomized in Error|2|||
146020779|NCT01535599|526586761|FG001|Overall Study|Randomized in Error|4|||
146020780|NCT01535599|526586760|FG000|Overall Study|Did not use product|1|||
146020781|NCT01535599|526586761|FG001|Overall Study|Did not use product|0|||
146020782|NCT01535599|526586760|FG000|Overall Study|Other|1|||
146020783|NCT01535599|526586761|FG001|Overall Study|Other|0|||
146020784|NCT01535599|526586760|FG000|Overall Study|Stopped medication|0|||
146020785|NCT01535599|526586761|FG001|Overall Study|Stopped medication|1|||
146020786|NCT01535599|526586760|FG000|Overall Study|Noncompliance|0|||
146020787|NCT01535599|526586761|FG001|Overall Study|Noncompliance|1|||
146020788|NCT03172325|526586765|FG000|Overall Study|Adverse Event|2|||
146020789|NCT03172325|526586766|FG001|Overall Study|Adverse Event|3|||
146020790|NCT03172325|526586765|FG000|Overall Study|Positive PPD|1|||
146020791|NCT03172325|526586766|FG001|Overall Study|Positive PPD|0|||
146020792|NCT03172325|526586765|FG000|Overall Study|Poor Compliance|1|||
146020793|NCT03172325|526586766|FG001|Overall Study|Poor Compliance|1|||
146020794|NCT01229254|526586775|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
146020795|NCT01229254|526586776|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
146020796|NCT01229254|526586777|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
146020797|NCT01229254|526586775|FG000|Overall Study|Adverse Event|4|||
146020798|NCT01229254|526586776|FG001|Overall Study|Adverse Event|5|||
146020799|NCT01229254|526586777|FG002|Overall Study|Adverse Event|3|||
146020800|NCT01229254|526586775|FG000|Overall Study|Lost to Follow-up|3|||
146020801|NCT01229254|526586776|FG001|Overall Study|Lost to Follow-up|0|||
146020802|NCT01229254|526586777|FG002|Overall Study|Lost to Follow-up|1|||
146020803|NCT01229254|526586775|FG000|Overall Study|Physician Decision|0|||
146020804|NCT01229254|526586776|FG001|Overall Study|Physician Decision|3|||
146020805|NCT01229254|526586777|FG002|Overall Study|Physician Decision|0|||
146020806|NCT01229254|526586775|FG000|Overall Study|Protocol Violation|4|||
146020807|NCT01229254|526586776|FG001|Overall Study|Protocol Violation|6|||
146020808|NCT01229254|526586777|FG002|Overall Study|Protocol Violation|5|||
146020809|NCT01229254|526586775|FG000|Overall Study|Withdrawal by Subject|1|||
146020810|NCT01229254|526586776|FG001|Overall Study|Withdrawal by Subject|0|||
146020811|NCT01229254|526586777|FG002|Overall Study|Withdrawal by Subject|1|||
146020812|NCT01229254|526586775|FG000|Overall Study|Non-compliance with Study Drug|0|||
146020813|NCT01229254|526586776|FG001|Overall Study|Non-compliance with Study Drug|1|||
146020814|NCT01229254|526586777|FG002|Overall Study|Non-compliance with Study Drug|1|||
146020815|NCT01694121|526586778|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
146020816|NCT01694121|526586779|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
146020817|NCT02928029|526586782|FG000|Overall Study|Withdrawal by Subject|0|||
146020818|NCT02928029|526586783|FG001|Overall Study|Withdrawal by Subject|1|||
146020819|NCT02928029|526586782|FG000|Overall Study|Radiological progression|1|||
146020820|NCT02928029|526586783|FG001|Overall Study|Radiological progression|0|||
146020821|NCT02928029|526586782|FG000|Overall Study|Clinical progression|1|||
146020822|NCT02928029|526586783|FG001|Overall Study|Clinical progression|2|||
146020823|NCT02928029|526586782|FG000|Overall Study|AE not related to clinical progression|1|||
146020824|NCT02928029|526586783|FG001|Overall Study|AE not related to clinical progression|1|||
146020825|NCT05427539|526586788|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146020826|NCT05427539|526586789|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146020827|NCT05427539|526586788|FG000|Period 1|Withdrawal by Subject|1|||
146020828|NCT05427539|526586789|FG001|Period 1|Withdrawal by Subject|0|||
146020829|NCT03359785|526586790|FG000|Overall Study|Protocol Violation|0|||
146020830|NCT03359785|526586791|FG001|Overall Study|Protocol Violation|1|||
146020831|NCT03359785|526586792|FG002|Overall Study|Protocol Violation|0|||
146020832|NCT03359785|526586793|FG003|Overall Study|Protocol Violation|0|||
146020833|NCT03359785|526586790|FG000|Overall Study|Early study termination due to study pause|0|||
146020834|NCT03359785|526586791|FG001|Overall Study|Early study termination due to study pause|0|||
146020835|NCT03359785|526586792|FG002|Overall Study|Early study termination due to study pause|2|||
146020836|NCT03359785|526586793|FG003|Overall Study|Early study termination due to study pause|0|||
146020837|NCT03359785|526586790|FG000|Overall Study|Withdrawal by Subject|2|||
146020838|NCT03359785|526586791|FG001|Overall Study|Withdrawal by Subject|2|||
146020839|NCT03359785|526586792|FG002|Overall Study|Withdrawal by Subject|0|||
146020840|NCT03359785|526586793|FG003|Overall Study|Withdrawal by Subject|0|||
146020841|NCT00223977|526586794|FG000|Overall Study|Adverse Event|7|||
146020842|NCT00223977|526586795|FG001|Overall Study|Adverse Event|10|||
146020843|NCT00223977|526586796|FG002|Overall Study|Adverse Event|0|||
146020844|NCT00223977|526586794|FG000|Overall Study|Protocol Violation|0|||
146020845|NCT00223977|526586795|FG001|Overall Study|Protocol Violation|0|||
146020846|NCT00223977|526586796|FG002|Overall Study|Protocol Violation|1|||
146020847|NCT00223977|526586794|FG000|Overall Study|Withdrawal by Subject|1|||
146020848|NCT00223977|526586795|FG001|Overall Study|Withdrawal by Subject|1|||
146020849|NCT00223977|526586796|FG002|Overall Study|Withdrawal by Subject|2|||
146020850|NCT00223977|526586794|FG000|Overall Study|Other|1|||
146020851|NCT00223977|526586795|FG001|Overall Study|Other|0|||
146020852|NCT00223977|526586796|FG002|Overall Study|Other|0|||
146020853|NCT01895543|526586797|FG000|Overall Study|Withdrawal by Subject|43|||
146020854|NCT01895543|526586797|FG000|Overall Study|Lost to Follow-up|25|||
146020855|NCT01895543|526586797|FG000|Overall Study|Adverse Event|28|||
146020856|NCT01895543|526586797|FG000|Overall Study|Subject's substantial non-compliance|6|||
146020857|NCT01895543|526586797|FG000|Overall Study|Protocol Violation|1|||
146020858|NCT01895543|526586797|FG000|Overall Study|Physician Decision|2|||
146020859|NCT01895543|526586797|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
146020860|NCT00082368|526586809|FG000|Overall Study|Not treated-pt had poor IV access|1|||
146020861|NCT03559517|526586810|FG000|Overall Study|Withdrawal by Subject|1|||
146020862|NCT03559517|526586811|FG001|Overall Study|Withdrawal by Subject|0|||
146020863|NCT03559517|526586812|FG002|Overall Study|Withdrawal by Subject|0|||
146020864|NCT01846299|526586813|FG000|Overall Study|Physician Decision|4|||
146020865|NCT01846299|526586814|FG001|Overall Study|Physician Decision|2|||
146020866|NCT01846299|526586813|FG000|Overall Study|Protocol deviation|1|||
146020867|NCT01846299|526586814|FG001|Overall Study|Protocol deviation|0|||
146020868|NCT01846299|526586813|FG000|Overall Study|Death|1|||
146020869|NCT01846299|526586814|FG001|Overall Study|Death|2|||
146020870|NCT01846299|526586813|FG000|Overall Study|Lost to Follow-up|3|||
146020871|NCT01846299|526586814|FG001|Overall Study|Lost to Follow-up|0|||
146020872|NCT01846299|526586813|FG000|Overall Study|Withdrawal by Subject|1|||
146020873|NCT01846299|526586814|FG001|Overall Study|Withdrawal by Subject|6|||
146020874|NCT01846299|526586813|FG000|Overall Study|Adverse Event|2|||
146020875|NCT01846299|526586814|FG001|Overall Study|Adverse Event|0|||
146020876|NCT01330628|526586815|FG000|Overall Study|Death|2|||
146020877|NCT01330628|526586816|FG001|Overall Study|Death|3|||
146094166|NCT00566501|526866565|FG001|Overall Study|Adverse Event|59|||
146094167|NCT00566501|526866564|FG000|Overall Study|Medication Non-compliance|5|||
146094168|NCT00566501|526866565|FG001|Overall Study|Medication Non-compliance|0|||
146094169|NCT00566501|526866564|FG000|Overall Study|Protocol Violation|2|||
146094170|NCT00566501|526866565|FG001|Overall Study|Protocol Violation|2|||
146094171|NCT00566501|526866564|FG000|Overall Study|Request of Investigator or Sponsor|6|||
146020878|NCT01330628|526586815|FG000|Overall Study|Lost to Follow-up|5|||
146020879|NCT01330628|526586816|FG001|Overall Study|Lost to Follow-up|6|||
146020880|NCT01330628|526586815|FG000|Overall Study|Adverse Event|44|||
146020881|NCT01330628|526586816|FG001|Overall Study|Adverse Event|25|||
146020882|NCT01330628|526586815|FG000|Overall Study|Withdrawn|18|||
146020883|NCT01330628|526586816|FG001|Overall Study|Withdrawn|6|||
146020884|NCT01330628|526586815|FG000|Overall Study|Didn't receive study treatment|1|||
146020885|NCT01330628|526586816|FG001|Overall Study|Didn't receive study treatment|0|||
146020886|NCT01740089|526588841|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
146020887|NCT01740089|526588842|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
146020888|NCT01740089|526588843|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
146020889|NCT01740089|526588841|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
146020890|NCT01740089|526588842|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
146020891|NCT01740089|526588843|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
146020892|NCT01740089|526588841|FG000|After 12 Weeks|Lack of Efficacy|3|||
146020893|NCT01740089|526588842|FG001|After 12 Weeks|Lack of Efficacy|1|||
146020894|NCT01740089|526588843|FG002|After 12 Weeks|Lack of Efficacy|4|||
146020895|NCT01740089|526588841|FG000|After 12 Weeks|Adverse Event|2|||
146020896|NCT01740089|526588842|FG001|After 12 Weeks|Adverse Event|0|||
146020897|NCT01740089|526588843|FG002|After 12 Weeks|Adverse Event|5|||
146020898|NCT01740089|526588841|FG000|After 12 Weeks|Protocol Violation|1|||
146020899|NCT01740089|526588842|FG001|After 12 Weeks|Protocol Violation|1|||
146020900|NCT01740089|526588843|FG002|After 12 Weeks|Protocol Violation|1|||
146020901|NCT01740089|526588841|FG000|After 12 Weeks|Withdrawal by Subject|1|||
146020902|NCT01740089|526588842|FG001|After 12 Weeks|Withdrawal by Subject|1|||
146020903|NCT01740089|526588843|FG002|After 12 Weeks|Withdrawal by Subject|1|||
146020904|NCT01448824|526588846|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020905|NCT01448824|526588847|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020906|NCT01448824|526588848|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020907|NCT01448824|526588849|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020908|NCT01448824|526588850|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020909|NCT01448824|526588851|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020910|NCT01448824|526588852|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
146020911|NCT01448824|526588853|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
146020912|NCT01448824|526588846|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146020913|NCT01448824|526588847|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146020914|NCT01448824|526588848|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146020915|NCT01448824|526588849|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
146020916|NCT01448824|526588850|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
146020917|NCT01448824|526588851|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
146020918|NCT01448824|526588852|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146020919|NCT01448824|526588853|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
146020920|NCT01448824|526588846|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020921|NCT01448824|526588847|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020922|NCT01448824|526588848|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020923|NCT01448824|526588849|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020924|NCT01448824|526588850|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020925|NCT01448824|526588851|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
146020926|NCT01448824|526588852|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020927|NCT01448824|526588853|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
146020928|NCT01448824|526588846|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
146020929|NCT01448824|526588847|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
146020930|NCT01448824|526588848|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
146020931|NCT01448824|526588849|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
146020932|NCT01448824|526588850|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
146020933|NCT01448824|526588851|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
146020934|NCT01448824|526588852|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
146020935|NCT01448824|526588853|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
146020936|NCT01448824|526588846|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020937|NCT01448824|526588847|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020938|NCT01448824|526588848|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020939|NCT01448824|526588849|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020940|NCT01448824|526588850|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146094172|NCT00566501|526866565|FG001|Overall Study|Request of Investigator or Sponsor|7|||
146094173|NCT00566501|526866564|FG000|Overall Study|Withdrawal by Subject|33|||
146094174|NCT00566501|526866565|FG001|Overall Study|Withdrawal by Subject|30|||
146094175|NCT00566501|526866564|FG000|Overall Study|Lack of Efficacy|8|||
146094176|NCT00566501|526866565|FG001|Overall Study|Lack of Efficacy|3|||
146094177|NCT00566501|526866564|FG000|Overall Study|Other|25|||
146094178|NCT00566501|526866565|FG001|Overall Study|Other|21|||
146020941|NCT01448824|526588851|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020942|NCT01448824|526588852|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
146020943|NCT01448824|526588853|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
146020944|NCT01448824|526588846|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020945|NCT01448824|526588847|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020946|NCT01448824|526588848|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020947|NCT01448824|526588849|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020948|NCT01448824|526588850|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020949|NCT01448824|526588851|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020950|NCT01448824|526588852|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
146020951|NCT01448824|526588853|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
146020952|NCT01448824|526588846|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020953|NCT01448824|526588847|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020954|NCT01448824|526588848|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020955|NCT01448824|526588849|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146094179|NCT00925990|526866566|FG000|Overall Study|Adverse Event|1|||
146094180|NCT00925990|526866567|FG001|Overall Study|Adverse Event|3|||
146094181|NCT00925990|526866566|FG000|Overall Study|Withdrawal by Subject|2|||
146094182|NCT00925990|526866567|FG001|Overall Study|Withdrawal by Subject|2|||
146094183|NCT00925990|526866566|FG000|Overall Study|Lost to Follow-up|1|||
146094184|NCT00925990|526866567|FG001|Overall Study|Lost to Follow-up|3|||
146094185|NCT00925990|526866566|FG000|Overall Study|Physician Decision|1|||
146094186|NCT00925990|526866567|FG001|Overall Study|Physician Decision|1|||
146094187|NCT00925990|526866566|FG000|Overall Study|moved out of state, missed medication|0|||
146094188|NCT00925990|526866567|FG001|Overall Study|moved out of state, missed medication|2|||
146094189|NCT01368432|526866570|FG000|Overall Study|Lost to Follow-up|0|||
146094190|NCT01368432|526866571|FG001|Overall Study|Lost to Follow-up|1|||
146094191|NCT02310321|526866584|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
146094192|NCT02310321|526866585|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146094193|NCT02310321|526866586|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146094194|NCT02310321|526866584|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
146252497|NCT04879823|527436914|FG000|Overall Study|Protocol Violation|2|||
146252498|NCT04879823|527436915|FG001|Overall Study|Protocol Violation|3|||
146252499|NCT04879823|527436914|FG000|Overall Study|Lost to Follow-up|43|||
146252500|NCT04879823|527436915|FG001|Overall Study|Lost to Follow-up|35|||
146252501|NCT04468633|527436916|FG000|Overall Study|Withdrawal by Subject|4|||
146252502|NCT04468633|527436917|FG001|Overall Study|Withdrawal by Subject|0|||
146252503|NCT01498445|527436920|FG000|Overall Study|Lack of Efficacy|0|||
146252504|NCT01498445|527436921|FG001|Overall Study|Lack of Efficacy|0|||
146252505|NCT01498445|527436922|FG002|Overall Study|Lack of Efficacy|1|||
146252506|NCT01498445|527436923|FG003|Overall Study|Lack of Efficacy|2|||
146252507|NCT01498445|527436924|FG004|Overall Study|Lack of Efficacy|0|||
146252508|NCT01498445|527436925|FG005|Overall Study|Lack of Efficacy|0|||
146252509|NCT01498445|527436920|FG000|Overall Study|Screen Failure|0|||
146252510|NCT01498445|527436921|FG001|Overall Study|Screen Failure|0|||
146252511|NCT01498445|527436922|FG002|Overall Study|Screen Failure|0|||
146252512|NCT01498445|527436923|FG003|Overall Study|Screen Failure|0|||
146252513|NCT01498445|527436924|FG004|Overall Study|Screen Failure|1|||
146252514|NCT01498445|527436925|FG005|Overall Study|Screen Failure|1|||
146252515|NCT02465866|527436926|FG000|Period 3|Withdrawal by Subject|0|||
146252516|NCT02465866|527436927|FG001|Period 3|Withdrawal by Subject|1|||
146020956|NCT01448824|526588850|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020957|NCT01448824|526588851|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020958|NCT01448824|526588852|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
146020959|NCT01448824|526588853|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
146020960|NCT01448824|526588846|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020961|NCT01448824|526588847|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020962|NCT01448824|526588848|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020963|NCT01448824|526588849|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020964|NCT01448824|526588850|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020965|NCT01448824|526588851|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020966|NCT01448824|526588852|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
146020967|NCT01448824|526588853|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
146020968|NCT03285958|526588855|FG000|Overall Study|Lost to Follow-up|1|||
146020969|NCT03285958|526588856|FG001|Overall Study|Lost to Follow-up|1|||
146020970|NCT03285958|526588855|FG000|Overall Study|Withdrawal by Subject|1|||
146020971|NCT03285958|526588856|FG001|Overall Study|Withdrawal by Subject|0|||
146020972|NCT03285958|526588855|FG000|Overall Study|Not able to attend required orientation|3|||
146020973|NCT03285958|526588856|FG001|Overall Study|Not able to attend required orientation|0|||
146020974|NCT03116828|526588857|FG000|Overall Study|Adverse Event|1|||
146020975|NCT03116828|526588858|FG001|Overall Study|Adverse Event|10|||
146020976|NCT03116828|526588857|FG000|Overall Study|Withdrawal by Subject|4|||
146094195|NCT02310321|526866585|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146094196|NCT02310321|526866586|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146094197|NCT02310321|526866584|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
146252517|NCT02465866|527436928|FG002|Period 3|Withdrawal by Subject|0|||
146252518|NCT02465866|527436929|FG003|Period 3|Withdrawal by Subject|0|||
146252519|NCT00203502|527436930|FG000|Overall Study|Death|1|||
146252520|NCT02023099|527436931|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
146020977|NCT03116828|526588858|FG001|Overall Study|Withdrawal by Subject|8|||
146020978|NCT03116828|526588857|FG000|Overall Study|OTHER|3|||
146020979|NCT03116828|526588858|FG001|Overall Study|OTHER|3|||
146020980|NCT03002818|526588859|FG000|Overall Study|Decision of the investigator|1|||
146094198|NCT02310321|526866585|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146252521|NCT02023099|527436932|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
146252522|NCT02023099|527436933|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
146252523|NCT02023099|527436931|FG000|Overall Study|Withdrawn Consent|3|||
146252524|NCT02023099|527436932|FG001|Overall Study|Withdrawn Consent|0|||
146252525|NCT02023099|527436933|FG002|Overall Study|Withdrawn Consent|1|||
146020981|NCT01606787|526588864|FG000|Overall Study|Withdrawal by Subject|4|||
146020982|NCT01606787|526588865|FG001|Overall Study|Withdrawal by Subject|5|||
146020983|NCT01606787|526588864|FG000|Overall Study|Surgery canceled|0|||
146020984|NCT01606787|526588865|FG001|Overall Study|Surgery canceled|2|||
146020985|NCT05312632|526588869|FG000|Overall Study|Adverse Event|12|||
146020986|NCT05312632|526588869|FG000|Overall Study|Withdrawal by Subject|10|||
146020987|NCT05312632|526588869|FG000|Overall Study|Lack of Efficacy|4|||
146020988|NCT05312632|526588869|FG000|Overall Study|Non-compliance with study procedures|9|||
146020989|NCT05312632|526588869|FG000|Overall Study|Other|4|||
146020990|NCT00489736|526588870|FG000|Overall Study|Lack of Efficacy|53|||
146020991|NCT00489736|526588871|FG001|Overall Study|Lack of Efficacy|14|||
146020992|NCT00489736|526588870|FG000|Overall Study|Adverse Event|32|||
146020993|NCT00489736|526588871|FG001|Overall Study|Adverse Event|45|||
146020994|NCT00489736|526588870|FG000|Overall Study|Poor compliance|6|||
146020995|NCT00489736|526588871|FG001|Overall Study|Poor compliance|2|||
146020996|NCT00489736|526588870|FG000|Overall Study|Not coded/ Not pre-specified|5|||
146020997|NCT00489736|526588871|FG001|Overall Study|Not coded/ Not pre-specified|8|||
146020998|NCT01681069|526588872|FG000|Overall Study|Withdrawal by Subject|4|||
146020999|NCT01681069|526588873|FG001|Overall Study|Withdrawal by Subject|5|||
146021000|NCT01681069|526588872|FG000|Overall Study|Protocol Violation|1|||
146021001|NCT01681069|526588873|FG001|Overall Study|Protocol Violation|1|||
146021002|NCT01681069|526588872|FG000|Overall Study|Adverse Event|0|||
146021003|NCT01681069|526588873|FG001|Overall Study|Adverse Event|1|||
146021004|NCT03883165|526588874|FG000|Overall Study|Withdrawal by Subject|4|||
146021005|NCT03883165|526588875|FG001|Overall Study|Withdrawal by Subject|3|||
146021006|NCT00245050|526588876|FG000|Overall Study|Adverse Event|3|||
146021007|NCT00245050|526588877|FG001|Overall Study|Adverse Event|2|||
146021008|NCT05526781|526588878|FG000|Overall Study|Lost to Follow-up|1|||
146021009|NCT02743949|526588879|FG000|Overall Study|Adverse Event|0|||
146021010|NCT02743949|526588880|FG001|Overall Study|Adverse Event|0|||
146021011|NCT02743949|526588881|FG002|Overall Study|Adverse Event|2|||
146021012|NCT02743949|526588879|FG000|Overall Study|Significant Protocol Deviation|2|||
146021013|NCT02743949|526588880|FG001|Overall Study|Significant Protocol Deviation|0|||
146021014|NCT02743949|526588881|FG002|Overall Study|Significant Protocol Deviation|1|||
146021015|NCT02743949|526588879|FG000|Overall Study|Voluntary Withdrawal|2|||
146021016|NCT02743949|526588880|FG001|Overall Study|Voluntary Withdrawal|1|||
146021017|NCT02743949|526588881|FG002|Overall Study|Voluntary Withdrawal|0|||
146021018|NCT01498575|526588882|FG000|Overall Sample|Withdrawal by Subject|60|||
146021019|NCT01498575|526588883|FG001|Overall Sample|Withdrawal by Subject|14|||
146021020|NCT01498575|526588882|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
146021021|NCT01498575|526588883|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
146021022|NCT01498575|526588882|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
146021023|NCT01498575|526588883|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
146021024|NCT01972308|526588891|FG000|Overall Study|Withdrawal by Subject|0|||
146021025|NCT01972308|526588892|FG001|Overall Study|Withdrawal by Subject|1|||
146021026|NCT01972308|526588891|FG000|Overall Study|Lost to Follow-up|4|||
146021027|NCT01972308|526588892|FG001|Overall Study|Lost to Follow-up|6|||
146021028|NCT01972308|526588891|FG000|Overall Study|Death|4|||
146021029|NCT01972308|526588892|FG001|Overall Study|Death|1|||
146021030|NCT00847665|526588898|FG000|Overall Study|Withdrawal by Subject|1|||
146021031|NCT00847665|526588899|FG001|Overall Study|Withdrawal by Subject|0|||
146021032|NCT00585546|526588906|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
146021033|NCT00585546|526588906|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
146094199|NCT02310321|526866586|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
146094200|NCT02310321|526866584|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
146094201|NCT02310321|526866585|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
146094202|NCT02310321|526866586|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
146094203|NCT02310321|526866584|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146094204|NCT02310321|526866585|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
146094205|NCT02310321|526866586|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
146094206|NCT02310321|526866584|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
146094207|NCT02310321|526866585|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
146094208|NCT02310321|526866586|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
146094209|NCT02310321|526866584|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
146094210|NCT02310321|526866585|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
146094211|NCT02310321|526866586|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
146021034|NCT01562314|526588907|FG000|Overall Study|Adverse Event|10|||
146021035|NCT01562314|526588908|FG001|Overall Study|Adverse Event|5|||
146021036|NCT01562314|526588907|FG000|Overall Study|Met Withdrawal Criteria|3|||
146021037|NCT01562314|526588908|FG001|Overall Study|Met Withdrawal Criteria|2|||
146021038|NCT01562314|526588907|FG000|Overall Study|Withdrawal by Subject|0|||
146021039|NCT01562314|526588908|FG001|Overall Study|Withdrawal by Subject|1|||
146021040|NCT02851797|526588909|FG000|Overall Study|Withdrawal by Subject|4|||
146252526|NCT02023099|527436931|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
146252527|NCT02023099|527436932|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
146252528|NCT02023099|527436933|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
146252529|NCT02592434|527436934|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
146252530|NCT02592434|527436935|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
146252531|NCT02592434|527436936|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
146252532|NCT02592434|527436934|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
146252533|NCT02592434|527436935|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
146252534|NCT02592434|527436936|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
146252535|NCT02592434|527436934|FG000|Open-Label Phase (18 Weeks)|Other|3|||
146252536|NCT02592434|527436935|FG001|Open-Label Phase (18 Weeks)|Other|0|||
146252537|NCT02592434|527436936|FG002|Open-Label Phase (18 Weeks)|Other|0|||
146252538|NCT02592434|527436934|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
146252539|NCT02592434|527436935|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
146252540|NCT02592434|527436936|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
146252541|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
146252542|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
146252543|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
146252544|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
146252545|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
146252546|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
146252547|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Other|0|||
146252548|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Other|1|||
146252549|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Other|0|||
146252550|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
146252551|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
146252552|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
146252553|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
146252554|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
146252555|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
146252556|NCT02592434|527436934|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
146252557|NCT02592434|527436935|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
146252558|NCT02592434|527436936|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
146252559|NCT01469819|527436937|FG000|Overall Study|Withdrawal by Subject|1|||
146252560|NCT01469819|527436937|FG000|Overall Study|Did not meet inclusionary criteria|2|||
146252561|NCT01469819|527436937|FG000|Overall Study|Could not swallow SmartPill|2|||
146252562|NCT01469819|527436937|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
146252563|NCT01695993|527436940|FG000|Overall Study|Lost to Follow-up|2|||
146252564|NCT01695993|527436941|FG001|Overall Study|Lost to Follow-up|1|||
146252565|NCT01695993|527436942|FG002|Overall Study|Lost to Follow-up|3|||
146021041|NCT02851797|526588910|FG001|Overall Study|Withdrawal by Subject|2|||
146021042|NCT02851797|526588909|FG000|Overall Study|Adverse Event|3|||
146021043|NCT02851797|526588910|FG001|Overall Study|Adverse Event|0|||
146021044|NCT00813865|526588911|FG000|Overall Study|Failure to Respond|3|||
146021045|NCT00813865|526588911|FG000|Overall Study|Lost to Follow-up|3|||
146021046|NCT00813865|526588911|FG000|Overall Study|Withdrawal by Subject|1|||
146021047|NCT00624585|526588914|FG000|Overall Study|Death|3|||
146021048|NCT00624585|526588914|FG000|Overall Study|Disease Progression|6|||
146021049|NCT00624585|526588914|FG000|Overall Study|Adverse Event|3|||
146021050|NCT02256384|526588915|FG000|Overall Study|Withdrawal by Subject|12|||
146021051|NCT02256384|526588915|FG000|Overall Study|Equipment not capturing data|2|||
146021052|NCT04295681|526588916|FG000|Overall Study|Eligibility error|1|||
146021053|NCT04295681|526588917|FG001|Overall Study|Eligibility error|3|||
146021054|NCT01425359|526588921|FG000|Overall Study|Randomized but Not Treated|2|||
146252566|NCT01695993|527436940|FG000|Overall Study|Withdrawal by Subject|2|||
146252567|NCT01695993|527436941|FG001|Overall Study|Withdrawal by Subject|2|||
146252568|NCT01695993|527436942|FG002|Overall Study|Withdrawal by Subject|2|||
146252569|NCT01695993|527436940|FG000|Overall Study|To ill to continue|1|||
146252570|NCT01695993|527436941|FG001|Overall Study|To ill to continue|2|||
146252571|NCT01695993|527436942|FG002|Overall Study|To ill to continue|0|||
146252572|NCT01695993|527436940|FG000|Overall Study|Changed Medical Facility|0|||
146252573|NCT01695993|527436941|FG001|Overall Study|Changed Medical Facility|0|||
146252574|NCT01695993|527436942|FG002|Overall Study|Changed Medical Facility|1|||
146252575|NCT04057937|527436965|FG000|Placebo-controlled Phase|Adverse Event|3|||
146252576|NCT04057937|527436966|FG001|Placebo-controlled Phase|Adverse Event|0|||
146252577|NCT04057937|527436965|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
146252578|NCT04057937|527436966|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
146252579|NCT04057937|527436965|FG000|Active-treatment Phase|Pregnancy|0|||
146252580|NCT04057937|527436966|FG001|Active-treatment Phase|Pregnancy|1|||
146021055|NCT01425359|526588922|FG001|Overall Study|Randomized but Not Treated|3|||
146021056|NCT01425359|526588921|FG000|Overall Study|Adverse Event|9|||
146021057|NCT01425359|526588922|FG001|Overall Study|Adverse Event|8|||
146021058|NCT01425359|526588921|FG000|Overall Study|Revascularization|0|||
146021059|NCT01425359|526588922|FG001|Overall Study|Revascularization|1|||
146021060|NCT01425359|526588921|FG000|Overall Study|Death|0|||
146021061|NCT01425359|526588922|FG001|Overall Study|Death|1|||
146021062|NCT01425359|526588921|FG000|Overall Study|Unsatisfactory Response|1|||
146021063|NCT01425359|526588922|FG001|Overall Study|Unsatisfactory Response|0|||
146021064|NCT01425359|526588921|FG000|Overall Study|Protocol Violation|1|||
146021065|NCT01425359|526588922|FG001|Overall Study|Protocol Violation|2|||
146021066|NCT01425359|526588921|FG000|Overall Study|Subject Withdrew Consent|1|||
146021067|NCT01425359|526588922|FG001|Overall Study|Subject Withdrew Consent|2|||
146021068|NCT01425359|526588921|FG000|Overall Study|Investigator's Discretion|2|||
146021069|NCT01425359|526588922|FG001|Overall Study|Investigator's Discretion|0|||
146021070|NCT01425359|526588921|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
146021071|NCT01425359|526588922|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
146021072|NCT00744978|526588923|FG000|Period 1|Lost to Follow-up|1|||
146021073|NCT00744978|526588924|FG001|Period 1|Lost to Follow-up|0|||
146021074|NCT00744978|526588923|FG000|Period 1|Withdrawal by Subject|0|||
146252581|NCT04057937|527436965|FG000|Active-treatment Phase|Physician Decision|0|||
146252582|NCT04057937|527436966|FG001|Active-treatment Phase|Physician Decision|1|||
146252583|NCT01072396|527436967|FG000|Period One|Adverse Event|1|||
146252584|NCT01072396|527436968|FG001|Period One|Adverse Event|1|||
146252585|NCT01072396|527436967|FG000|Period One|Protocol Violation|2|||
146252586|NCT01072396|527436968|FG001|Period One|Protocol Violation|1|||
146252587|NCT01072396|527436967|FG000|Period One|Withdrawal by Subject|2|||
146252588|NCT01072396|527436968|FG001|Period One|Withdrawal by Subject|0|||
146252589|NCT01072396|527436967|FG000|Washout Period|Missing termination information|0|||
146252590|NCT01072396|527436968|FG001|Washout Period|Missing termination information|1|||
146252591|NCT01072396|527436967|FG000|Period Two|Adverse Event|0|||
146252592|NCT01072396|527436968|FG001|Period Two|Adverse Event|3|||
146252593|NCT01072396|527436967|FG000|Period Two|Lost to Follow-up|1|||
146252594|NCT01072396|527436968|FG001|Period Two|Lost to Follow-up|0|||
146252595|NCT00472199|527436969|FG000|Overall Study|Adverse Event|19|||
146252596|NCT00472199|527436970|FG001|Overall Study|Adverse Event|23|||
146252597|NCT00472199|527436969|FG000|Overall Study|Lack of Efficacy|4|||
146252598|NCT00472199|527436970|FG001|Overall Study|Lack of Efficacy|25|||
146252599|NCT00472199|527436969|FG000|Overall Study|Lost to Follow-up|2|||
146252600|NCT00472199|527436970|FG001|Overall Study|Lost to Follow-up|4|||
146252601|NCT00472199|527436969|FG000|Overall Study|Protocol Violation|3|||
146252602|NCT00472199|527436970|FG001|Overall Study|Protocol Violation|2|||
146252603|NCT00472199|527436969|FG000|Overall Study|Withdrawal by Subject|6|||
146252604|NCT00472199|527436970|FG001|Overall Study|Withdrawal by Subject|5|||
146252605|NCT00472199|527436969|FG000|Overall Study|personal reason|0|||
146252606|NCT00472199|527436970|FG001|Overall Study|personal reason|1|||
146252607|NCT00472199|527436969|FG000|Overall Study|patient was asymptomatic|1|||
146252608|NCT00472199|527436970|FG001|Overall Study|patient was asymptomatic|0|||
146252609|NCT01268488|527436972|FG000|Overall Study|Adverse Event|3|||
146252610|NCT01268488|527436972|FG000|Overall Study|Physician Decision|2|||
146252611|NCT01014013|527436978|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
146252612|NCT01014013|527436979|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
146252613|NCT01014013|527436978|FG000|Overall Study|Clinical adverse experience|4|||
146252614|NCT01014013|527436979|FG001|Overall Study|Clinical adverse experience|2|||
146252615|NCT01014013|527436978|FG000|Overall Study|Laboratory adverse experience|1|||
146252616|NCT01014013|527436979|FG001|Overall Study|Laboratory adverse experience|1|||
146252617|NCT01014013|527436978|FG000|Overall Study|Protocol Violation|1|||
146252618|NCT01014013|527436979|FG001|Overall Study|Protocol Violation|3|||
146252619|NCT01014013|527436978|FG000|Overall Study|Withdrawal by Subject|7|||
146252620|NCT01014013|527436979|FG001|Overall Study|Withdrawal by Subject|4|||
146252621|NCT01014013|527436978|FG000|Overall Study|Clinical/microbiologic failure|1|||
146021075|NCT00744978|526588924|FG001|Period 1|Withdrawal by Subject|2|||
146021076|NCT00744978|526588923|FG000|Period 1|Other|0|||
146252622|NCT01014013|527436979|FG001|Overall Study|Clinical/microbiologic failure|2|||
146252623|NCT01014013|527436978|FG000|Overall Study|Pathogen culture = no growth|26|||
146252624|NCT01014013|527436979|FG001|Overall Study|Pathogen culture = no growth|34|||
146252625|NCT01014013|527436978|FG000|Overall Study|Negative urine culture|2|||
146252626|NCT01014013|527436979|FG001|Overall Study|Negative urine culture|0|||
146252627|NCT01014013|527436978|FG000|Overall Study|Pathogen resistant|7|||
146252628|NCT01014013|527436979|FG001|Overall Study|Pathogen resistant|4|||
146021077|NCT00744978|526588924|FG001|Period 1|Other|2|||
146021078|NCT00744978|526588923|FG000|Period 1|Adverse Event|4|||
146021079|NCT00744978|526588924|FG001|Period 1|Adverse Event|0|||
146252629|NCT01014013|527436978|FG000|Overall Study|Physician Decision|0|||
146252630|NCT01014013|527436979|FG001|Overall Study|Physician Decision|1|||
146021080|NCT00744978|526588923|FG000|Period 1|Randomized but not Treated|1|||
146252631|NCT01014013|527436978|FG000|Overall Study|Another antibiotic therapy required|0|||
146252632|NCT01014013|527436979|FG001|Overall Study|Another antibiotic therapy required|1|||
146252633|NCT01014013|527436978|FG000|Overall Study|Appendectomy|1|||
146252634|NCT01014013|527436979|FG001|Overall Study|Appendectomy|0|||
146252635|NCT01014013|527436978|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
146252636|NCT01014013|527436979|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
146021081|NCT00744978|526588924|FG001|Period 1|Randomized but not Treated|1|||
146021082|NCT00744978|526588923|FG000|Period 2|Adverse Event|0|||
146021083|NCT00744978|526588924|FG001|Period 2|Adverse Event|1|||
146021084|NCT04659174|526588926|FG000|Overall Study|Sponsor decision to discontinue study|0|||
146021085|NCT04659174|526588927|FG001|Overall Study|Sponsor decision to discontinue study|2|||
146021086|NCT04659174|526588926|FG000|Overall Study|Lost to Follow-up|9|||
146021087|NCT04659174|526588927|FG001|Overall Study|Lost to Follow-up|11|||
146021088|NCT04659174|526588926|FG000|Overall Study|Adverse Event|8|||
146021089|NCT04659174|526588927|FG001|Overall Study|Adverse Event|5|||
146021090|NCT04659174|526588926|FG000|Overall Study|Withdrawal by Subject|17|||
146021091|NCT04659174|526588927|FG001|Overall Study|Withdrawal by Subject|33|||
146021092|NCT04659174|526588926|FG000|Overall Study|Progressive disease|0|||
146021093|NCT04659174|526588927|FG001|Overall Study|Progressive disease|2|||
146021094|NCT04659174|526588926|FG000|Overall Study|Other reasons|0|||
146021095|NCT04659174|526588927|FG001|Overall Study|Other reasons|2|||
146021096|NCT04659174|526588926|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
146021097|NCT04659174|526588927|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
146021098|NCT04659174|526588926|FG000|Overall Study|Alcohol or illegal drug use|0|||
146021099|NCT04659174|526588927|FG001|Overall Study|Alcohol or illegal drug use|3|||
146021100|NCT04659174|526588926|FG000|Overall Study|Violation of entry criteria|1|||
146021101|NCT04659174|526588927|FG001|Overall Study|Violation of entry criteria|0|||
146021102|NCT04659174|526588926|FG000|Overall Study|Death|0|||
146021103|NCT04659174|526588927|FG001|Overall Study|Death|1|||
146021104|NCT03276026|526588930|FG000|Overall Study|Protocol Violation|1|||
146021105|NCT03276026|526588931|FG001|Overall Study|Protocol Violation|0|||
146021106|NCT03650803|526588933|FG000|Overall Study|Lost to Follow-up|6|||
146021107|NCT01534260|526588934|FG000|Overall Study|Adverse Event|1|||
146021108|NCT01534260|526588935|FG001|Overall Study|Adverse Event|8|||
146021109|NCT01534260|526588934|FG000|Overall Study|Death|2|||
146021110|NCT01534260|526588935|FG001|Overall Study|Death|0|||
146021111|NCT01534260|526588934|FG000|Overall Study|Lack of Efficacy|1|||
146021112|NCT01534260|526588935|FG001|Overall Study|Lack of Efficacy|1|||
146021113|NCT01534260|526588934|FG000|Overall Study|Withdrawal by Subject|1|||
146021114|NCT01534260|526588935|FG001|Overall Study|Withdrawal by Subject|3|||
146021115|NCT01534260|526588934|FG000|Overall Study|Disease Progression|8|||
146021116|NCT01534260|526588935|FG001|Overall Study|Disease Progression|6|||
146021117|NCT01534260|526588934|FG000|Overall Study|Physician Decision|3|||
146021118|NCT01534260|526588935|FG001|Overall Study|Physician Decision|1|||
146021119|NCT01534260|526588934|FG000|Overall Study|No treatment, per protocol|0|||
146021120|NCT01534260|526588935|FG001|Overall Study|No treatment, per protocol|1|||
146021121|NCT02359045|526588936|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
146021122|NCT02359045|526588937|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146021123|NCT02359045|526588936|FG000|Overall Study|Lost to Follow-up|1|||
146021124|NCT02359045|526588937|FG001|Overall Study|Lost to Follow-up|1|||
146021125|NCT02359045|526588936|FG000|Overall Study|Adverse Event|0|||
146021126|NCT02359045|526588937|FG001|Overall Study|Adverse Event|1|||
146021127|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
146021128|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
146021129|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
146021130|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
146021131|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
146021132|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
146021133|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
146021134|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
146021135|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
146021136|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
146252637|NCT02305797|527436980|FG000|Overall Study|Adverse Event|11|||
146252638|NCT02305797|527436981|FG001|Overall Study|Adverse Event|2|||
146252639|NCT02305797|527436980|FG000|Overall Study|Withdrawal by Subject|9|||
146252640|NCT02305797|527436981|FG001|Overall Study|Withdrawal by Subject|10|||
146252641|NCT02305797|527436980|FG000|Overall Study|Lack of Efficacy|6|||
146252642|NCT02305797|527436981|FG001|Overall Study|Lack of Efficacy|0|||
146252643|NCT02305797|527436980|FG000|Overall Study|Lost to Follow-up|5|||
146252644|NCT02305797|527436981|FG001|Overall Study|Lost to Follow-up|11|||
146021137|NCT01639339|526588941|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
146021138|NCT01639339|526588942|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
146021139|NCT01639339|526588941|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
146021140|NCT01639339|526588942|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
146021141|NCT01639339|526588941|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
146021142|NCT01639339|526588942|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
146021143|NCT01639339|526588941|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
146021144|NCT01639339|526588942|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
146252645|NCT02305797|527436980|FG000|Overall Study|Pregnancy|0|||
146021145|NCT01639339|526588941|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
146021146|NCT01639339|526588942|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
146021147|NCT00367744|526588943|FG000|Overall Study|Lost to Follow-up|4|||
146021148|NCT00367744|526588944|FG001|Overall Study|Lost to Follow-up|5|||
146021149|NCT00503581|526588951|FG000|Overall Study|Study closed|3|||
146021150|NCT00503581|526588952|FG001|Overall Study|Study closed|4|||
146021151|NCT00503581|526588953|FG002|Overall Study|Study closed|2|||
146021152|NCT04376684|526588954|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
146021153|NCT04376684|526588955|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
146021154|NCT04376684|526588956|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
146021155|NCT04376684|526588957|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
146021156|NCT04376684|526588954|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
146021157|NCT04376684|526588955|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
146021158|NCT04376684|526588956|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
146021159|NCT04376684|526588957|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
146021160|NCT04376684|526588954|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
146021161|NCT04376684|526588955|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
146021162|NCT04376684|526588956|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
146021163|NCT04376684|526588957|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
146021164|NCT04376684|526588954|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
146021165|NCT04376684|526588955|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
146021166|NCT04376684|526588956|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
146021167|NCT04376684|526588957|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
146021168|NCT04376684|526588954|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
146021169|NCT04376684|526588955|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
146021170|NCT04376684|526588956|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
146021171|NCT04376684|526588957|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
146021172|NCT04376684|526588954|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
146021173|NCT04376684|526588955|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
146021174|NCT04376684|526588956|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
146021175|NCT04376684|526588957|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
146021176|NCT04376684|526588954|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
146021177|NCT04376684|526588955|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
146021178|NCT04376684|526588956|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
146021179|NCT04376684|526588957|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
146021180|NCT01666119|526588958|FG000|Overall Study|Adverse Event|6|||
146021181|NCT01666119|526588958|FG000|Overall Study|Withdrawal by Subject|16|||
146021182|NCT01666119|526588958|FG000|Overall Study|Lost to Follow-up|7|||
146021183|NCT01666119|526588958|FG000|Overall Study|non compliance with study medication, pa|18|||
146021184|NCT01666119|526588958|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
146021185|NCT02979093|526588975|FG000|First Scan Session|Scanning data problems|1|||
146021186|NCT02979093|526588976|FG001|First Scan Session|Scanning data problems|2|||
146021187|NCT02979093|526588977|FG002|First Scan Session|Scanning data problems|2|||
146021188|NCT02979093|526588978|FG003|First Scan Session|Scanning data problems|0|||
146021189|NCT02979093|526588975|FG000|Second Scan Session|Scanning data problems|3|||
146021190|NCT02979093|526588976|FG001|Second Scan Session|Scanning data problems|0|||
146021191|NCT02979093|526588977|FG002|Second Scan Session|Scanning data problems|1|||
146021192|NCT02979093|526588978|FG003|Second Scan Session|Scanning data problems|3|||
146021193|NCT06107803|526588979|FG000|Overall Study|Adverse Event|1|||
146021194|NCT06107803|526588979|FG000|Overall Study|Withdrawal by Subject|2|||
146021195|NCT06107803|526588979|FG000|Overall Study|Protocol Violation|1|||
146021196|NCT05596734|526588980|FG000|Substudy A|Withdrawal by Subject|1|||
146021197|NCT05596734|526588981|FG001|Substudy A|Withdrawal by Subject|0|||
146021198|NCT05596734|526588982|FG002|Substudy A|Withdrawal by Subject|0|||
146021199|NCT05596734|526588983|FG003|Substudy A|Withdrawal by Subject|0|||
146021200|NCT05596734|526588984|FG004|Substudy A|Withdrawal by Subject|0|||
146021201|NCT05596734|526588985|FG005|Substudy A|Withdrawal by Subject|0|||
146021202|NCT05596734|526588986|FG006|Substudy A|Withdrawal by Subject|1|||
146021203|NCT05596734|526588987|FG007|Substudy A|Withdrawal by Subject|0|||
146021204|NCT05596734|526588988|FG008|Substudy A|Withdrawal by Subject|0|||
146021205|NCT05596734|526588989|FG009|Substudy A|Withdrawal by Subject|0|||
146094212|NCT02310321|526866584|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
146021206|NCT05596734|526588990|FG010|Substudy A|Withdrawal by Subject|0|||
146094213|NCT02310321|526866585|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
146094214|NCT02310321|526866586|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
146252646|NCT02305797|527436981|FG001|Overall Study|Pregnancy|2|||
146021207|NCT05596734|526588991|FG011|Substudy A|Withdrawal by Subject|0|||
146021208|NCT05596734|526588992|FG012|Substudy A|Withdrawal by Subject|0|||
146021209|NCT05596734|526588993|FG013|Substudy A|Withdrawal by Subject|0|||
146021210|NCT05596734|526588994|FG014|Substudy A|Withdrawal by Subject|0|||
146021211|NCT05596734|526588995|FG015|Substudy A|Withdrawal by Subject|0|||
146021212|NCT05596734|526588996|FG016|Substudy A|Withdrawal by Subject|0|||
146021213|NCT05596734|526588997|FG017|Substudy A|Withdrawal by Subject|0|||
146021214|NCT05596734|526588998|FG018|Substudy A|Withdrawal by Subject|0|||
146021215|NCT05596734|526588999|FG019|Substudy A|Withdrawal by Subject|0|||
146021216|NCT05596734|526589000|FG020|Substudy A|Withdrawal by Subject|0|||
146021217|NCT05596734|526589001|FG021|Substudy A|Withdrawal by Subject|0|||
146021218|NCT05596734|526589002|FG022|Substudy A|Withdrawal by Subject|0|||
146021219|NCT05596734|526589003|FG023|Substudy A|Withdrawal by Subject|0|||
146021220|NCT05596734|526588980|FG000|Substudy A|Lost to Follow-up|1|||
146021221|NCT05596734|526588981|FG001|Substudy A|Lost to Follow-up|0|||
146021222|NCT05596734|526588982|FG002|Substudy A|Lost to Follow-up|1|||
146021223|NCT05596734|526588983|FG003|Substudy A|Lost to Follow-up|0|||
146021224|NCT05596734|526588984|FG004|Substudy A|Lost to Follow-up|0|||
146021225|NCT05596734|526588985|FG005|Substudy A|Lost to Follow-up|0|||
146021226|NCT05596734|526588986|FG006|Substudy A|Lost to Follow-up|0|||
146021227|NCT05596734|526588987|FG007|Substudy A|Lost to Follow-up|0|||
146021228|NCT05596734|526588988|FG008|Substudy A|Lost to Follow-up|0|||
146021229|NCT05596734|526588989|FG009|Substudy A|Lost to Follow-up|0|||
146021230|NCT05596734|526588990|FG010|Substudy A|Lost to Follow-up|0|||
146021231|NCT05596734|526588991|FG011|Substudy A|Lost to Follow-up|0|||
146021232|NCT05596734|526588992|FG012|Substudy A|Lost to Follow-up|0|||
146021233|NCT05596734|526588993|FG013|Substudy A|Lost to Follow-up|0|||
146021234|NCT05596734|526588994|FG014|Substudy A|Lost to Follow-up|0|||
146021235|NCT05596734|526588995|FG015|Substudy A|Lost to Follow-up|0|||
146021236|NCT05596734|526588996|FG016|Substudy A|Lost to Follow-up|0|||
146021237|NCT05596734|526588997|FG017|Substudy A|Lost to Follow-up|0|||
146021238|NCT05596734|526588998|FG018|Substudy A|Lost to Follow-up|0|||
146094215|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
146094216|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
146094217|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
146094218|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
146094219|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
146094220|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
146094221|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
146094222|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
146094223|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
146094224|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
146094225|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
146094226|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
146094227|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
146094228|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
146094229|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
146094230|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
146094231|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
146094232|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
146094233|NCT02310321|526866584|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
146094234|NCT02310321|526866585|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
146094235|NCT02310321|526866586|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
146094236|NCT02310321|526866584|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
146094237|NCT02310321|526866585|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
146094238|NCT02310321|526866586|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
146094239|NCT02310321|526866584|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
146094240|NCT02310321|526866585|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
146094241|NCT02310321|526866586|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
146094242|NCT02310321|526866584|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
146094243|NCT02310321|526866585|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
146094244|NCT02310321|526866586|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
146094245|NCT02310321|526866584|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
146094246|NCT02310321|526866585|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
146094247|NCT02310321|526866586|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
146094248|NCT02310321|526866584|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
146094249|NCT02310321|526866585|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
146094250|NCT02310321|526866586|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
146094251|NCT02310321|526866584|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
146021239|NCT05596734|526588999|FG019|Substudy A|Lost to Follow-up|0|||
146021240|NCT05596734|526589000|FG020|Substudy A|Lost to Follow-up|0|||
146094252|NCT02310321|526866585|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
146094253|NCT02310321|526866586|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
146094254|NCT02310321|526866584|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
146094255|NCT02310321|526866585|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
146094256|NCT02310321|526866586|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
146252647|NCT02305797|527436980|FG000|Overall Study|Noncompliance|14|||
146021241|NCT05596734|526589001|FG021|Substudy A|Lost to Follow-up|0|||
146021242|NCT05596734|526589002|FG022|Substudy A|Lost to Follow-up|0|||
146021243|NCT05596734|526589003|FG023|Substudy A|Lost to Follow-up|0|||
146021244|NCT05596734|526588980|FG000|Substudy B|Withdrawal by Subject|0|||
146021245|NCT05596734|526588981|FG001|Substudy B|Withdrawal by Subject|0|||
146021246|NCT05596734|526588982|FG002|Substudy B|Withdrawal by Subject|0|||
146021247|NCT05596734|526588983|FG003|Substudy B|Withdrawal by Subject|0|||
146021248|NCT05596734|526588984|FG004|Substudy B|Withdrawal by Subject|0|||
146021249|NCT05596734|526588985|FG005|Substudy B|Withdrawal by Subject|0|||
146021250|NCT05596734|526588986|FG006|Substudy B|Withdrawal by Subject|0|||
146021251|NCT05596734|526588987|FG007|Substudy B|Withdrawal by Subject|0|||
146021252|NCT05596734|526588988|FG008|Substudy B|Withdrawal by Subject|0|||
146021253|NCT05596734|526588989|FG009|Substudy B|Withdrawal by Subject|0|||
146021254|NCT05596734|526588990|FG010|Substudy B|Withdrawal by Subject|0|||
146021255|NCT05596734|526588991|FG011|Substudy B|Withdrawal by Subject|0|||
146021256|NCT05596734|526588992|FG012|Substudy B|Withdrawal by Subject|1|||
146021257|NCT05596734|526588993|FG013|Substudy B|Withdrawal by Subject|0|||
146021258|NCT05596734|526588994|FG014|Substudy B|Withdrawal by Subject|1|||
146021259|NCT05596734|526588995|FG015|Substudy B|Withdrawal by Subject|2|||
146021260|NCT05596734|526588996|FG016|Substudy B|Withdrawal by Subject|2|||
146021261|NCT05596734|526588997|FG017|Substudy B|Withdrawal by Subject|1|||
146021262|NCT05596734|526588998|FG018|Substudy B|Withdrawal by Subject|2|||
146021263|NCT05596734|526588999|FG019|Substudy B|Withdrawal by Subject|0|||
146252648|NCT02305797|527436981|FG001|Overall Study|Noncompliance|12|||
146021264|NCT05596734|526589000|FG020|Substudy B|Withdrawal by Subject|0|||
146021265|NCT05596734|526589001|FG021|Substudy B|Withdrawal by Subject|0|||
146021266|NCT05596734|526589002|FG022|Substudy B|Withdrawal by Subject|0|||
146021267|NCT05596734|526589003|FG023|Substudy B|Withdrawal by Subject|1|||
146021268|NCT05596734|526588980|FG000|Substudy B|Physician Decision|0|||
146021269|NCT05596734|526588981|FG001|Substudy B|Physician Decision|0|||
146021270|NCT05596734|526588982|FG002|Substudy B|Physician Decision|0|||
146021271|NCT05596734|526588983|FG003|Substudy B|Physician Decision|0|||
146021272|NCT05596734|526588984|FG004|Substudy B|Physician Decision|0|||
146021273|NCT05596734|526588985|FG005|Substudy B|Physician Decision|0|||
146021274|NCT05596734|526588986|FG006|Substudy B|Physician Decision|0|||
146021275|NCT05596734|526588987|FG007|Substudy B|Physician Decision|0|||
146021276|NCT05596734|526588988|FG008|Substudy B|Physician Decision|0|||
146021277|NCT05596734|526588989|FG009|Substudy B|Physician Decision|0|||
146021278|NCT05596734|526588990|FG010|Substudy B|Physician Decision|0|||
146252649|NCT02305797|527436980|FG000|Overall Study|Reason not collected|0|||
146094257|NCT02310321|526866584|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
146094258|NCT02310321|526866585|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
146252650|NCT02305797|527436981|FG001|Overall Study|Reason not collected|1|||
146252651|NCT03508830|527436982|FG000|Overall Study|Withdrawal by Subject|3|||
146252652|NCT03508830|527436983|FG001|Overall Study|Withdrawal by Subject|4|||
146252653|NCT03508830|527436982|FG000|Overall Study|Physician Decision|2|||
146252654|NCT03508830|527436983|FG001|Overall Study|Physician Decision|2|||
146252655|NCT02097056|527436984|FG000|Overall Study|Protocol Violation|2|||
146021279|NCT05596734|526588991|FG011|Substudy B|Physician Decision|0|||
146021280|NCT05596734|526588992|FG012|Substudy B|Physician Decision|0|||
146021281|NCT05596734|526588993|FG013|Substudy B|Physician Decision|0|||
146021282|NCT05596734|526588994|FG014|Substudy B|Physician Decision|0|||
146021283|NCT05596734|526588995|FG015|Substudy B|Physician Decision|1|||
146021284|NCT05596734|526588996|FG016|Substudy B|Physician Decision|0|||
146021285|NCT05596734|526588997|FG017|Substudy B|Physician Decision|0|||
146021286|NCT05596734|526588998|FG018|Substudy B|Physician Decision|0|||
146021287|NCT05596734|526588999|FG019|Substudy B|Physician Decision|0|||
146252656|NCT02097056|527436984|FG000|Overall Study|Withdrawal by Subject|15|||
146252657|NCT02097056|527436984|FG000|Overall Study|Lost to Follow-up|2|||
146252658|NCT02097056|527436984|FG000|Overall Study|Adverse Event|37|||
146021288|NCT05596734|526589000|FG020|Substudy B|Physician Decision|0|||
146021289|NCT05596734|526589001|FG021|Substudy B|Physician Decision|0|||
146021290|NCT05596734|526589002|FG022|Substudy B|Physician Decision|0|||
146021291|NCT05596734|526589003|FG023|Substudy B|Physician Decision|0|||
146021292|NCT05596734|526588980|FG000|Substudy B|Lost to Follow-up|0|||
146021293|NCT05596734|526588981|FG001|Substudy B|Lost to Follow-up|0|||
146252659|NCT02097056|527436984|FG000|Overall Study|Other|2|||
146252660|NCT01446042|527436987|FG000|Overall Study|Withdrawal by Subject|12|||
146252661|NCT01446042|527436988|FG001|Overall Study|Withdrawal by Subject|2|||
146252662|NCT01446042|527436989|FG002|Overall Study|Withdrawal by Subject|4|||
146252663|NCT01446042|527436987|FG000|Overall Study|Adverse Event|1|||
146252664|NCT01446042|527436988|FG001|Overall Study|Adverse Event|0|||
146021294|NCT05596734|526588982|FG002|Substudy B|Lost to Follow-up|0|||
146021295|NCT05596734|526588983|FG003|Substudy B|Lost to Follow-up|0|||
146021296|NCT05596734|526588984|FG004|Substudy B|Lost to Follow-up|0|||
146021297|NCT05596734|526588985|FG005|Substudy B|Lost to Follow-up|0|||
146021298|NCT05596734|526588986|FG006|Substudy B|Lost to Follow-up|0|||
146021299|NCT05596734|526588987|FG007|Substudy B|Lost to Follow-up|0|||
146021300|NCT05596734|526588988|FG008|Substudy B|Lost to Follow-up|0|||
146021301|NCT05596734|526588989|FG009|Substudy B|Lost to Follow-up|0|||
146021302|NCT05596734|526588990|FG010|Substudy B|Lost to Follow-up|0|||
146021303|NCT05596734|526588991|FG011|Substudy B|Lost to Follow-up|0|||
146252665|NCT01446042|527436989|FG002|Overall Study|Adverse Event|4|||
146021304|NCT05596734|526588992|FG012|Substudy B|Lost to Follow-up|1|||
146021305|NCT05596734|526588993|FG013|Substudy B|Lost to Follow-up|0|||
146021306|NCT05596734|526588994|FG014|Substudy B|Lost to Follow-up|1|||
146021307|NCT05596734|526588995|FG015|Substudy B|Lost to Follow-up|1|||
146021308|NCT05596734|526588996|FG016|Substudy B|Lost to Follow-up|0|||
146021309|NCT05596734|526588997|FG017|Substudy B|Lost to Follow-up|0|||
146021310|NCT05596734|526588998|FG018|Substudy B|Lost to Follow-up|0|||
146021311|NCT05596734|526588999|FG019|Substudy B|Lost to Follow-up|0|||
146021312|NCT05596734|526589000|FG020|Substudy B|Lost to Follow-up|0|||
146021313|NCT05596734|526589001|FG021|Substudy B|Lost to Follow-up|0|||
146021314|NCT05596734|526589002|FG022|Substudy B|Lost to Follow-up|0|||
146021315|NCT05596734|526589003|FG023|Substudy B|Lost to Follow-up|0|||
146021316|NCT03219034|526589006|FG000|Overall Study|Lost to Follow-up|9|||
146021317|NCT03219034|526589007|FG001|Overall Study|Lost to Follow-up|13|||
146021318|NCT03219034|526589006|FG000|Overall Study|Additional dental work needed|1|||
146021319|NCT03219034|526589007|FG001|Overall Study|Additional dental work needed|0|||
146021320|NCT03219034|526589006|FG000|Overall Study|UPPP Surgery|1|||
146021321|NCT03219034|526589007|FG001|Overall Study|UPPP Surgery|0|||
146021322|NCT03219034|526589006|FG000|Overall Study|Dental sensitivity|0|||
146021323|NCT03219034|526589007|FG001|Overall Study|Dental sensitivity|1|||
146021324|NCT03219034|526589006|FG000|Overall Study|Death in family|0|||
146021325|NCT03219034|526589007|FG001|Overall Study|Death in family|1|||
146021326|NCT02136680|526589011|FG000|Overall Study|No Longer Interested|1|||
146021327|NCT02136680|526589012|FG001|Overall Study|No Longer Interested|1|||
146021328|NCT02136680|526589011|FG000|Overall Study|No longer receiving care at clinic|3|||
146021329|NCT02136680|526589012|FG001|Overall Study|No longer receiving care at clinic|5|||
146021330|NCT02136680|526589011|FG000|Overall Study|Moved away|5|||
146021331|NCT02136680|526589012|FG001|Overall Study|Moved away|4|||
146021332|NCT02136680|526589011|FG000|Overall Study|Unable to schedule|17|||
146021333|NCT02136680|526589012|FG001|Overall Study|Unable to schedule|16|||
146021334|NCT02136680|526589011|FG000|Overall Study|Study ended before interview due|6|||
146021335|NCT02136680|526589012|FG001|Overall Study|Study ended before interview due|3|||
146021336|NCT02825420|526589016|FG000|Overall Study|Death|30|||
146021337|NCT02825420|526589017|FG001|Overall Study|Death|12|||
146021338|NCT02825420|526589016|FG000|Overall Study|Progressive disease|6|||
146021339|NCT02825420|526589017|FG001|Overall Study|Progressive disease|1|||
146021340|NCT02825420|526589016|FG000|Overall Study|Lost to Follow-up|2|||
146021341|NCT02825420|526589017|FG001|Overall Study|Lost to Follow-up|2|||
146021342|NCT02825420|526589016|FG000|Overall Study|Withdrawal by Subject|1|||
146021343|NCT02825420|526589017|FG001|Overall Study|Withdrawal by Subject|1|||
146021344|NCT02825420|526589016|FG000|Overall Study|Protocol amendment not signed|1|||
146021345|NCT02825420|526589017|FG001|Overall Study|Protocol amendment not signed|1|||
146021346|NCT02825420|526589016|FG000|Overall Study|Physician Decision|1|||
146021347|NCT02825420|526589017|FG001|Overall Study|Physician Decision|0|||
146021348|NCT02825420|526589016|FG000|Overall Study|Did not receive PLD|2|||
146021349|NCT02825420|526589017|FG001|Overall Study|Did not receive PLD|0|||
146021350|NCT05243745|526591056|FG000|Overall Study|Withdrawal by Subject|0|||
146021351|NCT05243745|526591057|FG001|Overall Study|Withdrawal by Subject|0|||
146021352|NCT05243745|526591058|FG002|Overall Study|Withdrawal by Subject|0|||
146021353|NCT05243745|526591059|FG003|Overall Study|Withdrawal by Subject|1|||
146021354|NCT05243745|526591056|FG000|Overall Study|Unable to Attend Visit 6|0|||
146021355|NCT05243745|526591057|FG001|Overall Study|Unable to Attend Visit 6|0|||
146021356|NCT05243745|526591058|FG002|Overall Study|Unable to Attend Visit 6|1|||
146021357|NCT05243745|526591059|FG003|Overall Study|Unable to Attend Visit 6|0|||
146021358|NCT02998203|526591060|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
146021359|NCT02998203|526591061|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
146021360|NCT02998203|526591060|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
146021361|NCT02998203|526591061|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
146021362|NCT03842969|526591072|FG000|Overall Study|Participant declined follow-up visit|0|||
146021363|NCT03842969|526591073|FG001|Overall Study|Participant declined follow-up visit|1|||
146021364|NCT03842969|526591074|FG002|Overall Study|Participant declined follow-up visit|0|||
146021365|NCT03842969|526591072|FG000|Overall Study|Sponsor's decision|12|||
146021366|NCT03842969|526591073|FG001|Overall Study|Sponsor's decision|99|||
146021367|NCT03842969|526591074|FG002|Overall Study|Sponsor's decision|61|||
146021368|NCT03842969|526591072|FG000|Overall Study|Pregnancy|0|||
146021369|NCT03842969|526591073|FG001|Overall Study|Pregnancy|0|||
146021370|NCT03842969|526591074|FG002|Overall Study|Pregnancy|1|||
146021371|NCT03842969|526591072|FG000|Overall Study|Death|1|||
146021372|NCT03842969|526591073|FG001|Overall Study|Death|0|||
146021373|NCT03842969|526591074|FG002|Overall Study|Death|1|||
146021374|NCT03842969|526591072|FG000|Overall Study|Withdrawal by Subject|3|||
146021375|NCT03842969|526591073|FG001|Overall Study|Withdrawal by Subject|30|||
146021376|NCT03842969|526591074|FG002|Overall Study|Withdrawal by Subject|18|||
146021377|NCT03842969|526591072|FG000|Overall Study|Protocol Violation|1|||
146021378|NCT03842969|526591073|FG001|Overall Study|Protocol Violation|1|||
146021379|NCT03842969|526591074|FG002|Overall Study|Protocol Violation|0|||
146021380|NCT03842969|526591072|FG000|Overall Study|Physician Decision|0|||
146021381|NCT03842969|526591073|FG001|Overall Study|Physician Decision|3|||
146021382|NCT03842969|526591074|FG002|Overall Study|Physician Decision|0|||
146021383|NCT03842969|526591072|FG000|Overall Study|Lost to Follow-up|0|||
146021384|NCT03842969|526591073|FG001|Overall Study|Lost to Follow-up|2|||
146021385|NCT03842969|526591074|FG002|Overall Study|Lost to Follow-up|0|||
146021386|NCT03842969|526591072|FG000|Overall Study|Adverse Event|0|||
146021387|NCT03842969|526591073|FG001|Overall Study|Adverse Event|2|||
146021388|NCT03842969|526591074|FG002|Overall Study|Adverse Event|0|||
146021389|NCT04187144|526591075|FG000|Overall Study|Lost to Follow-up|12|||
146021390|NCT04187144|526591076|FG001|Overall Study|Lost to Follow-up|11|||
146021391|NCT04187144|526591075|FG000|Overall Study|Withdrawal by Subject|20|||
146021392|NCT04187144|526591076|FG001|Overall Study|Withdrawal by Subject|18|||
146021393|NCT04187144|526591075|FG000|Overall Study|Adverse Event|19|||
146021394|NCT04187144|526591076|FG001|Overall Study|Adverse Event|4|||
146021395|NCT04187144|526591075|FG000|Overall Study|Physician Decision|5|||
146021396|NCT04187144|526591076|FG001|Overall Study|Physician Decision|3|||
146021397|NCT04187144|526591075|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
146021398|NCT04187144|526591076|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
146021399|NCT04187144|526591075|FG000|Overall Study|Protocol Deviation|1|||
146021400|NCT04187144|526591076|FG001|Overall Study|Protocol Deviation|4|||
146021401|NCT02264665|526591079|FG000|Overall Study|Other|0|||
146021402|NCT02264665|526591080|FG001|Overall Study|Other|0|||
146021403|NCT02264665|526591081|FG002|Overall Study|Other|3|||
146021404|NCT02264665|526591082|FG003|Overall Study|Other|0|||
146021405|NCT02264665|526591083|FG004|Overall Study|Other|0|||
146021406|NCT02264665|526591084|FG005|Overall Study|Other|0|||
146021407|NCT02264665|526591085|FG006|Overall Study|Other|0|||
146021408|NCT02264665|526591079|FG000|Overall Study|Death|9|||
146021409|NCT02264665|526591080|FG001|Overall Study|Death|8|||
146021410|NCT02264665|526591081|FG002|Overall Study|Death|13|||
146021411|NCT02264665|526591082|FG003|Overall Study|Death|5|||
146021412|NCT02264665|526591083|FG004|Overall Study|Death|0|||
146021413|NCT02264665|526591084|FG005|Overall Study|Death|0|||
146021414|NCT02264665|526591085|FG006|Overall Study|Death|1|||
146021415|NCT02264665|526591079|FG000|Overall Study|Lost to Follow-up|1|||
146021416|NCT02264665|526591080|FG001|Overall Study|Lost to Follow-up|0|||
146021417|NCT02264665|526591081|FG002|Overall Study|Lost to Follow-up|2|||
146021418|NCT02264665|526591082|FG003|Overall Study|Lost to Follow-up|1|||
146021419|NCT02264665|526591083|FG004|Overall Study|Lost to Follow-up|0|||
146021420|NCT02264665|526591084|FG005|Overall Study|Lost to Follow-up|0|||
146021421|NCT02264665|526591085|FG006|Overall Study|Lost to Follow-up|0|||
146021422|NCT02264665|526591079|FG000|Overall Study|Participant decision|0|||
146021423|NCT02264665|526591080|FG001|Overall Study|Participant decision|0|||
146021424|NCT02264665|526591081|FG002|Overall Study|Participant decision|0|||
146021425|NCT02264665|526591082|FG003|Overall Study|Participant decision|1|||
146021426|NCT02264665|526591083|FG004|Overall Study|Participant decision|0|||
146021427|NCT02264665|526591084|FG005|Overall Study|Participant decision|0|||
146021428|NCT02264665|526591085|FG006|Overall Study|Participant decision|0|||
146021429|NCT02264665|526591079|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
146021430|NCT02264665|526591080|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146021431|NCT02264665|526591081|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146021432|NCT02264665|526591082|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146021433|NCT02264665|526591083|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146021434|NCT02264665|526591084|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
146021435|NCT02264665|526591085|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
146021436|NCT02264665|526591079|FG000|Overall Study|Data Missing|0|||
146021437|NCT02264665|526591080|FG001|Overall Study|Data Missing|0|||
146021438|NCT02264665|526591081|FG002|Overall Study|Data Missing|1|||
146021439|NCT02264665|526591082|FG003|Overall Study|Data Missing|0|||
146021440|NCT02264665|526591083|FG004|Overall Study|Data Missing|0|||
146021441|NCT02264665|526591084|FG005|Overall Study|Data Missing|0|||
146021442|NCT02264665|526591085|FG006|Overall Study|Data Missing|0|||
146021443|NCT00789581|526591086|FG000|AC Therapy|Adverse Event|2|||
146021444|NCT00789581|526591087|FG001|AC Therapy|Adverse Event|3|||
146021445|NCT00789581|526591086|FG000|AC Therapy|Withdrawal by Subject|4|||
146021446|NCT00789581|526591087|FG001|AC Therapy|Withdrawal by Subject|7|||
146021447|NCT00789581|526591086|FG000|AC Therapy|Disease recurrence|3|||
146021448|NCT00789581|526591087|FG001|AC Therapy|Disease recurrence|1|||
146021449|NCT00789581|526591086|FG000|AC Therapy|Intercurrent Illness|1|||
146021450|NCT00789581|526591087|FG001|AC Therapy|Intercurrent Illness|0|||
146021451|NCT00789581|526591086|FG000|AC Therapy|Never Treated|1|||
146021452|NCT00789581|526591087|FG001|AC Therapy|Never Treated|4|||
146021453|NCT00789581|526591086|FG000|AC Therapy|Other|0|||
146021454|NCT00789581|526591087|FG001|AC Therapy|Other|2|||
146021455|NCT00789581|526591086|FG000|Adjuvant Therapy|Never treated|2|||
146021456|NCT00789581|526591087|FG001|Adjuvant Therapy|Never treated|2|||
146021457|NCT00789581|526591086|FG000|Adjuvant Therapy|Adverse Event|20|||
146021458|NCT00789581|526591087|FG001|Adjuvant Therapy|Adverse Event|44|||
146021459|NCT00789581|526591086|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
146021460|NCT00789581|526591087|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
146021461|NCT00789581|526591086|FG000|Adjuvant Therapy|Disease recurrence|2|||
146021462|NCT00789581|526591087|FG001|Adjuvant Therapy|Disease recurrence|1|||
146021463|NCT00789581|526591086|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
146021464|NCT00789581|526591087|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
146021465|NCT00789581|526591086|FG000|Adjuvant Therapy|Protocol Violation|1|||
146021466|NCT00789581|526591087|FG001|Adjuvant Therapy|Protocol Violation|1|||
146021467|NCT00789581|526591086|FG000|Adjuvant Therapy|Other|0|||
146021468|NCT00789581|526591087|FG001|Adjuvant Therapy|Other|1|||
146252666|NCT01446042|527436987|FG000|Overall Study|Lost to Follow-up|5|||
146252667|NCT01446042|527436988|FG001|Overall Study|Lost to Follow-up|0|||
146252668|NCT01446042|527436989|FG002|Overall Study|Lost to Follow-up|0|||
146252669|NCT01446042|527436987|FG000|Overall Study|Other reasons|2|||
146021469|NCT01468207|526591088|FG000|Treatment Period 1|Adverse Event|1|||
146021470|NCT01468207|526591089|FG001|Treatment Period 1|Adverse Event|0|||
146021471|NCT01468207|526591090|FG002|Treatment Period 1|Adverse Event|0|||
146021472|NCT01468207|526591091|FG003|Treatment Period 1|Adverse Event|0|||
146021473|NCT01468207|526591092|FG004|Treatment Period 1|Adverse Event|0|||
146021474|NCT01468207|526591093|FG005|Treatment Period 1|Adverse Event|0|||
146021475|NCT01468207|526591088|FG000|Treatment Period 1|Protocol Violation|1|||
146021476|NCT01468207|526591089|FG001|Treatment Period 1|Protocol Violation|1|||
146021477|NCT01468207|526591090|FG002|Treatment Period 1|Protocol Violation|0|||
146021478|NCT01468207|526591091|FG003|Treatment Period 1|Protocol Violation|0|||
146021479|NCT01468207|526591092|FG004|Treatment Period 1|Protocol Violation|0|||
146021480|NCT01468207|526591093|FG005|Treatment Period 1|Protocol Violation|0|||
146021481|NCT01468207|526591088|FG000|Treatment Period 1|Withdrawal by Subject|5|||
146021482|NCT01468207|526591089|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146021483|NCT01468207|526591090|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146021484|NCT01468207|526591091|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146021485|NCT01468207|526591092|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146021486|NCT01468207|526591093|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146021487|NCT01468207|526591088|FG000|Treatment Period 1|Lost to Follow-up|2|||
146021488|NCT01468207|526591089|FG001|Treatment Period 1|Lost to Follow-up|1|||
146021489|NCT01468207|526591090|FG002|Treatment Period 1|Lost to Follow-up|0|||
146021490|NCT01468207|526591091|FG003|Treatment Period 1|Lost to Follow-up|0|||
146021491|NCT01468207|526591092|FG004|Treatment Period 1|Lost to Follow-up|0|||
146021492|NCT01468207|526591093|FG005|Treatment Period 1|Lost to Follow-up|0|||
146021493|NCT01468207|526591088|FG000|Treatment Period 1|Other|0|||
146021494|NCT01468207|526591089|FG001|Treatment Period 1|Other|2|||
146021495|NCT01468207|526591090|FG002|Treatment Period 1|Other|0|||
146021496|NCT01468207|526591091|FG003|Treatment Period 1|Other|0|||
146021497|NCT01468207|526591092|FG004|Treatment Period 1|Other|0|||
146021498|NCT01468207|526591093|FG005|Treatment Period 1|Other|0|||
146021499|NCT01468207|526591088|FG000|Treatment Period 2|Adverse Event|0|||
146021500|NCT01468207|526591089|FG001|Treatment Period 2|Adverse Event|0|||
146021501|NCT01468207|526591090|FG002|Treatment Period 2|Adverse Event|6|||
146021502|NCT01468207|526591091|FG003|Treatment Period 2|Adverse Event|1|||
146021503|NCT01468207|526591092|FG004|Treatment Period 2|Adverse Event|2|||
146021504|NCT01468207|526591093|FG005|Treatment Period 2|Adverse Event|1|||
146021505|NCT01468207|526591088|FG000|Treatment Period 2|Lack of Efficacy|0|||
146021506|NCT01468207|526591089|FG001|Treatment Period 2|Lack of Efficacy|0|||
146252670|NCT01446042|527436988|FG001|Overall Study|Other reasons|1|||
146252671|NCT01446042|527436989|FG002|Overall Study|Other reasons|1|||
146252672|NCT03906240|527436990|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
146252673|NCT03906240|527436991|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
146252674|NCT03906240|527436990|FG000|Overall Study|Lost to Follow-up|1|||
146252675|NCT03906240|527436991|FG001|Overall Study|Lost to Follow-up|0|||
146252676|NCT03906240|527436990|FG000|Overall Study|Withdrawal by Subject|0|||
146021507|NCT01468207|526591090|FG002|Treatment Period 2|Lack of Efficacy|1|||
146021508|NCT01468207|526591091|FG003|Treatment Period 2|Lack of Efficacy|1|||
146021509|NCT01468207|526591092|FG004|Treatment Period 2|Lack of Efficacy|0|||
146021510|NCT01468207|526591093|FG005|Treatment Period 2|Lack of Efficacy|2|||
146021511|NCT01468207|526591088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146252677|NCT03906240|527436991|FG001|Overall Study|Withdrawal by Subject|1|||
146252678|NCT05287178|527437009|FG000|Overall Study|Lost to Follow-up|2|||
146252679|NCT01426217|527437010|FG000|Overall Study|lost sample|8|||
146252680|NCT01426217|527437011|FG001|Overall Study|lost sample|14|||
146021512|NCT01468207|526591089|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146021513|NCT01468207|526591090|FG002|Treatment Period 2|Withdrawal by Subject|5|||
146021514|NCT01468207|526591091|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146021515|NCT01468207|526591092|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146021516|NCT01468207|526591093|FG005|Treatment Period 2|Withdrawal by Subject|2|||
146021517|NCT01468207|526591088|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
146021518|NCT01468207|526591089|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
146021519|NCT01468207|526591090|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
146021520|NCT01468207|526591091|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
146021521|NCT01468207|526591092|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
146252681|NCT01648699|527437012|FG000|Overall Study|Death|1|||
146021522|NCT01468207|526591093|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
146021523|NCT01468207|526591088|FG000|Treatment Period 2|Lost to Follow-up|0|||
146021524|NCT01468207|526591089|FG001|Treatment Period 2|Lost to Follow-up|0|||
146021525|NCT01468207|526591090|FG002|Treatment Period 2|Lost to Follow-up|5|||
146021526|NCT01468207|526591091|FG003|Treatment Period 2|Lost to Follow-up|1|||
146021527|NCT01468207|526591092|FG004|Treatment Period 2|Lost to Follow-up|0|||
146021528|NCT01468207|526591093|FG005|Treatment Period 2|Lost to Follow-up|0|||
146021529|NCT01468207|526591088|FG000|Treatment Period 2|Other|0|||
146021530|NCT01468207|526591089|FG001|Treatment Period 2|Other|0|||
146021531|NCT01468207|526591090|FG002|Treatment Period 2|Other|5|||
146021532|NCT01468207|526591091|FG003|Treatment Period 2|Other|1|||
146021533|NCT01468207|526591092|FG004|Treatment Period 2|Other|1|||
146021534|NCT01468207|526591093|FG005|Treatment Period 2|Other|2|||
146021535|NCT04225676|526591100|FG000|Overall Study|Physician Decision|1|||
146021536|NCT04225676|526591100|FG000|Overall Study|Lack of Efficacy|1|||
146021537|NCT04225676|526591100|FG000|Overall Study|Study terminated by sponsor|3|||
146021538|NCT03812185|526591107|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
146021539|NCT04085458|526591108|FG000|Overall Study|Other|1|||
146021540|NCT04085458|526591108|FG000|Overall Study|Withdrawal by Subject|2|||
146021541|NCT04085458|526591108|FG000|Overall Study|Adverse Event|2|||
146021542|NCT01921218|526591109|FG000|Overall Study|Death|2|||
146021543|NCT01921218|526591110|FG001|Overall Study|Death|1|||
146021544|NCT01921218|526591109|FG000|Overall Study|Withdrawal by Subject|0|||
146021545|NCT01921218|526591110|FG001|Overall Study|Withdrawal by Subject|2|||
146021546|NCT01921218|526591109|FG000|Overall Study|Kidney transplant|1|||
146021547|NCT01921218|526591110|FG001|Overall Study|Kidney transplant|1|||
146021548|NCT03389555|526591111|FG000|Overall Study|Protocol Violation|1|||
146021549|NCT03389555|526591112|FG001|Overall Study|Protocol Violation|3|||
146021550|NCT03389555|526591111|FG000|Overall Study|Death|1|||
146021551|NCT03389555|526591112|FG001|Overall Study|Death|0|||
146021552|NCT01885208|526591113|FG000|Overall Study|Unclassified|32|||
146021553|NCT01885208|526591114|FG001|Overall Study|Unclassified|38|||
146021554|NCT03224507|526591118|FG000|Overall Study|Death|3|||
146021555|NCT03224507|526591119|FG001|Overall Study|Death|0|||
146021556|NCT03224507|526591118|FG000|Overall Study|Lack of Efficacy|6|||
146021557|NCT03224507|526591119|FG001|Overall Study|Lack of Efficacy|0|||
146021558|NCT03224507|526591118|FG000|Overall Study|Withdrawal by Subject|6|||
146021559|NCT03224507|526591119|FG001|Overall Study|Withdrawal by Subject|0|||
146021560|NCT01032291|526591120|FG000|Safety Lead-in|Adverse Event|1|||
146021561|NCT01032291|526591121|FG001|Safety Lead-in|Adverse Event|0|||
146021562|NCT01032291|526591122|FG002|Safety Lead-in|Adverse Event|0|||
146021563|NCT01032291|526591120|FG000|Safety Lead-in|Death|1|||
146021564|NCT01032291|526591121|FG001|Safety Lead-in|Death|0|||
146021565|NCT01032291|526591122|FG002|Safety Lead-in|Death|0|||
146021566|NCT01032291|526591120|FG000|Proof of Concept|Adverse Event|0|||
146021567|NCT01032291|526591121|FG001|Proof of Concept|Adverse Event|5|||
146021568|NCT01032291|526591122|FG002|Proof of Concept|Adverse Event|1|||
146021569|NCT01032291|526591120|FG000|Proof of Concept|Death|0|||
146021570|NCT01032291|526591121|FG001|Proof of Concept|Death|1|||
146021571|NCT01032291|526591122|FG002|Proof of Concept|Death|2|||
146021572|NCT01032291|526591120|FG000|Proof of Concept|Lack of Efficacy|0|||
146021573|NCT01032291|526591121|FG001|Proof of Concept|Lack of Efficacy|1|||
146021574|NCT01032291|526591122|FG002|Proof of Concept|Lack of Efficacy|0|||
146021575|NCT01032291|526591120|FG000|Proof of Concept|Never Received Study Drug|0|||
146021576|NCT01032291|526591121|FG001|Proof of Concept|Never Received Study Drug|1|||
146021577|NCT01032291|526591122|FG002|Proof of Concept|Never Received Study Drug|0|||
146021578|NCT02449889|526591123|FG000|Overall Study|Adverse Event|1|||
146021579|NCT02449889|526591124|FG001|Overall Study|Adverse Event|2|||
146021580|NCT02449889|526591125|FG002|Overall Study|Adverse Event|0|||
146021581|NCT02449889|526591123|FG000|Overall Study|Protocol Violation|0|||
146021582|NCT02449889|526591124|FG001|Overall Study|Protocol Violation|4|||
146021583|NCT02449889|526591125|FG002|Overall Study|Protocol Violation|1|||
146021584|NCT01973387|526591126|FG000|Overall Study|Adverse Event|14|||
146021585|NCT01973387|526591127|FG001|Overall Study|Adverse Event|4|||
146021586|NCT01973387|526591126|FG000|Overall Study|Withdrawal by Subject|7|||
146021587|NCT01973387|526591127|FG001|Overall Study|Withdrawal by Subject|4|||
146021588|NCT01973387|526591126|FG000|Overall Study|Study terminated by sponsor|63|||
146021589|NCT01973387|526591127|FG001|Overall Study|Study terminated by sponsor|0|||
146021590|NCT01973387|526591126|FG000|Overall Study|Progressive disease or relapse|16|||
146021591|NCT01973387|526591127|FG001|Overall Study|Progressive disease or relapse|5|||
146021592|NCT01973387|526591126|FG000|Overall Study|Death|4|||
146021593|NCT01973387|526591127|FG001|Overall Study|Death|3|||
146021594|NCT01973387|526591126|FG000|Overall Study|Randomized, not treated|2|||
146021595|NCT01973387|526591127|FG001|Overall Study|Randomized, not treated|2|||
146021596|NCT03327220|526591128|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
146021597|NCT03327220|526591129|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
146021598|NCT03327220|526591128|FG000|Overall Study|Investigator Decision|2|||
146021599|NCT03327220|526591129|FG001|Overall Study|Investigator Decision|0|||
146021600|NCT03327220|526591128|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
146021601|NCT03327220|526591129|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
146021602|NCT03327220|526591128|FG000|Overall Study|Fungal infection|1|||
146021603|NCT03327220|526591129|FG001|Overall Study|Fungal infection|0|||
146021604|NCT03327220|526591128|FG000|Overall Study|Discharged to Rehabilitation|0|||
146021605|NCT03327220|526591129|FG001|Overall Study|Discharged to Rehabilitation|1|||
146021606|NCT03327220|526591128|FG000|Overall Study|Missing|1|||
146021607|NCT03327220|526591129|FG001|Overall Study|Missing|0|||
146021608|NCT00693017|526591130|FG000|Overall Study|Sponsor Decision|2|||
146021609|NCT00693017|526591131|FG001|Overall Study|Sponsor Decision|1|||
146021610|NCT00693017|526591130|FG000|Overall Study|Death|0|||
146021611|NCT00693017|526591131|FG001|Overall Study|Death|1|||
146021612|NCT00688324|526591133|FG000|Overall Study|Withdrawal by Subject|2|||
146021613|NCT00688324|526591133|FG000|Overall Study|Physician Decision|5|||
146021614|NCT00688324|526591133|FG000|Overall Study|Lost to Follow-up|1|||
146021615|NCT03272828|526591136|FG000|Overall Study|Lost to Follow-up|7|||
146021616|NCT03272828|526591137|FG001|Overall Study|Lost to Follow-up|7|||
146021617|NCT03272828|526591136|FG000|Overall Study|Withdrawal by Subject|2|||
146021618|NCT03272828|526591137|FG001|Overall Study|Withdrawal by Subject|0|||
146021619|NCT03272828|526591136|FG000|Overall Study|Deceased|1|||
146021620|NCT03272828|526591137|FG001|Overall Study|Deceased|1|||
146021621|NCT03272828|526591136|FG000|Overall Study|Failed implant|1|||
146021622|NCT03272828|526591137|FG001|Overall Study|Failed implant|2|||
146021623|NCT03176472|526591138|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
146021624|NCT03176472|526591139|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
146021625|NCT03176472|526591138|FG000|Double Blind Treatment Period|Adverse Event|0|||
146021626|NCT03176472|526591139|FG001|Double Blind Treatment Period|Adverse Event|5|||
146021627|NCT03176472|526591138|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
146021628|NCT03176472|526591139|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146021629|NCT03176472|526591138|FG000|Double Blind Treatment Period|Physician Decision|0|||
146021630|NCT03176472|526591139|FG001|Double Blind Treatment Period|Physician Decision|1|||
146021631|NCT03176472|526591138|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146021632|NCT03176472|526591139|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146021633|NCT03176472|526591138|FG000|Double Blind Treatment Period|Not Provided|1|||
146021634|NCT03176472|526591139|FG001|Double Blind Treatment Period|Not Provided|0|||
146021635|NCT03176472|526591138|FG000|Open Label Extension|Withdrawal by Subject|3|||
146021636|NCT03176472|526591139|FG001|Open Label Extension|Withdrawal by Subject|4|||
146021637|NCT03176472|526591138|FG000|Open Label Extension|Adverse Event|2|||
146021638|NCT03176472|526591139|FG001|Open Label Extension|Adverse Event|4|||
146021639|NCT03176472|526591138|FG000|Open Label Extension|Lost to Follow-up|1|||
146021640|NCT03176472|526591139|FG001|Open Label Extension|Lost to Follow-up|2|||
146021641|NCT03176472|526591138|FG000|Open Label Extension|Protocol Violation|0|||
146021642|NCT03176472|526591139|FG001|Open Label Extension|Protocol Violation|1|||
146021643|NCT03176472|526591138|FG000|Open Label Extension|Not Provided|2|||
146021644|NCT03176472|526591139|FG001|Open Label Extension|Not Provided|1|||
146021645|NCT03077438|526591140|FG000|Overall Study|Protocol Violation|3|||
146021646|NCT03077438|526591141|FG001|Overall Study|Protocol Violation|5|||
146021647|NCT03077438|526591140|FG000|Overall Study|Withdrawal by Subject|3|||
146021648|NCT03077438|526591141|FG001|Overall Study|Withdrawal by Subject|6|||
146021649|NCT03077438|526591140|FG000|Overall Study|Lost to Follow-up|6|||
146021650|NCT03077438|526591141|FG001|Overall Study|Lost to Follow-up|3|||
146021651|NCT04154345|526591146|FG000|Overall Study|Covid-19 pandemic|4|||
146021652|NCT04686084|526591148|FG000|Overall Study|Lost to Follow-up|1|||
146021653|NCT00676520|526591153|FG000|Overall Study|Withdrawal by Subject|163|||
146021654|NCT00676520|526591153|FG000|Overall Study|Lost to Follow-up|162|||
146021655|NCT00676520|526591153|FG000|Overall Study|Death|159|||
146021656|NCT00676520|526591153|FG000|Overall Study|Physician Decision|20|||
146021657|NCT00676520|526591153|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
146021658|NCT00676520|526591153|FG000|Overall Study|Other Reason|18|||
146021659|NCT04043234|526591154|FG000|Overall Study|Lost to Follow-up|1|||
146021660|NCT04043234|526591154|FG000|Overall Study|Withdrawal by Subject|1|||
146021661|NCT00866047|526591156|FG000|Treatment Period|Progressive disease|13|||
146021662|NCT00866047|526591156|FG000|Treatment Period|Adverse Event|16|||
146021663|NCT00866047|526591156|FG000|Treatment Period|Physician Decision|14|||
146021664|NCT00866047|526591156|FG000|Treatment Period|Withdrawal by Subject|5|||
146021665|NCT00866047|526591156|FG000|Follow-up Period|Lost to Follow-up|5|||
146021666|NCT03773133|526591157|FG000|Overall Study|Screen Failure|8|||
146021667|NCT04730635|526591158|FG000|Overall Study|Lost to Follow-up|1|||
146021668|NCT04730635|526591159|FG001|Overall Study|Lost to Follow-up|0|||
146021669|NCT04730635|526591158|FG000|Overall Study|Withdrawal by Subject|0|||
146021670|NCT04730635|526591159|FG001|Overall Study|Withdrawal by Subject|1|||
146021671|NCT03070223|526591160|FG000|Overall Study|Lost to Follow-up|34|||
146252682|NCT01648699|527437012|FG000|Overall Study|Lost to Follow-up|2|||
146021672|NCT03070223|526591161|FG001|Overall Study|Lost to Follow-up|27|||
146021673|NCT03070223|526591160|FG000|Overall Study|Withdrawal by Subject|12|||
146021674|NCT03070223|526591161|FG001|Overall Study|Withdrawal by Subject|22|||
146021675|NCT03070223|526591160|FG000|Overall Study|Protocol Violation|0|||
146021676|NCT03070223|526591161|FG001|Overall Study|Protocol Violation|1|||
146252683|NCT01648699|527437012|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
146252684|NCT00288353|527437013|FG000|Overall Study|Lack of Efficacy|2|||
146252685|NCT00288353|527437014|FG001|Overall Study|Lack of Efficacy|2|||
146252686|NCT00288353|527437013|FG000|Overall Study|Withdrawal by Subject|5|||
146252687|NCT00288353|527437014|FG001|Overall Study|Withdrawal by Subject|5|||
146252688|NCT00145496|527437024|FG000|Overall Study|Adverse Event|42|||
146252689|NCT00145496|527437025|FG001|Overall Study|Adverse Event|30|||
146252690|NCT00145496|527437024|FG000|Overall Study|Lack of Efficacy|12|||
146252691|NCT00145496|527437025|FG001|Overall Study|Lack of Efficacy|7|||
146252692|NCT00145496|527437024|FG000|Overall Study|Withdrawal by Subject|32|||
146252693|NCT00145496|527437025|FG001|Overall Study|Withdrawal by Subject|26|||
146252694|NCT00145496|527437024|FG000|Overall Study|Lost to Follow-up|12|||
146252695|NCT00145496|527437025|FG001|Overall Study|Lost to Follow-up|5|||
146252696|NCT00145496|527437024|FG000|Overall Study|Other|25|||
146252697|NCT00145496|527437025|FG001|Overall Study|Other|13|||
146252698|NCT03138499|527437027|FG000|Overall Study|Lost to Follow-up|1|||
146252699|NCT03138499|527437028|FG001|Overall Study|Lost to Follow-up|0|||
146252700|NCT03138499|527437027|FG000|Overall Study|Participants withdrew consent|1|||
146252701|NCT03138499|527437028|FG001|Overall Study|Participants withdrew consent|0|||
146252702|NCT03138499|527437027|FG000|Overall Study|Participant discontinued study before treatment|0|||
146252703|NCT03138499|527437028|FG001|Overall Study|Participant discontinued study before treatment|1|||
146252704|NCT03138499|527437027|FG000|Overall Study|Disease Progression|2|||
146252705|NCT03138499|527437028|FG001|Overall Study|Disease Progression|6|||
146252706|NCT03138499|527437027|FG000|Overall Study|Study drug toxicity|2|||
146252707|NCT03138499|527437028|FG001|Overall Study|Study drug toxicity|2|||
146252708|NCT03138499|527437027|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146252709|NCT03138499|527437028|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146252710|NCT03138499|527437027|FG000|Overall Study|Other reasons|2|||
146252711|NCT03138499|527437028|FG001|Overall Study|Other reasons|0|||
146252712|NCT01334606|527437029|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
146252713|NCT02312245|527437030|FG000|Overall Study|Death|0|||
146094259|NCT02310321|526866586|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
146094260|NCT01698905|526866587|FG000|Overall Study|Adverse Event|4|||
146094261|NCT01698905|526866587|FG000|Overall Study|Physician Decision|2|||
146094262|NCT01698905|526866587|FG000|Overall Study|Pregnancy|1|||
146094263|NCT01698905|526866587|FG000|Overall Study|Protocol Violation|1|||
146094264|NCT01698905|526866587|FG000|Overall Study|Subject/guardian decision|2|||
146252714|NCT02312245|527437031|FG001|Overall Study|Death|0|||
146252715|NCT02312245|527437032|FG002|Overall Study|Death|0|||
146252716|NCT02312245|527437033|FG003|Overall Study|Death|1|||
146252717|NCT02312245|527437030|FG000|Overall Study|Withdrawal by Subject|1|||
146252718|NCT02312245|527437031|FG001|Overall Study|Withdrawal by Subject|1|||
146252719|NCT02312245|527437032|FG002|Overall Study|Withdrawal by Subject|0|||
146252720|NCT02312245|527437033|FG003|Overall Study|Withdrawal by Subject|2|||
146252721|NCT02312245|527437030|FG000|Overall Study|Alternative Therapy|1|||
146252722|NCT02312245|527437031|FG001|Overall Study|Alternative Therapy|0|||
146252723|NCT02312245|527437032|FG002|Overall Study|Alternative Therapy|0|||
146252724|NCT02312245|527437033|FG003|Overall Study|Alternative Therapy|0|||
146252725|NCT02312245|527437030|FG000|Overall Study|Progression|0|||
146252726|NCT02312245|527437031|FG001|Overall Study|Progression|0|||
146252727|NCT02312245|527437032|FG002|Overall Study|Progression|0|||
146252728|NCT02312245|527437033|FG003|Overall Study|Progression|5|||
146252729|NCT02312245|527437030|FG000|Overall Study|Patient went to hospice|0|||
146252730|NCT02312245|527437031|FG001|Overall Study|Patient went to hospice|0|||
146252731|NCT02312245|527437032|FG002|Overall Study|Patient went to hospice|0|||
146252732|NCT02312245|527437033|FG003|Overall Study|Patient went to hospice|1|||
146252733|NCT02312245|527437030|FG000|Overall Study|Ineligible|1|||
146252734|NCT02312245|527437031|FG001|Overall Study|Ineligible|0|||
146252735|NCT02312245|527437032|FG002|Overall Study|Ineligible|0|||
146252736|NCT02312245|527437033|FG003|Overall Study|Ineligible|0|||
146252737|NCT00448344|527437034|FG000|Overall Study|Lost to Follow-up|20|||
146094265|NCT01698905|526866587|FG000|Overall Study|Death|1|||
146094266|NCT00764504|526866589|FG000|Overall Study|Death|12|||
146094267|NCT00764504|526866590|FG001|Overall Study|Death|6|||
146094268|NCT00764504|526866591|FG002|Overall Study|Death|13|||
146094269|NCT00764504|526866589|FG000|Overall Study|Revision of Device|12|||
146094270|NCT00764504|526866590|FG001|Overall Study|Revision of Device|23|||
146252738|NCT00448344|527437035|FG001|Overall Study|Lost to Follow-up|22|||
146252739|NCT00448344|527437034|FG000|Overall Study|Withdrawal by Subject|6|||
146252740|NCT00448344|527437035|FG001|Overall Study|Withdrawal by Subject|8|||
146252741|NCT00448344|527437034|FG000|Overall Study|Death|3|||
146252742|NCT00448344|527437035|FG001|Overall Study|Death|4|||
146252743|NCT00448344|527437034|FG000|Overall Study|Physician Decision|1|||
146252744|NCT00448344|527437035|FG001|Overall Study|Physician Decision|2|||
146252745|NCT01123200|527437039|FG000|Overall Study|Withdrawal by Subject|1|||
146252746|NCT01232569|527438885|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
146252747|NCT01232569|527438886|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146252748|NCT01232569|527438887|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146252749|NCT01232569|527438888|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
146252750|NCT01232569|527438885|FG000|Double-blind Treatment Period|Escape|2|||
146252751|NCT01232569|527438886|FG001|Double-blind Treatment Period|Escape|2|||
146252752|NCT01232569|527438887|FG002|Double-blind Treatment Period|Escape|0|||
146252753|NCT01232569|527438888|FG003|Double-blind Treatment Period|Escape|0|||
146252754|NCT01232569|527438885|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
146252755|NCT01232569|527438886|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146252756|NCT01232569|527438887|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146252757|NCT01232569|527438888|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
146252758|NCT01232569|527438885|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146252759|NCT01232569|527438886|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
146252760|NCT01232569|527438887|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
146252761|NCT01232569|527438888|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
146252762|NCT01232569|527438885|FG000|Double-blind Treatment Period|Physician Decision|1|||
146252763|NCT01232569|527438886|FG001|Double-blind Treatment Period|Physician Decision|0|||
146252764|NCT01232569|527438887|FG002|Double-blind Treatment Period|Physician Decision|0|||
146252765|NCT01232569|527438888|FG003|Double-blind Treatment Period|Physician Decision|0|||
146252766|NCT01232569|527438885|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
146252767|NCT01232569|527438886|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
146252768|NCT01232569|527438887|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
146252769|NCT01232569|527438888|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
146252770|NCT01232569|527438885|FG000|Double-blind Treatment Period|Death|2|||
146021677|NCT04934800|526591162|FG000|Overall Study|Other|1|||
146021678|NCT04934800|526591162|FG000|Overall Study|Withdrawal by Subject|5|||
146021679|NCT04934800|526591162|FG000|Overall Study|Lack of Efficacy|1|||
146021680|NCT04934800|526591162|FG000|Overall Study|Adverse Event|9|||
146021681|NCT04934800|526591162|FG000|Overall Study|Lost to Follow-up|5|||
146021682|NCT04934800|526591162|FG000|Overall Study|Enrolled but not treated|1|||
146021683|NCT00516906|526591163|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
146021684|NCT00516906|526591164|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
146021685|NCT02684058|526591172|FG000|Treatment Period|Progressive disease|4|||
146021686|NCT02684058|526591173|FG001|Treatment Period|Progressive disease|10|||
146021687|NCT02684058|526591174|FG002|Treatment Period|Progressive disease|19|||
146021688|NCT02684058|526591172|FG000|Treatment Period|Adverse Event|3|||
146021689|NCT02684058|526591173|FG001|Treatment Period|Adverse Event|8|||
146021690|NCT02684058|526591174|FG002|Treatment Period|Adverse Event|1|||
146021691|NCT02684058|526591172|FG000|Treatment Period|Physician Decision|5|||
146021692|NCT02684058|526591173|FG001|Treatment Period|Physician Decision|1|||
146021693|NCT02684058|526591174|FG002|Treatment Period|Physician Decision|2|||
146021694|NCT02684058|526591172|FG000|Treatment Period|New therapy for study indication|1|||
146021695|NCT02684058|526591173|FG001|Treatment Period|New therapy for study indication|0|||
146021696|NCT02684058|526591174|FG002|Treatment Period|New therapy for study indication|0|||
146021697|NCT02684058|526591172|FG000|Treatment Period|Protocol deviation|0|||
146021698|NCT02684058|526591173|FG001|Treatment Period|Protocol deviation|1|||
146021699|NCT02684058|526591174|FG002|Treatment Period|Protocol deviation|0|||
146021700|NCT02684058|526591172|FG000|Treatment Period|Subject/guardian decision|4|||
146021701|NCT02684058|526591173|FG001|Treatment Period|Subject/guardian decision|3|||
146021702|NCT02684058|526591174|FG002|Treatment Period|Subject/guardian decision|0|||
146021703|NCT02684058|526591172|FG000|Treatment Period|Death|0|||
146021704|NCT02684058|526591173|FG001|Treatment Period|Death|0|||
146021705|NCT02684058|526591174|FG002|Treatment Period|Death|2|||
146021706|NCT02684058|526591172|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
146021707|NCT02684058|526591173|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
146021708|NCT02684058|526591174|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
146021709|NCT02684058|526591172|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
146021710|NCT02684058|526591173|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
146021711|NCT02684058|526591174|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
146021712|NCT02684058|526591172|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146021713|NCT02684058|526591173|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
146021714|NCT02684058|526591174|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
146252771|NCT01232569|527438886|FG001|Double-blind Treatment Period|Death|0|||
146252772|NCT01232569|527438887|FG002|Double-blind Treatment Period|Death|0|||
146252773|NCT01232569|527438888|FG003|Double-blind Treatment Period|Death|0|||
146300268|NCT03681951|527615193|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146021715|NCT02684058|526591172|FG000|Post-treatment Efficacy Follow-up|Death|0|||
146021716|NCT02684058|526591173|FG001|Post-treatment Efficacy Follow-up|Death|0|||
146021717|NCT02684058|526591174|FG002|Post-treatment Efficacy Follow-up|Death|3|||
146021718|NCT02684058|526591172|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
146021719|NCT02684058|526591173|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
146252774|NCT01537120|527438896|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
146252775|NCT01537120|527438896|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
146021720|NCT02684058|526591174|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
146021721|NCT02684058|526591172|FG000|Post-treatment Survival Follow-up|Death|0|||
146021722|NCT02684058|526591173|FG001|Post-treatment Survival Follow-up|Death|0|||
146021723|NCT02684058|526591174|FG002|Post-treatment Survival Follow-up|Death|7|||
146021724|NCT02684058|526591172|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
146021725|NCT02684058|526591173|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
146021726|NCT02684058|526591174|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
146021727|NCT02684058|526591172|FG000|Crossover Treatment Period|Progressive disease|0|||
146021728|NCT02684058|526591173|FG001|Crossover Treatment Period|Progressive disease|1|||
146021729|NCT02684058|526591174|FG002|Crossover Treatment Period|Progressive disease|0|||
146021730|NCT00721578|526591175|FG000|Overall Study|Death|1|||
146021731|NCT00721578|526591176|FG001|Overall Study|Death|1|||
146021732|NCT00721578|526591175|FG000|Overall Study|Withdrawal by Subject|1|||
146021733|NCT00721578|526591176|FG001|Overall Study|Withdrawal by Subject|1|||
146021734|NCT05032690|526591185|FG000|Period 1|Adverse Event|0|||
146021735|NCT05032690|526591186|FG001|Period 1|Adverse Event|1|||
146021736|NCT05032690|526591187|FG002|Period 1|Adverse Event|0|||
146094271|NCT00764504|526866591|FG002|Overall Study|Revision of Device|14|||
146094272|NCT00764504|526866589|FG000|Overall Study|Physician Decision|1|||
146094273|NCT00764504|526866590|FG001|Overall Study|Physician Decision|0|||
146094274|NCT00764504|526866591|FG002|Overall Study|Physician Decision|0|||
146094275|NCT00764504|526866589|FG000|Overall Study|Withdrawal by Subject|1|||
146252776|NCT05335005|527438898|FG000|Overall Study|Lost to Follow-up|1|||
146252777|NCT00644332|527438900|FG000|Overall Study|Adverse Event|11|||
146252778|NCT00644332|527438900|FG000|Overall Study|Withdrawal by Subject|6|||
146252779|NCT00644332|527438900|FG000|Overall Study|Completion Status Unknown|2|||
146252780|NCT00644332|527438900|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
146252781|NCT00644332|527438900|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
146252782|NCT03694210|527438901|FG000|Overall Study|Death|1|||
146252783|NCT03694210|527438901|FG000|Overall Study|Screen Failure|7|||
146252784|NCT00443755|527438902|FG000|Overall Study|Withdrawal by Subject|2|||
146252785|NCT00443755|527438903|FG001|Overall Study|Withdrawal by Subject|1|||
146252786|NCT00678899|527438910|FG000|Overall Study|Adverse Event|1|||
146252787|NCT03451292|527438911|FG000|Overall Study|Death|44|||
146252788|NCT03451292|527438912|FG001|Overall Study|Death|59|||
146252789|NCT03451292|527438911|FG000|Overall Study|Withdrawal by Subject|18|||
146252790|NCT03451292|527438912|FG001|Overall Study|Withdrawal by Subject|13|||
146252791|NCT03451292|527438911|FG000|Overall Study|Transplantation|18|||
146252792|NCT03451292|527438912|FG001|Overall Study|Transplantation|12|||
146252793|NCT03451292|527438911|FG000|Overall Study|Lost to Follow-up|4|||
146252794|NCT03451292|527438912|FG001|Overall Study|Lost to Follow-up|12|||
146252795|NCT03451292|527438911|FG000|Overall Study|Physician Decision|4|||
146252796|NCT03451292|527438912|FG001|Overall Study|Physician Decision|3|||
146252797|NCT03451292|527438911|FG000|Overall Study|Adverse Event|3|||
146252798|NCT03451292|527438912|FG001|Overall Study|Adverse Event|3|||
146252799|NCT03451292|527438911|FG000|Overall Study|Non-compliance with Study Drug|2|||
146094276|NCT00764504|526866590|FG001|Overall Study|Withdrawal by Subject|7|||
146094277|NCT00764504|526866591|FG002|Overall Study|Withdrawal by Subject|4|||
146094278|NCT00764504|526866589|FG000|Overall Study|Lost to Follow-up|40|||
146094279|NCT00764504|526866590|FG001|Overall Study|Lost to Follow-up|34|||
146094280|NCT00764504|526866591|FG002|Overall Study|Lost to Follow-up|72|||
146094281|NCT02456103|526866592|FG000|Overall Study|Study Closure|207|||
146094282|NCT02456103|526866592|FG000|Overall Study|Physician Decision|1|||
146094283|NCT02456103|526866592|FG000|Overall Study|Required prohibited medications|5|||
146094284|NCT02456103|526866592|FG000|Overall Study|Protocol Violation|1|||
146252800|NCT03451292|527438912|FG001|Overall Study|Non-compliance with Study Drug|0|||
146021737|NCT05032690|526591188|FG003|Period 1|Adverse Event|0|||
146021738|NCT05032690|526591185|FG000|Period 1|Withdrawal by Subject|1|||
146021739|NCT05032690|526591186|FG001|Period 1|Withdrawal by Subject|0|||
146094285|NCT02456103|526866592|FG000|Overall Study|Adverse Event|5|||
146094286|NCT02456103|526866592|FG000|Overall Study|Abnormal Laboratory Value|2|||
146094287|NCT02456103|526866592|FG000|Overall Study|Lost to Follow-up|1|||
146094288|NCT02456103|526866592|FG000|Overall Study|Withdrawal by Subject|24|||
146094289|NCT04010539|526866593|FG000|Overall Study|Withdrawal by Subject|4|||
146252801|NCT04385849|527438913|FG000|Overall Study|Lost to Follow-up|1|||
146252802|NCT04385849|527438914|FG001|Overall Study|Lost to Follow-up|0|||
146252803|NCT01375777|527438915|FG000|Overall Study|Withdrawal by Subject|0|||
146252804|NCT01375777|527438916|FG001|Overall Study|Withdrawal by Subject|2|||
146252805|NCT01375777|527438917|FG002|Overall Study|Withdrawal by Subject|1|||
146252806|NCT01375777|527438918|FG003|Overall Study|Withdrawal by Subject|0|||
146300269|NCT03681951|527615194|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146300270|NCT03681951|527615195|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146094290|NCT04010539|526866594|FG001|Overall Study|Withdrawal by Subject|1|||
146094291|NCT04010539|526866593|FG000|Overall Study|Physician Decision|0|||
146094292|NCT04010539|526866594|FG001|Overall Study|Physician Decision|2|||
146252807|NCT01375777|527438919|FG004|Overall Study|Withdrawal by Subject|1|||
146252808|NCT01375777|527438920|FG005|Overall Study|Withdrawal by Subject|1|||
146021740|NCT05032690|526591187|FG002|Period 1|Withdrawal by Subject|0|||
146021741|NCT05032690|526591188|FG003|Period 1|Withdrawal by Subject|0|||
146021742|NCT05032690|526591185|FG000|Period 1|No longer meets eligibility criteria|0|||
146021743|NCT05032690|526591186|FG001|Period 1|No longer meets eligibility criteria|1|||
146021744|NCT05032690|526591187|FG002|Period 1|No longer meets eligibility criteria|0|||
146021745|NCT05032690|526591188|FG003|Period 1|No longer meets eligibility criteria|0|||
146021746|NCT05032690|526591185|FG000|Period 2|Adverse Event|1|||
146021747|NCT05032690|526591186|FG001|Period 2|Adverse Event|0|||
146021748|NCT05032690|526591187|FG002|Period 2|Adverse Event|0|||
146021749|NCT05032690|526591188|FG003|Period 2|Adverse Event|0|||
146021750|NCT05032690|526591185|FG000|Period 2|Withdrawal by Subject|0|||
146021751|NCT05032690|526591186|FG001|Period 2|Withdrawal by Subject|1|||
146021752|NCT05032690|526591187|FG002|Period 2|Withdrawal by Subject|0|||
146021753|NCT05032690|526591188|FG003|Period 2|Withdrawal by Subject|0|||
146021754|NCT05032690|526591185|FG000|Period 2|No longer meets eligibility criteria|0|||
146021755|NCT05032690|526591186|FG001|Period 2|No longer meets eligibility criteria|1|||
146021756|NCT05032690|526591187|FG002|Period 2|No longer meets eligibility criteria|0|||
146021757|NCT05032690|526591188|FG003|Period 2|No longer meets eligibility criteria|0|||
146021758|NCT05032690|526591185|FG000|Period 3|Adverse Event|0|||
146021759|NCT05032690|526591186|FG001|Period 3|Adverse Event|1|||
146021760|NCT05032690|526591187|FG002|Period 3|Adverse Event|0|||
146021761|NCT05032690|526591188|FG003|Period 3|Adverse Event|0|||
146021762|NCT05151445|526591189|FG000|Overall Study|Withdrawal by Subject|3|||
146021763|NCT02298179|526591190|FG000|Overall Study|Lost to Follow-up|0|||
146021764|NCT02298179|526591191|FG001|Overall Study|Lost to Follow-up|0|||
146021765|NCT02298179|526591192|FG002|Overall Study|Lost to Follow-up|1|||
146021766|NCT02298179|526591193|FG003|Overall Study|Lost to Follow-up|0|||
146021767|NCT02298179|526591194|FG004|Overall Study|Lost to Follow-up|0|||
146021768|NCT02298179|526591195|FG005|Overall Study|Lost to Follow-up|0|||
146021769|NCT02298179|526591196|FG006|Overall Study|Lost to Follow-up|0|||
146021770|NCT02298179|526591197|FG007|Overall Study|Lost to Follow-up|1|||
146021771|NCT02298179|526591198|FG008|Overall Study|Lost to Follow-up|0|||
146021772|NCT02298179|526591199|FG009|Overall Study|Lost to Follow-up|0|||
146021773|NCT02298179|526591200|FG010|Overall Study|Lost to Follow-up|0|||
146021774|NCT02298179|526591201|FG011|Overall Study|Lost to Follow-up|0|||
146021775|NCT00303446|526593109|FG000|Overall Study|Withdrawal by Subject|2|||
146021776|NCT00303446|526593110|FG001|Overall Study|Withdrawal by Subject|2|||
146021777|NCT00303446|526593109|FG000|Overall Study|Death|0|||
146021778|NCT00303446|526593110|FG001|Overall Study|Death|1|||
146021779|NCT00303446|526593109|FG000|Overall Study|Physician Decision|0|||
146021780|NCT00303446|526593110|FG001|Overall Study|Physician Decision|1|||
146021781|NCT04258995|526593111|FG000|Overall Study|Lost to Follow-up|1|||
146021782|NCT04258995|526593112|FG001|Overall Study|Lost to Follow-up|1|||
146021783|NCT00983515|526593118|FG000|Ritonavir Alone|liver panel out of range|6|||
146021784|NCT00983515|526593118|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
146021785|NCT01962987|526593121|FG000|Overall Study|Adverse Event|4|||
146021786|NCT01962987|526593122|FG001|Overall Study|Adverse Event|4|||
146021787|NCT01962987|526593123|FG002|Overall Study|Adverse Event|0|||
146021788|NCT01962987|526593121|FG000|Overall Study|Lost to Follow-up|0|||
146021789|NCT01962987|526593122|FG001|Overall Study|Lost to Follow-up|0|||
146021790|NCT01962987|526593123|FG002|Overall Study|Lost to Follow-up|1|||
146021791|NCT01962987|526593121|FG000|Overall Study|Non compliance with dosing requirements|4|||
146021792|NCT01962987|526593122|FG001|Overall Study|Non compliance with dosing requirements|2|||
146021793|NCT01962987|526593123|FG002|Overall Study|Non compliance with dosing requirements|0|||
146021794|NCT01962987|526593121|FG000|Overall Study|Miscellaneous|1|||
146021795|NCT01962987|526593122|FG001|Overall Study|Miscellaneous|9|||
146021796|NCT01962987|526593123|FG002|Overall Study|Miscellaneous|2|||
146021797|NCT01962987|526593121|FG000|Overall Study|Restricted medication|5|||
146021798|NCT01962987|526593122|FG001|Overall Study|Restricted medication|1|||
146021799|NCT01962987|526593123|FG002|Overall Study|Restricted medication|1|||
146021800|NCT01962987|526593121|FG000|Overall Study|Serious Adverse Event|1|||
146021801|NCT01962987|526593122|FG001|Overall Study|Serious Adverse Event|0|||
146021802|NCT01962987|526593123|FG002|Overall Study|Serious Adverse Event|0|||
146021803|NCT01962987|526593121|FG000|Overall Study|Withdrawal by Subject|11|||
146021804|NCT01962987|526593122|FG001|Overall Study|Withdrawal by Subject|10|||
146021805|NCT01962987|526593123|FG002|Overall Study|Withdrawal by Subject|6|||
146021806|NCT01962987|526593121|FG000|Overall Study|Randomized in Error|4|||
146021807|NCT01962987|526593122|FG001|Overall Study|Randomized in Error|2|||
146021808|NCT01962987|526593123|FG002|Overall Study|Randomized in Error|2|||
146021809|NCT01967823|526593124|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
146021810|NCT00413894|526593125|FG000|Overall Study|Withdrawal by Subject|10|||
146021811|NCT00413894|526593125|FG000|Overall Study|Administrative Reasons|1|||
146021812|NCT00413894|526593125|FG000|Overall Study|Hb <10 grams/deciliter|12|||
146021813|NCT00413894|526593125|FG000|Overall Study|Adverse Event|28|||
146021814|NCT00413894|526593125|FG000|Overall Study|Protocol Violation|11|||
146021815|NCT00413894|526593125|FG000|Overall Study|Other|18|||
146021816|NCT01942161|526593126|FG000|Overall Study|Adverse Event|1|||
146021817|NCT01942161|526593127|FG001|Overall Study|Adverse Event|2|||
146094293|NCT04010539|526866593|FG000|Overall Study|Lost to Follow-up|10|||
146094294|NCT04010539|526866594|FG001|Overall Study|Lost to Follow-up|14|||
146094295|NCT04010539|526866593|FG000|Overall Study|Adverse Event|3|||
146094296|NCT04010539|526866594|FG001|Overall Study|Adverse Event|0|||
146094297|NCT04010539|526866593|FG000|Overall Study|Participant Did Not Receive IP|0|||
146094298|NCT04010539|526866594|FG001|Overall Study|Participant Did Not Receive IP|1|||
146094299|NCT04010539|526866593|FG000|Overall Study|Protocol Deviation|0|||
146094300|NCT04010539|526866594|FG001|Overall Study|Protocol Deviation|1|||
146094301|NCT04010539|526866593|FG000|Overall Study|Randomized in Error/ Mistake|2|||
146094302|NCT04010539|526866594|FG001|Overall Study|Randomized in Error/ Mistake|0|||
146094303|NCT04010539|526866593|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
146094304|NCT04010539|526866594|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
146094305|NCT00249288|526866595|FG000|Overall Study|Lost to Follow-up|3|||
146094306|NCT00249288|526866596|FG001|Overall Study|Lost to Follow-up|3|||
146094307|NCT00249288|526866595|FG000|Overall Study|Withdrawal by Subject|2|||
146094308|NCT00249288|526866596|FG001|Overall Study|Withdrawal by Subject|2|||
146094309|NCT03059446|526866597|FG000|Overall Study|Adverse Event|11|||
146094310|NCT03059446|526866597|FG000|Overall Study|Withdrawal of Consent|16|||
146094311|NCT03059446|526866597|FG000|Overall Study|Lost to Follow-up|3|||
146094312|NCT03059446|526866597|FG000|Overall Study|Protocol Violation|1|||
146094313|NCT03059446|526866597|FG000|Overall Study|Study Terminated by Sponsor|131|||
146094314|NCT03059446|526866597|FG000|Overall Study|Reason not Specified|5|||
146094315|NCT00470847|526866598|FG000|Overall Study|Pt still receiving treatment|1|||
146021818|NCT01942161|526593128|FG002|Overall Study|Adverse Event|5|||
146021819|NCT01942161|526593126|FG000|Overall Study|Physician Decision|3|||
146021820|NCT01942161|526593127|FG001|Overall Study|Physician Decision|1|||
146021821|NCT01942161|526593128|FG002|Overall Study|Physician Decision|0|||
146021822|NCT01942161|526593126|FG000|Overall Study|Protocol Violation|1|||
146021823|NCT01942161|526593127|FG001|Overall Study|Protocol Violation|0|||
146021824|NCT01942161|526593128|FG002|Overall Study|Protocol Violation|0|||
146021825|NCT01942161|526593126|FG000|Overall Study|Withdrawal by Subject|3|||
146021826|NCT01942161|526593127|FG001|Overall Study|Withdrawal by Subject|3|||
146021827|NCT01942161|526593128|FG002|Overall Study|Withdrawal by Subject|1|||
146021828|NCT05289271|526593129|FG000|Overall Study|Mistakenly allocated, untreated|1|||
146021829|NCT05289271|526593130|FG001|Overall Study|Mistakenly allocated, untreated|0|||
146021830|NCT01257568|526593131|FG000|Overall Study|Lost to Follow-up|2|||
146021831|NCT01257568|526593131|FG000|Overall Study|Withdrawal by Subject|6|||
146021832|NCT01257568|526593131|FG000|Overall Study|Terminated|1|||
146021833|NCT01257568|526593131|FG000|Overall Study|Component Revision|24|||
146021834|NCT00416715|526593132|FG000|Overall Study|Not evaluable for joint aches|7|||
146021835|NCT00416715|526593132|FG000|Overall Study|Vitamin D levels not evaluable|8|||
146021836|NCT01007435|526593135|FG000|Overall Study|Adverse Event|16|||
146021837|NCT01007435|526593136|FG001|Overall Study|Adverse Event|25|||
146021838|NCT01007435|526593137|FG002|Overall Study|Adverse Event|47|||
146021839|NCT01007435|526593138|FG003|Overall Study|Adverse Event|31|||
146021840|NCT01007435|526593135|FG000|Overall Study|Death|2|||
146021841|NCT01007435|526593136|FG001|Overall Study|Death|4|||
146021842|NCT01007435|526593137|FG002|Overall Study|Death|2|||
146021843|NCT01007435|526593138|FG003|Overall Study|Death|1|||
146021844|NCT01007435|526593135|FG000|Overall Study|Insufficient Therapeutic Response|21|||
146021845|NCT01007435|526593136|FG001|Overall Study|Insufficient Therapeutic Response|7|||
146021846|NCT01007435|526593137|FG002|Overall Study|Insufficient Therapeutic Response|2|||
146021847|NCT01007435|526593138|FG003|Overall Study|Insufficient Therapeutic Response|9|||
146021848|NCT01007435|526593135|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
146021849|NCT01007435|526593136|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
146021850|NCT01007435|526593137|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
146021851|NCT01007435|526593138|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
146021852|NCT01007435|526593135|FG000|Overall Study|Other Protocol Violation|2|||
146021853|NCT01007435|526593136|FG001|Overall Study|Other Protocol Violation|0|||
146021854|NCT01007435|526593137|FG002|Overall Study|Other Protocol Violation|1|||
146021855|NCT01007435|526593138|FG003|Overall Study|Other Protocol Violation|0|||
146021856|NCT01007435|526593135|FG000|Overall Study|Refused Treatment|13|||
146021857|NCT01007435|526593136|FG001|Overall Study|Refused Treatment|13|||
146021858|NCT01007435|526593137|FG002|Overall Study|Refused Treatment|5|||
146021859|NCT01007435|526593138|FG003|Overall Study|Refused Treatment|8|||
146094316|NCT00467610|526866604|FG000|Overall Study|Withdrawal by Subject|1|||
146094317|NCT02001181|526866607|FG000|Overall Study|Adverse Event|0|||
146094318|NCT02001181|526866608|FG001|Overall Study|Adverse Event|2|||
146094319|NCT02001181|526866607|FG000|Overall Study|Lost to Follow-up|1|||
146094320|NCT02001181|526866608|FG001|Overall Study|Lost to Follow-up|0|||
146094321|NCT02001181|526866607|FG000|Overall Study|Withdrawal by Subject|0|||
146094322|NCT02001181|526866608|FG001|Overall Study|Withdrawal by Subject|1|||
146021860|NCT01007435|526593135|FG000|Overall Study|Failure to Return|5|||
146021861|NCT01007435|526593136|FG001|Overall Study|Failure to Return|4|||
146021862|NCT01007435|526593137|FG002|Overall Study|Failure to Return|3|||
146094323|NCT00445978|526866609|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
146094324|NCT00445978|526866609|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
146094325|NCT00445978|526866609|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
146094326|NCT00445978|526866609|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
146094327|NCT00445978|526866609|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
146094328|NCT00445978|526866609|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
146094329|NCT00445978|526866609|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
146094330|NCT00445978|526866609|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
146094331|NCT00445978|526866609|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
146094332|NCT02766465|526866612|FG000|Overall Study|Withdrawal by Subject|0|||
146094333|NCT02766465|526866613|FG001|Overall Study|Withdrawal by Subject|10|||
146094334|NCT02435069|526866614|FG000|Dose Response - First Intervention|Adverse Event|0|||
146094335|NCT02435069|526866615|FG001|Dose Response - First Intervention|Adverse Event|1|||
146094336|NCT02435069|526866616|FG002|Dose Response - First Intervention|Adverse Event|1|||
146021863|NCT01007435|526593138|FG003|Overall Study|Failure to Return|6|||
146021864|NCT01007435|526593135|FG000|Overall Study|Reason not Specified|1|||
146021865|NCT01007435|526593136|FG001|Overall Study|Reason not Specified|1|||
146021866|NCT01007435|526593137|FG002|Overall Study|Reason not Specified|2|||
146021867|NCT01007435|526593138|FG003|Overall Study|Reason not Specified|1|||
146021868|NCT00347438|526593139|FG000|Overall Study|Withdrawal by Subject|1|||
146021869|NCT00347438|526593139|FG000|Overall Study|Physician Decision|1|||
146021870|NCT02545517|526593140|FG000|Overall Study|Death|2|||
146021871|NCT02545517|526593141|FG001|Overall Study|Death|2|||
146021872|NCT02545517|526593142|FG002|Overall Study|Death|1|||
146021873|NCT02545517|526593140|FG000|Overall Study|Lost to Follow-up|14|||
146021874|NCT02545517|526593141|FG001|Overall Study|Lost to Follow-up|13|||
146021875|NCT02545517|526593142|FG002|Overall Study|Lost to Follow-up|17|||
146021876|NCT02545517|526593140|FG000|Overall Study|Protocol Violation|0|||
146021877|NCT02545517|526593141|FG001|Overall Study|Protocol Violation|1|||
146021878|NCT02545517|526593142|FG002|Overall Study|Protocol Violation|1|||
146021879|NCT02545517|526593140|FG000|Overall Study|Withdrawal by Subject|5|||
146094337|NCT02435069|526866617|FG003|Dose Response - First Intervention|Adverse Event|0|||
146094338|NCT02435069|526866618|FG004|Dose Response - First Intervention|Adverse Event|0|||
146094339|NCT02435069|526866614|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146094340|NCT02435069|526866615|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146094341|NCT02435069|526866616|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146094342|NCT02435069|526866617|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
146094343|NCT02435069|526866618|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
146094344|NCT03112590|526866619|FG000|Overall Study|Adverse Event|0|||
146094345|NCT03112590|526866620|FG001|Overall Study|Adverse Event|1|||
146094346|NCT03112590|526866621|FG002|Overall Study|Adverse Event|0|||
146094347|NCT02520661|526866624|FG000|Overall Study|Lost to Follow-up|7|||
146094348|NCT02520661|526866625|FG001|Overall Study|Lost to Follow-up|3|||
146094349|NCT02520661|526866624|FG000|Overall Study|Admitted from ED|49|||
146094350|NCT02520661|526866625|FG001|Overall Study|Admitted from ED|48|||
146094351|NCT02520661|526866624|FG000|Overall Study|ED greater than 24 hours|29|||
146094352|NCT02520661|526866625|FG001|Overall Study|ED greater than 24 hours|38|||
146094353|NCT02520661|526866624|FG000|Overall Study|other ineligibility|14|||
146094354|NCT02520661|526866625|FG001|Overall Study|other ineligibility|22|||
146094355|NCT02520661|526866624|FG000|Overall Study|Withdrawal by Subject|7|||
146094356|NCT02520661|526866625|FG001|Overall Study|Withdrawal by Subject|16|||
146094357|NCT00843726|526866626|FG000|Overall Study|Death|1|||
146094358|NCT00843726|526866627|FG001|Overall Study|Death|0|||
146094359|NCT00843726|526866626|FG000|Overall Study|Withdrawal by Subject|0|||
146094360|NCT00843726|526866627|FG001|Overall Study|Withdrawal by Subject|1|||
146094361|NCT02898116|526866634|FG000|Overall Study|Adverse Event|1|||
146094362|NCT02898116|526866634|FG000|Overall Study|Progressive disease|1|||
146094363|NCT03635788|526866635|FG000|Step 1|Death|1|||
146094364|NCT03635788|526866636|FG001|Step 1|Death|0|||
146094365|NCT03635788|526866637|FG002|Step 1|Death|0|||
146094366|NCT03635788|526866635|FG000|Step 1|Lost to Follow-up|31|||
146094367|NCT03635788|526866636|FG001|Step 1|Lost to Follow-up|0|||
146094368|NCT03635788|526866637|FG002|Step 1|Lost to Follow-up|0|||
146094369|NCT03635788|526866635|FG000|Step 1|Pregnancy|1|||
146094370|NCT03635788|526866636|FG001|Step 1|Pregnancy|0|||
146094371|NCT03635788|526866637|FG002|Step 1|Pregnancy|0|||
146094372|NCT03635788|526866635|FG000|Step 1|Protocol Violation|8|||
146094373|NCT03635788|526866636|FG001|Step 1|Protocol Violation|0|||
146094374|NCT03635788|526866637|FG002|Step 1|Protocol Violation|0|||
146021880|NCT02545517|526593141|FG001|Overall Study|Withdrawal by Subject|8|||
146021881|NCT02545517|526593142|FG002|Overall Study|Withdrawal by Subject|9|||
146021882|NCT02545517|526593140|FG000|Overall Study|Administrative reason|5|||
146094375|NCT03635788|526866635|FG000|Step 1|Withdrawal by Subject|13|||
146094376|NCT03635788|526866636|FG001|Step 1|Withdrawal by Subject|0|||
146094377|NCT03635788|526866637|FG002|Step 1|Withdrawal by Subject|0|||
146094378|NCT03635788|526866635|FG000|Step 1|Other reasons|12|||
146252809|NCT01375777|527438921|FG006|Overall Study|Withdrawal by Subject|1|||
146252810|NCT01375777|527438922|FG007|Overall Study|Withdrawal by Subject|2|||
146021883|NCT02545517|526593141|FG001|Overall Study|Administrative reason|6|||
146252811|NCT01375777|527438923|FG008|Overall Study|Withdrawal by Subject|1|||
146252812|NCT01375777|527438915|FG000|Overall Study|Lost to Follow-up|1|||
146252813|NCT01375777|527438916|FG001|Overall Study|Lost to Follow-up|0|||
146252814|NCT01375777|527438917|FG002|Overall Study|Lost to Follow-up|0|||
146252815|NCT01375777|527438918|FG003|Overall Study|Lost to Follow-up|0|||
146252816|NCT01375777|527438919|FG004|Overall Study|Lost to Follow-up|0|||
146252817|NCT01375777|527438920|FG005|Overall Study|Lost to Follow-up|0|||
146252818|NCT01375777|527438921|FG006|Overall Study|Lost to Follow-up|1|||
146252819|NCT01375777|527438922|FG007|Overall Study|Lost to Follow-up|0|||
146252820|NCT01375777|527438923|FG008|Overall Study|Lost to Follow-up|0|||
146252821|NCT01375777|527438915|FG000|Overall Study|Other|1|||
146252822|NCT01375777|527438916|FG001|Overall Study|Other|1|||
146252823|NCT01375777|527438917|FG002|Overall Study|Other|0|||
146252824|NCT01375777|527438918|FG003|Overall Study|Other|0|||
146252825|NCT01375777|527438919|FG004|Overall Study|Other|0|||
146252826|NCT01375777|527438920|FG005|Overall Study|Other|0|||
146021884|NCT02545517|526593142|FG002|Overall Study|Administrative reason|10|||
146021885|NCT02545517|526593140|FG000|Overall Study|Other|2|||
146021886|NCT02545517|526593141|FG001|Overall Study|Other|4|||
146021887|NCT02545517|526593142|FG002|Overall Study|Other|3|||
146021888|NCT01529515|526593143|FG000|TRANSITION PHASE|Adverse Event|16|||
146021889|NCT01529515|526593144|FG001|TRANSITION PHASE|Adverse Event|0|||
146021890|NCT01529515|526593145|FG002|TRANSITION PHASE|Adverse Event|0|||
146021891|NCT01529515|526593146|FG003|TRANSITION PHASE|Adverse Event|0|||
146021892|NCT01529515|526593143|FG000|TRANSITION PHASE|Death|1|||
146021893|NCT01529515|526593144|FG001|TRANSITION PHASE|Death|0|||
146021894|NCT01529515|526593145|FG002|TRANSITION PHASE|Death|0|||
146021895|NCT01529515|526593146|FG003|TRANSITION PHASE|Death|0|||
146021896|NCT01529515|526593143|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
146021897|NCT01529515|526593144|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
146021898|NCT01529515|526593145|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
146021899|NCT01529515|526593146|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
146021900|NCT01529515|526593143|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
146021901|NCT01529515|526593144|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
146021902|NCT01529515|526593145|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
146021903|NCT01529515|526593146|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
146021904|NCT01529515|526593143|FG000|TRANSITION PHASE|Protocol Violation|4|||
146021905|NCT01529515|526593144|FG001|TRANSITION PHASE|Protocol Violation|0|||
146021906|NCT01529515|526593145|FG002|TRANSITION PHASE|Protocol Violation|0|||
146021907|NCT01529515|526593146|FG003|TRANSITION PHASE|Protocol Violation|0|||
146021908|NCT01529515|526593143|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
146021909|NCT01529515|526593144|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
146021910|NCT01529515|526593145|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
146021911|NCT01529515|526593146|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
146021912|NCT01529515|526593143|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
146021913|NCT01529515|526593144|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146021914|NCT01529515|526593145|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146021915|NCT01529515|526593146|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
146021916|NCT01529515|526593143|FG000|TRANSITION PHASE|Other|9|||
146021917|NCT01529515|526593144|FG001|TRANSITION PHASE|Other|0|||
146021918|NCT01529515|526593145|FG002|TRANSITION PHASE|Other|0|||
146021919|NCT01529515|526593146|FG003|TRANSITION PHASE|Other|0|||
146021920|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Adverse Event|0|||
146021921|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Adverse Event|10|||
146021922|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Adverse Event|0|||
146021923|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Adverse Event|0|||
146021924|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
146021925|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
146021926|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
146021927|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
146021928|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
146021929|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
146021930|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
146021931|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
146021932|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
146021933|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
146252827|NCT01375777|527438921|FG006|Overall Study|Other|0|||
146252828|NCT01375777|527438922|FG007|Overall Study|Other|0|||
146252829|NCT01375777|527438923|FG008|Overall Study|Other|1|||
146021934|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
146021935|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
146021936|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146021937|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
146252830|NCT00355784|527438924|FG000|Overall Study|Withdrawal by Subject|0|||
146252831|NCT00355784|527438925|FG001|Overall Study|Withdrawal by Subject|0|||
146252832|NCT00355784|527438926|FG002|Overall Study|Withdrawal by Subject|2|||
146252833|NCT02543294|527438927|FG000|Overall Study|Lost to Follow-up|3|||
146252834|NCT02543294|527438927|FG000|Overall Study|Physician Decision|2|||
146252835|NCT02543294|527438927|FG000|Overall Study|Withdrawal by Subject|7|||
146252836|NCT03602053|527438928|FG000|Overall Study|Withdrawal by Subject|7|||
146252837|NCT03602053|527438929|FG001|Overall Study|Withdrawal by Subject|9|||
146252838|NCT03602053|527438930|FG002|Overall Study|Withdrawal by Subject|7|||
146021938|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146021939|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
146021940|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146021941|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
146021942|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146021943|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
146021944|NCT01529515|526593143|FG000|MAINTENANCE PHASE|Other|0|||
146021945|NCT01529515|526593144|FG001|MAINTENANCE PHASE|Other|10|||
146021946|NCT01529515|526593145|FG002|MAINTENANCE PHASE|Other|0|||
146021947|NCT01529515|526593146|FG003|MAINTENANCE PHASE|Other|0|||
146021948|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
146021949|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
146021950|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
146021951|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
146021952|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
146021953|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
146021954|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
146021955|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
146021956|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
146021957|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
146021958|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
146021959|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
146021960|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
146021961|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
146021962|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
146021963|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
146021964|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
146021965|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
146021966|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
146021967|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
146021968|NCT01529515|526593143|FG000|DOUBLE BLIND PHASE|Other|0|||
146021969|NCT01529515|526593144|FG001|DOUBLE BLIND PHASE|Other|0|||
146021970|NCT01529515|526593145|FG002|DOUBLE BLIND PHASE|Other|9|||
146021971|NCT01529515|526593146|FG003|DOUBLE BLIND PHASE|Other|2|||
146021972|NCT03334851|526593148|FG000|Overall Study|Other|0|||
146021973|NCT03334851|526593149|FG001|Overall Study|Other|0|||
146021974|NCT03334851|526593150|FG002|Overall Study|Other|0|||
146021975|NCT03334851|526593151|FG003|Overall Study|Other|0|||
146021976|NCT03334851|526593152|FG004|Overall Study|Other|0|||
146021977|NCT03334851|526593153|FG005|Overall Study|Other|0|||
146021978|NCT03334851|526593154|FG006|Overall Study|Other|0|||
146021979|NCT03334851|526593155|FG007|Overall Study|Other|1|||
146021980|NCT03334851|526593156|FG008|Overall Study|Other|0|||
146021981|NCT03334851|526593157|FG009|Overall Study|Other|0|||
146021982|NCT03334851|526593158|FG010|Overall Study|Other|0|||
146021983|NCT03334851|526593159|FG011|Overall Study|Other|0|||
146021984|NCT03334851|526593160|FG012|Overall Study|Other|0|||
146021985|NCT03334851|526593148|FG000|Overall Study|Adverse Event|0|||
146021986|NCT03334851|526593149|FG001|Overall Study|Adverse Event|0|||
146021987|NCT03334851|526593150|FG002|Overall Study|Adverse Event|0|||
146021988|NCT03334851|526593151|FG003|Overall Study|Adverse Event|0|||
146021989|NCT03334851|526593152|FG004|Overall Study|Adverse Event|0|||
146021990|NCT03334851|526593153|FG005|Overall Study|Adverse Event|0|||
146021991|NCT03334851|526593154|FG006|Overall Study|Adverse Event|0|||
146021992|NCT03334851|526593155|FG007|Overall Study|Adverse Event|1|||
146021993|NCT03334851|526593156|FG008|Overall Study|Adverse Event|0|||
146021994|NCT03334851|526593157|FG009|Overall Study|Adverse Event|0|||
146021995|NCT03334851|526593158|FG010|Overall Study|Adverse Event|0|||
146021996|NCT03334851|526593159|FG011|Overall Study|Adverse Event|0|||
146021997|NCT03334851|526593160|FG012|Overall Study|Adverse Event|0|||
146021998|NCT03334851|526593148|FG000|Overall Study|Withdrawal by Subject|0|||
146021999|NCT03334851|526593149|FG001|Overall Study|Withdrawal by Subject|0|||
146022000|NCT03334851|526593150|FG002|Overall Study|Withdrawal by Subject|0|||
146022001|NCT03334851|526593151|FG003|Overall Study|Withdrawal by Subject|0|||
146022002|NCT03334851|526593152|FG004|Overall Study|Withdrawal by Subject|0|||
146022003|NCT03334851|526593153|FG005|Overall Study|Withdrawal by Subject|0|||
146022004|NCT03334851|526593154|FG006|Overall Study|Withdrawal by Subject|0|||
146022005|NCT03334851|526593155|FG007|Overall Study|Withdrawal by Subject|0|||
146252839|NCT03602053|527438928|FG000|Overall Study|Lost to Follow-up|5|||
146252840|NCT03602053|527438929|FG001|Overall Study|Lost to Follow-up|6|||
146022006|NCT03334851|526593156|FG008|Overall Study|Withdrawal by Subject|0|||
146022007|NCT03334851|526593157|FG009|Overall Study|Withdrawal by Subject|0|||
146022008|NCT03334851|526593158|FG010|Overall Study|Withdrawal by Subject|1|||
146022009|NCT03334851|526593159|FG011|Overall Study|Withdrawal by Subject|0|||
146022010|NCT03334851|526593160|FG012|Overall Study|Withdrawal by Subject|1|||
146022011|NCT03334851|526593148|FG000|Overall Study|Lost to Follow-up|0|||
146022012|NCT03334851|526593149|FG001|Overall Study|Lost to Follow-up|0|||
146022013|NCT03334851|526593150|FG002|Overall Study|Lost to Follow-up|0|||
146022014|NCT03334851|526593151|FG003|Overall Study|Lost to Follow-up|0|||
146022015|NCT03334851|526593152|FG004|Overall Study|Lost to Follow-up|0|||
146022016|NCT03334851|526593153|FG005|Overall Study|Lost to Follow-up|0|||
146022017|NCT03334851|526593154|FG006|Overall Study|Lost to Follow-up|0|||
146022018|NCT03334851|526593155|FG007|Overall Study|Lost to Follow-up|0|||
146022019|NCT03334851|526593156|FG008|Overall Study|Lost to Follow-up|0|||
146022020|NCT03334851|526593157|FG009|Overall Study|Lost to Follow-up|0|||
146022021|NCT03334851|526593158|FG010|Overall Study|Lost to Follow-up|2|||
146022022|NCT03334851|526593159|FG011|Overall Study|Lost to Follow-up|1|||
146022023|NCT03334851|526593160|FG012|Overall Study|Lost to Follow-up|0|||
146252841|NCT03602053|527438930|FG002|Overall Study|Lost to Follow-up|0|||
146252842|NCT03602053|527438928|FG000|Overall Study|Protocol Violation|3|||
146252843|NCT03602053|527438929|FG001|Overall Study|Protocol Violation|0|||
146252844|NCT03602053|527438930|FG002|Overall Study|Protocol Violation|4|||
146252845|NCT03602053|527438928|FG000|Overall Study|Physician Decision|1|||
146252846|NCT03602053|527438929|FG001|Overall Study|Physician Decision|0|||
146252847|NCT03602053|527438930|FG002|Overall Study|Physician Decision|0|||
146252848|NCT03602053|527438928|FG000|Overall Study|migration|2|||
146252849|NCT03602053|527438929|FG001|Overall Study|migration|3|||
146252850|NCT03602053|527438930|FG002|Overall Study|migration|0|||
146252851|NCT03602053|527438928|FG000|Overall Study|Other|1|||
146252852|NCT03602053|527438929|FG001|Overall Study|Other|0|||
146252853|NCT03602053|527438930|FG002|Overall Study|Other|0|||
146252854|NCT02339506|527438935|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
146252855|NCT02339506|527438936|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
146252856|NCT02339506|527438935|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
146252857|NCT02339506|527438936|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
146252858|NCT03672188|527438937|FG000|Overall Study|Withdrawal by Subject|0|||
146252859|NCT03672188|527438938|FG001|Overall Study|Withdrawal by Subject|0|||
146252860|NCT03672188|527438939|FG002|Overall Study|Withdrawal by Subject|0|||
146252861|NCT03672188|527438940|FG003|Overall Study|Withdrawal by Subject|3|||
146252862|NCT03672188|527438941|FG004|Overall Study|Withdrawal by Subject|0|||
146252863|NCT03672188|527438942|FG005|Overall Study|Withdrawal by Subject|0|||
146252864|NCT03672188|527438943|FG006|Overall Study|Withdrawal by Subject|0|||
146252865|NCT03672188|527438944|FG007|Overall Study|Withdrawal by Subject|0|||
146252866|NCT03672188|527438945|FG008|Overall Study|Withdrawal by Subject|0|||
146252867|NCT03672188|527438946|FG009|Overall Study|Withdrawal by Subject|0|||
146252868|NCT03672188|527438947|FG010|Overall Study|Withdrawal by Subject|0|||
146252869|NCT03672188|527438948|FG011|Overall Study|Withdrawal by Subject|0|||
146252870|NCT03672188|527438949|FG012|Overall Study|Withdrawal by Subject|0|||
146252871|NCT03672188|527438950|FG013|Overall Study|Withdrawal by Subject|0|||
146252872|NCT03672188|527438951|FG014|Overall Study|Withdrawal by Subject|0|||
146252873|NCT03672188|527438937|FG000|Overall Study|Death|0|||
146252874|NCT03672188|527438938|FG001|Overall Study|Death|0|||
146252875|NCT03672188|527438939|FG002|Overall Study|Death|0|||
146252876|NCT03672188|527438940|FG003|Overall Study|Death|0|||
146022024|NCT00523705|526593161|FG000|Overall Study|No time for study.|0|||
146022025|NCT00523705|526593162|FG001|Overall Study|No time for study.|1|||
146022026|NCT00642369|526593164|FG000|Overall Study|Adverse Event|2|||
146022027|NCT00642369|526593165|FG001|Overall Study|Adverse Event|3|||
146022028|NCT00642369|526593164|FG000|Overall Study|Withdrawal by Subject|1|||
146022029|NCT00642369|526593165|FG001|Overall Study|Withdrawal by Subject|0|||
146022030|NCT00642369|526593164|FG000|Overall Study|misdiagnosis|0|||
146022031|NCT00642369|526593165|FG001|Overall Study|misdiagnosis|1|||
146022032|NCT00642369|526593164|FG000|Overall Study|Lack of Efficacy|2|||
146022033|NCT00642369|526593165|FG001|Overall Study|Lack of Efficacy|2|||
146022034|NCT00543803|526593172|FG000|Overall Study|Adverse Event|14|||
146022035|NCT00543803|526593172|FG000|Overall Study|Lack of Efficacy|22|||
146022036|NCT00543803|526593172|FG000|Overall Study|Lost to Follow-up|20|||
146022037|NCT00543803|526593172|FG000|Overall Study|Other|86|||
146252877|NCT03672188|527438941|FG004|Overall Study|Death|0|||
146252878|NCT03672188|527438942|FG005|Overall Study|Death|0|||
146252879|NCT03672188|527438943|FG006|Overall Study|Death|0|||
146252880|NCT03672188|527438944|FG007|Overall Study|Death|0|||
146252881|NCT03672188|527438945|FG008|Overall Study|Death|0|||
146252882|NCT03672188|527438946|FG009|Overall Study|Death|0|||
146252883|NCT03672188|527438947|FG010|Overall Study|Death|0|||
146252884|NCT03672188|527438948|FG011|Overall Study|Death|0|||
146252885|NCT03672188|527438949|FG012|Overall Study|Death|1|||
146252886|NCT03672188|527438950|FG013|Overall Study|Death|0|||
146252887|NCT03672188|527438951|FG014|Overall Study|Death|0|||
146252888|NCT03672188|527438937|FG000|Overall Study|Lost to Follow-up|0|||
146252889|NCT03672188|527438938|FG001|Overall Study|Lost to Follow-up|0|||
146022038|NCT01190475|526593173|FG000|Overall Study|Withdrawal by Subject|0|||
146022039|NCT01190475|526593174|FG001|Overall Study|Withdrawal by Subject|0|||
146022040|NCT01190475|526593175|FG002|Overall Study|Withdrawal by Subject|1|||
146022041|NCT01779856|526593176|FG000|Overall Study|Withdrawal by Subject|15|||
146022042|NCT01779856|526593176|FG000|Overall Study|Death|3|||
146252890|NCT03672188|527438939|FG002|Overall Study|Lost to Follow-up|1|||
146252891|NCT03672188|527438940|FG003|Overall Study|Lost to Follow-up|0|||
146022043|NCT01779856|526593176|FG000|Overall Study|Physician Decision|1|||
146022044|NCT01779856|526593176|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
146022045|NCT01779856|526593176|FG000|Overall Study|Delays in scheduling implant|1|||
146022046|NCT01779856|526593176|FG000|Overall Study|Subject ineligible for Implant|2|||
146022047|NCT00666588|526593179|FG000|Overall Study|ineligible|2|||
146022048|NCT00666588|526593180|FG001|Overall Study|ineligible|0|||
146022049|NCT00666588|526593181|FG002|Overall Study|ineligible|0|||
146022050|NCT00666588|526593182|FG003|Overall Study|ineligible|2|||
146022051|NCT00666588|526593179|FG000|Overall Study|inevaluable|2|||
146022052|NCT00666588|526593180|FG001|Overall Study|inevaluable|0|||
146022053|NCT00666588|526593181|FG002|Overall Study|inevaluable|0|||
146022054|NCT00666588|526593182|FG003|Overall Study|inevaluable|0|||
146022055|NCT03622112|526593186|FG000|Overall Study|Withdrawal by Subject|6|||
146022056|NCT03622112|526593187|FG001|Overall Study|Withdrawal by Subject|2|||
146022057|NCT03622112|526593188|FG002|Overall Study|Withdrawal by Subject|4|||
146022058|NCT03622112|526593189|FG003|Overall Study|Withdrawal by Subject|2|||
146022059|NCT03622112|526593190|FG004|Overall Study|Withdrawal by Subject|1|||
146022060|NCT03622112|526593191|FG005|Overall Study|Withdrawal by Subject|2|||
146022061|NCT03622112|526593192|FG006|Overall Study|Withdrawal by Subject|2|||
146022062|NCT03622112|526593186|FG000|Overall Study|Death|0|||
146022063|NCT03622112|526593187|FG001|Overall Study|Death|0|||
146022064|NCT03622112|526593188|FG002|Overall Study|Death|0|||
146022065|NCT03622112|526593189|FG003|Overall Study|Death|1|||
146022066|NCT03622112|526593190|FG004|Overall Study|Death|0|||
146022067|NCT03622112|526593191|FG005|Overall Study|Death|0|||
146022068|NCT03622112|526593192|FG006|Overall Study|Death|0|||
146022069|NCT03622112|526593186|FG000|Overall Study|Lost to Follow-up|1|||
146022070|NCT03622112|526593187|FG001|Overall Study|Lost to Follow-up|1|||
146022071|NCT03622112|526593188|FG002|Overall Study|Lost to Follow-up|0|||
146022072|NCT03622112|526593189|FG003|Overall Study|Lost to Follow-up|0|||
146022073|NCT03622112|526593190|FG004|Overall Study|Lost to Follow-up|0|||
146022074|NCT03622112|526593191|FG005|Overall Study|Lost to Follow-up|0|||
146022075|NCT03622112|526593192|FG006|Overall Study|Lost to Follow-up|0|||
146022076|NCT03622112|526593186|FG000|Overall Study|Study-specific withdrawal criteria|10|||
146022077|NCT03622112|526593187|FG001|Overall Study|Study-specific withdrawal criteria|8|||
146022078|NCT03622112|526593188|FG002|Overall Study|Study-specific withdrawal criteria|7|||
146022079|NCT03622112|526593189|FG003|Overall Study|Study-specific withdrawal criteria|6|||
146022080|NCT03622112|526593190|FG004|Overall Study|Study-specific withdrawal criteria|4|||
146022081|NCT03622112|526593191|FG005|Overall Study|Study-specific withdrawal criteria|18|||
146022082|NCT03622112|526593192|FG006|Overall Study|Study-specific withdrawal criteria|4|||
146022083|NCT03622112|526593186|FG000|Overall Study|Protocol Violation|2|||
146022084|NCT03622112|526593187|FG001|Overall Study|Protocol Violation|0|||
146022085|NCT03622112|526593188|FG002|Overall Study|Protocol Violation|1|||
146022086|NCT03622112|526593189|FG003|Overall Study|Protocol Violation|1|||
146022087|NCT03622112|526593190|FG004|Overall Study|Protocol Violation|0|||
146022088|NCT03622112|526593191|FG005|Overall Study|Protocol Violation|0|||
146022089|NCT03622112|526593192|FG006|Overall Study|Protocol Violation|0|||
146022090|NCT03622112|526593186|FG000|Overall Study|Adverse Event|6|||
146022091|NCT03622112|526593187|FG001|Overall Study|Adverse Event|8|||
146022092|NCT03622112|526593188|FG002|Overall Study|Adverse Event|4|||
146022093|NCT03622112|526593189|FG003|Overall Study|Adverse Event|11|||
146022094|NCT03622112|526593190|FG004|Overall Study|Adverse Event|4|||
146022095|NCT03622112|526593191|FG005|Overall Study|Adverse Event|20|||
146022096|NCT03622112|526593192|FG006|Overall Study|Adverse Event|2|||
146022097|NCT03622112|526593186|FG000|Overall Study|Reason not specified|0|||
146022098|NCT03622112|526593187|FG001|Overall Study|Reason not specified|1|||
146022099|NCT03622112|526593188|FG002|Overall Study|Reason not specified|0|||
146022100|NCT03622112|526593189|FG003|Overall Study|Reason not specified|1|||
146022101|NCT03622112|526593190|FG004|Overall Study|Reason not specified|1|||
146022102|NCT03622112|526593191|FG005|Overall Study|Reason not specified|2|||
146022103|NCT03622112|526593192|FG006|Overall Study|Reason not specified|1|||
146022104|NCT01165320|526593193|FG000|Overall Study|Clinical adverse experience|2|||
146022105|NCT01165320|526593194|FG001|Overall Study|Clinical adverse experience|1|||
146022106|NCT01165320|526593195|FG002|Overall Study|Clinical adverse experience|0|||
146022107|NCT01165320|526593193|FG000|Overall Study|Laboratory adverse experience|1|||
146022108|NCT01165320|526593194|FG001|Overall Study|Laboratory adverse experience|0|||
146022109|NCT01165320|526593195|FG002|Overall Study|Laboratory adverse experience|0|||
146022110|NCT01165320|526593193|FG000|Overall Study|Lack of Efficacy|0|||
146022111|NCT01165320|526593194|FG001|Overall Study|Lack of Efficacy|2|||
146022112|NCT01165320|526593195|FG002|Overall Study|Lack of Efficacy|0|||
146022113|NCT01165320|526593193|FG000|Overall Study|Reason unknown|0|||
146022114|NCT01165320|526593194|FG001|Overall Study|Reason unknown|1|||
146022115|NCT01165320|526593195|FG002|Overall Study|Reason unknown|0|||
146022116|NCT00385944|526593196|FG000|1st Maintenance Dose Period|Physician Decision|1|||
146022117|NCT00385944|526593197|FG001|1st Maintenance Dose Period|Physician Decision|0|||
146022118|NCT00385944|526593198|FG002|1st Maintenance Dose Period|Physician Decision|0|||
146022119|NCT00385944|526593196|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
146022120|NCT00385944|526593197|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
146252892|NCT03672188|527438941|FG004|Overall Study|Lost to Follow-up|0|||
146252893|NCT03672188|527438942|FG005|Overall Study|Lost to Follow-up|0|||
146252894|NCT03672188|527438943|FG006|Overall Study|Lost to Follow-up|0|||
146252895|NCT03672188|527438944|FG007|Overall Study|Lost to Follow-up|0|||
146252896|NCT03672188|527438945|FG008|Overall Study|Lost to Follow-up|0|||
146252897|NCT03672188|527438946|FG009|Overall Study|Lost to Follow-up|0|||
146252898|NCT03672188|527438947|FG010|Overall Study|Lost to Follow-up|0|||
146252899|NCT03672188|527438948|FG011|Overall Study|Lost to Follow-up|0|||
146252900|NCT03672188|527438949|FG012|Overall Study|Lost to Follow-up|0|||
146252901|NCT03672188|527438950|FG013|Overall Study|Lost to Follow-up|0|||
146252902|NCT03672188|527438951|FG014|Overall Study|Lost to Follow-up|0|||
146252903|NCT03997409|527438952|FG000|Overall Study|Protocol Violation|1|||
146252904|NCT03997409|527438953|FG001|Overall Study|Protocol Violation|1|||
146252905|NCT03997409|527438954|FG002|Overall Study|Protocol Violation|0|||
146252906|NCT03997409|527438952|FG000|Overall Study|Withdrawal by Subject|3|||
146252907|NCT03997409|527438953|FG001|Overall Study|Withdrawal by Subject|0|||
146252908|NCT03997409|527438954|FG002|Overall Study|Withdrawal by Subject|0|||
146252909|NCT03997409|527438952|FG000|Overall Study|Lost to Follow-up|0|||
146252910|NCT03997409|527438953|FG001|Overall Study|Lost to Follow-up|0|||
146252911|NCT03997409|527438954|FG002|Overall Study|Lost to Follow-up|1|||
146252912|NCT01636258|527438955|FG000|Overall Study|Lost to Follow-up|1|||
146252913|NCT01636258|527438956|FG001|Overall Study|Lost to Follow-up|0|||
146252914|NCT00907517|527438957|FG000|Overall Study|Progressive Disease|3|||
146252915|NCT00907517|527438958|FG001|Overall Study|Progressive Disease|3|||
146252916|NCT00907517|527438959|FG002|Overall Study|Progressive Disease|4|||
146252917|NCT00907517|527438960|FG003|Overall Study|Progressive Disease|4|||
146022121|NCT00385944|526593198|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
146022122|NCT00385944|526593196|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
146022123|NCT00385944|526593197|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
146022124|NCT00385944|526593198|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
146022125|NCT00385944|526593196|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
146022126|NCT00385944|526593197|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
146022127|NCT00385944|526593198|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
146022128|NCT01155466|526593199|FG000|Overall Study|Adverse Event|13|||
146022129|NCT01155466|526593200|FG001|Overall Study|Adverse Event|15|||
146022130|NCT01155466|526593201|FG002|Overall Study|Adverse Event|6|||
146022131|NCT01155466|526593202|FG003|Overall Study|Adverse Event|17|||
146022132|NCT01155466|526593203|FG004|Overall Study|Adverse Event|18|||
146022133|NCT01155466|526593199|FG000|Overall Study|Lost to Follow-up|0|||
146022134|NCT01155466|526593200|FG001|Overall Study|Lost to Follow-up|0|||
146022135|NCT01155466|526593201|FG002|Overall Study|Lost to Follow-up|0|||
146022136|NCT01155466|526593202|FG003|Overall Study|Lost to Follow-up|0|||
146022137|NCT01155466|526593203|FG004|Overall Study|Lost to Follow-up|2|||
146022138|NCT01155466|526593199|FG000|Overall Study|Withdrawal by Subject|7|||
146022139|NCT01155466|526593200|FG001|Overall Study|Withdrawal by Subject|5|||
146022140|NCT01155466|526593201|FG002|Overall Study|Withdrawal by Subject|9|||
146022141|NCT01155466|526593202|FG003|Overall Study|Withdrawal by Subject|4|||
146022142|NCT01155466|526593203|FG004|Overall Study|Withdrawal by Subject|4|||
146022143|NCT01155466|526593199|FG000|Overall Study|Protocol Violation|0|||
146022144|NCT01155466|526593200|FG001|Overall Study|Protocol Violation|0|||
146022145|NCT01155466|526593201|FG002|Overall Study|Protocol Violation|2|||
146022146|NCT01155466|526593202|FG003|Overall Study|Protocol Violation|0|||
146022147|NCT01155466|526593203|FG004|Overall Study|Protocol Violation|1|||
146022148|NCT01155466|526593199|FG000|Overall Study|Administrative|0|||
146022149|NCT01155466|526593200|FG001|Overall Study|Administrative|3|||
146022150|NCT01155466|526593201|FG002|Overall Study|Administrative|0|||
146022151|NCT01155466|526593202|FG003|Overall Study|Administrative|0|||
146022152|NCT01155466|526593203|FG004|Overall Study|Administrative|0|||
146022153|NCT01155466|526593199|FG000|Overall Study|Randomized not treated|2|||
146022154|NCT01155466|526593200|FG001|Overall Study|Randomized not treated|2|||
146022155|NCT01155466|526593201|FG002|Overall Study|Randomized not treated|3|||
146022156|NCT01155466|526593202|FG003|Overall Study|Randomized not treated|0|||
146252918|NCT00907517|527438961|FG004|Overall Study|Progressive Disease|4|||
146252919|NCT00907517|527438957|FG000|Overall Study|Symptomatic Deterioration|0|||
146252920|NCT00907517|527438958|FG001|Overall Study|Symptomatic Deterioration|0|||
146252921|NCT00907517|527438959|FG002|Overall Study|Symptomatic Deterioration|0|||
146252922|NCT00907517|527438960|FG003|Overall Study|Symptomatic Deterioration|0|||
146252923|NCT00907517|527438961|FG004|Overall Study|Symptomatic Deterioration|1|||
146252924|NCT02029521|527438963|FG000|Overall Study|Protocol Violation|1|||
146252925|NCT02029521|527438964|FG001|Overall Study|Protocol Violation|0|||
146252926|NCT02029521|527438963|FG000|Overall Study|Withdrawal by Subject|1|||
146252927|NCT02029521|527438964|FG001|Overall Study|Withdrawal by Subject|1|||
146022157|NCT01155466|526593203|FG004|Overall Study|Randomized not treated|2|||
146022158|NCT00590824|526593204|FG000|Overall Study|Disease could not be resected|0|||
146022159|NCT00590824|526593205|FG001|Overall Study|Disease could not be resected|2|||
146022160|NCT00590824|526593206|FG002|Overall Study|Disease could not be resected|1|||
146022161|NCT00590824|526593207|FG003|Overall Study|Disease could not be resected|0|||
146252928|NCT02446912|527438965|FG000|Overall Study|Adverse Event|3|||
146022162|NCT00590824|526593204|FG000|Overall Study|Adverse Event|0|||
146022163|NCT00590824|526593205|FG001|Overall Study|Adverse Event|0|||
146022164|NCT00590824|526593206|FG002|Overall Study|Adverse Event|0|||
146022165|NCT00590824|526593207|FG003|Overall Study|Adverse Event|1|||
146022166|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
146022167|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
146022168|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
146022169|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
146022170|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
146022171|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146022172|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
146022173|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
146022174|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
146022175|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
146022176|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Other|1|||
146022177|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Other|1|||
146022178|NCT02075047|526593208|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
146022179|NCT02075047|526593209|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
146022180|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
146022181|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
146022182|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
146022183|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
146022184|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
146022185|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
146022186|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
146022187|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
146022188|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
146022189|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
146022190|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Other|1|||
146022191|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Other|2|||
146022192|NCT02075047|526593208|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
146022193|NCT02075047|526593209|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
146022194|NCT01778049|526593217|FG000|Open Label Treatment Period|Adverse Event|5|||
146022195|NCT01778049|526593218|FG001|Open Label Treatment Period|Adverse Event|15|||
146022196|NCT01778049|526593219|FG002|Open Label Treatment Period|Adverse Event|0|||
146022197|NCT01778049|526593220|FG003|Open Label Treatment Period|Adverse Event|0|||
146022198|NCT01778049|526593221|FG004|Open Label Treatment Period|Adverse Event|0|||
146022199|NCT01778049|526593222|FG005|Open Label Treatment Period|Adverse Event|0|||
146022200|NCT01778049|526593217|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
146022201|NCT01778049|526593218|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
146022202|NCT01778049|526593219|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
146022203|NCT01778049|526593220|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
146022204|NCT01778049|526593221|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
146022205|NCT01778049|526593222|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
146022206|NCT01778049|526593217|FG000|Open Label Treatment Period|Protocol Violation|5|||
146022207|NCT01778049|526593218|FG001|Open Label Treatment Period|Protocol Violation|5|||
146022208|NCT01778049|526593219|FG002|Open Label Treatment Period|Protocol Violation|0|||
146022209|NCT01778049|526593220|FG003|Open Label Treatment Period|Protocol Violation|0|||
146022210|NCT01778049|526593221|FG004|Open Label Treatment Period|Protocol Violation|0|||
146022211|NCT01778049|526593222|FG005|Open Label Treatment Period|Protocol Violation|0|||
146022212|NCT01778049|526593217|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
146022213|NCT01778049|526593218|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
146022214|NCT01778049|526593219|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
146022215|NCT01778049|526593220|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
146022216|NCT01778049|526593221|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
146022217|NCT01778049|526593222|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
146022218|NCT01778049|526593217|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
146022219|NCT01778049|526593218|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
146022220|NCT01778049|526593219|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
146022221|NCT01778049|526593220|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
146022222|NCT01778049|526593221|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
146022223|NCT01778049|526593222|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
146022224|NCT01778049|526593217|FG000|Open Label Treatment Period|Not treated|2|||
146022225|NCT01778049|526593218|FG001|Open Label Treatment Period|Not treated|1|||
146022226|NCT01778049|526593219|FG002|Open Label Treatment Period|Not treated|0|||
146022227|NCT01778049|526593220|FG003|Open Label Treatment Period|Not treated|0|||
146022228|NCT01778049|526593221|FG004|Open Label Treatment Period|Not treated|0|||
146022229|NCT01778049|526593222|FG005|Open Label Treatment Period|Not treated|0|||
146022230|NCT01778049|526593217|FG000|Open Label Treatment Period|Other reason not defined above|77|||
146022231|NCT01778049|526593218|FG001|Open Label Treatment Period|Other reason not defined above|94|||
146094379|NCT03635788|526866636|FG001|Step 1|Other reasons|0|||
146022232|NCT01778049|526593219|FG002|Open Label Treatment Period|Other reason not defined above|0|||
146022233|NCT01778049|526593220|FG003|Open Label Treatment Period|Other reason not defined above|0|||
146022234|NCT01778049|526593221|FG004|Open Label Treatment Period|Other reason not defined above|0|||
146022235|NCT01778049|526593222|FG005|Open Label Treatment Period|Other reason not defined above|0|||
146022236|NCT01778049|526593217|FG000|Double Blind Treatment Period|Adverse Event|0|||
146022237|NCT01778049|526593218|FG001|Double Blind Treatment Period|Adverse Event|0|||
146022238|NCT01778049|526593219|FG002|Double Blind Treatment Period|Adverse Event|4|||
146022239|NCT01778049|526593220|FG003|Double Blind Treatment Period|Adverse Event|5|||
146022240|NCT01778049|526593221|FG004|Double Blind Treatment Period|Adverse Event|3|||
146022241|NCT01778049|526593222|FG005|Double Blind Treatment Period|Adverse Event|2|||
146022242|NCT01778049|526593217|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
146022243|NCT01778049|526593218|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146022244|NCT01778049|526593219|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146022245|NCT01778049|526593220|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
146022246|NCT01778049|526593221|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
146022247|NCT01778049|526593222|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
146022248|NCT01778049|526593217|FG000|Double Blind Treatment Period|Protocol Violation|0|||
146022249|NCT01778049|526593218|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146022250|NCT01778049|526593219|FG002|Double Blind Treatment Period|Protocol Violation|2|||
146022251|NCT01778049|526593220|FG003|Double Blind Treatment Period|Protocol Violation|0|||
146022252|NCT01778049|526593221|FG004|Double Blind Treatment Period|Protocol Violation|0|||
146022253|NCT01778049|526593222|FG005|Double Blind Treatment Period|Protocol Violation|0|||
146022254|NCT01778049|526593217|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
146022255|NCT01778049|526593218|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146022256|NCT01778049|526593219|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
146022257|NCT01778049|526593220|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
146022258|NCT01778049|526593221|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
146022259|NCT01778049|526593222|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
146022260|NCT01778049|526593217|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146022261|NCT01778049|526593218|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
146022262|NCT01778049|526593219|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
146022263|NCT01778049|526593220|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
146022264|NCT01778049|526593221|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146022265|NCT01778049|526593222|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
146022266|NCT01778049|526593217|FG000|Double Blind Treatment Period|Not treated|0|||
146022267|NCT01778049|526593218|FG001|Double Blind Treatment Period|Not treated|0|||
146022268|NCT01778049|526593219|FG002|Double Blind Treatment Period|Not treated|0|||
146022269|NCT01778049|526593220|FG003|Double Blind Treatment Period|Not treated|2|||
146022270|NCT01778049|526593221|FG004|Double Blind Treatment Period|Not treated|2|||
146022271|NCT01778049|526593222|FG005|Double Blind Treatment Period|Not treated|0|||
146022272|NCT01778049|526593217|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
146022273|NCT01778049|526593218|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
146022274|NCT01778049|526593219|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
146022275|NCT01778049|526593220|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
146022276|NCT01778049|526593221|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
146022277|NCT01778049|526593222|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
146022278|NCT00515294|526593226|FG000|Overall Study|Lost to Follow-up|3|||
146022279|NCT00515294|526593227|FG001|Overall Study|Lost to Follow-up|2|||
146022280|NCT00515294|526593228|FG002|Overall Study|Lost to Follow-up|3|||
146022281|NCT00515294|526593229|FG003|Overall Study|Lost to Follow-up|1|||
146022282|NCT00515294|526593226|FG000|Overall Study|Driver simulator problems|1|||
146022283|NCT00515294|526593227|FG001|Overall Study|Driver simulator problems|1|||
146022284|NCT00515294|526593228|FG002|Overall Study|Driver simulator problems|1|||
146022285|NCT00515294|526593229|FG003|Overall Study|Driver simulator problems|3|||
146022286|NCT00515294|526593226|FG000|Overall Study|Caffeine amount inaccurate|5|||
146022287|NCT00515294|526593227|FG001|Overall Study|Caffeine amount inaccurate|0|||
146022288|NCT00515294|526593228|FG002|Overall Study|Caffeine amount inaccurate|7|||
146252929|NCT02446912|527438966|FG001|Overall Study|Adverse Event|13|||
146252930|NCT02446912|527438967|FG002|Overall Study|Adverse Event|5|||
146252931|NCT02446912|527438965|FG000|Overall Study|Condition under investigation worsened|0|||
146252932|NCT02446912|527438966|FG001|Overall Study|Condition under investigation worsened|1|||
146022289|NCT00515294|526593229|FG003|Overall Study|Caffeine amount inaccurate|0|||
146022290|NCT03770728|526593232|FG000|Overall Study|Adverse Event|1|||
146022291|NCT03770728|526593233|FG001|Overall Study|Adverse Event|0|||
146022292|NCT03770728|526593234|FG002|Overall Study|Adverse Event|1|||
146252933|NCT02446912|527438967|FG002|Overall Study|Condition under investigation worsened|1|||
146252934|NCT02446912|527438965|FG000|Overall Study|Study-specific withdrawal criteria|1|||
146252935|NCT02446912|527438966|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146094380|NCT03635788|526866637|FG002|Step 1|Other reasons|0|||
146252936|NCT02446912|527438967|FG002|Overall Study|Study-specific withdrawal criteria|0|||
146022293|NCT03770728|526593235|FG003|Overall Study|Adverse Event|0|||
146022294|NCT03770728|526593232|FG000|Overall Study|Poor compliance to protocol|0|||
146022295|NCT03770728|526593233|FG001|Overall Study|Poor compliance to protocol|0|||
146022296|NCT03770728|526593234|FG002|Overall Study|Poor compliance to protocol|1|||
146022297|NCT03770728|526593235|FG003|Overall Study|Poor compliance to protocol|0|||
146022298|NCT03770728|526593232|FG000|Overall Study|Withdrawal by Subject|13|||
146022299|NCT03770728|526593233|FG001|Overall Study|Withdrawal by Subject|8|||
146022300|NCT03770728|526593234|FG002|Overall Study|Withdrawal by Subject|9|||
146022301|NCT03770728|526593235|FG003|Overall Study|Withdrawal by Subject|13|||
146022302|NCT03770728|526593232|FG000|Overall Study|Other than specified|24|||
146022303|NCT03770728|526593233|FG001|Overall Study|Other than specified|23|||
146022304|NCT03770728|526593234|FG002|Overall Study|Other than specified|21|||
146022305|NCT03770728|526593235|FG003|Overall Study|Other than specified|22|||
146022306|NCT02778555|526593239|FG000|Overall Study|Withdrawal by Subject|55|||
146022307|NCT02778555|526593240|FG001|Overall Study|Withdrawal by Subject|32|||
146022308|NCT02778555|526593241|FG002|Overall Study|Withdrawal by Subject|107|||
146022309|NCT02379988|526593242|FG000|Overall Study|Not eligible|1|||
146022310|NCT00107315|526593243|FG000|Overall Study|Disease Progression|9|||
146022311|NCT00107315|526593243|FG000|Overall Study|Adverse Event|4|||
146022312|NCT00107315|526593243|FG000|Overall Study|Withdrawal by Subject|2|||
146022313|NCT02509039|526593246|FG000|Overall Study|Adverse Event|0|||
146022314|NCT02509039|526593247|FG001|Overall Study|Adverse Event|1|||
146022315|NCT02509039|526593248|FG002|Overall Study|Adverse Event|1|||
146022316|NCT02509039|526593249|FG003|Overall Study|Adverse Event|1|||
146022317|NCT02509039|526593246|FG000|Overall Study|Withdrawal by Subject|0|||
146022318|NCT02509039|526593247|FG001|Overall Study|Withdrawal by Subject|0|||
146022319|NCT02509039|526593248|FG002|Overall Study|Withdrawal by Subject|1|||
146022320|NCT02509039|526593249|FG003|Overall Study|Withdrawal by Subject|0|||
146022321|NCT02509039|526593246|FG000|Overall Study|Progressive disease|2|||
146022322|NCT02509039|526593247|FG001|Overall Study|Progressive disease|2|||
146022323|NCT02509039|526593248|FG002|Overall Study|Progressive disease|1|||
146022324|NCT02509039|526593249|FG003|Overall Study|Progressive disease|5|||
146022325|NCT02509039|526593246|FG000|Overall Study|Study terminated by Sponsor|1|||
146022326|NCT02509039|526593247|FG001|Overall Study|Study terminated by Sponsor|0|||
146022327|NCT02509039|526593248|FG002|Overall Study|Study terminated by Sponsor|0|||
146022328|NCT02509039|526593249|FG003|Overall Study|Study terminated by Sponsor|0|||
146252937|NCT02446912|527438965|FG000|Overall Study|Lack of Efficacy|1|||
146252938|NCT02446912|527438966|FG001|Overall Study|Lack of Efficacy|4|||
146022329|NCT03943550|526593252|FG000|Overall Study|Adverse Event|0|||
146022330|NCT03943550|526593253|FG001|Overall Study|Adverse Event|0|||
146022331|NCT03943550|526593254|FG002|Overall Study|Adverse Event|1|||
146252939|NCT02446912|527438967|FG002|Overall Study|Lack of Efficacy|7|||
146252940|NCT02446912|527438965|FG000|Overall Study|Lost to Follow-up|0|||
146252941|NCT02446912|527438966|FG001|Overall Study|Lost to Follow-up|0|||
146252942|NCT02446912|527438967|FG002|Overall Study|Lost to Follow-up|2|||
146252943|NCT02446912|527438965|FG000|Overall Study|Severe non-compliance to protocol|1|||
146252944|NCT02446912|527438966|FG001|Overall Study|Severe non-compliance to protocol|0|||
146252945|NCT02446912|527438967|FG002|Overall Study|Severe non-compliance to protocol|1|||
146252946|NCT02446912|527438965|FG000|Overall Study|Withdrawal by Subject|10|||
146252947|NCT02446912|527438966|FG001|Overall Study|Withdrawal by Subject|15|||
146252948|NCT02446912|527438967|FG002|Overall Study|Withdrawal by Subject|15|||
146022332|NCT03943550|526593252|FG000|Overall Study|Lost to Follow-up|0|||
146022333|NCT03943550|526593253|FG001|Overall Study|Lost to Follow-up|0|||
146022334|NCT03943550|526593254|FG002|Overall Study|Lost to Follow-up|1|||
146022335|NCT03943550|526593252|FG000|Overall Study|Progressive Disease|0|||
146022336|NCT03943550|526593253|FG001|Overall Study|Progressive Disease|0|||
146022337|NCT03943550|526593254|FG002|Overall Study|Progressive Disease|2|||
146022338|NCT03943550|526593252|FG000|Overall Study|Participant Moved Out of the Country|0|||
146252949|NCT02446912|527438965|FG000|Overall Study|Miscellaneous|2|||
146252950|NCT02446912|527438966|FG001|Overall Study|Miscellaneous|2|||
146252951|NCT02446912|527438967|FG002|Overall Study|Miscellaneous|4|||
146252952|NCT01106586|527438970|FG000|Overall Study|Adverse Event|9|||
146252953|NCT01106586|527438971|FG001|Overall Study|Adverse Event|15|||
146252954|NCT01106586|527438970|FG000|Overall Study|Death|1|||
146252955|NCT01106586|527438971|FG001|Overall Study|Death|3|||
146252956|NCT01106586|527438970|FG000|Overall Study|Pregnancy|2|||
146252957|NCT01106586|527438971|FG001|Overall Study|Pregnancy|2|||
146252958|NCT01106586|527438970|FG000|Overall Study|Lack of Efficacy|1|||
146022339|NCT03943550|526593253|FG001|Overall Study|Participant Moved Out of the Country|1|||
146022340|NCT03943550|526593254|FG002|Overall Study|Participant Moved Out of the Country|0|||
146252959|NCT01106586|527438971|FG001|Overall Study|Lack of Efficacy|0|||
146022341|NCT00096226|526593255|FG000|Overall Study|Ineligible|2|||
146022342|NCT00096226|526593255|FG000|Overall Study|Protocol treatment not started|1|||
146022343|NCT04262882|526593256|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
146022344|NCT04262882|526593257|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
146022345|NCT04262882|526593256|FG000|Overall Study|Lost to Follow-up|1|||
146252960|NCT01106586|527438970|FG000|Overall Study|Investigator's Discretion|5|||
146022346|NCT04262882|526593257|FG001|Overall Study|Lost to Follow-up|0|||
146022347|NCT01327053|526593259|FG000|Overall Study|Adverse Event|23|||
146022348|NCT01327053|526593260|FG001|Overall Study|Adverse Event|57|||
146022349|NCT01327053|526593259|FG000|Overall Study|Patient/guardian decision|11|||
146022350|NCT01327053|526593260|FG001|Overall Study|Patient/guardian decision|35|||
146022351|NCT01327053|526593259|FG000|Overall Study|Physician Decision|10|||
146022352|NCT01327053|526593260|FG001|Overall Study|Physician Decision|14|||
146022353|NCT01327053|526593259|FG000|Overall Study|Death|1|||
146022354|NCT01327053|526593260|FG001|Overall Study|Death|5|||
146022355|NCT01327053|526593259|FG000|Overall Study|Lost to Follow-up|2|||
146022356|NCT01327053|526593260|FG001|Overall Study|Lost to Follow-up|4|||
146022357|NCT01327053|526593259|FG000|Overall Study|Non-compliance with study treatment|0|||
146022358|NCT01327053|526593260|FG001|Overall Study|Non-compliance with study treatment|5|||
146022359|NCT01327053|526593259|FG000|Overall Study|Study terminated by Sponsor|1|||
146022360|NCT01327053|526593260|FG001|Overall Study|Study terminated by Sponsor|3|||
146022361|NCT01327053|526593259|FG000|Overall Study|Progressive disease|31|||
146022362|NCT01327053|526593260|FG001|Overall Study|Progressive disease|26|||
146022363|NCT01327053|526593259|FG000|Overall Study|Protocol Violation|0|||
146022364|NCT01327053|526593260|FG001|Overall Study|Protocol Violation|1|||
146022365|NCT01327053|526593259|FG000|Overall Study|Untreated|0|||
146022366|NCT01327053|526593260|FG001|Overall Study|Untreated|1|||
146022367|NCT01638013|526593265|FG000|Overall Study|Adverse Event|36|||
146022368|NCT01638013|526593266|FG001|Overall Study|Adverse Event|29|||
146022369|NCT01638013|526593267|FG002|Overall Study|Adverse Event|48|||
146022370|NCT01638013|526593265|FG000|Overall Study|Lack of Efficacy|39|||
146022371|NCT01638013|526593266|FG001|Overall Study|Lack of Efficacy|11|||
146022372|NCT01638013|526593267|FG002|Overall Study|Lack of Efficacy|14|||
146022373|NCT01638013|526593265|FG000|Overall Study|Protocol Violation|10|||
146022374|NCT01638013|526593266|FG001|Overall Study|Protocol Violation|7|||
146022375|NCT01638013|526593267|FG002|Overall Study|Protocol Violation|11|||
146022376|NCT01638013|526593265|FG000|Overall Study|Met discontinuation criteria|4|||
146022377|NCT01638013|526593266|FG001|Overall Study|Met discontinuation criteria|0|||
146022378|NCT01638013|526593267|FG002|Overall Study|Met discontinuation criteria|7|||
146022379|NCT01638013|526593265|FG000|Overall Study|Subject Lost to Follow up|1|||
146022380|NCT01638013|526593266|FG001|Overall Study|Subject Lost to Follow up|0|||
146022381|NCT01638013|526593267|FG002|Overall Study|Subject Lost to Follow up|1|||
146022382|NCT01638013|526593265|FG000|Overall Study|Miscellaneous|25|||
146022383|NCT01638013|526593266|FG001|Overall Study|Miscellaneous|19|||
146022384|NCT01638013|526593267|FG002|Overall Study|Miscellaneous|23|||
146022385|NCT01638013|526593265|FG000|Overall Study|Withdrawal of Consent|16|||
146022386|NCT01638013|526593266|FG001|Overall Study|Withdrawal of Consent|12|||
146022387|NCT01638013|526593267|FG002|Overall Study|Withdrawal of Consent|16|||
146022388|NCT01638013|526593265|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
146022389|NCT01638013|526593266|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
146022390|NCT01638013|526593267|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
146022391|NCT02226198|526595139|FG000|Lead-in Phase|Protocol Violation|1|||
146022392|NCT02226198|526595140|FG001|Lead-in Phase|Protocol Violation|0|||
146022393|NCT02226198|526595141|FG002|Lead-in Phase|Protocol Violation|0|||
146022394|NCT02226198|526595139|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
146022395|NCT02226198|526595140|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
146022396|NCT02226198|526595141|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
146022397|NCT01440517|526595145|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
146022398|NCT01288612|526595147|FG000|Overall Study|Unable to contact|11|||
146022399|NCT01288612|526595148|FG001|Overall Study|Unable to contact|16|||
146022400|NCT01288612|526595149|FG002|Overall Study|Unable to contact|20|||
146022401|NCT01288612|526595147|FG000|Overall Study|Declined|78|||
146022402|NCT01288612|526595148|FG001|Overall Study|Declined|63|||
146022403|NCT01288612|526595149|FG002|Overall Study|Declined|62|||
146022404|NCT01288612|526595147|FG000|Overall Study|Unable to intubate|0|||
146022405|NCT01288612|526595148|FG001|Overall Study|Unable to intubate|3|||
146022406|NCT01288612|526595149|FG002|Overall Study|Unable to intubate|0|||
146022407|NCT00840060|526595150|FG000|Overall Study|Withdrawal by Subject|1|||
146022408|NCT00840060|526595151|FG001|Overall Study|Withdrawal by Subject|0|||
146022409|NCT00840060|526595150|FG000|Overall Study|Change in emotional/behavioral status|0|||
146022410|NCT00840060|526595151|FG001|Overall Study|Change in emotional/behavioral status|1|||
146094381|NCT03635788|526866635|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
146022411|NCT00871923|526595152|FG000|Overall Study|Death|1|||
146022412|NCT00871923|526595152|FG000|Overall Study|Withdrawal by Subject|1|||
146022413|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
146022414|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
146022415|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
146022416|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
146022417|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
146022418|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
146022419|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
146094382|NCT03635788|526866636|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
146022420|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
146252961|NCT01106586|527438971|FG001|Overall Study|Investigator's Discretion|8|||
146252962|NCT01106586|527438970|FG000|Overall Study|Withdrew Consent|18|||
146252963|NCT01106586|527438971|FG001|Overall Study|Withdrew Consent|30|||
146252964|NCT01106586|527438970|FG000|Overall Study|Lost to Follow-up|24|||
146252965|NCT01106586|527438971|FG001|Overall Study|Lost to Follow-up|20|||
146252966|NCT01106586|527438970|FG000|Overall Study|Participant Noncompliance|12|||
146252967|NCT01106586|527438971|FG001|Overall Study|Participant Noncompliance|10|||
146252968|NCT01106586|527438970|FG000|Overall Study|Protocol Violation|1|||
146252969|NCT01106586|527438971|FG001|Overall Study|Protocol Violation|0|||
146252970|NCT01106586|527438970|FG000|Overall Study|Participant Transferred to Another Study|212|||
146252971|NCT01106586|527438971|FG001|Overall Study|Participant Transferred to Another Study|197|||
146252972|NCT01757171|527438972|FG000|Overall Study|Adverse Event|5|||
146252973|NCT01757171|527438973|FG001|Overall Study|Adverse Event|1|||
146252974|NCT01757171|527438972|FG000|Overall Study|Disease Progression|1|||
146252975|NCT01757171|527438973|FG001|Overall Study|Disease Progression|0|||
146252976|NCT01757171|527438972|FG000|Overall Study|Hospitalization|1|||
146252977|NCT01757171|527438973|FG001|Overall Study|Hospitalization|0|||
146252978|NCT01757171|527438972|FG000|Overall Study|ECOG decline|1|||
146252979|NCT01757171|527438973|FG001|Overall Study|ECOG decline|0|||
146252980|NCT02504502|527438974|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
146300271|NCT03681951|527615196|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146022421|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
146022422|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
146022423|NCT01263015|526595157|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
146022424|NCT01263015|526595158|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
146022425|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
146022426|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
146022427|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
146252981|NCT02504502|527438975|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
146252982|NCT02504502|527438974|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
146252983|NCT02504502|527438975|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
146252984|NCT00428441|527438976|FG000|Overall Study|Lost to Follow-up|1|||
146252985|NCT02475733|527438977|FG000|Overall Study|Withdrawal by Subject|1|||
146252986|NCT02475733|527438978|FG001|Overall Study|Withdrawal by Subject|0|||
146252987|NCT02475733|527438977|FG000|Overall Study|Physician Decision|1|||
146252988|NCT02475733|527438978|FG001|Overall Study|Physician Decision|0|||
146252989|NCT00475735|527438979|FG000|Treatment Period 1|Adverse Event|2|||
146252990|NCT00475735|527438980|FG001|Treatment Period 1|Adverse Event|0|||
146022428|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
146022429|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
146022430|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
146022431|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
146022432|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
146022433|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
146022434|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
146022435|NCT01263015|526595157|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
146022436|NCT01263015|526595158|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
146022437|NCT05599451|526595159|FG000|Overall Study|Not randomized|11|||
146022438|NCT05599451|526595160|FG001|Overall Study|Not randomized|0|||
146022439|NCT05599451|526595161|FG002|Overall Study|Not randomized|0|||
146022440|NCT05599451|526595162|FG003|Overall Study|Not randomized|0|||
146022441|NCT05599451|526595163|FG004|Overall Study|Not randomized|0|||
146022442|NCT05599451|526595159|FG000|Overall Study|Physician Decision|0|||
146022443|NCT05599451|526595160|FG001|Overall Study|Physician Decision|0|||
146022444|NCT05599451|526595161|FG002|Overall Study|Physician Decision|0|||
146022445|NCT05599451|526595162|FG003|Overall Study|Physician Decision|1|||
146022446|NCT05599451|526595163|FG004|Overall Study|Physician Decision|0|||
146252991|NCT00475735|527438981|FG002|Treatment Period 1|Adverse Event|0|||
146252992|NCT00475735|527438982|FG003|Treatment Period 1|Adverse Event|0|||
146252993|NCT00475735|527438983|FG004|Treatment Period 1|Adverse Event|0|||
146252994|NCT00475735|527438984|FG005|Treatment Period 1|Adverse Event|0|||
146252995|NCT00475735|527438979|FG000|Treatment Period 1|Lack of Efficacy|1|||
146252996|NCT00475735|527438980|FG001|Treatment Period 1|Lack of Efficacy|0|||
146252997|NCT00475735|527438981|FG002|Treatment Period 1|Lack of Efficacy|0|||
146300272|NCT03681951|527615197|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146022447|NCT02723006|526595164|FG000|Overall Study|Withdrawal by Subject|0|||
146022448|NCT02723006|526595165|FG001|Overall Study|Withdrawal by Subject|1|||
146252998|NCT00475735|527438982|FG003|Treatment Period 1|Lack of Efficacy|0|||
146252999|NCT00475735|527438983|FG004|Treatment Period 1|Lack of Efficacy|0|||
146253000|NCT00475735|527438984|FG005|Treatment Period 1|Lack of Efficacy|0|||
146253001|NCT00475735|527438979|FG000|Treatment Period 1|Lost to Follow-up|0|||
146253002|NCT00475735|527438980|FG001|Treatment Period 1|Lost to Follow-up|0|||
146022449|NCT02723006|526595166|FG002|Overall Study|Withdrawal by Subject|1|||
146022450|NCT02723006|526595164|FG000|Overall Study|Study Terminated by Sponsor|1|||
146022451|NCT02723006|526595165|FG001|Overall Study|Study Terminated by Sponsor|6|||
146022452|NCT02723006|526595166|FG002|Overall Study|Study Terminated by Sponsor|6|||
146022453|NCT03392883|526595173|FG000|Overall Study|Lost to Follow-up|122|||
146022454|NCT03392883|526595174|FG001|Overall Study|Lost to Follow-up|13|||
146022455|NCT03392883|526595175|FG002|Overall Study|Lost to Follow-up|9|||
146022456|NCT03392883|526595173|FG000|Overall Study|Death|4|||
146022457|NCT03392883|526595174|FG001|Overall Study|Death|0|||
146022458|NCT03392883|526595175|FG002|Overall Study|Death|0|||
146022459|NCT03392883|526595173|FG000|Overall Study|Lack of Efficacy|29|||
146022460|NCT03392883|526595174|FG001|Overall Study|Lack of Efficacy|0|||
146022461|NCT03392883|526595175|FG002|Overall Study|Lack of Efficacy|0|||
146022462|NCT03392883|526595173|FG000|Overall Study|Withdrawal by Subject|180|||
146022463|NCT03392883|526595174|FG001|Overall Study|Withdrawal by Subject|0|||
146022464|NCT03392883|526595175|FG002|Overall Study|Withdrawal by Subject|0|||
146022465|NCT03392883|526595173|FG000|Overall Study|Adverse Event|1|||
146022466|NCT03392883|526595174|FG001|Overall Study|Adverse Event|0|||
146022467|NCT03392883|526595175|FG002|Overall Study|Adverse Event|0|||
146022468|NCT01739933|526595185|FG000|Overall Study|Death|89|||
146022469|NCT01739933|526595186|FG001|Overall Study|Death|86|||
146022470|NCT01739933|526595185|FG000|Overall Study|Withdrawal by Subject|10|||
146022471|NCT01739933|526595186|FG001|Overall Study|Withdrawal by Subject|8|||
146022472|NCT01739933|526595185|FG000|Overall Study|Lost to Follow-up|3|||
146022473|NCT01739933|526595186|FG001|Overall Study|Lost to Follow-up|10|||
146022474|NCT01739933|526595185|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
146022475|NCT01739933|526595186|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
146022476|NCT03356977|526595187|FG000|Overall Study|Lost to Follow-up|3|||
146022477|NCT03356977|526595187|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146022478|NCT00908115|526595193|FG000|Overall Study|Other|14|||
146022479|NCT01728077|526595194|FG000|Overall Study|Lack of Efficacy|3|||
146022480|NCT01728077|526595195|FG001|Overall Study|Lack of Efficacy|1|||
146022481|NCT01728077|526595194|FG000|Overall Study|Lost to Follow-up|1|||
146022482|NCT01728077|526595195|FG001|Overall Study|Lost to Follow-up|0|||
146022483|NCT01728077|526595194|FG000|Overall Study|Subject choice|2|||
146022484|NCT01728077|526595195|FG001|Overall Study|Subject choice|3|||
146022485|NCT01728077|526595194|FG000|Overall Study|Death|0|||
146022486|NCT01728077|526595195|FG001|Overall Study|Death|1|||
146022487|NCT01728077|526595194|FG000|Overall Study|Patient moving|1|||
146022488|NCT01728077|526595195|FG001|Overall Study|Patient moving|0|||
146022489|NCT01728077|526595194|FG000|Overall Study|Non compliance|1|||
146022490|NCT01728077|526595195|FG001|Overall Study|Non compliance|0|||
146022491|NCT00378599|526595199|FG000|Overall Study|Adverse Event|38|||
146022492|NCT00378599|526595199|FG000|Overall Study|Protocol Violation|2|||
146022493|NCT00378599|526595199|FG000|Overall Study|Treatment failure|7|||
146022494|NCT00378599|526595199|FG000|Overall Study|Withdrawal by Subject|5|||
146022495|NCT02680041|526595200|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
146022496|NCT02680041|526595200|FG000|Overall Study|Lost to Follow-up|2|||
146022497|NCT00521599|526595201|FG000|Overall Study|Adverse Event|5|||
146022498|NCT00521599|526595202|FG001|Overall Study|Adverse Event|7|||
146022499|NCT00521599|526595203|FG002|Overall Study|Adverse Event|6|||
146022500|NCT00521599|526595201|FG000|Overall Study|Treatment Failure|8|||
146022501|NCT00521599|526595202|FG001|Overall Study|Treatment Failure|9|||
146022502|NCT00521599|526595203|FG002|Overall Study|Treatment Failure|22|||
146022503|NCT00521599|526595201|FG000|Overall Study|Lost to Follow-up|2|||
146022504|NCT00521599|526595202|FG001|Overall Study|Lost to Follow-up|1|||
146022505|NCT00521599|526595203|FG002|Overall Study|Lost to Follow-up|2|||
146022506|NCT00521599|526595201|FG000|Overall Study|Withdrawal by Subject|3|||
146022507|NCT00521599|526595202|FG001|Overall Study|Withdrawal by Subject|5|||
146022508|NCT00521599|526595203|FG002|Overall Study|Withdrawal by Subject|1|||
146022509|NCT00521599|526595201|FG000|Overall Study|Withdrawal by subject treatment related|3|||
146022510|NCT00521599|526595202|FG001|Overall Study|Withdrawal by subject treatment related|1|||
146022511|NCT00521599|526595203|FG002|Overall Study|Withdrawal by subject treatment related|2|||
146022512|NCT00521599|526595201|FG000|Overall Study|Protocol Violation|2|||
146022513|NCT00521599|526595202|FG001|Overall Study|Protocol Violation|4|||
146022514|NCT00521599|526595203|FG002|Overall Study|Protocol Violation|2|||
146022515|NCT00521599|526595201|FG000|Overall Study|Did not meet protocol eligibility|2|||
146022516|NCT00521599|526595202|FG001|Overall Study|Did not meet protocol eligibility|2|||
146022517|NCT00521599|526595203|FG002|Overall Study|Did not meet protocol eligibility|1|||
146022518|NCT01610713|526595204|FG000|Overall Study|Adverse Event|3|||
146022519|NCT01610713|526595205|FG001|Overall Study|Adverse Event|0|||
146022520|NCT01610713|526595204|FG000|Overall Study|Lack of Efficacy|1|||
146022521|NCT01610713|526595205|FG001|Overall Study|Lack of Efficacy|0|||
146022522|NCT01610713|526595204|FG000|Overall Study|low mood and poor motivation|1|||
146022523|NCT01610713|526595205|FG001|Overall Study|low mood and poor motivation|0|||
146022524|NCT01610713|526595204|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
146022525|NCT01610713|526595205|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
146022526|NCT01610713|526595204|FG000|Overall Study|Lost to Follow-up|0|||
146022527|NCT01610713|526595205|FG001|Overall Study|Lost to Follow-up|1|||
146022528|NCT01774097|526595210|FG000|Overall Study|Withdrawal by Subject|1|||
146022529|NCT01774097|526595211|FG001|Overall Study|Withdrawal by Subject|1|||
146022530|NCT01774097|526595210|FG000|Overall Study|Adverse Event|1|||
146022531|NCT01774097|526595211|FG001|Overall Study|Adverse Event|1|||
146022532|NCT00557310|526595212|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
146022533|NCT00557310|526595212|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
146022534|NCT00557310|526595212|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
146022535|NCT00557310|526595212|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
146022536|NCT00557310|526595212|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
146022537|NCT00557310|526595212|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
146022538|NCT01271712|526595219|FG000|Double Blind Treatment|Death|2|||
146022539|NCT01271712|526595220|FG001|Double Blind Treatment|Death|0|||
146022540|NCT01271712|526595219|FG000|Double Blind Treatment|Lack of Efficacy|1|||
146022541|NCT01271712|526595220|FG001|Double Blind Treatment|Lack of Efficacy|0|||
146022542|NCT01271712|526595219|FG000|Double Blind Treatment|Adverse Event|9|||
146022543|NCT01271712|526595220|FG001|Double Blind Treatment|Adverse Event|4|||
146022544|NCT01271712|526595219|FG000|Double Blind Treatment|Progressive disease|23|||
146022545|NCT01271712|526595220|FG001|Double Blind Treatment|Progressive disease|3|||
146022546|NCT01271712|526595219|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
146022547|NCT01271712|526595220|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
146022548|NCT01271712|526595219|FG000|Double Blind Treatment|Non compliance with study drug|2|||
146022549|NCT01271712|526595220|FG001|Double Blind Treatment|Non compliance with study drug|0|||
146253003|NCT00475735|527438981|FG002|Treatment Period 1|Lost to Follow-up|0|||
146022550|NCT01271712|526595219|FG000|Double Blind Treatment|receive no study drug|1|||
146022551|NCT01271712|526595220|FG001|Double Blind Treatment|receive no study drug|0|||
146022552|NCT01271712|526595219|FG000|Open Label Treatment|Death|6|||
146022553|NCT01271712|526595220|FG001|Open Label Treatment|Death|5|||
146022554|NCT01271712|526595219|FG000|Open Label Treatment|Withdrawal by Subject|6|||
146022555|NCT01271712|526595220|FG001|Open Label Treatment|Withdrawal by Subject|11|||
146022556|NCT01271712|526595219|FG000|Open Label Treatment|Physician Decision|2|||
146022557|NCT01271712|526595220|FG001|Open Label Treatment|Physician Decision|0|||
146022558|NCT01271712|526595219|FG000|Open Label Treatment|Adverse Event|14|||
146022559|NCT01271712|526595220|FG001|Open Label Treatment|Adverse Event|8|||
146022560|NCT01271712|526595219|FG000|Open Label Treatment|Progressive disease|59|||
146022561|NCT01271712|526595220|FG001|Open Label Treatment|Progressive disease|32|||
146022562|NCT01271712|526595219|FG000|Open Label Treatment|transferred to rollover study|1|||
146022563|NCT01271712|526595220|FG001|Open Label Treatment|transferred to rollover study|0|||
146022564|NCT01271712|526595219|FG000|Open Label Treatment|Non-compliance with study drug|1|||
146022565|NCT01271712|526595220|FG001|Open Label Treatment|Non-compliance with study drug|0|||
146022566|NCT01271712|526595219|FG000|Open Label Treatment|Protocol Violation|0|||
146022567|NCT01271712|526595220|FG001|Open Label Treatment|Protocol Violation|1|||
146022568|NCT01271712|526595219|FG000|Open Label Treatment|Switching to other therapy|2|||
146022569|NCT01271712|526595220|FG001|Open Label Treatment|Switching to other therapy|1|||
146022570|NCT01271712|526595219|FG000|Safety Follow-up|Death|11|||
146253004|NCT00475735|527438982|FG003|Treatment Period 1|Lost to Follow-up|0|||
146253005|NCT00475735|527438983|FG004|Treatment Period 1|Lost to Follow-up|0|||
146253006|NCT00475735|527438984|FG005|Treatment Period 1|Lost to Follow-up|1|||
146253007|NCT00475735|527438979|FG000|Treatment Period 1|Protocol Violation|0|||
146253008|NCT00475735|527438980|FG001|Treatment Period 1|Protocol Violation|0|||
146253009|NCT00475735|527438981|FG002|Treatment Period 1|Protocol Violation|0|||
146253010|NCT00475735|527438982|FG003|Treatment Period 1|Protocol Violation|1|||
146253011|NCT00475735|527438983|FG004|Treatment Period 1|Protocol Violation|0|||
146253012|NCT00475735|527438984|FG005|Treatment Period 1|Protocol Violation|0|||
146253013|NCT00475735|527438979|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146253014|NCT00475735|527438980|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146253015|NCT00475735|527438981|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146253016|NCT00475735|527438982|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146253017|NCT00475735|527438983|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146253018|NCT00475735|527438984|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146253019|NCT00475735|527438979|FG000|Treatment Period 1|DC due to AE but continuing|0|||
146253020|NCT00475735|527438980|FG001|Treatment Period 1|DC due to AE but continuing|0|||
146253021|NCT00475735|527438981|FG002|Treatment Period 1|DC due to AE but continuing|0|||
146253022|NCT00475735|527438982|FG003|Treatment Period 1|DC due to AE but continuing|1|||
146022571|NCT01271712|526595220|FG001|Safety Follow-up|Death|7|||
146022572|NCT01271712|526595219|FG000|Safety Follow-up|Withdrawal by Subject|4|||
146022573|NCT01271712|526595220|FG001|Safety Follow-up|Withdrawal by Subject|2|||
146022574|NCT01271712|526595219|FG000|Safety Follow-up|Protocol Violation|1|||
146022575|NCT01271712|526595220|FG001|Safety Follow-up|Protocol Violation|1|||
146022576|NCT01271712|526595219|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
146022577|NCT01271712|526595220|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
146253023|NCT00475735|527438983|FG004|Treatment Period 1|DC due to AE but continuing|2|||
146253024|NCT00475735|527438984|FG005|Treatment Period 1|DC due to AE but continuing|2|||
146253025|NCT00475735|527438979|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146022578|NCT01271712|526595219|FG000|Safety Follow-up|No follow-up|1|||
146022579|NCT01271712|526595220|FG001|Safety Follow-up|No follow-up|1|||
146022580|NCT01271712|526595219|FG000|Safety Follow-up|Progressive disease|1|||
146022581|NCT01271712|526595220|FG001|Safety Follow-up|Progressive disease|0|||
146022582|NCT01271712|526595219|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
146022583|NCT01271712|526595220|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
146022584|NCT03099174|526595221|FG000|Overall Study|Withdrawal by Subject|0|||
146022585|NCT03099174|526595222|FG001|Overall Study|Withdrawal by Subject|0|||
146022586|NCT03099174|526595223|FG002|Overall Study|Withdrawal by Subject|1|||
146022587|NCT03099174|526595224|FG003|Overall Study|Withdrawal by Subject|0|||
146022588|NCT03099174|526595225|FG004|Overall Study|Withdrawal by Subject|2|||
146022589|NCT03099174|526595226|FG005|Overall Study|Withdrawal by Subject|2|||
146022590|NCT03099174|526595227|FG006|Overall Study|Withdrawal by Subject|1|||
146022591|NCT03099174|526595228|FG007|Overall Study|Withdrawal by Subject|4|||
146022592|NCT03099174|526595221|FG000|Overall Study|Adverse Event|0|||
146022593|NCT03099174|526595222|FG001|Overall Study|Adverse Event|1|||
146022594|NCT03099174|526595223|FG002|Overall Study|Adverse Event|1|||
146022595|NCT03099174|526595224|FG003|Overall Study|Adverse Event|2|||
146022596|NCT03099174|526595225|FG004|Overall Study|Adverse Event|5|||
146022597|NCT03099174|526595226|FG005|Overall Study|Adverse Event|3|||
146022598|NCT03099174|526595227|FG006|Overall Study|Adverse Event|6|||
146022599|NCT03099174|526595228|FG007|Overall Study|Adverse Event|4|||
146022600|NCT03099174|526595221|FG000|Overall Study|Other than listed|6|||
146022601|NCT03099174|526595222|FG001|Overall Study|Other than listed|6|||
146022602|NCT03099174|526595223|FG002|Overall Study|Other than listed|5|||
146022603|NCT03099174|526595224|FG003|Overall Study|Other than listed|6|||
146022604|NCT03099174|526595225|FG004|Overall Study|Other than listed|19|||
146022605|NCT03099174|526595226|FG005|Overall Study|Other than listed|10|||
146094383|NCT03635788|526866637|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
146094384|NCT03635788|526866635|FG000|Step 2|Lost to Follow-up|0|||
146094385|NCT03635788|526866636|FG001|Step 2|Lost to Follow-up|8|||
146094386|NCT03635788|526866637|FG002|Step 2|Lost to Follow-up|15|||
146094387|NCT03635788|526866635|FG000|Step 2|Withdrawal by Subject|0|||
146094388|NCT03635788|526866636|FG001|Step 2|Withdrawal by Subject|6|||
146094389|NCT03635788|526866637|FG002|Step 2|Withdrawal by Subject|6|||
146094390|NCT03635788|526866635|FG000|Step 2|Death|0|||
146094391|NCT03635788|526866636|FG001|Step 2|Death|2|||
146094392|NCT03635788|526866637|FG002|Step 2|Death|0|||
146094393|NCT03635788|526866635|FG000|Step 2|Incarceration|0|||
146094394|NCT03635788|526866636|FG001|Step 2|Incarceration|2|||
146094395|NCT03635788|526866637|FG002|Step 2|Incarceration|0|||
146094396|NCT03635788|526866635|FG000|Step 2|Non-Compliance With Study Requirements|0|||
146094397|NCT03635788|526866636|FG001|Step 2|Non-Compliance With Study Requirements|1|||
146094398|NCT03635788|526866637|FG002|Step 2|Non-Compliance With Study Requirements|1|||
146094399|NCT03635788|526866635|FG000|Step 2|Confounding Medical Condition|0|||
146094400|NCT03635788|526866636|FG001|Step 2|Confounding Medical Condition|0|||
146094401|NCT03635788|526866637|FG002|Step 2|Confounding Medical Condition|1|||
146094402|NCT03635788|526866635|FG000|Step 2|Out Of State With No Plan To Return|0|||
146094403|NCT03635788|526866636|FG001|Step 2|Out Of State With No Plan To Return|1|||
146094404|NCT03635788|526866637|FG002|Step 2|Out Of State With No Plan To Return|0|||
146094405|NCT03635788|526866635|FG000|Step 2|Switched To Injectables|0|||
146094406|NCT03635788|526866636|FG001|Step 2|Switched To Injectables|0|||
146094407|NCT03635788|526866637|FG002|Step 2|Switched To Injectables|1|||
146094408|NCT03635788|526866635|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
146094409|NCT03635788|526866636|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
146094410|NCT03635788|526866637|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
146094411|NCT01015131|526866638|FG000|Overall Study|Physician Decision|1|||
146094412|NCT01015131|526866638|FG000|Overall Study|Protocol Violation|1|||
146094413|NCT01015131|526866638|FG000|Overall Study|Withdrawal by Subject|2|||
146094414|NCT01015131|526866638|FG000|Overall Study|Other Protocol Specified Criteria|4|||
146094415|NCT05521906|526866644|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
146094416|NCT05521906|526866645|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
146094417|NCT02349061|526867792|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
146253026|NCT00475735|527438980|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
146253027|NCT00475735|527438981|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146022606|NCT03099174|526595227|FG006|Overall Study|Other than listed|26|||
146022607|NCT03099174|526595228|FG007|Overall Study|Other than listed|23|||
146022608|NCT04173260|526595229|FG000|Overall Study|Early termination|4|||
146022609|NCT02308163|526595230|FG000|Overall Study|Not fulfill eligible criteria|1|||
146022610|NCT02308163|526595231|FG001|Overall Study|Not fulfill eligible criteria|2|||
146094418|NCT02349061|526867793|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
146094419|NCT02349061|526867794|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
146094420|NCT02349061|526867792|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
146094421|NCT02349061|526867793|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
146022611|NCT02308163|526595232|FG002|Overall Study|Not fulfill eligible criteria|0|||
146094422|NCT02349061|526867794|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
146094423|NCT02349061|526867792|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
146022612|NCT02308163|526595233|FG003|Overall Study|Not fulfill eligible criteria|1|||
146022613|NCT02308163|526595234|FG004|Overall Study|Not fulfill eligible criteria|1|||
146022614|NCT02308163|526595230|FG000|Overall Study|Adverse Event|9|||
146022615|NCT02308163|526595231|FG001|Overall Study|Adverse Event|5|||
146022616|NCT02308163|526595232|FG002|Overall Study|Adverse Event|2|||
146022617|NCT02308163|526595233|FG003|Overall Study|Adverse Event|2|||
146022618|NCT02308163|526595234|FG004|Overall Study|Adverse Event|11|||
146022619|NCT02308163|526595230|FG000|Overall Study|Lack of Efficacy|11|||
146022620|NCT02308163|526595231|FG001|Overall Study|Lack of Efficacy|3|||
146022621|NCT02308163|526595232|FG002|Overall Study|Lack of Efficacy|8|||
146022622|NCT02308163|526595233|FG003|Overall Study|Lack of Efficacy|4|||
146022623|NCT02308163|526595234|FG004|Overall Study|Lack of Efficacy|6|||
146022624|NCT02308163|526595230|FG000|Overall Study|Withdrawal of consent|2|||
146022625|NCT02308163|526595231|FG001|Overall Study|Withdrawal of consent|3|||
146022626|NCT02308163|526595232|FG002|Overall Study|Withdrawal of consent|0|||
146022627|NCT02308163|526595233|FG003|Overall Study|Withdrawal of consent|2|||
146022628|NCT02308163|526595234|FG004|Overall Study|Withdrawal of consent|6|||
146022629|NCT02308163|526595230|FG000|Overall Study|Protocol Violation|3|||
146022630|NCT02308163|526595231|FG001|Overall Study|Protocol Violation|3|||
146022631|NCT02308163|526595232|FG002|Overall Study|Protocol Violation|3|||
146022632|NCT02308163|526595233|FG003|Overall Study|Protocol Violation|2|||
146022633|NCT02308163|526595234|FG004|Overall Study|Protocol Violation|5|||
146022634|NCT02308163|526595230|FG000|Overall Study|Lab data met discontinuation criteria|3|||
146022635|NCT02308163|526595231|FG001|Overall Study|Lab data met discontinuation criteria|0|||
146022636|NCT02308163|526595232|FG002|Overall Study|Lab data met discontinuation criteria|0|||
146094424|NCT02349061|526867793|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
146094425|NCT02349061|526867794|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
146094426|NCT02349061|526867792|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
146094427|NCT02349061|526867793|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
146094428|NCT02349061|526867794|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
146094429|NCT02349061|526867792|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
146094430|NCT02349061|526867793|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
146094431|NCT02349061|526867794|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
146094432|NCT02349061|526867792|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
146094433|NCT02349061|526867793|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
146094434|NCT02349061|526867794|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
146094435|NCT02349061|526867792|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
146094436|NCT02349061|526867793|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
146094437|NCT02349061|526867794|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
146094438|NCT02349061|526867792|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
146094439|NCT02349061|526867793|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
146094440|NCT02349061|526867794|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
146094441|NCT02349061|526867792|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
146094442|NCT02349061|526867793|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
146094443|NCT02349061|526867794|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
146094444|NCT02349061|526867792|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
146094445|NCT02349061|526867793|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
146094446|NCT02349061|526867794|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
146094447|NCT02349061|526867792|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
146094448|NCT02349061|526867793|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
146094449|NCT02349061|526867794|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
146094450|NCT02349061|526867792|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
146094451|NCT02349061|526867793|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
146094452|NCT02349061|526867794|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
146094453|NCT02349061|526867792|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
146094454|NCT02349061|526867793|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
146094455|NCT02349061|526867794|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
146094456|NCT02339285|526867795|FG000|Overall Study|Withdrawal by Subject|0|||
146094457|NCT02339285|526867796|FG001|Overall Study|Withdrawal by Subject|1|||
146253028|NCT00475735|527438982|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146022637|NCT02308163|526595233|FG003|Overall Study|Lab data met discontinuation criteria|2|||
146022638|NCT02308163|526595234|FG004|Overall Study|Lab data met discontinuation criteria|0|||
146022639|NCT02308163|526595230|FG000|Overall Study|Miscellaneous|2|||
146022640|NCT02308163|526595231|FG001|Overall Study|Miscellaneous|2|||
146022641|NCT02308163|526595232|FG002|Overall Study|Miscellaneous|1|||
146022642|NCT02308163|526595233|FG003|Overall Study|Miscellaneous|0|||
146094458|NCT02339285|526867797|FG002|Overall Study|Withdrawal by Subject|1|||
146094459|NCT02339285|526867795|FG000|Overall Study|Lost to Follow-up|1|||
146022643|NCT02308163|526595234|FG004|Overall Study|Miscellaneous|5|||
146022644|NCT02118766|526595240|FG000|Overall Study|Adverse Event|7|||
146022645|NCT02118766|526595241|FG001|Overall Study|Adverse Event|2|||
146253029|NCT00475735|527438983|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146253030|NCT00475735|527438984|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
146253031|NCT00475735|527438979|FG000|Treatment Washout|Lost to Follow-up|0|||
146253032|NCT00475735|527438980|FG001|Treatment Washout|Lost to Follow-up|1|||
146253033|NCT00475735|527438981|FG002|Treatment Washout|Lost to Follow-up|0|||
146253034|NCT00475735|527438982|FG003|Treatment Washout|Lost to Follow-up|0|||
146253035|NCT00475735|527438983|FG004|Treatment Washout|Lost to Follow-up|0|||
146253036|NCT00475735|527438984|FG005|Treatment Washout|Lost to Follow-up|0|||
146253037|NCT00475735|527438979|FG000|Treatment Washout|Protocol Violation|0|||
146253038|NCT00475735|527438980|FG001|Treatment Washout|Protocol Violation|1|||
146253039|NCT00475735|527438981|FG002|Treatment Washout|Protocol Violation|0|||
146253040|NCT00475735|527438982|FG003|Treatment Washout|Protocol Violation|0|||
146253041|NCT00475735|527438983|FG004|Treatment Washout|Protocol Violation|0|||
146253042|NCT00475735|527438984|FG005|Treatment Washout|Protocol Violation|0|||
146253043|NCT00475735|527438979|FG000|Treatment Period 2|Adverse Event|0|||
146253044|NCT00475735|527438980|FG001|Treatment Period 2|Adverse Event|1|||
146253045|NCT00475735|527438981|FG002|Treatment Period 2|Adverse Event|0|||
146253046|NCT00475735|527438982|FG003|Treatment Period 2|Adverse Event|2|||
146253047|NCT00475735|527438983|FG004|Treatment Period 2|Adverse Event|0|||
146253048|NCT00475735|527438984|FG005|Treatment Period 2|Adverse Event|0|||
146253049|NCT00475735|527438979|FG000|Treatment Period 2|Lack of Efficacy|0|||
146253050|NCT00475735|527438980|FG001|Treatment Period 2|Lack of Efficacy|0|||
146253051|NCT00475735|527438981|FG002|Treatment Period 2|Lack of Efficacy|0|||
146253052|NCT00475735|527438982|FG003|Treatment Period 2|Lack of Efficacy|0|||
146253053|NCT00475735|527438983|FG004|Treatment Period 2|Lack of Efficacy|0|||
146253054|NCT00475735|527438984|FG005|Treatment Period 2|Lack of Efficacy|1|||
146253055|NCT00475735|527438979|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146253056|NCT00475735|527438980|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146253057|NCT00475735|527438981|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146253058|NCT00475735|527438982|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146253059|NCT00475735|527438983|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146253060|NCT00475735|527438984|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146253061|NCT00296504|527438991|FG000|Interim Analysis|Withdrawal by Subject|8|||
146253062|NCT00296504|527438992|FG001|Interim Analysis|Withdrawal by Subject|0|||
146253063|NCT00296504|527438993|FG002|Interim Analysis|Withdrawal by Subject|12|||
146253064|NCT00296504|527438994|FG003|Interim Analysis|Withdrawal by Subject|0|||
146253065|NCT00296504|527438995|FG004|Interim Analysis|Withdrawal by Subject|5|||
146253066|NCT00296504|527438996|FG005|Interim Analysis|Withdrawal by Subject|5|||
146253067|NCT00296504|527438997|FG006|Interim Analysis|Withdrawal by Subject|9|||
146253068|NCT00296504|527438998|FG007|Interim Analysis|Withdrawal by Subject|3|||
146253069|NCT00296504|527438999|FG008|Interim Analysis|Withdrawal by Subject|0|||
146253070|NCT00296504|527438991|FG000|Interim Analysis|Lost to Follow-up|13|||
146253071|NCT00296504|527438992|FG001|Interim Analysis|Lost to Follow-up|3|||
146253072|NCT00296504|527438993|FG002|Interim Analysis|Lost to Follow-up|26|||
146253073|NCT00296504|527438994|FG003|Interim Analysis|Lost to Follow-up|8|||
146253074|NCT00296504|527438995|FG004|Interim Analysis|Lost to Follow-up|14|||
146253075|NCT00296504|527438996|FG005|Interim Analysis|Lost to Follow-up|4|||
146253076|NCT00296504|527438997|FG006|Interim Analysis|Lost to Follow-up|11|||
146253077|NCT00296504|527438998|FG007|Interim Analysis|Lost to Follow-up|4|||
146253078|NCT00296504|527438999|FG008|Interim Analysis|Lost to Follow-up|0|||
146253079|NCT00296504|527438991|FG000|Interim Analysis|Clinical Progression|1|||
146253080|NCT00296504|527438992|FG001|Interim Analysis|Clinical Progression|0|||
146022646|NCT02118766|526595240|FG000|Overall Study|Withdrawal by Subject|3|||
146022647|NCT02118766|526595241|FG001|Overall Study|Withdrawal by Subject|6|||
146022648|NCT02118766|526595240|FG000|Overall Study|Lost to Follow-up|5|||
146022649|NCT02118766|526595241|FG001|Overall Study|Lost to Follow-up|4|||
146022650|NCT02118766|526595240|FG000|Overall Study|Withdrawal by parent/guardian|12|||
146022651|NCT02118766|526595241|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146022652|NCT02118766|526595240|FG000|Overall Study|Other|3|||
146022653|NCT02118766|526595241|FG001|Overall Study|Other|1|||
146022654|NCT03941964|526595242|FG000|Overall Study|Adverse Event|1|||
146253081|NCT00296504|527438993|FG002|Interim Analysis|Clinical Progression|1|||
146253082|NCT00296504|527438994|FG003|Interim Analysis|Clinical Progression|1|||
146253083|NCT00296504|527438995|FG004|Interim Analysis|Clinical Progression|0|||
146253084|NCT00296504|527438996|FG005|Interim Analysis|Clinical Progression|2|||
146253085|NCT00296504|527438997|FG006|Interim Analysis|Clinical Progression|1|||
146253086|NCT00296504|527438998|FG007|Interim Analysis|Clinical Progression|2|||
146022655|NCT03941964|526595243|FG001|Overall Study|Adverse Event|8|||
146022656|NCT03941964|526595242|FG000|Overall Study|Progressive disease|7|||
146022657|NCT03941964|526595243|FG001|Overall Study|Progressive disease|3|||
146022658|NCT03941964|526595242|FG000|Overall Study|Lack of Efficacy|0|||
146094460|NCT02339285|526867796|FG001|Overall Study|Lost to Follow-up|1|||
146094461|NCT02339285|526867797|FG002|Overall Study|Lost to Follow-up|1|||
146253087|NCT00296504|527438999|FG008|Interim Analysis|Clinical Progression|0|||
146253088|NCT00296504|527438991|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
146022659|NCT03941964|526595243|FG001|Overall Study|Lack of Efficacy|1|||
146022660|NCT03941964|526595242|FG000|Overall Study|Death|3|||
146022661|NCT03941964|526595243|FG001|Overall Study|Death|1|||
146022662|NCT03941964|526595242|FG000|Overall Study|Withdrew consent|1|||
146022663|NCT03941964|526595243|FG001|Overall Study|Withdrew consent|3|||
146022664|NCT03941964|526595242|FG000|Overall Study|Physician Decision|9|||
146022665|NCT03941964|526595243|FG001|Overall Study|Physician Decision|2|||
146022666|NCT03941964|526595242|FG000|Overall Study|Other, not specified|2|||
146022667|NCT03941964|526595243|FG001|Overall Study|Other, not specified|1|||
146022668|NCT00118846|526595245|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
146022669|NCT00118846|526595246|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
146022670|NCT00118846|526595245|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
146022671|NCT00118846|526595246|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
146022672|NCT00118846|526595245|FG000|Overall Study|Physician Decision|1|||
146022673|NCT00118846|526595246|FG001|Overall Study|Physician Decision|0|||
146022674|NCT00118846|526595245|FG000|Overall Study|Medical condition|2|||
146022675|NCT00118846|526595246|FG001|Overall Study|Medical condition|2|||
146022676|NCT00118846|526595245|FG000|Overall Study|Lost to Follow-up|0|||
146022677|NCT00118846|526595246|FG001|Overall Study|Lost to Follow-up|2|||
146022678|NCT00118846|526595245|FG000|Overall Study|Personal reason|4|||
146022679|NCT00118846|526595246|FG001|Overall Study|Personal reason|5|||
146022680|NCT00443053|526595250|FG000|Overall Study|Adverse Event|2|||
146022681|NCT00443053|526595251|FG001|Overall Study|Adverse Event|1|||
146022682|NCT00443053|526595250|FG000|Overall Study|Withdrawal by Subject|9|||
146022683|NCT00443053|526595251|FG001|Overall Study|Withdrawal by Subject|18|||
146022684|NCT00443053|526595250|FG000|Overall Study|Lost to Follow-up|4|||
146022685|NCT00443053|526595251|FG001|Overall Study|Lost to Follow-up|5|||
146022686|NCT00443053|526595250|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
146022687|NCT00443053|526595251|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146022688|NCT00443053|526595250|FG000|Overall Study|Noncompliance|2|||
146022689|NCT00443053|526595251|FG001|Overall Study|Noncompliance|1|||
146022690|NCT00443053|526595250|FG000|Overall Study|Other|3|||
146022691|NCT00443053|526595251|FG001|Overall Study|Other|4|||
146022692|NCT00443053|526595250|FG000|Overall Study|Physician Decision|0|||
146022693|NCT00443053|526595251|FG001|Overall Study|Physician Decision|4|||
146022694|NCT00541866|526595252|FG000|Overall Study|Adverse Event|3|||
146022695|NCT00541866|526595253|FG001|Overall Study|Adverse Event|0|||
146022696|NCT00541866|526595254|FG002|Overall Study|Adverse Event|0|||
146022697|NCT00541866|526595255|FG003|Overall Study|Adverse Event|0|||
146022698|NCT00541866|526595256|FG004|Overall Study|Adverse Event|0|||
146022699|NCT00541866|526595252|FG000|Overall Study|Death|1|||
146022700|NCT00541866|526595253|FG001|Overall Study|Death|0|||
146022701|NCT00541866|526595254|FG002|Overall Study|Death|0|||
146022702|NCT00541866|526595255|FG003|Overall Study|Death|0|||
146022703|NCT00541866|526595256|FG004|Overall Study|Death|0|||
146022704|NCT00541866|526595252|FG000|Overall Study|Lack of Efficacy|19|||
146022705|NCT00541866|526595253|FG001|Overall Study|Lack of Efficacy|15|||
146022706|NCT00541866|526595254|FG002|Overall Study|Lack of Efficacy|10|||
146022707|NCT00541866|526595255|FG003|Overall Study|Lack of Efficacy|12|||
146022708|NCT00541866|526595256|FG004|Overall Study|Lack of Efficacy|14|||
146022709|NCT00541866|526595252|FG000|Overall Study|Not Reported or Other|11|||
146022710|NCT00541866|526595253|FG001|Overall Study|Not Reported or Other|3|||
146022711|NCT00541866|526595254|FG002|Overall Study|Not Reported or Other|3|||
146022712|NCT00541866|526595255|FG003|Overall Study|Not Reported or Other|3|||
146022713|NCT00541866|526595256|FG004|Overall Study|Not Reported or Other|1|||
146253089|NCT00296504|527438992|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
146253090|NCT00296504|527438993|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
146253091|NCT00296504|527438994|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
146253092|NCT00296504|527438995|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
146022714|NCT00541866|526595252|FG000|Overall Study|Physician Decision|0|||
146022715|NCT00541866|526595253|FG001|Overall Study|Physician Decision|0|||
146022716|NCT00541866|526595254|FG002|Overall Study|Physician Decision|2|||
146022717|NCT00541866|526595255|FG003|Overall Study|Physician Decision|1|||
146022718|NCT00541866|526595256|FG004|Overall Study|Physician Decision|0|||
146022719|NCT04669262|526595257|FG000|Overall Study|Withdrawal by Subject|0|||
146022720|NCT04669262|526595258|FG001|Overall Study|Withdrawal by Subject|0|||
146022721|NCT04669262|526595259|FG002|Overall Study|Withdrawal by Subject|0|||
146022722|NCT04669262|526595260|FG003|Overall Study|Withdrawal by Subject|1|||
146022723|NCT04669262|526595257|FG000|Overall Study|Randomized but Not Treated|0|||
146022724|NCT04669262|526595258|FG001|Overall Study|Randomized but Not Treated|1|||
146022725|NCT04669262|526595259|FG002|Overall Study|Randomized but Not Treated|0|||
146022726|NCT04669262|526595260|FG003|Overall Study|Randomized but Not Treated|0|||
146022727|NCT05463744|526595262|FG000|Treatment Period|Withdrawal by Subject|19|||
146253093|NCT00296504|527438996|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
146253094|NCT00296504|527438997|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
146022728|NCT05463744|526595263|FG001|Treatment Period|Withdrawal by Subject|16|||
146022729|NCT05463744|526595262|FG000|Treatment Period|Adverse Event|4|||
146022730|NCT05463744|526595263|FG001|Treatment Period|Adverse Event|4|||
146022731|NCT05463744|526595262|FG000|Treatment Period|Pregnancy|0|||
146253095|NCT00296504|527438998|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
146253096|NCT00296504|527438999|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
146253097|NCT00296504|527438991|FG000|Interim Analysis|Adverse Event|0|||
146253098|NCT00296504|527438992|FG001|Interim Analysis|Adverse Event|0|||
146253099|NCT00296504|527438993|FG002|Interim Analysis|Adverse Event|13|||
146253100|NCT00296504|527438994|FG003|Interim Analysis|Adverse Event|4|||
146253101|NCT00296504|527438995|FG004|Interim Analysis|Adverse Event|6|||
146253102|NCT00296504|527438996|FG005|Interim Analysis|Adverse Event|3|||
146253103|NCT00296504|527438997|FG006|Interim Analysis|Adverse Event|4|||
146253104|NCT00296504|527438998|FG007|Interim Analysis|Adverse Event|5|||
146253105|NCT00296504|527438999|FG008|Interim Analysis|Adverse Event|0|||
146253106|NCT00296504|527438991|FG000|Interim Analysis|Protocol Violation|0|||
146253107|NCT00296504|527438992|FG001|Interim Analysis|Protocol Violation|0|||
146253108|NCT00296504|527438993|FG002|Interim Analysis|Protocol Violation|2|||
146253109|NCT00296504|527438994|FG003|Interim Analysis|Protocol Violation|0|||
146253110|NCT00296504|527438995|FG004|Interim Analysis|Protocol Violation|1|||
146253111|NCT00296504|527438996|FG005|Interim Analysis|Protocol Violation|0|||
146253112|NCT00296504|527438997|FG006|Interim Analysis|Protocol Violation|0|||
146253113|NCT00296504|527438998|FG007|Interim Analysis|Protocol Violation|1|||
146253114|NCT00296504|527438999|FG008|Interim Analysis|Protocol Violation|0|||
146253115|NCT00296504|527438991|FG000|Interim Analysis|Insufficient CD4 Response|0|||
146253116|NCT00296504|527438992|FG001|Interim Analysis|Insufficient CD4 Response|0|||
146253117|NCT00296504|527438993|FG002|Interim Analysis|Insufficient CD4 Response|0|||
146253118|NCT00296504|527438994|FG003|Interim Analysis|Insufficient CD4 Response|0|||
146253119|NCT00296504|527438995|FG004|Interim Analysis|Insufficient CD4 Response|1|||
146253120|NCT00296504|527438996|FG005|Interim Analysis|Insufficient CD4 Response|1|||
146253121|NCT00296504|527438997|FG006|Interim Analysis|Insufficient CD4 Response|0|||
146253122|NCT00296504|527438998|FG007|Interim Analysis|Insufficient CD4 Response|0|||
146253123|NCT00296504|527438999|FG008|Interim Analysis|Insufficient CD4 Response|0|||
146253124|NCT00296504|527438991|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
146253125|NCT00296504|527438992|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
146253126|NCT00296504|527438993|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
146253127|NCT00296504|527438994|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
146253128|NCT00296504|527438995|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
146253129|NCT00296504|527438996|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
146253130|NCT00296504|527438997|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
146253131|NCT00296504|527438998|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
146253132|NCT00296504|527438999|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
146253133|NCT00296504|527438991|FG000|Interim Analysis|Pregnancy|4|||
146253134|NCT00296504|527438992|FG001|Interim Analysis|Pregnancy|1|||
146253135|NCT00296504|527438993|FG002|Interim Analysis|Pregnancy|4|||
146253136|NCT00296504|527438994|FG003|Interim Analysis|Pregnancy|2|||
146253137|NCT00296504|527438995|FG004|Interim Analysis|Pregnancy|0|||
146253138|NCT00296504|527438996|FG005|Interim Analysis|Pregnancy|1|||
146253139|NCT00296504|527438997|FG006|Interim Analysis|Pregnancy|1|||
146253140|NCT00296504|527438998|FG007|Interim Analysis|Pregnancy|1|||
146253141|NCT00296504|527438999|FG008|Interim Analysis|Pregnancy|0|||
146253142|NCT00296504|527438991|FG000|Interim Analysis|Death|1|||
146253143|NCT00296504|527438992|FG001|Interim Analysis|Death|0|||
146253144|NCT00296504|527438993|FG002|Interim Analysis|Death|3|||
146253145|NCT00296504|527438994|FG003|Interim Analysis|Death|0|||
146253146|NCT00296504|527438995|FG004|Interim Analysis|Death|0|||
146253147|NCT00296504|527438996|FG005|Interim Analysis|Death|0|||
146253148|NCT00296504|527438997|FG006|Interim Analysis|Death|0|||
146253149|NCT00296504|527438998|FG007|Interim Analysis|Death|0|||
146253150|NCT00296504|527438999|FG008|Interim Analysis|Death|0|||
146253151|NCT00296504|527438991|FG000|Interim Analysis|Participant Non-compliant|0|||
146022732|NCT05463744|526595263|FG001|Treatment Period|Pregnancy|3|||
146022733|NCT05463744|526595262|FG000|Treatment Period|Lost to Follow-up|1|||
146022734|NCT05463744|526595263|FG001|Treatment Period|Lost to Follow-up|3|||
146253152|NCT00296504|527438992|FG001|Interim Analysis|Participant Non-compliant|1|||
146253153|NCT00296504|527438993|FG002|Interim Analysis|Participant Non-compliant|2|||
146022735|NCT05463744|526595262|FG000|Treatment Period|Inadvertent enrollment|2|||
146022736|NCT05463744|526595263|FG001|Treatment Period|Inadvertent enrollment|1|||
146253154|NCT00296504|527438994|FG003|Interim Analysis|Participant Non-compliant|1|||
146253155|NCT00296504|527438995|FG004|Interim Analysis|Participant Non-compliant|1|||
146253156|NCT00296504|527438996|FG005|Interim Analysis|Participant Non-compliant|3|||
146253157|NCT00296504|527438997|FG006|Interim Analysis|Participant Non-compliant|6|||
146253158|NCT00296504|527438998|FG007|Interim Analysis|Participant Non-compliant|2|||
146253159|NCT00296504|527438999|FG008|Interim Analysis|Participant Non-compliant|0|||
146253160|NCT00296504|527438991|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146253161|NCT00296504|527438992|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146253162|NCT00296504|527438993|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
146253163|NCT00296504|527438994|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146022737|NCT05463744|526595262|FG000|Treatment Period|Death|0|||
146022738|NCT05463744|526595263|FG001|Treatment Period|Death|1|||
146022739|NCT05463744|526595262|FG000|Treatment Period|Non-compliance with Study Drug|1|||
146022740|NCT05463744|526595263|FG001|Treatment Period|Non-compliance with Study Drug|0|||
146022741|NCT05463744|526595262|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
146022742|NCT05463744|526595263|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
146022743|NCT05463744|526595262|FG000|Treatment Period|Physician Decision|0|||
146022744|NCT05463744|526595263|FG001|Treatment Period|Physician Decision|1|||
146022745|NCT05463744|526595262|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146022746|NCT05463744|526595263|FG001|Follow-Up Period|Withdrawal by Subject|1|||
146022747|NCT05463744|526595262|FG000|Follow-Up Period|Lost to Follow-up|1|||
146022748|NCT05463744|526595263|FG001|Follow-Up Period|Lost to Follow-up|1|||
146022749|NCT01904149|526595266|FG000|Overall Study|Adverse Event|3|||
146022750|NCT01904149|526595267|FG001|Overall Study|Adverse Event|4|||
146022751|NCT01904149|526595268|FG002|Overall Study|Adverse Event|0|||
146022752|NCT01904149|526595269|FG003|Overall Study|Adverse Event|1|||
146022753|NCT01904149|526595270|FG004|Overall Study|Adverse Event|1|||
146022754|NCT01904149|526595271|FG005|Overall Study|Adverse Event|2|||
146022755|NCT01904149|526595266|FG000|Overall Study|Lack of Efficacy|0|||
146022756|NCT01904149|526595267|FG001|Overall Study|Lack of Efficacy|3|||
146022757|NCT01904149|526595268|FG002|Overall Study|Lack of Efficacy|1|||
146022758|NCT01904149|526595269|FG003|Overall Study|Lack of Efficacy|3|||
146022759|NCT01904149|526595270|FG004|Overall Study|Lack of Efficacy|3|||
146022760|NCT01904149|526595271|FG005|Overall Study|Lack of Efficacy|1|||
146022761|NCT01904149|526595266|FG000|Overall Study|Withdrawal by Subject|1|||
146022762|NCT01904149|526595267|FG001|Overall Study|Withdrawal by Subject|3|||
146022763|NCT01904149|526595268|FG002|Overall Study|Withdrawal by Subject|1|||
146022764|NCT01904149|526595269|FG003|Overall Study|Withdrawal by Subject|0|||
146022765|NCT01904149|526595270|FG004|Overall Study|Withdrawal by Subject|1|||
146022766|NCT01904149|526595271|FG005|Overall Study|Withdrawal by Subject|0|||
146022767|NCT01904149|526595266|FG000|Overall Study|Protocol Violation|0|||
146022768|NCT01904149|526595267|FG001|Overall Study|Protocol Violation|1|||
146022769|NCT01904149|526595268|FG002|Overall Study|Protocol Violation|0|||
146022770|NCT01904149|526595269|FG003|Overall Study|Protocol Violation|0|||
146022771|NCT01904149|526595270|FG004|Overall Study|Protocol Violation|0|||
146022772|NCT01904149|526595271|FG005|Overall Study|Protocol Violation|0|||
146022773|NCT01904149|526595266|FG000|Overall Study|non compliance with study drug|1|||
146022774|NCT01904149|526595267|FG001|Overall Study|non compliance with study drug|0|||
146022775|NCT01904149|526595268|FG002|Overall Study|non compliance with study drug|0|||
146022776|NCT01904149|526595269|FG003|Overall Study|non compliance with study drug|0|||
146022777|NCT01904149|526595270|FG004|Overall Study|non compliance with study drug|0|||
146022778|NCT01904149|526595271|FG005|Overall Study|non compliance with study drug|0|||
146022779|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
146022780|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
146022781|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Death|1|||
146022782|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Death|0|||
146022783|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
146022784|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
146022785|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
146022786|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
146022787|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
146022788|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
146022789|NCT00350272|526595272|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
146022790|NCT00350272|526595273|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
146022791|NCT00350272|526595272|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
146022792|NCT00350272|526595273|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
146022793|NCT00350272|526595272|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
146094462|NCT02339285|526867795|FG000|Overall Study|Protocol Deviation|0|||
146253164|NCT00296504|527438995|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146022794|NCT00350272|526595273|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
146022795|NCT00350272|526595272|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
146022796|NCT00350272|526595273|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
146022797|NCT00350272|526595272|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
146022798|NCT00350272|526595273|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
146022799|NCT00350272|526595272|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
146022800|NCT00350272|526595273|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
146022801|NCT01357161|526595274|FG000|Part 1 (Open Label Run-in)|Death|5|||
146022802|NCT01357161|526595275|FG001|Part 1 (Open Label Run-in)|Death|0|||
146022803|NCT01357161|526595276|FG002|Part 1 (Open Label Run-in)|Death|0|||
146022804|NCT01357161|526595274|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
146022805|NCT01357161|526595275|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
146022806|NCT01357161|526595276|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
146022807|NCT01357161|526595274|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
146022808|NCT01357161|526595275|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
146022809|NCT01357161|526595276|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
146022810|NCT01357161|526595274|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
146022811|NCT01357161|526595275|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
146022812|NCT01357161|526595276|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
146022813|NCT01357161|526595274|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
146022814|NCT01357161|526595275|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
146022815|NCT01357161|526595276|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
146022816|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
146022817|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
146022818|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
146022819|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
146022820|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
146022821|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
146022822|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
146022823|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
146022824|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
146022825|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
146022826|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
146022827|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
146022828|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
146022829|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
146022830|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
146022831|NCT01357161|526595274|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
146022832|NCT01357161|526595275|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
146022833|NCT01357161|526595276|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
146022834|NCT00068250|526595277|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
146022835|NCT00068250|526595278|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
146022836|NCT00068250|526595279|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
146022837|NCT00068250|526595280|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
146022838|NCT01824823|526595281|FG000|Overall Study|Lack of Efficacy|1|||
146022839|NCT01824823|526595282|FG001|Overall Study|Lack of Efficacy|1|||
146022840|NCT01824823|526595281|FG000|Overall Study|Off-treatment reason not submitted|1|||
146022841|NCT01824823|526595282|FG001|Overall Study|Off-treatment reason not submitted|0|||
146022842|NCT00098748|526595284|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
146022843|NCT00098748|526595285|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
146022844|NCT00098748|526595286|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
146022845|NCT00098748|526595284|FG000|Received Study Treatment|Death|2|||
146022846|NCT00098748|526595285|FG001|Received Study Treatment|Death|1|||
146022847|NCT00098748|526595286|FG002|Received Study Treatment|Death|2|||
146022848|NCT00098748|526595284|FG000|Received Study Treatment|Adverse Event|1|||
146022849|NCT00098748|526595285|FG001|Received Study Treatment|Adverse Event|2|||
146022850|NCT00098748|526595286|FG002|Received Study Treatment|Adverse Event|5|||
146022851|NCT00098748|526595284|FG000|Received Study Treatment|Lack of Efficacy|40|||
146022852|NCT00098748|526595285|FG001|Received Study Treatment|Lack of Efficacy|27|||
146022853|NCT00098748|526595286|FG002|Received Study Treatment|Lack of Efficacy|27|||
146022854|NCT00098748|526595284|FG000|Received Study Treatment|Other|2|||
146022855|NCT00098748|526595285|FG001|Received Study Treatment|Other|2|||
146022856|NCT00098748|526595286|FG002|Received Study Treatment|Other|6|||
146022857|NCT00098748|526595284|FG000|Received Study Treatment|Subject defaulted|3|||
146022858|NCT00098748|526595285|FG001|Received Study Treatment|Subject defaulted|4|||
146022859|NCT00098748|526595286|FG002|Received Study Treatment|Subject defaulted|4|||
146022860|NCT00098748|526595284|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
146022861|NCT00098748|526595285|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
146022862|NCT00098748|526595286|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
146022863|NCT00098748|526595284|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
146022864|NCT00098748|526595285|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
146022865|NCT00098748|526595286|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
146022866|NCT00098748|526595284|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
146022867|NCT00098748|526595285|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
146022868|NCT00098748|526595286|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
146022869|NCT00098748|526595284|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
146022870|NCT00098748|526595285|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
146022871|NCT00098748|526595286|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
146022872|NCT00098748|526595284|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
146022873|NCT00098748|526595285|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
146094463|NCT02339285|526867796|FG001|Overall Study|Protocol Deviation|1|||
146253165|NCT00296504|527438996|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
146022874|NCT00098748|526595286|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
146022875|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
146022876|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
146253166|NCT00296504|527438997|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146253167|NCT00296504|527438998|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146253168|NCT00296504|527438999|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
146253169|NCT00296504|527438991|FG000|Interim Analysis|To Simplify Treatment|0|||
146253170|NCT00296504|527438992|FG001|Interim Analysis|To Simplify Treatment|0|||
146253171|NCT00296504|527438993|FG002|Interim Analysis|To Simplify Treatment|1|||
146253172|NCT00296504|527438994|FG003|Interim Analysis|To Simplify Treatment|0|||
146253173|NCT00296504|527438995|FG004|Interim Analysis|To Simplify Treatment|0|||
146253174|NCT00296504|527438996|FG005|Interim Analysis|To Simplify Treatment|0|||
146253175|NCT00296504|527438997|FG006|Interim Analysis|To Simplify Treatment|2|||
146253176|NCT00296504|527438998|FG007|Interim Analysis|To Simplify Treatment|0|||
146253177|NCT00296504|527438999|FG008|Interim Analysis|To Simplify Treatment|0|||
146253178|NCT00296504|527438991|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253179|NCT00296504|527438992|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253180|NCT00296504|527438993|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
146253181|NCT00296504|527438994|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253182|NCT00296504|527438995|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253183|NCT00296504|527438996|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253184|NCT00296504|527438997|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253185|NCT00296504|527438998|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253186|NCT00296504|527438999|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
146253187|NCT00296504|527438991|FG000|Interim Analysis|Participant Moved|1|||
146253188|NCT00296504|527438992|FG001|Interim Analysis|Participant Moved|0|||
146253189|NCT00296504|527438993|FG002|Interim Analysis|Participant Moved|1|||
146253190|NCT00296504|527438994|FG003|Interim Analysis|Participant Moved|0|||
146253191|NCT00296504|527438995|FG004|Interim Analysis|Participant Moved|0|||
146253192|NCT00296504|527438996|FG005|Interim Analysis|Participant Moved|1|||
146253193|NCT00296504|527438997|FG006|Interim Analysis|Participant Moved|1|||
146253194|NCT00296504|527438998|FG007|Interim Analysis|Participant Moved|0|||
146253195|NCT00296504|527438999|FG008|Interim Analysis|Participant Moved|0|||
146253196|NCT00296504|527438991|FG000|Interim Analysis|Participant Was Incarcerated|2|||
146253197|NCT00296504|527438992|FG001|Interim Analysis|Participant Was Incarcerated|0|||
146253198|NCT00296504|527438993|FG002|Interim Analysis|Participant Was Incarcerated|1|||
146253199|NCT00296504|527438994|FG003|Interim Analysis|Participant Was Incarcerated|0|||
146253200|NCT00296504|527438995|FG004|Interim Analysis|Participant Was Incarcerated|0|||
146253201|NCT00296504|527438996|FG005|Interim Analysis|Participant Was Incarcerated|0|||
146253202|NCT00296504|527438997|FG006|Interim Analysis|Participant Was Incarcerated|0|||
146253203|NCT00296504|527438998|FG007|Interim Analysis|Participant Was Incarcerated|0|||
146253204|NCT00296504|527438999|FG008|Interim Analysis|Participant Was Incarcerated|0|||
146253205|NCT00296504|527438991|FG000|Interim Analysis|Resistance to FPV|0|||
146253206|NCT00296504|527438992|FG001|Interim Analysis|Resistance to FPV|0|||
146253207|NCT00296504|527438993|FG002|Interim Analysis|Resistance to FPV|1|||
146253208|NCT00296504|527438994|FG003|Interim Analysis|Resistance to FPV|0|||
146253209|NCT00296504|527438995|FG004|Interim Analysis|Resistance to FPV|0|||
146253210|NCT00296504|527438996|FG005|Interim Analysis|Resistance to FPV|0|||
146253211|NCT00296504|527438997|FG006|Interim Analysis|Resistance to FPV|0|||
146253212|NCT00296504|527438998|FG007|Interim Analysis|Resistance to FPV|0|||
146022877|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Death|0|||
146022878|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Death|0|||
146022879|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146022880|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146022881|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
146022882|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
146022883|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
146022884|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
146022885|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
146022886|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
146022887|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
146022888|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
146022889|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
146022890|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
146022891|NCT00433160|526595291|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
146022892|NCT00433160|526595292|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
146253213|NCT00296504|527438999|FG008|Interim Analysis|Resistance to FPV|0|||
146253214|NCT00296504|527438991|FG000|Interim Analysis|Physician Decision|0|||
146253215|NCT00296504|527438992|FG001|Interim Analysis|Physician Decision|0|||
146253216|NCT00296504|527438993|FG002|Interim Analysis|Physician Decision|1|||
146253217|NCT00296504|527438994|FG003|Interim Analysis|Physician Decision|0|||
146253218|NCT00296504|527438995|FG004|Interim Analysis|Physician Decision|0|||
146022893|NCT00433160|526595291|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
146253219|NCT00296504|527438996|FG005|Interim Analysis|Physician Decision|0|||
146253220|NCT00296504|527438997|FG006|Interim Analysis|Physician Decision|0|||
146253221|NCT00296504|527438998|FG007|Interim Analysis|Physician Decision|0|||
146253222|NCT00296504|527438999|FG008|Interim Analysis|Physician Decision|0|||
146253223|NCT00296504|527438991|FG000|Interim Analysis|Principle Investigator Discretion|2|||
146253224|NCT00296504|527438992|FG001|Interim Analysis|Principle Investigator Discretion|0|||
146253225|NCT00296504|527438993|FG002|Interim Analysis|Principle Investigator Discretion|1|||
146253226|NCT00296504|527438994|FG003|Interim Analysis|Principle Investigator Discretion|1|||
146253227|NCT00296504|527438995|FG004|Interim Analysis|Principle Investigator Discretion|0|||
146253228|NCT00296504|527438996|FG005|Interim Analysis|Principle Investigator Discretion|0|||
146253229|NCT00296504|527438997|FG006|Interim Analysis|Principle Investigator Discretion|0|||
146253230|NCT00296504|527438998|FG007|Interim Analysis|Principle Investigator Discretion|0|||
146253231|NCT00296504|527438999|FG008|Interim Analysis|Principle Investigator Discretion|0|||
146253232|NCT00296504|527438991|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
146253233|NCT00296504|527438992|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
146253234|NCT00296504|527438993|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
146253235|NCT00296504|527438994|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
146253236|NCT00296504|527438995|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
146253237|NCT00296504|527438996|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
146253238|NCT00296504|527438997|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
146253239|NCT00296504|527438998|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
146253240|NCT00296504|527438999|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
146253241|NCT00296504|527438991|FG000|Interim Analysis|Non-adherence|2|||
146253242|NCT00296504|527438992|FG001|Interim Analysis|Non-adherence|0|||
146253243|NCT00296504|527438993|FG002|Interim Analysis|Non-adherence|0|||
146253244|NCT00296504|527438994|FG003|Interim Analysis|Non-adherence|0|||
146253245|NCT00296504|527438995|FG004|Interim Analysis|Non-adherence|1|||
146253246|NCT00296504|527438996|FG005|Interim Analysis|Non-adherence|0|||
146253247|NCT00296504|527438997|FG006|Interim Analysis|Non-adherence|0|||
146253248|NCT00296504|527438998|FG007|Interim Analysis|Non-adherence|1|||
146253249|NCT00296504|527438999|FG008|Interim Analysis|Non-adherence|0|||
146253250|NCT00296504|527438991|FG000|Interim Analysis|Site Closing|1|||
146253251|NCT00296504|527438992|FG001|Interim Analysis|Site Closing|0|||
146253252|NCT00296504|527438993|FG002|Interim Analysis|Site Closing|0|||
146253253|NCT00296504|527438994|FG003|Interim Analysis|Site Closing|0|||
146253254|NCT00296504|527438995|FG004|Interim Analysis|Site Closing|0|||
146253255|NCT00296504|527438996|FG005|Interim Analysis|Site Closing|1|||
146253256|NCT00296504|527438997|FG006|Interim Analysis|Site Closing|2|||
146253257|NCT00296504|527438998|FG007|Interim Analysis|Site Closing|0|||
146253258|NCT00296504|527438999|FG008|Interim Analysis|Site Closing|0|||
146022894|NCT00433160|526595292|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
146022895|NCT00433160|526595291|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
146022896|NCT00433160|526595292|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
146022897|NCT00433160|526595291|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
146022898|NCT00433160|526595292|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
146022899|NCT00433160|526595291|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
146022900|NCT00433160|526595292|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
146022901|NCT00433160|526595291|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
146022902|NCT00433160|526595292|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
146022903|NCT00433160|526595291|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
146253259|NCT00296504|527438991|FG000|Interim Analysis|Lack of Personnel at Site|1|||
146253260|NCT00296504|527438992|FG001|Interim Analysis|Lack of Personnel at Site|0|||
146253261|NCT00296504|527438993|FG002|Interim Analysis|Lack of Personnel at Site|0|||
146253262|NCT00296504|527438994|FG003|Interim Analysis|Lack of Personnel at Site|0|||
146253263|NCT00296504|527438995|FG004|Interim Analysis|Lack of Personnel at Site|0|||
146253264|NCT00296504|527438996|FG005|Interim Analysis|Lack of Personnel at Site|0|||
146253265|NCT00296504|527438997|FG006|Interim Analysis|Lack of Personnel at Site|0|||
146253266|NCT00296504|527438998|FG007|Interim Analysis|Lack of Personnel at Site|0|||
146253267|NCT00296504|527438999|FG008|Interim Analysis|Lack of Personnel at Site|0|||
146253268|NCT00296504|527438991|FG000|Interim Analysis|Missed Schedule Date|1|||
146253269|NCT00296504|527438992|FG001|Interim Analysis|Missed Schedule Date|0|||
146253270|NCT00296504|527438993|FG002|Interim Analysis|Missed Schedule Date|0|||
146253271|NCT00296504|527438994|FG003|Interim Analysis|Missed Schedule Date|0|||
146253272|NCT00296504|527438995|FG004|Interim Analysis|Missed Schedule Date|0|||
146253273|NCT00296504|527438996|FG005|Interim Analysis|Missed Schedule Date|0|||
146253274|NCT00296504|527438997|FG006|Interim Analysis|Missed Schedule Date|0|||
146253275|NCT00296504|527438998|FG007|Interim Analysis|Missed Schedule Date|0|||
146253276|NCT00296504|527438999|FG008|Interim Analysis|Missed Schedule Date|0|||
146022904|NCT00433160|526595292|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
146022905|NCT00433160|526595291|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
146022906|NCT00433160|526595292|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
146022907|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
146253277|NCT00296504|527438991|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
146253278|NCT00296504|527438992|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
146253279|NCT00296504|527438993|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
146253280|NCT00296504|527438994|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
146253281|NCT00296504|527438995|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
146253282|NCT00296504|527438996|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
146253283|NCT00296504|527438997|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
146253284|NCT00296504|527438998|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
146253285|NCT00296504|527438999|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
146253286|NCT00296504|527438991|FG000|Interim Analysis|Participant Stopped|0|||
146253287|NCT00296504|527438992|FG001|Interim Analysis|Participant Stopped|0|||
146253288|NCT00296504|527438993|FG002|Interim Analysis|Participant Stopped|0|||
146253289|NCT00296504|527438994|FG003|Interim Analysis|Participant Stopped|0|||
146253290|NCT00296504|527438995|FG004|Interim Analysis|Participant Stopped|1|||
146253291|NCT00296504|527438996|FG005|Interim Analysis|Participant Stopped|0|||
146253292|NCT00296504|527438997|FG006|Interim Analysis|Participant Stopped|0|||
146253293|NCT00296504|527438998|FG007|Interim Analysis|Participant Stopped|0|||
146253294|NCT00296504|527438999|FG008|Interim Analysis|Participant Stopped|0|||
146253295|NCT00296504|527438991|FG000|Interim Analysis|Physician and Participant Decision|0|||
146253296|NCT00296504|527438992|FG001|Interim Analysis|Physician and Participant Decision|0|||
146253297|NCT00296504|527438993|FG002|Interim Analysis|Physician and Participant Decision|0|||
146253298|NCT00296504|527438994|FG003|Interim Analysis|Physician and Participant Decision|0|||
146253299|NCT00296504|527438995|FG004|Interim Analysis|Physician and Participant Decision|0|||
146253300|NCT00296504|527438996|FG005|Interim Analysis|Physician and Participant Decision|1|||
146253301|NCT00296504|527438997|FG006|Interim Analysis|Physician and Participant Decision|0|||
146253302|NCT00296504|527438998|FG007|Interim Analysis|Physician and Participant Decision|0|||
146253303|NCT00296504|527438999|FG008|Interim Analysis|Physician and Participant Decision|0|||
146253304|NCT00296504|527438991|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
146253305|NCT00296504|527438992|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
146253306|NCT00296504|527438993|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
146253307|NCT00296504|527438994|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
146253308|NCT00296504|527438995|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
146253309|NCT00296504|527438996|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
146022908|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146022909|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146022910|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
146022911|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
146022912|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
146022913|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
146022914|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
146022915|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
146022916|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
146022917|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
146022918|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
146022919|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
146022920|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
146022921|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
146022922|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
146022923|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146022924|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
146022925|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146022926|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
146094464|NCT02339285|526867797|FG002|Overall Study|Protocol Deviation|0|||
146094465|NCT00282412|526867800|FG000|Overall Study|Death|2|||
146253310|NCT00296504|527438997|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
146253311|NCT00296504|527438998|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
146253312|NCT00296504|527438999|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
146253313|NCT00296504|527438991|FG000|Interim Analysis|Study Ended|0|||
146253314|NCT00296504|527438992|FG001|Interim Analysis|Study Ended|0|||
146253315|NCT00296504|527438993|FG002|Interim Analysis|Study Ended|0|||
146253316|NCT00296504|527438994|FG003|Interim Analysis|Study Ended|0|||
146253317|NCT00296504|527438995|FG004|Interim Analysis|Study Ended|0|||
146253318|NCT00296504|527438996|FG005|Interim Analysis|Study Ended|0|||
146253319|NCT00296504|527438997|FG006|Interim Analysis|Study Ended|1|||
146253320|NCT00296504|527438998|FG007|Interim Analysis|Study Ended|0|||
146022927|NCT03222973|526595301|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
146022928|NCT03222973|526595302|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
146022929|NCT03222973|526595303|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
146022930|NCT03222973|526595304|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
146022931|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146253321|NCT00296504|527438999|FG008|Interim Analysis|Study Ended|0|||
146022932|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146094466|NCT01507298|526867803|FG000|Overall Study|Protocol Violation|0|||
146253322|NCT00296504|527438991|FG000|Interim Analysis|Participant Needed Interferon|0|||
146253323|NCT00296504|527438992|FG001|Interim Analysis|Participant Needed Interferon|0|||
146253324|NCT00296504|527438993|FG002|Interim Analysis|Participant Needed Interferon|0|||
146253325|NCT00296504|527438994|FG003|Interim Analysis|Participant Needed Interferon|0|||
146253326|NCT00296504|527438995|FG004|Interim Analysis|Participant Needed Interferon|0|||
146253327|NCT00296504|527438996|FG005|Interim Analysis|Participant Needed Interferon|0|||
146253328|NCT00296504|527438997|FG006|Interim Analysis|Participant Needed Interferon|0|||
146253329|NCT00296504|527438998|FG007|Interim Analysis|Participant Needed Interferon|1|||
146253330|NCT00296504|527438999|FG008|Interim Analysis|Participant Needed Interferon|0|||
146253331|NCT00296504|527438991|FG000|Interim Analysis|Ongoing|32|||
146253332|NCT00296504|527438992|FG001|Interim Analysis|Ongoing|12|||
146253333|NCT00296504|527438993|FG002|Interim Analysis|Ongoing|16|||
146253334|NCT00296504|527438994|FG003|Interim Analysis|Ongoing|22|||
146253335|NCT00296504|527438995|FG004|Interim Analysis|Ongoing|0|||
146253336|NCT00296504|527438996|FG005|Interim Analysis|Ongoing|0|||
146253337|NCT00296504|527438997|FG006|Interim Analysis|Ongoing|30|||
146253338|NCT00296504|527438998|FG007|Interim Analysis|Ongoing|1|||
146253339|NCT00296504|527438999|FG008|Interim Analysis|Ongoing|0|||
146253340|NCT00296504|527438991|FG000|Final Analysis|Withdrawal by Subject|0|||
146253341|NCT00296504|527438992|FG001|Final Analysis|Withdrawal by Subject|0|||
146253342|NCT00296504|527438993|FG002|Final Analysis|Withdrawal by Subject|0|||
146253343|NCT00296504|527438994|FG003|Final Analysis|Withdrawal by Subject|0|||
146253344|NCT00296504|527438995|FG004|Final Analysis|Withdrawal by Subject|0|||
146253345|NCT00296504|527438996|FG005|Final Analysis|Withdrawal by Subject|0|||
146253346|NCT00296504|527438997|FG006|Final Analysis|Withdrawal by Subject|0|||
146253347|NCT00296504|527438998|FG007|Final Analysis|Withdrawal by Subject|0|||
146253348|NCT00296504|527438999|FG008|Final Analysis|Withdrawal by Subject|1|||
146253349|NCT00296504|527438991|FG000|Final Analysis|Lost to Follow-up|0|||
146253350|NCT00296504|527438992|FG001|Final Analysis|Lost to Follow-up|0|||
146253351|NCT00296504|527438993|FG002|Final Analysis|Lost to Follow-up|0|||
146253352|NCT00296504|527438994|FG003|Final Analysis|Lost to Follow-up|0|||
146253353|NCT00296504|527438995|FG004|Final Analysis|Lost to Follow-up|0|||
146253354|NCT00296504|527438996|FG005|Final Analysis|Lost to Follow-up|0|||
146253355|NCT00296504|527438997|FG006|Final Analysis|Lost to Follow-up|0|||
146253356|NCT00296504|527438998|FG007|Final Analysis|Lost to Follow-up|0|||
146253357|NCT00296504|527438999|FG008|Final Analysis|Lost to Follow-up|5|||
146253358|NCT00296504|527438991|FG000|Final Analysis|Insufficient Viral Load Response|0|||
146253359|NCT00296504|527438992|FG001|Final Analysis|Insufficient Viral Load Response|0|||
146253360|NCT00296504|527438993|FG002|Final Analysis|Insufficient Viral Load Response|0|||
146253361|NCT00296504|527438994|FG003|Final Analysis|Insufficient Viral Load Response|0|||
146253362|NCT00296504|527438995|FG004|Final Analysis|Insufficient Viral Load Response|0|||
146253363|NCT00296504|527438996|FG005|Final Analysis|Insufficient Viral Load Response|0|||
146253364|NCT00296504|527438997|FG006|Final Analysis|Insufficient Viral Load Response|0|||
146253365|NCT00296504|527438998|FG007|Final Analysis|Insufficient Viral Load Response|0|||
146253366|NCT00296504|527438999|FG008|Final Analysis|Insufficient Viral Load Response|6|||
146253367|NCT00296504|527438991|FG000|Final Analysis|Adverse Event|0|||
146253368|NCT00296504|527438992|FG001|Final Analysis|Adverse Event|0|||
146022933|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
146022934|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
146022935|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
146022936|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
146022937|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
146022938|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
146022939|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
146022940|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
146022941|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
146022942|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
146022943|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
146022944|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
146022945|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
146022946|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
146022947|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
146022948|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
146022949|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
146022950|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
146022951|NCT03222973|526595301|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146022952|NCT03222973|526595302|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146022953|NCT03222973|526595303|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
146253369|NCT00296504|527438993|FG002|Final Analysis|Adverse Event|0|||
146253370|NCT00296504|527438994|FG003|Final Analysis|Adverse Event|0|||
146253371|NCT00296504|527438995|FG004|Final Analysis|Adverse Event|0|||
146253372|NCT00296504|527438996|FG005|Final Analysis|Adverse Event|0|||
146253373|NCT00296504|527438997|FG006|Final Analysis|Adverse Event|0|||
146022954|NCT03222973|526595304|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
146022955|NCT02080481|526595305|FG000|Overall Study|Never received a block.|1|||
146022956|NCT02080481|526595306|FG001|Overall Study|Never received a block.|0|||
146022957|NCT01444027|526595309|FG000|Overall Study|Withdrawal by Subject|4|||
146022958|NCT01444027|526595310|FG001|Overall Study|Withdrawal by Subject|10|||
146022959|NCT01444027|526595311|FG002|Overall Study|Withdrawal by Subject|24|||
146022960|NCT01444027|526595309|FG000|Overall Study|Lost to Follow-up|26|||
146022961|NCT01444027|526595310|FG001|Overall Study|Lost to Follow-up|20|||
146022962|NCT01444027|526595311|FG002|Overall Study|Lost to Follow-up|14|||
146022963|NCT01730339|526597198|FG000|Overall Study|Withdrawal by Subject|3|||
146253374|NCT00296504|527438998|FG007|Final Analysis|Adverse Event|0|||
146253375|NCT00296504|527438999|FG008|Final Analysis|Adverse Event|2|||
146253376|NCT00296504|527438991|FG000|Final Analysis|Pregnancy|0|||
146253377|NCT00296504|527438992|FG001|Final Analysis|Pregnancy|0|||
146022964|NCT01730339|526597199|FG001|Overall Study|Withdrawal by Subject|2|||
146022965|NCT01730339|526597198|FG000|Overall Study|Lost to Follow-up|1|||
146022966|NCT01730339|526597199|FG001|Overall Study|Lost to Follow-up|1|||
146022967|NCT01730339|526597198|FG000|Overall Study|Un-specified|1|||
146022968|NCT01730339|526597199|FG001|Overall Study|Un-specified|0|||
146022969|NCT04143217|526597202|FG000|Overall Study|Withdrawal by Subject|42|||
146022970|NCT04143217|526597202|FG000|Overall Study|Adverse Event|29|||
146022971|NCT04143217|526597202|FG000|Overall Study|Lost to Follow-up|29|||
146022972|NCT04143217|526597202|FG000|Overall Study|Lack of Efficacy|15|||
146022973|NCT04143217|526597202|FG000|Overall Study|Physician Decision|1|||
146022974|NCT04143217|526597202|FG000|Overall Study|Non-Compliance With Study Drug|6|||
146022975|NCT04143217|526597202|FG000|Overall Study|Other, Multiple Categories|11|||
146022976|NCT00316693|526597203|FG000|Overall Study|Adverse Event|6|||
146022977|NCT00316693|526597204|FG001|Overall Study|Adverse Event|1|||
146022978|NCT00316693|526597203|FG000|Overall Study|Protocol Violation|1|||
146022979|NCT00316693|526597204|FG001|Overall Study|Protocol Violation|0|||
146022980|NCT00316693|526597203|FG000|Overall Study|Withdrawal by Subject|6|||
146022981|NCT00316693|526597204|FG001|Overall Study|Withdrawal by Subject|6|||
146022982|NCT00316693|526597203|FG000|Overall Study|Lost to Follow-up|26|||
146022983|NCT00316693|526597204|FG001|Overall Study|Lost to Follow-up|34|||
146022984|NCT00316693|526597203|FG000|Overall Study|Other|38|||
146022985|NCT00316693|526597204|FG001|Overall Study|Other|44|||
146022986|NCT02982018|526597205|FG000|Overall Study|Incorrect Lens Dispensed|1|||
146022987|NCT02982018|526597206|FG001|Overall Study|Incorrect Lens Dispensed|0|||
146022988|NCT02982018|526597205|FG000|Overall Study|Protocol Violation|1|||
146022989|NCT02982018|526597206|FG001|Overall Study|Protocol Violation|1|||
146022990|NCT02982018|526597205|FG000|Overall Study|Adverse Event|1|||
146022991|NCT02982018|526597206|FG001|Overall Study|Adverse Event|1|||
146022992|NCT02982018|526597205|FG000|Overall Study|Lens Discomfort|2|||
146022993|NCT02982018|526597206|FG001|Overall Study|Lens Discomfort|0|||
146022994|NCT02982018|526597205|FG000|Overall Study|Withdrawal by Subject|0|||
146022995|NCT02982018|526597206|FG001|Overall Study|Withdrawal by Subject|1|||
146022996|NCT02251717|526597207|FG000|Overall Study|Adverse Event|0|||
146022997|NCT02251717|526597208|FG001|Overall Study|Adverse Event|1|||
146022998|NCT02251717|526597207|FG000|Overall Study|Withdrew Consent|1|||
146022999|NCT02251717|526597208|FG001|Overall Study|Withdrew Consent|0|||
146023000|NCT04098367|526597209|FG000|Overall Study|Adverse Event|0|||
146023001|NCT04098367|526597210|FG001|Overall Study|Adverse Event|0|||
146023002|NCT04098367|526597211|FG002|Overall Study|Adverse Event|1|||
146023003|NCT04098367|526597209|FG000|Overall Study|Lost to Follow-up|1|||
146023004|NCT04098367|526597210|FG001|Overall Study|Lost to Follow-up|5|||
146023005|NCT04098367|526597211|FG002|Overall Study|Lost to Follow-up|2|||
146023006|NCT04098367|526597209|FG000|Overall Study|Withdrawal by Subject|0|||
146023007|NCT04098367|526597210|FG001|Overall Study|Withdrawal by Subject|0|||
146023008|NCT04098367|526597211|FG002|Overall Study|Withdrawal by Subject|1|||
146023009|NCT04098367|526597209|FG000|Overall Study|Sick . Could not attend visit|1|||
146023010|NCT04098367|526597210|FG001|Overall Study|Sick . Could not attend visit|0|||
146023011|NCT04098367|526597211|FG002|Overall Study|Sick . Could not attend visit|0|||
146253378|NCT00296504|527438993|FG002|Final Analysis|Pregnancy|0|||
146253379|NCT00296504|527438994|FG003|Final Analysis|Pregnancy|0|||
146253380|NCT00296504|527438995|FG004|Final Analysis|Pregnancy|0|||
146023012|NCT00445939|526597212|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
146023013|NCT00445939|526597213|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
146023014|NCT00445939|526597214|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
146023015|NCT00445939|526597215|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
146023016|NCT00445939|526597212|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
146023017|NCT00445939|526597213|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
146023018|NCT00445939|526597214|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
146023019|NCT00445939|526597215|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
146023020|NCT02576535|526597231|FG000|Overall Study|Withdrawal by Subject|2|||
146023021|NCT00322023|526597232|FG000|Overall Study|various|0|||
146023022|NCT00322023|526597233|FG001|Overall Study|various|2|||
146023023|NCT00322023|526597234|FG002|Overall Study|various|6|||
146023024|NCT03920293|526597235|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
146023025|NCT03920293|526597236|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
146253381|NCT00296504|527438996|FG005|Final Analysis|Pregnancy|0|||
146023026|NCT03920293|526597235|FG000|Randomized-Controlled Period|Physician Decision|1|||
146023027|NCT03920293|526597236|FG001|Randomized-Controlled Period|Physician Decision|2|||
146023028|NCT03920293|526597235|FG000|Randomized-Controlled Period|Adverse Event|0|||
146023029|NCT03920293|526597236|FG001|Randomized-Controlled Period|Adverse Event|2|||
146023030|NCT03920293|526597235|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
146023031|NCT03920293|526597236|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
146023032|NCT03920293|526597235|FG000|Randomized-Controlled Period|Death|2|||
146023033|NCT03920293|526597236|FG001|Randomized-Controlled Period|Death|0|||
146023034|NCT03920293|526597235|FG000|Randomized-Controlled Period|Protocol Violation|1|||
146023035|NCT03920293|526597236|FG001|Randomized-Controlled Period|Protocol Violation|0|||
146023036|NCT03920293|526597235|FG000|Randomized-Controlled Period|Noncompliance|1|||
146023037|NCT03920293|526597236|FG001|Randomized-Controlled Period|Noncompliance|0|||
146023038|NCT03920293|526597235|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
146023039|NCT03920293|526597236|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
146023040|NCT03920293|526597235|FG000|Open- Label Extension Period|Death|3|||
146023041|NCT03920293|526597236|FG001|Open- Label Extension Period|Death|3|||
146023042|NCT03920293|526597235|FG000|Open- Label Extension Period|Physician Decision|5|||
146023043|NCT03920293|526597236|FG001|Open- Label Extension Period|Physician Decision|3|||
146023044|NCT03920293|526597235|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
146023045|NCT03920293|526597236|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
146023046|NCT01691885|526597242|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
146023047|NCT01691885|526597243|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
146023048|NCT01691885|526597242|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
146023049|NCT01691885|526597243|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
146023050|NCT03555981|526597244|FG000|Overall Study|Lost to Follow-up|0|||
146023051|NCT03555981|526597245|FG001|Overall Study|Lost to Follow-up|2|||
146023052|NCT00354107|526597246|FG000|Overall Study|Adverse Event|2|||
146023053|NCT00354107|526597246|FG000|Overall Study|Physician Decision|2|||
146023054|NCT00354107|526597246|FG000|Overall Study|Withdrawal by Subject|1|||
146023055|NCT04035564|526597248|FG000|Overall Study|Protocol Violation|1|||
146023056|NCT04035564|526597249|FG001|Overall Study|Protocol Violation|2|||
146023057|NCT04035564|526597248|FG000|Overall Study|No laboratory available|2|||
146023058|NCT04035564|526597249|FG001|Overall Study|No laboratory available|2|||
146023059|NCT04035564|526597248|FG000|Overall Study|Guardian declined consent|1|||
146023060|NCT04035564|526597249|FG001|Overall Study|Guardian declined consent|2|||
146023061|NCT00996281|526597253|FG000|Overall Study|Adverse Event|75|||
146023062|NCT00996281|526597254|FG001|Overall Study|Adverse Event|37|||
146023063|NCT00996281|526597253|FG000|Overall Study|Major Protocol Deviation|6|||
146023064|NCT00996281|526597254|FG001|Overall Study|Major Protocol Deviation|7|||
146023065|NCT00996281|526597253|FG000|Overall Study|Lost to Follow-up|14|||
146023066|NCT00996281|526597254|FG001|Overall Study|Lost to Follow-up|16|||
146023067|NCT00996281|526597253|FG000|Overall Study|Withdrawal by Subject|31|||
146023068|NCT00996281|526597254|FG001|Overall Study|Withdrawal by Subject|20|||
146023069|NCT00996281|526597253|FG000|Overall Study|Lack of Efficacy|0|||
146023070|NCT00996281|526597254|FG001|Overall Study|Lack of Efficacy|2|||
146023071|NCT00996281|526597253|FG000|Overall Study|Other|5|||
146023072|NCT00996281|526597254|FG001|Overall Study|Other|7|||
146023073|NCT03505788|526597257|FG000|Overall Study|Lost to Follow-up|2|||
146023074|NCT03505788|526597258|FG001|Overall Study|Lost to Follow-up|1|||
146023075|NCT03505788|526597257|FG000|Overall Study|Withdrawal by Subject|1|||
146023076|NCT03505788|526597258|FG001|Overall Study|Withdrawal by Subject|3|||
146023077|NCT03505788|526597257|FG000|Overall Study|Physician Decision|0|||
146023078|NCT03505788|526597258|FG001|Overall Study|Physician Decision|1|||
146023079|NCT03575065|526597259|FG000|Overall Study|Death|31|||
146023080|NCT03575065|526597260|FG001|Overall Study|Death|12|||
146023081|NCT03575065|526597259|FG000|Overall Study|Sponsor's Decision|28|||
146023082|NCT03575065|526597260|FG001|Overall Study|Sponsor's Decision|13|||
146023083|NCT03575065|526597259|FG000|Overall Study|Withdrawal by Subject|2|||
146023084|NCT03575065|526597260|FG001|Overall Study|Withdrawal by Subject|1|||
146023085|NCT03575065|526597259|FG000|Overall Study|Lost to Follow-up|1|||
146023086|NCT03575065|526597260|FG001|Overall Study|Lost to Follow-up|0|||
146023087|NCT03344549|526597265|FG000|Overall Study|Withdrawal by Subject|3|||
146023088|NCT03344549|526597266|FG001|Overall Study|Withdrawal by Subject|2|||
146023089|NCT03344549|526597265|FG000|Overall Study|Dialysis|2|||
146023090|NCT03344549|526597266|FG001|Overall Study|Dialysis|0|||
146023091|NCT03344549|526597265|FG000|Overall Study|Cancer|1|||
146023092|NCT03344549|526597266|FG001|Overall Study|Cancer|0|||
146023093|NCT03344549|526597265|FG000|Overall Study|Lack of electronic device|1|||
146023094|NCT03344549|526597266|FG001|Overall Study|Lack of electronic device|0|||
146023095|NCT03344549|526597265|FG000|Overall Study|Transportation difficulty|0|||
146023096|NCT03344549|526597266|FG001|Overall Study|Transportation difficulty|13|||
146023097|NCT00113399|526597267|FG000|Overall Study|Death|1|||
146023098|NCT00113399|526597268|FG001|Overall Study|Death|1|||
146023099|NCT00113399|526597267|FG000|Overall Study|Withdrawal by Subject|1|||
146023100|NCT00113399|526597268|FG001|Overall Study|Withdrawal by Subject|2|||
146023101|NCT00113399|526597267|FG000|Overall Study|Complete Response|0|||
146023102|NCT00113399|526597268|FG001|Overall Study|Complete Response|1|||
146023103|NCT00113399|526597267|FG000|Overall Study|Other|0|||
146023104|NCT00113399|526597268|FG001|Overall Study|Other|1|||
146023105|NCT00396136|526597269|FG000|Overall Study|Death|43|||
146023106|NCT00396136|526597269|FG000|Overall Study|Withdrawal by Subject|59|||
146023107|NCT00396136|526597269|FG000|Overall Study|Lost to Follow-up|15|||
146023108|NCT00396136|526597269|FG000|Overall Study|Study device explanted|8|||
146023109|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
146023110|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
146023111|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146023112|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
146023113|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
146023114|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146023115|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
146023116|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023117|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023118|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023119|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
146023120|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
146023121|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023122|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023123|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023124|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023125|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023126|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
146023127|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146023128|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023129|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146023130|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023131|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023132|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146023133|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
146023134|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023135|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023136|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023137|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023138|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023139|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023140|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023141|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023142|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023143|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023144|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
146023145|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023146|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023147|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
146023148|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023149|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023150|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023151|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023152|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023153|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023154|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023155|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023156|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023157|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023158|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023159|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023160|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023161|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023162|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
146023163|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023164|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023165|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
146023166|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023167|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146253382|NCT00296504|527438997|FG006|Final Analysis|Pregnancy|0|||
146023168|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023169|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023170|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023171|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023172|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023173|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023174|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023175|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023176|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023177|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023178|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023179|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023180|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
146023181|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023182|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023183|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023184|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023185|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023186|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023187|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023188|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023189|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023190|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023191|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
146023192|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023193|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023194|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023195|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023196|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023197|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023198|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
146023199|NCT03447314|526597272|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023200|NCT03447314|526597273|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023201|NCT03447314|526597274|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023202|NCT03447314|526597275|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
146023203|NCT03447314|526597276|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023204|NCT03447314|526597277|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
146023205|NCT03447314|526597278|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023206|NCT03447314|526597279|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023207|NCT03447314|526597280|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023208|NCT03447314|526597281|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023209|NCT03447314|526597282|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023210|NCT03447314|526597283|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023211|NCT03447314|526597284|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023212|NCT03447314|526597285|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023213|NCT03447314|526597286|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023214|NCT03447314|526597287|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023215|NCT03447314|526597288|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023216|NCT03447314|526597289|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
146023217|NCT01703208|526597290|FG000|Overall Study|Death|61|||
146023218|NCT01703208|526597291|FG001|Overall Study|Death|48|||
146023219|NCT01703208|526597290|FG000|Overall Study|Lack of Efficacy|1|||
146023220|NCT01703208|526597291|FG001|Overall Study|Lack of Efficacy|2|||
146023221|NCT01703208|526597290|FG000|Overall Study|Lost to Follow-up|68|||
146023222|NCT01703208|526597291|FG001|Overall Study|Lost to Follow-up|62|||
146253383|NCT00296504|527438998|FG007|Final Analysis|Pregnancy|0|||
146253384|NCT00296504|527438999|FG008|Final Analysis|Pregnancy|4|||
146253385|NCT00296504|527438991|FG000|Final Analysis|Tuberculosis|0|||
146253386|NCT00296504|527438992|FG001|Final Analysis|Tuberculosis|0|||
146094467|NCT01507298|526867804|FG001|Overall Study|Protocol Violation|6|||
146094468|NCT01920555|526867805|FG000|Overall Study|Physician Decision|1|||
146094469|NCT01920555|526867806|FG001|Overall Study|Physician Decision|2|||
146094470|NCT01920555|526867807|FG002|Overall Study|Physician Decision|1|||
146094471|NCT01920555|526867808|FG003|Overall Study|Physician Decision|2|||
146094472|NCT01920555|526867809|FG004|Overall Study|Physician Decision|0|||
146094473|NCT01920555|526867805|FG000|Overall Study|Lack of Efficacy|2|||
146094474|NCT01920555|526867806|FG001|Overall Study|Lack of Efficacy|0|||
146094475|NCT01920555|526867807|FG002|Overall Study|Lack of Efficacy|0|||
146094476|NCT01920555|526867808|FG003|Overall Study|Lack of Efficacy|0|||
146094477|NCT01920555|526867809|FG004|Overall Study|Lack of Efficacy|0|||
146094478|NCT01920555|526867805|FG000|Overall Study|Travel Difficulties|1|||
146094479|NCT01920555|526867806|FG001|Overall Study|Travel Difficulties|1|||
146094480|NCT01920555|526867807|FG002|Overall Study|Travel Difficulties|0|||
146094481|NCT01920555|526867808|FG003|Overall Study|Travel Difficulties|0|||
146094482|NCT01920555|526867809|FG004|Overall Study|Travel Difficulties|1|||
146094483|NCT01920555|526867805|FG000|Overall Study|Lost to Follow-up|0|||
146094484|NCT01920555|526867806|FG001|Overall Study|Lost to Follow-up|1|||
146094485|NCT01920555|526867807|FG002|Overall Study|Lost to Follow-up|0|||
146094486|NCT01920555|526867808|FG003|Overall Study|Lost to Follow-up|1|||
146094487|NCT01920555|526867809|FG004|Overall Study|Lost to Follow-up|0|||
146094488|NCT03911713|526867810|FG000|Overall Study|Lost to Follow-up|0|||
146094489|NCT03911713|526867811|FG001|Overall Study|Lost to Follow-up|2|||
146094490|NCT03911713|526867812|FG002|Overall Study|Lost to Follow-up|0|||
146094491|NCT03911713|526867813|FG003|Overall Study|Lost to Follow-up|0|||
146094492|NCT03911713|526867814|FG004|Overall Study|Lost to Follow-up|0|||
146094493|NCT03911713|526867810|FG000|Overall Study|Other|0|||
146094494|NCT03911713|526867811|FG001|Overall Study|Other|0|||
146094495|NCT03911713|526867812|FG002|Overall Study|Other|0|||
146094496|NCT03911713|526867813|FG003|Overall Study|Other|1|||
146094497|NCT03911713|526867814|FG004|Overall Study|Other|0|||
146094498|NCT03911713|526867810|FG000|Overall Study|Randomized, Never Dosed|1|||
146094499|NCT03911713|526867811|FG001|Overall Study|Randomized, Never Dosed|0|||
146094500|NCT03911713|526867812|FG002|Overall Study|Randomized, Never Dosed|0|||
146094501|NCT03911713|526867813|FG003|Overall Study|Randomized, Never Dosed|1|||
146094502|NCT03911713|526867814|FG004|Overall Study|Randomized, Never Dosed|0|||
146094503|NCT01845818|526867817|FG000|Overall Study|Withdrawal by Subject|0|||
146023223|NCT01703208|526597290|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146023224|NCT01703208|526597291|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146023225|NCT01703208|526597290|FG000|Overall Study|Excluded Medication|1|||
146023226|NCT01703208|526597291|FG001|Overall Study|Excluded Medication|2|||
146023227|NCT01703208|526597290|FG000|Overall Study|Site Discontinued Study Participation|23|||
146023228|NCT01703208|526597291|FG001|Overall Study|Site Discontinued Study Participation|27|||
146023229|NCT01703208|526597290|FG000|Overall Study|Physician Decision|11|||
146094504|NCT01845818|526867818|FG001|Overall Study|Withdrawal by Subject|1|||
146094505|NCT01845818|526867817|FG000|Overall Study|Lost to Follow-up|7|||
146094506|NCT01845818|526867818|FG001|Overall Study|Lost to Follow-up|5|||
146094507|NCT01845818|526867817|FG000|Overall Study|Administrative Reasons|3|||
146094508|NCT01845818|526867818|FG001|Overall Study|Administrative Reasons|1|||
146094509|NCT01845818|526867817|FG000|Overall Study|Serious Adverse Event|1|||
146094510|NCT01845818|526867818|FG001|Overall Study|Serious Adverse Event|1|||
146094511|NCT01845818|526867817|FG000|Overall Study|Other|25|||
146094512|NCT01845818|526867818|FG001|Overall Study|Other|8|||
146094513|NCT01845818|526867817|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
146094514|NCT01845818|526867818|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
146094515|NCT01845818|526867817|FG000|Overall Study|No Follow-Up Data Available|4|||
146094516|NCT01845818|526867818|FG001|Overall Study|No Follow-Up Data Available|1|||
146094517|NCT00195273|526867819|FG000|Overall Study|Adverse Event|9|||
146094518|NCT00195273|526867820|FG001|Overall Study|Adverse Event|9|||
146094519|NCT00195273|526867819|FG000|Overall Study|Protocol deviation|0|||
146094520|NCT00195273|526867820|FG001|Overall Study|Protocol deviation|1|||
146094521|NCT00195273|526867819|FG000|Overall Study|Lack of Efficacy|3|||
146094522|NCT00195273|526867820|FG001|Overall Study|Lack of Efficacy|1|||
146094523|NCT00195273|526867819|FG000|Overall Study|Procedural complications|9|||
146094524|NCT00195273|526867820|FG001|Overall Study|Procedural complications|3|||
146094525|NCT01680965|526867821|FG000|Overall Study|Death|0|||
146094526|NCT01680965|526867822|FG001|Overall Study|Death|0|||
146094527|NCT01680965|526867823|FG002|Overall Study|Death|0|||
146094528|NCT01680965|526867824|FG003|Overall Study|Death|6|||
146094529|NCT02595970|526867825|FG000|Overall Study|Withdrawal by Subject|2|||
146094530|NCT02595970|526867825|FG000|Overall Study|Physician Decision|2|||
146094531|NCT02595970|526867825|FG000|Overall Study|Protocol Violation|4|||
146094532|NCT02595970|526867825|FG000|Overall Study|Adverse Event|5|||
146094533|NCT02595970|526867825|FG000|Overall Study|Lack of Efficacy|7|||
146094534|NCT02570074|526867826|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
146023230|NCT01703208|526597291|FG001|Overall Study|Physician Decision|13|||
146023231|NCT01703208|526597290|FG000|Overall Study|Progressive disease|2|||
146023232|NCT01703208|526597291|FG001|Overall Study|Progressive disease|2|||
146094535|NCT02570074|526867827|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
146023233|NCT01703208|526597290|FG000|Overall Study|Protocol Violation|1|||
146023234|NCT01703208|526597291|FG001|Overall Study|Protocol Violation|1|||
146023235|NCT01703208|526597290|FG000|Overall Study|Study Terminated by Sponsor|1710|||
146023236|NCT01703208|526597291|FG001|Overall Study|Study Terminated by Sponsor|1716|||
146023237|NCT01703208|526597290|FG000|Overall Study|Withdrawal by Subject|205|||
146023238|NCT01703208|526597291|FG001|Overall Study|Withdrawal by Subject|209|||
146023239|NCT01703208|526597290|FG000|Overall Study|Adverse Event|14|||
146253387|NCT00296504|527438993|FG002|Final Analysis|Tuberculosis|0|||
146253388|NCT00296504|527438994|FG003|Final Analysis|Tuberculosis|0|||
146253389|NCT00296504|527438995|FG004|Final Analysis|Tuberculosis|0|||
146253390|NCT00296504|527438996|FG005|Final Analysis|Tuberculosis|0|||
146253391|NCT00296504|527438997|FG006|Final Analysis|Tuberculosis|0|||
146253392|NCT00296504|527438998|FG007|Final Analysis|Tuberculosis|0|||
146253393|NCT00296504|527438999|FG008|Final Analysis|Tuberculosis|1|||
146253394|NCT00296504|527438991|FG000|Final Analysis|Participant Moved to Another Country|0|||
146253395|NCT00296504|527438992|FG001|Final Analysis|Participant Moved to Another Country|0|||
146253396|NCT00296504|527438993|FG002|Final Analysis|Participant Moved to Another Country|0|||
146253397|NCT00296504|527438994|FG003|Final Analysis|Participant Moved to Another Country|0|||
146253398|NCT00296504|527438995|FG004|Final Analysis|Participant Moved to Another Country|0|||
146253399|NCT00296504|527438996|FG005|Final Analysis|Participant Moved to Another Country|0|||
146253400|NCT00296504|527438997|FG006|Final Analysis|Participant Moved to Another Country|0|||
146253401|NCT00296504|527438998|FG007|Final Analysis|Participant Moved to Another Country|0|||
146253402|NCT00296504|527438999|FG008|Final Analysis|Participant Moved to Another Country|1|||
146023240|NCT01703208|526597291|FG001|Overall Study|Adverse Event|19|||
146023241|NCT01703208|526597290|FG000|Overall Study|Technical Problems|0|||
146023242|NCT01703208|526597291|FG001|Overall Study|Technical Problems|1|||
146023243|NCT01703208|526597290|FG000|Overall Study|Protocol Deviation|2|||
146023244|NCT01703208|526597291|FG001|Overall Study|Protocol Deviation|0|||
146023245|NCT00252694|526597292|FG000|Overall Study|Withdrawal by Subject|83|||
146023246|NCT00252694|526597293|FG001|Overall Study|Withdrawal by Subject|91|||
146023247|NCT00252694|526597292|FG000|Overall Study|Death|36|||
146023248|NCT00252694|526597293|FG001|Overall Study|Death|34|||
146023249|NCT00252694|526597292|FG000|Overall Study|Mostly Lost to Follow Up|8|||
146023250|NCT00252694|526597293|FG001|Overall Study|Mostly Lost to Follow Up|13|||
146023251|NCT00252694|526597292|FG000|Overall Study|Patient Moving|17|||
146023252|NCT00252694|526597293|FG001|Overall Study|Patient Moving|16|||
146023253|NCT04003207|526597296|FG000|Overall Study|Protocol Violation|1|||
146023254|NCT00522418|526597297|FG000|Overall Study|Local IRB Consent Violation|5|||
146023255|NCT00522418|526597298|FG001|Overall Study|Local IRB Consent Violation|5|||
146023256|NCT00522418|526597297|FG000|Overall Study|Early Study Termination|46|||
146023257|NCT00522418|526597298|FG001|Overall Study|Early Study Termination|47|||
146023258|NCT00522418|526597297|FG000|Overall Study|Noncompliance|2|||
146023259|NCT00522418|526597298|FG001|Overall Study|Noncompliance|2|||
146023260|NCT00522418|526597297|FG000|Overall Study|Reason Not Specified|3|||
146023261|NCT00522418|526597298|FG001|Overall Study|Reason Not Specified|1|||
146023262|NCT00522418|526597297|FG000|Overall Study|Consent Withdraw|1|||
146023263|NCT00522418|526597298|FG001|Overall Study|Consent Withdraw|2|||
146023264|NCT00522418|526597297|FG000|Overall Study|Lack of Efficacy|0|||
146023265|NCT00522418|526597298|FG001|Overall Study|Lack of Efficacy|1|||
146023266|NCT01574157|526597299|FG000|Overall Study|Withdrawal by Subject|4|||
146023267|NCT01574157|526597300|FG001|Overall Study|Withdrawal by Subject|5|||
146023268|NCT01574157|526597299|FG000|Overall Study|Lost to Follow-up|0|||
146023269|NCT01574157|526597300|FG001|Overall Study|Lost to Follow-up|3|||
146023270|NCT00578877|526597303|FG000|Overall Study|Lost to Follow-up|8|||
146023271|NCT00578877|526597304|FG001|Overall Study|Lost to Follow-up|10|||
146023272|NCT00578877|526597303|FG000|Overall Study|early discontinue|61|||
146023273|NCT00578877|526597304|FG001|Overall Study|early discontinue|101|||
146253403|NCT00296504|527438991|FG000|Final Analysis|Poor Adherence|0|||
146253404|NCT00296504|527438992|FG001|Final Analysis|Poor Adherence|0|||
146253405|NCT00296504|527438993|FG002|Final Analysis|Poor Adherence|0|||
146253406|NCT00296504|527438994|FG003|Final Analysis|Poor Adherence|0|||
146023274|NCT00578877|526597303|FG000|Overall Study|did not provide follow-up data|12|||
146023275|NCT00578877|526597304|FG001|Overall Study|did not provide follow-up data|17|||
146023276|NCT01944098|526597309|FG000|Overall Study|Physician Decision|1|||
146023277|NCT01944098|526597310|FG001|Overall Study|Physician Decision|0|||
146023278|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
146023279|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
146023280|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
146023281|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
146023282|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
146023283|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
146023284|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
146023285|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
146023286|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
146023287|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
146023288|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
146023289|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
146023290|NCT01632241|526597311|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
146023291|NCT01632241|526597312|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
146023292|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
146023293|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
146023294|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
146023295|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
146023296|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
146023297|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
146023298|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
146023299|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
146023300|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
146023301|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
146023302|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
146023303|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
146023304|NCT01632241|526597311|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
146023305|NCT01632241|526597312|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
146094536|NCT02923427|526867828|FG000|Overall Study|convert to laparatomy|2|||
146094537|NCT02923427|526867829|FG001|Overall Study|convert to laparatomy|2|||
146094538|NCT02923427|526867828|FG000|Overall Study|destaturation|1|||
146094539|NCT02923427|526867829|FG001|Overall Study|destaturation|0|||
146094540|NCT02923427|526867828|FG000|Overall Study|can not replace LMA|1|||
146094541|NCT02923427|526867829|FG001|Overall Study|can not replace LMA|0|||
146094542|NCT01325623|526867830|FG000|Overall Study|Withdrawal by Subject|3|||
146094543|NCT01539642|526867835|FG000|Overall Study|Lack of Efficacy|20|||
146094544|NCT01539642|526867836|FG001|Overall Study|Lack of Efficacy|18|||
146094545|NCT01539642|526867835|FG000|Overall Study|Patient ready for early discharge|8|||
146094546|NCT01539642|526867836|FG001|Overall Study|Patient ready for early discharge|7|||
146094547|NCT01539642|526867835|FG000|Overall Study|Adverse Event|6|||
146094548|NCT01539642|526867836|FG001|Overall Study|Adverse Event|4|||
146094549|NCT01539642|526867835|FG000|Overall Study|Withdrawal by Subject|2|||
146094550|NCT01539642|526867836|FG001|Overall Study|Withdrawal by Subject|2|||
146253407|NCT00296504|527438995|FG004|Final Analysis|Poor Adherence|0|||
146023306|NCT03349645|526597315|FG000|Overall Study|Sponsor Terminated Study|75|||
146023307|NCT03349645|526597315|FG000|Overall Study|Withdrawal by Subject|4|||
146023308|NCT03349645|526597315|FG000|Overall Study|Protocol Violation|1|||
146023309|NCT03349645|526597315|FG000|Overall Study|Other|2|||
146023310|NCT01939002|526597327|FG000|Overall Study|Adverse Event|13|||
146023311|NCT01939002|526597328|FG001|Overall Study|Adverse Event|13|||
146023312|NCT01939002|526597327|FG000|Overall Study|Withdrawal by Subject|5|||
146023313|NCT01939002|526597328|FG001|Overall Study|Withdrawal by Subject|3|||
146023314|NCT01939002|526597327|FG000|Overall Study|Other|1|||
146023315|NCT01939002|526597328|FG001|Overall Study|Other|2|||
146023316|NCT02910401|526597331|FG000|Overall Study|Study closure Study closure|0|||
146023317|NCT02910401|526597332|FG001|Overall Study|Study closure Study closure|0|||
146023318|NCT02910401|526597333|FG002|Overall Study|Study closure Study closure|2|||
146023319|NCT02910401|526597331|FG000|Overall Study|Physician Decision|1|||
146023320|NCT02910401|526597332|FG001|Overall Study|Physician Decision|0|||
146023321|NCT02910401|526597333|FG002|Overall Study|Physician Decision|0|||
146023322|NCT01774253|526597335|FG000|Overall Study|Lack of Efficacy|4|||
146023323|NCT01774253|526597335|FG000|Overall Study|Physician Decision|2|||
146023324|NCT01774253|526597335|FG000|Overall Study|Withdrawal by Subject|2|||
146023325|NCT01774253|526597335|FG000|Overall Study|Death|1|||
146023326|NCT02240368|526597336|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
146023327|NCT02240368|526597337|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
146023328|NCT02240368|526597338|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
146023329|NCT02240368|526597336|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
146023330|NCT02240368|526597337|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
146023331|NCT02240368|526597338|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
146023332|NCT00871117|526597339|FG000|Overall Study|Lost to Follow-up|5|||
146094551|NCT00598702|526867837|FG000|Overall Study|Other|0|||
146023333|NCT00871117|526597340|FG001|Overall Study|Lost to Follow-up|6|||
146023334|NCT00871117|526597339|FG000|Overall Study|Other|0|||
146023335|NCT00871117|526597340|FG001|Overall Study|Other|4|||
146023336|NCT01170065|526597341|FG000|Overall Study|Adverse Event|17|||
146023337|NCT01170065|526597342|FG001|Overall Study|Adverse Event|50|||
146023338|NCT01170065|526597343|FG002|Overall Study|Adverse Event|10|||
146023339|NCT01170065|526597341|FG000|Overall Study|Lost to Follow-up|1|||
146023340|NCT01170065|526597342|FG001|Overall Study|Lost to Follow-up|4|||
146023341|NCT01170065|526597343|FG002|Overall Study|Lost to Follow-up|1|||
146023342|NCT01170065|526597341|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
146023343|NCT01170065|526597342|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
146023344|NCT01170065|526597343|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
146023345|NCT01170065|526597341|FG000|Overall Study|Reason other than specified|3|||
146094552|NCT00598702|526867838|FG001|Overall Study|Other|2|||
146253408|NCT00296504|527438996|FG005|Final Analysis|Poor Adherence|0|||
146253409|NCT00296504|527438997|FG006|Final Analysis|Poor Adherence|0|||
146253410|NCT00296504|527438998|FG007|Final Analysis|Poor Adherence|0|||
146253411|NCT00296504|527438999|FG008|Final Analysis|Poor Adherence|1|||
146253412|NCT01078571|527439000|FG000|Overall Study|Adverse Event|36|||
146253413|NCT01078571|527439000|FG000|Overall Study|Lack of effectiveness|36|||
146253414|NCT01078571|527439000|FG000|Overall Study|Reason not reported|21|||
146253415|NCT01078571|527439000|FG000|Overall Study|Withdrawal by Subject|12|||
146253416|NCT01078571|527439000|FG000|Overall Study|Lost to Follow-up|8|||
146253417|NCT01078571|527439000|FG000|Overall Study|Protocol Violation|2|||
146253418|NCT01047306|527439001|FG000|Overall Study|Withdrawal by Subject|2|||
146253419|NCT01047306|527439002|FG001|Overall Study|Withdrawal by Subject|0|||
146253420|NCT01047306|527439001|FG000|Overall Study|Lost to Follow-up|1|||
146253421|NCT01047306|527439002|FG001|Overall Study|Lost to Follow-up|0|||
146253422|NCT01878253|527439003|FG000|Overall Study|Death|1|||
146253423|NCT01878253|527439003|FG000|Overall Study|SIdus System Removal|3|||
146253424|NCT01878253|527439003|FG000|Overall Study|Withdrawal by Subject|1|||
146253425|NCT01878253|527439003|FG000|Overall Study|Lost to Follow-up|2|||
146253426|NCT01878253|527439003|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
146253427|NCT00274846|527439004|FG000|Overall Study|Did not receive adequate NK cells|1|||
146253428|NCT01920178|527439007|FG000|Overall Study|Lost to Follow-up|2|||
146253429|NCT01920178|527439008|FG001|Overall Study|Lost to Follow-up|1|||
146253430|NCT02849509|527439009|FG000|Overall Study|Worsening of disease under study|1|||
146253431|NCT02849509|527439010|FG001|Overall Study|Worsening of disease under study|1|||
146253432|NCT02849509|527439011|FG002|Overall Study|Worsening of disease under study|1|||
146253433|NCT02849509|527439009|FG000|Overall Study|Worsening of other pre-existing disease|0|||
146253434|NCT02849509|527439010|FG001|Overall Study|Worsening of other pre-existing disease|1|||
146253435|NCT02849509|527439011|FG002|Overall Study|Worsening of other pre-existing disease|2|||
146253436|NCT02849509|527439009|FG000|Overall Study|Other adverse event|36|||
146253437|NCT02849509|527439010|FG001|Overall Study|Other adverse event|41|||
146253438|NCT02849509|527439011|FG002|Overall Study|Other adverse event|8|||
146253439|NCT02849509|527439009|FG000|Overall Study|Withdrawal by Subject|6|||
146253440|NCT02849509|527439010|FG001|Overall Study|Withdrawal by Subject|17|||
146253441|NCT02849509|527439011|FG002|Overall Study|Withdrawal by Subject|12|||
146253442|NCT02849509|527439009|FG000|Overall Study|Lost to Follow-up|27|||
146253443|NCT02849509|527439010|FG001|Overall Study|Lost to Follow-up|67|||
146253444|NCT02849509|527439011|FG002|Overall Study|Lost to Follow-up|36|||
146253445|NCT02849509|527439009|FG000|Overall Study|Other, reason not specified|14|||
146253446|NCT02849509|527439010|FG001|Overall Study|Other, reason not specified|29|||
146253447|NCT02849509|527439011|FG002|Overall Study|Other, reason not specified|25|||
146253448|NCT02849509|527439009|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
146253449|NCT02849509|527439010|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
146023346|NCT01170065|526597342|FG001|Overall Study|Reason other than specified|8|||
146023347|NCT01170065|526597343|FG002|Overall Study|Reason other than specified|3|||
146023348|NCT01170065|526597341|FG000|Overall Study|Ongoing after planned observation time|5|||
146253450|NCT02849509|527439011|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
146253451|NCT02374476|527439013|FG000|VT Induced Ablation|Screening Failures|36|||
146253452|NCT02374476|527439014|FG001|VT Induced Ablation|Screening Failures|0|||
146023349|NCT01170065|526597342|FG001|Overall Study|Ongoing after planned observation time|26|||
146023350|NCT01170065|526597343|FG002|Overall Study|Ongoing after planned observation time|10|||
146023351|NCT03551665|526597344|FG000|Overall Study|Lost to Follow-up|11|||
146023352|NCT03551665|526597345|FG001|Overall Study|Lost to Follow-up|2|||
146023353|NCT00496483|526598675|FG000|Overall Study|Not dosed|9|||
146023354|NCT00496483|526598675|FG000|Overall Study|Adverse Event|2|||
146023355|NCT00496483|526598675|FG000|Overall Study|Lack of Efficacy|1|||
146023356|NCT00428220|526598677|FG000|Overall Study|Participant died|8|||
146023357|NCT00428220|526598677|FG000|Overall Study|Global deterioration of health status|7|||
146023358|NCT00428220|526598677|FG000|Overall Study|Lost to Follow-up|4|||
146023359|NCT00428220|526598677|FG000|Overall Study|Objective progression or relapse|123|||
146253453|NCT02374476|527439015|FG002|VT Induced Ablation|Screening Failures|0|||
146253454|NCT02374476|527439013|FG000|Arm Assignment|Withdrawal by Subject|0|||
146253455|NCT02374476|527439014|FG001|Arm Assignment|Withdrawal by Subject|0|||
146253456|NCT02374476|527439015|FG002|Arm Assignment|Withdrawal by Subject|1|||
146253457|NCT05431543|527439016|FG000|Overall Study|Medical History|1|||
146300273|NCT03681951|527615198|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146300274|NCT03681951|527615199|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
146023360|NCT00428220|526598677|FG000|Overall Study|Participant refused continued treatment|7|||
146023361|NCT00428220|526598677|FG000|Overall Study|Adverse Event|51|||
146023362|NCT00428220|526598677|FG000|Overall Study|Other|23|||
146023363|NCT00642174|526598684|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
146023364|NCT00642174|526598685|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
146023365|NCT00896363|526598686|FG000|Overall Study|Adverse Event|3|||
146253458|NCT05431543|527439017|FG001|Overall Study|Medical History|0|||
146253459|NCT05431543|527439018|FG002|Overall Study|Medical History|0|||
146253460|NCT01945086|527439021|FG000|Overall Study|Withdrawal by Subject|1|||
146023366|NCT00896363|526598687|FG001|Overall Study|Adverse Event|4|||
146023367|NCT00896363|526598688|FG002|Overall Study|Adverse Event|2|||
146023368|NCT00896363|526598686|FG000|Overall Study|Lack of Efficacy|0|||
146023369|NCT00896363|526598687|FG001|Overall Study|Lack of Efficacy|2|||
146023370|NCT00896363|526598688|FG002|Overall Study|Lack of Efficacy|1|||
146023371|NCT00896363|526598686|FG000|Overall Study|Withdrawal by Subject|3|||
146023372|NCT00896363|526598687|FG001|Overall Study|Withdrawal by Subject|5|||
146023373|NCT00896363|526598688|FG002|Overall Study|Withdrawal by Subject|5|||
146023374|NCT01145352|526598691|FG000|Overall Study|Found to have been registered twice|6|||
146023375|NCT01145352|526598691|FG000|Overall Study|Treated before marketing approval|4|||
146023376|NCT01145352|526598691|FG000|Overall Study|Syringe formulation was used|1|||
146023377|NCT03095027|526598692|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
146023378|NCT03095027|526598693|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
146023379|NCT03245736|526598694|FG000|Overall Study|Adverse Event|1|||
146023380|NCT03245736|526598694|FG000|Overall Study|Progressive Disease|4|||
146023381|NCT00132691|526598696|FG000|Overall Study|Lost to Follow-up|5|||
146023382|NCT00132691|526598697|FG001|Overall Study|Lost to Follow-up|8|||
146023383|NCT00132691|526598696|FG000|Overall Study|Missed 2-year visit|4|||
146023384|NCT00132691|526598697|FG001|Overall Study|Missed 2-year visit|4|||
146023385|NCT00132691|526598696|FG000|Overall Study|Death|2|||
146023386|NCT00132691|526598697|FG001|Overall Study|Death|0|||
146023387|NCT03361189|526598702|FG000|Overall Study|Received heart transplant|1|||
146023388|NCT03361189|526598703|FG001|Overall Study|Received heart transplant|0|||
146023389|NCT03361189|526598702|FG000|Overall Study|Pacemake replacement|0|||
146023390|NCT03361189|526598703|FG001|Overall Study|Pacemake replacement|1|||
146023391|NCT02323126|526598704|FG000|Overall Study|Patient / guardian decision|0|||
146023392|NCT02323126|526598705|FG001|Overall Study|Patient / guardian decision|1|||
146023393|NCT02323126|526598706|FG002|Overall Study|Patient / guardian decision|2|||
146023394|NCT02323126|526598704|FG000|Overall Study|Progressive disease|14|||
146023395|NCT02323126|526598705|FG001|Overall Study|Progressive disease|8|||
146023396|NCT02323126|526598706|FG002|Overall Study|Progressive disease|14|||
146023397|NCT02323126|526598704|FG000|Overall Study|Physician Decision|0|||
146023398|NCT02323126|526598705|FG001|Overall Study|Physician Decision|1|||
146023399|NCT02323126|526598706|FG002|Overall Study|Physician Decision|3|||
146023400|NCT02323126|526598704|FG000|Overall Study|Death|1|||
146023401|NCT02323126|526598705|FG001|Overall Study|Death|1|||
146023402|NCT02323126|526598706|FG002|Overall Study|Death|4|||
146023403|NCT02323126|526598704|FG000|Overall Study|Adverse Event|3|||
146023404|NCT02323126|526598705|FG001|Overall Study|Adverse Event|5|||
146023405|NCT02323126|526598706|FG002|Overall Study|Adverse Event|7|||
146023406|NCT03333252|526598707|FG000|Overall Study|Adverse Event|10|||
146023407|NCT03333252|526598708|FG001|Overall Study|Adverse Event|6|||
146023408|NCT03333252|526598709|FG002|Overall Study|Adverse Event|5|||
146023409|NCT03333252|526598710|FG003|Overall Study|Adverse Event|2|||
146023410|NCT03333252|526598707|FG000|Overall Study|Death|1|||
146023411|NCT03333252|526598708|FG001|Overall Study|Death|3|||
146023412|NCT03333252|526598709|FG002|Overall Study|Death|0|||
146023413|NCT03333252|526598710|FG003|Overall Study|Death|0|||
146023414|NCT03333252|526598707|FG000|Overall Study|Lack of Efficacy|8|||
146023415|NCT03333252|526598708|FG001|Overall Study|Lack of Efficacy|4|||
146023416|NCT03333252|526598709|FG002|Overall Study|Lack of Efficacy|0|||
146023417|NCT03333252|526598710|FG003|Overall Study|Lack of Efficacy|7|||
146023418|NCT03333252|526598707|FG000|Overall Study|Lost to Follow-up|0|||
146023419|NCT03333252|526598708|FG001|Overall Study|Lost to Follow-up|5|||
146023420|NCT03333252|526598709|FG002|Overall Study|Lost to Follow-up|9|||
146023421|NCT03333252|526598710|FG003|Overall Study|Lost to Follow-up|3|||
146023422|NCT03333252|526598707|FG000|Overall Study|Withdrawal by Subject|14|||
146023423|NCT03333252|526598708|FG001|Overall Study|Withdrawal by Subject|24|||
146023424|NCT03333252|526598709|FG002|Overall Study|Withdrawal by Subject|11|||
146023425|NCT03333252|526598710|FG003|Overall Study|Withdrawal by Subject|17|||
146023426|NCT01685801|526598716|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146023427|NCT01685801|526598717|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146023428|NCT01685801|526598718|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
146023429|NCT01685801|526598719|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
146023430|NCT01685801|526598716|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
146023431|NCT01685801|526598717|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
146023432|NCT01685801|526598718|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
146023433|NCT01685801|526598719|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
146023434|NCT03350256|526598720|FG000|Overall Study|Inclusion/exclusion violation|4|||
146023435|NCT03350256|526598720|FG000|Overall Study|Recommended for other therapies|2|||
146023436|NCT03350256|526598720|FG000|Overall Study|Protocol Violation|3|||
146023437|NCT03350256|526598720|FG000|Overall Study|Non compliance|2|||
146023438|NCT03350256|526598720|FG000|Overall Study|Denial by insurance|1|||
146023439|NCT03350256|526598720|FG000|Overall Study|Adverse Event|2|||
146023440|NCT03350256|526598720|FG000|Overall Study|Trial failure|12|||
146023441|NCT03350256|526598720|FG000|Overall Study|Did not proceed to permanent implant|3|||
146023442|NCT03350256|526598720|FG000|Overall Study|Withdrawal by Subject|3|||
146023443|NCT03350256|526598720|FG000|Overall Study|Subject moving out of state|1|||
146023444|NCT03350256|526598720|FG000|Overall Study|Lost to Follow-up|1|||
146023445|NCT03350256|526598720|FG000|Overall Study|Lack of Efficacy|2|||
146023446|NCT03960580|526598721|FG000|Overall Study|Adverse Event|2|||
146023447|NCT03960580|526598722|FG001|Overall Study|Adverse Event|1|||
146023448|NCT03960580|526598723|FG002|Overall Study|Adverse Event|1|||
146023449|NCT03960580|526598721|FG000|Overall Study|Lost to Follow-up|1|||
146023450|NCT03960580|526598722|FG001|Overall Study|Lost to Follow-up|0|||
146023451|NCT03960580|526598723|FG002|Overall Study|Lost to Follow-up|0|||
146023452|NCT03960580|526598721|FG000|Overall Study|Lack of Efficacy|2|||
146023453|NCT03960580|526598722|FG001|Overall Study|Lack of Efficacy|1|||
146023454|NCT03960580|526598723|FG002|Overall Study|Lack of Efficacy|0|||
146023455|NCT03960580|526598721|FG000|Overall Study|Protocol Violation|0|||
146023456|NCT03960580|526598722|FG001|Overall Study|Protocol Violation|0|||
146023457|NCT03960580|526598723|FG002|Overall Study|Protocol Violation|1|||
146023458|NCT03960580|526598721|FG000|Overall Study|Withdrawal by Subject|1|||
146023459|NCT03960580|526598722|FG001|Overall Study|Withdrawal by Subject|1|||
146023460|NCT03960580|526598723|FG002|Overall Study|Withdrawal by Subject|1|||
146023461|NCT03960580|526598721|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
146023462|NCT03960580|526598722|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
146023463|NCT03960580|526598723|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
146023464|NCT00791479|526598729|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146023465|NCT00791479|526598730|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146023466|NCT00791479|526598731|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146023467|NCT00791479|526598732|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146023468|NCT00791479|526598733|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
146023469|NCT00791479|526598734|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
146023470|NCT00791479|526598729|FG000|Overall Study|Adverse Event|0|||
146023471|NCT00791479|526598730|FG001|Overall Study|Adverse Event|1|||
146023472|NCT00791479|526598731|FG002|Overall Study|Adverse Event|0|||
146023473|NCT00791479|526598732|FG003|Overall Study|Adverse Event|2|||
146023474|NCT00791479|526598733|FG004|Overall Study|Adverse Event|0|||
146023475|NCT00791479|526598734|FG005|Overall Study|Adverse Event|1|||
146023476|NCT00791479|526598729|FG000|Overall Study|Lost to Follow-up|0|||
146023477|NCT00791479|526598730|FG001|Overall Study|Lost to Follow-up|1|||
146023478|NCT00791479|526598731|FG002|Overall Study|Lost to Follow-up|0|||
146023479|NCT00791479|526598732|FG003|Overall Study|Lost to Follow-up|0|||
146023480|NCT00791479|526598733|FG004|Overall Study|Lost to Follow-up|0|||
146023481|NCT00791479|526598734|FG005|Overall Study|Lost to Follow-up|1|||
146023482|NCT00791479|526598729|FG000|Overall Study|Protocol Violation|2|||
146023483|NCT00791479|526598730|FG001|Overall Study|Protocol Violation|1|||
146023484|NCT00791479|526598731|FG002|Overall Study|Protocol Violation|0|||
146023485|NCT00791479|526598732|FG003|Overall Study|Protocol Violation|1|||
146023486|NCT00791479|526598733|FG004|Overall Study|Protocol Violation|0|||
146023487|NCT00791479|526598734|FG005|Overall Study|Protocol Violation|0|||
146023488|NCT00791479|526598729|FG000|Overall Study|Withdrawal by Subject|0|||
146023489|NCT00791479|526598730|FG001|Overall Study|Withdrawal by Subject|0|||
146023490|NCT00791479|526598731|FG002|Overall Study|Withdrawal by Subject|0|||
146023491|NCT00791479|526598732|FG003|Overall Study|Withdrawal by Subject|1|||
146023492|NCT00791479|526598733|FG004|Overall Study|Withdrawal by Subject|0|||
146023493|NCT00791479|526598734|FG005|Overall Study|Withdrawal by Subject|1|||
146023494|NCT00543296|526598739|FG000|Overall Study|Physician Decision|7|||
146023495|NCT00934947|526598742|FG000|Overall Study|Adverse Event|0|||
146023496|NCT00934947|526598743|FG001|Overall Study|Adverse Event|2|||
146023497|NCT01920568|526598745|FG000|Overall Study|Adverse Event|27|||
146023498|NCT01920568|526598746|FG001|Overall Study|Adverse Event|8|||
146023499|NCT01920568|526598745|FG000|Overall Study|Protocol Violation|5|||
146023500|NCT01920568|526598746|FG001|Overall Study|Protocol Violation|3|||
146023501|NCT01920568|526598745|FG000|Overall Study|Lost to Follow-up|2|||
146023502|NCT01920568|526598746|FG001|Overall Study|Lost to Follow-up|2|||
146023503|NCT01920568|526598745|FG000|Overall Study|Physician Decision|13|||
146023504|NCT01920568|526598746|FG001|Overall Study|Physician Decision|4|||
146023505|NCT01920568|526598745|FG000|Overall Study|Withdrawal by Subject|79|||
146023506|NCT01920568|526598746|FG001|Overall Study|Withdrawal by Subject|55|||
146253461|NCT01945086|527439022|FG001|Overall Study|Withdrawal by Subject|0|||
146253462|NCT01945086|527439023|FG002|Overall Study|Withdrawal by Subject|1|||
146253463|NCT01945086|527439021|FG000|Overall Study|Adverse Event|0|||
146253464|NCT01945086|527439022|FG001|Overall Study|Adverse Event|0|||
146023507|NCT01920568|526598745|FG000|Overall Study|Death due to disease progression|25|||
146023508|NCT01920568|526598746|FG001|Overall Study|Death due to disease progression|12|||
146023509|NCT03664674|526598750|FG000|Overall Study|Adverse Event|1|||
146023510|NCT03664674|526598751|FG001|Overall Study|Adverse Event|1|||
146023511|NCT03664674|526598750|FG000|Overall Study|Physician Decision|0|||
146023512|NCT03664674|526598751|FG001|Overall Study|Physician Decision|1|||
146023513|NCT03664674|526598750|FG000|Overall Study|Withdrawal by Subject|2|||
146023514|NCT03664674|526598751|FG001|Overall Study|Withdrawal by Subject|0|||
146023515|NCT01342965|526598752|FG000|Overall Study|Death|58|||
146023516|NCT01342965|526598753|FG001|Overall Study|Death|57|||
146023517|NCT01342965|526598752|FG000|Overall Study|Lost to Follow-up|5|||
146023518|NCT01342965|526598753|FG001|Overall Study|Lost to Follow-up|3|||
146023519|NCT01342965|526598752|FG000|Overall Study|Other Reasons- Unspecified|44|||
146023520|NCT01342965|526598753|FG001|Overall Study|Other Reasons- Unspecified|38|||
146023521|NCT01342965|526598752|FG000|Overall Study|Withdrawal by Subject|2|||
146023522|NCT01342965|526598753|FG001|Overall Study|Withdrawal by Subject|9|||
146023523|NCT01170598|526598754|FG000|Overall Study|Withdrawal by Subject|1|||
146023524|NCT01170598|526598754|FG000|Overall Study|Death|3|||
146023525|NCT01170598|526598754|FG000|Overall Study|Lost to Follow-up|1|||
146023526|NCT01170598|526598754|FG000|Overall Study|Refused|1|||
146023527|NCT03022097|526598755|FG000|Overall Study|Adverse Event|3|||
146094553|NCT00598702|526867839|FG002|Overall Study|Other|0|||
146094554|NCT00598702|526867840|FG003|Overall Study|Other|0|||
146094555|NCT00598702|526867841|FG004|Overall Study|Other|0|||
146253465|NCT01945086|527439023|FG002|Overall Study|Adverse Event|1|||
146253466|NCT04853394|527439027|FG000|Follow-up Interviews|Lost to Follow-up|22|||
146253467|NCT04853394|527439028|FG001|Follow-up Interviews|Lost to Follow-up|15|||
146253468|NCT00748098|527439029|FG000|First Treatment Intervention Period|Adverse Event|1|||
146253469|NCT00748098|527439030|FG001|First Treatment Intervention Period|Adverse Event|1|||
146253470|NCT00748098|527439029|FG000|First Treatment Intervention Period|Protocol Violation|1|||
146253471|NCT00748098|527439030|FG001|First Treatment Intervention Period|Protocol Violation|0|||
146253472|NCT00748098|527439029|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
146253473|NCT00748098|527439030|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
146253474|NCT00748098|527439029|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
146253475|NCT00748098|527439030|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
146253476|NCT00748098|527439029|FG000|First Taper Period|Protocol Violation|1|||
146253477|NCT00748098|527439030|FG001|First Taper Period|Protocol Violation|0|||
146253478|NCT00748098|527439029|FG000|First Taper Period|Withdrawal by Subject|2|||
146253479|NCT00748098|527439030|FG001|First Taper Period|Withdrawal by Subject|0|||
146253480|NCT00748098|527439029|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
146253481|NCT00748098|527439030|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
146253482|NCT00748098|527439029|FG000|1-Week Washout Period|Adverse Event|0|||
146253483|NCT00748098|527439030|FG001|1-Week Washout Period|Adverse Event|1|||
146253484|NCT00748098|527439029|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
146094556|NCT00598702|526867842|FG005|Overall Study|Other|1|||
146094557|NCT00598702|526867843|FG006|Overall Study|Other|0|||
146094558|NCT00598702|526867844|FG007|Overall Study|Other|0|||
146253485|NCT00748098|527439030|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
146253486|NCT00748098|527439029|FG000|Second Treatment Intervention Period|Adverse Event|4|||
146253487|NCT00748098|527439030|FG001|Second Treatment Intervention Period|Adverse Event|1|||
146253488|NCT00748098|527439029|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
146253489|NCT00748098|527439030|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
146253490|NCT00748098|527439029|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
146253491|NCT00748098|527439030|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
146253492|NCT04212299|527439031|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
146253493|NCT00088452|527440761|FG000|Overall Study|Did not receive intervention|1|||
146253494|NCT00088452|527440762|FG001|Overall Study|Did not receive intervention|0|||
146253495|NCT00088452|527440763|FG002|Overall Study|Did not receive intervention|1|||
146253496|NCT04044352|527440769|FG000|Overall Study|Lost to Follow-up|9|||
146253497|NCT04044352|527440769|FG000|Overall Study|Withdrawal by Subject|2|||
146253498|NCT02176356|527440771|FG000|Overall Study|Screen Failure|14|||
146253499|NCT02176356|527440771|FG000|Overall Study|Lost to Follow-up|4|||
146253500|NCT02176356|527440771|FG000|Overall Study|Personal Reasons|3|||
146253501|NCT02176356|527440771|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146253502|NCT02706834|527440772|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146253503|NCT02706834|527440773|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146253504|NCT02706834|527440774|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146253505|NCT02706834|527440775|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146253506|NCT02706834|527440776|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146253507|NCT02706834|527440777|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
146253508|NCT02706834|527440778|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
146253509|NCT02706834|527440779|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
146023528|NCT03022097|526598756|FG001|Overall Study|Adverse Event|4|||
146094559|NCT00598702|526867837|FG000|Overall Study|Early discharge from hospital|0|||
146094560|NCT00598702|526867838|FG001|Overall Study|Early discharge from hospital|0|||
146253510|NCT02706834|527440780|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
146253511|NCT02706834|527440781|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
146253512|NCT02706834|527440782|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
146253513|NCT02706834|527440772|FG000|Overall Study|Lost to Follow-up|0|||
146023529|NCT03022097|526598757|FG002|Overall Study|Adverse Event|1|||
146023530|NCT03022097|526598758|FG003|Overall Study|Adverse Event|3|||
146023531|NCT03022097|526598755|FG000|Overall Study|Progressive Disease|2|||
146094561|NCT00598702|526867839|FG002|Overall Study|Early discharge from hospital|2|||
146023532|NCT03022097|526598756|FG001|Overall Study|Progressive Disease|0|||
146023533|NCT03022097|526598757|FG002|Overall Study|Progressive Disease|5|||
146023534|NCT03022097|526598758|FG003|Overall Study|Progressive Disease|2|||
146023535|NCT03022097|526598755|FG000|Overall Study|Lack of Efficacy|0|||
146023536|NCT03022097|526598756|FG001|Overall Study|Lack of Efficacy|0|||
146023537|NCT03022097|526598757|FG002|Overall Study|Lack of Efficacy|3|||
146023538|NCT03022097|526598758|FG003|Overall Study|Lack of Efficacy|3|||
146023539|NCT03022097|526598755|FG000|Overall Study|Protocol Violation|1|||
146023540|NCT03022097|526598756|FG001|Overall Study|Protocol Violation|0|||
146023541|NCT03022097|526598757|FG002|Overall Study|Protocol Violation|1|||
146023542|NCT03022097|526598758|FG003|Overall Study|Protocol Violation|0|||
146023543|NCT03022097|526598755|FG000|Overall Study|Withdrawal by Subject|11|||
146023544|NCT03022097|526598756|FG001|Overall Study|Withdrawal by Subject|13|||
146023545|NCT03022097|526598757|FG002|Overall Study|Withdrawal by Subject|15|||
146023546|NCT03022097|526598758|FG003|Overall Study|Withdrawal by Subject|21|||
146023547|NCT03022097|526598755|FG000|Overall Study|Lost to Follow-up|0|||
146023548|NCT03022097|526598756|FG001|Overall Study|Lost to Follow-up|0|||
146023549|NCT03022097|526598757|FG002|Overall Study|Lost to Follow-up|1|||
146023550|NCT03022097|526598758|FG003|Overall Study|Lost to Follow-up|1|||
146023551|NCT03022097|526598755|FG000|Overall Study|Other|4|||
146023552|NCT03022097|526598756|FG001|Overall Study|Other|1|||
146023553|NCT03022097|526598757|FG002|Overall Study|Other|6|||
146023554|NCT03022097|526598758|FG003|Overall Study|Other|4|||
146023555|NCT03022097|526598755|FG000|Overall Study|Due to COVID-19 pandemic|0|||
146023556|NCT03022097|526598756|FG001|Overall Study|Due to COVID-19 pandemic|1|||
146023557|NCT03022097|526598757|FG002|Overall Study|Due to COVID-19 pandemic|0|||
146023558|NCT03022097|526598758|FG003|Overall Study|Due to COVID-19 pandemic|0|||
146023559|NCT01451931|526598759|FG000|Overall Study|Lost to Follow-up|17|||
146023560|NCT01451931|526598760|FG001|Overall Study|Lost to Follow-up|36|||
146023561|NCT01451931|526598761|FG002|Overall Study|Lost to Follow-up|21|||
146023562|NCT01451931|526598759|FG000|Overall Study|Withdrawal by Subject|16|||
146023563|NCT01451931|526598760|FG001|Overall Study|Withdrawal by Subject|22|||
146023564|NCT01451931|526598761|FG002|Overall Study|Withdrawal by Subject|22|||
146023565|NCT00855933|526598768|FG000|Overall Study|Withdrawal by Subject|0|||
146023566|NCT00855933|526598769|FG001|Overall Study|Withdrawal by Subject|1|||
146023567|NCT00951080|526598770|FG000|Overall Study|Adverse Event|3|||
146023568|NCT00951080|526598771|FG001|Overall Study|Adverse Event|3|||
146023569|NCT00951080|526598770|FG000|Overall Study|Lost to Follow-up|0|||
146023570|NCT00951080|526598771|FG001|Overall Study|Lost to Follow-up|1|||
146023571|NCT00951080|526598770|FG000|Overall Study|Physician Decision|4|||
146023572|NCT00951080|526598771|FG001|Overall Study|Physician Decision|1|||
146023573|NCT00951080|526598770|FG000|Overall Study|Other|19|||
146023574|NCT00951080|526598771|FG001|Overall Study|Other|22|||
146023575|NCT01960998|526598772|FG000|Overall Study|Lost to Follow-up|3|||
146023576|NCT01960998|526598773|FG001|Overall Study|Lost to Follow-up|7|||
146253514|NCT02706834|527440773|FG001|Overall Study|Lost to Follow-up|0|||
146253515|NCT02706834|527440774|FG002|Overall Study|Lost to Follow-up|1|||
146253516|NCT02706834|527440775|FG003|Overall Study|Lost to Follow-up|0|||
146253517|NCT02706834|527440776|FG004|Overall Study|Lost to Follow-up|0|||
146253518|NCT02706834|527440777|FG005|Overall Study|Lost to Follow-up|0|||
146253519|NCT02706834|527440778|FG006|Overall Study|Lost to Follow-up|0|||
146253520|NCT02706834|527440779|FG007|Overall Study|Lost to Follow-up|0|||
146253521|NCT02706834|527440780|FG008|Overall Study|Lost to Follow-up|0|||
146253522|NCT02706834|527440781|FG009|Overall Study|Lost to Follow-up|0|||
146253523|NCT02706834|527440782|FG010|Overall Study|Lost to Follow-up|0|||
146253524|NCT02706834|527440772|FG000|Overall Study|Voluntary Withdrawal|1|||
146253525|NCT02706834|527440773|FG001|Overall Study|Voluntary Withdrawal|0|||
146253526|NCT02706834|527440774|FG002|Overall Study|Voluntary Withdrawal|0|||
146253527|NCT02706834|527440775|FG003|Overall Study|Voluntary Withdrawal|0|||
146253528|NCT02706834|527440776|FG004|Overall Study|Voluntary Withdrawal|0|||
146253529|NCT02706834|527440777|FG005|Overall Study|Voluntary Withdrawal|0|||
146253530|NCT02706834|527440778|FG006|Overall Study|Voluntary Withdrawal|0|||
146253531|NCT02706834|527440779|FG007|Overall Study|Voluntary Withdrawal|0|||
146253532|NCT02706834|527440780|FG008|Overall Study|Voluntary Withdrawal|0|||
146253533|NCT02706834|527440781|FG009|Overall Study|Voluntary Withdrawal|1|||
146253534|NCT02706834|527440782|FG010|Overall Study|Voluntary Withdrawal|0|||
146023577|NCT01960998|526598772|FG000|Overall Study|Death|0|||
146023578|NCT01960998|526598773|FG001|Overall Study|Death|1|||
146253535|NCT02706834|527440772|FG000|Overall Study|Other Reason Not Specified|1|||
146023579|NCT01960998|526598772|FG000|Overall Study|Withdrawal by Subject|8|||
146023580|NCT01960998|526598773|FG001|Overall Study|Withdrawal by Subject|2|||
146023581|NCT01960998|526598772|FG000|Overall Study|lost computer access|0|||
146023582|NCT01960998|526598773|FG001|Overall Study|lost computer access|1|||
146023583|NCT00835640|526598774|FG000|Second Intervention|Protocol Violation|1|||
146023584|NCT00835640|526598775|FG001|Second Intervention|Protocol Violation|0|||
146023585|NCT00812006|526598776|FG000|Overall Study|Lost to Follow-up|0|||
146023586|NCT00812006|526598777|FG001|Overall Study|Lost to Follow-up|0|||
146023587|NCT00812006|526598778|FG002|Overall Study|Lost to Follow-up|2|||
146023588|NCT00812006|526598776|FG000|Overall Study|Physician Decision|0|||
146023589|NCT00812006|526598777|FG001|Overall Study|Physician Decision|0|||
146023590|NCT00812006|526598778|FG002|Overall Study|Physician Decision|1|||
146023591|NCT00812006|526598776|FG000|Overall Study|Withdrawal by Subject|2|||
146023592|NCT00812006|526598777|FG001|Overall Study|Withdrawal by Subject|1|||
146023593|NCT00812006|526598778|FG002|Overall Study|Withdrawal by Subject|1|||
146023594|NCT00812006|526598776|FG000|Overall Study|Lack of Qualifying Event|4|||
146023595|NCT00812006|526598777|FG001|Overall Study|Lack of Qualifying Event|2|||
146023596|NCT00812006|526598778|FG002|Overall Study|Lack of Qualifying Event|2|||
146023597|NCT00235391|526598779|FG000|Overall Study|Adverse Event|4|||
146023598|NCT00235391|526598780|FG001|Overall Study|Adverse Event|5|||
146023599|NCT00235391|526598781|FG002|Overall Study|Adverse Event|10|||
146023600|NCT00235391|526598782|FG003|Overall Study|Adverse Event|72|||
146023601|NCT00235391|526598783|FG004|Overall Study|Adverse Event|5|||
146023602|NCT00235391|526598784|FG005|Overall Study|Adverse Event|2|||
146023603|NCT00235391|526598779|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146023604|NCT00235391|526598780|FG001|Overall Study|Abnormal laboratory value(s)|5|||
146023605|NCT00235391|526598781|FG002|Overall Study|Abnormal laboratory value(s)|4|||
146023606|NCT00235391|526598782|FG003|Overall Study|Abnormal laboratory value(s)|27|||
146023607|NCT00235391|526598783|FG004|Overall Study|Abnormal laboratory value(s)|1|||
146023608|NCT00235391|526598784|FG005|Overall Study|Abnormal laboratory value(s)|2|||
146023609|NCT00235391|526598779|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146023610|NCT00235391|526598780|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146023611|NCT00235391|526598781|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146023612|NCT00235391|526598782|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
146023613|NCT00235391|526598783|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
146023614|NCT00235391|526598784|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
146023615|NCT00235391|526598779|FG000|Overall Study|Condition no longer requires treatment|3|||
146023616|NCT00235391|526598780|FG001|Overall Study|Condition no longer requires treatment|0|||
146023617|NCT00235391|526598781|FG002|Overall Study|Condition no longer requires treatment|0|||
146023618|NCT00235391|526598782|FG003|Overall Study|Condition no longer requires treatment|11|||
146023619|NCT00235391|526598783|FG004|Overall Study|Condition no longer requires treatment|1|||
146023620|NCT00235391|526598784|FG005|Overall Study|Condition no longer requires treatment|0|||
146023621|NCT00235391|526598779|FG000|Overall Study|Protocol deviation|0|||
146023622|NCT00235391|526598780|FG001|Overall Study|Protocol deviation|0|||
146023623|NCT00235391|526598781|FG002|Overall Study|Protocol deviation|1|||
146023624|NCT00235391|526598782|FG003|Overall Study|Protocol deviation|11|||
146023625|NCT00235391|526598783|FG004|Overall Study|Protocol deviation|0|||
146023626|NCT00235391|526598784|FG005|Overall Study|Protocol deviation|0|||
146023627|NCT00235391|526598779|FG000|Overall Study|Withdrawal by Subject|2|||
146023628|NCT00235391|526598780|FG001|Overall Study|Withdrawal by Subject|3|||
146023629|NCT00235391|526598781|FG002|Overall Study|Withdrawal by Subject|3|||
146023630|NCT00235391|526598782|FG003|Overall Study|Withdrawal by Subject|61|||
146023631|NCT00235391|526598783|FG004|Overall Study|Withdrawal by Subject|5|||
146023632|NCT00235391|526598784|FG005|Overall Study|Withdrawal by Subject|0|||
146023633|NCT00235391|526598779|FG000|Overall Study|Lost to Follow-up|0|||
146023634|NCT00235391|526598780|FG001|Overall Study|Lost to Follow-up|3|||
146023635|NCT00235391|526598781|FG002|Overall Study|Lost to Follow-up|3|||
146023636|NCT00235391|526598782|FG003|Overall Study|Lost to Follow-up|16|||
146023637|NCT00235391|526598783|FG004|Overall Study|Lost to Follow-up|0|||
146023638|NCT00235391|526598784|FG005|Overall Study|Lost to Follow-up|0|||
146023639|NCT00235391|526598779|FG000|Overall Study|Administrative problems|0|||
146023640|NCT00235391|526598780|FG001|Overall Study|Administrative problems|0|||
146023641|NCT00235391|526598781|FG002|Overall Study|Administrative problems|0|||
146023642|NCT00235391|526598782|FG003|Overall Study|Administrative problems|1|||
146023643|NCT00235391|526598783|FG004|Overall Study|Administrative problems|0|||
146094562|NCT00598702|526867840|FG003|Overall Study|Early discharge from hospital|5|||
146094563|NCT00598702|526867841|FG004|Overall Study|Early discharge from hospital|0|||
146253536|NCT02706834|527440773|FG001|Overall Study|Other Reason Not Specified|0|||
146253537|NCT02706834|527440774|FG002|Overall Study|Other Reason Not Specified|0|||
146253538|NCT02706834|527440775|FG003|Overall Study|Other Reason Not Specified|0|||
146253539|NCT02706834|527440776|FG004|Overall Study|Other Reason Not Specified|1|||
146023644|NCT00235391|526598784|FG005|Overall Study|Administrative problems|0|||
146023645|NCT00235391|526598779|FG000|Overall Study|Death|0|||
146023646|NCT00235391|526598780|FG001|Overall Study|Death|0|||
146023647|NCT00235391|526598781|FG002|Overall Study|Death|1|||
146023648|NCT00235391|526598782|FG003|Overall Study|Death|4|||
146023649|NCT00235391|526598783|FG004|Overall Study|Death|0|||
146023650|NCT00235391|526598784|FG005|Overall Study|Death|0|||
146023651|NCT02927925|526598789|FG000|Overall Study|Death|16|||
146023652|NCT02927925|526598789|FG000|Overall Study|Physician Decision|1|||
146023653|NCT02927925|526598789|FG000|Overall Study|Withdrawal by Subject|11|||
146023654|NCT02927925|526598789|FG000|Overall Study|Other|3|||
146023655|NCT02927925|526598789|FG000|Overall Study|Disease progression at clinical cutoff|1|||
146023656|NCT00580034|526598790|FG000|Overall Study|Toxicity|10|||
146023657|NCT00580034|526598791|FG001|Overall Study|Toxicity|0|||
146253540|NCT02706834|527440777|FG005|Overall Study|Other Reason Not Specified|0|||
146023658|NCT00772369|526598793|FG000|Overall Study|Did not return record release form|1|||
146023659|NCT03372460|526598794|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
146023660|NCT03372460|526598795|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
146023661|NCT02499900|526598796|FG000|Core Study Period|Other|1|||
146023662|NCT02499900|526598797|FG001|Core Study Period|Other|4|||
146023663|NCT02499900|526598796|FG000|Core Study Period|Lost to Follow-up|1|||
146023664|NCT02499900|526598797|FG001|Core Study Period|Lost to Follow-up|2|||
146023665|NCT02499900|526598796|FG000|Core Study Period|Per sponsor request|0|||
146023666|NCT02499900|526598797|FG001|Core Study Period|Per sponsor request|1|||
146023667|NCT02499900|526598796|FG000|Core Study Period|Pregnancy|1|||
146023668|NCT02499900|526598797|FG001|Core Study Period|Pregnancy|0|||
146023669|NCT02499900|526598796|FG000|Core Study Period|Protocol Violation|3|||
146023670|NCT02499900|526598797|FG001|Core Study Period|Protocol Violation|0|||
146023671|NCT02499900|526598796|FG000|Core Study Period|Withdrawal by Subject|11|||
146023672|NCT02499900|526598797|FG001|Core Study Period|Withdrawal by Subject|10|||
146023673|NCT02499900|526598796|FG000|Core Study Period|Adverse Event|18|||
146023674|NCT02499900|526598797|FG001|Core Study Period|Adverse Event|14|||
146023675|NCT02499900|526598796|FG000|Core Study Period|Death|0|||
146023676|NCT02499900|526598797|FG001|Core Study Period|Death|1|||
146253541|NCT02706834|527440778|FG006|Overall Study|Other Reason Not Specified|0|||
146023677|NCT02499900|526598796|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
146023678|NCT02499900|526598797|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
146023679|NCT02499900|526598796|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
146023680|NCT02499900|526598797|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
146023681|NCT02499900|526598796|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
146253542|NCT02706834|527440779|FG007|Overall Study|Other Reason Not Specified|0|||
146253543|NCT02706834|527440780|FG008|Overall Study|Other Reason Not Specified|0|||
146253544|NCT02706834|527440781|FG009|Overall Study|Other Reason Not Specified|0|||
146253545|NCT02706834|527440782|FG010|Overall Study|Other Reason Not Specified|0|||
146253546|NCT02131155|527440786|FG000|Overall Study|Adverse Event|1|||
146253547|NCT02131155|527440787|FG001|Overall Study|Adverse Event|0|||
146253548|NCT02131155|527440786|FG000|Overall Study|Treatment completed|1|||
146023682|NCT02499900|526598797|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
146023683|NCT02499900|526598796|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
146023684|NCT02499900|526598797|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
146023685|NCT02499900|526598796|FG000|Extension Study Period|Adverse Event|2|||
146023686|NCT02499900|526598797|FG001|Extension Study Period|Adverse Event|4|||
146023687|NCT02499900|526598796|FG000|Extension Study Period|Withdrawal by Subject|5|||
146023688|NCT02499900|526598797|FG001|Extension Study Period|Withdrawal by Subject|2|||
146023689|NCT02499900|526598796|FG000|Extension Study Period|Physician Decision|2|||
146023690|NCT02499900|526598797|FG001|Extension Study Period|Physician Decision|5|||
146023691|NCT02499900|526598796|FG000|Extension Study Period|Pregnancy|1|||
146023692|NCT02499900|526598797|FG001|Extension Study Period|Pregnancy|2|||
146023693|NCT02499900|526598796|FG000|Extension Study Period|Lost to Follow-up|2|||
146023694|NCT02499900|526598797|FG001|Extension Study Period|Lost to Follow-up|5|||
146023695|NCT02499900|526598796|FG000|Extension Study Period|Other|0|||
146023696|NCT02499900|526598797|FG001|Extension Study Period|Other|2|||
146023697|NCT00916058|526598798|FG000|Phase 1|Screen Failure|0|||
146023698|NCT00916058|526598799|FG001|Phase 1|Screen Failure|0|||
146023699|NCT00916058|526598800|FG002|Phase 1|Screen Failure|0|||
146023700|NCT00916058|526598801|FG003|Phase 1|Screen Failure|0|||
146023701|NCT00916058|526598802|FG004|Phase 1|Screen Failure|0|||
146023702|NCT00916058|526598803|FG005|Phase 1|Screen Failure|1|||
146023703|NCT00916058|526598804|FG006|Phase 1|Screen Failure|0|||
146023704|NCT00916058|526598798|FG000|Phase 2|Screen Failure|0|||
146023705|NCT00916058|526598799|FG001|Phase 2|Screen Failure|0|||
146023706|NCT00916058|526598800|FG002|Phase 2|Screen Failure|0|||
146023707|NCT00916058|526598801|FG003|Phase 2|Screen Failure|0|||
146253549|NCT02131155|527440787|FG001|Overall Study|Treatment completed|0|||
146023708|NCT00916058|526598802|FG004|Phase 2|Screen Failure|0|||
146023709|NCT00916058|526598803|FG005|Phase 2|Screen Failure|0|||
146023710|NCT00916058|526598804|FG006|Phase 2|Screen Failure|3|||
146300275|NCT03681951|527615192|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
146253550|NCT02131155|527440786|FG000|Overall Study|Primary tumour recurrence|2|||
146253551|NCT02131155|527440787|FG001|Overall Study|Primary tumour recurrence|1|||
146253552|NCT02131155|527440786|FG000|Overall Study|Refused to continue study medication|1|||
146253553|NCT02131155|527440787|FG001|Overall Study|Refused to continue study medication|0|||
146023711|NCT02439450|526598805|FG000|Overall Study|Adverse Event|4|||
146023712|NCT02439450|526598806|FG001|Overall Study|Adverse Event|1|||
146023713|NCT02439450|526598807|FG002|Overall Study|Adverse Event|0|||
146023714|NCT02439450|526598808|FG003|Overall Study|Adverse Event|0|||
146023715|NCT02439450|526598805|FG000|Overall Study|Withdrawal by Subject|1|||
146023716|NCT02439450|526598806|FG001|Overall Study|Withdrawal by Subject|2|||
146023717|NCT02439450|526598807|FG002|Overall Study|Withdrawal by Subject|0|||
146023718|NCT02439450|526598808|FG003|Overall Study|Withdrawal by Subject|0|||
146253554|NCT02131155|527440786|FG000|Overall Study|Study early termination|20|||
146253555|NCT02131155|527440787|FG001|Overall Study|Study early termination|10|||
146253556|NCT01887418|527440788|FG000|Overall Study|Travelling difficulties|0|||
146253557|NCT01887418|527440789|FG001|Overall Study|Travelling difficulties|0|||
146253558|NCT01887418|527440790|FG002|Overall Study|Travelling difficulties|1|||
146253559|NCT03132753|527440791|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
146253560|NCT03132753|527440792|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
146253561|NCT03132753|527440791|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
146253562|NCT03132753|527440792|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
146253563|NCT00084747|527440793|FG000|Overall Study|Relapsed|8|||
146253564|NCT00084747|527440793|FG000|Overall Study|Death|3|||
146253565|NCT00084747|527440793|FG000|Overall Study|Withdrawal by Subject|2|||
146253566|NCT02744898|527440795|FG000|Overall Study|Progressive Disease|2|||
146253567|NCT02744898|527440795|FG000|Overall Study|Physician Decision|1|||
146253568|NCT02744898|527440795|FG000|Overall Study|Toxicity|1|||
146253569|NCT03751280|527440797|FG000|Overall Study|Adverse Event|0|||
146253570|NCT03751280|527440798|FG001|Overall Study|Adverse Event|1|||
146253571|NCT03751280|527440797|FG000|Overall Study|Lost to Follow-up|3|||
146253572|NCT03751280|527440798|FG001|Overall Study|Lost to Follow-up|5|||
146253573|NCT03751280|527440797|FG000|Overall Study|Physician Decision|0|||
146253574|NCT03751280|527440798|FG001|Overall Study|Physician Decision|2|||
146253575|NCT03751280|527440797|FG000|Overall Study|Protocol Violation|0|||
146253576|NCT03751280|527440798|FG001|Overall Study|Protocol Violation|2|||
146253577|NCT03751280|527440797|FG000|Overall Study|Withdrawal by Subject|5|||
146253578|NCT03751280|527440798|FG001|Overall Study|Withdrawal by Subject|2|||
146253579|NCT02162771|527440799|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
146253580|NCT02162771|527440800|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
146253581|NCT02162771|527440799|FG000|Core Study Period (Part 2)|Adverse Event|4|||
146253582|NCT02162771|527440800|FG001|Core Study Period (Part 2)|Adverse Event|1|||
146253583|NCT02162771|527440799|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
146253584|NCT02162771|527440800|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
146253585|NCT02162771|527440799|FG000|Core Study Period (Part 2)|Physician Decision|0|||
146253586|NCT02162771|527440800|FG001|Core Study Period (Part 2)|Physician Decision|2|||
146253587|NCT02162771|527440799|FG000|Core Study Period (Part 2)|Death|1|||
146253588|NCT02162771|527440800|FG001|Core Study Period (Part 2)|Death|0|||
146253589|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
146253590|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
146253591|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
146253592|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
146253593|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Death|2|||
146253594|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Death|1|||
146253595|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
146253596|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
146253597|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
146253598|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
146253599|NCT02162771|527440799|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
146253600|NCT02162771|527440800|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
146253601|NCT03647709|527440809|FG000|Overall Study|Lost to Follow-up|5|||
146253602|NCT03647709|527440809|FG000|Overall Study|Physician Decision|6|||
146253603|NCT03647709|527440809|FG000|Overall Study|Withdrawal by Subject|3|||
146253604|NCT04393779|527440812|FG000|Overall Study|Death|1|||
146253605|NCT04393779|527440812|FG000|Overall Study|Device reintervention or explant|4|||
146253606|NCT03802513|527440814|FG000|Overall Study|Lost to Follow-up|1|||
146253607|NCT01190228|527440819|FG000|Overall Study|Protocol Violation|4|||
146300276|NCT03681951|527615193|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146023719|NCT02439450|526598805|FG000|Overall Study|Death|3|||
146023720|NCT02439450|526598806|FG001|Overall Study|Death|0|||
146023721|NCT02439450|526598807|FG002|Overall Study|Death|0|||
146023722|NCT02439450|526598808|FG003|Overall Study|Death|1|||
146023723|NCT02439450|526598805|FG000|Overall Study|Progressive Disease|18|||
146023724|NCT02439450|526598806|FG001|Overall Study|Progressive Disease|41|||
146023725|NCT02439450|526598807|FG002|Overall Study|Progressive Disease|2|||
146023726|NCT02439450|526598808|FG003|Overall Study|Progressive Disease|3|||
146253608|NCT01190228|527440820|FG001|Overall Study|Protocol Violation|0|||
146253609|NCT01190228|527440821|FG002|Overall Study|Protocol Violation|0|||
146253610|NCT01190228|527440819|FG000|Overall Study|Withdrawal by Subject|1|||
146253611|NCT01190228|527440820|FG001|Overall Study|Withdrawal by Subject|0|||
146253612|NCT01190228|527440821|FG002|Overall Study|Withdrawal by Subject|0|||
146253613|NCT01395914|527440822|FG000|Overall Study|Unrelated to study drug AE|6|||
146253614|NCT01395914|527440823|FG001|Overall Study|Unrelated to study drug AE|1|||
146253615|NCT01395914|527440822|FG000|Overall Study|Death|23|||
146253616|NCT01395914|527440823|FG001|Overall Study|Death|17|||
146253617|NCT01395914|527440822|FG000|Overall Study|Other|9|||
146253618|NCT01395914|527440823|FG001|Overall Study|Other|3|||
146253619|NCT01395914|527440822|FG000|Overall Study|Withdrawal by patient|27|||
146023727|NCT01071200|526598809|FG000|Overall Study|Lack of ovarian response|1|||
146253620|NCT01395914|527440823|FG001|Overall Study|Withdrawal by patient|14|||
146253621|NCT01395914|527440822|FG000|Overall Study|Study drug-related AE|1|||
146253622|NCT01395914|527440823|FG001|Overall Study|Study drug-related AE|0|||
146023728|NCT01071200|526598810|FG001|Overall Study|Lack of ovarian response|1|||
146023729|NCT01071200|526598809|FG000|Overall Study|No fertilization|4|||
146023730|NCT01071200|526598810|FG001|Overall Study|No fertilization|0|||
146023731|NCT01071200|526598809|FG000|Overall Study|No oocytes retrieved|1|||
146023732|NCT01071200|526598810|FG001|Overall Study|No oocytes retrieved|1|||
146023733|NCT01071200|526598809|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
146023734|NCT01071200|526598810|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
146023735|NCT01071200|526598809|FG000|Overall Study|No viable embryos|0|||
146023736|NCT01071200|526598810|FG001|Overall Study|No viable embryos|1|||
146023737|NCT01646645|526598817|FG000|Overall Study|No Treated|1|||
146023738|NCT01646645|526598817|FG000|Overall Study|Inevaluable Donor|29|||
146023739|NCT00717522|526598818|FG000|Overall Study|Disease Progression|5|||
146023740|NCT00717522|526598818|FG000|Overall Study|Adverse Event|1|||
146023741|NCT00717522|526598818|FG000|Overall Study|Death|1|||
146023742|NCT04049266|526600775|FG000|Overall Study|Adverse Event|16|||
146023743|NCT04049266|526600776|FG001|Overall Study|Adverse Event|9|||
146023744|NCT04049266|526600775|FG000|Overall Study|Non-compliance with study drug|0|||
146023745|NCT04049266|526600776|FG001|Overall Study|Non-compliance with study drug|3|||
146023746|NCT04049266|526600775|FG000|Overall Study|Withdrawal by Subject|6|||
146023747|NCT04049266|526600776|FG001|Overall Study|Withdrawal by Subject|10|||
146023748|NCT04049266|526600775|FG000|Overall Study|Lost to Follow-up|2|||
146023749|NCT04049266|526600776|FG001|Overall Study|Lost to Follow-up|2|||
146023750|NCT04049266|526600775|FG000|Overall Study|Progressive disease|11|||
146023751|NCT04049266|526600776|FG001|Overall Study|Progressive disease|2|||
146023752|NCT04049266|526600775|FG000|Overall Study|Physician Decision|1|||
146023753|NCT04049266|526600776|FG001|Overall Study|Physician Decision|0|||
146023754|NCT04049266|526600775|FG000|Overall Study|Patient moved out of state|1|||
146023755|NCT04049266|526600776|FG001|Overall Study|Patient moved out of state|0|||
146023756|NCT04600076|526600778|FG000|Overall Study|Lost to Follow-up|3|||
146023757|NCT02891681|526600779|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
146023758|NCT02891681|526600780|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
146023759|NCT02891681|526600781|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
146023760|NCT02891681|526600779|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
146023761|NCT02891681|526600780|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
146023762|NCT02891681|526600781|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
146023763|NCT02891681|526600779|FG000|Overall Study|Taken off study after first imaging appointment|1|||
146023764|NCT02891681|526600780|FG001|Overall Study|Taken off study after first imaging appointment|0|||
146023765|NCT02891681|526600781|FG002|Overall Study|Taken off study after first imaging appointment|0|||
146023766|NCT02174523|526600782|FG000|Overall Study|Withdrawal by Subject|1|||
146023767|NCT02174523|526600783|FG001|Overall Study|Withdrawal by Subject|0|||
146023768|NCT02780856|526600794|FG000|Overall Study|Lost to Follow-up|1|||
146023769|NCT05479097|526600795|FG000|Overall Study|Withdrawal by Subject|2|||
146023770|NCT03894969|526600799|FG000|Overall Study|Adverse Event|0|||
146023771|NCT03894969|526600800|FG001|Overall Study|Adverse Event|2|||
146023772|NCT03894969|526600801|FG002|Overall Study|Adverse Event|0|||
146023773|NCT03894969|526600802|FG003|Overall Study|Adverse Event|1|||
146023774|NCT03894969|526600803|FG004|Overall Study|Adverse Event|2|||
146023775|NCT03894969|526600799|FG000|Overall Study|Lost to Follow-up|3|||
146023776|NCT03894969|526600800|FG001|Overall Study|Lost to Follow-up|1|||
146023777|NCT03894969|526600801|FG002|Overall Study|Lost to Follow-up|1|||
146023778|NCT03894969|526600802|FG003|Overall Study|Lost to Follow-up|0|||
146023779|NCT03894969|526600803|FG004|Overall Study|Lost to Follow-up|0|||
146023780|NCT03894969|526600799|FG000|Overall Study|Withdrawal by Subject|2|||
146023781|NCT03894969|526600800|FG001|Overall Study|Withdrawal by Subject|1|||
146023782|NCT03894969|526600801|FG002|Overall Study|Withdrawal by Subject|3|||
146023783|NCT03894969|526600802|FG003|Overall Study|Withdrawal by Subject|4|||
146023784|NCT03894969|526600803|FG004|Overall Study|Withdrawal by Subject|8|||
146023785|NCT03894969|526600799|FG000|Overall Study|Other|0|||
146023786|NCT03894969|526600800|FG001|Overall Study|Other|0|||
146023787|NCT03894969|526600801|FG002|Overall Study|Other|0|||
146023788|NCT03894969|526600802|FG003|Overall Study|Other|0|||
146023789|NCT03894969|526600803|FG004|Overall Study|Other|3|||
146023790|NCT03894969|526600799|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146023791|NCT03894969|526600800|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146094564|NCT00598702|526867842|FG005|Overall Study|Early discharge from hospital|10|||
146023792|NCT03894969|526600801|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
146023793|NCT03894969|526600802|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
146023794|NCT03894969|526600803|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
146094565|NCT00598702|526867843|FG006|Overall Study|Early discharge from hospital|1|||
146253623|NCT01395914|527440822|FG000|Overall Study|Lost to Follow-up|6|||
146023795|NCT03894969|526600799|FG000|Overall Study|Solicited Adverse Event|0|||
146023796|NCT03894969|526600800|FG001|Overall Study|Solicited Adverse Event|1|||
146253624|NCT01395914|527440823|FG001|Overall Study|Lost to Follow-up|2|||
146253625|NCT03023878|527440824|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
146253626|NCT03023878|527440824|FG000|Pre-Study Run-In Period|Death|1|||
146253627|NCT03023878|527440824|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
146253628|NCT03023878|527440824|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
146253629|NCT03023878|527440824|FG000|Treatment Period|Disease Progression|1|||
146253630|NCT03023878|527440824|FG000|Treatment Period|Withdrawal by Subject|1|||
146253631|NCT03023878|527440824|FG000|Treatment Period|Adverse Event|1|||
146253632|NCT03023878|527440824|FG000|Long Term Follow-Up Period|Death|2|||
146253633|NCT00832650|527440828|FG000|Overall Study|Randomized but not treated|0|||
146253634|NCT00832650|527440829|FG001|Overall Study|Randomized but not treated|0|||
146253635|NCT00832650|527440830|FG002|Overall Study|Randomized but not treated|1|||
146094566|NCT00598702|526867844|FG007|Overall Study|Early discharge from hospital|0|||
146094567|NCT00598702|526867837|FG000|Overall Study|Adverse Event|0|||
146094568|NCT00598702|526867838|FG001|Overall Study|Adverse Event|0|||
146023797|NCT03894969|526600801|FG002|Overall Study|Solicited Adverse Event|0|||
146094569|NCT00598702|526867839|FG002|Overall Study|Adverse Event|0|||
146094570|NCT00598702|526867840|FG003|Overall Study|Adverse Event|1|||
146094571|NCT00598702|526867841|FG004|Overall Study|Adverse Event|0|||
146094572|NCT00598702|526867842|FG005|Overall Study|Adverse Event|0|||
146094573|NCT00598702|526867843|FG006|Overall Study|Adverse Event|0|||
146094574|NCT00598702|526867844|FG007|Overall Study|Adverse Event|0|||
146094575|NCT00598702|526867837|FG000|Overall Study|Withdrawal by Subject|0|||
146253636|NCT03219216|527440831|FG000|Overall Study|Lost to Follow-up|0|||
146023798|NCT03894969|526600802|FG003|Overall Study|Solicited Adverse Event|0|||
146023799|NCT03894969|526600803|FG004|Overall Study|Solicited Adverse Event|0|||
146023800|NCT00468676|526600804|FG000|Overall Study|Lost to Follow-up|14|||
146253637|NCT03219216|527440832|FG001|Overall Study|Lost to Follow-up|1|||
146253638|NCT02332824|527440833|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
146253639|NCT02332824|527440834|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146253640|NCT02332824|527440835|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146253641|NCT02332824|527440836|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146253642|NCT02332824|527440837|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
146253643|NCT02332824|527440838|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
146253644|NCT02332824|527440833|FG000|Overall Study|Voluntary Withdrawal|1|||
146253645|NCT02332824|527440834|FG001|Overall Study|Voluntary Withdrawal|0|||
146253646|NCT02332824|527440835|FG002|Overall Study|Voluntary Withdrawal|0|||
146253647|NCT02332824|527440836|FG003|Overall Study|Voluntary Withdrawal|0|||
146253648|NCT02332824|527440837|FG004|Overall Study|Voluntary Withdrawal|0|||
146253649|NCT02332824|527440838|FG005|Overall Study|Voluntary Withdrawal|0|||
146253650|NCT02332824|527440833|FG000|Overall Study|Inconvenient schedule|1|||
146253651|NCT02332824|527440834|FG001|Overall Study|Inconvenient schedule|1|||
146253652|NCT02332824|527440835|FG002|Overall Study|Inconvenient schedule|0|||
146253653|NCT02332824|527440836|FG003|Overall Study|Inconvenient schedule|0|||
146253654|NCT02332824|527440837|FG004|Overall Study|Inconvenient schedule|0|||
146253655|NCT02332824|527440838|FG005|Overall Study|Inconvenient schedule|0|||
146023801|NCT00468676|526600805|FG001|Overall Study|Lost to Follow-up|11|||
146023802|NCT00468676|526600804|FG000|Overall Study|Death|2|||
146023803|NCT00468676|526600805|FG001|Overall Study|Death|1|||
146023804|NCT02378298|526600808|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
146023805|NCT02378298|526600809|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
146023806|NCT02378298|526600810|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
146023807|NCT02378298|526600808|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
146023808|NCT02378298|526600809|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
146023809|NCT02378298|526600810|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
146253656|NCT02332824|527440833|FG000|Overall Study|Transfer|0|||
146253657|NCT02332824|527440834|FG001|Overall Study|Transfer|0|||
146253658|NCT02332824|527440835|FG002|Overall Study|Transfer|1|||
146253659|NCT02332824|527440836|FG003|Overall Study|Transfer|1|||
146253660|NCT02332824|527440837|FG004|Overall Study|Transfer|0|||
146253661|NCT02332824|527440838|FG005|Overall Study|Transfer|0|||
146253662|NCT00440037|527440839|FG000|Overall Study|Withdrawal by Subject|6|||
146253663|NCT00440037|527440839|FG000|Overall Study|Administrative decision|3|||
146094576|NCT00598702|526867838|FG001|Overall Study|Withdrawal by Subject|0|||
146094577|NCT00598702|526867839|FG002|Overall Study|Withdrawal by Subject|0|||
146094578|NCT00598702|526867840|FG003|Overall Study|Withdrawal by Subject|1|||
146094579|NCT00598702|526867841|FG004|Overall Study|Withdrawal by Subject|1|||
146253664|NCT00498797|527440840|FG000|Overall Study|Withdrawal by Subject|4|||
146253665|NCT00498797|527440841|FG001|Overall Study|Withdrawal by Subject|2|||
146253666|NCT00498797|527440840|FG000|Overall Study|Adverse Event|12|||
146253667|NCT00498797|527440841|FG001|Overall Study|Adverse Event|5|||
146253668|NCT00498797|527440840|FG000|Overall Study|Condition under investigation worsened|19|||
146253669|NCT00498797|527440841|FG001|Overall Study|Condition under investigation worsened|21|||
146253670|NCT00498797|527440840|FG000|Overall Study|Other|3|||
146023810|NCT02378298|526600808|FG000|Surveillance (19-68 Weeks)|Death|1|||
146023811|NCT02378298|526600809|FG001|Surveillance (19-68 Weeks)|Death|0|||
146023812|NCT02378298|526600810|FG002|Surveillance (19-68 Weeks)|Death|0|||
146023813|NCT01779869|526600813|FG000|Overall Study|Physician Decision|2|||
146023814|NCT03006458|526600816|FG000|First Intervention|Unsatisfied Vision|0|||
146023815|NCT03006458|526600817|FG001|First Intervention|Unsatisfied Vision|3|||
146023816|NCT00957944|526600818|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
146023817|NCT00957944|526600819|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
146023818|NCT01482169|526600821|FG000|Overall Study|Physician Decision|2|||
146023819|NCT01468233|526600822|FG000|Treatment Period 1|Adverse Event|5|||
146023820|NCT01468233|526600823|FG001|Treatment Period 1|Adverse Event|3|||
146023821|NCT01468233|526600824|FG002|Treatment Period 1|Adverse Event|0|||
146023822|NCT01468233|526600825|FG003|Treatment Period 1|Adverse Event|0|||
146023823|NCT01468233|526600826|FG004|Treatment Period 1|Adverse Event|0|||
146023824|NCT01468233|526600827|FG005|Treatment Period 1|Adverse Event|0|||
146023825|NCT01468233|526600822|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146023826|NCT01468233|526600823|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146023827|NCT01468233|526600824|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146023828|NCT01468233|526600825|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146023829|NCT01468233|526600826|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146023830|NCT01468233|526600827|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146023831|NCT01468233|526600822|FG000|Treatment Period 1|Lost to Follow-up|3|||
146023832|NCT01468233|526600823|FG001|Treatment Period 1|Lost to Follow-up|0|||
146023833|NCT01468233|526600824|FG002|Treatment Period 1|Lost to Follow-up|0|||
146023834|NCT01468233|526600825|FG003|Treatment Period 1|Lost to Follow-up|0|||
146023835|NCT01468233|526600826|FG004|Treatment Period 1|Lost to Follow-up|0|||
146023836|NCT01468233|526600827|FG005|Treatment Period 1|Lost to Follow-up|0|||
146023837|NCT01468233|526600822|FG000|Treatment Period 1|Other|1|||
146023838|NCT01468233|526600823|FG001|Treatment Period 1|Other|1|||
146023839|NCT01468233|526600824|FG002|Treatment Period 1|Other|0|||
146023840|NCT01468233|526600825|FG003|Treatment Period 1|Other|0|||
146023841|NCT01468233|526600826|FG004|Treatment Period 1|Other|0|||
146023842|NCT01468233|526600827|FG005|Treatment Period 1|Other|0|||
146023843|NCT01468233|526600822|FG000|Treatment Period 2|Adverse Event|0|||
146023844|NCT01468233|526600823|FG001|Treatment Period 2|Adverse Event|0|||
146023845|NCT01468233|526600824|FG002|Treatment Period 2|Adverse Event|3|||
146023846|NCT01468233|526600825|FG003|Treatment Period 2|Adverse Event|0|||
146023847|NCT01468233|526600826|FG004|Treatment Period 2|Adverse Event|2|||
146023848|NCT01468233|526600827|FG005|Treatment Period 2|Adverse Event|1|||
146023849|NCT01468233|526600822|FG000|Treatment Period 2|Lack of Efficacy|0|||
146023850|NCT01468233|526600823|FG001|Treatment Period 2|Lack of Efficacy|0|||
146023851|NCT01468233|526600824|FG002|Treatment Period 2|Lack of Efficacy|9|||
146023852|NCT01468233|526600825|FG003|Treatment Period 2|Lack of Efficacy|2|||
146023853|NCT01468233|526600826|FG004|Treatment Period 2|Lack of Efficacy|0|||
146023854|NCT01468233|526600827|FG005|Treatment Period 2|Lack of Efficacy|1|||
146023855|NCT01468233|526600822|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146023856|NCT01468233|526600823|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146023857|NCT01468233|526600824|FG002|Treatment Period 2|Withdrawal by Subject|9|||
146253671|NCT00498797|527440841|FG001|Overall Study|Other|1|||
146253672|NCT03928821|527440842|FG000|Overall Study|Death|0|||
146253673|NCT03928821|527440843|FG001|Overall Study|Death|1|||
146253674|NCT03928821|527440844|FG002|Overall Study|Death|0|||
146253675|NCT03928821|527440845|FG003|Overall Study|Death|0|||
146253676|NCT03928821|527440842|FG000|Overall Study|Lost to Follow-up|0|||
146253677|NCT03928821|527440843|FG001|Overall Study|Lost to Follow-up|2|||
146253678|NCT03928821|527440844|FG002|Overall Study|Lost to Follow-up|3|||
146253679|NCT03928821|527440845|FG003|Overall Study|Lost to Follow-up|0|||
146253680|NCT03928821|527440842|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146253681|NCT03928821|527440843|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146253682|NCT03928821|527440844|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
146253683|NCT03928821|527440845|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
146023858|NCT01468233|526600825|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146023859|NCT01468233|526600826|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146023860|NCT01468233|526600827|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146023861|NCT01468233|526600822|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
146023862|NCT01468233|526600823|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
146023863|NCT01468233|526600824|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
146023864|NCT01468233|526600825|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
146023865|NCT01468233|526600826|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
146023866|NCT01468233|526600827|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
146253684|NCT03740919|527440846|FG000|Lead-in Period|Lost to Follow-up|1|||
146253685|NCT03740919|527440847|FG001|Lead-in Period|Lost to Follow-up|0|||
146253686|NCT03740919|527440848|FG002|Lead-in Period|Lost to Follow-up|0|||
146023867|NCT01468233|526600822|FG000|Treatment Period 2|Lost to Follow-up|0|||
146023868|NCT01468233|526600823|FG001|Treatment Period 2|Lost to Follow-up|0|||
146023869|NCT01468233|526600824|FG002|Treatment Period 2|Lost to Follow-up|3|||
146023870|NCT01468233|526600825|FG003|Treatment Period 2|Lost to Follow-up|0|||
146023871|NCT01468233|526600826|FG004|Treatment Period 2|Lost to Follow-up|2|||
146023872|NCT01468233|526600827|FG005|Treatment Period 2|Lost to Follow-up|0|||
146023873|NCT01468233|526600822|FG000|Treatment Period 2|Other|0|||
146023874|NCT01468233|526600823|FG001|Treatment Period 2|Other|0|||
146023875|NCT01468233|526600824|FG002|Treatment Period 2|Other|3|||
146023876|NCT01468233|526600825|FG003|Treatment Period 2|Other|0|||
146023877|NCT01468233|526600826|FG004|Treatment Period 2|Other|1|||
146023878|NCT01468233|526600827|FG005|Treatment Period 2|Other|0|||
146253687|NCT03740919|527440849|FG003|Lead-in Period|Lost to Follow-up|0|||
146253688|NCT03740919|527440846|FG000|Lead-in Period|Physician Decision|2|||
146253689|NCT03740919|527440847|FG001|Lead-in Period|Physician Decision|0|||
146253690|NCT03740919|527440848|FG002|Lead-in Period|Physician Decision|0|||
146253691|NCT03740919|527440849|FG003|Lead-in Period|Physician Decision|0|||
146253692|NCT03740919|527440846|FG000|Lead-in Period|Protocol Violation|1|||
146253693|NCT03740919|527440847|FG001|Lead-in Period|Protocol Violation|0|||
146253694|NCT03740919|527440848|FG002|Lead-in Period|Protocol Violation|0|||
146253695|NCT03740919|527440849|FG003|Lead-in Period|Protocol Violation|0|||
146253696|NCT03740919|527440846|FG000|Lead-in Period|Withdrawal by Subject|10|||
146253697|NCT03740919|527440847|FG001|Lead-in Period|Withdrawal by Subject|0|||
146253698|NCT03740919|527440848|FG002|Lead-in Period|Withdrawal by Subject|0|||
146253699|NCT03740919|527440849|FG003|Lead-in Period|Withdrawal by Subject|0|||
146253700|NCT03740919|527440846|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
146253701|NCT03740919|527440847|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146253702|NCT03740919|527440848|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146253703|NCT03740919|527440849|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
146253704|NCT03740919|527440846|FG000|Lead-in Period|Study Task Too Burdensome|1|||
146253705|NCT03740919|527440847|FG001|Lead-in Period|Study Task Too Burdensome|0|||
146253706|NCT03740919|527440848|FG002|Lead-in Period|Study Task Too Burdensome|0|||
146253707|NCT03740919|527440849|FG003|Lead-in Period|Study Task Too Burdensome|0|||
146253708|NCT03740919|527440846|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
146253709|NCT03740919|527440847|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146253710|NCT03740919|527440848|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146253711|NCT03740919|527440849|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
146253712|NCT03740919|527440846|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
146253713|NCT03740919|527440847|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146253714|NCT03740919|527440848|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146253715|NCT03740919|527440849|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
146253716|NCT03740919|527440846|FG000|Treatment Period|Adverse Event|0|||
146253717|NCT03740919|527440847|FG001|Treatment Period|Adverse Event|0|||
146253718|NCT03740919|527440848|FG002|Treatment Period|Adverse Event|2|||
146253719|NCT03740919|527440849|FG003|Treatment Period|Adverse Event|0|||
146253720|NCT03740919|527440846|FG000|Treatment Period|Protocol Violation|0|||
146253721|NCT03740919|527440847|FG001|Treatment Period|Protocol Violation|1|||
146253722|NCT03740919|527440848|FG002|Treatment Period|Protocol Violation|0|||
146023879|NCT00457821|526600833|FG000|Part 2|Withdrawal by Subject|0|||
146023880|NCT00457821|526600834|FG001|Part 2|Withdrawal by Subject|0|||
146023881|NCT00457821|526600835|FG002|Part 2|Withdrawal by Subject|0|||
146023882|NCT00457821|526600836|FG003|Part 2|Withdrawal by Subject|0|||
146023883|NCT00457821|526600837|FG004|Part 2|Withdrawal by Subject|0|||
146023884|NCT00457821|526600838|FG005|Part 2|Withdrawal by Subject|0|||
146023885|NCT00457821|526600839|FG006|Part 2|Withdrawal by Subject|0|||
146023886|NCT00457821|526600840|FG007|Part 2|Withdrawal by Subject|1|||
146023887|NCT02437409|526600843|FG000|Overall Study|Withdrawal by Subject|3|||
146023888|NCT02437409|526600843|FG000|Overall Study|Screening failure|12|||
146023889|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
146023890|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
146023891|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
146023892|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
146023893|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
146023894|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
146023895|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
146253723|NCT03740919|527440849|FG003|Treatment Period|Protocol Violation|0|||
146253724|NCT03740919|527440846|FG000|Treatment Period|Withdrawal by Subject|0|||
146023896|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
146023897|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
146253725|NCT03740919|527440847|FG001|Treatment Period|Withdrawal by Subject|7|||
146253726|NCT03740919|527440848|FG002|Treatment Period|Withdrawal by Subject|6|||
146253727|NCT03740919|527440849|FG003|Treatment Period|Withdrawal by Subject|2|||
146253728|NCT03740919|527440846|FG000|Treatment Period|Terminated by Sponsor|0|||
146023898|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
146023899|NCT03549871|526600856|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
146023900|NCT03549871|526600857|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
146023901|NCT03549871|526600856|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
146023902|NCT03549871|526600857|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
146023903|NCT03549871|526600856|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
146023904|NCT03549871|526600857|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
146023905|NCT03549871|526600856|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
146023906|NCT03549871|526600857|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
146023907|NCT03549871|526600856|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
146023908|NCT03549871|526600857|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
146023909|NCT03549871|526600856|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
146023910|NCT03549871|526600857|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
146023911|NCT01369680|526600858|FG000|Overall Study|Lost to Follow-up|0|||
146023912|NCT01369680|526600859|FG001|Overall Study|Lost to Follow-up|0|||
146023913|NCT01369680|526600860|FG002|Overall Study|Lost to Follow-up|1|||
146023914|NCT01369680|526600861|FG003|Overall Study|Lost to Follow-up|2|||
146023915|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
146023916|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
146023917|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
146023918|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
146023919|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
146023920|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
146023921|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
146023922|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
146023923|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
146023924|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
146023925|NCT00737568|526600868|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
146023926|NCT00737568|526600869|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
146023927|NCT00737568|526600868|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
146023928|NCT00737568|526600869|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
146023929|NCT00737568|526600868|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
146023930|NCT00737568|526600869|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
146023931|NCT00737568|526600868|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
146023932|NCT00737568|526600869|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
146023933|NCT01133626|526600870|FG000|Overall Study|Adverse Event|0|||
146023934|NCT01133626|526600871|FG001|Overall Study|Adverse Event|1|||
146023935|NCT01133626|526600872|FG002|Overall Study|Adverse Event|0|||
146023936|NCT01133626|526600870|FG000|Overall Study|Withdrawal by Subject|1|||
146023937|NCT01133626|526600871|FG001|Overall Study|Withdrawal by Subject|2|||
146023938|NCT01133626|526600872|FG002|Overall Study|Withdrawal by Subject|2|||
146023939|NCT01133626|526600870|FG000|Overall Study|Other|0|||
146023940|NCT01133626|526600871|FG001|Overall Study|Other|2|||
146023941|NCT01133626|526600872|FG002|Overall Study|Other|0|||
146023942|NCT00759356|526600873|FG000|Overall Study|Adverse Event|0|||
146023943|NCT00759356|526600874|FG001|Overall Study|Adverse Event|1|||
146023944|NCT00759356|526600873|FG000|Overall Study|Withdrawal by Subject|0|||
146023945|NCT00759356|526600874|FG001|Overall Study|Withdrawal by Subject|2|||
146023946|NCT00759356|526600873|FG000|Overall Study|Subject was unable to return|1|||
146023947|NCT00759356|526600874|FG001|Overall Study|Subject was unable to return|0|||
146023948|NCT02851407|526600875|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146023949|NCT02851407|526600876|FG001|Overall Study|Withdrawal by parent/guardian|7|||
146023950|NCT02851407|526600875|FG000|Overall Study|Protocol deviation|0|||
146023951|NCT02851407|526600876|FG001|Overall Study|Protocol deviation|1|||
146023952|NCT02851407|526600875|FG000|Overall Study|Transferred to another hospital to continue|1|||
146023953|NCT02851407|526600876|FG001|Overall Study|Transferred to another hospital to continue|0|||
146023954|NCT02851407|526600875|FG000|Overall Study|Other Death|30|||
146023955|NCT02851407|526600876|FG001|Overall Study|Other Death|20|||
146023956|NCT02851407|526600875|FG000|Overall Study|Adverse event, serious fatal|6|||
146023957|NCT02851407|526600876|FG001|Overall Study|Adverse event, serious fatal|8|||
146023958|NCT02851407|526600875|FG000|Overall Study|Consent withdrawn by participant|5|||
146023959|NCT02851407|526600876|FG001|Overall Study|Consent withdrawn by participant|3|||
146023960|NCT02851407|526600875|FG000|Overall Study|Screen failure|2|||
146023961|NCT02851407|526600876|FG001|Overall Study|Screen failure|1|||
146253729|NCT03740919|527440847|FG001|Treatment Period|Terminated by Sponsor|1|||
146023962|NCT02851407|526600875|FG000|Overall Study|Disease relapse|9|||
146023963|NCT02851407|526600876|FG001|Overall Study|Disease relapse|6|||
146023964|NCT02851407|526600875|FG000|Overall Study|Physician Decision|7|||
146023965|NCT02851407|526600876|FG001|Overall Study|Physician Decision|6|||
146253730|NCT03740919|527440848|FG002|Treatment Period|Terminated by Sponsor|0|||
146253731|NCT03740919|527440849|FG003|Treatment Period|Terminated by Sponsor|0|||
146253732|NCT03740919|527440846|FG000|Treatment Period|Issue with Insulin Pump|0|||
146023966|NCT02851407|526600875|FG000|Overall Study|Transferred to hospital closer to home|0|||
146023967|NCT02851407|526600876|FG001|Overall Study|Transferred to hospital closer to home|1|||
146023968|NCT02851407|526600875|FG000|Overall Study|Enrolled in an investigational study|0|||
146023969|NCT02851407|526600876|FG001|Overall Study|Enrolled in an investigational study|1|||
146023970|NCT02851407|526600875|FG000|Overall Study|Early recovery|1|||
146023971|NCT02851407|526600876|FG001|Overall Study|Early recovery|0|||
146023972|NCT02851407|526600875|FG000|Overall Study|Adverse event, non-fatal|7|||
146023973|NCT02851407|526600876|FG001|Overall Study|Adverse event, non-fatal|5|||
146023974|NCT02851407|526600875|FG000|Overall Study|Lost to Follow-up|0|||
146023975|NCT02851407|526600876|FG001|Overall Study|Lost to Follow-up|2|||
146023976|NCT01713283|526600880|FG000|Overall Study|Lack of Efficacy|10|||
146023977|NCT01713283|526600881|FG001|Overall Study|Lack of Efficacy|2|||
146023978|NCT01713283|526600880|FG000|Overall Study|Lost to Follow-up|1|||
146023979|NCT01713283|526600881|FG001|Overall Study|Lost to Follow-up|1|||
146023980|NCT03761394|526600883|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
146023981|NCT03761394|526600884|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
146023982|NCT03761394|526600885|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
146023983|NCT03761394|526600886|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
146023984|NCT03761394|526600883|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
146023985|NCT03761394|526600884|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
146023986|NCT03761394|526600885|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
146023987|NCT03761394|526600886|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
146023988|NCT03761394|526600883|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146023989|NCT03761394|526600884|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146023990|NCT03761394|526600885|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
146023991|NCT03761394|526600886|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
146023992|NCT03761394|526600883|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146023993|NCT03761394|526600884|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146023994|NCT03761394|526600885|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
146023995|NCT03761394|526600886|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
146023996|NCT01080768|526600887|FG000|Overall Study|Protocol Deviation|2|||
146023997|NCT01080768|526600888|FG001|Overall Study|Protocol Deviation|1|||
146023998|NCT03054350|526600890|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
146023999|NCT03054350|526600891|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
146024000|NCT03054350|526600892|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
146024001|NCT03054350|526600893|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
146024002|NCT03054350|526600894|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
146024003|NCT03054350|526600895|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
146024004|NCT03054350|526600890|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146024005|NCT03054350|526600891|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146024006|NCT03054350|526600892|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
146024007|NCT03054350|526600893|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146024008|NCT03054350|526600894|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146024009|NCT03054350|526600895|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
146024010|NCT03054350|526600890|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
146024011|NCT03054350|526600891|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146024012|NCT03054350|526600892|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146024013|NCT03054350|526600893|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
146024014|NCT03054350|526600894|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146024015|NCT03054350|526600895|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
146024016|NCT03054350|526600890|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146024017|NCT03054350|526600891|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146024018|NCT03054350|526600892|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
146024019|NCT03054350|526600893|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146024020|NCT03054350|526600894|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146024021|NCT03054350|526600895|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
146024022|NCT03510468|526600896|FG000|Overall Study|Lost to Follow-up|1|||
146024023|NCT03510468|526600896|FG000|Overall Study|Adverse Event|5|||
146024024|NCT03510468|526600896|FG000|Overall Study|Physician Decision|1|||
146024025|NCT03510468|526600896|FG000|Overall Study|non-compliant with treatment|2|||
146300277|NCT03681951|527615194|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146024026|NCT03510468|526600896|FG000|Overall Study|Missed visit|1|||
146024027|NCT03730961|526600919|FG000|Overall Study|Adverse Event|0|||
146024028|NCT03730961|526600920|FG001|Overall Study|Adverse Event|1|||
146024029|NCT00919867|526600921|FG000|First Intervention|Withdrawal by Subject|0|||
146024030|NCT00919867|526600922|FG001|First Intervention|Withdrawal by Subject|0|||
146024031|NCT00919867|526600923|FG002|First Intervention|Withdrawal by Subject|1|||
146024032|NCT00919867|526600924|FG003|First Intervention|Withdrawal by Subject|0|||
146024033|NCT00919867|526600925|FG004|First Intervention|Withdrawal by Subject|0|||
146024034|NCT00919867|526600926|FG005|First Intervention|Withdrawal by Subject|0|||
146024035|NCT00919867|526600921|FG000|First Intervention|Physician Decision|0|||
146024036|NCT00919867|526600922|FG001|First Intervention|Physician Decision|0|||
146024037|NCT00919867|526600923|FG002|First Intervention|Physician Decision|0|||
146024038|NCT00919867|526600924|FG003|First Intervention|Physician Decision|0|||
146024039|NCT00919867|526600925|FG004|First Intervention|Physician Decision|0|||
146024040|NCT00919867|526600926|FG005|First Intervention|Physician Decision|1|||
146024041|NCT02323204|526600930|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
146024042|NCT02323204|526600931|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
146024043|NCT02323204|526600932|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
146024044|NCT02323204|526600933|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
146024045|NCT02323204|526600930|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
146024046|NCT02323204|526600931|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
146024047|NCT02323204|526600932|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
146024048|NCT02323204|526600933|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
146024049|NCT02323204|526600930|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
146024050|NCT02323204|526600931|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
146024051|NCT02323204|526600932|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
146024052|NCT02323204|526600933|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
146024053|NCT02323204|526600930|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
146024054|NCT02323204|526600931|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
146024055|NCT02323204|526600932|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
146024056|NCT02323204|526600933|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
146024057|NCT02323204|526600930|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
146024058|NCT02323204|526600931|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
146024059|NCT02323204|526600932|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
146024060|NCT02323204|526600933|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
146024061|NCT02323204|526600930|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
146024062|NCT02323204|526600931|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
146024063|NCT02323204|526600932|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
146024064|NCT02323204|526600933|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
146024065|NCT02323204|526600930|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146024066|NCT02323204|526600931|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
146024067|NCT02323204|526600932|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146024068|NCT02323204|526600933|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
146024069|NCT02323204|526600930|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
146024070|NCT02323204|526600931|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
146024071|NCT02323204|526600932|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
146024072|NCT02323204|526600933|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
146024073|NCT02323204|526600930|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146024074|NCT02323204|526600931|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
146024075|NCT02323204|526600932|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
146024076|NCT02323204|526600933|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
146024077|NCT04508751|526600936|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
146024078|NCT04508751|526600937|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
146024079|NCT04508751|526600938|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
146024080|NCT02752958|526600939|FG000|Overall Study|Adverse Event|3|||
146024081|NCT02752958|526600939|FG000|Overall Study|Lost to Follow-up|1|||
146024082|NCT02752958|526600939|FG000|Overall Study|Protocol Violation|1|||
146024083|NCT02752958|526600939|FG000|Overall Study|Withdrawal by Subject|2|||
146024084|NCT02752958|526600939|FG000|Overall Study|Other (Reason not specified)|2|||
146024085|NCT00853125|526600940|FG000|Overall Study|Study participant's donor was CMV +|1|||
146024086|NCT03023826|526600942|FG000|Period 1|Withdrawal by Subject|0|||
146024087|NCT03023826|526600943|FG001|Period 1|Withdrawal by Subject|0|||
146024088|NCT03023826|526600944|FG002|Period 1|Withdrawal by Subject|0|||
146024089|NCT03023826|526600945|FG003|Period 1|Withdrawal by Subject|0|||
146094580|NCT00598702|526867842|FG005|Overall Study|Withdrawal by Subject|0|||
146094581|NCT00598702|526867843|FG006|Overall Study|Withdrawal by Subject|0|||
146094582|NCT00598702|526867844|FG007|Overall Study|Withdrawal by Subject|0|||
146253733|NCT03740919|527440847|FG001|Treatment Period|Issue with Insulin Pump|1|||
146024090|NCT03023826|526600946|FG004|Period 1|Withdrawal by Subject|1|||
146024091|NCT03023826|526600947|FG005|Period 1|Withdrawal by Subject|0|||
146024092|NCT00072293|526600948|FG000|Overall Study|Lost to Follow-up|1|||
146024093|NCT00072293|526600949|FG001|Overall Study|Lost to Follow-up|1|||
146024094|NCT00072293|526600948|FG000|Overall Study|Withdrawal by Subject|0|||
146024095|NCT00072293|526600949|FG001|Overall Study|Withdrawal by Subject|1|||
146024096|NCT04209114|526600950|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
146253734|NCT03740919|527440848|FG002|Treatment Period|Issue with Insulin Pump|0|||
146253735|NCT03740919|527440849|FG003|Treatment Period|Issue with Insulin Pump|0|||
146253736|NCT03740919|527440846|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
146253737|NCT03740919|527440847|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
146253738|NCT03740919|527440848|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
146253739|NCT03740919|527440849|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
146024097|NCT04209114|526600951|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
146024098|NCT04209114|526600952|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
146024099|NCT04209114|526600950|FG000|Pre-Treatment Phase|Other reasons|0|||
146024100|NCT04209114|526600951|FG001|Pre-Treatment Phase|Other reasons|0|||
146024101|NCT04209114|526600952|FG002|Pre-Treatment Phase|Other reasons|1|||
146024102|NCT04209114|526600950|FG000|Pre-Treatment Phase|Death|0|||
146024103|NCT04209114|526600951|FG001|Pre-Treatment Phase|Death|0|||
146024104|NCT04209114|526600952|FG002|Pre-Treatment Phase|Death|1|||
146024105|NCT04209114|526600950|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
146024106|NCT04209114|526600951|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
146024107|NCT04209114|526600952|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
146024108|NCT04209114|526600950|FG000|Treatment Phase|Other reasons|5|||
146024109|NCT04209114|526600951|FG001|Treatment Phase|Other reasons|3|||
146024110|NCT04209114|526600952|FG002|Treatment Phase|Other reasons|0|||
146024111|NCT04209114|526600950|FG000|Treatment Phase|Lost to Follow-up|1|||
146024112|NCT04209114|526600951|FG001|Treatment Phase|Lost to Follow-up|0|||
146024113|NCT04209114|526600952|FG002|Treatment Phase|Lost to Follow-up|0|||
146024114|NCT04209114|526600950|FG000|Treatment Phase|Participant withdrew consent|1|||
146024115|NCT04209114|526600951|FG001|Treatment Phase|Participant withdrew consent|0|||
146024116|NCT04209114|526600952|FG002|Treatment Phase|Participant withdrew consent|0|||
146024117|NCT04209114|526600950|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
146024118|NCT04209114|526600951|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
146024119|NCT04209114|526600952|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
146024120|NCT04209114|526600950|FG000|Treatment Phase|Death|4|||
146024121|NCT04209114|526600951|FG001|Treatment Phase|Death|1|||
146024122|NCT04209114|526600952|FG002|Treatment Phase|Death|0|||
146024123|NCT04209114|526600950|FG000|Treatment Phase|Study drug toxicity|4|||
146024124|NCT04209114|526600951|FG001|Treatment Phase|Study drug toxicity|6|||
146024125|NCT04209114|526600952|FG002|Treatment Phase|Study drug toxicity|0|||
146024126|NCT04209114|526600950|FG000|Treatment Phase|Disease progression|6|||
146024127|NCT04209114|526600951|FG001|Treatment Phase|Disease progression|9|||
146024128|NCT04209114|526600952|FG002|Treatment Phase|Disease progression|0|||
146024129|NCT01896271|526600957|FG000|Overall Study|Physician Decision|10|||
146024130|NCT01514240|526602501|FG000|Overall Study|Adverse Event|4|||
146024131|NCT01514240|526602502|FG001|Overall Study|Adverse Event|4|||
146024132|NCT01514240|526602501|FG000|Overall Study|Subject Decision|2|||
146024133|NCT01514240|526602502|FG001|Overall Study|Subject Decision|7|||
146024134|NCT00509093|526602503|FG000|Overall Study|Adverse Event|10|||
146024135|NCT00509093|526602503|FG000|Overall Study|Disease Progression|9|||
146024136|NCT00509093|526602503|FG000|Overall Study|Transformed into MDS|1|||
146024137|NCT00509093|526602503|FG000|Overall Study|Withdrawal by Subject|3|||
146024138|NCT00509093|526602503|FG000|Overall Study|Physician Decision|1|||
146094583|NCT00598702|526867837|FG000|Overall Study|Physician Decision|0|||
146094584|NCT00598702|526867838|FG001|Overall Study|Physician Decision|0|||
146094585|NCT00598702|526867839|FG002|Overall Study|Physician Decision|0|||
146253740|NCT03740919|527440846|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
146253741|NCT03740919|527440847|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
146253742|NCT03740919|527440848|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
146253743|NCT03740919|527440849|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
146253744|NCT03740919|527440846|FG000|Treatment Period|Not Completing Diary|0|||
146253745|NCT03740919|527440847|FG001|Treatment Period|Not Completing Diary|0|||
146253746|NCT03740919|527440848|FG002|Treatment Period|Not Completing Diary|1|||
146253747|NCT03740919|527440849|FG003|Treatment Period|Not Completing Diary|0|||
146253748|NCT03740919|527440846|FG000|Treatment Period|Insulin Painful to Participant|0|||
146253749|NCT03740919|527440847|FG001|Treatment Period|Insulin Painful to Participant|0|||
146253750|NCT03740919|527440848|FG002|Treatment Period|Insulin Painful to Participant|1|||
146094586|NCT00598702|526867840|FG003|Overall Study|Physician Decision|0|||
146253751|NCT03740919|527440849|FG003|Treatment Period|Insulin Painful to Participant|0|||
146253752|NCT00985621|527440852|FG000|Overall Study|Adverse Event|2|||
146253753|NCT00985621|527440853|FG001|Overall Study|Adverse Event|3|||
146094587|NCT00598702|526867841|FG004|Overall Study|Physician Decision|1|||
146024139|NCT01103063|526602504|FG000|Overall Study|Adverse Event|3|||
146024140|NCT01103063|526602505|FG001|Overall Study|Adverse Event|1|||
146024141|NCT01103063|526602504|FG000|Overall Study|Lost to Follow-up|68|||
146024142|NCT01103063|526602505|FG001|Overall Study|Lost to Follow-up|51|||
146024143|NCT01103063|526602504|FG000|Overall Study|Withdrawal by Subject|60|||
146024144|NCT01103063|526602505|FG001|Overall Study|Withdrawal by Subject|15|||
146024145|NCT01103063|526602504|FG000|Overall Study|Other|16|||
146024146|NCT01103063|526602505|FG001|Overall Study|Other|11|||
146094588|NCT00598702|526867842|FG005|Overall Study|Physician Decision|0|||
146094589|NCT00598702|526867843|FG006|Overall Study|Physician Decision|0|||
146024147|NCT01103063|526602504|FG000|Overall Study|Protocol Violation|1|||
146024148|NCT01103063|526602505|FG001|Overall Study|Protocol Violation|0|||
146024149|NCT01103063|526602504|FG000|Overall Study|Study terminated by Sponsor|326|||
146024150|NCT01103063|526602505|FG001|Overall Study|Study terminated by Sponsor|342|||
146024151|NCT01103063|526602504|FG000|Overall Study|Death|3|||
146024152|NCT01103063|526602505|FG001|Overall Study|Death|1|||
146024153|NCT05320393|526602506|FG000|Overall Study|Withdrawal by Subject|1|||
146024154|NCT05320393|526602507|FG001|Overall Study|Withdrawal by Subject|0|||
146024155|NCT05320393|526602508|FG002|Overall Study|Withdrawal by Subject|2|||
146024156|NCT05320393|526602506|FG000|Overall Study|Lost to Follow-up|1|||
146024157|NCT05320393|526602507|FG001|Overall Study|Lost to Follow-up|2|||
146024158|NCT05320393|526602508|FG002|Overall Study|Lost to Follow-up|1|||
146024159|NCT05320393|526602506|FG000|Overall Study|Moved; too much driving|0|||
146024160|NCT05320393|526602507|FG001|Overall Study|Moved; too much driving|0|||
146024161|NCT05320393|526602508|FG002|Overall Study|Moved; too much driving|2|||
146024162|NCT05320393|526602506|FG000|Overall Study|Did not receive treatment|0|||
146024163|NCT05320393|526602507|FG001|Overall Study|Did not receive treatment|0|||
146024164|NCT05320393|526602508|FG002|Overall Study|Did not receive treatment|1|||
146024165|NCT03283098|526602509|FG000|Overall Study|Withdrawal by Subject|0|||
146024166|NCT03283098|526602510|FG001|Overall Study|Withdrawal by Subject|1|||
146024167|NCT00798317|526602511|FG000|Overall Study|Physician Decision|0|||
146024168|NCT00798317|526602512|FG001|Overall Study|Physician Decision|1|||
146024169|NCT00798317|526602511|FG000|Overall Study|Withdrawal by Subject|5|||
146024170|NCT00798317|526602512|FG001|Overall Study|Withdrawal by Subject|4|||
146024171|NCT00798317|526602511|FG000|Overall Study|Lost to Follow-up|2|||
146024172|NCT00798317|526602512|FG001|Overall Study|Lost to Follow-up|2|||
146024173|NCT00798317|526602511|FG000|Overall Study|Adverse Event|2|||
146024174|NCT00798317|526602512|FG001|Overall Study|Adverse Event|0|||
146024175|NCT00798317|526602511|FG000|Overall Study|Death|1|||
146024176|NCT00798317|526602512|FG001|Overall Study|Death|0|||
146024177|NCT01069861|526602514|FG000|Overall Study|Death|1|||
146024178|NCT01069861|526602514|FG000|Overall Study|Adverse Event|1|||
146024179|NCT01069861|526602514|FG000|Overall Study|Did not meet entrance criteria|1|||
146024180|NCT01187446|526602515|FG000|Overall Study|Patient started non-protocol therapy|0|||
146024181|NCT01187446|526602516|FG001|Overall Study|Patient started non-protocol therapy|1|||
146024182|NCT00823212|526602517|FG000|Overall Study|Death|8|||
146024183|NCT00823212|526602518|FG001|Overall Study|Death|10|||
146024184|NCT00823212|526602517|FG000|Overall Study|Withdrawal by Subject|6|||
146024185|NCT00823212|526602518|FG001|Overall Study|Withdrawal by Subject|1|||
146024186|NCT00823212|526602517|FG000|Overall Study|Incarcerated|0|||
146024187|NCT00823212|526602518|FG001|Overall Study|Incarcerated|1|||
146024188|NCT00823212|526602517|FG000|Overall Study|Missed 12-month visit|21|||
146024189|NCT00823212|526602518|FG001|Overall Study|Missed 12-month visit|21|||
146024190|NCT00496197|526602519|FG000|Overall Study|Discontinued study due to death|43|||
146024191|NCT00496197|526602519|FG000|Overall Study|Adverse Event|13|||
146024192|NCT00496197|526602519|FG000|Overall Study|Does not meet entrance criteria|5|||
146024193|NCT00496197|526602519|FG000|Overall Study|Insufficient clinical response|3|||
146024194|NCT00496197|526602519|FG000|Overall Study|Insufficient bacteriological response|10|||
146024195|NCT00496197|526602519|FG000|Overall Study|Lost to Follow-up|11|||
146024196|NCT00496197|526602519|FG000|Overall Study|Withdrawal by Subject|11|||
146024197|NCT00496197|526602519|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
146024198|NCT00496197|526602519|FG000|Overall Study|Other|14|||
146024199|NCT00496197|526602519|FG000|Overall Study|Protocol Violation|8|||
146024200|NCT04431713|526602520|FG000|Overall Study|Withdrawal by Subject|2|||
146024201|NCT04431713|526602521|FG001|Overall Study|Withdrawal by Subject|0|||
146024202|NCT04431713|526602520|FG000|Overall Study|Death|2|||
146024203|NCT04431713|526602521|FG001|Overall Study|Death|2|||
146024204|NCT00149994|526602522|FG000|Overall Study|Administrative problems:|1|||
146024205|NCT00149994|526602523|FG001|Overall Study|Administrative problems:|0|||
146024206|NCT00149994|526602522|FG000|Overall Study|Protocol Violation|0|||
146094590|NCT00598702|526867844|FG007|Overall Study|Physician Decision|0|||
146024207|NCT00149994|526602523|FG001|Overall Study|Protocol Violation|1|||
146024208|NCT01344538|526602524|FG000|Overall Study|Adverse Event|1|||
146024209|NCT01344538|526602525|FG001|Overall Study|Adverse Event|1|||
146024210|NCT01344538|526602524|FG000|Overall Study|Lost to Follow-up|1|||
146024211|NCT01344538|526602525|FG001|Overall Study|Lost to Follow-up|0|||
146024212|NCT01655381|526602528|FG000|Overall Study|Investigator Decision|1|||
146024213|NCT01655381|526602528|FG000|Overall Study|Moved to Another City|1|||
146024214|NCT01655381|526602528|FG000|Overall Study|Insufficient Treatment Response|1|||
146024215|NCT02324205|526602529|FG000|Overall Study|Withdrawal by Subject|37|||
146024216|NCT04195438|526602530|FG000|Overall Study|Withdrawal by Subject|1|||
146024217|NCT00613925|526602535|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
146024218|NCT00613925|526602536|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
146024219|NCT03136497|526602537|FG000|Overall Study|Screen Failure|1|||
146024220|NCT03136497|526602538|FG001|Overall Study|Screen Failure|0|||
146024221|NCT03136497|526602539|FG002|Overall Study|Screen Failure|0|||
146024222|NCT00794365|526602543|FG000|Overall Study|Lost to Follow-up|38|||
146024223|NCT00794365|526602543|FG000|Overall Study|Other|17|||
146024224|NCT00794365|526602543|FG000|Overall Study|Poor Compliance|11|||
146024225|NCT00794365|526602543|FG000|Overall Study|Adverse Event|10|||
146024226|NCT00794365|526602543|FG000|Overall Study|Lack of Efficacy|3|||
146024227|NCT00856206|526602544|FG000|Overall Study|Protocol Violation|6|||
146024228|NCT00856206|526602545|FG001|Overall Study|Protocol Violation|18|||
146024229|NCT00856206|526602544|FG000|Overall Study|Adverse Event|10|||
146024230|NCT00856206|526602545|FG001|Overall Study|Adverse Event|46|||
146024231|NCT00856206|526602544|FG000|Overall Study|Lack of Efficacy|1|||
146024232|NCT00856206|526602545|FG001|Overall Study|Lack of Efficacy|2|||
146024233|NCT00856206|526602544|FG000|Overall Study|Withdrawal by Subject|15|||
146024234|NCT00856206|526602545|FG001|Overall Study|Withdrawal by Subject|36|||
146024235|NCT00856206|526602544|FG000|Overall Study|Lost to Follow-up|13|||
146024236|NCT00856206|526602545|FG001|Overall Study|Lost to Follow-up|39|||
146024237|NCT00856206|526602544|FG000|Overall Study|Death|2|||
146024238|NCT00856206|526602545|FG001|Overall Study|Death|2|||
146024239|NCT00856206|526602544|FG000|Overall Study|Decision by the Sponsor|4|||
146024240|NCT00856206|526602545|FG001|Overall Study|Decision by the Sponsor|8|||
146024241|NCT00856206|526602544|FG000|Overall Study|Other than specified above|3|||
146024242|NCT00856206|526602545|FG001|Overall Study|Other than specified above|10|||
146024243|NCT03538444|526602557|FG000|Overall Study|opioid withdrawal|1|||
146024244|NCT03538444|526602558|FG001|Overall Study|opioid withdrawal|0|||
146024245|NCT04584346|526602559|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
146024246|NCT04584346|526602560|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
146024247|NCT03640052|526602563|FG000|Overall Study|Lost to Follow-up|0|||
146024248|NCT03640052|526602564|FG001|Overall Study|Lost to Follow-up|1|||
146024249|NCT03640052|526602565|FG002|Overall Study|Lost to Follow-up|0|||
146024250|NCT03640052|526602566|FG003|Overall Study|Lost to Follow-up|0|||
146024251|NCT03640052|526602567|FG004|Overall Study|Lost to Follow-up|0|||
146024252|NCT00790647|526602568|FG000|Overall Study|Adverse Event|1|||
146024253|NCT00075725|526602582|FG000|Overall Study|Adverse Event|6|||
146024254|NCT00075725|526602583|FG001|Overall Study|Adverse Event|6|||
146024255|NCT00075725|526602584|FG002|Overall Study|Adverse Event|20|||
146024256|NCT00075725|526602585|FG003|Overall Study|Adverse Event|8|||
146024257|NCT00075725|526602586|FG004|Overall Study|Adverse Event|4|||
146024258|NCT00075725|526602587|FG005|Overall Study|Adverse Event|38|||
146024259|NCT00075725|526602588|FG006|Overall Study|Adverse Event|3|||
146024260|NCT00075725|526602589|FG007|Overall Study|Adverse Event|51|||
146024261|NCT00075725|526602590|FG008|Overall Study|Adverse Event|15|||
146024262|NCT00075725|526602591|FG009|Overall Study|Adverse Event|4|||
146024263|NCT00075725|526602592|FG010|Overall Study|Adverse Event|2|||
146024264|NCT00075725|526602593|FG011|Overall Study|Adverse Event|2|||
146024265|NCT00075725|526602582|FG000|Overall Study|Death|3|||
146024266|NCT00075725|526602583|FG001|Overall Study|Death|5|||
146024267|NCT00075725|526602584|FG002|Overall Study|Death|10|||
146024268|NCT00075725|526602585|FG003|Overall Study|Death|2|||
146024269|NCT00075725|526602586|FG004|Overall Study|Death|3|||
146024270|NCT00075725|526602587|FG005|Overall Study|Death|25|||
146024271|NCT00075725|526602588|FG006|Overall Study|Death|4|||
146024272|NCT00075725|526602589|FG007|Overall Study|Death|22|||
146024273|NCT00075725|526602590|FG008|Overall Study|Death|14|||
146024274|NCT00075725|526602591|FG009|Overall Study|Death|4|||
146024275|NCT00075725|526602592|FG010|Overall Study|Death|3|||
146024276|NCT00075725|526602593|FG011|Overall Study|Death|0|||
146024277|NCT00075725|526602582|FG000|Overall Study|Lost to Follow-up|1|||
146024278|NCT00075725|526602583|FG001|Overall Study|Lost to Follow-up|1|||
146024279|NCT00075725|526602584|FG002|Overall Study|Lost to Follow-up|4|||
146024280|NCT00075725|526602585|FG003|Overall Study|Lost to Follow-up|1|||
146024281|NCT00075725|526602586|FG004|Overall Study|Lost to Follow-up|0|||
146024282|NCT00075725|526602587|FG005|Overall Study|Lost to Follow-up|13|||
146024283|NCT00075725|526602588|FG006|Overall Study|Lost to Follow-up|2|||
146024284|NCT00075725|526602589|FG007|Overall Study|Lost to Follow-up|4|||
146024285|NCT00075725|526602590|FG008|Overall Study|Lost to Follow-up|1|||
146024286|NCT00075725|526602591|FG009|Overall Study|Lost to Follow-up|0|||
146024287|NCT00075725|526602592|FG010|Overall Study|Lost to Follow-up|0|||
146024288|NCT00075725|526602593|FG011|Overall Study|Lost to Follow-up|0|||
146024289|NCT00075725|526602582|FG000|Overall Study|Physician Decision|2|||
146024290|NCT00075725|526602583|FG001|Overall Study|Physician Decision|6|||
146024291|NCT00075725|526602584|FG002|Overall Study|Physician Decision|5|||
146024292|NCT00075725|526602585|FG003|Overall Study|Physician Decision|8|||
146253754|NCT00985621|527440854|FG002|Overall Study|Adverse Event|4|||
146024293|NCT00075725|526602586|FG004|Overall Study|Physician Decision|4|||
146024294|NCT00075725|526602587|FG005|Overall Study|Physician Decision|19|||
146024295|NCT00075725|526602588|FG006|Overall Study|Physician Decision|3|||
146024296|NCT00075725|526602589|FG007|Overall Study|Physician Decision|17|||
146024297|NCT00075725|526602590|FG008|Overall Study|Physician Decision|5|||
146024298|NCT00075725|526602591|FG009|Overall Study|Physician Decision|0|||
146024299|NCT00075725|526602592|FG010|Overall Study|Physician Decision|1|||
146024300|NCT00075725|526602593|FG011|Overall Study|Physician Decision|0|||
146024301|NCT00075725|526602582|FG000|Overall Study|Pregnancy|0|||
146024302|NCT00075725|526602583|FG001|Overall Study|Pregnancy|0|||
146024303|NCT00075725|526602584|FG002|Overall Study|Pregnancy|0|||
146024304|NCT00075725|526602585|FG003|Overall Study|Pregnancy|0|||
146024305|NCT00075725|526602586|FG004|Overall Study|Pregnancy|0|||
146024306|NCT00075725|526602587|FG005|Overall Study|Pregnancy|1|||
146024307|NCT00075725|526602588|FG006|Overall Study|Pregnancy|0|||
146024308|NCT00075725|526602589|FG007|Overall Study|Pregnancy|1|||
146024309|NCT00075725|526602590|FG008|Overall Study|Pregnancy|0|||
146024310|NCT00075725|526602591|FG009|Overall Study|Pregnancy|0|||
146024311|NCT00075725|526602592|FG010|Overall Study|Pregnancy|0|||
146024312|NCT00075725|526602593|FG011|Overall Study|Pregnancy|0|||
146024313|NCT00075725|526602582|FG000|Overall Study|Protocol Violation|1|||
146024314|NCT00075725|526602583|FG001|Overall Study|Protocol Violation|1|||
146024315|NCT00075725|526602584|FG002|Overall Study|Protocol Violation|0|||
146024316|NCT00075725|526602585|FG003|Overall Study|Protocol Violation|3|||
146024317|NCT00075725|526602586|FG004|Overall Study|Protocol Violation|3|||
146024318|NCT00075725|526602587|FG005|Overall Study|Protocol Violation|2|||
146024319|NCT00075725|526602588|FG006|Overall Study|Protocol Violation|1|||
146024320|NCT00075725|526602589|FG007|Overall Study|Protocol Violation|2|||
146024321|NCT00075725|526602590|FG008|Overall Study|Protocol Violation|3|||
146024322|NCT00075725|526602591|FG009|Overall Study|Protocol Violation|0|||
146024323|NCT00075725|526602592|FG010|Overall Study|Protocol Violation|0|||
146024324|NCT00075725|526602593|FG011|Overall Study|Protocol Violation|1|||
146024325|NCT00075725|526602582|FG000|Overall Study|Withdrawal by Subject|12|||
146024326|NCT00075725|526602583|FG001|Overall Study|Withdrawal by Subject|3|||
146024327|NCT00075725|526602584|FG002|Overall Study|Withdrawal by Subject|6|||
146024328|NCT00075725|526602585|FG003|Overall Study|Withdrawal by Subject|10|||
146024329|NCT00075725|526602586|FG004|Overall Study|Withdrawal by Subject|6|||
146024330|NCT00075725|526602587|FG005|Overall Study|Withdrawal by Subject|27|||
146024331|NCT00075725|526602588|FG006|Overall Study|Withdrawal by Subject|7|||
146024332|NCT00075725|526602589|FG007|Overall Study|Withdrawal by Subject|31|||
146024333|NCT00075725|526602590|FG008|Overall Study|Withdrawal by Subject|10|||
146024334|NCT00075725|526602591|FG009|Overall Study|Withdrawal by Subject|2|||
146024335|NCT00075725|526602592|FG010|Overall Study|Withdrawal by Subject|0|||
146024336|NCT00075725|526602593|FG011|Overall Study|Withdrawal by Subject|0|||
146024337|NCT00075725|526602582|FG000|Overall Study|Disease Progression, all other reasons|17|||
146024338|NCT00075725|526602583|FG001|Overall Study|Disease Progression, all other reasons|5|||
146024339|NCT00075725|526602584|FG002|Overall Study|Disease Progression, all other reasons|33|||
146024340|NCT00075725|526602585|FG003|Overall Study|Disease Progression, all other reasons|6|||
146024341|NCT00075725|526602586|FG004|Overall Study|Disease Progression, all other reasons|21|||
146024342|NCT00075725|526602587|FG005|Overall Study|Disease Progression, all other reasons|59|||
146024343|NCT00075725|526602588|FG006|Overall Study|Disease Progression, all other reasons|20|||
146024344|NCT00075725|526602589|FG007|Overall Study|Disease Progression, all other reasons|46|||
146024345|NCT00075725|526602590|FG008|Overall Study|Disease Progression, all other reasons|21|||
146024346|NCT00075725|526602591|FG009|Overall Study|Disease Progression, all other reasons|4|||
146024347|NCT00075725|526602592|FG010|Overall Study|Disease Progression, all other reasons|0|||
146024348|NCT00075725|526602593|FG011|Overall Study|Disease Progression, all other reasons|5|||
146024349|NCT00075725|526602582|FG000|Overall Study|Patient off treatment|0|||
146024350|NCT00075725|526602583|FG001|Overall Study|Patient off treatment|0|||
146024351|NCT00075725|526602584|FG002|Overall Study|Patient off treatment|1|||
146024352|NCT00075725|526602585|FG003|Overall Study|Patient off treatment|2|||
146024353|NCT00075725|526602586|FG004|Overall Study|Patient off treatment|1|||
146024354|NCT00075725|526602587|FG005|Overall Study|Patient off treatment|0|||
146024355|NCT00075725|526602588|FG006|Overall Study|Patient off treatment|0|||
146024356|NCT00075725|526602589|FG007|Overall Study|Patient off treatment|2|||
146024357|NCT00075725|526602590|FG008|Overall Study|Patient off treatment|1|||
146024358|NCT00075725|526602591|FG009|Overall Study|Patient off treatment|0|||
146024359|NCT00075725|526602592|FG010|Overall Study|Patient off treatment|0|||
146024360|NCT00075725|526602593|FG011|Overall Study|Patient off treatment|0|||
146024361|NCT00075725|526602582|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
146024362|NCT00075725|526602583|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
146253755|NCT00985621|527440855|FG003|Overall Study|Adverse Event|16|||
146253756|NCT00985621|527440852|FG000|Overall Study|Lack of Efficacy|10|||
146253757|NCT00985621|527440853|FG001|Overall Study|Lack of Efficacy|6|||
146253758|NCT00985621|527440854|FG002|Overall Study|Lack of Efficacy|5|||
146253759|NCT00985621|527440855|FG003|Overall Study|Lack of Efficacy|12|||
146024363|NCT00075725|526602584|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
146024364|NCT00075725|526602585|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
146024365|NCT00075725|526602586|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
146024366|NCT00075725|526602587|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
146024367|NCT00075725|526602588|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
146024368|NCT00075725|526602589|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
146024369|NCT00075725|526602590|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
146024370|NCT00075725|526602591|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
146024371|NCT00075725|526602592|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
146024372|NCT00075725|526602593|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
146024373|NCT00075725|526602582|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
146024374|NCT00075725|526602583|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
146024375|NCT00075725|526602584|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
146024376|NCT00075725|526602585|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
146024377|NCT00075725|526602586|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
146024378|NCT00075725|526602587|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
146024379|NCT00075725|526602588|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
146024380|NCT00075725|526602589|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
146024381|NCT00075725|526602590|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
146024382|NCT00075725|526602591|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
146024383|NCT00075725|526602592|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
146024384|NCT00075725|526602593|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
146024385|NCT00075725|526602582|FG000|Overall Study|Pt non compliant with therapy|2|||
146024386|NCT00075725|526602583|FG001|Overall Study|Pt non compliant with therapy|1|||
146024387|NCT00075725|526602584|FG002|Overall Study|Pt non compliant with therapy|1|||
146024388|NCT00075725|526602585|FG003|Overall Study|Pt non compliant with therapy|0|||
146024389|NCT00075725|526602586|FG004|Overall Study|Pt non compliant with therapy|2|||
146024390|NCT00075725|526602587|FG005|Overall Study|Pt non compliant with therapy|14|||
146024391|NCT00075725|526602588|FG006|Overall Study|Pt non compliant with therapy|2|||
146024392|NCT00075725|526602589|FG007|Overall Study|Pt non compliant with therapy|5|||
146024393|NCT00075725|526602590|FG008|Overall Study|Pt non compliant with therapy|3|||
146024394|NCT00075725|526602591|FG009|Overall Study|Pt non compliant with therapy|0|||
146024395|NCT00075725|526602592|FG010|Overall Study|Pt non compliant with therapy|0|||
146024396|NCT00075725|526602593|FG011|Overall Study|Pt non compliant with therapy|0|||
146024397|NCT00075725|526602582|FG000|Overall Study|Pt age out of range for treatment|0|||
146024398|NCT00075725|526602583|FG001|Overall Study|Pt age out of range for treatment|1|||
146024399|NCT00075725|526602584|FG002|Overall Study|Pt age out of range for treatment|0|||
146024400|NCT00075725|526602585|FG003|Overall Study|Pt age out of range for treatment|0|||
146024401|NCT00075725|526602586|FG004|Overall Study|Pt age out of range for treatment|0|||
146024402|NCT00075725|526602587|FG005|Overall Study|Pt age out of range for treatment|1|||
146024403|NCT00075725|526602588|FG006|Overall Study|Pt age out of range for treatment|0|||
146024404|NCT00075725|526602589|FG007|Overall Study|Pt age out of range for treatment|1|||
146024405|NCT00075725|526602590|FG008|Overall Study|Pt age out of range for treatment|0|||
146024406|NCT00075725|526602591|FG009|Overall Study|Pt age out of range for treatment|0|||
146024407|NCT00075725|526602592|FG010|Overall Study|Pt age out of range for treatment|0|||
146024408|NCT00075725|526602593|FG011|Overall Study|Pt age out of range for treatment|0|||
146024409|NCT00075725|526602582|FG000|Overall Study|Insurance issues|0|||
146024410|NCT00075725|526602583|FG001|Overall Study|Insurance issues|1|||
146024411|NCT00075725|526602584|FG002|Overall Study|Insurance issues|0|||
146024412|NCT00075725|526602585|FG003|Overall Study|Insurance issues|1|||
146024413|NCT00075725|526602586|FG004|Overall Study|Insurance issues|1|||
146024414|NCT00075725|526602587|FG005|Overall Study|Insurance issues|1|||
146024415|NCT00075725|526602588|FG006|Overall Study|Insurance issues|0|||
146024416|NCT00075725|526602589|FG007|Overall Study|Insurance issues|1|||
146024417|NCT00075725|526602590|FG008|Overall Study|Insurance issues|0|||
146024418|NCT00075725|526602591|FG009|Overall Study|Insurance issues|0|||
146024419|NCT00075725|526602592|FG010|Overall Study|Insurance issues|0|||
146094591|NCT00598702|526867837|FG000|Overall Study|Dose limiting toxicity|0|||
146094592|NCT00598702|526867838|FG001|Overall Study|Dose limiting toxicity|0|||
146253760|NCT00985621|527440852|FG000|Overall Study|Lost to Follow-up|2|||
146253761|NCT00985621|527440853|FG001|Overall Study|Lost to Follow-up|3|||
146253762|NCT00985621|527440854|FG002|Overall Study|Lost to Follow-up|4|||
146253763|NCT00985621|527440855|FG003|Overall Study|Lost to Follow-up|4|||
146253764|NCT00985621|527440852|FG000|Overall Study|Study Terminated by Sponsor|89|||
146253765|NCT00985621|527440853|FG001|Overall Study|Study Terminated by Sponsor|108|||
146253766|NCT00985621|527440854|FG002|Overall Study|Study Terminated by Sponsor|99|||
146253767|NCT00985621|527440855|FG003|Overall Study|Study Terminated by Sponsor|92|||
146253768|NCT00985621|527440852|FG000|Overall Study|Protocol Violation|1|||
146253769|NCT00985621|527440853|FG001|Overall Study|Protocol Violation|1|||
146253770|NCT00985621|527440854|FG002|Overall Study|Protocol Violation|1|||
146253771|NCT00985621|527440855|FG003|Overall Study|Protocol Violation|0|||
146253772|NCT00985621|527440852|FG000|Overall Study|Withdrawal by Subject|8|||
146253773|NCT00985621|527440853|FG001|Overall Study|Withdrawal by Subject|10|||
146253774|NCT00985621|527440854|FG002|Overall Study|Withdrawal by Subject|8|||
146253775|NCT00985621|527440855|FG003|Overall Study|Withdrawal by Subject|12|||
146253776|NCT00985621|527440852|FG000|Overall Study|Other|1|||
146253777|NCT00985621|527440853|FG001|Overall Study|Other|0|||
146253778|NCT00985621|527440854|FG002|Overall Study|Other|0|||
146253779|NCT00985621|527440855|FG003|Overall Study|Other|0|||
146024420|NCT00075725|526602593|FG011|Overall Study|Insurance issues|0|||
146024421|NCT00075725|526602582|FG000|Overall Study|MRD positive after extended ind|0|||
146024422|NCT00075725|526602583|FG001|Overall Study|MRD positive after extended ind|1|||
146024423|NCT00075725|526602584|FG002|Overall Study|MRD positive after extended ind|1|||
146024424|NCT00075725|526602585|FG003|Overall Study|MRD positive after extended ind|0|||
146024425|NCT00075725|526602586|FG004|Overall Study|MRD positive after extended ind|1|||
146024426|NCT00075725|526602587|FG005|Overall Study|MRD positive after extended ind|2|||
146024427|NCT00075725|526602588|FG006|Overall Study|MRD positive after extended ind|0|||
146024428|NCT00075725|526602589|FG007|Overall Study|MRD positive after extended ind|1|||
146024429|NCT00075725|526602590|FG008|Overall Study|MRD positive after extended ind|0|||
146024430|NCT00075725|526602591|FG009|Overall Study|MRD positive after extended ind|0|||
146024431|NCT00075725|526602592|FG010|Overall Study|MRD positive after extended ind|0|||
146024432|NCT00075725|526602593|FG011|Overall Study|MRD positive after extended ind|0|||
146024433|NCT00075725|526602582|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
146024434|NCT00075725|526602583|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
146024435|NCT00075725|526602584|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
146024436|NCT00075725|526602585|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
146024437|NCT00075725|526602586|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
146024438|NCT00075725|526602587|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
146024439|NCT00075725|526602588|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
146024440|NCT00075725|526602589|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
146024441|NCT00075725|526602590|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
146024442|NCT00075725|526602591|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
146024443|NCT00075725|526602592|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
146024444|NCT00075725|526602593|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
146024445|NCT00075725|526602582|FG000|Overall Study|Inevaluable|1|||
146024446|NCT00075725|526602583|FG001|Overall Study|Inevaluable|1|||
146024447|NCT00075725|526602584|FG002|Overall Study|Inevaluable|4|||
146024448|NCT00075725|526602585|FG003|Overall Study|Inevaluable|2|||
146024449|NCT00075725|526602586|FG004|Overall Study|Inevaluable|2|||
146024450|NCT00075725|526602587|FG005|Overall Study|Inevaluable|9|||
146024451|NCT00075725|526602588|FG006|Overall Study|Inevaluable|1|||
146024452|NCT00075725|526602589|FG007|Overall Study|Inevaluable|11|||
146024453|NCT00075725|526602590|FG008|Overall Study|Inevaluable|2|||
146024454|NCT00075725|526602591|FG009|Overall Study|Inevaluable|0|||
146024455|NCT00075725|526602592|FG010|Overall Study|Inevaluable|1|||
146024456|NCT00075725|526602593|FG011|Overall Study|Inevaluable|0|||
146024457|NCT00075725|526602582|FG000|Overall Study|Other|4|||
146024458|NCT00075725|526602583|FG001|Overall Study|Other|2|||
146024459|NCT00075725|526602584|FG002|Overall Study|Other|1|||
146024460|NCT00075725|526602585|FG003|Overall Study|Other|1|||
146024461|NCT00075725|526602586|FG004|Overall Study|Other|1|||
146024462|NCT00075725|526602587|FG005|Overall Study|Other|4|||
146024463|NCT00075725|526602588|FG006|Overall Study|Other|2|||
146024464|NCT00075725|526602589|FG007|Overall Study|Other|9|||
146024465|NCT00075725|526602590|FG008|Overall Study|Other|2|||
146024466|NCT00075725|526602591|FG009|Overall Study|Other|1|||
146024467|NCT00075725|526602592|FG010|Overall Study|Other|0|||
146024468|NCT00075725|526602593|FG011|Overall Study|Other|3|||
146024469|NCT00075725|526602582|FG000|Overall Study|Pt trying to find a BM donor|0|||
146024470|NCT00075725|526602583|FG001|Overall Study|Pt trying to find a BM donor|1|||
146024471|NCT00075725|526602584|FG002|Overall Study|Pt trying to find a BM donor|0|||
146024472|NCT00075725|526602585|FG003|Overall Study|Pt trying to find a BM donor|0|||
146024473|NCT00075725|526602586|FG004|Overall Study|Pt trying to find a BM donor|0|||
146024474|NCT00075725|526602587|FG005|Overall Study|Pt trying to find a BM donor|0|||
146024475|NCT00075725|526602588|FG006|Overall Study|Pt trying to find a BM donor|0|||
146024476|NCT00075725|526602589|FG007|Overall Study|Pt trying to find a BM donor|0|||
146024477|NCT00075725|526602590|FG008|Overall Study|Pt trying to find a BM donor|0|||
146024478|NCT00075725|526602591|FG009|Overall Study|Pt trying to find a BM donor|0|||
146024479|NCT00075725|526602592|FG010|Overall Study|Pt trying to find a BM donor|0|||
146024480|NCT00075725|526602593|FG011|Overall Study|Pt trying to find a BM donor|0|||
146024481|NCT00075725|526602582|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
146024482|NCT00075725|526602583|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
146024483|NCT00075725|526602584|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
146024484|NCT00075725|526602585|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
146024485|NCT00075725|526602586|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
146024486|NCT00075725|526602587|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
146024487|NCT00075725|526602588|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
146024488|NCT00075725|526602589|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
146024489|NCT00075725|526602590|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
146024490|NCT00075725|526602591|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
146024491|NCT00075725|526602592|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
146024492|NCT00075725|526602593|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
146024493|NCT00075725|526602582|FG000|Overall Study|Unsuccessful institutional transfer|0|||
146024494|NCT00075725|526602583|FG001|Overall Study|Unsuccessful institutional transfer|0|||
146024495|NCT00075725|526602584|FG002|Overall Study|Unsuccessful institutional transfer|2|||
146024496|NCT00075725|526602585|FG003|Overall Study|Unsuccessful institutional transfer|0|||
146024497|NCT00075725|526602586|FG004|Overall Study|Unsuccessful institutional transfer|0|||
146024498|NCT00075725|526602587|FG005|Overall Study|Unsuccessful institutional transfer|0|||
146024499|NCT00075725|526602588|FG006|Overall Study|Unsuccessful institutional transfer|0|||
146024500|NCT00075725|526602589|FG007|Overall Study|Unsuccessful institutional transfer|0|||
146024501|NCT00075725|526602590|FG008|Overall Study|Unsuccessful institutional transfer|0|||
146024502|NCT00075725|526602591|FG009|Overall Study|Unsuccessful institutional transfer|1|||
146024503|NCT00075725|526602592|FG010|Overall Study|Unsuccessful institutional transfer|0|||
146024504|NCT00075725|526602593|FG011|Overall Study|Unsuccessful institutional transfer|0|||
146024505|NCT00075725|526602582|FG000|Overall Study|specimen(s) not submitted|0|||
146024506|NCT00075725|526602583|FG001|Overall Study|specimen(s) not submitted|0|||
146024507|NCT00075725|526602584|FG002|Overall Study|specimen(s) not submitted|2|||
146024508|NCT00075725|526602585|FG003|Overall Study|specimen(s) not submitted|0|||
146024509|NCT00075725|526602586|FG004|Overall Study|specimen(s) not submitted|0|||
146024510|NCT00075725|526602587|FG005|Overall Study|specimen(s) not submitted|0|||
146024511|NCT00075725|526602588|FG006|Overall Study|specimen(s) not submitted|0|||
146024512|NCT00075725|526602589|FG007|Overall Study|specimen(s) not submitted|0|||
146024513|NCT00075725|526602590|FG008|Overall Study|specimen(s) not submitted|0|||
146024514|NCT00075725|526602591|FG009|Overall Study|specimen(s) not submitted|0|||
146024515|NCT00075725|526602592|FG010|Overall Study|specimen(s) not submitted|0|||
146024516|NCT00075725|526602593|FG011|Overall Study|specimen(s) not submitted|0|||
146024517|NCT00075725|526602582|FG000|Overall Study|Pt went to transplant|0|||
146024518|NCT00075725|526602583|FG001|Overall Study|Pt went to transplant|0|||
146300278|NCT03681951|527615195|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146300279|NCT03681951|527615196|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146300280|NCT03681951|527615197|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146300281|NCT03681951|527615198|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146300282|NCT03681951|527615199|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
146300283|NCT02187809|527615200|FG000|Overall Study|The study was terminated|3|||
146300284|NCT01020448|527615201|FG000|Pre-assignment|Adverse Event|6|||
146300285|NCT01020448|527615201|FG000|Pre-assignment|Withdrawal by Subject|5|||
146024519|NCT00075725|526602584|FG002|Overall Study|Pt went to transplant|0|||
146024520|NCT00075725|526602585|FG003|Overall Study|Pt went to transplant|1|||
146024521|NCT00075725|526602586|FG004|Overall Study|Pt went to transplant|0|||
146024522|NCT00075725|526602587|FG005|Overall Study|Pt went to transplant|1|||
146024523|NCT00075725|526602588|FG006|Overall Study|Pt went to transplant|0|||
146024524|NCT00075725|526602589|FG007|Overall Study|Pt went to transplant|0|||
146024525|NCT00075725|526602590|FG008|Overall Study|Pt went to transplant|0|||
146024526|NCT00075725|526602591|FG009|Overall Study|Pt went to transplant|0|||
146024527|NCT00075725|526602592|FG010|Overall Study|Pt went to transplant|0|||
146024528|NCT00075725|526602593|FG011|Overall Study|Pt went to transplant|0|||
146024529|NCT00075725|526602582|FG000|Overall Study|Pt received additional steroids|0|||
146024530|NCT00075725|526602583|FG001|Overall Study|Pt received additional steroids|0|||
146024531|NCT00075725|526602584|FG002|Overall Study|Pt received additional steroids|0|||
146024532|NCT00075725|526602585|FG003|Overall Study|Pt received additional steroids|1|||
146024533|NCT00075725|526602586|FG004|Overall Study|Pt received additional steroids|0|||
146024534|NCT00075725|526602587|FG005|Overall Study|Pt received additional steroids|0|||
146024535|NCT00075725|526602588|FG006|Overall Study|Pt received additional steroids|0|||
146024536|NCT00075725|526602589|FG007|Overall Study|Pt received additional steroids|0|||
146024537|NCT00075725|526602590|FG008|Overall Study|Pt received additional steroids|0|||
146024538|NCT00075725|526602591|FG009|Overall Study|Pt received additional steroids|0|||
146024539|NCT00075725|526602592|FG010|Overall Study|Pt received additional steroids|0|||
146024540|NCT00075725|526602593|FG011|Overall Study|Pt received additional steroids|0|||
146024541|NCT00075725|526602582|FG000|Overall Study|Pt relocated|0|||
146024542|NCT00075725|526602583|FG001|Overall Study|Pt relocated|0|||
146024543|NCT00075725|526602584|FG002|Overall Study|Pt relocated|0|||
146024544|NCT00075725|526602585|FG003|Overall Study|Pt relocated|2|||
146024545|NCT00075725|526602586|FG004|Overall Study|Pt relocated|0|||
146024546|NCT00075725|526602587|FG005|Overall Study|Pt relocated|1|||
146253780|NCT00985621|527440852|FG000|Overall Study|Randomized but not Treated|1|||
146253781|NCT00985621|527440853|FG001|Overall Study|Randomized but not Treated|0|||
146253782|NCT00985621|527440854|FG002|Overall Study|Randomized but not Treated|2|||
146253783|NCT00985621|527440855|FG003|Overall Study|Randomized but not Treated|1|||
146253784|NCT01911819|527440856|FG000|Overall Study|Adverse Event|0|||
146253785|NCT01911819|527440857|FG001|Overall Study|Adverse Event|1|||
146253786|NCT01911819|527440858|FG002|Overall Study|Adverse Event|0|||
146300286|NCT01020448|527615201|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
146300287|NCT01020448|527615201|FG000|Treatment|Adverse Event|11|||
146024547|NCT00075725|526602588|FG006|Overall Study|Pt relocated|1|||
146024548|NCT00075725|526602589|FG007|Overall Study|Pt relocated|2|||
146024549|NCT00075725|526602590|FG008|Overall Study|Pt relocated|1|||
146253787|NCT01911819|527440856|FG000|Overall Study|Withdrawal by Subject|1|||
146253788|NCT01911819|527440857|FG001|Overall Study|Withdrawal by Subject|1|||
146300288|NCT01020448|527615201|FG000|Treatment|Consent Withdrawn|3|||
146024550|NCT00075725|526602591|FG009|Overall Study|Pt relocated|0|||
146024551|NCT00075725|526602592|FG010|Overall Study|Pt relocated|0|||
146024552|NCT00075725|526602593|FG011|Overall Study|Pt relocated|0|||
146024553|NCT00075725|526602582|FG000|Overall Study|Institution Terminated|0|||
146024554|NCT00075725|526602583|FG001|Overall Study|Institution Terminated|0|||
146024555|NCT00075725|526602584|FG002|Overall Study|Institution Terminated|0|||
146024556|NCT00075725|526602585|FG003|Overall Study|Institution Terminated|0|||
146024557|NCT00075725|526602586|FG004|Overall Study|Institution Terminated|1|||
146024558|NCT00075725|526602587|FG005|Overall Study|Institution Terminated|0|||
146024559|NCT00075725|526602588|FG006|Overall Study|Institution Terminated|0|||
146024560|NCT00075725|526602589|FG007|Overall Study|Institution Terminated|3|||
146024561|NCT00075725|526602590|FG008|Overall Study|Institution Terminated|0|||
146024562|NCT00075725|526602591|FG009|Overall Study|Institution Terminated|0|||
146024563|NCT00075725|526602592|FG010|Overall Study|Institution Terminated|0|||
146024564|NCT00075725|526602593|FG011|Overall Study|Institution Terminated|0|||
146024565|NCT00075725|526602582|FG000|Overall Study|Study Closure|1|||
146024566|NCT00075725|526602583|FG001|Overall Study|Study Closure|0|||
146024567|NCT00075725|526602584|FG002|Overall Study|Study Closure|0|||
146024568|NCT00075725|526602585|FG003|Overall Study|Study Closure|0|||
146024569|NCT00075725|526602586|FG004|Overall Study|Study Closure|1|||
146024570|NCT00075725|526602587|FG005|Overall Study|Study Closure|3|||
146024571|NCT00075725|526602588|FG006|Overall Study|Study Closure|0|||
146024572|NCT00075725|526602589|FG007|Overall Study|Study Closure|1|||
146024573|NCT00075725|526602590|FG008|Overall Study|Study Closure|0|||
146024574|NCT00075725|526602591|FG009|Overall Study|Study Closure|0|||
146024575|NCT00075725|526602592|FG010|Overall Study|Study Closure|0|||
146024576|NCT00075725|526602593|FG011|Overall Study|Study Closure|0|||
146024577|NCT00075725|526602582|FG000|Overall Study|Other complications|0|||
146024578|NCT00075725|526602583|FG001|Overall Study|Other complications|0|||
146024579|NCT00075725|526602584|FG002|Overall Study|Other complications|0|||
146024580|NCT00075725|526602585|FG003|Overall Study|Other complications|0|||
146024581|NCT00075725|526602586|FG004|Overall Study|Other complications|0|||
146024582|NCT00075725|526602587|FG005|Overall Study|Other complications|1|||
146024583|NCT00075725|526602588|FG006|Overall Study|Other complications|0|||
146024584|NCT00075725|526602589|FG007|Overall Study|Other complications|0|||
146024585|NCT00075725|526602590|FG008|Overall Study|Other complications|0|||
146024586|NCT00075725|526602591|FG009|Overall Study|Other complications|0|||
146024587|NCT00075725|526602592|FG010|Overall Study|Other complications|0|||
146024588|NCT00075725|526602593|FG011|Overall Study|Other complications|0|||
146024589|NCT00075725|526602582|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
146024590|NCT00075725|526602583|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
146024591|NCT00075725|526602584|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
146024592|NCT00075725|526602585|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
146024593|NCT00075725|526602586|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
146024594|NCT00075725|526602587|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
146024595|NCT00075725|526602588|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
146024596|NCT00075725|526602589|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
146024597|NCT00075725|526602590|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
146024598|NCT00075725|526602591|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
146024599|NCT00075725|526602592|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
146024600|NCT00075725|526602593|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
146024601|NCT00075725|526602582|FG000|Overall Study|Pt incarcerated|0|||
146024602|NCT00075725|526602583|FG001|Overall Study|Pt incarcerated|0|||
146024603|NCT00075725|526602584|FG002|Overall Study|Pt incarcerated|0|||
146024604|NCT00075725|526602585|FG003|Overall Study|Pt incarcerated|0|||
146024605|NCT00075725|526602586|FG004|Overall Study|Pt incarcerated|0|||
146024606|NCT00075725|526602587|FG005|Overall Study|Pt incarcerated|0|||
146024607|NCT00075725|526602588|FG006|Overall Study|Pt incarcerated|0|||
146024608|NCT00075725|526602589|FG007|Overall Study|Pt incarcerated|1|||
146024609|NCT00075725|526602590|FG008|Overall Study|Pt incarcerated|0|||
146024610|NCT00075725|526602591|FG009|Overall Study|Pt incarcerated|0|||
146024611|NCT00075725|526602592|FG010|Overall Study|Pt incarcerated|0|||
146024612|NCT00075725|526602593|FG011|Overall Study|Pt incarcerated|0|||
146024613|NCT03242772|526602594|FG000|Overall Study|Lost to Follow-up|2|||
146024614|NCT03242772|526602595|FG001|Overall Study|Lost to Follow-up|0|||
146024615|NCT03242772|526602594|FG000|Overall Study|Physician Decision|0|||
146024616|NCT03242772|526602595|FG001|Overall Study|Physician Decision|1|||
146024617|NCT03242772|526602594|FG000|Overall Study|Withdrawal by Subject|1|||
146024618|NCT03242772|526602595|FG001|Overall Study|Withdrawal by Subject|0|||
146024619|NCT03385265|526602599|FG000|Overall Study|Withdrawal by Subject|5|||
146024620|NCT03385265|526602600|FG001|Overall Study|Withdrawal by Subject|2|||
146024621|NCT03385265|526602601|FG002|Overall Study|Withdrawal by Subject|5|||
146024622|NCT03385265|526602602|FG003|Overall Study|Withdrawal by Subject|2|||
146024623|NCT02437305|526602603|FG000|Overall Study|Lost to Follow-up|18|||
146024624|NCT02437305|526602604|FG001|Overall Study|Lost to Follow-up|12|||
146024625|NCT03220581|526602605|FG000|Overall Study|Withdrawal by Subject|0|||
146024626|NCT03220581|526602606|FG001|Overall Study|Withdrawal by Subject|1|||
146024627|NCT03220581|526602605|FG000|Overall Study|Lost to Follow-up|3|||
146024628|NCT03220581|526602606|FG001|Overall Study|Lost to Follow-up|6|||
146024629|NCT02434354|526602607|FG000|Overall Study|screen fail|3|||
146024630|NCT01920893|526602608|FG000|Overall Study|Adverse Event|5|||
146024631|NCT01920893|526602609|FG001|Overall Study|Adverse Event|2|||
146024632|NCT01920893|526602608|FG000|Overall Study|Lack of Efficacy|2|||
146024633|NCT01920893|526602609|FG001|Overall Study|Lack of Efficacy|0|||
146024634|NCT03440918|526602610|FG000|Overall Study|Protocol Violation|0|||
146024635|NCT03440918|526602611|FG001|Overall Study|Protocol Violation|16|||
146024636|NCT03576755|526602623|FG000|Overall Study|Withdrawal by Subject|1|||
146024637|NCT03576755|526602624|FG001|Overall Study|Withdrawal by Subject|0|||
146024638|NCT03576755|526602625|FG002|Overall Study|Withdrawal by Subject|0|||
146024639|NCT03576755|526602626|FG003|Overall Study|Withdrawal by Subject|0|||
146024640|NCT01396265|526602627|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
146024641|NCT01767493|526602628|FG000|Overall Study|screen failures|3|||
146024642|NCT03746600|526602629|FG000|Overall Study|Withdrawal by Subject|3|||
146253789|NCT01911819|527440858|FG002|Overall Study|Withdrawal by Subject|0|||
146253790|NCT03953079|527440859|FG000|Core Study|Withdrawal by Subject|1|||
146094593|NCT00598702|526867839|FG002|Overall Study|Dose limiting toxicity|0|||
146094594|NCT00598702|526867840|FG003|Overall Study|Dose limiting toxicity|1|||
146094595|NCT00598702|526867841|FG004|Overall Study|Dose limiting toxicity|1|||
146024643|NCT03746600|526602630|FG001|Overall Study|Withdrawal by Subject|3|||
146024644|NCT03746600|526602629|FG000|Overall Study|dismissed from study|1|||
146024645|NCT03746600|526602630|FG001|Overall Study|dismissed from study|0|||
146024646|NCT03746600|526602629|FG000|Overall Study|Lost to Follow-up|1|||
146024647|NCT03746600|526602630|FG001|Overall Study|Lost to Follow-up|0|||
146024648|NCT00884039|526602631|FG000|Overall Study|Withdrawal by Subject|0|||
146024649|NCT00884039|526602632|FG001|Overall Study|Withdrawal by Subject|1|||
146024650|NCT00884039|526602631|FG000|Overall Study|Lack of Efficacy|2|||
146024651|NCT00884039|526602632|FG001|Overall Study|Lack of Efficacy|0|||
146024652|NCT00405964|526602636|FG000|Overall Study|Treatment Failure|17|||
146024653|NCT00405964|526602637|FG001|Overall Study|Treatment Failure|45|||
146024654|NCT00405964|526602636|FG000|Overall Study|Adverse Event|7|||
146024655|NCT00405964|526602637|FG001|Overall Study|Adverse Event|16|||
146024656|NCT00405964|526602636|FG000|Overall Study|Lost to Follow-up|5|||
146024657|NCT00405964|526602637|FG001|Overall Study|Lost to Follow-up|5|||
146024658|NCT00405964|526602636|FG000|Overall Study|Withdrawal by Subject|19|||
146024659|NCT00405964|526602637|FG001|Overall Study|Withdrawal by Subject|23|||
146024660|NCT00405964|526602636|FG000|Overall Study|Protocol Violation|11|||
146024661|NCT00405964|526602637|FG001|Overall Study|Protocol Violation|6|||
146024662|NCT02981407|526602640|FG000|Overall Study|Withdrawal by Subject|2|||
146024663|NCT02981407|526602641|FG001|Overall Study|Withdrawal by Subject|0|||
146024664|NCT01300819|526602644|FG000|Overall Study|Adverse Event|9|||
146024665|NCT01300819|526602645|FG001|Overall Study|Adverse Event|27|||
146024666|NCT01300819|526602644|FG000|Overall Study|Lack of Efficacy|2|||
146024667|NCT01300819|526602645|FG001|Overall Study|Lack of Efficacy|1|||
146024668|NCT01300819|526602644|FG000|Overall Study|Withdrawal by Subject|10|||
146024669|NCT01300819|526602645|FG001|Overall Study|Withdrawal by Subject|12|||
146094596|NCT00598702|526867842|FG005|Overall Study|Dose limiting toxicity|1|||
146094597|NCT00598702|526867843|FG006|Overall Study|Dose limiting toxicity|0|||
146094598|NCT00598702|526867844|FG007|Overall Study|Dose limiting toxicity|0|||
146094599|NCT02063880|526867845|FG000|Overall Study|Death|21|||
146094600|NCT02063880|526867846|FG001|Overall Study|Death|18|||
146094601|NCT02063880|526867845|FG000|Overall Study|Lost to Follow-up|7|||
146094602|NCT02063880|526867846|FG001|Overall Study|Lost to Follow-up|7|||
146094603|NCT02063880|526867845|FG000|Overall Study|Ineligible|0|||
146094604|NCT02063880|526867846|FG001|Overall Study|Ineligible|2|||
146094605|NCT02600351|526867847|FG000|Overall Study|Lack of Efficacy|3|||
146094606|NCT02600351|526867848|FG001|Overall Study|Lack of Efficacy|0|||
146094607|NCT02600351|526867849|FG002|Overall Study|Lack of Efficacy|5|||
146094608|NCT02600351|526867850|FG003|Overall Study|Lack of Efficacy|2|||
146253791|NCT03953079|527440860|FG001|Core Study|Withdrawal by Subject|2|||
146253792|NCT03953079|527440861|FG002|Core Study|Withdrawal by Subject|1|||
146253793|NCT03953079|527440859|FG000|Core Study|COVID-19|0|||
146253794|NCT03953079|527440860|FG001|Core Study|COVID-19|1|||
146253795|NCT03953079|527440861|FG002|Core Study|COVID-19|0|||
146253796|NCT03953079|527440859|FG000|Core Study|Difficulties leaving the house|0|||
146253797|NCT03953079|527440860|FG001|Core Study|Difficulties leaving the house|1|||
146253798|NCT03953079|527440861|FG002|Core Study|Difficulties leaving the house|0|||
146253799|NCT03953079|527440859|FG000|Extension Study|Withdrawal by Subject|1|||
146253800|NCT03953079|527440860|FG001|Extension Study|Withdrawal by Subject|0|||
146253801|NCT03953079|527440861|FG002|Extension Study|Withdrawal by Subject|0|||
146253802|NCT03953079|527440859|FG000|Extension Study|Received Rescue Treatment|5|||
146253803|NCT03953079|527440860|FG001|Extension Study|Received Rescue Treatment|6|||
146253804|NCT03953079|527440861|FG002|Extension Study|Received Rescue Treatment|5|||
146300289|NCT01020448|527615201|FG000|Treatment|Disease Progression|2|||
146024670|NCT01300819|526602644|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
146024671|NCT01300819|526602645|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
146024672|NCT01300819|526602644|FG000|Overall Study|Refusal to down titrate study drug|0|||
146024673|NCT01300819|526602645|FG001|Overall Study|Refusal to down titrate study drug|1|||
146024674|NCT01300819|526602644|FG000|Overall Study|Administrative reason|0|||
146094609|NCT02600351|526867847|FG000|Overall Study|Lost to Follow-up|1|||
146253805|NCT04394624|527440865|FG000|Overall Study|Adverse Event|6|||
146024675|NCT01300819|526602645|FG001|Overall Study|Administrative reason|1|||
146024676|NCT01300819|526602644|FG000|Overall Study|Safety follow up not done by mistake|0|||
146024677|NCT01300819|526602645|FG001|Overall Study|Safety follow up not done by mistake|1|||
146024678|NCT01300819|526602644|FG000|Overall Study|Follow up call was not done|1|||
146024679|NCT01300819|526602645|FG001|Overall Study|Follow up call was not done|0|||
146024680|NCT02818036|526602646|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
146024681|NCT02818036|526602647|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
146024682|NCT02818036|526602646|FG000|Overall Study|Withdrawal by Subject|1|||
146024683|NCT02818036|526602647|FG001|Overall Study|Withdrawal by Subject|0|||
146024684|NCT01319721|526602659|FG000|Overall Study|Lost to Follow-up|1|||
146024685|NCT01319721|526602660|FG001|Overall Study|Lost to Follow-up|6|||
146024686|NCT00468845|526602662|FG000|Overall Study|Adverse Event|9|||
146024687|NCT00468845|526602663|FG001|Overall Study|Adverse Event|14|||
146024688|NCT00468845|526602664|FG002|Overall Study|Adverse Event|11|||
146024689|NCT00468845|526602662|FG000|Overall Study|Lost to Follow-up|2|||
146024690|NCT00468845|526602663|FG001|Overall Study|Lost to Follow-up|1|||
146024691|NCT00468845|526602664|FG002|Overall Study|Lost to Follow-up|2|||
146024692|NCT00468845|526602662|FG000|Overall Study|Other|4|||
146024693|NCT00468845|526602663|FG001|Overall Study|Other|9|||
146024694|NCT00468845|526602664|FG002|Overall Study|Other|5|||
146024695|NCT00468845|526602662|FG000|Overall Study|No longer willing to participate|5|||
146024696|NCT00468845|526602663|FG001|Overall Study|No longer willing to participate|6|||
146024697|NCT00468845|526602664|FG002|Overall Study|No longer willing to participate|10|||
146024698|NCT00468845|526602662|FG000|Overall Study|Randomized, not treated|1|||
146024699|NCT00468845|526602663|FG001|Overall Study|Randomized, not treated|4|||
146024700|NCT00468845|526602664|FG002|Overall Study|Randomized, not treated|2|||
146024701|NCT00461305|526602665|FG000|Treatment|Adverse Event|26|||
146024702|NCT00461305|526602666|FG001|Treatment|Adverse Event|3|||
146024703|NCT00461305|526602665|FG000|Treatment|Lost to Follow-up|4|||
146024704|NCT00461305|526602666|FG001|Treatment|Lost to Follow-up|2|||
146024705|NCT00461305|526602665|FG000|Treatment|Protocol Violation|13|||
146024706|NCT00461305|526602666|FG001|Treatment|Protocol Violation|2|||
146024707|NCT00461305|526602665|FG000|Treatment|Withdrawal by Subject|48|||
146024708|NCT00461305|526602666|FG001|Treatment|Withdrawal by Subject|2|||
146024709|NCT00461305|526602665|FG000|Treatment|Never dispensed|5|||
146024710|NCT00461305|526602666|FG001|Treatment|Never dispensed|0|||
146024711|NCT00461305|526602665|FG000|Treatment|Study drug not taken|1|||
146024712|NCT00461305|526602666|FG001|Treatment|Study drug not taken|0|||
146024713|NCT00461305|526602665|FG000|Treatment|Partially missing diary|2|||
146024714|NCT00461305|526602666|FG001|Treatment|Partially missing diary|0|||
146024715|NCT00461305|526602665|FG000|Treatment|Other (missing drug etc)|2|||
146024716|NCT00461305|526602666|FG001|Treatment|Other (missing drug etc)|0|||
146024717|NCT00461305|526602665|FG000|Continued Treatment|Adverse Event|26|||
146024718|NCT00461305|526602666|FG001|Continued Treatment|Adverse Event|0|||
146024719|NCT00461305|526602665|FG000|Continued Treatment|Lost to Follow-up|4|||
146024720|NCT00461305|526602666|FG001|Continued Treatment|Lost to Follow-up|0|||
146024721|NCT00461305|526602665|FG000|Continued Treatment|Protocol Violation|13|||
146024722|NCT00461305|526602666|FG001|Continued Treatment|Protocol Violation|0|||
146024723|NCT00461305|526602665|FG000|Continued Treatment|Withdrawal by Subject|48|||
146024724|NCT00461305|526602666|FG001|Continued Treatment|Withdrawal by Subject|0|||
146024725|NCT00461305|526602665|FG000|Continued Treatment|Partially missing diary|2|||
146024726|NCT00461305|526602666|FG001|Continued Treatment|Partially missing diary|0|||
146024727|NCT00461305|526602665|FG000|Continued Treatment|Other (missing drug etc)|2|||
146024728|NCT00461305|526602666|FG001|Continued Treatment|Other (missing drug etc)|0|||
146024729|NCT00953680|526602670|FG000|Period 1|Withdrawal by Subject|0|||
146024730|NCT00953680|526602671|FG001|Period 1|Withdrawal by Subject|1|||
146024731|NCT00549900|526604850|FG000|Overall Study|Adverse Event|1|||
146024732|NCT02210832|526604852|FG000|Overall Study|Pregnancy termination .|3|||
146024733|NCT02210832|526604853|FG001|Overall Study|Pregnancy termination .|4|||
146024734|NCT02210832|526604854|FG002|Overall Study|Pregnancy termination .|1|||
146024735|NCT02210832|526604852|FG000|Overall Study|Lost to Follow-up|26|||
146024736|NCT02210832|526604853|FG001|Overall Study|Lost to Follow-up|32|||
146024737|NCT02210832|526604854|FG002|Overall Study|Lost to Follow-up|17|||
146024738|NCT02754141|526604859|FG000|Overall Study|Disease progression|11|||
146024739|NCT02754141|526604860|FG001|Overall Study|Disease progression|7|||
146024740|NCT02754141|526604861|FG002|Overall Study|Disease progression|8|||
146024741|NCT02754141|526604862|FG003|Overall Study|Disease progression|5|||
146253806|NCT04394624|527440866|FG001|Overall Study|Adverse Event|0|||
146024742|NCT02754141|526604863|FG004|Overall Study|Disease progression|7|||
146024743|NCT02754141|526604864|FG005|Overall Study|Disease progression|7|||
146024744|NCT02754141|526604865|FG006|Overall Study|Disease progression|7|||
146024745|NCT02754141|526604866|FG007|Overall Study|Disease progression|6|||
146024746|NCT02754141|526604867|FG008|Overall Study|Disease progression|11|||
146024747|NCT02754141|526604868|FG009|Overall Study|Disease progression|16|||
146024748|NCT02754141|526604869|FG010|Overall Study|Disease progression|18|||
146024749|NCT02754141|526604870|FG011|Overall Study|Disease progression|13|||
146253807|NCT04394624|527440865|FG000|Overall Study|Progressive disease|24|||
146253808|NCT04394624|527440866|FG001|Overall Study|Progressive disease|0|||
146024750|NCT02754141|526604871|FG012|Overall Study|Disease progression|10|||
146024751|NCT02754141|526604872|FG013|Overall Study|Disease progression|12|||
146024752|NCT02754141|526604873|FG014|Overall Study|Disease progression|12|||
146024753|NCT02754141|526604874|FG015|Overall Study|Disease progression|14|||
146024754|NCT02754141|526604875|FG016|Overall Study|Disease progression|0|||
146024755|NCT02754141|526604876|FG017|Overall Study|Disease progression|1|||
146024756|NCT02754141|526604859|FG000|Overall Study|Study drug toxicity|1|||
146024757|NCT02754141|526604860|FG001|Overall Study|Study drug toxicity|1|||
146024758|NCT02754141|526604861|FG002|Overall Study|Study drug toxicity|0|||
146024759|NCT02754141|526604862|FG003|Overall Study|Study drug toxicity|0|||
146024760|NCT02754141|526604863|FG004|Overall Study|Study drug toxicity|0|||
146024761|NCT02754141|526604864|FG005|Overall Study|Study drug toxicity|0|||
146024762|NCT02754141|526604865|FG006|Overall Study|Study drug toxicity|0|||
146024763|NCT02754141|526604866|FG007|Overall Study|Study drug toxicity|0|||
146024764|NCT02754141|526604867|FG008|Overall Study|Study drug toxicity|0|||
146024765|NCT02754141|526604868|FG009|Overall Study|Study drug toxicity|0|||
146024766|NCT02754141|526604869|FG010|Overall Study|Study drug toxicity|2|||
146024767|NCT02754141|526604870|FG011|Overall Study|Study drug toxicity|1|||
146024768|NCT02754141|526604871|FG012|Overall Study|Study drug toxicity|1|||
146024769|NCT02754141|526604872|FG013|Overall Study|Study drug toxicity|0|||
146024770|NCT02754141|526604873|FG014|Overall Study|Study drug toxicity|0|||
146024771|NCT02754141|526604874|FG015|Overall Study|Study drug toxicity|0|||
146024772|NCT02754141|526604875|FG016|Overall Study|Study drug toxicity|0|||
146024773|NCT02754141|526604876|FG017|Overall Study|Study drug toxicity|0|||
146024774|NCT02754141|526604859|FG000|Overall Study|AE unrelated to study drug|1|||
146024775|NCT02754141|526604860|FG001|Overall Study|AE unrelated to study drug|1|||
146024776|NCT02754141|526604861|FG002|Overall Study|AE unrelated to study drug|0|||
146024777|NCT02754141|526604862|FG003|Overall Study|AE unrelated to study drug|1|||
146024778|NCT02754141|526604863|FG004|Overall Study|AE unrelated to study drug|3|||
146024779|NCT02754141|526604864|FG005|Overall Study|AE unrelated to study drug|2|||
146024780|NCT02754141|526604865|FG006|Overall Study|AE unrelated to study drug|1|||
146024781|NCT02754141|526604866|FG007|Overall Study|AE unrelated to study drug|0|||
146024782|NCT02754141|526604867|FG008|Overall Study|AE unrelated to study drug|0|||
146024783|NCT02754141|526604868|FG009|Overall Study|AE unrelated to study drug|0|||
146024784|NCT02754141|526604869|FG010|Overall Study|AE unrelated to study drug|0|||
146024785|NCT02754141|526604870|FG011|Overall Study|AE unrelated to study drug|0|||
146024786|NCT02754141|526604871|FG012|Overall Study|AE unrelated to study drug|0|||
146024787|NCT02754141|526604872|FG013|Overall Study|AE unrelated to study drug|0|||
146024788|NCT02754141|526604873|FG014|Overall Study|AE unrelated to study drug|0|||
146024789|NCT02754141|526604874|FG015|Overall Study|AE unrelated to study drug|0|||
146024790|NCT02754141|526604875|FG016|Overall Study|AE unrelated to study drug|0|||
146024791|NCT02754141|526604876|FG017|Overall Study|AE unrelated to study drug|0|||
146024792|NCT02754141|526604859|FG000|Overall Study|Request to discontinue|0|||
146024793|NCT02754141|526604860|FG001|Overall Study|Request to discontinue|0|||
146024794|NCT02754141|526604861|FG002|Overall Study|Request to discontinue|0|||
146024795|NCT02754141|526604862|FG003|Overall Study|Request to discontinue|0|||
146024796|NCT02754141|526604863|FG004|Overall Study|Request to discontinue|0|||
146024797|NCT02754141|526604864|FG005|Overall Study|Request to discontinue|0|||
146253809|NCT04394624|527440865|FG000|Overall Study|Not related to COVID-19|1|||
146253810|NCT04394624|527440866|FG001|Overall Study|Not related to COVID-19|0|||
146253811|NCT00603278|527440868|FG000|Overall Study|Lack of Efficacy|35|||
146024798|NCT02754141|526604865|FG006|Overall Study|Request to discontinue|0|||
146024799|NCT02754141|526604866|FG007|Overall Study|Request to discontinue|0|||
146024800|NCT02754141|526604867|FG008|Overall Study|Request to discontinue|1|||
146024801|NCT02754141|526604868|FG009|Overall Study|Request to discontinue|0|||
146024802|NCT02754141|526604869|FG010|Overall Study|Request to discontinue|0|||
146024803|NCT02754141|526604870|FG011|Overall Study|Request to discontinue|0|||
146024804|NCT02754141|526604871|FG012|Overall Study|Request to discontinue|0|||
146024805|NCT02754141|526604872|FG013|Overall Study|Request to discontinue|1|||
146024806|NCT02754141|526604873|FG014|Overall Study|Request to discontinue|1|||
146024807|NCT02754141|526604874|FG015|Overall Study|Request to discontinue|0|||
146024808|NCT02754141|526604875|FG016|Overall Study|Request to discontinue|0|||
146024809|NCT02754141|526604876|FG017|Overall Study|Request to discontinue|0|||
146024810|NCT02754141|526604859|FG000|Overall Study|Withdrew consent|0|||
146024811|NCT02754141|526604860|FG001|Overall Study|Withdrew consent|0|||
146024812|NCT02754141|526604861|FG002|Overall Study|Withdrew consent|0|||
146024813|NCT02754141|526604862|FG003|Overall Study|Withdrew consent|0|||
146024814|NCT02754141|526604863|FG004|Overall Study|Withdrew consent|0|||
146024815|NCT02754141|526604864|FG005|Overall Study|Withdrew consent|0|||
146024816|NCT02754141|526604865|FG006|Overall Study|Withdrew consent|0|||
146024817|NCT02754141|526604866|FG007|Overall Study|Withdrew consent|0|||
146024818|NCT02754141|526604867|FG008|Overall Study|Withdrew consent|0|||
146024819|NCT02754141|526604868|FG009|Overall Study|Withdrew consent|1|||
146024820|NCT02754141|526604869|FG010|Overall Study|Withdrew consent|0|||
146253812|NCT00603278|527440869|FG001|Overall Study|Lack of Efficacy|10|||
146253813|NCT00603278|527440870|FG002|Overall Study|Lack of Efficacy|11|||
146024821|NCT02754141|526604870|FG011|Overall Study|Withdrew consent|0|||
146024822|NCT02754141|526604871|FG012|Overall Study|Withdrew consent|0|||
146024823|NCT02754141|526604872|FG013|Overall Study|Withdrew consent|0|||
146024824|NCT02754141|526604873|FG014|Overall Study|Withdrew consent|0|||
146024825|NCT02754141|526604874|FG015|Overall Study|Withdrew consent|0|||
146024826|NCT02754141|526604875|FG016|Overall Study|Withdrew consent|0|||
146024827|NCT02754141|526604876|FG017|Overall Study|Withdrew consent|0|||
146024828|NCT02754141|526604859|FG000|Overall Study|Maximum clinical benefit|0|||
146024829|NCT02754141|526604860|FG001|Overall Study|Maximum clinical benefit|0|||
146024830|NCT02754141|526604861|FG002|Overall Study|Maximum clinical benefit|0|||
146024831|NCT02754141|526604862|FG003|Overall Study|Maximum clinical benefit|1|||
146024832|NCT02754141|526604863|FG004|Overall Study|Maximum clinical benefit|0|||
146024833|NCT02754141|526604864|FG005|Overall Study|Maximum clinical benefit|0|||
146024834|NCT02754141|526604865|FG006|Overall Study|Maximum clinical benefit|0|||
146024835|NCT02754141|526604866|FG007|Overall Study|Maximum clinical benefit|0|||
146024836|NCT02754141|526604867|FG008|Overall Study|Maximum clinical benefit|0|||
146024837|NCT02754141|526604868|FG009|Overall Study|Maximum clinical benefit|0|||
146024838|NCT02754141|526604869|FG010|Overall Study|Maximum clinical benefit|0|||
146024839|NCT02754141|526604870|FG011|Overall Study|Maximum clinical benefit|0|||
146024840|NCT02754141|526604871|FG012|Overall Study|Maximum clinical benefit|0|||
146024841|NCT02754141|526604872|FG013|Overall Study|Maximum clinical benefit|0|||
146024842|NCT02754141|526604873|FG014|Overall Study|Maximum clinical benefit|0|||
146024843|NCT02754141|526604874|FG015|Overall Study|Maximum clinical benefit|0|||
146024844|NCT02754141|526604875|FG016|Overall Study|Maximum clinical benefit|0|||
146024845|NCT02754141|526604876|FG017|Overall Study|Maximum clinical benefit|0|||
146024846|NCT02754141|526604859|FG000|Overall Study|No longer meets study criteria|0|||
146024847|NCT02754141|526604860|FG001|Overall Study|No longer meets study criteria|0|||
146024848|NCT02754141|526604861|FG002|Overall Study|No longer meets study criteria|0|||
146024849|NCT02754141|526604862|FG003|Overall Study|No longer meets study criteria|1|||
146024850|NCT02754141|526604863|FG004|Overall Study|No longer meets study criteria|0|||
146024851|NCT02754141|526604864|FG005|Overall Study|No longer meets study criteria|0|||
146024852|NCT02754141|526604865|FG006|Overall Study|No longer meets study criteria|0|||
146024853|NCT02754141|526604866|FG007|Overall Study|No longer meets study criteria|0|||
146024854|NCT02754141|526604867|FG008|Overall Study|No longer meets study criteria|0|||
146024855|NCT02754141|526604868|FG009|Overall Study|No longer meets study criteria|0|||
146024856|NCT02754141|526604869|FG010|Overall Study|No longer meets study criteria|0|||
146024857|NCT02754141|526604870|FG011|Overall Study|No longer meets study criteria|0|||
146024858|NCT02754141|526604871|FG012|Overall Study|No longer meets study criteria|0|||
146024859|NCT02754141|526604872|FG013|Overall Study|No longer meets study criteria|0|||
146024860|NCT02754141|526604873|FG014|Overall Study|No longer meets study criteria|0|||
146024861|NCT02754141|526604874|FG015|Overall Study|No longer meets study criteria|0|||
146024862|NCT02754141|526604875|FG016|Overall Study|No longer meets study criteria|0|||
146024863|NCT02754141|526604876|FG017|Overall Study|No longer meets study criteria|0|||
146024864|NCT02754141|526604859|FG000|Overall Study|Other reasons|0|||
146024865|NCT02754141|526604860|FG001|Overall Study|Other reasons|0|||
146253814|NCT00603278|527440871|FG003|Overall Study|Lack of Efficacy|8|||
146253815|NCT00603278|527440872|FG004|Overall Study|Lack of Efficacy|7|||
146253816|NCT00603278|527440873|FG005|Overall Study|Lack of Efficacy|14|||
146253817|NCT00603278|527440868|FG000|Overall Study|Adverse Event|0|||
146253818|NCT00603278|527440869|FG001|Overall Study|Adverse Event|3|||
146253819|NCT00603278|527440870|FG002|Overall Study|Adverse Event|1|||
146253820|NCT00603278|527440871|FG003|Overall Study|Adverse Event|0|||
146253821|NCT00603278|527440872|FG004|Overall Study|Adverse Event|2|||
146253822|NCT00603278|527440873|FG005|Overall Study|Adverse Event|1|||
146253823|NCT00603278|527440868|FG000|Overall Study|Withdrawal by Subject|2|||
146024866|NCT02754141|526604861|FG002|Overall Study|Other reasons|0|||
146024867|NCT02754141|526604862|FG003|Overall Study|Other reasons|0|||
146024868|NCT02754141|526604863|FG004|Overall Study|Other reasons|0|||
146024869|NCT02754141|526604864|FG005|Overall Study|Other reasons|0|||
146024870|NCT02754141|526604865|FG006|Overall Study|Other reasons|0|||
146024871|NCT02754141|526604866|FG007|Overall Study|Other reasons|1|||
146024872|NCT02754141|526604867|FG008|Overall Study|Other reasons|0|||
146024873|NCT02754141|526604868|FG009|Overall Study|Other reasons|0|||
146024874|NCT02754141|526604869|FG010|Overall Study|Other reasons|0|||
146024875|NCT02754141|526604870|FG011|Overall Study|Other reasons|0|||
146024876|NCT02754141|526604871|FG012|Overall Study|Other reasons|2|||
146024877|NCT02754141|526604872|FG013|Overall Study|Other reasons|0|||
146024878|NCT02754141|526604873|FG014|Overall Study|Other reasons|0|||
146024879|NCT02754141|526604874|FG015|Overall Study|Other reasons|0|||
146024880|NCT02754141|526604875|FG016|Overall Study|Other reasons|0|||
146094610|NCT02600351|526867848|FG001|Overall Study|Lost to Follow-up|0|||
146094611|NCT02600351|526867849|FG002|Overall Study|Lost to Follow-up|0|||
146024881|NCT02754141|526604876|FG017|Overall Study|Other reasons|0|||
146253824|NCT00603278|527440869|FG001|Overall Study|Withdrawal by Subject|3|||
146253825|NCT00603278|527440870|FG002|Overall Study|Withdrawal by Subject|1|||
146253826|NCT00603278|527440871|FG003|Overall Study|Withdrawal by Subject|2|||
146024882|NCT02754141|526604859|FG000|Overall Study|Completed treatment as per protocol|0|||
146024883|NCT02754141|526604860|FG001|Overall Study|Completed treatment as per protocol|1|||
146024884|NCT02754141|526604861|FG002|Overall Study|Completed treatment as per protocol|0|||
146024885|NCT02754141|526604862|FG003|Overall Study|Completed treatment as per protocol|0|||
146024886|NCT02754141|526604863|FG004|Overall Study|Completed treatment as per protocol|0|||
146024887|NCT02754141|526604864|FG005|Overall Study|Completed treatment as per protocol|0|||
146024888|NCT02754141|526604865|FG006|Overall Study|Completed treatment as per protocol|0|||
146024889|NCT02754141|526604866|FG007|Overall Study|Completed treatment as per protocol|0|||
146024890|NCT02754141|526604867|FG008|Overall Study|Completed treatment as per protocol|0|||
146024891|NCT02754141|526604868|FG009|Overall Study|Completed treatment as per protocol|0|||
146024892|NCT02754141|526604869|FG010|Overall Study|Completed treatment as per protocol|0|||
146024893|NCT02754141|526604870|FG011|Overall Study|Completed treatment as per protocol|0|||
146024894|NCT02754141|526604871|FG012|Overall Study|Completed treatment as per protocol|1|||
146024895|NCT02754141|526604872|FG013|Overall Study|Completed treatment as per protocol|0|||
146024896|NCT02754141|526604873|FG014|Overall Study|Completed treatment as per protocol|0|||
146024897|NCT02754141|526604874|FG015|Overall Study|Completed treatment as per protocol|0|||
146024898|NCT02754141|526604875|FG016|Overall Study|Completed treatment as per protocol|0|||
146024899|NCT02754141|526604876|FG017|Overall Study|Completed treatment as per protocol|0|||
146024900|NCT02754141|526604859|FG000|Overall Study|Not completing monotherapy|0|||
146024901|NCT02754141|526604860|FG001|Overall Study|Not completing monotherapy|0|||
146024902|NCT02754141|526604861|FG002|Overall Study|Not completing monotherapy|0|||
146024903|NCT02754141|526604862|FG003|Overall Study|Not completing monotherapy|0|||
146024904|NCT02754141|526604863|FG004|Overall Study|Not completing monotherapy|0|||
146024905|NCT02754141|526604864|FG005|Overall Study|Not completing monotherapy|0|||
146024906|NCT02754141|526604865|FG006|Overall Study|Not completing monotherapy|0|||
146024907|NCT02754141|526604866|FG007|Overall Study|Not completing monotherapy|0|||
146024908|NCT02754141|526604867|FG008|Overall Study|Not completing monotherapy|0|||
146024909|NCT02754141|526604868|FG009|Overall Study|Not completing monotherapy|0|||
146024910|NCT02754141|526604869|FG010|Overall Study|Not completing monotherapy|0|||
146024911|NCT02754141|526604870|FG011|Overall Study|Not completing monotherapy|0|||
146024912|NCT02754141|526604871|FG012|Overall Study|Not completing monotherapy|0|||
146024913|NCT02754141|526604872|FG013|Overall Study|Not completing monotherapy|1|||
146024914|NCT02754141|526604873|FG014|Overall Study|Not completing monotherapy|0|||
146024915|NCT02754141|526604874|FG015|Overall Study|Not completing monotherapy|0|||
146024916|NCT02754141|526604875|FG016|Overall Study|Not completing monotherapy|0|||
146024917|NCT02754141|526604876|FG017|Overall Study|Not completing monotherapy|0|||
146024918|NCT00623545|526604881|FG000|Overall Study|Adverse Event|6|||
146024919|NCT00623545|526604881|FG000|Overall Study|Withdrawal by Subject|4|||
146024920|NCT04239222|526604882|FG000|Baseline|Withdrawal by Subject|0|||
146024921|NCT04239222|526604883|FG001|Baseline|Withdrawal by Subject|0|||
146024922|NCT04239222|526604884|FG002|Baseline|Withdrawal by Subject|1|||
146024923|NCT04239222|526604885|FG003|Baseline|Withdrawal by Subject|1|||
146024924|NCT04239222|526604882|FG000|First Foot Assignment|Withdrawal by Subject|0|||
146024925|NCT04239222|526604883|FG001|First Foot Assignment|Withdrawal by Subject|0|||
146024926|NCT04239222|526604884|FG002|First Foot Assignment|Withdrawal by Subject|1|||
146024927|NCT04239222|526604885|FG003|First Foot Assignment|Withdrawal by Subject|0|||
146024928|NCT04239222|526604882|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146024929|NCT04239222|526604883|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146024930|NCT04239222|526604884|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
146024931|NCT04239222|526604885|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
146024932|NCT00937404|526604891|FG000|Overall Study|Protocol Violation|1|||
146024933|NCT00937404|526604891|FG000|Overall Study|Withdrawal by Subject|1|||
146024934|NCT00230282|526604896|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
146024935|NCT00230282|526604896|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
146094612|NCT02600351|526867850|FG003|Overall Study|Lost to Follow-up|0|||
146024936|NCT00230282|526604896|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
146024937|NCT00230282|526604896|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
146024938|NCT01691105|526604900|FG000|1 Month Follow-up|Lost to Follow-up|41|||
146024939|NCT01691105|526604901|FG001|1 Month Follow-up|Lost to Follow-up|38|||
146024940|NCT01691105|526604900|FG000|1 Month Follow-up|Death|2|||
146024941|NCT01691105|526604901|FG001|1 Month Follow-up|Death|3|||
146024942|NCT01691105|526604900|FG000|6 Month Follow-up|Lost to Follow-up|39|||
146024943|NCT01691105|526604901|FG001|6 Month Follow-up|Lost to Follow-up|58|||
146024944|NCT01691105|526604900|FG000|6 Month Follow-up|Death|13|||
146024945|NCT01691105|526604901|FG001|6 Month Follow-up|Death|13|||
146024946|NCT01691105|526604900|FG000|12 Month Follow-up|Lost to Follow-up|50|||
146024947|NCT01691105|526604901|FG001|12 Month Follow-up|Lost to Follow-up|71|||
146024948|NCT01691105|526604900|FG000|12 Month Follow-up|Death|22|||
146024949|NCT01691105|526604901|FG001|12 Month Follow-up|Death|30|||
146024950|NCT01691105|526604900|FG000|12 Month Biochemical Verification|Death|22|||
146024951|NCT01691105|526604901|FG001|12 Month Biochemical Verification|Death|30|||
146024952|NCT01691105|526604900|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
146024953|NCT01691105|526604901|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
146024954|NCT01691105|526604900|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
146024955|NCT01691105|526604901|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
146024956|NCT00445848|526604902|FG000|Overall Study|Adverse Event|14|||
146024957|NCT00445848|526604902|FG000|Overall Study|Withdrawal by Subject|4|||
146024958|NCT00445848|526604902|FG000|Overall Study|Progression|62|||
146024959|NCT00445848|526604902|FG000|Overall Study|Other-Not protocol specified|5|||
146024960|NCT01777542|526604907|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
146024961|NCT01777542|526604908|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
146024962|NCT00027378|526604909|FG000|Overall Study|Physician Decision|0|||
146024963|NCT00027378|526604910|FG001|Overall Study|Physician Decision|3|||
146024964|NCT05605691|526604914|FG000|Overall Study|Lost to Follow-up|1|||
146024965|NCT02279719|526604915|FG000|Overall Study|Patients randomized but never treated|0|||
146024966|NCT02279719|526604916|FG001|Overall Study|Patients randomized but never treated|0|||
146024967|NCT02279719|526604917|FG002|Overall Study|Patients randomized but never treated|0|||
146024968|NCT02279719|526604918|FG003|Overall Study|Patients randomized but never treated|0|||
146024969|NCT02279719|526604919|FG004|Overall Study|Patients randomized but never treated|3|||
146024970|NCT02279719|526604920|FG005|Overall Study|Patients randomized but never treated|0|||
146024971|NCT02279719|526604921|FG006|Overall Study|Patients randomized but never treated|3|||
146024972|NCT04706273|526604922|FG000|Overall Study|Withdrawal by Subject|27|||
146024973|NCT04706273|526604922|FG000|Overall Study|Physician Decision|1|||
146024974|NCT04706273|526604922|FG000|Overall Study|Lost to Follow-up|42|||
146024975|NCT04706273|526604922|FG000|Overall Study|Death|85|||
146024976|NCT04706273|526604922|FG000|Overall Study|Amputation that removes study device|2|||
146024977|NCT04706273|526604922|FG000|Overall Study|Surgical bypass|3|||
146024978|NCT04706273|526604922|FG000|Overall Study|Changing hospital|23|||
146024979|NCT04706273|526604922|FG000|Overall Study|Unable to attend hospital|2|||
146024980|NCT02701777|526604923|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
146024981|NCT02701777|526604924|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
146024982|NCT02701777|526604925|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
146024983|NCT02701777|526604926|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
146024984|NCT02701777|526604923|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
146024985|NCT02701777|526604924|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
146024986|NCT02701777|526604925|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
146024987|NCT02701777|526604926|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
146024988|NCT03199053|526604929|FG000|ST Period|Withdrawal by Subject|2|||
146024989|NCT03199053|526604930|FG001|ST Period|Withdrawal by Subject|4|||
146024990|NCT03199053|526604931|FG002|ST Period|Withdrawal by Subject|6|||
146024991|NCT03199053|526604929|FG000|ST Period|Withdrawal by parent/guardian|1|||
146024992|NCT03199053|526604930|FG001|ST Period|Withdrawal by parent/guardian|1|||
146024993|NCT03199053|526604931|FG002|ST Period|Withdrawal by parent/guardian|1|||
146024994|NCT03199053|526604929|FG000|ST Period|Lost to Follow-up|2|||
146024995|NCT03199053|526604930|FG001|ST Period|Lost to Follow-up|0|||
146024996|NCT03199053|526604931|FG002|ST Period|Lost to Follow-up|1|||
146024997|NCT03199053|526604929|FG000|LT Period|Withdrawal by Subject|1|||
146024998|NCT03199053|526604930|FG001|LT Period|Withdrawal by Subject|3|||
146024999|NCT03199053|526604931|FG002|LT Period|Withdrawal by Subject|3|||
146025000|NCT03199053|526604929|FG000|LT Period|Withdrawal by parent/guardian|0|||
146025001|NCT03199053|526604930|FG001|LT Period|Withdrawal by parent/guardian|0|||
146025002|NCT03199053|526604931|FG002|LT Period|Withdrawal by parent/guardian|1|||
146025003|NCT03199053|526604929|FG000|LT Period|Lost to Follow-up|0|||
146025004|NCT03199053|526604930|FG001|LT Period|Lost to Follow-up|1|||
146025005|NCT03199053|526604931|FG002|LT Period|Lost to Follow-up|1|||
146025006|NCT03199053|526604929|FG000|LT Period|Miscellaneous|0|||
146025007|NCT03199053|526604930|FG001|LT Period|Miscellaneous|0|||
146025008|NCT03199053|526604931|FG002|LT Period|Miscellaneous|2|||
146025009|NCT03199053|526604929|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
146025010|NCT03199053|526604930|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
146025011|NCT03199053|526604931|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
146025012|NCT03199053|526604929|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
146025013|NCT03199053|526604930|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
146025014|NCT03199053|526604931|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
146025015|NCT03199053|526604929|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
146025016|NCT03199053|526604930|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
146025017|NCT03199053|526604931|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
146025018|NCT03199053|526604929|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
146025019|NCT03199053|526604930|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
146025020|NCT03199053|526604931|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
146025021|NCT03298984|526604932|FG000|Overall Study|Physician Decision|1|||
146025022|NCT03298984|526604933|FG001|Overall Study|Physician Decision|0|||
146025023|NCT03298984|526604934|FG002|Overall Study|Physician Decision|0|||
146025024|NCT03298984|526604935|FG003|Overall Study|Physician Decision|6|||
146025025|NCT03298984|526604932|FG000|Overall Study|Lack of Efficacy|0|||
146025026|NCT03298984|526604933|FG001|Overall Study|Lack of Efficacy|1|||
146025027|NCT03298984|526604934|FG002|Overall Study|Lack of Efficacy|1|||
146025028|NCT03298984|526604935|FG003|Overall Study|Lack of Efficacy|4|||
146025029|NCT03298984|526604932|FG000|Overall Study|Relapsed disease (following remission)|0|||
146025030|NCT03298984|526604933|FG001|Overall Study|Relapsed disease (following remission)|0|||
146025031|NCT03298984|526604934|FG002|Overall Study|Relapsed disease (following remission)|1|||
146025032|NCT03298984|526604935|FG003|Overall Study|Relapsed disease (following remission)|1|||
146025033|NCT03298984|526604932|FG000|Overall Study|Adverse Event|0|||
146025034|NCT03298984|526604933|FG001|Overall Study|Adverse Event|0|||
146025035|NCT03298984|526604934|FG002|Overall Study|Adverse Event|0|||
146025036|NCT03298984|526604935|FG003|Overall Study|Adverse Event|1|||
146025037|NCT03298984|526604932|FG000|Overall Study|Death|0|||
146025038|NCT03298984|526604933|FG001|Overall Study|Death|0|||
146025039|NCT03298984|526604934|FG002|Overall Study|Death|0|||
146025040|NCT03298984|526604935|FG003|Overall Study|Death|2|||
146025041|NCT03298984|526604932|FG000|Overall Study|Insurance Company Decision|0|||
146025042|NCT03298984|526604933|FG001|Overall Study|Insurance Company Decision|0|||
146025043|NCT03298984|526604934|FG002|Overall Study|Insurance Company Decision|0|||
146025044|NCT03298984|526604935|FG003|Overall Study|Insurance Company Decision|1|||
146025045|NCT02403635|526604938|FG000|Overall Study|Not eligible|9|||
146025046|NCT02585830|526604942|FG000|Overall Study|Withdrawal by Subject|3|||
146025047|NCT02509052|526604943|FG000|Overall Study|Non compliance|0|||
146025048|NCT02509052|526604944|FG001|Overall Study|Non compliance|0|||
146025049|NCT02509052|526604945|FG002|Overall Study|Non compliance|1|||
146025050|NCT00585221|526604946|FG000|Overall Study|Protocol Violation|8|||
146025051|NCT03263923|526604947|FG000|Overall Study|Withdrawal by Subject|10|||
146025052|NCT03263923|526604948|FG001|Overall Study|Withdrawal by Subject|8|||
146025053|NCT03263923|526604947|FG000|Overall Study|Lost to Follow-up|15|||
146025054|NCT03263923|526604948|FG001|Overall Study|Lost to Follow-up|13|||
146025055|NCT02098369|526604949|FG000|Overall Study|Withdrawal by Subject|1|||
146025056|NCT02098369|526604950|FG001|Overall Study|Withdrawal by Subject|5|||
146025057|NCT02098369|526604951|FG002|Overall Study|Withdrawal by Subject|0|||
146025058|NCT02098369|526604949|FG000|Overall Study|Lost to Follow-up|5|||
146025059|NCT02098369|526604950|FG001|Overall Study|Lost to Follow-up|1|||
146025060|NCT02098369|526604951|FG002|Overall Study|Lost to Follow-up|3|||
146025061|NCT02098369|526604949|FG000|Overall Study|Death|1|||
146025062|NCT02098369|526604950|FG001|Overall Study|Death|1|||
146025063|NCT02098369|526604951|FG002|Overall Study|Death|1|||
146025064|NCT02098369|526604949|FG000|Overall Study|Other|0|||
146025065|NCT02098369|526604950|FG001|Overall Study|Other|2|||
146025066|NCT02098369|526604951|FG002|Overall Study|Other|1|||
146025067|NCT03362931|526604953|FG000|Overall Study|Adverse Event|1|||
146025068|NCT03362931|526604953|FG000|Overall Study|Death|2|||
146025069|NCT01323270|526604954|FG000|Overall Study|Withdrawal by Subject|19|||
146025070|NCT01323270|526604955|FG001|Overall Study|Withdrawal by Subject|10|||
146025071|NCT01323270|526604954|FG000|Overall Study|Protocol Violation|9|||
146025072|NCT01323270|526604955|FG001|Overall Study|Protocol Violation|7|||
146025073|NCT01323270|526604954|FG000|Overall Study|Lost to Follow-up|4|||
146025074|NCT01323270|526604955|FG001|Overall Study|Lost to Follow-up|6|||
146025075|NCT01323270|526604954|FG000|Overall Study|Adverse Event|8|||
146025076|NCT01323270|526604955|FG001|Overall Study|Adverse Event|0|||
146025077|NCT01323270|526604954|FG000|Overall Study|Other|0|||
146025078|NCT01323270|526604955|FG001|Overall Study|Other|3|||
146025079|NCT01323270|526604954|FG000|Overall Study|Physician Decision|0|||
146025080|NCT01323270|526604955|FG001|Overall Study|Physician Decision|2|||
146025081|NCT01323270|526604954|FG000|Overall Study|Not eligible|1|||
146025082|NCT01323270|526604955|FG001|Overall Study|Not eligible|1|||
146025083|NCT01323270|526604954|FG000|Overall Study|Death|1|||
146025084|NCT01323270|526604955|FG001|Overall Study|Death|0|||
146025085|NCT01323270|526604954|FG000|Overall Study|Randomized, but not vaccinated|1|||
146025086|NCT01323270|526604955|FG001|Overall Study|Randomized, but not vaccinated|0|||
146025087|NCT02229214|526604957|FG000|Overall Study|Adverse Event|2|||
146025088|NCT02229214|526604958|FG001|Overall Study|Adverse Event|0|||
146025089|NCT02229214|526604957|FG000|Overall Study|Withdrawal by Subject|4|||
146025090|NCT02229214|526604958|FG001|Overall Study|Withdrawal by Subject|0|||
146025091|NCT04677660|526604959|FG000|Overall Study|Lost to Follow-up|0|||
146025092|NCT04677660|526604960|FG001|Overall Study|Lost to Follow-up|2|||
146025093|NCT04677660|526604959|FG000|Overall Study|Withdrawal by Subject|0|||
146025094|NCT04677660|526604960|FG001|Overall Study|Withdrawal by Subject|1|||
146025095|NCT04677660|526604959|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
146025096|NCT04677660|526604960|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
146025097|NCT04065074|526604961|FG000|Overall Study|Adverse Event|1|||
146025098|NCT04065074|526604961|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
146025099|NCT01560637|526604962|FG000|Overall Study|Adverse Event|63|||
146025100|NCT01560637|526604962|FG000|Overall Study|Death|69|||
146025101|NCT01560637|526604962|FG000|Overall Study|Lost to Follow-up|8|||
146025102|NCT01560637|526604962|FG000|Overall Study|Protocol Violation|8|||
146025103|NCT01560637|526604962|FG000|Overall Study|Withdrawal by Subject|24|||
146025104|NCT01560637|526604962|FG000|Overall Study|Progressive Disease|20|||
146025105|NCT01560637|526604962|FG000|Overall Study|Other Reason Not Specified|6|||
146025106|NCT01185964|526604965|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
146025107|NCT01185964|526604966|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
146025108|NCT01185964|526604967|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
146025109|NCT01185964|526604968|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
146025110|NCT01185964|526604965|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
146025111|NCT01185964|526604966|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
146025112|NCT01185964|526604967|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
146025113|NCT01185964|526604968|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
146025114|NCT01185964|526604965|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146025115|NCT01185964|526604966|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146025116|NCT01185964|526604967|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
146025117|NCT01185964|526604968|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
146025118|NCT01185964|526604965|FG000|Phase 1b and Phase 2|Adverse Event|1|||
146025119|NCT01185964|526604966|FG001|Phase 1b and Phase 2|Adverse Event|0|||
146025120|NCT01185964|526604967|FG002|Phase 1b and Phase 2|Adverse Event|2|||
146025121|NCT01185964|526604968|FG003|Phase 1b and Phase 2|Adverse Event|0|||
146025122|NCT01185964|526604965|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
146025123|NCT01185964|526604966|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
146025124|NCT01185964|526604967|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
146025125|NCT01185964|526604968|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
146025126|NCT01185964|526604965|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146025127|NCT01185964|526604966|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146025128|NCT01185964|526604967|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
146025129|NCT01185964|526604968|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
146025130|NCT01185964|526604965|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146025131|NCT01185964|526604966|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146025132|NCT01185964|526604967|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
146025133|NCT01185964|526604968|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
146025134|NCT01185964|526604965|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146025135|NCT01185964|526604966|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146025136|NCT01185964|526604967|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
146025137|NCT01185964|526604968|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
146025138|NCT03444766|526604969|FG000|Overall Study|Other Reasons|2|||
146025139|NCT03444766|526604969|FG000|Overall Study|Participant Withdrew Consent|5|||
146025140|NCT03444766|526604969|FG000|Overall Study|Lost to Follow-up|2|||
146025141|NCT03444766|526604969|FG000|Overall Study|Death|2|||
146025142|NCT03444766|526604969|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
146025143|NCT03444766|526604969|FG000|Overall Study|Disease Progression|49|||
146025144|NCT04346108|526604970|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
146025145|NCT04346108|526604971|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
146025146|NCT04346108|526604972|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
146025147|NCT04346108|526604970|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
146025148|NCT04346108|526604971|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
146025149|NCT04346108|526604972|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
146025150|NCT01081301|526604973|FG000|Overall Study|Bereaved|3|||
146025151|NCT01081301|526604973|FG000|Overall Study|Too busy|5|||
146025152|NCT01081301|526604973|FG000|Overall Study|Patient too ill|2|||
146025153|NCT01081301|526604973|FG000|Overall Study|Lost to Follow-up|4|||
146025154|NCT00724854|526604974|FG000|Overall Study|Lack of Efficacy|187|||
146025155|NCT00724854|526604975|FG001|Overall Study|Lack of Efficacy|13|||
146025156|NCT00724854|526604974|FG000|Overall Study|Lost to Follow-up|87|||
146025157|NCT00724854|526604975|FG001|Overall Study|Lost to Follow-up|10|||
146025158|NCT00724854|526604974|FG000|Overall Study|Adverse Event|62|||
146025159|NCT00724854|526604975|FG001|Overall Study|Adverse Event|4|||
146025160|NCT00724854|526604974|FG000|Overall Study|Other|42|||
146025161|NCT00724854|526604975|FG001|Overall Study|Other|3|||
146094613|NCT02600351|526867847|FG000|Overall Study|Randomized but Not Treated|1|||
146300290|NCT01020448|527615201|FG000|Treatment|Lack of Efficacy|8|||
146025162|NCT00724854|526604974|FG000|Overall Study|Death|11|||
146025163|NCT00724854|526604975|FG001|Overall Study|Death|0|||
146025164|NCT00724854|526604974|FG000|Overall Study|Change of treatment|7|||
146025165|NCT00724854|526604975|FG001|Overall Study|Change of treatment|0|||
146025166|NCT00724854|526604974|FG000|Overall Study|Withdrawal by Subject|5|||
146025167|NCT00724854|526604975|FG001|Overall Study|Withdrawal by Subject|0|||
146025168|NCT00724854|526604974|FG000|Overall Study|Adverse event + lack of efficacy|2|||
146025169|NCT00724854|526604975|FG001|Overall Study|Adverse event + lack of efficacy|1|||
146025170|NCT02046226|526604976|FG000|Overall Study|Lost to Follow-up|7|||
146025171|NCT01095653|526604977|FG000|Overall Study|Lack of Efficacy|3|||
146025172|NCT01095653|526604978|FG001|Overall Study|Lack of Efficacy|0|||
146025173|NCT01095653|526604979|FG002|Overall Study|Lack of Efficacy|0|||
146025174|NCT01095653|526604977|FG000|Overall Study|Adverse Event|1|||
146025175|NCT01095653|526604978|FG001|Overall Study|Adverse Event|4|||
146025176|NCT01095653|526604979|FG002|Overall Study|Adverse Event|4|||
146094614|NCT02600351|526867848|FG001|Overall Study|Randomized but Not Treated|0|||
146025177|NCT01095653|526604977|FG000|Overall Study|Lost to Follow-up|1|||
146025178|NCT01095653|526604978|FG001|Overall Study|Lost to Follow-up|0|||
146025179|NCT01095653|526604979|FG002|Overall Study|Lost to Follow-up|4|||
146025180|NCT01095653|526604977|FG000|Overall Study|Withdrawal by Subject|4|||
146025181|NCT01095653|526604978|FG001|Overall Study|Withdrawal by Subject|5|||
146025182|NCT01095653|526604979|FG002|Overall Study|Withdrawal by Subject|3|||
146025183|NCT01095653|526604977|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
146025184|NCT01095653|526604978|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
146025185|NCT01095653|526604979|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
146025186|NCT00171925|526604980|FG000|Overall Study|Adverse Event|10|||
146025187|NCT00171925|526604981|FG001|Overall Study|Adverse Event|6|||
146025188|NCT00171925|526604980|FG000|Overall Study|Protocol Violation|1|||
146025189|NCT00171925|526604981|FG001|Overall Study|Protocol Violation|1|||
146025190|NCT00171925|526604980|FG000|Overall Study|Withdrawal by Subject|6|||
146025191|NCT00171925|526604981|FG001|Overall Study|Withdrawal by Subject|9|||
146025192|NCT00171925|526604980|FG000|Overall Study|Lost to Follow-up|2|||
146025193|NCT00171925|526604981|FG001|Overall Study|Lost to Follow-up|2|||
146025194|NCT00171925|526604980|FG000|Overall Study|Administrative problems|10|||
146025195|NCT00171925|526604981|FG001|Overall Study|Administrative problems|11|||
146025196|NCT00171925|526604980|FG000|Overall Study|Death|1|||
146025197|NCT00171925|526604981|FG001|Overall Study|Death|2|||
146025198|NCT02182440|526604982|FG000|Overall Study|Adverse Event|0|||
146025199|NCT02182440|526604983|FG001|Overall Study|Adverse Event|1|||
146025200|NCT02182440|526604984|FG002|Overall Study|Adverse Event|0|||
146025201|NCT02182440|526604985|FG003|Overall Study|Adverse Event|0|||
146025202|NCT02182440|526604982|FG000|Overall Study|Death|31|||
146025203|NCT02182440|526604983|FG001|Overall Study|Death|8|||
146025204|NCT02182440|526604984|FG002|Overall Study|Death|5|||
146025205|NCT02182440|526604985|FG003|Overall Study|Death|16|||
146025206|NCT02182440|526604982|FG000|Overall Study|Protocol Violation|0|||
146025207|NCT02182440|526604983|FG001|Overall Study|Protocol Violation|1|||
146025208|NCT02182440|526604984|FG002|Overall Study|Protocol Violation|0|||
146025209|NCT02182440|526604985|FG003|Overall Study|Protocol Violation|0|||
146025210|NCT02182440|526604982|FG000|Overall Study|Physician Decision|1|||
146025211|NCT02182440|526604983|FG001|Overall Study|Physician Decision|0|||
146025212|NCT02182440|526604984|FG002|Overall Study|Physician Decision|0|||
146025213|NCT02182440|526604985|FG003|Overall Study|Physician Decision|0|||
146025214|NCT02182440|526604982|FG000|Overall Study|Withdrawal by Subject|1|||
146025215|NCT02182440|526604983|FG001|Overall Study|Withdrawal by Subject|1|||
146025216|NCT02182440|526604984|FG002|Overall Study|Withdrawal by Subject|3|||
146025217|NCT02182440|526604985|FG003|Overall Study|Withdrawal by Subject|4|||
146025218|NCT02182440|526604982|FG000|Overall Study|different, e.g adm other hospital|12|||
146025219|NCT02182440|526604983|FG001|Overall Study|different, e.g adm other hospital|3|||
146025220|NCT02182440|526604984|FG002|Overall Study|different, e.g adm other hospital|3|||
146025221|NCT02182440|526604985|FG003|Overall Study|different, e.g adm other hospital|10|||
146025222|NCT03754582|526604986|FG000|Treatment Phase|Adverse Event|0|||
146025223|NCT03754582|526604987|FG001|Treatment Phase|Adverse Event|1|||
146025224|NCT03754582|526604988|FG002|Treatment Phase|Adverse Event|0|||
146025225|NCT03754582|526604986|FG000|Follow-up Phase|Other|0|||
146025226|NCT03754582|526604987|FG001|Follow-up Phase|Other|0|||
146025227|NCT03754582|526604988|FG002|Follow-up Phase|Other|1|||
146025228|NCT01799239|526604989|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
146025229|NCT01799239|526604990|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
146025230|NCT01799239|526604989|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
146025231|NCT01799239|526604990|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
146025232|NCT01799239|526604989|FG000|Period 1 (7 Days)|Protocol Violation|0|||
146025233|NCT01799239|526604990|FG001|Period 1 (7 Days)|Protocol Violation|1|||
146025234|NCT01799239|526604989|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
146025235|NCT01799239|526604990|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
146025236|NCT01799239|526604989|FG000|Period 2 (7 Days)|Protocol Violation|1|||
146025237|NCT01799239|526604990|FG001|Period 2 (7 Days)|Protocol Violation|0|||
146025238|NCT01561755|526604993|FG000|Overall Study|Lost to Follow-up|0|||
146025239|NCT01561755|526604994|FG001|Overall Study|Lost to Follow-up|1|||
146025240|NCT01166958|526604995|FG000|Overall Study|Withdrawal by Subject|1|||
146025241|NCT01166958|526604996|FG001|Overall Study|Withdrawal by Subject|0|||
146025242|NCT02680574|526604997|FG000|Overall Study|Death|137|||
146025243|NCT02680574|526604998|FG001|Overall Study|Death|137|||
146025244|NCT02680574|526604997|FG000|Overall Study|Withdrawal by Subject|17|||
146025245|NCT02680574|526604998|FG001|Overall Study|Withdrawal by Subject|9|||
146025246|NCT02680574|526604997|FG000|Overall Study|Lost to Follow-up|4|||
146025247|NCT02680574|526604998|FG001|Overall Study|Lost to Follow-up|6|||
146025248|NCT01286987|526604999|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
146025249|NCT01286987|526605000|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
146025250|NCT01286987|526605001|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
146025251|NCT01286987|526605002|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
146025252|NCT01286987|526605003|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
146025253|NCT01286987|526605004|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
146025254|NCT01286987|526605005|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
146025255|NCT01286987|526605006|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
146025256|NCT01286987|526605007|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
146025257|NCT01286987|526605008|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
146025258|NCT01286987|526605009|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
146025259|NCT01286987|526605010|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
146025260|NCT01286987|526605011|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
146025261|NCT01286987|526605012|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
146025262|NCT01286987|526605013|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
146025263|NCT01286987|526604999|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
146025264|NCT01286987|526605000|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
146025265|NCT01286987|526605001|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
146025266|NCT01286987|526605002|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
146025267|NCT01286987|526605003|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
146025268|NCT01286987|526605004|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
146025269|NCT01286987|526605005|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
146025270|NCT01286987|526605006|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
146025271|NCT01286987|526605007|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
146025272|NCT01286987|526605008|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
146025273|NCT01286987|526605009|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
146025274|NCT01286987|526605010|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
146025275|NCT01286987|526605011|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
146025276|NCT01286987|526605012|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
146025277|NCT01286987|526605013|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
146025278|NCT01286987|526604999|FG000|Part 1: Dose Escalation|Physician Decision|0|||
146025279|NCT01286987|526605000|FG001|Part 1: Dose Escalation|Physician Decision|0|||
146025280|NCT01286987|526605001|FG002|Part 1: Dose Escalation|Physician Decision|0|||
146025281|NCT01286987|526605002|FG003|Part 1: Dose Escalation|Physician Decision|0|||
146025282|NCT01286987|526605003|FG004|Part 1: Dose Escalation|Physician Decision|1|||
146025283|NCT01286987|526605004|FG005|Part 1: Dose Escalation|Physician Decision|0|||
146025284|NCT01286987|526605005|FG006|Part 1: Dose Escalation|Physician Decision|0|||
146025285|NCT01286987|526605006|FG007|Part 1: Dose Escalation|Physician Decision|0|||
146025286|NCT01286987|526605007|FG008|Part 1: Dose Escalation|Physician Decision|0|||
146025287|NCT01286987|526605008|FG009|Part 1: Dose Escalation|Physician Decision|0|||
146025288|NCT01286987|526605009|FG010|Part 1: Dose Escalation|Physician Decision|0|||
146025289|NCT01286987|526605010|FG011|Part 1: Dose Escalation|Physician Decision|0|||
146025290|NCT01286987|526605011|FG012|Part 1: Dose Escalation|Physician Decision|0|||
146025291|NCT01286987|526605012|FG013|Part 1: Dose Escalation|Physician Decision|0|||
146025292|NCT01286987|526605013|FG014|Part 1: Dose Escalation|Physician Decision|0|||
146025293|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Death|0|||
146025294|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Death|0|||
146025295|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Death|0|||
146025296|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Death|0|||
146025297|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Death|0|||
146025298|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Death|0|||
146025299|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Death|0|||
146025300|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Death|0|||
146025301|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Death|0|||
146025302|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Death|0|||
146025303|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Death|0|||
146025304|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Death|0|||
146025305|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Death|1|||
146025306|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Death|1|||
146025307|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Death|0|||
146025308|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Physician Decision|0|||
146025309|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Physician Decision|0|||
146025310|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Physician Decision|0|||
146025311|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Physician Decision|0|||
146025312|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Physician Decision|0|||
146025313|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Physician Decision|0|||
146025314|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Physician Decision|0|||
146025315|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Physician Decision|0|||
146025316|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Physician Decision|0|||
146025317|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Physician Decision|0|||
146025318|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Physician Decision|1|||
146025319|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Physician Decision|1|||
146025320|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Physician Decision|0|||
146025321|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Physician Decision|1|||
146025322|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Physician Decision|0|||
146025323|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Other|0|||
146025324|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Other|0|||
146025325|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Other|0|||
146025326|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Other|0|||
146025327|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Other|0|||
146025328|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Other|0|||
146025329|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Other|0|||
146025330|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Other|0|||
146025331|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Other|0|||
146025332|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Other|0|||
146025333|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Other|0|||
146025334|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Other|0|||
146025335|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Other|0|||
146025336|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Other|1|||
146025337|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Other|0|||
146025338|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
146025339|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
146025340|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
146025341|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
146025342|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
146025343|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
146025344|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
146025345|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
146025346|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
146025347|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
146025348|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
146025349|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
146025350|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
146025351|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
146025352|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
146025353|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
146025354|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
146025355|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
146025356|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
146025357|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
146025358|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
146025359|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
146025360|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
146025361|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
146025362|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
146025363|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
146025364|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
146025365|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
146025366|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
146025367|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
146025368|NCT01286987|526604999|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025369|NCT01286987|526605000|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025370|NCT01286987|526605001|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025371|NCT01286987|526605002|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025372|NCT01286987|526605003|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025373|NCT01286987|526605004|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025374|NCT01286987|526605005|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025375|NCT01286987|526605006|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025376|NCT01286987|526605007|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025377|NCT01286987|526605008|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025378|NCT01286987|526605009|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
146025379|NCT01286987|526605010|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025380|NCT01286987|526605011|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025381|NCT01286987|526605012|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025382|NCT01286987|526605013|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
146025383|NCT00681564|526605018|FG000|Overall Study|Lost to Follow-up|6|||
146025384|NCT00681564|526605019|FG001|Overall Study|Lost to Follow-up|6|||
146025385|NCT00681564|526605018|FG000|Overall Study|Withdrawal by Subject|0|||
146025386|NCT00681564|526605019|FG001|Overall Study|Withdrawal by Subject|1|||
146025387|NCT00681564|526605018|FG000|Overall Study|Death|0|||
146025388|NCT00681564|526605019|FG001|Overall Study|Death|1|||
146025389|NCT02826421|526605020|FG000|Overall Study|Adverse Event|1|||
146025390|NCT02826421|526605021|FG001|Overall Study|Adverse Event|0|||
146025391|NCT02826421|526605022|FG002|Overall Study|Adverse Event|0|||
146025392|NCT02826421|526605023|FG003|Overall Study|Adverse Event|1|||
146025393|NCT02826421|526605020|FG000|Overall Study|Withdrawal by Subject|1|||
146025394|NCT02826421|526605021|FG001|Overall Study|Withdrawal by Subject|3|||
146025395|NCT02826421|526605022|FG002|Overall Study|Withdrawal by Subject|1|||
146025396|NCT02826421|526605023|FG003|Overall Study|Withdrawal by Subject|1|||
146025397|NCT02826421|526605020|FG000|Overall Study|Reason not given|1|||
146025398|NCT02826421|526605021|FG001|Overall Study|Reason not given|0|||
146025399|NCT02826421|526605022|FG002|Overall Study|Reason not given|1|||
146025400|NCT02826421|526605023|FG003|Overall Study|Reason not given|0|||
146025401|NCT02210221|526605028|FG000|Overall Study|Lack of Efficacy|7|||
146025402|NCT02210221|526605028|FG000|Overall Study|Withdrawal by Subject|43|||
146025403|NCT02185014|526605031|FG000|Overall Study|Adverse Event|18|||
146025404|NCT02185014|526605031|FG000|Overall Study|Withdrew Consent|8|||
146025405|NCT02185014|526605031|FG000|Overall Study|Lost to Follow-up|4|||
146025406|NCT02185014|526605031|FG000|Overall Study|Lack of Efficacy|14|||
146025407|NCT02185014|526605031|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
146025408|NCT02185014|526605031|FG000|Overall Study|Subject Noncompliance|1|||
146025409|NCT02185014|526605031|FG000|Overall Study|Other|4|||
146025410|NCT00392808|526605032|FG000|Overall Study|Lost to Follow-up|3|||
146025411|NCT00392808|526605033|FG001|Overall Study|Lost to Follow-up|2|||
146025412|NCT00392808|526605034|FG002|Overall Study|Lost to Follow-up|1|||
146025413|NCT00392808|526605035|FG003|Overall Study|Lost to Follow-up|2|||
146025414|NCT00392808|526605032|FG000|Overall Study|Unable to withdraw blood|3|||
146025415|NCT00392808|526605033|FG001|Overall Study|Unable to withdraw blood|1|||
146025416|NCT00392808|526605034|FG002|Overall Study|Unable to withdraw blood|1|||
146025417|NCT00392808|526605035|FG003|Overall Study|Unable to withdraw blood|2|||
146025418|NCT02649855|526605036|FG000|Overall Study|Refused further treatment|2|||
146025419|NCT02649855|526605037|FG001|Overall Study|Refused further treatment|1|||
146025420|NCT02649855|526605038|FG002|Overall Study|Refused further treatment|1|||
146025421|NCT02649855|526605036|FG000|Overall Study|Withdrew consent|0|||
146025422|NCT02649855|526605037|FG001|Overall Study|Withdrew consent|1|||
146025423|NCT02649855|526605038|FG002|Overall Study|Withdrew consent|0|||
146025424|NCT02649855|526605036|FG000|Overall Study|Switched to alternative treatment|0|||
146025425|NCT02649855|526605037|FG001|Overall Study|Switched to alternative treatment|1|||
146025426|NCT02649855|526605038|FG002|Overall Study|Switched to alternative treatment|1|||
146025427|NCT02649855|526605036|FG000|Overall Study|Principal investigator discretion|0|||
146025428|NCT02649855|526605037|FG001|Overall Study|Principal investigator discretion|1|||
146025429|NCT02649855|526605038|FG002|Overall Study|Principal investigator discretion|1|||
146025430|NCT02649855|526605036|FG000|Overall Study|No treatment, per protocol|1|||
146025431|NCT02649855|526605037|FG001|Overall Study|No treatment, per protocol|0|||
146025432|NCT02649855|526605038|FG002|Overall Study|No treatment, per protocol|0|||
146025433|NCT02649855|526605036|FG000|Overall Study|Initiate new treatment|1|||
146025434|NCT02649855|526605037|FG001|Overall Study|Initiate new treatment|0|||
146025435|NCT02649855|526605038|FG002|Overall Study|Initiate new treatment|0|||
146025436|NCT02653495|526605039|FG000|Overall Study|Lost to Follow-up|2|||
146025437|NCT02653495|526605040|FG001|Overall Study|Lost to Follow-up|0|||
146025438|NCT02653495|526605039|FG000|Overall Study|Screening Failure|10|||
146025439|NCT02653495|526605040|FG001|Overall Study|Screening Failure|0|||
146025440|NCT03966885|526607201|FG000|Overall Study|Death|1|||
146025441|NCT03966885|526607202|FG001|Overall Study|Death|0|||
146025442|NCT03966885|526607201|FG000|Overall Study|Lost to Follow-up|1|||
146025443|NCT03966885|526607202|FG001|Overall Study|Lost to Follow-up|2|||
146025444|NCT03966885|526607201|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
146025445|NCT03966885|526607202|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
146025446|NCT03966885|526607201|FG000|Overall Study|Moved from study area.|0|||
146025447|NCT03966885|526607202|FG001|Overall Study|Moved from study area.|2|||
146025448|NCT03187834|526607203|FG000|Overall Study|Lost to Follow-up|0|||
146025449|NCT03187834|526607204|FG001|Overall Study|Lost to Follow-up|1|||
146025450|NCT03187834|526607205|FG002|Overall Study|Lost to Follow-up|2|||
146025451|NCT03187834|526607206|FG003|Overall Study|Lost to Follow-up|2|||
146025452|NCT03187834|526607203|FG000|Overall Study|Had invalid anthropometric measurements|5|||
146025453|NCT03187834|526607204|FG001|Overall Study|Had invalid anthropometric measurements|3|||
146025454|NCT03187834|526607205|FG002|Overall Study|Had invalid anthropometric measurements|4|||
146025455|NCT03187834|526607206|FG003|Overall Study|Had invalid anthropometric measurements|2|||
146025456|NCT03710876|526607207|FG000|Overall Study|Death|0|||
146025457|NCT03710876|526607208|FG001|Overall Study|Death|2|||
146025458|NCT03710876|526607207|FG000|Overall Study|Withdrawal by Subject|0|||
146025459|NCT03710876|526607208|FG001|Overall Study|Withdrawal by Subject|2|||
146025460|NCT01007123|526607209|FG000|Overall Study|Adverse Event|3|||
146025461|NCT01007123|526607210|FG001|Overall Study|Adverse Event|4|||
146025462|NCT01007123|526607211|FG002|Overall Study|Adverse Event|7|||
146025463|NCT01007123|526607212|FG003|Overall Study|Adverse Event|1|||
146025464|NCT01007123|526607209|FG000|Overall Study|Lack of Efficacy|1|||
146025465|NCT01007123|526607210|FG001|Overall Study|Lack of Efficacy|0|||
146253827|NCT00603278|527440872|FG004|Overall Study|Withdrawal by Subject|1|||
146253828|NCT00603278|527440873|FG005|Overall Study|Withdrawal by Subject|2|||
146025466|NCT01007123|526607211|FG002|Overall Study|Lack of Efficacy|1|||
146025467|NCT01007123|526607212|FG003|Overall Study|Lack of Efficacy|4|||
146253829|NCT00603278|527440868|FG000|Overall Study|Protocol Violation|3|||
146025468|NCT01007123|526607209|FG000|Overall Study|Protocol Violation|1|||
146094615|NCT02600351|526867849|FG002|Overall Study|Randomized but Not Treated|1|||
146094616|NCT02600351|526867850|FG003|Overall Study|Randomized but Not Treated|3|||
146253830|NCT00603278|527440869|FG001|Overall Study|Protocol Violation|0|||
146253831|NCT00603278|527440870|FG002|Overall Study|Protocol Violation|1|||
146025469|NCT01007123|526607210|FG001|Overall Study|Protocol Violation|1|||
146025470|NCT01007123|526607211|FG002|Overall Study|Protocol Violation|2|||
146025471|NCT01007123|526607212|FG003|Overall Study|Protocol Violation|1|||
146025472|NCT01007123|526607209|FG000|Overall Study|Withdrawal by Subject|1|||
146253832|NCT00603278|527440871|FG003|Overall Study|Protocol Violation|1|||
146253833|NCT00603278|527440872|FG004|Overall Study|Protocol Violation|0|||
146253834|NCT00603278|527440873|FG005|Overall Study|Protocol Violation|1|||
146253835|NCT00603278|527440868|FG000|Overall Study|Physician Decision|0|||
146253836|NCT00603278|527440869|FG001|Overall Study|Physician Decision|1|||
146253837|NCT00603278|527440870|FG002|Overall Study|Physician Decision|0|||
146253838|NCT00603278|527440871|FG003|Overall Study|Physician Decision|0|||
146253839|NCT00603278|527440872|FG004|Overall Study|Physician Decision|2|||
146253840|NCT00603278|527440873|FG005|Overall Study|Physician Decision|1|||
146253841|NCT00603278|527440868|FG000|Overall Study|Lost to Follow-up|1|||
146253842|NCT00603278|527440869|FG001|Overall Study|Lost to Follow-up|0|||
146253843|NCT00603278|527440870|FG002|Overall Study|Lost to Follow-up|0|||
146253844|NCT00603278|527440871|FG003|Overall Study|Lost to Follow-up|0|||
146253845|NCT00603278|527440872|FG004|Overall Study|Lost to Follow-up|1|||
146253846|NCT00603278|527440873|FG005|Overall Study|Lost to Follow-up|0|||
146253847|NCT04743999|527440875|FG000|3-month Questionnaire|Death|1|||
146253848|NCT04743999|527440875|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
146253849|NCT04743999|527440875|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
146253850|NCT04743999|527440875|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
146253851|NCT01721759|527440876|FG000|Treatment Period|Disease Progression|85|||
146253852|NCT01721759|527440876|FG000|Treatment Period|Study drug toxicity|14|||
146253853|NCT01721759|527440876|FG000|Treatment Period|Death|1|||
146253854|NCT01721759|527440876|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
146253855|NCT01721759|527440876|FG000|Treatment Period|Participant request to withdraw|3|||
146253856|NCT01721759|527440876|FG000|Treatment Period|Other Reasons|3|||
146253857|NCT01721759|527440876|FG000|End of Study Period|Participant Withdrew Consent|5|||
146253858|NCT01721759|527440876|FG000|End of Study Period|Death|101|||
146253859|NCT01721759|527440876|FG000|End of Study Period|Lost to Follow-up|1|||
146253860|NCT01721759|527440876|FG000|End of Study Period|Other Reasons|10|||
146253861|NCT02577315|527440883|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146253862|NCT02577315|527440884|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146253863|NCT00417989|527440885|FG000|Overall Study|Withdrawal by Subject|13|||
146253864|NCT00417989|527440886|FG001|Overall Study|Withdrawal by Subject|13|||
146253865|NCT00417989|527440885|FG000|Overall Study|Lost to Follow-up|1|||
146253866|NCT00417989|527440886|FG001|Overall Study|Lost to Follow-up|6|||
146253867|NCT00417989|527440885|FG000|Overall Study|Protocol Violation|1|||
146253868|NCT00417989|527440886|FG001|Overall Study|Protocol Violation|0|||
146253869|NCT00417989|527440885|FG000|Overall Study|Death|0|||
146253870|NCT00417989|527440886|FG001|Overall Study|Death|1|||
146253871|NCT00417989|527440885|FG000|Overall Study|Physician Decision|5|||
146253872|NCT00417989|527440886|FG001|Overall Study|Physician Decision|2|||
146253873|NCT01636778|527440889|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
146253874|NCT01636778|527440890|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
146253875|NCT01636778|527440891|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
146253876|NCT01636778|527440889|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
146253877|NCT01636778|527440890|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
146253878|NCT01636778|527440891|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
146253879|NCT01636778|527440889|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
146253880|NCT01636778|527440890|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
146253881|NCT01636778|527440891|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
146253882|NCT01636778|527440889|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
146253883|NCT01636778|527440890|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
146253884|NCT01636778|527440891|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
146253885|NCT01636778|527440889|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
146253886|NCT01636778|527440890|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
146253887|NCT01636778|527440891|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
146253888|NCT01636778|527440889|FG000|Follow-up Period After Part 2|Other|0|||
146253889|NCT01636778|527440890|FG001|Follow-up Period After Part 2|Other|0|||
146253890|NCT01636778|527440891|FG002|Follow-up Period After Part 2|Other|1|||
146253891|NCT01636778|527440889|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
146253892|NCT01636778|527440890|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
146253893|NCT01636778|527440891|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
146300291|NCT01020448|527615201|FG000|Treatment|Lost to Follow-up|2|||
146253894|NCT01636778|527440889|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
146253895|NCT01636778|527440890|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
146253896|NCT01636778|527440891|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
146300292|NCT01505010|527615202|FG000|Overall Study|Protocol Violation|0|||
146300293|NCT01505010|527615203|FG001|Overall Study|Protocol Violation|1|||
146300294|NCT01505010|527615202|FG000|Overall Study|Lost to Follow-up|0|||
146253897|NCT00990821|527440895|FG000|Overall Study|Withdrawal by Subject|0|||
146253898|NCT00990821|527440896|FG001|Overall Study|Withdrawal by Subject|2|||
146253899|NCT00990821|527440897|FG002|Overall Study|Withdrawal by Subject|0|||
146253900|NCT00990821|527440898|FG003|Overall Study|Withdrawal by Subject|0|||
146253901|NCT00990821|527440899|FG004|Overall Study|Withdrawal by Subject|3|||
146253902|NCT00990821|527440900|FG005|Overall Study|Withdrawal by Subject|3|||
146253903|NCT00990821|527440901|FG006|Overall Study|Withdrawal by Subject|1|||
146253904|NCT00990821|527440902|FG007|Overall Study|Withdrawal by Subject|0|||
146253905|NCT00990821|527440903|FG008|Overall Study|Withdrawal by Subject|0|||
146253906|NCT00990821|527440904|FG009|Overall Study|Withdrawal by Subject|1|||
146253907|NCT00990821|527440905|FG010|Overall Study|Withdrawal by Subject|3|||
146253908|NCT00990821|527440906|FG011|Overall Study|Withdrawal by Subject|5|||
146253909|NCT00990821|527440907|FG012|Overall Study|Withdrawal by Subject|2|||
146253910|NCT00990821|527440908|FG013|Overall Study|Withdrawal by Subject|1|||
146253911|NCT03530345|527440909|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
146253912|NCT03530345|527440910|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
146253913|NCT03530345|527440909|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
146253914|NCT03530345|527440910|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
146253915|NCT03530345|527440909|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
146253916|NCT03530345|527440910|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
146253917|NCT03530345|527440909|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
146253918|NCT03530345|527440910|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
146253919|NCT04150250|527440911|FG000|Overall Study|Lost to Follow-up|0|||
146253920|NCT04150250|527440912|FG001|Overall Study|Lost to Follow-up|2|||
146253921|NCT02442622|527440918|FG000|Overall Study|Withdrawal by Subject|3|||
146253922|NCT02442622|527440919|FG001|Overall Study|Withdrawal by Subject|1|||
146253923|NCT00383500|527440920|FG000|Overall Study|Withdrawal by Subject|8|||
146253924|NCT00383500|527440921|FG001|Overall Study|Withdrawal by Subject|3|||
146253925|NCT00383500|527440922|FG002|Overall Study|Withdrawal by Subject|0|||
146253926|NCT00383500|527440920|FG000|Overall Study|Lost to Follow-up|0|||
146253927|NCT00383500|527440921|FG001|Overall Study|Lost to Follow-up|0|||
146253928|NCT00383500|527440922|FG002|Overall Study|Lost to Follow-up|2|||
146025473|NCT01007123|526607210|FG001|Overall Study|Withdrawal by Subject|0|||
146025474|NCT01007123|526607211|FG002|Overall Study|Withdrawal by Subject|1|||
146025475|NCT01007123|526607212|FG003|Overall Study|Withdrawal by Subject|0|||
146025476|NCT01007123|526607209|FG000|Overall Study|Lost to Follow-up|0|||
146025477|NCT01007123|526607210|FG001|Overall Study|Lost to Follow-up|1|||
146025478|NCT01007123|526607211|FG002|Overall Study|Lost to Follow-up|0|||
146025479|NCT01007123|526607212|FG003|Overall Study|Lost to Follow-up|0|||
146025480|NCT02838901|526607213|FG000|Overall Study|Withdrawal by Subject|1|||
146025481|NCT02838901|526607214|FG001|Overall Study|Withdrawal by Subject|1|||
146025482|NCT02838901|526607213|FG000|Overall Study|Lost to Follow-up|1|||
146025483|NCT02838901|526607214|FG001|Overall Study|Lost to Follow-up|1|||
146025484|NCT00320255|526607215|FG000|Overall Study|Lack of Efficacy|1|||
146025485|NCT00320255|526607216|FG001|Overall Study|Lack of Efficacy|0|||
146025486|NCT00320255|526607217|FG002|Overall Study|Lack of Efficacy|0|||
146025487|NCT00320255|526607218|FG003|Overall Study|Lack of Efficacy|0|||
146025488|NCT00320255|526607219|FG004|Overall Study|Lack of Efficacy|0|||
146025489|NCT00320255|526607220|FG005|Overall Study|Lack of Efficacy|0|||
146025490|NCT00320255|526607215|FG000|Overall Study|Adverse Event|5|||
146025491|NCT00320255|526607216|FG001|Overall Study|Adverse Event|2|||
146025492|NCT00320255|526607217|FG002|Overall Study|Adverse Event|3|||
146025493|NCT00320255|526607218|FG003|Overall Study|Adverse Event|2|||
146025494|NCT00320255|526607219|FG004|Overall Study|Adverse Event|0|||
146025495|NCT00320255|526607220|FG005|Overall Study|Adverse Event|0|||
146025496|NCT00320255|526607215|FG000|Overall Study|Withdrawal by Subject|1|||
146025497|NCT00320255|526607216|FG001|Overall Study|Withdrawal by Subject|2|||
146025498|NCT00320255|526607217|FG002|Overall Study|Withdrawal by Subject|2|||
146025499|NCT00320255|526607218|FG003|Overall Study|Withdrawal by Subject|4|||
146025500|NCT00320255|526607219|FG004|Overall Study|Withdrawal by Subject|0|||
146025501|NCT00320255|526607220|FG005|Overall Study|Withdrawal by Subject|0|||
146025502|NCT00320255|526607215|FG000|Overall Study|Poor compliance/noncompliance|1|||
146253929|NCT01002547|527442939|FG000|Overall Study|Withdrawal by Subject|4|||
146253930|NCT01002547|527442940|FG001|Overall Study|Withdrawal by Subject|0|||
146253931|NCT01002547|527442941|FG002|Overall Study|Withdrawal by Subject|5|||
146253932|NCT01002547|527442939|FG000|Overall Study|Lost to Follow-up|2|||
146253933|NCT01002547|527442940|FG001|Overall Study|Lost to Follow-up|1|||
146253934|NCT01002547|527442941|FG002|Overall Study|Lost to Follow-up|1|||
146253935|NCT01002547|527442939|FG000|Overall Study|Physician Decision|1|||
146025503|NCT00320255|526607216|FG001|Overall Study|Poor compliance/noncompliance|1|||
146025504|NCT00320255|526607217|FG002|Overall Study|Poor compliance/noncompliance|0|||
146253936|NCT01002547|527442940|FG001|Overall Study|Physician Decision|0|||
146253937|NCT01002547|527442941|FG002|Overall Study|Physician Decision|0|||
146253938|NCT01002547|527442939|FG000|Overall Study|Death|0|||
146253939|NCT01002547|527442940|FG001|Overall Study|Death|2|||
146025505|NCT00320255|526607218|FG003|Overall Study|Poor compliance/noncompliance|1|||
146025506|NCT00320255|526607219|FG004|Overall Study|Poor compliance/noncompliance|0|||
146025507|NCT00320255|526607220|FG005|Overall Study|Poor compliance/noncompliance|0|||
146025508|NCT00320255|526607215|FG000|Overall Study|No longer meets study criteria|0|||
146025509|NCT00320255|526607216|FG001|Overall Study|No longer meets study criteria|0|||
146025510|NCT00320255|526607217|FG002|Overall Study|No longer meets study criteria|0|||
146025511|NCT00320255|526607218|FG003|Overall Study|No longer meets study criteria|1|||
146025512|NCT00320255|526607219|FG004|Overall Study|No longer meets study criteria|0|||
146025513|NCT00320255|526607220|FG005|Overall Study|No longer meets study criteria|0|||
146025514|NCT00320255|526607215|FG000|Overall Study|Other|3|||
146025515|NCT00320255|526607216|FG001|Overall Study|Other|2|||
146025516|NCT00320255|526607217|FG002|Overall Study|Other|1|||
146025517|NCT00320255|526607218|FG003|Overall Study|Other|0|||
146025518|NCT00320255|526607219|FG004|Overall Study|Other|0|||
146025519|NCT00320255|526607220|FG005|Overall Study|Other|0|||
146025520|NCT03405935|526607222|FG000|Overall Study|Adverse Event|3|||
146025521|NCT03405935|526607222|FG000|Overall Study|Death|2|||
146025522|NCT03405935|526607222|FG000|Overall Study|Withdrawal by Subject|1|||
146025523|NCT03405935|526607222|FG000|Overall Study|Lost to Follow-up|2|||
146025524|NCT04979897|526607228|FG000|Overall Study|Death|1|||
146025525|NCT04979897|526607229|FG001|Overall Study|Death|8|||
146025526|NCT04979897|526607228|FG000|Overall Study|Lost to Follow-up|111|||
146025527|NCT04979897|526607229|FG001|Overall Study|Lost to Follow-up|56|||
146025528|NCT04979897|526607228|FG000|Overall Study|Withdrawal by Subject|7|||
146025529|NCT04979897|526607229|FG001|Overall Study|Withdrawal by Subject|2|||
146025530|NCT02781792|526607233|FG000|Overall Study|Adverse Event|1|||
146025531|NCT02781792|526607234|FG001|Overall Study|Adverse Event|2|||
146025532|NCT02781792|526607233|FG000|Overall Study|Withdrawal by Subject|3|||
146025533|NCT02781792|526607234|FG001|Overall Study|Withdrawal by Subject|1|||
146025534|NCT02781792|526607233|FG000|Overall Study|Lack of Efficacy|1|||
146025535|NCT02781792|526607234|FG001|Overall Study|Lack of Efficacy|1|||
146025536|NCT02781792|526607233|FG000|Overall Study|Hospice|0|||
146025537|NCT02781792|526607234|FG001|Overall Study|Hospice|1|||
146025538|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
146025539|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
146025540|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
146025541|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
146025542|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
146025543|NCT01224821|526607242|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
146025544|NCT01224821|526607242|FG000|Long-Term Follow-Up|Death|2|||
146025545|NCT01224821|526607242|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
146025546|NCT00683917|526607243|FG000|Overall Study|Study prematurely terminated|10|||
146025547|NCT04422561|526607247|FG000|Overall Study|Lost to Follow-up|25|||
146025548|NCT04422561|526607248|FG001|Overall Study|Lost to Follow-up|11|||
146025549|NCT02685748|526607249|FG000|Overall Study|Withdrawal by Subject|3|||
146025550|NCT02685748|526607250|FG001|Overall Study|Withdrawal by Subject|2|||
146025551|NCT03500172|526607251|FG000|Period 1: Baseline Randomization|Death|0|||
146025552|NCT03500172|526607252|FG001|Period 1: Baseline Randomization|Death|0|||
146025553|NCT03500172|526607253|FG002|Period 1: Baseline Randomization|Death|0|||
146025554|NCT03500172|526607254|FG003|Period 1: Baseline Randomization|Death|0|||
146025555|NCT03500172|526607255|FG004|Period 1: Baseline Randomization|Death|0|||
146025556|NCT03500172|526607256|FG005|Period 1: Baseline Randomization|Death|0|||
146025557|NCT03500172|526607257|FG006|Period 1: Baseline Randomization|Death|0|||
146025558|NCT03500172|526607258|FG007|Period 1: Baseline Randomization|Death|0|||
146025559|NCT03500172|526607259|FG008|Period 1: Baseline Randomization|Death|0|||
146025560|NCT03500172|526607260|FG009|Period 1: Baseline Randomization|Death|2|||
146025561|NCT03500172|526607261|FG010|Period 1: Baseline Randomization|Death|0|||
146025562|NCT03500172|526607251|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
146025563|NCT03500172|526607252|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
146025564|NCT03500172|526607253|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
146025565|NCT03500172|526607254|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
146025566|NCT03500172|526607255|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
146025567|NCT03500172|526607256|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
146025568|NCT03500172|526607257|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
146025569|NCT03500172|526607258|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
146025570|NCT03500172|526607259|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
146025571|NCT03500172|526607260|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
146025572|NCT03500172|526607261|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
146025573|NCT03500172|526607251|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
146025574|NCT03500172|526607252|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
146253940|NCT01002547|527442941|FG002|Overall Study|Death|2|||
146253941|NCT01002547|527442939|FG000|Overall Study|Adverse Event|1|||
146253942|NCT01002547|527442940|FG001|Overall Study|Adverse Event|0|||
146253943|NCT01002547|527442941|FG002|Overall Study|Adverse Event|0|||
146025575|NCT03500172|526607253|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
146025576|NCT03500172|526607254|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
146025577|NCT03500172|526607255|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
146025578|NCT03500172|526607256|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
146025579|NCT03500172|526607257|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
146025580|NCT03500172|526607258|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
146025581|NCT03500172|526607259|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
146025582|NCT03500172|526607260|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
146025583|NCT03500172|526607261|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
146025584|NCT03500172|526607251|FG000|Period 2: Re-Randomization|Death|0|||
146025585|NCT03500172|526607252|FG001|Period 2: Re-Randomization|Death|0|||
146025586|NCT03500172|526607253|FG002|Period 2: Re-Randomization|Death|0|||
146025587|NCT03500172|526607254|FG003|Period 2: Re-Randomization|Death|4|||
146025588|NCT03500172|526607255|FG004|Period 2: Re-Randomization|Death|2|||
146025589|NCT03500172|526607256|FG005|Period 2: Re-Randomization|Death|0|||
146025590|NCT03500172|526607257|FG006|Period 2: Re-Randomization|Death|5|||
146025591|NCT03500172|526607258|FG007|Period 2: Re-Randomization|Death|2|||
146025592|NCT03500172|526607259|FG008|Period 2: Re-Randomization|Death|0|||
146025593|NCT03500172|526607260|FG009|Period 2: Re-Randomization|Death|0|||
146025594|NCT03500172|526607261|FG010|Period 2: Re-Randomization|Death|0|||
146025595|NCT00090233|526607266|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
146025596|NCT00090233|526607267|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
146025597|NCT00090233|526607266|FG000|Overall Study|Adverse Event|214|||
146025598|NCT00090233|526607267|FG001|Overall Study|Adverse Event|198|||
146025599|NCT00090233|526607266|FG000|Overall Study|Lost to Follow-up|68|||
146025600|NCT00090233|526607267|FG001|Overall Study|Lost to Follow-up|95|||
146025601|NCT00090233|526607266|FG000|Overall Study|Protocol Violation|960|||
146025602|NCT00090233|526607267|FG001|Overall Study|Protocol Violation|1022|||
146025603|NCT00090233|526607266|FG000|Overall Study|Withdrawal by Subject|182|||
146025604|NCT00090233|526607267|FG001|Overall Study|Withdrawal by Subject|211|||
146025605|NCT00090233|526607266|FG000|Overall Study|Moved|203|||
146025606|NCT00090233|526607267|FG001|Overall Study|Moved|189|||
146025607|NCT00090233|526607266|FG000|Overall Study|Other|1211|||
146025608|NCT00090233|526607267|FG001|Overall Study|Other|1160|||
146025609|NCT00090233|526607266|FG000|Overall Study|Data not available at data cut-off point|1552|||
146025610|NCT00090233|526607267|FG001|Overall Study|Data not available at data cut-off point|1563|||
146025611|NCT04863248|526607268|FG000|Overall Study|Sponsor Terminated|4|||
146025612|NCT04863248|526607269|FG001|Overall Study|Sponsor Terminated|1|||
146025613|NCT04863248|526607268|FG000|Overall Study|Death|0|||
146025614|NCT04863248|526607269|FG001|Overall Study|Death|1|||
146025615|NCT04863248|526607268|FG000|Overall Study|Withdrawal by Subject|0|||
146025616|NCT04863248|526607269|FG001|Overall Study|Withdrawal by Subject|1|||
146025617|NCT03541187|526607272|FG000|Overall Study|Lost to Follow-up|2|||
146025618|NCT03541187|526607273|FG001|Overall Study|Lost to Follow-up|6|||
146025619|NCT03541187|526607272|FG000|Overall Study|Pregnancy|0|||
146025620|NCT03541187|526607273|FG001|Overall Study|Pregnancy|1|||
146025621|NCT03541187|526607272|FG000|Overall Study|Withdrawal by Subject|6|||
146025622|NCT03541187|526607273|FG001|Overall Study|Withdrawal by Subject|2|||
146025623|NCT03541187|526607272|FG000|Overall Study|Moved out of town|1|||
146025624|NCT03541187|526607273|FG001|Overall Study|Moved out of town|0|||
146025625|NCT03541187|526607272|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
146025626|NCT03541187|526607273|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
146025627|NCT03541187|526607272|FG000|Overall Study|Did not meet randomization criteria|1|||
146025628|NCT03541187|526607273|FG001|Overall Study|Did not meet randomization criteria|1|||
146025629|NCT03541187|526607272|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
146025630|NCT03541187|526607273|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
146025631|NCT03541187|526607272|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
146025632|NCT03541187|526607273|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
146025633|NCT00869050|526607274|FG000|Overall Study|Screen Failure|3|||
146025634|NCT00246025|526607278|FG000|Overall Study|Adverse Event|7|||
146025635|NCT00246025|526607279|FG001|Overall Study|Adverse Event|9|||
146025636|NCT00246025|526607280|FG002|Overall Study|Adverse Event|9|||
146025637|NCT00246025|526607281|FG003|Overall Study|Adverse Event|10|||
146025638|NCT00246025|526607278|FG000|Overall Study|Withdrawal by Subject|3|||
146025639|NCT00246025|526607279|FG001|Overall Study|Withdrawal by Subject|0|||
146025640|NCT00246025|526607280|FG002|Overall Study|Withdrawal by Subject|1|||
146025641|NCT00246025|526607281|FG003|Overall Study|Withdrawal by Subject|2|||
146025642|NCT00246025|526607278|FG000|Overall Study|unsuitable medical history was found|0|||
146025643|NCT00246025|526607279|FG001|Overall Study|unsuitable medical history was found|0|||
146025644|NCT00246025|526607280|FG002|Overall Study|unsuitable medical history was found|0|||
146025645|NCT00246025|526607281|FG003|Overall Study|unsuitable medical history was found|1|||
146025646|NCT01643850|526607282|FG000|Overall Study|Withdrawal by Subject|0|||
146025647|NCT01643850|526607283|FG001|Overall Study|Withdrawal by Subject|0|||
146025648|NCT01643850|526607284|FG002|Overall Study|Withdrawal by Subject|0|||
146300295|NCT01505010|527615203|FG001|Overall Study|Lost to Follow-up|1|||
146025649|NCT01643850|526607285|FG003|Overall Study|Withdrawal by Subject|0|||
146025650|NCT01643850|526607286|FG004|Overall Study|Withdrawal by Subject|1|||
146025651|NCT01643850|526607287|FG005|Overall Study|Withdrawal by Subject|0|||
146025652|NCT01643850|526607288|FG006|Overall Study|Withdrawal by Subject|0|||
146253944|NCT00705614|527442946|FG000|Initial Intervention|Adverse Event|40|||
146025653|NCT01643850|526607289|FG007|Overall Study|Withdrawal by Subject|0|||
146025654|NCT01643850|526607290|FG008|Overall Study|Withdrawal by Subject|0|||
146025655|NCT01643850|526607282|FG000|Overall Study|Lost to Follow-up|0|||
146025656|NCT01643850|526607283|FG001|Overall Study|Lost to Follow-up|0|||
146025657|NCT01643850|526607284|FG002|Overall Study|Lost to Follow-up|0|||
146025658|NCT01643850|526607285|FG003|Overall Study|Lost to Follow-up|0|||
146025659|NCT01643850|526607286|FG004|Overall Study|Lost to Follow-up|0|||
146025660|NCT01643850|526607287|FG005|Overall Study|Lost to Follow-up|0|||
146025661|NCT01643850|526607288|FG006|Overall Study|Lost to Follow-up|1|||
146025662|NCT01643850|526607289|FG007|Overall Study|Lost to Follow-up|0|||
146025663|NCT01643850|526607290|FG008|Overall Study|Lost to Follow-up|1|||
146025664|NCT01643850|526607282|FG000|Overall Study|Adverse Event|0|||
146025665|NCT01643850|526607283|FG001|Overall Study|Adverse Event|0|||
146025666|NCT01643850|526607284|FG002|Overall Study|Adverse Event|0|||
146025667|NCT01643850|526607285|FG003|Overall Study|Adverse Event|0|||
146025668|NCT01643850|526607286|FG004|Overall Study|Adverse Event|1|||
146025669|NCT01643850|526607287|FG005|Overall Study|Adverse Event|0|||
146025670|NCT01643850|526607288|FG006|Overall Study|Adverse Event|0|||
146025671|NCT01643850|526607289|FG007|Overall Study|Adverse Event|0|||
146025672|NCT01643850|526607290|FG008|Overall Study|Adverse Event|0|||
146025673|NCT01643850|526607282|FG000|Overall Study|Administrative Problems|0|||
146025674|NCT01643850|526607283|FG001|Overall Study|Administrative Problems|0|||
146025675|NCT01643850|526607284|FG002|Overall Study|Administrative Problems|1|||
146025676|NCT01643850|526607285|FG003|Overall Study|Administrative Problems|0|||
146025677|NCT01643850|526607286|FG004|Overall Study|Administrative Problems|1|||
146025678|NCT01643850|526607287|FG005|Overall Study|Administrative Problems|0|||
146025679|NCT01643850|526607288|FG006|Overall Study|Administrative Problems|0|||
146025680|NCT01643850|526607289|FG007|Overall Study|Administrative Problems|0|||
146025681|NCT01643850|526607290|FG008|Overall Study|Administrative Problems|0|||
146025682|NCT00931723|526607293|FG000|Overall Study|Withdrawal by Subject|11|||
146025683|NCT00931723|526607294|FG001|Overall Study|Withdrawal by Subject|13|||
146025684|NCT00931723|526607293|FG000|Overall Study|Adverse Event|6|||
146025685|NCT00931723|526607294|FG001|Overall Study|Adverse Event|13|||
146025686|NCT00931723|526607293|FG000|Overall Study|Lithium found in blood|0|||
146025687|NCT00931723|526607294|FG001|Overall Study|Lithium found in blood|1|||
146025688|NCT00931723|526607293|FG000|Overall Study|Condition under investigation worsened|1|||
146025689|NCT00931723|526607294|FG001|Overall Study|Condition under investigation worsened|2|||
146025690|NCT00931723|526607293|FG000|Overall Study|Lost to Follow-up|1|||
146025691|NCT00931723|526607294|FG001|Overall Study|Lost to Follow-up|2|||
146025692|NCT00931723|526607293|FG000|Overall Study|Study-specific discontinuation criteria|1|||
146025693|NCT00931723|526607294|FG001|Overall Study|Study-specific discontinuation criteria|1|||
146025694|NCT00931723|526607293|FG000|Overall Study|Severe non-compliance to protocol|2|||
146025695|NCT00931723|526607294|FG001|Overall Study|Severe non-compliance to protocol|0|||
146025696|NCT00931723|526607293|FG000|Overall Study|Safety reasons|0|||
146025697|NCT00931723|526607294|FG001|Overall Study|Safety reasons|1|||
146025698|NCT00931723|526607293|FG000|Overall Study|Took prohibited concomitant medication|0|||
146025699|NCT00931723|526607294|FG001|Overall Study|Took prohibited concomitant medication|1|||
146025700|NCT00931723|526607293|FG000|Overall Study|Lack or insufficient theraputic response|2|||
146025701|NCT00931723|526607294|FG001|Overall Study|Lack or insufficient theraputic response|5|||
146025702|NCT00931723|526607293|FG000|Overall Study|Sponsor decision|1|||
146025703|NCT00931723|526607294|FG001|Overall Study|Sponsor decision|0|||
146025704|NCT00931723|526607293|FG000|Overall Study|Late hospital discharge|1|||
146253945|NCT00705614|527442947|FG001|Initial Intervention|Adverse Event|21|||
146253946|NCT00705614|527442946|FG000|Initial Intervention|Lost to Follow-up|310|||
146253947|NCT00705614|527442947|FG001|Initial Intervention|Lost to Follow-up|191|||
146253948|NCT00705614|527442946|FG000|Initial Intervention|Withdrawal by Subject|114|||
146253949|NCT00705614|527442947|FG001|Initial Intervention|Withdrawal by Subject|71|||
146253950|NCT00705614|527442946|FG000|Initial Intervention|Administrative Reason|51|||
146253951|NCT00705614|527442947|FG001|Initial Intervention|Administrative Reason|38|||
146253952|NCT00705614|527442946|FG000|Initial Intervention|Status completion unknown|3|||
146253953|NCT00705614|527442947|FG001|Initial Intervention|Status completion unknown|0|||
146253954|NCT00705614|527442946|FG000|Switch to Remicade|Adverse Event|0|||
146253955|NCT00705614|527442947|FG001|Switch to Remicade|Adverse Event|5|||
146253956|NCT00705614|527442946|FG000|Switch to Remicade|Lost to Follow-up|0|||
146025705|NCT00931723|526607294|FG001|Overall Study|Late hospital discharge|0|||
146025706|NCT03300024|526607295|FG000|Overall Study|Physician Decision|4|||
146025707|NCT03300024|526607296|FG001|Overall Study|Physician Decision|6|||
146025708|NCT03305081|526607297|FG000|Overall Study|Lost to Follow-up|10|||
146025709|NCT03305081|526607298|FG001|Overall Study|Lost to Follow-up|15|||
146025710|NCT00570037|526607299|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
146025711|NCT00570037|526607300|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
146025712|NCT00554619|526607301|FG000|Overall Study|Adverse Event|1|||
146025713|NCT00554619|526607301|FG000|Overall Study|Physician Decision|1|||
146025714|NCT00554619|526607301|FG000|Overall Study|Liver Function Test Abnormality|1|||
146253957|NCT00705614|527442947|FG001|Switch to Remicade|Lost to Follow-up|23|||
146025715|NCT01571284|526607302|FG000|Overall Study|Participant's decision|84|||
146253958|NCT00705614|527442946|FG000|Switch to Remicade|Withdrawal by Subject|0|||
146253959|NCT00705614|527442947|FG001|Switch to Remicade|Withdrawal by Subject|12|||
146253960|NCT00705614|527442946|FG000|Switch to Remicade|Administrative Reason|0|||
146253961|NCT00705614|527442947|FG001|Switch to Remicade|Administrative Reason|9|||
146253962|NCT00925288|527442948|FG000|Overall Study|Lost to Follow-up|9|||
146253963|NCT00925288|527442949|FG001|Overall Study|Lost to Follow-up|7|||
146253964|NCT02081196|527442950|FG000|Overall Study|Lost to Follow-up|1|||
146094617|NCT00567593|526867851|FG000|Overall Study|Adverse Event|1|||
146094618|NCT00567593|526867851|FG000|Overall Study|Physician Decision|1|||
146094619|NCT02106910|526867854|FG000|Overall Study|Lost to Follow-up|1|||
146094620|NCT02106910|526867855|FG001|Overall Study|Lost to Follow-up|1|||
146094621|NCT00700570|526867856|FG000|Overall Study|Adverse Event|2|||
146094622|NCT00700570|526867857|FG001|Overall Study|Adverse Event|6|||
146253965|NCT00434577|527442951|FG000|Months 0-3|Serious Adverse Event|0|||
146253966|NCT00434577|527442952|FG001|Months 0-3|Serious Adverse Event|0|||
146253967|NCT00434577|527442953|FG002|Months 0-3|Serious Adverse Event|1|||
146253968|NCT00434577|527442954|FG003|Months 0-3|Serious Adverse Event|0|||
146253969|NCT00434577|527442955|FG004|Months 0-3|Serious Adverse Event|0|||
146253970|NCT00434577|527442951|FG000|Months 0-3|Adverse Event|0|||
146253971|NCT00434577|527442952|FG001|Months 0-3|Adverse Event|1|||
146253972|NCT00434577|527442953|FG002|Months 0-3|Adverse Event|1|||
146253973|NCT00434577|527442954|FG003|Months 0-3|Adverse Event|0|||
146253974|NCT00434577|527442955|FG004|Months 0-3|Adverse Event|0|||
146253975|NCT00434577|527442951|FG000|Months 0-3|Lost to Follow-up|0|||
146253976|NCT00434577|527442952|FG001|Months 0-3|Lost to Follow-up|0|||
146253977|NCT00434577|527442953|FG002|Months 0-3|Lost to Follow-up|0|||
146253978|NCT00434577|527442954|FG003|Months 0-3|Lost to Follow-up|0|||
146253979|NCT00434577|527442955|FG004|Months 0-3|Lost to Follow-up|2|||
146253980|NCT00434577|527442951|FG000|Months 0-3|Protocol Violation|1|||
146253981|NCT00434577|527442952|FG001|Months 0-3|Protocol Violation|0|||
146253982|NCT00434577|527442953|FG002|Months 0-3|Protocol Violation|1|||
146253983|NCT00434577|527442954|FG003|Months 0-3|Protocol Violation|0|||
146253984|NCT00434577|527442955|FG004|Months 0-3|Protocol Violation|0|||
146253985|NCT00434577|527442951|FG000|Months 0-3|Withdrawal by Subject|2|||
146025716|NCT01571284|526607302|FG000|Overall Study|Lost to Follow-up|3|||
146025717|NCT01571284|526607302|FG000|Overall Study|Enrolled but not treated|2|||
146025718|NCT01571284|526607302|FG000|Overall Study|Other than specified above|80|||
146025719|NCT01218100|526607303|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
146025720|NCT01218100|526607304|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
146025721|NCT01218100|526607305|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
146025722|NCT01218100|526607306|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
146025723|NCT01218100|526607303|FG000|Overall Study|Adverse Event|4|||
146025724|NCT01218100|526607304|FG001|Overall Study|Adverse Event|6|||
146025725|NCT01218100|526607305|FG002|Overall Study|Adverse Event|6|||
146025726|NCT01218100|526607306|FG003|Overall Study|Adverse Event|7|||
146025727|NCT01218100|526607303|FG000|Overall Study|Lack of Efficacy|9|||
146025728|NCT01218100|526607304|FG001|Overall Study|Lack of Efficacy|6|||
146025729|NCT01218100|526607305|FG002|Overall Study|Lack of Efficacy|5|||
146025730|NCT01218100|526607306|FG003|Overall Study|Lack of Efficacy|12|||
146025731|NCT01218100|526607303|FG000|Overall Study|Protocol Violation|0|||
146025732|NCT01218100|526607304|FG001|Overall Study|Protocol Violation|0|||
146025733|NCT01218100|526607305|FG002|Overall Study|Protocol Violation|1|||
146025734|NCT01218100|526607306|FG003|Overall Study|Protocol Violation|1|||
146025735|NCT01218100|526607303|FG000|Overall Study|Withdrawal by Subject|5|||
146025736|NCT01218100|526607304|FG001|Overall Study|Withdrawal by Subject|2|||
146025737|NCT01218100|526607305|FG002|Overall Study|Withdrawal by Subject|6|||
146025738|NCT01218100|526607306|FG003|Overall Study|Withdrawal by Subject|7|||
146025739|NCT01218100|526607303|FG000|Overall Study|Lost to Follow-up|3|||
146025740|NCT01218100|526607304|FG001|Overall Study|Lost to Follow-up|8|||
146025741|NCT01218100|526607305|FG002|Overall Study|Lost to Follow-up|2|||
146025742|NCT01218100|526607306|FG003|Overall Study|Lost to Follow-up|1|||
146253986|NCT00434577|527442952|FG001|Months 0-3|Withdrawal by Subject|1|||
146253987|NCT00434577|527442953|FG002|Months 0-3|Withdrawal by Subject|1|||
146300296|NCT01006265|527615212|FG000|Overall Study|Lost to Follow-up|1|||
146025743|NCT01218100|526607303|FG000|Overall Study|Other Reason|2|||
146025744|NCT01218100|526607304|FG001|Overall Study|Other Reason|2|||
146025745|NCT01218100|526607305|FG002|Overall Study|Other Reason|6|||
146025746|NCT01218100|526607306|FG003|Overall Study|Other Reason|4|||
146025747|NCT01118520|526607307|FG000|Overall Study|AAA repair|9|||
146025748|NCT01118520|526607308|FG001|Overall Study|AAA repair|7|||
146025749|NCT01118520|526607309|FG002|Overall Study|AAA repair|9|||
146025750|NCT01118520|526607307|FG000|Overall Study|Adverse Event|3|||
146025751|NCT01118520|526607308|FG001|Overall Study|Adverse Event|3|||
146094623|NCT00700570|526867856|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
146253988|NCT00434577|527442954|FG003|Months 0-3|Withdrawal by Subject|1|||
146253989|NCT00434577|527442955|FG004|Months 0-3|Withdrawal by Subject|1|||
146253990|NCT00635570|527442956|FG000|Overall Study|Lost to Follow-up|8|||
146253991|NCT00635570|527442957|FG001|Overall Study|Lost to Follow-up|8|||
146253992|NCT00635570|527442956|FG000|Overall Study|Withdrawal by Subject|1|||
146253993|NCT00635570|527442957|FG001|Overall Study|Withdrawal by Subject|1|||
146253994|NCT00635570|527442956|FG000|Overall Study|Adverse Event|2|||
146253995|NCT00635570|527442957|FG001|Overall Study|Adverse Event|0|||
146253996|NCT00635570|527442956|FG000|Overall Study|Physician Decision|1|||
146253997|NCT00635570|527442957|FG001|Overall Study|Physician Decision|0|||
146253998|NCT00635570|527442956|FG000|Overall Study|Did not complete survey|2|||
146253999|NCT00635570|527442957|FG001|Overall Study|Did not complete survey|1|||
146254000|NCT00635570|527442956|FG000|Overall Study|Early termination(No sexual activity)|1|||
146254001|NCT00635570|527442957|FG001|Overall Study|Early termination(No sexual activity)|1|||
146254002|NCT04816708|527442963|FG000|Overall Study|Lost to Follow-up|10|||
146254003|NCT04816708|527442964|FG001|Overall Study|Lost to Follow-up|4|||
146254004|NCT01503515|527442968|FG000|Overall Study|Adverse Event|4|||
146254005|NCT01503515|527442969|FG001|Overall Study|Adverse Event|5|||
146254006|NCT01503515|527442968|FG000|Overall Study|Death|0|||
146254007|NCT01503515|527442969|FG001|Overall Study|Death|1|||
146254008|NCT01503515|527442968|FG000|Overall Study|Physician Decision|14|||
146254009|NCT01503515|527442969|FG001|Overall Study|Physician Decision|23|||
146254010|NCT01503515|527442968|FG000|Overall Study|Withdrawal by Subject|0|||
146254011|NCT01503515|527442969|FG001|Overall Study|Withdrawal by Subject|1|||
146254012|NCT01503515|527442968|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
146254013|NCT01503515|527442969|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
146254014|NCT01503515|527442968|FG000|Overall Study|Ineligible|1|||
146254015|NCT01503515|527442969|FG001|Overall Study|Ineligible|1|||
146254016|NCT04050722|527442970|FG000|Overall Study|Withdrawal by Subject|1|||
146254017|NCT04050722|527442971|FG001|Overall Study|Withdrawal by Subject|0|||
146254018|NCT01350102|527442972|FG000|Overall Study|Adverse Event|0|||
146254019|NCT01350102|527442973|FG001|Overall Study|Adverse Event|0|||
146254020|NCT01350102|527442974|FG002|Overall Study|Adverse Event|1|||
146254021|NCT01350102|527442975|FG003|Overall Study|Adverse Event|0|||
146254022|NCT03087851|527442979|FG000|Overall Study|Withdraw on medical grounds|0|||
146254023|NCT03087851|527442980|FG001|Overall Study|Withdraw on medical grounds|1|||
146254024|NCT03087851|527442981|FG002|Overall Study|Withdraw on medical grounds|2|||
146254025|NCT00377312|527442984|FG000|Overall Study|Adverse Event|1|||
146254026|NCT00377312|527442985|FG001|Overall Study|Adverse Event|1|||
146254027|NCT02775214|527442986|FG000|Overall Study|Withdrawal by Subject|2|||
146254028|NCT02775214|527442987|FG001|Overall Study|Withdrawal by Subject|0|||
146254029|NCT00762723|527442988|FG000|Overall Study|Study Terminated slow enrollement|5|||
146254030|NCT00762723|527442989|FG001|Overall Study|Study Terminated slow enrollement|5|||
146254031|NCT00762723|527442990|FG002|Overall Study|Study Terminated slow enrollement|3|||
146254032|NCT01572493|527442995|FG000|Overall Study|Physician Decision|1|||
146254033|NCT01572493|527442996|FG001|Overall Study|Physician Decision|0|||
146254034|NCT01572493|527442997|FG002|Overall Study|Physician Decision|0|||
146254035|NCT01572493|527442998|FG003|Overall Study|Physician Decision|0|||
146254036|NCT01572493|527442999|FG004|Overall Study|Physician Decision|0|||
146254037|NCT01572493|527443000|FG005|Overall Study|Physician Decision|0|||
146254038|NCT01572493|527443001|FG006|Overall Study|Physician Decision|0|||
146025752|NCT01118520|526607309|FG002|Overall Study|Adverse Event|3|||
146025753|NCT01118520|526607307|FG000|Overall Study|Withdrawal by Subject|8|||
146025754|NCT01118520|526607308|FG001|Overall Study|Withdrawal by Subject|13|||
146025755|NCT01118520|526607309|FG002|Overall Study|Withdrawal by Subject|8|||
146025756|NCT01089023|526607312|FG000|Overall Study|Lost to Follow-up|3|||
146025757|NCT01089023|526607312|FG000|Overall Study|Adverse Event|1|||
146254039|NCT01572493|527443002|FG007|Overall Study|Physician Decision|0|||
146254040|NCT01572493|527443003|FG008|Overall Study|Physician Decision|0|||
146254041|NCT01572493|527442995|FG000|Overall Study|Switched to alternative treatment|0|||
146254042|NCT01572493|527442996|FG001|Overall Study|Switched to alternative treatment|1|||
146254043|NCT01572493|527442997|FG002|Overall Study|Switched to alternative treatment|2|||
146254044|NCT01572493|527442998|FG003|Overall Study|Switched to alternative treatment|1|||
146254045|NCT01572493|527442999|FG004|Overall Study|Switched to alternative treatment|2|||
146254046|NCT01572493|527443000|FG005|Overall Study|Switched to alternative treatment|0|||
146254047|NCT01572493|527443001|FG006|Overall Study|Switched to alternative treatment|2|||
146254048|NCT01572493|527443002|FG007|Overall Study|Switched to alternative treatment|0|||
146254049|NCT01572493|527443003|FG008|Overall Study|Switched to alternative treatment|2|||
146025758|NCT01089023|526607312|FG000|Overall Study|Withdrawal by Subject|1|||
146254050|NCT01572493|527442995|FG000|Overall Study|Death|0|||
146254051|NCT01572493|527442996|FG001|Overall Study|Death|0|||
146254052|NCT01572493|527442997|FG002|Overall Study|Death|0|||
146254053|NCT01572493|527442998|FG003|Overall Study|Death|1|||
146254054|NCT01572493|527442999|FG004|Overall Study|Death|0|||
146254055|NCT01572493|527443000|FG005|Overall Study|Death|1|||
146254056|NCT01572493|527443001|FG006|Overall Study|Death|0|||
146254057|NCT01572493|527443002|FG007|Overall Study|Death|0|||
146254058|NCT01572493|527443003|FG008|Overall Study|Death|0|||
146254059|NCT01572493|527442995|FG000|Overall Study|Adverse Event|0|||
146254060|NCT01572493|527442996|FG001|Overall Study|Adverse Event|0|||
146254061|NCT01572493|527442997|FG002|Overall Study|Adverse Event|0|||
146254062|NCT01572493|527442998|FG003|Overall Study|Adverse Event|0|||
146254063|NCT01572493|527442999|FG004|Overall Study|Adverse Event|0|||
146025759|NCT01089023|526607312|FG000|Overall Study|Protocol Violation|1|||
146025760|NCT01089023|526607312|FG000|Overall Study|Lack of Efficacy|1|||
146025761|NCT03883113|526607315|FG000|Overall Study|Physician Decision|4|||
146025762|NCT03883113|526607316|FG001|Overall Study|Physician Decision|2|||
146025763|NCT03883113|526607315|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
146025764|NCT03883113|526607316|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
146025765|NCT03883113|526607315|FG000|Overall Study|Pregnancy|1|||
146025766|NCT03883113|526607316|FG001|Overall Study|Pregnancy|0|||
146025767|NCT03883113|526607315|FG000|Overall Study|Adverse Event|0|||
146025768|NCT03883113|526607316|FG001|Overall Study|Adverse Event|1|||
146025769|NCT03883113|526607315|FG000|Overall Study|Withdrawal by Subject|1|||
146025770|NCT03883113|526607316|FG001|Overall Study|Withdrawal by Subject|2|||
146025771|NCT03883113|526607315|FG000|Overall Study|Lost to Follow-up|1|||
146025772|NCT03883113|526607316|FG001|Overall Study|Lost to Follow-up|0|||
146025773|NCT04465877|526607317|FG000|Overall Study|Noncompliant with study requirements|0|||
146025774|NCT04465877|526607318|FG001|Overall Study|Noncompliant with study requirements|0|||
146025775|NCT04465877|526607319|FG002|Overall Study|Noncompliant with study requirements|1|||
146025776|NCT04465877|526607320|FG003|Overall Study|Noncompliant with study requirements|0|||
146025777|NCT04962230|526607326|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
146025778|NCT04962230|526607326|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
146025779|NCT03958656|526607329|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146025780|NCT03958656|526607330|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
146025781|NCT03958656|526607331|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146025782|NCT03958656|526607332|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
146025783|NCT03958656|526607329|FG000|Overall Study|No longer meets eligibility criteria|0|||
146025784|NCT03958656|526607330|FG001|Overall Study|No longer meets eligibility criteria|0|||
146025785|NCT03958656|526607331|FG002|Overall Study|No longer meets eligibility criteria|1|||
146025786|NCT03958656|526607332|FG003|Overall Study|No longer meets eligibility criteria|0|||
146025787|NCT03958656|526607329|FG000|Overall Study|Started anti-cancer treatment|0|||
146025788|NCT03958656|526607330|FG001|Overall Study|Started anti-cancer treatment|0|||
146025789|NCT03958656|526607331|FG002|Overall Study|Started anti-cancer treatment|1|||
146025790|NCT03958656|526607332|FG003|Overall Study|Started anti-cancer treatment|0|||
146025791|NCT01598753|526607335|FG000|Overall Study|Adverse Event|1|||
146025792|NCT01598753|526607336|FG001|Overall Study|Adverse Event|9|||
146025793|NCT01598753|526607337|FG002|Overall Study|Adverse Event|1|||
146025794|NCT01598753|526607338|FG003|Overall Study|Adverse Event|7|||
146025795|NCT01598753|526607335|FG000|Overall Study|Lost to Follow-up|4|||
146025796|NCT01598753|526607336|FG001|Overall Study|Lost to Follow-up|3|||
146025797|NCT01598753|526607337|FG002|Overall Study|Lost to Follow-up|7|||
146025798|NCT01598753|526607338|FG003|Overall Study|Lost to Follow-up|5|||
146025799|NCT01598753|526607335|FG000|Overall Study|Physician Decision|0|||
146025800|NCT01598753|526607336|FG001|Overall Study|Physician Decision|1|||
146025801|NCT01598753|526607337|FG002|Overall Study|Physician Decision|0|||
146025802|NCT01598753|526607338|FG003|Overall Study|Physician Decision|2|||
146025803|NCT01598753|526607335|FG000|Overall Study|Withdrawal by Subject|7|||
146025804|NCT01598753|526607336|FG001|Overall Study|Withdrawal by Subject|2|||
146025805|NCT01598753|526607337|FG002|Overall Study|Withdrawal by Subject|0|||
146025806|NCT01598753|526607338|FG003|Overall Study|Withdrawal by Subject|1|||
146025807|NCT03158012|526607339|FG000|Overall Study|Withdrawal by Subject|0|||
146025808|NCT03158012|526607340|FG001|Overall Study|Withdrawal by Subject|1|||
146025809|NCT02275117|526607341|FG000|Overall Study|Adverse Event|0|||
146025810|NCT02275117|526607342|FG001|Overall Study|Adverse Event|0|||
146025811|NCT02275117|526607343|FG002|Overall Study|Adverse Event|0|||
146025812|NCT02275117|526607344|FG003|Overall Study|Adverse Event|0|||
146025813|NCT02275117|526607345|FG004|Overall Study|Adverse Event|1|||
146025814|NCT02275117|526607341|FG000|Overall Study|Lack of Efficacy|6|||
146025815|NCT02275117|526607342|FG001|Overall Study|Lack of Efficacy|7|||
146025816|NCT02275117|526607343|FG002|Overall Study|Lack of Efficacy|5|||
146025817|NCT02275117|526607344|FG003|Overall Study|Lack of Efficacy|2|||
146025818|NCT02275117|526607345|FG004|Overall Study|Lack of Efficacy|10|||
146025819|NCT02275117|526607341|FG000|Overall Study|Lost to Follow-up|11|||
146025820|NCT02275117|526607342|FG001|Overall Study|Lost to Follow-up|16|||
146025821|NCT02275117|526607343|FG002|Overall Study|Lost to Follow-up|15|||
146025822|NCT02275117|526607344|FG003|Overall Study|Lost to Follow-up|16|||
146025823|NCT02275117|526607345|FG004|Overall Study|Lost to Follow-up|8|||
146025824|NCT02275117|526607341|FG000|Overall Study|Physician Decision|0|||
146025825|NCT02275117|526607342|FG001|Overall Study|Physician Decision|1|||
146025826|NCT02275117|526607343|FG002|Overall Study|Physician Decision|1|||
146025827|NCT02275117|526607344|FG003|Overall Study|Physician Decision|0|||
146025828|NCT02275117|526607345|FG004|Overall Study|Physician Decision|1|||
146025829|NCT02275117|526607341|FG000|Overall Study|Protocol Violation|1|||
146025830|NCT02275117|526607342|FG001|Overall Study|Protocol Violation|0|||
146025831|NCT02275117|526607343|FG002|Overall Study|Protocol Violation|1|||
146025832|NCT02275117|526607344|FG003|Overall Study|Protocol Violation|1|||
146025833|NCT02275117|526607345|FG004|Overall Study|Protocol Violation|0|||
146025834|NCT02275117|526607341|FG000|Overall Study|Withdrawal by Subject|6|||
146025835|NCT02275117|526607342|FG001|Overall Study|Withdrawal by Subject|4|||
146025836|NCT02275117|526607343|FG002|Overall Study|Withdrawal by Subject|7|||
146025837|NCT02275117|526607344|FG003|Overall Study|Withdrawal by Subject|3|||
146025838|NCT02275117|526607345|FG004|Overall Study|Withdrawal by Subject|3|||
146025839|NCT02275117|526607341|FG000|Overall Study|Terminated by Sponsor|4|||
146025840|NCT02275117|526607342|FG001|Overall Study|Terminated by Sponsor|4|||
146025841|NCT02275117|526607343|FG002|Overall Study|Terminated by Sponsor|4|||
146025842|NCT02275117|526607344|FG003|Overall Study|Terminated by Sponsor|6|||
146025843|NCT02275117|526607345|FG004|Overall Study|Terminated by Sponsor|4|||
146025844|NCT02275117|526607341|FG000|Overall Study|Worsening of Study Indication|0|||
146025845|NCT02275117|526607342|FG001|Overall Study|Worsening of Study Indication|1|||
146025846|NCT02275117|526607343|FG002|Overall Study|Worsening of Study Indication|2|||
146025847|NCT02275117|526607344|FG003|Overall Study|Worsening of Study Indication|0|||
146025848|NCT02275117|526607345|FG004|Overall Study|Worsening of Study Indication|0|||
146025849|NCT02275117|526607341|FG000|Overall Study|Study Burden|5|||
146025850|NCT02275117|526607342|FG001|Overall Study|Study Burden|4|||
146025851|NCT02275117|526607343|FG002|Overall Study|Study Burden|7|||
146025852|NCT02275117|526607344|FG003|Overall Study|Study Burden|5|||
146025853|NCT02275117|526607345|FG004|Overall Study|Study Burden|7|||
146025854|NCT02275117|526607341|FG000|Overall Study|Other|1|||
146025855|NCT02275117|526607342|FG001|Overall Study|Other|0|||
146025856|NCT02275117|526607343|FG002|Overall Study|Other|0|||
146025857|NCT02275117|526607344|FG003|Overall Study|Other|0|||
146025858|NCT02275117|526607345|FG004|Overall Study|Other|2|||
146025859|NCT01865812|526607348|FG000|Primary Treatment Phase|Adverse Event|2|||
146025860|NCT01865812|526607349|FG001|Primary Treatment Phase|Adverse Event|0|||
146025861|NCT01865812|526607348|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
146025862|NCT01865812|526607349|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
146025863|NCT01865812|526607348|FG000|Long-term Safety Extension Phase|Pruritus|0|||
146025864|NCT01865812|526607349|FG001|Long-term Safety Extension Phase|Pruritus|3|||
146025865|NCT01865812|526607348|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
146025866|NCT01865812|526607349|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
146025867|NCT01865812|526607348|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
146025868|NCT01865812|526607349|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
146025869|NCT01819129|526607350|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
146025870|NCT01819129|526607351|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
146025871|NCT01819129|526607350|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
146025872|NCT01819129|526607351|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
146025873|NCT01819129|526607350|FG000|Overall Study|Other, Subject moved out of the country|0|||
146025874|NCT01819129|526607351|FG001|Overall Study|Other, Subject moved out of the country|1|||
146025875|NCT01819129|526607350|FG000|Overall Study|Withdrawal by Subject|15|||
146025876|NCT01819129|526607351|FG001|Overall Study|Withdrawal by Subject|15|||
146025877|NCT01819129|526607350|FG000|Overall Study|Lost to Follow-up|5|||
146025878|NCT01819129|526607351|FG001|Overall Study|Lost to Follow-up|2|||
146025879|NCT01819129|526607350|FG000|Overall Study|Lack of Efficacy|0|||
146025880|NCT01819129|526607351|FG001|Overall Study|Lack of Efficacy|1|||
146025881|NCT01819129|526607350|FG000|Overall Study|Adverse Event|1|||
146025882|NCT01819129|526607351|FG001|Overall Study|Adverse Event|4|||
146025883|NCT01819129|526607350|FG000|Overall Study|Death|1|||
146025884|NCT01819129|526607351|FG001|Overall Study|Death|1|||
146025885|NCT01819129|526607350|FG000|Overall Study|Withdrawal Criteria|20|||
146025886|NCT01819129|526607351|FG001|Overall Study|Withdrawal Criteria|15|||
146025887|NCT00054691|526607357|FG000|Overall Study|Unmeasurable Disease|2|||
146025888|NCT00054691|526607357|FG000|Overall Study|Noncompliant|1|||
146025889|NCT02836873|526607358|FG000|Overall Study|Protocol Violation|0|||
146025890|NCT02836873|526607359|FG001|Overall Study|Protocol Violation|1|||
146025891|NCT02836873|526607358|FG000|Overall Study|Adverse Event|1|||
146025892|NCT02836873|526607359|FG001|Overall Study|Adverse Event|4|||
146025893|NCT02836873|526607358|FG000|Overall Study|Withdrawal by Subject|2|||
146025894|NCT02836873|526607359|FG001|Overall Study|Withdrawal by Subject|2|||
146025895|NCT02836873|526607358|FG000|Overall Study|Lost to Follow-up|1|||
146025896|NCT02836873|526607359|FG001|Overall Study|Lost to Follow-up|3|||
146025897|NCT02836873|526607358|FG000|Overall Study|Physician Decision|0|||
146025898|NCT02836873|526607359|FG001|Overall Study|Physician Decision|1|||
146025899|NCT02836873|526607358|FG000|Overall Study|Other|1|||
146025900|NCT02836873|526607359|FG001|Overall Study|Other|0|||
146025901|NCT02142283|526607368|FG000|Overall Study|Death|20|||
146025902|NCT02142283|526607369|FG001|Overall Study|Death|18|||
146025903|NCT02142283|526607368|FG000|Overall Study|Withdrawal by Subject|1|||
146025904|NCT02142283|526607369|FG001|Overall Study|Withdrawal by Subject|3|||
146025905|NCT00747344|526607370|FG000|Controlled Period|Adverse Event|3|||
146025906|NCT00747344|526607371|FG001|Controlled Period|Adverse Event|0|||
146025907|NCT00747344|526607372|FG002|Controlled Period|Adverse Event|0|||
146025908|NCT00747344|526607373|FG003|Controlled Period|Adverse Event|0|||
146025909|NCT00747344|526607370|FG000|Controlled Period|Lack of Efficacy|2|||
146025910|NCT00747344|526607371|FG001|Controlled Period|Lack of Efficacy|1|||
146254064|NCT01572493|527443000|FG005|Overall Study|Adverse Event|0|||
146254065|NCT01572493|527443001|FG006|Overall Study|Adverse Event|1|||
146254066|NCT01572493|527443002|FG007|Overall Study|Adverse Event|0|||
146254067|NCT01572493|527443003|FG008|Overall Study|Adverse Event|0|||
146254068|NCT00609245|527443004|FG000|Overall Study|Adverse Event|1|||
146254069|NCT01090076|527443005|FG000|Overall Study|Death|1|||
146254070|NCT01090076|527443006|FG001|Overall Study|Death|1|||
146254071|NCT01090076|527443005|FG000|Overall Study|Withdrawal by Subject|0|||
146254072|NCT01090076|527443006|FG001|Overall Study|Withdrawal by Subject|1|||
146254073|NCT01116440|527443007|FG000|Treatment|Withdrawal by Subject|2|||
146254074|NCT01116440|527443008|FG001|Treatment|Withdrawal by Subject|2|||
146254075|NCT01116440|527443007|FG000|Treatment|Lost to Follow-up|1|||
146254076|NCT01116440|527443008|FG001|Treatment|Lost to Follow-up|1|||
146254077|NCT01116440|527443007|FG000|Treatment|Protocol Violation|0|||
146254078|NCT01116440|527443008|FG001|Treatment|Protocol Violation|2|||
146254079|NCT01116440|527443007|FG000|Treatment|Lack of Efficacy|0|||
146254080|NCT01116440|527443008|FG001|Treatment|Lack of Efficacy|1|||
146254081|NCT01116440|527443007|FG000|Treatment|Adverse Event|0|||
146254082|NCT01116440|527443008|FG001|Treatment|Adverse Event|1|||
146254083|NCT01116440|527443007|FG000|Withdrawal|Withdrawal by Subject|0|||
146025911|NCT00747344|526607372|FG002|Controlled Period|Lack of Efficacy|0|||
146025912|NCT00747344|526607373|FG003|Controlled Period|Lack of Efficacy|0|||
146025913|NCT00747344|526607370|FG000|Controlled Period|Other|0|||
146025914|NCT00747344|526607371|FG001|Controlled Period|Other|3|||
146025915|NCT00747344|526607372|FG002|Controlled Period|Other|0|||
146025916|NCT00747344|526607373|FG003|Controlled Period|Other|0|||
146025917|NCT00747344|526607370|FG000|After Controlled Period|Adverse Event|0|||
146025918|NCT00747344|526607371|FG001|After Controlled Period|Adverse Event|0|||
146025919|NCT00747344|526607372|FG002|After Controlled Period|Adverse Event|0|||
146025920|NCT00747344|526607373|FG003|After Controlled Period|Adverse Event|1|||
146025921|NCT02374814|526607374|FG000|Overall Study|Lost to Follow-up|1|||
146025922|NCT02374814|526607375|FG001|Overall Study|Lost to Follow-up|1|||
146025923|NCT02374814|526607376|FG002|Overall Study|Lost to Follow-up|0|||
146025924|NCT02374814|526607377|FG003|Overall Study|Lost to Follow-up|1|||
146025925|NCT02374814|526607378|FG004|Overall Study|Lost to Follow-up|0|||
146025926|NCT02374814|526607379|FG005|Overall Study|Lost to Follow-up|0|||
146025927|NCT02374814|526607374|FG000|Overall Study|Withdrawal by Subject|0|||
146025928|NCT02374814|526607375|FG001|Overall Study|Withdrawal by Subject|0|||
146025929|NCT02374814|526607376|FG002|Overall Study|Withdrawal by Subject|1|||
146025930|NCT02374814|526607377|FG003|Overall Study|Withdrawal by Subject|1|||
146025931|NCT02374814|526607378|FG004|Overall Study|Withdrawal by Subject|0|||
146025932|NCT02374814|526607379|FG005|Overall Study|Withdrawal by Subject|0|||
146025933|NCT03093974|526607380|FG000|Overall Study|Withdrawal by Subject|32|||
146025934|NCT03093974|526607381|FG001|Overall Study|Withdrawal by Subject|27|||
146025935|NCT03093974|526607380|FG000|Overall Study|Adverse Event|17|||
146025936|NCT03093974|526607381|FG001|Overall Study|Adverse Event|24|||
146025937|NCT03093974|526607380|FG000|Overall Study|Death|0|||
146025938|NCT03093974|526607381|FG001|Overall Study|Death|1|||
146025939|NCT03093974|526607380|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146094624|NCT00700570|526867857|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
146094625|NCT00700570|526867856|FG000|Overall Study|Disease Progression|8|||
146094626|NCT00700570|526867857|FG001|Overall Study|Disease Progression|11|||
146094627|NCT00700570|526867856|FG000|Overall Study|Withdrawal by Subject|1|||
146094628|NCT00700570|526867857|FG001|Overall Study|Withdrawal by Subject|6|||
146094629|NCT02556203|526867858|FG000|Overall Study|Withdrawal by Subject|21|||
146094630|NCT02556203|526867859|FG001|Overall Study|Withdrawal by Subject|21|||
146094631|NCT02556203|526867858|FG000|Overall Study|Lost to Follow-up|5|||
146094632|NCT02556203|526867859|FG001|Overall Study|Lost to Follow-up|5|||
146094633|NCT02556203|526867858|FG000|Overall Study|Adverse Event|1|||
146254084|NCT01116440|527443008|FG001|Withdrawal|Withdrawal by Subject|1|||
146254085|NCT01116440|527443007|FG000|Withdrawal|Lost to Follow-up|0|||
146254086|NCT01116440|527443008|FG001|Withdrawal|Lost to Follow-up|1|||
146094634|NCT02556203|526867859|FG001|Overall Study|Adverse Event|0|||
146094635|NCT02943460|526867865|FG000|Blinded Study Phase|Adverse Event|3|||
146094636|NCT02943460|526867866|FG001|Blinded Study Phase|Adverse Event|0|||
146094637|NCT02943460|526867867|FG002|Blinded Study Phase|Adverse Event|0|||
146094638|NCT02943460|526867865|FG000|Blinded Study Phase|Withdrew Consent|0|||
146094639|NCT02943460|526867866|FG001|Blinded Study Phase|Withdrew Consent|1|||
146094640|NCT02943460|526867867|FG002|Blinded Study Phase|Withdrew Consent|0|||
146094641|NCT02943460|526867865|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
146094642|NCT02943460|526867866|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
146254087|NCT01116440|527443007|FG000|Follow-up|Lost to Follow-up|0|||
146254088|NCT01116440|527443008|FG001|Follow-up|Lost to Follow-up|1|||
146254089|NCT01116440|527443007|FG000|Follow-up|Withdrawal by Subject|0|||
146254090|NCT01116440|527443008|FG001|Follow-up|Withdrawal by Subject|1|||
146254091|NCT02402465|527443020|FG000|Overall Study|Withdrawal by Subject|0|||
146094643|NCT02943460|526867867|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
146094644|NCT02943460|526867865|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
146254092|NCT02402465|527443021|FG001|Overall Study|Withdrawal by Subject|0|||
146094645|NCT02943460|526867866|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
146094646|NCT02943460|526867867|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
146094647|NCT02943460|526867865|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
146094648|NCT02943460|526867866|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
146094649|NCT02943460|526867867|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
146094650|NCT03875768|526867868|FG000|Overall Study|Lost to Follow-up|16|||
146094651|NCT03875768|526867869|FG001|Overall Study|Lost to Follow-up|13|||
146094652|NCT03875768|526867868|FG000|Overall Study|Withdrawal by Subject|10|||
146094653|NCT03875768|526867869|FG001|Overall Study|Withdrawal by Subject|21|||
146094654|NCT03875768|526867868|FG000|Overall Study|Did not complete assessment|21|||
146094655|NCT03875768|526867869|FG001|Overall Study|Did not complete assessment|12|||
146094656|NCT03875768|526867868|FG000|Overall Study|Became ineligible|1|||
146094657|NCT03875768|526867869|FG001|Overall Study|Became ineligible|0|||
146094658|NCT01925274|526867870|FG000|Overall Study|Death|1|||
146094659|NCT01925274|526867871|FG001|Overall Study|Death|0|||
146094660|NCT01925274|526867872|FG002|Overall Study|Death|0|||
146094661|NCT01925274|526867870|FG000|Overall Study|Lost to Follow-up|0|||
146094662|NCT01925274|526867871|FG001|Overall Study|Lost to Follow-up|1|||
146094663|NCT01925274|526867872|FG002|Overall Study|Lost to Follow-up|0|||
146094664|NCT01925274|526867870|FG000|Overall Study|Withdrawal by Subject|1|||
146094665|NCT01925274|526867871|FG001|Overall Study|Withdrawal by Subject|2|||
146094666|NCT01925274|526867872|FG002|Overall Study|Withdrawal by Subject|0|||
146094667|NCT01925274|526867870|FG000|Overall Study|Study terminated by sponsor|4|||
146094668|NCT01925274|526867871|FG001|Overall Study|Study terminated by sponsor|0|||
146094669|NCT01925274|526867872|FG002|Overall Study|Study terminated by sponsor|0|||
146094670|NCT01925274|526867870|FG000|Overall Study|Protocol amendment|1|||
146094671|NCT01925274|526867871|FG001|Overall Study|Protocol amendment|3|||
146094672|NCT01925274|526867872|FG002|Overall Study|Protocol amendment|6|||
146094673|NCT04327674|526867873|FG000|Overall Study|Protocol Violation|19|||
146094674|NCT00437320|526867878|FG000|Overall Study|Participant request|2|||
146094675|NCT00437320|526867879|FG001|Overall Study|Participant request|1|||
146094676|NCT00437320|526867880|FG002|Overall Study|Participant request|4|||
146094677|NCT01400815|526867882|FG000|Overall Study|Adverse Event|3|||
146094678|NCT01400815|526867883|FG001|Overall Study|Adverse Event|0|||
146094679|NCT01400815|526867882|FG000|Overall Study|Death|0|||
146094680|NCT01400815|526867883|FG001|Overall Study|Death|1|||
146094681|NCT01400815|526867882|FG000|Overall Study|Lost to Follow-up|18|||
146094682|NCT01400815|526867883|FG001|Overall Study|Lost to Follow-up|11|||
146094683|NCT01400815|526867882|FG000|Overall Study|Protocol Violation|0|||
146094684|NCT01400815|526867883|FG001|Overall Study|Protocol Violation|1|||
146094685|NCT01400815|526867882|FG000|Overall Study|Physician Decision|1|||
146094686|NCT01400815|526867883|FG001|Overall Study|Physician Decision|0|||
146094687|NCT01400815|526867882|FG000|Overall Study|Withdrawal by Subject|15|||
146094688|NCT01400815|526867883|FG001|Overall Study|Withdrawal by Subject|8|||
146094689|NCT01400815|526867882|FG000|Overall Study|Subject in jail|1|||
146094690|NCT01400815|526867883|FG001|Overall Study|Subject in jail|0|||
146094691|NCT01123850|526867884|FG000|Overall Study|Slow enrollment|45|||
146094692|NCT00381381|526867887|FG000|Overall Study|Adverse Event|3|||
146094693|NCT00381381|526867887|FG000|Overall Study|Lost to Follow-up|52|||
146094694|NCT00381381|526867887|FG000|Overall Study|Withdrawal by Subject|9|||
146094695|NCT00568685|526867890|FG000|Overall Study|Adverse Event|2|||
146094696|NCT00568685|526867891|FG001|Overall Study|Adverse Event|3|||
146094697|NCT00568685|526867892|FG002|Overall Study|Adverse Event|3|||
146094698|NCT00568685|526867890|FG000|Overall Study|Withdrawal by Subject|7|||
146094699|NCT00568685|526867891|FG001|Overall Study|Withdrawal by Subject|2|||
146094700|NCT00568685|526867892|FG002|Overall Study|Withdrawal by Subject|2|||
146025940|NCT03093974|526607381|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146025941|NCT03093974|526607380|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
146025942|NCT03093974|526607381|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
146025943|NCT03093974|526607380|FG000|Overall Study|Lost to Follow-up|0|||
146025944|NCT03093974|526607381|FG001|Overall Study|Lost to Follow-up|1|||
146025945|NCT03093974|526607380|FG000|Overall Study|Other|1|||
146025946|NCT03093974|526607381|FG001|Overall Study|Other|2|||
146025947|NCT02141490|526607382|FG000|Overall Study|Screening failures|4|||
146025948|NCT02141490|526607383|FG001|Overall Study|Screening failures|0|||
146025949|NCT02141490|526607384|FG002|Overall Study|Screening failures|0|||
146025950|NCT00033540|526607387|FG000|Overall Study|Adverse Event|14|||
146094701|NCT00568685|526867890|FG000|Overall Study|Protocol Violation|1|||
146094702|NCT00568685|526867891|FG001|Overall Study|Protocol Violation|0|||
146300297|NCT01006265|527615213|FG001|Overall Study|Lost to Follow-up|0|||
146094703|NCT00568685|526867892|FG002|Overall Study|Protocol Violation|0|||
146094704|NCT01638819|526867894|FG000|Overall Study|Lost to Follow-up|1|||
146094705|NCT01638819|526867895|FG001|Overall Study|Lost to Follow-up|0|||
146094706|NCT00471146|526867898|FG000|Overall Study|Adverse Event|32|||
146094707|NCT00471146|526867899|FG001|Overall Study|Adverse Event|33|||
146094708|NCT00471146|526867898|FG000|Overall Study|Withdrawal by Subject|14|||
146094709|NCT00471146|526867899|FG001|Overall Study|Withdrawal by Subject|11|||
146094710|NCT00471146|526867898|FG000|Overall Study|Death|11|||
146094711|NCT00471146|526867899|FG001|Overall Study|Death|12|||
146025951|NCT00033540|526607387|FG000|Overall Study|Death|1|||
146025952|NCT00033540|526607387|FG000|Overall Study|Progression|26|||
146025953|NCT00033540|526607387|FG000|Overall Study|Withdrawal by Subject|6|||
146025954|NCT00033540|526607387|FG000|Overall Study|Other|5|||
146025955|NCT00033540|526607387|FG000|Overall Study|Ineligible|3|||
146025956|NCT00033540|526607387|FG000|Overall Study|Never received treatment|2|||
146025957|NCT01253265|526607390|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
146025958|NCT01253265|526607391|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
146025959|NCT01253265|526607392|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
146025960|NCT01253265|526607393|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
146025961|NCT01253265|526607394|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
146025962|NCT01253265|526607390|FG000|Overall Study|Withdrawal by Subject|0|||
146025963|NCT01253265|526607391|FG001|Overall Study|Withdrawal by Subject|0|||
146025964|NCT01253265|526607392|FG002|Overall Study|Withdrawal by Subject|0|||
146025965|NCT01253265|526607393|FG003|Overall Study|Withdrawal by Subject|0|||
146025966|NCT01253265|526607394|FG004|Overall Study|Withdrawal by Subject|1|||
146025967|NCT00434759|526607397|FG000|Overall Study|Lack of Efficacy|5|||
146025968|NCT00434759|526607398|FG001|Overall Study|Lack of Efficacy|4|||
146025969|NCT00434759|526607397|FG000|Overall Study|Withdrawal by Subject|17|||
146025970|NCT00434759|526607398|FG001|Overall Study|Withdrawal by Subject|1|||
146025971|NCT00434759|526607397|FG000|Overall Study|family affairs|2|||
146025972|NCT00434759|526607398|FG001|Overall Study|family affairs|0|||
146025973|NCT00495521|526607399|FG000|Overall Study|Physician Decision|0|||
146025974|NCT00495521|526607400|FG001|Overall Study|Physician Decision|1|||
146094712|NCT00471146|526867898|FG000|Overall Study|Lost to Follow-up|4|||
146094713|NCT00471146|526867899|FG001|Overall Study|Lost to Follow-up|2|||
146094714|NCT00471146|526867898|FG000|Overall Study|Protocol Violation|2|||
146094715|NCT00471146|526867899|FG001|Overall Study|Protocol Violation|2|||
146094716|NCT00471146|526867898|FG000|Overall Study|Objective progression or relapse|84|||
146094717|NCT00471146|526867899|FG001|Overall Study|Objective progression or relapse|87|||
146094718|NCT00471146|526867898|FG000|Overall Study|Global deterioration of health status|12|||
146094719|NCT00471146|526867899|FG001|Overall Study|Global deterioration of health status|14|||
146094720|NCT00471146|526867898|FG000|Overall Study|Randomized but not treated|9|||
146094721|NCT00471146|526867899|FG001|Overall Study|Randomized but not treated|8|||
146094722|NCT00471146|526867898|FG000|Overall Study|Other|4|||
146094723|NCT00471146|526867899|FG001|Overall Study|Other|5|||
146094724|NCT03538431|526867900|FG000|Overall Study|Physician Decision|0|||
146025975|NCT02410824|526607401|FG000|First Intervention (One Week)|Headache|0|||
146025976|NCT02410824|526607402|FG001|First Intervention (One Week)|Headache|1|||
146025977|NCT02782325|526607403|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
146025978|NCT02782325|526607404|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
146025979|NCT02782325|526607405|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
146025980|NCT02782325|526607403|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
146025981|NCT02782325|526607404|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
146025982|NCT02782325|526607405|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
146025983|NCT01038713|526607406|FG000|Overall Study|Patient to hospice|1|||
146025984|NCT01038713|526607407|FG001|Overall Study|Patient to hospice|1|||
146025985|NCT01038713|526607408|FG002|Overall Study|Patient to hospice|1|||
146025986|NCT01038713|526607406|FG000|Overall Study|Lost to Follow-up|3|||
146025987|NCT01038713|526607407|FG001|Overall Study|Lost to Follow-up|0|||
146025988|NCT01038713|526607408|FG002|Overall Study|Lost to Follow-up|0|||
146025989|NCT01038713|526607406|FG000|Overall Study|Neuroendocrine Tumor|0|||
146025990|NCT01038713|526607407|FG001|Overall Study|Neuroendocrine Tumor|1|||
146025991|NCT01038713|526607408|FG002|Overall Study|Neuroendocrine Tumor|0|||
146025992|NCT01038713|526607406|FG000|Overall Study|died from PEP|0|||
146025993|NCT01038713|526607407|FG001|Overall Study|died from PEP|1|||
146025994|NCT01038713|526607408|FG002|Overall Study|died from PEP|0|||
146025995|NCT01038713|526607406|FG000|Overall Study|Autoimmune Pancreatitis|1|||
146025996|NCT01038713|526607407|FG001|Overall Study|Autoimmune Pancreatitis|0|||
146025997|NCT01038713|526607408|FG002|Overall Study|Autoimmune Pancreatitis|0|||
146025998|NCT03777917|526607409|FG000|Overall Study|Withdrawal by Subject|1|||
146025999|NCT03777917|526607410|FG001|Overall Study|Withdrawal by Subject|0|||
146026000|NCT03777917|526607409|FG000|Overall Study|Physician Decision|1|||
146026001|NCT03777917|526607410|FG001|Overall Study|Physician Decision|0|||
146026002|NCT03777917|526607409|FG000|Overall Study|Lost to Follow-up|6|||
146026003|NCT03777917|526607410|FG001|Overall Study|Lost to Follow-up|2|||
146026004|NCT03777917|526607409|FG000|Overall Study|Other|1|||
146026005|NCT03777917|526607410|FG001|Overall Study|Other|0|||
146026006|NCT00930969|526607411|FG000|Overall Study|Death|5|||
146026007|NCT00930969|526607411|FG000|Overall Study|Lost to Follow-up|1|||
146026008|NCT00930969|526607411|FG000|Overall Study|Physician Decision|13|||
146094725|NCT03538431|526867901|FG001|Overall Study|Physician Decision|1|||
146094726|NCT03538431|526867900|FG000|Overall Study|Withdrawal by Subject|1|||
146094727|NCT03538431|526867901|FG001|Overall Study|Withdrawal by Subject|0|||
146026009|NCT00930969|526607411|FG000|Overall Study|Withdrawal by Subject|19|||
146026010|NCT00657150|526607412|FG000|Overall Study|Adverse Event|19|||
146026011|NCT00657150|526607413|FG001|Overall Study|Adverse Event|10|||
146026012|NCT00657150|526607412|FG000|Overall Study|Non-compliant with protocol|5|||
146026013|NCT00657150|526607413|FG001|Overall Study|Non-compliant with protocol|9|||
146026014|NCT00657150|526607412|FG000|Overall Study|Lost to Follow-up|2|||
146026015|NCT00657150|526607413|FG001|Overall Study|Lost to Follow-up|0|||
146026016|NCT00657150|526607412|FG000|Overall Study|Withdrawal by Subject|51|||
146026017|NCT00657150|526607413|FG001|Overall Study|Withdrawal by Subject|36|||
146094728|NCT03643159|526867904|FG000|Overall Study|Adverse Event|1|||
146094729|NCT03643159|526867904|FG000|Overall Study|Withdrawal by Subject|1|||
146094730|NCT03438383|526867905|FG000|Overall Study|Protocol Violation|9|||
146094731|NCT03438383|526867906|FG001|Overall Study|Protocol Violation|3|||
146094732|NCT01528033|526867907|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
146094733|NCT01528033|526867908|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
146094734|NCT01528033|526867907|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
146094735|NCT01528033|526867908|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
146094736|NCT01528033|526867907|FG000|Primary Endpoint Assessment ITT|Death|2|||
146094737|NCT01528033|526867908|FG001|Primary Endpoint Assessment ITT|Death|2|||
146094738|NCT01528033|526867907|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
146094739|NCT01528033|526867908|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
146094740|NCT01528033|526867907|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
146094741|NCT01528033|526867908|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
146094742|NCT01528033|526867907|FG000|Follow Up|No data available|46|||
146094743|NCT01528033|526867908|FG001|Follow Up|No data available|44|||
146094744|NCT02030938|526867911|FG000|Overall Study|Lost to Follow-up|4|||
146094745|NCT02030938|526867911|FG000|Overall Study|Withdrawal by Subject|1|||
146094746|NCT03148275|526867916|FG000|Overall Study|Death|6|||
146094747|NCT03148275|526867916|FG000|Overall Study|Adverse Event|3|||
146094748|NCT03148275|526867916|FG000|Overall Study|Liver transplant|2|||
146094749|NCT03148275|526867916|FG000|Overall Study|Patient decision|5|||
146300298|NCT01006265|527615214|FG002|Overall Study|Lost to Follow-up|1|||
146300299|NCT01006265|527615215|FG003|Overall Study|Lost to Follow-up|0|||
146300300|NCT01006265|527615212|FG000|Overall Study|Withdrawal by Subject|4|||
146300301|NCT01006265|527615213|FG001|Overall Study|Withdrawal by Subject|7|||
146300302|NCT01006265|527615214|FG002|Overall Study|Withdrawal by Subject|5|||
146300303|NCT01006265|527615215|FG003|Overall Study|Withdrawal by Subject|5|||
146300304|NCT01006265|527615212|FG000|Overall Study|Administrative reason|1|||
146300305|NCT01006265|527615213|FG001|Overall Study|Administrative reason|2|||
146300306|NCT01006265|527615214|FG002|Overall Study|Administrative reason|3|||
146300307|NCT01006265|527615215|FG003|Overall Study|Administrative reason|0|||
146300308|NCT00698932|527615216|FG000|Overall Study|Adverse Event|0|||
146300309|NCT00698932|527615217|FG001|Overall Study|Adverse Event|2|||
146300310|NCT00698932|527615216|FG000|Overall Study|Incorrect enrollment|0|||
146300311|NCT00698932|527615217|FG001|Overall Study|Incorrect enrollment|2|||
146026018|NCT00657150|526607412|FG000|Overall Study|Other|38|||
146026019|NCT00657150|526607413|FG001|Overall Study|Other|38|||
146026020|NCT00657150|526607412|FG000|Treatment|Adverse Event|60|||
146026021|NCT00657150|526607413|FG001|Treatment|Adverse Event|53|||
146026022|NCT00657150|526607412|FG000|Treatment|Non-compliant with protocol|10|||
146026023|NCT00657150|526607413|FG001|Treatment|Non-compliant with protocol|9|||
146026024|NCT00657150|526607412|FG000|Treatment|Lost to Follow-up|1|||
146026025|NCT00657150|526607413|FG001|Treatment|Lost to Follow-up|0|||
146026026|NCT00657150|526607412|FG000|Treatment|Withdrawal by Subject|23|||
146026027|NCT00657150|526607413|FG001|Treatment|Withdrawal by Subject|20|||
146026028|NCT00657150|526607412|FG000|Treatment|Other|13|||
146026029|NCT00657150|526607413|FG001|Treatment|Other|15|||
146026030|NCT02966795|526607414|FG000|Overall Study|Patient Left the Country|0|||
146026031|NCT02966795|526607415|FG001|Overall Study|Patient Left the Country|1|||
146026032|NCT00432744|526607416|FG000|Months 0-6|Withdrawal by Subject|4|||
146026033|NCT00432744|526607417|FG001|Months 0-6|Withdrawal by Subject|4|||
146026034|NCT00432744|526607416|FG000|Months 0-6|Too disabled to score|1|||
146026035|NCT00432744|526607417|FG001|Months 0-6|Too disabled to score|0|||
146026036|NCT00432744|526607416|FG000|Months 7 - 12|Withdrawal by Subject|1|||
146094750|NCT03148275|526867916|FG000|Overall Study|transition to commercial drug|1|||
146094751|NCT03148275|526867916|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
146300312|NCT00698932|527615216|FG000|Overall Study|Study specific discontinuation criteria|3|||
146300313|NCT00698932|527615217|FG001|Overall Study|Study specific discontinuation criteria|4|||
146094752|NCT05098938|526867917|FG000|Overall Study|Adverse Event|4|||
146094753|NCT05098938|526867918|FG001|Overall Study|Adverse Event|3|||
146300314|NCT00698932|527615216|FG000|Overall Study|Withdrawal by Subject|11|||
146300315|NCT00698932|527615217|FG001|Overall Study|Withdrawal by Subject|23|||
146300316|NCT00698932|527615216|FG000|Overall Study|Lost to Follow-up|6|||
146026037|NCT00432744|526607417|FG001|Months 7 - 12|Withdrawal by Subject|0|||
146026038|NCT00432744|526607416|FG000|Months 7 - 12|Too disabled to score|0|||
146026039|NCT00432744|526607417|FG001|Months 7 - 12|Too disabled to score|1|||
146026040|NCT01416441|526607418|FG000|Overall Study|Lost to Follow-up|5|||
146026041|NCT01416441|526607418|FG000|Overall Study|Adverse Event|6|||
146026042|NCT01416441|526607418|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
146094754|NCT05098938|526867917|FG000|Overall Study|inclusion/exclusion criteria change|11|||
146094755|NCT05098938|526867918|FG001|Overall Study|inclusion/exclusion criteria change|5|||
146094756|NCT05098938|526867917|FG000|Overall Study|lack of compliance|26|||
146094757|NCT05098938|526867918|FG001|Overall Study|lack of compliance|19|||
146094758|NCT05098938|526867917|FG000|Overall Study|Lost to Follow-up|37|||
146094759|NCT05098938|526867918|FG001|Overall Study|Lost to Follow-up|40|||
146094760|NCT05098938|526867917|FG000|Overall Study|Lost in treatment period|17|||
146094761|NCT05098938|526867918|FG001|Overall Study|Lost in treatment period|13|||
146094762|NCT05098938|526867917|FG000|Overall Study|Met an exclusion criterion|0|||
146094763|NCT05098938|526867918|FG001|Overall Study|Met an exclusion criterion|3|||
146094764|NCT05098938|526867917|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
146094765|NCT05098938|526867918|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
146094766|NCT05098938|526867917|FG000|Overall Study|Physician Decision|25|||
146094767|NCT05098938|526867918|FG001|Overall Study|Physician Decision|32|||
146094768|NCT05098938|526867917|FG000|Overall Study|Run in failure in treatment phase|1|||
146094769|NCT05098938|526867918|FG001|Overall Study|Run in failure in treatment phase|1|||
146094770|NCT05098938|526867917|FG000|Overall Study|Withdrawal by Subject|0|||
146094771|NCT05098938|526867918|FG001|Overall Study|Withdrawal by Subject|3|||
146094772|NCT05098938|526867917|FG000|Overall Study|Run-in Failure in early study|505|||
146094773|NCT05098938|526867918|FG001|Overall Study|Run-in Failure in early study|514|||
146094774|NCT05098938|526867917|FG000|Overall Study|IMP delivery missed|1|||
146094775|NCT05098938|526867918|FG001|Overall Study|IMP delivery missed|5|||
146094776|NCT05098938|526867917|FG000|Overall Study|6 months visit was missed|2|||
146094777|NCT05098938|526867918|FG001|Overall Study|6 months visit was missed|0|||
146094778|NCT05098938|526867917|FG000|Overall Study|fit for use was not completed within window|3|||
146094779|NCT05098938|526867918|FG001|Overall Study|fit for use was not completed within window|0|||
146094780|NCT05098938|526867917|FG000|Overall Study|V2 visit was not completed within window|0|||
146094781|NCT05098938|526867918|FG001|Overall Study|V2 visit was not completed within window|1|||
146094782|NCT05098938|526867917|FG000|Overall Study|exclusionary medication use|1|||
146094783|NCT05098938|526867918|FG001|Overall Study|exclusionary medication use|2|||
146094784|NCT05098938|526867917|FG000|Overall Study|change in medication|1|||
146094785|NCT05098938|526867918|FG001|Overall Study|change in medication|0|||
146094786|NCT05098938|526867917|FG000|Overall Study|treatment failure|2|||
146094787|NCT05098938|526867918|FG001|Overall Study|treatment failure|1|||
146094788|NCT03803683|526867919|FG000|Overall Study|Lost to Follow-up|41|||
146094789|NCT03803683|526867920|FG001|Overall Study|Lost to Follow-up|18|||
146094790|NCT03803683|526867921|FG002|Overall Study|Lost to Follow-up|12|||
146094791|NCT03803683|526867919|FG000|Overall Study|Withdrawal by Subject|9|||
146094792|NCT03803683|526867920|FG001|Overall Study|Withdrawal by Subject|1|||
146094793|NCT03803683|526867921|FG002|Overall Study|Withdrawal by Subject|4|||
146094794|NCT00492050|526867922|FG000|Overall Study|Adverse Event|1|||
146094795|NCT00492050|526867922|FG000|Overall Study|Lack of Efficacy|1|||
146094796|NCT00492050|526867922|FG000|Overall Study|Withdrawal by Subject|3|||
146094797|NCT00492050|526867922|FG000|Overall Study|Unable to collect SCT|2|||
146094798|NCT00492050|526867922|FG000|Overall Study|Progressive Disease|2|||
146094799|NCT00537238|526869604|FG000|Overall Study|Death|1|||
146094800|NCT00537238|526869605|FG001|Overall Study|Death|2|||
146094801|NCT00537238|526869604|FG000|Overall Study|Adverse Event|31|||
146094802|NCT00537238|526869605|FG001|Overall Study|Adverse Event|22|||
146094803|NCT00537238|526869604|FG000|Overall Study|Lack of Efficacy|20|||
146094804|NCT00537238|526869605|FG001|Overall Study|Lack of Efficacy|21|||
146094805|NCT00537238|526869604|FG000|Overall Study|Lost to Follow-up|12|||
146094806|NCT00537238|526869605|FG001|Overall Study|Lost to Follow-up|8|||
146094807|NCT00537238|526869604|FG000|Overall Study|Withdrawal by Subject|51|||
146094808|NCT00537238|526869605|FG001|Overall Study|Withdrawal by Subject|47|||
146094809|NCT00537238|526869604|FG000|Overall Study|Protocol Violation|15|||
146094810|NCT00537238|526869605|FG001|Overall Study|Protocol Violation|19|||
146094811|NCT00537238|526869604|FG000|Overall Study|Does not meet entrance criteria|0|||
146094812|NCT00537238|526869605|FG001|Overall Study|Does not meet entrance criteria|2|||
146094813|NCT00537238|526869604|FG000|Overall Study|Other|44|||
146094814|NCT00537238|526869605|FG001|Overall Study|Other|52|||
146254093|NCT02402465|527443022|FG002|Overall Study|Withdrawal by Subject|0|||
146254094|NCT02402465|527443023|FG003|Overall Study|Withdrawal by Subject|0|||
146254095|NCT02402465|527443024|FG004|Overall Study|Withdrawal by Subject|0|||
146254096|NCT02402465|527443025|FG005|Overall Study|Withdrawal by Subject|1|||
146254097|NCT02402465|527443020|FG000|Overall Study|Lost to Follow-up|0|||
146094815|NCT01193660|526869608|FG000|Overall Study|Withdrawal by Subject|2|||
146094816|NCT01193660|526869609|FG001|Overall Study|Withdrawal by Subject|3|||
146094817|NCT01193660|526869610|FG002|Overall Study|Withdrawal by Subject|1|||
146094818|NCT01193660|526869608|FG000|Overall Study|Death|1|||
146094819|NCT01193660|526869609|FG001|Overall Study|Death|0|||
146094820|NCT01193660|526869610|FG002|Overall Study|Death|0|||
146094821|NCT01193660|526869608|FG000|Overall Study|Physician Decision|1|||
146094822|NCT01193660|526869609|FG001|Overall Study|Physician Decision|0|||
146094823|NCT01193660|526869610|FG002|Overall Study|Physician Decision|1|||
146094824|NCT02367131|526869611|FG000|Overall Study|Adverse Event|64|||
146254098|NCT02402465|527443021|FG001|Overall Study|Lost to Follow-up|1|||
146026043|NCT01416441|526607418|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
146026044|NCT01416441|526607418|FG000|Overall Study|Investigator Withdrew Subject|2|||
146026045|NCT01416441|526607418|FG000|Overall Study|Subject Withdrew Consent|12|||
146026046|NCT01416441|526607418|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
146094825|NCT02367131|526869611|FG000|Overall Study|No visit since the first visit|3|||
146094826|NCT02367131|526869611|FG000|Overall Study|Request by patient|53|||
146094827|NCT02367131|526869611|FG000|Overall Study|Improvement/remission|2|||
146094828|NCT02367131|526869611|FG000|Overall Study|No change/progressive disease|78|||
146094829|NCT02367131|526869611|FG000|Overall Study|Other than stated above|20|||
146094830|NCT02367131|526869611|FG000|Overall Study|Not treated|2|||
146094831|NCT05061966|526869612|FG000|Overall Study|Lost to Follow-up|13|||
146094832|NCT05061966|526869613|FG001|Overall Study|Lost to Follow-up|13|||
146094833|NCT01675427|526869618|FG000|Overall Study|Withdrawal by Subject|7|||
146094834|NCT01675427|526869618|FG000|Overall Study|Participant Refused Sample Collection|18|||
146094835|NCT01675427|526869618|FG000|Overall Study|Sample not Collected by Mistake|2|||
146094836|NCT01675427|526869618|FG000|Overall Study|Lost to Follow-up|5|||
146094837|NCT01675427|526869618|FG000|Overall Study|Other|2|||
146094838|NCT00611533|526869619|FG000|First Intervention (6 Weeks)|Never started study|0|||
146094839|NCT00611533|526869620|FG001|First Intervention (6 Weeks)|Never started study|1|||
146094840|NCT00611533|526869619|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
146094841|NCT00611533|526869620|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
146094842|NCT00611533|526869619|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
146094843|NCT00611533|526869620|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
146094844|NCT04171765|526869624|FG000|Overall Study|Adverse Event|2|||
146094845|NCT04171765|526869625|FG001|Overall Study|Adverse Event|0|||
146094846|NCT04171765|526869626|FG002|Overall Study|Adverse Event|1|||
146094847|NCT04171765|526869627|FG003|Overall Study|Adverse Event|0|||
146094848|NCT04171765|526869624|FG000|Overall Study|Lost to Follow-up|0|||
146094849|NCT04171765|526869625|FG001|Overall Study|Lost to Follow-up|2|||
146094850|NCT04171765|526869626|FG002|Overall Study|Lost to Follow-up|2|||
146094851|NCT04171765|526869627|FG003|Overall Study|Lost to Follow-up|2|||
146094852|NCT04171765|526869624|FG000|Overall Study|Week 58 visit missed|0|||
146094853|NCT04171765|526869625|FG001|Overall Study|Week 58 visit missed|0|||
146026047|NCT04030247|526609397|FG000|Overall Study|Withdrawal by Subject|4|||
146026048|NCT04030247|526609397|FG000|Overall Study|Lost to Follow-up|13|||
146026049|NCT01930890|526609399|FG000|Overall Study|Study Termination|14|||
146026050|NCT01930890|526609400|FG001|Overall Study|Study Termination|28|||
146026051|NCT01930890|526609401|FG002|Overall Study|Study Termination|13|||
146026052|NCT01930890|526609402|FG003|Overall Study|Study Termination|25|||
146026053|NCT01930890|526609399|FG000|Overall Study|Death|0|||
146026054|NCT01930890|526609400|FG001|Overall Study|Death|0|||
146026055|NCT01930890|526609401|FG002|Overall Study|Death|0|||
146026056|NCT01930890|526609402|FG003|Overall Study|Death|1|||
146026057|NCT01930890|526609399|FG000|Overall Study|Investigator Decision|0|||
146026058|NCT01930890|526609400|FG001|Overall Study|Investigator Decision|1|||
146026059|NCT01930890|526609401|FG002|Overall Study|Investigator Decision|0|||
146026060|NCT01930890|526609402|FG003|Overall Study|Investigator Decision|0|||
146026061|NCT01930890|526609399|FG000|Overall Study|Consent Withdrawn|0|||
146026062|NCT01930890|526609400|FG001|Overall Study|Consent Withdrawn|3|||
146026063|NCT01930890|526609401|FG002|Overall Study|Consent Withdrawn|0|||
146026064|NCT01930890|526609402|FG003|Overall Study|Consent Withdrawn|1|||
146026065|NCT01930890|526609399|FG000|Overall Study|Adverse Event|0|||
146026066|NCT01930890|526609400|FG001|Overall Study|Adverse Event|1|||
146026067|NCT01930890|526609401|FG002|Overall Study|Adverse Event|0|||
146026068|NCT01930890|526609402|FG003|Overall Study|Adverse Event|0|||
146026069|NCT01596335|526609403|FG000|Overall Study|exacerbation of primary disease|5|||
146026070|NCT01596335|526609404|FG001|Overall Study|exacerbation of primary disease|9|||
146026071|NCT01460719|526609405|FG000|Overall Study|Adverse Event|1|||
146026072|NCT01460719|526609405|FG000|Overall Study|Withdrawal by Subject|1|||
146026073|NCT03602885|526609412|FG000|Overall Study|Lost to Follow-up|3|||
146254099|NCT02402465|527443022|FG002|Overall Study|Lost to Follow-up|0|||
146254100|NCT02402465|527443023|FG003|Overall Study|Lost to Follow-up|0|||
146254101|NCT02402465|527443024|FG004|Overall Study|Lost to Follow-up|1|||
146026074|NCT03602885|526609413|FG001|Overall Study|Lost to Follow-up|0|||
146026075|NCT03383783|526609418|FG000|Overall Study|Withdrawal by Subject|2|||
146094854|NCT04171765|526869626|FG002|Overall Study|Week 58 visit missed|1|||
146094855|NCT04171765|526869627|FG003|Overall Study|Week 58 visit missed|0|||
146094856|NCT04171765|526869624|FG000|Overall Study|Study terminated by sponsor|2|||
146094857|NCT04171765|526869625|FG001|Overall Study|Study terminated by sponsor|0|||
146254102|NCT02402465|527443025|FG005|Overall Study|Lost to Follow-up|0|||
146026076|NCT00350623|526609422|FG000|Overall Study|Lost to Follow-up|8|||
146026077|NCT00350623|526609423|FG001|Overall Study|Lost to Follow-up|3|||
146026078|NCT00350623|526609424|FG002|Overall Study|Lost to Follow-up|4|||
146026079|NCT00350623|526609422|FG000|Overall Study|Withdrawal by Subject|0|||
146026080|NCT00350623|526609423|FG001|Overall Study|Withdrawal by Subject|1|||
146026081|NCT00350623|526609424|FG002|Overall Study|Withdrawal by Subject|1|||
146026082|NCT00350623|526609422|FG000|Overall Study|patient traveling outside the country|0|||
146026083|NCT00350623|526609423|FG001|Overall Study|patient traveling outside the country|0|||
146026084|NCT00350623|526609424|FG002|Overall Study|patient traveling outside the country|1|||
146026085|NCT04126564|526609426|FG000|Overall Study|Withdrawal by Subject|0|||
146026086|NCT04126564|526609427|FG001|Overall Study|Withdrawal by Subject|2|||
146026087|NCT04126564|526609426|FG000|Overall Study|Lost to Follow-up|0|||
146026088|NCT04126564|526609427|FG001|Overall Study|Lost to Follow-up|1|||
146026089|NCT02536300|526609428|FG000|Overall Study|Investigator's Discretion|17|||
146026090|NCT02536300|526609429|FG001|Overall Study|Investigator's Discretion|11|||
146026091|NCT02536300|526609430|FG002|Overall Study|Investigator's Discretion|2|||
146026092|NCT02536300|526609428|FG000|Overall Study|Progressive Disease|11|||
146026093|NCT02536300|526609429|FG001|Overall Study|Progressive Disease|7|||
146026094|NCT02536300|526609430|FG002|Overall Study|Progressive Disease|6|||
146026095|NCT02536300|526609428|FG000|Overall Study|Study Terminated by Sponsor|6|||
146026096|NCT02536300|526609429|FG001|Overall Study|Study Terminated by Sponsor|4|||
146026097|NCT02536300|526609430|FG002|Overall Study|Study Terminated by Sponsor|7|||
146026098|NCT02536300|526609428|FG000|Overall Study|Death|7|||
146026099|NCT02536300|526609429|FG001|Overall Study|Death|0|||
146026100|NCT02536300|526609430|FG002|Overall Study|Death|5|||
146026101|NCT02536300|526609428|FG000|Overall Study|Withdrew Consent|4|||
146026102|NCT02536300|526609429|FG001|Overall Study|Withdrew Consent|2|||
146026103|NCT02536300|526609430|FG002|Overall Study|Withdrew Consent|0|||
146026104|NCT02536300|526609428|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
146026105|NCT02536300|526609429|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
146026106|NCT02536300|526609430|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
146026107|NCT02536300|526609428|FG000|Overall Study|Enrolled but Never Treated|0|||
146026108|NCT02536300|526609429|FG001|Overall Study|Enrolled but Never Treated|0|||
146026109|NCT02536300|526609430|FG002|Overall Study|Enrolled but Never Treated|1|||
146026110|NCT02536300|526609428|FG000|Overall Study|Non-compliance With Study Drug|1|||
146026111|NCT02536300|526609429|FG001|Overall Study|Non-compliance With Study Drug|0|||
146026112|NCT02536300|526609430|FG002|Overall Study|Non-compliance With Study Drug|0|||
146026113|NCT02536300|526609428|FG000|Overall Study|Protocol Violation|0|||
146026114|NCT02536300|526609429|FG001|Overall Study|Protocol Violation|1|||
146026115|NCT02536300|526609430|FG002|Overall Study|Protocol Violation|0|||
146026116|NCT00096174|526609431|FG000|Overall Study|Lack of Efficacy|9|||
146026117|NCT00096174|526609431|FG000|Overall Study|Adverse Event|15|||
146026118|NCT00096174|526609431|FG000|Overall Study|Death|6|||
146026119|NCT00096174|526609431|FG000|Overall Study|Withdrawal by Subject|15|||
146026120|NCT00096174|526609431|FG000|Overall Study|Not started protocol therapy|3|||
146026121|NCT00096174|526609431|FG000|Overall Study|Ineligible|6|||
146026122|NCT00096174|526609431|FG000|Overall Study|other reason|8|||
146094858|NCT04171765|526869626|FG002|Overall Study|Study terminated by sponsor|0|||
146094859|NCT04171765|526869627|FG003|Overall Study|Study terminated by sponsor|0|||
146094860|NCT04171765|526869624|FG000|Overall Study|Withdrawal by Subject|1|||
146094861|NCT04171765|526869625|FG001|Overall Study|Withdrawal by Subject|0|||
146094862|NCT04171765|526869626|FG002|Overall Study|Withdrawal by Subject|0|||
146094863|NCT04171765|526869627|FG003|Overall Study|Withdrawal by Subject|3|||
146094864|NCT00122109|526869628|FG000|Overall Study|Did not meet criteria|6|||
146094865|NCT00122109|526869629|FG001|Overall Study|Did not meet criteria|7|||
146094866|NCT00100178|526869630|FG000|Overall Study|Lost to Follow-up|0|||
146094867|NCT00100178|526869631|FG001|Overall Study|Lost to Follow-up|6|||
146094868|NCT00100178|526869632|FG002|Overall Study|Lost to Follow-up|5|||
146094869|NCT00100178|526869630|FG000|Overall Study|Adverse Event|2|||
146094870|NCT00100178|526869631|FG001|Overall Study|Adverse Event|2|||
146094871|NCT00100178|526869632|FG002|Overall Study|Adverse Event|1|||
146094872|NCT00100178|526869630|FG000|Overall Study|Withdrawal by Subject|1|||
146094873|NCT00100178|526869631|FG001|Overall Study|Withdrawal by Subject|1|||
146094874|NCT00100178|526869632|FG002|Overall Study|Withdrawal by Subject|1|||
146026123|NCT00294645|526609441|FG000|Overall Study|Death|10|||
146026124|NCT00294645|526609442|FG001|Overall Study|Death|18|||
146094875|NCT00100178|526869630|FG000|Overall Study|Physician Decision|6|||
146026125|NCT00294645|526609441|FG000|Overall Study|Lost to Follow-up|1|||
146026126|NCT00294645|526609442|FG001|Overall Study|Lost to Follow-up|10|||
146026127|NCT00294645|526609441|FG000|Overall Study|Withdrawal by Subject|18|||
146026128|NCT00294645|526609442|FG001|Overall Study|Withdrawal by Subject|34|||
146026129|NCT00294645|526609441|FG000|Overall Study|Physician Decision|15|||
146094876|NCT00100178|526869631|FG001|Overall Study|Physician Decision|1|||
146094877|NCT00100178|526869632|FG002|Overall Study|Physician Decision|3|||
146094878|NCT00631696|526869639|FG000|Overall Study|Entered, not randomized to treatment|1|||
146254103|NCT01284634|527443026|FG000|Overall Study|Adverse Event|1|||
146254104|NCT01284634|527443027|FG001|Overall Study|Adverse Event|0|||
146254105|NCT01284634|527443028|FG002|Overall Study|Adverse Event|2|||
146026130|NCT00294645|526609442|FG001|Overall Study|Physician Decision|20|||
146026131|NCT00294645|526609441|FG000|Overall Study|Other|4|||
146026132|NCT00294645|526609442|FG001|Overall Study|Other|10|||
146094879|NCT00631696|526869640|FG001|Overall Study|Entered, not randomized to treatment|1|||
146094880|NCT00631696|526869639|FG000|Overall Study|Discontinued after database release date|1|||
146026133|NCT01238835|526609453|FG000|Overall Study|Death|124|||
146026134|NCT01238835|526609453|FG000|Overall Study|Withdrawal by Subject|9|||
146026135|NCT01238835|526609453|FG000|Overall Study|Lost to Follow-up|1|||
146026136|NCT01238835|526609453|FG000|Overall Study|Site early discontinuation|2|||
146026137|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Death|1|||
146026138|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Death|1|||
146026139|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Death|0|||
146026140|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Death|0|||
146026141|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Death|1|||
146026142|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Death|0|||
146026143|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Death|0|||
146026144|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Death|0|||
146026145|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Death|0|||
146026146|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Death|0|||
146026147|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
146026148|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
146026149|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
146026150|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026151|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
146026152|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026153|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026154|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026155|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026156|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
146026157|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026158|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026159|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026160|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026161|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
146026162|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026163|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026164|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026165|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026166|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
146026167|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
146026168|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026169|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026170|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026171|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026172|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026173|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026174|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026175|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026176|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
146026177|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
146026178|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026179|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026180|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
146026181|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
146026182|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026183|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026184|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026185|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026186|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
146026187|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
146026188|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026189|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026190|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
146026191|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026192|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026193|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026194|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026195|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026196|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
146026197|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
146026198|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146026199|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146026200|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
146026201|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
146026202|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146026203|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146026204|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146026205|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146026206|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
146026207|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
146026208|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146026209|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146026210|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026211|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
146026212|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026213|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026214|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026215|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026216|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026217|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
146026218|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026219|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026220|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
146026221|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
146026222|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026223|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026224|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026225|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026226|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
146026227|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026228|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026229|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026230|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026231|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026232|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026233|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026234|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026235|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026236|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026237|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026238|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026239|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
146026240|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026241|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
146026242|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026243|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026244|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026245|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026246|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026247|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
146026248|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
146026249|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
146026250|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
146026251|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
146026252|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146094881|NCT00631696|526869640|FG001|Overall Study|Discontinued after database release date|0|||
146094882|NCT00631696|526869639|FG000|Overall Study|Follow up after database release date|1|||
146026253|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146026254|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146026255|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146026256|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
146026257|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026258|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026259|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026260|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
146026261|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
146026262|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026263|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026264|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026265|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026266|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026267|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146026268|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026269|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146026270|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146026271|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146026272|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026273|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026274|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026275|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026276|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026277|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
146026278|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026279|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026280|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026281|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
146026282|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026283|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026284|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026285|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026286|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
146026287|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026288|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026289|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026290|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026291|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
146026292|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026293|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026294|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026295|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026296|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026297|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026298|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
146026299|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026300|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026301|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
146026302|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026303|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146094883|NCT00631696|526869640|FG001|Overall Study|Follow up after database release date|0|||
146094884|NCT00631696|526869639|FG000|Overall Study|Lost to Follow-up|7|||
146094885|NCT00631696|526869640|FG001|Overall Study|Lost to Follow-up|10|||
146094886|NCT00631696|526869639|FG000|Overall Study|Withdrawal by Subject|2|||
146094887|NCT00631696|526869640|FG001|Overall Study|Withdrawal by Subject|9|||
146094888|NCT00631696|526869639|FG000|Overall Study|Other|8|||
146026304|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026305|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026306|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
146026307|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
146026308|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026309|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026310|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026311|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
146026312|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026313|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026314|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026315|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026316|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
146026317|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
146026318|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026319|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
146026320|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026321|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
146026322|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026323|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026324|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026325|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026326|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
146026327|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Other|5|||
146026328|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Other|1|||
146026329|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Other|0|||
146026330|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Other|3|||
146026331|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Other|0|||
146026332|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Other|0|||
146026333|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Other|0|||
146026334|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Other|0|||
146026335|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Other|0|||
146026336|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Other|0|||
146026337|NCT03352557|526609457|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026338|NCT03352557|526609458|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026339|NCT03352557|526609459|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026340|NCT03352557|526609460|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026341|NCT03352557|526609461|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
146026342|NCT03352557|526609462|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026343|NCT03352557|526609463|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026344|NCT03352557|526609464|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026345|NCT03352557|526609465|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026346|NCT03352557|526609466|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
146026347|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Death|0|||
146026348|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Death|0|||
146026349|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Death|0|||
146026350|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Death|0|||
146026351|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Death|0|||
146026352|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Death|1|||
146026353|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Death|0|||
146026354|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Death|1|||
146026355|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Death|1|||
146026356|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Death|1|||
146026357|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026358|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026359|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026360|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026361|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026362|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
146026363|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026364|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026365|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026366|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
146026367|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026368|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026369|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026370|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146094889|NCT00631696|526869640|FG001|Overall Study|Other|8|||
146094890|NCT00631696|526869639|FG000|Overall Study|Protocol Violation|9|||
146254106|NCT01284634|527443029|FG003|Overall Study|Adverse Event|1|||
146254107|NCT02236598|527443030|FG000|Overall Study|Adverse Event|0|||
146026371|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026372|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026373|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026374|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026375|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
146026376|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
146026377|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146026378|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146026379|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146026380|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146026381|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
146026382|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
146026383|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
146026384|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
146026385|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
146026386|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
146026387|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026388|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026389|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026390|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026391|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026392|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
146026393|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
146026394|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
146026395|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
146026396|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
146026397|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026398|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026399|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026400|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026401|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026402|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026403|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026404|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026405|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
146026406|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
146026407|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026408|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026409|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026410|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026411|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026412|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146026413|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
146026414|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146026415|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
146026416|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
146026417|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026418|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026419|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026420|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026421|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146094891|NCT00631696|526869640|FG001|Overall Study|Protocol Violation|9|||
146094892|NCT00631696|526869639|FG000|Overall Study|Study terminated by sponsor|3|||
146094893|NCT00631696|526869640|FG001|Overall Study|Study terminated by sponsor|3|||
146254108|NCT02236598|527443031|FG001|Overall Study|Adverse Event|1|||
146254109|NCT02236598|527443030|FG000|Overall Study|Withdrawal by Subject|0|||
146254110|NCT02236598|527443031|FG001|Overall Study|Withdrawal by Subject|1|||
146026422|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026423|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026424|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
146026425|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
146026426|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
146026427|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026428|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026429|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026430|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026431|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026432|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026433|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026434|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
146026435|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026436|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
146026437|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026438|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026439|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026440|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026441|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026442|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026443|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026444|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
146026445|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026446|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
146026447|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026448|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026449|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026450|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026451|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026452|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026453|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026454|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
146026455|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
146026456|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
146026457|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026458|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026459|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026460|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026461|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026462|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
146026463|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026464|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026465|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
146026466|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
146026467|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026468|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026469|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026470|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026471|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026472|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026473|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026474|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026475|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
146026476|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
146094894|NCT00631696|526869639|FG000|Overall Study|Adverse Event|5|||
146094895|NCT00631696|526869640|FG001|Overall Study|Adverse Event|0|||
146094896|NCT01439568|526869642|FG000|Overall Study|Lost to Follow-up|1|||
146094897|NCT01439568|526869643|FG001|Overall Study|Lost to Follow-up|0|||
146094898|NCT01439568|526869642|FG000|Overall Study|Withdrawal by Subject|2|||
146026477|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026478|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026479|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026480|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026481|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026482|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026483|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026484|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
146026485|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
146026486|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
146026487|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026488|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026489|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026490|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026491|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026492|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026493|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026494|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
146026495|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
146026496|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
146026497|NCT03352557|526609457|FG000|LTE Period: Week 80 to Week 173|Other|0|||
146026498|NCT03352557|526609458|FG001|LTE Period: Week 80 to Week 173|Other|0|||
146026499|NCT03352557|526609459|FG002|LTE Period: Week 80 to Week 173|Other|0|||
146026500|NCT03352557|526609460|FG003|LTE Period: Week 80 to Week 173|Other|0|||
146026501|NCT03352557|526609461|FG004|LTE Period: Week 80 to Week 173|Other|0|||
146026502|NCT03352557|526609462|FG005|LTE Period: Week 80 to Week 173|Other|0|||
146026503|NCT03352557|526609463|FG006|LTE Period: Week 80 to Week 173|Other|0|||
146026504|NCT03352557|526609464|FG007|LTE Period: Week 80 to Week 173|Other|1|||
146026505|NCT03352557|526609465|FG008|LTE Period: Week 80 to Week 173|Other|0|||
146026506|NCT03352557|526609466|FG009|LTE Period: Week 80 to Week 173|Other|0|||
146026507|NCT00907803|526609467|FG000|Overall Study|Withdrawal of consent - long commute|1|||
146026508|NCT00907803|526609468|FG001|Overall Study|Withdrawal of consent - long commute|0|||
146026509|NCT00907803|526609469|FG002|Overall Study|Withdrawal of consent - long commute|0|||
146026510|NCT00907803|526609467|FG000|Overall Study|Adverse Event|2|||
146026511|NCT00907803|526609468|FG001|Overall Study|Adverse Event|0|||
146026512|NCT00907803|526609469|FG002|Overall Study|Adverse Event|0|||
146026513|NCT00907803|526609467|FG000|Overall Study|Withdrawal by Subject|0|||
146026514|NCT00907803|526609468|FG001|Overall Study|Withdrawal by Subject|1|||
146026515|NCT00907803|526609469|FG002|Overall Study|Withdrawal by Subject|0|||
146026516|NCT00907803|526609467|FG000|Overall Study|Lost to Follow-up|0|||
146026517|NCT00907803|526609468|FG001|Overall Study|Lost to Follow-up|1|||
146026518|NCT00907803|526609469|FG002|Overall Study|Lost to Follow-up|0|||
146026519|NCT00907803|526609467|FG000|Overall Study|Protocol Violation|0|||
146026520|NCT00907803|526609468|FG001|Overall Study|Protocol Violation|1|||
146026521|NCT00907803|526609469|FG002|Overall Study|Protocol Violation|0|||
146026522|NCT04612842|526609470|FG000|Overall Study|Lost to Follow-up|20|||
146026523|NCT04612842|526609471|FG001|Overall Study|Lost to Follow-up|11|||
146026524|NCT04612842|526609470|FG000|Overall Study|Withdrawal by Subject|26|||
146026525|NCT04612842|526609471|FG001|Overall Study|Withdrawal by Subject|15|||
146094899|NCT01439568|526869643|FG001|Overall Study|Withdrawal by Subject|2|||
146254111|NCT03334747|527443043|FG000|Treatment Phase|Technical problems|0|||
146026526|NCT04612842|526609470|FG000|Overall Study|Death|2|||
146026527|NCT04612842|526609471|FG001|Overall Study|Death|2|||
146026528|NCT05426031|526609472|FG000|Overall Study|Circulatory Arrest|3|||
146026529|NCT05426031|526609473|FG001|Overall Study|Circulatory Arrest|2|||
146026530|NCT02419131|526609474|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
146026531|NCT02419131|526609475|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
146026532|NCT02419131|526609476|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
146254112|NCT03334747|527443044|FG001|Treatment Phase|Technical problems|0|||
146254113|NCT03334747|527443045|FG002|Treatment Phase|Technical problems|0|||
146026533|NCT02419131|526609474|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
146026534|NCT02419131|526609475|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
146026535|NCT02419131|526609476|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
146026536|NCT03060512|526609477|FG000|Overall Study|Adverse Event|4|||
146026537|NCT03060512|526609478|FG001|Overall Study|Adverse Event|6|||
146026538|NCT03060512|526609477|FG000|Overall Study|Lost to Follow-up|1|||
146026539|NCT03060512|526609478|FG001|Overall Study|Lost to Follow-up|1|||
146026540|NCT03060512|526609477|FG000|Overall Study|Withdrawal by Subject|1|||
146094900|NCT01578330|526869644|FG000|Overall Study|Adverse Event|2|||
146094901|NCT01578330|526869644|FG000|Overall Study|Protocol Violation|5|||
146094902|NCT01134731|526869645|FG000|Overall Study|Adverse Event|3|||
146094903|NCT01134731|526869646|FG001|Overall Study|Adverse Event|2|||
146094904|NCT01134731|526869647|FG002|Overall Study|Adverse Event|1|||
146094905|NCT01134731|526869645|FG000|Overall Study|Physician Decision|2|||
146094906|NCT01134731|526869646|FG001|Overall Study|Physician Decision|2|||
146094907|NCT01134731|526869647|FG002|Overall Study|Physician Decision|2|||
146094908|NCT01134731|526869645|FG000|Overall Study|Lack of Efficacy|0|||
146094909|NCT01134731|526869646|FG001|Overall Study|Lack of Efficacy|0|||
146094910|NCT01134731|526869647|FG002|Overall Study|Lack of Efficacy|1|||
146094911|NCT01134731|526869645|FG000|Overall Study|Withdrawal by Subject|3|||
146094912|NCT01134731|526869646|FG001|Overall Study|Withdrawal by Subject|3|||
146094913|NCT01134731|526869647|FG002|Overall Study|Withdrawal by Subject|1|||
146094914|NCT01134731|526869645|FG000|Overall Study|Lost to Follow-up|5|||
146094915|NCT01134731|526869646|FG001|Overall Study|Lost to Follow-up|4|||
146094916|NCT01134731|526869647|FG002|Overall Study|Lost to Follow-up|3|||
146094917|NCT01669928|526869648|FG000|First Intervention|Withdrawal by Subject|3|||
146094918|NCT01669928|526869649|FG001|First Intervention|Withdrawal by Subject|5|||
146094919|NCT01465191|526869652|FG000|Overall Study|Protocol Violation|6|||
146094920|NCT01465191|526869653|FG001|Overall Study|Protocol Violation|3|||
146094921|NCT01465191|526869654|FG002|Overall Study|Protocol Violation|3|||
146094922|NCT01465191|526869652|FG000|Overall Study|Lost to Follow-up|3|||
146094923|NCT01465191|526869653|FG001|Overall Study|Lost to Follow-up|6|||
146094924|NCT01465191|526869654|FG002|Overall Study|Lost to Follow-up|4|||
146094925|NCT02448810|526869655|FG000|Overall Study|Adverse Event|0|||
146094926|NCT02448810|526869656|FG001|Overall Study|Adverse Event|0|||
146094927|NCT02448810|526869657|FG002|Overall Study|Adverse Event|1|||
146094928|NCT02448810|526869658|FG003|Overall Study|Adverse Event|0|||
146094929|NCT02448810|526869659|FG004|Overall Study|Adverse Event|0|||
146094930|NCT02448810|526869660|FG005|Overall Study|Adverse Event|0|||
146094931|NCT02448810|526869661|FG006|Overall Study|Adverse Event|0|||
146094932|NCT02448810|526869662|FG007|Overall Study|Adverse Event|0|||
146094933|NCT02448810|526869655|FG000|Overall Study|Withdrawal by Subject|0|||
146094934|NCT02448810|526869656|FG001|Overall Study|Withdrawal by Subject|0|||
146094935|NCT02448810|526869657|FG002|Overall Study|Withdrawal by Subject|1|||
146094936|NCT02448810|526869658|FG003|Overall Study|Withdrawal by Subject|0|||
146094937|NCT02448810|526869659|FG004|Overall Study|Withdrawal by Subject|3|||
146094938|NCT02448810|526869660|FG005|Overall Study|Withdrawal by Subject|5|||
146094939|NCT02448810|526869661|FG006|Overall Study|Withdrawal by Subject|0|||
146094940|NCT02448810|526869662|FG007|Overall Study|Withdrawal by Subject|2|||
146094941|NCT02448810|526869655|FG000|Overall Study|Other (study terminated by sponsor)|0|||
146094942|NCT02448810|526869656|FG001|Overall Study|Other (study terminated by sponsor)|0|||
146094943|NCT02448810|526869657|FG002|Overall Study|Other (study terminated by sponsor)|0|||
146094944|NCT02448810|526869658|FG003|Overall Study|Other (study terminated by sponsor)|0|||
146094945|NCT02448810|526869659|FG004|Overall Study|Other (study terminated by sponsor)|4|||
146094946|NCT02448810|526869660|FG005|Overall Study|Other (study terminated by sponsor)|2|||
146094947|NCT02448810|526869661|FG006|Overall Study|Other (study terminated by sponsor)|2|||
146094948|NCT02448810|526869662|FG007|Overall Study|Other (study terminated by sponsor)|1|||
146094949|NCT02448810|526869655|FG000|Overall Study|Death|1|||
146094950|NCT02448810|526869656|FG001|Overall Study|Death|0|||
146094951|NCT02448810|526869657|FG002|Overall Study|Death|1|||
146094952|NCT02448810|526869658|FG003|Overall Study|Death|0|||
146094953|NCT02448810|526869659|FG004|Overall Study|Death|1|||
146094954|NCT02448810|526869660|FG005|Overall Study|Death|0|||
146094955|NCT02448810|526869661|FG006|Overall Study|Death|0|||
146094956|NCT02448810|526869662|FG007|Overall Study|Death|0|||
146094957|NCT02448810|526869655|FG000|Overall Study|Other (Progressive disease)|2|||
146094958|NCT02448810|526869656|FG001|Overall Study|Other (Progressive disease)|2|||
146094959|NCT02448810|526869657|FG002|Overall Study|Other (Progressive disease)|0|||
146094960|NCT02448810|526869658|FG003|Overall Study|Other (Progressive disease)|3|||
146094961|NCT02448810|526869659|FG004|Overall Study|Other (Progressive disease)|23|||
146094962|NCT02448810|526869660|FG005|Overall Study|Other (Progressive disease)|9|||
146094963|NCT02448810|526869661|FG006|Overall Study|Other (Progressive disease)|14|||
146094964|NCT02448810|526869662|FG007|Overall Study|Other (Progressive disease)|5|||
146094965|NCT02448810|526869655|FG000|Overall Study|Lost to Follow-up|0|||
146254114|NCT03334747|527443046|FG003|Treatment Phase|Technical problems|0|||
146094966|NCT02448810|526869656|FG001|Overall Study|Lost to Follow-up|1|||
146094967|NCT02448810|526869657|FG002|Overall Study|Lost to Follow-up|0|||
146094968|NCT02448810|526869658|FG003|Overall Study|Lost to Follow-up|0|||
146094969|NCT02448810|526869659|FG004|Overall Study|Lost to Follow-up|0|||
146094970|NCT02448810|526869660|FG005|Overall Study|Lost to Follow-up|0|||
146094971|NCT02448810|526869661|FG006|Overall Study|Lost to Follow-up|0|||
146094972|NCT02448810|526869662|FG007|Overall Study|Lost to Follow-up|0|||
146094973|NCT02448810|526869655|FG000|Overall Study|Other (unspecified)|0|||
146094974|NCT02448810|526869656|FG001|Overall Study|Other (unspecified)|0|||
146094975|NCT02448810|526869657|FG002|Overall Study|Other (unspecified)|0|||
146094976|NCT02448810|526869658|FG003|Overall Study|Other (unspecified)|0|||
146094977|NCT02448810|526869659|FG004|Overall Study|Other (unspecified)|0|||
146094978|NCT02448810|526869660|FG005|Overall Study|Other (unspecified)|0|||
146026541|NCT03060512|526609478|FG001|Overall Study|Withdrawal by Subject|0|||
146026542|NCT03060512|526609477|FG000|Overall Study|Non-compliance with study medication|1|||
146026543|NCT03060512|526609478|FG001|Overall Study|Non-compliance with study medication|2|||
146026544|NCT03831880|526609481|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
146026545|NCT03831880|526609482|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
146026546|NCT03831880|526609481|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
146026547|NCT03831880|526609482|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
146026548|NCT02446418|526609486|FG000|Overall Study|Adverse Event|4|||
146026549|NCT02446418|526609487|FG001|Overall Study|Adverse Event|8|||
146026550|NCT02446418|526609486|FG000|Overall Study|Physician Decision|5|||
146026551|NCT02446418|526609487|FG001|Overall Study|Physician Decision|1|||
146026552|NCT02446418|526609486|FG000|Overall Study|Withdrawal by Subject|3|||
146026553|NCT02446418|526609487|FG001|Overall Study|Withdrawal by Subject|3|||
146026554|NCT02446418|526609486|FG000|Overall Study|Lost to Follow-up|2|||
146026555|NCT02446418|526609487|FG001|Overall Study|Lost to Follow-up|2|||
146026556|NCT02446418|526609486|FG000|Overall Study|Protocol Violation|1|||
146026557|NCT02446418|526609487|FG001|Overall Study|Protocol Violation|2|||
146026558|NCT02446418|526609486|FG000|Overall Study|Lack of Efficacy|2|||
146026559|NCT02446418|526609487|FG001|Overall Study|Lack of Efficacy|0|||
146026560|NCT02446418|526609486|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
146026561|NCT02446418|526609487|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
146026562|NCT02014480|526609488|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146026563|NCT02014480|526609489|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146026564|NCT02014480|526609490|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146026565|NCT02014480|526609491|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146026566|NCT02014480|526609492|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146026567|NCT02014480|526609493|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146026568|NCT02014480|526609488|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146026569|NCT02014480|526609489|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146026570|NCT02014480|526609490|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146026571|NCT02014480|526609491|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
146026572|NCT02014480|526609492|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146026573|NCT02014480|526609493|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146026574|NCT02014480|526609488|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146026575|NCT02014480|526609489|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146026576|NCT02014480|526609490|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
146026577|NCT02014480|526609491|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146026578|NCT02014480|526609492|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146026579|NCT02014480|526609493|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
146026580|NCT02014480|526609488|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146026581|NCT02014480|526609489|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146026582|NCT02014480|526609490|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
146026583|NCT02014480|526609491|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146026584|NCT02014480|526609492|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146026585|NCT02014480|526609493|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146026586|NCT02014480|526609488|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146026587|NCT02014480|526609489|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
146026588|NCT02014480|526609490|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146026589|NCT02014480|526609491|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146026590|NCT02014480|526609492|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146026591|NCT02014480|526609493|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
146026592|NCT02014480|526609488|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
146026593|NCT02014480|526609489|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
146026594|NCT02014480|526609490|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
146026595|NCT02014480|526609491|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
146026596|NCT02014480|526609492|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
146026597|NCT02014480|526609493|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
146026598|NCT02014480|526609488|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146026599|NCT02014480|526609489|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146026600|NCT02014480|526609490|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146026601|NCT02014480|526609491|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146026602|NCT02014480|526609492|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146026603|NCT02014480|526609493|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146026604|NCT01338610|526609496|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
146026605|NCT01338610|526609497|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
146026606|NCT01338610|526609498|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
146026607|NCT01338610|526609496|FG000|Overall Study|Protocol Violation|1|||
146254115|NCT03334747|527443047|FG004|Treatment Phase|Technical problems|1|||
146026608|NCT01338610|526609497|FG001|Overall Study|Protocol Violation|0|||
146026609|NCT01338610|526609498|FG002|Overall Study|Protocol Violation|1|||
146094979|NCT02448810|526869661|FG006|Overall Study|Other (unspecified)|2|||
146026610|NCT01338610|526609496|FG000|Overall Study|Adverse Event|3|||
146026611|NCT01338610|526609497|FG001|Overall Study|Adverse Event|0|||
146026612|NCT01338610|526609498|FG002|Overall Study|Adverse Event|0|||
146026613|NCT02692040|526609499|FG000|Overall Study|Protocol Violation|0|||
146026614|NCT02692040|526609500|FG001|Overall Study|Protocol Violation|0|||
146026615|NCT02692040|526609501|FG002|Overall Study|Protocol Violation|0|||
146026616|NCT02692040|526609502|FG003|Overall Study|Protocol Violation|0|||
146026617|NCT02692040|526609503|FG004|Overall Study|Protocol Violation|0|||
146026618|NCT02692040|526609504|FG005|Overall Study|Protocol Violation|0|||
146026619|NCT02692040|526609505|FG006|Overall Study|Protocol Violation|0|||
146026620|NCT02692040|526609506|FG007|Overall Study|Protocol Violation|0|||
146026621|NCT02692040|526609507|FG008|Overall Study|Protocol Violation|0|||
146026622|NCT02692040|526609508|FG009|Overall Study|Protocol Violation|0|||
146026623|NCT02692040|526609509|FG010|Overall Study|Protocol Violation|0|||
146026624|NCT02692040|526609510|FG011|Overall Study|Protocol Violation|0|||
146026625|NCT02692040|526609511|FG012|Overall Study|Protocol Violation|1|||
146026626|NCT02692040|526609512|FG013|Overall Study|Protocol Violation|0|||
146026627|NCT02692040|526609513|FG014|Overall Study|Protocol Violation|0|||
146026628|NCT02692040|526609514|FG015|Overall Study|Protocol Violation|0|||
146026629|NCT02692040|526609515|FG016|Overall Study|Protocol Violation|0|||
146026630|NCT02692040|526609499|FG000|Overall Study|Adverse Event|0|||
146026631|NCT02692040|526609500|FG001|Overall Study|Adverse Event|0|||
146026632|NCT02692040|526609501|FG002|Overall Study|Adverse Event|0|||
146026633|NCT02692040|526609502|FG003|Overall Study|Adverse Event|0|||
146026634|NCT02692040|526609503|FG004|Overall Study|Adverse Event|0|||
146026635|NCT02692040|526609504|FG005|Overall Study|Adverse Event|0|||
146026636|NCT02692040|526609505|FG006|Overall Study|Adverse Event|0|||
146026637|NCT02692040|526609506|FG007|Overall Study|Adverse Event|0|||
146026638|NCT02692040|526609507|FG008|Overall Study|Adverse Event|0|||
146026639|NCT02692040|526609508|FG009|Overall Study|Adverse Event|0|||
146026640|NCT02692040|526609509|FG010|Overall Study|Adverse Event|0|||
146026641|NCT02692040|526609510|FG011|Overall Study|Adverse Event|0|||
146026642|NCT02692040|526609511|FG012|Overall Study|Adverse Event|0|||
146026643|NCT02692040|526609512|FG013|Overall Study|Adverse Event|3|||
146026644|NCT02692040|526609513|FG014|Overall Study|Adverse Event|1|||
146026645|NCT02692040|526609514|FG015|Overall Study|Adverse Event|1|||
146026646|NCT02692040|526609515|FG016|Overall Study|Adverse Event|0|||
146026647|NCT00435162|526609519|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
146026648|NCT00435162|526609520|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
146026649|NCT00435162|526609521|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
146026650|NCT00435162|526609522|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
146026651|NCT00435162|526609523|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
146026652|NCT00435162|526609524|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
146026653|NCT00694096|526609525|FG000|Overall Study|Withdrawal by Subject|5|||
146026654|NCT02914548|526609535|FG000|Overall Study|Adverse Event|15|||
146026655|NCT02914548|526609536|FG001|Overall Study|Adverse Event|7|||
146026656|NCT02914548|526609537|FG002|Overall Study|Adverse Event|15|||
146026657|NCT02914548|526609535|FG000|Overall Study|Physician Decision|2|||
146026658|NCT02914548|526609536|FG001|Overall Study|Physician Decision|2|||
146026659|NCT02914548|526609537|FG002|Overall Study|Physician Decision|0|||
146026660|NCT02914548|526609535|FG000|Overall Study|Protocol Violation|1|||
146026661|NCT02914548|526609536|FG001|Overall Study|Protocol Violation|0|||
146026662|NCT02914548|526609537|FG002|Overall Study|Protocol Violation|0|||
146026663|NCT02914548|526609535|FG000|Overall Study|Withdrawal by Subject|3|||
146026664|NCT02914548|526609536|FG001|Overall Study|Withdrawal by Subject|4|||
146026665|NCT02914548|526609537|FG002|Overall Study|Withdrawal by Subject|4|||
146026666|NCT02914548|526609535|FG000|Overall Study|>40% of body surface area|0|||
146026667|NCT02914548|526609536|FG001|Overall Study|>40% of body surface area|1|||
146026668|NCT02914548|526609537|FG002|Overall Study|>40% of body surface area|1|||
146026669|NCT00977938|526609543|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
146026670|NCT00977938|526609544|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
146026671|NCT00977938|526609545|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
146026672|NCT00977938|526609546|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
146026673|NCT00977938|526609543|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
146026674|NCT00977938|526609544|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
146026675|NCT00977938|526609545|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
146026676|NCT00977938|526609546|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
146026677|NCT00977938|526609543|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
146026678|NCT00977938|526609544|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
146026679|NCT00977938|526609545|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
146026680|NCT00977938|526609546|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
146026681|NCT00977938|526609543|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
146026682|NCT00977938|526609544|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
146026683|NCT00977938|526609545|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
146026684|NCT00977938|526609546|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
146094980|NCT02448810|526869662|FG007|Overall Study|Other (unspecified)|0|||
146026685|NCT00977938|526609543|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
146026686|NCT00977938|526609544|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
146026687|NCT00977938|526609545|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
146026688|NCT00977938|526609546|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
146026689|NCT00977938|526609543|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
146026690|NCT00977938|526609544|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
146026691|NCT00977938|526609545|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
146026692|NCT00977938|526609546|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
146026693|NCT02460783|526609552|FG000|Overall Study|Withdrawal by Subject|1|||
146026694|NCT02460783|526609553|FG001|Overall Study|Withdrawal by Subject|3|||
146026695|NCT02460783|526609552|FG000|Overall Study|Lost to Follow-up|1|||
146026696|NCT02460783|526609553|FG001|Overall Study|Lost to Follow-up|1|||
146026697|NCT01484834|526609554|FG000|Overall Study|Lost to Follow-up|5|||
146026698|NCT01484834|526609555|FG001|Overall Study|Lost to Follow-up|8|||
146026699|NCT01484834|526609556|FG002|Overall Study|Lost to Follow-up|1|||
146026700|NCT01484834|526609557|FG003|Overall Study|Lost to Follow-up|4|||
146026701|NCT01371643|526609562|FG000|Overall Study|Withdrawal by Subject|3|||
146026702|NCT01371643|526609563|FG001|Overall Study|Withdrawal by Subject|0|||
146026703|NCT02214225|526609565|FG000|Overall Study|Lost to Follow-up|46|||
146026704|NCT02214225|526609566|FG001|Overall Study|Lost to Follow-up|18|||
146026705|NCT02214225|526609567|FG002|Overall Study|Lost to Follow-up|18|||
146026706|NCT02214225|526609565|FG000|Overall Study|Withdrawal by Subject|2|||
146026707|NCT02214225|526609566|FG001|Overall Study|Withdrawal by Subject|0|||
146026708|NCT02214225|526609567|FG002|Overall Study|Withdrawal by Subject|2|||
146026709|NCT02214225|526609565|FG000|Overall Study|Death|5|||
146026710|NCT02214225|526609566|FG001|Overall Study|Death|0|||
146026711|NCT02214225|526609567|FG002|Overall Study|Death|1|||
146026712|NCT02214225|526609565|FG000|Overall Study|randomized in error, not vaccinated|2|||
146026713|NCT02214225|526609566|FG001|Overall Study|randomized in error, not vaccinated|1|||
146026714|NCT02214225|526609567|FG002|Overall Study|randomized in error, not vaccinated|1|||
146026715|NCT03987932|526609572|FG000|Overall Study|Lost to Follow-up|2|||
146026716|NCT03987932|526609573|FG001|Overall Study|Lost to Follow-up|1|||
146026717|NCT03987932|526609574|FG002|Overall Study|Lost to Follow-up|1|||
146026718|NCT03987932|526609572|FG000|Overall Study|Non-study related elective surgery|0|||
146026719|NCT03987932|526609573|FG001|Overall Study|Non-study related elective surgery|0|||
146026720|NCT03987932|526609574|FG002|Overall Study|Non-study related elective surgery|1|||
146026721|NCT01605227|526609575|FG000|Overall Study|Did not receive study treatment|2|||
146026722|NCT01605227|526609576|FG001|Overall Study|Did not receive study treatment|3|||
146026723|NCT01605227|526609575|FG000|Overall Study|Adverse Event|228|||
146026724|NCT01605227|526609576|FG001|Overall Study|Adverse Event|42|||
146026725|NCT01605227|526609575|FG000|Overall Study|Progressive Disease|132|||
146026726|NCT01605227|526609576|FG001|Overall Study|Progressive Disease|128|||
146026727|NCT01605227|526609575|FG000|Overall Study|Clinical Deterioration|227|||
146026728|NCT01605227|526609576|FG001|Overall Study|Clinical Deterioration|133|||
146026729|NCT01605227|526609575|FG000|Overall Study|Lost to Follow-up|1|||
146026730|NCT01605227|526609576|FG001|Overall Study|Lost to Follow-up|0|||
146026731|NCT01605227|526609575|FG000|Overall Study|Protocol Violation|1|||
146026732|NCT01605227|526609576|FG001|Overall Study|Protocol Violation|0|||
146026733|NCT01605227|526609575|FG000|Overall Study|Physician Decision|9|||
146026734|NCT01605227|526609576|FG001|Overall Study|Physician Decision|7|||
146026735|NCT01605227|526609575|FG000|Overall Study|Withdrawal by Subject|18|||
146026736|NCT01605227|526609576|FG001|Overall Study|Withdrawal by Subject|14|||
146026737|NCT01605227|526609575|FG000|Overall Study|Sponsor Decision|2|||
146026738|NCT01605227|526609576|FG001|Overall Study|Sponsor Decision|0|||
146026739|NCT01605227|526609575|FG000|Overall Study|Started New Therapy|1|||
146026740|NCT01605227|526609576|FG001|Overall Study|Started New Therapy|0|||
146026741|NCT01605227|526609575|FG000|Overall Study|Subject Decision|0|||
146026742|NCT01605227|526609576|FG001|Overall Study|Subject Decision|1|||
146026743|NCT01605227|526609575|FG000|Overall Study|Dose Held >6 weeks|0|||
146026744|NCT01605227|526609576|FG001|Overall Study|Dose Held >6 weeks|1|||
146026745|NCT02847858|526609578|FG000|Overall Study|Lost to Follow-up|401|||
146026746|NCT02847858|526609579|FG001|Overall Study|Lost to Follow-up|269|||
146026747|NCT00624819|526609580|FG000|Follow-up Period: Year 4|Parents decision|0|||
146026748|NCT00624819|526609581|FG001|Follow-up Period: Year 4|Parents decision|0|||
146026749|NCT00624819|526609582|FG002|Follow-up Period: Year 4|Parents decision|1|||
146026750|NCT00624819|526609583|FG003|Follow-up Period: Year 4|Parents decision|0|||
146026751|NCT00624819|526609580|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
146026752|NCT00624819|526609581|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
146026753|NCT00624819|526609582|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
146026754|NCT00624819|526609583|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
146026755|NCT02387164|526609584|FG000|Overall Study|Lost to Follow-up|2|||
146026756|NCT02387164|526609585|FG001|Overall Study|Lost to Follow-up|0|||
146026757|NCT02387164|526609584|FG000|Overall Study|Diagnosed|1|||
146026758|NCT02387164|526609585|FG001|Overall Study|Diagnosed|2|||
146026759|NCT03271047|526609586|FG000|Phase 1b: Dose Finding Period|Death|8|||
146026760|NCT03271047|526609587|FG001|Phase 1b: Dose Finding Period|Death|8|||
146026761|NCT03271047|526609588|FG002|Phase 1b: Dose Finding Period|Death|0|||
146026762|NCT03271047|526609589|FG003|Phase 1b: Dose Finding Period|Death|0|||
146026763|NCT03271047|526609586|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
146026764|NCT03271047|526609587|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146026765|NCT03271047|526609588|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146026766|NCT03271047|526609589|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
146026767|NCT03271047|526609586|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146026768|NCT03271047|526609587|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
146026769|NCT03271047|526609588|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146026770|NCT03271047|526609589|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
146026771|NCT03271047|526609586|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
146026772|NCT03271047|526609587|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
146026773|NCT03271047|526609588|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
146026774|NCT03271047|526609589|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
146026775|NCT03271047|526609586|FG000|Randomized Phase 2 Period|Other|0|||
146026776|NCT03271047|526609587|FG001|Randomized Phase 2 Period|Other|0|||
146026777|NCT03271047|526609588|FG002|Randomized Phase 2 Period|Other|0|||
146026778|NCT03271047|526609589|FG003|Randomized Phase 2 Period|Other|1|||
146026779|NCT03271047|526609586|FG000|Randomized Phase 2 Period|Death|0|||
146026780|NCT03271047|526609587|FG001|Randomized Phase 2 Period|Death|0|||
146026781|NCT03271047|526609588|FG002|Randomized Phase 2 Period|Death|20|||
146026782|NCT03271047|526609589|FG003|Randomized Phase 2 Period|Death|21|||
146026783|NCT03271047|526609586|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
146026784|NCT03271047|526609587|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
146026785|NCT03271047|526609588|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
146026786|NCT03271047|526609589|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
146026787|NCT03271047|526609586|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146026788|NCT03271047|526609587|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146026789|NCT03271047|526609588|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
146026790|NCT03271047|526609589|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
146026791|NCT03271047|526609586|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146026792|NCT03271047|526609587|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146026793|NCT03271047|526609588|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
146026794|NCT03271047|526609589|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
146026795|NCT02436408|526609590|FG000|Overall Study|Death|1|||
146026796|NCT00042432|526609591|FG000|Overall Study|Adverse Event|4|||
146026797|NCT00042432|526609592|FG001|Overall Study|Adverse Event|1|||
146026798|NCT00042432|526609591|FG000|Overall Study|Withdrawal by Subject|1|||
146026799|NCT00042432|526609592|FG001|Overall Study|Withdrawal by Subject|3|||
146026800|NCT00042432|526609591|FG000|Overall Study|Death|0|||
146026801|NCT00042432|526609592|FG001|Overall Study|Death|2|||
146026802|NCT00042432|526609591|FG000|Overall Study|Ineligibility determined|1|||
146026803|NCT00042432|526609592|FG001|Overall Study|Ineligibility determined|0|||
146026804|NCT00042432|526609591|FG000|Overall Study|Initiation of maintenance dialysis|1|||
146026805|NCT00042432|526609592|FG001|Overall Study|Initiation of maintenance dialysis|1|||
146026806|NCT00042432|526609591|FG000|Overall Study|Other|2|||
146026807|NCT00042432|526609592|FG001|Overall Study|Other|0|||
146026808|NCT04070326|526609600|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
146026809|NCT04070326|526609601|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
146026810|NCT00526110|526609605|FG000|Overall Study|Adverse Event|2|||
146026811|NCT00526110|526609606|FG001|Overall Study|Adverse Event|9|||
146026812|NCT00526110|526609605|FG000|Overall Study|Disease Progression|0|||
146026813|NCT00526110|526609606|FG001|Overall Study|Disease Progression|19|||
146026814|NCT00526110|526609605|FG000|Overall Study|Maximal Response|0|||
146026815|NCT00526110|526609606|FG001|Overall Study|Maximal Response|6|||
146026816|NCT00526110|526609605|FG000|Overall Study|Withdrawal by Subject|0|||
146026817|NCT00526110|526609606|FG001|Overall Study|Withdrawal by Subject|2|||
146026818|NCT00526110|526609605|FG000|Overall Study|Poor Tolerance|0|||
146026819|NCT00526110|526609606|FG001|Overall Study|Poor Tolerance|5|||
146026820|NCT01400243|526609607|FG000|Overall Study|Protocol Violation|8|||
146026821|NCT01400243|526609608|FG001|Overall Study|Protocol Violation|11|||
146026822|NCT02278614|526609612|FG000|Overall Study|Withdrawal by Subject|3|||
146026823|NCT02278614|526609613|FG001|Overall Study|Withdrawal by Subject|5|||
146026824|NCT02278614|526609612|FG000|Overall Study|Adverse Event|1|||
146026825|NCT02278614|526609613|FG001|Overall Study|Adverse Event|0|||
146026826|NCT02278614|526609612|FG000|Overall Study|left eye was not eligible|1|||
146026827|NCT02278614|526609613|FG001|Overall Study|left eye was not eligible|0|||
146026828|NCT03762616|526609615|FG000|Overall Study|Protocol Violation|2|||
146026829|NCT03959982|526612249|FG000|Overall Study|Withdrawal by Subject|1|||
146026830|NCT03959982|526612250|FG001|Overall Study|Withdrawal by Subject|0|||
146026831|NCT03959982|526612249|FG000|Overall Study|Physician Decision|2|||
146026832|NCT03959982|526612250|FG001|Overall Study|Physician Decision|0|||
146026833|NCT03959982|526612249|FG000|Overall Study|Lost to Follow-up|1|||
146026834|NCT03959982|526612250|FG001|Overall Study|Lost to Follow-up|0|||
146026835|NCT00262847|526612251|FG000|Overall Study|Disease Progression|309|||
146094981|NCT01916967|526869666|FG000|Overall Study|Adverse Event|0|||
146094982|NCT01916967|526869667|FG001|Overall Study|Adverse Event|0|||
146254116|NCT03334747|527443048|FG005|Treatment Phase|Technical problems|0|||
146026836|NCT00262847|526612252|FG001|Overall Study|Disease Progression|274|||
146026837|NCT00262847|526612253|FG002|Overall Study|Disease Progression|195|||
146026838|NCT00262847|526612251|FG000|Overall Study|Patient Refusal|41|||
146026839|NCT00262847|526612252|FG001|Overall Study|Patient Refusal|52|||
146026840|NCT00262847|526612253|FG002|Overall Study|Patient Refusal|47|||
146026841|NCT00262847|526612251|FG000|Overall Study|Adverse Event|74|||
146026842|NCT00262847|526612252|FG001|Overall Study|Adverse Event|88|||
146026843|NCT00262847|526612253|FG002|Overall Study|Adverse Event|108|||
146026844|NCT00262847|526612251|FG000|Overall Study|Death|8|||
146026845|NCT00262847|526612252|FG001|Overall Study|Death|8|||
146026846|NCT00262847|526612253|FG002|Overall Study|Death|11|||
146026847|NCT00262847|526612251|FG000|Overall Study|Concomitant disease|3|||
146026848|NCT00262847|526612252|FG001|Overall Study|Concomitant disease|2|||
146026849|NCT00262847|526612253|FG002|Overall Study|Concomitant disease|4|||
146026850|NCT00262847|526612251|FG000|Overall Study|Other Reasons|79|||
146026851|NCT00262847|526612252|FG001|Overall Study|Other Reasons|88|||
146026852|NCT00262847|526612253|FG002|Overall Study|Other Reasons|27|||
146026853|NCT00262847|526612251|FG000|Overall Study|Did not receive study treatment|4|||
146026854|NCT00262847|526612252|FG001|Overall Study|Did not receive study treatment|1|||
146026855|NCT00262847|526612253|FG002|Overall Study|Did not receive study treatment|4|||
146026856|NCT00758589|526612254|FG000|Overall Study|Adverse Event|3|||
146026857|NCT00758589|526612255|FG001|Overall Study|Adverse Event|2|||
146026858|NCT00758589|526612256|FG002|Overall Study|Adverse Event|5|||
146026859|NCT00758589|526612257|FG003|Overall Study|Adverse Event|4|||
146026860|NCT00758589|526612254|FG000|Overall Study|Withdrawal by Subject|0|||
146026861|NCT00758589|526612255|FG001|Overall Study|Withdrawal by Subject|1|||
146026862|NCT00758589|526612256|FG002|Overall Study|Withdrawal by Subject|1|||
146026863|NCT00758589|526612257|FG003|Overall Study|Withdrawal by Subject|1|||
146026864|NCT00758589|526612254|FG000|Overall Study|Palm stopped to work|0|||
146026865|NCT00758589|526612255|FG001|Overall Study|Palm stopped to work|0|||
146026866|NCT00758589|526612256|FG002|Overall Study|Palm stopped to work|0|||
146026867|NCT00758589|526612257|FG003|Overall Study|Palm stopped to work|1|||
146026868|NCT05013424|526612258|FG000|Overall Study|Lost to Follow-up|1|||
146026869|NCT05013424|526612259|FG001|Overall Study|Lost to Follow-up|1|||
146026870|NCT05013424|526612260|FG002|Overall Study|Lost to Follow-up|1|||
146026871|NCT05013424|526612258|FG000|Overall Study|Withdrawal by Subject|0|||
146026872|NCT05013424|526612259|FG001|Overall Study|Withdrawal by Subject|1|||
146026873|NCT05013424|526612260|FG002|Overall Study|Withdrawal by Subject|0|||
146026874|NCT03899064|526612263|FG000|Overall Study|Lost to Follow-up|1|||
146026875|NCT03899064|526612263|FG000|Overall Study|Protocol Violation|2|||
146026876|NCT03899064|526612263|FG000|Overall Study|Withdrawal by Subject|2|||
146026877|NCT03899064|526612263|FG000|Overall Study|Other|2|||
146026878|NCT03559699|526612266|FG000|Overall Study|Withdrawal by Subject|6|||
146026879|NCT03559699|526612266|FG000|Overall Study|Lost to Follow-up|1|||
146026880|NCT00031460|526612267|FG000|Overall Study|Lost to Follow-up|0|||
146026881|NCT00031460|526612268|FG001|Overall Study|Lost to Follow-up|1|||
146026882|NCT00031460|526612267|FG000|Overall Study|Withdrawal by Subject|1|||
146026883|NCT00031460|526612268|FG001|Overall Study|Withdrawal by Subject|1|||
146026884|NCT00031460|526612267|FG000|Overall Study|Non-Compliant|1|||
146026885|NCT00031460|526612268|FG001|Overall Study|Non-Compliant|1|||
146026886|NCT00031460|526612267|FG000|Overall Study|Death|0|||
146026887|NCT00031460|526612268|FG001|Overall Study|Death|1|||
146026888|NCT00031460|526612267|FG000|Overall Study|Reactivation of Disease|5|||
146026889|NCT00031460|526612268|FG001|Overall Study|Reactivation of Disease|9|||
146026890|NCT00031460|526612267|FG000|Overall Study|Disruption of blinded drug supply|2|||
146026891|NCT00031460|526612268|FG001|Overall Study|Disruption of blinded drug supply|0|||
146026892|NCT00031460|526612267|FG000|Overall Study|Confirmed unevaluable|0|||
146026893|NCT00031460|526612268|FG001|Overall Study|Confirmed unevaluable|1|||
146026894|NCT02091284|526612274|FG000|Overall Study|Withdrawal by Subject|2|||
146026895|NCT02091284|526612275|FG001|Overall Study|Withdrawal by Subject|1|||
146026896|NCT02091284|526612274|FG000|Overall Study|unreliable data|1|||
146026897|NCT02091284|526612275|FG001|Overall Study|unreliable data|0|||
146026898|NCT01278407|526612276|FG000|Confirmatory Phase|Adverse Event|5|||
146026899|NCT01278407|526612277|FG001|Confirmatory Phase|Adverse Event|10|||
146026900|NCT01278407|526612278|FG002|Confirmatory Phase|Adverse Event|1|||
146026901|NCT01278407|526612279|FG003|Confirmatory Phase|Adverse Event|0|||
146026902|NCT01278407|526612280|FG004|Confirmatory Phase|Adverse Event|0|||
146026903|NCT01278407|526612276|FG000|Confirmatory Phase|Participant's Choice|3|||
146026904|NCT01278407|526612277|FG001|Confirmatory Phase|Participant's Choice|5|||
146026905|NCT01278407|526612278|FG002|Confirmatory Phase|Participant's Choice|3|||
146026906|NCT01278407|526612279|FG003|Confirmatory Phase|Participant's Choice|0|||
146026907|NCT01278407|526612280|FG004|Confirmatory Phase|Participant's Choice|0|||
146026908|NCT01278407|526612276|FG000|Confirmatory Phase|Other|1|||
146026909|NCT01278407|526612277|FG001|Confirmatory Phase|Other|1|||
146026910|NCT01278407|526612278|FG002|Confirmatory Phase|Other|2|||
146094983|NCT01916967|526869668|FG002|Overall Study|Adverse Event|2|||
146026911|NCT01278407|526612279|FG003|Confirmatory Phase|Other|0|||
146026912|NCT01278407|526612280|FG004|Confirmatory Phase|Other|0|||
146026913|NCT01278407|526612276|FG000|Extension Phase|Adverse Event|0|||
146026914|NCT01278407|526612277|FG001|Extension Phase|Adverse Event|0|||
146026915|NCT01278407|526612278|FG002|Extension Phase|Adverse Event|0|||
146026916|NCT01278407|526612279|FG003|Extension Phase|Adverse Event|7|||
146026917|NCT01278407|526612280|FG004|Extension Phase|Adverse Event|16|||
146026918|NCT01278407|526612276|FG000|Extension Phase|Participant's Choice|0|||
146026919|NCT01278407|526612277|FG001|Extension Phase|Participant's Choice|0|||
146026920|NCT01278407|526612278|FG002|Extension Phase|Participant's Choice|0|||
146026921|NCT01278407|526612279|FG003|Extension Phase|Participant's Choice|4|||
146026922|NCT01278407|526612280|FG004|Extension Phase|Participant's Choice|11|||
146026923|NCT01278407|526612276|FG000|Extension Phase|Other|0|||
146026924|NCT01278407|526612277|FG001|Extension Phase|Other|0|||
146026925|NCT01278407|526612278|FG002|Extension Phase|Other|0|||
146026926|NCT01278407|526612279|FG003|Extension Phase|Other|1|||
146026927|NCT01278407|526612280|FG004|Extension Phase|Other|3|||
146026928|NCT02534935|526612281|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
146026929|NCT02534935|526612282|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
146026930|NCT02534935|526612283|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
146026931|NCT02534935|526612281|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
146026932|NCT02534935|526612282|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
146026933|NCT02534935|526612283|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
146026934|NCT02534935|526612281|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
146026935|NCT02534935|526612282|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
146026936|NCT02534935|526612283|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
146026937|NCT02534935|526612281|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
146026938|NCT02534935|526612282|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
146026939|NCT02534935|526612283|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
146026940|NCT02534935|526612281|FG000|Stage 1: 24 Months|Adverse Event|0|||
146026941|NCT02534935|526612282|FG001|Stage 1: 24 Months|Adverse Event|2|||
146026942|NCT02534935|526612283|FG002|Stage 1: 24 Months|Adverse Event|0|||
146026943|NCT02534935|526612281|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
146026944|NCT02534935|526612282|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
146026945|NCT02534935|526612283|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
146026946|NCT02534935|526612281|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
146026947|NCT02534935|526612282|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
146026948|NCT02534935|526612283|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
146026949|NCT04524455|526612288|FG000|Overall Study|Death|3|||
146026950|NCT04524455|526612289|FG001|Overall Study|Death|3|||
146026951|NCT04524455|526612288|FG000|Overall Study|Decision by Sponsor|0|||
146026952|NCT04524455|526612289|FG001|Overall Study|Decision by Sponsor|2|||
146026953|NCT04524455|526612288|FG000|Overall Study|Withdrawal of Consent From Study|1|||
146026954|NCT04524455|526612289|FG001|Overall Study|Withdrawal of Consent From Study|0|||
146026955|NCT04524455|526612288|FG000|Overall Study|Lost to Follow-up|0|||
146026956|NCT04524455|526612289|FG001|Overall Study|Lost to Follow-up|1|||
146026957|NCT01176565|526612290|FG000|Overall Study|Lost to Follow-up|12|||
146026958|NCT01176565|526612291|FG001|Overall Study|Lost to Follow-up|16|||
146026959|NCT01176565|526612290|FG000|Overall Study|Withdrawal by Subject|7|||
146026960|NCT01176565|526612291|FG001|Overall Study|Withdrawal by Subject|1|||
146026961|NCT01176565|526612290|FG000|Overall Study|Not Analyzed (any other reason)|1|||
146026962|NCT01176565|526612291|FG001|Overall Study|Not Analyzed (any other reason)|2|||
146026963|NCT02285114|526612293|FG000|Main Phase|Investigator's Discretion|0|||
146026964|NCT02285114|526612294|FG001|Main Phase|Investigator's Discretion|2|||
146026965|NCT02285114|526612295|FG002|Main Phase|Investigator's Discretion|0|||
146026966|NCT02285114|526612296|FG003|Main Phase|Investigator's Discretion|0|||
146026967|NCT02285114|526612297|FG004|Main Phase|Investigator's Discretion|0|||
146026968|NCT02285114|526612298|FG005|Main Phase|Investigator's Discretion|0|||
146026969|NCT02285114|526612293|FG000|Main Phase|Enrolled but Never Treated|1|||
146026970|NCT02285114|526612294|FG001|Main Phase|Enrolled but Never Treated|0|||
146026971|NCT02285114|526612295|FG002|Main Phase|Enrolled but Never Treated|0|||
146026972|NCT02285114|526612296|FG003|Main Phase|Enrolled but Never Treated|0|||
146026973|NCT02285114|526612297|FG004|Main Phase|Enrolled but Never Treated|0|||
146026974|NCT02285114|526612298|FG005|Main Phase|Enrolled but Never Treated|0|||
146026975|NCT02285114|526612293|FG000|Main Phase|Withdrew Consent|0|||
146026976|NCT02285114|526612294|FG001|Main Phase|Withdrew Consent|0|||
146026977|NCT02285114|526612295|FG002|Main Phase|Withdrew Consent|1|||
146026978|NCT02285114|526612296|FG003|Main Phase|Withdrew Consent|0|||
146026979|NCT02285114|526612297|FG004|Main Phase|Withdrew Consent|0|||
146026980|NCT02285114|526612298|FG005|Main Phase|Withdrew Consent|0|||
146026981|NCT02285114|526612293|FG000|Extension Phase|Investigator's Discretion|0|||
146026982|NCT02285114|526612294|FG001|Extension Phase|Investigator's Discretion|0|||
146026983|NCT02285114|526612295|FG002|Extension Phase|Investigator's Discretion|0|||
146026984|NCT02285114|526612296|FG003|Extension Phase|Investigator's Discretion|14|||
146026985|NCT02285114|526612297|FG004|Extension Phase|Investigator's Discretion|1|||
146094984|NCT01916967|526869666|FG000|Overall Study|Lack of Efficacy|0|||
146094985|NCT01916967|526869667|FG001|Overall Study|Lack of Efficacy|0|||
146094986|NCT01916967|526869668|FG002|Overall Study|Lack of Efficacy|6|||
146094987|NCT01916967|526869666|FG000|Overall Study|Physician Decision|0|||
146094988|NCT01916967|526869667|FG001|Overall Study|Physician Decision|0|||
146094989|NCT01916967|526869668|FG002|Overall Study|Physician Decision|1|||
146094990|NCT01916967|526869666|FG000|Overall Study|Protocol Violation|0|||
146094991|NCT01916967|526869667|FG001|Overall Study|Protocol Violation|1|||
146094992|NCT01916967|526869668|FG002|Overall Study|Protocol Violation|0|||
146094993|NCT00620464|526869669|FG000|Overall Study|Adverse Event|15|||
146094994|NCT00620464|526869670|FG001|Overall Study|Adverse Event|17|||
146094995|NCT00620464|526869669|FG000|Overall Study|Lost to Follow-up|1|||
146094996|NCT00620464|526869670|FG001|Overall Study|Lost to Follow-up|1|||
146094997|NCT00620464|526869669|FG000|Overall Study|Planning Pregnancy|1|||
146094998|NCT00620464|526869670|FG001|Overall Study|Planning Pregnancy|4|||
146094999|NCT00620464|526869669|FG000|Overall Study|Personal|2|||
146095000|NCT00620464|526869670|FG001|Overall Study|Personal|2|||
146095001|NCT00620464|526869669|FG000|Overall Study|Used prohibited medication|1|||
146095002|NCT00620464|526869670|FG001|Overall Study|Used prohibited medication|0|||
146095003|NCT01336569|526869671|FG000|Overall Study|Lost to Follow-up|4|||
146095004|NCT03911154|526869674|FG000|Overall Study|Withdrawal by Subject|1|||
146095005|NCT00406354|526869675|FG000|All Randomized Patients|Protocol Violation|0|||
146095006|NCT00406354|526869676|FG001|All Randomized Patients|Protocol Violation|0|||
146095007|NCT00406354|526869677|FG002|All Randomized Patients|Protocol Violation|1|||
146095008|NCT00406354|526869675|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
146095009|NCT00406354|526869676|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
146095010|NCT00406354|526869677|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
146095011|NCT00406354|526869675|FG000|All Randomized and Treated Patients|Adverse Event|6|||
146095012|NCT00406354|526869676|FG001|All Randomized and Treated Patients|Adverse Event|2|||
146095013|NCT00406354|526869677|FG002|All Randomized and Treated Patients|Adverse Event|1|||
146095014|NCT00406354|526869675|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
146095015|NCT00406354|526869676|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
146095016|NCT00406354|526869677|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
146095017|NCT00406354|526869675|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
146095018|NCT00406354|526869676|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
146095019|NCT00406354|526869677|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
146095020|NCT00406354|526869675|FG000|All Randomized and Treated Patients|Physician Decision|0|||
146095021|NCT00406354|526869676|FG001|All Randomized and Treated Patients|Physician Decision|0|||
146095022|NCT00406354|526869677|FG002|All Randomized and Treated Patients|Physician Decision|1|||
146095023|NCT01231347|526869678|FG000|Overall Study|Full Consent withdrawn|19|||
146095024|NCT01231347|526869679|FG001|Overall Study|Full Consent withdrawn|19|||
146095025|NCT01231347|526869680|FG002|Overall Study|Full Consent withdrawn|11|||
146095026|NCT01231347|526869678|FG000|Overall Study|Lost to Follow-up|4|||
146095027|NCT01231347|526869679|FG001|Overall Study|Lost to Follow-up|2|||
146095028|NCT01231347|526869680|FG002|Overall Study|Lost to Follow-up|2|||
146095029|NCT01231347|526869678|FG000|Overall Study|Death|202|||
146095030|NCT01231347|526869679|FG001|Overall Study|Death|210|||
146095031|NCT01231347|526869680|FG002|Overall Study|Death|101|||
146095032|NCT01231347|526869678|FG000|Overall Study|other event|7|||
146095033|NCT01231347|526869679|FG001|Overall Study|other event|9|||
146095034|NCT01231347|526869680|FG002|Overall Study|other event|3|||
146095035|NCT01460368|526869681|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095036|NCT01460368|526869682|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095037|NCT01460368|526869683|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095038|NCT01460368|526869684|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095039|NCT01460368|526869685|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
146095040|NCT01460368|526869686|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095041|NCT01460368|526869687|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
146095042|NCT01460368|526869681|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146095043|NCT01460368|526869682|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
146095044|NCT01460368|526869683|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146095045|NCT01460368|526869684|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146095046|NCT01460368|526869685|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146095047|NCT01460368|526869686|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
146254117|NCT03334747|527443049|FG006|Treatment Phase|Technical problems|0|||
146095048|NCT01460368|526869687|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
146095049|NCT01460368|526869681|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095050|NCT01460368|526869682|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
146095051|NCT01460368|526869683|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095052|NCT01460368|526869684|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095053|NCT01460368|526869685|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095054|NCT01460368|526869686|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095055|NCT01460368|526869687|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
146095056|NCT01460368|526869681|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095057|NCT01460368|526869682|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095058|NCT01460368|526869683|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
146095059|NCT01460368|526869684|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095060|NCT01460368|526869685|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095061|NCT01460368|526869686|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095062|NCT01460368|526869687|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
146095063|NCT01460368|526869681|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146095064|NCT01460368|526869682|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146095065|NCT01460368|526869683|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146095066|NCT01460368|526869684|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146095067|NCT01460368|526869685|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146095068|NCT01460368|526869686|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
146095069|NCT01460368|526869687|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
146095070|NCT02322021|526869688|FG000|Core Phase|Adverse Event|1|||
146095071|NCT02322021|526869689|FG001|Core Phase|Adverse Event|3|||
146095072|NCT02322021|526869690|FG002|Core Phase|Adverse Event|4|||
146095073|NCT02322021|526869691|FG003|Core Phase|Adverse Event|2|||
146095074|NCT02322021|526869692|FG004|Core Phase|Adverse Event|0|||
146095075|NCT02322021|526869688|FG000|Core Phase|Participant Choice|4|||
146095076|NCT02322021|526869689|FG001|Core Phase|Participant Choice|5|||
146095077|NCT02322021|526869690|FG002|Core Phase|Participant Choice|4|||
146095078|NCT02322021|526869691|FG003|Core Phase|Participant Choice|2|||
146095079|NCT02322021|526869692|FG004|Core Phase|Participant Choice|0|||
146095080|NCT02322021|526869688|FG000|Core Phase|Lost to Follow-up|0|||
146095081|NCT02322021|526869689|FG001|Core Phase|Lost to Follow-up|0|||
146095082|NCT02322021|526869690|FG002|Core Phase|Lost to Follow-up|0|||
146095083|NCT02322021|526869691|FG003|Core Phase|Lost to Follow-up|1|||
146095084|NCT02322021|526869692|FG004|Core Phase|Lost to Follow-up|0|||
146095085|NCT02322021|526869688|FG000|Core Phase|Other|0|||
146095086|NCT02322021|526869689|FG001|Core Phase|Other|0|||
146095087|NCT02322021|526869690|FG002|Core Phase|Other|1|||
146095088|NCT02322021|526869691|FG003|Core Phase|Other|0|||
146095089|NCT02322021|526869692|FG004|Core Phase|Other|0|||
146095090|NCT02322021|526869688|FG000|Extension Phase|Adverse Event|0|||
146095091|NCT02322021|526869689|FG001|Extension Phase|Adverse Event|0|||
146095092|NCT02322021|526869690|FG002|Extension Phase|Adverse Event|0|||
146095093|NCT02322021|526869691|FG003|Extension Phase|Adverse Event|0|||
146095094|NCT02322021|526869692|FG004|Extension Phase|Adverse Event|3|||
146095095|NCT02322021|526869688|FG000|Extension Phase|Participant Choice|0|||
146095096|NCT02322021|526869689|FG001|Extension Phase|Participant Choice|0|||
146095097|NCT02322021|526869690|FG002|Extension Phase|Participant Choice|0|||
146095098|NCT02322021|526869691|FG003|Extension Phase|Participant Choice|0|||
146095099|NCT02322021|526869692|FG004|Extension Phase|Participant Choice|6|||
146095100|NCT02322021|526869688|FG000|Extension Phase|Other|0|||
146095101|NCT02322021|526869689|FG001|Extension Phase|Other|0|||
146095102|NCT02322021|526869690|FG002|Extension Phase|Other|0|||
146095103|NCT02322021|526869691|FG003|Extension Phase|Other|0|||
146095104|NCT02322021|526869692|FG004|Extension Phase|Other|3|||
146095105|NCT02322021|526869688|FG000|Extension Phase|Lost to Follow-up|0|||
146095106|NCT02322021|526869689|FG001|Extension Phase|Lost to Follow-up|0|||
146095107|NCT02322021|526869690|FG002|Extension Phase|Lost to Follow-up|0|||
146095108|NCT02322021|526869691|FG003|Extension Phase|Lost to Follow-up|0|||
146095109|NCT02322021|526869692|FG004|Extension Phase|Lost to Follow-up|1|||
146095110|NCT02322021|526869688|FG000|Extension Phase|Study terminated by sponsor|0|||
146095111|NCT02322021|526869689|FG001|Extension Phase|Study terminated by sponsor|0|||
146095112|NCT02322021|526869690|FG002|Extension Phase|Study terminated by sponsor|0|||
146095113|NCT02322021|526869691|FG003|Extension Phase|Study terminated by sponsor|0|||
146095114|NCT02322021|526869692|FG004|Extension Phase|Study terminated by sponsor|28|||
146095115|NCT01385371|526869705|FG000|Overall Study|Adverse Event|54|||
146095116|NCT01385371|526869706|FG001|Overall Study|Adverse Event|19|||
146095117|NCT01385371|526869705|FG000|Overall Study|Lost to Follow-up|16|||
146095118|NCT01385371|526869706|FG001|Overall Study|Lost to Follow-up|16|||
146095119|NCT01385371|526869705|FG000|Overall Study|Withdrawal by Subject|52|||
146095120|NCT01385371|526869706|FG001|Overall Study|Withdrawal by Subject|39|||
146254118|NCT03334747|527443050|FG007|Treatment Phase|Technical problems|0|||
146254119|NCT03334747|527443051|FG008|Treatment Phase|Technical problems|0|||
146095121|NCT01385371|526869705|FG000|Overall Study|Protocol Violation|25|||
146095122|NCT01385371|526869706|FG001|Overall Study|Protocol Violation|21|||
146095123|NCT01385371|526869705|FG000|Overall Study|Administrative|2|||
146095124|NCT01385371|526869706|FG001|Overall Study|Administrative|2|||
146095125|NCT00292318|526869712|FG000|Overall Study|Study terminated by officials|2|||
146095126|NCT00292318|526869713|FG001|Overall Study|Study terminated by officials|1|||
146095127|NCT02027376|526869714|FG000|Overall Study|Death|1|||
146095128|NCT02027376|526869715|FG001|Overall Study|Death|0|||
146095129|NCT02027376|526869716|FG002|Overall Study|Death|0|||
146026986|NCT02285114|526612298|FG005|Extension Phase|Investigator's Discretion|0|||
146026987|NCT02285114|526612293|FG000|Extension Phase|Lost to Follow-up|0|||
146026988|NCT02285114|526612294|FG001|Extension Phase|Lost to Follow-up|0|||
146026989|NCT02285114|526612295|FG002|Extension Phase|Lost to Follow-up|0|||
146026990|NCT02285114|526612296|FG003|Extension Phase|Lost to Follow-up|1|||
146026991|NCT02285114|526612297|FG004|Extension Phase|Lost to Follow-up|1|||
146026992|NCT02285114|526612298|FG005|Extension Phase|Lost to Follow-up|0|||
146026993|NCT02285114|526612293|FG000|Extension Phase|Non-compliance with Study Drug|0|||
146026994|NCT02285114|526612294|FG001|Extension Phase|Non-compliance with Study Drug|0|||
146026995|NCT02285114|526612295|FG002|Extension Phase|Non-compliance with Study Drug|0|||
146026996|NCT02285114|526612296|FG003|Extension Phase|Non-compliance with Study Drug|2|||
146026997|NCT02285114|526612297|FG004|Extension Phase|Non-compliance with Study Drug|0|||
146026998|NCT02285114|526612298|FG005|Extension Phase|Non-compliance with Study Drug|0|||
146026999|NCT02285114|526612293|FG000|Extension Phase|Pregnancy|0|||
146027000|NCT02285114|526612294|FG001|Extension Phase|Pregnancy|0|||
146027001|NCT02285114|526612295|FG002|Extension Phase|Pregnancy|0|||
146027002|NCT02285114|526612296|FG003|Extension Phase|Pregnancy|1|||
146027003|NCT02285114|526612297|FG004|Extension Phase|Pregnancy|0|||
146027004|NCT02285114|526612298|FG005|Extension Phase|Pregnancy|0|||
146027005|NCT01156389|526612299|FG000|Overall Study|Elevated liver enzymes|4|||
146027006|NCT01156389|526612300|FG001|Overall Study|Elevated liver enzymes|0|||
146027007|NCT01156389|526612299|FG000|Overall Study|Vomiting|0|||
146027008|NCT01156389|526612300|FG001|Overall Study|Vomiting|1|||
146027009|NCT02233738|526612307|FG000|Overall Study|Lost to Follow-up|5|||
146027010|NCT02233738|526612308|FG001|Overall Study|Lost to Follow-up|12|||
146027011|NCT02233738|526612307|FG000|Overall Study|Death|0|||
146027012|NCT02233738|526612308|FG001|Overall Study|Death|1|||
146027013|NCT02233738|526612307|FG000|Overall Study|Withdrawal by Subject|0|||
146027014|NCT02233738|526612308|FG001|Overall Study|Withdrawal by Subject|1|||
146027015|NCT02233738|526612307|FG000|Overall Study|Did not return after Baseline|3|||
146027016|NCT02233738|526612308|FG001|Overall Study|Did not return after Baseline|2|||
146027017|NCT00330928|526612309|FG000|Overall Study|Lost to Follow-up|6|||
146027018|NCT00330928|526612309|FG000|Overall Study|Physician Decision|9|||
146027019|NCT00330928|526612309|FG000|Overall Study|Death|1|||
146027020|NCT00330928|526612309|FG000|Overall Study|IVUS could not be performed.|1|||
146027021|NCT03028480|526612312|FG000|Overall Study|No revisit after the first prescription date|2|||
146027022|NCT03028480|526612312|FG000|Overall Study|Did not use the drug|1|||
146027023|NCT03028480|526612312|FG000|Overall Study|Violation of the enrollment deadline|10|||
146027024|NCT03028480|526612312|FG000|Overall Study|Case report forms were not collected|21|||
146027025|NCT01030874|526612313|FG000|Overall Study|Withdrawal by Subject|1|||
146027026|NCT01030874|526612314|FG001|Overall Study|Withdrawal by Subject|0|||
146027027|NCT01030874|526612313|FG000|Overall Study|Discharged in first 2 weeks|17|||
146027028|NCT01030874|526612314|FG001|Overall Study|Discharged in first 2 weeks|16|||
146027029|NCT03554772|526612317|FG000|Overall Study|Lost to Follow-up|0|||
146027030|NCT03554772|526612318|FG001|Overall Study|Lost to Follow-up|0|||
146027031|NCT03554772|526612319|FG002|Overall Study|Lost to Follow-up|0|||
146027032|NCT03554772|526612320|FG003|Overall Study|Lost to Follow-up|2|||
146027033|NCT01133405|526612324|FG000|Period 1|Withdrawal by Subject|0|||
146027034|NCT01133405|526612325|FG001|Period 1|Withdrawal by Subject|1|||
146027035|NCT01133405|526612326|FG002|Period 1|Withdrawal by Subject|0|||
146027036|NCT01133405|526612327|FG003|Period 1|Withdrawal by Subject|1|||
146027037|NCT01133405|526612328|FG004|Period 1|Withdrawal by Subject|0|||
146027038|NCT01133405|526612329|FG005|Period 1|Withdrawal by Subject|1|||
146027039|NCT01133405|526612330|FG006|Period 1|Withdrawal by Subject|0|||
146027040|NCT01133405|526612331|FG007|Period 1|Withdrawal by Subject|0|||
146027041|NCT01133405|526612332|FG008|Period 1|Withdrawal by Subject|0|||
146027042|NCT01133405|526612333|FG009|Period 1|Withdrawal by Subject|0|||
146027043|NCT01133405|526612324|FG000|Period 1|Physician Decision|0|||
146027044|NCT01133405|526612325|FG001|Period 1|Physician Decision|0|||
146027045|NCT01133405|526612326|FG002|Period 1|Physician Decision|0|||
146027046|NCT01133405|526612327|FG003|Period 1|Physician Decision|1|||
146027047|NCT01133405|526612328|FG004|Period 1|Physician Decision|0|||
146027048|NCT01133405|526612329|FG005|Period 1|Physician Decision|0|||
146027049|NCT01133405|526612330|FG006|Period 1|Physician Decision|0|||
146027050|NCT01133405|526612331|FG007|Period 1|Physician Decision|0|||
146027051|NCT01133405|526612332|FG008|Period 1|Physician Decision|0|||
146027052|NCT01133405|526612333|FG009|Period 1|Physician Decision|0|||
146027053|NCT01133405|526612324|FG000|Period 1|Discontinued after randomization|1|||
146027054|NCT01133405|526612325|FG001|Period 1|Discontinued after randomization|0|||
146027055|NCT01133405|526612326|FG002|Period 1|Discontinued after randomization|0|||
146027056|NCT01133405|526612327|FG003|Period 1|Discontinued after randomization|0|||
146027057|NCT01133405|526612328|FG004|Period 1|Discontinued after randomization|0|||
146027058|NCT01133405|526612329|FG005|Period 1|Discontinued after randomization|0|||
146027059|NCT01133405|526612330|FG006|Period 1|Discontinued after randomization|1|||
146027060|NCT01133405|526612331|FG007|Period 1|Discontinued after randomization|0|||
146027061|NCT01133405|526612332|FG008|Period 1|Discontinued after randomization|0|||
146027062|NCT01133405|526612333|FG009|Period 1|Discontinued after randomization|0|||
146027063|NCT01133405|526612324|FG000|Period 1|Received drug only in period 2|0|||
146095130|NCT01278160|526869720|FG000|Overall Study|Adverse Event|1|||
146095131|NCT01278160|526869721|FG001|Overall Study|Adverse Event|1|||
146095132|NCT01278160|526869720|FG000|Overall Study|Lost to Follow-up|0|||
146095133|NCT01278160|526869721|FG001|Overall Study|Lost to Follow-up|1|||
146095134|NCT01278160|526869720|FG000|Overall Study|Withdrawal by Subject|3|||
146027064|NCT01133405|526612325|FG001|Period 1|Received drug only in period 2|1|||
146027065|NCT01133405|526612326|FG002|Period 1|Received drug only in period 2|0|||
146027066|NCT01133405|526612327|FG003|Period 1|Received drug only in period 2|2|||
146027067|NCT01133405|526612328|FG004|Period 1|Received drug only in period 2|0|||
146027068|NCT01133405|526612329|FG005|Period 1|Received drug only in period 2|1|||
146027069|NCT01133405|526612330|FG006|Period 1|Received drug only in period 2|0|||
146027070|NCT01133405|526612331|FG007|Period 1|Received drug only in period 2|0|||
146027071|NCT01133405|526612332|FG008|Period 1|Received drug only in period 2|0|||
146027072|NCT01133405|526612333|FG009|Period 1|Received drug only in period 2|0|||
146027073|NCT01133405|526612324|FG000|Period 1|Received drug only in period 3|0|||
146027074|NCT01133405|526612325|FG001|Period 1|Received drug only in period 3|1|||
146027075|NCT01133405|526612326|FG002|Period 1|Received drug only in period 3|1|||
146027076|NCT01133405|526612327|FG003|Period 1|Received drug only in period 3|0|||
146027077|NCT01133405|526612328|FG004|Period 1|Received drug only in period 3|0|||
146027078|NCT01133405|526612329|FG005|Period 1|Received drug only in period 3|0|||
146027079|NCT01133405|526612330|FG006|Period 1|Received drug only in period 3|0|||
146027080|NCT01133405|526612331|FG007|Period 1|Received drug only in period 3|0|||
146027081|NCT01133405|526612332|FG008|Period 1|Received drug only in period 3|0|||
146027082|NCT01133405|526612333|FG009|Period 1|Received drug only in period 3|0|||
146027083|NCT01133405|526612324|FG000|Period 2|Adverse Event|0|||
146027084|NCT01133405|526612325|FG001|Period 2|Adverse Event|0|||
146027085|NCT01133405|526612326|FG002|Period 2|Adverse Event|1|||
146027086|NCT01133405|526612327|FG003|Period 2|Adverse Event|0|||
146027087|NCT01133405|526612328|FG004|Period 2|Adverse Event|0|||
146027088|NCT01133405|526612329|FG005|Period 2|Adverse Event|0|||
146027089|NCT01133405|526612330|FG006|Period 2|Adverse Event|0|||
146027090|NCT01133405|526612331|FG007|Period 2|Adverse Event|0|||
146027091|NCT01133405|526612332|FG008|Period 2|Adverse Event|0|||
146027092|NCT01133405|526612333|FG009|Period 2|Adverse Event|0|||
146027093|NCT01133405|526612324|FG000|Period 2|Withdrawal by Subject|0|||
146027094|NCT01133405|526612325|FG001|Period 2|Withdrawal by Subject|0|||
146027095|NCT01133405|526612326|FG002|Period 2|Withdrawal by Subject|0|||
146027096|NCT01133405|526612327|FG003|Period 2|Withdrawal by Subject|1|||
146027097|NCT01133405|526612328|FG004|Period 2|Withdrawal by Subject|0|||
146027098|NCT01133405|526612329|FG005|Period 2|Withdrawal by Subject|1|||
146027099|NCT01133405|526612330|FG006|Period 2|Withdrawal by Subject|0|||
146027100|NCT01133405|526612331|FG007|Period 2|Withdrawal by Subject|0|||
146027101|NCT01133405|526612332|FG008|Period 2|Withdrawal by Subject|0|||
146027102|NCT01133405|526612333|FG009|Period 2|Withdrawal by Subject|0|||
146027103|NCT01133405|526612324|FG000|Period 2|Entry Criteria Not Met|0|||
146027104|NCT01133405|526612325|FG001|Period 2|Entry Criteria Not Met|1|||
146027105|NCT01133405|526612326|FG002|Period 2|Entry Criteria Not Met|0|||
146027106|NCT01133405|526612327|FG003|Period 2|Entry Criteria Not Met|0|||
146027107|NCT01133405|526612328|FG004|Period 2|Entry Criteria Not Met|0|||
146027108|NCT01133405|526612329|FG005|Period 2|Entry Criteria Not Met|0|||
146027109|NCT01133405|526612330|FG006|Period 2|Entry Criteria Not Met|0|||
146027110|NCT01133405|526612331|FG007|Period 2|Entry Criteria Not Met|0|||
146027111|NCT01133405|526612332|FG008|Period 2|Entry Criteria Not Met|0|||
146027112|NCT01133405|526612333|FG009|Period 2|Entry Criteria Not Met|0|||
146027113|NCT01133405|526612324|FG000|Period 2|Physician Decision|0|||
146027114|NCT01133405|526612325|FG001|Period 2|Physician Decision|0|||
146027115|NCT01133405|526612326|FG002|Period 2|Physician Decision|0|||
146027116|NCT01133405|526612327|FG003|Period 2|Physician Decision|0|||
146095135|NCT01278160|526869721|FG001|Overall Study|Withdrawal by Subject|2|||
146095136|NCT01278160|526869720|FG000|Overall Study|Unclassified|1|||
146095137|NCT01278160|526869721|FG001|Overall Study|Unclassified|2|||
146095138|NCT00304239|526869724|FG000|Overall Study|Protocol Deviations/Violations|15|||
146254120|NCT03334747|527443043|FG000|Treatment Phase|Subject/guardian decision|1|||
146254121|NCT03334747|527443044|FG001|Treatment Phase|Subject/guardian decision|0|||
146254122|NCT03334747|527443045|FG002|Treatment Phase|Subject/guardian decision|0|||
146254123|NCT03334747|527443046|FG003|Treatment Phase|Subject/guardian decision|0|||
146254124|NCT03334747|527443047|FG004|Treatment Phase|Subject/guardian decision|0|||
146027117|NCT01133405|526612328|FG004|Period 2|Physician Decision|0|||
146027118|NCT01133405|526612329|FG005|Period 2|Physician Decision|1|||
146027119|NCT01133405|526612330|FG006|Period 2|Physician Decision|0|||
146027120|NCT01133405|526612331|FG007|Period 2|Physician Decision|0|||
146027121|NCT01133405|526612332|FG008|Period 2|Physician Decision|0|||
146027122|NCT01133405|526612333|FG009|Period 2|Physician Decision|0|||
146027123|NCT00089986|526612336|FG000|Overall Study|Adverse Event|6|||
146027124|NCT00089986|526612337|FG001|Overall Study|Adverse Event|9|||
146027125|NCT00089986|526612338|FG002|Overall Study|Adverse Event|6|||
146027126|NCT00089986|526612336|FG000|Overall Study|Lost to Follow-up|3|||
146027127|NCT00089986|526612337|FG001|Overall Study|Lost to Follow-up|1|||
146095139|NCT00304239|526869725|FG001|Overall Study|Protocol Deviations/Violations|0|||
146027128|NCT00089986|526612338|FG002|Overall Study|Lost to Follow-up|1|||
146095140|NCT00304239|526869724|FG000|Overall Study|Adverse Event|2|||
146095141|NCT00304239|526869725|FG001|Overall Study|Adverse Event|0|||
146095142|NCT02979197|526869726|FG000|Overall Study|Adverse Event|4|||
146095143|NCT02979197|526869727|FG001|Overall Study|Adverse Event|2|||
146095144|NCT02979197|526869728|FG002|Overall Study|Adverse Event|0|||
146095145|NCT02979197|526869726|FG000|Overall Study|Protocol Violation|0|||
146027129|NCT00089986|526612336|FG000|Overall Study|Protocol Violation|0|||
146027130|NCT00089986|526612337|FG001|Overall Study|Protocol Violation|1|||
146027131|NCT00089986|526612338|FG002|Overall Study|Protocol Violation|0|||
146027132|NCT00089986|526612336|FG000|Overall Study|Patient transferred to another hospital|2|||
146027133|NCT00089986|526612337|FG001|Overall Study|Patient transferred to another hospital|1|||
146027134|NCT00089986|526612338|FG002|Overall Study|Patient transferred to another hospital|0|||
146027135|NCT00089986|526612336|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
146027136|NCT00089986|526612337|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
146027137|NCT00089986|526612338|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
146027138|NCT00089986|526612336|FG000|Overall Study|Hemohlobin stopping rule|0|||
146027139|NCT00089986|526612337|FG001|Overall Study|Hemohlobin stopping rule|1|||
146027140|NCT00089986|526612338|FG002|Overall Study|Hemohlobin stopping rule|0|||
146027141|NCT00089986|526612336|FG000|Overall Study|Investigator decision to withdrew|0|||
146027142|NCT00089986|526612337|FG001|Overall Study|Investigator decision to withdrew|1|||
146027143|NCT00089986|526612338|FG002|Overall Study|Investigator decision to withdrew|0|||
146027144|NCT00089986|526612336|FG000|Overall Study|Enrollment in another study|0|||
146027145|NCT00089986|526612337|FG001|Overall Study|Enrollment in another study|1|||
146027146|NCT00089986|526612338|FG002|Overall Study|Enrollment in another study|0|||
146027147|NCT00089986|526612336|FG000|Overall Study|Family decision|0|||
146027148|NCT00089986|526612337|FG001|Overall Study|Family decision|1|||
146027149|NCT00089986|526612338|FG002|Overall Study|Family decision|0|||
146027150|NCT00089986|526612336|FG000|Overall Study|Do not resuscitate (DNR)|0|||
146027151|NCT00089986|526612337|FG001|Overall Study|Do not resuscitate (DNR)|0|||
146027152|NCT00089986|526612338|FG002|Overall Study|Do not resuscitate (DNR)|1|||
146027153|NCT00089986|526612336|FG000|Overall Study|Withdrawal by Subject|3|||
146027154|NCT00089986|526612337|FG001|Overall Study|Withdrawal by Subject|6|||
146027155|NCT00089986|526612338|FG002|Overall Study|Withdrawal by Subject|2|||
146027156|NCT03946124|526612339|FG000|Overall Study|Withdrawal by Subject|19|||
146027157|NCT00241631|526612340|FG000|Run in (2 Weeks)|Physician Decision|3|||
146027158|NCT00241631|526612341|FG001|Run in (2 Weeks)|Physician Decision|3|||
146027159|NCT00241631|526612340|FG000|Phase 1 (4 Weeks)|sore throat|1|||
146027160|NCT00241631|526612341|FG001|Phase 1 (4 Weeks)|sore throat|0|||
146027161|NCT00241631|526612340|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
146027162|NCT00241631|526612341|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
146027163|NCT00241631|526612340|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
146095146|NCT02979197|526869727|FG001|Overall Study|Protocol Violation|1|||
146095147|NCT02979197|526869728|FG002|Overall Study|Protocol Violation|0|||
146095148|NCT02979197|526869726|FG000|Overall Study|Subject unable to commit to study dates|0|||
146095149|NCT02979197|526869727|FG001|Overall Study|Subject unable to commit to study dates|1|||
146095150|NCT02979197|526869728|FG002|Overall Study|Subject unable to commit to study dates|0|||
146095151|NCT01631812|526869729|FG000|Overall Study|Adverse Event|25|||
146095152|NCT01631812|526869729|FG000|Overall Study|Lack of Efficacy|5|||
146095153|NCT01631812|526869729|FG000|Overall Study|Withdrawal by Subject|4|||
146095154|NCT01631812|526869729|FG000|Overall Study|Physician Decision|3|||
146095155|NCT01414608|526869730|FG000|Overall Study|Ineligible|5|||
146095156|NCT01414608|526869731|FG001|Overall Study|Ineligible|2|||
146095157|NCT05156073|526869732|FG000|Overall Study|Patient canceled appointment with PCP|1|||
146095158|NCT00973349|526869733|FG000|Overall Study|Adverse Event|0|||
146095159|NCT00973349|526869734|FG001|Overall Study|Adverse Event|0|||
146095160|NCT00973349|526869735|FG002|Overall Study|Adverse Event|0|||
146095161|NCT00973349|526869736|FG003|Overall Study|Adverse Event|0|||
146095162|NCT00973349|526869737|FG004|Overall Study|Adverse Event|1|||
146095163|NCT00973349|526869738|FG005|Overall Study|Adverse Event|0|||
146095164|NCT00973349|526869739|FG006|Overall Study|Adverse Event|0|||
146095165|NCT00973349|526869740|FG007|Overall Study|Adverse Event|0|||
146095166|NCT00973349|526869741|FG008|Overall Study|Adverse Event|1|||
146095167|NCT00973349|526869742|FG009|Overall Study|Adverse Event|0|||
146095168|NCT00973349|526869743|FG010|Overall Study|Adverse Event|0|||
146027164|NCT00241631|526612341|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
146027165|NCT00241631|526612340|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
146027166|NCT00241631|526612341|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
146095169|NCT00973349|526869744|FG011|Overall Study|Adverse Event|0|||
146095170|NCT00973349|526869745|FG012|Overall Study|Adverse Event|0|||
146095171|NCT00973349|526869746|FG013|Overall Study|Adverse Event|0|||
146095172|NCT00973349|526869747|FG014|Overall Study|Adverse Event|1|||
146095173|NCT00973349|526869748|FG015|Overall Study|Adverse Event|0|||
146095174|NCT00973349|526869733|FG000|Overall Study|Withdrawal by Subject|1|||
146095175|NCT00973349|526869734|FG001|Overall Study|Withdrawal by Subject|2|||
146095176|NCT00973349|526869735|FG002|Overall Study|Withdrawal by Subject|2|||
146254125|NCT03334747|527443048|FG005|Treatment Phase|Subject/guardian decision|1|||
146095177|NCT00973349|526869736|FG003|Overall Study|Withdrawal by Subject|3|||
146095178|NCT00973349|526869737|FG004|Overall Study|Withdrawal by Subject|2|||
146095179|NCT00973349|526869738|FG005|Overall Study|Withdrawal by Subject|0|||
146095180|NCT00973349|526869739|FG006|Overall Study|Withdrawal by Subject|2|||
146095181|NCT00973349|526869740|FG007|Overall Study|Withdrawal by Subject|2|||
146095182|NCT00973349|526869741|FG008|Overall Study|Withdrawal by Subject|0|||
146095183|NCT00973349|526869742|FG009|Overall Study|Withdrawal by Subject|2|||
146095184|NCT00973349|526869743|FG010|Overall Study|Withdrawal by Subject|0|||
146095185|NCT00973349|526869744|FG011|Overall Study|Withdrawal by Subject|1|||
146095186|NCT00973349|526869745|FG012|Overall Study|Withdrawal by Subject|0|||
146095187|NCT00973349|526869746|FG013|Overall Study|Withdrawal by Subject|0|||
146095188|NCT00973349|526869747|FG014|Overall Study|Withdrawal by Subject|0|||
146095189|NCT00973349|526869748|FG015|Overall Study|Withdrawal by Subject|0|||
146095190|NCT00973349|526869733|FG000|Overall Study|Lost to Follow-up|3|||
146095191|NCT00973349|526869734|FG001|Overall Study|Lost to Follow-up|1|||
146095192|NCT00973349|526869735|FG002|Overall Study|Lost to Follow-up|2|||
146095193|NCT00973349|526869736|FG003|Overall Study|Lost to Follow-up|2|||
146095194|NCT00973349|526869737|FG004|Overall Study|Lost to Follow-up|1|||
146095195|NCT00973349|526869738|FG005|Overall Study|Lost to Follow-up|3|||
146095196|NCT00973349|526869739|FG006|Overall Study|Lost to Follow-up|0|||
146095197|NCT00973349|526869740|FG007|Overall Study|Lost to Follow-up|1|||
146095198|NCT00973349|526869741|FG008|Overall Study|Lost to Follow-up|2|||
146095199|NCT00973349|526869742|FG009|Overall Study|Lost to Follow-up|1|||
146095200|NCT00973349|526869743|FG010|Overall Study|Lost to Follow-up|0|||
146095201|NCT00973349|526869744|FG011|Overall Study|Lost to Follow-up|1|||
146095202|NCT00973349|526869745|FG012|Overall Study|Lost to Follow-up|0|||
146095203|NCT00973349|526869746|FG013|Overall Study|Lost to Follow-up|0|||
146095204|NCT00973349|526869747|FG014|Overall Study|Lost to Follow-up|0|||
146095205|NCT00973349|526869748|FG015|Overall Study|Lost to Follow-up|1|||
146095206|NCT00973349|526869733|FG000|Overall Study|Inappropriate enrolment|0|||
146095207|NCT00973349|526869734|FG001|Overall Study|Inappropriate enrolment|0|||
146095208|NCT00973349|526869735|FG002|Overall Study|Inappropriate enrolment|1|||
146095209|NCT00973349|526869736|FG003|Overall Study|Inappropriate enrolment|0|||
146095210|NCT00973349|526869737|FG004|Overall Study|Inappropriate enrolment|0|||
146095211|NCT00973349|526869738|FG005|Overall Study|Inappropriate enrolment|0|||
146095212|NCT00973349|526869739|FG006|Overall Study|Inappropriate enrolment|0|||
146095213|NCT00973349|526869740|FG007|Overall Study|Inappropriate enrolment|0|||
146095214|NCT00973349|526869741|FG008|Overall Study|Inappropriate enrolment|0|||
146095215|NCT00973349|526869742|FG009|Overall Study|Inappropriate enrolment|2|||
146095216|NCT00973349|526869743|FG010|Overall Study|Inappropriate enrolment|0|||
146095217|NCT00973349|526869744|FG011|Overall Study|Inappropriate enrolment|0|||
146095218|NCT00973349|526869745|FG012|Overall Study|Inappropriate enrolment|1|||
146095219|NCT00973349|526869746|FG013|Overall Study|Inappropriate enrolment|0|||
146027167|NCT00413920|526612345|FG000|Overall Study|Adverse Event|9|||
146027168|NCT00413920|526612346|FG001|Overall Study|Adverse Event|11|||
146027169|NCT00413920|526612345|FG000|Overall Study|Lack of Efficacy|11|||
146027170|NCT00413920|526612346|FG001|Overall Study|Lack of Efficacy|9|||
146027171|NCT00413920|526612345|FG000|Overall Study|Death|3|||
146027172|NCT00413920|526612346|FG001|Overall Study|Death|5|||
146027173|NCT00413920|526612345|FG000|Overall Study|Graft Loss|5|||
146027174|NCT00413920|526612346|FG001|Overall Study|Graft Loss|3|||
146027175|NCT02788201|526612347|FG000|Overall Study|Death|1|||
146027176|NCT02788201|526612348|FG001|Overall Study|Death|1|||
146027177|NCT02788201|526612349|FG002|Overall Study|Death|1|||
146027178|NCT02788201|526612350|FG003|Overall Study|Death|1|||
146027179|NCT02788201|526612351|FG004|Overall Study|Death|0|||
146027180|NCT02788201|526612352|FG005|Overall Study|Death|1|||
146027181|NCT02788201|526612347|FG000|Overall Study|Ineligible|0|||
146027182|NCT02788201|526612348|FG001|Overall Study|Ineligible|0|||
146027183|NCT02788201|526612349|FG002|Overall Study|Ineligible|0|||
146027184|NCT02788201|526612350|FG003|Overall Study|Ineligible|0|||
146027185|NCT02788201|526612351|FG004|Overall Study|Ineligible|0|||
146095220|NCT00973349|526869747|FG014|Overall Study|Inappropriate enrolment|1|||
146095221|NCT00973349|526869748|FG015|Overall Study|Inappropriate enrolment|1|||
146095222|NCT00973349|526869733|FG000|Overall Study|Protocol Violation|0|||
146095223|NCT00973349|526869734|FG001|Overall Study|Protocol Violation|0|||
146095224|NCT00973349|526869735|FG002|Overall Study|Protocol Violation|0|||
146095225|NCT00973349|526869736|FG003|Overall Study|Protocol Violation|0|||
146095226|NCT00973349|526869737|FG004|Overall Study|Protocol Violation|0|||
146095227|NCT00973349|526869738|FG005|Overall Study|Protocol Violation|0|||
146095228|NCT00973349|526869739|FG006|Overall Study|Protocol Violation|0|||
146095229|NCT00973349|526869740|FG007|Overall Study|Protocol Violation|0|||
146095230|NCT00973349|526869741|FG008|Overall Study|Protocol Violation|1|||
146254126|NCT03334747|527443049|FG006|Treatment Phase|Subject/guardian decision|0|||
146254127|NCT03334747|527443050|FG007|Treatment Phase|Subject/guardian decision|0|||
146027186|NCT02788201|526612352|FG005|Overall Study|Ineligible|1|||
146027187|NCT02788201|526612347|FG000|Overall Study|Withdrawal by Subject|0|||
146027188|NCT02788201|526612348|FG001|Overall Study|Withdrawal by Subject|0|||
146027189|NCT02788201|526612349|FG002|Overall Study|Withdrawal by Subject|0|||
146027190|NCT02788201|526612350|FG003|Overall Study|Withdrawal by Subject|0|||
146027191|NCT02788201|526612351|FG004|Overall Study|Withdrawal by Subject|0|||
146027192|NCT02788201|526612352|FG005|Overall Study|Withdrawal by Subject|1|||
146027193|NCT01852825|526612353|FG000|Overall Study|Withdrawal by Subject|2|||
146027194|NCT01852825|526612354|FG001|Overall Study|Withdrawal by Subject|0|||
146027195|NCT01852825|526612355|FG002|Overall Study|Withdrawal by Subject|0|||
146027196|NCT03421743|526612360|FG000|Overall Study|Lack of Efficacy|1|||
146027197|NCT03421743|526612361|FG001|Overall Study|Lack of Efficacy|0|||
146027198|NCT03421743|526612360|FG000|Overall Study|Adverse Event|2|||
146027199|NCT03421743|526612361|FG001|Overall Study|Adverse Event|1|||
146027200|NCT03421743|526612360|FG000|Overall Study|Withdrawal by Subject|0|||
146027201|NCT03421743|526612361|FG001|Overall Study|Withdrawal by Subject|1|||
146027202|NCT01457950|526612362|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
146027203|NCT01457950|526612363|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
146027204|NCT01457950|526612364|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
146027205|NCT01457950|526612365|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
146027206|NCT01457950|526612362|FG000|Double-Blind Phase|Protocol Violation|2|||
146027207|NCT01457950|526612363|FG001|Double-Blind Phase|Protocol Violation|1|||
146027208|NCT01457950|526612364|FG002|Double-Blind Phase|Protocol Violation|0|||
146027209|NCT01457950|526612365|FG003|Double-Blind Phase|Protocol Violation|0|||
146027210|NCT01457950|526612362|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
146027211|NCT01457950|526612363|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
146027212|NCT01457950|526612364|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146027213|NCT01457950|526612365|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146027214|NCT01457950|526612362|FG000|Open-Label Phase|Adverse Event|0|||
146027215|NCT01457950|526612363|FG001|Open-Label Phase|Adverse Event|0|||
146027216|NCT01457950|526612364|FG002|Open-Label Phase|Adverse Event|0|||
146027217|NCT01457950|526612365|FG003|Open-Label Phase|Adverse Event|1|||
146027218|NCT01457950|526612362|FG000|Open-Label Phase|Protocol Violation|0|||
146027219|NCT01457950|526612363|FG001|Open-Label Phase|Protocol Violation|0|||
146027220|NCT01457950|526612364|FG002|Open-Label Phase|Protocol Violation|0|||
146027221|NCT01457950|526612365|FG003|Open-Label Phase|Protocol Violation|1|||
146027222|NCT01457950|526612362|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146027223|NCT01457950|526612363|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146027224|NCT01457950|526612364|FG002|Open-Label Phase|Withdrawal by Subject|2|||
146027225|NCT01457950|526612365|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146027226|NCT01765426|526612366|FG000|Overall Study|Lost to Follow-up|0|||
146027227|NCT01765426|526612367|FG001|Overall Study|Lost to Follow-up|1|||
146027228|NCT01765426|526612368|FG002|Overall Study|Lost to Follow-up|0|||
146027229|NCT01765426|526612369|FG003|Overall Study|Lost to Follow-up|0|||
146027230|NCT01166373|526612370|FG000|Overall Study|Lost to Follow-up|3|||
146027231|NCT01166373|526612371|FG001|Overall Study|Lost to Follow-up|2|||
146027232|NCT01166373|526612372|FG002|Overall Study|Lost to Follow-up|2|||
146027233|NCT01166373|526612373|FG003|Overall Study|Lost to Follow-up|2|||
146027234|NCT01166373|526612370|FG000|Overall Study|Withdrawal by Subject|1|||
146027235|NCT01166373|526612371|FG001|Overall Study|Withdrawal by Subject|2|||
146027236|NCT01166373|526612372|FG002|Overall Study|Withdrawal by Subject|2|||
146027237|NCT01166373|526612373|FG003|Overall Study|Withdrawal by Subject|3|||
146027238|NCT01166373|526612370|FG000|Overall Study|Physician Decision|1|||
146027239|NCT01166373|526612371|FG001|Overall Study|Physician Decision|0|||
146027240|NCT01166373|526612372|FG002|Overall Study|Physician Decision|0|||
146027241|NCT01166373|526612373|FG003|Overall Study|Physician Decision|0|||
146027242|NCT01510184|526612374|FG000|Overall Study|Sponsor discretion|28|||
146027243|NCT01510184|526612375|FG001|Overall Study|Sponsor discretion|28|||
146027244|NCT01510184|526612374|FG000|Overall Study|Death|1|||
146027245|NCT01510184|526612375|FG001|Overall Study|Death|2|||
146027246|NCT01510184|526612374|FG000|Overall Study|Withdrawal by Subject|1|||
146027247|NCT01510184|526612375|FG001|Overall Study|Withdrawal by Subject|4|||
146027248|NCT01510184|526612374|FG000|Overall Study|Other|0|||
146027249|NCT01510184|526612375|FG001|Overall Study|Other|1|||
146027250|NCT02310230|526612376|FG000|Overall Study|Physician Decision|1|||
146027251|NCT02310230|526612377|FG001|Overall Study|Physician Decision|3|||
146027252|NCT02310230|526612376|FG000|Overall Study|monitor baseline taken after induction|2|||
146027253|NCT02310230|526612377|FG001|Overall Study|monitor baseline taken after induction|7|||
146027254|NCT02310230|526612376|FG000|Overall Study|Poor signal quality|5|||
146027255|NCT02310230|526612377|FG001|Overall Study|Poor signal quality|8|||
146027256|NCT02310230|526612376|FG000|Overall Study|Case cancelled|1|||
146027257|NCT02310230|526612377|FG001|Overall Study|Case cancelled|0|||
146027258|NCT03593681|526612381|FG000|Overall Study|Inadequate sample collected|12|||
146027259|NCT03593681|526612381|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
146027260|NCT03593681|526612381|FG000|Overall Study|Protocol Violation|3|||
146027261|NCT03593681|526612381|FG000|Overall Study|Withdrawal by Subject|3|||
146027262|NCT03593681|526612381|FG000|Overall Study|Procedure not attempted|3|||
146027263|NCT03593681|526612381|FG000|Overall Study|Adverse Event|2|||
146027264|NCT03593681|526612381|FG000|Overall Study|Physician Decision|1|||
146027265|NCT02078102|526612382|FG000|Overall Study|Adverse Event|1|||
146027266|NCT02078102|526612383|FG001|Overall Study|Adverse Event|0|||
146027267|NCT02078102|526612382|FG000|Overall Study|Withdrawal by Subject|1|||
146027268|NCT02078102|526612383|FG001|Overall Study|Withdrawal by Subject|0|||
146027269|NCT02078102|526612382|FG000|Overall Study|Physician Decision|0|||
146027270|NCT02078102|526612383|FG001|Overall Study|Physician Decision|1|||
146027271|NCT02370641|526612386|FG000|Overall Study|dropped study|4|||
146027272|NCT02370641|526612387|FG001|Overall Study|dropped study|2|||
146027273|NCT05291936|526612391|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
146027274|NCT05291936|526612392|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
146027275|NCT05291936|526612391|FG000|Period 1|Withdrew Consent during study|1|||
146027276|NCT05291936|526612392|FG001|Period 1|Withdrew Consent during study|0|||
146027277|NCT05291936|526612391|FG000|Period 2|Adverse Event|0|||
146027278|NCT05291936|526612392|FG001|Period 2|Adverse Event|1|||
146027279|NCT05291936|526612391|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146027280|NCT05291936|526612392|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146027281|NCT01154283|526612397|FG000|0-6 Weeks|Withdrawal by Subject|7|||
146027282|NCT01154283|526612398|FG001|0-6 Weeks|Withdrawal by Subject|2|||
146027283|NCT01154283|526612397|FG000|0-6 Weeks|Death|0|||
146027284|NCT01154283|526612398|FG001|0-6 Weeks|Death|1|||
146027285|NCT01154283|526612397|FG000|7-12 Weeks|Death|1|||
146027286|NCT01154283|526612398|FG001|7-12 Weeks|Death|0|||
146027287|NCT01154283|526612397|FG000|7-12 Weeks|Withdrawal by Subject|0|||
146027288|NCT01154283|526612398|FG001|7-12 Weeks|Withdrawal by Subject|1|||
146027289|NCT00320372|526612399|FG000|Overall Study|Physician Decision|4|||
146027290|NCT00320372|526612400|FG001|Overall Study|Physician Decision|7|||
146027291|NCT00320372|526612399|FG000|Overall Study|Death|7|||
146027292|NCT00320372|526612400|FG001|Overall Study|Death|8|||
146027293|NCT00320372|526612399|FG000|Overall Study|Withdrawal by Subject|55|||
146027294|NCT00320372|526612400|FG001|Overall Study|Withdrawal by Subject|37|||
146027295|NCT00320372|526612399|FG000|Overall Study|Non-Compliance|40|||
146027296|NCT00320372|526612400|FG001|Overall Study|Non-Compliance|39|||
146027297|NCT00320372|526612399|FG000|Overall Study|Did not Meet (I/E)|3|||
146027298|NCT00320372|526612400|FG001|Overall Study|Did not Meet (I/E)|1|||
146027299|NCT00320372|526612399|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
146027300|NCT00320372|526612400|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
146027301|NCT01853072|526612401|FG000|Overall Study|Adverse event prior to treatment|0|||
146027302|NCT01853072|526612402|FG001|Overall Study|Adverse event prior to treatment|1|||
146027303|NCT01853072|526612401|FG000|Overall Study|Adverse Event|0|||
146027304|NCT01853072|526612402|FG001|Overall Study|Adverse Event|3|||
146027305|NCT01853072|526612401|FG000|Overall Study|Death|1|||
146027306|NCT01853072|526612402|FG001|Overall Study|Death|4|||
146027307|NCT01853072|526612401|FG000|Overall Study|Lost to Follow-up|0|||
146027308|NCT01853072|526612402|FG001|Overall Study|Lost to Follow-up|3|||
146027309|NCT01853072|526612401|FG000|Overall Study|Non-compliance with study drug|0|||
146027310|NCT01853072|526612402|FG001|Overall Study|Non-compliance with study drug|1|||
146095231|NCT00973349|526869742|FG009|Overall Study|Protocol Violation|0|||
146095232|NCT00973349|526869743|FG010|Overall Study|Protocol Violation|0|||
146095233|NCT00973349|526869744|FG011|Overall Study|Protocol Violation|0|||
146095234|NCT00973349|526869745|FG012|Overall Study|Protocol Violation|0|||
146095235|NCT00973349|526869746|FG013|Overall Study|Protocol Violation|0|||
146095236|NCT00973349|526869747|FG014|Overall Study|Protocol Violation|0|||
146095237|NCT00973349|526869748|FG015|Overall Study|Protocol Violation|0|||
146095238|NCT00973349|526869733|FG000|Overall Study|Unable to classify|0|||
146095239|NCT00973349|526869734|FG001|Overall Study|Unable to classify|0|||
146095240|NCT00973349|526869735|FG002|Overall Study|Unable to classify|0|||
146095241|NCT00973349|526869736|FG003|Overall Study|Unable to classify|0|||
146095242|NCT00973349|526869737|FG004|Overall Study|Unable to classify|1|||
146095243|NCT00973349|526869738|FG005|Overall Study|Unable to classify|1|||
146095244|NCT00973349|526869739|FG006|Overall Study|Unable to classify|0|||
146095245|NCT00973349|526869740|FG007|Overall Study|Unable to classify|0|||
146095246|NCT00973349|526869741|FG008|Overall Study|Unable to classify|0|||
146095247|NCT00973349|526869742|FG009|Overall Study|Unable to classify|1|||
146095248|NCT00973349|526869743|FG010|Overall Study|Unable to classify|0|||
146095249|NCT00973349|526869744|FG011|Overall Study|Unable to classify|0|||
146095250|NCT00973349|526869745|FG012|Overall Study|Unable to classify|0|||
146254128|NCT03334747|527443051|FG008|Treatment Phase|Subject/guardian decision|0|||
146254129|NCT03334747|527443043|FG000|Follow-Up Phase|Subject/guardian decision|0|||
146027311|NCT01853072|526612401|FG000|Overall Study|Physician Decision|1|||
146027312|NCT01853072|526612402|FG001|Overall Study|Physician Decision|1|||
146027313|NCT01853072|526612401|FG000|Overall Study|Withdrawal by Subject|1|||
146027314|NCT01853072|526612402|FG001|Overall Study|Withdrawal by Subject|2|||
146095251|NCT00973349|526869746|FG013|Overall Study|Unable to classify|0|||
146095252|NCT00973349|526869747|FG014|Overall Study|Unable to classify|0|||
146095253|NCT00973349|526869748|FG015|Overall Study|Unable to classify|0|||
146095254|NCT05597020|526869752|FG000|Washout|Forbidden medication|2|||
146095255|NCT05597020|526869753|FG001|Washout|Forbidden medication|0|||
146095256|NCT05597020|526869752|FG000|Treatment Period II|Advice from primary care physician|1|||
146095257|NCT05597020|526869753|FG001|Treatment Period II|Advice from primary care physician|0|||
146027315|NCT01853072|526612401|FG000|Overall Study|Reason not specified|9|||
146027316|NCT01853072|526612402|FG001|Overall Study|Reason not specified|6|||
146300317|NCT00698932|527615217|FG001|Overall Study|Lost to Follow-up|1|||
146027317|NCT01287221|526612403|FG000|Overall Study|Lack of Perceived Benefit|1|||
146027318|NCT01287221|526612404|FG001|Overall Study|Lack of Perceived Benefit|1|||
146027319|NCT01287221|526612403|FG000|Overall Study|Adverse Event|3|||
146027320|NCT01287221|526612404|FG001|Overall Study|Adverse Event|3|||
146027321|NCT01287221|526612403|FG000|Overall Study|Withdrawal by Subject|0|||
146027322|NCT01287221|526612404|FG001|Overall Study|Withdrawal by Subject|1|||
146027323|NCT02761694|526612415|FG000|Overall Study|Lack of Efficacy|0|||
146027324|NCT02761694|526612416|FG001|Overall Study|Lack of Efficacy|0|||
146027325|NCT02761694|526612417|FG002|Overall Study|Lack of Efficacy|0|||
146027326|NCT02761694|526612418|FG003|Overall Study|Lack of Efficacy|0|||
146027327|NCT02761694|526612419|FG004|Overall Study|Lack of Efficacy|0|||
146027328|NCT02761694|526612420|FG005|Overall Study|Lack of Efficacy|0|||
146027329|NCT02761694|526612421|FG006|Overall Study|Lack of Efficacy|6|||
146027330|NCT02761694|526612422|FG007|Overall Study|Lack of Efficacy|0|||
146027331|NCT02761694|526612423|FG008|Overall Study|Lack of Efficacy|0|||
146027332|NCT02761694|526612424|FG009|Overall Study|Lack of Efficacy|1|||
146027333|NCT02761694|526612425|FG010|Overall Study|Lack of Efficacy|1|||
146027334|NCT02761694|526612426|FG011|Overall Study|Lack of Efficacy|4|||
146027335|NCT02761694|526612415|FG000|Overall Study|Death|0|||
146027336|NCT02761694|526612416|FG001|Overall Study|Death|0|||
146027337|NCT02761694|526612417|FG002|Overall Study|Death|0|||
146027338|NCT02761694|526612418|FG003|Overall Study|Death|0|||
146027339|NCT02761694|526612419|FG004|Overall Study|Death|0|||
146027340|NCT02761694|526612420|FG005|Overall Study|Death|0|||
146027341|NCT02761694|526612421|FG006|Overall Study|Death|2|||
146027342|NCT02761694|526612422|FG007|Overall Study|Death|0|||
146027343|NCT02761694|526612423|FG008|Overall Study|Death|2|||
146027344|NCT02761694|526612424|FG009|Overall Study|Death|2|||
146027345|NCT02761694|526612425|FG010|Overall Study|Death|1|||
146027346|NCT02761694|526612426|FG011|Overall Study|Death|0|||
146027347|NCT02761694|526612415|FG000|Overall Study|Physician Decision|0|||
146027348|NCT02761694|526612416|FG001|Overall Study|Physician Decision|0|||
146027349|NCT02761694|526612417|FG002|Overall Study|Physician Decision|0|||
146027350|NCT02761694|526612418|FG003|Overall Study|Physician Decision|0|||
146027351|NCT02761694|526612419|FG004|Overall Study|Physician Decision|0|||
146027352|NCT02761694|526612420|FG005|Overall Study|Physician Decision|0|||
146027353|NCT02761694|526612421|FG006|Overall Study|Physician Decision|1|||
146027354|NCT02761694|526612422|FG007|Overall Study|Physician Decision|0|||
146027355|NCT02761694|526612423|FG008|Overall Study|Physician Decision|0|||
146027356|NCT02761694|526612424|FG009|Overall Study|Physician Decision|0|||
146027357|NCT02761694|526612425|FG010|Overall Study|Physician Decision|0|||
146027358|NCT02761694|526612426|FG011|Overall Study|Physician Decision|0|||
146027359|NCT02761694|526612415|FG000|Overall Study|Withdrawal by Subject|0|||
146027360|NCT02761694|526612416|FG001|Overall Study|Withdrawal by Subject|0|||
146027361|NCT02761694|526612417|FG002|Overall Study|Withdrawal by Subject|0|||
146027362|NCT02761694|526612418|FG003|Overall Study|Withdrawal by Subject|1|||
146027363|NCT02761694|526612419|FG004|Overall Study|Withdrawal by Subject|0|||
146027364|NCT02761694|526612420|FG005|Overall Study|Withdrawal by Subject|0|||
146027365|NCT02761694|526612421|FG006|Overall Study|Withdrawal by Subject|4|||
146027366|NCT02761694|526612422|FG007|Overall Study|Withdrawal by Subject|0|||
146027367|NCT02761694|526612423|FG008|Overall Study|Withdrawal by Subject|2|||
146027368|NCT02761694|526612424|FG009|Overall Study|Withdrawal by Subject|1|||
146027369|NCT02761694|526612425|FG010|Overall Study|Withdrawal by Subject|0|||
146027370|NCT02761694|526612426|FG011|Overall Study|Withdrawal by Subject|0|||
146027371|NCT02761694|526612415|FG000|Overall Study|Lost to Follow-up|0|||
146027372|NCT02761694|526612416|FG001|Overall Study|Lost to Follow-up|0|||
146027373|NCT02761694|526612417|FG002|Overall Study|Lost to Follow-up|0|||
146027374|NCT02761694|526612418|FG003|Overall Study|Lost to Follow-up|0|||
146027375|NCT02761694|526612419|FG004|Overall Study|Lost to Follow-up|0|||
146027376|NCT02761694|526612420|FG005|Overall Study|Lost to Follow-up|0|||
146027377|NCT02761694|526612421|FG006|Overall Study|Lost to Follow-up|1|||
146027378|NCT02761694|526612422|FG007|Overall Study|Lost to Follow-up|0|||
146027379|NCT02761694|526612423|FG008|Overall Study|Lost to Follow-up|0|||
146027380|NCT02761694|526612424|FG009|Overall Study|Lost to Follow-up|0|||
146027381|NCT02761694|526612425|FG010|Overall Study|Lost to Follow-up|0|||
146027382|NCT02761694|526612426|FG011|Overall Study|Lost to Follow-up|1|||
146027383|NCT02761694|526612415|FG000|Overall Study|Adverse Event|0|||
146027384|NCT02761694|526612416|FG001|Overall Study|Adverse Event|0|||
146027385|NCT02761694|526612417|FG002|Overall Study|Adverse Event|0|||
146027386|NCT02761694|526612418|FG003|Overall Study|Adverse Event|0|||
146027387|NCT02761694|526612419|FG004|Overall Study|Adverse Event|0|||
146027388|NCT02761694|526612420|FG005|Overall Study|Adverse Event|0|||
146027389|NCT02761694|526612421|FG006|Overall Study|Adverse Event|1|||
146027390|NCT02761694|526612422|FG007|Overall Study|Adverse Event|0|||
146027391|NCT02761694|526612423|FG008|Overall Study|Adverse Event|1|||
146027392|NCT02761694|526612424|FG009|Overall Study|Adverse Event|0|||
146027393|NCT02761694|526612425|FG010|Overall Study|Adverse Event|0|||
146027394|NCT02761694|526612426|FG011|Overall Study|Adverse Event|1|||
146027395|NCT02761694|526612415|FG000|Overall Study|Other|4|||
146027396|NCT02761694|526612416|FG001|Overall Study|Other|4|||
146027397|NCT02761694|526612417|FG002|Overall Study|Other|1|||
146027398|NCT02761694|526612418|FG003|Overall Study|Other|2|||
146027399|NCT02761694|526612419|FG004|Overall Study|Other|3|||
146027400|NCT02761694|526612420|FG005|Overall Study|Other|3|||
146027401|NCT02761694|526612421|FG006|Overall Study|Other|18|||
146027402|NCT02761694|526612422|FG007|Overall Study|Other|8|||
146027403|NCT02761694|526612423|FG008|Overall Study|Other|0|||
146027404|NCT02761694|526612424|FG009|Overall Study|Other|1|||
146027405|NCT02761694|526612425|FG010|Overall Study|Other|1|||
146027406|NCT02761694|526612426|FG011|Overall Study|Other|0|||
146027407|NCT02395055|526612427|FG000|Overall Study|Withdrawal by Subject|7|||
146027408|NCT02395055|526612428|FG001|Overall Study|Withdrawal by Subject|3|||
146027409|NCT00787930|526612429|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
146027410|NCT02513823|526612430|FG000|Overall Study|Lost to Follow-up|4|||
146027411|NCT02513823|526612430|FG000|Overall Study|Physician Decision|1|||
146027412|NCT01294462|526612432|FG000|Overall Study|Lost to Follow-up|1|||
146027413|NCT01294462|526612433|FG001|Overall Study|Lost to Follow-up|0|||
146027414|NCT01294462|526612432|FG000|Overall Study|Withdrawal by Subject|65|||
146027415|NCT01294462|526612433|FG001|Overall Study|Withdrawal by Subject|63|||
146027416|NCT02743780|526612434|FG000|Part 3 (7 Days)|Adverse Event|0|||
146027417|NCT02743780|526612435|FG001|Part 3 (7 Days)|Adverse Event|0|||
146027418|NCT02743780|526612436|FG002|Part 3 (7 Days)|Adverse Event|1|||
146027419|NCT02743780|526612437|FG003|Part 3 (7 Days)|Adverse Event|0|||
146027420|NCT02743780|526612438|FG004|Part 3 (7 Days)|Adverse Event|0|||
146027421|NCT04342689|526612446|FG000|Overall Study|Withdrawal by Subject|32|||
146027422|NCT04342689|526612447|FG001|Overall Study|Withdrawal by Subject|33|||
146027423|NCT04342689|526612446|FG000|Overall Study|Lost to Follow-up|10|||
146027424|NCT04342689|526612447|FG001|Overall Study|Lost to Follow-up|12|||
146027425|NCT01460407|526612448|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
146027426|NCT01460407|526612449|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
146027427|NCT01367704|526612452|FG000|Overall Study|Lost to Follow-up|47|||
146027428|NCT01367704|526612453|FG001|Overall Study|Lost to Follow-up|161|||
146027429|NCT02193087|526612454|FG000|Overall Study|Adverse Event|2|||
146027430|NCT02193087|526612455|FG001|Overall Study|Adverse Event|0|||
146027431|NCT02193087|526612456|FG002|Overall Study|Adverse Event|0|||
146027432|NCT02193087|526612457|FG003|Overall Study|Adverse Event|11|||
146027433|NCT02193087|526612454|FG000|Overall Study|Lost to Follow-up|14|||
146027434|NCT02193087|526612455|FG001|Overall Study|Lost to Follow-up|6|||
146027435|NCT02193087|526612456|FG002|Overall Study|Lost to Follow-up|4|||
146027436|NCT02193087|526612457|FG003|Overall Study|Lost to Follow-up|37|||
146027437|NCT02193087|526612454|FG000|Overall Study|Protocol Violation|2|||
146027438|NCT02193087|526612455|FG001|Overall Study|Protocol Violation|0|||
146027439|NCT02193087|526612456|FG002|Overall Study|Protocol Violation|1|||
146027440|NCT02193087|526612457|FG003|Overall Study|Protocol Violation|2|||
146027441|NCT02193087|526612454|FG000|Overall Study|Withdrawal by Subject|10|||
146027442|NCT02193087|526612455|FG001|Overall Study|Withdrawal by Subject|3|||
146027443|NCT02193087|526612456|FG002|Overall Study|Withdrawal by Subject|1|||
146027444|NCT02193087|526612457|FG003|Overall Study|Withdrawal by Subject|19|||
146027445|NCT02193087|526612454|FG000|Overall Study|Other Reason Not Specified|7|||
146027446|NCT02193087|526612455|FG001|Overall Study|Other Reason Not Specified|2|||
146027447|NCT02193087|526612456|FG002|Overall Study|Other Reason Not Specified|1|||
146027448|NCT02193087|526612457|FG003|Overall Study|Other Reason Not Specified|9|||
146027449|NCT02193087|526612454|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
146027450|NCT02193087|526612455|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
146027451|NCT02193087|526612456|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
146027452|NCT02193087|526612457|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
146027453|NCT01510145|526612458|FG000|Overall Study|Adverse Event|6|||
146027454|NCT01510145|526612458|FG000|Overall Study|Lost to Follow-up|5|||
146027455|NCT01510145|526612458|FG000|Overall Study|Withdrawal by Subject|6|||
146027456|NCT01510145|526612458|FG000|Overall Study|Relative reported subject withdrew|1|||
146027457|NCT02279498|526612462|FG000|Overall Study|Adverse Event|3|||
146027458|NCT02279498|526612463|FG001|Overall Study|Adverse Event|0|||
146027459|NCT02279498|526612462|FG000|Overall Study|Lack of Efficacy|4|||
146027460|NCT02279498|526612463|FG001|Overall Study|Lack of Efficacy|0|||
146027461|NCT02279498|526612462|FG000|Overall Study|Lost to Follow-up|0|||
146027462|NCT02279498|526612463|FG001|Overall Study|Lost to Follow-up|1|||
146027463|NCT02279498|526612462|FG000|Overall Study|Withdrawal by Subject|9|||
146095258|NCT05597020|526869752|FG000|Treatment Period II|Subject lost investigational product|1|||
146027464|NCT02279498|526612463|FG001|Overall Study|Withdrawal by Subject|2|||
146027465|NCT02279498|526612462|FG000|Overall Study|Undefined|2|||
146027466|NCT02279498|526612463|FG001|Overall Study|Undefined|1|||
146027467|NCT00737711|526612464|FG000|Overall Study|Adverse Event|2|||
146027468|NCT00737711|526612464|FG000|Overall Study|Death|8|||
146027469|NCT00737711|526612464|FG000|Overall Study|Failure to return|4|||
146027470|NCT00737711|526612464|FG000|Overall Study|Protocol Violation|1|||
146027471|NCT00737711|526612464|FG000|Overall Study|Withdrawal by Subject|5|||
146027472|NCT00737711|526612464|FG000|Overall Study|Blood transfusion|6|||
146027473|NCT00737711|526612464|FG000|Overall Study|Other|5|||
146027474|NCT00624780|526612468|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
146027475|NCT00624780|526612469|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
146027476|NCT00624780|526612470|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
146027477|NCT00624780|526612471|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
146027478|NCT00624780|526612472|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
146027479|NCT00624780|526612473|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
146027480|NCT00624780|526612468|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
146027481|NCT00624780|526612469|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
146027482|NCT00624780|526612470|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
146027483|NCT00624780|526612471|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
146027484|NCT00624780|526612472|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
146027485|NCT00624780|526612473|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
146027486|NCT00624780|526612468|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
146027487|NCT00624780|526612469|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
146027488|NCT00624780|526612470|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
146027489|NCT00624780|526612471|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
146027490|NCT00624780|526612472|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
146027491|NCT00624780|526612473|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
146027492|NCT00624780|526612468|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
146027493|NCT00624780|526612469|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
146027494|NCT00624780|526612470|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
146027495|NCT00624780|526612471|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
146027496|NCT00624780|526612472|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
146027497|NCT00624780|526612473|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
146027498|NCT00624780|526612468|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
146027499|NCT00624780|526612469|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
146027500|NCT00624780|526612470|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
146027501|NCT00624780|526612471|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
146027502|NCT00624780|526612472|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
146027503|NCT00624780|526612473|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
146027504|NCT00624780|526612468|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
146027505|NCT00624780|526612469|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
146027506|NCT00624780|526612470|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
146027507|NCT00624780|526612471|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
146027508|NCT00624780|526612472|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
146027509|NCT00624780|526612473|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
146027510|NCT00624780|526612468|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146027511|NCT00624780|526612469|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
146027512|NCT00624780|526612470|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146027513|NCT00624780|526612471|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
146027514|NCT00624780|526612472|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
146027515|NCT00624780|526612473|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
146027516|NCT00624780|526612468|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146027517|NCT00624780|526612469|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
146027518|NCT00624780|526612470|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146027519|NCT00624780|526612471|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
146027520|NCT00624780|526612472|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146027521|NCT00624780|526612473|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
146027522|NCT00624780|526612468|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
146027523|NCT00624780|526612469|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
146027524|NCT00624780|526612470|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
146027525|NCT00624780|526612471|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
146027526|NCT00624780|526612472|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
146027527|NCT00624780|526612473|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
146027528|NCT00624780|526612468|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
146027529|NCT00624780|526612469|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
146027530|NCT00624780|526612470|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
146027531|NCT00624780|526612471|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
146027532|NCT00624780|526612472|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
146027533|NCT00624780|526612473|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
146027534|NCT00624780|526612468|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146027535|NCT00624780|526612469|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
146027536|NCT00624780|526612470|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
146027537|NCT00624780|526612471|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146027538|NCT00624780|526612472|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
146027539|NCT00624780|526612473|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
146027540|NCT00624780|526612468|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
146027541|NCT00624780|526612469|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146095259|NCT05597020|526869753|FG001|Treatment Period II|Subject lost investigational product|0|||
146027542|NCT00624780|526612470|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146027543|NCT00624780|526612471|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146027544|NCT00624780|526612472|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146027545|NCT00624780|526612473|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
146027546|NCT00624780|526612468|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146027547|NCT00624780|526612469|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146027548|NCT00624780|526612470|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
146027549|NCT00624780|526612471|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146027550|NCT00624780|526612472|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146027551|NCT00624780|526612473|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
146027552|NCT00624780|526612468|FG000|Follow-up (Week 26)|Death|0|||
146027553|NCT00624780|526612469|FG001|Follow-up (Week 26)|Death|0|||
146027554|NCT00624780|526612470|FG002|Follow-up (Week 26)|Death|1|||
146027555|NCT00624780|526612471|FG003|Follow-up (Week 26)|Death|0|||
146027556|NCT00624780|526612472|FG004|Follow-up (Week 26)|Death|0|||
146027557|NCT00624780|526612473|FG005|Follow-up (Week 26)|Death|0|||
146027558|NCT00624780|526612468|FG000|Follow-up (Week 26)|Adverse Event|0|||
146027559|NCT00624780|526612469|FG001|Follow-up (Week 26)|Adverse Event|0|||
146027560|NCT00624780|526612470|FG002|Follow-up (Week 26)|Adverse Event|0|||
146027561|NCT00624780|526612471|FG003|Follow-up (Week 26)|Adverse Event|0|||
146027562|NCT00624780|526612472|FG004|Follow-up (Week 26)|Adverse Event|1|||
146027563|NCT00624780|526612473|FG005|Follow-up (Week 26)|Adverse Event|0|||
146027564|NCT00624780|526612468|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
146027565|NCT00624780|526612469|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
146027566|NCT00624780|526612470|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
146027567|NCT00624780|526612471|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
146027568|NCT00624780|526612472|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
146027569|NCT00624780|526612473|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
146027570|NCT00624780|526612468|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
146027571|NCT00624780|526612469|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
146027572|NCT00624780|526612470|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
146027573|NCT00624780|526612471|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
146027574|NCT00624780|526612472|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
146027575|NCT00624780|526612473|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
146027576|NCT00624780|526612468|FG000|Follow-up (Week 26)|Other|1|||
146027577|NCT00624780|526612469|FG001|Follow-up (Week 26)|Other|1|||
146027578|NCT00624780|526612470|FG002|Follow-up (Week 26)|Other|0|||
146027579|NCT00624780|526612471|FG003|Follow-up (Week 26)|Other|0|||
146027580|NCT00624780|526612472|FG004|Follow-up (Week 26)|Other|0|||
146027581|NCT00624780|526612473|FG005|Follow-up (Week 26)|Other|0|||
146027582|NCT04068519|526612474|FG000|Dose Verification|Death|15|||
146027583|NCT04068519|526612474|FG000|Dose Verification|Withdrawal by Subject|1|||
146027584|NCT04068519|526612474|FG000|Pharmacokinetic Sub-study|Death|35|||
146027585|NCT04068519|526612474|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
146027586|NCT04068519|526612474|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
146027587|NCT04068519|526612474|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
146027588|NCT04068519|526612474|FG000|Indication Expansion|Death|152|||
146027589|NCT04068519|526612474|FG000|Indication Expansion|Withdrawal by Subject|10|||
146027590|NCT04068519|526612474|FG000|Indication Expansion|Lost to Follow-up|7|||
146027591|NCT00969761|526612475|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146027592|NCT00969761|526612476|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027593|NCT00969761|526612477|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027594|NCT00969761|526612478|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146027595|NCT00969761|526612479|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027596|NCT00969761|526612480|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027597|NCT00969761|526612481|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027598|NCT00969761|526612482|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027599|NCT00969761|526612483|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146027600|NCT00969761|526612484|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
146027601|NCT00969761|526612485|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027602|NCT00969761|526612486|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
146027603|NCT00969761|526612475|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027604|NCT00969761|526612476|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027605|NCT00969761|526612477|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
146027606|NCT00969761|526612478|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027607|NCT00969761|526612479|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027608|NCT00969761|526612480|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027609|NCT00969761|526612481|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027610|NCT00969761|526612482|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027611|NCT00969761|526612483|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027612|NCT00969761|526612484|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027613|NCT00969761|526612485|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027614|NCT00969761|526612486|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
146027615|NCT00969761|526612475|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027616|NCT00969761|526612476|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027617|NCT00969761|526612477|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
146027618|NCT00969761|526612478|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027619|NCT00969761|526612479|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027620|NCT00969761|526612480|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027621|NCT00969761|526612481|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027622|NCT00969761|526612482|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027623|NCT00969761|526612483|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027624|NCT00969761|526612484|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027625|NCT00969761|526612485|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027626|NCT00969761|526612486|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
146027627|NCT00969761|526612475|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027628|NCT00969761|526612476|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027629|NCT00969761|526612477|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027630|NCT00969761|526612478|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027631|NCT00969761|526612479|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027632|NCT00969761|526612480|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027633|NCT00969761|526612481|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027634|NCT00969761|526612482|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027635|NCT00969761|526612483|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
146027636|NCT00969761|526612484|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027637|NCT00969761|526612485|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027638|NCT00969761|526612486|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
146027639|NCT00969761|526612475|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146027640|NCT00969761|526612476|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027641|NCT00969761|526612477|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
146027642|NCT00969761|526612478|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027643|NCT00969761|526612479|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146027644|NCT00969761|526612480|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027645|NCT00969761|526612481|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027646|NCT00969761|526612482|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
146027647|NCT00969761|526612483|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
146027648|NCT00969761|526612484|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
146027649|NCT00969761|526612485|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027650|NCT00969761|526612486|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
146027651|NCT00969761|526612475|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027652|NCT00969761|526612476|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027653|NCT00969761|526612477|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027654|NCT00969761|526612478|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
146027655|NCT00969761|526612479|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
146027656|NCT00969761|526612480|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027657|NCT00969761|526612481|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027658|NCT00969761|526612482|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027659|NCT00969761|526612483|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
146027660|NCT00969761|526612484|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027661|NCT00969761|526612485|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027662|NCT00969761|526612486|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
146027663|NCT04411420|526614529|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
146027664|NCT04411420|526614530|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
146027665|NCT04411420|526614529|FG000|Survey Subset|Lost to Follow-up|134|||
146027666|NCT04411420|526614530|FG001|Survey Subset|Lost to Follow-up|120|||
146027667|NCT00471887|526614531|FG000|Overall Study|Adverse Event|9|||
146027668|NCT05438602|526614532|FG000|Treatment (15 Days)|Adverse Event|2|||
146027669|NCT05438602|526614533|FG001|Treatment (15 Days)|Adverse Event|1|||
146027670|NCT05438602|526614534|FG002|Treatment (15 Days)|Adverse Event|3|||
146095260|NCT05597020|526869752|FG000|Treatment Period II|Private reasons|0|||
146095261|NCT05597020|526869753|FG001|Treatment Period II|Private reasons|1|||
146095262|NCT05430022|526869754|FG000|Overall Study|Withdrawal by Subject|4|||
146095263|NCT05430022|526869755|FG001|Overall Study|Withdrawal by Subject|4|||
146095264|NCT02718300|526869758|FG000|Overall Study|Death|4|||
146254130|NCT03334747|527443044|FG001|Follow-Up Phase|Subject/guardian decision|0|||
146254131|NCT03334747|527443045|FG002|Follow-Up Phase|Subject/guardian decision|0|||
146027671|NCT05438602|526614532|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
146027672|NCT05438602|526614533|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
146027673|NCT05438602|526614534|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
146027674|NCT05438602|526614532|FG000|Treatment (15 Days)|Other|0|||
146027675|NCT05438602|526614533|FG001|Treatment (15 Days)|Other|0|||
146027676|NCT05438602|526614534|FG002|Treatment (15 Days)|Other|1|||
146027677|NCT05438602|526614532|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
146027678|NCT05438602|526614533|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
146027679|NCT05438602|526614534|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
146027680|NCT05438602|526614532|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
146027681|NCT05438602|526614533|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
146027682|NCT05438602|526614534|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
146027683|NCT05438602|526614532|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
146027684|NCT05438602|526614533|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
146027685|NCT05438602|526614534|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
146027686|NCT05438602|526614532|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
146027687|NCT05438602|526614533|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
146027688|NCT05438602|526614534|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
146027689|NCT05438602|526614532|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
146027690|NCT05438602|526614533|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
146027691|NCT05438602|526614534|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
146027692|NCT05438602|526614532|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
146027693|NCT05438602|526614533|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
146027694|NCT05438602|526614534|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
146027695|NCT05438602|526614532|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
146027696|NCT05438602|526614533|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
146027697|NCT05438602|526614534|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
146027698|NCT00076336|526614537|FG000|Overall Study|Death|13|||
146027699|NCT00076336|526614538|FG001|Overall Study|Death|17|||
146027700|NCT00076336|526614537|FG000|Overall Study|Adverse Event|4|||
146027701|NCT00076336|526614538|FG001|Overall Study|Adverse Event|4|||
146027702|NCT00076336|526614537|FG000|Overall Study|Lost to Follow-up|4|||
146027703|NCT00076336|526614538|FG001|Overall Study|Lost to Follow-up|4|||
146027704|NCT00076336|526614537|FG000|Overall Study|Non-Compliance|2|||
146027705|NCT00076336|526614538|FG001|Overall Study|Non-Compliance|0|||
146027706|NCT00076336|526614537|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
146027707|NCT00076336|526614538|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
146027708|NCT00076336|526614537|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
146027709|NCT00076336|526614538|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
146027710|NCT00076336|526614537|FG000|Overall Study|Liver Transplantation|3|||
146027711|NCT00076336|526614538|FG001|Overall Study|Liver Transplantation|3|||
146027712|NCT00076336|526614537|FG000|Overall Study|Virologic Breakthrough|14|||
146027713|NCT00076336|526614538|FG001|Overall Study|Virologic Breakthrough|16|||
146027714|NCT00076336|526614537|FG000|Overall Study|Treatment failure|4|||
146027715|NCT00076336|526614538|FG001|Overall Study|Treatment failure|5|||
146027716|NCT00098722|526614542|FG000|Double Blind Phase|Adverse Event|7|||
146027717|NCT00098722|526614543|FG001|Double Blind Phase|Adverse Event|7|||
146027718|NCT00098722|526614544|FG002|Double Blind Phase|Adverse Event|3|||
146027719|NCT00098722|526614545|FG003|Double Blind Phase|Adverse Event|0|||
146027720|NCT00098722|526614546|FG004|Double Blind Phase|Adverse Event|0|||
146027721|NCT00098722|526614547|FG005|Double Blind Phase|Adverse Event|0|||
146027722|NCT00098722|526614548|FG006|Double Blind Phase|Adverse Event|0|||
146027723|NCT00098722|526614542|FG000|Double Blind Phase|Death|2|||
146027724|NCT00098722|526614543|FG001|Double Blind Phase|Death|5|||
146027725|NCT00098722|526614544|FG002|Double Blind Phase|Death|0|||
146027726|NCT00098722|526614545|FG003|Double Blind Phase|Death|0|||
146027727|NCT00098722|526614546|FG004|Double Blind Phase|Death|0|||
146027728|NCT00098722|526614547|FG005|Double Blind Phase|Death|0|||
146027729|NCT00098722|526614548|FG006|Double Blind Phase|Death|0|||
146027730|NCT00098722|526614542|FG000|Double Blind Phase|Lack of Efficacy|21|||
146027731|NCT00098722|526614543|FG001|Double Blind Phase|Lack of Efficacy|23|||
146027732|NCT00098722|526614544|FG002|Double Blind Phase|Lack of Efficacy|15|||
146027733|NCT00098722|526614545|FG003|Double Blind Phase|Lack of Efficacy|0|||
146027734|NCT00098722|526614546|FG004|Double Blind Phase|Lack of Efficacy|0|||
146027735|NCT00098722|526614547|FG005|Double Blind Phase|Lack of Efficacy|0|||
146027736|NCT00098722|526614548|FG006|Double Blind Phase|Lack of Efficacy|0|||
146027737|NCT00098722|526614542|FG000|Double Blind Phase|Participant defaulted|16|||
146027738|NCT00098722|526614543|FG001|Double Blind Phase|Participant defaulted|11|||
146027739|NCT00098722|526614544|FG002|Double Blind Phase|Participant defaulted|9|||
146027740|NCT00098722|526614545|FG003|Double Blind Phase|Participant defaulted|0|||
146027741|NCT00098722|526614546|FG004|Double Blind Phase|Participant defaulted|0|||
146027742|NCT00098722|526614547|FG005|Double Blind Phase|Participant defaulted|0|||
146027743|NCT00098722|526614548|FG006|Double Blind Phase|Participant defaulted|0|||
146254132|NCT03334747|527443046|FG003|Follow-Up Phase|Subject/guardian decision|0|||
146027744|NCT00098722|526614542|FG000|Double Blind Phase|Pregnancy|1|||
146027745|NCT00098722|526614543|FG001|Double Blind Phase|Pregnancy|0|||
146027746|NCT00098722|526614544|FG002|Double Blind Phase|Pregnancy|0|||
146027747|NCT00098722|526614545|FG003|Double Blind Phase|Pregnancy|0|||
146027748|NCT00098722|526614546|FG004|Double Blind Phase|Pregnancy|0|||
146027749|NCT00098722|526614547|FG005|Double Blind Phase|Pregnancy|0|||
146027750|NCT00098722|526614548|FG006|Double Blind Phase|Pregnancy|0|||
146027751|NCT00098722|526614542|FG000|Double Blind Phase|Randomized, not treated|4|||
146027752|NCT00098722|526614543|FG001|Double Blind Phase|Randomized, not treated|3|||
146027753|NCT00098722|526614544|FG002|Double Blind Phase|Randomized, not treated|3|||
146027754|NCT00098722|526614545|FG003|Double Blind Phase|Randomized, not treated|0|||
146027755|NCT00098722|526614546|FG004|Double Blind Phase|Randomized, not treated|0|||
146027756|NCT00098722|526614547|FG005|Double Blind Phase|Randomized, not treated|0|||
146027757|NCT00098722|526614548|FG006|Double Blind Phase|Randomized, not treated|0|||
146027758|NCT00098722|526614542|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
146027759|NCT00098722|526614543|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
146027760|NCT00098722|526614544|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
146027761|NCT00098722|526614545|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
146027762|NCT00098722|526614546|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
146027763|NCT00098722|526614547|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
146027764|NCT00098722|526614548|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
146027765|NCT00098722|526614542|FG000|Double Blind Phase|Other|7|||
146027766|NCT00098722|526614543|FG001|Double Blind Phase|Other|8|||
146027767|NCT00098722|526614544|FG002|Double Blind Phase|Other|7|||
146027768|NCT00098722|526614545|FG003|Double Blind Phase|Other|0|||
146027769|NCT00098722|526614546|FG004|Double Blind Phase|Other|0|||
146027770|NCT00098722|526614547|FG005|Double Blind Phase|Other|0|||
146027771|NCT00098722|526614548|FG006|Double Blind Phase|Other|0|||
146027772|NCT00098722|526614542|FG000|Open Label Phase|Adverse Event|0|||
146027773|NCT00098722|526614543|FG001|Open Label Phase|Adverse Event|0|||
146027774|NCT00098722|526614544|FG002|Open Label Phase|Adverse Event|0|||
146027775|NCT00098722|526614545|FG003|Open Label Phase|Adverse Event|5|||
146027776|NCT00098722|526614546|FG004|Open Label Phase|Adverse Event|0|||
146027777|NCT00098722|526614547|FG005|Open Label Phase|Adverse Event|0|||
146027778|NCT00098722|526614548|FG006|Open Label Phase|Adverse Event|0|||
146027779|NCT00098722|526614542|FG000|Open Label Phase|Death|0|||
146027780|NCT00098722|526614543|FG001|Open Label Phase|Death|0|||
146027781|NCT00098722|526614544|FG002|Open Label Phase|Death|0|||
146027782|NCT00098722|526614545|FG003|Open Label Phase|Death|2|||
146027783|NCT00098722|526614546|FG004|Open Label Phase|Death|0|||
146027784|NCT00098722|526614547|FG005|Open Label Phase|Death|0|||
146027785|NCT00098722|526614548|FG006|Open Label Phase|Death|0|||
146027786|NCT00098722|526614542|FG000|Open Label Phase|Lack of Efficacy|0|||
146027787|NCT00098722|526614543|FG001|Open Label Phase|Lack of Efficacy|0|||
146027788|NCT00098722|526614544|FG002|Open Label Phase|Lack of Efficacy|0|||
146027789|NCT00098722|526614545|FG003|Open Label Phase|Lack of Efficacy|8|||
146027790|NCT00098722|526614546|FG004|Open Label Phase|Lack of Efficacy|0|||
146027791|NCT00098722|526614547|FG005|Open Label Phase|Lack of Efficacy|0|||
146027792|NCT00098722|526614548|FG006|Open Label Phase|Lack of Efficacy|0|||
146027793|NCT00098722|526614542|FG000|Open Label Phase|Pregnancy|0|||
146027794|NCT00098722|526614543|FG001|Open Label Phase|Pregnancy|0|||
146027795|NCT00098722|526614544|FG002|Open Label Phase|Pregnancy|0|||
146027796|NCT00098722|526614545|FG003|Open Label Phase|Pregnancy|1|||
146027797|NCT00098722|526614546|FG004|Open Label Phase|Pregnancy|0|||
146027798|NCT00098722|526614547|FG005|Open Label Phase|Pregnancy|0|||
146027799|NCT00098722|526614548|FG006|Open Label Phase|Pregnancy|0|||
146027800|NCT00098722|526614542|FG000|Open Label Phase|Participant defaulted|0|||
146027801|NCT00098722|526614543|FG001|Open Label Phase|Participant defaulted|0|||
146027802|NCT00098722|526614544|FG002|Open Label Phase|Participant defaulted|0|||
146027803|NCT00098722|526614545|FG003|Open Label Phase|Participant defaulted|18|||
146027804|NCT00098722|526614546|FG004|Open Label Phase|Participant defaulted|0|||
146027805|NCT00098722|526614547|FG005|Open Label Phase|Participant defaulted|0|||
146027806|NCT00098722|526614548|FG006|Open Label Phase|Participant defaulted|0|||
146027807|NCT00098722|526614542|FG000|Open Label Phase|Ongoing at cut-off date|0|||
146027808|NCT00098722|526614543|FG001|Open Label Phase|Ongoing at cut-off date|0|||
146027809|NCT00098722|526614544|FG002|Open Label Phase|Ongoing at cut-off date|0|||
146027810|NCT00098722|526614545|FG003|Open Label Phase|Ongoing at cut-off date|220|||
146027811|NCT00098722|526614546|FG004|Open Label Phase|Ongoing at cut-off date|50|||
146027812|NCT00098722|526614547|FG005|Open Label Phase|Ongoing at cut-off date|0|||
146027813|NCT00098722|526614548|FG006|Open Label Phase|Ongoing at cut-off date|0|||
146027814|NCT00098722|526614542|FG000|Open Label Phase|Other|0|||
146027815|NCT00098722|526614543|FG001|Open Label Phase|Other|0|||
146027816|NCT00098722|526614544|FG002|Open Label Phase|Other|0|||
146027817|NCT00098722|526614545|FG003|Open Label Phase|Other|18|||
146027818|NCT00098722|526614546|FG004|Open Label Phase|Other|0|||
146027819|NCT00098722|526614547|FG005|Open Label Phase|Other|0|||
146027820|NCT00098722|526614548|FG006|Open Label Phase|Other|0|||
146027821|NCT00098722|526614542|FG000|Observation Phase|Death|0|||
146027822|NCT00098722|526614543|FG001|Observation Phase|Death|0|||
146027823|NCT00098722|526614544|FG002|Observation Phase|Death|0|||
146027824|NCT00098722|526614545|FG003|Observation Phase|Death|0|||
146027825|NCT00098722|526614546|FG004|Observation Phase|Death|0|||
146027826|NCT00098722|526614547|FG005|Observation Phase|Death|5|||
146027827|NCT00098722|526614548|FG006|Observation Phase|Death|3|||
146027828|NCT00098722|526614542|FG000|Observation Phase|Lack of Efficacy|0|||
146027829|NCT00098722|526614543|FG001|Observation Phase|Lack of Efficacy|0|||
146027830|NCT00098722|526614544|FG002|Observation Phase|Lack of Efficacy|0|||
146027831|NCT00098722|526614545|FG003|Observation Phase|Lack of Efficacy|0|||
146027832|NCT00098722|526614546|FG004|Observation Phase|Lack of Efficacy|0|||
146027833|NCT00098722|526614547|FG005|Observation Phase|Lack of Efficacy|2|||
146027834|NCT00098722|526614548|FG006|Observation Phase|Lack of Efficacy|0|||
146027835|NCT00098722|526614542|FG000|Observation Phase|Participant defaulted|0|||
146027836|NCT00098722|526614543|FG001|Observation Phase|Participant defaulted|0|||
146027837|NCT00098722|526614544|FG002|Observation Phase|Participant defaulted|0|||
146027838|NCT00098722|526614545|FG003|Observation Phase|Participant defaulted|0|||
146027839|NCT00098722|526614546|FG004|Observation Phase|Participant defaulted|0|||
146027840|NCT00098722|526614547|FG005|Observation Phase|Participant defaulted|17|||
146027841|NCT00098722|526614548|FG006|Observation Phase|Participant defaulted|4|||
146027842|NCT00098722|526614542|FG000|Observation Phase|Other|0|||
146027843|NCT00098722|526614543|FG001|Observation Phase|Other|0|||
146027844|NCT00098722|526614544|FG002|Observation Phase|Other|0|||
146027845|NCT00098722|526614545|FG003|Observation Phase|Other|0|||
146027846|NCT00098722|526614546|FG004|Observation Phase|Other|0|||
146027847|NCT00098722|526614547|FG005|Observation Phase|Other|21|||
146027848|NCT00098722|526614548|FG006|Observation Phase|Other|10|||
146027849|NCT02351349|526614554|FG000|Overall Study|Withdrawal by Subject|2|||
146027850|NCT02351349|526614555|FG001|Overall Study|Withdrawal by Subject|3|||
146027851|NCT01703117|526614556|FG000|Overall Study|Adverse Event|4|||
146027852|NCT01703117|526614557|FG001|Overall Study|Adverse Event|3|||
146027853|NCT01703117|526614556|FG000|Overall Study|Withdrawal by Subject|0|||
146027854|NCT01703117|526614557|FG001|Overall Study|Withdrawal by Subject|1|||
146027855|NCT01340937|526614559|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
146027856|NCT01340937|526614560|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
146027857|NCT01340937|526614561|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
146027858|NCT01340937|526614562|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
146027859|NCT01340937|526614559|FG000|Period 1: Infant Series|Adverse Event|0|||
146027860|NCT01340937|526614560|FG001|Period 1: Infant Series|Adverse Event|1|||
146027861|NCT01340937|526614561|FG002|Period 1: Infant Series|Adverse Event|4|||
146027862|NCT01340937|526614562|FG003|Period 1: Infant Series|Adverse Event|0|||
146027863|NCT01340937|526614559|FG000|Period 1: Infant Series|Death|2|||
146027864|NCT01340937|526614560|FG001|Period 1: Infant Series|Death|0|||
146027865|NCT01340937|526614561|FG002|Period 1: Infant Series|Death|2|||
146027866|NCT01340937|526614562|FG003|Period 1: Infant Series|Death|0|||
146027867|NCT01340937|526614559|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
146027868|NCT01340937|526614560|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
146027869|NCT01340937|526614561|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
146027870|NCT01340937|526614562|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
146027871|NCT01340937|526614559|FG000|Period 1: Infant Series|Physician Decision|2|||
146027872|NCT01340937|526614560|FG001|Period 1: Infant Series|Physician Decision|3|||
146027873|NCT01340937|526614561|FG002|Period 1: Infant Series|Physician Decision|1|||
146027874|NCT01340937|526614562|FG003|Period 1: Infant Series|Physician Decision|0|||
146027875|NCT01340937|526614559|FG000|Period 1: Infant Series|Protocol Violation|1|||
146027876|NCT01340937|526614560|FG001|Period 1: Infant Series|Protocol Violation|4|||
146027877|NCT01340937|526614561|FG002|Period 1: Infant Series|Protocol Violation|4|||
146027878|NCT01340937|526614562|FG003|Period 1: Infant Series|Protocol Violation|3|||
146027879|NCT01340937|526614559|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
146027880|NCT01340937|526614560|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
146027881|NCT01340937|526614561|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
146027882|NCT01340937|526614562|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
146027883|NCT01340937|526614559|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
146027884|NCT01340937|526614560|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
146027885|NCT01340937|526614561|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
146027886|NCT01340937|526614562|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
146027887|NCT01340937|526614559|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
146027888|NCT01340937|526614560|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
146027889|NCT01340937|526614561|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
146254133|NCT03334747|527443047|FG004|Follow-Up Phase|Subject/guardian decision|0|||
146254134|NCT03334747|527443048|FG005|Follow-Up Phase|Subject/guardian decision|0|||
146027890|NCT01340937|526614562|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
146027891|NCT01340937|526614559|FG000|Period 2: Interim Period|Adverse Event|1|||
146027892|NCT01340937|526614560|FG001|Period 2: Interim Period|Adverse Event|0|||
146027893|NCT01340937|526614561|FG002|Period 2: Interim Period|Adverse Event|1|||
146254135|NCT03334747|527443049|FG006|Follow-Up Phase|Subject/guardian decision|1|||
146027894|NCT01340937|526614562|FG003|Period 2: Interim Period|Adverse Event|0|||
146027895|NCT01340937|526614559|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
146027896|NCT01340937|526614560|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
146027897|NCT01340937|526614561|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
146027898|NCT01340937|526614562|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
146027899|NCT01340937|526614559|FG000|Period 2: Interim Period|Physician Decision|0|||
146027900|NCT01340937|526614560|FG001|Period 2: Interim Period|Physician Decision|1|||
146027901|NCT01340937|526614561|FG002|Period 2: Interim Period|Physician Decision|1|||
146027902|NCT01340937|526614562|FG003|Period 2: Interim Period|Physician Decision|0|||
146027903|NCT01340937|526614559|FG000|Period 2: Interim Period|Protocol Violation|5|||
146027904|NCT01340937|526614560|FG001|Period 2: Interim Period|Protocol Violation|3|||
146027905|NCT01340937|526614561|FG002|Period 2: Interim Period|Protocol Violation|6|||
146027906|NCT01340937|526614562|FG003|Period 2: Interim Period|Protocol Violation|3|||
146027907|NCT01340937|526614559|FG000|Period 2: Interim Period|Technical problems|4|||
146027908|NCT01340937|526614560|FG001|Period 2: Interim Period|Technical problems|4|||
146027909|NCT01340937|526614561|FG002|Period 2: Interim Period|Technical problems|6|||
146027910|NCT01340937|526614562|FG003|Period 2: Interim Period|Technical problems|3|||
146027911|NCT01340937|526614559|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
146027912|NCT01340937|526614560|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
146027913|NCT01340937|526614561|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
146027914|NCT01340937|526614562|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
146027915|NCT01340937|526614559|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
146027916|NCT01340937|526614560|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
146027917|NCT01340937|526614561|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
146027918|NCT01340937|526614562|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
146027919|NCT01340937|526614559|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146027920|NCT01340937|526614560|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146027921|NCT01340937|526614561|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
146027922|NCT01340937|526614562|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
146027923|NCT01340937|526614559|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
146027924|NCT01340937|526614560|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
146027925|NCT01340937|526614561|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
146027926|NCT01340937|526614562|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
146027927|NCT00440310|526614563|FG000|Overall Study|Lost to Follow-up|4|||
146027928|NCT00440310|526614564|FG001|Overall Study|Lost to Follow-up|5|||
146027929|NCT00440310|526614563|FG000|Overall Study|Protocol Violation|0|||
146027930|NCT00440310|526614564|FG001|Overall Study|Protocol Violation|1|||
146027931|NCT00440310|526614563|FG000|Overall Study|Withdrawal by Subject|15|||
146027932|NCT00440310|526614564|FG001|Overall Study|Withdrawal by Subject|14|||
146027933|NCT00440310|526614563|FG000|Overall Study|No Reply at EOS|7|||
146027934|NCT00440310|526614564|FG001|Overall Study|No Reply at EOS|7|||
146027935|NCT00440310|526614563|FG000|Overall Study|Other|1|||
146027936|NCT00440310|526614564|FG001|Overall Study|Other|0|||
146027937|NCT00440310|526614563|FG000|Overall Study|Status Unknown|1|||
146027938|NCT00440310|526614564|FG001|Overall Study|Status Unknown|3|||
146027939|NCT02469415|526614565|FG000|Overall Study|Withdrawal by Subject|1|||
146027940|NCT02469415|526614565|FG000|Overall Study|Investigational agent placed on hold|2|||
146027941|NCT02119156|526614566|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
146027942|NCT02119156|526614567|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
146027943|NCT02119156|526614568|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
146027944|NCT02119156|526614566|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
146027945|NCT02119156|526614567|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
146027946|NCT02119156|526614568|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
146027947|NCT02119156|526614566|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
146027948|NCT02119156|526614567|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
146027949|NCT02119156|526614568|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
146027950|NCT02119156|526614566|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
146027951|NCT02119156|526614567|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
146027952|NCT02119156|526614568|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
146027953|NCT02119156|526614566|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
146027954|NCT02119156|526614567|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
146027955|NCT02119156|526614568|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
146027956|NCT01610596|526614580|FG000|Overall Study|Lost to Follow-up|0|||
146027957|NCT01610596|526614581|FG001|Overall Study|Lost to Follow-up|1|||
146027958|NCT04599166|526614582|FG000|Overall Study|Technological failure connecting to study app|80|||
146095265|NCT02718300|526869759|FG001|Overall Study|Death|5|||
146095266|NCT02718300|526869760|FG002|Overall Study|Death|17|||
146095267|NCT02718300|526869758|FG000|Overall Study|Lost to Follow-up|1|||
146027959|NCT02317809|526614583|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
146027960|NCT02317809|526614584|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
146027961|NCT02317809|526614583|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
146095268|NCT02718300|526869759|FG001|Overall Study|Lost to Follow-up|0|||
146095269|NCT02718300|526869760|FG002|Overall Study|Lost to Follow-up|2|||
146027962|NCT02317809|526614584|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
146027963|NCT01974752|526614585|FG000|Overall Study|Death|33|||
146027964|NCT01974752|526614586|FG001|Overall Study|Death|11|||
146027965|NCT01974752|526614585|FG000|Overall Study|Lost to Follow-up|2|||
146027966|NCT01974752|526614586|FG001|Overall Study|Lost to Follow-up|0|||
146027967|NCT01974752|526614585|FG000|Overall Study|Withdrawal by Subject|2|||
146027968|NCT01974752|526614586|FG001|Overall Study|Withdrawal by Subject|3|||
146027969|NCT01974752|526614585|FG000|Overall Study|Other Eligibility Criteria|0|||
146027970|NCT01974752|526614586|FG001|Overall Study|Other Eligibility Criteria|1|||
146027971|NCT02435680|526614587|FG000|Overall Study|Physician Decision|3|||
146027972|NCT02435680|526614588|FG001|Overall Study|Physician Decision|0|||
146027973|NCT02435680|526614589|FG002|Overall Study|Physician Decision|0|||
146027974|NCT02435680|526614587|FG000|Overall Study|subject / guardian decision|0|||
146027975|NCT02435680|526614588|FG001|Overall Study|subject / guardian decision|3|||
146027976|NCT02435680|526614589|FG002|Overall Study|subject / guardian decision|2|||
146027977|NCT02435680|526614587|FG000|Overall Study|Adverse Event|8|||
146027978|NCT02435680|526614588|FG001|Overall Study|Adverse Event|3|||
146027979|NCT02435680|526614589|FG002|Overall Study|Adverse Event|2|||
146027980|NCT02435680|526614587|FG000|Overall Study|progressive disease|10|||
146027981|NCT02435680|526614588|FG001|Overall Study|progressive disease|7|||
146027982|NCT02435680|526614589|FG002|Overall Study|progressive disease|11|||
146027983|NCT02435680|526614587|FG000|Overall Study|not treated|0|||
146027984|NCT02435680|526614588|FG001|Overall Study|not treated|0|||
146027985|NCT02435680|526614589|FG002|Overall Study|not treated|1|||
146027986|NCT00953524|526614590|FG000|Overall Study|Adverse Event|2|||
146027987|NCT00953524|526614591|FG001|Overall Study|Adverse Event|0|||
146027988|NCT00953524|526614592|FG002|Overall Study|Adverse Event|1|||
146027989|NCT00953524|526614593|FG003|Overall Study|Adverse Event|2|||
146027990|NCT00953524|526614590|FG000|Overall Study|Protocol Violation|18|||
146027991|NCT00953524|526614591|FG001|Overall Study|Protocol Violation|10|||
146027992|NCT00953524|526614592|FG002|Overall Study|Protocol Violation|11|||
146027993|NCT00953524|526614593|FG003|Overall Study|Protocol Violation|6|||
146027994|NCT00953524|526614590|FG000|Overall Study|Lost to Follow-up|0|||
146027995|NCT00953524|526614591|FG001|Overall Study|Lost to Follow-up|1|||
146027996|NCT00953524|526614592|FG002|Overall Study|Lost to Follow-up|1|||
146027997|NCT00953524|526614593|FG003|Overall Study|Lost to Follow-up|0|||
146027998|NCT00953524|526614590|FG000|Overall Study|Withdrawal by Subject|2|||
146027999|NCT00953524|526614591|FG001|Overall Study|Withdrawal by Subject|4|||
146028000|NCT00953524|526614592|FG002|Overall Study|Withdrawal by Subject|1|||
146028001|NCT00953524|526614593|FG003|Overall Study|Withdrawal by Subject|0|||
146028002|NCT01998893|526614602|FG000|Overall Study|Adverse Event|2|||
146028003|NCT01998893|526614602|FG000|Overall Study|Death|1|||
146028004|NCT01998893|526614602|FG000|Overall Study|Lost to Follow-up|8|||
146028005|NCT01998893|526614602|FG000|Overall Study|Physician Decision|2|||
146028006|NCT01998893|526614602|FG000|Overall Study|Protocol Violation|2|||
146028007|NCT01998893|526614602|FG000|Overall Study|Withdrawal by Subject|1|||
146028008|NCT01998893|526614602|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
146028009|NCT05136898|526614603|FG000|Overall Study|Adverse Event|2|||
146028010|NCT00867087|526614604|FG000|Overall Study|Other|1|||
146028011|NCT00867087|526614604|FG000|Overall Study|Withdrawal by Subject|4|||
146028012|NCT00867087|526614604|FG000|Overall Study|Death|37|||
146028013|NCT02334683|526614613|FG000|First 12 Week Period|Lost to Follow-up|1|||
146028014|NCT02334683|526614614|FG001|First 12 Week Period|Lost to Follow-up|0|||
146028015|NCT02334683|526614613|FG000|Second 12 Week Period|Adverse Event|0|||
146028016|NCT02334683|526614614|FG001|Second 12 Week Period|Adverse Event|1|||
146028017|NCT01891344|526614615|FG000|Overall Study|Ongoing|6|||
146028018|NCT01891344|526614616|FG001|Overall Study|Ongoing|2|||
146028019|NCT01891344|526614617|FG002|Overall Study|Ongoing|0|||
146028020|NCT01891344|526614618|FG003|Overall Study|Ongoing|1|||
146028021|NCT01891344|526614619|FG004|Overall Study|Ongoing|4|||
146028022|NCT01891344|526614620|FG005|Overall Study|Ongoing|1|||
146028023|NCT01891344|526614621|FG006|Overall Study|Ongoing|0|||
146028024|NCT01891344|526614622|FG007|Overall Study|Ongoing|0|||
146028025|NCT02969590|526614623|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
146028026|NCT02969590|526614624|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
146028027|NCT02969590|526614625|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
146028028|NCT01414205|526614626|FG000|Overall Study|Death|5|||
146028029|NCT01414205|526614627|FG001|Overall Study|Death|1|||
146028030|NCT01414205|526614626|FG000|Overall Study|Lost to Follow-up|1|||
146028031|NCT01414205|526614627|FG001|Overall Study|Lost to Follow-up|4|||
146028032|NCT01414205|526614626|FG000|Overall Study|Physician Decision|0|||
146028033|NCT01414205|526614627|FG001|Overall Study|Physician Decision|1|||
146028034|NCT01414205|526614626|FG000|Overall Study|Randomized but not Treated|1|||
146028035|NCT01414205|526614627|FG001|Overall Study|Randomized but not Treated|1|||
146028036|NCT02498067|526614628|FG000|Overall Study|Lost to Follow-up|22|||
146028037|NCT02498067|526614628|FG000|Overall Study|Did not meet inclusion criteria|11|||
146028038|NCT00541099|526614636|FG000|Overall Study|Ineligible|3|||
146028039|NCT00066469|526614637|FG000|Overall Study|Death|3|||
146028040|NCT00066469|526614637|FG000|Overall Study|Lack of Efficacy|9|||
146028041|NCT00066469|526614637|FG000|Overall Study|Lost to Follow-up|1|||
146254136|NCT03334747|527443050|FG007|Follow-Up Phase|Subject/guardian decision|0|||
146254137|NCT03334747|527443051|FG008|Follow-Up Phase|Subject/guardian decision|1|||
146254138|NCT00730925|527443052|FG000|Overall Study|Progressive Disease|21|||
146254139|NCT00730925|527443052|FG000|Overall Study|Dose reducing Event|2|||
146254140|NCT00730925|527443052|FG000|Overall Study|Other Averse Event|7|||
146028042|NCT00066469|526614637|FG000|Overall Study|Physician Decision|1|||
146028043|NCT00066469|526614637|FG000|Overall Study|Withdrawal by Subject|1|||
146028044|NCT00066469|526614637|FG000|Overall Study|ineligible|1|||
146028045|NCT00711802|526614638|FG000|Overall Study|Not treated (no further detail)|2|||
146028046|NCT00711802|526614639|FG001|Overall Study|Not treated (no further detail)|1|||
146028047|NCT00711802|526614640|FG002|Overall Study|Not treated (no further detail)|2|||
146028048|NCT00711802|526614641|FG003|Overall Study|Not treated (no further detail)|0|||
146028049|NCT00711802|526614642|FG004|Overall Study|Not treated (no further detail)|2|||
146028050|NCT00711802|526614643|FG005|Overall Study|Not treated (no further detail)|0|||
146028051|NCT00711802|526614644|FG006|Overall Study|Not treated (no further detail)|0|||
146095270|NCT02718300|526869758|FG000|Overall Study|Physician Decision|1|||
146095271|NCT02718300|526869759|FG001|Overall Study|Physician Decision|0|||
146095272|NCT02718300|526869760|FG002|Overall Study|Physician Decision|2|||
146095273|NCT02718300|526869758|FG000|Overall Study|Study Terminated by Sponsor|6|||
146095274|NCT02718300|526869759|FG001|Overall Study|Study Terminated by Sponsor|3|||
146095275|NCT02718300|526869760|FG002|Overall Study|Study Terminated by Sponsor|4|||
146095276|NCT02718300|526869758|FG000|Overall Study|Withdrawal by Subject|0|||
146095277|NCT02718300|526869759|FG001|Overall Study|Withdrawal by Subject|4|||
146095278|NCT02718300|526869760|FG002|Overall Study|Withdrawal by Subject|3|||
146095279|NCT02718300|526869758|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
146095280|NCT02718300|526869759|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
146095281|NCT02718300|526869760|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
146095282|NCT02452697|526869761|FG000|Overall Study|Physician Decision|4|||
146095283|NCT02452697|526869762|FG001|Overall Study|Physician Decision|4|||
146095284|NCT02452697|526869763|FG002|Overall Study|Physician Decision|3|||
146095285|NCT02452697|526869764|FG003|Overall Study|Physician Decision|2|||
146095286|NCT02452697|526869761|FG000|Overall Study|Withdrawal by Subject|1|||
146095287|NCT02452697|526869762|FG001|Overall Study|Withdrawal by Subject|0|||
146095288|NCT02452697|526869763|FG002|Overall Study|Withdrawal by Subject|0|||
146095289|NCT02452697|526869764|FG003|Overall Study|Withdrawal by Subject|0|||
146095290|NCT02452697|526869761|FG000|Overall Study|still in follow-up|2|||
146095291|NCT02452697|526869762|FG001|Overall Study|still in follow-up|2|||
146095292|NCT02452697|526869763|FG002|Overall Study|still in follow-up|1|||
146095293|NCT02452697|526869764|FG003|Overall Study|still in follow-up|3|||
146095294|NCT02887859|526869767|FG000|Overall Study|Ongoing|6|||
146095295|NCT02887859|526869767|FG000|Overall Study|Adverse Event|7|||
146095296|NCT02887859|526869767|FG000|Overall Study|Death|1|||
146095297|NCT02887859|526869767|FG000|Overall Study|Physician Decision|1|||
146095298|NCT00257608|526872230|FG000|Chemotherapy Phase|Adverse Event|138|||
146095299|NCT00257608|526872231|FG001|Chemotherapy Phase|Adverse Event|0|||
146095300|NCT00257608|526872232|FG002|Chemotherapy Phase|Adverse Event|0|||
146095301|NCT00257608|526872230|FG000|Chemotherapy Phase|Disease progression|139|||
146095302|NCT00257608|526872231|FG001|Chemotherapy Phase|Disease progression|0|||
146095303|NCT00257608|526872232|FG002|Chemotherapy Phase|Disease progression|0|||
146095304|NCT00257608|526872230|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
146095305|NCT00257608|526872231|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
146095306|NCT00257608|526872232|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
146095307|NCT00257608|526872230|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
146095308|NCT00257608|526872231|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146095309|NCT00257608|526872232|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146095310|NCT00257608|526872230|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
146095311|NCT00257608|526872231|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
146095312|NCT00257608|526872232|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
146095313|NCT00257608|526872230|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
146095314|NCT00257608|526872231|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
146095315|NCT00257608|526872232|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
146095316|NCT00257608|526872230|FG000|Chemotherapy Phase|Physician Decision|28|||
146095317|NCT00257608|526872231|FG001|Chemotherapy Phase|Physician Decision|0|||
146095318|NCT00257608|526872232|FG002|Chemotherapy Phase|Physician Decision|0|||
146254141|NCT00730925|527443052|FG000|Overall Study|Protocol Violation|1|||
146028052|NCT00711802|526614645|FG007|Overall Study|Not treated (no further detail)|0|||
146028053|NCT00711802|526614638|FG000|Overall Study|Adverse Event|0|||
146095319|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Adverse Event|0|||
146095320|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Adverse Event|34|||
146095321|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Adverse Event|38|||
146095322|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Disease progression|0|||
146095323|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Disease progression|204|||
146254142|NCT00730925|527443052|FG000|Overall Study|Withdrawal by Subject|1|||
146254143|NCT00730925|527443052|FG000|Overall Study|Switch to combination therapy|8|||
146095324|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Disease progression|168|||
146095325|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
146095326|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
146095327|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
146095328|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
146095329|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
146095330|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
146095331|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
146095332|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
146095333|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
146095334|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
146095335|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
146095336|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
146095337|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
146095338|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
146095339|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
146095340|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Physician Decision|0|||
146095341|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Physician Decision|8|||
146095342|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Physician Decision|11|||
146095343|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
146095344|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
146095345|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
146095346|NCT00257608|526872230|FG000|Post Chemotherapy Phase|Not treated|0|||
146095347|NCT00257608|526872231|FG001|Post Chemotherapy Phase|Not treated|4|||
146095348|NCT00257608|526872232|FG002|Post Chemotherapy Phase|Not treated|7|||
146095349|NCT00866788|526872233|FG000|Overall Study|Adverse Event|0|||
146095350|NCT00866788|526872234|FG001|Overall Study|Adverse Event|2|||
146095351|NCT00866788|526872235|FG002|Overall Study|Adverse Event|0|||
146095352|NCT00866788|526872236|FG003|Overall Study|Adverse Event|1|||
146095353|NCT00866788|526872233|FG000|Overall Study|Lost to Follow-up|1|||
146095354|NCT00866788|526872234|FG001|Overall Study|Lost to Follow-up|1|||
146095355|NCT00866788|526872235|FG002|Overall Study|Lost to Follow-up|0|||
146095356|NCT00866788|526872236|FG003|Overall Study|Lost to Follow-up|2|||
146095357|NCT00866788|526872233|FG000|Overall Study|Withdrawal by Subject|2|||
146095358|NCT00866788|526872234|FG001|Overall Study|Withdrawal by Subject|1|||
146095359|NCT00866788|526872235|FG002|Overall Study|Withdrawal by Subject|0|||
146095360|NCT00866788|526872236|FG003|Overall Study|Withdrawal by Subject|1|||
146095361|NCT00866788|526872233|FG000|Overall Study|Pregnancy|0|||
146095362|NCT00866788|526872234|FG001|Overall Study|Pregnancy|1|||
146095363|NCT00866788|526872235|FG002|Overall Study|Pregnancy|0|||
146095364|NCT00866788|526872236|FG003|Overall Study|Pregnancy|0|||
146095365|NCT00866788|526872233|FG000|Overall Study|Disease progression|3|||
146095366|NCT00866788|526872234|FG001|Overall Study|Disease progression|1|||
146095367|NCT00866788|526872235|FG002|Overall Study|Disease progression|1|||
146095368|NCT00866788|526872236|FG003|Overall Study|Disease progression|0|||
146095369|NCT00866788|526872233|FG000|Overall Study|Physician Decision|0|||
146095370|NCT00866788|526872234|FG001|Overall Study|Physician Decision|0|||
146095371|NCT00866788|526872235|FG002|Overall Study|Physician Decision|1|||
146095372|NCT00866788|526872236|FG003|Overall Study|Physician Decision|1|||
146095373|NCT01854658|526872237|FG000|Overall Study|Protocol Violation|6|||
146095374|NCT01854658|526872238|FG001|Overall Study|Protocol Violation|2|||
146095375|NCT01854658|526872239|FG002|Overall Study|Protocol Violation|2|||
146095376|NCT01854658|526872240|FG003|Overall Study|Protocol Violation|1|||
146095377|NCT01854658|526872237|FG000|Overall Study|Physician Decision|7|||
146095378|NCT01854658|526872238|FG001|Overall Study|Physician Decision|5|||
146095379|NCT01854658|526872239|FG002|Overall Study|Physician Decision|2|||
146095380|NCT01854658|526872240|FG003|Overall Study|Physician Decision|4|||
146095381|NCT01854658|526872237|FG000|Overall Study|Lost to Follow-up|8|||
146095382|NCT01854658|526872238|FG001|Overall Study|Lost to Follow-up|9|||
146095383|NCT01854658|526872239|FG002|Overall Study|Lost to Follow-up|8|||
146254144|NCT00730925|527443052|FG000|Overall Study|Other|1|||
146254145|NCT00191984|527443053|FG000|Overall Study|Disease Progression|21|||
146095384|NCT01854658|526872240|FG003|Overall Study|Lost to Follow-up|4|||
146095385|NCT01854658|526872237|FG000|Overall Study|Withdrawal by Subject|28|||
146095386|NCT01854658|526872238|FG001|Overall Study|Withdrawal by Subject|21|||
146095387|NCT01854658|526872239|FG002|Overall Study|Withdrawal by Subject|29|||
146095388|NCT01854658|526872240|FG003|Overall Study|Withdrawal by Subject|15|||
146254146|NCT00191984|527443053|FG000|Overall Study|Adverse Event|4|||
146095389|NCT01854658|526872237|FG000|Overall Study|Protocol-specified criteria|15|||
146095390|NCT01854658|526872238|FG001|Overall Study|Protocol-specified criteria|15|||
146095391|NCT01854658|526872239|FG002|Overall Study|Protocol-specified criteria|10|||
146095392|NCT01854658|526872240|FG003|Overall Study|Protocol-specified criteria|7|||
146095393|NCT01854658|526872237|FG000|Overall Study|Lack of Efficacy|3|||
146254147|NCT00191984|527443053|FG000|Overall Study|Death|2|||
146254148|NCT00191984|527443053|FG000|Overall Study|Entry Criteria Exclusion|1|||
146095394|NCT01854658|526872238|FG001|Overall Study|Lack of Efficacy|8|||
146095395|NCT01854658|526872239|FG002|Overall Study|Lack of Efficacy|4|||
146095396|NCT01854658|526872240|FG003|Overall Study|Lack of Efficacy|7|||
146095397|NCT01854658|526872237|FG000|Overall Study|Adverse Event|21|||
146095398|NCT01854658|526872238|FG001|Overall Study|Adverse Event|14|||
146095399|NCT01854658|526872239|FG002|Overall Study|Adverse Event|23|||
146095400|NCT01854658|526872240|FG003|Overall Study|Adverse Event|19|||
146095401|NCT01854658|526872237|FG000|Overall Study|Administrative reasons|5|||
146095402|NCT01854658|526872238|FG001|Overall Study|Administrative reasons|1|||
146095403|NCT01854658|526872239|FG002|Overall Study|Administrative reasons|2|||
146095404|NCT01854658|526872240|FG003|Overall Study|Administrative reasons|2|||
146095405|NCT01973569|526872246|FG000|Overall Study|Adverse Event|9|||
146095406|NCT01973569|526872247|FG001|Overall Study|Adverse Event|2|||
146095407|NCT01973569|526872248|FG002|Overall Study|Adverse Event|4|||
146095408|NCT01973569|526872246|FG000|Overall Study|Protocol Violation|2|||
146095409|NCT01973569|526872247|FG001|Overall Study|Protocol Violation|1|||
146095410|NCT01973569|526872248|FG002|Overall Study|Protocol Violation|3|||
146095411|NCT01973569|526872246|FG000|Overall Study|Withdrawal by Subject|7|||
146095412|NCT01973569|526872247|FG001|Overall Study|Withdrawal by Subject|5|||
146028054|NCT00711802|526614639|FG001|Overall Study|Adverse Event|0|||
146028055|NCT00711802|526614640|FG002|Overall Study|Adverse Event|0|||
146028056|NCT00711802|526614641|FG003|Overall Study|Adverse Event|0|||
146028057|NCT00711802|526614642|FG004|Overall Study|Adverse Event|1|||
146028058|NCT00711802|526614643|FG005|Overall Study|Adverse Event|1|||
146028059|NCT00711802|526614644|FG006|Overall Study|Adverse Event|0|||
146028060|NCT00711802|526614645|FG007|Overall Study|Adverse Event|0|||
146028061|NCT00711802|526614638|FG000|Overall Study|Microbiological failure|0|||
146028062|NCT00711802|526614639|FG001|Overall Study|Microbiological failure|1|||
146028063|NCT00711802|526614640|FG002|Overall Study|Microbiological failure|0|||
146028064|NCT00711802|526614641|FG003|Overall Study|Microbiological failure|0|||
146028065|NCT00711802|526614642|FG004|Overall Study|Microbiological failure|0|||
146028066|NCT00711802|526614643|FG005|Overall Study|Microbiological failure|1|||
146028067|NCT00711802|526614644|FG006|Overall Study|Microbiological failure|0|||
146028068|NCT00711802|526614645|FG007|Overall Study|Microbiological failure|0|||
146028069|NCT00711802|526614638|FG000|Overall Study|Protocol Violation|0|||
146028070|NCT00711802|526614639|FG001|Overall Study|Protocol Violation|0|||
146028071|NCT00711802|526614640|FG002|Overall Study|Protocol Violation|0|||
146028072|NCT00711802|526614641|FG003|Overall Study|Protocol Violation|1|||
146028073|NCT00711802|526614642|FG004|Overall Study|Protocol Violation|0|||
146028074|NCT00711802|526614643|FG005|Overall Study|Protocol Violation|0|||
146028075|NCT00711802|526614644|FG006|Overall Study|Protocol Violation|0|||
146028076|NCT00711802|526614645|FG007|Overall Study|Protocol Violation|0|||
146028077|NCT00711802|526614638|FG000|Overall Study|Physician Decision|0|||
146028078|NCT00711802|526614639|FG001|Overall Study|Physician Decision|2|||
146028079|NCT00711802|526614640|FG002|Overall Study|Physician Decision|0|||
146028080|NCT00711802|526614641|FG003|Overall Study|Physician Decision|0|||
146028081|NCT00711802|526614642|FG004|Overall Study|Physician Decision|0|||
146028082|NCT00711802|526614643|FG005|Overall Study|Physician Decision|0|||
146028083|NCT00711802|526614644|FG006|Overall Study|Physician Decision|0|||
146028084|NCT00711802|526614645|FG007|Overall Study|Physician Decision|0|||
146028085|NCT00711802|526614638|FG000|Overall Study|Withdrawal by Subject|0|||
146028086|NCT00711802|526614639|FG001|Overall Study|Withdrawal by Subject|1|||
146028087|NCT00711802|526614640|FG002|Overall Study|Withdrawal by Subject|0|||
146028088|NCT00711802|526614641|FG003|Overall Study|Withdrawal by Subject|1|||
146028089|NCT00711802|526614642|FG004|Overall Study|Withdrawal by Subject|0|||
146028090|NCT00711802|526614643|FG005|Overall Study|Withdrawal by Subject|0|||
146028091|NCT00711802|526614644|FG006|Overall Study|Withdrawal by Subject|0|||
146028092|NCT00711802|526614645|FG007|Overall Study|Withdrawal by Subject|0|||
146028093|NCT00711802|526614638|FG000|Overall Study|Lost to Follow-up|0|||
146028094|NCT00711802|526614639|FG001|Overall Study|Lost to Follow-up|0|||
146028095|NCT00711802|526614640|FG002|Overall Study|Lost to Follow-up|3|||
146028096|NCT00711802|526614641|FG003|Overall Study|Lost to Follow-up|1|||
146028097|NCT00711802|526614642|FG004|Overall Study|Lost to Follow-up|10|||
146028098|NCT00711802|526614643|FG005|Overall Study|Lost to Follow-up|6|||
146028099|NCT00711802|526614644|FG006|Overall Study|Lost to Follow-up|4|||
146028100|NCT00711802|526614645|FG007|Overall Study|Lost to Follow-up|2|||
146028101|NCT00711802|526614638|FG000|Overall Study|Reason not reported|0|||
146028102|NCT00711802|526614639|FG001|Overall Study|Reason not reported|1|||
146028103|NCT00711802|526614640|FG002|Overall Study|Reason not reported|1|||
146028104|NCT00711802|526614641|FG003|Overall Study|Reason not reported|0|||
146028105|NCT00711802|526614642|FG004|Overall Study|Reason not reported|1|||
146095413|NCT01973569|526872248|FG002|Overall Study|Withdrawal by Subject|2|||
146095414|NCT01973569|526872246|FG000|Overall Study|Invasive dental treatment|3|||
146028106|NCT00711802|526614643|FG005|Overall Study|Reason not reported|0|||
146028107|NCT00711802|526614644|FG006|Overall Study|Reason not reported|1|||
146028108|NCT00711802|526614645|FG007|Overall Study|Reason not reported|0|||
146028109|NCT00581828|526614646|FG000|Overall Study|Protocol Violation|1|||
146028110|NCT02370095|526614647|FG000|Overall Study|Withdrawal by Subject|0|||
146028111|NCT02370095|526614648|FG001|Overall Study|Withdrawal by Subject|1|||
146095415|NCT01973569|526872247|FG001|Overall Study|Invasive dental treatment|5|||
146095416|NCT01973569|526872248|FG002|Overall Study|Invasive dental treatment|6|||
146095417|NCT01973569|526872246|FG000|Overall Study|Prohibited concomitant d|1|||
146095418|NCT01973569|526872247|FG001|Overall Study|Prohibited concomitant d|5|||
146095419|NCT01973569|526872248|FG002|Overall Study|Prohibited concomitant d|0|||
146095420|NCT01973569|526872246|FG000|Overall Study|Disease progression|0|||
146095421|NCT01973569|526872247|FG001|Overall Study|Disease progression|3|||
146095422|NCT01973569|526872248|FG002|Overall Study|Disease progression|0|||
146095423|NCT01973569|526872246|FG000|Overall Study|Other|1|||
146095424|NCT01973569|526872247|FG001|Overall Study|Other|1|||
146095425|NCT01973569|526872248|FG002|Overall Study|Other|0|||
146095426|NCT01973569|526872246|FG000|Overall Study|Did not receive study drug|6|||
146095427|NCT01973569|526872247|FG001|Overall Study|Did not receive study drug|3|||
146095428|NCT01973569|526872248|FG002|Overall Study|Did not receive study drug|3|||
146095429|NCT03793556|526872249|FG000|Overall Study|Withdrawal by Subject|12|||
146095430|NCT03793556|526872250|FG001|Overall Study|Withdrawal by Subject|1|||
146095431|NCT03793556|526872249|FG000|Overall Study|Lost to Follow-up|1|||
146095432|NCT03793556|526872250|FG001|Overall Study|Lost to Follow-up|1|||
146095433|NCT01461980|526872255|FG000|Overall Study|Other|9|||
146095434|NCT01461980|526872256|FG001|Overall Study|Other|8|||
146095435|NCT01461980|526872257|FG002|Overall Study|Other|6|||
146095436|NCT01461980|526872255|FG000|Overall Study|Medication error|7|||
146095437|NCT01461980|526872256|FG001|Overall Study|Medication error|5|||
146095438|NCT01461980|526872257|FG002|Overall Study|Medication error|6|||
146095439|NCT01461980|526872255|FG000|Overall Study|Adverse Event|12|||
146095440|NCT01461980|526872256|FG001|Overall Study|Adverse Event|5|||
146095441|NCT01461980|526872257|FG002|Overall Study|Adverse Event|6|||
146095442|NCT01461980|526872255|FG000|Overall Study|Protocol Violation|12|||
146095443|NCT01461980|526872256|FG001|Overall Study|Protocol Violation|19|||
146028112|NCT01667562|526614649|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
146028113|NCT01667562|526614650|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
146028114|NCT01667562|526614649|FG000|Erlotinib Phase|Lost to Follow-up|0|||
146028115|NCT01667562|526614650|FG001|Erlotinib Phase|Lost to Follow-up|1|||
146028116|NCT01667562|526614649|FG000|Erlotinib Phase|Adverse Event|0|||
146028117|NCT01667562|526614650|FG001|Erlotinib Phase|Adverse Event|1|||
146028118|NCT01667562|526614649|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
146028119|NCT01667562|526614650|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
146028120|NCT01129882|526614651|FG000|Overall Study|Adverse Event|39|||
146028121|NCT01129882|526614651|FG000|Overall Study|Death|6|||
146095444|NCT01461980|526872257|FG002|Overall Study|Protocol Violation|16|||
146095445|NCT01461980|526872255|FG000|Overall Study|No longer meets eligibility criteria|18|||
146095446|NCT01461980|526872256|FG001|Overall Study|No longer meets eligibility criteria|9|||
146095447|NCT01461980|526872257|FG002|Overall Study|No longer meets eligibility criteria|19|||
146095448|NCT01461980|526872255|FG000|Overall Study|Lost to Follow-up|52|||
146095449|NCT01461980|526872256|FG001|Overall Study|Lost to Follow-up|53|||
146095450|NCT01461980|526872257|FG002|Overall Study|Lost to Follow-up|51|||
146095451|NCT01461980|526872255|FG000|Overall Study|No longer willing to participate|52|||
146095452|NCT01461980|526872256|FG001|Overall Study|No longer willing to participate|38|||
146095453|NCT01461980|526872257|FG002|Overall Study|No longer willing to participate|54|||
146095454|NCT01461980|526872255|FG000|Overall Study|Randomized but not vaccinated|4|||
146095455|NCT01461980|526872256|FG001|Overall Study|Randomized but not vaccinated|8|||
146095456|NCT01461980|526872257|FG002|Overall Study|Randomized but not vaccinated|7|||
146095457|NCT00809354|526872261|FG000|Overall Study|Adverse Event|32|||
146095458|NCT00809354|526872262|FG001|Overall Study|Adverse Event|45|||
146095459|NCT00809354|526872263|FG002|Overall Study|Adverse Event|37|||
146095460|NCT00809354|526872264|FG003|Overall Study|Adverse Event|53|||
146095461|NCT00809354|526872265|FG004|Overall Study|Adverse Event|26|||
146095462|NCT00809354|526872266|FG005|Overall Study|Adverse Event|33|||
146095463|NCT00809354|526872267|FG006|Overall Study|Adverse Event|44|||
146095464|NCT00809354|526872268|FG007|Overall Study|Adverse Event|40|||
146095465|NCT00809354|526872269|FG008|Overall Study|Adverse Event|46|||
146095466|NCT00809354|526872270|FG009|Overall Study|Adverse Event|26|||
146095467|NCT00809354|526872261|FG000|Overall Study|Lack of Efficacy|23|||
146095468|NCT00809354|526872262|FG001|Overall Study|Lack of Efficacy|23|||
146095469|NCT00809354|526872263|FG002|Overall Study|Lack of Efficacy|22|||
146095470|NCT00809354|526872264|FG003|Overall Study|Lack of Efficacy|15|||
146300318|NCT00698932|527615216|FG000|Overall Study|Severe non-compliance to protocol|1|||
146028122|NCT01129882|526614651|FG000|Overall Study|Lack of Efficacy|5|||
146095471|NCT00809354|526872265|FG004|Overall Study|Lack of Efficacy|40|||
146095472|NCT00809354|526872266|FG005|Overall Study|Lack of Efficacy|19|||
146095473|NCT00809354|526872267|FG006|Overall Study|Lack of Efficacy|21|||
146095474|NCT00809354|526872268|FG007|Overall Study|Lack of Efficacy|15|||
146095475|NCT00809354|526872269|FG008|Overall Study|Lack of Efficacy|18|||
146095476|NCT00809354|526872270|FG009|Overall Study|Lack of Efficacy|38|||
146095477|NCT00809354|526872261|FG000|Overall Study|Lost to Follow-up|10|||
146095478|NCT00809354|526872262|FG001|Overall Study|Lost to Follow-up|11|||
146095479|NCT00809354|526872263|FG002|Overall Study|Lost to Follow-up|8|||
146095480|NCT00809354|526872264|FG003|Overall Study|Lost to Follow-up|13|||
146028123|NCT01129882|526614651|FG000|Overall Study|Lost to Follow-up|13|||
146028124|NCT01129882|526614651|FG000|Overall Study|Physician Decision|27|||
146028125|NCT01129882|526614651|FG000|Overall Study|Protocol Deviation|3|||
146028126|NCT01129882|526614651|FG000|Overall Study|Withdrawal Criteria Met|19|||
146028127|NCT01129882|526614651|FG000|Overall Study|Trial Termination by Sponsor|6|||
146028128|NCT01129882|526614651|FG000|Overall Study|Withdrawal by Subject|160|||
146028129|NCT02130986|526614652|FG000|Overall Study|Withdrawal by Subject|4|||
146028130|NCT02130986|526614653|FG001|Overall Study|Withdrawal by Subject|4|||
146028131|NCT02130986|526614652|FG000|Overall Study|Lost to Follow-up|151|||
146028132|NCT02130986|526614653|FG001|Overall Study|Lost to Follow-up|160|||
146028133|NCT02305849|526614654|FG000|Overall Study|Adverse Event|10|||
146028134|NCT02305849|526614655|FG001|Overall Study|Adverse Event|12|||
146028135|NCT02305849|526614656|FG002|Overall Study|Adverse Event|7|||
146028136|NCT02305849|526614657|FG003|Overall Study|Adverse Event|3|||
146028137|NCT02305849|526614654|FG000|Overall Study|Lack of Efficacy|10|||
146095481|NCT00809354|526872265|FG004|Overall Study|Lost to Follow-up|6|||
146095482|NCT00809354|526872266|FG005|Overall Study|Lost to Follow-up|2|||
146095483|NCT00809354|526872267|FG006|Overall Study|Lost to Follow-up|0|||
146095484|NCT00809354|526872268|FG007|Overall Study|Lost to Follow-up|5|||
146095485|NCT00809354|526872269|FG008|Overall Study|Lost to Follow-up|4|||
146095486|NCT00809354|526872270|FG009|Overall Study|Lost to Follow-up|0|||
146095487|NCT00809354|526872261|FG000|Overall Study|Protocol Violation|7|||
146095488|NCT00809354|526872262|FG001|Overall Study|Protocol Violation|14|||
146095489|NCT00809354|526872263|FG002|Overall Study|Protocol Violation|14|||
146095490|NCT00809354|526872264|FG003|Overall Study|Protocol Violation|12|||
146095491|NCT00809354|526872265|FG004|Overall Study|Protocol Violation|14|||
146095492|NCT00809354|526872266|FG005|Overall Study|Protocol Violation|6|||
146095493|NCT00809354|526872267|FG006|Overall Study|Protocol Violation|4|||
146095494|NCT00809354|526872268|FG007|Overall Study|Protocol Violation|6|||
146095495|NCT00809354|526872269|FG008|Overall Study|Protocol Violation|9|||
146095496|NCT00809354|526872270|FG009|Overall Study|Protocol Violation|3|||
146095497|NCT00809354|526872261|FG000|Overall Study|Withdrawal by Subject|32|||
146095498|NCT00809354|526872262|FG001|Overall Study|Withdrawal by Subject|27|||
146095499|NCT00809354|526872263|FG002|Overall Study|Withdrawal by Subject|31|||
146095500|NCT00809354|526872264|FG003|Overall Study|Withdrawal by Subject|33|||
146095501|NCT00809354|526872265|FG004|Overall Study|Withdrawal by Subject|34|||
146095502|NCT00809354|526872266|FG005|Overall Study|Withdrawal by Subject|29|||
146095503|NCT00809354|526872267|FG006|Overall Study|Withdrawal by Subject|27|||
146095504|NCT00809354|526872268|FG007|Overall Study|Withdrawal by Subject|19|||
146095505|NCT00809354|526872269|FG008|Overall Study|Withdrawal by Subject|18|||
146095506|NCT00809354|526872270|FG009|Overall Study|Withdrawal by Subject|20|||
146095507|NCT00809354|526872261|FG000|Overall Study|Other|10|||
146095508|NCT00809354|526872262|FG001|Overall Study|Other|2|||
146095509|NCT00809354|526872263|FG002|Overall Study|Other|7|||
146095510|NCT00809354|526872264|FG003|Overall Study|Other|10|||
146095511|NCT00809354|526872265|FG004|Overall Study|Other|5|||
146095512|NCT00809354|526872266|FG005|Overall Study|Other|3|||
146095513|NCT00809354|526872267|FG006|Overall Study|Other|2|||
146095514|NCT00809354|526872268|FG007|Overall Study|Other|3|||
146095515|NCT00809354|526872269|FG008|Overall Study|Other|4|||
146095516|NCT00809354|526872270|FG009|Overall Study|Other|3|||
146095517|NCT00809354|526872261|FG000|Overall Study|Study terminated by sponsor|138|||
146095518|NCT00809354|526872262|FG001|Overall Study|Study terminated by sponsor|134|||
146095519|NCT00809354|526872263|FG002|Overall Study|Study terminated by sponsor|129|||
146095520|NCT00809354|526872264|FG003|Overall Study|Study terminated by sponsor|120|||
146095521|NCT00809354|526872265|FG004|Overall Study|Study terminated by sponsor|126|||
146095522|NCT00809354|526872266|FG005|Overall Study|Study terminated by sponsor|133|||
146095523|NCT00809354|526872267|FG006|Overall Study|Study terminated by sponsor|124|||
146095524|NCT00809354|526872268|FG007|Overall Study|Study terminated by sponsor|148|||
146095525|NCT00809354|526872269|FG008|Overall Study|Study terminated by sponsor|127|||
146095526|NCT00809354|526872270|FG009|Overall Study|Study terminated by sponsor|135|||
146095527|NCT00809354|526872261|FG000|Overall Study|Withdrawn due to pregnancy|0|||
146095528|NCT00809354|526872262|FG001|Overall Study|Withdrawn due to pregnancy|1|||
146095529|NCT00809354|526872263|FG002|Overall Study|Withdrawn due to pregnancy|0|||
146095530|NCT00809354|526872264|FG003|Overall Study|Withdrawn due to pregnancy|0|||
146095531|NCT00809354|526872265|FG004|Overall Study|Withdrawn due to pregnancy|0|||
146095532|NCT00809354|526872266|FG005|Overall Study|Withdrawn due to pregnancy|0|||
146095533|NCT00809354|526872267|FG006|Overall Study|Withdrawn due to pregnancy|0|||
146095534|NCT00809354|526872268|FG007|Overall Study|Withdrawn due to pregnancy|0|||
146095535|NCT00809354|526872269|FG008|Overall Study|Withdrawn due to pregnancy|0|||
146095536|NCT00809354|526872270|FG009|Overall Study|Withdrawn due to pregnancy|0|||
146095537|NCT00809354|526872261|FG000|Overall Study|Randomized but not Treated|3|||
146095538|NCT00809354|526872262|FG001|Overall Study|Randomized but not Treated|1|||
146095539|NCT00809354|526872263|FG002|Overall Study|Randomized but not Treated|6|||
146095540|NCT00809354|526872264|FG003|Overall Study|Randomized but not Treated|0|||
146095541|NCT00809354|526872265|FG004|Overall Study|Randomized but not Treated|5|||
146095542|NCT00809354|526872266|FG005|Overall Study|Randomized but not Treated|0|||
146095543|NCT00809354|526872267|FG006|Overall Study|Randomized but not Treated|1|||
146028138|NCT02305849|526614655|FG001|Overall Study|Lack of Efficacy|6|||
146028139|NCT02305849|526614656|FG002|Overall Study|Lack of Efficacy|3|||
146028140|NCT02305849|526614657|FG003|Overall Study|Lack of Efficacy|9|||
146028141|NCT02305849|526614654|FG000|Overall Study|Withdrawal by Subject|2|||
146028142|NCT02305849|526614655|FG001|Overall Study|Withdrawal by Subject|2|||
146028143|NCT02305849|526614656|FG002|Overall Study|Withdrawal by Subject|1|||
146028144|NCT02305849|526614657|FG003|Overall Study|Withdrawal by Subject|4|||
146028145|NCT02305849|526614654|FG000|Overall Study|Lost to Follow-up|0|||
146028146|NCT02305849|526614655|FG001|Overall Study|Lost to Follow-up|2|||
146028147|NCT02305849|526614656|FG002|Overall Study|Lost to Follow-up|0|||
146028148|NCT02305849|526614657|FG003|Overall Study|Lost to Follow-up|0|||
146028149|NCT02305849|526614654|FG000|Overall Study|Protocol Violation|3|||
146028150|NCT02305849|526614655|FG001|Overall Study|Protocol Violation|2|||
146028151|NCT02305849|526614656|FG002|Overall Study|Protocol Violation|1|||
146028152|NCT02305849|526614657|FG003|Overall Study|Protocol Violation|1|||
146028153|NCT02305849|526614654|FG000|Overall Study|Lab data met discontinuation criteria|0|||
146028154|NCT02305849|526614655|FG001|Overall Study|Lab data met discontinuation criteria|1|||
146028155|NCT02305849|526614656|FG002|Overall Study|Lab data met discontinuation criteria|2|||
146028156|NCT02305849|526614657|FG003|Overall Study|Lab data met discontinuation criteria|1|||
146028157|NCT02305849|526614654|FG000|Overall Study|Miscellaneous|1|||
146028158|NCT02305849|526614655|FG001|Overall Study|Miscellaneous|2|||
146028159|NCT02305849|526614656|FG002|Overall Study|Miscellaneous|4|||
146028160|NCT02305849|526614657|FG003|Overall Study|Miscellaneous|1|||
146028161|NCT02305849|526614654|FG000|Overall Study|Not fulfill eligibility criteria|1|||
146028162|NCT02305849|526614655|FG001|Overall Study|Not fulfill eligibility criteria|1|||
146028163|NCT02305849|526614656|FG002|Overall Study|Not fulfill eligibility criteria|0|||
146028164|NCT02305849|526614657|FG003|Overall Study|Not fulfill eligibility criteria|0|||
146028165|NCT00355342|526614658|FG000|Overall Study|Adverse Event|13|||
146028166|NCT00355342|526614659|FG001|Overall Study|Adverse Event|15|||
146028167|NCT00355342|526614658|FG000|Overall Study|Lost to Follow-up|4|||
146028168|NCT00355342|526614659|FG001|Overall Study|Lost to Follow-up|2|||
146028169|NCT00355342|526614658|FG000|Overall Study|Withdrawal by Subject|14|||
146028170|NCT00355342|526614659|FG001|Overall Study|Withdrawal by Subject|11|||
146028171|NCT00355342|526614658|FG000|Overall Study|Sponsor terminated study|2|||
146028172|NCT00355342|526614659|FG001|Overall Study|Sponsor terminated study|2|||
146028173|NCT00355342|526614658|FG000|Overall Study|Overcompliant-PI discretion|1|||
146028174|NCT00355342|526614659|FG001|Overall Study|Overcompliant-PI discretion|0|||
146028175|NCT00355342|526614658|FG000|Overall Study|Use of prohibited medication|1|||
146028176|NCT00355342|526614659|FG001|Overall Study|Use of prohibited medication|0|||
146028177|NCT00355342|526614658|FG000|Overall Study|COPD exacerbation|1|||
146028178|NCT00355342|526614659|FG001|Overall Study|COPD exacerbation|1|||
146028179|NCT00355342|526614658|FG000|Overall Study|Dispensed wrong study drug kit|1|||
146028180|NCT00355342|526614659|FG001|Overall Study|Dispensed wrong study drug kit|0|||
146028181|NCT00355342|526614658|FG000|Overall Study|Non-compliance with Dexa scans|1|||
146028182|NCT00355342|526614659|FG001|Overall Study|Non-compliance with Dexa scans|0|||
146028183|NCT00355342|526614658|FG000|Overall Study|Withdrawal by participant and physician|1|||
146028184|NCT00355342|526614659|FG001|Overall Study|Withdrawal by participant and physician|0|||
146028185|NCT00355342|526614658|FG000|Overall Study|Participant relocated|0|||
146028186|NCT00355342|526614659|FG001|Overall Study|Participant relocated|1|||
146028187|NCT00355342|526614658|FG000|Overall Study|Participant discontinued study drug|0|||
146028188|NCT00355342|526614659|FG001|Overall Study|Participant discontinued study drug|1|||
146028189|NCT00355342|526614658|FG000|Overall Study|Study management|0|||
146028190|NCT00355342|526614659|FG001|Overall Study|Study management|1|||
146028191|NCT00355342|526614658|FG000|Overall Study|Protocol Violation|0|||
146028192|NCT00355342|526614659|FG001|Overall Study|Protocol Violation|1|||
146028193|NCT00355342|526614658|FG000|Overall Study|Use of protocol excluded medication|0|||
146028194|NCT00355342|526614659|FG001|Overall Study|Use of protocol excluded medication|1|||
146028195|NCT00536874|526614660|FG000|Overall Study|Adverse Event|1|||
146028196|NCT00536874|526614660|FG000|Overall Study|Death|2|||
146028197|NCT00536874|526614660|FG000|Overall Study|Withdrawal by Subject|1|||
146028198|NCT02084238|526614662|FG000|Overall Study|Lost to Follow-up|2|||
146028199|NCT00391391|526614663|FG000|Overall Study|Adverse Event|0|||
146028200|NCT00391391|526614664|FG001|Overall Study|Adverse Event|0|||
146028201|NCT00391391|526614665|FG002|Overall Study|Adverse Event|0|||
146095544|NCT00809354|526872268|FG007|Overall Study|Randomized but not Treated|1|||
146028202|NCT00391391|526614666|FG003|Overall Study|Adverse Event|1|||
146028203|NCT00391391|526614663|FG000|Overall Study|Lost to Follow-up|1|||
146300319|NCT00698932|527615217|FG001|Overall Study|Severe non-compliance to protocol|2|||
146028204|NCT00391391|526614664|FG001|Overall Study|Lost to Follow-up|3|||
146028205|NCT00391391|526614665|FG002|Overall Study|Lost to Follow-up|7|||
146028206|NCT00391391|526614666|FG003|Overall Study|Lost to Follow-up|4|||
146028207|NCT00391391|526614663|FG000|Overall Study|Protocol Violation|2|||
146028208|NCT00391391|526614664|FG001|Overall Study|Protocol Violation|3|||
146095545|NCT00809354|526872269|FG008|Overall Study|Randomized but not Treated|2|||
146028209|NCT00391391|526614665|FG002|Overall Study|Protocol Violation|6|||
146028210|NCT00391391|526614666|FG003|Overall Study|Protocol Violation|7|||
146254149|NCT00191984|527443053|FG000|Overall Study|Withdrawal by Subject|7|||
146254150|NCT00191984|527443053|FG000|Overall Study|Physician Decision|4|||
146254151|NCT03303521|527443054|FG000|Overall Study|Withdrawal by Subject|2|||
146254152|NCT03303521|527443055|FG001|Overall Study|Withdrawal by Subject|0|||
146254153|NCT03303521|527443054|FG000|Overall Study|Death|1|||
146028211|NCT00391391|526614663|FG000|Overall Study|Withdrawal by Subject|6|||
146028212|NCT00391391|526614664|FG001|Overall Study|Withdrawal by Subject|4|||
146028213|NCT00391391|526614665|FG002|Overall Study|Withdrawal by Subject|10|||
146028214|NCT00391391|526614666|FG003|Overall Study|Withdrawal by Subject|7|||
146028215|NCT04096820|526614668|FG000|Overall Study|Did not return for intervention|2|||
146028216|NCT04096820|526614668|FG000|Overall Study|Death|1|||
146028217|NCT00475865|526614669|FG000|Overall Study|Adverse Event|0|||
146028218|NCT00475865|526614670|FG001|Overall Study|Adverse Event|3|||
146028219|NCT00475865|526614671|FG002|Overall Study|Adverse Event|4|||
146028220|NCT00475865|526614669|FG000|Overall Study|Lack of Efficacy|1|||
146028221|NCT00475865|526614670|FG001|Overall Study|Lack of Efficacy|0|||
146028222|NCT00475865|526614671|FG002|Overall Study|Lack of Efficacy|0|||
146028223|NCT00475865|526614669|FG000|Overall Study|Progressive disease|0|||
146028224|NCT00475865|526614670|FG001|Overall Study|Progressive disease|1|||
146028225|NCT00475865|526614671|FG002|Overall Study|Progressive disease|2|||
146028226|NCT00475865|526614669|FG000|Overall Study|Participant did not wish to continue|1|||
146028227|NCT00475865|526614670|FG001|Overall Study|Participant did not wish to continue|0|||
146028228|NCT00475865|526614671|FG002|Overall Study|Participant did not wish to continue|0|||
146028229|NCT00475865|526614669|FG000|Overall Study|Other than above|0|||
146028230|NCT00475865|526614670|FG001|Overall Study|Other than above|1|||
146028231|NCT00475865|526614671|FG002|Overall Study|Other than above|0|||
146028232|NCT03158272|526614677|FG000|Overall Study|Disease progression|3|||
146028233|NCT03158272|526614678|FG001|Overall Study|Disease progression|3|||
146028234|NCT03158272|526614679|FG002|Overall Study|Disease progression|4|||
146028235|NCT03158272|526614680|FG003|Overall Study|Disease progression|6|||
146028236|NCT03158272|526614677|FG000|Overall Study|Death|0|||
146028237|NCT03158272|526614678|FG001|Overall Study|Death|0|||
146028238|NCT03158272|526614679|FG002|Overall Study|Death|1|||
146028239|NCT03158272|526614680|FG003|Overall Study|Death|0|||
146028240|NCT03158272|526614677|FG000|Overall Study|Other reasons|0|||
146028241|NCT03158272|526614678|FG001|Overall Study|Other reasons|0|||
146028242|NCT03158272|526614679|FG002|Overall Study|Other reasons|1|||
146028243|NCT03158272|526614680|FG003|Overall Study|Other reasons|0|||
146028244|NCT03158272|526614677|FG000|Overall Study|Adverse event unrelated to the drug|0|||
146028245|NCT03158272|526614678|FG001|Overall Study|Adverse event unrelated to the drug|1|||
146028246|NCT03158272|526614679|FG002|Overall Study|Adverse event unrelated to the drug|0|||
146028247|NCT03158272|526614680|FG003|Overall Study|Adverse event unrelated to the drug|0|||
146028248|NCT01822535|526614681|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
146028249|NCT01822535|526614682|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
146028250|NCT01822535|526614681|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
146028251|NCT01822535|526614682|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
146028252|NCT01822535|526614681|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
146028253|NCT01822535|526614682|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
146028254|NCT01048866|526614683|FG000|Overall Study|Adverse Event|1|||
146028255|NCT01048866|526614684|FG001|Overall Study|Adverse Event|0|||
146028256|NCT01048866|526614683|FG000|Overall Study|Protocol Violation|1|||
146028257|NCT01048866|526614684|FG001|Overall Study|Protocol Violation|0|||
146028258|NCT01048866|526614683|FG000|Overall Study|Physician Decision|1|||
146028259|NCT01048866|526614684|FG001|Overall Study|Physician Decision|0|||
146028260|NCT01048866|526614683|FG000|Overall Study|Withdrawal by Subject|0|||
146028261|NCT01048866|526614684|FG001|Overall Study|Withdrawal by Subject|2|||
146028262|NCT01048866|526614683|FG000|Overall Study|Lost to Follow-up|0|||
146028263|NCT01048866|526614684|FG001|Overall Study|Lost to Follow-up|2|||
146028264|NCT01048866|526614683|FG000|Overall Study|Other|1|||
146028265|NCT01048866|526614684|FG001|Overall Study|Other|1|||
146028266|NCT03582813|526614685|FG000|Overall Study|Lost to Follow-up|18|||
146028267|NCT03582813|526614686|FG001|Overall Study|Lost to Follow-up|21|||
146028268|NCT03582813|526614685|FG000|Overall Study|Withdrawal by Subject|1|||
146028269|NCT03582813|526614686|FG001|Overall Study|Withdrawal by Subject|0|||
146028270|NCT03081858|526616071|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
146028271|NCT03081858|526616072|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146028272|NCT03081858|526616073|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146028273|NCT03081858|526616074|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
146028274|NCT00387647|526616079|FG000|Overall Study|Death|18|||
146028275|NCT02032407|526616080|FG000|Overall Study|Lost to Follow-up|2|||
146028276|NCT02032407|526616080|FG000|Overall Study|Pregnancy|1|||
146028277|NCT02032407|526616080|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146028278|NCT01309269|526616081|FG000|Overall Study|Adverse Event|56|||
146028279|NCT01309269|526616081|FG000|Overall Study|Withdrawal by Subject|25|||
146028280|NCT01309269|526616081|FG000|Overall Study|Lack of Acceptance|15|||
146095546|NCT00809354|526872270|FG009|Overall Study|Randomized but not Treated|1|||
146095547|NCT00809354|526872261|FG000|Overall Study|Death|0|||
146095548|NCT00809354|526872262|FG001|Overall Study|Death|0|||
146095549|NCT00809354|526872263|FG002|Overall Study|Death|0|||
146095550|NCT00809354|526872264|FG003|Overall Study|Death|0|||
146095551|NCT00809354|526872265|FG004|Overall Study|Death|0|||
146095552|NCT00809354|526872266|FG005|Overall Study|Death|0|||
146095553|NCT00809354|526872267|FG006|Overall Study|Death|0|||
146095554|NCT00809354|526872268|FG007|Overall Study|Death|1|||
146095555|NCT00809354|526872269|FG008|Overall Study|Death|0|||
146095556|NCT00809354|526872270|FG009|Overall Study|Death|0|||
146095557|NCT02477839|526872273|FG000|Overall Study|Adverse Event|0|||
146095558|NCT02477839|526872274|FG001|Overall Study|Adverse Event|1|||
146095559|NCT02477839|526872273|FG000|Overall Study|Protocol Violation|0|||
146095560|NCT02477839|526872274|FG001|Overall Study|Protocol Violation|2|||
146095561|NCT02477839|526872273|FG000|Overall Study|Withdrawal by Subject|3|||
146095562|NCT02477839|526872274|FG001|Overall Study|Withdrawal by Subject|3|||
146095563|NCT02477839|526872273|FG000|Overall Study|Participant had PGS during V6|0|||
146095564|NCT02477839|526872274|FG001|Overall Study|Participant had PGS during V6|1|||
146095565|NCT02477839|526872273|FG000|Overall Study|Parents decided to stop medication|0|||
146095566|NCT02477839|526872274|FG001|Overall Study|Parents decided to stop medication|1|||
146095567|NCT02477839|526872273|FG000|Overall Study|Lack of tolerability|0|||
146095568|NCT02477839|526872274|FG001|Overall Study|Lack of tolerability|1|||
146095569|NCT02477839|526872273|FG000|Overall Study|Exclusion criterion|0|||
146095570|NCT02477839|526872274|FG001|Overall Study|Exclusion criterion|1|||
146095571|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
146095572|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
146095573|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
146095574|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
146095575|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
146095576|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
146095577|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
146095578|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
146095579|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
146095580|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
146095581|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
146095582|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
146095583|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
146095584|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
146095585|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
146095586|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
146095587|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
146095588|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
146095589|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
146095590|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
146095591|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
146095592|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
146095593|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
146095594|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
146095595|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Death|2|||
146095596|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Death|1|||
146095597|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Death|0|||
146095598|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Death|0|||
146095599|NCT02607930|526872275|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
146095600|NCT02607930|526872276|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146095601|NCT02607930|526872277|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146095602|NCT02607930|526872278|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
146095603|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
146095604|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
146095605|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
146095606|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
146095607|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
146095608|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
146095609|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
146095610|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
146095611|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
146095612|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
146095613|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
146095614|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
146095615|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
146095616|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
146254154|NCT03303521|527443055|FG001|Overall Study|Death|0|||
146254155|NCT03303521|527443054|FG000|Overall Study|Kidney transplantation|0|||
146028281|NCT01309269|526616081|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
146028282|NCT01309269|526616081|FG000|Overall Study|Kidney Transplant|25|||
146028283|NCT01309269|526616081|FG000|Overall Study|Administrative Problems|141|||
146028284|NCT01309269|526616081|FG000|Overall Study|Other|256|||
146028285|NCT01309269|526616081|FG000|Overall Study|Other|1|||
146028286|NCT01309269|526616081|FG000|Overall Study|Study Completion Data Not Recorded|95|||
146028287|NCT01309269|526616081|FG000|Overall Study|Enrolled but not Treated|107|||
146028288|NCT00524589|526616097|FG000|Overall Study|Withdrawal by Subject|2|||
146028289|NCT00524589|526616097|FG000|Overall Study|Disease Progression|16|||
146028290|NCT01519674|526616100|FG000|Overall Study|Adverse Event|3|||
146028291|NCT01519674|526616101|FG001|Overall Study|Adverse Event|3|||
146028292|NCT01519674|526616102|FG002|Overall Study|Adverse Event|0|||
146028293|NCT01519674|526616100|FG000|Overall Study|Lack of Efficacy|1|||
146028294|NCT01519674|526616101|FG001|Overall Study|Lack of Efficacy|1|||
146028295|NCT01519674|526616102|FG002|Overall Study|Lack of Efficacy|1|||
146028296|NCT01519674|526616100|FG000|Overall Study|Protocol Violation|0|||
146028297|NCT01519674|526616101|FG001|Overall Study|Protocol Violation|3|||
146028298|NCT01519674|526616102|FG002|Overall Study|Protocol Violation|1|||
146028299|NCT01519674|526616100|FG000|Overall Study|Withdrawal Criteria|7|||
146028300|NCT01519674|526616101|FG001|Overall Study|Withdrawal Criteria|2|||
146028301|NCT01519674|526616102|FG002|Overall Study|Withdrawal Criteria|7|||
146028302|NCT01519674|526616100|FG000|Overall Study|Unsclassified|10|||
146028303|NCT01519674|526616101|FG001|Overall Study|Unsclassified|4|||
146028304|NCT01519674|526616102|FG002|Overall Study|Unsclassified|3|||
146028305|NCT00799591|526616105|FG000|Overall Study|De-escalation of doses|20|||
146028306|NCT00799591|526616105|FG000|Overall Study|Death|14|||
146028307|NCT00799591|526616105|FG000|Overall Study|Technical failure|12|||
146028308|NCT00799591|526616105|FG000|Overall Study|Resistant germ|11|||
146028309|NCT00799591|526616105|FG000|Overall Study|New infection|4|||
146028310|NCT00799591|526616105|FG000|Overall Study|Resistance germ and technical failure|2|||
146028311|NCT00799591|526616105|FG000|Overall Study|Persistance of fever undetermined origin|1|||
146028312|NCT00799591|526616105|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
146028313|NCT00799591|526616105|FG000|Overall Study|Infectious origin not probable|1|||
146028314|NCT03276052|526616106|FG000|Overall Study|Withdrawal by Subject|5|||
146028315|NCT03276052|526616106|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
146028316|NCT01994863|526616107|FG000|Period 1|Adverse Event|4|||
146028317|NCT01994863|526616108|FG001|Period 1|Adverse Event|0|||
146028318|NCT01994863|526616107|FG000|Period 1|Withdrawal by Subject|1|||
146028319|NCT01994863|526616108|FG001|Period 1|Withdrawal by Subject|0|||
146028320|NCT01994863|526616107|FG000|Period 1|Trial stopped by sponsor|1|||
146028321|NCT01994863|526616108|FG001|Period 1|Trial stopped by sponsor|3|||
146028322|NCT01994863|526616107|FG000|Period 1|Lack of Efficacy|1|||
146028323|NCT01994863|526616108|FG001|Period 1|Lack of Efficacy|0|||
146028324|NCT01994863|526616107|FG000|Period 2|Adverse Event|0|||
146028325|NCT01994863|526616108|FG001|Period 2|Adverse Event|1|||
146028326|NCT01994863|526616107|FG000|Period 2|Lack of Efficacy|0|||
146028327|NCT01994863|526616108|FG001|Period 2|Lack of Efficacy|2|||
146028328|NCT01994863|526616107|FG000|Period 2|Withdrawal by Subject|1|||
146028329|NCT01994863|526616108|FG001|Period 2|Withdrawal by Subject|1|||
146028330|NCT03784846|526616109|FG000|Pre-COVID Study|Lost to Follow-up|3|||
146028331|NCT03784846|526616110|FG001|Pre-COVID Study|Lost to Follow-up|3|||
146028332|NCT03784846|526616111|FG002|Pre-COVID Study|Lost to Follow-up|2|||
146028333|NCT03784846|526616109|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
146028334|NCT03784846|526616110|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
146028335|NCT03784846|526616111|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
146028336|NCT03784846|526616109|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
146028337|NCT03784846|526616110|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
146028338|NCT03784846|526616111|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
146028339|NCT03784846|526616109|FG000|Post-COVID Study|Lost to Follow-up|3|||
146028340|NCT03784846|526616110|FG001|Post-COVID Study|Lost to Follow-up|5|||
146028341|NCT03784846|526616111|FG002|Post-COVID Study|Lost to Follow-up|1|||
146028342|NCT03784846|526616109|FG000|Post-COVID Study|Withdrawal by Subject|1|||
146028343|NCT03784846|526616110|FG001|Post-COVID Study|Withdrawal by Subject|2|||
146028344|NCT03784846|526616111|FG002|Post-COVID Study|Withdrawal by Subject|0|||
146028345|NCT02046174|526616116|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
146028346|NCT02046174|526616117|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
146028347|NCT03294135|526616121|FG000|Overall Study|Serious Adverse Event|1|||
146028348|NCT03294135|526616122|FG001|Overall Study|Serious Adverse Event|0|||
146028349|NCT03294135|526616123|FG002|Overall Study|Serious Adverse Event|0|||
146028350|NCT03294135|526616121|FG000|Overall Study|Lost to Follow-up|1|||
146028351|NCT03294135|526616122|FG001|Overall Study|Lost to Follow-up|0|||
146028352|NCT03294135|526616123|FG002|Overall Study|Lost to Follow-up|1|||
146028353|NCT03294135|526616121|FG000|Overall Study|Withdrawal by Subject|0|||
146028354|NCT03294135|526616122|FG001|Overall Study|Withdrawal by Subject|0|||
146028355|NCT03294135|526616123|FG002|Overall Study|Withdrawal by Subject|1|||
146028356|NCT03294135|526616121|FG000|Overall Study|Other|2|||
146028357|NCT03294135|526616122|FG001|Overall Study|Other|0|||
146028358|NCT03294135|526616123|FG002|Overall Study|Other|0|||
146028359|NCT00186537|526616124|FG000|Overall Study|Withdrawal by Subject|4|||
146028360|NCT00186537|526616125|FG001|Overall Study|Withdrawal by Subject|0|||
146028361|NCT00186537|526616126|FG002|Overall Study|Withdrawal by Subject|3|||
146028362|NCT00186537|526616124|FG000|Overall Study|ALT > 1.5 x ULN|3|||
146028363|NCT00186537|526616125|FG001|Overall Study|ALT > 1.5 x ULN|0|||
146028364|NCT00186537|526616126|FG002|Overall Study|ALT > 1.5 x ULN|0|||
146028365|NCT02763254|526616127|FG000|Overall Study|Adverse Event|1|||
146028366|NCT01143051|526616131|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
146028367|NCT01143051|526616132|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
146028368|NCT01143051|526616133|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
146028369|NCT01143051|526616134|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
146028370|NCT01143051|526616135|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
146028371|NCT01143051|526616136|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
146028372|NCT01143051|526616131|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
146028373|NCT01143051|526616132|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
146028374|NCT01143051|526616133|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
146028375|NCT01143051|526616134|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
146028376|NCT01143051|526616135|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
146028377|NCT01143051|526616136|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
146028378|NCT02231762|526616139|FG000|Combination Phase|Adverse Event|10|||
146028379|NCT02231762|526616140|FG001|Combination Phase|Adverse Event|0|||
146028380|NCT02231762|526616141|FG002|Combination Phase|Adverse Event|0|||
146028381|NCT02231762|526616142|FG003|Combination Phase|Adverse Event|0|||
146028382|NCT02231762|526616139|FG000|Combination Phase|Withdrawal by Subject|2|||
146028383|NCT02231762|526616140|FG001|Combination Phase|Withdrawal by Subject|0|||
146028384|NCT02231762|526616141|FG002|Combination Phase|Withdrawal by Subject|0|||
146028385|NCT02231762|526616142|FG003|Combination Phase|Withdrawal by Subject|0|||
146028386|NCT02231762|526616139|FG000|Combination Phase|Disease Progression|6|||
146028387|NCT02231762|526616140|FG001|Combination Phase|Disease Progression|0|||
146028388|NCT02231762|526616141|FG002|Combination Phase|Disease Progression|0|||
146028389|NCT02231762|526616142|FG003|Combination Phase|Disease Progression|0|||
146028390|NCT02231762|526616139|FG000|Combination Phase|Did not meet inclusion criteria|1|||
146028391|NCT02231762|526616140|FG001|Combination Phase|Did not meet inclusion criteria|0|||
146028392|NCT02231762|526616141|FG002|Combination Phase|Did not meet inclusion criteria|0|||
146028393|NCT02231762|526616142|FG003|Combination Phase|Did not meet inclusion criteria|0|||
146028394|NCT02231762|526616139|FG000|Combination Phase|Protocol Violation|1|||
146028395|NCT02231762|526616140|FG001|Combination Phase|Protocol Violation|0|||
146028396|NCT02231762|526616141|FG002|Combination Phase|Protocol Violation|0|||
146028397|NCT02231762|526616142|FG003|Combination Phase|Protocol Violation|0|||
146028398|NCT02231762|526616139|FG000|Maintenance Phase|Disease progression|0|||
146028399|NCT02231762|526616140|FG001|Maintenance Phase|Disease progression|3|||
146028400|NCT02231762|526616141|FG002|Maintenance Phase|Disease progression|4|||
146028401|NCT02231762|526616142|FG003|Maintenance Phase|Disease progression|3|||
146028402|NCT02231762|526616139|FG000|Maintenance Phase|Adverse Event|0|||
146028403|NCT02231762|526616140|FG001|Maintenance Phase|Adverse Event|0|||
146028404|NCT02231762|526616141|FG002|Maintenance Phase|Adverse Event|1|||
146028405|NCT02231762|526616142|FG003|Maintenance Phase|Adverse Event|2|||
146028406|NCT01669421|526616145|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
146028407|NCT01669421|526616145|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
146028408|NCT01149486|526616146|FG000|First Intervention|Adverse Event|0|||
146095617|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
146095618|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
146095619|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
146095620|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
146095621|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
146095622|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
146028409|NCT01149486|526616147|FG001|First Intervention|Adverse Event|1|||
146028410|NCT02961790|526616152|FG000|Overall Study|Canceled|4|||
146028411|NCT02961790|526616153|FG001|Overall Study|Canceled|5|||
146028412|NCT02961790|526616154|FG002|Overall Study|Canceled|1|||
146028413|NCT02961790|526616155|FG003|Overall Study|Canceled|4|||
146028414|NCT02961790|526616152|FG000|Overall Study|without baseline data|4|||
146028415|NCT02961790|526616153|FG001|Overall Study|without baseline data|0|||
146028416|NCT02961790|526616154|FG002|Overall Study|without baseline data|1|||
146028417|NCT02961790|526616155|FG003|Overall Study|without baseline data|0|||
146028418|NCT02961790|526616152|FG000|Overall Study|without post baseline data|7|||
146028419|NCT02961790|526616153|FG001|Overall Study|without post baseline data|6|||
146028420|NCT02961790|526616154|FG002|Overall Study|without post baseline data|4|||
146028421|NCT02961790|526616155|FG003|Overall Study|without post baseline data|1|||
146028422|NCT01135914|526616158|FG000|Overall Study|Withdrawal by Subject|1|||
146028423|NCT01135914|526616159|FG001|Overall Study|Withdrawal by Subject|3|||
146028424|NCT01135914|526616160|FG002|Overall Study|Withdrawal by Subject|6|||
146028425|NCT01135914|526616158|FG000|Overall Study|Lost to Follow-up|1|||
146095623|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
146095624|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
146095625|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
146095626|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
146095627|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
146095628|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
146095629|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
146095630|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
146095631|NCT02607930|526872275|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146095632|NCT02607930|526872276|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146095633|NCT02607930|526872277|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
146095634|NCT02607930|526872278|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
146095635|NCT01050543|526872281|FG000|Overall Study|Withdrawal by Subject|0|||
146095636|NCT01050543|526872282|FG001|Overall Study|Withdrawal by Subject|2|||
146095637|NCT01050543|526872281|FG000|Overall Study|Protocol Violation|0|||
146095638|NCT01050543|526872282|FG001|Overall Study|Protocol Violation|1|||
146095639|NCT01050543|526872281|FG000|Overall Study|Administrative|4|||
146095640|NCT01050543|526872282|FG001|Overall Study|Administrative|1|||
146095641|NCT03053271|526872285|FG000|Overall Study|Did not meet randomization criteria|3|||
146095642|NCT03053271|526872285|FG000|Overall Study|Withdrawal by Subject|1|||
146095643|NCT00570765|526872286|FG000|DB Phase|Withdrawal by Subject|1|||
146095644|NCT00570765|526872287|FG001|DB Phase|Withdrawal by Subject|0|||
146095645|NCT00570765|526872288|FG002|DB Phase|Withdrawal by Subject|0|||
146095646|NCT00570765|526872289|FG003|DB Phase|Withdrawal by Subject|0|||
146095647|NCT00570765|526872286|FG000|DB Phase|Protocol Violation|0|||
146095648|NCT00570765|526872287|FG001|DB Phase|Protocol Violation|1|||
146095649|NCT00570765|526872288|FG002|DB Phase|Protocol Violation|0|||
146095650|NCT00570765|526872289|FG003|DB Phase|Protocol Violation|0|||
146095651|NCT00570765|526872286|FG000|DB Phase|Adverse Event|3|||
146095652|NCT00570765|526872287|FG001|DB Phase|Adverse Event|6|||
146095653|NCT00570765|526872288|FG002|DB Phase|Adverse Event|0|||
146095654|NCT00570765|526872289|FG003|DB Phase|Adverse Event|0|||
146095655|NCT00570765|526872286|FG000|DB Phase|Did Not Receive Study Drug|0|||
146095656|NCT00570765|526872287|FG001|DB Phase|Did Not Receive Study Drug|0|||
146095657|NCT00570765|526872288|FG002|DB Phase|Did Not Receive Study Drug|1|||
146095658|NCT00570765|526872289|FG003|DB Phase|Did Not Receive Study Drug|0|||
146095659|NCT00570765|526872286|FG000|LTSE Phase|Withdrawal by Subject|0|||
146095660|NCT00570765|526872287|FG001|LTSE Phase|Withdrawal by Subject|0|||
146095661|NCT00570765|526872288|FG002|LTSE Phase|Withdrawal by Subject|0|||
146095662|NCT00570765|526872289|FG003|LTSE Phase|Withdrawal by Subject|1|||
146095663|NCT00570765|526872286|FG000|LTSE Phase|Adverse Event|0|||
146095664|NCT00570765|526872287|FG001|LTSE Phase|Adverse Event|0|||
146095665|NCT00570765|526872288|FG002|LTSE Phase|Adverse Event|0|||
146095666|NCT00570765|526872289|FG003|LTSE Phase|Adverse Event|7|||
146095667|NCT00570765|526872286|FG000|LTSE Phase|Physician Decision|0|||
146095668|NCT00570765|526872287|FG001|LTSE Phase|Physician Decision|0|||
146095669|NCT00570765|526872288|FG002|LTSE Phase|Physician Decision|0|||
146095670|NCT00570765|526872289|FG003|LTSE Phase|Physician Decision|4|||
146095671|NCT02517866|526872290|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146095672|NCT02517866|526872291|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146095673|NCT02517866|526872292|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146095674|NCT02517866|526872290|FG000|Overall Study|Significant Protocol Deviation|4|||
146095675|NCT02517866|526872291|FG001|Overall Study|Significant Protocol Deviation|1|||
146095676|NCT02517866|526872292|FG002|Overall Study|Significant Protocol Deviation|0|||
146095677|NCT02517866|526872290|FG000|Overall Study|Lost to Follow-up|1|||
146095678|NCT02517866|526872291|FG001|Overall Study|Lost to Follow-up|0|||
146095679|NCT02517866|526872292|FG002|Overall Study|Lost to Follow-up|0|||
146095680|NCT02517866|526872290|FG000|Overall Study|Voluntary Withdrawal|2|||
146095681|NCT02517866|526872291|FG001|Overall Study|Voluntary Withdrawal|2|||
146095682|NCT02517866|526872292|FG002|Overall Study|Voluntary Withdrawal|0|||
146095683|NCT02517866|526872290|FG000|Overall Study|Investigator Decision|2|||
146095684|NCT02517866|526872291|FG001|Overall Study|Investigator Decision|1|||
146095685|NCT02517866|526872292|FG002|Overall Study|Investigator Decision|0|||
146095686|NCT02517866|526872290|FG000|Overall Study|Reason not specified|2|||
146095687|NCT02517866|526872291|FG001|Overall Study|Reason not specified|0|||
146095688|NCT02517866|526872292|FG002|Overall Study|Reason not specified|0|||
146095689|NCT03114488|526872294|FG000|Time Period 2|Withdrawal by Subject|1|||
146254156|NCT03303521|527443055|FG001|Overall Study|Kidney transplantation|1|||
146095690|NCT03114488|526872295|FG001|Time Period 2|Withdrawal by Subject|3|||
146095691|NCT03711266|526872297|FG000|Overall Study|Lost to Follow-up|10|||
146095692|NCT01954342|526872300|FG000|Overall Study|Missing data from 13-16week study visit|0|||
146095693|NCT01954342|526872301|FG001|Overall Study|Missing data from 13-16week study visit|0|||
146095694|NCT01954342|526872302|FG002|Overall Study|Missing data from 13-16week study visit|0|||
146095695|NCT01954342|526872303|FG003|Overall Study|Missing data from 13-16week study visit|1|||
146095696|NCT01954342|526872300|FG000|Overall Study|Miscarriage|0|||
146095697|NCT01954342|526872301|FG001|Overall Study|Miscarriage|0|||
146095698|NCT01954342|526872302|FG002|Overall Study|Miscarriage|0|||
146095699|NCT01954342|526872303|FG003|Overall Study|Miscarriage|3|||
146095700|NCT01954342|526872300|FG000|Overall Study|Lost to Follow-up|0|||
146095701|NCT01954342|526872301|FG001|Overall Study|Lost to Follow-up|0|||
146095702|NCT01954342|526872302|FG002|Overall Study|Lost to Follow-up|0|||
146095703|NCT01954342|526872303|FG003|Overall Study|Lost to Follow-up|5|||
146095704|NCT01954342|526872300|FG000|Overall Study|Preterm delivery|0|||
146095705|NCT01954342|526872301|FG001|Overall Study|Preterm delivery|0|||
146095706|NCT01954342|526872302|FG002|Overall Study|Preterm delivery|0|||
146095707|NCT01954342|526872303|FG003|Overall Study|Preterm delivery|3|||
146095708|NCT01954342|526872300|FG000|Overall Study|Pre-eclampsia|0|||
146095709|NCT01954342|526872301|FG001|Overall Study|Pre-eclampsia|0|||
146095710|NCT01954342|526872302|FG002|Overall Study|Pre-eclampsia|0|||
146095711|NCT01954342|526872303|FG003|Overall Study|Pre-eclampsia|4|||
146095712|NCT01954342|526872300|FG000|Overall Study|Unreliable Data|0|||
146095713|NCT01954342|526872301|FG001|Overall Study|Unreliable Data|0|||
146095714|NCT01954342|526872302|FG002|Overall Study|Unreliable Data|0|||
146095715|NCT01954342|526872303|FG003|Overall Study|Unreliable Data|2|||
146095716|NCT01646073|526872304|FG000|Period A (12 Weeks)|Adverse Event|0|||
146095717|NCT01646073|526872305|FG001|Period A (12 Weeks)|Adverse Event|2|||
146095718|NCT01646073|526872304|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
146095719|NCT01646073|526872305|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
146095720|NCT01646073|526872304|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
146095721|NCT01646073|526872305|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
146095722|NCT01646073|526872304|FG000|Period A (12 Weeks)|Protocol Violation|0|||
146095723|NCT01646073|526872305|FG001|Period A (12 Weeks)|Protocol Violation|1|||
146095724|NCT01646073|526872304|FG000|Period A (12 Weeks)|Other|0|||
146095725|NCT01646073|526872305|FG001|Period A (12 Weeks)|Other|1|||
146095726|NCT01646073|526872304|FG000|Period B (12 Weeks)|Adverse Event|0|||
146095727|NCT01646073|526872305|FG001|Period B (12 Weeks)|Adverse Event|7|||
146095728|NCT01646073|526872304|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
146095729|NCT01646073|526872305|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
146095730|NCT01646073|526872304|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
146095731|NCT01646073|526872305|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
146095732|NCT05095454|526872308|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
146095733|NCT05095454|526872309|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
146095734|NCT00057876|526872310|FG000|Overall Study|Adverse Event|8|||
146095735|NCT00057876|526872311|FG001|Overall Study|Adverse Event|8|||
146095736|NCT00057876|526872310|FG000|Overall Study|Death|2|||
146095737|NCT00057876|526872311|FG001|Overall Study|Death|1|||
146095738|NCT00057876|526872310|FG000|Overall Study|Withdrawal by Subject|5|||
146095739|NCT00057876|526872311|FG001|Overall Study|Withdrawal by Subject|6|||
146095740|NCT00057876|526872310|FG000|Overall Study|Lack of Efficacy|10|||
146095741|NCT00057876|526872311|FG001|Overall Study|Lack of Efficacy|8|||
146095742|NCT00057876|526872310|FG000|Overall Study|Ineligible|1|||
146095743|NCT00057876|526872311|FG001|Overall Study|Ineligible|2|||
146095744|NCT00057876|526872310|FG000|Overall Study|other reason|2|||
146095745|NCT00057876|526872311|FG001|Overall Study|other reason|2|||
146095746|NCT00057876|526872310|FG000|Overall Study|other complicating disease|1|||
146095747|NCT00057876|526872311|FG001|Overall Study|other complicating disease|0|||
146095748|NCT00679055|526872312|FG000|Overall Study|Adverse Event|0|||
146095749|NCT00679055|526872313|FG001|Overall Study|Adverse Event|1|||
146095750|NCT00679055|526872312|FG000|Overall Study|Other|0|||
146095751|NCT00679055|526872313|FG001|Overall Study|Other|3|||
146095752|NCT00679055|526872312|FG000|Overall Study|Study Terminated|2|||
146095753|NCT00679055|526872313|FG001|Overall Study|Study Terminated|1|||
146095754|NCT02758171|526872314|FG000|Wash-out|Withdrawal by Subject|1|||
146095755|NCT02758171|526872315|FG001|Wash-out|Withdrawal by Subject|0|||
146095756|NCT02758171|526872314|FG000|Wash-out|Other reason|1|||
146254157|NCT03303521|527443054|FG000|Overall Study|Investigational product discontinuation|0|||
146254158|NCT03303521|527443055|FG001|Overall Study|Investigational product discontinuation|1|||
146254159|NCT03303521|527443054|FG000|Overall Study|Transferred to non-study dialysis center|1|||
146254160|NCT03303521|527443055|FG001|Overall Study|Transferred to non-study dialysis center|0|||
146254161|NCT03303521|527443054|FG000|Overall Study|Non-comliance to study protocol|0|||
146254162|NCT03303521|527443055|FG001|Overall Study|Non-comliance to study protocol|1|||
146254163|NCT03303521|527443054|FG000|Overall Study|Adverse Event|1|||
146095757|NCT02758171|526872315|FG001|Wash-out|Other reason|0|||
146095758|NCT00853073|526872316|FG000|Overall Study|Withdrawal by Subject|3|||
146095759|NCT00853073|526872317|FG001|Overall Study|Withdrawal by Subject|2|||
146095760|NCT01999114|526872318|FG000|Overall Study|Adverse Event|8|||
146095761|NCT01999114|526872319|FG001|Overall Study|Adverse Event|7|||
146095762|NCT01999114|526872320|FG002|Overall Study|Adverse Event|2|||
146095763|NCT01999114|526872321|FG003|Overall Study|Adverse Event|2|||
146095764|NCT01999114|526872322|FG004|Overall Study|Adverse Event|1|||
146095765|NCT01999114|526872318|FG000|Overall Study|Withdrawal by Subject|0|||
146095766|NCT01999114|526872319|FG001|Overall Study|Withdrawal by Subject|0|||
146095767|NCT01999114|526872320|FG002|Overall Study|Withdrawal by Subject|1|||
146095768|NCT01999114|526872321|FG003|Overall Study|Withdrawal by Subject|0|||
146300320|NCT00698932|527615216|FG000|Overall Study|Safety reasons|0|||
146300321|NCT00698932|527615217|FG001|Overall Study|Safety reasons|2|||
146300322|NCT00698932|527615216|FG000|Overall Study|Death|1|||
146300323|NCT00698932|527615217|FG001|Overall Study|Death|0|||
146300324|NCT00757003|527615218|FG000|Overall Study|Death|33|||
146028426|NCT01135914|526616159|FG001|Overall Study|Lost to Follow-up|0|||
146028427|NCT01135914|526616160|FG002|Overall Study|Lost to Follow-up|1|||
146028428|NCT01135914|526616158|FG000|Overall Study|Protocol Violation|0|||
146028429|NCT01135914|526616159|FG001|Overall Study|Protocol Violation|0|||
146028430|NCT01135914|526616160|FG002|Overall Study|Protocol Violation|3|||
146028431|NCT01135914|526616158|FG000|Overall Study|Lack of Efficacy|2|||
146028432|NCT01135914|526616159|FG001|Overall Study|Lack of Efficacy|1|||
146028433|NCT01135914|526616160|FG002|Overall Study|Lack of Efficacy|10|||
146028434|NCT01135914|526616158|FG000|Overall Study|Adverse Event|0|||
146028435|NCT01135914|526616159|FG001|Overall Study|Adverse Event|1|||
146028436|NCT01135914|526616160|FG002|Overall Study|Adverse Event|2|||
146028437|NCT02594098|526616161|FG000|Overall Study|Lack of Efficacy|17|||
146028438|NCT02594098|526616162|FG001|Overall Study|Lack of Efficacy|6|||
146028439|NCT02594098|526616161|FG000|Overall Study|Withdrawal by Subject|1|||
146028440|NCT02594098|526616162|FG001|Overall Study|Withdrawal by Subject|3|||
146028441|NCT02594098|526616161|FG000|Overall Study|Terminated participation|6|||
146028442|NCT02594098|526616162|FG001|Overall Study|Terminated participation|2|||
146028443|NCT02594098|526616161|FG000|Overall Study|Seek alternative treatment|2|||
146028444|NCT02594098|526616162|FG001|Overall Study|Seek alternative treatment|1|||
146028445|NCT02594098|526616161|FG000|Overall Study|Other|0|||
146028446|NCT02594098|526616162|FG001|Overall Study|Other|1|||
146028447|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
146028448|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
146028449|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
146028450|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
146028451|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
146028452|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
146028453|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
146028454|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
146028455|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
146028456|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
146028457|NCT03906656|526616166|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
146028458|NCT03906656|526616167|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
146028459|NCT03906656|526616166|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
146028460|NCT03906656|526616167|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
146028461|NCT03906656|526616166|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
146028462|NCT03906656|526616167|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
146028463|NCT03906656|526616166|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
146028464|NCT03906656|526616167|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
146028465|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
146028466|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
146028467|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
146028468|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
146028469|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
146028470|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
146028471|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
146028472|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
146028473|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
146028474|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
146028475|NCT03906656|526616166|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
146028476|NCT03906656|526616167|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
146028477|NCT03906656|526616166|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
146028478|NCT03906656|526616167|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
146028479|NCT03906656|526616166|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
146028480|NCT03906656|526616167|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
146028481|NCT03906656|526616166|FG000|Home Use 2 (3 Months)|Death|2|||
146028482|NCT03906656|526616167|FG001|Home Use 2 (3 Months)|Death|0|||
146028483|NCT03906656|526616166|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
146028484|NCT03906656|526616167|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
146028485|NCT03906656|526616166|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
146028486|NCT03906656|526616167|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
146028487|NCT01036529|526616168|FG000|Overall Study|Adverse Event|0|||
146028488|NCT01036529|526616169|FG001|Overall Study|Adverse Event|1|||
146028489|NCT01036529|526616168|FG000|Overall Study|Lost to Follow-up|0|||
146028490|NCT01036529|526616169|FG001|Overall Study|Lost to Follow-up|1|||
146028491|NCT01036529|526616168|FG000|Overall Study|Physician Decision|1|||
146300325|NCT00757003|527615218|FG000|Overall Study|Lost to Follow-up|9|||
146300326|NCT00757003|527615218|FG000|Overall Study|Withdrawal by Subject|4|||
146028492|NCT01036529|526616169|FG001|Overall Study|Physician Decision|0|||
146028493|NCT01036529|526616168|FG000|Overall Study|Withdrawal by Subject|1|||
146028494|NCT01036529|526616169|FG001|Overall Study|Withdrawal by Subject|1|||
146028495|NCT01036529|526616168|FG000|Overall Study|Sponsor study termination|11|||
146028496|NCT01036529|526616169|FG001|Overall Study|Sponsor study termination|12|||
146028497|NCT00693472|526616170|FG000|Part 1|Adverse Event|1|||
146028498|NCT00693472|526616171|FG001|Part 1|Adverse Event|1|||
146028499|NCT00693472|526616172|FG002|Part 1|Adverse Event|0|||
146028500|NCT00693472|526616173|FG003|Part 1|Adverse Event|0|||
146028501|NCT00693472|526616170|FG000|Part 1|Lost to Follow-up|0|||
146028502|NCT00693472|526616171|FG001|Part 1|Lost to Follow-up|1|||
146028503|NCT00693472|526616172|FG002|Part 1|Lost to Follow-up|0|||
146028504|NCT00693472|526616173|FG003|Part 1|Lost to Follow-up|0|||
146028505|NCT00693472|526616170|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
146028506|NCT00693472|526616171|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
146028507|NCT00693472|526616172|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
146028508|NCT00693472|526616173|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
146028509|NCT00693472|526616170|FG000|Part 2|Adverse Event|0|||
146028510|NCT00693472|526616171|FG001|Part 2|Adverse Event|0|||
146028511|NCT00693472|526616172|FG002|Part 2|Adverse Event|1|||
146028512|NCT00693472|526616173|FG003|Part 2|Adverse Event|0|||
146028513|NCT00693472|526616170|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
146028514|NCT00693472|526616171|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
146028515|NCT00693472|526616172|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
146028516|NCT00693472|526616173|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
146028517|NCT03412604|526616174|FG000|Overall Study|Withdrawal by Subject|1|||
146028518|NCT00993499|526616181|FG000|Run-in Period (8 Days)|Adverse Event|0|||
146028519|NCT00993499|526616182|FG001|Run-in Period (8 Days)|Adverse Event|1|||
146028520|NCT00993499|526616183|FG002|Run-in Period (8 Days)|Adverse Event|0|||
146028521|NCT00993499|526616184|FG003|Run-in Period (8 Days)|Adverse Event|0|||
146028522|NCT00993499|526616185|FG004|Run-in Period (8 Days)|Adverse Event|0|||
146028523|NCT00993499|526616186|FG005|Run-in Period (8 Days)|Adverse Event|0|||
146028524|NCT00993499|526616181|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
146028525|NCT00993499|526616182|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146028526|NCT00993499|526616183|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146028527|NCT00993499|526616184|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146028528|NCT00993499|526616185|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146028529|NCT00993499|526616186|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
146028530|NCT00993499|526616181|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
146028531|NCT00993499|526616182|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
146028532|NCT00993499|526616183|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
146028533|NCT00993499|526616184|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
146028534|NCT00993499|526616185|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
146028535|NCT00993499|526616186|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
146028536|NCT00993499|526616181|FG000|Run-in Period (8 Days)|Progressive disease|0|||
146028537|NCT00993499|526616182|FG001|Run-in Period (8 Days)|Progressive disease|1|||
146028538|NCT00993499|526616183|FG002|Run-in Period (8 Days)|Progressive disease|1|||
146028539|NCT00993499|526616184|FG003|Run-in Period (8 Days)|Progressive disease|0|||
146028540|NCT00993499|526616185|FG004|Run-in Period (8 Days)|Progressive disease|0|||
146028541|NCT00993499|526616186|FG005|Run-in Period (8 Days)|Progressive disease|0|||
146028542|NCT00993499|526616181|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
146028543|NCT00993499|526616182|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
146028544|NCT00993499|526616183|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
146028545|NCT00993499|526616184|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
146028546|NCT00993499|526616185|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
146028547|NCT00993499|526616186|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
146028548|NCT00993499|526616181|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
146028549|NCT00993499|526616182|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
146028550|NCT00993499|526616183|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146028551|NCT00993499|526616184|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146028552|NCT00993499|526616185|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146028553|NCT00993499|526616186|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
146028554|NCT00993499|526616181|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146028555|NCT00993499|526616182|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146028556|NCT00993499|526616183|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
146028557|NCT00993499|526616184|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
146028558|NCT00993499|526616185|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146028559|NCT00993499|526616186|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
146028560|NCT00993499|526616181|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146028561|NCT00993499|526616182|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146028562|NCT00993499|526616183|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
146028563|NCT00993499|526616184|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146028564|NCT00993499|526616185|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146028565|NCT00993499|526616186|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
146028566|NCT00993499|526616181|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146028567|NCT00993499|526616182|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
146028568|NCT00993499|526616183|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146028569|NCT00993499|526616184|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146028570|NCT00993499|526616185|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146028571|NCT00993499|526616186|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
146028572|NCT00993499|526616181|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
146028573|NCT00993499|526616182|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
146028574|NCT00993499|526616183|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
146028575|NCT00993499|526616184|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
146028576|NCT00993499|526616185|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
146028577|NCT00993499|526616186|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
146028578|NCT00993499|526616181|FG000|Discontinued After Starting Course 3|DLT|1|||
146028579|NCT00993499|526616182|FG001|Discontinued After Starting Course 3|DLT|0|||
146028580|NCT00993499|526616183|FG002|Discontinued After Starting Course 3|DLT|2|||
146028581|NCT00993499|526616184|FG003|Discontinued After Starting Course 3|DLT|1|||
146028582|NCT00993499|526616185|FG004|Discontinued After Starting Course 3|DLT|0|||
146028583|NCT00993499|526616186|FG005|Discontinued After Starting Course 3|DLT|0|||
146028584|NCT00993499|526616181|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
146028585|NCT00993499|526616182|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
146028586|NCT00993499|526616183|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
146028587|NCT00993499|526616184|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
146028588|NCT00993499|526616185|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
146028589|NCT00993499|526616186|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
146028590|NCT01945775|526616187|FG000|Overall Study|Death|214|||
146028591|NCT01945775|526616188|FG001|Overall Study|Death|98|||
146028592|NCT01945775|526616187|FG000|Overall Study|Lost to Follow-up|12|||
146028593|NCT01945775|526616188|FG001|Overall Study|Lost to Follow-up|7|||
146028594|NCT01945775|526616187|FG000|Overall Study|Withdrawal by Subject|11|||
146028595|NCT01945775|526616188|FG001|Overall Study|Withdrawal by Subject|21|||
146028596|NCT01945775|526616187|FG000|Overall Study|Other|50|||
146028597|NCT01945775|526616188|FG001|Overall Study|Other|18|||
146028598|NCT02876328|526616189|FG000|Overall Study|Death|2|||
146028599|NCT02876328|526616190|FG001|Overall Study|Death|1|||
146028600|NCT02876328|526616191|FG002|Overall Study|Death|3|||
146028601|NCT02876328|526616192|FG003|Overall Study|Death|0|||
146028602|NCT02876328|526616193|FG004|Overall Study|Death|0|||
146028603|NCT02876328|526616194|FG005|Overall Study|Death|0|||
146028604|NCT02876328|526616195|FG006|Overall Study|Death|1|||
146028605|NCT02876328|526616196|FG007|Overall Study|Death|3|||
146028606|NCT02876328|526616197|FG008|Overall Study|Death|0|||
146028607|NCT02876328|526616198|FG009|Overall Study|Death|1|||
146028608|NCT02876328|526616199|FG010|Overall Study|Death|1|||
146028609|NCT02876328|526616200|FG011|Overall Study|Death|0|||
146028610|NCT02876328|526616201|FG012|Overall Study|Death|0|||
146028611|NCT02876328|526616202|FG013|Overall Study|Death|0|||
146028612|NCT02876328|526616203|FG014|Overall Study|Death|0|||
146028613|NCT02876328|526616204|FG015|Overall Study|Death|0|||
146028614|NCT02876328|526616205|FG016|Overall Study|Death|1|||
146028615|NCT02876328|526616206|FG017|Overall Study|Death|1|||
146300327|NCT00757003|527615218|FG000|Overall Study|Surgically explanted|2|||
146028616|NCT02876328|526616207|FG018|Overall Study|Death|0|||
146028617|NCT02876328|526616208|FG019|Overall Study|Death|0|||
146028618|NCT02876328|526616209|FG020|Overall Study|Death|0|||
146028619|NCT02876328|526616210|FG021|Overall Study|Death|1|||
146028620|NCT02876328|526616211|FG022|Overall Study|Death|0|||
146028621|NCT02876328|526616212|FG023|Overall Study|Death|0|||
146028622|NCT02876328|526616189|FG000|Overall Study|Withdrawal by Subject|0|||
146028623|NCT02876328|526616190|FG001|Overall Study|Withdrawal by Subject|2|||
146028624|NCT02876328|526616191|FG002|Overall Study|Withdrawal by Subject|3|||
146028625|NCT02876328|526616192|FG003|Overall Study|Withdrawal by Subject|3|||
146028626|NCT02876328|526616193|FG004|Overall Study|Withdrawal by Subject|0|||
146028627|NCT02876328|526616194|FG005|Overall Study|Withdrawal by Subject|1|||
146028628|NCT02876328|526616195|FG006|Overall Study|Withdrawal by Subject|0|||
146028629|NCT02876328|526616196|FG007|Overall Study|Withdrawal by Subject|1|||
146028630|NCT02876328|526616197|FG008|Overall Study|Withdrawal by Subject|1|||
146028631|NCT02876328|526616198|FG009|Overall Study|Withdrawal by Subject|2|||
146028632|NCT02876328|526616199|FG010|Overall Study|Withdrawal by Subject|0|||
146028633|NCT02876328|526616200|FG011|Overall Study|Withdrawal by Subject|0|||
146028634|NCT02876328|526616201|FG012|Overall Study|Withdrawal by Subject|0|||
146028635|NCT02876328|526616202|FG013|Overall Study|Withdrawal by Subject|0|||
146095769|NCT01999114|526872322|FG004|Overall Study|Withdrawal by Subject|1|||
146095770|NCT01999114|526872318|FG000|Overall Study|Lost to Follow-up|0|||
146028636|NCT02876328|526616203|FG014|Overall Study|Withdrawal by Subject|0|||
146028637|NCT02876328|526616204|FG015|Overall Study|Withdrawal by Subject|0|||
146028638|NCT02876328|526616205|FG016|Overall Study|Withdrawal by Subject|1|||
146028639|NCT02876328|526616206|FG017|Overall Study|Withdrawal by Subject|3|||
146028640|NCT02876328|526616207|FG018|Overall Study|Withdrawal by Subject|0|||
146028641|NCT02876328|526616208|FG019|Overall Study|Withdrawal by Subject|0|||
146028642|NCT02876328|526616209|FG020|Overall Study|Withdrawal by Subject|1|||
146028643|NCT02876328|526616210|FG021|Overall Study|Withdrawal by Subject|0|||
146028644|NCT02876328|526616211|FG022|Overall Study|Withdrawal by Subject|0|||
146028645|NCT02876328|526616212|FG023|Overall Study|Withdrawal by Subject|0|||
146028646|NCT02876328|526616189|FG000|Overall Study|Missed 12 Month Visit|15|||
146028647|NCT02876328|526616190|FG001|Overall Study|Missed 12 Month Visit|10|||
146028648|NCT02876328|526616191|FG002|Overall Study|Missed 12 Month Visit|11|||
146028649|NCT02876328|526616192|FG003|Overall Study|Missed 12 Month Visit|6|||
146028650|NCT02876328|526616193|FG004|Overall Study|Missed 12 Month Visit|10|||
146028651|NCT02876328|526616194|FG005|Overall Study|Missed 12 Month Visit|14|||
146028652|NCT02876328|526616195|FG006|Overall Study|Missed 12 Month Visit|3|||
146028653|NCT02876328|526616196|FG007|Overall Study|Missed 12 Month Visit|8|||
146028654|NCT02876328|526616197|FG008|Overall Study|Missed 12 Month Visit|9|||
146028655|NCT02876328|526616198|FG009|Overall Study|Missed 12 Month Visit|5|||
146028656|NCT02876328|526616199|FG010|Overall Study|Missed 12 Month Visit|4|||
146028657|NCT02876328|526616200|FG011|Overall Study|Missed 12 Month Visit|1|||
146028658|NCT02876328|526616201|FG012|Overall Study|Missed 12 Month Visit|5|||
146028659|NCT02876328|526616202|FG013|Overall Study|Missed 12 Month Visit|4|||
146028660|NCT02876328|526616203|FG014|Overall Study|Missed 12 Month Visit|4|||
146028661|NCT02876328|526616204|FG015|Overall Study|Missed 12 Month Visit|4|||
146028662|NCT02876328|526616205|FG016|Overall Study|Missed 12 Month Visit|3|||
146028663|NCT02876328|526616206|FG017|Overall Study|Missed 12 Month Visit|6|||
146028664|NCT02876328|526616207|FG018|Overall Study|Missed 12 Month Visit|2|||
146028665|NCT02876328|526616208|FG019|Overall Study|Missed 12 Month Visit|2|||
146028666|NCT02876328|526616209|FG020|Overall Study|Missed 12 Month Visit|11|||
146028667|NCT02876328|526616210|FG021|Overall Study|Missed 12 Month Visit|7|||
146028668|NCT02876328|526616211|FG022|Overall Study|Missed 12 Month Visit|1|||
146028669|NCT02876328|526616212|FG023|Overall Study|Missed 12 Month Visit|0|||
146028670|NCT03464422|526616216|FG000|Overall Study|Lost to Follow-up|2|||
146028671|NCT03464422|526616216|FG000|Overall Study|Withdrawal by Subject|2|||
146028672|NCT00844805|526616220|FG000|Treatment Phase|Adverse Event|5|||
146028673|NCT00844805|526616221|FG001|Treatment Phase|Adverse Event|1|||
146028674|NCT00844805|526616222|FG002|Treatment Phase|Adverse Event|0|||
146028675|NCT00844805|526616223|FG003|Treatment Phase|Adverse Event|0|||
146028676|NCT00844805|526616220|FG000|Treatment Phase|Withdrawal by Subject|3|||
146028677|NCT00844805|526616221|FG001|Treatment Phase|Withdrawal by Subject|4|||
146028678|NCT00844805|526616222|FG002|Treatment Phase|Withdrawal by Subject|0|||
146095771|NCT01999114|526872319|FG001|Overall Study|Lost to Follow-up|0|||
146095772|NCT01999114|526872320|FG002|Overall Study|Lost to Follow-up|1|||
146095773|NCT01999114|526872321|FG003|Overall Study|Lost to Follow-up|0|||
146095774|NCT01999114|526872322|FG004|Overall Study|Lost to Follow-up|0|||
146095775|NCT01999114|526872318|FG000|Overall Study|Administrative|0|||
146095776|NCT01999114|526872319|FG001|Overall Study|Administrative|0|||
146095777|NCT01999114|526872320|FG002|Overall Study|Administrative|1|||
146095778|NCT01999114|526872321|FG003|Overall Study|Administrative|1|||
146095779|NCT01999114|526872322|FG004|Overall Study|Administrative|2|||
146095780|NCT01199731|526872325|FG000|Overall Study|Adverse Event|0|||
146095781|NCT01199731|526872326|FG001|Overall Study|Adverse Event|1|||
146095782|NCT01199731|526872327|FG002|Overall Study|Adverse Event|0|||
146254164|NCT03303521|527443055|FG001|Overall Study|Adverse Event|0|||
146254165|NCT01654289|527443056|FG000|Overall Study|Withdrawal by Subject|10|||
146254166|NCT01654289|527443057|FG001|Overall Study|Withdrawal by Subject|8|||
146254167|NCT01654289|527443058|FG002|Overall Study|Withdrawal by Subject|5|||
146254168|NCT01654289|527443056|FG000|Overall Study|Withdrew from intervention only|17|||
146028679|NCT00844805|526616223|FG003|Treatment Phase|Withdrawal by Subject|0|||
146028680|NCT00844805|526616220|FG000|Treatment Phase|Noncompliance With Protocol|1|||
146028681|NCT00844805|526616221|FG001|Treatment Phase|Noncompliance With Protocol|0|||
146028682|NCT00844805|526616222|FG002|Treatment Phase|Noncompliance With Protocol|0|||
146028683|NCT00844805|526616223|FG003|Treatment Phase|Noncompliance With Protocol|0|||
146028684|NCT00844805|526616220|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
146028685|NCT00844805|526616221|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
146028686|NCT00844805|526616222|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
146028687|NCT00844805|526616223|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
146028688|NCT00844805|526616220|FG000|Follow-Up Phase|Adverse Event|0|||
146095783|NCT01199731|526872325|FG000|Overall Study|Study closed/terminated|7|||
146095784|NCT01199731|526872326|FG001|Overall Study|Study closed/terminated|9|||
146095785|NCT01199731|526872327|FG002|Overall Study|Study closed/terminated|7|||
146254169|NCT01654289|527443057|FG001|Overall Study|Withdrew from intervention only|20|||
146028689|NCT00844805|526616221|FG001|Follow-Up Phase|Adverse Event|0|||
146028690|NCT00844805|526616222|FG002|Follow-Up Phase|Adverse Event|1|||
146028691|NCT00844805|526616223|FG003|Follow-Up Phase|Adverse Event|0|||
146028692|NCT00844805|526616220|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
146028693|NCT00844805|526616221|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146028694|NCT00844805|526616222|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
146028695|NCT00844805|526616223|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
146028696|NCT00844805|526616220|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
146028697|NCT00844805|526616221|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
146028698|NCT00844805|526616222|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
146028699|NCT00844805|526616223|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
146028700|NCT00844805|526616220|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
146028701|NCT00844805|526616221|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
146028702|NCT00844805|526616222|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
146028703|NCT00844805|526616223|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
146028704|NCT00844805|526616220|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146028705|NCT00844805|526616221|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146028706|NCT00844805|526616222|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
146028707|NCT00844805|526616223|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
146028708|NCT02726880|526616224|FG000|Overall Study|Withdrawal by Subject|2|||
146028709|NCT02726880|526616225|FG001|Overall Study|Withdrawal by Subject|0|||
146028710|NCT02726880|526616224|FG000|Overall Study|Lost to Follow-up|1|||
146028711|NCT02726880|526616225|FG001|Overall Study|Lost to Follow-up|3|||
146028712|NCT04316741|526616226|FG000|Baseline Enrollment|Lost to Follow-up|1|||
146028713|NCT04316741|526616227|FG001|Baseline Enrollment|Lost to Follow-up|1|||
146095786|NCT01199731|526872325|FG000|Overall Study|Lost to Follow-up|0|||
146095787|NCT01199731|526872326|FG001|Overall Study|Lost to Follow-up|0|||
146095788|NCT01199731|526872327|FG002|Overall Study|Lost to Follow-up|2|||
146095789|NCT01199731|526872325|FG000|Overall Study|Physician Decision|0|||
146095790|NCT01199731|526872326|FG001|Overall Study|Physician Decision|1|||
146095791|NCT01199731|526872327|FG002|Overall Study|Physician Decision|1|||
146095792|NCT01199731|526872325|FG000|Overall Study|Withdrawal by Subject|2|||
146095793|NCT01199731|526872326|FG001|Overall Study|Withdrawal by Subject|0|||
146095794|NCT01199731|526872327|FG002|Overall Study|Withdrawal by Subject|0|||
146095795|NCT00943124|526872328|FG000|Period 1|Withdrawal by Subject|1|||
146095796|NCT00943124|526872329|FG001|Period 1|Withdrawal by Subject|1|||
146095797|NCT00943124|526872328|FG000|Period 1|Did Not Follow Study Procedures|1|||
146095798|NCT00943124|526872329|FG001|Period 1|Did Not Follow Study Procedures|0|||
146095799|NCT00943124|526872328|FG000|Period 1|Personal Reasons|0|||
146095800|NCT00943124|526872329|FG001|Period 1|Personal Reasons|1|||
146095801|NCT02992132|526872330|FG000|Overall Study|Adverse Event|4|||
146095802|NCT02992132|526872331|FG001|Overall Study|Adverse Event|1|||
146095803|NCT02992132|526872332|FG002|Overall Study|Adverse Event|3|||
146095804|NCT02992132|526872330|FG000|Overall Study|Lack of Efficacy|2|||
146095805|NCT02992132|526872331|FG001|Overall Study|Lack of Efficacy|0|||
146095806|NCT02992132|526872332|FG002|Overall Study|Lack of Efficacy|0|||
146095807|NCT02992132|526872330|FG000|Overall Study|Non-compliance with study drug|2|||
146095808|NCT02992132|526872331|FG001|Overall Study|Non-compliance with study drug|0|||
146095809|NCT02992132|526872332|FG002|Overall Study|Non-compliance with study drug|0|||
146095810|NCT02992132|526872330|FG000|Overall Study|Progressive disease|1|||
146095811|NCT02992132|526872331|FG001|Overall Study|Progressive disease|0|||
146095812|NCT02992132|526872332|FG002|Overall Study|Progressive disease|0|||
146095813|NCT02992132|526872330|FG000|Overall Study|Protocol Violation|2|||
146095814|NCT02992132|526872331|FG001|Overall Study|Protocol Violation|2|||
146095815|NCT02992132|526872332|FG002|Overall Study|Protocol Violation|0|||
146254170|NCT01654289|527443058|FG002|Overall Study|Withdrew from intervention only|0|||
146254171|NCT01732627|527443059|FG000|Overall Study|Withdrawal by Subject|1|||
146254172|NCT01732627|527443060|FG001|Overall Study|Withdrawal by Subject|0|||
146028714|NCT04316741|526616226|FG000|Immediate Post-Test|Lost to Follow-up|5|||
146028715|NCT04316741|526616227|FG001|Immediate Post-Test|Lost to Follow-up|1|||
146028716|NCT04316741|526616226|FG000|1-month Post-test|Lost to Follow-up|7|||
146028717|NCT04316741|526616227|FG001|1-month Post-test|Lost to Follow-up|2|||
146028718|NCT04316741|526616226|FG000|3-month Follow-up|Lost to Follow-up|10|||
146028719|NCT04316741|526616227|FG001|3-month Follow-up|Lost to Follow-up|2|||
146028720|NCT00787202|526616228|FG000|Overall Study|Adverse Event|3|||
146028721|NCT00787202|526616229|FG001|Overall Study|Adverse Event|2|||
146028722|NCT00787202|526616230|FG002|Overall Study|Adverse Event|0|||
146028723|NCT00787202|526616231|FG003|Overall Study|Adverse Event|0|||
146028724|NCT00787202|526616232|FG004|Overall Study|Adverse Event|2|||
146028725|NCT00787202|526616228|FG000|Overall Study|Lack of Efficacy|5|||
146028726|NCT00787202|526616229|FG001|Overall Study|Lack of Efficacy|6|||
146095816|NCT02992132|526872330|FG000|Overall Study|Caregiver withdrew consent|2|||
146095817|NCT02992132|526872331|FG001|Overall Study|Caregiver withdrew consent|3|||
146095818|NCT02992132|526872332|FG002|Overall Study|Caregiver withdrew consent|2|||
146095819|NCT02992132|526872330|FG000|Overall Study|Withdrawal by Subject|0|||
146095820|NCT02992132|526872331|FG001|Overall Study|Withdrawal by Subject|2|||
146095821|NCT02992132|526872332|FG002|Overall Study|Withdrawal by Subject|1|||
146095822|NCT02992132|526872330|FG000|Overall Study|Physician Decision|0|||
146095823|NCT02992132|526872331|FG001|Overall Study|Physician Decision|0|||
146095824|NCT02992132|526872332|FG002|Overall Study|Physician Decision|1|||
146095825|NCT01104155|526872345|FG000|Overall Study|Adverse Event|15|||
146095826|NCT01104155|526872346|FG001|Overall Study|Adverse Event|8|||
146095827|NCT01104155|526872345|FG000|Overall Study|Participant choice|6|||
146095828|NCT01104155|526872346|FG001|Overall Study|Participant choice|5|||
146254173|NCT02137239|527443061|FG000|Overall Study|Discontinued Study Treatment|0|||
146254174|NCT02137239|527443062|FG001|Overall Study|Discontinued Study Treatment|3|||
146254175|NCT02137239|527443061|FG000|Overall Study|Withdrew Consent|1|||
146254176|NCT02137239|527443062|FG001|Overall Study|Withdrew Consent|1|||
146254177|NCT02137239|527443061|FG000|Overall Study|Adverse Event|2|||
146028727|NCT00787202|526616230|FG002|Overall Study|Lack of Efficacy|5|||
146028728|NCT00787202|526616231|FG003|Overall Study|Lack of Efficacy|2|||
146028729|NCT00787202|526616232|FG004|Overall Study|Lack of Efficacy|1|||
146028730|NCT00787202|526616228|FG000|Overall Study|Lost to Follow-up|1|||
146028731|NCT00787202|526616229|FG001|Overall Study|Lost to Follow-up|0|||
146028732|NCT00787202|526616230|FG002|Overall Study|Lost to Follow-up|0|||
146028733|NCT00787202|526616231|FG003|Overall Study|Lost to Follow-up|0|||
146028734|NCT00787202|526616232|FG004|Overall Study|Lost to Follow-up|0|||
146028735|NCT00787202|526616228|FG000|Overall Study|Withdrawal by Subject|2|||
146028736|NCT00787202|526616229|FG001|Overall Study|Withdrawal by Subject|2|||
146028737|NCT00787202|526616230|FG002|Overall Study|Withdrawal by Subject|2|||
146028738|NCT00787202|526616231|FG003|Overall Study|Withdrawal by Subject|0|||
146028739|NCT00787202|526616232|FG004|Overall Study|Withdrawal by Subject|0|||
146028740|NCT00787202|526616228|FG000|Overall Study|Protocol Violation|2|||
146028741|NCT00787202|526616229|FG001|Overall Study|Protocol Violation|1|||
146028742|NCT00787202|526616230|FG002|Overall Study|Protocol Violation|0|||
146028743|NCT00787202|526616231|FG003|Overall Study|Protocol Violation|0|||
146028744|NCT00787202|526616232|FG004|Overall Study|Protocol Violation|1|||
146028745|NCT00787202|526616228|FG000|Overall Study|Randomized, not treated|1|||
146028746|NCT00787202|526616229|FG001|Overall Study|Randomized, not treated|0|||
146028747|NCT00787202|526616230|FG002|Overall Study|Randomized, not treated|0|||
146028748|NCT00787202|526616231|FG003|Overall Study|Randomized, not treated|0|||
146028749|NCT00787202|526616232|FG004|Overall Study|Randomized, not treated|0|||
146028750|NCT01360398|526616233|FG000|Overall Study|Withdrawal by Subject|14|||
146028751|NCT01360398|526616233|FG000|Overall Study|Other|7|||
146028752|NCT01360398|526616233|FG000|Overall Study|Migrated/moved from study area|1|||
146028753|NCT01453946|526616234|FG000|Overall Study|Did not receive drug for the taper phase|1|||
146028754|NCT01453946|526616234|FG000|Overall Study|Protocol Violation|2|||
146028755|NCT01453946|526616234|FG000|Overall Study|Lack of Efficacy|3|||
146028756|NCT01453946|526616234|FG000|Overall Study|Adverse Event|3|||
146028757|NCT00846040|526616235|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
146028758|NCT00846040|526616236|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
146028759|NCT00846040|526616237|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
146028760|NCT00846040|526616235|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
146028761|NCT00846040|526616236|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
146028762|NCT00846040|526616237|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
146028763|NCT03697993|526616239|FG000|Overall Study|Became Ineligible after Enrollment|1|||
146028764|NCT03697993|526616240|FG001|Overall Study|Became Ineligible after Enrollment|3|||
146028765|NCT03697993|526616239|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
146028766|NCT03697993|526616240|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
146028767|NCT03697993|526616239|FG000|Overall Study|Lost to Follow-up|3|||
146028768|NCT03697993|526616240|FG001|Overall Study|Lost to Follow-up|0|||
146028769|NCT03697993|526616239|FG000|Overall Study|Physician Decision|4|||
146028770|NCT03697993|526616240|FG001|Overall Study|Physician Decision|0|||
146028771|NCT03697993|526616239|FG000|Overall Study|Initial Urine Culture Negative|0|||
146028772|NCT03697993|526616240|FG001|Overall Study|Initial Urine Culture Negative|1|||
146028773|NCT02230683|526616241|FG000|Overall Study|Adverse Event|1|||
146028774|NCT02191605|526617672|FG000|Overall Study|Lost to Follow-up|9|||
146028775|NCT02191605|526617673|FG001|Overall Study|Lost to Follow-up|4|||
146028776|NCT02191605|526617674|FG002|Overall Study|Lost to Follow-up|7|||
146028777|NCT02191605|526617675|FG003|Overall Study|Lost to Follow-up|3|||
146028778|NCT02191605|526617676|FG004|Overall Study|Lost to Follow-up|4|||
146028779|NCT00734071|526617677|FG000|Overall Study|Adverse Event|4|||
146028780|NCT00734071|526617678|FG001|Overall Study|Adverse Event|3|||
146028781|NCT00734071|526617677|FG000|Overall Study|Lack of Efficacy|3|||
146028782|NCT00734071|526617678|FG001|Overall Study|Lack of Efficacy|1|||
146028783|NCT00734071|526617677|FG000|Overall Study|Noncompliance|2|||
146028784|NCT00734071|526617678|FG001|Overall Study|Noncompliance|2|||
146028785|NCT00734071|526617677|FG000|Overall Study|Protocol Deviations|3|||
146028786|NCT00734071|526617678|FG001|Overall Study|Protocol Deviations|4|||
146028787|NCT00734071|526617677|FG000|Overall Study|Voluntary Withdrawal|9|||
146028788|NCT00734071|526617678|FG001|Overall Study|Voluntary Withdrawal|7|||
146028789|NCT00734071|526617677|FG000|Overall Study|Lost to Follow-up|16|||
146095829|NCT01104155|526872345|FG000|Overall Study|Withdrawal of consent|1|||
146095830|NCT01104155|526872346|FG001|Overall Study|Withdrawal of consent|1|||
146095831|NCT01104155|526872345|FG000|Overall Study|Other|3|||
146095832|NCT01104155|526872346|FG001|Overall Study|Other|4|||
146095833|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Adverse Event|10|||
146095834|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Adverse Event|0|||
146095835|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
146095836|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
146095837|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
146095838|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
146095839|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
146095840|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
146095841|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
146095842|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
146095843|NCT02787551|526872352|FG000|Core Period: 26 Weeks|Other than specified|3|||
146095844|NCT02787551|526872353|FG001|Core Period: 26 Weeks|Other than specified|1|||
146095845|NCT02787551|526872352|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
146095846|NCT02787551|526872353|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
146095847|NCT02787551|526872352|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
146095848|NCT02787551|526872353|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
146095849|NCT02787551|526872352|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
146095850|NCT02787551|526872353|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
146095851|NCT03799211|526872354|FG000|Overall Study|Lost to Follow-up|2|||
146095852|NCT03799211|526872355|FG001|Overall Study|Lost to Follow-up|13|||
146095853|NCT03799211|526872354|FG000|Overall Study|Withdrawal by Subject|2|||
146095854|NCT03799211|526872355|FG001|Overall Study|Withdrawal by Subject|0|||
146095855|NCT00764491|526872356|FG000|Overall Study|Lost to Follow-up|35|||
146095856|NCT00764491|526872357|FG001|Overall Study|Lost to Follow-up|17|||
146095857|NCT00923936|526872358|FG000|Overall Study|progressive disease on study|2|||
146095858|NCT00923936|526872359|FG001|Overall Study|progressive disease on study|1|||
146095859|NCT00923936|526872358|FG000|Overall Study|Adverse Event|2|||
146095860|NCT00923936|526872359|FG001|Overall Study|Adverse Event|1|||
146095861|NCT00923936|526872358|FG000|Overall Study|Lost to follow up|2|||
146095862|NCT00923936|526872359|FG001|Overall Study|Lost to follow up|0|||
146095863|NCT00923936|526872358|FG000|Overall Study|Continuing in follow up period|2|||
146095864|NCT00923936|526872359|FG001|Overall Study|Continuing in follow up period|1|||
146095865|NCT02038452|526872361|FG000|Overall Study|Withdrawal by Subject|7|||
146095866|NCT02038452|526872362|FG001|Overall Study|Withdrawal by Subject|9|||
146095867|NCT02038452|526872361|FG000|Overall Study|Lost to Follow-up|31|||
146095868|NCT02038452|526872362|FG001|Overall Study|Lost to Follow-up|28|||
146095869|NCT03139279|526872363|FG000|Overall Study|Physician Decision|2|||
146254178|NCT02137239|527443062|FG001|Overall Study|Adverse Event|2|||
146028790|NCT00734071|526617678|FG001|Overall Study|Lost to Follow-up|8|||
146028791|NCT00734071|526617677|FG000|Overall Study|Other|1|||
146028792|NCT00734071|526617678|FG001|Overall Study|Other|2|||
146028793|NCT00240110|526617679|FG000|Overall Study|Lost to Follow-up|6|||
146028794|NCT00240110|526617680|FG001|Overall Study|Lost to Follow-up|7|||
146028795|NCT00583791|526617681|FG000|Overall Study|Other|67|||
146028796|NCT00583791|526617681|FG000|Overall Study|Death|6|||
146028797|NCT00203021|526617682|FG000|Overall Study|Death|4|||
146028798|NCT00203021|526617683|FG001|Overall Study|Death|1|||
146028799|NCT00203021|526617682|FG000|Overall Study|Adverse Event|10|||
146028800|NCT00203021|526617683|FG001|Overall Study|Adverse Event|5|||
146028801|NCT00203021|526617682|FG000|Overall Study|Withdrawal by Subject|45|||
146028802|NCT00203021|526617683|FG001|Overall Study|Withdrawal by Subject|48|||
146028803|NCT00203021|526617682|FG000|Overall Study|Lost to Follow-up|9|||
146028804|NCT00203021|526617683|FG001|Overall Study|Lost to Follow-up|7|||
146028805|NCT00203021|526617682|FG000|Overall Study|Other than specified|11|||
146028806|NCT00203021|526617683|FG001|Overall Study|Other than specified|16|||
146028807|NCT02080260|526617684|FG000|Overall Study|Death|18|||
146028808|NCT02080260|526617684|FG000|Overall Study|Withdrawal by Subject|1|||
146028809|NCT03747120|526617689|FG000|Overall Study|treatment related toxicity|3|||
146028810|NCT03747120|526617690|FG001|Overall Study|treatment related toxicity|0|||
146028811|NCT03747120|526617691|FG002|Overall Study|treatment related toxicity|0|||
146028812|NCT03747120|526617689|FG000|Overall Study|Withdrawal by Subject|0|||
146028813|NCT03747120|526617690|FG001|Overall Study|Withdrawal by Subject|1|||
146028814|NCT03747120|526617691|FG002|Overall Study|Withdrawal by Subject|2|||
146028815|NCT03627065|526617692|FG000|Overall Study|Study Terminated by sponsor|1|||
146028816|NCT03627065|526617692|FG000|Overall Study|Withdrawal by Subject|2|||
146028817|NCT00289198|526617693|FG000|Overall Study|Adverse Event|0|||
146028818|NCT00289198|526617694|FG001|Overall Study|Adverse Event|2|||
146028819|NCT00289198|526617693|FG000|Overall Study|Protocol Violation|2|||
146028820|NCT00289198|526617694|FG001|Overall Study|Protocol Violation|1|||
146028821|NCT00289198|526617693|FG000|Overall Study|Withdrawal by Subject|4|||
146095870|NCT03139279|526872364|FG001|Overall Study|Physician Decision|0|||
146095871|NCT03139279|526872363|FG000|Overall Study|Protocol Violation|5|||
146095872|NCT03139279|526872364|FG001|Overall Study|Protocol Violation|4|||
146095873|NCT03139279|526872363|FG000|Overall Study|Withdrawal by Subject|0|||
146028822|NCT00289198|526617694|FG001|Overall Study|Withdrawal by Subject|1|||
146028823|NCT00289198|526617693|FG000|Overall Study|Lack of Efficacy|2|||
146028824|NCT00289198|526617694|FG001|Overall Study|Lack of Efficacy|0|||
146028825|NCT00289198|526617693|FG000|Overall Study|Other: Low compliance|0|||
146028826|NCT00289198|526617694|FG001|Overall Study|Other: Low compliance|1|||
146028827|NCT00289198|526617693|FG000|Overall Study|Other: Physician's decision|0|||
146028828|NCT00289198|526617694|FG001|Overall Study|Other: Physician's decision|1|||
146028829|NCT00289198|526617693|FG000|Overall Study|Other: Unable to attend on schedule|2|||
146028830|NCT00289198|526617694|FG001|Overall Study|Other: Unable to attend on schedule|1|||
146028831|NCT00289198|526617693|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
146028832|NCT00289198|526617694|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
146028833|NCT00289198|526617693|FG000|Overall Study|Other: Impossible to come on visit|0|||
146028834|NCT00289198|526617694|FG001|Overall Study|Other: Impossible to come on visit|1|||
146028835|NCT01062061|526617695|FG000|Overall Study|Enrolled more than once|2|||
146028836|NCT01062061|526617695|FG000|Overall Study|Investigated before study start|13|||
146028837|NCT01062061|526617695|FG000|Overall Study|Outside chief indications|10|||
146028838|NCT01062061|526617695|FG000|Overall Study|Failed to meet inclusion criteria|2|||
146028839|NCT01266317|526617696|FG000|Overall Study|Withdrawal by Subject|2|||
146028840|NCT00490776|526617697|FG000|Overall Study|Withdrawal by Subject|1|||
146028841|NCT00490776|526617697|FG000|Overall Study|Administrative Problems|1|||
146028842|NCT00490776|526617697|FG000|Overall Study|Death|1|||
146028843|NCT00490776|526617697|FG000|Overall Study|New Cancer Therapy|1|||
146028844|NCT00490776|526617697|FG000|Overall Study|Disease Progression|5|||
146028845|NCT00046930|526617698|FG000|Overall Study|Ineligible|12|||
146028846|NCT00046930|526617699|FG001|Overall Study|Ineligible|4|||
146028847|NCT01657760|526617700|FG000|Overall Study|Withdrawal by Subject|0|||
146028848|NCT01657760|526617701|FG001|Overall Study|Withdrawal by Subject|0|||
146028849|NCT01657760|526617702|FG002|Overall Study|Withdrawal by Subject|0|||
146028850|NCT01657760|526617703|FG003|Overall Study|Withdrawal by Subject|1|||
146028851|NCT01657760|526617700|FG000|Overall Study|Physician Decision|1|||
146028852|NCT01657760|526617701|FG001|Overall Study|Physician Decision|1|||
146028853|NCT01657760|526617702|FG002|Overall Study|Physician Decision|1|||
146028854|NCT01657760|526617703|FG003|Overall Study|Physician Decision|2|||
146028855|NCT01062841|526617706|FG000|Overall Study|Indwelling Device Removed|41|||
146028856|NCT01062841|526617707|FG001|Overall Study|Indwelling Device Removed|48|||
146028857|NCT01062841|526617706|FG000|Overall Study|Death|3|||
146028858|NCT01062841|526617707|FG001|Overall Study|Death|5|||
146028859|NCT01062841|526617706|FG000|Overall Study|Withdrawal by Subject|2|||
146028860|NCT01062841|526617707|FG001|Overall Study|Withdrawal by Subject|0|||
146028861|NCT01062841|526617706|FG000|Overall Study|Withdrawal by Study|3|||
146028862|NCT01062841|526617707|FG001|Overall Study|Withdrawal by Study|0|||
146028863|NCT00765882|526617709|FG000|Overall Study|Adverse Event|10|||
146028864|NCT00765882|526617710|FG001|Overall Study|Adverse Event|21|||
146028865|NCT00765882|526617711|FG002|Overall Study|Adverse Event|20|||
146028866|NCT00765882|526617709|FG000|Overall Study|Lack of Efficacy|4|||
146028867|NCT00765882|526617710|FG001|Overall Study|Lack of Efficacy|0|||
146028868|NCT00765882|526617711|FG002|Overall Study|Lack of Efficacy|1|||
146028869|NCT00765882|526617709|FG000|Overall Study|Protocol Violation|4|||
146028870|NCT00765882|526617710|FG001|Overall Study|Protocol Violation|3|||
146028871|NCT00765882|526617711|FG002|Overall Study|Protocol Violation|1|||
146028872|NCT00765882|526617709|FG000|Overall Study|Withdrawal by Subject|2|||
146028873|NCT00765882|526617710|FG001|Overall Study|Withdrawal by Subject|6|||
146028874|NCT00765882|526617711|FG002|Overall Study|Withdrawal by Subject|6|||
146028875|NCT00765882|526617709|FG000|Overall Study|Lost to Follow-up|1|||
146028876|NCT00765882|526617710|FG001|Overall Study|Lost to Follow-up|9|||
146028877|NCT00765882|526617711|FG002|Overall Study|Lost to Follow-up|6|||
146028878|NCT00765882|526617709|FG000|Overall Study|Other Reason|3|||
146028879|NCT00765882|526617710|FG001|Overall Study|Other Reason|1|||
146028880|NCT00765882|526617711|FG002|Overall Study|Other Reason|2|||
146028881|NCT03351114|526617712|FG000|Overall Study|Withdrawal by Subject|1|||
146028882|NCT01874275|526617713|FG000|Overall Study|Lost to Follow-up|1|||
146028883|NCT01874275|526617714|FG001|Overall Study|Lost to Follow-up|0|||
146028884|NCT01665430|526617718|FG000|Overall Study|Adverse Event|1|||
146028885|NCT01665430|526617718|FG000|Overall Study|Withdrawal by Subject|6|||
146028886|NCT01665430|526617718|FG000|Overall Study|Other Unspecified|2|||
146028887|NCT03249935|526617723|FG000|Overall Study|Discharged from facility early|36|||
146028888|NCT03249935|526617723|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
146028889|NCT03249935|526617723|FG000|Overall Study|Protocol Violation|5|||
146028890|NCT00989235|526617724|FG000|Overall Study|Death|0|||
146028891|NCT00989235|526617725|FG001|Overall Study|Death|1|||
146028892|NCT00989235|526617724|FG000|Overall Study|Adverse Event|0|||
146028893|NCT00989235|526617725|FG001|Overall Study|Adverse Event|1|||
146028894|NCT00989235|526617724|FG000|Overall Study|Lack of Efficacy|1|||
146028895|NCT00989235|526617725|FG001|Overall Study|Lack of Efficacy|0|||
146028896|NCT00989235|526617724|FG000|Overall Study|Withdrawal of Consent|1|||
146028897|NCT00989235|526617725|FG001|Overall Study|Withdrawal of Consent|1|||
146028898|NCT00989235|526617724|FG000|Overall Study|Desire to Become Pregnant|1|||
146028899|NCT00989235|526617725|FG001|Overall Study|Desire to Become Pregnant|0|||
146254179|NCT00005908|527443065|FG000|Overall Study|Withdrawal by Subject|1|||
146254180|NCT00005908|527443066|FG001|Overall Study|Withdrawal by Subject|0|||
146028900|NCT00989235|526617724|FG000|Overall Study|Randomized by Mistake|0|||
146028901|NCT00989235|526617725|FG001|Overall Study|Randomized by Mistake|2|||
146028902|NCT00989235|526617724|FG000|Overall Study|Lost to Follow-up|0|||
146028903|NCT00989235|526617725|FG001|Overall Study|Lost to Follow-up|1|||
146028904|NCT02813668|526617726|FG000|Overall Study|Death|4|||
146028905|NCT02813668|526617726|FG000|Overall Study|Lost to Follow-up|509|||
146028906|NCT02813668|526617726|FG000|Overall Study|Withdrawal by Subject|148|||
146028907|NCT02813668|526617726|FG000|Overall Study|No longer at worksite|85|||
146028908|NCT02813668|526617726|FG000|Overall Study|Medical reasons not related to the study|4|||
146028909|NCT04662073|526617727|FG000|Overall Study|Withdrawal by Subject|1|||
146028910|NCT04662073|526617728|FG001|Overall Study|Withdrawal by Subject|0|||
146028911|NCT00598078|526617733|FG000|Period 2 (Day 2)|Adverse Event|1|||
146028912|NCT00598078|526617734|FG001|Period 2 (Day 2)|Adverse Event|0|||
146028913|NCT01813721|526617735|FG000|Overall Study|Ineligibility determined|63|||
146028914|NCT01813721|526617735|FG000|Overall Study|Withdrawal by Subject|1|||
146028915|NCT01479595|526617738|FG000|Overall Study|Protocol deviation|0|||
146028916|NCT01479595|526617739|FG001|Overall Study|Protocol deviation|1|||
146028917|NCT01479595|526617738|FG000|Overall Study|Adverse Event|2|||
146028918|NCT01479595|526617739|FG001|Overall Study|Adverse Event|1|||
146028919|NCT00810901|526617740|FG000|Overall Study|Lost to Follow-up|88|||
146028920|NCT00810901|526617741|FG001|Overall Study|Lost to Follow-up|58|||
146028921|NCT02133664|526617742|FG000|Overall Study|Lost to Follow-up|2|||
146028922|NCT02133664|526617743|FG001|Overall Study|Lost to Follow-up|1|||
146028923|NCT02133664|526617742|FG000|Overall Study|Adverse Event|3|||
146028924|NCT02133664|526617743|FG001|Overall Study|Adverse Event|6|||
146028925|NCT03366103|526617746|FG000|Overall Study|Disease Progression|3|||
146028926|NCT03366103|526617747|FG001|Overall Study|Disease Progression|1|||
146028927|NCT03366103|526617748|FG002|Overall Study|Disease Progression|0|||
146028928|NCT03366103|526617746|FG000|Overall Study|Adverse Event|0|||
146028929|NCT03366103|526617747|FG001|Overall Study|Adverse Event|1|||
146028930|NCT03366103|526617748|FG002|Overall Study|Adverse Event|0|||
146028931|NCT02120365|526617755|FG000|Overall Study|Withdrawal by Subject|0|||
146028932|NCT02120365|526617756|FG001|Overall Study|Withdrawal by Subject|0|||
146028933|NCT02120365|526617757|FG002|Overall Study|Withdrawal by Subject|2|||
146028934|NCT02120365|526617758|FG003|Overall Study|Withdrawal by Subject|4|||
146028935|NCT02120365|526617759|FG004|Overall Study|Withdrawal by Subject|0|||
146028936|NCT02120365|526617760|FG005|Overall Study|Withdrawal by Subject|2|||
146028937|NCT00343915|526617761|FG000|Primary Study|Withdrawal by Subject|1|||
146028938|NCT00343915|526617762|FG001|Primary Study|Withdrawal by Subject|0|||
146028939|NCT00343915|526617761|FG000|Primary Study|Lost to Follow-up|2|||
146028940|NCT00343915|526617762|FG001|Primary Study|Lost to Follow-up|3|||
146028941|NCT00343915|526617761|FG000|Primary Study|Other|1|||
146028942|NCT00343915|526617762|FG001|Primary Study|Other|0|||
146028943|NCT01719003|526617767|FG000|Overall Study|Non compliant with protocol|1|||
146028944|NCT01719003|526617768|FG001|Overall Study|Non compliant with protocol|1|||
146028945|NCT01719003|526617769|FG002|Overall Study|Non compliant with protocol|0|||
146028946|NCT01719003|526617770|FG003|Overall Study|Non compliant with protocol|1|||
146028947|NCT01719003|526617771|FG004|Overall Study|Non compliant with protocol|2|||
146028948|NCT01719003|526617772|FG005|Overall Study|Non compliant with protocol|1|||
146028949|NCT01719003|526617773|FG006|Overall Study|Non compliant with protocol|2|||
146028950|NCT01719003|526617774|FG007|Overall Study|Non compliant with protocol|3|||
146028951|NCT01719003|526617775|FG008|Overall Study|Non compliant with protocol|0|||
146028952|NCT01719003|526617767|FG000|Overall Study|Adverse Event|6|||
146028953|NCT01719003|526617768|FG001|Overall Study|Adverse Event|5|||
146028954|NCT01719003|526617769|FG002|Overall Study|Adverse Event|4|||
146028955|NCT01719003|526617770|FG003|Overall Study|Adverse Event|3|||
146028956|NCT01719003|526617771|FG004|Overall Study|Adverse Event|4|||
146028957|NCT01719003|526617772|FG005|Overall Study|Adverse Event|3|||
146028958|NCT01719003|526617773|FG006|Overall Study|Adverse Event|6|||
146254181|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Adverse Event|3|||
146254182|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Adverse Event|0|||
146254183|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
146028959|NCT01719003|526617774|FG007|Overall Study|Adverse Event|5|||
146028960|NCT01719003|526617775|FG008|Overall Study|Adverse Event|0|||
146028961|NCT01719003|526617767|FG000|Overall Study|Lost to Follow-up|0|||
146028962|NCT01719003|526617768|FG001|Overall Study|Lost to Follow-up|6|||
146028963|NCT01719003|526617769|FG002|Overall Study|Lost to Follow-up|7|||
146028964|NCT01719003|526617770|FG003|Overall Study|Lost to Follow-up|2|||
146028965|NCT01719003|526617771|FG004|Overall Study|Lost to Follow-up|3|||
146028966|NCT01719003|526617772|FG005|Overall Study|Lost to Follow-up|4|||
146254184|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
146028967|NCT01719003|526617773|FG006|Overall Study|Lost to Follow-up|3|||
146028968|NCT01719003|526617774|FG007|Overall Study|Lost to Follow-up|2|||
146028969|NCT01719003|526617775|FG008|Overall Study|Lost to Follow-up|2|||
146028970|NCT01719003|526617767|FG000|Overall Study|Refusal to continue, not due to AE|2|||
146254185|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Disease Progression|23|||
146254186|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Disease Progression|22|||
146028971|NCT01719003|526617768|FG001|Overall Study|Refusal to continue, not due to AE|5|||
146028972|NCT01719003|526617769|FG002|Overall Study|Refusal to continue, not due to AE|4|||
146028973|NCT01719003|526617770|FG003|Overall Study|Refusal to continue, not due to AE|4|||
146028974|NCT01719003|526617771|FG004|Overall Study|Refusal to continue, not due to AE|4|||
146028975|NCT01719003|526617772|FG005|Overall Study|Refusal to continue, not due to AE|3|||
146028976|NCT01719003|526617773|FG006|Overall Study|Refusal to continue, not due to AE|8|||
146028977|NCT01719003|526617774|FG007|Overall Study|Refusal to continue, not due to AE|7|||
146028978|NCT01719003|526617775|FG008|Overall Study|Refusal to continue, not due to AE|1|||
146028979|NCT01719003|526617767|FG000|Overall Study|Reason other than those specified|0|||
146028980|NCT01719003|526617768|FG001|Overall Study|Reason other than those specified|0|||
146028981|NCT01719003|526617769|FG002|Overall Study|Reason other than those specified|2|||
146028982|NCT01719003|526617770|FG003|Overall Study|Reason other than those specified|3|||
146028983|NCT01719003|526617771|FG004|Overall Study|Reason other than those specified|4|||
146028984|NCT01719003|526617772|FG005|Overall Study|Reason other than those specified|1|||
146028985|NCT01719003|526617773|FG006|Overall Study|Reason other than those specified|0|||
146028986|NCT01719003|526617774|FG007|Overall Study|Reason other than those specified|3|||
146028987|NCT01719003|526617775|FG008|Overall Study|Reason other than those specified|1|||
146028988|NCT01719003|526617767|FG000|Overall Study|Lack of Efficacy|0|||
146028989|NCT01719003|526617768|FG001|Overall Study|Lack of Efficacy|0|||
146028990|NCT01719003|526617769|FG002|Overall Study|Lack of Efficacy|0|||
146028991|NCT01719003|526617770|FG003|Overall Study|Lack of Efficacy|0|||
146028992|NCT01719003|526617771|FG004|Overall Study|Lack of Efficacy|0|||
146028993|NCT01719003|526617772|FG005|Overall Study|Lack of Efficacy|0|||
146028994|NCT01719003|526617773|FG006|Overall Study|Lack of Efficacy|1|||
146028995|NCT01719003|526617774|FG007|Overall Study|Lack of Efficacy|0|||
146028996|NCT01719003|526617775|FG008|Overall Study|Lack of Efficacy|0|||
146028997|NCT00882908|526617776|FG000|Overall Study|Adverse Event|0|||
146028998|NCT00882908|526617777|FG001|Overall Study|Adverse Event|0|||
146028999|NCT00882908|526617778|FG002|Overall Study|Adverse Event|1|||
146029000|NCT00882908|526617779|FG003|Overall Study|Adverse Event|0|||
146029001|NCT00882908|526617780|FG004|Overall Study|Adverse Event|1|||
146029002|NCT00882908|526617776|FG000|Overall Study|Lost to Follow-up|3|||
146029003|NCT00882908|526617777|FG001|Overall Study|Lost to Follow-up|5|||
146029004|NCT00882908|526617778|FG002|Overall Study|Lost to Follow-up|3|||
146029005|NCT00882908|526617779|FG003|Overall Study|Lost to Follow-up|1|||
146029006|NCT00882908|526617780|FG004|Overall Study|Lost to Follow-up|2|||
146029007|NCT00882908|526617776|FG000|Overall Study|Protocol Violation|0|||
146029008|NCT00882908|526617777|FG001|Overall Study|Protocol Violation|1|||
146029009|NCT00882908|526617778|FG002|Overall Study|Protocol Violation|0|||
146029010|NCT00882908|526617779|FG003|Overall Study|Protocol Violation|0|||
146029011|NCT00882908|526617780|FG004|Overall Study|Protocol Violation|0|||
146029012|NCT00882908|526617776|FG000|Overall Study|Withdrawal by Subject|0|||
146029013|NCT00882908|526617777|FG001|Overall Study|Withdrawal by Subject|0|||
146029014|NCT00882908|526617778|FG002|Overall Study|Withdrawal by Subject|3|||
146029015|NCT00882908|526617779|FG003|Overall Study|Withdrawal by Subject|5|||
146029016|NCT00882908|526617780|FG004|Overall Study|Withdrawal by Subject|2|||
146029017|NCT00882908|526617776|FG000|Overall Study|Subject reached a virologic endpoint|0|||
146029018|NCT00882908|526617777|FG001|Overall Study|Subject reached a virologic endpoint|0|||
146029019|NCT00882908|526617778|FG002|Overall Study|Subject reached a virologic endpoint|0|||
146029020|NCT00882908|526617779|FG003|Overall Study|Subject reached a virologic endpoint|0|||
146029021|NCT00882908|526617780|FG004|Overall Study|Subject reached a virologic endpoint|1|||
146029022|NCT00882908|526617776|FG000|Overall Study|Study terminated in error|0|||
146029023|NCT00882908|526617777|FG001|Overall Study|Study terminated in error|0|||
146029024|NCT00882908|526617778|FG002|Overall Study|Study terminated in error|0|||
146029025|NCT00882908|526617779|FG003|Overall Study|Study terminated in error|1|||
146029026|NCT00882908|526617780|FG004|Overall Study|Study terminated in error|0|||
146029027|NCT01344629|526617782|FG000|Crossover Period 2|Withdrawal by Subject|0|||
146029028|NCT01344629|526617783|FG001|Crossover Period 2|Withdrawal by Subject|1|||
146029029|NCT05590000|526617787|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
146254187|NCT01379521|527443071|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
146254188|NCT01379521|527443072|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
146029030|NCT00762996|526617788|FG000|Period One|Protocol Violation|0|||
146029031|NCT00762996|526617789|FG001|Period One|Protocol Violation|0|||
146029032|NCT00762996|526617790|FG002|Period One|Protocol Violation|1|||
146029033|NCT00762996|526617791|FG003|Period One|Protocol Violation|0|||
146029034|NCT00762996|526617788|FG000|Period One|ineligible|0|||
146029035|NCT00762996|526617789|FG001|Period One|ineligible|0|||
146095874|NCT03139279|526872364|FG001|Overall Study|Withdrawal by Subject|2|||
146300328|NCT00757003|527615218|FG000|Overall Study|Not implanted|1|||
146029036|NCT00762996|526617790|FG002|Period One|ineligible|1|||
146029037|NCT00762996|526617791|FG003|Period One|ineligible|1|||
146029038|NCT00762996|526617788|FG000|Period One|Adverse Event|0|||
146029039|NCT00762996|526617789|FG001|Period One|Adverse Event|0|||
146029040|NCT00762996|526617790|FG002|Period One|Adverse Event|1|||
146095875|NCT05394350|526872365|FG000|Overall Study|Death|2|||
146095876|NCT05394350|526872366|FG001|Overall Study|Death|2|||
146095877|NCT05394350|526872367|FG002|Overall Study|Death|4|||
146095878|NCT05394350|526872368|FG003|Overall Study|Death|0|||
146095879|NCT05394350|526872369|FG004|Overall Study|Death|1|||
146095880|NCT05394350|526872370|FG005|Overall Study|Death|0|||
146095881|NCT05394350|526872365|FG000|Overall Study|Study terminated by sponsor|1|||
146095882|NCT05394350|526872366|FG001|Overall Study|Study terminated by sponsor|1|||
146095883|NCT05394350|526872367|FG002|Overall Study|Study terminated by sponsor|7|||
146095884|NCT05394350|526872368|FG003|Overall Study|Study terminated by sponsor|3|||
146095885|NCT05394350|526872369|FG004|Overall Study|Study terminated by sponsor|2|||
146095886|NCT05394350|526872370|FG005|Overall Study|Study terminated by sponsor|4|||
146095887|NCT02337738|526872371|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
146095888|NCT02337738|526872372|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
146095889|NCT02337738|526872373|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
146095890|NCT02337738|526872371|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146095891|NCT02337738|526872372|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
146095892|NCT02337738|526872373|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
146095893|NCT02337738|526872371|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
146095894|NCT02337738|526872372|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
146095895|NCT02337738|526872373|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
146095896|NCT02337738|526872371|FG000|Overall Study|Voluntary Withdrawal|10|||
146095897|NCT02337738|526872372|FG001|Overall Study|Voluntary Withdrawal|5|||
146095898|NCT02337738|526872373|FG002|Overall Study|Voluntary Withdrawal|2|||
146095899|NCT02337738|526872371|FG000|Overall Study|Lack of Efficacy|2|||
146095900|NCT02337738|526872372|FG001|Overall Study|Lack of Efficacy|4|||
146095901|NCT02337738|526872373|FG002|Overall Study|Lack of Efficacy|0|||
146095902|NCT02337738|526872371|FG000|Overall Study|Investigator's Judgment|1|||
146095903|NCT02337738|526872372|FG001|Overall Study|Investigator's Judgment|1|||
146095904|NCT02337738|526872373|FG002|Overall Study|Investigator's Judgment|3|||
146095905|NCT01565642|526872374|FG000|Overall Study|Withdrawal by Subject|2|||
146095906|NCT01565642|526872375|FG001|Overall Study|Withdrawal by Subject|1|||
146095907|NCT01934972|526872376|FG000|Overall Study|Withdrawal by Subject|9|||
146095908|NCT01934972|526872377|FG001|Overall Study|Withdrawal by Subject|6|||
146095909|NCT02436681|526872379|FG000|Overall Study|Lost to Follow-up|10|||
146095910|NCT02436681|526872379|FG000|Overall Study|Withdrawal by Subject|2|||
146095911|NCT02436681|526872379|FG000|Overall Study|Death|2|||
146095912|NCT03954132|526872380|FG000|Overall Study|Adverse Event|2|||
146095913|NCT03954132|526872381|FG001|Overall Study|Adverse Event|0|||
146095914|NCT03954132|526872380|FG000|Overall Study|Patient's wish|5|||
146095915|NCT03954132|526872381|FG001|Overall Study|Patient's wish|0|||
146095916|NCT03954132|526872380|FG000|Overall Study|Lost to Follow-up|10|||
146095917|NCT03954132|526872381|FG001|Overall Study|Lost to Follow-up|0|||
146095918|NCT03954132|526872380|FG000|Overall Study|Screening failure|0|||
146095919|NCT03954132|526872381|FG001|Overall Study|Screening failure|1|||
146095920|NCT03954132|526872380|FG000|Overall Study|No registration after Visit 1|5|||
146095921|NCT03954132|526872381|FG001|Overall Study|No registration after Visit 1|2|||
146300329|NCT00601705|527615219|FG000|Overall Study|Withdrawal by Subject|1|||
146300330|NCT02146599|527615223|FG000|Overall Study|Failed to meet inclusion criteria|5|||
146095922|NCT03954132|526872380|FG000|Overall Study|Other reason than listed|2|||
146095923|NCT03954132|526872381|FG001|Overall Study|Other reason than listed|2|||
146095924|NCT03954132|526872380|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
146095925|NCT03954132|526872381|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
146095926|NCT03954132|526872380|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
146095927|NCT03954132|526872381|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
146095928|NCT00932737|526872384|FG000|Overall Study|Not treated in second episode|1|||
146095929|NCT00932737|526872385|FG001|Overall Study|Not treated in second episode|0|||
146095930|NCT00932737|526872384|FG000|Overall Study|Adverse Event|0|||
146095931|NCT00932737|526872385|FG001|Overall Study|Adverse Event|1|||
146095932|NCT02906332|526872388|FG000|Overall Study|Withdrawal by Subject|1|||
146095933|NCT02949700|526872389|FG000|Phase I|Withdrawal by Subject|1|||
146095934|NCT02949700|526872390|FG001|Phase I|Withdrawal by Subject|1|||
146300331|NCT02101021|527615227|FG000|Overall Study|Death|4|||
146300332|NCT02101021|527615228|FG001|Overall Study|Death|3|||
146300333|NCT02101021|527615229|FG002|Overall Study|Death|6|||
146095935|NCT02949700|526872391|FG002|Phase I|Withdrawal by Subject|0|||
146095936|NCT02949700|526872392|FG003|Phase I|Withdrawal by Subject|0|||
146095937|NCT02949700|526872389|FG000|Phase I|Protocol Violation|1|||
146095938|NCT02949700|526872390|FG001|Phase I|Protocol Violation|0|||
146095939|NCT02949700|526872391|FG002|Phase I|Protocol Violation|0|||
146095940|NCT02949700|526872392|FG003|Phase I|Protocol Violation|0|||
146095941|NCT02949700|526872389|FG000|Phase II|Withdrawal by Subject|0|||
146095942|NCT02949700|526872390|FG001|Phase II|Withdrawal by Subject|0|||
146095943|NCT02949700|526872391|FG002|Phase II|Withdrawal by Subject|0|||
146095944|NCT02949700|526872392|FG003|Phase II|Withdrawal by Subject|2|||
146095945|NCT02949700|526872389|FG000|Phase II|Protocol Violation|0|||
146300334|NCT02101021|527615230|FG003|Overall Study|Death|0|||
146095946|NCT02949700|526872390|FG001|Phase II|Protocol Violation|0|||
146095947|NCT02949700|526872391|FG002|Phase II|Protocol Violation|1|||
146095948|NCT02949700|526872392|FG003|Phase II|Protocol Violation|3|||
146095949|NCT00560885|526872396|FG000|Overall Study|Death|7|||
146095950|NCT00560885|526872396|FG000|Overall Study|Withdrawal by Subject|1|||
146095951|NCT01554397|526872397|FG000|Overall Study|Withdrawal by Subject|1|||
146095952|NCT01554397|526872398|FG001|Overall Study|Withdrawal by Subject|0|||
146095953|NCT01554397|526872397|FG000|Overall Study|Ineligible|7|||
146095954|NCT01554397|526872398|FG001|Overall Study|Ineligible|0|||
146095955|NCT01896050|526874393|FG000|Overall Study|Adverse Event|37|||
146095956|NCT01896050|526874394|FG001|Overall Study|Adverse Event|2|||
146095957|NCT01896050|526874393|FG000|Overall Study|Death|1|||
146095958|NCT01896050|526874394|FG001|Overall Study|Death|0|||
146095959|NCT03693300|526874395|FG000|Overall Study|Withdrawal by Subject|6|||
146095960|NCT03693300|526874396|FG001|Overall Study|Withdrawal by Subject|0|||
146095961|NCT03693300|526874395|FG000|Overall Study|Death|50|||
146095962|NCT03693300|526874396|FG001|Overall Study|Death|2|||
146095963|NCT03693300|526874395|FG000|Overall Study|Lost to Follow-up|2|||
146095964|NCT03693300|526874396|FG001|Overall Study|Lost to Follow-up|0|||
146095965|NCT02206048|526874397|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
146095966|NCT00697073|526874398|FG000|Overall Study|Withdrawal by Subject|2|||
146095967|NCT00697073|526874398|FG000|Overall Study|Pregnancy|1|||
146095968|NCT00697073|526874398|FG000|Overall Study|non compliance and other|6|||
146095969|NCT03265665|526874399|FG000|24-week Data Collection|Withdrawal by Subject|2|||
146095970|NCT03265665|526874400|FG001|24-week Data Collection|Withdrawal by Subject|2|||
146095971|NCT03265665|526874399|FG000|24-week Data Collection|Lost to Follow-up|4|||
146095972|NCT03265665|526874400|FG001|24-week Data Collection|Lost to Follow-up|5|||
146095973|NCT03265665|526874399|FG000|36-week Data Collection|Lost to Follow-up|6|||
146095974|NCT03265665|526874400|FG001|36-week Data Collection|Lost to Follow-up|8|||
146095975|NCT01858376|526874401|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
146095976|NCT00108433|526874405|FG000|Overall Study|Lack of Efficacy|1|||
146029041|NCT00762996|526617791|FG003|Period One|Adverse Event|0|||
146029042|NCT00762996|526617788|FG000|Period One|Withdrawal by Subject|0|||
146029043|NCT00762996|526617789|FG001|Period One|Withdrawal by Subject|0|||
146029044|NCT00762996|526617790|FG002|Period One|Withdrawal by Subject|1|||
146029045|NCT00762996|526617791|FG003|Period One|Withdrawal by Subject|0|||
146029046|NCT02689076|526617793|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
146029047|NCT02689076|526617794|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
146029048|NCT02689076|526617795|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
146029049|NCT02689076|526617793|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
146029050|NCT02689076|526617794|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
146029051|NCT02689076|526617795|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
146029052|NCT02689076|526617793|FG000|Overall Study|Did not have an HIE match|2|||
146029053|NCT02689076|526617794|FG001|Overall Study|Did not have an HIE match|0|||
146029054|NCT02689076|526617795|FG002|Overall Study|Did not have an HIE match|0|||
146029055|NCT02689076|526617793|FG000|Overall Study|Death during non-VA encounter|2|||
146029056|NCT02689076|526617794|FG001|Overall Study|Death during non-VA encounter|5|||
146029057|NCT02689076|526617795|FG002|Overall Study|Death during non-VA encounter|0|||
146029058|NCT02689076|526617793|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
146029059|NCT02689076|526617794|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
146029060|NCT02689076|526617795|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
146029061|NCT02689076|526617793|FG000|Overall Study|Participant no longer active in VA system|1|||
146029062|NCT02689076|526617794|FG001|Overall Study|Participant no longer active in VA system|0|||
146029063|NCT02689076|526617795|FG002|Overall Study|Participant no longer active in VA system|0|||
146029064|NCT02689076|526617793|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
146029065|NCT02689076|526617794|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
146029066|NCT02689076|526617795|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
146029067|NCT04063787|526617802|FG000|Overall Study|Inadequate Doppler data|4|||
146029068|NCT04063787|526617802|FG000|Overall Study|Lost to Follow-up|2|||
146029069|NCT04063787|526617802|FG000|Overall Study|Death|3|||
146029070|NCT01816906|526617803|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
146095977|NCT00108433|526874406|FG001|Overall Study|Lack of Efficacy|2|||
146095978|NCT00108433|526874405|FG000|Overall Study|Death|3|||
146095979|NCT00108433|526874406|FG001|Overall Study|Death|0|||
146095980|NCT00108433|526874405|FG000|Overall Study|Adverse Event|3|||
146095981|NCT00108433|526874406|FG001|Overall Study|Adverse Event|1|||
146095982|NCT00108433|526874405|FG000|Overall Study|Other|14|||
146095983|NCT00108433|526874406|FG001|Overall Study|Other|14|||
146095984|NCT02203071|526874407|FG000|Overall Study|Lost to Follow-up|3|||
146095985|NCT02203071|526874408|FG001|Overall Study|Lost to Follow-up|1|||
146095986|NCT01886716|526874411|FG000|Week 1|Lost to Follow-up|0|||
146095987|NCT01886716|526874412|FG001|Week 1|Lost to Follow-up|0|||
146095988|NCT01886716|526874413|FG002|Week 1|Lost to Follow-up|2|||
146095989|NCT01886716|526874414|FG003|Week 1|Lost to Follow-up|2|||
146095990|NCT01886716|526874411|FG000|Week 2|Lost to Follow-up|3|||
146095991|NCT01886716|526874412|FG001|Week 2|Lost to Follow-up|2|||
146095992|NCT01886716|526874413|FG002|Week 2|Lost to Follow-up|1|||
146095993|NCT01886716|526874414|FG003|Week 2|Lost to Follow-up|3|||
146095994|NCT01886716|526874411|FG000|Week 3|Lost to Follow-up|1|||
146095995|NCT01886716|526874412|FG001|Week 3|Lost to Follow-up|1|||
146095996|NCT01886716|526874413|FG002|Week 3|Lost to Follow-up|0|||
146095997|NCT01886716|526874414|FG003|Week 3|Lost to Follow-up|1|||
146095998|NCT03894046|526874415|FG000|Overall Study|Protocol Violation|1|||
146095999|NCT03894046|526874416|FG001|Overall Study|Protocol Violation|0|||
146096000|NCT03894046|526874417|FG002|Overall Study|Protocol Violation|0|||
146096001|NCT03894046|526874415|FG000|Overall Study|Adverse Event|0|||
146096002|NCT03894046|526874416|FG001|Overall Study|Adverse Event|1|||
146096003|NCT03894046|526874417|FG002|Overall Study|Adverse Event|0|||
146096004|NCT03894046|526874415|FG000|Overall Study|Withdrawal by Subject|2|||
146096005|NCT03894046|526874416|FG001|Overall Study|Withdrawal by Subject|3|||
146096006|NCT03894046|526874417|FG002|Overall Study|Withdrawal by Subject|1|||
146096007|NCT03894046|526874415|FG000|Overall Study|Death|15|||
146096008|NCT03894046|526874416|FG001|Overall Study|Death|21|||
146096009|NCT03894046|526874417|FG002|Overall Study|Death|4|||
146096010|NCT03894046|526874415|FG000|Overall Study|No growth of ABC|2|||
146096011|NCT03894046|526874416|FG001|Overall Study|No growth of ABC|1|||
146096012|NCT03894046|526874417|FG002|Overall Study|No growth of ABC|0|||
146096013|NCT03894046|526874415|FG000|Overall Study|Physician Decision|1|||
146096014|NCT03894046|526874416|FG001|Overall Study|Physician Decision|1|||
146096015|NCT03894046|526874417|FG002|Overall Study|Physician Decision|1|||
146096016|NCT03894046|526874415|FG000|Overall Study|Prohibited concomitant medication|1|||
146096017|NCT03894046|526874416|FG001|Overall Study|Prohibited concomitant medication|0|||
146096018|NCT03894046|526874417|FG002|Overall Study|Prohibited concomitant medication|0|||
146096019|NCT03894046|526874415|FG000|Overall Study|Transferred to other arm/group|1|||
146096020|NCT03894046|526874416|FG001|Overall Study|Transferred to other arm/group|1|||
146096021|NCT03894046|526874417|FG002|Overall Study|Transferred to other arm/group|0|||
146096022|NCT04806503|526874424|FG000|Overall Study|Lost to Follow-up|0|||
146096023|NCT04806503|526874425|FG001|Overall Study|Lost to Follow-up|0|||
146096024|NCT04806503|526874426|FG002|Overall Study|Lost to Follow-up|1|||
146096025|NCT04806503|526874427|FG003|Overall Study|Lost to Follow-up|0|||
146096026|NCT04806503|526874428|FG004|Overall Study|Lost to Follow-up|0|||
146096027|NCT04806503|526874424|FG000|Overall Study|Withdrawal by Subject|1|||
146096028|NCT04806503|526874425|FG001|Overall Study|Withdrawal by Subject|0|||
146096029|NCT04806503|526874426|FG002|Overall Study|Withdrawal by Subject|1|||
146096030|NCT04806503|526874427|FG003|Overall Study|Withdrawal by Subject|1|||
146096031|NCT04806503|526874428|FG004|Overall Study|Withdrawal by Subject|1|||
146096032|NCT04806503|526874424|FG000|Overall Study|Adverse Event|1|||
146096033|NCT04806503|526874425|FG001|Overall Study|Adverse Event|1|||
146096034|NCT04806503|526874426|FG002|Overall Study|Adverse Event|0|||
146096035|NCT04806503|526874427|FG003|Overall Study|Adverse Event|1|||
146096036|NCT04806503|526874428|FG004|Overall Study|Adverse Event|0|||
146096037|NCT03589469|526874429|FG000|Overall Study|Withdrawal by Subject|8|||
146029071|NCT01816906|526617804|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
146029072|NCT01816906|526617803|FG000|Six Months|Lost to Follow-up|14|||
146029073|NCT01816906|526617804|FG001|Six Months|Lost to Follow-up|16|||
146029074|NCT01816906|526617803|FG000|12 Months|Adverse Event|2|||
146029075|NCT01816906|526617804|FG001|12 Months|Adverse Event|2|||
146029076|NCT01816906|526617803|FG000|12 Months|Death|0|||
146029077|NCT01816906|526617804|FG001|12 Months|Death|2|||
146029078|NCT01816906|526617803|FG000|12 Months|Lost to Follow-up|2|||
146029079|NCT01816906|526617804|FG001|12 Months|Lost to Follow-up|1|||
146029080|NCT01527383|526617805|FG000|Overall Study|Adverse Event|5|||
146029081|NCT01527383|526617806|FG001|Overall Study|Adverse Event|0|||
146029082|NCT01527383|526617805|FG000|Overall Study|Lost to Follow-up|3|||
146029083|NCT01527383|526617806|FG001|Overall Study|Lost to Follow-up|0|||
146029084|NCT01527383|526617805|FG000|Overall Study|Physician Decision|2|||
146029085|NCT01527383|526617806|FG001|Overall Study|Physician Decision|0|||
146029086|NCT01527383|526617805|FG000|Overall Study|Pregnancy|1|||
146029087|NCT01527383|526617806|FG001|Overall Study|Pregnancy|0|||
146096038|NCT03589469|526874429|FG000|Overall Study|Physician Decision|20|||
146096039|NCT03589469|526874429|FG000|Overall Study|Death|97|||
146096040|NCT03589469|526874429|FG000|Overall Study|Lost to Follow-up|8|||
146096041|NCT03589469|526874429|FG000|Overall Study|Miscellaneous|1|||
146096042|NCT02202837|526874432|FG000|Overall Study|Enbrel treatment discontinued|36|||
146096043|NCT02202837|526874433|FG001|Overall Study|Enbrel treatment discontinued|4|||
146096044|NCT02202837|526874432|FG000|Overall Study|Other|10|||
146096045|NCT02202837|526874433|FG001|Overall Study|Other|0|||
146096046|NCT02202837|526874432|FG000|Overall Study|Lost to Follow-up|7|||
146096047|NCT02202837|526874433|FG001|Overall Study|Lost to Follow-up|1|||
146096048|NCT02486302|526874434|FG000|Overall Study|Discontinued prematurely|410|||
146096049|NCT02486302|526874434|FG000|Overall Study|Documentation not completed|255|||
146096050|NCT02486302|526874434|FG000|Overall Study|Excluded due to legal reasons|8|||
146096051|NCT02486302|526874434|FG000|Overall Study|Not treated|3|||
146029088|NCT01527383|526617805|FG000|Overall Study|Protocol Violation|1|||
146029089|NCT01527383|526617806|FG001|Overall Study|Protocol Violation|0|||
146029090|NCT01527383|526617805|FG000|Overall Study|Screen failure|1|||
146029091|NCT01527383|526617806|FG001|Overall Study|Screen failure|0|||
146029092|NCT01527383|526617805|FG000|Overall Study|Participant moved|0|||
146029093|NCT01527383|526617806|FG001|Overall Study|Participant moved|1|||
146029094|NCT01527383|526617805|FG000|Overall Study|Withdrawal by Subject|2|||
146029095|NCT01527383|526617806|FG001|Overall Study|Withdrawal by Subject|3|||
146029096|NCT00746733|526617807|FG000|Second Intervention|Adverse Event|1|||
146029097|NCT00746733|526617808|FG001|Second Intervention|Adverse Event|0|||
146029098|NCT00746733|526617807|FG000|Third Intervention|Withdrawal by Subject|1|||
146029099|NCT00746733|526617808|FG001|Third Intervention|Withdrawal by Subject|1|||
146029100|NCT02558400|526617812|FG000|Overall Study|Adverse Event|47|||
146029101|NCT02558400|526617813|FG001|Overall Study|Adverse Event|53|||
146029102|NCT02558400|526617814|FG002|Overall Study|Adverse Event|4|||
146029103|NCT02558400|526617812|FG000|Overall Study|Withdrawal by Subject|13|||
146029104|NCT02558400|526617813|FG001|Overall Study|Withdrawal by Subject|9|||
146029105|NCT02558400|526617814|FG002|Overall Study|Withdrawal by Subject|8|||
146029106|NCT02558400|526617812|FG000|Overall Study|Non-Compliant|0|||
146029107|NCT02558400|526617813|FG001|Overall Study|Non-Compliant|1|||
146029108|NCT02558400|526617814|FG002|Overall Study|Non-Compliant|3|||
146029109|NCT02558400|526617812|FG000|Overall Study|Lost to Follow-up|5|||
146029110|NCT02558400|526617813|FG001|Overall Study|Lost to Follow-up|5|||
146029111|NCT02558400|526617814|FG002|Overall Study|Lost to Follow-up|4|||
146029112|NCT02558400|526617812|FG000|Overall Study|Lack of Efficacy|0|||
146029113|NCT02558400|526617813|FG001|Overall Study|Lack of Efficacy|13|||
146029114|NCT02558400|526617814|FG002|Overall Study|Lack of Efficacy|1|||
146029115|NCT02558400|526617812|FG000|Overall Study|Disallowed Concurrent Medication|6|||
146029116|NCT02558400|526617813|FG001|Overall Study|Disallowed Concurrent Medication|7|||
146029117|NCT02558400|526617814|FG002|Overall Study|Disallowed Concurrent Medication|5|||
146029118|NCT02558400|526617812|FG000|Overall Study|Physician Decision|2|||
146029119|NCT02558400|526617813|FG001|Overall Study|Physician Decision|2|||
146029120|NCT02558400|526617814|FG002|Overall Study|Physician Decision|0|||
146029121|NCT02558400|526617812|FG000|Overall Study|Protocol Violation|6|||
146029122|NCT02558400|526617813|FG001|Overall Study|Protocol Violation|3|||
146029123|NCT02558400|526617814|FG002|Overall Study|Protocol Violation|8|||
146029124|NCT02558400|526617812|FG000|Overall Study|Death|0|||
146029125|NCT02558400|526617813|FG001|Overall Study|Death|1|||
146029126|NCT02558400|526617814|FG002|Overall Study|Death|0|||
146029127|NCT02558400|526617812|FG000|Overall Study|Ineligible for the study|0|||
146029128|NCT02558400|526617813|FG001|Overall Study|Ineligible for the study|2|||
146029129|NCT02558400|526617814|FG002|Overall Study|Ineligible for the study|0|||
146029130|NCT00456599|526617815|FG000|Overall Study|Non-compliance|1|||
146029131|NCT00456599|526617815|FG000|Overall Study|Withdrawal by Subject|2|||
146029132|NCT00664326|526620377|FG000|Overall Study|Adverse Event|14|||
146029133|NCT00664326|526620377|FG000|Overall Study|Noncompliance with study medication|3|||
146029134|NCT00664326|526620377|FG000|Overall Study|Withdrawal by Subject|1|||
146029135|NCT00664326|526620377|FG000|Overall Study|Physician Decision|1|||
146029136|NCT00664326|526620377|FG000|Overall Study|Other Reasons|3|||
146029137|NCT00664326|526620377|FG000|Overall Study|Death|2|||
146029138|NCT00664326|526620377|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
146029139|NCT05079477|526620380|FG000|Overall Study|Lost to Follow-up|2|||
146029140|NCT05079477|526620381|FG001|Overall Study|Lost to Follow-up|0|||
146029141|NCT05079477|526620380|FG000|Overall Study|Withdrawal by Subject|1|||
146029142|NCT05079477|526620381|FG001|Overall Study|Withdrawal by Subject|0|||
146029143|NCT05079477|526620380|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
146029144|NCT05079477|526620381|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
146029145|NCT05079477|526620380|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
146029146|NCT05079477|526620381|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
146029147|NCT05275582|526620386|FG000|Overall Study|Lost to Follow-up|1|||
146029148|NCT05275582|526620387|FG001|Overall Study|Lost to Follow-up|0|||
146029149|NCT05275582|526620386|FG000|Overall Study|Withdrawal by Subject|0|||
146029150|NCT05275582|526620387|FG001|Overall Study|Withdrawal by Subject|2|||
146029151|NCT05275582|526620386|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
146029152|NCT05275582|526620387|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
146029153|NCT05275582|526620386|FG000|Overall Study|Death|1|||
146029154|NCT05275582|526620387|FG001|Overall Study|Death|0|||
146029155|NCT05275582|526620386|FG000|Overall Study|Protocol Violation|1|||
146029156|NCT05275582|526620387|FG001|Overall Study|Protocol Violation|0|||
146029157|NCT03204890|526620392|FG000|Overall Study|Withdrawal by Subject|1|||
146300335|NCT02101021|527615231|FG004|Overall Study|Death|3|||
146029158|NCT03769311|526620393|FG000|Overall Study|Withdrawal by Subject|1|||
146029159|NCT02853435|526620394|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146029160|NCT02853435|526620395|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146029161|NCT02853435|526620396|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146029162|NCT02853435|526620397|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146029163|NCT02853435|526620398|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
146029164|NCT02853435|526620399|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
146029165|NCT00996801|526620400|FG000|Overall Study|Adverse Event|6|||
146029166|NCT00996801|526620401|FG001|Overall Study|Adverse Event|4|||
146029167|NCT00996801|526620402|FG002|Overall Study|Adverse Event|12|||
146029168|NCT00996801|526620403|FG003|Overall Study|Adverse Event|17|||
146029169|NCT00996801|526620404|FG004|Overall Study|Adverse Event|31|||
146029170|NCT00996801|526620405|FG005|Overall Study|Adverse Event|3|||
146029171|NCT00996801|526620400|FG000|Overall Study|Lack of Efficacy|3|||
146029172|NCT00996801|526620401|FG001|Overall Study|Lack of Efficacy|0|||
146029173|NCT00996801|526620402|FG002|Overall Study|Lack of Efficacy|1|||
146029174|NCT00996801|526620403|FG003|Overall Study|Lack of Efficacy|3|||
146029175|NCT00996801|526620404|FG004|Overall Study|Lack of Efficacy|0|||
146029176|NCT00996801|526620405|FG005|Overall Study|Lack of Efficacy|1|||
146029177|NCT00996801|526620400|FG000|Overall Study|Lost to Follow-up|0|||
146029178|NCT00996801|526620401|FG001|Overall Study|Lost to Follow-up|0|||
146029179|NCT00996801|526620402|FG002|Overall Study|Lost to Follow-up|0|||
146029180|NCT00996801|526620403|FG003|Overall Study|Lost to Follow-up|3|||
146029181|NCT00996801|526620404|FG004|Overall Study|Lost to Follow-up|3|||
146029182|NCT00996801|526620405|FG005|Overall Study|Lost to Follow-up|2|||
146029183|NCT00996801|526620400|FG000|Overall Study|Physician Decision|0|||
146029184|NCT00996801|526620401|FG001|Overall Study|Physician Decision|0|||
146029185|NCT00996801|526620402|FG002|Overall Study|Physician Decision|0|||
146029186|NCT00996801|526620403|FG003|Overall Study|Physician Decision|1|||
146029187|NCT00996801|526620404|FG004|Overall Study|Physician Decision|0|||
146029188|NCT00996801|526620405|FG005|Overall Study|Physician Decision|0|||
146029189|NCT00996801|526620400|FG000|Overall Study|Progressive Disease|0|||
146029190|NCT00996801|526620401|FG001|Overall Study|Progressive Disease|1|||
146029191|NCT00996801|526620402|FG002|Overall Study|Progressive Disease|0|||
146029192|NCT00996801|526620403|FG003|Overall Study|Progressive Disease|0|||
146029193|NCT00996801|526620404|FG004|Overall Study|Progressive Disease|0|||
146029194|NCT00996801|526620405|FG005|Overall Study|Progressive Disease|0|||
146029195|NCT00996801|526620400|FG000|Overall Study|Protocol Violation|3|||
146029196|NCT00996801|526620401|FG001|Overall Study|Protocol Violation|4|||
146029197|NCT00996801|526620402|FG002|Overall Study|Protocol Violation|1|||
146029198|NCT00996801|526620403|FG003|Overall Study|Protocol Violation|2|||
146029199|NCT00996801|526620404|FG004|Overall Study|Protocol Violation|3|||
146029200|NCT00996801|526620405|FG005|Overall Study|Protocol Violation|4|||
146029201|NCT00996801|526620400|FG000|Overall Study|Study Terminated by Sponsor|0|||
146029202|NCT00996801|526620401|FG001|Overall Study|Study Terminated by Sponsor|1|||
146029203|NCT00996801|526620402|FG002|Overall Study|Study Terminated by Sponsor|0|||
146029204|NCT00996801|526620403|FG003|Overall Study|Study Terminated by Sponsor|0|||
146029205|NCT00996801|526620404|FG004|Overall Study|Study Terminated by Sponsor|46|||
146029206|NCT00996801|526620405|FG005|Overall Study|Study Terminated by Sponsor|0|||
146029207|NCT00996801|526620400|FG000|Overall Study|Withdrawal by Subject|8|||
146029208|NCT00996801|526620401|FG001|Overall Study|Withdrawal by Subject|6|||
146029209|NCT00996801|526620402|FG002|Overall Study|Withdrawal by Subject|9|||
146029210|NCT00996801|526620403|FG003|Overall Study|Withdrawal by Subject|5|||
146029211|NCT00996801|526620404|FG004|Overall Study|Withdrawal by Subject|5|||
146029212|NCT00996801|526620405|FG005|Overall Study|Withdrawal by Subject|9|||
146029213|NCT01688739|526620406|FG000|Overall Study|Administrative Decision|1|||
146029214|NCT01688739|526620407|FG001|Overall Study|Administrative Decision|0|||
146029215|NCT01688739|526620408|FG002|Overall Study|Administrative Decision|0|||
146029216|NCT01688739|526620409|FG003|Overall Study|Administrative Decision|0|||
146029217|NCT01688739|526620410|FG004|Overall Study|Administrative Decision|0|||
146029218|NCT01688739|526620411|FG005|Overall Study|Administrative Decision|0|||
146029219|NCT01688739|526620412|FG006|Overall Study|Administrative Decision|0|||
146029220|NCT01688739|526620413|FG007|Overall Study|Administrative Decision|0|||
146029221|NCT01688739|526620414|FG008|Overall Study|Administrative Decision|0|||
146029222|NCT01688739|526620415|FG009|Overall Study|Administrative Decision|0|||
146029223|NCT03369431|526620417|FG000|Overall Study|Lost to Follow-up|1|||
146029224|NCT03369431|526620418|FG001|Overall Study|Lost to Follow-up|3|||
146029225|NCT03369431|526620417|FG000|Overall Study|Withdrawal by Subject|2|||
146029226|NCT03369431|526620418|FG001|Overall Study|Withdrawal by Subject|3|||
146029227|NCT03369431|526620417|FG000|Overall Study|Protocol Violation|1|||
146029228|NCT03369431|526620418|FG001|Overall Study|Protocol Violation|1|||
146029229|NCT01113580|526620425|FG000|Overall Study|Protocol Violation|1|||
146029230|NCT01113580|526620426|FG001|Overall Study|Protocol Violation|0|||
146029231|NCT01145053|526620427|FG000|Overall Study|Adverse Event|22|||
146029232|NCT01145053|526620427|FG000|Overall Study|Lost to Follow-up|28|||
146029233|NCT01145053|526620427|FG000|Overall Study|Withdrawal by Subject|25|||
146029234|NCT01145053|526620427|FG000|Overall Study|Other|18|||
146029235|NCT02088073|526620428|FG000|Acute Phase|Withdrawal by Subject|5|||
146029236|NCT02088073|526620429|FG001|Acute Phase|Withdrawal by Subject|0|||
146029237|NCT02088073|526620430|FG002|Acute Phase|Withdrawal by Subject|0|||
146029238|NCT02088073|526620431|FG003|Acute Phase|Withdrawal by Subject|0|||
146029239|NCT02088073|526620432|FG004|Acute Phase|Withdrawal by Subject|0|||
146029240|NCT02088073|526620428|FG000|Acute Phase|Hyperkalemia|2|||
146029241|NCT02088073|526620429|FG001|Acute Phase|Hyperkalemia|0|||
146029242|NCT02088073|526620430|FG002|Acute Phase|Hyperkalemia|0|||
146029243|NCT02088073|526620431|FG003|Acute Phase|Hyperkalemia|0|||
146029244|NCT02088073|526620432|FG004|Acute Phase|Hyperkalemia|0|||
146029245|NCT02088073|526620428|FG000|Maintanance Phase|Withdrawal by Subject|0|||
146029246|NCT02088073|526620429|FG001|Maintanance Phase|Withdrawal by Subject|2|||
146029247|NCT02088073|526620430|FG002|Maintanance Phase|Withdrawal by Subject|0|||
146029248|NCT02088073|526620431|FG003|Maintanance Phase|Withdrawal by Subject|0|||
146029249|NCT02088073|526620432|FG004|Maintanance Phase|Withdrawal by Subject|0|||
146029250|NCT02088073|526620428|FG000|Maintanance Phase|Adverse Event|0|||
146029251|NCT02088073|526620429|FG001|Maintanance Phase|Adverse Event|0|||
146029252|NCT02088073|526620430|FG002|Maintanance Phase|Adverse Event|3|||
146029253|NCT02088073|526620431|FG003|Maintanance Phase|Adverse Event|0|||
146029254|NCT02088073|526620432|FG004|Maintanance Phase|Adverse Event|1|||
146029255|NCT02088073|526620428|FG000|Maintanance Phase|Physician Decision|0|||
146029256|NCT02088073|526620429|FG001|Maintanance Phase|Physician Decision|0|||
146029257|NCT02088073|526620430|FG002|Maintanance Phase|Physician Decision|0|||
146029258|NCT02088073|526620431|FG003|Maintanance Phase|Physician Decision|0|||
146029259|NCT02088073|526620432|FG004|Maintanance Phase|Physician Decision|1|||
146029260|NCT02088073|526620428|FG000|Maintanance Phase|Sponsor's decision|0|||
146029261|NCT02088073|526620429|FG001|Maintanance Phase|Sponsor's decision|2|||
146029262|NCT02088073|526620430|FG002|Maintanance Phase|Sponsor's decision|0|||
146029263|NCT02088073|526620431|FG003|Maintanance Phase|Sponsor's decision|2|||
146029264|NCT02088073|526620432|FG004|Maintanance Phase|Sponsor's decision|1|||
146029265|NCT02088073|526620428|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
146029266|NCT02088073|526620429|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
146029267|NCT02088073|526620430|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
146029268|NCT02088073|526620431|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
146029269|NCT02088073|526620432|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
146029270|NCT02088073|526620428|FG000|Maintanance Phase|Miscellaneous|0|||
146029271|NCT02088073|526620429|FG001|Maintanance Phase|Miscellaneous|2|||
146029272|NCT02088073|526620430|FG002|Maintanance Phase|Miscellaneous|1|||
146029273|NCT02088073|526620431|FG003|Maintanance Phase|Miscellaneous|2|||
146029274|NCT02088073|526620432|FG004|Maintanance Phase|Miscellaneous|1|||
146029275|NCT02088073|526620428|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
146029276|NCT02088073|526620429|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
146029277|NCT02088073|526620430|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
146029278|NCT02088073|526620431|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
146029279|NCT02088073|526620432|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
146029280|NCT02088073|526620428|FG000|Maintanance Phase|Subject compliance|0|||
146029281|NCT02088073|526620429|FG001|Maintanance Phase|Subject compliance|1|||
146029282|NCT02088073|526620430|FG002|Maintanance Phase|Subject compliance|0|||
146029283|NCT02088073|526620431|FG003|Maintanance Phase|Subject compliance|0|||
146029284|NCT02088073|526620432|FG004|Maintanance Phase|Subject compliance|0|||
146029285|NCT00520013|526620433|FG000|Overall Study|Withdrawal by Subject|0|||
146029286|NCT00520013|526620434|FG001|Overall Study|Withdrawal by Subject|0|||
146029287|NCT00520013|526620435|FG002|Overall Study|Withdrawal by Subject|1|||
146096052|NCT01871142|526874435|FG000|Overall Study|Adverse Event|1|||
146096053|NCT00734474|526874439|FG000|Overall Study|Entry Criteria Not Met|0|||
146096054|NCT00734474|526874440|FG001|Overall Study|Entry Criteria Not Met|0|||
146096055|NCT00734474|526874441|FG002|Overall Study|Entry Criteria Not Met|5|||
146096056|NCT00734474|526874442|FG003|Overall Study|Entry Criteria Not Met|0|||
146096057|NCT00734474|526874443|FG004|Overall Study|Entry Criteria Not Met|3|||
146096058|NCT00734474|526874444|FG005|Overall Study|Entry Criteria Not Met|1|||
146096059|NCT00734474|526874445|FG006|Overall Study|Entry Criteria Not Met|0|||
146096060|NCT00734474|526874446|FG007|Overall Study|Entry Criteria Not Met|1|||
146096061|NCT00734474|526874447|FG008|Overall Study|Entry Criteria Not Met|1|||
146096062|NCT00734474|526874439|FG000|Overall Study|Lost to Follow-up|1|||
146096063|NCT00734474|526874440|FG001|Overall Study|Lost to Follow-up|0|||
146096064|NCT00734474|526874441|FG002|Overall Study|Lost to Follow-up|13|||
146096065|NCT00734474|526874442|FG003|Overall Study|Lost to Follow-up|0|||
146096066|NCT00734474|526874443|FG004|Overall Study|Lost to Follow-up|11|||
146096067|NCT00734474|526874444|FG005|Overall Study|Lost to Follow-up|1|||
146096068|NCT00734474|526874445|FG006|Overall Study|Lost to Follow-up|0|||
146096069|NCT00734474|526874446|FG007|Overall Study|Lost to Follow-up|9|||
146096070|NCT00734474|526874447|FG008|Overall Study|Lost to Follow-up|4|||
146096071|NCT00734474|526874439|FG000|Overall Study|Withdrawal by Subject|2|||
146096072|NCT00734474|526874440|FG001|Overall Study|Withdrawal by Subject|1|||
146096073|NCT00734474|526874441|FG002|Overall Study|Withdrawal by Subject|18|||
146096074|NCT00734474|526874442|FG003|Overall Study|Withdrawal by Subject|0|||
146096075|NCT00734474|526874443|FG004|Overall Study|Withdrawal by Subject|24|||
146096076|NCT00734474|526874444|FG005|Overall Study|Withdrawal by Subject|2|||
146096077|NCT00734474|526874445|FG006|Overall Study|Withdrawal by Subject|0|||
146096078|NCT00734474|526874446|FG007|Overall Study|Withdrawal by Subject|36|||
146096079|NCT00734474|526874447|FG008|Overall Study|Withdrawal by Subject|21|||
146096080|NCT00734474|526874439|FG000|Overall Study|Physician Decision|0|||
146096081|NCT00734474|526874440|FG001|Overall Study|Physician Decision|0|||
146029288|NCT00520013|526620433|FG000|Overall Study|Adverse Event|2|||
146029289|NCT00520013|526620434|FG001|Overall Study|Adverse Event|10|||
146029290|NCT00520013|526620435|FG002|Overall Study|Adverse Event|7|||
146029291|NCT00520013|526620433|FG000|Overall Study|Progressive Disease|7|||
146029292|NCT00520013|526620434|FG001|Overall Study|Progressive Disease|3|||
146029293|NCT00520013|526620435|FG002|Overall Study|Progressive Disease|0|||
146029294|NCT00520013|526620433|FG000|Overall Study|Clinical Progression|3|||
146029295|NCT00520013|526620434|FG001|Overall Study|Clinical Progression|1|||
146029296|NCT00520013|526620435|FG002|Overall Study|Clinical Progression|0|||
146029297|NCT00520013|526620433|FG000|Overall Study|Death|0|||
146029298|NCT00520013|526620434|FG001|Overall Study|Death|1|||
146029299|NCT00520013|526620435|FG002|Overall Study|Death|0|||
146029300|NCT00520013|526620433|FG000|Overall Study|Physician Decision|0|||
146029301|NCT00520013|526620434|FG001|Overall Study|Physician Decision|0|||
146029302|NCT00520013|526620435|FG002|Overall Study|Physician Decision|3|||
146029303|NCT03684304|526620436|FG000|Overall Study|Lost to Follow-up|19|||
146029304|NCT03684304|526620437|FG001|Overall Study|Lost to Follow-up|17|||
146029305|NCT01009346|526620438|FG000|Overall Study|Adverse Event|4|||
146029306|NCT02266875|526620443|FG000|Overall Study|Withdrawal by Subject|9|||
146029307|NCT02266875|526620444|FG001|Overall Study|Withdrawal by Subject|0|||
146029308|NCT02266875|526620443|FG000|Overall Study|Lost to Follow-up|2|||
146029309|NCT02266875|526620444|FG001|Overall Study|Lost to Follow-up|0|||
146029310|NCT02956850|526620446|FG000|Overall Study|Withdrawal by Subject|0|||
146029311|NCT02956850|526620447|FG001|Overall Study|Withdrawal by Subject|0|||
146029312|NCT02956850|526620448|FG002|Overall Study|Withdrawal by Subject|0|||
146029313|NCT02956850|526620449|FG003|Overall Study|Withdrawal by Subject|0|||
146029314|NCT02956850|526620450|FG004|Overall Study|Withdrawal by Subject|0|||
146029315|NCT02956850|526620451|FG005|Overall Study|Withdrawal by Subject|0|||
146029316|NCT02956850|526620452|FG006|Overall Study|Withdrawal by Subject|0|||
146029317|NCT02956850|526620453|FG007|Overall Study|Withdrawal by Subject|0|||
146029318|NCT02956850|526620454|FG008|Overall Study|Withdrawal by Subject|0|||
146029319|NCT02956850|526620455|FG009|Overall Study|Withdrawal by Subject|0|||
146029320|NCT02956850|526620456|FG010|Overall Study|Withdrawal by Subject|0|||
146029321|NCT02956850|526620457|FG011|Overall Study|Withdrawal by Subject|0|||
146029322|NCT02956850|526620458|FG012|Overall Study|Withdrawal by Subject|0|||
146029323|NCT02956850|526620459|FG013|Overall Study|Withdrawal by Subject|0|||
146029324|NCT02956850|526620460|FG014|Overall Study|Withdrawal by Subject|0|||
146029325|NCT02956850|526620461|FG015|Overall Study|Withdrawal by Subject|0|||
146029326|NCT02956850|526620462|FG016|Overall Study|Withdrawal by Subject|0|||
146029327|NCT02956850|526620463|FG017|Overall Study|Withdrawal by Subject|1|||
146029328|NCT01920152|526620466|FG000|Overall Study|Withdrawal by Subject|1|||
146029329|NCT01920152|526620467|FG001|Overall Study|Withdrawal by Subject|2|||
146029330|NCT00849875|526620469|FG000|Overall Study|Death|28|||
146029331|NCT00849875|526620469|FG000|Overall Study|Ongoing (unknown completion status)|11|||
146029332|NCT00849875|526620469|FG000|Overall Study|Others|6|||
146029333|NCT00849875|526620469|FG000|Overall Study|Lost to Follow-up|2|||
146029334|NCT01304329|526620470|FG000|Third Intervention (3 Days)|Adverse Event|0|||
146029335|NCT01304329|526620471|FG001|Third Intervention (3 Days)|Adverse Event|1|||
146029336|NCT01304329|526620472|FG002|Third Intervention (3 Days)|Adverse Event|0|||
146029337|NCT01304329|526620473|FG003|Third Intervention (3 Days)|Adverse Event|0|||
146029338|NCT01304329|526620474|FG004|Third Intervention (3 Days)|Adverse Event|0|||
146029339|NCT01304329|526620475|FG005|Third Intervention (3 Days)|Adverse Event|0|||
146029340|NCT03515941|526620487|FG000|Overall Study|Adverse Event|1|||
146029341|NCT03515941|526620488|FG001|Overall Study|Adverse Event|0|||
146029342|NCT00276094|526620489|FG000|Overall Study|Adverse Event|15|||
146029343|NCT00276094|526620490|FG001|Overall Study|Adverse Event|13|||
146029344|NCT00276094|526620491|FG002|Overall Study|Adverse Event|11|||
146029345|NCT00276094|526620489|FG000|Overall Study|Withdrawal by Subject|14|||
146029346|NCT00276094|526620490|FG001|Overall Study|Withdrawal by Subject|14|||
146029347|NCT00276094|526620491|FG002|Overall Study|Withdrawal by Subject|12|||
146029348|NCT00276094|526620489|FG000|Overall Study|Protocol Violation|16|||
146029349|NCT00276094|526620490|FG001|Overall Study|Protocol Violation|7|||
146029350|NCT00276094|526620491|FG002|Overall Study|Protocol Violation|10|||
146029351|NCT00276094|526620489|FG000|Overall Study|Lost to Follow-up|8|||
146029352|NCT00276094|526620490|FG001|Overall Study|Lost to Follow-up|6|||
146029353|NCT00276094|526620491|FG002|Overall Study|Lost to Follow-up|4|||
146096082|NCT00734474|526874441|FG002|Overall Study|Physician Decision|4|||
146029354|NCT00276094|526620489|FG000|Overall Study|Other-Subject moved out of country|1|||
146029355|NCT00276094|526620490|FG001|Overall Study|Other-Subject moved out of country|0|||
146029356|NCT00276094|526620491|FG002|Overall Study|Other-Subject moved out of country|0|||
146029357|NCT00276094|526620489|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
146029358|NCT00276094|526620490|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
146029359|NCT00276094|526620491|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
146029360|NCT00276094|526620489|FG000|Overall Study|Other-Lack of efficacy|1|||
146029361|NCT00276094|526620490|FG001|Overall Study|Other-Lack of efficacy|0|||
146029362|NCT00276094|526620491|FG002|Overall Study|Other-Lack of efficacy|0|||
146029363|NCT00276094|526620489|FG000|Overall Study|Other-Refused follow-up visit|1|||
146029364|NCT00276094|526620490|FG001|Overall Study|Other-Refused follow-up visit|0|||
146029365|NCT00276094|526620491|FG002|Overall Study|Other-Refused follow-up visit|0|||
146029366|NCT00276094|526620489|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
146029367|NCT00276094|526620490|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
146029368|NCT00276094|526620491|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
146029369|NCT00276094|526620489|FG000|Overall Study|Other-Relocation|0|||
146029370|NCT00276094|526620490|FG001|Overall Study|Other-Relocation|1|||
146029371|NCT00276094|526620491|FG002|Overall Study|Other-Relocation|0|||
146029372|NCT00276094|526620489|FG000|Overall Study|Other-Study medication lost|0|||
146029373|NCT00276094|526620490|FG001|Overall Study|Other-Study medication lost|0|||
146029374|NCT00276094|526620491|FG002|Overall Study|Other-Study medication lost|1|||
146029375|NCT02759315|526620492|FG000|Overall Study|Adverse Event|0|||
146029376|NCT02759315|526620493|FG001|Overall Study|Adverse Event|0|||
146029377|NCT02759315|526620494|FG002|Overall Study|Adverse Event|0|||
146029378|NCT02759315|526620495|FG003|Overall Study|Adverse Event|1|||
146029379|NCT02759315|526620496|FG004|Overall Study|Adverse Event|0|||
146029380|NCT02759315|526620492|FG000|Overall Study|Death|0|||
146029381|NCT02759315|526620493|FG001|Overall Study|Death|0|||
146029382|NCT02759315|526620494|FG002|Overall Study|Death|1|||
146029383|NCT02759315|526620495|FG003|Overall Study|Death|0|||
146029384|NCT02759315|526620496|FG004|Overall Study|Death|0|||
146029385|NCT02759315|526620492|FG000|Overall Study|Lost to Follow-up|2|||
146029386|NCT02759315|526620493|FG001|Overall Study|Lost to Follow-up|0|||
146029387|NCT02759315|526620494|FG002|Overall Study|Lost to Follow-up|4|||
146029388|NCT02759315|526620495|FG003|Overall Study|Lost to Follow-up|0|||
146029389|NCT02759315|526620496|FG004|Overall Study|Lost to Follow-up|0|||
146029390|NCT02759315|526620492|FG000|Overall Study|Protocol Violation|0|||
146029391|NCT02759315|526620493|FG001|Overall Study|Protocol Violation|1|||
146029392|NCT02759315|526620494|FG002|Overall Study|Protocol Violation|0|||
146029393|NCT02759315|526620495|FG003|Overall Study|Protocol Violation|0|||
146029394|NCT02759315|526620496|FG004|Overall Study|Protocol Violation|0|||
146029395|NCT02759315|526620492|FG000|Overall Study|Study terminated prior to completion|2|||
146029396|NCT02759315|526620493|FG001|Overall Study|Study terminated prior to completion|0|||
146029397|NCT02759315|526620494|FG002|Overall Study|Study terminated prior to completion|5|||
146029398|NCT02759315|526620495|FG003|Overall Study|Study terminated prior to completion|0|||
146029399|NCT02759315|526620496|FG004|Overall Study|Study terminated prior to completion|1|||
146029400|NCT01406015|526620499|FG000|Overall Study|Withdrawal by Subject|3|||
146029401|NCT01406015|526620500|FG001|Overall Study|Withdrawal by Subject|3|||
146029402|NCT00787137|526620501|FG000|Overall Study|Study Termination|0|||
146029403|NCT00787137|526620502|FG001|Overall Study|Study Termination|0|||
146029404|NCT00787137|526620503|FG002|Overall Study|Study Termination|1|||
146029405|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
146029406|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
146029407|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
146029408|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
146029409|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
146029410|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
146029411|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146029412|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146029413|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
146029414|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
146029415|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
146029416|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
146029417|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
146029418|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
146029419|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
146029420|NCT00554099|526620507|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146029421|NCT00554099|526620508|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
146029422|NCT00554099|526620509|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146029423|NCT00554099|526620507|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
146029424|NCT00554099|526620508|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
146029425|NCT00554099|526620509|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
146254189|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
146029426|NCT00554099|526620507|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
146029427|NCT00554099|526620508|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
146029428|NCT00554099|526620509|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
146029429|NCT00554099|526620507|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
146029430|NCT00554099|526620508|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
146029431|NCT00554099|526620509|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
146029432|NCT02075632|526620513|FG000|Overall Study|Adverse Event|1|||
146029433|NCT02075632|526620514|FG001|Overall Study|Adverse Event|1|||
146254190|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
146029434|NCT02075632|526620513|FG000|Overall Study|Lost to Follow-up|0|||
146029435|NCT02075632|526620514|FG001|Overall Study|Lost to Follow-up|3|||
146029436|NCT02075632|526620513|FG000|Overall Study|Withdrawal by Subject|0|||
146029437|NCT02075632|526620514|FG001|Overall Study|Withdrawal by Subject|1|||
146029438|NCT01628367|526620517|FG000|Overall Study|Adverse Event|1|||
146029439|NCT01628367|526620518|FG001|Overall Study|Adverse Event|0|||
146029440|NCT03353922|526620521|FG000|Overall Study|Withdrawal by Subject|1|||
146029441|NCT03353922|526620522|FG001|Overall Study|Withdrawal by Subject|0|||
146029442|NCT03353922|526620523|FG002|Overall Study|Withdrawal by Subject|1|||
146029443|NCT03353922|526620524|FG003|Overall Study|Withdrawal by Subject|1|||
146029444|NCT03353922|526620525|FG004|Overall Study|Withdrawal by Subject|0|||
146029445|NCT03353922|526620526|FG005|Overall Study|Withdrawal by Subject|0|||
146029446|NCT03353922|526620521|FG000|Overall Study|Adverse Event|0|||
146029447|NCT03353922|526620522|FG001|Overall Study|Adverse Event|1|||
146029448|NCT03353922|526620523|FG002|Overall Study|Adverse Event|0|||
146029449|NCT03353922|526620524|FG003|Overall Study|Adverse Event|0|||
146029450|NCT03353922|526620525|FG004|Overall Study|Adverse Event|0|||
146029451|NCT03353922|526620526|FG005|Overall Study|Adverse Event|0|||
146029452|NCT00740714|526620527|FG000|Overall Study|Withdrawal by Subject|17|||
146029453|NCT00740714|526620528|FG001|Overall Study|Withdrawal by Subject|19|||
146029454|NCT00740714|526620529|FG002|Overall Study|Withdrawal by Subject|29|||
146029455|NCT03688555|526620530|FG000|Treatment Period|Adverse Event|0|||
146029456|NCT03688555|526620531|FG001|Treatment Period|Adverse Event|0|||
146029457|NCT03688555|526620532|FG002|Treatment Period|Adverse Event|1|||
146029458|NCT00886119|526620537|FG000|Period 1|Did not meet inclusion criteria|1|||
146029459|NCT00886119|526620538|FG001|Period 1|Did not meet inclusion criteria|0|||
146029460|NCT00394901|526620539|FG000|Baseline Phase|Protocol Violation|0|||
146029461|NCT00394901|526620540|FG001|Baseline Phase|Protocol Violation|0|||
146029462|NCT00394901|526620541|FG002|Baseline Phase|Protocol Violation|1|||
146029463|NCT00394901|526620542|FG003|Baseline Phase|Protocol Violation|0|||
146029464|NCT00394901|526620539|FG000|Double-blind Phase|Adverse Event|5|||
146029465|NCT00394901|526620540|FG001|Double-blind Phase|Adverse Event|7|||
146029466|NCT00394901|526620541|FG002|Double-blind Phase|Adverse Event|16|||
146029467|NCT00394901|526620542|FG003|Double-blind Phase|Adverse Event|20|||
146029468|NCT00394901|526620539|FG000|Double-blind Phase|Lack of Efficacy|6|||
146029469|NCT00394901|526620540|FG001|Double-blind Phase|Lack of Efficacy|4|||
146029470|NCT00394901|526620541|FG002|Double-blind Phase|Lack of Efficacy|1|||
146029471|NCT00394901|526620542|FG003|Double-blind Phase|Lack of Efficacy|3|||
146029472|NCT00394901|526620539|FG000|Double-blind Phase|Withdrawal by Subject|2|||
146029473|NCT00394901|526620540|FG001|Double-blind Phase|Withdrawal by Subject|0|||
146029474|NCT00394901|526620541|FG002|Double-blind Phase|Withdrawal by Subject|0|||
146029475|NCT00394901|526620542|FG003|Double-blind Phase|Withdrawal by Subject|0|||
146029476|NCT00394901|526620539|FG000|Double-blind Phase|Lost to Follow-up|0|||
146029477|NCT00394901|526620540|FG001|Double-blind Phase|Lost to Follow-up|0|||
146029478|NCT00394901|526620541|FG002|Double-blind Phase|Lost to Follow-up|0|||
146029479|NCT00394901|526620542|FG003|Double-blind Phase|Lost to Follow-up|1|||
146029480|NCT00394901|526620539|FG000|Double-blind Phase|Protocol Violation|0|||
146029481|NCT00394901|526620540|FG001|Double-blind Phase|Protocol Violation|0|||
146029482|NCT00394901|526620541|FG002|Double-blind Phase|Protocol Violation|0|||
146029483|NCT00394901|526620542|FG003|Double-blind Phase|Protocol Violation|1|||
146029484|NCT00394901|526620539|FG000|Double-blind Phase|Death|1|||
146029485|NCT00394901|526620540|FG001|Double-blind Phase|Death|0|||
146029486|NCT00394901|526620541|FG002|Double-blind Phase|Death|0|||
146029487|NCT00394901|526620542|FG003|Double-blind Phase|Death|0|||
146029488|NCT00394901|526620539|FG000|Double-blind Phase|Subject's Personal Reason|1|||
146029489|NCT00394901|526620540|FG001|Double-blind Phase|Subject's Personal Reason|0|||
146029490|NCT00394901|526620541|FG002|Double-blind Phase|Subject's Personal Reason|0|||
146029491|NCT00394901|526620542|FG003|Double-blind Phase|Subject's Personal Reason|1|||
146029492|NCT00394901|526620539|FG000|Double-blind Phase|Lack of Compliance|0|||
146029493|NCT00394901|526620540|FG001|Double-blind Phase|Lack of Compliance|3|||
146029494|NCT00394901|526620541|FG002|Double-blind Phase|Lack of Compliance|0|||
146029495|NCT00394901|526620542|FG003|Double-blind Phase|Lack of Compliance|0|||
146029496|NCT00394901|526620539|FG000|Double-blind Phase|Entry into another study was found|0|||
146029497|NCT00394901|526620540|FG001|Double-blind Phase|Entry into another study was found|0|||
146029498|NCT00394901|526620541|FG002|Double-blind Phase|Entry into another study was found|1|||
146029499|NCT00394901|526620542|FG003|Double-blind Phase|Entry into another study was found|0|||
146029500|NCT00394901|526620539|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
146029501|NCT00394901|526620540|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
146029502|NCT00394901|526620541|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
146029503|NCT00394901|526620542|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
146029504|NCT03002623|526620543|FG000|Overall Study|Lost to Follow-up|1|||
146029505|NCT03002623|526620544|FG001|Overall Study|Lost to Follow-up|0|||
146029506|NCT03002623|526620543|FG000|Overall Study|Physician Decision|1|||
146029507|NCT03002623|526620544|FG001|Overall Study|Physician Decision|1|||
146029508|NCT02256267|526620545|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
146029509|NCT02256267|526620545|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
146029510|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
146029511|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
146096083|NCT00734474|526874442|FG003|Overall Study|Physician Decision|1|||
146029512|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
146029513|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
146029514|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
146029515|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
146029516|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
146029517|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
146029518|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
146029519|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
146029520|NCT01352741|526620548|FG000|Open-label Tapentadol Titration Period|Other|4|||
146029521|NCT01352741|526620549|FG001|Open-label Tapentadol Titration Period|Other|0|||
146029522|NCT01352741|526620548|FG000|Double-blind Comparative Period|Protocol Violation|2|||
146029523|NCT01352741|526620549|FG001|Double-blind Comparative Period|Protocol Violation|0|||
146029524|NCT01352741|526620548|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
146029525|NCT01352741|526620549|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
146029526|NCT01352741|526620548|FG000|Double-blind Comparative Period|Adverse Event|16|||
146029527|NCT01352741|526620549|FG001|Double-blind Comparative Period|Adverse Event|17|||
146029528|NCT01352741|526620548|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
146029529|NCT01352741|526620549|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
146029530|NCT01352741|526620548|FG000|Double-blind Comparative Period|Death|0|||
146029531|NCT01352741|526620549|FG001|Double-blind Comparative Period|Death|1|||
146029532|NCT01352741|526620548|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
146029533|NCT01352741|526620549|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
146029534|NCT01352741|526620548|FG000|Double-blind Comparative Period|Other|1|||
146029535|NCT01352741|526620549|FG001|Double-blind Comparative Period|Other|2|||
146029536|NCT01352741|526620548|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
146029537|NCT01352741|526620549|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
146029538|NCT01352741|526620548|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
146029539|NCT01352741|526620549|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
146029540|NCT01352741|526620548|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
146029541|NCT01352741|526620549|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
146029542|NCT01352741|526620548|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
146029543|NCT01352741|526620549|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
146029544|NCT00259298|526620550|FG000|Overall Study|Withdrawal by Subject|1|||
146029545|NCT00259298|526620550|FG000|Overall Study|Physician Decision|2|||
146029546|NCT00645528|526620551|FG000|Overall Study|Did not show up for Visit 2|7|||
146029547|NCT03618628|526620555|FG000|Overall Study|Death|1|||
146029548|NCT03618628|526620555|FG000|Overall Study|Lost to Follow-up|1|||
146029549|NCT01969500|526620556|FG000|Overall Study|Death|0|||
146029550|NCT01969500|526620557|FG001|Overall Study|Death|1|||
146029551|NCT01969500|526620556|FG000|Overall Study|extended hospitalization|1|||
146029552|NCT01969500|526620557|FG001|Overall Study|extended hospitalization|1|||
146029553|NCT01741532|526620558|FG000|Overall Study|Adverse Event|4|||
146029554|NCT01741532|526620559|FG001|Overall Study|Adverse Event|0|||
146029555|NCT01741532|526620558|FG000|Overall Study|Withdrawal by Subject|1|||
146029556|NCT01741532|526620559|FG001|Overall Study|Withdrawal by Subject|1|||
146029557|NCT01741532|526620558|FG000|Overall Study|Protocol Violation|0|||
146029558|NCT01741532|526620559|FG001|Overall Study|Protocol Violation|1|||
146029559|NCT01741532|526620558|FG000|Overall Study|Worsening of the disease|3|||
146029560|NCT01741532|526620559|FG001|Overall Study|Worsening of the disease|1|||
146029561|NCT01741532|526620558|FG000|Overall Study|Sponsor decision|1|||
146029562|NCT01741532|526620559|FG001|Overall Study|Sponsor decision|0|||
146029563|NCT01741532|526620558|FG000|Overall Study|Medical event|1|||
146029564|NCT01741532|526620559|FG001|Overall Study|Medical event|0|||
146029565|NCT02463032|526620560|FG000|Overall Study|Lack of Efficacy|61|||
146029566|NCT02463032|526620561|FG001|Overall Study|Lack of Efficacy|50|||
146029567|NCT02463032|526620560|FG000|Overall Study|Death|8|||
146096084|NCT00734474|526874443|FG004|Overall Study|Physician Decision|11|||
146096085|NCT00734474|526874444|FG005|Overall Study|Physician Decision|0|||
146096086|NCT00734474|526874445|FG006|Overall Study|Physician Decision|0|||
146029568|NCT02463032|526620561|FG001|Overall Study|Death|8|||
146029569|NCT02463032|526620560|FG000|Overall Study|Adverse Event|2|||
146029570|NCT02463032|526620561|FG001|Overall Study|Adverse Event|6|||
146029571|NCT00613080|526620562|FG000|Overall Study|Ineligible / no protocol treatment|11|||
146096087|NCT00734474|526874446|FG007|Overall Study|Physician Decision|9|||
146029572|NCT00612508|526620563|FG000|Overall Study|Withdrawal by Subject|3|||
146029573|NCT00612508|526620564|FG001|Overall Study|Withdrawal by Subject|4|||
146029574|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
146029575|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
146029576|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
146096088|NCT00734474|526874447|FG008|Overall Study|Physician Decision|9|||
146096089|NCT00734474|526874439|FG000|Overall Study|Adverse Event|4|||
146096090|NCT00734474|526874440|FG001|Overall Study|Adverse Event|4|||
146300336|NCT02101021|527615227|FG000|Overall Study|Withdrew Consent from study|1|||
146300337|NCT02101021|527615228|FG001|Overall Study|Withdrew Consent from study|1|||
146300338|NCT02101021|527615229|FG002|Overall Study|Withdrew Consent from study|0|||
146300339|NCT02101021|527615230|FG003|Overall Study|Withdrew Consent from study|2|||
146029577|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
146029578|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
146029579|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
146029580|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
146029581|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
146029582|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
146029583|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
146029584|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
146029585|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
146029586|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
146029587|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
146029588|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
146029589|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
146029590|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
146029591|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
146029592|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
146029593|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
146029594|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
146029595|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
146029596|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
146029597|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
146029598|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
146029599|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
146029600|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
146029601|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
146029602|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
146029603|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
146029604|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
146029605|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
146029606|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
146029607|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
146029608|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
146029609|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
146029610|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
146029611|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
146029612|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
146029613|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
146029614|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
146029615|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
146029616|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
146029617|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
146029618|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
146029619|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
146029620|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
146029621|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
146029622|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
146029623|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
146029624|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
146029625|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
146029626|NCT02008357|526620565|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
146029627|NCT02008357|526620566|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
146300340|NCT02101021|527615231|FG004|Overall Study|Withdrew Consent from study|0|||
146029628|NCT02008357|526620565|FG000|Open-label Extension Period|Adverse Event|8|||
146029629|NCT02008357|526620566|FG001|Open-label Extension Period|Adverse Event|7|||
146300341|NCT02101021|527615227|FG000|Overall Study|Lost to Follow-up|1|||
146300342|NCT02101021|527615228|FG001|Overall Study|Lost to Follow-up|0|||
146254191|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
146254192|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
146254193|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
146254194|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
146254195|NCT01379521|527443071|FG000|Overall Study -Treatment Period|Death|2|||
146254196|NCT01379521|527443072|FG001|Overall Study -Treatment Period|Death|1|||
146254197|NCT01379521|527443071|FG000|Post-Treatment Evaluations|Disease Progression|22|||
146029630|NCT02008357|526620565|FG000|Open-label Extension Period|Death|7|||
146029631|NCT02008357|526620566|FG001|Open-label Extension Period|Death|4|||
146029632|NCT02008357|526620565|FG000|Open-label Extension Period|Lack of Efficacy|9|||
146029633|NCT02008357|526620566|FG001|Open-label Extension Period|Lack of Efficacy|5|||
146029634|NCT02008357|526620565|FG000|Open-label Extension Period|Lost to Follow-up|2|||
146029635|NCT02008357|526620566|FG001|Open-label Extension Period|Lost to Follow-up|2|||
146029636|NCT02008357|526620565|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
146029637|NCT02008357|526620566|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
146029638|NCT02008357|526620565|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
146029639|NCT02008357|526620566|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
146029640|NCT02008357|526620565|FG000|Open-label Extension Period|Safety Risk|2|||
146029641|NCT02008357|526620566|FG001|Open-label Extension Period|Safety Risk|1|||
146029642|NCT02008357|526620565|FG000|Open-label Extension Period|Non-Compliance|0|||
146029643|NCT02008357|526620566|FG001|Open-label Extension Period|Non-Compliance|1|||
146029644|NCT02008357|526620565|FG000|Open-label Extension Period|Investigator Recommendation|0|||
146029645|NCT02008357|526620566|FG001|Open-label Extension Period|Investigator Recommendation|1|||
146029646|NCT02008357|526620565|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
146029647|NCT02008357|526620566|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
146029648|NCT02008357|526620565|FG000|Open-label Extension Period|Coordinating Center Request|2|||
146029649|NCT02008357|526620566|FG001|Open-label Extension Period|Coordinating Center Request|4|||
146029650|NCT02008357|526620565|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
146029651|NCT02008357|526620566|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
146029652|NCT02008357|526620565|FG000|Open-label Extension Period|Study Ended|20|||
146029653|NCT02008357|526620566|FG001|Open-label Extension Period|Study Ended|25|||
146029654|NCT02008357|526620565|FG000|Open-label Extension Period|Personal Reasons|0|||
146029655|NCT02008357|526620566|FG001|Open-label Extension Period|Personal Reasons|1|||
146029656|NCT02008357|526620565|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
146029657|NCT02008357|526620566|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
146029658|NCT02008357|526620565|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
146029659|NCT02008357|526620566|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
146029660|NCT02008357|526620565|FG000|Open-label Extension Period|Other|2|||
146029661|NCT02008357|526620566|FG001|Open-label Extension Period|Other|0|||
146029662|NCT01442064|526620567|FG000|Overall Study|Adverse Event|2|||
146029663|NCT01442064|526620568|FG001|Overall Study|Adverse Event|2|||
146029664|NCT01442064|526620569|FG002|Overall Study|Adverse Event|2|||
146029665|NCT01442064|526620570|FG003|Overall Study|Adverse Event|1|||
146029666|NCT01442064|526620571|FG004|Overall Study|Adverse Event|2|||
146029667|NCT01442064|526620572|FG005|Overall Study|Adverse Event|0|||
146029668|NCT01442064|526620567|FG000|Overall Study|Death|0|||
146029669|NCT01442064|526620568|FG001|Overall Study|Death|1|||
146029670|NCT01442064|526620569|FG002|Overall Study|Death|3|||
146029671|NCT01442064|526620570|FG003|Overall Study|Death|3|||
146029672|NCT01442064|526620571|FG004|Overall Study|Death|1|||
146029673|NCT01442064|526620572|FG005|Overall Study|Death|3|||
146029674|NCT01442064|526620567|FG000|Overall Study|Lost to Follow-up|5|||
146029675|NCT01442064|526620568|FG001|Overall Study|Lost to Follow-up|5|||
146029676|NCT01442064|526620569|FG002|Overall Study|Lost to Follow-up|1|||
146029677|NCT01442064|526620570|FG003|Overall Study|Lost to Follow-up|1|||
146029678|NCT01442064|526620571|FG004|Overall Study|Lost to Follow-up|3|||
146029679|NCT01442064|526620572|FG005|Overall Study|Lost to Follow-up|3|||
146029680|NCT01442064|526620567|FG000|Overall Study|Physician Decision|1|||
146029681|NCT01442064|526620568|FG001|Overall Study|Physician Decision|1|||
146029682|NCT01442064|526620569|FG002|Overall Study|Physician Decision|2|||
146029683|NCT01442064|526620570|FG003|Overall Study|Physician Decision|3|||
146029684|NCT01442064|526620571|FG004|Overall Study|Physician Decision|3|||
146029685|NCT01442064|526620572|FG005|Overall Study|Physician Decision|1|||
146029686|NCT01442064|526620567|FG000|Overall Study|Withdrawal by Subject|6|||
146029687|NCT01442064|526620568|FG001|Overall Study|Withdrawal by Subject|3|||
146029688|NCT01442064|526620569|FG002|Overall Study|Withdrawal by Subject|2|||
146254198|NCT01379521|527443072|FG001|Post-Treatment Evaluations|Disease Progression|20|||
146029689|NCT01442064|526620570|FG003|Overall Study|Withdrawal by Subject|2|||
146029690|NCT01442064|526620571|FG004|Overall Study|Withdrawal by Subject|2|||
146029691|NCT01442064|526620572|FG005|Overall Study|Withdrawal by Subject|1|||
146029692|NCT01442064|526620567|FG000|Overall Study|Sponsor decision|82|||
146029693|NCT01442064|526620568|FG001|Overall Study|Sponsor decision|88|||
146029694|NCT01442064|526620569|FG002|Overall Study|Sponsor decision|92|||
146029695|NCT01442064|526620570|FG003|Overall Study|Sponsor decision|88|||
146029696|NCT01442064|526620571|FG004|Overall Study|Sponsor decision|95|||
146029697|NCT01442064|526620572|FG005|Overall Study|Sponsor decision|87|||
146029698|NCT01442064|526620567|FG000|Overall Study|Subject non-compliance|0|||
146029699|NCT01442064|526620568|FG001|Overall Study|Subject non-compliance|0|||
146029700|NCT01442064|526620569|FG002|Overall Study|Subject non-compliance|0|||
146029701|NCT01442064|526620570|FG003|Overall Study|Subject non-compliance|0|||
146029702|NCT01442064|526620571|FG004|Overall Study|Subject non-compliance|0|||
146029703|NCT01442064|526620572|FG005|Overall Study|Subject non-compliance|2|||
146029704|NCT01442064|526620567|FG000|Overall Study|Condition mandated other intervention|1|||
146029705|NCT01442064|526620568|FG001|Overall Study|Condition mandated other intervention|1|||
146029706|NCT01442064|526620569|FG002|Overall Study|Condition mandated other intervention|2|||
146029707|NCT01442064|526620570|FG003|Overall Study|Condition mandated other intervention|0|||
146029708|NCT01442064|526620571|FG004|Overall Study|Condition mandated other intervention|0|||
146029709|NCT01442064|526620572|FG005|Overall Study|Condition mandated other intervention|2|||
146029710|NCT02312219|526620573|FG000|Overall Study|Withdrawal by Subject|1|||
146029711|NCT02312219|526620574|FG001|Overall Study|Withdrawal by Subject|2|||
146029712|NCT02312219|526620573|FG000|Overall Study|could not schedule imaging in time|0|||
146029713|NCT02312219|526620574|FG001|Overall Study|could not schedule imaging in time|2|||
146029714|NCT02312219|526620573|FG000|Overall Study|Other|0|||
146029715|NCT02312219|526620574|FG001|Overall Study|Other|1|||
146029716|NCT02312219|526620573|FG000|Overall Study|Not randomized. Ineligible|0|||
146029717|NCT02312219|526620574|FG001|Overall Study|Not randomized. Ineligible|1|||
146029718|NCT02153346|526620575|FG000|Overall Study|Lost to Follow-up|11|||
146029719|NCT01522404|526620580|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
146029720|NCT01522404|526620581|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
146029721|NCT01522404|526620580|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
146029722|NCT01522404|526620581|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
146029723|NCT01522404|526620580|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
146029724|NCT01522404|526620581|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
146029725|NCT01591863|526620582|FG000|Overall Study|Adverse Event|3|||
146029726|NCT01591863|526620582|FG000|Overall Study|Withdrawal by Subject|1|||
146029727|NCT01591863|526620582|FG000|Overall Study|recurrence|9|||
146029728|NCT01591863|526620582|FG000|Overall Study|Lack of Efficacy|1|||
146029729|NCT02366767|526620585|FG000|Overall Study|left for home after 1 day at camp|1|||
146029730|NCT02366767|526620586|FG001|Overall Study|left for home after 1 day at camp|0|||
146029731|NCT00260065|526620589|FG000|Overall Study|Progressive Disease|22|||
146029732|NCT00260065|526620589|FG000|Overall Study|Adverse Event|17|||
146029733|NCT00260065|526620589|FG000|Overall Study|Death|13|||
146029734|NCT00260065|526620589|FG000|Overall Study|Withdrawal by Subject|13|||
146029735|NCT00260065|526620589|FG000|Overall Study|Physician Decision|19|||
146029736|NCT00260065|526620589|FG000|Overall Study|Not otherwise specified|8|||
146029737|NCT00260065|526620589|FG000|Overall Study|Medication Noncompliance|1|||
146029738|NCT04912895|526622197|FG000|Overall Study|Unable to provide specimen|2|||
146029739|NCT04912895|526622198|FG001|Overall Study|Unable to provide specimen|0|||
146029740|NCT04912895|526622199|FG002|Overall Study|Unable to provide specimen|0|||
146029741|NCT02785458|526622200|FG000|1 Month|Withdrawal by Subject|2|||
146029742|NCT02785458|526622201|FG001|1 Month|Withdrawal by Subject|1|||
146029743|NCT02785458|526622200|FG000|1 Month|Lost to Follow-up|38|||
146029744|NCT02785458|526622201|FG001|1 Month|Lost to Follow-up|31|||
146029745|NCT02785458|526622200|FG000|1 Month|Deemed Ineligible|1|||
146029746|NCT02785458|526622201|FG001|1 Month|Deemed Ineligible|0|||
146029747|NCT02785458|526622200|FG000|1 Month|Completed Evaluation by Baseline|42|||
146029748|NCT02785458|526622201|FG001|1 Month|Completed Evaluation by Baseline|39|||
146029749|NCT02785458|526622200|FG000|1 Month|Partial Interview|0|||
146029750|NCT02785458|526622201|FG001|1 Month|Partial Interview|4|||
146029751|NCT02785458|526622200|FG000|3 Months|Withdrawal by Subject|3|||
146029752|NCT02785458|526622201|FG001|3 Months|Withdrawal by Subject|1|||
146029753|NCT02785458|526622200|FG000|3 Months|Lost to Follow-up|25|||
146029754|NCT02785458|526622201|FG001|3 Months|Lost to Follow-up|21|||
146029755|NCT02785458|526622200|FG000|3 Months|Completed Evaluation at 1 Month|100|||
146029756|NCT02785458|526622201|FG001|3 Months|Completed Evaluation at 1 Month|89|||
146029757|NCT01146652|526622202|FG000|Overall Study|Adverse Event|506|||
146029758|NCT01146652|526622203|FG001|Overall Study|Adverse Event|15|||
146029759|NCT01146652|526622202|FG000|Overall Study|Lack of Efficacy|91|||
146029760|NCT01146652|526622203|FG001|Overall Study|Lack of Efficacy|7|||
146254199|NCT01379521|527443071|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
146254200|NCT01379521|527443072|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
146254201|NCT01379521|527443071|FG000|Post-Treatment Evaluations|Death|1|||
146254202|NCT01379521|527443072|FG001|Post-Treatment Evaluations|Death|0|||
146029761|NCT01146652|526622202|FG000|Overall Study|Poor compliance to protocol|38|||
146029762|NCT01146652|526622203|FG001|Overall Study|Poor compliance to protocol|1|||
146029763|NCT01146652|526622202|FG000|Overall Study|Other unspecified reasons|314|||
146029764|NCT01146652|526622203|FG001|Overall Study|Other unspecified reasons|22|||
146029765|NCT01146652|526622202|FG000|Overall Study|Enrolled but not treated|2|||
146029766|NCT01146652|526622203|FG001|Overall Study|Enrolled but not treated|0|||
146029767|NCT02118597|526622204|FG000|Overall Study|Sponsor terminated the study|14|||
146029768|NCT02118597|526622204|FG000|Overall Study|Serious Adverse Event|1|||
146029769|NCT02118597|526622204|FG000|Overall Study|Investigator's decision|1|||
146029770|NCT02590562|526622209|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
146029771|NCT00824005|526622210|FG000|Overall Study|Death|0|||
146029772|NCT00824005|526622211|FG001|Overall Study|Death|1|||
146029773|NCT00824005|526622210|FG000|Overall Study|Lost to Follow-up|0|||
146029774|NCT00824005|526622211|FG001|Overall Study|Lost to Follow-up|1|||
146029775|NCT01866423|526622212|FG000|Overall Study|Lack of Efficacy|3|||
146029776|NCT01866423|526622212|FG000|Overall Study|Sponsor Decision|1|||
146029777|NCT02255565|526622213|FG000|Overall Study|Withdrawal by Subject|0|||
146029778|NCT02255565|526622214|FG001|Overall Study|Withdrawal by Subject|1|||
146029779|NCT02255565|526622215|FG002|Overall Study|Withdrawal by Subject|0|||
146029780|NCT02699450|526622216|FG000|Overall Study|Death|2|||
146029781|NCT02699450|526622217|FG001|Overall Study|Death|1|||
146029782|NCT02699450|526622218|FG002|Overall Study|Death|2|||
146029783|NCT02699450|526622216|FG000|Overall Study|Met Criteria for Study Exit|0|||
146029784|NCT02699450|526622217|FG001|Overall Study|Met Criteria for Study Exit|0|||
146029785|NCT02699450|526622218|FG002|Overall Study|Met Criteria for Study Exit|1|||
146029786|NCT02699450|526622216|FG000|Overall Study|Protocol Violation|4|||
146029787|NCT02699450|526622217|FG001|Overall Study|Protocol Violation|3|||
146029788|NCT02699450|526622218|FG002|Overall Study|Protocol Violation|5|||
146029789|NCT02699450|526622216|FG000|Overall Study|Lost to Follow-up|3|||
146029790|NCT02699450|526622217|FG001|Overall Study|Lost to Follow-up|0|||
146029791|NCT02699450|526622218|FG002|Overall Study|Lost to Follow-up|5|||
146029792|NCT02699450|526622216|FG000|Overall Study|Physician Decision|2|||
146029793|NCT02699450|526622217|FG001|Overall Study|Physician Decision|0|||
146029794|NCT02699450|526622218|FG002|Overall Study|Physician Decision|0|||
146029795|NCT02699450|526622216|FG000|Overall Study|Withdrawal by Subject|3|||
146029796|NCT02699450|526622217|FG001|Overall Study|Withdrawal by Subject|1|||
146029797|NCT02699450|526622218|FG002|Overall Study|Withdrawal by Subject|2|||
146029798|NCT02699450|526622216|FG000|Overall Study|Adverse Event|1|||
146029799|NCT02699450|526622217|FG001|Overall Study|Adverse Event|0|||
146029800|NCT02699450|526622218|FG002|Overall Study|Adverse Event|0|||
146029801|NCT00900146|526622221|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
146029802|NCT00900146|526622222|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
146029803|NCT00900146|526622223|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
146029804|NCT00900146|526622224|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
146029805|NCT00900146|526622225|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
146029806|NCT00900146|526622221|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
146029807|NCT00900146|526622222|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
146029808|NCT00900146|526622223|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
146029809|NCT00900146|526622224|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
146029810|NCT00900146|526622225|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
146029811|NCT00900146|526622221|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
146029812|NCT00900146|526622222|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146029813|NCT00900146|526622223|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146029814|NCT00900146|526622224|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146029815|NCT00900146|526622225|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
146029816|NCT00900146|526622221|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
146029817|NCT00900146|526622222|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
146096091|NCT00734474|526874441|FG002|Overall Study|Adverse Event|63|||
146096092|NCT00734474|526874442|FG003|Overall Study|Adverse Event|1|||
146096093|NCT00734474|526874443|FG004|Overall Study|Adverse Event|64|||
146254203|NCT00938041|527443073|FG000|Overall Study|Lost to Follow-up|6|||
146254204|NCT00938041|527443073|FG000|Overall Study|Received Alternative Therapy|1|||
146254205|NCT00938041|527443073|FG000|Overall Study|Progressive Disease|5|||
146254206|NCT00938041|527443073|FG000|Overall Study|Death|12|||
146254207|NCT00938041|527443073|FG000|Overall Study|Adrenal Insufficiency|3|||
146254208|NCT03042559|527443077|FG000|Overall Study|drop out|1|||
146254209|NCT03042559|527443078|FG001|Overall Study|drop out|1|||
146254210|NCT01536535|527443082|FG000|Overall Study|Withdrawal by Subject|10|||
146254211|NCT01536535|527443083|FG001|Overall Study|Withdrawal by Subject|5|||
146254212|NCT01536535|527443082|FG000|Overall Study|Lost to Follow-up|4|||
146029818|NCT00900146|526622223|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
146029819|NCT00900146|526622224|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
146029820|NCT00900146|526622225|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
146029821|NCT00900146|526622221|FG000|Intermediate: Period III|Lost to Follow-up|2|||
146029822|NCT00900146|526622222|FG001|Intermediate: Period III|Lost to Follow-up|0|||
146029823|NCT00900146|526622223|FG002|Intermediate: Period III|Lost to Follow-up|0|||
146029824|NCT00900146|526622224|FG003|Intermediate: Period III|Lost to Follow-up|0|||
146029825|NCT00900146|526622225|FG004|Intermediate: Period III|Lost to Follow-up|1|||
146096094|NCT00734474|526874444|FG005|Overall Study|Adverse Event|0|||
146254213|NCT01536535|527443083|FG001|Overall Study|Lost to Follow-up|6|||
146254214|NCT01536535|527443082|FG000|Overall Study|Physician Decision|1|||
146254215|NCT01536535|527443083|FG001|Overall Study|Physician Decision|1|||
146029826|NCT00900146|526622221|FG000|Intermediate: Period III|Administrative problems|85|||
146029827|NCT00900146|526622222|FG001|Intermediate: Period III|Administrative problems|92|||
146029828|NCT00900146|526622223|FG002|Intermediate: Period III|Administrative problems|84|||
146029829|NCT00900146|526622224|FG003|Intermediate: Period III|Administrative problems|90|||
146029830|NCT00900146|526622225|FG004|Intermediate: Period III|Administrative problems|163|||
146029831|NCT00700102|526622226|FG000|Overall Study|Died|394|||
146029832|NCT00700102|526622227|FG001|Overall Study|Died|385|||
146029833|NCT00700102|526622226|FG000|Overall Study|Lost to Follow-up|8|||
146029834|NCT00700102|526622227|FG001|Overall Study|Lost to Follow-up|10|||
146029835|NCT02525939|526622232|FG000|Overall Study|Lost to Follow-up|27|||
146029836|NCT02525939|526622233|FG001|Overall Study|Lost to Follow-up|24|||
146029837|NCT02525939|526622232|FG000|Overall Study|Physician Decision|0|||
146029838|NCT02525939|526622233|FG001|Overall Study|Physician Decision|1|||
146029839|NCT02525939|526622232|FG000|Overall Study|Withdrawal by Subject|24|||
146029840|NCT02525939|526622233|FG001|Overall Study|Withdrawal by Subject|39|||
146029841|NCT02525939|526622232|FG000|Overall Study|Death|180|||
146029842|NCT02525939|526622233|FG001|Overall Study|Death|179|||
146029843|NCT01635764|526622234|FG000|Overall Study|Adverse Event|46|||
146029844|NCT01635764|526622234|FG000|Overall Study|Lack of Efficacy|76|||
146029845|NCT01635764|526622234|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
146029846|NCT01635764|526622234|FG000|Overall Study|Protocol Deviation|1|||
146029847|NCT01635764|526622234|FG000|Overall Study|Withdrew Consent|67|||
146029848|NCT01635764|526622234|FG000|Overall Study|Lost to Follow-up|53|||
146029849|NCT01635764|526622234|FG000|Overall Study|Other|28|||
146029850|NCT00933244|526622235|FG000|Overall Study|Withdrawal by Subject|5|||
146029851|NCT00933244|526622236|FG001|Overall Study|Withdrawal by Subject|1|||
146029852|NCT00933244|526622237|FG002|Overall Study|Withdrawal by Subject|3|||
146029853|NCT01174004|526622238|FG000|Overall Study|Adverse Event|2|||
146029854|NCT01174004|526622239|FG001|Overall Study|Adverse Event|10|||
146029855|NCT01174004|526622238|FG000|Overall Study|Withdrawal by Subject|2|||
146029856|NCT01174004|526622239|FG001|Overall Study|Withdrawal by Subject|3|||
146029857|NCT01174004|526622238|FG000|Overall Study|At Discretion of Sponsor|2|||
146029858|NCT01174004|526622239|FG001|Overall Study|At Discretion of Sponsor|2|||
146029859|NCT01174004|526622238|FG000|Overall Study|Protocol Violation|0|||
146029860|NCT01174004|526622239|FG001|Overall Study|Protocol Violation|1|||
146029861|NCT01174004|526622238|FG000|Overall Study|Physician Decision|1|||
146029862|NCT01174004|526622239|FG001|Overall Study|Physician Decision|0|||
146029863|NCT01995552|526622240|FG000|Overall Study|Protocol Violation|1|||
146029864|NCT01995552|526622240|FG000|Overall Study|Lack of Efficacy|15|||
146029865|NCT01995552|526622240|FG000|Overall Study|Death|1|||
146029866|NCT01515475|526622241|FG000|Overall Study|Lost to Follow-up|20|||
146029867|NCT01515475|526622242|FG001|Overall Study|Lost to Follow-up|15|||
146029868|NCT01515475|526622243|FG002|Overall Study|Lost to Follow-up|12|||
146029869|NCT01515475|526622244|FG003|Overall Study|Lost to Follow-up|12|||
146029870|NCT01420627|526622246|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
146029871|NCT04957758|526622249|FG000|Overall Study|Adverse Event|1|||
146029872|NCT04957758|526622250|FG001|Overall Study|Adverse Event|0|||
146029873|NCT04957758|526622249|FG000|Overall Study|Lost to Follow-up|0|||
146029874|NCT04957758|526622250|FG001|Overall Study|Lost to Follow-up|2|||
146029875|NCT04957758|526622249|FG000|Overall Study|Withdrawal by Subject|4|||
146029876|NCT04957758|526622250|FG001|Overall Study|Withdrawal by Subject|2|||
146029877|NCT04957758|526622249|FG000|Overall Study|Protocol Violation|0|||
146029878|NCT04957758|526622250|FG001|Overall Study|Protocol Violation|1|||
146029879|NCT01685983|526622251|FG000|Overall Study|Adverse Event|7|||
146029880|NCT01685983|526622251|FG000|Overall Study|Death|1|||
146029881|NCT01685983|526622251|FG000|Overall Study|Withdrawal by Subject|19|||
146029882|NCT01685983|526622251|FG000|Overall Study|Protocol Violation|2|||
146029883|NCT01685983|526622251|FG000|Overall Study|Physician Decision|13|||
146029884|NCT01685983|526622251|FG000|Overall Study|Other|7|||
146029885|NCT01685983|526622251|FG000|Overall Study|Progressive Disease|32|||
146029886|NCT01685983|526622251|FG000|Overall Study|Noncompliance with Study Drug|1|||
146029887|NCT02639338|526622258|FG000|Overall Study|Lost to Follow-up|2|||
146029888|NCT02639338|526622259|FG001|Overall Study|Lost to Follow-up|2|||
146029889|NCT02639338|526622258|FG000|Overall Study|Withdrew Consent|1|||
146029890|NCT02639338|526622259|FG001|Overall Study|Withdrew Consent|2|||
146029891|NCT02639338|526622258|FG000|Overall Study|Death|1|||
146029892|NCT02639338|526622259|FG001|Overall Study|Death|0|||
146029893|NCT02639338|526622258|FG000|Overall Study|Randomized but Not Treated|0|||
146029894|NCT02639338|526622259|FG001|Overall Study|Randomized but Not Treated|1|||
146029895|NCT02360293|526622263|FG000|Overall Study|Lost to Follow-up|73|||
146029896|NCT02360293|526622264|FG001|Overall Study|Lost to Follow-up|95|||
146029897|NCT02360293|526622263|FG000|Overall Study|Withdrawal by Subject|2|||
146029898|NCT02360293|526622264|FG001|Overall Study|Withdrawal by Subject|1|||
146029899|NCT02360293|526622263|FG000|Overall Study|Excluded|1|||
146029900|NCT02360293|526622264|FG001|Overall Study|Excluded|0|||
146029901|NCT02226549|526622265|FG000|Overall Study|Randomized but Never Treated|1|||
146029902|NCT02226549|526622266|FG001|Overall Study|Randomized but Never Treated|0|||
146029903|NCT02226549|526622265|FG000|Overall Study|Lost to Follow-up|0|||
146029904|NCT02226549|526622266|FG001|Overall Study|Lost to Follow-up|1|||
146029905|NCT01269385|526622268|FG000|Overall Study|Adverse Event|1|||
146029906|NCT01269385|526622269|FG001|Overall Study|Adverse Event|1|||
146029907|NCT01269385|526622270|FG002|Overall Study|Adverse Event|0|||
146029908|NCT01269385|526622271|FG003|Overall Study|Adverse Event|0|||
146029909|NCT02741570|526622273|FG000|Pre-Treatment Period|Other reasons|0|||
146029910|NCT02741570|526622274|FG001|Pre-Treatment Period|Other reasons|3|||
146029911|NCT02741570|526622273|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
146029912|NCT02741570|526622274|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
146029913|NCT02741570|526622273|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
146029914|NCT02741570|526622274|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
146029915|NCT02741570|526622273|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
146029916|NCT02741570|526622274|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
146029917|NCT02741570|526622273|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
146029918|NCT02741570|526622274|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
146029919|NCT02741570|526622273|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
146029920|NCT02741570|526622274|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
146029921|NCT02741570|526622273|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146029922|NCT02741570|526622274|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146029923|NCT02741570|526622273|FG000|Pre-Treatment Period|Death|0|||
146029924|NCT02741570|526622274|FG001|Pre-Treatment Period|Death|1|||
146029925|NCT02741570|526622273|FG000|Pre-Treatment Period|Disease progression|0|||
146029926|NCT02741570|526622274|FG001|Pre-Treatment Period|Disease progression|1|||
146029927|NCT02741570|526622273|FG000|Treatment Period|Other reasons|47|||
146029928|NCT02741570|526622274|FG001|Treatment Period|Other reasons|12|||
146029929|NCT02741570|526622273|FG000|Treatment Period|Poor/non-compliance|0|||
146029930|NCT02741570|526622274|FG001|Treatment Period|Poor/non-compliance|2|||
146029931|NCT02741570|526622273|FG000|Treatment Period|Maximum clinical benefit|4|||
146029932|NCT02741570|526622274|FG001|Treatment Period|Maximum clinical benefit|6|||
146029933|NCT02741570|526622273|FG000|Treatment Period|Lost to Follow-up|1|||
146029934|NCT02741570|526622274|FG001|Treatment Period|Lost to Follow-up|3|||
146029935|NCT02741570|526622273|FG000|Treatment Period|Participant withdrew consent|9|||
146029936|NCT02741570|526622274|FG001|Treatment Period|Participant withdrew consent|13|||
146029937|NCT02741570|526622273|FG000|Treatment Period|Participant request to discontinue treatment|8|||
146029938|NCT02741570|526622274|FG001|Treatment Period|Participant request to discontinue treatment|23|||
146029939|NCT02741570|526622273|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
146029940|NCT02741570|526622274|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
146029941|NCT02741570|526622273|FG000|Treatment Period|Death|9|||
146029942|NCT02741570|526622274|FG001|Treatment Period|Death|7|||
146029943|NCT02741570|526622273|FG000|Treatment Period|Study drug toxicity|55|||
146029944|NCT02741570|526622274|FG001|Treatment Period|Study drug toxicity|47|||
146029945|NCT02741570|526622273|FG000|Treatment Period|Disease progression|294|||
146029946|NCT02741570|526622274|FG001|Treatment Period|Disease progression|301|||
146029947|NCT02741570|526622273|FG000|Treatment Period|Administrative reason by sponsor|0|||
146029948|NCT02741570|526622274|FG001|Treatment Period|Administrative reason by sponsor|1|||
146029949|NCT01498185|526622275|FG000|Overall Study|Adverse Event|0|||
146029950|NCT01498185|526622276|FG001|Overall Study|Adverse Event|0|||
146029951|NCT01498185|526622277|FG002|Overall Study|Adverse Event|0|||
146029952|NCT01498185|526622278|FG003|Overall Study|Adverse Event|1|||
146029953|NCT01498185|526622279|FG004|Overall Study|Adverse Event|0|||
146029954|NCT01498185|526622275|FG000|Overall Study|Withdrawal by Subject|1|||
146029955|NCT01498185|526622276|FG001|Overall Study|Withdrawal by Subject|1|||
146029956|NCT01498185|526622277|FG002|Overall Study|Withdrawal by Subject|0|||
146029957|NCT01498185|526622278|FG003|Overall Study|Withdrawal by Subject|2|||
146029958|NCT01498185|526622279|FG004|Overall Study|Withdrawal by Subject|1|||
146029959|NCT01498185|526622275|FG000|Overall Study|No longer met criteria, etc|0|||
146254216|NCT01536535|527443082|FG000|Overall Study|Participant moved|0|||
146029960|NCT01498185|526622276|FG001|Overall Study|No longer met criteria, etc|0|||
146029961|NCT01498185|526622277|FG002|Overall Study|No longer met criteria, etc|0|||
146029962|NCT01498185|526622278|FG003|Overall Study|No longer met criteria, etc|0|||
146029963|NCT01498185|526622279|FG004|Overall Study|No longer met criteria, etc|2|||
146029964|NCT00946322|526622280|FG000|Pre-treatment|participant failure to follow up|1|||
146029965|NCT00946322|526622280|FG000|Post-treatment|participant failure to follow up|2|||
146029966|NCT03352453|526622282|FG000|Overall Study|Miscellaneous Reasons|1|||
146254217|NCT01536535|527443083|FG001|Overall Study|Participant moved|1|||
146029967|NCT03352453|526622283|FG001|Overall Study|Miscellaneous Reasons|2|||
146029968|NCT03352453|526622282|FG000|Overall Study|Lack of Efficacy|1|||
146029969|NCT03352453|526622283|FG001|Overall Study|Lack of Efficacy|0|||
146029970|NCT03352453|526622282|FG000|Overall Study|Withdrawal by Subject|8|||
146029971|NCT03352453|526622283|FG001|Overall Study|Withdrawal by Subject|14|||
146029972|NCT03352453|526622282|FG000|Overall Study|Study Terminated by Sponsor|2|||
146029973|NCT03352453|526622283|FG001|Overall Study|Study Terminated by Sponsor|1|||
146029974|NCT03352453|526622282|FG000|Overall Study|Protocol Deviation|1|||
146029975|NCT03352453|526622283|FG001|Overall Study|Protocol Deviation|0|||
146029976|NCT03352453|526622282|FG000|Overall Study|Lost to Follow-up|7|||
146029977|NCT03352453|526622283|FG001|Overall Study|Lost to Follow-up|6|||
146029978|NCT03352453|526622282|FG000|Overall Study|Adverse Event|2|||
146029979|NCT03352453|526622283|FG001|Overall Study|Adverse Event|9|||
146029980|NCT00514020|526622286|FG000|Overall Study|Adverse Event|6|||
146029981|NCT00514020|526622286|FG000|Overall Study|Withdrawal by Subject|3|||
146029982|NCT00514020|526622286|FG000|Overall Study|Physician Decision|1|||
146029983|NCT00514020|526622286|FG000|Overall Study|disease progression|9|||
146029984|NCT00514020|526622286|FG000|Overall Study|other complicating disease|2|||
146029985|NCT00514020|526622286|FG000|Overall Study|patient went to radiation treatment|1|||
146029986|NCT00514020|526622286|FG000|Overall Study|"patients moved to the no tx group"|6|||
146029987|NCT02725593|526622287|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
146029988|NCT02725593|526622288|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
146029989|NCT02725593|526622287|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
146029990|NCT02725593|526622288|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
146029991|NCT02725593|526622287|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
146029992|NCT02725593|526622288|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
146029993|NCT02725593|526622287|FG000|Long Term Extension|Withdrawal by Subject|1|||
146029994|NCT02725593|526622288|FG001|Long Term Extension|Withdrawal by Subject|3|||
146029995|NCT01688921|526622289|FG000|Overall Study|Lost to Follow-up|7|||
146029996|NCT01688921|526622290|FG001|Overall Study|Lost to Follow-up|13|||
146029997|NCT01688921|526622289|FG000|Overall Study|Physician Decision|6|||
146029998|NCT01688921|526622290|FG001|Overall Study|Physician Decision|1|||
146029999|NCT01688921|526622289|FG000|Overall Study|Protocol Violation|0|||
146030000|NCT01688921|526622290|FG001|Overall Study|Protocol Violation|1|||
146030001|NCT01688921|526622289|FG000|Overall Study|informed consent|3|||
146030002|NCT01688921|526622290|FG001|Overall Study|informed consent|0|||
146030003|NCT04384107|526622298|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
146030004|NCT04384107|526622299|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146030005|NCT04384107|526622298|FG000|Overall Study|Lost to Follow-up|1|||
146030006|NCT04384107|526622299|FG001|Overall Study|Lost to Follow-up|0|||
146030007|NCT00276614|526622302|FG000|Overall Study|Progression of disease under study|3|||
146030008|NCT00459537|526622316|FG000|Overall Study|Adverse Event|1|||
146030009|NCT00459537|526622317|FG001|Overall Study|Adverse Event|6|||
146030010|NCT00459537|526622316|FG000|Overall Study|Lack of Efficacy|10|||
146030011|NCT00459537|526622317|FG001|Overall Study|Lack of Efficacy|11|||
146030012|NCT00459537|526622316|FG000|Overall Study|Withdrawal by Subject|20|||
146030013|NCT00459537|526622317|FG001|Overall Study|Withdrawal by Subject|26|||
146030014|NCT00459537|526622316|FG000|Overall Study|Lost to Follow-up|27|||
146030015|NCT00459537|526622317|FG001|Overall Study|Lost to Follow-up|30|||
146030016|NCT00459537|526622316|FG000|Overall Study|Administrative problems|3|||
146030017|NCT00459537|526622317|FG001|Overall Study|Administrative problems|0|||
146030018|NCT00459537|526622316|FG000|Overall Study|Protocol Violation|4|||
146030019|NCT00459537|526622317|FG001|Overall Study|Protocol Violation|3|||
146030020|NCT00459537|526622316|FG000|Overall Study|Missing|1|||
146030021|NCT00459537|526622317|FG001|Overall Study|Missing|0|||
146030022|NCT01831817|526622318|FG000|Overall Study|Lost to Follow-up|1|||
146030023|NCT01831817|526622319|FG001|Overall Study|Lost to Follow-up|0|||
146030024|NCT01831817|526622320|FG002|Overall Study|Lost to Follow-up|0|||
146030025|NCT01831817|526622321|FG003|Overall Study|Lost to Follow-up|0|||
146030026|NCT01831817|526622318|FG000|Overall Study|Withdrawl of Consent|3|||
146030027|NCT01831817|526622319|FG001|Overall Study|Withdrawl of Consent|0|||
146030028|NCT01831817|526622320|FG002|Overall Study|Withdrawl of Consent|0|||
146030029|NCT01831817|526622321|FG003|Overall Study|Withdrawl of Consent|0|||
146030030|NCT03159104|526622322|FG000|Overall Study|Violation of inclusion criteria|1|||
146030031|NCT03159104|526622323|FG001|Overall Study|Violation of inclusion criteria|2|||
146030032|NCT00958217|526622324|FG000|Overall Study|Death|2|||
146030033|NCT00958217|526622325|FG001|Overall Study|Death|1|||
146030034|NCT00958217|526622324|FG000|Overall Study|Withdrawal by Subject|4|||
146030035|NCT00958217|526622325|FG001|Overall Study|Withdrawal by Subject|3|||
146030036|NCT00958217|526622324|FG000|Overall Study|Lost to Follow-up|17|||
146030037|NCT00958217|526622325|FG001|Overall Study|Lost to Follow-up|19|||
146030038|NCT00958217|526622324|FG000|Overall Study|Moved out of area|1|||
146030039|NCT00958217|526622325|FG001|Overall Study|Moved out of area|1|||
146030040|NCT00958217|526622324|FG000|Overall Study|Inpatient hospitalization|0|||
146030041|NCT00958217|526622325|FG001|Overall Study|Inpatient hospitalization|1|||
146030042|NCT02198235|526622327|FG000|Overall Study|Lost to Follow-up|3|||
146030043|NCT02198235|526622328|FG001|Overall Study|Lost to Follow-up|2|||
146030044|NCT02198235|526622329|FG002|Overall Study|Lost to Follow-up|2|||
146030045|NCT04573881|526622332|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
146030046|NCT01999218|526622333|FG000|Overall Study|Hyperglycemia|18|||
146030047|NCT01999218|526622334|FG001|Overall Study|Hyperglycemia|17|||
146030048|NCT01999218|526622335|FG002|Overall Study|Hyperglycemia|17|||
146030049|NCT01999218|526622333|FG000|Overall Study|Lack of Efficacy|1|||
146030050|NCT01999218|526622334|FG001|Overall Study|Lack of Efficacy|0|||
146030051|NCT01999218|526622335|FG002|Overall Study|Lack of Efficacy|1|||
146030052|NCT01999218|526622333|FG000|Overall Study|Lost to Follow-up|22|||
146030053|NCT01999218|526622334|FG001|Overall Study|Lost to Follow-up|17|||
146030054|NCT01999218|526622335|FG002|Overall Study|Lost to Follow-up|18|||
146030055|NCT01999218|526622333|FG000|Overall Study|Non-Compliance With Study Drug|6|||
146030056|NCT01999218|526622334|FG001|Overall Study|Non-Compliance With Study Drug|4|||
146030057|NCT01999218|526622335|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146030058|NCT01999218|526622333|FG000|Overall Study|Physician Decision|1|||
146030059|NCT01999218|526622334|FG001|Overall Study|Physician Decision|4|||
146030060|NCT01999218|526622335|FG002|Overall Study|Physician Decision|6|||
146030061|NCT01999218|526622333|FG000|Overall Study|Protocol Violation|4|||
146030062|NCT01999218|526622334|FG001|Overall Study|Protocol Violation|5|||
146030063|NCT01999218|526622335|FG002|Overall Study|Protocol Violation|4|||
146030064|NCT01999218|526622333|FG000|Overall Study|Screen failure|0|||
146030065|NCT01999218|526622334|FG001|Overall Study|Screen failure|1|||
146030066|NCT01999218|526622335|FG002|Overall Study|Screen failure|0|||
146030067|NCT01999218|526622333|FG000|Overall Study|Study Terminated By Sponsor|7|||
146030068|NCT01999218|526622334|FG001|Overall Study|Study Terminated By Sponsor|5|||
146030069|NCT01999218|526622335|FG002|Overall Study|Study Terminated By Sponsor|12|||
146030070|NCT01999218|526622333|FG000|Overall Study|Participant moves|2|||
146030071|NCT01999218|526622334|FG001|Overall Study|Participant moves|5|||
146030072|NCT01999218|526622335|FG002|Overall Study|Participant moves|3|||
146030073|NCT01999218|526622333|FG000|Overall Study|Withdrawal by Subject|28|||
146030074|NCT01999218|526622334|FG001|Overall Study|Withdrawal by Subject|29|||
146030075|NCT01999218|526622335|FG002|Overall Study|Withdrawal by Subject|34|||
146030076|NCT01999218|526622333|FG000|Overall Study|Creatinine/eGFR|0|||
146030077|NCT01999218|526622334|FG001|Overall Study|Creatinine/eGFR|0|||
146030078|NCT01999218|526622335|FG002|Overall Study|Creatinine/eGFR|1|||
146030079|NCT01999218|526622333|FG000|Overall Study|Death|7|||
146030080|NCT01999218|526622334|FG001|Overall Study|Death|1|||
146030081|NCT01999218|526622335|FG002|Overall Study|Death|2|||
146030082|NCT01999218|526622333|FG000|Overall Study|Excluded Medication|1|||
146030083|NCT01999218|526622334|FG001|Overall Study|Excluded Medication|1|||
146030084|NCT01999218|526622335|FG002|Overall Study|Excluded Medication|2|||
146030085|NCT01999218|526622333|FG000|Overall Study|Adverse Event|9|||
146030086|NCT01999218|526622334|FG001|Overall Study|Adverse Event|7|||
146030087|NCT01999218|526622335|FG002|Overall Study|Adverse Event|7|||
146030088|NCT01999218|526622333|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
146030089|NCT01999218|526622334|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
146030090|NCT01999218|526622335|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
146030091|NCT00546260|526622336|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
146030092|NCT00546260|526622337|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
146030093|NCT03780959|526622338|FG000|Part 1|Adverse Event|1|||
146030094|NCT03780959|526622339|FG001|Part 1|Adverse Event|0|||
146030095|NCT03780959|526622340|FG002|Part 1|Adverse Event|0|||
146030096|NCT03780959|526622338|FG000|Part 1|Withdrawal by Subject|1|||
146030097|NCT03780959|526622339|FG001|Part 1|Withdrawal by Subject|0|||
146030098|NCT03780959|526622340|FG002|Part 1|Withdrawal by Subject|0|||
146030099|NCT03780959|526622338|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
146030100|NCT03780959|526622339|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
146030101|NCT03780959|526622340|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
146030102|NCT03780959|526622338|FG000|Part 1|Response Status|2|||
146030103|NCT03780959|526622339|FG001|Part 1|Response Status|0|||
146030104|NCT03780959|526622340|FG002|Part 1|Response Status|0|||
146030105|NCT03780959|526622338|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
146030106|NCT03780959|526622339|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
146030107|NCT03780959|526622340|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
146030108|NCT03780959|526622338|FG000|Part 2|Response Status|0|||
146030109|NCT03780959|526622339|FG001|Part 2|Response Status|18|||
146030110|NCT03780959|526622340|FG002|Part 2|Response Status|6|||
146056184|NCT00097500|526721116|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
146056185|NCT00097500|526721117|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
146056186|NCT00097500|526721116|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146056187|NCT00097500|526721117|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
146056188|NCT00097500|526721116|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
146056189|NCT00097500|526721117|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
146056190|NCT00097500|526721116|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
146056191|NCT00097500|526721117|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
146056192|NCT00097500|526721116|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
146056193|NCT00097500|526721117|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
146056194|NCT01600885|526721118|FG000|First Period|Adverse Event|1|||
146056195|NCT01600885|526721119|FG001|First Period|Adverse Event|1|||
146056196|NCT01600885|526721118|FG000|First Period|moved out of area|1|||
146056197|NCT01600885|526721119|FG001|First Period|moved out of area|0|||
146056198|NCT00642356|526721123|FG000|Overall Study|Adverse Event|1|||
146056199|NCT00642356|526721124|FG001|Overall Study|Adverse Event|0|||
146056200|NCT00642356|526721123|FG000|Overall Study|Protocol Violation|0|||
146056201|NCT00642356|526721124|FG001|Overall Study|Protocol Violation|3|||
146056202|NCT00642356|526721123|FG000|Overall Study|Lack of Efficacy|1|||
146056203|NCT00642356|526721124|FG001|Overall Study|Lack of Efficacy|0|||
146056204|NCT01009060|526721133|FG000|Overall Study|Adverse Event|1|||
146096095|NCT00734474|526874445|FG006|Overall Study|Adverse Event|1|||
146096096|NCT00734474|526874446|FG007|Overall Study|Adverse Event|65|||
146096097|NCT00734474|526874447|FG008|Overall Study|Adverse Event|39|||
146096098|NCT00734474|526874439|FG000|Overall Study|Protocol Violation|0|||
146096099|NCT00734474|526874440|FG001|Overall Study|Protocol Violation|0|||
146096100|NCT00734474|526874441|FG002|Overall Study|Protocol Violation|4|||
146096101|NCT00734474|526874442|FG003|Overall Study|Protocol Violation|0|||
146096102|NCT00734474|526874443|FG004|Overall Study|Protocol Violation|3|||
146096103|NCT00734474|526874444|FG005|Overall Study|Protocol Violation|0|||
146096104|NCT00734474|526874445|FG006|Overall Study|Protocol Violation|0|||
146096105|NCT00734474|526874446|FG007|Overall Study|Protocol Violation|3|||
146096106|NCT00734474|526874447|FG008|Overall Study|Protocol Violation|1|||
146096107|NCT00734474|526874439|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
146096108|NCT00734474|526874440|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
146096109|NCT00734474|526874441|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146096110|NCT00734474|526874442|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
146096111|NCT00734474|526874443|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146096112|NCT00734474|526874444|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
146096113|NCT00734474|526874445|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
146096114|NCT00734474|526874446|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146096115|NCT00734474|526874447|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
146096116|NCT00734474|526874439|FG000|Overall Study|Sponsor Decision|0|||
146096117|NCT00734474|526874440|FG001|Overall Study|Sponsor Decision|0|||
146096118|NCT00734474|526874441|FG002|Overall Study|Sponsor Decision|0|||
146096119|NCT00734474|526874442|FG003|Overall Study|Sponsor Decision|0|||
146096120|NCT00734474|526874443|FG004|Overall Study|Sponsor Decision|2|||
146096121|NCT00734474|526874444|FG005|Overall Study|Sponsor Decision|0|||
146096122|NCT00734474|526874445|FG006|Overall Study|Sponsor Decision|0|||
146096123|NCT00734474|526874446|FG007|Overall Study|Sponsor Decision|0|||
146096124|NCT00734474|526874447|FG008|Overall Study|Sponsor Decision|0|||
146096125|NCT00734474|526874439|FG000|Overall Study|Death|0|||
146096126|NCT00734474|526874440|FG001|Overall Study|Death|0|||
146096127|NCT00734474|526874441|FG002|Overall Study|Death|1|||
146096128|NCT00734474|526874442|FG003|Overall Study|Death|0|||
146096129|NCT00734474|526874443|FG004|Overall Study|Death|0|||
146096130|NCT00734474|526874444|FG005|Overall Study|Death|0|||
146096131|NCT00734474|526874445|FG006|Overall Study|Death|0|||
146096132|NCT00734474|526874446|FG007|Overall Study|Death|2|||
146096133|NCT00734474|526874447|FG008|Overall Study|Death|1|||
146096134|NCT00734474|526874439|FG000|Overall Study|Lack of Efficacy|0|||
146096135|NCT00734474|526874440|FG001|Overall Study|Lack of Efficacy|0|||
146096136|NCT00734474|526874441|FG002|Overall Study|Lack of Efficacy|4|||
146096137|NCT00734474|526874442|FG003|Overall Study|Lack of Efficacy|0|||
146096138|NCT00734474|526874443|FG004|Overall Study|Lack of Efficacy|0|||
146096139|NCT00734474|526874444|FG005|Overall Study|Lack of Efficacy|0|||
146096140|NCT00734474|526874445|FG006|Overall Study|Lack of Efficacy|0|||
146096141|NCT00734474|526874446|FG007|Overall Study|Lack of Efficacy|4|||
146096142|NCT00734474|526874447|FG008|Overall Study|Lack of Efficacy|6|||
146096143|NCT00231842|526874456|FG000|Overall Study|Withdrawal by Subject|3|||
146096144|NCT00231842|526874456|FG000|Overall Study|Did not complete the last 3 cycle|8|||
146096145|NCT00639678|526874457|FG000|Overall Study|Withdrawal by Subject|3|||
146096146|NCT00639678|526874458|FG001|Overall Study|Withdrawal by Subject|0|||
146096147|NCT00639678|526874459|FG002|Overall Study|Withdrawal by Subject|4|||
146096148|NCT00639678|526874460|FG003|Overall Study|Withdrawal by Subject|0|||
146096149|NCT00639678|526874457|FG000|Overall Study|Lost to Follow-up|1|||
146096150|NCT00639678|526874458|FG001|Overall Study|Lost to Follow-up|0|||
146096151|NCT00639678|526874459|FG002|Overall Study|Lost to Follow-up|6|||
146096152|NCT00639678|526874460|FG003|Overall Study|Lost to Follow-up|0|||
146096153|NCT00639678|526874457|FG000|Overall Study|Adverse Event|0|||
146096154|NCT00639678|526874458|FG001|Overall Study|Adverse Event|1|||
146096155|NCT00639678|526874459|FG002|Overall Study|Adverse Event|0|||
146300343|NCT02101021|527615229|FG002|Overall Study|Lost to Follow-up|0|||
146300344|NCT02101021|527615230|FG003|Overall Study|Lost to Follow-up|0|||
146096156|NCT00639678|526874460|FG003|Overall Study|Adverse Event|0|||
146096157|NCT00639678|526874457|FG000|Overall Study|Lack of Compliance|0|||
146096158|NCT00639678|526874458|FG001|Overall Study|Lack of Compliance|0|||
146096159|NCT00639678|526874459|FG002|Overall Study|Lack of Compliance|1|||
146096160|NCT00639678|526874460|FG003|Overall Study|Lack of Compliance|0|||
146096161|NCT02436304|526874461|FG000|Overall Study|Lost to Follow-up|0|||
146096162|NCT02436304|526874462|FG001|Overall Study|Lost to Follow-up|1|||
146096163|NCT02436304|526874463|FG002|Overall Study|Lost to Follow-up|0|||
146096164|NCT02436304|526874461|FG000|Overall Study|Withdrawal by Subject|0|||
146096165|NCT02436304|526874462|FG001|Overall Study|Withdrawal by Subject|1|||
146096166|NCT02436304|526874463|FG002|Overall Study|Withdrawal by Subject|0|||
146096167|NCT02436304|526874461|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
146096168|NCT02436304|526874462|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
146096169|NCT02436304|526874463|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
146096170|NCT04416633|526874464|FG000|Overall Study|Death|1|||
146168151|NCT02496767|527128092|FG007|Open-label Lead-in Phase|Adverse Event|0|||
146096171|NCT04416633|526874464|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
146096172|NCT04416633|526874464|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
146254218|NCT01485991|527443087|FG000|Overall Study|Adverse Event|0|||
146030111|NCT03647267|526623748|FG000|Overall Study|Lost to Follow-up|1|||
146030112|NCT03647267|526623749|FG001|Overall Study|Lost to Follow-up|0|||
146030113|NCT03131596|526623750|FG000|Overall Study|Protocol Violation|3|||
146030114|NCT03131596|526623751|FG001|Overall Study|Protocol Violation|3|||
146030115|NCT03131596|526623750|FG000|Overall Study|Lost to Follow-up|3|||
146030116|NCT03131596|526623751|FG001|Overall Study|Lost to Follow-up|0|||
146030117|NCT03654885|526623752|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
146030118|NCT03654885|526623753|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
146030119|NCT03654885|526623752|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
146030120|NCT03654885|526623753|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
146030121|NCT03654885|526623752|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
146030122|NCT03654885|526623753|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
146030123|NCT03654885|526623752|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
146030124|NCT03654885|526623753|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
146030125|NCT03654885|526623752|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
146030126|NCT03654885|526623753|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
146030127|NCT03654885|526623752|FG000|Overall Study|Adverse Event in Study Eye|3|||
146030128|NCT03654885|526623753|FG001|Overall Study|Adverse Event in Study Eye|0|||
146030129|NCT03654885|526623752|FG000|Overall Study|Consent Withdrawn|1|||
146030130|NCT03654885|526623753|FG001|Overall Study|Consent Withdrawn|0|||
146030131|NCT03654885|526623752|FG000|Overall Study|Death|3|||
146030132|NCT03654885|526623753|FG001|Overall Study|Death|1|||
146030133|NCT03654885|526623752|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
146030134|NCT03654885|526623753|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
146030135|NCT03654885|526623752|FG000|Overall Study|Lost to Follow-up|3|||
146030136|NCT03654885|526623753|FG001|Overall Study|Lost to Follow-up|3|||
146030137|NCT00004445|526623754|FG000|Overall Study|Physician Decision|2|||
146030138|NCT00004445|526623754|FG000|Overall Study|Withdrawal by Subject|1|||
146030139|NCT02753127|526623755|FG000|Overall Study|Lost to Follow-up|13|||
146030140|NCT02753127|526623756|FG001|Overall Study|Lost to Follow-up|11|||
146030141|NCT02753127|526623755|FG000|Overall Study|Withdrawal by Subject|37|||
146030142|NCT02753127|526623756|FG001|Overall Study|Withdrawal by Subject|47|||
146030143|NCT02753127|526623755|FG000|Overall Study|Other|3|||
146030144|NCT02753127|526623756|FG001|Overall Study|Other|8|||
146030145|NCT02753127|526623755|FG000|Overall Study|Hospice|0|||
146030146|NCT02753127|526623756|FG001|Overall Study|Hospice|2|||
146030147|NCT00293709|526623759|FG000|Overall Study|Other|47|||
146030148|NCT02981524|526623761|FG000|Overall Study|Progressive Disease|14|||
146030149|NCT02981524|526623761|FG000|Overall Study|Death (unrelated)|1|||
146030150|NCT02981524|526623761|FG000|Overall Study|Treatment Related Toxicity|1|||
146030151|NCT02981524|526623761|FG000|Overall Study|Withdrawal by Subject|1|||
146030152|NCT01146288|526623763|FG000|First Intervention(1 Day)|Adverse Event|0|||
146030153|NCT01146288|526623764|FG001|First Intervention(1 Day)|Adverse Event|1|||
146030154|NCT03458702|526623765|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
146030155|NCT03458702|526623766|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
146030156|NCT03458702|526623765|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
146030157|NCT03458702|526623766|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
146030158|NCT01697462|526623767|FG000|Overall Study|Disease Progression|1|||
146030159|NCT01697462|526623767|FG000|Overall Study|Adverse Event|6|||
146030160|NCT01697462|526623767|FG000|Overall Study|Lost to Follow-up|21|||
146030161|NCT01697462|526623767|FG000|Overall Study|Withdrawal by Subject|12|||
146030162|NCT01697462|526623767|FG000|Overall Study|Investigator Decision|21|||
146030163|NCT01697462|526623767|FG000|Overall Study|Death|1|||
146030164|NCT01697462|526623767|FG000|Overall Study|Other|10|||
146030165|NCT01697462|526623767|FG000|Overall Study|Missing|5|||
146030166|NCT00168103|526623768|FG000|Overall Study|Withdrawal by Subject|1|||
146030167|NCT00168103|526623769|FG001|Overall Study|Withdrawal by Subject|2|||
146030168|NCT00168103|526623770|FG002|Overall Study|Withdrawal by Subject|1|||
146030169|NCT00168103|526623771|FG003|Overall Study|Withdrawal by Subject|0|||
146030170|NCT00168103|526623768|FG000|Overall Study|Lost to Follow-up|1|||
146030171|NCT00168103|526623769|FG001|Overall Study|Lost to Follow-up|3|||
146030172|NCT00168103|526623770|FG002|Overall Study|Lost to Follow-up|0|||
146030173|NCT00168103|526623771|FG003|Overall Study|Lost to Follow-up|0|||
146030174|NCT00545532|526623772|FG000|Overall Study|Withdrawal by Subject|1|||
146030175|NCT00545532|526623773|FG001|Overall Study|Withdrawal by Subject|3|||
146030176|NCT00545532|526623772|FG000|Overall Study|Lost to Follow-up|5|||
146030177|NCT00545532|526623773|FG001|Overall Study|Lost to Follow-up|6|||
146030178|NCT00545532|526623772|FG000|Overall Study|Death|0|||
146030179|NCT00545532|526623773|FG001|Overall Study|Death|1|||
146030180|NCT03532932|526623777|FG000|Overall Study|Protocol Deviation|33|||
146096173|NCT04416633|526874464|FG000|Overall Study|Adverse Event|6|||
146030181|NCT03532932|526623778|FG001|Overall Study|Protocol Deviation|31|||
146030182|NCT03532932|526623777|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
146030183|NCT03532932|526623778|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
146030184|NCT03532932|526623777|FG000|Overall Study|Withdrawal by Subject|2|||
146030185|NCT03532932|526623778|FG001|Overall Study|Withdrawal by Subject|0|||
146030186|NCT03532932|526623777|FG000|Overall Study|Lost to Follow-up|15|||
146030187|NCT03532932|526623778|FG001|Overall Study|Lost to Follow-up|9|||
146030188|NCT03532932|526623777|FG000|Overall Study|Adverse Event|4|||
146030189|NCT03532932|526623778|FG001|Overall Study|Adverse Event|3|||
146030190|NCT03532932|526623777|FG000|Overall Study|Death|0|||
146030191|NCT03532932|526623778|FG001|Overall Study|Death|2|||
146030192|NCT03532932|526623777|FG000|Overall Study|Other|11|||
146030193|NCT03532932|526623778|FG001|Overall Study|Other|16|||
146030194|NCT00931801|526623779|FG000|Overall Study|Adverse Event|0|||
146030195|NCT00931801|526623780|FG001|Overall Study|Adverse Event|0|||
146030196|NCT00931801|526623781|FG002|Overall Study|Adverse Event|1|||
146030197|NCT00931801|526623779|FG000|Overall Study|Lost to Follow-up|0|||
146030198|NCT00931801|526623780|FG001|Overall Study|Lost to Follow-up|1|||
146030199|NCT00931801|526623781|FG002|Overall Study|Lost to Follow-up|0|||
146030200|NCT00931801|526623779|FG000|Overall Study|Withdrawal by Subject|1|||
146030201|NCT00931801|526623780|FG001|Overall Study|Withdrawal by Subject|0|||
146030202|NCT00931801|526623781|FG002|Overall Study|Withdrawal by Subject|0|||
146030203|NCT00931801|526623779|FG000|Overall Study|Confirmed Virologic Failure|0|||
146030204|NCT00931801|526623780|FG001|Overall Study|Confirmed Virologic Failure|0|||
146030205|NCT00931801|526623781|FG002|Overall Study|Confirmed Virologic Failure|3|||
146030206|NCT03283150|526623782|FG000|Overall Study|Withdrawal by Subject|6|||
146030207|NCT03283150|526623783|FG001|Overall Study|Withdrawal by Subject|0|||
146030208|NCT03283150|526623784|FG002|Overall Study|Withdrawal by Subject|0|||
146030209|NCT01028716|526623785|FG000|Overall Study|Physician Decision|1|||
146030210|NCT04375397|526623788|FG000|Overall Study|Death|1|||
146030211|NCT04375397|526623789|FG001|Overall Study|Death|1|||
146030212|NCT04375397|526623788|FG000|Overall Study|Withdrew consent|2|||
146030213|NCT04375397|526623789|FG001|Overall Study|Withdrew consent|0|||
146030214|NCT04375397|526623788|FG000|Overall Study|Lost to Follow-up|6|||
146030215|NCT04375397|526623789|FG001|Overall Study|Lost to Follow-up|4|||
146056205|NCT01009060|526721134|FG001|Overall Study|Adverse Event|2|||
146056206|NCT01009060|526721133|FG000|Overall Study|Protocol Violation|0|||
146056207|NCT01009060|526721134|FG001|Overall Study|Protocol Violation|1|||
146056208|NCT01009060|526721133|FG000|Overall Study|Lost to Follow-up|1|||
146056209|NCT01009060|526721134|FG001|Overall Study|Lost to Follow-up|0|||
146056210|NCT01009060|526721133|FG000|Overall Study|Physician Decision|1|||
146056211|NCT01009060|526721134|FG001|Overall Study|Physician Decision|1|||
146056212|NCT01009060|526721133|FG000|Overall Study|Withdrawal by Subject|1|||
146056213|NCT01009060|526721134|FG001|Overall Study|Withdrawal by Subject|1|||
146056214|NCT04201431|526721135|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
146056215|NCT04201431|526721136|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
146056216|NCT04201431|526721137|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
146056217|NCT00667888|526721140|FG000|Overall Study|Death|1|||
146056218|NCT00667888|526721141|FG001|Overall Study|Death|1|||
146056219|NCT00667888|526721140|FG000|Overall Study|Withdrawal by Subject|6|||
146056220|NCT00667888|526721141|FG001|Overall Study|Withdrawal by Subject|3|||
146056221|NCT00667888|526721140|FG000|Overall Study|Proceed with other treatment|3|||
146056222|NCT00667888|526721141|FG001|Overall Study|Proceed with other treatment|3|||
146056223|NCT00667888|526721140|FG000|Overall Study|Ineligible after SIM|0|||
146056224|NCT00667888|526721141|FG001|Overall Study|Ineligible after SIM|2|||
146056225|NCT02140047|526721142|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146056226|NCT02140047|526721143|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146056227|NCT02140047|526721144|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146056228|NCT02174731|526721145|FG000|Overall Study|Participant decision|67|||
146056229|NCT02174731|526721146|FG001|Overall Study|Participant decision|64|||
146056230|NCT02174731|526721145|FG000|Overall Study|Incorrect enrolment before randomization|0|||
146056231|NCT02174731|526721146|FG001|Overall Study|Incorrect enrolment before randomization|1|||
146056232|NCT02174731|526721145|FG000|Overall Study|Missing|2|||
146056233|NCT02174731|526721146|FG001|Overall Study|Missing|0|||
146056234|NCT03119259|526721147|FG000|Overall Study|Withdrawn as no longer eligible|1|||
146056235|NCT03119259|526721148|FG001|Overall Study|Withdrawn as no longer eligible|0|||
146056236|NCT03119259|526721147|FG000|Overall Study|Withdrawal by Subject|4|||
146056237|NCT03119259|526721148|FG001|Overall Study|Withdrawal by Subject|2|||
146056238|NCT03119259|526721147|FG000|Overall Study|Lost to Follow-up|0|||
146056239|NCT03119259|526721148|FG001|Overall Study|Lost to Follow-up|1|||
146056240|NCT00325897|526721149|FG000|Overall Study|Lost to Follow-up|12|||
146056241|NCT00325897|526721150|FG001|Overall Study|Lost to Follow-up|13|||
146056242|NCT03535974|526721151|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
146056243|NCT03535974|526721152|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
146056244|NCT03535974|526721153|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
146096174|NCT04416633|526874464|FG000|Overall Study|Withdrawal by Subject|6|||
146096175|NCT00785928|526874465|FG000|Treatment Phase|Adverse Event|1|||
146096176|NCT00785928|526874466|FG001|Treatment Phase|Adverse Event|1|||
146096177|NCT00785928|526874467|FG002|Treatment Phase|Adverse Event|2|||
146096178|NCT00785928|526874468|FG003|Treatment Phase|Adverse Event|0|||
146096179|NCT00785928|526874469|FG004|Treatment Phase|Adverse Event|0|||
146096180|NCT00785928|526874470|FG005|Treatment Phase|Adverse Event|0|||
146096181|NCT00785928|526874471|FG006|Treatment Phase|Adverse Event|2|||
146096182|NCT00785928|526874465|FG000|Treatment Phase|Inadequate Response|0|||
146096183|NCT00785928|526874466|FG001|Treatment Phase|Inadequate Response|1|||
146096184|NCT00785928|526874467|FG002|Treatment Phase|Inadequate Response|0|||
146096185|NCT00785928|526874468|FG003|Treatment Phase|Inadequate Response|0|||
146096186|NCT00785928|526874469|FG004|Treatment Phase|Inadequate Response|0|||
146096187|NCT00785928|526874470|FG005|Treatment Phase|Inadequate Response|0|||
146096188|NCT00785928|526874471|FG006|Treatment Phase|Inadequate Response|0|||
146096189|NCT00785928|526874465|FG000|Treatment Phase|Lack of Efficacy|0|||
146096190|NCT00785928|526874466|FG001|Treatment Phase|Lack of Efficacy|1|||
146096191|NCT00785928|526874467|FG002|Treatment Phase|Lack of Efficacy|1|||
146096192|NCT00785928|526874468|FG003|Treatment Phase|Lack of Efficacy|0|||
146096193|NCT00785928|526874469|FG004|Treatment Phase|Lack of Efficacy|0|||
146096194|NCT00785928|526874470|FG005|Treatment Phase|Lack of Efficacy|0|||
146096195|NCT00785928|526874471|FG006|Treatment Phase|Lack of Efficacy|0|||
146096196|NCT00785928|526874465|FG000|Treatment Phase|Physician Decision|0|||
146096197|NCT00785928|526874466|FG001|Treatment Phase|Physician Decision|0|||
146096198|NCT00785928|526874467|FG002|Treatment Phase|Physician Decision|0|||
146096199|NCT00785928|526874468|FG003|Treatment Phase|Physician Decision|0|||
146096200|NCT00785928|526874469|FG004|Treatment Phase|Physician Decision|1|||
146096201|NCT00785928|526874470|FG005|Treatment Phase|Physician Decision|0|||
146096202|NCT00785928|526874471|FG006|Treatment Phase|Physician Decision|0|||
146096203|NCT00785928|526874465|FG000|Treatment Phase|Sponsor Decision|1|||
146096204|NCT00785928|526874466|FG001|Treatment Phase|Sponsor Decision|0|||
146096205|NCT00785928|526874467|FG002|Treatment Phase|Sponsor Decision|0|||
146096206|NCT00785928|526874468|FG003|Treatment Phase|Sponsor Decision|0|||
146096207|NCT00785928|526874469|FG004|Treatment Phase|Sponsor Decision|0|||
146096208|NCT00785928|526874470|FG005|Treatment Phase|Sponsor Decision|0|||
146030216|NCT04375397|526623788|FG000|Overall Study|Other, not specified|0|||
146030217|NCT04375397|526623789|FG001|Overall Study|Other, not specified|1|||
146030218|NCT00086502|526623790|FG000|Overall Study|Adverse Event|11|||
146030219|NCT00086502|526623791|FG001|Overall Study|Adverse Event|2|||
146030220|NCT00086502|526623790|FG000|Overall Study|Lack of Efficacy|0|||
146030221|NCT00086502|526623791|FG001|Overall Study|Lack of Efficacy|2|||
146030222|NCT00086502|526623790|FG000|Overall Study|Lost to Follow-up|3|||
146030223|NCT00086502|526623791|FG001|Overall Study|Lost to Follow-up|1|||
146030224|NCT00086502|526623790|FG000|Overall Study|Physician Decision|1|||
146030225|NCT00086502|526623791|FG001|Overall Study|Physician Decision|1|||
146030226|NCT00086502|526623790|FG000|Overall Study|Pregnancy|0|||
146030227|NCT00086502|526623791|FG001|Overall Study|Pregnancy|1|||
146030228|NCT00086502|526623790|FG000|Overall Study|Protocol Violation|3|||
146030229|NCT00086502|526623791|FG001|Overall Study|Protocol Violation|3|||
146030230|NCT00086502|526623790|FG000|Overall Study|Withdrawal by Subject|5|||
146030231|NCT00086502|526623791|FG001|Overall Study|Withdrawal by Subject|6|||
146030232|NCT00086502|526623790|FG000|Overall Study|Patient Moved|1|||
146030233|NCT00086502|526623791|FG001|Overall Study|Patient Moved|1|||
146096209|NCT00785928|526874471|FG006|Treatment Phase|Sponsor Decision|1|||
146096210|NCT00785928|526874465|FG000|Treatment Phase|Withdrawal by Subject|1|||
146096211|NCT00785928|526874466|FG001|Treatment Phase|Withdrawal by Subject|2|||
146096212|NCT00785928|526874467|FG002|Treatment Phase|Withdrawal by Subject|0|||
146096213|NCT00785928|526874468|FG003|Treatment Phase|Withdrawal by Subject|0|||
146254219|NCT01485991|527443088|FG001|Overall Study|Adverse Event|4|||
146254220|NCT01485991|527443087|FG000|Overall Study|Lost to Follow-up|13|||
146254221|NCT01485991|527443088|FG001|Overall Study|Lost to Follow-up|10|||
146030234|NCT00086502|526623790|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
146030235|NCT00086502|526623791|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
146030236|NCT00086502|526623790|FG000|Overall Study|Patient Accidentally Unblinded|1|||
146030237|NCT00086502|526623791|FG001|Overall Study|Patient Accidentally Unblinded|0|||
146030238|NCT05545644|526623793|FG000|Overall Study|Lost to Follow-up|4|||
146254222|NCT01485991|527443087|FG000|Overall Study|Withdrawal by Subject|13|||
146030239|NCT05545644|526623794|FG001|Overall Study|Lost to Follow-up|3|||
146030240|NCT00610441|526623795|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146096214|NCT00785928|526874469|FG004|Treatment Phase|Withdrawal by Subject|1|||
146096215|NCT00785928|526874470|FG005|Treatment Phase|Withdrawal by Subject|0|||
146096216|NCT00785928|526874471|FG006|Treatment Phase|Withdrawal by Subject|0|||
146096217|NCT05021081|526874486|FG000|Phase 2|Subject enrolled in error|1|||
146096218|NCT05021081|526874487|FG001|Phase 2|Subject enrolled in error|1|||
146096219|NCT05021081|526874488|FG002|Phase 2|Subject enrolled in error|0|||
146096220|NCT00369122|526874489|FG000|Overall Study|Ineligible|10|||
146096221|NCT00369122|526874489|FG000|Overall Study|No protocol treatment|1|||
146254223|NCT01485991|527443088|FG001|Overall Study|Withdrawal by Subject|20|||
146030241|NCT00610441|526623796|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146030242|NCT00610441|526623797|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
146030243|NCT00610441|526623798|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
146030244|NCT00610441|526623795|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146030245|NCT00610441|526623796|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146030246|NCT00610441|526623797|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
146030247|NCT00610441|526623798|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
146030248|NCT00610441|526623795|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146030249|NCT00610441|526623796|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146030250|NCT00610441|526623797|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
146030251|NCT00610441|526623798|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
146030252|NCT00610441|526623795|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146030253|NCT00610441|526623796|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
146030254|NCT00610441|526623797|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146030255|NCT00610441|526623798|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
146030256|NCT00610441|526623795|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146030257|NCT00610441|526623796|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146030258|NCT00610441|526623797|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
146030259|NCT00610441|526623798|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
146030260|NCT00610441|526623795|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146030261|NCT00610441|526623796|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
146030262|NCT00610441|526623797|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146030263|NCT00610441|526623798|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
146030264|NCT00610441|526623795|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
146030265|NCT00610441|526623796|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
146030266|NCT00610441|526623797|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
146030267|NCT00610441|526623798|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
146030268|NCT00610441|526623795|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146030269|NCT00610441|526623796|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146030270|NCT00610441|526623797|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
146030271|NCT00610441|526623798|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
146030272|NCT00610441|526623795|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
146030273|NCT00610441|526623796|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146030274|NCT00610441|526623797|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146030275|NCT00610441|526623798|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
146030276|NCT01842581|526623803|FG000|Overall Study|Adverse Event|6|||
146030277|NCT01842581|526623804|FG001|Overall Study|Adverse Event|4|||
146030278|NCT01842581|526623803|FG000|Overall Study|HE breakthrough|26|||
146030279|NCT01842581|526623804|FG001|Overall Study|HE breakthrough|13|||
146030280|NCT01842581|526623803|FG000|Overall Study|Liver transplant|2|||
146030281|NCT01842581|526623804|FG001|Overall Study|Liver transplant|0|||
146030282|NCT01842581|526623803|FG000|Overall Study|Lost to Follow-up|2|||
146030283|NCT01842581|526623804|FG001|Overall Study|Lost to Follow-up|5|||
146030284|NCT01842581|526623803|FG000|Overall Study|Withdrawal by Subject|5|||
146030285|NCT01842581|526623804|FG001|Overall Study|Withdrawal by Subject|7|||
146030286|NCT01842581|526623803|FG000|Overall Study|Other than specified|3|||
146030287|NCT01842581|526623804|FG001|Overall Study|Other than specified|1|||
146030288|NCT01287195|526623805|FG000|Overall Study|Withdrawal by Subject|2|||
146030289|NCT02068118|526623809|FG000|18-month Comparative Study Period|Death|90|||
146030290|NCT02068118|526623810|FG001|18-month Comparative Study Period|Death|97|||
146030291|NCT02068118|526623809|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
146030292|NCT02068118|526623810|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
146030293|NCT02068118|526623809|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
146030294|NCT02068118|526623810|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
146030295|NCT02068118|526623809|FG000|18-month Comparative Study Period|Heart transplant|9|||
146030296|NCT02068118|526623810|FG001|18-month Comparative Study Period|Heart transplant|15|||
146030297|NCT02068118|526623809|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
146030298|NCT02068118|526623810|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
146030299|NCT02068118|526623809|FG000|18-month Comparative Study Period|Hemiplegia|0|||
146030300|NCT02068118|526623810|FG001|18-month Comparative Study Period|Hemiplegia|1|||
146030301|NCT02068118|526623809|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
146030302|NCT02068118|526623810|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
146030303|NCT02068118|526623809|FG000|18-month Comparative Study Period|Move|0|||
146030304|NCT02068118|526623810|FG001|18-month Comparative Study Period|Move|1|||
146030305|NCT02068118|526623809|FG000|18-month Comparative Study Period|Hearing loss|0|||
146030306|NCT02068118|526623810|FG001|18-month Comparative Study Period|Hearing loss|1|||
146030307|NCT02068118|526623809|FG000|Extension Period|Death|0|||
146030308|NCT02068118|526623810|FG001|Extension Period|Death|2|||
146030309|NCT02068118|526623809|FG000|Extension Period|Withdrawal by Subject|1|||
146030310|NCT02068118|526623810|FG001|Extension Period|Withdrawal by Subject|0|||
146030311|NCT02068118|526623809|FG000|Extension Period|Heart transplant|1|||
146030312|NCT02068118|526623810|FG001|Extension Period|Heart transplant|0|||
146030313|NCT02068118|526623809|FG000|Extension Period|Wrong device use|0|||
146030314|NCT02068118|526623810|FG001|Extension Period|Wrong device use|1|||
146030315|NCT00334282|526623811|FG000|Overall Study|Lost to Follow-up|11|||
146030316|NCT00334282|526623812|FG001|Overall Study|Lost to Follow-up|5|||
146030317|NCT00334282|526623811|FG000|Overall Study|Withdrawal by Subject|17|||
146030318|NCT00334282|526623812|FG001|Overall Study|Withdrawal by Subject|3|||
146030319|NCT00334282|526623811|FG000|Overall Study|Death|194|||
146030320|NCT00334282|526623812|FG001|Overall Study|Death|100|||
146030321|NCT00283868|526623813|FG000|Overall Study|Lost to Follow-up|7|||
146030322|NCT00283868|526623814|FG001|Overall Study|Lost to Follow-up|8|||
146030323|NCT00837876|526623815|FG000|Overall Study|Death|2|||
146030324|NCT00837876|526623815|FG000|Overall Study|Adverse Event|7|||
146030325|NCT00837876|526623815|FG000|Overall Study|Physician Decision|1|||
146030326|NCT00837876|526623815|FG000|Overall Study|Withdrawal by Subject|3|||
146030327|NCT00837876|526623815|FG000|Overall Study|disease progression|24|||
146030328|NCT00453973|526623818|FG000|Overall Study|Adverse Event|4|||
146030329|NCT00453973|526623819|FG001|Overall Study|Adverse Event|9|||
146030330|NCT00453973|526623818|FG000|Overall Study|Withdrawal by Subject|7|||
146030331|NCT00453973|526623819|FG001|Overall Study|Withdrawal by Subject|6|||
146030332|NCT00453973|526623818|FG000|Overall Study|PI Decision|0|||
146030333|NCT00453973|526623819|FG001|Overall Study|PI Decision|2|||
146030334|NCT00453973|526623818|FG000|Overall Study|Relocation|1|||
146030335|NCT00453973|526623819|FG001|Overall Study|Relocation|0|||
146030336|NCT00453973|526623818|FG000|Overall Study|Renal transplant|1|||
146030337|NCT00453973|526623819|FG001|Overall Study|Renal transplant|1|||
146030338|NCT00453973|526623818|FG000|Overall Study|Site closed by sponsor|3|||
146030339|NCT00453973|526623819|FG001|Overall Study|Site closed by sponsor|0|||
146030340|NCT00453973|526623818|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
146030341|NCT00453973|526623819|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
146030342|NCT01996592|526623824|FG000|Overall Study|no response to text/no diary entry|32|||
146030343|NCT01996592|526623824|FG000|Overall Study|change in surgical date|4|||
146030344|NCT01996592|526623824|FG000|Overall Study|Withdrawal by Subject|5|||
146030345|NCT01996592|526623824|FG000|Overall Study|change in mode of delivery|4|||
146030346|NCT00870194|526623825|FG000|Overall Study|Adverse Event|10|||
146030347|NCT00870194|526623826|FG001|Overall Study|Adverse Event|5|||
146030348|NCT00870194|526623825|FG000|Overall Study|Lack of Efficacy|0|||
146030349|NCT00870194|526623826|FG001|Overall Study|Lack of Efficacy|1|||
146030350|NCT00870194|526623825|FG000|Overall Study|Lost to Follow-up|2|||
146030351|NCT00870194|526623826|FG001|Overall Study|Lost to Follow-up|0|||
146030352|NCT00870194|526623825|FG000|Overall Study|Physician Decision|3|||
146030353|NCT00870194|526623826|FG001|Overall Study|Physician Decision|1|||
146030354|NCT00870194|526623825|FG000|Overall Study|Protocol Violation|3|||
146030355|NCT00870194|526623826|FG001|Overall Study|Protocol Violation|3|||
146030356|NCT00870194|526623825|FG000|Overall Study|Entry Criteria Not Met|1|||
146030357|NCT00870194|526623826|FG001|Overall Study|Entry Criteria Not Met|2|||
146030358|NCT00870194|526623825|FG000|Overall Study|Subject Decision|7|||
146030359|NCT00870194|526623826|FG001|Overall Study|Subject Decision|2|||
146030360|NCT00707746|526623827|FG000|Treatment Period|Adverse Event|2|||
146030361|NCT00707746|526623828|FG001|Treatment Period|Adverse Event|4|||
146030362|NCT00707746|526623827|FG000|Treatment Period|Ineligibility|0|||
146030363|NCT00707746|526623828|FG001|Treatment Period|Ineligibility|1|||
146030364|NCT02642965|526623831|FG000|Overall Study|Lack of Efficacy|4|||
146030365|NCT02642965|526623831|FG000|Overall Study|Physician Decision|9|||
146030366|NCT01167907|526623838|FG000|Overall Study|Protocol Violation|1|||
146030367|NCT01167907|526623839|FG001|Overall Study|Protocol Violation|0|||
146030368|NCT01167907|526623838|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
146030369|NCT01167907|526623839|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
146030370|NCT03077698|526623840|FG000|Progestin Monotherapy|Stable Disease|8|||
146030371|NCT03077698|526623841|FG001|Progestin Monotherapy|Stable Disease|0|||
146030372|NCT03077698|526623840|FG000|Progestin Monotherapy|Adverse Event|1|||
146030373|NCT03077698|526623841|FG001|Progestin Monotherapy|Adverse Event|0|||
146030374|NCT03077698|526623840|FG000|Progestin Monotherapy|Death|1|||
146030375|NCT03077698|526623841|FG001|Progestin Monotherapy|Death|0|||
146030376|NCT03077698|526623840|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
146030377|NCT03077698|526623841|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
146030378|NCT03077698|526623840|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
146030379|NCT03077698|526623841|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
146030380|NCT03077698|526623840|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
146030381|NCT03077698|526623841|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
146030382|NCT03077698|526623840|FG000|Safety Follow Up|Withdrawal by Subject|2|||
146030383|NCT03077698|526623841|FG001|Safety Follow Up|Withdrawal by Subject|1|||
146030384|NCT03077698|526623840|FG000|Safety Follow Up|Transfer of care to hospice|1|||
146030385|NCT03077698|526623841|FG001|Safety Follow Up|Transfer of care to hospice|0|||
146030386|NCT01439074|526623842|FG000|Overall Study|Lost to Follow-up|3|||
146030387|NCT01439074|526623843|FG001|Overall Study|Lost to Follow-up|4|||
146030388|NCT01439074|526623842|FG000|Overall Study|Subject shedding|1|||
146096222|NCT02651467|526874490|FG000|Overall Study|Withdrawal by Subject|0|||
146096223|NCT02651467|526874491|FG001|Overall Study|Withdrawal by Subject|0|||
146096224|NCT02651467|526874492|FG002|Overall Study|Withdrawal by Subject|2|||
146096225|NCT02651467|526874490|FG000|Overall Study|Other (Not specified)|1|||
146096226|NCT02651467|526874491|FG001|Overall Study|Other (Not specified)|0|||
146096227|NCT02651467|526874492|FG002|Overall Study|Other (Not specified)|2|||
146096228|NCT00408629|526874495|FG000|Overall Study|Adverse Event|13|||
146096229|NCT00408629|526874496|FG001|Overall Study|Adverse Event|27|||
146096230|NCT00408629|526874495|FG000|Overall Study|Withdrawal by Subject|8|||
146096231|NCT00408629|526874496|FG001|Overall Study|Withdrawal by Subject|4|||
146096232|NCT00408629|526874495|FG000|Overall Study|Lost to Follow-up|1|||
146096233|NCT00408629|526874496|FG001|Overall Study|Lost to Follow-up|1|||
146096234|NCT00408629|526874495|FG000|Overall Study|Lack of Efficacy|63|||
146096235|NCT00408629|526874496|FG001|Overall Study|Lack of Efficacy|73|||
146096236|NCT00408629|526874495|FG000|Overall Study|Protocol Violation|1|||
146096237|NCT00408629|526874496|FG001|Overall Study|Protocol Violation|5|||
146096238|NCT00408629|526874495|FG000|Overall Study|Miscellaneous|11|||
146096239|NCT00408629|526874496|FG001|Overall Study|Miscellaneous|15|||
146096240|NCT00191906|526874497|FG000|Study Period II|Adverse Event|0|||
146096241|NCT00191906|526874498|FG001|Study Period II|Adverse Event|1|||
146096242|NCT00191906|526874499|FG002|Study Period II|Adverse Event|0|||
146096243|NCT00191906|526874500|FG003|Study Period II|Adverse Event|0|||
146096244|NCT00191906|526874497|FG000|Study Period II|Withdrawal by Subject|0|||
146096245|NCT00191906|526874498|FG001|Study Period II|Withdrawal by Subject|3|||
146096246|NCT00191906|526874499|FG002|Study Period II|Withdrawal by Subject|0|||
146096247|NCT00191906|526874500|FG003|Study Period II|Withdrawal by Subject|0|||
146096248|NCT00191906|526874497|FG000|Study Period II|Parent/Caregiver Decision|0|||
146096249|NCT00191906|526874498|FG001|Study Period II|Parent/Caregiver Decision|1|||
146096250|NCT00191906|526874499|FG002|Study Period II|Parent/Caregiver Decision|0|||
146096251|NCT00191906|526874500|FG003|Study Period II|Parent/Caregiver Decision|0|||
146096252|NCT00191906|526874497|FG000|Study Period II|Entry Criteria Exclusion|0|||
146096253|NCT00191906|526874498|FG001|Study Period II|Entry Criteria Exclusion|0|||
146096254|NCT00191906|526874499|FG002|Study Period II|Entry Criteria Exclusion|1|||
146096255|NCT00191906|526874500|FG003|Study Period II|Entry Criteria Exclusion|0|||
146096256|NCT00191906|526874497|FG000|Study Period III|Adverse Event|1|||
146096257|NCT00191906|526874498|FG001|Study Period III|Adverse Event|0|||
146096258|NCT00191906|526874499|FG002|Study Period III|Adverse Event|0|||
146096259|NCT00191906|526874500|FG003|Study Period III|Adverse Event|0|||
146096260|NCT00191906|526874497|FG000|Study Period III|Lost to Follow-up|0|||
146096261|NCT00191906|526874498|FG001|Study Period III|Lost to Follow-up|1|||
146096262|NCT00191906|526874499|FG002|Study Period III|Lost to Follow-up|0|||
146096263|NCT00191906|526874500|FG003|Study Period III|Lost to Follow-up|0|||
146096264|NCT00191906|526874497|FG000|Study Period III|Parent/Caregiver Decision|1|||
146096265|NCT00191906|526874498|FG001|Study Period III|Parent/Caregiver Decision|0|||
146096266|NCT00191906|526874499|FG002|Study Period III|Parent/Caregiver Decision|0|||
146096267|NCT00191906|526874500|FG003|Study Period III|Parent/Caregiver Decision|0|||
146096268|NCT00191906|526874497|FG000|Study Period III|Lack of Efficacy|3|||
146096269|NCT00191906|526874498|FG001|Study Period III|Lack of Efficacy|3|||
146096270|NCT00191906|526874499|FG002|Study Period III|Lack of Efficacy|0|||
146096271|NCT00191906|526874500|FG003|Study Period III|Lack of Efficacy|0|||
146096272|NCT00573937|526874501|FG000|Overall Study|Study Terminated|0|||
146096273|NCT00573937|526874502|FG001|Overall Study|Study Terminated|1|||
146096274|NCT00333801|526874503|FG000|Overall Study|Moved to another state|5|||
146096275|NCT00333801|526874504|FG001|Overall Study|Moved to another state|3|||
146096276|NCT00333801|526874503|FG000|Overall Study|Lost to Follow-up|2|||
146096277|NCT00333801|526874504|FG001|Overall Study|Lost to Follow-up|0|||
146096278|NCT00333801|526874503|FG000|Overall Study|Incarcerated|1|||
146096279|NCT00333801|526874504|FG001|Overall Study|Incarcerated|2|||
146096280|NCT00333801|526874503|FG000|Overall Study|Withdrawal by Subject|0|||
146096281|NCT00333801|526874504|FG001|Overall Study|Withdrawal by Subject|1|||
146096282|NCT03633617|526874505|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
146096283|NCT03633617|526874506|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
146096284|NCT03633617|526874507|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096285|NCT03633617|526874508|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096286|NCT03633617|526874509|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096287|NCT03633617|526874510|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096288|NCT03633617|526874511|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096289|NCT03633617|526874512|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096290|NCT03633617|526874513|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096291|NCT03633617|526874514|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096292|NCT03633617|526874515|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
146096293|NCT03633617|526874505|FG000|Part A|Unconfirmed early termination visit|1|||
146096294|NCT03633617|526874506|FG001|Part A|Unconfirmed early termination visit|0|||
146300345|NCT02101021|527615231|FG004|Overall Study|Lost to Follow-up|0|||
146300346|NCT02101021|527615227|FG000|Overall Study|Study Terminated by Sponsor|1|||
146300347|NCT02101021|527615228|FG001|Overall Study|Study Terminated by Sponsor|0|||
146300348|NCT02101021|527615229|FG002|Overall Study|Study Terminated by Sponsor|1|||
146300349|NCT02101021|527615230|FG003|Overall Study|Study Terminated by Sponsor|1|||
146300350|NCT02101021|527615231|FG004|Overall Study|Study Terminated by Sponsor|1|||
146300351|NCT00387764|527615232|FG000|Overall Study|Adverse Event|12|||
146300352|NCT00387764|527615232|FG000|Overall Study|Withdrawal by Subject|8|||
146300353|NCT00387764|527615232|FG000|Overall Study|Sponsor Terminated Study|1|||
146300354|NCT00387764|527615232|FG000|Overall Study|Physician Decision|1|||
146300355|NCT00387764|527615232|FG000|Overall Study|Other|2|||
146030389|NCT01439074|526623843|FG001|Overall Study|Subject shedding|0|||
146030390|NCT01439074|526623842|FG000|Overall Study|Withdrawal by Subject|1|||
146030391|NCT01439074|526623843|FG001|Overall Study|Withdrawal by Subject|5|||
146030392|NCT01439074|526623842|FG000|Overall Study|Other|4|||
146030393|NCT01439074|526623843|FG001|Overall Study|Other|4|||
146030394|NCT01140568|526623844|FG000|Overall Study|disease progression|31|||
146030395|NCT01140568|526623844|FG000|Overall Study|Withdrawal by Subject|1|||
146030396|NCT01140568|526623844|FG000|Overall Study|Screen Fail|4|||
146030397|NCT00815191|526623845|FG000|Overall Study|Protocol Violation|1|||
146030398|NCT00815191|526623846|FG001|Overall Study|Protocol Violation|1|||
146030399|NCT00493636|526623847|FG000|Overall Study|Withdrawal by Subject|1|||
146030400|NCT00493636|526623848|FG001|Overall Study|Withdrawal by Subject|0|||
146030401|NCT00493636|526623847|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
146030402|NCT00493636|526623848|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
146030403|NCT00493636|526623847|FG000|Overall Study|Mis-randomization|1|||
146030404|NCT00493636|526623848|FG001|Overall Study|Mis-randomization|1|||
146030405|NCT01873729|526623850|FG000|Overall Study|Withdrawal by Subject|1|||
146030406|NCT01066780|526623851|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
146030407|NCT01066780|526623852|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
146030408|NCT03099148|526623853|FG000|Wash-out|scheduling conflict|0|||
146030409|NCT03099148|526623854|FG001|Wash-out|scheduling conflict|1|||
146030410|NCT03099148|526623855|FG002|Wash-out|scheduling conflict|0|||
146030411|NCT03099148|526623856|FG003|Wash-out|scheduling conflict|0|||
146030412|NCT03099148|526623853|FG000|Wash-out|Adverse Event|0|||
146030413|NCT03099148|526623854|FG001|Wash-out|Adverse Event|1|||
146030414|NCT03099148|526623855|FG002|Wash-out|Adverse Event|0|||
146030415|NCT03099148|526623856|FG003|Wash-out|Adverse Event|0|||
146030416|NCT01827332|526623857|FG000|Overall Study|Lost to Follow-up|2|||
146030417|NCT01827332|526623858|FG001|Overall Study|Lost to Follow-up|1|||
146030418|NCT01241760|526623859|FG000|Overall Study|Adverse Event|1|||
146030419|NCT01241760|526623860|FG001|Overall Study|Adverse Event|0|||
146030420|NCT01241760|526623859|FG000|Overall Study|Lost to Follow-up|18|||
146030421|NCT01241760|526623860|FG001|Overall Study|Lost to Follow-up|22|||
146030422|NCT01241760|526623859|FG000|Overall Study|Withdrawal by Subject|13|||
146030423|NCT01241760|526623860|FG001|Overall Study|Withdrawal by Subject|13|||
146030424|NCT01241760|526623859|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
146030425|NCT01241760|526623860|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
146030426|NCT01241760|526623859|FG000|Overall Study|Other|1|||
146030427|NCT01241760|526623860|FG001|Overall Study|Other|1|||
146030428|NCT02644356|526623863|FG000|Overall Study|Withdrawal by Subject|2|||
146030429|NCT02210091|526623865|FG000|Overall Study|Physician Decision|0|||
146030430|NCT02210091|526623866|FG001|Overall Study|Physician Decision|1|||
146030431|NCT02210091|526623865|FG000|Overall Study|Withdrawal by Sponsor|0|||
146030432|NCT02210091|526623866|FG001|Overall Study|Withdrawal by Sponsor|1|||
146030433|NCT01711866|526623867|FG000|Overall Study|Noncompliant|3|||
146030434|NCT01711866|526623867|FG000|Overall Study|Withdrawal by Subject|3|||
146030435|NCT01711866|526623867|FG000|Overall Study|Adverse Event|2|||
146030436|NCT00897390|526623868|FG000|Overall Study|Adverse Event|2|||
146030437|NCT00897390|526623868|FG000|Overall Study|No Longer Met Study Criteria|1|||
146030438|NCT00897390|526623868|FG000|Overall Study|Personal Reasons|1|||
146030439|NCT00897390|526623868|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
146030440|NCT02804750|526625730|FG000|Period 1|Adverse Event|0|||
146030441|NCT02804750|526625731|FG001|Period 1|Adverse Event|2|||
146030442|NCT02804750|526625730|FG000|Period 1|Withdrawal by Subject|0|||
146030443|NCT02804750|526625731|FG001|Period 1|Withdrawal by Subject|1|||
146030444|NCT02804750|526625730|FG000|Period 2|Adverse Event|1|||
146030445|NCT02804750|526625731|FG001|Period 2|Adverse Event|0|||
146300356|NCT00387764|527615232|FG000|Overall Study|Death|7|||
146300357|NCT01326728|527615233|FG000|Overall Study|Death|13|||
146300358|NCT01326728|527615234|FG001|Overall Study|Death|0|||
146030446|NCT02804750|526625730|FG000|Period 3|Adverse Event|0|||
146030447|NCT02804750|526625731|FG001|Period 3|Adverse Event|2|||
146030448|NCT02804750|526625730|FG000|Period 4|Adverse Event|0|||
146030449|NCT02804750|526625731|FG001|Period 4|Adverse Event|5|||
146030450|NCT02559414|526625732|FG000|Overall Study|Lost to Follow-up|0|||
146030451|NCT02559414|526625733|FG001|Overall Study|Lost to Follow-up|1|||
146030452|NCT02559414|526625734|FG002|Overall Study|Lost to Follow-up|0|||
146030453|NCT02559414|526625732|FG000|Overall Study|Withdrawal by Subject|1|||
146030454|NCT02559414|526625733|FG001|Overall Study|Withdrawal by Subject|0|||
146096295|NCT03633617|526874507|FG002|Part A|Unconfirmed early termination visit|0|||
146096296|NCT03633617|526874508|FG003|Part A|Unconfirmed early termination visit|0|||
146096297|NCT03633617|526874509|FG004|Part A|Unconfirmed early termination visit|0|||
146096298|NCT03633617|526874510|FG005|Part A|Unconfirmed early termination visit|0|||
146096299|NCT03633617|526874511|FG006|Part A|Unconfirmed early termination visit|0|||
146096300|NCT03633617|526874512|FG007|Part A|Unconfirmed early termination visit|0|||
146096301|NCT03633617|526874513|FG008|Part A|Unconfirmed early termination visit|0|||
146096302|NCT03633617|526874514|FG009|Part A|Unconfirmed early termination visit|0|||
146096303|NCT03633617|526874515|FG010|Part A|Unconfirmed early termination visit|0|||
146096304|NCT03633617|526874505|FG000|Part A|Adverse Event|0|||
146096305|NCT03633617|526874506|FG001|Part A|Adverse Event|1|||
146096306|NCT03633617|526874507|FG002|Part A|Adverse Event|0|||
146096307|NCT03633617|526874508|FG003|Part A|Adverse Event|0|||
146096308|NCT03633617|526874509|FG004|Part A|Adverse Event|0|||
146096309|NCT03633617|526874510|FG005|Part A|Adverse Event|0|||
146096310|NCT03633617|526874511|FG006|Part A|Adverse Event|0|||
146096311|NCT03633617|526874512|FG007|Part A|Adverse Event|0|||
146096312|NCT03633617|526874513|FG008|Part A|Adverse Event|0|||
146096313|NCT03633617|526874514|FG009|Part A|Adverse Event|0|||
146096314|NCT03633617|526874515|FG010|Part A|Adverse Event|0|||
146096315|NCT03633617|526874505|FG000|Part A|Pregnancy|1|||
146096316|NCT03633617|526874506|FG001|Part A|Pregnancy|0|||
146096317|NCT03633617|526874507|FG002|Part A|Pregnancy|0|||
146096318|NCT03633617|526874508|FG003|Part A|Pregnancy|0|||
146096319|NCT03633617|526874509|FG004|Part A|Pregnancy|0|||
146096320|NCT03633617|526874510|FG005|Part A|Pregnancy|0|||
146096321|NCT03633617|526874511|FG006|Part A|Pregnancy|0|||
146096322|NCT03633617|526874512|FG007|Part A|Pregnancy|0|||
146096323|NCT03633617|526874513|FG008|Part A|Pregnancy|0|||
146096324|NCT03633617|526874514|FG009|Part A|Pregnancy|0|||
146096325|NCT03633617|526874515|FG010|Part A|Pregnancy|0|||
146096326|NCT03633617|526874505|FG000|Part A|Withdrawal by Subject|0|||
146096327|NCT03633617|526874506|FG001|Part A|Withdrawal by Subject|1|||
146096328|NCT03633617|526874507|FG002|Part A|Withdrawal by Subject|0|||
146096329|NCT03633617|526874508|FG003|Part A|Withdrawal by Subject|0|||
146096330|NCT03633617|526874509|FG004|Part A|Withdrawal by Subject|0|||
146096331|NCT03633617|526874510|FG005|Part A|Withdrawal by Subject|0|||
146096332|NCT03633617|526874511|FG006|Part A|Withdrawal by Subject|0|||
146030455|NCT02559414|526625734|FG002|Overall Study|Withdrawal by Subject|1|||
146030456|NCT02559414|526625732|FG000|Overall Study|Other|0|||
146030457|NCT02559414|526625733|FG001|Overall Study|Other|1|||
146030458|NCT02559414|526625734|FG002|Overall Study|Other|1|||
146030459|NCT00940485|526625742|FG000|Overall Study|HBeAb positive at Baseline|3|||
146030460|NCT00940485|526625743|FG001|Overall Study|HBeAb positive at Baseline|2|||
146030461|NCT00940485|526625742|FG000|Overall Study|Lost to Follow-up|2|||
146030462|NCT00940485|526625743|FG001|Overall Study|Lost to Follow-up|3|||
146030463|NCT00940485|526625742|FG000|Overall Study|Adverse Event|8|||
146030464|NCT00940485|526625743|FG001|Overall Study|Adverse Event|0|||
146030465|NCT00940485|526625742|FG000|Overall Study|Withdrawal by Subject|1|||
146030466|NCT00940485|526625743|FG001|Overall Study|Withdrawal by Subject|1|||
146030467|NCT00940485|526625742|FG000|Overall Study|Others|1|||
146030468|NCT00940485|526625743|FG001|Overall Study|Others|1|||
146030469|NCT04271475|526625744|FG000|DB Period: Day 1 up to EODBT|Death|1|||
146030470|NCT04271475|526625745|FG001|DB Period: Day 1 up to EODBT|Death|0|||
146030471|NCT04271475|526625746|FG002|DB Period: Day 1 up to EODBT|Death|0|||
146030472|NCT04271475|526625747|FG003|DB Period: Day 1 up to EODBT|Death|0|||
146030473|NCT04271475|526625744|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
146030474|NCT04271475|526625745|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
146030475|NCT04271475|526625746|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
146030476|NCT04271475|526625747|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
146096333|NCT03633617|526874512|FG007|Part A|Withdrawal by Subject|0|||
146096334|NCT03633617|526874513|FG008|Part A|Withdrawal by Subject|0|||
146030477|NCT04271475|526625744|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
146030478|NCT04271475|526625745|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
146030479|NCT04271475|526625746|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
146096335|NCT03633617|526874514|FG009|Part A|Withdrawal by Subject|0|||
146096336|NCT03633617|526874515|FG010|Part A|Withdrawal by Subject|0|||
146096337|NCT03633617|526874505|FG000|Part B|Adverse Event|0|||
146096338|NCT03633617|526874506|FG001|Part B|Adverse Event|0|||
146096339|NCT03633617|526874507|FG002|Part B|Adverse Event|2|||
146096340|NCT03633617|526874508|FG003|Part B|Adverse Event|2|||
146096341|NCT03633617|526874509|FG004|Part B|Adverse Event|1|||
146096342|NCT03633617|526874510|FG005|Part B|Adverse Event|0|||
146096343|NCT03633617|526874511|FG006|Part B|Adverse Event|0|||
146030480|NCT04271475|526625747|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
146030481|NCT04271475|526625744|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
146096344|NCT03633617|526874512|FG007|Part B|Adverse Event|0|||
146096345|NCT03633617|526874513|FG008|Part B|Adverse Event|0|||
146096346|NCT03633617|526874514|FG009|Part B|Adverse Event|0|||
146096347|NCT03633617|526874515|FG010|Part B|Adverse Event|0|||
146096348|NCT03633617|526874505|FG000|Part B|Withdrawal by Subject|0|||
146096349|NCT03633617|526874506|FG001|Part B|Withdrawal by Subject|0|||
146096350|NCT03633617|526874507|FG002|Part B|Withdrawal by Subject|1|||
146096351|NCT03633617|526874508|FG003|Part B|Withdrawal by Subject|0|||
146096352|NCT03633617|526874509|FG004|Part B|Withdrawal by Subject|2|||
146096353|NCT03633617|526874510|FG005|Part B|Withdrawal by Subject|0|||
146096354|NCT03633617|526874511|FG006|Part B|Withdrawal by Subject|0|||
146096355|NCT03633617|526874512|FG007|Part B|Withdrawal by Subject|0|||
146096356|NCT03633617|526874513|FG008|Part B|Withdrawal by Subject|0|||
146096357|NCT03633617|526874514|FG009|Part B|Withdrawal by Subject|0|||
146096358|NCT03633617|526874515|FG010|Part B|Withdrawal by Subject|0|||
146096359|NCT03633617|526874505|FG000|Part B|Lost to Follow-up|0|||
146096360|NCT03633617|526874506|FG001|Part B|Lost to Follow-up|0|||
146096361|NCT03633617|526874507|FG002|Part B|Lost to Follow-up|0|||
146096362|NCT03633617|526874508|FG003|Part B|Lost to Follow-up|0|||
146096363|NCT03633617|526874509|FG004|Part B|Lost to Follow-up|1|||
146096364|NCT03633617|526874510|FG005|Part B|Lost to Follow-up|0|||
146096365|NCT03633617|526874511|FG006|Part B|Lost to Follow-up|0|||
146096366|NCT03633617|526874512|FG007|Part B|Lost to Follow-up|0|||
146096367|NCT03633617|526874513|FG008|Part B|Lost to Follow-up|0|||
146096368|NCT03633617|526874514|FG009|Part B|Lost to Follow-up|0|||
146096369|NCT03633617|526874515|FG010|Part B|Lost to Follow-up|0|||
146096370|NCT03633617|526874505|FG000|Part B|Physician Decision|0|||
146096371|NCT03633617|526874506|FG001|Part B|Physician Decision|0|||
146096372|NCT03633617|526874507|FG002|Part B|Physician Decision|0|||
146096373|NCT03633617|526874508|FG003|Part B|Physician Decision|0|||
146096374|NCT03633617|526874509|FG004|Part B|Physician Decision|1|||
146096375|NCT03633617|526874510|FG005|Part B|Physician Decision|0|||
146096376|NCT03633617|526874511|FG006|Part B|Physician Decision|0|||
146096377|NCT03633617|526874512|FG007|Part B|Physician Decision|0|||
146096378|NCT03633617|526874513|FG008|Part B|Physician Decision|0|||
146096379|NCT03633617|526874514|FG009|Part B|Physician Decision|0|||
146096380|NCT03633617|526874515|FG010|Part B|Physician Decision|0|||
146096381|NCT03633617|526874505|FG000|Part B|COVID-19 Restrictions|0|||
146096382|NCT03633617|526874506|FG001|Part B|COVID-19 Restrictions|0|||
146096383|NCT03633617|526874507|FG002|Part B|COVID-19 Restrictions|1|||
146096384|NCT03633617|526874508|FG003|Part B|COVID-19 Restrictions|0|||
146096385|NCT03633617|526874509|FG004|Part B|COVID-19 Restrictions|0|||
146096386|NCT03633617|526874510|FG005|Part B|COVID-19 Restrictions|0|||
146096387|NCT03633617|526874511|FG006|Part B|COVID-19 Restrictions|0|||
146096388|NCT03633617|526874512|FG007|Part B|COVID-19 Restrictions|0|||
146096389|NCT03633617|526874513|FG008|Part B|COVID-19 Restrictions|0|||
146096390|NCT03633617|526874514|FG009|Part B|COVID-19 Restrictions|0|||
146096391|NCT03633617|526874515|FG010|Part B|COVID-19 Restrictions|0|||
146096392|NCT03633617|526874505|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146300359|NCT01326728|527615233|FG000|Overall Study|Early closure of study|34|||
146030482|NCT04271475|526625745|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
146030483|NCT04271475|526625746|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
146030484|NCT04271475|526625747|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
146030485|NCT04271475|526625744|FG000|DB Period: Day 1 up to EODBT|Other|8|||
146030486|NCT04271475|526625745|FG001|DB Period: Day 1 up to EODBT|Other|5|||
146030487|NCT04271475|526625746|FG002|DB Period: Day 1 up to EODBT|Other|0|||
146030488|NCT04271475|526625747|FG003|DB Period: Day 1 up to EODBT|Other|0|||
146030489|NCT04271475|526625744|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
146030490|NCT04271475|526625745|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
146030491|NCT04271475|526625746|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
146030492|NCT04271475|526625747|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
146030493|NCT04271475|526625744|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146030494|NCT04271475|526625745|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146030495|NCT04271475|526625746|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
146030496|NCT04271475|526625747|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
146030497|NCT06250738|526625750|FG000|Overall Study|Lost to Follow-up|1|||
146030498|NCT02936284|526625752|FG000|Overall Study|Withdrawal by Subject|3|||
146030499|NCT02936284|526625753|FG001|Overall Study|Withdrawal by Subject|1|||
146030500|NCT02936284|526625752|FG000|Overall Study|Lost to Follow-up|7|||
146030501|NCT02936284|526625753|FG001|Overall Study|Lost to Follow-up|8|||
146096393|NCT03633617|526874506|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096394|NCT03633617|526874507|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
146096395|NCT03633617|526874508|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096396|NCT03633617|526874509|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096397|NCT03633617|526874510|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096398|NCT03633617|526874511|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096399|NCT03633617|526874512|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096400|NCT03633617|526874513|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096401|NCT03633617|526874514|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146030502|NCT04619004|526625756|FG000|Overall Study|Death|114|||
146030503|NCT04619004|526625757|FG001|Overall Study|Death|28|||
146030504|NCT04619004|526625756|FG000|Overall Study|Lost to Follow-up|1|||
146030505|NCT04619004|526625757|FG001|Overall Study|Lost to Follow-up|1|||
146030506|NCT04619004|526625756|FG000|Overall Study|Withdrawal by Subject|24|||
146030507|NCT04619004|526625757|FG001|Overall Study|Withdrawal by Subject|7|||
146030508|NCT04619004|526625756|FG000|Overall Study|Other - Not specified|0|||
146030509|NCT04619004|526625757|FG001|Overall Study|Other - Not specified|1|||
146030510|NCT01114360|526625760|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
146030511|NCT01114360|526625761|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
146030512|NCT02677844|526625766|FG000|Period 3|Withdrawal by Subject|0|||
146030513|NCT02677844|526625767|FG001|Period 3|Withdrawal by Subject|0|||
146030514|NCT02677844|526625768|FG002|Period 3|Withdrawal by Subject|0|||
146030515|NCT02677844|526625769|FG003|Period 3|Withdrawal by Subject|1|||
146030516|NCT02677844|526625770|FG004|Period 3|Withdrawal by Subject|0|||
146030517|NCT02677844|526625771|FG005|Period 3|Withdrawal by Subject|0|||
146030518|NCT02677844|526625772|FG006|Period 3|Withdrawal by Subject|0|||
146030519|NCT01390779|526625773|FG000|Overall Study|Physician Decision|1|||
146030520|NCT03455829|526625774|FG000|Overall Study|Death|2|||
146030521|NCT03455829|526625775|FG001|Overall Study|Death|3|||
146030522|NCT03455829|526625776|FG002|Overall Study|Death|2|||
146030523|NCT03455829|526625777|FG003|Overall Study|Death|4|||
146030524|NCT03455829|526625778|FG004|Overall Study|Death|2|||
146030525|NCT03455829|526625774|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
146030526|NCT03455829|526625775|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
146030527|NCT03455829|526625776|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
146030528|NCT03455829|526625777|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
146030529|NCT03455829|526625778|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
146030530|NCT03455829|526625774|FG000|Overall Study|Disease progression|0|||
146030531|NCT03455829|526625775|FG001|Overall Study|Disease progression|0|||
146030532|NCT03455829|526625776|FG002|Overall Study|Disease progression|0|||
146030533|NCT03455829|526625777|FG003|Overall Study|Disease progression|1|||
146030534|NCT03455829|526625778|FG004|Overall Study|Disease progression|1|||
146030535|NCT03630302|526625779|FG000|Surgery|hardware issue prevented LFP recordings|1|||
146030536|NCT03630302|526625779|FG000|3 Month Visit|Adverse Event|2|||
146030537|NCT03630302|526625779|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
146030538|NCT01133275|526625783|FG000|Overall Study|Withdrawal by Subject|1|||
146030539|NCT01133275|526625783|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
146030540|NCT01143896|526625784|FG000|Overall Study|Did not complete Baseline Interview|5|||
146030541|NCT01143896|526625785|FG001|Overall Study|Did not complete Baseline Interview|4|||
146030542|NCT01143896|526625784|FG000|Overall Study|Lost to Follow-up|18|||
146030543|NCT01143896|526625785|FG001|Overall Study|Lost to Follow-up|13|||
146030544|NCT01143896|526625784|FG000|Overall Study|Withdrawal by Subject|13|||
146030545|NCT01143896|526625785|FG001|Overall Study|Withdrawal by Subject|5|||
146030546|NCT01143896|526625784|FG000|Overall Study|Death|6|||
146030547|NCT01143896|526625785|FG001|Overall Study|Death|3|||
146030548|NCT01318070|526625786|FG000|Overall Study|Adverse Event|1|||
146030549|NCT01318070|526625787|FG001|Overall Study|Adverse Event|1|||
146030550|NCT01318070|526625788|FG002|Overall Study|Adverse Event|5|||
146030551|NCT01318070|526625786|FG000|Overall Study|Withdrawal by Subject|0|||
146030552|NCT01318070|526625787|FG001|Overall Study|Withdrawal by Subject|1|||
146030553|NCT01318070|526625788|FG002|Overall Study|Withdrawal by Subject|1|||
146030554|NCT01318070|526625786|FG000|Overall Study|Lack of Efficacy|0|||
146030555|NCT01318070|526625787|FG001|Overall Study|Lack of Efficacy|0|||
146030556|NCT01318070|526625788|FG002|Overall Study|Lack of Efficacy|1|||
146030557|NCT01318070|526625786|FG000|Overall Study|Principal Investigator Discretion|1|||
146030558|NCT01318070|526625787|FG001|Overall Study|Principal Investigator Discretion|0|||
146030559|NCT01318070|526625788|FG002|Overall Study|Principal Investigator Discretion|0|||
146030560|NCT01219933|526625797|FG000|Overall Study|Adverse Event|8|||
146030561|NCT01219933|526625797|FG000|Overall Study|No LDA reached|5|||
146030562|NCT01219933|526625797|FG000|Overall Study|No LDA maintained|7|||
146030563|NCT01219933|526625797|FG000|Overall Study|Lost to Follow-up|3|||
146030564|NCT01219933|526625797|FG000|Overall Study|GC free|1|||
146030565|NCT01219933|526625797|FG000|Overall Study|Withdrawal by Subject|5|||
146030566|NCT01219933|526625797|FG000|Overall Study|Protocol Violation|8|||
146030567|NCT01219933|526625797|FG000|Overall Study|Lack of Efficacy|1|||
146168152|NCT02496767|527128085|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
146030568|NCT01443130|526625799|FG000|Overall Study|Lost to Follow-up|44|||
146030569|NCT01443130|526625800|FG001|Overall Study|Lost to Follow-up|42|||
146030570|NCT01443130|526625801|FG002|Overall Study|Lost to Follow-up|50|||
146030571|NCT01443130|526625802|FG003|Overall Study|Lost to Follow-up|23|||
146030572|NCT01443130|526625803|FG004|Overall Study|Lost to Follow-up|25|||
146030573|NCT01443130|526625804|FG005|Overall Study|Lost to Follow-up|21|||
146168153|NCT02496767|527128086|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
146168154|NCT02496767|527128087|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
146168155|NCT02496767|527128088|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
146096402|NCT03633617|526874515|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
146096403|NCT03633617|526874505|FG000|Part C (& Follow-up)|Adverse Event|0|||
146096404|NCT03633617|526874506|FG001|Part C (& Follow-up)|Adverse Event|0|||
146096405|NCT03633617|526874507|FG002|Part C (& Follow-up)|Adverse Event|0|||
146096406|NCT03633617|526874508|FG003|Part C (& Follow-up)|Adverse Event|0|||
146096407|NCT03633617|526874509|FG004|Part C (& Follow-up)|Adverse Event|0|||
146096408|NCT03633617|526874510|FG005|Part C (& Follow-up)|Adverse Event|1|||
146096409|NCT03633617|526874511|FG006|Part C (& Follow-up)|Adverse Event|0|||
146096410|NCT03633617|526874512|FG007|Part C (& Follow-up)|Adverse Event|1|||
146096411|NCT03633617|526874513|FG008|Part C (& Follow-up)|Adverse Event|0|||
146096412|NCT03633617|526874514|FG009|Part C (& Follow-up)|Adverse Event|0|||
146096413|NCT03633617|526874515|FG010|Part C (& Follow-up)|Adverse Event|0|||
146096414|NCT03633617|526874505|FG000|Part C (& Follow-up)|Pregnancy|0|||
146096415|NCT03633617|526874506|FG001|Part C (& Follow-up)|Pregnancy|0|||
146096416|NCT03633617|526874507|FG002|Part C (& Follow-up)|Pregnancy|0|||
146096417|NCT03633617|526874508|FG003|Part C (& Follow-up)|Pregnancy|0|||
146096418|NCT03633617|526874509|FG004|Part C (& Follow-up)|Pregnancy|0|||
146096419|NCT03633617|526874510|FG005|Part C (& Follow-up)|Pregnancy|0|||
146096420|NCT03633617|526874511|FG006|Part C (& Follow-up)|Pregnancy|0|||
146096421|NCT03633617|526874512|FG007|Part C (& Follow-up)|Pregnancy|0|||
146096422|NCT03633617|526874513|FG008|Part C (& Follow-up)|Pregnancy|0|||
146096423|NCT03633617|526874514|FG009|Part C (& Follow-up)|Pregnancy|1|||
146096424|NCT03633617|526874515|FG010|Part C (& Follow-up)|Pregnancy|0|||
146096425|NCT03633617|526874505|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096426|NCT03633617|526874506|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096427|NCT03633617|526874507|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096428|NCT03633617|526874508|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096429|NCT03633617|526874509|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096430|NCT03633617|526874510|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
146096431|NCT03633617|526874511|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
146096432|NCT03633617|526874512|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
146096433|NCT03633617|526874513|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
146096434|NCT03633617|526874514|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
146096435|NCT03633617|526874515|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
146096436|NCT03633617|526874505|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
146096437|NCT03633617|526874506|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
146096438|NCT03633617|526874507|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
146096439|NCT03633617|526874508|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
146096440|NCT03633617|526874509|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
146030574|NCT01443130|526625799|FG000|Overall Study|Death|0|||
146030575|NCT01443130|526625800|FG001|Overall Study|Death|1|||
146030576|NCT01443130|526625801|FG002|Overall Study|Death|0|||
146030577|NCT01443130|526625802|FG003|Overall Study|Death|7|||
146030578|NCT01443130|526625803|FG004|Overall Study|Death|10|||
146030579|NCT01443130|526625804|FG005|Overall Study|Death|8|||
146030580|NCT01443130|526625799|FG000|Overall Study|Adverse Event|2|||
146030581|NCT01443130|526625800|FG001|Overall Study|Adverse Event|1|||
146030582|NCT01443130|526625801|FG002|Overall Study|Adverse Event|1|||
146030583|NCT01443130|526625802|FG003|Overall Study|Adverse Event|0|||
146030584|NCT01443130|526625803|FG004|Overall Study|Adverse Event|0|||
146030585|NCT01443130|526625804|FG005|Overall Study|Adverse Event|0|||
146030586|NCT01443130|526625799|FG000|Overall Study|Protocol Violation|2|||
146030587|NCT01443130|526625800|FG001|Overall Study|Protocol Violation|1|||
146030588|NCT01443130|526625801|FG002|Overall Study|Protocol Violation|3|||
146030589|NCT01443130|526625802|FG003|Overall Study|Protocol Violation|2|||
146030590|NCT01443130|526625803|FG004|Overall Study|Protocol Violation|2|||
146030591|NCT01443130|526625804|FG005|Overall Study|Protocol Violation|3|||
146030592|NCT01443130|526625799|FG000|Overall Study|Withdrawal by Subject|15|||
146030593|NCT01443130|526625800|FG001|Overall Study|Withdrawal by Subject|14|||
146030594|NCT01443130|526625801|FG002|Overall Study|Withdrawal by Subject|12|||
146030595|NCT01443130|526625802|FG003|Overall Study|Withdrawal by Subject|7|||
146030596|NCT01443130|526625803|FG004|Overall Study|Withdrawal by Subject|7|||
146030597|NCT01443130|526625804|FG005|Overall Study|Withdrawal by Subject|2|||
146030598|NCT01443130|526625799|FG000|Overall Study|Death of Subject's Infant|5|||
146030599|NCT01443130|526625800|FG001|Overall Study|Death of Subject's Infant|10|||
146030600|NCT01443130|526625801|FG002|Overall Study|Death of Subject's Infant|11|||
146030601|NCT01443130|526625802|FG003|Overall Study|Death of Subject's Infant|0|||
146096441|NCT03633617|526874510|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
146096442|NCT03633617|526874511|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
146096443|NCT03633617|526874512|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
146096444|NCT03633617|526874513|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
146096445|NCT03633617|526874514|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
146096446|NCT03633617|526874515|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
146096447|NCT03633617|526874505|FG000|Part C (& Follow-up)|Physician Decision|0|||
146030602|NCT01443130|526625803|FG004|Overall Study|Death of Subject's Infant|0|||
146030603|NCT01443130|526625804|FG005|Overall Study|Death of Subject's Infant|0|||
146096448|NCT03633617|526874506|FG001|Part C (& Follow-up)|Physician Decision|0|||
146096449|NCT03633617|526874507|FG002|Part C (& Follow-up)|Physician Decision|0|||
146096450|NCT03633617|526874508|FG003|Part C (& Follow-up)|Physician Decision|0|||
146096451|NCT03633617|526874509|FG004|Part C (& Follow-up)|Physician Decision|0|||
146096452|NCT03633617|526874510|FG005|Part C (& Follow-up)|Physician Decision|0|||
146096453|NCT03633617|526874511|FG006|Part C (& Follow-up)|Physician Decision|0|||
146096454|NCT03633617|526874512|FG007|Part C (& Follow-up)|Physician Decision|1|||
146096455|NCT03633617|526874513|FG008|Part C (& Follow-up)|Physician Decision|0|||
146096456|NCT03633617|526874514|FG009|Part C (& Follow-up)|Physician Decision|0|||
146096457|NCT03633617|526874515|FG010|Part C (& Follow-up)|Physician Decision|1|||
146096458|NCT03633617|526874505|FG000|Part C (& Follow-up)|COVID-19 related|0|||
146096459|NCT03633617|526874506|FG001|Part C (& Follow-up)|COVID-19 related|0|||
146096460|NCT03633617|526874507|FG002|Part C (& Follow-up)|COVID-19 related|0|||
146096461|NCT03633617|526874508|FG003|Part C (& Follow-up)|COVID-19 related|0|||
146096462|NCT03633617|526874509|FG004|Part C (& Follow-up)|COVID-19 related|0|||
146096463|NCT03633617|526874510|FG005|Part C (& Follow-up)|COVID-19 related|1|||
146096464|NCT03633617|526874511|FG006|Part C (& Follow-up)|COVID-19 related|0|||
146096465|NCT03633617|526874512|FG007|Part C (& Follow-up)|COVID-19 related|0|||
146096466|NCT03633617|526874513|FG008|Part C (& Follow-up)|COVID-19 related|0|||
146096467|NCT03633617|526874514|FG009|Part C (& Follow-up)|COVID-19 related|0|||
146030604|NCT00685373|526625805|FG000|Overall Study|Adverse Event|3|||
146030605|NCT00685373|526625805|FG000|Overall Study|Withdrawal by Subject|5|||
146030606|NCT00685373|526625805|FG000|Overall Study|Lack of Efficacy|3|||
146030607|NCT00685373|526625805|FG000|Overall Study|Condition no longer requires study drug|1|||
146030608|NCT00685373|526625805|FG000|Overall Study|Lost to Follow-up|2|||
146030609|NCT00685373|526625805|FG000|Overall Study|Protocol Violation|1|||
146030610|NCT00582738|526625806|FG000|Overall Study|Administrative Problems|7|||
146030611|NCT00582738|526625807|FG001|Overall Study|Administrative Problems|8|||
146030612|NCT00582738|526625806|FG000|Overall Study|Adverse Event|0|||
146030613|NCT00582738|526625807|FG001|Overall Study|Adverse Event|5|||
146030614|NCT00582738|526625806|FG000|Overall Study|Graft Lost|0|||
146030615|NCT00582738|526625807|FG001|Overall Study|Graft Lost|1|||
146030616|NCT00582738|526625806|FG000|Overall Study|Other|1|||
146030617|NCT00582738|526625807|FG001|Overall Study|Other|0|||
146030618|NCT00582738|526625806|FG000|Overall Study|Protocol Violation|1|||
146030619|NCT00582738|526625807|FG001|Overall Study|Protocol Violation|1|||
146030620|NCT00582738|526625806|FG000|Overall Study|Withdrawal by Subject|0|||
146030621|NCT00582738|526625807|FG001|Overall Study|Withdrawal by Subject|3|||
146030622|NCT02758301|526625808|FG000|Overall Study|Death|12|||
146030623|NCT02758301|526625809|FG001|Overall Study|Death|0|||
146030624|NCT02758301|526625808|FG000|Overall Study|Physician Decision|10|||
146030625|NCT02758301|526625809|FG001|Overall Study|Physician Decision|1|||
146030626|NCT02758301|526625808|FG000|Overall Study|Withdrawal by Subject|5|||
146030627|NCT02758301|526625809|FG001|Overall Study|Withdrawal by Subject|6|||
146030628|NCT02758301|526625808|FG000|Overall Study|Lost to Follow-up|7|||
146030629|NCT02758301|526625809|FG001|Overall Study|Lost to Follow-up|0|||
146030630|NCT02758301|526625808|FG000|Overall Study|Protocol Violation|0|||
146030631|NCT02758301|526625809|FG001|Overall Study|Protocol Violation|1|||
146030632|NCT00364533|526625810|FG000|Overall Study|Adverse Event|8|||
146030633|NCT00364533|526625811|FG001|Overall Study|Adverse Event|7|||
146030634|NCT00364533|526625812|FG002|Overall Study|Adverse Event|15|||
146030635|NCT00364533|526625813|FG003|Overall Study|Adverse Event|5|||
146030636|NCT00364533|526625814|FG004|Overall Study|Adverse Event|2|||
146030637|NCT00364533|526625810|FG000|Overall Study|Withdrawal by Subject|4|||
146030638|NCT00364533|526625811|FG001|Overall Study|Withdrawal by Subject|8|||
146030639|NCT00364533|526625812|FG002|Overall Study|Withdrawal by Subject|6|||
146030640|NCT00364533|526625813|FG003|Overall Study|Withdrawal by Subject|6|||
146030641|NCT00364533|526625814|FG004|Overall Study|Withdrawal by Subject|6|||
146030642|NCT00364533|526625810|FG000|Overall Study|Lack of Efficacy|22|||
146030643|NCT00364533|526625811|FG001|Overall Study|Lack of Efficacy|22|||
146096468|NCT03633617|526874515|FG010|Part C (& Follow-up)|COVID-19 related|0|||
146096469|NCT03633617|526874505|FG000|Part C (& Follow-up)|Protocol Violation|0|||
146096470|NCT03633617|526874506|FG001|Part C (& Follow-up)|Protocol Violation|0|||
146096471|NCT03633617|526874507|FG002|Part C (& Follow-up)|Protocol Violation|0|||
146096472|NCT03633617|526874508|FG003|Part C (& Follow-up)|Protocol Violation|0|||
146030644|NCT00364533|526625812|FG002|Overall Study|Lack of Efficacy|21|||
146030645|NCT00364533|526625813|FG003|Overall Study|Lack of Efficacy|17|||
146030646|NCT00364533|526625814|FG004|Overall Study|Lack of Efficacy|42|||
146030647|NCT00364533|526625810|FG000|Overall Study|Subject discharged from hospital|4|||
146030648|NCT00364533|526625811|FG001|Overall Study|Subject discharged from hospital|1|||
146030649|NCT00364533|526625812|FG002|Overall Study|Subject discharged from hospital|2|||
146030650|NCT00364533|526625813|FG003|Overall Study|Subject discharged from hospital|3|||
146096473|NCT03633617|526874509|FG004|Part C (& Follow-up)|Protocol Violation|0|||
146096474|NCT03633617|526874510|FG005|Part C (& Follow-up)|Protocol Violation|0|||
146096475|NCT03633617|526874511|FG006|Part C (& Follow-up)|Protocol Violation|0|||
146096476|NCT03633617|526874512|FG007|Part C (& Follow-up)|Protocol Violation|0|||
146096477|NCT03633617|526874513|FG008|Part C (& Follow-up)|Protocol Violation|0|||
146254224|NCT01485991|527443087|FG000|Overall Study|randomized but not treated|6|||
146030651|NCT00364533|526625814|FG004|Overall Study|Subject discharged from hospital|1|||
146030652|NCT00364533|526625810|FG000|Overall Study|Variations in drug compliance|2|||
146030653|NCT00364533|526625811|FG001|Overall Study|Variations in drug compliance|1|||
146030654|NCT00364533|526625812|FG002|Overall Study|Variations in drug compliance|1|||
146030655|NCT00364533|526625813|FG003|Overall Study|Variations in drug compliance|0|||
146030656|NCT00364533|526625814|FG004|Overall Study|Variations in drug compliance|0|||
146030657|NCT00364533|526625810|FG000|Overall Study|Non-compliance|1|||
146030658|NCT00364533|526625811|FG001|Overall Study|Non-compliance|0|||
146030659|NCT00364533|526625812|FG002|Overall Study|Non-compliance|0|||
146254225|NCT01485991|527443088|FG001|Overall Study|randomized but not treated|2|||
146030660|NCT00364533|526625813|FG003|Overall Study|Non-compliance|0|||
146030661|NCT00364533|526625814|FG004|Overall Study|Non-compliance|0|||
146030662|NCT00364533|526625810|FG000|Overall Study|Protocol Violation|1|||
146030663|NCT00364533|526625811|FG001|Overall Study|Protocol Violation|1|||
146030664|NCT00364533|526625812|FG002|Overall Study|Protocol Violation|0|||
146030665|NCT00364533|526625813|FG003|Overall Study|Protocol Violation|0|||
146030666|NCT00364533|526625814|FG004|Overall Study|Protocol Violation|0|||
146030667|NCT01886690|526625816|FG000|Overall Study|Protocol Violation|0|||
146030668|NCT01886690|526625817|FG001|Overall Study|Protocol Violation|1|||
146030669|NCT01886690|526625816|FG000|Overall Study|Personal Reasons|0|||
146030670|NCT01886690|526625817|FG001|Overall Study|Personal Reasons|1|||
146030671|NCT03461406|526625818|FG000|Overall Study|Death|1|||
146030672|NCT03461406|526625819|FG001|Overall Study|Death|2|||
146030673|NCT03461406|526625818|FG000|Overall Study|Consent Withdrawn by Participant|0|||
146030674|NCT03461406|526625819|FG001|Overall Study|Consent Withdrawn by Participant|1|||
146030675|NCT03461406|526625818|FG000|Overall Study|Screen Failure|3|||
146030676|NCT03461406|526625819|FG001|Overall Study|Screen Failure|1|||
146030677|NCT03461406|526625818|FG000|Overall Study|Reason not Specified|1|||
146030678|NCT03461406|526625819|FG001|Overall Study|Reason not Specified|3|||
146030679|NCT03461406|526625818|FG000|Overall Study|Lost to Follow-up|3|||
146030680|NCT03461406|526625819|FG001|Overall Study|Lost to Follow-up|0|||
146030681|NCT01011933|526625820|FG000|Overall Study|Wrong cell type|1|||
146030682|NCT01011933|526625820|FG000|Overall Study|Improper pre-protocol Rx|1|||
146030683|NCT01011933|526625820|FG000|Overall Study|Inadequate pathology|1|||
146030684|NCT01011933|526625820|FG000|Overall Study|Never treated|1|||
146030685|NCT02900170|526625823|FG000|Overall Study|Lost to Follow-up|8|||
146030686|NCT01814670|526625824|FG000|Overall Study|Protocol Violation|12|||
146030687|NCT02012686|526625828|FG000|Overall Study|muscle contraction|0|||
146030688|NCT02012686|526625829|FG001|Overall Study|muscle contraction|1|||
146030689|NCT02012686|526625828|FG000|Overall Study|electrocardiography monitoring noise|0|||
146030690|NCT02012686|526625829|FG001|Overall Study|electrocardiography monitoring noise|1|||
146030691|NCT00966719|526625830|FG000|Overall Study|Lost to Follow-up|6|||
146030692|NCT00966719|526625831|FG001|Overall Study|Lost to Follow-up|11|||
146030693|NCT01703065|526625834|FG000|Overall Study|Lack of Efficacy|1|||
146030694|NCT01703065|526625835|FG001|Overall Study|Lack of Efficacy|0|||
146030695|NCT00160199|526625838|FG000|Overall Study|Adverse Event|5|||
146030696|NCT00160199|526625839|FG001|Overall Study|Adverse Event|14|||
146030697|NCT00160199|526625838|FG000|Overall Study|Lack of Efficacy|0|||
146030698|NCT00160199|526625839|FG001|Overall Study|Lack of Efficacy|1|||
146030699|NCT00160199|526625838|FG000|Overall Study|Lost to Follow-up|7|||
146030700|NCT00160199|526625839|FG001|Overall Study|Lost to Follow-up|7|||
146030701|NCT00160199|526625838|FG000|Overall Study|Withdrawal by Subject|4|||
146030702|NCT00160199|526625839|FG001|Overall Study|Withdrawal by Subject|6|||
146030703|NCT00160199|526625838|FG000|Overall Study|Administrative|0|||
146030704|NCT00160199|526625839|FG001|Overall Study|Administrative|1|||
146030705|NCT00160199|526625838|FG000|Overall Study|Protocol Violation|8|||
146030706|NCT00160199|526625839|FG001|Overall Study|Protocol Violation|8|||
146030707|NCT01710527|526625840|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
146030708|NCT01710527|526625841|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
146030709|NCT02124772|526625842|FG000|Overall Study|Lack of Efficacy|2|||
146030710|NCT02124772|526625843|FG001|Overall Study|Lack of Efficacy|0|||
146030711|NCT02124772|526625844|FG002|Overall Study|Lack of Efficacy|0|||
146030712|NCT02124772|526625845|FG003|Overall Study|Lack of Efficacy|1|||
146030713|NCT02124772|526625846|FG004|Overall Study|Lack of Efficacy|2|||
146030714|NCT02124772|526625847|FG005|Overall Study|Lack of Efficacy|3|||
146030715|NCT02124772|526625848|FG006|Overall Study|Lack of Efficacy|0|||
146030716|NCT02124772|526625849|FG007|Overall Study|Lack of Efficacy|2|||
146030717|NCT02124772|526625850|FG008|Overall Study|Lack of Efficacy|0|||
146030718|NCT02124772|526625851|FG009|Overall Study|Lack of Efficacy|1|||
146030719|NCT02124772|526625852|FG010|Overall Study|Lack of Efficacy|0|||
146030720|NCT02124772|526625853|FG011|Overall Study|Lack of Efficacy|0|||
146030721|NCT02124772|526625854|FG012|Overall Study|Lack of Efficacy|1|||
146030722|NCT02124772|526625842|FG000|Overall Study|Adverse Event|1|||
146030723|NCT02124772|526625843|FG001|Overall Study|Adverse Event|4|||
146030724|NCT02124772|526625844|FG002|Overall Study|Adverse Event|1|||
146254226|NCT02538471|527443089|FG000|Overall Study|Progression of disease|2|||
146254227|NCT01475370|527443090|FG000|Overall Study|Exacerbation of primary disease|2|||
146030725|NCT02124772|526625845|FG003|Overall Study|Adverse Event|5|||
146030726|NCT02124772|526625846|FG004|Overall Study|Adverse Event|2|||
146030727|NCT02124772|526625847|FG005|Overall Study|Adverse Event|1|||
146030728|NCT02124772|526625848|FG006|Overall Study|Adverse Event|1|||
146030729|NCT02124772|526625849|FG007|Overall Study|Adverse Event|5|||
146030730|NCT02124772|526625850|FG008|Overall Study|Adverse Event|0|||
146030731|NCT02124772|526625851|FG009|Overall Study|Adverse Event|3|||
146030732|NCT02124772|526625852|FG010|Overall Study|Adverse Event|1|||
146030733|NCT02124772|526625853|FG011|Overall Study|Adverse Event|3|||
146030734|NCT02124772|526625854|FG012|Overall Study|Adverse Event|1|||
146030735|NCT02124772|526625842|FG000|Overall Study|Withdrawal consent|0|||
146030736|NCT02124772|526625843|FG001|Overall Study|Withdrawal consent|1|||
146030737|NCT02124772|526625844|FG002|Overall Study|Withdrawal consent|1|||
146030738|NCT02124772|526625845|FG003|Overall Study|Withdrawal consent|1|||
146030739|NCT02124772|526625846|FG004|Overall Study|Withdrawal consent|0|||
146030740|NCT02124772|526625847|FG005|Overall Study|Withdrawal consent|1|||
146030741|NCT02124772|526625848|FG006|Overall Study|Withdrawal consent|1|||
146030742|NCT02124772|526625849|FG007|Overall Study|Withdrawal consent|0|||
146030743|NCT02124772|526625850|FG008|Overall Study|Withdrawal consent|0|||
146030744|NCT02124772|526625851|FG009|Overall Study|Withdrawal consent|1|||
146030745|NCT02124772|526625852|FG010|Overall Study|Withdrawal consent|0|||
146030746|NCT02124772|526625853|FG011|Overall Study|Withdrawal consent|1|||
146030747|NCT02124772|526625854|FG012|Overall Study|Withdrawal consent|0|||
146030748|NCT02124772|526625842|FG000|Overall Study|Investigator discretion|0|||
146030749|NCT02124772|526625843|FG001|Overall Study|Investigator discretion|2|||
146030750|NCT02124772|526625844|FG002|Overall Study|Investigator discretion|2|||
146030751|NCT02124772|526625845|FG003|Overall Study|Investigator discretion|1|||
146030752|NCT02124772|526625846|FG004|Overall Study|Investigator discretion|1|||
146030753|NCT02124772|526625847|FG005|Overall Study|Investigator discretion|0|||
146030754|NCT02124772|526625848|FG006|Overall Study|Investigator discretion|1|||
146030755|NCT02124772|526625849|FG007|Overall Study|Investigator discretion|0|||
146030756|NCT02124772|526625850|FG008|Overall Study|Investigator discretion|0|||
146030757|NCT02124772|526625851|FG009|Overall Study|Investigator discretion|1|||
146030758|NCT02124772|526625852|FG010|Overall Study|Investigator discretion|0|||
146030759|NCT02124772|526625853|FG011|Overall Study|Investigator discretion|1|||
146030760|NCT02124772|526625854|FG012|Overall Study|Investigator discretion|0|||
146030761|NCT02124772|526625842|FG000|Overall Study|Progressive disease|0|||
146030762|NCT02124772|526625843|FG001|Overall Study|Progressive disease|0|||
146030763|NCT02124772|526625844|FG002|Overall Study|Progressive disease|0|||
146030764|NCT02124772|526625845|FG003|Overall Study|Progressive disease|0|||
146030765|NCT02124772|526625846|FG004|Overall Study|Progressive disease|0|||
146030766|NCT02124772|526625847|FG005|Overall Study|Progressive disease|0|||
146030767|NCT02124772|526625848|FG006|Overall Study|Progressive disease|1|||
146030768|NCT02124772|526625849|FG007|Overall Study|Progressive disease|1|||
146030769|NCT02124772|526625850|FG008|Overall Study|Progressive disease|0|||
146030770|NCT02124772|526625851|FG009|Overall Study|Progressive disease|0|||
146030771|NCT02124772|526625852|FG010|Overall Study|Progressive disease|0|||
146030772|NCT02124772|526625853|FG011|Overall Study|Progressive disease|0|||
146030773|NCT02124772|526625854|FG012|Overall Study|Progressive disease|0|||
146030774|NCT02124772|526625842|FG000|Overall Study|Other|0|||
146030775|NCT02124772|526625843|FG001|Overall Study|Other|7|||
146030776|NCT02124772|526625844|FG002|Overall Study|Other|2|||
146030777|NCT02124772|526625845|FG003|Overall Study|Other|5|||
146030778|NCT02124772|526625846|FG004|Overall Study|Other|4|||
146030779|NCT02124772|526625847|FG005|Overall Study|Other|3|||
146030780|NCT02124772|526625848|FG006|Overall Study|Other|4|||
146030781|NCT02124772|526625849|FG007|Overall Study|Other|1|||
146030782|NCT02124772|526625850|FG008|Overall Study|Other|1|||
146030783|NCT02124772|526625851|FG009|Overall Study|Other|1|||
146030784|NCT02124772|526625852|FG010|Overall Study|Other|1|||
146030785|NCT02124772|526625853|FG011|Overall Study|Other|1|||
146030786|NCT02124772|526625854|FG012|Overall Study|Other|0|||
146030787|NCT02827500|526625855|FG000|Overall Study|Death|7|||
146030788|NCT02827500|526625856|FG001|Overall Study|Death|3|||
146030789|NCT02827500|526625855|FG000|Overall Study|Lost to Follow-up|1|||
146030790|NCT02827500|526625856|FG001|Overall Study|Lost to Follow-up|1|||
146030791|NCT02827500|526625855|FG000|Overall Study|Withdrawal by Subject|3|||
146030792|NCT02827500|526625856|FG001|Overall Study|Withdrawal by Subject|1|||
146030793|NCT02827500|526625855|FG000|Overall Study|Missing primary endpoint data|3|||
146030794|NCT02827500|526625856|FG001|Overall Study|Missing primary endpoint data|1|||
146030795|NCT02827500|526625855|FG000|Overall Study|Other|5|||
146030796|NCT02827500|526625856|FG001|Overall Study|Other|1|||
146030797|NCT03089944|526625859|FG000|Overall Study|Lost to Follow-up|8|||
146030798|NCT03089944|526625859|FG000|Overall Study|Withdrew Consent|2|||
146030799|NCT03089944|526625859|FG000|Overall Study|Adverse Event|1|||
146030800|NCT03089944|526625859|FG000|Overall Study|Other|1|||
146030801|NCT01636713|526625860|FG000|Overall Study|Adverse Event|16|||
146030802|NCT01636713|526625861|FG001|Overall Study|Adverse Event|16|||
146030803|NCT01636713|526625862|FG002|Overall Study|Adverse Event|7|||
146030804|NCT01636713|526625860|FG000|Overall Study|Lack of Efficacy|6|||
146030805|NCT01636713|526625861|FG001|Overall Study|Lack of Efficacy|6|||
146096478|NCT03633617|526874514|FG009|Part C (& Follow-up)|Protocol Violation|3|||
146096479|NCT03633617|526874515|FG010|Part C (& Follow-up)|Protocol Violation|1|||
146096480|NCT03633617|526874505|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
146096481|NCT03633617|526874506|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
146096482|NCT03633617|526874507|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
146096483|NCT03633617|526874508|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
146096484|NCT03633617|526874509|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
146096485|NCT03633617|526874510|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
146096486|NCT03633617|526874511|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
146096487|NCT03633617|526874512|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
146096488|NCT03633617|526874513|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
146096489|NCT03633617|526874514|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
146096490|NCT03633617|526874515|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
146096491|NCT01890746|526874516|FG000|Overall Study|Death|39|||
146096492|NCT01890746|526874517|FG001|Overall Study|Death|30|||
146096493|NCT01890746|526874516|FG000|Overall Study|Adverse Event|1|||
146096494|NCT01890746|526874517|FG001|Overall Study|Adverse Event|0|||
146096495|NCT01890746|526874516|FG000|Overall Study|Lost to Follow-up|4|||
146096496|NCT01890746|526874517|FG001|Overall Study|Lost to Follow-up|1|||
146096497|NCT01890746|526874516|FG000|Overall Study|Physician Decision|3|||
146096498|NCT01890746|526874517|FG001|Overall Study|Physician Decision|2|||
146096499|NCT01890746|526874516|FG000|Overall Study|Withdrawal by Subject|5|||
146096500|NCT01890746|526874517|FG001|Overall Study|Withdrawal by Subject|8|||
146096501|NCT00777205|526874520|FG000|Overall Study|Lost to Follow-up|25|||
146096502|NCT00777205|526874521|FG001|Overall Study|Lost to Follow-up|9|||
146096503|NCT00777205|526874520|FG000|Overall Study|Withdrawal by Subject|6|||
146096504|NCT00777205|526874521|FG001|Overall Study|Withdrawal by Subject|4|||
146096505|NCT00777205|526874520|FG000|Overall Study|Death|0|||
146096506|NCT00777205|526874521|FG001|Overall Study|Death|2|||
146096507|NCT00777205|526874520|FG000|Overall Study|Protocol Violation|0|||
146096508|NCT00777205|526874521|FG001|Overall Study|Protocol Violation|56|||
146096509|NCT03257371|526874522|FG000|Overall Study|Lost to Follow-up|1|||
146096510|NCT03198078|526874526|FG000|Overall Study|Adverse Event|0|||
146096511|NCT03198078|526874527|FG001|Overall Study|Adverse Event|1|||
146096512|NCT03198078|526874528|FG002|Overall Study|Adverse Event|2|||
146096513|NCT03198078|526874526|FG000|Overall Study|Lack of Efficacy|0|||
146096514|NCT03198078|526874527|FG001|Overall Study|Lack of Efficacy|0|||
146096515|NCT03198078|526874528|FG002|Overall Study|Lack of Efficacy|3|||
146096516|NCT03198078|526874526|FG000|Overall Study|Lost to Follow-up|1|||
146096517|NCT03198078|526874527|FG001|Overall Study|Lost to Follow-up|0|||
146096518|NCT03198078|526874528|FG002|Overall Study|Lost to Follow-up|0|||
146096519|NCT03198078|526874526|FG000|Overall Study|Pregnancy|0|||
146096520|NCT03198078|526874527|FG001|Overall Study|Pregnancy|1|||
146096521|NCT03198078|526874528|FG002|Overall Study|Pregnancy|0|||
146096522|NCT03198078|526874526|FG000|Overall Study|Withdrawal by Subject|1|||
146096523|NCT03198078|526874527|FG001|Overall Study|Withdrawal by Subject|0|||
146096524|NCT03198078|526874528|FG002|Overall Study|Withdrawal by Subject|2|||
146096525|NCT03198078|526874526|FG000|Overall Study|Withdrawal by Caregiver|1|||
146096526|NCT03198078|526874527|FG001|Overall Study|Withdrawal by Caregiver|3|||
146096527|NCT03198078|526874528|FG002|Overall Study|Withdrawal by Caregiver|5|||
146096528|NCT01676727|526874529|FG000|Overall Study|Death|18|||
146096529|NCT01676727|526874529|FG000|Overall Study|Withdrawal by Subject|6|||
146096530|NCT01676727|526874529|FG000|Overall Study|Screening failure|5|||
146096531|NCT01676727|526874529|FG000|Overall Study|Not willing to attend 1-year visit|2|||
146096532|NCT01676727|526874529|FG000|Overall Study|Valve explanted|1|||
146096533|NCT00580970|526874530|FG000|Pre-treatment|Non-compliance|1|||
146096534|NCT00580970|526874530|FG000|Treatment (Lovastatin)|Non-compliance|6|||
146096535|NCT00580970|526874530|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
146096536|NCT00580970|526874530|FG000|Treatment (Lovastatin)|Physician Decision|4|||
146096537|NCT00580970|526874530|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
146096538|NCT00580970|526874530|FG000|Treatment (Lovastatin)|Death|1|||
146300360|NCT01326728|527615234|FG001|Overall Study|Early closure of study|9|||
146096539|NCT03161093|526874533|FG000|Overall Study|Protocol Violation|11|||
146096540|NCT03161093|526874534|FG001|Overall Study|Protocol Violation|14|||
146096541|NCT03161093|526874535|FG002|Overall Study|Protocol Violation|6|||
146096542|NCT03161093|526874536|FG003|Overall Study|Protocol Violation|13|||
146096543|NCT03161093|526874537|FG004|Overall Study|Protocol Violation|1|||
146096544|NCT03161093|526874538|FG005|Overall Study|Protocol Violation|0|||
146096545|NCT03161093|526874533|FG000|Overall Study|Adverse Event|5|||
146096546|NCT03161093|526874534|FG001|Overall Study|Adverse Event|21|||
146096547|NCT03161093|526874535|FG002|Overall Study|Adverse Event|16|||
146096548|NCT03161093|526874536|FG003|Overall Study|Adverse Event|35|||
146096549|NCT03161093|526874537|FG004|Overall Study|Adverse Event|2|||
146096550|NCT03161093|526874538|FG005|Overall Study|Adverse Event|1|||
146096551|NCT03161093|526874533|FG000|Overall Study|Lack of Efficacy|9|||
146096552|NCT03161093|526874534|FG001|Overall Study|Lack of Efficacy|13|||
146096553|NCT03161093|526874535|FG002|Overall Study|Lack of Efficacy|9|||
146096554|NCT03161093|526874536|FG003|Overall Study|Lack of Efficacy|24|||
146096555|NCT03161093|526874537|FG004|Overall Study|Lack of Efficacy|4|||
146030806|NCT01636713|526625862|FG002|Overall Study|Lack of Efficacy|2|||
146030807|NCT01636713|526625860|FG000|Overall Study|Protocol Violation|3|||
146030808|NCT01636713|526625861|FG001|Overall Study|Protocol Violation|0|||
146030809|NCT01636713|526625862|FG002|Overall Study|Protocol Violation|1|||
146030810|NCT01636713|526625860|FG000|Overall Study|Lost to Follow-up|0|||
146030811|NCT01636713|526625861|FG001|Overall Study|Lost to Follow-up|0|||
146030812|NCT01636713|526625862|FG002|Overall Study|Lost to Follow-up|1|||
146030813|NCT01636713|526625860|FG000|Overall Study|Withdrawal by Subject|5|||
146030814|NCT01636713|526625861|FG001|Overall Study|Withdrawal by Subject|4|||
146030815|NCT01636713|526625862|FG002|Overall Study|Withdrawal by Subject|8|||
146030816|NCT01636713|526625860|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146030817|NCT01636713|526625861|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146030818|NCT01636713|526625862|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
146030819|NCT03689244|526625863|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
146030820|NCT03689244|526625864|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
146030821|NCT03689244|526625865|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
146030822|NCT03689244|526625866|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
146030823|NCT03689244|526625863|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
146030824|NCT03689244|526625864|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
146030825|NCT03689244|526625865|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
146030826|NCT03689244|526625866|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
146030827|NCT03689244|526625863|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
146030828|NCT03689244|526625864|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
146030829|NCT03689244|526625865|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
146030830|NCT03689244|526625866|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
146030831|NCT03689244|526625863|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
146030832|NCT03689244|526625864|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
146030833|NCT03689244|526625865|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
146030834|NCT03689244|526625866|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
146030835|NCT03689244|526625863|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
146030836|NCT03689244|526625864|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
146030837|NCT03689244|526625865|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
146030838|NCT03689244|526625866|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
146030839|NCT03689244|526625863|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146030840|NCT03689244|526625864|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146030841|NCT03689244|526625865|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
146030842|NCT03689244|526625866|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
146030843|NCT03689244|526625863|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146030844|NCT03689244|526625864|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146030845|NCT03689244|526625865|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
146030846|NCT03689244|526625866|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
146030847|NCT03689244|526625863|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
146030848|NCT03689244|526625864|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
146030849|NCT03689244|526625865|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
146030850|NCT03689244|526625866|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
146030851|NCT02308488|526625869|FG000|Overall Study|Withdrawal by Subject|2|||
146030852|NCT01541917|526625870|FG000|Overall Study|Lost to Follow-up|2|||
146030853|NCT01541917|526625871|FG001|Overall Study|Lost to Follow-up|2|||
146030854|NCT01541917|526625870|FG000|Overall Study|Withdrawal by Subject|13|||
146030855|NCT01541917|526625871|FG001|Overall Study|Withdrawal by Subject|7|||
146030856|NCT01739803|526625872|FG000|Overall Study|Lost to Follow-up|9|||
146030857|NCT01739803|526625873|FG001|Overall Study|Lost to Follow-up|6|||
146030858|NCT03759041|526625883|FG000|Overall Study|Withdrawal by Subject|4|||
146030859|NCT03759041|526625884|FG001|Overall Study|Withdrawal by Subject|10|||
146030860|NCT03759041|526625885|FG002|Overall Study|Withdrawal by Subject|10|||
146030861|NCT03759041|526625883|FG000|Overall Study|Adverse Event|1|||
146030862|NCT03759041|526625884|FG001|Overall Study|Adverse Event|3|||
146030863|NCT03759041|526625885|FG002|Overall Study|Adverse Event|4|||
146030864|NCT03759041|526625883|FG000|Overall Study|Lack of Efficacy|0|||
146030865|NCT03759041|526625884|FG001|Overall Study|Lack of Efficacy|0|||
146030866|NCT03759041|526625885|FG002|Overall Study|Lack of Efficacy|1|||
146030867|NCT03759041|526625883|FG000|Overall Study|Study Terminated by Sponsor|15|||
146030868|NCT03759041|526625884|FG001|Overall Study|Study Terminated by Sponsor|16|||
146030869|NCT03759041|526625885|FG002|Overall Study|Study Terminated by Sponsor|10|||
146096556|NCT03161093|526874538|FG005|Overall Study|Lack of Efficacy|1|||
146030870|NCT03759041|526625883|FG000|Overall Study|Other reason for discontinuation|0|||
146030871|NCT03759041|526625884|FG001|Overall Study|Other reason for discontinuation|2|||
146030872|NCT03759041|526625885|FG002|Overall Study|Other reason for discontinuation|1|||
146030873|NCT03759041|526625883|FG000|Overall Study|Lost to Follow-up|7|||
146030874|NCT03759041|526625884|FG001|Overall Study|Lost to Follow-up|2|||
146030875|NCT03759041|526625885|FG002|Overall Study|Lost to Follow-up|2|||
146030876|NCT03759041|526625883|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
146030877|NCT03759041|526625884|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
146030878|NCT03759041|526625885|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
146030879|NCT00525824|526625891|FG000|Overall Study|Adverse Event|7|||
146030880|NCT00525824|526625892|FG001|Overall Study|Adverse Event|11|||
146030881|NCT00525824|526625893|FG002|Overall Study|Adverse Event|6|||
146030882|NCT00525824|526625894|FG003|Overall Study|Adverse Event|7|||
146030883|NCT00525824|526625891|FG000|Overall Study|Withdrawal by Subject|5|||
146030884|NCT00525824|526625892|FG001|Overall Study|Withdrawal by Subject|9|||
146030885|NCT00525824|526625893|FG002|Overall Study|Withdrawal by Subject|3|||
146030886|NCT00525824|526625894|FG003|Overall Study|Withdrawal by Subject|4|||
146030887|NCT00525824|526625891|FG000|Overall Study|Lost to Follow-up|4|||
146030888|NCT00525824|526625892|FG001|Overall Study|Lost to Follow-up|2|||
146030889|NCT00525824|526625893|FG002|Overall Study|Lost to Follow-up|4|||
146030890|NCT00525824|526625894|FG003|Overall Study|Lost to Follow-up|0|||
146030891|NCT00525824|526625891|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
146030892|NCT00525824|526625892|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
146030893|NCT00525824|526625893|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
146030894|NCT00525824|526625894|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
146030895|NCT00525824|526625891|FG000|Overall Study|Severe non-compliance|0|||
146030896|NCT00525824|526625892|FG001|Overall Study|Severe non-compliance|1|||
146030897|NCT00525824|526625893|FG002|Overall Study|Severe non-compliance|1|||
146030898|NCT00525824|526625894|FG003|Overall Study|Severe non-compliance|1|||
146030899|NCT00525824|526625891|FG000|Overall Study|Safety reasons|1|||
146030900|NCT00525824|526625892|FG001|Overall Study|Safety reasons|0|||
146030901|NCT00525824|526625893|FG002|Overall Study|Safety reasons|1|||
146030902|NCT00525824|526625894|FG003|Overall Study|Safety reasons|0|||
146030903|NCT00525824|526625891|FG000|Overall Study|Other|1|||
146030904|NCT00525824|526625892|FG001|Overall Study|Other|3|||
146030905|NCT00525824|526625893|FG002|Overall Study|Other|3|||
146030906|NCT00525824|526625894|FG003|Overall Study|Other|1|||
146030907|NCT01490294|526625899|FG000|Overall Study|Prematurely discontinuation|4|||
146030908|NCT01490294|526625900|FG001|Overall Study|Prematurely discontinuation|0|||
146030909|NCT01490294|526625901|FG002|Overall Study|Prematurely discontinuation|1|||
146030910|NCT01490294|526625902|FG003|Overall Study|Prematurely discontinuation|1|||
146030911|NCT01490294|526625899|FG000|Overall Study|Adverse Event|1|||
146030912|NCT01490294|526625900|FG001|Overall Study|Adverse Event|0|||
146030913|NCT01490294|526625901|FG002|Overall Study|Adverse Event|0|||
146030914|NCT01490294|526625902|FG003|Overall Study|Adverse Event|0|||
146030915|NCT01751776|526625905|FG000|Overall Study|Adverse Event|0|||
146030916|NCT01751776|526625906|FG001|Overall Study|Adverse Event|0|||
146030917|NCT01751776|526625907|FG002|Overall Study|Adverse Event|0|||
146030918|NCT01751776|526625908|FG003|Overall Study|Adverse Event|0|||
146030919|NCT01751776|526625909|FG004|Overall Study|Adverse Event|0|||
146030920|NCT01751776|526625910|FG005|Overall Study|Adverse Event|0|||
146030921|NCT01751776|526625911|FG006|Overall Study|Adverse Event|4|||
146030922|NCT01751776|526625912|FG007|Overall Study|Adverse Event|2|||
146030923|NCT01751776|526625905|FG000|Overall Study|Consent withdrawn|0|||
146030924|NCT01751776|526625906|FG001|Overall Study|Consent withdrawn|0|||
146030925|NCT01751776|526625907|FG002|Overall Study|Consent withdrawn|0|||
146030926|NCT01751776|526625908|FG003|Overall Study|Consent withdrawn|0|||
146030927|NCT01751776|526625909|FG004|Overall Study|Consent withdrawn|0|||
146030928|NCT01751776|526625910|FG005|Overall Study|Consent withdrawn|0|||
146030929|NCT01751776|526625911|FG006|Overall Study|Consent withdrawn|0|||
146030930|NCT01751776|526625912|FG007|Overall Study|Consent withdrawn|1|||
146030931|NCT01751776|526625905|FG000|Overall Study|Other reason not specified above|0|||
146030932|NCT01751776|526625906|FG001|Overall Study|Other reason not specified above|0|||
146030933|NCT01751776|526625907|FG002|Overall Study|Other reason not specified above|0|||
146030934|NCT01751776|526625908|FG003|Overall Study|Other reason not specified above|0|||
146030935|NCT01751776|526625909|FG004|Overall Study|Other reason not specified above|0|||
146030936|NCT01751776|526625910|FG005|Overall Study|Other reason not specified above|0|||
146030937|NCT01751776|526625911|FG006|Overall Study|Other reason not specified above|0|||
146030938|NCT01751776|526625912|FG007|Overall Study|Other reason not specified above|1|||
146030939|NCT00160654|526625913|FG000|Overall Study|Adverse Event|14|||
146030940|NCT00160654|526625913|FG000|Overall Study|Lack of Efficacy|4|||
146030941|NCT00160654|526625913|FG000|Overall Study|Lost to Follow-up|2|||
146030942|NCT00160654|526625913|FG000|Overall Study|Intake of expired drug|7|||
146030943|NCT00160654|526625913|FG000|Overall Study|Psychological trauma|1|||
146030944|NCT00160654|526625913|FG000|Overall Study|Sponsor decision|1|||
146030945|NCT00160654|526625913|FG000|Overall Study|Patient met exclusion criteria|1|||
146030946|NCT00160654|526625913|FG000|Overall Study|Patient decision|1|||
146030947|NCT00160654|526625913|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
146030948|NCT00160654|526625913|FG000|Overall Study|Met exclusion criteria|1|||
146030949|NCT00528996|526627240|FG000|Overall Study|Other reasons than listing|6|||
146030950|NCT00528996|526627241|FG001|Overall Study|Other reasons than listing|7|||
146030951|NCT00528996|526627242|FG002|Overall Study|Other reasons than listing|14|||
146096557|NCT03161093|526874533|FG000|Overall Study|Physician Decision|0|||
146096558|NCT03161093|526874534|FG001|Overall Study|Physician Decision|1|||
146096559|NCT03161093|526874535|FG002|Overall Study|Physician Decision|0|||
146096560|NCT03161093|526874536|FG003|Overall Study|Physician Decision|2|||
146096561|NCT03161093|526874537|FG004|Overall Study|Physician Decision|17|||
146096562|NCT03161093|526874538|FG005|Overall Study|Physician Decision|15|||
146096563|NCT03161093|526874533|FG000|Overall Study|Withdrawal by Subject|24|||
146096564|NCT03161093|526874534|FG001|Overall Study|Withdrawal by Subject|73|||
146096565|NCT03161093|526874535|FG002|Overall Study|Withdrawal by Subject|44|||
146096566|NCT03161093|526874536|FG003|Overall Study|Withdrawal by Subject|97|||
146096567|NCT03161093|526874537|FG004|Overall Study|Withdrawal by Subject|11|||
146096568|NCT03161093|526874538|FG005|Overall Study|Withdrawal by Subject|10|||
146096569|NCT03161093|526874533|FG000|Overall Study|Lost to Follow-up|3|||
146096570|NCT03161093|526874534|FG001|Overall Study|Lost to Follow-up|12|||
146096571|NCT03161093|526874535|FG002|Overall Study|Lost to Follow-up|4|||
146096572|NCT03161093|526874536|FG003|Overall Study|Lost to Follow-up|7|||
146096573|NCT03161093|526874537|FG004|Overall Study|Lost to Follow-up|8|||
146096574|NCT03161093|526874538|FG005|Overall Study|Lost to Follow-up|13|||
146096575|NCT03161093|526874533|FG000|Overall Study|Death|3|||
146096576|NCT03161093|526874534|FG001|Overall Study|Death|9|||
146096577|NCT03161093|526874535|FG002|Overall Study|Death|7|||
146096578|NCT03161093|526874536|FG003|Overall Study|Death|9|||
146096579|NCT03161093|526874537|FG004|Overall Study|Death|0|||
146096580|NCT03161093|526874538|FG005|Overall Study|Death|0|||
146096581|NCT03161093|526874533|FG000|Overall Study|Unknown - Not reported|0|||
146096582|NCT03161093|526874534|FG001|Overall Study|Unknown - Not reported|1|||
146030952|NCT00528996|526627243|FG003|Overall Study|Other reasons than listing|11|||
146030953|NCT00528996|526627244|FG004|Overall Study|Other reasons than listing|5|||
146030954|NCT00528996|526627240|FG000|Overall Study|Refused continue medication|16|||
146030955|NCT00528996|526627241|FG001|Overall Study|Refused continue medication|0|||
146030956|NCT00528996|526627242|FG002|Overall Study|Refused continue medication|3|||
146030957|NCT00528996|526627243|FG003|Overall Study|Refused continue medication|3|||
146030958|NCT00528996|526627244|FG004|Overall Study|Refused continue medication|6|||
146030959|NCT00528996|526627240|FG000|Overall Study|Lost to Follow-up|2|||
146030960|NCT00528996|526627241|FG001|Overall Study|Lost to Follow-up|0|||
146030961|NCT00528996|526627242|FG002|Overall Study|Lost to Follow-up|4|||
146030962|NCT00528996|526627243|FG003|Overall Study|Lost to Follow-up|1|||
146030963|NCT00528996|526627244|FG004|Overall Study|Lost to Follow-up|3|||
146030964|NCT00528996|526627240|FG000|Overall Study|Protocol Violation|1|||
146030965|NCT00528996|526627241|FG001|Overall Study|Protocol Violation|2|||
146096583|NCT03161093|526874535|FG002|Overall Study|Unknown - Not reported|0|||
146096584|NCT03161093|526874536|FG003|Overall Study|Unknown - Not reported|0|||
146096585|NCT03161093|526874537|FG004|Overall Study|Unknown - Not reported|0|||
146096586|NCT03161093|526874538|FG005|Overall Study|Unknown - Not reported|1|||
146096587|NCT01031706|526874539|FG000|Overall Study|Adverse Event|1|||
146096588|NCT01031706|526874540|FG001|Overall Study|Adverse Event|0|||
146096589|NCT01031706|526874539|FG000|Overall Study|Withdrawal by Subject|1|||
146096590|NCT01031706|526874540|FG001|Overall Study|Withdrawal by Subject|1|||
146096591|NCT02124161|526874541|FG000|Overall Study|Other unspecified|0|||
146096592|NCT02124161|526874542|FG001|Overall Study|Other unspecified|1|||
146096593|NCT02124161|526874541|FG000|Overall Study|Death|1|||
146096594|NCT02124161|526874542|FG001|Overall Study|Death|0|||
146096595|NCT02124161|526874541|FG000|Overall Study|Protocol Violation|2|||
146096596|NCT02124161|526874542|FG001|Overall Study|Protocol Violation|1|||
146096597|NCT02124161|526874541|FG000|Overall Study|Withdrawal by Subject|1|||
146096598|NCT02124161|526874542|FG001|Overall Study|Withdrawal by Subject|2|||
146096599|NCT02124161|526874541|FG000|Overall Study|Adverse Event|2|||
146096600|NCT02124161|526874542|FG001|Overall Study|Adverse Event|0|||
146096601|NCT02124161|526874541|FG000|Overall Study|Does not meet entrance criteria|2|||
146096602|NCT02124161|526874542|FG001|Overall Study|Does not meet entrance criteria|3|||
146096603|NCT02124161|526874541|FG000|Overall Study|No longer meets eligibility criteria|5|||
146096604|NCT02124161|526874542|FG001|Overall Study|No longer meets eligibility criteria|4|||
146096605|NCT02124161|526874541|FG000|Overall Study|Lost to Follow-up|3|||
146096606|NCT02124161|526874542|FG001|Overall Study|Lost to Follow-up|4|||
146030966|NCT00528996|526627242|FG002|Overall Study|Protocol Violation|3|||
146096607|NCT01008150|526874544|FG000|Overall Study|did not receive study drug|1|||
146096608|NCT01008150|526874545|FG001|Overall Study|did not receive study drug|1|||
146096609|NCT01008150|526874546|FG002|Overall Study|did not receive study drug|1|||
146096610|NCT01008150|526874547|FG003|Overall Study|did not receive study drug|0|||
146096611|NCT01309165|526874548|FG000|Overall Study|Lost to Follow-up|4|||
146030967|NCT00528996|526627243|FG003|Overall Study|Protocol Violation|3|||
146096612|NCT01309165|526874549|FG001|Overall Study|Lost to Follow-up|3|||
146254228|NCT01475370|527443091|FG001|Overall Study|Exacerbation of primary disease|2|||
146254229|NCT01475370|527443092|FG002|Overall Study|Exacerbation of primary disease|2|||
146030968|NCT00528996|526627244|FG004|Overall Study|Protocol Violation|2|||
146030969|NCT00528996|526627240|FG000|Overall Study|Lack of Efficacy|7|||
146096613|NCT01309165|526874548|FG000|Overall Study|Return to work|1|||
146096614|NCT01309165|526874549|FG001|Overall Study|Return to work|2|||
146096615|NCT01309165|526874548|FG000|Overall Study|Left country|0|||
146030970|NCT00528996|526627241|FG001|Overall Study|Lack of Efficacy|2|||
146030971|NCT00528996|526627242|FG002|Overall Study|Lack of Efficacy|1|||
146030972|NCT00528996|526627243|FG003|Overall Study|Lack of Efficacy|3|||
146030973|NCT00528996|526627244|FG004|Overall Study|Lack of Efficacy|3|||
146030974|NCT00528996|526627240|FG000|Overall Study|Adverse Event|32|||
146030975|NCT00528996|526627241|FG001|Overall Study|Adverse Event|13|||
146030976|NCT00528996|526627242|FG002|Overall Study|Adverse Event|18|||
146030977|NCT00528996|526627243|FG003|Overall Study|Adverse Event|29|||
146030978|NCT00528996|526627244|FG004|Overall Study|Adverse Event|18|||
146030979|NCT02831933|526627246|FG000|Overall Study|Physician Decision|11|||
146030980|NCT05065190|526627250|FG000|Overall Study|Other than listed|2|||
146030981|NCT05065190|526627251|FG001|Overall Study|Other than listed|12|||
146030982|NCT05065190|526627250|FG000|Overall Study|Lack of Efficacy|4|||
146030983|NCT05065190|526627251|FG001|Overall Study|Lack of Efficacy|0|||
146030984|NCT05065190|526627250|FG000|Overall Study|Adverse Event|1|||
146030985|NCT05065190|526627251|FG001|Overall Study|Adverse Event|10|||
146030986|NCT04938037|526627252|FG000|Overall Study|Lost to Follow-up|4|||
146030987|NCT04938037|526627253|FG001|Overall Study|Lost to Follow-up|3|||
146030988|NCT03323736|526627256|FG000|Overall Study|Screen Failure|14|||
146030989|NCT03323736|526627257|FG001|Overall Study|Screen Failure|9|||
146030990|NCT03323736|526627258|FG002|Overall Study|Screen Failure|1|||
146030991|NCT03323736|526627256|FG000|Overall Study|Withdrawal Before Treatment|3|||
146030992|NCT03323736|526627257|FG001|Overall Study|Withdrawal Before Treatment|1|||
146030993|NCT03323736|526627258|FG002|Overall Study|Withdrawal Before Treatment|1|||
146030994|NCT03323736|526627256|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
146030995|NCT03323736|526627257|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
146030996|NCT03323736|526627258|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
146030997|NCT05160766|526627260|FG000|Overall Study|Adverse Event|0|||
146030998|NCT05160766|526627261|FG001|Overall Study|Adverse Event|1|||
146030999|NCT05160766|526627262|FG002|Overall Study|Adverse Event|0|||
146031000|NCT05160766|526627263|FG003|Overall Study|Adverse Event|0|||
146031001|NCT05160766|526627260|FG000|Overall Study|COVID-19 infection|0|||
146031002|NCT05160766|526627261|FG001|Overall Study|COVID-19 infection|1|||
146031003|NCT05160766|526627262|FG002|Overall Study|COVID-19 infection|0|||
146031004|NCT05160766|526627263|FG003|Overall Study|COVID-19 infection|0|||
146031005|NCT05160766|526627260|FG000|Overall Study|travel time|1|||
146031006|NCT05160766|526627261|FG001|Overall Study|travel time|0|||
146031007|NCT05160766|526627262|FG002|Overall Study|travel time|0|||
146031008|NCT05160766|526627263|FG003|Overall Study|travel time|1|||
146031009|NCT05160766|526627260|FG000|Overall Study|Withdrawal by Subject|3|||
146031010|NCT05160766|526627261|FG001|Overall Study|Withdrawal by Subject|5|||
146031011|NCT05160766|526627262|FG002|Overall Study|Withdrawal by Subject|4|||
146031012|NCT05160766|526627263|FG003|Overall Study|Withdrawal by Subject|2|||
146031013|NCT05160766|526627260|FG000|Overall Study|Death|0|||
146031014|NCT05160766|526627261|FG001|Overall Study|Death|0|||
146031015|NCT05160766|526627262|FG002|Overall Study|Death|2|||
146031016|NCT05160766|526627263|FG003|Overall Study|Death|5|||
146031017|NCT05160766|526627260|FG000|Overall Study|Lost to Follow-up|0|||
146031018|NCT05160766|526627261|FG001|Overall Study|Lost to Follow-up|0|||
146031019|NCT05160766|526627262|FG002|Overall Study|Lost to Follow-up|1|||
146031020|NCT05160766|526627263|FG003|Overall Study|Lost to Follow-up|2|||
146031021|NCT05160766|526627260|FG000|Overall Study|No show|0|||
146031022|NCT05160766|526627261|FG001|Overall Study|No show|0|||
146031023|NCT05160766|526627262|FG002|Overall Study|No show|1|||
146031024|NCT05160766|526627263|FG003|Overall Study|No show|1|||
146031025|NCT05160766|526627260|FG000|Overall Study|Physician Decision|0|||
146031026|NCT05160766|526627261|FG001|Overall Study|Physician Decision|0|||
146031027|NCT05160766|526627262|FG002|Overall Study|Physician Decision|0|||
146031028|NCT05160766|526627263|FG003|Overall Study|Physician Decision|1|||
146031029|NCT05160766|526627260|FG000|Overall Study|Protocol Violation|0|||
146031030|NCT05160766|526627261|FG001|Overall Study|Protocol Violation|0|||
146031031|NCT05160766|526627262|FG002|Overall Study|Protocol Violation|1|||
146031032|NCT05160766|526627263|FG003|Overall Study|Protocol Violation|0|||
146031033|NCT02654236|526627264|FG000|Overall Study|Withdrawal by Subject|0|||
146031034|NCT02654236|526627265|FG001|Overall Study|Withdrawal by Subject|0|||
146031035|NCT02654236|526627266|FG002|Overall Study|Withdrawal by Subject|2|||
146031036|NCT01549873|526627267|FG000|Overall Study|Physician Decision|0|||
146031037|NCT01549873|526627268|FG001|Overall Study|Physician Decision|1|||
146031038|NCT02943915|526627269|FG000|Overall Study|Withdrawal by Subject|2|||
146031039|NCT02943915|526627270|FG001|Overall Study|Withdrawal by Subject|1|||
146031040|NCT02943915|526627271|FG002|Overall Study|Withdrawal by Subject|0|||
146031041|NCT02943915|526627272|FG003|Overall Study|Withdrawal by Subject|0|||
146031042|NCT02943915|526627269|FG000|Overall Study|Lost to Follow-up|3|||
146031043|NCT02943915|526627270|FG001|Overall Study|Lost to Follow-up|1|||
146031044|NCT02943915|526627271|FG002|Overall Study|Lost to Follow-up|0|||
146031045|NCT02943915|526627272|FG003|Overall Study|Lost to Follow-up|0|||
146031046|NCT02943915|526627269|FG000|Overall Study|excluded|0|||
146031047|NCT02943915|526627270|FG001|Overall Study|excluded|1|||
146031048|NCT02943915|526627271|FG002|Overall Study|excluded|0|||
146031049|NCT02943915|526627272|FG003|Overall Study|excluded|0|||
146031050|NCT00701805|526627273|FG000|Overall Study|Withdrawal by Subject|3|||
146031051|NCT00701805|526627274|FG001|Overall Study|Withdrawal by Subject|1|||
146031052|NCT00701805|526627275|FG002|Overall Study|Withdrawal by Subject|4|||
146031053|NCT00701805|526627276|FG003|Overall Study|Withdrawal by Subject|3|||
146031054|NCT00701805|526627273|FG000|Overall Study|Adverse Event|0|||
146031055|NCT00701805|526627274|FG001|Overall Study|Adverse Event|1|||
146031056|NCT00701805|526627275|FG002|Overall Study|Adverse Event|1|||
146031057|NCT00701805|526627276|FG003|Overall Study|Adverse Event|0|||
146031058|NCT00701805|526627273|FG000|Overall Study|Missed 7 consecutive doses|0|||
146031059|NCT00701805|526627274|FG001|Overall Study|Missed 7 consecutive doses|1|||
146031060|NCT00701805|526627275|FG002|Overall Study|Missed 7 consecutive doses|0|||
146031061|NCT00701805|526627276|FG003|Overall Study|Missed 7 consecutive doses|0|||
146031062|NCT00701805|526627273|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
146031063|NCT00701805|526627274|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
146031064|NCT00701805|526627275|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
146031065|NCT00701805|526627276|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
146031066|NCT00701805|526627273|FG000|Overall Study|Physician decision, change of therapy|0|||
146031067|NCT00701805|526627274|FG001|Overall Study|Physician decision, change of therapy|0|||
146031068|NCT00701805|526627275|FG002|Overall Study|Physician decision, change of therapy|0|||
146031069|NCT00701805|526627276|FG003|Overall Study|Physician decision, change of therapy|1|||
146031070|NCT00701805|526627273|FG000|Overall Study|Difficult to travel to dialysis site|0|||
146031071|NCT00701805|526627274|FG001|Overall Study|Difficult to travel to dialysis site|0|||
146031072|NCT00701805|526627275|FG002|Overall Study|Difficult to travel to dialysis site|1|||
146031073|NCT00701805|526627276|FG003|Overall Study|Difficult to travel to dialysis site|0|||
146031074|NCT00701805|526627273|FG000|Overall Study|Resumption criteria were not met|0|||
146031075|NCT00701805|526627274|FG001|Overall Study|Resumption criteria were not met|1|||
146031076|NCT00701805|526627275|FG002|Overall Study|Resumption criteria were not met|0|||
146031077|NCT00701805|526627276|FG003|Overall Study|Resumption criteria were not met|0|||
146031078|NCT04692077|526627282|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
146031079|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
146031080|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
146031081|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
146031082|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
146031083|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
146031084|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
146031085|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
146031086|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
146031087|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
146031088|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146031089|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146031090|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
146031091|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
146031092|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
146031093|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
146031094|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
146031095|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
146031096|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146031097|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146031098|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
146031099|NCT05149313|526627283|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
146031100|NCT05149313|526627284|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
146031101|NCT05149313|526627285|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
146031102|NCT05149313|526627286|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
146031103|NCT05149313|526627283|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
146031104|NCT05149313|526627284|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
146031105|NCT05149313|526627285|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
146031106|NCT05149313|526627286|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
146031107|NCT05149313|526627283|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146031108|NCT05149313|526627284|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
146031109|NCT05149313|526627285|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
146031110|NCT05149313|526627286|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
146031111|NCT05149313|526627283|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146031112|NCT05149313|526627284|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
146031113|NCT05149313|526627285|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
146031114|NCT05149313|526627286|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
146031115|NCT05149313|526627283|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146031116|NCT05149313|526627284|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146031117|NCT05149313|526627285|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
146096616|NCT01309165|526874549|FG001|Overall Study|Left country|1|||
146096617|NCT01309165|526874548|FG000|Overall Study|No transportation|0|||
146096618|NCT01309165|526874549|FG001|Overall Study|No transportation|1|||
146096619|NCT01309165|526874548|FG000|Overall Study|Admitted to hospital for second stroke|1|||
146096620|NCT01309165|526874549|FG001|Overall Study|Admitted to hospital for second stroke|0|||
146096621|NCT01497275|526874551|FG000|Overall Study|Death|1|||
146096622|NCT01497275|526874551|FG000|Overall Study|Adverse Event|1|||
146096623|NCT01626495|526874554|FG000|Overall Study|Adverse Event|3|||
146096624|NCT01626495|526874554|FG000|Overall Study|Disease progression|27|||
146096625|NCT01626495|526874554|FG000|Overall Study|Withdrawal by Subject|1|||
146096626|NCT01626495|526874554|FG000|Overall Study|Administrative problem|1|||
146096627|NCT01626495|526874554|FG000|Overall Study|Death|2|||
146096628|NCT01626495|526874554|FG000|Overall Study|Physician Decision|1|||
146096629|NCT01626495|526874554|FG000|Overall Study|New cancer therapy|16|||
146096630|NCT01626495|526874554|FG000|Overall Study|Manufacturing failure|1|||
146096631|NCT03387683|526875800|FG000|Overall Study|In receipt of disallowed medication|1|||
146096632|NCT03387683|526875801|FG001|Overall Study|In receipt of disallowed medication|0|||
146096633|NCT03387683|526875800|FG000|Overall Study|Did not receive treatment|1|||
146096634|NCT03387683|526875801|FG001|Overall Study|Did not receive treatment|0|||
146096635|NCT01393301|526875802|FG000|Overall Study|Lost to Follow-up|5|||
146096636|NCT01393301|526875803|FG001|Overall Study|Lost to Follow-up|3|||
146096637|NCT01393301|526875802|FG000|Overall Study|Withdrawal by Subject|2|||
146096638|NCT01393301|526875803|FG001|Overall Study|Withdrawal by Subject|0|||
146096639|NCT01393301|526875802|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
146096640|NCT01393301|526875803|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
146096641|NCT03342963|526875804|FG000|Overall Study|Adverse Event|1|||
146096642|NCT03342963|526875805|FG001|Overall Study|Adverse Event|2|||
146096643|NCT03342963|526875806|FG002|Overall Study|Adverse Event|0|||
146096644|NCT03342963|526875807|FG003|Overall Study|Adverse Event|0|||
146096645|NCT03342963|526875804|FG000|Overall Study|Withdrawal by Subject|1|||
146096646|NCT03342963|526875805|FG001|Overall Study|Withdrawal by Subject|0|||
146096647|NCT03342963|526875806|FG002|Overall Study|Withdrawal by Subject|0|||
146096648|NCT03342963|526875807|FG003|Overall Study|Withdrawal by Subject|0|||
146096649|NCT00722423|526875808|FG000|Overall Study|Protocol Violation|0|||
146096650|NCT00722423|526875809|FG001|Overall Study|Protocol Violation|1|||
146096651|NCT01950169|526875810|FG000|Overall Study|Withdrawal by Subject|2|||
146096652|NCT01950169|526875811|FG001|Overall Study|Withdrawal by Subject|8|||
146096653|NCT01950169|526875812|FG002|Overall Study|Withdrawal by Subject|1|||
146096654|NCT01950169|526875810|FG000|Overall Study|Death|1|||
146096655|NCT01950169|526875811|FG001|Overall Study|Death|0|||
146096656|NCT01950169|526875812|FG002|Overall Study|Death|0|||
146096657|NCT01938573|526875814|FG000|Overall Study|Lack of Efficacy|1|||
146096658|NCT01938573|526875815|FG001|Overall Study|Lack of Efficacy|0|||
146096659|NCT01938573|526875814|FG000|Overall Study|Operation at other hospital|1|||
146096660|NCT01938573|526875815|FG001|Overall Study|Operation at other hospital|0|||
146096661|NCT00737438|526875819|FG000|Overall Study|Withdrawal by Subject|2|||
146096662|NCT00737438|526875819|FG000|Overall Study|Patient ineligible|1|||
146096663|NCT02410551|526875823|FG000|Overall Study|Adverse Event|1|||
146096664|NCT02410551|526875823|FG000|Overall Study|Withdrawal by Subject|1|||
146096665|NCT02410551|526875823|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
146096666|NCT01739309|526875824|FG000|Overall Study|Adverse Event|1|||
146096667|NCT01739309|526875824|FG000|Overall Study|Withdrawal by Subject|1|||
146096668|NCT05085730|526875827|FG000|Overall Study|Withdrawal by Subject|4|||
146096669|NCT05085730|526875827|FG000|Overall Study|Physician Decision|1|||
146096670|NCT05447897|526875828|FG000|Overall Study|Did not participate in survey|2|||
146096671|NCT04553679|526875829|FG000|Overall Study|Withdrawal by Subject|2|||
146096672|NCT04553679|526875830|FG001|Overall Study|Withdrawal by Subject|0|||
146096673|NCT04553679|526875829|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
146096674|NCT04553679|526875830|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
146096675|NCT01649804|526875831|FG000|Overall Study|Administrative/Other|8|||
146096676|NCT03719586|526875832|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
146096677|NCT03719586|526875833|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
146096678|NCT03719586|526875834|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
146096679|NCT03719586|526875835|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
146096680|NCT00178633|526875836|FG000|Overall Study|Lost to Follow-up|6|||
146096681|NCT03845543|526875837|FG000|Overall Study|Death|25|||
146096682|NCT03845543|526875837|FG000|Overall Study|Withdrawal by Subject|2|||
146096683|NCT03845543|526875837|FG000|Overall Study|Lost to Follow-up|12|||
146096684|NCT03845543|526875837|FG000|Overall Study|Adverse Event|17|||
146096685|NCT02028871|526875846|FG000|Overall Study|Positive urine drug screen|1|||
146254230|NCT01475370|527443090|FG000|Overall Study|Study drug administration difficult|0|||
146254231|NCT01475370|527443091|FG001|Overall Study|Study drug administration difficult|1|||
146254232|NCT01475370|527443092|FG002|Overall Study|Study drug administration difficult|1|||
146096686|NCT02028871|526875847|FG001|Overall Study|Positive urine drug screen|1|||
146096687|NCT02028871|526875846|FG000|Overall Study|Withdrawal by Subject|1|||
146096688|NCT02028871|526875847|FG001|Overall Study|Withdrawal by Subject|2|||
146096689|NCT02028871|526875846|FG000|Overall Study|IV placement difficulty|1|||
146096690|NCT02028871|526875847|FG001|Overall Study|IV placement difficulty|0|||
146096691|NCT02028871|526875846|FG000|Overall Study|Current Illness|1|||
146096692|NCT02028871|526875847|FG001|Overall Study|Current Illness|0|||
146096693|NCT02633501|526875850|FG000|Overall Study|Adverse Event|0|||
146096694|NCT02633501|526875851|FG001|Overall Study|Adverse Event|0|||
146096695|NCT02633501|526875852|FG002|Overall Study|Adverse Event|1|||
146096696|NCT02633501|526875853|FG003|Overall Study|Adverse Event|0|||
146031118|NCT05149313|526627286|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
146031119|NCT05149313|526627283|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146031120|NCT05149313|526627284|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146031121|NCT05149313|526627285|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
146031122|NCT05149313|526627286|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
146031123|NCT01867086|526627287|FG000|Overall Study|Disease Progression|1|||
146031124|NCT03681678|526627288|FG000|Overall Study|Lost to Follow-up|20|||
146031125|NCT03106415|526627294|FG000|Phase 1|Withdrawal by Subject|1|||
146031126|NCT03106415|526627295|FG001|Phase 1|Withdrawal by Subject|0|||
146031127|NCT03106415|526627296|FG002|Phase 1|Withdrawal by Subject|0|||
146031128|NCT03106415|526627294|FG000|Phase 1|Adverse Event|1|||
146031129|NCT03106415|526627295|FG001|Phase 1|Adverse Event|1|||
146096697|NCT02633501|526875854|FG004|Overall Study|Adverse Event|1|||
146096698|NCT02633501|526875855|FG005|Overall Study|Adverse Event|1|||
146096699|NCT02633501|526875850|FG000|Overall Study|Withdrawal by Subject|2|||
146096700|NCT02633501|526875851|FG001|Overall Study|Withdrawal by Subject|1|||
146096701|NCT02633501|526875852|FG002|Overall Study|Withdrawal by Subject|2|||
146096702|NCT02633501|526875853|FG003|Overall Study|Withdrawal by Subject|2|||
146096703|NCT02633501|526875854|FG004|Overall Study|Withdrawal by Subject|1|||
146096704|NCT02633501|526875855|FG005|Overall Study|Withdrawal by Subject|3|||
146096705|NCT02633501|526875850|FG000|Overall Study|Various other reasons|0|||
146031130|NCT03106415|526627296|FG002|Phase 1|Adverse Event|0|||
146031131|NCT03106415|526627294|FG000|Phase 1|Protocol Violation|0|||
146031132|NCT03106415|526627295|FG001|Phase 1|Protocol Violation|1|||
146031133|NCT03106415|526627296|FG002|Phase 1|Protocol Violation|0|||
146031134|NCT01804582|526627297|FG000|Overall Study|Lost to Follow-up|47|||
146031135|NCT01804582|526627298|FG001|Overall Study|Lost to Follow-up|56|||
146031136|NCT01804582|526627297|FG000|Overall Study|Physician Decision|2|||
146031137|NCT01804582|526627298|FG001|Overall Study|Physician Decision|0|||
146031138|NCT00159913|526627301|FG000|Overall Study|Adverse Event|1|||
146031139|NCT00159913|526627302|FG001|Overall Study|Adverse Event|0|||
146031140|NCT00159913|526627303|FG002|Overall Study|Adverse Event|1|||
146031141|NCT00159913|526627304|FG003|Overall Study|Adverse Event|0|||
146031142|NCT00159913|526627301|FG000|Overall Study|Withdrawal by Subject|0|||
146031143|NCT00159913|526627302|FG001|Overall Study|Withdrawal by Subject|0|||
146031144|NCT00159913|526627303|FG002|Overall Study|Withdrawal by Subject|0|||
146031145|NCT00159913|526627304|FG003|Overall Study|Withdrawal by Subject|1|||
146031146|NCT00159913|526627301|FG000|Overall Study|Lost to Follow-up|0|||
146031147|NCT00159913|526627302|FG001|Overall Study|Lost to Follow-up|0|||
146031148|NCT00159913|526627303|FG002|Overall Study|Lost to Follow-up|0|||
146031149|NCT00159913|526627304|FG003|Overall Study|Lost to Follow-up|1|||
146031150|NCT00159913|526627301|FG000|Overall Study|Protocol Violation|1|||
146031151|NCT00159913|526627302|FG001|Overall Study|Protocol Violation|0|||
146031152|NCT00159913|526627303|FG002|Overall Study|Protocol Violation|1|||
146096706|NCT02633501|526875851|FG001|Overall Study|Various other reasons|2|||
146096707|NCT02633501|526875852|FG002|Overall Study|Various other reasons|4|||
146096708|NCT02633501|526875853|FG003|Overall Study|Various other reasons|1|||
146096709|NCT02633501|526875854|FG004|Overall Study|Various other reasons|7|||
146096710|NCT02633501|526875855|FG005|Overall Study|Various other reasons|11|||
146096711|NCT02633501|526875850|FG000|Overall Study|Lost to Follow-up|0|||
146096712|NCT02633501|526875851|FG001|Overall Study|Lost to Follow-up|0|||
146096713|NCT02633501|526875852|FG002|Overall Study|Lost to Follow-up|0|||
146096714|NCT02633501|526875853|FG003|Overall Study|Lost to Follow-up|1|||
146096715|NCT02633501|526875854|FG004|Overall Study|Lost to Follow-up|2|||
146096716|NCT02633501|526875855|FG005|Overall Study|Lost to Follow-up|0|||
146096717|NCT01912963|526875856|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
146096718|NCT01912963|526875857|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
146031153|NCT00159913|526627304|FG003|Overall Study|Protocol Violation|0|||
146031154|NCT00385723|526627305|FG000|Overall Study|Lost to Follow-up|1|||
146031155|NCT00385723|526627306|FG001|Overall Study|Lost to Follow-up|1|||
146031156|NCT00385723|526627307|FG002|Overall Study|Lost to Follow-up|0|||
146031157|NCT00385723|526627305|FG000|Overall Study|Withdrawal by Subject|1|||
146031158|NCT00385723|526627306|FG001|Overall Study|Withdrawal by Subject|0|||
146031159|NCT00385723|526627307|FG002|Overall Study|Withdrawal by Subject|2|||
146096719|NCT01912963|526875858|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
146096720|NCT01912963|526875856|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
146096721|NCT01912963|526875857|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
146096722|NCT01912963|526875858|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
146096723|NCT01912963|526875856|FG000|Overall Study|Adverse Event|0|||
146096724|NCT01912963|526875857|FG001|Overall Study|Adverse Event|1|||
146096725|NCT01912963|526875858|FG002|Overall Study|Adverse Event|1|||
146096726|NCT01912963|526875856|FG000|Overall Study|Withdrawal by Subject|0|||
146096727|NCT01912963|526875857|FG001|Overall Study|Withdrawal by Subject|1|||
146096728|NCT01912963|526875858|FG002|Overall Study|Withdrawal by Subject|0|||
146096729|NCT01912963|526875856|FG000|Overall Study|Sought treatment locally|0|||
146096730|NCT01912963|526875857|FG001|Overall Study|Sought treatment locally|1|||
146096731|NCT01912963|526875858|FG002|Overall Study|Sought treatment locally|0|||
146096732|NCT01147172|526875869|FG000|Overall Study|Withdrawal by Subject|2|||
146096733|NCT01147172|526875869|FG000|Overall Study|Lost to Follow-up|2|||
146096734|NCT01069627|526875870|FG000|Overall Study|Disease progression|7|||
146096735|NCT01069627|526875870|FG000|Overall Study|Adverse Event|12|||
146096736|NCT01069627|526875870|FG000|Overall Study|Protocol Violation|1|||
146096737|NCT02963935|526875875|FG000|Overall Study|Adverse Event|12|||
146096738|NCT02963935|526875876|FG001|Overall Study|Adverse Event|6|||
146096739|NCT02963935|526875875|FG000|Overall Study|Protocol Violation|2|||
146096740|NCT02963935|526875876|FG001|Overall Study|Protocol Violation|1|||
146096741|NCT02963935|526875875|FG000|Overall Study|Lack of Efficacy|0|||
146096742|NCT02963935|526875876|FG001|Overall Study|Lack of Efficacy|2|||
146096743|NCT02963935|526875875|FG000|Overall Study|Lost to Follow-up|1|||
146096744|NCT02963935|526875876|FG001|Overall Study|Lost to Follow-up|6|||
146096745|NCT02963935|526875875|FG000|Overall Study|Unclassified|13|||
146096746|NCT02963935|526875876|FG001|Overall Study|Unclassified|22|||
146096747|NCT00464269|526875877|FG000|Overall Study|Lack of Efficacy|1|||
146096748|NCT00464269|526875878|FG001|Overall Study|Lack of Efficacy|0|||
146096749|NCT00464269|526875879|FG002|Overall Study|Lack of Efficacy|0|||
146096750|NCT00464269|526875880|FG003|Overall Study|Lack of Efficacy|0|||
146096751|NCT00464269|526875877|FG000|Overall Study|Lost to Follow-up|0|||
146096752|NCT00464269|526875878|FG001|Overall Study|Lost to Follow-up|4|||
146096753|NCT00464269|526875879|FG002|Overall Study|Lost to Follow-up|0|||
146096754|NCT00464269|526875880|FG003|Overall Study|Lost to Follow-up|1|||
146096755|NCT00464269|526875877|FG000|Overall Study|Withdrawal by Subject|0|||
146096756|NCT00464269|526875878|FG001|Overall Study|Withdrawal by Subject|2|||
146096757|NCT00464269|526875879|FG002|Overall Study|Withdrawal by Subject|1|||
146096758|NCT00464269|526875880|FG003|Overall Study|Withdrawal by Subject|1|||
146096759|NCT00464269|526875877|FG000|Overall Study|Other reason|3|||
146096760|NCT00464269|526875878|FG001|Overall Study|Other reason|3|||
146096761|NCT00464269|526875879|FG002|Overall Study|Other reason|1|||
146096762|NCT00464269|526875880|FG003|Overall Study|Other reason|1|||
146096763|NCT00464269|526875877|FG000|Overall Study|AE, serious fatal|0|||
146096764|NCT00464269|526875878|FG001|Overall Study|AE, serious fatal|0|||
146096765|NCT00464269|526875879|FG002|Overall Study|AE, serious fatal|1|||
146096766|NCT00464269|526875880|FG003|Overall Study|AE, serious fatal|1|||
146096767|NCT00464269|526875877|FG000|Overall Study|SAE, non-fatal|0|||
146096768|NCT00464269|526875878|FG001|Overall Study|SAE, non-fatal|0|||
146096769|NCT00464269|526875879|FG002|Overall Study|SAE, non-fatal|0|||
146096770|NCT00464269|526875880|FG003|Overall Study|SAE, non-fatal|1|||
146096771|NCT00464269|526875877|FG000|Overall Study|AE, non-serious non-fatal|2|||
146096772|NCT00464269|526875878|FG001|Overall Study|AE, non-serious non-fatal|8|||
146096773|NCT00464269|526875879|FG002|Overall Study|AE, non-serious non-fatal|3|||
146096774|NCT00464269|526875880|FG003|Overall Study|AE, non-serious non-fatal|4|||
146096775|NCT00464269|526875877|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146096776|NCT00464269|526875878|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146096777|NCT00464269|526875879|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
146096778|NCT00464269|526875880|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146096779|NCT00747461|526875881|FG000|Overall Study|study terminated by sponsor|5|||
146096780|NCT02149875|526875882|FG000|Overall Study|Lost to Follow-up|3|||
146096781|NCT02149875|526875883|FG001|Overall Study|Lost to Follow-up|4|||
146096782|NCT02149875|526875884|FG002|Overall Study|Lost to Follow-up|5|||
146096783|NCT02149875|526875882|FG000|Overall Study|Withdrawal by Subject|3|||
146096784|NCT02149875|526875883|FG001|Overall Study|Withdrawal by Subject|2|||
146096785|NCT02149875|526875884|FG002|Overall Study|Withdrawal by Subject|2|||
146096786|NCT02149875|526875882|FG000|Overall Study|Physician Decision|1|||
146096787|NCT02149875|526875883|FG001|Overall Study|Physician Decision|2|||
146096788|NCT02149875|526875884|FG002|Overall Study|Physician Decision|2|||
146096789|NCT00299182|526875886|FG000|Overall Study|Withdrawal by Subject|0|||
146096790|NCT00299182|526875887|FG001|Overall Study|Withdrawal by Subject|0|||
146096791|NCT00299182|526875888|FG002|Overall Study|Withdrawal by Subject|1|||
146096792|NCT00299182|526875889|FG003|Overall Study|Withdrawal by Subject|0|||
146096793|NCT00299182|526875890|FG004|Overall Study|Withdrawal by Subject|1|||
146096794|NCT00299182|526875891|FG005|Overall Study|Withdrawal by Subject|2|||
146096795|NCT00299182|526875892|FG006|Overall Study|Withdrawal by Subject|0|||
146096796|NCT00299182|526875886|FG000|Overall Study|Chemotherapy Changed|0|||
146096797|NCT00299182|526875887|FG001|Overall Study|Chemotherapy Changed|0|||
146096798|NCT00299182|526875888|FG002|Overall Study|Chemotherapy Changed|1|||
146096799|NCT00299182|526875889|FG003|Overall Study|Chemotherapy Changed|0|||
146096800|NCT00299182|526875890|FG004|Overall Study|Chemotherapy Changed|1|||
146096801|NCT00299182|526875891|FG005|Overall Study|Chemotherapy Changed|0|||
146096802|NCT00299182|526875892|FG006|Overall Study|Chemotherapy Changed|1|||
146096803|NCT00299182|526875886|FG000|Overall Study|Adverse Event|0|||
146096804|NCT00299182|526875887|FG001|Overall Study|Adverse Event|0|||
146096805|NCT00299182|526875888|FG002|Overall Study|Adverse Event|0|||
146096806|NCT00299182|526875889|FG003|Overall Study|Adverse Event|0|||
146096807|NCT00299182|526875890|FG004|Overall Study|Adverse Event|0|||
146096808|NCT00299182|526875891|FG005|Overall Study|Adverse Event|1|||
146096809|NCT00299182|526875892|FG006|Overall Study|Adverse Event|0|||
146096810|NCT00299182|526875886|FG000|Overall Study|Not Eligible|0|||
146096811|NCT00299182|526875887|FG001|Overall Study|Not Eligible|0|||
146096812|NCT00299182|526875888|FG002|Overall Study|Not Eligible|0|||
146096813|NCT00299182|526875889|FG003|Overall Study|Not Eligible|0|||
146096814|NCT00299182|526875890|FG004|Overall Study|Not Eligible|1|||
146096815|NCT00299182|526875891|FG005|Overall Study|Not Eligible|0|||
146096816|NCT00299182|526875892|FG006|Overall Study|Not Eligible|0|||
146096817|NCT00771316|526875898|FG000|Overall Study|Adverse Event|0|||
146096818|NCT00771316|526875899|FG001|Overall Study|Adverse Event|1|||
146096819|NCT00771316|526875898|FG000|Overall Study|Patient withdrew consent|1|||
146096820|NCT00771316|526875899|FG001|Overall Study|Patient withdrew consent|0|||
146096821|NCT00771316|526875898|FG000|Overall Study|Discontinued due to early termination|1|||
146096822|NCT00771316|526875899|FG001|Overall Study|Discontinued due to early termination|0|||
146096823|NCT02955797|526875900|FG000|Overall Study|Protocol Violation|1|||
146096824|NCT02955797|526875901|FG001|Overall Study|Protocol Violation|0|||
146096825|NCT02955797|526875902|FG002|Overall Study|Protocol Violation|0|||
146096826|NCT02955797|526875903|FG003|Overall Study|Protocol Violation|1|||
146096827|NCT02955797|526875900|FG000|Overall Study|Withdrawal by Subject|2|||
146096828|NCT02955797|526875901|FG001|Overall Study|Withdrawal by Subject|2|||
146096829|NCT02955797|526875902|FG002|Overall Study|Withdrawal by Subject|0|||
146096830|NCT02955797|526875903|FG003|Overall Study|Withdrawal by Subject|1|||
146096831|NCT02955797|526875900|FG000|Overall Study|Lost to Follow-up|0|||
146096832|NCT02955797|526875901|FG001|Overall Study|Lost to Follow-up|1|||
146096833|NCT02955797|526875902|FG002|Overall Study|Lost to Follow-up|0|||
146096834|NCT02955797|526875903|FG003|Overall Study|Lost to Follow-up|0|||
146096835|NCT03131453|526875904|FG000|Overall Study|Study terminated by Sponsor|424|||
146096836|NCT03131453|526875905|FG001|Overall Study|Study terminated by Sponsor|222|||
146096837|NCT03131453|526875906|FG002|Overall Study|Study terminated by Sponsor|438|||
146096838|NCT03131453|526875904|FG000|Overall Study|Withdrawal by Subject|18|||
146096839|NCT03131453|526875905|FG001|Overall Study|Withdrawal by Subject|7|||
146096840|NCT03131453|526875906|FG002|Overall Study|Withdrawal by Subject|13|||
146096841|NCT03131453|526875904|FG000|Overall Study|Adverse Event|10|||
146096842|NCT03131453|526875905|FG001|Overall Study|Adverse Event|3|||
146096843|NCT03131453|526875906|FG002|Overall Study|Adverse Event|3|||
146096844|NCT03131453|526875904|FG000|Overall Study|Lost to Follow-up|1|||
146096845|NCT03131453|526875905|FG001|Overall Study|Lost to Follow-up|0|||
146096846|NCT03131453|526875906|FG002|Overall Study|Lost to Follow-up|1|||
146096847|NCT03131453|526875904|FG000|Overall Study|Physician Decision|1|||
146096848|NCT03131453|526875905|FG001|Overall Study|Physician Decision|0|||
146096849|NCT03131453|526875906|FG002|Overall Study|Physician Decision|1|||
146096850|NCT03131453|526875904|FG000|Overall Study|Non-compliance with study treatment|1|||
146096851|NCT03131453|526875905|FG001|Overall Study|Non-compliance with study treatment|0|||
146096852|NCT03131453|526875906|FG002|Overall Study|Non-compliance with study treatment|0|||
146096853|NCT03131453|526875904|FG000|Overall Study|Technical problems|1|||
146096854|NCT03131453|526875905|FG001|Overall Study|Technical problems|0|||
146096855|NCT03131453|526875906|FG002|Overall Study|Technical problems|0|||
146096856|NCT03131453|526875904|FG000|Overall Study|Protocol deviation|0|||
146096857|NCT03131453|526875905|FG001|Overall Study|Protocol deviation|1|||
146096858|NCT03131453|526875906|FG002|Overall Study|Protocol deviation|0|||
146096859|NCT02081183|526875907|FG000|Overall Study|Lost to Follow-up|0|||
146096860|NCT02081183|526875908|FG001|Overall Study|Lost to Follow-up|1|||
146096861|NCT02081183|526875907|FG000|Overall Study|Protocol Violation|1|||
146096862|NCT02081183|526875908|FG001|Overall Study|Protocol Violation|0|||
146096863|NCT02081183|526875907|FG000|Overall Study|Other|3|||
146096864|NCT02081183|526875908|FG001|Overall Study|Other|3|||
146096865|NCT04176705|526875909|FG000|Overall Study|Withdrawal by Subject|4|||
146096866|NCT04176705|526875910|FG001|Overall Study|Withdrawal by Subject|4|||
146096867|NCT04176705|526875909|FG000|Overall Study|Death|1|||
146096868|NCT04176705|526875910|FG001|Overall Study|Death|1|||
146096869|NCT04176705|526875909|FG000|Overall Study|Lost to Follow-up|3|||
146096870|NCT04176705|526875910|FG001|Overall Study|Lost to Follow-up|3|||
146096871|NCT02024555|526875911|FG000|Overall Study|Lost to Follow-up|1|||
146096872|NCT02024555|526875912|FG001|Overall Study|Lost to Follow-up|1|||
146096873|NCT02024555|526875911|FG000|Overall Study|Withdrawal by Subject|5|||
146096874|NCT02024555|526875912|FG001|Overall Study|Withdrawal by Subject|1|||
146096875|NCT03805646|526875925|FG000|Overall Study|Death|40|||
146096876|NCT03805646|526875926|FG001|Overall Study|Death|49|||
146096877|NCT03805646|526875925|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
146096878|NCT03805646|526875926|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
146096879|NCT02925923|526877428|FG000|Overall Study|blood samples hemolyzed|0|||
146096880|NCT02925923|526877429|FG001|Overall Study|blood samples hemolyzed|2|||
146096881|NCT01863953|526877430|FG000|Overall Study|Adverse Event|0|||
146096882|NCT01863953|526877431|FG001|Overall Study|Adverse Event|0|||
146096883|NCT01863953|526877432|FG002|Overall Study|Adverse Event|1|||
146096884|NCT01824342|526877440|FG000|Overall Study|Withdrawal by Subject|0|||
146096885|NCT01824342|526877441|FG001|Overall Study|Withdrawal by Subject|3|||
146096886|NCT01824342|526877440|FG000|Overall Study|Adverse Event|1|||
146096887|NCT01824342|526877441|FG001|Overall Study|Adverse Event|1|||
146096888|NCT01824342|526877440|FG000|Overall Study|Disease Progression|1|||
146031160|NCT03689712|526627309|FG000|Overall Study|Adverse Event|1|||
146031161|NCT03689712|526627310|FG001|Overall Study|Adverse Event|0|||
146031162|NCT03689712|526627309|FG000|Overall Study|Death|20|||
146031163|NCT03689712|526627310|FG001|Overall Study|Death|10|||
146031164|NCT03689712|526627309|FG000|Overall Study|Lost to Follow-up|6|||
146031165|NCT03689712|526627310|FG001|Overall Study|Lost to Follow-up|6|||
146031166|NCT03689712|526627309|FG000|Overall Study|Other|1|||
146031167|NCT03689712|526627310|FG001|Overall Study|Other|0|||
146031168|NCT03689712|526627309|FG000|Overall Study|Patient Non-Compliance|0|||
146031169|NCT03689712|526627310|FG001|Overall Study|Patient Non-Compliance|1|||
146031170|NCT03689712|526627309|FG000|Overall Study|Withdrawal by Subject|20|||
146031171|NCT03689712|526627310|FG001|Overall Study|Withdrawal by Subject|4|||
146031172|NCT03689712|526627309|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
146031173|NCT03689712|526627310|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
146031174|NCT03689712|526627309|FG000|Overall Study|Randomized but not Treated|13|||
146031175|NCT03689712|526627310|FG001|Overall Study|Randomized but not Treated|7|||
146031176|NCT03689712|526627309|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
146031177|NCT03689712|526627310|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
146031178|NCT00689793|526627311|FG000|Overall Study|Lost to Follow-up|4|||
146031179|NCT00689793|526627312|FG001|Overall Study|Lost to Follow-up|5|||
146031180|NCT00875056|526627313|FG000|Overall Study|Adverse Event|6|||
146031181|NCT00875056|526627314|FG001|Overall Study|Adverse Event|1|||
146031182|NCT00875056|526627315|FG002|Overall Study|Adverse Event|2|||
146031183|NCT00875056|526627313|FG000|Overall Study|Progressive Disease|14|||
146031184|NCT00875056|526627314|FG001|Overall Study|Progressive Disease|8|||
146031185|NCT00875056|526627315|FG002|Overall Study|Progressive Disease|3|||
146031186|NCT00875056|526627313|FG000|Overall Study|Withdrawal by Subject|3|||
146031187|NCT00875056|526627314|FG001|Overall Study|Withdrawal by Subject|0|||
146031188|NCT00875056|526627315|FG002|Overall Study|Withdrawal by Subject|1|||
146031189|NCT02573246|526627321|FG000|Overall Study|Lost to Follow-up|2|||
146031190|NCT02573246|526627322|FG001|Overall Study|Lost to Follow-up|0|||
146031191|NCT02573246|526627323|FG002|Overall Study|Lost to Follow-up|0|||
146031192|NCT02573246|526627324|FG003|Overall Study|Lost to Follow-up|0|||
146031193|NCT02573246|526627325|FG004|Overall Study|Lost to Follow-up|1|||
146031194|NCT02573246|526627321|FG000|Overall Study|Withdrawal by Subject|0|||
146031195|NCT02573246|526627322|FG001|Overall Study|Withdrawal by Subject|0|||
146031196|NCT02573246|526627323|FG002|Overall Study|Withdrawal by Subject|0|||
146031197|NCT02573246|526627324|FG003|Overall Study|Withdrawal by Subject|0|||
146031198|NCT02573246|526627325|FG004|Overall Study|Withdrawal by Subject|1|||
146031199|NCT02573246|526627321|FG000|Overall Study|Physician Decision|1|||
146031200|NCT02573246|526627322|FG001|Overall Study|Physician Decision|1|||
146031201|NCT02573246|526627323|FG002|Overall Study|Physician Decision|3|||
146031202|NCT02573246|526627324|FG003|Overall Study|Physician Decision|2|||
146031203|NCT02573246|526627325|FG004|Overall Study|Physician Decision|2|||
146031204|NCT01902888|526627326|FG000|Overall Study|Study Terminated|3|||
146031205|NCT03149003|526627327|FG000|Overall Study|Randomized but not treated|0|||
146031206|NCT03149003|526627328|FG001|Overall Study|Randomized but not treated|1|||
146031207|NCT03149003|526627329|FG002|Overall Study|Randomized but not treated|18|||
146096889|NCT01824342|526877441|FG001|Overall Study|Disease Progression|1|||
146096890|NCT01824342|526877440|FG000|Overall Study|Physician Decision|5|||
146096891|NCT01824342|526877441|FG001|Overall Study|Physician Decision|0|||
146096892|NCT01824342|526877440|FG000|Overall Study|Death|2|||
146096893|NCT01824342|526877441|FG001|Overall Study|Death|0|||
146096894|NCT04195906|526877444|FG000|Part 1|Adverse Event|3|||
146096895|NCT04195906|526877445|FG001|Part 1|Adverse Event|7|||
146096896|NCT04195906|526877444|FG000|Part 1|Withdrawal by Subject|0|||
146096897|NCT04195906|526877445|FG001|Part 1|Withdrawal by Subject|1|||
146031208|NCT00973102|526627335|FG000|Overall Study|Protocol Violation|1|||
146031209|NCT00973102|526627336|FG001|Overall Study|Protocol Violation|0|||
146031210|NCT00973102|526627335|FG000|Overall Study|Prisoner|0|||
146031211|NCT00973102|526627336|FG001|Overall Study|Prisoner|1|||
146031212|NCT04941807|526627337|FG000|Overall Study|Lost to Follow-up|1|||
146031213|NCT04941807|526627338|FG001|Overall Study|Lost to Follow-up|1|||
146031214|NCT01100567|526627339|FG000|Overall Study|Withdrawal by Subject|5|||
146031215|NCT01100567|526627340|FG001|Overall Study|Withdrawal by Subject|8|||
146031216|NCT01100567|526627339|FG000|Overall Study|Early Hospital Discharge|6|||
146031217|NCT01100567|526627340|FG001|Overall Study|Early Hospital Discharge|4|||
146096898|NCT04195906|526877444|FG000|Part 2|Adverse Event|1|||
146031218|NCT01100567|526627339|FG000|Overall Study|Lost to Follow-up|1|||
146031219|NCT01100567|526627340|FG001|Overall Study|Lost to Follow-up|2|||
146031220|NCT01100567|526627339|FG000|Overall Study|Physician Decision|0|||
146031221|NCT01100567|526627340|FG001|Overall Study|Physician Decision|1|||
146031222|NCT01100567|526627339|FG000|Overall Study|Deemed ineligible after consent|0|||
146031223|NCT01100567|526627340|FG001|Overall Study|Deemed ineligible after consent|1|||
146031224|NCT01565564|526627344|FG000|Overall Study|Lost to Follow-up|5|||
146031225|NCT01565564|526627345|FG001|Overall Study|Lost to Follow-up|1|||
146031226|NCT02449018|526627346|FG000|Overall Study|Abnormal laboratory value|0|||
146031227|NCT02449018|526627347|FG001|Overall Study|Abnormal laboratory value|1|||
146031228|NCT02449018|526627346|FG000|Overall Study|Administrative problems|1|||
146031229|NCT02449018|526627347|FG001|Overall Study|Administrative problems|0|||
146031230|NCT02449018|526627346|FG000|Overall Study|Adverse Event|5|||
146031231|NCT02449018|526627347|FG001|Overall Study|Adverse Event|1|||
146031232|NCT02449018|526627346|FG000|Overall Study|Protocol deviation|4|||
146031233|NCT02449018|526627347|FG001|Overall Study|Protocol deviation|0|||
146031234|NCT02449018|526627346|FG000|Overall Study|Patient decision|2|||
146031235|NCT02449018|526627347|FG001|Overall Study|Patient decision|0|||
146031236|NCT00094107|526627348|FG000|Overall Study|Lack of Efficacy|23|||
146031237|NCT00094107|526627348|FG000|Overall Study|Death|5|||
146031238|NCT00094107|526627348|FG000|Overall Study|Adverse Event|3|||
146031239|NCT00094107|526627348|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
146031240|NCT00831701|526627372|FG000|Overall Study|Withdrawal by Subject|2|||
146031241|NCT00831701|526627373|FG001|Overall Study|Withdrawal by Subject|0|||
146031242|NCT00831701|526627372|FG000|Overall Study|Stone expulsion before first medication|2|||
146031243|NCT00831701|526627373|FG001|Overall Study|Stone expulsion before first medication|2|||
146031244|NCT00831701|526627372|FG000|Overall Study|Lost to Follow-up|1|||
146031245|NCT00831701|526627373|FG001|Overall Study|Lost to Follow-up|3|||
146031246|NCT01440881|526627374|FG000|Overall Study|Death|0|||
146031247|NCT01440881|526627375|FG001|Overall Study|Death|1|||
146031248|NCT02242981|526627378|FG000|Overall Study|Withdrawal by Subject|1|||
146031249|NCT03474081|526627379|FG000|Overall Study|Adverse Event|6|||
146031250|NCT03474081|526627380|FG001|Overall Study|Adverse Event|3|||
146031251|NCT03474081|526627379|FG000|Overall Study|Lost to Follow-up|2|||
146031252|NCT03474081|526627380|FG001|Overall Study|Lost to Follow-up|1|||
146031253|NCT03474081|526627379|FG000|Overall Study|Physician Decision|3|||
146031254|NCT03474081|526627380|FG001|Overall Study|Physician Decision|2|||
146031255|NCT03474081|526627379|FG000|Overall Study|Withdrawal by Subject|5|||
146031256|NCT03474081|526627380|FG001|Overall Study|Withdrawal by Subject|7|||
146031257|NCT03474081|526627379|FG000|Overall Study|Investigator site closed|1|||
146031258|NCT03474081|526627380|FG001|Overall Study|Investigator site closed|0|||
146031259|NCT01977690|526627383|FG000|Overall Study|Withdrawal by Subject|0|||
146031260|NCT01977690|526627384|FG001|Overall Study|Withdrawal by Subject|4|||
146031261|NCT02290938|526627390|FG000|Overall Study|Lost to Follow-up|14|||
146031262|NCT02290938|526627391|FG001|Overall Study|Lost to Follow-up|43|||
146031263|NCT02769962|526628930|FG000|Overall Study|Physician Decision|0|||
146031264|NCT02769962|526628931|FG001|Overall Study|Physician Decision|0|||
146031265|NCT02769962|526628932|FG002|Overall Study|Physician Decision|0|||
146031266|NCT02769962|526628933|FG003|Overall Study|Physician Decision|0|||
146031267|NCT02769962|526628934|FG004|Overall Study|Physician Decision|0|||
146031268|NCT02769962|526628935|FG005|Overall Study|Physician Decision|1|||
146031269|NCT02769962|526628936|FG006|Overall Study|Physician Decision|0|||
146031270|NCT02769962|526628937|FG007|Overall Study|Physician Decision|1|||
146031271|NCT02769962|526628930|FG000|Overall Study|Refused further treatment|0|||
146031272|NCT02769962|526628931|FG001|Overall Study|Refused further treatment|0|||
146031273|NCT02769962|526628932|FG002|Overall Study|Refused further treatment|0|||
146031274|NCT02769962|526628933|FG003|Overall Study|Refused further treatment|0|||
146031275|NCT02769962|526628934|FG004|Overall Study|Refused further treatment|0|||
146031276|NCT02769962|526628935|FG005|Overall Study|Refused further treatment|1|||
146031277|NCT02769962|526628936|FG006|Overall Study|Refused further treatment|1|||
146031278|NCT02769962|526628937|FG007|Overall Study|Refused further treatment|0|||
146031279|NCT03826342|526628941|FG000|Overall Study|Withdrawal by Subject|8|||
146031280|NCT03826342|526628942|FG001|Overall Study|Withdrawal by Subject|1|||
146031281|NCT03826342|526628941|FG000|Overall Study|Lost to Follow-up|7|||
146031282|NCT03826342|526628942|FG001|Overall Study|Lost to Follow-up|7|||
146031283|NCT03826342|526628941|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
146096899|NCT04195906|526877445|FG001|Part 2|Adverse Event|1|||
146096900|NCT04195906|526877444|FG000|Part 2|Withdrawal by Subject|0|||
146254233|NCT01475370|527443090|FG000|Overall Study|Other than specified|1|||
146031284|NCT03826342|526628942|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
146031285|NCT02212678|526628949|FG000|Overall Study|Adverse Event|1|||
146031286|NCT02337634|526628950|FG000|Overall Study|Protocol Violation|3|||
146031287|NCT02337634|526628951|FG001|Overall Study|Protocol Violation|1|||
146031288|NCT02337634|526628950|FG000|Overall Study|Lost to Follow-up|1|||
146031289|NCT02337634|526628951|FG001|Overall Study|Lost to Follow-up|0|||
146031290|NCT04068610|526628952|FG000|Overall Study|Death|4|||
146031291|NCT04068610|526628953|FG001|Overall Study|Death|8|||
146031292|NCT04068610|526628954|FG002|Overall Study|Death|13|||
146096901|NCT04195906|526877445|FG001|Part 2|Withdrawal by Subject|3|||
146096902|NCT04195906|526877444|FG000|Part 2|Other|1|||
146096903|NCT04195906|526877445|FG001|Part 2|Other|3|||
146096904|NCT00385762|526877452|FG000|Overall Study|Adverse Event|1|||
146096905|NCT00385762|526877452|FG000|Overall Study|Lost to Follow-up|1|||
146096906|NCT02104752|526877453|FG000|Overall Study|Withdrawal by Subject|1|||
146096907|NCT02104752|526877454|FG001|Overall Study|Withdrawal by Subject|0|||
146096908|NCT02104752|526877453|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
146096909|NCT02104752|526877454|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
146096910|NCT02899299|526877455|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
146096911|NCT02899299|526877456|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
146096912|NCT02899299|526877455|FG000|Pre-treatment|Participant withdrew consent|1|||
146096913|NCT02899299|526877456|FG001|Pre-treatment|Participant withdrew consent|11|||
146096914|NCT02899299|526877455|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
146096915|NCT02899299|526877456|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
146096916|NCT02899299|526877455|FG000|Pre-treatment|Not reported|0|||
146096917|NCT02899299|526877456|FG001|Pre-treatment|Not reported|1|||
146096918|NCT02899299|526877455|FG000|Treatment|Disease Progression|182|||
146096919|NCT02899299|526877456|FG001|Treatment|Disease Progression|43|||
146096920|NCT02899299|526877455|FG000|Treatment|Study Drug Toxicity|60|||
146096921|NCT02899299|526877456|FG001|Treatment|Study Drug Toxicity|24|||
146096922|NCT02899299|526877455|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
146096923|NCT02899299|526877456|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
146096924|NCT02899299|526877455|FG000|Treatment|Participant request to discontinue Study treatment|4|||
146096925|NCT02899299|526877456|FG001|Treatment|Participant request to discontinue Study treatment|10|||
146096926|NCT02899299|526877455|FG000|Treatment|Participant withdrew consent|6|||
146096927|NCT02899299|526877456|FG001|Treatment|Participant withdrew consent|3|||
146096928|NCT02899299|526877455|FG000|Treatment|Lost to Follow-up|0|||
146096929|NCT02899299|526877456|FG001|Treatment|Lost to Follow-up|2|||
146096930|NCT02899299|526877455|FG000|Treatment|Maximum Clinical Benefit|11|||
146096931|NCT02899299|526877456|FG001|Treatment|Maximum Clinical Benefit|2|||
146096932|NCT02899299|526877455|FG000|Treatment|Poor/Non-compliance|1|||
146096933|NCT02899299|526877456|FG001|Treatment|Poor/Non-compliance|0|||
146096934|NCT02899299|526877455|FG000|Treatment|Participant no longer meets Study criteria|4|||
146096935|NCT02899299|526877456|FG001|Treatment|Participant no longer meets Study criteria|0|||
146096936|NCT02899299|526877455|FG000|Treatment|Administrative reason by Sponsor|2|||
146096937|NCT02899299|526877456|FG001|Treatment|Administrative reason by Sponsor|0|||
146096938|NCT02899299|526877455|FG000|Treatment|Other reasons|12|||
146096939|NCT02899299|526877456|FG001|Treatment|Other reasons|2|||
146096940|NCT02899299|526877455|FG000|Treatment|Not reported|7|||
146096941|NCT02899299|526877456|FG001|Treatment|Not reported|0|||
146096942|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
146096943|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
146096944|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
146096945|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
146096946|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
146096947|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
146096948|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
146096949|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
146096950|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
146096951|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
146096952|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
146096953|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
146096954|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
146096955|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
146096956|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
146096957|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
146096958|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
146096959|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
146096960|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
146096961|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
146096962|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
146096963|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
146096964|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
146096965|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
146096966|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
146096967|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
146096968|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
146096969|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
146096970|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
146096971|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
146168156|NCT02496767|527128089|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
146031293|NCT04068610|526628952|FG000|Overall Study|Lost to Follow-up|0|||
146031294|NCT04068610|526628953|FG001|Overall Study|Lost to Follow-up|2|||
146031295|NCT04068610|526628954|FG002|Overall Study|Lost to Follow-up|0|||
146031296|NCT04068610|526628952|FG000|Overall Study|Withdrawal by Subject|0|||
146031297|NCT04068610|526628953|FG001|Overall Study|Withdrawal by Subject|4|||
146031298|NCT04068610|526628954|FG002|Overall Study|Withdrawal by Subject|2|||
146031299|NCT04068610|526628952|FG000|Overall Study|Other|3|||
146031300|NCT04068610|526628953|FG001|Overall Study|Other|12|||
146031301|NCT04068610|526628954|FG002|Overall Study|Other|11|||
146031302|NCT02046070|526628955|FG000|Overall Study|Progressive Disease|18|||
146031303|NCT02046070|526628956|FG001|Overall Study|Progressive Disease|11|||
146031304|NCT02046070|526628957|FG002|Overall Study|Progressive Disease|40|||
146031305|NCT02046070|526628955|FG000|Overall Study|Adverse Event|8|||
146031306|NCT02046070|526628956|FG001|Overall Study|Adverse Event|10|||
146031307|NCT02046070|526628957|FG002|Overall Study|Adverse Event|17|||
146031308|NCT02046070|526628955|FG000|Overall Study|Withdrawal by Subject|1|||
146031309|NCT02046070|526628956|FG001|Overall Study|Withdrawal by Subject|2|||
146031310|NCT02046070|526628957|FG002|Overall Study|Withdrawal by Subject|6|||
146031311|NCT02046070|526628955|FG000|Overall Study|Study Terminated by Sponsor|1|||
146031312|NCT02046070|526628956|FG001|Overall Study|Study Terminated by Sponsor|1|||
146031313|NCT02046070|526628957|FG002|Overall Study|Study Terminated by Sponsor|1|||
146031314|NCT02046070|526628955|FG000|Overall Study|Reason not Specified|4|||
146031315|NCT02046070|526628956|FG001|Overall Study|Reason not Specified|4|||
146031316|NCT02046070|526628957|FG002|Overall Study|Reason not Specified|6|||
146031317|NCT01818284|526628958|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
146031318|NCT01818284|526628959|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
146031319|NCT01818284|526628958|FG000|Overall Study|Death|0|||
146031320|NCT01818284|526628959|FG001|Overall Study|Death|2|||
146031321|NCT04030962|526628960|FG000|Stage 2|Adverse Event|0|||
146031322|NCT04030962|526628961|FG001|Stage 2|Adverse Event|0|||
146031323|NCT04030962|526628962|FG002|Stage 2|Adverse Event|0|||
146031324|NCT04030962|526628963|FG003|Stage 2|Adverse Event|0|||
146031325|NCT04030962|526628964|FG004|Stage 2|Adverse Event|0|||
146031326|NCT04030962|526628965|FG005|Stage 2|Adverse Event|0|||
146031327|NCT04030962|526628966|FG006|Stage 2|Adverse Event|0|||
146031328|NCT04030962|526628967|FG007|Stage 2|Adverse Event|0|||
146031329|NCT04030962|526628968|FG008|Stage 2|Adverse Event|1|||
146031330|NCT04030962|526628969|FG009|Stage 2|Adverse Event|0|||
146031331|NCT04030962|526628970|FG010|Stage 2|Adverse Event|1|||
146031332|NCT04030962|526628971|FG011|Stage 2|Adverse Event|1|||
146031333|NCT04030962|526628972|FG012|Stage 2|Adverse Event|1|||
146031334|NCT04030962|526628960|FG000|Stage 2|Withdrawal by Subject|0|||
146031335|NCT04030962|526628961|FG001|Stage 2|Withdrawal by Subject|0|||
146031336|NCT04030962|526628962|FG002|Stage 2|Withdrawal by Subject|0|||
146031337|NCT04030962|526628963|FG003|Stage 2|Withdrawal by Subject|0|||
146031338|NCT04030962|526628964|FG004|Stage 2|Withdrawal by Subject|0|||
146031339|NCT04030962|526628965|FG005|Stage 2|Withdrawal by Subject|0|||
146031340|NCT04030962|526628966|FG006|Stage 2|Withdrawal by Subject|0|||
146031341|NCT04030962|526628967|FG007|Stage 2|Withdrawal by Subject|0|||
146031342|NCT04030962|526628968|FG008|Stage 2|Withdrawal by Subject|1|||
146031343|NCT04030962|526628969|FG009|Stage 2|Withdrawal by Subject|0|||
146031344|NCT04030962|526628970|FG010|Stage 2|Withdrawal by Subject|0|||
146031345|NCT04030962|526628971|FG011|Stage 2|Withdrawal by Subject|2|||
146031346|NCT04030962|526628972|FG012|Stage 2|Withdrawal by Subject|1|||
146031347|NCT04030962|526628960|FG000|Stage 2|Lost to Follow-up|0|||
146031348|NCT04030962|526628961|FG001|Stage 2|Lost to Follow-up|0|||
146031349|NCT04030962|526628962|FG002|Stage 2|Lost to Follow-up|0|||
146031350|NCT04030962|526628963|FG003|Stage 2|Lost to Follow-up|0|||
146031351|NCT04030962|526628964|FG004|Stage 2|Lost to Follow-up|0|||
146031352|NCT04030962|526628965|FG005|Stage 2|Lost to Follow-up|0|||
146254234|NCT01475370|527443091|FG001|Overall Study|Other than specified|0|||
146254235|NCT01475370|527443092|FG002|Overall Study|Other than specified|0|||
146254236|NCT00125853|527443093|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
146031353|NCT04030962|526628966|FG006|Stage 2|Lost to Follow-up|0|||
146031354|NCT04030962|526628967|FG007|Stage 2|Lost to Follow-up|0|||
146031355|NCT04030962|526628968|FG008|Stage 2|Lost to Follow-up|1|||
146031356|NCT04030962|526628969|FG009|Stage 2|Lost to Follow-up|0|||
146031357|NCT04030962|526628970|FG010|Stage 2|Lost to Follow-up|0|||
146031358|NCT04030962|526628971|FG011|Stage 2|Lost to Follow-up|0|||
146031359|NCT04030962|526628972|FG012|Stage 2|Lost to Follow-up|0|||
146031360|NCT04030962|526628960|FG000|Stage 2|Technical Problems|0|||
146031361|NCT04030962|526628961|FG001|Stage 2|Technical Problems|0|||
146031362|NCT04030962|526628962|FG002|Stage 2|Technical Problems|0|||
146031363|NCT04030962|526628963|FG003|Stage 2|Technical Problems|0|||
146031364|NCT04030962|526628964|FG004|Stage 2|Technical Problems|0|||
146031365|NCT04030962|526628965|FG005|Stage 2|Technical Problems|0|||
146031366|NCT04030962|526628966|FG006|Stage 2|Technical Problems|0|||
146254237|NCT00125853|527443094|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
146031367|NCT04030962|526628967|FG007|Stage 2|Technical Problems|0|||
146031368|NCT04030962|526628968|FG008|Stage 2|Technical Problems|0|||
146031369|NCT04030962|526628969|FG009|Stage 2|Technical Problems|0|||
146031370|NCT04030962|526628970|FG010|Stage 2|Technical Problems|0|||
146096972|NCT00313300|526877457|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
146096973|NCT00313300|526877458|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146096974|NCT00313300|526877459|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146096975|NCT00313300|526877460|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146096976|NCT00313300|526877461|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
146096977|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
146096978|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
146096979|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
146096980|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
146096981|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
146096982|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
146096983|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
146096984|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
146096985|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
146096986|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
146096987|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
146096988|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
146096989|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
146096990|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
146096991|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
146096992|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
146096993|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
146096994|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
146096995|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
146096996|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
146096997|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
146096998|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
146096999|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
146097000|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
146097001|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
146097002|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
146097003|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
146097004|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
146097005|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
146097006|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
146097007|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
146097008|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
146097009|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
146097010|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
146097011|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
146097012|NCT00313300|526877457|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
146097013|NCT00313300|526877458|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
146097014|NCT00313300|526877459|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
146097015|NCT00313300|526877460|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
146097016|NCT00313300|526877461|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
146097017|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
146097018|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
146097019|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
146097020|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
146097021|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
146097022|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
146097023|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
146097024|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
146097025|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
146097026|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
146097027|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146097028|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
146097029|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
146097030|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146254238|NCT02522299|527443095|FG000|Overall Study|Adverse Event|2|||
146254239|NCT02522299|527443096|FG001|Overall Study|Adverse Event|0|||
146254240|NCT02522299|527443095|FG000|Overall Study|Physician Decision|0|||
146254241|NCT02522299|527443096|FG001|Overall Study|Physician Decision|1|||
146254242|NCT02522299|527443095|FG000|Overall Study|Withdrawal by Subject|2|||
146254243|NCT02522299|527443096|FG001|Overall Study|Withdrawal by Subject|0|||
146254244|NCT04908800|527443097|FG000|Overall Study|Adverse Event|0|||
146254245|NCT04908800|527443098|FG001|Overall Study|Adverse Event|0|||
146031371|NCT04030962|526628971|FG011|Stage 2|Technical Problems|1|||
146031372|NCT04030962|526628972|FG012|Stage 2|Technical Problems|0|||
146031373|NCT05601102|526628976|FG000|Overall Study|Death|1|||
146031374|NCT05601102|526628977|FG001|Overall Study|Death|2|||
146031375|NCT05601102|526628976|FG000|Overall Study|Withdrawal by Subject|1|||
146031376|NCT05601102|526628977|FG001|Overall Study|Withdrawal by Subject|1|||
146031377|NCT05601102|526628976|FG000|Overall Study|Lost to Follow-up|0|||
146031378|NCT05601102|526628977|FG001|Overall Study|Lost to Follow-up|2|||
146031379|NCT05288166|526628978|FG000|Overall Study|Adverse Event|1|||
146031380|NCT05288166|526628979|FG001|Overall Study|Adverse Event|0|||
146031381|NCT05288166|526628978|FG000|Overall Study|Lost to Follow-up|2|||
146031382|NCT05288166|526628979|FG001|Overall Study|Lost to Follow-up|0|||
146031383|NCT05288166|526628978|FG000|Overall Study|Physician Decision|0|||
146031384|NCT05288166|526628979|FG001|Overall Study|Physician Decision|2|||
146031385|NCT05288166|526628978|FG000|Overall Study|Screen Failure|1|||
146031386|NCT05288166|526628979|FG001|Overall Study|Screen Failure|1|||
146031387|NCT05288166|526628978|FG000|Overall Study|Withdrawal by Subject|4|||
146031388|NCT05288166|526628979|FG001|Overall Study|Withdrawal by Subject|2|||
146031389|NCT05288166|526628978|FG000|Overall Study|On Study Treatment|408|||
146031390|NCT05288166|526628979|FG001|Overall Study|On Study Treatment|418|||
146031391|NCT03007745|526628980|FG000|Overall Study|Sleep test negative for OSA|53|||
146031392|NCT03007745|526628981|FG001|Overall Study|Sleep test negative for OSA|49|||
146031393|NCT03007745|526628980|FG000|Overall Study|Physician Decision|6|||
146031394|NCT03007745|526628981|FG001|Overall Study|Physician Decision|9|||
146031395|NCT03007745|526628980|FG000|Overall Study|Withdrawal by Subject|38|||
146031396|NCT03007745|526628981|FG001|Overall Study|Withdrawal by Subject|16|||
146031397|NCT03007745|526628980|FG000|Overall Study|Lost to Follow-up|19|||
146031398|NCT03007745|526628981|FG001|Overall Study|Lost to Follow-up|25|||
146031399|NCT03007745|526628980|FG000|Overall Study|Unable to login to website|17|||
146031400|NCT03007745|526628981|FG001|Overall Study|Unable to login to website|4|||
146031401|NCT04284813|526628982|FG000|Overall Study|Withdrawal by Subject|1|||
146031402|NCT03921554|526628983|FG000|Overall Study|Adverse Event|2|||
146031403|NCT03921554|526628983|FG000|Overall Study|Withdrawal by Subject|1|||
146031404|NCT03921554|526628983|FG000|Overall Study|Death|3|||
146031405|NCT00431951|526628985|FG000|Overall Study|Inability to follow study procedures|1|||
146031406|NCT00431951|526628986|FG001|Overall Study|Inability to follow study procedures|0|||
146031407|NCT00431951|526628987|FG002|Overall Study|Inability to follow study procedures|1|||
146031408|NCT00431951|526628988|FG003|Overall Study|Inability to follow study procedures|2|||
146031409|NCT00431951|526628985|FG000|Overall Study|Lost to Follow-up|0|||
146031410|NCT00431951|526628986|FG001|Overall Study|Lost to Follow-up|1|||
146031411|NCT00431951|526628987|FG002|Overall Study|Lost to Follow-up|0|||
146031412|NCT00431951|526628988|FG003|Overall Study|Lost to Follow-up|0|||
146031413|NCT00431951|526628985|FG000|Overall Study|Withdrawal by Subject|0|||
146031414|NCT00431951|526628986|FG001|Overall Study|Withdrawal by Subject|1|||
146031415|NCT00431951|526628987|FG002|Overall Study|Withdrawal by Subject|0|||
146031416|NCT00431951|526628988|FG003|Overall Study|Withdrawal by Subject|0|||
146031417|NCT00431951|526628985|FG000|Overall Study|Adverse Event|0|||
146031418|NCT00431951|526628986|FG001|Overall Study|Adverse Event|0|||
146031419|NCT00431951|526628987|FG002|Overall Study|Adverse Event|1|||
146031420|NCT00431951|526628988|FG003|Overall Study|Adverse Event|0|||
146031421|NCT00096018|526628999|FG000|Overall Study|Became Ineligible (not treated)|0|||
146031422|NCT00096018|526629000|FG001|Overall Study|Became Ineligible (not treated)|3|||
146031423|NCT00096018|526628999|FG000|Overall Study|Miscellaneous (not treated)|0|||
146031424|NCT00096018|526629000|FG001|Overall Study|Miscellaneous (not treated)|2|||
146031425|NCT00096018|526628999|FG000|Overall Study|Adverse Event|0|||
146031426|NCT00096018|526629000|FG001|Overall Study|Adverse Event|5|||
146031427|NCT00096018|526628999|FG000|Overall Study|Death|0|||
146031428|NCT00096018|526629000|FG001|Overall Study|Death|1|||
146031429|NCT00096018|526628999|FG000|Overall Study|Withdrawal by Subject|0|||
146031430|NCT00096018|526629000|FG001|Overall Study|Withdrawal by Subject|2|||
146031431|NCT00096018|526628999|FG000|Overall Study|Miscellaneous|2|||
146031432|NCT00096018|526629000|FG001|Overall Study|Miscellaneous|1|||
146031433|NCT03968159|526629004|FG000|Overall Study|Adverse Event|4|||
146031434|NCT03968159|526629005|FG001|Overall Study|Adverse Event|4|||
146031435|NCT03968159|526629004|FG000|Overall Study|Lost to Follow-up|1|||
146031436|NCT03968159|526629005|FG001|Overall Study|Lost to Follow-up|1|||
146031437|NCT03968159|526629004|FG000|Overall Study|Use of prohibited medication|0|||
146031438|NCT03968159|526629005|FG001|Overall Study|Use of prohibited medication|1|||
146031439|NCT03968159|526629004|FG000|Overall Study|Protocol Violation|2|||
146031440|NCT03968159|526629005|FG001|Overall Study|Protocol Violation|2|||
146031441|NCT03968159|526629004|FG000|Overall Study|Withdrawal by Subject|4|||
146031442|NCT03968159|526629005|FG001|Overall Study|Withdrawal by Subject|6|||
146031443|NCT03968159|526629004|FG000|Overall Study|Lack of Efficacy|0|||
146031444|NCT03968159|526629005|FG001|Overall Study|Lack of Efficacy|1|||
146031445|NCT03968159|526629004|FG000|Overall Study|Not further specified|2|||
146031446|NCT03968159|526629005|FG001|Overall Study|Not further specified|0|||
146031447|NCT00895661|526629013|FG000|Overall Study|Death|1|||
146031448|NCT00895661|526629013|FG000|Overall Study|reason unknown|2|||
146031449|NCT02006069|526629014|FG000|Overall Study|MPP other programming|239|||
146031450|NCT02006069|526629015|FG001|Overall Study|MPP other programming|0|||
146031451|NCT02006069|526629014|FG000|Overall Study|RV only pacing|0|||
146031452|NCT02006069|526629015|FG001|Overall Study|RV only pacing|3|||
146031453|NCT00791557|526629016|FG000|Overall Study|Adverse Event|1|||
146031454|NCT02066129|526629017|FG000|Overall Study|Lost to Follow-up|13|||
146031455|NCT02066129|526629018|FG001|Overall Study|Lost to Follow-up|12|||
146031456|NCT02066129|526629017|FG000|Overall Study|Withdrawal by Subject|7|||
146031457|NCT02066129|526629018|FG001|Overall Study|Withdrawal by Subject|10|||
146031458|NCT02066129|526629017|FG000|Overall Study|Lack of Efficacy|8|||
146031459|NCT02066129|526629018|FG001|Overall Study|Lack of Efficacy|10|||
146031460|NCT02066129|526629017|FG000|Overall Study|Physician Decision|1|||
146031461|NCT02066129|526629018|FG001|Overall Study|Physician Decision|1|||
146031462|NCT02322190|526629019|FG000|Overall Study|Death on study|1|||
146031463|NCT02322190|526629020|FG001|Overall Study|Death on study|0|||
146031464|NCT00357656|526629021|FG000|Overall Study|Other, No surgery performed|0|||
146031465|NCT00357656|526629022|FG001|Overall Study|Other, No surgery performed|3|||
146031466|NCT00316888|526629024|FG000|Overall Study|Adverse Event|4|||
146031467|NCT00316888|526629025|FG001|Overall Study|Adverse Event|5|||
146031468|NCT00316888|526629024|FG000|Overall Study|Withdrawal by Subject|2|||
146031469|NCT00316888|526629025|FG001|Overall Study|Withdrawal by Subject|2|||
146031470|NCT00316888|526629024|FG000|Overall Study|Not start protocol therapy|0|||
146031471|NCT00316888|526629025|FG001|Overall Study|Not start protocol therapy|1|||
146031472|NCT03553498|526629028|FG000|Overall Study|Missing primary outcome|1|||
146031473|NCT03553498|526629029|FG001|Overall Study|Missing primary outcome|2|||
146031474|NCT02713529|526629030|FG000|Overall Study|Withdrawal by Subject|3|||
146031475|NCT02713529|526629031|FG001|Overall Study|Withdrawal by Subject|1|||
146031476|NCT02713529|526629032|FG002|Overall Study|Withdrawal by Subject|4|||
146031477|NCT02713529|526629033|FG003|Overall Study|Withdrawal by Subject|2|||
146031478|NCT02713529|526629034|FG004|Overall Study|Withdrawal by Subject|0|||
146031479|NCT02713529|526629035|FG005|Overall Study|Withdrawal by Subject|1|||
146031480|NCT02713529|526629036|FG006|Overall Study|Withdrawal by Subject|1|||
146031481|NCT02713529|526629030|FG000|Overall Study|Lost to Follow-up|1|||
146031482|NCT02713529|526629031|FG001|Overall Study|Lost to Follow-up|0|||
146031483|NCT02713529|526629032|FG002|Overall Study|Lost to Follow-up|1|||
146031484|NCT02713529|526629033|FG003|Overall Study|Lost to Follow-up|0|||
146031485|NCT02713529|526629034|FG004|Overall Study|Lost to Follow-up|0|||
146031486|NCT02713529|526629035|FG005|Overall Study|Lost to Follow-up|0|||
146031487|NCT02713529|526629036|FG006|Overall Study|Lost to Follow-up|0|||
146031488|NCT02713529|526629030|FG000|Overall Study|Death|3|||
146031489|NCT02713529|526629031|FG001|Overall Study|Death|3|||
146031490|NCT02713529|526629032|FG002|Overall Study|Death|26|||
146031491|NCT02713529|526629033|FG003|Overall Study|Death|27|||
146031492|NCT02713529|526629034|FG004|Overall Study|Death|3|||
146031493|NCT02713529|526629035|FG005|Overall Study|Death|13|||
146031494|NCT02713529|526629036|FG006|Overall Study|Death|3|||
146031495|NCT03995355|526629039|FG000|Overall Study|Adverse Event|1|||
146031496|NCT03995355|526629040|FG001|Overall Study|Adverse Event|0|||
146031497|NCT03995355|526629039|FG000|Overall Study|Withdrawal by Subject|1|||
146031498|NCT03995355|526629040|FG001|Overall Study|Withdrawal by Subject|0|||
146031499|NCT03995355|526629039|FG000|Overall Study|Scheduling Issues|0|||
146031500|NCT03995355|526629040|FG001|Overall Study|Scheduling Issues|1|||
146031501|NCT02698371|526629045|FG000|All Participants Flow|Lost to Follow-up|3|||
146031502|NCT02698371|526629045|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
146031503|NCT02698371|526629045|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
146031504|NCT02698371|526629045|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
146031505|NCT02698371|526629045|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
146031506|NCT02698371|526629045|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
146031507|NCT02698371|526629045|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
146031508|NCT02525094|526629046|FG000|Overall Study|Lost to Follow-up|2|||
146031509|NCT02525094|526629047|FG001|Overall Study|Lost to Follow-up|1|||
146031510|NCT02525094|526629046|FG000|Overall Study|Withdrawal by Subject|5|||
146031511|NCT02525094|526629047|FG001|Overall Study|Withdrawal by Subject|6|||
146254246|NCT04908800|527443099|FG002|Overall Study|Adverse Event|0|||
146254247|NCT04908800|527443100|FG003|Overall Study|Adverse Event|0|||
146254248|NCT04908800|527443101|FG004|Overall Study|Adverse Event|0|||
146031512|NCT02525094|526629046|FG000|Overall Study|Not Treated|1|||
146031513|NCT02525094|526629047|FG001|Overall Study|Not Treated|1|||
146031514|NCT00969436|526629049|FG000|Overall Study|Protocol Violation|1|||
146031515|NCT00969436|526629050|FG001|Overall Study|Protocol Violation|3|||
146031516|NCT00969436|526629051|FG002|Overall Study|Protocol Violation|0|||
146031517|NCT00969436|526629049|FG000|Overall Study|Migrated/moved from study area|12|||
146031518|NCT00969436|526629050|FG001|Overall Study|Migrated/moved from study area|10|||
146031519|NCT00969436|526629051|FG002|Overall Study|Migrated/moved from study area|2|||
146031520|NCT00969436|526629049|FG000|Overall Study|Father - serious health problem|0|||
146031521|NCT00969436|526629050|FG001|Overall Study|Father - serious health problem|0|||
146031522|NCT00969436|526629051|FG002|Overall Study|Father - serious health problem|1|||
146031523|NCT00969436|526629049|FG000|Overall Study|Parents personal problem|0|||
146031524|NCT00969436|526629050|FG001|Overall Study|Parents personal problem|0|||
146031525|NCT00969436|526629051|FG002|Overall Study|Parents personal problem|1|||
146031526|NCT00969436|526629049|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
146031527|NCT00969436|526629050|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
146031528|NCT00969436|526629051|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
146031529|NCT00969436|526629049|FG000|Overall Study|Withdrawal by Subject|3|||
146031530|NCT00969436|526629050|FG001|Overall Study|Withdrawal by Subject|0|||
146031531|NCT00969436|526629051|FG002|Overall Study|Withdrawal by Subject|2|||
146031532|NCT00969436|526629049|FG000|Overall Study|Lost to Follow-up|8|||
146031533|NCT00969436|526629050|FG001|Overall Study|Lost to Follow-up|8|||
146031534|NCT00969436|526629051|FG002|Overall Study|Lost to Follow-up|5|||
146031535|NCT02117349|526629055|FG000|Overall Study|Withdrawal by Subject|1|||
146031536|NCT02117349|526629056|FG001|Overall Study|Withdrawal by Subject|0|||
146031537|NCT02117349|526629055|FG000|Overall Study|Lost to Follow-up|1|||
146031538|NCT02117349|526629056|FG001|Overall Study|Lost to Follow-up|1|||
146031539|NCT02117349|526629055|FG000|Overall Study|Death|1|||
146031540|NCT02117349|526629056|FG001|Overall Study|Death|0|||
146031541|NCT02535416|526629057|FG000|Overall Study|Family bereavement overseas|1|||
146031542|NCT02535416|526629058|FG001|Overall Study|Family bereavement overseas|0|||
146031543|NCT02535416|526629059|FG002|Overall Study|Family bereavement overseas|0|||
146031544|NCT02535416|526629060|FG003|Overall Study|Family bereavement overseas|0|||
146031545|NCT02535416|526629061|FG004|Overall Study|Family bereavement overseas|0|||
146031546|NCT02535416|526629062|FG005|Overall Study|Family bereavement overseas|0|||
146031547|NCT02535416|526629063|FG006|Overall Study|Family bereavement overseas|0|||
146031548|NCT02535416|526629064|FG007|Overall Study|Family bereavement overseas|0|||
146031549|NCT02535416|526629065|FG008|Overall Study|Family bereavement overseas|0|||
146031550|NCT02739321|526629066|FG000|Overall Study|Lack of Efficacy|1|||
146031551|NCT02739321|526629067|FG001|Overall Study|Lack of Efficacy|1|||
146031552|NCT02739321|526629066|FG000|Overall Study|Lost to Follow-up|1|||
146031553|NCT02739321|526629067|FG001|Overall Study|Lost to Follow-up|1|||
146031554|NCT02739321|526629066|FG000|Overall Study|Withdrawal by Subject|1|||
146031555|NCT02739321|526629067|FG001|Overall Study|Withdrawal by Subject|2|||
146031556|NCT02440789|526629070|FG000|Overall Study|Withdrawal by Subject|3|||
146031557|NCT02440789|526629070|FG000|Overall Study|Not willing to adhere to reqs|1|||
146031558|NCT03172130|526630161|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
146031559|NCT03172130|526630162|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
146031560|NCT01350115|526630166|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
146031561|NCT01350115|526630167|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
146031562|NCT01350115|526630166|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
146031563|NCT01350115|526630167|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
146031564|NCT01350115|526630166|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
146031565|NCT01350115|526630167|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
146031566|NCT05565937|526630168|FG000|Overall Study|Adverse Event|0|||
146031567|NCT05565937|526630169|FG001|Overall Study|Adverse Event|1|||
146031568|NCT05565937|526630168|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
146031569|NCT05565937|526630169|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
146031570|NCT05565937|526630168|FG000|Overall Study|Lost to Follow-up|2|||
146031571|NCT05565937|526630169|FG001|Overall Study|Lost to Follow-up|0|||
146031572|NCT05565937|526630168|FG000|Overall Study|Pregnancy|0|||
146031573|NCT05565937|526630169|FG001|Overall Study|Pregnancy|2|||
146031574|NCT05565937|526630168|FG000|Overall Study|Anisometropia|0|||
146031575|NCT05565937|526630169|FG001|Overall Study|Anisometropia|1|||
146031576|NCT04544683|526630170|FG000|Overall Study|Lost to Follow-up|2|||
146031577|NCT04544683|526630170|FG000|Overall Study|Underwent cervical spine surgery|6|||
146031578|NCT00151372|526630171|FG000|Overall Study|Death|12|||
146031579|NCT00151372|526630172|FG001|Overall Study|Death|11|||
146031580|NCT00151372|526630171|FG000|Overall Study|Lost to Follow-up|5|||
146031581|NCT00151372|526630172|FG001|Overall Study|Lost to Follow-up|5|||
146031582|NCT00151372|526630171|FG000|Overall Study|Too sick medically to continue|5|||
146031583|NCT00151372|526630172|FG001|Overall Study|Too sick medically to continue|6|||
146031584|NCT00151372|526630171|FG000|Overall Study|Withdrawal by Subject|7|||
146031585|NCT00151372|526630172|FG001|Overall Study|Withdrawal by Subject|7|||
146031586|NCT02783170|526630175|FG000|Overall Study|Randomized but not Vaccinated|1|||
146031587|NCT02783170|526630176|FG001|Overall Study|Randomized but not Vaccinated|0|||
146031588|NCT00541346|526630177|FG000|Follow-up|Adverse Event|1|||
146031589|NCT02008773|526630178|FG000|Overall Study|Adverse Event|3|||
146300361|NCT02966223|527615235|FG000|Overall Study|Physician Decision|3|||
146031590|NCT02008773|526630179|FG001|Overall Study|Adverse Event|3|||
146031591|NCT02008773|526630180|FG002|Overall Study|Adverse Event|1|||
146031592|NCT02008773|526630181|FG003|Overall Study|Adverse Event|2|||
146031593|NCT02008773|526630178|FG000|Overall Study|Medication Non-compliance|2|||
146031594|NCT02008773|526630179|FG001|Overall Study|Medication Non-compliance|1|||
146300362|NCT02966223|527615235|FG000|Overall Study|Withdrawal by Subject|11|||
146031595|NCT02008773|526630180|FG002|Overall Study|Medication Non-compliance|3|||
146031596|NCT02008773|526630181|FG003|Overall Study|Medication Non-compliance|2|||
146031597|NCT02008773|526630178|FG000|Overall Study|Withdrawal by Subject|8|||
146031598|NCT02008773|526630179|FG001|Overall Study|Withdrawal by Subject|4|||
146031599|NCT02008773|526630180|FG002|Overall Study|Withdrawal by Subject|7|||
146031600|NCT02008773|526630181|FG003|Overall Study|Withdrawal by Subject|6|||
146031601|NCT02008773|526630178|FG000|Overall Study|Lost to Follow-up|0|||
146031602|NCT02008773|526630179|FG001|Overall Study|Lost to Follow-up|1|||
146031603|NCT02008773|526630180|FG002|Overall Study|Lost to Follow-up|3|||
146031604|NCT02008773|526630181|FG003|Overall Study|Lost to Follow-up|2|||
146031605|NCT04732949|526630184|FG000|Overall Study|Withdrawal by Subject|23|||
146031606|NCT04732949|526630185|FG001|Overall Study|Withdrawal by Subject|27|||
146031607|NCT04732949|526630184|FG000|Overall Study|Protocol Violation|0|||
146031608|NCT04732949|526630185|FG001|Overall Study|Protocol Violation|1|||
146031609|NCT04732949|526630184|FG000|Overall Study|Non-compliance|0|||
146031610|NCT04732949|526630185|FG001|Overall Study|Non-compliance|2|||
146031611|NCT04732949|526630184|FG000|Overall Study|Physician Decision|2|||
146031612|NCT04732949|526630185|FG001|Overall Study|Physician Decision|1|||
146031613|NCT04732949|526630184|FG000|Overall Study|Serious adverse event (Fatal)|16|||
146031614|NCT04732949|526630185|FG001|Overall Study|Serious adverse event (Fatal)|18|||
146031615|NCT04732949|526630184|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
146031616|NCT04732949|526630185|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
146031617|NCT04732949|526630184|FG000|Overall Study|Non-serious adverse event|1|||
146031618|NCT04732949|526630185|FG001|Overall Study|Non-serious adverse event|3|||
146031619|NCT04732949|526630184|FG000|Overall Study|Lost to Follow-up|26|||
146031620|NCT04732949|526630185|FG001|Overall Study|Lost to Follow-up|27|||
146031621|NCT04732949|526630184|FG000|Overall Study|Other|6|||
146031622|NCT04732949|526630185|FG001|Overall Study|Other|3|||
146031623|NCT01806064|526630186|FG000|Overall Study|Randomized Not Enrolled|0|||
146031624|NCT01806064|526630187|FG001|Overall Study|Randomized Not Enrolled|0|||
146031625|NCT01806064|526630188|FG002|Overall Study|Randomized Not Enrolled|0|||
146031626|NCT01806064|526630189|FG003|Overall Study|Randomized Not Enrolled|1|||
146031627|NCT01806064|526630190|FG004|Overall Study|Randomized Not Enrolled|2|||
146031628|NCT01286077|526630193|FG000|Overall Study|Adverse Event|2|||
146031629|NCT01286077|526630194|FG001|Overall Study|Adverse Event|0|||
146031630|NCT01286077|526630193|FG000|Overall Study|Death|1|||
146031631|NCT01286077|526630194|FG001|Overall Study|Death|0|||
146031632|NCT01286077|526630193|FG000|Overall Study|Protocol Violation|1|||
146031633|NCT01286077|526630194|FG001|Overall Study|Protocol Violation|1|||
146031634|NCT01286077|526630193|FG000|Overall Study|Withdrawal by Subject|0|||
146031635|NCT01286077|526630194|FG001|Overall Study|Withdrawal by Subject|2|||
146031636|NCT01286077|526630193|FG000|Overall Study|Intercurrent illness|1|||
146031637|NCT01286077|526630194|FG001|Overall Study|Intercurrent illness|0|||
146031638|NCT01286077|526630193|FG000|Overall Study|Non-compliance|1|||
146031639|NCT01286077|526630194|FG001|Overall Study|Non-compliance|0|||
146031640|NCT01286077|526630193|FG000|Overall Study|The subject starts with alternative MMY|0|||
146031641|NCT01286077|526630194|FG001|Overall Study|The subject starts with alternative MMY|3|||
146031642|NCT01286077|526630193|FG000|Overall Study|Patient's decision to stop treatment|3|||
146031643|NCT01286077|526630194|FG001|Overall Study|Patient's decision to stop treatment|0|||
146031644|NCT01286077|526630193|FG000|Overall Study|Progression of disease|0|||
146031645|NCT01286077|526630194|FG001|Overall Study|Progression of disease|1|||
146031646|NCT01286077|526630193|FG000|Overall Study|refill medication not received in time|1|||
146031647|NCT01286077|526630194|FG001|Overall Study|refill medication not received in time|0|||
146031648|NCT01282294|526630197|FG000|Overall Study|Lost to Follow-up|14|||
146031649|NCT01282294|526630197|FG000|Overall Study|Screening failure|1|||
146031650|NCT01282294|526630197|FG000|Overall Study|Adverse Event|1|||
146031651|NCT01282294|526630197|FG000|Overall Study|Patient non-compliance|2|||
146031652|NCT01282294|526630197|FG000|Overall Study|Physician Decision|1|||
146031653|NCT02408523|526630198|FG000|Overall Study|Adverse Event|4|||
146031654|NCT02408523|526630199|FG001|Overall Study|Adverse Event|10|||
146031655|NCT02408523|526630198|FG000|Overall Study|Lack of Efficacy|0|||
146031656|NCT02408523|526630199|FG001|Overall Study|Lack of Efficacy|1|||
146031657|NCT02408523|526630198|FG000|Overall Study|Protocol Violation|1|||
146031658|NCT02408523|526630199|FG001|Overall Study|Protocol Violation|2|||
146031659|NCT02408523|526630198|FG000|Overall Study|Lost to Follow-up|2|||
146031660|NCT02408523|526630199|FG001|Overall Study|Lost to Follow-up|3|||
146031661|NCT02408523|526630198|FG000|Overall Study|Withdrawal by Subject|3|||
146031662|NCT02408523|526630199|FG001|Overall Study|Withdrawal by Subject|1|||
146031663|NCT02408523|526630198|FG000|Overall Study|Sponsor request|1|||
146031664|NCT02408523|526630199|FG001|Overall Study|Sponsor request|0|||
146031665|NCT02408523|526630198|FG000|Overall Study|Did not satisfy extension conditions|0|||
146031666|NCT02408523|526630199|FG001|Overall Study|Did not satisfy extension conditions|1|||
146097031|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
146097032|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
146031667|NCT04256512|526630200|FG000|Overall Study|Withdrawal by Subject|1|||
146031668|NCT02797184|526630209|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
146031669|NCT02797184|526630210|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
146031670|NCT03199391|526630215|FG000|Overall Study|Death|1|||
146097033|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
146097034|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
146097035|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
146097036|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
146097037|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146097038|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146097039|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
146097040|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
146097041|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
146097042|NCT00313300|526877457|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
146097043|NCT00313300|526877458|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146097044|NCT00313300|526877459|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146097045|NCT00313300|526877460|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
146097046|NCT00313300|526877461|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
146097047|NCT02336373|526877462|FG000|Overall Study|Protocol closed early|4|||
146097048|NCT02336373|526877462|FG000|Overall Study|Physician Decision|14|||
146031671|NCT03199391|526630215|FG000|Overall Study|Lost to Follow-up|3|||
146031672|NCT03199391|526630215|FG000|Overall Study|Adverse Event|2|||
146031673|NCT03199391|526630215|FG000|Overall Study|Withdrawal by Subject|10|||
146031674|NCT05824936|526630222|FG000|Overall Study|Lost to Follow-up|1|||
146097049|NCT00428792|526877463|FG000|Overall Study|Lack of Efficacy|1|||
146097050|NCT00428792|526877464|FG001|Overall Study|Lack of Efficacy|3|||
146097051|NCT00428792|526877463|FG000|Overall Study|Lost to Follow-up|0|||
146097052|NCT00428792|526877464|FG001|Overall Study|Lost to Follow-up|1|||
146097053|NCT00850343|526877465|FG000|Overall Study|Withdrawal by Subject|11|||
146097054|NCT00850343|526877466|FG001|Overall Study|Withdrawal by Subject|0|||
146097055|NCT00850343|526877467|FG002|Overall Study|Withdrawal by Subject|3|||
146097056|NCT00850343|526877468|FG003|Overall Study|Withdrawal by Subject|2|||
146097057|NCT00850343|526877465|FG000|Overall Study|Adverse Event|15|||
146097058|NCT00850343|526877466|FG001|Overall Study|Adverse Event|2|||
146097059|NCT00850343|526877467|FG002|Overall Study|Adverse Event|6|||
146097060|NCT00850343|526877468|FG003|Overall Study|Adverse Event|6|||
146097061|NCT00850343|526877465|FG000|Overall Study|Pregnancy|0|||
146097062|NCT00850343|526877466|FG001|Overall Study|Pregnancy|0|||
146097063|NCT00850343|526877467|FG002|Overall Study|Pregnancy|0|||
146097064|NCT00850343|526877468|FG003|Overall Study|Pregnancy|1|||
146097065|NCT00850343|526877465|FG000|Overall Study|Lack of Efficacy|17|||
146097066|NCT00850343|526877466|FG001|Overall Study|Lack of Efficacy|0|||
146097067|NCT00850343|526877467|FG002|Overall Study|Lack of Efficacy|3|||
146097068|NCT00850343|526877468|FG003|Overall Study|Lack of Efficacy|2|||
146097069|NCT00850343|526877465|FG000|Overall Study|Non-compliance with Study Procedures|1|||
146097070|NCT00850343|526877466|FG001|Overall Study|Non-compliance with Study Procedures|0|||
146097071|NCT00850343|526877467|FG002|Overall Study|Non-compliance with Study Procedures|1|||
146097072|NCT00850343|526877468|FG003|Overall Study|Non-compliance with Study Procedures|1|||
146097073|NCT00850343|526877465|FG000|Overall Study|Physician Decision|2|||
146097074|NCT00850343|526877466|FG001|Overall Study|Physician Decision|1|||
146097075|NCT00850343|526877467|FG002|Overall Study|Physician Decision|1|||
146097076|NCT00850343|526877468|FG003|Overall Study|Physician Decision|1|||
146097077|NCT00371826|526877469|FG000|Core Phase (12 Months)|Adverse Event|15|||
146097078|NCT00371826|526877470|FG001|Core Phase (12 Months)|Adverse Event|4|||
146097079|NCT00371826|526877471|FG002|Core Phase (12 Months)|Adverse Event|9|||
146097080|NCT00371826|526877469|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
146097081|NCT00371826|526877470|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
146097082|NCT00371826|526877471|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
146097083|NCT00371826|526877469|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
146254249|NCT04908800|527443102|FG005|Overall Study|Adverse Event|0|||
146254250|NCT04908800|527443103|FG006|Overall Study|Adverse Event|0|||
146254251|NCT04908800|527443104|FG007|Overall Study|Adverse Event|0|||
146254252|NCT04908800|527443105|FG008|Overall Study|Adverse Event|0|||
146031675|NCT00673881|526630223|FG000|Overall Study|Withdrawal by Subject|1|||
146031676|NCT01299571|526630228|FG000|Overall Study|Protocol Violation|107|||
146031677|NCT00413010|526630229|FG000|Overall Study|Adverse Event|8|||
146031678|NCT00413010|526630230|FG001|Overall Study|Adverse Event|4|||
146031679|NCT00413010|526630229|FG000|Overall Study|Laboratory abnormality|0|||
146031680|NCT00413010|526630230|FG001|Overall Study|Laboratory abnormality|2|||
146031681|NCT00413010|526630229|FG000|Overall Study|Lack of Efficacy|0|||
146031682|NCT00413010|526630230|FG001|Overall Study|Lack of Efficacy|3|||
146031683|NCT00413010|526630229|FG000|Overall Study|Lost to Follow-up|3|||
146031684|NCT00413010|526630230|FG001|Overall Study|Lost to Follow-up|0|||
146031685|NCT00413010|526630229|FG000|Overall Study|Withdrawal by Subject|7|||
146031686|NCT00413010|526630230|FG001|Overall Study|Withdrawal by Subject|2|||
146031687|NCT00413010|526630229|FG000|Overall Study|Due to termination of the study|54|||
146031688|NCT00413010|526630230|FG001|Overall Study|Due to termination of the study|52|||
146031689|NCT00708734|526630231|FG000|Overall Study|scheduling conflict|2|||
146031690|NCT00708734|526630231|FG000|Overall Study|moved|1|||
146031691|NCT00708734|526630231|FG000|Overall Study|leg injury|1|||
146031692|NCT00708734|526630231|FG000|Overall Study|knee replacement|1|||
146031693|NCT00708734|526630231|FG000|Overall Study|vertigo|1|||
146031694|NCT00708734|526630231|FG000|Overall Study|leg fracture|1|||
146031695|NCT01533922|526630232|FG000|Overall Study|Adverse Event|5|||
146031696|NCT01533922|526630233|FG001|Overall Study|Adverse Event|8|||
146031697|NCT01533922|526630234|FG002|Overall Study|Adverse Event|6|||
146031698|NCT01533922|526630235|FG003|Overall Study|Adverse Event|3|||
146031699|NCT01533922|526630236|FG004|Overall Study|Adverse Event|4|||
146031700|NCT01533922|526630232|FG000|Overall Study|Lack of Efficacy|0|||
146031701|NCT01533922|526630233|FG001|Overall Study|Lack of Efficacy|0|||
146031702|NCT01533922|526630234|FG002|Overall Study|Lack of Efficacy|1|||
146031703|NCT01533922|526630235|FG003|Overall Study|Lack of Efficacy|0|||
146031704|NCT01533922|526630236|FG004|Overall Study|Lack of Efficacy|0|||
146031705|NCT01533922|526630232|FG000|Overall Study|Protocol Violation|0|||
146031706|NCT01533922|526630233|FG001|Overall Study|Protocol Violation|3|||
146031707|NCT01533922|526630234|FG002|Overall Study|Protocol Violation|0|||
146031708|NCT01533922|526630235|FG003|Overall Study|Protocol Violation|0|||
146031709|NCT01533922|526630236|FG004|Overall Study|Protocol Violation|1|||
146031710|NCT01533922|526630232|FG000|Overall Study|Withdrawal by Subject|3|||
146031711|NCT01533922|526630233|FG001|Overall Study|Withdrawal by Subject|1|||
146031712|NCT01533922|526630234|FG002|Overall Study|Withdrawal by Subject|2|||
146031713|NCT01533922|526630235|FG003|Overall Study|Withdrawal by Subject|2|||
146031714|NCT01533922|526630236|FG004|Overall Study|Withdrawal by Subject|1|||
146031715|NCT01533922|526630232|FG000|Overall Study|Other reason not defined above|2|||
146031716|NCT01533922|526630233|FG001|Overall Study|Other reason not defined above|0|||
146031717|NCT01533922|526630234|FG002|Overall Study|Other reason not defined above|1|||
146031718|NCT01533922|526630235|FG003|Overall Study|Other reason not defined above|0|||
146031719|NCT01533922|526630236|FG004|Overall Study|Other reason not defined above|0|||
146031720|NCT05432167|526630237|FG000|Overall Study|Adverse Event|0|||
146031721|NCT05432167|526630238|FG001|Overall Study|Adverse Event|2|||
146031722|NCT05432167|526630239|FG002|Overall Study|Adverse Event|1|||
146031723|NCT05432167|526630237|FG000|Overall Study|Lost to Follow-up|3|||
146031724|NCT05432167|526630238|FG001|Overall Study|Lost to Follow-up|3|||
146031725|NCT05432167|526630239|FG002|Overall Study|Lost to Follow-up|2|||
146031726|NCT05432167|526630237|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
146031727|NCT05432167|526630238|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
146031728|NCT05432167|526630239|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
146031729|NCT05432167|526630237|FG000|Overall Study|Physician Decision|1|||
146031730|NCT05432167|526630238|FG001|Overall Study|Physician Decision|0|||
146031731|NCT05432167|526630239|FG002|Overall Study|Physician Decision|0|||
146031732|NCT05432167|526630237|FG000|Overall Study|Withdrawal by Subject|7|||
146031733|NCT05432167|526630238|FG001|Overall Study|Withdrawal by Subject|4|||
146031734|NCT05432167|526630239|FG002|Overall Study|Withdrawal by Subject|11|||
146031735|NCT05432167|526630237|FG000|Overall Study|Other|0|||
146031736|NCT05432167|526630238|FG001|Overall Study|Other|0|||
146031737|NCT05432167|526630239|FG002|Overall Study|Other|1|||
146031738|NCT01267175|526630240|FG000|Overall Study|Withdrawal by Subject|1|||
146031739|NCT01267175|526630240|FG000|Overall Study|Lost to Follow-up|1|||
146031740|NCT02690649|526630243|FG000|Overall Study|Withdrawal by Subject|1|||
146031741|NCT02690649|526630244|FG001|Overall Study|Withdrawal by Subject|1|||
146031742|NCT02690649|526630243|FG000|Overall Study|Protocol Violation|0|||
146031743|NCT02690649|526630244|FG001|Overall Study|Protocol Violation|3|||
146031744|NCT02276547|526630245|FG000|Overall Study|Death|2|||
146031745|NCT02276547|526630245|FG000|Overall Study|Explant|2|||
146031746|NCT00530920|526630246|FG000|Overall Study|Randomized but not treated|0|||
146031747|NCT00530920|526630247|FG001|Overall Study|Randomized but not treated|2|||
146031748|NCT00530920|526630248|FG002|Overall Study|Randomized but not treated|0|||
146031749|NCT00530920|526630246|FG000|Overall Study|Adverse Event|0|||
146031750|NCT00530920|526630247|FG001|Overall Study|Adverse Event|0|||
146031751|NCT00530920|526630248|FG002|Overall Study|Adverse Event|3|||
146031752|NCT00530920|526630246|FG000|Overall Study|Withdrawal by Subject|0|||
146031753|NCT00530920|526630247|FG001|Overall Study|Withdrawal by Subject|0|||
146031754|NCT00530920|526630248|FG002|Overall Study|Withdrawal by Subject|1|||
146031755|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
146031756|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
146031757|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
146031758|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
146031759|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
146031760|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
146031761|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
146031762|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
146031763|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
146031764|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
146031765|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
146031766|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
146031767|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
146031768|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
146031769|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
146031770|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
146031771|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
146031772|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
146031773|NCT01302054|526630259|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
146031774|NCT01302054|526630260|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
146031775|NCT01302054|526630261|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
146031776|NCT01302054|526630259|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
146031777|NCT01302054|526630260|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
146031778|NCT01302054|526630261|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
146031779|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146031780|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
146031781|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
146031782|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146031783|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146031784|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146031785|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146031786|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
146031787|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
146031788|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
146031789|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
146031790|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
146031791|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146031792|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
146031793|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
146031794|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
146031795|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
146031796|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
146031797|NCT01302054|526630259|FG000|Double-Blind Treatment Phase|Other|0|||
146031798|NCT01302054|526630260|FG001|Double-Blind Treatment Phase|Other|4|||
146031799|NCT01302054|526630261|FG002|Double-Blind Treatment Phase|Other|9|||
146031800|NCT03757130|526630264|FG000|Overall Study|Lost to Follow-up|0|||
146031801|NCT03757130|526630265|FG001|Overall Study|Lost to Follow-up|0|||
146031802|NCT03757130|526630266|FG002|Overall Study|Lost to Follow-up|0|||
146031803|NCT03757130|526630267|FG003|Overall Study|Lost to Follow-up|1|||
146031804|NCT03757130|526630268|FG004|Overall Study|Lost to Follow-up|0|||
146031805|NCT03757130|526630269|FG005|Overall Study|Lost to Follow-up|0|||
146031806|NCT03757130|526630270|FG006|Overall Study|Lost to Follow-up|0|||
146031807|NCT03757130|526630271|FG007|Overall Study|Lost to Follow-up|1|||
146031808|NCT03757130|526630264|FG000|Overall Study|Withdrawal by Subject|0|||
146031809|NCT03757130|526630265|FG001|Overall Study|Withdrawal by Subject|0|||
146031810|NCT03757130|526630266|FG002|Overall Study|Withdrawal by Subject|0|||
146031811|NCT03757130|526630267|FG003|Overall Study|Withdrawal by Subject|0|||
146031812|NCT03757130|526630268|FG004|Overall Study|Withdrawal by Subject|0|||
146031813|NCT03757130|526630269|FG005|Overall Study|Withdrawal by Subject|0|||
146031814|NCT03757130|526630270|FG006|Overall Study|Withdrawal by Subject|1|||
146031815|NCT03757130|526630271|FG007|Overall Study|Withdrawal by Subject|0|||
146031816|NCT01439126|526630272|FG000|Overall Study|Adverse Event|2|||
146031817|NCT01439126|526630273|FG001|Overall Study|Adverse Event|0|||
146031818|NCT01439126|526630272|FG000|Overall Study|Withdrawal by Subject|5|||
146031819|NCT01439126|526630273|FG001|Overall Study|Withdrawal by Subject|21|||
146031820|NCT01439126|526630272|FG000|Overall Study|Protocol Violation|6|||
146031821|NCT01439126|526630273|FG001|Overall Study|Protocol Violation|4|||
146031822|NCT01439126|526630272|FG000|Overall Study|Lost to Follow-up|6|||
146031823|NCT01439126|526630273|FG001|Overall Study|Lost to Follow-up|3|||
146031824|NCT01439126|526630272|FG000|Overall Study|Other-Use of prohibited treatment|0|||
146031825|NCT01439126|526630273|FG001|Overall Study|Other-Use of prohibited treatment|2|||
146031826|NCT01439126|526630272|FG000|Overall Study|Other-Miscellaneous|12|||
146031827|NCT01439126|526630273|FG001|Overall Study|Other-Miscellaneous|12|||
146031828|NCT00687609|526630274|FG000|Overall Study|Physician Decision|1|||
146031829|NCT00687609|526630274|FG000|Overall Study|Withdrawal by Subject|2|||
146031830|NCT00780273|526630276|FG000|Overall Study|Death|1|||
146031831|NCT00780273|526630276|FG000|Overall Study|Lost to Follow-up|1|||
146031832|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
146031833|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
146031834|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
146031835|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
146031836|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
146031837|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
146031838|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
146097084|NCT00371826|526877470|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
146097085|NCT00371826|526877471|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
146097086|NCT00371826|526877469|FG000|Core Phase (12 Months)|Protocol Violation|1|||
146097087|NCT00371826|526877470|FG001|Core Phase (12 Months)|Protocol Violation|0|||
146097088|NCT00371826|526877471|FG002|Core Phase (12 Months)|Protocol Violation|1|||
146097089|NCT00371826|526877469|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
146097090|NCT00371826|526877470|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
146097091|NCT00371826|526877471|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
146097092|NCT00371826|526877469|FG000|Core Phase (12 Months)|Administrative problems|1|||
146097093|NCT00371826|526877470|FG001|Core Phase (12 Months)|Administrative problems|0|||
146097094|NCT00371826|526877471|FG002|Core Phase (12 Months)|Administrative problems|8|||
146097095|NCT00371826|526877469|FG000|Core Phase (12 Months)|Graft Loss|0|||
146097096|NCT00371826|526877470|FG001|Core Phase (12 Months)|Graft Loss|1|||
146097097|NCT00371826|526877471|FG002|Core Phase (12 Months)|Graft Loss|0|||
146097098|NCT00371826|526877469|FG000|Extension Phase (24 Months)|Adverse Event|4|||
146097099|NCT00371826|526877470|FG001|Extension Phase (24 Months)|Adverse Event|5|||
146097100|NCT00371826|526877471|FG002|Extension Phase (24 Months)|Adverse Event|0|||
146097101|NCT00371826|526877469|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
146097102|NCT00371826|526877470|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
146097103|NCT00371826|526877471|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
146097104|NCT00371826|526877469|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
146097105|NCT00371826|526877470|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
146097106|NCT00371826|526877471|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
146097107|NCT00371826|526877469|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
146097108|NCT00371826|526877470|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
146097109|NCT00371826|526877471|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
146097110|NCT00371826|526877469|FG000|Extension Phase (24 Months)|Administrative problems|0|||
146097111|NCT00371826|526877470|FG001|Extension Phase (24 Months)|Administrative problems|0|||
146097112|NCT00371826|526877471|FG002|Extension Phase (24 Months)|Administrative problems|2|||
146097113|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Death|1|||
146097114|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Death|1|||
146097115|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Death|0|||
146097116|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Death|0|||
146097117|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
146097118|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146097119|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146097120|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
146097121|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
146097122|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
146097123|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
146097124|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
146097125|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
146097126|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
146097127|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
146097128|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
146097129|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
146097130|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
146097131|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
146097132|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
146097133|NCT04612790|526877477|FG000|DB Period (Up to 36 Weeks)|Other|1|||
146097134|NCT04612790|526877478|FG001|DB Period (Up to 36 Weeks)|Other|0|||
146097135|NCT04612790|526877479|FG002|DB Period (Up to 36 Weeks)|Other|0|||
146097136|NCT04612790|526877480|FG003|DB Period (Up to 36 Weeks)|Other|0|||
146097137|NCT04612790|526877477|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146097138|NCT04612790|526877478|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146097139|NCT04612790|526877479|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
146097140|NCT04612790|526877480|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
146097141|NCT04612790|526877477|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
146097142|NCT04612790|526877478|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
146097143|NCT04612790|526877479|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
146097144|NCT04612790|526877480|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
146097145|NCT04612790|526877477|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
146097146|NCT04612790|526877478|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
146097147|NCT04612790|526877479|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
146097148|NCT04612790|526877480|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
146097149|NCT04612790|526877477|FG000|OLE Period (Up to 1 Year)|Other|0|||
146097150|NCT04612790|526877478|FG001|OLE Period (Up to 1 Year)|Other|0|||
146097151|NCT04612790|526877479|FG002|OLE Period (Up to 1 Year)|Other|0|||
146097152|NCT04612790|526877480|FG003|OLE Period (Up to 1 Year)|Other|1|||
146097153|NCT02497612|526877481|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
146097154|NCT02497612|526877482|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
146097155|NCT02497612|526877483|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
146097156|NCT02497612|526877484|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
146097157|NCT02497612|526877481|FG000|Overall Study|Participant's request|2|||
146097158|NCT02497612|526877482|FG001|Overall Study|Participant's request|3|||
146097159|NCT02497612|526877483|FG002|Overall Study|Participant's request|4|||
146097160|NCT02497612|526877484|FG003|Overall Study|Participant's request|1|||
146097161|NCT02497612|526877481|FG000|Overall Study|Investigator's judgement|1|||
146097162|NCT02497612|526877482|FG001|Overall Study|Investigator's judgement|0|||
146097163|NCT02497612|526877483|FG002|Overall Study|Investigator's judgement|0|||
146097164|NCT02497612|526877484|FG003|Overall Study|Investigator's judgement|2|||
146097165|NCT02497612|526877481|FG000|Overall Study|Adverse Event|3|||
146097166|NCT02497612|526877482|FG001|Overall Study|Adverse Event|1|||
146097167|NCT02497612|526877483|FG002|Overall Study|Adverse Event|4|||
146097168|NCT02497612|526877484|FG003|Overall Study|Adverse Event|1|||
146097169|NCT02497612|526877481|FG000|Overall Study|Lost to Follow-up|1|||
146097170|NCT02497612|526877482|FG001|Overall Study|Lost to Follow-up|1|||
146097171|NCT02497612|526877483|FG002|Overall Study|Lost to Follow-up|0|||
146097172|NCT02497612|526877484|FG003|Overall Study|Lost to Follow-up|1|||
146097173|NCT02497612|526877481|FG000|Overall Study|Other unspecified|1|||
146097174|NCT02497612|526877482|FG001|Overall Study|Other unspecified|1|||
146097175|NCT02497612|526877483|FG002|Overall Study|Other unspecified|2|||
146097176|NCT02497612|526877484|FG003|Overall Study|Other unspecified|0|||
146097177|NCT02497612|526877481|FG000|Overall Study|Not eligible|1|||
146097178|NCT02497612|526877482|FG001|Overall Study|Not eligible|0|||
146097179|NCT02497612|526877483|FG002|Overall Study|Not eligible|0|||
146097180|NCT02497612|526877484|FG003|Overall Study|Not eligible|1|||
146097181|NCT00629772|526877487|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
146097182|NCT00629772|526877488|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
146097183|NCT00629772|526877487|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
146097184|NCT00629772|526877488|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
146097185|NCT01495975|526877489|FG000|Overall Study|Lost to Follow-up|1|||
146097186|NCT01495975|526877490|FG001|Overall Study|Lost to Follow-up|0|||
146097187|NCT01254292|526877492|FG000|Comparative Phase|Adverse Event|25|||
146097188|NCT01254292|526877493|FG001|Comparative Phase|Adverse Event|25|||
146097189|NCT01254292|526877492|FG000|Comparative Phase|Lost to Follow-up|3|||
146097190|NCT01254292|526877493|FG001|Comparative Phase|Lost to Follow-up|21|||
146097191|NCT01254292|526877492|FG000|Comparative Phase|Pregnancy|2|||
146097192|NCT01254292|526877493|FG001|Comparative Phase|Pregnancy|6|||
146097193|NCT01254292|526877492|FG000|Comparative Phase|Withdrawal by Subject|20|||
146097194|NCT01254292|526877493|FG001|Comparative Phase|Withdrawal by Subject|21|||
146097195|NCT01254292|526877492|FG000|Comparative Phase|Protocol Violation|1|||
146097196|NCT01254292|526877493|FG001|Comparative Phase|Protocol Violation|2|||
146097197|NCT01254292|526877492|FG000|Comparative Phase|Wish for pregnancy|4|||
146097198|NCT01254292|526877493|FG001|Comparative Phase|Wish for pregnancy|6|||
146097199|NCT01254292|526877492|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
146097200|NCT01254292|526877493|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
146097201|NCT01254292|526877492|FG000|LCS12 Extension Phase|Adverse Event|9|||
146097202|NCT01254292|526877493|FG001|LCS12 Extension Phase|Adverse Event|0|||
146097203|NCT01254292|526877492|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
146097204|NCT01254292|526877493|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
146097205|NCT01254292|526877492|FG000|LCS12 Extension Phase|Other unknown|4|||
146097206|NCT01254292|526877493|FG001|LCS12 Extension Phase|Other unknown|0|||
146097207|NCT01254292|526877492|FG000|LCS12 Extension Phase|Pregnancy|2|||
146097208|NCT01254292|526877493|FG001|LCS12 Extension Phase|Pregnancy|0|||
146097209|NCT01254292|526877492|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
146097210|NCT01254292|526877493|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
146097211|NCT01484132|526877494|FG000|Overall Study|Lost to Follow-up|8|||
146097212|NCT01484132|526877494|FG000|Overall Study|Difficulty with time commitment|2|||
146097213|NCT01484132|526877494|FG000|Overall Study|Ineligible|1|||
146097214|NCT01484132|526877494|FG000|Overall Study|No pre-treatment urine sample collected|1|||
146097215|NCT01484132|526877494|FG000|Overall Study|No post-treatment urine sample collected|10|||
146097216|NCT01697358|526877497|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
146097217|NCT01697358|526877498|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
146300363|NCT02966223|527615235|FG000|Overall Study|Lost to Follow-up|1|||
146097218|NCT01697358|526877497|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
146097219|NCT01697358|526877498|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
146097220|NCT01697358|526877497|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
146097221|NCT01697358|526877498|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
146097222|NCT01697358|526877497|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
146097223|NCT01697358|526877498|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
146097224|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
146097225|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
146097226|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
146300364|NCT01184053|527615236|FG000|Overall Study|progression while on treatment|3|||
146097227|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
146097228|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
146097229|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
146097230|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
146097231|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
146097232|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
146097233|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
146097234|NCT01697358|526877497|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
146097235|NCT01697358|526877498|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
146097236|NCT05055128|526877499|FG000|Overall Study|Adverse Event|0|||
146097237|NCT05055128|526877500|FG001|Overall Study|Adverse Event|0|||
146097238|NCT05055128|526877501|FG002|Overall Study|Adverse Event|0|||
146097239|NCT05055128|526877502|FG003|Overall Study|Adverse Event|1|||
146097240|NCT05055128|526877503|FG004|Overall Study|Adverse Event|1|||
146097241|NCT05055128|526877499|FG000|Overall Study|Protocol Violation|0|||
146097242|NCT05055128|526877500|FG001|Overall Study|Protocol Violation|0|||
146097243|NCT05055128|526877501|FG002|Overall Study|Protocol Violation|0|||
146097244|NCT05055128|526877502|FG003|Overall Study|Protocol Violation|1|||
146097245|NCT05055128|526877503|FG004|Overall Study|Protocol Violation|0|||
146097246|NCT05055128|526877499|FG000|Overall Study|Withdrawal by Subject|5|||
146097247|NCT05055128|526877500|FG001|Overall Study|Withdrawal by Subject|2|||
146097248|NCT05055128|526877501|FG002|Overall Study|Withdrawal by Subject|2|||
146097249|NCT05055128|526877502|FG003|Overall Study|Withdrawal by Subject|4|||
146097250|NCT05055128|526877503|FG004|Overall Study|Withdrawal by Subject|2|||
146097251|NCT05055128|526877499|FG000|Overall Study|Randomized By Mistake|0|||
146097252|NCT05055128|526877500|FG001|Overall Study|Randomized By Mistake|1|||
146097253|NCT05055128|526877501|FG002|Overall Study|Randomized By Mistake|0|||
146097254|NCT05055128|526877502|FG003|Overall Study|Randomized By Mistake|0|||
146097255|NCT05055128|526877503|FG004|Overall Study|Randomized By Mistake|0|||
146097256|NCT05055128|526877499|FG000|Overall Study|Other|1|||
146097257|NCT05055128|526877500|FG001|Overall Study|Other|0|||
146097258|NCT05055128|526877501|FG002|Overall Study|Other|0|||
146097259|NCT05055128|526877502|FG003|Overall Study|Other|0|||
146097260|NCT05055128|526877503|FG004|Overall Study|Other|0|||
146097261|NCT00936611|526877510|FG000|Overall Study|Progressive Disease|3|||
146097262|NCT00936611|526877510|FG000|Overall Study|New Systemic Therapy|22|||
146097263|NCT00936611|526877510|FG000|Overall Study|Lost to Follow-up|1|||
146097264|NCT00936611|526877510|FG000|Overall Study|Withdrawal by Subject|2|||
146097265|NCT00936611|526877510|FG000|Overall Study|Still on Follow-up|1|||
146097266|NCT00936611|526877510|FG000|Overall Study|Still on Active Therapy|7|||
146097267|NCT00936611|526877510|FG000|Overall Study|Ineligible for Study Drug|3|||
146097268|NCT01822496|526877514|FG000|Overall Study|Protocol Violation|2|||
146097269|NCT01822496|526877515|FG001|Overall Study|Protocol Violation|2|||
146097270|NCT01822496|526877516|FG002|Overall Study|Protocol Violation|0|||
146097271|NCT01822496|526877517|FG003|Overall Study|Protocol Violation|1|||
146097272|NCT01822496|526877514|FG000|Overall Study|Withdrawal by Subject|0|||
146097273|NCT01822496|526877515|FG001|Overall Study|Withdrawal by Subject|0|||
146097274|NCT01822496|526877516|FG002|Overall Study|Withdrawal by Subject|0|||
146031839|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
146031840|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
146031841|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146031842|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146031843|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
146031844|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
146031845|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
146031846|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
146031847|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
146031848|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
146031849|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
146031850|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
146031851|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
146097275|NCT01822496|526877517|FG003|Overall Study|Withdrawal by Subject|3|||
146254253|NCT04908800|527443106|FG009|Overall Study|Adverse Event|0|||
146254254|NCT04908800|527443107|FG010|Overall Study|Adverse Event|1|||
146031852|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
146031853|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
146031854|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
146097276|NCT03841448|526877520|FG000|Double-blind Treatment (DBT) Period|Death|1|||
146097277|NCT03841448|526877521|FG001|Double-blind Treatment (DBT) Period|Death|1|||
146254255|NCT04908800|527443108|FG011|Overall Study|Adverse Event|0|||
146097278|NCT03841448|526877522|FG002|Double-blind Treatment (DBT) Period|Death|0|||
146254256|NCT04908800|527443109|FG012|Overall Study|Adverse Event|0|||
146097279|NCT03841448|526877523|FG003|Double-blind Treatment (DBT) Period|Death|0|||
146097280|NCT03841448|526877520|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
146031855|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
146031856|NCT01672866|526630278|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
146031857|NCT01672866|526630279|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
146031858|NCT01672866|526630280|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
146031859|NCT01672866|526630278|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
146031860|NCT01672866|526630279|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
146031861|NCT01672866|526630280|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
146031862|NCT01672866|526630278|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
146031863|NCT01672866|526630279|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
146031864|NCT01672866|526630280|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
146031865|NCT01672866|526630278|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
146031866|NCT01672866|526630279|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
146097281|NCT03841448|526877521|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
146097282|NCT03841448|526877522|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
146097283|NCT03841448|526877523|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
146097284|NCT03841448|526877520|FG000|Open-Label Extension (OLE) Period|Death|0|||
146097285|NCT03841448|526877521|FG001|Open-Label Extension (OLE) Period|Death|0|||
146097286|NCT03841448|526877522|FG002|Open-Label Extension (OLE) Period|Death|0|||
146097287|NCT03841448|526877523|FG003|Open-Label Extension (OLE) Period|Death|1|||
146097288|NCT03841448|526877520|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
146097289|NCT03841448|526877521|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
146097290|NCT03841448|526877522|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
146097291|NCT03841448|526877523|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
146097292|NCT03841448|526877520|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
146097293|NCT03841448|526877521|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
146097294|NCT03841448|526877522|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
146097295|NCT03841448|526877523|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
146097296|NCT03841448|526877520|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
146097297|NCT03841448|526877521|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
146097298|NCT03841448|526877522|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
146097299|NCT03841448|526877523|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
146097300|NCT00543543|526877524|FG000|Base Study|Adverse Event|1|||
146097301|NCT00543543|526877525|FG001|Base Study|Adverse Event|11|||
146097302|NCT00543543|526877526|FG002|Base Study|Adverse Event|0|||
146097303|NCT00543543|526877527|FG003|Base Study|Adverse Event|5|||
146097304|NCT00543543|526877524|FG000|Base Study|Lost to Follow-up|12|||
146097305|NCT00543543|526877525|FG001|Base Study|Lost to Follow-up|749|||
146097306|NCT00543543|526877526|FG002|Base Study|Lost to Follow-up|9|||
146097307|NCT00543543|526877527|FG003|Base Study|Lost to Follow-up|701|||
146097308|NCT00543543|526877524|FG000|Base Study|Physician Decision|0|||
146097309|NCT00543543|526877525|FG001|Base Study|Physician Decision|4|||
146097310|NCT00543543|526877526|FG002|Base Study|Physician Decision|0|||
146097311|NCT00543543|526877527|FG003|Base Study|Physician Decision|7|||
146097312|NCT00543543|526877524|FG000|Base Study|Protocol Violation|0|||
146097313|NCT00543543|526877525|FG001|Base Study|Protocol Violation|6|||
146097314|NCT00543543|526877526|FG002|Base Study|Protocol Violation|0|||
146097315|NCT00543543|526877527|FG003|Base Study|Protocol Violation|6|||
146097316|NCT00543543|526877524|FG000|Base Study|Withdrawal by Subject|7|||
146097317|NCT00543543|526877525|FG001|Base Study|Withdrawal by Subject|482|||
146097318|NCT00543543|526877526|FG002|Base Study|Withdrawal by Subject|5|||
146097319|NCT00543543|526877527|FG003|Base Study|Withdrawal by Subject|503|||
146097320|NCT00543543|526877524|FG000|Extension Study|Adverse Event|0|||
146097321|NCT00543543|526877525|FG001|Extension Study|Adverse Event|0|||
146097322|NCT00543543|526877526|FG002|Extension Study|Adverse Event|0|||
146097323|NCT00543543|526877527|FG003|Extension Study|Adverse Event|5|||
146097324|NCT00543543|526877524|FG000|Extension Study|Lost to Follow-up|0|||
146097325|NCT00543543|526877525|FG001|Extension Study|Lost to Follow-up|0|||
146097326|NCT00543543|526877526|FG002|Extension Study|Lost to Follow-up|0|||
146097327|NCT00543543|526877527|FG003|Extension Study|Lost to Follow-up|77|||
146300365|NCT03785678|527615237|FG000|Overall Study|Death|44|||
146300366|NCT03785678|527615238|FG001|Overall Study|Death|42|||
146031867|NCT01672866|526630280|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
146031868|NCT01672866|526630278|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
146031869|NCT01672866|526630279|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
146031870|NCT01672866|526630280|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
146300367|NCT03785678|527615237|FG000|Overall Study|Lost to Follow-up|4|||
146097328|NCT00543543|526877524|FG000|Extension Study|Physician Decision|0|||
146097329|NCT00543543|526877525|FG001|Extension Study|Physician Decision|0|||
146097330|NCT00543543|526877526|FG002|Extension Study|Physician Decision|0|||
146097331|NCT00543543|526877527|FG003|Extension Study|Physician Decision|7|||
146097332|NCT00543543|526877524|FG000|Extension Study|Pregnancy|0|||
146097333|NCT00543543|526877525|FG001|Extension Study|Pregnancy|0|||
146300368|NCT03785678|527615238|FG001|Overall Study|Lost to Follow-up|2|||
146097334|NCT00543543|526877526|FG002|Extension Study|Pregnancy|0|||
146097335|NCT00543543|526877527|FG003|Extension Study|Pregnancy|6|||
146097336|NCT00543543|526877524|FG000|Extension Study|Protocol Violation|0|||
146097337|NCT00543543|526877525|FG001|Extension Study|Protocol Violation|0|||
146097338|NCT00543543|526877526|FG002|Extension Study|Protocol Violation|0|||
146097339|NCT00543543|526877527|FG003|Extension Study|Protocol Violation|11|||
146097340|NCT00543543|526877524|FG000|Extension Study|Withdrawal by Subject|0|||
146097341|NCT00543543|526877525|FG001|Extension Study|Withdrawal by Subject|0|||
146097342|NCT00543543|526877526|FG002|Extension Study|Withdrawal by Subject|0|||
146097343|NCT00543543|526877527|FG003|Extension Study|Withdrawal by Subject|120|||
146097344|NCT04308304|526877528|FG000|Overall Study|Withdrawal by Subject|4|||
146097345|NCT04308304|526877529|FG001|Overall Study|Withdrawal by Subject|0|||
146097346|NCT04308304|526877528|FG000|Overall Study|Protocol Violation|1|||
146097347|NCT04308304|526877529|FG001|Overall Study|Protocol Violation|0|||
146097348|NCT00945555|526877530|FG000|Overall Study|Referred to another hospital|5|||
146097349|NCT00945555|526877530|FG000|Overall Study|Worsening condition, intensive care unit|1|||
146097350|NCT00945555|526877530|FG000|Overall Study|Withdrawal by Subject|2|||
146097351|NCT00945555|526877530|FG000|Overall Study|Participant continued treatment at home|1|||
146097352|NCT00945555|526877530|FG000|Overall Study|Death|18|||
146097353|NCT00945555|526877530|FG000|Overall Study|Other|1|||
146097354|NCT04502979|526877532|FG000|Overall Study|Lost to Follow-up|1|||
146097355|NCT04502979|526877533|FG001|Overall Study|Lost to Follow-up|3|||
146097356|NCT04502979|526877532|FG000|Overall Study|Withdrawal by Subject|2|||
146097357|NCT04502979|526877533|FG001|Overall Study|Withdrawal by Subject|1|||
146097358|NCT00165984|526877538|FG000|Overall Study|Death|15|||
146097359|NCT03945266|526877539|FG000|Overall Study|Withdrawal by Subject|1|||
146097360|NCT03945266|526877540|FG001|Overall Study|Withdrawal by Subject|0|||
146097361|NCT03945266|526877539|FG000|Overall Study|Miscarriage|0|||
146097362|NCT03945266|526877540|FG001|Overall Study|Miscarriage|2|||
146097363|NCT03945266|526877539|FG000|Overall Study|Lost to Follow-up|1|||
146097364|NCT03945266|526877540|FG001|Overall Study|Lost to Follow-up|0|||
146097365|NCT01686828|526877541|FG000|Overall Study|Physician Decision|1|||
146097366|NCT01686828|526877542|FG001|Overall Study|Physician Decision|0|||
146097367|NCT01686828|526877543|FG002|Overall Study|Physician Decision|0|||
146097368|NCT01686828|526877544|FG003|Overall Study|Physician Decision|0|||
146097369|NCT01686828|526877541|FG000|Overall Study|New Job|0|||
146097370|NCT01686828|526877542|FG001|Overall Study|New Job|1|||
146097371|NCT01686828|526877543|FG002|Overall Study|New Job|0|||
146097372|NCT01686828|526877544|FG003|Overall Study|New Job|0|||
146097373|NCT01686828|526877541|FG000|Overall Study|Weight Loss|0|||
146097374|NCT01686828|526877542|FG001|Overall Study|Weight Loss|0|||
146097375|NCT01686828|526877543|FG002|Overall Study|Weight Loss|1|||
146097376|NCT01686828|526877544|FG003|Overall Study|Weight Loss|0|||
146097377|NCT01736124|526877547|FG000|Post-intervention Assessment|Death|2|||
146097378|NCT01736124|526877548|FG001|Post-intervention Assessment|Death|2|||
146097379|NCT01736124|526877547|FG000|Post-intervention Assessment|lost computer access|1|||
146300369|NCT03785678|527615237|FG000|Overall Study|Physician Decision|0|||
146300370|NCT03785678|527615238|FG001|Overall Study|Physician Decision|2|||
146300371|NCT03785678|527615237|FG000|Overall Study|Withdrawal by Subject|5|||
146300372|NCT03785678|527615238|FG001|Overall Study|Withdrawal by Subject|3|||
146300373|NCT00705432|527615242|FG000|Treatment Period|Adverse Event|45|||
146300374|NCT00705432|527615243|FG001|Treatment Period|Adverse Event|37|||
146300375|NCT00705432|527615244|FG002|Treatment Period|Adverse Event|51|||
146300376|NCT00705432|527615245|FG003|Treatment Period|Adverse Event|12|||
146300377|NCT00705432|527615246|FG004|Treatment Period|Adverse Event|8|||
146300378|NCT00705432|527615247|FG005|Treatment Period|Adverse Event|9|||
146300379|NCT00705432|527615242|FG000|Treatment Period|Treatment failure|92|||
146300380|NCT00705432|527615243|FG001|Treatment Period|Treatment failure|42|||
146300381|NCT00705432|527615244|FG002|Treatment Period|Treatment failure|33|||
146300382|NCT00705432|527615245|FG003|Treatment Period|Treatment failure|25|||
146300383|NCT00705432|527615246|FG004|Treatment Period|Treatment failure|13|||
146300384|NCT00705432|527615247|FG005|Treatment Period|Treatment failure|14|||
146300385|NCT00705432|527615242|FG000|Treatment Period|Non medical reason|26|||
146097380|NCT01736124|526877548|FG001|Post-intervention Assessment|lost computer access|1|||
146097381|NCT01736124|526877547|FG000|Post-intervention Assessment|Moved away|3|||
146097382|NCT01736124|526877548|FG001|Post-intervention Assessment|Moved away|1|||
146097383|NCT01736124|526877547|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
146097384|NCT01736124|526877548|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
146097385|NCT01736124|526877547|FG000|Post-intervention Assessment|Illness|3|||
146097386|NCT01736124|526877548|FG001|Post-intervention Assessment|Illness|2|||
146097387|NCT01736124|526877547|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
146300386|NCT00705432|527615243|FG001|Treatment Period|Non medical reason|32|||
146097388|NCT01736124|526877548|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
146097389|NCT01736124|526877547|FG000|Post-intervention Assessment|Temporarily away|3|||
146097390|NCT01736124|526877548|FG001|Post-intervention Assessment|Temporarily away|1|||
146097391|NCT01736124|526877547|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
146097392|NCT01736124|526877548|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
146300387|NCT00705432|527615244|FG002|Treatment Period|Non medical reason|37|||
146031871|NCT01012323|526630284|FG000|Overall Study|Investigator Judgment|1|||
146031872|NCT02273960|526630285|FG000|Short Term Period|Lost to Follow-up|1|||
146031873|NCT02273960|526630286|FG001|Short Term Period|Lost to Follow-up|0|||
146031874|NCT02273960|526630287|FG002|Short Term Period|Lost to Follow-up|0|||
146031875|NCT02273960|526630288|FG003|Short Term Period|Lost to Follow-up|0|||
146031876|NCT02273960|526630285|FG000|Short Term Period|Lack of Efficacy|0|||
146031877|NCT02273960|526630286|FG001|Short Term Period|Lack of Efficacy|0|||
146031878|NCT02273960|526630287|FG002|Short Term Period|Lack of Efficacy|0|||
146031879|NCT02273960|526630288|FG003|Short Term Period|Lack of Efficacy|1|||
146031880|NCT02273960|526630285|FG000|Short Term Period|ST complete, not entering LTE|4|||
146031881|NCT02273960|526630286|FG001|Short Term Period|ST complete, not entering LTE|6|||
146031882|NCT02273960|526630287|FG002|Short Term Period|ST complete, not entering LTE|4|||
146031883|NCT02273960|526630288|FG003|Short Term Period|ST complete, not entering LTE|5|||
146031884|NCT02273960|526630285|FG000|Long Term Extension|Death|0|||
146031885|NCT02273960|526630286|FG001|Long Term Extension|Death|0|||
146031886|NCT02273960|526630287|FG002|Long Term Extension|Death|0|||
146031887|NCT02273960|526630288|FG003|Long Term Extension|Death|1|||
146031888|NCT01789606|526630289|FG000|Overall Study|Participant not Purchased the Product|0|||
146031889|NCT01789606|526630290|FG001|Overall Study|Participant not Purchased the Product|20|||
146031890|NCT01789606|526630289|FG000|Overall Study|Withdrawal by Subject|0|||
146031891|NCT01789606|526630290|FG001|Overall Study|Withdrawal by Subject|1|||
146031892|NCT01789606|526630289|FG000|Overall Study|Ineligible|6|||
146031893|NCT01789606|526630290|FG001|Overall Study|Ineligible|2|||
146031894|NCT01789606|526630289|FG000|Overall Study|Administrative Reasons|17|||
146031895|NCT01789606|526630290|FG001|Overall Study|Administrative Reasons|6|||
146031896|NCT01789606|526630289|FG000|Overall Study|No Study Medication Taken|0|||
146031897|NCT01789606|526630290|FG001|Overall Study|No Study Medication Taken|1|||
146031898|NCT01789606|526630289|FG000|Overall Study|Protocol Violation|0|||
146031899|NCT01789606|526630290|FG001|Overall Study|Protocol Violation|55|||
146031900|NCT01789606|526630289|FG000|Overall Study|Adverse Event|0|||
146031901|NCT01789606|526630290|FG001|Overall Study|Adverse Event|3|||
146031902|NCT01789606|526630289|FG000|Overall Study|Lost to Follow-up|0|||
146031903|NCT01789606|526630290|FG001|Overall Study|Lost to Follow-up|14|||
146031904|NCT01789606|526630289|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
146031905|NCT01789606|526630290|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
146031906|NCT01105377|526630296|FG000|Overall Study|Withdrawal by Subject|0|||
146031907|NCT01105377|526630297|FG001|Overall Study|Withdrawal by Subject|1|||
146031908|NCT01825941|526631746|FG000|Overall Study|Lost to Follow-up|4|||
146031909|NCT01825941|526631747|FG001|Overall Study|Lost to Follow-up|1|||
146031910|NCT03495102|526631748|FG000|Overall Study|Adverse Event|5|||
146031911|NCT03495102|526631749|FG001|Overall Study|Adverse Event|7|||
146031912|NCT03495102|526631750|FG002|Overall Study|Adverse Event|10|||
146031913|NCT03495102|526631748|FG000|Overall Study|Death|3|||
146031914|NCT03495102|526631749|FG001|Overall Study|Death|4|||
146031915|NCT03495102|526631750|FG002|Overall Study|Death|4|||
146031916|NCT03495102|526631748|FG000|Overall Study|Lost to Follow-up|15|||
146031917|NCT03495102|526631749|FG001|Overall Study|Lost to Follow-up|16|||
146031918|NCT03495102|526631750|FG002|Overall Study|Lost to Follow-up|17|||
146031919|NCT03495102|526631748|FG000|Overall Study|Physician Decision|2|||
146031920|NCT03495102|526631749|FG001|Overall Study|Physician Decision|0|||
146031921|NCT03495102|526631750|FG002|Overall Study|Physician Decision|2|||
146031922|NCT03495102|526631748|FG000|Overall Study|Withdrawal by Subject|25|||
146031923|NCT03495102|526631749|FG001|Overall Study|Withdrawal by Subject|36|||
146031924|NCT03495102|526631750|FG002|Overall Study|Withdrawal by Subject|18|||
146031925|NCT03495102|526631748|FG000|Overall Study|Protocol Violation|1|||
146031926|NCT03495102|526631749|FG001|Overall Study|Protocol Violation|1|||
146031927|NCT03495102|526631750|FG002|Overall Study|Protocol Violation|0|||
146031928|NCT03495102|526631748|FG000|Overall Study|Site Closure|3|||
146031929|NCT03495102|526631749|FG001|Overall Study|Site Closure|1|||
146031930|NCT03495102|526631750|FG002|Overall Study|Site Closure|2|||
146031931|NCT03495102|526631748|FG000|Overall Study|Non-compliance|1|||
146031932|NCT03495102|526631749|FG001|Overall Study|Non-compliance|0|||
146031933|NCT03495102|526631750|FG002|Overall Study|Non-compliance|0|||
146031934|NCT03495102|526631748|FG000|Overall Study|Participant Duplicated at Another Site|0|||
146031935|NCT03495102|526631749|FG001|Overall Study|Participant Duplicated at Another Site|0|||
146031936|NCT03495102|526631750|FG002|Overall Study|Participant Duplicated at Another Site|1|||
146031937|NCT03495102|526631748|FG000|Overall Study|Primary Care Physician Recommendation|0|||
146031938|NCT03495102|526631749|FG001|Overall Study|Primary Care Physician Recommendation|1|||
146031939|NCT03495102|526631750|FG002|Overall Study|Primary Care Physician Recommendation|0|||
146031940|NCT03495102|526631748|FG000|Overall Study|Relocated to Another Country|0|||
146097393|NCT01736124|526877547|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
146031941|NCT03495102|526631749|FG001|Overall Study|Relocated to Another Country|1|||
146031942|NCT03495102|526631750|FG002|Overall Study|Relocated to Another Country|0|||
146031943|NCT03495102|526631748|FG000|Overall Study|Participant was in Rehabilitation|1|||
146097394|NCT01736124|526877548|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
146031944|NCT03495102|526631749|FG001|Overall Study|Participant was in Rehabilitation|0|||
146031945|NCT03495102|526631750|FG002|Overall Study|Participant was in Rehabilitation|0|||
146031946|NCT01161537|526631751|FG000|Part B|Withdrawal by Subject|2|||
146031947|NCT00358436|526631754|FG000|Overall Study|Adverse Event|29|||
146031948|NCT00358436|526631755|FG001|Overall Study|Adverse Event|13|||
146031949|NCT00358436|526631754|FG000|Overall Study|Lack of Efficacy|34|||
146031950|NCT00358436|526631755|FG001|Overall Study|Lack of Efficacy|36|||
146031951|NCT00358436|526631754|FG000|Overall Study|Lost to Follow-up|11|||
146031952|NCT00358436|526631755|FG001|Overall Study|Lost to Follow-up|6|||
146031953|NCT00358436|526631754|FG000|Overall Study|Protocol Violation|8|||
146031954|NCT00358436|526631755|FG001|Overall Study|Protocol Violation|3|||
146031955|NCT00358436|526631754|FG000|Overall Study|Withdrawal by Subject|40|||
146031956|NCT00358436|526631755|FG001|Overall Study|Withdrawal by Subject|17|||
146031957|NCT00358436|526631754|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
146031958|NCT00358436|526631755|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
146031959|NCT00358436|526631754|FG000|Overall Study|COPD exacerbation|22|||
146031960|NCT00358436|526631755|FG001|Overall Study|COPD exacerbation|10|||
146031961|NCT00358436|526631754|FG000|Overall Study|Other|6|||
146031962|NCT00358436|526631755|FG001|Overall Study|Other|1|||
146031963|NCT03938324|526631757|FG000|Overall Study|Lost to Follow-up|42|||
146031964|NCT03938324|526631758|FG001|Overall Study|Lost to Follow-up|21|||
146031965|NCT03938324|526631757|FG000|Overall Study|Withdrawal by Subject|6|||
146031966|NCT03938324|526631758|FG001|Overall Study|Withdrawal by Subject|1|||
146031967|NCT01300351|526631763|FG000|Overall Study|Did not receive treatment|2|||
146031968|NCT01300351|526631764|FG001|Overall Study|Did not receive treatment|0|||
146031969|NCT01300351|526631763|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
146031970|NCT01300351|526631764|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
146031971|NCT01300351|526631763|FG000|Overall Study|Lost to Follow-up|0|||
146031972|NCT01300351|526631764|FG001|Overall Study|Lost to Follow-up|1|||
146031973|NCT01300351|526631763|FG000|Overall Study|Adverse Event|0|||
146031974|NCT01300351|526631764|FG001|Overall Study|Adverse Event|4|||
146031975|NCT01300351|526631763|FG000|Overall Study|Withdrawal by Subject|7|||
146031976|NCT01300351|526631764|FG001|Overall Study|Withdrawal by Subject|10|||
146031977|NCT02258529|526631768|FG000|Overall Study|Study Terminated by Sponsor|9|||
146031978|NCT02258529|526631768|FG000|Overall Study|Adverse Event|1|||
146031979|NCT00443781|526631769|FG000|Overall Study|Lost to Follow-up|10|||
146031980|NCT00443781|526631769|FG000|Overall Study|Physician Decision|2|||
146031981|NCT00443781|526631769|FG000|Overall Study|Protocol Violation|1|||
146031982|NCT00443781|526631769|FG000|Overall Study|Withdrawal by Subject|6|||
146031983|NCT00443781|526631769|FG000|Overall Study|Unable to comply with study follow up|2|||
146031984|NCT00443781|526631769|FG000|Overall Study|Investigator terminated participation|1|||
146031985|NCT00443781|526631769|FG000|Overall Study|Insurance not covered|2|||
146031986|NCT00443781|526631769|FG000|Overall Study|PD/FAD not done|1|||
146031987|NCT00430937|526631770|FG000|Overall Study|Adverse Event|3|||
146031988|NCT00430937|526631771|FG001|Overall Study|Adverse Event|8|||
146031989|NCT00430937|526631770|FG000|Overall Study|Death|0|||
146031990|NCT00430937|526631771|FG001|Overall Study|Death|1|||
146031991|NCT00430937|526631770|FG000|Overall Study|Lost to Follow-up|6|||
146031992|NCT00430937|526631771|FG001|Overall Study|Lost to Follow-up|6|||
146031993|NCT00430937|526631770|FG000|Overall Study|Withdrawal by Subject|5|||
146031994|NCT00430937|526631771|FG001|Overall Study|Withdrawal by Subject|2|||
146031995|NCT00430937|526631770|FG000|Overall Study|Protocol Violation|3|||
146031996|NCT00430937|526631771|FG001|Overall Study|Protocol Violation|2|||
146031997|NCT00430937|526631770|FG000|Overall Study|Lack of Efficacy|6|||
146031998|NCT00430937|526631771|FG001|Overall Study|Lack of Efficacy|5|||
146031999|NCT00430937|526631770|FG000|Overall Study|Inappropriate enrollment|2|||
146032000|NCT00430937|526631771|FG001|Overall Study|Inappropriate enrollment|1|||
146032001|NCT00430937|526631770|FG000|Overall Study|Administrative reasons|1|||
146032002|NCT00430937|526631771|FG001|Overall Study|Administrative reasons|0|||
146032003|NCT00430937|526631770|FG000|Overall Study|Protocol discontinuation criteria met|1|||
146032004|NCT00430937|526631771|FG001|Overall Study|Protocol discontinuation criteria met|2|||
146032005|NCT00430937|526631770|FG000|Overall Study|Unable to classify|0|||
146032006|NCT00430937|526631771|FG001|Overall Study|Unable to classify|1|||
146032007|NCT02634606|526631772|FG000|Overall Study|unable to obtain the drug at start|13|||
146032008|NCT00353873|526631776|FG000|Overall Study|Protocol Violation|1|||
146032009|NCT00353873|526631777|FG001|Overall Study|Protocol Violation|2|||
146032010|NCT00353873|526631776|FG000|Overall Study|Exacerbation|1|||
146300388|NCT00705432|527615245|FG003|Treatment Period|Non medical reason|4|||
146032011|NCT00353873|526631777|FG001|Overall Study|Exacerbation|0|||
146032012|NCT00353873|526631776|FG000|Overall Study|Adverse Event|1|||
146032013|NCT00353873|526631777|FG001|Overall Study|Adverse Event|0|||
146032014|NCT00353873|526631776|FG000|Overall Study|Physician Decision|2|||
146032015|NCT00353873|526631777|FG001|Overall Study|Physician Decision|0|||
146032016|NCT00353873|526631776|FG000|Overall Study|Withdrawal by Subject|1|||
146032017|NCT00353873|526631777|FG001|Overall Study|Withdrawal by Subject|1|||
146032018|NCT03743064|526631778|FG000|Overall Study|Adverse Event|7|||
146032019|NCT03743064|526631779|FG001|Overall Study|Adverse Event|9|||
146032020|NCT03743064|526631778|FG000|Overall Study|Death|25|||
146032021|NCT03743064|526631779|FG001|Overall Study|Death|28|||
146032022|NCT03743064|526631778|FG000|Overall Study|Lost to Follow-up|3|||
146032023|NCT03743064|526631779|FG001|Overall Study|Lost to Follow-up|6|||
146032024|NCT03743064|526631778|FG000|Overall Study|Withdrawal by Subject|28|||
146032025|NCT03743064|526631779|FG001|Overall Study|Withdrawal by Subject|25|||
146032026|NCT03743064|526631778|FG000|Overall Study|Physician Decision|2|||
146032027|NCT03743064|526631779|FG001|Overall Study|Physician Decision|4|||
146032028|NCT03743064|526631778|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
146032029|NCT03743064|526631779|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
146032030|NCT00286221|526631780|FG000|Overall Study|Protocol Violation|2|||
146032031|NCT00286221|526631781|FG001|Overall Study|Protocol Violation|1|||
146032032|NCT00286221|526631782|FG002|Overall Study|Protocol Violation|6|||
146032033|NCT00286221|526631783|FG003|Overall Study|Protocol Violation|4|||
146032034|NCT00286221|526631780|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
146032035|NCT00286221|526631781|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
146032036|NCT00286221|526631782|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
146032037|NCT00286221|526631783|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
146032038|NCT00286221|526631780|FG000|Overall Study|Inability to trigger PCA|2|||
146032039|NCT00286221|526631781|FG001|Overall Study|Inability to trigger PCA|0|||
146032040|NCT00286221|526631782|FG002|Overall Study|Inability to trigger PCA|0|||
146032041|NCT00286221|526631783|FG003|Overall Study|Inability to trigger PCA|0|||
146032042|NCT00286221|526631780|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
146032043|NCT00286221|526631781|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
146032044|NCT00286221|526631782|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
146032045|NCT00286221|526631783|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
146032046|NCT02771626|526631787|FG000|Overall Study|Adverse Event|1|||
146032047|NCT02771626|526631788|FG001|Overall Study|Adverse Event|5|||
146032048|NCT02771626|526631789|FG002|Overall Study|Adverse Event|3|||
146032049|NCT02771626|526631790|FG003|Overall Study|Adverse Event|0|||
146032050|NCT02771626|526631791|FG004|Overall Study|Adverse Event|1|||
146032051|NCT02771626|526631792|FG005|Overall Study|Adverse Event|1|||
146032052|NCT02771626|526631787|FG000|Overall Study|Radiologic Disease Progression|6|||
146032053|NCT02771626|526631788|FG001|Overall Study|Radiologic Disease Progression|13|||
146032054|NCT02771626|526631789|FG002|Overall Study|Radiologic Disease Progression|10|||
146032055|NCT02771626|526631790|FG003|Overall Study|Radiologic Disease Progression|7|||
146032056|NCT02771626|526631791|FG004|Overall Study|Radiologic Disease Progression|28|||
146032057|NCT02771626|526631792|FG005|Overall Study|Radiologic Disease Progression|15|||
146032058|NCT02771626|526631787|FG000|Overall Study|Symptomatic Deterioration|0|||
146032059|NCT02771626|526631788|FG001|Overall Study|Symptomatic Deterioration|4|||
146032060|NCT02771626|526631789|FG002|Overall Study|Symptomatic Deterioration|2|||
146032061|NCT02771626|526631790|FG003|Overall Study|Symptomatic Deterioration|0|||
146032062|NCT02771626|526631791|FG004|Overall Study|Symptomatic Deterioration|5|||
146032063|NCT02771626|526631792|FG005|Overall Study|Symptomatic Deterioration|2|||
146032064|NCT02771626|526631787|FG000|Overall Study|Participant Request|0|||
146032065|NCT02771626|526631788|FG001|Overall Study|Participant Request|1|||
146032066|NCT02771626|526631789|FG002|Overall Study|Participant Request|0|||
146032067|NCT02771626|526631790|FG003|Overall Study|Participant Request|2|||
146032068|NCT02771626|526631791|FG004|Overall Study|Participant Request|0|||
146032069|NCT02771626|526631792|FG005|Overall Study|Participant Request|1|||
146032070|NCT02771626|526631787|FG000|Overall Study|Investigator Decision|0|||
146032071|NCT02771626|526631788|FG001|Overall Study|Investigator Decision|1|||
146032072|NCT02771626|526631789|FG002|Overall Study|Investigator Decision|0|||
146032073|NCT02771626|526631790|FG003|Overall Study|Investigator Decision|0|||
146032074|NCT02771626|526631791|FG004|Overall Study|Investigator Decision|1|||
146032075|NCT02771626|526631792|FG005|Overall Study|Investigator Decision|0|||
146032076|NCT02771626|526631787|FG000|Overall Study|Study Termination by Sponsor|0|||
146032077|NCT02771626|526631788|FG001|Overall Study|Study Termination by Sponsor|2|||
146032078|NCT02771626|526631789|FG002|Overall Study|Study Termination by Sponsor|1|||
146032079|NCT02771626|526631790|FG003|Overall Study|Study Termination by Sponsor|0|||
146032080|NCT02771626|526631791|FG004|Overall Study|Study Termination by Sponsor|1|||
146032081|NCT02771626|526631792|FG005|Overall Study|Study Termination by Sponsor|0|||
146032082|NCT02771626|526631787|FG000|Overall Study|Informed Consent Withdrawn|0|||
146032083|NCT02771626|526631788|FG001|Overall Study|Informed Consent Withdrawn|0|||
146032084|NCT02771626|526631789|FG002|Overall Study|Informed Consent Withdrawn|1|||
146032085|NCT02771626|526631790|FG003|Overall Study|Informed Consent Withdrawn|0|||
146032086|NCT02771626|526631791|FG004|Overall Study|Informed Consent Withdrawn|1|||
146032087|NCT02771626|526631792|FG005|Overall Study|Informed Consent Withdrawn|1|||
146032088|NCT02771626|526631787|FG000|Overall Study|Other, Not Specified|1|||
146032089|NCT02771626|526631788|FG001|Overall Study|Other, Not Specified|0|||
146032090|NCT02771626|526631789|FG002|Overall Study|Other, Not Specified|0|||
146032091|NCT02771626|526631790|FG003|Overall Study|Other, Not Specified|0|||
146032092|NCT02771626|526631791|FG004|Overall Study|Other, Not Specified|0|||
146032093|NCT02771626|526631792|FG005|Overall Study|Other, Not Specified|1|||
146032094|NCT02648217|526631795|FG000|Overall Study|Adverse Event|0|||
146032095|NCT02648217|526631796|FG001|Overall Study|Adverse Event|1|||
146032096|NCT02648217|526631795|FG000|Overall Study|Lost to Follow-up|1|||
146097395|NCT01736124|526877547|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
146097396|NCT01736124|526877548|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
146097397|NCT01736124|526877547|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
146097398|NCT01736124|526877548|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
146097399|NCT01736124|526877547|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
146097400|NCT01736124|526877548|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
146097401|NCT01736124|526877547|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
146097402|NCT01736124|526877548|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
146097403|NCT01736124|526877547|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
146097404|NCT01736124|526877548|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
146097405|NCT01736124|526877547|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
146097406|NCT01736124|526877548|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
146097407|NCT01736124|526877547|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
146097408|NCT01736124|526877548|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
146097409|NCT02734433|526877559|FG000|Overall Study|Disease progression|1|||
146097410|NCT02734433|526877560|FG001|Overall Study|Disease progression|5|||
146097411|NCT02734433|526877559|FG000|Overall Study|Clinical progression|0|||
146097412|NCT02734433|526877560|FG001|Overall Study|Clinical progression|1|||
146097413|NCT02734433|526877559|FG000|Overall Study|Withdrawal by Subject|1|||
146097414|NCT02734433|526877560|FG001|Overall Study|Withdrawal by Subject|2|||
146097415|NCT02628769|526877561|FG000|First Intervention|Adverse Event|1|||
146097416|NCT02628769|526877562|FG001|First Intervention|Adverse Event|0|||
146097417|NCT02628769|526877561|FG000|First Intervention|Withdrawal by Subject|0|||
146097418|NCT02628769|526877562|FG001|First Intervention|Withdrawal by Subject|1|||
146097419|NCT02628769|526877561|FG000|Second Intervention|Adverse Event|2|||
146097420|NCT02628769|526877562|FG001|Second Intervention|Adverse Event|0|||
146097421|NCT02628769|526877561|FG000|Second Intervention|Physician Decision|0|||
146097422|NCT02628769|526877562|FG001|Second Intervention|Physician Decision|1|||
146097423|NCT01066000|526877566|FG000|Overall Study|Protocol Violation|4|||
146097424|NCT01066000|526877566|FG000|Overall Study|Death|3|||
146097425|NCT01066000|526877566|FG000|Overall Study|Withdrawal by Subject|1|||
146097426|NCT01066000|526877566|FG000|Overall Study|Adverse Event|1|||
146097427|NCT03507400|526877567|FG000|Overall Study|discontinued|5|||
146097428|NCT03507400|526877568|FG001|Overall Study|discontinued|1|||
146097429|NCT03507400|526877567|FG000|Overall Study|Lost to Follow-up|8|||
146097430|NCT03507400|526877568|FG001|Overall Study|Lost to Follow-up|6|||
146097431|NCT03507400|526877567|FG000|Overall Study|Protocol Violation|0|||
146097432|NCT03507400|526877568|FG001|Overall Study|Protocol Violation|1|||
146097433|NCT03673046|526879150|FG000|Overall Study|Adverse Event|1|||
146097434|NCT03673046|526879151|FG001|Overall Study|Adverse Event|1|||
146097435|NCT03673046|526879150|FG000|Overall Study|Withdrawal by Subject|8|||
146097436|NCT03673046|526879151|FG001|Overall Study|Withdrawal by Subject|2|||
146097437|NCT03817879|526879152|FG000|Overall Study|Drop out|5|||
146097438|NCT03817879|526879153|FG001|Overall Study|Drop out|12|||
146097439|NCT03817879|526879152|FG000|Overall Study|Withdrawal by Subject|0|||
146097440|NCT03817879|526879153|FG001|Overall Study|Withdrawal by Subject|1|||
146097441|NCT00392015|526879156|FG000|Overall Study|Lost to Follow-up|2|||
146097442|NCT00392015|526879157|FG001|Overall Study|Lost to Follow-up|0|||
146097443|NCT00392015|526879158|FG002|Overall Study|Lost to Follow-up|2|||
146097444|NCT00392015|526879159|FG003|Overall Study|Lost to Follow-up|1|||
146097445|NCT00392015|526879160|FG004|Overall Study|Lost to Follow-up|1|||
146097446|NCT00392015|526879161|FG005|Overall Study|Lost to Follow-up|0|||
146097447|NCT00392015|526879156|FG000|Overall Study|Withdrawal by Subject|0|||
146097448|NCT00392015|526879157|FG001|Overall Study|Withdrawal by Subject|0|||
146097449|NCT00392015|526879158|FG002|Overall Study|Withdrawal by Subject|2|||
146097450|NCT00392015|526879159|FG003|Overall Study|Withdrawal by Subject|0|||
146097451|NCT00392015|526879160|FG004|Overall Study|Withdrawal by Subject|0|||
146097452|NCT00392015|526879161|FG005|Overall Study|Withdrawal by Subject|0|||
146097453|NCT00392015|526879156|FG000|Overall Study|Adverse Event|0|||
146097454|NCT00392015|526879157|FG001|Overall Study|Adverse Event|0|||
146097455|NCT00392015|526879158|FG002|Overall Study|Adverse Event|0|||
146097456|NCT00392015|526879159|FG003|Overall Study|Adverse Event|0|||
146097457|NCT00392015|526879160|FG004|Overall Study|Adverse Event|1|||
146097458|NCT00392015|526879161|FG005|Overall Study|Adverse Event|0|||
146097459|NCT00392015|526879156|FG000|Overall Study|Previous trial recipient|0|||
146097460|NCT00392015|526879157|FG001|Overall Study|Previous trial recipient|0|||
146097461|NCT00392015|526879158|FG002|Overall Study|Previous trial recipient|0|||
146097462|NCT00392015|526879159|FG003|Overall Study|Previous trial recipient|0|||
146097463|NCT00392015|526879160|FG004|Overall Study|Previous trial recipient|1|||
146097464|NCT00392015|526879161|FG005|Overall Study|Previous trial recipient|0|||
146254257|NCT00157209|527443110|FG000|Overall Study|Ongoing at data cut-off|10|||
146254258|NCT00157209|527443111|FG001|Overall Study|Ongoing at data cut-off|0|||
146254259|NCT04474691|527443112|FG000|Overall Study|Withdrawal by Subject|9|||
146254260|NCT01323309|527443113|FG000|Overall Study|Death|9|||
146097465|NCT00717093|526879163|FG000|Overall Study|Adverse Event|19|||
146097466|NCT00717093|526879164|FG001|Overall Study|Adverse Event|9|||
146097467|NCT00717093|526879163|FG000|Overall Study|Lack of Efficacy|3|||
146032097|NCT02648217|526631796|FG001|Overall Study|Lost to Follow-up|1|||
146032098|NCT02648217|526631795|FG000|Overall Study|Withdrawal by Subject|4|||
146032099|NCT02648217|526631796|FG001|Overall Study|Withdrawal by Subject|3|||
146032100|NCT02648217|526631795|FG000|Overall Study|Unclassified|5|||
146032101|NCT02648217|526631796|FG001|Overall Study|Unclassified|0|||
146032102|NCT02553538|526631797|FG000|Overall Study|Could Not Reach by Telephone|133|||
146032103|NCT02553538|526631798|FG001|Overall Study|Could Not Reach by Telephone|0|||
146032104|NCT02553538|526631797|FG000|Overall Study|Died or Left Network|54|||
146032105|NCT02553538|526631798|FG001|Overall Study|Died or Left Network|56|||
146032106|NCT04094584|526631799|FG000|Overall Study|No interest in study|88|||
146032107|NCT04094584|526631799|FG000|Overall Study|Unwilling to undergo screening tests|36|||
146032108|NCT04094584|526631799|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
146032109|NCT04094584|526631799|FG000|Overall Study|Opioid use|7|||
146032110|NCT04094584|526631799|FG000|Overall Study|Need for major surgery in study period|4|||
146032111|NCT04094584|526631799|FG000|Overall Study|eligible but declined enrollment|4|||
146032112|NCT04094584|526631799|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
146032113|NCT04094584|526631799|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
146032114|NCT04094584|526631799|FG000|Overall Study|Lost to Follow-up|3|||
146032115|NCT04094584|526631799|FG000|Overall Study|Withdrawal by Subject|2|||
146032116|NCT00106691|526631800|FG000|Overall Study|Adverse Event|60|||
146032117|NCT00106691|526631801|FG001|Overall Study|Adverse Event|64|||
146032118|NCT00106691|526631800|FG000|Overall Study|Lost to Follow-up|23|||
146032119|NCT00106691|526631801|FG001|Overall Study|Lost to Follow-up|18|||
146032120|NCT00106691|526631800|FG000|Overall Study|Physician Decision|18|||
146032121|NCT00106691|526631801|FG001|Overall Study|Physician Decision|21|||
146032122|NCT00106691|526631800|FG000|Overall Study|Protocol Violation|13|||
146032123|NCT00106691|526631801|FG001|Overall Study|Protocol Violation|18|||
146032124|NCT00106691|526631800|FG000|Overall Study|Withdrawal by Subject|75|||
146032125|NCT00106691|526631801|FG001|Overall Study|Withdrawal by Subject|70|||
146032126|NCT00106691|526631800|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
146032127|NCT00106691|526631801|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
146032128|NCT00106691|526631800|FG000|Overall Study|QTc>480|3|||
146032129|NCT00106691|526631801|FG001|Overall Study|QTc>480|1|||
146032130|NCT00106691|526631800|FG000|Overall Study|mililtary deployment|2|||
146032131|NCT00106691|526631801|FG001|Overall Study|mililtary deployment|0|||
146032132|NCT00106691|526631800|FG000|Overall Study|Study Site Closing/PI Moved|1|||
146032133|NCT00106691|526631801|FG001|Overall Study|Study Site Closing/PI Moved|2|||
146032134|NCT00106691|526631800|FG000|Overall Study|Cardiologist recommendation|1|||
146032135|NCT00106691|526631801|FG001|Overall Study|Cardiologist recommendation|0|||
146032136|NCT00106691|526631800|FG000|Overall Study|Pt. moved to another state|1|||
146032137|NCT00106691|526631801|FG001|Overall Study|Pt. moved to another state|0|||
146032138|NCT00106691|526631800|FG000|Overall Study|Taking exclusionary avodart|1|||
146032139|NCT00106691|526631801|FG001|Overall Study|Taking exclusionary avodart|0|||
146032140|NCT00106691|526631800|FG000|Overall Study|Not able to discontinue plavix|0|||
146032141|NCT00106691|526631801|FG001|Overall Study|Not able to discontinue plavix|1|||
146032142|NCT01754194|526631802|FG000|Overall Study|Lost to Follow-up|39|||
146032143|NCT01754194|526631803|FG001|Overall Study|Lost to Follow-up|14|||
146032144|NCT01754194|526631802|FG000|Overall Study|Withdrawal by Subject|4|||
146032145|NCT01754194|526631803|FG001|Overall Study|Withdrawal by Subject|5|||
146032146|NCT01754194|526631802|FG000|Overall Study|Other|9|||
146032147|NCT01754194|526631803|FG001|Overall Study|Other|8|||
146032148|NCT00907296|526631804|FG000|Overall Study|Ineligibility Determined|1|||
146032149|NCT00907296|526631805|FG001|Overall Study|Ineligibility Determined|0|||
146032150|NCT00907296|526631806|FG002|Overall Study|Ineligibility Determined|0|||
146032151|NCT00907296|526631807|FG003|Overall Study|Ineligibility Determined|1|||
146032152|NCT00907296|526631808|FG004|Overall Study|Ineligibility Determined|0|||
146032153|NCT00907296|526631809|FG005|Overall Study|Ineligibility Determined|0|||
146032154|NCT00907296|526631810|FG006|Overall Study|Ineligibility Determined|0|||
146032155|NCT00907296|526631811|FG007|Overall Study|Ineligibility Determined|1|||
146032156|NCT00907296|526631812|FG008|Overall Study|Ineligibility Determined|0|||
146032157|NCT00907296|526631813|FG009|Overall Study|Ineligibility Determined|0|||
146097468|NCT00717093|526879164|FG001|Overall Study|Lack of Efficacy|13|||
146097469|NCT00717093|526879163|FG000|Overall Study|Lost to Follow-up|9|||
146032158|NCT00907296|526631804|FG000|Overall Study|Protocol Deviation|0|||
146032159|NCT00907296|526631805|FG001|Overall Study|Protocol Deviation|1|||
146032160|NCT00907296|526631806|FG002|Overall Study|Protocol Deviation|0|||
146032161|NCT00907296|526631807|FG003|Overall Study|Protocol Deviation|0|||
146032162|NCT00907296|526631808|FG004|Overall Study|Protocol Deviation|0|||
146032163|NCT00907296|526631809|FG005|Overall Study|Protocol Deviation|0|||
146032164|NCT00907296|526631810|FG006|Overall Study|Protocol Deviation|0|||
146032165|NCT00907296|526631811|FG007|Overall Study|Protocol Deviation|0|||
146032166|NCT00907296|526631812|FG008|Overall Study|Protocol Deviation|0|||
146032167|NCT00907296|526631813|FG009|Overall Study|Protocol Deviation|0|||
146032168|NCT00907296|526631804|FG000|Overall Study|Noncompliance|1|||
146097470|NCT00717093|526879164|FG001|Overall Study|Lost to Follow-up|6|||
146254261|NCT01323309|527443114|FG001|Overall Study|Death|15|||
146097471|NCT00717093|526879163|FG000|Overall Study|Withdrawal by Subject|12|||
146097472|NCT00717093|526879164|FG001|Overall Study|Withdrawal by Subject|19|||
146097473|NCT00717093|526879163|FG000|Overall Study|Other|0|||
146097474|NCT00717093|526879164|FG001|Overall Study|Other|1|||
146097475|NCT00717093|526879163|FG000|Overall Study|Randomized but not treated|1|||
146097476|NCT00717093|526879164|FG001|Overall Study|Randomized but not treated|0|||
146097477|NCT01543698|526879169|FG000|Phase 1b|Disease progression|2|||
146097478|NCT01543698|526879170|FG001|Phase 1b|Disease progression|4|||
146097479|NCT01543698|526879171|FG002|Phase 1b|Disease progression|3|||
146097480|NCT01543698|526879172|FG003|Phase 1b|Disease progression|2|||
146097481|NCT01543698|526879173|FG004|Phase 1b|Disease progression|10|||
146097482|NCT01543698|526879174|FG005|Phase 1b|Disease progression|6|||
146097483|NCT01543698|526879175|FG006|Phase 1b|Disease progression|5|||
146097484|NCT01543698|526879176|FG007|Phase 1b|Disease progression|3|||
146097485|NCT01543698|526879177|FG008|Phase 1b|Disease progression|4|||
146097486|NCT01543698|526879178|FG009|Phase 1b|Disease progression|5|||
146097487|NCT01543698|526879179|FG010|Phase 1b|Disease progression|1|||
146097488|NCT01543698|526879180|FG011|Phase 1b|Disease progression|0|||
146097489|NCT01543698|526879181|FG012|Phase 1b|Disease progression|0|||
146097490|NCT01543698|526879182|FG013|Phase 1b|Disease progression|0|||
146097491|NCT01543698|526879183|FG014|Phase 1b|Disease progression|0|||
146097492|NCT01543698|526879169|FG000|Phase 1b|Death|0|||
146097493|NCT01543698|526879170|FG001|Phase 1b|Death|0|||
146097494|NCT01543698|526879171|FG002|Phase 1b|Death|1|||
146097495|NCT01543698|526879172|FG003|Phase 1b|Death|1|||
146097496|NCT01543698|526879173|FG004|Phase 1b|Death|0|||
146097497|NCT01543698|526879174|FG005|Phase 1b|Death|0|||
146097498|NCT01543698|526879175|FG006|Phase 1b|Death|0|||
146097499|NCT01543698|526879176|FG007|Phase 1b|Death|0|||
146097500|NCT01543698|526879177|FG008|Phase 1b|Death|0|||
146097501|NCT01543698|526879178|FG009|Phase 1b|Death|0|||
146097502|NCT01543698|526879179|FG010|Phase 1b|Death|1|||
146097503|NCT01543698|526879180|FG011|Phase 1b|Death|0|||
146097504|NCT01543698|526879181|FG012|Phase 1b|Death|0|||
146097505|NCT01543698|526879182|FG013|Phase 1b|Death|0|||
146097506|NCT01543698|526879183|FG014|Phase 1b|Death|0|||
146097507|NCT01543698|526879169|FG000|Phase 1b|Withdrawal by Subject|0|||
146097508|NCT01543698|526879170|FG001|Phase 1b|Withdrawal by Subject|1|||
146097509|NCT01543698|526879171|FG002|Phase 1b|Withdrawal by Subject|0|||
146097510|NCT01543698|526879172|FG003|Phase 1b|Withdrawal by Subject|1|||
146097511|NCT01543698|526879173|FG004|Phase 1b|Withdrawal by Subject|0|||
146097512|NCT01543698|526879174|FG005|Phase 1b|Withdrawal by Subject|0|||
146097513|NCT01543698|526879175|FG006|Phase 1b|Withdrawal by Subject|1|||
146097514|NCT01543698|526879176|FG007|Phase 1b|Withdrawal by Subject|0|||
146097515|NCT01543698|526879177|FG008|Phase 1b|Withdrawal by Subject|0|||
146097516|NCT01543698|526879178|FG009|Phase 1b|Withdrawal by Subject|0|||
146097517|NCT01543698|526879179|FG010|Phase 1b|Withdrawal by Subject|0|||
146097518|NCT01543698|526879180|FG011|Phase 1b|Withdrawal by Subject|0|||
146097519|NCT01543698|526879181|FG012|Phase 1b|Withdrawal by Subject|0|||
146097520|NCT01543698|526879182|FG013|Phase 1b|Withdrawal by Subject|0|||
146097521|NCT01543698|526879183|FG014|Phase 1b|Withdrawal by Subject|0|||
146097522|NCT01543698|526879169|FG000|Phase 1b|Adverse Event|1|||
146097523|NCT01543698|526879170|FG001|Phase 1b|Adverse Event|0|||
146097524|NCT01543698|526879171|FG002|Phase 1b|Adverse Event|0|||
146097525|NCT01543698|526879172|FG003|Phase 1b|Adverse Event|1|||
146097526|NCT01543698|526879173|FG004|Phase 1b|Adverse Event|2|||
146097527|NCT01543698|526879174|FG005|Phase 1b|Adverse Event|2|||
146097528|NCT01543698|526879175|FG006|Phase 1b|Adverse Event|0|||
146097529|NCT01543698|526879176|FG007|Phase 1b|Adverse Event|0|||
146097530|NCT01543698|526879177|FG008|Phase 1b|Adverse Event|1|||
146097531|NCT01543698|526879178|FG009|Phase 1b|Adverse Event|1|||
146097532|NCT01543698|526879179|FG010|Phase 1b|Adverse Event|2|||
146097533|NCT01543698|526879180|FG011|Phase 1b|Adverse Event|0|||
146097534|NCT01543698|526879181|FG012|Phase 1b|Adverse Event|0|||
146097535|NCT01543698|526879182|FG013|Phase 1b|Adverse Event|0|||
146097536|NCT01543698|526879183|FG014|Phase 1b|Adverse Event|0|||
146097537|NCT01543698|526879169|FG000|Phase 1b|Administrative problems|1|||
146097538|NCT01543698|526879170|FG001|Phase 1b|Administrative problems|0|||
146097539|NCT01543698|526879171|FG002|Phase 1b|Administrative problems|0|||
146097540|NCT01543698|526879172|FG003|Phase 1b|Administrative problems|0|||
146097541|NCT01543698|526879173|FG004|Phase 1b|Administrative problems|1|||
146097542|NCT01543698|526879174|FG005|Phase 1b|Administrative problems|0|||
146097543|NCT01543698|526879175|FG006|Phase 1b|Administrative problems|0|||
146097544|NCT01543698|526879176|FG007|Phase 1b|Administrative problems|1|||
146097545|NCT01543698|526879177|FG008|Phase 1b|Administrative problems|0|||
146097546|NCT01543698|526879178|FG009|Phase 1b|Administrative problems|0|||
146097547|NCT01543698|526879179|FG010|Phase 1b|Administrative problems|2|||
146097548|NCT01543698|526879180|FG011|Phase 1b|Administrative problems|0|||
146097549|NCT01543698|526879181|FG012|Phase 1b|Administrative problems|0|||
146097550|NCT01543698|526879182|FG013|Phase 1b|Administrative problems|0|||
146097551|NCT01543698|526879183|FG014|Phase 1b|Administrative problems|0|||
146097552|NCT01543698|526879169|FG000|Phase 1b|Protocol Violation|2|||
146097553|NCT01543698|526879170|FG001|Phase 1b|Protocol Violation|0|||
146097554|NCT01543698|526879171|FG002|Phase 1b|Protocol Violation|0|||
146032169|NCT00907296|526631805|FG001|Overall Study|Noncompliance|1|||
146254262|NCT01323309|527443115|FG002|Overall Study|Death|5|||
146254263|NCT01323309|527443113|FG000|Overall Study|Lost to Follow-up|11|||
146032170|NCT00907296|526631806|FG002|Overall Study|Noncompliance|1|||
146032171|NCT00907296|526631807|FG003|Overall Study|Noncompliance|0|||
146032172|NCT00907296|526631808|FG004|Overall Study|Noncompliance|0|||
146032173|NCT00907296|526631809|FG005|Overall Study|Noncompliance|1|||
146032174|NCT00907296|526631810|FG006|Overall Study|Noncompliance|0|||
146032175|NCT00907296|526631811|FG007|Overall Study|Noncompliance|2|||
146032176|NCT00907296|526631812|FG008|Overall Study|Noncompliance|0|||
146032177|NCT00907296|526631813|FG009|Overall Study|Noncompliance|0|||
146032178|NCT00907296|526631804|FG000|Overall Study|Adverse Event|2|||
146032179|NCT00907296|526631805|FG001|Overall Study|Adverse Event|0|||
146032180|NCT00907296|526631806|FG002|Overall Study|Adverse Event|0|||
146032181|NCT00907296|526631807|FG003|Overall Study|Adverse Event|0|||
146032182|NCT00907296|526631808|FG004|Overall Study|Adverse Event|0|||
146032183|NCT00907296|526631809|FG005|Overall Study|Adverse Event|0|||
146032184|NCT00907296|526631810|FG006|Overall Study|Adverse Event|1|||
146032185|NCT00907296|526631811|FG007|Overall Study|Adverse Event|0|||
146032186|NCT00907296|526631812|FG008|Overall Study|Adverse Event|0|||
146032187|NCT00907296|526631813|FG009|Overall Study|Adverse Event|1|||
146032188|NCT00907296|526631804|FG000|Overall Study|Withdrawal by Subject|7|||
146032189|NCT00907296|526631805|FG001|Overall Study|Withdrawal by Subject|2|||
146032190|NCT00907296|526631806|FG002|Overall Study|Withdrawal by Subject|1|||
146032191|NCT00907296|526631807|FG003|Overall Study|Withdrawal by Subject|1|||
146032192|NCT00907296|526631808|FG004|Overall Study|Withdrawal by Subject|1|||
146032193|NCT00907296|526631809|FG005|Overall Study|Withdrawal by Subject|5|||
146032194|NCT00907296|526631810|FG006|Overall Study|Withdrawal by Subject|3|||
146032195|NCT00907296|526631811|FG007|Overall Study|Withdrawal by Subject|2|||
146032196|NCT00907296|526631812|FG008|Overall Study|Withdrawal by Subject|4|||
146032197|NCT00907296|526631813|FG009|Overall Study|Withdrawal by Subject|2|||
146032198|NCT00907296|526631804|FG000|Overall Study|Lost to Follow-up|9|||
146032199|NCT00907296|526631805|FG001|Overall Study|Lost to Follow-up|1|||
146032200|NCT00907296|526631806|FG002|Overall Study|Lost to Follow-up|0|||
146032201|NCT00907296|526631807|FG003|Overall Study|Lost to Follow-up|2|||
146032202|NCT00907296|526631808|FG004|Overall Study|Lost to Follow-up|0|||
146032203|NCT00907296|526631809|FG005|Overall Study|Lost to Follow-up|3|||
146032204|NCT00907296|526631810|FG006|Overall Study|Lost to Follow-up|2|||
146032205|NCT00907296|526631811|FG007|Overall Study|Lost to Follow-up|2|||
146032206|NCT00907296|526631812|FG008|Overall Study|Lost to Follow-up|0|||
146032207|NCT00907296|526631813|FG009|Overall Study|Lost to Follow-up|4|||
146032208|NCT02392403|526631814|FG000|Overall Study|Adverse Event|1|||
146032209|NCT02392403|526631814|FG000|Overall Study|Death|1|||
146032210|NCT02392403|526631814|FG000|Overall Study|Withdrawal by Subject|1|||
146032211|NCT02776033|526631815|FG000|Overall Study|Withdrawal by Subject|0|||
146032212|NCT02776033|526631816|FG001|Overall Study|Withdrawal by Subject|0|||
146032213|NCT02776033|526631817|FG002|Overall Study|Withdrawal by Subject|2|||
146032214|NCT02776033|526631815|FG000|Overall Study|Physician Decision|2|||
146032215|NCT02776033|526631816|FG001|Overall Study|Physician Decision|0|||
146032216|NCT02776033|526631817|FG002|Overall Study|Physician Decision|0|||
146032217|NCT02776033|526631815|FG000|Overall Study|Lost to Follow-up|1|||
146032218|NCT02776033|526631816|FG001|Overall Study|Lost to Follow-up|0|||
146032219|NCT02776033|526631817|FG002|Overall Study|Lost to Follow-up|0|||
146032220|NCT02776033|526631815|FG000|Overall Study|Adverse Event|1|||
146032221|NCT02776033|526631816|FG001|Overall Study|Adverse Event|2|||
146032222|NCT02776033|526631817|FG002|Overall Study|Adverse Event|0|||
146032223|NCT02616393|526631818|FG000|Overall Study|Death|5|||
146032224|NCT02616393|526631819|FG001|Overall Study|Death|12|||
146032225|NCT02616393|526631820|FG002|Overall Study|Death|1|||
146032226|NCT02616393|526631818|FG000|Overall Study|Termination by Sponsor|4|||
146032227|NCT02616393|526631819|FG001|Overall Study|Termination by Sponsor|5|||
146032228|NCT02616393|526631820|FG002|Overall Study|Termination by Sponsor|2|||
146032229|NCT02616393|526631818|FG000|Overall Study|Other|3|||
146254264|NCT01323309|527443114|FG001|Overall Study|Lost to Follow-up|14|||
146032230|NCT02616393|526631819|FG001|Overall Study|Other|0|||
146032231|NCT02616393|526631820|FG002|Overall Study|Other|0|||
146032232|NCT02616393|526631818|FG000|Overall Study|Withdrawal by Subject|1|||
146032233|NCT02616393|526631819|FG001|Overall Study|Withdrawal by Subject|1|||
146032234|NCT02616393|526631820|FG002|Overall Study|Withdrawal by Subject|0|||
146032235|NCT02616393|526631818|FG000|Overall Study|Lost to Follow-up|0|||
146032236|NCT02616393|526631819|FG001|Overall Study|Lost to Follow-up|2|||
146032237|NCT02616393|526631820|FG002|Overall Study|Lost to Follow-up|0|||
146032238|NCT02713867|526631821|FG000|Randomization|Other Reason|2|||
146254265|NCT01323309|527443115|FG002|Overall Study|Lost to Follow-up|24|||
146032239|NCT02713867|526631822|FG001|Randomization|Other Reason|1|||
146032240|NCT02713867|526631821|FG000|Randomization|Participant Withdrew consent|0|||
146032241|NCT02713867|526631822|FG001|Randomization|Participant Withdrew consent|2|||
146032242|NCT02713867|526631821|FG000|Treatment Period|Other Reasons|22|||
146032243|NCT02713867|526631822|FG001|Treatment Period|Other Reasons|28|||
146032244|NCT02713867|526631821|FG000|Treatment Period|Administrative reason by sponsor|21|||
146097555|NCT01543698|526879172|FG003|Phase 1b|Protocol Violation|0|||
146097556|NCT01543698|526879173|FG004|Phase 1b|Protocol Violation|0|||
146097557|NCT01543698|526879174|FG005|Phase 1b|Protocol Violation|0|||
146097558|NCT01543698|526879175|FG006|Phase 1b|Protocol Violation|0|||
146097559|NCT01543698|526879176|FG007|Phase 1b|Protocol Violation|0|||
146097560|NCT01543698|526879177|FG008|Phase 1b|Protocol Violation|0|||
146097561|NCT01543698|526879178|FG009|Phase 1b|Protocol Violation|0|||
146097562|NCT01543698|526879179|FG010|Phase 1b|Protocol Violation|0|||
146097563|NCT01543698|526879180|FG011|Phase 1b|Protocol Violation|0|||
146097564|NCT01543698|526879181|FG012|Phase 1b|Protocol Violation|0|||
146097565|NCT01543698|526879182|FG013|Phase 1b|Protocol Violation|0|||
146097566|NCT01543698|526879183|FG014|Phase 1b|Protocol Violation|0|||
146097567|NCT01543698|526879169|FG000|Phase 2|Protocol Violation|0|||
146097568|NCT01543698|526879170|FG001|Phase 2|Protocol Violation|0|||
146097569|NCT01543698|526879171|FG002|Phase 2|Protocol Violation|0|||
146097570|NCT01543698|526879172|FG003|Phase 2|Protocol Violation|0|||
146097571|NCT01543698|526879173|FG004|Phase 2|Protocol Violation|0|||
146097572|NCT01543698|526879174|FG005|Phase 2|Protocol Violation|0|||
146097573|NCT01543698|526879175|FG006|Phase 2|Protocol Violation|0|||
146097574|NCT01543698|526879176|FG007|Phase 2|Protocol Violation|0|||
146097575|NCT01543698|526879177|FG008|Phase 2|Protocol Violation|0|||
146097576|NCT01543698|526879178|FG009|Phase 2|Protocol Violation|0|||
146097577|NCT01543698|526879179|FG010|Phase 2|Protocol Violation|0|||
146097578|NCT01543698|526879180|FG011|Phase 2|Protocol Violation|0|||
146097579|NCT01543698|526879181|FG012|Phase 2|Protocol Violation|1|||
146097580|NCT01543698|526879182|FG013|Phase 2|Protocol Violation|0|||
146097581|NCT01543698|526879183|FG014|Phase 2|Protocol Violation|0|||
146097582|NCT01543698|526879169|FG000|Phase 2|Disease progression|0|||
146097583|NCT01543698|526879170|FG001|Phase 2|Disease progression|0|||
146097584|NCT01543698|526879171|FG002|Phase 2|Disease progression|0|||
146097585|NCT01543698|526879172|FG003|Phase 2|Disease progression|0|||
146097586|NCT01543698|526879173|FG004|Phase 2|Disease progression|0|||
146097587|NCT01543698|526879174|FG005|Phase 2|Disease progression|0|||
146097588|NCT01543698|526879175|FG006|Phase 2|Disease progression|0|||
146097589|NCT01543698|526879176|FG007|Phase 2|Disease progression|0|||
146097590|NCT01543698|526879177|FG008|Phase 2|Disease progression|0|||
146097591|NCT01543698|526879178|FG009|Phase 2|Disease progression|0|||
146097592|NCT01543698|526879179|FG010|Phase 2|Disease progression|0|||
146097593|NCT01543698|526879180|FG011|Phase 2|Disease progression|10|||
146097594|NCT01543698|526879181|FG012|Phase 2|Disease progression|21|||
146097595|NCT01543698|526879182|FG013|Phase 2|Disease progression|30|||
146097596|NCT01543698|526879183|FG014|Phase 2|Disease progression|25|||
146097597|NCT01543698|526879169|FG000|Phase 2|Death|0|||
146097598|NCT01543698|526879170|FG001|Phase 2|Death|0|||
146097599|NCT01543698|526879171|FG002|Phase 2|Death|0|||
146097600|NCT01543698|526879172|FG003|Phase 2|Death|0|||
146097601|NCT01543698|526879173|FG004|Phase 2|Death|0|||
146097602|NCT01543698|526879174|FG005|Phase 2|Death|0|||
146097603|NCT01543698|526879175|FG006|Phase 2|Death|0|||
146097604|NCT01543698|526879176|FG007|Phase 2|Death|0|||
146097605|NCT01543698|526879177|FG008|Phase 2|Death|0|||
146097606|NCT01543698|526879178|FG009|Phase 2|Death|0|||
146097607|NCT01543698|526879179|FG010|Phase 2|Death|0|||
146097608|NCT01543698|526879180|FG011|Phase 2|Death|0|||
146097609|NCT01543698|526879181|FG012|Phase 2|Death|1|||
146097610|NCT01543698|526879182|FG013|Phase 2|Death|1|||
146097611|NCT01543698|526879183|FG014|Phase 2|Death|1|||
146097612|NCT01543698|526879169|FG000|Phase 2|Administrative problems|0|||
146097613|NCT01543698|526879170|FG001|Phase 2|Administrative problems|0|||
146097614|NCT01543698|526879171|FG002|Phase 2|Administrative problems|0|||
146097615|NCT01543698|526879172|FG003|Phase 2|Administrative problems|0|||
146097616|NCT01543698|526879173|FG004|Phase 2|Administrative problems|0|||
146097617|NCT01543698|526879174|FG005|Phase 2|Administrative problems|0|||
146097618|NCT01543698|526879175|FG006|Phase 2|Administrative problems|0|||
146097619|NCT01543698|526879176|FG007|Phase 2|Administrative problems|0|||
146097620|NCT01543698|526879177|FG008|Phase 2|Administrative problems|0|||
146254266|NCT01323309|527443113|FG000|Overall Study|Withdrawal by Subject|14|||
146097621|NCT01543698|526879178|FG009|Phase 2|Administrative problems|0|||
146097622|NCT01543698|526879179|FG010|Phase 2|Administrative problems|0|||
146097623|NCT01543698|526879180|FG011|Phase 2|Administrative problems|0|||
146097624|NCT01543698|526879181|FG012|Phase 2|Administrative problems|0|||
146254267|NCT01323309|527443114|FG001|Overall Study|Withdrawal by Subject|14|||
146097625|NCT01543698|526879182|FG013|Phase 2|Administrative problems|3|||
146097626|NCT01543698|526879183|FG014|Phase 2|Administrative problems|1|||
146097627|NCT01543698|526879169|FG000|Phase 2|Withdrawal by Subject|0|||
146097628|NCT01543698|526879170|FG001|Phase 2|Withdrawal by Subject|0|||
146097629|NCT01543698|526879171|FG002|Phase 2|Withdrawal by Subject|0|||
146097630|NCT01543698|526879172|FG003|Phase 2|Withdrawal by Subject|0|||
146097631|NCT01543698|526879173|FG004|Phase 2|Withdrawal by Subject|0|||
146097632|NCT01543698|526879174|FG005|Phase 2|Withdrawal by Subject|0|||
146097633|NCT01543698|526879175|FG006|Phase 2|Withdrawal by Subject|0|||
146097634|NCT01543698|526879176|FG007|Phase 2|Withdrawal by Subject|0|||
146097635|NCT01543698|526879177|FG008|Phase 2|Withdrawal by Subject|0|||
146032245|NCT02713867|526631822|FG001|Treatment Period|Administrative reason by sponsor|16|||
146032246|NCT02713867|526631821|FG000|Treatment Period|No longer meets study criteria|2|||
146032247|NCT02713867|526631822|FG001|Treatment Period|No longer meets study criteria|1|||
146032248|NCT02713867|526631821|FG000|Treatment Period|Poor/Non Compliance|1|||
146032249|NCT02713867|526631822|FG001|Treatment Period|Poor/Non Compliance|0|||
146032250|NCT02713867|526631821|FG000|Treatment Period|Maximum Clinical Benefit|5|||
146032251|NCT02713867|526631822|FG001|Treatment Period|Maximum Clinical Benefit|6|||
146032252|NCT02713867|526631821|FG000|Treatment Period|Withdrew consent|3|||
146032253|NCT02713867|526631822|FG001|Treatment Period|Withdrew consent|6|||
146032254|NCT02713867|526631821|FG000|Treatment Period|Requested to Discontinue|8|||
146032255|NCT02713867|526631822|FG001|Treatment Period|Requested to Discontinue|8|||
146032256|NCT02713867|526631821|FG000|Treatment Period|AE unrelated to Study Drug|11|||
146032257|NCT02713867|526631822|FG001|Treatment Period|AE unrelated to Study Drug|10|||
146032258|NCT02713867|526631821|FG000|Treatment Period|Death|7|||
146032259|NCT02713867|526631822|FG001|Treatment Period|Death|3|||
146032260|NCT02713867|526631821|FG000|Treatment Period|Study Drug Toxicity|16|||
146032261|NCT02713867|526631822|FG001|Treatment Period|Study Drug Toxicity|19|||
146032262|NCT02713867|526631821|FG000|Treatment Period|Disease Progression|82|||
146032263|NCT02713867|526631822|FG001|Treatment Period|Disease Progression|83|||
146032264|NCT00857948|526631823|FG000|Overall Study|Withdrawal by Subject|2|||
146032265|NCT00857948|526631824|FG001|Overall Study|Withdrawal by Subject|0|||
146032266|NCT00857948|526631825|FG002|Overall Study|Withdrawal by Subject|0|||
146032267|NCT00857948|526631826|FG003|Overall Study|Withdrawal by Subject|0|||
146032268|NCT00857948|526631823|FG000|Overall Study|Protocol Violation|1|||
146032269|NCT00857948|526631824|FG001|Overall Study|Protocol Violation|0|||
146032270|NCT00857948|526631825|FG002|Overall Study|Protocol Violation|1|||
146032271|NCT00857948|526631826|FG003|Overall Study|Protocol Violation|0|||
146032272|NCT04135859|526631828|FG000|Overall Study|Withdrawal by Subject|1|||
146032273|NCT04135859|526631829|FG001|Overall Study|Withdrawal by Subject|0|||
146032274|NCT04135859|526631828|FG000|Overall Study|Withdrawal due to screening failure|1|||
146032275|NCT04135859|526631829|FG001|Overall Study|Withdrawal due to screening failure|2|||
146032276|NCT04135859|526631828|FG000|Overall Study|Did not complete stress test|3|||
146032277|NCT04135859|526631829|FG001|Overall Study|Did not complete stress test|3|||
146032278|NCT04135859|526631828|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
146032279|NCT04135859|526631829|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
146032280|NCT03242018|526631835|FG000|Overall Study|Adverse Event|7|||
146032281|NCT03242018|526631836|FG001|Overall Study|Adverse Event|7|||
146032282|NCT03242018|526631837|FG002|Overall Study|Adverse Event|6|||
146032283|NCT03242018|526631835|FG000|Overall Study|Lost to Follow-up|2|||
146032284|NCT03242018|526631836|FG001|Overall Study|Lost to Follow-up|2|||
146032285|NCT03242018|526631837|FG002|Overall Study|Lost to Follow-up|2|||
146032286|NCT03242018|526631835|FG000|Overall Study|At the Participant's Own Request|5|||
146032287|NCT03242018|526631836|FG001|Overall Study|At the Participant's Own Request|1|||
146032288|NCT03242018|526631837|FG002|Overall Study|At the Participant's Own Request|4|||
146032289|NCT03242018|526631835|FG000|Overall Study|Reason Not Specified|3|||
146032290|NCT03242018|526631836|FG001|Overall Study|Reason Not Specified|4|||
146032291|NCT03242018|526631837|FG002|Overall Study|Reason Not Specified|1|||
146032292|NCT03242018|526631835|FG000|Overall Study|Study Terminated by Sponsor|1|||
146032293|NCT03242018|526631836|FG001|Overall Study|Study Terminated by Sponsor|0|||
146032294|NCT03242018|526631837|FG002|Overall Study|Study Terminated by Sponsor|1|||
146032295|NCT02365285|526631838|FG000|Overall Study|Physician Decision|0|||
146032296|NCT02365285|526631839|FG001|Overall Study|Physician Decision|1|||
146032297|NCT02365285|526631840|FG002|Overall Study|Physician Decision|1|||
146032298|NCT02365285|526631841|FG003|Overall Study|Physician Decision|0|||
146032299|NCT02365285|526631838|FG000|Overall Study|Adverse Event|0|||
146032300|NCT02365285|526631839|FG001|Overall Study|Adverse Event|0|||
146032301|NCT02365285|526631840|FG002|Overall Study|Adverse Event|0|||
146032302|NCT02365285|526631841|FG003|Overall Study|Adverse Event|2|||
146032303|NCT02635347|526631844|FG000|Overall Study|Failed screening|20|||
146032304|NCT02635347|526631845|FG001|Overall Study|Failed screening|7|||
146032305|NCT01617447|526631846|FG000|Overall Study|Adverse Event|0|||
146032306|NCT01617447|526631847|FG001|Overall Study|Adverse Event|1|||
146032307|NCT01617447|526631846|FG000|Overall Study|Physician Decision|0|||
146032308|NCT01617447|526631847|FG001|Overall Study|Physician Decision|2|||
146032309|NCT01283542|526631848|FG000|Main Phase|Acute or progressive vision loss|1|||
146032310|NCT01283542|526631848|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
146032311|NCT01283542|526631848|FG000|Main Phase|abnormal laboratory values|5|||
146032312|NCT01283542|526631848|FG000|Extension Phase|Physician Decision|1|||
146032313|NCT01283542|526631848|FG000|Extension Phase|Adverse Event|1|||
146032314|NCT01283542|526631848|FG000|Extension Phase|Administrative problems|1|||
146032315|NCT03443427|526631849|FG000|Overall Study|Adverse Event|2|||
146032316|NCT03443427|526631850|FG001|Overall Study|Adverse Event|3|||
146032317|NCT03443427|526631849|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
146032318|NCT03443427|526631850|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
146032319|NCT03443427|526631849|FG000|Overall Study|Other|4|||
146032320|NCT03443427|526631850|FG001|Overall Study|Other|6|||
146097636|NCT01543698|526879178|FG009|Phase 2|Withdrawal by Subject|0|||
146097637|NCT01543698|526879179|FG010|Phase 2|Withdrawal by Subject|0|||
146097638|NCT01543698|526879180|FG011|Phase 2|Withdrawal by Subject|0|||
146032321|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
146032322|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
146097639|NCT01543698|526879181|FG012|Phase 2|Withdrawal by Subject|0|||
146097640|NCT01543698|526879182|FG013|Phase 2|Withdrawal by Subject|3|||
146097641|NCT01543698|526879183|FG014|Phase 2|Withdrawal by Subject|1|||
146097642|NCT01543698|526879169|FG000|Phase 2|Adverse Event|0|||
146097643|NCT01543698|526879170|FG001|Phase 2|Adverse Event|0|||
146097644|NCT01543698|526879171|FG002|Phase 2|Adverse Event|0|||
146097645|NCT01543698|526879172|FG003|Phase 2|Adverse Event|0|||
146097646|NCT01543698|526879173|FG004|Phase 2|Adverse Event|0|||
146097647|NCT01543698|526879174|FG005|Phase 2|Adverse Event|0|||
146097648|NCT01543698|526879175|FG006|Phase 2|Adverse Event|0|||
146097649|NCT01543698|526879176|FG007|Phase 2|Adverse Event|0|||
146097650|NCT01543698|526879177|FG008|Phase 2|Adverse Event|0|||
146097651|NCT01543698|526879178|FG009|Phase 2|Adverse Event|0|||
146097652|NCT01543698|526879179|FG010|Phase 2|Adverse Event|0|||
146097653|NCT01543698|526879180|FG011|Phase 2|Adverse Event|1|||
146097654|NCT01543698|526879181|FG012|Phase 2|Adverse Event|3|||
146097655|NCT01543698|526879182|FG013|Phase 2|Adverse Event|5|||
146097656|NCT01543698|526879183|FG014|Phase 2|Adverse Event|14|||
146097657|NCT00217620|526879184|FG000|Overall Study|Adverse Event|2|||
146097658|NCT00217620|526879184|FG000|Overall Study|Progression|31|||
146097659|NCT00217620|526879184|FG000|Overall Study|Not Protocol Specified|4|||
146097660|NCT00217620|526879184|FG000|Overall Study|Ineligible|13|||
146097661|NCT00217620|526879184|FG000|Overall Study|Never received treatment|1|||
146097662|NCT02742441|526879192|FG000|Overall Study|Lost to Follow-up|4|||
146097663|NCT02742441|526879193|FG001|Overall Study|Lost to Follow-up|4|||
146097664|NCT02742441|526879192|FG000|Overall Study|Withdrawal by Subject|2|||
146097665|NCT02742441|526879193|FG001|Overall Study|Withdrawal by Subject|2|||
146097666|NCT02742441|526879192|FG000|Overall Study|Adverse Event|0|||
146097667|NCT02742441|526879193|FG001|Overall Study|Adverse Event|2|||
146097668|NCT02008318|526879199|FG000|Overall Study|Adverse Event|4|||
146097669|NCT02008318|526879200|FG001|Overall Study|Adverse Event|0|||
146097670|NCT02008318|526879199|FG000|Overall Study|Physician Decision|2|||
146097671|NCT02008318|526879200|FG001|Overall Study|Physician Decision|0|||
146032323|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
146032324|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
146032325|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
146032326|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
146032327|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
146032328|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
146032329|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
146032330|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
146032331|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
146032332|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
146032333|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
146032334|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
146032335|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
146032336|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
146032337|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
146032338|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
146097672|NCT02008318|526879199|FG000|Overall Study|Progressive Disease|2|||
146097673|NCT02008318|526879200|FG001|Overall Study|Progressive Disease|0|||
146097674|NCT02008318|526879199|FG000|Overall Study|Protocol Violation|1|||
146097675|NCT02008318|526879200|FG001|Overall Study|Protocol Violation|1|||
146097676|NCT02008318|526879199|FG000|Overall Study|Withdrawal by Subject|3|||
146097677|NCT02008318|526879200|FG001|Overall Study|Withdrawal by Subject|0|||
146097678|NCT02281773|526879202|FG000|Overall Study|Adverse Event|6|||
146097679|NCT02281773|526879203|FG001|Overall Study|Adverse Event|1|||
146097680|NCT02281773|526879204|FG002|Overall Study|Adverse Event|4|||
146032339|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
146097681|NCT02281773|526879205|FG003|Overall Study|Adverse Event|8|||
146097682|NCT02281773|526879206|FG004|Overall Study|Adverse Event|9|||
146097683|NCT02281773|526879202|FG000|Overall Study|Protocol Violation|1|||
146097684|NCT02281773|526879203|FG001|Overall Study|Protocol Violation|0|||
146097685|NCT02281773|526879204|FG002|Overall Study|Protocol Violation|0|||
146097686|NCT02281773|526879205|FG003|Overall Study|Protocol Violation|2|||
146097687|NCT02281773|526879206|FG004|Overall Study|Protocol Violation|2|||
146097688|NCT02281773|526879202|FG000|Overall Study|Lost to Follow-up|2|||
146097689|NCT02281773|526879203|FG001|Overall Study|Lost to Follow-up|2|||
146097690|NCT02281773|526879204|FG002|Overall Study|Lost to Follow-up|6|||
146097691|NCT02281773|526879205|FG003|Overall Study|Lost to Follow-up|2|||
146097692|NCT02281773|526879206|FG004|Overall Study|Lost to Follow-up|10|||
146097693|NCT02281773|526879202|FG000|Overall Study|Withdrawal by Subject|2|||
146097694|NCT02281773|526879203|FG001|Overall Study|Withdrawal by Subject|8|||
146097695|NCT02281773|526879204|FG002|Overall Study|Withdrawal by Subject|6|||
146097696|NCT02281773|526879205|FG003|Overall Study|Withdrawal by Subject|6|||
146097697|NCT02281773|526879206|FG004|Overall Study|Withdrawal by Subject|8|||
146097698|NCT02281773|526879202|FG000|Overall Study|Other Reason|0|||
146097699|NCT02281773|526879203|FG001|Overall Study|Other Reason|4|||
146097700|NCT02281773|526879204|FG002|Overall Study|Other Reason|2|||
146097701|NCT02281773|526879205|FG003|Overall Study|Other Reason|3|||
146097702|NCT02281773|526879206|FG004|Overall Study|Other Reason|1|||
146097703|NCT02422303|526879209|FG000|Overall Study|Lost to Follow-up|1|||
146097704|NCT02422303|526879210|FG001|Overall Study|Lost to Follow-up|1|||
146097705|NCT01364649|526879213|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
146097706|NCT01364649|526879214|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
146097707|NCT01364649|526879213|FG000|Overall Study|Lack of Efficacy|6|||
146097708|NCT01364649|526879214|FG001|Overall Study|Lack of Efficacy|0|||
146097709|NCT01364649|526879213|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
146097710|NCT01364649|526879214|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
146097711|NCT01364649|526879213|FG000|Overall Study|Protocol Deviations|4|||
146097712|NCT01364649|526879214|FG001|Overall Study|Protocol Deviations|8|||
146097713|NCT01364649|526879213|FG000|Overall Study|Withdrawal of Consent|9|||
146097714|NCT01364649|526879214|FG001|Overall Study|Withdrawal of Consent|7|||
146097715|NCT01364649|526879213|FG000|Overall Study|Lost to Follow-up|12|||
146097716|NCT01364649|526879214|FG001|Overall Study|Lost to Follow-up|13|||
146097717|NCT01364649|526879213|FG000|Overall Study|Other|4|||
146097718|NCT01364649|526879214|FG001|Overall Study|Other|1|||
146097719|NCT00902668|526879215|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
146097720|NCT00004635|526879216|FG000|Period One|refused|2|||
146097721|NCT00004635|526879217|FG001|Period One|refused|1|||
146097722|NCT00004635|526879216|FG000|Period One|Withdrawal by Subject|1|||
146097723|NCT00004635|526879217|FG001|Period One|Withdrawal by Subject|1|||
146097724|NCT00004635|526879216|FG000|Period One|Protocol Violation|1|||
146097725|NCT00004635|526879217|FG001|Period One|Protocol Violation|0|||
146097726|NCT00004635|526879216|FG000|Period One|PSA did not go <5 ng/mL|1|||
146097727|NCT00004635|526879217|FG001|Period One|PSA did not go <5 ng/mL|0|||
146097728|NCT00004635|526879216|FG000|Period One|second malignancy|1|||
146097729|NCT00004635|526879217|FG001|Period One|second malignancy|0|||
146097730|NCT00004635|526879216|FG000|Period One|progressed|0|||
146097731|NCT00004635|526879217|FG001|Period One|progressed|2|||
146097732|NCT00004635|526879216|FG000|Period One|health problem|0|||
146097733|NCT00004635|526879217|FG001|Period One|health problem|1|||
146097734|NCT00004635|526879216|FG000|Period One|discrepancy in data entry|0|||
146097735|NCT00004635|526879217|FG001|Period One|discrepancy in data entry|1|||
146097736|NCT00004635|526879216|FG000|Period Two|progression|2|||
146097737|NCT00004635|526879217|FG001|Period Two|progression|3|||
146097738|NCT00004635|526879216|FG000|Period Two|Adverse Event|1|||
146254268|NCT01323309|527443115|FG002|Overall Study|Withdrawal by Subject|18|||
146254269|NCT01323309|527443113|FG000|Overall Study|Disease progression|5|||
146254270|NCT01323309|527443114|FG001|Overall Study|Disease progression|11|||
146254271|NCT01323309|527443115|FG002|Overall Study|Disease progression|4|||
146254272|NCT01348763|527443119|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
146254273|NCT01348763|527443119|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
146254274|NCT00449033|527443129|FG000|Treatment Period|Adverse Event|117|||
146097739|NCT00004635|526879217|FG001|Period Two|Adverse Event|0|||
146097740|NCT00004635|526879216|FG000|Period Two|refused|0|||
146097741|NCT00004635|526879217|FG001|Period Two|refused|2|||
146097742|NCT00004635|526879216|FG000|Period Two|health problem|1|||
146097743|NCT00004635|526879217|FG001|Period Two|health problem|1|||
146097744|NCT00004635|526879216|FG000|Period Two|travel issues|0|||
146097745|NCT00004635|526879217|FG001|Period Two|travel issues|1|||
146097746|NCT00004635|526879216|FG000|Period Two|secondary malignancy|1|||
146097747|NCT00004635|526879217|FG001|Period Two|secondary malignancy|1|||
146097748|NCT00004635|526879216|FG000|Period Two|Lost to Follow-up|1|||
146097749|NCT00004635|526879217|FG001|Period Two|Lost to Follow-up|0|||
146254275|NCT00449033|527443130|FG001|Treatment Period|Adverse Event|83|||
146254276|NCT00449033|527443129|FG000|Treatment Period|Death|21|||
146097750|NCT00004635|526879216|FG000|Period Two|discrepancy in data entry|0|||
146097751|NCT00004635|526879217|FG001|Period Two|discrepancy in data entry|1|||
146097752|NCT01788046|526879218|FG000|Overall Study|Withdrawal by Subject|12|||
146097753|NCT01788046|526879219|FG001|Overall Study|Withdrawal by Subject|12|||
146097754|NCT01788046|526879218|FG000|Overall Study|Lost to Follow-up|12|||
146097755|NCT01788046|526879219|FG001|Overall Study|Lost to Follow-up|19|||
146097756|NCT01788046|526879218|FG000|Overall Study|Death|7|||
146254277|NCT00449033|527443130|FG001|Treatment Period|Death|12|||
146097757|NCT01788046|526879219|FG001|Overall Study|Death|5|||
146097758|NCT01788046|526879218|FG000|Overall Study|Protocol Specified Criteria|25|||
146097759|NCT01788046|526879219|FG001|Overall Study|Protocol Specified Criteria|1|||
146254278|NCT00449033|527443129|FG000|Treatment Period|Lost to Follow-up|0|||
146097760|NCT03840174|526879220|FG000|Overall Study|Withdrawal by Subject|1|||
146097761|NCT03840174|526879221|FG001|Overall Study|Withdrawal by Subject|0|||
146097762|NCT03840174|526879222|FG002|Overall Study|Withdrawal by Subject|0|||
146032340|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
146032341|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
146032342|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
146032343|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
146032344|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
146032345|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
146032346|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146032347|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146032348|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
146032349|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
146032350|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
146032351|NCT00121641|526631851|FG000|24-week Short-term Treatment Period|Other Reason|1|||
146032352|NCT00121641|526631852|FG001|24-week Short-term Treatment Period|Other Reason|0|||
146032353|NCT00121641|526631853|FG002|24-week Short-term Treatment Period|Other Reason|0|||
146032354|NCT00121641|526631854|FG003|24-week Short-term Treatment Period|Other Reason|0|||
146032355|NCT00121641|526631855|FG004|24-week Short-term Treatment Period|Other Reason|0|||
146032356|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
146032357|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
146032358|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
146032359|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
146032360|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
146032361|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
146032362|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
146032363|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
146032364|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
146032365|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
146032366|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
146032367|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
146032368|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
146032369|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
146032370|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
146032371|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
146032372|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
146032373|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
146032374|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
146032375|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
146032376|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
146032377|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
146032378|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
146032379|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
146032380|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
146032381|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
146032382|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
146032383|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
146032384|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
146032385|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
146032386|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
146032387|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
146032388|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
146032389|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
146032390|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
146032391|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
146032392|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
146032393|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
146032394|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
146032395|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
146032396|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Death|0|||
146032397|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Death|0|||
146032398|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Death|0|||
146097763|NCT03840174|526879223|FG003|Overall Study|Withdrawal by Subject|0|||
146300389|NCT00705432|527615246|FG004|Treatment Period|Non medical reason|7|||
146300390|NCT00705432|527615247|FG005|Treatment Period|Non medical reason|7|||
146300391|NCT00705432|527615242|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
146300392|NCT00705432|527615243|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
146097764|NCT00808483|526879226|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
146097765|NCT00808483|526879227|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
146097766|NCT00808483|526879226|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
146097767|NCT00808483|526879227|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
146097768|NCT00808483|526879226|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
146097769|NCT00808483|526879227|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
146097770|NCT02038881|526879228|FG000|Overall Study|Withdrawal by Subject|0|||
146097771|NCT02038881|526879229|FG001|Overall Study|Withdrawal by Subject|0|||
146097772|NCT02038881|526879230|FG002|Overall Study|Withdrawal by Subject|1|||
146097773|NCT02038881|526879228|FG000|Overall Study|Lost to Follow-up|2|||
146097774|NCT02038881|526879229|FG001|Overall Study|Lost to Follow-up|0|||
146097775|NCT02038881|526879230|FG002|Overall Study|Lost to Follow-up|0|||
146097776|NCT02038881|526879228|FG000|Overall Study|incarcerated|1|||
146097777|NCT02038881|526879229|FG001|Overall Study|incarcerated|0|||
146097778|NCT02038881|526879230|FG002|Overall Study|incarcerated|0|||
146097779|NCT00333840|526879231|FG000|First-line Treatment Period|Adverse Event|38|||
146032399|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Death|1|||
146032400|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Death|0|||
146032401|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Missing|0|||
146032402|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Missing|0|||
146032403|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Missing|1|||
146032404|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Missing|0|||
146032405|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Missing|0|||
146032406|NCT00121641|526631851|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
146032407|NCT00121641|526631852|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
146032408|NCT00121641|526631853|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
146032409|NCT00121641|526631854|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
146032410|NCT00121641|526631855|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
146032411|NCT00249613|526631858|FG000|12 Month Follow-up|Death|1|||
146032412|NCT00249613|526631859|FG001|12 Month Follow-up|Death|1|||
146032413|NCT00249613|526631858|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
146032414|NCT00249613|526631859|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
146032415|NCT00249613|526631858|FG000|12 Month Follow-up|Lost to Follow-up|10|||
146032416|NCT00249613|526631859|FG001|12 Month Follow-up|Lost to Follow-up|8|||
146032417|NCT00806442|526631861|FG000|Overall Study|Lost to Follow-up|3|||
146032418|NCT00806442|526631862|FG001|Overall Study|Lost to Follow-up|2|||
146032419|NCT00806442|526631861|FG000|Overall Study|Withdrawal by Subject|1|||
146032420|NCT00806442|526631862|FG001|Overall Study|Withdrawal by Subject|5|||
146032421|NCT00619489|526631872|FG000|Overall Study|Adverse Event|0|||
146032422|NCT00619489|526631873|FG001|Overall Study|Adverse Event|7|||
146032423|NCT00619489|526631872|FG000|Overall Study|Withdrawal by Subject|1|||
146032424|NCT00619489|526631873|FG001|Overall Study|Withdrawal by Subject|1|||
146032425|NCT00619489|526631872|FG000|Overall Study|Lack of Efficacy|0|||
146032426|NCT00619489|526631873|FG001|Overall Study|Lack of Efficacy|11|||
146032427|NCT00619489|526631872|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
146032428|NCT00619489|526631873|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
146032429|NCT02356887|526631874|FG000|Overall Study|poor compliance|2|||
146032430|NCT02544373|526631878|FG000|Overall Study|Lost to Follow-up|5|||
146032431|NCT02544373|526631879|FG001|Overall Study|Lost to Follow-up|3|||
146032432|NCT02544373|526631878|FG000|Overall Study|Withdrawal by Subject|8|||
146032433|NCT02544373|526631879|FG001|Overall Study|Withdrawal by Subject|2|||
146032434|NCT02404649|526631880|FG000|Overall Study|Adverse Event|1|||
146032435|NCT02404649|526631881|FG001|Overall Study|Adverse Event|2|||
146032436|NCT00162266|526631885|FG000|Double-Blind Period|Adverse Event|5|||
146032437|NCT00162266|526631886|FG001|Double-Blind Period|Adverse Event|9|||
146032438|NCT00162266|526631887|FG002|Double-Blind Period|Adverse Event|11|||
146032439|NCT00162266|526631888|FG003|Double-Blind Period|Adverse Event|0|||
146032440|NCT00162266|526631885|FG000|Double-Blind Period|Death|0|||
146032441|NCT00162266|526631886|FG001|Double-Blind Period|Death|1|||
146032442|NCT00162266|526631887|FG002|Double-Blind Period|Death|0|||
146097780|NCT00333840|526879232|FG001|First-line Treatment Period|Adverse Event|37|||
146097781|NCT00333840|526879233|FG002|First-line Treatment Period|Adverse Event|0|||
146097782|NCT00333840|526879234|FG003|First-line Treatment Period|Adverse Event|0|||
146300393|NCT00705432|527615244|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
146300394|NCT00705432|527615245|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146300395|NCT00705432|527615246|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146032443|NCT00162266|526631888|FG003|Double-Blind Period|Death|0|||
146032444|NCT00162266|526631885|FG000|Double-Blind Period|Lost to Follow-up|1|||
146032445|NCT00162266|526631886|FG001|Double-Blind Period|Lost to Follow-up|2|||
146032446|NCT00162266|526631887|FG002|Double-Blind Period|Lost to Follow-up|0|||
146032447|NCT00162266|526631888|FG003|Double-Blind Period|Lost to Follow-up|0|||
146032448|NCT00162266|526631885|FG000|Double-Blind Period|Other Reason|1|||
146032449|NCT00162266|526631886|FG001|Double-Blind Period|Other Reason|0|||
146097783|NCT00333840|526879231|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
146032450|NCT00162266|526631887|FG002|Double-Blind Period|Other Reason|1|||
146254279|NCT00449033|527443130|FG001|Treatment Period|Lost to Follow-up|2|||
146254280|NCT00449033|527443129|FG000|Treatment Period|Physician Decision|4|||
146254281|NCT00449033|527443130|FG001|Treatment Period|Physician Decision|5|||
146032451|NCT00162266|526631888|FG003|Double-Blind Period|Other Reason|0|||
146032452|NCT00162266|526631885|FG000|Double-Blind Period|Lack of Efficacy|13|||
146032453|NCT00162266|526631886|FG001|Double-Blind Period|Lack of Efficacy|17|||
146032454|NCT00162266|526631887|FG002|Double-Blind Period|Lack of Efficacy|30|||
146032455|NCT00162266|526631888|FG003|Double-Blind Period|Lack of Efficacy|0|||
146032456|NCT00162266|526631885|FG000|Double-Blind Period|Withdrawal by Subject|5|||
146032457|NCT00162266|526631886|FG001|Double-Blind Period|Withdrawal by Subject|2|||
146032458|NCT00162266|526631887|FG002|Double-Blind Period|Withdrawal by Subject|6|||
146032459|NCT00162266|526631888|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146032460|NCT00162266|526631885|FG000|Open-Label Period|Death|0|||
146032461|NCT00162266|526631886|FG001|Open-Label Period|Death|0|||
146032462|NCT00162266|526631887|FG002|Open-Label Period|Death|0|||
146032463|NCT00162266|526631888|FG003|Open-Label Period|Death|7|||
146032464|NCT00162266|526631885|FG000|Open-Label Period|Adverse Event|0|||
146032465|NCT00162266|526631886|FG001|Open-Label Period|Adverse Event|0|||
146032466|NCT00162266|526631887|FG002|Open-Label Period|Adverse Event|0|||
146032467|NCT00162266|526631888|FG003|Open-Label Period|Adverse Event|46|||
146032468|NCT00162266|526631885|FG000|Open-Label Period|Lack of Efficacy|0|||
146032469|NCT00162266|526631886|FG001|Open-Label Period|Lack of Efficacy|0|||
146032470|NCT00162266|526631887|FG002|Open-Label Period|Lack of Efficacy|0|||
146032471|NCT00162266|526631888|FG003|Open-Label Period|Lack of Efficacy|26|||
146032472|NCT00162266|526631885|FG000|Open-Label Period|Lost to Follow-up|0|||
146032473|NCT00162266|526631886|FG001|Open-Label Period|Lost to Follow-up|0|||
146032474|NCT00162266|526631887|FG002|Open-Label Period|Lost to Follow-up|0|||
146032475|NCT00162266|526631888|FG003|Open-Label Period|Lost to Follow-up|3|||
146032476|NCT00162266|526631885|FG000|Open-Label Period|Withdrawal by Subject|0|||
146032477|NCT00162266|526631886|FG001|Open-Label Period|Withdrawal by Subject|0|||
146032478|NCT00162266|526631887|FG002|Open-Label Period|Withdrawal by Subject|0|||
146032479|NCT00162266|526631888|FG003|Open-Label Period|Withdrawal by Subject|31|||
146032480|NCT00162266|526631885|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
146032481|NCT00162266|526631886|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
146032482|NCT00162266|526631887|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
146032483|NCT00162266|526631888|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
146032484|NCT00162266|526631885|FG000|Open-Label Period|Other Reasons|0|||
146032485|NCT00162266|526631886|FG001|Open-Label Period|Other Reasons|0|||
146032486|NCT00162266|526631887|FG002|Open-Label Period|Other Reasons|0|||
146032487|NCT00162266|526631888|FG003|Open-Label Period|Other Reasons|15|||
146032488|NCT04208087|526631889|FG000|Overall Study|Adverse Event|1|||
146032489|NCT04208087|526631890|FG001|Overall Study|Adverse Event|0|||
146032490|NCT04208087|526631891|FG002|Overall Study|Adverse Event|0|||
146032491|NCT04208087|526631892|FG003|Overall Study|Adverse Event|0|||
146032492|NCT04208087|526631893|FG004|Overall Study|Adverse Event|0|||
146032493|NCT04208087|526631889|FG000|Overall Study|Withdrawal by Subject|0|||
146032494|NCT04208087|526631890|FG001|Overall Study|Withdrawal by Subject|0|||
146032495|NCT04208087|526631891|FG002|Overall Study|Withdrawal by Subject|1|||
146032496|NCT04208087|526631892|FG003|Overall Study|Withdrawal by Subject|0|||
146032497|NCT04208087|526631893|FG004|Overall Study|Withdrawal by Subject|0|||
146032498|NCT04208087|526631889|FG000|Overall Study|Other|0|||
146032499|NCT04208087|526631890|FG001|Overall Study|Other|0|||
146032500|NCT04208087|526631891|FG002|Overall Study|Other|0|||
146032501|NCT04208087|526631892|FG003|Overall Study|Other|0|||
146032502|NCT04208087|526631893|FG004|Overall Study|Other|1|||
146032503|NCT01839656|526631894|FG000|Overall Study|Withdrawal by Subject|1|||
146032504|NCT01839656|526631895|FG001|Overall Study|Withdrawal by Subject|1|||
146032505|NCT01839656|526631894|FG000|Overall Study|Adverse event, serious fatal|1|||
146032506|NCT01839656|526631895|FG001|Overall Study|Adverse event, serious fatal|4|||
146032507|NCT01839656|526631894|FG000|Overall Study|Early study closure|0|||
146032508|NCT01839656|526631895|FG001|Overall Study|Early study closure|11|||
146032509|NCT01839656|526631894|FG000|Overall Study|Adverse Event|1|||
146032510|NCT01839656|526631895|FG001|Overall Study|Adverse Event|0|||
146032511|NCT02621073|526631905|FG000|Overall Study|Lost to Follow-up|0|||
146032512|NCT02621073|526631906|FG001|Overall Study|Lost to Follow-up|1|||
146032513|NCT02621073|526631905|FG000|Overall Study|Physician Decision|3|||
146032514|NCT02621073|526631906|FG001|Overall Study|Physician Decision|2|||
146032515|NCT01595581|526631907|FG000|Overall Study|Withdrawal by Subject|1|||
146032516|NCT01595581|526631908|FG001|Overall Study|Withdrawal by Subject|0|||
146032517|NCT00495755|526631909|FG000|Overall Study|Adverse Event|3|||
146032518|NCT01073930|526633497|FG000|Overall Study|Withdrawal by Subject|3|||
146032519|NCT01073930|526633498|FG001|Overall Study|Withdrawal by Subject|2|||
146032520|NCT01073930|526633497|FG000|Overall Study|Lost to Follow-up|0|||
146032521|NCT01073930|526633498|FG001|Overall Study|Lost to Follow-up|1|||
146032522|NCT01073930|526633497|FG000|Overall Study|Adverse Event|0|||
146032523|NCT01073930|526633498|FG001|Overall Study|Adverse Event|1|||
146032524|NCT01073930|526633497|FG000|Overall Study|Noncompliance with study drug|0|||
146032525|NCT01073930|526633498|FG001|Overall Study|Noncompliance with study drug|1|||
146032526|NCT01073930|526633497|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
146032527|NCT01073930|526633498|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
146032528|NCT01266590|526633499|FG000|Overall Study|Adverse Event|3|||
146032529|NCT01266590|526633499|FG000|Overall Study|Lost to Follow-up|1|||
146032530|NCT01266590|526633499|FG000|Overall Study|Withdrawal by Subject|1|||
146032531|NCT01266590|526633499|FG000|Overall Study|Physician Decision|1|||
146032532|NCT00720343|526633500|FG000|Overall Study|Lost to Follow-up|1|||
146032533|NCT00720343|526633501|FG001|Overall Study|Lost to Follow-up|0|||
146032534|NCT00720343|526633500|FG000|Overall Study|Protocol Violation|0|||
146032535|NCT00720343|526633501|FG001|Overall Study|Protocol Violation|2|||
146032536|NCT03459365|526633502|FG000|Overall Study|Withdrawal by Subject|6|||
146032537|NCT03459365|526633502|FG000|Overall Study|Protocol Violation|8|||
146032538|NCT04037254|526633503|FG000|Overall Study|Protocol Violation|1|||
146032539|NCT04037254|526633504|FG001|Overall Study|Protocol Violation|0|||
146032540|NCT04037254|526633505|FG002|Overall Study|Protocol Violation|0|||
146032541|NCT04037254|526633506|FG003|Overall Study|Protocol Violation|0|||
146032542|NCT04037254|526633507|FG004|Overall Study|Protocol Violation|0|||
146032543|NCT04037254|526633503|FG000|Overall Study|Withdrawal by Subject|0|||
146032544|NCT04037254|526633504|FG001|Overall Study|Withdrawal by Subject|0|||
146032545|NCT04037254|526633505|FG002|Overall Study|Withdrawal by Subject|1|||
146032546|NCT04037254|526633506|FG003|Overall Study|Withdrawal by Subject|0|||
146032547|NCT04037254|526633507|FG004|Overall Study|Withdrawal by Subject|0|||
146032548|NCT04037254|526633503|FG000|Overall Study|Delayed or incomplete treatment|0|||
146032549|NCT04037254|526633504|FG001|Overall Study|Delayed or incomplete treatment|2|||
146032550|NCT04037254|526633505|FG002|Overall Study|Delayed or incomplete treatment|1|||
146032551|NCT04037254|526633506|FG003|Overall Study|Delayed or incomplete treatment|0|||
146032552|NCT04037254|526633507|FG004|Overall Study|Delayed or incomplete treatment|0|||
146032553|NCT03320330|526633508|FG000|Overall Study|Lack of Efficacy|5|||
146032554|NCT03320330|526633509|FG001|Overall Study|Lack of Efficacy|5|||
146032555|NCT03320330|526633510|FG002|Overall Study|Lack of Efficacy|14|||
146032556|NCT03320330|526633508|FG000|Overall Study|Physician Decision|1|||
146032557|NCT03320330|526633509|FG001|Overall Study|Physician Decision|0|||
146032558|NCT03320330|526633510|FG002|Overall Study|Physician Decision|0|||
146032559|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
146032560|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146032561|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146032562|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
146032563|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
146032564|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146032565|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146032566|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
146032567|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
146032568|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146032569|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146032570|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
146032571|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
146032572|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146032573|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146032574|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
146032575|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
146032576|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
146032577|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
146032578|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
146032579|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
146032580|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146032581|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146032582|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
146032583|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
146032584|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146032585|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146254282|NCT00449033|527443129|FG000|Treatment Period|Protocol Violation|8|||
146254283|NCT00449033|527443130|FG001|Treatment Period|Protocol Violation|7|||
146032586|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
146032587|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
146032588|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146032589|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146032590|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
146032591|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
146032592|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146032593|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146032594|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
146032595|NCT02198794|526633511|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
146097784|NCT00333840|526879232|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
146097785|NCT00333840|526879233|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
146097786|NCT00333840|526879234|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
146097787|NCT00333840|526879231|FG000|First-line Treatment Period|Abnormal procedure|2|||
146097788|NCT00333840|526879232|FG001|First-line Treatment Period|Abnormal procedure|0|||
146097789|NCT00333840|526879233|FG002|First-line Treatment Period|Abnormal procedure|0|||
146097790|NCT00333840|526879234|FG003|First-line Treatment Period|Abnormal procedure|0|||
146097791|NCT00333840|526879231|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
146097792|NCT00333840|526879232|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
146097793|NCT00333840|526879233|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146097794|NCT00333840|526879234|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146097795|NCT00333840|526879231|FG000|First-line Treatment Period|No longer required study drug|21|||
146097796|NCT00333840|526879232|FG001|First-line Treatment Period|No longer required study drug|8|||
146097797|NCT00333840|526879233|FG002|First-line Treatment Period|No longer required study drug|0|||
146097798|NCT00333840|526879234|FG003|First-line Treatment Period|No longer required study drug|0|||
146097799|NCT00333840|526879231|FG000|First-line Treatment Period|Protocol Violation|17|||
146097800|NCT00333840|526879232|FG001|First-line Treatment Period|Protocol Violation|17|||
146097801|NCT00333840|526879233|FG002|First-line Treatment Period|Protocol Violation|0|||
146097802|NCT00333840|526879234|FG003|First-line Treatment Period|Protocol Violation|0|||
146097803|NCT00333840|526879231|FG000|First-line Treatment Period|Subject withdrew consent|57|||
146097804|NCT00333840|526879232|FG001|First-line Treatment Period|Subject withdrew consent|77|||
146097805|NCT00333840|526879233|FG002|First-line Treatment Period|Subject withdrew consent|0|||
146097806|NCT00333840|526879234|FG003|First-line Treatment Period|Subject withdrew consent|0|||
146097807|NCT00333840|526879231|FG000|First-line Treatment Period|Lost to Follow-up|15|||
146097808|NCT00333840|526879232|FG001|First-line Treatment Period|Lost to Follow-up|6|||
146097809|NCT00333840|526879233|FG002|First-line Treatment Period|Lost to Follow-up|0|||
146097810|NCT00333840|526879234|FG003|First-line Treatment Period|Lost to Follow-up|0|||
146097811|NCT00333840|526879231|FG000|First-line Treatment Period|Administrative problems|12|||
146097812|NCT00333840|526879232|FG001|First-line Treatment Period|Administrative problems|6|||
146097813|NCT00333840|526879233|FG002|First-line Treatment Period|Administrative problems|0|||
146097814|NCT00333840|526879234|FG003|First-line Treatment Period|Administrative problems|0|||
146254284|NCT00449033|527443129|FG000|Treatment Period|Disease Progression|231|||
146254285|NCT00449033|527443130|FG001|Treatment Period|Disease Progression|288|||
146254286|NCT00449033|527443129|FG000|Treatment Period|Consent Withdrawn|36|||
146254287|NCT00449033|527443130|FG001|Treatment Period|Consent Withdrawn|20|||
146032596|NCT02198794|526633512|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146032597|NCT02198794|526633513|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146032598|NCT02198794|526633514|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
146032599|NCT02198794|526633511|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
146032600|NCT02198794|526633512|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
146032601|NCT02198794|526633513|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
146032602|NCT02198794|526633514|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
146032603|NCT02198794|526633511|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
146032604|NCT02198794|526633512|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
146032605|NCT02198794|526633513|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
146032606|NCT02198794|526633514|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
146032607|NCT02198794|526633511|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146032608|NCT02198794|526633512|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146032609|NCT02198794|526633513|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
146032610|NCT02198794|526633514|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
146032611|NCT02198794|526633511|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146032612|NCT02198794|526633512|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146032613|NCT02198794|526633513|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
146032614|NCT02198794|526633514|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
146032615|NCT02198794|526633511|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
146032616|NCT02198794|526633512|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
146032617|NCT02198794|526633513|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
146032618|NCT02198794|526633514|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
146097815|NCT00333840|526879231|FG000|First-line Treatment Period|Death|19|||
146097816|NCT00333840|526879232|FG001|First-line Treatment Period|Death|2|||
146097817|NCT00333840|526879233|FG002|First-line Treatment Period|Death|0|||
146097818|NCT00333840|526879234|FG003|First-line Treatment Period|Death|0|||
146097819|NCT00333840|526879231|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
146097820|NCT00333840|526879232|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
146097821|NCT00333840|526879233|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
146097822|NCT00333840|526879234|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
146097823|NCT00333840|526879231|FG000|Second-line Treatment Period|Adverse Event|0|||
146097824|NCT00333840|526879232|FG001|Second-line Treatment Period|Adverse Event|0|||
146032619|NCT04435600|526633515|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032620|NCT04435600|526633516|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032621|NCT04435600|526633517|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
146032622|NCT04435600|526633518|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032623|NCT04435600|526633519|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032624|NCT04435600|526633520|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032625|NCT04435600|526633521|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032626|NCT04435600|526633522|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032627|NCT04435600|526633523|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032628|NCT04435600|526633524|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
146032629|NCT04435600|526633515|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032630|NCT04435600|526633516|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032631|NCT04435600|526633517|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032632|NCT04435600|526633518|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032633|NCT04435600|526633519|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032634|NCT04435600|526633520|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032635|NCT04435600|526633521|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032636|NCT04435600|526633522|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032637|NCT04435600|526633523|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
146032638|NCT04435600|526633524|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
146032639|NCT04435600|526633515|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032640|NCT04435600|526633516|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032641|NCT04435600|526633517|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032642|NCT04435600|526633518|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032643|NCT04435600|526633519|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032644|NCT04435600|526633520|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032645|NCT04435600|526633521|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032646|NCT04435600|526633522|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032647|NCT04435600|526633523|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
146032648|NCT04435600|526633524|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
146032649|NCT04435600|526633515|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032650|NCT04435600|526633516|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032651|NCT04435600|526633517|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032652|NCT04435600|526633518|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032653|NCT04435600|526633519|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032654|NCT04435600|526633520|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032655|NCT04435600|526633521|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032656|NCT04435600|526633522|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032657|NCT04435600|526633523|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
146032658|NCT04435600|526633524|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
146032659|NCT03344172|526633528|FG000|Overall Study|Received <1 dose of treatment|1|||
146032660|NCT03344172|526633529|FG001|Overall Study|Received <1 dose of treatment|0|||
146032661|NCT02066415|526633530|FG000|Overall Study|Decision by Sponsor|5|||
146032662|NCT02066415|526633531|FG001|Overall Study|Decision by Sponsor|4|||
146032663|NCT02066415|526633532|FG002|Overall Study|Decision by Sponsor|2|||
146032664|NCT02066415|526633530|FG000|Overall Study|Withdrawal by Subject|9|||
146032665|NCT02066415|526633531|FG001|Overall Study|Withdrawal by Subject|1|||
146032666|NCT02066415|526633532|FG002|Overall Study|Withdrawal by Subject|4|||
146032667|NCT02066415|526633530|FG000|Overall Study|Lost to Follow-up|7|||
146032668|NCT02066415|526633531|FG001|Overall Study|Lost to Follow-up|2|||
146032669|NCT02066415|526633532|FG002|Overall Study|Lost to Follow-up|2|||
146032670|NCT02989805|526633533|FG000|Overall Study|invalid consent|6|||
146032671|NCT02989805|526633534|FG001|Overall Study|invalid consent|4|||
146032672|NCT03230292|526633535|FG000|Overall Study|Adverse Event|1|||
146032673|NCT03230292|526633535|FG000|Overall Study|Protocol Violation|1|||
146032674|NCT03230292|526633535|FG000|Overall Study|Lost to Follow-up|1|||
146032675|NCT03230292|526633535|FG000|Overall Study|Withdrawal by Subject|3|||
146032676|NCT04047420|526633536|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
146097825|NCT00333840|526879233|FG002|Second-line Treatment Period|Adverse Event|3|||
146097826|NCT00333840|526879234|FG003|Second-line Treatment Period|Adverse Event|34|||
146097827|NCT00333840|526879231|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146032677|NCT04047420|526633536|FG000|Washout Period|Refused Participation|2|||
146032678|NCT01639755|526633537|FG000|Overall Study|Study Ongoing|15|||
146032679|NCT01639755|526633537|FG000|Overall Study|Patient had device explantation|4|||
146032680|NCT03629912|526633540|FG000|Overall Study|Lost to Follow-up|19|||
146032681|NCT03629912|526633541|FG001|Overall Study|Lost to Follow-up|7|||
146097828|NCT00333840|526879232|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146097829|NCT00333840|526879233|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
146032682|NCT03629912|526633542|FG002|Overall Study|Lost to Follow-up|5|||
146300396|NCT00705432|527615247|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
146032683|NCT03629912|526633543|FG003|Overall Study|Lost to Follow-up|1|||
146032684|NCT03629912|526633540|FG000|Overall Study|Withdrawal by Subject|6|||
146032685|NCT03629912|526633541|FG001|Overall Study|Withdrawal by Subject|0|||
146032686|NCT03629912|526633542|FG002|Overall Study|Withdrawal by Subject|1|||
146032687|NCT03629912|526633543|FG003|Overall Study|Withdrawal by Subject|2|||
146032688|NCT03629912|526633540|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
146032689|NCT03629912|526633541|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
146032690|NCT03629912|526633542|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
146032691|NCT03629912|526633543|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
146032692|NCT03629912|526633540|FG000|Overall Study|Death|1|||
146032693|NCT03629912|526633541|FG001|Overall Study|Death|0|||
146032694|NCT03629912|526633542|FG002|Overall Study|Death|0|||
146032695|NCT03629912|526633543|FG003|Overall Study|Death|0|||
146032696|NCT03262116|526633546|FG000|Overall Study|Physician Decision|0|||
146032697|NCT03262116|526633547|FG001|Overall Study|Physician Decision|2|||
146032698|NCT03262116|526633548|FG002|Overall Study|Physician Decision|1|||
146032699|NCT03262116|526633549|FG003|Overall Study|Physician Decision|1|||
146032700|NCT03262116|526633550|FG004|Overall Study|Physician Decision|1|||
146032701|NCT03262116|526633551|FG005|Overall Study|Physician Decision|2|||
146032702|NCT02608450|526633553|FG000|Overall Study|Lost to Follow-up|39|||
146032703|NCT02608450|526633554|FG001|Overall Study|Lost to Follow-up|32|||
146032704|NCT02608450|526633553|FG000|Overall Study|Withdrawal by Subject|21|||
146032705|NCT02608450|526633554|FG001|Overall Study|Withdrawal by Subject|15|||
146032706|NCT02608450|526633553|FG000|Overall Study|Adverse Event|3|||
146032707|NCT02608450|526633554|FG001|Overall Study|Adverse Event|6|||
146032708|NCT02608450|526633553|FG000|Overall Study|Withdrawal by parent|2|||
146032709|NCT02608450|526633554|FG001|Overall Study|Withdrawal by parent|3|||
146032710|NCT02608450|526633553|FG000|Overall Study|Lack of Efficacy|0|||
146032711|NCT02608450|526633554|FG001|Overall Study|Lack of Efficacy|3|||
146032712|NCT02608450|526633553|FG000|Overall Study|Noncompliance with study drug|0|||
146032713|NCT02608450|526633554|FG001|Overall Study|Noncompliance with study drug|2|||
146032714|NCT02608450|526633553|FG000|Overall Study|Physician Decision|0|||
146032715|NCT02608450|526633554|FG001|Overall Study|Physician Decision|1|||
146032716|NCT02608450|526633553|FG000|Overall Study|Pregnancy|0|||
146032717|NCT02608450|526633554|FG001|Overall Study|Pregnancy|1|||
146032718|NCT02608450|526633553|FG000|Overall Study|Progressive disease|1|||
146032719|NCT02608450|526633554|FG001|Overall Study|Progressive disease|0|||
146032720|NCT02608450|526633553|FG000|Overall Study|Multiple reasons|0|||
146032721|NCT02608450|526633554|FG001|Overall Study|Multiple reasons|2|||
146032722|NCT00635089|526633555|FG000|Overall Study|Adverse Event|7|||
146032723|NCT00635089|526633555|FG000|Overall Study|Lack of Efficacy|28|||
146032724|NCT00635089|526633555|FG000|Overall Study|Protocol Deviation|4|||
146032725|NCT00635089|526633555|FG000|Overall Study|Lost to Follow-up|8|||
146032726|NCT00635089|526633555|FG000|Overall Study|Other|31|||
146032727|NCT02636946|526633559|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
146032728|NCT02636946|526633560|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
146032729|NCT02636946|526633559|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
146032730|NCT02636946|526633560|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
146032731|NCT02636946|526633559|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
146032732|NCT02636946|526633560|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
146032733|NCT02636946|526633559|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
146300397|NCT00705432|527615242|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
146300398|NCT00705432|527615243|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
146300399|NCT00705432|527615244|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
146300400|NCT00705432|527615245|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
146300401|NCT00705432|527615246|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
146300402|NCT00705432|527615247|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
146300403|NCT01102803|527615248|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
146300404|NCT01102803|527615249|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
146300405|NCT01102803|527615248|FG000|Post to Follow-Up|Lost to Follow-up|1|||
146300406|NCT01102803|527615249|FG001|Post to Follow-Up|Lost to Follow-up|3|||
146300407|NCT00521053|527615250|FG000|Observation Phase|Disease Progression|55|||
146300408|NCT00521053|527615250|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
146032734|NCT02636946|526633560|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
146032735|NCT02636946|526633559|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
146300409|NCT00521053|527615250|FG000|Observation Phase|Death|2|||
146300410|NCT00521053|527615250|FG000|Observation Phase|Adverse Event|1|||
146300411|NCT00521053|527615250|FG000|Observation Phase|Other non-study melanoma treatment|1|||
146032736|NCT02636946|526633560|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
146300412|NCT00521053|527615250|FG000|Observation Phase|Physician Decision|1|||
146032737|NCT02636946|526633559|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
146032738|NCT02636946|526633560|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
146032739|NCT05059977|526633561|FG000|Overall Study|Withdrawal by Subject|0|||
146032740|NCT05059977|526633562|FG001|Overall Study|Withdrawal by Subject|0|||
146032741|NCT05059977|526633563|FG002|Overall Study|Withdrawal by Subject|1|||
146032742|NCT00576472|526633564|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032743|NCT00576472|526633565|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032744|NCT00576472|526633566|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032745|NCT00576472|526633567|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
146032746|NCT00576472|526633568|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032747|NCT00576472|526633569|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032748|NCT00576472|526633570|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032749|NCT00576472|526633571|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032750|NCT00576472|526633572|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032751|NCT00576472|526633573|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032752|NCT00576472|526633574|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032753|NCT00576472|526633575|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032754|NCT00576472|526633576|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032755|NCT00576472|526633577|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032756|NCT00576472|526633578|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
146032757|NCT00576472|526633564|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
146032758|NCT00576472|526633565|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
146032759|NCT00576472|526633566|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
146032760|NCT00576472|526633567|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
146032761|NCT00576472|526633568|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
146032762|NCT00576472|526633569|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
146032763|NCT00576472|526633570|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
146032764|NCT00576472|526633571|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
146032765|NCT00576472|526633572|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
146032766|NCT00576472|526633573|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
146032767|NCT00576472|526633574|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
146032768|NCT00576472|526633575|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
146032769|NCT00576472|526633576|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
146032770|NCT00576472|526633577|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
146032771|NCT00576472|526633578|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
146032772|NCT00576472|526633564|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032773|NCT00576472|526633565|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032774|NCT00576472|526633566|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032775|NCT00576472|526633567|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
146032776|NCT00576472|526633568|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032777|NCT00576472|526633569|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032778|NCT00576472|526633570|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032779|NCT00576472|526633571|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032780|NCT00576472|526633572|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032781|NCT00576472|526633573|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032782|NCT00576472|526633574|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032783|NCT00576472|526633575|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032784|NCT00576472|526633576|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032785|NCT00576472|526633577|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032786|NCT00576472|526633578|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
146032787|NCT00576472|526633564|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
146032788|NCT00576472|526633565|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
146032789|NCT00576472|526633566|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
146032790|NCT00576472|526633567|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
146032791|NCT00576472|526633568|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
146032792|NCT00576472|526633569|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
146032793|NCT00576472|526633570|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
146032794|NCT00576472|526633571|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
146032795|NCT00576472|526633572|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
146032796|NCT00576472|526633573|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
146032797|NCT00576472|526633574|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
146032798|NCT00576472|526633575|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
146032799|NCT00576472|526633576|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
146032800|NCT00576472|526633577|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
146032801|NCT00576472|526633578|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
146032802|NCT00576472|526633564|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032803|NCT00576472|526633565|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032804|NCT00576472|526633566|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032805|NCT00576472|526633567|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
146032806|NCT00576472|526633568|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032807|NCT00576472|526633569|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032808|NCT00576472|526633570|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
146097830|NCT00333840|526879234|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
146032809|NCT00576472|526633571|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032810|NCT00576472|526633572|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032811|NCT00576472|526633573|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032812|NCT00576472|526633574|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032813|NCT00576472|526633575|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032814|NCT00576472|526633576|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032815|NCT00576472|526633577|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032816|NCT00576472|526633578|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
146032817|NCT00576472|526633564|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032818|NCT00576472|526633565|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032819|NCT00576472|526633566|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032820|NCT00576472|526633567|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032821|NCT00576472|526633568|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032822|NCT00576472|526633569|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032823|NCT00576472|526633570|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
146032824|NCT00576472|526633571|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032825|NCT00576472|526633572|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032826|NCT00576472|526633573|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032827|NCT00576472|526633574|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032828|NCT00576472|526633575|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032829|NCT00576472|526633576|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032830|NCT00576472|526633577|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032831|NCT00576472|526633578|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
146032832|NCT00576472|526633564|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
146032833|NCT00576472|526633565|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
146032834|NCT00576472|526633566|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
146032835|NCT00576472|526633567|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
146032836|NCT00576472|526633568|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
146032837|NCT00576472|526633569|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
146032838|NCT00576472|526633570|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
146032839|NCT00576472|526633571|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
146032840|NCT00576472|526633572|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
146032841|NCT00576472|526633573|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
146032842|NCT00576472|526633574|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
146032843|NCT00576472|526633575|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
146032844|NCT00576472|526633576|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
146032845|NCT00576472|526633577|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
146032846|NCT00576472|526633578|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
146032847|NCT00576472|526633564|FG000|MPH Cross Over Phase|Physician Decision|0|||
146032848|NCT00576472|526633565|FG001|MPH Cross Over Phase|Physician Decision|0|||
146032849|NCT00576472|526633566|FG002|MPH Cross Over Phase|Physician Decision|0|||
146032850|NCT00576472|526633567|FG003|MPH Cross Over Phase|Physician Decision|0|||
146032851|NCT00576472|526633568|FG004|MPH Cross Over Phase|Physician Decision|0|||
146032852|NCT00576472|526633569|FG005|MPH Cross Over Phase|Physician Decision|0|||
146032853|NCT00576472|526633570|FG006|MPH Cross Over Phase|Physician Decision|4|||
146032854|NCT00576472|526633571|FG007|MPH Cross Over Phase|Physician Decision|0|||
146032855|NCT00576472|526633572|FG008|MPH Cross Over Phase|Physician Decision|0|||
146032856|NCT00576472|526633573|FG009|MPH Cross Over Phase|Physician Decision|0|||
146032857|NCT00576472|526633574|FG010|MPH Cross Over Phase|Physician Decision|0|||
146032858|NCT00576472|526633575|FG011|MPH Cross Over Phase|Physician Decision|0|||
146032859|NCT00576472|526633576|FG012|MPH Cross Over Phase|Physician Decision|0|||
146032860|NCT00576472|526633577|FG013|MPH Cross Over Phase|Physician Decision|0|||
146032861|NCT00576472|526633578|FG014|MPH Cross Over Phase|Physician Decision|0|||
146032862|NCT00576472|526633564|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032863|NCT00576472|526633565|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032864|NCT00576472|526633566|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032865|NCT00576472|526633567|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032866|NCT00576472|526633568|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032867|NCT00576472|526633569|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032868|NCT00576472|526633570|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032869|NCT00576472|526633571|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032870|NCT00576472|526633572|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
146032871|NCT00576472|526633573|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032872|NCT00576472|526633574|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
146032873|NCT00576472|526633575|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
146032874|NCT00576472|526633576|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032875|NCT00576472|526633577|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032876|NCT00576472|526633578|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
146032877|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032878|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146097831|NCT00333840|526879231|FG000|Second-line Treatment Period|Abnormal procedure|0|||
146097832|NCT00333840|526879232|FG001|Second-line Treatment Period|Abnormal procedure|0|||
146097833|NCT00333840|526879233|FG002|Second-line Treatment Period|Abnormal procedure|0|||
146097834|NCT00333840|526879234|FG003|Second-line Treatment Period|Abnormal procedure|1|||
146097835|NCT00333840|526879231|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146097836|NCT00333840|526879232|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
146097837|NCT00333840|526879233|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
146097838|NCT00333840|526879234|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
146097839|NCT00333840|526879231|FG000|Second-line Treatment Period|No longer required study drug|0|||
146097840|NCT00333840|526879232|FG001|Second-line Treatment Period|No longer required study drug|0|||
146097841|NCT00333840|526879233|FG002|Second-line Treatment Period|No longer required study drug|1|||
146097842|NCT00333840|526879234|FG003|Second-line Treatment Period|No longer required study drug|14|||
146097843|NCT00333840|526879231|FG000|Second-line Treatment Period|Protocol Violation|0|||
146097844|NCT00333840|526879232|FG001|Second-line Treatment Period|Protocol Violation|0|||
146097845|NCT00333840|526879233|FG002|Second-line Treatment Period|Protocol Violation|1|||
146097846|NCT00333840|526879234|FG003|Second-line Treatment Period|Protocol Violation|10|||
146097847|NCT00333840|526879231|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
146097848|NCT00333840|526879232|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
146097849|NCT00333840|526879233|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
146097850|NCT00333840|526879234|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
146097851|NCT00333840|526879231|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
146097852|NCT00333840|526879232|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
146097853|NCT00333840|526879233|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
146097854|NCT00333840|526879234|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
146097855|NCT00333840|526879231|FG000|Second-line Treatment Period|Administrative problems|0|||
146097856|NCT00333840|526879232|FG001|Second-line Treatment Period|Administrative problems|0|||
146097857|NCT00333840|526879233|FG002|Second-line Treatment Period|Administrative problems|0|||
146097858|NCT00333840|526879234|FG003|Second-line Treatment Period|Administrative problems|7|||
146097859|NCT00333840|526879231|FG000|Second-line Treatment Period|Death|0|||
146097860|NCT00333840|526879232|FG001|Second-line Treatment Period|Death|0|||
146097861|NCT00333840|526879233|FG002|Second-line Treatment Period|Death|0|||
146097862|NCT00333840|526879234|FG003|Second-line Treatment Period|Death|9|||
146097863|NCT01453725|526879235|FG000|Overall Study|Adverse Event|3|||
146097864|NCT01453725|526879236|FG001|Overall Study|Adverse Event|3|||
146097865|NCT01453725|526879235|FG000|Overall Study|Lost to Follow-up|4|||
146097866|NCT01453725|526879236|FG001|Overall Study|Lost to Follow-up|0|||
146097867|NCT01453725|526879235|FG000|Overall Study|Non-compliance With Protocol|1|||
146097868|NCT01453725|526879236|FG001|Overall Study|Non-compliance With Protocol|2|||
146097869|NCT01453725|526879235|FG000|Overall Study|Protocol Violation|1|||
146097870|NCT01453725|526879236|FG001|Overall Study|Protocol Violation|0|||
146097871|NCT01453725|526879235|FG000|Overall Study|Withdrawal by Subject|2|||
146097872|NCT01453725|526879236|FG001|Overall Study|Withdrawal by Subject|3|||
146097873|NCT01453725|526879235|FG000|Overall Study|Pregnancy Wish|0|||
146097874|NCT01453725|526879236|FG001|Overall Study|Pregnancy Wish|2|||
146097875|NCT01453725|526879235|FG000|Overall Study|Pregnancy|1|||
146097876|NCT01453725|526879236|FG001|Overall Study|Pregnancy|0|||
146097877|NCT01453725|526879235|FG000|Overall Study|Physician Decision|1|||
146097878|NCT01453725|526879236|FG001|Overall Study|Physician Decision|1|||
146097879|NCT03945214|526879237|FG000|Overall Study|Lost to Follow-up|3|||
146097880|NCT03945214|526879238|FG001|Overall Study|Lost to Follow-up|4|||
146097881|NCT03945214|526879239|FG002|Overall Study|Lost to Follow-up|7|||
146097882|NCT03945214|526879240|FG003|Overall Study|Lost to Follow-up|4|||
146097883|NCT01436396|526879251|FG000|Overall Study|Protocol Violation|7|||
146097884|NCT01436396|526879252|FG001|Overall Study|Protocol Violation|5|||
146097885|NCT01436396|526879251|FG000|Overall Study|Adverse Event|1|||
146097886|NCT01436396|526879252|FG001|Overall Study|Adverse Event|2|||
146097887|NCT01436396|526879251|FG000|Overall Study|Withdrawal by Subject|19|||
146097888|NCT01436396|526879252|FG001|Overall Study|Withdrawal by Subject|29|||
146097889|NCT01436396|526879251|FG000|Overall Study|Serious adverse event|2|||
146097890|NCT01436396|526879252|FG001|Overall Study|Serious adverse event|3|||
146097891|NCT01436396|526879251|FG000|Overall Study|Lost to Follow-up|3|||
146097892|NCT01436396|526879252|FG001|Overall Study|Lost to Follow-up|3|||
146097893|NCT00875979|526879253|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
146097894|NCT00875979|526879254|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
146097895|NCT00875979|526879253|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
146097896|NCT00875979|526879254|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
146097897|NCT00875979|526879253|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
146097898|NCT00875979|526879254|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
146097899|NCT00875979|526879253|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
146097900|NCT00875979|526879254|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
146097901|NCT00875979|526879253|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
146032879|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032880|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032881|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032882|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032883|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032884|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032885|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032886|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032887|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032888|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032889|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032890|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
146032891|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
146032892|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
146032893|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
146032894|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
146032895|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
146032896|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
146032897|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
146032898|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
146032899|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
146032900|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
146032901|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
146032902|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
146032903|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
146032904|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
146032905|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
146032906|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
146032907|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
146032908|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
146032909|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
146032910|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
146032911|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
146032912|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
146032913|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
146032914|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
146032915|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
146032916|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
146032917|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
146032918|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
146032919|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
146032920|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
146032921|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
146032922|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Side effects|0|||
146032923|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Side effects|0|||
146032924|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Side effects|0|||
146032925|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Side effects|0|||
146032926|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Side effects|0|||
146032927|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Side effects|0|||
146032928|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Side effects|0|||
146032929|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Side effects|0|||
146032930|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Side effects|0|||
146032931|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Side effects|0|||
146032932|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Side effects|0|||
146032933|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Side effects|0|||
146032934|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Side effects|0|||
146032935|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Side effects|0|||
146032936|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Side effects|8|||
146097902|NCT00875979|526879254|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
146097903|NCT00875979|526879253|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
146097904|NCT00875979|526879254|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
146097905|NCT00875979|526879253|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
146097906|NCT00875979|526879254|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
146097907|NCT00875979|526879253|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
146032937|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032938|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032939|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032940|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032941|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032942|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032943|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032944|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032945|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032946|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032947|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032948|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032949|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032950|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
146032951|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
146032952|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
146032953|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
146032954|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
146032955|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
146032956|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
146032957|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
146032958|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
146032959|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
146032960|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
146032961|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
146032962|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
146032963|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
146032964|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
146032965|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
146032966|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
146032967|NCT00576472|526633564|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146254288|NCT00449033|527443129|FG000|Treatment Period|Amended Protocol Criteria|22|||
146254289|NCT00449033|527443130|FG001|Treatment Period|Amended Protocol Criteria|18|||
146254290|NCT00449033|527443129|FG000|Treatment Period|Non-compliance|7|||
146254291|NCT00449033|527443130|FG001|Treatment Period|Non-compliance|8|||
146254292|NCT00449033|527443129|FG000|Treatment Period|Second Malignancy|0|||
146032968|NCT00576472|526633565|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032969|NCT00576472|526633566|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032970|NCT00576472|526633567|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032971|NCT00576472|526633568|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032972|NCT00576472|526633569|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032973|NCT00576472|526633570|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032974|NCT00576472|526633571|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032975|NCT00576472|526633572|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032976|NCT00576472|526633573|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032977|NCT00576472|526633574|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032978|NCT00576472|526633575|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032979|NCT00576472|526633576|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032980|NCT00576472|526633577|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
146032981|NCT00576472|526633578|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
146032982|NCT04405245|526633581|FG000|Overall Study|Adverse Event|0|||
146032983|NCT04405245|526633582|FG001|Overall Study|Adverse Event|1|||
146254293|NCT00449033|527443130|FG001|Treatment Period|Second Malignancy|1|||
146254294|NCT00449033|527443129|FG000|Treatment Period|Reason Missing|0|||
146254295|NCT00449033|527443130|FG001|Treatment Period|Reason Missing|4|||
146254296|NCT00449033|527443129|FG000|Treatment Period|Treatment Ongoing|6|||
146254297|NCT00449033|527443130|FG001|Treatment Period|Treatment Ongoing|4|||
146254298|NCT00449033|527443129|FG000|Follow-up Period|Death|299|||
146254299|NCT00449033|527443130|FG001|Follow-up Period|Death|311|||
146032984|NCT04405245|526633583|FG002|Overall Study|Adverse Event|0|||
146032985|NCT02576860|526633585|FG000|Overall Study|Adverse Event|6|||
146032986|NCT02576860|526633586|FG001|Overall Study|Adverse Event|6|||
146032987|NCT02576860|526633585|FG000|Overall Study|Lost to Follow-up|5|||
146254300|NCT00449033|527443129|FG000|Follow-up Period|Lost to Follow-up|6|||
146032988|NCT02576860|526633586|FG001|Overall Study|Lost to Follow-up|7|||
146032989|NCT02576860|526633585|FG000|Overall Study|Physician Decision|0|||
146254301|NCT00449033|527443130|FG001|Follow-up Period|Lost to Follow-up|10|||
146254302|NCT00449033|527443129|FG000|Follow-up Period|Reason Missing|120|||
146254303|NCT00449033|527443130|FG001|Follow-up Period|Reason Missing|113|||
146254304|NCT02784535|527443134|FG000|Overall Study|Adverse Event|1|||
146254305|NCT02784535|527443135|FG001|Overall Study|Adverse Event|0|||
146032990|NCT02576860|526633586|FG001|Overall Study|Physician Decision|1|||
146032991|NCT02576860|526633585|FG000|Overall Study|Protocol Violation|0|||
146032992|NCT02576860|526633586|FG001|Overall Study|Protocol Violation|2|||
146254306|NCT02784535|527443134|FG000|Overall Study|Withdrawal by Subject|0|||
146254307|NCT02784535|527443135|FG001|Overall Study|Withdrawal by Subject|1|||
146254308|NCT02784535|527443134|FG000|Overall Study|Physician Decision|0|||
146254309|NCT02784535|527443135|FG001|Overall Study|Physician Decision|1|||
146097908|NCT00875979|526879254|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
146097909|NCT00875979|526879253|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
146097910|NCT00875979|526879254|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
146097911|NCT03605212|526879256|FG000|Treatment Period|Adverse Event|1|||
146097912|NCT03605212|526879257|FG001|Treatment Period|Adverse Event|0|||
146097913|NCT03605212|526879258|FG002|Treatment Period|Adverse Event|0|||
146097914|NCT03605212|526879259|FG003|Treatment Period|Adverse Event|0|||
146097915|NCT03605212|526879260|FG004|Treatment Period|Adverse Event|0|||
146097916|NCT03605212|526879256|FG000|Treatment Period|Physician Decision|0|||
146097917|NCT03605212|526879257|FG001|Treatment Period|Physician Decision|0|||
146097918|NCT03605212|526879258|FG002|Treatment Period|Physician Decision|0|||
146097919|NCT03605212|526879259|FG003|Treatment Period|Physician Decision|0|||
146097920|NCT03605212|526879260|FG004|Treatment Period|Physician Decision|1|||
146097921|NCT02083081|526879261|FG000|Overall Study|Lost to Follow-up|31|||
146097922|NCT02083081|526879262|FG001|Overall Study|Lost to Follow-up|9|||
146097923|NCT04209348|526879266|FG000|Overall Study|Lost to Follow-up|1|||
146097924|NCT04209348|526879267|FG001|Overall Study|Lost to Follow-up|0|||
146097925|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
146097926|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
146097927|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Death|1|||
146097928|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Death|0|||
146097929|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
146097930|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
146097931|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
146097932|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
146097933|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
146097934|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
146097935|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
146097936|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
146097937|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
146097938|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
146097939|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
146097940|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
146097941|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
146097942|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
146097943|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
146097944|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
146097945|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
146097946|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
146097947|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
146097948|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
146097949|NCT02927262|526879268|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
146097950|NCT02927262|526879269|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
146097951|NCT02927262|526879268|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
146097952|NCT02927262|526879269|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
146097953|NCT02927262|526879268|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
146097954|NCT02927262|526879269|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
146097955|NCT02927262|526879268|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
146097956|NCT02927262|526879269|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
146097957|NCT04043728|526879270|FG000|Overall Study|Lost to Follow-up|1|||
146097958|NCT04043728|526879271|FG001|Overall Study|Lost to Follow-up|2|||
146097959|NCT04043728|526879272|FG002|Overall Study|Lost to Follow-up|0|||
146097960|NCT03698331|526879276|FG000|Overall Study|Adverse Event|2|||
146097961|NCT03698331|526879277|FG001|Overall Study|Adverse Event|3|||
146097962|NCT03698331|526879276|FG000|Overall Study|Withdrawal by Subject|1|||
146097963|NCT03698331|526879277|FG001|Overall Study|Withdrawal by Subject|1|||
146097964|NCT03698331|526879276|FG000|Overall Study|Lost to Follow-up|0|||
146097965|NCT03698331|526879277|FG001|Overall Study|Lost to Follow-up|2|||
146097966|NCT03698331|526879276|FG000|Overall Study|Non-compliance with study drug|1|||
146097967|NCT03698331|526879277|FG001|Overall Study|Non-compliance with study drug|0|||
146254310|NCT01904019|527444551|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
146254311|NCT01904019|527444551|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
146254312|NCT01904019|527444551|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
146097968|NCT02130024|526879279|FG000|Overall Study|Adverse Event|10|||
146097969|NCT02130024|526879280|FG001|Overall Study|Adverse Event|11|||
146097970|NCT02130024|526879279|FG000|Overall Study|Death|2|||
146097971|NCT02130024|526879280|FG001|Overall Study|Death|2|||
146097972|NCT02130024|526879279|FG000|Overall Study|Lost to Follow-up|1|||
146097973|NCT02130024|526879280|FG001|Overall Study|Lost to Follow-up|1|||
146300413|NCT00375219|527615251|FG000|Overall Study|Failure to achieve a response|16|||
146300414|NCT00375219|527615252|FG001|Overall Study|Failure to achieve a response|2|||
146032993|NCT02576860|526633585|FG000|Overall Study|Withdrawal by Subject|13|||
146032994|NCT02576860|526633586|FG001|Overall Study|Withdrawal by Subject|8|||
146032995|NCT02576860|526633585|FG000|Overall Study|Disallowed medication|1|||
146032996|NCT02576860|526633586|FG001|Overall Study|Disallowed medication|0|||
146032997|NCT00477269|526633587|FG000|Core Study|Adverse Event|6|||
146032998|NCT00477269|526633588|FG001|Core Study|Adverse Event|4|||
146032999|NCT00477269|526633589|FG002|Core Study|Adverse Event|0|||
146033000|NCT00477269|526633587|FG000|Core Study|Death|3|||
146033001|NCT00477269|526633588|FG001|Core Study|Death|3|||
146033002|NCT00477269|526633589|FG002|Core Study|Death|0|||
146033003|NCT00477269|526633587|FG000|Core Study|Withdrawn Consent|0|||
146033004|NCT00477269|526633588|FG001|Core Study|Withdrawn Consent|1|||
146033005|NCT00477269|526633589|FG002|Core Study|Withdrawn Consent|0|||
146033006|NCT00477269|526633587|FG000|Open Label Extension|Adverse Event|0|||
146033007|NCT00477269|526633588|FG001|Open Label Extension|Adverse Event|0|||
146033008|NCT00477269|526633589|FG002|Open Label Extension|Adverse Event|4|||
146033009|NCT00477269|526633587|FG000|Open Label Extension|Abnormal laboratory values|0|||
146033010|NCT00477269|526633588|FG001|Open Label Extension|Abnormal laboratory values|0|||
146033011|NCT00477269|526633589|FG002|Open Label Extension|Abnormal laboratory values|1|||
146033012|NCT00477269|526633587|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
146033013|NCT00477269|526633588|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
146033014|NCT00477269|526633589|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
146033015|NCT00477269|526633587|FG000|Open Label Extension|Adminiatrative problems|0|||
146033016|NCT00477269|526633588|FG001|Open Label Extension|Adminiatrative problems|0|||
146033017|NCT00477269|526633589|FG002|Open Label Extension|Adminiatrative problems|2|||
146033018|NCT00477269|526633587|FG000|Open Label Extension|Death|0|||
146033019|NCT00477269|526633588|FG001|Open Label Extension|Death|0|||
146033020|NCT00477269|526633589|FG002|Open Label Extension|Death|4|||
146033021|NCT02391961|526633590|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
146033022|NCT02391961|526633591|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
146033023|NCT02391961|526633590|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146033024|NCT02391961|526633591|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
146033025|NCT02391961|526633590|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146033026|NCT02391961|526633591|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146033027|NCT01792518|526633600|FG000|Overall Study|Adverse Event|3|||
146033028|NCT01792518|526633601|FG001|Overall Study|Adverse Event|4|||
146033029|NCT01792518|526633600|FG000|Overall Study|Protocol Violation|0|||
146033030|NCT01792518|526633601|FG001|Overall Study|Protocol Violation|1|||
146033031|NCT01792518|526633600|FG000|Overall Study|Lost to Follow-up|3|||
146033032|NCT01792518|526633601|FG001|Overall Study|Lost to Follow-up|1|||
146033033|NCT01792518|526633600|FG000|Overall Study|Withdrawal by Subject|2|||
146033034|NCT01792518|526633601|FG001|Overall Study|Withdrawal by Subject|0|||
146033035|NCT01792518|526633600|FG000|Overall Study|Other Reason|0|||
146033036|NCT01792518|526633601|FG001|Overall Study|Other Reason|1|||
146033037|NCT03263780|526633602|FG000|Overall Study|Withdrawal by Subject|3|||
146033038|NCT03263780|526633602|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
146033039|NCT00424190|526633614|FG000|Overall Study|Withdrew consent|3|||
146033040|NCT00424190|526633615|FG001|Overall Study|Withdrew consent|4|||
146033041|NCT00424190|526633614|FG000|Overall Study|Death|3|||
146033042|NCT00424190|526633615|FG001|Overall Study|Death|0|||
146033043|NCT00424190|526633614|FG000|Overall Study|Noncompliance|1|||
146033044|NCT00424190|526633615|FG001|Overall Study|Noncompliance|2|||
146033045|NCT00424190|526633614|FG000|Overall Study|Request of sponsor or investigator|0|||
146033046|NCT00424190|526633615|FG001|Overall Study|Request of sponsor or investigator|2|||
146033047|NCT00424190|526633614|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
146033048|NCT00424190|526633615|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
146033049|NCT00424190|526633614|FG000|Overall Study|Other|15|||
146033050|NCT00424190|526633615|FG001|Overall Study|Other|21|||
146033051|NCT00351273|526633616|FG000|Overall Study|Lost to Follow-up|1|||
146033052|NCT00351273|526633617|FG001|Overall Study|Lost to Follow-up|2|||
146033053|NCT00351273|526633618|FG002|Overall Study|Lost to Follow-up|5|||
146033054|NCT01378429|526633620|FG000|Overall Study|Noncompliance with study drug|1|||
146033055|NCT01378429|526633621|FG001|Overall Study|Noncompliance with study drug|0|||
146033056|NCT02241187|526633622|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
146033057|NCT00199888|526633625|FG000|Overall Study|Lost to Follow-up|1|||
146033058|NCT05219669|526633626|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
146033059|NCT05219669|526633627|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
146033060|NCT05219669|526633628|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
146033061|NCT05219669|526633629|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
146033062|NCT05219669|526633630|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
146033063|NCT05219669|526633631|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
146033064|NCT00330668|526633634|FG000|BID Dosing Period|Adverse Event|1|||
146033065|NCT00330668|526633634|FG000|BID Dosing Period|Lost to Follow-up|7|||
146033066|NCT00330668|526633634|FG000|BID Dosing Period|Non-Compliance|5|||
146033067|NCT00330668|526633634|FG000|BID Dosing Period|Withdrawal by Subject|19|||
146254313|NCT01904019|527444551|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
146254314|NCT01904019|527444551|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
146033068|NCT00330668|526633634|FG000|BID Dosing Period|Sponsor's decision|1|||
146033069|NCT00330668|526633634|FG000|BID Dosing Period|Other|3|||
146033070|NCT00330668|526633634|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
146033071|NCT00330668|526633634|FG000|QD Dosing Period|Other|1|||
146033072|NCT00330668|526633634|FG000|QD Dosing Period|Withdrawal by Subject|1|||
146033073|NCT00330668|526633634|FG000|QD Dosing Period|Lost to Follow-up|2|||
146033074|NCT02265796|526633635|FG000|Overall Study|Death|1|||
146033075|NCT02265796|526633636|FG001|Overall Study|Death|0|||
146033076|NCT02265796|526633635|FG000|Overall Study|started on excluded medication|1|||
146033077|NCT02265796|526633636|FG001|Overall Study|started on excluded medication|0|||
146033078|NCT02265796|526633635|FG000|Overall Study|Withdrawal by Subject|1|||
146033079|NCT02265796|526633636|FG001|Overall Study|Withdrawal by Subject|1|||
146033080|NCT02920957|526633637|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
146033081|NCT02920957|526633638|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
146033082|NCT02920957|526633637|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
146033083|NCT02920957|526633638|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
146033084|NCT02920957|526633637|FG000|First Intervention : 1 Month|Adverse Event|1|||
146033085|NCT02920957|526633638|FG001|First Intervention : 1 Month|Adverse Event|0|||
146033086|NCT02920957|526633637|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
146033087|NCT02920957|526633638|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
146033088|NCT00558272|526633639|FG000|Overall Study|Adverse Event|10|||
146033089|NCT00558272|526633640|FG001|Overall Study|Adverse Event|0|||
146033090|NCT00558272|526633639|FG000|Overall Study|Death|1|||
146033091|NCT00558272|526633640|FG001|Overall Study|Death|0|||
146033092|NCT00558272|526633639|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
146033093|NCT00558272|526633640|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
146033094|NCT00558272|526633639|FG000|Overall Study|AZ study team decision|0|||
146033095|NCT00558272|526633640|FG001|Overall Study|AZ study team decision|1|||
146033096|NCT00558272|526633639|FG000|Overall Study|Incorrectly enrolled|1|||
146033097|NCT00558272|526633640|FG001|Overall Study|Incorrectly enrolled|0|||
146033098|NCT00558272|526633639|FG000|Overall Study|Withdrawal by Subject|0|||
146033099|NCT00558272|526633640|FG001|Overall Study|Withdrawal by Subject|1|||
146033100|NCT02014584|526633642|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146033101|NCT02014584|526633643|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
146033102|NCT02014584|526633644|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146033103|NCT02014584|526633645|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146033104|NCT02014584|526633646|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146033105|NCT02014584|526633647|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
146033106|NCT02014584|526633642|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
146033107|NCT02014584|526633643|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
146033108|NCT02014584|526633644|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146033109|NCT02014584|526633645|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146033110|NCT02014584|526633646|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146033111|NCT02014584|526633647|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
146033112|NCT02014584|526633642|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146033113|NCT02014584|526633643|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146033114|NCT02014584|526633644|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
146033115|NCT02014584|526633645|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146033116|NCT02014584|526633646|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146033117|NCT02014584|526633647|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
146033118|NCT02014584|526633642|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146033119|NCT02014584|526633643|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146033120|NCT02014584|526633644|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
146033121|NCT02014584|526633645|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
146033122|NCT02014584|526633646|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146033123|NCT02014584|526633647|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
146033124|NCT02014584|526633642|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146033125|NCT02014584|526633643|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146033126|NCT02014584|526633644|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146033127|NCT02014584|526633645|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146033128|NCT02014584|526633646|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
146033129|NCT02014584|526633647|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
146033130|NCT00483002|526633648|FG000|Overall Study|Adverse Event|68|||
146033131|NCT00483002|526633648|FG000|Overall Study|Lack of Efficacy|555|||
146033132|NCT00483002|526633648|FG000|Overall Study|Lost to Follow-up|962|||
146033133|NCT00483002|526633648|FG000|Overall Study|Other|2|||
146033134|NCT00483002|526633648|FG000|Overall Study|Other|967|||
146033135|NCT03442296|526633649|FG000|3 Month Follow-up|Death|3|||
146033136|NCT03442296|526633650|FG001|3 Month Follow-up|Death|1|||
146033137|NCT03442296|526633649|FG000|3 Month Follow-up|Lost to Follow-up|1|||
146033138|NCT03442296|526633650|FG001|3 Month Follow-up|Lost to Follow-up|1|||
146033139|NCT03442296|526633649|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
146033140|NCT03442296|526633650|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
146033141|NCT03442296|526633649|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
146033142|NCT03442296|526633650|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
146033143|NCT03442296|526633649|FG000|12 Month Follow-up|Incomplete measurement|1|||
146033144|NCT03442296|526633650|FG001|12 Month Follow-up|Incomplete measurement|1|||
146033145|NCT03684694|526633651|FG000|Phase 1|Withdrawal by Subject|1|||
146033146|NCT03684694|526633652|FG001|Phase 1|Withdrawal by Subject|0|||
146033147|NCT03684694|526633653|FG002|Phase 1|Withdrawal by Subject|0|||
146033148|NCT03684694|526633654|FG003|Phase 1|Withdrawal by Subject|0|||
146033149|NCT03684694|526633655|FG004|Phase 1|Withdrawal by Subject|0|||
146033150|NCT03684694|526633656|FG005|Phase 1|Withdrawal by Subject|0|||
146033151|NCT03684694|526633651|FG000|Phase 1|Investigator/Sponsor Decision|12|||
146033152|NCT03684694|526633652|FG001|Phase 1|Investigator/Sponsor Decision|2|||
146033153|NCT03684694|526633653|FG002|Phase 1|Investigator/Sponsor Decision|1|||
146033154|NCT03684694|526633654|FG003|Phase 1|Investigator/Sponsor Decision|0|||
146033155|NCT03684694|526633655|FG004|Phase 1|Investigator/Sponsor Decision|0|||
146033156|NCT03684694|526633656|FG005|Phase 1|Investigator/Sponsor Decision|0|||
146033157|NCT03684694|526633651|FG000|Phase 1|Death|24|||
146033158|NCT03684694|526633652|FG001|Phase 1|Death|0|||
146033159|NCT03684694|526633653|FG002|Phase 1|Death|3|||
146033160|NCT03684694|526633654|FG003|Phase 1|Death|0|||
146033161|NCT03684694|526633655|FG004|Phase 1|Death|0|||
146033162|NCT03684694|526633656|FG005|Phase 1|Death|0|||
146033163|NCT03684694|526633651|FG000|Phase 1|Lost to Follow-up|0|||
146033164|NCT03684694|526633652|FG001|Phase 1|Lost to Follow-up|0|||
146033165|NCT03684694|526633653|FG002|Phase 1|Lost to Follow-up|1|||
146033166|NCT03684694|526633654|FG003|Phase 1|Lost to Follow-up|0|||
146033167|NCT03684694|526633655|FG004|Phase 1|Lost to Follow-up|0|||
146033168|NCT03684694|526633656|FG005|Phase 1|Lost to Follow-up|0|||
146033169|NCT03684694|526633651|FG000|Phase 1|Miscellaneous|0|||
146033170|NCT03684694|526633652|FG001|Phase 1|Miscellaneous|1|||
146033171|NCT03684694|526633653|FG002|Phase 1|Miscellaneous|0|||
146033172|NCT03684694|526633654|FG003|Phase 1|Miscellaneous|0|||
146033173|NCT03684694|526633655|FG004|Phase 1|Miscellaneous|0|||
146033174|NCT03684694|526633656|FG005|Phase 1|Miscellaneous|0|||
146033175|NCT03684694|526633651|FG000|Phase 2|Withdrawal by Subject|0|||
146033176|NCT03684694|526633652|FG001|Phase 2|Withdrawal by Subject|0|||
146033177|NCT03684694|526633653|FG002|Phase 2|Withdrawal by Subject|0|||
146033178|NCT03684694|526633654|FG003|Phase 2|Withdrawal by Subject|0|||
146033179|NCT03684694|526633655|FG004|Phase 2|Withdrawal by Subject|0|||
146033180|NCT03684694|526633656|FG005|Phase 2|Withdrawal by Subject|1|||
146033181|NCT03684694|526633651|FG000|Phase 2|Investigator/Sponsor Decision|0|||
146033182|NCT03684694|526633652|FG001|Phase 2|Investigator/Sponsor Decision|0|||
146033183|NCT03684694|526633653|FG002|Phase 2|Investigator/Sponsor Decision|0|||
146033184|NCT03684694|526633654|FG003|Phase 2|Investigator/Sponsor Decision|17|||
146033185|NCT03684694|526633655|FG004|Phase 2|Investigator/Sponsor Decision|16|||
146033186|NCT03684694|526633656|FG005|Phase 2|Investigator/Sponsor Decision|6|||
146033187|NCT03684694|526633651|FG000|Phase 2|Death|0|||
146033188|NCT03684694|526633652|FG001|Phase 2|Death|0|||
146033189|NCT03684694|526633653|FG002|Phase 2|Death|0|||
146033190|NCT03684694|526633654|FG003|Phase 2|Death|28|||
146033191|NCT03684694|526633655|FG004|Phase 2|Death|14|||
146033192|NCT03684694|526633656|FG005|Phase 2|Death|3|||
146033193|NCT03684694|526633651|FG000|Phase 2|Lost to Follow-up|0|||
146033194|NCT03684694|526633652|FG001|Phase 2|Lost to Follow-up|0|||
146033195|NCT03684694|526633653|FG002|Phase 2|Lost to Follow-up|0|||
146033196|NCT03684694|526633654|FG003|Phase 2|Lost to Follow-up|1|||
146033197|NCT03684694|526633655|FG004|Phase 2|Lost to Follow-up|0|||
146033198|NCT03684694|526633656|FG005|Phase 2|Lost to Follow-up|0|||
146033199|NCT03684694|526633651|FG000|Phase 2|Miscellaneous|0|||
146097974|NCT02130024|526879279|FG000|Overall Study|Physician Decision|1|||
146033200|NCT03684694|526633652|FG001|Phase 2|Miscellaneous|0|||
146033201|NCT03684694|526633653|FG002|Phase 2|Miscellaneous|0|||
146033202|NCT03684694|526633654|FG003|Phase 2|Miscellaneous|3|||
146033203|NCT03684694|526633655|FG004|Phase 2|Miscellaneous|0|||
146033204|NCT03684694|526633656|FG005|Phase 2|Miscellaneous|0|||
146033205|NCT05011513|526635088|FG000|Overall Study|Death|0|||
146033206|NCT05011513|526635089|FG001|Overall Study|Death|1|||
146033207|NCT05011513|526635088|FG000|Overall Study|Lost to Follow-up|4|||
146033208|NCT05011513|526635089|FG001|Overall Study|Lost to Follow-up|0|||
146033209|NCT05011513|526635088|FG000|Overall Study|Withdrawal by Subject|18|||
146033210|NCT05011513|526635089|FG001|Overall Study|Withdrawal by Subject|17|||
146033211|NCT05011513|526635088|FG000|Overall Study|Other|4|||
146033212|NCT05011513|526635089|FG001|Overall Study|Other|2|||
146033213|NCT03667690|526635090|FG000|Overall Study|Adverse Event|0|||
146033214|NCT03667690|526635091|FG001|Overall Study|Adverse Event|3|||
146033215|NCT03667690|526635090|FG000|Overall Study|Death|22|||
146033216|NCT03667690|526635091|FG001|Overall Study|Death|21|||
146033217|NCT03667690|526635090|FG000|Overall Study|Lost to Follow-up|4|||
146033218|NCT03667690|526635091|FG001|Overall Study|Lost to Follow-up|5|||
146033219|NCT03667690|526635090|FG000|Overall Study|Withdrawal by Subject|7|||
146033220|NCT03667690|526635091|FG001|Overall Study|Withdrawal by Subject|8|||
146033221|NCT03667690|526635090|FG000|Overall Study|Subject could not return for additional investigational product|1|||
146033222|NCT03667690|526635091|FG001|Overall Study|Subject could not return for additional investigational product|0|||
146033223|NCT03667690|526635090|FG000|Overall Study|Subject discharged to hospice care|2|||
146033224|NCT03667690|526635091|FG001|Overall Study|Subject discharged to hospice care|0|||
146033225|NCT03667690|526635090|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
146033226|NCT03667690|526635091|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
146033227|NCT03667690|526635090|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
146033228|NCT03667690|526635091|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
146033229|NCT03667690|526635090|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
146033230|NCT03667690|526635091|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
146033231|NCT03667690|526635090|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
146033232|NCT03667690|526635091|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
146033233|NCT03667690|526635090|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
146033234|NCT03667690|526635091|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
146033235|NCT04327024|526635093|FG000|Overall Study|Death|1|||
146033236|NCT04327024|526635094|FG001|Overall Study|Death|2|||
146033237|NCT04327024|526635095|FG002|Overall Study|Death|1|||
146033238|NCT04327024|526635093|FG000|Overall Study|Non-compliance with study drug|0|||
146033239|NCT04327024|526635094|FG001|Overall Study|Non-compliance with study drug|1|||
146033240|NCT04327024|526635095|FG002|Overall Study|Non-compliance with study drug|0|||
146033241|NCT04327024|526635093|FG000|Overall Study|Withdrawal by Subject|1|||
146033242|NCT04327024|526635094|FG001|Overall Study|Withdrawal by Subject|1|||
146033243|NCT04327024|526635095|FG002|Overall Study|Withdrawal by Subject|2|||
146033244|NCT00837759|526635097|FG000|Overall Study|Protocol Violation|3|||
146033245|NCT00837759|526635097|FG000|Overall Study|Lost to Follow-up|1|||
146033246|NCT01022424|526635098|FG000|Overall Study|Adverse Event|1|||
146033247|NCT01022424|526635098|FG000|Overall Study|Physician Decision|1|||
146033248|NCT01022424|526635098|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
146033249|NCT01918332|526635100|FG000|Overall Study|Adverse Event|0|||
146033250|NCT01918332|526635101|FG001|Overall Study|Adverse Event|0|||
146033251|NCT01918332|526635102|FG002|Overall Study|Adverse Event|0|||
146033252|NCT01918332|526635103|FG003|Overall Study|Adverse Event|1|||
146033253|NCT01918332|526635100|FG000|Overall Study|Withdrawal by Subject|2|||
146033254|NCT01918332|526635101|FG001|Overall Study|Withdrawal by Subject|3|||
146033255|NCT01918332|526635102|FG002|Overall Study|Withdrawal by Subject|2|||
146033256|NCT01918332|526635103|FG003|Overall Study|Withdrawal by Subject|3|||
146033257|NCT01918332|526635100|FG000|Overall Study|Protocol Violation|6|||
146033258|NCT01918332|526635101|FG001|Overall Study|Protocol Violation|2|||
146033259|NCT01918332|526635102|FG002|Overall Study|Protocol Violation|6|||
146033260|NCT01918332|526635103|FG003|Overall Study|Protocol Violation|3|||
146033261|NCT01918332|526635100|FG000|Overall Study|lipid result by central lab did not meet|0|||
146033262|NCT01918332|526635101|FG001|Overall Study|lipid result by central lab did not meet|0|||
146033263|NCT01918332|526635102|FG002|Overall Study|lipid result by central lab did not meet|1|||
146033264|NCT01918332|526635103|FG003|Overall Study|lipid result by central lab did not meet|0|||
146033265|NCT02905006|526635104|FG000|Overall Study|Adverse Event|1|||
146033266|NCT02905006|526635105|FG001|Overall Study|Adverse Event|1|||
146033267|NCT02905006|526635106|FG002|Overall Study|Adverse Event|1|||
146033268|NCT02905006|526635107|FG003|Overall Study|Adverse Event|1|||
146033269|NCT02905006|526635108|FG004|Overall Study|Adverse Event|0|||
146033270|NCT02905006|526635109|FG005|Overall Study|Adverse Event|1|||
146033271|NCT02905006|526635104|FG000|Overall Study|Lack of Efficacy|1|||
146033272|NCT02905006|526635105|FG001|Overall Study|Lack of Efficacy|0|||
146033273|NCT02905006|526635106|FG002|Overall Study|Lack of Efficacy|0|||
146033274|NCT02905006|526635107|FG003|Overall Study|Lack of Efficacy|0|||
146033275|NCT02905006|526635108|FG004|Overall Study|Lack of Efficacy|0|||
146033276|NCT02905006|526635109|FG005|Overall Study|Lack of Efficacy|0|||
146033277|NCT02905006|526635104|FG000|Overall Study|Protocol Violation|2|||
146033278|NCT02905006|526635105|FG001|Overall Study|Protocol Violation|0|||
146033279|NCT02905006|526635106|FG002|Overall Study|Protocol Violation|0|||
146033280|NCT02905006|526635107|FG003|Overall Study|Protocol Violation|0|||
146033281|NCT02905006|526635108|FG004|Overall Study|Protocol Violation|0|||
146033282|NCT02905006|526635109|FG005|Overall Study|Protocol Violation|0|||
146033283|NCT02905006|526635104|FG000|Overall Study|Lost to Follow-up|0|||
146033284|NCT02905006|526635105|FG001|Overall Study|Lost to Follow-up|0|||
146033285|NCT02905006|526635106|FG002|Overall Study|Lost to Follow-up|0|||
146033286|NCT02905006|526635107|FG003|Overall Study|Lost to Follow-up|1|||
146033287|NCT02905006|526635108|FG004|Overall Study|Lost to Follow-up|1|||
146033288|NCT02905006|526635109|FG005|Overall Study|Lost to Follow-up|0|||
146033289|NCT02905006|526635104|FG000|Overall Study|Withdrawal by Subject|0|||
146097975|NCT02130024|526879280|FG001|Overall Study|Physician Decision|3|||
146097976|NCT02130024|526879279|FG000|Overall Study|Protocol Deviation|4|||
146254315|NCT01904019|527444551|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
146254316|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
146254317|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
146254318|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
146254319|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
146033290|NCT02905006|526635105|FG001|Overall Study|Withdrawal by Subject|0|||
146033291|NCT02905006|526635106|FG002|Overall Study|Withdrawal by Subject|1|||
146033292|NCT02905006|526635107|FG003|Overall Study|Withdrawal by Subject|1|||
146033293|NCT02905006|526635108|FG004|Overall Study|Withdrawal by Subject|0|||
146033294|NCT02905006|526635109|FG005|Overall Study|Withdrawal by Subject|1|||
146033295|NCT02905006|526635104|FG000|Overall Study|Screening exclusion criteria met|1|||
146033296|NCT02905006|526635105|FG001|Overall Study|Screening exclusion criteria met|0|||
146033297|NCT02905006|526635106|FG002|Overall Study|Screening exclusion criteria met|0|||
146033298|NCT02905006|526635107|FG003|Overall Study|Screening exclusion criteria met|0|||
146033299|NCT02905006|526635108|FG004|Overall Study|Screening exclusion criteria met|0|||
146033300|NCT02905006|526635109|FG005|Overall Study|Screening exclusion criteria met|0|||
146033301|NCT02905006|526635104|FG000|Overall Study|Lab withdrawal criterion met|0|||
146033302|NCT02905006|526635105|FG001|Overall Study|Lab withdrawal criterion met|1|||
146033303|NCT02905006|526635106|FG002|Overall Study|Lab withdrawal criterion met|2|||
146033304|NCT02905006|526635107|FG003|Overall Study|Lab withdrawal criterion met|2|||
146033305|NCT02905006|526635108|FG004|Overall Study|Lab withdrawal criterion met|2|||
146033306|NCT02905006|526635109|FG005|Overall Study|Lab withdrawal criterion met|1|||
146033307|NCT02905006|526635104|FG000|Overall Study|Positive for Tuberculosis|0|||
146033308|NCT02905006|526635105|FG001|Overall Study|Positive for Tuberculosis|1|||
146033309|NCT02905006|526635106|FG002|Overall Study|Positive for Tuberculosis|0|||
146033310|NCT02905006|526635107|FG003|Overall Study|Positive for Tuberculosis|0|||
146033311|NCT02905006|526635108|FG004|Overall Study|Positive for Tuberculosis|0|||
146033312|NCT02905006|526635109|FG005|Overall Study|Positive for Tuberculosis|0|||
146033313|NCT02905006|526635104|FG000|Overall Study|Subject positive for Hep B|0|||
146033314|NCT02905006|526635105|FG001|Overall Study|Subject positive for Hep B|0|||
146033315|NCT02905006|526635106|FG002|Overall Study|Subject positive for Hep B|1|||
146033316|NCT02905006|526635107|FG003|Overall Study|Subject positive for Hep B|0|||
146033317|NCT02905006|526635108|FG004|Overall Study|Subject positive for Hep B|0|||
146033318|NCT02905006|526635109|FG005|Overall Study|Subject positive for Hep B|0|||
146033319|NCT02905006|526635104|FG000|Overall Study|Patient moved abroad|0|||
146033320|NCT02905006|526635105|FG001|Overall Study|Patient moved abroad|0|||
146033321|NCT02905006|526635106|FG002|Overall Study|Patient moved abroad|0|||
146033322|NCT02905006|526635107|FG003|Overall Study|Patient moved abroad|1|||
146033323|NCT02905006|526635108|FG004|Overall Study|Patient moved abroad|0|||
146033324|NCT02905006|526635109|FG005|Overall Study|Patient moved abroad|0|||
146033325|NCT02905006|526635104|FG000|Overall Study|Patient randomized by mistake|0|||
146033326|NCT02905006|526635105|FG001|Overall Study|Patient randomized by mistake|0|||
146033327|NCT02905006|526635106|FG002|Overall Study|Patient randomized by mistake|0|||
146033328|NCT02905006|526635107|FG003|Overall Study|Patient randomized by mistake|0|||
146033329|NCT02905006|526635108|FG004|Overall Study|Patient randomized by mistake|0|||
146033330|NCT02905006|526635109|FG005|Overall Study|Patient randomized by mistake|1|||
146033331|NCT05063539|526635110|FG000|Overall Study|Adverse Event|1|||
146033332|NCT05063539|526635111|FG001|Overall Study|Adverse Event|2|||
146033333|NCT05063539|526635112|FG002|Overall Study|Adverse Event|1|||
146033334|NCT05063539|526635110|FG000|Overall Study|Death|0|||
146033335|NCT05063539|526635111|FG001|Overall Study|Death|1|||
146033336|NCT05063539|526635112|FG002|Overall Study|Death|1|||
146033337|NCT05063539|526635110|FG000|Overall Study|Lost to Follow-up|0|||
146033338|NCT05063539|526635111|FG001|Overall Study|Lost to Follow-up|1|||
146033339|NCT05063539|526635112|FG002|Overall Study|Lost to Follow-up|0|||
146033340|NCT05063539|526635110|FG000|Overall Study|Physician Decision|4|||
146033341|NCT05063539|526635111|FG001|Overall Study|Physician Decision|3|||
146033342|NCT05063539|526635112|FG002|Overall Study|Physician Decision|1|||
146033343|NCT05063539|526635110|FG000|Overall Study|Progressive Disease|0|||
146033344|NCT05063539|526635111|FG001|Overall Study|Progressive Disease|2|||
146033345|NCT05063539|526635112|FG002|Overall Study|Progressive Disease|0|||
146033346|NCT05063539|526635110|FG000|Overall Study|Withdrawal by Subject|17|||
146033347|NCT05063539|526635111|FG001|Overall Study|Withdrawal by Subject|26|||
146254320|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
146254321|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
146254322|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
146033348|NCT05063539|526635112|FG002|Overall Study|Withdrawal by Subject|14|||
146033349|NCT05063539|526635110|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146033350|NCT05063539|526635111|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146033351|NCT05063539|526635112|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
146033352|NCT05063539|526635110|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
146033353|NCT05063539|526635111|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
146300415|NCT00375219|527615253|FG002|Overall Study|Failure to achieve a response|0|||
146300416|NCT00375219|527615251|FG000|Overall Study|Adverse Event|8|||
146300417|NCT00375219|527615252|FG001|Overall Study|Adverse Event|2|||
146033354|NCT05063539|526635112|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
146033355|NCT05063539|526635110|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
146033356|NCT05063539|526635111|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
146033357|NCT05063539|526635112|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
146033358|NCT05063539|526635110|FG000|Overall Study|Discontinued due to Common Close Design|0|||
146033359|NCT05063539|526635111|FG001|Overall Study|Discontinued due to Common Close Design|1|||
146033360|NCT05063539|526635112|FG002|Overall Study|Discontinued due to Common Close Design|0|||
146033361|NCT05063539|526635110|FG000|Overall Study|Participant not co-operative|0|||
146033362|NCT05063539|526635111|FG001|Overall Study|Participant not co-operative|1|||
146033363|NCT05063539|526635112|FG002|Overall Study|Participant not co-operative|0|||
146033364|NCT05063539|526635110|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
146033365|NCT05063539|526635111|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
146033366|NCT05063539|526635112|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
146033367|NCT05063539|526635110|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
146033368|NCT05063539|526635111|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
146033369|NCT05063539|526635112|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
146033370|NCT02017522|526635113|FG000|Overall Study|Withdrawal by Subject|1|||
146033371|NCT05856227|526635114|FG000|Overall Study|Adverse Event|0|||
146033372|NCT05856227|526635115|FG001|Overall Study|Adverse Event|1|||
146033373|NCT05856227|526635114|FG000|Overall Study|Due to Investigator absence|1|||
146033374|NCT05856227|526635115|FG001|Overall Study|Due to Investigator absence|0|||
146033375|NCT05856227|526635114|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
146033376|NCT05856227|526635115|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
146033377|NCT01751139|526635116|FG000|Overall Study|Other|135|||
146033378|NCT01751139|526635116|FG000|Overall Study|Sponsor study termination|1609|||
146033379|NCT01751139|526635116|FG000|Overall Study|Lost to Follow-up|240|||
146033380|NCT01751139|526635116|FG000|Overall Study|Withdrawal by Subject|251|||
146033381|NCT01751139|526635116|FG000|Overall Study|Adverse Event|1|||
146033382|NCT01751139|526635116|FG000|Overall Study|Death|31|||
146033383|NCT04736628|526635117|FG000|Overall Study|Not treated|0|||
146033384|NCT04736628|526635118|FG001|Overall Study|Not treated|0|||
146033385|NCT04736628|526635119|FG002|Overall Study|Not treated|0|||
146033386|NCT04736628|526635120|FG003|Overall Study|Not treated|2|||
146033387|NCT04736628|526635117|FG000|Overall Study|Other reason than listed|1|||
146033388|NCT04736628|526635118|FG001|Overall Study|Other reason than listed|2|||
146033389|NCT04736628|526635119|FG002|Overall Study|Other reason than listed|2|||
146033390|NCT04736628|526635120|FG003|Overall Study|Other reason than listed|3|||
146033391|NCT04736628|526635117|FG000|Overall Study|Protocol deviation|0|||
146033392|NCT04736628|526635118|FG001|Overall Study|Protocol deviation|0|||
146033393|NCT04736628|526635119|FG002|Overall Study|Protocol deviation|0|||
146033394|NCT04736628|526635120|FG003|Overall Study|Protocol deviation|1|||
146033395|NCT04736628|526635117|FG000|Overall Study|Burden of study procedures|1|||
146033396|NCT04736628|526635118|FG001|Overall Study|Burden of study procedures|0|||
146033397|NCT04736628|526635119|FG002|Overall Study|Burden of study procedures|0|||
146033398|NCT04736628|526635120|FG003|Overall Study|Burden of study procedures|1|||
146033399|NCT04736628|526635117|FG000|Overall Study|Change of residence|0|||
146033400|NCT04736628|526635118|FG001|Overall Study|Change of residence|1|||
146033401|NCT04736628|526635119|FG002|Overall Study|Change of residence|0|||
146033402|NCT04736628|526635120|FG003|Overall Study|Change of residence|0|||
146033403|NCT04736628|526635117|FG000|Overall Study|Perceived lack of efficacy|1|||
146033404|NCT04736628|526635118|FG001|Overall Study|Perceived lack of efficacy|0|||
146033405|NCT04736628|526635119|FG002|Overall Study|Perceived lack of efficacy|0|||
146033406|NCT04736628|526635120|FG003|Overall Study|Perceived lack of efficacy|1|||
146033407|NCT04736628|526635117|FG000|Overall Study|Adverse Event|3|||
146097977|NCT02130024|526879280|FG001|Overall Study|Protocol Deviation|0|||
146097978|NCT02130024|526879279|FG000|Overall Study|Site Administration Problems|1|||
146097979|NCT02130024|526879280|FG001|Overall Study|Site Administration Problems|0|||
146097980|NCT02130024|526879279|FG000|Overall Study|Subject Withdrew Consent|6|||
146097981|NCT02130024|526879280|FG001|Overall Study|Subject Withdrew Consent|14|||
146097982|NCT01467583|526879281|FG000|Overall Study|Death|1|||
146097983|NCT01467583|526879282|FG001|Overall Study|Death|1|||
146097984|NCT01467583|526879283|FG002|Overall Study|Death|0|||
146097985|NCT01467583|526879281|FG000|Overall Study|Withdrawal by Subject|1|||
146097986|NCT01467583|526879282|FG001|Overall Study|Withdrawal by Subject|0|||
146033408|NCT04736628|526635118|FG001|Overall Study|Adverse Event|2|||
146033409|NCT04736628|526635119|FG002|Overall Study|Adverse Event|4|||
146033410|NCT04736628|526635120|FG003|Overall Study|Adverse Event|3|||
146033411|NCT02428205|526635123|FG000|Overall Study|Lack of Efficacy|1|||
146033412|NCT02428205|526635124|FG001|Overall Study|Lack of Efficacy|0|||
146033413|NCT02428205|526635123|FG000|Overall Study|Lost to Follow-up|1|||
146033414|NCT02428205|526635124|FG001|Overall Study|Lost to Follow-up|1|||
146033415|NCT02428205|526635123|FG000|Overall Study|Worse behavior|0|||
146033416|NCT02428205|526635124|FG001|Overall Study|Worse behavior|1|||
146033417|NCT00527319|526635125|FG000|Overall Study|Withdrawal by Subject|5|||
146033418|NCT00527319|526635126|FG001|Overall Study|Withdrawal by Subject|0|||
146033419|NCT00527319|526635127|FG002|Overall Study|Withdrawal by Subject|1|||
146033420|NCT00527319|526635125|FG000|Overall Study|Lost to Follow-up|1|||
146033421|NCT00527319|526635126|FG001|Overall Study|Lost to Follow-up|0|||
146033422|NCT00527319|526635127|FG002|Overall Study|Lost to Follow-up|0|||
146033423|NCT00527319|526635125|FG000|Overall Study|Death|0|||
146033424|NCT00527319|526635126|FG001|Overall Study|Death|3|||
146033425|NCT00527319|526635127|FG002|Overall Study|Death|1|||
146033426|NCT00527319|526635125|FG000|Overall Study|Intercurrent Medical Illness|0|||
146033427|NCT00527319|526635126|FG001|Overall Study|Intercurrent Medical Illness|1|||
146033428|NCT00527319|526635127|FG002|Overall Study|Intercurrent Medical Illness|3|||
146033429|NCT00527319|526635125|FG000|Overall Study|Adverse Event|0|||
146033430|NCT00527319|526635126|FG001|Overall Study|Adverse Event|0|||
146033431|NCT00527319|526635127|FG002|Overall Study|Adverse Event|1|||
146033432|NCT00680368|526635129|FG000|Overall Study|not supervised, not eligible|15|||
146033433|NCT00483041|526635130|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
146033434|NCT00483041|526635131|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
146033435|NCT03779503|526635132|FG000|First Intervention|Adverse Event|0|||
146033436|NCT03779503|526635133|FG001|First Intervention|Adverse Event|1|||
146033437|NCT03779503|526635132|FG000|First Intervention|Withdrawal by Subject|1|||
146033438|NCT03779503|526635133|FG001|First Intervention|Withdrawal by Subject|0|||
146033439|NCT00864851|526635134|FG000|Overall Study|Withdrawal by Subject|0|||
146033440|NCT00864851|526635135|FG001|Overall Study|Withdrawal by Subject|1|||
146033441|NCT00864851|526635136|FG002|Overall Study|Withdrawal by Subject|0|||
146033442|NCT00864851|526635134|FG000|Overall Study|Physician Decision|1|||
146033443|NCT00864851|526635135|FG001|Overall Study|Physician Decision|0|||
146033444|NCT00864851|526635136|FG002|Overall Study|Physician Decision|0|||
146033445|NCT00864851|526635134|FG000|Overall Study|Death|1|||
146033446|NCT00864851|526635135|FG001|Overall Study|Death|0|||
146033447|NCT00864851|526635136|FG002|Overall Study|Death|0|||
146033448|NCT00864851|526635134|FG000|Overall Study|Patient uncooperative|1|||
146033449|NCT00864851|526635135|FG001|Overall Study|Patient uncooperative|0|||
146033450|NCT00864851|526635136|FG002|Overall Study|Patient uncooperative|0|||
146033451|NCT03242252|526635138|FG000|Overall Study|At the Participant's own Request|18|||
146033452|NCT03242252|526635139|FG001|Overall Study|At the Participant's own Request|10|||
146033453|NCT03242252|526635140|FG002|Overall Study|At the Participant's own Request|15|||
146033454|NCT03242252|526635138|FG000|Overall Study|Adverse Event|8|||
146033455|NCT03242252|526635139|FG001|Overall Study|Adverse Event|6|||
146033456|NCT03242252|526635140|FG002|Overall Study|Adverse Event|9|||
146033457|NCT03242252|526635138|FG000|Overall Study|Poor Compliance to Protocol|0|||
146033458|NCT03242252|526635139|FG001|Overall Study|Poor Compliance to Protocol|2|||
146033459|NCT03242252|526635140|FG002|Overall Study|Poor Compliance to Protocol|3|||
146033460|NCT03242252|526635138|FG000|Overall Study|Study Terminated by Sponsor|1|||
146033461|NCT03242252|526635139|FG001|Overall Study|Study Terminated by Sponsor|0|||
146033462|NCT03242252|526635140|FG002|Overall Study|Study Terminated by Sponsor|0|||
146033463|NCT03242252|526635138|FG000|Overall Study|Reason not Specified|4|||
146033464|NCT03242252|526635139|FG001|Overall Study|Reason not Specified|4|||
146033465|NCT03242252|526635140|FG002|Overall Study|Reason not Specified|1|||
146033466|NCT03242252|526635138|FG000|Overall Study|Lost to Follow-up|5|||
146033467|NCT03242252|526635139|FG001|Overall Study|Lost to Follow-up|1|||
146033468|NCT03242252|526635140|FG002|Overall Study|Lost to Follow-up|4|||
146033469|NCT01116427|526635141|FG000|Core Phase|Adverse Event|0|||
146033470|NCT01116427|526635142|FG001|Core Phase|Adverse Event|1|||
146033471|NCT01116427|526635141|FG000|Core Phase|Lost to Follow-up|1|||
146033472|NCT01116427|526635142|FG001|Core Phase|Lost to Follow-up|0|||
146033473|NCT01116427|526635141|FG000|Core Phase|Withdrawal by Subject|3|||
146033474|NCT01116427|526635142|FG001|Core Phase|Withdrawal by Subject|0|||
146033475|NCT01116427|526635141|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
146033476|NCT01116427|526635142|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
146300418|NCT00375219|527615253|FG002|Overall Study|Adverse Event|1|||
146033477|NCT01116427|526635141|FG000|Extension Phase|Adverse Event|1|||
146033478|NCT01116427|526635142|FG001|Extension Phase|Adverse Event|1|||
146033479|NCT01116427|526635141|FG000|Extension Phase|Lost to Follow-up|2|||
146033480|NCT01116427|526635142|FG001|Extension Phase|Lost to Follow-up|0|||
146033481|NCT01116427|526635141|FG000|Extension Phase|Withdrawal by Subject|5|||
146033482|NCT01116427|526635142|FG001|Extension Phase|Withdrawal by Subject|1|||
146033483|NCT01116427|526635141|FG000|Extension Phase|Not using appropriate birth control|1|||
146033484|NCT01116427|526635142|FG001|Extension Phase|Not using appropriate birth control|0|||
146033485|NCT02211313|526635143|FG000|Overall Study|Treatment Failure|5|||
146033486|NCT02211313|526635144|FG001|Overall Study|Treatment Failure|2|||
146033487|NCT02211313|526635143|FG000|Overall Study|No Follow up Questionnaires|1|||
146033488|NCT02211313|526635144|FG001|Overall Study|No Follow up Questionnaires|1|||
146033489|NCT02717130|526635145|FG000|Overall Study|Withdrawal by Subject|1|||
146097987|NCT01467583|526879283|FG002|Overall Study|Withdrawal by Subject|0|||
146097988|NCT01467583|526879281|FG000|Overall Study|Protocol Violation|0|||
146097989|NCT01467583|526879282|FG001|Overall Study|Protocol Violation|0|||
146097990|NCT01467583|526879283|FG002|Overall Study|Protocol Violation|2|||
146097991|NCT05274165|526879284|FG000|Overall Study|Withdrawal by Subject|3|||
146097992|NCT05274165|526879285|FG001|Overall Study|Withdrawal by Subject|3|||
146097993|NCT04916769|526879292|FG000|Period 1|Physician Decision|0|||
146097994|NCT04916769|526879293|FG001|Period 1|Physician Decision|0|||
146097995|NCT04916769|526879294|FG002|Period 1|Physician Decision|0|||
146097996|NCT04916769|526879295|FG003|Period 1|Physician Decision|0|||
146097997|NCT04916769|526879296|FG004|Period 1|Physician Decision|0|||
146097998|NCT04916769|526879297|FG005|Period 1|Physician Decision|1|||
146097999|NCT04916769|526879292|FG000|Period 2|Physician Decision|0|||
146098000|NCT04916769|526879293|FG001|Period 2|Physician Decision|1|||
146098001|NCT04916769|526879294|FG002|Period 2|Physician Decision|0|||
146098002|NCT04916769|526879295|FG003|Period 2|Physician Decision|0|||
146098003|NCT04916769|526879296|FG004|Period 2|Physician Decision|0|||
146098004|NCT04916769|526879297|FG005|Period 2|Physician Decision|0|||
146098005|NCT05736224|526879298|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
146098006|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
146098007|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098008|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098009|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098010|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098011|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098012|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
146098013|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
146098014|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146254323|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
146254324|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
146254325|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
146254326|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
146254327|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
146254328|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
146254329|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
146254330|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
146254331|NCT00332488|527444552|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
146254332|NCT00332488|527444553|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
146033490|NCT02717130|526635145|FG000|Overall Study|Adverse Event|1|||
146033491|NCT02717130|526635145|FG000|Overall Study|Physician Decision|1|||
146033492|NCT02717130|526635145|FG000|Overall Study|Study Closure|4|||
146033493|NCT03344640|526635146|FG000|Overall Study|Adverse Event|1|||
146033494|NCT03344640|526635147|FG001|Overall Study|Adverse Event|0|||
146033495|NCT03344640|526635146|FG000|Overall Study|Physician Decision|1|||
146033496|NCT03344640|526635147|FG001|Overall Study|Physician Decision|1|||
146033497|NCT03344640|526635146|FG000|Overall Study|Withdrawal by Subject|1|||
146033498|NCT03344640|526635147|FG001|Overall Study|Withdrawal by Subject|2|||
146033499|NCT03344640|526635146|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
146033500|NCT03344640|526635147|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
146033501|NCT00657371|526635151|FG000|Overall Study|Poor bowel preparation|15|||
146033502|NCT00657371|526635151|FG000|Overall Study|Unable to intubate the cecum|5|||
146033503|NCT00657371|526635151|FG000|Overall Study|Protocol Violation|2|||
146033504|NCT00657371|526635151|FG000|Overall Study|Device- related reasons|13|||
146033505|NCT00657371|526635151|FG000|Overall Study|Pre-existing medical condition|4|||
146033506|NCT00652899|526635157|FG000|Overall Study|Death|1|||
146033507|NCT00652899|526635157|FG000|Overall Study|Treating physician decision|1|||
146033508|NCT01943552|526635158|FG000|Overall Study|Adverse Event|3|||
146033509|NCT01943552|526635159|FG001|Overall Study|Adverse Event|2|||
146033510|NCT01943552|526635158|FG000|Overall Study|Withdrawal by Subject|6|||
146033511|NCT01943552|526635159|FG001|Overall Study|Withdrawal by Subject|6|||
146033512|NCT01943552|526635158|FG000|Overall Study|Other Reasons|16|||
146098015|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146098016|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146098017|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146098018|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146033513|NCT01943552|526635159|FG001|Overall Study|Other Reasons|17|||
146033514|NCT01600053|526635160|FG000|Overall Study|Adverse Event|2|||
146033515|NCT01600053|526635160|FG000|Overall Study|trial will not meet the interim endpoint|9|||
146033516|NCT02715726|526635161|FG000|Overall Study|Adverse Event|2|||
146033517|NCT02715726|526635162|FG001|Overall Study|Adverse Event|6|||
146033518|NCT02715726|526635161|FG000|Overall Study|Protocol Violation|1|||
146033519|NCT02715726|526635162|FG001|Overall Study|Protocol Violation|0|||
146033520|NCT02715726|526635161|FG000|Overall Study|Death|2|||
146033521|NCT02715726|526635162|FG001|Overall Study|Death|1|||
146033522|NCT02715726|526635161|FG000|Overall Study|Participant moved|1|||
146033523|NCT02715726|526635162|FG001|Overall Study|Participant moved|3|||
146033524|NCT02715726|526635161|FG000|Overall Study|Other than specified above|11|||
146033525|NCT02715726|526635162|FG001|Overall Study|Other than specified above|15|||
146033526|NCT02715726|526635161|FG000|Overall Study|Randomized but not treated|1|||
146033527|NCT02715726|526635162|FG001|Overall Study|Randomized but not treated|2|||
146033528|NCT02445573|526635163|FG000|Overall Study|Withdrawal by Subject|1|||
146033529|NCT02445573|526635164|FG001|Overall Study|Withdrawal by Subject|1|||
146033530|NCT02445573|526635163|FG000|Overall Study|Lost to Follow-up|0|||
146033531|NCT02445573|526635164|FG001|Overall Study|Lost to Follow-up|1|||
146033532|NCT01565941|526635165|FG000|Overall Study|Withdrawn by parent/guardian|3|||
146033533|NCT01565941|526635166|FG001|Overall Study|Withdrawn by parent/guardian|2|||
146033534|NCT01565941|526635165|FG000|Overall Study|Randomized; did not receive intevention|8|||
146033535|NCT01565941|526635166|FG001|Overall Study|Randomized; did not receive intevention|2|||
146033536|NCT02855944|526635167|FG000|Period 1: Treatment|Ongoing|14|||
146033537|NCT02855944|526635168|FG001|Period 1: Treatment|Ongoing|0|||
146033538|NCT02855944|526635167|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
146033539|NCT02855944|526635168|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
146033540|NCT02855944|526635167|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
146033541|NCT02855944|526635168|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
146033542|NCT02358044|526635171|FG000|Overall Study|Adverse Event|0|||
146033543|NCT02358044|526635172|FG001|Overall Study|Adverse Event|1|||
146033544|NCT02358044|526635171|FG000|Overall Study|Lost to Follow-up|2|||
146033545|NCT02358044|526635172|FG001|Overall Study|Lost to Follow-up|1|||
146033546|NCT02358044|526635171|FG000|Overall Study|Physician Decision|0|||
146033547|NCT02358044|526635172|FG001|Overall Study|Physician Decision|1|||
146033548|NCT02358044|526635171|FG000|Overall Study|Withdrawal by Subject|0|||
146033549|NCT02358044|526635172|FG001|Overall Study|Withdrawal by Subject|4|||
146033550|NCT01455220|526635176|FG000|Overall Study|screen fail|30|||
146033551|NCT00267150|526635177|FG000|Overall Study|Adverse Event|1|||
146033552|NCT04881747|526635179|FG000|Period 2 Washout|Adverse Event|1|||
146033553|NCT04881747|526635180|FG001|Period 2 Washout|Adverse Event|0|||
146033554|NCT04881747|526635181|FG002|Period 2 Washout|Adverse Event|0|||
146033555|NCT04881747|526635182|FG003|Period 2 Washout|Adverse Event|0|||
146033556|NCT04881747|526635183|FG004|Period 2 Washout|Adverse Event|1|||
146033557|NCT04881747|526635184|FG005|Period 2 Washout|Adverse Event|0|||
146033558|NCT04881747|526635179|FG000|Period 2 Washout|Withdrawal by Subject|1|||
146033559|NCT04881747|526635180|FG001|Period 2 Washout|Withdrawal by Subject|0|||
146033560|NCT04881747|526635181|FG002|Period 2 Washout|Withdrawal by Subject|0|||
146033561|NCT04881747|526635182|FG003|Period 2 Washout|Withdrawal by Subject|1|||
146033562|NCT04881747|526635183|FG004|Period 2 Washout|Withdrawal by Subject|0|||
146033563|NCT04881747|526635184|FG005|Period 2 Washout|Withdrawal by Subject|0|||
146033564|NCT00521222|526635185|FG000|Overall Study|Lost to Follow-up|0|||
146033565|NCT00521222|526635186|FG001|Overall Study|Lost to Follow-up|0|||
146033566|NCT00521222|526635187|FG002|Overall Study|Lost to Follow-up|1|||
146033567|NCT00521222|526635188|FG003|Overall Study|Lost to Follow-up|1|||
146033568|NCT00521222|526635185|FG000|Overall Study|Withdrawal by Subject|0|||
146033569|NCT00521222|526635186|FG001|Overall Study|Withdrawal by Subject|0|||
146033570|NCT00521222|526635187|FG002|Overall Study|Withdrawal by Subject|2|||
146033571|NCT00521222|526635188|FG003|Overall Study|Withdrawal by Subject|0|||
146033572|NCT00521222|526635185|FG000|Overall Study|Physician Decision|0|||
146033573|NCT00521222|526635186|FG001|Overall Study|Physician Decision|1|||
146033574|NCT00521222|526635187|FG002|Overall Study|Physician Decision|0|||
146033575|NCT00521222|526635188|FG003|Overall Study|Physician Decision|1|||
146033576|NCT02745535|526635194|FG000|Overall Study|Death|1|||
146033577|NCT02745535|526635194|FG000|Overall Study|Adverse Event|3|||
146033578|NCT02745535|526635194|FG000|Overall Study|Lost to Follow-up|2|||
146033579|NCT01345682|526635198|FG000|Overall Study|Progressive disease per RECIST|226|||
146033580|NCT01345682|526635199|FG001|Overall Study|Progressive disease per RECIST|93|||
146033581|NCT01345682|526635198|FG000|Overall Study|Worsening of underlying cancer disease|23|||
146033582|NCT01345682|526635199|FG001|Overall Study|Worsening of underlying cancer disease|12|||
146033583|NCT01345682|526635198|FG000|Overall Study|Adverse Event|51|||
146033584|NCT01345682|526635199|FG001|Overall Study|Adverse Event|41|||
146033585|NCT01345682|526635198|FG000|Overall Study|Non-compliance with protocol|0|||
146033586|NCT01345682|526635199|FG001|Overall Study|Non-compliance with protocol|1|||
146033587|NCT01345682|526635198|FG000|Overall Study|Lost to Follow-up|0|||
146033588|NCT01345682|526635199|FG001|Overall Study|Lost to Follow-up|1|||
146033589|NCT01345682|526635198|FG000|Overall Study|Refused to continue trial medication|16|||
146033590|NCT01345682|526635199|FG001|Overall Study|Refused to continue trial medication|9|||
146033591|NCT01345682|526635198|FG000|Overall Study|Not treated|2|||
146033592|NCT01345682|526635199|FG001|Overall Study|Not treated|1|||
146033593|NCT01345682|526635198|FG000|Overall Study|Reason other than those specified above|4|||
146033594|NCT01345682|526635199|FG001|Overall Study|Reason other than those specified above|3|||
146033595|NCT01075984|526635200|FG000|Treatment Phase|Adverse Event|0|||
146033596|NCT01075984|526635201|FG001|Treatment Phase|Adverse Event|1|||
146033597|NCT01075984|526635202|FG002|Treatment Phase|Adverse Event|3|||
146033598|NCT01075984|526635203|FG003|Treatment Phase|Adverse Event|7|||
146033599|NCT01075984|526635204|FG004|Treatment Phase|Adverse Event|35|||
146033600|NCT01075984|526635200|FG000|Treatment Phase|Protocol Violation|0|||
146033601|NCT01075984|526635201|FG001|Treatment Phase|Protocol Violation|0|||
146033602|NCT01075984|526635202|FG002|Treatment Phase|Protocol Violation|1|||
146033603|NCT01075984|526635203|FG003|Treatment Phase|Protocol Violation|0|||
146033604|NCT01075984|526635204|FG004|Treatment Phase|Protocol Violation|3|||
146033605|NCT01075984|526635200|FG000|Treatment Phase|Withdrawal by Subject|0|||
146033606|NCT01075984|526635201|FG001|Treatment Phase|Withdrawal by Subject|0|||
146033607|NCT01075984|526635202|FG002|Treatment Phase|Withdrawal by Subject|2|||
146033608|NCT01075984|526635203|FG003|Treatment Phase|Withdrawal by Subject|0|||
146033609|NCT01075984|526635204|FG004|Treatment Phase|Withdrawal by Subject|15|||
146033610|NCT01075984|526635200|FG000|Treatment Phase|Treatment Failure|0|||
146033611|NCT01075984|526635201|FG001|Treatment Phase|Treatment Failure|0|||
146033612|NCT01075984|526635202|FG002|Treatment Phase|Treatment Failure|1|||
146033613|NCT01075984|526635203|FG003|Treatment Phase|Treatment Failure|0|||
146033614|NCT01075984|526635204|FG004|Treatment Phase|Treatment Failure|5|||
146033615|NCT01075984|526635200|FG000|Treatment Phase|Progression of disease|0|||
146033616|NCT01075984|526635201|FG001|Treatment Phase|Progression of disease|0|||
146033617|NCT01075984|526635202|FG002|Treatment Phase|Progression of disease|0|||
146033618|NCT01075984|526635203|FG003|Treatment Phase|Progression of disease|0|||
146033619|NCT01075984|526635204|FG004|Treatment Phase|Progression of disease|2|||
146033620|NCT01075984|526635200|FG000|Follow-up Phase|Protocol Violation|0|||
146033621|NCT01075984|526635201|FG001|Follow-up Phase|Protocol Violation|0|||
146033622|NCT01075984|526635202|FG002|Follow-up Phase|Protocol Violation|1|||
146033623|NCT01075984|526635203|FG003|Follow-up Phase|Protocol Violation|0|||
146033624|NCT01075984|526635204|FG004|Follow-up Phase|Protocol Violation|3|||
146033625|NCT01075984|526635200|FG000|Follow-up Phase|Adverse Event|0|||
146033626|NCT01075984|526635201|FG001|Follow-up Phase|Adverse Event|0|||
146033627|NCT01075984|526635202|FG002|Follow-up Phase|Adverse Event|0|||
146033628|NCT01075984|526635203|FG003|Follow-up Phase|Adverse Event|2|||
146033629|NCT01075984|526635204|FG004|Follow-up Phase|Adverse Event|27|||
146033630|NCT01075984|526635200|FG000|Follow-up Phase|Administrative|0|||
146033631|NCT01075984|526635201|FG001|Follow-up Phase|Administrative|0|||
146033632|NCT01075984|526635202|FG002|Follow-up Phase|Administrative|0|||
146033633|NCT01075984|526635203|FG003|Follow-up Phase|Administrative|0|||
146033634|NCT01075984|526635204|FG004|Follow-up Phase|Administrative|1|||
146033635|NCT01075984|526635200|FG000|Follow-up Phase|Withdrawal by Subject|0|||
146033636|NCT01075984|526635201|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146033637|NCT01075984|526635202|FG002|Follow-up Phase|Withdrawal by Subject|0|||
146033638|NCT01075984|526635203|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146033639|NCT01075984|526635204|FG004|Follow-up Phase|Withdrawal by Subject|10|||
146033640|NCT01075984|526635200|FG000|Follow-up Phase|Progression of disease|0|||
146033641|NCT01075984|526635201|FG001|Follow-up Phase|Progression of disease|0|||
146033642|NCT01075984|526635202|FG002|Follow-up Phase|Progression of disease|0|||
146033643|NCT01075984|526635203|FG003|Follow-up Phase|Progression of disease|0|||
146033644|NCT01075984|526635204|FG004|Follow-up Phase|Progression of disease|2|||
146033645|NCT01075984|526635200|FG000|Follow-up Phase|Treatment failure|0|||
146033646|NCT01075984|526635201|FG001|Follow-up Phase|Treatment failure|0|||
146033647|NCT01075984|526635202|FG002|Follow-up Phase|Treatment failure|0|||
146033648|NCT01075984|526635203|FG003|Follow-up Phase|Treatment failure|0|||
146033649|NCT01075984|526635204|FG004|Follow-up Phase|Treatment failure|4|||
146033650|NCT01274429|526635212|FG000|Overall Study|Study closed do to lack of funding|5|||
146033651|NCT04046250|526635222|FG000|Overall Study|Death|0|||
146033652|NCT04046250|526635223|FG001|Overall Study|Death|1|||
146033653|NCT04046250|526635222|FG000|Overall Study|Withdrawal by Subject|3|||
146033654|NCT04046250|526635223|FG001|Overall Study|Withdrawal by Subject|3|||
146033655|NCT01597635|526637194|FG000|Part A|Adverse Event|3|||
146300419|NCT00375219|527615251|FG000|Overall Study|Protocol Violation|1|||
146033656|NCT01597635|526637195|FG001|Part A|Adverse Event|0|||
146033657|NCT01597635|526637196|FG002|Part A|Adverse Event|0|||
146033658|NCT01597635|526637194|FG000|Part B|Adverse Event|0|||
146033659|NCT01597635|526637195|FG001|Part B|Adverse Event|0|||
146033660|NCT01597635|526637196|FG002|Part B|Adverse Event|1|||
146033661|NCT01597635|526637194|FG000|Part B|Protocol Violation|0|||
146033662|NCT01597635|526637195|FG001|Part B|Protocol Violation|1|||
146033663|NCT01597635|526637196|FG002|Part B|Protocol Violation|0|||
146033664|NCT01597635|526637194|FG000|Part B|Protocol-defined stopping criteria|0|||
146033665|NCT01597635|526637195|FG001|Part B|Protocol-defined stopping criteria|4|||
146033666|NCT01597635|526637196|FG002|Part B|Protocol-defined stopping criteria|3|||
146033667|NCT01597635|526637194|FG000|Part B|Withdrawal by Subject|0|||
146033668|NCT01597635|526637195|FG001|Part B|Withdrawal by Subject|1|||
146033669|NCT01597635|526637196|FG002|Part B|Withdrawal by Subject|0|||
146033670|NCT01192568|526637197|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
146033671|NCT01192568|526637198|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
146033672|NCT01192568|526637199|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
146033673|NCT01192568|526637200|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
146033674|NCT01192568|526637197|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
146033675|NCT01192568|526637198|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
146033676|NCT01192568|526637199|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
146033677|NCT01192568|526637200|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
146033678|NCT00652951|526637201|FG000|Booster Phase|Adverse event, non-fatal|0|||
146033679|NCT00652951|526637202|FG001|Booster Phase|Adverse event, non-fatal|1|||
146033680|NCT00652951|526637203|FG002|Booster Phase|Adverse event, non-fatal|0|||
146033681|NCT00652951|526637201|FG000|Booster Phase|Other|1|||
146033682|NCT00652951|526637202|FG001|Booster Phase|Other|0|||
146033683|NCT00652951|526637203|FG002|Booster Phase|Other|0|||
146033684|NCT02593825|526637204|FG000|Intervention|Lost to Follow-up|10|||
146033685|NCT02593825|526637205|FG001|Intervention|Lost to Follow-up|12|||
146033686|NCT02100969|526637206|FG000|Overall Study|Did not pass screening phase|1|||
146033687|NCT06359080|526637207|FG000|Overall Study|Withdrawal by Subject|3|||
146033688|NCT00511134|526637208|FG000|Overall Study|Withdrawal by Subject|0|||
146033689|NCT00511134|526637209|FG001|Overall Study|Withdrawal by Subject|2|||
146033690|NCT01949090|526637210|FG000|Overall Study|Serious Adverse Event|0|||
146033691|NCT01949090|526637211|FG001|Overall Study|Serious Adverse Event|1|||
146033692|NCT01949090|526637212|FG002|Overall Study|Serious Adverse Event|2|||
146033693|NCT01949090|526637213|FG003|Overall Study|Serious Adverse Event|0|||
146033694|NCT01949090|526637214|FG004|Overall Study|Serious Adverse Event|1|||
146033695|NCT01949090|526637210|FG000|Overall Study|Withdrawal by Subject|2|||
146033696|NCT01949090|526637211|FG001|Overall Study|Withdrawal by Subject|0|||
146033697|NCT01949090|526637212|FG002|Overall Study|Withdrawal by Subject|0|||
146033698|NCT01949090|526637213|FG003|Overall Study|Withdrawal by Subject|0|||
146033699|NCT01949090|526637214|FG004|Overall Study|Withdrawal by Subject|1|||
146033700|NCT01949090|526637210|FG000|Overall Study|Protocol non-compliance|0|||
146033701|NCT01949090|526637211|FG001|Overall Study|Protocol non-compliance|0|||
146033702|NCT01949090|526637212|FG002|Overall Study|Protocol non-compliance|0|||
146033703|NCT01949090|526637213|FG003|Overall Study|Protocol non-compliance|0|||
146033704|NCT01949090|526637214|FG004|Overall Study|Protocol non-compliance|1|||
146033705|NCT01949090|526637210|FG000|Overall Study|Lost to Follow-up|2|||
146033706|NCT01949090|526637211|FG001|Overall Study|Lost to Follow-up|1|||
146033707|NCT01949090|526637212|FG002|Overall Study|Lost to Follow-up|0|||
146033708|NCT01949090|526637213|FG003|Overall Study|Lost to Follow-up|1|||
146033709|NCT01949090|526637214|FG004|Overall Study|Lost to Follow-up|1|||
146033710|NCT00707954|526637215|FG000|Overall Study|Physician Decision|0|||
146033711|NCT00707954|526637216|FG001|Overall Study|Physician Decision|0|||
146033712|NCT00707954|526637217|FG002|Overall Study|Physician Decision|0|||
146033713|NCT00707954|526637218|FG003|Overall Study|Physician Decision|0|||
146033714|NCT00707954|526637219|FG004|Overall Study|Physician Decision|1|||
146033715|NCT00599755|526637220|FG000|Overall Study|Adverse Event|11|||
146033716|NCT00599755|526637220|FG000|Overall Study|Withdrawal by Subject|2|||
146033717|NCT00599755|526637220|FG000|Overall Study|Progression of Disease|3|||
146033718|NCT00599755|526637220|FG000|Overall Study|Other Reason|2|||
146033719|NCT00599755|526637220|FG000|Overall Study|No data available|1|||
146033720|NCT01306656|526637221|FG000|Overall Study|Lost to Follow-up|1|||
146033721|NCT01306656|526637222|FG001|Overall Study|Lost to Follow-up|0|||
146033722|NCT00417963|526637228|FG000|Overall Study|Lost to Follow-up|3|||
146033723|NCT00417963|526637228|FG000|Overall Study|Withdrawal by Subject|18|||
146033724|NCT00417963|526637228|FG000|Overall Study|Death|17|||
146033725|NCT00417963|526637228|FG000|Overall Study|Study device could not be deployed|3|||
146033726|NCT00477152|526637229|FG000|Overall Study|Parent withdrew consent|2|||
146033727|NCT00477152|526637229|FG000|Overall Study|Adverse Event|1|||
146033728|NCT01023672|526637230|FG000|Overall Study|Worsening disease|2|||
146033729|NCT01023672|526637230|FG000|Overall Study|Death|1|||
146033730|NCT02504580|526637231|FG000|Overall Study|Other|1|||
146033731|NCT02504580|526637232|FG001|Overall Study|Other|0|||
146033732|NCT02504580|526637233|FG002|Overall Study|Other|0|||
146033733|NCT02504580|526637234|FG003|Overall Study|Other|2|||
146033734|NCT02504580|526637235|FG004|Overall Study|Other|1|||
146033735|NCT02504580|526637236|FG005|Overall Study|Other|1|||
146254333|NCT00332488|527444554|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
146254334|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
146033736|NCT02504580|526637237|FG006|Overall Study|Other|1|||
146033737|NCT02504580|526637238|FG007|Overall Study|Other|2|||
146033738|NCT02504580|526637239|FG008|Overall Study|Other|0|||
146033739|NCT02504580|526637240|FG009|Overall Study|Other|0|||
146033740|NCT02504580|526637241|FG010|Overall Study|Other|0|||
146033741|NCT02504580|526637242|FG011|Overall Study|Other|2|||
146033742|NCT02504580|526637231|FG000|Overall Study|Subject refusal to continue|0|||
146033743|NCT02504580|526637232|FG001|Overall Study|Subject refusal to continue|1|||
146033744|NCT02504580|526637233|FG002|Overall Study|Subject refusal to continue|0|||
146033745|NCT02504580|526637234|FG003|Overall Study|Subject refusal to continue|0|||
146033746|NCT02504580|526637235|FG004|Overall Study|Subject refusal to continue|0|||
146033747|NCT02504580|526637236|FG005|Overall Study|Subject refusal to continue|0|||
146098019|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
146098020|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
146098021|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146098022|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146098023|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146033748|NCT02504580|526637237|FG006|Overall Study|Subject refusal to continue|0|||
146033749|NCT02504580|526637238|FG007|Overall Study|Subject refusal to continue|0|||
146033750|NCT02504580|526637239|FG008|Overall Study|Subject refusal to continue|0|||
146098024|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146098025|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146098026|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
146098027|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
146098028|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098029|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098030|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098031|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098032|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098033|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
146098034|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
146098035|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098036|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098037|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098038|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098039|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098040|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
146098041|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
146098042|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098043|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098044|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098045|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098046|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098047|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
146098048|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
146098049|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146098050|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146098051|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146098052|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146098053|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146098054|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
146168157|NCT02496767|527128090|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
146168158|NCT02496767|527128091|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
146033751|NCT02504580|526637240|FG009|Overall Study|Subject refusal to continue|0|||
146033752|NCT02504580|526637241|FG010|Overall Study|Subject refusal to continue|0|||
146033753|NCT02504580|526637242|FG011|Overall Study|Subject refusal to continue|0|||
146033754|NCT00448747|526637243|FG000|Overall Study|collapsed veins|1|||
146033755|NCT00448747|526637244|FG001|Overall Study|collapsed veins|0|||
146033756|NCT02704689|526637250|FG000|Overall Study|Physician Decision|1|||
146033757|NCT02704689|526637250|FG000|Overall Study|Study device not implanted|2|||
146033758|NCT01646203|526637251|FG000|Overall Study|Adverse Event|2|||
146033759|NCT01646203|526637252|FG001|Overall Study|Adverse Event|0|||
146033760|NCT01646203|526637253|FG002|Overall Study|Adverse Event|1|||
146033761|NCT01646203|526637251|FG000|Overall Study|Withdrawal by Subject|0|||
146033762|NCT01646203|526637252|FG001|Overall Study|Withdrawal by Subject|1|||
146033763|NCT01646203|526637253|FG002|Overall Study|Withdrawal by Subject|0|||
146033764|NCT01646203|526637251|FG000|Overall Study|Physician's Decision|0|||
146033765|NCT01646203|526637252|FG001|Overall Study|Physician's Decision|1|||
146033766|NCT01646203|526637253|FG002|Overall Study|Physician's Decision|0|||
146033767|NCT01100528|526637257|FG000|Overall Study|Death|1|||
146033768|NCT01100528|526637257|FG000|Overall Study|Withdrawal by Subject|2|||
146033769|NCT00551291|526637260|FG000|Overall Study|Physician Decision|1|||
146033770|NCT01177969|526637261|FG000|Overall Study|Protocol Violation|2|||
146033771|NCT01177969|526637262|FG001|Overall Study|Protocol Violation|1|||
146033772|NCT01177969|526637261|FG000|Overall Study|Withdrawal by Subject|1|||
146033773|NCT01177969|526637262|FG001|Overall Study|Withdrawal by Subject|2|||
146033774|NCT01475162|526637266|FG000|Overall Study|Physician Decision|1|||
146033775|NCT01475162|526637266|FG000|Overall Study|Death|10|||
146033776|NCT01475162|526637266|FG000|Overall Study|Study closed for safety|3|||
146033777|NCT00490022|526637267|FG000|Overall Study|Adverse Event|0|||
146033778|NCT00490022|526637268|FG001|Overall Study|Adverse Event|2|||
146033779|NCT00490022|526637267|FG000|Overall Study|Withdrawal by Subject|1|||
146033780|NCT00490022|526637268|FG001|Overall Study|Withdrawal by Subject|0|||
146033781|NCT00490022|526637267|FG000|Overall Study|Subject failed to disclose concommitant|0|||
146033782|NCT00490022|526637268|FG001|Overall Study|Subject failed to disclose concommitant|1|||
146033783|NCT01504204|526637269|FG000|Overall Study|Lost to Follow-up|1|||
146033784|NCT01504204|526637270|FG001|Overall Study|Lost to Follow-up|1|||
146033785|NCT00903331|526637271|FG000|Overall Study|Death|4|||
146033786|NCT00903331|526637272|FG001|Overall Study|Death|8|||
146033787|NCT00903331|526637271|FG000|Overall Study|Withdrawal of consent|1|||
146033788|NCT00903331|526637272|FG001|Overall Study|Withdrawal of consent|8|||
146033789|NCT00903331|526637271|FG000|Overall Study|Lung transplant|0|||
146033790|NCT00903331|526637272|FG001|Overall Study|Lung transplant|2|||
146033791|NCT03426631|526637273|FG000|Overall Study|Lost to Follow-up|0|||
146033792|NCT03426631|526637274|FG001|Overall Study|Lost to Follow-up|1|||
146033793|NCT00654004|526637275|FG000|Overall Study|Lost to Follow-up|1|||
146033794|NCT00654004|526637276|FG001|Overall Study|Lost to Follow-up|0|||
146033795|NCT00444067|526637277|FG000|Overall Study|Lost to Follow-up|0|||
146033796|NCT00444067|526637278|FG001|Overall Study|Lost to Follow-up|1|||
146033797|NCT00710385|526637283|FG000|Overall Study|Did not qualify|1|||
146033798|NCT00710385|526637283|FG000|Overall Study|Withdrawal by Subject|1|||
146033799|NCT00710385|526637283|FG000|Overall Study|Undisclosed back pain|1|||
146033800|NCT00710385|526637283|FG000|Overall Study|Physician Decision|1|||
146033801|NCT00710385|526637283|FG000|Overall Study|Undisclosed excessive methadone use|1|||
146033802|NCT01264770|526637284|FG000|Overall Study|Not reported|0|||
146033803|NCT01264770|526637285|FG001|Overall Study|Not reported|0|||
146033804|NCT01264770|526637286|FG002|Overall Study|Not reported|1|||
146033805|NCT01264770|526637287|FG003|Overall Study|Not reported|0|||
146033806|NCT01264770|526637288|FG004|Overall Study|Not reported|0|||
146033807|NCT01264770|526637289|FG005|Overall Study|Not reported|0|||
146033808|NCT01264770|526637284|FG000|Overall Study|e.g., change in circumstances|8|||
146033809|NCT01264770|526637285|FG001|Overall Study|e.g., change in circumstances|3|||
146033810|NCT01264770|526637286|FG002|Overall Study|e.g., change in circumstances|3|||
146033811|NCT01264770|526637287|FG003|Overall Study|e.g., change in circumstances|3|||
146033812|NCT01264770|526637288|FG004|Overall Study|e.g., change in circumstances|4|||
146033813|NCT01264770|526637289|FG005|Overall Study|e.g., change in circumstances|4|||
146033814|NCT01264770|526637284|FG000|Overall Study|Severe non-compliance to protocol|0|||
146033815|NCT01264770|526637285|FG001|Overall Study|Severe non-compliance to protocol|0|||
146033816|NCT01264770|526637286|FG002|Overall Study|Severe non-compliance to protocol|1|||
146033817|NCT01264770|526637287|FG003|Overall Study|Severe non-compliance to protocol|1|||
146033818|NCT01264770|526637288|FG004|Overall Study|Severe non-compliance to protocol|0|||
146300420|NCT00375219|527615252|FG001|Overall Study|Protocol Violation|0|||
146033819|NCT01264770|526637289|FG005|Overall Study|Severe non-compliance to protocol|0|||
146033820|NCT01264770|526637284|FG000|Overall Study|Lack of therapeutic response|1|||
146033821|NCT01264770|526637285|FG001|Overall Study|Lack of therapeutic response|0|||
146033822|NCT01264770|526637286|FG002|Overall Study|Lack of therapeutic response|2|||
146033823|NCT01264770|526637287|FG003|Overall Study|Lack of therapeutic response|1|||
146033824|NCT01264770|526637288|FG004|Overall Study|Lack of therapeutic response|1|||
146033825|NCT01264770|526637289|FG005|Overall Study|Lack of therapeutic response|0|||
146033826|NCT01264770|526637284|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
146033827|NCT01264770|526637285|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
146033828|NCT01264770|526637286|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
146033829|NCT01264770|526637287|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
146033830|NCT01264770|526637288|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
146033831|NCT01264770|526637289|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
146033832|NCT01264770|526637284|FG000|Overall Study|Lost to Follow-up|0|||
146033833|NCT01264770|526637285|FG001|Overall Study|Lost to Follow-up|0|||
146033834|NCT01264770|526637286|FG002|Overall Study|Lost to Follow-up|1|||
146033835|NCT01264770|526637287|FG003|Overall Study|Lost to Follow-up|1|||
146033836|NCT01264770|526637288|FG004|Overall Study|Lost to Follow-up|0|||
146033837|NCT01264770|526637289|FG005|Overall Study|Lost to Follow-up|0|||
146033838|NCT01264770|526637284|FG000|Overall Study|Adverse Event|7|||
146033839|NCT01264770|526637285|FG001|Overall Study|Adverse Event|7|||
146033840|NCT01264770|526637286|FG002|Overall Study|Adverse Event|8|||
146033841|NCT01264770|526637287|FG003|Overall Study|Adverse Event|0|||
146033842|NCT01264770|526637288|FG004|Overall Study|Adverse Event|2|||
146033843|NCT01264770|526637289|FG005|Overall Study|Adverse Event|1|||
146033844|NCT02528357|526637292|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033845|NCT02528357|526637293|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
146033846|NCT02528357|526637294|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033847|NCT02528357|526637295|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033848|NCT02528357|526637296|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033849|NCT02528357|526637297|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033850|NCT02528357|526637298|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033851|NCT02528357|526637299|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033852|NCT02528357|526637300|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033853|NCT02528357|526637301|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033854|NCT02528357|526637302|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033855|NCT02528357|526637303|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033856|NCT02528357|526637304|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033857|NCT02528357|526637305|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033858|NCT02528357|526637306|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033859|NCT02528357|526637307|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033860|NCT02528357|526637308|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033861|NCT02528357|526637309|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033862|NCT02528357|526637310|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
146033863|NCT02528357|526637292|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033864|NCT02528357|526637293|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033865|NCT02528357|526637294|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033866|NCT02528357|526637295|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
146033867|NCT02528357|526637296|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033868|NCT02528357|526637297|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
146033869|NCT02528357|526637298|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033870|NCT02528357|526637299|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
146033871|NCT02528357|526637300|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033872|NCT02528357|526637301|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033873|NCT02528357|526637302|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033874|NCT02528357|526637303|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033875|NCT02528357|526637304|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033876|NCT02528357|526637305|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033877|NCT02528357|526637306|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033878|NCT02528357|526637307|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033879|NCT02528357|526637308|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033880|NCT02528357|526637309|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033881|NCT02528357|526637310|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
146033882|NCT02528357|526637292|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033883|NCT02528357|526637293|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033884|NCT02528357|526637294|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
146033885|NCT02528357|526637295|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033886|NCT02528357|526637296|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
146033887|NCT02528357|526637297|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033888|NCT02528357|526637298|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
146033889|NCT02528357|526637299|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
146033890|NCT02528357|526637300|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033891|NCT02528357|526637301|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033892|NCT02528357|526637302|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033893|NCT02528357|526637303|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033894|NCT02528357|526637304|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033895|NCT02528357|526637305|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033896|NCT02528357|526637306|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033897|NCT02528357|526637307|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146300421|NCT00375219|527615253|FG002|Overall Study|Protocol Violation|1|||
146300422|NCT00375219|527615251|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
146033898|NCT02528357|526637308|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033899|NCT02528357|526637309|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033900|NCT02528357|526637310|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
146033901|NCT02528357|526637292|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033902|NCT02528357|526637293|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033903|NCT02528357|526637294|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033904|NCT02528357|526637295|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033905|NCT02528357|526637296|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146033906|NCT02528357|526637297|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033907|NCT02528357|526637298|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033908|NCT02528357|526637299|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033909|NCT02528357|526637300|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033910|NCT02528357|526637301|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033911|NCT02528357|526637302|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033912|NCT02528357|526637303|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033913|NCT02528357|526637304|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033914|NCT02528357|526637305|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033915|NCT02528357|526637306|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033916|NCT02528357|526637307|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033917|NCT02528357|526637308|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033918|NCT02528357|526637309|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033919|NCT02528357|526637310|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033920|NCT02528357|526637292|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033921|NCT02528357|526637293|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033922|NCT02528357|526637294|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033923|NCT02528357|526637295|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033924|NCT02528357|526637296|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033925|NCT02528357|526637297|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033926|NCT02528357|526637298|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033927|NCT02528357|526637299|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033928|NCT02528357|526637300|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033929|NCT02528357|526637301|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033930|NCT02528357|526637302|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033931|NCT02528357|526637303|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033932|NCT02528357|526637304|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033933|NCT02528357|526637305|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
146033934|NCT02528357|526637306|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
146033935|NCT02528357|526637307|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033936|NCT02528357|526637308|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033937|NCT02528357|526637309|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033938|NCT02528357|526637310|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
146033939|NCT02528357|526637292|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033940|NCT02528357|526637293|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033941|NCT02528357|526637294|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033942|NCT02528357|526637295|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033943|NCT02528357|526637296|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033944|NCT02528357|526637297|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033945|NCT02528357|526637298|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033946|NCT02528357|526637299|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033947|NCT02528357|526637300|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033948|NCT02528357|526637301|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033949|NCT02528357|526637302|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033950|NCT02528357|526637303|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033951|NCT02528357|526637304|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033952|NCT02528357|526637305|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
146033953|NCT02528357|526637306|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033954|NCT02528357|526637307|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033955|NCT02528357|526637308|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033956|NCT02528357|526637309|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033957|NCT02528357|526637310|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
146033958|NCT02528357|526637292|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033959|NCT02528357|526637293|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033960|NCT02528357|526637294|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033961|NCT02528357|526637295|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033962|NCT02528357|526637296|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033963|NCT02528357|526637297|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033964|NCT02528357|526637298|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033965|NCT02528357|526637299|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033966|NCT02528357|526637300|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033967|NCT02528357|526637301|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033968|NCT02528357|526637302|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
146033969|NCT02528357|526637303|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033970|NCT02528357|526637304|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
146033971|NCT02528357|526637305|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
146033972|NCT02528357|526637306|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
146033973|NCT02528357|526637307|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033974|NCT02528357|526637308|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146300423|NCT00375219|527615252|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
146300424|NCT00375219|527615253|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
146300425|NCT00375219|527615251|FG000|Overall Study|Lost to Follow-up|1|||
146300426|NCT00375219|527615252|FG001|Overall Study|Lost to Follow-up|1|||
146300427|NCT00375219|527615253|FG002|Overall Study|Lost to Follow-up|0|||
146300428|NCT00375219|527615251|FG000|Overall Study|Disease progression|18|||
146300429|NCT00375219|527615252|FG001|Overall Study|Disease progression|9|||
146300430|NCT00375219|527615253|FG002|Overall Study|Disease progression|12|||
146300431|NCT00375219|527615251|FG000|Overall Study|Death|4|||
146300432|NCT00375219|527615252|FG001|Overall Study|Death|3|||
146300433|NCT00375219|527615253|FG002|Overall Study|Death|7|||
146300434|NCT00375219|527615251|FG000|Overall Study|Hematologic resistance|1|||
146300435|NCT00375219|527615252|FG001|Overall Study|Hematologic resistance|0|||
146033975|NCT02528357|526637309|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033976|NCT02528357|526637310|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
146033977|NCT02528357|526637292|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033978|NCT02528357|526637293|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033979|NCT02528357|526637294|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033980|NCT02528357|526637295|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033981|NCT02528357|526637296|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033982|NCT02528357|526637297|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033983|NCT02528357|526637298|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033984|NCT02528357|526637299|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033985|NCT02528357|526637300|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146033986|NCT02528357|526637301|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146033987|NCT02528357|526637302|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033988|NCT02528357|526637303|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
146033989|NCT02528357|526637304|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
146033990|NCT02528357|526637305|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146033991|NCT02528357|526637306|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146033992|NCT02528357|526637307|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033993|NCT02528357|526637308|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033994|NCT02528357|526637309|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146033995|NCT02528357|526637310|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146300436|NCT00375219|527615253|FG002|Overall Study|Hematologic resistance|0|||
146300437|NCT00375219|527615251|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
146300438|NCT00375219|527615252|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
146300439|NCT00375219|527615253|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
146300440|NCT00375219|527615251|FG000|Overall Study|Allograft|2|||
146300441|NCT00375219|527615252|FG001|Overall Study|Allograft|0|||
146300442|NCT00375219|527615253|FG002|Overall Study|Allograft|0|||
146033996|NCT02528357|526637292|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146033997|NCT02528357|526637293|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146033998|NCT02528357|526637294|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146033999|NCT02528357|526637295|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034000|NCT02528357|526637296|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034001|NCT02528357|526637297|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034002|NCT02528357|526637298|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034003|NCT02528357|526637299|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034004|NCT02528357|526637300|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034005|NCT02528357|526637301|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034006|NCT02528357|526637302|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034007|NCT02528357|526637303|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034008|NCT02528357|526637304|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034009|NCT02528357|526637305|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034010|NCT02528357|526637306|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034011|NCT02528357|526637307|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034012|NCT02528357|526637308|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
146034013|NCT02528357|526637309|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034014|NCT02528357|526637310|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
146034015|NCT02528357|526637292|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034016|NCT02528357|526637293|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034017|NCT02528357|526637294|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034018|NCT02528357|526637295|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034019|NCT02528357|526637296|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034020|NCT02528357|526637297|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034021|NCT02528357|526637298|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034022|NCT02528357|526637299|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034023|NCT02528357|526637300|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034024|NCT02528357|526637301|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034025|NCT02528357|526637302|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034026|NCT02528357|526637303|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034027|NCT02528357|526637304|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034028|NCT02528357|526637305|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034029|NCT02528357|526637306|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034030|NCT02528357|526637307|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
146034031|NCT02528357|526637308|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
146034032|NCT02528357|526637309|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
146034033|NCT02528357|526637310|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
146034034|NCT02477553|526637316|FG000|Overall Study|Screening up-to-date|12|||
146034035|NCT02477553|526637317|FG001|Overall Study|Screening up-to-date|13|||
146034036|NCT02477553|526637316|FG000|Overall Study|No MD visit|1|||
146034037|NCT02477553|526637317|FG001|Overall Study|No MD visit|1|||
146034038|NCT02477553|526637316|FG000|Overall Study|Workup consistent w/CRC|1|||
146034039|NCT02477553|526637317|FG001|Overall Study|Workup consistent w/CRC|1|||
146034040|NCT02477553|526637316|FG000|Overall Study|Technical issues with intervention|2|||
146034041|NCT02477553|526637317|FG001|Overall Study|Technical issues with intervention|0|||
146034042|NCT02477553|526637316|FG000|Overall Study|Elevated risk for CRC|2|||
146034043|NCT02477553|526637317|FG001|Overall Study|Elevated risk for CRC|2|||
146034044|NCT02477553|526637316|FG000|Overall Study|MD advised against screening|1|||
146034045|NCT02477553|526637317|FG001|Overall Study|MD advised against screening|3|||
146034046|NCT02477553|526637316|FG000|Overall Study|patient deceased|1|||
146034047|NCT02477553|526637317|FG001|Overall Study|patient deceased|0|||
146034048|NCT01291277|526637318|FG000|Overall Study|Death|2|||
146034049|NCT01291277|526637319|FG001|Overall Study|Death|2|||
146098055|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
146098056|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146098057|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146300443|NCT00375219|527615251|FG000|Overall Study|Cord blood transplantation|1|||
146300444|NCT00375219|527615252|FG001|Overall Study|Cord blood transplantation|0|||
146300445|NCT00375219|527615253|FG002|Overall Study|Cord blood transplantation|0|||
146034050|NCT01291277|526637318|FG000|Overall Study|Lost to Follow-up|3|||
146034051|NCT01291277|526637319|FG001|Overall Study|Lost to Follow-up|1|||
146034052|NCT00849108|526637320|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
146034053|NCT00849108|526637321|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
146034054|NCT00849108|526637320|FG000|Cohort 2 Efficacy|Adverse Event|0|||
146034055|NCT00849108|526637321|FG001|Cohort 2 Efficacy|Adverse Event|1|||
146034056|NCT00849108|526637320|FG000|Cohort 2 Efficacy|Other|0|||
146034057|NCT00849108|526637321|FG001|Cohort 2 Efficacy|Other|9|||
146034058|NCT02963701|526637322|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
146034059|NCT02963701|526637323|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
146034060|NCT03480009|526637324|FG000|Overall Study|Lost to Follow-up|4|||
146034061|NCT03480009|526637325|FG001|Overall Study|Lost to Follow-up|5|||
146034062|NCT03480009|526637326|FG002|Overall Study|Lost to Follow-up|4|||
146034063|NCT03480009|526637327|FG003|Overall Study|Lost to Follow-up|0|||
146034064|NCT00637572|526637330|FG000|Overall Study|Adverse Event|1|||
146034065|NCT00637572|526637331|FG001|Overall Study|Adverse Event|2|||
146034066|NCT00637572|526637330|FG000|Overall Study|Death|0|||
146034067|NCT00637572|526637331|FG001|Overall Study|Death|1|||
146034068|NCT00637572|526637330|FG000|Overall Study|Lost to Follow-up|0|||
146034069|NCT00637572|526637331|FG001|Overall Study|Lost to Follow-up|1|||
146034070|NCT00637572|526637330|FG000|Overall Study|Physician Decision|1|||
146034071|NCT00637572|526637331|FG001|Overall Study|Physician Decision|1|||
146034072|NCT00637572|526637330|FG000|Overall Study|Withdrawal by Subject|0|||
146034073|NCT00637572|526637331|FG001|Overall Study|Withdrawal by Subject|2|||
146034074|NCT00637572|526637330|FG000|Overall Study|Illicit Drug Use|1|||
146034075|NCT00637572|526637331|FG001|Overall Study|Illicit Drug Use|0|||
146034076|NCT00896649|526637332|FG000|Overall Study|Physician Decision|1|||
146034077|NCT00896649|526637332|FG000|Overall Study|Pregnancy|1|||
146034078|NCT00896649|526637332|FG000|Overall Study|missing documentation|1|||
146034079|NCT00896649|526637332|FG000|Overall Study|technical difficulties|2|||
146034080|NCT03652675|526637336|FG000|Overall Study|Lost to Follow-up|4|||
146034081|NCT03652675|526637337|FG001|Overall Study|Lost to Follow-up|4|||
146034082|NCT01638559|526637338|FG000|Overall Study|Lost to Follow-up|1|||
146034083|NCT01638559|526637338|FG000|Overall Study|Withdrawal by Subject|1|||
146034084|NCT01638559|526637338|FG000|Overall Study|Subject declined to travel for biopsy|1|||
146034085|NCT00752726|526637342|FG000|Overall Study|Lost to Follow-up|2|||
146034086|NCT00752726|526637343|FG001|Overall Study|Lost to Follow-up|1|||
146034087|NCT00752726|526637342|FG000|Overall Study|Adverse Event|3|||
146034088|NCT00752726|526637343|FG001|Overall Study|Adverse Event|0|||
146034089|NCT00752726|526637342|FG000|Overall Study|Withdrawal by Subject|5|||
146034090|NCT00752726|526637343|FG001|Overall Study|Withdrawal by Subject|10|||
146034091|NCT00752726|526637342|FG000|Overall Study|Other Reason|1|||
146034092|NCT00752726|526637343|FG001|Overall Study|Other Reason|2|||
146034093|NCT01403116|526637344|FG000|Overall Study|Adverse Event|7|||
146034094|NCT01403116|526637345|FG001|Overall Study|Adverse Event|4|||
146034095|NCT01403116|526637344|FG000|Overall Study|Lost to Follow-up|7|||
146034096|NCT01403116|526637345|FG001|Overall Study|Lost to Follow-up|5|||
146034097|NCT01403116|526637344|FG000|Overall Study|Withdrawal by Subject|12|||
146034098|NCT01403116|526637345|FG001|Overall Study|Withdrawal by Subject|15|||
146034099|NCT01403116|526637344|FG000|Overall Study|Non-compliance of study drug|3|||
146034100|NCT01403116|526637345|FG001|Overall Study|Non-compliance of study drug|0|||
146034101|NCT01403116|526637344|FG000|Overall Study|Protocol Violation|0|||
146034102|NCT01403116|526637345|FG001|Overall Study|Protocol Violation|1|||
146034103|NCT01403116|526637344|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
146034104|NCT01403116|526637345|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
146034105|NCT01403116|526637344|FG000|Overall Study|Hct >54%|2|||
146034106|NCT01403116|526637345|FG001|Overall Study|Hct >54%|0|||
146034107|NCT01403116|526637344|FG000|Overall Study|unable to keep appointments|0|||
146034108|NCT01403116|526637345|FG001|Overall Study|unable to keep appointments|2|||
146034109|NCT01895309|526637346|FG000|Overall Study|Adverse Event|13|||
146034110|NCT01895309|526637347|FG001|Overall Study|Adverse Event|17|||
146034111|NCT01895309|526637346|FG000|Overall Study|Protocol Violation|1|||
146034112|NCT01895309|526637347|FG001|Overall Study|Protocol Violation|0|||
146034113|NCT01895309|526637346|FG000|Overall Study|Lack of Efficacy|1|||
146034114|NCT01895309|526637347|FG001|Overall Study|Lack of Efficacy|3|||
146034115|NCT01895309|526637346|FG000|Overall Study|Lost to Follow-up|1|||
146034116|NCT01895309|526637347|FG001|Overall Study|Lost to Follow-up|3|||
146034117|NCT01895309|526637346|FG000|Overall Study|Physician Decision|15|||
146034118|NCT01895309|526637347|FG001|Overall Study|Physician Decision|10|||
146034119|NCT01895309|526637346|FG000|Overall Study|Withdrawal by Subject|9|||
146034120|NCT01895309|526637347|FG001|Overall Study|Withdrawal by Subject|18|||
146034121|NCT00042666|526637348|FG000|Overall Study|Adverse Event|2|||
146034122|NCT00042666|526637348|FG000|Overall Study|Death|4|||
146034123|NCT00042666|526637348|FG000|Overall Study|Protocol Violation|1|||
146034124|NCT00042666|526637348|FG000|Overall Study|Participant/Physician Perception|1|||
146034125|NCT00042666|526637348|FG000|Overall Study|Progressive Disease|41|||
146034126|NCT00042666|526637348|FG000|Overall Study|Other|1|||
146034127|NCT00042666|526637348|FG000|Overall Study|Other|4|||
146034128|NCT04232215|526637349|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146034129|NCT04232215|526637350|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146034130|NCT00447122|526637351|FG000|Overall Study|worsening medical condition -came off|0|||
146034131|NCT00447122|526637352|FG001|Overall Study|worsening medical condition -came off|1|||
146034132|NCT00447122|526637353|FG002|Overall Study|worsening medical condition -came off|0|||
146034133|NCT00447122|526637354|FG003|Overall Study|worsening medical condition -came off|0|||
146034134|NCT02409342|526637355|FG000|Overall Study|Death|211|||
146034135|NCT02409342|526637356|FG001|Overall Study|Death|201|||
146034136|NCT02409342|526637355|FG000|Overall Study|Withdrawal by Subject|24|||
146034137|NCT02409342|526637356|FG001|Overall Study|Withdrawal by Subject|17|||
146034138|NCT02409342|526637355|FG000|Overall Study|Study Terminated By Sponsor|48|||
146034139|NCT02409342|526637356|FG001|Overall Study|Study Terminated By Sponsor|59|||
146034140|NCT02409342|526637355|FG000|Overall Study|Lost to Follow-up|3|||
146034141|NCT02409342|526637356|FG001|Overall Study|Lost to Follow-up|5|||
146034142|NCT02409342|526637355|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
146034143|NCT02409342|526637356|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
146034144|NCT02409342|526637355|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
146034145|NCT02409342|526637356|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
146034146|NCT02409342|526637355|FG000|Overall Study|Sponsor Decision|1|||
146034147|NCT02409342|526637356|FG001|Overall Study|Sponsor Decision|0|||
146034148|NCT00279812|526637357|FG000|Overall Study|Protocol Violation|1|||
146034149|NCT00279812|526637358|FG001|Overall Study|Protocol Violation|1|||
146034150|NCT00279812|526637359|FG002|Overall Study|Protocol Violation|0|||
146034151|NCT00279812|526637360|FG003|Overall Study|Protocol Violation|0|||
146034152|NCT00279812|526637361|FG004|Overall Study|Protocol Violation|1|||
146034153|NCT00279812|526637362|FG005|Overall Study|Protocol Violation|0|||
146034154|NCT00279812|526637357|FG000|Overall Study|Withdrawal by Subject|0|||
146034155|NCT00279812|526637358|FG001|Overall Study|Withdrawal by Subject|4|||
146034156|NCT00279812|526637359|FG002|Overall Study|Withdrawal by Subject|2|||
146034157|NCT00279812|526637360|FG003|Overall Study|Withdrawal by Subject|0|||
146034158|NCT00279812|526637361|FG004|Overall Study|Withdrawal by Subject|0|||
146034159|NCT00279812|526637362|FG005|Overall Study|Withdrawal by Subject|0|||
146034160|NCT00279812|526637357|FG000|Overall Study|Adverse Event|0|||
146034161|NCT00279812|526637358|FG001|Overall Study|Adverse Event|1|||
146034162|NCT00279812|526637359|FG002|Overall Study|Adverse Event|1|||
146034163|NCT00279812|526637360|FG003|Overall Study|Adverse Event|0|||
146034164|NCT00279812|526637361|FG004|Overall Study|Adverse Event|2|||
146034165|NCT00279812|526637362|FG005|Overall Study|Adverse Event|1|||
146034166|NCT01439373|526637363|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
146034167|NCT01439373|526637364|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
146034168|NCT01439373|526637363|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
146034169|NCT01439373|526637364|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
146034170|NCT04576897|526637365|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
146034171|NCT03834220|526637366|FG000|Overall Study|Adverse Event|1|||
146034172|NCT03834220|526637367|FG001|Overall Study|Adverse Event|0|||
146034173|NCT03834220|526637368|FG002|Overall Study|Adverse Event|0|||
146034174|NCT03834220|526637366|FG000|Overall Study|Death|8|||
146034175|NCT03834220|526637367|FG001|Overall Study|Death|1|||
146034176|NCT03834220|526637368|FG002|Overall Study|Death|17|||
146034177|NCT03834220|526637366|FG000|Overall Study|Reason not Specified|9|||
146034178|NCT03834220|526637367|FG001|Overall Study|Reason not Specified|0|||
146034179|NCT03834220|526637368|FG002|Overall Study|Reason not Specified|6|||
146034180|NCT03834220|526637366|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
146034181|NCT03834220|526637367|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
146034182|NCT03834220|526637368|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
146034183|NCT03834220|526637366|FG000|Overall Study|Withdrawal of Consent|2|||
146034184|NCT03834220|526637367|FG001|Overall Study|Withdrawal of Consent|2|||
146034185|NCT03834220|526637368|FG002|Overall Study|Withdrawal of Consent|2|||
146034186|NCT02593318|526637371|FG000|Overall Study|Withdrawal by Subject|1|||
146034187|NCT02593318|526637372|FG001|Overall Study|Withdrawal by Subject|1|||
146034188|NCT01174173|526637374|FG000|Overall Study|drug-drug interaction|1|||
146034189|NCT00527332|526637378|FG000|Overall Study|Protocol Violation|4|||
146168159|NCT02496767|527128092|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
146034190|NCT00527332|526637379|FG001|Overall Study|Protocol Violation|8|||
146034191|NCT00527332|526637378|FG000|Overall Study|Withdrew consent|5|||
146034192|NCT00527332|526637379|FG001|Overall Study|Withdrew consent|1|||
146034193|NCT03268941|526639456|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034194|NCT03268941|526639457|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034195|NCT03268941|526639458|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034196|NCT03268941|526639459|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
146034197|NCT03268941|526639460|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034198|NCT03268941|526639461|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034199|NCT03268941|526639462|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
146034200|NCT03268941|526639456|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034201|NCT03268941|526639457|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034202|NCT03268941|526639458|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034203|NCT03268941|526639459|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
146034204|NCT03268941|526639460|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034205|NCT03268941|526639461|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034206|NCT03268941|526639462|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
146034207|NCT03268941|526639456|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
146034208|NCT03268941|526639457|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146254335|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
146254336|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
146034209|NCT03268941|526639458|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146034210|NCT03268941|526639459|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146034211|NCT03268941|526639460|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146034212|NCT03268941|526639461|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146034213|NCT03268941|526639462|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
146034214|NCT03268941|526639456|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
146034215|NCT03268941|526639457|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
146034216|NCT03268941|526639458|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
146034217|NCT03268941|526639459|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
146034218|NCT03268941|526639460|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
146034219|NCT03268941|526639461|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
146034220|NCT03268941|526639462|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
146034221|NCT03268941|526639456|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034222|NCT03268941|526639457|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034223|NCT03268941|526639458|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034224|NCT03268941|526639459|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034225|NCT03268941|526639460|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034226|NCT03268941|526639461|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
146034227|NCT03268941|526639462|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
146034228|NCT01216683|526639463|FG000|Induction|Never started treatment|0|||
146034229|NCT01216683|526639464|FG001|Induction|Never started treatment|6|||
146034230|NCT01216683|526639465|FG002|Induction|Never started treatment|3|||
146034231|NCT01216683|526639463|FG000|Induction|Lack of Efficacy|4|||
146034232|NCT01216683|526639464|FG001|Induction|Lack of Efficacy|3|||
146034233|NCT01216683|526639465|FG002|Induction|Lack of Efficacy|7|||
146034234|NCT01216683|526639463|FG000|Induction|Adverse Event|0|||
146034235|NCT01216683|526639464|FG001|Induction|Adverse Event|5|||
146034236|NCT01216683|526639465|FG002|Induction|Adverse Event|5|||
146034237|NCT01216683|526639463|FG000|Induction|Death|0|||
146034238|NCT01216683|526639464|FG001|Induction|Death|0|||
146034239|NCT01216683|526639465|FG002|Induction|Death|2|||
146034240|NCT01216683|526639463|FG000|Induction|Withdrawal by Subject|0|||
146034241|NCT01216683|526639464|FG001|Induction|Withdrawal by Subject|4|||
146034242|NCT01216683|526639465|FG002|Induction|Withdrawal by Subject|2|||
146034243|NCT01216683|526639463|FG000|Induction|Other disease|0|||
146034244|NCT01216683|526639464|FG001|Induction|Other disease|1|||
146034245|NCT01216683|526639465|FG002|Induction|Other disease|2|||
146034246|NCT01216683|526639463|FG000|Continuation|Lack of Efficacy|3|||
146034247|NCT01216683|526639464|FG001|Continuation|Lack of Efficacy|2|||
146034248|NCT01216683|526639465|FG002|Continuation|Lack of Efficacy|7|||
146034249|NCT01216683|526639463|FG000|Continuation|Adverse Event|5|||
146034250|NCT01216683|526639464|FG001|Continuation|Adverse Event|3|||
146254337|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
146254338|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
146254339|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
146254340|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
146034251|NCT01216683|526639465|FG002|Continuation|Adverse Event|16|||
146034252|NCT01216683|526639463|FG000|Continuation|Death|1|||
146034253|NCT01216683|526639464|FG001|Continuation|Death|0|||
146034254|NCT01216683|526639465|FG002|Continuation|Death|2|||
146034255|NCT01216683|526639463|FG000|Continuation|Withdrawal by Subject|4|||
146254341|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
146034256|NCT01216683|526639464|FG001|Continuation|Withdrawal by Subject|5|||
146034257|NCT01216683|526639465|FG002|Continuation|Withdrawal by Subject|9|||
146034258|NCT01216683|526639463|FG000|Continuation|Other diseases|0|||
146034259|NCT01216683|526639464|FG001|Continuation|Other diseases|2|||
146034260|NCT01216683|526639465|FG002|Continuation|Other diseases|1|||
146034261|NCT01216683|526639463|FG000|Continuation|Physician Decision|1|||
146034262|NCT01216683|526639464|FG001|Continuation|Physician Decision|0|||
146034263|NCT01216683|526639465|FG002|Continuation|Physician Decision|1|||
146034264|NCT01216683|526639463|FG000|Continuation|Non-compliance|1|||
146034265|NCT01216683|526639464|FG001|Continuation|Non-compliance|0|||
146034266|NCT01216683|526639465|FG002|Continuation|Non-compliance|1|||
146034267|NCT01216683|526639463|FG000|Continuation|Insurance change|0|||
146034268|NCT01216683|526639464|FG001|Continuation|Insurance change|1|||
146034269|NCT01216683|526639465|FG002|Continuation|Insurance change|0|||
146098058|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146098059|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146098060|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146098061|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
146098062|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
146098063|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146254342|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
146034270|NCT01216683|526639463|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
146034271|NCT01216683|526639464|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
146034272|NCT01216683|526639465|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
146034273|NCT01216683|526639463|FG000|Continuation|Not reported|0|||
146034274|NCT01216683|526639464|FG001|Continuation|Not reported|0|||
146034275|NCT01216683|526639465|FG002|Continuation|Not reported|1|||
146034276|NCT01216683|526639463|FG000|Continuation|Never started treatment|0|||
146034277|NCT01216683|526639464|FG001|Continuation|Never started treatment|1|||
146034278|NCT01216683|526639465|FG002|Continuation|Never started treatment|5|||
146034279|NCT01629953|526639466|FG000|Overall Study|Death|3|||
146034280|NCT01629953|526639467|FG001|Overall Study|Death|1|||
146034281|NCT01629953|526639466|FG000|Overall Study|Lost to Follow-up|10|||
146034282|NCT01629953|526639467|FG001|Overall Study|Lost to Follow-up|14|||
146034283|NCT00344500|526639468|FG000|Overall Study|Adverse Event|6|||
146034284|NCT00344500|526639469|FG001|Overall Study|Adverse Event|2|||
146034285|NCT00344500|526639470|FG002|Overall Study|Adverse Event|0|||
146034286|NCT00344500|526639468|FG000|Overall Study|Lost to Follow-up|5|||
146034287|NCT00344500|526639469|FG001|Overall Study|Lost to Follow-up|13|||
146034288|NCT00344500|526639470|FG002|Overall Study|Lost to Follow-up|1|||
146034289|NCT00344500|526639468|FG000|Overall Study|Withdrawal by Subject|7|||
146034290|NCT00344500|526639469|FG001|Overall Study|Withdrawal by Subject|10|||
146034291|NCT00344500|526639470|FG002|Overall Study|Withdrawal by Subject|0|||
146034292|NCT00344500|526639468|FG000|Overall Study|Protocol Violation|4|||
146034293|NCT00344500|526639469|FG001|Overall Study|Protocol Violation|7|||
146034294|NCT00344500|526639470|FG002|Overall Study|Protocol Violation|1|||
146034295|NCT00344500|526639468|FG000|Overall Study|Not Noted|1|||
146034296|NCT00344500|526639469|FG001|Overall Study|Not Noted|3|||
146034297|NCT00344500|526639470|FG002|Overall Study|Not Noted|0|||
146034298|NCT02252965|526639472|FG000|Overall Study|Adverse Event|9|||
146034299|NCT02252965|526639473|FG001|Overall Study|Adverse Event|14|||
146034300|NCT02252965|526639472|FG000|Overall Study|Lost to Follow-up|16|||
146034301|NCT02252965|526639473|FG001|Overall Study|Lost to Follow-up|8|||
146034302|NCT02252965|526639472|FG000|Overall Study|Protocol Violation|4|||
146034303|NCT02252965|526639473|FG001|Overall Study|Protocol Violation|5|||
146034304|NCT02252965|526639472|FG000|Overall Study|Lack of Efficacy|0|||
146034305|NCT02252965|526639473|FG001|Overall Study|Lack of Efficacy|2|||
146034306|NCT02252965|526639472|FG000|Overall Study|Withdrawal by Subject|7|||
146034307|NCT02252965|526639473|FG001|Overall Study|Withdrawal by Subject|9|||
146034308|NCT02252965|526639472|FG000|Overall Study|Other|4|||
146034309|NCT02252965|526639473|FG001|Overall Study|Other|5|||
146034310|NCT02615691|526639476|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
146034311|NCT02615691|526639476|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
146034312|NCT02615691|526639476|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
146034313|NCT02615691|526639476|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
146034314|NCT04279613|526639478|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146034315|NCT04279613|526639479|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146034316|NCT04279613|526639480|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146034317|NCT04279613|526639481|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
146034318|NCT04279613|526639482|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
146034319|NCT04279613|526639478|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146034320|NCT04279613|526639479|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
146034321|NCT04279613|526639480|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146034322|NCT04279613|526639481|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146034323|NCT04279613|526639482|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
146034324|NCT04279613|526639478|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146034325|NCT04279613|526639479|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146034326|NCT04279613|526639480|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
146034327|NCT04279613|526639481|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146034328|NCT04279613|526639482|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
146034329|NCT04279613|526639478|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146034330|NCT04279613|526639479|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146034331|NCT04279613|526639480|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146034332|NCT04279613|526639481|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
146034333|NCT04279613|526639482|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
146098064|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146098065|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146098066|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146098067|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146098068|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
146098069|NCT04526509|526879299|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
146098070|NCT04526509|526879300|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098071|NCT04526509|526879301|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098072|NCT04526509|526879302|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098073|NCT04526509|526879303|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098074|NCT04526509|526879304|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098075|NCT04526509|526879305|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
146098076|NCT04526509|526879299|FG000|Enrolled|Study Terminated by Sponsor|0|||
146098077|NCT04526509|526879300|FG001|Enrolled|Study Terminated by Sponsor|0|||
146098078|NCT04526509|526879301|FG002|Enrolled|Study Terminated by Sponsor|0|||
146098079|NCT04526509|526879302|FG003|Enrolled|Study Terminated by Sponsor|0|||
146098080|NCT04526509|526879303|FG004|Enrolled|Study Terminated by Sponsor|0|||
146098081|NCT04526509|526879304|FG005|Enrolled|Study Terminated by Sponsor|0|||
146098082|NCT04526509|526879305|FG006|Enrolled|Study Terminated by Sponsor|1|||
146098083|NCT04526509|526879299|FG000|Enrolled|Death prior to lymphodepletion|0|||
146098084|NCT04526509|526879300|FG001|Enrolled|Death prior to lymphodepletion|0|||
146098085|NCT04526509|526879301|FG002|Enrolled|Death prior to lymphodepletion|0|||
146098086|NCT04526509|526879302|FG003|Enrolled|Death prior to lymphodepletion|1|||
146098087|NCT04526509|526879303|FG004|Enrolled|Death prior to lymphodepletion|0|||
146098088|NCT04526509|526879304|FG005|Enrolled|Death prior to lymphodepletion|0|||
146098089|NCT04526509|526879305|FG006|Enrolled|Death prior to lymphodepletion|0|||
146098090|NCT04526509|526879299|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098091|NCT04526509|526879300|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098092|NCT04526509|526879301|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098093|NCT04526509|526879302|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
146098094|NCT04526509|526879303|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098095|NCT04526509|526879304|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098096|NCT04526509|526879305|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
146098097|NCT04526509|526879299|FG000|Enrolled|Physician Decision|0|||
146098098|NCT04526509|526879300|FG001|Enrolled|Physician Decision|1|||
146098099|NCT04526509|526879301|FG002|Enrolled|Physician Decision|0|||
146098100|NCT04526509|526879302|FG003|Enrolled|Physician Decision|0|||
146098101|NCT04526509|526879303|FG004|Enrolled|Physician Decision|0|||
146098102|NCT04526509|526879304|FG005|Enrolled|Physician Decision|0|||
146098103|NCT04526509|526879305|FG006|Enrolled|Physician Decision|0|||
146098104|NCT02719327|526879308|FG000|Overall Study|Withdrawal by Subject|11|||
146098105|NCT02719327|526879309|FG001|Overall Study|Withdrawal by Subject|8|||
146098106|NCT04340193|526879310|FG000|Overall Study|Other reason|0|||
146098107|NCT04340193|526879311|FG001|Overall Study|Other reason|0|||
146098108|NCT04340193|526879312|FG002|Overall Study|Other reason|1|||
146098109|NCT04340193|526879310|FG000|Overall Study|Disease recurrence|0|||
146098110|NCT04340193|526879311|FG001|Overall Study|Disease recurrence|1|||
146098111|NCT04340193|526879312|FG002|Overall Study|Disease recurrence|0|||
146098112|NCT04340193|526879310|FG000|Overall Study|Study drug toxicity|1|||
146098113|NCT04340193|526879311|FG001|Overall Study|Study drug toxicity|0|||
146098114|NCT04340193|526879312|FG002|Overall Study|Study drug toxicity|0|||
146098115|NCT04340193|526879310|FG000|Overall Study|Disease progression|1|||
146098116|NCT04340193|526879311|FG001|Overall Study|Disease progression|2|||
146098117|NCT04340193|526879312|FG002|Overall Study|Disease progression|3|||
146098118|NCT04340193|526879310|FG000|Overall Study|Administrative reasons by sponsor|0|||
146098119|NCT04340193|526879311|FG001|Overall Study|Administrative reasons by sponsor|1|||
146098120|NCT04340193|526879312|FG002|Overall Study|Administrative reasons by sponsor|0|||
146098121|NCT04340193|526879310|FG000|Overall Study|Adverse Event|1|||
146098122|NCT04340193|526879311|FG001|Overall Study|Adverse Event|1|||
146098123|NCT04340193|526879312|FG002|Overall Study|Adverse Event|0|||
146098124|NCT03350620|526879313|FG000|Stage 2|Adverse Event|0|||
146098125|NCT03350620|526879314|FG001|Stage 2|Adverse Event|1|||
146098126|NCT03350620|526879315|FG002|Stage 2|Adverse Event|1|||
146098127|NCT03350620|526879313|FG000|Stage 2|Lack of Efficacy|0|||
146098128|NCT03350620|526879314|FG001|Stage 2|Lack of Efficacy|2|||
146098129|NCT03350620|526879315|FG002|Stage 2|Lack of Efficacy|0|||
146098130|NCT03350620|526879313|FG000|Stage 2|Lost to Follow-up|1|||
146098131|NCT03350620|526879314|FG001|Stage 2|Lost to Follow-up|2|||
146098132|NCT03350620|526879315|FG002|Stage 2|Lost to Follow-up|2|||
146098133|NCT03350620|526879313|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
146098134|NCT03350620|526879314|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
146098135|NCT03350620|526879315|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
146098136|NCT03001882|526879318|FG000|Overall Study|Death|1|||
146098137|NCT03001882|526879319|FG001|Overall Study|Death|0|||
146098138|NCT03001882|526879320|FG002|Overall Study|Death|0|||
146098139|NCT03001882|526879321|FG003|Overall Study|Death|3|||
146098140|NCT03001882|526879318|FG000|Overall Study|Participant withdrew consent|0|||
146098141|NCT03001882|526879319|FG001|Overall Study|Participant withdrew consent|1|||
146098142|NCT03001882|526879320|FG002|Overall Study|Participant withdrew consent|0|||
146098143|NCT03001882|526879321|FG003|Overall Study|Participant withdrew consent|5|||
146098144|NCT03001882|526879318|FG000|Overall Study|Other reasons|1|||
146098145|NCT03001882|526879319|FG001|Overall Study|Other reasons|2|||
146098146|NCT03001882|526879320|FG002|Overall Study|Other reasons|0|||
146098147|NCT03001882|526879321|FG003|Overall Study|Other reasons|5|||
146098148|NCT03001882|526879318|FG000|Overall Study|Administrative reason by sponsor|0|||
146098149|NCT03001882|526879319|FG001|Overall Study|Administrative reason by sponsor|0|||
146098150|NCT03001882|526879320|FG002|Overall Study|Administrative reason by sponsor|0|||
146098151|NCT03001882|526879321|FG003|Overall Study|Administrative reason by sponsor|1|||
146098152|NCT03001882|526879318|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146098153|NCT03001882|526879319|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
146098154|NCT03001882|526879320|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146098155|NCT03001882|526879321|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
146098156|NCT03001882|526879318|FG000|Overall Study|Not reported|0|||
146098157|NCT03001882|526879319|FG001|Overall Study|Not reported|0|||
146098158|NCT03001882|526879320|FG002|Overall Study|Not reported|0|||
146098159|NCT03001882|526879321|FG003|Overall Study|Not reported|6|||
146098160|NCT03001882|526879318|FG000|Overall Study|Maximum clinical benefit|2|||
146098161|NCT03001882|526879319|FG001|Overall Study|Maximum clinical benefit|3|||
146098162|NCT03001882|526879320|FG002|Overall Study|Maximum clinical benefit|0|||
146098163|NCT03001882|526879321|FG003|Overall Study|Maximum clinical benefit|10|||
146098164|NCT03001882|526879318|FG000|Overall Study|AE unrelated to study drug|3|||
146098165|NCT03001882|526879319|FG001|Overall Study|AE unrelated to study drug|3|||
146098166|NCT03001882|526879320|FG002|Overall Study|AE unrelated to study drug|0|||
146098167|NCT03001882|526879321|FG003|Overall Study|AE unrelated to study drug|11|||
146098168|NCT03001882|526879318|FG000|Overall Study|Study Drug Toxicity|8|||
146098169|NCT03001882|526879319|FG001|Overall Study|Study Drug Toxicity|5|||
146098170|NCT03001882|526879320|FG002|Overall Study|Study Drug Toxicity|0|||
146098171|NCT03001882|526879321|FG003|Overall Study|Study Drug Toxicity|37|||
146098172|NCT03001882|526879318|FG000|Overall Study|Disease progression|16|||
146098173|NCT03001882|526879319|FG001|Overall Study|Disease progression|14|||
146098174|NCT03001882|526879320|FG002|Overall Study|Disease progression|1|||
146098175|NCT03001882|526879321|FG003|Overall Study|Disease progression|90|||
146098176|NCT01386008|526879322|FG000|Overall Study|exited w/o incident /study discontinued|17|||
146098177|NCT01386008|526879322|FG000|Overall Study|Adverse Event|3|||
146098178|NCT04449861|526879323|FG000|Overall Study|Withdrawal by Subject|4|||
146098179|NCT04449861|526879323|FG000|Overall Study|Lost to Follow-up|5|||
146098180|NCT04449861|526879323|FG000|Overall Study|Death|112|||
146098181|NCT05268055|526879324|FG000|Overall Study|Lost to Follow-up|68|||
146098182|NCT05268055|526879325|FG001|Overall Study|Lost to Follow-up|68|||
146098183|NCT05268055|526879324|FG000|Overall Study|Withdrawal by Subject|12|||
146098184|NCT05268055|526879325|FG001|Overall Study|Withdrawal by Subject|8|||
146098185|NCT01555983|526879326|FG000|Overall Study|Withdrawal by Subject|1|||
146098186|NCT01555983|526879327|FG001|Overall Study|Withdrawal by Subject|0|||
146098187|NCT01555983|526879328|FG002|Overall Study|Withdrawal by Subject|0|||
146098188|NCT01555983|526879329|FG003|Overall Study|Withdrawal by Subject|0|||
146098189|NCT01555983|526879330|FG004|Overall Study|Withdrawal by Subject|1|||
146098190|NCT01555983|526879331|FG005|Overall Study|Withdrawal by Subject|1|||
146098191|NCT05439941|526881076|FG000|Overall Study|Lack of Efficacy|8|||
146098192|NCT05439941|526881077|FG001|Overall Study|Lack of Efficacy|5|||
146098193|NCT05439941|526881078|FG002|Overall Study|Lack of Efficacy|3|||
146098194|NCT05439941|526881076|FG000|Overall Study|Treatment Failure|0|||
146098195|NCT05439941|526881077|FG001|Overall Study|Treatment Failure|1|||
146098196|NCT05439941|526881078|FG002|Overall Study|Treatment Failure|0|||
146098197|NCT05439941|526881076|FG000|Overall Study|Adverse Event|1|||
146254343|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
146254344|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
146254345|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
146098198|NCT05439941|526881077|FG001|Overall Study|Adverse Event|3|||
146098199|NCT05439941|526881078|FG002|Overall Study|Adverse Event|0|||
146098200|NCT05439941|526881076|FG000|Overall Study|Adverse Event - Parent Study|1|||
146098201|NCT05439941|526881077|FG001|Overall Study|Adverse Event - Parent Study|0|||
146034334|NCT04279613|526639478|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146034335|NCT04279613|526639479|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146034336|NCT04279613|526639480|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146034337|NCT04279613|526639481|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
146034338|NCT04279613|526639482|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
146034339|NCT04051827|526639483|FG000|Overall Study|Death|1|||
146034340|NCT04051827|526639483|FG000|Overall Study|Withdrawal by Subject|4|||
146034341|NCT04051827|526639483|FG000|Overall Study|Progressive disease|16|||
146034342|NCT04051827|526639483|FG000|Overall Study|Physician Decision|1|||
146034343|NCT04051827|526639483|FG000|Overall Study|Other|4|||
146034344|NCT02888743|526639484|FG000|Overall Study|Withdrawal by Subject|1|||
146034345|NCT02888743|526639485|FG001|Overall Study|Withdrawal by Subject|2|||
146034346|NCT02888743|526639486|FG002|Overall Study|Withdrawal by Subject|2|||
146034347|NCT02888743|526639487|FG003|Overall Study|Withdrawal by Subject|0|||
146034348|NCT02888743|526639488|FG004|Overall Study|Withdrawal by Subject|1|||
146034349|NCT02888743|526639484|FG000|Overall Study|Disease progression before treatment|2|||
146034350|NCT02888743|526639485|FG001|Overall Study|Disease progression before treatment|0|||
146034351|NCT02888743|526639486|FG002|Overall Study|Disease progression before treatment|2|||
146034352|NCT02888743|526639487|FG003|Overall Study|Disease progression before treatment|0|||
146034353|NCT02888743|526639488|FG004|Overall Study|Disease progression before treatment|0|||
146034354|NCT02888743|526639484|FG000|Overall Study|Patient ineligible|1|||
146034355|NCT02888743|526639485|FG001|Overall Study|Patient ineligible|2|||
146034356|NCT02888743|526639486|FG002|Overall Study|Patient ineligible|0|||
146034357|NCT02888743|526639487|FG003|Overall Study|Patient ineligible|0|||
146034358|NCT02888743|526639488|FG004|Overall Study|Patient ineligible|0|||
146034359|NCT01424566|526639489|FG000|Single-blind Treatment|Adverse Event|71|||
146034360|NCT01424566|526639490|FG001|Single-blind Treatment|Adverse Event|0|||
146034361|NCT01424566|526639491|FG002|Single-blind Treatment|Adverse Event|0|||
146034362|NCT01424566|526639489|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
146034363|NCT01424566|526639490|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
146034364|NCT01424566|526639491|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
146034365|NCT01424566|526639489|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
146034366|NCT01424566|526639490|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
146034367|NCT01424566|526639491|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
146034368|NCT01424566|526639489|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
146034369|NCT01424566|526639490|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
146034370|NCT01424566|526639491|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
146034371|NCT01424566|526639489|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
146034372|NCT01424566|526639490|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
146034373|NCT01424566|526639491|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
146034374|NCT01424566|526639489|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
146034375|NCT01424566|526639490|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
146034376|NCT01424566|526639491|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
146034377|NCT01424566|526639489|FG000|Double-blind Treatment|Adverse Event|0|||
146034378|NCT01424566|526639490|FG001|Double-blind Treatment|Adverse Event|21|||
146034379|NCT01424566|526639491|FG002|Double-blind Treatment|Adverse Event|13|||
146034380|NCT01424566|526639489|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
146034381|NCT01424566|526639490|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
146034382|NCT01424566|526639491|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
146034383|NCT01424566|526639489|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
146034384|NCT01424566|526639490|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
146034385|NCT01424566|526639491|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
146034386|NCT01424566|526639489|FG000|Double-blind Treatment|Lack of Efficacy|0|||
146034387|NCT01424566|526639490|FG001|Double-blind Treatment|Lack of Efficacy|1|||
146034388|NCT01424566|526639491|FG002|Double-blind Treatment|Lack of Efficacy|1|||
146034389|NCT01659255|526639496|FG000|Overall Study|Adverse Event|0|||
146034390|NCT01659255|526639497|FG001|Overall Study|Adverse Event|0|||
146034391|NCT01659255|526639498|FG002|Overall Study|Adverse Event|0|||
146034392|NCT01659255|526639499|FG003|Overall Study|Adverse Event|0|||
146034393|NCT01659255|526639500|FG004|Overall Study|Adverse Event|0|||
146034394|NCT01659255|526639501|FG005|Overall Study|Adverse Event|1|||
146034395|NCT01659255|526639502|FG006|Overall Study|Adverse Event|1|||
146034396|NCT01659255|526639503|FG007|Overall Study|Adverse Event|0|||
146034397|NCT01659255|526639504|FG008|Overall Study|Adverse Event|0|||
146034398|NCT01659255|526639505|FG009|Overall Study|Adverse Event|1|||
146034399|NCT01659255|526639506|FG010|Overall Study|Adverse Event|0|||
146034400|NCT01659255|526639507|FG011|Overall Study|Adverse Event|1|||
146034401|NCT01659255|526639508|FG012|Overall Study|Adverse Event|0|||
146034402|NCT01659255|526639509|FG013|Overall Study|Adverse Event|2|||
146034403|NCT01659255|526639510|FG014|Overall Study|Adverse Event|0|||
146034404|NCT01659255|526639511|FG015|Overall Study|Adverse Event|1|||
146098202|NCT05439941|526881078|FG002|Overall Study|Adverse Event - Parent Study|0|||
146098203|NCT05439941|526881076|FG000|Overall Study|Pregnancy|1|||
146098204|NCT05439941|526881077|FG001|Overall Study|Pregnancy|0|||
146034405|NCT01659255|526639512|FG016|Overall Study|Adverse Event|0|||
146034406|NCT01659255|526639496|FG000|Overall Study|Death|0|||
146034407|NCT01659255|526639497|FG001|Overall Study|Death|1|||
146034408|NCT01659255|526639498|FG002|Overall Study|Death|0|||
146034409|NCT01659255|526639499|FG003|Overall Study|Death|0|||
146034410|NCT01659255|526639500|FG004|Overall Study|Death|0|||
146034411|NCT01659255|526639501|FG005|Overall Study|Death|0|||
146034412|NCT01659255|526639502|FG006|Overall Study|Death|0|||
146034413|NCT01659255|526639503|FG007|Overall Study|Death|1|||
146034414|NCT01659255|526639504|FG008|Overall Study|Death|1|||
146034415|NCT01659255|526639505|FG009|Overall Study|Death|0|||
146034416|NCT01659255|526639506|FG010|Overall Study|Death|0|||
146034417|NCT01659255|526639507|FG011|Overall Study|Death|0|||
146034418|NCT01659255|526639508|FG012|Overall Study|Death|1|||
146034419|NCT01659255|526639509|FG013|Overall Study|Death|1|||
146034420|NCT01659255|526639510|FG014|Overall Study|Death|2|||
146034421|NCT01659255|526639511|FG015|Overall Study|Death|1|||
146034422|NCT01659255|526639512|FG016|Overall Study|Death|0|||
146034423|NCT01659255|526639496|FG000|Overall Study|Progressive Disease|2|||
146034424|NCT01659255|526639497|FG001|Overall Study|Progressive Disease|0|||
146034425|NCT01659255|526639498|FG002|Overall Study|Progressive Disease|0|||
146034426|NCT01659255|526639499|FG003|Overall Study|Progressive Disease|0|||
146034427|NCT01659255|526639500|FG004|Overall Study|Progressive Disease|0|||
146034428|NCT01659255|526639501|FG005|Overall Study|Progressive Disease|0|||
146034429|NCT01659255|526639502|FG006|Overall Study|Progressive Disease|0|||
146034430|NCT01659255|526639503|FG007|Overall Study|Progressive Disease|1|||
146034431|NCT01659255|526639504|FG008|Overall Study|Progressive Disease|0|||
146034432|NCT01659255|526639505|FG009|Overall Study|Progressive Disease|2|||
146034433|NCT01659255|526639506|FG010|Overall Study|Progressive Disease|2|||
146034434|NCT01659255|526639507|FG011|Overall Study|Progressive Disease|3|||
146034435|NCT01659255|526639508|FG012|Overall Study|Progressive Disease|5|||
146034436|NCT01659255|526639509|FG013|Overall Study|Progressive Disease|13|||
146034437|NCT01659255|526639510|FG014|Overall Study|Progressive Disease|6|||
146034438|NCT01659255|526639511|FG015|Overall Study|Progressive Disease|2|||
146034439|NCT01659255|526639512|FG016|Overall Study|Progressive Disease|3|||
146034440|NCT01659255|526639496|FG000|Overall Study|Withdrew Consent|0|||
146034441|NCT01659255|526639497|FG001|Overall Study|Withdrew Consent|0|||
146034442|NCT01659255|526639498|FG002|Overall Study|Withdrew Consent|0|||
146034443|NCT01659255|526639499|FG003|Overall Study|Withdrew Consent|0|||
146034444|NCT01659255|526639500|FG004|Overall Study|Withdrew Consent|0|||
146034445|NCT01659255|526639501|FG005|Overall Study|Withdrew Consent|0|||
146034446|NCT01659255|526639502|FG006|Overall Study|Withdrew Consent|0|||
146034447|NCT01659255|526639503|FG007|Overall Study|Withdrew Consent|0|||
146034448|NCT01659255|526639504|FG008|Overall Study|Withdrew Consent|0|||
146034449|NCT01659255|526639505|FG009|Overall Study|Withdrew Consent|0|||
146034450|NCT01659255|526639506|FG010|Overall Study|Withdrew Consent|1|||
146034451|NCT01659255|526639507|FG011|Overall Study|Withdrew Consent|0|||
146034452|NCT01659255|526639508|FG012|Overall Study|Withdrew Consent|0|||
146034453|NCT01659255|526639509|FG013|Overall Study|Withdrew Consent|1|||
146034454|NCT01659255|526639510|FG014|Overall Study|Withdrew Consent|0|||
146034455|NCT01659255|526639511|FG015|Overall Study|Withdrew Consent|0|||
146098205|NCT05439941|526881078|FG002|Overall Study|Pregnancy|0|||
146098206|NCT05439941|526881076|FG000|Overall Study|Withdrawal by Subject|9|||
146034456|NCT01659255|526639512|FG016|Overall Study|Withdrew Consent|0|||
146034457|NCT01659255|526639496|FG000|Overall Study|Investigator Decision|0|||
146034458|NCT01659255|526639497|FG001|Overall Study|Investigator Decision|0|||
146034459|NCT01659255|526639498|FG002|Overall Study|Investigator Decision|0|||
146034460|NCT01659255|526639499|FG003|Overall Study|Investigator Decision|0|||
146034461|NCT01659255|526639500|FG004|Overall Study|Investigator Decision|0|||
146034462|NCT01659255|526639501|FG005|Overall Study|Investigator Decision|0|||
146034463|NCT01659255|526639502|FG006|Overall Study|Investigator Decision|0|||
146034464|NCT01659255|526639503|FG007|Overall Study|Investigator Decision|0|||
146034465|NCT01659255|526639504|FG008|Overall Study|Investigator Decision|0|||
146034466|NCT01659255|526639505|FG009|Overall Study|Investigator Decision|0|||
146034467|NCT01659255|526639506|FG010|Overall Study|Investigator Decision|0|||
146034468|NCT01659255|526639507|FG011|Overall Study|Investigator Decision|0|||
146034469|NCT01659255|526639508|FG012|Overall Study|Investigator Decision|1|||
146034470|NCT01659255|526639509|FG013|Overall Study|Investigator Decision|1|||
146034471|NCT01659255|526639510|FG014|Overall Study|Investigator Decision|0|||
146034472|NCT01659255|526639511|FG015|Overall Study|Investigator Decision|0|||
146034473|NCT01659255|526639512|FG016|Overall Study|Investigator Decision|0|||
146034474|NCT01659255|526639496|FG000|Overall Study|Sponsor's Decision|0|||
146034475|NCT01659255|526639497|FG001|Overall Study|Sponsor's Decision|0|||
146034476|NCT01659255|526639498|FG002|Overall Study|Sponsor's Decision|0|||
146034477|NCT01659255|526639499|FG003|Overall Study|Sponsor's Decision|0|||
146034478|NCT01659255|526639500|FG004|Overall Study|Sponsor's Decision|0|||
146034479|NCT01659255|526639501|FG005|Overall Study|Sponsor's Decision|0|||
146034480|NCT01659255|526639502|FG006|Overall Study|Sponsor's Decision|1|||
146034481|NCT01659255|526639503|FG007|Overall Study|Sponsor's Decision|0|||
146034482|NCT01659255|526639504|FG008|Overall Study|Sponsor's Decision|0|||
146098207|NCT05439941|526881077|FG001|Overall Study|Withdrawal by Subject|6|||
146300446|NCT00375219|527615251|FG000|Overall Study|Withdrawal by Subject|1|||
146300447|NCT00375219|527615252|FG001|Overall Study|Withdrawal by Subject|0|||
146300448|NCT00375219|527615253|FG002|Overall Study|Withdrawal by Subject|0|||
146300449|NCT01667107|527615254|FG000|Overall Study|Adverse Event|4|||
146300450|NCT01667107|527615255|FG001|Overall Study|Adverse Event|3|||
146034483|NCT01659255|526639505|FG009|Overall Study|Sponsor's Decision|0|||
146034484|NCT01659255|526639506|FG010|Overall Study|Sponsor's Decision|0|||
146034485|NCT01659255|526639507|FG011|Overall Study|Sponsor's Decision|0|||
146034486|NCT01659255|526639508|FG012|Overall Study|Sponsor's Decision|0|||
146034487|NCT01659255|526639509|FG013|Overall Study|Sponsor's Decision|0|||
146034488|NCT01659255|526639510|FG014|Overall Study|Sponsor's Decision|0|||
146034489|NCT01659255|526639511|FG015|Overall Study|Sponsor's Decision|0|||
146034490|NCT01659255|526639512|FG016|Overall Study|Sponsor's Decision|0|||
146034491|NCT01659255|526639496|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034492|NCT01659255|526639497|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034493|NCT01659255|526639498|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034494|NCT01659255|526639499|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034495|NCT01659255|526639500|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034496|NCT01659255|526639501|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034497|NCT01659255|526639502|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034498|NCT01659255|526639503|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034499|NCT01659255|526639504|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034500|NCT01659255|526639505|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034501|NCT01659255|526639506|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034502|NCT01659255|526639507|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034503|NCT01659255|526639508|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034504|NCT01659255|526639509|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034505|NCT01659255|526639510|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034506|NCT01659255|526639511|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
146034507|NCT01659255|526639512|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
146034508|NCT01659255|526639496|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
146034509|NCT01659255|526639497|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
146034510|NCT01659255|526639498|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
146034511|NCT01659255|526639499|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
146034512|NCT01659255|526639500|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
146034513|NCT01659255|526639501|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
146034514|NCT01659255|526639502|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
146034515|NCT01659255|526639503|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
146034516|NCT01659255|526639504|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
146034517|NCT01659255|526639505|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
146034518|NCT01659255|526639506|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
146034519|NCT01659255|526639507|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
146034520|NCT01659255|526639508|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
146034521|NCT01659255|526639509|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
146034522|NCT01659255|526639510|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
146034523|NCT01659255|526639511|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
146034524|NCT01659255|526639512|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
146034525|NCT01079936|526639515|FG000|Phase I: MTD|First Remission Status|2|||
146034526|NCT01079936|526639516|FG001|Phase I: MTD|First Remission Status|0|||
146034527|NCT01079936|526639517|FG002|Phase I: MTD|First Remission Status|0|||
146034528|NCT01079936|526639518|FG003|Phase I: MTD|First Remission Status|0|||
146034529|NCT01079936|526639519|FG004|Phase I: MTD|First Remission Status|0|||
146034530|NCT01079936|526639515|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
146034531|NCT01079936|526639516|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
146034532|NCT01079936|526639517|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
146034533|NCT01079936|526639518|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
146034534|NCT01079936|526639519|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
146034535|NCT01079936|526639515|FG000|Phase II|Adverse Event|0|||
146034536|NCT01079936|526639516|FG001|Phase II|Adverse Event|0|||
146034537|NCT01079936|526639517|FG002|Phase II|Adverse Event|1|||
146034538|NCT01079936|526639518|FG003|Phase II|Adverse Event|0|||
146034539|NCT01079936|526639519|FG004|Phase II|Adverse Event|0|||
146034540|NCT01079936|526639515|FG000|Phase II|Insurance Issue|0|||
146034541|NCT01079936|526639516|FG001|Phase II|Insurance Issue|0|||
146034542|NCT01079936|526639517|FG002|Phase II|Insurance Issue|0|||
146034543|NCT01079936|526639518|FG003|Phase II|Insurance Issue|0|||
146034544|NCT01079936|526639519|FG004|Phase II|Insurance Issue|1|||
146034545|NCT02335424|526639520|FG000|Overall Study|Withdrawal by Subject|19|||
146034546|NCT02335424|526639520|FG000|Overall Study|Adverse Event|25|||
146034547|NCT02335424|526639520|FG000|Overall Study|Death|273|||
146034548|NCT02335424|526639520|FG000|Overall Study|Lost to Follow-up|3|||
146034549|NCT02335424|526639520|FG000|Overall Study|Physician Decision|13|||
146034550|NCT02335424|526639520|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
146034551|NCT02335424|526639520|FG000|Overall Study|Protocol Violation|1|||
146034552|NCT02335424|526639520|FG000|Overall Study|Screen failure|1|||
146034553|NCT02712424|526639521|FG000|Overall Study|Lost to Follow-up|34|||
146034554|NCT02712424|526639522|FG001|Overall Study|Lost to Follow-up|32|||
146034555|NCT02809053|526639523|FG000|Overall Study|Death|0|||
146034556|NCT02809053|526639524|FG001|Overall Study|Death|1|||
146034557|NCT02809053|526639523|FG000|Overall Study|Lost to Follow-up|3|||
146034558|NCT02809053|526639524|FG001|Overall Study|Lost to Follow-up|1|||
146034559|NCT02809053|526639523|FG000|Overall Study|Withdrawal by Subject|2|||
146034560|NCT02809053|526639524|FG001|Overall Study|Withdrawal by Subject|3|||
146034561|NCT02809053|526639523|FG000|Overall Study|Disease Progression|2|||
146034562|NCT02809053|526639524|FG001|Overall Study|Disease Progression|1|||
146034563|NCT02723175|526639527|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
146034564|NCT02723175|526639528|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
146034565|NCT02723175|526639527|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
146034566|NCT02723175|526639528|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
146034567|NCT02049138|526639529|FG000|Overall Study|Adverse Event|46|||
146034568|NCT02049138|526639530|FG001|Overall Study|Adverse Event|25|||
146034569|NCT02049138|526639531|FG002|Overall Study|Adverse Event|1|||
146034570|NCT02049138|526639529|FG000|Overall Study|Withdrawal by Subject|57|||
146034571|NCT02049138|526639530|FG001|Overall Study|Withdrawal by Subject|21|||
146034572|NCT02049138|526639531|FG002|Overall Study|Withdrawal by Subject|5|||
146034573|NCT02049138|526639529|FG000|Overall Study|Lost to Follow-up|18|||
146034574|NCT02049138|526639530|FG001|Overall Study|Lost to Follow-up|5|||
146034575|NCT02049138|526639531|FG002|Overall Study|Lost to Follow-up|1|||
146034576|NCT02049138|526639529|FG000|Overall Study|Lack of Efficacy|10|||
146034577|NCT02049138|526639530|FG001|Overall Study|Lack of Efficacy|26|||
146034578|NCT02049138|526639531|FG002|Overall Study|Lack of Efficacy|1|||
146034579|NCT02049138|526639529|FG000|Overall Study|Non-Compliance|15|||
146034580|NCT02049138|526639530|FG001|Overall Study|Non-Compliance|6|||
146034581|NCT02049138|526639531|FG002|Overall Study|Non-Compliance|0|||
146034582|NCT02049138|526639529|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
146034583|NCT02049138|526639530|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
146034584|NCT02049138|526639531|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
146034585|NCT02049138|526639529|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
146034586|NCT02049138|526639530|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146034587|NCT02049138|526639531|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146034588|NCT02049138|526639529|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146034589|NCT02049138|526639530|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
146034590|NCT02049138|526639531|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146034591|NCT02049138|526639529|FG000|Overall Study|Other|15|||
146034592|NCT02049138|526639530|FG001|Overall Study|Other|13|||
146034593|NCT02049138|526639531|FG002|Overall Study|Other|0|||
146034594|NCT02049138|526639529|FG000|Overall Study|Missing|0|||
146034595|NCT02049138|526639530|FG001|Overall Study|Missing|1|||
146034596|NCT02049138|526639531|FG002|Overall Study|Missing|0|||
146034597|NCT00491608|526639532|FG000|Overall Study|Death|2|||
146034598|NCT00491608|526639532|FG000|Overall Study|Withdrawal by Subject|1|||
146034599|NCT00257660|526639533|FG000|Overall Study|Lack of Efficacy|5|||
146034600|NCT00257660|526639534|FG001|Overall Study|Lack of Efficacy|23|||
146034601|NCT00257660|526639533|FG000|Overall Study|Withdrawal by Subject|2|||
146034602|NCT00257660|526639534|FG001|Overall Study|Withdrawal by Subject|0|||
146034603|NCT00257660|526639533|FG000|Overall Study|Lost to Follow-up|1|||
146034604|NCT00257660|526639534|FG001|Overall Study|Lost to Follow-up|0|||
146034605|NCT00257660|526639533|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
146034606|NCT00257660|526639534|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
146034607|NCT00257660|526639533|FG000|Overall Study|No longer wanted to do blood draws|1|||
146034608|NCT00257660|526639534|FG001|Overall Study|No longer wanted to do blood draws|0|||
146034609|NCT04109976|526639535|FG000|Overall Study|Withdrawal by Subject|1|||
146034610|NCT04109976|526639536|FG001|Overall Study|Withdrawal by Subject|0|||
146034611|NCT03869333|526639546|FG000|Overall Study|Lost to Follow-up|1|||
146098208|NCT05439941|526881078|FG002|Overall Study|Withdrawal by Subject|10|||
146098209|NCT05439941|526881076|FG000|Overall Study|Non-Compliance|1|||
146098210|NCT05439941|526881077|FG001|Overall Study|Non-Compliance|1|||
146098211|NCT05439941|526881078|FG002|Overall Study|Non-Compliance|1|||
146098212|NCT05439941|526881076|FG000|Overall Study|Lost to Follow-up|2|||
146098213|NCT05439941|526881077|FG001|Overall Study|Lost to Follow-up|2|||
146034612|NCT03869333|526639547|FG001|Overall Study|Lost to Follow-up|0|||
146034613|NCT03869333|526639548|FG002|Overall Study|Lost to Follow-up|0|||
146034614|NCT03869333|526639549|FG003|Overall Study|Lost to Follow-up|0|||
146034615|NCT03869333|526639546|FG000|Overall Study|Pregnancy|1|||
146034616|NCT03869333|526639547|FG001|Overall Study|Pregnancy|0|||
146034617|NCT03869333|526639548|FG002|Overall Study|Pregnancy|0|||
146034618|NCT03869333|526639549|FG003|Overall Study|Pregnancy|0|||
146098214|NCT05439941|526881078|FG002|Overall Study|Lost to Follow-up|0|||
146034619|NCT03869333|526639546|FG000|Overall Study|Physician Decision|0|||
146098215|NCT05439941|526881076|FG000|Overall Study|Physician Decision|1|||
146098216|NCT05439941|526881077|FG001|Overall Study|Physician Decision|0|||
146098217|NCT05439941|526881078|FG002|Overall Study|Physician Decision|0|||
146098218|NCT05439941|526881076|FG000|Overall Study|Trial Termination by Sponsor|78|||
146098219|NCT05439941|526881077|FG001|Overall Study|Trial Termination by Sponsor|83|||
146098220|NCT05439941|526881078|FG002|Overall Study|Trial Termination by Sponsor|65|||
146098221|NCT05439941|526881076|FG000|Overall Study|Other than Reasons Listed|2|||
146098222|NCT05439941|526881077|FG001|Overall Study|Other than Reasons Listed|1|||
146098223|NCT05439941|526881078|FG002|Overall Study|Other than Reasons Listed|0|||
146098224|NCT00573183|526881079|FG000|Overall Study|Lost to Follow-up|52|||
146098225|NCT00573183|526881080|FG001|Overall Study|Lost to Follow-up|50|||
146098226|NCT00573183|526881079|FG000|Overall Study|Withdrawal by Subject|8|||
146098227|NCT00573183|526881080|FG001|Overall Study|Withdrawal by Subject|2|||
146098228|NCT00573183|526881079|FG000|Overall Study|Death|0|||
146098229|NCT00573183|526881080|FG001|Overall Study|Death|1|||
146098230|NCT00573183|526881079|FG000|Overall Study|Adverse Event|2|||
146098231|NCT00573183|526881080|FG001|Overall Study|Adverse Event|0|||
146098232|NCT00573183|526881079|FG000|Overall Study|Incarceration|5|||
146098233|NCT00573183|526881080|FG001|Overall Study|Incarceration|8|||
146098234|NCT00573183|526881079|FG000|Overall Study|Other|5|||
146098235|NCT00573183|526881080|FG001|Overall Study|Other|2|||
146098236|NCT01926015|526881082|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146098237|NCT01926015|526881083|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146098238|NCT01926015|526881082|FG000|Overall Study|Randomized not treated|2|||
146098239|NCT01926015|526881083|FG001|Overall Study|Randomized not treated|0|||
146098240|NCT01914757|526881084|FG000|Overall Study|Severe non-compliance to protocol|3|||
146098241|NCT01914757|526881085|FG001|Overall Study|Severe non-compliance to protocol|1|||
146098242|NCT01914757|526881086|FG002|Overall Study|Severe non-compliance to protocol|2|||
146098243|NCT01914757|526881084|FG000|Overall Study|Lost to Follow-up|5|||
146098244|NCT01914757|526881085|FG001|Overall Study|Lost to Follow-up|8|||
146098245|NCT01914757|526881086|FG002|Overall Study|Lost to Follow-up|6|||
146098246|NCT01914757|526881084|FG000|Overall Study|Withdrawal by Subject|15|||
146098247|NCT01914757|526881085|FG001|Overall Study|Withdrawal by Subject|27|||
146098248|NCT01914757|526881086|FG002|Overall Study|Withdrawal by Subject|19|||
146098249|NCT01914757|526881084|FG000|Overall Study|Death|2|||
146098250|NCT01914757|526881085|FG001|Overall Study|Death|2|||
146098251|NCT01914757|526881086|FG002|Overall Study|Death|1|||
146098252|NCT01914757|526881084|FG000|Overall Study|Adverse Event|4|||
146098253|NCT01914757|526881085|FG001|Overall Study|Adverse Event|3|||
146098254|NCT01914757|526881086|FG002|Overall Study|Adverse Event|4|||
146098255|NCT01914757|526881084|FG000|Overall Study|Study specific withdrawal criteria|0|||
146098256|NCT01914757|526881085|FG001|Overall Study|Study specific withdrawal criteria|1|||
146034620|NCT03869333|526639547|FG001|Overall Study|Physician Decision|1|||
146034621|NCT03869333|526639548|FG002|Overall Study|Physician Decision|0|||
146034622|NCT03869333|526639549|FG003|Overall Study|Physician Decision|0|||
146034623|NCT01927055|526639550|FG000|Open-label|Adverse Event|6|||
146034624|NCT01927055|526639551|FG001|Open-label|Adverse Event|0|||
146034625|NCT01927055|526639552|FG002|Open-label|Adverse Event|0|||
146034626|NCT01927055|526639550|FG000|Open-label|Withdrawal by Subject|1|||
146034627|NCT01927055|526639551|FG001|Open-label|Withdrawal by Subject|0|||
146034628|NCT01927055|526639552|FG002|Open-label|Withdrawal by Subject|0|||
146034629|NCT01927055|526639550|FG000|Open-label|Study Stopped|4|||
146034630|NCT01927055|526639551|FG001|Open-label|Study Stopped|0|||
146034631|NCT01927055|526639552|FG002|Open-label|Study Stopped|0|||
146034632|NCT01927055|526639550|FG000|Open-label|Supine Hypertension|4|||
146034633|NCT01927055|526639551|FG001|Open-label|Supine Hypertension|0|||
146034634|NCT01927055|526639552|FG002|Open-label|Supine Hypertension|0|||
146034635|NCT01927055|526639550|FG000|Open-label|Difficulty attending study visits|1|||
146034636|NCT01927055|526639551|FG001|Open-label|Difficulty attending study visits|0|||
146034637|NCT01927055|526639552|FG002|Open-label|Difficulty attending study visits|0|||
146034638|NCT01927055|526639550|FG000|Double-Blind|Adverse Event|0|||
146034639|NCT01927055|526639551|FG001|Double-Blind|Adverse Event|1|||
146034640|NCT01927055|526639552|FG002|Double-Blind|Adverse Event|1|||
146098257|NCT01914757|526881086|FG002|Overall Study|Study specific withdrawal criteria|0|||
146098258|NCT01914757|526881084|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146098259|NCT01914757|526881085|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146098260|NCT01914757|526881086|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146098261|NCT01914757|526881084|FG000|Overall Study|Other reasons|5|||
146034641|NCT01927055|526639550|FG000|Double-Blind|Protocol Violation|0|||
146098262|NCT01914757|526881085|FG001|Overall Study|Other reasons|9|||
146098263|NCT01914757|526881086|FG002|Overall Study|Other reasons|4|||
146098264|NCT00615108|526881087|FG000|Overall Study|Adverse Event|122|||
146254346|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
146034642|NCT01927055|526639551|FG001|Double-Blind|Protocol Violation|0|||
146034643|NCT01927055|526639552|FG002|Double-Blind|Protocol Violation|1|||
146034644|NCT01927055|526639550|FG000|Double-Blind|Withdrawal by Subject|0|||
146034645|NCT01927055|526639551|FG001|Double-Blind|Withdrawal by Subject|2|||
146034646|NCT01927055|526639552|FG002|Double-Blind|Withdrawal by Subject|3|||
146034647|NCT01927055|526639550|FG000|Double-Blind|Study Stopped|0|||
146034648|NCT01927055|526639551|FG001|Double-Blind|Study Stopped|7|||
146034649|NCT01927055|526639552|FG002|Double-Blind|Study Stopped|7|||
146034650|NCT01927055|526639550|FG000|Double-Blind|Supine Hypertension|0|||
146034651|NCT01927055|526639551|FG001|Double-Blind|Supine Hypertension|0|||
146034652|NCT01927055|526639552|FG002|Double-Blind|Supine Hypertension|1|||
146034653|NCT01927055|526639550|FG000|Double-Blind|Extended Vacation|0|||
146034654|NCT01927055|526639551|FG001|Double-Blind|Extended Vacation|1|||
146034655|NCT01927055|526639552|FG002|Double-Blind|Extended Vacation|0|||
146034656|NCT02598128|526639553|FG000|Period A: Days -7 to -1|Adverse Event|1|||
146034657|NCT02598128|526639554|FG001|Period A: Days -7 to -1|Adverse Event|0|||
146034658|NCT02598128|526639555|FG002|Period A: Days -7 to -1|Adverse Event|0|||
146034659|NCT02598128|526639556|FG003|Period A: Days -7 to -1|Adverse Event|0|||
146034660|NCT01459913|526639557|FG000|Overall Study|Adverse Event|0|||
146034661|NCT01459913|526639558|FG001|Overall Study|Adverse Event|0|||
146034662|NCT01459913|526639559|FG002|Overall Study|Adverse Event|0|||
146034663|NCT01459913|526639560|FG003|Overall Study|Adverse Event|3|||
146034664|NCT01459913|526639557|FG000|Overall Study|Withdrawal by Subject|4|||
146034665|NCT01459913|526639558|FG001|Overall Study|Withdrawal by Subject|0|||
146034666|NCT01459913|526639559|FG002|Overall Study|Withdrawal by Subject|0|||
146034667|NCT01459913|526639560|FG003|Overall Study|Withdrawal by Subject|5|||
146034668|NCT01459913|526639557|FG000|Overall Study|Lost to Follow-up|7|||
146034669|NCT01459913|526639558|FG001|Overall Study|Lost to Follow-up|4|||
146034670|NCT01459913|526639559|FG002|Overall Study|Lost to Follow-up|1|||
146034671|NCT01459913|526639560|FG003|Overall Study|Lost to Follow-up|8|||
146034672|NCT01459913|526639557|FG000|Overall Study|Death|0|||
146034673|NCT01459913|526639558|FG001|Overall Study|Death|0|||
146034674|NCT01459913|526639559|FG002|Overall Study|Death|0|||
146034675|NCT01459913|526639560|FG003|Overall Study|Death|1|||
146034676|NCT01459913|526639557|FG000|Overall Study|Non- Compliance|0|||
146034677|NCT01459913|526639558|FG001|Overall Study|Non- Compliance|0|||
146034678|NCT01459913|526639559|FG002|Overall Study|Non- Compliance|0|||
146034679|NCT01459913|526639560|FG003|Overall Study|Non- Compliance|3|||
146034680|NCT01459913|526639557|FG000|Overall Study|Physician Decision|0|||
146034681|NCT01459913|526639558|FG001|Overall Study|Physician Decision|1|||
146034682|NCT01459913|526639559|FG002|Overall Study|Physician Decision|0|||
146034683|NCT01459913|526639560|FG003|Overall Study|Physician Decision|0|||
146034684|NCT01459913|526639557|FG000|Overall Study|Study Terminated by Sponsor|30|||
146034685|NCT01459913|526639558|FG001|Overall Study|Study Terminated by Sponsor|15|||
146034686|NCT01459913|526639559|FG002|Overall Study|Study Terminated by Sponsor|9|||
146034687|NCT01459913|526639560|FG003|Overall Study|Study Terminated by Sponsor|11|||
146034688|NCT01459913|526639557|FG000|Overall Study|Other|0|||
146034689|NCT01459913|526639558|FG001|Overall Study|Other|0|||
146034690|NCT01459913|526639559|FG002|Overall Study|Other|3|||
146034691|NCT01459913|526639560|FG003|Overall Study|Other|1|||
146034692|NCT01459913|526639557|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
146034693|NCT01459913|526639558|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
146034694|NCT01459913|526639559|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
146034695|NCT01459913|526639560|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
146034696|NCT01064687|526639563|FG000|Overall Study|Adverse Event|9|||
146034697|NCT01064687|526639564|FG001|Overall Study|Adverse Event|4|||
146034698|NCT01064687|526639565|FG002|Overall Study|Adverse Event|10|||
146034699|NCT01064687|526639566|FG003|Overall Study|Adverse Event|3|||
146034700|NCT01064687|526639563|FG000|Overall Study|Death|1|||
146034701|NCT01064687|526639564|FG001|Overall Study|Death|1|||
146034702|NCT01064687|526639565|FG002|Overall Study|Death|0|||
146034703|NCT01064687|526639566|FG003|Overall Study|Death|0|||
146034704|NCT01064687|526639563|FG000|Overall Study|Entry Criteria Not Met|3|||
146034705|NCT01064687|526639564|FG001|Overall Study|Entry Criteria Not Met|0|||
146034706|NCT01064687|526639565|FG002|Overall Study|Entry Criteria Not Met|0|||
146034707|NCT01064687|526639566|FG003|Overall Study|Entry Criteria Not Met|0|||
146034708|NCT01064687|526639563|FG000|Overall Study|Lack of Efficacy|1|||
146034709|NCT01064687|526639564|FG001|Overall Study|Lack of Efficacy|0|||
146034710|NCT01064687|526639565|FG002|Overall Study|Lack of Efficacy|2|||
146034711|NCT01064687|526639566|FG003|Overall Study|Lack of Efficacy|3|||
146034712|NCT01064687|526639563|FG000|Overall Study|Lost to Follow-up|7|||
146034713|NCT01064687|526639564|FG001|Overall Study|Lost to Follow-up|10|||
146034714|NCT01064687|526639565|FG002|Overall Study|Lost to Follow-up|13|||
146034715|NCT01064687|526639566|FG003|Overall Study|Lost to Follow-up|5|||
146034716|NCT01064687|526639563|FG000|Overall Study|Physician Decision|2|||
146034717|NCT01064687|526639564|FG001|Overall Study|Physician Decision|2|||
146034718|NCT01064687|526639565|FG002|Overall Study|Physician Decision|0|||
146034719|NCT01064687|526639566|FG003|Overall Study|Physician Decision|0|||
146034720|NCT01064687|526639563|FG000|Overall Study|Protocol Violation|1|||
146034721|NCT01064687|526639564|FG001|Overall Study|Protocol Violation|1|||
146034722|NCT01064687|526639565|FG002|Overall Study|Protocol Violation|0|||
146034723|NCT01064687|526639566|FG003|Overall Study|Protocol Violation|1|||
146034724|NCT01064687|526639563|FG000|Overall Study|Sponsor Decision|0|||
146034725|NCT01064687|526639564|FG001|Overall Study|Sponsor Decision|0|||
146034726|NCT01064687|526639565|FG002|Overall Study|Sponsor Decision|3|||
146098265|NCT00615108|526881087|FG000|Overall Study|Other|370|||
146098266|NCT00615108|526881087|FG000|Overall Study|Lost to Follow-up|15|||
146034727|NCT01064687|526639566|FG003|Overall Study|Sponsor Decision|0|||
146034728|NCT01064687|526639563|FG000|Overall Study|Withdrawal by Subject|9|||
146034729|NCT01064687|526639564|FG001|Overall Study|Withdrawal by Subject|7|||
146034730|NCT01064687|526639565|FG002|Overall Study|Withdrawal by Subject|12|||
146034731|NCT01064687|526639566|FG003|Overall Study|Withdrawal by Subject|5|||
146034732|NCT01064687|526639563|FG000|Overall Study|Treatment Noncompliance|1|||
146034733|NCT01064687|526639564|FG001|Overall Study|Treatment Noncompliance|1|||
146034734|NCT01064687|526639565|FG002|Overall Study|Treatment Noncompliance|1|||
146034735|NCT01064687|526639566|FG003|Overall Study|Treatment Noncompliance|0|||
146034736|NCT03134183|526639567|FG000|Overall Study|Withdrawal by Subject|1|||
146034737|NCT03134183|526639568|FG001|Overall Study|Withdrawal by Subject|1|||
146034738|NCT00845065|526639571|FG000|Overall Study|Adverse Event|3|||
146034739|NCT00845065|526639572|FG001|Overall Study|Adverse Event|23|||
146034740|NCT00845065|526639571|FG000|Overall Study|Lack of Efficacy|43|||
146034741|NCT00845065|526639572|FG001|Overall Study|Lack of Efficacy|21|||
146034742|NCT00845065|526639571|FG000|Overall Study|Non-Medical Reasons|1|||
146034743|NCT00845065|526639572|FG001|Overall Study|Non-Medical Reasons|11|||
146034744|NCT02299076|526639573|FG000|Overall Study|Fraudulent Entries|20|||
146034745|NCT02299076|526639574|FG001|Overall Study|Fraudulent Entries|14|||
146034746|NCT01198509|526639575|FG000|Overall Study|Withdrawal by Subject|1|||
146034747|NCT01198509|526639576|FG001|Overall Study|Withdrawal by Subject|0|||
146034748|NCT01198509|526639577|FG002|Overall Study|Withdrawal by Subject|0|||
146034749|NCT01198509|526639578|FG003|Overall Study|Withdrawal by Subject|0|||
146034750|NCT01198509|526639579|FG004|Overall Study|Withdrawal by Subject|0|||
146034751|NCT01198509|526639580|FG005|Overall Study|Withdrawal by Subject|0|||
146034752|NCT00499746|526639589|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
146034753|NCT00499746|526639589|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
146034754|NCT00499746|526639589|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
146034755|NCT00499746|526639589|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
146034756|NCT02228096|526639590|FG000|Overall Study|Study terminated by Sponsor|24|||
146034757|NCT02228096|526639590|FG000|Overall Study|Lack of Efficacy|18|||
146034758|NCT02228096|526639590|FG000|Overall Study|Death|12|||
146034759|NCT02228096|526639590|FG000|Overall Study|Physician Decision|3|||
146034760|NCT02228096|526639590|FG000|Overall Study|Subject/guardian decision|2|||
146034761|NCT02228096|526639590|FG000|Overall Study|New therapy for study indication|1|||
146034762|NCT02228096|526639590|FG000|Overall Study|Enrolled, not infused|11|||
146034763|NCT01969721|526639591|FG000|Overall Study|Adverse Event|3|||
146034764|NCT01969721|526639592|FG001|Overall Study|Adverse Event|8|||
146034765|NCT01969721|526639593|FG002|Overall Study|Adverse Event|3|||
146034766|NCT01969721|526639594|FG003|Overall Study|Adverse Event|2|||
146034767|NCT01969721|526639591|FG000|Overall Study|Lack of Efficacy|0|||
146034768|NCT01969721|526639592|FG001|Overall Study|Lack of Efficacy|0|||
146034769|NCT01969721|526639593|FG002|Overall Study|Lack of Efficacy|1|||
146034770|NCT01969721|526639594|FG003|Overall Study|Lack of Efficacy|0|||
146034771|NCT01969721|526639591|FG000|Overall Study|Non compliant with protocol|1|||
146034772|NCT01969721|526639592|FG001|Overall Study|Non compliant with protocol|1|||
146034773|NCT01969721|526639593|FG002|Overall Study|Non compliant with protocol|0|||
146034774|NCT01969721|526639594|FG003|Overall Study|Non compliant with protocol|2|||
146034775|NCT01969721|526639591|FG000|Overall Study|Other not defined above|0|||
146034776|NCT01969721|526639592|FG001|Overall Study|Other not defined above|2|||
146034777|NCT01969721|526639593|FG002|Overall Study|Other not defined above|0|||
146098267|NCT01147640|526881088|FG000|Overall Study|Adverse Event|2|||
146098268|NCT01147640|526881089|FG001|Overall Study|Adverse Event|0|||
146098269|NCT01147640|526881088|FG000|Overall Study|Physician Decision|1|||
146098270|NCT01147640|526881089|FG001|Overall Study|Physician Decision|0|||
146098271|NCT01147640|526881088|FG000|Overall Study|Withdrawal by Subject|1|||
146098272|NCT01147640|526881089|FG001|Overall Study|Withdrawal by Subject|0|||
146098273|NCT01147640|526881088|FG000|Overall Study|Lost to Follow-up|0|||
146034778|NCT01969721|526639594|FG003|Overall Study|Other not defined above|0|||
146034779|NCT01969721|526639591|FG000|Overall Study|Discontinued during washout periods.|0|||
146034780|NCT01969721|526639592|FG001|Overall Study|Discontinued during washout periods.|1|||
146034781|NCT01969721|526639593|FG002|Overall Study|Discontinued during washout periods.|1|||
146034782|NCT01969721|526639594|FG003|Overall Study|Discontinued during washout periods.|2|||
146034783|NCT02383433|526639597|FG000|Overall Study|Disease progression|2|||
146034784|NCT00952614|526639600|FG000|Overall Study|Death|3|||
146034785|NCT00952614|526639600|FG000|Overall Study|Lost to Follow-up|3|||
146034786|NCT00952614|526639600|FG000|Overall Study|other reason|1|||
146034787|NCT04311463|526639601|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
146034788|NCT04311463|526639602|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
146034789|NCT04311463|526639601|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
146098274|NCT01147640|526881089|FG001|Overall Study|Lost to Follow-up|1|||
146098275|NCT01147640|526881088|FG000|Overall Study|Didn't meet eligibility criteria|1|||
146098276|NCT01147640|526881089|FG001|Overall Study|Didn't meet eligibility criteria|0|||
146098277|NCT01856907|526881092|FG000|Overall Study|Pregnancy|0|||
146034790|NCT04311463|526639602|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
146034791|NCT04311463|526639601|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
146034792|NCT04311463|526639602|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
146034793|NCT04023682|526639604|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
146034794|NCT03180307|526639613|FG000|Overall Study|Lost to Follow-up|2|||
146034795|NCT03180307|526639614|FG001|Overall Study|Lost to Follow-up|0|||
146034796|NCT03180307|526639613|FG000|Overall Study|Death|1|||
146034797|NCT03180307|526639614|FG001|Overall Study|Death|0|||
146034798|NCT03180307|526639613|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
146034799|NCT03180307|526639614|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
146034800|NCT01563172|526639617|FG000|Overall Study|Adverse Event|5|||
146034801|NCT01563172|526639617|FG000|Overall Study|Lost to Follow-up|2|||
146034802|NCT01563172|526639617|FG000|Overall Study|Other (Protocol deviation)|5|||
146034803|NCT01563172|526639617|FG000|Overall Study|Other (Not specified)|1|||
146034804|NCT02986854|526639619|FG000|Overall Study|Withdrawal by Subject|0|||
146034805|NCT02986854|526639620|FG001|Overall Study|Withdrawal by Subject|1|||
146034806|NCT02986854|526639621|FG002|Overall Study|Withdrawal by Subject|1|||
146034807|NCT02986854|526639619|FG000|Overall Study|Lost to Follow-up|3|||
146034808|NCT02986854|526639620|FG001|Overall Study|Lost to Follow-up|11|||
146034809|NCT02986854|526639621|FG002|Overall Study|Lost to Follow-up|2|||
146034810|NCT00718770|526639624|FG000|Overall Study|Adverse Event|1|||
146034811|NCT00718770|526639624|FG000|Overall Study|Lack of Efficacy|1|||
146034812|NCT00718770|526639624|FG000|Overall Study|Lack of Efficacy|1|||
146034813|NCT00718770|526639624|FG000|Overall Study|Adverse Event|1|||
146034814|NCT00718770|526639624|FG000|Overall Study|Lack of Efficacy|1|||
146034815|NCT00718770|526639624|FG000|Overall Study|Adverse Event|1|||
146034816|NCT00718770|526639624|FG000|Overall Study|Lack of Efficacy|1|||
146034817|NCT00718770|526639624|FG000|Overall Study|Adverse Event|1|||
146034818|NCT01624090|526639628|FG000|Overall Study|DLT, taken off therapy|0|||
146034819|NCT01624090|526639629|FG001|Overall Study|DLT, taken off therapy|1|||
146034820|NCT01624090|526639630|FG002|Overall Study|DLT, taken off therapy|0|||
146034821|NCT01624090|526639631|FG003|Overall Study|DLT, taken off therapy|0|||
146034822|NCT01624090|526639628|FG000|Overall Study|Withdrew prior to treatment|0|||
146034823|NCT01624090|526639629|FG001|Overall Study|Withdrew prior to treatment|1|||
146034824|NCT01624090|526639630|FG002|Overall Study|Withdrew prior to treatment|0|||
146034825|NCT01624090|526639631|FG003|Overall Study|Withdrew prior to treatment|0|||
146034826|NCT01624090|526639628|FG000|Overall Study|Died on study|0|||
146034827|NCT01624090|526639629|FG001|Overall Study|Died on study|0|||
146034828|NCT01624090|526639630|FG002|Overall Study|Died on study|2|||
146034829|NCT01624090|526639631|FG003|Overall Study|Died on study|0|||
146034830|NCT01624090|526639628|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
146034831|NCT01624090|526639629|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
146034832|NCT01624090|526639630|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
146034833|NCT01624090|526639631|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
146034834|NCT01624090|526639628|FG000|Overall Study|Dose escalated|0|||
146034835|NCT01624090|526639629|FG001|Overall Study|Dose escalated|0|||
146034836|NCT01624090|526639630|FG002|Overall Study|Dose escalated|3|||
146034837|NCT01624090|526639631|FG003|Overall Study|Dose escalated|0|||
146034838|NCT00772109|526639632|FG000|Overall Study|Serious adverse event|1|||
146034839|NCT00772109|526639633|FG001|Overall Study|Serious adverse event|0|||
146034840|NCT00772109|526639634|FG002|Overall Study|Serious adverse event|1|||
146034841|NCT00772109|526639635|FG003|Overall Study|Serious adverse event|0|||
146034842|NCT00772109|526639632|FG000|Overall Study|Protocol Violation|5|||
146034843|NCT00772109|526639633|FG001|Overall Study|Protocol Violation|8|||
146034844|NCT00772109|526639634|FG002|Overall Study|Protocol Violation|7|||
146034845|NCT00772109|526639635|FG003|Overall Study|Protocol Violation|6|||
146034846|NCT00772109|526639632|FG000|Overall Study|Lost to Follow-up|7|||
146034847|NCT00772109|526639633|FG001|Overall Study|Lost to Follow-up|3|||
146034848|NCT00772109|526639634|FG002|Overall Study|Lost to Follow-up|5|||
146034849|NCT00772109|526639635|FG003|Overall Study|Lost to Follow-up|9|||
146034850|NCT00772109|526639632|FG000|Overall Study|Withdrawal by Subject|8|||
146034851|NCT00772109|526639633|FG001|Overall Study|Withdrawal by Subject|8|||
146034852|NCT00772109|526639634|FG002|Overall Study|Withdrawal by Subject|6|||
146034853|NCT00772109|526639635|FG003|Overall Study|Withdrawal by Subject|16|||
146254347|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
146034854|NCT01555125|526639638|FG000|Induction Period|Lost to Follow-up|0|||
146034855|NCT01555125|526639639|FG001|Induction Period|Lost to Follow-up|2|||
146034856|NCT01555125|526639640|FG002|Induction Period|Lost to Follow-up|0|||
146254348|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
146254349|NCT00332488|527444552|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
146254350|NCT00332488|527444553|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
146034857|NCT01555125|526639641|FG003|Induction Period|Lost to Follow-up|0|||
146034858|NCT01555125|526639642|FG004|Induction Period|Lost to Follow-up|0|||
146034859|NCT01555125|526639638|FG000|Induction Period|Adverse Event|0|||
146034860|NCT01555125|526639639|FG001|Induction Period|Adverse Event|1|||
146098278|NCT01856907|526881093|FG001|Overall Study|Pregnancy|1|||
146098279|NCT01856907|526881094|FG002|Overall Study|Pregnancy|0|||
146098280|NCT01856907|526881092|FG000|Overall Study|Pregnancy|0|||
146098281|NCT01856907|526881093|FG001|Overall Study|Pregnancy|1|||
146098282|NCT01856907|526881094|FG002|Overall Study|Pregnancy|0|||
146098283|NCT01856907|526881092|FG000|Overall Study|Withdrawal by Subject|0|||
146098284|NCT01856907|526881093|FG001|Overall Study|Withdrawal by Subject|1|||
146098285|NCT01856907|526881094|FG002|Overall Study|Withdrawal by Subject|0|||
146098286|NCT01797731|526881095|FG000|Overall Study|Didn't have proper radiographs required|3|||
146098287|NCT01797731|526881096|FG001|Overall Study|Didn't have proper radiographs required|3|||
146098288|NCT00091442|526881098|FG000|Overall Study|Progressive Disease|220|||
146098289|NCT00091442|526881099|FG001|Overall Study|Progressive Disease|189|||
146098290|NCT00091442|526881098|FG000|Overall Study|Physician Decision|61|||
146098291|NCT00091442|526881099|FG001|Overall Study|Physician Decision|58|||
146098292|NCT00091442|526881098|FG000|Overall Study|Withdrawal by Subject|38|||
146098293|NCT00091442|526881099|FG001|Overall Study|Withdrawal by Subject|46|||
146098294|NCT00091442|526881098|FG000|Overall Study|Adverse Event|29|||
146098295|NCT00091442|526881099|FG001|Overall Study|Adverse Event|48|||
146098296|NCT00091442|526881098|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
146098297|NCT00091442|526881099|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
146098298|NCT00091442|526881098|FG000|Overall Study|Death|9|||
146098299|NCT00091442|526881099|FG001|Overall Study|Death|7|||
146098300|NCT00091442|526881098|FG000|Overall Study|Lost to Follow-up|1|||
146098301|NCT00091442|526881099|FG001|Overall Study|Lost to Follow-up|3|||
146098302|NCT00091442|526881098|FG000|Overall Study|Other|2|||
146098303|NCT00091442|526881099|FG001|Overall Study|Other|6|||
146098304|NCT00917501|526881100|FG000|Overall Study|Lost to Follow-up|4|||
146098305|NCT00917501|526881101|FG001|Overall Study|Lost to Follow-up|1|||
146098306|NCT00917501|526881100|FG000|Overall Study|Withdrawal by Subject|3|||
146098307|NCT00917501|526881101|FG001|Overall Study|Withdrawal by Subject|1|||
146098308|NCT00917501|526881100|FG000|Overall Study|Lack of Efficacy|1|||
146098309|NCT00917501|526881101|FG001|Overall Study|Lack of Efficacy|2|||
146098310|NCT00917501|526881100|FG000|Overall Study|trouble swollowing capsules|0|||
146098311|NCT00917501|526881101|FG001|Overall Study|trouble swollowing capsules|1|||
146098312|NCT00986830|526881110|FG000|Overall Study|Death|1|||
146098313|NCT00986830|526881110|FG000|Overall Study|Lost to Follow-up|1|||
146098314|NCT00986830|526881110|FG000|Overall Study|Lack of Efficacy|1|||
146098315|NCT00986830|526881110|FG000|Overall Study|Unable to access sinus with device|5|||
146098316|NCT00285818|526881113|FG000|Overall Study|Withdrawal by Subject|3|||
146098317|NCT00285818|526881114|FG001|Overall Study|Withdrawal by Subject|2|||
146098318|NCT00285818|526881113|FG000|Overall Study|Lost to Follow-up|1|||
146098319|NCT00285818|526881114|FG001|Overall Study|Lost to Follow-up|0|||
146098320|NCT04041375|526881118|FG000|Intervention Phase|Withdrawal by Subject|2|||
146098321|NCT04041375|526881119|FG001|Intervention Phase|Withdrawal by Subject|2|||
146098322|NCT04041375|526881118|FG000|Follow-up Phase|Death|2|||
146098323|NCT04041375|526881119|FG001|Follow-up Phase|Death|0|||
146098324|NCT04041375|526881118|FG000|Follow-up Phase|Lost to Follow-up|2|||
146098325|NCT04041375|526881119|FG001|Follow-up Phase|Lost to Follow-up|1|||
146098326|NCT04041375|526881118|FG000|Follow-up Phase|Too ill|3|||
146098327|NCT04041375|526881119|FG001|Follow-up Phase|Too ill|0|||
146098328|NCT04674644|526881125|FG000|Overall Study|with missing data|37|||
146098329|NCT01230710|526881128|FG000|Overall Study|Disease Progression|41|||
146098330|NCT01230710|526881128|FG000|Overall Study|Lost to Follow-up|3|||
146254351|NCT00332488|527444554|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
146254352|NCT04357964|527444555|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
146300451|NCT01667107|527615254|FG000|Overall Study|Tolerability issues|0|||
146034861|NCT01555125|526639640|FG002|Induction Period|Adverse Event|0|||
146034862|NCT01555125|526639641|FG003|Induction Period|Adverse Event|0|||
146034863|NCT01555125|526639642|FG004|Induction Period|Adverse Event|1|||
146034864|NCT01555125|526639638|FG000|Induction Period|Subject / guardian decision|0|||
146034865|NCT01555125|526639639|FG001|Induction Period|Subject / guardian decision|0|||
146034866|NCT01555125|526639640|FG002|Induction Period|Subject / guardian decision|0|||
146034867|NCT01555125|526639641|FG003|Induction Period|Subject / guardian decision|0|||
146034868|NCT01555125|526639642|FG004|Induction Period|Subject / guardian decision|2|||
146034869|NCT01555125|526639638|FG000|Induction Period|Death|1|||
146098331|NCT01230710|526881128|FG000|Overall Study|Death|4|||
146098332|NCT01230710|526881128|FG000|Overall Study|Withdrawal of Consent|1|||
146098333|NCT02905149|526881129|FG000|Overall Study|Lost to Follow-up|2|||
146098334|NCT02905149|526881130|FG001|Overall Study|Lost to Follow-up|0|||
146098335|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
146098336|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
146098337|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Physician Decision|1|||
146098338|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Physician Decision|0|||
146098339|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
146098340|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
146098341|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
146098342|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
146098343|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Adverse Event|15|||
146098344|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Adverse Event|0|||
146098345|NCT03277690|526881131|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
146098346|NCT03277690|526881132|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
146098347|NCT03277690|526881131|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
146098348|NCT03277690|526881132|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
146098349|NCT00747812|526881133|FG000|Overall Study|Research Site Staff Relocation|5|||
146098350|NCT00747812|526881134|FG001|Overall Study|Research Site Staff Relocation|3|||
146098351|NCT01708161|526881135|FG000|Overall Study|Adverse Event|1|||
146098352|NCT01708161|526881136|FG001|Overall Study|Adverse Event|3|||
146098353|NCT01708161|526881137|FG002|Overall Study|Adverse Event|4|||
146098354|NCT01708161|526881138|FG003|Overall Study|Adverse Event|2|||
146098355|NCT01708161|526881139|FG004|Overall Study|Adverse Event|3|||
146098356|NCT01708161|526881140|FG005|Overall Study|Adverse Event|0|||
146098357|NCT01708161|526881135|FG000|Overall Study|Death|0|||
146098358|NCT01708161|526881136|FG001|Overall Study|Death|0|||
146098359|NCT01708161|526881137|FG002|Overall Study|Death|0|||
146098360|NCT01708161|526881138|FG003|Overall Study|Death|1|||
146098361|NCT01708161|526881139|FG004|Overall Study|Death|0|||
146098362|NCT01708161|526881140|FG005|Overall Study|Death|1|||
146098363|NCT01708161|526881135|FG000|Overall Study|Withdrawal by Subject|0|||
146098364|NCT01708161|526881136|FG001|Overall Study|Withdrawal by Subject|1|||
146098365|NCT01708161|526881137|FG002|Overall Study|Withdrawal by Subject|1|||
146098366|NCT01708161|526881138|FG003|Overall Study|Withdrawal by Subject|0|||
146098367|NCT01708161|526881139|FG004|Overall Study|Withdrawal by Subject|0|||
146098368|NCT01708161|526881140|FG005|Overall Study|Withdrawal by Subject|0|||
146098369|NCT01708161|526881135|FG000|Overall Study|Administrative problems|0|||
146098370|NCT01708161|526881136|FG001|Overall Study|Administrative problems|1|||
146098371|NCT01708161|526881137|FG002|Overall Study|Administrative problems|0|||
146098372|NCT01708161|526881138|FG003|Overall Study|Administrative problems|0|||
146098373|NCT01708161|526881139|FG004|Overall Study|Administrative problems|0|||
146098374|NCT01708161|526881140|FG005|Overall Study|Administrative problems|0|||
146098375|NCT01708161|526881135|FG000|Overall Study|Disease progression|3|||
146098376|NCT01708161|526881136|FG001|Overall Study|Disease progression|5|||
146098377|NCT01708161|526881137|FG002|Overall Study|Disease progression|5|||
146098378|NCT01708161|526881138|FG003|Overall Study|Disease progression|13|||
146098379|NCT01708161|526881139|FG004|Overall Study|Disease progression|3|||
146098380|NCT01708161|526881140|FG005|Overall Study|Disease progression|0|||
146098381|NCT01268150|526881143|FG000|Treatment Phase|Progression of disease|18|||
146098382|NCT01268150|526881143|FG000|Treatment Phase|Adverse Event|3|||
146098383|NCT01268150|526881143|FG000|Treatment Phase|Withdrawal by Subject|3|||
146098384|NCT01268150|526881143|FG000|Treatment Phase|Other|4|||
146098385|NCT01268150|526881143|FG000|Extension Phase|Adverse Event|3|||
146098386|NCT01268150|526881143|FG000|Extension Phase|Disease progression|18|||
146098387|NCT01268150|526881143|FG000|Extension Phase|Other|6|||
146098388|NCT00395733|526881144|FG000|Period 2|Withdrawal by Subject|1|||
146098389|NCT00395733|526881145|FG001|Period 2|Withdrawal by Subject|2|||
146098390|NCT00395733|526881144|FG000|Period 2|Protocol Violation|0|||
146098391|NCT00395733|526881145|FG001|Period 2|Protocol Violation|1|||
146098392|NCT00395733|526881144|FG000|Period 2|Adverse Event|0|||
146098393|NCT00395733|526881145|FG001|Period 2|Adverse Event|2|||
146098394|NCT00395733|526881144|FG000|Period 2|Technical problems|1|||
146098395|NCT00395733|526881145|FG001|Period 2|Technical problems|0|||
146098396|NCT03725852|526881146|FG000|Overall Study|Death|1|||
146098397|NCT03725852|526881147|FG001|Overall Study|Death|0|||
146098398|NCT03725852|526881146|FG000|Overall Study|Withdrawal by Subject|1|||
146098399|NCT03725852|526881147|FG001|Overall Study|Withdrawal by Subject|0|||
146098400|NCT03725852|526881146|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
146098401|NCT03725852|526881147|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
146098402|NCT01986140|526881148|FG000|Overall Study|Withdrawal by Subject|31|||
146098403|NCT01986140|526881149|FG001|Overall Study|Withdrawal by Subject|25|||
146098404|NCT01986140|526881148|FG000|Overall Study|alternative treatment|1|||
146098405|NCT01986140|526881149|FG001|Overall Study|alternative treatment|1|||
146098406|NCT01986140|526881148|FG000|Overall Study|found not eligible|3|||
146098407|NCT01986140|526881149|FG001|Overall Study|found not eligible|0|||
146098408|NCT01986140|526881148|FG000|Overall Study|Adverse Event|0|||
146098409|NCT01986140|526881149|FG001|Overall Study|Adverse Event|1|||
146098410|NCT01986140|526881148|FG000|Overall Study|progression disease|0|||
146098411|NCT01986140|526881149|FG001|Overall Study|progression disease|1|||
146098412|NCT02808650|526881150|FG000|Overall Study|Death|0|||
146098413|NCT02808650|526881151|FG001|Overall Study|Death|0|||
146098414|NCT02808650|526881152|FG002|Overall Study|Death|0|||
146098415|NCT02808650|526881153|FG003|Overall Study|Death|0|||
146098416|NCT02808650|526881154|FG004|Overall Study|Death|1|||
146300452|NCT01667107|527615255|FG001|Overall Study|Tolerability issues|2|||
146098417|NCT02808650|526881150|FG000|Overall Study|Lack of Efficacy|5|||
146098418|NCT02808650|526881151|FG001|Overall Study|Lack of Efficacy|5|||
146098419|NCT02808650|526881152|FG002|Overall Study|Lack of Efficacy|6|||
146098420|NCT02808650|526881153|FG003|Overall Study|Lack of Efficacy|5|||
146034870|NCT01555125|526639639|FG001|Induction Period|Death|0|||
146034871|NCT01555125|526639640|FG002|Induction Period|Death|0|||
146034872|NCT01555125|526639641|FG003|Induction Period|Death|0|||
146034873|NCT01555125|526639642|FG004|Induction Period|Death|0|||
146034874|NCT01555125|526639638|FG000|Maintenance Period|Adverse Event|1|||
146034875|NCT01555125|526639639|FG001|Maintenance Period|Adverse Event|1|||
146034876|NCT01555125|526639640|FG002|Maintenance Period|Adverse Event|0|||
146034877|NCT01555125|526639641|FG003|Maintenance Period|Adverse Event|0|||
146034878|NCT01555125|526639642|FG004|Maintenance Period|Adverse Event|0|||
146034879|NCT01555125|526639638|FG000|Maintenance Period|Subject / guardian decision|1|||
146034880|NCT01555125|526639639|FG001|Maintenance Period|Subject / guardian decision|2|||
146034881|NCT01555125|526639640|FG002|Maintenance Period|Subject / guardian decision|0|||
146034882|NCT01555125|526639641|FG003|Maintenance Period|Subject / guardian decision|0|||
146034883|NCT01555125|526639642|FG004|Maintenance Period|Subject / guardian decision|0|||
146034884|NCT01555125|526639638|FG000|Maintenance Period|Lost to Follow-up|2|||
146034885|NCT01555125|526639639|FG001|Maintenance Period|Lost to Follow-up|0|||
146034886|NCT01555125|526639640|FG002|Maintenance Period|Lost to Follow-up|0|||
146034887|NCT01555125|526639641|FG003|Maintenance Period|Lost to Follow-up|1|||
146034888|NCT01555125|526639642|FG004|Maintenance Period|Lost to Follow-up|0|||
146034889|NCT01555125|526639638|FG000|Maintenance Period|Lack of Efficacy|6|||
146034890|NCT01555125|526639639|FG001|Maintenance Period|Lack of Efficacy|1|||
146034891|NCT01555125|526639640|FG002|Maintenance Period|Lack of Efficacy|3|||
146034892|NCT01555125|526639641|FG003|Maintenance Period|Lack of Efficacy|0|||
146034893|NCT01555125|526639642|FG004|Maintenance Period|Lack of Efficacy|0|||
146034894|NCT01555125|526639638|FG000|Maintenance Period|Physician Decision|0|||
146034895|NCT01555125|526639639|FG001|Maintenance Period|Physician Decision|0|||
146034896|NCT01555125|526639640|FG002|Maintenance Period|Physician Decision|1|||
146034897|NCT01555125|526639641|FG003|Maintenance Period|Physician Decision|0|||
146034898|NCT01555125|526639642|FG004|Maintenance Period|Physician Decision|0|||
146034899|NCT01555125|526639638|FG000|Maintenance Period|Death|0|||
146034900|NCT01555125|526639639|FG001|Maintenance Period|Death|0|||
146034901|NCT01555125|526639640|FG002|Maintenance Period|Death|0|||
146034902|NCT01555125|526639641|FG003|Maintenance Period|Death|1|||
146034903|NCT01555125|526639642|FG004|Maintenance Period|Death|0|||
146034904|NCT01555125|526639638|FG000|Extension|Adverse Event|1|||
146034905|NCT01555125|526639639|FG001|Extension|Adverse Event|2|||
146034906|NCT01555125|526639640|FG002|Extension|Adverse Event|1|||
146034907|NCT01555125|526639641|FG003|Extension|Adverse Event|1|||
146034908|NCT01555125|526639642|FG004|Extension|Adverse Event|0|||
146034909|NCT01555125|526639638|FG000|Extension|Protocol deviation|1|||
146034910|NCT01555125|526639639|FG001|Extension|Protocol deviation|0|||
146034911|NCT01555125|526639640|FG002|Extension|Protocol deviation|0|||
146034912|NCT01555125|526639641|FG003|Extension|Protocol deviation|0|||
146034913|NCT01555125|526639642|FG004|Extension|Protocol deviation|0|||
146034914|NCT01555125|526639638|FG000|Extension|Lack of Efficacy|7|||
146034915|NCT01555125|526639639|FG001|Extension|Lack of Efficacy|6|||
146034916|NCT01555125|526639640|FG002|Extension|Lack of Efficacy|3|||
146034917|NCT01555125|526639641|FG003|Extension|Lack of Efficacy|0|||
146034918|NCT01555125|526639642|FG004|Extension|Lack of Efficacy|0|||
146034919|NCT01555125|526639638|FG000|Extension|Lost to Follow-up|2|||
146034920|NCT01555125|526639639|FG001|Extension|Lost to Follow-up|1|||
146034921|NCT01555125|526639640|FG002|Extension|Lost to Follow-up|2|||
146034922|NCT01555125|526639641|FG003|Extension|Lost to Follow-up|0|||
146034923|NCT01555125|526639642|FG004|Extension|Lost to Follow-up|0|||
146034924|NCT01555125|526639638|FG000|Extension|Study terminated by sponsor|32|||
146034925|NCT01555125|526639639|FG001|Extension|Study terminated by sponsor|33|||
146034926|NCT01555125|526639640|FG002|Extension|Study terminated by sponsor|16|||
146034927|NCT01555125|526639641|FG003|Extension|Study terminated by sponsor|20|||
146034928|NCT01555125|526639642|FG004|Extension|Study terminated by sponsor|0|||
146034929|NCT01555125|526639638|FG000|Extension|Subject/guardian decision|1|||
146034930|NCT01555125|526639639|FG001|Extension|Subject/guardian decision|9|||
146034931|NCT01555125|526639640|FG002|Extension|Subject/guardian decision|1|||
146034932|NCT01555125|526639641|FG003|Extension|Subject/guardian decision|0|||
146034933|NCT01555125|526639642|FG004|Extension|Subject/guardian decision|0|||
146034934|NCT01555125|526639638|FG000|Extension|Technical Problems|1|||
146034935|NCT01555125|526639639|FG001|Extension|Technical Problems|0|||
146034936|NCT01555125|526639640|FG002|Extension|Technical Problems|0|||
146034937|NCT01555125|526639641|FG003|Extension|Technical Problems|1|||
146034938|NCT01555125|526639642|FG004|Extension|Technical Problems|0|||
146034939|NCT01555125|526639638|FG000|Follow-Up Period|Lost to Follow-up|1|||
146034940|NCT01555125|526639639|FG001|Follow-Up Period|Lost to Follow-up|0|||
146034941|NCT01555125|526639640|FG002|Follow-Up Period|Lost to Follow-up|0|||
146034942|NCT01555125|526639641|FG003|Follow-Up Period|Lost to Follow-up|0|||
146034943|NCT01555125|526639642|FG004|Follow-Up Period|Lost to Follow-up|0|||
146034944|NCT01555125|526639638|FG000|Follow-Up Period|Subject / guardian decision|3|||
146034945|NCT01555125|526639639|FG001|Follow-Up Period|Subject / guardian decision|1|||
146034946|NCT01555125|526639640|FG002|Follow-Up Period|Subject / guardian decision|1|||
146034947|NCT01555125|526639641|FG003|Follow-Up Period|Subject / guardian decision|1|||
146254353|NCT04357964|527444556|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
146254354|NCT04357964|527444555|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
146254355|NCT04357964|527444556|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
146254356|NCT04357964|527444555|FG000|Overall Study|Adipose sample was insufficient quality|0|||
146254357|NCT04357964|527444556|FG001|Overall Study|Adipose sample was insufficient quality|1|||
146254358|NCT00733226|527444557|FG000|Overall Study|Withdrawal by Subject|1|||
146254359|NCT00733226|527444558|FG001|Overall Study|Withdrawal by Subject|0|||
146254360|NCT00733226|527444557|FG000|Overall Study|Lost to Follow-up|2|||
146254361|NCT00733226|527444558|FG001|Overall Study|Lost to Follow-up|0|||
146300453|NCT01667107|527615254|FG000|Overall Study|Protocol Violation|0|||
146034948|NCT01555125|526639642|FG004|Follow-Up Period|Subject / guardian decision|0|||
146034949|NCT02651220|526639643|FG000|Overall Study|Adverse Event|1|||
146034950|NCT02651220|526639644|FG001|Overall Study|Adverse Event|5|||
146034951|NCT02651220|526639645|FG002|Overall Study|Adverse Event|1|||
146034952|NCT02651220|526639643|FG000|Overall Study|Lost to Follow-up|8|||
146034953|NCT02651220|526639644|FG001|Overall Study|Lost to Follow-up|14|||
146034954|NCT02651220|526639645|FG002|Overall Study|Lost to Follow-up|14|||
146034955|NCT02651220|526639643|FG000|Overall Study|Non-Compliance with Study Drug|4|||
146034956|NCT02651220|526639644|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146034957|NCT02651220|526639645|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146034958|NCT02651220|526639643|FG000|Overall Study|Pregnancy|1|||
146034959|NCT02651220|526639644|FG001|Overall Study|Pregnancy|0|||
146034960|NCT02651220|526639645|FG002|Overall Study|Pregnancy|1|||
146034961|NCT02651220|526639643|FG000|Overall Study|Protocol Violation|0|||
146034962|NCT02651220|526639644|FG001|Overall Study|Protocol Violation|0|||
146034963|NCT02651220|526639645|FG002|Overall Study|Protocol Violation|1|||
146034964|NCT02651220|526639643|FG000|Overall Study|Withdrawal by Subject|5|||
146034965|NCT02651220|526639644|FG001|Overall Study|Withdrawal by Subject|6|||
146034966|NCT02651220|526639645|FG002|Overall Study|Withdrawal by Subject|8|||
146034967|NCT02651220|526639643|FG000|Overall Study|Miscellaneous|4|||
146034968|NCT02651220|526639644|FG001|Overall Study|Miscellaneous|1|||
146034969|NCT02651220|526639645|FG002|Overall Study|Miscellaneous|2|||
146034970|NCT02651220|526639643|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146034971|NCT02651220|526639644|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146034972|NCT02651220|526639645|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
146034973|NCT04268745|526639646|FG000|Overall Study|Lost to Follow-up|2|||
146034974|NCT04268745|526639647|FG001|Overall Study|Lost to Follow-up|3|||
146034975|NCT04268745|526639646|FG000|Overall Study|Withdrawal by Subject|4|||
146034976|NCT04268745|526639647|FG001|Overall Study|Withdrawal by Subject|2|||
146034977|NCT04268745|526639646|FG000|Overall Study|Death in the family|1|||
146034978|NCT04268745|526639647|FG001|Overall Study|Death in the family|0|||
146034979|NCT05327361|526639659|FG000|Overall Study|Lost to Follow-up|4|||
146034980|NCT02720692|526641355|FG000|Overall Study|Withdrawal by Subject|3|||
146034981|NCT02720692|526641356|FG001|Overall Study|Withdrawal by Subject|0|||
146034982|NCT02720692|526641355|FG000|Overall Study|Physician Decision|1|||
146034983|NCT02720692|526641356|FG001|Overall Study|Physician Decision|0|||
146034984|NCT02720692|526641355|FG000|Overall Study|Lost to Follow-up|8|||
146034985|NCT02720692|526641356|FG001|Overall Study|Lost to Follow-up|3|||
146034986|NCT02720692|526641355|FG000|Overall Study|Subject unable to return for visit|1|||
146034987|NCT02720692|526641356|FG001|Overall Study|Subject unable to return for visit|0|||
146034988|NCT02503501|526641357|FG000|Overall Study|Physician Decision|1|||
146034989|NCT02503501|526641358|FG001|Overall Study|Physician Decision|0|||
146034990|NCT02503501|526641357|FG000|Overall Study|Protocol Violation|0|||
146034991|NCT02503501|526641358|FG001|Overall Study|Protocol Violation|1|||
146034992|NCT02503501|526641357|FG000|Overall Study|Withdrawal by Subject|0|||
146034993|NCT02503501|526641358|FG001|Overall Study|Withdrawal by Subject|2|||
146034994|NCT01740401|526641359|FG000|Overall Study|Progression of disease|6|||
146034995|NCT01740401|526641359|FG000|Overall Study|Adverse Event|2|||
146034996|NCT01740401|526641359|FG000|Overall Study|Did not reach primary endpoint|2|||
146034997|NCT03878758|526641360|FG000|Overall Study|Withdrawal by Subject|1|||
146034998|NCT03878758|526641360|FG000|Overall Study|Protocol defined|2|||
146034999|NCT03878758|526641360|FG000|Overall Study|Improper consent documentation|1|||
146035000|NCT00765063|526641361|FG000|Overall Study|Lack of Efficacy|5|||
146035001|NCT00765063|526641361|FG000|Overall Study|Withdrawal by Subject|1|||
146035002|NCT00765063|526641361|FG000|Overall Study|Other|16|||
146035003|NCT00765063|526641361|FG000|Overall Study|Protocol Violation|6|||
146035004|NCT00765063|526641361|FG000|Overall Study|Adverse Event|4|||
146035005|NCT03614325|526641362|FG000|Overall Study|Withdrawal by Subject|0|||
146035006|NCT03614325|526641363|FG001|Overall Study|Withdrawal by Subject|2|||
146035007|NCT03614325|526641362|FG000|Overall Study|Surgery Cancelled|2|||
146035008|NCT03614325|526641363|FG001|Overall Study|Surgery Cancelled|1|||
146035009|NCT03614325|526641362|FG000|Overall Study|Lost to Follow-up|2|||
146035010|NCT03614325|526641363|FG001|Overall Study|Lost to Follow-up|1|||
146035011|NCT03614325|526641362|FG000|Overall Study|Surgery never scheduled|1|||
146035012|NCT03614325|526641363|FG001|Overall Study|Surgery never scheduled|0|||
146035013|NCT00321464|526641364|FG000|Overall Study|Death|169|||
146300454|NCT01667107|527615255|FG001|Overall Study|Protocol Violation|1|||
146300455|NCT01667107|527615254|FG000|Overall Study|Lack of Efficacy|0|||
146300456|NCT01667107|527615255|FG001|Overall Study|Lack of Efficacy|1|||
146300457|NCT03427125|527615256|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
146300458|NCT03427125|527615257|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
146300459|NCT03427125|527615258|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
146035014|NCT00321464|526641365|FG001|Overall Study|Death|174|||
146035015|NCT00321464|526641364|FG000|Overall Study|Disease progression|124|||
146035016|NCT00321464|526641365|FG001|Overall Study|Disease progression|124|||
146035017|NCT00321464|526641364|FG000|Overall Study|Withdrawal by Subject|117|||
146035018|NCT00321464|526641365|FG001|Overall Study|Withdrawal by Subject|118|||
146035019|NCT00321464|526641364|FG000|Overall Study|Participant request|57|||
146035020|NCT00321464|526641365|FG001|Overall Study|Participant request|61|||
146035021|NCT00321464|526641364|FG000|Overall Study|Adverse Event|43|||
146035022|NCT00321464|526641365|FG001|Overall Study|Adverse Event|28|||
146035023|NCT00321464|526641364|FG000|Overall Study|Physician Decision|15|||
146035024|NCT00321464|526641365|FG001|Overall Study|Physician Decision|14|||
146035025|NCT00321464|526641364|FG000|Overall Study|Noncompliance|4|||
146035026|NCT00321464|526641365|FG001|Overall Study|Noncompliance|10|||
146035027|NCT00321464|526641364|FG000|Overall Study|Lost to Follow-up|7|||
146035028|NCT00321464|526641365|FG001|Overall Study|Lost to Follow-up|8|||
146035029|NCT00321464|526641364|FG000|Overall Study|Protocol deviation|0|||
146035030|NCT00321464|526641365|FG001|Overall Study|Protocol deviation|2|||
146035031|NCT00321464|526641364|FG000|Overall Study|Ineligibility determined|2|||
146035032|NCT00321464|526641365|FG001|Overall Study|Ineligibility determined|1|||
146035033|NCT00321464|526641364|FG000|Overall Study|Other|21|||
146035034|NCT00321464|526641365|FG001|Overall Study|Other|18|||
146035035|NCT01673620|526641366|FG000|Overall Study|Adverse Event|1|||
146035036|NCT01673620|526641367|FG001|Overall Study|Adverse Event|0|||
146035037|NCT01206582|526641368|FG000|Overall Study|Withdrew prior to study|1|||
146035038|NCT01206582|526641369|FG001|Overall Study|Withdrew prior to study|0|||
146035039|NCT01206582|526641368|FG000|Overall Study|Discontinued intervention before week 8|1|||
146035040|NCT01206582|526641369|FG001|Overall Study|Discontinued intervention before week 8|2|||
146035041|NCT02522325|526641370|FG000|Overall Study|Adverse Event|0|||
146035042|NCT02522325|526641371|FG001|Overall Study|Adverse Event|1|||
146035043|NCT02081599|526641374|FG000|Period 1：Double-blind Period|Adverse Event|3|||
146035044|NCT02081599|526641375|FG001|Period 1：Double-blind Period|Adverse Event|0|||
146035045|NCT02081599|526641374|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
146035046|NCT02081599|526641375|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
146035047|NCT02081599|526641374|FG000|Period 1：Double-blind Period|Physician Decision|1|||
146035048|NCT02081599|526641375|FG001|Period 1：Double-blind Period|Physician Decision|0|||
146035049|NCT02081599|526641374|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
146035050|NCT02081599|526641375|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
146035051|NCT02081599|526641374|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
146035052|NCT02081599|526641375|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
146035053|NCT02081599|526641374|FG000|Period 1：Double-blind Period|stopping criteria|1|||
146035054|NCT02081599|526641375|FG001|Period 1：Double-blind Period|stopping criteria|0|||
146035055|NCT02081599|526641374|FG000|Period 2：Open-label Period|Adverse Event|1|||
146035056|NCT02081599|526641375|FG001|Period 2：Open-label Period|Adverse Event|0|||
146035057|NCT02081599|526641374|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
146035058|NCT02081599|526641375|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
146035059|NCT02081599|526641374|FG000|Period 2：Open-label Period|Physician Decision|1|||
146035060|NCT02081599|526641375|FG001|Period 2：Open-label Period|Physician Decision|0|||
146035061|NCT02081599|526641374|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
146035062|NCT02081599|526641375|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
146035063|NCT00306527|526641381|FG000|Overall Study|Lost to Follow-up|3|||
146035064|NCT00306527|526641382|FG001|Overall Study|Lost to Follow-up|4|||
146035065|NCT00306527|526641383|FG002|Overall Study|Lost to Follow-up|3|||
146035066|NCT00306527|526641384|FG003|Overall Study|Lost to Follow-up|0|||
146035067|NCT00306527|526641381|FG000|Overall Study|Withdrawal by Subject|2|||
146035068|NCT00306527|526641382|FG001|Overall Study|Withdrawal by Subject|3|||
146035069|NCT00306527|526641383|FG002|Overall Study|Withdrawal by Subject|0|||
146035070|NCT00306527|526641384|FG003|Overall Study|Withdrawal by Subject|3|||
146035071|NCT00306527|526641381|FG000|Overall Study|Adverse Event|0|||
146035072|NCT00306527|526641382|FG001|Overall Study|Adverse Event|0|||
146035073|NCT00306527|526641383|FG002|Overall Study|Adverse Event|1|||
146035074|NCT00306527|526641384|FG003|Overall Study|Adverse Event|1|||
146035075|NCT00306527|526641381|FG000|Overall Study|Death|1|||
146035076|NCT00306527|526641382|FG001|Overall Study|Death|0|||
146035077|NCT00306527|526641383|FG002|Overall Study|Death|1|||
146035078|NCT00306527|526641384|FG003|Overall Study|Death|2|||
146035079|NCT00785980|526641385|FG000|7 Day Washout Period|Protocol Violation|3|||
146035080|NCT00528801|526641386|FG000|Overall Study|Withdrawal by Subject|1|||
146035081|NCT00528801|526641387|FG001|Overall Study|Withdrawal by Subject|1|||
146098421|NCT02808650|526881154|FG004|Overall Study|Lack of Efficacy|4|||
146098422|NCT02808650|526881150|FG000|Overall Study|Physician Decision|1|||
146098423|NCT02808650|526881151|FG001|Overall Study|Physician Decision|1|||
146300460|NCT02684279|527615259|FG000|Overall Study|Adverse Event|87|||
146300461|NCT02684279|527615259|FG000|Overall Study|Lack of Efficacy|4|||
146300462|NCT02684279|527615259|FG000|Overall Study|Lost to Follow-up|61|||
146300463|NCT02684279|527615259|FG000|Overall Study|Protocol Violation|6|||
146300464|NCT02684279|527615259|FG000|Overall Study|Pregnancy|8|||
146300465|NCT02684279|527615259|FG000|Overall Study|Withdrawal by Subject|92|||
146300466|NCT02684279|527615259|FG000|Overall Study|non-compliance with study drug|9|||
146300467|NCT02684279|527615259|FG000|Overall Study|non compliance with study visits|2|||
146300468|NCT02684279|527615259|FG000|Overall Study|subject to have surgery|1|||
146300469|NCT02684279|527615259|FG000|Overall Study|family emergency|1|||
146300470|NCT02684279|527615259|FG000|Overall Study|Site closures|7|||
146300471|NCT02684279|527615259|FG000|Overall Study|Physician Decision|1|||
146300472|NCT01162239|527615260|FG000|Treatment Phase|Withdrawal by Subject|1|||
146300473|NCT01162239|527615261|FG001|Treatment Phase|Withdrawal by Subject|3|||
146300474|NCT01162239|527615262|FG002|Treatment Phase|Withdrawal by Subject|2|||
146300475|NCT01162239|527615263|FG003|Treatment Phase|Withdrawal by Subject|3|||
146300476|NCT01162239|527615260|FG000|Treatment Phase|Death|0|||
146300477|NCT01162239|527615261|FG001|Treatment Phase|Death|0|||
146035082|NCT00528801|526641386|FG000|Overall Study|Protocol Violation|11|||
146300478|NCT01162239|527615262|FG002|Treatment Phase|Death|0|||
146300479|NCT01162239|527615263|FG003|Treatment Phase|Death|1|||
146300480|NCT01162239|527615260|FG000|Treatment Phase|Lost to Follow-up|5|||
146300481|NCT01162239|527615261|FG001|Treatment Phase|Lost to Follow-up|4|||
146300482|NCT01162239|527615262|FG002|Treatment Phase|Lost to Follow-up|2|||
146300483|NCT01162239|527615263|FG003|Treatment Phase|Lost to Follow-up|1|||
146300484|NCT01162239|527615260|FG000|Extended Follow-up|Lost to Follow-up|8|||
146300485|NCT01162239|527615261|FG001|Extended Follow-up|Lost to Follow-up|13|||
146300486|NCT01162239|527615262|FG002|Extended Follow-up|Lost to Follow-up|8|||
146300487|NCT01162239|527615263|FG003|Extended Follow-up|Lost to Follow-up|6|||
146300488|NCT04448756|527615266|FG000|Overall Study|Adverse Event|0|||
146035083|NCT00528801|526641387|FG001|Overall Study|Protocol Violation|5|||
146035084|NCT00528801|526641386|FG000|Overall Study|Lost to Follow-up|15|||
146035085|NCT00528801|526641387|FG001|Overall Study|Lost to Follow-up|4|||
146035086|NCT00528801|526641386|FG000|Overall Study|Administrative Reasons|0|||
146035087|NCT00528801|526641387|FG001|Overall Study|Administrative Reasons|1|||
146035088|NCT02207491|526641388|FG000|Overall Study|Adverse Event|20|||
146035089|NCT02207491|526641389|FG001|Overall Study|Adverse Event|4|||
146035090|NCT02207491|526641388|FG000|Overall Study|Withdrawal by Subject|3|||
146035091|NCT02207491|526641389|FG001|Overall Study|Withdrawal by Subject|2|||
146035092|NCT02207491|526641388|FG000|Overall Study|Non-compliant|0|||
146035093|NCT02207491|526641389|FG001|Overall Study|Non-compliant|1|||
146035094|NCT02207491|526641388|FG000|Overall Study|Lost to Follow-up|0|||
146035095|NCT02207491|526641389|FG001|Overall Study|Lost to Follow-up|1|||
146035096|NCT02207491|526641388|FG000|Overall Study|Lack of Efficacy|3|||
146035097|NCT02207491|526641389|FG001|Overall Study|Lack of Efficacy|0|||
146035098|NCT02207491|526641388|FG000|Overall Study|Physician Decision|2|||
146035099|NCT02207491|526641389|FG001|Overall Study|Physician Decision|0|||
146035100|NCT02207491|526641388|FG000|Overall Study|Protocol Violation|3|||
146035101|NCT02207491|526641389|FG001|Overall Study|Protocol Violation|5|||
146035102|NCT00387725|526641390|FG000|Overall Study|Adverse Event|0|||
146035103|NCT00387725|526641391|FG001|Overall Study|Adverse Event|0|||
146035104|NCT00387725|526641392|FG002|Overall Study|Adverse Event|0|||
146035105|NCT00387725|526641393|FG003|Overall Study|Adverse Event|1|||
146035106|NCT00387725|526641390|FG000|Overall Study|Protocol Violation|0|||
146035107|NCT00387725|526641391|FG001|Overall Study|Protocol Violation|1|||
146035108|NCT00387725|526641392|FG002|Overall Study|Protocol Violation|0|||
146035109|NCT00387725|526641393|FG003|Overall Study|Protocol Violation|0|||
146035110|NCT00387725|526641390|FG000|Overall Study|Withdrawal by Subject|1|||
146035111|NCT00387725|526641391|FG001|Overall Study|Withdrawal by Subject|0|||
146035112|NCT00387725|526641392|FG002|Overall Study|Withdrawal by Subject|1|||
146035113|NCT00387725|526641393|FG003|Overall Study|Withdrawal by Subject|0|||
146035114|NCT00387725|526641390|FG000|Overall Study|Parent/legal guardian request|0|||
146035115|NCT00387725|526641391|FG001|Overall Study|Parent/legal guardian request|0|||
146035116|NCT00387725|526641392|FG002|Overall Study|Parent/legal guardian request|1|||
146035117|NCT00387725|526641393|FG003|Overall Study|Parent/legal guardian request|1|||
146035118|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
146035119|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
146098424|NCT02808650|526881152|FG002|Overall Study|Physician Decision|0|||
146098425|NCT02808650|526881153|FG003|Overall Study|Physician Decision|0|||
146300489|NCT04448756|527615267|FG001|Overall Study|Adverse Event|1|||
146300490|NCT04448756|527615268|FG002|Overall Study|Adverse Event|0|||
146300491|NCT04448756|527615266|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
146300492|NCT04448756|527615267|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
146300493|NCT04448756|527615268|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
146300494|NCT04448756|527615266|FG000|Overall Study|Withdrawal by Subject|0|||
146300495|NCT04448756|527615267|FG001|Overall Study|Withdrawal by Subject|3|||
146035120|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
146035121|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
146035122|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
146035123|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
146035124|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
146035125|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
146035126|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
146035127|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
146035128|NCT02429791|526641395|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
146035129|NCT02429791|526641396|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
146035130|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
146035131|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
146035132|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
146035133|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
146035134|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
146035135|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
146035136|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
146035137|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
146035138|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
146035139|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
146035140|NCT02429791|526641395|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
146035141|NCT02429791|526641396|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
146035142|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
146035143|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
146035144|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
146035145|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
146035146|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
146035147|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
146035148|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
146035149|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
146035150|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
146035151|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
146035152|NCT02429791|526641395|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
146035153|NCT02429791|526641396|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
146035154|NCT04201093|526641397|FG000|Overall Study|Adverse Event|6|||
146035155|NCT04201093|526641398|FG001|Overall Study|Adverse Event|29|||
146035156|NCT04201093|526641399|FG002|Overall Study|Adverse Event|35|||
146035157|NCT04201093|526641397|FG000|Overall Study|Death|2|||
146035158|NCT04201093|526641398|FG001|Overall Study|Death|1|||
146035159|NCT04201093|526641399|FG002|Overall Study|Death|0|||
146035160|NCT04201093|526641397|FG000|Overall Study|Lack of Efficacy|5|||
146035161|NCT04201093|526641398|FG001|Overall Study|Lack of Efficacy|1|||
146035162|NCT04201093|526641399|FG002|Overall Study|Lack of Efficacy|2|||
146035163|NCT04201093|526641397|FG000|Overall Study|Lost to Follow-up|0|||
146035164|NCT04201093|526641398|FG001|Overall Study|Lost to Follow-up|0|||
146035165|NCT04201093|526641399|FG002|Overall Study|Lost to Follow-up|1|||
146035166|NCT04201093|526641397|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
146035167|NCT04201093|526641398|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
146035168|NCT04201093|526641399|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
146035169|NCT04201093|526641397|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146035170|NCT04201093|526641398|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146035171|NCT04201093|526641399|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
146035172|NCT04201093|526641397|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
146035173|NCT04201093|526641398|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
146035174|NCT04201093|526641399|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
146035175|NCT04201093|526641397|FG000|Overall Study|Physician Decision|1|||
146035176|NCT04201093|526641398|FG001|Overall Study|Physician Decision|0|||
146035177|NCT04201093|526641399|FG002|Overall Study|Physician Decision|0|||
146035178|NCT04201093|526641397|FG000|Overall Study|Protocol Deviation|1|||
146035179|NCT04201093|526641398|FG001|Overall Study|Protocol Deviation|0|||
146035180|NCT04201093|526641399|FG002|Overall Study|Protocol Deviation|0|||
146035181|NCT04201093|526641397|FG000|Overall Study|Site Terminated by Sponsor|5|||
146035182|NCT04201093|526641398|FG001|Overall Study|Site Terminated by Sponsor|3|||
146035183|NCT04201093|526641399|FG002|Overall Study|Site Terminated by Sponsor|1|||
146035184|NCT04201093|526641397|FG000|Overall Study|Withdrawal by Subject|7|||
146035185|NCT04201093|526641398|FG001|Overall Study|Withdrawal by Subject|8|||
146035186|NCT04201093|526641399|FG002|Overall Study|Withdrawal by Subject|15|||
146035187|NCT04201093|526641397|FG000|Overall Study|Other|0|||
146035188|NCT04201093|526641398|FG001|Overall Study|Other|1|||
146035189|NCT04201093|526641399|FG002|Overall Study|Other|2|||
146035190|NCT00007020|526641400|FG000|Overall Study|Death|16|||
146035191|NCT00007020|526641400|FG000|Overall Study|Lost to Follow-up|13|||
146035192|NCT00007020|526641400|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
146035193|NCT00007020|526641400|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
146035194|NCT00007020|526641400|FG000|Overall Study|Pt cared for by outside physician|4|||
146035195|NCT00007020|526641400|FG000|Overall Study|No evidence of treatment|6|||
146035196|NCT00881504|526641401|FG000|Overall Study|Withdrawal by Subject|1|||
146035197|NCT01276223|526641402|FG000|Overall Study|Adverse Event|7|||
146035198|NCT01276223|526641403|FG001|Overall Study|Adverse Event|4|||
146035199|NCT01276223|526641404|FG002|Overall Study|Adverse Event|1|||
146035200|NCT01276223|526641402|FG000|Overall Study|Lost to Follow-up|0|||
146035201|NCT01276223|526641403|FG001|Overall Study|Lost to Follow-up|0|||
146035202|NCT01276223|526641404|FG002|Overall Study|Lost to Follow-up|1|||
146035203|NCT01276223|526641402|FG000|Overall Study|Other|0|||
146035204|NCT01276223|526641403|FG001|Overall Study|Other|0|||
146035205|NCT01276223|526641404|FG002|Overall Study|Other|1|||
146035206|NCT01276223|526641402|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
146035207|NCT01276223|526641403|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
146035208|NCT01276223|526641404|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
146035209|NCT01276223|526641402|FG000|Overall Study|Protocol Violation|1|||
146035210|NCT01276223|526641403|FG001|Overall Study|Protocol Violation|0|||
146035211|NCT01276223|526641404|FG002|Overall Study|Protocol Violation|0|||
146035212|NCT05011058|526641405|FG000|Overall Study|Sponsor Decision|2|||
146035213|NCT05011058|526641406|FG001|Overall Study|Sponsor Decision|0|||
146035214|NCT05011058|526641407|FG002|Overall Study|Sponsor Decision|14|||
146035215|NCT05011058|526641408|FG003|Overall Study|Sponsor Decision|0|||
146035216|NCT05011058|526641409|FG004|Overall Study|Sponsor Decision|0|||
146035217|NCT05011058|526641410|FG005|Overall Study|Sponsor Decision|1|||
146035218|NCT05011058|526641411|FG006|Overall Study|Sponsor Decision|0|||
146035219|NCT05011058|526641412|FG007|Overall Study|Sponsor Decision|5|||
146035220|NCT02596230|526641413|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
146035221|NCT02596230|526641414|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
146035222|NCT02596230|526641415|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
146035223|NCT02596230|526641416|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
146035224|NCT02596230|526641417|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
146035225|NCT02596230|526641413|FG000|Objective 2, One Year|Lost to Follow-up|0|||
146035226|NCT02596230|526641414|FG001|Objective 2, One Year|Lost to Follow-up|41|||
146035227|NCT02596230|526641415|FG002|Objective 2, One Year|Lost to Follow-up|41|||
146035228|NCT02596230|526641416|FG003|Objective 2, One Year|Lost to Follow-up|32|||
146035229|NCT02596230|526641417|FG004|Objective 2, One Year|Lost to Follow-up|46|||
146035230|NCT02596230|526641413|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
146035231|NCT02596230|526641414|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
146035232|NCT02596230|526641415|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
146035233|NCT02596230|526641416|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
146035234|NCT02596230|526641417|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
146035235|NCT02596230|526641413|FG000|Objective 2, One Year|Adverse drug reaction|0|||
146035236|NCT02596230|526641414|FG001|Objective 2, One Year|Adverse drug reaction|1|||
146035237|NCT02596230|526641415|FG002|Objective 2, One Year|Adverse drug reaction|0|||
146035238|NCT02596230|526641416|FG003|Objective 2, One Year|Adverse drug reaction|0|||
146035239|NCT02596230|526641417|FG004|Objective 2, One Year|Adverse drug reaction|0|||
146035240|NCT02596230|526641413|FG000|Objective 2, One Year|Death|0|||
146035241|NCT02596230|526641414|FG001|Objective 2, One Year|Death|12|||
146035242|NCT02596230|526641415|FG002|Objective 2, One Year|Death|41|||
146035243|NCT02596230|526641416|FG003|Objective 2, One Year|Death|21|||
146035244|NCT02596230|526641417|FG004|Objective 2, One Year|Death|30|||
146035245|NCT02596230|526641413|FG000|Objective 2, One Year|Other|0|||
146035246|NCT02596230|526641414|FG001|Objective 2, One Year|Other|3|||
146035247|NCT02596230|526641415|FG002|Objective 2, One Year|Other|2|||
146035248|NCT02596230|526641416|FG003|Objective 2, One Year|Other|0|||
146035249|NCT02596230|526641417|FG004|Objective 2, One Year|Other|0|||
146035250|NCT01571232|526641418|FG000|Overall Study|Lost to Follow-up|0|||
146035251|NCT01571232|526641419|FG001|Overall Study|Lost to Follow-up|1|||
146035252|NCT01571232|526641418|FG000|Overall Study|Withdrawal by Subject|1|||
146035253|NCT01571232|526641419|FG001|Overall Study|Withdrawal by Subject|0|||
146035254|NCT02478164|526641420|FG000|Overall Study|Lack of Efficacy|13|||
146035255|NCT02478164|526641420|FG000|Overall Study|Adverse Event|1|||
146035256|NCT02478164|526641420|FG000|Overall Study|Withdrawal by Subject|1|||
146035257|NCT00802893|526641421|FG000|Overall Study|study terminated|3|||
146035258|NCT00320424|526641422|FG000|Overall Study|Adverse Event|3|||
146035259|NCT00320424|526641422|FG000|Overall Study|Other|3|||
146035260|NCT00231413|526641427|FG000|Overall Study|Non-serious AE|0|||
146035261|NCT00231413|526641428|FG001|Overall Study|Non-serious AE|0|||
146035262|NCT00231413|526641429|FG002|Overall Study|Non-serious AE|1|||
146035263|NCT00231413|526641430|FG003|Overall Study|Non-serious AE|0|||
146035264|NCT00231413|526641431|FG004|Overall Study|Non-serious AE|0|||
146035265|NCT00231413|526641432|FG005|Overall Study|Non-serious AE|0|||
146300496|NCT04448756|527615268|FG002|Overall Study|Withdrawal by Subject|1|||
146300497|NCT04448756|527615266|FG000|Overall Study|Death|2|||
146300498|NCT04448756|527615267|FG001|Overall Study|Death|1|||
146300499|NCT04448756|527615268|FG002|Overall Study|Death|0|||
146300500|NCT02733185|527615269|FG000|Overall Study|Withdrawal by Subject|12|||
146300501|NCT02733185|527615270|FG001|Overall Study|Withdrawal by Subject|10|||
146300502|NCT02733185|527615271|FG002|Overall Study|Withdrawal by Subject|17|||
146300503|NCT02733185|527615272|FG003|Overall Study|Withdrawal by Subject|21|||
146300504|NCT02733185|527615269|FG000|Overall Study|Death|46|||
146300505|NCT02733185|527615270|FG001|Overall Study|Death|34|||
146300506|NCT02733185|527615271|FG002|Overall Study|Death|35|||
146300507|NCT02733185|527615272|FG003|Overall Study|Death|43|||
146300508|NCT02733185|527615269|FG000|Overall Study|Lost to Follow-up|17|||
146300509|NCT02733185|527615270|FG001|Overall Study|Lost to Follow-up|18|||
146300510|NCT02733185|527615271|FG002|Overall Study|Lost to Follow-up|16|||
146300511|NCT02733185|527615272|FG003|Overall Study|Lost to Follow-up|11|||
146300512|NCT04252287|527615273|FG000|Overall Study|Death|5|||
146300513|NCT04252287|527615274|FG001|Overall Study|Death|3|||
146300514|NCT04252287|527615273|FG000|Overall Study|Lost to Follow-up|4|||
146300515|NCT04252287|527615274|FG001|Overall Study|Lost to Follow-up|6|||
146300516|NCT04252287|527615273|FG000|Overall Study|Withdrawal by Subject|19|||
146300517|NCT04252287|527615274|FG001|Overall Study|Withdrawal by Subject|16|||
146300518|NCT04252287|527615273|FG000|Overall Study|Protocol Violation|3|||
146300519|NCT04252287|527615274|FG001|Overall Study|Protocol Violation|4|||
146300520|NCT04572854|527615276|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
146300521|NCT04572854|527615277|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
146035266|NCT00231413|526641433|FG006|Overall Study|Non-serious AE|1|||
146035267|NCT00231413|526641427|FG000|Overall Study|Withdrawal by Subject|3|||
146035268|NCT00231413|526641428|FG001|Overall Study|Withdrawal by Subject|1|||
146035269|NCT00231413|526641429|FG002|Overall Study|Withdrawal by Subject|4|||
146035270|NCT00231413|526641430|FG003|Overall Study|Withdrawal by Subject|2|||
146035271|NCT00231413|526641431|FG004|Overall Study|Withdrawal by Subject|2|||
146035272|NCT00231413|526641432|FG005|Overall Study|Withdrawal by Subject|0|||
146035273|NCT00231413|526641433|FG006|Overall Study|Withdrawal by Subject|3|||
146035274|NCT00231413|526641427|FG000|Overall Study|Migrated/moved from study area|0|||
146035275|NCT00231413|526641428|FG001|Overall Study|Migrated/moved from study area|0|||
146035276|NCT00231413|526641429|FG002|Overall Study|Migrated/moved from study area|1|||
146035277|NCT00231413|526641430|FG003|Overall Study|Migrated/moved from study area|0|||
146035278|NCT00231413|526641431|FG004|Overall Study|Migrated/moved from study area|0|||
146035279|NCT00231413|526641432|FG005|Overall Study|Migrated/moved from study area|1|||
146035280|NCT00231413|526641433|FG006|Overall Study|Migrated/moved from study area|0|||
146035281|NCT00231413|526641427|FG000|Overall Study|Lost to Follow-up|4|||
146035282|NCT00231413|526641428|FG001|Overall Study|Lost to Follow-up|4|||
146035283|NCT00231413|526641429|FG002|Overall Study|Lost to Follow-up|1|||
146035284|NCT00231413|526641430|FG003|Overall Study|Lost to Follow-up|1|||
146035285|NCT00231413|526641431|FG004|Overall Study|Lost to Follow-up|1|||
146035286|NCT00231413|526641432|FG005|Overall Study|Lost to Follow-up|4|||
146035287|NCT00231413|526641433|FG006|Overall Study|Lost to Follow-up|0|||
146035288|NCT00231413|526641427|FG000|Overall Study|Pregnancy|1|||
146035289|NCT00231413|526641428|FG001|Overall Study|Pregnancy|0|||
146035290|NCT00231413|526641429|FG002|Overall Study|Pregnancy|0|||
146035291|NCT00231413|526641430|FG003|Overall Study|Pregnancy|0|||
146035292|NCT00231413|526641431|FG004|Overall Study|Pregnancy|0|||
146035293|NCT00231413|526641432|FG005|Overall Study|Pregnancy|0|||
146300522|NCT04572854|527615278|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
146300523|NCT04572854|527615279|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
146300524|NCT04572854|527615276|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146300525|NCT04572854|527615277|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146300526|NCT04572854|527615278|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
146300527|NCT04572854|527615279|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
146300528|NCT04223791|527615280|FG000|Overall Study|Lost to Follow-up|0|||
146300529|NCT04223791|527615281|FG001|Overall Study|Lost to Follow-up|4|||
146300530|NCT04223791|527615280|FG000|Overall Study|Physician Decision|5|||
146300531|NCT04223791|527615281|FG001|Overall Study|Physician Decision|1|||
146300532|NCT04223791|527615280|FG000|Overall Study|Protocol Violation|1|||
146300533|NCT04223791|527615281|FG001|Overall Study|Protocol Violation|1|||
146300534|NCT04223791|527615280|FG000|Overall Study|Withdrawal by Subject|10|||
146300535|NCT04223791|527615281|FG001|Overall Study|Withdrawal by Subject|12|||
146035294|NCT00231413|526641433|FG006|Overall Study|Pregnancy|0|||
146035295|NCT03316950|526641434|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
146035296|NCT03316950|526641435|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
146035297|NCT03316950|526641436|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
146035298|NCT03316950|526641437|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
146098426|NCT02808650|526881154|FG004|Overall Study|Physician Decision|0|||
146300536|NCT04223791|527615280|FG000|Overall Study|Pregnancy|1|||
146300537|NCT04223791|527615281|FG001|Overall Study|Pregnancy|1|||
146300538|NCT04223791|527615280|FG000|Overall Study|Ongoing in Study|305|||
146035299|NCT03316950|526641434|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
146035300|NCT03316950|526641435|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
146035301|NCT03316950|526641436|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
146035302|NCT03316950|526641437|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
146035303|NCT03316950|526641434|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
146035304|NCT03316950|526641435|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
146035305|NCT03316950|526641436|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
146035306|NCT03316950|526641437|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
146035307|NCT02565810|526641438|FG000|Overall Study|Withdrawal by Subject|1|||
146035308|NCT05086510|526641441|FG000|Overall Study|Lost to Follow-up|0|||
146035309|NCT05086510|526641442|FG001|Overall Study|Lost to Follow-up|2|||
146035310|NCT05086510|526641441|FG000|Overall Study|Death|0|||
146035311|NCT05086510|526641442|FG001|Overall Study|Death|2|||
146035312|NCT00413374|526641443|FG000|Overall Study|Ineligible due to screening criteria.|3|||
146035313|NCT00413374|526641444|FG001|Overall Study|Ineligible due to screening criteria.|0|||
146035314|NCT00413374|526641443|FG000|Overall Study|Adverse Event|1|||
146035315|NCT00413374|526641444|FG001|Overall Study|Adverse Event|0|||
146035316|NCT00413374|526641443|FG000|Overall Study|Lost to Follow-up|1|||
146035317|NCT00413374|526641444|FG001|Overall Study|Lost to Follow-up|0|||
146035318|NCT00413374|526641443|FG000|Overall Study|Surgery|1|||
146035319|NCT00413374|526641444|FG001|Overall Study|Surgery|0|||
146035320|NCT00552760|526641445|FG000|Overall Study|Adverse Event|3|||
146035321|NCT00552760|526641446|FG001|Overall Study|Adverse Event|5|||
146035322|NCT00552760|526641445|FG000|Overall Study|Relapsed- Depressed Event|10|||
146035323|NCT00552760|526641446|FG001|Overall Study|Relapsed- Depressed Event|16|||
146035324|NCT00552760|526641445|FG000|Overall Study|Relapse- Manic Event|3|||
146035325|NCT00552760|526641446|FG001|Overall Study|Relapse- Manic Event|3|||
146035326|NCT00552760|526641445|FG000|Overall Study|Relapsed- Mixed Event|3|||
146035327|NCT00552760|526641446|FG001|Overall Study|Relapsed- Mixed Event|5|||
146035328|NCT00552760|526641445|FG000|Overall Study|Protocol Violation|0|||
146035329|NCT00552760|526641446|FG001|Overall Study|Protocol Violation|1|||
146035330|NCT00552760|526641445|FG000|Overall Study|Lost to Follow-up|1|||
146035331|NCT00552760|526641446|FG001|Overall Study|Lost to Follow-up|1|||
146035332|NCT00552760|526641445|FG000|Overall Study|Non-compliance|1|||
146035333|NCT00552760|526641446|FG001|Overall Study|Non-compliance|1|||
146035334|NCT00552760|526641445|FG000|Overall Study|Medical Condition|1|||
146035335|NCT00552760|526641446|FG001|Overall Study|Medical Condition|1|||
146035336|NCT00552760|526641445|FG000|Overall Study|Withdrawal by Subject|3|||
146035337|NCT00552760|526641446|FG001|Overall Study|Withdrawal by Subject|0|||
146035338|NCT00552760|526641445|FG000|Overall Study|Medication Change|1|||
146035339|NCT00552760|526641446|FG001|Overall Study|Medication Change|0|||
146035340|NCT03022981|526641447|FG000|Overall Study|Adverse Event|0|||
146035341|NCT03022981|526641448|FG001|Overall Study|Adverse Event|1|||
146035342|NCT03022981|526641449|FG002|Overall Study|Adverse Event|0|||
146035343|NCT03022981|526641447|FG000|Overall Study|Investigator's Discretion|0|||
146035344|NCT03022981|526641448|FG001|Overall Study|Investigator's Discretion|1|||
146035345|NCT03022981|526641449|FG002|Overall Study|Investigator's Discretion|2|||
146035346|NCT03022981|526641447|FG000|Overall Study|Lost to Follow-up|6|||
146035347|NCT03022981|526641448|FG001|Overall Study|Lost to Follow-up|2|||
146035348|NCT03022981|526641449|FG002|Overall Study|Lost to Follow-up|1|||
146035349|NCT03022981|526641447|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146035350|NCT03022981|526641448|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146035351|NCT03022981|526641449|FG002|Overall Study|Non-Compliance With Study Drug|2|||
146035352|NCT03022981|526641447|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
146035353|NCT03022981|526641448|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
146035354|NCT03022981|526641449|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
146035355|NCT03615066|526641451|FG000|Main Study|Withdrew Consent|0|||
146035356|NCT03615066|526641452|FG001|Main Study|Withdrew Consent|1|||
146035357|NCT03615066|526641453|FG002|Main Study|Withdrew Consent|1|||
146035358|NCT03615066|526641451|FG000|Main Study|Lost to Follow-up|0|||
146035359|NCT03615066|526641452|FG001|Main Study|Lost to Follow-up|0|||
146035360|NCT03615066|526641453|FG002|Main Study|Lost to Follow-up|1|||
146098427|NCT02808650|526881150|FG000|Overall Study|Withdrawal by Subject|0|||
146254362|NCT00733226|527444557|FG000|Overall Study|moved to another place|2|||
146254363|NCT00733226|527444558|FG001|Overall Study|moved to another place|0|||
146035361|NCT03615066|526641451|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
146035362|NCT03615066|526641452|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
146035363|NCT03615066|526641453|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
146035364|NCT03615066|526641451|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
146035365|NCT03615066|526641452|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
146035366|NCT03615066|526641453|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
146035367|NCT03615066|526641451|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
146035368|NCT03615066|526641452|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
146035369|NCT03615066|526641453|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
146035370|NCT00924404|526641454|FG000|Overall Study|Lost to Follow-up|6|||
146035371|NCT00924404|526641455|FG001|Overall Study|Lost to Follow-up|4|||
146035372|NCT02437084|526641456|FG000|Overall Study|Withdrawal by Subject|2|||
146035373|NCT02437084|526641456|FG000|Overall Study|Physician Decision|1|||
146035374|NCT01571453|526641457|FG000|Overall Study|Adverse Event|14|||
146035375|NCT01571453|526641458|FG001|Overall Study|Adverse Event|32|||
146035376|NCT01571453|526641457|FG000|Overall Study|Lack of Efficacy|8|||
146035377|NCT01571453|526641458|FG001|Overall Study|Lack of Efficacy|3|||
146035378|NCT01571453|526641457|FG000|Overall Study|Non-compliance|2|||
146035379|NCT01571453|526641458|FG001|Overall Study|Non-compliance|4|||
146035380|NCT01571453|526641457|FG000|Overall Study|Protocol Violation|1|||
146035381|NCT01571453|526641458|FG001|Overall Study|Protocol Violation|5|||
146035382|NCT01571453|526641457|FG000|Overall Study|Withdrawal of consent|5|||
146035383|NCT01571453|526641458|FG001|Overall Study|Withdrawal of consent|13|||
146035384|NCT01571453|526641457|FG000|Overall Study|Lost to Follow-up|4|||
146035385|NCT01571453|526641458|FG001|Overall Study|Lost to Follow-up|2|||
146035386|NCT01571453|526641457|FG000|Overall Study|Administrative or other reason(s)|4|||
146035387|NCT01571453|526641458|FG001|Overall Study|Administrative or other reason(s)|3|||
146035388|NCT00129961|526641460|FG000|Overall Study|Adverse Event|1|||
146035389|NCT00129961|526641461|FG001|Overall Study|Adverse Event|0|||
146035390|NCT00129961|526641460|FG000|Overall Study|Death|1|||
146035391|NCT00129961|526641461|FG001|Overall Study|Death|1|||
146035392|NCT00129961|526641460|FG000|Overall Study|Withdrawal by Sponsor|14|||
146035393|NCT00129961|526641461|FG001|Overall Study|Withdrawal by Sponsor|20|||
146035394|NCT00129961|526641460|FG000|Overall Study|Physician Decision|1|||
146035395|NCT00129961|526641461|FG001|Overall Study|Physician Decision|0|||
146035396|NCT00129961|526641460|FG000|Overall Study|Withdrawal by Subject|2|||
146035397|NCT00129961|526641461|FG001|Overall Study|Withdrawal by Subject|1|||
146035398|NCT00129961|526641460|FG000|Overall Study|Missing Record|0|||
146035399|NCT00129961|526641461|FG001|Overall Study|Missing Record|1|||
146035400|NCT01985360|526641462|FG000|Overall Study|Withdrawal by Subject|4|||
146035401|NCT01985360|526641463|FG001|Overall Study|Withdrawal by Subject|0|||
146035402|NCT01985360|526641462|FG000|Overall Study|Lost to Follow-up|5|||
146035403|NCT01985360|526641463|FG001|Overall Study|Lost to Follow-up|3|||
146035404|NCT00084487|526641464|FG000|Overall Study|Death|1|||
146035405|NCT03691779|526641469|FG000|Part B (24 Weeks)|Adverse Event|0|||
146035406|NCT03691779|526641470|FG001|Part B (24 Weeks)|Adverse Event|1|||
146035407|NCT03691779|526641469|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
146035408|NCT03691779|526641470|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
146035409|NCT01561963|526641473|FG000|Overall Study|Adverse Event|1|||
146035410|NCT04598269|526641474|FG000|Overall Study|Adverse Event|0|||
146035411|NCT04598269|526641475|FG001|Overall Study|Adverse Event|3|||
146035412|NCT04598269|526641474|FG000|Overall Study|Withdrawal by Subject|1|||
146035413|NCT04598269|526641475|FG001|Overall Study|Withdrawal by Subject|4|||
146035414|NCT04598269|526641474|FG000|Overall Study|Lost to Follow-up|1|||
146035415|NCT04598269|526641475|FG001|Overall Study|Lost to Follow-up|0|||
146035416|NCT04598269|526641474|FG000|Overall Study|Not Treated|2|||
146035417|NCT04598269|526641475|FG001|Overall Study|Not Treated|0|||
146035418|NCT02966015|526641477|FG000|Inclusion Visit|did not answer questionnaire|8|||
146035419|NCT02966015|526641478|FG001|Inclusion Visit|did not answer questionnaire|3|||
146035420|NCT02039856|526641481|FG000|Overall Study|Death|5|||
146035421|NCT02039856|526641482|FG001|Overall Study|Death|3|||
146035422|NCT02039856|526641481|FG000|Overall Study|Partial survey completion|61|||
146035423|NCT02039856|526641482|FG001|Overall Study|Partial survey completion|26|||
146035424|NCT02039856|526641481|FG000|Overall Study|Lost to Follow-up|388|||
146035425|NCT02039856|526641482|FG001|Overall Study|Lost to Follow-up|206|||
146035426|NCT02039856|526641481|FG000|Overall Study|Withdrawal by Subject|1573|||
146035427|NCT02039856|526641482|FG001|Overall Study|Withdrawal by Subject|618|||
146035428|NCT02540291|526641483|FG000|Overall Study|Death|7|||
146035429|NCT02540291|526641484|FG001|Overall Study|Death|7|||
146035430|NCT02540291|526641485|FG002|Overall Study|Death|5|||
146035431|NCT02540291|526641486|FG003|Overall Study|Death|7|||
146035432|NCT02540291|526641483|FG000|Overall Study|Lost to Follow-up|0|||
146035433|NCT02540291|526641484|FG001|Overall Study|Lost to Follow-up|0|||
146035434|NCT02540291|526641485|FG002|Overall Study|Lost to Follow-up|1|||
146035435|NCT02540291|526641486|FG003|Overall Study|Lost to Follow-up|0|||
146035436|NCT02540291|526641483|FG000|Overall Study|Withdrawal Of Consent|0|||
146035437|NCT02540291|526641484|FG001|Overall Study|Withdrawal Of Consent|1|||
146035438|NCT02540291|526641485|FG002|Overall Study|Withdrawal Of Consent|0|||
146035439|NCT02540291|526641486|FG003|Overall Study|Withdrawal Of Consent|0|||
146035440|NCT02540291|526641483|FG000|Overall Study|Study Terminated By Sponsor|1|||
146035441|NCT02540291|526641484|FG001|Overall Study|Study Terminated By Sponsor|0|||
146035442|NCT02540291|526641485|FG002|Overall Study|Study Terminated By Sponsor|0|||
146035443|NCT02540291|526641486|FG003|Overall Study|Study Terminated By Sponsor|0|||
146035444|NCT02540291|526641483|FG000|Overall Study|Other|0|||
146035445|NCT02540291|526641484|FG001|Overall Study|Other|0|||
146035446|NCT02540291|526641485|FG002|Overall Study|Other|1|||
146035447|NCT02540291|526641486|FG003|Overall Study|Other|0|||
146035448|NCT02666105|526641496|FG000|Overall Study|Death|1|||
146035449|NCT02806960|526643630|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146035450|NCT02806960|526643631|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146035451|NCT02806960|526643632|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146035452|NCT02806960|526643633|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
146035453|NCT01769196|526643634|FG000|Overall Study|Adverse Event|24|||
146035454|NCT01769196|526643635|FG001|Overall Study|Adverse Event|20|||
146035455|NCT01769196|526643634|FG000|Overall Study|Death|21|||
146035456|NCT01769196|526643635|FG001|Overall Study|Death|26|||
146035457|NCT01769196|526643634|FG000|Overall Study|Investigator Discretion|7|||
146035458|NCT01769196|526643635|FG001|Overall Study|Investigator Discretion|3|||
146035459|NCT01769196|526643634|FG000|Overall Study|Lack of Efficacy|3|||
146035460|NCT01769196|526643635|FG001|Overall Study|Lack of Efficacy|2|||
146035461|NCT01769196|526643634|FG000|Overall Study|Progressive disease|11|||
146035462|NCT01769196|526643635|FG001|Overall Study|Progressive disease|6|||
146035463|NCT01769196|526643634|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
146035464|NCT01769196|526643635|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
146035465|NCT01769196|526643634|FG000|Overall Study|Protocol Violation|0|||
146035466|NCT01769196|526643635|FG001|Overall Study|Protocol Violation|3|||
146035467|NCT01769196|526643634|FG000|Overall Study|Study terminated by sponsor|160|||
146035468|NCT01769196|526643635|FG001|Overall Study|Study terminated by sponsor|161|||
146035469|NCT01769196|526643634|FG000|Overall Study|Participant never dosed with study drug|1|||
146035470|NCT01769196|526643635|FG001|Overall Study|Participant never dosed with study drug|0|||
146035471|NCT01769196|526643634|FG000|Overall Study|Withdrew consent|36|||
146035472|NCT01769196|526643635|FG001|Overall Study|Withdrew consent|40|||
146035473|NCT00126776|526643636|FG000|Overall Study|follow up complete on all patients|0|||
146035474|NCT00126776|526643637|FG001|Overall Study|follow up complete on all patients|0|||
146035475|NCT01272869|526643649|FG000|Period 2 (14 Days)|Adverse Event|1|||
146035476|NCT01272869|526643650|FG001|Period 2 (14 Days)|Adverse Event|0|||
146035477|NCT00771615|526643651|FG000|Overall Study|Withdrawal by Subject|0|||
146035478|NCT00771615|526643652|FG001|Overall Study|Withdrawal by Subject|1|||
146035479|NCT00771615|526643653|FG002|Overall Study|Withdrawal by Subject|0|||
146035480|NCT00771615|526643654|FG003|Overall Study|Withdrawal by Subject|0|||
146035481|NCT00771615|526643655|FG004|Overall Study|Withdrawal by Subject|0|||
146035482|NCT00771615|526643656|FG005|Overall Study|Withdrawal by Subject|0|||
146035483|NCT00771615|526643657|FG006|Overall Study|Withdrawal by Subject|0|||
146035484|NCT00771615|526643658|FG007|Overall Study|Withdrawal by Subject|1|||
146035485|NCT00771615|526643659|FG008|Overall Study|Withdrawal by Subject|0|||
146035486|NCT00771615|526643651|FG000|Overall Study|Lost to Follow-up|1|||
146035487|NCT00771615|526643652|FG001|Overall Study|Lost to Follow-up|1|||
146035488|NCT00771615|526643653|FG002|Overall Study|Lost to Follow-up|1|||
146035489|NCT00771615|526643654|FG003|Overall Study|Lost to Follow-up|1|||
146035490|NCT00771615|526643655|FG004|Overall Study|Lost to Follow-up|0|||
146035491|NCT00771615|526643656|FG005|Overall Study|Lost to Follow-up|1|||
146035492|NCT00771615|526643657|FG006|Overall Study|Lost to Follow-up|1|||
146035493|NCT00771615|526643658|FG007|Overall Study|Lost to Follow-up|0|||
146035494|NCT00771615|526643659|FG008|Overall Study|Lost to Follow-up|0|||
146035495|NCT02455076|526643660|FG000|Inpatient|Withdrawal by Subject|1|||
146035496|NCT02455076|526643661|FG001|Inpatient|Withdrawal by Subject|0|||
146035497|NCT02455076|526643662|FG002|Inpatient|Withdrawal by Subject|0|||
146035498|NCT02455076|526643663|FG003|Inpatient|Withdrawal by Subject|0|||
146035499|NCT02455076|526643664|FG004|Inpatient|Withdrawal by Subject|0|||
146035500|NCT02455076|526643660|FG000|Inpatient|Discharged <24 h after admission|0|||
146035501|NCT02455076|526643661|FG001|Inpatient|Discharged <24 h after admission|1|||
146035502|NCT02455076|526643662|FG002|Inpatient|Discharged <24 h after admission|0|||
146035503|NCT02455076|526643663|FG003|Inpatient|Discharged <24 h after admission|0|||
146035504|NCT02455076|526643664|FG004|Inpatient|Discharged <24 h after admission|0|||
146035505|NCT02455076|526643660|FG000|Inpatient|Adverse Event|3|||
146035506|NCT02455076|526643661|FG001|Inpatient|Adverse Event|0|||
146035507|NCT02455076|526643662|FG002|Inpatient|Adverse Event|0|||
146035508|NCT02455076|526643663|FG003|Inpatient|Adverse Event|0|||
146035509|NCT02455076|526643664|FG004|Inpatient|Adverse Event|0|||
146035510|NCT02455076|526643660|FG000|Outpatient|Adverse Event|0|||
146035511|NCT02455076|526643661|FG001|Outpatient|Adverse Event|0|||
146035512|NCT02455076|526643662|FG002|Outpatient|Adverse Event|0|||
146035513|NCT02455076|526643663|FG003|Outpatient|Adverse Event|5|||
146035514|NCT02455076|526643664|FG004|Outpatient|Adverse Event|0|||
146035515|NCT02455076|526643660|FG000|Outpatient|Lost to Follow-up|0|||
146035516|NCT02455076|526643661|FG001|Outpatient|Lost to Follow-up|0|||
146035517|NCT02455076|526643662|FG002|Outpatient|Lost to Follow-up|0|||
146035518|NCT02455076|526643663|FG003|Outpatient|Lost to Follow-up|1|||
146035519|NCT02455076|526643664|FG004|Outpatient|Lost to Follow-up|12|||
146035520|NCT00859937|526643665|FG000|Overall Study|Protocol Violation|1|||
146035521|NCT00859937|526643666|FG001|Overall Study|Protocol Violation|0|||
146035522|NCT03908476|526643667|FG000|Overall Study|Death|3|||
146035523|NCT03908476|526643668|FG001|Overall Study|Death|0|||
146035524|NCT03908476|526643667|FG000|Overall Study|Lost to Follow-up|3|||
146035525|NCT03908476|526643668|FG001|Overall Study|Lost to Follow-up|1|||
146035526|NCT03908476|526643667|FG000|Overall Study|Withdrawal by Subject|7|||
146035527|NCT03908476|526643668|FG001|Overall Study|Withdrawal by Subject|1|||
146035528|NCT03908476|526643667|FG000|Overall Study|Physician Decision|2|||
146035529|NCT03908476|526643668|FG001|Overall Study|Physician Decision|0|||
146035530|NCT03908476|526643667|FG000|Overall Study|System Explanted and not Replaced|4|||
146035531|NCT03908476|526643668|FG001|Overall Study|System Explanted and not Replaced|0|||
146035532|NCT03908476|526643667|FG000|Overall Study|Intrathecal Pump|1|||
146035533|NCT03908476|526643668|FG001|Overall Study|Intrathecal Pump|0|||
146035534|NCT03908476|526643667|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
146035535|NCT03908476|526643668|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
146035536|NCT05194267|526643669|FG000|Overall Study|Withdrawal by Subject|2|||
146035537|NCT02868229|526643670|FG000|Overall Study|Adverse Event|1|||
146035538|NCT02868229|526643671|FG001|Overall Study|Adverse Event|0|||
146035539|NCT02868229|526643672|FG002|Overall Study|Adverse Event|0|||
146035540|NCT02868229|526643673|FG003|Overall Study|Adverse Event|1|||
146035541|NCT02868229|526643670|FG000|Overall Study|Death|0|||
146035542|NCT02868229|526643671|FG001|Overall Study|Death|0|||
146035543|NCT02868229|526643672|FG002|Overall Study|Death|1|||
146035544|NCT02868229|526643673|FG003|Overall Study|Death|1|||
146035545|NCT02868229|526643670|FG000|Overall Study|Missed dose|0|||
146035546|NCT02868229|526643671|FG001|Overall Study|Missed dose|0|||
146035547|NCT02868229|526643672|FG002|Overall Study|Missed dose|0|||
146035548|NCT02868229|526643673|FG003|Overall Study|Missed dose|3|||
146035549|NCT02540668|526643676|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
146035550|NCT02540668|526643677|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
146035551|NCT03270891|526643678|FG000|Overall Study|Lost to Follow-up|3|||
146035552|NCT03270891|526643679|FG001|Overall Study|Lost to Follow-up|6|||
146035553|NCT03270891|526643680|FG002|Overall Study|Lost to Follow-up|0|||
146035554|NCT03270891|526643678|FG000|Overall Study|Withdrawal by Subject|1|||
146035555|NCT03270891|526643679|FG001|Overall Study|Withdrawal by Subject|0|||
146035556|NCT03270891|526643680|FG002|Overall Study|Withdrawal by Subject|0|||
146035557|NCT03270891|526643678|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
146035558|NCT03270891|526643679|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
146035559|NCT03270891|526643680|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
146035560|NCT05779007|526643681|FG000|Overall Study|not meeting eligibility criteria|3517|||
146035561|NCT05779007|526643682|FG001|Overall Study|not meeting eligibility criteria|2009|||
146035562|NCT05147662|526643685|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146035563|NCT05147662|526643685|FG000|Overall Study|Assigned to treatment but never treated|1|||
146035564|NCT04676867|526643688|FG000|Overall Study|Screen failure|0|||
146035565|NCT04676867|526643689|FG001|Overall Study|Screen failure|0|||
146035566|NCT04676867|526643690|FG002|Overall Study|Screen failure|6|||
146035567|NCT04676867|526643691|FG003|Overall Study|Screen failure|2|||
146035568|NCT04676867|526643688|FG000|Overall Study|Death|0|||
146035569|NCT04676867|526643689|FG001|Overall Study|Death|0|||
146035570|NCT04676867|526643690|FG002|Overall Study|Death|1|||
146035571|NCT04676867|526643691|FG003|Overall Study|Death|0|||
146035572|NCT04676867|526643688|FG000|Overall Study|Withdrawal by Subject|2|||
146035573|NCT04676867|526643689|FG001|Overall Study|Withdrawal by Subject|2|||
146035574|NCT04676867|526643690|FG002|Overall Study|Withdrawal by Subject|4|||
146035575|NCT04676867|526643691|FG003|Overall Study|Withdrawal by Subject|4|||
146035576|NCT04676867|526643688|FG000|Overall Study|Lost to Follow-up|1|||
146035577|NCT04676867|526643689|FG001|Overall Study|Lost to Follow-up|0|||
146035578|NCT04676867|526643690|FG002|Overall Study|Lost to Follow-up|0|||
146035579|NCT04676867|526643691|FG003|Overall Study|Lost to Follow-up|0|||
146035580|NCT00549770|526643692|FG000|Overall Study|Protocol deviation|1|||
146035581|NCT00549770|526643693|FG001|Overall Study|Protocol deviation|1|||
146035582|NCT00549770|526643694|FG002|Overall Study|Protocol deviation|1|||
146035583|NCT00549770|526643695|FG003|Overall Study|Protocol deviation|2|||
146035584|NCT00549770|526643696|FG004|Overall Study|Protocol deviation|2|||
146035585|NCT00549770|526643697|FG005|Overall Study|Protocol deviation|2|||
146035586|NCT00549770|526643698|FG006|Overall Study|Protocol deviation|1|||
146035587|NCT00549770|526643699|FG007|Overall Study|Protocol deviation|2|||
146035588|NCT00549770|526643692|FG000|Overall Study|Administrative problems|0|||
146035589|NCT00549770|526643693|FG001|Overall Study|Administrative problems|1|||
146035590|NCT00549770|526643694|FG002|Overall Study|Administrative problems|0|||
146035591|NCT00549770|526643695|FG003|Overall Study|Administrative problems|0|||
146035592|NCT00549770|526643696|FG004|Overall Study|Administrative problems|0|||
146035593|NCT00549770|526643697|FG005|Overall Study|Administrative problems|0|||
146035594|NCT00549770|526643698|FG006|Overall Study|Administrative problems|0|||
146300539|NCT04223791|527615281|FG001|Overall Study|Ongoing in Study|302|||
146035595|NCT00549770|526643699|FG007|Overall Study|Administrative problems|1|||
146300540|NCT00395863|527617039|FG000|Overall Study|Patients did not complete both exams|2|||
146035596|NCT00549770|526643692|FG000|Overall Study|Lost to Follow-up|0|||
146035597|NCT00549770|526643693|FG001|Overall Study|Lost to Follow-up|0|||
146035598|NCT00549770|526643694|FG002|Overall Study|Lost to Follow-up|2|||
146035599|NCT00549770|526643695|FG003|Overall Study|Lost to Follow-up|2|||
146035600|NCT00549770|526643696|FG004|Overall Study|Lost to Follow-up|3|||
146035601|NCT00549770|526643697|FG005|Overall Study|Lost to Follow-up|2|||
146035602|NCT00549770|526643698|FG006|Overall Study|Lost to Follow-up|0|||
146035603|NCT00549770|526643699|FG007|Overall Study|Lost to Follow-up|0|||
146035604|NCT00549770|526643692|FG000|Overall Study|Withdrawal by Subject|4|||
146035605|NCT00549770|526643693|FG001|Overall Study|Withdrawal by Subject|6|||
146035606|NCT00549770|526643694|FG002|Overall Study|Withdrawal by Subject|4|||
146035607|NCT00549770|526643695|FG003|Overall Study|Withdrawal by Subject|5|||
146035608|NCT00549770|526643696|FG004|Overall Study|Withdrawal by Subject|6|||
146035609|NCT00549770|526643697|FG005|Overall Study|Withdrawal by Subject|6|||
146035610|NCT00549770|526643698|FG006|Overall Study|Withdrawal by Subject|4|||
146035611|NCT00549770|526643699|FG007|Overall Study|Withdrawal by Subject|9|||
146035612|NCT00549770|526643692|FG000|Overall Study|Lack of Efficacy|1|||
146035613|NCT00549770|526643693|FG001|Overall Study|Lack of Efficacy|0|||
146035614|NCT00549770|526643694|FG002|Overall Study|Lack of Efficacy|2|||
146035615|NCT00549770|526643695|FG003|Overall Study|Lack of Efficacy|3|||
146035616|NCT00549770|526643696|FG004|Overall Study|Lack of Efficacy|5|||
146035617|NCT00549770|526643697|FG005|Overall Study|Lack of Efficacy|1|||
146035618|NCT00549770|526643698|FG006|Overall Study|Lack of Efficacy|3|||
146035619|NCT00549770|526643699|FG007|Overall Study|Lack of Efficacy|8|||
146035620|NCT00549770|526643692|FG000|Overall Study|Abnormal test procedure results|0|||
146035621|NCT00549770|526643693|FG001|Overall Study|Abnormal test procedure results|0|||
146035622|NCT00549770|526643694|FG002|Overall Study|Abnormal test procedure results|0|||
146035623|NCT00549770|526643695|FG003|Overall Study|Abnormal test procedure results|2|||
146035624|NCT00549770|526643696|FG004|Overall Study|Abnormal test procedure results|0|||
146035625|NCT00549770|526643697|FG005|Overall Study|Abnormal test procedure results|1|||
146035626|NCT00549770|526643698|FG006|Overall Study|Abnormal test procedure results|1|||
146035627|NCT00549770|526643699|FG007|Overall Study|Abnormal test procedure results|1|||
146035628|NCT00549770|526643692|FG000|Overall Study|Abnormal laboratory values|0|||
146035629|NCT00549770|526643693|FG001|Overall Study|Abnormal laboratory values|0|||
146035630|NCT00549770|526643694|FG002|Overall Study|Abnormal laboratory values|0|||
146035631|NCT00549770|526643695|FG003|Overall Study|Abnormal laboratory values|0|||
146035632|NCT00549770|526643696|FG004|Overall Study|Abnormal laboratory values|0|||
146035633|NCT00549770|526643697|FG005|Overall Study|Abnormal laboratory values|1|||
146035634|NCT00549770|526643698|FG006|Overall Study|Abnormal laboratory values|0|||
146035635|NCT00549770|526643699|FG007|Overall Study|Abnormal laboratory values|0|||
146035636|NCT00549770|526643692|FG000|Overall Study|Adverse Event|1|||
146035637|NCT00549770|526643693|FG001|Overall Study|Adverse Event|3|||
146035638|NCT00549770|526643694|FG002|Overall Study|Adverse Event|1|||
146035639|NCT00549770|526643695|FG003|Overall Study|Adverse Event|2|||
146035640|NCT00549770|526643696|FG004|Overall Study|Adverse Event|1|||
146035641|NCT00549770|526643697|FG005|Overall Study|Adverse Event|0|||
146254364|NCT02561078|527444559|FG000|Overall Study|Adverse Event|5|||
146254365|NCT02561078|527444560|FG001|Overall Study|Adverse Event|2|||
146254366|NCT02561078|527444559|FG000|Overall Study|Death|2|||
146254367|NCT02561078|527444560|FG001|Overall Study|Death|1|||
146254368|NCT02561078|527444559|FG000|Overall Study|Lost to Follow-up|2|||
146254369|NCT02561078|527444560|FG001|Overall Study|Lost to Follow-up|6|||
146254370|NCT02561078|527444559|FG000|Overall Study|Non-Compliance with Study Drug|6|||
146254371|NCT02561078|527444560|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146254372|NCT02561078|527444559|FG000|Overall Study|Physician Decision|2|||
146254373|NCT02561078|527444560|FG001|Overall Study|Physician Decision|3|||
146254374|NCT02561078|527444559|FG000|Overall Study|Withdrawal by Subject|13|||
146254375|NCT02561078|527444560|FG001|Overall Study|Withdrawal by Subject|10|||
146254376|NCT04736602|527444563|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
146254377|NCT04736602|527444563|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
146254378|NCT00404547|527444564|FG000|Overall Study|Adverse Event|39|||
146254379|NCT00404547|527444565|FG001|Overall Study|Adverse Event|6|||
146254380|NCT00404547|527444564|FG000|Overall Study|Withdrawal by Subject|19|||
146254381|NCT00404547|527444565|FG001|Overall Study|Withdrawal by Subject|2|||
146254382|NCT00404547|527444564|FG000|Overall Study|Protocol Violation|0|||
146254383|NCT00404547|527444565|FG001|Overall Study|Protocol Violation|1|||
146254384|NCT00404547|527444564|FG000|Overall Study|Lost to Follow-up|20|||
146254385|NCT00404547|527444565|FG001|Overall Study|Lost to Follow-up|9|||
146254386|NCT00404547|527444564|FG000|Overall Study|Lack of compliance|5|||
146254387|NCT00404547|527444565|FG001|Overall Study|Lack of compliance|1|||
146254388|NCT00404547|527444564|FG000|Overall Study|Other|4|||
146254389|NCT00404547|527444565|FG001|Overall Study|Other|0|||
146254390|NCT00404547|527444564|FG000|Overall Study|Reason not stated|3|||
146254391|NCT00404547|527444565|FG001|Overall Study|Reason not stated|6|||
146254392|NCT02350127|527444571|FG000|4-Month Assessment|Withdrawal by Subject|10|||
146254393|NCT02350127|527444572|FG001|4-Month Assessment|Withdrawal by Subject|9|||
146254394|NCT02350127|527444571|FG000|4-Month Assessment|Death|1|||
146254395|NCT02350127|527444572|FG001|4-Month Assessment|Death|0|||
146254396|NCT02350127|527444571|FG000|8-Month Assessment|Death|1|||
146254397|NCT02350127|527444572|FG001|8-Month Assessment|Death|1|||
146254398|NCT02350127|527444571|FG000|8-Month Assessment|Withdrawal by Subject|5|||
146254399|NCT02350127|527444572|FG001|8-Month Assessment|Withdrawal by Subject|8|||
146254400|NCT03575572|527444575|FG000|Overall Study|Withdrawal by Subject|2|||
146035642|NCT00549770|526643698|FG006|Overall Study|Adverse Event|5|||
146254401|NCT03575572|527444575|FG000|Overall Study|Physician Decision|2|||
146254402|NCT03048058|527444578|FG000|Overall Study|Lost to Follow-up|4|||
146035643|NCT00549770|526643699|FG007|Overall Study|Adverse Event|4|||
146035644|NCT02294734|526643700|FG000|Overall Study|Adverse Event|5|||
146035645|NCT02294734|526643701|FG001|Overall Study|Adverse Event|5|||
146035646|NCT02294734|526643700|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
146035647|NCT02294734|526643701|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
146035648|NCT02294734|526643700|FG000|Overall Study|Lost to Follow-up|2|||
146035649|NCT02294734|526643701|FG001|Overall Study|Lost to Follow-up|0|||
146035650|NCT02294734|526643700|FG000|Overall Study|Physician Decision|2|||
146035651|NCT02294734|526643701|FG001|Overall Study|Physician Decision|1|||
146035652|NCT02294734|526643700|FG000|Overall Study|Withdrawal by Subject|4|||
146035653|NCT02294734|526643701|FG001|Overall Study|Withdrawal by Subject|2|||
146035654|NCT00548717|526643702|FG000|Overall Study|Death|5|||
146035655|NCT00548717|526643703|FG001|Overall Study|Death|2|||
146035656|NCT00548717|526643702|FG000|Overall Study|Relapse|3|||
146035657|NCT00548717|526643703|FG001|Overall Study|Relapse|0|||
146035658|NCT00548717|526643702|FG000|Overall Study|Alternative treatment for GVHD|1|||
146035659|NCT00548717|526643703|FG001|Overall Study|Alternative treatment for GVHD|0|||
146035660|NCT00908037|526643709|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035661|NCT00908037|526643710|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035662|NCT00908037|526643711|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035663|NCT00908037|526643712|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035664|NCT00908037|526643713|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
146035665|NCT00908037|526643714|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035666|NCT00908037|526643715|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
146035667|NCT00908037|526643716|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035668|NCT00908037|526643717|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
146035669|NCT00908037|526643718|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035670|NCT00908037|526643719|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035671|NCT00908037|526643720|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
146035672|NCT00908037|526643709|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035673|NCT00908037|526643710|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035674|NCT00908037|526643711|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035675|NCT00908037|526643712|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035676|NCT00908037|526643713|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
146035677|NCT00908037|526643714|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035678|NCT00908037|526643715|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035679|NCT00908037|526643716|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035680|NCT00908037|526643717|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
146035681|NCT00908037|526643718|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035682|NCT00908037|526643719|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035683|NCT00908037|526643720|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
146035684|NCT00908037|526643709|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035685|NCT00908037|526643710|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035686|NCT00908037|526643711|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035687|NCT00908037|526643712|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
146035688|NCT00908037|526643713|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035689|NCT00908037|526643714|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035690|NCT00908037|526643715|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
146035691|NCT00908037|526643716|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035692|NCT00908037|526643717|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035693|NCT00908037|526643718|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035694|NCT00908037|526643719|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035695|NCT00908037|526643720|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
146035696|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035697|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035698|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035699|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035700|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035701|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035702|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035703|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035704|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035705|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035706|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
146035707|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
146035708|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146254403|NCT03048058|527444579|FG001|Overall Study|Lost to Follow-up|0|||
146300541|NCT00395863|527617040|FG001|Overall Study|Patients did not complete both exams|3|||
146300542|NCT02592551|527617041|FG000|Overall Study|Not evaluable|1|||
146300543|NCT02592551|527617042|FG001|Overall Study|Not evaluable|3|||
146300544|NCT02592551|527617043|FG002|Overall Study|Not evaluable|0|||
146300545|NCT01876251|527617044|FG000|Overall Study|Clinical progression|1|||
146300546|NCT01876251|527617045|FG001|Overall Study|Clinical progression|0|||
146300547|NCT01876251|527617046|FG002|Overall Study|Clinical progression|0|||
146300548|NCT01876251|527617044|FG000|Overall Study|Death|2|||
146300549|NCT01876251|527617045|FG001|Overall Study|Death|0|||
146300550|NCT01876251|527617046|FG002|Overall Study|Death|1|||
146300551|NCT01876251|527617044|FG000|Overall Study|Participant started new treatment|1|||
146300552|NCT01876251|527617045|FG001|Overall Study|Participant started new treatment|0|||
146035709|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035710|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035711|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035712|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035713|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035714|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035715|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035716|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035717|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
146035718|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
146035719|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
146035720|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035721|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035722|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035723|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035724|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035725|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035726|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035727|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035728|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035729|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
146035730|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035731|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
146035732|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035733|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035734|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035735|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035736|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035737|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035738|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035739|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035740|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035741|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035742|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
146035743|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
146035744|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035745|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035746|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035747|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035748|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035749|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035750|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035751|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035752|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035753|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
146300553|NCT01876251|527617046|FG002|Overall Study|Participant started new treatment|1|||
146300554|NCT01876251|527617044|FG000|Overall Study|Participant refused further follow-up|0|||
146300555|NCT01876251|527617045|FG001|Overall Study|Participant refused further follow-up|0|||
146300556|NCT01876251|527617046|FG002|Overall Study|Participant refused further follow-up|1|||
146300557|NCT01876251|527617044|FG000|Overall Study|Study terminated|1|||
146035754|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035755|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
146035756|NCT00908037|526643709|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146098428|NCT02808650|526881151|FG001|Overall Study|Withdrawal by Subject|0|||
146098429|NCT02808650|526881152|FG002|Overall Study|Withdrawal by Subject|0|||
146098430|NCT02808650|526881153|FG003|Overall Study|Withdrawal by Subject|1|||
146098431|NCT02808650|526881154|FG004|Overall Study|Withdrawal by Subject|1|||
146098432|NCT02853344|526881155|FG000|Overall Study|Lost to Follow-up|1|||
146098433|NCT02853344|526881156|FG001|Overall Study|Lost to Follow-up|1|||
146098434|NCT02853344|526881155|FG000|Overall Study|Withdrawal by Subject|2|||
146098435|NCT02853344|526881156|FG001|Overall Study|Withdrawal by Subject|4|||
146098436|NCT02853344|526881155|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
146098437|NCT02853344|526881156|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
146098438|NCT02853344|526881155|FG000|Overall Study|Death|70|||
146098439|NCT02853344|526881156|FG001|Overall Study|Death|112|||
146098440|NCT02913612|526881157|FG000|Overall Study|Lost to Follow-up|6|||
146098441|NCT02913612|526881158|FG001|Overall Study|Lost to Follow-up|5|||
146098442|NCT02913612|526881159|FG002|Overall Study|Lost to Follow-up|2|||
146098443|NCT02913612|526881160|FG003|Overall Study|Lost to Follow-up|0|||
146098444|NCT02913612|526881157|FG000|Overall Study|Physician Decision|1|||
146098445|NCT02913612|526881158|FG001|Overall Study|Physician Decision|4|||
146098446|NCT02913612|526881159|FG002|Overall Study|Physician Decision|1|||
146098447|NCT02913612|526881160|FG003|Overall Study|Physician Decision|0|||
146098448|NCT02913612|526881157|FG000|Overall Study|Withdrawal by Subject|2|||
146098449|NCT02913612|526881158|FG001|Overall Study|Withdrawal by Subject|4|||
146098450|NCT02913612|526881159|FG002|Overall Study|Withdrawal by Subject|0|||
146098451|NCT02913612|526881160|FG003|Overall Study|Withdrawal by Subject|0|||
146098452|NCT02913612|526881157|FG000|Overall Study|Hemangioma resolved|1|||
146098453|NCT02913612|526881158|FG001|Overall Study|Hemangioma resolved|0|||
146098454|NCT02913612|526881159|FG002|Overall Study|Hemangioma resolved|0|||
146098455|NCT02913612|526881160|FG003|Overall Study|Hemangioma resolved|0|||
146098456|NCT02913612|526881157|FG000|Overall Study|Local IRB decision|1|||
146098457|NCT02913612|526881158|FG001|Overall Study|Local IRB decision|0|||
146098458|NCT02913612|526881159|FG002|Overall Study|Local IRB decision|0|||
146098459|NCT02913612|526881160|FG003|Overall Study|Local IRB decision|0|||
146098460|NCT02913612|526881157|FG000|Overall Study|Study drug non-compliance|1|||
146098461|NCT02913612|526881158|FG001|Overall Study|Study drug non-compliance|1|||
146098462|NCT02913612|526881159|FG002|Overall Study|Study drug non-compliance|0|||
146098463|NCT02913612|526881160|FG003|Overall Study|Study drug non-compliance|0|||
146098464|NCT02913612|526881157|FG000|Overall Study|Insurance issues|0|||
146098465|NCT02913612|526881158|FG001|Overall Study|Insurance issues|1|||
146098466|NCT02913612|526881159|FG002|Overall Study|Insurance issues|0|||
146098467|NCT02913612|526881160|FG003|Overall Study|Insurance issues|0|||
146098468|NCT02913612|526881157|FG000|Overall Study|Needed to treat second hemangioma|0|||
146098469|NCT02913612|526881158|FG001|Overall Study|Needed to treat second hemangioma|1|||
146098470|NCT02913612|526881159|FG002|Overall Study|Needed to treat second hemangioma|0|||
146098471|NCT02913612|526881160|FG003|Overall Study|Needed to treat second hemangioma|0|||
146098472|NCT02913612|526881157|FG000|Overall Study|Study completion criteria not met|0|||
146254404|NCT03048058|527444578|FG000|Overall Study|Withdrawal by Subject|0|||
146254405|NCT03048058|527444579|FG001|Overall Study|Withdrawal by Subject|4|||
146254406|NCT01257698|527444580|FG000|Overall Study|Protocol Violation|4|||
146254407|NCT01257698|527444581|FG001|Overall Study|Protocol Violation|0|||
146254408|NCT00050167|527444583|FG000|Overall Study|not eligible not invasive|1|||
146254409|NCT00050167|527444584|FG001|Overall Study|not eligible not invasive|1|||
146254410|NCT02038803|527444588|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
146254411|NCT02038803|527444588|FG000|Overall Study|Lost to Follow-up|1|||
146254412|NCT04754594|527444589|FG000|Blinded Period|Withdrawal by Subject|4|||
146254413|NCT04754594|527444590|FG001|Blinded Period|Withdrawal by Subject|9|||
146254414|NCT04754594|527444591|FG002|Blinded Period|Withdrawal by Subject|0|||
146254415|NCT04754594|527444592|FG003|Blinded Period|Withdrawal by Subject|0|||
146254416|NCT04754594|527444589|FG000|Blinded Period|Protocol Violation|2|||
146254417|NCT04754594|527444590|FG001|Blinded Period|Protocol Violation|2|||
146254418|NCT04754594|527444591|FG002|Blinded Period|Protocol Violation|0|||
146254419|NCT04754594|527444592|FG003|Blinded Period|Protocol Violation|0|||
146098473|NCT02913612|526881158|FG001|Overall Study|Study completion criteria not met|1|||
146098474|NCT02913612|526881159|FG002|Overall Study|Study completion criteria not met|0|||
146098475|NCT02913612|526881160|FG003|Overall Study|Study completion criteria not met|0|||
146098476|NCT02913612|526881157|FG000|Overall Study|Ineligible|0|||
146098477|NCT02913612|526881158|FG001|Overall Study|Ineligible|1|||
146254420|NCT04754594|527444589|FG000|Blinded Period|Lost to Follow-up|1|||
146098478|NCT02913612|526881159|FG002|Overall Study|Ineligible|0|||
146098479|NCT02913612|526881160|FG003|Overall Study|Ineligible|0|||
146098480|NCT01898208|526881166|FG000|Overall Study|Positive blood culture|17|||
146098481|NCT01898208|526881167|FG001|Overall Study|Positive blood culture|23|||
146098482|NCT01898208|526881168|FG002|Overall Study|Positive blood culture|15|||
146098483|NCT01898208|526881166|FG000|Overall Study|Death/comfort care within 24 hours|10|||
146098484|NCT01898208|526881167|FG001|Overall Study|Death/comfort care within 24 hours|9|||
146098485|NCT01898208|526881168|FG002|Overall Study|Death/comfort care within 24 hours|8|||
146098486|NCT01898208|526881166|FG000|Overall Study|Negative Gram Stain|6|||
146098487|NCT01898208|526881167|FG001|Overall Study|Negative Gram Stain|9|||
146098488|NCT01898208|526881168|FG002|Overall Study|Negative Gram Stain|6|||
146098489|NCT01898208|526881166|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
146098490|NCT01898208|526881167|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
146098491|NCT01898208|526881168|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
146098492|NCT01898208|526881166|FG000|Overall Study|System/Technical Error|1|||
146098493|NCT01898208|526881167|FG001|Overall Study|System/Technical Error|2|||
146098494|NCT01898208|526881168|FG002|Overall Study|System/Technical Error|3|||
146098495|NCT01898208|526881166|FG000|Overall Study|Lost to Follow-up|3|||
146098496|NCT01898208|526881167|FG001|Overall Study|Lost to Follow-up|1|||
146098497|NCT01898208|526881168|FG002|Overall Study|Lost to Follow-up|1|||
146098498|NCT02711345|526881170|FG000|Overall Study|Adverse Event|0|||
146098499|NCT02711345|526881171|FG001|Overall Study|Adverse Event|0|||
146098500|NCT02711345|526881172|FG002|Overall Study|Adverse Event|0|||
146098501|NCT02711345|526881173|FG003|Overall Study|Adverse Event|1|||
146098502|NCT02711345|526881174|FG004|Overall Study|Adverse Event|1|||
146098503|NCT02711345|526881175|FG005|Overall Study|Adverse Event|2|||
146098504|NCT02711345|526881176|FG006|Overall Study|Adverse Event|1|||
146098505|NCT02711345|526881177|FG007|Overall Study|Adverse Event|0|||
146098506|NCT02711345|526881178|FG008|Overall Study|Adverse Event|0|||
146098507|NCT02711345|526881179|FG009|Overall Study|Adverse Event|2|||
146098508|NCT02711345|526881170|FG000|Overall Study|Physician Decision|0|||
146098509|NCT02711345|526881171|FG001|Overall Study|Physician Decision|0|||
146098510|NCT02711345|526881172|FG002|Overall Study|Physician Decision|1|||
146098511|NCT02711345|526881173|FG003|Overall Study|Physician Decision|0|||
146098512|NCT02711345|526881174|FG004|Overall Study|Physician Decision|0|||
146098513|NCT02711345|526881175|FG005|Overall Study|Physician Decision|0|||
146098514|NCT02711345|526881176|FG006|Overall Study|Physician Decision|0|||
146035757|NCT00908037|526643710|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035758|NCT00908037|526643711|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035759|NCT00908037|526643712|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035760|NCT00908037|526643713|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035761|NCT00908037|526643714|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035762|NCT00908037|526643715|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035763|NCT00908037|526643716|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035764|NCT00908037|526643717|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035765|NCT00908037|526643718|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035766|NCT00908037|526643719|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
146035767|NCT00908037|526643720|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
146035768|NCT00869401|526643721|FG000|Overall Study|Withdrawal by Subject|0|||
146035769|NCT00869401|526643722|FG001|Overall Study|Withdrawal by Subject|0|||
146035770|NCT00869401|526643723|FG002|Overall Study|Withdrawal by Subject|0|||
146035771|NCT00869401|526643724|FG003|Overall Study|Withdrawal by Subject|5|||
146035772|NCT00869401|526643725|FG004|Overall Study|Withdrawal by Subject|3|||
146035773|NCT03129360|526643726|FG000|Overall Study|Did not meet entry criteria|0|||
146035774|NCT03129360|526643727|FG001|Overall Study|Did not meet entry criteria|2|||
146035775|NCT03129360|526643728|FG002|Overall Study|Did not meet entry criteria|1|||
146035776|NCT03129360|526643726|FG000|Overall Study|Excluded due to motion in scanner|1|||
146035777|NCT03129360|526643727|FG001|Overall Study|Excluded due to motion in scanner|0|||
146035778|NCT03129360|526643728|FG002|Overall Study|Excluded due to motion in scanner|0|||
146035779|NCT00025155|526643729|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
146035780|NCT00025155|526643729|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
146035781|NCT00109577|526643732|FG000|Overall Study|Withdrawal by Subject|3|||
146035782|NCT00109577|526643733|FG001|Overall Study|Withdrawal by Subject|3|||
146035783|NCT00587847|526643734|FG000|Overall Study|Lack of Efficacy|5|||
146035784|NCT00587847|526643734|FG000|Overall Study|Adverse Event|2|||
146035785|NCT02613169|526643735|FG000|Overall Study|Withdrawal by Subject|4|||
146035786|NCT02613169|526643736|FG001|Overall Study|Withdrawal by Subject|1|||
146035787|NCT02613169|526643735|FG000|Overall Study|Lost to Follow-up|0|||
146035788|NCT02613169|526643736|FG001|Overall Study|Lost to Follow-up|5|||
146035789|NCT02613169|526643735|FG000|Overall Study|HIV|0|||
146035790|NCT02613169|526643736|FG001|Overall Study|HIV|2|||
146098515|NCT02711345|526881177|FG007|Overall Study|Physician Decision|0|||
146098516|NCT02711345|526881178|FG008|Overall Study|Physician Decision|1|||
146098517|NCT02711345|526881179|FG009|Overall Study|Physician Decision|0|||
146098518|NCT02711345|526881170|FG000|Overall Study|Progressive disease|1|||
146098519|NCT02711345|526881171|FG001|Overall Study|Progressive disease|3|||
146098520|NCT02711345|526881172|FG002|Overall Study|Progressive disease|5|||
146098521|NCT02711345|526881173|FG003|Overall Study|Progressive disease|3|||
146098522|NCT02711345|526881174|FG004|Overall Study|Progressive disease|7|||
146098523|NCT02711345|526881175|FG005|Overall Study|Progressive disease|2|||
146035791|NCT02613169|526643735|FG000|Overall Study|No TB infection endpoint|14|||
146035792|NCT02613169|526643736|FG001|Overall Study|No TB infection endpoint|9|||
146035793|NCT00343382|526643737|FG000|Overall Study|Adverse Event|2|||
146035794|NCT00343382|526643738|FG001|Overall Study|Adverse Event|10|||
146035795|NCT00343382|526643739|FG002|Overall Study|Adverse Event|7|||
146035796|NCT00343382|526643737|FG000|Overall Study|Withdrawal by Subject|1|||
146035797|NCT00343382|526643738|FG001|Overall Study|Withdrawal by Subject|2|||
146035798|NCT00343382|526643739|FG002|Overall Study|Withdrawal by Subject|6|||
146035799|NCT00343382|526643737|FG000|Overall Study|Other Reason Not Specified|1|||
146035800|NCT00343382|526643738|FG001|Overall Study|Other Reason Not Specified|2|||
146035801|NCT00343382|526643739|FG002|Overall Study|Other Reason Not Specified|4|||
146035802|NCT04032080|526643740|FG000|Overall Study|Death|6|||
146035803|NCT03729245|526643744|FG000|Overall Study|Lost to Follow-up|5|||
146035804|NCT03729245|526643745|FG001|Overall Study|Lost to Follow-up|6|||
146035805|NCT03729245|526643744|FG000|Overall Study|Withdrawal by Subject|16|||
146035806|NCT03729245|526643745|FG001|Overall Study|Withdrawal by Subject|19|||
146035807|NCT03729245|526643744|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
146035808|NCT03729245|526643745|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
146035809|NCT00884832|526643747|FG000|Overall Study|Withdrawal by Subject|0|||
146035810|NCT00884832|526643748|FG001|Overall Study|Withdrawal by Subject|1|||
146035811|NCT03322423|526643749|FG000|Period 1|Subject no longer eligible|0|||
146035812|NCT03322423|526643750|FG001|Period 1|Subject no longer eligible|1|||
146035813|NCT03322423|526643749|FG000|Period 1|Withdrawal by Subject|0|||
146035814|NCT03322423|526643750|FG001|Period 1|Withdrawal by Subject|1|||
146035815|NCT03322423|526643749|FG000|Period 1|Incorrect Lens Dispensed|1|||
146035816|NCT03322423|526643750|FG001|Period 1|Incorrect Lens Dispensed|0|||
146035817|NCT03322423|526643749|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
146035818|NCT03322423|526643750|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
146035819|NCT03322423|526643749|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
146035820|NCT03322423|526643750|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
146035821|NCT03322423|526643749|FG000|Period 2|Protocol Violation|1|||
146035822|NCT03322423|526643750|FG001|Period 2|Protocol Violation|0|||
146035823|NCT03322423|526643749|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
146035824|NCT03322423|526643750|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
146035825|NCT03040986|526643752|FG000|Overall Study|Hospice|1|||
146035826|NCT03040986|526643753|FG001|Overall Study|Hospice|0|||
146035827|NCT03040986|526643752|FG000|Overall Study|Adverse Event|2|||
146035828|NCT03040986|526643753|FG001|Overall Study|Adverse Event|1|||
146035829|NCT03040986|526643752|FG000|Overall Study|Disease progression on study|3|||
146035830|NCT03040986|526643753|FG001|Overall Study|Disease progression on study|1|||
146035831|NCT02177838|526643754|FG000|Overall Study|Withdrawal by Subject|1|||
146035832|NCT02177838|526643754|FG000|Overall Study|Physician Decision|1|||
146035833|NCT02177838|526643754|FG000|Overall Study|Death|1|||
146035834|NCT03517566|526643755|FG000|Overall Study|Adverse Event|5|||
146035835|NCT03517566|526643756|FG001|Overall Study|Adverse Event|2|||
146035836|NCT03517566|526643757|FG002|Overall Study|Adverse Event|2|||
146035837|NCT03517566|526643758|FG003|Overall Study|Adverse Event|8|||
146035838|NCT03517566|526643759|FG004|Overall Study|Adverse Event|7|||
146035839|NCT03517566|526643755|FG000|Overall Study|Lack of Efficacy|3|||
146035840|NCT03517566|526643756|FG001|Overall Study|Lack of Efficacy|2|||
146035841|NCT03517566|526643757|FG002|Overall Study|Lack of Efficacy|1|||
146035842|NCT03517566|526643758|FG003|Overall Study|Lack of Efficacy|1|||
146035843|NCT03517566|526643759|FG004|Overall Study|Lack of Efficacy|4|||
146035844|NCT03517566|526643755|FG000|Overall Study|Lost to Follow-up|3|||
146035845|NCT03517566|526643756|FG001|Overall Study|Lost to Follow-up|1|||
146035846|NCT03517566|526643757|FG002|Overall Study|Lost to Follow-up|1|||
146035847|NCT03517566|526643758|FG003|Overall Study|Lost to Follow-up|1|||
146035848|NCT03517566|526643759|FG004|Overall Study|Lost to Follow-up|0|||
146035849|NCT03517566|526643755|FG000|Overall Study|Physician Decision|1|||
146035850|NCT03517566|526643756|FG001|Overall Study|Physician Decision|1|||
146035851|NCT03517566|526643757|FG002|Overall Study|Physician Decision|0|||
146035852|NCT03517566|526643758|FG003|Overall Study|Physician Decision|1|||
146035853|NCT03517566|526643759|FG004|Overall Study|Physician Decision|0|||
146035854|NCT03517566|526643755|FG000|Overall Study|Pregnancy|0|||
146035855|NCT03517566|526643756|FG001|Overall Study|Pregnancy|1|||
146035856|NCT03517566|526643757|FG002|Overall Study|Pregnancy|0|||
146035857|NCT03517566|526643758|FG003|Overall Study|Pregnancy|0|||
146035858|NCT03517566|526643759|FG004|Overall Study|Pregnancy|0|||
146035859|NCT03517566|526643755|FG000|Overall Study|Protocol Deviation|0|||
146035860|NCT03517566|526643756|FG001|Overall Study|Protocol Deviation|1|||
146035861|NCT03517566|526643757|FG002|Overall Study|Protocol Deviation|0|||
146035862|NCT03517566|526643758|FG003|Overall Study|Protocol Deviation|1|||
146035863|NCT03517566|526643759|FG004|Overall Study|Protocol Deviation|1|||
146035864|NCT03517566|526643755|FG000|Overall Study|Study terminated by Sponsor|11|||
146035865|NCT03517566|526643756|FG001|Overall Study|Study terminated by Sponsor|5|||
146035866|NCT03517566|526643757|FG002|Overall Study|Study terminated by Sponsor|6|||
146035867|NCT03517566|526643758|FG003|Overall Study|Study terminated by Sponsor|14|||
146035868|NCT03517566|526643759|FG004|Overall Study|Study terminated by Sponsor|12|||
146254421|NCT04754594|527444590|FG001|Blinded Period|Lost to Follow-up|1|||
146035869|NCT03517566|526643755|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
146035870|NCT03517566|526643756|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
146098524|NCT02711345|526881176|FG006|Overall Study|Progressive disease|8|||
146098525|NCT02711345|526881177|FG007|Overall Study|Progressive disease|4|||
146098526|NCT02711345|526881178|FG008|Overall Study|Progressive disease|5|||
146098527|NCT02711345|526881179|FG009|Overall Study|Progressive disease|6|||
146098528|NCT02711345|526881170|FG000|Overall Study|Subject/guardian decision|0|||
146098529|NCT02711345|526881171|FG001|Overall Study|Subject/guardian decision|0|||
146098530|NCT02711345|526881172|FG002|Overall Study|Subject/guardian decision|0|||
146098531|NCT02711345|526881173|FG003|Overall Study|Subject/guardian decision|0|||
146098532|NCT02711345|526881174|FG004|Overall Study|Subject/guardian decision|0|||
146098533|NCT02711345|526881175|FG005|Overall Study|Subject/guardian decision|2|||
146098534|NCT02711345|526881176|FG006|Overall Study|Subject/guardian decision|3|||
146098535|NCT02711345|526881177|FG007|Overall Study|Subject/guardian decision|1|||
146098536|NCT02711345|526881178|FG008|Overall Study|Subject/guardian decision|0|||
146098537|NCT02711345|526881179|FG009|Overall Study|Subject/guardian decision|4|||
146098538|NCT02711345|526881170|FG000|Overall Study|Death|1|||
146098539|NCT02711345|526881171|FG001|Overall Study|Death|0|||
146098540|NCT02711345|526881172|FG002|Overall Study|Death|0|||
146098541|NCT02711345|526881173|FG003|Overall Study|Death|0|||
146098542|NCT02711345|526881174|FG004|Overall Study|Death|0|||
146098543|NCT02711345|526881175|FG005|Overall Study|Death|0|||
146098544|NCT02711345|526881176|FG006|Overall Study|Death|0|||
146098545|NCT02711345|526881177|FG007|Overall Study|Death|1|||
146098546|NCT02711345|526881178|FG008|Overall Study|Death|0|||
146098547|NCT02711345|526881179|FG009|Overall Study|Death|0|||
146098548|NCT00961649|526881180|FG000|Overall Study|Adverse Event|4|||
146098549|NCT00961649|526881181|FG001|Overall Study|Adverse Event|0|||
146098550|NCT00961649|526881182|FG002|Overall Study|Adverse Event|0|||
146098551|NCT00961649|526881183|FG003|Overall Study|Adverse Event|2|||
146098552|NCT00961649|526881180|FG000|Overall Study|Inadequate control of IOP|0|||
146098553|NCT00961649|526881181|FG001|Overall Study|Inadequate control of IOP|0|||
146098554|NCT00961649|526881182|FG002|Overall Study|Inadequate control of IOP|0|||
146098555|NCT00961649|526881183|FG003|Overall Study|Inadequate control of IOP|1|||
146098556|NCT00961649|526881180|FG000|Overall Study|Patient has travel plans during holidays|0|||
146098557|NCT00961649|526881181|FG001|Overall Study|Patient has travel plans during holidays|0|||
146098558|NCT00961649|526881182|FG002|Overall Study|Patient has travel plans during holidays|1|||
146098559|NCT00961649|526881183|FG003|Overall Study|Patient has travel plans during holidays|0|||
146098560|NCT00961649|526881180|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
146098561|NCT00961649|526881181|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
146098562|NCT00961649|526881182|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
146098563|NCT00961649|526881183|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
146098564|NCT00961649|526881180|FG000|Overall Study|Study terminated by sponsor|4|||
146098565|NCT00961649|526881181|FG001|Overall Study|Study terminated by sponsor|4|||
146098566|NCT00961649|526881182|FG002|Overall Study|Study terminated by sponsor|4|||
146098567|NCT00961649|526881183|FG003|Overall Study|Study terminated by sponsor|1|||
146098568|NCT01011738|526881184|FG000|Overall Study|Death|12|||
146098569|NCT01011738|526881185|FG001|Overall Study|Death|3|||
146098570|NCT01011738|526881186|FG002|Overall Study|Death|0|||
146098571|NCT01011738|526881184|FG000|Overall Study|Unknown reasons|312|||
146098572|NCT01011738|526881185|FG001|Overall Study|Unknown reasons|291|||
146098573|NCT01011738|526881186|FG002|Overall Study|Unknown reasons|17|||
146098574|NCT00072176|526881189|FG000|Overall Study|Withdrawal by Subject|1|||
146098575|NCT00072176|526881190|FG001|Overall Study|Withdrawal by Subject|0|||
146098576|NCT00072176|526881189|FG000|Overall Study|Protocol Violation|0|||
146098577|NCT00072176|526881190|FG001|Overall Study|Protocol Violation|1|||
146098578|NCT02919696|526881191|FG000|Overall Study|Adverse Event|1|||
146098579|NCT02919696|526881192|FG001|Overall Study|Adverse Event|2|||
146098580|NCT02919696|526881191|FG000|Overall Study|Withdrawal by Subject|2|||
146098581|NCT02919696|526881192|FG001|Overall Study|Withdrawal by Subject|1|||
146098582|NCT02919696|526881191|FG000|Overall Study|Sponsor Decision|1|||
146098583|NCT02919696|526881192|FG001|Overall Study|Sponsor Decision|1|||
146098584|NCT02919696|526881191|FG000|Overall Study|Never Treated|0|||
146254422|NCT04754594|527444591|FG002|Blinded Period|Lost to Follow-up|0|||
146254423|NCT04754594|527444592|FG003|Blinded Period|Lost to Follow-up|0|||
146098585|NCT02919696|526881192|FG001|Overall Study|Never Treated|1|||
146254424|NCT04754594|527444589|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
146254425|NCT04754594|527444590|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
146098586|NCT03181893|526881193|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098587|NCT03181893|526881194|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
146098588|NCT03181893|526881195|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098589|NCT03181893|526881196|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098590|NCT03181893|526881197|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098591|NCT03181893|526881198|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098592|NCT03181893|526881199|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098593|NCT03181893|526881200|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098594|NCT03181893|526881201|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146300558|NCT01876251|527617045|FG001|Overall Study|Study terminated|0|||
146035871|NCT03517566|526643757|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
146035872|NCT03517566|526643758|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
146035873|NCT03517566|526643759|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
146035874|NCT01183468|526643760|FG000|Overall Study|Lost to Follow-up|2|||
146035875|NCT01183468|526643761|FG001|Overall Study|Lost to Follow-up|1|||
146035876|NCT01183468|526643762|FG002|Overall Study|Lost to Follow-up|0|||
146035877|NCT01183468|526643763|FG003|Overall Study|Lost to Follow-up|0|||
146035878|NCT01183468|526643760|FG000|Overall Study|Physician Decision|1|||
146035879|NCT01183468|526643761|FG001|Overall Study|Physician Decision|0|||
146035880|NCT01183468|526643762|FG002|Overall Study|Physician Decision|0|||
146035881|NCT01183468|526643763|FG003|Overall Study|Physician Decision|0|||
146035882|NCT01183468|526643760|FG000|Overall Study|Withdrawal by Subject|0|||
146035883|NCT01183468|526643761|FG001|Overall Study|Withdrawal by Subject|1|||
146035884|NCT01183468|526643762|FG002|Overall Study|Withdrawal by Subject|0|||
146035885|NCT01183468|526643763|FG003|Overall Study|Withdrawal by Subject|0|||
146035886|NCT00454649|526643769|FG000|Overall Study|Lack of Efficacy|2|||
146035887|NCT00454649|526643770|FG001|Overall Study|Lack of Efficacy|2|||
146035888|NCT00454649|526643771|FG002|Overall Study|Lack of Efficacy|10|||
146035889|NCT00454649|526643772|FG003|Overall Study|Lack of Efficacy|3|||
146035890|NCT00454649|526643773|FG004|Overall Study|Lack of Efficacy|0|||
146035891|NCT00454649|526643774|FG005|Overall Study|Lack of Efficacy|4|||
146035892|NCT00454649|526643775|FG006|Overall Study|Lack of Efficacy|5|||
146035893|NCT00454649|526643776|FG007|Overall Study|Lack of Efficacy|13|||
146035894|NCT00454649|526643777|FG008|Overall Study|Lack of Efficacy|10|||
146035895|NCT00454649|526643778|FG009|Overall Study|Lack of Efficacy|2|||
146035896|NCT00454649|526643769|FG000|Overall Study|Adverse Event|0|||
146035897|NCT00454649|526643770|FG001|Overall Study|Adverse Event|1|||
146035898|NCT00454649|526643771|FG002|Overall Study|Adverse Event|3|||
146035899|NCT00454649|526643772|FG003|Overall Study|Adverse Event|0|||
146035900|NCT00454649|526643773|FG004|Overall Study|Adverse Event|1|||
146035901|NCT00454649|526643774|FG005|Overall Study|Adverse Event|2|||
146035902|NCT00454649|526643775|FG006|Overall Study|Adverse Event|3|||
146035903|NCT00454649|526643776|FG007|Overall Study|Adverse Event|4|||
146035904|NCT00454649|526643777|FG008|Overall Study|Adverse Event|6|||
146035905|NCT00454649|526643778|FG009|Overall Study|Adverse Event|2|||
146035906|NCT00454649|526643769|FG000|Overall Study|Lost to Follow-up|0|||
146035907|NCT00454649|526643770|FG001|Overall Study|Lost to Follow-up|0|||
146035908|NCT00454649|526643771|FG002|Overall Study|Lost to Follow-up|1|||
146035909|NCT00454649|526643772|FG003|Overall Study|Lost to Follow-up|0|||
146035910|NCT00454649|526643773|FG004|Overall Study|Lost to Follow-up|0|||
146035911|NCT00454649|526643774|FG005|Overall Study|Lost to Follow-up|0|||
146035912|NCT00454649|526643775|FG006|Overall Study|Lost to Follow-up|1|||
146035913|NCT00454649|526643776|FG007|Overall Study|Lost to Follow-up|0|||
146035914|NCT00454649|526643777|FG008|Overall Study|Lost to Follow-up|0|||
146035915|NCT00454649|526643778|FG009|Overall Study|Lost to Follow-up|0|||
146035916|NCT00454649|526643769|FG000|Overall Study|Other|1|||
146035917|NCT00454649|526643770|FG001|Overall Study|Other|1|||
146035918|NCT00454649|526643771|FG002|Overall Study|Other|5|||
146035919|NCT00454649|526643772|FG003|Overall Study|Other|3|||
146035920|NCT00454649|526643773|FG004|Overall Study|Other|0|||
146035921|NCT00454649|526643774|FG005|Overall Study|Other|0|||
146035922|NCT00454649|526643775|FG006|Overall Study|Other|0|||
146035923|NCT00454649|526643776|FG007|Overall Study|Other|0|||
146035924|NCT00454649|526643777|FG008|Overall Study|Other|3|||
146035925|NCT00454649|526643778|FG009|Overall Study|Other|1|||
146035926|NCT00454649|526643769|FG000|Overall Study|Withdrawal by Subject|0|||
146035927|NCT00454649|526643770|FG001|Overall Study|Withdrawal by Subject|0|||
146035928|NCT00454649|526643771|FG002|Overall Study|Withdrawal by Subject|0|||
146035929|NCT00454649|526643772|FG003|Overall Study|Withdrawal by Subject|0|||
146098595|NCT03181893|526881202|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098596|NCT03181893|526881203|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
146098597|NCT03181893|526881193|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
146035930|NCT00454649|526643773|FG004|Overall Study|Withdrawal by Subject|0|||
146035931|NCT00454649|526643774|FG005|Overall Study|Withdrawal by Subject|1|||
146035932|NCT00454649|526643775|FG006|Overall Study|Withdrawal by Subject|0|||
146035933|NCT00454649|526643776|FG007|Overall Study|Withdrawal by Subject|2|||
146035934|NCT00454649|526643777|FG008|Overall Study|Withdrawal by Subject|1|||
146035935|NCT00454649|526643778|FG009|Overall Study|Withdrawal by Subject|0|||
146035936|NCT00737633|526643779|FG000|Overall Study|Study terminated by sponsor|44|||
146035937|NCT00737633|526643780|FG001|Overall Study|Study terminated by sponsor|55|||
146035938|NCT00737633|526643779|FG000|Overall Study|Lost to Follow-up|0|||
146035939|NCT00737633|526643780|FG001|Overall Study|Lost to Follow-up|1|||
146035940|NCT00737633|526643779|FG000|Overall Study|protocol non-compliance|0|||
146035941|NCT00737633|526643780|FG001|Overall Study|protocol non-compliance|1|||
146035942|NCT00377364|526643781|FG000|Overall Study|Lost to Follow-up|1|||
146035943|NCT00377364|526643782|FG001|Overall Study|Lost to Follow-up|0|||
146035944|NCT00377364|526643781|FG000|Overall Study|Withdrawal by Subject|1|||
146035945|NCT00377364|526643782|FG001|Overall Study|Withdrawal by Subject|0|||
146035946|NCT02925728|526643783|FG000|Overall Study|Death|3|||
146035947|NCT02925728|526643784|FG001|Overall Study|Death|5|||
146035948|NCT02925728|526643783|FG000|Overall Study|Physician Decision|1|||
146035949|NCT02925728|526643784|FG001|Overall Study|Physician Decision|0|||
146035950|NCT02925728|526643783|FG000|Overall Study|Withdrawal by Subject|1|||
146035951|NCT02925728|526643784|FG001|Overall Study|Withdrawal by Subject|0|||
146035952|NCT03101085|526643785|FG000|Overall Study|Lost to Follow-up|0|||
146035953|NCT03101085|526643786|FG001|Overall Study|Lost to Follow-up|1|||
146035954|NCT00695864|526643790|FG000|Placebo|Withdrawal by Subject|1|||
146035955|NCT00695864|526643790|FG000|Placebo|Physician Decision|4|||
146035956|NCT01879072|526643791|FG000|Overall Study|Withdrawal by Subject|121|||
146035957|NCT01879072|526643791|FG000|Overall Study|Not Transplanted|30|||
146035958|NCT00626405|526643799|FG000|Overall Study|Deemed Ineligible|1|||
146035959|NCT00626405|526643800|FG001|Overall Study|Deemed Ineligible|0|||
146035960|NCT00626405|526643799|FG000|Overall Study|Withdrawal by Subject|0|||
146035961|NCT00626405|526643800|FG001|Overall Study|Withdrawal by Subject|1|||
146035962|NCT01264419|526643804|FG000|Overall Study|Lost to Follow-up|3|||
146035963|NCT02100475|526645570|FG000|Overall Study|Unclassified|1|||
146035964|NCT02100475|526645571|FG001|Overall Study|Unclassified|2|||
146035965|NCT02100475|526645570|FG000|Overall Study|Withdrawal criteria|1|||
146035966|NCT02100475|526645571|FG001|Overall Study|Withdrawal criteria|0|||
146035967|NCT01041287|526645572|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
146035968|NCT01041287|526645573|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
146035969|NCT01041287|526645572|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
146035970|NCT01041287|526645573|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
146035971|NCT00527982|526645580|FG000|Overall Study|Physician Decision|1|||
146035972|NCT00527982|526645581|FG001|Overall Study|Physician Decision|0|||
146035973|NCT01939366|526645582|FG000|Overall Study|Adverse Event|8|||
146035974|NCT01939366|526645583|FG001|Overall Study|Adverse Event|17|||
146035975|NCT01939366|526645584|FG002|Overall Study|Adverse Event|30|||
146035976|NCT01939366|526645585|FG003|Overall Study|Adverse Event|8|||
146035977|NCT01939366|526645586|FG004|Overall Study|Adverse Event|5|||
146035978|NCT01939366|526645582|FG000|Overall Study|Lack of Efficacy|2|||
146035979|NCT01939366|526645583|FG001|Overall Study|Lack of Efficacy|1|||
146035980|NCT01939366|526645584|FG002|Overall Study|Lack of Efficacy|1|||
146035981|NCT01939366|526645585|FG003|Overall Study|Lack of Efficacy|1|||
146035982|NCT01939366|526645586|FG004|Overall Study|Lack of Efficacy|3|||
146035983|NCT01939366|526645582|FG000|Overall Study|Lost to Follow-up|1|||
146035984|NCT01939366|526645583|FG001|Overall Study|Lost to Follow-up|1|||
146035985|NCT01939366|526645584|FG002|Overall Study|Lost to Follow-up|0|||
146035986|NCT01939366|526645585|FG003|Overall Study|Lost to Follow-up|0|||
146035987|NCT01939366|526645586|FG004|Overall Study|Lost to Follow-up|0|||
146035988|NCT01939366|526645582|FG000|Overall Study|Withdrawal by Subject|1|||
146035989|NCT01939366|526645583|FG001|Overall Study|Withdrawal by Subject|0|||
146035990|NCT01939366|526645584|FG002|Overall Study|Withdrawal by Subject|2|||
146035991|NCT01939366|526645585|FG003|Overall Study|Withdrawal by Subject|2|||
146035992|NCT01939366|526645586|FG004|Overall Study|Withdrawal by Subject|3|||
146035993|NCT01939366|526645582|FG000|Overall Study|Inclusion criteria not met|0|||
146035994|NCT01939366|526645583|FG001|Overall Study|Inclusion criteria not met|1|||
146035995|NCT01939366|526645584|FG002|Overall Study|Inclusion criteria not met|1|||
146035996|NCT01939366|526645585|FG003|Overall Study|Inclusion criteria not met|0|||
146035997|NCT01939366|526645586|FG004|Overall Study|Inclusion criteria not met|1|||
146035998|NCT01939366|526645582|FG000|Overall Study|Other|0|||
146035999|NCT01939366|526645583|FG001|Overall Study|Other|0|||
146036000|NCT01939366|526645584|FG002|Overall Study|Other|2|||
146036001|NCT01939366|526645585|FG003|Overall Study|Other|2|||
146036002|NCT01939366|526645586|FG004|Overall Study|Other|1|||
146036003|NCT01939366|526645582|FG000|Overall Study|Protocol Violation|0|||
146036004|NCT01939366|526645583|FG001|Overall Study|Protocol Violation|0|||
146036005|NCT01939366|526645584|FG002|Overall Study|Protocol Violation|0|||
146036006|NCT01939366|526645585|FG003|Overall Study|Protocol Violation|1|||
146036007|NCT01939366|526645586|FG004|Overall Study|Protocol Violation|0|||
146036008|NCT01939366|526645582|FG000|Overall Study|Sponsor decision|0|||
146036009|NCT01939366|526645583|FG001|Overall Study|Sponsor decision|0|||
146036010|NCT01939366|526645584|FG002|Overall Study|Sponsor decision|0|||
146036011|NCT01939366|526645585|FG003|Overall Study|Sponsor decision|0|||
146036012|NCT01939366|526645586|FG004|Overall Study|Sponsor decision|2|||
146036013|NCT01939366|526645582|FG000|Overall Study|GCP non-compliance at site|2|||
146036014|NCT01939366|526645583|FG001|Overall Study|GCP non-compliance at site|3|||
146036015|NCT01939366|526645584|FG002|Overall Study|GCP non-compliance at site|2|||
146036016|NCT01939366|526645585|FG003|Overall Study|GCP non-compliance at site|3|||
146036017|NCT01939366|526645586|FG004|Overall Study|GCP non-compliance at site|3|||
146036018|NCT04680975|526645591|FG000|Overall Study|Adverse Event|3|||
146036019|NCT04680975|526645591|FG000|Overall Study|Death|1|||
146036020|NCT04680975|526645591|FG000|Overall Study|Progressive Disease|1|||
146036021|NCT04680975|526645591|FG000|Overall Study|Withdrawal by Subject|1|||
146036022|NCT03909152|526645592|FG000|Overall Study|Adverse Event|14|||
146036023|NCT03909152|526645593|FG001|Overall Study|Adverse Event|5|||
146036024|NCT03909152|526645594|FG002|Overall Study|Adverse Event|1|||
146036025|NCT03909152|526645595|FG003|Overall Study|Adverse Event|14|||
146036026|NCT02702414|526645598|FG000|Overall Study|Death|96|||
146254426|NCT04754594|527444591|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
146300559|NCT01876251|527617046|FG002|Overall Study|Study terminated|0|||
146036027|NCT02702414|526645599|FG001|Overall Study|Death|42|||
146036028|NCT02702414|526645598|FG000|Overall Study|Lost to Follow-up|0|||
146036029|NCT02702414|526645599|FG001|Overall Study|Lost to Follow-up|1|||
146036030|NCT02702414|526645598|FG000|Overall Study|Withdrawal by Subject|0|||
146036031|NCT02702414|526645599|FG001|Overall Study|Withdrawal by Subject|1|||
146036032|NCT02702414|526645598|FG000|Overall Study|Protocol Violation|1|||
146036033|NCT02702414|526645599|FG001|Overall Study|Protocol Violation|0|||
146036034|NCT02702414|526645598|FG000|Overall Study|Sponsor Decision|8|||
146036035|NCT02702414|526645599|FG001|Overall Study|Sponsor Decision|7|||
146036036|NCT04541628|526645600|FG000|Overall Study|Study Terminated|1|||
146036037|NCT04541628|526645601|FG001|Overall Study|Study Terminated|1|||
146036038|NCT04541628|526645602|FG002|Overall Study|Study Terminated|1|||
146036039|NCT01192412|526645607|FG000|Overall Study|Lost to Follow-up|2|||
146036040|NCT01192412|526645608|FG001|Overall Study|Lost to Follow-up|1|||
146036041|NCT01192412|526645607|FG000|Overall Study|Withdrawal by Subject|2|||
146036042|NCT01192412|526645608|FG001|Overall Study|Withdrawal by Subject|1|||
146036043|NCT00151476|526645609|FG000|FAP Identified Subjects|Protocol Violation|0|||
146036044|NCT00151476|526645610|FG001|FAP Identified Subjects|Protocol Violation|1|||
146036045|NCT00151476|526645609|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
146036046|NCT00151476|526645610|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
146036047|NCT00151476|526645609|FG000|FAP Analyzed Subjects|Other study participation|0|||
146036048|NCT00151476|526645610|FG001|FAP Analyzed Subjects|Other study participation|1|||
146036049|NCT04099511|526645615|FG000|Overall Study|Lost to Follow-up|2|||
146036050|NCT04099511|526645616|FG001|Overall Study|Lost to Follow-up|2|||
146036051|NCT04099511|526645615|FG000|Overall Study|Withdrawal by Subject|8|||
146036052|NCT04099511|526645616|FG001|Overall Study|Withdrawal by Subject|4|||
146036053|NCT06151288|526645618|FG000|Overall Study|Lost to Follow-up|4|||
146036054|NCT06151288|526645619|FG001|Overall Study|Lost to Follow-up|2|||
146036055|NCT06151288|526645620|FG002|Overall Study|Lost to Follow-up|4|||
146036056|NCT06151288|526645621|FG003|Overall Study|Lost to Follow-up|3|||
146036057|NCT06151288|526645618|FG000|Overall Study|Withdrawal by Subject|4|||
146036058|NCT06151288|526645619|FG001|Overall Study|Withdrawal by Subject|5|||
146036059|NCT06151288|526645620|FG002|Overall Study|Withdrawal by Subject|1|||
146036060|NCT06151288|526645621|FG003|Overall Study|Withdrawal by Subject|1|||
146036061|NCT01240200|526645623|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
146036062|NCT01240200|526645624|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
146036063|NCT03194438|526645627|FG000|Overall Study|Withdrawal by Subject|2|||
146036064|NCT02708485|526645628|FG000|Overall Study|Withdrawal by Subject|3|||
146036065|NCT02708485|526645629|FG001|Overall Study|Withdrawal by Subject|2|||
146036066|NCT01554514|526645634|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
146036067|NCT01554514|526645634|FG000|Overall Study|Physician Decision|1|||
146036068|NCT01423916|526645635|FG000|Overall Study|Adverse Event|5|||
146036069|NCT01423916|526645636|FG001|Overall Study|Adverse Event|9|||
146036070|NCT01423916|526645637|FG002|Overall Study|Adverse Event|2|||
146036071|NCT01423916|526645635|FG000|Overall Study|Met Withdrawal Criteria|1|||
146036072|NCT01423916|526645636|FG001|Overall Study|Met Withdrawal Criteria|1|||
146036073|NCT01423916|526645637|FG002|Overall Study|Met Withdrawal Criteria|1|||
146036074|NCT01423916|526645635|FG000|Overall Study|Physician Decision|1|||
146036075|NCT01423916|526645636|FG001|Overall Study|Physician Decision|0|||
146036076|NCT01423916|526645637|FG002|Overall Study|Physician Decision|1|||
146036077|NCT01423916|526645635|FG000|Overall Study|Withdrawal by Subject|3|||
146036078|NCT01423916|526645636|FG001|Overall Study|Withdrawal by Subject|10|||
146036079|NCT01423916|526645637|FG002|Overall Study|Withdrawal by Subject|3|||
146036080|NCT01423916|526645635|FG000|Overall Study|Protocol Deviation|1|||
146036081|NCT01423916|526645636|FG001|Overall Study|Protocol Deviation|0|||
146036082|NCT01423916|526645637|FG002|Overall Study|Protocol Deviation|0|||
146036083|NCT03157583|526645640|FG000|Overall Study|Other (did not meet study criteria)|1|||
146036084|NCT01581619|526645646|FG000|Overall Study|Withdrawal by Subject|1|||
146036085|NCT01581619|526645646|FG000|Overall Study|Lost to Follow-up|1|||
146036086|NCT00290498|526645647|FG000|Overall Study|Death|2|||
146036087|NCT00290498|526645648|FG001|Overall Study|Death|0|||
146036088|NCT00290498|526645647|FG000|Overall Study|Physician Decision|1|||
146036089|NCT00290498|526645648|FG001|Overall Study|Physician Decision|0|||
146036090|NCT00290498|526645647|FG000|Overall Study|Withdrawal by Subject|1|||
146036091|NCT00290498|526645648|FG001|Overall Study|Withdrawal by Subject|0|||
146036092|NCT00290498|526645647|FG000|Overall Study|Ineligible|3|||
146036093|NCT00290498|526645648|FG001|Overall Study|Ineligible|0|||
146036094|NCT00290498|526645647|FG000|Overall Study|Non-Compliance|1|||
146036095|NCT00290498|526645648|FG001|Overall Study|Non-Compliance|0|||
146036096|NCT02250664|526645651|FG000|Overall Study|Lost to Follow-up|18|||
146036097|NCT02250664|526645652|FG001|Overall Study|Lost to Follow-up|28|||
146036098|NCT02250664|526645653|FG002|Overall Study|Lost to Follow-up|33|||
146036099|NCT02250664|526645651|FG000|Overall Study|Personal Reasons|7|||
146036100|NCT02250664|526645652|FG001|Overall Study|Personal Reasons|8|||
146036101|NCT02250664|526645653|FG002|Overall Study|Personal Reasons|14|||
146036102|NCT02250664|526645651|FG000|Overall Study|Adverse Event|6|||
146036103|NCT02250664|526645652|FG001|Overall Study|Adverse Event|3|||
146036104|NCT02250664|526645653|FG002|Overall Study|Adverse Event|8|||
146036105|NCT02250664|526645651|FG000|Overall Study|Incarcerated|2|||
146036106|NCT02250664|526645652|FG001|Overall Study|Incarcerated|1|||
146036107|NCT02250664|526645653|FG002|Overall Study|Incarcerated|2|||
146036108|NCT02250664|526645651|FG000|Overall Study|Withdrawal by Subject|0|||
146036109|NCT02250664|526645652|FG001|Overall Study|Withdrawal by Subject|1|||
146036110|NCT02250664|526645653|FG002|Overall Study|Withdrawal by Subject|2|||
146036111|NCT02250664|526645651|FG000|Overall Study|Death|0|||
146036112|NCT02250664|526645652|FG001|Overall Study|Death|1|||
146036113|NCT02250664|526645653|FG002|Overall Study|Death|1|||
146036114|NCT02250664|526645651|FG000|Overall Study|Physician Decision|1|||
146036115|NCT02250664|526645652|FG001|Overall Study|Physician Decision|3|||
146036116|NCT02250664|526645653|FG002|Overall Study|Physician Decision|1|||
146036117|NCT02250664|526645651|FG000|Overall Study|Protocol Violation|1|||
146036118|NCT02250664|526645652|FG001|Overall Study|Protocol Violation|0|||
146036119|NCT02250664|526645653|FG002|Overall Study|Protocol Violation|1|||
146036120|NCT02250664|526645651|FG000|Overall Study|Reason unknown|1|||
146036121|NCT02250664|526645652|FG001|Overall Study|Reason unknown|0|||
146036122|NCT02250664|526645653|FG002|Overall Study|Reason unknown|0|||
146036123|NCT03847909|526645655|FG000|Overall Study|Withdrawal by Subject|1|||
146036124|NCT03847909|526645656|FG001|Overall Study|Withdrawal by Subject|1|||
146036125|NCT04268173|526645657|FG000|Overall Study|Lost to Follow-up|75|||
146036126|NCT04268173|526645658|FG001|Overall Study|Lost to Follow-up|108|||
146036127|NCT00975143|526645659|FG000|Overall Study|Adverse Event|19|||
146036128|NCT00975143|526645660|FG001|Overall Study|Adverse Event|15|||
146036129|NCT00975143|526645659|FG000|Overall Study|Withdrawal by Subject|15|||
146036130|NCT00975143|526645660|FG001|Overall Study|Withdrawal by Subject|15|||
146036131|NCT00975143|526645659|FG000|Overall Study|Lost to Follow-up|20|||
146036132|NCT00975143|526645660|FG001|Overall Study|Lost to Follow-up|16|||
146036133|NCT00975143|526645659|FG000|Overall Study|Non-compliance|5|||
146036134|NCT00975143|526645660|FG001|Overall Study|Non-compliance|8|||
146036135|NCT00975143|526645659|FG000|Overall Study|Physician Decision|1|||
146036136|NCT00975143|526645660|FG001|Overall Study|Physician Decision|2|||
146036137|NCT00975143|526645659|FG000|Overall Study|Details not available|10|||
146036138|NCT00975143|526645660|FG001|Overall Study|Details not available|4|||
146036139|NCT01147900|526645661|FG000|At Year 10|Lost to Follow-up|0|||
146036140|NCT01147900|526645662|FG001|At Year 10|Lost to Follow-up|1|||
146036141|NCT01147900|526645663|FG002|At Year 10|Lost to Follow-up|0|||
146036142|NCT01375608|526645664|FG000|Overall Study|Withdrawal by Subject|2|||
146036143|NCT00581360|526645665|FG000|Overall Study|Withdrawal by Subject|1|||
146036144|NCT00545103|526645666|FG000|Overall Study|Lack of Efficacy|48|||
146036145|NCT00545103|526645667|FG001|Overall Study|Lack of Efficacy|45|||
146036146|NCT00545103|526645668|FG002|Overall Study|Lack of Efficacy|31|||
146036147|NCT00545103|526645669|FG003|Overall Study|Lack of Efficacy|27|||
146036148|NCT00545103|526645666|FG000|Overall Study|Withdrawal by Subject|6|||
146036149|NCT00545103|526645667|FG001|Overall Study|Withdrawal by Subject|10|||
146036150|NCT00545103|526645668|FG002|Overall Study|Withdrawal by Subject|18|||
146036151|NCT00545103|526645669|FG003|Overall Study|Withdrawal by Subject|22|||
146036152|NCT00545103|526645666|FG000|Overall Study|Adverse Event|11|||
146036153|NCT00545103|526645667|FG001|Overall Study|Adverse Event|12|||
146036154|NCT00545103|526645668|FG002|Overall Study|Adverse Event|17|||
146036155|NCT00545103|526645669|FG003|Overall Study|Adverse Event|10|||
146036156|NCT00545103|526645666|FG000|Overall Study|Lost to Follow-up|4|||
146036157|NCT00545103|526645667|FG001|Overall Study|Lost to Follow-up|6|||
146036158|NCT00545103|526645668|FG002|Overall Study|Lost to Follow-up|3|||
146036159|NCT00545103|526645669|FG003|Overall Study|Lost to Follow-up|4|||
146036160|NCT00545103|526645666|FG000|Overall Study|Protocol Violation|1|||
146036161|NCT00545103|526645667|FG001|Overall Study|Protocol Violation|2|||
146098598|NCT03181893|526881194|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
146098599|NCT03181893|526881195|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146036162|NCT00545103|526645668|FG002|Overall Study|Protocol Violation|3|||
146036163|NCT00545103|526645669|FG003|Overall Study|Protocol Violation|0|||
146036164|NCT00545103|526645666|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
146036165|NCT00545103|526645667|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
146036166|NCT00545103|526645668|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
146036167|NCT00545103|526645669|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
146036168|NCT00545103|526645666|FG000|Overall Study|Difficult to open package|0|||
146036169|NCT00545103|526645667|FG001|Overall Study|Difficult to open package|0|||
146036170|NCT00545103|526645668|FG002|Overall Study|Difficult to open package|0|||
146036171|NCT00545103|526645669|FG003|Overall Study|Difficult to open package|1|||
146036172|NCT00545103|526645666|FG000|Overall Study|Investigational product not taken|1|||
146036173|NCT00545103|526645667|FG001|Overall Study|Investigational product not taken|0|||
146036174|NCT00545103|526645668|FG002|Overall Study|Investigational product not taken|0|||
146036175|NCT00545103|526645669|FG003|Overall Study|Investigational product not taken|1|||
146036176|NCT00545103|526645666|FG000|Overall Study|Wish to start a family|0|||
146036177|NCT00545103|526645667|FG001|Overall Study|Wish to start a family|0|||
146036178|NCT00545103|526645668|FG002|Overall Study|Wish to start a family|0|||
146036179|NCT00545103|526645669|FG003|Overall Study|Wish to start a family|1|||
146036180|NCT00545103|526645666|FG000|Overall Study|Diverticulitis crisis|0|||
146036181|NCT00545103|526645667|FG001|Overall Study|Diverticulitis crisis|0|||
146036182|NCT00545103|526645668|FG002|Overall Study|Diverticulitis crisis|0|||
146036183|NCT00545103|526645669|FG003|Overall Study|Diverticulitis crisis|1|||
146036184|NCT00545103|526645666|FG000|Overall Study|Personal reasons|1|||
146036185|NCT00545103|526645667|FG001|Overall Study|Personal reasons|0|||
146036186|NCT00545103|526645668|FG002|Overall Study|Personal reasons|0|||
146036187|NCT00545103|526645669|FG003|Overall Study|Personal reasons|0|||
146036188|NCT00545103|526645666|FG000|Overall Study|Subject's decision|1|||
146036189|NCT00545103|526645667|FG001|Overall Study|Subject's decision|0|||
146036190|NCT00545103|526645668|FG002|Overall Study|Subject's decision|0|||
146036191|NCT00545103|526645669|FG003|Overall Study|Subject's decision|0|||
146036192|NCT00545103|526645666|FG000|Overall Study|Noncompliance|0|||
146036193|NCT00545103|526645667|FG001|Overall Study|Noncompliance|1|||
146036194|NCT00545103|526645668|FG002|Overall Study|Noncompliance|0|||
146036195|NCT00545103|526645669|FG003|Overall Study|Noncompliance|0|||
146036196|NCT00545103|526645666|FG000|Overall Study|Investigator decision|0|||
146036197|NCT00545103|526645667|FG001|Overall Study|Investigator decision|0|||
146036198|NCT00545103|526645668|FG002|Overall Study|Investigator decision|1|||
146036199|NCT00545103|526645669|FG003|Overall Study|Investigator decision|0|||
146036200|NCT00545103|526645666|FG000|Overall Study|Subject moved|0|||
146036201|NCT00545103|526645667|FG001|Overall Study|Subject moved|1|||
146036202|NCT00545103|526645668|FG002|Overall Study|Subject moved|0|||
146036203|NCT00545103|526645669|FG003|Overall Study|Subject moved|0|||
146036204|NCT00545103|526645666|FG000|Overall Study|Use of prohibited medication|0|||
146036205|NCT00545103|526645667|FG001|Overall Study|Use of prohibited medication|0|||
146036206|NCT00545103|526645668|FG002|Overall Study|Use of prohibited medication|1|||
146036207|NCT00545103|526645669|FG003|Overall Study|Use of prohibited medication|0|||
146036208|NCT00545103|526645666|FG000|Overall Study|Does not want to take study drug anymore|1|||
146036209|NCT00545103|526645667|FG001|Overall Study|Does not want to take study drug anymore|0|||
146036210|NCT00545103|526645668|FG002|Overall Study|Does not want to take study drug anymore|1|||
146036211|NCT00545103|526645669|FG003|Overall Study|Does not want to take study drug anymore|0|||
146036212|NCT00545103|526645666|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
146036213|NCT00545103|526645667|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
146036214|NCT00545103|526645668|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
146036215|NCT00545103|526645669|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
146036216|NCT00545103|526645666|FG000|Overall Study|Death|0|||
146036217|NCT00545103|526645667|FG001|Overall Study|Death|1|||
146036218|NCT00545103|526645668|FG002|Overall Study|Death|0|||
146036219|NCT00545103|526645669|FG003|Overall Study|Death|0|||
146036220|NCT01353911|526645670|FG000|Overall Study|Lost to Follow-up|2|||
146036221|NCT01353911|526645671|FG001|Overall Study|Lost to Follow-up|6|||
146036222|NCT01353911|526645672|FG002|Overall Study|Lost to Follow-up|4|||
146036223|NCT01353911|526645673|FG003|Overall Study|Lost to Follow-up|0|||
146036224|NCT01353911|526645674|FG004|Overall Study|Lost to Follow-up|4|||
146036225|NCT01353911|526645675|FG005|Overall Study|Lost to Follow-up|4|||
146036226|NCT01353911|526645676|FG006|Overall Study|Lost to Follow-up|3|||
146036227|NCT01353911|526645677|FG007|Overall Study|Lost to Follow-up|6|||
146036228|NCT01353911|526645670|FG000|Overall Study|Withdrawal by Subject|2|||
146036229|NCT01353911|526645671|FG001|Overall Study|Withdrawal by Subject|3|||
146036230|NCT01353911|526645672|FG002|Overall Study|Withdrawal by Subject|4|||
146036231|NCT01353911|526645673|FG003|Overall Study|Withdrawal by Subject|2|||
146036232|NCT01353911|526645674|FG004|Overall Study|Withdrawal by Subject|2|||
146036233|NCT01353911|526645675|FG005|Overall Study|Withdrawal by Subject|3|||
146036234|NCT01353911|526645676|FG006|Overall Study|Withdrawal by Subject|3|||
146036235|NCT01353911|526645677|FG007|Overall Study|Withdrawal by Subject|9|||
146036236|NCT01353911|526645670|FG000|Overall Study|Status Not Recorded|4|||
146036237|NCT01353911|526645671|FG001|Overall Study|Status Not Recorded|0|||
146036238|NCT01353911|526645672|FG002|Overall Study|Status Not Recorded|1|||
146036239|NCT01353911|526645673|FG003|Overall Study|Status Not Recorded|0|||
146036240|NCT01353911|526645674|FG004|Overall Study|Status Not Recorded|0|||
146036241|NCT01353911|526645675|FG005|Overall Study|Status Not Recorded|0|||
146036242|NCT01353911|526645676|FG006|Overall Study|Status Not Recorded|0|||
146036243|NCT01353911|526645677|FG007|Overall Study|Status Not Recorded|0|||
146036244|NCT00082381|526645678|FG000|Overall Study|Adverse Event|27|||
146036245|NCT00082381|526645679|FG001|Overall Study|Adverse Event|2|||
146036246|NCT00082381|526645678|FG000|Overall Study|Lost to Follow-up|5|||
146036247|NCT00082381|526645679|FG001|Overall Study|Lost to Follow-up|7|||
146036248|NCT00082381|526645678|FG000|Overall Study|Patient Decision|8|||
146036249|NCT00082381|526645679|FG001|Overall Study|Patient Decision|4|||
146036250|NCT00082381|526645678|FG000|Overall Study|Physician Decision|1|||
146036251|NCT00082381|526645679|FG001|Overall Study|Physician Decision|2|||
146036252|NCT00082381|526645678|FG000|Overall Study|Protocol Violation|10|||
146036253|NCT00082381|526645679|FG001|Overall Study|Protocol Violation|11|||
146036254|NCT00082381|526645678|FG000|Overall Study|Loss of Glucose Control|4|||
146036255|NCT00082381|526645679|FG001|Overall Study|Loss of Glucose Control|0|||
146098600|NCT03181893|526881196|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098601|NCT03181893|526881197|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098602|NCT03181893|526881198|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098603|NCT03181893|526881199|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098604|NCT03181893|526881200|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098605|NCT03181893|526881201|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098606|NCT03181893|526881202|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098607|NCT03181893|526881203|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
146098608|NCT03181893|526881193|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098609|NCT03181893|526881194|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098610|NCT03181893|526881195|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098611|NCT03181893|526881196|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098612|NCT03181893|526881197|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098613|NCT03181893|526881198|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098614|NCT03181893|526881199|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098615|NCT03181893|526881200|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
146098616|NCT03181893|526881201|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
146098617|NCT03181893|526881202|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098618|NCT03181893|526881203|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
146098619|NCT03181893|526881193|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098620|NCT03181893|526881194|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098621|NCT03181893|526881195|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098622|NCT03181893|526881196|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098623|NCT03181893|526881197|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098624|NCT03181893|526881198|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098625|NCT03181893|526881199|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098626|NCT03181893|526881200|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098627|NCT03181893|526881201|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098628|NCT03181893|526881202|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
146098629|NCT03181893|526881203|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
146098630|NCT03181893|526881193|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098631|NCT03181893|526881194|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098632|NCT03181893|526881195|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098633|NCT03181893|526881196|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098634|NCT03181893|526881197|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098635|NCT03181893|526881198|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098636|NCT03181893|526881199|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098637|NCT03181893|526881200|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098638|NCT03181893|526881201|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098639|NCT03181893|526881202|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
146098640|NCT03181893|526881203|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
146098641|NCT04128371|526881204|FG000|Overall Study|Lack of Efficacy|1|||
146098642|NCT00968864|526881208|FG000|Overall Study|Protocol exception/ not evaluable|1|||
146098643|NCT01346969|526881209|FG000|Overall Study|Withdrawal by Subject|0|||
146098644|NCT01346969|526881210|FG001|Overall Study|Withdrawal by Subject|0|||
146098645|NCT01346969|526881211|FG002|Overall Study|Withdrawal by Subject|1|||
146098646|NCT01346969|526881212|FG003|Overall Study|Withdrawal by Subject|0|||
146098647|NCT01346969|526881209|FG000|Overall Study|Lost to Follow-up|1|||
146254427|NCT04754594|527444592|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
146254428|NCT04754594|527444589|FG000|Unblinded Period|Withdrawal by Subject|6|||
146254429|NCT04754594|527444590|FG001|Unblinded Period|Withdrawal by Subject|8|||
146254430|NCT04754594|527444591|FG002|Unblinded Period|Withdrawal by Subject|0|||
146254431|NCT04754594|527444592|FG003|Unblinded Period|Withdrawal by Subject|0|||
146254432|NCT04754594|527444589|FG000|Unblinded Period|Lost to Follow-up|5|||
146254433|NCT04754594|527444590|FG001|Unblinded Period|Lost to Follow-up|3|||
146254434|NCT04754594|527444591|FG002|Unblinded Period|Lost to Follow-up|0|||
146254435|NCT04754594|527444592|FG003|Unblinded Period|Lost to Follow-up|0|||
146254436|NCT04754594|527444589|FG000|Unblinded Period|Protocol Violation|2|||
146254437|NCT04754594|527444590|FG001|Unblinded Period|Protocol Violation|4|||
146098648|NCT01346969|526881210|FG001|Overall Study|Lost to Follow-up|0|||
146098649|NCT01346969|526881211|FG002|Overall Study|Lost to Follow-up|2|||
146098650|NCT01346969|526881212|FG003|Overall Study|Lost to Follow-up|0|||
146098651|NCT01346969|526881209|FG000|Overall Study|Physician Decision|0|||
146098652|NCT01346969|526881210|FG001|Overall Study|Physician Decision|0|||
146098653|NCT01346969|526881211|FG002|Overall Study|Physician Decision|0|||
146098654|NCT01346969|526881212|FG003|Overall Study|Physician Decision|1|||
146098655|NCT01346969|526881209|FG000|Overall Study|Randomized but not treated|1|||
146098656|NCT01346969|526881210|FG001|Overall Study|Randomized but not treated|0|||
146098657|NCT01346969|526881211|FG002|Overall Study|Randomized but not treated|0|||
146098658|NCT01346969|526881212|FG003|Overall Study|Randomized but not treated|0|||
146036256|NCT02925741|526645682|FG000|Overall Study|Withdrawal by Subject|11|||
146036257|NCT02925741|526645683|FG001|Overall Study|Withdrawal by Subject|0|||
146036258|NCT00494507|526645686|FG000|Double-Blind Phase|Adverse Event|2|||
146036259|NCT00494507|526645687|FG001|Double-Blind Phase|Adverse Event|0|||
146036260|NCT00494507|526645688|FG002|Double-Blind Phase|Adverse Event|1|||
146036261|NCT00494507|526645689|FG003|Double-Blind Phase|Adverse Event|0|||
146036262|NCT00494507|526645686|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
146036263|NCT00494507|526645687|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
146036264|NCT00494507|526645688|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146036265|NCT00494507|526645689|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146036266|NCT00494507|526645686|FG000|Double-Blind Phase|Subject Non-compliance|0|||
146036267|NCT00494507|526645687|FG001|Double-Blind Phase|Subject Non-compliance|0|||
146036268|NCT00494507|526645688|FG002|Double-Blind Phase|Subject Non-compliance|1|||
146036269|NCT00494507|526645689|FG003|Double-Blind Phase|Subject Non-compliance|0|||
146036270|NCT00494507|526645686|FG000|Double-Blind Phase|Negative DNA test|0|||
146036271|NCT00494507|526645687|FG001|Double-Blind Phase|Negative DNA test|0|||
146036272|NCT00494507|526645688|FG002|Double-Blind Phase|Negative DNA test|0|||
146036273|NCT00494507|526645689|FG003|Double-Blind Phase|Negative DNA test|1|||
146036274|NCT00494507|526645686|FG000|Open-Label Phase|Adverse Event|0|||
146036275|NCT00494507|526645687|FG001|Open-Label Phase|Adverse Event|1|||
146036276|NCT00494507|526645688|FG002|Open-Label Phase|Adverse Event|5|||
146036277|NCT00494507|526645689|FG003|Open-Label Phase|Adverse Event|3|||
146036278|NCT00494507|526645686|FG000|Open-Label Phase|Worsening Disease|0|||
146036279|NCT00494507|526645687|FG001|Open-Label Phase|Worsening Disease|0|||
146036280|NCT00494507|526645688|FG002|Open-Label Phase|Worsening Disease|0|||
146036281|NCT00494507|526645689|FG003|Open-Label Phase|Worsening Disease|2|||
146036282|NCT00295932|526645690|FG000|Overall Study|Not Treated|0|||
146036283|NCT00295932|526645691|FG001|Overall Study|Not Treated|0|||
146036284|NCT00295932|526645692|FG002|Overall Study|Not Treated|0|||
146036285|NCT00295932|526645693|FG003|Overall Study|Not Treated|0|||
146036286|NCT00295932|526645694|FG004|Overall Study|Not Treated|0|||
146036287|NCT00295932|526645695|FG005|Overall Study|Not Treated|0|||
146036288|NCT00295932|526645696|FG006|Overall Study|Not Treated|0|||
146036289|NCT00295932|526645697|FG007|Overall Study|Not Treated|0|||
146036290|NCT00295932|526645698|FG008|Overall Study|Not Treated|0|||
146036291|NCT00295932|526645699|FG009|Overall Study|Not Treated|0|||
146036292|NCT00295932|526645700|FG010|Overall Study|Not Treated|1|||
146036293|NCT02337725|526645701|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
146036294|NCT02337725|526645702|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
146036295|NCT02337725|526645701|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
146036296|NCT02337725|526645702|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
146036297|NCT02337725|526645701|FG000|Overall Study|Major Protocol Deviation|0|||
146036298|NCT02337725|526645702|FG001|Overall Study|Major Protocol Deviation|1|||
146036299|NCT02337725|526645701|FG000|Overall Study|Voluntary Withdrawal|14|||
146036300|NCT02337725|526645702|FG001|Overall Study|Voluntary Withdrawal|3|||
146036301|NCT02337725|526645701|FG000|Overall Study|Lack of Efficacy|4|||
146036302|NCT02337725|526645702|FG001|Overall Study|Lack of Efficacy|0|||
146036303|NCT02096263|526645703|FG000|Overall Study|Adverse Event|1|||
146036304|NCT02096263|526645704|FG001|Overall Study|Adverse Event|0|||
146036305|NCT02096263|526645705|FG002|Overall Study|Adverse Event|1|||
146036306|NCT02096263|526645703|FG000|Overall Study|Lost to Follow-up|14|||
146036307|NCT02096263|526645704|FG001|Overall Study|Lost to Follow-up|18|||
146036308|NCT02096263|526645705|FG002|Overall Study|Lost to Follow-up|15|||
146036309|NCT02096263|526645703|FG000|Overall Study|Other|7|||
146036310|NCT02096263|526645704|FG001|Overall Study|Other|9|||
146036311|NCT02096263|526645705|FG002|Overall Study|Other|6|||
146036312|NCT02096263|526645703|FG000|Overall Study|Sponsor study termination|0|||
146036313|NCT02096263|526645704|FG001|Overall Study|Sponsor study termination|0|||
146036314|NCT02096263|526645705|FG002|Overall Study|Sponsor study termination|1|||
146036315|NCT02096263|526645703|FG000|Overall Study|Protocol Violation|7|||
146036316|NCT02096263|526645704|FG001|Overall Study|Protocol Violation|2|||
146036317|NCT02096263|526645705|FG002|Overall Study|Protocol Violation|8|||
146036318|NCT02096263|526645703|FG000|Overall Study|Withdrawal by Subject|5|||
146036319|NCT02096263|526645704|FG001|Overall Study|Withdrawal by Subject|7|||
146036320|NCT02096263|526645705|FG002|Overall Study|Withdrawal by Subject|8|||
146036321|NCT04891107|526645706|FG000|Overall Study|Physician Decision|1|||
146036322|NCT04891107|526645706|FG000|Overall Study|Withdrawal by Subject|1|||
146036323|NCT04891107|526645706|FG000|Overall Study|Screen failure after consent|1|||
146036324|NCT00500760|526645713|FG000|Overall Study|Death|32|||
146036325|NCT00500760|526645714|FG001|Overall Study|Death|15|||
146036326|NCT00500760|526645713|FG000|Overall Study|Withdrawal by Subject|5|||
146036327|NCT00500760|526645714|FG001|Overall Study|Withdrawal by Subject|7|||
146036328|NCT00500760|526645713|FG000|Overall Study|Administrative decision|2|||
146036329|NCT00500760|526645714|FG001|Overall Study|Administrative decision|0|||
146036330|NCT00500760|526645713|FG000|Overall Study|Lost to Follow-up|3|||
146036331|NCT00500760|526645714|FG001|Overall Study|Lost to Follow-up|0|||
146036332|NCT00500760|526645713|FG000|Overall Study|Other|1|||
146036333|NCT00500760|526645714|FG001|Overall Study|Other|2|||
146036334|NCT01600092|526645715|FG000|Overall Study|Adverse Event|2|||
146098659|NCT04815031|526881213|FG000|Overall Study|No adverse event information (missing information)|33|||
146098660|NCT00586625|526881214|FG000|Overall Study|Adverse Event|6|||
146098661|NCT00586625|526881215|FG001|Overall Study|Adverse Event|6|||
146098662|NCT00586625|526881214|FG000|Overall Study|Protocol Violation|3|||
146098663|NCT00586625|526881215|FG001|Overall Study|Protocol Violation|0|||
146098664|NCT00586625|526881214|FG000|Overall Study|Withdrawal by Subject|32|||
146098665|NCT00586625|526881215|FG001|Overall Study|Withdrawal by Subject|10|||
146098666|NCT00586625|526881214|FG000|Overall Study|Subject non-compliance|0|||
146098667|NCT00586625|526881215|FG001|Overall Study|Subject non-compliance|1|||
146098668|NCT00586625|526881214|FG000|Overall Study|Subject unable to return for visit|2|||
146098669|NCT00586625|526881215|FG001|Overall Study|Subject unable to return for visit|0|||
146098670|NCT04032652|526881216|FG000|Overall Study|The study was terminated and the PI has|1|||
146098671|NCT04032652|526881217|FG001|Overall Study|The study was terminated and the PI has|1|||
146098672|NCT01558739|526881218|FG000|Overall Study|Adverse Event|7|||
146098673|NCT01558739|526881218|FG000|Overall Study|Withdrawal by Subject|2|||
146098674|NCT01558739|526881218|FG000|Overall Study|Death|3|||
146098675|NCT01558739|526881218|FG000|Overall Study|Disease Progression|4|||
146098676|NCT01558739|526881218|FG000|Overall Study|Protocol Violation|1|||
146098677|NCT02423772|526881220|FG000|Overall Study|Lost to Follow-up|3|||
146098678|NCT02423772|526881221|FG001|Overall Study|Lost to Follow-up|3|||
146098679|NCT02423772|526881220|FG000|Overall Study|Did not begin intervention|2|||
146098680|NCT02423772|526881221|FG001|Overall Study|Did not begin intervention|5|||
146098681|NCT01193842|526881222|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146098682|NCT01193842|526881223|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
146098683|NCT01193842|526881224|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146098684|NCT01193842|526881225|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146098685|NCT01193842|526881226|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
146098686|NCT01193842|526881222|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
146098687|NCT01193842|526881223|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146098688|NCT01193842|526881224|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146098689|NCT01193842|526881225|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146098690|NCT01193842|526881226|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
146098691|NCT01193842|526881222|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146098692|NCT01193842|526881223|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146098693|NCT01193842|526881224|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
146098694|NCT01193842|526881225|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146098695|NCT01193842|526881226|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
146098696|NCT01193842|526881222|FG000|Phase II: Randomized Groups|Death|0|||
146098697|NCT01193842|526881223|FG001|Phase II: Randomized Groups|Death|0|||
146098698|NCT01193842|526881224|FG002|Phase II: Randomized Groups|Death|0|||
146098699|NCT01193842|526881225|FG003|Phase II: Randomized Groups|Death|1|||
146098700|NCT01193842|526881226|FG004|Phase II: Randomized Groups|Death|1|||
146098701|NCT01193842|526881222|FG000|Phase II: Randomized Groups|Adverse Event|0|||
146098702|NCT01193842|526881223|FG001|Phase II: Randomized Groups|Adverse Event|0|||
146098703|NCT01193842|526881224|FG002|Phase II: Randomized Groups|Adverse Event|0|||
146098704|NCT01193842|526881225|FG003|Phase II: Randomized Groups|Adverse Event|5|||
146098705|NCT01193842|526881226|FG004|Phase II: Randomized Groups|Adverse Event|3|||
146098706|NCT01193842|526881222|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146098707|NCT01193842|526881223|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146098708|NCT01193842|526881224|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
146098709|NCT01193842|526881225|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
146098710|NCT01193842|526881226|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
146036335|NCT01600092|526645716|FG001|Overall Study|Adverse Event|0|||
146036336|NCT01600092|526645715|FG000|Overall Study|Lost to Follow-up|4|||
146036337|NCT01600092|526645716|FG001|Overall Study|Lost to Follow-up|6|||
146036338|NCT01600092|526645715|FG000|Overall Study|Withdrawal by parent/guardian|8|||
146036339|NCT01600092|526645716|FG001|Overall Study|Withdrawal by parent/guardian|6|||
146036340|NCT01600092|526645715|FG000|Overall Study|Physician Decision|1|||
146036341|NCT01600092|526645716|FG001|Overall Study|Physician Decision|1|||
146036342|NCT01600092|526645715|FG000|Overall Study|Randomized but not vaccinated|3|||
146036343|NCT01600092|526645716|FG001|Overall Study|Randomized but not vaccinated|3|||
146098711|NCT01193842|526881222|FG000|Phase II: Randomized Groups|Ineligible|0|||
146098712|NCT01193842|526881223|FG001|Phase II: Randomized Groups|Ineligible|0|||
146098713|NCT01193842|526881224|FG002|Phase II: Randomized Groups|Ineligible|0|||
146098714|NCT01193842|526881225|FG003|Phase II: Randomized Groups|Ineligible|0|||
146036344|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
146098715|NCT01193842|526881226|FG004|Phase II: Randomized Groups|Ineligible|1|||
146098716|NCT01193842|526881222|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146098717|NCT01193842|526881223|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146098718|NCT01193842|526881224|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
146098719|NCT01193842|526881225|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
146098720|NCT01193842|526881226|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
146036345|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
146036346|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
146036347|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
146036348|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
146036349|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
146036350|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146036351|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146036352|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146036353|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146036354|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
146036355|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
146036356|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
146036357|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
146036358|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036359|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
146036360|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
146036361|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036362|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036363|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036364|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036365|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
146036366|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036367|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
146036368|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146036369|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146036370|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
146036371|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
146036372|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036373|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036374|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036375|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036376|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
146036377|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
146036378|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
146036379|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
146036380|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036381|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
146036382|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
146036383|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036384|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036385|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036386|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036387|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
146036388|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036389|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036390|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
146036391|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036392|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036393|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
146036394|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036395|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036396|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036397|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036398|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
146036399|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
146036400|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036401|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036402|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036403|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036404|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036405|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036406|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146254438|NCT04754594|527444591|FG002|Unblinded Period|Protocol Violation|0|||
146254439|NCT04754594|527444592|FG003|Unblinded Period|Protocol Violation|0|||
146254440|NCT04754594|527444589|FG000|Unblinded Period|Other|3|||
146254441|NCT04754594|527444590|FG001|Unblinded Period|Other|0|||
146254442|NCT04754594|527444591|FG002|Unblinded Period|Other|0|||
146036407|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036408|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036409|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
146036410|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036411|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036412|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
146036413|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036414|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036415|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036416|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036417|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036418|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036419|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036420|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
146036421|NCT02914561|526645717|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
146036422|NCT02914561|526645718|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036423|NCT02914561|526645719|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146036424|NCT02914561|526645720|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146036425|NCT02914561|526645721|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146036426|NCT02914561|526645722|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
146036427|NCT02914561|526645723|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036428|NCT02914561|526645724|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036429|NCT02914561|526645725|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036430|NCT02914561|526645726|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036431|NCT02914561|526645727|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
146036432|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036433|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036434|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036435|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036436|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036437|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
146036438|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
146036439|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
146036440|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
146036441|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
146036442|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
146036443|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036444|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036445|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036446|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036447|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036448|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
146036449|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
146036450|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
146036451|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
146036452|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
146036453|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
146036454|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036455|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036456|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036457|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036458|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036459|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
146036460|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
146036461|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
146036462|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
146036463|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
146036464|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
146036465|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036466|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036467|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036468|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036469|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036470|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146254443|NCT04754594|527444592|FG003|Unblinded Period|Other|0|||
146254444|NCT04754594|527444589|FG000|Infant Participants|Withdrawal by Subject|0|||
146036471|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
146036472|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036473|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
146036474|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
146036475|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
146036476|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036477|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036478|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036479|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036480|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036481|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036482|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
146036483|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
146036484|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
146036485|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
146036486|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
146036487|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036488|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036489|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036490|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036491|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036492|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036493|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
146036494|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036495|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
146036496|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036497|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
146036498|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036499|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036500|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036501|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036502|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036503|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036504|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036505|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036506|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
146036507|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036508|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
146036509|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036510|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036511|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036512|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036513|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036514|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036515|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
146036516|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036517|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036518|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036519|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
146036520|NCT02914561|526645717|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036521|NCT02914561|526645718|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036522|NCT02914561|526645719|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036523|NCT02914561|526645720|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036524|NCT02914561|526645721|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036525|NCT02914561|526645722|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036526|NCT02914561|526645723|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036527|NCT02914561|526645724|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
146036528|NCT02914561|526645725|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146036529|NCT02914561|526645726|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146254445|NCT04754594|527444590|FG001|Infant Participants|Withdrawal by Subject|0|||
146036530|NCT02914561|526645727|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
146254446|NCT04754594|527444591|FG002|Infant Participants|Withdrawal by Subject|9|||
146254447|NCT04754594|527444592|FG003|Infant Participants|Withdrawal by Subject|17|||
146254448|NCT04754594|527444589|FG000|Infant Participants|Lost to Follow-up|0|||
146036531|NCT01300455|526645728|FG000|Washout|Withdrawal by Subject|1|||
146036532|NCT01300455|526645729|FG001|Washout|Withdrawal by Subject|0|||
146036533|NCT03332160|526645730|FG000|Overall Study|Withdrawal by Subject|1|||
146036534|NCT03332160|526645731|FG001|Overall Study|Withdrawal by Subject|1|||
146036535|NCT03332160|526645730|FG000|Overall Study|Adverse Event|0|||
146036536|NCT03332160|526645731|FG001|Overall Study|Adverse Event|1|||
146036537|NCT03332160|526645730|FG000|Overall Study|Developed Exclusion Criteria|0|||
146036538|NCT03332160|526645731|FG001|Overall Study|Developed Exclusion Criteria|1|||
146036539|NCT03332160|526645730|FG000|Overall Study|Non-adherence to treatment|0|||
146036540|NCT03332160|526645731|FG001|Overall Study|Non-adherence to treatment|2|||
146036541|NCT01270256|526645737|FG000|Overall Study|Withdrawal by Subject|1|||
146036542|NCT01270256|526645738|FG001|Overall Study|Withdrawal by Subject|0|||
146036543|NCT02879578|526645741|FG000|Overall Study|Adverse Event|1|||
146036544|NCT02879578|526645742|FG001|Overall Study|Adverse Event|2|||
146036545|NCT02879578|526645743|FG002|Overall Study|Adverse Event|14|||
146036546|NCT02879578|526645741|FG000|Overall Study|Protocol Violation|0|||
146036547|NCT02879578|526645742|FG001|Overall Study|Protocol Violation|1|||
146036548|NCT02879578|526645743|FG002|Overall Study|Protocol Violation|1|||
146036549|NCT02879578|526645741|FG000|Overall Study|Withdrawal by Subject|8|||
146036550|NCT02879578|526645742|FG001|Overall Study|Withdrawal by Subject|6|||
146036551|NCT02879578|526645743|FG002|Overall Study|Withdrawal by Subject|9|||
146036552|NCT02879578|526645741|FG000|Overall Study|Lost to Follow-up|1|||
146036553|NCT02879578|526645742|FG001|Overall Study|Lost to Follow-up|0|||
146036554|NCT02879578|526645743|FG002|Overall Study|Lost to Follow-up|4|||
146036555|NCT02879578|526645741|FG000|Overall Study|Physician Decision|0|||
146036556|NCT02879578|526645742|FG001|Overall Study|Physician Decision|0|||
146036557|NCT02879578|526645743|FG002|Overall Study|Physician Decision|4|||
146036558|NCT05098509|526645744|FG000|Overall Study|Withdrawal by Subject|0|||
146036559|NCT05098509|526645745|FG001|Overall Study|Withdrawal by Subject|0|||
146036560|NCT05098509|526645746|FG002|Overall Study|Withdrawal by Subject|1|||
146036561|NCT05098509|526645747|FG003|Overall Study|Withdrawal by Subject|0|||
146036562|NCT05098509|526645744|FG000|Overall Study|Early study termination|1|||
146036563|NCT05098509|526645745|FG001|Overall Study|Early study termination|1|||
146036564|NCT05098509|526645746|FG002|Overall Study|Early study termination|1|||
146036565|NCT05098509|526645747|FG003|Overall Study|Early study termination|0|||
146036566|NCT01972789|526645750|FG000|Overall Study|Adverse Event|11|||
146036567|NCT01972789|526645751|FG001|Overall Study|Adverse Event|4|||
146036568|NCT01972789|526645750|FG000|Overall Study|Subject withdrew consent|14|||
146036569|NCT01972789|526645751|FG001|Overall Study|Subject withdrew consent|12|||
146098721|NCT02484690|526881228|FG000|Overall Study|Adverse Event|1|||
146098722|NCT02484690|526881229|FG001|Overall Study|Adverse Event|3|||
146098723|NCT02484690|526881230|FG002|Overall Study|Adverse Event|0|||
146098724|NCT02484690|526881231|FG003|Overall Study|Adverse Event|0|||
146098725|NCT02484690|526881232|FG004|Overall Study|Adverse Event|5|||
146098726|NCT02484690|526881228|FG000|Overall Study|Death|0|||
146098727|NCT02484690|526881229|FG001|Overall Study|Death|0|||
146098728|NCT02484690|526881230|FG002|Overall Study|Death|0|||
146098729|NCT02484690|526881231|FG003|Overall Study|Death|0|||
146098730|NCT02484690|526881232|FG004|Overall Study|Death|1|||
146098731|NCT02484690|526881228|FG000|Overall Study|Withdrawal by Subject|1|||
146098732|NCT02484690|526881229|FG001|Overall Study|Withdrawal by Subject|3|||
146098733|NCT02484690|526881230|FG002|Overall Study|Withdrawal by Subject|1|||
146098734|NCT02484690|526881231|FG003|Overall Study|Withdrawal by Subject|2|||
146098735|NCT02484690|526881232|FG004|Overall Study|Withdrawal by Subject|0|||
146098736|NCT02484690|526881228|FG000|Overall Study|Physician Decision|2|||
146098737|NCT02484690|526881229|FG001|Overall Study|Physician Decision|0|||
146098738|NCT02484690|526881230|FG002|Overall Study|Physician Decision|1|||
146098739|NCT02484690|526881231|FG003|Overall Study|Physician Decision|0|||
146098740|NCT02484690|526881232|FG004|Overall Study|Physician Decision|0|||
146098741|NCT02484690|526881228|FG000|Overall Study|Lost to Follow-up|0|||
146098742|NCT02484690|526881229|FG001|Overall Study|Lost to Follow-up|0|||
146036570|NCT01972789|526645750|FG000|Overall Study|Lost to Follow-up|4|||
146036571|NCT01972789|526645751|FG001|Overall Study|Lost to Follow-up|7|||
146036572|NCT01972789|526645750|FG000|Overall Study|Death|7|||
146036573|NCT01972789|526645751|FG001|Overall Study|Death|5|||
146036574|NCT01972789|526645750|FG000|Overall Study|Protocol deviation|1|||
146036575|NCT01972789|526645751|FG001|Overall Study|Protocol deviation|0|||
146036576|NCT01972789|526645750|FG000|Overall Study|Physician Decision|3|||
146036577|NCT01972789|526645751|FG001|Overall Study|Physician Decision|2|||
146036578|NCT00086411|526645754|FG000|Overall Study|Lost to Follow-up|11|||
146036579|NCT00086411|526645755|FG001|Overall Study|Lost to Follow-up|11|||
146036580|NCT00086411|526645756|FG002|Overall Study|Lost to Follow-up|13|||
146036581|NCT00086411|526645757|FG003|Overall Study|Lost to Follow-up|12|||
146098743|NCT02484690|526881230|FG002|Overall Study|Lost to Follow-up|1|||
146098744|NCT02484690|526881231|FG003|Overall Study|Lost to Follow-up|0|||
146098745|NCT02484690|526881232|FG004|Overall Study|Lost to Follow-up|0|||
146098746|NCT03672643|526881233|FG000|Overall Study|Adverse Event|3|||
146098747|NCT03672643|526881233|FG000|Overall Study|Death|2|||
146098748|NCT03672643|526881233|FG000|Overall Study|Withdrawal by Subject|1|||
146098749|NCT03672643|526881233|FG000|Overall Study|Progressive disease|11|||
146036582|NCT01078168|526645760|FG000|Overall Study|Physician Decision|0|||
146036583|NCT01078168|526645761|FG001|Overall Study|Physician Decision|1|||
146036584|NCT03109184|526647397|FG000|Overall Study|Lost to Follow-up|6|||
146036585|NCT03109184|526647398|FG001|Overall Study|Lost to Follow-up|6|||
146036586|NCT03109184|526647397|FG000|Overall Study|Withdrawal by Subject|1|||
146036587|NCT03109184|526647398|FG001|Overall Study|Withdrawal by Subject|1|||
146036588|NCT00602420|526647399|FG000|Overall Study|Death|1|||
146036589|NCT00602420|526647400|FG001|Overall Study|Death|4|||
146036590|NCT00602420|526647399|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
146036591|NCT00602420|526647400|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
146036592|NCT00602420|526647399|FG000|Overall Study|Withdrawal by Subject|18|||
146036593|NCT00602420|526647400|FG001|Overall Study|Withdrawal by Subject|17|||
146036594|NCT00602420|526647399|FG000|Overall Study|Adverse Event|1|||
146036595|NCT00602420|526647400|FG001|Overall Study|Adverse Event|0|||
146036596|NCT02315560|526647404|FG000|Overall Study|noncompliance by subjects|3|||
146036597|NCT01209078|526647405|FG000|Overall Study|Adverse Event|5|||
146036598|NCT01209078|526647406|FG001|Overall Study|Adverse Event|0|||
146036599|NCT01209078|526647405|FG000|Overall Study|Lost to Follow-up|4|||
146036600|NCT01209078|526647406|FG001|Overall Study|Lost to Follow-up|0|||
146036601|NCT01209078|526647405|FG000|Overall Study|Physician Decision|5|||
146036602|NCT01209078|526647406|FG001|Overall Study|Physician Decision|2|||
146036603|NCT01209078|526647405|FG000|Overall Study|Withdrawal by Subject|2|||
146036604|NCT01209078|526647406|FG001|Overall Study|Withdrawal by Subject|1|||
146036605|NCT00924508|526647407|FG000|Overall Study|Withdrawal by Subject|3|||
146036606|NCT03464019|526647408|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
146036607|NCT03464019|526647409|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
146036608|NCT03464019|526647410|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
146036609|NCT03464019|526647408|FG000|NODE-301 Part 1|Ablation|0|||
146036610|NCT03464019|526647409|FG001|NODE-301 Part 1|Ablation|0|||
146036611|NCT03464019|526647410|FG002|NODE-301 Part 1|Ablation|16|||
146036612|NCT03464019|526647408|FG000|NODE-301 Part 1|Test Dose Failure|0|||
146036613|NCT03464019|526647409|FG001|NODE-301 Part 1|Test Dose Failure|0|||
146036614|NCT03464019|526647410|FG002|NODE-301 Part 1|Test Dose Failure|8|||
146036615|NCT03464019|526647408|FG000|NODE-301 Part 1|Adverse Event|0|||
146036616|NCT03464019|526647409|FG001|NODE-301 Part 1|Adverse Event|0|||
146036617|NCT03464019|526647410|FG002|NODE-301 Part 1|Adverse Event|5|||
146036618|NCT03464019|526647408|FG000|NODE-301 Part 1|Physician Decision|0|||
146036619|NCT03464019|526647409|FG001|NODE-301 Part 1|Physician Decision|0|||
146036620|NCT03464019|526647410|FG002|NODE-301 Part 1|Physician Decision|4|||
146036621|NCT03464019|526647408|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
146036622|NCT03464019|526647409|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
146036623|NCT03464019|526647410|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
146036624|NCT03464019|526647408|FG000|NODE-301 Part 1|Protocol Violation|0|||
146036625|NCT03464019|526647409|FG001|NODE-301 Part 1|Protocol Violation|0|||
146036626|NCT03464019|526647410|FG002|NODE-301 Part 1|Protocol Violation|2|||
146036627|NCT03464019|526647408|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
146036628|NCT03464019|526647409|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
146036629|NCT03464019|526647410|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
146036630|NCT03464019|526647408|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
146036631|NCT03464019|526647409|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
146036632|NCT03464019|526647410|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
146036633|NCT03464019|526647408|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
146036634|NCT03464019|526647409|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
146036635|NCT03464019|526647410|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
146036636|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
146036637|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
146036638|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
146036639|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
146036640|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
146036641|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
146036642|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
146036643|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
146036644|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
146036645|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
146036646|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
146036647|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
146036648|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
146036649|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
146036650|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
146036651|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
146098750|NCT03672643|526881233|FG000|Overall Study|Global deterioration of health status|1|||
146036652|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
146036653|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
146036654|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
146098751|NCT03672643|526881233|FG000|Overall Study|Refused further treatment|7|||
146098752|NCT03672643|526881233|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
146098753|NCT00589290|526881234|FG000|Overall Study|Withdrawal by Subject|1|||
146098754|NCT01067976|526881235|FG000|Overall Study|Study drug never administered|20|||
146098755|NCT01067976|526881235|FG000|Overall Study|Study prematurely discontinued|2|||
146098756|NCT00566111|526881236|FG000|Overall Study|Adverse Event|0|||
146098757|NCT00566111|526881237|FG001|Overall Study|Adverse Event|2|||
146098758|NCT00976677|526881238|FG000|Overall Study|Adverse Event|1|||
146098759|NCT00976677|526881239|FG001|Overall Study|Adverse Event|0|||
146098760|NCT00976677|526881238|FG000|Overall Study|Withdrawal by Subject|0|||
146098761|NCT00976677|526881239|FG001|Overall Study|Withdrawal by Subject|2|||
146098762|NCT00976677|526881238|FG000|Overall Study|Disease progression|1|||
146098763|NCT00976677|526881239|FG001|Overall Study|Disease progression|1|||
146098764|NCT00976677|526881238|FG000|Overall Study|Trial unblinded|2|||
146098765|NCT00976677|526881239|FG001|Overall Study|Trial unblinded|2|||
146098766|NCT00976677|526881238|FG000|Overall Study|Unknown/Missing|1|||
146098767|NCT00976677|526881239|FG001|Overall Study|Unknown/Missing|0|||
146098768|NCT02468232|526882636|FG000|Core Part of Study|Adverse Event|0|||
146098769|NCT02468232|526882637|FG001|Core Part of Study|Adverse Event|1|||
146098770|NCT02468232|526882638|FG002|Core Part of Study|Adverse Event|0|||
146098771|NCT02468232|526882639|FG003|Core Part of Study|Adverse Event|0|||
146098772|NCT02468232|526882636|FG000|Core Part of Study|Death|20|||
146098773|NCT02468232|526882637|FG001|Core Part of Study|Death|17|||
146098774|NCT02468232|526882638|FG002|Core Part of Study|Death|0|||
146098775|NCT02468232|526882639|FG003|Core Part of Study|Death|0|||
146098776|NCT02468232|526882636|FG000|Core Part of Study|Technical Problems|1|||
146098777|NCT02468232|526882637|FG001|Core Part of Study|Technical Problems|1|||
146098778|NCT02468232|526882638|FG002|Core Part of Study|Technical Problems|0|||
146098779|NCT02468232|526882639|FG003|Core Part of Study|Technical Problems|0|||
146098780|NCT02468232|526882636|FG000|OLE Part of Study|Adverse Event|0|||
146098781|NCT02468232|526882637|FG001|OLE Part of Study|Adverse Event|0|||
146098782|NCT02468232|526882638|FG002|OLE Part of Study|Adverse Event|4|||
146098783|NCT02468232|526882639|FG003|OLE Part of Study|Adverse Event|5|||
146098784|NCT02468232|526882636|FG000|OLE Part of Study|Death|0|||
146098785|NCT02468232|526882637|FG001|OLE Part of Study|Death|0|||
146098786|NCT02468232|526882638|FG002|OLE Part of Study|Death|4|||
146098787|NCT02468232|526882639|FG003|OLE Part of Study|Death|2|||
146098788|NCT02468232|526882636|FG000|OLE Part of Study|Physician Decision|0|||
146098789|NCT02468232|526882637|FG001|OLE Part of Study|Physician Decision|0|||
146098790|NCT02468232|526882638|FG002|OLE Part of Study|Physician Decision|4|||
146098791|NCT02468232|526882639|FG003|OLE Part of Study|Physician Decision|0|||
146098792|NCT02468232|526882636|FG000|OLE Part of Study|Subject/Guardian decision|0|||
146098793|NCT02468232|526882637|FG001|OLE Part of Study|Subject/Guardian decision|0|||
146098794|NCT02468232|526882638|FG002|OLE Part of Study|Subject/Guardian decision|2|||
146098795|NCT02468232|526882639|FG003|OLE Part of Study|Subject/Guardian decision|5|||
146098796|NCT02024529|526882642|FG000|Overall Study|Withdrawal by Subject|11|||
146098797|NCT02024529|526882643|FG001|Overall Study|Withdrawal by Subject|21|||
146098798|NCT02024529|526882642|FG000|Overall Study|Lost to Follow-up|2|||
146098799|NCT02024529|526882643|FG001|Overall Study|Lost to Follow-up|4|||
146098800|NCT00354614|526882644|FG000|Overall Study|Lack of Efficacy|28|||
146098801|NCT03650556|526882645|FG000|Overall Study|Death|2|||
146098802|NCT03650556|526882645|FG000|Overall Study|Withdrawal by Subject|20|||
146098803|NCT03650556|526882645|FG000|Overall Study|Physician Decision|2|||
146098804|NCT03650556|526882645|FG000|Overall Study|Lost to Follow-up|8|||
146098805|NCT03650556|526882645|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
146098806|NCT03650556|526882645|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
146098807|NCT01426438|526882648|FG000|Overall Study|Lost to Follow-up|1|||
146098808|NCT01426438|526882649|FG001|Overall Study|Lost to Follow-up|3|||
146098809|NCT01426438|526882648|FG000|Overall Study|Off study Treatment|9|||
146098810|NCT01426438|526882649|FG001|Overall Study|Off study Treatment|3|||
146098811|NCT01426438|526882648|FG000|Overall Study|Poor scan quality|3|||
146098812|NCT01426438|526882649|FG001|Overall Study|Poor scan quality|2|||
146098813|NCT01426438|526882648|FG000|Overall Study|Missed Scan|2|||
146098814|NCT01426438|526882649|FG001|Overall Study|Missed Scan|2|||
146098815|NCT02122458|526882650|FG000|Overall Study|Withdrawal by Subject|0|||
146098816|NCT02122458|526882651|FG001|Overall Study|Withdrawal by Subject|0|||
146098817|NCT02122458|526882652|FG002|Overall Study|Withdrawal by Subject|0|||
146098818|NCT02122458|526882653|FG003|Overall Study|Withdrawal by Subject|4|||
146098819|NCT02122458|526882654|FG004|Overall Study|Withdrawal by Subject|4|||
146098820|NCT02122458|526882655|FG005|Overall Study|Withdrawal by Subject|4|||
146098821|NCT02122458|526882656|FG006|Overall Study|Withdrawal by Subject|0|||
146098822|NCT02122458|526882650|FG000|Overall Study|Lost to Follow-up|1|||
146098823|NCT02122458|526882651|FG001|Overall Study|Lost to Follow-up|3|||
146098824|NCT02122458|526882652|FG002|Overall Study|Lost to Follow-up|0|||
146098825|NCT02122458|526882653|FG003|Overall Study|Lost to Follow-up|7|||
146098826|NCT02122458|526882654|FG004|Overall Study|Lost to Follow-up|5|||
146098827|NCT02122458|526882655|FG005|Overall Study|Lost to Follow-up|15|||
146036655|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
146036656|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
146036657|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
146036658|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
146036659|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
146036660|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
146036661|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
146036662|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
146036663|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
146036664|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
146036665|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
146036666|NCT03464019|526647408|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
146036667|NCT03464019|526647409|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
146036668|NCT03464019|526647410|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
146036669|NCT00767806|526647411|FG000|Overall Study|Adverse Event|30|||
146036670|NCT00767806|526647412|FG001|Overall Study|Adverse Event|11|||
146036671|NCT00767806|526647411|FG000|Overall Study|Withdrawal by Subject|8|||
146036672|NCT00767806|526647412|FG001|Overall Study|Withdrawal by Subject|13|||
146036673|NCT00767806|526647411|FG000|Overall Study|Protocol Violation|6|||
146036674|NCT00767806|526647412|FG001|Overall Study|Protocol Violation|5|||
146036675|NCT00767806|526647411|FG000|Overall Study|Lack of Efficacy|1|||
146036676|NCT00767806|526647412|FG001|Overall Study|Lack of Efficacy|9|||
146036677|NCT00767806|526647411|FG000|Overall Study|Physician Decision|4|||
146036678|NCT00767806|526647412|FG001|Overall Study|Physician Decision|3|||
146036679|NCT00767806|526647411|FG000|Overall Study|Lost to Follow-up|1|||
146036680|NCT00767806|526647412|FG001|Overall Study|Lost to Follow-up|4|||
146036681|NCT00767806|526647411|FG000|Overall Study|Entry Criteria Not Met|1|||
146036682|NCT00767806|526647412|FG001|Overall Study|Entry Criteria Not Met|1|||
146036683|NCT00767806|526647411|FG000|Overall Study|Sponsor Decision|0|||
146036684|NCT00767806|526647412|FG001|Overall Study|Sponsor Decision|1|||
146036685|NCT00372697|526647413|FG000|Overall Study|Protocol Violation|1|||
146036686|NCT00372697|526647414|FG001|Overall Study|Protocol Violation|1|||
146036687|NCT01815840|526647415|FG000|Overall Study|Missing|1|||
146036688|NCT01815840|526647416|FG001|Overall Study|Missing|0|||
146036689|NCT01815840|526647415|FG000|Overall Study|Withdrew Consent|31|||
146036690|NCT01815840|526647416|FG001|Overall Study|Withdrew Consent|30|||
146036691|NCT01815840|526647415|FG000|Overall Study|Administrative/Other|1|||
146036692|NCT01815840|526647416|FG001|Overall Study|Administrative/Other|3|||
146036693|NCT01815840|526647415|FG000|Overall Study|Adverse Event|10|||
146036694|NCT01815840|526647416|FG001|Overall Study|Adverse Event|16|||
146036695|NCT01815840|526647415|FG000|Overall Study|Death|2|||
146036696|NCT01815840|526647416|FG001|Overall Study|Death|2|||
146036697|NCT01815840|526647415|FG000|Overall Study|Disease progression|3|||
146036698|NCT01815840|526647416|FG001|Overall Study|Disease progression|2|||
146036699|NCT01815840|526647415|FG000|Overall Study|Investigators Decision|2|||
146036700|NCT01815840|526647416|FG001|Overall Study|Investigators Decision|3|||
146036701|NCT01815840|526647415|FG000|Overall Study|Lost to Follow-up|3|||
146036702|NCT01815840|526647416|FG001|Overall Study|Lost to Follow-up|6|||
146036703|NCT01815840|526647415|FG000|Overall Study|Refused Treatment|5|||
146036704|NCT01815840|526647416|FG001|Overall Study|Refused Treatment|1|||
146036705|NCT01815840|526647415|FG000|Overall Study|Sponsor Termination Treatment|1|||
146036706|NCT01815840|526647416|FG001|Overall Study|Sponsor Termination Treatment|0|||
146036707|NCT03221842|526647417|FG000|Period 1 (Open-label)|Adverse Event|4|||
146036708|NCT03221842|526647418|FG001|Period 1 (Open-label)|Adverse Event|0|||
146036709|NCT03221842|526647417|FG000|Period 1 (Open-label)|Physician Decision|2|||
146036710|NCT03221842|526647418|FG001|Period 1 (Open-label)|Physician Decision|0|||
146036711|NCT03221842|526647417|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
146036712|NCT03221842|526647418|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
146036713|NCT03221842|526647417|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
146036714|NCT03221842|526647418|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
146036715|NCT03221842|526647417|FG000|Period 1 (Open-label)|Other|2|||
146036716|NCT03221842|526647418|FG001|Period 1 (Open-label)|Other|0|||
146036717|NCT03221842|526647417|FG000|Period 2 (Randomized, Blinded)|Death|0|||
146036718|NCT03221842|526647418|FG001|Period 2 (Randomized, Blinded)|Death|1|||
146254449|NCT04754594|527444590|FG001|Infant Participants|Lost to Follow-up|0|||
146036719|NCT03221842|526647417|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
146036720|NCT03221842|526647418|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
146036721|NCT00704288|526647420|FG000|Overall Treatment Period|Adverse Event|11|||
146036722|NCT00704288|526647421|FG001|Overall Treatment Period|Adverse Event|8|||
146036723|NCT00704288|526647422|FG002|Overall Treatment Period|Adverse Event|22|||
146254450|NCT04754594|527444591|FG002|Infant Participants|Lost to Follow-up|4|||
146036724|NCT00704288|526647420|FG000|Overall Treatment Period|Death|0|||
146036725|NCT00704288|526647421|FG001|Overall Treatment Period|Death|0|||
146036726|NCT00704288|526647422|FG002|Overall Treatment Period|Death|1|||
146036727|NCT00704288|526647420|FG000|Overall Treatment Period|Physician Decision|0|||
146036728|NCT00704288|526647421|FG001|Overall Treatment Period|Physician Decision|2|||
146036729|NCT00704288|526647422|FG002|Overall Treatment Period|Physician Decision|0|||
146036730|NCT00704288|526647420|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
146036731|NCT00704288|526647421|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
146036732|NCT00704288|526647422|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
146036733|NCT00704288|526647420|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
146036734|NCT00704288|526647421|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
146036735|NCT00704288|526647422|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
146036736|NCT00704288|526647420|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
146036737|NCT00704288|526647421|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
146036738|NCT00704288|526647422|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
146036739|NCT00704288|526647420|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
146036740|NCT00704288|526647421|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
146036741|NCT00704288|526647422|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
146036742|NCT00704288|526647420|FG000|Overall Treatment Period|Roll-over to another study|1|||
146036743|NCT00704288|526647421|FG001|Overall Treatment Period|Roll-over to another study|0|||
146036744|NCT00704288|526647422|FG002|Overall Treatment Period|Roll-over to another study|4|||
146036745|NCT00704288|526647420|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
146036746|NCT00704288|526647421|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
146036747|NCT00704288|526647422|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
146036748|NCT00704288|526647420|FG000|Extended Post Treatment Follow Up Period|Death|41|||
146036749|NCT00704288|526647421|FG001|Extended Post Treatment Follow Up Period|Death|50|||
146036750|NCT00704288|526647422|FG002|Extended Post Treatment Follow Up Period|Death|93|||
146036751|NCT00704288|526647420|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
146036752|NCT00704288|526647421|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
146036753|NCT00704288|526647422|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
146036754|NCT00704288|526647420|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
146036755|NCT00704288|526647421|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
146036756|NCT00704288|526647422|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
146036757|NCT00704288|526647420|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
146036758|NCT00704288|526647421|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
146036759|NCT00704288|526647422|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
146036760|NCT01055314|526647423|FG000|Overall Study|Adverse Event|7|||
146036761|NCT01055314|526647424|FG001|Overall Study|Adverse Event|4|||
146036762|NCT01055314|526647423|FG000|Overall Study|Death|2|||
146036763|NCT01055314|526647424|FG001|Overall Study|Death|1|||
146036764|NCT01055314|526647423|FG000|Overall Study|Lack of Efficacy|11|||
146036765|NCT01055314|526647424|FG001|Overall Study|Lack of Efficacy|19|||
146036766|NCT01055314|526647423|FG000|Overall Study|Physician Decision|10|||
146036767|NCT01055314|526647424|FG001|Overall Study|Physician Decision|5|||
146036768|NCT01055314|526647423|FG000|Overall Study|Withdrawal by Subject|1|||
146036769|NCT01055314|526647424|FG001|Overall Study|Withdrawal by Subject|0|||
146036770|NCT01055314|526647423|FG000|Overall Study|Ineligible|3|||
146036771|NCT01055314|526647424|FG001|Overall Study|Ineligible|5|||
146036772|NCT01055314|526647423|FG000|Overall Study|Refusal of further protocol therapy|10|||
146036773|NCT01055314|526647424|FG001|Overall Study|Refusal of further protocol therapy|4|||
146036774|NCT01055314|526647423|FG000|Overall Study|No treatment|1|||
146036775|NCT01055314|526647424|FG001|Overall Study|No treatment|0|||
146036776|NCT00568126|526647425|FG000|Overall Study|Adverse Event|3|||
146036777|NCT00568126|526647426|FG001|Overall Study|Adverse Event|0|||
146036778|NCT00568126|526647425|FG000|Overall Study|Withdrawal by Subject|2|||
146036779|NCT00568126|526647426|FG001|Overall Study|Withdrawal by Subject|3|||
146036780|NCT00568126|526647425|FG000|Overall Study|Lost to Follow-up|4|||
146036781|NCT00568126|526647426|FG001|Overall Study|Lost to Follow-up|3|||
146036782|NCT00568126|526647425|FG000|Overall Study|Lack of Efficacy|0|||
146036783|NCT00568126|526647426|FG001|Overall Study|Lack of Efficacy|1|||
146036784|NCT00568126|526647425|FG000|Overall Study|Physician Decision|2|||
146036785|NCT00568126|526647426|FG001|Overall Study|Physician Decision|2|||
146036786|NCT04395690|526647427|FG000|Overall Study|Lost to Follow-up|1|||
146036787|NCT04395690|526647428|FG001|Overall Study|Lost to Follow-up|1|||
146036788|NCT04512976|526647429|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146036789|NCT04512976|526647430|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146036790|NCT04512976|526647431|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146036791|NCT04512976|526647432|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146036792|NCT04512976|526647433|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
146036793|NCT04512976|526647434|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
146098828|NCT02122458|526882656|FG006|Overall Study|Lost to Follow-up|1|||
146098829|NCT02122458|526882650|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
146168160|NCT02496767|527128085|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
146036794|NCT03446456|526647435|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
146036795|NCT03446456|526647436|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
146036796|NCT03446456|526647435|FG000|Overall Study|Lost to Follow-up|1|||
146036797|NCT03446456|526647436|FG001|Overall Study|Lost to Follow-up|3|||
146036798|NCT03446456|526647435|FG000|Overall Study|Participant failed the toxicology test|1|||
146036799|NCT03446456|526647436|FG001|Overall Study|Participant failed the toxicology test|0|||
146036800|NCT03446456|526647435|FG000|Overall Study|Break down of the experimental equipment|1|||
146036801|NCT03446456|526647436|FG001|Overall Study|Break down of the experimental equipment|0|||
146036802|NCT04369950|526647437|FG000|Overall Study|Protocol Violation|2|||
146036803|NCT04369950|526647438|FG001|Overall Study|Protocol Violation|2|||
146036804|NCT00989963|526647439|FG000|Overall Study|Adverse Event|1|||
146036805|NCT00989963|526647440|FG001|Overall Study|Adverse Event|1|||
146036806|NCT00989963|526647441|FG002|Overall Study|Adverse Event|1|||
146036807|NCT01529034|526647450|FG000|Overall Study|Discontinued prior to study treatment|14|||
146036808|NCT01529034|526647450|FG000|Overall Study|Site closure|62|||
146036809|NCT01529034|526647450|FG000|Overall Study|Study termination|29|||
146036810|NCT01529034|526647450|FG000|Overall Study|Withdrawal by Subject|25|||
146036811|NCT01529034|526647450|FG000|Overall Study|No treated SCs within protocol window|13|||
146036812|NCT01529034|526647450|FG000|Overall Study|Noncompliance|8|||
146036813|NCT01529034|526647450|FG000|Overall Study|Caregiver no longer available|7|||
146036814|NCT01529034|526647450|FG000|Overall Study|Adverse Event|4|||
146036815|NCT01529034|526647450|FG000|Overall Study|Protocol Violation|4|||
146036816|NCT01529034|526647450|FG000|Overall Study|Lack of Efficacy|4|||
146036817|NCT01529034|526647450|FG000|Overall Study|Investigator no longer available|2|||
146036818|NCT01529034|526647450|FG000|Overall Study|Study drug not available|2|||
146036819|NCT04588389|526647451|FG000|Overall Study|Issues with anesthesia during surgery|2|||
146036820|NCT04588389|526647452|FG001|Overall Study|Issues with anesthesia during surgery|0|||
146036821|NCT04588389|526647453|FG002|Overall Study|Issues with anesthesia during surgery|0|||
146036822|NCT02649894|526647456|FG000|Overall Study|Adverse Event|1|||
146036823|NCT02649894|526647457|FG001|Overall Study|Adverse Event|0|||
146036824|NCT02649894|526647456|FG000|Overall Study|Physician Decision|0|||
146036825|NCT02649894|526647457|FG001|Overall Study|Physician Decision|1|||
146036826|NCT02649894|526647456|FG000|Overall Study|Withdrawal by Subject|5|||
146036827|NCT02649894|526647457|FG001|Overall Study|Withdrawal by Subject|2|||
146036828|NCT02649894|526647456|FG000|Overall Study|Lost to Follow-up|2|||
146036829|NCT02649894|526647457|FG001|Overall Study|Lost to Follow-up|1|||
146036830|NCT02649894|526647456|FG000|Overall Study|Death|30|||
146036831|NCT02649894|526647457|FG001|Overall Study|Death|7|||
146036832|NCT02649894|526647456|FG000|Overall Study|Other, not specified|6|||
146036833|NCT02649894|526647457|FG001|Overall Study|Other, not specified|0|||
146036834|NCT00719680|526647458|FG000|Overall Study|Adverse Event|1|||
146036835|NCT00719680|526647458|FG000|Overall Study|Lost to Follow-up|1|||
146036836|NCT00719680|526647458|FG000|Overall Study|Withdrawal by Subject|3|||
146036837|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
146036838|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
146036839|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
146036840|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
146036841|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
146036842|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
146036843|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Death|1|||
146036844|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Death|4|||
146036845|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
146036846|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
146036847|NCT00658814|526647459|FG000|Remission Induction Chemotherapy|Not eligible|1|||
146036848|NCT00658814|526647460|FG001|Remission Induction Chemotherapy|Not eligible|2|||
146036849|NCT00658814|526647459|FG000|Consolidation Therapy|Not protocol specified|0|||
146036850|NCT00658814|526647460|FG001|Consolidation Therapy|Not protocol specified|1|||
146036851|NCT00658814|526647459|FG000|Consolidation Therapy|Not eligible|2|||
146036852|NCT00658814|526647460|FG001|Consolidation Therapy|Not eligible|2|||
146036853|NCT00658814|526647459|FG000|Maintenance Therapy|Adverse Event|1|||
146036854|NCT00658814|526647460|FG001|Maintenance Therapy|Adverse Event|1|||
146036855|NCT00658814|526647459|FG000|Maintenance Therapy|Not protocol specified|1|||
146036856|NCT00658814|526647460|FG001|Maintenance Therapy|Not protocol specified|0|||
146036857|NCT00658814|526647459|FG000|Maintenance Therapy|Not eligible|1|||
146036858|NCT00658814|526647460|FG001|Maintenance Therapy|Not eligible|0|||
146036859|NCT02911142|526647461|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
146036860|NCT02911142|526647461|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
146036861|NCT02911142|526647461|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
146036862|NCT02911142|526647461|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
146036863|NCT00847015|526647464|FG000|Overall Study|Withdrawal by Subject|1|||
146036864|NCT00847015|526647464|FG000|Overall Study|declined any surgery|1|||
146036865|NCT00847015|526647464|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
146098830|NCT02122458|526882651|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098831|NCT02122458|526882652|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098832|NCT02122458|526882653|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098833|NCT02122458|526882654|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098834|NCT02122458|526882655|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098835|NCT02122458|526882656|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
146098836|NCT02122458|526882650|FG000|Overall Study|Adverse Event|1|||
146098837|NCT02122458|526882651|FG001|Overall Study|Adverse Event|0|||
146098838|NCT02122458|526882652|FG002|Overall Study|Adverse Event|0|||
146098839|NCT02122458|526882653|FG003|Overall Study|Adverse Event|0|||
146098840|NCT02122458|526882654|FG004|Overall Study|Adverse Event|0|||
146098841|NCT02122458|526882655|FG005|Overall Study|Adverse Event|0|||
146098842|NCT02122458|526882656|FG006|Overall Study|Adverse Event|0|||
146036866|NCT01141478|526647465|FG000|Overall Study|Withdrawal by Subject|1|||
146036867|NCT01141478|526647466|FG001|Overall Study|Withdrawal by Subject|1|||
146036868|NCT01953913|526647471|FG000|Overall Study|Disease Progression|349|||
146036869|NCT01953913|526647471|FG000|Overall Study|Worsening of underlying cancer|22|||
146036870|NCT01953913|526647471|FG000|Overall Study|Adverse Event|20|||
146036871|NCT01953913|526647471|FG000|Overall Study|Protocol Violation|6|||
146036872|NCT01953913|526647471|FG000|Overall Study|Lost to Follow-up|4|||
146036873|NCT01953913|526647471|FG000|Overall Study|Withdrawal by Subject|32|||
146036874|NCT01953913|526647471|FG000|Overall Study|Other than listed|108|||
146036875|NCT01953913|526647471|FG000|Overall Study|Not Treated|1|||
146036876|NCT05026853|526647472|FG000|Overall Study|Cancelled appointment|1|||
146036877|NCT05026853|526647473|FG001|Overall Study|Cancelled appointment|0|||
146036878|NCT05026853|526647472|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
146036879|NCT05026853|526647473|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
146036880|NCT05026853|526647472|FG000|Overall Study|Did not complete 12-week survey|16|||
146036881|NCT05026853|526647473|FG001|Overall Study|Did not complete 12-week survey|16|||
146036882|NCT03836677|526647474|FG000|Period 1|Adverse Event|0|||
146036883|NCT03836677|526647475|FG001|Period 1|Adverse Event|1|||
146036884|NCT03836677|526647474|FG000|Period 2|Severe non-compliance to protocol|1|||
146036885|NCT03836677|526647475|FG001|Period 2|Severe non-compliance to protocol|0|||
146036886|NCT01732913|526647476|FG000|Overall Study|Study Terminated by Sponsor|105|||
146036887|NCT01732913|526647477|FG001|Overall Study|Study Terminated by Sponsor|55|||
146036888|NCT01732913|526647476|FG000|Overall Study|Withdrawal by Subject|27|||
146036889|NCT01732913|526647477|FG001|Overall Study|Withdrawal by Subject|4|||
146036890|NCT01732913|526647476|FG000|Overall Study|Physician Decision|14|||
146036891|NCT01732913|526647477|FG001|Overall Study|Physician Decision|7|||
146036892|NCT01732913|526647476|FG000|Overall Study|Other|7|||
146036893|NCT01732913|526647477|FG001|Overall Study|Other|1|||
146036894|NCT01732913|526647476|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
146036895|NCT01732913|526647477|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
146036896|NCT02895945|526647478|FG000|Overall Study|Physician Decision|2|||
146036897|NCT02895945|526647479|FG001|Overall Study|Physician Decision|1|||
146036898|NCT03233438|526647482|FG000|Overall Study|Lost to Follow-up|4|||
146036899|NCT03233438|526647483|FG001|Overall Study|Lost to Follow-up|9|||
146036900|NCT03233438|526647482|FG000|Overall Study|Withdrawal by Subject|2|||
146036901|NCT03233438|526647483|FG001|Overall Study|Withdrawal by Subject|1|||
146036902|NCT03233438|526647482|FG000|Overall Study|No recording of dalbavancin|0|||
146036903|NCT03233438|526647483|FG001|Overall Study|No recording of dalbavancin|1|||
146036904|NCT02345330|526647484|FG000|Overall Study|Death|1|||
146036905|NCT02345330|526647484|FG000|Overall Study|Progressive Disease|2|||
146036906|NCT03831945|526647485|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
146036907|NCT03831945|526647486|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
146098843|NCT02122458|526882650|FG000|Overall Study|Experimental Error|0|||
146254451|NCT04754594|527444592|FG003|Infant Participants|Lost to Follow-up|10|||
146036908|NCT03831945|526647485|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
146036909|NCT03831945|526647486|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
146036910|NCT03831945|526647485|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
146098844|NCT02122458|526882651|FG001|Overall Study|Experimental Error|0|||
146098845|NCT02122458|526882652|FG002|Overall Study|Experimental Error|0|||
146098846|NCT02122458|526882653|FG003|Overall Study|Experimental Error|0|||
146098847|NCT02122458|526882654|FG004|Overall Study|Experimental Error|3|||
146254452|NCT04754594|527444589|FG000|Infant Participants|Death|0|||
146036911|NCT03831945|526647486|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
146036912|NCT03178669|526647487|FG000|Overall Study|Adverse Event|4|||
146036913|NCT03178669|526647488|FG001|Overall Study|Adverse Event|1|||
146098848|NCT02122458|526882655|FG005|Overall Study|Experimental Error|0|||
146098849|NCT02122458|526882656|FG006|Overall Study|Experimental Error|0|||
146098850|NCT02122458|526882650|FG000|Overall Study|Deployed or Moved|0|||
146098851|NCT02122458|526882651|FG001|Overall Study|Deployed or Moved|0|||
146098852|NCT02122458|526882652|FG002|Overall Study|Deployed or Moved|0|||
146098853|NCT02122458|526882653|FG003|Overall Study|Deployed or Moved|0|||
146098854|NCT02122458|526882654|FG004|Overall Study|Deployed or Moved|1|||
146098855|NCT02122458|526882655|FG005|Overall Study|Deployed or Moved|0|||
146098856|NCT02122458|526882656|FG006|Overall Study|Deployed or Moved|0|||
146098857|NCT02122458|526882650|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
146098858|NCT02122458|526882651|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
146098859|NCT02122458|526882652|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
146098860|NCT02122458|526882653|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
146098861|NCT02122458|526882654|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
146098862|NCT02122458|526882655|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
146098863|NCT02122458|526882656|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
146098864|NCT02122458|526882650|FG000|Overall Study|Noncompliance|0|||
146098865|NCT02122458|526882651|FG001|Overall Study|Noncompliance|1|||
146098866|NCT02122458|526882652|FG002|Overall Study|Noncompliance|0|||
146098867|NCT02122458|526882653|FG003|Overall Study|Noncompliance|0|||
146098868|NCT02122458|526882654|FG004|Overall Study|Noncompliance|0|||
146098869|NCT02122458|526882655|FG005|Overall Study|Noncompliance|0|||
146098870|NCT02122458|526882656|FG006|Overall Study|Noncompliance|0|||
146098871|NCT02833350|526882657|FG000|Overall Study|Adverse Event|0|||
146098872|NCT02833350|526882658|FG001|Overall Study|Adverse Event|3|||
146098873|NCT02833350|526882659|FG002|Overall Study|Adverse Event|4|||
146098874|NCT02833350|526882660|FG003|Overall Study|Adverse Event|4|||
146098875|NCT02833350|526882661|FG004|Overall Study|Adverse Event|1|||
146098876|NCT02833350|526882662|FG005|Overall Study|Adverse Event|0|||
146098877|NCT02833350|526882663|FG006|Overall Study|Adverse Event|1|||
146098878|NCT02833350|526882657|FG000|Overall Study|Death|0|||
146098879|NCT02833350|526882658|FG001|Overall Study|Death|0|||
146098880|NCT02833350|526882659|FG002|Overall Study|Death|1|||
146098881|NCT02833350|526882660|FG003|Overall Study|Death|0|||
146098882|NCT02833350|526882661|FG004|Overall Study|Death|0|||
146098883|NCT02833350|526882662|FG005|Overall Study|Death|0|||
146098884|NCT02833350|526882663|FG006|Overall Study|Death|0|||
146098885|NCT02833350|526882657|FG000|Overall Study|Lack of Efficacy|0|||
146098886|NCT02833350|526882658|FG001|Overall Study|Lack of Efficacy|2|||
146098887|NCT02833350|526882659|FG002|Overall Study|Lack of Efficacy|1|||
146098888|NCT02833350|526882660|FG003|Overall Study|Lack of Efficacy|4|||
146098889|NCT02833350|526882661|FG004|Overall Study|Lack of Efficacy|0|||
146098890|NCT02833350|526882662|FG005|Overall Study|Lack of Efficacy|1|||
146098891|NCT02833350|526882663|FG006|Overall Study|Lack of Efficacy|1|||
146098892|NCT02833350|526882657|FG000|Overall Study|Lost to Follow-up|0|||
146098893|NCT02833350|526882658|FG001|Overall Study|Lost to Follow-up|1|||
146036914|NCT03178669|526647489|FG002|Overall Study|Adverse Event|4|||
146036915|NCT03178669|526647490|FG003|Overall Study|Adverse Event|2|||
146036916|NCT03178669|526647491|FG004|Overall Study|Adverse Event|2|||
146036917|NCT03178669|526647487|FG000|Overall Study|Lack of Efficacy|0|||
146036918|NCT03178669|526647488|FG001|Overall Study|Lack of Efficacy|0|||
146036919|NCT03178669|526647489|FG002|Overall Study|Lack of Efficacy|2|||
146036920|NCT03178669|526647490|FG003|Overall Study|Lack of Efficacy|0|||
146036921|NCT03178669|526647491|FG004|Overall Study|Lack of Efficacy|1|||
146036922|NCT03178669|526647487|FG000|Overall Study|Physician Decision|0|||
146036923|NCT03178669|526647488|FG001|Overall Study|Physician Decision|0|||
146036924|NCT03178669|526647489|FG002|Overall Study|Physician Decision|0|||
146036925|NCT03178669|526647490|FG003|Overall Study|Physician Decision|0|||
146036926|NCT03178669|526647491|FG004|Overall Study|Physician Decision|1|||
146098894|NCT02833350|526882659|FG002|Overall Study|Lost to Follow-up|0|||
146098895|NCT02833350|526882660|FG003|Overall Study|Lost to Follow-up|0|||
146098896|NCT02833350|526882661|FG004|Overall Study|Lost to Follow-up|0|||
146098897|NCT02833350|526882662|FG005|Overall Study|Lost to Follow-up|0|||
146036927|NCT03178669|526647487|FG000|Overall Study|Withdrawal by Subject|1|||
146036928|NCT03178669|526647488|FG001|Overall Study|Withdrawal by Subject|0|||
146098898|NCT02833350|526882663|FG006|Overall Study|Lost to Follow-up|1|||
146098899|NCT02833350|526882657|FG000|Overall Study|Withdrawal by Subject|3|||
146098900|NCT02833350|526882658|FG001|Overall Study|Withdrawal by Subject|3|||
146098901|NCT02833350|526882659|FG002|Overall Study|Withdrawal by Subject|2|||
146098902|NCT02833350|526882660|FG003|Overall Study|Withdrawal by Subject|0|||
146098903|NCT02833350|526882661|FG004|Overall Study|Withdrawal by Subject|2|||
146098904|NCT02833350|526882662|FG005|Overall Study|Withdrawal by Subject|0|||
146098905|NCT02833350|526882663|FG006|Overall Study|Withdrawal by Subject|2|||
146098906|NCT01500031|526882666|FG000|Overall Study|Death|1|||
146098907|NCT01500031|526882666|FG000|Overall Study|Withdrawal by Subject|4|||
146036929|NCT03178669|526647489|FG002|Overall Study|Withdrawal by Subject|1|||
146098908|NCT01604408|526882672|FG000|Treatment Period 1|Protocol Violation|0|||
146098909|NCT01604408|526882673|FG001|Treatment Period 1|Protocol Violation|1|||
146098910|NCT01604408|526882672|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146098911|NCT01604408|526882673|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146036930|NCT03178669|526647490|FG003|Overall Study|Withdrawal by Subject|1|||
146036931|NCT03178669|526647491|FG004|Overall Study|Withdrawal by Subject|0|||
146036932|NCT03178669|526647487|FG000|Overall Study|Lost to Follow-up|0|||
146036933|NCT03178669|526647488|FG001|Overall Study|Lost to Follow-up|0|||
146036934|NCT03178669|526647489|FG002|Overall Study|Lost to Follow-up|0|||
146036935|NCT03178669|526647490|FG003|Overall Study|Lost to Follow-up|1|||
146036936|NCT03178669|526647491|FG004|Overall Study|Lost to Follow-up|0|||
146036937|NCT02976103|526647493|FG000|Overall Study|Withdrawal by Subject|1|||
146036938|NCT02976103|526647494|FG001|Overall Study|Withdrawal by Subject|0|||
146036939|NCT02976103|526647493|FG000|Overall Study|Lost to Follow-up|12|||
146036940|NCT02976103|526647494|FG001|Overall Study|Lost to Follow-up|8|||
146036941|NCT00565136|526647495|FG000|Overall Study|Lost to Follow-up|1|||
146036942|NCT00565136|526647495|FG000|Overall Study|Withdrawal by Subject|1|||
146036943|NCT00565136|526647495|FG000|Overall Study|Protocol Violation|1|||
146036944|NCT00694304|526647504|FG000|Overall Study|Adverse Event|42|||
146036945|NCT00694304|526647504|FG000|Overall Study|Lack of Efficacy|35|||
146036946|NCT00694304|526647504|FG000|Overall Study|Non-compliance With Study Product|16|||
146036947|NCT00694304|526647504|FG000|Overall Study|Protocol Violation|6|||
146036948|NCT00694304|526647504|FG000|Overall Study|Withdrawal of Consent|61|||
146036949|NCT00694304|526647504|FG000|Overall Study|Lost to Follow-up|15|||
146036950|NCT00694304|526647504|FG000|Overall Study|Administrative or Other Reasons|32|||
146036951|NCT02438813|526647505|FG000|Overall Study|Patient Decision|59|||
146036952|NCT02438813|526647505|FG000|Overall Study|Patient Lost to Follow-Up|137|||
146036953|NCT02438813|526647505|FG000|Overall Study|Study Ended by Sponsor|80|||
146036954|NCT02438813|526647505|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
146036955|NCT00576576|526647508|FG000|Overall Study|Lost to Follow-up|6|||
146036956|NCT00576576|526647508|FG000|Overall Study|Protocol Violation|1|||
146036957|NCT03135210|526647509|FG000|Overall Study|Death|0|||
146036958|NCT03135210|526647510|FG001|Overall Study|Death|1|||
146036959|NCT01805037|526647516|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
146036960|NCT01805037|526647517|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
146036961|NCT01805037|526647516|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
146036962|NCT01805037|526647517|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
146036963|NCT01805037|526647516|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
146036964|NCT01805037|526647517|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
146036965|NCT01805037|526647516|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
146036966|NCT01805037|526647517|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
146036967|NCT01805037|526647516|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
146036968|NCT01805037|526647517|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
146036969|NCT01805037|526647516|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
146036970|NCT01805037|526647517|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
146036971|NCT01805037|526647516|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
146036972|NCT01805037|526647517|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
146036973|NCT01805037|526647516|FG000|Follow Up (up to 3 Years)|Death|0|||
146036974|NCT01805037|526647517|FG001|Follow Up (up to 3 Years)|Death|2|||
146036975|NCT01805037|526647516|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
146036976|NCT01805037|526647517|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
146036977|NCT01805037|526647516|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
146036978|NCT01805037|526647517|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
146036979|NCT04566692|526647518|FG000|Overall Study|Adverse Event|2|||
146036980|NCT04566692|526647519|FG001|Overall Study|Adverse Event|0|||
146036981|NCT04566692|526647518|FG000|Overall Study|Withdrawal by Subject|1|||
146036982|NCT04566692|526647519|FG001|Overall Study|Withdrawal by Subject|1|||
146036983|NCT00671437|526647520|FG000|Overall Study|Progressive disease before C1 week 8|8|||
146036984|NCT00671437|526647520|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
146036985|NCT00671437|526647520|FG000|Overall Study|Adverse Event|3|||
146036986|NCT00671437|526647520|FG000|Overall Study|Ineligible post-hoc|1|||
146036987|NCT04033068|526647521|FG000|Overall Study|Withdrawal by Subject|0|||
146036988|NCT04033068|526647522|FG001|Overall Study|Withdrawal by Subject|0|||
146036989|NCT04033068|526647523|FG002|Overall Study|Withdrawal by Subject|1|||
146036990|NCT04033068|526647524|FG003|Overall Study|Withdrawal by Subject|0|||
146036991|NCT04033068|526647521|FG000|Overall Study|Lost to Follow-up|0|||
146036992|NCT04033068|526647522|FG001|Overall Study|Lost to Follow-up|1|||
146036993|NCT04033068|526647523|FG002|Overall Study|Lost to Follow-up|0|||
146036994|NCT04033068|526647524|FG003|Overall Study|Lost to Follow-up|0|||
146036995|NCT04033068|526647521|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146036996|NCT04033068|526647522|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146036997|NCT04033068|526647523|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
146036998|NCT04033068|526647524|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
146036999|NCT02540265|526647528|FG000|Overall Study|Lost to Follow-up|0|||
146037000|NCT02540265|526647529|FG001|Overall Study|Lost to Follow-up|0|||
146037001|NCT02540265|526647530|FG002|Overall Study|Lost to Follow-up|1|||
146037002|NCT01887353|526647541|FG000|Overall Study|Study stopped early|4|||
146037003|NCT01887353|526647542|FG001|Overall Study|Study stopped early|3|||
146037004|NCT00649428|526649548|FG000|Overall Study|Adverse Event|2|||
146037005|NCT00649428|526649549|FG001|Overall Study|Adverse Event|2|||
146037006|NCT00649428|526649548|FG000|Overall Study|Withdrawal by Subject|6|||
146037007|NCT00649428|526649549|FG001|Overall Study|Withdrawal by Subject|6|||
146037008|NCT00649428|526649548|FG000|Overall Study|Lost to Follow-up|1|||
146037009|NCT00649428|526649549|FG001|Overall Study|Lost to Follow-up|3|||
146037010|NCT00649428|526649548|FG000|Overall Study|Insufficient manufacturing yield|5|||
146037011|NCT00649428|526649549|FG001|Overall Study|Insufficient manufacturing yield|1|||
146037012|NCT00649428|526649548|FG000|Overall Study|Protocol Violation|6|||
146037013|NCT00649428|526649549|FG001|Overall Study|Protocol Violation|2|||
146037014|NCT00649428|526649548|FG000|Overall Study|Physician Decision|0|||
146037015|NCT00649428|526649549|FG001|Overall Study|Physician Decision|1|||
146037016|NCT04599465|526649550|FG000|Overall Study|Physician Decision|1|||
146037017|NCT04599465|526649550|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
146037018|NCT00495625|526649553|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
146037019|NCT02702180|526649555|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146037020|NCT02702180|526649556|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146037021|NCT02702180|526649557|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146037022|NCT02702180|526649555|FG000|Double-blind Treatment Period|Adverse Event|0|||
146037023|NCT02702180|526649556|FG001|Double-blind Treatment Period|Adverse Event|0|||
146037024|NCT02702180|526649557|FG002|Double-blind Treatment Period|Adverse Event|1|||
146037025|NCT02702180|526649555|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
146037026|NCT02702180|526649556|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
146037027|NCT02702180|526649557|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
146037028|NCT02702180|526649555|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146037029|NCT02702180|526649556|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146037030|NCT02702180|526649557|FG002|Double-blind Treatment Period|Protocol Violation|2|||
146037031|NCT02702180|526649555|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
146037032|NCT02702180|526649556|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
146037033|NCT02702180|526649557|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
146037034|NCT02702180|526649555|FG000|Open-label Treatment Period|Withdrawn in error|0|||
146037035|NCT02702180|526649556|FG001|Open-label Treatment Period|Withdrawn in error|0|||
146037036|NCT02702180|526649557|FG002|Open-label Treatment Period|Withdrawn in error|1|||
146037037|NCT00679172|526649561|FG000|Overall Study|Non-compliance|1|||
146037038|NCT00679172|526649562|FG001|Overall Study|Non-compliance|1|||
146037039|NCT00679172|526649563|FG002|Overall Study|Non-compliance|0|||
146037040|NCT00679172|526649564|FG003|Overall Study|Non-compliance|1|||
146037041|NCT00679172|526649565|FG004|Overall Study|Non-compliance|0|||
146037042|NCT00679172|526649561|FG000|Overall Study|Other not specified|0|||
146037043|NCT00679172|526649562|FG001|Overall Study|Other not specified|0|||
146037044|NCT00679172|526649563|FG002|Overall Study|Other not specified|1|||
146098912|NCT01604408|526882672|FG000|Treatment Period 2|Protocol Violation|1|||
146098913|NCT01604408|526882673|FG001|Treatment Period 2|Protocol Violation|0|||
146098914|NCT01604408|526882672|FG000|Treatment Period 2|Adverse Event|0|||
146098915|NCT01604408|526882673|FG001|Treatment Period 2|Adverse Event|1|||
146098916|NCT01604408|526882672|FG000|Treatment Period 3|Protocol Violation|1|||
146098917|NCT01604408|526882673|FG001|Treatment Period 3|Protocol Violation|1|||
146098918|NCT01604408|526882672|FG000|Treatment Period 3|Adverse Event|0|||
146098919|NCT01604408|526882673|FG001|Treatment Period 3|Adverse Event|3|||
146098920|NCT01604408|526882672|FG000|Treatment Period 3|Withdrawal by Subject|3|||
146098921|NCT01604408|526882673|FG001|Treatment Period 3|Withdrawal by Subject|1|||
146098922|NCT01604408|526882672|FG000|Treatment Period 3|Sponsor Decision|1|||
146098923|NCT01604408|526882673|FG001|Treatment Period 3|Sponsor Decision|0|||
146098924|NCT01604408|526882672|FG000|Treatment Period 4|Death|1|||
146098925|NCT01604408|526882673|FG001|Treatment Period 4|Death|0|||
146098926|NCT01604408|526882672|FG000|Treatment Period 4|Withdrawal by Subject|2|||
146098927|NCT01604408|526882673|FG001|Treatment Period 4|Withdrawal by Subject|1|||
146098928|NCT01604408|526882672|FG000|Treatment Period 4|Adverse Event|0|||
146098929|NCT01604408|526882673|FG001|Treatment Period 4|Adverse Event|1|||
146098930|NCT01604408|526882672|FG000|Treatment Period 5|Adverse Event|4|||
146098931|NCT01604408|526882673|FG001|Treatment Period 5|Adverse Event|0|||
146098932|NCT01604408|526882672|FG000|Treatment Period 6|Lost to Follow-up|0|||
146098933|NCT01604408|526882673|FG001|Treatment Period 6|Lost to Follow-up|1|||
146098934|NCT01604408|526882672|FG000|Treatment Period 6|Adverse Event|2|||
146037045|NCT00679172|526649564|FG003|Overall Study|Other not specified|0|||
146037046|NCT00679172|526649565|FG004|Overall Study|Other not specified|0|||
146037047|NCT02241343|526649569|FG000|Overall Study|Adverse Event|1|||
146037048|NCT00753454|526649570|FG000|Overall Study|Adverse Event|4|||
146037049|NCT00753454|526649570|FG000|Overall Study|Lack of Efficacy|1|||
146037050|NCT00753454|526649570|FG000|Overall Study|Lost to Follow-up|3|||
146098935|NCT01604408|526882673|FG001|Treatment Period 6|Adverse Event|0|||
146037051|NCT00753454|526649570|FG000|Overall Study|Withdrawal by Subject|5|||
146037052|NCT00753454|526649570|FG000|Overall Study|Investigator Decision|1|||
146037053|NCT05249569|526649571|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
146037054|NCT03927144|526649572|FG000|Core Phase|Adverse Event|9|||
146037055|NCT03927144|526649573|FG001|Core Phase|Adverse Event|5|||
146037056|NCT03927144|526649572|FG000|Core Phase|Lost to Follow-up|3|||
146098936|NCT01604408|526882672|FG000|Treatment Period 6|Sponsor decision|0|||
146098937|NCT01604408|526882673|FG001|Treatment Period 6|Sponsor decision|1|||
146098938|NCT01604408|526882672|FG000|Observation Period|Adverse Event|1|||
146098939|NCT01604408|526882673|FG001|Observation Period|Adverse Event|1|||
146098940|NCT01604408|526882672|FG000|Observation Period|Withdrawal by Subject|0|||
146098941|NCT01604408|526882673|FG001|Observation Period|Withdrawal by Subject|2|||
146098942|NCT00216476|526882676|FG000|Overall Study|Withdrawal by Subject|59|||
146098943|NCT00216476|526882677|FG001|Overall Study|Withdrawal by Subject|72|||
146098944|NCT00216476|526882678|FG002|Overall Study|Withdrawal by Subject|9|||
146098945|NCT00216476|526882676|FG000|Overall Study|Lost to Follow-up|10|||
146098946|NCT00216476|526882677|FG001|Overall Study|Lost to Follow-up|9|||
146098947|NCT00216476|526882678|FG002|Overall Study|Lost to Follow-up|1|||
146098948|NCT00216476|526882676|FG000|Overall Study|Adverse Event|6|||
146098949|NCT00216476|526882677|FG001|Overall Study|Adverse Event|10|||
146098950|NCT00216476|526882678|FG002|Overall Study|Adverse Event|1|||
146098951|NCT00216476|526882676|FG000|Overall Study|Lack of Efficacy|4|||
146098952|NCT00216476|526882677|FG001|Overall Study|Lack of Efficacy|3|||
146098953|NCT00216476|526882678|FG002|Overall Study|Lack of Efficacy|0|||
146098954|NCT00216476|526882676|FG000|Overall Study|Death|2|||
146098955|NCT00216476|526882677|FG001|Overall Study|Death|0|||
146098956|NCT00216476|526882678|FG002|Overall Study|Death|0|||
146098957|NCT00216476|526882676|FG000|Overall Study|Pregnancy|0|||
146098958|NCT00216476|526882677|FG001|Overall Study|Pregnancy|1|||
146098959|NCT00216476|526882678|FG002|Overall Study|Pregnancy|1|||
146098960|NCT00216476|526882676|FG000|Overall Study|Other|0|||
146098961|NCT00216476|526882677|FG001|Overall Study|Other|0|||
146098962|NCT00216476|526882678|FG002|Overall Study|Other|1|||
146098963|NCT00216476|526882676|FG000|Overall Study|Refuses Injection|11|||
146098964|NCT00216476|526882677|FG001|Overall Study|Refuses Injection|0|||
146098965|NCT00216476|526882678|FG002|Overall Study|Refuses Injection|0|||
146098966|NCT00216476|526882676|FG000|Overall Study|No Further Need for Treatment|3|||
146098967|NCT00216476|526882677|FG001|Overall Study|No Further Need for Treatment|4|||
146098968|NCT00216476|526882678|FG002|Overall Study|No Further Need for Treatment|1|||
146098969|NCT00216476|526882676|FG000|Overall Study|Non-compliance|0|||
146098970|NCT00216476|526882677|FG001|Overall Study|Non-compliance|4|||
146098971|NCT00216476|526882678|FG002|Overall Study|Non-compliance|1|||
146098972|NCT00216476|526882676|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
146098973|NCT00216476|526882677|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
146098974|NCT00216476|526882678|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
146098975|NCT00216476|526882676|FG000|Overall Study|Administrative Reasons|1|||
146098976|NCT00216476|526882677|FG001|Overall Study|Administrative Reasons|1|||
146098977|NCT00216476|526882678|FG002|Overall Study|Administrative Reasons|0|||
146098978|NCT00216476|526882676|FG000|Overall Study|Protocol Deviation|5|||
146098979|NCT00216476|526882677|FG001|Overall Study|Protocol Deviation|1|||
146098980|NCT00216476|526882678|FG002|Overall Study|Protocol Deviation|0|||
146098981|NCT00216476|526882676|FG000|Overall Study|Patient Moved|2|||
146098982|NCT00216476|526882677|FG001|Overall Study|Patient Moved|2|||
146098983|NCT00216476|526882678|FG002|Overall Study|Patient Moved|0|||
146098984|NCT02191137|526882679|FG000|Treatment|Death|4|||
146098985|NCT02191137|526882679|FG000|Treatment|Withdrawal by Subject|3|||
146098986|NCT02191137|526882679|FG000|Treatment|Adverse Event|2|||
146098987|NCT02191137|526882679|FG000|Treatment|Other|1|||
146098988|NCT02191137|526882679|FG000|Follow-up|Lost to Follow-up|2|||
146098989|NCT02191137|526882679|FG000|Follow-up|Ongoing/unknown|2|||
146098990|NCT02191137|526882679|FG000|Follow-up|Adverse Event|1|||
146098991|NCT01332331|526882680|FG000|Overall Study|Lost to Follow-up|0|||
146098992|NCT01332331|526882681|FG001|Overall Study|Lost to Follow-up|1|||
146098993|NCT01332331|526882680|FG000|Overall Study|Adverse Event|1|||
146098994|NCT01332331|526882681|FG001|Overall Study|Adverse Event|1|||
146098995|NCT01332331|526882680|FG000|Overall Study|Physician Decision|1|||
146098996|NCT01332331|526882681|FG001|Overall Study|Physician Decision|0|||
146098997|NCT00538291|526882682|FG000|Overall Study|Adverse Event|2|||
146098998|NCT00538291|526882682|FG000|Overall Study|Withdrawal by Subject|1|||
146098999|NCT00694707|526882683|FG000|Overall Study|Did Not Receive Treatment|0|||
146099000|NCT00694707|526882684|FG001|Overall Study|Did Not Receive Treatment|0|||
146099001|NCT00694707|526882685|FG002|Overall Study|Did Not Receive Treatment|1|||
146099002|NCT00694707|526882686|FG003|Overall Study|Did Not Receive Treatment|1|||
146099003|NCT00694707|526882687|FG004|Overall Study|Did Not Receive Treatment|1|||
146099004|NCT00694707|526882683|FG000|Overall Study|Adverse Event|22|||
146099005|NCT00694707|526882684|FG001|Overall Study|Adverse Event|14|||
146099006|NCT00694707|526882685|FG002|Overall Study|Adverse Event|8|||
146099007|NCT00694707|526882686|FG003|Overall Study|Adverse Event|12|||
146099008|NCT00694707|526882687|FG004|Overall Study|Adverse Event|13|||
146099009|NCT00694707|526882683|FG000|Overall Study|Insufficient Therapeutic Response|33|||
146099010|NCT00694707|526882684|FG001|Overall Study|Insufficient Therapeutic Response|18|||
146099011|NCT00694707|526882685|FG002|Overall Study|Insufficient Therapeutic Response|17|||
146099012|NCT00694707|526882686|FG003|Overall Study|Insufficient Therapeutic Response|15|||
146099013|NCT00694707|526882687|FG004|Overall Study|Insufficient Therapeutic Response|10|||
146099014|NCT00694707|526882683|FG000|Overall Study|Protocol Violation|1|||
146099015|NCT00694707|526882684|FG001|Overall Study|Protocol Violation|2|||
146099016|NCT00694707|526882685|FG002|Overall Study|Protocol Violation|1|||
146099017|NCT00694707|526882686|FG003|Overall Study|Protocol Violation|3|||
146099018|NCT00694707|526882687|FG004|Overall Study|Protocol Violation|1|||
146099019|NCT00694707|526882683|FG000|Overall Study|Withdrawal of Consent|14|||
146099020|NCT00694707|526882684|FG001|Overall Study|Withdrawal of Consent|18|||
146099021|NCT00694707|526882685|FG002|Overall Study|Withdrawal of Consent|22|||
146099022|NCT00694707|526882686|FG003|Overall Study|Withdrawal of Consent|16|||
146099023|NCT00694707|526882687|FG004|Overall Study|Withdrawal of Consent|15|||
146099024|NCT00694707|526882683|FG000|Overall Study|Lost to Follow-up|0|||
146099025|NCT00694707|526882684|FG001|Overall Study|Lost to Follow-up|1|||
146099026|NCT00694707|526882685|FG002|Overall Study|Lost to Follow-up|2|||
146099027|NCT00694707|526882686|FG003|Overall Study|Lost to Follow-up|0|||
146099028|NCT00694707|526882687|FG004|Overall Study|Lost to Follow-up|0|||
146099029|NCT00694707|526882683|FG000|Overall Study|Jeopardizing Parole Status|1|||
146099030|NCT00694707|526882684|FG001|Overall Study|Jeopardizing Parole Status|0|||
146099031|NCT00694707|526882685|FG002|Overall Study|Jeopardizing Parole Status|0|||
146099032|NCT00694707|526882686|FG003|Overall Study|Jeopardizing Parole Status|0|||
146099033|NCT00694707|526882687|FG004|Overall Study|Jeopardizing Parole Status|0|||
146099034|NCT00694707|526882683|FG000|Overall Study|Death in the Family|1|||
146099035|NCT00694707|526882684|FG001|Overall Study|Death in the Family|0|||
146099036|NCT00694707|526882685|FG002|Overall Study|Death in the Family|0|||
146099037|NCT00694707|526882686|FG003|Overall Study|Death in the Family|0|||
146099038|NCT00694707|526882687|FG004|Overall Study|Death in the Family|0|||
146099039|NCT00694707|526882683|FG000|Overall Study|Arrest by Police|0|||
146099040|NCT00694707|526882684|FG001|Overall Study|Arrest by Police|1|||
146099041|NCT00694707|526882685|FG002|Overall Study|Arrest by Police|0|||
146099042|NCT00694707|526882686|FG003|Overall Study|Arrest by Police|0|||
146099043|NCT00694707|526882687|FG004|Overall Study|Arrest by Police|0|||
146099044|NCT00694707|526882683|FG000|Overall Study|Administrative Reasons|0|||
146099045|NCT00694707|526882684|FG001|Overall Study|Administrative Reasons|1|||
146037057|NCT03927144|526649573|FG001|Core Phase|Lost to Follow-up|2|||
146037058|NCT03927144|526649572|FG000|Core Phase|New Therapy for Study Indication|0|||
146037059|NCT03927144|526649573|FG001|Core Phase|New Therapy for Study Indication|1|||
146037060|NCT03927144|526649572|FG000|Core Phase|No Longer Clinically Benefiting|4|||
146037061|NCT03927144|526649573|FG001|Core Phase|No Longer Clinically Benefiting|4|||
146037062|NCT03927144|526649572|FG000|Core Phase|Physician Decision|2|||
146037063|NCT03927144|526649573|FG001|Core Phase|Physician Decision|8|||
146037064|NCT03927144|526649572|FG000|Core Phase|Protocol Violation|2|||
146037065|NCT03927144|526649573|FG001|Core Phase|Protocol Violation|2|||
146037066|NCT03927144|526649572|FG000|Core Phase|Withdrawal by Subject|16|||
146037067|NCT03927144|526649573|FG001|Core Phase|Withdrawal by Subject|40|||
146099046|NCT00694707|526882685|FG002|Overall Study|Administrative Reasons|0|||
146099047|NCT00694707|526882686|FG003|Overall Study|Administrative Reasons|2|||
146099048|NCT00694707|526882687|FG004|Overall Study|Administrative Reasons|0|||
146099049|NCT00694707|526882683|FG000|Overall Study|Notification of Past Head Injury|0|||
146099050|NCT00694707|526882684|FG001|Overall Study|Notification of Past Head Injury|0|||
146099051|NCT00694707|526882685|FG002|Overall Study|Notification of Past Head Injury|0|||
146099052|NCT00694707|526882686|FG003|Overall Study|Notification of Past Head Injury|1|||
146099053|NCT00694707|526882687|FG004|Overall Study|Notification of Past Head Injury|0|||
146099054|NCT01904058|526882697|FG000|Overall Study|Adverse Event|2|||
146099055|NCT01904058|526882698|FG001|Overall Study|Adverse Event|0|||
146099056|NCT01904058|526882699|FG002|Overall Study|Adverse Event|0|||
146099057|NCT01904058|526882700|FG003|Overall Study|Adverse Event|0|||
146099058|NCT01904058|526882697|FG000|Overall Study|Withdrawal by Subject|1|||
146099059|NCT01904058|526882698|FG001|Overall Study|Withdrawal by Subject|0|||
146099060|NCT01904058|526882699|FG002|Overall Study|Withdrawal by Subject|1|||
146099061|NCT01904058|526882700|FG003|Overall Study|Withdrawal by Subject|0|||
146099062|NCT01904058|526882697|FG000|Overall Study|Pregnancy|0|||
146099063|NCT01904058|526882698|FG001|Overall Study|Pregnancy|0|||
146099064|NCT01904058|526882699|FG002|Overall Study|Pregnancy|0|||
146037068|NCT03927144|526649572|FG000|Extension Phase|Adverse Event|2|||
146037069|NCT03927144|526649573|FG001|Extension Phase|Adverse Event|1|||
146037070|NCT03927144|526649572|FG000|Extension Phase|No longer clinically benefiting|4|||
146037071|NCT03927144|526649573|FG001|Extension Phase|No longer clinically benefiting|5|||
146099065|NCT01904058|526882700|FG003|Overall Study|Pregnancy|1|||
146099066|NCT04810481|526882701|FG000|Overall Study|Disqualified data sets|10|||
146099067|NCT04810481|526882702|FG001|Overall Study|Disqualified data sets|28|||
146099068|NCT03096483|526882704|FG000|Overall Study|Withdrawal by site|1|||
146099069|NCT00369707|526882709|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
146037072|NCT03927144|526649572|FG000|Extension Phase|Pregnancy|1|||
146099070|NCT00369707|526882709|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
146037073|NCT03927144|526649573|FG001|Extension Phase|Pregnancy|0|||
146037074|NCT03927144|526649572|FG000|Extension Phase|Protocol Violation|0|||
146037075|NCT03927144|526649573|FG001|Extension Phase|Protocol Violation|1|||
146037076|NCT03927144|526649572|FG000|Extension Phase|Withdrawal by Subject|8|||
146099071|NCT00369707|526882709|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
146099072|NCT00369707|526882709|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
146037077|NCT03927144|526649573|FG001|Extension Phase|Withdrawal by Subject|3|||
146099073|NCT00369707|526882709|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
146099074|NCT00369707|526882709|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
146099075|NCT00369707|526882709|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
146099076|NCT00369707|526882709|FG000|Follow up for 2 Years After Treatment|Death|1|||
146300560|NCT01876251|527617044|FG000|Overall Study|Objective progression or relapse|10|||
146300561|NCT01876251|527617045|FG001|Overall Study|Objective progression or relapse|3|||
146300562|NCT01876251|527617046|FG002|Overall Study|Objective progression or relapse|8|||
146300563|NCT01650285|527617051|FG000|Overall Study|Adverse Event|1|||
146300564|NCT00283049|527617052|FG000|Overall Study|Adverse Event|6|||
146037078|NCT02271945|526649576|FG000|Overall Study|Death|3|||
146099077|NCT00369707|526882709|FG000|Follow up for 2 Years After Treatment|Other|2|||
146099078|NCT02046733|526882715|FG000|Overall Study|never initiated 'treatment visits'|6|||
146099079|NCT02046733|526882716|FG001|Overall Study|never initiated 'treatment visits'|0|||
146037079|NCT02271945|526649577|FG001|Overall Study|Death|3|||
146037080|NCT02271945|526649576|FG000|Overall Study|Withdrawal by Subject|1|||
146037081|NCT02271945|526649577|FG001|Overall Study|Withdrawal by Subject|1|||
146037082|NCT02271945|526649576|FG000|Overall Study|Other|1|||
146037083|NCT02271945|526649577|FG001|Overall Study|Other|1|||
146037084|NCT01452919|526649578|FG000|Open-Label Treatment|Adverse Event|5|||
146037085|NCT01452919|526649579|FG001|Open-Label Treatment|Adverse Event|0|||
146037086|NCT01452919|526649580|FG002|Open-Label Treatment|Adverse Event|0|||
146037087|NCT01452919|526649578|FG000|Open-Label Treatment|Lost to Follow-up|4|||
146037088|NCT01452919|526649579|FG001|Open-Label Treatment|Lost to Follow-up|0|||
146037089|NCT01452919|526649580|FG002|Open-Label Treatment|Lost to Follow-up|0|||
146037090|NCT01452919|526649578|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
146037091|NCT01452919|526649579|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
146037092|NCT01452919|526649580|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
146037093|NCT01452919|526649578|FG000|Open-Label Treatment|Protocol Violation|4|||
146037094|NCT01452919|526649579|FG001|Open-Label Treatment|Protocol Violation|0|||
146037095|NCT01452919|526649580|FG002|Open-Label Treatment|Protocol Violation|0|||
146037096|NCT01452919|526649578|FG000|Open-Label Treatment|Sponsor Decision|1|||
146037097|NCT01452919|526649579|FG001|Open-Label Treatment|Sponsor Decision|0|||
146037098|NCT01452919|526649580|FG002|Open-Label Treatment|Sponsor Decision|0|||
146037099|NCT01452919|526649578|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
146037100|NCT01452919|526649579|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146037101|NCT01452919|526649580|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
146037102|NCT01452919|526649578|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
146037103|NCT01452919|526649579|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
146037104|NCT01452919|526649580|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
146037105|NCT01452919|526649578|FG000|Randomization Treatment|Adverse Event|0|||
146037106|NCT01452919|526649579|FG001|Randomization Treatment|Adverse Event|0|||
146037107|NCT01452919|526649580|FG002|Randomization Treatment|Adverse Event|2|||
146037108|NCT01452919|526649578|FG000|Randomization Treatment|Sponsor Decision|0|||
146037109|NCT01452919|526649579|FG001|Randomization Treatment|Sponsor Decision|1|||
146037110|NCT01452919|526649580|FG002|Randomization Treatment|Sponsor Decision|0|||
146037111|NCT01452919|526649578|FG000|Randomization Treatment|Withdrawal by Subject|0|||
146037112|NCT01452919|526649579|FG001|Randomization Treatment|Withdrawal by Subject|1|||
146037113|NCT01452919|526649580|FG002|Randomization Treatment|Withdrawal by Subject|0|||
146037114|NCT01452919|526649578|FG000|Randomization Treatment|Subject is moving or has moved|0|||
146037115|NCT01452919|526649579|FG001|Randomization Treatment|Subject is moving or has moved|1|||
146037116|NCT01452919|526649580|FG002|Randomization Treatment|Subject is moving or has moved|0|||
146037117|NCT00615030|526649582|FG000|Period I|Administrative problem|0|||
146037118|NCT00615030|526649583|FG001|Period I|Administrative problem|0|||
146037119|NCT00615030|526649584|FG002|Period I|Administrative problem|0|||
146037120|NCT00615030|526649585|FG003|Period I|Administrative problem|0|||
146037121|NCT00615030|526649586|FG004|Period I|Administrative problem|1|||
146037122|NCT00615030|526649587|FG005|Period I|Administrative problem|0|||
146037123|NCT00615030|526649588|FG006|Period I|Administrative problem|0|||
146037124|NCT00615030|526649589|FG007|Period I|Administrative problem|0|||
146037125|NCT00615030|526649590|FG008|Period I|Administrative problem|0|||
146037126|NCT00615030|526649591|FG009|Period I|Administrative problem|0|||
146099080|NCT01756053|526882717|FG000|Period 1 (10 Days)|Protocol Violation|1|||
146099081|NCT01756053|526882718|FG001|Period 1 (10 Days)|Protocol Violation|1|||
146099082|NCT01756053|526882717|FG000|Period 2 (10 Days)|Protocol Violation|0|||
146037127|NCT00615030|526649592|FG010|Period I|Administrative problem|0|||
146037128|NCT00615030|526649593|FG011|Period I|Administrative problem|0|||
146037129|NCT00615030|526649582|FG000|Period I|Protocol deviation|1|||
146037130|NCT00615030|526649583|FG001|Period I|Protocol deviation|0|||
146037131|NCT00615030|526649584|FG002|Period I|Protocol deviation|0|||
146099083|NCT01756053|526882718|FG001|Period 2 (10 Days)|Protocol Violation|2|||
146099084|NCT02019277|526882719|FG000|Overall Study|Withdrawal by Subject|3|||
146300565|NCT00283049|527617053|FG001|Overall Study|Adverse Event|1|||
146037132|NCT00615030|526649585|FG003|Period I|Protocol deviation|0|||
146037133|NCT00615030|526649586|FG004|Period I|Protocol deviation|0|||
146037134|NCT00615030|526649587|FG005|Period I|Protocol deviation|0|||
146099085|NCT02019277|526882719|FG000|Overall Study|Death|7|||
146099086|NCT02019277|526882719|FG000|Overall Study|Did no Cooperate|1|||
146099087|NCT02019277|526882719|FG000|Overall Study|Adverse Event|1|||
146099088|NCT01672736|526882726|FG000|Overall Study|Available drug expired on 31 May 16|3|||
146099089|NCT04251273|526882729|FG000|Overall Study|Lost to Follow-up|331|||
146099090|NCT04251273|526882730|FG001|Overall Study|Lost to Follow-up|290|||
146099091|NCT00810693|526882731|FG000|Treatment Period|Adverse Event|8|||
146099092|NCT00810693|526882732|FG001|Treatment Period|Adverse Event|1|||
146099093|NCT00810693|526882733|FG002|Treatment Period|Adverse Event|7|||
146099094|NCT00810693|526882731|FG000|Treatment Period|Death|0|||
146099095|NCT00810693|526882732|FG001|Treatment Period|Death|1|||
146099096|NCT00810693|526882733|FG002|Treatment Period|Death|2|||
146099097|NCT00810693|526882731|FG000|Treatment Period|Lack of Efficacy|0|||
146099098|NCT00810693|526882732|FG001|Treatment Period|Lack of Efficacy|0|||
146099099|NCT00810693|526882733|FG002|Treatment Period|Lack of Efficacy|1|||
146099100|NCT00810693|526882731|FG000|Treatment Period|Lost to Follow-up|1|||
146099101|NCT00810693|526882732|FG001|Treatment Period|Lost to Follow-up|0|||
146099102|NCT00810693|526882733|FG002|Treatment Period|Lost to Follow-up|0|||
146099103|NCT00810693|526882731|FG000|Treatment Period|Non-compliance|1|||
146099104|NCT00810693|526882732|FG001|Treatment Period|Non-compliance|0|||
146099105|NCT00810693|526882733|FG002|Treatment Period|Non-compliance|0|||
146099106|NCT00810693|526882731|FG000|Treatment Period|Protocol Violation|1|||
146099107|NCT00810693|526882732|FG001|Treatment Period|Protocol Violation|2|||
146099108|NCT00810693|526882733|FG002|Treatment Period|Protocol Violation|2|||
146099109|NCT00810693|526882731|FG000|Treatment Period|Withdrawal by Subject|6|||
146099110|NCT00810693|526882732|FG001|Treatment Period|Withdrawal by Subject|2|||
146099111|NCT00810693|526882733|FG002|Treatment Period|Withdrawal by Subject|3|||
146099112|NCT00810693|526882731|FG000|Treatment Period|Not treated|0|||
146099113|NCT00810693|526882732|FG001|Treatment Period|Not treated|1|||
146099114|NCT00810693|526882733|FG002|Treatment Period|Not treated|1|||
146099115|NCT00810693|526882731|FG000|Follow-up Period (FUP)|Adverse Event|3|||
146099116|NCT00810693|526882732|FG001|Follow-up Period (FUP)|Adverse Event|1|||
146099117|NCT00810693|526882733|FG002|Follow-up Period (FUP)|Adverse Event|1|||
146099118|NCT00810693|526882731|FG000|Follow-up Period (FUP)|Death|2|||
146099119|NCT00810693|526882732|FG001|Follow-up Period (FUP)|Death|0|||
146099120|NCT00810693|526882733|FG002|Follow-up Period (FUP)|Death|1|||
146099121|NCT00810693|526882731|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
146099122|NCT00810693|526882732|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
146099123|NCT00810693|526882733|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
146099124|NCT00810693|526882731|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
146099125|NCT00810693|526882732|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
146099126|NCT00810693|526882733|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
146099127|NCT00810693|526882731|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
146099128|NCT00810693|526882732|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
146099129|NCT00810693|526882733|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
146099130|NCT00331422|526882738|FG000|Overall Study|Did not receive entire study regimen|5|||
146099131|NCT02345226|526882739|FG000|Double-Blind Phase|Adverse Event|5|||
146099132|NCT02345226|526882740|FG001|Double-Blind Phase|Adverse Event|6|||
146099133|NCT02345226|526882739|FG000|Double-Blind Phase|Death|3|||
146099134|NCT02345226|526882740|FG001|Double-Blind Phase|Death|0|||
146099135|NCT02345226|526882739|FG000|Double-Blind Phase|Pregnancy|0|||
146099136|NCT02345226|526882740|FG001|Double-Blind Phase|Pregnancy|1|||
146099137|NCT02345226|526882739|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146099138|NCT02345226|526882740|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146099139|NCT02345226|526882739|FG000|Double-Blind Phase|Investigator's Discretion|4|||
146099140|NCT02345226|526882740|FG001|Double-Blind Phase|Investigator's Discretion|3|||
146099141|NCT02345226|526882739|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146099142|NCT02345226|526882740|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
146099143|NCT02345226|526882739|FG000|Double-Blind Phase|Withdrew Consent|41|||
146099144|NCT02345226|526882740|FG001|Double-Blind Phase|Withdrew Consent|39|||
146099145|NCT02345226|526882739|FG000|Double-Blind Phase|Lost to Follow-up|12|||
146099146|NCT02345226|526882740|FG001|Double-Blind Phase|Lost to Follow-up|16|||
146099147|NCT02345226|526882739|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
146099148|NCT02345226|526882740|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
146099149|NCT02345226|526882739|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146099150|NCT02345226|526882740|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146099151|NCT01710046|526882743|FG000|Overall Study|Lost to Follow-up|1|||
146099152|NCT01710046|526882744|FG001|Overall Study|Lost to Follow-up|0|||
146099153|NCT04357782|526882751|FG000|Overall Study|Discharged from hospital|1|||
146099154|NCT04357782|526882752|FG001|Overall Study|Discharged from hospital|0|||
146099155|NCT04357782|526882751|FG000|Overall Study|Death|0|||
146099156|NCT04357782|526882752|FG001|Overall Study|Death|2|||
146099157|NCT01033851|526882754|FG000|Overall Study|Withdrawal by Subject|3|||
146099158|NCT01033851|526882755|FG001|Overall Study|Withdrawal by Subject|7|||
146099159|NCT03896165|526882756|FG000|Overall Study|Withdrawal by Subject|2|||
146099160|NCT03666624|526882759|FG000|Overall Study|participant grieving over recent death of parent|1|||
146099161|NCT03666624|526882760|FG001|Overall Study|participant grieving over recent death of parent|0|||
146037135|NCT00615030|526649588|FG006|Period I|Protocol deviation|0|||
146037136|NCT00615030|526649589|FG007|Period I|Protocol deviation|0|||
146037137|NCT00615030|526649590|FG008|Period I|Protocol deviation|0|||
146037138|NCT00615030|526649591|FG009|Period I|Protocol deviation|0|||
146037139|NCT00615030|526649592|FG010|Period I|Protocol deviation|0|||
146037140|NCT00615030|526649593|FG011|Period I|Protocol deviation|0|||
146037141|NCT00615030|526649582|FG000|Period I|Subject withdrew consent|0|||
146037142|NCT00615030|526649583|FG001|Period I|Subject withdrew consent|0|||
146037143|NCT00615030|526649584|FG002|Period I|Subject withdrew consent|0|||
146037144|NCT00615030|526649585|FG003|Period I|Subject withdrew consent|0|||
146037145|NCT00615030|526649586|FG004|Period I|Subject withdrew consent|0|||
146037146|NCT00615030|526649587|FG005|Period I|Subject withdrew consent|0|||
146037147|NCT00615030|526649588|FG006|Period I|Subject withdrew consent|0|||
146037148|NCT00615030|526649589|FG007|Period I|Subject withdrew consent|0|||
146037149|NCT00615030|526649590|FG008|Period I|Subject withdrew consent|1|||
146037150|NCT00615030|526649591|FG009|Period I|Subject withdrew consent|0|||
146037151|NCT00615030|526649592|FG010|Period I|Subject withdrew consent|1|||
146037152|NCT00615030|526649593|FG011|Period I|Subject withdrew consent|1|||
146037153|NCT00615030|526649582|FG000|Period I|Abnormal laboratory value(s)|0|||
146037154|NCT00615030|526649583|FG001|Period I|Abnormal laboratory value(s)|0|||
146037155|NCT00615030|526649584|FG002|Period I|Abnormal laboratory value(s)|0|||
146037156|NCT00615030|526649585|FG003|Period I|Abnormal laboratory value(s)|0|||
146037157|NCT00615030|526649586|FG004|Period I|Abnormal laboratory value(s)|0|||
146037158|NCT00615030|526649587|FG005|Period I|Abnormal laboratory value(s)|1|||
146037159|NCT00615030|526649588|FG006|Period I|Abnormal laboratory value(s)|0|||
146037160|NCT00615030|526649589|FG007|Period I|Abnormal laboratory value(s)|0|||
146037161|NCT00615030|526649590|FG008|Period I|Abnormal laboratory value(s)|0|||
146037162|NCT00615030|526649591|FG009|Period I|Abnormal laboratory value(s)|0|||
146037163|NCT00615030|526649592|FG010|Period I|Abnormal laboratory value(s)|0|||
146037164|NCT00615030|526649593|FG011|Period I|Abnormal laboratory value(s)|0|||
146037165|NCT00615030|526649582|FG000|Period II|Adverse Event|0|||
146037166|NCT00615030|526649583|FG001|Period II|Adverse Event|0|||
146037167|NCT00615030|526649584|FG002|Period II|Adverse Event|1|||
146037168|NCT00615030|526649585|FG003|Period II|Adverse Event|0|||
146037169|NCT00615030|526649586|FG004|Period II|Adverse Event|0|||
146037170|NCT00615030|526649587|FG005|Period II|Adverse Event|0|||
146037171|NCT00615030|526649588|FG006|Period II|Adverse Event|0|||
146037172|NCT00615030|526649589|FG007|Period II|Adverse Event|0|||
146037173|NCT00615030|526649590|FG008|Period II|Adverse Event|1|||
146037174|NCT00615030|526649591|FG009|Period II|Adverse Event|0|||
146037175|NCT00615030|526649592|FG010|Period II|Adverse Event|0|||
146037176|NCT00615030|526649593|FG011|Period II|Adverse Event|0|||
146037177|NCT00615030|526649582|FG000|Period II|Subject withdrew consent|0|||
146037178|NCT00615030|526649583|FG001|Period II|Subject withdrew consent|0|||
146037179|NCT00615030|526649584|FG002|Period II|Subject withdrew consent|0|||
146037180|NCT00615030|526649585|FG003|Period II|Subject withdrew consent|1|||
146037181|NCT00615030|526649586|FG004|Period II|Subject withdrew consent|0|||
146037182|NCT00615030|526649587|FG005|Period II|Subject withdrew consent|0|||
146037183|NCT00615030|526649588|FG006|Period II|Subject withdrew consent|1|||
146037184|NCT00615030|526649589|FG007|Period II|Subject withdrew consent|0|||
146037185|NCT00615030|526649590|FG008|Period II|Subject withdrew consent|0|||
146037186|NCT00615030|526649591|FG009|Period II|Subject withdrew consent|0|||
146037187|NCT00615030|526649592|FG010|Period II|Subject withdrew consent|0|||
146037188|NCT00615030|526649593|FG011|Period II|Subject withdrew consent|0|||
146037189|NCT00615030|526649582|FG000|Period III|Administrative problems|1|||
146037190|NCT00615030|526649583|FG001|Period III|Administrative problems|0|||
146037191|NCT00615030|526649584|FG002|Period III|Administrative problems|0|||
146037192|NCT00615030|526649585|FG003|Period III|Administrative problems|1|||
146037193|NCT00615030|526649586|FG004|Period III|Administrative problems|0|||
146037194|NCT00615030|526649587|FG005|Period III|Administrative problems|0|||
146037195|NCT00615030|526649588|FG006|Period III|Administrative problems|0|||
146037196|NCT00615030|526649589|FG007|Period III|Administrative problems|0|||
146037197|NCT00615030|526649590|FG008|Period III|Administrative problems|0|||
146037198|NCT00615030|526649591|FG009|Period III|Administrative problems|0|||
146037199|NCT00615030|526649592|FG010|Period III|Administrative problems|0|||
146037200|NCT00615030|526649593|FG011|Period III|Administrative problems|0|||
146037201|NCT01359943|526649594|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
146037202|NCT01359943|526649595|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
146037203|NCT01359943|526649596|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
146254453|NCT04754594|527444590|FG001|Infant Participants|Death|0|||
146254454|NCT04754594|527444591|FG002|Infant Participants|Death|1|||
146254455|NCT04754594|527444592|FG003|Infant Participants|Death|1|||
146037204|NCT01359943|526649594|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
146037205|NCT01359943|526649595|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
146037206|NCT01359943|526649596|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
146037207|NCT01359943|526649594|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
146037208|NCT01359943|526649595|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
146254456|NCT04754594|527444589|FG000|Infant Participants|Other|0|||
146037209|NCT01359943|526649596|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
146037210|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
146037211|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
146037212|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
146037213|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
146037214|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
146037215|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
146037216|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
146037217|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
146037218|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
146037219|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146037220|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146037221|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
146037222|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
146037223|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
146037224|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
146037225|NCT01359943|526649594|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
146037226|NCT01359943|526649595|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
146037227|NCT01359943|526649596|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
146037228|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
146037229|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
146037230|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
146037231|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
146037232|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
146037233|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
146037234|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
146037235|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
146037236|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
146037237|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146037238|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146037239|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
146037240|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
146037241|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
146037242|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
146037243|NCT01359943|526649594|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
146037244|NCT01359943|526649595|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
146037245|NCT01359943|526649596|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
146037246|NCT00308074|526649601|FG000|Overall Study|Withdrawal by Subject|1|||
146037247|NCT03002311|526649602|FG000|Overall Study|Lost to Follow-up|13|||
146037248|NCT03002311|526649603|FG001|Overall Study|Lost to Follow-up|26|||
146037249|NCT03002311|526649602|FG000|Overall Study|Referral provider called to schedule app|3|||
146037250|NCT03002311|526649603|FG001|Overall Study|Referral provider called to schedule app|3|||
146037251|NCT03002311|526649602|FG000|Overall Study|Physician Decision|3|||
146037252|NCT03002311|526649603|FG001|Overall Study|Physician Decision|1|||
146037253|NCT03722524|526649607|FG000|Overall Study|Protocol Violation|86|||
146037254|NCT03722524|526649607|FG000|Overall Study|Adverse Event|7|||
146037255|NCT03722524|526649607|FG000|Overall Study|Lost to Follow-up|1|||
146037256|NCT03722524|526649607|FG000|Overall Study|Reason is not stated|1|||
146037257|NCT03722524|526649607|FG000|Overall Study|Physician Decision|1|||
146037258|NCT03722524|526649607|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
146037259|NCT01286740|526649608|FG000|Overall Study|Enrolled but not treated|1|||
146037260|NCT01286740|526649608|FG000|Overall Study|Protocol Violation|1|||
146037261|NCT03266172|526649609|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
146037262|NCT03266172|526649610|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
146037263|NCT03266172|526649611|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
146037264|NCT03266172|526649609|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
146037265|NCT03266172|526649610|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
146037266|NCT03266172|526649611|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
146037267|NCT03266172|526649609|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
146037268|NCT03266172|526649610|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
146037269|NCT03266172|526649611|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
146037270|NCT03266172|526649609|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
146037271|NCT03266172|526649610|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
146037272|NCT03266172|526649611|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
146037273|NCT03266172|526649609|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146037274|NCT03266172|526649610|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146037275|NCT03266172|526649611|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
146037276|NCT03266172|526649609|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146099162|NCT02959983|526882768|FG000|Overall Study|Protocol Violation|0|||
146037277|NCT03266172|526649610|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
146037278|NCT03266172|526649611|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
146037279|NCT04856904|526649613|FG000|Overall Study|Physician Decision|1|||
146037280|NCT04856904|526649614|FG001|Overall Study|Physician Decision|1|||
146037281|NCT04856904|526649613|FG000|Overall Study|Withdrawal by Subject|13|||
146037282|NCT04856904|526649614|FG001|Overall Study|Withdrawal by Subject|13|||
146037283|NCT04856904|526649613|FG000|Overall Study|Adverse Event|1|||
146037284|NCT04856904|526649614|FG001|Overall Study|Adverse Event|1|||
146037285|NCT04856904|526649613|FG000|Overall Study|Non-compliance with study drug|1|||
146037286|NCT04856904|526649614|FG001|Overall Study|Non-compliance with study drug|1|||
146037287|NCT04856904|526649613|FG000|Overall Study|Lost to Follow-up|4|||
146037288|NCT04856904|526649614|FG001|Overall Study|Lost to Follow-up|4|||
146037289|NCT04856904|526649613|FG000|Overall Study|Withdrawal by Subject|1|||
146037290|NCT04856904|526649614|FG001|Overall Study|Withdrawal by Subject|1|||
146037291|NCT04856904|526649613|FG000|Overall Study|Protocol Violation|1|||
146037292|NCT04856904|526649614|FG001|Overall Study|Protocol Violation|1|||
146037293|NCT00902174|526649615|FG000|Overall Study|Adverse Event|27|||
146037294|NCT00902174|526649616|FG001|Overall Study|Adverse Event|7|||
146037295|NCT00902174|526649615|FG000|Overall Study|Lack of Efficacy|1|||
146037296|NCT00902174|526649616|FG001|Overall Study|Lack of Efficacy|5|||
146037297|NCT00902174|526649615|FG000|Overall Study|Death|2|||
146037298|NCT00902174|526649616|FG001|Overall Study|Death|2|||
146037299|NCT00902174|526649615|FG000|Overall Study|Withdrawal by Subject|2|||
146037300|NCT00902174|526649616|FG001|Overall Study|Withdrawal by Subject|1|||
146037301|NCT00902174|526649615|FG000|Overall Study|Abnormal labs|1|||
146037302|NCT00902174|526649616|FG001|Overall Study|Abnormal labs|1|||
146037303|NCT00902174|526649615|FG000|Overall Study|Protocol Violation|1|||
146037304|NCT00902174|526649616|FG001|Overall Study|Protocol Violation|1|||
146037305|NCT00902174|526649615|FG000|Overall Study|Administration problem|0|||
146037306|NCT00902174|526649616|FG001|Overall Study|Administration problem|1|||
146037307|NCT00454584|526649617|FG000|Controlled Period|Adverse Event|5|||
146037308|NCT00454584|526649618|FG001|Controlled Period|Adverse Event|2|||
146037309|NCT00454584|526649619|FG002|Controlled Period|Adverse Event|1|||
146037310|NCT00454584|526649620|FG003|Controlled Period|Adverse Event|0|||
146037311|NCT00454584|526649621|FG004|Controlled Period|Adverse Event|0|||
146037312|NCT00454584|526649622|FG005|Controlled Period|Adverse Event|0|||
146037313|NCT00454584|526649617|FG000|Controlled Period|Lost to Follow-up|1|||
146037314|NCT00454584|526649618|FG001|Controlled Period|Lost to Follow-up|2|||
146037315|NCT00454584|526649619|FG002|Controlled Period|Lost to Follow-up|2|||
146037316|NCT00454584|526649620|FG003|Controlled Period|Lost to Follow-up|0|||
146037317|NCT00454584|526649621|FG004|Controlled Period|Lost to Follow-up|0|||
146037318|NCT00454584|526649622|FG005|Controlled Period|Lost to Follow-up|0|||
146037319|NCT00454584|526649617|FG000|Controlled Period|Other|5|||
146037320|NCT00454584|526649618|FG001|Controlled Period|Other|4|||
146037321|NCT00454584|526649619|FG002|Controlled Period|Other|2|||
146037322|NCT00454584|526649620|FG003|Controlled Period|Other|0|||
146037323|NCT00454584|526649621|FG004|Controlled Period|Other|0|||
146037324|NCT00454584|526649622|FG005|Controlled Period|Other|0|||
146037325|NCT00454584|526649617|FG000|After Controlled Period|Adverse Event|0|||
146037326|NCT00454584|526649618|FG001|After Controlled Period|Adverse Event|0|||
146037327|NCT00454584|526649619|FG002|After Controlled Period|Adverse Event|0|||
146037328|NCT00454584|526649620|FG003|After Controlled Period|Adverse Event|9|||
146037329|NCT00454584|526649621|FG004|After Controlled Period|Adverse Event|3|||
146037330|NCT00454584|526649622|FG005|After Controlled Period|Adverse Event|9|||
146037331|NCT00454584|526649617|FG000|After Controlled Period|Lack of Efficacy|0|||
146037332|NCT00454584|526649618|FG001|After Controlled Period|Lack of Efficacy|0|||
146037333|NCT00454584|526649619|FG002|After Controlled Period|Lack of Efficacy|0|||
146037334|NCT00454584|526649620|FG003|After Controlled Period|Lack of Efficacy|1|||
146037335|NCT00454584|526649621|FG004|After Controlled Period|Lack of Efficacy|0|||
146037336|NCT00454584|526649622|FG005|After Controlled Period|Lack of Efficacy|0|||
146037337|NCT00454584|526649617|FG000|After Controlled Period|Lost to Follow-up|0|||
146037338|NCT00454584|526649618|FG001|After Controlled Period|Lost to Follow-up|0|||
146037339|NCT00454584|526649619|FG002|After Controlled Period|Lost to Follow-up|0|||
146037340|NCT00454584|526649620|FG003|After Controlled Period|Lost to Follow-up|2|||
146037341|NCT00454584|526649621|FG004|After Controlled Period|Lost to Follow-up|4|||
146037342|NCT00454584|526649622|FG005|After Controlled Period|Lost to Follow-up|6|||
146037343|NCT00454584|526649617|FG000|After Controlled Period|Other|0|||
146037344|NCT00454584|526649618|FG001|After Controlled Period|Other|0|||
146037345|NCT00454584|526649619|FG002|After Controlled Period|Other|0|||
146037346|NCT00454584|526649620|FG003|After Controlled Period|Other|1|||
146037347|NCT00454584|526649621|FG004|After Controlled Period|Other|0|||
146037348|NCT00454584|526649622|FG005|After Controlled Period|Other|0|||
146037349|NCT00454584|526649617|FG000|After Controlled Period|Other|0|||
146037350|NCT00454584|526649618|FG001|After Controlled Period|Other|0|||
146037351|NCT00454584|526649619|FG002|After Controlled Period|Other|0|||
146037352|NCT00454584|526649620|FG003|After Controlled Period|Other|13|||
146037353|NCT00454584|526649621|FG004|After Controlled Period|Other|5|||
146037354|NCT00454584|526649622|FG005|After Controlled Period|Other|17|||
146300566|NCT00283049|527617054|FG002|Overall Study|Adverse Event|4|||
146037355|NCT01716104|526649623|FG000|Overall Study|Do not meet inclusion criteria|6|||
146037356|NCT01716104|526649624|FG001|Overall Study|Do not meet inclusion criteria|7|||
146037357|NCT03429543|526649627|FG000|Overall Study|Adverse Event|1|||
146037358|NCT03429543|526649628|FG001|Overall Study|Adverse Event|1|||
146037359|NCT03429543|526649629|FG002|Overall Study|Adverse Event|0|||
146037360|NCT03429543|526649630|FG003|Overall Study|Adverse Event|0|||
146037361|NCT03429543|526649631|FG004|Overall Study|Adverse Event|0|||
146037362|NCT03429543|526649632|FG005|Overall Study|Adverse Event|2|||
146037363|NCT03429543|526649633|FG006|Overall Study|Adverse Event|0|||
146037364|NCT03429543|526649627|FG000|Overall Study|Lost to Follow-up|1|||
146037365|NCT03429543|526649628|FG001|Overall Study|Lost to Follow-up|0|||
146037366|NCT03429543|526649629|FG002|Overall Study|Lost to Follow-up|0|||
146037367|NCT03429543|526649630|FG003|Overall Study|Lost to Follow-up|0|||
146037368|NCT03429543|526649631|FG004|Overall Study|Lost to Follow-up|1|||
146037369|NCT03429543|526649632|FG005|Overall Study|Lost to Follow-up|0|||
146037370|NCT03429543|526649633|FG006|Overall Study|Lost to Follow-up|0|||
146037371|NCT03429543|526649627|FG000|Overall Study|Withdrawal by Subject|5|||
146037372|NCT03429543|526649628|FG001|Overall Study|Withdrawal by Subject|0|||
146037373|NCT03429543|526649629|FG002|Overall Study|Withdrawal by Subject|1|||
146037374|NCT03429543|526649630|FG003|Overall Study|Withdrawal by Subject|2|||
146037375|NCT03429543|526649631|FG004|Overall Study|Withdrawal by Subject|6|||
146037376|NCT03429543|526649632|FG005|Overall Study|Withdrawal by Subject|3|||
146037377|NCT03429543|526649633|FG006|Overall Study|Withdrawal by Subject|1|||
146037378|NCT03429543|526649627|FG000|Overall Study|Other reason than listed|0|||
146037379|NCT03429543|526649628|FG001|Overall Study|Other reason than listed|1|||
146037380|NCT03429543|526649629|FG002|Overall Study|Other reason than listed|0|||
146037381|NCT03429543|526649630|FG003|Overall Study|Other reason than listed|0|||
146037382|NCT03429543|526649631|FG004|Overall Study|Other reason than listed|4|||
146037383|NCT03429543|526649632|FG005|Overall Study|Other reason than listed|4|||
146037384|NCT03429543|526649633|FG006|Overall Study|Other reason than listed|0|||
146037385|NCT03429543|526649627|FG000|Overall Study|Not treated|0|||
146037386|NCT03429543|526649628|FG001|Overall Study|Not treated|0|||
146037387|NCT03429543|526649629|FG002|Overall Study|Not treated|0|||
146037388|NCT03429543|526649630|FG003|Overall Study|Not treated|0|||
146037389|NCT03429543|526649631|FG004|Overall Study|Not treated|1|||
146037390|NCT03429543|526649632|FG005|Overall Study|Not treated|0|||
146037391|NCT03429543|526649633|FG006|Overall Study|Not treated|0|||
146037392|NCT01818492|526649634|FG000|Overall Study|Adverse Event|2|||
146037393|NCT01818492|526649634|FG000|Overall Study|Death|3|||
146037394|NCT01818492|526649634|FG000|Overall Study|Withdrawal by Subject|1|||
146037395|NCT01818492|526649634|FG000|Overall Study|Additional therapy when not allowed PP|4|||
146037396|NCT00454181|526649638|FG000|Overall Study|Adverse Event|1|||
146037397|NCT00454181|526649639|FG001|Overall Study|Adverse Event|1|||
146037398|NCT00454181|526649638|FG000|Overall Study|Lost to Follow-up|11|||
146037399|NCT00454181|526649639|FG001|Overall Study|Lost to Follow-up|1|||
146037400|NCT00454181|526649638|FG000|Overall Study|Protocol Violation|1|||
146037401|NCT00454181|526649639|FG001|Overall Study|Protocol Violation|1|||
146037402|NCT00454181|526649638|FG000|Overall Study|Withdrawal by Subject|2|||
146037403|NCT00454181|526649639|FG001|Overall Study|Withdrawal by Subject|0|||
146037404|NCT00079677|526649643|FG000|Overall Study|Adverse Event|5|||
146037405|NCT00079677|526649644|FG001|Overall Study|Adverse Event|6|||
146037406|NCT00079677|526649643|FG000|Overall Study|Lack of Efficacy|1|||
146037407|NCT00079677|526649644|FG001|Overall Study|Lack of Efficacy|0|||
146037408|NCT00079677|526649643|FG000|Overall Study|Lost to Follow-up|2|||
146037409|NCT00079677|526649644|FG001|Overall Study|Lost to Follow-up|2|||
146037410|NCT00079677|526649643|FG000|Overall Study|Physician Decision|3|||
146037411|NCT00079677|526649644|FG001|Overall Study|Physician Decision|0|||
146037412|NCT00079677|526649643|FG000|Overall Study|Protocol Violation|2|||
146037413|NCT00079677|526649644|FG001|Overall Study|Protocol Violation|3|||
146037414|NCT00079677|526649643|FG000|Overall Study|Withdrawal by Subject|5|||
146099163|NCT02959983|526882769|FG001|Overall Study|Protocol Violation|1|||
146037415|NCT00079677|526649644|FG001|Overall Study|Withdrawal by Subject|3|||
146099164|NCT02959983|526882768|FG000|Overall Study|Lack of Efficacy|0|||
146099165|NCT02959983|526882769|FG001|Overall Study|Lack of Efficacy|1|||
146037416|NCT00079677|526649643|FG000|Overall Study|Miscellaneous|2|||
146037417|NCT00079677|526649644|FG001|Overall Study|Miscellaneous|0|||
146037418|NCT00989781|526649647|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
146037419|NCT00989781|526649648|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
146037420|NCT00409344|526649649|FG000|Overall Study|no enrollment|0|||
146037421|NCT00409344|526649650|FG001|Overall Study|no enrollment|0|||
146037422|NCT05096312|526649651|FG000|Overall Study|Lost to Follow-up|2|||
146037423|NCT05096312|526649652|FG001|Overall Study|Lost to Follow-up|4|||
146037424|NCT05096312|526649651|FG000|Overall Study|Adverse Event|1|||
146037425|NCT05096312|526649652|FG001|Overall Study|Adverse Event|0|||
146037426|NCT03927404|526649653|FG000|Overall Study|Withdrawal by Subject|1|||
146037427|NCT01229449|526649654|FG000|Overall Study|Withdrawal by Subject|0|||
146037428|NCT01229449|526649655|FG001|Overall Study|Withdrawal by Subject|3|||
146037429|NCT01229449|526649656|FG002|Overall Study|Withdrawal by Subject|0|||
146037430|NCT01229449|526649657|FG003|Overall Study|Withdrawal by Subject|1|||
146037431|NCT01229449|526649658|FG004|Overall Study|Withdrawal by Subject|1|||
146037432|NCT01229449|526649654|FG000|Overall Study|Lost to Follow-up|1|||
146037433|NCT01229449|526649655|FG001|Overall Study|Lost to Follow-up|1|||
146037434|NCT01229449|526649656|FG002|Overall Study|Lost to Follow-up|1|||
146037435|NCT01229449|526649657|FG003|Overall Study|Lost to Follow-up|0|||
146037436|NCT01229449|526649658|FG004|Overall Study|Lost to Follow-up|0|||
146037437|NCT01229449|526649654|FG000|Overall Study|Physician Decision|0|||
146037438|NCT01229449|526649655|FG001|Overall Study|Physician Decision|0|||
146037439|NCT01229449|526649656|FG002|Overall Study|Physician Decision|1|||
146037440|NCT01229449|526649657|FG003|Overall Study|Physician Decision|0|||
146037441|NCT01229449|526649658|FG004|Overall Study|Physician Decision|0|||
146037442|NCT03203291|526649661|FG000|Overall Study|Withdrawal by Subject|1|||
146037443|NCT03157037|526649662|FG000|Overall Study|Death|1|||
146037444|NCT02102399|526649663|FG000|Overall Study|Withdrawal by Subject|6|||
146037445|NCT02102399|526649664|FG001|Overall Study|Withdrawal by Subject|4|||
146037446|NCT04349033|526649665|FG000|Overall Study|Lost to Follow-up|3|||
146037447|NCT04349033|526649666|FG001|Overall Study|Lost to Follow-up|1|||
146037448|NCT04349033|526649667|FG002|Overall Study|Lost to Follow-up|1|||
146037449|NCT00324233|526649670|FG000|First Period|unable to insert catheter|1|||
146037450|NCT00324233|526649671|FG001|First Period|unable to insert catheter|0|||
146037451|NCT00324233|526649670|FG000|Second Period|unable to insert catheter|1|||
146037452|NCT00324233|526649671|FG001|Second Period|unable to insert catheter|1|||
146037453|NCT00324233|526649670|FG000|Second Period|Protocol Violation|4|||
146037454|NCT00324233|526649671|FG001|Second Period|Protocol Violation|6|||
146037455|NCT01704456|526649674|FG000|Overall Study|Lost to Follow-up|8|||
146037456|NCT01704456|526649675|FG001|Overall Study|Lost to Follow-up|14|||
146037457|NCT00498355|526649676|FG000|Overall Study|Lost to Follow-up|1|||
146037458|NCT00410605|526649677|FG000|Overall Study|Adverse Event|12|||
146037459|NCT00410605|526649677|FG000|Overall Study|Physician Decision|3|||
146037460|NCT00410605|526649677|FG000|Overall Study|Withdrawal by Subject|5|||
146037461|NCT00410605|526649677|FG000|Overall Study|Started Non-Protocol Therapy|3|||
146037462|NCT00410605|526649677|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
146037463|NCT00410605|526649677|FG000|Overall Study|Transferred to another Institution|1|||
146037464|NCT04583956|526649678|FG000|Overall Study|Death|9|||
146037465|NCT04583956|526649679|FG001|Overall Study|Death|11|||
146037466|NCT04583956|526649678|FG000|Overall Study|Lost to Follow-up|7|||
146037467|NCT04583956|526649679|FG001|Overall Study|Lost to Follow-up|9|||
146037468|NCT04583956|526649678|FG000|Overall Study|Protocol Violation|2|||
146037469|NCT04583956|526649679|FG001|Overall Study|Protocol Violation|0|||
146037470|NCT04583956|526649678|FG000|Overall Study|Withdrawal by Subject|0|||
146037471|NCT04583956|526649679|FG001|Overall Study|Withdrawal by Subject|2|||
146037472|NCT04583956|526649678|FG000|Overall Study|Randomized but not dosed|2|||
146037473|NCT04583956|526649679|FG001|Overall Study|Randomized but not dosed|3|||
146037474|NCT04583956|526649678|FG000|Overall Study|Withdrawal of consent before product administration|1|||
146037475|NCT04583956|526649679|FG001|Overall Study|Withdrawal of consent before product administration|0|||
146037476|NCT03908970|526649680|FG000|Overall Study|Adverse Event|7|||
146037477|NCT03908970|526649681|FG001|Overall Study|Adverse Event|21|||
146037478|NCT03908970|526649680|FG000|Overall Study|Physician Decision|1|||
146037479|NCT03908970|526649681|FG001|Overall Study|Physician Decision|4|||
146037480|NCT03908970|526649680|FG000|Overall Study|Withdrawal by Subject|9|||
146037481|NCT03908970|526649681|FG001|Overall Study|Withdrawal by Subject|22|||
146037482|NCT04407234|526649682|FG000|Overall Study|Adverse Event|3|||
146037483|NCT04407234|526649683|FG001|Overall Study|Adverse Event|3|||
146037484|NCT00428844|526649690|FG000|Completed Study Drug Treatment|Adverse Event|2|||
146037485|NCT00428844|526649691|FG001|Completed Study Drug Treatment|Adverse Event|4|||
146037486|NCT00428844|526649692|FG002|Completed Study Drug Treatment|Adverse Event|4|||
146037487|NCT00428844|526649690|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
146037488|NCT00428844|526649691|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
146037489|NCT00428844|526649692|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
146037490|NCT00428844|526649690|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
146037491|NCT00428844|526649691|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
146037492|NCT00428844|526649692|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
146037493|NCT00428844|526649690|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
146300567|NCT00283049|527617052|FG000|Overall Study|Protocol Violation|3|||
146037494|NCT00428844|526649691|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
146037495|NCT00428844|526649692|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
146037496|NCT00428844|526649690|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
146037497|NCT00428844|526649691|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
146037498|NCT00428844|526649692|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
146037499|NCT00428844|526649690|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
146037500|NCT00428844|526649691|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
146037501|NCT00428844|526649692|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
146037502|NCT00428844|526649690|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
146037503|NCT00428844|526649691|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
146037504|NCT00428844|526649692|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
146037505|NCT00428844|526649690|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
146254457|NCT04754594|527444590|FG001|Infant Participants|Other|0|||
146254458|NCT04754594|527444591|FG002|Infant Participants|Other|1|||
146254459|NCT04754594|527444592|FG003|Infant Participants|Other|1|||
146254460|NCT01247922|527444593|FG000|Overall Study|Disease progression|4|||
146037506|NCT00428844|526649691|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
146037507|NCT00428844|526649692|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
146037508|NCT00428844|526649690|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
146037509|NCT00428844|526649691|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
146037510|NCT00428844|526649692|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
146037511|NCT00488826|526649695|FG000|Overall Study|Withdrawal by Subject|40|||
146037512|NCT00488826|526649696|FG001|Overall Study|Withdrawal by Subject|35|||
146037513|NCT00488826|526649697|FG002|Overall Study|Withdrawal by Subject|19|||
146037514|NCT00488826|526649695|FG000|Overall Study|Protocol Violation|0|||
146037515|NCT00488826|526649696|FG001|Overall Study|Protocol Violation|0|||
146037516|NCT00488826|526649697|FG002|Overall Study|Protocol Violation|2|||
146037517|NCT00488826|526649695|FG000|Overall Study|Adverse Event|9|||
146037518|NCT00488826|526649696|FG001|Overall Study|Adverse Event|15|||
146037519|NCT00488826|526649697|FG002|Overall Study|Adverse Event|4|||
146037520|NCT00488826|526649695|FG000|Overall Study|Lost to Follow-up|5|||
146037521|NCT00488826|526649696|FG001|Overall Study|Lost to Follow-up|1|||
146037522|NCT00488826|526649697|FG002|Overall Study|Lost to Follow-up|0|||
146037523|NCT00488826|526649695|FG000|Overall Study|Protocol Deviations|2|||
146037524|NCT00488826|526649696|FG001|Overall Study|Protocol Deviations|1|||
146037525|NCT00488826|526649697|FG002|Overall Study|Protocol Deviations|1|||
146037526|NCT04667104|526649705|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
146037527|NCT04667104|526649706|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
146037528|NCT04667104|526649707|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
146037529|NCT00605345|526649708|FG000|Overall Study|Withdrawal by Subject|1|||
146037530|NCT00605345|526649709|FG001|Overall Study|Withdrawal by Subject|0|||
146037531|NCT00605345|526649708|FG000|Overall Study|Adverse Event|0|||
146037532|NCT00605345|526649709|FG001|Overall Study|Adverse Event|1|||
146037533|NCT00605345|526649708|FG000|Overall Study|Protocol Violation|0|||
146037534|NCT00605345|526649709|FG001|Overall Study|Protocol Violation|2|||
146037535|NCT00761527|526649712|FG000|Overall Study|Adverse Event|3|||
146037536|NCT00761527|526649712|FG000|Overall Study|Poor Compliance|8|||
146037537|NCT00761527|526649712|FG000|Overall Study|Lost to Follow-up|9|||
146037538|NCT00761527|526649712|FG000|Overall Study|Unknown reason|2|||
146037539|NCT02008227|526651250|FG000|Overall Study|Lost to Follow-up|7|||
146037540|NCT02008227|526651251|FG001|Overall Study|Lost to Follow-up|9|||
146037541|NCT02008227|526651250|FG000|Overall Study|Death|494|||
146037542|NCT02008227|526651251|FG001|Overall Study|Death|485|||
146037543|NCT02008227|526651250|FG000|Overall Study|Withdrawal by Subject|67|||
146037544|NCT02008227|526651251|FG001|Overall Study|Withdrawal by Subject|36|||
146037545|NCT02008227|526651250|FG000|Overall Study|Study Terminated By Sponsor|44|||
146037546|NCT02008227|526651251|FG001|Overall Study|Study Terminated By Sponsor|83|||
146037547|NCT00742417|526651252|FG000|Randomized|Withdrawal by legal representative|0|||
146037548|NCT00742417|526651253|FG001|Randomized|Withdrawal by legal representative|1|||
146037549|NCT00742417|526651252|FG000|Randomized|Withdrawal by Subject|1|||
146037550|NCT00742417|526651253|FG001|Randomized|Withdrawal by Subject|0|||
146037551|NCT00742417|526651252|FG000|Randomized|Physician Decision|1|||
146037552|NCT00742417|526651253|FG001|Randomized|Physician Decision|0|||
146037553|NCT00742417|526651252|FG000|Intensive Period|Withdrawal by Subject|1|||
146037554|NCT00742417|526651253|FG001|Intensive Period|Withdrawal by Subject|1|||
146037555|NCT00742417|526651252|FG000|Intensive Period|Adverse Event|2|||
146037556|NCT00742417|526651253|FG001|Intensive Period|Adverse Event|0|||
146037557|NCT00965575|526651256|FG000|Overall Study|subject unwillingness to swallow study c|1|||
146037558|NCT00965575|526651257|FG001|Overall Study|subject unwillingness to swallow study c|0|||
146099166|NCT02959983|526882768|FG000|Overall Study|Lost to Follow-up|12|||
146254461|NCT02588027|527444594|FG000|Overall Study|Withdrawal by Subject|1|||
146254462|NCT02588027|527444595|FG001|Overall Study|Withdrawal by Subject|3|||
146037559|NCT02814175|526651260|FG000|Part 1|Adverse Event|2|||
146037560|NCT02814175|526651261|FG001|Part 1|Adverse Event|3|||
146037561|NCT02814175|526651262|FG002|Part 1|Adverse Event|0|||
146037562|NCT02814175|526651263|FG003|Part 1|Adverse Event|0|||
146037563|NCT02814175|526651264|FG004|Part 1|Adverse Event|0|||
146037564|NCT02814175|526651265|FG005|Part 1|Adverse Event|0|||
146037565|NCT02814175|526651260|FG000|Part 1|Withdrawal Consent|8|||
146037566|NCT02814175|526651261|FG001|Part 1|Withdrawal Consent|1|||
146037567|NCT02814175|526651262|FG002|Part 1|Withdrawal Consent|0|||
146099167|NCT02959983|526882769|FG001|Overall Study|Lost to Follow-up|9|||
146037568|NCT02814175|526651263|FG003|Part 1|Withdrawal Consent|0|||
146254463|NCT02588027|527444594|FG000|Overall Study|Protocol Violation|4|||
146254464|NCT02588027|527444595|FG001|Overall Study|Protocol Violation|1|||
146037569|NCT02814175|526651264|FG004|Part 1|Withdrawal Consent|0|||
146037570|NCT02814175|526651265|FG005|Part 1|Withdrawal Consent|0|||
146037571|NCT02814175|526651260|FG000|Part 1|Lost to Follow-up|1|||
146037572|NCT02814175|526651261|FG001|Part 1|Lost to Follow-up|0|||
146037573|NCT02814175|526651262|FG002|Part 1|Lost to Follow-up|0|||
146037574|NCT02814175|526651263|FG003|Part 1|Lost to Follow-up|0|||
146037575|NCT02814175|526651264|FG004|Part 1|Lost to Follow-up|0|||
146037576|NCT02814175|526651265|FG005|Part 1|Lost to Follow-up|0|||
146037577|NCT02814175|526651260|FG000|Part 1|Lack of Efficacy|1|||
146037578|NCT02814175|526651261|FG001|Part 1|Lack of Efficacy|2|||
146037579|NCT02814175|526651262|FG002|Part 1|Lack of Efficacy|0|||
146037580|NCT02814175|526651263|FG003|Part 1|Lack of Efficacy|0|||
146037581|NCT02814175|526651264|FG004|Part 1|Lack of Efficacy|0|||
146037582|NCT02814175|526651265|FG005|Part 1|Lack of Efficacy|0|||
146037583|NCT02814175|526651260|FG000|Part 2|Adverse Event|0|||
146037584|NCT02814175|526651261|FG001|Part 2|Adverse Event|0|||
146037585|NCT02814175|526651262|FG002|Part 2|Adverse Event|0|||
146037586|NCT02814175|526651263|FG003|Part 2|Adverse Event|1|||
146037587|NCT02814175|526651264|FG004|Part 2|Adverse Event|1|||
146037588|NCT02814175|526651265|FG005|Part 2|Adverse Event|2|||
146037589|NCT02814175|526651260|FG000|Part 2|Withdrawal Consent|0|||
146037590|NCT02814175|526651261|FG001|Part 2|Withdrawal Consent|0|||
146037591|NCT02814175|526651262|FG002|Part 2|Withdrawal Consent|0|||
146037592|NCT02814175|526651263|FG003|Part 2|Withdrawal Consent|2|||
146037593|NCT02814175|526651264|FG004|Part 2|Withdrawal Consent|1|||
146037594|NCT02814175|526651265|FG005|Part 2|Withdrawal Consent|1|||
146037595|NCT02814175|526651260|FG000|Part 2|Lost to Follow-up|0|||
146037596|NCT02814175|526651261|FG001|Part 2|Lost to Follow-up|0|||
146037597|NCT02814175|526651262|FG002|Part 2|Lost to Follow-up|0|||
146037598|NCT02814175|526651263|FG003|Part 2|Lost to Follow-up|1|||
146037599|NCT02814175|526651264|FG004|Part 2|Lost to Follow-up|0|||
146037600|NCT02814175|526651265|FG005|Part 2|Lost to Follow-up|0|||
146037601|NCT02814175|526651260|FG000|Part 2|Lack of Efficacy|0|||
146037602|NCT02814175|526651261|FG001|Part 2|Lack of Efficacy|0|||
146037603|NCT02814175|526651262|FG002|Part 2|Lack of Efficacy|0|||
146037604|NCT02814175|526651263|FG003|Part 2|Lack of Efficacy|0|||
146037605|NCT02814175|526651264|FG004|Part 2|Lack of Efficacy|0|||
146037606|NCT02814175|526651265|FG005|Part 2|Lack of Efficacy|3|||
146037607|NCT01912339|526651266|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
146037608|NCT01912339|526651267|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
146037609|NCT01912339|526651268|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
146037610|NCT01912339|526651266|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
146037611|NCT01912339|526651267|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
146037612|NCT01912339|526651268|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
146037613|NCT01912339|526651266|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
146037614|NCT01912339|526651267|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
146037615|NCT01912339|526651268|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
146037616|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
146037617|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
146037618|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
146037619|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
146037620|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
146037621|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
146037622|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
146037623|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
146037624|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
146037625|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
146037626|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
146037627|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
146037628|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
146037629|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
146037630|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
146037631|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
146037632|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
146037633|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
146037634|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
146037635|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
146037636|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
146099168|NCT02959983|526882768|FG000|Overall Study|Other|1|||
146099169|NCT02959983|526882769|FG001|Overall Study|Other|1|||
146037637|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
146037638|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
146037639|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
146037640|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
146037641|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
146037642|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
146099170|NCT02959983|526882768|FG000|Overall Study|Physician Decision|1|||
146099171|NCT02959983|526882769|FG001|Overall Study|Physician Decision|0|||
146099172|NCT02959983|526882768|FG000|Overall Study|Adverse Event|5|||
146037643|NCT01912339|526651266|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
146037644|NCT01912339|526651267|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
146037645|NCT01912339|526651268|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
146037646|NCT01754493|526651269|FG000|Overall Study|Adverse Event|1|||
146037647|NCT01754493|526651269|FG000|Overall Study|Lost to Follow-up|3|||
146037648|NCT01754493|526651269|FG000|Overall Study|Withdrawal by Subject|1|||
146037649|NCT01754493|526651269|FG000|Overall Study|Moved out of town|1|||
146037650|NCT01754493|526651269|FG000|Overall Study|Scheduling conflict|1|||
146037651|NCT02489942|526651270|FG000|Overall Study|Request by patient|602|||
146037652|NCT02489942|526651270|FG000|Overall Study|Improvement/remission|157|||
146037653|NCT02489942|526651270|FG000|Overall Study|No change/Progressive disease|263|||
146037654|NCT02489942|526651270|FG000|Overall Study|Adverse Event|522|||
146037655|NCT02489942|526651270|FG000|Overall Study|Other personal reasons|1218|||
146037656|NCT02489942|526651270|FG000|Overall Study|Lost to Follow-up|456|||
146037657|NCT02489942|526651270|FG000|Overall Study|Not continuously investigated|7|||
146037658|NCT02489942|526651270|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
146037659|NCT02489942|526651270|FG000|Overall Study|Multiple registration|1|||
146037660|NCT02489942|526651270|FG000|Overall Study|No patient visit after entry|100|||
146037661|NCT02489942|526651270|FG000|Overall Study|No treatment with Jardiance|2|||
146037662|NCT02489942|526651270|FG000|Overall Study|Patient received Jardiance before registration|1|||
146037663|NCT02489942|526651270|FG000|Overall Study|No CRF collected|86|||
146037664|NCT01272635|526651271|FG000|Overall Study|Lost to Follow-up|31|||
146037665|NCT01272635|526651272|FG001|Overall Study|Lost to Follow-up|20|||
146037666|NCT01272635|526651273|FG002|Overall Study|Lost to Follow-up|31|||
146037667|NCT01272635|526651274|FG003|Overall Study|Lost to Follow-up|23|||
146037668|NCT01543776|526651277|FG000|Overall Study|Withdrawal by Subject|2|||
146037669|NCT01543776|526651278|FG001|Overall Study|Withdrawal by Subject|2|||
146037670|NCT03626545|526651279|FG000|Overall Study|Progressive disease|3|||
146037671|NCT03626545|526651280|FG001|Overall Study|Progressive disease|82|||
146037672|NCT03626545|526651281|FG002|Overall Study|Progressive disease|85|||
146037673|NCT03626545|526651279|FG000|Overall Study|Adverse Event|3|||
146037674|NCT03626545|526651280|FG001|Overall Study|Adverse Event|13|||
146037675|NCT03626545|526651281|FG002|Overall Study|Adverse Event|10|||
146037676|NCT03626545|526651279|FG000|Overall Study|Physician Decision|1|||
146037677|NCT03626545|526651280|FG001|Overall Study|Physician Decision|18|||
146037678|NCT03626545|526651281|FG002|Overall Study|Physician Decision|14|||
146037679|NCT03626545|526651279|FG000|Overall Study|Subject Decision|0|||
146037680|NCT03626545|526651280|FG001|Overall Study|Subject Decision|5|||
146037681|NCT03626545|526651281|FG002|Overall Study|Subject Decision|5|||
146037682|NCT03626545|526651279|FG000|Overall Study|Death|1|||
146037683|NCT03626545|526651280|FG001|Overall Study|Death|1|||
146037684|NCT03626545|526651281|FG002|Overall Study|Death|1|||
146037685|NCT03626545|526651279|FG000|Overall Study|Protocol Deviation|0|||
146037686|NCT03626545|526651280|FG001|Overall Study|Protocol Deviation|1|||
146037687|NCT03626545|526651281|FG002|Overall Study|Protocol Deviation|1|||
146037688|NCT03626545|526651279|FG000|Overall Study|Guardian Decision|0|||
146037689|NCT03626545|526651280|FG001|Overall Study|Guardian Decision|0|||
146037690|NCT03626545|526651281|FG002|Overall Study|Guardian Decision|1|||
146037691|NCT03387020|526651283|FG000|Overall Study|Adverse Event|0|||
146037692|NCT03387020|526651284|FG001|Overall Study|Adverse Event|2|||
146037693|NCT03387020|526651285|FG002|Overall Study|Adverse Event|0|||
146037694|NCT03387020|526651283|FG000|Overall Study|Withdrawal by Subject|2|||
146037695|NCT03387020|526651284|FG001|Overall Study|Withdrawal by Subject|0|||
146037696|NCT03387020|526651285|FG002|Overall Study|Withdrawal by Subject|0|||
146037697|NCT00434642|526651286|FG000|Blinded Treatment Phase|Adverse Event|12|||
146037698|NCT00434642|526651287|FG001|Blinded Treatment Phase|Adverse Event|58|||
146037699|NCT00434642|526651286|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
146037700|NCT00434642|526651287|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
146037701|NCT00434642|526651286|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
146037702|NCT00434642|526651287|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
146037703|NCT00434642|526651286|FG000|Blinded Treatment Phase|Physician Decision|19|||
146037704|NCT00434642|526651287|FG001|Blinded Treatment Phase|Physician Decision|27|||
146037705|NCT00434642|526651286|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
146037706|NCT00434642|526651287|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
146037707|NCT00434642|526651286|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
146037708|NCT00434642|526651287|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
146037709|NCT00434642|526651286|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
146037710|NCT00434642|526651287|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
146037711|NCT00434642|526651286|FG000|Open-label Treatment Phase|Adverse Event|0|||
146037712|NCT00434642|526651287|FG001|Open-label Treatment Phase|Adverse Event|5|||
146037713|NCT00434642|526651286|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
146037714|NCT00434642|526651287|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
146037715|NCT02421588|526651288|FG000|Overall Study|Non-treatment-related AE|8|||
146037716|NCT02421588|526651289|FG001|Overall Study|Non-treatment-related AE|8|||
146037717|NCT02421588|526651288|FG000|Overall Study|Progressive disease|152|||
146037718|NCT02421588|526651289|FG001|Overall Study|Progressive disease|135|||
146037719|NCT02421588|526651288|FG000|Overall Study|Death|11|||
146037720|NCT02421588|526651289|FG001|Overall Study|Death|3|||
146037721|NCT02421588|526651288|FG000|Overall Study|Physician Decision|8|||
146037722|NCT02421588|526651289|FG001|Overall Study|Physician Decision|17|||
146037723|NCT02421588|526651288|FG000|Overall Study|Other reason not specified|3|||
146037724|NCT02421588|526651289|FG001|Overall Study|Other reason not specified|1|||
146037725|NCT02421588|526651288|FG000|Overall Study|Symptomatic deterioration|13|||
146037726|NCT02421588|526651289|FG001|Overall Study|Symptomatic deterioration|19|||
146037727|NCT02421588|526651288|FG000|Overall Study|Treatment-related AE|10|||
146037728|NCT02421588|526651289|FG001|Overall Study|Treatment-related AE|14|||
146037729|NCT02421588|526651288|FG000|Overall Study|Withdrawal by Subject|14|||
146037730|NCT02421588|526651289|FG001|Overall Study|Withdrawal by Subject|16|||
146037731|NCT02421588|526651288|FG000|Overall Study|Not treated|2|||
146037732|NCT02421588|526651289|FG001|Overall Study|Not treated|8|||
146037733|NCT04071158|526651296|FG000|Overall Study|Lost to Follow-up|1|||
146037734|NCT04071158|526651297|FG001|Overall Study|Lost to Follow-up|2|||
146037735|NCT04071158|526651298|FG002|Overall Study|Lost to Follow-up|3|||
146037736|NCT04071158|526651299|FG003|Overall Study|Lost to Follow-up|3|||
146037737|NCT04071158|526651300|FG004|Overall Study|Lost to Follow-up|5|||
146037738|NCT04071158|526651296|FG000|Overall Study|Randomized but not treated|2|||
146037739|NCT04071158|526651297|FG001|Overall Study|Randomized but not treated|2|||
146037740|NCT04071158|526651298|FG002|Overall Study|Randomized but not treated|0|||
146037741|NCT04071158|526651299|FG003|Overall Study|Randomized but not treated|0|||
146037742|NCT04071158|526651300|FG004|Overall Study|Randomized but not treated|0|||
146037743|NCT01178099|526651301|FG000|Overall Study|Physician Decision|0|||
146037744|NCT01178099|526651302|FG001|Overall Study|Physician Decision|1|||
146037745|NCT02473367|526651305|FG000|Wait 1|Withdrawal by Subject|1|||
146037746|NCT02473367|526651305|FG000|Period 4|Lost to Follow-up|1|||
146037747|NCT04816721|526651306|FG000|Overall Study|Withdrawal by Subject|0|||
146037748|NCT04816721|526651307|FG001|Overall Study|Withdrawal by Subject|2|||
146037749|NCT04816721|526651308|FG002|Overall Study|Withdrawal by Subject|0|||
146037750|NCT04816721|526651309|FG003|Overall Study|Withdrawal by Subject|1|||
146037751|NCT04816721|526651310|FG004|Overall Study|Withdrawal by Subject|1|||
146037752|NCT04816721|526651311|FG005|Overall Study|Withdrawal by Subject|0|||
146037753|NCT04816721|526651312|FG006|Overall Study|Withdrawal by Subject|0|||
146037754|NCT04816721|526651313|FG007|Overall Study|Withdrawal by Subject|0|||
146037755|NCT04816721|526651306|FG000|Overall Study|Miscellaneous|0|||
146037756|NCT04816721|526651307|FG001|Overall Study|Miscellaneous|0|||
146037757|NCT04816721|526651308|FG002|Overall Study|Miscellaneous|0|||
146037758|NCT04816721|526651309|FG003|Overall Study|Miscellaneous|0|||
146037759|NCT04816721|526651310|FG004|Overall Study|Miscellaneous|0|||
146037760|NCT04816721|526651311|FG005|Overall Study|Miscellaneous|1|||
146037761|NCT04816721|526651312|FG006|Overall Study|Miscellaneous|0|||
146037762|NCT04816721|526651313|FG007|Overall Study|Miscellaneous|0|||
146037763|NCT04816721|526651306|FG000|Overall Study|Lost to Follow-up|0|||
146037764|NCT04816721|526651307|FG001|Overall Study|Lost to Follow-up|0|||
146037765|NCT04816721|526651308|FG002|Overall Study|Lost to Follow-up|0|||
146037766|NCT04816721|526651309|FG003|Overall Study|Lost to Follow-up|1|||
146037767|NCT04816721|526651310|FG004|Overall Study|Lost to Follow-up|0|||
146037768|NCT04816721|526651311|FG005|Overall Study|Lost to Follow-up|0|||
146037769|NCT04816721|526651312|FG006|Overall Study|Lost to Follow-up|0|||
146037770|NCT04816721|526651313|FG007|Overall Study|Lost to Follow-up|0|||
146037771|NCT02678923|526651328|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
146037772|NCT02678923|526651329|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
146037773|NCT02678923|526651328|FG000|Overall Study|Withdrawal by Subject|3|||
146037774|NCT02678923|526651329|FG001|Overall Study|Withdrawal by Subject|2|||
146037775|NCT02678923|526651328|FG000|Overall Study|Lost to Follow-up|1|||
146037776|NCT02678923|526651329|FG001|Overall Study|Lost to Follow-up|0|||
146037777|NCT02678923|526651328|FG000|Overall Study|Did Not Return for Study Visits|1|||
146037778|NCT02678923|526651329|FG001|Overall Study|Did Not Return for Study Visits|0|||
146037779|NCT00455143|526651330|FG000|Overall Study|Physician Decision|1|||
146037780|NCT00455143|526651330|FG000|Overall Study|Withdrawal by Subject|1|||
146037781|NCT00455143|526651330|FG000|Overall Study|Staff was not avail to follow patient|2|||
146037782|NCT00455143|526651330|FG000|Overall Study|No longer met Inclusion Criteria|1|||
146037783|NCT00455143|526651330|FG000|Overall Study|Surgical time, staff not available|1|||
146037784|NCT05222555|526651333|FG000|Overall Study|Ongoing|2|||
146037785|NCT05222555|526651334|FG001|Overall Study|Ongoing|18|||
146037786|NCT05222555|526651333|FG000|Overall Study|Adverse Event|1|||
146037787|NCT05222555|526651334|FG001|Overall Study|Adverse Event|1|||
146037788|NCT05222555|526651333|FG000|Overall Study|Death|0|||
146037789|NCT05222555|526651334|FG001|Overall Study|Death|6|||
146037790|NCT05222555|526651333|FG000|Overall Study|Withdrawal by Subject|0|||
146037791|NCT05222555|526651334|FG001|Overall Study|Withdrawal by Subject|11|||
146037792|NCT00300365|526651335|FG000|Overall Study|Lost to Follow-up|1|||
146037793|NCT00300365|526651336|FG001|Overall Study|Lost to Follow-up|0|||
146037794|NCT00300365|526651335|FG000|Overall Study|Physician Decision|2|||
146037795|NCT00300365|526651336|FG001|Overall Study|Physician Decision|0|||
146099173|NCT02959983|526882769|FG001|Overall Study|Adverse Event|1|||
146037796|NCT00300365|526651335|FG000|Overall Study|Withdrawal by Subject|1|||
146037797|NCT00300365|526651336|FG001|Overall Study|Withdrawal by Subject|0|||
146037798|NCT00300365|526651335|FG000|Overall Study|Adverse Event|0|||
146037799|NCT00300365|526651336|FG001|Overall Study|Adverse Event|2|||
146037800|NCT01374178|526651339|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
146037801|NCT01374178|526651340|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
146037802|NCT01374178|526651339|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
146037803|NCT01374178|526651340|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
146037804|NCT01422824|526651341|FG000|Overall Study|Case record form not evaluated|1|||
146037805|NCT01422824|526651341|FG000|Overall Study|Lost to Follow-up|37|||
146037806|NCT01641822|526651342|FG000|Run-in Phase|Noncompliance with study drug|1|||
146037807|NCT01641822|526651343|FG001|Run-in Phase|Noncompliance with study drug|0|||
146037808|NCT01641822|526651344|FG002|Run-in Phase|Noncompliance with study drug|0|||
146037809|NCT01641822|526651342|FG000|Run-in Phase|Adverse Event|3|||
146037810|NCT01641822|526651343|FG001|Run-in Phase|Adverse Event|0|||
146037811|NCT01641822|526651344|FG002|Run-in Phase|Adverse Event|0|||
146037812|NCT01641822|526651342|FG000|Run-in Phase|Withdrew consent|1|||
146037813|NCT01641822|526651343|FG001|Run-in Phase|Withdrew consent|0|||
146037814|NCT01641822|526651344|FG002|Run-in Phase|Withdrew consent|0|||
146037815|NCT01641822|526651342|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
146037816|NCT01641822|526651343|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
146037817|NCT01641822|526651344|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
146037818|NCT01641822|526651342|FG000|Comparative Phase|Noncompliance with study drug|0|||
146037819|NCT01641822|526651343|FG001|Comparative Phase|Noncompliance with study drug|1|||
146037820|NCT01641822|526651344|FG002|Comparative Phase|Noncompliance with study drug|0|||
146037821|NCT01641822|526651342|FG000|Comparative Phase|Investigator's discretion|0|||
146037822|NCT01641822|526651343|FG001|Comparative Phase|Investigator's discretion|0|||
146037823|NCT01641822|526651344|FG002|Comparative Phase|Investigator's discretion|1|||
146037824|NCT01641822|526651342|FG000|Comparative Phase|Pregnancy|0|||
146037825|NCT01641822|526651343|FG001|Comparative Phase|Pregnancy|0|||
146037826|NCT01641822|526651344|FG002|Comparative Phase|Pregnancy|1|||
146037827|NCT01641822|526651342|FG000|Comparative Phase|Adverse event, serious fatal|0|||
146037828|NCT01641822|526651343|FG001|Comparative Phase|Adverse event, serious fatal|1|||
146037829|NCT01641822|526651344|FG002|Comparative Phase|Adverse event, serious fatal|0|||
146037830|NCT01641822|526651342|FG000|Comparative Phase|Withdrew consent|0|||
146037831|NCT01641822|526651343|FG001|Comparative Phase|Withdrew consent|3|||
146037832|NCT01641822|526651344|FG002|Comparative Phase|Withdrew consent|7|||
146037833|NCT01641822|526651342|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
146037834|NCT01641822|526651343|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
146037835|NCT01641822|526651344|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
146037836|NCT02760810|526651345|FG000|Overall Study|Protocol Violation|1|||
146037837|NCT02421601|526651346|FG000|Overall Study|Adverse Event|4|||
146037838|NCT02421601|526651346|FG000|Overall Study|Lack of Efficacy|5|||
146037839|NCT02421601|526651346|FG000|Overall Study|Physician Decision|1|||
146037840|NCT02421601|526651346|FG000|Overall Study|Withdrawal by Subject|31|||
146037841|NCT02421601|526651346|FG000|Overall Study|Others|41|||
146037842|NCT00470418|526651351|FG000|Overall Study|Withdrawal by Subject|1|||
146037843|NCT00470418|526651352|FG001|Overall Study|Withdrawal by Subject|0|||
146037844|NCT00599638|526651353|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
146037845|NCT00599638|526651354|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
146037846|NCT00599638|526651355|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
146037847|NCT00599638|526651356|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
146037848|NCT00599638|526651353|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
146037849|NCT00599638|526651354|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
146037850|NCT00599638|526651355|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
146037851|NCT00599638|526651356|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
146037852|NCT00599638|526651353|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
146037853|NCT00599638|526651354|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
146037854|NCT00599638|526651355|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
146037855|NCT00599638|526651356|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
146037856|NCT00599638|526651353|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
146037857|NCT00599638|526651354|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
146037858|NCT00599638|526651355|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
146037859|NCT00599638|526651356|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
146037860|NCT00599638|526651353|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146037861|NCT00599638|526651354|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
146037862|NCT00599638|526651355|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
146037863|NCT00599638|526651356|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146037864|NCT00599638|526651353|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
146037865|NCT00599638|526651354|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
146037866|NCT00599638|526651355|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
146037867|NCT00599638|526651356|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
146037868|NCT00599638|526651353|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146037869|NCT00599638|526651354|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146037870|NCT00599638|526651355|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
146037871|NCT00599638|526651356|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
146037872|NCT00599638|526651353|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
146037873|NCT00599638|526651354|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
146037874|NCT00599638|526651355|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
146037875|NCT00599638|526651356|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
146037876|NCT00599638|526651353|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
146037877|NCT00599638|526651354|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146037878|NCT00599638|526651355|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146037879|NCT00599638|526651356|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
146037880|NCT03006887|526651357|FG000|Overall Study|Adverse Event|1|||
146037881|NCT00462748|526651358|FG000|Overall Study|Adverse Event|7|||
146037882|NCT00462748|526651359|FG001|Overall Study|Adverse Event|5|||
146037883|NCT00462748|526651360|FG002|Overall Study|Adverse Event|9|||
146037884|NCT00462748|526651358|FG000|Overall Study|Protocol Violation|0|||
146037885|NCT00462748|526651359|FG001|Overall Study|Protocol Violation|2|||
146037886|NCT00462748|526651360|FG002|Overall Study|Protocol Violation|1|||
146037887|NCT00462748|526651358|FG000|Overall Study|Withdrew consent|3|||
146037888|NCT00462748|526651359|FG001|Overall Study|Withdrew consent|3|||
146037889|NCT00462748|526651360|FG002|Overall Study|Withdrew consent|0|||
146037890|NCT00462748|526651358|FG000|Overall Study|Lost to Follow-up|1|||
146037891|NCT00462748|526651359|FG001|Overall Study|Lost to Follow-up|1|||
146037892|NCT00462748|526651360|FG002|Overall Study|Lost to Follow-up|1|||
146037893|NCT00462748|526651358|FG000|Overall Study|Discontinued after 41 days Rx|1|||
146037894|NCT00462748|526651359|FG001|Overall Study|Discontinued after 41 days Rx|0|||
146037895|NCT00462748|526651360|FG002|Overall Study|Discontinued after 41 days Rx|0|||
146037896|NCT01729208|526651361|FG000|Baseline|Physician Decision|5|||
146037897|NCT01729208|526651362|FG001|Baseline|Physician Decision|4|||
146037898|NCT01729208|526651361|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
146037899|NCT01729208|526651362|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
146037900|NCT01729208|526651361|FG000|12 Months Follow-up|Lost to Follow-up|3|||
146037901|NCT01729208|526651362|FG001|12 Months Follow-up|Lost to Follow-up|3|||
146037902|NCT01729208|526651361|FG000|24 Months Follow-up|Lost to Follow-up|3|||
146037903|NCT01729208|526651362|FG001|24 Months Follow-up|Lost to Follow-up|0|||
146037904|NCT01729208|526651361|FG000|36 Months Follow-up|Physician Decision|1|||
146037905|NCT01729208|526651362|FG001|36 Months Follow-up|Physician Decision|0|||
146037906|NCT01729208|526651361|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
146037907|NCT01729208|526651362|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
146037908|NCT02428413|526651363|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
146037909|NCT02428413|526651364|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
146037910|NCT02428413|526651363|FG000|Overall Study|Protocol Violation|1|||
146037911|NCT02428413|526651364|FG001|Overall Study|Protocol Violation|2|||
146037912|NCT02428413|526651363|FG000|Overall Study|Case Cancelled|2|||
146037913|NCT02428413|526651364|FG001|Overall Study|Case Cancelled|0|||
146037914|NCT02428413|526651363|FG000|Overall Study|Missed Cases|1|||
146037915|NCT02428413|526651364|FG001|Overall Study|Missed Cases|2|||
146037916|NCT02428413|526651363|FG000|Overall Study|Nurse Refusal|1|||
146037917|NCT02428413|526651364|FG001|Overall Study|Nurse Refusal|0|||
146037918|NCT03689855|526651367|FG000|Overall Study|Adverse Event|3|||
146037919|NCT03689855|526651367|FG000|Overall Study|Withdrawal by Subject|1|||
146037920|NCT01438177|526651368|FG000|Overall Study|Withdrawal by Subject|1|||
146037921|NCT01438177|526651368|FG000|Overall Study|Initiation of new therapy|1|||
146037922|NCT02772978|526651369|FG000|Overall Study|Withdrawal by Subject|1|||
146037923|NCT02772978|526651370|FG001|Overall Study|Withdrawal by Subject|1|||
146037924|NCT01026220|526651371|FG000|Induction|Death|1|||
146037925|NCT01026220|526651372|FG001|Induction|Death|0|||
146099174|NCT02959983|526882768|FG000|Overall Study|Withdrawal by Subject|7|||
146099175|NCT02959983|526882769|FG001|Overall Study|Withdrawal by Subject|12|||
146037926|NCT01026220|526651373|FG002|Induction|Death|0|||
146037927|NCT01026220|526651371|FG000|Induction|Lack of Efficacy|2|||
146037928|NCT01026220|526651372|FG001|Induction|Lack of Efficacy|0|||
146037929|NCT01026220|526651373|FG002|Induction|Lack of Efficacy|0|||
146037930|NCT01026220|526651371|FG000|Induction|Physician Decision|12|||
146037931|NCT01026220|526651372|FG001|Induction|Physician Decision|0|||
146037932|NCT01026220|526651373|FG002|Induction|Physician Decision|0|||
146099176|NCT01254630|526882770|FG000|Overall Study|Adverse Event|36|||
146099177|NCT01254630|526882771|FG001|Overall Study|Adverse Event|15|||
146099178|NCT01254630|526882772|FG002|Overall Study|Adverse Event|40|||
146037933|NCT01026220|526651371|FG000|Induction|Withdrawal by Subject|9|||
146037934|NCT01026220|526651372|FG001|Induction|Withdrawal by Subject|0|||
146037935|NCT01026220|526651373|FG002|Induction|Withdrawal by Subject|0|||
146037936|NCT01026220|526651371|FG000|Induction|Ineligible|1|||
146037937|NCT01026220|526651372|FG001|Induction|Ineligible|0|||
146037938|NCT01026220|526651373|FG002|Induction|Ineligible|0|||
146037939|NCT01026220|526651371|FG000|Consolidation Maintenance|Death|0|||
146037940|NCT01026220|526651372|FG001|Consolidation Maintenance|Death|1|||
146037941|NCT01026220|526651373|FG002|Consolidation Maintenance|Death|0|||
146037942|NCT01026220|526651371|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
146037943|NCT01026220|526651372|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
146037944|NCT01026220|526651373|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
146037945|NCT01026220|526651371|FG000|Consolidation Maintenance|Physician Decision|0|||
146037946|NCT01026220|526651372|FG001|Consolidation Maintenance|Physician Decision|2|||
146037947|NCT01026220|526651373|FG002|Consolidation Maintenance|Physician Decision|7|||
146037948|NCT01026220|526651371|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
146037949|NCT01026220|526651372|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
146037950|NCT01026220|526651373|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
146037951|NCT04058886|526651379|FG000|Overall Study|Withdrawal by Subject|4|||
146037952|NCT04058886|526651379|FG000|Overall Study|Inadequate deafness interpreter service|1|||
146037953|NCT01069705|526651380|FG000|Overall Study|Adverse Event|1|||
146037954|NCT01069705|526651380|FG000|Overall Study|Withdrawal by Subject|2|||
146037955|NCT00727558|526651381|FG000|Overall Study|Lens issue|0|||
146037956|NCT00727558|526651382|FG001|Overall Study|Lens issue|1|||
146037957|NCT00727558|526651381|FG000|Overall Study|Adverse Event|0|||
146037958|NCT00727558|526651382|FG001|Overall Study|Adverse Event|1|||
146037959|NCT00727558|526651381|FG000|Overall Study|Subject unable to return for follow-up|1|||
146037960|NCT00727558|526651382|FG001|Overall Study|Subject unable to return for follow-up|1|||
146037961|NCT00727558|526651381|FG000|Overall Study|Lost to Follow-up|1|||
146037962|NCT00727558|526651382|FG001|Overall Study|Lost to Follow-up|0|||
146037963|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
146037964|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
146037965|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
146037966|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
146037967|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
146037968|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
146037969|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
146037970|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
146037971|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Death|0|||
146037972|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Death|1|||
146037973|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
146037974|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
146037975|NCT03281304|526651388|FG000|Treatment Phase (up to 42 Months)|Other|0|||
146037976|NCT03281304|526651389|FG001|Treatment Phase (up to 42 Months)|Other|2|||
146037977|NCT03281304|526651388|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
146037978|NCT03281304|526651389|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
146037979|NCT01114438|526651390|FG000|Overall Study|Adverse Event|10|||
146037980|NCT01114438|526651390|FG000|Overall Study|concomitant medication|1|||
146037981|NCT01114438|526651390|FG000|Overall Study|Physician Decision|1|||
146037982|NCT01114438|526651390|FG000|Overall Study|Withdrawal by Subject|2|||
146037983|NCT03208088|526651391|FG000|Period 2|Withdrawal by Subject|0|||
146037984|NCT03208088|526651392|FG001|Period 2|Withdrawal by Subject|0|||
146037985|NCT03208088|526651393|FG002|Period 2|Withdrawal by Subject|0|||
146037986|NCT03208088|526651394|FG003|Period 2|Withdrawal by Subject|0|||
146037987|NCT03208088|526651395|FG004|Period 2|Withdrawal by Subject|0|||
146037988|NCT03208088|526651396|FG005|Period 2|Withdrawal by Subject|0|||
146037989|NCT03208088|526651397|FG006|Period 2|Withdrawal by Subject|0|||
146037990|NCT03208088|526651398|FG007|Period 2|Withdrawal by Subject|0|||
146037991|NCT03208088|526651399|FG008|Period 2|Withdrawal by Subject|1|||
146037992|NCT03208088|526651400|FG009|Period 2|Withdrawal by Subject|0|||
146037993|NCT03208088|526651391|FG000|Period 3|Unsatisfactory Test Article|0|||
146037994|NCT03208088|526651392|FG001|Period 3|Unsatisfactory Test Article|0|||
146037995|NCT03208088|526651393|FG002|Period 3|Unsatisfactory Test Article|0|||
146037996|NCT03208088|526651394|FG003|Period 3|Unsatisfactory Test Article|1|||
146037997|NCT03208088|526651395|FG004|Period 3|Unsatisfactory Test Article|0|||
146037998|NCT03208088|526651396|FG005|Period 3|Unsatisfactory Test Article|0|||
146037999|NCT03208088|526651397|FG006|Period 3|Unsatisfactory Test Article|0|||
146038000|NCT03208088|526651398|FG007|Period 3|Unsatisfactory Test Article|0|||
146038001|NCT03208088|526651399|FG008|Period 3|Unsatisfactory Test Article|0|||
146038002|NCT03208088|526651400|FG009|Period 3|Unsatisfactory Test Article|0|||
146038003|NCT03208088|526651391|FG000|Period 4|Unsatisfactory Test Article|0|||
146099179|NCT01254630|526882773|FG003|Overall Study|Adverse Event|8|||
146099180|NCT01254630|526882770|FG000|Overall Study|Death|461|||
146300568|NCT00283049|527617053|FG001|Overall Study|Protocol Violation|0|||
146038004|NCT03208088|526651392|FG001|Period 4|Unsatisfactory Test Article|0|||
146038005|NCT03208088|526651393|FG002|Period 4|Unsatisfactory Test Article|0|||
146038006|NCT03208088|526651394|FG003|Period 4|Unsatisfactory Test Article|1|||
146038007|NCT03208088|526651395|FG004|Period 4|Unsatisfactory Test Article|0|||
146300569|NCT00283049|527617054|FG002|Overall Study|Protocol Violation|3|||
146038008|NCT03208088|526651396|FG005|Period 4|Unsatisfactory Test Article|0|||
146099181|NCT01254630|526882771|FG001|Overall Study|Death|151|||
146038009|NCT03208088|526651397|FG006|Period 4|Unsatisfactory Test Article|0|||
146038010|NCT03208088|526651398|FG007|Period 4|Unsatisfactory Test Article|0|||
146038011|NCT03208088|526651399|FG008|Period 4|Unsatisfactory Test Article|0|||
146038012|NCT03208088|526651400|FG009|Period 4|Unsatisfactory Test Article|0|||
146038013|NCT02577016|526651403|FG000|Overall Study|Adverse Event|2|||
146038014|NCT02577016|526651404|FG001|Overall Study|Adverse Event|1|||
146038015|NCT02577016|526651403|FG000|Overall Study|Physician Decision|0|||
146038016|NCT02577016|526651404|FG001|Overall Study|Physician Decision|1|||
146038017|NCT02126839|526651405|FG000|Overall Study|Adverse Event|0|||
146038018|NCT02126839|526651406|FG001|Overall Study|Adverse Event|1|||
146038019|NCT02126839|526651405|FG000|Overall Study|Withdrawal by Subject|1|||
146038020|NCT02126839|526651406|FG001|Overall Study|Withdrawal by Subject|0|||
146038021|NCT02126839|526651405|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146038022|NCT02126839|526651406|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146038023|NCT02126839|526651405|FG000|Overall Study|Protocol Violation|2|||
146038024|NCT02126839|526651406|FG001|Overall Study|Protocol Violation|3|||
146038025|NCT02126839|526651405|FG000|Overall Study|Sponsor request|0|||
146038026|NCT02126839|526651406|FG001|Overall Study|Sponsor request|1|||
146038027|NCT02126839|526651405|FG000|Overall Study|Lost to Follow-up|1|||
146038028|NCT02126839|526651406|FG001|Overall Study|Lost to Follow-up|4|||
146038029|NCT02126839|526651405|FG000|Overall Study|Other|5|||
146038030|NCT02126839|526651406|FG001|Overall Study|Other|5|||
146038031|NCT00422383|526651407|FG000|Overall Study|Adverse Event|5|||
146038032|NCT00422383|526651408|FG001|Overall Study|Adverse Event|3|||
146038033|NCT00422383|526651409|FG002|Overall Study|Adverse Event|1|||
146038034|NCT00422383|526651410|FG003|Overall Study|Adverse Event|1|||
146038035|NCT00422383|526651411|FG004|Overall Study|Adverse Event|0|||
146038036|NCT00422383|526651407|FG000|Overall Study|Lack of Efficacy|4|||
146038037|NCT00422383|526651408|FG001|Overall Study|Lack of Efficacy|4|||
146038038|NCT00422383|526651409|FG002|Overall Study|Lack of Efficacy|2|||
146038039|NCT00422383|526651410|FG003|Overall Study|Lack of Efficacy|1|||
146038040|NCT00422383|526651411|FG004|Overall Study|Lack of Efficacy|1|||
146038041|NCT00422383|526651407|FG000|Overall Study|Lost to Follow-up|0|||
146038042|NCT00422383|526651408|FG001|Overall Study|Lost to Follow-up|1|||
146038043|NCT00422383|526651409|FG002|Overall Study|Lost to Follow-up|0|||
146038044|NCT00422383|526651410|FG003|Overall Study|Lost to Follow-up|0|||
146038045|NCT00422383|526651411|FG004|Overall Study|Lost to Follow-up|1|||
146038046|NCT00422383|526651407|FG000|Overall Study|Protocol Violation|1|||
146038047|NCT00422383|526651408|FG001|Overall Study|Protocol Violation|1|||
146038048|NCT00422383|526651409|FG002|Overall Study|Protocol Violation|1|||
146038049|NCT00422383|526651410|FG003|Overall Study|Protocol Violation|0|||
146038050|NCT00422383|526651411|FG004|Overall Study|Protocol Violation|0|||
146038051|NCT00422383|526651407|FG000|Overall Study|Withdrawal by Subject|5|||
146038052|NCT00422383|526651408|FG001|Overall Study|Withdrawal by Subject|5|||
146038053|NCT00422383|526651409|FG002|Overall Study|Withdrawal by Subject|0|||
146038054|NCT00422383|526651410|FG003|Overall Study|Withdrawal by Subject|0|||
146038055|NCT00422383|526651411|FG004|Overall Study|Withdrawal by Subject|1|||
146038056|NCT00566254|526651412|FG000|Overall Study|Adverse Event|3|||
146038057|NCT00566254|526651413|FG001|Overall Study|Adverse Event|1|||
146038058|NCT00566254|526651412|FG000|Overall Study|Protocol Violation|1|||
146038059|NCT00566254|526651413|FG001|Overall Study|Protocol Violation|3|||
146038060|NCT00566254|526651412|FG000|Overall Study|Withdrawal by Subject|1|||
146038061|NCT00566254|526651413|FG001|Overall Study|Withdrawal by Subject|2|||
146038062|NCT00566254|526651412|FG000|Overall Study|Lack of Efficacy|5|||
146038063|NCT00566254|526651413|FG001|Overall Study|Lack of Efficacy|6|||
146038064|NCT00566254|526651412|FG000|Overall Study|Other|0|||
146038065|NCT00566254|526651413|FG001|Overall Study|Other|2|||
146038066|NCT00411632|526651414|FG000|Overall Study|Death|1|||
146038067|NCT01108523|526651415|FG000|Overall Study|Protocol Violation|4|||
146038068|NCT03831100|526653440|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
146038069|NCT03831100|526653441|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
146038070|NCT04566601|526653442|FG000|Overall Study|Other than listed|13|||
146038071|NCT04566601|526653443|FG001|Overall Study|Other than listed|4|||
146099182|NCT01254630|526882772|FG002|Overall Study|Death|478|||
146038072|NCT04566601|526653444|FG002|Overall Study|Other than listed|2|||
146038073|NCT04566601|526653445|FG003|Overall Study|Other than listed|1|||
146038074|NCT04566601|526653446|FG004|Overall Study|Other than listed|4|||
146038075|NCT04566601|526653442|FG000|Overall Study|Protocol deviation|3|||
146038076|NCT04566601|526653443|FG001|Overall Study|Protocol deviation|0|||
146099183|NCT01254630|526882773|FG003|Overall Study|Death|139|||
146038077|NCT04566601|526653444|FG002|Overall Study|Protocol deviation|1|||
146038078|NCT04566601|526653445|FG003|Overall Study|Protocol deviation|1|||
146038079|NCT04566601|526653446|FG004|Overall Study|Protocol deviation|1|||
146038080|NCT04566601|526653442|FG000|Overall Study|Technical problems|0|||
146038081|NCT04566601|526653443|FG001|Overall Study|Technical problems|0|||
146038082|NCT04566601|526653444|FG002|Overall Study|Technical problems|1|||
146038083|NCT04566601|526653445|FG003|Overall Study|Technical problems|0|||
146099184|NCT01254630|526882770|FG000|Overall Study|Lost to Follow-up|80|||
146099185|NCT01254630|526882771|FG001|Overall Study|Lost to Follow-up|26|||
146038084|NCT04566601|526653446|FG004|Overall Study|Technical problems|0|||
146038085|NCT04566601|526653442|FG000|Overall Study|No reason available|3|||
146038086|NCT04566601|526653443|FG001|Overall Study|No reason available|2|||
146038087|NCT04566601|526653444|FG002|Overall Study|No reason available|7|||
146038088|NCT04566601|526653445|FG003|Overall Study|No reason available|1|||
146038089|NCT04566601|526653446|FG004|Overall Study|No reason available|5|||
146038090|NCT04566601|526653442|FG000|Overall Study|Burden of study procedures|3|||
146038091|NCT04566601|526653443|FG001|Overall Study|Burden of study procedures|0|||
146038092|NCT04566601|526653444|FG002|Overall Study|Burden of study procedures|0|||
146038093|NCT04566601|526653445|FG003|Overall Study|Burden of study procedures|3|||
146038094|NCT04566601|526653446|FG004|Overall Study|Burden of study procedures|1|||
146038095|NCT04566601|526653442|FG000|Overall Study|Change of residence|2|||
146038096|NCT04566601|526653443|FG001|Overall Study|Change of residence|2|||
146038097|NCT04566601|526653444|FG002|Overall Study|Change of residence|0|||
146038098|NCT04566601|526653445|FG003|Overall Study|Change of residence|1|||
146038099|NCT04566601|526653446|FG004|Overall Study|Change of residence|2|||
146038100|NCT04566601|526653442|FG000|Overall Study|Perceived lack of efficacy|2|||
146038101|NCT04566601|526653443|FG001|Overall Study|Perceived lack of efficacy|0|||
146038102|NCT04566601|526653444|FG002|Overall Study|Perceived lack of efficacy|1|||
146038103|NCT04566601|526653445|FG003|Overall Study|Perceived lack of efficacy|1|||
146038104|NCT04566601|526653446|FG004|Overall Study|Perceived lack of efficacy|2|||
146038105|NCT04566601|526653442|FG000|Overall Study|Adverse Event|7|||
146038106|NCT04566601|526653443|FG001|Overall Study|Adverse Event|4|||
146038107|NCT04566601|526653444|FG002|Overall Study|Adverse Event|6|||
146038108|NCT04566601|526653445|FG003|Overall Study|Adverse Event|5|||
146038109|NCT04566601|526653446|FG004|Overall Study|Adverse Event|12|||
146038110|NCT03047031|526653448|FG000|Overall Study|Other than listed|1|||
146038111|NCT03047031|526653449|FG001|Overall Study|Other than listed|0|||
146038112|NCT03047031|526653450|FG002|Overall Study|Other than listed|0|||
146038113|NCT03047031|526653448|FG000|Overall Study|Lost to Follow-up|4|||
146038114|NCT03047031|526653449|FG001|Overall Study|Lost to Follow-up|0|||
146038115|NCT03047031|526653450|FG002|Overall Study|Lost to Follow-up|0|||
146038116|NCT03047031|526653448|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
146038117|NCT03047031|526653449|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
146038118|NCT03047031|526653450|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
146038119|NCT03047031|526653448|FG000|Overall Study|Adverse Event|1|||
146038120|NCT03047031|526653449|FG001|Overall Study|Adverse Event|0|||
146038121|NCT03047031|526653450|FG002|Overall Study|Adverse Event|0|||
146038122|NCT03047031|526653448|FG000|Overall Study|Withdrawal by Subject|2|||
146038123|NCT03047031|526653449|FG001|Overall Study|Withdrawal by Subject|0|||
146038124|NCT03047031|526653450|FG002|Overall Study|Withdrawal by Subject|0|||
146038125|NCT03047031|526653448|FG000|Overall Study|Change to other medication|2|||
146038126|NCT03047031|526653449|FG001|Overall Study|Change to other medication|0|||
146038127|NCT03047031|526653450|FG002|Overall Study|Change to other medication|0|||
146038128|NCT03047031|526653448|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
146038129|NCT03047031|526653449|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
146038130|NCT03047031|526653450|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
146038131|NCT01450098|526653451|FG000|Period 3|Protocol Violation|0|||
146038132|NCT01450098|526653452|FG001|Period 3|Protocol Violation|1|||
146038133|NCT01450098|526653451|FG000|Period 3|Withdrawal by Subject|0|||
146038134|NCT01450098|526653452|FG001|Period 3|Withdrawal by Subject|2|||
146038135|NCT03229109|526653454|FG000|Overall Study|Withdrawal by Subject|0|||
146038136|NCT03229109|526653455|FG001|Overall Study|Withdrawal by Subject|0|||
146038137|NCT03229109|526653456|FG002|Overall Study|Withdrawal by Subject|0|||
146038138|NCT03229109|526653457|FG003|Overall Study|Withdrawal by Subject|1|||
146038139|NCT04207749|526653458|FG000|Overall Study|Lost to Follow-up|0|||
146038140|NCT04207749|526653459|FG001|Overall Study|Lost to Follow-up|2|||
146038141|NCT04207749|526653458|FG000|Overall Study|Protocol Violation|0|||
146038142|NCT04207749|526653459|FG001|Overall Study|Protocol Violation|1|||
146038143|NCT04207749|526653458|FG000|Overall Study|Withdrawal by Subject|3|||
146038144|NCT04207749|526653459|FG001|Overall Study|Withdrawal by Subject|0|||
146038145|NCT04207749|526653458|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
146038146|NCT04207749|526653459|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
146038147|NCT01971008|526653462|FG000|Overall Study|Protocol Violation|2|||
146038148|NCT01971008|526653463|FG001|Overall Study|Protocol Violation|1|||
146038149|NCT03416127|526653464|FG000|Overall Study|Withdrawal by Subject|0|||
146038150|NCT03416127|526653465|FG001|Overall Study|Withdrawal by Subject|1|||
146038151|NCT03416127|526653466|FG002|Overall Study|Withdrawal by Subject|1|||
146038152|NCT03775512|526653467|FG000|Overall Study|Death|1|||
146038153|NCT03775512|526653468|FG001|Overall Study|Death|1|||
146038154|NCT03775512|526653467|FG000|Overall Study|Withdrawal by Subject|7|||
146038155|NCT03775512|526653468|FG001|Overall Study|Withdrawal by Subject|4|||
146038156|NCT03775512|526653467|FG000|Overall Study|Lost to Follow-up|5|||
146038157|NCT03775512|526653468|FG001|Overall Study|Lost to Follow-up|5|||
146038158|NCT03775512|526653467|FG000|Overall Study|Excluded before Catheter insertion|14|||
146038159|NCT03775512|526653468|FG001|Overall Study|Excluded before Catheter insertion|5|||
146038160|NCT03775512|526653467|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
146038161|NCT03775512|526653468|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
146038162|NCT03775512|526653467|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
146038163|NCT03775512|526653468|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
146038164|NCT00858208|526653469|FG000|Overall Study|Adverse Event|3|||
146038165|NCT00858208|526653469|FG000|Overall Study|Lost to Follow-up|26|||
146038166|NCT00858208|526653469|FG000|Overall Study|Participant refused|40|||
146038167|NCT00858208|526653469|FG000|Overall Study|Other|10|||
146038168|NCT00567359|526653470|FG000|Overall Study|Withdrawal by Subject|1|||
146038169|NCT02397057|526653471|FG000|Overall Study|Withdrawal by Subject|6|||
146038170|NCT02397057|526653472|FG001|Overall Study|Withdrawal by Subject|7|||
146038171|NCT02397057|526653471|FG000|Overall Study|Lost to Follow-up|4|||
146038172|NCT02397057|526653472|FG001|Overall Study|Lost to Follow-up|3|||
146038173|NCT02397057|526653471|FG000|Overall Study|Death|1|||
146038174|NCT02397057|526653472|FG001|Overall Study|Death|0|||
146038175|NCT02397057|526653471|FG000|Overall Study|Adverse Event|0|||
146038176|NCT02397057|526653472|FG001|Overall Study|Adverse Event|1|||
146038177|NCT02397057|526653471|FG000|Overall Study|Physician Decision|0|||
146038178|NCT02397057|526653472|FG001|Overall Study|Physician Decision|1|||
146038179|NCT02397057|526653471|FG000|Overall Study|Subject did not receive study drug|0|||
146038180|NCT02397057|526653472|FG001|Overall Study|Subject did not receive study drug|1|||
146038181|NCT00539305|526653473|FG000|Overall Study|Adverse Event|1|||
146038182|NCT00539305|526653474|FG001|Overall Study|Adverse Event|0|||
146038183|NCT00539305|526653473|FG000|Overall Study|Substance Use|0|||
146038184|NCT00539305|526653474|FG001|Overall Study|Substance Use|1|||
146038185|NCT00539305|526653473|FG000|Overall Study|Withdrawal by Subject|0|||
146038186|NCT00539305|526653474|FG001|Overall Study|Withdrawal by Subject|1|||
146038187|NCT00793325|526653476|FG000|Overall Study|Protocol Violation|18|||
146038188|NCT00793325|526653476|FG000|Overall Study|Lost to Follow-up|1|||
146038189|NCT01329939|526653481|FG000|Overall Study|Lost to Follow-up|3|||
146038190|NCT01329939|526653482|FG001|Overall Study|Lost to Follow-up|0|||
146038191|NCT01329939|526653483|FG002|Overall Study|Lost to Follow-up|1|||
146038192|NCT01329939|526653484|FG003|Overall Study|Lost to Follow-up|2|||
146038193|NCT01329939|526653481|FG000|Overall Study|Withdrawal by Subject|0|||
146038194|NCT01329939|526653482|FG001|Overall Study|Withdrawal by Subject|1|||
146038195|NCT01329939|526653483|FG002|Overall Study|Withdrawal by Subject|0|||
146038196|NCT01329939|526653484|FG003|Overall Study|Withdrawal by Subject|0|||
146038197|NCT01329939|526653481|FG000|Overall Study|Adverse Event|0|||
146038198|NCT01329939|526653482|FG001|Overall Study|Adverse Event|0|||
146038199|NCT01329939|526653483|FG002|Overall Study|Adverse Event|0|||
146038200|NCT01329939|526653484|FG003|Overall Study|Adverse Event|3|||
146038201|NCT01966445|526653485|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146038202|NCT01966445|526653486|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146038203|NCT01966445|526653487|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146038204|NCT01966445|526653488|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
146038205|NCT01966445|526653489|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146038206|NCT01966445|526653490|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
146038207|NCT01966445|526653491|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
146038208|NCT01966445|526653485|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146038209|NCT01966445|526653486|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146038210|NCT01966445|526653487|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146038211|NCT01966445|526653488|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146038212|NCT01966445|526653489|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
146038213|NCT01966445|526653490|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146038214|NCT01966445|526653491|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
146038215|NCT01966445|526653485|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146038216|NCT01966445|526653486|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
146038217|NCT01966445|526653487|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
146038218|NCT01966445|526653488|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146038219|NCT01966445|526653489|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
146038220|NCT01966445|526653490|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146038221|NCT01966445|526653491|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
146038222|NCT01966445|526653485|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038223|NCT01966445|526653486|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038224|NCT01966445|526653487|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038225|NCT01966445|526653488|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038226|NCT01966445|526653489|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038227|NCT01966445|526653490|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
146038228|NCT01966445|526653491|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
146038229|NCT01966445|526653485|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146038230|NCT01966445|526653486|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146254465|NCT04372186|527444596|FG000|Overall Study|Death|24|||
146254466|NCT04372186|527444597|FG001|Overall Study|Death|11|||
146254467|NCT04372186|527444596|FG000|Overall Study|Transferred to a different facility for care|0|||
146254468|NCT04372186|527444597|FG001|Overall Study|Transferred to a different facility for care|2|||
146254469|NCT04736472|527444598|FG000|Overall Study|Lost to Follow-up|1|||
146254470|NCT04736472|527444599|FG001|Overall Study|Lost to Follow-up|0|||
146254471|NCT04736472|527444600|FG002|Overall Study|Lost to Follow-up|0|||
146300570|NCT00283049|527617052|FG000|Overall Study|Death|1|||
146038231|NCT01966445|526653487|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146038232|NCT01966445|526653488|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146038233|NCT01966445|526653489|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146038234|NCT01966445|526653490|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
146038235|NCT01966445|526653491|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
146038236|NCT00117793|526653494|FG000|Overall Study|Withdrawal by Subject|12|||
146038237|NCT01753401|526653495|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
146038238|NCT01753401|526653496|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
146038239|NCT01753401|526653497|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
146038240|NCT01753401|526653498|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
146038241|NCT01753401|526653495|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
146038242|NCT01753401|526653496|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
146038243|NCT01753401|526653497|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
146038244|NCT01753401|526653498|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
146038245|NCT01753401|526653495|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146038246|NCT01753401|526653496|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
146038247|NCT01753401|526653497|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146038248|NCT01753401|526653498|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
146038249|NCT01753401|526653495|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
146038250|NCT01753401|526653496|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
146038251|NCT01753401|526653497|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
146038252|NCT01753401|526653498|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
146038253|NCT01753401|526653495|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146038254|NCT01753401|526653496|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146038255|NCT01753401|526653497|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
146038256|NCT01753401|526653498|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
146038257|NCT01753401|526653495|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
146038258|NCT01753401|526653496|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
146038259|NCT01753401|526653497|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
146038260|NCT01753401|526653498|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
146038261|NCT01753401|526653495|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
146038262|NCT01753401|526653496|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
146038263|NCT01753401|526653497|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
146038264|NCT01753401|526653498|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
146038265|NCT03688100|526653503|FG000|Overall Study|Lost to Follow-up|21|||
146038266|NCT03688100|526653504|FG001|Overall Study|Lost to Follow-up|15|||
146038267|NCT03688100|526653505|FG002|Overall Study|Lost to Follow-up|15|||
146038268|NCT03688100|526653506|FG003|Overall Study|Lost to Follow-up|18|||
146038269|NCT03688100|526653503|FG000|Overall Study|Withdrawal by Subject|19|||
146038270|NCT03688100|526653504|FG001|Overall Study|Withdrawal by Subject|16|||
146038271|NCT03688100|526653505|FG002|Overall Study|Withdrawal by Subject|0|||
146038272|NCT03688100|526653506|FG003|Overall Study|Withdrawal by Subject|0|||
146038273|NCT03688100|526653503|FG000|Overall Study|Death|36|||
146038274|NCT03688100|526653504|FG001|Overall Study|Death|27|||
146038275|NCT03688100|526653505|FG002|Overall Study|Death|0|||
146038276|NCT03688100|526653506|FG003|Overall Study|Death|0|||
146038277|NCT02453555|526653514|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
146038278|NCT02453555|526653515|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
146038279|NCT02453555|526653516|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
146038280|NCT02453555|526653517|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
146038281|NCT02453555|526653518|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
146038282|NCT02453555|526653519|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
146038283|NCT02453555|526653514|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
146038284|NCT02453555|526653515|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146038285|NCT02453555|526653516|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146038286|NCT02453555|526653517|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146300571|NCT00283049|527617053|FG001|Overall Study|Death|1|||
146038287|NCT02453555|526653518|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146038288|NCT02453555|526653519|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
146038289|NCT02453555|526653514|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
146038290|NCT02453555|526653515|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
146254472|NCT04736472|527444598|FG000|Overall Study|Withdrawal by Subject|2|||
146300572|NCT00283049|527617054|FG002|Overall Study|Death|1|||
146038291|NCT02453555|526653516|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146038292|NCT02453555|526653517|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146038293|NCT02453555|526653518|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146038294|NCT02453555|526653519|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146038295|NCT02453555|526653514|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
146038296|NCT02453555|526653515|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
146038297|NCT02453555|526653516|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
146038298|NCT02453555|526653517|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
146038299|NCT02453555|526653518|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
146038300|NCT02453555|526653519|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
146038301|NCT02453555|526653514|FG000|Extension Period|Adverse Event|0|||
146038302|NCT02453555|526653515|FG001|Extension Period|Adverse Event|0|||
146038303|NCT02453555|526653516|FG002|Extension Period|Adverse Event|1|||
146038304|NCT02453555|526653517|FG003|Extension Period|Adverse Event|2|||
146038305|NCT02453555|526653518|FG004|Extension Period|Adverse Event|1|||
146038306|NCT02453555|526653519|FG005|Extension Period|Adverse Event|1|||
146038307|NCT02453555|526653514|FG000|Extension Period|Protocol Violation|0|||
146038308|NCT02453555|526653515|FG001|Extension Period|Protocol Violation|0|||
146038309|NCT02453555|526653516|FG002|Extension Period|Protocol Violation|1|||
146038310|NCT02453555|526653517|FG003|Extension Period|Protocol Violation|0|||
146038311|NCT02453555|526653518|FG004|Extension Period|Protocol Violation|0|||
146038312|NCT02453555|526653519|FG005|Extension Period|Protocol Violation|0|||
146038313|NCT02453555|526653514|FG000|Extension Period|Withdrawal by Subject|0|||
146038314|NCT02453555|526653515|FG001|Extension Period|Withdrawal by Subject|0|||
146038315|NCT02453555|526653516|FG002|Extension Period|Withdrawal by Subject|1|||
146038316|NCT02453555|526653517|FG003|Extension Period|Withdrawal by Subject|0|||
146038317|NCT02453555|526653518|FG004|Extension Period|Withdrawal by Subject|0|||
146038318|NCT02453555|526653519|FG005|Extension Period|Withdrawal by Subject|0|||
146038319|NCT02409719|526653524|FG000|Overall Study|Lost to Follow-up|3|||
146038320|NCT02409719|526653525|FG001|Overall Study|Lost to Follow-up|3|||
146038321|NCT02479139|526653526|FG000|Overall Study|Lost to Follow-up|2|||
146038322|NCT02479139|526653527|FG001|Overall Study|Lost to Follow-up|4|||
146038323|NCT02479139|526653528|FG002|Overall Study|Lost to Follow-up|4|||
146038324|NCT02479139|526653529|FG003|Overall Study|Lost to Follow-up|2|||
146038325|NCT02479139|526653530|FG004|Overall Study|Lost to Follow-up|3|||
146038326|NCT02479139|526653531|FG005|Overall Study|Lost to Follow-up|5|||
146038327|NCT02479139|526653526|FG000|Overall Study|Withdrew Consent|5|||
146038328|NCT02479139|526653527|FG001|Overall Study|Withdrew Consent|6|||
146038329|NCT02479139|526653528|FG002|Overall Study|Withdrew Consent|1|||
146038330|NCT02479139|526653529|FG003|Overall Study|Withdrew Consent|4|||
146038331|NCT02479139|526653530|FG004|Overall Study|Withdrew Consent|1|||
146038332|NCT02479139|526653531|FG005|Overall Study|Withdrew Consent|1|||
146038333|NCT02479139|526653526|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146038334|NCT02479139|526653527|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146038335|NCT02479139|526653528|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
146038336|NCT02479139|526653529|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146038337|NCT02479139|526653530|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146038338|NCT02479139|526653531|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
146038339|NCT02479139|526653526|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146038340|NCT02479139|526653527|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146038341|NCT02479139|526653528|FG002|Overall Study|Other Miscellaneous Reasons|1|||
146038342|NCT02479139|526653529|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146038343|NCT02479139|526653530|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146038344|NCT02479139|526653531|FG005|Overall Study|Other Miscellaneous Reasons|0|||
146038345|NCT00764673|526653532|FG000|Overall Study|Death|1|||
146038346|NCT00764673|526653532|FG000|Overall Study|Lost to Follow-up|3|||
146038347|NCT00764673|526653532|FG000|Overall Study|Withdrawal by Subject|6|||
146038348|NCT00764673|526653532|FG000|Overall Study|Revision of Device|2|||
146038349|NCT01727336|526653533|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146038350|NCT01727336|526653534|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
146038351|NCT01727336|526653535|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
146038352|NCT01727336|526653536|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146038353|NCT01727336|526653537|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146254473|NCT04736472|527444599|FG001|Overall Study|Withdrawal by Subject|0|||
146038354|NCT01727336|526653538|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
146038355|NCT01727336|526653533|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
146038356|NCT01727336|526653534|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
146038357|NCT01727336|526653535|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
146038358|NCT01727336|526653536|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146038359|NCT01727336|526653537|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146038360|NCT01727336|526653538|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
146038361|NCT01727336|526653533|FG000|Part 2 Blinded|Death|0|||
146038362|NCT01727336|526653534|FG001|Part 2 Blinded|Death|0|||
146038363|NCT01727336|526653535|FG002|Part 2 Blinded|Death|0|||
146038364|NCT01727336|526653536|FG003|Part 2 Blinded|Death|0|||
146038365|NCT01727336|526653537|FG004|Part 2 Blinded|Death|20|||
146038366|NCT01727336|526653538|FG005|Part 2 Blinded|Death|16|||
146038367|NCT01727336|526653533|FG000|Part 2 Blinded|Lack of Efficacy|0|||
146038368|NCT01727336|526653534|FG001|Part 2 Blinded|Lack of Efficacy|0|||
146038369|NCT01727336|526653535|FG002|Part 2 Blinded|Lack of Efficacy|0|||
146038370|NCT01727336|526653536|FG003|Part 2 Blinded|Lack of Efficacy|0|||
146038371|NCT01727336|526653537|FG004|Part 2 Blinded|Lack of Efficacy|42|||
146038372|NCT01727336|526653538|FG005|Part 2 Blinded|Lack of Efficacy|44|||
146038373|NCT01727336|526653533|FG000|Part 2 Blinded|Lost to Follow-up|0|||
146038374|NCT01727336|526653534|FG001|Part 2 Blinded|Lost to Follow-up|0|||
146038375|NCT01727336|526653535|FG002|Part 2 Blinded|Lost to Follow-up|0|||
146038376|NCT01727336|526653536|FG003|Part 2 Blinded|Lost to Follow-up|0|||
146038377|NCT01727336|526653537|FG004|Part 2 Blinded|Lost to Follow-up|0|||
146038378|NCT01727336|526653538|FG005|Part 2 Blinded|Lost to Follow-up|1|||
146038379|NCT01727336|526653533|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
146038380|NCT01727336|526653534|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
146038381|NCT01727336|526653535|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
146038382|NCT01727336|526653536|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
146038383|NCT01727336|526653537|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
146038384|NCT01727336|526653538|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
146038385|NCT01727336|526653533|FG000|Part 2 Blinded|use of prohibited medications|0|||
146038386|NCT01727336|526653534|FG001|Part 2 Blinded|use of prohibited medications|0|||
146038387|NCT01727336|526653535|FG002|Part 2 Blinded|use of prohibited medications|0|||
146038388|NCT01727336|526653536|FG003|Part 2 Blinded|use of prohibited medications|0|||
146038389|NCT01727336|526653537|FG004|Part 2 Blinded|use of prohibited medications|1|||
146038390|NCT01727336|526653538|FG005|Part 2 Blinded|use of prohibited medications|3|||
146038391|NCT00619099|526653541|FG000|Overall Study|Progressive Disease|7|||
146038392|NCT00619099|526653542|FG001|Overall Study|Progressive Disease|5|||
146038393|NCT00619099|526653541|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
146038394|NCT00619099|526653542|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
146038395|NCT00619099|526653541|FG000|Overall Study|Adverse Event|4|||
146038396|NCT00619099|526653542|FG001|Overall Study|Adverse Event|3|||
146038397|NCT00619099|526653541|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
146038398|NCT00619099|526653542|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
146038399|NCT00619099|526653541|FG000|Overall Study|Withdrawal by Subject|10|||
146038400|NCT00619099|526653542|FG001|Overall Study|Withdrawal by Subject|2|||
146038401|NCT00619099|526653541|FG000|Overall Study|Physician Decision|9|||
146038402|NCT00619099|526653542|FG001|Overall Study|Physician Decision|6|||
146038403|NCT00885482|526653543|FG000|Overall Study|Pregnancy|1|||
146038404|NCT00885482|526653543|FG000|Overall Study|Lack of Efficacy|1|||
146038405|NCT00885482|526653543|FG000|Overall Study|Death|1|||
146038406|NCT00885482|526653543|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
146038407|NCT00084656|526653544|FG000|Overall Study|Other reasons|0|||
146038408|NCT00084656|526653545|FG001|Overall Study|Other reasons|12|||
146038409|NCT00084656|526653546|FG002|Overall Study|Other reasons|11|||
146038410|NCT00084656|526653544|FG000|Overall Study|Withdrawal by Subject|15|||
146038411|NCT00084656|526653545|FG001|Overall Study|Withdrawal by Subject|4|||
146038412|NCT00084656|526653546|FG002|Overall Study|Withdrawal by Subject|4|||
146038413|NCT00084656|526653544|FG000|Overall Study|Disease relapse|0|||
146038414|NCT00084656|526653545|FG001|Overall Study|Disease relapse|9|||
146038415|NCT00084656|526653546|FG002|Overall Study|Disease relapse|10|||
146038416|NCT00084656|526653544|FG000|Overall Study|Disease progression|9|||
146038417|NCT00084656|526653545|FG001|Overall Study|Disease progression|0|||
146038418|NCT00084656|526653546|FG002|Overall Study|Disease progression|0|||
146038419|NCT00084656|526653544|FG000|Overall Study|Lost to Follow-up|1|||
146038420|NCT00084656|526653545|FG001|Overall Study|Lost to Follow-up|0|||
146038421|NCT00084656|526653546|FG002|Overall Study|Lost to Follow-up|1|||
146038422|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
146038423|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
146038424|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
146038425|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
146038426|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
146038427|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
146300573|NCT00283049|527617052|FG000|Overall Study|Lack of Efficacy|0|||
146038428|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
146300574|NCT00283049|527617053|FG001|Overall Study|Lack of Efficacy|1|||
146038429|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
146038430|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
146038431|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
146038432|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
146038433|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
146038434|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
146038435|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
146038436|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
146038437|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
146038438|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
146038439|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
146038440|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
146038441|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
146038442|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
146038443|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
146038444|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
146038445|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
146038446|NCT01532869|526653547|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
146038447|NCT01532869|526653548|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
146038448|NCT01532869|526653547|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
146038449|NCT01532869|526653548|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
146038450|NCT01532869|526653547|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
146038451|NCT01532869|526653548|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
146038452|NCT01532869|526653547|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
146038453|NCT01532869|526653548|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
146038454|NCT01532869|526653547|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
146038455|NCT01532869|526653548|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
146038456|NCT00778895|526653549|FG000|Active Phase|Adverse Event|3|||
146038457|NCT00778895|526653550|FG001|Active Phase|Adverse Event|1|||
146038458|NCT00778895|526653551|FG002|Active Phase|Adverse Event|0|||
146038459|NCT00778895|526653549|FG000|Active Phase|Withdrawal by Subject|1|||
146038460|NCT00778895|526653550|FG001|Active Phase|Withdrawal by Subject|4|||
146038461|NCT00778895|526653551|FG002|Active Phase|Withdrawal by Subject|0|||
146038462|NCT00778895|526653549|FG000|Active Phase|Lost to Follow-up|1|||
146038463|NCT00778895|526653550|FG001|Active Phase|Lost to Follow-up|1|||
146038464|NCT00778895|526653551|FG002|Active Phase|Lost to Follow-up|0|||
146038465|NCT00778895|526653549|FG000|Active Phase|Other|2|||
146038466|NCT00778895|526653550|FG001|Active Phase|Other|0|||
146038467|NCT00778895|526653551|FG002|Active Phase|Other|0|||
146038468|NCT00778895|526653549|FG000|ESFU Phase|Adverse Event|2|||
146038469|NCT00778895|526653550|FG001|ESFU Phase|Adverse Event|1|||
146038470|NCT00778895|526653551|FG002|ESFU Phase|Adverse Event|0|||
146038471|NCT00778895|526653549|FG000|ESFU Phase|Withdrawal by Subject|1|||
146038472|NCT00778895|526653550|FG001|ESFU Phase|Withdrawal by Subject|4|||
146038473|NCT00778895|526653551|FG002|ESFU Phase|Withdrawal by Subject|0|||
146038474|NCT00778895|526653549|FG000|ESFU Phase|Lost to Follow-up|6|||
146038475|NCT00778895|526653550|FG001|ESFU Phase|Lost to Follow-up|7|||
146038476|NCT00778895|526653551|FG002|ESFU Phase|Lost to Follow-up|2|||
146038477|NCT00778895|526653549|FG000|ESFU Phase|Other|2|||
146038478|NCT00778895|526653550|FG001|ESFU Phase|Other|0|||
146038479|NCT00778895|526653551|FG002|ESFU Phase|Other|0|||
146038480|NCT01009086|526653555|FG000|Overall Study|Lack of Efficacy|16|||
146038481|NCT01009086|526653556|FG001|Overall Study|Lack of Efficacy|15|||
146038482|NCT01009086|526653557|FG002|Overall Study|Lack of Efficacy|9|||
146038483|NCT01009086|526653555|FG000|Overall Study|Lost to Follow-up|4|||
146038484|NCT01009086|526653556|FG001|Overall Study|Lost to Follow-up|5|||
146038485|NCT01009086|526653557|FG002|Overall Study|Lost to Follow-up|3|||
146038486|NCT01009086|526653555|FG000|Overall Study|Adverse Event|12|||
146038487|NCT01009086|526653556|FG001|Overall Study|Adverse Event|11|||
146038488|NCT01009086|526653557|FG002|Overall Study|Adverse Event|8|||
146038489|NCT01009086|526653555|FG000|Overall Study|Withdrawal by Subject|9|||
146038490|NCT01009086|526653556|FG001|Overall Study|Withdrawal by Subject|11|||
146038491|NCT01009086|526653557|FG002|Overall Study|Withdrawal by Subject|13|||
146038492|NCT01009086|526653555|FG000|Overall Study|Other|3|||
146038493|NCT01009086|526653556|FG001|Overall Study|Other|5|||
146038494|NCT01009086|526653557|FG002|Overall Study|Other|1|||
146038495|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
146038496|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
146038497|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
146038498|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
146038499|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
146038500|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
146038501|NCT01389323|526653558|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
146038502|NCT01389323|526653558|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
146038503|NCT01389323|526653558|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
146038504|NCT01389323|526653558|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
146038505|NCT01389323|526653558|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
146038506|NCT01147848|526653564|FG000|Run-in Period|Screen Failure|623|||
146038507|NCT01147848|526653565|FG001|Run-in Period|Screen Failure|0|||
146038508|NCT01147848|526653566|FG002|Run-in Period|Screen Failure|0|||
146038509|NCT01147848|526653564|FG000|Run-in Period|Run-in Failure|135|||
146038510|NCT01147848|526653565|FG001|Run-in Period|Run-in Failure|0|||
146038511|NCT01147848|526653566|FG002|Run-in Period|Run-in Failure|0|||
146038512|NCT01147848|526653564|FG000|Randomized Phase|Adverse Event|0|||
146038513|NCT01147848|526653565|FG001|Randomized Phase|Adverse Event|6|||
146038514|NCT01147848|526653566|FG002|Randomized Phase|Adverse Event|8|||
146038515|NCT01147848|526653564|FG000|Randomized Phase|Lack of Efficacy|0|||
146038516|NCT01147848|526653565|FG001|Randomized Phase|Lack of Efficacy|20|||
146038517|NCT01147848|526653566|FG002|Randomized Phase|Lack of Efficacy|11|||
146038518|NCT01147848|526653564|FG000|Randomized Phase|Protocol Violation|0|||
146038519|NCT01147848|526653565|FG001|Randomized Phase|Protocol Violation|7|||
146038520|NCT01147848|526653566|FG002|Randomized Phase|Protocol Violation|10|||
146038521|NCT01147848|526653564|FG000|Randomized Phase|Lost to Follow-up|0|||
146038522|NCT01147848|526653565|FG001|Randomized Phase|Lost to Follow-up|5|||
146038523|NCT01147848|526653566|FG002|Randomized Phase|Lost to Follow-up|7|||
146038524|NCT01147848|526653564|FG000|Randomized Phase|Physician Decision|0|||
146038525|NCT01147848|526653565|FG001|Randomized Phase|Physician Decision|0|||
146038526|NCT01147848|526653566|FG002|Randomized Phase|Physician Decision|1|||
146038527|NCT01147848|526653564|FG000|Randomized Phase|Withdrawal by Subject|0|||
146038528|NCT01147848|526653565|FG001|Randomized Phase|Withdrawal by Subject|7|||
146038529|NCT01147848|526653566|FG002|Randomized Phase|Withdrawal by Subject|9|||
146038530|NCT03596450|526653579|FG000|Overall Study|Death|9|||
146038531|NCT03596450|526653580|FG001|Overall Study|Death|9|||
146038532|NCT03596450|526653579|FG000|Overall Study|Protocol Violation|18|||
146038533|NCT03596450|526653580|FG001|Overall Study|Protocol Violation|26|||
146038534|NCT03596450|526653579|FG000|Overall Study|Lost to Follow-up|50|||
146038535|NCT03596450|526653580|FG001|Overall Study|Lost to Follow-up|56|||
146038536|NCT03596450|526653579|FG000|Overall Study|Adverse Event|14|||
146038537|NCT03596450|526653580|FG001|Overall Study|Adverse Event|7|||
146038538|NCT03596450|526653579|FG000|Overall Study|Withdrawal by Subject|38|||
146038539|NCT03596450|526653580|FG001|Overall Study|Withdrawal by Subject|36|||
146038540|NCT03596450|526653579|FG000|Overall Study|Accidentally Randomized|2|||
146038541|NCT03596450|526653580|FG001|Overall Study|Accidentally Randomized|0|||
146038542|NCT03596450|526653579|FG000|Overall Study|Other reasons|48|||
146038543|NCT03596450|526653580|FG001|Overall Study|Other reasons|53|||
146038544|NCT03596450|526653579|FG000|Overall Study|Pregnancy|2|||
146038545|NCT03596450|526653580|FG001|Overall Study|Pregnancy|0|||
146038546|NCT03624127|526653581|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
146038547|NCT03624127|526653582|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
146038548|NCT03624127|526653583|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
146038549|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
146038550|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
146038551|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
146038552|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Death|0|||
146038553|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Death|1|||
146038554|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Death|0|||
146038555|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
146038556|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
146038557|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
146038558|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
146038559|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
146038560|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
146038561|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
146038562|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
146038563|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
146038564|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
146038565|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
146038566|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
146038567|NCT03624127|526653581|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
146038568|NCT03624127|526653582|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
146038569|NCT03624127|526653583|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
146038570|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
146038571|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
146038572|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
146038573|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
146038574|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146038575|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
146099186|NCT01254630|526882772|FG002|Overall Study|Lost to Follow-up|89|||
146038576|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146038577|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
146038578|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
146038579|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
146038580|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
146038581|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
146099187|NCT01254630|526882773|FG003|Overall Study|Lost to Follow-up|32|||
146038582|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
146038583|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
146038584|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
146038585|NCT03624127|526653581|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
146038586|NCT03624127|526653582|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
146038587|NCT03624127|526653583|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
146038588|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
146038589|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
146038590|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
146038591|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
146038592|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146038593|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
146038594|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
146038595|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
146038596|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
146038597|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
146038598|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
146038599|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
146038600|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
146038601|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
146038602|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
146038603|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
146038604|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146038605|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
146038606|NCT03624127|526653581|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
146038607|NCT03624127|526653582|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
146038608|NCT03624127|526653583|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
146038609|NCT00915551|526653584|FG000|Overall Study|Withdrawal by Subject|0|||
146038610|NCT00915551|526653585|FG001|Overall Study|Withdrawal by Subject|1|||
146038611|NCT04390841|526653586|FG000|Overall Study|Withdrawal by Subject|2|||
146038612|NCT02999633|526653587|FG000|Overall Study|Adverse Event|2|||
146038613|NCT02999633|526653587|FG000|Overall Study|Progressive disease|12|||
146038614|NCT01545050|526653588|FG000|Overall Study|Lack of Efficacy|0|||
146038615|NCT01545050|526653589|FG001|Overall Study|Lack of Efficacy|0|||
146038616|NCT01545050|526653590|FG002|Overall Study|Lack of Efficacy|0|||
146038617|NCT01545050|526653591|FG003|Overall Study|Lack of Efficacy|3|||
146038618|NCT01545050|526653592|FG004|Overall Study|Lack of Efficacy|2|||
146038619|NCT01545050|526653588|FG000|Overall Study|Adverse Event|1|||
146038620|NCT01545050|526653589|FG001|Overall Study|Adverse Event|1|||
146038621|NCT01545050|526653590|FG002|Overall Study|Adverse Event|2|||
146038622|NCT01545050|526653591|FG003|Overall Study|Adverse Event|2|||
146038623|NCT01545050|526653592|FG004|Overall Study|Adverse Event|0|||
146038624|NCT01545050|526653588|FG000|Overall Study|Discontinued study treatment|1|||
146038625|NCT01545050|526653589|FG001|Overall Study|Discontinued study treatment|0|||
146038626|NCT01545050|526653590|FG002|Overall Study|Discontinued study treatment|0|||
146038627|NCT01545050|526653591|FG003|Overall Study|Discontinued study treatment|0|||
146038628|NCT01545050|526653592|FG004|Overall Study|Discontinued study treatment|0|||
146038629|NCT01545050|526653588|FG000|Overall Study|Withdrawal by Subject|1|||
146038630|NCT01545050|526653589|FG001|Overall Study|Withdrawal by Subject|0|||
146038631|NCT01545050|526653590|FG002|Overall Study|Withdrawal by Subject|0|||
146038632|NCT01545050|526653591|FG003|Overall Study|Withdrawal by Subject|2|||
146038633|NCT01545050|526653592|FG004|Overall Study|Withdrawal by Subject|1|||
146038634|NCT01545050|526653588|FG000|Overall Study|Participant no longer meets study criteria|0|||
146038635|NCT01545050|526653589|FG001|Overall Study|Participant no longer meets study criteria|2|||
146038636|NCT01545050|526653590|FG002|Overall Study|Participant no longer meets study criteria|0|||
146038637|NCT01545050|526653591|FG003|Overall Study|Participant no longer meets study criteria|0|||
146038638|NCT01545050|526653592|FG004|Overall Study|Participant no longer meets study criteria|1|||
146038639|NCT01545050|526653588|FG000|Overall Study|Administrative reason by sponsor|4|||
146038640|NCT01545050|526653589|FG001|Overall Study|Administrative reason by sponsor|2|||
146254474|NCT04736472|527444600|FG002|Overall Study|Withdrawal by Subject|0|||
146254475|NCT04736472|527444598|FG000|Overall Study|Protocol Violation|48|||
146254476|NCT04736472|527444599|FG001|Overall Study|Protocol Violation|0|||
146254477|NCT04736472|527444600|FG002|Overall Study|Protocol Violation|6|||
146038641|NCT01545050|526653590|FG002|Overall Study|Administrative reason by sponsor|3|||
146038642|NCT01545050|526653591|FG003|Overall Study|Administrative reason by sponsor|5|||
146038643|NCT01545050|526653592|FG004|Overall Study|Administrative reason by sponsor|5|||
146038644|NCT03262441|526653593|FG000|Overall Study|Withdrawal by Subject|1|||
146038645|NCT02607228|526653594|FG000|Overall Study|Progressive Disease|4|||
146038646|NCT02607228|526653595|FG001|Overall Study|Progressive Disease|3|||
146038647|NCT02607228|526653596|FG002|Overall Study|Progressive Disease|1|||
146038648|NCT02607228|526653597|FG003|Overall Study|Progressive Disease|5|||
146038649|NCT02607228|526653598|FG004|Overall Study|Progressive Disease|4|||
146038650|NCT02607228|526653599|FG005|Overall Study|Progressive Disease|3|||
146254478|NCT02116582|527444601|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
146038651|NCT02607228|526653600|FG006|Overall Study|Progressive Disease|1|||
146038652|NCT02607228|526653594|FG000|Overall Study|Adverse Event|1|||
146038653|NCT02607228|526653595|FG001|Overall Study|Adverse Event|0|||
146038654|NCT02607228|526653596|FG002|Overall Study|Adverse Event|1|||
146038655|NCT02607228|526653597|FG003|Overall Study|Adverse Event|0|||
146038656|NCT02607228|526653598|FG004|Overall Study|Adverse Event|1|||
146038657|NCT02607228|526653599|FG005|Overall Study|Adverse Event|1|||
146038658|NCT02607228|526653600|FG006|Overall Study|Adverse Event|1|||
146038659|NCT02607228|526653594|FG000|Overall Study|Investigator's Discretion|0|||
146038660|NCT02607228|526653595|FG001|Overall Study|Investigator's Discretion|0|||
146038661|NCT02607228|526653596|FG002|Overall Study|Investigator's Discretion|1|||
146038662|NCT02607228|526653597|FG003|Overall Study|Investigator's Discretion|0|||
146038663|NCT02607228|526653598|FG004|Overall Study|Investigator's Discretion|0|||
146038664|NCT02607228|526653599|FG005|Overall Study|Investigator's Discretion|1|||
146038665|NCT02607228|526653600|FG006|Overall Study|Investigator's Discretion|0|||
146038666|NCT02607228|526653594|FG000|Overall Study|Withdrew Consent|0|||
146038667|NCT02607228|526653595|FG001|Overall Study|Withdrew Consent|1|||
146038668|NCT02607228|526653596|FG002|Overall Study|Withdrew Consent|0|||
146038669|NCT02607228|526653597|FG003|Overall Study|Withdrew Consent|0|||
146038670|NCT02607228|526653598|FG004|Overall Study|Withdrew Consent|0|||
146038671|NCT02607228|526653599|FG005|Overall Study|Withdrew Consent|1|||
146038672|NCT02607228|526653600|FG006|Overall Study|Withdrew Consent|0|||
146038673|NCT02607228|526653594|FG000|Overall Study|Study Terminated by Sponsor|0|||
146038674|NCT02607228|526653595|FG001|Overall Study|Study Terminated by Sponsor|0|||
146038675|NCT02607228|526653596|FG002|Overall Study|Study Terminated by Sponsor|0|||
146038676|NCT02607228|526653597|FG003|Overall Study|Study Terminated by Sponsor|1|||
146038677|NCT02607228|526653598|FG004|Overall Study|Study Terminated by Sponsor|0|||
146038678|NCT02607228|526653599|FG005|Overall Study|Study Terminated by Sponsor|0|||
146038679|NCT02607228|526653600|FG006|Overall Study|Study Terminated by Sponsor|0|||
146038680|NCT03235089|526653601|FG000|Overall Study|Lost to Follow-up|1|||
146038681|NCT03235089|526653602|FG001|Overall Study|Lost to Follow-up|1|||
146038682|NCT03235089|526653601|FG000|Overall Study|Physician Decision|2|||
146038683|NCT03235089|526653602|FG001|Overall Study|Physician Decision|2|||
146038684|NCT00559988|526653614|FG000|Overall Study|Death|147|||
146038685|NCT00559988|526653615|FG001|Overall Study|Death|140|||
146038686|NCT00559988|526653614|FG000|Overall Study|Withdrawal by Subject|152|||
146038687|NCT00559988|526653615|FG001|Overall Study|Withdrawal by Subject|139|||
146038688|NCT00559988|526653614|FG000|Overall Study|Lost to Follow-up|42|||
146038689|NCT00559988|526653615|FG001|Overall Study|Lost to Follow-up|56|||
146038690|NCT00559988|526653614|FG000|Overall Study|ICD device explanted|10|||
146038691|NCT00559988|526653615|FG001|Overall Study|ICD device explanted|17|||
146038692|NCT01455194|526653616|FG000|Overall Study|Screen Failure|20|||
146038693|NCT01455194|526653617|FG001|Overall Study|Screen Failure|0|||
146038694|NCT01455194|526653618|FG002|Overall Study|Screen Failure|0|||
146038695|NCT01455194|526653619|FG003|Overall Study|Screen Failure|0|||
146038696|NCT01455194|526653616|FG000|Overall Study|Randomisation Failure|90|||
146038697|NCT01455194|526653617|FG001|Overall Study|Randomisation Failure|0|||
146038698|NCT01455194|526653618|FG002|Overall Study|Randomisation Failure|0|||
146038699|NCT01455194|526653619|FG003|Overall Study|Randomisation Failure|0|||
146038700|NCT01455194|526653616|FG000|Overall Study|Deterioration in asthma|12|||
146038701|NCT01455194|526653617|FG001|Overall Study|Deterioration in asthma|6|||
146038702|NCT01455194|526653618|FG002|Overall Study|Deterioration in asthma|14|||
146038703|NCT01455194|526653619|FG003|Overall Study|Deterioration in asthma|9|||
146038704|NCT01455194|526653616|FG000|Overall Study|Adverse Event|1|||
146038705|NCT01455194|526653617|FG001|Overall Study|Adverse Event|1|||
146038706|NCT01455194|526653618|FG002|Overall Study|Adverse Event|1|||
146038707|NCT01455194|526653619|FG003|Overall Study|Adverse Event|3|||
146038708|NCT01455194|526653616|FG000|Overall Study|Withdrawal by Subject|21|||
146038709|NCT01455194|526653617|FG001|Overall Study|Withdrawal by Subject|16|||
146038710|NCT01455194|526653618|FG002|Overall Study|Withdrawal by Subject|12|||
146038711|NCT01455194|526653619|FG003|Overall Study|Withdrawal by Subject|9|||
146099188|NCT01254630|526882770|FG000|Overall Study|Physician Decision|24|||
146300575|NCT00283049|527617054|FG002|Overall Study|Lack of Efficacy|1|||
146038712|NCT01455194|526653616|FG000|Overall Study|Lost to Follow-up|2|||
146038713|NCT01455194|526653617|FG001|Overall Study|Lost to Follow-up|0|||
146038714|NCT01455194|526653618|FG002|Overall Study|Lost to Follow-up|1|||
146038715|NCT01455194|526653619|FG003|Overall Study|Lost to Follow-up|1|||
146038716|NCT01455194|526653616|FG000|Overall Study|Pregnancy|0|||
146038717|NCT01455194|526653617|FG001|Overall Study|Pregnancy|1|||
146038718|NCT01455194|526653618|FG002|Overall Study|Pregnancy|1|||
146038719|NCT01455194|526653619|FG003|Overall Study|Pregnancy|0|||
146038720|NCT01455194|526653616|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
146038721|NCT01455194|526653617|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
146038722|NCT01455194|526653618|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
146038723|NCT01455194|526653619|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
146038724|NCT01455194|526653616|FG000|Overall Study|Miscellaneous|4|||
146038725|NCT01455194|526653617|FG001|Overall Study|Miscellaneous|5|||
146038726|NCT01455194|526653618|FG002|Overall Study|Miscellaneous|1|||
146300576|NCT00283049|527617052|FG000|Overall Study|Lost to Follow-up|4|||
146038727|NCT01455194|526653619|FG003|Overall Study|Miscellaneous|4|||
146038728|NCT01196416|526653620|FG000|Overall Study|Withdrawal by Subject|2|||
146038729|NCT00788710|526653621|FG000|Overall Study|Adverse Event|1|||
146038730|NCT00788710|526653622|FG001|Overall Study|Adverse Event|3|||
146038731|NCT00788710|526653623|FG002|Overall Study|Adverse Event|4|||
146038732|NCT00788710|526653621|FG000|Overall Study|Lack of Efficacy|0|||
146038733|NCT00788710|526653622|FG001|Overall Study|Lack of Efficacy|0|||
146038734|NCT00788710|526653623|FG002|Overall Study|Lack of Efficacy|1|||
146038735|NCT00788710|526653621|FG000|Overall Study|Lost to Follow-up|0|||
146038736|NCT00788710|526653622|FG001|Overall Study|Lost to Follow-up|1|||
146038737|NCT00788710|526653623|FG002|Overall Study|Lost to Follow-up|0|||
146038738|NCT00788710|526653621|FG000|Overall Study|Physician Decision|2|||
146038739|NCT00788710|526653622|FG001|Overall Study|Physician Decision|1|||
146038740|NCT00788710|526653623|FG002|Overall Study|Physician Decision|0|||
146038741|NCT00788710|526653621|FG000|Overall Study|Protocol Violation|0|||
146038742|NCT00788710|526653622|FG001|Overall Study|Protocol Violation|1|||
146038743|NCT00788710|526653623|FG002|Overall Study|Protocol Violation|1|||
146038744|NCT00788710|526653621|FG000|Overall Study|Withdrawal by Subject|2|||
146038745|NCT00788710|526653622|FG001|Overall Study|Withdrawal by Subject|2|||
146038746|NCT00788710|526653623|FG002|Overall Study|Withdrawal by Subject|0|||
146038747|NCT01717326|526653626|FG000|Overall Study|Death|0|||
146038748|NCT01717326|526653627|FG001|Overall Study|Death|0|||
146038749|NCT01717326|526653628|FG002|Overall Study|Death|0|||
146038750|NCT01717326|526653629|FG003|Overall Study|Death|0|||
146038751|NCT01717326|526653630|FG004|Overall Study|Death|0|||
146038752|NCT01717326|526653631|FG005|Overall Study|Death|0|||
146038753|NCT01717326|526653632|FG006|Overall Study|Death|0|||
146038754|NCT01717326|526653633|FG007|Overall Study|Death|0|||
146038755|NCT01717326|526653634|FG008|Overall Study|Death|0|||
146038756|NCT01717326|526653635|FG009|Overall Study|Death|0|||
146038757|NCT01717326|526653636|FG010|Overall Study|Death|1|||
146038758|NCT01717326|526653637|FG011|Overall Study|Death|0|||
146038759|NCT01717326|526653638|FG012|Overall Study|Death|0|||
146038760|NCT01717326|526653639|FG013|Overall Study|Death|0|||
146038761|NCT01717326|526653640|FG014|Overall Study|Death|0|||
146038762|NCT01717326|526653641|FG015|Overall Study|Death|0|||
146038763|NCT01717326|526653642|FG016|Overall Study|Death|0|||
146038764|NCT01717326|526653643|FG017|Overall Study|Death|0|||
146038765|NCT01717326|526653644|FG018|Overall Study|Death|0|||
146038766|NCT01717326|526653645|FG019|Overall Study|Death|0|||
146038767|NCT01717326|526653626|FG000|Overall Study|Lost to Follow-up|3|||
146038768|NCT01717326|526653627|FG001|Overall Study|Lost to Follow-up|0|||
146038769|NCT01717326|526653628|FG002|Overall Study|Lost to Follow-up|0|||
146038770|NCT01717326|526653629|FG003|Overall Study|Lost to Follow-up|2|||
146038771|NCT01717326|526653630|FG004|Overall Study|Lost to Follow-up|1|||
146038772|NCT01717326|526653631|FG005|Overall Study|Lost to Follow-up|0|||
146038773|NCT01717326|526653632|FG006|Overall Study|Lost to Follow-up|1|||
146038774|NCT01717326|526653633|FG007|Overall Study|Lost to Follow-up|0|||
146038775|NCT01717326|526653634|FG008|Overall Study|Lost to Follow-up|0|||
146038776|NCT01717326|526653635|FG009|Overall Study|Lost to Follow-up|0|||
146038777|NCT01717326|526653636|FG010|Overall Study|Lost to Follow-up|1|||
146038778|NCT01717326|526653637|FG011|Overall Study|Lost to Follow-up|0|||
146038779|NCT01717326|526653638|FG012|Overall Study|Lost to Follow-up|0|||
146038780|NCT01717326|526653639|FG013|Overall Study|Lost to Follow-up|0|||
146038781|NCT01717326|526653640|FG014|Overall Study|Lost to Follow-up|0|||
146038782|NCT01717326|526653641|FG015|Overall Study|Lost to Follow-up|2|||
146038783|NCT01717326|526653642|FG016|Overall Study|Lost to Follow-up|1|||
146038784|NCT01717326|526653643|FG017|Overall Study|Lost to Follow-up|0|||
146038785|NCT01717326|526653644|FG018|Overall Study|Lost to Follow-up|2|||
146038786|NCT01717326|526653645|FG019|Overall Study|Lost to Follow-up|3|||
146038787|NCT01717326|526653626|FG000|Overall Study|Physician Decision|0|||
146038788|NCT01717326|526653627|FG001|Overall Study|Physician Decision|0|||
146038789|NCT01717326|526653628|FG002|Overall Study|Physician Decision|0|||
146038790|NCT01717326|526653629|FG003|Overall Study|Physician Decision|0|||
146038791|NCT01717326|526653630|FG004|Overall Study|Physician Decision|0|||
146038792|NCT01717326|526653631|FG005|Overall Study|Physician Decision|0|||
146038793|NCT01717326|526653632|FG006|Overall Study|Physician Decision|0|||
146038794|NCT01717326|526653633|FG007|Overall Study|Physician Decision|0|||
146038795|NCT01717326|526653634|FG008|Overall Study|Physician Decision|0|||
146038796|NCT01717326|526653635|FG009|Overall Study|Physician Decision|1|||
146038797|NCT01717326|526653636|FG010|Overall Study|Physician Decision|0|||
146038798|NCT01717326|526653637|FG011|Overall Study|Physician Decision|0|||
146038799|NCT01717326|526653638|FG012|Overall Study|Physician Decision|0|||
146038800|NCT01717326|526653639|FG013|Overall Study|Physician Decision|0|||
146099189|NCT01254630|526882771|FG001|Overall Study|Physician Decision|8|||
146038801|NCT01717326|526653640|FG014|Overall Study|Physician Decision|0|||
146038802|NCT01717326|526653641|FG015|Overall Study|Physician Decision|0|||
146038803|NCT01717326|526653642|FG016|Overall Study|Physician Decision|0|||
146038804|NCT01717326|526653643|FG017|Overall Study|Physician Decision|0|||
146038805|NCT01717326|526653644|FG018|Overall Study|Physician Decision|0|||
146038806|NCT01717326|526653645|FG019|Overall Study|Physician Decision|0|||
146038807|NCT01717326|526653626|FG000|Overall Study|Protocol Violation|0|||
146038808|NCT01717326|526653627|FG001|Overall Study|Protocol Violation|0|||
146038809|NCT01717326|526653628|FG002|Overall Study|Protocol Violation|0|||
146038810|NCT01717326|526653629|FG003|Overall Study|Protocol Violation|0|||
146038811|NCT01717326|526653630|FG004|Overall Study|Protocol Violation|1|||
146038812|NCT01717326|526653631|FG005|Overall Study|Protocol Violation|0|||
146038813|NCT01717326|526653632|FG006|Overall Study|Protocol Violation|0|||
146038814|NCT01717326|526653633|FG007|Overall Study|Protocol Violation|0|||
146038815|NCT01717326|526653634|FG008|Overall Study|Protocol Violation|0|||
146038816|NCT01717326|526653635|FG009|Overall Study|Protocol Violation|0|||
146038817|NCT01717326|526653636|FG010|Overall Study|Protocol Violation|0|||
146038818|NCT01717326|526653637|FG011|Overall Study|Protocol Violation|0|||
146038819|NCT01717326|526653638|FG012|Overall Study|Protocol Violation|0|||
146038820|NCT01717326|526653639|FG013|Overall Study|Protocol Violation|0|||
146038821|NCT01717326|526653640|FG014|Overall Study|Protocol Violation|0|||
146038822|NCT01717326|526653641|FG015|Overall Study|Protocol Violation|0|||
146038823|NCT01717326|526653642|FG016|Overall Study|Protocol Violation|0|||
146038824|NCT01717326|526653643|FG017|Overall Study|Protocol Violation|0|||
146038825|NCT01717326|526653644|FG018|Overall Study|Protocol Violation|0|||
146038826|NCT01717326|526653645|FG019|Overall Study|Protocol Violation|0|||
146038827|NCT01717326|526653626|FG000|Overall Study|Withdrawal by Subject|0|||
146038828|NCT01717326|526653627|FG001|Overall Study|Withdrawal by Subject|1|||
146038829|NCT01717326|526653628|FG002|Overall Study|Withdrawal by Subject|0|||
146038830|NCT01717326|526653629|FG003|Overall Study|Withdrawal by Subject|0|||
146038831|NCT01717326|526653630|FG004|Overall Study|Withdrawal by Subject|0|||
146038832|NCT01717326|526653631|FG005|Overall Study|Withdrawal by Subject|0|||
146038833|NCT01717326|526653632|FG006|Overall Study|Withdrawal by Subject|0|||
146038834|NCT01717326|526653633|FG007|Overall Study|Withdrawal by Subject|0|||
146038835|NCT01717326|526653634|FG008|Overall Study|Withdrawal by Subject|0|||
146038836|NCT01717326|526653635|FG009|Overall Study|Withdrawal by Subject|1|||
146038837|NCT01717326|526653636|FG010|Overall Study|Withdrawal by Subject|0|||
146038838|NCT01717326|526653637|FG011|Overall Study|Withdrawal by Subject|0|||
146038839|NCT01717326|526653638|FG012|Overall Study|Withdrawal by Subject|1|||
146038840|NCT01717326|526653639|FG013|Overall Study|Withdrawal by Subject|0|||
146038841|NCT01717326|526653640|FG014|Overall Study|Withdrawal by Subject|0|||
146038842|NCT01717326|526653641|FG015|Overall Study|Withdrawal by Subject|1|||
146038843|NCT01717326|526653642|FG016|Overall Study|Withdrawal by Subject|0|||
146038844|NCT01717326|526653643|FG017|Overall Study|Withdrawal by Subject|0|||
146038845|NCT01717326|526653644|FG018|Overall Study|Withdrawal by Subject|2|||
146038846|NCT01717326|526653645|FG019|Overall Study|Withdrawal by Subject|3|||
146038847|NCT01123707|526653646|FG000|Overall Study|Lost to Follow-up|3|||
146038848|NCT01123707|526653647|FG001|Overall Study|Lost to Follow-up|1|||
146038849|NCT01123707|526653648|FG002|Overall Study|Lost to Follow-up|3|||
146038850|NCT01123707|526653649|FG003|Overall Study|Lost to Follow-up|2|||
146038851|NCT01123707|526653646|FG000|Overall Study|Adverse Event|5|||
146038852|NCT01123707|526653647|FG001|Overall Study|Adverse Event|7|||
146038853|NCT01123707|526653648|FG002|Overall Study|Adverse Event|5|||
146038854|NCT01123707|526653649|FG003|Overall Study|Adverse Event|3|||
146038855|NCT01123707|526653646|FG000|Overall Study|Sponsor Discontinued Study|30|||
146038856|NCT01123707|526653647|FG001|Overall Study|Sponsor Discontinued Study|24|||
146038857|NCT01123707|526653648|FG002|Overall Study|Sponsor Discontinued Study|25|||
146038858|NCT01123707|526653649|FG003|Overall Study|Sponsor Discontinued Study|40|||
146038859|NCT01123707|526653646|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
146038860|NCT01123707|526653647|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146038861|NCT01123707|526653648|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
146038862|NCT01123707|526653649|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
146038863|NCT01123707|526653646|FG000|Overall Study|Investigator Withdrew Participant|0|||
146038864|NCT01123707|526653647|FG001|Overall Study|Investigator Withdrew Participant|1|||
146038865|NCT01123707|526653648|FG002|Overall Study|Investigator Withdrew Participant|1|||
146038866|NCT01123707|526653649|FG003|Overall Study|Investigator Withdrew Participant|1|||
146038867|NCT01123707|526653646|FG000|Overall Study|Subject Withdrew Consent|4|||
146038868|NCT01123707|526653647|FG001|Overall Study|Subject Withdrew Consent|5|||
146038869|NCT01123707|526653648|FG002|Overall Study|Subject Withdrew Consent|1|||
146038870|NCT01123707|526653649|FG003|Overall Study|Subject Withdrew Consent|2|||
146038871|NCT01123707|526653646|FG000|Overall Study|Lack of Efficacy|1|||
146038872|NCT01123707|526653647|FG001|Overall Study|Lack of Efficacy|2|||
146300577|NCT00283049|527617053|FG001|Overall Study|Lost to Follow-up|2|||
146038873|NCT01123707|526653648|FG002|Overall Study|Lack of Efficacy|1|||
146038874|NCT01123707|526653649|FG003|Overall Study|Lack of Efficacy|0|||
146038875|NCT01123707|526653646|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
146038876|NCT01123707|526653647|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
146038877|NCT01123707|526653648|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
146038878|NCT01123707|526653649|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
146038879|NCT00687531|526653652|FG000|Overall Study|Did not meet protocol eligibility|104|||
146038880|NCT00687531|526653652|FG000|Overall Study|Adverse Event|5|||
146038881|NCT00687531|526653652|FG000|Overall Study|Lost to Follow-up|26|||
146038882|NCT02353728|526653653|FG000|Overall Study|Subject non-compliance|1|||
146099190|NCT01254630|526882772|FG002|Overall Study|Physician Decision|16|||
146038883|NCT02301624|526653654|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
146038884|NCT02301624|526653655|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
146038885|NCT02301624|526653654|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
146038886|NCT02301624|526653655|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
146038887|NCT02301624|526653654|FG000|Open-label Maintenance Phase|Adverse Event|2|||
146038888|NCT02301624|526653655|FG001|Open-label Maintenance Phase|Adverse Event|5|||
146038889|NCT02301624|526653654|FG000|Open-label Maintenance Phase|Physician Decision|3|||
146038890|NCT02301624|526653655|FG001|Open-label Maintenance Phase|Physician Decision|3|||
146038891|NCT02301624|526653654|FG000|Open-label Maintenance Phase|Death|2|||
146038892|NCT02301624|526653655|FG001|Open-label Maintenance Phase|Death|1|||
146038893|NCT02301624|526653654|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
146038894|NCT02301624|526653655|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
146038895|NCT03210961|526655982|FG000|Overall Study|Adverse Event|0|||
146038896|NCT03210961|526655983|FG001|Overall Study|Adverse Event|0|||
146038897|NCT03210961|526655984|FG002|Overall Study|Adverse Event|0|||
146038898|NCT03210961|526655985|FG003|Overall Study|Adverse Event|0|||
146038899|NCT03210961|526655986|FG004|Overall Study|Adverse Event|0|||
146038900|NCT03210961|526655987|FG005|Overall Study|Adverse Event|0|||
146038901|NCT03210961|526655988|FG006|Overall Study|Adverse Event|0|||
146038902|NCT03210961|526655989|FG007|Overall Study|Adverse Event|0|||
146038903|NCT03210961|526655990|FG008|Overall Study|Adverse Event|0|||
146038904|NCT03210961|526655991|FG009|Overall Study|Adverse Event|0|||
146038905|NCT03210961|526655992|FG010|Overall Study|Adverse Event|0|||
146038906|NCT03210961|526655993|FG011|Overall Study|Adverse Event|0|||
146038907|NCT03210961|526655994|FG012|Overall Study|Adverse Event|0|||
146038908|NCT03210961|526655995|FG013|Overall Study|Adverse Event|1|||
146038909|NCT03210961|526655996|FG014|Overall Study|Adverse Event|0|||
146038910|NCT03210961|526655982|FG000|Overall Study|Lost to Follow-up|0|||
146038911|NCT03210961|526655983|FG001|Overall Study|Lost to Follow-up|0|||
146038912|NCT03210961|526655984|FG002|Overall Study|Lost to Follow-up|0|||
146038913|NCT03210961|526655985|FG003|Overall Study|Lost to Follow-up|0|||
146038914|NCT03210961|526655986|FG004|Overall Study|Lost to Follow-up|0|||
146038915|NCT03210961|526655987|FG005|Overall Study|Lost to Follow-up|0|||
146038916|NCT03210961|526655988|FG006|Overall Study|Lost to Follow-up|0|||
146038917|NCT03210961|526655989|FG007|Overall Study|Lost to Follow-up|0|||
146038918|NCT03210961|526655990|FG008|Overall Study|Lost to Follow-up|0|||
146038919|NCT03210961|526655991|FG009|Overall Study|Lost to Follow-up|0|||
146038920|NCT03210961|526655992|FG010|Overall Study|Lost to Follow-up|0|||
146038921|NCT03210961|526655993|FG011|Overall Study|Lost to Follow-up|0|||
146038922|NCT03210961|526655994|FG012|Overall Study|Lost to Follow-up|0|||
146038923|NCT03210961|526655995|FG013|Overall Study|Lost to Follow-up|0|||
146038924|NCT03210961|526655996|FG014|Overall Study|Lost to Follow-up|1|||
146038925|NCT03210961|526655982|FG000|Overall Study|Withdrawal by Subject|0|||
146038926|NCT03210961|526655983|FG001|Overall Study|Withdrawal by Subject|0|||
146038927|NCT03210961|526655984|FG002|Overall Study|Withdrawal by Subject|0|||
146038928|NCT03210961|526655985|FG003|Overall Study|Withdrawal by Subject|0|||
146038929|NCT03210961|526655986|FG004|Overall Study|Withdrawal by Subject|0|||
146038930|NCT03210961|526655987|FG005|Overall Study|Withdrawal by Subject|0|||
146038931|NCT03210961|526655988|FG006|Overall Study|Withdrawal by Subject|0|||
146038932|NCT03210961|526655989|FG007|Overall Study|Withdrawal by Subject|0|||
146038933|NCT03210961|526655990|FG008|Overall Study|Withdrawal by Subject|0|||
146038934|NCT03210961|526655991|FG009|Overall Study|Withdrawal by Subject|0|||
146038935|NCT03210961|526655992|FG010|Overall Study|Withdrawal by Subject|0|||
146038936|NCT03210961|526655993|FG011|Overall Study|Withdrawal by Subject|0|||
146038937|NCT03210961|526655994|FG012|Overall Study|Withdrawal by Subject|0|||
146038938|NCT03210961|526655995|FG013|Overall Study|Withdrawal by Subject|0|||
146038939|NCT03210961|526655996|FG014|Overall Study|Withdrawal by Subject|1|||
146038940|NCT03210961|526655982|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038941|NCT03210961|526655983|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038942|NCT03210961|526655984|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038943|NCT03210961|526655985|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146099191|NCT01254630|526882773|FG003|Overall Study|Physician Decision|7|||
146099192|NCT01254630|526882770|FG000|Overall Study|Withdrawal by Subject|201|||
146099193|NCT01254630|526882771|FG001|Overall Study|Withdrawal by Subject|94|||
146038944|NCT03210961|526655986|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038945|NCT03210961|526655987|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146099194|NCT01254630|526882772|FG002|Overall Study|Withdrawal by Subject|188|||
146099195|NCT01254630|526882773|FG003|Overall Study|Withdrawal by Subject|89|||
146038946|NCT03210961|526655988|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038947|NCT03210961|526655989|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146099196|NCT01254630|526882770|FG000|Overall Study|Study terminated by sponsor|0|||
146038948|NCT03210961|526655990|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038949|NCT03210961|526655991|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038950|NCT03210961|526655992|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
146254479|NCT02116582|527444601|FG000|Overall Study|Adverse Event|22|||
146038951|NCT03210961|526655993|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038952|NCT03210961|526655994|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038953|NCT03210961|526655995|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
146038954|NCT03210961|526655996|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
146038955|NCT03210961|526655982|FG000|Overall Study|Other|0|||
146038956|NCT03210961|526655983|FG001|Overall Study|Other|0|||
146038957|NCT03210961|526655984|FG002|Overall Study|Other|0|||
146038958|NCT03210961|526655985|FG003|Overall Study|Other|1|||
146038959|NCT03210961|526655986|FG004|Overall Study|Other|0|||
146038960|NCT03210961|526655987|FG005|Overall Study|Other|0|||
146038961|NCT03210961|526655988|FG006|Overall Study|Other|1|||
146038962|NCT03210961|526655989|FG007|Overall Study|Other|0|||
146038963|NCT03210961|526655990|FG008|Overall Study|Other|0|||
146038964|NCT03210961|526655991|FG009|Overall Study|Other|0|||
146038965|NCT03210961|526655992|FG010|Overall Study|Other|1|||
146038966|NCT03210961|526655993|FG011|Overall Study|Other|0|||
146038967|NCT03210961|526655994|FG012|Overall Study|Other|2|||
146038968|NCT03210961|526655995|FG013|Overall Study|Other|2|||
146038969|NCT03210961|526655996|FG014|Overall Study|Other|0|||
146038970|NCT02467582|526655997|FG000|Allocation|Withdrawal by Subject|1|||
146038971|NCT02467582|526655998|FG001|Allocation|Withdrawal by Subject|0|||
146038972|NCT02467582|526655997|FG000|Follow-up|Death|5|||
146038973|NCT02467582|526655998|FG001|Follow-up|Death|4|||
146038974|NCT02467582|526655997|FG000|Follow-up|Lost to Follow-up|6|||
146038975|NCT02467582|526655998|FG001|Follow-up|Lost to Follow-up|5|||
146038976|NCT00703924|526655999|FG000|Overall Study|Withdrawal by Subject|1|||
146038977|NCT00703924|526656000|FG001|Overall Study|Withdrawal by Subject|1|||
146038978|NCT01031979|526656003|FG000|Overall Study|Lost to Follow-up|5|||
146038979|NCT01031979|526656004|FG001|Overall Study|Lost to Follow-up|4|||
146038980|NCT03592368|526656006|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146038981|NCT03592368|526656007|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
146038982|NCT03592368|526656008|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146038983|NCT03592368|526656009|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
146038984|NCT03592368|526656006|FG000|Overall Study|Adverse Event|0|||
146038985|NCT03592368|526656007|FG001|Overall Study|Adverse Event|0|||
146038986|NCT03592368|526656008|FG002|Overall Study|Adverse Event|0|||
146038987|NCT03592368|526656009|FG003|Overall Study|Adverse Event|1|||
146038988|NCT03592368|526656006|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
146038989|NCT03592368|526656007|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
146038990|NCT03592368|526656008|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
146038991|NCT03592368|526656009|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
146038992|NCT03354273|526656017|FG000|Overall Study|Adverse Event|5|||
146038993|NCT03354273|526656017|FG000|Overall Study|Screen Failure|21|||
146038994|NCT03354273|526656017|FG000|Overall Study|Withdrawal by Subject|34|||
146038995|NCT03354273|526656017|FG000|Overall Study|Technical Problems|30|||
146038996|NCT03354273|526656017|FG000|Overall Study|Lost to Follow-up|4|||
146038997|NCT03354273|526656017|FG000|Overall Study|Investigator Decision|3|||
146038998|NCT03354273|526656017|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
146038999|NCT03354273|526656017|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
146039000|NCT03354273|526656017|FG000|Overall Study|COVID-19 Restrictions|9|||
146039001|NCT03354273|526656017|FG000|Overall Study|Other|5|||
146039002|NCT00705367|526656020|FG000|Long-term Extension Period|Adverse Event|2|||
146039003|NCT00705367|526656021|FG001|Long-term Extension Period|Adverse Event|0|||
146039004|NCT00705367|526656020|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
146039005|NCT00705367|526656021|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
146039006|NCT00705367|526656020|FG000|Long-term Extension Period|Lack of Efficacy|1|||
146039007|NCT00705367|526656021|FG001|Long-term Extension Period|Lack of Efficacy|0|||
146039008|NCT00705367|526656020|FG000|Long-term Extension Period|No longer met study criteria|1|||
146039009|NCT00705367|526656021|FG001|Long-term Extension Period|No longer met study criteria|0|||
146039010|NCT00705367|526656020|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
146039011|NCT00705367|526656021|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
146039012|NCT01959139|526656025|FG000|Phase II|Disease progression|0|||
146039013|NCT01959139|526656026|FG001|Phase II|Disease progression|0|||
146039014|NCT01959139|526656027|FG002|Phase II|Disease progression|26|||
146039015|NCT01959139|526656028|FG003|Phase II|Disease progression|34|||
146039016|NCT01959139|526656025|FG000|Phase II|Adverse Event|0|||
146039017|NCT01959139|526656026|FG001|Phase II|Adverse Event|0|||
146039018|NCT01959139|526656027|FG002|Phase II|Adverse Event|10|||
146039019|NCT01959139|526656028|FG003|Phase II|Adverse Event|11|||
146039020|NCT01959139|526656025|FG000|Phase II|Patient Refusal|0|||
146039021|NCT01959139|526656026|FG001|Phase II|Patient Refusal|0|||
146039022|NCT01959139|526656027|FG002|Phase II|Patient Refusal|5|||
146039023|NCT01959139|526656028|FG003|Phase II|Patient Refusal|4|||
146039024|NCT01959139|526656025|FG000|Phase II|Death|0|||
146039025|NCT01959139|526656026|FG001|Phase II|Death|0|||
146039026|NCT01959139|526656027|FG002|Phase II|Death|3|||
146039027|NCT01959139|526656028|FG003|Phase II|Death|1|||
146039028|NCT01959139|526656025|FG000|Phase II|Other/Unknown|0|||
146039029|NCT01959139|526656026|FG001|Phase II|Other/Unknown|0|||
146039030|NCT01959139|526656027|FG002|Phase II|Other/Unknown|8|||
146039031|NCT01959139|526656028|FG003|Phase II|Other/Unknown|5|||
146039032|NCT01959139|526656025|FG000|Phase II|On treatment|0|||
146039033|NCT01959139|526656026|FG001|Phase II|On treatment|0|||
146039034|NCT01959139|526656027|FG002|Phase II|On treatment|4|||
146039035|NCT01959139|526656028|FG003|Phase II|On treatment|0|||
146039036|NCT03679624|526656029|FG000|Overall Study|Adverse Event|1|||
146039037|NCT03679624|526656030|FG001|Overall Study|Adverse Event|0|||
146039038|NCT02629822|526656031|FG000|Base Study|Lost to Follow-up|2|||
146039039|NCT02629822|526656031|FG000|Base Study|Non-Compliance With Study Drug|1|||
146039040|NCT02629822|526656031|FG000|Extension Study|Adverse Event|1|||
146039041|NCT02629822|526656031|FG000|Extension Study|Lost to Follow-up|1|||
146039042|NCT00741013|526656032|FG000|Overall Study|Adverse Event|1|||
146039043|NCT00741013|526656033|FG001|Overall Study|Adverse Event|0|||
146039044|NCT00741013|526656034|FG002|Overall Study|Adverse Event|0|||
146039045|NCT00741013|526656032|FG000|Overall Study|Withdrawal by Subject|0|||
146039046|NCT00741013|526656033|FG001|Overall Study|Withdrawal by Subject|0|||
146039047|NCT00741013|526656034|FG002|Overall Study|Withdrawal by Subject|1|||
146039048|NCT00741013|526656032|FG000|Overall Study|Discovered failed screen after enrolled|0|||
146039049|NCT00741013|526656033|FG001|Overall Study|Discovered failed screen after enrolled|2|||
146039050|NCT00741013|526656034|FG002|Overall Study|Discovered failed screen after enrolled|0|||
146039051|NCT00082407|526656035|FG000|Overall Study|Adverse Event|20|||
146039052|NCT00082407|526656036|FG001|Overall Study|Adverse Event|0|||
146039053|NCT00082407|526656035|FG000|Overall Study|Protocol Violation|14|||
146039054|NCT00082407|526656036|FG001|Overall Study|Protocol Violation|12|||
146039055|NCT00082407|526656035|FG000|Overall Study|Patient Decision|13|||
146039056|NCT00082407|526656036|FG001|Overall Study|Patient Decision|6|||
146039057|NCT00082407|526656035|FG000|Overall Study|Physician Decision|5|||
146039058|NCT00082407|526656036|FG001|Overall Study|Physician Decision|3|||
146039059|NCT00082407|526656035|FG000|Overall Study|Loss of Glucose Control|2|||
146039060|NCT00082407|526656036|FG001|Overall Study|Loss of Glucose Control|2|||
146039061|NCT00082407|526656035|FG000|Overall Study|Death|2|||
146039062|NCT00082407|526656036|FG001|Overall Study|Death|1|||
146039063|NCT00082407|526656035|FG000|Overall Study|Lost to Follow-up|0|||
146039064|NCT00082407|526656036|FG001|Overall Study|Lost to Follow-up|3|||
146039065|NCT02352753|526656037|FG000|6-Month Dosing Period|Decision by sponsor|2|||
146039066|NCT02352753|526656037|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
146039067|NCT02352753|526656037|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
146039068|NCT02352753|526656037|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
146039069|NCT02352753|526656037|FG000|3-Month Dosing Period|Decision by sponsor|14|||
146039070|NCT02352753|526656037|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
146039071|NCT01393639|526656040|FG000|Overall Study|Protocol Violation|0|||
146039072|NCT01393639|526656041|FG001|Overall Study|Protocol Violation|0|||
146039073|NCT01393639|526656042|FG002|Overall Study|Protocol Violation|0|||
146039074|NCT01393639|526656043|FG003|Overall Study|Protocol Violation|1|||
146039075|NCT01393639|526656044|FG004|Overall Study|Protocol Violation|0|||
146039076|NCT01393639|526656045|FG005|Overall Study|Protocol Violation|0|||
146254480|NCT02116582|527444601|FG000|Overall Study|Death|9|||
146254481|NCT02116582|527444601|FG000|Overall Study|Progressive Disease|148|||
146254482|NCT02116582|527444601|FG000|Overall Study|Protocol Violation|3|||
146254483|NCT02116582|527444601|FG000|Overall Study|Withdrawal by Subject|8|||
146039077|NCT01393639|526656046|FG006|Overall Study|Protocol Violation|0|||
146039078|NCT01393639|526656040|FG000|Overall Study|Other|0|||
146254484|NCT02116582|527444601|FG000|Overall Study|Other: Miscellaneous|11|||
146039079|NCT01393639|526656041|FG001|Overall Study|Other|2|||
146039080|NCT01393639|526656042|FG002|Overall Study|Other|0|||
146039081|NCT01393639|526656043|FG003|Overall Study|Other|2|||
146254485|NCT02116582|527444601|FG000|Overall Study|Lost to Follow-up|1|||
146300578|NCT00283049|527617054|FG002|Overall Study|Lost to Follow-up|5|||
146039082|NCT01393639|526656044|FG004|Overall Study|Other|1|||
146039083|NCT01393639|526656045|FG005|Overall Study|Other|0|||
146039084|NCT01393639|526656046|FG006|Overall Study|Other|1|||
146039085|NCT01393639|526656040|FG000|Overall Study|Withdrawal by Subject|1|||
146039086|NCT01393639|526656041|FG001|Overall Study|Withdrawal by Subject|1|||
146039087|NCT01393639|526656042|FG002|Overall Study|Withdrawal by Subject|0|||
146039088|NCT01393639|526656043|FG003|Overall Study|Withdrawal by Subject|0|||
146039089|NCT01393639|526656044|FG004|Overall Study|Withdrawal by Subject|0|||
146254486|NCT02116582|527444601|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
146039090|NCT01393639|526656045|FG005|Overall Study|Withdrawal by Subject|0|||
146039091|NCT01393639|526656046|FG006|Overall Study|Withdrawal by Subject|1|||
146039092|NCT01393639|526656040|FG000|Overall Study|Medication error without associated AE|0|||
146039093|NCT01393639|526656041|FG001|Overall Study|Medication error without associated AE|0|||
146039094|NCT01393639|526656042|FG002|Overall Study|Medication error without associated AE|0|||
146254487|NCT01876823|527444602|FG000|Overall Study|Withdrawal by Subject|5|||
146039095|NCT01393639|526656043|FG003|Overall Study|Medication error without associated AE|0|||
146039096|NCT01393639|526656044|FG004|Overall Study|Medication error without associated AE|0|||
146039097|NCT01393639|526656045|FG005|Overall Study|Medication error without associated AE|0|||
146039098|NCT01393639|526656046|FG006|Overall Study|Medication error without associated AE|1|||
146039099|NCT01393639|526656040|FG000|Overall Study|Lost to Follow-up|0|||
146039100|NCT01393639|526656041|FG001|Overall Study|Lost to Follow-up|1|||
146039101|NCT01393639|526656042|FG002|Overall Study|Lost to Follow-up|0|||
146039102|NCT01393639|526656043|FG003|Overall Study|Lost to Follow-up|0|||
146039103|NCT01393639|526656044|FG004|Overall Study|Lost to Follow-up|0|||
146039104|NCT01393639|526656045|FG005|Overall Study|Lost to Follow-up|0|||
146039105|NCT01393639|526656046|FG006|Overall Study|Lost to Follow-up|1|||
146039106|NCT01393639|526656040|FG000|Overall Study|Lack of Efficacy|0|||
146039107|NCT01393639|526656041|FG001|Overall Study|Lack of Efficacy|0|||
146039108|NCT01393639|526656042|FG002|Overall Study|Lack of Efficacy|0|||
146039109|NCT01393639|526656043|FG003|Overall Study|Lack of Efficacy|0|||
146039110|NCT01393639|526656044|FG004|Overall Study|Lack of Efficacy|0|||
146039111|NCT01393639|526656045|FG005|Overall Study|Lack of Efficacy|0|||
146039112|NCT01393639|526656046|FG006|Overall Study|Lack of Efficacy|1|||
146039113|NCT01393639|526656040|FG000|Overall Study|Adverse Event|2|||
146039114|NCT01393639|526656041|FG001|Overall Study|Adverse Event|3|||
146039115|NCT01393639|526656042|FG002|Overall Study|Adverse Event|1|||
146039116|NCT01393639|526656043|FG003|Overall Study|Adverse Event|2|||
146039117|NCT01393639|526656044|FG004|Overall Study|Adverse Event|0|||
146039118|NCT01393639|526656045|FG005|Overall Study|Adverse Event|2|||
146039119|NCT01393639|526656046|FG006|Overall Study|Adverse Event|3|||
146039120|NCT01440816|526656047|FG000|Overall Study|Disease Progression|0|||
146039121|NCT01440816|526656048|FG001|Overall Study|Disease Progression|9|||
146039122|NCT01440816|526656047|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
146039123|NCT01440816|526656048|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
146039124|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039125|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039126|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
146039127|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
146039128|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
146039129|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039130|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
146039131|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
146039132|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
146039133|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039134|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039135|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039136|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
146039137|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
146039138|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146039139|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
146039140|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146039141|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146039142|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146039143|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
146039144|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
146039145|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
146039146|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146039147|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146039148|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146039149|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
146039150|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039151|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146039152|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146039153|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039154|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039155|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146039156|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
146039157|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039158|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039159|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039160|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039161|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039162|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
146039163|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039164|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146039165|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146039166|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039167|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039168|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039169|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146039170|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039171|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
146039172|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039173|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039174|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039175|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
146039176|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039177|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039178|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039179|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
146039180|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039181|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039182|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039183|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
146039184|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039185|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039186|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039187|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039188|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
146039189|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039190|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039191|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039192|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
146039193|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039194|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039195|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
146039196|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039197|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039198|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039199|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039200|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039201|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
146039202|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039203|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
146039204|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039205|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039206|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039207|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039208|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039209|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039210|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039211|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039212|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039213|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039214|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
146039215|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
146039216|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039217|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039218|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039219|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039220|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039221|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039222|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039223|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039224|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039225|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039226|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039227|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
146039228|NCT03100058|526656055|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039229|NCT03100058|526656056|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039230|NCT03100058|526656057|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039231|NCT03100058|526656058|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039232|NCT03100058|526656059|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039233|NCT03100058|526656060|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039234|NCT03100058|526656061|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
146039235|NCT03100058|526656062|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039236|NCT03100058|526656063|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039237|NCT03100058|526656064|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039238|NCT03100058|526656065|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039239|NCT03100058|526656066|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039240|NCT03100058|526656067|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
146039241|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039242|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039243|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039244|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039245|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039246|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039247|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039248|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039249|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039250|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
146039251|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
146039252|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
146039253|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
146039254|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039255|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039256|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039257|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039258|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039259|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039260|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039261|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039262|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039263|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039264|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
146039265|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
146039266|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
146039267|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039268|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039269|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039270|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039271|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039272|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039273|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039274|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039275|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039276|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
146039277|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
146039278|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
146039279|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
146039280|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039281|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039282|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039283|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039284|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039285|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039286|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146099197|NCT01254630|526882771|FG001|Overall Study|Study terminated by sponsor|994|||
146099198|NCT01254630|526882772|FG002|Overall Study|Study terminated by sponsor|0|||
146099199|NCT01254630|526882773|FG003|Overall Study|Study terminated by sponsor|1010|||
146099200|NCT01254630|526882770|FG000|Overall Study|Status not recorded|0|||
146099201|NCT01254630|526882771|FG001|Overall Study|Status not recorded|0|||
146099202|NCT01254630|526882772|FG002|Overall Study|Status not recorded|1|||
146099203|NCT01254630|526882773|FG003|Overall Study|Status not recorded|0|||
146099204|NCT00484094|526882774|FG000|Overall Study|Discontinued|39|||
146099205|NCT00484094|526882774|FG000|Overall Study|Other|3|||
146099206|NCT01826604|526884450|FG000|Overall Study|Lost to Follow-up|8|||
146099207|NCT01826604|526884451|FG001|Overall Study|Lost to Follow-up|9|||
146300579|NCT00283049|527617052|FG000|Overall Study|Withdrawal by Subject|26|||
146039287|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039288|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146099208|NCT01303861|526884465|FG000|Overall Study|Lost to Follow-up|34|||
146039289|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039290|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
146039291|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039292|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
146039293|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039294|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039295|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039296|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039297|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039298|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039299|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039300|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039301|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039302|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039303|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039304|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
146039305|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
146039306|NCT03100058|526656055|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039307|NCT03100058|526656056|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039308|NCT03100058|526656057|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039309|NCT03100058|526656058|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039310|NCT03100058|526656059|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039311|NCT03100058|526656060|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039312|NCT03100058|526656061|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039313|NCT03100058|526656062|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039314|NCT03100058|526656063|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039315|NCT03100058|526656064|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
146039316|NCT03100058|526656065|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039317|NCT03100058|526656066|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039318|NCT03100058|526656067|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
146039319|NCT02942485|526656068|FG000|Overall Study|Lost to Follow-up|1|||
146039320|NCT02942485|526656069|FG001|Overall Study|Lost to Follow-up|0|||
146039321|NCT04302545|526656072|FG000|Overall Study|Lost to Follow-up|3|||
146039322|NCT04302545|526656073|FG001|Overall Study|Lost to Follow-up|4|||
146039323|NCT02516592|526656074|FG000|Overall Study|Patient withdrew consent|5|||
146039324|NCT02516592|526656075|FG001|Overall Study|Patient withdrew consent|2|||
146039325|NCT02516592|526656074|FG000|Overall Study|Protocol deviation|4|||
146039326|NCT02516592|526656075|FG001|Overall Study|Protocol deviation|4|||
146039327|NCT02516592|526656074|FG000|Overall Study|Lost to Follow-up|2|||
146039328|NCT02516592|526656075|FG001|Overall Study|Lost to Follow-up|3|||
146039329|NCT02516592|526656074|FG000|Overall Study|Patient/guardian decision|2|||
146039330|NCT02516592|526656075|FG001|Overall Study|Patient/guardian decision|1|||
146039331|NCT02516592|526656074|FG000|Overall Study|Adverse Event|1|||
146039332|NCT02516592|526656075|FG001|Overall Study|Adverse Event|2|||
146039333|NCT02516592|526656074|FG000|Overall Study|Abnormal test procedure result|1|||
146039334|NCT02516592|526656075|FG001|Overall Study|Abnormal test procedure result|0|||
146039335|NCT02516592|526656074|FG000|Overall Study|Death|1|||
146039336|NCT02516592|526656075|FG001|Overall Study|Death|1|||
146039337|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
146039338|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
146039339|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
146039340|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
146039341|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Death|2|||
146254488|NCT01876823|527444602|FG000|Overall Study|Physician Decision|2|||
146254489|NCT01876823|527444602|FG000|Overall Study|Patients moved|2|||
146039342|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Death|2|||
146039343|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Death|0|||
146039344|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Death|0|||
146039345|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
146039346|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
146039347|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
146039348|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
146254490|NCT02256488|527444605|FG000|Overall Study|Lost to Follow-up|6|||
146099209|NCT01303861|526884466|FG001|Overall Study|Lost to Follow-up|14|||
146039349|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
146039350|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146099210|NCT01303861|526884467|FG002|Overall Study|Lost to Follow-up|27|||
146254491|NCT02256488|527444606|FG001|Overall Study|Lost to Follow-up|6|||
146254492|NCT02256488|527444607|FG002|Overall Study|Lost to Follow-up|9|||
146254493|NCT02256488|527444608|FG003|Overall Study|Lost to Follow-up|3|||
146039351|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146039352|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
146039353|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
146039354|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
146039355|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
146039356|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
146039357|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
146039358|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146039359|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146039360|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
146039361|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146039362|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
146039363|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146039364|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
146039365|NCT03068754|526656076|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
146039366|NCT03068754|526656077|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
146039367|NCT03068754|526656078|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
146039368|NCT03068754|526656079|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
146039369|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
146039370|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
146039371|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
146039372|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
146039373|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Death|0|||
146039374|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Death|0|||
146039375|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Death|0|||
146039376|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Death|1|||
146039377|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
146039378|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
146039379|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
146039380|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
146039381|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146039382|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146039383|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
146039384|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
146039385|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146039386|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146039387|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
146039388|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
146039389|NCT03068754|526656076|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
146039390|NCT03068754|526656077|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
146039391|NCT03068754|526656078|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
146039392|NCT03068754|526656079|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
146039393|NCT01110382|526656081|FG000|Overall Study|Withdrawal by Subject|0|||
146039394|NCT01110382|526656082|FG001|Overall Study|Withdrawal by Subject|1|||
146039395|NCT01110382|526656081|FG000|Overall Study|Protocol Violation|0|||
146039396|NCT01110382|526656082|FG001|Overall Study|Protocol Violation|1|||
146039397|NCT00098306|526656083|FG000|Double Blind|Randomized, not treated|9|||
146039398|NCT00098306|526656084|FG001|Double Blind|Randomized, not treated|5|||
146039399|NCT00098306|526656085|FG002|Double Blind|Randomized, not treated|2|||
146039400|NCT00098306|526656086|FG003|Double Blind|Randomized, not treated|0|||
146039401|NCT00098306|526656087|FG004|Double Blind|Randomized, not treated|0|||
146039402|NCT00098306|526656088|FG005|Double Blind|Randomized, not treated|0|||
146039403|NCT00098306|526656089|FG006|Double Blind|Randomized, not treated|0|||
146039404|NCT00098306|526656083|FG000|Double Blind|Ongoing at cut-off date|151|||
146039405|NCT00098306|526656084|FG001|Double Blind|Ongoing at cut-off date|166|||
146039406|NCT00098306|526656085|FG002|Double Blind|Ongoing at cut-off date|72|||
146039407|NCT00098306|526656086|FG003|Double Blind|Ongoing at cut-off date|0|||
146039408|NCT00098306|526656087|FG004|Double Blind|Ongoing at cut-off date|0|||
146254494|NCT02256488|527444605|FG000|Overall Study|OTHER|1|||
146254495|NCT02256488|527444606|FG001|Overall Study|OTHER|0|||
146254496|NCT02256488|527444607|FG002|Overall Study|OTHER|1|||
146254497|NCT02256488|527444608|FG003|Overall Study|OTHER|1|||
146099211|NCT01303861|526884468|FG003|Overall Study|Lost to Follow-up|31|||
146039409|NCT00098306|526656088|FG005|Double Blind|Ongoing at cut-off date|0|||
146039410|NCT00098306|526656089|FG006|Double Blind|Ongoing at cut-off date|0|||
146099212|NCT01303861|526884465|FG000|Overall Study|Lack of Efficacy|3|||
146254498|NCT02256488|527444605|FG000|Overall Study|Withdrawal by Subject|1|||
146254499|NCT02256488|527444606|FG001|Overall Study|Withdrawal by Subject|0|||
146254500|NCT02256488|527444607|FG002|Overall Study|Withdrawal by Subject|0|||
146039411|NCT00098306|526656083|FG000|Double Blind|Adverse Event|11|||
146039412|NCT00098306|526656084|FG001|Double Blind|Adverse Event|10|||
146039413|NCT00098306|526656085|FG002|Double Blind|Adverse Event|6|||
146039414|NCT00098306|526656086|FG003|Double Blind|Adverse Event|0|||
146039415|NCT00098306|526656087|FG004|Double Blind|Adverse Event|0|||
146039416|NCT00098306|526656088|FG005|Double Blind|Adverse Event|0|||
146039417|NCT00098306|526656089|FG006|Double Blind|Adverse Event|0|||
146039418|NCT00098306|526656083|FG000|Double Blind|Lack of Efficacy|43|||
146039419|NCT00098306|526656084|FG001|Double Blind|Lack of Efficacy|34|||
146039420|NCT00098306|526656085|FG002|Double Blind|Lack of Efficacy|17|||
146039421|NCT00098306|526656086|FG003|Double Blind|Lack of Efficacy|0|||
146039422|NCT00098306|526656087|FG004|Double Blind|Lack of Efficacy|0|||
146039423|NCT00098306|526656088|FG005|Double Blind|Lack of Efficacy|0|||
146039424|NCT00098306|526656089|FG006|Double Blind|Lack of Efficacy|0|||
146039425|NCT00098306|526656083|FG000|Double Blind|Death|1|||
146039426|NCT00098306|526656084|FG001|Double Blind|Death|4|||
146039427|NCT00098306|526656085|FG002|Double Blind|Death|1|||
146039428|NCT00098306|526656086|FG003|Double Blind|Death|0|||
146039429|NCT00098306|526656087|FG004|Double Blind|Death|0|||
146039430|NCT00098306|526656088|FG005|Double Blind|Death|0|||
146039431|NCT00098306|526656089|FG006|Double Blind|Death|0|||
146039432|NCT00098306|526656083|FG000|Double Blind|Participant defaulted|19|||
146039433|NCT00098306|526656084|FG001|Double Blind|Participant defaulted|18|||
146039434|NCT00098306|526656085|FG002|Double Blind|Participant defaulted|11|||
146039435|NCT00098306|526656086|FG003|Double Blind|Participant defaulted|0|||
146039436|NCT00098306|526656087|FG004|Double Blind|Participant defaulted|0|||
146039437|NCT00098306|526656088|FG005|Double Blind|Participant defaulted|0|||
146039438|NCT00098306|526656089|FG006|Double Blind|Participant defaulted|0|||
146039439|NCT00098306|526656083|FG000|Double Blind|Un-specified|7|||
146039440|NCT00098306|526656084|FG001|Double Blind|Un-specified|3|||
146039441|NCT00098306|526656085|FG002|Double Blind|Un-specified|11|||
146039442|NCT00098306|526656086|FG003|Double Blind|Un-specified|0|||
146039443|NCT00098306|526656087|FG004|Double Blind|Un-specified|0|||
146039444|NCT00098306|526656088|FG005|Double Blind|Un-specified|0|||
146039445|NCT00098306|526656089|FG006|Double Blind|Un-specified|0|||
146039446|NCT00098306|526656083|FG000|Open Label|Lack of Efficacy|0|||
146039447|NCT00098306|526656084|FG001|Open Label|Lack of Efficacy|0|||
146039448|NCT00098306|526656085|FG002|Open Label|Lack of Efficacy|0|||
146039449|NCT00098306|526656086|FG003|Open Label|Lack of Efficacy|13|||
146039450|NCT00098306|526656087|FG004|Open Label|Lack of Efficacy|0|||
146039451|NCT00098306|526656088|FG005|Open Label|Lack of Efficacy|0|||
146039452|NCT00098306|526656089|FG006|Open Label|Lack of Efficacy|0|||
146039453|NCT00098306|526656083|FG000|Open Label|Adverse Event|0|||
146039454|NCT00098306|526656084|FG001|Open Label|Adverse Event|0|||
146039455|NCT00098306|526656085|FG002|Open Label|Adverse Event|0|||
146039456|NCT00098306|526656086|FG003|Open Label|Adverse Event|2|||
146039457|NCT00098306|526656087|FG004|Open Label|Adverse Event|0|||
146039458|NCT00098306|526656088|FG005|Open Label|Adverse Event|0|||
146039459|NCT00098306|526656089|FG006|Open Label|Adverse Event|0|||
146039460|NCT00098306|526656083|FG000|Open Label|Death|0|||
146039461|NCT00098306|526656084|FG001|Open Label|Death|0|||
146039462|NCT00098306|526656085|FG002|Open Label|Death|0|||
146039463|NCT00098306|526656086|FG003|Open Label|Death|4|||
146039464|NCT00098306|526656087|FG004|Open Label|Death|0|||
146039465|NCT00098306|526656088|FG005|Open Label|Death|0|||
146039466|NCT00098306|526656089|FG006|Open Label|Death|0|||
146039467|NCT00098306|526656083|FG000|Open Label|Participant defaulted|0|||
146039468|NCT00098306|526656084|FG001|Open Label|Participant defaulted|0|||
146039469|NCT00098306|526656085|FG002|Open Label|Participant defaulted|0|||
146039470|NCT00098306|526656086|FG003|Open Label|Participant defaulted|24|||
146039471|NCT00098306|526656087|FG004|Open Label|Participant defaulted|0|||
146039472|NCT00098306|526656088|FG005|Open Label|Participant defaulted|0|||
146039473|NCT00098306|526656089|FG006|Open Label|Participant defaulted|0|||
146039474|NCT00098306|526656083|FG000|Open Label|Un-specified|0|||
146300580|NCT00283049|527617053|FG001|Overall Study|Withdrawal by Subject|24|||
146300581|NCT00283049|527617054|FG002|Overall Study|Withdrawal by Subject|19|||
146039475|NCT00098306|526656084|FG001|Open Label|Un-specified|0|||
146039476|NCT00098306|526656085|FG002|Open Label|Un-specified|0|||
146039477|NCT00098306|526656086|FG003|Open Label|Un-specified|15|||
146039478|NCT00098306|526656087|FG004|Open Label|Un-specified|0|||
146039479|NCT00098306|526656088|FG005|Open Label|Un-specified|0|||
146039480|NCT00098306|526656089|FG006|Open Label|Un-specified|0|||
146039481|NCT00098306|526656083|FG000|Open Label|Ongoing at cut-off date|0|||
146039482|NCT00098306|526656084|FG001|Open Label|Ongoing at cut-off date|0|||
146039483|NCT00098306|526656085|FG002|Open Label|Ongoing at cut-off date|0|||
146039484|NCT00098306|526656086|FG003|Open Label|Ongoing at cut-off date|269|||
146039485|NCT00098306|526656087|FG004|Open Label|Ongoing at cut-off date|62|||
146039486|NCT00098306|526656088|FG005|Open Label|Ongoing at cut-off date|0|||
146039487|NCT00098306|526656089|FG006|Open Label|Ongoing at cut-off date|0|||
146039488|NCT00098306|526656083|FG000|Observational Phase|Death|0|||
146039489|NCT00098306|526656084|FG001|Observational Phase|Death|0|||
146039490|NCT00098306|526656085|FG002|Observational Phase|Death|0|||
146039491|NCT00098306|526656086|FG003|Observational Phase|Death|0|||
146300582|NCT00283049|527617052|FG000|Overall Study|Discontinuation of Study|18|||
146039492|NCT00098306|526656087|FG004|Observational Phase|Death|0|||
146039493|NCT00098306|526656088|FG005|Observational Phase|Death|5|||
146039494|NCT00098306|526656089|FG006|Observational Phase|Death|4|||
146039495|NCT00098306|526656083|FG000|Observational Phase|Participant defaulted|0|||
146039496|NCT00098306|526656084|FG001|Observational Phase|Participant defaulted|0|||
146039497|NCT00098306|526656085|FG002|Observational Phase|Participant defaulted|0|||
146039498|NCT00098306|526656086|FG003|Observational Phase|Participant defaulted|0|||
146039499|NCT00098306|526656087|FG004|Observational Phase|Participant defaulted|0|||
146039500|NCT00098306|526656088|FG005|Observational Phase|Participant defaulted|34|||
146039501|NCT00098306|526656089|FG006|Observational Phase|Participant defaulted|18|||
146039502|NCT00098306|526656083|FG000|Observational Phase|Un-specified|0|||
146039503|NCT00098306|526656084|FG001|Observational Phase|Un-specified|0|||
146039504|NCT00098306|526656085|FG002|Observational Phase|Un-specified|0|||
146039505|NCT00098306|526656086|FG003|Observational Phase|Un-specified|0|||
146039506|NCT00098306|526656087|FG004|Observational Phase|Un-specified|0|||
146039507|NCT00098306|526656088|FG005|Observational Phase|Un-specified|7|||
146039508|NCT00098306|526656089|FG006|Observational Phase|Un-specified|4|||
146039509|NCT00077649|526656090|FG000|Overall Study|Adverse Event|5|||
146039510|NCT00077649|526656091|FG001|Overall Study|Adverse Event|1|||
146039511|NCT00077649|526656092|FG002|Overall Study|Adverse Event|7|||
146039512|NCT00077649|526656093|FG003|Overall Study|Adverse Event|9|||
146039513|NCT00077649|526656090|FG000|Overall Study|Lack of Efficacy|5|||
146039514|NCT00077649|526656091|FG001|Overall Study|Lack of Efficacy|3|||
146039515|NCT00077649|526656092|FG002|Overall Study|Lack of Efficacy|3|||
146039516|NCT00077649|526656093|FG003|Overall Study|Lack of Efficacy|2|||
146039517|NCT00077649|526656090|FG000|Overall Study|Withdrawal by Subject|0|||
146039518|NCT00077649|526656091|FG001|Overall Study|Withdrawal by Subject|1|||
146039519|NCT00077649|526656092|FG002|Overall Study|Withdrawal by Subject|1|||
146039520|NCT00077649|526656093|FG003|Overall Study|Withdrawal by Subject|2|||
146039521|NCT00077649|526656090|FG000|Overall Study|Lost to Follow-up|2|||
146039522|NCT00077649|526656091|FG001|Overall Study|Lost to Follow-up|2|||
146039523|NCT00077649|526656092|FG002|Overall Study|Lost to Follow-up|3|||
146039524|NCT00077649|526656093|FG003|Overall Study|Lost to Follow-up|2|||
146039525|NCT00077649|526656090|FG000|Overall Study|Abnormality of Laboratory Test|1|||
146039526|NCT00077649|526656091|FG001|Overall Study|Abnormality of Laboratory Test|2|||
146039527|NCT00077649|526656092|FG002|Overall Study|Abnormality of Laboratory Test|1|||
146039528|NCT00077649|526656093|FG003|Overall Study|Abnormality of Laboratory Test|2|||
146039529|NCT00077649|526656090|FG000|Overall Study|Randomized but never dosed|1|||
146039530|NCT00077649|526656091|FG001|Overall Study|Randomized but never dosed|0|||
146039531|NCT00077649|526656092|FG002|Overall Study|Randomized but never dosed|0|||
146039532|NCT00077649|526656093|FG003|Overall Study|Randomized but never dosed|0|||
146039533|NCT01424228|526656094|FG000|Overall Study|Withdrawal by Subject|27|||
146039534|NCT01424228|526656095|FG001|Overall Study|Withdrawal by Subject|11|||
146039535|NCT01424228|526656094|FG000|Overall Study|Adverse Event|10|||
146039536|NCT01424228|526656095|FG001|Overall Study|Adverse Event|14|||
146039537|NCT01424228|526656094|FG000|Overall Study|Sponsor's decision|9|||
146039538|NCT01424228|526656095|FG001|Overall Study|Sponsor's decision|12|||
146039539|NCT01424228|526656094|FG000|Overall Study|Lack of Efficacy|5|||
146099213|NCT01303861|526884466|FG001|Overall Study|Lack of Efficacy|2|||
146039540|NCT01424228|526656095|FG001|Overall Study|Lack of Efficacy|7|||
146039541|NCT01424228|526656094|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
146039542|NCT01424228|526656095|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
146039543|NCT01424228|526656094|FG000|Overall Study|Non-compliance|2|||
146039544|NCT01424228|526656095|FG001|Overall Study|Non-compliance|0|||
146039545|NCT01424228|526656094|FG000|Overall Study|Worsening of symptoms|1|||
146099214|NCT01303861|526884467|FG002|Overall Study|Lack of Efficacy|1|||
146099215|NCT01303861|526884468|FG003|Overall Study|Lack of Efficacy|0|||
146099216|NCT01303861|526884465|FG000|Overall Study|Withdrawal by Subject|16|||
146099217|NCT01303861|526884466|FG001|Overall Study|Withdrawal by Subject|8|||
146099218|NCT01303861|526884467|FG002|Overall Study|Withdrawal by Subject|8|||
146039546|NCT01424228|526656095|FG001|Overall Study|Worsening of symptoms|0|||
146039547|NCT01424228|526656094|FG000|Overall Study|Unplanned journey|0|||
146039548|NCT01424228|526656095|FG001|Overall Study|Unplanned journey|1|||
146039549|NCT00590577|526656098|FG000|Overall Study|Lack of Efficacy|31|||
146099219|NCT01303861|526884468|FG003|Overall Study|Withdrawal by Subject|23|||
146254501|NCT02256488|527444608|FG003|Overall Study|Withdrawal by Subject|2|||
146254502|NCT00975130|527444609|FG000|Study Part 1|Adverse Event|150|||
146039550|NCT00590577|526656099|FG001|Overall Study|Lack of Efficacy|28|||
146254503|NCT00975130|527444610|FG001|Study Part 1|Adverse Event|0|||
146254504|NCT00975130|527444611|FG002|Study Part 1|Adverse Event|0|||
146039551|NCT00590577|526656100|FG002|Overall Study|Lack of Efficacy|23|||
146039552|NCT00590577|526656101|FG003|Overall Study|Lack of Efficacy|45|||
146039553|NCT00590577|526656098|FG000|Overall Study|Withdrawal by Subject|23|||
146039554|NCT00590577|526656099|FG001|Overall Study|Withdrawal by Subject|28|||
146039555|NCT00590577|526656100|FG002|Overall Study|Withdrawal by Subject|30|||
146039556|NCT00590577|526656101|FG003|Overall Study|Withdrawal by Subject|26|||
146254505|NCT00975130|527444609|FG000|Study Part 1|Lost to Follow-up|19|||
146254506|NCT00975130|527444610|FG001|Study Part 1|Lost to Follow-up|0|||
146099220|NCT01303861|526884465|FG000|Overall Study|Adverse Event|4|||
146099221|NCT01303861|526884466|FG001|Overall Study|Adverse Event|1|||
146099222|NCT01303861|526884467|FG002|Overall Study|Adverse Event|0|||
146099223|NCT01303861|526884468|FG003|Overall Study|Adverse Event|5|||
146099224|NCT01303861|526884465|FG000|Overall Study|Pregnancy|1|||
146099225|NCT01303861|526884466|FG001|Overall Study|Pregnancy|0|||
146099226|NCT01303861|526884467|FG002|Overall Study|Pregnancy|0|||
146099227|NCT01303861|526884468|FG003|Overall Study|Pregnancy|0|||
146099228|NCT03270644|526884472|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
146099229|NCT03270644|526884472|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
146099230|NCT01868503|526884473|FG000|Overall Study|Withdrawal by Subject|1|||
146099231|NCT01868503|526884473|FG000|Overall Study|Protocol Violation|1|||
146099232|NCT02476201|526884478|FG000|Overall Study|Unable to program MPP|9|||
146099233|NCT02476201|526884478|FG000|Overall Study|Study echo not performed|5|||
146099234|NCT02476201|526884478|FG000|Overall Study|Adverse Event|4|||
146099235|NCT02476201|526884478|FG000|Overall Study|Death|2|||
146099236|NCT02476201|526884478|FG000|Overall Study|Lost to Follow-up|2|||
146099237|NCT02476201|526884478|FG000|Overall Study|MPP programmed to OFF|2|||
146099238|NCT02476201|526884478|FG000|Overall Study|Withdrawal by Subject|1|||
146099239|NCT02476201|526884478|FG000|Overall Study|Unsuccessful implant|1|||
146099240|NCT02642029|526884479|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
146039557|NCT00590577|526656098|FG000|Overall Study|Adverse Event|10|||
146039558|NCT00590577|526656099|FG001|Overall Study|Adverse Event|10|||
146039559|NCT00590577|526656100|FG002|Overall Study|Adverse Event|13|||
146039560|NCT00590577|526656101|FG003|Overall Study|Adverse Event|11|||
146039561|NCT00590577|526656098|FG000|Overall Study|Lost to Follow-up|12|||
146039562|NCT00590577|526656099|FG001|Overall Study|Lost to Follow-up|6|||
146039563|NCT00590577|526656100|FG002|Overall Study|Lost to Follow-up|6|||
146039564|NCT00590577|526656101|FG003|Overall Study|Lost to Follow-up|9|||
146039565|NCT00590577|526656098|FG000|Overall Study|Pregnancy|0|||
146039566|NCT00590577|526656099|FG001|Overall Study|Pregnancy|1|||
146039567|NCT00590577|526656100|FG002|Overall Study|Pregnancy|0|||
146039568|NCT00590577|526656101|FG003|Overall Study|Pregnancy|0|||
146039569|NCT00590577|526656098|FG000|Overall Study|Various reasons|1|||
146039570|NCT00590577|526656099|FG001|Overall Study|Various reasons|3|||
146039571|NCT00590577|526656100|FG002|Overall Study|Various reasons|1|||
146039572|NCT00590577|526656101|FG003|Overall Study|Various reasons|2|||
146039573|NCT01300260|526656102|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
146039574|NCT01300260|526656103|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
146039575|NCT01300260|526656102|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
146039576|NCT01300260|526656103|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
146039577|NCT01300260|526656102|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
146039578|NCT01300260|526656103|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
146039579|NCT00235716|526656115|FG000|Overall Study|Death|26|||
146039580|NCT00235716|526656116|FG001|Overall Study|Death|39|||
146039581|NCT00235716|526656117|FG002|Overall Study|Death|32|||
146039582|NCT00235716|526656118|FG003|Overall Study|Death|31|||
146039583|NCT00235716|526656115|FG000|Overall Study|Withdrawal by Subject|23|||
146039584|NCT00235716|526656116|FG001|Overall Study|Withdrawal by Subject|19|||
146039585|NCT00235716|526656117|FG002|Overall Study|Withdrawal by Subject|17|||
146039586|NCT00235716|526656118|FG003|Overall Study|Withdrawal by Subject|18|||
146039587|NCT00235716|526656115|FG000|Overall Study|Lost to Follow-up|12|||
146039588|NCT00235716|526656116|FG001|Overall Study|Lost to Follow-up|7|||
146039589|NCT00235716|526656117|FG002|Overall Study|Lost to Follow-up|14|||
146039590|NCT00235716|526656118|FG003|Overall Study|Lost to Follow-up|10|||
146039591|NCT00235716|526656115|FG000|Overall Study|Adverse Event|1|||
146039592|NCT00235716|526656116|FG001|Overall Study|Adverse Event|1|||
146039593|NCT00235716|526656117|FG002|Overall Study|Adverse Event|1|||
146039594|NCT00235716|526656118|FG003|Overall Study|Adverse Event|0|||
146039595|NCT00235716|526656115|FG000|Overall Study|Physician Decision|0|||
146039596|NCT00235716|526656116|FG001|Overall Study|Physician Decision|1|||
146039597|NCT00235716|526656117|FG002|Overall Study|Physician Decision|1|||
146039598|NCT00235716|526656118|FG003|Overall Study|Physician Decision|3|||
146039599|NCT03238924|526656119|FG000|Overall Study|Withdrawal by Subject|2|||
146039600|NCT03238924|526656120|FG001|Overall Study|Withdrawal by Subject|2|||
146039601|NCT03576716|526656121|FG000|Overall Study|Withdrawal by Subject|0|||
146039602|NCT03576716|526656122|FG001|Overall Study|Withdrawal by Subject|1|||
146039603|NCT02891382|526656123|FG000|Overall Study|Lost to Follow-up|3|||
146099241|NCT02642029|526884480|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146099242|NCT02642029|526884481|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146254507|NCT00975130|527444611|FG002|Study Part 1|Lost to Follow-up|0|||
146039604|NCT02891382|526656124|FG001|Overall Study|Lost to Follow-up|4|||
146039605|NCT02891382|526656125|FG002|Overall Study|Lost to Follow-up|5|||
146039606|NCT02891382|526656126|FG003|Overall Study|Lost to Follow-up|3|||
146039607|NCT02891382|526656127|FG004|Overall Study|Lost to Follow-up|4|||
146099243|NCT02642029|526884482|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146099244|NCT02642029|526884483|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146099245|NCT02642029|526884484|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
146254508|NCT00975130|527444609|FG000|Study Part 1|Withdrawal by Subject|61|||
146254509|NCT00975130|527444610|FG001|Study Part 1|Withdrawal by Subject|0|||
146039608|NCT02516228|526656128|FG000|Overall Study|Lost to Follow-up|1|||
146039609|NCT02516228|526656128|FG000|Overall Study|Withdrawal by Subject|1|||
146039610|NCT02516228|526656128|FG000|Overall Study|Physician Decision|1|||
146039611|NCT03916484|526656129|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146039612|NCT03916484|526656130|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
146039613|NCT03916484|526656131|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146039614|NCT03916484|526656132|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
146039615|NCT03916484|526656129|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
146039616|NCT03916484|526656130|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
146039617|NCT03916484|526656131|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
146039618|NCT03916484|526656132|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
146039619|NCT01990859|526656133|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
146039620|NCT01990859|526656133|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
146039621|NCT02262754|526656134|FG000|Overall Study|Adverse Event|3|||
146039622|NCT02262754|526656135|FG001|Overall Study|Adverse Event|4|||
146039623|NCT02262754|526656136|FG002|Overall Study|Adverse Event|0|||
146039624|NCT02262754|526656134|FG000|Overall Study|Lack of Efficacy|2|||
146039625|NCT02262754|526656135|FG001|Overall Study|Lack of Efficacy|0|||
146039626|NCT02262754|526656136|FG002|Overall Study|Lack of Efficacy|1|||
146039627|NCT02262754|526656134|FG000|Overall Study|Lost to Follow-up|0|||
146039628|NCT02262754|526656135|FG001|Overall Study|Lost to Follow-up|0|||
146039629|NCT02262754|526656136|FG002|Overall Study|Lost to Follow-up|1|||
146039630|NCT02262754|526656134|FG000|Overall Study|No longer meets eligibility criteria|0|||
146039631|NCT02262754|526656135|FG001|Overall Study|No longer meets eligibility criteria|1|||
146039632|NCT02262754|526656136|FG002|Overall Study|No longer meets eligibility criteria|0|||
146039633|NCT02262754|526656134|FG000|Overall Study|Study terminated by sponsor|5|||
146039634|NCT02262754|526656135|FG001|Overall Study|Study terminated by sponsor|4|||
146039635|NCT02262754|526656136|FG002|Overall Study|Study terminated by sponsor|4|||
146039636|NCT02262754|526656134|FG000|Overall Study|Protocol Violation|1|||
146039637|NCT02262754|526656135|FG001|Overall Study|Protocol Violation|0|||
146039638|NCT02262754|526656136|FG002|Overall Study|Protocol Violation|0|||
146039639|NCT02262754|526656134|FG000|Overall Study|Withdrawal by Subject|1|||
146039640|NCT02262754|526656135|FG001|Overall Study|Withdrawal by Subject|0|||
146039641|NCT02262754|526656136|FG002|Overall Study|Withdrawal by Subject|1|||
146039642|NCT02262754|526656134|FG000|Overall Study|Other|4|||
146039643|NCT02262754|526656135|FG001|Overall Study|Other|0|||
146039644|NCT02262754|526656136|FG002|Overall Study|Other|2|||
146039645|NCT04079114|526656139|FG000|Overall Study|Study prematuely terminated.|166|||
146039646|NCT00629798|526656144|FG000|Overall Study|Not Treated|4|||
146039647|NCT02554981|526656145|FG000|Overall Study|Adverse Event|1|||
146039648|NCT02554981|526656145|FG000|Overall Study|Administrative Reasons|1|||
146039649|NCT02554981|526656145|FG000|Overall Study|Other Miscellaneous Reasons|3|||
146039650|NCT02292706|526656148|FG000|Overall Study|Lost to Follow-up|20|||
146039651|NCT02292706|526656149|FG001|Overall Study|Lost to Follow-up|44|||
146039652|NCT02292706|526656150|FG002|Overall Study|Lost to Follow-up|24|||
146039653|NCT02292706|526656151|FG003|Overall Study|Lost to Follow-up|61|||
146039654|NCT02292706|526656152|FG004|Overall Study|Lost to Follow-up|21|||
146039655|NCT02292706|526656153|FG005|Overall Study|Lost to Follow-up|52|||
146039656|NCT02292706|526656154|FG006|Overall Study|Lost to Follow-up|25|||
146039657|NCT02292706|526656155|FG007|Overall Study|Lost to Follow-up|0|||
146039658|NCT02292706|526656148|FG000|Overall Study|Withdrew consent|15|||
146039659|NCT02292706|526656149|FG001|Overall Study|Withdrew consent|56|||
146039660|NCT02292706|526656150|FG002|Overall Study|Withdrew consent|43|||
146039661|NCT02292706|526656151|FG003|Overall Study|Withdrew consent|36|||
146039662|NCT02292706|526656152|FG004|Overall Study|Withdrew consent|13|||
146039663|NCT02292706|526656153|FG005|Overall Study|Withdrew consent|51|||
146039664|NCT02292706|526656154|FG006|Overall Study|Withdrew consent|20|||
146039665|NCT02292706|526656155|FG007|Overall Study|Withdrew consent|0|||
146039666|NCT02292706|526656148|FG000|Overall Study|Death|3|||
146039667|NCT02292706|526656149|FG001|Overall Study|Death|11|||
146039668|NCT02292706|526656150|FG002|Overall Study|Death|16|||
146039669|NCT02292706|526656151|FG003|Overall Study|Death|22|||
146039670|NCT02292706|526656152|FG004|Overall Study|Death|8|||
146039671|NCT02292706|526656153|FG005|Overall Study|Death|17|||
146039672|NCT02292706|526656154|FG006|Overall Study|Death|3|||
146039673|NCT02292706|526656155|FG007|Overall Study|Death|0|||
146039674|NCT02292706|526656148|FG000|Overall Study|Study terminated by sponsor|0|||
146039675|NCT02292706|526656149|FG001|Overall Study|Study terminated by sponsor|9|||
146039676|NCT02292706|526656150|FG002|Overall Study|Study terminated by sponsor|4|||
146039677|NCT02292706|526656151|FG003|Overall Study|Study terminated by sponsor|21|||
146039678|NCT02292706|526656152|FG004|Overall Study|Study terminated by sponsor|11|||
146039679|NCT02292706|526656153|FG005|Overall Study|Study terminated by sponsor|13|||
146039680|NCT02292706|526656154|FG006|Overall Study|Study terminated by sponsor|3|||
146039681|NCT02292706|526656155|FG007|Overall Study|Study terminated by sponsor|0|||
146039682|NCT02292706|526656148|FG000|Overall Study|Investigator's discretion|4|||
146039683|NCT02292706|526656149|FG001|Overall Study|Investigator's discretion|9|||
146099246|NCT02642029|526884479|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146099247|NCT02642029|526884480|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
146099248|NCT02642029|526884481|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146099249|NCT02642029|526884482|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146099250|NCT02642029|526884483|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146099251|NCT02642029|526884484|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
146099252|NCT02642029|526884479|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146099253|NCT02642029|526884480|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146099254|NCT02642029|526884481|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146099255|NCT02642029|526884482|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146099256|NCT02642029|526884483|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
146099257|NCT02642029|526884484|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
146099258|NCT02642029|526884479|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
146099259|NCT02642029|526884480|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
146099260|NCT02642029|526884481|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
146099261|NCT02642029|526884482|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
146099262|NCT02642029|526884483|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
146099263|NCT02642029|526884484|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
146099264|NCT02642029|526884479|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
146099265|NCT02642029|526884480|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146099266|NCT02642029|526884481|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146099267|NCT02642029|526884482|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146099268|NCT02642029|526884483|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146099269|NCT02642029|526884484|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
146099270|NCT02642029|526884479|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
146099271|NCT02642029|526884480|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146099272|NCT02642029|526884481|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146099273|NCT02642029|526884482|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146099274|NCT02642029|526884483|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146099275|NCT02642029|526884484|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
146099276|NCT00691301|526884485|FG000|Overall Study|Adverse Event|10|||
146099277|NCT00691301|526884485|FG000|Overall Study|Death|2|||
146099278|NCT00691301|526884485|FG000|Overall Study|Lack of Efficacy|32|||
146099279|NCT00691301|526884485|FG000|Overall Study|Withdrawal by Subject|4|||
146099280|NCT00691301|526884485|FG000|Overall Study|Concurrent illness|2|||
146099281|NCT00691301|526884485|FG000|Overall Study|other reason|3|||
146099282|NCT00691301|526884485|FG000|Overall Study|Did not initiate study treatment|1|||
146099283|NCT01823146|526884486|FG000|Overall Study|Withdrawal by Subject|0|||
146099284|NCT01823146|526884487|FG001|Overall Study|Withdrawal by Subject|1|||
146099285|NCT01823146|526884486|FG000|Overall Study|Lost to Follow-up|2|||
146099286|NCT01823146|526884487|FG001|Overall Study|Lost to Follow-up|1|||
146099287|NCT00463580|526884489|FG000|Overall Study|Lost to Follow-up|1|||
146099288|NCT00463580|526884490|FG001|Overall Study|Lost to Follow-up|0|||
146099289|NCT00463580|526884489|FG000|Overall Study|Schedule conflict|2|||
146099290|NCT00463580|526884490|FG001|Overall Study|Schedule conflict|0|||
146099291|NCT00463580|526884489|FG000|Overall Study|Medical/psychiatric complications|0|||
146099292|NCT00463580|526884490|FG001|Overall Study|Medical/psychiatric complications|2|||
146099293|NCT03917459|526884491|FG000|Overall Study|Adverse Event|1|||
146099294|NCT03917459|526884492|FG001|Overall Study|Adverse Event|0|||
146099295|NCT03917459|526884491|FG000|Overall Study|Withdrawal by Subject|0|||
146099296|NCT03917459|526884492|FG001|Overall Study|Withdrawal by Subject|1|||
146099297|NCT00736944|526884493|FG000|Induction|Death|1|||
146099298|NCT00736944|526884493|FG000|Definitive Treatment|Physician Decision|1|||
146099299|NCT00676338|526884494|FG000|Overall Study|Adverse Event|6|||
146099300|NCT00676338|526884495|FG001|Overall Study|Adverse Event|6|||
146099301|NCT00676338|526884496|FG002|Overall Study|Adverse Event|5|||
146254510|NCT00975130|527444611|FG002|Study Part 1|Withdrawal by Subject|0|||
146254511|NCT00975130|527444609|FG000|Study Part 1|Protocol Violation|13|||
146254512|NCT00975130|527444610|FG001|Study Part 1|Protocol Violation|0|||
146254513|NCT00975130|527444611|FG002|Study Part 1|Protocol Violation|0|||
146254514|NCT00975130|527444609|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
146254515|NCT00975130|527444610|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
146254516|NCT00975130|527444611|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
146254517|NCT00975130|527444609|FG000|Study Part 1|Administrative|4|||
146300583|NCT00283049|527617053|FG001|Overall Study|Discontinuation of Study|16|||
146300584|NCT00283049|527617054|FG002|Overall Study|Discontinuation of Study|20|||
146099302|NCT00676338|526884497|FG003|Overall Study|Adverse Event|1|||
146254518|NCT00975130|527444610|FG001|Study Part 1|Administrative|0|||
146254519|NCT00975130|527444611|FG002|Study Part 1|Administrative|0|||
146254520|NCT00975130|527444609|FG000|Study Part 1|Withdrew Consent|24|||
146254521|NCT00975130|527444610|FG001|Study Part 1|Withdrew Consent|0|||
146039684|NCT02292706|526656150|FG002|Overall Study|Investigator's discretion|7|||
146039685|NCT02292706|526656151|FG003|Overall Study|Investigator's discretion|11|||
146039686|NCT02292706|526656152|FG004|Overall Study|Investigator's discretion|4|||
146039687|NCT02292706|526656153|FG005|Overall Study|Investigator's discretion|10|||
146039688|NCT02292706|526656154|FG006|Overall Study|Investigator's discretion|1|||
146039689|NCT02292706|526656155|FG007|Overall Study|Investigator's discretion|0|||
146039690|NCT02292706|526656148|FG000|Overall Study|Liver transplant|1|||
146039691|NCT02292706|526656149|FG001|Overall Study|Liver transplant|1|||
146039692|NCT02292706|526656150|FG002|Overall Study|Liver transplant|11|||
146039693|NCT02292706|526656151|FG003|Overall Study|Liver transplant|16|||
146039694|NCT02292706|526656152|FG004|Overall Study|Liver transplant|5|||
146039695|NCT02292706|526656153|FG005|Overall Study|Liver transplant|6|||
146039696|NCT02292706|526656154|FG006|Overall Study|Liver transplant|5|||
146039697|NCT02292706|526656155|FG007|Overall Study|Liver transplant|0|||
146039698|NCT02292706|526656148|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
146039699|NCT02292706|526656149|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
146039700|NCT02292706|526656150|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
146039701|NCT02292706|526656151|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
146039702|NCT02292706|526656152|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
146039703|NCT02292706|526656153|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
146039704|NCT02292706|526656154|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
146039705|NCT02292706|526656155|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
146039706|NCT02292706|526656148|FG000|Overall Study|Subject terminated by sponsor|1|||
146039707|NCT02292706|526656149|FG001|Overall Study|Subject terminated by sponsor|0|||
146039708|NCT02292706|526656150|FG002|Overall Study|Subject terminated by sponsor|0|||
146039709|NCT02292706|526656151|FG003|Overall Study|Subject terminated by sponsor|2|||
146039710|NCT02292706|526656152|FG004|Overall Study|Subject terminated by sponsor|1|||
146039711|NCT02292706|526656153|FG005|Overall Study|Subject terminated by sponsor|0|||
146039712|NCT02292706|526656154|FG006|Overall Study|Subject terminated by sponsor|0|||
146039713|NCT02292706|526656155|FG007|Overall Study|Subject terminated by sponsor|0|||
146039714|NCT02292706|526656148|FG000|Overall Study|Missing|0|||
146039715|NCT02292706|526656149|FG001|Overall Study|Missing|0|||
146039716|NCT02292706|526656150|FG002|Overall Study|Missing|1|||
146039717|NCT02292706|526656151|FG003|Overall Study|Missing|1|||
146039718|NCT02292706|526656152|FG004|Overall Study|Missing|0|||
146039719|NCT02292706|526656153|FG005|Overall Study|Missing|1|||
146039720|NCT02292706|526656154|FG006|Overall Study|Missing|0|||
146039721|NCT02292706|526656155|FG007|Overall Study|Missing|0|||
146039722|NCT02292706|526656148|FG000|Overall Study|Virologic relapse or reinfection|1|||
146039723|NCT02292706|526656149|FG001|Overall Study|Virologic relapse or reinfection|0|||
146039724|NCT02292706|526656150|FG002|Overall Study|Virologic relapse or reinfection|0|||
146039725|NCT02292706|526656151|FG003|Overall Study|Virologic relapse or reinfection|1|||
146039726|NCT02292706|526656152|FG004|Overall Study|Virologic relapse or reinfection|0|||
146039727|NCT02292706|526656153|FG005|Overall Study|Virologic relapse or reinfection|1|||
146039728|NCT02292706|526656154|FG006|Overall Study|Virologic relapse or reinfection|0|||
146039729|NCT02292706|526656155|FG007|Overall Study|Virologic relapse or reinfection|0|||
146039730|NCT01990612|526656158|FG000|Overall Study|Lost to Follow-up|2|||
146039731|NCT01990612|526656159|FG001|Overall Study|Lost to Follow-up|1|||
146039732|NCT01990612|526656158|FG000|Overall Study|Withdrawal by Subject|5|||
146039733|NCT01990612|526656159|FG001|Overall Study|Withdrawal by Subject|2|||
146039734|NCT02725866|526656160|FG000|Overall Study|Failure to return|6|||
146039735|NCT02725866|526656160|FG000|Overall Study|Withdrew consent|3|||
146039736|NCT02725866|526656160|FG000|Overall Study|Insufficient virological response|1|||
146039737|NCT02725866|526656160|FG000|Overall Study|Other, not specified|4|||
146039738|NCT02188849|526656163|FG000|Overall Study|Lost to Follow-up|3|||
146039739|NCT02188849|526656164|FG001|Overall Study|Lost to Follow-up|8|||
146039740|NCT00812565|526656168|FG000|Overall Study|Did Not Receive Study Medication|1|||
146039741|NCT00812565|526656169|FG001|Overall Study|Did Not Receive Study Medication|1|||
146039742|NCT00812565|526656170|FG002|Overall Study|Did Not Receive Study Medication|0|||
146039743|NCT00812565|526656171|FG003|Overall Study|Did Not Receive Study Medication|0|||
146039744|NCT00812565|526656172|FG004|Overall Study|Did Not Receive Study Medication|0|||
146039745|NCT00812565|526656173|FG005|Overall Study|Did Not Receive Study Medication|0|||
146039746|NCT00812565|526656174|FG006|Overall Study|Did Not Receive Study Medication|0|||
146039747|NCT00812565|526656175|FG007|Overall Study|Did Not Receive Study Medication|0|||
146039748|NCT00812565|526656168|FG000|Overall Study|Adverse Event|0|||
146039749|NCT00812565|526656169|FG001|Overall Study|Adverse Event|0|||
146039750|NCT00812565|526656170|FG002|Overall Study|Adverse Event|0|||
146039751|NCT00812565|526656171|FG003|Overall Study|Adverse Event|2|||
146039752|NCT00812565|526656172|FG004|Overall Study|Adverse Event|0|||
146039753|NCT00812565|526656173|FG005|Overall Study|Adverse Event|0|||
146039754|NCT00812565|526656174|FG006|Overall Study|Adverse Event|0|||
146039755|NCT00812565|526656175|FG007|Overall Study|Adverse Event|1|||
146039756|NCT00812565|526656168|FG000|Overall Study|Did Not Come to Study Visit|1|||
146039757|NCT00812565|526656169|FG001|Overall Study|Did Not Come to Study Visit|0|||
146039758|NCT00812565|526656170|FG002|Overall Study|Did Not Come to Study Visit|0|||
146039759|NCT00812565|526656171|FG003|Overall Study|Did Not Come to Study Visit|0|||
146039760|NCT00812565|526656172|FG004|Overall Study|Did Not Come to Study Visit|0|||
146039761|NCT00812565|526656173|FG005|Overall Study|Did Not Come to Study Visit|0|||
146039762|NCT00812565|526656174|FG006|Overall Study|Did Not Come to Study Visit|0|||
146039763|NCT00812565|526656175|FG007|Overall Study|Did Not Come to Study Visit|0|||
146039764|NCT00812565|526656168|FG000|Overall Study|Withdrawal of Consent|1|||
146039765|NCT00812565|526656169|FG001|Overall Study|Withdrawal of Consent|0|||
146039766|NCT00812565|526656170|FG002|Overall Study|Withdrawal of Consent|0|||
146039767|NCT00812565|526656171|FG003|Overall Study|Withdrawal of Consent|0|||
146039768|NCT00812565|526656172|FG004|Overall Study|Withdrawal of Consent|1|||
146039769|NCT00812565|526656173|FG005|Overall Study|Withdrawal of Consent|0|||
146039770|NCT00812565|526656174|FG006|Overall Study|Withdrawal of Consent|0|||
146039771|NCT00812565|526656175|FG007|Overall Study|Withdrawal of Consent|0|||
146039772|NCT00812565|526656168|FG000|Overall Study|Reason Not Specified|0|||
146039773|NCT00812565|526656169|FG001|Overall Study|Reason Not Specified|0|||
146039774|NCT00812565|526656170|FG002|Overall Study|Reason Not Specified|0|||
146039775|NCT00812565|526656171|FG003|Overall Study|Reason Not Specified|0|||
146039776|NCT00812565|526656172|FG004|Overall Study|Reason Not Specified|0|||
146039777|NCT00812565|526656173|FG005|Overall Study|Reason Not Specified|1|||
146039778|NCT00812565|526656174|FG006|Overall Study|Reason Not Specified|0|||
146039779|NCT00812565|526656175|FG007|Overall Study|Reason Not Specified|0|||
146039780|NCT01345669|526656176|FG000|Overall Study|Primary tumour recurrence|53|||
146039781|NCT01345669|526656177|FG001|Overall Study|Primary tumour recurrence|32|||
146039782|NCT01345669|526656176|FG000|Overall Study|Second primary tumour|4|||
146039783|NCT01345669|526656177|FG001|Overall Study|Second primary tumour|3|||
146039784|NCT01345669|526656176|FG000|Overall Study|Adverse Event|63|||
146039785|NCT01345669|526656177|FG001|Overall Study|Adverse Event|9|||
146039786|NCT01345669|526656176|FG000|Overall Study|Protocol Violation|3|||
146039787|NCT01345669|526656177|FG001|Overall Study|Protocol Violation|1|||
146039788|NCT01345669|526656176|FG000|Overall Study|Lost to Follow-up|1|||
146039789|NCT01345669|526656177|FG001|Overall Study|Lost to Follow-up|1|||
146039790|NCT01345669|526656176|FG000|Overall Study|Withdrawal by Subject|52|||
146039791|NCT01345669|526656177|FG001|Overall Study|Withdrawal by Subject|13|||
146039792|NCT01345669|526656176|FG000|Overall Study|Other Reasons|111|||
146039793|NCT01345669|526656177|FG001|Overall Study|Other Reasons|60|||
146039794|NCT01793883|526656178|FG000|Overall Study|Withdrawal by Subject|3|||
146039795|NCT01793883|526656179|FG001|Overall Study|Withdrawal by Subject|7|||
146039796|NCT01793883|526656180|FG002|Overall Study|Withdrawal by Subject|3|||
146039797|NCT01793883|526656178|FG000|Overall Study|Subject noncompliance|0|||
146039798|NCT01793883|526656179|FG001|Overall Study|Subject noncompliance|1|||
146039799|NCT01793883|526656180|FG002|Overall Study|Subject noncompliance|1|||
146039800|NCT01793883|526656178|FG000|Overall Study|Lost to Follow-up|5|||
146039801|NCT01793883|526656179|FG001|Overall Study|Lost to Follow-up|1|||
146039802|NCT01793883|526656180|FG002|Overall Study|Lost to Follow-up|3|||
146039803|NCT01793883|526656178|FG000|Overall Study|Randomized in error|1|||
146039804|NCT01793883|526656179|FG001|Overall Study|Randomized in error|0|||
146039805|NCT01793883|526656180|FG002|Overall Study|Randomized in error|0|||
146039806|NCT01793883|526656178|FG000|Overall Study|Unable to complete spriometry|1|||
146039807|NCT01793883|526656179|FG001|Overall Study|Unable to complete spriometry|0|||
146039808|NCT01793883|526656180|FG002|Overall Study|Unable to complete spriometry|0|||
146039809|NCT01793883|526656178|FG000|Overall Study|Unable to complete measurements|1|||
146039810|NCT01793883|526656179|FG001|Overall Study|Unable to complete measurements|0|||
146039811|NCT01793883|526656180|FG002|Overall Study|Unable to complete measurements|0|||
146039812|NCT01793883|526656178|FG000|Overall Study|Met exclusion criteria|1|||
146039813|NCT01793883|526656179|FG001|Overall Study|Met exclusion criteria|0|||
146039814|NCT01793883|526656180|FG002|Overall Study|Met exclusion criteria|0|||
146039815|NCT01793883|526656178|FG000|Overall Study|Dosing error|0|||
146039816|NCT01793883|526656179|FG001|Overall Study|Dosing error|1|||
146039817|NCT01793883|526656180|FG002|Overall Study|Dosing error|0|||
146039818|NCT01793883|526656178|FG000|Overall Study|Respiratory distress during spirometry|0|||
146039819|NCT01793883|526656179|FG001|Overall Study|Respiratory distress during spirometry|0|||
146039820|NCT01793883|526656180|FG002|Overall Study|Respiratory distress during spirometry|1|||
146039821|NCT00895310|526656183|FG000|Overall Study|Withdrawal by Subject|1|||
146039822|NCT00659230|526656184|FG000|Overall Study|Lost to Follow-up|2|||
146039823|NCT00659230|526656185|FG001|Overall Study|Lost to Follow-up|5|||
146039824|NCT00659230|526656184|FG000|Overall Study|Lost source documentation|5|||
146254522|NCT00975130|527444611|FG002|Study Part 1|Withdrew Consent|0|||
146039825|NCT00659230|526656185|FG001|Overall Study|Lost source documentation|4|||
146039826|NCT00659230|526656184|FG000|Overall Study|Did not return post-randomization|2|||
146039827|NCT00659230|526656185|FG001|Overall Study|Did not return post-randomization|3|||
146039828|NCT00547521|526656186|FG000|Short Term Study (4 Months)|Adverse Event|1|||
146039829|NCT00547521|526656187|FG001|Short Term Study (4 Months)|Adverse Event|0|||
146039830|NCT00547521|526656186|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
146254523|NCT00975130|527444609|FG000|Study Part 2|Adverse Event|0|||
146254524|NCT00975130|527444610|FG001|Study Part 2|Adverse Event|14|||
146254525|NCT00975130|527444611|FG002|Study Part 2|Adverse Event|7|||
146099303|NCT00676338|526884494|FG000|Overall Study|Lost to Follow-up|4|||
146099304|NCT00676338|526884495|FG001|Overall Study|Lost to Follow-up|1|||
146099305|NCT00676338|526884496|FG002|Overall Study|Lost to Follow-up|3|||
146099306|NCT00676338|526884497|FG003|Overall Study|Lost to Follow-up|4|||
146099307|NCT00676338|526884494|FG000|Overall Study|Physician Decision|3|||
146099308|NCT00676338|526884495|FG001|Overall Study|Physician Decision|3|||
146039831|NCT00547521|526656187|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
146039832|NCT00547521|526656186|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
146039833|NCT00547521|526656187|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
146039834|NCT00547521|526656186|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
146039835|NCT00547521|526656187|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
146039836|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
146039837|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
146039838|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
146039839|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
146039840|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
146039841|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
146039842|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
146039843|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
146039844|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Other|0|||
146039845|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Other|2|||
146039846|NCT00547521|526656186|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
146039847|NCT00547521|526656187|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
146039848|NCT05066165|526657941|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
146039849|NCT05066165|526657942|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
146039850|NCT05066165|526657941|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
146039851|NCT05066165|526657942|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
146039852|NCT02454478|526657946|FG000|Overall Study|Incomplete DLT Evaluation|1|||
146039853|NCT01959841|526657953|FG000|Overall Study|Adverse Event|1|||
146039854|NCT01959841|526657954|FG001|Overall Study|Adverse Event|3|||
146039855|NCT01959841|526657955|FG002|Overall Study|Adverse Event|2|||
146039856|NCT01959841|526657953|FG000|Overall Study|Lack of Efficacy|5|||
146039857|NCT01959841|526657954|FG001|Overall Study|Lack of Efficacy|0|||
146039858|NCT01959841|526657955|FG002|Overall Study|Lack of Efficacy|0|||
146039859|NCT01959841|526657953|FG000|Overall Study|Lost to Follow-up|1|||
146039860|NCT01959841|526657954|FG001|Overall Study|Lost to Follow-up|1|||
146039861|NCT01959841|526657955|FG002|Overall Study|Lost to Follow-up|0|||
146039862|NCT01959841|526657953|FG000|Overall Study|Physician Decision|0|||
146039863|NCT01959841|526657954|FG001|Overall Study|Physician Decision|2|||
146039864|NCT01959841|526657955|FG002|Overall Study|Physician Decision|3|||
146039865|NCT01959841|526657953|FG000|Overall Study|Protocol Violation|16|||
146039866|NCT01959841|526657954|FG001|Overall Study|Protocol Violation|23|||
146039867|NCT01959841|526657955|FG002|Overall Study|Protocol Violation|16|||
146039868|NCT01959841|526657953|FG000|Overall Study|Withdrawal by Subject|7|||
146039869|NCT01959841|526657954|FG001|Overall Study|Withdrawal by Subject|7|||
146039870|NCT01959841|526657955|FG002|Overall Study|Withdrawal by Subject|5|||
146039871|NCT01959841|526657953|FG000|Overall Study|Clinical laboratory value|2|||
146039872|NCT01959841|526657954|FG001|Overall Study|Clinical laboratory value|6|||
146039873|NCT01959841|526657955|FG002|Overall Study|Clinical laboratory value|6|||
146039874|NCT01959841|526657953|FG000|Overall Study|Platelet count below on day1 or 4|11|||
146039875|NCT01959841|526657954|FG001|Overall Study|Platelet count below on day1 or 4|15|||
146039876|NCT01959841|526657955|FG002|Overall Study|Platelet count below on day1 or 4|11|||
146039877|NCT00780416|526657957|FG000|Overall Study|Physician Decision|3|||
146039878|NCT00780416|526657958|FG001|Overall Study|Physician Decision|3|||
146039879|NCT00780416|526657957|FG000|Overall Study|Protocol Violation|1|||
146039880|NCT00780416|526657958|FG001|Overall Study|Protocol Violation|0|||
146039881|NCT00780416|526657957|FG000|Overall Study|Withdrawal by Subject|8|||
146039882|NCT00780416|526657958|FG001|Overall Study|Withdrawal by Subject|6|||
146039883|NCT00666224|526657961|FG000|Double-Blind|Adverse Event|15|||
146099309|NCT00676338|526884496|FG002|Overall Study|Physician Decision|2|||
146099310|NCT00676338|526884497|FG003|Overall Study|Physician Decision|3|||
146099311|NCT00676338|526884494|FG000|Overall Study|Protocol Violation|5|||
146099312|NCT00676338|526884495|FG001|Overall Study|Protocol Violation|9|||
146099313|NCT00676338|526884496|FG002|Overall Study|Protocol Violation|2|||
146099314|NCT00676338|526884497|FG003|Overall Study|Protocol Violation|5|||
146099315|NCT00676338|526884494|FG000|Overall Study|Withdrawal by Subject|17|||
146039884|NCT00666224|526657962|FG001|Double-Blind|Adverse Event|5|||
146039885|NCT00666224|526657961|FG000|Double-Blind|Lost to Follow-up|2|||
146039886|NCT00666224|526657962|FG001|Double-Blind|Lost to Follow-up|2|||
146039887|NCT00666224|526657961|FG000|Double-Blind|Withdrawal by Subject|18|||
146039888|NCT00666224|526657962|FG001|Double-Blind|Withdrawal by Subject|14|||
146039889|NCT00666224|526657961|FG000|Double-Blind|Physician Decision|0|||
146039890|NCT00666224|526657962|FG001|Double-Blind|Physician Decision|3|||
146039891|NCT00666224|526657961|FG000|Double-Blind|Sponsor decision|1|||
146099316|NCT00676338|526884495|FG001|Overall Study|Withdrawal by Subject|9|||
146039892|NCT00666224|526657962|FG001|Double-Blind|Sponsor decision|0|||
146039893|NCT00666224|526657961|FG000|Double-Blind|Pregnancy|3|||
146039894|NCT00666224|526657962|FG001|Double-Blind|Pregnancy|2|||
146039895|NCT00666224|526657961|FG000|Double-Blind|Noncompliance|1|||
146254526|NCT00975130|527444609|FG000|Study Part 2|Lost to Follow-up|0|||
146254527|NCT00975130|527444610|FG001|Study Part 2|Lost to Follow-up|0|||
146254528|NCT00975130|527444611|FG002|Study Part 2|Lost to Follow-up|1|||
146254529|NCT00975130|527444609|FG000|Study Part 2|Withdrawal by Subject|0|||
146039896|NCT00666224|526657962|FG001|Double-Blind|Noncompliance|0|||
146039897|NCT00666224|526657961|FG000|Double-Blind|Death|1|||
146039898|NCT00666224|526657962|FG001|Double-Blind|Death|0|||
146039899|NCT00666224|526657961|FG000|Double-Blind|Undefined/Unknown|4|||
146039900|NCT00666224|526657962|FG001|Double-Blind|Undefined/Unknown|1|||
146039901|NCT00666224|526657961|FG000|Open-Label|Adverse Event|8|||
146039902|NCT00666224|526657962|FG001|Open-Label|Adverse Event|43|||
146039903|NCT00666224|526657961|FG000|Open-Label|Lost to Follow-up|4|||
146039904|NCT00666224|526657962|FG001|Open-Label|Lost to Follow-up|5|||
146039905|NCT00666224|526657961|FG000|Open-Label|Withdrawal by Subject|12|||
146039906|NCT00666224|526657962|FG001|Open-Label|Withdrawal by Subject|25|||
146039907|NCT00666224|526657961|FG000|Open-Label|Physician Decision|7|||
146039908|NCT00666224|526657962|FG001|Open-Label|Physician Decision|5|||
146039909|NCT00666224|526657961|FG000|Open-Label|Pregnancy|1|||
146039910|NCT00666224|526657962|FG001|Open-Label|Pregnancy|5|||
146039911|NCT00666224|526657961|FG000|Open-Label|Noncompliance|2|||
146039912|NCT00666224|526657962|FG001|Open-Label|Noncompliance|1|||
146039913|NCT00666224|526657961|FG000|Open-Label|Undefined/Unknown|1|||
146039914|NCT00666224|526657962|FG001|Open-Label|Undefined/Unknown|1|||
146039915|NCT03521141|526657972|FG000|Overall Study|Death|1|||
146039916|NCT03521141|526657973|FG001|Overall Study|Death|0|||
146039917|NCT03521141|526657974|FG002|Overall Study|Death|1|||
146039918|NCT00655629|526657982|FG000|Overall Study|Adverse Event|4|||
146039919|NCT00655629|526657983|FG001|Overall Study|Adverse Event|1|||
146039920|NCT00655629|526657982|FG000|Overall Study|Lack of Efficacy|2|||
146039921|NCT00655629|526657983|FG001|Overall Study|Lack of Efficacy|12|||
146039922|NCT00655629|526657982|FG000|Overall Study|Lost to Follow-up|4|||
146039923|NCT00655629|526657983|FG001|Overall Study|Lost to Follow-up|3|||
146039924|NCT00655629|526657982|FG000|Overall Study|Protocol Violation|5|||
146099317|NCT00676338|526884496|FG002|Overall Study|Withdrawal by Subject|12|||
146099318|NCT00676338|526884497|FG003|Overall Study|Withdrawal by Subject|6|||
146099319|NCT00676338|526884494|FG000|Overall Study|Entry Criteria Not Met|0|||
146099320|NCT00676338|526884495|FG001|Overall Study|Entry Criteria Not Met|2|||
146099321|NCT00676338|526884496|FG002|Overall Study|Entry Criteria Not Met|1|||
146099322|NCT00676338|526884497|FG003|Overall Study|Entry Criteria Not Met|1|||
146099323|NCT00676338|526884494|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146099324|NCT00676338|526884495|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146099325|NCT00676338|526884496|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
146099326|NCT00676338|526884497|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
146099327|NCT00412542|526884498|FG000|Overall Study|Withdrawal by Subject|0|||
146099328|NCT00412542|526884499|FG001|Overall Study|Withdrawal by Subject|2|||
146099329|NCT00412542|526884498|FG000|Overall Study|Not Eligible|0|||
146099330|NCT00412542|526884499|FG001|Overall Study|Not Eligible|1|||
146099331|NCT00075218|526884500|FG000|Double-Blind Treatment|Adverse Event|23|||
146099332|NCT00075218|526884501|FG001|Double-Blind Treatment|Adverse Event|4|||
146099333|NCT00075218|526884502|FG002|Double-Blind Treatment|Adverse Event|0|||
146099334|NCT00075218|526884500|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
146099335|NCT00075218|526884501|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
146099336|NCT00075218|526884502|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
146099337|NCT00075218|526884500|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
146099338|NCT00075218|526884501|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
146254530|NCT00975130|527444610|FG001|Study Part 2|Withdrawal by Subject|13|||
146254531|NCT00975130|527444611|FG002|Study Part 2|Withdrawal by Subject|5|||
146254532|NCT00975130|527444609|FG000|Study Part 2|Withdrew Consent|0|||
146254533|NCT00975130|527444610|FG001|Study Part 2|Withdrew Consent|6|||
146039925|NCT00655629|526657983|FG001|Overall Study|Protocol Violation|3|||
146039926|NCT00655629|526657982|FG000|Overall Study|consent withdrawn|6|||
146039927|NCT00655629|526657983|FG001|Overall Study|consent withdrawn|4|||
146039928|NCT01610336|526657984|FG000|Overall Study|Progressive Disease|4|||
146039929|NCT01610336|526657985|FG001|Overall Study|Progressive Disease|6|||
146039930|NCT01610336|526657986|FG002|Overall Study|Progressive Disease|6|||
146039931|NCT01610336|526657987|FG003|Overall Study|Progressive Disease|5|||
146099339|NCT00075218|526884502|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
146099340|NCT00075218|526884500|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
146099341|NCT00075218|526884501|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
146254534|NCT00975130|527444611|FG002|Study Part 2|Withdrew Consent|2|||
146254535|NCT00975130|527444609|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
146039932|NCT01610336|526657988|FG004|Overall Study|Progressive Disease|3|||
146039933|NCT01610336|526657989|FG005|Overall Study|Progressive Disease|10|||
146039934|NCT01610336|526657990|FG006|Overall Study|Progressive Disease|1|||
146039935|NCT01610336|526657991|FG007|Overall Study|Progressive Disease|6|||
146254536|NCT00975130|527444610|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
146254537|NCT00975130|527444611|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
146254538|NCT00975130|527444609|FG000|Study Part 2|Administrative|0|||
146254539|NCT00975130|527444610|FG001|Study Part 2|Administrative|1|||
146039936|NCT01610336|526657992|FG008|Overall Study|Progressive Disease|6|||
146039937|NCT01610336|526657993|FG009|Overall Study|Progressive Disease|40|||
146039938|NCT01610336|526657994|FG010|Overall Study|Progressive Disease|36|||
146039939|NCT01610336|526657984|FG000|Overall Study|Adverse Event|0|||
146039940|NCT01610336|526657985|FG001|Overall Study|Adverse Event|0|||
146039941|NCT01610336|526657986|FG002|Overall Study|Adverse Event|0|||
146039942|NCT01610336|526657987|FG003|Overall Study|Adverse Event|1|||
146039943|NCT01610336|526657988|FG004|Overall Study|Adverse Event|1|||
146039944|NCT01610336|526657989|FG005|Overall Study|Adverse Event|1|||
146039945|NCT01610336|526657990|FG006|Overall Study|Adverse Event|0|||
146039946|NCT01610336|526657991|FG007|Overall Study|Adverse Event|0|||
146039947|NCT01610336|526657992|FG008|Overall Study|Adverse Event|2|||
146039948|NCT01610336|526657993|FG009|Overall Study|Adverse Event|8|||
146039949|NCT01610336|526657994|FG010|Overall Study|Adverse Event|6|||
146039950|NCT01610336|526657984|FG000|Overall Study|Subject/Guardian decision|1|||
146039951|NCT01610336|526657985|FG001|Overall Study|Subject/Guardian decision|1|||
146039952|NCT01610336|526657986|FG002|Overall Study|Subject/Guardian decision|0|||
146039953|NCT01610336|526657987|FG003|Overall Study|Subject/Guardian decision|1|||
146039954|NCT01610336|526657988|FG004|Overall Study|Subject/Guardian decision|0|||
146039955|NCT01610336|526657989|FG005|Overall Study|Subject/Guardian decision|0|||
146039956|NCT01610336|526657990|FG006|Overall Study|Subject/Guardian decision|0|||
146039957|NCT01610336|526657991|FG007|Overall Study|Subject/Guardian decision|1|||
146039958|NCT01610336|526657992|FG008|Overall Study|Subject/Guardian decision|0|||
146039959|NCT01610336|526657993|FG009|Overall Study|Subject/Guardian decision|2|||
146039960|NCT01610336|526657994|FG010|Overall Study|Subject/Guardian decision|2|||
146039961|NCT01610336|526657984|FG000|Overall Study|Death|0|||
146039962|NCT01610336|526657985|FG001|Overall Study|Death|0|||
146039963|NCT01610336|526657986|FG002|Overall Study|Death|0|||
146039964|NCT01610336|526657987|FG003|Overall Study|Death|0|||
146039965|NCT01610336|526657988|FG004|Overall Study|Death|0|||
146039966|NCT01610336|526657989|FG005|Overall Study|Death|1|||
146039967|NCT01610336|526657990|FG006|Overall Study|Death|3|||
146039968|NCT01610336|526657991|FG007|Overall Study|Death|0|||
146039969|NCT01610336|526657992|FG008|Overall Study|Death|0|||
146039970|NCT01610336|526657993|FG009|Overall Study|Death|1|||
146039971|NCT01610336|526657994|FG010|Overall Study|Death|2|||
146039972|NCT01610336|526657984|FG000|Overall Study|Non-Compliance with study treatment|0|||
146039973|NCT01610336|526657985|FG001|Overall Study|Non-Compliance with study treatment|0|||
146039974|NCT01610336|526657986|FG002|Overall Study|Non-Compliance with study treatment|0|||
146039975|NCT01610336|526657987|FG003|Overall Study|Non-Compliance with study treatment|0|||
146039976|NCT01610336|526657988|FG004|Overall Study|Non-Compliance with study treatment|0|||
146039977|NCT01610336|526657989|FG005|Overall Study|Non-Compliance with study treatment|0|||
146039978|NCT01610336|526657990|FG006|Overall Study|Non-Compliance with study treatment|0|||
146039979|NCT01610336|526657991|FG007|Overall Study|Non-Compliance with study treatment|0|||
146039980|NCT01610336|526657992|FG008|Overall Study|Non-Compliance with study treatment|0|||
146039981|NCT01610336|526657993|FG009|Overall Study|Non-Compliance with study treatment|1|||
146039982|NCT01610336|526657994|FG010|Overall Study|Non-Compliance with study treatment|0|||
146039983|NCT01610336|526657984|FG000|Overall Study|Physician Decision|0|||
146039984|NCT01610336|526657985|FG001|Overall Study|Physician Decision|0|||
146039985|NCT01610336|526657986|FG002|Overall Study|Physician Decision|0|||
146039986|NCT01610336|526657987|FG003|Overall Study|Physician Decision|0|||
146039987|NCT01610336|526657988|FG004|Overall Study|Physician Decision|0|||
146039988|NCT01610336|526657989|FG005|Overall Study|Physician Decision|0|||
146039989|NCT01610336|526657990|FG006|Overall Study|Physician Decision|1|||
146039990|NCT01610336|526657991|FG007|Overall Study|Physician Decision|0|||
146039991|NCT01610336|526657992|FG008|Overall Study|Physician Decision|0|||
146039992|NCT01610336|526657993|FG009|Overall Study|Physician Decision|0|||
146039993|NCT01610336|526657994|FG010|Overall Study|Physician Decision|0|||
146039994|NCT01610336|526657984|FG000|Overall Study|Protocol Deviation|0|||
146039995|NCT01610336|526657985|FG001|Overall Study|Protocol Deviation|0|||
146039996|NCT01610336|526657986|FG002|Overall Study|Protocol Deviation|0|||
146039997|NCT01610336|526657987|FG003|Overall Study|Protocol Deviation|0|||
146039998|NCT01610336|526657988|FG004|Overall Study|Protocol Deviation|0|||
146039999|NCT01610336|526657989|FG005|Overall Study|Protocol Deviation|0|||
146040000|NCT01610336|526657990|FG006|Overall Study|Protocol Deviation|0|||
146254540|NCT00975130|527444611|FG002|Study Part 2|Administrative|0|||
146254541|NCT00975130|527444609|FG000|Study Part 2|Protocol Violation|0|||
146254542|NCT00975130|527444610|FG001|Study Part 2|Protocol Violation|0|||
146040001|NCT01610336|526657991|FG007|Overall Study|Protocol Deviation|0|||
146040002|NCT01610336|526657992|FG008|Overall Study|Protocol Deviation|0|||
146040003|NCT01610336|526657993|FG009|Overall Study|Protocol Deviation|1|||
146040004|NCT01610336|526657994|FG010|Overall Study|Protocol Deviation|0|||
146040005|NCT01610336|526657984|FG000|Overall Study|Transfer to another trial|0|||
146254543|NCT00975130|527444611|FG002|Study Part 2|Protocol Violation|1|||
146254544|NCT02268526|527444612|FG000|Overall Study|Adverse Event|0|||
146099342|NCT00075218|526884502|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
146099343|NCT00075218|526884500|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
146099344|NCT00075218|526884501|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
146040006|NCT01610336|526657985|FG001|Overall Study|Transfer to another trial|0|||
146040007|NCT01610336|526657986|FG002|Overall Study|Transfer to another trial|0|||
146040008|NCT01610336|526657987|FG003|Overall Study|Transfer to another trial|0|||
146040009|NCT01610336|526657988|FG004|Overall Study|Transfer to another trial|0|||
146040010|NCT01610336|526657989|FG005|Overall Study|Transfer to another trial|0|||
146040011|NCT01610336|526657990|FG006|Overall Study|Transfer to another trial|0|||
146040012|NCT01610336|526657991|FG007|Overall Study|Transfer to another trial|0|||
146040013|NCT01610336|526657992|FG008|Overall Study|Transfer to another trial|0|||
146040014|NCT01610336|526657993|FG009|Overall Study|Transfer to another trial|0|||
146040015|NCT01610336|526657994|FG010|Overall Study|Transfer to another trial|1|||
146040016|NCT01559675|526657997|FG000|Overall Study|Protocol Violation|1|||
146040017|NCT01559675|526657998|FG001|Overall Study|Protocol Violation|2|||
146040018|NCT01559675|526657997|FG000|Overall Study|2nd operation on same patient excluded|14|||
146040019|NCT01559675|526657998|FG001|Overall Study|2nd operation on same patient excluded|12|||
146040020|NCT00193180|526658001|FG000|Overall Study|Lack of Efficacy|1|||
146040021|NCT00193180|526658001|FG000|Overall Study|Adverse Event|8|||
146040022|NCT00193180|526658001|FG000|Overall Study|Protocol Violation|1|||
146040023|NCT01832155|526658002|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
146040024|NCT01832155|526658003|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
146040025|NCT01832155|526658002|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
146040026|NCT01832155|526658003|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
146040027|NCT01279616|526658004|FG000|Overall Study|donor could not be located|5|||
146040028|NCT01279616|526658004|FG000|Overall Study|no signs of sickle cell disease|2|||
146040029|NCT01369641|526658005|FG000|Overall Study|Withdrawal by Subject|1|||
146040030|NCT00842543|526658006|FG000|Overall Study|Withdrawal by Subject|2|||
146040031|NCT00842543|526658007|FG001|Overall Study|Withdrawal by Subject|0|||
146040032|NCT00842543|526658008|FG002|Overall Study|Withdrawal by Subject|3|||
146040033|NCT00842543|526658009|FG003|Overall Study|Withdrawal by Subject|4|||
146040034|NCT01483183|526658010|FG000|Overall Study|Physician Decision|0|||
146040035|NCT01483183|526658011|FG001|Overall Study|Physician Decision|0|||
146040036|NCT01483183|526658012|FG002|Overall Study|Physician Decision|0|||
146040037|NCT01483183|526658013|FG003|Overall Study|Physician Decision|0|||
146040038|NCT01483183|526658014|FG004|Overall Study|Physician Decision|0|||
146040039|NCT01483183|526658015|FG005|Overall Study|Physician Decision|0|||
146040040|NCT01483183|526658016|FG006|Overall Study|Physician Decision|2|||
146040041|NCT01483183|526658017|FG007|Overall Study|Physician Decision|0|||
146040042|NCT01483183|526658018|FG008|Overall Study|Physician Decision|0|||
146040043|NCT01483183|526658019|FG009|Overall Study|Physician Decision|0|||
146040044|NCT01483183|526658010|FG000|Overall Study|Withdrawal by Subject|0|||
146040045|NCT01483183|526658011|FG001|Overall Study|Withdrawal by Subject|0|||
146040046|NCT01483183|526658012|FG002|Overall Study|Withdrawal by Subject|0|||
146040047|NCT01483183|526658013|FG003|Overall Study|Withdrawal by Subject|0|||
146040048|NCT01483183|526658014|FG004|Overall Study|Withdrawal by Subject|0|||
146040049|NCT01483183|526658015|FG005|Overall Study|Withdrawal by Subject|0|||
146040050|NCT01483183|526658016|FG006|Overall Study|Withdrawal by Subject|0|||
146040051|NCT01483183|526658017|FG007|Overall Study|Withdrawal by Subject|0|||
146040052|NCT01483183|526658018|FG008|Overall Study|Withdrawal by Subject|0|||
146040053|NCT01483183|526658019|FG009|Overall Study|Withdrawal by Subject|1|||
146040054|NCT00239928|526658020|FG000|Overall Study|Lack of Efficacy|1|||
146040055|NCT00239928|526658020|FG000|Overall Study|Adverse Event|4|||
146040056|NCT00239928|526658020|FG000|Overall Study|Not need to continue study|3|||
146040057|NCT00239928|526658020|FG000|Overall Study|Withdrawal by Subject|2|||
146040058|NCT02718716|526658023|FG000|Overall Study|Lack of Efficacy|1|||
146040059|NCT02718716|526658024|FG001|Overall Study|Lack of Efficacy|0|||
146040060|NCT02718716|526658025|FG002|Overall Study|Lack of Efficacy|0|||
146040061|NCT02718716|526658026|FG003|Overall Study|Lack of Efficacy|0|||
146040062|NCT02718716|526658027|FG004|Overall Study|Lack of Efficacy|0|||
146040063|NCT03194646|526658034|FG000|Overall Study|Adverse Event|24|||
146040064|NCT03194646|526658035|FG001|Overall Study|Adverse Event|25|||
146099345|NCT00075218|526884502|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
146099346|NCT00075218|526884500|FG000|Double-Blind Treatment|No study medication taken|2|||
146040065|NCT03194646|526658036|FG002|Overall Study|Adverse Event|14|||
146040066|NCT03194646|526658037|FG003|Overall Study|Adverse Event|17|||
146040067|NCT03194646|526658034|FG000|Overall Study|Lack of Efficacy|4|||
146040068|NCT03194646|526658035|FG001|Overall Study|Lack of Efficacy|2|||
146099347|NCT00075218|526884501|FG001|Double-Blind Treatment|No study medication taken|0|||
146040069|NCT03194646|526658036|FG002|Overall Study|Lack of Efficacy|2|||
146040070|NCT03194646|526658037|FG003|Overall Study|Lack of Efficacy|12|||
146040071|NCT03194646|526658034|FG000|Overall Study|Lost to Follow-up|30|||
146040072|NCT03194646|526658035|FG001|Overall Study|Lost to Follow-up|22|||
146040073|NCT03194646|526658036|FG002|Overall Study|Lost to Follow-up|12|||
146040074|NCT03194646|526658037|FG003|Overall Study|Lost to Follow-up|35|||
146099348|NCT00075218|526884502|FG002|Double-Blind Treatment|No study medication taken|0|||
146099349|NCT00075218|526884500|FG000|Open-Label Treatment|Lack of Efficacy|0|||
146099350|NCT00075218|526884501|FG001|Open-Label Treatment|Lack of Efficacy|0|||
146099351|NCT00075218|526884502|FG002|Open-Label Treatment|Lack of Efficacy|174|||
146099352|NCT00075218|526884500|FG000|Open-Label Treatment|Adverse Event|0|||
146099353|NCT00075218|526884501|FG001|Open-Label Treatment|Adverse Event|0|||
146099354|NCT00075218|526884502|FG002|Open-Label Treatment|Adverse Event|51|||
146099355|NCT00075218|526884500|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
146099356|NCT00075218|526884501|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
146099357|NCT00075218|526884502|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
146099358|NCT00075218|526884500|FG000|Open-Label Treatment|Decision of Sponsor|0|||
146099359|NCT00075218|526884501|FG001|Open-Label Treatment|Decision of Sponsor|0|||
146099360|NCT00075218|526884502|FG002|Open-Label Treatment|Decision of Sponsor|8|||
146099361|NCT00075218|526884500|FG000|Open-Label Treatment|Protocol Violation|0|||
146099362|NCT00075218|526884501|FG001|Open-Label Treatment|Protocol Violation|0|||
146099363|NCT00075218|526884502|FG002|Open-Label Treatment|Protocol Violation|1|||
146099364|NCT00075218|526884500|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
146099365|NCT00075218|526884501|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
146099366|NCT00075218|526884502|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
146099367|NCT03643575|526884503|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
146099368|NCT03643575|526884504|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
146099369|NCT03643575|526884505|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
146099370|NCT03643575|526884506|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
146099371|NCT03643575|526884507|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
146099372|NCT03643575|526884508|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
146099373|NCT03643575|526884503|FG000|Washout: 7 Days|Adverse Event|1|||
146099374|NCT03643575|526884504|FG001|Washout: 7 Days|Adverse Event|0|||
146099375|NCT03643575|526884505|FG002|Washout: 7 Days|Adverse Event|0|||
146099376|NCT03643575|526884506|FG003|Washout: 7 Days|Adverse Event|0|||
146099377|NCT03643575|526884507|FG004|Washout: 7 Days|Adverse Event|0|||
146099378|NCT03643575|526884508|FG005|Washout: 7 Days|Adverse Event|0|||
146099379|NCT03643575|526884503|FG000|Washout: 7 Days|Non compliance check in|0|||
146099380|NCT03643575|526884504|FG001|Washout: 7 Days|Non compliance check in|1|||
146099381|NCT03643575|526884505|FG002|Washout: 7 Days|Non compliance check in|0|||
146099382|NCT03643575|526884506|FG003|Washout: 7 Days|Non compliance check in|0|||
146099383|NCT03643575|526884507|FG004|Washout: 7 Days|Non compliance check in|0|||
146099384|NCT03643575|526884508|FG005|Washout: 7 Days|Non compliance check in|0|||
146099385|NCT01189604|526884509|FG000|Overall Study|Impossible to visit|0|||
146099386|NCT01189604|526884510|FG001|Overall Study|Impossible to visit|0|||
146099387|NCT01189604|526884511|FG002|Overall Study|Impossible to visit|0|||
146099388|NCT01189604|526884512|FG003|Overall Study|Impossible to visit|0|||
146099389|NCT01189604|526884513|FG004|Overall Study|Impossible to visit|0|||
146099390|NCT01189604|526884514|FG005|Overall Study|Impossible to visit|1|||
146099391|NCT01189604|526884515|FG006|Overall Study|Impossible to visit|0|||
146099392|NCT01189604|526884509|FG000|Overall Study|Adverse Event|0|||
146099393|NCT01189604|526884510|FG001|Overall Study|Adverse Event|1|||
146040075|NCT03194646|526658034|FG000|Overall Study|Non-compliance with study drug|4|||
146040076|NCT03194646|526658035|FG001|Overall Study|Non-compliance with study drug|0|||
146040077|NCT03194646|526658036|FG002|Overall Study|Non-compliance with study drug|1|||
146040078|NCT03194646|526658037|FG003|Overall Study|Non-compliance with study drug|1|||
146040079|NCT03194646|526658034|FG000|Overall Study|Other|89|||
146040080|NCT03194646|526658035|FG001|Overall Study|Other|68|||
146040081|NCT03194646|526658036|FG002|Overall Study|Other|34|||
146040082|NCT03194646|526658037|FG003|Overall Study|Other|31|||
146040083|NCT03194646|526658034|FG000|Overall Study|Physician Decision|7|||
146040084|NCT03194646|526658035|FG001|Overall Study|Physician Decision|9|||
146040085|NCT03194646|526658036|FG002|Overall Study|Physician Decision|5|||
146040086|NCT03194646|526658037|FG003|Overall Study|Physician Decision|4|||
146040087|NCT03194646|526658034|FG000|Overall Study|Pregnancy|4|||
146040088|NCT03194646|526658035|FG001|Overall Study|Pregnancy|5|||
146040089|NCT03194646|526658036|FG002|Overall Study|Pregnancy|1|||
146040090|NCT03194646|526658037|FG003|Overall Study|Pregnancy|2|||
146040091|NCT03194646|526658034|FG000|Overall Study|Protocol Violation|4|||
146040092|NCT03194646|526658035|FG001|Overall Study|Protocol Violation|2|||
146040093|NCT03194646|526658036|FG002|Overall Study|Protocol Violation|1|||
146040094|NCT03194646|526658037|FG003|Overall Study|Protocol Violation|1|||
146040095|NCT03194646|526658034|FG000|Overall Study|Site terminated by sponsor|0|||
146099394|NCT01189604|526884511|FG002|Overall Study|Adverse Event|0|||
146099395|NCT01189604|526884512|FG003|Overall Study|Adverse Event|0|||
146099396|NCT01189604|526884513|FG004|Overall Study|Adverse Event|2|||
146040096|NCT03194646|526658035|FG001|Overall Study|Site terminated by sponsor|0|||
146099397|NCT01189604|526884514|FG005|Overall Study|Adverse Event|0|||
146099398|NCT01189604|526884515|FG006|Overall Study|Adverse Event|1|||
146099399|NCT01189604|526884509|FG000|Overall Study|Withdrawal by Subject|1|||
146099400|NCT01189604|526884510|FG001|Overall Study|Withdrawal by Subject|0|||
146099401|NCT01189604|526884511|FG002|Overall Study|Withdrawal by Subject|0|||
146099402|NCT01189604|526884512|FG003|Overall Study|Withdrawal by Subject|0|||
146099403|NCT01189604|526884513|FG004|Overall Study|Withdrawal by Subject|0|||
146040097|NCT03194646|526658036|FG002|Overall Study|Site terminated by sponsor|2|||
146040098|NCT03194646|526658037|FG003|Overall Study|Site terminated by sponsor|0|||
146040099|NCT03194646|526658034|FG000|Overall Study|Study terminated by sponsor|62|||
146040100|NCT03194646|526658035|FG001|Overall Study|Study terminated by sponsor|61|||
146040101|NCT03194646|526658036|FG002|Overall Study|Study terminated by sponsor|30|||
146040102|NCT03194646|526658037|FG003|Overall Study|Study terminated by sponsor|34|||
146040103|NCT03194646|526658034|FG000|Overall Study|Withdrawal by Subject|75|||
146040104|NCT03194646|526658035|FG001|Overall Study|Withdrawal by Subject|74|||
146040105|NCT03194646|526658036|FG002|Overall Study|Withdrawal by Subject|36|||
146040106|NCT03194646|526658037|FG003|Overall Study|Withdrawal by Subject|131|||
146040107|NCT03194646|526658034|FG000|Overall Study|Missing|1|||
146040108|NCT03194646|526658035|FG001|Overall Study|Missing|0|||
146040109|NCT03194646|526658036|FG002|Overall Study|Missing|1|||
146040110|NCT03194646|526658037|FG003|Overall Study|Missing|12|||
146040111|NCT04869358|526658038|FG000|Overall Study|Wish to have children.|1|||
146040112|NCT04869358|526658039|FG001|Overall Study|Wish to have children.|0|||
146040113|NCT04869358|526658040|FG002|Overall Study|Wish to have children.|0|||
146040114|NCT04869358|526658041|FG003|Overall Study|Wish to have children.|0|||
146040115|NCT02141360|526658042|FG000|Overall Study|Withdrawal by Subject|6|||
146040116|NCT02141360|526658043|FG001|Overall Study|Withdrawal by Subject|0|||
146040117|NCT02141360|526658044|FG002|Overall Study|Withdrawal by Subject|0|||
146040118|NCT02141360|526658042|FG000|Overall Study|Study Terminated before Visit|1|||
146040119|NCT02141360|526658043|FG001|Overall Study|Study Terminated before Visit|0|||
146040120|NCT02141360|526658044|FG002|Overall Study|Study Terminated before Visit|0|||
146040121|NCT00129467|526658047|FG000|Received Intervention|Death|1|||
146040122|NCT00129467|526658048|FG001|Received Intervention|Death|1|||
146040123|NCT00129467|526658047|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
146040124|NCT00129467|526658048|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
146040125|NCT00129467|526658047|FG000|Received Intervention|Delirium|2|||
146040126|NCT00129467|526658048|FG001|Received Intervention|Delirium|0|||
146040127|NCT00129467|526658047|FG000|Received Intervention|Withdrawal by Subject|1|||
146040128|NCT00129467|526658048|FG001|Received Intervention|Withdrawal by Subject|0|||
146040129|NCT00129467|526658047|FG000|Received Intervention|Nausea|1|||
146040130|NCT00129467|526658048|FG001|Received Intervention|Nausea|0|||
146040131|NCT00129467|526658047|FG000|Received Intervention|Intolerance to citalopram|0|||
146040132|NCT00129467|526658048|FG001|Received Intervention|Intolerance to citalopram|1|||
146040133|NCT00129467|526658047|FG000|Received Intervention|Dizzyness, fatigue|0|||
146040134|NCT00129467|526658048|FG001|Received Intervention|Dizzyness, fatigue|1|||
146040135|NCT00129467|526658047|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
146040136|NCT00129467|526658048|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
146040137|NCT00129467|526658047|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
146040138|NCT00129467|526658048|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
146040139|NCT01331291|526658049|FG000|Overall Study|Lack of Efficacy|2|||
146040140|NCT01331291|526658050|FG001|Overall Study|Lack of Efficacy|8|||
146040141|NCT01331291|526658049|FG000|Overall Study|Death|0|||
146040142|NCT01331291|526658050|FG001|Overall Study|Death|1|||
146040143|NCT03550404|526658051|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
146040144|NCT03550404|526658052|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
146040145|NCT03550404|526658053|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
146040146|NCT03550404|526658051|FG000|Phase 2|Vacated position|1|||
146040147|NCT03550404|526658052|FG001|Phase 2|Vacated position|0|||
146040148|NCT03550404|526658053|FG002|Phase 2|Vacated position|0|||
146040149|NCT00932165|526658054|FG000|Overall Study|Lost to Follow-up|1|||
146040150|NCT02690714|526658055|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
146040151|NCT02690714|526658055|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
146040152|NCT00293020|526658056|FG000|Overall Study|Withdrawal by Subject|34|||
146040153|NCT00293020|526658056|FG000|Overall Study|Adverse Event|30|||
146040154|NCT00293020|526658056|FG000|Overall Study|Death|32|||
146040155|NCT00293020|526658056|FG000|Overall Study|Lack of Efficacy|12|||
146040156|NCT00293020|526658056|FG000|Overall Study|Lost to Follow-up|4|||
146040157|NCT00293020|526658056|FG000|Overall Study|Protocol Violation|6|||
146040158|NCT00293020|526658056|FG000|Overall Study|Physician Decision|21|||
146040159|NCT00293020|526658056|FG000|Overall Study|Other Reason|22|||
146040160|NCT00293020|526658056|FG000|Overall Study|No dose taken|1|||
146040161|NCT00666965|526658057|FG000|Overall Study|Adverse Event|0|||
146040162|NCT00666965|526658058|FG001|Overall Study|Adverse Event|2|||
146040163|NCT00666965|526658059|FG002|Overall Study|Adverse Event|1|||
146040164|NCT00666965|526658060|FG003|Overall Study|Adverse Event|9|||
146040165|NCT00666965|526658057|FG000|Overall Study|Lack of Efficacy|1|||
146040166|NCT00666965|526658058|FG001|Overall Study|Lack of Efficacy|1|||
146040167|NCT00666965|526658059|FG002|Overall Study|Lack of Efficacy|0|||
146040168|NCT00666965|526658060|FG003|Overall Study|Lack of Efficacy|0|||
146040169|NCT00666965|526658057|FG000|Overall Study|Protocol Violation|0|||
146040170|NCT00666965|526658058|FG001|Overall Study|Protocol Violation|0|||
146040171|NCT00666965|526658059|FG002|Overall Study|Protocol Violation|0|||
146040172|NCT00666965|526658060|FG003|Overall Study|Protocol Violation|2|||
146040173|NCT00666965|526658057|FG000|Overall Study|Discontinuation criteria|2|||
146040174|NCT00666965|526658058|FG001|Overall Study|Discontinuation criteria|1|||
146040175|NCT00666965|526658059|FG002|Overall Study|Discontinuation criteria|1|||
146040176|NCT00666965|526658060|FG003|Overall Study|Discontinuation criteria|2|||
146040177|NCT00666965|526658057|FG000|Overall Study|Withdrawal by Subject|0|||
146040178|NCT00666965|526658058|FG001|Overall Study|Withdrawal by Subject|0|||
146040179|NCT00666965|526658059|FG002|Overall Study|Withdrawal by Subject|0|||
146040180|NCT00666965|526658060|FG003|Overall Study|Withdrawal by Subject|2|||
146040181|NCT01894022|526658066|FG000|Overall Study|Death|1|||
146040182|NCT01894022|526658067|FG001|Overall Study|Death|0|||
146040183|NCT01894022|526658066|FG000|Overall Study|Adverse Event, non-fatal|1|||
146040184|NCT01894022|526658067|FG001|Overall Study|Adverse Event, non-fatal|0|||
146040185|NCT01894022|526658066|FG000|Overall Study|Study Closed/terminated|7|||
146040186|NCT01894022|526658067|FG001|Overall Study|Study Closed/terminated|10|||
146040187|NCT02249182|526658071|FG000|Treatment Phase|Lost to Follow-up|4|||
146040188|NCT02249182|526658072|FG001|Treatment Phase|Lost to Follow-up|0|||
146040189|NCT02249182|526658073|FG002|Treatment Phase|Lost to Follow-up|0|||
146040190|NCT02249182|526658074|FG003|Treatment Phase|Lost to Follow-up|0|||
146040191|NCT02249182|526658075|FG004|Treatment Phase|Lost to Follow-up|0|||
146040192|NCT00504894|526658080|FG000|Overall Study|fMRI technical problems|1|||
146040193|NCT00504894|526658081|FG001|Overall Study|fMRI technical problems|1|||
146040194|NCT00504894|526658082|FG002|Overall Study|fMRI technical problems|0|||
146040195|NCT00504894|526658080|FG000|Overall Study|Withdrawal by Subject|0|||
146040196|NCT00504894|526658081|FG001|Overall Study|Withdrawal by Subject|1|||
146040197|NCT00504894|526658082|FG002|Overall Study|Withdrawal by Subject|0|||
146040198|NCT00504894|526658080|FG000|Overall Study|Infusion technical problems|0|||
146040199|NCT00504894|526658081|FG001|Overall Study|Infusion technical problems|1|||
146040200|NCT00504894|526658082|FG002|Overall Study|Infusion technical problems|0|||
146040201|NCT00504894|526658080|FG000|Overall Study|poor subject data|2|||
146040202|NCT00504894|526658081|FG001|Overall Study|poor subject data|0|||
146040203|NCT00504894|526658082|FG002|Overall Study|poor subject data|0|||
146040204|NCT05090852|526658083|FG000|Overall Study|Physician Decision|5|||
146040205|NCT00148941|526658084|FG000|Overall Study|Lost to Follow-up|17|||
146040206|NCT00148941|526658085|FG001|Overall Study|Lost to Follow-up|24|||
146040207|NCT00148941|526658086|FG002|Overall Study|Lost to Follow-up|18|||
146040208|NCT00148941|526658087|FG003|Overall Study|Lost to Follow-up|22|||
146040209|NCT00148941|526658084|FG000|Overall Study|Withdrawal by Subject|1|||
146040210|NCT00148941|526658085|FG001|Overall Study|Withdrawal by Subject|0|||
146040211|NCT00148941|526658086|FG002|Overall Study|Withdrawal by Subject|1|||
146040212|NCT00148941|526658087|FG003|Overall Study|Withdrawal by Subject|0|||
146040213|NCT00148941|526658084|FG000|Overall Study|Other|0|||
146040214|NCT00148941|526658085|FG001|Overall Study|Other|0|||
146040215|NCT00148941|526658086|FG002|Overall Study|Other|1|||
146040216|NCT00148941|526658087|FG003|Overall Study|Other|2|||
146040217|NCT03244826|526658088|FG000|Overall Study|Withdrawal by Subject|2|||
146040218|NCT03244826|526658089|FG001|Overall Study|Withdrawal by Subject|0|||
146040219|NCT03244826|526658088|FG000|Overall Study|Transplant delayed or withdrawn|12|||
146040220|NCT03244826|526658089|FG001|Overall Study|Transplant delayed or withdrawn|10|||
146040221|NCT02673684|526658090|FG000|Overall Study|Study not completed d/t loss of funding|9|||
146040222|NCT02673684|526658091|FG001|Overall Study|Study not completed d/t loss of funding|8|||
146040223|NCT01092663|526658094|FG000|Overall Study|Withdrawal by Subject|3|||
146040224|NCT01092663|526658095|FG001|Overall Study|Withdrawal by Subject|2|||
146040225|NCT01092663|526658094|FG000|Overall Study|Glucose >300mg/dL|1|||
146040226|NCT01092663|526658095|FG001|Overall Study|Glucose >300mg/dL|0|||
146040227|NCT01092663|526658094|FG000|Overall Study|High fasting triglyceride|2|||
146040228|NCT01092663|526658095|FG001|Overall Study|High fasting triglyceride|0|||
146040229|NCT01092663|526658094|FG000|Overall Study|Adverse Event|1|||
146040230|NCT01092663|526658095|FG001|Overall Study|Adverse Event|1|||
146040231|NCT01092663|526658094|FG000|Overall Study|Protocol Violation|0|||
146040232|NCT01092663|526658095|FG001|Overall Study|Protocol Violation|1|||
146040233|NCT04356040|526658096|FG000|Overall Study|Death|2|||
146040234|NCT04356040|526658097|FG001|Overall Study|Death|0|||
146040235|NCT04356040|526658096|FG000|Overall Study|Lost to Follow-up|1|||
146040236|NCT04356040|526658097|FG001|Overall Study|Lost to Follow-up|0|||
146040237|NCT04356040|526658096|FG000|Overall Study|Physician Decision|0|||
146040238|NCT04356040|526658097|FG001|Overall Study|Physician Decision|1|||
146040239|NCT04356040|526658096|FG000|Overall Study|Withdrawal by Subject|13|||
146040240|NCT04356040|526658097|FG001|Overall Study|Withdrawal by Subject|1|||
146040241|NCT04356040|526658096|FG000|Overall Study|Enrollment Pause|10|||
146040242|NCT04356040|526658097|FG001|Overall Study|Enrollment Pause|0|||
146040243|NCT04356040|526658096|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
146040244|NCT04356040|526658097|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
146040245|NCT04356040|526658096|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
146040246|NCT04356040|526658097|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
146040247|NCT04356040|526658096|FG000|Overall Study|PI left institution|3|||
146254545|NCT02268526|527444613|FG001|Overall Study|Adverse Event|2|||
146040248|NCT04356040|526658097|FG001|Overall Study|PI left institution|0|||
146099404|NCT01189604|526884514|FG005|Overall Study|Withdrawal by Subject|0|||
146099405|NCT01189604|526884515|FG006|Overall Study|Withdrawal by Subject|0|||
146099406|NCT03626168|526884516|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146099407|NCT03626168|526884517|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146099408|NCT03626168|526884516|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
146099409|NCT03626168|526884517|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
146099410|NCT03626168|526884516|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146099411|NCT03626168|526884517|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
146099412|NCT02357979|526884518|FG000|Overall Study|Lost to Follow-up|5|||
146099413|NCT02357979|526884519|FG001|Overall Study|Lost to Follow-up|5|||
146099414|NCT05047770|526884523|FG000|Overall Study|Withdrawal by Subject|15|||
146099415|NCT05047770|526884524|FG001|Overall Study|Withdrawal by Subject|10|||
146099416|NCT05047770|526884525|FG002|Overall Study|Withdrawal by Subject|6|||
146099417|NCT05047770|526884526|FG003|Overall Study|Withdrawal by Subject|12|||
146099418|NCT05047770|526884523|FG000|Overall Study|Lost to Follow-up|7|||
146099419|NCT05047770|526884524|FG001|Overall Study|Lost to Follow-up|5|||
146099420|NCT05047770|526884525|FG002|Overall Study|Lost to Follow-up|12|||
146099421|NCT05047770|526884526|FG003|Overall Study|Lost to Follow-up|13|||
146099422|NCT05047770|526884523|FG000|Overall Study|Other|1|||
146099423|NCT05047770|526884524|FG001|Overall Study|Other|0|||
146099424|NCT05047770|526884525|FG002|Overall Study|Other|1|||
146099425|NCT05047770|526884526|FG003|Overall Study|Other|0|||
146254546|NCT02268526|527444614|FG002|Overall Study|Adverse Event|1|||
146254547|NCT02268526|527444612|FG000|Overall Study|Death|1|||
146254548|NCT02268526|527444613|FG001|Overall Study|Death|11|||
146254549|NCT02268526|527444614|FG002|Overall Study|Death|0|||
146254550|NCT02268526|527444612|FG000|Overall Study|protocol deviation|0|||
146254551|NCT02268526|527444613|FG001|Overall Study|protocol deviation|1|||
146254552|NCT02268526|527444614|FG002|Overall Study|protocol deviation|0|||
146040249|NCT01008904|526658098|FG000|Overall Study|Lost to Follow-up|1|||
146040250|NCT01008904|526658098|FG000|Overall Study|Adverse Event|2|||
146040251|NCT01008904|526658098|FG000|Overall Study|unexpected unrelated surgery|1|||
146040252|NCT00360568|526658099|FG000|Overall Study|Adverse Event|1|||
146040253|NCT00360568|526658100|FG001|Overall Study|Adverse Event|2|||
146040254|NCT00360568|526658099|FG000|Overall Study|Lack of Efficacy|1|||
146040255|NCT00360568|526658100|FG001|Overall Study|Lack of Efficacy|0|||
146040256|NCT00360568|526658099|FG000|Overall Study|Withdrawal by Subject|0|||
146040257|NCT00360568|526658100|FG001|Overall Study|Withdrawal by Subject|3|||
146040258|NCT01008449|526658101|FG000|Overall Study|Lost to Follow-up|29|||
146040259|NCT01008449|526658102|FG001|Overall Study|Lost to Follow-up|19|||
146040260|NCT01220180|526658103|FG000|Overall Study|Lost to Follow-up|76|||
146040261|NCT01220180|526658103|FG000|Overall Study|Other|72|||
146040262|NCT01220180|526658103|FG000|Overall Study|Adverse Event|35|||
146040263|NCT01220180|526658103|FG000|Overall Study|Lack of Efficacy|22|||
146040264|NCT01220180|526658103|FG000|Overall Study|Death|1|||
146040265|NCT01220180|526658103|FG000|Overall Study|Randomized but not treated|1|||
146040266|NCT01067469|526658104|FG000|Overall Study|Withdrawal by Subject|0|||
146040267|NCT01067469|526658105|FG001|Overall Study|Withdrawal by Subject|1|||
146040268|NCT01067469|526658104|FG000|Overall Study|Disease Progression|0|||
146040269|NCT01067469|526658105|FG001|Overall Study|Disease Progression|1|||
146040270|NCT01364389|526658108|FG000|Overall Study|Withdrawal by Subject|0|||
146040271|NCT01364389|526658109|FG001|Overall Study|Withdrawal by Subject|1|||
146040272|NCT01364389|526658110|FG002|Overall Study|Withdrawal by Subject|0|||
146040273|NCT01364389|526658108|FG000|Overall Study|Protocol deviation|0|||
146040274|NCT01364389|526658109|FG001|Overall Study|Protocol deviation|0|||
146040275|NCT01364389|526658110|FG002|Overall Study|Protocol deviation|1|||
146040276|NCT01364389|526658108|FG000|Overall Study|Administrative problems|1|||
146040277|NCT01364389|526658109|FG001|Overall Study|Administrative problems|0|||
146040278|NCT01364389|526658110|FG002|Overall Study|Administrative problems|0|||
146040279|NCT01364389|526658108|FG000|Overall Study|Adverse Event|1|||
146040280|NCT01364389|526658109|FG001|Overall Study|Adverse Event|0|||
146040281|NCT01364389|526658110|FG002|Overall Study|Adverse Event|0|||
146040282|NCT01534195|526658111|FG000|Overall Study|Withdrawal by Subject|1|||
146040283|NCT01534195|526658112|FG001|Overall Study|Withdrawal by Subject|1|||
146040284|NCT01959243|526658119|FG000|Overall Study|Investigator Decision|3|||
146040285|NCT01959243|526658120|FG001|Overall Study|Investigator Decision|0|||
146040286|NCT01959243|526658119|FG000|Overall Study|Adverse Event|5|||
146099426|NCT01772160|526884527|FG000|Overall Study|Death|3|||
146099427|NCT01772160|526884527|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
146099428|NCT01772160|526884527|FG000|Overall Study|Consent withdrawal|3|||
146099429|NCT01772160|526884527|FG000|Overall Study|Migrated / moved from the study area|4|||
146099430|NCT01772160|526884527|FG000|Overall Study|Lost to Follow-up|30|||
146254553|NCT02268526|527444612|FG000|Overall Study|Physician Decision|0|||
146040287|NCT01959243|526658120|FG001|Overall Study|Adverse Event|2|||
146040288|NCT01959243|526658119|FG000|Overall Study|Administrative reasons|2|||
146040289|NCT01959243|526658120|FG001|Overall Study|Administrative reasons|1|||
146040290|NCT01959243|526658119|FG000|Overall Study|Lost to Follow-up|3|||
146254554|NCT02268526|527444613|FG001|Overall Study|Physician Decision|0|||
146099431|NCT01772160|526884527|FG000|Overall Study|Other|5|||
146099432|NCT00669396|526884530|FG000|Overall Study|Lost to Follow-up|10|||
146099433|NCT00669396|526884531|FG001|Overall Study|Lost to Follow-up|12|||
146099434|NCT01262573|526884532|FG000|Overall Study|Withdrawal by Subject|0|||
146099435|NCT01262573|526884533|FG001|Overall Study|Withdrawal by Subject|1|||
146099436|NCT04402060|526884534|FG000|Overall Study|Death|1|||
146099437|NCT04402060|526884535|FG001|Overall Study|Death|12|||
146099438|NCT04402060|526884536|FG002|Overall Study|Death|7|||
146099439|NCT04402060|526884534|FG000|Overall Study|Adverse Event|0|||
146099440|NCT04402060|526884535|FG001|Overall Study|Adverse Event|0|||
146099441|NCT04402060|526884536|FG002|Overall Study|Adverse Event|1|||
146099442|NCT04402060|526884534|FG000|Overall Study|Withdrawal by Subject|0|||
146099443|NCT04402060|526884535|FG001|Overall Study|Withdrawal by Subject|1|||
146099444|NCT04402060|526884536|FG002|Overall Study|Withdrawal by Subject|2|||
146099445|NCT04402060|526884534|FG000|Overall Study|Sponsor Request|0|||
146099446|NCT04402060|526884535|FG001|Overall Study|Sponsor Request|2|||
146099447|NCT04402060|526884536|FG002|Overall Study|Sponsor Request|0|||
146099448|NCT04402060|526884534|FG000|Overall Study|Physician Decision|0|||
146099449|NCT04402060|526884535|FG001|Overall Study|Physician Decision|0|||
146099450|NCT04402060|526884536|FG002|Overall Study|Physician Decision|1|||
146099451|NCT04402060|526884534|FG000|Overall Study|Other|0|||
146099452|NCT04402060|526884535|FG001|Overall Study|Other|1|||
146099453|NCT04402060|526884536|FG002|Overall Study|Other|0|||
146099454|NCT03386474|526884539|FG000|Overall Study|Death|1|||
146099455|NCT03386474|526884540|FG001|Overall Study|Death|0|||
146099456|NCT03386474|526884539|FG000|Overall Study|Adverse Event|0|||
146099457|NCT03386474|526884540|FG001|Overall Study|Adverse Event|1|||
146099458|NCT02282358|526884541|FG000|Overall Study|Nonevaluable|1|||
146099459|NCT02155881|526884542|FG000|Overall Study|Withdrawal by Subject|0|||
146099460|NCT02155881|526884543|FG001|Overall Study|Withdrawal by Subject|2|||
146099461|NCT02155881|526884542|FG000|Overall Study|Inappropriately randomized|2|||
146099462|NCT02155881|526884543|FG001|Overall Study|Inappropriately randomized|2|||
146099463|NCT01786148|526884544|FG000|Overall Study|Lost to Follow-up|21|||
146099464|NCT01786148|526884545|FG001|Overall Study|Lost to Follow-up|13|||
146099465|NCT01786148|526884544|FG000|Overall Study|Death|0|||
146099466|NCT01786148|526884545|FG001|Overall Study|Death|1|||
146099467|NCT01786148|526884544|FG000|Overall Study|Withdrawal by Subject|0|||
146099468|NCT01786148|526884545|FG001|Overall Study|Withdrawal by Subject|7|||
146099469|NCT01786148|526884544|FG000|Overall Study|Incarceration|1|||
146099470|NCT01786148|526884545|FG001|Overall Study|Incarceration|1|||
146099471|NCT03780543|526884546|FG000|Overall Study|Adverse Event|1|||
146099472|NCT03780543|526884547|FG001|Overall Study|Adverse Event|0|||
146099473|NCT03780543|526884548|FG002|Overall Study|Adverse Event|2|||
146099474|NCT03780543|526884546|FG000|Overall Study|Lost to Follow-up|2|||
146099475|NCT03780543|526884547|FG001|Overall Study|Lost to Follow-up|0|||
146099476|NCT03780543|526884548|FG002|Overall Study|Lost to Follow-up|1|||
146099477|NCT03780543|526884546|FG000|Overall Study|Study terminated by Sponsor|8|||
146099478|NCT03780543|526884547|FG001|Overall Study|Study terminated by Sponsor|7|||
146099479|NCT03780543|526884548|FG002|Overall Study|Study terminated by Sponsor|13|||
146099480|NCT03780543|526884546|FG000|Overall Study|Withdrawal by Subject|1|||
146099481|NCT03780543|526884547|FG001|Overall Study|Withdrawal by Subject|8|||
146099482|NCT03780543|526884548|FG002|Overall Study|Withdrawal by Subject|1|||
146099483|NCT03780543|526884546|FG000|Overall Study|Noncompliance with study drug|1|||
146099484|NCT03780543|526884547|FG001|Overall Study|Noncompliance with study drug|0|||
146099485|NCT03780543|526884548|FG002|Overall Study|Noncompliance with study drug|0|||
146099486|NCT00066729|526884549|FG000|Overall Study|Lost to Follow-up|1|||
146099487|NCT00066729|526884549|FG000|Overall Study|Disease progression|1|||
146099488|NCT02215096|526884550|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
146099489|NCT02215096|526884551|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
146099490|NCT02215096|526884552|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
146099491|NCT02215096|526884553|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
146099492|NCT02215096|526884554|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
146099493|NCT02215096|526884550|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146099494|NCT02215096|526884551|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146099495|NCT02215096|526884552|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146099496|NCT02215096|526884553|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
146099497|NCT02215096|526884554|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
146099498|NCT02215096|526884550|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146099499|NCT02215096|526884551|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146099500|NCT02215096|526884552|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146099501|NCT02215096|526884553|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
146099502|NCT02215096|526884554|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
146099503|NCT02215096|526884550|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
146099504|NCT02215096|526884551|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
146099505|NCT02215096|526884552|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
146254555|NCT02268526|527444614|FG002|Overall Study|Physician Decision|1|||
146099506|NCT02215096|526884553|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
146099507|NCT02215096|526884554|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
146040291|NCT01959243|526658120|FG001|Overall Study|Lost to Follow-up|1|||
146040292|NCT02478255|526658122|FG000|Overall Study|Physician Decision|6|||
146040293|NCT02478255|526658123|FG001|Overall Study|Physician Decision|0|||
146040294|NCT02478255|526658122|FG000|Overall Study|Withdrawal by Subject|2|||
146040295|NCT02478255|526658123|FG001|Overall Study|Withdrawal by Subject|0|||
146099508|NCT02349542|526884555|FG000|Overall Study|Withdrawal by Subject|5|||
146099509|NCT01163266|526884556|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
146040296|NCT01730586|526658124|FG000|Overall Study|Progressive Disease|2|||
146040297|NCT01730586|526658124|FG000|Overall Study|Inadequate Trial|8|||
146040298|NCT01730586|526658124|FG000|Overall Study|Adverse Event|2|||
146040299|NCT01730586|526658124|FG000|Overall Study|Hospice|1|||
146040300|NCT01431963|526658125|FG000|Overall Study|Adverse Event|18|||
146040301|NCT01431963|526658125|FG000|Overall Study|Lack of Efficacy|7|||
146040302|NCT01431963|526658125|FG000|Overall Study|Protocol Violation|1|||
146040303|NCT01431963|526658125|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
146040304|NCT01431963|526658125|FG000|Overall Study|Physician Decision|4|||
146040305|NCT01431963|526658125|FG000|Overall Study|Withdrawal by Subject|3|||
146040306|NCT03343626|526660021|FG000|Overall Study|Lost to Follow-up|4|||
146040307|NCT03343626|526660022|FG001|Overall Study|Lost to Follow-up|3|||
146040308|NCT03343626|526660023|FG002|Overall Study|Lost to Follow-up|2|||
146099510|NCT01163266|526884557|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
146099511|NCT01163266|526884558|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
146099512|NCT01163266|526884556|FG000|Overall Study|Lack of Efficacy|1|||
146099513|NCT01163266|526884557|FG001|Overall Study|Lack of Efficacy|3|||
146099514|NCT01163266|526884558|FG002|Overall Study|Lack of Efficacy|1|||
146099515|NCT01163266|526884556|FG000|Overall Study|Noncompliance with Study Drug|0|||
146099516|NCT01163266|526884557|FG001|Overall Study|Noncompliance with Study Drug|2|||
146099517|NCT01163266|526884558|FG002|Overall Study|Noncompliance with Study Drug|0|||
146099518|NCT01163266|526884556|FG000|Overall Study|Protocol Deviations|2|||
146099519|NCT01163266|526884557|FG001|Overall Study|Protocol Deviations|2|||
146099520|NCT01163266|526884558|FG002|Overall Study|Protocol Deviations|5|||
146099521|NCT01163266|526884556|FG000|Overall Study|Withdrawal of Consent|5|||
146099522|NCT01163266|526884557|FG001|Overall Study|Withdrawal of Consent|7|||
146099523|NCT01163266|526884558|FG002|Overall Study|Withdrawal of Consent|3|||
146099524|NCT01163266|526884556|FG000|Overall Study|Lost to Follow-up|7|||
146099525|NCT01163266|526884557|FG001|Overall Study|Lost to Follow-up|7|||
146099526|NCT01163266|526884558|FG002|Overall Study|Lost to Follow-up|10|||
146040309|NCT03343626|526660024|FG003|Overall Study|Lost to Follow-up|5|||
146040310|NCT03343626|526660025|FG004|Overall Study|Lost to Follow-up|4|||
146040311|NCT03343626|526660026|FG005|Overall Study|Lost to Follow-up|4|||
146040312|NCT03343626|526660027|FG006|Overall Study|Lost to Follow-up|4|||
146040313|NCT03343626|526660028|FG007|Overall Study|Lost to Follow-up|7|||
146040314|NCT03343626|526660021|FG000|Overall Study|Withdrawal of Consent|2|||
146040315|NCT03343626|526660022|FG001|Overall Study|Withdrawal of Consent|1|||
146040316|NCT03343626|526660023|FG002|Overall Study|Withdrawal of Consent|0|||
146040317|NCT03343626|526660024|FG003|Overall Study|Withdrawal of Consent|3|||
146040318|NCT03343626|526660025|FG004|Overall Study|Withdrawal of Consent|3|||
146040319|NCT03343626|526660026|FG005|Overall Study|Withdrawal of Consent|1|||
146040320|NCT03343626|526660027|FG006|Overall Study|Withdrawal of Consent|1|||
146040321|NCT03343626|526660028|FG007|Overall Study|Withdrawal of Consent|2|||
146040322|NCT03343626|526660021|FG000|Overall Study|Reason not Specified|0|||
146040323|NCT03343626|526660022|FG001|Overall Study|Reason not Specified|1|||
146040324|NCT03343626|526660023|FG002|Overall Study|Reason not Specified|0|||
146040325|NCT03343626|526660024|FG003|Overall Study|Reason not Specified|0|||
146040326|NCT03343626|526660025|FG004|Overall Study|Reason not Specified|0|||
146040327|NCT03343626|526660026|FG005|Overall Study|Reason not Specified|0|||
146040328|NCT03343626|526660027|FG006|Overall Study|Reason not Specified|0|||
146040329|NCT03343626|526660028|FG007|Overall Study|Reason not Specified|1|||
146040330|NCT03343626|526660021|FG000|Overall Study|Data Entry Error|0|||
146099527|NCT01163266|526884556|FG000|Overall Study|Other|1|||
146099528|NCT01163266|526884557|FG001|Overall Study|Other|1|||
146099529|NCT01163266|526884558|FG002|Overall Study|Other|2|||
146099530|NCT02586064|526884559|FG000|Overall Study|Other Obligations|6|||
146099531|NCT02586064|526884560|FG001|Overall Study|Other Obligations|6|||
146099532|NCT02586064|526884559|FG000|Overall Study|Other|3|||
146099533|NCT02586064|526884560|FG001|Overall Study|Other|7|||
146099534|NCT02586064|526884559|FG000|Overall Study|Never Started|3|||
146099535|NCT02586064|526884560|FG001|Overall Study|Never Started|3|||
146099536|NCT02586064|526884559|FG000|Overall Study|Lost Interest|1|||
146099537|NCT02586064|526884560|FG001|Overall Study|Lost Interest|4|||
146099538|NCT02586064|526884559|FG000|Overall Study|Miscellaneous Life Issues|0|||
146040331|NCT03343626|526660022|FG001|Overall Study|Data Entry Error|0|||
146040332|NCT03343626|526660023|FG002|Overall Study|Data Entry Error|0|||
146099539|NCT02586064|526884560|FG001|Overall Study|Miscellaneous Life Issues|5|||
146099540|NCT02586064|526884559|FG000|Overall Study|Infrequent Attendance|2|||
146099541|NCT02586064|526884560|FG001|Overall Study|Infrequent Attendance|1|||
146040333|NCT03343626|526660024|FG003|Overall Study|Data Entry Error|0|||
146040334|NCT03343626|526660025|FG004|Overall Study|Data Entry Error|0|||
146040335|NCT03343626|526660026|FG005|Overall Study|Data Entry Error|0|||
146040336|NCT03343626|526660027|FG006|Overall Study|Data Entry Error|0|||
146040337|NCT03343626|526660028|FG007|Overall Study|Data Entry Error|1|||
146040338|NCT01487265|526660032|FG000|Overall Study|Adverse Event|8|||
146040339|NCT01487265|526660032|FG000|Overall Study|Withdrawal by Subject|5|||
146040340|NCT01487265|526660032|FG000|Overall Study|Disease Progression|21|||
146040341|NCT01487265|526660032|FG000|Overall Study|Death|2|||
146040342|NCT01487265|526660032|FG000|Overall Study|Still on Treatment|1|||
146040343|NCT01618695|526660033|FG000|Core Phase|Adverse Event|4|||
146040344|NCT01618695|526660034|FG001|Core Phase|Adverse Event|5|||
146040345|NCT01618695|526660035|FG002|Core Phase|Adverse Event|15|||
146040346|NCT01618695|526660036|FG003|Core Phase|Adverse Event|20|||
146040347|NCT01618695|526660033|FG000|Core Phase|Lost to Follow-up|0|||
146040348|NCT01618695|526660034|FG001|Core Phase|Lost to Follow-up|0|||
146040349|NCT01618695|526660035|FG002|Core Phase|Lost to Follow-up|1|||
146040350|NCT01618695|526660036|FG003|Core Phase|Lost to Follow-up|0|||
146040351|NCT01618695|526660033|FG000|Core Phase|Withdrawal by Subject|16|||
146040352|NCT01618695|526660034|FG001|Core Phase|Withdrawal by Subject|11|||
146040353|NCT01618695|526660035|FG002|Core Phase|Withdrawal by Subject|9|||
146040354|NCT01618695|526660036|FG003|Core Phase|Withdrawal by Subject|13|||
146040355|NCT01618695|526660033|FG000|Core Phase|Pregnancy|2|||
146040356|NCT01618695|526660034|FG001|Core Phase|Pregnancy|0|||
146040357|NCT01618695|526660035|FG002|Core Phase|Pregnancy|0|||
146040358|NCT01618695|526660036|FG003|Core Phase|Pregnancy|0|||
146040359|NCT01618695|526660033|FG000|Core Phase|Lack of Efficacy|1|||
146040360|NCT01618695|526660034|FG001|Core Phase|Lack of Efficacy|2|||
146040361|NCT01618695|526660035|FG002|Core Phase|Lack of Efficacy|1|||
146040362|NCT01618695|526660036|FG003|Core Phase|Lack of Efficacy|1|||
146040363|NCT01618695|526660033|FG000|Core Phase|Other than specified|1|||
146040364|NCT01618695|526660034|FG001|Core Phase|Other than specified|2|||
146040365|NCT01618695|526660035|FG002|Core Phase|Other than specified|2|||
146040366|NCT01618695|526660036|FG003|Core Phase|Other than specified|2|||
146040367|NCT01618695|526660033|FG000|Core Phase|Not treated|1|||
146040368|NCT01618695|526660034|FG001|Core Phase|Not treated|0|||
146040369|NCT01618695|526660035|FG002|Core Phase|Not treated|2|||
146040370|NCT01618695|526660036|FG003|Core Phase|Not treated|0|||
146040371|NCT01618695|526660033|FG000|Extension Phase|Lack of Efficacy|17|||
146040372|NCT01618695|526660034|FG001|Extension Phase|Lack of Efficacy|33|||
146040373|NCT01618695|526660035|FG002|Extension Phase|Lack of Efficacy|26|||
146040374|NCT01618695|526660036|FG003|Extension Phase|Lack of Efficacy|24|||
146040375|NCT01618695|526660033|FG000|Extension Phase|Pregnancy|2|||
146040376|NCT01618695|526660034|FG001|Extension Phase|Pregnancy|0|||
146040377|NCT01618695|526660035|FG002|Extension Phase|Pregnancy|1|||
146040378|NCT01618695|526660036|FG003|Extension Phase|Pregnancy|1|||
146040379|NCT01618695|526660033|FG000|Extension Phase|Withdrawal by Subject|43|||
146040380|NCT01618695|526660034|FG001|Extension Phase|Withdrawal by Subject|48|||
146040381|NCT01618695|526660035|FG002|Extension Phase|Withdrawal by Subject|42|||
146040382|NCT01618695|526660036|FG003|Extension Phase|Withdrawal by Subject|33|||
146040383|NCT01618695|526660033|FG000|Extension Phase|Adverse Event|18|||
146040384|NCT01618695|526660034|FG001|Extension Phase|Adverse Event|16|||
146040385|NCT01618695|526660035|FG002|Extension Phase|Adverse Event|9|||
146040386|NCT01618695|526660036|FG003|Extension Phase|Adverse Event|20|||
146040387|NCT01618695|526660033|FG000|Extension Phase|Lost to Follow-up|2|||
146040388|NCT01618695|526660034|FG001|Extension Phase|Lost to Follow-up|1|||
146040389|NCT01618695|526660035|FG002|Extension Phase|Lost to Follow-up|1|||
146040390|NCT01618695|526660036|FG003|Extension Phase|Lost to Follow-up|1|||
146099542|NCT02586064|526884559|FG000|Overall Study|Timed Out|2|||
146099543|NCT02586064|526884560|FG001|Overall Study|Timed Out|0|||
146099544|NCT02586064|526884559|FG000|Overall Study|AUD relapse|0|||
146040391|NCT01618695|526660033|FG000|Extension Phase|Other than specified|13|||
146040392|NCT01618695|526660034|FG001|Extension Phase|Other than specified|18|||
146099545|NCT02586064|526884560|FG001|Overall Study|AUD relapse|2|||
146099546|NCT02586064|526884559|FG000|Overall Study|Legal Issue|1|||
146254556|NCT02268526|527444612|FG000|Overall Study|Subject/guardian decision|0|||
146254557|NCT02268526|527444613|FG001|Overall Study|Subject/guardian decision|7|||
146040393|NCT01618695|526660035|FG002|Extension Phase|Other than specified|13|||
146040394|NCT01618695|526660036|FG003|Extension Phase|Other than specified|18|||
146040395|NCT02291419|526660037|FG000|Overall Study|Early study termination|1|||
146040396|NCT02291419|526660038|FG001|Overall Study|Early study termination|5|||
146040397|NCT01732770|526660043|FG000|Overall Study|Lost to Follow-up|2|||
146040398|NCT01732770|526660044|FG001|Overall Study|Lost to Follow-up|3|||
146099547|NCT02586064|526884560|FG001|Overall Study|Legal Issue|0|||
146040399|NCT01732770|526660043|FG000|Overall Study|Withdrawal by Subject|5|||
146040400|NCT01732770|526660044|FG001|Overall Study|Withdrawal by Subject|3|||
146040401|NCT01732770|526660043|FG000|Overall Study|Decision by Sponsor|2|||
146040402|NCT01732770|526660044|FG001|Overall Study|Decision by Sponsor|2|||
146040403|NCT01732770|526660043|FG000|Overall Study|Death|1|||
146040404|NCT01732770|526660044|FG001|Overall Study|Death|0|||
146040405|NCT03828617|526660050|FG000|Overall Study|Lost to Follow-up|22|||
146099548|NCT02158975|526884561|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
146099549|NCT02840721|526884562|FG000|Treatment Period|Adverse Event|1|||
146099550|NCT02840721|526884562|FG000|Follow-Up|Lack of Efficacy|1|||
146099551|NCT02840721|526884562|FG000|Follow-Up|Withdrawal by Subject|4|||
146099552|NCT02840721|526884562|FG000|Follow-Up|Withdrawal of Consent|2|||
146099553|NCT01967173|526884563|FG000|Overall Study|Lost to Follow-up|5|||
146099554|NCT01967173|526884564|FG001|Overall Study|Lost to Follow-up|3|||
146099555|NCT01967173|526884565|FG002|Overall Study|Lost to Follow-up|2|||
146099556|NCT01967173|526884566|FG003|Overall Study|Lost to Follow-up|4|||
146099557|NCT01967173|526884567|FG004|Overall Study|Lost to Follow-up|8|||
146099558|NCT01967173|526884568|FG005|Overall Study|Lost to Follow-up|12|||
146099559|NCT01967173|526884569|FG006|Overall Study|Lost to Follow-up|6|||
146099560|NCT01967173|526884570|FG007|Overall Study|Lost to Follow-up|8|||
146099561|NCT01967173|526884563|FG000|Overall Study|Physician Decision|2|||
146099562|NCT01967173|526884564|FG001|Overall Study|Physician Decision|0|||
146099563|NCT01967173|526884565|FG002|Overall Study|Physician Decision|2|||
146099564|NCT01967173|526884566|FG003|Overall Study|Physician Decision|1|||
146099565|NCT01967173|526884567|FG004|Overall Study|Physician Decision|1|||
146099566|NCT01967173|526884568|FG005|Overall Study|Physician Decision|1|||
146099567|NCT01967173|526884569|FG006|Overall Study|Physician Decision|1|||
146099568|NCT01967173|526884570|FG007|Overall Study|Physician Decision|0|||
146099569|NCT01967173|526884563|FG000|Overall Study|Lack of Efficacy|2|||
146099570|NCT01967173|526884564|FG001|Overall Study|Lack of Efficacy|0|||
146099571|NCT01967173|526884565|FG002|Overall Study|Lack of Efficacy|2|||
146099572|NCT01967173|526884566|FG003|Overall Study|Lack of Efficacy|2|||
146099573|NCT01967173|526884567|FG004|Overall Study|Lack of Efficacy|0|||
146099574|NCT01967173|526884568|FG005|Overall Study|Lack of Efficacy|1|||
146099575|NCT01967173|526884569|FG006|Overall Study|Lack of Efficacy|0|||
146099576|NCT01967173|526884570|FG007|Overall Study|Lack of Efficacy|2|||
146099577|NCT01967173|526884563|FG000|Overall Study|Pregnancy|0|||
146099578|NCT01967173|526884564|FG001|Overall Study|Pregnancy|0|||
146099579|NCT01967173|526884565|FG002|Overall Study|Pregnancy|0|||
146099580|NCT01967173|526884566|FG003|Overall Study|Pregnancy|0|||
146099581|NCT01967173|526884567|FG004|Overall Study|Pregnancy|0|||
146099582|NCT01967173|526884568|FG005|Overall Study|Pregnancy|0|||
146099583|NCT01967173|526884569|FG006|Overall Study|Pregnancy|1|||
146099584|NCT01967173|526884570|FG007|Overall Study|Pregnancy|1|||
146099585|NCT01967173|526884563|FG000|Overall Study|Adverse Event|0|||
146099586|NCT01967173|526884564|FG001|Overall Study|Adverse Event|0|||
146099587|NCT01967173|526884565|FG002|Overall Study|Adverse Event|0|||
146099588|NCT01967173|526884566|FG003|Overall Study|Adverse Event|0|||
146099589|NCT01967173|526884567|FG004|Overall Study|Adverse Event|0|||
146099590|NCT01967173|526884568|FG005|Overall Study|Adverse Event|0|||
146099591|NCT01967173|526884569|FG006|Overall Study|Adverse Event|0|||
146099592|NCT01967173|526884570|FG007|Overall Study|Adverse Event|1|||
146099593|NCT01967173|526884563|FG000|Overall Study|Withdrawal by Subject|15|||
146099594|NCT01967173|526884564|FG001|Overall Study|Withdrawal by Subject|14|||
146099595|NCT01967173|526884565|FG002|Overall Study|Withdrawal by Subject|10|||
146099596|NCT01967173|526884566|FG003|Overall Study|Withdrawal by Subject|7|||
146099597|NCT01967173|526884567|FG004|Overall Study|Withdrawal by Subject|8|||
146099598|NCT01967173|526884568|FG005|Overall Study|Withdrawal by Subject|9|||
146099599|NCT01967173|526884569|FG006|Overall Study|Withdrawal by Subject|10|||
146099600|NCT01967173|526884570|FG007|Overall Study|Withdrawal by Subject|12|||
146099601|NCT03540030|526884574|FG000|Overall Study|Withdrawal by Subject|2|||
146099602|NCT03540030|526884575|FG001|Overall Study|Withdrawal by Subject|1|||
146099603|NCT03540030|526884574|FG000|Overall Study|screen fail|7|||
146099604|NCT03540030|526884575|FG001|Overall Study|screen fail|1|||
146099605|NCT03540030|526884574|FG000|Overall Study|never had surgery after signing consent|9|||
146099606|NCT03540030|526884575|FG001|Overall Study|never had surgery after signing consent|1|||
146099607|NCT00397215|526884576|FG000|Month 0 (Day 0)|Adverse Event|0|||
146099608|NCT00397215|526884577|FG001|Month 0 (Day 0)|Adverse Event|1|||
146099609|NCT00397215|526884578|FG002|Month 0 (Day 0)|Adverse Event|0|||
146099610|NCT00397215|526884579|FG003|Month 0 (Day 0)|Adverse Event|0|||
146099611|NCT00397215|526884576|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
146099612|NCT00397215|526884577|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
146099613|NCT00397215|526884578|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
146099614|NCT00397215|526884579|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
146099615|NCT00397215|526884576|FG000|Month 0 (Day 0)|Other|4|||
146099616|NCT00397215|526884577|FG001|Month 0 (Day 0)|Other|1|||
146099617|NCT00397215|526884578|FG002|Month 0 (Day 0)|Other|3|||
146099618|NCT00397215|526884579|FG003|Month 0 (Day 0)|Other|3|||
146099619|NCT00397215|526884576|FG000|Month 6 (Day 180)|Adverse Event|0|||
146099620|NCT00397215|526884577|FG001|Month 6 (Day 180)|Adverse Event|3|||
146099621|NCT00397215|526884578|FG002|Month 6 (Day 180)|Adverse Event|2|||
146099622|NCT00397215|526884579|FG003|Month 6 (Day 180)|Adverse Event|0|||
146099623|NCT00397215|526884576|FG000|Month 6 (Day 180)|Other|2|||
146099624|NCT00397215|526884577|FG001|Month 6 (Day 180)|Other|0|||
146099625|NCT00397215|526884578|FG002|Month 6 (Day 180)|Other|3|||
146099626|NCT00397215|526884579|FG003|Month 6 (Day 180)|Other|0|||
146099627|NCT01361568|526884584|FG000|Overall Study|Adverse Event|0|||
146099628|NCT01361568|526884585|FG001|Overall Study|Adverse Event|0|||
146099629|NCT01361568|526884586|FG002|Overall Study|Adverse Event|0|||
146040406|NCT03828617|526660051|FG001|Overall Study|Lost to Follow-up|12|||
146040407|NCT03828617|526660052|FG002|Overall Study|Lost to Follow-up|23|||
146040408|NCT03828617|526660053|FG003|Overall Study|Lost to Follow-up|7|||
146040409|NCT03828617|526660050|FG000|Overall Study|No longer met eligibility criteria|0|||
146040410|NCT03828617|526660051|FG001|Overall Study|No longer met eligibility criteria|1|||
146040411|NCT03828617|526660052|FG002|Overall Study|No longer met eligibility criteria|1|||
146040412|NCT03828617|526660053|FG003|Overall Study|No longer met eligibility criteria|3|||
146040413|NCT03828617|526660050|FG000|Overall Study|Protocol Violation|0|||
146040414|NCT03828617|526660051|FG001|Overall Study|Protocol Violation|2|||
146040415|NCT03828617|526660052|FG002|Overall Study|Protocol Violation|0|||
146040416|NCT03828617|526660053|FG003|Overall Study|Protocol Violation|0|||
146040417|NCT03828617|526660050|FG000|Overall Study|Withdrawal by Subject|2|||
146040418|NCT03828617|526660051|FG001|Overall Study|Withdrawal by Subject|0|||
146040419|NCT03828617|526660052|FG002|Overall Study|Withdrawal by Subject|2|||
146040420|NCT03828617|526660053|FG003|Overall Study|Withdrawal by Subject|0|||
146040421|NCT01271725|526660054|FG000|Part A|Progressive disease according to RECIST|8|||
146040422|NCT01271725|526660055|FG001|Part A|Progressive disease according to RECIST|0|||
146040423|NCT01271725|526660054|FG000|Part A|Clinical signs/symptoms of progression|2|||
146040424|NCT01271725|526660055|FG001|Part A|Clinical signs/symptoms of progression|0|||
146040425|NCT01271725|526660054|FG000|Part A|Other Adverse Event|8|||
146040426|NCT01271725|526660055|FG001|Part A|Other Adverse Event|0|||
146040427|NCT01271725|526660054|FG000|Part A|Lost to Follow-up|1|||
146040428|NCT01271725|526660055|FG001|Part A|Lost to Follow-up|0|||
146040429|NCT01271725|526660054|FG000|Part A|Withdrawal by Subject|12|||
146040430|NCT01271725|526660055|FG001|Part A|Withdrawal by Subject|0|||
146040431|NCT01271725|526660054|FG000|Part A|Other than specified|3|||
146040432|NCT01271725|526660055|FG001|Part A|Other than specified|0|||
146040433|NCT01271725|526660054|FG000|Part A|Protocol Violation|1|||
146040434|NCT01271725|526660055|FG001|Part A|Protocol Violation|0|||
146040435|NCT01271725|526660054|FG000|Part B|Other than specified|0|||
146040436|NCT01271725|526660055|FG001|Part B|Other than specified|2|||
146040437|NCT01271725|526660054|FG000|Part B|Clinical signs/symptoms of progression|0|||
146040438|NCT01271725|526660055|FG001|Part B|Clinical signs/symptoms of progression|2|||
146040439|NCT01271725|526660054|FG000|Part B|Other Adverse Event|0|||
146040440|NCT01271725|526660055|FG001|Part B|Other Adverse Event|1|||
146040441|NCT01271725|526660054|FG000|Part B|Protocol Violation|0|||
146040442|NCT01271725|526660055|FG001|Part B|Protocol Violation|1|||
146040443|NCT01271725|526660054|FG000|Part B|Withdrawal by Subject|0|||
146040444|NCT01271725|526660055|FG001|Part B|Withdrawal by Subject|6|||
146040445|NCT02950480|526660058|FG000|Overall Study|Withdrawal by Subject|1|||
146040446|NCT02950480|526660059|FG001|Overall Study|Withdrawal by Subject|0|||
146040447|NCT01363661|526660066|FG000|Overall Study|Adverse Event|9|||
146040448|NCT01363661|526660067|FG001|Overall Study|Adverse Event|2|||
146040449|NCT01363661|526660066|FG000|Overall Study|Withdrawal by Subject|1|||
146040450|NCT01363661|526660067|FG001|Overall Study|Withdrawal by Subject|1|||
146040451|NCT01363661|526660066|FG000|Overall Study|Protocol Violation|1|||
146040452|NCT01363661|526660067|FG001|Overall Study|Protocol Violation|0|||
146040453|NCT01363661|526660066|FG000|Overall Study|Lost to Follow-up|3|||
146040454|NCT01363661|526660067|FG001|Overall Study|Lost to Follow-up|1|||
146040455|NCT01835223|526660068|FG000|Overall Study|Adverse Event|1|||
146040456|NCT01835223|526660069|FG001|Overall Study|Adverse Event|0|||
146040457|NCT01835223|526660068|FG000|Overall Study|Withdrawal by Subject|2|||
146040458|NCT01835223|526660069|FG001|Overall Study|Withdrawal by Subject|0|||
146040459|NCT01835223|526660068|FG000|Overall Study|Disease progression|2|||
146040460|NCT01835223|526660069|FG001|Overall Study|Disease progression|1|||
146040461|NCT01835223|526660068|FG000|Overall Study|Became Inelligible|4|||
146040462|NCT01835223|526660069|FG001|Overall Study|Became Inelligible|0|||
146040463|NCT03149055|526660074|FG000|Overall Study|Not treated|4|||
146040464|NCT01378325|526660075|FG000|Overall Study|Protocol Violation|0|||
146040465|NCT01378325|526660076|FG001|Overall Study|Protocol Violation|1|||
146040466|NCT01726582|526660077|FG000|Overall Study|Physician Decision|99|||
146040467|NCT01726582|526660077|FG000|Overall Study|Death|85|||
146040468|NCT02462720|526660078|FG000|Part 2|Withdrawal by Subject|1|||
146040469|NCT02462720|526660079|FG001|Part 2|Withdrawal by Subject|0|||
146040470|NCT02462720|526660078|FG000|Part 2|Protocol Violation|0|||
146040471|NCT02462720|526660079|FG001|Part 2|Protocol Violation|1|||
146040472|NCT00413036|526660080|FG000|Overall Study|Adverse Event|44|||
146040473|NCT00413036|526660080|FG000|Overall Study|Lack of Efficacy|129|||
146040474|NCT00413036|526660080|FG000|Overall Study|Withdrawal by Subject|7|||
146040475|NCT00413036|526660080|FG000|Overall Study|Death|9|||
146040476|NCT00413036|526660080|FG000|Overall Study|Other|26|||
146040477|NCT00413036|526660080|FG000|Overall Study|Missing|2|||
146040478|NCT00183625|526660085|FG000|Overall Study|Withdrawal by Subject|18|||
146040479|NCT00183625|526660086|FG001|Overall Study|Withdrawal by Subject|18|||
146040480|NCT00183625|526660087|FG002|Overall Study|Withdrawal by Subject|19|||
146040481|NCT00183625|526660088|FG003|Overall Study|Withdrawal by Subject|14|||
146040482|NCT00820222|526660096|FG000|Overall Study|Lost to Follow-up|10|||
146040483|NCT00820222|526660097|FG001|Overall Study|Lost to Follow-up|9|||
146040484|NCT00820222|526660096|FG000|Overall Study|Withdrawal by Subject|19|||
146040485|NCT00820222|526660097|FG001|Overall Study|Withdrawal by Subject|21|||
146040486|NCT00820222|526660096|FG000|Overall Study|Physician Decision|93|||
146040487|NCT00820222|526660097|FG001|Overall Study|Physician Decision|88|||
146040488|NCT00820222|526660096|FG000|Overall Study|Sponsor Terminated Study|43|||
146040489|NCT00820222|526660097|FG001|Overall Study|Sponsor Terminated Study|65|||
146040490|NCT00820222|526660096|FG000|Overall Study|Unkown|11|||
146040491|NCT00820222|526660097|FG001|Overall Study|Unkown|7|||
146040492|NCT04496453|526660098|FG000|Overall Study|Lost to Follow-up|6|||
146040493|NCT01361178|526660099|FG000|Overall Study|Death|13|||
146040494|NCT01361178|526660100|FG001|Overall Study|Death|0|||
146040495|NCT04294147|526660107|FG000|Overall Study|Protocol Violation|2|||
146040496|NCT04294147|526660108|FG001|Overall Study|Protocol Violation|0|||
146040497|NCT05392803|526660109|FG000|Overall Study|Lost to Follow-up|0|||
146040498|NCT05392803|526660110|FG001|Overall Study|Lost to Follow-up|2|||
146040499|NCT02332291|526660111|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
146040500|NCT02332291|526660112|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
146040501|NCT02332291|526660111|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
146040502|NCT02332291|526660112|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
146040503|NCT02332291|526660111|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
146040504|NCT02332291|526660112|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
146040505|NCT02332291|526660111|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
146040506|NCT02332291|526660112|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
146040507|NCT02332291|526660111|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
146040508|NCT02332291|526660112|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
146040509|NCT02332291|526660111|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
146040510|NCT02332291|526660112|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
146040511|NCT02828020|526660115|FG000|Treatment Period|Adverse Event|3|||
146040512|NCT02828020|526660116|FG001|Treatment Period|Adverse Event|1|||
146040513|NCT02828020|526660117|FG002|Treatment Period|Adverse Event|1|||
146040514|NCT02828020|526660115|FG000|Treatment Period|Withdrawal of Consent|10|||
146040515|NCT02828020|526660116|FG001|Treatment Period|Withdrawal of Consent|14|||
146040516|NCT02828020|526660117|FG002|Treatment Period|Withdrawal of Consent|9|||
146040517|NCT02828020|526660115|FG000|Treatment Period|Lost to Follow-up|21|||
146040518|NCT02828020|526660116|FG001|Treatment Period|Lost to Follow-up|24|||
146040519|NCT02828020|526660117|FG002|Treatment Period|Lost to Follow-up|18|||
146040520|NCT02828020|526660115|FG000|Treatment Period|Lack of Qualifying Event|44|||
146040521|NCT02828020|526660116|FG001|Treatment Period|Lack of Qualifying Event|53|||
146040522|NCT02828020|526660117|FG002|Treatment Period|Lack of Qualifying Event|43|||
146040523|NCT02828020|526660115|FG000|Treatment Period|Pregnancy|0|||
146040524|NCT02828020|526660116|FG001|Treatment Period|Pregnancy|2|||
146040525|NCT02828020|526660117|FG002|Treatment Period|Pregnancy|0|||
146040526|NCT02828020|526660115|FG000|Treatment Period|Protocol Violation|2|||
146040527|NCT02828020|526660116|FG001|Treatment Period|Protocol Violation|4|||
146040528|NCT02828020|526660117|FG002|Treatment Period|Protocol Violation|7|||
146040529|NCT02828020|526660115|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
146040530|NCT02828020|526660116|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
146040531|NCT02828020|526660117|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
146040532|NCT02828020|526660115|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
146040533|NCT02828020|526660116|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
146040534|NCT02828020|526660117|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
146040535|NCT02828020|526660115|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
146040536|NCT02828020|526660116|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
146040537|NCT02828020|526660117|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
146040538|NCT02828020|526660115|FG000|Safety Follow-up Period|Protocol Violation|0|||
146040539|NCT02828020|526660116|FG001|Safety Follow-up Period|Protocol Violation|2|||
146040540|NCT02828020|526660117|FG002|Safety Follow-up Period|Protocol Violation|1|||
146040541|NCT02828020|526660115|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
146040542|NCT02828020|526660116|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146040543|NCT02828020|526660117|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146040544|NCT03688620|526660118|FG000|Overall Study|Other|0|||
146040545|NCT03688620|526660119|FG001|Overall Study|Other|0|||
146040546|NCT03688620|526660120|FG002|Overall Study|Other|1|||
146040547|NCT03688620|526660118|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
146040548|NCT03688620|526660119|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
146040549|NCT03688620|526660120|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
146040550|NCT03688620|526660118|FG000|Overall Study|Lost to Follow-up|16|||
146040551|NCT03688620|526660119|FG001|Overall Study|Lost to Follow-up|0|||
146040552|NCT03688620|526660120|FG002|Overall Study|Lost to Follow-up|1|||
146040553|NCT03688620|526660118|FG000|Overall Study|Withdrawal by Subject|0|||
146040554|NCT03688620|526660119|FG001|Overall Study|Withdrawal by Subject|0|||
146099630|NCT01361568|526884587|FG003|Overall Study|Adverse Event|0|||
146040555|NCT03688620|526660120|FG002|Overall Study|Withdrawal by Subject|6|||
146099631|NCT01361568|526884588|FG004|Overall Study|Adverse Event|1|||
146040556|NCT01630889|526660129|FG000|Overall Study|Death|2|||
146040557|NCT01630889|526660129|FG000|Overall Study|Withdrawal by Subject|1|||
146040558|NCT01630889|526660129|FG000|Overall Study|Other than Specified|2|||
146040559|NCT01630889|526660129|FG000|Overall Study|Lost to Follow-up|4|||
146040560|NCT01630889|526660129|FG000|Overall Study|Other|1|||
146040561|NCT02974842|526660130|FG000|Overall Study|Withdrawal by Subject|4|||
146040562|NCT02974842|526660130|FG000|Overall Study|Screen failures|4|||
146040563|NCT01068158|526660136|FG000|Overall Study|Withdrawal by Subject|1|||
146040564|NCT01068158|526660137|FG001|Overall Study|Withdrawal by Subject|2|||
146040565|NCT01068158|526660136|FG000|Overall Study|Lost to Follow-up|7|||
146040566|NCT01068158|526660137|FG001|Overall Study|Lost to Follow-up|0|||
146040567|NCT01068158|526660136|FG000|Overall Study|Protocol Violation|0|||
146040568|NCT01068158|526660137|FG001|Overall Study|Protocol Violation|2|||
146040569|NCT01368081|526660144|FG000|Overall Study|Adverse Event|4|||
146040570|NCT01368081|526660145|FG001|Overall Study|Adverse Event|4|||
146040571|NCT01368081|526660146|FG002|Overall Study|Adverse Event|3|||
146040572|NCT01368081|526660147|FG003|Overall Study|Adverse Event|2|||
146040573|NCT01368081|526660148|FG004|Overall Study|Adverse Event|2|||
146040574|NCT01368081|526660149|FG005|Overall Study|Adverse Event|5|||
146040575|NCT01368081|526660150|FG006|Overall Study|Adverse Event|6|||
146040576|NCT01368081|526660151|FG007|Overall Study|Adverse Event|2|||
146040577|NCT01368081|526660152|FG008|Overall Study|Adverse Event|3|||
146040578|NCT01368081|526660153|FG009|Overall Study|Adverse Event|5|||
146040579|NCT01368081|526660154|FG010|Overall Study|Adverse Event|6|||
146040580|NCT01368081|526660155|FG011|Overall Study|Adverse Event|1|||
146040581|NCT01368081|526660156|FG012|Overall Study|Adverse Event|3|||
146040582|NCT01368081|526660144|FG000|Overall Study|Lack of Efficacy|0|||
146040583|NCT01368081|526660145|FG001|Overall Study|Lack of Efficacy|1|||
146040584|NCT01368081|526660146|FG002|Overall Study|Lack of Efficacy|0|||
146040585|NCT01368081|526660147|FG003|Overall Study|Lack of Efficacy|1|||
146040586|NCT01368081|526660148|FG004|Overall Study|Lack of Efficacy|0|||
146040587|NCT01368081|526660149|FG005|Overall Study|Lack of Efficacy|0|||
146040588|NCT01368081|526660150|FG006|Overall Study|Lack of Efficacy|0|||
146040589|NCT01368081|526660151|FG007|Overall Study|Lack of Efficacy|2|||
146040590|NCT01368081|526660152|FG008|Overall Study|Lack of Efficacy|0|||
146040591|NCT01368081|526660153|FG009|Overall Study|Lack of Efficacy|0|||
146040592|NCT01368081|526660154|FG010|Overall Study|Lack of Efficacy|0|||
146040593|NCT01368081|526660155|FG011|Overall Study|Lack of Efficacy|0|||
146040594|NCT01368081|526660156|FG012|Overall Study|Lack of Efficacy|0|||
146040595|NCT01368081|526660144|FG000|Overall Study|Protocol Violation|0|||
146040596|NCT01368081|526660145|FG001|Overall Study|Protocol Violation|0|||
146040597|NCT01368081|526660146|FG002|Overall Study|Protocol Violation|0|||
146040598|NCT01368081|526660147|FG003|Overall Study|Protocol Violation|0|||
146040599|NCT01368081|526660148|FG004|Overall Study|Protocol Violation|0|||
146040600|NCT01368081|526660149|FG005|Overall Study|Protocol Violation|1|||
146040601|NCT01368081|526660150|FG006|Overall Study|Protocol Violation|0|||
146040602|NCT01368081|526660151|FG007|Overall Study|Protocol Violation|1|||
146040603|NCT01368081|526660152|FG008|Overall Study|Protocol Violation|0|||
146040604|NCT01368081|526660153|FG009|Overall Study|Protocol Violation|0|||
146040605|NCT01368081|526660154|FG010|Overall Study|Protocol Violation|0|||
146040606|NCT01368081|526660155|FG011|Overall Study|Protocol Violation|0|||
146040607|NCT01368081|526660156|FG012|Overall Study|Protocol Violation|0|||
146040608|NCT01368081|526660144|FG000|Overall Study|Lost to Follow-up|0|||
146040609|NCT01368081|526660145|FG001|Overall Study|Lost to Follow-up|0|||
146040610|NCT01368081|526660146|FG002|Overall Study|Lost to Follow-up|0|||
146040611|NCT01368081|526660147|FG003|Overall Study|Lost to Follow-up|0|||
146040612|NCT01368081|526660148|FG004|Overall Study|Lost to Follow-up|0|||
146040613|NCT01368081|526660149|FG005|Overall Study|Lost to Follow-up|0|||
146040614|NCT01368081|526660150|FG006|Overall Study|Lost to Follow-up|0|||
146040615|NCT01368081|526660151|FG007|Overall Study|Lost to Follow-up|0|||
146040616|NCT01368081|526660152|FG008|Overall Study|Lost to Follow-up|0|||
146099632|NCT01361568|526884589|FG005|Overall Study|Adverse Event|0|||
146300585|NCT00283049|527617052|FG000|Overall Study|No longer requires study treatment|0|||
146040617|NCT01368081|526660153|FG009|Overall Study|Lost to Follow-up|0|||
146040618|NCT01368081|526660154|FG010|Overall Study|Lost to Follow-up|0|||
146040619|NCT01368081|526660155|FG011|Overall Study|Lost to Follow-up|0|||
146040620|NCT01368081|526660156|FG012|Overall Study|Lost to Follow-up|1|||
146040621|NCT01368081|526660144|FG000|Overall Study|Withdrawal by Subject|4|||
146300586|NCT00283049|527617053|FG001|Overall Study|No longer requires study treatment|0|||
146300587|NCT00283049|527617054|FG002|Overall Study|No longer requires study treatment|1|||
146300588|NCT01086410|527617055|FG000|Overall Study|Adverse Event|1|||
146300589|NCT01086410|527617056|FG001|Overall Study|Adverse Event|0|||
146300590|NCT01086410|527617057|FG002|Overall Study|Adverse Event|0|||
146300591|NCT01086410|527617058|FG003|Overall Study|Adverse Event|2|||
146040622|NCT01368081|526660145|FG001|Overall Study|Withdrawal by Subject|4|||
146040623|NCT01368081|526660146|FG002|Overall Study|Withdrawal by Subject|1|||
146040624|NCT01368081|526660147|FG003|Overall Study|Withdrawal by Subject|1|||
146040625|NCT01368081|526660148|FG004|Overall Study|Withdrawal by Subject|0|||
146040626|NCT01368081|526660149|FG005|Overall Study|Withdrawal by Subject|3|||
146040627|NCT01368081|526660150|FG006|Overall Study|Withdrawal by Subject|4|||
146300592|NCT01086410|527617055|FG000|Overall Study|Lack of Efficacy|1|||
146300593|NCT01086410|527617056|FG001|Overall Study|Lack of Efficacy|1|||
146300594|NCT01086410|527617057|FG002|Overall Study|Lack of Efficacy|0|||
146300595|NCT01086410|527617058|FG003|Overall Study|Lack of Efficacy|0|||
146300596|NCT01086410|527617055|FG000|Overall Study|Protocol Violation|1|||
146300597|NCT01086410|527617056|FG001|Overall Study|Protocol Violation|1|||
146300598|NCT01086410|527617057|FG002|Overall Study|Protocol Violation|0|||
146300599|NCT01086410|527617058|FG003|Overall Study|Protocol Violation|0|||
146300600|NCT01086410|527617055|FG000|Overall Study|Lost to Follow-up|0|||
146300601|NCT01086410|527617056|FG001|Overall Study|Lost to Follow-up|0|||
146300602|NCT01086410|527617057|FG002|Overall Study|Lost to Follow-up|1|||
146300603|NCT01086410|527617058|FG003|Overall Study|Lost to Follow-up|0|||
146300604|NCT01950247|527617059|FG000|Overall Study|Withdrawal by Subject|28|||
146300605|NCT01950247|527617060|FG001|Overall Study|Withdrawal by Subject|13|||
146300606|NCT01950247|527617059|FG000|Overall Study|Lost to Follow-up|18|||
146300607|NCT01950247|527617060|FG001|Overall Study|Lost to Follow-up|16|||
146300608|NCT01950247|527617059|FG000|Overall Study|Physician Decision|3|||
146300609|NCT01950247|527617060|FG001|Overall Study|Physician Decision|4|||
146300610|NCT01950247|527617059|FG000|Overall Study|Adverse Event|3|||
146040628|NCT01368081|526660151|FG007|Overall Study|Withdrawal by Subject|2|||
146040629|NCT01368081|526660152|FG008|Overall Study|Withdrawal by Subject|5|||
146040630|NCT01368081|526660153|FG009|Overall Study|Withdrawal by Subject|4|||
146040631|NCT01368081|526660154|FG010|Overall Study|Withdrawal by Subject|3|||
146040632|NCT01368081|526660155|FG011|Overall Study|Withdrawal by Subject|2|||
146040633|NCT01368081|526660156|FG012|Overall Study|Withdrawal by Subject|0|||
146040634|NCT01368081|526660144|FG000|Overall Study|Other reason not defined above|2|||
146040635|NCT01368081|526660145|FG001|Overall Study|Other reason not defined above|0|||
146040636|NCT01368081|526660146|FG002|Overall Study|Other reason not defined above|0|||
146040637|NCT01368081|526660147|FG003|Overall Study|Other reason not defined above|1|||
146040638|NCT01368081|526660148|FG004|Overall Study|Other reason not defined above|0|||
146040639|NCT01368081|526660149|FG005|Overall Study|Other reason not defined above|1|||
146040640|NCT01368081|526660150|FG006|Overall Study|Other reason not defined above|2|||
146040641|NCT01368081|526660151|FG007|Overall Study|Other reason not defined above|0|||
146040642|NCT01368081|526660152|FG008|Overall Study|Other reason not defined above|0|||
146040643|NCT01368081|526660153|FG009|Overall Study|Other reason not defined above|1|||
146040644|NCT01368081|526660154|FG010|Overall Study|Other reason not defined above|0|||
146040645|NCT01368081|526660155|FG011|Overall Study|Other reason not defined above|0|||
146040646|NCT01368081|526660156|FG012|Overall Study|Other reason not defined above|3|||
146040647|NCT00238238|526660162|FG000|Overall Study|Withdrawal by Subject|0|||
146040648|NCT00238238|526660163|FG001|Overall Study|Withdrawal by Subject|3|||
146040649|NCT00238238|526660164|FG002|Overall Study|Withdrawal by Subject|0|||
146040650|NCT01007838|526660165|FG000|Overall Study|Withdrawal by Subject|1|||
146040651|NCT01007838|526660166|FG001|Overall Study|Withdrawal by Subject|0|||
146040652|NCT01007838|526660167|FG002|Overall Study|Withdrawal by Subject|0|||
146040653|NCT01007838|526660168|FG003|Overall Study|Withdrawal by Subject|0|||
146040654|NCT01007838|526660165|FG000|Overall Study|Physician Decision|1|||
146040655|NCT01007838|526660166|FG001|Overall Study|Physician Decision|0|||
146040656|NCT01007838|526660167|FG002|Overall Study|Physician Decision|0|||
146040657|NCT01007838|526660168|FG003|Overall Study|Physician Decision|0|||
146040658|NCT01007838|526660165|FG000|Overall Study|Started home haemodialysis|1|||
146040659|NCT01007838|526660166|FG001|Overall Study|Started home haemodialysis|0|||
146040660|NCT01007838|526660167|FG002|Overall Study|Started home haemodialysis|0|||
146040661|NCT01007838|526660168|FG003|Overall Study|Started home haemodialysis|0|||
146040662|NCT02277119|526660172|FG000|Overall Study|Lack of Efficacy|1|||
146040663|NCT02277119|526660173|FG001|Overall Study|Lack of Efficacy|1|||
146040664|NCT02277119|526660174|FG002|Overall Study|Lack of Efficacy|1|||
146040665|NCT02277119|526660172|FG000|Overall Study|Protocol Violation|2|||
146040666|NCT02277119|526660173|FG001|Overall Study|Protocol Violation|3|||
146040667|NCT02277119|526660174|FG002|Overall Study|Protocol Violation|7|||
146040668|NCT04699461|526660175|FG000|Overall Study|Withdrawal by Subject|1|||
146040669|NCT04699461|526660176|FG001|Overall Study|Withdrawal by Subject|0|||
146040670|NCT04699461|526660175|FG000|Overall Study|Study termination by sponsor|2|||
146040671|NCT04699461|526660176|FG001|Overall Study|Study termination by sponsor|1|||
146040672|NCT04699461|526660175|FG000|Overall Study|Death|1|||
146040673|NCT04699461|526660176|FG001|Overall Study|Death|0|||
146040674|NCT04699461|526660175|FG000|Overall Study|Radiographic progression|0|||
146040675|NCT04699461|526660176|FG001|Overall Study|Radiographic progression|1|||
146040676|NCT03068767|526660182|FG000|Overall Study|Lost to Follow-up|7|||
146040677|NCT03068767|526660183|FG001|Overall Study|Lost to Follow-up|3|||
146040678|NCT03068767|526660182|FG000|Overall Study|Protocol Violation|3|||
146040679|NCT03068767|526660183|FG001|Overall Study|Protocol Violation|0|||
146040680|NCT00061633|526660184|FG000|Overall Study|Adverse Event|1|||
146040681|NCT00061633|526660185|FG001|Overall Study|Adverse Event|2|||
146099633|NCT01361568|526884584|FG000|Overall Study|Physician Decision|0|||
146099634|NCT01361568|526884585|FG001|Overall Study|Physician Decision|0|||
146099635|NCT01361568|526884586|FG002|Overall Study|Physician Decision|0|||
146300611|NCT01950247|527617060|FG001|Overall Study|Adverse Event|2|||
146300612|NCT01950247|527617059|FG000|Overall Study|Death|1|||
146040682|NCT00061633|526660184|FG000|Overall Study|Withdrawal by Subject|2|||
146040683|NCT00061633|526660185|FG001|Overall Study|Withdrawal by Subject|2|||
146040684|NCT00061633|526660184|FG000|Overall Study|Lost to Follow-up|1|||
146040685|NCT00061633|526660185|FG001|Overall Study|Lost to Follow-up|4|||
146040686|NCT00061633|526660184|FG000|Overall Study|Other|1|||
146040687|NCT00061633|526660185|FG001|Overall Study|Other|1|||
146040688|NCT00061633|526660184|FG000|Overall Study|Never received study treatment|0|||
146040689|NCT00061633|526660185|FG001|Overall Study|Never received study treatment|2|||
146040690|NCT01370265|526661960|FG000|First Intervention|Adverse Event|1|||
146040691|NCT01370265|526661961|FG001|First Intervention|Adverse Event|1|||
146040692|NCT02611817|526661962|FG000|Open-label Induction Phase|Reason not Specified|9|||
146040693|NCT02611817|526661963|FG001|Open-label Induction Phase|Reason not Specified|0|||
146040694|NCT02611817|526661964|FG002|Open-label Induction Phase|Reason not Specified|0|||
146040695|NCT02611817|526661962|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
146040696|NCT02611817|526661963|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
146040697|NCT02611817|526661964|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
146040698|NCT02611817|526661962|FG000|Open-label Induction Phase|Pregnancy|1|||
146040699|NCT02611817|526661963|FG001|Open-label Induction Phase|Pregnancy|0|||
146040700|NCT02611817|526661964|FG002|Open-label Induction Phase|Pregnancy|0|||
146040701|NCT02611817|526661962|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
146040702|NCT02611817|526661963|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
146040703|NCT02611817|526661964|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
146040704|NCT02611817|526661962|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
146040705|NCT02611817|526661963|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
146040706|NCT02611817|526661964|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
146040707|NCT02611817|526661962|FG000|Open-label Induction Phase|Protocol Violation|5|||
146040708|NCT02611817|526661963|FG001|Open-label Induction Phase|Protocol Violation|0|||
146040709|NCT02611817|526661964|FG002|Open-label Induction Phase|Protocol Violation|0|||
146040710|NCT02611817|526661962|FG000|Open-label Induction Phase|Adverse Event|16|||
146040711|NCT02611817|526661963|FG001|Open-label Induction Phase|Adverse Event|0|||
146040712|NCT02611817|526661964|FG002|Open-label Induction Phase|Adverse Event|0|||
146040713|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
146040714|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
146040715|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
146040716|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
146040717|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
146040718|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
146040719|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
146040720|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
146040721|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
146040722|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
146040723|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
146040724|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
146040725|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
146040726|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
146040727|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
146040728|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
146040729|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
146040730|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
146040731|NCT02611817|526661962|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
146040732|NCT02611817|526661963|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
146040733|NCT02611817|526661964|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
146040734|NCT03077919|526661965|FG000|Overall Study|Lost to Follow-up|4|||
146040735|NCT03077919|526661966|FG001|Overall Study|Lost to Follow-up|1|||
146040736|NCT03738618|526661967|FG000|Overall Study|Protocol deviation|23|||
146040737|NCT03738618|526661968|FG001|Overall Study|Protocol deviation|0|||
146040738|NCT03738618|526661967|FG000|Overall Study|Adverse Event|4|||
146040739|NCT03738618|526661968|FG001|Overall Study|Adverse Event|0|||
146040740|NCT03738618|526661967|FG000|Overall Study|Lost to Follow-up|2|||
146040741|NCT03738618|526661968|FG001|Overall Study|Lost to Follow-up|0|||
146040742|NCT03738618|526661967|FG000|Overall Study|Randomization failure|1|||
146040743|NCT03738618|526661968|FG001|Overall Study|Randomization failure|0|||
146040744|NCT03738618|526661967|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
146040745|NCT03738618|526661968|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
146040746|NCT03738618|526661967|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
146040747|NCT03738618|526661968|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
146040748|NCT00826618|526661969|FG000|Overall Study|Withdrawal by Subject|1|||
146040749|NCT03499314|526661972|FG000|Overall Study|Time Commitment|1|||
146040750|NCT03499314|526661973|FG001|Overall Study|Time Commitment|2|||
146040751|NCT03499314|526661972|FG000|Overall Study|Medical issue unrelated to research study|1|||
146040752|NCT03499314|526661973|FG001|Overall Study|Medical issue unrelated to research study|1|||
146099636|NCT01361568|526884587|FG003|Overall Study|Physician Decision|0|||
146099637|NCT01361568|526884588|FG004|Overall Study|Physician Decision|0|||
146099638|NCT01361568|526884589|FG005|Overall Study|Physician Decision|1|||
146099639|NCT01361568|526884584|FG000|Overall Study|Withdrawal by Subject|2|||
146099640|NCT01361568|526884585|FG001|Overall Study|Withdrawal by Subject|1|||
146099641|NCT01361568|526884586|FG002|Overall Study|Withdrawal by Subject|0|||
146099642|NCT01361568|526884587|FG003|Overall Study|Withdrawal by Subject|0|||
146099643|NCT01361568|526884588|FG004|Overall Study|Withdrawal by Subject|0|||
146099644|NCT01361568|526884589|FG005|Overall Study|Withdrawal by Subject|1|||
146099645|NCT02728596|526884590|FG000|Overall Study|Refusal unrelated to adverse event|3|||
146099646|NCT02728596|526884591|FG001|Overall Study|Refusal unrelated to adverse event|6|||
146099647|NCT02728596|526884592|FG002|Overall Study|Refusal unrelated to adverse event|7|||
146099648|NCT02728596|526884593|FG003|Overall Study|Refusal unrelated to adverse event|7|||
146099649|NCT02728596|526884590|FG000|Overall Study|Death|44|||
146099650|NCT02728596|526884591|FG001|Overall Study|Death|42|||
146099651|NCT02728596|526884592|FG002|Overall Study|Death|123|||
146099652|NCT02728596|526884593|FG003|Overall Study|Death|68|||
146099653|NCT03439657|526884594|FG000|Overall Study|Adverse Event|2|||
146099654|NCT03439657|526884595|FG001|Overall Study|Adverse Event|3|||
146099655|NCT03439657|526884594|FG000|Overall Study|Lost to Follow-up|1|||
146099656|NCT03439657|526884595|FG001|Overall Study|Lost to Follow-up|0|||
146099657|NCT03439657|526884594|FG000|Overall Study|Protocol Violation|1|||
146099658|NCT03439657|526884595|FG001|Overall Study|Protocol Violation|1|||
146099659|NCT03439657|526884594|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
146099660|NCT03439657|526884595|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
146099661|NCT00370071|526884597|FG000|Overall Study|Withdrawal by Subject|2|||
146099662|NCT03553927|526884600|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
146099663|NCT03553927|526884601|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
146099664|NCT03553927|526884600|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
146099665|NCT03553927|526884601|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
146099666|NCT02557295|526884610|FG000|Overall Study|Withdrawal by Subject|9|||
146099667|NCT02557295|526884611|FG001|Overall Study|Withdrawal by Subject|2|||
146099668|NCT02557295|526884612|FG002|Overall Study|Withdrawal by Subject|4|||
146099669|NCT02557295|526884613|FG003|Overall Study|Withdrawal by Subject|0|||
146099670|NCT02557295|526884614|FG004|Overall Study|Withdrawal by Subject|0|||
146099671|NCT02557295|526884615|FG005|Overall Study|Withdrawal by Subject|0|||
146099672|NCT02557295|526884616|FG006|Overall Study|Withdrawal by Subject|15|||
146099673|NCT02557295|526884617|FG007|Overall Study|Withdrawal by Subject|1|||
146099674|NCT02557295|526884618|FG008|Overall Study|Withdrawal by Subject|3|||
146099675|NCT02557295|526884610|FG000|Overall Study|Disease Progression|0|||
146099676|NCT02557295|526884611|FG001|Overall Study|Disease Progression|0|||
146099677|NCT02557295|526884612|FG002|Overall Study|Disease Progression|0|||
146099678|NCT02557295|526884613|FG003|Overall Study|Disease Progression|0|||
146099679|NCT02557295|526884614|FG004|Overall Study|Disease Progression|0|||
146099680|NCT02557295|526884615|FG005|Overall Study|Disease Progression|0|||
146099681|NCT02557295|526884616|FG006|Overall Study|Disease Progression|1|||
146099682|NCT02557295|526884617|FG007|Overall Study|Disease Progression|0|||
146099683|NCT02557295|526884618|FG008|Overall Study|Disease Progression|0|||
146099684|NCT02557295|526884610|FG000|Overall Study|Lack of Efficacy|24|||
146099685|NCT02557295|526884611|FG001|Overall Study|Lack of Efficacy|1|||
146099686|NCT02557295|526884612|FG002|Overall Study|Lack of Efficacy|3|||
146099687|NCT02557295|526884613|FG003|Overall Study|Lack of Efficacy|0|||
146099688|NCT02557295|526884614|FG004|Overall Study|Lack of Efficacy|0|||
146099689|NCT02557295|526884615|FG005|Overall Study|Lack of Efficacy|0|||
146099690|NCT02557295|526884616|FG006|Overall Study|Lack of Efficacy|12|||
146099691|NCT02557295|526884617|FG007|Overall Study|Lack of Efficacy|1|||
146099692|NCT02557295|526884618|FG008|Overall Study|Lack of Efficacy|0|||
146099693|NCT02557295|526884610|FG000|Overall Study|Adverse Event|16|||
146099694|NCT02557295|526884611|FG001|Overall Study|Adverse Event|2|||
146099695|NCT02557295|526884612|FG002|Overall Study|Adverse Event|3|||
146099696|NCT02557295|526884613|FG003|Overall Study|Adverse Event|0|||
146099697|NCT02557295|526884614|FG004|Overall Study|Adverse Event|0|||
146099698|NCT02557295|526884615|FG005|Overall Study|Adverse Event|0|||
146099699|NCT02557295|526884616|FG006|Overall Study|Adverse Event|2|||
146099700|NCT02557295|526884617|FG007|Overall Study|Adverse Event|1|||
146099701|NCT02557295|526884618|FG008|Overall Study|Adverse Event|1|||
146099702|NCT02557295|526884610|FG000|Overall Study|Lost to Follow-up|4|||
146099703|NCT02557295|526884611|FG001|Overall Study|Lost to Follow-up|0|||
146099704|NCT02557295|526884612|FG002|Overall Study|Lost to Follow-up|0|||
146099705|NCT02557295|526884613|FG003|Overall Study|Lost to Follow-up|0|||
146099706|NCT02557295|526884614|FG004|Overall Study|Lost to Follow-up|0|||
146099707|NCT02557295|526884615|FG005|Overall Study|Lost to Follow-up|0|||
146099708|NCT02557295|526884616|FG006|Overall Study|Lost to Follow-up|9|||
146099709|NCT02557295|526884617|FG007|Overall Study|Lost to Follow-up|0|||
146099710|NCT02557295|526884618|FG008|Overall Study|Lost to Follow-up|0|||
146099711|NCT02557295|526884610|FG000|Overall Study|Study Close|54|||
146099712|NCT02557295|526884611|FG001|Overall Study|Study Close|3|||
146099713|NCT02557295|526884612|FG002|Overall Study|Study Close|5|||
146099714|NCT02557295|526884613|FG003|Overall Study|Study Close|3|||
146099715|NCT02557295|526884614|FG004|Overall Study|Study Close|0|||
146099716|NCT02557295|526884615|FG005|Overall Study|Study Close|0|||
146099717|NCT02557295|526884616|FG006|Overall Study|Study Close|37|||
146099718|NCT02557295|526884617|FG007|Overall Study|Study Close|3|||
146099719|NCT02557295|526884618|FG008|Overall Study|Study Close|19|||
146099720|NCT02557295|526884610|FG000|Overall Study|except for study close|4|||
146099721|NCT02557295|526884611|FG001|Overall Study|except for study close|0|||
146099722|NCT02557295|526884612|FG002|Overall Study|except for study close|0|||
146099723|NCT02557295|526884613|FG003|Overall Study|except for study close|0|||
146099724|NCT02557295|526884614|FG004|Overall Study|except for study close|0|||
146099725|NCT02557295|526884615|FG005|Overall Study|except for study close|0|||
146099726|NCT02557295|526884616|FG006|Overall Study|except for study close|5|||
146099727|NCT02557295|526884617|FG007|Overall Study|except for study close|1|||
146099728|NCT02557295|526884618|FG008|Overall Study|except for study close|0|||
146099729|NCT03487549|526884619|FG000|Overall Study|Protocol Violation|0|||
146099730|NCT03487549|526884620|FG001|Overall Study|Protocol Violation|1|||
146099731|NCT03487549|526884619|FG000|Overall Study|Lost to Follow-up|2|||
146099732|NCT03487549|526884620|FG001|Overall Study|Lost to Follow-up|1|||
146099733|NCT03487549|526884619|FG000|Overall Study|Withdrawal by Subject|2|||
146099734|NCT03487549|526884620|FG001|Overall Study|Withdrawal by Subject|0|||
146099735|NCT01313858|526886437|FG000|Overall Study|Premature Treatment Termination|251|||
146099736|NCT01313858|526886438|FG001|Overall Study|Premature Treatment Termination|219|||
146099737|NCT01313858|526886439|FG002|Overall Study|Premature Treatment Termination|191|||
146099738|NCT01313858|526886437|FG000|Overall Study|Lost to Follow-up|35|||
146099739|NCT01313858|526886438|FG001|Overall Study|Lost to Follow-up|51|||
146099740|NCT01313858|526886439|FG002|Overall Study|Lost to Follow-up|47|||
146099741|NCT01626456|526886442|FG000|Overall Study|Withdrawal by Subject|21|||
146099742|NCT01626456|526886443|FG001|Overall Study|Withdrawal by Subject|46|||
146099743|NCT01626456|526886442|FG000|Overall Study|Adverse Event|2|||
146099744|NCT01626456|526886443|FG001|Overall Study|Adverse Event|27|||
146099745|NCT01626456|526886442|FG000|Overall Study|Lost to Follow-up|2|||
146099746|NCT01626456|526886443|FG001|Overall Study|Lost to Follow-up|27|||
146099747|NCT01626456|526886442|FG000|Overall Study|Lack of Efficacy|6|||
146099748|NCT01626456|526886443|FG001|Overall Study|Lack of Efficacy|7|||
146099749|NCT01626456|526886442|FG000|Overall Study|Physician Decision|1|||
146099750|NCT01626456|526886443|FG001|Overall Study|Physician Decision|4|||
146099751|NCT01626456|526886442|FG000|Overall Study|Protocol Violation|1|||
146099752|NCT01626456|526886443|FG001|Overall Study|Protocol Violation|1|||
146099753|NCT01626456|526886442|FG000|Overall Study|Site Closure|2|||
146099754|NCT01626456|526886443|FG001|Overall Study|Site Closure|3|||
146099755|NCT01626456|526886442|FG000|Overall Study|Incarceration|0|||
146099756|NCT01626456|526886443|FG001|Overall Study|Incarceration|2|||
146099757|NCT01816074|526886444|FG000|Phase 1|Time commitment issues|0|||
146099758|NCT01816074|526886445|FG001|Phase 1|Time commitment issues|0|||
146099759|NCT01816074|526886446|FG002|Phase 1|Time commitment issues|1|||
146099760|NCT01816074|526886447|FG003|Phase 1|Time commitment issues|0|||
146099761|NCT01816074|526886444|FG000|Phase 2|Time commitment Issues|0|||
146099762|NCT01816074|526886445|FG001|Phase 2|Time commitment Issues|2|||
146099763|NCT01816074|526886446|FG002|Phase 2|Time commitment Issues|0|||
146099764|NCT01816074|526886447|FG003|Phase 2|Time commitment Issues|0|||
146099765|NCT01816074|526886444|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
146099766|NCT01816074|526886445|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
146099767|NCT01816074|526886446|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
146099768|NCT01816074|526886447|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
146099769|NCT01816074|526886444|FG000|Phase 2|Physician Decision|0|||
146099770|NCT01816074|526886445|FG001|Phase 2|Physician Decision|0|||
146099771|NCT01816074|526886446|FG002|Phase 2|Physician Decision|0|||
146099772|NCT01816074|526886447|FG003|Phase 2|Physician Decision|1|||
146099773|NCT01816074|526886444|FG000|Phase 2|Withdrawal by Subject|1|||
146099774|NCT01816074|526886445|FG001|Phase 2|Withdrawal by Subject|0|||
146099775|NCT01816074|526886446|FG002|Phase 2|Withdrawal by Subject|0|||
146099776|NCT01816074|526886447|FG003|Phase 2|Withdrawal by Subject|0|||
146099777|NCT00131508|526886455|FG000|Overall Study|Disease progression|0|||
146099778|NCT00131508|526886456|FG001|Overall Study|Disease progression|2|||
146099779|NCT00131508|526886455|FG000|Overall Study|Non-Compliance|2|||
146099780|NCT00131508|526886456|FG001|Overall Study|Non-Compliance|4|||
146099781|NCT00131508|526886455|FG000|Overall Study|Withdrawal by Subject|1|||
146099782|NCT00131508|526886456|FG001|Overall Study|Withdrawal by Subject|2|||
146099783|NCT01330030|526886457|FG000|Overall Study|Lost to Follow-up|16|||
146099784|NCT01330030|526886458|FG001|Overall Study|Lost to Follow-up|17|||
146099785|NCT00845858|526886459|FG000|Overall Study|Withdrawal by Subject|5|||
146099786|NCT00845858|526886460|FG001|Overall Study|Withdrawal by Subject|1|||
146099787|NCT00845858|526886461|FG002|Overall Study|Withdrawal by Subject|1|||
146099788|NCT00845858|526886459|FG000|Overall Study|Adverse Event|3|||
146099789|NCT00845858|526886460|FG001|Overall Study|Adverse Event|8|||
146099790|NCT00845858|526886461|FG002|Overall Study|Adverse Event|4|||
146099791|NCT00845858|526886459|FG000|Overall Study|Protocol Violation|0|||
146099792|NCT00845858|526886460|FG001|Overall Study|Protocol Violation|0|||
146099793|NCT00845858|526886461|FG002|Overall Study|Protocol Violation|1|||
146040753|NCT00872599|526661974|FG000|Second Washout Period|Adverse Event|1|||
146040754|NCT00872599|526661975|FG001|Second Washout Period|Adverse Event|1|||
146040755|NCT04794270|526661976|FG000|Period 1|Non Compliance|1|||
146040756|NCT04794270|526661977|FG001|Period 1|Non Compliance|0|||
146040757|NCT04794270|526661976|FG000|Period 1|Adverse Event|1|||
146040758|NCT04794270|526661977|FG001|Period 1|Adverse Event|0|||
146040759|NCT04794270|526661976|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
146040760|NCT04794270|526661977|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
146040761|NCT02510001|526661980|FG000|Overall Study|Early disease progression|0|||
146040762|NCT02510001|526661981|FG001|Overall Study|Early disease progression|0|||
146040763|NCT02510001|526661982|FG002|Overall Study|Early disease progression|0|||
146040764|NCT02510001|526661983|FG003|Overall Study|Early disease progression|1|||
146040765|NCT02510001|526661984|FG004|Overall Study|Early disease progression|1|||
146040766|NCT02510001|526661985|FG005|Overall Study|Early disease progression|1|||
146040767|NCT02510001|526661986|FG006|Overall Study|Early disease progression|0|||
146040768|NCT02510001|526661987|FG007|Overall Study|Early disease progression|0|||
146040769|NCT02510001|526661980|FG000|Overall Study|Adverse Event|0|||
146040770|NCT02510001|526661981|FG001|Overall Study|Adverse Event|0|||
146040771|NCT02510001|526661982|FG002|Overall Study|Adverse Event|0|||
146040772|NCT02510001|526661983|FG003|Overall Study|Adverse Event|1|||
146040773|NCT02510001|526661984|FG004|Overall Study|Adverse Event|2|||
146040774|NCT02510001|526661985|FG005|Overall Study|Adverse Event|1|||
146040775|NCT02510001|526661986|FG006|Overall Study|Adverse Event|2|||
146040776|NCT02510001|526661987|FG007|Overall Study|Adverse Event|5|||
146040777|NCT02510001|526661980|FG000|Overall Study|Physician Decision|0|||
146040778|NCT02510001|526661981|FG001|Overall Study|Physician Decision|0|||
146040779|NCT02510001|526661982|FG002|Overall Study|Physician Decision|0|||
146040780|NCT02510001|526661983|FG003|Overall Study|Physician Decision|0|||
146040781|NCT02510001|526661984|FG004|Overall Study|Physician Decision|1|||
146040782|NCT02510001|526661985|FG005|Overall Study|Physician Decision|0|||
146040783|NCT02510001|526661986|FG006|Overall Study|Physician Decision|0|||
146040784|NCT02510001|526661987|FG007|Overall Study|Physician Decision|0|||
146040785|NCT02510001|526661980|FG000|Overall Study|Withdrawal by Subject|0|||
146040786|NCT02510001|526661981|FG001|Overall Study|Withdrawal by Subject|0|||
146040787|NCT02510001|526661982|FG002|Overall Study|Withdrawal by Subject|0|||
146040788|NCT02510001|526661983|FG003|Overall Study|Withdrawal by Subject|0|||
146040789|NCT02510001|526661984|FG004|Overall Study|Withdrawal by Subject|0|||
146040790|NCT02510001|526661985|FG005|Overall Study|Withdrawal by Subject|0|||
146040791|NCT02510001|526661986|FG006|Overall Study|Withdrawal by Subject|0|||
146040792|NCT02510001|526661987|FG007|Overall Study|Withdrawal by Subject|2|||
146040793|NCT00303485|526662001|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
146040794|NCT00303485|526662002|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
146040795|NCT00303485|526662001|FG000|Overall Study|Failure to return|0|||
146040796|NCT00303485|526662002|FG001|Overall Study|Failure to return|1|||
146040797|NCT00303485|526662001|FG000|Overall Study|Withdrawal by Subject|1|||
146040798|NCT00303485|526662002|FG001|Overall Study|Withdrawal by Subject|0|||
146040799|NCT01504841|526662003|FG000|Overall Study|Withdrawal by Subject|1|||
146040800|NCT01504841|526662004|FG001|Overall Study|Withdrawal by Subject|1|||
146040801|NCT01504841|526662005|FG002|Overall Study|Withdrawal by Subject|0|||
146040802|NCT01496469|526662013|FG000|Overall Study|Adverse Event|1|||
146040803|NCT01496469|526662014|FG001|Overall Study|Adverse Event|0|||
146040804|NCT01496469|526662013|FG000|Overall Study|Protocol Violation|2|||
146040805|NCT01496469|526662014|FG001|Overall Study|Protocol Violation|0|||
146040806|NCT01496469|526662013|FG000|Overall Study|Lost to Follow-up|1|||
146040807|NCT01496469|526662014|FG001|Overall Study|Lost to Follow-up|1|||
146040808|NCT01496469|526662013|FG000|Overall Study|Withdrawal by Subject|4|||
146040809|NCT01496469|526662014|FG001|Overall Study|Withdrawal by Subject|4|||
146040810|NCT01496469|526662013|FG000|Overall Study|BP exceeds protocol limits|1|||
146040811|NCT01496469|526662014|FG001|Overall Study|BP exceeds protocol limits|2|||
146040812|NCT01496469|526662013|FG000|Overall Study|Other|1|||
146040813|NCT01496469|526662014|FG001|Overall Study|Other|1|||
146040814|NCT00630344|526662016|FG000|Overall Study|Adverse Event|5|||
146040815|NCT00630344|526662016|FG000|Overall Study|Progressive Disease|19|||
146040816|NCT00630344|526662016|FG000|Overall Study|Physician Decision|9|||
146040817|NCT00630344|526662016|FG000|Overall Study|Withdrawal by Subject|1|||
146040818|NCT00630344|526662016|FG000|Overall Study|Intercurrent Illness|1|||
146040819|NCT00630344|526662016|FG000|Overall Study|Other|1|||
146040820|NCT01357551|526662017|FG000|Overall Study|Withdrawal by Subject|6|||
146040821|NCT01357551|526662018|FG001|Overall Study|Withdrawal by Subject|4|||
146040822|NCT01357551|526662017|FG000|Overall Study|Death|0|||
146040823|NCT01357551|526662018|FG001|Overall Study|Death|1|||
146040824|NCT01357551|526662017|FG000|Overall Study|Lost to Follow-up|16|||
146040825|NCT01357551|526662018|FG001|Overall Study|Lost to Follow-up|6|||
146040826|NCT00891228|526662021|FG000|Overall Study|Adverse Event|0|||
146099794|NCT00845858|526886459|FG000|Overall Study|not eligible|0|||
146040827|NCT00891228|526662022|FG001|Overall Study|Adverse Event|2|||
146040828|NCT00891228|526662023|FG002|Overall Study|Adverse Event|3|||
146040829|NCT00891228|526662021|FG000|Overall Study|Withdrawal by Subject|2|||
146099795|NCT00845858|526886460|FG001|Overall Study|not eligible|3|||
146040830|NCT00891228|526662022|FG001|Overall Study|Withdrawal by Subject|4|||
146040831|NCT00891228|526662023|FG002|Overall Study|Withdrawal by Subject|5|||
146040832|NCT00891228|526662021|FG000|Overall Study|Protocol Violation|3|||
146040833|NCT00891228|526662022|FG001|Overall Study|Protocol Violation|1|||
146040834|NCT00891228|526662023|FG002|Overall Study|Protocol Violation|2|||
146040835|NCT00891228|526662021|FG000|Overall Study|Physician Decision|2|||
146040836|NCT00891228|526662022|FG001|Overall Study|Physician Decision|1|||
146040837|NCT00891228|526662023|FG002|Overall Study|Physician Decision|0|||
146040838|NCT00891228|526662021|FG000|Overall Study|Lost to Follow-up|4|||
146040839|NCT00891228|526662022|FG001|Overall Study|Lost to Follow-up|4|||
146040840|NCT00891228|526662023|FG002|Overall Study|Lost to Follow-up|5|||
146040841|NCT00891228|526662021|FG000|Overall Study|Pregnancy|0|||
146040842|NCT00891228|526662022|FG001|Overall Study|Pregnancy|1|||
146040843|NCT00891228|526662023|FG002|Overall Study|Pregnancy|0|||
146040844|NCT02688985|526662032|FG000|Overall Study|Adverse Event|1|||
146040845|NCT02688985|526662033|FG001|Overall Study|Adverse Event|2|||
146040846|NCT02688985|526662034|FG002|Overall Study|Adverse Event|2|||
146040847|NCT02688985|526662035|FG003|Overall Study|Adverse Event|0|||
146040848|NCT02688985|526662036|FG004|Overall Study|Adverse Event|0|||
146040849|NCT02688985|526662032|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
146040850|NCT02688985|526662033|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
146040851|NCT02688985|526662034|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
146040852|NCT02688985|526662035|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
146040853|NCT02688985|526662036|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
146040854|NCT02688985|526662032|FG000|Overall Study|Death|0|||
146040855|NCT02688985|526662033|FG001|Overall Study|Death|0|||
146040856|NCT02688985|526662034|FG002|Overall Study|Death|0|||
146040857|NCT02688985|526662035|FG003|Overall Study|Death|0|||
146040858|NCT02688985|526662036|FG004|Overall Study|Death|1|||
146040859|NCT02688985|526662032|FG000|Overall Study|Lack of Efficacy|0|||
146040860|NCT02688985|526662033|FG001|Overall Study|Lack of Efficacy|0|||
146040861|NCT02688985|526662034|FG002|Overall Study|Lack of Efficacy|0|||
146040862|NCT02688985|526662035|FG003|Overall Study|Lack of Efficacy|0|||
146040863|NCT02688985|526662036|FG004|Overall Study|Lack of Efficacy|1|||
146040864|NCT02688985|526662032|FG000|Overall Study|Lost to Follow-up|2|||
146040865|NCT02688985|526662033|FG001|Overall Study|Lost to Follow-up|0|||
146040866|NCT02688985|526662034|FG002|Overall Study|Lost to Follow-up|1|||
146040867|NCT02688985|526662035|FG003|Overall Study|Lost to Follow-up|1|||
146040868|NCT02688985|526662036|FG004|Overall Study|Lost to Follow-up|1|||
146040869|NCT02688985|526662032|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146040870|NCT02688985|526662033|FG001|Overall Study|Non-Compliance With Study Drug|3|||
146040871|NCT02688985|526662034|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146040872|NCT02688985|526662035|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146040873|NCT02688985|526662036|FG004|Overall Study|Non-Compliance With Study Drug|1|||
146040874|NCT02688985|526662032|FG000|Overall Study|Other|3|||
146040875|NCT02688985|526662033|FG001|Overall Study|Other|4|||
146040876|NCT02688985|526662034|FG002|Overall Study|Other|1|||
146040877|NCT02688985|526662035|FG003|Overall Study|Other|0|||
146040878|NCT02688985|526662036|FG004|Overall Study|Other|0|||
146040879|NCT02688985|526662032|FG000|Overall Study|Physician Decision|2|||
146040880|NCT02688985|526662033|FG001|Overall Study|Physician Decision|2|||
146040881|NCT02688985|526662034|FG002|Overall Study|Physician Decision|0|||
146040882|NCT02688985|526662035|FG003|Overall Study|Physician Decision|0|||
146040883|NCT02688985|526662036|FG004|Overall Study|Physician Decision|1|||
146040884|NCT02688985|526662032|FG000|Overall Study|Pregnancy|0|||
146040885|NCT02688985|526662033|FG001|Overall Study|Pregnancy|0|||
146040886|NCT02688985|526662034|FG002|Overall Study|Pregnancy|2|||
146040887|NCT02688985|526662035|FG003|Overall Study|Pregnancy|1|||
146040888|NCT02688985|526662036|FG004|Overall Study|Pregnancy|0|||
146040889|NCT02688985|526662032|FG000|Overall Study|Study Terminated By Sponsor|0|||
146040890|NCT02688985|526662033|FG001|Overall Study|Study Terminated By Sponsor|0|||
146040891|NCT02688985|526662034|FG002|Overall Study|Study Terminated By Sponsor|0|||
146040892|NCT02688985|526662035|FG003|Overall Study|Study Terminated By Sponsor|1|||
146040893|NCT02688985|526662036|FG004|Overall Study|Study Terminated By Sponsor|0|||
146040894|NCT02688985|526662032|FG000|Overall Study|Withdrawal by Subject|2|||
146040895|NCT02688985|526662033|FG001|Overall Study|Withdrawal by Subject|8|||
146040896|NCT02688985|526662034|FG002|Overall Study|Withdrawal by Subject|7|||
146040897|NCT02688985|526662035|FG003|Overall Study|Withdrawal by Subject|1|||
146040898|NCT02688985|526662036|FG004|Overall Study|Withdrawal by Subject|4|||
146040899|NCT00930553|526662039|FG000|Overall Study|Adverse Event|1|||
146040900|NCT00930553|526662039|FG000|Overall Study|Lack of Efficacy|7|||
146040901|NCT00930553|526662039|FG000|Overall Study|Physician Decision|39|||
146040902|NCT00930553|526662039|FG000|Overall Study|Protocol Violation|1|||
146040903|NCT00930553|526662039|FG000|Overall Study|Pregnancy|1|||
146040904|NCT00930553|526662039|FG000|Overall Study|Withdrawal by Subject|88|||
146040905|NCT00930553|526662039|FG000|Overall Study|Lost to Follow-up|25|||
146040906|NCT00930553|526662039|FG000|Overall Study|Death|9|||
146040907|NCT00930553|526662039|FG000|Overall Study|Study terminated by sponsor|24|||
146040908|NCT00930553|526662039|FG000|Overall Study|Other than specified above|28|||
146040909|NCT01964963|526662040|FG000|Overall Study|Case Report Forms Uncollected|888|||
146040910|NCT01964963|526662040|FG000|Overall Study|Protocol Deviation|50|||
146040911|NCT01964963|526662040|FG000|Overall Study|Data Reliability was not Assured|5|||
146040912|NCT01235234|526662041|FG000|Overall Study|Adverse Event|2|||
146040913|NCT01235234|526662042|FG001|Overall Study|Adverse Event|2|||
146040914|NCT01235234|526662043|FG002|Overall Study|Adverse Event|1|||
146040915|NCT02630472|526662044|FG000|Overall Study|Physician Decision|10|||
146040916|NCT02630472|526662045|FG001|Overall Study|Physician Decision|0|||
146040917|NCT03704688|526662050|FG000|Overall Study|Adverse Event|0|||
146040918|NCT03704688|526662051|FG001|Overall Study|Adverse Event|0|||
146040919|NCT03704688|526662052|FG002|Overall Study|Adverse Event|0|||
146040920|NCT03704688|526662053|FG003|Overall Study|Adverse Event|4|||
146040921|NCT03704688|526662054|FG004|Overall Study|Adverse Event|1|||
146040922|NCT03704688|526662055|FG005|Overall Study|Adverse Event|0|||
146040923|NCT03704688|526662050|FG000|Overall Study|Disease Progression|0|||
146040924|NCT03704688|526662051|FG001|Overall Study|Disease Progression|0|||
146040925|NCT03704688|526662052|FG002|Overall Study|Disease Progression|0|||
146040926|NCT03704688|526662053|FG003|Overall Study|Disease Progression|3|||
146040927|NCT03704688|526662054|FG004|Overall Study|Disease Progression|1|||
146040928|NCT03704688|526662055|FG005|Overall Study|Disease Progression|0|||
146040929|NCT03704688|526662050|FG000|Overall Study|Death|0|||
146040930|NCT03704688|526662051|FG001|Overall Study|Death|0|||
146040931|NCT03704688|526662052|FG002|Overall Study|Death|0|||
146040932|NCT03704688|526662053|FG003|Overall Study|Death|0|||
146040933|NCT03704688|526662054|FG004|Overall Study|Death|3|||
146040934|NCT03704688|526662055|FG005|Overall Study|Death|0|||
146040935|NCT00787189|526662056|FG000|Overall Study|Lost to Follow-up|2|||
146040936|NCT00787189|526662057|FG001|Overall Study|Lost to Follow-up|2|||
146040937|NCT03250182|526662058|FG000|Overall Study|Withdrawal by Subject|1|||
146040938|NCT01068769|526662059|FG000|Overall Study|Ineligible|1|||
146040939|NCT03671304|526662064|FG000|Overall Study|study terminated|7|||
146040940|NCT00596830|526662065|FG000|Overall Study|Death|258|||
146040941|NCT00596830|526662066|FG001|Overall Study|Death|247|||
146040942|NCT00596830|526662065|FG000|Overall Study|Lost to Follow-up|7|||
146040943|NCT00596830|526662066|FG001|Overall Study|Lost to Follow-up|11|||
146040944|NCT00596830|526662065|FG000|Overall Study|Withdrawal by Subject|22|||
146040945|NCT00596830|526662066|FG001|Overall Study|Withdrawal by Subject|12|||
146040946|NCT00596830|526662065|FG000|Overall Study|Study terminated by sponsor|51|||
146040947|NCT00596830|526662066|FG001|Overall Study|Study terminated by sponsor|62|||
146040948|NCT00596830|526662065|FG000|Overall Study|Follow-up was discontinued|1|||
146040949|NCT00596830|526662066|FG001|Overall Study|Follow-up was discontinued|0|||
146040950|NCT00596830|526662065|FG000|Overall Study|Randomized but not treated|3|||
146040951|NCT00596830|526662066|FG001|Overall Study|Randomized but not treated|7|||
146040952|NCT00887926|526662067|FG000|Overall Study|Withdrawal by Subject|0|||
146040953|NCT00887926|526662068|FG001|Overall Study|Withdrawal by Subject|1|||
146040954|NCT00887926|526662069|FG002|Overall Study|Withdrawal by Subject|0|||
146040955|NCT00887926|526662070|FG003|Overall Study|Withdrawal by Subject|0|||
146040956|NCT02097030|526662071|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
146040957|NCT02097030|526662072|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
146040958|NCT02097030|526662071|FG000|First Intervention (3 Days)|Visual Acuity|0|||
146040959|NCT02097030|526662072|FG001|First Intervention (3 Days)|Visual Acuity|1|||
146040960|NCT00774800|526662073|FG000|Intervention 4|Withdrawal by Subject|1|||
146040961|NCT01973998|526662078|FG000|Overall Study|Death|2|||
146040962|NCT01973998|526662079|FG001|Overall Study|Death|2|||
146040963|NCT00646399|526662080|FG000|Overall Study|Death|63|||
146040964|NCT00646399|526662081|FG001|Overall Study|Death|53|||
146040965|NCT00646399|526662080|FG000|Overall Study|Withdrawal by Subject|9|||
146040966|NCT00646399|526662081|FG001|Overall Study|Withdrawal by Subject|10|||
146040967|NCT00646399|526662080|FG000|Overall Study|Other Reason|11|||
146040968|NCT00646399|526662081|FG001|Overall Study|Other Reason|11|||
146040969|NCT02540993|526662084|FG000|Overall Study|Lost to Follow-up|5|||
146040970|NCT02540993|526662085|FG001|Overall Study|Lost to Follow-up|3|||
146040971|NCT02540993|526662084|FG000|Overall Study|Withdrawal by Subject|4|||
146040972|NCT02540993|526662085|FG001|Overall Study|Withdrawal by Subject|6|||
146040973|NCT02540993|526662084|FG000|Overall Study|GCP violations|33|||
146040974|NCT02540993|526662085|FG001|Overall Study|GCP violations|27|||
146040975|NCT00844558|526662086|FG000|Overall Study|Withdrawal by Subject|9|||
146040976|NCT00844558|526662087|FG001|Overall Study|Withdrawal by Subject|2|||
146254558|NCT02268526|527444614|FG002|Overall Study|Subject/guardian decision|3|||
146040977|NCT00844558|526662086|FG000|Overall Study|Death|1|||
146040978|NCT00844558|526662087|FG001|Overall Study|Death|0|||
146040979|NCT00844558|526662086|FG000|Overall Study|Protocol Violation|1|||
146040980|NCT00844558|526662087|FG001|Overall Study|Protocol Violation|1|||
146040981|NCT00844558|526662086|FG000|Overall Study|Lost to Follow-up|0|||
146040982|NCT00844558|526662087|FG001|Overall Study|Lost to Follow-up|1|||
146040983|NCT00844558|526662086|FG000|Overall Study|Physician Decision|1|||
146040984|NCT00844558|526662087|FG001|Overall Study|Physician Decision|0|||
146040985|NCT00588094|526662088|FG000|Overall Study|Adverse Event|3|||
146040986|NCT00588094|526662088|FG000|Overall Study|Progression of Disease|2|||
146040987|NCT01336023|526662089|FG000|Week 0 to Week 26|Adverse Event|8|||
146040988|NCT01336023|526662090|FG001|Week 0 to Week 26|Adverse Event|10|||
146040989|NCT01336023|526662091|FG002|Week 0 to Week 26|Adverse Event|24|||
146040990|NCT01336023|526662089|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
146040991|NCT01336023|526662090|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
146040992|NCT01336023|526662091|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
146040993|NCT01336023|526662089|FG000|Week 0 to Week 26|Protocol Violation|1|||
146040994|NCT01336023|526662090|FG001|Week 0 to Week 26|Protocol Violation|2|||
146040995|NCT01336023|526662091|FG002|Week 0 to Week 26|Protocol Violation|0|||
146040996|NCT01336023|526662089|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
146040997|NCT01336023|526662090|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
146040998|NCT01336023|526662091|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
146040999|NCT01336023|526662089|FG000|Week 0 to Week 26|Unclassified|5|||
146041000|NCT01336023|526662090|FG001|Week 0 to Week 26|Unclassified|16|||
146041001|NCT01336023|526662091|FG002|Week 0 to Week 26|Unclassified|9|||
146041002|NCT01336023|526662089|FG000|Week 27 to 52|Adverse Event|1|||
146041003|NCT01336023|526662090|FG001|Week 27 to 52|Adverse Event|5|||
146041004|NCT01336023|526662091|FG002|Week 27 to 52|Adverse Event|2|||
146041005|NCT01336023|526662089|FG000|Week 27 to 52|Protocol Violation|0|||
146041006|NCT01336023|526662090|FG001|Week 27 to 52|Protocol Violation|2|||
146041007|NCT01336023|526662091|FG002|Week 27 to 52|Protocol Violation|1|||
146041008|NCT01336023|526662089|FG000|Week 27 to 52|Withdrawal Criteria|14|||
146041009|NCT01336023|526662090|FG001|Week 27 to 52|Withdrawal Criteria|19|||
146041010|NCT01336023|526662091|FG002|Week 27 to 52|Withdrawal Criteria|16|||
146041011|NCT01336023|526662089|FG000|Week 27 to 52|Unclassified|13|||
146041012|NCT01336023|526662090|FG001|Week 27 to 52|Unclassified|18|||
146041013|NCT01336023|526662091|FG002|Week 27 to 52|Unclassified|9|||
146041014|NCT02202538|526662092|FG000|Overall Study|Withdrawal by Subject|5|||
146041015|NCT02202538|526662092|FG000|Overall Study|Did not meet all inclusion criteria|2|||
146041016|NCT02202538|526662092|FG000|Overall Study|Investigator Decision|1|||
146041017|NCT01457846|526662093|FG000|Overall Study|Death before treatment|1|||
146041018|NCT01457846|526662094|FG001|Overall Study|Death before treatment|2|||
146041019|NCT01457846|526662093|FG000|Overall Study|Did not receive treatment|0|||
146041020|NCT01457846|526662094|FG001|Overall Study|Did not receive treatment|1|||
146041021|NCT01457846|526662093|FG000|Overall Study|Death|27|||
146041022|NCT01457846|526662094|FG001|Overall Study|Death|16|||
146041023|NCT01457846|526662093|FG000|Overall Study|Unclassified reason for not completed|11|||
146041024|NCT01457846|526662094|FG001|Overall Study|Unclassified reason for not completed|10|||
146041025|NCT01457846|526662093|FG000|Overall Study|Withdrawal by Subject|1|||
146041026|NCT01457846|526662094|FG001|Overall Study|Withdrawal by Subject|1|||
146041027|NCT01457846|526662093|FG000|Overall Study|Lost to Follow-up|1|||
146041028|NCT01457846|526662094|FG001|Overall Study|Lost to Follow-up|0|||
146041029|NCT01846741|526662095|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
146041030|NCT01853878|526662096|FG000|Overall Study|Recurrence|2|||
146041031|NCT01853878|526662097|FG001|Overall Study|Recurrence|0|||
146041032|NCT01853878|526662096|FG000|Overall Study|Adverse Event|2|||
146041033|NCT01853878|526662097|FG001|Overall Study|Adverse Event|0|||
146041034|NCT01853878|526662096|FG000|Overall Study|Withdrawal by Subject|3|||
146041035|NCT01853878|526662097|FG001|Overall Study|Withdrawal by Subject|1|||
146041036|NCT01853878|526662096|FG000|Overall Study|Migrated/moved from the study area|1|||
146041037|NCT01853878|526662097|FG001|Overall Study|Migrated/moved from the study area|0|||
146041038|NCT01853878|526662096|FG000|Overall Study|Other|55|||
146041039|NCT01853878|526662097|FG001|Overall Study|Other|43|||
146041040|NCT00465647|526662104|FG000|Overall Study|Administrative|2|||
146041041|NCT00465647|526662105|FG001|Overall Study|Administrative|2|||
146041042|NCT00465647|526662106|FG002|Overall Study|Administrative|3|||
146041043|NCT00465647|526662107|FG003|Overall Study|Administrative|2|||
146041044|NCT00465647|526662104|FG000|Overall Study|Adverse Event|2|||
146041045|NCT00465647|526662105|FG001|Overall Study|Adverse Event|0|||
146041046|NCT00465647|526662106|FG002|Overall Study|Adverse Event|3|||
146041047|NCT00465647|526662107|FG003|Overall Study|Adverse Event|2|||
146041048|NCT00465647|526662104|FG000|Overall Study|Withdrawal by Subject|1|||
146041049|NCT00465647|526662105|FG001|Overall Study|Withdrawal by Subject|2|||
146041050|NCT00465647|526662106|FG002|Overall Study|Withdrawal by Subject|2|||
146041051|NCT00465647|526662107|FG003|Overall Study|Withdrawal by Subject|7|||
146041052|NCT00465647|526662104|FG000|Overall Study|"The other reasons included loss of IV"|8|||
146041053|NCT00465647|526662105|FG001|Overall Study|"The other reasons included loss of IV"|4|||
146041054|NCT00465647|526662106|FG002|Overall Study|"The other reasons included loss of IV"|3|||
146041055|NCT00465647|526662107|FG003|Overall Study|"The other reasons included loss of IV"|2|||
146041056|NCT03916081|526662108|FG000|Overall Study|Adverse Event|1|||
146041057|NCT03916081|526662109|FG001|Overall Study|Adverse Event|0|||
146041058|NCT03916081|526662110|FG002|Overall Study|Adverse Event|0|||
146041059|NCT03916081|526662108|FG000|Overall Study|Physician Decision|0|||
146041060|NCT03916081|526662109|FG001|Overall Study|Physician Decision|0|||
146041061|NCT03916081|526662110|FG002|Overall Study|Physician Decision|1|||
146041062|NCT03916081|526662108|FG000|Overall Study|Lost to Follow-up|0|||
146041063|NCT03916081|526662109|FG001|Overall Study|Lost to Follow-up|1|||
146041064|NCT03916081|526662110|FG002|Overall Study|Lost to Follow-up|0|||
146041065|NCT03916081|526662108|FG000|Overall Study|Withdrawal by Subject|3|||
146099796|NCT00845858|526886461|FG002|Overall Study|not eligible|2|||
146099797|NCT02980783|526886462|FG000|Overall Study|Lost to Follow-up|1|||
146099798|NCT00850070|526886463|FG000|Overall Study|Lack of Efficacy|1|||
146099799|NCT00850070|526886464|FG001|Overall Study|Lack of Efficacy|1|||
146099800|NCT00850070|526886463|FG000|Overall Study|Adverse Event|2|||
146099801|NCT00850070|526886464|FG001|Overall Study|Adverse Event|0|||
146099802|NCT03758443|526886465|FG000|Induction Period|Adverse Event|2|||
146099803|NCT03758443|526886466|FG001|Induction Period|Adverse Event|4|||
146099804|NCT03758443|526886467|FG002|Induction Period|Adverse Event|2|||
146099805|NCT03758443|526886468|FG003|Induction Period|Adverse Event|3|||
146099806|NCT03758443|526886465|FG000|Induction Period|Physician Decision|1|||
146099807|NCT03758443|526886466|FG001|Induction Period|Physician Decision|1|||
146099808|NCT03758443|526886467|FG002|Induction Period|Physician Decision|3|||
146099809|NCT03758443|526886468|FG003|Induction Period|Physician Decision|0|||
146099810|NCT03758443|526886465|FG000|Induction Period|Protocol Violation|0|||
146099811|NCT03758443|526886466|FG001|Induction Period|Protocol Violation|0|||
146099812|NCT03758443|526886467|FG002|Induction Period|Protocol Violation|0|||
146099813|NCT03758443|526886468|FG003|Induction Period|Protocol Violation|1|||
146099814|NCT03758443|526886465|FG000|Induction Period|Withdrawal by Subject|3|||
146099815|NCT03758443|526886466|FG001|Induction Period|Withdrawal by Subject|2|||
146099816|NCT03758443|526886467|FG002|Induction Period|Withdrawal by Subject|2|||
146099817|NCT03758443|526886468|FG003|Induction Period|Withdrawal by Subject|4|||
146099818|NCT03758443|526886465|FG000|Extended Induction Period|Adverse Event|1|||
146099819|NCT03758443|526886466|FG001|Extended Induction Period|Adverse Event|1|||
146099820|NCT03758443|526886467|FG002|Extended Induction Period|Adverse Event|0|||
146099821|NCT03758443|526886468|FG003|Extended Induction Period|Adverse Event|1|||
146099822|NCT03758443|526886465|FG000|Extended Induction Period|Lost to Follow-up|1|||
146099823|NCT03758443|526886466|FG001|Extended Induction Period|Lost to Follow-up|0|||
146099824|NCT03758443|526886467|FG002|Extended Induction Period|Lost to Follow-up|0|||
146099825|NCT03758443|526886468|FG003|Extended Induction Period|Lost to Follow-up|0|||
146099826|NCT03758443|526886465|FG000|Extended Induction Period|Physician Decision|2|||
146099827|NCT03758443|526886466|FG001|Extended Induction Period|Physician Decision|1|||
146099828|NCT03758443|526886467|FG002|Extended Induction Period|Physician Decision|2|||
146041066|NCT03916081|526662109|FG001|Overall Study|Withdrawal by Subject|0|||
146041067|NCT03916081|526662110|FG002|Overall Study|Withdrawal by Subject|1|||
146041068|NCT03916081|526662108|FG000|Overall Study|Worsening of AD|0|||
146041069|NCT03916081|526662109|FG001|Overall Study|Worsening of AD|0|||
146041070|NCT03916081|526662110|FG002|Overall Study|Worsening of AD|1|||
146041071|NCT01240135|526662111|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
146041072|NCT01240135|526662112|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
146041073|NCT01240135|526662111|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
146041074|NCT01240135|526662112|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
146041075|NCT00699335|526662113|FG000|Overall Study|Combination of multiple reasons|176|||
146041076|NCT00699335|526662113|FG000|Overall Study|Missing data|52|||
146041077|NCT02726022|526662117|FG000|Overall Study|Adverse Event|14|||
146041078|NCT02726022|526662117|FG000|Overall Study|Treatment Failure|8|||
146041079|NCT02726022|526662117|FG000|Overall Study|Poor Compliance|13|||
146041080|NCT02726022|526662117|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
146041081|NCT00416455|526662126|FG000|Overall Study|PET / CT not done|3|||
146041082|NCT00416455|526662127|FG001|Overall Study|PET / CT not done|5|||
146041083|NCT00416455|526662126|FG000|Overall Study|PET / CT poor quality|2|||
146041084|NCT00416455|526662127|FG001|Overall Study|PET / CT poor quality|1|||
146041085|NCT00416455|526662126|FG000|Overall Study|Inadequate pathology|11|||
146041086|NCT00416455|526662127|FG001|Overall Study|Inadequate pathology|2|||
146041087|NCT01183065|526662129|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
146041088|NCT02456857|526662130|FG000|Overall Study|Disease Progression|4|||
146041089|NCT00781859|526662131|FG000|Overall Study|Adverse Event|2|||
146041090|NCT00781859|526662132|FG001|Overall Study|Adverse Event|2|||
146041091|NCT00781859|526662131|FG000|Overall Study|Withdrawal by Subject|8|||
146041092|NCT00781859|526662132|FG001|Overall Study|Withdrawal by Subject|4|||
146099829|NCT03758443|526886468|FG003|Extended Induction Period|Physician Decision|2|||
146099830|NCT03758443|526886465|FG000|Extended Induction Period|Protocol Violation|0|||
146099831|NCT03758443|526886466|FG001|Extended Induction Period|Protocol Violation|0|||
146041093|NCT00781859|526662131|FG000|Overall Study|Lost to Follow-up|6|||
146041094|NCT00781859|526662132|FG001|Overall Study|Lost to Follow-up|3|||
146041095|NCT00781859|526662131|FG000|Overall Study|Death|3|||
146254559|NCT01261793|527444615|FG000|Overall Study|Lack of Efficacy|44|||
146041096|NCT00781859|526662132|FG001|Overall Study|Death|0|||
146041097|NCT01983774|526662136|FG000|Overall Study|Lung Transplant|0|||
146041098|NCT01983774|526662137|FG001|Overall Study|Lung Transplant|1|||
146099832|NCT03758443|526886467|FG002|Extended Induction Period|Protocol Violation|0|||
146099833|NCT03758443|526886468|FG003|Extended Induction Period|Protocol Violation|1|||
146099834|NCT03758443|526886465|FG000|Extended Induction Period|Withdrawal by Subject|8|||
146099835|NCT03758443|526886466|FG001|Extended Induction Period|Withdrawal by Subject|1|||
146099836|NCT03758443|526886467|FG002|Extended Induction Period|Withdrawal by Subject|7|||
146099837|NCT03758443|526886468|FG003|Extended Induction Period|Withdrawal by Subject|3|||
146099838|NCT03758443|526886465|FG000|Extended Induction Period|Miscellaneous|1|||
146099839|NCT03758443|526886466|FG001|Extended Induction Period|Miscellaneous|0|||
146041099|NCT01983774|526662136|FG000|Overall Study|Lost to Follow-up|1|||
146041100|NCT01983774|526662137|FG001|Overall Study|Lost to Follow-up|0|||
146041101|NCT01339897|526662138|FG000|Overall Study|Adverse Event|1|||
146041102|NCT01339897|526662139|FG001|Overall Study|Adverse Event|0|||
146041103|NCT01339897|526662140|FG002|Overall Study|Adverse Event|0|||
146041104|NCT01339897|526662141|FG003|Overall Study|Adverse Event|1|||
146041105|NCT03657095|526662143|FG000|Overall Study|Withdrawal by Subject|1|||
146041106|NCT03657095|526662144|FG001|Overall Study|Withdrawal by Subject|1|||
146041107|NCT03657095|526662143|FG000|Overall Study|Adverse Event|0|||
146041108|NCT03657095|526662144|FG001|Overall Study|Adverse Event|3|||
146041109|NCT03657095|526662143|FG000|Overall Study|Study Terminated by Sponsor|58|||
146041110|NCT03657095|526662144|FG001|Overall Study|Study Terminated by Sponsor|49|||
146041111|NCT03043651|526662149|FG000|Overall Study|Death|1|||
146041112|NCT03043651|526662149|FG000|Overall Study|Progressive Disease|2|||
146041113|NCT03043651|526662149|FG000|Overall Study|Adverse Event|2|||
146041114|NCT03043651|526662149|FG000|Overall Study|Withdrawal by Subject|4|||
146041115|NCT03043651|526662149|FG000|Overall Study|Study Terminated by Sponsor|39|||
146041116|NCT02980133|526662150|FG000|Overall Study|Other than specified|1|||
146041117|NCT02980133|526662151|FG001|Overall Study|Other than specified|1|||
146041118|NCT02980133|526662152|FG002|Overall Study|Other than specified|2|||
146041119|NCT02980133|526662153|FG003|Overall Study|Other than specified|2|||
146041120|NCT02980133|526662150|FG000|Overall Study|Lost to Follow-up|0|||
146041121|NCT02980133|526662151|FG001|Overall Study|Lost to Follow-up|0|||
146041122|NCT02980133|526662152|FG002|Overall Study|Lost to Follow-up|1|||
146041123|NCT02980133|526662153|FG003|Overall Study|Lost to Follow-up|3|||
146041124|NCT02980133|526662150|FG000|Overall Study|Protocol Violation|0|||
146041125|NCT02980133|526662151|FG001|Overall Study|Protocol Violation|1|||
146041126|NCT02980133|526662152|FG002|Overall Study|Protocol Violation|0|||
146041127|NCT02980133|526662153|FG003|Overall Study|Protocol Violation|0|||
146041128|NCT02980133|526662150|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146041129|NCT02980133|526662151|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146041130|NCT02980133|526662152|FG002|Overall Study|Withdrawal by parent/guardian|3|||
146041131|NCT02980133|526662153|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146041132|NCT02980133|526662150|FG000|Overall Study|Withdrawal by Subject|0|||
146041133|NCT02980133|526662151|FG001|Overall Study|Withdrawal by Subject|0|||
146041134|NCT02980133|526662152|FG002|Overall Study|Withdrawal by Subject|1|||
146041135|NCT02980133|526662153|FG003|Overall Study|Withdrawal by Subject|0|||
146041136|NCT02596945|526662154|FG000|Overall Study|No documentation of study drug dosing|3|||
146041137|NCT02596945|526662154|FG000|Overall Study|Other|32|||
146041138|NCT02596945|526662154|FG000|Overall Study|Change to hemodialysis|15|||
146041139|NCT02596945|526662154|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
146041140|NCT02596945|526662154|FG000|Overall Study|Withdrawal by Subject|1|||
146041141|NCT02596945|526662154|FG000|Overall Study|Missing|1|||
146041142|NCT04440813|526663720|FG000|Overall Study|Lost to Follow-up|5|||
146041143|NCT04440813|526663721|FG001|Overall Study|Lost to Follow-up|5|||
146041144|NCT00291018|526663726|FG000|Overall Study|Not Consented or Declined PAS|12|||
146041145|NCT00291018|526663727|FG001|Overall Study|Not Consented or Declined PAS|15|||
146041146|NCT00291018|526663728|FG002|Overall Study|Not Consented or Declined PAS|15|||
146041147|NCT00291018|526663726|FG000|Overall Study|Death|3|||
146041148|NCT00291018|526663727|FG001|Overall Study|Death|3|||
146041149|NCT00291018|526663728|FG002|Overall Study|Death|4|||
146041150|NCT00291018|526663726|FG000|Overall Study|Withdrawal by Subject|2|||
146041151|NCT00291018|526663727|FG001|Overall Study|Withdrawal by Subject|8|||
146041152|NCT00291018|526663728|FG002|Overall Study|Withdrawal by Subject|1|||
146041153|NCT00291018|526663726|FG000|Overall Study|Failures|5|||
146041154|NCT00291018|526663727|FG001|Overall Study|Failures|12|||
146041155|NCT00291018|526663728|FG002|Overall Study|Failures|5|||
146041156|NCT00291018|526663726|FG000|Overall Study|Lost to Follow-up|3|||
146041157|NCT00291018|526663727|FG001|Overall Study|Lost to Follow-up|4|||
146041158|NCT00291018|526663728|FG002|Overall Study|Lost to Follow-up|18|||
146041159|NCT02219334|526663730|FG000|Overall Study|Withdrawal by Subject|1|||
146041160|NCT02219334|526663731|FG001|Overall Study|Withdrawal by Subject|0|||
146041161|NCT02219334|526663730|FG000|Overall Study|Protocol Violation|7|||
146041162|NCT02219334|526663731|FG001|Overall Study|Protocol Violation|3|||
146041163|NCT05362058|526663732|FG000|Treatment Period|Adverse Event|3|||
146041164|NCT05362058|526663733|FG001|Treatment Period|Adverse Event|3|||
146099840|NCT03758443|526886467|FG002|Extended Induction Period|Miscellaneous|0|||
146300613|NCT01950247|527617060|FG001|Overall Study|Death|1|||
146041165|NCT05362058|526663732|FG000|Treatment Period|Assigned treatment by mistake|3|||
146041166|NCT05362058|526663733|FG001|Treatment Period|Assigned treatment by mistake|4|||
146041167|NCT05362058|526663732|FG000|Treatment Period|Death|1|||
146041168|NCT05362058|526663733|FG001|Treatment Period|Death|1|||
146041169|NCT05362058|526663732|FG000|Treatment Period|Lost to Follow-up|6|||
146041170|NCT05362058|526663733|FG001|Treatment Period|Lost to Follow-up|3|||
146041171|NCT05362058|526663732|FG000|Treatment Period|Non-compliance with study drug|0|||
146099841|NCT03758443|526886468|FG003|Extended Induction Period|Miscellaneous|0|||
146041172|NCT05362058|526663733|FG001|Treatment Period|Non-compliance with study drug|1|||
146041173|NCT05362058|526663732|FG000|Treatment Period|Physician Decision|1|||
146041174|NCT05362058|526663733|FG001|Treatment Period|Physician Decision|0|||
146041175|NCT05362058|526663732|FG000|Treatment Period|Protocol deviation|1|||
146041176|NCT05362058|526663733|FG001|Treatment Period|Protocol deviation|0|||
146041177|NCT05362058|526663732|FG000|Treatment Period|Withdrawal by Subject|10|||
146041178|NCT05362058|526663733|FG001|Treatment Period|Withdrawal by Subject|11|||
146041179|NCT05362058|526663732|FG000|Follow-Up Period|Death|1|||
146041180|NCT05362058|526663733|FG001|Follow-Up Period|Death|0|||
146041181|NCT05362058|526663732|FG000|Follow-Up Period|Lost to Follow-up|2|||
146041182|NCT05362058|526663733|FG001|Follow-Up Period|Lost to Follow-up|1|||
146041183|NCT05362058|526663732|FG000|Follow-Up Period|Protocol deviation|1|||
146041184|NCT05362058|526663733|FG001|Follow-Up Period|Protocol deviation|1|||
146041185|NCT05362058|526663732|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146041186|NCT05362058|526663733|FG001|Follow-Up Period|Withdrawal by Subject|3|||
146041187|NCT00711971|526663734|FG000|Overall Study|Lost to Follow-up|3|||
146041188|NCT00711971|526663735|FG001|Overall Study|Lost to Follow-up|4|||
146041189|NCT00711971|526663736|FG002|Overall Study|Lost to Follow-up|1|||
146041190|NCT04774926|526663740|FG000|Overall Study|Adverse Event|15|||
146041191|NCT04774926|526663740|FG000|Overall Study|Lost to Follow-up|3|||
146041192|NCT04774926|526663740|FG000|Overall Study|Physician Decision|6|||
146041193|NCT04774926|526663740|FG000|Overall Study|Withdrawal by Subject|3|||
146041194|NCT04774926|526663740|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
146041195|NCT00847886|526663741|FG000|Overall Study|Adverse Event|0|||
146041196|NCT00847886|526663742|FG001|Overall Study|Adverse Event|1|||
146041197|NCT01858740|526663744|FG000|Overall Study|Death|4|||
146041198|NCT03386487|526663745|FG000|Overall Study|Lost to Follow-up|5|||
146041199|NCT03386487|526663746|FG001|Overall Study|Lost to Follow-up|6|||
146041200|NCT03386487|526663745|FG000|Overall Study|Withdrawal by Subject|11|||
146041201|NCT03386487|526663746|FG001|Overall Study|Withdrawal by Subject|7|||
146041202|NCT03386487|526663745|FG000|Overall Study|Physician Decision|11|||
146041203|NCT03386487|526663746|FG001|Overall Study|Physician Decision|8|||
146041204|NCT02524158|526663747|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
146041205|NCT02524158|526663748|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
146041206|NCT02524158|526663747|FG000|12-weeks Assessment|Lost to Follow-up|18|||
146041207|NCT02524158|526663748|FG001|12-weeks Assessment|Lost to Follow-up|12|||
146041208|NCT02524158|526663747|FG000|6-month Assessment|Withdrawal by Subject|1|||
146041209|NCT02524158|526663748|FG001|6-month Assessment|Withdrawal by Subject|1|||
146041210|NCT02524158|526663747|FG000|6-month Assessment|Lost to Follow-up|21|||
146041211|NCT02524158|526663748|FG001|6-month Assessment|Lost to Follow-up|20|||
146041212|NCT00773747|526663755|FG000|Overall Study|Lack of Efficacy|112|||
146041213|NCT00773747|526663756|FG001|Overall Study|Lack of Efficacy|144|||
146041214|NCT00773747|526663755|FG000|Overall Study|Physician Decision|26|||
146041215|NCT00773747|526663756|FG001|Overall Study|Physician Decision|18|||
146041216|NCT00773747|526663755|FG000|Overall Study|Lost to Follow-up|0|||
146041217|NCT00773747|526663756|FG001|Overall Study|Lost to Follow-up|1|||
146041218|NCT00773747|526663755|FG000|Overall Study|Protocol Violation|2|||
146041219|NCT00773747|526663756|FG001|Overall Study|Protocol Violation|2|||
146041220|NCT00773747|526663755|FG000|Overall Study|Withdrawal by Subject|89|||
146041221|NCT00773747|526663756|FG001|Overall Study|Withdrawal by Subject|61|||
146041222|NCT00773747|526663755|FG000|Overall Study|Adverse Event|61|||
146041223|NCT00773747|526663756|FG001|Overall Study|Adverse Event|62|||
146041224|NCT00773747|526663755|FG000|Overall Study|Death|5|||
146041225|NCT00773747|526663756|FG001|Overall Study|Death|8|||
146041226|NCT00773747|526663755|FG000|Overall Study|Not Treated|2|||
146041227|NCT00773747|526663756|FG001|Overall Study|Not Treated|0|||
146041228|NCT02161757|526663765|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
146041229|NCT02161757|526663766|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
146041230|NCT02161757|526663767|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
146041231|NCT02161757|526663765|FG000|Treatment Through Study Completion|Adverse Event|1|||
146041232|NCT02161757|526663766|FG001|Treatment Through Study Completion|Adverse Event|1|||
146041233|NCT02161757|526663767|FG002|Treatment Through Study Completion|Adverse Event|0|||
146041234|NCT02161757|526663765|FG000|Treatment Through Study Completion|Protocol Violation|0|||
146041235|NCT02161757|526663766|FG001|Treatment Through Study Completion|Protocol Violation|1|||
146041236|NCT02161757|526663767|FG002|Treatment Through Study Completion|Protocol Violation|2|||
146300614|NCT01950247|527617059|FG000|Overall Study|Not Defined|4|||
146300615|NCT01950247|527617060|FG001|Overall Study|Not Defined|10|||
146041237|NCT02161757|526663765|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
146041238|NCT02161757|526663766|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
146041239|NCT02161757|526663767|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
146041240|NCT02161757|526663765|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
146041241|NCT02161757|526663766|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
146041242|NCT02161757|526663767|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
146041243|NCT02161757|526663765|FG000|Treatment Through Study Completion|Other|20|||
146041244|NCT02161757|526663766|FG001|Treatment Through Study Completion|Other|19|||
146300616|NCT00884325|527617063|FG000|Overall Study|Lost to Follow-up|1|||
146099842|NCT03758443|526886465|FG000|Maintenance Period|Adverse Event|1|||
146099843|NCT03758443|526886466|FG001|Maintenance Period|Adverse Event|2|||
146099844|NCT03758443|526886467|FG002|Maintenance Period|Adverse Event|0|||
146099845|NCT03758443|526886468|FG003|Maintenance Period|Adverse Event|0|||
146099846|NCT03758443|526886465|FG000|Maintenance Period|Lost to Follow-up|0|||
146099847|NCT03758443|526886466|FG001|Maintenance Period|Lost to Follow-up|0|||
146099848|NCT03758443|526886467|FG002|Maintenance Period|Lost to Follow-up|0|||
146099849|NCT03758443|526886468|FG003|Maintenance Period|Lost to Follow-up|1|||
146099850|NCT03758443|526886465|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
146099851|NCT03758443|526886466|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
146099852|NCT03758443|526886467|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
146099853|NCT03758443|526886468|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
146099854|NCT03758443|526886465|FG000|Maintenance Period|Protocol Violation|0|||
146099855|NCT03758443|526886466|FG001|Maintenance Period|Protocol Violation|1|||
146099856|NCT03758443|526886467|FG002|Maintenance Period|Protocol Violation|0|||
146099857|NCT03758443|526886468|FG003|Maintenance Period|Protocol Violation|0|||
146099858|NCT03758443|526886465|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
146099859|NCT03758443|526886466|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
146099860|NCT03758443|526886467|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
146099861|NCT03758443|526886468|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
146099862|NCT03758443|526886465|FG000|Maintenance Period|Withdrawal by Subject|1|||
146099863|NCT03758443|526886466|FG001|Maintenance Period|Withdrawal by Subject|0|||
146099864|NCT03758443|526886467|FG002|Maintenance Period|Withdrawal by Subject|1|||
146099865|NCT03758443|526886468|FG003|Maintenance Period|Withdrawal by Subject|1|||
146099866|NCT03758443|526886465|FG000|Maintenance Period|Miscellaneous|0|||
146099867|NCT03758443|526886466|FG001|Maintenance Period|Miscellaneous|0|||
146099868|NCT03758443|526886467|FG002|Maintenance Period|Miscellaneous|1|||
146099869|NCT03758443|526886468|FG003|Maintenance Period|Miscellaneous|0|||
146099870|NCT01522248|526886472|FG000|Overall Study|Lost to Follow-up|1|||
146099871|NCT01522248|526886473|FG001|Overall Study|Lost to Follow-up|0|||
146099872|NCT00696800|526886478|FG000|Overall Study|Adverse Event|16|||
146099873|NCT00696800|526886479|FG001|Overall Study|Adverse Event|3|||
146099874|NCT00696800|526886478|FG000|Overall Study|Insufficient compliance with medication|2|||
146099875|NCT00696800|526886479|FG001|Overall Study|Insufficient compliance with medication|1|||
146099876|NCT00696800|526886478|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
146099877|NCT00696800|526886479|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
146099878|NCT00696800|526886478|FG000|Overall Study|Insufficient ovarian response|4|||
146099879|NCT00696800|526886479|FG001|Overall Study|Insufficient ovarian response|1|||
146099880|NCT00696800|526886478|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
146099881|NCT00696800|526886479|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
146099882|NCT00696800|526886478|FG000|Overall Study|Too high ovarian response|6|||
146099883|NCT00696800|526886479|FG001|Overall Study|Too high ovarian response|1|||
146099884|NCT00696800|526886478|FG000|Overall Study|No/too few/bad quality oocytes|4|||
146099885|NCT00696800|526886479|FG001|Overall Study|No/too few/bad quality oocytes|3|||
146099886|NCT00696800|526886478|FG000|Overall Study|No/abnormal fertilization|11|||
146099887|NCT00696800|526886479|FG001|Overall Study|No/abnormal fertilization|13|||
146099888|NCT00696800|526886478|FG000|Overall Study|No/too few/bad quality embryos|24|||
146041245|NCT02161757|526663767|FG002|Treatment Through Study Completion|Other|12|||
146041246|NCT02161757|526663765|FG000|Treatment Through Study Completion|Death|2|||
146041247|NCT02161757|526663766|FG001|Treatment Through Study Completion|Death|1|||
146041248|NCT02161757|526663767|FG002|Treatment Through Study Completion|Death|1|||
146041249|NCT00391625|526663768|FG000|Month 14|Withdrawal by Subject|1|||
146041250|NCT00391625|526663768|FG000|Month 50|Physician Decision|1|||
146041251|NCT03997825|526663769|FG000|Overall Study|Death|3|||
146041252|NCT03997825|526663769|FG000|Overall Study|Lost to Follow-up|10|||
146041253|NCT03997825|526663769|FG000|Overall Study|Withdrawal by Subject|3|||
146041254|NCT03997825|526663769|FG000|Overall Study|Refused participation|1|||
146041255|NCT00383162|526663770|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
146041256|NCT00383162|526663771|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
146041257|NCT00383162|526663770|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
146041258|NCT00383162|526663771|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
146041259|NCT00383162|526663770|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
146041260|NCT00383162|526663771|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
146099889|NCT00696800|526886479|FG001|Overall Study|No/too few/bad quality embryos|18|||
146099890|NCT00696800|526886478|FG000|Overall Study|Other Reasons|5|||
146099891|NCT00696800|526886479|FG001|Overall Study|Other Reasons|3|||
146099892|NCT00696800|526886478|FG000|Overall Study|Not treated|1|||
146099893|NCT00696800|526886479|FG001|Overall Study|Not treated|2|||
146099894|NCT01696695|526886480|FG000|Overall Study|Disease progression|373|||
146099895|NCT01696695|526886480|FG000|Overall Study|Death|29|||
146099896|NCT01696695|526886480|FG000|Overall Study|Adverse Event|74|||
146099897|NCT01696695|526886480|FG000|Overall Study|Withdrawal by Subject|92|||
146099898|NCT01696695|526886480|FG000|Overall Study|Lost to Follow-up|48|||
146099899|NCT01696695|526886480|FG000|Overall Study|Other|74|||
146099900|NCT01696695|526886480|FG000|Overall Study|Major Protocol Violation|192|||
146099901|NCT05224141|526886483|FG000|Overall Study|Ongoing|75|||
146099902|NCT05224141|526886484|FG001|Overall Study|Ongoing|88|||
146099903|NCT05224141|526886483|FG000|Overall Study|Withdrawal by Subject|2|||
146099904|NCT05224141|526886484|FG001|Overall Study|Withdrawal by Subject|4|||
146099905|NCT05224141|526886483|FG000|Overall Study|Death|153|||
146099906|NCT05224141|526886484|FG001|Overall Study|Death|138|||
146099907|NCT00199875|526886496|FG000|Overall Study|Withdrawal by Subject|0|||
146099908|NCT00199875|526886497|FG001|Overall Study|Withdrawal by Subject|0|||
146099909|NCT00199875|526886498|FG002|Overall Study|Withdrawal by Subject|0|||
146099910|NCT00199875|526886499|FG003|Overall Study|Withdrawal by Subject|0|||
146099911|NCT00199875|526886500|FG004|Overall Study|Withdrawal by Subject|1|||
146099912|NCT02404220|526886502|FG000|Overall Study|Adverse Event|0|||
146099913|NCT02404220|526886503|FG001|Overall Study|Adverse Event|0|||
146099914|NCT02404220|526886504|FG002|Overall Study|Adverse Event|1|||
146099915|NCT02404220|526886505|FG003|Overall Study|Adverse Event|0|||
146099916|NCT02404220|526886502|FG000|Overall Study|Death|5|||
146099917|NCT02404220|526886503|FG001|Overall Study|Death|5|||
146099918|NCT02404220|526886504|FG002|Overall Study|Death|3|||
146099919|NCT02404220|526886505|FG003|Overall Study|Death|8|||
146099920|NCT02404220|526886502|FG000|Overall Study|Progressive Disease|0|||
146099921|NCT02404220|526886503|FG001|Overall Study|Progressive Disease|0|||
146099922|NCT02404220|526886504|FG002|Overall Study|Progressive Disease|1|||
146099923|NCT02404220|526886505|FG003|Overall Study|Progressive Disease|1|||
146099924|NCT02404220|526886502|FG000|Overall Study|Study Terminated by Sponsor|0|||
146099925|NCT02404220|526886503|FG001|Overall Study|Study Terminated by Sponsor|0|||
146099926|NCT02404220|526886504|FG002|Overall Study|Study Terminated by Sponsor|2|||
146099927|NCT02404220|526886505|FG003|Overall Study|Study Terminated by Sponsor|1|||
146099928|NCT02404220|526886502|FG000|Overall Study|Withdrawal by Subject|0|||
146099929|NCT02404220|526886503|FG001|Overall Study|Withdrawal by Subject|1|||
146099930|NCT02404220|526886504|FG002|Overall Study|Withdrawal by Subject|0|||
146041261|NCT00383162|526663770|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
146041262|NCT00383162|526663771|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
146041263|NCT00383162|526663770|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
146041264|NCT00383162|526663771|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
146041265|NCT00383162|526663770|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
146041266|NCT00383162|526663771|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
146041267|NCT00383162|526663770|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
146041268|NCT00383162|526663771|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
146041269|NCT00383162|526663770|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
146041270|NCT00383162|526663771|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
146041271|NCT00383162|526663770|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
146041272|NCT00383162|526663771|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
146041273|NCT03664765|526663772|FG000|Overall Study|Withdrawal by Subject|4|||
146041274|NCT03664765|526663773|FG001|Overall Study|Withdrawal by Subject|1|||
146041275|NCT03664765|526663772|FG000|Overall Study|Lost to Follow-up|0|||
146041276|NCT03664765|526663773|FG001|Overall Study|Lost to Follow-up|1|||
146041277|NCT00767819|526663774|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
146041278|NCT00767819|526663775|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
146041279|NCT00767819|526663776|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146041280|NCT00767819|526663774|FG000|Overall Study|Withdrawal by Subject|1|||
146041281|NCT00767819|526663775|FG001|Overall Study|Withdrawal by Subject|1|||
146041282|NCT00767819|526663776|FG002|Overall Study|Withdrawal by Subject|0|||
146041283|NCT00767819|526663774|FG000|Overall Study|Administrative problems|0|||
146041284|NCT00767819|526663775|FG001|Overall Study|Administrative problems|1|||
146099931|NCT02404220|526886505|FG003|Overall Study|Withdrawal by Subject|0|||
146099932|NCT02404220|526886502|FG000|Overall Study|Enrolled but Never Treated|0|||
146099933|NCT02404220|526886503|FG001|Overall Study|Enrolled but Never Treated|2|||
146099934|NCT02404220|526886504|FG002|Overall Study|Enrolled but Never Treated|0|||
146099935|NCT02404220|526886505|FG003|Overall Study|Enrolled but Never Treated|0|||
146099936|NCT03469934|526886508|FG000|Overall Study|Withdrawal by Subject|0|||
146099937|NCT03469934|526886509|FG001|Overall Study|Withdrawal by Subject|1|||
146099938|NCT01024231|526886513|FG000|Overall Study|Other Reasons|1|||
146099939|NCT01024231|526886514|FG001|Overall Study|Other Reasons|2|||
146099940|NCT01024231|526886515|FG002|Overall Study|Other Reasons|0|||
146099941|NCT01024231|526886516|FG003|Overall Study|Other Reasons|0|||
146099942|NCT01024231|526886517|FG004|Overall Study|Other Reasons|2|||
146099943|NCT01024231|526886518|FG005|Overall Study|Other Reasons|0|||
146041285|NCT00767819|526663776|FG002|Overall Study|Administrative problems|0|||
146041286|NCT00767819|526663774|FG000|Overall Study|Death|2|||
146041287|NCT00767819|526663775|FG001|Overall Study|Death|3|||
146099944|NCT01024231|526886519|FG006|Overall Study|Other Reasons|1|||
146099945|NCT01024231|526886513|FG000|Overall Study|Maximum Clinical Benefit|1|||
146099946|NCT01024231|526886514|FG001|Overall Study|Maximum Clinical Benefit|2|||
146099947|NCT01024231|526886515|FG002|Overall Study|Maximum Clinical Benefit|0|||
146099948|NCT01024231|526886516|FG003|Overall Study|Maximum Clinical Benefit|1|||
146041288|NCT00767819|526663776|FG002|Overall Study|Death|0|||
146041289|NCT00767819|526663774|FG000|Overall Study|Adverse Event|2|||
146041290|NCT00767819|526663775|FG001|Overall Study|Adverse Event|0|||
146041291|NCT00767819|526663776|FG002|Overall Study|Adverse Event|0|||
146041292|NCT00767819|526663774|FG000|Overall Study|Abnormal lab values|1|||
146041293|NCT00767819|526663775|FG001|Overall Study|Abnormal lab values|0|||
146041294|NCT00767819|526663776|FG002|Overall Study|Abnormal lab values|0|||
146041295|NCT00767819|526663774|FG000|Overall Study|Lost to Follow-up|1|||
146041296|NCT00767819|526663775|FG001|Overall Study|Lost to Follow-up|0|||
146041297|NCT00767819|526663776|FG002|Overall Study|Lost to Follow-up|0|||
146041298|NCT01153698|526663777|FG000|Overall Study|Adverse Event|12|||
146041299|NCT01153698|526663777|FG000|Overall Study|Lost to Follow-up|4|||
146041300|NCT01153698|526663777|FG000|Overall Study|Withdrawal by Subject|2|||
146041301|NCT01153698|526663777|FG000|Overall Study|Switch to other anticoagulants|4|||
146041302|NCT01153698|526663777|FG000|Overall Study|Other|2|||
146041303|NCT01153698|526663777|FG000|Overall Study|Not treated with Pradaxa|5|||
146041304|NCT01371305|526663782|FG000|Overall Study|Adverse Event|0|||
146041305|NCT01371305|526663783|FG001|Overall Study|Adverse Event|0|||
146041306|NCT01371305|526663784|FG002|Overall Study|Adverse Event|0|||
146041307|NCT01371305|526663785|FG003|Overall Study|Adverse Event|2|||
146041308|NCT01371305|526663786|FG004|Overall Study|Adverse Event|1|||
146041309|NCT01371305|526663787|FG005|Overall Study|Adverse Event|0|||
146041310|NCT01371305|526663782|FG000|Overall Study|Study terminated by sponsor|0|||
146041311|NCT01371305|526663783|FG001|Overall Study|Study terminated by sponsor|0|||
146041312|NCT01371305|526663784|FG002|Overall Study|Study terminated by sponsor|0|||
146041313|NCT01371305|526663785|FG003|Overall Study|Study terminated by sponsor|0|||
146041314|NCT01371305|526663786|FG004|Overall Study|Study terminated by sponsor|3|||
146041315|NCT01371305|526663787|FG005|Overall Study|Study terminated by sponsor|1|||
146041316|NCT01371305|526663782|FG000|Overall Study|Subject request|0|||
146041317|NCT01371305|526663783|FG001|Overall Study|Subject request|0|||
146041318|NCT01371305|526663784|FG002|Overall Study|Subject request|0|||
146041319|NCT01371305|526663785|FG003|Overall Study|Subject request|0|||
146041320|NCT01371305|526663786|FG004|Overall Study|Subject request|0|||
146041321|NCT01371305|526663787|FG005|Overall Study|Subject request|1|||
146041322|NCT04038567|526663788|FG000|Overall Study|Lost to Follow-up|6|||
146041323|NCT04038567|526663789|FG001|Overall Study|Lost to Follow-up|4|||
146041324|NCT04038567|526663790|FG002|Overall Study|Lost to Follow-up|5|||
146041325|NCT04038567|526663791|FG003|Overall Study|Lost to Follow-up|4|||
146041326|NCT04038567|526663792|FG004|Overall Study|Lost to Follow-up|6|||
146041327|NCT04038567|526663793|FG005|Overall Study|Lost to Follow-up|4|||
146041328|NCT04038567|526663794|FG006|Overall Study|Lost to Follow-up|4|||
146041329|NCT04038567|526663795|FG007|Overall Study|Lost to Follow-up|1|||
146041330|NCT04038567|526663788|FG000|Overall Study|Withdrawal by Subject|2|||
146041331|NCT04038567|526663789|FG001|Overall Study|Withdrawal by Subject|1|||
146041332|NCT04038567|526663790|FG002|Overall Study|Withdrawal by Subject|1|||
146041333|NCT04038567|526663791|FG003|Overall Study|Withdrawal by Subject|1|||
146041334|NCT04038567|526663792|FG004|Overall Study|Withdrawal by Subject|4|||
146041335|NCT04038567|526663793|FG005|Overall Study|Withdrawal by Subject|1|||
146041336|NCT04038567|526663794|FG006|Overall Study|Withdrawal by Subject|1|||
146041337|NCT04038567|526663795|FG007|Overall Study|Withdrawal by Subject|1|||
146041338|NCT04038567|526663788|FG000|Overall Study|missed survey window|1|||
146041339|NCT04038567|526663789|FG001|Overall Study|missed survey window|2|||
146041340|NCT04038567|526663790|FG002|Overall Study|missed survey window|0|||
146041341|NCT04038567|526663791|FG003|Overall Study|missed survey window|0|||
146041342|NCT04038567|526663792|FG004|Overall Study|missed survey window|1|||
146041343|NCT04038567|526663793|FG005|Overall Study|missed survey window|1|||
146041344|NCT04038567|526663794|FG006|Overall Study|missed survey window|2|||
146041345|NCT04038567|526663795|FG007|Overall Study|missed survey window|2|||
146041346|NCT04038567|526663788|FG000|Overall Study|technical issues|0|||
146041347|NCT04038567|526663789|FG001|Overall Study|technical issues|0|||
146041348|NCT04038567|526663790|FG002|Overall Study|technical issues|0|||
146041349|NCT04038567|526663791|FG003|Overall Study|technical issues|0|||
146041350|NCT04038567|526663792|FG004|Overall Study|technical issues|0|||
146041351|NCT04038567|526663793|FG005|Overall Study|technical issues|0|||
146041352|NCT04038567|526663794|FG006|Overall Study|technical issues|1|||
146041353|NCT04038567|526663795|FG007|Overall Study|technical issues|0|||
146041354|NCT04038567|526663788|FG000|Overall Study|Medical issues (i.e., illness)|0|||
146041355|NCT04038567|526663789|FG001|Overall Study|Medical issues (i.e., illness)|1|||
146041356|NCT04038567|526663790|FG002|Overall Study|Medical issues (i.e., illness)|2|||
146041357|NCT04038567|526663791|FG003|Overall Study|Medical issues (i.e., illness)|1|||
146041358|NCT04038567|526663792|FG004|Overall Study|Medical issues (i.e., illness)|1|||
146041359|NCT04038567|526663793|FG005|Overall Study|Medical issues (i.e., illness)|1|||
146041360|NCT04038567|526663794|FG006|Overall Study|Medical issues (i.e., illness)|0|||
146041361|NCT04038567|526663795|FG007|Overall Study|Medical issues (i.e., illness)|0|||
146041362|NCT04038567|526663788|FG000|Overall Study|Death|0|||
146041363|NCT04038567|526663789|FG001|Overall Study|Death|0|||
146041364|NCT04038567|526663790|FG002|Overall Study|Death|0|||
146041365|NCT04038567|526663791|FG003|Overall Study|Death|1|||
146099949|NCT01024231|526886517|FG004|Overall Study|Maximum Clinical Benefit|1|||
146099950|NCT01024231|526886518|FG005|Overall Study|Maximum Clinical Benefit|0|||
146099951|NCT01024231|526886519|FG006|Overall Study|Maximum Clinical Benefit|0|||
146099952|NCT01024231|526886513|FG000|Overall Study|Disease Progression|3|||
146099953|NCT01024231|526886514|FG001|Overall Study|Disease Progression|1|||
146099954|NCT01024231|526886515|FG002|Overall Study|Disease Progression|3|||
146099955|NCT01024231|526886516|FG003|Overall Study|Disease Progression|0|||
146099956|NCT01024231|526886517|FG004|Overall Study|Disease Progression|4|||
146099957|NCT01024231|526886518|FG005|Overall Study|Disease Progression|11|||
146099958|NCT01024231|526886519|FG006|Overall Study|Disease Progression|6|||
146099959|NCT01024231|526886513|FG000|Overall Study|AE unrelated to Study Drug|0|||
146099960|NCT01024231|526886514|FG001|Overall Study|AE unrelated to Study Drug|1|||
146099961|NCT01024231|526886515|FG002|Overall Study|AE unrelated to Study Drug|0|||
146099962|NCT01024231|526886516|FG003|Overall Study|AE unrelated to Study Drug|0|||
146099963|NCT01024231|526886517|FG004|Overall Study|AE unrelated to Study Drug|0|||
146099964|NCT01024231|526886518|FG005|Overall Study|AE unrelated to Study Drug|0|||
146099965|NCT01024231|526886519|FG006|Overall Study|AE unrelated to Study Drug|0|||
146099966|NCT01024231|526886513|FG000|Overall Study|No longer meets criteria|0|||
146099967|NCT01024231|526886514|FG001|Overall Study|No longer meets criteria|0|||
146099968|NCT01024231|526886515|FG002|Overall Study|No longer meets criteria|0|||
146099969|NCT01024231|526886516|FG003|Overall Study|No longer meets criteria|0|||
146099970|NCT01024231|526886517|FG004|Overall Study|No longer meets criteria|1|||
146099971|NCT01024231|526886518|FG005|Overall Study|No longer meets criteria|0|||
146099972|NCT01024231|526886519|FG006|Overall Study|No longer meets criteria|1|||
146099973|NCT01024231|526886513|FG000|Overall Study|Study Drug Toxicity|1|||
146099974|NCT01024231|526886514|FG001|Overall Study|Study Drug Toxicity|6|||
146099975|NCT01024231|526886515|FG002|Overall Study|Study Drug Toxicity|6|||
146099976|NCT01024231|526886516|FG003|Overall Study|Study Drug Toxicity|4|||
146099977|NCT01024231|526886517|FG004|Overall Study|Study Drug Toxicity|2|||
146099978|NCT01024231|526886518|FG005|Overall Study|Study Drug Toxicity|0|||
146099979|NCT01024231|526886519|FG006|Overall Study|Study Drug Toxicity|7|||
146099980|NCT01024231|526886513|FG000|Overall Study|Death|6|||
146099981|NCT01024231|526886514|FG001|Overall Study|Death|2|||
146099982|NCT01024231|526886515|FG002|Overall Study|Death|1|||
146099983|NCT01024231|526886516|FG003|Overall Study|Death|0|||
146099984|NCT01024231|526886517|FG004|Overall Study|Death|4|||
146099985|NCT01024231|526886518|FG005|Overall Study|Death|3|||
146099986|NCT01024231|526886519|FG006|Overall Study|Death|5|||
146099987|NCT01024231|526886513|FG000|Overall Study|Lost to Follow-up|0|||
146099988|NCT01024231|526886514|FG001|Overall Study|Lost to Follow-up|0|||
146099989|NCT01024231|526886515|FG002|Overall Study|Lost to Follow-up|0|||
146099990|NCT01024231|526886516|FG003|Overall Study|Lost to Follow-up|0|||
146099991|NCT01024231|526886517|FG004|Overall Study|Lost to Follow-up|0|||
146099992|NCT01024231|526886518|FG005|Overall Study|Lost to Follow-up|0|||
146099993|NCT01024231|526886519|FG006|Overall Study|Lost to Follow-up|1|||
146099994|NCT01024231|526886513|FG000|Overall Study|Withdrew Consent|0|||
146099995|NCT01024231|526886514|FG001|Overall Study|Withdrew Consent|1|||
146099996|NCT01024231|526886515|FG002|Overall Study|Withdrew Consent|0|||
146099997|NCT01024231|526886516|FG003|Overall Study|Withdrew Consent|0|||
146099998|NCT01024231|526886517|FG004|Overall Study|Withdrew Consent|0|||
146099999|NCT01024231|526886518|FG005|Overall Study|Withdrew Consent|0|||
146100000|NCT01024231|526886519|FG006|Overall Study|Withdrew Consent|0|||
146100001|NCT01024231|526886513|FG000|Overall Study|Continuing on Treatment|0|||
146100002|NCT01024231|526886514|FG001|Overall Study|Continuing on Treatment|0|||
146100003|NCT01024231|526886515|FG002|Overall Study|Continuing on Treatment|0|||
146254560|NCT01261793|527444616|FG001|Overall Study|Lack of Efficacy|37|||
146254561|NCT01261793|527444617|FG002|Overall Study|Lack of Efficacy|32|||
146254562|NCT01261793|527444615|FG000|Overall Study|Protocol Violation|3|||
146254563|NCT01261793|527444616|FG001|Overall Study|Protocol Violation|5|||
146254564|NCT01261793|527444617|FG002|Overall Study|Protocol Violation|6|||
146041366|NCT04038567|526663792|FG004|Overall Study|Death|1|||
146041367|NCT04038567|526663793|FG005|Overall Study|Death|0|||
146041368|NCT04038567|526663794|FG006|Overall Study|Death|0|||
146041369|NCT04038567|526663795|FG007|Overall Study|Death|1|||
146041370|NCT02220712|526663796|FG000|Overall Study|Adverse Event|1|||
146041371|NCT02220712|526663796|FG000|Overall Study|Withdrawal by Subject|2|||
146041372|NCT02220712|526663796|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
146041373|NCT00760838|526663800|FG000|Overall Study|Adverse Event|1|||
146041374|NCT00760838|526663801|FG001|Overall Study|Adverse Event|1|||
146041375|NCT00760838|526663800|FG000|Overall Study|Lack of Efficacy|1|||
146041376|NCT00760838|526663801|FG001|Overall Study|Lack of Efficacy|0|||
146041377|NCT00760838|526663800|FG000|Overall Study|Lost to Follow-up|2|||
146041378|NCT00760838|526663801|FG001|Overall Study|Lost to Follow-up|0|||
146041379|NCT00760838|526663800|FG000|Overall Study|Withdrawal by Subject|1|||
146041380|NCT00760838|526663801|FG001|Overall Study|Withdrawal by Subject|1|||
146041381|NCT01817959|526663802|FG000|Overall Study|Graft loss|1|||
146041382|NCT01817959|526663803|FG001|Overall Study|Graft loss|1|||
146041383|NCT01817959|526663802|FG000|Overall Study|forbidden medication|1|||
146041384|NCT01817959|526663803|FG001|Overall Study|forbidden medication|1|||
146041385|NCT01817959|526663802|FG000|Overall Study|Adverse Event|1|||
146100004|NCT01024231|526886516|FG003|Overall Study|Continuing on Treatment|0|||
146100005|NCT01024231|526886517|FG004|Overall Study|Continuing on Treatment|3|||
146100006|NCT01024231|526886518|FG005|Overall Study|Continuing on Treatment|2|||
146100007|NCT01024231|526886519|FG006|Overall Study|Continuing on Treatment|0|||
146100008|NCT01691898|526886520|FG000|Overall Study|Death|34|||
146100009|NCT01691898|526886521|FG001|Overall Study|Death|32|||
146100010|NCT01691898|526886522|FG002|Overall Study|Death|6|||
146100011|NCT01691898|526886523|FG003|Overall Study|Death|3|||
146100012|NCT01691898|526886524|FG004|Overall Study|Death|8|||
146100013|NCT01691898|526886525|FG005|Overall Study|Death|31|||
146100014|NCT01691898|526886520|FG000|Overall Study|Adverse Event|0|||
146100015|NCT01691898|526886521|FG001|Overall Study|Adverse Event|1|||
146100016|NCT01691898|526886522|FG002|Overall Study|Adverse Event|0|||
146100017|NCT01691898|526886523|FG003|Overall Study|Adverse Event|1|||
146100018|NCT01691898|526886524|FG004|Overall Study|Adverse Event|1|||
146100019|NCT01691898|526886525|FG005|Overall Study|Adverse Event|0|||
146100020|NCT01691898|526886520|FG000|Overall Study|Progression of Disease|1|||
146100021|NCT01691898|526886521|FG001|Overall Study|Progression of Disease|2|||
146100022|NCT01691898|526886522|FG002|Overall Study|Progression of Disease|1|||
146100023|NCT01691898|526886523|FG003|Overall Study|Progression of Disease|0|||
146100024|NCT01691898|526886524|FG004|Overall Study|Progression of Disease|0|||
146100025|NCT01691898|526886525|FG005|Overall Study|Progression of Disease|1|||
146100026|NCT01691898|526886520|FG000|Overall Study|Lost to Follow-up|3|||
146100027|NCT01691898|526886521|FG001|Overall Study|Lost to Follow-up|1|||
146100028|NCT01691898|526886522|FG002|Overall Study|Lost to Follow-up|0|||
146100029|NCT01691898|526886523|FG003|Overall Study|Lost to Follow-up|0|||
146100030|NCT01691898|526886524|FG004|Overall Study|Lost to Follow-up|1|||
146100031|NCT01691898|526886525|FG005|Overall Study|Lost to Follow-up|0|||
146100032|NCT01691898|526886520|FG000|Overall Study|Withdrawal by Subject|9|||
146100033|NCT01691898|526886521|FG001|Overall Study|Withdrawal by Subject|8|||
146100034|NCT01691898|526886522|FG002|Overall Study|Withdrawal by Subject|2|||
146100035|NCT01691898|526886523|FG003|Overall Study|Withdrawal by Subject|1|||
146100036|NCT01691898|526886524|FG004|Overall Study|Withdrawal by Subject|3|||
146100037|NCT01691898|526886525|FG005|Overall Study|Withdrawal by Subject|3|||
146100038|NCT01691898|526886520|FG000|Overall Study|Non-Compliance|0|||
146100039|NCT01691898|526886521|FG001|Overall Study|Non-Compliance|0|||
146100040|NCT01691898|526886522|FG002|Overall Study|Non-Compliance|0|||
146100041|NCT01691898|526886523|FG003|Overall Study|Non-Compliance|0|||
146100042|NCT01691898|526886524|FG004|Overall Study|Non-Compliance|1|||
146100043|NCT01691898|526886525|FG005|Overall Study|Non-Compliance|0|||
146100044|NCT01013350|526886526|FG000|Overall Study|Lost to Follow-up|15|||
146100045|NCT01013350|526886527|FG001|Overall Study|Lost to Follow-up|95|||
146100046|NCT01013350|526886526|FG000|Overall Study|Adverse Event|0|||
146100047|NCT01013350|526886527|FG001|Overall Study|Adverse Event|1|||
146100048|NCT01013350|526886526|FG000|Overall Study|Physician Decision|4|||
146041386|NCT01817959|526663803|FG001|Overall Study|Adverse Event|0|||
146041387|NCT01817959|526663802|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
146041388|NCT01817959|526663803|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
146041389|NCT04356352|526663810|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
146041390|NCT04356352|526663811|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
146041391|NCT04356352|526663812|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
146041392|NCT04356352|526663810|FG000|Overall Study|Protocol Violation|0|||
146041393|NCT04356352|526663811|FG001|Overall Study|Protocol Violation|3|||
146041394|NCT04356352|526663812|FG002|Overall Study|Protocol Violation|1|||
146041395|NCT01138501|526663813|FG000|Overall Study|Protocol Violation|2|||
146041396|NCT01138501|526663813|FG000|Overall Study|Withdrawal by Subject|3|||
146041397|NCT00348309|526663814|FG000|Overall Study|Adverse Event|56|||
146041398|NCT00348309|526663815|FG001|Overall Study|Adverse Event|28|||
146041399|NCT00348309|526663816|FG002|Overall Study|Adverse Event|63|||
146041400|NCT00348309|526663814|FG000|Overall Study|Lost to Follow-up|6|||
146041401|NCT00348309|526663815|FG001|Overall Study|Lost to Follow-up|7|||
146041402|NCT00348309|526663816|FG002|Overall Study|Lost to Follow-up|4|||
146041403|NCT00348309|526663814|FG000|Overall Study|Protocol Violation|7|||
146041404|NCT00348309|526663815|FG001|Overall Study|Protocol Violation|12|||
146041405|NCT00348309|526663816|FG002|Overall Study|Protocol Violation|7|||
146041406|NCT00348309|526663814|FG000|Overall Study|Withdrawal by Subject|33|||
146041407|NCT00348309|526663815|FG001|Overall Study|Withdrawal by Subject|37|||
146041408|NCT00348309|526663816|FG002|Overall Study|Withdrawal by Subject|40|||
146041409|NCT00348309|526663814|FG000|Overall Study|Non-compliance|8|||
146100049|NCT01013350|526886527|FG001|Overall Study|Physician Decision|20|||
146100050|NCT01013350|526886526|FG000|Overall Study|Withdrawal by Subject|15|||
146100051|NCT01013350|526886527|FG001|Overall Study|Withdrawal by Subject|38|||
146100052|NCT01013350|526886526|FG000|Overall Study|Death|3|||
146100053|NCT01013350|526886527|FG001|Overall Study|Death|5|||
146100054|NCT01013350|526886526|FG000|Overall Study|Participant entered interventional study|0|||
146041410|NCT00348309|526663815|FG001|Overall Study|Non-compliance|6|||
146100055|NCT01013350|526886527|FG001|Overall Study|Participant entered interventional study|8|||
146100056|NCT01013350|526886526|FG000|Overall Study|Other|1|||
146041411|NCT00348309|526663816|FG002|Overall Study|Non-compliance|8|||
146041412|NCT00348309|526663814|FG000|Overall Study|Death of caregiver|1|||
146041413|NCT00348309|526663815|FG001|Overall Study|Death of caregiver|0|||
146041414|NCT00348309|526663816|FG002|Overall Study|Death of caregiver|1|||
146041415|NCT00348309|526663814|FG000|Overall Study|Lack of insight, dementia|1|||
146041416|NCT00348309|526663815|FG001|Overall Study|Lack of insight, dementia|0|||
146041417|NCT00348309|526663816|FG002|Overall Study|Lack of insight, dementia|0|||
146041418|NCT00348309|526663814|FG000|Overall Study|Wrong bottle allocated|1|||
146041419|NCT00348309|526663815|FG001|Overall Study|Wrong bottle allocated|0|||
146041420|NCT00348309|526663816|FG002|Overall Study|Wrong bottle allocated|0|||
146041421|NCT00348309|526663814|FG000|Overall Study|Caregiver sick|1|||
146041422|NCT00348309|526663815|FG001|Overall Study|Caregiver sick|0|||
146041423|NCT00348309|526663816|FG002|Overall Study|Caregiver sick|0|||
146041424|NCT00348309|526663814|FG000|Overall Study|Use of prohibited medication|5|||
146041425|NCT00348309|526663815|FG001|Overall Study|Use of prohibited medication|2|||
146041426|NCT00348309|526663816|FG002|Overall Study|Use of prohibited medication|2|||
146041427|NCT00348309|526663814|FG000|Overall Study|Caregiver withdrawal|3|||
146041428|NCT00348309|526663815|FG001|Overall Study|Caregiver withdrawal|0|||
146041429|NCT00348309|526663816|FG002|Overall Study|Caregiver withdrawal|7|||
146041430|NCT00348309|526663814|FG000|Overall Study|Unable to complete ET visit|1|||
146041431|NCT00348309|526663815|FG001|Overall Study|Unable to complete ET visit|0|||
146041432|NCT00348309|526663816|FG002|Overall Study|Unable to complete ET visit|0|||
146041433|NCT00348309|526663814|FG000|Overall Study|PI closing medical practice|1|||
146041434|NCT00348309|526663815|FG001|Overall Study|PI closing medical practice|0|||
146041435|NCT00348309|526663816|FG002|Overall Study|PI closing medical practice|0|||
146041436|NCT00348309|526663814|FG000|Overall Study|Principal investigator's decision|1|||
146041437|NCT00348309|526663815|FG001|Overall Study|Principal investigator's decision|0|||
146041438|NCT00348309|526663816|FG002|Overall Study|Principal investigator's decision|0|||
146041439|NCT00348309|526663814|FG000|Overall Study|No disponibility of medication|1|||
146041440|NCT00348309|526663815|FG001|Overall Study|No disponibility of medication|0|||
146041441|NCT00348309|526663816|FG002|Overall Study|No disponibility of medication|0|||
146041442|NCT00348309|526663814|FG000|Overall Study|Worsened neurodegenerative disease|1|||
146041443|NCT00348309|526663815|FG001|Overall Study|Worsened neurodegenerative disease|0|||
146041444|NCT00348309|526663816|FG002|Overall Study|Worsened neurodegenerative disease|0|||
146041445|NCT00348309|526663814|FG000|Overall Study|Cognitive and behaviour worsening|2|||
146041446|NCT00348309|526663815|FG001|Overall Study|Cognitive and behaviour worsening|0|||
146041447|NCT00348309|526663816|FG002|Overall Study|Cognitive and behaviour worsening|0|||
146041448|NCT00348309|526663814|FG000|Overall Study|Worsening of alzheimer|1|||
146041449|NCT00348309|526663815|FG001|Overall Study|Worsening of alzheimer|0|||
146041450|NCT00348309|526663816|FG002|Overall Study|Worsening of alzheimer|1|||
146041451|NCT00348309|526663814|FG000|Overall Study|Did not appear in time for Visit 3|1|||
146041452|NCT00348309|526663815|FG001|Overall Study|Did not appear in time for Visit 3|0|||
146041453|NCT00348309|526663816|FG002|Overall Study|Did not appear in time for Visit 3|0|||
146041454|NCT00348309|526663814|FG000|Overall Study|Participant died|2|||
146041455|NCT00348309|526663815|FG001|Overall Study|Participant died|1|||
146041456|NCT00348309|526663816|FG002|Overall Study|Participant died|1|||
146041457|NCT00348309|526663814|FG000|Overall Study|Decision of sponsor|1|||
146041458|NCT00348309|526663815|FG001|Overall Study|Decision of sponsor|0|||
146041459|NCT00348309|526663816|FG002|Overall Study|Decision of sponsor|0|||
146041460|NCT00348309|526663814|FG000|Overall Study|Ineffectiveness of treatment|0|||
146041461|NCT00348309|526663815|FG001|Overall Study|Ineffectiveness of treatment|1|||
146041462|NCT00348309|526663816|FG002|Overall Study|Ineffectiveness of treatment|0|||
146041463|NCT00348309|526663814|FG000|Overall Study|A foul of exclusion criteria|0|||
146041464|NCT00348309|526663815|FG001|Overall Study|A foul of exclusion criteria|1|||
146041465|NCT00348309|526663816|FG002|Overall Study|A foul of exclusion criteria|0|||
146041466|NCT00348309|526663814|FG000|Overall Study|Participant was hospitalized|0|||
146041467|NCT00348309|526663815|FG001|Overall Study|Participant was hospitalized|1|||
146041468|NCT00348309|526663816|FG002|Overall Study|Participant was hospitalized|0|||
146041469|NCT00348309|526663814|FG000|Overall Study|Sponsor refuseal|0|||
146041470|NCT00348309|526663815|FG001|Overall Study|Sponsor refuseal|1|||
146041471|NCT00348309|526663816|FG002|Overall Study|Sponsor refuseal|1|||
146041472|NCT00348309|526663814|FG000|Overall Study|Forgot often medication|0|||
146041473|NCT00348309|526663815|FG001|Overall Study|Forgot often medication|1|||
146041474|NCT00348309|526663816|FG002|Overall Study|Forgot often medication|0|||
146041475|NCT00348309|526663814|FG000|Overall Study|Medical Monitor decision|0|||
146041476|NCT00348309|526663815|FG001|Overall Study|Medical Monitor decision|0|||
146041477|NCT00348309|526663816|FG002|Overall Study|Medical Monitor decision|1|||
146041478|NCT00348309|526663814|FG000|Overall Study|Increased dose of Aricept|0|||
146041479|NCT00348309|526663815|FG001|Overall Study|Increased dose of Aricept|0|||
146041480|NCT00348309|526663816|FG002|Overall Study|Increased dose of Aricept|1|||
146041481|NCT00348309|526663814|FG000|Overall Study|Site closure|0|||
146041482|NCT00348309|526663815|FG001|Overall Study|Site closure|0|||
146041483|NCT00348309|526663816|FG002|Overall Study|Site closure|1|||
146041484|NCT00348309|526663814|FG000|Overall Study|Adverse event not attended|0|||
146041485|NCT00348309|526663815|FG001|Overall Study|Adverse event not attended|0|||
146041486|NCT00348309|526663816|FG002|Overall Study|Adverse event not attended|1|||
146041487|NCT00348309|526663814|FG000|Overall Study|ECG abnormal|0|||
146041488|NCT00348309|526663815|FG001|Overall Study|ECG abnormal|0|||
146041489|NCT00348309|526663816|FG002|Overall Study|ECG abnormal|2|||
146041490|NCT00348309|526663814|FG000|Overall Study|Cardiologist recommendations|0|||
146041491|NCT00348309|526663815|FG001|Overall Study|Cardiologist recommendations|0|||
146041492|NCT00348309|526663816|FG002|Overall Study|Cardiologist recommendations|1|||
146041493|NCT00348309|526663814|FG000|Overall Study|HCV career|0|||
146041494|NCT00348309|526663815|FG001|Overall Study|HCV career|0|||
146041495|NCT00348309|526663816|FG002|Overall Study|HCV career|1|||
146041496|NCT00622388|526663817|FG000|Overall Study|Disease Progression|47|||
146041497|NCT00622388|526663817|FG000|Overall Study|Adverse Event|6|||
146041498|NCT00622388|526663817|FG000|Overall Study|Protocol Violation|3|||
146041499|NCT00622388|526663817|FG000|Overall Study|Participant Refusal|1|||
146041500|NCT00622388|526663817|FG000|Overall Study|Death|3|||
146041501|NCT00622388|526663817|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
146041502|NCT00622388|526663817|FG000|Overall Study|Took Prohibited Medication|2|||
146041503|NCT00622388|526663817|FG000|Overall Study|Withdrew Consent|1|||
146041504|NCT00622388|526663817|FG000|Overall Study|Insurance Expired|1|||
146041505|NCT01743040|526663818|FG000|Overall Study|Death|1|||
146041506|NCT01743040|526663818|FG000|Overall Study|Lost to Follow-up|66|||
146041507|NCT01743040|526663818|FG000|Overall Study|Physician Decision|40|||
146041508|NCT01743040|526663818|FG000|Overall Study|Protocol Violation|1|||
146041509|NCT01743040|526663818|FG000|Overall Study|Withdrawal by Subject|121|||
146041510|NCT01894243|526663819|FG000|Overall Study|Adverse Event|0|||
146041511|NCT01894243|526663820|FG001|Overall Study|Adverse Event|1|||
146041512|NCT01894243|526663821|FG002|Overall Study|Adverse Event|2|||
146041513|NCT01894243|526663819|FG000|Overall Study|Death|0|||
146041514|NCT01894243|526663820|FG001|Overall Study|Death|0|||
146041515|NCT01894243|526663821|FG002|Overall Study|Death|3|||
146041516|NCT01894243|526663819|FG000|Overall Study|Lack of Efficacy|3|||
146041517|NCT01894243|526663820|FG001|Overall Study|Lack of Efficacy|3|||
146041518|NCT01894243|526663821|FG002|Overall Study|Lack of Efficacy|1|||
146041519|NCT01894243|526663819|FG000|Overall Study|Condition under investigation worsened|8|||
146041520|NCT01894243|526663820|FG001|Overall Study|Condition under investigation worsened|6|||
146041521|NCT01894243|526663821|FG002|Overall Study|Condition under investigation worsened|2|||
146041522|NCT01894243|526663819|FG000|Overall Study|Subject decision|1|||
146041523|NCT01894243|526663820|FG001|Overall Study|Subject decision|0|||
146041524|NCT01894243|526663821|FG002|Overall Study|Subject decision|0|||
146041525|NCT01894243|526663819|FG000|Overall Study|Other|1|||
146041526|NCT01894243|526663820|FG001|Overall Study|Other|0|||
146041527|NCT01894243|526663821|FG002|Overall Study|Other|0|||
146041528|NCT00828750|526663822|FG000|Overall Study|Lack of Efficacy|3|||
146041529|NCT00828750|526663822|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
146041530|NCT04006392|526663823|FG000|Overall Study|Lost to Follow-up|0|||
146041531|NCT04006392|526663824|FG001|Overall Study|Lost to Follow-up|1|||
146041532|NCT01299116|526663825|FG000|Overall Study|Lost to Follow-up|65|||
146041533|NCT01299116|526663826|FG001|Overall Study|Lost to Follow-up|9|||
146041534|NCT01299116|526663827|FG002|Overall Study|Lost to Follow-up|11|||
146041535|NCT01620944|526663828|FG000|Overall Study|Early termination of Study|2|||
146041536|NCT01620944|526663829|FG001|Overall Study|Early termination of Study|1|||
146041537|NCT04378114|526663830|FG000|Overall Study|Withdrawal by Subject|5|||
146041538|NCT00830180|526663831|FG000|Overall Study|Adverse Event|6|||
146041539|NCT00830180|526663831|FG000|Overall Study|Death|11|||
146041540|NCT00830180|526663831|FG000|Overall Study|Insufficient clinical response|1|||
146041541|NCT00830180|526663831|FG000|Overall Study|Withdrawal by Subject|5|||
146041542|NCT00830180|526663831|FG000|Overall Study|Progressive disease|2|||
146041543|NCT00830180|526663831|FG000|Overall Study|Other - Unspecified|1|||
146100057|NCT01013350|526886527|FG001|Overall Study|Other|25|||
146100058|NCT04738734|526886529|FG000|Overall Study|Withdrawal by Subject|2|||
146100059|NCT04738734|526886530|FG001|Overall Study|Withdrawal by Subject|4|||
146100060|NCT04738734|526886529|FG000|Overall Study|Lost to Follow-up|5|||
146100061|NCT04738734|526886530|FG001|Overall Study|Lost to Follow-up|2|||
146100062|NCT04738734|526886529|FG000|Overall Study|Physician Decision|0|||
146100063|NCT04738734|526886530|FG001|Overall Study|Physician Decision|1|||
146100064|NCT04738734|526886529|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
146100065|NCT04738734|526886530|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
146100066|NCT02639546|526886531|FG000|Overall Study|Death|2|||
146100067|NCT02639546|526886532|FG001|Overall Study|Death|2|||
146100068|NCT02639546|526886533|FG002|Overall Study|Death|1|||
146100069|NCT02639546|526886534|FG003|Overall Study|Death|2|||
146041544|NCT01832532|526663832|FG000|Overall Study|Withdrawal by Subject|5|||
146041545|NCT01832532|526663833|FG001|Overall Study|Withdrawal by Subject|2|||
146041546|NCT00392990|526663834|FG000|Treatment on Study|Adverse Event|3|||
146041547|NCT00392990|526663835|FG001|Treatment on Study|Adverse Event|1|||
146041548|NCT00392990|526663834|FG000|Follow up for 2 Years|Death|4|||
146041549|NCT00392990|526663835|FG001|Follow up for 2 Years|Death|0|||
146041550|NCT00991406|526663839|FG000|Overall Study|One participant did not respond to FES.|1|||
146041551|NCT03824587|526663840|FG000|Run-in Period|Screen Failure|0|||
146041552|NCT03824587|526663841|FG001|Run-in Period|Screen Failure|275|||
146041553|NCT03824587|526663840|FG000|Treatment Period|Adverse Event|4|||
146041554|NCT03824587|526663841|FG001|Treatment Period|Adverse Event|1|||
146041555|NCT03824587|526663840|FG000|Treatment Period|Withdrawal by Subject|0|||
146041556|NCT03824587|526663841|FG001|Treatment Period|Withdrawal by Subject|1|||
146041557|NCT03824587|526663840|FG000|Treatment Period|Kidney Transplant|1|||
146041558|NCT03824587|526663841|FG001|Treatment Period|Kidney Transplant|1|||
146041559|NCT00986362|526663842|FG000|Overall Study|Death|2|||
146041560|NCT00986362|526663843|FG001|Overall Study|Death|0|||
146041561|NCT00986362|526663842|FG000|Overall Study|Lost to Follow-up|0|||
146041562|NCT00986362|526663843|FG001|Overall Study|Lost to Follow-up|1|||
146041563|NCT01300572|526663844|FG000|Overall Study|HAMA + post dosimetry|1|||
146041564|NCT03597061|526663845|FG000|Overall Study|Lost to Follow-up|1|||
146041565|NCT03597061|526663846|FG001|Overall Study|Lost to Follow-up|0|||
146041566|NCT03597061|526663845|FG000|Overall Study|Protocol Violation|0|||
146041567|NCT03597061|526663846|FG001|Overall Study|Protocol Violation|1|||
146041568|NCT02160145|526663847|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
146041569|NCT02160145|526663848|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
146041570|NCT02160145|526663849|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
146041571|NCT02160145|526663847|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
146041572|NCT02160145|526663848|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
146041573|NCT02160145|526663849|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
146041574|NCT02160145|526663847|FG000|Randomized Double-blind Period|Subject decision|0|||
146041575|NCT02160145|526663848|FG001|Randomized Double-blind Period|Subject decision|21|||
146041576|NCT02160145|526663849|FG002|Randomized Double-blind Period|Subject decision|20|||
146041577|NCT02160145|526663847|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
146041578|NCT02160145|526663848|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
146041579|NCT02160145|526663849|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
146041580|NCT02160145|526663847|FG000|Randomized Double-blind Period|Physician Decision|0|||
146041581|NCT02160145|526663848|FG001|Randomized Double-blind Period|Physician Decision|7|||
146041582|NCT02160145|526663849|FG002|Randomized Double-blind Period|Physician Decision|5|||
146041583|NCT02006979|526663850|FG000|Overall Study|Withdrawal by Subject|1|||
146041584|NCT02006979|526663851|FG001|Overall Study|Withdrawal by Subject|1|||
146041585|NCT02006979|526663850|FG000|Overall Study|Protocol Violation|0|||
146041586|NCT02006979|526663851|FG001|Overall Study|Protocol Violation|1|||
146041587|NCT03170193|526663852|FG000|Overall Study|Withdrawal by Subject|0|||
146041588|NCT03170193|526663853|FG001|Overall Study|Withdrawal by Subject|0|||
146041589|NCT03170193|526663854|FG002|Overall Study|Withdrawal by Subject|0|||
146041590|NCT03170193|526663855|FG003|Overall Study|Withdrawal by Subject|1|||
146041591|NCT03170193|526663856|FG004|Overall Study|Withdrawal by Subject|0|||
146041592|NCT03170193|526663857|FG005|Overall Study|Withdrawal by Subject|0|||
146041593|NCT03170193|526663858|FG006|Overall Study|Withdrawal by Subject|0|||
146041594|NCT03170193|526663852|FG000|Overall Study|Lost to Follow-up|1|||
146041595|NCT03170193|526663853|FG001|Overall Study|Lost to Follow-up|1|||
146041596|NCT03170193|526663854|FG002|Overall Study|Lost to Follow-up|0|||
146041597|NCT03170193|526663855|FG003|Overall Study|Lost to Follow-up|0|||
146041598|NCT03170193|526663856|FG004|Overall Study|Lost to Follow-up|0|||
146041599|NCT03170193|526663857|FG005|Overall Study|Lost to Follow-up|0|||
146041600|NCT03170193|526663858|FG006|Overall Study|Lost to Follow-up|0|||
146041601|NCT00375518|526663859|FG000|Overall Study|Withdrawal by Subject|2|||
146041602|NCT00375518|526663860|FG001|Overall Study|Withdrawal by Subject|10|||
146041603|NCT00375518|526663859|FG000|Overall Study|Patient Not Treated|6|||
146041604|NCT00375518|526663860|FG001|Overall Study|Patient Not Treated|6|||
146041605|NCT00375518|526663859|FG000|Overall Study|Death|0|||
146041606|NCT00375518|526663860|FG001|Overall Study|Death|1|||
146041607|NCT03052816|526663865|FG000|Overall Study|Withdrawal by Subject|1|||
146041608|NCT03052816|526663866|FG001|Overall Study|Withdrawal by Subject|0|||
146041609|NCT03052816|526663865|FG000|Overall Study|Desired opioids|2|||
146041610|NCT03052816|526663866|FG001|Overall Study|Desired opioids|0|||
146041611|NCT03755661|526663867|FG000|Overall Study|Lost to Follow-up|1|||
146041612|NCT03755661|526663868|FG001|Overall Study|Lost to Follow-up|0|||
146041613|NCT00931606|526666945|FG000|Overall Study|Death|1|||
146041614|NCT00931606|526666946|FG001|Overall Study|Death|3|||
146041615|NCT00931606|526666947|FG002|Overall Study|Death|2|||
146041616|NCT00931606|526666948|FG003|Overall Study|Death|0|||
146041617|NCT00931606|526666945|FG000|Overall Study|Lost to Follow-up|0|||
146041618|NCT00931606|526666946|FG001|Overall Study|Lost to Follow-up|1|||
146041619|NCT00931606|526666947|FG002|Overall Study|Lost to Follow-up|0|||
146041620|NCT00931606|526666948|FG003|Overall Study|Lost to Follow-up|0|||
146041621|NCT00931606|526666945|FG000|Overall Study|Physician Decision|0|||
146041622|NCT00931606|526666946|FG001|Overall Study|Physician Decision|0|||
146041623|NCT00931606|526666947|FG002|Overall Study|Physician Decision|3|||
146041624|NCT00931606|526666948|FG003|Overall Study|Physician Decision|0|||
146041625|NCT00931606|526666945|FG000|Overall Study|Sponsor Decision|1|||
146041626|NCT00931606|526666946|FG001|Overall Study|Sponsor Decision|4|||
146041627|NCT00931606|526666947|FG002|Overall Study|Sponsor Decision|0|||
146041628|NCT00931606|526666948|FG003|Overall Study|Sponsor Decision|2|||
146100070|NCT02639546|526886535|FG004|Overall Study|Death|2|||
146100071|NCT02639546|526886536|FG005|Overall Study|Death|2|||
146100072|NCT02639546|526886537|FG006|Overall Study|Death|0|||
146100073|NCT02639546|526886538|FG007|Overall Study|Death|0|||
146100074|NCT02639546|526886531|FG000|Overall Study|Lost to Follow-up|0|||
146100075|NCT02639546|526886532|FG001|Overall Study|Lost to Follow-up|0|||
146100076|NCT02639546|526886533|FG002|Overall Study|Lost to Follow-up|1|||
146100077|NCT02639546|526886534|FG003|Overall Study|Lost to Follow-up|0|||
146100078|NCT02639546|526886535|FG004|Overall Study|Lost to Follow-up|1|||
146100079|NCT02639546|526886536|FG005|Overall Study|Lost to Follow-up|1|||
146100080|NCT02639546|526886537|FG006|Overall Study|Lost to Follow-up|0|||
146100081|NCT02639546|526886538|FG007|Overall Study|Lost to Follow-up|1|||
146100082|NCT02639546|526886531|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
146100083|NCT02639546|526886532|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
146100084|NCT02639546|526886533|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
146100085|NCT02639546|526886534|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
146100086|NCT02639546|526886535|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
146100087|NCT02639546|526886536|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
146100088|NCT02639546|526886537|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
146100089|NCT02639546|526886538|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
146100090|NCT02639546|526886531|FG000|Overall Study|Study Terminated By Sponsor|0|||
146100091|NCT02639546|526886532|FG001|Overall Study|Study Terminated By Sponsor|2|||
146041629|NCT00931606|526666945|FG000|Overall Study|Withdrawal by Subject|3|||
146100092|NCT02639546|526886533|FG002|Overall Study|Study Terminated By Sponsor|3|||
146100093|NCT02639546|526886534|FG003|Overall Study|Study Terminated By Sponsor|4|||
146041630|NCT00931606|526666946|FG001|Overall Study|Withdrawal by Subject|1|||
146041631|NCT00931606|526666947|FG002|Overall Study|Withdrawal by Subject|1|||
146041632|NCT00931606|526666948|FG003|Overall Study|Withdrawal by Subject|1|||
146041633|NCT00871338|526666953|FG000|Prior to Booster|Withdrawal by Subject|1|||
146041634|NCT00871338|526666954|FG001|Prior to Booster|Withdrawal by Subject|3|||
146041635|NCT00871338|526666953|FG000|Prior to Booster|Lost to Follow-up|1|||
146041636|NCT00871338|526666954|FG001|Prior to Booster|Lost to Follow-up|0|||
146041637|NCT02391363|526666955|FG000|Overall Study|Lost to Follow-up|5|||
146041638|NCT02391363|526666956|FG001|Overall Study|Lost to Follow-up|5|||
146041639|NCT02391363|526666955|FG000|Overall Study|Withdrawal by Subject|6|||
146041640|NCT02391363|526666956|FG001|Overall Study|Withdrawal by Subject|3|||
146041641|NCT00799266|526666959|FG000|Overall Study|Adverse Event|0|||
146041642|NCT00799266|526666960|FG001|Overall Study|Adverse Event|1|||
146041643|NCT00799266|526666959|FG000|Overall Study|Subject withdrew consent|3|||
146041644|NCT00799266|526666960|FG001|Overall Study|Subject withdrew consent|0|||
146041645|NCT01016600|526666961|FG000|Overall Study|Did not start treatment|1|||
146041646|NCT01016600|526666962|FG001|Overall Study|Did not start treatment|0|||
146041647|NCT01016600|526666963|FG002|Overall Study|Did not start treatment|0|||
146041648|NCT01016600|526666964|FG003|Overall Study|Did not start treatment|0|||
146041649|NCT01702025|526666968|FG000|Overall Study|Equipment failure|1|||
146041650|NCT01702025|526666969|FG001|Overall Study|Equipment failure|0|||
146041651|NCT01702025|526666970|FG002|Overall Study|Equipment failure|0|||
146041652|NCT01702025|526666971|FG003|Overall Study|Equipment failure|0|||
146041653|NCT01702025|526666968|FG000|Overall Study|Adverse Event|1|||
146041654|NCT01702025|526666969|FG001|Overall Study|Adverse Event|1|||
146041655|NCT01702025|526666970|FG002|Overall Study|Adverse Event|1|||
146041656|NCT01702025|526666971|FG003|Overall Study|Adverse Event|0|||
146041657|NCT00265317|526666974|FG000|Lead-In|Objective progression or relapse|6|||
146041658|NCT00265317|526666975|FG001|Lead-In|Objective progression or relapse|11|||
146041659|NCT00265317|526666976|FG002|Lead-In|Objective progression or relapse|0|||
146041660|NCT00265317|526666977|FG003|Lead-In|Objective progression or relapse|0|||
146041661|NCT00265317|526666974|FG000|Lead-In|Adverse Event|2|||
146041662|NCT00265317|526666975|FG001|Lead-In|Adverse Event|1|||
146041663|NCT00265317|526666976|FG002|Lead-In|Adverse Event|0|||
146041664|NCT00265317|526666977|FG003|Lead-In|Adverse Event|0|||
146041665|NCT00265317|526666974|FG000|Lead-In|Death|3|||
146041666|NCT00265317|526666975|FG001|Lead-In|Death|5|||
146041667|NCT00265317|526666976|FG002|Lead-In|Death|0|||
146041668|NCT00265317|526666977|FG003|Lead-In|Death|0|||
146041669|NCT00265317|526666974|FG000|Lead-In|Withdrawal/other than adverse event|1|||
146041670|NCT00265317|526666975|FG001|Lead-In|Withdrawal/other than adverse event|0|||
146041671|NCT00265317|526666976|FG002|Lead-In|Withdrawal/other than adverse event|0|||
146041672|NCT00265317|526666977|FG003|Lead-In|Withdrawal/other than adverse event|0|||
146041673|NCT00265317|526666974|FG000|Phase 2|Objective progression or relapse|0|||
146100094|NCT02639546|526886535|FG004|Overall Study|Study Terminated By Sponsor|4|||
146100095|NCT02639546|526886536|FG005|Overall Study|Study Terminated By Sponsor|3|||
146100096|NCT02639546|526886537|FG006|Overall Study|Study Terminated By Sponsor|3|||
146100097|NCT02639546|526886538|FG007|Overall Study|Study Terminated By Sponsor|9|||
146100098|NCT02639546|526886531|FG000|Overall Study|Withdrawal by Subject|2|||
146100099|NCT02639546|526886532|FG001|Overall Study|Withdrawal by Subject|2|||
146041674|NCT00265317|526666975|FG001|Phase 2|Objective progression or relapse|0|||
146041675|NCT00265317|526666976|FG002|Phase 2|Objective progression or relapse|37|||
146041676|NCT00265317|526666977|FG003|Phase 2|Objective progression or relapse|38|||
146041677|NCT00265317|526666974|FG000|Phase 2|Global deterioration of health status|0|||
146041678|NCT00265317|526666975|FG001|Phase 2|Global deterioration of health status|0|||
146041679|NCT00265317|526666976|FG002|Phase 2|Global deterioration of health status|3|||
146041680|NCT00265317|526666977|FG003|Phase 2|Global deterioration of health status|0|||
146041681|NCT00265317|526666974|FG000|Phase 2|Adverse Event|0|||
146041682|NCT00265317|526666975|FG001|Phase 2|Adverse Event|0|||
146041683|NCT00265317|526666976|FG002|Phase 2|Adverse Event|7|||
146041684|NCT00265317|526666977|FG003|Phase 2|Adverse Event|5|||
146041685|NCT00265317|526666974|FG000|Phase 2|Death|0|||
146041686|NCT00265317|526666975|FG001|Phase 2|Death|0|||
146041687|NCT00265317|526666976|FG002|Phase 2|Death|12|||
146041688|NCT00265317|526666977|FG003|Phase 2|Death|15|||
146041689|NCT00265317|526666974|FG000|Phase 2|Protocol Violation|0|||
146041690|NCT00265317|526666975|FG001|Phase 2|Protocol Violation|0|||
146041691|NCT00265317|526666976|FG002|Phase 2|Protocol Violation|1|||
146041692|NCT00265317|526666977|FG003|Phase 2|Protocol Violation|4|||
146041693|NCT00265317|526666974|FG000|Phase 2|Lost to Follow-up|0|||
146041694|NCT00265317|526666975|FG001|Phase 2|Lost to Follow-up|0|||
146041695|NCT00265317|526666976|FG002|Phase 2|Lost to Follow-up|0|||
146041696|NCT00265317|526666977|FG003|Phase 2|Lost to Follow-up|1|||
146041697|NCT00265317|526666974|FG000|Phase 2|Withdrawal/other than adverse event|0|||
146041698|NCT00265317|526666975|FG001|Phase 2|Withdrawal/other than adverse event|0|||
146041699|NCT00265317|526666976|FG002|Phase 2|Withdrawal/other than adverse event|2|||
146041700|NCT00265317|526666977|FG003|Phase 2|Withdrawal/other than adverse event|1|||
146041701|NCT00265317|526666974|FG000|Phase 2|Study terminated by sponsor|0|||
146041702|NCT00265317|526666975|FG001|Phase 2|Study terminated by sponsor|0|||
146041703|NCT00265317|526666976|FG002|Phase 2|Study terminated by sponsor|1|||
146041704|NCT00265317|526666977|FG003|Phase 2|Study terminated by sponsor|0|||
146041705|NCT00265317|526666974|FG000|Phase 2|Other|0|||
146041706|NCT00265317|526666975|FG001|Phase 2|Other|0|||
146041707|NCT00265317|526666976|FG002|Phase 2|Other|1|||
146041708|NCT00265317|526666977|FG003|Phase 2|Other|1|||
146041709|NCT00801229|526666978|FG000|Signed Consent|Withdrawal by Subject|2|||
146041710|NCT00801229|526666979|FG001|Signed Consent|Withdrawal by Subject|2|||
146041711|NCT00801229|526666978|FG000|Signed Consent|Found Ineligible|1|||
146041712|NCT00801229|526666979|FG001|Signed Consent|Found Ineligible|1|||
146041713|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
146041714|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
146041715|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
146041716|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
146041717|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
146041718|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
146041719|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
146041720|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
146041721|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
146041722|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
146041723|NCT00801229|526666978|FG000|Received Study Drug/Placebo|Adverse Event|1|||
146041724|NCT00801229|526666979|FG001|Received Study Drug/Placebo|Adverse Event|1|||
146041725|NCT00732875|526666980|FG000|Overall Study|Adverse Event|16|||
146041726|NCT00732875|526666980|FG000|Overall Study|Withdrawal by Subject|6|||
146041727|NCT00732875|526666980|FG000|Overall Study|Lack of Efficacy|13|||
146041728|NCT03826186|526666983|FG000|Overall Study|Protocol Violation|2|||
146041729|NCT03826186|526666984|FG001|Overall Study|Protocol Violation|0|||
146041730|NCT03826186|526666983|FG000|Overall Study|Withdrawal by Subject|1|||
146041731|NCT03826186|526666984|FG001|Overall Study|Withdrawal by Subject|0|||
146041732|NCT02300259|526666985|FG000|Period 1|Adverse Event|0|||
146041733|NCT02300259|526666986|FG001|Period 1|Adverse Event|0|||
146041734|NCT02300259|526666987|FG002|Period 1|Adverse Event|1|||
146041735|NCT02300259|526666985|FG000|Period 1|Withdrawal by Subject|0|||
146100100|NCT02639546|526886533|FG002|Overall Study|Withdrawal by Subject|1|||
146041736|NCT02300259|526666986|FG001|Period 1|Withdrawal by Subject|0|||
146041737|NCT02300259|526666987|FG002|Period 1|Withdrawal by Subject|1|||
146041738|NCT02300259|526666985|FG000|Period 2|Adverse Event|1|||
146041739|NCT02300259|526666986|FG001|Period 2|Adverse Event|0|||
146041740|NCT02300259|526666987|FG002|Period 2|Adverse Event|0|||
146041741|NCT02300259|526666985|FG000|Period 2|Withdrawal by Subject|0|||
146041742|NCT02300259|526666986|FG001|Period 2|Withdrawal by Subject|0|||
146100101|NCT02639546|526886534|FG003|Overall Study|Withdrawal by Subject|0|||
146041743|NCT02300259|526666987|FG002|Period 2|Withdrawal by Subject|1|||
146041744|NCT02737475|526666988|FG000|Overall Study|Other reasons|0|||
146254565|NCT01261793|527444615|FG000|Overall Study|Lost to Follow-up|10|||
146041745|NCT02737475|526666989|FG001|Overall Study|Other reasons|0|||
146041746|NCT02737475|526666990|FG002|Overall Study|Other reasons|0|||
146041747|NCT02737475|526666991|FG003|Overall Study|Other reasons|0|||
146041748|NCT02737475|526666992|FG004|Overall Study|Other reasons|1|||
146041749|NCT02737475|526666993|FG005|Overall Study|Other reasons|1|||
146041750|NCT02737475|526666994|FG006|Overall Study|Other reasons|0|||
146041751|NCT02737475|526666995|FG007|Overall Study|Other reasons|0|||
146041752|NCT02737475|526666996|FG008|Overall Study|Other reasons|1|||
146041753|NCT02737475|526666997|FG009|Overall Study|Other reasons|0|||
146041754|NCT02737475|526666998|FG010|Overall Study|Other reasons|1|||
146041755|NCT02737475|526666999|FG011|Overall Study|Other reasons|0|||
146041756|NCT02737475|526667000|FG012|Overall Study|Other reasons|0|||
146041757|NCT02737475|526667001|FG013|Overall Study|Other reasons|0|||
146041758|NCT02737475|526667002|FG014|Overall Study|Other reasons|0|||
146041759|NCT02737475|526667003|FG015|Overall Study|Other reasons|0|||
146041760|NCT02737475|526667004|FG016|Overall Study|Other reasons|0|||
146041761|NCT02737475|526667005|FG017|Overall Study|Other reasons|0|||
146041762|NCT02737475|526667006|FG018|Overall Study|Other reasons|0|||
146041763|NCT02737475|526667007|FG019|Overall Study|Other reasons|0|||
146041764|NCT02737475|526667008|FG020|Overall Study|Other reasons|0|||
146041765|NCT02737475|526667009|FG021|Overall Study|Other reasons|1|||
146041766|NCT02737475|526667010|FG022|Overall Study|Other reasons|0|||
146041767|NCT02737475|526667011|FG023|Overall Study|Other reasons|1|||
146041768|NCT02737475|526667012|FG024|Overall Study|Other reasons|1|||
146041769|NCT02737475|526667013|FG025|Overall Study|Other reasons|1|||
146041770|NCT02737475|526667014|FG026|Overall Study|Other reasons|0|||
146041771|NCT02737475|526666988|FG000|Overall Study|Death|1|||
146041772|NCT02737475|526666989|FG001|Overall Study|Death|0|||
146041773|NCT02737475|526666990|FG002|Overall Study|Death|0|||
146041774|NCT02737475|526666991|FG003|Overall Study|Death|1|||
146041775|NCT02737475|526666992|FG004|Overall Study|Death|0|||
146041776|NCT02737475|526666993|FG005|Overall Study|Death|0|||
146041777|NCT02737475|526666994|FG006|Overall Study|Death|0|||
146041778|NCT02737475|526666995|FG007|Overall Study|Death|2|||
146041779|NCT02737475|526666996|FG008|Overall Study|Death|0|||
146041780|NCT02737475|526666997|FG009|Overall Study|Death|0|||
146041781|NCT02737475|526666998|FG010|Overall Study|Death|0|||
146041782|NCT02737475|526666999|FG011|Overall Study|Death|4|||
146041783|NCT02737475|526667000|FG012|Overall Study|Death|2|||
146041784|NCT02737475|526667001|FG013|Overall Study|Death|2|||
146041785|NCT02737475|526667002|FG014|Overall Study|Death|0|||
146041786|NCT02737475|526667003|FG015|Overall Study|Death|2|||
146041787|NCT02737475|526667004|FG016|Overall Study|Death|2|||
146041788|NCT02737475|526667005|FG017|Overall Study|Death|2|||
146041789|NCT02737475|526667006|FG018|Overall Study|Death|1|||
146041790|NCT02737475|526667007|FG019|Overall Study|Death|0|||
146041791|NCT02737475|526667008|FG020|Overall Study|Death|0|||
146041792|NCT02737475|526667009|FG021|Overall Study|Death|0|||
146041793|NCT02737475|526667010|FG022|Overall Study|Death|0|||
146041794|NCT02737475|526667011|FG023|Overall Study|Death|0|||
146041795|NCT02737475|526667012|FG024|Overall Study|Death|0|||
146041796|NCT02737475|526667013|FG025|Overall Study|Death|0|||
146041797|NCT02737475|526667014|FG026|Overall Study|Death|0|||
146041798|NCT02737475|526666988|FG000|Overall Study|Participant withdrew consent|0|||
146041799|NCT02737475|526666989|FG001|Overall Study|Participant withdrew consent|0|||
146041800|NCT02737475|526666990|FG002|Overall Study|Participant withdrew consent|0|||
146041801|NCT02737475|526666991|FG003|Overall Study|Participant withdrew consent|0|||
146041802|NCT02737475|526666992|FG004|Overall Study|Participant withdrew consent|0|||
146041803|NCT02737475|526666993|FG005|Overall Study|Participant withdrew consent|2|||
146041804|NCT02737475|526666994|FG006|Overall Study|Participant withdrew consent|0|||
146041805|NCT02737475|526666995|FG007|Overall Study|Participant withdrew consent|0|||
146041806|NCT02737475|526666996|FG008|Overall Study|Participant withdrew consent|0|||
146041807|NCT02737475|526666997|FG009|Overall Study|Participant withdrew consent|0|||
146041808|NCT02737475|526666998|FG010|Overall Study|Participant withdrew consent|0|||
146041809|NCT02737475|526666999|FG011|Overall Study|Participant withdrew consent|0|||
146041810|NCT02737475|526667000|FG012|Overall Study|Participant withdrew consent|0|||
146041811|NCT02737475|526667001|FG013|Overall Study|Participant withdrew consent|0|||
146041812|NCT02737475|526667002|FG014|Overall Study|Participant withdrew consent|1|||
146041813|NCT02737475|526667003|FG015|Overall Study|Participant withdrew consent|0|||
146041814|NCT02737475|526667004|FG016|Overall Study|Participant withdrew consent|0|||
146041815|NCT02737475|526667005|FG017|Overall Study|Participant withdrew consent|2|||
146041816|NCT02737475|526667006|FG018|Overall Study|Participant withdrew consent|1|||
146041817|NCT02737475|526667007|FG019|Overall Study|Participant withdrew consent|0|||
146041818|NCT02737475|526667008|FG020|Overall Study|Participant withdrew consent|2|||
146041819|NCT02737475|526667009|FG021|Overall Study|Participant withdrew consent|0|||
146041820|NCT02737475|526667010|FG022|Overall Study|Participant withdrew consent|0|||
146041821|NCT02737475|526667011|FG023|Overall Study|Participant withdrew consent|0|||
146041822|NCT02737475|526667012|FG024|Overall Study|Participant withdrew consent|0|||
146041823|NCT02737475|526667013|FG025|Overall Study|Participant withdrew consent|0|||
146041824|NCT02737475|526667014|FG026|Overall Study|Participant withdrew consent|0|||
146041825|NCT02737475|526666988|FG000|Overall Study|Lost to Follow-up|0|||
146041826|NCT02737475|526666989|FG001|Overall Study|Lost to Follow-up|0|||
146041827|NCT02737475|526666990|FG002|Overall Study|Lost to Follow-up|0|||
146041828|NCT02737475|526666991|FG003|Overall Study|Lost to Follow-up|0|||
146041829|NCT02737475|526666992|FG004|Overall Study|Lost to Follow-up|0|||
146041830|NCT02737475|526666993|FG005|Overall Study|Lost to Follow-up|0|||
146041831|NCT02737475|526666994|FG006|Overall Study|Lost to Follow-up|0|||
146100102|NCT02639546|526886535|FG004|Overall Study|Withdrawal by Subject|0|||
146100103|NCT02639546|526886536|FG005|Overall Study|Withdrawal by Subject|1|||
146100104|NCT02639546|526886537|FG006|Overall Study|Withdrawal by Subject|2|||
146100105|NCT02639546|526886538|FG007|Overall Study|Withdrawal by Subject|1|||
146100106|NCT02478372|526886539|FG000|Overall Study|Protocol Violation|12|||
146100107|NCT02478372|526886540|FG001|Overall Study|Protocol Violation|8|||
146100108|NCT02478372|526886539|FG000|Overall Study|Lost to Follow-up|1|||
146100109|NCT02478372|526886540|FG001|Overall Study|Lost to Follow-up|4|||
146100110|NCT02478372|526886539|FG000|Overall Study|Death|0|||
146100111|NCT02478372|526886540|FG001|Overall Study|Death|2|||
146100112|NCT03212690|526886543|FG000|Overall Study|Protocol Violation|1|||
146100113|NCT01297920|526886544|FG000|Overall Study|Adverse Event|42|||
146100114|NCT01297920|526886545|FG001|Overall Study|Adverse Event|10|||
146100115|NCT01297920|526886546|FG002|Overall Study|Adverse Event|38|||
146100116|NCT01297920|526886544|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
146100117|NCT01297920|526886545|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
146100118|NCT01297920|526886546|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
146100119|NCT01297920|526886544|FG000|Overall Study|Noncompliance|1|||
146100120|NCT01297920|526886545|FG001|Overall Study|Noncompliance|0|||
146100121|NCT01297920|526886546|FG002|Overall Study|Noncompliance|0|||
146100122|NCT01297920|526886544|FG000|Overall Study|Protocol Violation|1|||
146100123|NCT01297920|526886545|FG001|Overall Study|Protocol Violation|3|||
146100124|NCT01297920|526886546|FG002|Overall Study|Protocol Violation|0|||
146100125|NCT01297920|526886544|FG000|Overall Study|Inadequate Control of IOP|7|||
146100126|NCT01297920|526886545|FG001|Overall Study|Inadequate Control of IOP|9|||
146100127|NCT01297920|526886546|FG002|Overall Study|Inadequate Control of IOP|17|||
146100128|NCT01297920|526886544|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
146100129|NCT01297920|526886545|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
146100130|NCT01297920|526886546|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
146100131|NCT02507973|526886548|FG000|Overall Study|Adverse Event|1|||
146100132|NCT00474760|526886549|FG000|Overall Study|Death|0|||
146100133|NCT00474760|526886550|FG001|Overall Study|Death|0|||
146100134|NCT00474760|526886551|FG002|Overall Study|Death|0|||
146100135|NCT00474760|526886552|FG003|Overall Study|Death|0|||
146100136|NCT00474760|526886553|FG004|Overall Study|Death|2|||
146100137|NCT00474760|526886554|FG005|Overall Study|Death|0|||
146100138|NCT00474760|526886555|FG006|Overall Study|Death|0|||
146100139|NCT00474760|526886549|FG000|Overall Study|Adverse Event|0|||
146100140|NCT00474760|526886550|FG001|Overall Study|Adverse Event|0|||
146100141|NCT00474760|526886551|FG002|Overall Study|Adverse Event|0|||
146100142|NCT00474760|526886552|FG003|Overall Study|Adverse Event|0|||
146100143|NCT00474760|526886553|FG004|Overall Study|Adverse Event|1|||
146100144|NCT00474760|526886554|FG005|Overall Study|Adverse Event|7|||
146100145|NCT00474760|526886555|FG006|Overall Study|Adverse Event|0|||
146100146|NCT00474760|526886549|FG000|Overall Study|Laboratory abnormality|0|||
146100147|NCT00474760|526886550|FG001|Overall Study|Laboratory abnormality|0|||
146100148|NCT00474760|526886551|FG002|Overall Study|Laboratory abnormality|0|||
146100149|NCT00474760|526886552|FG003|Overall Study|Laboratory abnormality|0|||
146100150|NCT00474760|526886553|FG004|Overall Study|Laboratory abnormality|0|||
146100151|NCT00474760|526886554|FG005|Overall Study|Laboratory abnormality|1|||
146100152|NCT00474760|526886555|FG006|Overall Study|Laboratory abnormality|0|||
146100153|NCT00474760|526886549|FG000|Overall Study|Withdrawal by Subject|0|||
146254566|NCT01261793|527444616|FG001|Overall Study|Lost to Follow-up|3|||
146254567|NCT01261793|527444617|FG002|Overall Study|Lost to Follow-up|7|||
146254568|NCT01261793|527444615|FG000|Overall Study|Withdrawal by Subject|12|||
146254569|NCT01261793|527444616|FG001|Overall Study|Withdrawal by Subject|14|||
146254570|NCT01261793|527444617|FG002|Overall Study|Withdrawal by Subject|14|||
146254571|NCT01261793|527444615|FG000|Overall Study|Death|3|||
146041832|NCT02737475|526666995|FG007|Overall Study|Lost to Follow-up|0|||
146041833|NCT02737475|526666996|FG008|Overall Study|Lost to Follow-up|0|||
146041834|NCT02737475|526666997|FG009|Overall Study|Lost to Follow-up|0|||
146041835|NCT02737475|526666998|FG010|Overall Study|Lost to Follow-up|0|||
146041836|NCT02737475|526666999|FG011|Overall Study|Lost to Follow-up|0|||
146041837|NCT02737475|526667000|FG012|Overall Study|Lost to Follow-up|0|||
146041838|NCT02737475|526667001|FG013|Overall Study|Lost to Follow-up|0|||
146041839|NCT02737475|526667002|FG014|Overall Study|Lost to Follow-up|0|||
146041840|NCT02737475|526667003|FG015|Overall Study|Lost to Follow-up|1|||
146041841|NCT02737475|526667004|FG016|Overall Study|Lost to Follow-up|0|||
146041842|NCT02737475|526667005|FG017|Overall Study|Lost to Follow-up|0|||
146041843|NCT02737475|526667006|FG018|Overall Study|Lost to Follow-up|0|||
146100154|NCT00474760|526886550|FG001|Overall Study|Withdrawal by Subject|0|||
146100155|NCT00474760|526886551|FG002|Overall Study|Withdrawal by Subject|0|||
146100156|NCT00474760|526886552|FG003|Overall Study|Withdrawal by Subject|1|||
146100157|NCT00474760|526886553|FG004|Overall Study|Withdrawal by Subject|0|||
146100158|NCT00474760|526886554|FG005|Overall Study|Withdrawal by Subject|1|||
146100159|NCT00474760|526886555|FG006|Overall Study|Withdrawal by Subject|1|||
146100160|NCT00474760|526886549|FG000|Overall Study|Other|0|||
146100161|NCT00474760|526886550|FG001|Overall Study|Other|1|||
146100162|NCT00474760|526886551|FG002|Overall Study|Other|0|||
146100163|NCT00474760|526886552|FG003|Overall Study|Other|0|||
146100164|NCT00474760|526886553|FG004|Overall Study|Other|1|||
146100165|NCT00474760|526886554|FG005|Overall Study|Other|0|||
146100166|NCT00474760|526886555|FG006|Overall Study|Other|0|||
146100167|NCT00474760|526886549|FG000|Overall Study|Progressive disease|3|||
146100168|NCT00474760|526886550|FG001|Overall Study|Progressive disease|2|||
146100169|NCT00474760|526886551|FG002|Overall Study|Progressive disease|3|||
146100170|NCT00474760|526886552|FG003|Overall Study|Progressive disease|2|||
146100171|NCT00474760|526886553|FG004|Overall Study|Progressive disease|8|||
146100172|NCT00474760|526886554|FG005|Overall Study|Progressive disease|20|||
146100173|NCT00474760|526886555|FG006|Overall Study|Progressive disease|7|||
146100174|NCT00474760|526886549|FG000|Overall Study|Terminated by sponsor|0|||
146100175|NCT00474760|526886550|FG001|Overall Study|Terminated by sponsor|0|||
146100176|NCT00474760|526886551|FG002|Overall Study|Terminated by sponsor|0|||
146100177|NCT00474760|526886552|FG003|Overall Study|Terminated by sponsor|0|||
146254572|NCT01261793|527444616|FG001|Overall Study|Death|1|||
146254573|NCT01261793|527444617|FG002|Overall Study|Death|0|||
146254574|NCT01261793|527444615|FG000|Overall Study|Adverse Event|9|||
146254575|NCT01261793|527444616|FG001|Overall Study|Adverse Event|24|||
146254576|NCT01261793|527444617|FG002|Overall Study|Adverse Event|19|||
146041844|NCT02737475|526667007|FG019|Overall Study|Lost to Follow-up|0|||
146041845|NCT02737475|526667008|FG020|Overall Study|Lost to Follow-up|0|||
146041846|NCT02737475|526667009|FG021|Overall Study|Lost to Follow-up|0|||
146041847|NCT02737475|526667010|FG022|Overall Study|Lost to Follow-up|0|||
146041848|NCT02737475|526667011|FG023|Overall Study|Lost to Follow-up|0|||
146041849|NCT02737475|526667012|FG024|Overall Study|Lost to Follow-up|0|||
146041850|NCT02737475|526667013|FG025|Overall Study|Lost to Follow-up|0|||
146041851|NCT02737475|526667014|FG026|Overall Study|Lost to Follow-up|0|||
146041852|NCT02737475|526666988|FG000|Overall Study|Disease Progression|0|||
146041853|NCT02737475|526666989|FG001|Overall Study|Disease Progression|0|||
146041854|NCT02737475|526666990|FG002|Overall Study|Disease Progression|0|||
146041855|NCT02737475|526666991|FG003|Overall Study|Disease Progression|0|||
146041856|NCT02737475|526666992|FG004|Overall Study|Disease Progression|0|||
146041857|NCT02737475|526666993|FG005|Overall Study|Disease Progression|0|||
146041858|NCT02737475|526666994|FG006|Overall Study|Disease Progression|0|||
146041859|NCT02737475|526666995|FG007|Overall Study|Disease Progression|0|||
146041860|NCT02737475|526666996|FG008|Overall Study|Disease Progression|0|||
146041861|NCT02737475|526666997|FG009|Overall Study|Disease Progression|0|||
146041862|NCT02737475|526666998|FG010|Overall Study|Disease Progression|0|||
146041863|NCT02737475|526666999|FG011|Overall Study|Disease Progression|0|||
146041864|NCT02737475|526667000|FG012|Overall Study|Disease Progression|0|||
146041865|NCT02737475|526667001|FG013|Overall Study|Disease Progression|0|||
146041866|NCT02737475|526667002|FG014|Overall Study|Disease Progression|0|||
146041867|NCT02737475|526667003|FG015|Overall Study|Disease Progression|0|||
146041868|NCT02737475|526667004|FG016|Overall Study|Disease Progression|0|||
146041869|NCT02737475|526667005|FG017|Overall Study|Disease Progression|0|||
146041870|NCT02737475|526667006|FG018|Overall Study|Disease Progression|0|||
146041871|NCT02737475|526667007|FG019|Overall Study|Disease Progression|0|||
146041872|NCT02737475|526667008|FG020|Overall Study|Disease Progression|0|||
146041873|NCT02737475|526667009|FG021|Overall Study|Disease Progression|0|||
146041874|NCT02737475|526667010|FG022|Overall Study|Disease Progression|0|||
146041875|NCT02737475|526667011|FG023|Overall Study|Disease Progression|0|||
146041876|NCT02737475|526667012|FG024|Overall Study|Disease Progression|0|||
146041877|NCT02737475|526667013|FG025|Overall Study|Disease Progression|0|||
146041878|NCT02737475|526667014|FG026|Overall Study|Disease Progression|1|||
146041879|NCT02255461|526667019|FG000|Overall Study|Adverse Event|0|||
146041880|NCT02255461|526667020|FG001|Overall Study|Adverse Event|1|||
146041881|NCT02255461|526667021|FG002|Overall Study|Adverse Event|0|||
146041882|NCT02255461|526667022|FG003|Overall Study|Adverse Event|0|||
146041883|NCT02255461|526667023|FG004|Overall Study|Adverse Event|1|||
146041884|NCT02255461|526667019|FG000|Overall Study|Withdrawal by Subject|0|||
146041885|NCT02255461|526667020|FG001|Overall Study|Withdrawal by Subject|0|||
146100178|NCT00474760|526886553|FG004|Overall Study|Terminated by sponsor|0|||
146100179|NCT00474760|526886554|FG005|Overall Study|Terminated by sponsor|0|||
146100180|NCT00474760|526886555|FG006|Overall Study|Terminated by sponsor|2|||
146100181|NCT01927627|526886556|FG000|Overall Study|Adverse Event|3|||
146100182|NCT01927627|526886556|FG000|Overall Study|Lack of Efficacy|1|||
146100183|NCT01927627|526886556|FG000|Overall Study|Financial Concerns|1|||
146100184|NCT00910273|526886557|FG000|Overall Study|Lack of Efficacy|6|||
146254577|NCT01261793|527444615|FG000|Overall Study|Patient non-availability|1|||
146041886|NCT02255461|526667021|FG002|Overall Study|Withdrawal by Subject|1|||
146041887|NCT02255461|526667022|FG003|Overall Study|Withdrawal by Subject|0|||
146041888|NCT02255461|526667023|FG004|Overall Study|Withdrawal by Subject|1|||
146041889|NCT02255461|526667019|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
146041890|NCT02255461|526667020|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
146041891|NCT02255461|526667021|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
146041892|NCT02255461|526667022|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
146041893|NCT02255461|526667023|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
146100185|NCT00910273|526886558|FG001|Overall Study|Lack of Efficacy|9|||
146254578|NCT01261793|527444616|FG001|Overall Study|Patient non-availability|1|||
146254579|NCT01261793|527444617|FG002|Overall Study|Patient non-availability|1|||
146254580|NCT01261793|527444615|FG000|Overall Study|Suspected pregnancy|1|||
146254581|NCT01261793|527444616|FG001|Overall Study|Suspected pregnancy|1|||
146254582|NCT01261793|527444617|FG002|Overall Study|Suspected pregnancy|0|||
146254583|NCT01261793|527444615|FG000|Overall Study|Patient non-compliance|1|||
146041894|NCT04207060|526667028|FG000|Overall Study|Lost to Follow-up|2|||
146041895|NCT04207060|526667029|FG001|Overall Study|Lost to Follow-up|0|||
146041896|NCT01067144|526667030|FG000|Treatment|Did not receive allocated intervention|4|||
146041897|NCT01067144|526667031|FG001|Treatment|Did not receive allocated intervention|7|||
146041898|NCT01067144|526667030|FG000|Follow-up|Lost to Follow-up|22|||
146041899|NCT01067144|526667031|FG001|Follow-up|Lost to Follow-up|12|||
146041900|NCT01067144|526667030|FG000|Follow-up|Censored owing to second surgery|19|||
146041901|NCT01067144|526667031|FG001|Follow-up|Censored owing to second surgery|28|||
146041902|NCT01067144|526667030|FG000|Follow-up|Withdrawal by Subject|18|||
146041903|NCT01067144|526667031|FG001|Follow-up|Withdrawal by Subject|14|||
146041904|NCT01067144|526667030|FG000|Follow-up|Surgery cancelled|0|||
146041905|NCT01067144|526667031|FG001|Follow-up|Surgery cancelled|1|||
146041906|NCT01067144|526667030|FG000|Follow-up|Death|0|||
146041907|NCT01067144|526667031|FG001|Follow-up|Death|1|||
146041908|NCT01835158|526667034|FG000|Overall Study|Withdrawal by Subject|1|||
146041909|NCT01835158|526667035|FG001|Overall Study|Withdrawal by Subject|6|||
146041910|NCT00296140|526667036|FG000|Overall Study|Lost to Follow-up|1|||
146041911|NCT00296140|526667037|FG001|Overall Study|Lost to Follow-up|0|||
146041912|NCT00296140|526667036|FG000|Overall Study|Withdrawal by Subject|1|||
146041913|NCT00296140|526667037|FG001|Overall Study|Withdrawal by Subject|0|||
146041914|NCT00296140|526667036|FG000|Overall Study|Discharge to Nursing Home|1|||
146041915|NCT00296140|526667037|FG001|Overall Study|Discharge to Nursing Home|0|||
146041916|NCT01856582|526667038|FG000|Overall Study|Died prior to Boost infusion|1|||
146041917|NCT00880191|526667039|FG000|Overall Study|Refused further treatment|4|||
146041918|NCT00880191|526667040|FG001|Overall Study|Refused further treatment|1|||
146041919|NCT00880191|526667039|FG000|Overall Study|Adverse Event|8|||
146041920|NCT00880191|526667040|FG001|Overall Study|Adverse Event|6|||
146041921|NCT00880191|526667039|FG000|Overall Study|Hospitalization/efficacy|1|||
146041922|NCT00880191|526667040|FG001|Overall Study|Hospitalization/efficacy|1|||
146041923|NCT01919801|526667043|FG000|Overall Study|Withdrawal by Subject|1|||
146041924|NCT01919801|526667044|FG001|Overall Study|Withdrawal by Subject|0|||
146041925|NCT01919801|526667043|FG000|Overall Study|Physician Decision|0|||
146041926|NCT01919801|526667044|FG001|Overall Study|Physician Decision|1|||
146041927|NCT01919801|526667043|FG000|Overall Study|Lost to Follow-up|0|||
146041928|NCT01919801|526667044|FG001|Overall Study|Lost to Follow-up|1|||
146041929|NCT01919801|526667043|FG000|Overall Study|Other|0|||
146041930|NCT01919801|526667044|FG001|Overall Study|Other|1|||
146041931|NCT01843062|526667045|FG000|Overall Study|Protocol Violation|1|||
146041932|NCT01843062|526667046|FG001|Overall Study|Protocol Violation|0|||
146041933|NCT01843062|526667045|FG000|Overall Study|New treatment following progression|2|||
146041934|NCT01843062|526667046|FG001|Overall Study|New treatment following progression|0|||
146041935|NCT01843062|526667045|FG000|Overall Study|Pregnancy|1|||
146041936|NCT01843062|526667046|FG001|Overall Study|Pregnancy|0|||
146041937|NCT01843062|526667045|FG000|Overall Study|Adverse Event|2|||
146041938|NCT01843062|526667046|FG001|Overall Study|Adverse Event|0|||
146041939|NCT01843062|526667045|FG000|Overall Study|Incorrect randomisation|1|||
146041940|NCT01843062|526667046|FG001|Overall Study|Incorrect randomisation|0|||
146041941|NCT01843062|526667045|FG000|Overall Study|Withdrawal by Subject|12|||
146041942|NCT01843062|526667046|FG001|Overall Study|Withdrawal by Subject|3|||
146041943|NCT01843062|526667045|FG000|Overall Study|Death|1|||
146041944|NCT01843062|526667046|FG001|Overall Study|Death|2|||
146041945|NCT01843062|526667045|FG000|Overall Study|Lost to Follow-up|2|||
146041946|NCT01843062|526667046|FG001|Overall Study|Lost to Follow-up|4|||
146041947|NCT01677858|526667047|FG000|Overall Study|Adverse Event|0|||
146041948|NCT01677858|526667048|FG001|Overall Study|Adverse Event|0|||
146041949|NCT01677858|526667049|FG002|Overall Study|Adverse Event|2|||
146041950|NCT01677858|526667050|FG003|Overall Study|Adverse Event|3|||
146041951|NCT01677858|526667051|FG004|Overall Study|Adverse Event|13|||
146041952|NCT01677858|526667047|FG000|Overall Study|Death|0|||
146041953|NCT01677858|526667048|FG001|Overall Study|Death|0|||
146041954|NCT01677858|526667049|FG002|Overall Study|Death|0|||
146041955|NCT01677858|526667050|FG003|Overall Study|Death|0|||
146041956|NCT01677858|526667051|FG004|Overall Study|Death|1|||
146041957|NCT01677858|526667047|FG000|Overall Study|Physician Decision|1|||
146041958|NCT01677858|526667048|FG001|Overall Study|Physician Decision|0|||
146254584|NCT01261793|527444616|FG001|Overall Study|Patient non-compliance|0|||
146254585|NCT01261793|527444617|FG002|Overall Study|Patient non-compliance|1|||
146254586|NCT01261793|527444615|FG000|Overall Study|Patient pregnant|1|||
146041959|NCT01677858|526667049|FG002|Overall Study|Physician Decision|2|||
146041960|NCT01677858|526667050|FG003|Overall Study|Physician Decision|0|||
146041961|NCT01677858|526667051|FG004|Overall Study|Physician Decision|12|||
146041962|NCT01677858|526667047|FG000|Overall Study|Progressive Disease|2|||
146041963|NCT01677858|526667048|FG001|Overall Study|Progressive Disease|1|||
146254587|NCT01261793|527444616|FG001|Overall Study|Patient pregnant|0|||
146100186|NCT00910273|526886557|FG000|Overall Study|Adverse Event|1|||
146100187|NCT00910273|526886558|FG001|Overall Study|Adverse Event|1|||
146100188|NCT00910273|526886557|FG000|Overall Study|Withdrawal by Subject|1|||
146100189|NCT00910273|526886558|FG001|Overall Study|Withdrawal by Subject|0|||
146100190|NCT00910273|526886557|FG000|Overall Study|Discontinuation of study by sponsor|8|||
146100191|NCT00910273|526886558|FG001|Overall Study|Discontinuation of study by sponsor|2|||
146100192|NCT00910273|526886557|FG000|Overall Study|Protocol Violation|1|||
146100193|NCT00910273|526886558|FG001|Overall Study|Protocol Violation|0|||
146100194|NCT00910273|526886557|FG000|Overall Study|Lost to Follow-up|1|||
146100195|NCT00910273|526886558|FG001|Overall Study|Lost to Follow-up|1|||
146100196|NCT03021304|526886559|FG000|Overall Study|Lack of Efficacy|1|||
146100197|NCT04122534|526886565|FG000|Overall Study|Lost to Follow-up|4|||
146100198|NCT02128932|526886569|FG000|Overall Study|Withdrawal by Subject|11|||
146100199|NCT02128932|526886570|FG001|Overall Study|Withdrawal by Subject|7|||
146100200|NCT02128932|526886571|FG002|Overall Study|Withdrawal by Subject|8|||
146100201|NCT02128932|526886569|FG000|Overall Study|Death|2|||
146100202|NCT02128932|526886570|FG001|Overall Study|Death|0|||
146100203|NCT02128932|526886571|FG002|Overall Study|Death|2|||
146100204|NCT02128932|526886569|FG000|Overall Study|Lost to Follow-up|2|||
146100205|NCT02128932|526886570|FG001|Overall Study|Lost to Follow-up|1|||
146100206|NCT02128932|526886571|FG002|Overall Study|Lost to Follow-up|1|||
146100207|NCT02128932|526886569|FG000|Overall Study|No reason for withdrawal|12|||
146100208|NCT02128932|526886570|FG001|Overall Study|No reason for withdrawal|11|||
146100209|NCT02128932|526886571|FG002|Overall Study|No reason for withdrawal|7|||
146100210|NCT02020577|526886572|FG000|Overall Study|Progressive disease|3|||
146100211|NCT02020577|526886573|FG001|Overall Study|Progressive disease|38|||
146100212|NCT02020577|526886572|FG000|Overall Study|Other AE or clinical progression|0|||
146100213|NCT02020577|526886573|FG001|Overall Study|Other AE or clinical progression|15|||
146100214|NCT02020577|526886572|FG000|Overall Study|Withdrawal by Subject|0|||
146100215|NCT02020577|526886573|FG001|Overall Study|Withdrawal by Subject|1|||
146100216|NCT02020577|526886572|FG000|Overall Study|Other than stated above|0|||
146100217|NCT02020577|526886573|FG001|Overall Study|Other than stated above|1|||
146100218|NCT03113916|526886574|FG000|Overall Study|Withdrawal by Subject|9|||
146100219|NCT03113916|526886575|FG001|Overall Study|Withdrawal by Subject|7|||
146100220|NCT03113916|526886574|FG000|Overall Study|Pregnancy|1|||
146100221|NCT03113916|526886575|FG001|Overall Study|Pregnancy|3|||
146100222|NCT03113916|526886574|FG000|Overall Study|Lost to Follow-up|1|||
146100223|NCT03113916|526886575|FG001|Overall Study|Lost to Follow-up|2|||
146100224|NCT02663908|526886576|FG000|Overall Study|Withdrawal by Subject|8|||
146100225|NCT02663908|526886577|FG001|Overall Study|Withdrawal by Subject|5|||
146100226|NCT02663908|526886576|FG000|Overall Study|Lost to Follow-up|1|||
146100227|NCT02663908|526886577|FG001|Overall Study|Lost to Follow-up|5|||
146100228|NCT02663908|526886576|FG000|Overall Study|Adverse Event|13|||
146100229|NCT02663908|526886577|FG001|Overall Study|Adverse Event|11|||
146100230|NCT02663908|526886576|FG000|Overall Study|Protocol Violation|1|||
146100231|NCT02663908|526886577|FG001|Overall Study|Protocol Violation|2|||
146254588|NCT01261793|527444617|FG002|Overall Study|Patient pregnant|0|||
146254589|NCT01261793|527444615|FG000|Overall Study|Outside the study area|0|||
146254590|NCT01261793|527444616|FG001|Overall Study|Outside the study area|2|||
146254591|NCT01261793|527444617|FG002|Overall Study|Outside the study area|1|||
146100232|NCT02663908|526886576|FG000|Overall Study|Lack of therapeutic response|2|||
146100233|NCT02663908|526886577|FG001|Overall Study|Lack of therapeutic response|0|||
146100234|NCT02663908|526886576|FG000|Overall Study|COVID-19|1|||
146100235|NCT02663908|526886577|FG001|Overall Study|COVID-19|0|||
146100236|NCT02663908|526886576|FG000|Overall Study|Site closed|1|||
146100237|NCT02663908|526886577|FG001|Overall Study|Site closed|0|||
146100238|NCT02663908|526886576|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
146100239|NCT02663908|526886577|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
146100240|NCT02663908|526886576|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
146100241|NCT02663908|526886577|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
146254592|NCT01261793|527444615|FG000|Overall Study|Lack of efficacy & patient not available|0|||
146254593|NCT01261793|527444616|FG001|Overall Study|Lack of efficacy & patient not available|1|||
146254594|NCT01261793|527444617|FG002|Overall Study|Lack of efficacy & patient not available|0|||
146254595|NCT01261793|527444615|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
146100242|NCT02663908|526886576|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
146100243|NCT02663908|526886577|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
146100244|NCT02663908|526886576|FG000|Overall Study|Death|1|||
146100245|NCT02663908|526886577|FG001|Overall Study|Death|0|||
146100246|NCT02663908|526886576|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
146100247|NCT02663908|526886577|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
146100248|NCT02663908|526886576|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
146100249|NCT02663908|526886577|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
146100250|NCT01999868|526886578|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
146100251|NCT01999868|526886579|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
146100252|NCT01999868|526886580|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
146100253|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
146100254|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
146100255|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
146100256|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
146100257|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
146100258|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
146100259|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
146100260|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
146100261|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
146100262|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
146100263|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
146100264|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
146100265|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
146100266|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
146100267|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
146100268|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
146100269|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
146100270|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
146100271|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
146100272|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
146100273|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
146100274|NCT01999868|526886578|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
146100275|NCT01999868|526886579|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
146100276|NCT01999868|526886580|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
146100277|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
146100278|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
146100279|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
146100280|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
146100281|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
146100282|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
146100283|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
146100284|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
146100285|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
146100286|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
146100287|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
146100288|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
146100289|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
146100290|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
146100291|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
146100292|NCT01999868|526886578|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
146100293|NCT01999868|526886579|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
146100294|NCT01999868|526886580|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
146100295|NCT00761631|526886581|FG000|Overall Study|Parent/legal guardian request|8|||
146100296|NCT00761631|526886582|FG001|Overall Study|Parent/legal guardian request|3|||
146100297|NCT00761631|526886583|FG002|Overall Study|Parent/legal guardian request|8|||
146100298|NCT00761631|526886584|FG003|Overall Study|Parent/legal guardian request|0|||
146100299|NCT00761631|526886585|FG004|Overall Study|Parent/legal guardian request|5|||
146100300|NCT00761631|526886586|FG005|Overall Study|Parent/legal guardian request|0|||
146100301|NCT00761631|526886581|FG000|Overall Study|Lost to Follow-up|2|||
146100302|NCT00761631|526886582|FG001|Overall Study|Lost to Follow-up|4|||
146100303|NCT00761631|526886583|FG002|Overall Study|Lost to Follow-up|7|||
146254596|NCT01261793|527444616|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
146100304|NCT00761631|526886584|FG003|Overall Study|Lost to Follow-up|1|||
146100305|NCT00761631|526886585|FG004|Overall Study|Lost to Follow-up|6|||
146100306|NCT00761631|526886586|FG005|Overall Study|Lost to Follow-up|1|||
146100307|NCT00761631|526886581|FG000|Overall Study|Protocol Violation|2|||
146100308|NCT00761631|526886582|FG001|Overall Study|Protocol Violation|0|||
146100309|NCT00761631|526886583|FG002|Overall Study|Protocol Violation|0|||
146100310|NCT00761631|526886584|FG003|Overall Study|Protocol Violation|1|||
146100311|NCT00761631|526886585|FG004|Overall Study|Protocol Violation|5|||
146100312|NCT00761631|526886586|FG005|Overall Study|Protocol Violation|1|||
146254597|NCT01261793|527444617|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
146100313|NCT00761631|526886581|FG000|Overall Study|Randomized, not treated|1|||
146100314|NCT00761631|526886582|FG001|Overall Study|Randomized, not treated|0|||
146254598|NCT01261793|527444615|FG000|Overall Study|Randomization error|0|||
146041964|NCT01677858|526667049|FG002|Overall Study|Progressive Disease|9|||
146041965|NCT01677858|526667050|FG003|Overall Study|Progressive Disease|3|||
146041966|NCT01677858|526667051|FG004|Overall Study|Progressive Disease|43|||
146041967|NCT01677858|526667047|FG000|Overall Study|Withdrawal by Subject|0|||
146041968|NCT01677858|526667048|FG001|Overall Study|Withdrawal by Subject|1|||
146041969|NCT01677858|526667049|FG002|Overall Study|Withdrawal by Subject|1|||
146041970|NCT01677858|526667050|FG003|Overall Study|Withdrawal by Subject|0|||
146041971|NCT01677858|526667051|FG004|Overall Study|Withdrawal by Subject|15|||
146041972|NCT01677858|526667047|FG000|Overall Study|Lost to Follow-up|0|||
146041973|NCT01677858|526667048|FG001|Overall Study|Lost to Follow-up|0|||
146041974|NCT01677858|526667049|FG002|Overall Study|Lost to Follow-up|0|||
146041975|NCT01677858|526667050|FG003|Overall Study|Lost to Follow-up|0|||
146041976|NCT01677858|526667051|FG004|Overall Study|Lost to Follow-up|1|||
146041977|NCT01331109|526667052|FG000|Overall Study|Adverse Event|6|||
146041978|NCT01331109|526667052|FG000|Overall Study|Lack of Efficacy|2|||
146041979|NCT01331109|526667052|FG000|Overall Study|Protocol Violation|3|||
146041980|NCT01331109|526667052|FG000|Overall Study|Withdrawal by Subject|7|||
146041981|NCT01331109|526667052|FG000|Overall Study|Lost to Follow-up|1|||
146041982|NCT01331109|526667052|FG000|Overall Study|Study Terminated by Sponsor|38|||
146041983|NCT00988091|526667056|FG000|Double-blind Period|Withdrawal by Subject|15|||
146041984|NCT00988091|526667057|FG001|Double-blind Period|Withdrawal by Subject|13|||
146041985|NCT00988091|526667056|FG000|Double-blind Period|Lost to Follow-up|12|||
146041986|NCT00988091|526667057|FG001|Double-blind Period|Lost to Follow-up|14|||
146041987|NCT00988091|526667056|FG000|Double-blind Period|Other|8|||
146041988|NCT00988091|526667057|FG001|Double-blind Period|Other|8|||
146041989|NCT00988091|526667056|FG000|Double-blind Period|Adverse Event|6|||
146041990|NCT00988091|526667057|FG001|Double-blind Period|Adverse Event|9|||
146041991|NCT00988091|526667056|FG000|Double-blind Period|Use of exclusionary medication|2|||
146041992|NCT00988091|526667057|FG001|Double-blind Period|Use of exclusionary medication|3|||
146041993|NCT00988091|526667056|FG000|Open-label Period|Adverse Event|4|||
146041994|NCT00988091|526667057|FG001|Open-label Period|Adverse Event|7|||
146041995|NCT00988091|526667056|FG000|Open-label Period|Use of exclusionary medication|1|||
146041996|NCT00988091|526667057|FG001|Open-label Period|Use of exclusionary medication|1|||
146041997|NCT00988091|526667056|FG000|Open-label Period|Protocol Violation|1|||
146041998|NCT00988091|526667057|FG001|Open-label Period|Protocol Violation|1|||
146041999|NCT00988091|526667056|FG000|Open-label Period|Withdrawal by Subject|10|||
146042000|NCT00988091|526667057|FG001|Open-label Period|Withdrawal by Subject|16|||
146042001|NCT00988091|526667056|FG000|Open-label Period|Lost to Follow-up|3|||
146042002|NCT00988091|526667057|FG001|Open-label Period|Lost to Follow-up|5|||
146042003|NCT00988091|526667056|FG000|Open-label Period|Other|2|||
146042004|NCT00988091|526667057|FG001|Open-label Period|Other|3|||
146042005|NCT02669212|526667060|FG000|Overall Study|Lost to Follow-up|1|||
146042006|NCT02669212|526667061|FG001|Overall Study|Lost to Follow-up|0|||
146042007|NCT02669212|526667060|FG000|Overall Study|Medical Condition|3|||
146042008|NCT02669212|526667061|FG001|Overall Study|Medical Condition|4|||
146042009|NCT02669212|526667060|FG000|Overall Study|Withdrawal by Subject|0|||
146042010|NCT02669212|526667061|FG001|Overall Study|Withdrawal by Subject|2|||
146042011|NCT02669212|526667060|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
146042012|NCT02669212|526667061|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
146042013|NCT03549104|526667062|FG000|Overall Study|Withdrawal by Subject|5|||
146042014|NCT03549104|526667063|FG001|Overall Study|Withdrawal by Subject|2|||
146042015|NCT03549104|526667062|FG000|Overall Study|Covid shelter in place|1|||
146042016|NCT03549104|526667063|FG001|Overall Study|Covid shelter in place|2|||
146042017|NCT03078855|526667067|FG000|Overall Study|Lack of Efficacy|62|||
146042018|NCT03078855|526667068|FG001|Overall Study|Lack of Efficacy|31|||
146042019|NCT03078855|526667067|FG000|Overall Study|Death|1|||
146042020|NCT03078855|526667068|FG001|Overall Study|Death|0|||
146042021|NCT03078855|526667067|FG000|Overall Study|Withdrawal by Subject|12|||
146042022|NCT03078855|526667068|FG001|Overall Study|Withdrawal by Subject|6|||
146042023|NCT03078855|526667067|FG000|Overall Study|Physician Decision|3|||
146042024|NCT03078855|526667068|FG001|Overall Study|Physician Decision|2|||
146042025|NCT03078855|526667067|FG000|Overall Study|Second Malignancy|4|||
146042026|NCT03078855|526667068|FG001|Overall Study|Second Malignancy|0|||
146042027|NCT03078855|526667067|FG000|Overall Study|Ineligible|2|||
146042028|NCT03078855|526667068|FG001|Overall Study|Ineligible|0|||
146042029|NCT03078855|526667067|FG000|Overall Study|Withdrew before day 1 treatment|2|||
146042030|NCT03078855|526667068|FG001|Overall Study|Withdrew before day 1 treatment|1|||
146042031|NCT00391027|526667069|FG000|Overall Study|Adverse Event|8|||
146042032|NCT00391027|526667070|FG001|Overall Study|Adverse Event|8|||
146042033|NCT00391027|526667069|FG000|Overall Study|Lack of Efficacy|3|||
146042034|NCT00391027|526667070|FG001|Overall Study|Lack of Efficacy|0|||
146042035|NCT00391027|526667069|FG000|Overall Study|Withdrawal by Subject|10|||
146042036|NCT00391027|526667070|FG001|Overall Study|Withdrawal by Subject|1|||
146042037|NCT00391027|526667069|FG000|Overall Study|Other|4|||
146042038|NCT00391027|526667070|FG001|Overall Study|Other|3|||
146042039|NCT03422536|526667071|FG000|Randomized|Physician Decision|1|||
146042040|NCT03422536|526667072|FG001|Randomized|Physician Decision|1|||
146100315|NCT00761631|526886583|FG002|Overall Study|Randomized, not treated|0|||
146254599|NCT01261793|527444616|FG001|Overall Study|Randomization error|1|||
146254600|NCT01261793|527444617|FG002|Overall Study|Randomization error|0|||
146254601|NCT01261793|527444615|FG000|Overall Study|Patient unable to start IV line|0|||
146254602|NCT01261793|527444616|FG001|Overall Study|Patient unable to start IV line|0|||
146254603|NCT01261793|527444617|FG002|Overall Study|Patient unable to start IV line|1|||
146254604|NCT00577096|527444618|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
146042041|NCT03422536|526667071|FG000|Allocation - Received Intervention|Disease progression|19|||
146042042|NCT03422536|526667072|FG001|Allocation - Received Intervention|Disease progression|25|||
146042043|NCT03422536|526667071|FG000|Allocation - Received Intervention|Death|1|||
146042044|NCT03422536|526667072|FG001|Allocation - Received Intervention|Death|3|||
146042045|NCT03422536|526667071|FG000|Allocation - Received Intervention|Adverse Event|1|||
146042046|NCT03422536|526667072|FG001|Allocation - Received Intervention|Adverse Event|0|||
146042047|NCT03422536|526667071|FG000|Allocation - Received Intervention|Physician Decision|1|||
146042048|NCT03422536|526667072|FG001|Allocation - Received Intervention|Physician Decision|1|||
146042049|NCT03422536|526667071|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
146042050|NCT03422536|526667072|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
146042051|NCT03422536|526667071|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
146042052|NCT03422536|526667072|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
146042053|NCT00532298|526667073|FG000|Overall Study|Adverse Event|1|||
146042054|NCT00532298|526667074|FG001|Overall Study|Adverse Event|0|||
146042055|NCT00532298|526667075|FG002|Overall Study|Adverse Event|0|||
146042056|NCT00532298|526667076|FG003|Overall Study|Adverse Event|0|||
146042057|NCT00532298|526667077|FG004|Overall Study|Adverse Event|1|||
146042058|NCT00532298|526667078|FG005|Overall Study|Adverse Event|1|||
146042059|NCT00532298|526667073|FG000|Overall Study|Lost to Follow-up|1|||
146042060|NCT00532298|526667074|FG001|Overall Study|Lost to Follow-up|1|||
146042061|NCT00532298|526667075|FG002|Overall Study|Lost to Follow-up|1|||
146042062|NCT00532298|526667076|FG003|Overall Study|Lost to Follow-up|0|||
146042063|NCT00532298|526667077|FG004|Overall Study|Lost to Follow-up|0|||
146042064|NCT00532298|526667078|FG005|Overall Study|Lost to Follow-up|1|||
146042065|NCT00479856|526667079|FG000|Overall Study|Adverse Event|1|||
146042066|NCT00479856|526667079|FG000|Overall Study|Withdrawal by Subject|1|||
146042067|NCT00479856|526667079|FG000|Overall Study|Physician Decision|1|||
146042068|NCT04164732|526667086|FG000|Treatment run-in Period|Adverse Event|4|||
146042069|NCT04164732|526667087|FG001|Treatment run-in Period|Adverse Event|0|||
146042070|NCT04164732|526667088|FG002|Treatment run-in Period|Adverse Event|0|||
146042071|NCT04164732|526667086|FG000|Treatment run-in Period|Physician Decision|1|||
146042072|NCT04164732|526667087|FG001|Treatment run-in Period|Physician Decision|0|||
146042073|NCT04164732|526667088|FG002|Treatment run-in Period|Physician Decision|0|||
146042074|NCT04164732|526667086|FG000|Treatment run-in Period|Screen Failure|1|||
146042075|NCT04164732|526667087|FG001|Treatment run-in Period|Screen Failure|0|||
146042076|NCT04164732|526667088|FG002|Treatment run-in Period|Screen Failure|0|||
146042077|NCT04164732|526667086|FG000|Randomized Treatment Period|Adverse Event|0|||
146042078|NCT04164732|526667087|FG001|Randomized Treatment Period|Adverse Event|1|||
146042079|NCT04164732|526667088|FG002|Randomized Treatment Period|Adverse Event|0|||
146042080|NCT04164732|526667086|FG000|Randomized Treatment Period|Protocol Deviation|0|||
146042081|NCT04164732|526667087|FG001|Randomized Treatment Period|Protocol Deviation|1|||
146042082|NCT04164732|526667088|FG002|Randomized Treatment Period|Protocol Deviation|1|||
146042083|NCT04164732|526667086|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
146042084|NCT04164732|526667087|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
146042085|NCT04164732|526667088|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
146042086|NCT00661622|526667089|FG000|Overall Study|Protocol Violation|1|||
146042087|NCT00661622|526667090|FG001|Overall Study|Protocol Violation|0|||
146042088|NCT04765202|526667095|FG000|Overall Study|Lost to Follow-up|1|||
146042089|NCT04765202|526667096|FG001|Overall Study|Lost to Follow-up|1|||
146042090|NCT04765202|526667097|FG002|Overall Study|Lost to Follow-up|2|||
146042091|NCT04765202|526667098|FG003|Overall Study|Lost to Follow-up|2|||
146042092|NCT04765202|526667095|FG000|Overall Study|Physician Decision|0|||
146042093|NCT04765202|526667096|FG001|Overall Study|Physician Decision|0|||
146042094|NCT04765202|526667097|FG002|Overall Study|Physician Decision|1|||
146042095|NCT04765202|526667098|FG003|Overall Study|Physician Decision|1|||
146042096|NCT04929249|526667099|FG000|Overall Study|Adverse Event|2|||
146042097|NCT04929249|526667100|FG001|Overall Study|Adverse Event|1|||
146042098|NCT04929249|526667099|FG000|Overall Study|Death|2|||
146042099|NCT04929249|526667100|FG001|Overall Study|Death|1|||
146042100|NCT04929249|526667099|FG000|Overall Study|Lost to Follow-up|3|||
146042101|NCT04929249|526667100|FG001|Overall Study|Lost to Follow-up|11|||
146042102|NCT04929249|526667099|FG000|Overall Study|Technical problems|0|||
146254605|NCT00577096|527444619|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
146042103|NCT04929249|526667100|FG001|Overall Study|Technical problems|1|||
146042104|NCT04929249|526667099|FG000|Overall Study|Subject decision|6|||
146042105|NCT04929249|526667100|FG001|Overall Study|Subject decision|8|||
146042106|NCT04929249|526667099|FG000|Overall Study|Withdrew consent|0|||
146042107|NCT04929249|526667100|FG001|Overall Study|Withdrew consent|8|||
146042108|NCT01620762|526667101|FG000|Overall Study|Protocol Violation|1|||
146300617|NCT00884325|527617064|FG001|Overall Study|Lost to Follow-up|2|||
146042109|NCT01620762|526667102|FG001|Overall Study|Protocol Violation|1|||
146042110|NCT01620762|526667103|FG002|Overall Study|Protocol Violation|1|||
146042111|NCT01620762|526667101|FG000|Overall Study|Adverse Event|9|||
146042112|NCT01620762|526667102|FG001|Overall Study|Adverse Event|5|||
146042113|NCT01620762|526667103|FG002|Overall Study|Adverse Event|2|||
146042114|NCT01620762|526667101|FG000|Overall Study|Withdrawal by Subject|23|||
146042115|NCT01620762|526667102|FG001|Overall Study|Withdrawal by Subject|26|||
146042116|NCT01620762|526667103|FG002|Overall Study|Withdrawal by Subject|27|||
146042117|NCT01620762|526667101|FG000|Overall Study|Lost to Follow-up|11|||
146042118|NCT01620762|526667102|FG001|Overall Study|Lost to Follow-up|17|||
146042119|NCT01620762|526667103|FG002|Overall Study|Lost to Follow-up|10|||
146042120|NCT01620762|526667101|FG000|Overall Study|Protocol deviation|1|||
146042121|NCT01620762|526667102|FG001|Overall Study|Protocol deviation|1|||
146042122|NCT01620762|526667103|FG002|Overall Study|Protocol deviation|6|||
146042123|NCT01620762|526667101|FG000|Overall Study|Subject deterioration|0|||
146042124|NCT01620762|526667102|FG001|Overall Study|Subject deterioration|1|||
146042125|NCT01620762|526667103|FG002|Overall Study|Subject deterioration|1|||
146042126|NCT01620762|526667101|FG000|Overall Study|Non-specified|3|||
146042127|NCT01620762|526667102|FG001|Overall Study|Non-specified|6|||
146042128|NCT01620762|526667103|FG002|Overall Study|Non-specified|5|||
146042129|NCT01620762|526667101|FG000|Overall Study|Use of prohibted therapies|0|||
146042130|NCT01620762|526667102|FG001|Overall Study|Use of prohibted therapies|1|||
146042131|NCT01620762|526667103|FG002|Overall Study|Use of prohibted therapies|1|||
146042132|NCT00705146|526667104|FG000|Overall Study|Lost to Follow-up|1|||
146042133|NCT00705146|526667105|FG001|Overall Study|Lost to Follow-up|1|||
146042134|NCT00095173|526667106|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
146042135|NCT00095173|526667107|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146042136|NCT00095173|526667108|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146042137|NCT00095173|526667109|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146042138|NCT00095173|526667110|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146042139|NCT00095173|526667111|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
146042140|NCT00095173|526667106|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
146042141|NCT00095173|526667107|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146042142|NCT00095173|526667108|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146042143|NCT00095173|526667109|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146042144|NCT00095173|526667110|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146042145|NCT00095173|526667111|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
146042146|NCT00095173|526667106|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
146042147|NCT00095173|526667107|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146042148|NCT00095173|526667108|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146042149|NCT00095173|526667109|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146042150|NCT00095173|526667110|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146042151|NCT00095173|526667111|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
146042152|NCT00095173|526667106|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
146042153|NCT00095173|526667107|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
146042154|NCT00095173|526667108|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
146042155|NCT00095173|526667109|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
146042156|NCT00095173|526667110|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
146042157|NCT00095173|526667111|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
146042158|NCT00095173|526667106|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146042159|NCT00095173|526667107|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
146042160|NCT00095173|526667108|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
146042161|NCT00095173|526667109|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146042162|NCT00095173|526667110|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146042163|NCT00095173|526667111|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
146042164|NCT00095173|526667106|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146042165|NCT00095173|526667107|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
146042166|NCT00095173|526667108|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146042167|NCT00095173|526667109|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146042168|NCT00095173|526667110|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146042169|NCT00095173|526667111|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
146042170|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Death|0|||
146042171|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Death|0|||
146042172|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Death|0|||
146042173|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Death|0|||
146042174|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Death|0|||
146042175|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Death|1|||
146042176|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146042177|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146042178|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
146042179|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
146042180|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
146254606|NCT00577096|527444618|FG000|Short Term Participation|Withdrawal by Subject|3|||
146254607|NCT00577096|527444619|FG001|Short Term Participation|Withdrawal by Subject|5|||
146254608|NCT00577096|527444618|FG000|Short Term Participation|Death|1|||
146254609|NCT00577096|527444619|FG001|Short Term Participation|Death|1|||
146254610|NCT03305458|527444620|FG000|Overall Study|Withdrawal by Subject|50|||
146254611|NCT03305458|527444621|FG001|Overall Study|Withdrawal by Subject|46|||
146254612|NCT03305458|527444622|FG002|Overall Study|Withdrawal by Subject|93|||
146042181|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
146042182|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146100316|NCT00761631|526886584|FG003|Overall Study|Randomized, not treated|0|||
146100317|NCT00761631|526886585|FG004|Overall Study|Randomized, not treated|0|||
146100318|NCT00761631|526886586|FG005|Overall Study|Randomized, not treated|0|||
146100319|NCT00761631|526886581|FG000|Overall Study|Failed to return|1|||
146100320|NCT00761631|526886582|FG001|Overall Study|Failed to return|0|||
146100321|NCT00761631|526886583|FG002|Overall Study|Failed to return|1|||
146100322|NCT00761631|526886584|FG003|Overall Study|Failed to return|1|||
146100323|NCT00761631|526886585|FG004|Overall Study|Failed to return|5|||
146100324|NCT00761631|526886586|FG005|Overall Study|Failed to return|2|||
146100325|NCT00761631|526886581|FG000|Overall Study|Physician Decision|1|||
146100326|NCT00761631|526886582|FG001|Overall Study|Physician Decision|0|||
146100327|NCT00761631|526886583|FG002|Overall Study|Physician Decision|0|||
146100328|NCT00761631|526886584|FG003|Overall Study|Physician Decision|0|||
146100329|NCT00761631|526886585|FG004|Overall Study|Physician Decision|0|||
146100330|NCT00761631|526886586|FG005|Overall Study|Physician Decision|0|||
146100331|NCT00761631|526886581|FG000|Overall Study|Other|0|||
146042183|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146042184|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
146042185|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
146042186|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
146042187|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
146042188|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146042189|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146042190|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
146042191|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
146042192|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
146042193|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
146042194|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146042195|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146042196|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146042197|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
146042198|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
146042199|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
146042200|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146042201|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146042202|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146042203|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
146042204|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
146042205|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
146042206|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146042207|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146042208|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146042209|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
146042210|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
146042211|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
146042212|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146042213|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146042214|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
146042215|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
146042216|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
146042217|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
146042218|NCT00095173|526667106|FG000|Open-Label Extension Phase (Period C)|Other|0|||
146042219|NCT00095173|526667107|FG001|Open-Label Extension Phase (Period C)|Other|0|||
146100332|NCT00761631|526886582|FG001|Overall Study|Other|0|||
146100333|NCT00761631|526886583|FG002|Overall Study|Other|0|||
146100334|NCT00761631|526886584|FG003|Overall Study|Other|0|||
146100335|NCT00761631|526886585|FG004|Overall Study|Other|1|||
146100336|NCT00761631|526886586|FG005|Overall Study|Other|1|||
146100337|NCT00289016|526886591|FG000|Overall Study|Disease Progression|29|||
146100338|NCT00289016|526886591|FG000|Overall Study|Death|2|||
146254613|NCT03305458|527444620|FG000|Overall Study|Lost to Follow-up|85|||
146254614|NCT03305458|527444621|FG001|Overall Study|Lost to Follow-up|85|||
146100339|NCT00289016|526886591|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
146100340|NCT00289016|526886591|FG000|Overall Study|Withdrawal by Subject|2|||
146100341|NCT00289016|526886591|FG000|Overall Study|Adverse Event|1|||
146100342|NCT00289016|526886591|FG000|Overall Study|Other|1|||
146100343|NCT00319501|526886592|FG000|Double-blind Period|Withdrawal by Subject|0|||
146100344|NCT00319501|526886593|FG001|Double-blind Period|Withdrawal by Subject|3|||
146100345|NCT00319501|526886592|FG000|Double-blind Period|Sponsor Request|1|||
146100346|NCT00319501|526886593|FG001|Double-blind Period|Sponsor Request|0|||
146100347|NCT00319501|526886592|FG000|Double-blind Period|Did not receive treatment|42|||
146100348|NCT00319501|526886593|FG001|Double-blind Period|Did not receive treatment|29|||
146100349|NCT00319501|526886592|FG000|Open-label Period|Adverse Event|5|||
146100350|NCT00319501|526886593|FG001|Open-label Period|Adverse Event|0|||
146100351|NCT00319501|526886592|FG000|Open-label Period|Protocol Violation|6|||
146100352|NCT00319501|526886593|FG001|Open-label Period|Protocol Violation|0|||
146100353|NCT00319501|526886592|FG000|Open-label Period|Withdrawal by Subject|38|||
146100354|NCT00319501|526886593|FG001|Open-label Period|Withdrawal by Subject|0|||
146100355|NCT00319501|526886592|FG000|Open-label Period|Principal Investigator decision|6|||
146100356|NCT00319501|526886593|FG001|Open-label Period|Principal Investigator decision|0|||
146100357|NCT00319501|526886592|FG000|Open-label Period|Sponsor request|12|||
146100358|NCT00319501|526886593|FG001|Open-label Period|Sponsor request|0|||
146100359|NCT00319501|526886592|FG000|Open-label Period|Lost to Follow-up|5|||
146100360|NCT00319501|526886593|FG001|Open-label Period|Lost to Follow-up|0|||
146100361|NCT00319501|526886592|FG000|Open-label Period|Did not receive treatment|33|||
146100362|NCT00319501|526886593|FG001|Open-label Period|Did not receive treatment|0|||
146100363|NCT00319501|526886592|FG000|Open-label Period|Other|11|||
146100364|NCT00319501|526886593|FG001|Open-label Period|Other|0|||
146100365|NCT00319501|526886592|FG000|Open-label Extension Period|Adverse Event|2|||
146100366|NCT00319501|526886593|FG001|Open-label Extension Period|Adverse Event|0|||
146100367|NCT00319501|526886592|FG000|Open-label Extension Period|Did not receive treatment|18|||
146100368|NCT00319501|526886593|FG001|Open-label Extension Period|Did not receive treatment|0|||
146100369|NCT00319501|526886592|FG000|Open-label Extension Period|Other|1|||
146100370|NCT00319501|526886593|FG001|Open-label Extension Period|Other|0|||
146100371|NCT00319501|526886592|FG000|Open-label Extension Period|Principal investigator decision|2|||
146100372|NCT00319501|526886593|FG001|Open-label Extension Period|Principal investigator decision|0|||
146100373|NCT00319501|526886592|FG000|Open-label Extension Period|Sponsor request|26|||
146100374|NCT00319501|526886593|FG001|Open-label Extension Period|Sponsor request|0|||
146100375|NCT00319501|526886592|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
146100376|NCT00319501|526886593|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
146100377|NCT00667875|526886595|FG000|Overall Study|Adverse Event|0|||
146100378|NCT00667875|526886596|FG001|Overall Study|Adverse Event|2|||
146100379|NCT00667875|526886597|FG002|Overall Study|Adverse Event|6|||
146100380|NCT00667875|526886595|FG000|Overall Study|Withdrawal by Subject|10|||
146100381|NCT00667875|526886596|FG001|Overall Study|Withdrawal by Subject|9|||
146100382|NCT00667875|526886597|FG002|Overall Study|Withdrawal by Subject|7|||
146100383|NCT00450255|526886598|FG000|Overall Study|Prior RFA ablation of liver|1|||
146100384|NCT02569671|526886599|FG000|Overall Study|Lost to Follow-up|2|||
146100385|NCT02569671|526886600|FG001|Overall Study|Lost to Follow-up|1|||
146100386|NCT02569671|526886599|FG000|Overall Study|Withdrawal by Subject|1|||
146042220|NCT00095173|526667108|FG002|Open-Label Extension Phase (Period C)|Other|0|||
146042221|NCT00095173|526667109|FG003|Open-Label Extension Phase (Period C)|Other|4|||
146042222|NCT00095173|526667110|FG004|Open-Label Extension Phase (Period C)|Other|6|||
146042223|NCT00095173|526667111|FG005|Open-Label Extension Phase (Period C)|Other|8|||
146042224|NCT02951429|526667119|FG000|Overall Study|Adverse Event|3|||
146042225|NCT02951429|526667120|FG001|Overall Study|Adverse Event|7|||
146042226|NCT02951429|526667119|FG000|Overall Study|Death|28|||
146042227|NCT02951429|526667120|FG001|Overall Study|Death|36|||
146042228|NCT02951429|526667119|FG000|Overall Study|Lack of Efficacy|0|||
146042229|NCT02951429|526667120|FG001|Overall Study|Lack of Efficacy|1|||
146042230|NCT02951429|526667119|FG000|Overall Study|Lost to Follow-up|0|||
146100387|NCT02569671|526886600|FG001|Overall Study|Withdrawal by Subject|3|||
146042231|NCT02951429|526667120|FG001|Overall Study|Lost to Follow-up|1|||
146042232|NCT02951429|526667119|FG000|Overall Study|Lung Transplantation|9|||
146042233|NCT02951429|526667120|FG001|Overall Study|Lung Transplantation|6|||
146100388|NCT02612129|526886601|FG000|Single Dose Treatment Period|Screening Failure|1|||
146100389|NCT02612129|526886602|FG001|Single Dose Treatment Period|Screening Failure|0|||
146100390|NCT02612129|526886603|FG002|Single Dose Treatment Period|Screening Failure|0|||
146100391|NCT02612129|526886601|FG000|Continuous Treatment Period|Early Escape|0|||
146100392|NCT02612129|526886602|FG001|Continuous Treatment Period|Early Escape|2|||
146042234|NCT02951429|526667119|FG000|Overall Study|Other|1|||
146042235|NCT02951429|526667120|FG001|Overall Study|Other|3|||
146042236|NCT02951429|526667119|FG000|Overall Study|Progressive Disease|1|||
146100393|NCT02612129|526886603|FG002|Continuous Treatment Period|Early Escape|0|||
146254615|NCT03305458|527444622|FG002|Overall Study|Lost to Follow-up|35|||
146042237|NCT02951429|526667120|FG001|Overall Study|Progressive Disease|1|||
146100394|NCT02612129|526886601|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
146100395|NCT02612129|526886602|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
146100396|NCT02612129|526886603|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
146100397|NCT02612129|526886601|FG000|Continuous Treatment Period|Safety Reasons|0|||
146100398|NCT02612129|526886602|FG001|Continuous Treatment Period|Safety Reasons|3|||
146100399|NCT02612129|526886603|FG002|Continuous Treatment Period|Safety Reasons|0|||
146100400|NCT02612129|526886601|FG000|Continuous Treatment Period|Death|0|||
146100401|NCT02612129|526886602|FG001|Continuous Treatment Period|Death|1|||
146100402|NCT02612129|526886603|FG002|Continuous Treatment Period|Death|0|||
146100403|NCT02612129|526886601|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
146100404|NCT02612129|526886602|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
146100405|NCT02612129|526886603|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
146254616|NCT03562117|527444624|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
146254617|NCT03562117|527444625|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
146254618|NCT03562117|527444626|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
146254619|NCT02418819|527444635|FG000|Overall Study|Adverse Event|0|||
146254620|NCT02418819|527444636|FG001|Overall Study|Adverse Event|0|||
146254621|NCT02418819|527444637|FG002|Overall Study|Adverse Event|1|||
146254622|NCT02418819|527444638|FG003|Overall Study|Adverse Event|0|||
146254623|NCT02418819|527444635|FG000|Overall Study|Lost to Follow-up|1|||
146254624|NCT02418819|527444636|FG001|Overall Study|Lost to Follow-up|0|||
146254625|NCT02418819|527444637|FG002|Overall Study|Lost to Follow-up|0|||
146254626|NCT02418819|527444638|FG003|Overall Study|Lost to Follow-up|0|||
146254627|NCT02418819|527444635|FG000|Overall Study|No longer meets eligibility criteria|0|||
146254628|NCT02418819|527444636|FG001|Overall Study|No longer meets eligibility criteria|0|||
146100406|NCT01757535|526886604|FG000|Overall Study|Disease Relapse|151|||
146100407|NCT01757535|526886605|FG001|Overall Study|Disease Relapse|181|||
146100408|NCT01757535|526886604|FG000|Overall Study|Other Reasons|28|||
146100409|NCT01757535|526886605|FG001|Overall Study|Other Reasons|27|||
146100410|NCT01757535|526886604|FG000|Overall Study|Adverse Event|31|||
146100411|NCT01757535|526886605|FG001|Overall Study|Adverse Event|11|||
146100412|NCT01757535|526886604|FG000|Overall Study|Withdrew Consent|19|||
146100413|NCT01757535|526886605|FG001|Overall Study|Withdrew Consent|13|||
146100414|NCT01757535|526886604|FG000|Overall Study|Physician Decision|7|||
146100415|NCT01757535|526886605|FG001|Overall Study|Physician Decision|0|||
146100416|NCT01757535|526886604|FG000|Overall Study|Death|2|||
146100417|NCT01757535|526886605|FG001|Overall Study|Death|2|||
146100418|NCT06238362|526886606|FG000|Overall Study|Insufficient total sleep time|1|||
146100419|NCT06238362|526886607|FG001|Overall Study|Insufficient total sleep time|0|||
146100420|NCT06238362|526886606|FG000|Overall Study|Inadequate signal quality|1|||
146100421|NCT06238362|526886607|FG001|Overall Study|Inadequate signal quality|0|||
146100422|NCT03689530|526887843|FG000|Overall Study|Withdrawal by Subject|53|||
146100423|NCT03689530|526887844|FG001|Overall Study|Withdrawal by Subject|16|||
146100424|NCT01392443|526887845|FG000|Overall Study|Disease progression|30|||
146100425|NCT01392443|526887845|FG000|Overall Study|Adverse Event|24|||
146100426|NCT01392443|526887845|FG000|Overall Study|Death|7|||
146100427|NCT01392443|526887845|FG000|Overall Study|Withdrawal by Subject|5|||
146100428|NCT01392443|526887845|FG000|Overall Study|Lost to Follow-up|1|||
146100429|NCT01392443|526887845|FG000|Overall Study|Protocol Violation|1|||
146100430|NCT01977794|526887846|FG000|Overall Study|Adverse Event|2|||
146100431|NCT01977794|526887847|FG001|Overall Study|Adverse Event|2|||
146100432|NCT01977794|526887846|FG000|Overall Study|Lost to Follow-up|2|||
146100433|NCT01977794|526887847|FG001|Overall Study|Lost to Follow-up|1|||
146100434|NCT01977794|526887846|FG000|Overall Study|Protocol Violation|1|||
146100435|NCT01977794|526887847|FG001|Overall Study|Protocol Violation|0|||
146100436|NCT01977794|526887846|FG000|Overall Study|Death|1|||
146100437|NCT01977794|526887847|FG001|Overall Study|Death|1|||
146100438|NCT01977794|526887846|FG000|Overall Study|Withdrew consent|2|||
146100439|NCT01977794|526887847|FG001|Overall Study|Withdrew consent|1|||
146254629|NCT02418819|527444637|FG002|Overall Study|No longer meets eligibility criteria|1|||
146254630|NCT02418819|527444638|FG003|Overall Study|No longer meets eligibility criteria|0|||
146254631|NCT02418819|527444635|FG000|Overall Study|No longer willing to participate|0|||
146254632|NCT02418819|527444636|FG001|Overall Study|No longer willing to participate|0|||
146254633|NCT02418819|527444637|FG002|Overall Study|No longer willing to participate|2|||
146254634|NCT02418819|527444638|FG003|Overall Study|No longer willing to participate|1|||
146254635|NCT04374253|527444642|FG000|Overall Study|Adverse Event|0|||
146100440|NCT01977794|526887846|FG000|Overall Study|Other|0|||
146100441|NCT01977794|526887847|FG001|Overall Study|Other|1|||
146100442|NCT01546207|526887861|FG000|Overall Study|Death|1|||
146100443|NCT00246753|526887864|FG000|Overall Study|Withdrawal by Subject|2|||
146100444|NCT00246753|526887864|FG000|Overall Study|Physician Decision|2|||
146254636|NCT04374253|527444643|FG001|Overall Study|Adverse Event|26|||
146100445|NCT00246753|526887864|FG000|Overall Study|Adverse Event|2|||
146100446|NCT00246753|526887864|FG000|Overall Study|Unacceptable toxicity|2|||
146254637|NCT04374253|527444644|FG002|Overall Study|Adverse Event|2|||
146254638|NCT04374253|527444645|FG003|Overall Study|Adverse Event|12|||
146100447|NCT03019185|526887867|FG000|Overall Study|Lost to Follow-up|3|||
146100448|NCT03019185|526887868|FG001|Overall Study|Lost to Follow-up|0|||
146100449|NCT03019185|526887869|FG002|Overall Study|Lost to Follow-up|2|||
146100450|NCT03019185|526887867|FG000|Overall Study|Withdrawal by Subject|1|||
146100451|NCT03019185|526887868|FG001|Overall Study|Withdrawal by Subject|1|||
146100452|NCT03019185|526887869|FG002|Overall Study|Withdrawal by Subject|0|||
146100453|NCT03019185|526887867|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
146100454|NCT03019185|526887868|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
146100455|NCT03019185|526887869|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
146100456|NCT03019185|526887867|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
146100457|NCT03019185|526887868|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
146100458|NCT03019185|526887869|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
146100459|NCT00617851|526887870|FG000|Overall Study|Death|0|||
146100460|NCT00617851|526887871|FG001|Overall Study|Death|0|||
146100461|NCT00617851|526887872|FG002|Overall Study|Death|0|||
146100462|NCT00617851|526887873|FG003|Overall Study|Death|1|||
146100463|NCT00617851|526887870|FG000|Overall Study|Withdrawal by Subject|14|||
146100464|NCT00617851|526887871|FG001|Overall Study|Withdrawal by Subject|7|||
146100465|NCT00617851|526887872|FG002|Overall Study|Withdrawal by Subject|12|||
146100466|NCT00617851|526887873|FG003|Overall Study|Withdrawal by Subject|4|||
146100467|NCT00617851|526887870|FG000|Overall Study|Lost to Follow-up|27|||
146100468|NCT00617851|526887871|FG001|Overall Study|Lost to Follow-up|29|||
146100469|NCT00617851|526887872|FG002|Overall Study|Lost to Follow-up|31|||
146100470|NCT00617851|526887873|FG003|Overall Study|Lost to Follow-up|19|||
146100471|NCT00617851|526887870|FG000|Overall Study|Inappropriate Enrollment|5|||
146100472|NCT00617851|526887871|FG001|Overall Study|Inappropriate Enrollment|4|||
146100473|NCT00617851|526887872|FG002|Overall Study|Inappropriate Enrollment|1|||
146100474|NCT00617851|526887873|FG003|Overall Study|Inappropriate Enrollment|1|||
146100475|NCT00617851|526887870|FG000|Overall Study|Unable to classify|1|||
146100476|NCT00617851|526887871|FG001|Overall Study|Unable to classify|0|||
146100477|NCT00617851|526887872|FG002|Overall Study|Unable to classify|1|||
146100478|NCT00617851|526887873|FG003|Overall Study|Unable to classify|0|||
146100479|NCT01601132|526887877|FG000|Overall Study|Patient withdrew consent|1|||
146100480|NCT01601132|526887877|FG000|Overall Study|Protocol deviation|1|||
146100481|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Adverse Event|3|||
146100482|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Adverse Event|0|||
146100483|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
146100484|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
146100485|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
146100486|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
146100487|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Physician Decision|0|||
146100488|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Physician Decision|2|||
146100489|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
146100490|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
146100491|NCT02110238|526887878|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
146100492|NCT02110238|526887879|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
146100493|NCT02110238|526887878|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
146100494|NCT02110238|526887879|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
146100495|NCT02110238|526887878|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
146100496|NCT02110238|526887879|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
146100497|NCT02110238|526887878|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
146042238|NCT02951429|526667119|FG000|Overall Study|Withdrawal by Subject|7|||
146042239|NCT02951429|526667120|FG001|Overall Study|Withdrawal by Subject|11|||
146042240|NCT02951429|526667119|FG000|Overall Study|Participant ongoing in the study|23|||
146042241|NCT02951429|526667120|FG001|Overall Study|Participant ongoing in the study|17|||
146042242|NCT01620528|526667121|FG000|Treatment Period|Did Not Receive Study Drug|0|||
146042243|NCT01620528|526667122|FG001|Treatment Period|Did Not Receive Study Drug|0|||
146042244|NCT01620528|526667123|FG002|Treatment Period|Did Not Receive Study Drug|1|||
146042245|NCT01620528|526667121|FG000|Treatment Period|Withdrawal by Subject|35|||
146042246|NCT01620528|526667122|FG001|Treatment Period|Withdrawal by Subject|21|||
146042247|NCT01620528|526667123|FG002|Treatment Period|Withdrawal by Subject|16|||
146100498|NCT02110238|526887879|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
146100499|NCT02110238|526887878|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
146042248|NCT01620528|526667121|FG000|Treatment Period|Adverse Event|17|||
146100500|NCT02110238|526887879|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
146100501|NCT02110238|526887878|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
146042249|NCT01620528|526667122|FG001|Treatment Period|Adverse Event|13|||
146100502|NCT02110238|526887879|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
146100503|NCT03228433|526887884|FG000|Overall Study|Lost to Follow-up|1|||
146100504|NCT03228433|526887885|FG001|Overall Study|Lost to Follow-up|0|||
146100505|NCT03228433|526887886|FG002|Overall Study|Lost to Follow-up|0|||
146100506|NCT03228433|526887887|FG003|Overall Study|Lost to Follow-up|0|||
146100507|NCT03228433|526887888|FG004|Overall Study|Lost to Follow-up|0|||
146100508|NCT03228433|526887889|FG005|Overall Study|Lost to Follow-up|0|||
146042250|NCT01620528|526667123|FG002|Treatment Period|Adverse Event|21|||
146042251|NCT01620528|526667121|FG000|Treatment Period|Lost to Follow-up|16|||
146042252|NCT01620528|526667122|FG001|Treatment Period|Lost to Follow-up|8|||
146042253|NCT01620528|526667123|FG002|Treatment Period|Lost to Follow-up|14|||
146042254|NCT01620528|526667121|FG000|Treatment Period|Other|9|||
146042255|NCT01620528|526667122|FG001|Treatment Period|Other|5|||
146042256|NCT01620528|526667123|FG002|Treatment Period|Other|7|||
146042257|NCT01620528|526667121|FG000|Treatment Period|Subject Noncompliant|11|||
146042258|NCT01620528|526667122|FG001|Treatment Period|Subject Noncompliant|2|||
146042259|NCT01620528|526667123|FG002|Treatment Period|Subject Noncompliant|2|||
146042260|NCT01620528|526667121|FG000|Treatment Period|Pregnancy|7|||
146042261|NCT01620528|526667122|FG001|Treatment Period|Pregnancy|2|||
146042262|NCT01620528|526667123|FG002|Treatment Period|Pregnancy|2|||
146042263|NCT01620528|526667121|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
146042264|NCT01620528|526667122|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
146042265|NCT01620528|526667123|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
146042266|NCT01620528|526667121|FG000|Treatment Period|Exclusionary Medication Received|0|||
146042267|NCT01620528|526667122|FG001|Treatment Period|Exclusionary Medication Received|1|||
146042268|NCT01620528|526667123|FG002|Treatment Period|Exclusionary Medication Received|0|||
146042269|NCT01620528|526667121|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
146042270|NCT01620528|526667122|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
146042271|NCT01620528|526667123|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
146042272|NCT01620528|526667121|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
146042273|NCT01620528|526667122|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146042274|NCT01620528|526667123|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
146042275|NCT01620528|526667121|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
146042276|NCT01620528|526667122|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
146042277|NCT01620528|526667123|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
146042278|NCT01620528|526667121|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
146042279|NCT01620528|526667122|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
146042280|NCT01620528|526667123|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
146042281|NCT01620528|526667121|FG000|Post-Treatment Follow-Up Period|Other|6|||
146042282|NCT01620528|526667122|FG001|Post-Treatment Follow-Up Period|Other|4|||
146042283|NCT01620528|526667123|FG002|Post-Treatment Follow-Up Period|Other|2|||
146042284|NCT01628965|526667130|FG000|Overall Study|Adverse Event|30|||
146042285|NCT01628965|526667130|FG000|Overall Study|Lack of Efficacy|7|||
146042286|NCT01628965|526667130|FG000|Overall Study|Withdrawal by Subject|3|||
146042287|NCT01628965|526667130|FG000|Overall Study|Lost to Follow-up|1|||
146042288|NCT01628965|526667130|FG000|Overall Study|Discontinuation criteria|8|||
146042289|NCT00330681|526667131|FG000|Overall Study|Adverse Event|3|||
146042290|NCT00330681|526667132|FG001|Overall Study|Adverse Event|6|||
146042291|NCT00330681|526667131|FG000|Overall Study|Protocol Violation|0|||
146042292|NCT00330681|526667132|FG001|Overall Study|Protocol Violation|1|||
146042293|NCT00330681|526667131|FG000|Overall Study|Withdrawal by Subject|5|||
146042294|NCT00330681|526667132|FG001|Overall Study|Withdrawal by Subject|5|||
146042295|NCT00330681|526667131|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
146042296|NCT00330681|526667132|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
146042297|NCT00847197|526667133|FG000|Overall Study|Adverse Event|21|||
146042298|NCT00847197|526667134|FG001|Overall Study|Adverse Event|3|||
146042299|NCT00847197|526667133|FG000|Overall Study|Protocol Violation|0|||
146042300|NCT00847197|526667134|FG001|Overall Study|Protocol Violation|1|||
146042301|NCT00847197|526667133|FG000|Overall Study|Withdrawal by Subject|3|||
146042302|NCT00847197|526667134|FG001|Overall Study|Withdrawal by Subject|1|||
146042303|NCT00825812|526667137|FG000|Overall Study|Never entered follow up|0|||
146042304|NCT00825812|526667138|FG001|Overall Study|Never entered follow up|0|||
146042305|NCT00825812|526667139|FG002|Overall Study|Never entered follow up|0|||
146042306|NCT00825812|526667140|FG003|Overall Study|Never entered follow up|1|||
146042307|NCT00825812|526667137|FG000|Overall Study|Adverse Event|0|||
146042308|NCT00825812|526667138|FG001|Overall Study|Adverse Event|0|||
146042309|NCT00825812|526667139|FG002|Overall Study|Adverse Event|0|||
146042310|NCT00825812|526667140|FG003|Overall Study|Adverse Event|1|||
146042311|NCT00825812|526667137|FG000|Overall Study|Subject withdrew consent|0|||
146042312|NCT00825812|526667138|FG001|Overall Study|Subject withdrew consent|0|||
146042313|NCT00825812|526667139|FG002|Overall Study|Subject withdrew consent|3|||
146042314|NCT00825812|526667140|FG003|Overall Study|Subject withdrew consent|2|||
146042315|NCT00825812|526667137|FG000|Overall Study|Non-compliance with protocol|0|||
146042316|NCT00825812|526667138|FG001|Overall Study|Non-compliance with protocol|0|||
146042317|NCT00825812|526667139|FG002|Overall Study|Non-compliance with protocol|0|||
146100509|NCT03228433|526887884|FG000|Overall Study|Positive alcohol test|0|||
146042318|NCT00825812|526667140|FG003|Overall Study|Non-compliance with protocol|1|||
146042319|NCT00825812|526667137|FG000|Overall Study|Administrative|0|||
146042320|NCT00825812|526667138|FG001|Overall Study|Administrative|1|||
146042321|NCT00825812|526667139|FG002|Overall Study|Administrative|3|||
146042322|NCT00825812|526667140|FG003|Overall Study|Administrative|5|||
146042323|NCT00895453|526667141|FG000|Overall Study|Lost to Follow-up|25|||
146100510|NCT03228433|526887885|FG001|Overall Study|Positive alcohol test|0|||
146100511|NCT03228433|526887886|FG002|Overall Study|Positive alcohol test|0|||
146100512|NCT03228433|526887887|FG003|Overall Study|Positive alcohol test|1|||
146100513|NCT03228433|526887888|FG004|Overall Study|Positive alcohol test|0|||
146100514|NCT03228433|526887889|FG005|Overall Study|Positive alcohol test|0|||
146100515|NCT01365052|526887897|FG000|Overall Study|Adverse Event|4|||
146100516|NCT01365052|526887898|FG001|Overall Study|Adverse Event|4|||
146100517|NCT00116428|526887906|FG000|Overall Study|Withdrawal by Subject|2|||
146100518|NCT00116428|526887907|FG001|Overall Study|Withdrawal by Subject|5|||
146100519|NCT00116428|526887906|FG000|Overall Study|Did not meet inclusion criteria|1|||
146100520|NCT00116428|526887907|FG001|Overall Study|Did not meet inclusion criteria|0|||
146100521|NCT00113087|526887908|FG000|Overall Study|Death or Transplant|14|||
146100522|NCT00113087|526887909|FG001|Overall Study|Death or Transplant|16|||
146100523|NCT00113087|526887908|FG000|Overall Study|Family or MD withdrew subject|10|||
146100524|NCT00113087|526887909|FG001|Overall Study|Family or MD withdrew subject|5|||
146100525|NCT03452228|526887910|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146100526|NCT03452228|526887911|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
146100527|NCT03452228|526887912|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
146100528|NCT03452228|526887910|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146100529|NCT03452228|526887911|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146100530|NCT03452228|526887912|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146100531|NCT03452228|526887910|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
146100532|NCT03452228|526887911|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
146100533|NCT03452228|526887912|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
146100534|NCT03452228|526887910|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146100535|NCT03452228|526887911|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146100536|NCT03452228|526887912|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
146100537|NCT00386607|526887913|FG000|Core|Adverse Event|40|||
146100538|NCT00386607|526887914|FG001|Core|Adverse Event|0|||
146100539|NCT00386607|526887913|FG000|Core|Abnormal laboratory value(s)|3|||
146100540|NCT00386607|526887914|FG001|Core|Abnormal laboratory value(s)|0|||
146100541|NCT00386607|526887913|FG000|Core|Unsatisfactory therapeutic effect|23|||
146100542|NCT00386607|526887914|FG001|Core|Unsatisfactory therapeutic effect|0|||
146100543|NCT00386607|526887913|FG000|Core|Condition no longer requires study drug|4|||
146100544|NCT00386607|526887914|FG001|Core|Condition no longer requires study drug|0|||
146100545|NCT00386607|526887913|FG000|Core|Patient withdrew consent|15|||
146100546|NCT00386607|526887914|FG001|Core|Patient withdrew consent|0|||
146100547|NCT00386607|526887913|FG000|Core|Lost to Follow-up|23|||
146100548|NCT00386607|526887914|FG001|Core|Lost to Follow-up|0|||
146100549|NCT00386607|526887913|FG000|Core|Administrative problems|1|||
146100550|NCT00386607|526887914|FG001|Core|Administrative problems|0|||
146100551|NCT00386607|526887913|FG000|Core|Protocol Deviation|6|||
146100552|NCT00386607|526887914|FG001|Core|Protocol Deviation|0|||
146100553|NCT00386607|526887913|FG000|Extension|Adverse Event|0|||
146100554|NCT00386607|526887914|FG001|Extension|Adverse Event|6|||
146100555|NCT00386607|526887913|FG000|Extension|Abnormal laboratory value(s)|0|||
146100556|NCT00386607|526887914|FG001|Extension|Abnormal laboratory value(s)|1|||
146100557|NCT00386607|526887913|FG000|Extension|Administrative problems|0|||
146100558|NCT00386607|526887914|FG001|Extension|Administrative problems|1|||
146100559|NCT00386607|526887913|FG000|Extension|Lost to Follow-up|0|||
146100560|NCT00386607|526887914|FG001|Extension|Lost to Follow-up|3|||
146100561|NCT00386607|526887913|FG000|Extension|Patient withdrew consent|0|||
146100562|NCT00386607|526887914|FG001|Extension|Patient withdrew consent|5|||
146100563|NCT00386607|526887913|FG000|Extension|Unsatisfactory therapeutic effect|0|||
146254639|NCT04374253|527444642|FG000|Overall Study|Study terminated by sponsor|13|||
146254640|NCT04374253|527444643|FG001|Overall Study|Study terminated by sponsor|593|||
146254641|NCT04374253|527444644|FG002|Overall Study|Study terminated by sponsor|21|||
146254642|NCT04374253|527444645|FG003|Overall Study|Study terminated by sponsor|567|||
146254643|NCT04374253|527444642|FG000|Overall Study|Withdrawal by Subject|0|||
146254644|NCT04374253|527444643|FG001|Overall Study|Withdrawal by Subject|55|||
146254645|NCT04374253|527444644|FG002|Overall Study|Withdrawal by Subject|3|||
146254646|NCT04374253|527444645|FG003|Overall Study|Withdrawal by Subject|40|||
146100564|NCT00386607|526887914|FG001|Extension|Unsatisfactory therapeutic effect|1|||
146254647|NCT04374253|527444642|FG000|Overall Study|Physician Decision|1|||
146254648|NCT04374253|527444643|FG001|Overall Study|Physician Decision|10|||
146100565|NCT03000569|526887915|FG000|Overall Study|Withdrawal by Subject|1|||
146100566|NCT03000569|526887916|FG001|Overall Study|Withdrawal by Subject|0|||
146100567|NCT02298023|526887917|FG000|Overall Study|Withdrawal by Subject|1|||
146100568|NCT02298023|526887918|FG001|Overall Study|Withdrawal by Subject|0|||
146100569|NCT02298023|526887919|FG002|Overall Study|Withdrawal by Subject|0|||
146100570|NCT00423514|526887924|FG000|Overall Study|Ineligible|1|||
146100571|NCT00423514|526887925|FG001|Overall Study|Ineligible|0|||
146254649|NCT04374253|527444644|FG002|Overall Study|Physician Decision|1|||
146254650|NCT04374253|527444645|FG003|Overall Study|Physician Decision|10|||
146100572|NCT04729621|526887926|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
146100573|NCT04729621|526887927|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
146100574|NCT04729621|526887928|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146100575|NCT04729621|526887929|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146100576|NCT04729621|526887930|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
146100577|NCT04729621|526887926|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
146100578|NCT04729621|526887927|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
146100579|NCT04729621|526887928|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146100580|NCT04729621|526887929|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146100581|NCT04729621|526887930|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
146100582|NCT04729621|526887926|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
146100583|NCT04729621|526887927|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
146100584|NCT04729621|526887928|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146100585|NCT04729621|526887929|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146100586|NCT04729621|526887930|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
146100587|NCT04729621|526887926|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146100588|NCT04729621|526887927|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146100589|NCT04729621|526887928|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
146100590|NCT04729621|526887929|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
146100591|NCT04729621|526887930|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
146100592|NCT04729621|526887926|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146100593|NCT04729621|526887927|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146100594|NCT04729621|526887928|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146100595|NCT04729621|526887929|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
146100596|NCT04729621|526887930|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
146100597|NCT04729621|526887926|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
146100598|NCT04729621|526887927|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
146100599|NCT04729621|526887928|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
146100600|NCT04729621|526887929|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
146100601|NCT04729621|526887930|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
146100602|NCT03308786|526887931|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
146100603|NCT02004522|526887932|FG000|Overall Study|Adverse Event|55|||
146100604|NCT02004522|526887933|FG001|Overall Study|Adverse Event|6|||
146100605|NCT02004522|526887932|FG000|Overall Study|Withdrawal by Subject|13|||
146100606|NCT02004522|526887933|FG001|Overall Study|Withdrawal by Subject|7|||
146100607|NCT02004522|526887932|FG000|Overall Study|Death|12|||
146100608|NCT02004522|526887933|FG001|Overall Study|Death|3|||
146100609|NCT02004522|526887932|FG000|Overall Study|Physician Decision|3|||
146100610|NCT02004522|526887933|FG001|Overall Study|Physician Decision|4|||
146100611|NCT02004522|526887932|FG000|Overall Study|Protocol Violation|1|||
146100612|NCT02004522|526887933|FG001|Overall Study|Protocol Violation|0|||
146100613|NCT02004522|526887932|FG000|Overall Study|Other is reason listed by PI|4|||
146100614|NCT02004522|526887933|FG001|Overall Study|Other is reason listed by PI|1|||
146100615|NCT02004522|526887932|FG000|Overall Study|Never Dosed|2|||
146100616|NCT02004522|526887933|FG001|Overall Study|Never Dosed|4|||
146100617|NCT02004522|526887932|FG000|Overall Study|Disease Progression|35|||
146100618|NCT02004522|526887933|FG001|Overall Study|Disease Progression|31|||
146100619|NCT02004522|526887932|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
146100620|NCT02004522|526887933|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
146100621|NCT01787331|526887935|FG000|Overall Study|Physician Decision|1|||
146100622|NCT01787331|526887935|FG000|Overall Study|Withdrawal by Subject|1|||
146100623|NCT01441180|526887936|FG000|Overall Study|Lost to Follow-up|1|||
146300618|NCT00884325|527617063|FG000|Overall Study|Lack of Efficacy|0|||
146300619|NCT00884325|527617064|FG001|Overall Study|Lack of Efficacy|1|||
146100624|NCT01441180|526887937|FG001|Overall Study|Lost to Follow-up|1|||
146100625|NCT01441180|526887938|FG002|Overall Study|Lost to Follow-up|1|||
146100626|NCT01441180|526887936|FG000|Overall Study|Discontinued|0|||
146100627|NCT01441180|526887937|FG001|Overall Study|Discontinued|0|||
146100628|NCT01441180|526887938|FG002|Overall Study|Discontinued|2|||
146100629|NCT01402011|526887939|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
146100630|NCT01402011|526887940|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
146100631|NCT01402011|526887941|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
146100632|NCT01402011|526887939|FG000|Active Treatment Period|Withdrawal by Subject|1|||
146100633|NCT01402011|526887940|FG001|Active Treatment Period|Withdrawal by Subject|3|||
146300620|NCT00884325|527617063|FG000|Overall Study|Withdrawal by Subject|1|||
146100634|NCT01402011|526887941|FG002|Active Treatment Period|Withdrawal by Subject|0|||
146100635|NCT01402011|526887939|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
146100636|NCT01402011|526887940|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
146100637|NCT01402011|526887941|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
146100638|NCT00142298|526887942|FG000|Overall Study|Adverse Event|10|||
146100639|NCT00142298|526887943|FG001|Overall Study|Adverse Event|10|||
146100640|NCT00142298|526887944|FG002|Overall Study|Adverse Event|1|||
146100641|NCT00142298|526887945|FG003|Overall Study|Adverse Event|5|||
146100642|NCT00142298|526887946|FG004|Overall Study|Adverse Event|2|||
146100643|NCT00142298|526887947|FG005|Overall Study|Adverse Event|2|||
146100644|NCT00142298|526887948|FG006|Overall Study|Adverse Event|0|||
146100645|NCT00142298|526887949|FG007|Overall Study|Adverse Event|0|||
146100646|NCT00142298|526887950|FG008|Overall Study|Adverse Event|0|||
146100647|NCT00142298|526887951|FG009|Overall Study|Adverse Event|0|||
146100648|NCT00142298|526887942|FG000|Overall Study|Clinical disease progression|1|||
146100649|NCT00142298|526887943|FG001|Overall Study|Clinical disease progression|0|||
146100650|NCT00142298|526887944|FG002|Overall Study|Clinical disease progression|0|||
146100651|NCT00142298|526887945|FG003|Overall Study|Clinical disease progression|0|||
146100652|NCT00142298|526887946|FG004|Overall Study|Clinical disease progression|0|||
146100653|NCT00142298|526887947|FG005|Overall Study|Clinical disease progression|0|||
146100654|NCT00142298|526887948|FG006|Overall Study|Clinical disease progression|0|||
146100655|NCT00142298|526887949|FG007|Overall Study|Clinical disease progression|0|||
146100656|NCT00142298|526887950|FG008|Overall Study|Clinical disease progression|0|||
146100657|NCT00142298|526887951|FG009|Overall Study|Clinical disease progression|0|||
146100658|NCT00142298|526887942|FG000|Overall Study|Death|1|||
146100659|NCT00142298|526887943|FG001|Overall Study|Death|1|||
146100660|NCT00142298|526887944|FG002|Overall Study|Death|1|||
146100661|NCT00142298|526887945|FG003|Overall Study|Death|0|||
146100662|NCT00142298|526887946|FG004|Overall Study|Death|0|||
146100663|NCT00142298|526887947|FG005|Overall Study|Death|6|||
146100664|NCT00142298|526887948|FG006|Overall Study|Death|0|||
146100665|NCT00142298|526887949|FG007|Overall Study|Death|0|||
146100666|NCT00142298|526887950|FG008|Overall Study|Death|0|||
146100667|NCT00142298|526887951|FG009|Overall Study|Death|0|||
146100668|NCT00142298|526887942|FG000|Overall Study|Lack of Efficacy|44|||
146100669|NCT00142298|526887943|FG001|Overall Study|Lack of Efficacy|62|||
146100670|NCT00142298|526887944|FG002|Overall Study|Lack of Efficacy|9|||
146100671|NCT00142298|526887945|FG003|Overall Study|Lack of Efficacy|12|||
146100672|NCT00142298|526887946|FG004|Overall Study|Lack of Efficacy|1|||
146100673|NCT00142298|526887947|FG005|Overall Study|Lack of Efficacy|0|||
146100674|NCT00142298|526887948|FG006|Overall Study|Lack of Efficacy|0|||
146100675|NCT00142298|526887949|FG007|Overall Study|Lack of Efficacy|1|||
146100676|NCT00142298|526887950|FG008|Overall Study|Lack of Efficacy|0|||
146100677|NCT00142298|526887951|FG009|Overall Study|Lack of Efficacy|0|||
146100678|NCT00142298|526887942|FG000|Overall Study|Non-compliance|15|||
146100679|NCT00142298|526887943|FG001|Overall Study|Non-compliance|13|||
146100680|NCT00142298|526887944|FG002|Overall Study|Non-compliance|0|||
146100681|NCT00142298|526887945|FG003|Overall Study|Non-compliance|6|||
146100682|NCT00142298|526887946|FG004|Overall Study|Non-compliance|1|||
146100683|NCT00142298|526887947|FG005|Overall Study|Non-compliance|0|||
146100684|NCT00142298|526887948|FG006|Overall Study|Non-compliance|0|||
146100685|NCT00142298|526887949|FG007|Overall Study|Non-compliance|3|||
146100686|NCT00142298|526887950|FG008|Overall Study|Non-compliance|3|||
146100687|NCT00142298|526887951|FG009|Overall Study|Non-compliance|0|||
146100688|NCT00142298|526887942|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
146100689|NCT00142298|526887943|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
146100690|NCT00142298|526887944|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
146100691|NCT00142298|526887945|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
146100692|NCT00142298|526887946|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
146100693|NCT00142298|526887947|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
146100694|NCT00142298|526887948|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
146100695|NCT00142298|526887949|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
146100696|NCT00142298|526887950|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
146100697|NCT00142298|526887951|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
146100698|NCT00142298|526887942|FG000|Overall Study|Pregnancy|4|||
146100699|NCT00142298|526887943|FG001|Overall Study|Pregnancy|4|||
146100700|NCT00142298|526887944|FG002|Overall Study|Pregnancy|2|||
146100701|NCT00142298|526887945|FG003|Overall Study|Pregnancy|3|||
146100702|NCT00142298|526887946|FG004|Overall Study|Pregnancy|0|||
146100703|NCT00142298|526887947|FG005|Overall Study|Pregnancy|0|||
146100704|NCT00142298|526887948|FG006|Overall Study|Pregnancy|0|||
146254651|NCT04374253|527444642|FG000|Overall Study|Protocol Violation|0|||
146100705|NCT00142298|526887949|FG007|Overall Study|Pregnancy|0|||
146100706|NCT00142298|526887950|FG008|Overall Study|Pregnancy|1|||
146100707|NCT00142298|526887951|FG009|Overall Study|Pregnancy|0|||
146100708|NCT00142298|526887942|FG000|Overall Study|Virologic breakthrough|19|||
146100709|NCT00142298|526887943|FG001|Overall Study|Virologic breakthrough|23|||
146100710|NCT00142298|526887944|FG002|Overall Study|Virologic breakthrough|9|||
146100711|NCT00142298|526887945|FG003|Overall Study|Virologic breakthrough|7|||
146100712|NCT00142298|526887946|FG004|Overall Study|Virologic breakthrough|2|||
146100713|NCT00142298|526887947|FG005|Overall Study|Virologic breakthrough|3|||
146100714|NCT00142298|526887948|FG006|Overall Study|Virologic breakthrough|3|||
146100715|NCT00142298|526887949|FG007|Overall Study|Virologic breakthrough|0|||
146254652|NCT04374253|527444643|FG001|Overall Study|Protocol Violation|0|||
146042324|NCT00895453|526667142|FG001|Overall Study|Lost to Follow-up|25|||
146042325|NCT00895453|526667143|FG002|Overall Study|Lost to Follow-up|23|||
146042326|NCT01736618|526667146|FG000|Overall Study|Death|294|||
146042327|NCT01736618|526667146|FG000|Overall Study|Lost to Follow-up|193|||
146042328|NCT01736618|526667146|FG000|Overall Study|Withdrawal by Subject|54|||
146042329|NCT01736618|526667146|FG000|Overall Study|Subject unable to be followed at study location|223|||
146042330|NCT01736618|526667146|FG000|Overall Study|Physician Decision|33|||
146042331|NCT01736618|526667146|FG000|Overall Study|Transplant or removal of target organ|19|||
146042332|NCT01736618|526667146|FG000|Overall Study|Change in indication or condition|78|||
146042333|NCT01736618|526667146|FG000|Overall Study|Study device explant|103|||
146042334|NCT01736618|526667146|FG000|Overall Study|Unable to complete implant|2|||
146042335|NCT04167137|526667148|FG000|Overall Study|Disease progression|1|||
146042336|NCT04167137|526667149|FG001|Overall Study|Disease progression|1|||
146042337|NCT04167137|526667150|FG002|Overall Study|Disease progression|3|||
146042338|NCT04167137|526667151|FG003|Overall Study|Disease progression|3|||
146042339|NCT04167137|526667152|FG004|Overall Study|Disease progression|2|||
146042340|NCT04167137|526667153|FG005|Overall Study|Disease progression|3|||
146042341|NCT04167137|526667154|FG006|Overall Study|Disease progression|2|||
146042342|NCT04167137|526667155|FG007|Overall Study|Disease progression|2|||
146042343|NCT04167137|526667148|FG000|Overall Study|Withdrawal by Subject|1|||
146042344|NCT04167137|526667149|FG001|Overall Study|Withdrawal by Subject|0|||
146042345|NCT04167137|526667150|FG002|Overall Study|Withdrawal by Subject|0|||
146042346|NCT04167137|526667151|FG003|Overall Study|Withdrawal by Subject|1|||
146042347|NCT04167137|526667152|FG004|Overall Study|Withdrawal by Subject|0|||
146042348|NCT04167137|526667153|FG005|Overall Study|Withdrawal by Subject|2|||
146042349|NCT04167137|526667154|FG006|Overall Study|Withdrawal by Subject|1|||
146042350|NCT04167137|526667155|FG007|Overall Study|Withdrawal by Subject|0|||
146042351|NCT04167137|526667148|FG000|Overall Study|Adverse Event|0|||
146042352|NCT04167137|526667149|FG001|Overall Study|Adverse Event|0|||
146042353|NCT04167137|526667150|FG002|Overall Study|Adverse Event|0|||
146042354|NCT04167137|526667151|FG003|Overall Study|Adverse Event|0|||
146042355|NCT04167137|526667152|FG004|Overall Study|Adverse Event|0|||
146042356|NCT04167137|526667153|FG005|Overall Study|Adverse Event|1|||
146042357|NCT04167137|526667154|FG006|Overall Study|Adverse Event|0|||
146042358|NCT04167137|526667155|FG007|Overall Study|Adverse Event|1|||
146042359|NCT04167137|526667148|FG000|Overall Study|Physician Decision|0|||
146042360|NCT04167137|526667149|FG001|Overall Study|Physician Decision|0|||
146042361|NCT04167137|526667150|FG002|Overall Study|Physician Decision|0|||
146042362|NCT04167137|526667151|FG003|Overall Study|Physician Decision|1|||
146042363|NCT04167137|526667152|FG004|Overall Study|Physician Decision|0|||
146042364|NCT04167137|526667153|FG005|Overall Study|Physician Decision|0|||
146042365|NCT04167137|526667154|FG006|Overall Study|Physician Decision|1|||
146042366|NCT04167137|526667155|FG007|Overall Study|Physician Decision|0|||
146042367|NCT04167137|526667148|FG000|Overall Study|Death|0|||
146042368|NCT04167137|526667149|FG001|Overall Study|Death|1|||
146042369|NCT04167137|526667150|FG002|Overall Study|Death|0|||
146042370|NCT04167137|526667151|FG003|Overall Study|Death|0|||
146042371|NCT04167137|526667152|FG004|Overall Study|Death|0|||
146042372|NCT04167137|526667153|FG005|Overall Study|Death|0|||
146042373|NCT04167137|526667154|FG006|Overall Study|Death|0|||
146042374|NCT04167137|526667155|FG007|Overall Study|Death|0|||
146042375|NCT04167137|526667148|FG000|Overall Study|Study terminated by Sponsor|0|||
146042376|NCT04167137|526667149|FG001|Overall Study|Study terminated by Sponsor|0|||
146042377|NCT04167137|526667150|FG002|Overall Study|Study terminated by Sponsor|0|||
146042378|NCT04167137|526667151|FG003|Overall Study|Study terminated by Sponsor|0|||
146042379|NCT04167137|526667152|FG004|Overall Study|Study terminated by Sponsor|0|||
146042380|NCT04167137|526667153|FG005|Overall Study|Study terminated by Sponsor|0|||
146042381|NCT04167137|526667154|FG006|Overall Study|Study terminated by Sponsor|0|||
146042382|NCT04167137|526667155|FG007|Overall Study|Study terminated by Sponsor|1|||
146042383|NCT00400569|526667158|FG000|Overall Study|Death|1|||
146042384|NCT02461745|526667162|FG000|Overall Study|Lack of Efficacy|9|||
146042385|NCT02461745|526667163|FG001|Overall Study|Lack of Efficacy|1|||
146042386|NCT02461745|526667162|FG000|Overall Study|Lost to Follow-up|2|||
146042387|NCT02461745|526667163|FG001|Overall Study|Lost to Follow-up|2|||
146042388|NCT02461745|526667162|FG000|Overall Study|Withdrawal by Subject|3|||
146042389|NCT02461745|526667163|FG001|Overall Study|Withdrawal by Subject|1|||
146042390|NCT03848949|526667164|FG000|Overall Study|Lost to Follow-up|5|||
146042391|NCT03848949|526667165|FG001|Overall Study|Lost to Follow-up|7|||
146042392|NCT01865448|526669382|FG000|Overall Study|Adverse Event|1|||
146042393|NCT01865448|526669383|FG001|Overall Study|Adverse Event|1|||
146042394|NCT01865448|526669382|FG000|Overall Study|Pregnancy|0|||
146042395|NCT01865448|526669383|FG001|Overall Study|Pregnancy|1|||
146042396|NCT01865448|526669382|FG000|Overall Study|dropout unrelated to study|1|||
146042397|NCT01865448|526669383|FG001|Overall Study|dropout unrelated to study|1|||
146042398|NCT05128578|526669387|FG000|Overall Study|Withdrawal by Subject|9|||
146042399|NCT05128578|526669387|FG000|Overall Study|Lost to Follow-up|5|||
146042400|NCT02679755|526669388|FG000|Overall Study|Death|0|||
146042401|NCT02679755|526669389|FG001|Overall Study|Death|3|||
146254653|NCT04374253|527444644|FG002|Overall Study|Protocol Violation|0|||
146254654|NCT04374253|527444645|FG003|Overall Study|Protocol Violation|2|||
146100716|NCT00142298|526887950|FG008|Overall Study|Virologic breakthrough|0|||
146100717|NCT00142298|526887951|FG009|Overall Study|Virologic breakthrough|0|||
146100718|NCT00142298|526887942|FG000|Overall Study|Other- not specified|0|||
146042402|NCT02679755|526669388|FG000|Overall Study|Global deterioration of health status|1|||
146042403|NCT02679755|526669389|FG001|Overall Study|Global deterioration of health status|8|||
146042404|NCT02679755|526669388|FG000|Overall Study|Lost to Follow-up|1|||
146042405|NCT02679755|526669389|FG001|Overall Study|Lost to Follow-up|0|||
146042406|NCT02679755|526669388|FG000|Overall Study|Objective progression or relapse|24|||
146042407|NCT02679755|526669389|FG001|Overall Study|Objective progression or relapse|83|||
146042408|NCT02679755|526669388|FG000|Overall Study|Not defined|0|||
146042409|NCT02679755|526669389|FG001|Overall Study|Not defined|2|||
146042410|NCT02679755|526669388|FG000|Overall Study|Withdrawal by participant|6|||
146042411|NCT02679755|526669389|FG001|Overall Study|Withdrawal by participant|3|||
146042412|NCT02679755|526669388|FG000|Overall Study|Adverse Event|1|||
146042413|NCT02679755|526669389|FG001|Overall Study|Adverse Event|4|||
146042414|NCT02679755|526669388|FG000|Overall Study|Adverse events not related to study drug|1|||
146042415|NCT02679755|526669389|FG001|Overall Study|Adverse events not related to study drug|2|||
146042416|NCT01061359|526669390|FG000|Overall Study|Death|32|||
146042417|NCT01061359|526669390|FG000|Overall Study|Lost to Follow-up|1072|||
146042418|NCT01061359|526669390|FG000|Overall Study|Relapse|187|||
146042419|NCT01061359|526669390|FG000|Overall Study|Secondary neoplasm|11|||
146042420|NCT02610777|526669393|FG000|Overall Study|Lost to Follow-up|1|||
146042421|NCT02610777|526669394|FG001|Overall Study|Lost to Follow-up|0|||
146042422|NCT02610777|526669393|FG000|Overall Study|Site Terminated by Sponsor|9|||
146042423|NCT02610777|526669394|FG001|Overall Study|Site Terminated by Sponsor|8|||
146042424|NCT02610777|526669393|FG000|Overall Study|Withdrawal by Subject|2|||
146042425|NCT02610777|526669394|FG001|Overall Study|Withdrawal by Subject|2|||
146042426|NCT02610777|526669393|FG000|Overall Study|Reason not Specified|0|||
146042427|NCT02610777|526669394|FG001|Overall Study|Reason not Specified|1|||
146042428|NCT02610777|526669393|FG000|Overall Study|Death|50|||
146042429|NCT02610777|526669394|FG001|Overall Study|Death|47|||
146042430|NCT00660179|526669395|FG000|Overall Study|Death|44|||
146042431|NCT00660179|526669396|FG001|Overall Study|Death|47|||
146042432|NCT00660179|526669397|FG002|Overall Study|Death|34|||
146042433|NCT00660179|526669395|FG000|Overall Study|Withdrawal of consent|4|||
146042434|NCT00660179|526669396|FG001|Overall Study|Withdrawal of consent|6|||
146042435|NCT00660179|526669397|FG002|Overall Study|Withdrawal of consent|4|||
146042436|NCT00660179|526669395|FG000|Overall Study|Lost to Follow-up|7|||
146042437|NCT00660179|526669396|FG001|Overall Study|Lost to Follow-up|5|||
146042438|NCT00660179|526669397|FG002|Overall Study|Lost to Follow-up|2|||
146042439|NCT00660179|526669395|FG000|Overall Study|Administrative reason|0|||
146042440|NCT00660179|526669396|FG001|Overall Study|Administrative reason|0|||
146042441|NCT00660179|526669397|FG002|Overall Study|Administrative reason|1|||
146042442|NCT00660179|526669395|FG000|Overall Study|Incorrect randomization|1|||
146042443|NCT00660179|526669396|FG001|Overall Study|Incorrect randomization|0|||
146042444|NCT00660179|526669397|FG002|Overall Study|Incorrect randomization|0|||
146042445|NCT04171219|526669402|FG000|Overall Study|Adverse Event|1|||
146042446|NCT04171219|526669403|FG001|Overall Study|Adverse Event|0|||
146042447|NCT04171219|526669402|FG000|Overall Study|Death|0|||
146042448|NCT04171219|526669403|FG001|Overall Study|Death|1|||
146042449|NCT04171219|526669402|FG000|Overall Study|Lack of Efficacy|9|||
146042450|NCT04171219|526669403|FG001|Overall Study|Lack of Efficacy|13|||
146042451|NCT04171219|526669402|FG000|Overall Study|Withdrawal by Subject|1|||
146042452|NCT04171219|526669403|FG001|Overall Study|Withdrawal by Subject|2|||
146042453|NCT04171219|526669402|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
146042454|NCT04171219|526669403|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
146042455|NCT04171219|526669402|FG000|Overall Study|Clinical PD/Patient choice|1|||
146042456|NCT04171219|526669403|FG001|Overall Study|Clinical PD/Patient choice|0|||
146042457|NCT04171219|526669402|FG000|Overall Study|Toxicity/ Patient choice|1|||
146042458|NCT04171219|526669403|FG001|Overall Study|Toxicity/ Patient choice|0|||
146042459|NCT02974257|526669406|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
146042460|NCT02974257|526669407|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
146042461|NCT02974257|526669406|FG000|Overall Study|Clinical indication for thiamine|1|||
146042462|NCT02974257|526669407|FG001|Overall Study|Clinical indication for thiamine|0|||
146042463|NCT02974257|526669406|FG000|Overall Study|Already on thiamine|1|||
146042464|NCT02974257|526669407|FG001|Overall Study|Already on thiamine|0|||
146042465|NCT02974257|526669406|FG000|Overall Study|Extubated prior to study drug|0|||
146042466|NCT02974257|526669407|FG001|Overall Study|Extubated prior to study drug|1|||
146042467|NCT02974257|526669406|FG000|Overall Study|Death|0|||
146042468|NCT02974257|526669407|FG001|Overall Study|Death|1|||
146100719|NCT00142298|526887943|FG001|Overall Study|Other- not specified|3|||
146300621|NCT00884325|527617064|FG001|Overall Study|Withdrawal by Subject|1|||
146042469|NCT00398567|526669410|FG000|Overall Study|Disease Progression|3|||
146042470|NCT00398567|526669411|FG001|Overall Study|Disease Progression|4|||
146042471|NCT00398567|526669412|FG002|Overall Study|Disease Progression|27|||
146100720|NCT00142298|526887944|FG002|Overall Study|Other- not specified|0|||
146100721|NCT00142298|526887945|FG003|Overall Study|Other- not specified|1|||
146100722|NCT00142298|526887946|FG004|Overall Study|Other- not specified|0|||
146100723|NCT00142298|526887947|FG005|Overall Study|Other- not specified|0|||
146254655|NCT04374253|527444642|FG000|Overall Study|Death|0|||
146254656|NCT04374253|527444643|FG001|Overall Study|Death|3|||
146042472|NCT00398567|526669410|FG000|Overall Study|Withdrawal by Subject|1|||
146042473|NCT00398567|526669411|FG001|Overall Study|Withdrawal by Subject|0|||
146042474|NCT00398567|526669412|FG002|Overall Study|Withdrawal by Subject|4|||
146042475|NCT00398567|526669410|FG000|Overall Study|Adverse Event|0|||
146042476|NCT00398567|526669411|FG001|Overall Study|Adverse Event|0|||
146042477|NCT00398567|526669412|FG002|Overall Study|Adverse Event|2|||
146042478|NCT00398567|526669410|FG000|Overall Study|Protocol Violation|0|||
146042479|NCT00398567|526669411|FG001|Overall Study|Protocol Violation|0|||
146042480|NCT00398567|526669412|FG002|Overall Study|Protocol Violation|1|||
146042481|NCT04878211|526669419|FG000|Overall Study|Lost to Follow-up|0|||
146042482|NCT04878211|526669420|FG001|Overall Study|Lost to Follow-up|0|||
146042483|NCT04878211|526669421|FG002|Overall Study|Lost to Follow-up|0|||
146042484|NCT04878211|526669422|FG003|Overall Study|Lost to Follow-up|1|||
146042485|NCT04878211|526669423|FG004|Overall Study|Lost to Follow-up|0|||
146042486|NCT04878211|526669424|FG005|Overall Study|Lost to Follow-up|1|||
146042487|NCT04878211|526669419|FG000|Overall Study|Protocol deviation|1|||
146042488|NCT04878211|526669420|FG001|Overall Study|Protocol deviation|0|||
146042489|NCT04878211|526669421|FG002|Overall Study|Protocol deviation|0|||
146042490|NCT04878211|526669422|FG003|Overall Study|Protocol deviation|0|||
146042491|NCT04878211|526669423|FG004|Overall Study|Protocol deviation|0|||
146042492|NCT04878211|526669424|FG005|Overall Study|Protocol deviation|0|||
146042493|NCT04878211|526669419|FG000|Overall Study|Study terminated by sponsor|0|||
146042494|NCT04878211|526669420|FG001|Overall Study|Study terminated by sponsor|0|||
146042495|NCT04878211|526669421|FG002|Overall Study|Study terminated by sponsor|0|||
146042496|NCT04878211|526669422|FG003|Overall Study|Study terminated by sponsor|0|||
146042497|NCT04878211|526669423|FG004|Overall Study|Study terminated by sponsor|9|||
146042498|NCT04878211|526669424|FG005|Overall Study|Study terminated by sponsor|4|||
146042499|NCT04878211|526669419|FG000|Overall Study|Subject decision|0|||
146042500|NCT04878211|526669420|FG001|Overall Study|Subject decision|0|||
146042501|NCT04878211|526669421|FG002|Overall Study|Subject decision|0|||
146042502|NCT04878211|526669422|FG003|Overall Study|Subject decision|0|||
146042503|NCT04878211|526669423|FG004|Overall Study|Subject decision|1|||
146042504|NCT04878211|526669424|FG005|Overall Study|Subject decision|0|||
146042505|NCT01687101|526669431|FG000|Overall Study|Lost to Follow-up|7|||
146042506|NCT05274269|526669432|FG000|Overall Study|Adverse Event|0|||
146042507|NCT05274269|526669433|FG001|Overall Study|Adverse Event|3|||
146042508|NCT05274269|526669432|FG000|Overall Study|Death|0|||
146042509|NCT05274269|526669433|FG001|Overall Study|Death|1|||
146042510|NCT05274269|526669432|FG000|Overall Study|Other|0|||
146042511|NCT05274269|526669433|FG001|Overall Study|Other|2|||
146042512|NCT05274269|526669432|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146042513|NCT05274269|526669433|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146042514|NCT02206035|526669434|FG000|Overall Study|Physician Decision|10|||
146042515|NCT02206035|526669435|FG001|Overall Study|Physician Decision|0|||
146042516|NCT02206035|526669436|FG002|Overall Study|Physician Decision|175|||
146042517|NCT02936843|526669437|FG000|Overall Study|Lost to Follow-up|3|||
146042518|NCT02936843|526669438|FG001|Overall Study|Lost to Follow-up|1|||
146042519|NCT02936843|526669437|FG000|Overall Study|Withdrawal by Subject|1|||
146042520|NCT02936843|526669438|FG001|Overall Study|Withdrawal by Subject|1|||
146042521|NCT03668613|526669441|FG000|Overall Study|Adverse Event|1|||
146042522|NCT03668613|526669442|FG001|Overall Study|Adverse Event|2|||
146042523|NCT03668613|526669441|FG000|Overall Study|Lack of Efficacy|5|||
146042524|NCT03668613|526669442|FG001|Overall Study|Lack of Efficacy|1|||
146042525|NCT03668613|526669441|FG000|Overall Study|Pregnancy|0|||
146254657|NCT04374253|527444644|FG002|Overall Study|Death|1|||
146042526|NCT03668613|526669442|FG001|Overall Study|Pregnancy|2|||
146042527|NCT03668613|526669441|FG000|Overall Study|Protocol Violation|1|||
146100724|NCT00142298|526887948|FG006|Overall Study|Other- not specified|0|||
146042528|NCT03668613|526669442|FG001|Overall Study|Protocol Violation|0|||
146042529|NCT03668613|526669441|FG000|Overall Study|Physician Decision|1|||
146042530|NCT03668613|526669442|FG001|Overall Study|Physician Decision|0|||
146042531|NCT03668613|526669441|FG000|Overall Study|Withdrawal by Subject|2|||
146042532|NCT03668613|526669442|FG001|Overall Study|Withdrawal by Subject|1|||
146042533|NCT03668613|526669441|FG000|Overall Study|Guardian decision|1|||
146042534|NCT03668613|526669442|FG001|Overall Study|Guardian decision|0|||
146100725|NCT00142298|526887949|FG007|Overall Study|Other- not specified|0|||
146254658|NCT04374253|527444645|FG003|Overall Study|Death|1|||
146254659|NCT04374253|527444642|FG000|Overall Study|Lack of Efficacy|0|||
146042535|NCT00709618|526669445|FG000|Overall Study|Withdrawal by Subject|4|||
146042536|NCT00709618|526669445|FG000|Overall Study|Lost to Follow-up|1|||
146042537|NCT00709618|526669445|FG000|Overall Study|Study Closed/Terminated|25|||
146042538|NCT04042909|526669446|FG000|Overall Study|Withdrawal by Subject|1|||
146042539|NCT04042909|526669447|FG001|Overall Study|Withdrawal by Subject|0|||
146042540|NCT04042909|526669448|FG002|Overall Study|Withdrawal by Subject|0|||
146254660|NCT04374253|527444643|FG001|Overall Study|Lack of Efficacy|0|||
146254661|NCT04374253|527444644|FG002|Overall Study|Lack of Efficacy|0|||
146254662|NCT04374253|527444645|FG003|Overall Study|Lack of Efficacy|1|||
146254663|NCT04374253|527444642|FG000|Overall Study|Lost to Follow-up|1|||
146254664|NCT04374253|527444643|FG001|Overall Study|Lost to Follow-up|1|||
146254665|NCT04374253|527444644|FG002|Overall Study|Lost to Follow-up|0|||
146254666|NCT04374253|527444645|FG003|Overall Study|Lost to Follow-up|2|||
146254667|NCT04374253|527444642|FG000|Overall Study|Reason Not Specified|0|||
146254668|NCT04374253|527444643|FG001|Overall Study|Reason Not Specified|8|||
146254669|NCT04374253|527444644|FG002|Overall Study|Reason Not Specified|0|||
146254670|NCT04374253|527444645|FG003|Overall Study|Reason Not Specified|8|||
146254671|NCT01207453|527444648|FG000|First Intervention|Adverse Event|2|||
146042541|NCT04042909|526669446|FG000|Overall Study|duplicate cases|2|||
146042542|NCT04042909|526669447|FG001|Overall Study|duplicate cases|0|||
146042543|NCT04042909|526669448|FG002|Overall Study|duplicate cases|0|||
146042544|NCT04042909|526669446|FG000|Overall Study|technical problem|0|||
146042545|NCT04042909|526669447|FG001|Overall Study|technical problem|1|||
146042546|NCT04042909|526669448|FG002|Overall Study|technical problem|0|||
146042547|NCT00894361|526669451|FG000|Overall Study|deaths and less than 2 years followup|24|||
146042548|NCT00894361|526669452|FG001|Overall Study|deaths and less than 2 years followup|64|||
146042549|NCT00286494|526669457|FG000|Overall Study|Hyperglycemic rescue|12|||
146042550|NCT00286494|526669458|FG001|Overall Study|Hyperglycemic rescue|19|||
146042551|NCT00286494|526669459|FG002|Overall Study|Hyperglycemic rescue|18|||
146042552|NCT00286494|526669457|FG000|Overall Study|Withdrawal by Subject|2|||
146042553|NCT00286494|526669458|FG001|Overall Study|Withdrawal by Subject|10|||
146042554|NCT00286494|526669459|FG002|Overall Study|Withdrawal by Subject|9|||
146042555|NCT00286494|526669457|FG000|Overall Study|Adverse Event|3|||
146042556|NCT00286494|526669458|FG001|Overall Study|Adverse Event|8|||
146042557|NCT00286494|526669459|FG002|Overall Study|Adverse Event|6|||
146042558|NCT00286494|526669457|FG000|Overall Study|Physician Decision|5|||
146042559|NCT00286494|526669458|FG001|Overall Study|Physician Decision|5|||
146042560|NCT00286494|526669459|FG002|Overall Study|Physician Decision|1|||
146042561|NCT00286494|526669457|FG000|Overall Study|Lost to Follow-up|3|||
146042562|NCT00286494|526669458|FG001|Overall Study|Lost to Follow-up|1|||
146042563|NCT00286494|526669459|FG002|Overall Study|Lost to Follow-up|3|||
146042564|NCT00286494|526669457|FG000|Overall Study|Protocol Violation|1|||
146042565|NCT00286494|526669458|FG001|Overall Study|Protocol Violation|1|||
146042566|NCT00286494|526669459|FG002|Overall Study|Protocol Violation|2|||
146042567|NCT04776317|526669460|FG000|Overall Study|Physician Decision|0|||
146042568|NCT04776317|526669461|FG001|Overall Study|Physician Decision|1|||
146042569|NCT04776317|526669462|FG002|Overall Study|Physician Decision|0|||
146042570|NCT04776317|526669463|FG003|Overall Study|Physician Decision|0|||
146042571|NCT04776317|526669464|FG004|Overall Study|Physician Decision|0|||
146042572|NCT04776317|526669465|FG005|Overall Study|Physician Decision|0|||
146042573|NCT04776317|526669466|FG006|Overall Study|Physician Decision|0|||
146042574|NCT04776317|526669467|FG007|Overall Study|Physician Decision|0|||
146042575|NCT04776317|526669468|FG008|Overall Study|Physician Decision|0|||
146042576|NCT04776317|526669469|FG009|Overall Study|Physician Decision|0|||
146042577|NCT04776317|526669470|FG010|Overall Study|Physician Decision|0|||
146042578|NCT04776317|526669471|FG011|Overall Study|Physician Decision|0|||
146042579|NCT04776317|526669472|FG012|Overall Study|Physician Decision|0|||
146042580|NCT04776317|526669473|FG013|Overall Study|Physician Decision|0|||
146042581|NCT04776317|526669474|FG014|Overall Study|Physician Decision|0|||
146042582|NCT04776317|526669460|FG000|Overall Study|Protocol Violation|0|||
146042583|NCT04776317|526669461|FG001|Overall Study|Protocol Violation|0|||
146042584|NCT04776317|526669462|FG002|Overall Study|Protocol Violation|1|||
146042585|NCT04776317|526669463|FG003|Overall Study|Protocol Violation|0|||
146042586|NCT04776317|526669464|FG004|Overall Study|Protocol Violation|0|||
146100726|NCT00142298|526887950|FG008|Overall Study|Other- not specified|0|||
146254672|NCT01207453|527444649|FG001|First Intervention|Adverse Event|1|||
146254673|NCT01207453|527444648|FG000|Washout|Adverse Event|1|||
146042587|NCT04776317|526669465|FG005|Overall Study|Protocol Violation|0|||
146042588|NCT04776317|526669466|FG006|Overall Study|Protocol Violation|0|||
146100727|NCT00142298|526887951|FG009|Overall Study|Other- not specified|0|||
146254674|NCT01207453|527444649|FG001|Washout|Adverse Event|0|||
146254675|NCT01207453|527444648|FG000|Washout|Lost to Follow-up|1|||
146254676|NCT01207453|527444649|FG001|Washout|Lost to Follow-up|0|||
146254677|NCT01207453|527444648|FG000|2nd Intervention|Adverse Event|1|||
146254678|NCT01207453|527444649|FG001|2nd Intervention|Adverse Event|2|||
146042589|NCT04776317|526669467|FG007|Overall Study|Protocol Violation|0|||
146100728|NCT00142298|526887942|FG000|Overall Study|Lost to Follow-up|0|||
146254679|NCT01207453|527444648|FG000|2nd Intervention|Lost to Follow-up|1|||
146042590|NCT04776317|526669468|FG008|Overall Study|Protocol Violation|0|||
146042591|NCT04776317|526669469|FG009|Overall Study|Protocol Violation|0|||
146042592|NCT04776317|526669470|FG010|Overall Study|Protocol Violation|0|||
146042593|NCT04776317|526669471|FG011|Overall Study|Protocol Violation|0|||
146042594|NCT04776317|526669472|FG012|Overall Study|Protocol Violation|0|||
146042595|NCT04776317|526669473|FG013|Overall Study|Protocol Violation|0|||
146042596|NCT04776317|526669474|FG014|Overall Study|Protocol Violation|0|||
146254680|NCT01207453|527444649|FG001|2nd Intervention|Lost to Follow-up|0|||
146100729|NCT00142298|526887943|FG001|Overall Study|Lost to Follow-up|0|||
146100730|NCT00142298|526887944|FG002|Overall Study|Lost to Follow-up|0|||
146100731|NCT00142298|526887945|FG003|Overall Study|Lost to Follow-up|0|||
146100732|NCT00142298|526887946|FG004|Overall Study|Lost to Follow-up|0|||
146100733|NCT00142298|526887947|FG005|Overall Study|Lost to Follow-up|0|||
146100734|NCT00142298|526887948|FG006|Overall Study|Lost to Follow-up|2|||
146100735|NCT00142298|526887949|FG007|Overall Study|Lost to Follow-up|0|||
146100736|NCT00142298|526887950|FG008|Overall Study|Lost to Follow-up|0|||
146100737|NCT00142298|526887951|FG009|Overall Study|Lost to Follow-up|0|||
146100738|NCT00142298|526887942|FG000|Overall Study|Treatment Failure|0|||
146100739|NCT00142298|526887943|FG001|Overall Study|Treatment Failure|0|||
146100740|NCT00142298|526887944|FG002|Overall Study|Treatment Failure|0|||
146100741|NCT00142298|526887945|FG003|Overall Study|Treatment Failure|0|||
146100742|NCT00142298|526887946|FG004|Overall Study|Treatment Failure|0|||
146100743|NCT00142298|526887947|FG005|Overall Study|Treatment Failure|2|||
146100744|NCT00142298|526887948|FG006|Overall Study|Treatment Failure|2|||
146100745|NCT00142298|526887949|FG007|Overall Study|Treatment Failure|0|||
146100746|NCT00142298|526887950|FG008|Overall Study|Treatment Failure|0|||
146100747|NCT00142298|526887951|FG009|Overall Study|Treatment Failure|0|||
146100748|NCT03360747|526887952|FG000|Overall Study|Voluntary Withdrawal|1|||
146100749|NCT01759511|526887953|FG000|Overall Study|Adverse Event|4|||
146100750|NCT01759511|526887953|FG000|Overall Study|Death|2|||
146100751|NCT01759511|526887953|FG000|Overall Study|Lack of Efficacy|2|||
146100752|NCT01759511|526887953|FG000|Overall Study|Physician Decision|1|||
146100753|NCT01759511|526887953|FG000|Overall Study|Progressive Disease|5|||
146100754|NCT01759511|526887953|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
146100755|NCT01759511|526887953|FG000|Overall Study|Study Terminated by Sponsor|13|||
146100756|NCT01759511|526887953|FG000|Overall Study|Withdrawal by Subject|3|||
146100757|NCT00531934|526889817|FG000|Overall Study|Adverse Event|4|||
146100758|NCT00531934|526889818|FG001|Overall Study|Adverse Event|8|||
146100759|NCT00531934|526889817|FG000|Overall Study|Progression|52|||
146254681|NCT00676663|527444650|FG000|Overall Study|Death|43|||
146254682|NCT00676663|527444651|FG001|Overall Study|Death|27|||
146100760|NCT00531934|526889818|FG001|Overall Study|Progression|42|||
146100761|NCT00531934|526889817|FG000|Overall Study|Death|7|||
146100762|NCT00531934|526889818|FG001|Overall Study|Death|10|||
146100763|NCT00531934|526889817|FG000|Overall Study|Withdrawal by Subject|1|||
146100764|NCT00531934|526889818|FG001|Overall Study|Withdrawal by Subject|1|||
146100765|NCT00531934|526889817|FG000|Overall Study|Other|2|||
146100766|NCT00531934|526889818|FG001|Overall Study|Other|2|||
146100767|NCT00150709|526889820|FG000|Overall Study|Protocol Violation|7|||
146100768|NCT00150709|526889821|FG001|Overall Study|Protocol Violation|8|||
146100769|NCT00150709|526889822|FG002|Overall Study|Protocol Violation|3|||
146100770|NCT00150709|526889823|FG003|Overall Study|Protocol Violation|1|||
146100771|NCT00150709|526889820|FG000|Overall Study|Adverse Event|8|||
146100772|NCT00150709|526889821|FG001|Overall Study|Adverse Event|2|||
146100773|NCT00150709|526889822|FG002|Overall Study|Adverse Event|2|||
146100774|NCT00150709|526889823|FG003|Overall Study|Adverse Event|3|||
146100775|NCT00150709|526889820|FG000|Overall Study|Lack of Efficacy|6|||
146100776|NCT00150709|526889821|FG001|Overall Study|Lack of Efficacy|11|||
146100777|NCT00150709|526889822|FG002|Overall Study|Lack of Efficacy|9|||
146100778|NCT00150709|526889823|FG003|Overall Study|Lack of Efficacy|0|||
146100779|NCT00150709|526889820|FG000|Overall Study|Withdrawal by Subject|7|||
146100780|NCT00150709|526889821|FG001|Overall Study|Withdrawal by Subject|10|||
146100781|NCT00150709|526889822|FG002|Overall Study|Withdrawal by Subject|5|||
146100782|NCT00150709|526889823|FG003|Overall Study|Withdrawal by Subject|0|||
146100783|NCT00150709|526889820|FG000|Overall Study|Lost to Follow-up|3|||
146100784|NCT00150709|526889821|FG001|Overall Study|Lost to Follow-up|2|||
146100785|NCT00150709|526889822|FG002|Overall Study|Lost to Follow-up|0|||
146100786|NCT00150709|526889823|FG003|Overall Study|Lost to Follow-up|0|||
146254683|NCT00676663|527444650|FG000|Overall Study|Withdrew Consent|1|||
146254684|NCT00676663|527444651|FG001|Overall Study|Withdrew Consent|8|||
146254685|NCT00676663|527444650|FG000|Overall Study|Lost to Follow-up|1|||
146254686|NCT00676663|527444651|FG001|Overall Study|Lost to Follow-up|3|||
146100787|NCT00150709|526889820|FG000|Overall Study|Sponsor decision|0|||
146100788|NCT00150709|526889821|FG001|Overall Study|Sponsor decision|0|||
146100789|NCT00150709|526889822|FG002|Overall Study|Sponsor decision|0|||
146100790|NCT00150709|526889823|FG003|Overall Study|Sponsor decision|1|||
146100791|NCT00150709|526889820|FG000|Overall Study|Site/Investigator discontinued the study|5|||
146100792|NCT00150709|526889821|FG001|Overall Study|Site/Investigator discontinued the study|5|||
146100793|NCT00150709|526889822|FG002|Overall Study|Site/Investigator discontinued the study|2|||
146100794|NCT00150709|526889823|FG003|Overall Study|Site/Investigator discontinued the study|0|||
146100795|NCT00150709|526889820|FG000|Overall Study|Decision of parent(s)|1|||
146100796|NCT00150709|526889821|FG001|Overall Study|Decision of parent(s)|2|||
146100797|NCT00150709|526889822|FG002|Overall Study|Decision of parent(s)|0|||
146100798|NCT00150709|526889823|FG003|Overall Study|Decision of parent(s)|0|||
146100799|NCT00150709|526889820|FG000|Overall Study|Decision of parent(s) and investigator|3|||
146100800|NCT00150709|526889821|FG001|Overall Study|Decision of parent(s) and investigator|0|||
146254687|NCT04382053|527444657|FG000|Overall Study|Death|6|||
146100801|NCT00150709|526889822|FG002|Overall Study|Decision of parent(s) and investigator|0|||
146100802|NCT00150709|526889823|FG003|Overall Study|Decision of parent(s) and investigator|0|||
146100803|NCT00150709|526889820|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
146100804|NCT00150709|526889821|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
146100805|NCT00150709|526889822|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
146100806|NCT00150709|526889823|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
146100807|NCT00150709|526889820|FG000|Overall Study|Investigator decision|1|||
146100808|NCT00150709|526889821|FG001|Overall Study|Investigator decision|0|||
146100809|NCT00150709|526889822|FG002|Overall Study|Investigator decision|0|||
146100810|NCT00150709|526889823|FG003|Overall Study|Investigator decision|1|||
146100811|NCT00150709|526889820|FG000|Overall Study|Subject relocated|2|||
146100812|NCT00150709|526889821|FG001|Overall Study|Subject relocated|2|||
146100813|NCT00150709|526889822|FG002|Overall Study|Subject relocated|1|||
146100814|NCT00150709|526889823|FG003|Overall Study|Subject relocated|0|||
146100815|NCT00150709|526889820|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
146100816|NCT00150709|526889821|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
146100817|NCT00150709|526889822|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
146100818|NCT00150709|526889823|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
146100819|NCT00150709|526889820|FG000|Overall Study|Convenience|0|||
146100820|NCT00150709|526889821|FG001|Overall Study|Convenience|1|||
146100821|NCT00150709|526889822|FG002|Overall Study|Convenience|0|||
146100822|NCT00150709|526889823|FG003|Overall Study|Convenience|0|||
146100823|NCT00150709|526889820|FG000|Overall Study|Subject entered new drug study|0|||
146100824|NCT00150709|526889821|FG001|Overall Study|Subject entered new drug study|1|||
146100825|NCT00150709|526889822|FG002|Overall Study|Subject entered new drug study|0|||
146100826|NCT00150709|526889823|FG003|Overall Study|Subject entered new drug study|0|||
146100827|NCT00150709|526889820|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
146100828|NCT00150709|526889821|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
146100829|NCT00150709|526889822|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
146100830|NCT00150709|526889823|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
146100831|NCT00150709|526889820|FG000|Overall Study|Lack of ease of swallowing|0|||
146100832|NCT00150709|526889821|FG001|Overall Study|Lack of ease of swallowing|1|||
146100833|NCT00150709|526889822|FG002|Overall Study|Lack of ease of swallowing|0|||
146100834|NCT00150709|526889823|FG003|Overall Study|Lack of ease of swallowing|0|||
146100835|NCT04092582|526889824|FG000|Overall Study|Death|1|||
146100836|NCT04092582|526889825|FG001|Overall Study|Death|1|||
146100837|NCT04092582|526889824|FG000|Overall Study|Withdrawal by Subject|4|||
146100838|NCT04092582|526889825|FG001|Overall Study|Withdrawal by Subject|1|||
146100839|NCT04092582|526889824|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
146100840|NCT04092582|526889825|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
146100841|NCT01644565|526889826|FG000|Overall Study|Undisclosed Medical History|1|||
146100842|NCT01644565|526889827|FG001|Overall Study|Undisclosed Medical History|0|||
146100843|NCT01644565|526889828|FG002|Overall Study|Undisclosed Medical History|0|||
146100844|NCT01644565|526889829|FG003|Overall Study|Undisclosed Medical History|0|||
146100845|NCT01644565|526889830|FG004|Overall Study|Undisclosed Medical History|0|||
146100846|NCT01644565|526889831|FG005|Overall Study|Undisclosed Medical History|0|||
146100847|NCT01644565|526889832|FG006|Overall Study|Undisclosed Medical History|0|||
146100848|NCT01644565|526889833|FG007|Overall Study|Undisclosed Medical History|0|||
146100849|NCT01644565|526889834|FG008|Overall Study|Undisclosed Medical History|0|||
146100850|NCT01644565|526889826|FG000|Overall Study|Lost to Follow-up|0|||
146100851|NCT01644565|526889827|FG001|Overall Study|Lost to Follow-up|0|||
146100852|NCT01644565|526889828|FG002|Overall Study|Lost to Follow-up|0|||
146100853|NCT01644565|526889829|FG003|Overall Study|Lost to Follow-up|1|||
146100854|NCT01644565|526889830|FG004|Overall Study|Lost to Follow-up|0|||
146100855|NCT01644565|526889831|FG005|Overall Study|Lost to Follow-up|0|||
146100856|NCT01644565|526889832|FG006|Overall Study|Lost to Follow-up|0|||
146100857|NCT01644565|526889833|FG007|Overall Study|Lost to Follow-up|2|||
146100858|NCT01644565|526889834|FG008|Overall Study|Lost to Follow-up|0|||
146100859|NCT01644565|526889826|FG000|Overall Study|Family emergency|0|||
146100860|NCT01644565|526889827|FG001|Overall Study|Family emergency|0|||
146300622|NCT00884325|527617063|FG000|Overall Study|Not provided|1|||
146300623|NCT00884325|527617064|FG001|Overall Study|Not provided|0|||
146300624|NCT00832117|527617065|FG000|Overall Study|Death|1|||
146100861|NCT01644565|526889828|FG002|Overall Study|Family emergency|0|||
146100862|NCT01644565|526889829|FG003|Overall Study|Family emergency|0|||
146100863|NCT01644565|526889830|FG004|Overall Study|Family emergency|1|||
146100864|NCT01644565|526889831|FG005|Overall Study|Family emergency|0|||
146300625|NCT00832117|527617065|FG000|Overall Study|Disease Progression|11|||
146300626|NCT04439071|527617066|FG000|Overall Study|Lost to Follow-up|0|||
146100865|NCT01644565|526889832|FG006|Overall Study|Family emergency|0|||
146100866|NCT01644565|526889833|FG007|Overall Study|Family emergency|0|||
146100867|NCT01644565|526889834|FG008|Overall Study|Family emergency|0|||
146100868|NCT01644565|526889826|FG000|Overall Study|Relocation|0|||
146100869|NCT01644565|526889827|FG001|Overall Study|Relocation|0|||
146100870|NCT01644565|526889828|FG002|Overall Study|Relocation|0|||
146100871|NCT01644565|526889829|FG003|Overall Study|Relocation|0|||
146100872|NCT01644565|526889830|FG004|Overall Study|Relocation|0|||
146100873|NCT01644565|526889831|FG005|Overall Study|Relocation|0|||
146100874|NCT01644565|526889832|FG006|Overall Study|Relocation|0|||
146100875|NCT01644565|526889833|FG007|Overall Study|Relocation|0|||
146100876|NCT01644565|526889834|FG008|Overall Study|Relocation|1|||
146100877|NCT02280304|526889835|FG000|Overall Study|Lost to Follow-up|7|||
146100878|NCT02280304|526889836|FG001|Overall Study|Lost to Follow-up|8|||
146100879|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
146100880|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
146100881|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
146100882|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
146100883|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
146100884|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
146100885|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
146100886|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
146100887|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
146100888|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100889|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100890|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100891|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100892|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100893|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100894|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
146100895|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
146100896|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100897|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100898|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100899|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100900|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100901|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100902|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
146100903|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
146100904|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100905|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100906|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100907|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100908|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100909|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100910|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
146100911|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
146100912|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100913|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100914|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100915|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100916|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100917|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100918|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
146100919|NCT00533897|526889837|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
146100920|NCT00533897|526889838|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100921|NCT00533897|526889839|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100922|NCT00533897|526889840|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100923|NCT00533897|526889841|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100924|NCT00533897|526889842|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100925|NCT00533897|526889843|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100926|NCT00533897|526889844|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
146100927|NCT00533897|526889837|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100928|NCT00533897|526889838|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
146100929|NCT00533897|526889839|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
146100930|NCT00533897|526889840|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100931|NCT00533897|526889841|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100932|NCT00533897|526889842|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100933|NCT00533897|526889843|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100934|NCT00533897|526889844|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
146100935|NCT00533897|526889837|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100936|NCT00533897|526889838|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100937|NCT00533897|526889839|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
146100938|NCT00533897|526889840|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146254688|NCT04382053|527444658|FG001|Overall Study|Death|8|||
146254689|NCT04382053|527444657|FG000|Overall Study|Lost to Follow-up|0|||
146100939|NCT00533897|526889841|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100940|NCT00533897|526889842|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100941|NCT00533897|526889843|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100942|NCT00533897|526889844|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
146100943|NCT00533897|526889837|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100944|NCT00533897|526889838|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100945|NCT00533897|526889839|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100946|NCT00533897|526889840|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100947|NCT00533897|526889841|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100948|NCT00533897|526889842|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
146100949|NCT00533897|526889843|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100950|NCT00533897|526889844|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
146100951|NCT00533897|526889837|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100952|NCT00533897|526889838|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100953|NCT00533897|526889839|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100954|NCT00533897|526889840|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100955|NCT00533897|526889841|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100956|NCT00533897|526889842|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
146100957|NCT00533897|526889843|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100958|NCT00533897|526889844|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
146100959|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100960|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100961|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100962|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100963|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100964|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
146100965|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
146100966|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
146100967|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Death|0|||
146100968|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Death|0|||
146100969|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Death|0|||
146100970|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Death|0|||
146100971|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Death|0|||
146100972|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Death|0|||
146100973|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Death|1|||
146100974|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Death|3|||
146100975|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100976|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100977|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100978|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100979|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100980|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
146100981|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
146100982|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
146100983|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100984|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100985|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100986|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100987|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100988|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100989|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
146100990|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
146100991|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Adverse Event|0|||
146100992|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Adverse Event|0|||
146100993|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Adverse Event|0|||
146100994|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Adverse Event|0|||
146100995|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Adverse Event|0|||
146100996|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Adverse Event|0|||
146100997|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Adverse Event|2|||
146100998|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Adverse Event|5|||
146100999|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Pregnancy|0|||
146101000|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Pregnancy|0|||
146101001|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Pregnancy|0|||
146101002|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Pregnancy|0|||
146254690|NCT04382053|527444658|FG001|Overall Study|Lost to Follow-up|2|||
146101003|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Pregnancy|0|||
146101004|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Pregnancy|0|||
146101005|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Pregnancy|0|||
146254691|NCT04382053|527444657|FG000|Overall Study|Protocol Deviation|1|||
146254692|NCT04382053|527444658|FG001|Overall Study|Protocol Deviation|2|||
146254693|NCT04382053|527444657|FG000|Overall Study|Withdrawal by Subject|2|||
146254694|NCT04382053|527444658|FG001|Overall Study|Withdrawal by Subject|1|||
146254695|NCT01399905|527444661|FG000|Overall Study|Withdrawal by Subject|1|||
146254696|NCT01399905|527444662|FG001|Overall Study|Withdrawal by Subject|1|||
146254697|NCT00714688|527444670|FG000|Overall Study|Lack of Efficacy|14|||
146254698|NCT00714688|527444671|FG001|Overall Study|Lack of Efficacy|1|||
146254699|NCT00714688|527444672|FG002|Overall Study|Lack of Efficacy|4|||
146254700|NCT00714688|527444670|FG000|Overall Study|Withdrawal by Subject|4|||
146300627|NCT04439071|527617067|FG001|Overall Study|Lost to Follow-up|3|||
146300628|NCT04439071|527617066|FG000|Overall Study|Withdrawal by Subject|3|||
146042597|NCT04776317|526669460|FG000|Overall Study|Withdrawal by Subject|0|||
146042598|NCT04776317|526669461|FG001|Overall Study|Withdrawal by Subject|0|||
146042599|NCT04776317|526669462|FG002|Overall Study|Withdrawal by Subject|0|||
146042600|NCT04776317|526669463|FG003|Overall Study|Withdrawal by Subject|0|||
146042601|NCT04776317|526669464|FG004|Overall Study|Withdrawal by Subject|1|||
146042602|NCT04776317|526669465|FG005|Overall Study|Withdrawal by Subject|0|||
146042603|NCT04776317|526669466|FG006|Overall Study|Withdrawal by Subject|0|||
146042604|NCT04776317|526669467|FG007|Overall Study|Withdrawal by Subject|0|||
146042605|NCT04776317|526669468|FG008|Overall Study|Withdrawal by Subject|0|||
146042606|NCT04776317|526669469|FG009|Overall Study|Withdrawal by Subject|0|||
146042607|NCT04776317|526669470|FG010|Overall Study|Withdrawal by Subject|0|||
146042608|NCT04776317|526669471|FG011|Overall Study|Withdrawal by Subject|0|||
146042609|NCT04776317|526669472|FG012|Overall Study|Withdrawal by Subject|0|||
146042610|NCT04776317|526669473|FG013|Overall Study|Withdrawal by Subject|0|||
146042611|NCT04776317|526669474|FG014|Overall Study|Withdrawal by Subject|0|||
146042612|NCT05438576|526669475|FG000|Overall Study|Death|1|||
146042613|NCT05438576|526669476|FG001|Overall Study|Death|1|||
146042614|NCT05438576|526669475|FG000|Overall Study|Withdrawal by Subject|4|||
146042615|NCT05438576|526669476|FG001|Overall Study|Withdrawal by Subject|2|||
146042616|NCT05438576|526669475|FG000|Overall Study|Not Eligible|2|||
146042617|NCT05438576|526669476|FG001|Overall Study|Not Eligible|1|||
146042618|NCT05438576|526669475|FG000|Overall Study|Did not complete baseline testing|22|||
146042619|NCT05438576|526669476|FG001|Overall Study|Did not complete baseline testing|4|||
146042620|NCT02881762|526669477|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
146042621|NCT02881762|526669478|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146042622|NCT01415401|526669485|FG000|Overall Study|Adverse Event|5|||
146042623|NCT01415401|526669485|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
146042624|NCT01415401|526669485|FG000|Overall Study|Terminated by Sponsor|1|||
146042625|NCT00994422|526669486|FG000|Overall Study|Lost to Follow-up|7|||
146042626|NCT00994422|526669487|FG001|Overall Study|Lost to Follow-up|1|||
146042627|NCT04124705|526669488|FG000|Titration Period|Adverse Event|9|||
146042628|NCT04124705|526669489|FG001|Titration Period|Adverse Event|5|||
146042629|NCT04124705|526669488|FG000|Titration Period|Withdrawal by Subject|6|||
146042630|NCT04124705|526669489|FG001|Titration Period|Withdrawal by Subject|3|||
146042631|NCT04124705|526669488|FG000|Titration Period|Lost to Follow-up|0|||
146042632|NCT04124705|526669489|FG001|Titration Period|Lost to Follow-up|1|||
146042633|NCT04124705|526669488|FG000|Titration Period|Death|1|||
146042634|NCT04124705|526669489|FG001|Titration Period|Death|1|||
146042635|NCT04124705|526669488|FG000|Titration Period|Lack of Efficacy|2|||
146042636|NCT04124705|526669489|FG001|Titration Period|Lack of Efficacy|0|||
146042637|NCT04124705|526669488|FG000|Titration Period|Physician Decision|2|||
146042638|NCT04124705|526669489|FG001|Titration Period|Physician Decision|0|||
146042639|NCT04124705|526669488|FG000|Titration Period|Non-compliance with Study Drug|2|||
146042640|NCT04124705|526669489|FG001|Titration Period|Non-compliance with Study Drug|0|||
146042641|NCT04124705|526669488|FG000|Titration Period|Other|4|||
146042642|NCT04124705|526669489|FG001|Titration Period|Other|9|||
146042643|NCT04124705|526669488|FG000|Stabilization Period|Adverse Event|4|||
146042644|NCT04124705|526669489|FG001|Stabilization Period|Adverse Event|2|||
146042645|NCT04124705|526669488|FG000|Stabilization Period|Withdrawal by Subject|1|||
146042646|NCT04124705|526669489|FG001|Stabilization Period|Withdrawal by Subject|1|||
146042647|NCT04124705|526669488|FG000|Stabilization Period|Lost to Follow-up|0|||
146042648|NCT04124705|526669489|FG001|Stabilization Period|Lost to Follow-up|1|||
146042649|NCT04124705|526669488|FG000|Stabilization Period|Lack of Efficacy|4|||
146042650|NCT04124705|526669489|FG001|Stabilization Period|Lack of Efficacy|2|||
146042651|NCT04124705|526669488|FG000|Stabilization Period|Protocol Deviation|0|||
146042652|NCT04124705|526669489|FG001|Stabilization Period|Protocol Deviation|2|||
146042653|NCT04124705|526669488|FG000|Stabilization Period|Other|2|||
146042654|NCT04124705|526669489|FG001|Stabilization Period|Other|2|||
146042655|NCT01636986|526669494|FG000|Overall Study|Withdrawal by Subject|0|||
146042656|NCT01636986|526669495|FG001|Overall Study|Withdrawal by Subject|1|||
146042657|NCT01636986|526669494|FG000|Overall Study|Corneal Staining|0|||
146254701|NCT00714688|527444671|FG001|Overall Study|Withdrawal by Subject|3|||
146254702|NCT00714688|527444672|FG002|Overall Study|Withdrawal by Subject|3|||
146042658|NCT01636986|526669495|FG001|Overall Study|Corneal Staining|1|||
146042659|NCT00395850|526669503|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
146254703|NCT00714688|527444670|FG000|Overall Study|Lost to Follow-up|5|||
146254704|NCT00714688|527444671|FG001|Overall Study|Lost to Follow-up|2|||
146254705|NCT00714688|527444672|FG002|Overall Study|Lost to Follow-up|0|||
146254706|NCT00714688|527444670|FG000|Overall Study|Adverse Event|2|||
146254707|NCT00714688|527444671|FG001|Overall Study|Adverse Event|15|||
146254708|NCT00714688|527444672|FG002|Overall Study|Adverse Event|19|||
146101006|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Pregnancy|2|||
146101007|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101008|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101009|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101010|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101011|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101012|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
146101013|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
146101014|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
146101015|NCT00533897|526889837|FG000|Long Term Extension (LTE)|Other|0|||
146101016|NCT00533897|526889838|FG001|Long Term Extension (LTE)|Other|0|||
146101017|NCT00533897|526889839|FG002|Long Term Extension (LTE)|Other|0|||
146101018|NCT00533897|526889840|FG003|Long Term Extension (LTE)|Other|0|||
146101019|NCT00533897|526889841|FG004|Long Term Extension (LTE)|Other|0|||
146101020|NCT00533897|526889842|FG005|Long Term Extension (LTE)|Other|0|||
146101021|NCT00533897|526889843|FG006|Long Term Extension (LTE)|Other|1|||
146101022|NCT00533897|526889844|FG007|Long Term Extension (LTE)|Other|6|||
146101023|NCT00713323|526889847|FG000|Overall Study|Adverse Event|75|||
146101024|NCT00713323|526889847|FG000|Overall Study|Withdrawal by Subject|15|||
146254709|NCT00714688|527444670|FG000|Overall Study|Subject Non-compliant|3|||
146254710|NCT00714688|527444671|FG001|Overall Study|Subject Non-compliant|5|||
146254711|NCT00714688|527444672|FG002|Overall Study|Subject Non-compliant|5|||
146254712|NCT00714688|527444670|FG000|Overall Study|Ineligible to Continue the Study|0|||
146254713|NCT00714688|527444671|FG001|Overall Study|Ineligible to Continue the Study|1|||
146042660|NCT00395850|526669504|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146042661|NCT00395850|526669505|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146042662|NCT00395850|526669506|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
146042663|NCT00395850|526669503|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
146042664|NCT00395850|526669504|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146042665|NCT00395850|526669505|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146042666|NCT00395850|526669506|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
146042667|NCT00395850|526669503|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
146042668|NCT00395850|526669504|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146042669|NCT00395850|526669505|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146042670|NCT00395850|526669506|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
146042671|NCT00395850|526669503|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
146042672|NCT00395850|526669504|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
146042673|NCT00395850|526669505|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
146042674|NCT00395850|526669506|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
146042675|NCT00395850|526669503|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
146042676|NCT00395850|526669504|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146042677|NCT00395850|526669505|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146042678|NCT00395850|526669506|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
146042679|NCT00395850|526669503|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
146042680|NCT00395850|526669504|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146042681|NCT00395850|526669505|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146042682|NCT00395850|526669506|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
146042683|NCT00395850|526669503|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
146042684|NCT00395850|526669504|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146042685|NCT00395850|526669505|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146042686|NCT00395850|526669506|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
146042687|NCT01844778|526669513|FG000|Overall Study|Protocol deviation|0|||
146042688|NCT01844778|526669514|FG001|Overall Study|Protocol deviation|1|||
146042689|NCT01844778|526669515|FG002|Overall Study|Protocol deviation|2|||
146042690|NCT01844778|526669513|FG000|Overall Study|Withdrawal by Subject|2|||
146042691|NCT01844778|526669514|FG001|Overall Study|Withdrawal by Subject|0|||
146101025|NCT00713323|526889847|FG000|Overall Study|Lost to Follow-up|11|||
146101026|NCT00713323|526889847|FG000|Overall Study|Lack of Efficacy|36|||
146101027|NCT00713323|526889847|FG000|Overall Study|Low creatine clearance at screening|1|||
146254714|NCT00714688|527444672|FG002|Overall Study|Ineligible to Continue the Study|1|||
146254715|NCT00714688|527444670|FG000|Overall Study|Sponsor's Decision|0|||
146101028|NCT00713323|526889847|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
146254716|NCT00714688|527444671|FG001|Overall Study|Sponsor's Decision|2|||
146254717|NCT00714688|527444672|FG002|Overall Study|Sponsor's Decision|0|||
146254718|NCT00714688|527444670|FG000|Overall Study|Other|1|||
146254719|NCT00714688|527444671|FG001|Overall Study|Other|6|||
146254720|NCT00714688|527444672|FG002|Overall Study|Other|5|||
146254721|NCT01786551|527444673|FG000|Overall Study|Participant withdrew consent|2|||
146254722|NCT01123642|527444676|FG000|Overall Study|Lost to Follow-up|23|||
146254723|NCT01123642|527444676|FG000|Overall Study|Withdrawal by Subject|9|||
146254724|NCT01123642|527444676|FG000|Overall Study|ineligible at baseline assessment|36|||
146254725|NCT00651937|527446656|FG000|Overall Study|Withdrawal by Subject|4|||
146254726|NCT00651937|527446657|FG001|Overall Study|Withdrawal by Subject|1|||
146254727|NCT00848393|527446664|FG000|Overall Study|Protocol Violation|0|||
146254728|NCT00848393|527446665|FG001|Overall Study|Protocol Violation|0|||
146254729|NCT00848393|527446666|FG002|Overall Study|Protocol Violation|1|||
146254730|NCT00848393|527446664|FG000|Overall Study|surgical complications unrelated to stud|0|||
146254731|NCT00848393|527446665|FG001|Overall Study|surgical complications unrelated to stud|0|||
146254732|NCT00848393|527446666|FG002|Overall Study|surgical complications unrelated to stud|2|||
146254733|NCT00443898|527446671|FG000|Overall Study|Adverse Event|0|||
146254734|NCT00443898|527446672|FG001|Overall Study|Adverse Event|0|||
146254735|NCT00443898|527446673|FG002|Overall Study|Adverse Event|1|||
146254736|NCT00443898|527446674|FG003|Overall Study|Adverse Event|1|||
146254737|NCT00443898|527446671|FG000|Overall Study|Lack of Efficacy|2|||
146254738|NCT00443898|527446672|FG001|Overall Study|Lack of Efficacy|3|||
146254739|NCT00443898|527446673|FG002|Overall Study|Lack of Efficacy|3|||
146254740|NCT00443898|527446674|FG003|Overall Study|Lack of Efficacy|1|||
146254741|NCT00443898|527446671|FG000|Overall Study|Protocol Violation|1|||
146254742|NCT00443898|527446672|FG001|Overall Study|Protocol Violation|1|||
146254743|NCT00443898|527446673|FG002|Overall Study|Protocol Violation|1|||
146254744|NCT00443898|527446674|FG003|Overall Study|Protocol Violation|0|||
146254745|NCT00443898|527446671|FG000|Overall Study|Withdrawal by Subject|11|||
146254746|NCT00443898|527446672|FG001|Overall Study|Withdrawal by Subject|10|||
146254747|NCT00443898|527446673|FG002|Overall Study|Withdrawal by Subject|10|||
146254748|NCT00443898|527446674|FG003|Overall Study|Withdrawal by Subject|6|||
146254749|NCT00443898|527446671|FG000|Overall Study|Lost to Follow-up|10|||
146254750|NCT00443898|527446672|FG001|Overall Study|Lost to Follow-up|10|||
146254751|NCT00443898|527446673|FG002|Overall Study|Lost to Follow-up|14|||
146254752|NCT00443898|527446674|FG003|Overall Study|Lost to Follow-up|10|||
146254753|NCT00443898|527446671|FG000|Overall Study|Death|0|||
146254754|NCT00443898|527446672|FG001|Overall Study|Death|1|||
146254755|NCT00443898|527446673|FG002|Overall Study|Death|0|||
146254756|NCT00443898|527446674|FG003|Overall Study|Death|0|||
146254757|NCT00043186|527446675|FG000|Overall Study|Physician Decision|0|||
146254758|NCT00043186|527446676|FG001|Overall Study|Physician Decision|0|||
146254759|NCT00043186|527446677|FG002|Overall Study|Physician Decision|3|||
146254760|NCT00043186|527446678|FG003|Overall Study|Physician Decision|0|||
146254761|NCT00043186|527446679|FG004|Overall Study|Physician Decision|1|||
146254762|NCT00043186|527446680|FG005|Overall Study|Physician Decision|0|||
146254763|NCT00043186|527446681|FG006|Overall Study|Physician Decision|0|||
146254764|NCT00043186|527446682|FG007|Overall Study|Physician Decision|1|||
146254765|NCT00043186|527446683|FG008|Overall Study|Physician Decision|1|||
146254766|NCT00043186|527446675|FG000|Overall Study|Adverse Event|2|||
146254767|NCT00043186|527446676|FG001|Overall Study|Adverse Event|2|||
146254768|NCT00043186|527446677|FG002|Overall Study|Adverse Event|2|||
146254769|NCT00043186|527446678|FG003|Overall Study|Adverse Event|3|||
146254770|NCT00043186|527446679|FG004|Overall Study|Adverse Event|2|||
146254771|NCT00043186|527446680|FG005|Overall Study|Adverse Event|1|||
146254772|NCT00043186|527446681|FG006|Overall Study|Adverse Event|2|||
146042692|NCT01844778|526669515|FG002|Overall Study|Withdrawal by Subject|0|||
146042693|NCT01844778|526669513|FG000|Overall Study|Adverse Event|0|||
146042694|NCT01844778|526669514|FG001|Overall Study|Adverse Event|2|||
146042695|NCT01844778|526669515|FG002|Overall Study|Adverse Event|2|||
146042696|NCT01496846|526669523|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
146042697|NCT01496846|526669524|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
146042698|NCT01496846|526669525|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146042699|NCT01496846|526669526|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146042700|NCT01496846|526669527|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146042701|NCT01496846|526669528|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
146042702|NCT00923845|526669529|FG000|Induction Therapy|Poor performance status|0|||
146254773|NCT00043186|527446682|FG007|Overall Study|Adverse Event|1|||
146254774|NCT00043186|527446683|FG008|Overall Study|Adverse Event|3|||
146254775|NCT00043186|527446675|FG000|Overall Study|Withdrawal by Subject|11|||
146254776|NCT00043186|527446676|FG001|Overall Study|Withdrawal by Subject|8|||
146300629|NCT04439071|527617067|FG001|Overall Study|Withdrawal by Subject|8|||
146042703|NCT00923845|526669530|FG001|Induction Therapy|Poor performance status|2|||
146254777|NCT00043186|527446677|FG002|Overall Study|Withdrawal by Subject|11|||
146254778|NCT00043186|527446678|FG003|Overall Study|Withdrawal by Subject|13|||
146254779|NCT00043186|527446679|FG004|Overall Study|Withdrawal by Subject|14|||
146254780|NCT00043186|527446680|FG005|Overall Study|Withdrawal by Subject|6|||
146101029|NCT00713323|526889847|FG000|Overall Study|Surgery cured allodynic pain|1|||
146101030|NCT00713323|526889847|FG000|Overall Study|Pain free|1|||
146101031|NCT00713323|526889847|FG000|Overall Study|Non-compliance|1|||
146101032|NCT00713323|526889847|FG000|Overall Study|Pain resolved|1|||
146101033|NCT00713323|526889847|FG000|Overall Study|Subject travelling to USA|1|||
146101034|NCT00713323|526889847|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
146101035|NCT00713323|526889847|FG000|Overall Study|Treatment that may interact with Sativex|1|||
146101036|NCT00506662|526889848|FG000|Overall Study|Adverse Event|0|||
146101037|NCT00506662|526889849|FG001|Overall Study|Adverse Event|2|||
146101038|NCT00506662|526889848|FG000|Overall Study|Lack of Efficacy|1|||
146101039|NCT00506662|526889849|FG001|Overall Study|Lack of Efficacy|0|||
146101040|NCT00506662|526889848|FG000|Overall Study|Protocol Violation|2|||
146101041|NCT00506662|526889849|FG001|Overall Study|Protocol Violation|4|||
146101042|NCT00506662|526889848|FG000|Overall Study|Trial terminated|10|||
146101043|NCT00506662|526889849|FG001|Overall Study|Trial terminated|16|||
146101044|NCT00506662|526889848|FG000|Overall Study|Not recorded|4|||
146101045|NCT00506662|526889849|FG001|Overall Study|Not recorded|6|||
146101046|NCT04015336|526889850|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
146101047|NCT00491075|526889851|FG000|Overall Study|Withdrawal by Subject|1|||
146101048|NCT00491075|526889851|FG000|Overall Study|Physician Decision|1|||
146101049|NCT01603355|526889852|FG000|Overall Study|Lack of Efficacy|2|||
146101050|NCT02764333|526889855|FG000|Overall Study|Ineligible|1|||
146101051|NCT03355365|526889856|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
146101052|NCT03355365|526889857|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
146101053|NCT03355365|526889856|FG000|Year 1, First Intervention|Protocol Violation|1|||
146101054|NCT03355365|526889857|FG001|Year 1, First Intervention|Protocol Violation|0|||
146101055|NCT03355365|526889856|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
146101056|NCT03355365|526889857|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
146101057|NCT03355365|526889856|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
146101058|NCT03355365|526889857|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
146101059|NCT03355365|526889856|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
146101060|NCT03355365|526889857|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
146101061|NCT03355365|526889856|FG000|Year 2, Crossover Intervention|severe COVID|0|||
146101062|NCT03355365|526889857|FG001|Year 2, Crossover Intervention|severe COVID|1|||
146101063|NCT03355365|526889856|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
146101064|NCT03355365|526889857|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
146101065|NCT04622306|526889858|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146101066|NCT04622306|526889859|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146101067|NCT04622306|526889860|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
146101068|NCT04622306|526889861|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
146101069|NCT04622306|526889862|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
146101070|NCT04622306|526889863|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
146101071|NCT04622306|526889858|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146101072|NCT04622306|526889859|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146101073|NCT04622306|526889860|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
146101074|NCT04622306|526889861|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
146101075|NCT04622306|526889862|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146101076|NCT04622306|526889863|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
146101077|NCT01200524|526889864|FG000|Overall Study|Withdrawal by Subject|1|||
146101078|NCT01200524|526889865|FG001|Overall Study|Withdrawal by Subject|1|||
146101079|NCT01200524|526889866|FG002|Overall Study|Withdrawal by Subject|3|||
146101080|NCT01200524|526889864|FG000|Overall Study|Adverse Event|1|||
146101081|NCT01200524|526889865|FG001|Overall Study|Adverse Event|0|||
146101082|NCT01200524|526889866|FG002|Overall Study|Adverse Event|0|||
146254781|NCT00043186|527446681|FG006|Overall Study|Withdrawal by Subject|12|||
146254782|NCT00043186|527446682|FG007|Overall Study|Withdrawal by Subject|9|||
146254783|NCT00043186|527446683|FG008|Overall Study|Withdrawal by Subject|10|||
146254784|NCT00043186|527446675|FG000|Overall Study|Death|0|||
146254785|NCT00043186|527446676|FG001|Overall Study|Death|0|||
146101083|NCT01200524|526889864|FG000|Overall Study|Non availability of study nurse|0|||
146101084|NCT01200524|526889865|FG001|Overall Study|Non availability of study nurse|0|||
146101085|NCT01200524|526889866|FG002|Overall Study|Non availability of study nurse|1|||
146101086|NCT00491764|526889868|FG000|Overall Study|Adverse Event|1|||
146101087|NCT00491764|526889869|FG001|Overall Study|Adverse Event|2|||
146101088|NCT00491764|526889870|FG002|Overall Study|Adverse Event|4|||
146101089|NCT00491764|526889871|FG003|Overall Study|Adverse Event|4|||
146101090|NCT00491764|526889872|FG004|Overall Study|Adverse Event|0|||
146254786|NCT00043186|527446677|FG002|Overall Study|Death|1|||
146254787|NCT00043186|527446678|FG003|Overall Study|Death|0|||
146254788|NCT00043186|527446679|FG004|Overall Study|Death|0|||
146101091|NCT00491764|526889873|FG005|Overall Study|Adverse Event|1|||
146254789|NCT00043186|527446680|FG005|Overall Study|Death|0|||
146042704|NCT01748825|526669531|FG000|Dose Escalation|Refused further treatment|2|||
146042705|NCT01748825|526669532|FG001|Dose Escalation|Refused further treatment|2|||
146042706|NCT01748825|526669533|FG002|Dose Escalation|Refused further treatment|0|||
146042707|NCT01748825|526669534|FG003|Dose Escalation|Refused further treatment|0|||
146042708|NCT01748825|526669535|FG004|Dose Escalation|Refused further treatment|1|||
146042709|NCT01748825|526669536|FG005|Dose Escalation|Refused further treatment|2|||
146042710|NCT01748825|526669537|FG006|Dose Escalation|Refused further treatment|0|||
146042711|NCT01748825|526669538|FG007|Dose Escalation|Refused further treatment|0|||
146042712|NCT01748825|526669539|FG008|Dose Escalation|Refused further treatment|0|||
146042713|NCT01748825|526669540|FG009|Dose Escalation|Refused further treatment|0|||
146042714|NCT01748825|526669531|FG000|Dose Escalation|Switched to alternative treatment|0|||
146042715|NCT01748825|526669532|FG001|Dose Escalation|Switched to alternative treatment|0|||
146042716|NCT01748825|526669533|FG002|Dose Escalation|Switched to alternative treatment|0|||
146042717|NCT01748825|526669534|FG003|Dose Escalation|Switched to alternative treatment|1|||
146042718|NCT01748825|526669535|FG004|Dose Escalation|Switched to alternative treatment|0|||
146042719|NCT01748825|526669536|FG005|Dose Escalation|Switched to alternative treatment|0|||
146042720|NCT01748825|526669537|FG006|Dose Escalation|Switched to alternative treatment|0|||
146042721|NCT01748825|526669538|FG007|Dose Escalation|Switched to alternative treatment|0|||
146042722|NCT01748825|526669539|FG008|Dose Escalation|Switched to alternative treatment|0|||
146042723|NCT01748825|526669540|FG009|Dose Escalation|Switched to alternative treatment|0|||
146042724|NCT01748825|526669531|FG000|Dose Escalation|Adverse Event|0|||
146042725|NCT01748825|526669532|FG001|Dose Escalation|Adverse Event|0|||
146042726|NCT01748825|526669533|FG002|Dose Escalation|Adverse Event|0|||
146042727|NCT01748825|526669534|FG003|Dose Escalation|Adverse Event|0|||
146042728|NCT01748825|526669535|FG004|Dose Escalation|Adverse Event|0|||
146042729|NCT01748825|526669536|FG005|Dose Escalation|Adverse Event|0|||
146042730|NCT01748825|526669537|FG006|Dose Escalation|Adverse Event|1|||
146042731|NCT01748825|526669538|FG007|Dose Escalation|Adverse Event|0|||
146042732|NCT01748825|526669539|FG008|Dose Escalation|Adverse Event|0|||
146042733|NCT01748825|526669540|FG009|Dose Escalation|Adverse Event|0|||
146042734|NCT01748825|526669531|FG000|Dose Expansion|Refused further treatment|0|||
146042735|NCT01748825|526669532|FG001|Dose Expansion|Refused further treatment|0|||
146042736|NCT01748825|526669533|FG002|Dose Expansion|Refused further treatment|0|||
146042737|NCT01748825|526669534|FG003|Dose Expansion|Refused further treatment|0|||
146042738|NCT01748825|526669535|FG004|Dose Expansion|Refused further treatment|0|||
146042739|NCT01748825|526669536|FG005|Dose Expansion|Refused further treatment|0|||
146042740|NCT01748825|526669537|FG006|Dose Expansion|Refused further treatment|0|||
146042741|NCT01748825|526669538|FG007|Dose Expansion|Refused further treatment|0|||
146042742|NCT01748825|526669539|FG008|Dose Expansion|Refused further treatment|1|||
146042743|NCT01748825|526669540|FG009|Dose Expansion|Refused further treatment|1|||
146042744|NCT01748825|526669531|FG000|Dose Expansion|Switched to alternative treatment|0|||
146042745|NCT01748825|526669532|FG001|Dose Expansion|Switched to alternative treatment|0|||
146042746|NCT01748825|526669533|FG002|Dose Expansion|Switched to alternative treatment|0|||
146042747|NCT01748825|526669534|FG003|Dose Expansion|Switched to alternative treatment|0|||
146042748|NCT01748825|526669535|FG004|Dose Expansion|Switched to alternative treatment|0|||
146042749|NCT01748825|526669536|FG005|Dose Expansion|Switched to alternative treatment|0|||
146042750|NCT01748825|526669537|FG006|Dose Expansion|Switched to alternative treatment|0|||
146042751|NCT01748825|526669538|FG007|Dose Expansion|Switched to alternative treatment|0|||
146042752|NCT01748825|526669539|FG008|Dose Expansion|Switched to alternative treatment|0|||
146042753|NCT01748825|526669540|FG009|Dose Expansion|Switched to alternative treatment|1|||
146042754|NCT01748825|526669531|FG000|Dose Expansion|Adverse Event|0|||
146042755|NCT01748825|526669532|FG001|Dose Expansion|Adverse Event|0|||
146042756|NCT01748825|526669533|FG002|Dose Expansion|Adverse Event|0|||
146042757|NCT01748825|526669534|FG003|Dose Expansion|Adverse Event|0|||
146042758|NCT01748825|526669535|FG004|Dose Expansion|Adverse Event|0|||
146042759|NCT01748825|526669536|FG005|Dose Expansion|Adverse Event|0|||
146042760|NCT01748825|526669537|FG006|Dose Expansion|Adverse Event|0|||
146042761|NCT01748825|526669538|FG007|Dose Expansion|Adverse Event|0|||
146042762|NCT01748825|526669539|FG008|Dose Expansion|Adverse Event|0|||
146042763|NCT01748825|526669540|FG009|Dose Expansion|Adverse Event|3|||
146042764|NCT01748825|526669531|FG000|Dose Expansion|Physician Decision|0|||
146042765|NCT01748825|526669532|FG001|Dose Expansion|Physician Decision|0|||
146042766|NCT01748825|526669533|FG002|Dose Expansion|Physician Decision|0|||
146042767|NCT01748825|526669534|FG003|Dose Expansion|Physician Decision|0|||
146042768|NCT01748825|526669535|FG004|Dose Expansion|Physician Decision|0|||
146042769|NCT01748825|526669536|FG005|Dose Expansion|Physician Decision|0|||
146042770|NCT01748825|526669537|FG006|Dose Expansion|Physician Decision|0|||
146042771|NCT01748825|526669538|FG007|Dose Expansion|Physician Decision|0|||
146042772|NCT01748825|526669539|FG008|Dose Expansion|Physician Decision|1|||
146042773|NCT01748825|526669540|FG009|Dose Expansion|Physician Decision|0|||
146042774|NCT02921087|526669541|FG000|Overall Study|Withdrawal by Subject|0|||
146101092|NCT00491764|526889868|FG000|Overall Study|Lost to Follow-up|0|||
146042775|NCT02921087|526669542|FG001|Overall Study|Withdrawal by Subject|1|||
146042776|NCT00211887|526669543|FG000|Overall Study|Adverse Event|8|||
146042777|NCT00211887|526669544|FG001|Overall Study|Adverse Event|4|||
146042778|NCT00211887|526669545|FG002|Overall Study|Adverse Event|6|||
146101093|NCT00491764|526889869|FG001|Overall Study|Lost to Follow-up|1|||
146101094|NCT00491764|526889870|FG002|Overall Study|Lost to Follow-up|0|||
146101095|NCT00491764|526889871|FG003|Overall Study|Lost to Follow-up|1|||
146101096|NCT00491764|526889872|FG004|Overall Study|Lost to Follow-up|0|||
146101097|NCT00491764|526889873|FG005|Overall Study|Lost to Follow-up|3|||
146101098|NCT00491764|526889868|FG000|Overall Study|Withdrawal by Subject|2|||
146101099|NCT00491764|526889869|FG001|Overall Study|Withdrawal by Subject|3|||
146101100|NCT00491764|526889870|FG002|Overall Study|Withdrawal by Subject|1|||
146101101|NCT00491764|526889871|FG003|Overall Study|Withdrawal by Subject|2|||
146101102|NCT00491764|526889872|FG004|Overall Study|Withdrawal by Subject|2|||
146101103|NCT00491764|526889873|FG005|Overall Study|Withdrawal by Subject|4|||
146101104|NCT00491764|526889868|FG000|Overall Study|Non Compliance with the Protocol|1|||
146101105|NCT00491764|526889869|FG001|Overall Study|Non Compliance with the Protocol|0|||
146101106|NCT00491764|526889870|FG002|Overall Study|Non Compliance with the Protocol|0|||
146101107|NCT00491764|526889871|FG003|Overall Study|Non Compliance with the Protocol|0|||
146101108|NCT00491764|526889872|FG004|Overall Study|Non Compliance with the Protocol|0|||
146101109|NCT00491764|526889873|FG005|Overall Study|Non Compliance with the Protocol|0|||
146101110|NCT00491764|526889868|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
146101111|NCT00491764|526889869|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
146101112|NCT00491764|526889870|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
146101113|NCT00491764|526889871|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
146101114|NCT00491764|526889872|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
146101115|NCT00491764|526889873|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
146101116|NCT00491764|526889868|FG000|Overall Study|Administrative|1|||
146101117|NCT00491764|526889869|FG001|Overall Study|Administrative|0|||
146042779|NCT00211887|526669543|FG000|Overall Study|Death|1|||
146042780|NCT00211887|526669544|FG001|Overall Study|Death|1|||
146042781|NCT00211887|526669545|FG002|Overall Study|Death|1|||
146042782|NCT00211887|526669543|FG000|Overall Study|Lost to Follow-up|28|||
146042783|NCT00211887|526669544|FG001|Overall Study|Lost to Follow-up|13|||
146042784|NCT00211887|526669545|FG002|Overall Study|Lost to Follow-up|9|||
146042785|NCT00211887|526669543|FG000|Overall Study|Non-medical reason|31|||
146042786|NCT00211887|526669544|FG001|Overall Study|Non-medical reason|14|||
146042787|NCT00211887|526669545|FG002|Overall Study|Non-medical reason|8|||
146042788|NCT00211887|526669543|FG000|Overall Study|Other medical reason|15|||
146042789|NCT00211887|526669544|FG001|Overall Study|Other medical reason|11|||
146042790|NCT00211887|526669545|FG002|Overall Study|Other medical reason|7|||
146042791|NCT00211887|526669543|FG000|Overall Study|Side effects|19|||
146042792|NCT00211887|526669544|FG001|Overall Study|Side effects|13|||
146042793|NCT00211887|526669545|FG002|Overall Study|Side effects|5|||
146042794|NCT00619307|526669547|FG000|Overall Study|Adverse Event|0|||
146042795|NCT00619307|526669548|FG001|Overall Study|Adverse Event|1|||
146042796|NCT00619307|526669547|FG000|Overall Study|Lost to Follow-up|0|||
146042797|NCT00619307|526669548|FG001|Overall Study|Lost to Follow-up|1|||
146042798|NCT00619307|526669547|FG000|Overall Study|Protocol Violation|3|||
146042799|NCT00619307|526669548|FG001|Overall Study|Protocol Violation|0|||
146042800|NCT00619307|526669547|FG000|Overall Study|Withdrew consent|1|||
146042801|NCT00619307|526669548|FG001|Overall Study|Withdrew consent|0|||
146042802|NCT00619307|526669547|FG000|Overall Study|Severe migraine|0|||
146042803|NCT00619307|526669548|FG001|Overall Study|Severe migraine|1|||
146042804|NCT00619307|526669547|FG000|Overall Study|MS attack plus steroids|0|||
146042805|NCT00619307|526669548|FG001|Overall Study|MS attack plus steroids|1|||
146042806|NCT02147288|526669549|FG000|Overall Study|post-operative hematoma|1|||
146042807|NCT02147288|526669550|FG001|Overall Study|post-operative hematoma|1|||
146042808|NCT02147288|526669551|FG002|Overall Study|post-operative hematoma|0|||
146042809|NCT02147288|526669552|FG003|Overall Study|post-operative hematoma|0|||
146042810|NCT02147288|526669553|FG004|Overall Study|post-operative hematoma|0|||
146042811|NCT02147288|526669554|FG005|Overall Study|post-operative hematoma|0|||
146042812|NCT02147288|526669555|FG006|Overall Study|post-operative hematoma|0|||
146042813|NCT02147288|526669556|FG007|Overall Study|post-operative hematoma|0|||
146042814|NCT02147288|526669557|FG008|Overall Study|post-operative hematoma|0|||
146101118|NCT00491764|526889870|FG002|Overall Study|Administrative|2|||
146101119|NCT00491764|526889871|FG003|Overall Study|Administrative|1|||
146101120|NCT00491764|526889872|FG004|Overall Study|Administrative|0|||
146101121|NCT00491764|526889873|FG005|Overall Study|Administrative|0|||
146101122|NCT00697788|526889876|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101123|NCT00697788|526889877|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
146101124|NCT00697788|526889878|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101125|NCT00697788|526889879|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101126|NCT00697788|526889880|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101127|NCT00697788|526889881|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101128|NCT00697788|526889882|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101129|NCT00697788|526889883|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
146101130|NCT00697788|526889876|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101131|NCT00697788|526889877|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146254790|NCT00043186|527446681|FG006|Overall Study|Death|2|||
146101132|NCT00697788|526889878|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101133|NCT00697788|526889879|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101134|NCT00697788|526889880|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
146101135|NCT00697788|526889881|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101136|NCT00697788|526889882|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101137|NCT00697788|526889883|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
146101138|NCT00074984|526889886|FG000|Overall Study|Death|1|||
146101139|NCT00074984|526889887|FG001|Overall Study|Death|2|||
146101140|NCT00074984|526889886|FG000|Overall Study|Withdrawal by Subject|2|||
146101141|NCT00074984|526889887|FG001|Overall Study|Withdrawal by Subject|3|||
146101142|NCT00074984|526889886|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
146101143|NCT00074984|526889887|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
146101144|NCT03080454|526889888|FG000|Baseline|Adverse Event|2|||
146101145|NCT03080454|526889888|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
146101146|NCT03080454|526889888|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
146101147|NCT02202980|526889889|FG000|Overall Study|Lack of Efficacy|1|||
146101148|NCT02202980|526889890|FG001|Overall Study|Lack of Efficacy|0|||
146101149|NCT02202980|526889891|FG002|Overall Study|Lack of Efficacy|7|||
146101150|NCT02202980|526889892|FG003|Overall Study|Lack of Efficacy|0|||
146101151|NCT02202980|526889893|FG004|Overall Study|Lack of Efficacy|3|||
146101152|NCT02202980|526889894|FG005|Overall Study|Lack of Efficacy|1|||
146101153|NCT02202980|526889895|FG006|Overall Study|Lack of Efficacy|11|||
146101154|NCT02202980|526889896|FG007|Overall Study|Lack of Efficacy|2|||
146101155|NCT02202980|526889897|FG008|Overall Study|Lack of Efficacy|2|||
146101156|NCT02202980|526889898|FG009|Overall Study|Lack of Efficacy|0|||
146101157|NCT02202980|526889899|FG010|Overall Study|Lack of Efficacy|0|||
146101158|NCT02202980|526889900|FG011|Overall Study|Lack of Efficacy|3|||
146101159|NCT02202980|526889901|FG012|Overall Study|Lack of Efficacy|10|||
146101160|NCT02202980|526889902|FG013|Overall Study|Lack of Efficacy|0|||
146101161|NCT02202980|526889889|FG000|Overall Study|Protocol Violation|0|||
146101162|NCT02202980|526889890|FG001|Overall Study|Protocol Violation|0|||
146042815|NCT02147288|526669558|FG009|Overall Study|post-operative hematoma|0|||
146042816|NCT02147288|526669549|FG000|Overall Study|complications from concurrent hernia rep|0|||
146042817|NCT02147288|526669550|FG001|Overall Study|complications from concurrent hernia rep|1|||
146042818|NCT02147288|526669551|FG002|Overall Study|complications from concurrent hernia rep|0|||
146042819|NCT02147288|526669552|FG003|Overall Study|complications from concurrent hernia rep|0|||
146042820|NCT02147288|526669553|FG004|Overall Study|complications from concurrent hernia rep|0|||
146042821|NCT02147288|526669554|FG005|Overall Study|complications from concurrent hernia rep|0|||
146042822|NCT02147288|526669555|FG006|Overall Study|complications from concurrent hernia rep|0|||
146042823|NCT02147288|526669556|FG007|Overall Study|complications from concurrent hernia rep|0|||
146042824|NCT02147288|526669557|FG008|Overall Study|complications from concurrent hernia rep|0|||
146042825|NCT02147288|526669558|FG009|Overall Study|complications from concurrent hernia rep|0|||
146042826|NCT02069392|526669561|FG000|Overall Study|Withdrawal by Subject|4|||
146042827|NCT02069392|526669562|FG001|Overall Study|Withdrawal by Subject|2|||
146042828|NCT00269633|526669563|FG000|Overall Study|Withdrawal by Subject|1|||
146042829|NCT00269633|526669564|FG001|Overall Study|Withdrawal by Subject|0|||
146042830|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Adverse Event|33|||
146042831|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
146042832|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
146042833|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
146042834|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Physician Decision|6|||
146042835|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
146042836|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
146042837|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
146101163|NCT02202980|526889891|FG002|Overall Study|Protocol Violation|0|||
146101164|NCT02202980|526889892|FG003|Overall Study|Protocol Violation|3|||
146101165|NCT02202980|526889893|FG004|Overall Study|Protocol Violation|3|||
146101166|NCT02202980|526889894|FG005|Overall Study|Protocol Violation|0|||
146101167|NCT02202980|526889895|FG006|Overall Study|Protocol Violation|0|||
146101168|NCT02202980|526889896|FG007|Overall Study|Protocol Violation|0|||
146101169|NCT02202980|526889897|FG008|Overall Study|Protocol Violation|0|||
146101170|NCT02202980|526889898|FG009|Overall Study|Protocol Violation|0|||
146101171|NCT02202980|526889899|FG010|Overall Study|Protocol Violation|0|||
146101172|NCT02202980|526889900|FG011|Overall Study|Protocol Violation|0|||
146101173|NCT02202980|526889901|FG012|Overall Study|Protocol Violation|0|||
146042838|NCT00965419|526669565|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
146101174|NCT02202980|526889902|FG013|Overall Study|Protocol Violation|0|||
146101175|NCT02202980|526889889|FG000|Overall Study|Lost to Follow-up|0|||
146101176|NCT02202980|526889890|FG001|Overall Study|Lost to Follow-up|1|||
146101177|NCT02202980|526889891|FG002|Overall Study|Lost to Follow-up|1|||
146101178|NCT02202980|526889892|FG003|Overall Study|Lost to Follow-up|1|||
146101179|NCT02202980|526889893|FG004|Overall Study|Lost to Follow-up|0|||
146101180|NCT02202980|526889894|FG005|Overall Study|Lost to Follow-up|0|||
146101181|NCT02202980|526889895|FG006|Overall Study|Lost to Follow-up|0|||
146101182|NCT02202980|526889896|FG007|Overall Study|Lost to Follow-up|1|||
146101183|NCT02202980|526889897|FG008|Overall Study|Lost to Follow-up|1|||
146101184|NCT02202980|526889898|FG009|Overall Study|Lost to Follow-up|0|||
146101185|NCT02202980|526889899|FG010|Overall Study|Lost to Follow-up|0|||
146101186|NCT02202980|526889900|FG011|Overall Study|Lost to Follow-up|0|||
146101187|NCT02202980|526889901|FG012|Overall Study|Lost to Follow-up|1|||
146101188|NCT02202980|526889902|FG013|Overall Study|Lost to Follow-up|0|||
146101189|NCT02202980|526889889|FG000|Overall Study|Withdrew Consent|0|||
146101190|NCT02202980|526889890|FG001|Overall Study|Withdrew Consent|1|||
146101191|NCT02202980|526889891|FG002|Overall Study|Withdrew Consent|2|||
146101192|NCT02202980|526889892|FG003|Overall Study|Withdrew Consent|0|||
146101193|NCT02202980|526889893|FG004|Overall Study|Withdrew Consent|0|||
146101194|NCT02202980|526889894|FG005|Overall Study|Withdrew Consent|0|||
146101195|NCT02202980|526889895|FG006|Overall Study|Withdrew Consent|0|||
146101196|NCT02202980|526889896|FG007|Overall Study|Withdrew Consent|0|||
146101197|NCT02202980|526889897|FG008|Overall Study|Withdrew Consent|1|||
146101198|NCT02202980|526889898|FG009|Overall Study|Withdrew Consent|0|||
146101199|NCT02202980|526889899|FG010|Overall Study|Withdrew Consent|0|||
146101200|NCT02202980|526889900|FG011|Overall Study|Withdrew Consent|0|||
146101201|NCT02202980|526889901|FG012|Overall Study|Withdrew Consent|0|||
146101202|NCT02202980|526889902|FG013|Overall Study|Withdrew Consent|0|||
146101203|NCT04138810|526889906|FG000|Overall Study|Withdrawal by Subject|0|||
146101204|NCT04138810|526889907|FG001|Overall Study|Withdrawal by Subject|1|||
146101205|NCT04138810|526889906|FG000|Overall Study|Subject cancelled surgery|1|||
146101206|NCT04138810|526889907|FG001|Overall Study|Subject cancelled surgery|0|||
146101207|NCT00591344|526889908|FG000|Overall Study|Transportation issues|1|||
146101208|NCT00591344|526889909|FG001|Overall Study|Transportation issues|0|||
146101209|NCT00591344|526889908|FG000|Overall Study|Moved out of state|1|||
146101210|NCT00591344|526889909|FG001|Overall Study|Moved out of state|0|||
146101211|NCT00591344|526889908|FG000|Overall Study|Medical complications|1|||
146101212|NCT00591344|526889909|FG001|Overall Study|Medical complications|3|||
146101213|NCT00591344|526889908|FG000|Overall Study|Underwent DBS|2|||
146101214|NCT00591344|526889909|FG001|Overall Study|Underwent DBS|2|||
146101215|NCT00591344|526889908|FG000|Overall Study|Death|0|||
146101216|NCT00591344|526889909|FG001|Overall Study|Death|1|||
146101217|NCT00591344|526889908|FG000|Overall Study|Lost to Follow-up|0|||
146101218|NCT00591344|526889909|FG001|Overall Study|Lost to Follow-up|1|||
146101219|NCT00591344|526889908|FG000|Overall Study|Did not want to come off medication|0|||
146101220|NCT00591344|526889909|FG001|Overall Study|Did not want to come off medication|1|||
146101221|NCT01058655|526889914|FG000|Overall Study|Withdrawal by Subject|1|||
146101222|NCT01058655|526889915|FG001|Overall Study|Withdrawal by Subject|0|||
146101223|NCT01058655|526889916|FG002|Overall Study|Withdrawal by Subject|3|||
146101224|NCT01058655|526889917|FG003|Overall Study|Withdrawal by Subject|4|||
146101225|NCT01058655|526889914|FG000|Overall Study|Prolonged Treatment Delay|0|||
146101226|NCT01058655|526889915|FG001|Overall Study|Prolonged Treatment Delay|0|||
146042839|NCT00965419|526669565|FG000|Follow-up Phase|Adverse Event|9|||
146042840|NCT00965419|526669565|FG000|Follow-up Phase|Protocol Violation|4|||
146042841|NCT00965419|526669565|FG000|Follow-up Phase|Withdrawal by Subject|8|||
146042842|NCT00965419|526669565|FG000|Follow-up Phase|Physician Decision|4|||
146042843|NCT00965419|526669565|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
146042844|NCT00965419|526669565|FG000|Follow-up Phase|Lack of Efficacy|28|||
146042845|NCT04412707|526669566|FG000|Cycle 1|Death|0|||
146042846|NCT04412707|526669567|FG001|Cycle 1|Death|3|||
146042847|NCT04412707|526669566|FG000|Cycle 1|Disease progression|1|||
146042848|NCT04412707|526669567|FG001|Cycle 1|Disease progression|2|||
146042849|NCT04412707|526669566|FG000|Cycle 2|Death|0|||
146042850|NCT04412707|526669567|FG001|Cycle 2|Death|1|||
146042851|NCT04412707|526669566|FG000|Cycle 2|Disease progression|3|||
146042852|NCT04412707|526669567|FG001|Cycle 2|Disease progression|0|||
146042853|NCT04412707|526669566|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
146042854|NCT04412707|526669567|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
146042855|NCT04412707|526669566|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
146042856|NCT04412707|526669567|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
146042857|NCT04412707|526669566|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
146042858|NCT04412707|526669567|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
146042859|NCT04412707|526669566|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
146042860|NCT04412707|526669567|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
146101227|NCT01058655|526889916|FG002|Overall Study|Prolonged Treatment Delay|0|||
146101228|NCT01058655|526889917|FG003|Overall Study|Prolonged Treatment Delay|2|||
146042861|NCT02927938|526669568|FG000|Overall Study|Death|0|||
146101229|NCT01058655|526889914|FG000|Overall Study|Symptomatic Deterioration|0|||
146101230|NCT01058655|526889915|FG001|Overall Study|Symptomatic Deterioration|0|||
146101231|NCT01058655|526889916|FG002|Overall Study|Symptomatic Deterioration|0|||
146101232|NCT01058655|526889917|FG003|Overall Study|Symptomatic Deterioration|1|||
146101233|NCT01058655|526889914|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
146042862|NCT02927938|526669569|FG001|Overall Study|Death|1|||
146101234|NCT01058655|526889915|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
146101235|NCT01058655|526889916|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
146300630|NCT04439071|527617066|FG000|Overall Study|Death|6|||
146300631|NCT04439071|527617067|FG001|Overall Study|Death|4|||
146300632|NCT04439071|527617066|FG000|Overall Study|Other than specified|3|||
146300633|NCT04439071|527617067|FG001|Overall Study|Other than specified|3|||
146042863|NCT02927938|526669570|FG002|Overall Study|Death|0|||
146042864|NCT02927938|526669571|FG003|Overall Study|Death|4|||
146042865|NCT02927938|526669568|FG000|Overall Study|Early Study Termination|1|||
146042866|NCT02927938|526669569|FG001|Overall Study|Early Study Termination|5|||
146042867|NCT02927938|526669570|FG002|Overall Study|Early Study Termination|4|||
146042868|NCT02927938|526669571|FG003|Overall Study|Early Study Termination|3|||
146042869|NCT02475278|526671259|FG000|Overall Study|Lost to Follow-up|1|||
146042870|NCT02475278|526671259|FG000|Overall Study|Reason Not Specified|1|||
146042871|NCT01946152|526671260|FG000|Overall Study|Adverse Event|1|||
146042872|NCT01946152|526671261|FG001|Overall Study|Adverse Event|0|||
146042873|NCT01946152|526671262|FG002|Overall Study|Adverse Event|0|||
146042874|NCT01946152|526671263|FG003|Overall Study|Adverse Event|0|||
146042875|NCT01946152|526671260|FG000|Overall Study|Withdrawal by Subject|0|||
146042876|NCT01946152|526671261|FG001|Overall Study|Withdrawal by Subject|2|||
146042877|NCT01946152|526671262|FG002|Overall Study|Withdrawal by Subject|0|||
146042878|NCT01946152|526671263|FG003|Overall Study|Withdrawal by Subject|0|||
146042879|NCT01946152|526671260|FG000|Overall Study|Progression|0|||
146042880|NCT01946152|526671261|FG001|Overall Study|Progression|1|||
146042881|NCT01946152|526671262|FG002|Overall Study|Progression|4|||
146042882|NCT01946152|526671263|FG003|Overall Study|Progression|7|||
146042883|NCT01946152|526671260|FG000|Overall Study|Physician Decision|0|||
146042884|NCT01946152|526671261|FG001|Overall Study|Physician Decision|0|||
146042885|NCT01946152|526671262|FG002|Overall Study|Physician Decision|1|||
146042886|NCT01946152|526671263|FG003|Overall Study|Physician Decision|0|||
146042887|NCT01946152|526671260|FG000|Overall Study|Second malignancy|0|||
146042888|NCT01946152|526671261|FG001|Overall Study|Second malignancy|0|||
146042889|NCT01946152|526671262|FG002|Overall Study|Second malignancy|1|||
146042890|NCT01946152|526671263|FG003|Overall Study|Second malignancy|0|||
146042891|NCT01946152|526671260|FG000|Overall Study|Adverse Event|0|||
146042892|NCT01946152|526671261|FG001|Overall Study|Adverse Event|0|||
146042893|NCT01946152|526671262|FG002|Overall Study|Adverse Event|0|||
146042894|NCT01946152|526671263|FG003|Overall Study|Adverse Event|1|||
146042895|NCT03712787|526671264|FG000|Overall Study|Adverse Event|2|||
146042896|NCT03712787|526671265|FG001|Overall Study|Adverse Event|3|||
146042897|NCT03712787|526671266|FG002|Overall Study|Adverse Event|0|||
146042898|NCT03712787|526671267|FG003|Overall Study|Adverse Event|4|||
146042899|NCT03712787|526671264|FG000|Overall Study|Withdrawal by Subject|4|||
146042900|NCT03712787|526671265|FG001|Overall Study|Withdrawal by Subject|14|||
146042901|NCT03712787|526671266|FG002|Overall Study|Withdrawal by Subject|12|||
146042902|NCT03712787|526671267|FG003|Overall Study|Withdrawal by Subject|8|||
146042903|NCT03712787|526671264|FG000|Overall Study|Lost to Follow-up|1|||
146042904|NCT03712787|526671265|FG001|Overall Study|Lost to Follow-up|1|||
146042905|NCT03712787|526671266|FG002|Overall Study|Lost to Follow-up|2|||
146042906|NCT03712787|526671267|FG003|Overall Study|Lost to Follow-up|1|||
146042907|NCT03712787|526671264|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146042908|NCT03712787|526671265|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146042909|NCT03712787|526671266|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
146042910|NCT03712787|526671267|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
146042911|NCT03712787|526671264|FG000|Overall Study|COVID-19 Infection|0|||
146042912|NCT03712787|526671265|FG001|Overall Study|COVID-19 Infection|1|||
146042913|NCT03712787|526671266|FG002|Overall Study|COVID-19 Infection|0|||
146042914|NCT03712787|526671267|FG003|Overall Study|COVID-19 Infection|0|||
146042915|NCT03712787|526671264|FG000|Overall Study|Other, Not Specified|79|||
146042916|NCT03712787|526671265|FG001|Overall Study|Other, Not Specified|77|||
146042917|NCT03712787|526671266|FG002|Overall Study|Other, Not Specified|74|||
146042918|NCT03712787|526671267|FG003|Overall Study|Other, Not Specified|78|||
146042919|NCT05111249|526671268|FG000|Overall Study|Lost to Follow-up|0|||
146042920|NCT05111249|526671269|FG001|Overall Study|Lost to Follow-up|2|||
146042921|NCT05111249|526671268|FG000|Overall Study|Physician Decision|0|||
146042922|NCT05111249|526671269|FG001|Overall Study|Physician Decision|1|||
146042923|NCT05111249|526671268|FG000|Overall Study|Participant decision|1|||
146042924|NCT05111249|526671269|FG001|Overall Study|Participant decision|5|||
146042925|NCT03688074|526671272|FG000|Overall Study|Adverse Event|0|||
146042926|NCT03688074|526671273|FG001|Overall Study|Adverse Event|1|||
146042927|NCT03688074|526671272|FG000|Overall Study|Other|1|||
146042928|NCT03688074|526671273|FG001|Overall Study|Other|0|||
146042929|NCT03056339|526671274|FG000|Overall Study|Failed Requirements|0|||
146042930|NCT03056339|526671275|FG001|Overall Study|Failed Requirements|2|||
146042931|NCT03056339|526671276|FG002|Overall Study|Failed Requirements|7|||
146042932|NCT03056339|526671277|FG003|Overall Study|Failed Requirements|1|||
146042933|NCT01363908|526671280|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
146042934|NCT01363908|526671281|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
146042935|NCT01363908|526671280|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
146042936|NCT01363908|526671281|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
146300634|NCT04439071|527617066|FG000|Overall Study|Randomized but not treated|2|||
146042937|NCT01363908|526671280|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
146042938|NCT01363908|526671281|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
146042939|NCT01363908|526671280|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
146042940|NCT01363908|526671281|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
146042941|NCT02644343|526671282|FG000|Overall Study|Withdrawal by Subject|1|||
146042942|NCT03437577|526671283|FG000|Pre-Randomization|Withdrawal by Subject|0|||
146042943|NCT03437577|526671284|FG001|Pre-Randomization|Withdrawal by Subject|0|||
146042944|NCT03437577|526671285|FG002|Pre-Randomization|Withdrawal by Subject|10|||
146042945|NCT03437577|526671283|FG000|Post-Randomization|Physician Decision|0|||
146042946|NCT03437577|526671284|FG001|Post-Randomization|Physician Decision|2|||
146042947|NCT03437577|526671285|FG002|Post-Randomization|Physician Decision|0|||
146042948|NCT00536471|526671286|FG000|Overall Study|Lost to Follow-up|48|||
146042949|NCT00536471|526671287|FG001|Overall Study|Lost to Follow-up|23|||
146042950|NCT00536471|526671288|FG002|Overall Study|Lost to Follow-up|48|||
146042951|NCT00536471|526671289|FG003|Overall Study|Lost to Follow-up|22|||
146042952|NCT00536471|526671286|FG000|Overall Study|Adverse Event|32|||
146042953|NCT00536471|526671287|FG001|Overall Study|Adverse Event|16|||
146042954|NCT00536471|526671288|FG002|Overall Study|Adverse Event|28|||
146042955|NCT00536471|526671289|FG003|Overall Study|Adverse Event|13|||
146042956|NCT00536471|526671286|FG000|Overall Study|Withdrawal by Subject|40|||
146042957|NCT00536471|526671287|FG001|Overall Study|Withdrawal by Subject|24|||
146042958|NCT00536471|526671288|FG002|Overall Study|Withdrawal by Subject|43|||
146042959|NCT00536471|526671289|FG003|Overall Study|Withdrawal by Subject|21|||
146042960|NCT00536471|526671286|FG000|Overall Study|Lack of Efficacy|17|||
146101236|NCT01058655|526889917|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
146101237|NCT01058655|526889914|FG000|Overall Study|Death|0|||
146101238|NCT01058655|526889915|FG001|Overall Study|Death|1|||
146101239|NCT01058655|526889916|FG002|Overall Study|Death|1|||
146101240|NCT01058655|526889917|FG003|Overall Study|Death|0|||
146101241|NCT01058655|526889914|FG000|Overall Study|Disease Progression|1|||
146101242|NCT01058655|526889915|FG001|Overall Study|Disease Progression|2|||
146101243|NCT01058655|526889916|FG002|Overall Study|Disease Progression|4|||
146101244|NCT01058655|526889917|FG003|Overall Study|Disease Progression|24|||
146101245|NCT01058655|526889914|FG000|Overall Study|Other|0|||
146101246|NCT01058655|526889915|FG001|Overall Study|Other|0|||
146101247|NCT01058655|526889916|FG002|Overall Study|Other|0|||
146101248|NCT01058655|526889917|FG003|Overall Study|Other|4|||
146101249|NCT00619177|526889920|FG000|Overall Study|Adverse Event|18|||
146101250|NCT00619177|526889920|FG000|Overall Study|Lost to Follow-up|2|||
146101251|NCT00619177|526889920|FG000|Overall Study|Lack of Efficacy|1|||
146101252|NCT00619177|526889920|FG000|Overall Study|Missing termination information|481|||
146101253|NCT00619177|526889920|FG000|Overall Study|Not specified reasons|6|||
146101254|NCT02435147|526889922|FG000|Overall Study|non-evaluable DXA scan|11|||
146101255|NCT02939079|526889923|FG000|Overall Study|Adverse Event|2|||
146101256|NCT02939079|526889924|FG001|Overall Study|Adverse Event|1|||
146101257|NCT02939079|526889923|FG000|Overall Study|Lost to Follow-up|0|||
146101258|NCT02939079|526889924|FG001|Overall Study|Lost to Follow-up|2|||
146101259|NCT02939079|526889923|FG000|Overall Study|Protocol Violation|1|||
146101260|NCT02939079|526889924|FG001|Overall Study|Protocol Violation|0|||
146101261|NCT02939079|526889923|FG000|Overall Study|Withdrawal by Subject|0|||
146101262|NCT02939079|526889924|FG001|Overall Study|Withdrawal by Subject|1|||
146101263|NCT02939079|526889923|FG000|Overall Study|relapse during the study|1|||
146101264|NCT02939079|526889924|FG001|Overall Study|relapse during the study|1|||
146101265|NCT04093414|526889925|FG000|3 Month Follow up|Physician Decision|0|||
146101266|NCT04093414|526889926|FG001|3 Month Follow up|Physician Decision|1|||
146101267|NCT04093414|526889925|FG000|6month Follow up|Physician Decision|1|||
146101268|NCT04093414|526889926|FG001|6month Follow up|Physician Decision|3|||
146101269|NCT04889222|526889927|FG000|Overall Study|Did not meet eligibility criteria|8|||
146101270|NCT04889222|526889927|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
146101271|NCT04889222|526889927|FG000|Overall Study|Did not proceed due to time constraints|5|||
146101272|NCT01180647|526889928|FG000|Overall Study|Lost to Follow-up|5|||
146101273|NCT01180647|526889929|FG001|Overall Study|Lost to Follow-up|6|||
146101274|NCT03800173|526889941|FG000|Overall Study|Lost to Follow-up|0|||
146101275|NCT03800173|526889942|FG001|Overall Study|Lost to Follow-up|0|||
146254791|NCT00043186|527446682|FG007|Overall Study|Death|0|||
146042961|NCT00536471|526671287|FG001|Overall Study|Lack of Efficacy|18|||
146042962|NCT00536471|526671288|FG002|Overall Study|Lack of Efficacy|11|||
146042963|NCT00536471|526671289|FG003|Overall Study|Lack of Efficacy|9|||
146042964|NCT00536471|526671286|FG000|Overall Study|Protocol Violation|8|||
146101276|NCT03800173|526889943|FG002|Overall Study|Lost to Follow-up|0|||
146101277|NCT03800173|526889944|FG003|Overall Study|Lost to Follow-up|0|||
146101278|NCT03800173|526889945|FG004|Overall Study|Lost to Follow-up|1|||
146101279|NCT00338104|526889963|FG000|Overall Study|Protocol Violation|2|||
146101280|NCT00338104|526889964|FG001|Overall Study|Protocol Violation|1|||
146101281|NCT00338104|526889965|FG002|Overall Study|Protocol Violation|3|||
146101282|NCT00633750|526889966|FG000|Overall Study|Adverse Event|2|||
146101283|NCT00633750|526889966|FG000|Overall Study|Withdrawal by Subject|3|||
146101284|NCT02362269|526889969|FG000|Overall Study|Moved|1|||
146101285|NCT02362269|526889970|FG001|Overall Study|Moved|0|||
146254792|NCT00043186|527446683|FG008|Overall Study|Death|0|||
146254793|NCT00043186|527446675|FG000|Overall Study|Disease progression|1|||
146254794|NCT00043186|527446676|FG001|Overall Study|Disease progression|0|||
146254795|NCT00043186|527446677|FG002|Overall Study|Disease progression|0|||
146254796|NCT00043186|527446678|FG003|Overall Study|Disease progression|3|||
146254797|NCT00043186|527446679|FG004|Overall Study|Disease progression|0|||
146254798|NCT00043186|527446680|FG005|Overall Study|Disease progression|0|||
146254799|NCT00043186|527446681|FG006|Overall Study|Disease progression|0|||
146254800|NCT00043186|527446682|FG007|Overall Study|Disease progression|4|||
146254801|NCT00043186|527446683|FG008|Overall Study|Disease progression|0|||
146254802|NCT00043186|527446675|FG000|Overall Study|Ineligibility determined|0|||
146254803|NCT00043186|527446676|FG001|Overall Study|Ineligibility determined|0|||
146254804|NCT00043186|527446677|FG002|Overall Study|Ineligibility determined|0|||
146254805|NCT00043186|527446678|FG003|Overall Study|Ineligibility determined|0|||
146254806|NCT00043186|527446679|FG004|Overall Study|Ineligibility determined|0|||
146254807|NCT00043186|527446680|FG005|Overall Study|Ineligibility determined|0|||
146254808|NCT00043186|527446681|FG006|Overall Study|Ineligibility determined|0|||
146254809|NCT00043186|527446682|FG007|Overall Study|Ineligibility determined|0|||
146254810|NCT00043186|527446683|FG008|Overall Study|Ineligibility determined|1|||
146254811|NCT00043186|527446675|FG000|Overall Study|Lost to Follow-up|3|||
146254812|NCT00043186|527446676|FG001|Overall Study|Lost to Follow-up|5|||
146254813|NCT00043186|527446677|FG002|Overall Study|Lost to Follow-up|1|||
146254814|NCT00043186|527446678|FG003|Overall Study|Lost to Follow-up|1|||
146254815|NCT00043186|527446679|FG004|Overall Study|Lost to Follow-up|1|||
146254816|NCT00043186|527446680|FG005|Overall Study|Lost to Follow-up|1|||
146254817|NCT00043186|527446681|FG006|Overall Study|Lost to Follow-up|1|||
146254818|NCT00043186|527446682|FG007|Overall Study|Lost to Follow-up|1|||
146254819|NCT00043186|527446683|FG008|Overall Study|Lost to Follow-up|2|||
146254820|NCT00043186|527446675|FG000|Overall Study|Noncompliance|0|||
146254821|NCT00043186|527446676|FG001|Overall Study|Noncompliance|0|||
146254822|NCT00043186|527446677|FG002|Overall Study|Noncompliance|1|||
146254823|NCT00043186|527446678|FG003|Overall Study|Noncompliance|1|||
146254824|NCT00043186|527446679|FG004|Overall Study|Noncompliance|0|||
146254825|NCT00043186|527446680|FG005|Overall Study|Noncompliance|0|||
146254826|NCT00043186|527446681|FG006|Overall Study|Noncompliance|0|||
146254827|NCT00043186|527446682|FG007|Overall Study|Noncompliance|0|||
146254828|NCT00043186|527446683|FG008|Overall Study|Noncompliance|0|||
146254829|NCT00043186|527446675|FG000|Overall Study|Other|0|||
146254830|NCT00043186|527446676|FG001|Overall Study|Other|0|||
146254831|NCT00043186|527446677|FG002|Overall Study|Other|1|||
146254832|NCT00043186|527446678|FG003|Overall Study|Other|1|||
146254833|NCT00043186|527446679|FG004|Overall Study|Other|0|||
146254834|NCT00043186|527446680|FG005|Overall Study|Other|0|||
146042965|NCT00536471|526671287|FG001|Overall Study|Protocol Violation|1|||
146042966|NCT00536471|526671288|FG002|Overall Study|Protocol Violation|2|||
146042967|NCT00536471|526671289|FG003|Overall Study|Protocol Violation|3|||
146042968|NCT00536471|526671286|FG000|Overall Study|Physician Decision|11|||
146042969|NCT00536471|526671287|FG001|Overall Study|Physician Decision|1|||
146042970|NCT00536471|526671288|FG002|Overall Study|Physician Decision|3|||
146042971|NCT00536471|526671289|FG003|Overall Study|Physician Decision|2|||
146042972|NCT00536471|526671286|FG000|Overall Study|Death|0|||
146254835|NCT00043186|527446681|FG006|Overall Study|Other|0|||
146254836|NCT00043186|527446682|FG007|Overall Study|Other|0|||
146254837|NCT00043186|527446683|FG008|Overall Study|Other|0|||
146254838|NCT00958711|527446684|FG000|Overall Study|Withdrawal by Subject|0|||
146254839|NCT00958711|527446685|FG001|Overall Study|Withdrawal by Subject|4|||
146254840|NCT00958711|527446684|FG000|Overall Study|Physician Decision|5|||
146042973|NCT00536471|526671287|FG001|Overall Study|Death|0|||
146254841|NCT00958711|527446685|FG001|Overall Study|Physician Decision|7|||
146254842|NCT00958711|527446684|FG000|Overall Study|Lost to Follow-up|4|||
146254843|NCT00958711|527446685|FG001|Overall Study|Lost to Follow-up|1|||
146254844|NCT00958711|527446684|FG000|Overall Study|Other|2|||
146254845|NCT00958711|527446685|FG001|Overall Study|Other|5|||
146254846|NCT00958711|527446684|FG000|Overall Study|Death|1|||
146254847|NCT00958711|527446685|FG001|Overall Study|Death|2|||
146254848|NCT00958711|527446684|FG000|Overall Study|Adverse Event|1|||
146254849|NCT00958711|527446685|FG001|Overall Study|Adverse Event|2|||
146254850|NCT03722485|527446686|FG000|Overall Study|Withdrawal by Subject|1|||
146254851|NCT03722485|527446687|FG001|Overall Study|Withdrawal by Subject|0|||
146254852|NCT03722485|527446686|FG000|Overall Study|Adverse Event|0|||
146254853|NCT03722485|527446687|FG001|Overall Study|Adverse Event|2|||
146254854|NCT03722485|527446686|FG000|Overall Study|subject discharged prior to study completion|1|||
146254855|NCT03722485|527446687|FG001|Overall Study|subject discharged prior to study completion|5|||
146254856|NCT03722485|527446686|FG000|Overall Study|eligibility criteria not met|2|||
146254857|NCT03722485|527446687|FG001|Overall Study|eligibility criteria not met|0|||
146042974|NCT00536471|526671288|FG002|Overall Study|Death|1|||
146042975|NCT00536471|526671289|FG003|Overall Study|Death|2|||
146254858|NCT02151643|527446688|FG000|Overall Study|Adverse Event|2|||
146254859|NCT02151643|527446689|FG001|Overall Study|Adverse Event|0|||
146254860|NCT02151643|527446690|FG002|Overall Study|Adverse Event|1|||
146254861|NCT02151643|527446691|FG003|Overall Study|Adverse Event|4|||
146042976|NCT00536471|526671286|FG000|Overall Study|Sponsor Decision|0|||
146042977|NCT00536471|526671287|FG001|Overall Study|Sponsor Decision|1|||
146042978|NCT00536471|526671288|FG002|Overall Study|Sponsor Decision|3|||
146042979|NCT00536471|526671289|FG003|Overall Study|Sponsor Decision|2|||
146042980|NCT04273893|526671292|FG000|Overall Study|Withdrawal by Subject|0|||
146042981|NCT04273893|526671293|FG001|Overall Study|Withdrawal by Subject|2|||
146042982|NCT04273893|526671292|FG000|Overall Study|Treatment of Disease Progression|0|||
146042983|NCT04273893|526671293|FG001|Overall Study|Treatment of Disease Progression|2|||
146042984|NCT04273893|526671292|FG000|Overall Study|Death|1|||
146042985|NCT04273893|526671293|FG001|Overall Study|Death|2|||
146042986|NCT04273893|526671292|FG000|Overall Study|Lost to Follow-up|0|||
146042987|NCT04273893|526671293|FG001|Overall Study|Lost to Follow-up|2|||
146042988|NCT04273893|526671292|FG000|Overall Study|Physician Decision|1|||
146042989|NCT04273893|526671293|FG001|Overall Study|Physician Decision|0|||
146042990|NCT02783599|526671298|FG000|Overall Study|Progressive disease|23|||
146042991|NCT02783599|526671298|FG000|Overall Study|Surgical Resection|10|||
146042992|NCT02783599|526671298|FG000|Overall Study|Adverse Event|4|||
146042993|NCT02783599|526671298|FG000|Overall Study|Physician Decision|2|||
146042994|NCT02783599|526671298|FG000|Overall Study|Death|1|||
146042995|NCT00856544|526671305|FG000|Overall Study|Randomized but not treated|3|||
146042996|NCT00856544|526671306|FG001|Overall Study|Randomized but not treated|0|||
146042997|NCT00856544|526671307|FG002|Overall Study|Randomized but not treated|0|||
146042998|NCT00856544|526671308|FG003|Overall Study|Randomized but not treated|0|||
146042999|NCT00856544|526671305|FG000|Overall Study|Death|0|||
146043000|NCT00856544|526671306|FG001|Overall Study|Death|2|||
146043001|NCT00856544|526671307|FG002|Overall Study|Death|0|||
146043002|NCT00856544|526671308|FG003|Overall Study|Death|0|||
146043003|NCT00856544|526671305|FG000|Overall Study|Adverse Event|20|||
146043004|NCT00856544|526671306|FG001|Overall Study|Adverse Event|29|||
146043005|NCT00856544|526671307|FG002|Overall Study|Adverse Event|2|||
146043006|NCT00856544|526671308|FG003|Overall Study|Adverse Event|3|||
146043007|NCT00856544|526671305|FG000|Overall Study|Lack of Efficacy|16|||
146043008|NCT00856544|526671306|FG001|Overall Study|Lack of Efficacy|12|||
146043009|NCT00856544|526671307|FG002|Overall Study|Lack of Efficacy|3|||
146043010|NCT00856544|526671308|FG003|Overall Study|Lack of Efficacy|3|||
146043011|NCT00856544|526671305|FG000|Overall Study|Other|9|||
146043012|NCT00856544|526671306|FG001|Overall Study|Other|16|||
146043013|NCT00856544|526671307|FG002|Overall Study|Other|1|||
146043014|NCT00856544|526671308|FG003|Overall Study|Other|6|||
146043015|NCT00856544|526671305|FG000|Overall Study|Lost to Follow-up|1|||
146043016|NCT00856544|526671306|FG001|Overall Study|Lost to Follow-up|2|||
146043017|NCT00856544|526671307|FG002|Overall Study|Lost to Follow-up|2|||
146043018|NCT00856544|526671308|FG003|Overall Study|Lost to Follow-up|0|||
146043019|NCT00856544|526671305|FG000|Overall Study|Withdrawal by Subject|8|||
146043020|NCT00856544|526671306|FG001|Overall Study|Withdrawal by Subject|5|||
146043021|NCT00856544|526671307|FG002|Overall Study|Withdrawal by Subject|0|||
146043022|NCT00856544|526671308|FG003|Overall Study|Withdrawal by Subject|1|||
146043023|NCT01564732|526671309|FG000|Overall Study|Early termination by the study sponsor|6|||
146043024|NCT01564732|526671310|FG001|Overall Study|Early termination by the study sponsor|5|||
146043025|NCT01036321|526671313|FG000|Overall Study|Ineligible after randomization|0|||
146043026|NCT01036321|526671314|FG001|Overall Study|Ineligible after randomization|1|||
146043027|NCT01036321|526671313|FG000|Overall Study|Withdrawal by Subject|3|||
146043028|NCT01036321|526671314|FG001|Overall Study|Withdrawal by Subject|2|||
146043029|NCT01036321|526671313|FG000|Overall Study|Adverse Event|2|||
146043030|NCT01036321|526671314|FG001|Overall Study|Adverse Event|1|||
146043031|NCT00381693|526671317|FG000|Overall Study|Death|1|||
146043032|NCT00381693|526671317|FG000|Overall Study|Adverse Event|4|||
146043033|NCT00381693|526671317|FG000|Overall Study|Patient Choice|1|||
146043034|NCT00381693|526671317|FG000|Overall Study|Progression|2|||
146043035|NCT02003534|526671323|FG000|Overall Study|Lost to Follow-up|47|||
146043036|NCT03920254|526671325|FG000|Overall Study|Adverse Event|1|||
146043037|NCT03920254|526671326|FG001|Overall Study|Adverse Event|0|||
146043038|NCT03920254|526671327|FG002|Overall Study|Adverse Event|0|||
146043039|NCT03920254|526671325|FG000|Overall Study|Physician Decision|0|||
146043040|NCT03920254|526671326|FG001|Overall Study|Physician Decision|1|||
146043041|NCT03920254|526671327|FG002|Overall Study|Physician Decision|2|||
146043042|NCT03920254|526671325|FG000|Overall Study|Study Terminated By Sponsor|12|||
146043043|NCT03920254|526671326|FG001|Overall Study|Study Terminated By Sponsor|17|||
146043044|NCT03920254|526671327|FG002|Overall Study|Study Terminated By Sponsor|12|||
146043045|NCT03920254|526671325|FG000|Overall Study|Withdrawal by Subject|0|||
146043046|NCT03920254|526671326|FG001|Overall Study|Withdrawal by Subject|0|||
146043047|NCT03920254|526671327|FG002|Overall Study|Withdrawal by Subject|1|||
146043048|NCT03040674|526671328|FG000|Overall Study|Lost to Follow-up|225|||
146043049|NCT03040674|526671328|FG000|Overall Study|Death|23|||
146043050|NCT05173012|526671329|FG000|Overall Study|Adverse Event|2|||
146043051|NCT05173012|526671330|FG001|Overall Study|Adverse Event|3|||
146043052|NCT05173012|526671331|FG002|Overall Study|Adverse Event|4|||
146043053|NCT05173012|526671332|FG003|Overall Study|Adverse Event|13|||
146043054|NCT05173012|526671333|FG004|Overall Study|Adverse Event|0|||
146043055|NCT05173012|526671334|FG005|Overall Study|Adverse Event|0|||
146043056|NCT05173012|526671335|FG006|Overall Study|Adverse Event|2|||
146043057|NCT05173012|526671336|FG007|Overall Study|Adverse Event|4|||
146043058|NCT05173012|526671329|FG000|Overall Study|Lost to Follow-up|0|||
146043059|NCT05173012|526671330|FG001|Overall Study|Lost to Follow-up|0|||
146043060|NCT05173012|526671331|FG002|Overall Study|Lost to Follow-up|0|||
146043061|NCT05173012|526671332|FG003|Overall Study|Lost to Follow-up|1|||
146043062|NCT05173012|526671333|FG004|Overall Study|Lost to Follow-up|0|||
146043063|NCT05173012|526671334|FG005|Overall Study|Lost to Follow-up|0|||
146043064|NCT05173012|526671335|FG006|Overall Study|Lost to Follow-up|0|||
146043065|NCT05173012|526671336|FG007|Overall Study|Lost to Follow-up|0|||
146043066|NCT05173012|526671329|FG000|Overall Study|Withdrawal by Subject|1|||
146043067|NCT05173012|526671330|FG001|Overall Study|Withdrawal by Subject|0|||
146043068|NCT05173012|526671331|FG002|Overall Study|Withdrawal by Subject|1|||
146043069|NCT05173012|526671332|FG003|Overall Study|Withdrawal by Subject|3|||
146043070|NCT05173012|526671333|FG004|Overall Study|Withdrawal by Subject|1|||
146043071|NCT05173012|526671334|FG005|Overall Study|Withdrawal by Subject|0|||
146043072|NCT05173012|526671335|FG006|Overall Study|Withdrawal by Subject|1|||
146043073|NCT05173012|526671336|FG007|Overall Study|Withdrawal by Subject|0|||
146043074|NCT05173012|526671329|FG000|Overall Study|Protocol Deviation|0|||
146043075|NCT05173012|526671330|FG001|Overall Study|Protocol Deviation|0|||
146043076|NCT05173012|526671331|FG002|Overall Study|Protocol Deviation|0|||
146043077|NCT05173012|526671332|FG003|Overall Study|Protocol Deviation|1|||
146043078|NCT05173012|526671333|FG004|Overall Study|Protocol Deviation|0|||
146043079|NCT05173012|526671334|FG005|Overall Study|Protocol Deviation|0|||
146043080|NCT05173012|526671335|FG006|Overall Study|Protocol Deviation|0|||
146043081|NCT05173012|526671336|FG007|Overall Study|Protocol Deviation|0|||
146043082|NCT05173012|526671329|FG000|Overall Study|Other|0|||
146043083|NCT05173012|526671330|FG001|Overall Study|Other|0|||
146043084|NCT05173012|526671331|FG002|Overall Study|Other|0|||
146043085|NCT05173012|526671332|FG003|Overall Study|Other|2|||
146043086|NCT05173012|526671333|FG004|Overall Study|Other|0|||
146043087|NCT05173012|526671334|FG005|Overall Study|Other|0|||
146043088|NCT05173012|526671335|FG006|Overall Study|Other|0|||
146043089|NCT05173012|526671336|FG007|Overall Study|Other|0|||
146043090|NCT00517361|526671337|FG000|Overall Study|Death|6|||
146043091|NCT00517361|526671337|FG000|Overall Study|The study was terminated|5|||
146043092|NCT03517228|526671341|FG000|Overall Study|Withdrawal by Subject|2|||
146043093|NCT03517228|526671341|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
146043094|NCT03517228|526671341|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
146043095|NCT03517228|526671341|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
146043096|NCT03517228|526671341|FG000|Overall Study|Canceled due to device being updated|1|||
146043097|NCT03517228|526671341|FG000|Overall Study|No V Cares in stock|1|||
146043098|NCT03517228|526671341|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
146043099|NCT03781414|526671346|FG000|Overall Study|Study terminated by sponsor|39|||
146043100|NCT03781414|526671347|FG001|Overall Study|Study terminated by sponsor|34|||
146043101|NCT03781414|526671348|FG002|Overall Study|Study terminated by sponsor|25|||
146043102|NCT03781414|526671346|FG000|Overall Study|Adverse Event|3|||
146043103|NCT03781414|526671347|FG001|Overall Study|Adverse Event|6|||
146043104|NCT03781414|526671348|FG002|Overall Study|Adverse Event|3|||
146043105|NCT03781414|526671346|FG000|Overall Study|Physician Decision|2|||
146043106|NCT03781414|526671347|FG001|Overall Study|Physician Decision|0|||
146043107|NCT03781414|526671348|FG002|Overall Study|Physician Decision|1|||
146043108|NCT03781414|526671346|FG000|Overall Study|Withdrawal by Subject|2|||
146043109|NCT03781414|526671347|FG001|Overall Study|Withdrawal by Subject|3|||
146043110|NCT03781414|526671348|FG002|Overall Study|Withdrawal by Subject|3|||
146043111|NCT03781414|526671346|FG000|Overall Study|Death|1|||
146043112|NCT03781414|526671347|FG001|Overall Study|Death|4|||
146043113|NCT03781414|526671348|FG002|Overall Study|Death|0|||
146043114|NCT03781414|526671346|FG000|Overall Study|Lost to Follow-up|1|||
146043115|NCT03781414|526671347|FG001|Overall Study|Lost to Follow-up|1|||
146043116|NCT03781414|526671348|FG002|Overall Study|Lost to Follow-up|0|||
146254862|NCT02151643|527446692|FG004|Overall Study|Adverse Event|0|||
146254863|NCT02151643|527446688|FG000|Overall Study|Withdrawal by Subject|0|||
146043117|NCT04752358|526671351|FG000|Overall Study|Death|2|||
146043118|NCT04752358|526671352|FG001|Overall Study|Death|1|||
146043119|NCT00719355|526671353|FG000|Overall Study|Death|0|||
146043120|NCT00719355|526671354|FG001|Overall Study|Death|1|||
146043121|NCT00719355|526671353|FG000|Overall Study|Medical|14|||
146043122|NCT00719355|526671354|FG001|Overall Study|Medical|5|||
146043123|NCT00719355|526671353|FG000|Overall Study|Compliance|4|||
146043124|NCT00719355|526671354|FG001|Overall Study|Compliance|6|||
146254864|NCT02151643|527446689|FG001|Overall Study|Withdrawal by Subject|1|||
146043125|NCT00719355|526671353|FG000|Overall Study|Moved|0|||
146043126|NCT00719355|526671354|FG001|Overall Study|Moved|1|||
146043127|NCT01824355|526671355|FG000|Overall Study|Adverse Event|2|||
146043128|NCT01824355|526671355|FG000|Overall Study|unevaluable reference method results per|1|||
146043129|NCT00836186|526671359|FG000|Overall Study|Blood could not be drawn|1|||
146043130|NCT05232864|526671365|FG000|Overall Study|Adverse Event|0|||
146043131|NCT05232864|526671366|FG001|Overall Study|Adverse Event|1|||
146043132|NCT05232864|526671365|FG000|Overall Study|Study terminated by sponsor|16|||
146043133|NCT05232864|526671366|FG001|Overall Study|Study terminated by sponsor|14|||
146043134|NCT02023996|526671367|FG000|Overall Study|Protocol Violation|6|||
146043135|NCT01772576|526671368|FG000|Overall Study|Death|15|||
146043136|NCT01772576|526671368|FG000|Overall Study|Protocol Violation|1|||
146043137|NCT01772576|526671368|FG000|Overall Study|Lost to Follow-up|3|||
146043138|NCT01772576|526671368|FG000|Overall Study|Study device not used|3|||
146043139|NCT01772576|526671368|FG000|Overall Study|Adverse Event|6|||
146043140|NCT01772576|526671368|FG000|Overall Study|Withdrawal by Subject|6|||
146043141|NCT00379912|526671370|FG000|Overall Study|Lack of Efficacy|1|||
146043142|NCT00379912|526671371|FG001|Overall Study|Lack of Efficacy|0|||
146043143|NCT02578186|526671372|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
146043144|NCT02578186|526671373|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
146043145|NCT02578186|526671372|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
146043146|NCT02578186|526671373|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
146043147|NCT02873338|526671374|FG000|Overall Study|Adverse Event|0|||
146043148|NCT02873338|526671375|FG001|Overall Study|Adverse Event|2|||
146043149|NCT02873338|526671376|FG002|Overall Study|Adverse Event|1|||
146043150|NCT02873338|526671374|FG000|Overall Study|Death|2|||
146043151|NCT02873338|526671375|FG001|Overall Study|Death|1|||
146043152|NCT02873338|526671376|FG002|Overall Study|Death|1|||
146043153|NCT02873338|526671374|FG000|Overall Study|Withdrawal by Subject|2|||
146043154|NCT02873338|526671375|FG001|Overall Study|Withdrawal by Subject|1|||
146043155|NCT02873338|526671376|FG002|Overall Study|Withdrawal by Subject|3|||
146043156|NCT02873338|526671374|FG000|Overall Study|Lack of Efficacy|0|||
146043157|NCT02873338|526671375|FG001|Overall Study|Lack of Efficacy|2|||
146043158|NCT02873338|526671376|FG002|Overall Study|Lack of Efficacy|0|||
146043159|NCT02873338|526671374|FG000|Overall Study|Other or Missing|14|||
146043160|NCT02873338|526671375|FG001|Overall Study|Other or Missing|15|||
146043161|NCT02873338|526671376|FG002|Overall Study|Other or Missing|13|||
146043162|NCT02038075|526671377|FG000|Overall Study|Withdrawal by Subject|3|||
146043163|NCT02038075|526671378|FG001|Overall Study|Withdrawal by Subject|0|||
146043164|NCT04000581|526671379|FG000|Overall Study|Withdrawal by Subject|0|||
146043165|NCT04000581|526671380|FG001|Overall Study|Withdrawal by Subject|1|||
146043166|NCT03477838|526671381|FG000|Overall Study|Lost to Follow-up|14|||
146043167|NCT02519595|526671383|FG000|Overall Study|Protocol Violation|8|||
146043168|NCT02519595|526671384|FG001|Overall Study|Protocol Violation|22|||
146043169|NCT02519595|526671385|FG002|Overall Study|Protocol Violation|16|||
146043170|NCT00850538|526671386|FG000|Overall Study|unable/unwilling to complete MRI|13|||
146043171|NCT00850538|526671386|FG000|Overall Study|specimen missed due to scheduling error|14|||
146043172|NCT00850538|526671386|FG000|Overall Study|specimen unusable|7|||
146043173|NCT00850538|526671386|FG000|Overall Study|Withdrawal by Subject|3|||
146043174|NCT00850538|526671386|FG000|Overall Study|radiology error|2|||
146043175|NCT00850538|526671386|FG000|Overall Study|Protocol Violation|2|||
146043176|NCT03188510|526671394|FG000|Overall Study|Inappropriate behavior with site staff|0|||
146043177|NCT03188510|526671395|FG001|Overall Study|Inappropriate behavior with site staff|1|||
146043178|NCT03188510|526671396|FG002|Overall Study|Inappropriate behavior with site staff|0|||
146043179|NCT01088399|526671401|FG000|Overall Study|Adverse Event|211|||
146043180|NCT01088399|526671402|FG001|Overall Study|Adverse Event|16|||
146043181|NCT01088399|526671403|FG002|Overall Study|Adverse Event|0|||
146043182|NCT01088399|526671401|FG000|Overall Study|Death|204|||
146043183|NCT01088399|526671402|FG001|Overall Study|Death|45|||
146043184|NCT01088399|526671403|FG002|Overall Study|Death|0|||
146043185|NCT01088399|526671401|FG000|Overall Study|Lack of Efficacy|298|||
146043186|NCT01088399|526671402|FG001|Overall Study|Lack of Efficacy|7|||
146043187|NCT01088399|526671403|FG002|Overall Study|Lack of Efficacy|5|||
146043188|NCT01088399|526671401|FG000|Overall Study|Lost to Follow-up|1070|||
146043189|NCT01088399|526671402|FG001|Overall Study|Lost to Follow-up|278|||
146043190|NCT01088399|526671403|FG002|Overall Study|Lost to Follow-up|58|||
146043191|NCT01088399|526671401|FG000|Overall Study|Physician Decision|531|||
146043192|NCT01088399|526671402|FG001|Overall Study|Physician Decision|88|||
146043193|NCT01088399|526671403|FG002|Overall Study|Physician Decision|16|||
146043194|NCT01088399|526671401|FG000|Overall Study|Withdrawal by Subject|544|||
146043195|NCT01088399|526671402|FG001|Overall Study|Withdrawal by Subject|195|||
146043196|NCT01088399|526671403|FG002|Overall Study|Withdrawal by Subject|33|||
146043197|NCT01088399|526671401|FG000|Overall Study|Change to or start of somatropin therapy|234|||
146043198|NCT01088399|526671402|FG001|Overall Study|Change to or start of somatropin therapy|17|||
146043199|NCT01088399|526671403|FG002|Overall Study|Change to or start of somatropin therapy|12|||
146043200|NCT01088399|526671401|FG000|Overall Study|Sponsor decision|1573|||
146043201|NCT01088399|526671402|FG001|Overall Study|Sponsor decision|298|||
146043202|NCT01088399|526671403|FG002|Overall Study|Sponsor decision|7|||
146043203|NCT01088399|526671401|FG000|Overall Study|Protocol Violation|10|||
146043204|NCT01088399|526671402|FG001|Overall Study|Protocol Violation|1|||
146043205|NCT01088399|526671403|FG002|Overall Study|Protocol Violation|0|||
146043206|NCT01088399|526671401|FG000|Overall Study|Enrollment criteria not met|48|||
146043207|NCT01088399|526671402|FG001|Overall Study|Enrollment criteria not met|119|||
146043208|NCT01088399|526671403|FG002|Overall Study|Enrollment criteria not met|70|||
146043209|NCT01088399|526671401|FG000|Overall Study|Study summary visit not completed|2398|||
146043210|NCT01088399|526671402|FG001|Overall Study|Study summary visit not completed|283|||
146043211|NCT01088399|526671403|FG002|Overall Study|Study summary visit not completed|80|||
146043212|NCT00852241|526671404|FG000|Overall Study|Physician Decision|18|||
146043213|NCT00118430|526671407|FG000|Overall Study|Withdrawal by Subject|6|||
146043214|NCT00118430|526671408|FG001|Overall Study|Withdrawal by Subject|2|||
146043215|NCT00118430|526671409|FG002|Overall Study|Withdrawal by Subject|0|||
146043216|NCT00118430|526671407|FG000|Overall Study|Lost to Follow-up|15|||
146043217|NCT00118430|526671408|FG001|Overall Study|Lost to Follow-up|22|||
146043218|NCT00118430|526671409|FG002|Overall Study|Lost to Follow-up|28|||
146043219|NCT01504412|526672992|FG000|Overall Study|Adverse Event|1|||
146043220|NCT01504412|526672993|FG001|Overall Study|Adverse Event|8|||
146043221|NCT01504412|526672994|FG002|Overall Study|Adverse Event|1|||
146043222|NCT01504412|526672995|FG003|Overall Study|Adverse Event|7|||
146043223|NCT01504412|526672996|FG004|Overall Study|Adverse Event|10|||
146043224|NCT01504412|526672992|FG000|Overall Study|Withdrawal by Subject|2|||
146043225|NCT01504412|526672993|FG001|Overall Study|Withdrawal by Subject|1|||
146043226|NCT01504412|526672994|FG002|Overall Study|Withdrawal by Subject|1|||
146043227|NCT01504412|526672995|FG003|Overall Study|Withdrawal by Subject|5|||
146043228|NCT01504412|526672996|FG004|Overall Study|Withdrawal by Subject|1|||
146043229|NCT01504412|526672992|FG000|Overall Study|Other|2|||
146043230|NCT01504412|526672993|FG001|Overall Study|Other|1|||
146043231|NCT01504412|526672994|FG002|Overall Study|Other|1|||
146043232|NCT01504412|526672995|FG003|Overall Study|Other|6|||
146043233|NCT01504412|526672996|FG004|Overall Study|Other|1|||
146043234|NCT01504412|526672992|FG000|Overall Study|Lost to Follow-up|0|||
146043235|NCT01504412|526672993|FG001|Overall Study|Lost to Follow-up|2|||
146043236|NCT01504412|526672994|FG002|Overall Study|Lost to Follow-up|0|||
146043237|NCT01504412|526672995|FG003|Overall Study|Lost to Follow-up|0|||
146043238|NCT01504412|526672996|FG004|Overall Study|Lost to Follow-up|0|||
146043239|NCT01504412|526672992|FG000|Overall Study|Lack of Efficacy|0|||
146043240|NCT01504412|526672993|FG001|Overall Study|Lack of Efficacy|0|||
146043241|NCT01504412|526672994|FG002|Overall Study|Lack of Efficacy|1|||
146043242|NCT01504412|526672995|FG003|Overall Study|Lack of Efficacy|0|||
146043243|NCT01504412|526672996|FG004|Overall Study|Lack of Efficacy|1|||
146043244|NCT01504412|526672992|FG000|Overall Study|Death|0|||
146043245|NCT01504412|526672993|FG001|Overall Study|Death|0|||
146043246|NCT01504412|526672994|FG002|Overall Study|Death|0|||
146043247|NCT01504412|526672995|FG003|Overall Study|Death|1|||
146043248|NCT01504412|526672996|FG004|Overall Study|Death|0|||
146043249|NCT02598297|526673001|FG000|Overall Study|Study terminated by Sponsor|21|||
146043250|NCT02598297|526673002|FG001|Overall Study|Study terminated by Sponsor|23|||
146043251|NCT02598297|526673001|FG000|Overall Study|Adverse Event|1|||
146043252|NCT02598297|526673002|FG001|Overall Study|Adverse Event|1|||
146043253|NCT02598297|526673001|FG000|Overall Study|Physician Decision|1|||
146043254|NCT02598297|526673002|FG001|Overall Study|Physician Decision|0|||
146043255|NCT02598297|526673001|FG000|Overall Study|Subject/guardian decision|1|||
146043256|NCT02598297|526673002|FG001|Overall Study|Subject/guardian decision|0|||
146043257|NCT02598297|526673001|FG000|Overall Study|Followed for survival|1|||
146043258|NCT02598297|526673002|FG001|Overall Study|Followed for survival|0|||
146043259|NCT01934010|526673012|FG000|Overall Study|Adverse Event|1|||
146043260|NCT01934010|526673013|FG001|Overall Study|Adverse Event|1|||
146043261|NCT01934010|526673014|FG002|Overall Study|Adverse Event|0|||
146043262|NCT01934010|526673012|FG000|Overall Study|Withdrawal by Subject|15|||
146043263|NCT01934010|526673013|FG001|Overall Study|Withdrawal by Subject|6|||
146043264|NCT01934010|526673014|FG002|Overall Study|Withdrawal by Subject|2|||
146043265|NCT01934010|526673012|FG000|Overall Study|Lost to Follow-up|7|||
146043266|NCT01934010|526673013|FG001|Overall Study|Lost to Follow-up|4|||
146043267|NCT01934010|526673014|FG002|Overall Study|Lost to Follow-up|0|||
146043268|NCT01393821|526673015|FG000|Overall Study|Cancel|1|||
146043269|NCT01393821|526673016|FG001|Overall Study|Cancel|1|||
146043270|NCT01393821|526673015|FG000|Overall Study|not evaluable for primary endpoint|4|||
146043271|NCT01393821|526673016|FG001|Overall Study|not evaluable for primary endpoint|2|||
146043272|NCT00377858|526673027|FG000|Overall Study|Withdrawal by Subject|12|||
146043273|NCT00377858|526673028|FG001|Overall Study|Withdrawal by Subject|11|||
146043274|NCT00377858|526673027|FG000|Overall Study|Lost to Follow-up|6|||
146043275|NCT00377858|526673028|FG001|Overall Study|Lost to Follow-up|1|||
146043276|NCT00377858|526673027|FG000|Overall Study|Physician Decision|5|||
146043277|NCT00377858|526673028|FG001|Overall Study|Physician Decision|5|||
146101286|NCT02362269|526889969|FG000|Overall Study|Lost to Follow-up|0|||
146101287|NCT02362269|526889970|FG001|Overall Study|Lost to Follow-up|6|||
146101288|NCT01903031|526889971|FG000|Overall Study|Not Able to Attend Clinic|1|||
146043278|NCT00377858|526673027|FG000|Overall Study|Protocol Violation|3|||
146043279|NCT00377858|526673028|FG001|Overall Study|Protocol Violation|4|||
146043280|NCT00377858|526673027|FG000|Overall Study|Adverse Event|2|||
146043281|NCT00377858|526673028|FG001|Overall Study|Adverse Event|1|||
146043282|NCT00377858|526673027|FG000|Overall Study|Entry Criteria Not Met|2|||
146043283|NCT00377858|526673028|FG001|Overall Study|Entry Criteria Not Met|0|||
146101289|NCT01903031|526889972|FG001|Overall Study|Not Able to Attend Clinic|1|||
146101290|NCT01903031|526889973|FG002|Overall Study|Not Able to Attend Clinic|0|||
146300635|NCT04439071|527617067|FG001|Overall Study|Randomized but not treated|0|||
146300636|NCT01087957|527617074|FG000|Overall Study|Death|2|||
146300637|NCT01087957|527617075|FG001|Overall Study|Death|2|||
146043284|NCT00377858|526673027|FG000|Overall Study|Sponsor Decision|1|||
146043285|NCT00377858|526673028|FG001|Overall Study|Sponsor Decision|2|||
146043286|NCT00377858|526673027|FG000|Overall Study|Death|0|||
146043287|NCT00377858|526673028|FG001|Overall Study|Death|3|||
146043288|NCT03534141|526673029|FG000|Overall Study|Enrolled in other clinical trial|1|||
146043289|NCT03534141|526673030|FG001|Overall Study|Enrolled in other clinical trial|0|||
146043290|NCT03534141|526673029|FG000|Overall Study|Liver transplant aborted after randomization|0|||
146043291|NCT03534141|526673030|FG001|Overall Study|Liver transplant aborted after randomization|2|||
146043292|NCT03534141|526673029|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
146043293|NCT03534141|526673030|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
146043294|NCT04303572|526673031|FG000|Overall Study|Study closed due to poor enrollment|1|||
146043295|NCT06312592|526673032|FG000|Overall Study|Lost to Follow-up|29|||
146043296|NCT06312592|526673033|FG001|Overall Study|Lost to Follow-up|13|||
146043297|NCT03785405|526673036|FG000|Overall Study|Adverse Event|16|||
146043298|NCT03785405|526673037|FG001|Overall Study|Adverse Event|1|||
146043299|NCT03785405|526673036|FG000|Overall Study|Death|6|||
146043300|NCT03785405|526673037|FG001|Overall Study|Death|4|||
146043301|NCT03785405|526673036|FG000|Overall Study|Guardian decision|4|||
146043302|NCT03785405|526673037|FG001|Overall Study|Guardian decision|1|||
146043303|NCT03785405|526673036|FG000|Overall Study|Lost to Follow-up|1|||
146043304|NCT03785405|526673037|FG001|Overall Study|Lost to Follow-up|0|||
146043305|NCT03785405|526673036|FG000|Overall Study|Physician Decision|8|||
146043306|NCT03785405|526673037|FG001|Overall Study|Physician Decision|5|||
146043307|NCT03785405|526673036|FG000|Overall Study|Participant decision|2|||
146043308|NCT03785405|526673037|FG001|Overall Study|Participant decision|0|||
146043309|NCT03785405|526673036|FG000|Overall Study|Other|1|||
146043310|NCT03785405|526673037|FG001|Overall Study|Other|0|||
146043311|NCT03785405|526673036|FG000|Overall Study|No treatment was received|0|||
146043312|NCT03785405|526673037|FG001|Overall Study|No treatment was received|1|||
146043313|NCT01948063|526673038|FG000|Overall Study|Boston MCI halted research protocol|0|||
146043314|NCT01948063|526673039|FG001|Overall Study|Boston MCI halted research protocol|1|||
146043315|NCT01948063|526673038|FG000|Overall Study|Discovered an enrollment in other study|0|||
146043316|NCT01948063|526673039|FG001|Overall Study|Discovered an enrollment in other study|1|||
146043317|NCT01948063|526673038|FG000|Overall Study|Blood samples were accidentally thawed|1|||
146043318|NCT01948063|526673039|FG001|Overall Study|Blood samples were accidentally thawed|0|||
146043319|NCT00245037|526673044|FG000|Overall Study|Death|17|||
146043320|NCT00203424|526673050|FG000|Treatment Period|Withdrawal by Subject|4|||
146043321|NCT00203424|526673050|FG000|Treatment Period|Adverse Event|5|||
146043322|NCT00203424|526673050|FG000|Treatment Period|progressive disease|2|||
146043323|NCT00203424|526673050|FG000|Follow-up Period|Withdrawal by Subject|1|||
146043324|NCT00203424|526673050|FG000|Follow-up Period|progressive disease|4|||
146043325|NCT00203424|526673050|FG000|Follow-up Period|Lost to Follow-up|1|||
146043326|NCT00475709|526673051|FG000|Overall Study|Did not meet eligibility criteria|8|||
146043327|NCT00475709|526673051|FG000|Overall Study|Death|41|||
146043328|NCT00475709|526673051|FG000|Overall Study|Device Explant|6|||
146043329|NCT00475709|526673051|FG000|Overall Study|Lost to Follow-up|21|||
146043330|NCT00555672|526673052|FG000|Overall Study|Death|0|||
146043331|NCT00555672|526673053|FG001|Overall Study|Death|2|||
146043332|NCT00555672|526673052|FG000|Overall Study|Adverse Event|8|||
146043333|NCT00555672|526673053|FG001|Overall Study|Adverse Event|2|||
146043334|NCT00555672|526673052|FG000|Overall Study|Objective progression or relapse|11|||
146043335|NCT00555672|526673053|FG001|Overall Study|Objective progression or relapse|5|||
146043336|NCT00555672|526673052|FG000|Overall Study|Other|3|||
146043337|NCT00555672|526673053|FG001|Overall Study|Other|1|||
146101291|NCT01903031|526889971|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
146101292|NCT01903031|526889972|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
146101293|NCT01903031|526889973|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
146101294|NCT01903031|526889971|FG000|Overall Study|Adverse Event|0|||
146101295|NCT01903031|526889972|FG001|Overall Study|Adverse Event|1|||
146101296|NCT01903031|526889973|FG002|Overall Study|Adverse Event|0|||
146101297|NCT01903031|526889971|FG000|Overall Study|Withdrawal by Subject|0|||
146101298|NCT01903031|526889972|FG001|Overall Study|Withdrawal by Subject|1|||
146043338|NCT00555672|526673052|FG000|Overall Study|Participant refused|2|||
146043339|NCT00555672|526673053|FG001|Overall Study|Participant refused|0|||
146043340|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
146043341|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146043342|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146043343|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146101299|NCT01903031|526889973|FG002|Overall Study|Withdrawal by Subject|1|||
146101300|NCT01903031|526889971|FG000|Overall Study|Protocol Violation|0|||
146043344|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146043345|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
146043346|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
146043347|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146043348|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146043349|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146043350|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146043351|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
146043352|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
146043353|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146043354|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146043355|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146043356|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146043357|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
146043358|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
146043359|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
146043360|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
146043361|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
146043362|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
146043363|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
146043364|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
146043365|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
146043366|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
146043367|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
146043368|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
146043369|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
146043370|NCT01053988|526673054|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
146043371|NCT01053988|526673055|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146043372|NCT01053988|526673056|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146043373|NCT01053988|526673057|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146043374|NCT01053988|526673058|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146043375|NCT01053988|526673059|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
146043376|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146043377|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
146043378|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
146043379|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
146043380|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
146043381|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
146043382|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146043383|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146043384|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146043385|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
146043386|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
146043387|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
146043388|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
146043389|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
146043390|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
146043391|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
146043392|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
146043393|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
146043394|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146043395|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
146043396|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146043397|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146043398|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
146043399|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
146043400|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146043401|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
146043402|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
146043403|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
146254865|NCT02151643|527446690|FG002|Overall Study|Withdrawal by Subject|1|||
146254866|NCT02151643|527446691|FG003|Overall Study|Withdrawal by Subject|1|||
146254867|NCT02151643|527446692|FG004|Overall Study|Withdrawal by Subject|1|||
146043404|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146043405|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
146043406|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146043407|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
146043408|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146043409|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146043410|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146043411|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
146043412|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146043413|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
146043414|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
146043415|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
146043416|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
146043417|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
146043418|NCT01053988|526673054|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146043419|NCT01053988|526673055|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
146043420|NCT01053988|526673056|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146043421|NCT01053988|526673057|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
146043422|NCT01053988|526673058|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
146043423|NCT01053988|526673059|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146043424|NCT01922271|526673060|FG000|WASHOUT Period|Withdrawal by Subject|1|||
146043425|NCT01922271|526673061|FG001|WASHOUT Period|Withdrawal by Subject|0|||
146043426|NCT02123823|526673066|FG000|Overall Study|Lack of Efficacy|0|||
146043427|NCT02123823|526673067|FG001|Overall Study|Lack of Efficacy|2|||
146043428|NCT02123823|526673068|FG002|Overall Study|Lack of Efficacy|8|||
146043429|NCT02123823|526673069|FG003|Overall Study|Lack of Efficacy|10|||
146043430|NCT02123823|526673066|FG000|Overall Study|Progressive disease|3|||
146043431|NCT02123823|526673067|FG001|Overall Study|Progressive disease|19|||
146043432|NCT02123823|526673068|FG002|Overall Study|Progressive disease|52|||
146043433|NCT02123823|526673069|FG003|Overall Study|Progressive disease|53|||
146043434|NCT02123823|526673066|FG000|Overall Study|Withdrawal by Subject|0|||
146043435|NCT02123823|526673067|FG001|Overall Study|Withdrawal by Subject|0|||
146043436|NCT02123823|526673068|FG002|Overall Study|Withdrawal by Subject|7|||
146043437|NCT02123823|526673069|FG003|Overall Study|Withdrawal by Subject|2|||
146043438|NCT02123823|526673066|FG000|Overall Study|Adverse Event|0|||
146043439|NCT02123823|526673067|FG001|Overall Study|Adverse Event|0|||
146043440|NCT02123823|526673068|FG002|Overall Study|Adverse Event|3|||
146043441|NCT02123823|526673069|FG003|Overall Study|Adverse Event|5|||
146043442|NCT02104947|526673070|FG000|Overall Study|Withdrawal by Subject|10|||
146043443|NCT02104947|526673071|FG001|Overall Study|Withdrawal by Subject|3|||
146043444|NCT02104947|526673070|FG000|Overall Study|Lost to Follow-up|4|||
146043445|NCT02104947|526673071|FG001|Overall Study|Lost to Follow-up|4|||
146043446|NCT02104947|526673070|FG000|Overall Study|Protocol Violation|6|||
146043447|NCT02104947|526673071|FG001|Overall Study|Protocol Violation|8|||
146043448|NCT02104947|526673070|FG000|Overall Study|Adverse Event|57|||
146043449|NCT02104947|526673071|FG001|Overall Study|Adverse Event|38|||
146043450|NCT02104947|526673070|FG000|Overall Study|Other than stated above|2|||
146043451|NCT02104947|526673071|FG001|Overall Study|Other than stated above|3|||
146043452|NCT02106403|526673085|FG000|Follow-Up Visit 3|Other Reason|0|||
146043453|NCT02106403|526673086|FG001|Follow-Up Visit 3|Other Reason|0|||
146043454|NCT02106403|526673087|FG002|Follow-Up Visit 3|Other Reason|0|||
146043455|NCT02106403|526673088|FG003|Follow-Up Visit 3|Other Reason|0|||
146043456|NCT02106403|526673089|FG004|Follow-Up Visit 3|Other Reason|0|||
146043457|NCT02106403|526673090|FG005|Follow-Up Visit 3|Other Reason|1|||
146043458|NCT01128946|526673097|FG000|Period I|Protocol Violation|0|||
146043459|NCT01128946|526673098|FG001|Period I|Protocol Violation|1|||
146043460|NCT01128946|526673099|FG002|Period I|Protocol Violation|0|||
146043461|NCT01128946|526673100|FG003|Period I|Protocol Violation|0|||
146043462|NCT01128946|526673097|FG000|Period I|Withdrawal by Subject|0|||
146043463|NCT01128946|526673098|FG001|Period I|Withdrawal by Subject|0|||
146043464|NCT01128946|526673099|FG002|Period I|Withdrawal by Subject|1|||
146043465|NCT01128946|526673100|FG003|Period I|Withdrawal by Subject|1|||
146043466|NCT01128946|526673097|FG000|Period II|Protocol Violation|0|||
146043467|NCT01128946|526673098|FG001|Period II|Protocol Violation|1|||
146043468|NCT01128946|526673099|FG002|Period II|Protocol Violation|0|||
146043469|NCT01128946|526673100|FG003|Period II|Protocol Violation|0|||
146043470|NCT01128946|526673097|FG000|Period II|Withdrawal by Subject|0|||
146043471|NCT01128946|526673098|FG001|Period II|Withdrawal by Subject|0|||
146043472|NCT01128946|526673099|FG002|Period II|Withdrawal by Subject|0|||
146043473|NCT01128946|526673100|FG003|Period II|Withdrawal by Subject|1|||
146043474|NCT01128946|526673097|FG000|Period III|Protocol Violation|1|||
146043475|NCT01128946|526673098|FG001|Period III|Protocol Violation|0|||
146043476|NCT01128946|526673099|FG002|Period III|Protocol Violation|0|||
146043477|NCT01128946|526673100|FG003|Period III|Protocol Violation|0|||
146043478|NCT04698993|526673101|FG000|Overall Study|PCR results not accessible|2|||
146101301|NCT01903031|526889972|FG001|Overall Study|Protocol Violation|0|||
146101302|NCT01903031|526889973|FG002|Overall Study|Protocol Violation|2|||
146101303|NCT01903031|526889971|FG000|Overall Study|Lost to Follow-up|0|||
146101304|NCT01903031|526889972|FG001|Overall Study|Lost to Follow-up|0|||
146101305|NCT01903031|526889973|FG002|Overall Study|Lost to Follow-up|1|||
146101306|NCT01903031|526889971|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
146101307|NCT01903031|526889972|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
146101308|NCT01903031|526889973|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
146101309|NCT01811225|526889974|FG000|Treatment Period 1|Adverse Event|2|||
146101310|NCT01811225|526889975|FG001|Treatment Period 1|Adverse Event|3|||
146101311|NCT01811225|526889974|FG000|Treatment Period 1|Lost to Follow-up|12|||
146101312|NCT01811225|526889975|FG001|Treatment Period 1|Lost to Follow-up|8|||
146101313|NCT01811225|526889974|FG000|Treatment Period 1|transporation|1|||
146101314|NCT01811225|526889975|FG001|Treatment Period 1|transporation|0|||
146101315|NCT01811225|526889974|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
146101316|NCT01811225|526889975|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
146101317|NCT01811225|526889974|FG000|Treatment Period 2|Lost to Follow-up|1|||
146101318|NCT01811225|526889975|FG001|Treatment Period 2|Lost to Follow-up|2|||
146101319|NCT01811225|526889974|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
146101320|NCT01811225|526889975|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
146101321|NCT00287365|526889976|FG000|Overall Study|sample not acquired|13|||
146101322|NCT01187433|526889980|FG000|Overall Study|Protocol Violation|6|||
146101323|NCT01187433|526889981|FG001|Overall Study|Protocol Violation|2|||
146101324|NCT01187433|526889980|FG000|Overall Study|Withdrawal by Subject|5|||
146101325|NCT01187433|526889981|FG001|Overall Study|Withdrawal by Subject|2|||
146101326|NCT00302107|526889982|FG000|Overall Study|Lost to Follow-up|6|||
146101327|NCT00302107|526889983|FG001|Overall Study|Lost to Follow-up|5|||
146101328|NCT00302107|526889982|FG000|Overall Study|Protocol Violation|1|||
146101329|NCT00302107|526889983|FG001|Overall Study|Protocol Violation|0|||
146101330|NCT00302107|526889982|FG000|Overall Study|Relocation|0|||
146101331|NCT00302107|526889983|FG001|Overall Study|Relocation|1|||
146101332|NCT00302107|526889982|FG000|Overall Study|Withdrawal by Subject|0|||
146101333|NCT00302107|526889983|FG001|Overall Study|Withdrawal by Subject|3|||
146101334|NCT00302107|526889982|FG000|Overall Study|Adverse Event|1|||
146101335|NCT00302107|526889983|FG001|Overall Study|Adverse Event|0|||
146101336|NCT00437983|526889984|FG000|Overall Study|Adverse Event|6|||
146101337|NCT00437983|526889985|FG001|Overall Study|Adverse Event|6|||
146101338|NCT00437983|526889984|FG000|Overall Study|Protocol Violation|2|||
146101339|NCT00437983|526889985|FG001|Overall Study|Protocol Violation|1|||
146101340|NCT00437983|526889984|FG000|Overall Study|Withdrawal by Subject|5|||
146101341|NCT00437983|526889985|FG001|Overall Study|Withdrawal by Subject|6|||
146101342|NCT01790932|526889986|FG000|Overall Study|Disease Progression|41|||
146101343|NCT01790932|526889986|FG000|Overall Study|Adverse Event|7|||
146101344|NCT01790932|526889986|FG000|Overall Study|Physician Decision|1|||
146101345|NCT01790932|526889986|FG000|Overall Study|Withdrawal by Subject|1|||
146101346|NCT00594659|526889989|FG000|Overall Study|Lost to Follow-up|13|||
146101347|NCT00594659|526889990|FG001|Overall Study|Lost to Follow-up|9|||
146101348|NCT00594659|526889991|FG002|Overall Study|Lost to Follow-up|7|||
146101349|NCT00300274|526889992|FG000|Overall Study|Withdrawal by Subject|12|||
146101350|NCT00300274|526889993|FG001|Overall Study|Withdrawal by Subject|3|||
146101351|NCT00300274|526889994|FG002|Overall Study|Withdrawal by Subject|14|||
146101352|NCT00300274|526889992|FG000|Overall Study|Lost to Follow-up|3|||
146101353|NCT00300274|526889993|FG001|Overall Study|Lost to Follow-up|4|||
146101354|NCT00300274|526889994|FG002|Overall Study|Lost to Follow-up|5|||
146101355|NCT00300274|526889992|FG000|Overall Study|Death|31|||
146101356|NCT00300274|526889993|FG001|Overall Study|Death|20|||
146101357|NCT00300274|526889994|FG002|Overall Study|Death|25|||
146101358|NCT00300274|526889992|FG000|Overall Study|Re-transplant|0|||
146101359|NCT00300274|526889993|FG001|Overall Study|Re-transplant|0|||
146101360|NCT00300274|526889994|FG002|Overall Study|Re-transplant|1|||
146101361|NCT00242216|526889995|FG000|Overall Study|Lost to Follow-up|12|||
146101362|NCT00242216|526889996|FG001|Overall Study|Lost to Follow-up|17|||
146101363|NCT00242216|526889995|FG000|Overall Study|Death|4|||
146101364|NCT00242216|526889996|FG001|Overall Study|Death|2|||
146101365|NCT00242216|526889995|FG000|Overall Study|Lack of Efficacy|1|||
146101366|NCT00242216|526889996|FG001|Overall Study|Lack of Efficacy|2|||
146101367|NCT00242216|526889995|FG000|Overall Study|no medicaiton dispensed|1|||
146101368|NCT00242216|526889996|FG001|Overall Study|no medicaiton dispensed|1|||
146101369|NCT00678080|526889998|FG000|Overall Study|Physician Decision|2|||
146101370|NCT00678080|526889999|FG001|Overall Study|Physician Decision|0|||
146101371|NCT00678080|526889998|FG000|Overall Study|Lost to Follow-up|1|||
146101372|NCT00678080|526889999|FG001|Overall Study|Lost to Follow-up|0|||
146101373|NCT00678080|526889998|FG000|Overall Study|Withdrawal by Subject|0|||
146101374|NCT00678080|526889999|FG001|Overall Study|Withdrawal by Subject|1|||
146101375|NCT04439201|526890009|FG000|Overall Study|Ineligible|2|||
146101376|NCT04439201|526890009|FG000|Overall Study|Never start protocol therapy|1|||
146101377|NCT04439201|526890009|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
146101378|NCT04439201|526890009|FG000|Overall Study|Mutation status not confirmed|4|||
146043479|NCT04698993|526673102|FG001|Overall Study|PCR results not accessible|7|||
146043480|NCT04698993|526673101|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
146043481|NCT04698993|526673102|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
146254868|NCT02151643|527446688|FG000|Overall Study|Hyperphosphataemia|1|||
146254869|NCT02151643|527446689|FG001|Overall Study|Hyperphosphataemia|0|||
146254870|NCT02151643|527446690|FG002|Overall Study|Hyperphosphataemia|0|||
146254871|NCT02151643|527446691|FG003|Overall Study|Hyperphosphataemia|0|||
146254872|NCT02151643|527446692|FG004|Overall Study|Hyperphosphataemia|1|||
146254873|NCT02151643|527446688|FG000|Overall Study|High Ferritin levels|3|||
146254874|NCT02151643|527446689|FG001|Overall Study|High Ferritin levels|3|||
146254875|NCT02151643|527446690|FG002|Overall Study|High Ferritin levels|2|||
146254876|NCT02151643|527446691|FG003|Overall Study|High Ferritin levels|2|||
146254877|NCT02151643|527446692|FG004|Overall Study|High Ferritin levels|1|||
146254878|NCT00197106|527446695|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
146254879|NCT00197106|527446696|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
146254880|NCT00197106|527446697|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
146254881|NCT00197106|527446695|FG000|Overall Treatment Period|Lack of Efficacy|0|||
146254882|NCT00197106|527446696|FG001|Overall Treatment Period|Lack of Efficacy|1|||
146254883|NCT00197106|527446697|FG002|Overall Treatment Period|Lack of Efficacy|0|||
146254884|NCT00197106|527446695|FG000|Overall Treatment Period|Lost to Follow-up|0|||
146254885|NCT00197106|527446696|FG001|Overall Treatment Period|Lost to Follow-up|0|||
146254886|NCT00197106|527446697|FG002|Overall Treatment Period|Lost to Follow-up|2|||
146254887|NCT00197106|527446695|FG000|Overall Treatment Period|Protocol Violation|0|||
146254888|NCT00197106|527446696|FG001|Overall Treatment Period|Protocol Violation|0|||
146254889|NCT00197106|527446697|FG002|Overall Treatment Period|Protocol Violation|2|||
146254890|NCT00197106|527446695|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
146254891|NCT00197106|527446696|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
146254892|NCT00197106|527446697|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
146254893|NCT00755716|527446698|FG000|Overall Study|Adverse Event|1|||
146254894|NCT00755716|527446699|FG001|Overall Study|Adverse Event|4|||
146254895|NCT00755716|527446700|FG002|Overall Study|Adverse Event|1|||
146254896|NCT00755716|527446698|FG000|Overall Study|Lack of Efficacy|2|||
146254897|NCT00755716|527446699|FG001|Overall Study|Lack of Efficacy|0|||
146254898|NCT00755716|527446700|FG002|Overall Study|Lack of Efficacy|0|||
146254899|NCT00755716|527446698|FG000|Overall Study|Lost to Follow-up|5|||
146254900|NCT00755716|527446699|FG001|Overall Study|Lost to Follow-up|3|||
146254901|NCT00755716|527446700|FG002|Overall Study|Lost to Follow-up|1|||
146254902|NCT00755716|527446698|FG000|Overall Study|work schedule issues|0|||
146254903|NCT00755716|527446699|FG001|Overall Study|work schedule issues|1|||
146254904|NCT00755716|527446700|FG002|Overall Study|work schedule issues|1|||
146254905|NCT00726388|527446704|FG000|Overall Study|Withdrawal by Subject|5|||
146254906|NCT00726388|527446704|FG000|Overall Study|Adverse Event|3|||
146254907|NCT00726388|527446704|FG000|Overall Study|Lost to Follow-up|10|||
146254908|NCT00726388|527446704|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
146254909|NCT00726388|527446704|FG000|Overall Study|Other|5|||
146254910|NCT00726388|527446704|FG000|Overall Study|Enrolled, Not Treated|79|||
146254911|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
146254912|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
146254913|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
146254914|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
146254915|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
146254916|NCT00520403|527446705|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
146254917|NCT00520403|527446705|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
146254918|NCT00520403|527446705|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
146254919|NCT01145417|527446706|FG000|Overall Study|Death|1|||
146254920|NCT01145417|527446707|FG001|Overall Study|Death|0|||
146254921|NCT01145417|527446706|FG000|Overall Study|Lost to Follow-up|2|||
146254922|NCT01145417|527446707|FG001|Overall Study|Lost to Follow-up|1|||
146254923|NCT01145417|527446706|FG000|Overall Study|Withdrawal by Subject|1|||
146043482|NCT00145574|526673103|FG000|Double Blind|Adverse Event|0|||
146254924|NCT01145417|527446707|FG001|Overall Study|Withdrawal by Subject|2|||
146254925|NCT01145417|527446706|FG000|Overall Study|Pregnancy|1|||
146254926|NCT01145417|527446707|FG001|Overall Study|Pregnancy|0|||
146254927|NCT01145417|527446706|FG000|Overall Study|Adverse Event|0|||
146254928|NCT01145417|527446707|FG001|Overall Study|Adverse Event|1|||
146254929|NCT01145417|527446706|FG000|Overall Study|Study terminated by sponsor|35|||
146254930|NCT01145417|527446707|FG001|Overall Study|Study terminated by sponsor|43|||
146254931|NCT01145417|527446706|FG000|Overall Study|Other|1|||
146254932|NCT01145417|527446707|FG001|Overall Study|Other|0|||
146254933|NCT01797562|527446708|FG000|Overall Study|Protocol Violation|5|||
146254934|NCT00917462|527446711|FG000|Overall Study|Clinical Deterioration|1|||
146254935|NCT03341312|527446718|FG000|Period 1|Withdrawal by Subject|0|||
146254936|NCT03341312|527446719|FG001|Period 1|Withdrawal by Subject|1|||
146254937|NCT03341312|527446720|FG002|Period 1|Withdrawal by Subject|0|||
146254938|NCT03341312|527446721|FG003|Period 1|Withdrawal by Subject|0|||
146101379|NCT04439201|526890009|FG000|Overall Study|Adverse Event|1|||
146101380|NCT04439201|526890009|FG000|Overall Study|Death|7|||
146101381|NCT04439201|526890009|FG000|Overall Study|Withdrawal by Subject|2|||
146101382|NCT04439201|526890009|FG000|Overall Study|Disease progression|20|||
146101383|NCT04439201|526890009|FG000|Overall Study|Alternative therapy|1|||
146101384|NCT04439201|526890009|FG000|Overall Study|Physician Decision|1|||
146101385|NCT03320057|526891608|FG000|Overall Study|Lost to Follow-up|4|||
146101386|NCT03320057|526891609|FG001|Overall Study|Lost to Follow-up|17|||
146101387|NCT03320057|526891608|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
146101388|NCT03320057|526891609|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
146101389|NCT02323113|526891610|FG000|Overall Study|Adverse Event|3|||
146101390|NCT02323113|526891611|FG001|Overall Study|Adverse Event|3|||
146101391|NCT02323113|526891612|FG002|Overall Study|Adverse Event|2|||
146101392|NCT02323113|526891613|FG003|Overall Study|Adverse Event|5|||
146101393|NCT02323113|526891614|FG004|Overall Study|Adverse Event|8|||
146101394|NCT02323113|526891615|FG005|Overall Study|Adverse Event|3|||
146101395|NCT02323113|526891616|FG006|Overall Study|Adverse Event|6|||
146101396|NCT02323113|526891617|FG007|Overall Study|Adverse Event|0|||
146101397|NCT02323113|526891610|FG000|Overall Study|Progressive Disease|0|||
146101398|NCT02323113|526891611|FG001|Overall Study|Progressive Disease|1|||
146101399|NCT02323113|526891612|FG002|Overall Study|Progressive Disease|1|||
146101400|NCT02323113|526891613|FG003|Overall Study|Progressive Disease|0|||
146101401|NCT02323113|526891614|FG004|Overall Study|Progressive Disease|0|||
146101402|NCT02323113|526891615|FG005|Overall Study|Progressive Disease|3|||
146101403|NCT02323113|526891616|FG006|Overall Study|Progressive Disease|0|||
146101404|NCT02323113|526891617|FG007|Overall Study|Progressive Disease|0|||
146101405|NCT02323113|526891610|FG000|Overall Study|Symptomatic Deterioration|0|||
146101406|NCT02323113|526891611|FG001|Overall Study|Symptomatic Deterioration|0|||
146101407|NCT02323113|526891612|FG002|Overall Study|Symptomatic Deterioration|1|||
146101408|NCT02323113|526891613|FG003|Overall Study|Symptomatic Deterioration|0|||
146101409|NCT02323113|526891614|FG004|Overall Study|Symptomatic Deterioration|1|||
146101410|NCT02323113|526891615|FG005|Overall Study|Symptomatic Deterioration|0|||
146101411|NCT02323113|526891616|FG006|Overall Study|Symptomatic Deterioration|0|||
146101412|NCT02323113|526891617|FG007|Overall Study|Symptomatic Deterioration|0|||
146101413|NCT02323113|526891610|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
146101414|NCT02323113|526891611|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
146101415|NCT02323113|526891612|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146101416|NCT02323113|526891613|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
146101417|NCT02323113|526891614|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
146101418|NCT02323113|526891615|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
146101419|NCT02323113|526891616|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
146101420|NCT02323113|526891617|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
146101421|NCT02323113|526891610|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101422|NCT02323113|526891611|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
146101423|NCT02323113|526891612|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101424|NCT02323113|526891613|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101425|NCT02323113|526891614|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101426|NCT02323113|526891615|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101427|NCT02323113|526891616|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101428|NCT02323113|526891617|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
146101429|NCT00403234|526891618|FG000|Overall Study|Withdrawal by Subject|0|||
146101430|NCT00403234|526891619|FG001|Overall Study|Withdrawal by Subject|1|||
146101431|NCT00403234|526891620|FG002|Overall Study|Withdrawal by Subject|0|||
146101432|NCT00403234|526891621|FG003|Overall Study|Withdrawal by Subject|0|||
146101433|NCT00403234|526891618|FG000|Overall Study|Adverse Event|1|||
146101434|NCT00403234|526891619|FG001|Overall Study|Adverse Event|0|||
146101435|NCT00403234|526891620|FG002|Overall Study|Adverse Event|1|||
146101436|NCT00403234|526891621|FG003|Overall Study|Adverse Event|0|||
146101437|NCT00316719|526891622|FG000|Overall Study|Adverse Event|0|||
146101438|NCT00316719|526891623|FG001|Overall Study|Adverse Event|6|||
146101439|NCT00316719|526891622|FG000|Overall Study|Consent withdrawn|2|||
146101440|NCT00316719|526891623|FG001|Overall Study|Consent withdrawn|0|||
146101441|NCT02468674|526891626|FG000|Overall Study|Adverse Event|0|||
146101442|NCT02468674|526891627|FG001|Overall Study|Adverse Event|0|||
146101443|NCT02468674|526891628|FG002|Overall Study|Adverse Event|0|||
146101444|NCT02468674|526891629|FG003|Overall Study|Adverse Event|1|||
146101445|NCT02468674|526891630|FG004|Overall Study|Adverse Event|0|||
146101446|NCT02468674|526891631|FG005|Overall Study|Adverse Event|1|||
146101447|NCT02468674|526891632|FG006|Overall Study|Adverse Event|0|||
146101448|NCT02468674|526891633|FG007|Overall Study|Adverse Event|0|||
146101449|NCT02468674|526891634|FG008|Overall Study|Adverse Event|0|||
146101450|NCT02468674|526891626|FG000|Overall Study|Lost to Follow-up|1|||
146254939|NCT01631825|527446722|FG000|Overall Study|Adverse Event|42|||
146254940|NCT01631825|527446722|FG000|Overall Study|Lack of Efficacy|7|||
146254941|NCT01631825|527446722|FG000|Overall Study|Withdrawal by Subject|9|||
146254942|NCT01631825|527446722|FG000|Overall Study|Protocol Violation|4|||
146254943|NCT01631825|527446722|FG000|Overall Study|Discontinuation criteria|1|||
146254944|NCT01631825|527446722|FG000|Overall Study|Physician Decision|2|||
146254945|NCT03568708|527446724|FG000|Overall Study|Withdrawal by Subject|1|||
146254946|NCT03568708|527446725|FG001|Overall Study|Withdrawal by Subject|1|||
146254947|NCT03568708|527446724|FG000|Overall Study|Lost to Follow-up|0|||
146254948|NCT03568708|527446725|FG001|Overall Study|Lost to Follow-up|1|||
146254949|NCT00511147|527446726|FG000|Overall Study|Withdrawal by Subject|1|||
146043483|NCT00145574|526673104|FG001|Double Blind|Adverse Event|3|||
146043484|NCT00145574|526673105|FG002|Double Blind|Adverse Event|1|||
146043485|NCT00145574|526673103|FG000|Double Blind|Withdrawal by Subject|1|||
146043486|NCT00145574|526673104|FG001|Double Blind|Withdrawal by Subject|1|||
146043487|NCT00145574|526673105|FG002|Double Blind|Withdrawal by Subject|1|||
146043488|NCT00145574|526673103|FG000|Double Blind|required restricted medicine|0|||
146043489|NCT00145574|526673104|FG001|Double Blind|required restricted medicine|1|||
146043490|NCT00145574|526673105|FG002|Double Blind|required restricted medicine|0|||
146043491|NCT00145574|526673103|FG000|Open Label Long-term Extension|Adverse Event|0|||
146043492|NCT00145574|526673104|FG001|Open Label Long-term Extension|Adverse Event|0|||
146043493|NCT00145574|526673105|FG002|Open Label Long-term Extension|Adverse Event|5|||
146043494|NCT00145574|526673103|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
146043495|NCT00145574|526673104|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
146043496|NCT00145574|526673105|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
146043497|NCT00145574|526673103|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
146043498|NCT00145574|526673104|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
146043499|NCT00145574|526673105|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
146043500|NCT00145574|526673103|FG000|Open Label Long-term Extension|required restricted medicine|0|||
146043501|NCT00145574|526673104|FG001|Open Label Long-term Extension|required restricted medicine|0|||
146043502|NCT00145574|526673105|FG002|Open Label Long-term Extension|required restricted medicine|1|||
146043503|NCT00621140|526673106|FG000|Overall Study|Adverse Event|4|||
146043504|NCT00621140|526673107|FG001|Overall Study|Adverse Event|5|||
146043505|NCT00621140|526673106|FG000|Overall Study|Lost to Follow-up|1|||
146043506|NCT00621140|526673107|FG001|Overall Study|Lost to Follow-up|2|||
146043507|NCT00621140|526673106|FG000|Overall Study|Withdrawal by Subject|4|||
146043508|NCT00621140|526673107|FG001|Overall Study|Withdrawal by Subject|6|||
146043509|NCT00621140|526673106|FG000|Overall Study|Other incl. lack of efficacy|6|||
146043510|NCT00621140|526673107|FG001|Overall Study|Other incl. lack of efficacy|5|||
146043511|NCT00527904|526673108|FG000|Overall Study|Adverse Event|45|||
146043512|NCT00527904|526673108|FG000|Overall Study|Withdrawal by Subject|21|||
146043513|NCT00527904|526673108|FG000|Overall Study|Lost to Follow-up|8|||
146043514|NCT00527904|526673108|FG000|Overall Study|misc|22|||
146043515|NCT02669121|526673110|FG000|Overall Study|Adverse Event|4|||
146043516|NCT02669121|526673111|FG001|Overall Study|Adverse Event|5|||
146043517|NCT02669121|526673110|FG000|Overall Study|Lost to Follow-up|15|||
146043518|NCT02669121|526673111|FG001|Overall Study|Lost to Follow-up|27|||
146043519|NCT02669121|526673110|FG000|Overall Study|Withdrawal by Subject|132|||
146043520|NCT02669121|526673111|FG001|Overall Study|Withdrawal by Subject|140|||
146043521|NCT02669121|526673110|FG000|Overall Study|Pregnancy|0|||
146043522|NCT02669121|526673111|FG001|Overall Study|Pregnancy|1|||
146043523|NCT02669121|526673110|FG000|Overall Study|Discharged from US Military Active Service|117|||
146043524|NCT02669121|526673111|FG001|Overall Study|Discharged from US Military Active Service|91|||
146043525|NCT02669121|526673110|FG000|Overall Study|Reason not Specified|22|||
146043526|NCT02669121|526673111|FG001|Overall Study|Reason not Specified|18|||
146043527|NCT03216746|526673112|FG000|Overall Study|Lost to Follow-up|6|||
146043528|NCT03216746|526673113|FG001|Overall Study|Lost to Follow-up|8|||
146043529|NCT03216746|526673114|FG002|Overall Study|Lost to Follow-up|5|||
146043530|NCT03216746|526673115|FG003|Overall Study|Lost to Follow-up|6|||
146254950|NCT00511147|527446726|FG000|Overall Study|Disease progression|5|||
146254951|NCT00511147|527446726|FG000|Overall Study|Required platelet transfusion|1|||
146254952|NCT05372913|527446733|FG000|Overall Study|Withdrawal by Subject|0|||
146300638|NCT01087957|527617074|FG000|Overall Study|Lost to Follow-up|3|||
146043531|NCT04384523|526673116|FG000|Overall Study|Lost to Follow-up|0|||
146043532|NCT04384523|526673117|FG001|Overall Study|Lost to Follow-up|0|||
146043533|NCT04384523|526673118|FG002|Overall Study|Lost to Follow-up|0|||
146043534|NCT04384523|526673119|FG003|Overall Study|Lost to Follow-up|0|||
146043535|NCT04384523|526673120|FG004|Overall Study|Lost to Follow-up|0|||
146043536|NCT04384523|526673121|FG005|Overall Study|Lost to Follow-up|1|||
146043537|NCT04384523|526673116|FG000|Overall Study|Protocol Violation|0|||
146043538|NCT04384523|526673117|FG001|Overall Study|Protocol Violation|1|||
146043539|NCT04384523|526673118|FG002|Overall Study|Protocol Violation|0|||
146043540|NCT04384523|526673119|FG003|Overall Study|Protocol Violation|0|||
146254953|NCT05372913|527446734|FG001|Overall Study|Withdrawal by Subject|2|||
146254954|NCT05372913|527446733|FG000|Overall Study|Protocol Violation|2|||
146254955|NCT05372913|527446734|FG001|Overall Study|Protocol Violation|2|||
146101451|NCT02468674|526891627|FG001|Overall Study|Lost to Follow-up|0|||
146101452|NCT02468674|526891628|FG002|Overall Study|Lost to Follow-up|0|||
146101453|NCT02468674|526891629|FG003|Overall Study|Lost to Follow-up|0|||
146101454|NCT02468674|526891630|FG004|Overall Study|Lost to Follow-up|0|||
146101455|NCT02468674|526891631|FG005|Overall Study|Lost to Follow-up|0|||
146101456|NCT02468674|526891632|FG006|Overall Study|Lost to Follow-up|0|||
146101457|NCT02468674|526891633|FG007|Overall Study|Lost to Follow-up|1|||
146101458|NCT02468674|526891634|FG008|Overall Study|Lost to Follow-up|1|||
146101459|NCT02468674|526891626|FG000|Overall Study|Physician Decision|0|||
146101460|NCT02468674|526891627|FG001|Overall Study|Physician Decision|0|||
146101461|NCT02468674|526891628|FG002|Overall Study|Physician Decision|0|||
146101462|NCT02468674|526891629|FG003|Overall Study|Physician Decision|0|||
146101463|NCT02468674|526891630|FG004|Overall Study|Physician Decision|0|||
146101464|NCT02468674|526891631|FG005|Overall Study|Physician Decision|0|||
146101465|NCT02468674|526891632|FG006|Overall Study|Physician Decision|1|||
146101466|NCT02468674|526891633|FG007|Overall Study|Physician Decision|0|||
146101467|NCT02468674|526891634|FG008|Overall Study|Physician Decision|0|||
146101468|NCT02468674|526891626|FG000|Overall Study|Patient/Guardian Decision|0|||
146101469|NCT02468674|526891627|FG001|Overall Study|Patient/Guardian Decision|0|||
146101470|NCT02468674|526891628|FG002|Overall Study|Patient/Guardian Decision|0|||
146101471|NCT02468674|526891629|FG003|Overall Study|Patient/Guardian Decision|0|||
146101472|NCT02468674|526891630|FG004|Overall Study|Patient/Guardian Decision|1|||
146101473|NCT02468674|526891631|FG005|Overall Study|Patient/Guardian Decision|0|||
146101474|NCT02468674|526891632|FG006|Overall Study|Patient/Guardian Decision|0|||
146101475|NCT02468674|526891633|FG007|Overall Study|Patient/Guardian Decision|2|||
146101476|NCT02468674|526891634|FG008|Overall Study|Patient/Guardian Decision|1|||
146101477|NCT02468674|526891626|FG000|Overall Study|Protocol Deviation|0|||
146101478|NCT02468674|526891627|FG001|Overall Study|Protocol Deviation|0|||
146101479|NCT02468674|526891628|FG002|Overall Study|Protocol Deviation|0|||
146101480|NCT02468674|526891629|FG003|Overall Study|Protocol Deviation|0|||
146101481|NCT02468674|526891630|FG004|Overall Study|Protocol Deviation|0|||
146101482|NCT02468674|526891631|FG005|Overall Study|Protocol Deviation|0|||
146101483|NCT02468674|526891632|FG006|Overall Study|Protocol Deviation|0|||
146101484|NCT02468674|526891633|FG007|Overall Study|Protocol Deviation|1|||
146101485|NCT02468674|526891634|FG008|Overall Study|Protocol Deviation|1|||
146101486|NCT03281577|526891636|FG000|Overall Study|Adverse Event|0|||
146101487|NCT03281577|526891637|FG001|Overall Study|Adverse Event|0|||
146101488|NCT03281577|526891638|FG002|Overall Study|Adverse Event|0|||
146101489|NCT03281577|526891639|FG003|Overall Study|Adverse Event|1|||
146101490|NCT03281577|526891636|FG000|Overall Study|Withdrawal by Subject|1|||
146101491|NCT03281577|526891637|FG001|Overall Study|Withdrawal by Subject|0|||
146101492|NCT03281577|526891638|FG002|Overall Study|Withdrawal by Subject|0|||
146101493|NCT03281577|526891639|FG003|Overall Study|Withdrawal by Subject|0|||
146101494|NCT01550289|526891640|FG000|Overall Study|Protocol Violation|1|||
146101495|NCT01550289|526891641|FG001|Overall Study|Protocol Violation|0|||
146101496|NCT01550289|526891640|FG000|Overall Study|Lost to Follow-up|1|||
146101497|NCT01550289|526891641|FG001|Overall Study|Lost to Follow-up|1|||
146101498|NCT01550289|526891640|FG000|Overall Study|Withdrawal by Subject|11|||
146101499|NCT01550289|526891641|FG001|Overall Study|Withdrawal by Subject|3|||
146101500|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Adverse Event|16|||
146101501|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Adverse Event|17|||
146101502|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Adverse Event|13|||
146101503|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Adverse Event|18|||
146101504|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Adverse Event|0|||
146101505|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Adverse Event|0|||
146101506|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Adverse Event|0|||
146101507|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Adverse Event|0|||
146101508|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
146101509|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
146101510|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
146101511|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
146254956|NCT05372913|527446733|FG000|Overall Study|Adverse Event|0|||
146254957|NCT05372913|527446734|FG001|Overall Study|Adverse Event|1|||
146101512|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
146254958|NCT03275402|527446735|FG000|Overall Study|Death|17|||
146101513|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
146101514|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
146101515|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
146101516|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
146101517|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
146101518|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
146101519|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
146101520|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
146101521|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
146254959|NCT03275402|527446735|FG000|Overall Study|Study terminated by sponsor|21|||
146101522|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
146101523|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
146254960|NCT03275402|527446735|FG000|Overall Study|Withdrawal by Subject|1|||
146254961|NCT03193216|527446736|FG000|Overall Study|Lost to Follow-up|1|||
146254962|NCT03193216|527446737|FG001|Overall Study|Lost to Follow-up|0|||
146254963|NCT03193216|527446736|FG000|Overall Study|Withdrawal by Subject|5|||
146254964|NCT03193216|527446737|FG001|Overall Study|Withdrawal by Subject|0|||
146254965|NCT03193216|527446736|FG000|Overall Study|Physician Decision|4|||
146254966|NCT03193216|527446737|FG001|Overall Study|Physician Decision|0|||
146254967|NCT01514864|527446738|FG000|Overall Study|Disease progression|7|||
146254968|NCT01514864|527446739|FG001|Overall Study|Disease progression|5|||
146254969|NCT01514864|527446738|FG000|Overall Study|Study drug toxicity|2|||
146254970|NCT01514864|527446739|FG001|Overall Study|Study drug toxicity|0|||
146254971|NCT02986659|527446740|FG000|First Intervention Period|Adverse Event|3|||
146254972|NCT02986659|527446741|FG001|First Intervention Period|Adverse Event|1|||
146254973|NCT02986659|527446740|FG000|First Intervention Period|Lost to Follow-up|1|||
146254974|NCT02986659|527446741|FG001|First Intervention Period|Lost to Follow-up|0|||
146254975|NCT02986659|527446740|FG000|First Intervention Period|Withdrawal by Subject|0|||
146254976|NCT02986659|527446741|FG001|First Intervention Period|Withdrawal by Subject|1|||
146254977|NCT02986659|527446740|FG000|Second Intervention Period|Adverse Event|0|||
146254978|NCT02986659|527446741|FG001|Second Intervention Period|Adverse Event|6|||
146254979|NCT02254681|527446747|FG000|Overall Study|Lack of Efficacy|6|||
146254980|NCT02469077|527446748|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
146254981|NCT02469077|527446749|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
146254982|NCT02469077|527446748|FG000|Post Randomization/Intervention Period|Relocated|1|||
146254983|NCT02469077|527446749|FG001|Post Randomization/Intervention Period|Relocated|1|||
146254984|NCT02469077|527446748|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
146254985|NCT02469077|527446749|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
146254986|NCT02469077|527446748|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
146254987|NCT02469077|527446749|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
146254988|NCT01059526|527446750|FG000|Overall Study|Patient enrolled but not treated|20|||
146254989|NCT01059526|527446751|FG001|Overall Study|Patient enrolled but not treated|17|||
146254990|NCT01059526|527446750|FG000|Overall Study|Adverse Event|2|||
146254991|NCT01059526|527446751|FG001|Overall Study|Adverse Event|2|||
146254992|NCT01059526|527446750|FG000|Overall Study|Protocol Violation|0|||
146254993|NCT01059526|527446751|FG001|Overall Study|Protocol Violation|1|||
146254994|NCT01059526|527446750|FG000|Overall Study|Withdrawal by Subject|3|||
146254995|NCT01059526|527446751|FG001|Overall Study|Withdrawal by Subject|1|||
146254996|NCT01059526|527446750|FG000|Overall Study|Lost to Follow-up|4|||
146254997|NCT01059526|527446751|FG001|Overall Study|Lost to Follow-up|1|||
146254998|NCT01059526|527446750|FG000|Overall Study|Patient found to be dermatographic|1|||
146254999|NCT01059526|527446751|FG001|Overall Study|Patient found to be dermatographic|0|||
146255000|NCT01732588|527446752|FG000|First Intervention (7 Days)|Adverse Event|0|||
146255001|NCT01732588|527446753|FG001|First Intervention (7 Days)|Adverse Event|1|||
146255002|NCT01732588|527446754|FG002|First Intervention (7 Days)|Adverse Event|0|||
146255003|NCT02005029|527446755|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
146255004|NCT02005029|527446756|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
146255005|NCT02621047|527446757|FG000|Overall Study|Adverse Event|0|||
146255006|NCT02621047|527446758|FG001|Overall Study|Adverse Event|0|||
146255007|NCT02621047|527446759|FG002|Overall Study|Adverse Event|1|||
146255008|NCT01370018|527446760|FG000|Overall Study|Did not meet criteria for analysis|1|||
146255009|NCT01525641|527446763|FG000|Overall Study|Case report form not collected|25|||
146255010|NCT01525641|527446763|FG000|Overall Study|No visit since the first visit|16|||
146255011|NCT01525641|527446763|FG000|Overall Study|Adverse Event|73|||
146255012|NCT01525641|527446763|FG000|Overall Study|Lack of Efficacy|24|||
146255013|NCT01525641|527446763|FG000|Overall Study|Improvement|5|||
146043541|NCT04384523|526673120|FG004|Overall Study|Protocol Violation|0|||
146043542|NCT04384523|526673121|FG005|Overall Study|Protocol Violation|0|||
146255014|NCT01525641|527446763|FG000|Overall Study|Lost to follow-up (relocation)|1|||
146255015|NCT01525641|527446763|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
146255016|NCT01525641|527446763|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
146255017|NCT01525641|527446763|FG000|Overall Study|Other than stated above|7|||
146255018|NCT03772041|527446764|FG000|Overall Study|Adverse Event|8|||
146255019|NCT03772041|527446765|FG001|Overall Study|Adverse Event|3|||
146255020|NCT03772041|527446764|FG000|Overall Study|Withdrawal by Subject|0|||
146255021|NCT03772041|527446765|FG001|Overall Study|Withdrawal by Subject|2|||
146255022|NCT03772041|527446764|FG000|Overall Study|Protocol Violation|4|||
146255023|NCT03772041|527446765|FG001|Overall Study|Protocol Violation|2|||
146255024|NCT03772041|527446764|FG000|Overall Study|Physician Decision|2|||
146255025|NCT03772041|527446765|FG001|Overall Study|Physician Decision|3|||
146255026|NCT02204319|527446766|FG000|Overall Study|Pregnancy|1|||
146255027|NCT02204319|527446766|FG000|Overall Study|Withdrawal by Subject|2|||
146255028|NCT03544229|527446771|FG000|Overall Study|Adverse Event|1|||
146255029|NCT03544229|527446772|FG001|Overall Study|Adverse Event|0|||
146255030|NCT03544229|527446773|FG002|Overall Study|Adverse Event|1|||
146255031|NCT03544229|527446774|FG003|Overall Study|Adverse Event|0|||
146255032|NCT03544229|527446771|FG000|Overall Study|Protocol Deviation|0|||
146255033|NCT03544229|527446772|FG001|Overall Study|Protocol Deviation|0|||
146043543|NCT04384523|526673116|FG000|Overall Study|Withdrawal by Subject|1|||
146101524|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
146101525|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
146101526|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
146101527|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
146101528|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
146101529|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
146101530|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
146101531|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
146101532|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
146101533|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146101534|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
146101535|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
146101536|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146101537|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146101538|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146101539|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
146101540|NCT02975336|526891642|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
146101541|NCT02975336|526891643|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
146101542|NCT02975336|526891644|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
146101543|NCT02975336|526891645|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
146101544|NCT02975336|526891646|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
146101545|NCT02975336|526891647|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
146101546|NCT02975336|526891648|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
146101547|NCT02975336|526891649|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
146101548|NCT02975336|526891642|FG000|LTE (104 Weeks)|Adverse Event|0|||
146101549|NCT02975336|526891643|FG001|LTE (104 Weeks)|Adverse Event|0|||
146101550|NCT02975336|526891644|FG002|LTE (104 Weeks)|Adverse Event|0|||
146101551|NCT02975336|526891645|FG003|LTE (104 Weeks)|Adverse Event|0|||
146101552|NCT02975336|526891646|FG004|LTE (104 Weeks)|Adverse Event|7|||
146101553|NCT02975336|526891647|FG005|LTE (104 Weeks)|Adverse Event|4|||
146101554|NCT02975336|526891648|FG006|LTE (104 Weeks)|Adverse Event|2|||
146101555|NCT02975336|526891649|FG007|LTE (104 Weeks)|Adverse Event|0|||
146101556|NCT02975336|526891642|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
146101557|NCT02975336|526891643|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
146101558|NCT02975336|526891644|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
146101559|NCT02975336|526891645|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
146101560|NCT02975336|526891646|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
146101561|NCT02975336|526891647|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
146101562|NCT02975336|526891648|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
146101563|NCT02975336|526891649|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
146101564|NCT02975336|526891642|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
146101565|NCT02975336|526891643|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
146101566|NCT02975336|526891644|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
146101567|NCT02975336|526891645|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
146101568|NCT02975336|526891646|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
146101569|NCT02975336|526891647|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
146101570|NCT02975336|526891648|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
146101571|NCT02975336|526891649|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
146101572|NCT02975336|526891642|FG000|LTE (104 Weeks)|Other|0|||
146101573|NCT02975336|526891643|FG001|LTE (104 Weeks)|Other|0|||
146101574|NCT02975336|526891644|FG002|LTE (104 Weeks)|Other|0|||
146101575|NCT02975336|526891645|FG003|LTE (104 Weeks)|Other|0|||
146101576|NCT02975336|526891646|FG004|LTE (104 Weeks)|Other|55|||
146101577|NCT02975336|526891647|FG005|LTE (104 Weeks)|Other|63|||
146101578|NCT02975336|526891648|FG006|LTE (104 Weeks)|Other|76|||
146101579|NCT02975336|526891649|FG007|LTE (104 Weeks)|Other|72|||
146101580|NCT01897454|526891650|FG000|Overall Study|Withdrawal by Subject|1|||
146101581|NCT05154578|526891652|FG000|Overall Study|Withdrawal by Subject|2|||
146101582|NCT05154578|526891653|FG001|Overall Study|Withdrawal by Subject|3|||
146101583|NCT05154578|526891654|FG002|Overall Study|Withdrawal by Subject|2|||
146101584|NCT05154578|526891655|FG003|Overall Study|Withdrawal by Subject|4|||
146101585|NCT05154578|526891656|FG004|Overall Study|Withdrawal by Subject|0|||
146101586|NCT05154578|526891652|FG000|Overall Study|Lost to Follow-up|0|||
146101587|NCT05154578|526891653|FG001|Overall Study|Lost to Follow-up|1|||
146101588|NCT05154578|526891654|FG002|Overall Study|Lost to Follow-up|0|||
146101589|NCT05154578|526891655|FG003|Overall Study|Lost to Follow-up|3|||
146101590|NCT05154578|526891656|FG004|Overall Study|Lost to Follow-up|0|||
146101591|NCT05154578|526891652|FG000|Overall Study|Adverse Event|0|||
146101592|NCT05154578|526891653|FG001|Overall Study|Adverse Event|0|||
146101593|NCT05154578|526891654|FG002|Overall Study|Adverse Event|0|||
146101594|NCT05154578|526891655|FG003|Overall Study|Adverse Event|1|||
146101595|NCT05154578|526891656|FG004|Overall Study|Adverse Event|0|||
146101596|NCT05154578|526891652|FG000|Overall Study|Relocated to another province|0|||
146101597|NCT05154578|526891653|FG001|Overall Study|Relocated to another province|0|||
146101598|NCT05154578|526891654|FG002|Overall Study|Relocated to another province|1|||
146101599|NCT05154578|526891655|FG003|Overall Study|Relocated to another province|0|||
146101600|NCT05154578|526891656|FG004|Overall Study|Relocated to another province|1|||
146101601|NCT05154578|526891652|FG000|Overall Study|Baby loss|0|||
146101602|NCT05154578|526891653|FG001|Overall Study|Baby loss|1|||
146101603|NCT05154578|526891654|FG002|Overall Study|Baby loss|0|||
146101604|NCT05154578|526891655|FG003|Overall Study|Baby loss|0|||
146101605|NCT05154578|526891656|FG004|Overall Study|Baby loss|0|||
146101606|NCT00894166|526891664|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
146101607|NCT00894166|526891665|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
146101608|NCT00894166|526891666|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
146101609|NCT00894166|526891667|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
146101610|NCT00894166|526891668|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
146101611|NCT00894166|526891669|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
146101612|NCT00894166|526891670|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
146101613|NCT00894166|526891671|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
146101614|NCT00894166|526891664|FG000|Overall Study|Death|0|||
146101615|NCT00894166|526891665|FG001|Overall Study|Death|0|||
146101616|NCT00894166|526891666|FG002|Overall Study|Death|0|||
146101617|NCT00894166|526891667|FG003|Overall Study|Death|1|||
146101618|NCT00894166|526891668|FG004|Overall Study|Death|0|||
146101619|NCT00894166|526891669|FG005|Overall Study|Death|0|||
146101620|NCT00894166|526891670|FG006|Overall Study|Death|0|||
146101621|NCT00894166|526891671|FG007|Overall Study|Death|0|||
146101622|NCT05350410|526891672|FG000|Overall Study|Withdrawal by Subject|1|||
146101623|NCT04289623|526891676|FG000|Wave 1 Emails|Email was not delivered|268|||
146101624|NCT04289623|526891677|FG001|Wave 1 Emails|Email was not delivered|257|||
146101625|NCT04289623|526891678|FG002|Wave 1 Emails|Email was not delivered|0|||
146101626|NCT04289623|526891679|FG003|Wave 1 Emails|Email was not delivered|0|||
146101627|NCT04289623|526891680|FG004|Wave 1 Emails|Email was not delivered|0|||
146101628|NCT04289623|526891681|FG005|Wave 1 Emails|Email was not delivered|0|||
146101629|NCT04515394|526891686|FG000|Overall Study|Participant did not receive treatment|1|||
146101630|NCT00413244|526891687|FG000|Overall Study|Withdrawal by Subject|10|||
146101631|NCT00413244|526891688|FG001|Overall Study|Withdrawal by Subject|1|||
146101632|NCT01609231|526891690|FG000|Overall Study|Adverse Event|1|||
146101633|NCT01609231|526891691|FG001|Overall Study|Adverse Event|3|||
146101634|NCT01609231|526891690|FG000|Overall Study|Physician Decision|1|||
146101635|NCT01609231|526891691|FG001|Overall Study|Physician Decision|0|||
146101636|NCT01609231|526891690|FG000|Overall Study|Withdrawal by Subject|1|||
146101637|NCT01609231|526891691|FG001|Overall Study|Withdrawal by Subject|0|||
146101638|NCT02761733|526891693|FG000|Overall Study|Death|3|||
146101639|NCT02761733|526891694|FG001|Overall Study|Death|5|||
146101640|NCT02761733|526891695|FG002|Overall Study|Death|1|||
146101641|NCT02761733|526891696|FG003|Overall Study|Death|1|||
146101642|NCT02761733|526891693|FG000|Overall Study|Lost to Follow-up|6|||
146101643|NCT02761733|526891694|FG001|Overall Study|Lost to Follow-up|7|||
146101644|NCT02761733|526891695|FG002|Overall Study|Lost to Follow-up|0|||
146101645|NCT02761733|526891696|FG003|Overall Study|Lost to Follow-up|3|||
146101646|NCT02761733|526891693|FG000|Overall Study|Physician Decision|4|||
146101647|NCT02761733|526891694|FG001|Overall Study|Physician Decision|0|||
146101648|NCT02761733|526891695|FG002|Overall Study|Physician Decision|0|||
146101649|NCT02761733|526891696|FG003|Overall Study|Physician Decision|0|||
146101650|NCT02761733|526891693|FG000|Overall Study|Withdrawal by Subject|2|||
146101651|NCT02761733|526891694|FG001|Overall Study|Withdrawal by Subject|0|||
146101652|NCT02761733|526891695|FG002|Overall Study|Withdrawal by Subject|0|||
146101653|NCT02761733|526891696|FG003|Overall Study|Withdrawal by Subject|0|||
146101654|NCT02761733|526891693|FG000|Overall Study|Discharged from Study Site|10|||
146101655|NCT02761733|526891694|FG001|Overall Study|Discharged from Study Site|9|||
146101656|NCT02761733|526891695|FG002|Overall Study|Discharged from Study Site|25|||
146101657|NCT02761733|526891696|FG003|Overall Study|Discharged from Study Site|11|||
146101658|NCT02761733|526891693|FG000|Overall Study|Cognitive Impairment|5|||
146101659|NCT02761733|526891694|FG001|Overall Study|Cognitive Impairment|0|||
146101660|NCT02761733|526891695|FG002|Overall Study|Cognitive Impairment|1|||
146101661|NCT02761733|526891696|FG003|Overall Study|Cognitive Impairment|0|||
146101662|NCT02713204|526891697|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
146101663|NCT02713204|526891698|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101664|NCT02713204|526891699|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
146101665|NCT02713204|526891700|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101666|NCT02713204|526891701|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101667|NCT02713204|526891702|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101668|NCT02713204|526891703|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101669|NCT02713204|526891704|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
146101670|NCT02713204|526891697|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101671|NCT02713204|526891698|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101672|NCT02713204|526891699|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
146101673|NCT02713204|526891700|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101674|NCT02713204|526891701|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101675|NCT02713204|526891702|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101676|NCT02713204|526891703|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101677|NCT02713204|526891704|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146101678|NCT02713204|526891697|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101679|NCT02713204|526891698|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
146101680|NCT02713204|526891699|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101681|NCT02713204|526891700|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101682|NCT02713204|526891701|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101683|NCT02713204|526891702|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101684|NCT02713204|526891703|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101685|NCT02713204|526891704|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146101686|NCT02713204|526891697|FG000|From Week 12 up to Week 36|Adverse Event|1|||
146101687|NCT02713204|526891698|FG001|From Week 12 up to Week 36|Adverse Event|0|||
146101688|NCT02713204|526891699|FG002|From Week 12 up to Week 36|Adverse Event|0|||
146101689|NCT02713204|526891700|FG003|From Week 12 up to Week 36|Adverse Event|1|||
146101690|NCT02713204|526891701|FG004|From Week 12 up to Week 36|Adverse Event|1|||
146101691|NCT02713204|526891702|FG005|From Week 12 up to Week 36|Adverse Event|0|||
146101692|NCT02713204|526891703|FG006|From Week 12 up to Week 36|Adverse Event|2|||
146101693|NCT02713204|526891704|FG007|From Week 12 up to Week 36|Adverse Event|1|||
146101694|NCT02713204|526891697|FG000|From Week 12 up to Week 36|Death|0|||
146101695|NCT02713204|526891698|FG001|From Week 12 up to Week 36|Death|0|||
146101696|NCT02713204|526891699|FG002|From Week 12 up to Week 36|Death|0|||
146101697|NCT02713204|526891700|FG003|From Week 12 up to Week 36|Death|1|||
146101698|NCT02713204|526891701|FG004|From Week 12 up to Week 36|Death|0|||
146101699|NCT02713204|526891702|FG005|From Week 12 up to Week 36|Death|1|||
146101700|NCT02713204|526891703|FG006|From Week 12 up to Week 36|Death|0|||
146101701|NCT02713204|526891704|FG007|From Week 12 up to Week 36|Death|3|||
146101702|NCT02713204|526891697|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101703|NCT02713204|526891698|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101704|NCT02713204|526891699|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101705|NCT02713204|526891700|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
146101706|NCT02713204|526891701|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101707|NCT02713204|526891702|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101708|NCT02713204|526891703|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101709|NCT02713204|526891704|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
146101710|NCT02713204|526891697|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
146101711|NCT02713204|526891698|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
146101712|NCT02713204|526891699|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
146101713|NCT02713204|526891700|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
146101714|NCT02713204|526891701|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
146101715|NCT02713204|526891702|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
146101716|NCT02713204|526891703|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
146101717|NCT02713204|526891704|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
146101718|NCT00569270|526891708|FG000|Period: First Intervention|Protocol Violation|0|||
146043544|NCT04384523|526673117|FG001|Overall Study|Withdrawal by Subject|0|||
146043545|NCT04384523|526673118|FG002|Overall Study|Withdrawal by Subject|0|||
146043546|NCT04384523|526673119|FG003|Overall Study|Withdrawal by Subject|0|||
146043547|NCT04384523|526673120|FG004|Overall Study|Withdrawal by Subject|0|||
146043548|NCT04384523|526673121|FG005|Overall Study|Withdrawal by Subject|0|||
146043549|NCT00635882|526673122|FG000|Overall Study|Protocol Violation|1|||
146043550|NCT00635882|526673123|FG001|Overall Study|Protocol Violation|0|||
146043551|NCT00635882|526673124|FG002|Overall Study|Protocol Violation|0|||
146043552|NCT00635882|526673125|FG003|Overall Study|Protocol Violation|0|||
146043553|NCT00635882|526673126|FG004|Overall Study|Protocol Violation|0|||
146043554|NCT00635882|526673127|FG005|Overall Study|Protocol Violation|0|||
146043555|NCT02687581|526673128|FG000|Overall Study|Withdrawal by Subject|1|||
146043556|NCT02687581|526673129|FG001|Overall Study|Withdrawal by Subject|0|||
146043557|NCT02687581|526673130|FG002|Overall Study|Withdrawal by Subject|0|||
146043558|NCT02687581|526673131|FG003|Overall Study|Withdrawal by Subject|1|||
146043559|NCT02687581|526673128|FG000|Overall Study|Lost to Follow-up|2|||
146043560|NCT02687581|526673129|FG001|Overall Study|Lost to Follow-up|2|||
146043561|NCT02687581|526673130|FG002|Overall Study|Lost to Follow-up|0|||
146043562|NCT02687581|526673131|FG003|Overall Study|Lost to Follow-up|0|||
146043563|NCT02687581|526673128|FG000|Overall Study|the device is too small for the patient.|1|||
146043564|NCT02687581|526673129|FG001|Overall Study|the device is too small for the patient.|0|||
146101719|NCT00569270|526891709|FG001|Period: First Intervention|Protocol Violation|1|||
146101720|NCT00447005|526891710|FG000|Overall Study|Adverse Event|1|||
146101721|NCT00447005|526891710|FG000|Overall Study|Lack of Efficacy|11|||
146101722|NCT00492531|526891711|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
146101723|NCT00492531|526891712|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
146101724|NCT03685123|526891716|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
146101725|NCT03685123|526891717|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
146101726|NCT03685123|526891718|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
146043565|NCT02687581|526673130|FG002|Overall Study|the device is too small for the patient.|0|||
146043566|NCT02687581|526673131|FG003|Overall Study|the device is too small for the patient.|0|||
146043567|NCT00835341|526673132|FG000|Overall Study|Lost to Follow-up|3|||
146043568|NCT00835341|526673133|FG001|Overall Study|Lost to Follow-up|12|||
146043569|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
146043570|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
146043571|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
146043572|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043573|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043574|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043575|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043576|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043577|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
146043578|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Physician Decision|1|||
146043579|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Physician Decision|2|||
146043580|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Physician Decision|0|||
146043581|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Physician Decision|0|||
146043582|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Physician Decision|0|||
146043583|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Physician Decision|0|||
146043584|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Physician Decision|0|||
146043585|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Physician Decision|0|||
146043586|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Physician Decision|0|||
146043587|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
146043588|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
146043589|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
146043590|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
146043591|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
146043592|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
146043593|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
146043594|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
146043595|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
146043596|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
146043597|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043598|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043599|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043600|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043601|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043602|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043603|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043604|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
146043605|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
146043606|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
146043607|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043608|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043609|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043610|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043611|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043612|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043613|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
146043614|NCT04405076|526673135|FG000|Part A (Blinded Phase)|Other than Specified|0|||
146043615|NCT04405076|526673136|FG001|Part A (Blinded Phase)|Other than Specified|0|||
146043616|NCT04405076|526673137|FG002|Part A (Blinded Phase)|Other than Specified|3|||
146043617|NCT04405076|526673138|FG003|Part A (Blinded Phase)|Other than Specified|0|||
146043618|NCT04405076|526673139|FG004|Part A (Blinded Phase)|Other than Specified|0|||
146043619|NCT04405076|526673140|FG005|Part A (Blinded Phase)|Other than Specified|0|||
146043620|NCT04405076|526673141|FG006|Part A (Blinded Phase)|Other than Specified|0|||
146043621|NCT04405076|526673142|FG007|Part A (Blinded Phase)|Other than Specified|0|||
146043622|NCT04405076|526673143|FG008|Part A (Blinded Phase)|Other than Specified|0|||
146043623|NCT04405076|526673135|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043624|NCT04405076|526673136|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043625|NCT04405076|526673137|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043626|NCT04405076|526673138|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
146043627|NCT04405076|526673139|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
146043628|NCT04405076|526673140|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
146043629|NCT04405076|526673141|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043630|NCT04405076|526673142|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043631|NCT04405076|526673143|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
146043632|NCT04405076|526673135|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043633|NCT04405076|526673136|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043634|NCT04405076|526673137|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146101727|NCT03685123|526891716|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
146101728|NCT03685123|526891717|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
146101729|NCT03685123|526891718|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
146101730|NCT03685123|526891716|FG000|Weight Loss Phase|Lost to Follow-up|1|||
146101731|NCT03685123|526891717|FG001|Weight Loss Phase|Lost to Follow-up|0|||
146101732|NCT03685123|526891718|FG002|Weight Loss Phase|Lost to Follow-up|0|||
146101733|NCT03685123|526891716|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
146101734|NCT03685123|526891717|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
146101735|NCT03685123|526891718|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
146101736|NCT03685123|526891716|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
146101737|NCT03685123|526891717|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
146101738|NCT03685123|526891718|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
146101739|NCT03685123|526891716|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
146101740|NCT03685123|526891717|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
146101741|NCT03685123|526891718|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
146101742|NCT00400764|526891720|FG000|Phase Ib|Adverse Event|1|||
146101743|NCT00400764|526891721|FG001|Phase Ib|Adverse Event|0|||
146101744|NCT00400764|526891722|FG002|Phase Ib|Adverse Event|0|||
146101745|NCT00400764|526891723|FG003|Phase Ib|Adverse Event|0|||
146101746|NCT00400764|526891724|FG004|Phase Ib|Adverse Event|0|||
146101747|NCT00400764|526891720|FG000|Phase Ib|Death|1|||
146101748|NCT00400764|526891721|FG001|Phase Ib|Death|0|||
146101749|NCT00400764|526891722|FG002|Phase Ib|Death|0|||
146101750|NCT00400764|526891723|FG003|Phase Ib|Death|0|||
146101751|NCT00400764|526891724|FG004|Phase Ib|Death|0|||
146101752|NCT00400764|526891720|FG000|Phase Ib|Disease Progression|4|||
146101753|NCT00400764|526891721|FG001|Phase Ib|Disease Progression|4|||
146101754|NCT00400764|526891722|FG002|Phase Ib|Disease Progression|0|||
146101755|NCT00400764|526891723|FG003|Phase Ib|Disease Progression|0|||
146101756|NCT00400764|526891724|FG004|Phase Ib|Disease Progression|0|||
146101757|NCT00400764|526891720|FG000|Phase II|Death|0|||
146101758|NCT00400764|526891721|FG001|Phase II|Death|0|||
146101759|NCT00400764|526891722|FG002|Phase II|Death|1|||
146101760|NCT00400764|526891723|FG003|Phase II|Death|2|||
146101761|NCT00400764|526891724|FG004|Phase II|Death|0|||
146101762|NCT00400764|526891720|FG000|Phase II|Lost to Follow-up|0|||
146101763|NCT00400764|526891721|FG001|Phase II|Lost to Follow-up|0|||
146101764|NCT00400764|526891722|FG002|Phase II|Lost to Follow-up|1|||
146101765|NCT00400764|526891723|FG003|Phase II|Lost to Follow-up|0|||
146101766|NCT00400764|526891724|FG004|Phase II|Lost to Follow-up|0|||
146101767|NCT00400764|526891720|FG000|Phase II|Physician Decision|0|||
146101768|NCT00400764|526891721|FG001|Phase II|Physician Decision|0|||
146101769|NCT00400764|526891722|FG002|Phase II|Physician Decision|1|||
146101770|NCT00400764|526891723|FG003|Phase II|Physician Decision|1|||
146101771|NCT00400764|526891724|FG004|Phase II|Physician Decision|0|||
146101772|NCT00400764|526891720|FG000|Phase II|Sponsor's decision to terminate|0|||
146101773|NCT00400764|526891721|FG001|Phase II|Sponsor's decision to terminate|0|||
146101774|NCT00400764|526891722|FG002|Phase II|Sponsor's decision to terminate|18|||
146101775|NCT00400764|526891723|FG003|Phase II|Sponsor's decision to terminate|22|||
146255034|NCT03544229|527446773|FG002|Overall Study|Protocol Deviation|1|||
146255035|NCT03544229|527446774|FG003|Overall Study|Protocol Deviation|0|||
146255036|NCT03544229|527446771|FG000|Overall Study|Lost to Follow-up|3|||
146255037|NCT03544229|527446772|FG001|Overall Study|Lost to Follow-up|0|||
146255038|NCT03544229|527446773|FG002|Overall Study|Lost to Follow-up|0|||
146255039|NCT03544229|527446774|FG003|Overall Study|Lost to Follow-up|2|||
146255040|NCT03544229|527446771|FG000|Overall Study|Voluntary Withdrawal|2|||
146255041|NCT03544229|527446772|FG001|Overall Study|Voluntary Withdrawal|1|||
146255042|NCT03544229|527446773|FG002|Overall Study|Voluntary Withdrawal|3|||
146255043|NCT03544229|527446774|FG003|Overall Study|Voluntary Withdrawal|0|||
146255044|NCT03544229|527446771|FG000|Overall Study|Lack of Efficacy|0|||
146255045|NCT03544229|527446772|FG001|Overall Study|Lack of Efficacy|1|||
146255046|NCT03544229|527446773|FG002|Overall Study|Lack of Efficacy|0|||
146255047|NCT03544229|527446774|FG003|Overall Study|Lack of Efficacy|0|||
146255048|NCT05012397|527446776|FG000|Overall Study|Death|10|||
146255049|NCT05012397|527446776|FG000|Overall Study|Physician Decision|9|||
146255050|NCT05012397|527446776|FG000|Overall Study|Withdrawal by Subject|5|||
146255051|NCT05012397|527446776|FG000|Overall Study|Lost to Follow-up|2|||
146255052|NCT04748445|527446779|FG000|Overall Study|No longer met eligibility criteria|12|||
146255053|NCT04748445|527446779|FG000|Overall Study|Other|36|||
146101776|NCT00400764|526891724|FG004|Phase II|Sponsor's decision to terminate|11|||
146101777|NCT00400764|526891720|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
146101778|NCT00400764|526891721|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
146101779|NCT00400764|526891722|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
146101780|NCT00400764|526891723|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
146101781|NCT00400764|526891724|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
146101782|NCT00400764|526891720|FG000|Phase II|Withdrawal by Subject|0|||
146255054|NCT04748445|527446779|FG000|Overall Study|Withdrawal by Subject|553|||
146255055|NCT04748445|527446779|FG000|Overall Study|Lost to Follow-up|30|||
146255056|NCT00679549|527446782|FG000|Overall Study|dropout|2|||
146101783|NCT00400764|526891721|FG001|Phase II|Withdrawal by Subject|0|||
146043635|NCT04405076|526673138|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043636|NCT04405076|526673139|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
146043637|NCT04405076|526673140|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043638|NCT04405076|526673141|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043639|NCT04405076|526673142|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043640|NCT04405076|526673143|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
146043641|NCT04405076|526673135|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043642|NCT04405076|526673136|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043643|NCT04405076|526673137|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043644|NCT04405076|526673138|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
146043645|NCT04405076|526673139|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
146043646|NCT04405076|526673140|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
146043647|NCT04405076|526673141|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043648|NCT04405076|526673142|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043649|NCT04405076|526673143|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
146043650|NCT04405076|526673135|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043651|NCT04405076|526673136|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043652|NCT04405076|526673137|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043653|NCT04405076|526673138|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043654|NCT04405076|526673139|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043655|NCT04405076|526673140|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043656|NCT04405076|526673141|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
146043657|NCT04405076|526673142|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
146043658|NCT04405076|526673143|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
146043659|NCT04405076|526673135|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043660|NCT04405076|526673136|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043661|NCT04405076|526673137|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043662|NCT04405076|526673138|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043663|NCT04405076|526673139|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043664|NCT04405076|526673140|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043665|NCT04405076|526673141|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
146043666|NCT04405076|526673142|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043667|NCT04405076|526673143|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
146043668|NCT04310566|526673144|FG000|Period 1|Study Termination due to COVID-19|15|||
146043669|NCT04310566|526673145|FG001|Period 1|Study Termination due to COVID-19|17|||
146043670|NCT04310566|526673144|FG000|Period 1|Protocol Violation|0|||
146043671|NCT04310566|526673145|FG001|Period 1|Protocol Violation|1|||
146043672|NCT04310566|526673144|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
146043673|NCT04310566|526673145|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
146043674|NCT04310566|526673144|FG000|Period 1|Lost to Follow-up|1|||
146043675|NCT04310566|526673145|FG001|Period 1|Lost to Follow-up|0|||
146043676|NCT04310566|526673144|FG000|Period 1|Withdrawal by Subject|0|||
146043677|NCT04310566|526673145|FG001|Period 1|Withdrawal by Subject|1|||
146043678|NCT04310566|526673144|FG000|Period 2|Study Termination|7|||
146043679|NCT04310566|526673145|FG001|Period 2|Study Termination|5|||
146043680|NCT00384332|526673155|FG000|Overall Study|Lost to Follow-up|4|||
146043681|NCT00384332|526673156|FG001|Overall Study|Lost to Follow-up|0|||
146043682|NCT02560012|526673157|FG000|Overall Study|Study Terminated|2|||
146043683|NCT02218008|526673160|FG000|Stage 1 (S1)|Adverse Event|6|||
146043684|NCT02218008|526673161|FG001|Stage 1 (S1)|Adverse Event|5|||
146043685|NCT02218008|526673162|FG002|Stage 1 (S1)|Adverse Event|11|||
146043686|NCT02218008|526673163|FG003|Stage 1 (S1)|Adverse Event|0|||
146043687|NCT02218008|526673164|FG004|Stage 1 (S1)|Adverse Event|0|||
146043688|NCT02218008|526673165|FG005|Stage 1 (S1)|Adverse Event|0|||
146043689|NCT02218008|526673160|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
146043690|NCT02218008|526673161|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
146043691|NCT02218008|526673162|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
146043692|NCT02218008|526673163|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
146043693|NCT02218008|526673164|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
146043694|NCT02218008|526673165|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
146043695|NCT02218008|526673160|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
146043696|NCT02218008|526673161|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
146043697|NCT02218008|526673162|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
146043698|NCT02218008|526673163|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
146101784|NCT00400764|526891722|FG002|Phase II|Withdrawal by Subject|1|||
146101785|NCT00400764|526891723|FG003|Phase II|Withdrawal by Subject|1|||
146043699|NCT02218008|526673164|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
146043700|NCT02218008|526673165|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
146101786|NCT00400764|526891724|FG004|Phase II|Withdrawal by Subject|0|||
146101787|NCT00621959|526891728|FG000|Overall Study|Adverse Event|4|||
146255057|NCT00679549|527446783|FG001|Overall Study|dropout|4|||
146255058|NCT00679549|527446782|FG000|Overall Study|missing outcome echocardiograms|4|||
146255059|NCT00679549|527446783|FG001|Overall Study|missing outcome echocardiograms|5|||
146255060|NCT00139659|527446786|FG000|Overall Study|Adverse Event|12|||
146255061|NCT00139659|527446787|FG001|Overall Study|Adverse Event|1|||
146255062|NCT00139659|527446786|FG000|Overall Study|Lack of Efficacy|1|||
146255063|NCT00139659|527446787|FG001|Overall Study|Lack of Efficacy|1|||
146255064|NCT00139659|527446786|FG000|Overall Study|Lost to Follow-up|7|||
146255065|NCT00139659|527446787|FG001|Overall Study|Lost to Follow-up|3|||
146255066|NCT00139659|527446786|FG000|Overall Study|Reason not Specified|6|||
146255067|NCT00139659|527446787|FG001|Overall Study|Reason not Specified|3|||
146255068|NCT00139659|527446786|FG000|Overall Study|Withdrawal by Subject|14|||
146255069|NCT00139659|527446787|FG001|Overall Study|Withdrawal by Subject|10|||
146255070|NCT04089332|527446817|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
146255071|NCT04089332|527446817|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
146255072|NCT04089332|527446817|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
146255073|NCT06016127|527446822|FG000|Overall Study|Withdrawal by Subject|4|||
146255074|NCT06016127|527446823|FG001|Overall Study|Withdrawal by Subject|3|||
146255075|NCT00734851|527446826|FG000|Overall Study|Withdrawal by Subject|2|||
146255076|NCT00734851|527446826|FG000|Overall Study|Lost to Follow-up|1|||
146255077|NCT00734851|527446826|FG000|Overall Study|Physician Decision|18|||
146043701|NCT02218008|526673160|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
146043702|NCT02218008|526673161|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
146043703|NCT02218008|526673162|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
146043704|NCT02218008|526673163|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
146043705|NCT02218008|526673164|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
146043706|NCT02218008|526673165|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
146043707|NCT02218008|526673160|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
146043708|NCT02218008|526673161|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
146043709|NCT02218008|526673162|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146043710|NCT02218008|526673163|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146043711|NCT02218008|526673164|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146043712|NCT02218008|526673165|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
146043713|NCT02218008|526673160|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
146043714|NCT02218008|526673161|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
146043715|NCT02218008|526673162|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
146043716|NCT02218008|526673163|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
146043717|NCT02218008|526673164|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
146043718|NCT02218008|526673165|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
146043719|NCT02218008|526673160|FG000|Stage 1 (S1)|Pregnancy|0|||
146043720|NCT02218008|526673161|FG001|Stage 1 (S1)|Pregnancy|0|||
146043721|NCT02218008|526673162|FG002|Stage 1 (S1)|Pregnancy|1|||
146043722|NCT02218008|526673163|FG003|Stage 1 (S1)|Pregnancy|0|||
146043723|NCT02218008|526673164|FG004|Stage 1 (S1)|Pregnancy|0|||
146043724|NCT02218008|526673165|FG005|Stage 1 (S1)|Pregnancy|0|||
146043725|NCT02218008|526673160|FG000|Stage 1 (S1)|Protocol Violation|0|||
146043726|NCT02218008|526673161|FG001|Stage 1 (S1)|Protocol Violation|0|||
146043727|NCT02218008|526673162|FG002|Stage 1 (S1)|Protocol Violation|1|||
146043728|NCT02218008|526673163|FG003|Stage 1 (S1)|Protocol Violation|0|||
146043729|NCT02218008|526673164|FG004|Stage 1 (S1)|Protocol Violation|0|||
146043730|NCT02218008|526673165|FG005|Stage 1 (S1)|Protocol Violation|0|||
146043731|NCT02218008|526673160|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
146043732|NCT02218008|526673161|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146043733|NCT02218008|526673162|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146043734|NCT02218008|526673163|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146043735|NCT02218008|526673164|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146043736|NCT02218008|526673165|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
146043737|NCT02218008|526673160|FG000|Stage 2 (S2)|Adverse Event|0|||
146043738|NCT02218008|526673161|FG001|Stage 2 (S2)|Adverse Event|0|||
146043739|NCT02218008|526673162|FG002|Stage 2 (S2)|Adverse Event|0|||
146043740|NCT02218008|526673163|FG003|Stage 2 (S2)|Adverse Event|2|||
146043741|NCT02218008|526673164|FG004|Stage 2 (S2)|Adverse Event|3|||
146043742|NCT02218008|526673165|FG005|Stage 2 (S2)|Adverse Event|3|||
146043743|NCT02218008|526673160|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
146043744|NCT02218008|526673161|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
146043745|NCT02218008|526673162|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
146043746|NCT02218008|526673163|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
146043747|NCT02218008|526673164|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
146043748|NCT02218008|526673165|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
146043749|NCT02218008|526673160|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
146043750|NCT02218008|526673161|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
146043751|NCT02218008|526673162|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
146255078|NCT00170950|527446827|FG000|Overall Study|Death|236|||
146255079|NCT00170950|527446828|FG001|Overall Study|Death|274|||
146255080|NCT00170950|527446827|FG000|Overall Study|Withdrawal by Subject|496|||
146255081|NCT00170950|527446828|FG001|Overall Study|Withdrawal by Subject|498|||
146255082|NCT00170950|527446827|FG000|Overall Study|Lost to Follow-up|134|||
146255083|NCT00170950|527446828|FG001|Overall Study|Lost to Follow-up|115|||
146255084|NCT00170950|527446827|FG000|Overall Study|Missing|2|||
146255085|NCT00170950|527446828|FG001|Overall Study|Missing|1|||
146255086|NCT00170950|527446827|FG000|Overall Study|Termination Data Not Recorded|17|||
146255087|NCT00170950|527446828|FG001|Overall Study|Termination Data Not Recorded|22|||
146255088|NCT00381888|527448475|FG000|Overall Study|Death|1|||
146255089|NCT00381888|527448475|FG000|Overall Study|Withdrawal by Subject|1|||
146255090|NCT00381888|527448475|FG000|Overall Study|Physician Decision|1|||
146255091|NCT00381888|527448475|FG000|Overall Study|Protocol Violation|9|||
146255092|NCT00381888|527448475|FG000|Overall Study|Had laparoscopic surgery|2|||
146255093|NCT00381888|527448475|FG000|Overall Study|Surgery was cancelled|2|||
146255094|NCT00381888|527448475|FG000|Overall Study|Adverse Event|1|||
146255095|NCT01589523|527448478|FG000|Overall Study|Withdrawal by Subject|1|||
146255096|NCT00961896|527448479|FG000|Overall Study|Abnormal laboratory value|0|||
146255097|NCT00961896|527448480|FG001|Overall Study|Abnormal laboratory value|0|||
146255098|NCT00961896|527448481|FG002|Overall Study|Abnormal laboratory value|1|||
146255099|NCT00506922|527448482|FG000|Overall Study|Physician Decision|0|||
146255100|NCT00506922|527448483|FG001|Overall Study|Physician Decision|0|||
146255101|NCT00506922|527448484|FG002|Overall Study|Physician Decision|0|||
146255102|NCT00506922|527448485|FG003|Overall Study|Physician Decision|2|||
146255103|NCT00506922|527448486|FG004|Overall Study|Physician Decision|0|||
146255104|NCT00506922|527448482|FG000|Overall Study|Withdrawal by Subject|0|||
146255105|NCT00506922|527448483|FG001|Overall Study|Withdrawal by Subject|0|||
146255106|NCT00506922|527448484|FG002|Overall Study|Withdrawal by Subject|0|||
146255107|NCT00506922|527448485|FG003|Overall Study|Withdrawal by Subject|0|||
146255108|NCT00506922|527448486|FG004|Overall Study|Withdrawal by Subject|1|||
146255109|NCT00792259|527448487|FG000|Overall Study|Poor Quality Scans|1|||
146255110|NCT00792259|527448488|FG001|Overall Study|Poor Quality Scans|0|||
146255111|NCT00792259|527448489|FG002|Overall Study|Poor Quality Scans|0|||
146255112|NCT03721978|527448490|FG000|Overall Study|Withdrawal by Subject|6|||
146255113|NCT03721978|527448491|FG001|Overall Study|Withdrawal by Subject|1|||
146255114|NCT03721978|527448490|FG000|Overall Study|Adverse Event|1|||
146255115|NCT03721978|527448491|FG001|Overall Study|Adverse Event|1|||
146255116|NCT03721978|527448490|FG000|Overall Study|Progressive Disease|1|||
146255117|NCT03721978|527448491|FG001|Overall Study|Progressive Disease|0|||
146255118|NCT03721978|527448490|FG000|Overall Study|Lost to Follow-up|5|||
146255119|NCT03721978|527448491|FG001|Overall Study|Lost to Follow-up|1|||
146255120|NCT03721978|527448490|FG000|Overall Study|Reason not Specified|0|||
146255121|NCT03721978|527448491|FG001|Overall Study|Reason not Specified|2|||
146255122|NCT05244226|527448492|FG000|Overall Study|Adverse Event|1|||
146255123|NCT05244226|527448493|FG001|Overall Study|Adverse Event|0|||
146255124|NCT05244226|527448494|FG002|Overall Study|Adverse Event|0|||
146255125|NCT05244226|527448492|FG000|Overall Study|Lost to Follow-up|0|||
146255126|NCT05244226|527448493|FG001|Overall Study|Lost to Follow-up|0|||
146255127|NCT05244226|527448494|FG002|Overall Study|Lost to Follow-up|1|||
146255128|NCT05244226|527448492|FG000|Overall Study|Protocol Violation|0|||
146255129|NCT05244226|527448493|FG001|Overall Study|Protocol Violation|2|||
146255130|NCT05244226|527448494|FG002|Overall Study|Protocol Violation|2|||
146043752|NCT02218008|526673163|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
146043753|NCT02218008|526673164|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
146043754|NCT02218008|526673165|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
146043755|NCT02218008|526673160|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146043756|NCT02218008|526673161|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146043757|NCT02218008|526673162|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146043758|NCT02218008|526673163|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
146043759|NCT02218008|526673164|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146043760|NCT02218008|526673165|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
146043761|NCT02218008|526673160|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
146043762|NCT02218008|526673161|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
146043763|NCT02218008|526673162|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
146255131|NCT02507687|527448501|FG000|Overall Study|Adverse Event|3|||
146255132|NCT02507687|527448502|FG001|Overall Study|Adverse Event|2|||
146255133|NCT02507687|527448503|FG002|Overall Study|Adverse Event|2|||
146255134|NCT02507687|527448504|FG003|Overall Study|Adverse Event|2|||
146255135|NCT02507687|527448501|FG000|Overall Study|Withdrawal by Subject|1|||
146043764|NCT02218008|526673163|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
146255136|NCT02507687|527448502|FG001|Overall Study|Withdrawal by Subject|4|||
146255137|NCT02507687|527448503|FG002|Overall Study|Withdrawal by Subject|6|||
146255138|NCT02507687|527448504|FG003|Overall Study|Withdrawal by Subject|6|||
146255139|NCT02507687|527448501|FG000|Overall Study|Protocol Violation|1|||
146043765|NCT02218008|526673164|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
146043766|NCT02218008|526673165|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
146043767|NCT01278797|526673166|FG000|Period 1|Adverse Event|0|||
146255140|NCT02507687|527448502|FG001|Overall Study|Protocol Violation|0|||
146300639|NCT01087957|527617075|FG001|Overall Study|Lost to Follow-up|4|||
146255141|NCT02507687|527448503|FG002|Overall Study|Protocol Violation|2|||
146255142|NCT02507687|527448504|FG003|Overall Study|Protocol Violation|0|||
146255143|NCT02507687|527448501|FG000|Overall Study|Lost to Follow-up|0|||
146255144|NCT02507687|527448502|FG001|Overall Study|Lost to Follow-up|0|||
146255145|NCT02507687|527448503|FG002|Overall Study|Lost to Follow-up|2|||
146255146|NCT02507687|527448504|FG003|Overall Study|Lost to Follow-up|1|||
146255147|NCT02507687|527448501|FG000|Overall Study|Screen Failure|0|||
146255148|NCT02507687|527448502|FG001|Overall Study|Screen Failure|0|||
146255149|NCT02507687|527448503|FG002|Overall Study|Screen Failure|1|||
146255150|NCT02507687|527448504|FG003|Overall Study|Screen Failure|0|||
146255151|NCT02507687|527448501|FG000|Overall Study|Other, Not Specified|0|||
146043768|NCT01278797|526673167|FG001|Period 1|Adverse Event|1|||
146043769|NCT01278797|526673166|FG000|Period 1|Protocol Violation|1|||
146043770|NCT01278797|526673167|FG001|Period 1|Protocol Violation|0|||
146043771|NCT00620113|526673171|FG000|Overall Study|Adverse Event|3|||
146043772|NCT00620113|526673172|FG001|Overall Study|Adverse Event|2|||
146043773|NCT00620113|526673173|FG002|Overall Study|Adverse Event|2|||
146043774|NCT00620113|526673174|FG003|Overall Study|Adverse Event|1|||
146043775|NCT00620113|526673171|FG000|Overall Study|Lack of Efficacy|2|||
146043776|NCT00620113|526673172|FG001|Overall Study|Lack of Efficacy|3|||
146043777|NCT00620113|526673173|FG002|Overall Study|Lack of Efficacy|0|||
146043778|NCT00620113|526673174|FG003|Overall Study|Lack of Efficacy|2|||
146043779|NCT00620113|526673171|FG000|Overall Study|Physician Decision|1|||
146043780|NCT00620113|526673172|FG001|Overall Study|Physician Decision|0|||
146043781|NCT00620113|526673173|FG002|Overall Study|Physician Decision|0|||
146043782|NCT00620113|526673174|FG003|Overall Study|Physician Decision|2|||
146043783|NCT00620113|526673171|FG000|Overall Study|Protocol Violation|2|||
146043784|NCT00620113|526673172|FG001|Overall Study|Protocol Violation|1|||
146043785|NCT00620113|526673173|FG002|Overall Study|Protocol Violation|0|||
146043786|NCT00620113|526673174|FG003|Overall Study|Protocol Violation|0|||
146043787|NCT00620113|526673171|FG000|Overall Study|Withdrawal by Subject|5|||
146043788|NCT00620113|526673172|FG001|Overall Study|Withdrawal by Subject|1|||
146043789|NCT00620113|526673173|FG002|Overall Study|Withdrawal by Subject|3|||
146043790|NCT00620113|526673174|FG003|Overall Study|Withdrawal by Subject|5|||
146043791|NCT02476006|526673194|FG000|Overall Study|Death|4|||
146043792|NCT02476006|526673194|FG000|Overall Study|Lack of treatment efficacy|2|||
146043793|NCT02476006|526673194|FG000|Overall Study|Pregnancy|1|||
146043794|NCT02476006|526673194|FG000|Overall Study|Participant did not wish to continue|39|||
146043795|NCT02476006|526673194|FG000|Overall Study|Adverse Event|41|||
146043796|NCT02476006|526673194|FG000|Overall Study|Poor compliance to study protocol|3|||
146043797|NCT02476006|526673194|FG000|Overall Study|Sponsor decision|6|||
146043798|NCT02476006|526673194|FG000|Overall Study|Lost to Follow-up|5|||
146043799|NCT02476006|526673194|FG000|Overall Study|Physician Decision|5|||
146043800|NCT02476006|526673194|FG000|Overall Study|Study ended treatment not available|4|||
146043801|NCT02476006|526673194|FG000|Overall Study|Switched to commercial drug|4|||
146043802|NCT02476006|526673194|FG000|Overall Study|Excluded from study|1|||
146043803|NCT02476006|526673194|FG000|Overall Study|Protocol Violation|1|||
146043804|NCT02476006|526673194|FG000|Overall Study|Enrolled but not treated|4|||
146043805|NCT01698814|526675369|FG000|Overall Study|Adverse Event|0|||
146043806|NCT01698814|526675370|FG001|Overall Study|Adverse Event|2|||
146043807|NCT01698814|526675369|FG000|Overall Study|Lost to Follow-up|0|||
146043808|NCT01698814|526675370|FG001|Overall Study|Lost to Follow-up|1|||
146043809|NCT01698814|526675369|FG000|Overall Study|Pregnancy|1|||
146043810|NCT01698814|526675370|FG001|Overall Study|Pregnancy|0|||
146043811|NCT01698814|526675369|FG000|Overall Study|Randomized in error|1|||
146043812|NCT01698814|526675370|FG001|Overall Study|Randomized in error|0|||
146043813|NCT02813889|526675371|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
146043814|NCT02813889|526675372|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
146043815|NCT00368641|526675373|FG000|Overall Study|Adverse Event|2|||
146043816|NCT00368641|526675374|FG001|Overall Study|Adverse Event|1|||
146043817|NCT00368641|526675373|FG000|Overall Study|Death|1|||
146043818|NCT00368641|526675374|FG001|Overall Study|Death|0|||
146043819|NCT00368641|526675373|FG000|Overall Study|Withdrawal by Subject|1|||
146043820|NCT00368641|526675374|FG001|Overall Study|Withdrawal by Subject|0|||
146043821|NCT00368641|526675373|FG000|Overall Study|Sponsor decision to terminate study|2|||
146043822|NCT00368641|526675374|FG001|Overall Study|Sponsor decision to terminate study|5|||
146043823|NCT04014062|526675376|FG000|Period I: Dosing|Medical Grounds|4|||
146043824|NCT04014062|526675377|FG001|Period I: Dosing|Medical Grounds|5|||
146043825|NCT04014062|526675376|FG000|Period I: Dosing|Withdrawal by Subject|3|||
146043826|NCT04014062|526675377|FG001|Period I: Dosing|Withdrawal by Subject|1|||
146043827|NCT03038126|526675378|FG000|Overall Study|Death|1|||
146043828|NCT03038126|526675379|FG001|Overall Study|Death|1|||
146043829|NCT03038126|526675378|FG000|Overall Study|Withdrawal by Subject|5|||
146255152|NCT02507687|527448502|FG001|Overall Study|Other, Not Specified|0|||
146255153|NCT02507687|527448503|FG002|Overall Study|Other, Not Specified|2|||
146255154|NCT02507687|527448504|FG003|Overall Study|Other, Not Specified|4|||
146043830|NCT03038126|526675379|FG001|Overall Study|Withdrawal by Subject|0|||
146043831|NCT03038126|526675378|FG000|Overall Study|Lost to Follow-up|0|||
146043832|NCT03038126|526675379|FG001|Overall Study|Lost to Follow-up|1|||
146043833|NCT03038126|526675378|FG000|Overall Study|Long Term Hospitalization|2|||
146043834|NCT03038126|526675379|FG001|Overall Study|Long Term Hospitalization|0|||
146043835|NCT03038126|526675378|FG000|Overall Study|Too Ill to Participate|1|||
146043836|NCT03038126|526675379|FG001|Overall Study|Too Ill to Participate|2|||
146101788|NCT00621959|526891729|FG001|Overall Study|Adverse Event|2|||
146101789|NCT00621959|526891728|FG000|Overall Study|Lack of Efficacy|1|||
146101790|NCT00621959|526891729|FG001|Overall Study|Lack of Efficacy|1|||
146101791|NCT00621959|526891728|FG000|Overall Study|Lost to Follow-up|0|||
146101792|NCT00621959|526891729|FG001|Overall Study|Lost to Follow-up|2|||
146101793|NCT00621959|526891728|FG000|Overall Study|Withdrawal by Subject|1|||
146101794|NCT00621959|526891729|FG001|Overall Study|Withdrawal by Subject|1|||
146101795|NCT00621959|526891728|FG000|Overall Study|Other|1|||
146101796|NCT00621959|526891729|FG001|Overall Study|Other|3|||
146101797|NCT01758523|526891730|FG000|Overall Study|Adverse Event|2|||
146101798|NCT01758523|526891731|FG001|Overall Study|Adverse Event|1|||
146101799|NCT01758523|526891730|FG000|Overall Study|Lack of Efficacy|4|||
146043837|NCT02451917|526675380|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
146043838|NCT02451917|526675381|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
146043839|NCT02451917|526675380|FG000|First Intervention (24 Weeks)|Death|0|||
146043840|NCT02451917|526675381|FG001|First Intervention (24 Weeks)|Death|1|||
146043841|NCT02451917|526675380|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
146043842|NCT02451917|526675381|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
146043843|NCT01724866|526675382|FG000|Overall Study|Adverse Event|0|||
146043844|NCT01724866|526675383|FG001|Overall Study|Adverse Event|0|||
146043845|NCT01724866|526675384|FG002|Overall Study|Adverse Event|1|||
146043846|NCT01724866|526675385|FG003|Overall Study|Adverse Event|1|||
146043847|NCT01724866|526675382|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146043848|NCT01724866|526675383|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
146043849|NCT01724866|526675384|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146043850|NCT01724866|526675385|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
146043851|NCT01724866|526675382|FG000|Overall Study|Investigator's Discretion|0|||
146043852|NCT01724866|526675383|FG001|Overall Study|Investigator's Discretion|1|||
146043853|NCT01724866|526675384|FG002|Overall Study|Investigator's Discretion|1|||
146043854|NCT01724866|526675385|FG003|Overall Study|Investigator's Discretion|0|||
146043855|NCT01724866|526675382|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
146043856|NCT01724866|526675383|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146043857|NCT01724866|526675384|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146043858|NCT01724866|526675385|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
146043859|NCT01724866|526675382|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
146043860|NCT01724866|526675383|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
146043861|NCT01724866|526675384|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
146043862|NCT01724866|526675385|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
146043863|NCT00411671|526675388|FG000|Overall Study|Adverse Event|15|||
146043864|NCT00411671|526675388|FG000|Overall Study|Death|2|||
146043865|NCT00411671|526675388|FG000|Overall Study|Lost to Follow-up|3|||
146043866|NCT01424501|526675389|FG000|Overall Study|Withdrawal by Subject|1|||
146043867|NCT01424501|526675390|FG001|Overall Study|Withdrawal by Subject|0|||
146043868|NCT01424501|526675391|FG002|Overall Study|Withdrawal by Subject|1|||
146043869|NCT01424501|526675392|FG003|Overall Study|Withdrawal by Subject|0|||
146043870|NCT01424501|526675393|FG004|Overall Study|Withdrawal by Subject|0|||
146043871|NCT01424501|526675394|FG005|Overall Study|Withdrawal by Subject|0|||
146043872|NCT01424501|526675389|FG000|Overall Study|Lost to Follow-up|0|||
146043873|NCT01424501|526675390|FG001|Overall Study|Lost to Follow-up|1|||
146043874|NCT01424501|526675391|FG002|Overall Study|Lost to Follow-up|1|||
146043875|NCT01424501|526675392|FG003|Overall Study|Lost to Follow-up|0|||
146043876|NCT01424501|526675393|FG004|Overall Study|Lost to Follow-up|0|||
146043877|NCT01424501|526675394|FG005|Overall Study|Lost to Follow-up|0|||
146043878|NCT01980095|526675395|FG000|Overall Study|Lost to Follow-up|6|||
146043879|NCT01980095|526675396|FG001|Overall Study|Lost to Follow-up|7|||
146043880|NCT01980095|526675395|FG000|Overall Study|Withdrawal by Subject|2|||
146043881|NCT01980095|526675396|FG001|Overall Study|Withdrawal by Subject|3|||
146043882|NCT01980095|526675395|FG000|Overall Study|Poor compliance|5|||
146043883|NCT01980095|526675396|FG001|Overall Study|Poor compliance|0|||
146043884|NCT01980095|526675395|FG000|Overall Study|Safety issue|0|||
146043885|NCT01980095|526675396|FG001|Overall Study|Safety issue|1|||
146043886|NCT01980095|526675395|FG000|Overall Study|Study drug discontinued|1|||
146043887|NCT01980095|526675396|FG001|Overall Study|Study drug discontinued|0|||
146043888|NCT01980095|526675395|FG000|Overall Study|Randomized by mistake|1|||
146043889|NCT01980095|526675396|FG001|Overall Study|Randomized by mistake|0|||
146043890|NCT00546000|526675401|FG000|Overall Study|Adverse Event|1|||
146043891|NCT00546000|526675401|FG000|Overall Study|Lost to Follow-up|1|||
146101800|NCT01758523|526891731|FG001|Overall Study|Lack of Efficacy|2|||
146101801|NCT01758523|526891730|FG000|Overall Study|Lost to Follow-up|3|||
146101802|NCT01758523|526891731|FG001|Overall Study|Lost to Follow-up|4|||
146101803|NCT01758523|526891730|FG000|Overall Study|Withdrawal by Subject|12|||
146101804|NCT01758523|526891731|FG001|Overall Study|Withdrawal by Subject|7|||
146101805|NCT00722800|526891732|FG000|Overall Study|Withdrawal by Subject|1|||
146101806|NCT00722800|526891733|FG001|Overall Study|Withdrawal by Subject|0|||
146101807|NCT00722800|526891732|FG000|Overall Study|Physician Decision|1|||
146101808|NCT00722800|526891733|FG001|Overall Study|Physician Decision|0|||
146101809|NCT02130297|526891738|FG000|Overall Study|Lost to Follow-up|4|||
146101810|NCT01387789|526891739|FG000|Overall Study|Adverse Event|5|||
146101811|NCT01387789|526891739|FG000|Overall Study|Lack of Efficacy|2|||
146101812|NCT01387789|526891739|FG000|Overall Study|Lost to Follow-up|1|||
146101813|NCT00508755|526891743|FG000|Overall Study|Withdrawal by Subject|1|||
146101814|NCT00945893|526891744|FG000|Overall Study|Lost to Follow-up|2|||
146101815|NCT00945893|526891745|FG001|Overall Study|Lost to Follow-up|8|||
146101816|NCT00945893|526891744|FG000|Overall Study|Withdrawal of consent|1|||
146101817|NCT00945893|526891745|FG001|Overall Study|Withdrawal of consent|2|||
146101818|NCT03113071|526891746|FG000|Overall Study|Withdrawal by Subject|1|||
146101819|NCT03113071|526891747|FG001|Overall Study|Withdrawal by Subject|0|||
146101820|NCT01602120|526891748|FG000|Overall Study|Adverse Event|3|||
146101821|NCT01602120|526891749|FG001|Overall Study|Adverse Event|6|||
146101822|NCT01602120|526891750|FG002|Overall Study|Adverse Event|0|||
146101823|NCT01602120|526891751|FG003|Overall Study|Adverse Event|2|||
146101824|NCT01602120|526891748|FG000|Overall Study|Death|0|||
146101825|NCT01602120|526891749|FG001|Overall Study|Death|4|||
146101826|NCT01602120|526891750|FG002|Overall Study|Death|0|||
146101827|NCT01602120|526891751|FG003|Overall Study|Death|0|||
146101828|NCT01602120|526891748|FG000|Overall Study|Lost to Follow-up|0|||
146101829|NCT01602120|526891749|FG001|Overall Study|Lost to Follow-up|1|||
146101830|NCT01602120|526891750|FG002|Overall Study|Lost to Follow-up|0|||
146101831|NCT01602120|526891751|FG003|Overall Study|Lost to Follow-up|1|||
146101832|NCT01602120|526891748|FG000|Overall Study|Protocol Violation|1|||
146101833|NCT01602120|526891749|FG001|Overall Study|Protocol Violation|1|||
146101834|NCT01602120|526891750|FG002|Overall Study|Protocol Violation|0|||
146101835|NCT01602120|526891751|FG003|Overall Study|Protocol Violation|0|||
146101836|NCT01602120|526891748|FG000|Overall Study|Non-compliance|0|||
146101837|NCT01602120|526891749|FG001|Overall Study|Non-compliance|3|||
146101838|NCT01602120|526891750|FG002|Overall Study|Non-compliance|0|||
146101839|NCT01602120|526891751|FG003|Overall Study|Non-compliance|1|||
146101840|NCT01602120|526891748|FG000|Overall Study|Withdrawal by Subject|8|||
146101841|NCT01602120|526891749|FG001|Overall Study|Withdrawal by Subject|17|||
146101842|NCT01602120|526891750|FG002|Overall Study|Withdrawal by Subject|0|||
146101843|NCT01602120|526891751|FG003|Overall Study|Withdrawal by Subject|3|||
146101844|NCT01602120|526891748|FG000|Overall Study|Study Terminated by Sponsor|12|||
146101845|NCT01602120|526891749|FG001|Overall Study|Study Terminated by Sponsor|24|||
146101846|NCT01602120|526891750|FG002|Overall Study|Study Terminated by Sponsor|17|||
146101847|NCT01602120|526891751|FG003|Overall Study|Study Terminated by Sponsor|44|||
146101848|NCT01602120|526891748|FG000|Overall Study|Physician Decision|2|||
146101849|NCT01602120|526891749|FG001|Overall Study|Physician Decision|3|||
146101850|NCT01602120|526891750|FG002|Overall Study|Physician Decision|0|||
146101851|NCT01602120|526891751|FG003|Overall Study|Physician Decision|0|||
146101852|NCT01602120|526891748|FG000|Overall Study|Unspecified Reason|3|||
146101853|NCT01602120|526891749|FG001|Overall Study|Unspecified Reason|1|||
146101854|NCT01602120|526891750|FG002|Overall Study|Unspecified Reason|0|||
146101855|NCT01602120|526891751|FG003|Overall Study|Unspecified Reason|2|||
146101856|NCT04223973|526891763|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
146101857|NCT04223973|526891764|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
146101858|NCT04223973|526891763|FG000|Overall Study|Adverse Event|4|||
146101859|NCT04223973|526891764|FG001|Overall Study|Adverse Event|0|||
146101860|NCT04223973|526891763|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
146101861|NCT04223973|526891764|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
146101862|NCT04223973|526891763|FG000|Overall Study|Physician Decision|1|||
146101863|NCT04223973|526891764|FG001|Overall Study|Physician Decision|1|||
146101864|NCT04223973|526891763|FG000|Overall Study|Withdrawal by Subject|0|||
146101865|NCT04223973|526891764|FG001|Overall Study|Withdrawal by Subject|1|||
146101866|NCT05136690|526891770|FG000|Period 1|Withdrawal by Subject|0|||
146101867|NCT05136690|526891771|FG001|Period 1|Withdrawal by Subject|1|||
146101868|NCT05136690|526891770|FG000|Period 2|Lost to Follow-up|0|||
146101869|NCT05136690|526891771|FG001|Period 2|Lost to Follow-up|3|||
146101870|NCT05136690|526891770|FG000|Period 2|Withdrawal by Subject|0|||
146101871|NCT05136690|526891771|FG001|Period 2|Withdrawal by Subject|1|||
146101872|NCT00142935|526893293|FG000|Overall Study|Other reason|1|||
146101873|NCT00142935|526893294|FG001|Overall Study|Other reason|1|||
146101874|NCT00142935|526893295|FG002|Overall Study|Other reason|1|||
146101875|NCT00142935|526893293|FG000|Overall Study|Lost to Follow-up|2|||
146101876|NCT00142935|526893294|FG001|Overall Study|Lost to Follow-up|5|||
146101877|NCT00142935|526893295|FG002|Overall Study|Lost to Follow-up|5|||
146101878|NCT00142935|526893293|FG000|Overall Study|Death|0|||
146101879|NCT00142935|526893294|FG001|Overall Study|Death|2|||
146101880|NCT00142935|526893295|FG002|Overall Study|Death|1|||
146101881|NCT01180985|526893296|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
146101882|NCT01180985|526893297|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
146101883|NCT00705289|526893298|FG000|Overall Study|Subject or treating physician's choice|131|||
146101884|NCT01030536|526893299|FG000|Overall Study|Withdrawal by Subject|0|||
146101885|NCT01030536|526893300|FG001|Overall Study|Withdrawal by Subject|0|||
146101886|NCT01030536|526893301|FG002|Overall Study|Withdrawal by Subject|1|||
146101887|NCT01030536|526893302|FG003|Overall Study|Withdrawal by Subject|0|||
146101888|NCT01030536|526893303|FG004|Overall Study|Withdrawal by Subject|0|||
146101889|NCT01030536|526893299|FG000|Overall Study|undefined|1|||
146101890|NCT01030536|526893300|FG001|Overall Study|undefined|0|||
146101891|NCT01030536|526893301|FG002|Overall Study|undefined|1|||
146101892|NCT01030536|526893302|FG003|Overall Study|undefined|1|||
146101893|NCT01030536|526893303|FG004|Overall Study|undefined|0|||
146101894|NCT01030536|526893299|FG000|Overall Study|Adverse Event|0|||
146101895|NCT01030536|526893300|FG001|Overall Study|Adverse Event|3|||
146101896|NCT01030536|526893301|FG002|Overall Study|Adverse Event|1|||
146101897|NCT01030536|526893302|FG003|Overall Study|Adverse Event|0|||
146101898|NCT01030536|526893303|FG004|Overall Study|Adverse Event|1|||
146101899|NCT01030536|526893299|FG000|Overall Study|Progressive disease|6|||
146101900|NCT01030536|526893300|FG001|Overall Study|Progressive disease|2|||
146101901|NCT01030536|526893301|FG002|Overall Study|Progressive disease|3|||
146101902|NCT01030536|526893302|FG003|Overall Study|Progressive disease|2|||
146101903|NCT01030536|526893303|FG004|Overall Study|Progressive disease|0|||
146101904|NCT01030536|526893299|FG000|Overall Study|Death|0|||
146101905|NCT01030536|526893300|FG001|Overall Study|Death|1|||
146101906|NCT01030536|526893301|FG002|Overall Study|Death|0|||
146101907|NCT01030536|526893302|FG003|Overall Study|Death|0|||
146101908|NCT01030536|526893303|FG004|Overall Study|Death|0|||
146101909|NCT00129272|526893304|FG000|Overall Study|Lost to Follow-up|12|||
146101910|NCT00129272|526893305|FG001|Overall Study|Lost to Follow-up|11|||
146101911|NCT00129272|526893304|FG000|Overall Study|Withdrawal by Subject|5|||
146101912|NCT00129272|526893305|FG001|Overall Study|Withdrawal by Subject|11|||
146101913|NCT02601027|526893309|FG000|Registration to Surgery|Withdrawal by Subject|20|||
146101914|NCT02601027|526893310|FG001|Registration to Surgery|Withdrawal by Subject|10|||
146101915|NCT01419626|526893311|FG000|Overall Study|Protocol Violation|3|||
146101916|NCT01419626|526893312|FG001|Overall Study|Protocol Violation|2|||
146101917|NCT01419626|526893313|FG002|Overall Study|Protocol Violation|2|||
146101918|NCT01419626|526893311|FG000|Overall Study|Withdrawal by Subject|1|||
146101919|NCT01419626|526893312|FG001|Overall Study|Withdrawal by Subject|0|||
146101920|NCT01419626|526893313|FG002|Overall Study|Withdrawal by Subject|0|||
146101921|NCT01419626|526893311|FG000|Overall Study|Lost to Follow-up|0|||
146101922|NCT01419626|526893312|FG001|Overall Study|Lost to Follow-up|1|||
146101923|NCT01419626|526893313|FG002|Overall Study|Lost to Follow-up|1|||
146101924|NCT01146912|526893314|FG000|Overall Study|Already received influenza vaccination|817|||
146101925|NCT01146912|526893315|FG001|Overall Study|Already received influenza vaccination|822|||
146101926|NCT01146912|526893316|FG002|Overall Study|Already received influenza vaccination|13|||
146101927|NCT01146912|526893317|FG003|Overall Study|Already received influenza vaccination|15|||
146101928|NCT01146912|526893318|FG004|Overall Study|Already received influenza vaccination|41|||
146043892|NCT00546000|526675401|FG000|Overall Study|Baseline HPA Axis Supression|2|||
146043893|NCT01362608|526675406|FG000|Overall Study|Protocol Violation|0|||
146043894|NCT01362608|526675407|FG001|Overall Study|Protocol Violation|1|||
146043895|NCT01362608|526675406|FG000|Overall Study|Lost to Follow-up|3|||
146043896|NCT01362608|526675407|FG001|Overall Study|Lost to Follow-up|1|||
146043897|NCT01362608|526675406|FG000|Overall Study|Withdrawal by Subject|1|||
146043898|NCT01362608|526675407|FG001|Overall Study|Withdrawal by Subject|2|||
146043899|NCT01362608|526675406|FG000|Overall Study|Lack of Efficacy|0|||
146043900|NCT01362608|526675407|FG001|Overall Study|Lack of Efficacy|2|||
146043901|NCT01362608|526675406|FG000|Overall Study|Adverse Event|0|||
146043902|NCT01362608|526675407|FG001|Overall Study|Adverse Event|2|||
146043903|NCT04809285|526675418|FG000|Phase 1|Lost to Follow-up|6|||
146043904|NCT04809285|526675418|FG000|Phase 1|Protocol Violation|2|||
146043905|NCT04809285|526675418|FG000|Phase 1|Physician Decision|3|||
146043906|NCT04809285|526675418|FG000|Phase 1|Withdrawal by Subject|29|||
146043907|NCT04809285|526675418|FG000|Phase 2|Protocol Violation|3|||
146043908|NCT04809285|526675418|FG000|Phase 2|Withdrawal by Subject|4|||
146101929|NCT01146912|526893319|FG005|Overall Study|Already received influenza vaccination|61|||
146101930|NCT01146912|526893320|FG006|Overall Study|Already received influenza vaccination|56|||
146101931|NCT01146912|526893321|FG007|Overall Study|Already received influenza vaccination|0|||
146101932|NCT01146912|526893314|FG000|Overall Study|< 14 weeks gestational age|0|||
146101933|NCT01146912|526893315|FG001|Overall Study|< 14 weeks gestational age|0|||
146101934|NCT01146912|526893316|FG002|Overall Study|< 14 weeks gestational age|3|||
146101935|NCT01146912|526893317|FG003|Overall Study|< 14 weeks gestational age|2|||
146101936|NCT01146912|526893318|FG004|Overall Study|< 14 weeks gestational age|0|||
146101937|NCT01146912|526893319|FG005|Overall Study|< 14 weeks gestational age|0|||
146101938|NCT01146912|526893320|FG006|Overall Study|< 14 weeks gestational age|0|||
146101939|NCT01146912|526893321|FG007|Overall Study|< 14 weeks gestational age|0|||
146043909|NCT02837029|526675421|FG000|Screening|Failed to meet screening requirements.|7|||
146101940|NCT01146912|526893314|FG000|Overall Study|Duplicate patient|0|||
146101941|NCT01146912|526893315|FG001|Overall Study|Duplicate patient|0|||
146101942|NCT01146912|526893316|FG002|Overall Study|Duplicate patient|1|||
146101943|NCT01146912|526893317|FG003|Overall Study|Duplicate patient|0|||
146101944|NCT01146912|526893318|FG004|Overall Study|Duplicate patient|0|||
146101945|NCT01146912|526893319|FG005|Overall Study|Duplicate patient|0|||
146101946|NCT01146912|526893320|FG006|Overall Study|Duplicate patient|0|||
146101947|NCT01146912|526893321|FG007|Overall Study|Duplicate patient|0|||
146101948|NCT02248701|526893324|FG000|Overall Study|Withdrawal by Subject|2|||
146101949|NCT02248701|526893325|FG001|Overall Study|Withdrawal by Subject|1|||
146101950|NCT02248701|526893324|FG000|Overall Study|Physician Decision|0|||
146101951|NCT02248701|526893325|FG001|Overall Study|Physician Decision|1|||
146101952|NCT02248701|526893324|FG000|Overall Study|Adverse Event|1|||
146255155|NCT02675998|527448505|FG000|8-Week Treatment Period|Adverse Event|6|||
146255156|NCT02675998|527448506|FG001|8-Week Treatment Period|Adverse Event|5|||
146255157|NCT02675998|527448507|FG002|8-Week Treatment Period|Adverse Event|6|||
146043910|NCT02837029|526675422|FG001|Screening|Failed to meet screening requirements.|3|||
146043911|NCT02837029|526675423|FG002|Screening|Failed to meet screening requirements.|0|||
146043912|NCT02837029|526675421|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
146043913|NCT02837029|526675422|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
146043914|NCT02837029|526675423|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
146043915|NCT02837029|526675421|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
146043916|NCT02837029|526675422|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
146043917|NCT02837029|526675423|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
146043918|NCT02837029|526675421|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
146043919|NCT02837029|526675422|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
146043920|NCT02837029|526675423|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
146043921|NCT02837029|526675421|FG000|Cycle 2 and Beyond|Adverse Event|1|||
146043922|NCT02837029|526675422|FG001|Cycle 2 and Beyond|Adverse Event|0|||
146043923|NCT02837029|526675423|FG002|Cycle 2 and Beyond|Adverse Event|0|||
146043924|NCT02837029|526675421|FG000|2 Year Follow-up|Death|6|||
146043925|NCT02837029|526675422|FG001|2 Year Follow-up|Death|7|||
146043926|NCT02837029|526675423|FG002|2 Year Follow-up|Death|0|||
146043927|NCT02034877|526675426|FG000|Overall Study|Lost to Follow-up|0|||
146043928|NCT02034877|526675427|FG001|Overall Study|Lost to Follow-up|3|||
146043929|NCT02034877|526675426|FG000|Overall Study|No Longer Willing to Participate|0|||
146043930|NCT02034877|526675427|FG001|Overall Study|No Longer Willing to Participate|3|||
146043931|NCT00394706|526675433|FG000|Overall Study|Withdrawal by Subject|2|||
146043932|NCT00394706|526675434|FG001|Overall Study|Withdrawal by Subject|0|||
146043933|NCT00394706|526675435|FG002|Overall Study|Withdrawal by Subject|1|||
146043934|NCT00394706|526675436|FG003|Overall Study|Withdrawal by Subject|0|||
146043935|NCT00394706|526675437|FG004|Overall Study|Withdrawal by Subject|0|||
146043936|NCT00394706|526675438|FG005|Overall Study|Withdrawal by Subject|2|||
146043937|NCT00394706|526675439|FG006|Overall Study|Withdrawal by Subject|1|||
146043938|NCT00394706|526675440|FG007|Overall Study|Withdrawal by Subject|0|||
146043939|NCT00394706|526675433|FG000|Overall Study|Lost to Follow-up|2|||
146043940|NCT00394706|526675434|FG001|Overall Study|Lost to Follow-up|2|||
146043941|NCT00394706|526675435|FG002|Overall Study|Lost to Follow-up|8|||
146043942|NCT00394706|526675436|FG003|Overall Study|Lost to Follow-up|1|||
146043943|NCT00394706|526675437|FG004|Overall Study|Lost to Follow-up|2|||
146043944|NCT00394706|526675438|FG005|Overall Study|Lost to Follow-up|5|||
146043945|NCT00394706|526675439|FG006|Overall Study|Lost to Follow-up|2|||
146043946|NCT00394706|526675440|FG007|Overall Study|Lost to Follow-up|0|||
146043947|NCT00887549|526675443|FG000|Induction Therapy|Adverse Event|8|||
146043948|NCT00887549|526675443|FG000|Induction Therapy|Physician Decision|1|||
146043949|NCT00887549|526675443|FG000|Induction Therapy|Progressive Disease|13|||
146043950|NCT00887549|526675443|FG000|Induction Therapy|Death due to Study Disease|4|||
146043951|NCT00887549|526675443|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
146043952|NCT00887549|526675443|FG000|Maintenance Therapy|Adverse Event|16|||
146043953|NCT00887549|526675443|FG000|Maintenance Therapy|Physician Decision|1|||
146043954|NCT00887549|526675443|FG000|Maintenance Therapy|Progressive Disease|25|||
146043955|NCT00887549|526675443|FG000|Maintenance Therapy|Death due to adverse event|1|||
146101953|NCT02248701|526893325|FG001|Overall Study|Adverse Event|0|||
146101954|NCT02248701|526893324|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
146043956|NCT04112303|526675444|FG000|Overall Study|Death|1|||
146043957|NCT00100789|526675445|FG000|Overall Study|Adverse Event|10|||
146043958|NCT00100789|526675445|FG000|Overall Study|Withdrawal by Subject|1|||
146043959|NCT00100789|526675445|FG000|Overall Study|Progression/relapse|42|||
146043960|NCT00100789|526675445|FG000|Overall Study|Death|2|||
146043961|NCT00100789|526675445|FG000|Overall Study|Not protocol specified|5|||
146043962|NCT00100789|526675445|FG000|Overall Study|Ineligible|3|||
146101955|NCT02248701|526893325|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
146101956|NCT01145625|526893326|FG000|Overall Study|Lost to Follow-up|8|||
146101957|NCT01145625|526893327|FG001|Overall Study|Lost to Follow-up|9|||
146255158|NCT02675998|527448508|FG003|8-Week Treatment Period|Adverse Event|0|||
146043963|NCT00100789|526675445|FG000|Overall Study|Never received treatment|1|||
146043964|NCT03472950|526675446|FG000|Overall Study|Lost to Follow-up|0|||
146043965|NCT03472950|526675447|FG001|Overall Study|Lost to Follow-up|1|||
146043966|NCT03472950|526675446|FG000|Overall Study|Adverse Event|0|||
146043967|NCT03472950|526675447|FG001|Overall Study|Adverse Event|3|||
146043968|NCT02506192|526675451|FG000|Overall Study|Withdrawal by Subject|1|||
146043969|NCT02506192|526675452|FG001|Overall Study|Withdrawal by Subject|1|||
146043970|NCT01685697|526675453|FG000|Overall Study|Protocol Violation|3|||
146043971|NCT01685697|526675454|FG001|Overall Study|Protocol Violation|3|||
146043972|NCT02703324|526675455|FG000|Period Two|Withdrawal by Subject|0|||
146043973|NCT02703324|526675456|FG001|Period Two|Withdrawal by Subject|0|||
146043974|NCT02703324|526675457|FG002|Period Two|Withdrawal by Subject|1|||
146043975|NCT02703324|526675458|FG003|Period Two|Withdrawal by Subject|0|||
146043976|NCT02703324|526675459|FG004|Period Two|Withdrawal by Subject|0|||
146043977|NCT02703324|526675460|FG005|Period Two|Withdrawal by Subject|0|||
146043978|NCT06136897|526675461|FG000|Overall Study|Ineligible|3|||
146043979|NCT06136897|526675461|FG000|Overall Study|Mutation status not confirmed|7|||
146043980|NCT06136897|526675461|FG000|Overall Study|Adverse Event|2|||
146043981|NCT06136897|526675461|FG000|Overall Study|Death|1|||
146043982|NCT06136897|526675461|FG000|Overall Study|Disease progression|18|||
146043983|NCT06136897|526675461|FG000|Overall Study|Other complicating disease|1|||
146043984|NCT06136897|526675461|FG000|Overall Study|Withdrawal by Subject|1|||
146043985|NCT06136897|526675461|FG000|Overall Study|Still on treatment|1|||
146043986|NCT06136897|526675461|FG000|Overall Study|Lost to Follow-up|1|||
146043987|NCT03705559|526675462|FG000|Overall Study|COVID Shut down|1|||
146043988|NCT01858766|526675463|FG000|Overall Study|Randomized but Never Treated|0|||
146043989|NCT01858766|526675464|FG001|Overall Study|Randomized but Never Treated|0|||
146043990|NCT01858766|526675465|FG002|Overall Study|Randomized but Never Treated|0|||
146043991|NCT01858766|526675466|FG003|Overall Study|Randomized but Never Treated|0|||
146043992|NCT01858766|526675467|FG004|Overall Study|Randomized but Never Treated|0|||
146043993|NCT01858766|526675468|FG005|Overall Study|Randomized but Never Treated|1|||
146043994|NCT01858766|526675469|FG006|Overall Study|Randomized but Never Treated|0|||
146043995|NCT01858766|526675470|FG007|Overall Study|Randomized but Never Treated|0|||
146043996|NCT01858766|526675471|FG008|Overall Study|Randomized but Never Treated|0|||
146043997|NCT01858766|526675472|FG009|Overall Study|Randomized but Never Treated|0|||
146043998|NCT01858766|526675473|FG010|Overall Study|Randomized but Never Treated|0|||
146043999|NCT01858766|526675474|FG011|Overall Study|Randomized but Never Treated|0|||
146044000|NCT01858766|526675475|FG012|Overall Study|Randomized but Never Treated|0|||
146044001|NCT01858766|526675476|FG013|Overall Study|Randomized but Never Treated|0|||
146044002|NCT01858766|526675477|FG014|Overall Study|Randomized but Never Treated|0|||
146044003|NCT01858766|526675478|FG015|Overall Study|Randomized but Never Treated|0|||
146044004|NCT01858766|526675479|FG016|Overall Study|Randomized but Never Treated|0|||
146044005|NCT01858766|526675480|FG017|Overall Study|Randomized but Never Treated|1|||
146044006|NCT01858766|526675481|FG018|Overall Study|Randomized but Never Treated|0|||
146044007|NCT01858766|526675463|FG000|Overall Study|Death|0|||
146044008|NCT01858766|526675464|FG001|Overall Study|Death|0|||
146044009|NCT01858766|526675465|FG002|Overall Study|Death|1|||
146044010|NCT01858766|526675466|FG003|Overall Study|Death|0|||
146044011|NCT01858766|526675467|FG004|Overall Study|Death|0|||
146044012|NCT01858766|526675468|FG005|Overall Study|Death|0|||
146044013|NCT01858766|526675469|FG006|Overall Study|Death|0|||
146044014|NCT01858766|526675470|FG007|Overall Study|Death|0|||
146044015|NCT01858766|526675471|FG008|Overall Study|Death|0|||
146044016|NCT01858766|526675472|FG009|Overall Study|Death|0|||
146044017|NCT01858766|526675473|FG010|Overall Study|Death|0|||
146044018|NCT01858766|526675474|FG011|Overall Study|Death|0|||
146044019|NCT01858766|526675475|FG012|Overall Study|Death|0|||
146044020|NCT01858766|526675476|FG013|Overall Study|Death|0|||
146255159|NCT02675998|527448505|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
146255160|NCT02675998|527448506|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
146044021|NCT01858766|526675477|FG014|Overall Study|Death|0|||
146044022|NCT01858766|526675478|FG015|Overall Study|Death|0|||
146044023|NCT01858766|526675479|FG016|Overall Study|Death|0|||
146044024|NCT01858766|526675480|FG017|Overall Study|Death|0|||
146044025|NCT01858766|526675481|FG018|Overall Study|Death|0|||
146044026|NCT01858766|526675463|FG000|Overall Study|Lack of Efficacy|1|||
146044027|NCT01858766|526675464|FG001|Overall Study|Lack of Efficacy|0|||
146044028|NCT01858766|526675465|FG002|Overall Study|Lack of Efficacy|0|||
146044029|NCT01858766|526675466|FG003|Overall Study|Lack of Efficacy|0|||
146044030|NCT01858766|526675467|FG004|Overall Study|Lack of Efficacy|1|||
146044031|NCT01858766|526675468|FG005|Overall Study|Lack of Efficacy|2|||
146044032|NCT01858766|526675469|FG006|Overall Study|Lack of Efficacy|0|||
146044033|NCT01858766|526675470|FG007|Overall Study|Lack of Efficacy|0|||
146044034|NCT01858766|526675471|FG008|Overall Study|Lack of Efficacy|0|||
146044035|NCT01858766|526675472|FG009|Overall Study|Lack of Efficacy|0|||
146044036|NCT01858766|526675473|FG010|Overall Study|Lack of Efficacy|0|||
146255161|NCT02675998|527448507|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
146044037|NCT01858766|526675474|FG011|Overall Study|Lack of Efficacy|3|||
146044038|NCT01858766|526675475|FG012|Overall Study|Lack of Efficacy|5|||
146044039|NCT01858766|526675476|FG013|Overall Study|Lack of Efficacy|3|||
146044040|NCT01858766|526675477|FG014|Overall Study|Lack of Efficacy|5|||
146044041|NCT01858766|526675478|FG015|Overall Study|Lack of Efficacy|5|||
146044042|NCT01858766|526675479|FG016|Overall Study|Lack of Efficacy|2|||
146044043|NCT01858766|526675480|FG017|Overall Study|Lack of Efficacy|3|||
146044044|NCT01858766|526675481|FG018|Overall Study|Lack of Efficacy|3|||
146044045|NCT01858766|526675463|FG000|Overall Study|Lost to Follow-up|0|||
146044046|NCT01858766|526675464|FG001|Overall Study|Lost to Follow-up|0|||
146044047|NCT01858766|526675465|FG002|Overall Study|Lost to Follow-up|0|||
146044048|NCT01858766|526675466|FG003|Overall Study|Lost to Follow-up|0|||
146044049|NCT01858766|526675467|FG004|Overall Study|Lost to Follow-up|0|||
146044050|NCT01858766|526675468|FG005|Overall Study|Lost to Follow-up|1|||
146044051|NCT01858766|526675469|FG006|Overall Study|Lost to Follow-up|0|||
146044052|NCT01858766|526675470|FG007|Overall Study|Lost to Follow-up|2|||
146044053|NCT01858766|526675471|FG008|Overall Study|Lost to Follow-up|0|||
146044054|NCT01858766|526675472|FG009|Overall Study|Lost to Follow-up|0|||
146044055|NCT01858766|526675473|FG010|Overall Study|Lost to Follow-up|0|||
146044056|NCT01858766|526675474|FG011|Overall Study|Lost to Follow-up|1|||
146044057|NCT01858766|526675475|FG012|Overall Study|Lost to Follow-up|0|||
146044058|NCT01858766|526675476|FG013|Overall Study|Lost to Follow-up|0|||
146044059|NCT01858766|526675477|FG014|Overall Study|Lost to Follow-up|3|||
146044060|NCT01858766|526675478|FG015|Overall Study|Lost to Follow-up|1|||
146044061|NCT01858766|526675479|FG016|Overall Study|Lost to Follow-up|1|||
146044062|NCT01858766|526675480|FG017|Overall Study|Lost to Follow-up|0|||
146044063|NCT01858766|526675481|FG018|Overall Study|Lost to Follow-up|1|||
146044064|NCT01858766|526675463|FG000|Overall Study|Withdrew Consent|0|||
146044065|NCT01858766|526675464|FG001|Overall Study|Withdrew Consent|0|||
146044066|NCT01858766|526675465|FG002|Overall Study|Withdrew Consent|0|||
146044067|NCT01858766|526675466|FG003|Overall Study|Withdrew Consent|0|||
146044068|NCT01858766|526675467|FG004|Overall Study|Withdrew Consent|0|||
146044069|NCT01858766|526675468|FG005|Overall Study|Withdrew Consent|0|||
146044070|NCT01858766|526675469|FG006|Overall Study|Withdrew Consent|0|||
146044071|NCT01858766|526675470|FG007|Overall Study|Withdrew Consent|0|||
146044072|NCT01858766|526675471|FG008|Overall Study|Withdrew Consent|0|||
146044073|NCT01858766|526675472|FG009|Overall Study|Withdrew Consent|0|||
146044074|NCT01858766|526675473|FG010|Overall Study|Withdrew Consent|0|||
146044075|NCT01858766|526675474|FG011|Overall Study|Withdrew Consent|1|||
146044076|NCT01858766|526675475|FG012|Overall Study|Withdrew Consent|0|||
146044077|NCT01858766|526675476|FG013|Overall Study|Withdrew Consent|0|||
146044078|NCT01858766|526675477|FG014|Overall Study|Withdrew Consent|0|||
146044079|NCT01858766|526675478|FG015|Overall Study|Withdrew Consent|0|||
146044080|NCT01858766|526675479|FG016|Overall Study|Withdrew Consent|0|||
146044081|NCT01858766|526675480|FG017|Overall Study|Withdrew Consent|0|||
146044082|NCT01858766|526675481|FG018|Overall Study|Withdrew Consent|0|||
146044083|NCT03245398|526675488|FG000|Overall Study|Travelled to another island|1|||
146044084|NCT03245398|526675489|FG001|Overall Study|Travelled to another island|0|||
146044085|NCT04531241|526675490|FG000|Period 1|Withdrawal by Subject|2|||
146044086|NCT04531241|526675491|FG001|Period 1|Withdrawal by Subject|0|||
146044087|NCT04531241|526675490|FG000|Period 1|Dispesed incorrect lens power|1|||
146044088|NCT04531241|526675491|FG001|Period 1|Dispesed incorrect lens power|0|||
146044089|NCT04531241|526675490|FG000|Period 1|Protocol Violation|1|||
146044090|NCT04531241|526675491|FG001|Period 1|Protocol Violation|0|||
146044091|NCT04531241|526675490|FG000|Period 1|No longer eligible|0|||
146044092|NCT04531241|526675491|FG001|Period 1|No longer eligible|1|||
146044093|NCT04531241|526675490|FG000|Period 1|Lens Discomfort|0|||
146044094|NCT04531241|526675491|FG001|Period 1|Lens Discomfort|1|||
146044095|NCT04531241|526675490|FG000|Period 2|Covid-19 Related|1|||
146044096|NCT04531241|526675491|FG001|Period 2|Covid-19 Related|1|||
146044097|NCT03724890|526675492|FG000|Overall Study|Death|2|||
146044098|NCT03724890|526675493|FG001|Overall Study|Death|6|||
146044099|NCT03724890|526675494|FG002|Overall Study|Death|3|||
146044100|NCT03724890|526675495|FG003|Overall Study|Death|5|||
146044101|NCT03724890|526675496|FG004|Overall Study|Death|2|||
146044102|NCT03724890|526675497|FG005|Overall Study|Death|0|||
146044103|NCT03724890|526675498|FG006|Overall Study|Death|2|||
146044104|NCT03724890|526675499|FG007|Overall Study|Death|3|||
146044105|NCT03724890|526675500|FG008|Overall Study|Death|4|||
146044106|NCT03724890|526675501|FG009|Overall Study|Death|2|||
146044107|NCT03724890|526675502|FG010|Overall Study|Death|2|||
146101958|NCT01145625|526893326|FG000|Overall Study|Adverse Event|6|||
146101959|NCT01145625|526893327|FG001|Overall Study|Adverse Event|4|||
146300640|NCT01087957|527617074|FG000|Overall Study|Protocol Violation|13|||
146044108|NCT03724890|526675492|FG000|Overall Study|Lost to Follow-up|0|||
146044109|NCT03724890|526675493|FG001|Overall Study|Lost to Follow-up|3|||
146044110|NCT03724890|526675494|FG002|Overall Study|Lost to Follow-up|0|||
146044111|NCT03724890|526675495|FG003|Overall Study|Lost to Follow-up|1|||
146044112|NCT03724890|526675496|FG004|Overall Study|Lost to Follow-up|2|||
146044113|NCT03724890|526675497|FG005|Overall Study|Lost to Follow-up|2|||
146044114|NCT03724890|526675498|FG006|Overall Study|Lost to Follow-up|1|||
146044115|NCT03724890|526675499|FG007|Overall Study|Lost to Follow-up|0|||
146044116|NCT03724890|526675500|FG008|Overall Study|Lost to Follow-up|2|||
146044117|NCT03724890|526675501|FG009|Overall Study|Lost to Follow-up|0|||
146044118|NCT03724890|526675502|FG010|Overall Study|Lost to Follow-up|0|||
146255162|NCT02675998|527448508|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
146255163|NCT02675998|527448505|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
146255164|NCT02675998|527448506|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
146255165|NCT02675998|527448507|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
146255166|NCT02675998|527448508|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
146255167|NCT02675998|527448505|FG000|8-Week Treatment Period|Physician Decision|1|||
146255168|NCT02675998|527448506|FG001|8-Week Treatment Period|Physician Decision|0|||
146255169|NCT02675998|527448507|FG002|8-Week Treatment Period|Physician Decision|2|||
146044119|NCT03724890|526675492|FG000|Overall Study|Withdrawal by Subject|1|||
146044120|NCT03724890|526675493|FG001|Overall Study|Withdrawal by Subject|2|||
146044121|NCT03724890|526675494|FG002|Overall Study|Withdrawal by Subject|1|||
146044122|NCT03724890|526675495|FG003|Overall Study|Withdrawal by Subject|0|||
146044123|NCT03724890|526675496|FG004|Overall Study|Withdrawal by Subject|0|||
146044124|NCT03724890|526675497|FG005|Overall Study|Withdrawal by Subject|1|||
146044125|NCT03724890|526675498|FG006|Overall Study|Withdrawal by Subject|0|||
146044126|NCT03724890|526675499|FG007|Overall Study|Withdrawal by Subject|0|||
146044127|NCT03724890|526675500|FG008|Overall Study|Withdrawal by Subject|2|||
146044128|NCT03724890|526675501|FG009|Overall Study|Withdrawal by Subject|2|||
146044129|NCT03724890|526675502|FG010|Overall Study|Withdrawal by Subject|1|||
146044130|NCT03724890|526675492|FG000|Overall Study|Other|1|||
146044131|NCT03724890|526675493|FG001|Overall Study|Other|0|||
146044132|NCT03724890|526675494|FG002|Overall Study|Other|0|||
146044133|NCT03724890|526675495|FG003|Overall Study|Other|0|||
146044134|NCT03724890|526675496|FG004|Overall Study|Other|0|||
146044135|NCT03724890|526675497|FG005|Overall Study|Other|0|||
146044136|NCT03724890|526675498|FG006|Overall Study|Other|0|||
146044137|NCT03724890|526675499|FG007|Overall Study|Other|1|||
146044138|NCT03724890|526675500|FG008|Overall Study|Other|1|||
146044139|NCT03724890|526675501|FG009|Overall Study|Other|0|||
146044140|NCT03724890|526675502|FG010|Overall Study|Other|2|||
146044141|NCT04427072|526675504|FG000|Randomized Treatment Phase|Progressive disease|9|||
146044142|NCT04427072|526675505|FG001|Randomized Treatment Phase|Progressive disease|4|||
146044143|NCT04427072|526675504|FG000|Randomized Treatment Phase|Adverse Event|3|||
146044144|NCT04427072|526675505|FG001|Randomized Treatment Phase|Adverse Event|1|||
146044145|NCT04427072|526675504|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
146044146|NCT04427072|526675505|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
146044147|NCT04427072|526675504|FG000|Randomized Treatment Phase|Death|0|||
146044148|NCT04427072|526675505|FG001|Randomized Treatment Phase|Death|1|||
146044149|NCT04427072|526675504|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
146044150|NCT04427072|526675505|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
146044151|NCT04427072|526675504|FG000|Extension Treatment Phase|Progressive disease|0|||
146044152|NCT04427072|526675505|FG001|Extension Treatment Phase|Progressive disease|5|||
146044153|NCT03400176|526675509|FG000|Dose Escalation|Progressive disease|1|||
146044154|NCT03400176|526675510|FG001|Dose Escalation|Progressive disease|1|||
146044155|NCT03400176|526675511|FG002|Dose Escalation|Progressive disease|0|||
146044156|NCT03400176|526675512|FG003|Dose Escalation|Progressive disease|0|||
146044157|NCT03400176|526675513|FG004|Dose Escalation|Progressive disease|1|||
146044158|NCT03400176|526675509|FG000|Dose Escalation|Patient decision|0|||
146044159|NCT03400176|526675510|FG001|Dose Escalation|Patient decision|0|||
146044160|NCT03400176|526675511|FG002|Dose Escalation|Patient decision|0|||
146044161|NCT03400176|526675512|FG003|Dose Escalation|Patient decision|0|||
146044162|NCT03400176|526675513|FG004|Dose Escalation|Patient decision|1|||
146044163|NCT03400176|526675509|FG000|Dose Expansion|Patient decision|0|||
146044164|NCT03400176|526675510|FG001|Dose Expansion|Patient decision|0|||
146044165|NCT03400176|526675511|FG002|Dose Expansion|Patient decision|0|||
146044166|NCT03400176|526675512|FG003|Dose Expansion|Patient decision|1|||
146044167|NCT03400176|526675513|FG004|Dose Expansion|Patient decision|0|||
146044168|NCT03400176|526675509|FG000|Dose Expansion|Adverse Event|0|||
146044169|NCT03400176|526675510|FG001|Dose Expansion|Adverse Event|0|||
146044170|NCT03400176|526675511|FG002|Dose Expansion|Adverse Event|0|||
146044171|NCT03400176|526675512|FG003|Dose Expansion|Adverse Event|1|||
146044172|NCT03400176|526675513|FG004|Dose Expansion|Adverse Event|0|||
146044173|NCT03400176|526675509|FG000|Dose Expansion|Physician Decision|0|||
146044174|NCT03400176|526675510|FG001|Dose Expansion|Physician Decision|0|||
146044175|NCT03400176|526675511|FG002|Dose Expansion|Physician Decision|0|||
146044176|NCT03400176|526675512|FG003|Dose Expansion|Physician Decision|1|||
146044177|NCT03400176|526675513|FG004|Dose Expansion|Physician Decision|0|||
146044178|NCT03400176|526675509|FG000|Dose Expansion|Progressive disease|0|||
146044179|NCT03400176|526675510|FG001|Dose Expansion|Progressive disease|0|||
146044180|NCT03400176|526675511|FG002|Dose Expansion|Progressive disease|1|||
146044181|NCT03400176|526675512|FG003|Dose Expansion|Progressive disease|1|||
146044182|NCT03400176|526675513|FG004|Dose Expansion|Progressive disease|0|||
146044183|NCT01090063|526675518|FG000|Screen|Screen Failed|4|||
146255170|NCT02675998|527448508|FG003|8-Week Treatment Period|Physician Decision|0|||
146255171|NCT02675998|527448505|FG000|8-Week Treatment Period|GI side Effects|1|||
146044184|NCT01090063|526675518|FG000|Treatment|Withdrawal by Subject|4|||
146044185|NCT01371734|526675524|FG000|Overall Study|Other|2|||
146255172|NCT02675998|527448506|FG001|8-Week Treatment Period|GI side Effects|4|||
146044186|NCT01371734|526675525|FG001|Overall Study|Other|1|||
146044187|NCT01371734|526675526|FG002|Overall Study|Other|2|||
146044188|NCT01371734|526675524|FG000|Overall Study|Withdrawal by Subject|3|||
146044189|NCT01371734|526675525|FG001|Overall Study|Withdrawal by Subject|4|||
146044190|NCT01371734|526675526|FG002|Overall Study|Withdrawal by Subject|9|||
146044191|NCT01371734|526675524|FG000|Overall Study|Lost to Follow-up|5|||
146044192|NCT01371734|526675525|FG001|Overall Study|Lost to Follow-up|3|||
146044193|NCT01371734|526675526|FG002|Overall Study|Lost to Follow-up|1|||
146044194|NCT01371734|526675524|FG000|Overall Study|Protocol Violation|3|||
146044195|NCT01371734|526675525|FG001|Overall Study|Protocol Violation|1|||
146044196|NCT01371734|526675526|FG002|Overall Study|Protocol Violation|2|||
146044197|NCT01371734|526675524|FG000|Overall Study|Adverse Event|8|||
146044198|NCT01371734|526675525|FG001|Overall Study|Adverse Event|8|||
146044199|NCT01371734|526675526|FG002|Overall Study|Adverse Event|3|||
146044200|NCT01371734|526675524|FG000|Overall Study|Lack of Efficacy|2|||
146044201|NCT01371734|526675525|FG001|Overall Study|Lack of Efficacy|2|||
146044202|NCT01371734|526675526|FG002|Overall Study|Lack of Efficacy|0|||
146044203|NCT00958165|526675527|FG000|Overall Study|Lost to Follow-up|5|||
146044204|NCT00958165|526675527|FG000|Overall Study|Not eligible|9|||
146044205|NCT00206440|526675528|FG000|Overall Study|Protocol Violation|1|||
146044206|NCT00206440|526675529|FG001|Overall Study|Protocol Violation|2|||
146044207|NCT00206440|526675528|FG000|Overall Study|Adverse Event|4|||
146044208|NCT00206440|526675529|FG001|Overall Study|Adverse Event|2|||
146044209|NCT01298765|526675530|FG000|Titration Period|Adverse Event|26|||
146044210|NCT01298765|526675530|FG000|Titration Period|Death|1|||
146044211|NCT01298765|526675530|FG000|Titration Period|Lack of Efficacy|21|||
146044212|NCT01298765|526675530|FG000|Titration Period|Lost to Follow-up|9|||
146044213|NCT01298765|526675530|FG000|Titration Period|Physician Decision|1|||
146044214|NCT01298765|526675530|FG000|Titration Period|Withdrawal by Subject|10|||
146044215|NCT01298765|526675530|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
146044216|NCT01298765|526675530|FG000|Long-Term Treatment Period|Adverse Event|19|||
146044217|NCT01298765|526675530|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
146044218|NCT01298765|526675530|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
146044219|NCT01298765|526675530|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
146044220|NCT01298765|526675530|FG000|Long-Term Treatment Period|Physician Decision|1|||
146044221|NCT01298765|526675530|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
146044222|NCT03565237|526675531|FG000|Overall Study|Non-compliance of Investigational Product|1|||
146044223|NCT03565237|526675531|FG000|Overall Study|Physician Decision|1|||
146044224|NCT01140061|526675537|FG000|Part I|Adverse Event|1|||
146044225|NCT01140061|526675538|FG001|Part I|Adverse Event|0|||
146044226|NCT01140061|526675539|FG002|Part I|Adverse Event|0|||
146044227|NCT01140061|526675540|FG003|Part I|Adverse Event|0|||
146044228|NCT01140061|526675541|FG004|Part I|Adverse Event|0|||
146044229|NCT01140061|526675542|FG005|Part I|Adverse Event|0|||
146044230|NCT01140061|526675543|FG006|Part I|Adverse Event|0|||
146044231|NCT01140061|526675544|FG007|Part I|Adverse Event|0|||
146044232|NCT01140061|526675545|FG008|Part I|Adverse Event|0|||
146044233|NCT01140061|526675546|FG009|Part I|Adverse Event|0|||
146044234|NCT01140061|526675537|FG000|Extension|Laboratory Adverse Event|0|||
146044235|NCT01140061|526675538|FG001|Extension|Laboratory Adverse Event|0|||
146044236|NCT01140061|526675539|FG002|Extension|Laboratory Adverse Event|0|||
146044237|NCT01140061|526675540|FG003|Extension|Laboratory Adverse Event|0|||
146044238|NCT01140061|526675541|FG004|Extension|Laboratory Adverse Event|0|||
146044239|NCT01140061|526675542|FG005|Extension|Laboratory Adverse Event|0|||
146044240|NCT01140061|526675543|FG006|Extension|Laboratory Adverse Event|0|||
146044241|NCT01140061|526675544|FG007|Extension|Laboratory Adverse Event|0|||
146044242|NCT01140061|526675545|FG008|Extension|Laboratory Adverse Event|0|||
146044243|NCT01140061|526675546|FG009|Extension|Laboratory Adverse Event|1|||
146044244|NCT00428389|526675548|FG000|Core Phase|Adverse Event|6|||
146044245|NCT00428389|526675549|FG001|Core Phase|Adverse Event|4|||
146044246|NCT00428389|526675548|FG000|Core Phase|Lack of Efficacy|2|||
146044247|NCT00428389|526675549|FG001|Core Phase|Lack of Efficacy|0|||
146044248|NCT00428389|526675548|FG000|Core Phase|Abnormal test procedure result(s)|0|||
146044249|NCT00428389|526675549|FG001|Core Phase|Abnormal test procedure result(s)|1|||
146044250|NCT00428389|526675548|FG000|Core Phase|Withdrawal by Subject|3|||
146044251|NCT00428389|526675549|FG001|Core Phase|Withdrawal by Subject|4|||
146044252|NCT00428389|526675548|FG000|Core Phase|Protocol deviation|0|||
146044253|NCT00428389|526675549|FG001|Core Phase|Protocol deviation|2|||
146044254|NCT00428389|526675548|FG000|Extension Phase|Adverse Event|17|||
146044255|NCT00428389|526675549|FG001|Extension Phase|Adverse Event|11|||
146044256|NCT00428389|526675548|FG000|Extension Phase|Lack of Efficacy|4|||
146044257|NCT00428389|526675549|FG001|Extension Phase|Lack of Efficacy|3|||
146044258|NCT00428389|526675548|FG000|Extension Phase|Withdrawal by Subject|6|||
146044259|NCT00428389|526675549|FG001|Extension Phase|Withdrawal by Subject|6|||
146044260|NCT00428389|526675548|FG000|Extension Phase|Lost to Follow-up|0|||
146044261|NCT00428389|526675549|FG001|Extension Phase|Lost to Follow-up|3|||
146044262|NCT00428389|526675548|FG000|Extension Phase|Death|1|||
146044263|NCT00428389|526675549|FG001|Extension Phase|Death|0|||
146044264|NCT00428389|526675548|FG000|Extension Phase|Protocol Violation|3|||
146044265|NCT00428389|526675549|FG001|Extension Phase|Protocol Violation|2|||
146044266|NCT00428389|526675548|FG000|Extension Phase|Administrative problems|1|||
146044267|NCT00428389|526675549|FG001|Extension Phase|Administrative problems|1|||
146044268|NCT00766051|526675550|FG000|Overall Study|Withdrawal by Subject|2|||
146044269|NCT00766051|526675551|FG001|Overall Study|Withdrawal by Subject|0|||
146044270|NCT02305238|526675552|FG000|Overall Study|Death|2|||
146044271|NCT02305238|526675553|FG001|Overall Study|Death|1|||
146044272|NCT02305238|526675554|FG002|Overall Study|Death|0|||
146044273|NCT02305238|526675552|FG000|Overall Study|Progressive disease|4|||
146044274|NCT02305238|526675553|FG001|Overall Study|Progressive disease|4|||
146044275|NCT02305238|526675554|FG002|Overall Study|Progressive disease|0|||
146044276|NCT02305238|526675552|FG000|Overall Study|Logistical difficulties|1|||
146044277|NCT02305238|526675553|FG001|Overall Study|Logistical difficulties|3|||
146044278|NCT02305238|526675554|FG002|Overall Study|Logistical difficulties|0|||
146044279|NCT02305238|526675552|FG000|Overall Study|Protocol Violation|0|||
146044280|NCT02305238|526675553|FG001|Overall Study|Protocol Violation|3|||
146044281|NCT02305238|526675554|FG002|Overall Study|Protocol Violation|0|||
146044282|NCT02305238|526675552|FG000|Overall Study|Physician Decision|2|||
146044283|NCT02305238|526675553|FG001|Overall Study|Physician Decision|1|||
146044284|NCT02305238|526675554|FG002|Overall Study|Physician Decision|0|||
146044285|NCT02305238|526675552|FG000|Overall Study|Adverse Event|4|||
146044286|NCT02305238|526675553|FG001|Overall Study|Adverse Event|2|||
146044287|NCT02305238|526675554|FG002|Overall Study|Adverse Event|0|||
146044288|NCT02305238|526675552|FG000|Overall Study|Withdrawal by Subject|3|||
146044289|NCT02305238|526675553|FG001|Overall Study|Withdrawal by Subject|4|||
146044290|NCT02305238|526675554|FG002|Overall Study|Withdrawal by Subject|0|||
146044291|NCT02305238|526675552|FG000|Overall Study|Randomized failure|0|||
146044292|NCT02305238|526675553|FG001|Overall Study|Randomized failure|0|||
146044293|NCT02305238|526675554|FG002|Overall Study|Randomized failure|8|||
146044294|NCT02305238|526675552|FG000|Overall Study|Required procedure failed|0|||
146044295|NCT02305238|526675553|FG001|Overall Study|Required procedure failed|1|||
146044296|NCT02305238|526675554|FG002|Overall Study|Required procedure failed|0|||
146044297|NCT01711645|526675555|FG000|Overall Study|Withdrawal by Subject|8|||
146044298|NCT01711645|526675555|FG000|Overall Study|Lost to Follow-up|6|||
146044299|NCT01711645|526675555|FG000|Overall Study|Physician Decision|5|||
146044300|NCT00408434|526675556|FG000|Overall Study|Adverse Event|0|||
146044301|NCT00408434|526675557|FG001|Overall Study|Adverse Event|0|||
146044302|NCT00408434|526675558|FG002|Overall Study|Adverse Event|1|||
146044303|NCT00408434|526675559|FG003|Overall Study|Adverse Event|0|||
146044304|NCT00408434|526675560|FG004|Overall Study|Adverse Event|0|||
146044305|NCT00408434|526675561|FG005|Overall Study|Adverse Event|0|||
146044306|NCT00408434|526675562|FG006|Overall Study|Adverse Event|0|||
146044307|NCT00408434|526675556|FG000|Overall Study|Progressive disease|6|||
146044308|NCT00408434|526675557|FG001|Overall Study|Progressive disease|3|||
146044309|NCT00408434|526675558|FG002|Overall Study|Progressive disease|4|||
146044310|NCT00408434|526675559|FG003|Overall Study|Progressive disease|3|||
146044311|NCT00408434|526675560|FG004|Overall Study|Progressive disease|3|||
146044312|NCT00408434|526675561|FG005|Overall Study|Progressive disease|1|||
146044313|NCT00408434|526675562|FG006|Overall Study|Progressive disease|4|||
146044314|NCT00408434|526675556|FG000|Overall Study|Other|0|||
146044315|NCT00408434|526675557|FG001|Overall Study|Other|0|||
146044316|NCT00408434|526675558|FG002|Overall Study|Other|1|||
146044317|NCT00408434|526675559|FG003|Overall Study|Other|0|||
146044318|NCT00408434|526675560|FG004|Overall Study|Other|2|||
146044319|NCT00408434|526675561|FG005|Overall Study|Other|1|||
146044320|NCT00408434|526675562|FG006|Overall Study|Other|0|||
146044321|NCT00408434|526675556|FG000|Overall Study|Terminated by Investigator|0|||
146044322|NCT00408434|526675557|FG001|Overall Study|Terminated by Investigator|0|||
146044323|NCT00408434|526675558|FG002|Overall Study|Terminated by Investigator|0|||
146044324|NCT00408434|526675559|FG003|Overall Study|Terminated by Investigator|0|||
146044325|NCT00408434|526675560|FG004|Overall Study|Terminated by Investigator|1|||
146044326|NCT00408434|526675561|FG005|Overall Study|Terminated by Investigator|1|||
146044327|NCT00408434|526675562|FG006|Overall Study|Terminated by Investigator|0|||
146044328|NCT00588354|526675563|FG000|Baseline to 2 Weeks|Adverse Event|1|||
146044329|NCT00588354|526675564|FG001|Baseline to 2 Weeks|Adverse Event|0|||
146044330|NCT00588354|526675563|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
146044331|NCT00588354|526675564|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
146044332|NCT00588354|526675563|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
146044333|NCT00588354|526675564|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
146044334|NCT04230213|526675565|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
146044335|NCT04230213|526675566|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
146044336|NCT04230213|526675567|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
146044337|NCT04230213|526675565|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
146101960|NCT01145625|526893326|FG000|Overall Study|Protocol Violation|3|||
146101961|NCT01145625|526893327|FG001|Overall Study|Protocol Violation|1|||
146044338|NCT04230213|526675566|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
146044339|NCT04230213|526675567|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
146044340|NCT04230213|526675565|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
146044341|NCT04230213|526675566|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
146044342|NCT04230213|526675567|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
146044343|NCT04230213|526675565|FG000|TP2: Week 10 to Week 16|Other|0|||
146044344|NCT04230213|526675566|FG001|TP2: Week 10 to Week 16|Other|2|||
146044345|NCT04230213|526675567|FG002|TP2: Week 10 to Week 16|Other|1|||
146044346|NCT04230213|526675565|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
146044347|NCT04230213|526675566|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
146044348|NCT04230213|526675567|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
146044349|NCT04230213|526675565|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
146044350|NCT04230213|526675566|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
146044351|NCT04230213|526675567|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
146044352|NCT04230213|526675565|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
146044353|NCT04230213|526675566|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
146044354|NCT04230213|526675567|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
146044355|NCT04230213|526675565|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
146044356|NCT04230213|526675566|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
146044357|NCT04230213|526675567|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
146044358|NCT04230213|526675565|FG000|TP3: Week 16 to Week 22|Other|0|||
146044359|NCT04230213|526675566|FG001|TP3: Week 16 to Week 22|Other|1|||
146044360|NCT04230213|526675567|FG002|TP3: Week 16 to Week 22|Other|3|||
146044361|NCT04230213|526675565|FG000|TP4: Week 22 to Week 32|Other|0|||
146044362|NCT04230213|526675566|FG001|TP4: Week 22 to Week 32|Other|5|||
146044363|NCT04230213|526675567|FG002|TP4: Week 22 to Week 32|Other|5|||
146044364|NCT04230213|526675565|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
146044365|NCT04230213|526675566|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
146044366|NCT04230213|526675567|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
146044367|NCT04230213|526675565|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
146044368|NCT04230213|526675566|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
146044369|NCT04230213|526675567|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
146044370|NCT04230213|526675565|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
146044371|NCT04230213|526675566|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
146044372|NCT04230213|526675567|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
146044373|NCT04230213|526675565|FG000|Follow up: Week 32 to Week 36|Other|0|||
146044374|NCT04230213|526675566|FG001|Follow up: Week 32 to Week 36|Other|1|||
146044375|NCT04230213|526675567|FG002|Follow up: Week 32 to Week 36|Other|1|||
146044376|NCT03058692|526676803|FG000|Overall Study|Lost to Follow-up|2|||
146044377|NCT03058692|526676804|FG001|Overall Study|Lost to Follow-up|1|||
146044378|NCT03058692|526676803|FG000|Overall Study|Withdrawal by Subject|1|||
146044379|NCT03058692|526676804|FG001|Overall Study|Withdrawal by Subject|1|||
146044380|NCT00806988|526676805|FG000|Overall Study|Death|15|||
146044381|NCT00806988|526676806|FG001|Overall Study|Death|16|||
146044382|NCT00806988|526676805|FG000|Overall Study|Withdrawal by Subject|8|||
146044383|NCT00806988|526676806|FG001|Overall Study|Withdrawal by Subject|8|||
146044384|NCT00806988|526676805|FG000|Overall Study|Lost to Follow-up|4|||
146044385|NCT00806988|526676806|FG001|Overall Study|Lost to Follow-up|19|||
146044386|NCT04775953|526676808|FG000|Overall Study|Lost to Follow-up|6|||
146044387|NCT04775953|526676809|FG001|Overall Study|Lost to Follow-up|11|||
146044388|NCT04775953|526676808|FG000|Overall Study|Death|5|||
146044389|NCT04775953|526676809|FG001|Overall Study|Death|4|||
146044390|NCT04775953|526676808|FG000|Overall Study|Withdrawal by Subject|3|||
146044391|NCT04775953|526676809|FG001|Overall Study|Withdrawal by Subject|3|||
146044392|NCT04775953|526676808|FG000|Overall Study|Protocol Violation|2|||
146044393|NCT04775953|526676809|FG001|Overall Study|Protocol Violation|0|||
146044394|NCT04775953|526676808|FG000|Overall Study|Participant non-compliance|0|||
146044395|NCT04775953|526676809|FG001|Overall Study|Participant non-compliance|1|||
146044396|NCT00855959|526676810|FG000|Overall Study|Adverse Event|2|||
146044397|NCT00855959|526676810|FG000|Overall Study|Lost to Follow-up|2|||
146044398|NCT00855959|526676810|FG000|Overall Study|Withdrawal by Subject|3|||
146044399|NCT00855959|526676810|FG000|Overall Study|Pregnancy|1|||
146044400|NCT00855959|526676810|FG000|Overall Study|Incorrect enrolment|1|||
146044401|NCT04737278|526676816|FG000|Overall Study|Lost to Follow-up|1|||
146044402|NCT04737278|526676817|FG001|Overall Study|Lost to Follow-up|1|||
146044403|NCT04737278|526676816|FG000|Overall Study|Withdrawal by Subject|1|||
146044404|NCT04737278|526676817|FG001|Overall Study|Withdrawal by Subject|0|||
146044405|NCT04737278|526676816|FG000|Overall Study|Protocol Violation|1|||
146044406|NCT04737278|526676817|FG001|Overall Study|Protocol Violation|1|||
146044407|NCT04737278|526676816|FG000|Overall Study|failure to complete questionnaire|1|||
146044408|NCT04737278|526676817|FG001|Overall Study|failure to complete questionnaire|1|||
146044409|NCT01128244|526676820|FG000|Overall Study|Adverse Event|1|||
146044410|NCT01128244|526676820|FG000|Overall Study|Scheduling conflict|2|||
146044411|NCT04506502|526676824|FG000|Overall Study|Withdrawal by Subject|1|||
146044412|NCT04506502|526676824|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
146044413|NCT01449006|526676825|FG000|Overall Study|Lost to Follow-up|1|||
146044414|NCT01449006|526676826|FG001|Overall Study|Lost to Follow-up|0|||
146044415|NCT01449006|526676825|FG000|Overall Study|Withdrawal by Subject|1|||
146044416|NCT01449006|526676826|FG001|Overall Study|Withdrawal by Subject|0|||
146101962|NCT01145625|526893326|FG000|Overall Study|Withdrawal by Subject|7|||
146101963|NCT01145625|526893327|FG001|Overall Study|Withdrawal by Subject|16|||
146101964|NCT01145625|526893326|FG000|Overall Study|Pregnancy|0|||
146101965|NCT01145625|526893327|FG001|Overall Study|Pregnancy|1|||
146101966|NCT00885846|526893328|FG000|Overall Study|Withdrawal by Subject|2|||
146101967|NCT00885846|526893329|FG001|Overall Study|Withdrawal by Subject|5|||
146101968|NCT00885846|526893330|FG002|Overall Study|Withdrawal by Subject|2|||
146101969|NCT01952145|526893331|FG000|Overall Study|Protocol Violation|2|||
146101970|NCT01952145|526893332|FG001|Overall Study|Protocol Violation|1|||
146101971|NCT01952145|526893331|FG000|Overall Study|Death|0|||
146101972|NCT01952145|526893332|FG001|Overall Study|Death|1|||
146101973|NCT01952145|526893331|FG000|Overall Study|Adverse Event|9|||
146101974|NCT01952145|526893332|FG001|Overall Study|Adverse Event|0|||
146101975|NCT01952145|526893331|FG000|Overall Study|Withdrawal Criteria|16|||
146101976|NCT01952145|526893332|FG001|Overall Study|Withdrawal Criteria|11|||
146101977|NCT01952145|526893331|FG000|Overall Study|Unclassified|1|||
146101978|NCT01952145|526893332|FG001|Overall Study|Unclassified|1|||
146101979|NCT01540838|526893334|FG000|Overall Study|Open nasogastric tube|9|||
146101980|NCT01540838|526893335|FG001|Overall Study|Open nasogastric tube|7|||
146101981|NCT01540838|526893334|FG000|Overall Study|Treatment doses missing|8|||
146101982|NCT01540838|526893335|FG001|Overall Study|Treatment doses missing|12|||
146101983|NCT01540838|526893334|FG000|Overall Study|Additional antibiotic treatment|1|||
146101984|NCT01540838|526893335|FG001|Overall Study|Additional antibiotic treatment|2|||
146101985|NCT01540838|526893334|FG000|Overall Study|Died before treatment initiation|1|||
146101986|NCT01540838|526893335|FG001|Overall Study|Died before treatment initiation|1|||
146101987|NCT01540838|526893334|FG000|Overall Study|Not BM. Other treatment|3|||
146101988|NCT01540838|526893335|FG001|Overall Study|Not BM. Other treatment|1|||
146101989|NCT02130570|526893336|FG000|Overall Study|Death|3|||
146101990|NCT02130570|526893337|FG001|Overall Study|Death|5|||
146101991|NCT02130570|526893336|FG000|Overall Study|Withdrawal by Subject|6|||
146101992|NCT02130570|526893337|FG001|Overall Study|Withdrawal by Subject|3|||
146101993|NCT02130570|526893336|FG000|Overall Study|Part of practice that discontinued study|0|||
146101994|NCT02130570|526893337|FG001|Overall Study|Part of practice that discontinued study|5|||
146101995|NCT00493025|526893340|FG000|Overall Study|Physician Decision|19|||
146101996|NCT03863197|526893341|FG000|Overall Study|Lost to Follow-up|2|||
146101997|NCT03863197|526893342|FG001|Overall Study|Lost to Follow-up|3|||
146101998|NCT03863197|526893341|FG000|Overall Study|Withdrawal by Subject|4|||
146101999|NCT03863197|526893342|FG001|Overall Study|Withdrawal by Subject|0|||
146102000|NCT03863197|526893341|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
146102001|NCT03863197|526893342|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
146102002|NCT01065597|526893343|FG000|Overall Study|Adverse Event|1|||
146102003|NCT01622231|526893344|FG000|Overall Study|Physician Decision|1|||
146102004|NCT01622231|526893344|FG000|Overall Study|Withdrawal by Subject|1|||
146102005|NCT01032174|526893348|FG000|Overall Study|Adverse Event|0|||
146102006|NCT01032174|526893349|FG001|Overall Study|Adverse Event|1|||
146102007|NCT01986907|526893352|FG000|Overall Study|Adverse Event|11|||
146102008|NCT01986907|526893352|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
146102009|NCT01986907|526893352|FG000|Overall Study|Protocol Violation|4|||
146102010|NCT01986907|526893352|FG000|Overall Study|Withdrawal by Subject|76|||
146102011|NCT01986907|526893352|FG000|Overall Study|Lost to Follow-up|38|||
146102012|NCT01986907|526893352|FG000|Overall Study|Death|9|||
146102013|NCT00467857|526893355|FG000|Overall Study|Adverse Event|1|||
146102014|NCT00467857|526893356|FG001|Overall Study|Adverse Event|0|||
146102015|NCT00467857|526893355|FG000|Overall Study|Withdrew consent|2|||
146102016|NCT00467857|526893356|FG001|Overall Study|Withdrew consent|0|||
146102017|NCT00467857|526893355|FG000|Overall Study|Death|0|||
146102018|NCT00467857|526893356|FG001|Overall Study|Death|1|||
146102019|NCT00467857|526893355|FG000|Overall Study|Discharged from court service|0|||
146102020|NCT00467857|526893356|FG001|Overall Study|Discharged from court service|1|||
146102021|NCT00467857|526893355|FG000|Overall Study|Emergency care required|0|||
146102022|NCT00467857|526893356|FG001|Overall Study|Emergency care required|1|||
146102023|NCT00467857|526893355|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
146102024|NCT00467857|526893356|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
146102025|NCT00467857|526893355|FG000|Overall Study|Discontinuation reason missing|0|||
146102026|NCT00467857|526893356|FG001|Overall Study|Discontinuation reason missing|3|||
146102027|NCT03576495|526893358|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
146102028|NCT03576495|526893359|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
146102029|NCT02635776|526893360|FG000|Overall Study|Physician Decision|1|||
146102030|NCT02635776|526893361|FG001|Overall Study|Physician Decision|0|||
146102031|NCT02635776|526893360|FG000|Overall Study|Adverse Event|51|||
146102032|NCT02635776|526893361|FG001|Overall Study|Adverse Event|3|||
146102033|NCT02635776|526893360|FG000|Overall Study|Withdrawal by Subject|41|||
146102034|NCT02635776|526893361|FG001|Overall Study|Withdrawal by Subject|7|||
146102035|NCT02635776|526893360|FG000|Overall Study|Lost to Follow-up|4|||
146102036|NCT02635776|526893361|FG001|Overall Study|Lost to Follow-up|0|||
146102037|NCT02635776|526893360|FG000|Overall Study|Other reasons|5|||
146102038|NCT02635776|526893361|FG001|Overall Study|Other reasons|1|||
146102039|NCT00788073|526893363|FG000|STX209 Then Placebo|Adverse Event|1|||
146102040|NCT00788073|526893364|FG001|STX209 Then Placebo|Adverse Event|0|||
146102041|NCT00788073|526893363|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
146102042|NCT00788073|526893364|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
146102043|NCT00788073|526893363|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
146102044|NCT00788073|526893364|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
146102045|NCT00788073|526893363|FG000|STX209 Then Placebo|unable to return due to travel|0|||
146102046|NCT00788073|526893364|FG001|STX209 Then Placebo|unable to return due to travel|1|||
146102047|NCT00788073|526893363|FG000|Placebo Then STX209|Adverse Event|2|||
146300641|NCT01087957|527617075|FG001|Overall Study|Protocol Violation|25|||
146300642|NCT01087957|527617074|FG000|Overall Study|Withdrawal by Subject|18|||
146300643|NCT01087957|527617075|FG001|Overall Study|Withdrawal by Subject|15|||
146300644|NCT01087957|527617074|FG000|Overall Study|Physician Decision|5|||
146300645|NCT01087957|527617075|FG001|Overall Study|Physician Decision|9|||
146044417|NCT01449006|526676825|FG000|Overall Study|Protocol Violation|1|||
146044418|NCT01449006|526676826|FG001|Overall Study|Protocol Violation|0|||
146102048|NCT00788073|526893364|FG001|Placebo Then STX209|Adverse Event|0|||
146102049|NCT00788073|526893363|FG000|Placebo Then STX209|Protocol Violation|0|||
146102050|NCT00788073|526893364|FG001|Placebo Then STX209|Protocol Violation|1|||
146102051|NCT03608254|526893365|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
146102052|NCT03608254|526893365|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
146102053|NCT00660673|526893366|FG000|Overall Study|Adverse Event|84|||
146102054|NCT00660673|526893366|FG000|Overall Study|Lack of Efficacy|7|||
146102055|NCT00660673|526893366|FG000|Overall Study|Withdrawal by Subject|22|||
146102056|NCT00660673|526893366|FG000|Overall Study|Administrative|2|||
146044419|NCT03526146|526676827|FG000|Overall Study|Lost to Follow-up|5|||
146044420|NCT03526146|526676827|FG000|Overall Study|Withdrawal by Subject|6|||
146044421|NCT03526146|526676827|FG000|Overall Study|class canceled due to COVID-19|4|||
146044422|NCT02588261|526676828|FG000|Overall Study|Study Terminated by Sponsor|157|||
146044423|NCT02588261|526676829|FG001|Overall Study|Study Terminated by Sponsor|142|||
146044424|NCT02588261|526676828|FG000|Overall Study|Protocol Deviation|1|||
146044425|NCT02588261|526676829|FG001|Overall Study|Protocol Deviation|0|||
146044426|NCT02588261|526676828|FG000|Overall Study|Death|1|||
146044427|NCT02588261|526676829|FG001|Overall Study|Death|2|||
146044428|NCT02588261|526676828|FG000|Overall Study|Withdrawal by Subject|12|||
146044429|NCT02588261|526676829|FG001|Overall Study|Withdrawal by Subject|8|||
146044430|NCT02588261|526676828|FG000|Overall Study|Noncompliance with Study Drug|0|||
146044431|NCT02588261|526676829|FG001|Overall Study|Noncompliance with Study Drug|1|||
146044432|NCT02588261|526676828|FG000|Overall Study|Miscellaneous|5|||
146044433|NCT02588261|526676829|FG001|Overall Study|Miscellaneous|4|||
146044434|NCT02588261|526676828|FG000|Overall Study|Progressive Disease|61|||
146044435|NCT02588261|526676829|FG001|Overall Study|Progressive Disease|82|||
146044436|NCT02588261|526676828|FG000|Overall Study|Adverse Event|29|||
146044437|NCT02588261|526676829|FG001|Overall Study|Adverse Event|24|||
146044438|NCT02588261|526676828|FG000|Overall Study|Lost to Follow-up|1|||
146044439|NCT02588261|526676829|FG001|Overall Study|Lost to Follow-up|0|||
146044440|NCT01746368|526676834|FG000|Overall Study|Lost to Follow-up|2|||
146044441|NCT01746368|526676835|FG001|Overall Study|Lost to Follow-up|0|||
146044442|NCT01746368|526676834|FG000|Overall Study|Withdrawal by Subject|0|||
146044443|NCT01746368|526676835|FG001|Overall Study|Withdrawal by Subject|1|||
146044444|NCT05636852|526676836|FG000|Overall Study|Withdrawal by Subject|1|||
146044445|NCT05636852|526676836|FG000|Overall Study|Other than specified|1|||
146044446|NCT00195091|526676838|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
146044447|NCT01979952|526676848|FG000|Overall Study|Adverse Event|4|||
146044448|NCT01979952|526676849|FG001|Overall Study|Adverse Event|5|||
146044449|NCT01979952|526676848|FG000|Overall Study|Protocol Violation|1|||
146044450|NCT01979952|526676849|FG001|Overall Study|Protocol Violation|0|||
146044451|NCT01979952|526676848|FG000|Overall Study|Withdrawal by Subject|2|||
146044452|NCT01979952|526676849|FG001|Overall Study|Withdrawal by Subject|1|||
146044453|NCT01979952|526676848|FG000|Overall Study|Other than specified above|1|||
146044454|NCT01979952|526676849|FG001|Overall Study|Other than specified above|0|||
146044455|NCT03364738|526676850|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
146044456|NCT03364738|526676850|FG000|Overall Study|Withdrawal by Subject|1|||
146102057|NCT00660673|526893366|FG000|Overall Study|Protocol Violation|2|||
146102058|NCT00516074|526893368|FG000|Overall Study|Adverse Event|0|||
146102059|NCT00516074|526893369|FG001|Overall Study|Adverse Event|1|||
146102060|NCT00516074|526893368|FG000|Overall Study|Subject Decision|4|||
146102061|NCT00516074|526893369|FG001|Overall Study|Subject Decision|2|||
146102062|NCT00516074|526893368|FG000|Overall Study|Loss of Glucose Control|2|||
146102063|NCT00516074|526893369|FG001|Overall Study|Loss of Glucose Control|0|||
146102064|NCT05213481|526893370|FG000|Overall Study|Adverse Event|3|||
146102065|NCT05213481|526893370|FG000|Overall Study|Lost to Follow-up|1|||
146102066|NCT03822182|526893374|FG000|Overall Study|Protocol Violation|0|||
146102067|NCT03822182|526893375|FG001|Overall Study|Protocol Violation|1|||
146300646|NCT01186939|527617076|FG000|Overall Study|Death|7|||
146102068|NCT03822182|526893376|FG002|Overall Study|Protocol Violation|1|||
146102069|NCT01612858|526893378|FG000|Overall Study|Withdrawal by Subject|5|||
146102070|NCT01612858|526893379|FG001|Overall Study|Withdrawal by Subject|1|||
146044457|NCT03364738|526676850|FG000|Overall Study|Adverse Event|1|||
146102071|NCT01484275|526893380|FG000|Overall Study|Study terminated by sponsor|28|||
146102072|NCT01484275|526893381|FG001|Overall Study|Study terminated by sponsor|32|||
146102073|NCT01484275|526893380|FG000|Overall Study|Other|10|||
146102074|NCT01484275|526893381|FG001|Overall Study|Other|0|||
146102075|NCT01484275|526893380|FG000|Overall Study|Death|3|||
146102076|NCT01484275|526893381|FG001|Overall Study|Death|4|||
146102077|NCT01484275|526893380|FG000|Overall Study|Withdrawal by Subject|1|||
146102078|NCT01484275|526893381|FG001|Overall Study|Withdrawal by Subject|5|||
146102079|NCT01484275|526893380|FG000|Overall Study|Lost to Follow-up|1|||
146102080|NCT01484275|526893381|FG001|Overall Study|Lost to Follow-up|1|||
146102081|NCT00657358|526893384|FG000|Overall Study|Lack of Efficacy|6|||
146102082|NCT01893203|526893389|FG000|Overall Study|Withdrawal by Subject|1|||
146102083|NCT02925117|526893393|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
146102084|NCT02925117|526893394|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
146102085|NCT02925117|526893395|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
146102086|NCT02925117|526893396|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
146044458|NCT04079816|526676851|FG000|Overall Study|Request of Subject|2|||
146044459|NCT04079816|526676851|FG000|Overall Study|Unable to draw samples|1|||
146044460|NCT02576795|526676852|FG000|Overall Study|Lost to Follow-up|0|||
146044461|NCT02576795|526676853|FG001|Overall Study|Lost to Follow-up|0|||
146044462|NCT02576795|526676854|FG002|Overall Study|Lost to Follow-up|1|||
146044463|NCT02576795|526676855|FG003|Overall Study|Lost to Follow-up|0|||
146044464|NCT01702246|526676856|FG000|Overall Study|Lost to Follow-up|2|||
146044465|NCT01702246|526676856|FG000|Overall Study|Withdrawal by Subject|2|||
146044466|NCT01702246|526676856|FG000|Overall Study|Physician Decision|1|||
146044467|NCT01635855|526676867|FG000|Overall Study|Withdrawal by Subject|4|||
146044468|NCT02708355|526676871|FG000|Overall Study|Adverse Event|1|||
146044469|NCT02708355|526676872|FG001|Overall Study|Adverse Event|0|||
146044470|NCT02708355|526676873|FG002|Overall Study|Adverse Event|0|||
146044471|NCT01320202|526676874|FG000|Overall Study|Adverse Event|5|||
146044472|NCT01320202|526676875|FG001|Overall Study|Adverse Event|5|||
146044473|NCT01320202|526676874|FG000|Overall Study|Death|5|||
146044474|NCT01320202|526676875|FG001|Overall Study|Death|3|||
146044475|NCT01320202|526676874|FG000|Overall Study|Lost to Follow-up|1|||
146044476|NCT01320202|526676875|FG001|Overall Study|Lost to Follow-up|0|||
146044477|NCT01320202|526676874|FG000|Overall Study|Physician Decision|3|||
146044478|NCT01320202|526676875|FG001|Overall Study|Physician Decision|1|||
146044479|NCT01320202|526676874|FG000|Overall Study|Protocol Violation|2|||
146044480|NCT01320202|526676875|FG001|Overall Study|Protocol Violation|1|||
146044481|NCT01320202|526676874|FG000|Overall Study|Withdrawal by Subject|10|||
146044482|NCT01320202|526676875|FG001|Overall Study|Withdrawal by Subject|3|||
146044483|NCT01320202|526676874|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
146044484|NCT01320202|526676875|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
146044485|NCT01320202|526676874|FG000|Overall Study|kidney transplant|1|||
146044486|NCT01320202|526676875|FG001|Overall Study|kidney transplant|2|||
146044487|NCT01320202|526676874|FG000|Overall Study|blood transfusion|1|||
146044488|NCT01320202|526676875|FG001|Overall Study|blood transfusion|7|||
146044489|NCT01320202|526676874|FG000|Overall Study|moved/changed dialysis|5|||
146044490|NCT01320202|526676875|FG001|Overall Study|moved/changed dialysis|2|||
146044491|NCT01320202|526676874|FG000|Overall Study|sponsor request|2|||
146044492|NCT01320202|526676875|FG001|Overall Study|sponsor request|0|||
146044493|NCT01320202|526676874|FG000|Overall Study|ineligible|3|||
146044494|NCT01320202|526676875|FG001|Overall Study|ineligible|0|||
146044495|NCT01320202|526676874|FG000|Overall Study|regained renal function|1|||
146044496|NCT01320202|526676875|FG001|Overall Study|regained renal function|0|||
146044497|NCT04090242|526676876|FG000|Overall Study|Withdrawal by Subject|1|||
146044498|NCT04090242|526676877|FG001|Overall Study|Withdrawal by Subject|0|||
146044499|NCT02513472|526676878|FG000|Overall Study|Radiological Disease Progression|45|||
146044500|NCT02513472|526676879|FG001|Overall Study|Radiological Disease Progression|57|||
146102087|NCT02925117|526893397|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102088|NCT02925117|526893398|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102089|NCT02925117|526893399|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102090|NCT02925117|526893400|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102091|NCT02925117|526893401|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102092|NCT02925117|526893402|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102093|NCT02925117|526893403|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102094|NCT02925117|526893404|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
146102095|NCT02925117|526893393|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
146102096|NCT02925117|526893394|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
146102097|NCT02925117|526893395|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
146102098|NCT02925117|526893396|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102099|NCT02925117|526893397|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146044501|NCT02513472|526676878|FG000|Overall Study|Clinical Disease Progression|5|||
146044502|NCT02513472|526676879|FG001|Overall Study|Clinical Disease Progression|13|||
146044503|NCT02513472|526676878|FG000|Overall Study|Adverse Event|8|||
146044504|NCT02513472|526676879|FG001|Overall Study|Adverse Event|11|||
146044505|NCT02513472|526676878|FG000|Overall Study|Withdrawal by Subject|0|||
146044506|NCT02513472|526676879|FG001|Overall Study|Withdrawal by Subject|4|||
146044507|NCT02513472|526676878|FG000|Overall Study|Subject Choice|2|||
146044508|NCT02513472|526676879|FG001|Overall Study|Subject Choice|7|||
146044509|NCT02513472|526676878|FG000|Overall Study|Treatment Completed as per Protocol|3|||
146044510|NCT02513472|526676879|FG001|Overall Study|Treatment Completed as per Protocol|3|||
146255173|NCT02675998|527448507|FG002|8-Week Treatment Period|GI side Effects|2|||
146255174|NCT02675998|527448508|FG003|8-Week Treatment Period|GI side Effects|0|||
146255175|NCT02675998|527448505|FG000|8-Week Treatment Period|Protocol Violation|1|||
146044511|NCT02513472|526676878|FG000|Overall Study|Other|3|||
146044512|NCT02513472|526676879|FG001|Overall Study|Other|6|||
146044513|NCT01019369|526676880|FG000|Overall Study|Lost to Follow-up|10|||
146044514|NCT01019369|526676881|FG001|Overall Study|Lost to Follow-up|6|||
146044515|NCT01019369|526676880|FG000|Overall Study|Withdrawal by Subject|0|||
146044516|NCT01019369|526676881|FG001|Overall Study|Withdrawal by Subject|1|||
146044517|NCT00604695|526676882|FG000|Overall Study|Did not receive first bolus.|0|||
146044518|NCT00604695|526676883|FG001|Overall Study|Did not receive first bolus.|4|||
146044519|NCT03214406|526676884|FG000|Overall Study|did not meet enrollment criteria|9|||
146044520|NCT03214406|526676885|FG001|Overall Study|did not meet enrollment criteria|13|||
146044521|NCT03214406|526676884|FG000|Overall Study|Withdrawal by Subject|1|||
146044522|NCT03214406|526676885|FG001|Overall Study|Withdrawal by Subject|0|||
146044523|NCT03214406|526676884|FG000|Overall Study|Lost to Follow-up|0|||
146044524|NCT03214406|526676885|FG001|Overall Study|Lost to Follow-up|2|||
146044525|NCT01098305|526676888|FG000|Overall Study|Lost to Follow-up|31|||
146044526|NCT01098305|526676889|FG001|Overall Study|Lost to Follow-up|33|||
146044527|NCT04565951|526676896|FG000|Overall Study|Lost to Follow-up|66|||
146044528|NCT04565951|526676897|FG001|Overall Study|Lost to Follow-up|38|||
146044529|NCT04565951|526676896|FG000|Overall Study|Withdrawal by Subject|14|||
146044530|NCT04565951|526676897|FG001|Overall Study|Withdrawal by Subject|7|||
146044531|NCT04565951|526676896|FG000|Overall Study|Death|0|||
146044532|NCT04565951|526676897|FG001|Overall Study|Death|1|||
146044533|NCT00429169|526676899|FG000|Overall Study|Lost to Follow-up|0|||
146044534|NCT00429169|526676900|FG001|Overall Study|Lost to Follow-up|1|||
146044535|NCT00429169|526676899|FG000|Overall Study|Ineligibility discovered after entry|2|||
146044536|NCT00429169|526676900|FG001|Overall Study|Ineligibility discovered after entry|1|||
146044537|NCT01746173|526676906|FG000|Overall Study|Disease Progression|2|||
146044538|NCT00172042|526676910|FG000|Overall Study|Adverse Event|27|||
146044539|NCT00172042|526676911|FG001|Overall Study|Adverse Event|13|||
146044540|NCT00172042|526676910|FG000|Overall Study|Abnormal laboratory value(s)|5|||
146044541|NCT00172042|526676911|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146044542|NCT00172042|526676910|FG000|Overall Study|Abnormal test procedure(s)|0|||
146044543|NCT00172042|526676911|FG001|Overall Study|Abnormal test procedure(s)|3|||
146044544|NCT00172042|526676910|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
146044545|NCT00172042|526676911|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
146044546|NCT00172042|526676910|FG000|Overall Study|Patient no longer requires study drug|10|||
146044547|NCT00172042|526676911|FG001|Overall Study|Patient no longer requires study drug|8|||
146044548|NCT00172042|526676910|FG000|Overall Study|Protocol Violation|8|||
146044549|NCT00172042|526676911|FG001|Overall Study|Protocol Violation|7|||
146044550|NCT00172042|526676910|FG000|Overall Study|Withdrawal by Subject|37|||
146044551|NCT00172042|526676911|FG001|Overall Study|Withdrawal by Subject|25|||
146044552|NCT00172042|526676910|FG000|Overall Study|Lost to Follow-up|3|||
146044553|NCT00172042|526676911|FG001|Overall Study|Lost to Follow-up|5|||
146044554|NCT00172042|526676910|FG000|Overall Study|Administrative problems|13|||
146044555|NCT00172042|526676911|FG001|Overall Study|Administrative problems|10|||
146044556|NCT00172042|526676910|FG000|Overall Study|Death|42|||
146044557|NCT00172042|526676911|FG001|Overall Study|Death|42|||
146044558|NCT01771250|526676912|FG000|Period 1|Met exclusion criteria|1|||
146044559|NCT01771250|526676913|FG001|Period 1|Met exclusion criteria|0|||
146044560|NCT02508428|526676914|FG000|Overall Study|Death|32|||
146044561|NCT02508428|526676915|FG001|Overall Study|Death|33|||
146044562|NCT02508428|526676914|FG000|Overall Study|Liner revised|3|||
146044563|NCT02508428|526676915|FG001|Overall Study|Liner revised|19|||
146044564|NCT02508428|526676914|FG000|Overall Study|Incomplete follow-up|17|||
146044565|NCT02508428|526676915|FG001|Overall Study|Incomplete follow-up|15|||
146044566|NCT00534976|526676917|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
146044567|NCT00534976|526676918|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
146044568|NCT00534976|526676917|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
146044569|NCT00534976|526676918|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
146044570|NCT00534976|526676917|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
146044571|NCT00534976|526676918|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
146044572|NCT02092025|526676919|FG000|Overall Study|Case Report Forms Uncollected|44|||
146044573|NCT02092025|526676919|FG000|Overall Study|Protocol Deviation|24|||
146255176|NCT02675998|527448506|FG001|8-Week Treatment Period|Protocol Violation|1|||
146255177|NCT02675998|527448507|FG002|8-Week Treatment Period|Protocol Violation|1|||
146255178|NCT02675998|527448508|FG003|8-Week Treatment Period|Protocol Violation|0|||
146255179|NCT02675998|527448505|FG000|8-Week Treatment Period|Other|3|||
146255180|NCT02675998|527448506|FG001|8-Week Treatment Period|Other|1|||
146044574|NCT00264537|526676920|FG000|Overall Study|Death|0|||
146044575|NCT00264537|526676921|FG001|Overall Study|Death|3|||
146255181|NCT02675998|527448507|FG002|8-Week Treatment Period|Other|2|||
146255182|NCT02675998|527448508|FG003|8-Week Treatment Period|Other|0|||
146044576|NCT00264537|526676922|FG002|Overall Study|Death|3|||
146044577|NCT00264537|526676923|FG003|Overall Study|Death|2|||
146044578|NCT00264537|526676920|FG000|Overall Study|Lost to Follow-up|3|||
146044579|NCT00264537|526676921|FG001|Overall Study|Lost to Follow-up|4|||
146044580|NCT00264537|526676922|FG002|Overall Study|Lost to Follow-up|7|||
146044581|NCT00264537|526676923|FG003|Overall Study|Lost to Follow-up|6|||
146044582|NCT00264537|526676920|FG000|Overall Study|Adverse Event|21|||
146044583|NCT00264537|526676921|FG001|Overall Study|Adverse Event|32|||
146044584|NCT00264537|526676922|FG002|Overall Study|Adverse Event|24|||
146044585|NCT00264537|526676923|FG003|Overall Study|Adverse Event|34|||
146044586|NCT00264537|526676920|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146044587|NCT00264537|526676921|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
146044588|NCT00264537|526676922|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146044589|NCT00264537|526676923|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
146044590|NCT00264537|526676920|FG000|Overall Study|Other|21|||
146044591|NCT00264537|526676921|FG001|Overall Study|Other|11|||
146044592|NCT00264537|526676922|FG002|Overall Study|Other|10|||
146044593|NCT00264537|526676923|FG003|Overall Study|Other|11|||
146044594|NCT00264537|526676920|FG000|Overall Study|Not treated|0|||
146044595|NCT00264537|526676921|FG001|Overall Study|Not treated|2|||
146044596|NCT00264537|526676922|FG002|Overall Study|Not treated|1|||
146044597|NCT00264537|526676923|FG003|Overall Study|Not treated|0|||
146044598|NCT00615017|526678874|FG000|Overall Study|Adverse Event|0|||
146044599|NCT00615017|526678875|FG001|Overall Study|Adverse Event|1|||
146044600|NCT00615017|526678876|FG002|Overall Study|Adverse Event|2|||
146044601|NCT00615017|526678877|FG003|Overall Study|Adverse Event|0|||
146044602|NCT00615017|526678878|FG004|Overall Study|Adverse Event|0|||
146044603|NCT00615017|526678879|FG005|Overall Study|Adverse Event|1|||
146044604|NCT00615017|526678874|FG000|Overall Study|Death|0|||
146044605|NCT00615017|526678875|FG001|Overall Study|Death|0|||
146044606|NCT00615017|526678876|FG002|Overall Study|Death|2|||
146044607|NCT00615017|526678877|FG003|Overall Study|Death|0|||
146044608|NCT00615017|526678878|FG004|Overall Study|Death|1|||
146044609|NCT00615017|526678879|FG005|Overall Study|Death|1|||
146044610|NCT00615017|526678874|FG000|Overall Study|Sepsis resolved|0|||
146044611|NCT00615017|526678875|FG001|Overall Study|Sepsis resolved|0|||
146044612|NCT00615017|526678876|FG002|Overall Study|Sepsis resolved|1|||
146044613|NCT00615017|526678877|FG003|Overall Study|Sepsis resolved|0|||
146044614|NCT00615017|526678878|FG004|Overall Study|Sepsis resolved|0|||
146044615|NCT00615017|526678879|FG005|Overall Study|Sepsis resolved|0|||
146044616|NCT00615017|526678874|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
146044617|NCT00615017|526678875|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
146044618|NCT00615017|526678876|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
146044619|NCT00615017|526678877|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
146044620|NCT00615017|526678878|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
146044621|NCT00615017|526678879|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
146044622|NCT00615017|526678874|FG000|Overall Study|Physician discontinued drug|0|||
146044623|NCT00615017|526678875|FG001|Overall Study|Physician discontinued drug|0|||
146044624|NCT00615017|526678876|FG002|Overall Study|Physician discontinued drug|0|||
146044625|NCT00615017|526678877|FG003|Overall Study|Physician discontinued drug|0|||
146044626|NCT00615017|526678878|FG004|Overall Study|Physician discontinued drug|0|||
146044627|NCT00615017|526678879|FG005|Overall Study|Physician discontinued drug|1|||
146044628|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
146255183|NCT02675998|527448505|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
146255184|NCT02675998|527448506|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
146044629|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
146044630|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
146255185|NCT02675998|527448507|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
146255186|NCT02675998|527448508|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
146255187|NCT02675998|527448505|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
146255188|NCT02675998|527448506|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
146044631|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
146044632|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
146044633|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
146044634|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
146044635|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
146044636|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
146102100|NCT02925117|526893398|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102101|NCT02925117|526893399|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102102|NCT02925117|526893400|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102103|NCT02925117|526893401|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102104|NCT02925117|526893402|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102105|NCT02925117|526893403|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102106|NCT02925117|526893404|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
146102107|NCT02925117|526893393|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
146102108|NCT02925117|526893394|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
146102109|NCT02925117|526893395|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102110|NCT02925117|526893396|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102111|NCT02925117|526893397|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102112|NCT02925117|526893398|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102113|NCT02925117|526893399|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102114|NCT02925117|526893400|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102115|NCT02925117|526893401|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102116|NCT02925117|526893402|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102117|NCT02925117|526893403|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102118|NCT02925117|526893404|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
146102119|NCT02925117|526893393|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
146102120|NCT02925117|526893394|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
146102121|NCT02925117|526893395|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
146102122|NCT02925117|526893396|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
146102123|NCT02925117|526893397|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
146102124|NCT02925117|526893398|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
146102125|NCT02925117|526893399|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
146102126|NCT02925117|526893400|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
146102127|NCT02925117|526893401|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
146102128|NCT02925117|526893402|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
146102129|NCT02925117|526893403|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
146102130|NCT02925117|526893404|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
146102131|NCT02925117|526893393|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102132|NCT02925117|526893394|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102133|NCT02925117|526893395|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102134|NCT02925117|526893396|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102135|NCT02925117|526893397|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102136|NCT02925117|526893398|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
146102137|NCT02925117|526893399|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102138|NCT02925117|526893400|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102139|NCT02925117|526893401|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102140|NCT02925117|526893402|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
146102141|NCT02925117|526893403|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
146102142|NCT02925117|526893404|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
146102143|NCT02925117|526893393|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146102144|NCT02925117|526893394|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146102145|NCT02925117|526893395|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146102146|NCT02925117|526893396|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146102147|NCT02925117|526893397|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
146102148|NCT02925117|526893398|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
146102149|NCT02925117|526893399|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
146102150|NCT02925117|526893400|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
146102151|NCT02925117|526893401|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146102152|NCT02925117|526893402|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146102153|NCT02925117|526893403|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146102154|NCT02925117|526893404|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
146102155|NCT02925117|526893393|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146102156|NCT02925117|526893394|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146102157|NCT02925117|526893395|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146102158|NCT02925117|526893396|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146300647|NCT01186939|527617076|FG000|Overall Study|Withdrawal by Subject|2|||
146300648|NCT01186939|527617076|FG000|Overall Study|No longer receiving clinical benefit|17|||
146102159|NCT02925117|526893397|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146102160|NCT02925117|526893398|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
146102161|NCT02925117|526893399|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146102162|NCT02925117|526893400|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146102163|NCT02925117|526893401|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146102164|NCT02925117|526893402|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146102165|NCT02925117|526893403|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
146102166|NCT02925117|526893404|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
146102167|NCT02925117|526893393|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
146102168|NCT02925117|526893394|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
146102169|NCT02925117|526893395|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
146102170|NCT02925117|526893396|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
146102171|NCT02925117|526893397|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
146255189|NCT02675998|527448507|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
146255190|NCT02675998|527448508|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
146255191|NCT02675998|527448505|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146255192|NCT02675998|527448506|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146255193|NCT02675998|527448507|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
146255194|NCT02675998|527448508|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
146255195|NCT02675998|527448505|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
146255196|NCT02675998|527448506|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146255197|NCT02675998|527448507|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146255198|NCT02675998|527448508|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
146255199|NCT02675998|527448505|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146255200|NCT02675998|527448506|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146255201|NCT02675998|527448507|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
146255202|NCT02675998|527448508|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
146255203|NCT00275301|527448509|FG000|Overall Study|Adverse Event|5|||
146255204|NCT00598871|527448510|FG000|Overall Study|Adverse Event|0|||
146255205|NCT00598871|527448511|FG001|Overall Study|Adverse Event|1|||
146255206|NCT01194271|527448512|FG000|Overall Study|Withdrawal by Subject|1|||
146255207|NCT01194271|527448512|FG000|Overall Study|Ineligible, Screen Failure|1|||
146255208|NCT01194271|527448512|FG000|Overall Study|Death|1|||
146255209|NCT01983462|527448515|FG000|Overall Study|Adverse Event|1|||
146255210|NCT01983462|527448516|FG001|Overall Study|Adverse Event|0|||
146255211|NCT01983462|527448517|FG002|Overall Study|Adverse Event|0|||
146255212|NCT00550771|527448521|FG000|Overall Study|Adverse Event|11|||
146255213|NCT00550771|527448522|FG001|Overall Study|Adverse Event|3|||
146255214|NCT00550771|527448521|FG000|Overall Study|Discontinued for study-related reasons|0|||
146255215|NCT00550771|527448522|FG001|Overall Study|Discontinued for study-related reasons|1|||
146255216|NCT00550771|527448521|FG000|Overall Study|Physician Decision|2|||
146255217|NCT00550771|527448522|FG001|Overall Study|Physician Decision|0|||
146255218|NCT00550771|527448521|FG000|Overall Study|Withdrawal by Subject|0|||
146255219|NCT00550771|527448522|FG001|Overall Study|Withdrawal by Subject|1|||
146255220|NCT00550771|527448521|FG000|Overall Study|Protocol Violation|4|||
146255221|NCT00550771|527448522|FG001|Overall Study|Protocol Violation|5|||
146255222|NCT03022578|527448523|FG000|Overall Study|Adverse Event|1|||
146255223|NCT03022578|527448523|FG000|Overall Study|Lack of Efficacy|2|||
146255224|NCT03022578|527448523|FG000|Overall Study|Withdrawal by Subject|1|||
146255225|NCT03681353|527448524|FG000|Overall Study|Lost to Follow-up|2|||
146255226|NCT03681353|527448524|FG000|Overall Study|Withdrawal by Subject|3|||
146255227|NCT03681353|527448524|FG000|Overall Study|withdrawn by PI|2|||
146255228|NCT00382408|527448528|FG000|Overall Study|Did not meet protocol requirement|3|||
146255229|NCT00382408|527448529|FG001|Overall Study|Did not meet protocol requirement|3|||
146255230|NCT00382408|527448528|FG000|Overall Study|Protocol Violation|2|||
146300649|NCT01186939|527617076|FG000|Overall Study|Program closed|5|||
146044637|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
146044638|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
146044639|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
146044640|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
146044641|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
146044642|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
146044643|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
146044644|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146044645|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
146044646|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146044647|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
146044648|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
146102172|NCT02925117|526893398|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
146255231|NCT00382408|527448529|FG001|Overall Study|Protocol Violation|2|||
146255232|NCT00382408|527448528|FG000|Overall Study|Physician Decision|1|||
146255233|NCT00382408|527448529|FG001|Overall Study|Physician Decision|0|||
146255234|NCT00382408|527448528|FG000|Overall Study|Withdrawal by Subject|17|||
146255235|NCT00382408|527448529|FG001|Overall Study|Withdrawal by Subject|6|||
146255236|NCT00382408|527448528|FG000|Overall Study|Pregnancy|2|||
146255237|NCT00382408|527448529|FG001|Overall Study|Pregnancy|0|||
146255238|NCT00382408|527448528|FG000|Overall Study|Lost to Follow-up|19|||
146255239|NCT00382408|527448529|FG001|Overall Study|Lost to Follow-up|8|||
146255240|NCT00382408|527448528|FG000|Overall Study|Other|100|||
146044649|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
146102173|NCT02925117|526893399|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
146255241|NCT00382408|527448529|FG001|Overall Study|Other|35|||
146255242|NCT02110225|527448530|FG000|Overall Study|Lost to Follow-up|0|||
146255243|NCT02110225|527448531|FG001|Overall Study|Lost to Follow-up|1|||
146300650|NCT01186939|527617076|FG000|Overall Study|Sponsor decision|4|||
146255244|NCT02110225|527448532|FG002|Overall Study|Lost to Follow-up|0|||
146255245|NCT02176018|527448533|FG000|Overall Study|Adverse Event|0|||
146102174|NCT02925117|526893400|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
146102175|NCT02925117|526893401|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
146102176|NCT02925117|526893402|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
146102177|NCT02925117|526893403|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
146102178|NCT02925117|526893404|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
146102179|NCT00347360|526893405|FG000|Overall Study|Adverse Event|1|||
146102180|NCT00347360|526893406|FG001|Overall Study|Adverse Event|2|||
146102181|NCT00347360|526893407|FG002|Overall Study|Adverse Event|0|||
146102182|NCT00347360|526893408|FG003|Overall Study|Adverse Event|4|||
146102183|NCT00347360|526893409|FG004|Overall Study|Adverse Event|1|||
146102184|NCT00347360|526893410|FG005|Overall Study|Adverse Event|2|||
146102185|NCT00347360|526893411|FG006|Overall Study|Adverse Event|2|||
146102186|NCT00347360|526893412|FG007|Overall Study|Adverse Event|0|||
146102187|NCT00347360|526893413|FG008|Overall Study|Adverse Event|2|||
146102188|NCT00347360|526893414|FG009|Overall Study|Adverse Event|3|||
146102189|NCT00347360|526893415|FG010|Overall Study|Adverse Event|3|||
146102190|NCT00347360|526893416|FG011|Overall Study|Adverse Event|1|||
146102191|NCT00347360|526893417|FG012|Overall Study|Adverse Event|3|||
146102192|NCT00347360|526893418|FG013|Overall Study|Adverse Event|2|||
146102193|NCT00347360|526893419|FG014|Overall Study|Adverse Event|2|||
146102194|NCT00347360|526893405|FG000|Overall Study|Lost to Follow-up|0|||
146102195|NCT00347360|526893406|FG001|Overall Study|Lost to Follow-up|0|||
146102196|NCT00347360|526893407|FG002|Overall Study|Lost to Follow-up|0|||
146102197|NCT00347360|526893408|FG003|Overall Study|Lost to Follow-up|2|||
146102198|NCT00347360|526893409|FG004|Overall Study|Lost to Follow-up|1|||
146102199|NCT00347360|526893410|FG005|Overall Study|Lost to Follow-up|1|||
146102200|NCT00347360|526893411|FG006|Overall Study|Lost to Follow-up|0|||
146102201|NCT00347360|526893412|FG007|Overall Study|Lost to Follow-up|1|||
146102202|NCT00347360|526893413|FG008|Overall Study|Lost to Follow-up|1|||
146102203|NCT00347360|526893414|FG009|Overall Study|Lost to Follow-up|2|||
146102204|NCT00347360|526893415|FG010|Overall Study|Lost to Follow-up|0|||
146102205|NCT00347360|526893416|FG011|Overall Study|Lost to Follow-up|0|||
146102206|NCT00347360|526893417|FG012|Overall Study|Lost to Follow-up|1|||
146102207|NCT00347360|526893418|FG013|Overall Study|Lost to Follow-up|0|||
146102208|NCT00347360|526893419|FG014|Overall Study|Lost to Follow-up|0|||
146102209|NCT00347360|526893405|FG000|Overall Study|Protocol Violation|2|||
146102210|NCT00347360|526893406|FG001|Overall Study|Protocol Violation|3|||
146255246|NCT02176018|527448534|FG001|Overall Study|Adverse Event|2|||
146255247|NCT02176018|527448533|FG000|Overall Study|Lost to Follow-up|3|||
146255248|NCT02176018|527448534|FG001|Overall Study|Lost to Follow-up|1|||
146255249|NCT02176018|527448533|FG000|Overall Study|Protocol Violation|1|||
146255250|NCT02176018|527448534|FG001|Overall Study|Protocol Violation|1|||
146255251|NCT02176018|527448533|FG000|Overall Study|Withdrawal by Subject|1|||
146255252|NCT02176018|527448534|FG001|Overall Study|Withdrawal by Subject|2|||
146255253|NCT00265096|527448535|FG000|Overall Study|Adverse Event|14|||
146255254|NCT00265096|527448536|FG001|Overall Study|Adverse Event|18|||
146255255|NCT00265096|527448537|FG002|Overall Study|Adverse Event|18|||
146255256|NCT00265096|527448535|FG000|Overall Study|Lost to Follow-up|2|||
146255257|NCT00265096|527448536|FG001|Overall Study|Lost to Follow-up|5|||
146255258|NCT00265096|527448537|FG002|Overall Study|Lost to Follow-up|3|||
146255259|NCT00265096|527448535|FG000|Overall Study|Death|0|||
146255260|NCT00265096|527448536|FG001|Overall Study|Death|1|||
146255261|NCT00265096|527448537|FG002|Overall Study|Death|2|||
146300651|NCT01186939|527617076|FG000|Overall Study|Started additional treatment|1|||
146102211|NCT00347360|526893407|FG002|Overall Study|Protocol Violation|1|||
146102212|NCT00347360|526893408|FG003|Overall Study|Protocol Violation|2|||
146102213|NCT00347360|526893409|FG004|Overall Study|Protocol Violation|1|||
146300652|NCT01186939|527617076|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
146102214|NCT00347360|526893410|FG005|Overall Study|Protocol Violation|2|||
146102215|NCT00347360|526893411|FG006|Overall Study|Protocol Violation|0|||
146102216|NCT00347360|526893412|FG007|Overall Study|Protocol Violation|0|||
146300653|NCT01186939|527617076|FG000|Overall Study|Myocardial infarction|1|||
146102217|NCT00347360|526893413|FG008|Overall Study|Protocol Violation|1|||
146102218|NCT00347360|526893414|FG009|Overall Study|Protocol Violation|2|||
146300654|NCT01186939|527617076|FG000|Overall Study|Bone marrow transplant|1|||
146102219|NCT00347360|526893415|FG010|Overall Study|Protocol Violation|0|||
146102220|NCT00347360|526893416|FG011|Overall Study|Protocol Violation|0|||
146102221|NCT00347360|526893417|FG012|Overall Study|Protocol Violation|0|||
146300655|NCT01186939|527617076|FG000|Overall Study|Transformation to AML|1|||
146300656|NCT03945591|527617081|FG000|Overall Study|Participant not transplanted|1|||
146300657|NCT03945591|527617081|FG000|Overall Study|Change in treatment plan|3|||
146300658|NCT03945591|527617081|FG000|Overall Study|Adverse Event|1|||
146102222|NCT00347360|526893418|FG013|Overall Study|Protocol Violation|1|||
146102223|NCT00347360|526893419|FG014|Overall Study|Protocol Violation|0|||
146102224|NCT00347360|526893405|FG000|Overall Study|Withdrawal by Subject|0|||
146102225|NCT00347360|526893406|FG001|Overall Study|Withdrawal by Subject|1|||
146102226|NCT00347360|526893407|FG002|Overall Study|Withdrawal by Subject|2|||
146102227|NCT00347360|526893408|FG003|Overall Study|Withdrawal by Subject|4|||
146102228|NCT00347360|526893409|FG004|Overall Study|Withdrawal by Subject|1|||
146102229|NCT00347360|526893410|FG005|Overall Study|Withdrawal by Subject|2|||
146102230|NCT00347360|526893411|FG006|Overall Study|Withdrawal by Subject|1|||
146102231|NCT00347360|526893412|FG007|Overall Study|Withdrawal by Subject|1|||
146102232|NCT00347360|526893413|FG008|Overall Study|Withdrawal by Subject|1|||
146102233|NCT00347360|526893414|FG009|Overall Study|Withdrawal by Subject|1|||
146102234|NCT00347360|526893415|FG010|Overall Study|Withdrawal by Subject|0|||
146102235|NCT00347360|526893416|FG011|Overall Study|Withdrawal by Subject|3|||
146102236|NCT00347360|526893417|FG012|Overall Study|Withdrawal by Subject|4|||
146102237|NCT00347360|526893418|FG013|Overall Study|Withdrawal by Subject|2|||
146102238|NCT00347360|526893419|FG014|Overall Study|Withdrawal by Subject|1|||
146102239|NCT00347360|526893405|FG000|Overall Study|Lack of Efficacy|1|||
146102240|NCT00347360|526893406|FG001|Overall Study|Lack of Efficacy|1|||
146102241|NCT00347360|526893407|FG002|Overall Study|Lack of Efficacy|3|||
146102242|NCT00347360|526893408|FG003|Overall Study|Lack of Efficacy|1|||
146102243|NCT00347360|526893409|FG004|Overall Study|Lack of Efficacy|0|||
146102244|NCT00347360|526893410|FG005|Overall Study|Lack of Efficacy|1|||
146102245|NCT00347360|526893411|FG006|Overall Study|Lack of Efficacy|0|||
146102246|NCT00347360|526893412|FG007|Overall Study|Lack of Efficacy|1|||
146102247|NCT00347360|526893413|FG008|Overall Study|Lack of Efficacy|1|||
146102248|NCT00347360|526893414|FG009|Overall Study|Lack of Efficacy|0|||
146102249|NCT00347360|526893415|FG010|Overall Study|Lack of Efficacy|0|||
146102250|NCT00347360|526893416|FG011|Overall Study|Lack of Efficacy|0|||
146102251|NCT00347360|526893417|FG012|Overall Study|Lack of Efficacy|0|||
146102252|NCT00347360|526893418|FG013|Overall Study|Lack of Efficacy|0|||
146102253|NCT00347360|526893419|FG014|Overall Study|Lack of Efficacy|0|||
146102254|NCT00347360|526893405|FG000|Overall Study|Reason not listed/blank|1|||
146102255|NCT00347360|526893406|FG001|Overall Study|Reason not listed/blank|0|||
146102256|NCT00347360|526893407|FG002|Overall Study|Reason not listed/blank|0|||
146102257|NCT00347360|526893408|FG003|Overall Study|Reason not listed/blank|0|||
146102258|NCT00347360|526893409|FG004|Overall Study|Reason not listed/blank|0|||
146102259|NCT00347360|526893410|FG005|Overall Study|Reason not listed/blank|0|||
146102260|NCT00347360|526893411|FG006|Overall Study|Reason not listed/blank|1|||
146102261|NCT00347360|526893412|FG007|Overall Study|Reason not listed/blank|0|||
146102262|NCT00347360|526893413|FG008|Overall Study|Reason not listed/blank|0|||
146102263|NCT00347360|526893414|FG009|Overall Study|Reason not listed/blank|0|||
146102264|NCT00347360|526893415|FG010|Overall Study|Reason not listed/blank|0|||
146102265|NCT00347360|526893416|FG011|Overall Study|Reason not listed/blank|0|||
146102266|NCT00347360|526893417|FG012|Overall Study|Reason not listed/blank|0|||
146102267|NCT00347360|526893418|FG013|Overall Study|Reason not listed/blank|1|||
146102268|NCT00347360|526893419|FG014|Overall Study|Reason not listed/blank|0|||
146255262|NCT00265096|527448535|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146255263|NCT00265096|527448536|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146255264|NCT00265096|527448537|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146255265|NCT00265096|527448535|FG000|Overall Study|Other|11|||
146255266|NCT00265096|527448536|FG001|Overall Study|Other|19|||
146255267|NCT00265096|527448537|FG002|Overall Study|Other|10|||
146255268|NCT00774306|527448538|FG000|Overall Study|Adverse Event|3|||
146255269|NCT00774306|527448539|FG001|Overall Study|Adverse Event|0|||
146255270|NCT00774306|527448540|FG002|Overall Study|Adverse Event|0|||
146255271|NCT00774306|527448541|FG003|Overall Study|Adverse Event|0|||
146255272|NCT00774306|527448538|FG000|Overall Study|Protocol Violation|2|||
146255273|NCT00774306|527448539|FG001|Overall Study|Protocol Violation|0|||
146255274|NCT00774306|527448540|FG002|Overall Study|Protocol Violation|3|||
146255275|NCT00774306|527448541|FG003|Overall Study|Protocol Violation|0|||
146255276|NCT00774306|527448538|FG000|Overall Study|Withdrawal by Subject|6|||
146255277|NCT00774306|527448539|FG001|Overall Study|Withdrawal by Subject|1|||
146255278|NCT00774306|527448540|FG002|Overall Study|Withdrawal by Subject|1|||
146255279|NCT00774306|527448541|FG003|Overall Study|Withdrawal by Subject|0|||
146255280|NCT00774306|527448538|FG000|Overall Study|Lost to Follow-up|6|||
146255281|NCT00774306|527448539|FG001|Overall Study|Lost to Follow-up|0|||
146255282|NCT00774306|527448540|FG002|Overall Study|Lost to Follow-up|4|||
146255283|NCT00774306|527448541|FG003|Overall Study|Lost to Follow-up|5|||
146255284|NCT00774306|527448538|FG000|Overall Study|Death|1|||
146255285|NCT00774306|527448539|FG001|Overall Study|Death|1|||
146255286|NCT00774306|527448540|FG002|Overall Study|Death|0|||
146255287|NCT00774306|527448541|FG003|Overall Study|Death|0|||
146255288|NCT00809783|527448547|FG000|Overall Study|Death|1|||
146102269|NCT00347360|526893405|FG000|Overall Study|Per sponsors instruction|0|||
146102270|NCT00347360|526893406|FG001|Overall Study|Per sponsors instruction|1|||
146102271|NCT00347360|526893407|FG002|Overall Study|Per sponsors instruction|0|||
146102272|NCT00347360|526893408|FG003|Overall Study|Per sponsors instruction|0|||
146102273|NCT00347360|526893409|FG004|Overall Study|Per sponsors instruction|0|||
146255289|NCT00809783|527448548|FG001|Overall Study|Death|0|||
146255290|NCT00809783|527448549|FG002|Overall Study|Death|0|||
146255291|NCT00809783|527448547|FG000|Overall Study|Adverse Event|34|||
146255292|NCT00809783|527448548|FG001|Overall Study|Adverse Event|52|||
146255293|NCT00809783|527448549|FG002|Overall Study|Adverse Event|71|||
146255294|NCT00809783|527448547|FG000|Overall Study|Lack of Efficacy|39|||
146255295|NCT00809783|527448548|FG001|Overall Study|Lack of Efficacy|52|||
146255296|NCT00809783|527448549|FG002|Overall Study|Lack of Efficacy|63|||
146102274|NCT00347360|526893410|FG005|Overall Study|Per sponsors instruction|0|||
146102275|NCT00347360|526893411|FG006|Overall Study|Per sponsors instruction|0|||
146102276|NCT00347360|526893412|FG007|Overall Study|Per sponsors instruction|0|||
146102277|NCT00347360|526893413|FG008|Overall Study|Per sponsors instruction|0|||
146102278|NCT00347360|526893414|FG009|Overall Study|Per sponsors instruction|0|||
146102279|NCT00347360|526893415|FG010|Overall Study|Per sponsors instruction|0|||
146102280|NCT00347360|526893416|FG011|Overall Study|Per sponsors instruction|0|||
146102281|NCT00347360|526893417|FG012|Overall Study|Per sponsors instruction|0|||
146102282|NCT00347360|526893418|FG013|Overall Study|Per sponsors instruction|0|||
146102283|NCT00347360|526893419|FG014|Overall Study|Per sponsors instruction|0|||
146102284|NCT00347360|526893405|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
146102285|NCT00347360|526893406|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
146102286|NCT00347360|526893407|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
146102287|NCT00347360|526893408|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
146102288|NCT00347360|526893409|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
146102289|NCT00347360|526893410|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
146102290|NCT00347360|526893411|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
146102291|NCT00347360|526893412|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
146102292|NCT00347360|526893413|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
146102293|NCT00347360|526893414|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
146102294|NCT00347360|526893415|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
146102295|NCT00347360|526893416|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
146102296|NCT00347360|526893417|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
146102297|NCT00347360|526893418|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
146102298|NCT00347360|526893419|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
146102299|NCT00347360|526893405|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
146102300|NCT00347360|526893406|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
146102301|NCT00347360|526893407|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
146102302|NCT00347360|526893408|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
146102303|NCT00347360|526893409|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
146102304|NCT00347360|526893410|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
146102305|NCT00347360|526893411|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
146102306|NCT00347360|526893412|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
146102307|NCT00347360|526893413|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
146102308|NCT00347360|526893414|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
146102309|NCT00347360|526893415|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
146102310|NCT00347360|526893416|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
146102311|NCT00347360|526893417|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
146102312|NCT00347360|526893418|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
146102313|NCT00347360|526893419|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
146102314|NCT00347360|526893405|FG000|Overall Study|Abnormal lab values|0|||
146102315|NCT00347360|526893406|FG001|Overall Study|Abnormal lab values|0|||
146102316|NCT00347360|526893407|FG002|Overall Study|Abnormal lab values|0|||
146102317|NCT00347360|526893408|FG003|Overall Study|Abnormal lab values|0|||
146102318|NCT00347360|526893409|FG004|Overall Study|Abnormal lab values|0|||
146102319|NCT00347360|526893410|FG005|Overall Study|Abnormal lab values|0|||
146102320|NCT00347360|526893411|FG006|Overall Study|Abnormal lab values|1|||
146102321|NCT00347360|526893412|FG007|Overall Study|Abnormal lab values|0|||
146102322|NCT00347360|526893413|FG008|Overall Study|Abnormal lab values|0|||
146102323|NCT00347360|526893414|FG009|Overall Study|Abnormal lab values|0|||
146102324|NCT00347360|526893415|FG010|Overall Study|Abnormal lab values|0|||
146102325|NCT00347360|526893416|FG011|Overall Study|Abnormal lab values|0|||
146102326|NCT00347360|526893417|FG012|Overall Study|Abnormal lab values|0|||
146102327|NCT00347360|526893418|FG013|Overall Study|Abnormal lab values|0|||
146102328|NCT00347360|526893419|FG014|Overall Study|Abnormal lab values|0|||
146102329|NCT00347360|526893405|FG000|Overall Study|PI recommended early withdrawal|0|||
146102330|NCT00347360|526893406|FG001|Overall Study|PI recommended early withdrawal|0|||
146102331|NCT00347360|526893407|FG002|Overall Study|PI recommended early withdrawal|0|||
146102332|NCT00347360|526893408|FG003|Overall Study|PI recommended early withdrawal|0|||
146102333|NCT00347360|526893409|FG004|Overall Study|PI recommended early withdrawal|0|||
146102334|NCT00347360|526893410|FG005|Overall Study|PI recommended early withdrawal|0|||
146102335|NCT00347360|526893411|FG006|Overall Study|PI recommended early withdrawal|0|||
146102336|NCT00347360|526893412|FG007|Overall Study|PI recommended early withdrawal|0|||
146102337|NCT00347360|526893413|FG008|Overall Study|PI recommended early withdrawal|0|||
146102338|NCT00347360|526893414|FG009|Overall Study|PI recommended early withdrawal|1|||
146102339|NCT00347360|526893415|FG010|Overall Study|PI recommended early withdrawal|0|||
146102340|NCT00347360|526893416|FG011|Overall Study|PI recommended early withdrawal|0|||
146102341|NCT00347360|526893417|FG012|Overall Study|PI recommended early withdrawal|0|||
146102342|NCT00347360|526893418|FG013|Overall Study|PI recommended early withdrawal|0|||
146102343|NCT00347360|526893419|FG014|Overall Study|PI recommended early withdrawal|0|||
146102344|NCT00347360|526893405|FG000|Overall Study|Did not meet criteria before ABPM|0|||
146044650|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
146044651|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
146044652|NCT03777059|526678880|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
146044653|NCT03777059|526678881|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
146044654|NCT03777059|526678882|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
146044655|NCT03777059|526678883|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
146044656|NCT03777059|526678880|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
146044657|NCT03777059|526678881|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
146044658|NCT03777059|526678882|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
146044659|NCT03777059|526678883|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
146044660|NCT03777059|526678880|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
146044661|NCT03777059|526678881|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
146044662|NCT03777059|526678882|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
146044663|NCT03777059|526678883|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
146044664|NCT03777059|526678880|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
146044665|NCT03777059|526678881|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
146044666|NCT03777059|526678882|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
146044667|NCT03777059|526678883|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
146044668|NCT03777059|526678880|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
146044669|NCT03777059|526678881|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
146044670|NCT03777059|526678882|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
146044671|NCT03777059|526678883|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
146044672|NCT03350815|526678886|FG000|Period 1|Adverse Event|10|||
146044673|NCT03350815|526678887|FG001|Period 1|Adverse Event|0|||
146044674|NCT03350815|526678888|FG002|Period 1|Adverse Event|0|||
146044675|NCT03350815|526678889|FG003|Period 1|Adverse Event|0|||
146044676|NCT03350815|526678886|FG000|Period 1|Technical problems|1|||
146044677|NCT03350815|526678887|FG001|Period 1|Technical problems|0|||
146044678|NCT03350815|526678888|FG002|Period 1|Technical problems|0|||
146044679|NCT03350815|526678889|FG003|Period 1|Technical problems|0|||
146044680|NCT03350815|526678886|FG000|Period 1|Lost to Follow-up|3|||
146044681|NCT03350815|526678887|FG001|Period 1|Lost to Follow-up|0|||
146044682|NCT03350815|526678888|FG002|Period 1|Lost to Follow-up|0|||
146044683|NCT03350815|526678889|FG003|Period 1|Lost to Follow-up|0|||
146044684|NCT03350815|526678886|FG000|Period 1|Physician Decision|1|||
146044685|NCT03350815|526678887|FG001|Period 1|Physician Decision|0|||
146044686|NCT03350815|526678888|FG002|Period 1|Physician Decision|0|||
146044687|NCT03350815|526678889|FG003|Period 1|Physician Decision|0|||
146044688|NCT03350815|526678886|FG000|Period 1|Withdrawal by Subject|8|||
146044689|NCT03350815|526678887|FG001|Period 1|Withdrawal by Subject|0|||
146044690|NCT03350815|526678888|FG002|Period 1|Withdrawal by Subject|0|||
146044691|NCT03350815|526678889|FG003|Period 1|Withdrawal by Subject|0|||
146044692|NCT03350815|526678886|FG000|Period 1|Lack of Efficacy|15|||
146044693|NCT03350815|526678887|FG001|Period 1|Lack of Efficacy|0|||
146044694|NCT03350815|526678888|FG002|Period 1|Lack of Efficacy|0|||
146044695|NCT03350815|526678889|FG003|Period 1|Lack of Efficacy|0|||
146044696|NCT03350815|526678886|FG000|Period 1|Non-compliance with study treatment|2|||
146044697|NCT03350815|526678887|FG001|Period 1|Non-compliance with study treatment|0|||
146044698|NCT03350815|526678888|FG002|Period 1|Non-compliance with study treatment|0|||
146044699|NCT03350815|526678889|FG003|Period 1|Non-compliance with study treatment|0|||
146044700|NCT03350815|526678886|FG000|Period 1|Protocol Violation|3|||
146044701|NCT03350815|526678887|FG001|Period 1|Protocol Violation|0|||
146044702|NCT03350815|526678888|FG002|Period 1|Protocol Violation|0|||
146044703|NCT03350815|526678889|FG003|Period 1|Protocol Violation|0|||
146044704|NCT03350815|526678886|FG000|Period 2|Adverse Event|0|||
146044705|NCT03350815|526678887|FG001|Period 2|Adverse Event|3|||
146044706|NCT03350815|526678888|FG002|Period 2|Adverse Event|5|||
146044707|NCT03350815|526678889|FG003|Period 2|Adverse Event|0|||
146044708|NCT03350815|526678886|FG000|Period 2|Technical problem|0|||
146044709|NCT03350815|526678887|FG001|Period 2|Technical problem|1|||
146044710|NCT03350815|526678888|FG002|Period 2|Technical problem|0|||
146044711|NCT03350815|526678889|FG003|Period 2|Technical problem|0|||
146044712|NCT03350815|526678886|FG000|Period 2|Lost to Follow-up|0|||
146044713|NCT03350815|526678887|FG001|Period 2|Lost to Follow-up|3|||
146044714|NCT03350815|526678888|FG002|Period 2|Lost to Follow-up|3|||
146044715|NCT03350815|526678889|FG003|Period 2|Lost to Follow-up|0|||
146044716|NCT03350815|526678886|FG000|Period 2|Physician Decision|0|||
146044717|NCT03350815|526678887|FG001|Period 2|Physician Decision|0|||
146044718|NCT03350815|526678888|FG002|Period 2|Physician Decision|1|||
146044719|NCT03350815|526678889|FG003|Period 2|Physician Decision|0|||
146044720|NCT03350815|526678886|FG000|Period 2|Withdrawal by Subject|0|||
146044721|NCT03350815|526678887|FG001|Period 2|Withdrawal by Subject|3|||
146044722|NCT03350815|526678888|FG002|Period 2|Withdrawal by Subject|4|||
146044723|NCT03350815|526678889|FG003|Period 2|Withdrawal by Subject|0|||
146044724|NCT03350815|526678886|FG000|Period 2|Lack of Efficacy|0|||
146044725|NCT03350815|526678887|FG001|Period 2|Lack of Efficacy|6|||
146255297|NCT00809783|527448547|FG000|Overall Study|Lost to Follow-up|0|||
146255298|NCT00809783|527448548|FG001|Overall Study|Lost to Follow-up|3|||
146255299|NCT00809783|527448549|FG002|Overall Study|Lost to Follow-up|4|||
146255300|NCT00809783|527448547|FG000|Overall Study|Withdrawal by Subject|47|||
146255301|NCT00809783|527448548|FG001|Overall Study|Withdrawal by Subject|72|||
146255302|NCT00809783|527448549|FG002|Overall Study|Withdrawal by Subject|64|||
146255303|NCT00809783|527448547|FG000|Overall Study|Protocol Violation|2|||
146255304|NCT00809783|527448548|FG001|Overall Study|Protocol Violation|6|||
146255305|NCT00809783|527448549|FG002|Overall Study|Protocol Violation|5|||
146255306|NCT00809783|527448547|FG000|Overall Study|Randomized, but not treated|3|||
146255307|NCT00809783|527448548|FG001|Overall Study|Randomized, but not treated|0|||
146044726|NCT03350815|526678888|FG002|Period 2|Lack of Efficacy|2|||
146044727|NCT03350815|526678889|FG003|Period 2|Lack of Efficacy|0|||
146044728|NCT03350815|526678886|FG000|Period 2|Protocol Violation|0|||
146044729|NCT03350815|526678887|FG001|Period 2|Protocol Violation|0|||
146044730|NCT03350815|526678888|FG002|Period 2|Protocol Violation|1|||
146044731|NCT03350815|526678889|FG003|Period 2|Protocol Violation|0|||
146044732|NCT03350815|526678886|FG000|Period 2|New therapy for study indication|0|||
146044733|NCT03350815|526678887|FG001|Period 2|New therapy for study indication|0|||
146044734|NCT03350815|526678888|FG002|Period 2|New therapy for study indication|1|||
146255308|NCT00809783|527448549|FG002|Overall Study|Randomized, but not treated|2|||
146255309|NCT00809783|527448547|FG000|Overall Study|Study Terminated by Sponsor|378|||
146300659|NCT01118325|527617086|FG000|Overall Study|Adverse Event|1|||
146044735|NCT03350815|526678889|FG003|Period 2|New therapy for study indication|0|||
146044736|NCT02517541|526678894|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
146044737|NCT02517541|526678894|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
146044738|NCT02517541|526678894|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
146044739|NCT02517541|526678894|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
146044740|NCT02517541|526678894|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
146044741|NCT02517541|526678894|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
146044742|NCT00699608|526678895|FG000|First Intervention|Withdrawal by Subject|0|||
146044743|NCT00699608|526678896|FG001|First Intervention|Withdrawal by Subject|0|||
146044744|NCT00699608|526678897|FG002|First Intervention|Withdrawal by Subject|1|||
146044745|NCT00699608|526678898|FG003|First Intervention|Withdrawal by Subject|0|||
146044746|NCT00699608|526678899|FG004|First Intervention|Withdrawal by Subject|0|||
146044747|NCT00699608|526678900|FG005|First Intervention|Withdrawal by Subject|0|||
146044748|NCT00699608|526678895|FG000|First Intervention|Protocol Violation|0|||
146044749|NCT00699608|526678896|FG001|First Intervention|Protocol Violation|0|||
146044750|NCT00699608|526678897|FG002|First Intervention|Protocol Violation|0|||
146044751|NCT00699608|526678898|FG003|First Intervention|Protocol Violation|0|||
146044752|NCT00699608|526678899|FG004|First Intervention|Protocol Violation|1|||
146044753|NCT00699608|526678900|FG005|First Intervention|Protocol Violation|0|||
146044754|NCT00699608|526678895|FG000|Second Intervention|Adverse Event|0|||
146044755|NCT00699608|526678896|FG001|Second Intervention|Adverse Event|0|||
146044756|NCT00699608|526678897|FG002|Second Intervention|Adverse Event|1|||
146044757|NCT00699608|526678898|FG003|Second Intervention|Adverse Event|0|||
146044758|NCT00699608|526678899|FG004|Second Intervention|Adverse Event|0|||
146044759|NCT00699608|526678900|FG005|Second Intervention|Adverse Event|0|||
146044760|NCT00699608|526678895|FG000|Second Intervention|Withdrawal by Subject|0|||
146044761|NCT00699608|526678896|FG001|Second Intervention|Withdrawal by Subject|0|||
146044762|NCT00699608|526678897|FG002|Second Intervention|Withdrawal by Subject|0|||
146044763|NCT00699608|526678898|FG003|Second Intervention|Withdrawal by Subject|1|||
146044764|NCT00699608|526678899|FG004|Second Intervention|Withdrawal by Subject|0|||
146044765|NCT00699608|526678900|FG005|Second Intervention|Withdrawal by Subject|0|||
146044766|NCT01136408|526678901|FG000|Overall Study|Adverse Event|4|||
146044767|NCT01136408|526678902|FG001|Overall Study|Adverse Event|8|||
146044768|NCT01136408|526678903|FG002|Overall Study|Adverse Event|4|||
146044769|NCT01136408|526678901|FG000|Overall Study|Protocol Violation|1|||
146044770|NCT01136408|526678902|FG001|Overall Study|Protocol Violation|1|||
146044771|NCT01136408|526678903|FG002|Overall Study|Protocol Violation|1|||
146044772|NCT02828436|526678904|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
146044773|NCT02828436|526678905|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
146255310|NCT00809783|527448548|FG001|Overall Study|Study Terminated by Sponsor|626|||
146255311|NCT00809783|527448549|FG002|Overall Study|Study Terminated by Sponsor|565|||
146044774|NCT02828436|526678904|FG000|Period 1|Lost to Follow-up|0|||
146044775|NCT02828436|526678905|FG001|Period 1|Lost to Follow-up|1|||
146044776|NCT02828436|526678904|FG000|Period 2|Withdrawal by Subject|4|||
146044777|NCT02828436|526678905|FG001|Period 2|Withdrawal by Subject|0|||
146044778|NCT02828436|526678904|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
146044779|NCT02828436|526678905|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
146044780|NCT02828436|526678904|FG000|Period 2|Lost to Follow-up|1|||
146044781|NCT02828436|526678905|FG001|Period 2|Lost to Follow-up|0|||
146044782|NCT03078556|526678908|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
146044783|NCT03078556|526678909|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
146044784|NCT03078556|526678910|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
146255312|NCT00809783|527448547|FG000|Overall Study|Other|21|||
146255313|NCT00809783|527448548|FG001|Overall Study|Other|21|||
146102345|NCT00347360|526893406|FG001|Overall Study|Did not meet criteria before ABPM|0|||
146102346|NCT00347360|526893407|FG002|Overall Study|Did not meet criteria before ABPM|0|||
146102347|NCT00347360|526893408|FG003|Overall Study|Did not meet criteria before ABPM|0|||
146102348|NCT00347360|526893409|FG004|Overall Study|Did not meet criteria before ABPM|0|||
146102349|NCT00347360|526893410|FG005|Overall Study|Did not meet criteria before ABPM|0|||
146102350|NCT00347360|526893411|FG006|Overall Study|Did not meet criteria before ABPM|0|||
146102351|NCT00347360|526893412|FG007|Overall Study|Did not meet criteria before ABPM|0|||
146102352|NCT00347360|526893413|FG008|Overall Study|Did not meet criteria before ABPM|0|||
146102353|NCT00347360|526893414|FG009|Overall Study|Did not meet criteria before ABPM|0|||
146300660|NCT01118325|527617087|FG001|Overall Study|Adverse Event|0|||
146300661|NCT01118325|527617088|FG002|Overall Study|Adverse Event|1|||
146300662|NCT03678103|527617092|FG000|Overall Study|Withdrawn prior to completion|4|||
146300663|NCT02606461|527617101|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146300664|NCT02606461|527617102|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146300665|NCT02606461|527617103|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
146300666|NCT02606461|527617104|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146300667|NCT02606461|527617105|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146300668|NCT02606461|527617106|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
146300669|NCT02092350|527617107|FG000|Overall Study|Adverse Event|0|||
146300670|NCT02092350|527617108|FG001|Overall Study|Adverse Event|3|||
146300671|NCT02092350|527617107|FG000|Overall Study|Death|2|||
146300672|NCT02092350|527617108|FG001|Overall Study|Death|5|||
146300673|NCT02092350|527617107|FG000|Overall Study|Lost to Follow-up|3|||
146300674|NCT02092350|527617108|FG001|Overall Study|Lost to Follow-up|1|||
146300675|NCT02092350|527617107|FG000|Overall Study|Protocol Violation|1|||
146300676|NCT02092350|527617108|FG001|Overall Study|Protocol Violation|0|||
146300677|NCT02092350|527617107|FG000|Overall Study|Physician Decision|1|||
146300678|NCT02092350|527617108|FG001|Overall Study|Physician Decision|1|||
146300679|NCT02092350|527617107|FG000|Overall Study|Screen Failure|1|||
146300680|NCT02092350|527617108|FG001|Overall Study|Screen Failure|0|||
146300681|NCT02092350|527617107|FG000|Overall Study|Withdrawal by Subject|2|||
146300682|NCT02092350|527617108|FG001|Overall Study|Withdrawal by Subject|2|||
146300683|NCT00024167|527617109|FG000|Overall Study|Death|53|||
146300684|NCT00024167|527617110|FG001|Overall Study|Death|47|||
146300685|NCT00307333|527617124|FG000|Overall Study|Lost to Follow-up|11|||
146300686|NCT00307333|527617125|FG001|Overall Study|Lost to Follow-up|3|||
146300687|NCT01245387|527617126|FG000|Overall Study|Lost to Follow-up|106|||
146300688|NCT01245387|527617126|FG000|Overall Study|Lack of Efficacy|195|||
146300689|NCT01245387|527617126|FG000|Overall Study|Adverse Event|9|||
146044785|NCT03078556|526678911|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
146044786|NCT03078556|526678908|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
146044787|NCT03078556|526678909|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
146044788|NCT03078556|526678910|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
146044789|NCT03078556|526678911|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
146044790|NCT03078556|526678908|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
146044791|NCT03078556|526678909|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
146044792|NCT03078556|526678910|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
146044793|NCT03078556|526678911|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
146044794|NCT03078556|526678908|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
146044795|NCT03078556|526678909|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
146044796|NCT03078556|526678910|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
146044797|NCT03078556|526678911|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
146044798|NCT04421482|526678913|FG000|Overall Study|Physician Decision|1|||
146044799|NCT03010319|526678914|FG000|Overall Study|Adverse Event|15|||
146044800|NCT03010319|526678915|FG001|Overall Study|Adverse Event|9|||
146044801|NCT03010319|526678914|FG000|Overall Study|Withdrawal by Subject|1|||
146044802|NCT03010319|526678915|FG001|Overall Study|Withdrawal by Subject|6|||
146044803|NCT03010319|526678914|FG000|Overall Study|Physician Decision|2|||
146044804|NCT03010319|526678915|FG001|Overall Study|Physician Decision|4|||
146044805|NCT03010319|526678914|FG000|Overall Study|Sponsor requested withdrawal|2|||
146044806|NCT03010319|526678915|FG001|Overall Study|Sponsor requested withdrawal|2|||
146044807|NCT03010319|526678914|FG000|Overall Study|Death|1|||
146102354|NCT00347360|526893415|FG010|Overall Study|Did not meet criteria before ABPM|1|||
146300690|NCT01245387|527617126|FG000|Overall Study|Death|3|||
146102355|NCT00347360|526893416|FG011|Overall Study|Did not meet criteria before ABPM|0|||
146102356|NCT00347360|526893417|FG012|Overall Study|Did not meet criteria before ABPM|0|||
146300691|NCT01245387|527617126|FG000|Overall Study|Other|131|||
146300692|NCT01245387|527617126|FG000|Overall Study|Missing discontinuation status|369|||
146300693|NCT04246801|527617127|FG000|Overall Study|Adverse Event|1|||
146044808|NCT03010319|526678915|FG001|Overall Study|Death|0|||
146044809|NCT03010319|526678914|FG000|Overall Study|Lost to Follow-up|0|||
146044810|NCT03010319|526678915|FG001|Overall Study|Lost to Follow-up|1|||
146044811|NCT03010319|526678914|FG000|Overall Study|Other Reason|5|||
146044812|NCT03010319|526678915|FG001|Overall Study|Other Reason|7|||
146044813|NCT02128724|526678916|FG000|Overall Study|Death|1|||
146255314|NCT00809783|527448549|FG002|Overall Study|Other|16|||
146255315|NCT00126555|527448550|FG000|Overall Study|Withdrawal by Subject|1|||
146255316|NCT00126555|527448550|FG000|Overall Study|Adverse Event|2|||
146255317|NCT00126555|527448550|FG000|Overall Study|Progressive Disease|3|||
146255318|NCT01780545|527448554|FG000|Overall Study|Withdrawal by Subject|3|||
146255319|NCT01780545|527448555|FG001|Overall Study|Withdrawal by Subject|1|||
146255320|NCT01780545|527448554|FG000|Overall Study|Lost to Follow-up|1|||
146255321|NCT01780545|527448555|FG001|Overall Study|Lost to Follow-up|1|||
146255322|NCT05135156|527448562|FG000|Overall Study|Lost to Follow-up|0|||
146255323|NCT05135156|527448563|FG001|Overall Study|Lost to Follow-up|0|||
146255324|NCT05135156|527448564|FG002|Overall Study|Lost to Follow-up|2|||
146255325|NCT01264887|527448568|FG000|Overall Study|Adverse Event|5|||
146255326|NCT01264887|527448568|FG000|Overall Study|Death|7|||
146255327|NCT01264887|527448568|FG000|Overall Study|Lack of Efficacy|5|||
146255328|NCT01264887|527448568|FG000|Overall Study|Physician Decision|4|||
146255329|NCT01264887|527448568|FG000|Overall Study|Withdrawal by Subject|6|||
146255330|NCT01264887|527448568|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
146255331|NCT01264887|527448568|FG000|Overall Study|Other|2|||
146300694|NCT04246801|527617128|FG001|Overall Study|Adverse Event|1|||
146044814|NCT02128724|526678917|FG001|Overall Study|Death|0|||
146044815|NCT02128724|526678918|FG002|Overall Study|Death|0|||
146044816|NCT02128724|526678919|FG003|Overall Study|Death|0|||
146044817|NCT02128724|526678916|FG000|Overall Study|Adverse Event|0|||
146044818|NCT02128724|526678917|FG001|Overall Study|Adverse Event|1|||
146044819|NCT02128724|526678918|FG002|Overall Study|Adverse Event|0|||
146044820|NCT02128724|526678919|FG003|Overall Study|Adverse Event|0|||
146044821|NCT02128724|526678916|FG000|Overall Study|Physician Decision|0|||
146044822|NCT02128724|526678917|FG001|Overall Study|Physician Decision|0|||
146044823|NCT02128724|526678918|FG002|Overall Study|Physician Decision|0|||
146044824|NCT02128724|526678919|FG003|Overall Study|Physician Decision|2|||
146044825|NCT02128724|526678916|FG000|Overall Study|Withdrawal by Subject|0|||
146044826|NCT02128724|526678917|FG001|Overall Study|Withdrawal by Subject|0|||
146044827|NCT02128724|526678918|FG002|Overall Study|Withdrawal by Subject|0|||
146044828|NCT02128724|526678919|FG003|Overall Study|Withdrawal by Subject|1|||
146044829|NCT01442714|526678920|FG000|Overall Study|Death|11|||
146044830|NCT01442714|526678920|FG000|Overall Study|Withdrawal by Subject|1|||
146044831|NCT04306510|526678921|FG000|Overall Study|Voluntarily withdrawal|1|||
146044832|NCT04306510|526678921|FG000|Overall Study|Enrolled but Not Treated|1|||
146044833|NCT04720417|526678922|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
146044834|NCT03329092|526678923|FG000|Overall Study|Other|2|||
146044835|NCT03329092|526678924|FG001|Overall Study|Other|2|||
146044836|NCT03329092|526678923|FG000|Overall Study|Withdrawal by Subject|16|||
146044837|NCT03329092|526678924|FG001|Overall Study|Withdrawal by Subject|3|||
146044838|NCT03329092|526678923|FG000|Overall Study|Physician Decision|1|||
146044839|NCT03329092|526678924|FG001|Overall Study|Physician Decision|0|||
146044840|NCT03329092|526678923|FG000|Overall Study|Death|17|||
146044841|NCT03329092|526678924|FG001|Overall Study|Death|11|||
146044842|NCT03329092|526678923|FG000|Overall Study|Adverse Event|3|||
146044843|NCT03329092|526678924|FG001|Overall Study|Adverse Event|1|||
146044844|NCT03329092|526678923|FG000|Overall Study|Lost to Follow-up|1|||
146044845|NCT03329092|526678924|FG001|Overall Study|Lost to Follow-up|1|||
146044846|NCT03314987|526678925|FG000|Overall Study|Lost to Follow-up|13|||
146044847|NCT03314987|526678926|FG001|Overall Study|Lost to Follow-up|13|||
146044848|NCT03574779|526678927|FG000|Overall Study|Screening failure|13|||
146044849|NCT03574779|526678928|FG001|Overall Study|Screening failure|83|||
146044850|NCT02751580|526678929|FG000|Overall Study|Lost to Follow-up|4|||
146044851|NCT02751580|526678929|FG000|Overall Study|Death|2|||
146044852|NCT01076036|526678932|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
146044853|NCT02221674|526678933|FG000|Overall Study|Lost to Follow-up|1|||
146044854|NCT02221674|526678934|FG001|Overall Study|Lost to Follow-up|0|||
146044855|NCT02221674|526678935|FG002|Overall Study|Lost to Follow-up|0|||
146044856|NCT05292131|526678936|FG000|Overall Study|Lost to Follow-up|1|||
146044857|NCT05292131|526678937|FG001|Overall Study|Lost to Follow-up|1|||
146044858|NCT05292131|526678936|FG000|Overall Study|Withdrawal by Subject|0|||
146044859|NCT05292131|526678937|FG001|Overall Study|Withdrawal by Subject|1|||
146044860|NCT02557542|526678939|FG000|Overall Study|Poor recruitment|3|||
146044861|NCT02557542|526678940|FG001|Overall Study|Poor recruitment|0|||
146044862|NCT04390880|526678941|FG000|Overall Study|Withdrawal by Subject|1|||
146044863|NCT00465452|526678942|FG000|Overall Study|Adverse Event|1|||
146044864|NCT05715242|526678979|FG000|Overall Study|Lost to Follow-up|0|||
146255332|NCT00591409|527448569|FG000|Overall Study|Not Treated|0|||
146255333|NCT00591409|527448570|FG001|Overall Study|Not Treated|0|||
146255334|NCT00591409|527448571|FG002|Overall Study|Not Treated|0|||
146255335|NCT00591409|527448572|FG003|Overall Study|Not Treated|0|||
146255336|NCT00591409|527448573|FG004|Overall Study|Not Treated|1|||
146044865|NCT05715242|526678980|FG001|Overall Study|Lost to Follow-up|0|||
146044866|NCT05715242|526678981|FG002|Overall Study|Lost to Follow-up|1|||
146044867|NCT05715242|526678982|FG003|Overall Study|Lost to Follow-up|0|||
146044868|NCT05715242|526678983|FG004|Overall Study|Lost to Follow-up|0|||
146255337|NCT00591409|527448574|FG005|Overall Study|Not Treated|0|||
146044869|NCT05715242|526678984|FG005|Overall Study|Lost to Follow-up|1|||
146044870|NCT05715242|526678985|FG006|Overall Study|Lost to Follow-up|0|||
146044871|NCT05715242|526678986|FG007|Overall Study|Lost to Follow-up|0|||
146044872|NCT05715242|526678987|FG008|Overall Study|Lost to Follow-up|0|||
146044873|NCT05715242|526678988|FG009|Overall Study|Lost to Follow-up|0|||
146044874|NCT05715242|526678989|FG010|Overall Study|Lost to Follow-up|0|||
146044875|NCT05715242|526678990|FG011|Overall Study|Lost to Follow-up|0|||
146044876|NCT05715242|526678991|FG012|Overall Study|Lost to Follow-up|0|||
146044877|NCT05715242|526678992|FG013|Overall Study|Lost to Follow-up|0|||
146044878|NCT05715242|526678993|FG014|Overall Study|Lost to Follow-up|0|||
146044879|NCT05715242|526678994|FG015|Overall Study|Lost to Follow-up|0|||
146044880|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
146044881|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
146044882|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
146044883|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Death|0|||
146044884|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Death|2|||
146044885|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Death|0|||
146044886|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
146044887|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
146044888|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
146044889|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
146044890|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
146044891|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
146044892|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
146044893|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
146044894|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
146044895|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
146044896|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
146044897|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
146044898|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
146044899|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
146044900|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
146044901|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Recovery|1|||
146044902|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Recovery|0|||
146044903|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Recovery|1|||
146044904|NCT00195663|526678997|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
146044905|NCT00195663|526678998|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
146044906|NCT00195663|526678999|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
146044907|NCT00195663|526678997|FG000|Open-Label Extension Period|Adverse Event|21|||
146044908|NCT00195663|526678998|FG001|Open-Label Extension Period|Adverse Event|32|||
146044909|NCT00195663|526678999|FG002|Open-Label Extension Period|Adverse Event|36|||
146044910|NCT00195663|526678997|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
146044911|NCT00195663|526678998|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
146044912|NCT00195663|526678999|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
146044913|NCT00195663|526678997|FG000|Open-Label Extension Period|Recovery|0|||
146044914|NCT00195663|526678998|FG001|Open-Label Extension Period|Recovery|2|||
146044915|NCT00195663|526678999|FG002|Open-Label Extension Period|Recovery|2|||
146044916|NCT00195663|526678997|FG000|Open-Label Extension Period|Protocol Violation|3|||
146044917|NCT00195663|526678998|FG001|Open-Label Extension Period|Protocol Violation|4|||
146044918|NCT00195663|526678999|FG002|Open-Label Extension Period|Protocol Violation|4|||
146044919|NCT00195663|526678997|FG000|Open-Label Extension Period|Death|2|||
146044920|NCT00195663|526678998|FG001|Open-Label Extension Period|Death|2|||
146044921|NCT00195663|526678999|FG002|Open-Label Extension Period|Death|2|||
146044922|NCT00195663|526678997|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
146044923|NCT00195663|526678998|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
146044924|NCT00195663|526678999|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
146044925|NCT00195663|526678997|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
146044926|NCT00195663|526678998|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
146044927|NCT00195663|526678999|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
146044928|NCT00195663|526678997|FG000|Open-Label Extension Period|Administrative reasons|11|||
146044929|NCT00195663|526678998|FG001|Open-Label Extension Period|Administrative reasons|11|||
146044930|NCT00195663|526678999|FG002|Open-Label Extension Period|Administrative reasons|13|||
146102357|NCT00347360|526893418|FG013|Overall Study|Did not meet criteria before ABPM|0|||
146102358|NCT00347360|526893419|FG014|Overall Study|Did not meet criteria before ABPM|0|||
146102359|NCT00347360|526893405|FG000|Overall Study|Randomized in error|0|||
146102360|NCT00347360|526893406|FG001|Overall Study|Randomized in error|0|||
146102361|NCT00347360|526893407|FG002|Overall Study|Randomized in error|0|||
146255338|NCT00591409|527448575|FG006|Overall Study|Not Treated|0|||
146044931|NCT01180296|526679000|FG000|Overall Study|Protocol Violation|1|||
146102362|NCT00347360|526893408|FG003|Overall Study|Randomized in error|0|||
146255339|NCT00591409|527448576|FG007|Overall Study|Not Treated|0|||
146044932|NCT01180296|526679001|FG001|Overall Study|Protocol Violation|2|||
146044933|NCT00483938|526679002|FG000|Overall Study|Protocol Violation|0|||
146044934|NCT00483938|526679003|FG001|Overall Study|Protocol Violation|0|||
146044935|NCT00483938|526679004|FG002|Overall Study|Protocol Violation|0|||
146044936|NCT00483938|526679005|FG003|Overall Study|Protocol Violation|0|||
146044937|NCT00483938|526679006|FG004|Overall Study|Protocol Violation|0|||
146044938|NCT00483938|526679007|FG005|Overall Study|Protocol Violation|0|||
146044939|NCT00483938|526679008|FG006|Overall Study|Protocol Violation|3|||
146044940|NCT00483938|526679002|FG000|Overall Study|Withdrawal by Subject|1|||
146044941|NCT00483938|526679003|FG001|Overall Study|Withdrawal by Subject|6|||
146044942|NCT00483938|526679004|FG002|Overall Study|Withdrawal by Subject|0|||
146044943|NCT00483938|526679005|FG003|Overall Study|Withdrawal by Subject|0|||
146044944|NCT00483938|526679006|FG004|Overall Study|Withdrawal by Subject|1|||
146044945|NCT00483938|526679007|FG005|Overall Study|Withdrawal by Subject|3|||
146044946|NCT00483938|526679008|FG006|Overall Study|Withdrawal by Subject|2|||
146044947|NCT00483938|526679002|FG000|Overall Study|Lost to Follow-up|1|||
146044948|NCT00483938|526679003|FG001|Overall Study|Lost to Follow-up|2|||
146044949|NCT00483938|526679004|FG002|Overall Study|Lost to Follow-up|0|||
146044950|NCT00483938|526679005|FG003|Overall Study|Lost to Follow-up|2|||
146044951|NCT00483938|526679006|FG004|Overall Study|Lost to Follow-up|1|||
146044952|NCT00483938|526679007|FG005|Overall Study|Lost to Follow-up|1|||
146044953|NCT00483938|526679008|FG006|Overall Study|Lost to Follow-up|3|||
146044954|NCT00483938|526679002|FG000|Overall Study|Death|0|||
146044955|NCT00483938|526679003|FG001|Overall Study|Death|2|||
146044956|NCT00483938|526679004|FG002|Overall Study|Death|0|||
146044957|NCT00483938|526679005|FG003|Overall Study|Death|0|||
146044958|NCT00483938|526679006|FG004|Overall Study|Death|0|||
146044959|NCT00483938|526679007|FG005|Overall Study|Death|0|||
146044960|NCT00483938|526679008|FG006|Overall Study|Death|0|||
146044961|NCT00483938|526679002|FG000|Overall Study|Other|3|||
146044962|NCT00483938|526679003|FG001|Overall Study|Other|9|||
146044963|NCT00483938|526679004|FG002|Overall Study|Other|0|||
146044964|NCT00483938|526679005|FG003|Overall Study|Other|4|||
146044965|NCT00483938|526679006|FG004|Overall Study|Other|0|||
146044966|NCT00483938|526679007|FG005|Overall Study|Other|4|||
146044967|NCT00483938|526679008|FG006|Overall Study|Other|32|||
146044968|NCT00106353|526679011|FG000|Part 1|Disease progression|3|||
146044969|NCT00106353|526679012|FG001|Part 1|Disease progression|4|||
146044970|NCT00106353|526679013|FG002|Part 1|Disease progression|1|||
146044971|NCT00106353|526679014|FG003|Part 1|Disease progression|3|||
146044972|NCT00106353|526679015|FG004|Part 1|Disease progression|0|||
146044973|NCT00106353|526679016|FG005|Part 1|Disease progression|0|||
146044974|NCT00106353|526679017|FG006|Part 1|Disease progression|0|||
146044975|NCT00106353|526679011|FG000|Part 1|Withdrawal by Subject|0|||
146044976|NCT00106353|526679012|FG001|Part 1|Withdrawal by Subject|0|||
146044977|NCT00106353|526679013|FG002|Part 1|Withdrawal by Subject|1|||
146044978|NCT00106353|526679014|FG003|Part 1|Withdrawal by Subject|2|||
146044979|NCT00106353|526679015|FG004|Part 1|Withdrawal by Subject|0|||
146044980|NCT00106353|526679016|FG005|Part 1|Withdrawal by Subject|0|||
146044981|NCT00106353|526679017|FG006|Part 1|Withdrawal by Subject|0|||
146044982|NCT00106353|526679011|FG000|Part 1|Symptomatic deterioration|0|||
146044983|NCT00106353|526679012|FG001|Part 1|Symptomatic deterioration|0|||
146044984|NCT00106353|526679013|FG002|Part 1|Symptomatic deterioration|1|||
146044985|NCT00106353|526679014|FG003|Part 1|Symptomatic deterioration|0|||
146044986|NCT00106353|526679015|FG004|Part 1|Symptomatic deterioration|0|||
146044987|NCT00106353|526679016|FG005|Part 1|Symptomatic deterioration|0|||
146044988|NCT00106353|526679017|FG006|Part 1|Symptomatic deterioration|0|||
146044989|NCT00106353|526679011|FG000|Part 1|Entered follow-up phase|1|||
146044990|NCT00106353|526679012|FG001|Part 1|Entered follow-up phase|1|||
146044991|NCT00106353|526679013|FG002|Part 1|Entered follow-up phase|0|||
146044992|NCT00106353|526679014|FG003|Part 1|Entered follow-up phase|1|||
146044993|NCT00106353|526679015|FG004|Part 1|Entered follow-up phase|0|||
146044994|NCT00106353|526679016|FG005|Part 1|Entered follow-up phase|0|||
146044995|NCT00106353|526679017|FG006|Part 1|Entered follow-up phase|0|||
146044996|NCT00106353|526679011|FG000|Part 1|Adverse Event|0|||
146044997|NCT00106353|526679012|FG001|Part 1|Adverse Event|0|||
146044998|NCT00106353|526679013|FG002|Part 1|Adverse Event|0|||
146102363|NCT00347360|526893409|FG004|Overall Study|Randomized in error|0|||
146102364|NCT00347360|526893410|FG005|Overall Study|Randomized in error|0|||
146044999|NCT00106353|526679014|FG003|Part 1|Adverse Event|1|||
146045000|NCT00106353|526679015|FG004|Part 1|Adverse Event|0|||
146045001|NCT00106353|526679016|FG005|Part 1|Adverse Event|0|||
146045002|NCT00106353|526679017|FG006|Part 1|Adverse Event|0|||
146045003|NCT00106353|526679011|FG000|Part 2|Disease progression|0|||
146045004|NCT00106353|526679012|FG001|Part 2|Disease progression|0|||
146045005|NCT00106353|526679013|FG002|Part 2|Disease progression|0|||
146045006|NCT00106353|526679014|FG003|Part 2|Disease progression|0|||
146045007|NCT00106353|526679015|FG004|Part 2|Disease progression|8|||
146045008|NCT00106353|526679016|FG005|Part 2|Disease progression|14|||
146045009|NCT00106353|526679017|FG006|Part 2|Disease progression|13|||
146045010|NCT00106353|526679011|FG000|Part 2|Death|0|||
146045011|NCT00106353|526679012|FG001|Part 2|Death|0|||
146045012|NCT00106353|526679013|FG002|Part 2|Death|0|||
146045013|NCT00106353|526679014|FG003|Part 2|Death|0|||
146045014|NCT00106353|526679015|FG004|Part 2|Death|3|||
146045015|NCT00106353|526679016|FG005|Part 2|Death|0|||
146045016|NCT00106353|526679017|FG006|Part 2|Death|1|||
146045017|NCT00106353|526679011|FG000|Part 2|Symptomatic deterioration|0|||
146045018|NCT00106353|526679012|FG001|Part 2|Symptomatic deterioration|0|||
146045019|NCT00106353|526679013|FG002|Part 2|Symptomatic deterioration|0|||
146045020|NCT00106353|526679014|FG003|Part 2|Symptomatic deterioration|0|||
146045021|NCT00106353|526679015|FG004|Part 2|Symptomatic deterioration|3|||
146045022|NCT00106353|526679016|FG005|Part 2|Symptomatic deterioration|0|||
146045023|NCT00106353|526679017|FG006|Part 2|Symptomatic deterioration|0|||
146045024|NCT00106353|526679011|FG000|Part 2|Adverse Event|0|||
146045025|NCT00106353|526679012|FG001|Part 2|Adverse Event|0|||
146045026|NCT00106353|526679013|FG002|Part 2|Adverse Event|0|||
146045027|NCT00106353|526679014|FG003|Part 2|Adverse Event|0|||
146045028|NCT00106353|526679015|FG004|Part 2|Adverse Event|0|||
146045029|NCT00106353|526679016|FG005|Part 2|Adverse Event|2|||
146045030|NCT00106353|526679017|FG006|Part 2|Adverse Event|1|||
146045031|NCT00106353|526679011|FG000|Part 2|Other|0|||
146045032|NCT00106353|526679012|FG001|Part 2|Other|0|||
146045033|NCT00106353|526679013|FG002|Part 2|Other|0|||
146045034|NCT00106353|526679014|FG003|Part 2|Other|0|||
146045035|NCT00106353|526679015|FG004|Part 2|Other|1|||
146045036|NCT00106353|526679016|FG005|Part 2|Other|1|||
146045037|NCT00106353|526679017|FG006|Part 2|Other|1|||
146045038|NCT00106353|526679011|FG000|Part 2|Withdrawal by Subject|0|||
146102365|NCT00347360|526893411|FG006|Overall Study|Randomized in error|0|||
146102366|NCT00347360|526893412|FG007|Overall Study|Randomized in error|0|||
146102367|NCT00347360|526893413|FG008|Overall Study|Randomized in error|0|||
146255340|NCT00591409|527448577|FG008|Overall Study|Not Treated|0|||
146255341|NCT00591409|527448578|FG009|Overall Study|Not Treated|1|||
146255342|NCT02171130|527448579|FG000|Overall Study|Death|1|||
146255343|NCT02171130|527448579|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
146255344|NCT02171130|527448579|FG000|Overall Study|Discontinued; Site Termination|5|||
146255345|NCT02171130|527448579|FG000|Overall Study|Withdrawal by Subject|3|||
146255346|NCT02171130|527448579|FG000|Overall Study|Physician Decision|1|||
146255347|NCT02171130|527448579|FG000|Overall Study|Lost to Follow-up|1|||
146255348|NCT02171130|527448579|FG000|Overall Study|Met Exclusion Criteria|1|||
146255349|NCT04531813|527448580|FG000|Overall Study|Protocol Violation|1|||
146255350|NCT04531813|527448580|FG000|Overall Study|Withdrawal by Subject|1|||
146255351|NCT02853305|527448583|FG000|Overall Study|Death|287|||
146255352|NCT02853305|527448584|FG001|Overall Study|Death|249|||
146255353|NCT02853305|527448585|FG002|Overall Study|Death|300|||
146255354|NCT02853305|527448583|FG000|Overall Study|Withdrawal by Subject|2|||
146255355|NCT02853305|527448584|FG001|Overall Study|Withdrawal by Subject|8|||
146255356|NCT02853305|527448585|FG002|Overall Study|Withdrawal by Subject|3|||
146255357|NCT02853305|527448583|FG000|Overall Study|Transferred to Extension Study|46|||
146255358|NCT02853305|527448584|FG001|Overall Study|Transferred to Extension Study|30|||
146255359|NCT02853305|527448585|FG002|Overall Study|Transferred to Extension Study|25|||
146255360|NCT02853305|527448583|FG000|Overall Study|Did Not Continue on Extension Study|16|||
146255361|NCT02853305|527448584|FG001|Overall Study|Did Not Continue on Extension Study|20|||
146255362|NCT02853305|527448585|FG002|Overall Study|Did Not Continue on Extension Study|24|||
146255363|NCT04772313|527448586|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
146255364|NCT04772313|527448586|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
146255365|NCT01836198|527448587|FG000|Part A, Period 2|Protocol Violation|0|||
146255366|NCT01836198|527448588|FG001|Part A, Period 2|Protocol Violation|1|||
146255367|NCT01836198|527448589|FG002|Part A, Period 2|Protocol Violation|0|||
146255368|NCT03187353|527448590|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
146045039|NCT00106353|526679012|FG001|Part 2|Withdrawal by Subject|0|||
146102368|NCT00347360|526893414|FG009|Overall Study|Randomized in error|0|||
146255369|NCT03187353|527448591|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
146255370|NCT03187353|527448590|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146255371|NCT03187353|527448591|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146255372|NCT03187353|527448590|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
146255373|NCT03187353|527448591|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
146300695|NCT04246801|527617127|FG000|Overall Study|Protocol Violation|1|||
146045040|NCT00106353|526679013|FG002|Part 2|Withdrawal by Subject|0|||
146045041|NCT00106353|526679014|FG003|Part 2|Withdrawal by Subject|0|||
146045042|NCT00106353|526679015|FG004|Part 2|Withdrawal by Subject|1|||
146045043|NCT00106353|526679016|FG005|Part 2|Withdrawal by Subject|0|||
146102369|NCT00347360|526893415|FG010|Overall Study|Randomized in error|0|||
146102370|NCT00347360|526893416|FG011|Overall Study|Randomized in error|1|||
146255374|NCT03187353|527448590|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146255375|NCT03187353|527448591|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
146255376|NCT03187353|527448590|FG000|Washout (2 Weeks)|Adverse Event|2|||
146255377|NCT03187353|527448591|FG001|Washout (2 Weeks)|Adverse Event|0|||
146300696|NCT04246801|527617128|FG001|Overall Study|Protocol Violation|1|||
146045044|NCT00106353|526679017|FG006|Part 2|Withdrawal by Subject|0|||
146045045|NCT00106353|526679011|FG000|Part 2|Physician Decision|0|||
146045046|NCT00106353|526679012|FG001|Part 2|Physician Decision|0|||
146045047|NCT00106353|526679013|FG002|Part 2|Physician Decision|0|||
146255378|NCT03187353|527448590|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
146255379|NCT03187353|527448591|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
146255380|NCT03794609|527448595|FG000|Overall Study|Other|10|||
146255381|NCT03794609|527448595|FG000|Overall Study|Withdrawal by Subject|66|||
146255382|NCT03794609|527448595|FG000|Overall Study|The child is enrolled in an interventional study|70|||
146255383|NCT03794609|527448595|FG000|Overall Study|Inclusion/exclusion criteria|8|||
146255384|NCT03794609|527448595|FG000|Overall Study|At sponsor's request|151|||
146300697|NCT04246801|527617127|FG000|Overall Study|Lack of Efficacy|0|||
146300698|NCT04246801|527617128|FG001|Overall Study|Lack of Efficacy|2|||
146045048|NCT00106353|526679014|FG003|Part 2|Physician Decision|0|||
146045049|NCT00106353|526679015|FG004|Part 2|Physician Decision|0|||
146045050|NCT00106353|526679016|FG005|Part 2|Physician Decision|1|||
146045051|NCT00106353|526679017|FG006|Part 2|Physician Decision|0|||
146045052|NCT01371552|526679018|FG000|Part 1, First 3 Days|Inconvenience|0|||
146045053|NCT01371552|526679019|FG001|Part 1, First 3 Days|Inconvenience|0|||
146045054|NCT01371552|526679020|FG002|Part 1, First 3 Days|Inconvenience|1|||
146045055|NCT01371552|526679021|FG003|Part 1, First 3 Days|Inconvenience|0|||
146045056|NCT01371552|526679022|FG004|Part 1, First 3 Days|Inconvenience|0|||
146045057|NCT01371552|526679023|FG005|Part 1, First 3 Days|Inconvenience|0|||
146045058|NCT03364309|526679024|FG000|Induction Period|Adverse Event|4|||
146045059|NCT03364309|526679025|FG001|Induction Period|Adverse Event|0|||
146045060|NCT03364309|526679026|FG002|Induction Period|Adverse Event|1|||
146045061|NCT03364309|526679027|FG003|Induction Period|Adverse Event|0|||
146045062|NCT03364309|526679028|FG004|Induction Period|Adverse Event|0|||
146045063|NCT03364309|526679029|FG005|Induction Period|Adverse Event|0|||
146045064|NCT03364309|526679030|FG006|Induction Period|Adverse Event|0|||
146045065|NCT03364309|526679031|FG007|Induction Period|Adverse Event|0|||
146045066|NCT03364309|526679032|FG008|Induction Period|Adverse Event|0|||
146045067|NCT03364309|526679033|FG009|Induction Period|Adverse Event|0|||
146045068|NCT03364309|526679034|FG010|Induction Period|Adverse Event|0|||
146045069|NCT03364309|526679035|FG011|Induction Period|Adverse Event|0|||
146045070|NCT03364309|526679036|FG012|Induction Period|Adverse Event|0|||
146045071|NCT03364309|526679037|FG013|Induction Period|Adverse Event|0|||
146045072|NCT03364309|526679038|FG014|Induction Period|Adverse Event|0|||
146045073|NCT03364309|526679039|FG015|Induction Period|Adverse Event|0|||
146045074|NCT03364309|526679040|FG016|Induction Period|Adverse Event|0|||
146045075|NCT03364309|526679041|FG017|Induction Period|Adverse Event|0|||
146045076|NCT03364309|526679042|FG018|Induction Period|Adverse Event|0|||
146045077|NCT03364309|526679024|FG000|Induction Period|Withdrawal by Subject|1|||
146045078|NCT03364309|526679025|FG001|Induction Period|Withdrawal by Subject|3|||
146045079|NCT03364309|526679026|FG002|Induction Period|Withdrawal by Subject|0|||
146045080|NCT03364309|526679027|FG003|Induction Period|Withdrawal by Subject|0|||
146045081|NCT03364309|526679028|FG004|Induction Period|Withdrawal by Subject|0|||
146045082|NCT03364309|526679029|FG005|Induction Period|Withdrawal by Subject|0|||
146045083|NCT03364309|526679030|FG006|Induction Period|Withdrawal by Subject|0|||
146045084|NCT03364309|526679031|FG007|Induction Period|Withdrawal by Subject|0|||
146045085|NCT03364309|526679032|FG008|Induction Period|Withdrawal by Subject|0|||
146045086|NCT03364309|526679033|FG009|Induction Period|Withdrawal by Subject|0|||
146045087|NCT03364309|526679034|FG010|Induction Period|Withdrawal by Subject|0|||
146045088|NCT03364309|526679035|FG011|Induction Period|Withdrawal by Subject|0|||
146045089|NCT03364309|526679036|FG012|Induction Period|Withdrawal by Subject|0|||
146045090|NCT03364309|526679037|FG013|Induction Period|Withdrawal by Subject|0|||
146045091|NCT03364309|526679038|FG014|Induction Period|Withdrawal by Subject|0|||
146045092|NCT03364309|526679039|FG015|Induction Period|Withdrawal by Subject|0|||
146045093|NCT03364309|526679040|FG016|Induction Period|Withdrawal by Subject|0|||
146045094|NCT03364309|526679041|FG017|Induction Period|Withdrawal by Subject|0|||
146045095|NCT03364309|526679042|FG018|Induction Period|Withdrawal by Subject|0|||
146045096|NCT03364309|526679024|FG000|Induction Period|Lost to Follow-up|1|||
146045097|NCT03364309|526679025|FG001|Induction Period|Lost to Follow-up|0|||
146045098|NCT03364309|526679026|FG002|Induction Period|Lost to Follow-up|0|||
146045099|NCT03364309|526679027|FG003|Induction Period|Lost to Follow-up|0|||
146045100|NCT03364309|526679028|FG004|Induction Period|Lost to Follow-up|0|||
146045101|NCT03364309|526679029|FG005|Induction Period|Lost to Follow-up|0|||
146045102|NCT03364309|526679030|FG006|Induction Period|Lost to Follow-up|0|||
146045103|NCT03364309|526679031|FG007|Induction Period|Lost to Follow-up|0|||
146255385|NCT03794609|527448595|FG000|Overall Study|Physician Decision|1|||
146300699|NCT04246801|527617127|FG000|Overall Study|Lost to Follow-up|1|||
146300700|NCT04246801|527617128|FG001|Overall Study|Lost to Follow-up|1|||
146300701|NCT04246801|527617127|FG000|Overall Study|Withdrawal by Subject|2|||
146300702|NCT04246801|527617128|FG001|Overall Study|Withdrawal by Subject|1|||
146045104|NCT03364309|526679032|FG008|Induction Period|Lost to Follow-up|0|||
146045105|NCT03364309|526679033|FG009|Induction Period|Lost to Follow-up|0|||
146045106|NCT03364309|526679034|FG010|Induction Period|Lost to Follow-up|0|||
146045107|NCT03364309|526679035|FG011|Induction Period|Lost to Follow-up|0|||
146255386|NCT03794609|527448595|FG000|Overall Study|Lost to Follow-up|5|||
146255387|NCT02205476|527448596|FG000|Overall Study|Study termination by Sponsor|7|||
146300703|NCT01621542|527617129|FG000|Overall Study|Adverse Event|0|||
146102371|NCT00347360|526893417|FG012|Overall Study|Randomized in error|0|||
146102372|NCT00347360|526893418|FG013|Overall Study|Randomized in error|0|||
146102373|NCT00347360|526893419|FG014|Overall Study|Randomized in error|0|||
146102374|NCT00347360|526893405|FG000|Overall Study|Failed inclusion criteria #4|0|||
146102375|NCT00347360|526893406|FG001|Overall Study|Failed inclusion criteria #4|0|||
146102376|NCT00347360|526893407|FG002|Overall Study|Failed inclusion criteria #4|0|||
146102377|NCT00347360|526893408|FG003|Overall Study|Failed inclusion criteria #4|0|||
146102378|NCT00347360|526893409|FG004|Overall Study|Failed inclusion criteria #4|0|||
146102379|NCT00347360|526893410|FG005|Overall Study|Failed inclusion criteria #4|0|||
146102380|NCT00347360|526893411|FG006|Overall Study|Failed inclusion criteria #4|0|||
146102381|NCT00347360|526893412|FG007|Overall Study|Failed inclusion criteria #4|0|||
146102382|NCT00347360|526893413|FG008|Overall Study|Failed inclusion criteria #4|0|||
146102383|NCT00347360|526893414|FG009|Overall Study|Failed inclusion criteria #4|0|||
146102384|NCT00347360|526893415|FG010|Overall Study|Failed inclusion criteria #4|0|||
146102385|NCT00347360|526893416|FG011|Overall Study|Failed inclusion criteria #4|1|||
146102386|NCT00347360|526893417|FG012|Overall Study|Failed inclusion criteria #4|0|||
146102387|NCT00347360|526893418|FG013|Overall Study|Failed inclusion criteria #4|0|||
146102388|NCT00347360|526893419|FG014|Overall Study|Failed inclusion criteria #4|0|||
146102389|NCT00347360|526893405|FG000|Overall Study|Prolonged duration between visits|0|||
146102390|NCT00347360|526893406|FG001|Overall Study|Prolonged duration between visits|0|||
146102391|NCT00347360|526893407|FG002|Overall Study|Prolonged duration between visits|0|||
146102392|NCT00347360|526893408|FG003|Overall Study|Prolonged duration between visits|0|||
146102393|NCT00347360|526893409|FG004|Overall Study|Prolonged duration between visits|0|||
146102394|NCT00347360|526893410|FG005|Overall Study|Prolonged duration between visits|0|||
146102395|NCT00347360|526893411|FG006|Overall Study|Prolonged duration between visits|0|||
146102396|NCT00347360|526893412|FG007|Overall Study|Prolonged duration between visits|0|||
146102397|NCT00347360|526893413|FG008|Overall Study|Prolonged duration between visits|0|||
146102398|NCT00347360|526893414|FG009|Overall Study|Prolonged duration between visits|0|||
146102399|NCT00347360|526893415|FG010|Overall Study|Prolonged duration between visits|0|||
146102400|NCT00347360|526893416|FG011|Overall Study|Prolonged duration between visits|0|||
146102401|NCT00347360|526893417|FG012|Overall Study|Prolonged duration between visits|1|||
146102402|NCT00347360|526893418|FG013|Overall Study|Prolonged duration between visits|0|||
146102403|NCT00347360|526893419|FG014|Overall Study|Prolonged duration between visits|0|||
146102404|NCT00347360|526893405|FG000|Overall Study|Subject left town, ran out of study drug|0|||
146102405|NCT00347360|526893406|FG001|Overall Study|Subject left town, ran out of study drug|0|||
146102406|NCT00347360|526893407|FG002|Overall Study|Subject left town, ran out of study drug|0|||
146102407|NCT00347360|526893408|FG003|Overall Study|Subject left town, ran out of study drug|0|||
146102408|NCT00347360|526893409|FG004|Overall Study|Subject left town, ran out of study drug|0|||
146102409|NCT00347360|526893410|FG005|Overall Study|Subject left town, ran out of study drug|0|||
146102410|NCT00347360|526893411|FG006|Overall Study|Subject left town, ran out of study drug|0|||
146102411|NCT00347360|526893412|FG007|Overall Study|Subject left town, ran out of study drug|0|||
146102412|NCT00347360|526893413|FG008|Overall Study|Subject left town, ran out of study drug|0|||
146102413|NCT00347360|526893414|FG009|Overall Study|Subject left town, ran out of study drug|0|||
146102414|NCT00347360|526893415|FG010|Overall Study|Subject left town, ran out of study drug|0|||
146102415|NCT00347360|526893416|FG011|Overall Study|Subject left town, ran out of study drug|0|||
146102416|NCT00347360|526893417|FG012|Overall Study|Subject left town, ran out of study drug|0|||
146102417|NCT00347360|526893418|FG013|Overall Study|Subject left town, ran out of study drug|1|||
146102418|NCT00347360|526893419|FG014|Overall Study|Subject left town, ran out of study drug|0|||
146102419|NCT00347360|526893405|FG000|Overall Study|Subject refuse to sign updated consent|0|||
146102420|NCT00347360|526893406|FG001|Overall Study|Subject refuse to sign updated consent|0|||
146102421|NCT00347360|526893407|FG002|Overall Study|Subject refuse to sign updated consent|0|||
146102422|NCT00347360|526893408|FG003|Overall Study|Subject refuse to sign updated consent|0|||
146102423|NCT00347360|526893409|FG004|Overall Study|Subject refuse to sign updated consent|0|||
146102424|NCT00347360|526893410|FG005|Overall Study|Subject refuse to sign updated consent|0|||
146102425|NCT00347360|526893411|FG006|Overall Study|Subject refuse to sign updated consent|0|||
146102426|NCT00347360|526893412|FG007|Overall Study|Subject refuse to sign updated consent|0|||
146102427|NCT00347360|526893413|FG008|Overall Study|Subject refuse to sign updated consent|0|||
146102428|NCT00347360|526893414|FG009|Overall Study|Subject refuse to sign updated consent|0|||
146102429|NCT00347360|526893415|FG010|Overall Study|Subject refuse to sign updated consent|0|||
146102430|NCT00347360|526893416|FG011|Overall Study|Subject refuse to sign updated consent|0|||
146102431|NCT00347360|526893417|FG012|Overall Study|Subject refuse to sign updated consent|0|||
146102432|NCT00347360|526893418|FG013|Overall Study|Subject refuse to sign updated consent|0|||
146102433|NCT00347360|526893419|FG014|Overall Study|Subject refuse to sign updated consent|1|||
146102434|NCT00347360|526893405|FG000|Overall Study|Visits conflicted with new job|0|||
146255388|NCT02205476|527448597|FG001|Overall Study|Study termination by Sponsor|3|||
146102435|NCT00347360|526893406|FG001|Overall Study|Visits conflicted with new job|0|||
146102436|NCT00347360|526893407|FG002|Overall Study|Visits conflicted with new job|0|||
146102437|NCT00347360|526893408|FG003|Overall Study|Visits conflicted with new job|0|||
146045108|NCT03364309|526679036|FG012|Induction Period|Lost to Follow-up|0|||
146045109|NCT03364309|526679037|FG013|Induction Period|Lost to Follow-up|0|||
146045110|NCT03364309|526679038|FG014|Induction Period|Lost to Follow-up|0|||
146045111|NCT03364309|526679039|FG015|Induction Period|Lost to Follow-up|0|||
146045112|NCT03364309|526679040|FG016|Induction Period|Lost to Follow-up|0|||
146045113|NCT03364309|526679041|FG017|Induction Period|Lost to Follow-up|0|||
146045114|NCT03364309|526679042|FG018|Induction Period|Lost to Follow-up|0|||
146045115|NCT03364309|526679024|FG000|Induction Period|Physician Decision|0|||
146045116|NCT03364309|526679025|FG001|Induction Period|Physician Decision|1|||
146045117|NCT03364309|526679026|FG002|Induction Period|Physician Decision|0|||
146045118|NCT03364309|526679027|FG003|Induction Period|Physician Decision|0|||
146045119|NCT03364309|526679028|FG004|Induction Period|Physician Decision|0|||
146045120|NCT03364309|526679029|FG005|Induction Period|Physician Decision|0|||
146045121|NCT03364309|526679030|FG006|Induction Period|Physician Decision|0|||
146045122|NCT03364309|526679031|FG007|Induction Period|Physician Decision|0|||
146045123|NCT03364309|526679032|FG008|Induction Period|Physician Decision|0|||
146045124|NCT03364309|526679033|FG009|Induction Period|Physician Decision|0|||
146045125|NCT03364309|526679034|FG010|Induction Period|Physician Decision|0|||
146045126|NCT03364309|526679035|FG011|Induction Period|Physician Decision|0|||
146045127|NCT03364309|526679036|FG012|Induction Period|Physician Decision|0|||
146045128|NCT03364309|526679037|FG013|Induction Period|Physician Decision|0|||
146045129|NCT03364309|526679038|FG014|Induction Period|Physician Decision|0|||
146045130|NCT03364309|526679039|FG015|Induction Period|Physician Decision|0|||
146045131|NCT03364309|526679040|FG016|Induction Period|Physician Decision|0|||
146045132|NCT03364309|526679041|FG017|Induction Period|Physician Decision|0|||
146045133|NCT03364309|526679042|FG018|Induction Period|Physician Decision|0|||
146045134|NCT03364309|526679024|FG000|Maintenance Period|Withdrawal by Subject|0|||
146045135|NCT03364309|526679025|FG001|Maintenance Period|Withdrawal by Subject|0|||
146045136|NCT03364309|526679026|FG002|Maintenance Period|Withdrawal by Subject|0|||
146045137|NCT03364309|526679027|FG003|Maintenance Period|Withdrawal by Subject|1|||
146045138|NCT03364309|526679028|FG004|Maintenance Period|Withdrawal by Subject|3|||
146045139|NCT03364309|526679029|FG005|Maintenance Period|Withdrawal by Subject|1|||
146045140|NCT03364309|526679030|FG006|Maintenance Period|Withdrawal by Subject|3|||
146045141|NCT03364309|526679031|FG007|Maintenance Period|Withdrawal by Subject|0|||
146045142|NCT03364309|526679032|FG008|Maintenance Period|Withdrawal by Subject|1|||
146045143|NCT03364309|526679033|FG009|Maintenance Period|Withdrawal by Subject|1|||
146045144|NCT03364309|526679034|FG010|Maintenance Period|Withdrawal by Subject|2|||
146045145|NCT03364309|526679035|FG011|Maintenance Period|Withdrawal by Subject|0|||
146045146|NCT03364309|526679036|FG012|Maintenance Period|Withdrawal by Subject|0|||
146045147|NCT03364309|526679037|FG013|Maintenance Period|Withdrawal by Subject|0|||
146045148|NCT03364309|526679038|FG014|Maintenance Period|Withdrawal by Subject|0|||
146045149|NCT03364309|526679039|FG015|Maintenance Period|Withdrawal by Subject|0|||
146045150|NCT03364309|526679040|FG016|Maintenance Period|Withdrawal by Subject|0|||
146045151|NCT03364309|526679041|FG017|Maintenance Period|Withdrawal by Subject|0|||
146045152|NCT03364309|526679042|FG018|Maintenance Period|Withdrawal by Subject|0|||
146045153|NCT03364309|526679024|FG000|Maintenance Period|Adverse Event|0|||
146045154|NCT03364309|526679025|FG001|Maintenance Period|Adverse Event|0|||
146045155|NCT03364309|526679026|FG002|Maintenance Period|Adverse Event|0|||
146045156|NCT03364309|526679027|FG003|Maintenance Period|Adverse Event|0|||
146045157|NCT03364309|526679028|FG004|Maintenance Period|Adverse Event|2|||
146045158|NCT03364309|526679029|FG005|Maintenance Period|Adverse Event|0|||
146045159|NCT03364309|526679030|FG006|Maintenance Period|Adverse Event|3|||
146045160|NCT03364309|526679031|FG007|Maintenance Period|Adverse Event|0|||
146045161|NCT03364309|526679032|FG008|Maintenance Period|Adverse Event|1|||
146045162|NCT03364309|526679033|FG009|Maintenance Period|Adverse Event|0|||
146045163|NCT03364309|526679034|FG010|Maintenance Period|Adverse Event|2|||
146045164|NCT03364309|526679035|FG011|Maintenance Period|Adverse Event|0|||
146045165|NCT03364309|526679036|FG012|Maintenance Period|Adverse Event|0|||
146045166|NCT03364309|526679037|FG013|Maintenance Period|Adverse Event|0|||
146045167|NCT03364309|526679038|FG014|Maintenance Period|Adverse Event|0|||
146045168|NCT03364309|526679039|FG015|Maintenance Period|Adverse Event|0|||
146045169|NCT03364309|526679040|FG016|Maintenance Period|Adverse Event|0|||
146045170|NCT03364309|526679041|FG017|Maintenance Period|Adverse Event|0|||
146045171|NCT03364309|526679042|FG018|Maintenance Period|Adverse Event|0|||
146045172|NCT03364309|526679024|FG000|Maintenance Period|Relapsed|0|||
146045173|NCT03364309|526679025|FG001|Maintenance Period|Relapsed|0|||
146045174|NCT03364309|526679026|FG002|Maintenance Period|Relapsed|0|||
146045175|NCT03364309|526679027|FG003|Maintenance Period|Relapsed|43|||
146045176|NCT03364309|526679028|FG004|Maintenance Period|Relapsed|7|||
146045177|NCT03364309|526679029|FG005|Maintenance Period|Relapsed|45|||
146045178|NCT03364309|526679030|FG006|Maintenance Period|Relapsed|10|||
146045179|NCT03364309|526679031|FG007|Maintenance Period|Relapsed|2|||
146045180|NCT03364309|526679032|FG008|Maintenance Period|Relapsed|0|||
146045181|NCT03364309|526679033|FG009|Maintenance Period|Relapsed|0|||
146045182|NCT03364309|526679034|FG010|Maintenance Period|Relapsed|0|||
146045183|NCT03364309|526679035|FG011|Maintenance Period|Relapsed|0|||
146045184|NCT03364309|526679036|FG012|Maintenance Period|Relapsed|0|||
146045185|NCT03364309|526679037|FG013|Maintenance Period|Relapsed|0|||
146045186|NCT03364309|526679038|FG014|Maintenance Period|Relapsed|0|||
146045187|NCT03364309|526679039|FG015|Maintenance Period|Relapsed|0|||
146045188|NCT03364309|526679040|FG016|Maintenance Period|Relapsed|0|||
146045189|NCT03364309|526679041|FG017|Maintenance Period|Relapsed|0|||
146045190|NCT03364309|526679042|FG018|Maintenance Period|Relapsed|0|||
146045191|NCT03364309|526679024|FG000|Maintenance Period|Lack of Efficacy|0|||
146045192|NCT03364309|526679025|FG001|Maintenance Period|Lack of Efficacy|0|||
146045193|NCT03364309|526679026|FG002|Maintenance Period|Lack of Efficacy|0|||
146045194|NCT03364309|526679027|FG003|Maintenance Period|Lack of Efficacy|0|||
146045195|NCT03364309|526679028|FG004|Maintenance Period|Lack of Efficacy|0|||
146045196|NCT03364309|526679029|FG005|Maintenance Period|Lack of Efficacy|0|||
146045197|NCT03364309|526679030|FG006|Maintenance Period|Lack of Efficacy|0|||
146045198|NCT03364309|526679031|FG007|Maintenance Period|Lack of Efficacy|0|||
146045199|NCT03364309|526679032|FG008|Maintenance Period|Lack of Efficacy|1|||
146045200|NCT03364309|526679033|FG009|Maintenance Period|Lack of Efficacy|3|||
146045201|NCT03364309|526679034|FG010|Maintenance Period|Lack of Efficacy|2|||
146045202|NCT03364309|526679035|FG011|Maintenance Period|Lack of Efficacy|0|||
146045203|NCT03364309|526679036|FG012|Maintenance Period|Lack of Efficacy|0|||
146045204|NCT03364309|526679037|FG013|Maintenance Period|Lack of Efficacy|0|||
146045205|NCT03364309|526679038|FG014|Maintenance Period|Lack of Efficacy|0|||
146045206|NCT03364309|526679039|FG015|Maintenance Period|Lack of Efficacy|0|||
146045207|NCT03364309|526679040|FG016|Maintenance Period|Lack of Efficacy|0|||
146045208|NCT03364309|526679041|FG017|Maintenance Period|Lack of Efficacy|0|||
146045209|NCT03364309|526679042|FG018|Maintenance Period|Lack of Efficacy|0|||
146045210|NCT03364309|526679024|FG000|Maintenance Period|Death|0|||
146045211|NCT03364309|526679025|FG001|Maintenance Period|Death|0|||
146045212|NCT03364309|526679026|FG002|Maintenance Period|Death|0|||
146045213|NCT03364309|526679027|FG003|Maintenance Period|Death|0|||
146045214|NCT03364309|526679028|FG004|Maintenance Period|Death|0|||
146045215|NCT03364309|526679029|FG005|Maintenance Period|Death|0|||
146045216|NCT03364309|526679030|FG006|Maintenance Period|Death|0|||
146045217|NCT03364309|526679031|FG007|Maintenance Period|Death|0|||
146045218|NCT03364309|526679032|FG008|Maintenance Period|Death|1|||
146045219|NCT03364309|526679033|FG009|Maintenance Period|Death|0|||
146045220|NCT03364309|526679034|FG010|Maintenance Period|Death|0|||
146045221|NCT03364309|526679035|FG011|Maintenance Period|Death|0|||
146045222|NCT03364309|526679036|FG012|Maintenance Period|Death|0|||
146045223|NCT03364309|526679037|FG013|Maintenance Period|Death|0|||
146045224|NCT03364309|526679038|FG014|Maintenance Period|Death|0|||
146045225|NCT03364309|526679039|FG015|Maintenance Period|Death|0|||
146045226|NCT03364309|526679040|FG016|Maintenance Period|Death|0|||
146045227|NCT03364309|526679041|FG017|Maintenance Period|Death|0|||
146045228|NCT03364309|526679042|FG018|Maintenance Period|Death|0|||
146045229|NCT03364309|526679024|FG000|Maintenance Period|Lost to Follow-up|0|||
146045230|NCT03364309|526679025|FG001|Maintenance Period|Lost to Follow-up|0|||
146045231|NCT03364309|526679026|FG002|Maintenance Period|Lost to Follow-up|0|||
146045232|NCT03364309|526679027|FG003|Maintenance Period|Lost to Follow-up|0|||
146045233|NCT03364309|526679028|FG004|Maintenance Period|Lost to Follow-up|0|||
146045234|NCT03364309|526679029|FG005|Maintenance Period|Lost to Follow-up|0|||
146045235|NCT03364309|526679030|FG006|Maintenance Period|Lost to Follow-up|0|||
146045236|NCT03364309|526679031|FG007|Maintenance Period|Lost to Follow-up|0|||
146045237|NCT03364309|526679032|FG008|Maintenance Period|Lost to Follow-up|1|||
146045238|NCT03364309|526679033|FG009|Maintenance Period|Lost to Follow-up|0|||
146045239|NCT03364309|526679034|FG010|Maintenance Period|Lost to Follow-up|0|||
146045240|NCT03364309|526679035|FG011|Maintenance Period|Lost to Follow-up|0|||
146045241|NCT03364309|526679036|FG012|Maintenance Period|Lost to Follow-up|0|||
146045242|NCT03364309|526679037|FG013|Maintenance Period|Lost to Follow-up|0|||
146045243|NCT03364309|526679038|FG014|Maintenance Period|Lost to Follow-up|0|||
146045244|NCT03364309|526679039|FG015|Maintenance Period|Lost to Follow-up|0|||
146045245|NCT03364309|526679040|FG016|Maintenance Period|Lost to Follow-up|0|||
146045246|NCT03364309|526679041|FG017|Maintenance Period|Lost to Follow-up|0|||
146045247|NCT03364309|526679042|FG018|Maintenance Period|Lost to Follow-up|0|||
146045248|NCT03364309|526679024|FG000|Maintenance Period|Miscellaneous|0|||
146045249|NCT03364309|526679025|FG001|Maintenance Period|Miscellaneous|0|||
146255389|NCT02359552|527448602|FG000|Overall Study|Lost to Follow-up|3|||
146045250|NCT03364309|526679026|FG002|Maintenance Period|Miscellaneous|0|||
146045251|NCT03364309|526679027|FG003|Maintenance Period|Miscellaneous|0|||
146045252|NCT03364309|526679028|FG004|Maintenance Period|Miscellaneous|0|||
146045253|NCT03364309|526679029|FG005|Maintenance Period|Miscellaneous|0|||
146045254|NCT03364309|526679030|FG006|Maintenance Period|Miscellaneous|0|||
146045255|NCT03364309|526679031|FG007|Maintenance Period|Miscellaneous|0|||
146045256|NCT03364309|526679032|FG008|Maintenance Period|Miscellaneous|1|||
146045257|NCT03364309|526679033|FG009|Maintenance Period|Miscellaneous|0|||
146045258|NCT03364309|526679034|FG010|Maintenance Period|Miscellaneous|0|||
146045259|NCT03364309|526679035|FG011|Maintenance Period|Miscellaneous|0|||
146045260|NCT03364309|526679036|FG012|Maintenance Period|Miscellaneous|0|||
146045261|NCT03364309|526679037|FG013|Maintenance Period|Miscellaneous|0|||
146045262|NCT03364309|526679038|FG014|Maintenance Period|Miscellaneous|0|||
146045263|NCT03364309|526679039|FG015|Maintenance Period|Miscellaneous|0|||
146045264|NCT03364309|526679040|FG016|Maintenance Period|Miscellaneous|0|||
146045265|NCT03364309|526679041|FG017|Maintenance Period|Miscellaneous|0|||
146045266|NCT03364309|526679042|FG018|Maintenance Period|Miscellaneous|0|||
146045267|NCT03364309|526679024|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045268|NCT03364309|526679025|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045269|NCT03364309|526679026|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045270|NCT03364309|526679027|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045271|NCT03364309|526679028|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045272|NCT03364309|526679029|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045273|NCT03364309|526679030|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045274|NCT03364309|526679031|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045275|NCT03364309|526679032|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045276|NCT03364309|526679033|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045277|NCT03364309|526679034|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045278|NCT03364309|526679035|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045279|NCT03364309|526679036|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045280|NCT03364309|526679037|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146045281|NCT03364309|526679038|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146045282|NCT03364309|526679039|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
146045283|NCT03364309|526679040|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045284|NCT03364309|526679041|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045285|NCT03364309|526679042|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
146045286|NCT03364309|526679024|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045287|NCT03364309|526679025|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045288|NCT03364309|526679026|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045289|NCT03364309|526679027|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045290|NCT03364309|526679028|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045291|NCT03364309|526679029|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045292|NCT03364309|526679030|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045293|NCT03364309|526679031|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045294|NCT03364309|526679032|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045295|NCT03364309|526679033|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045296|NCT03364309|526679034|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045297|NCT03364309|526679035|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045298|NCT03364309|526679036|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045299|NCT03364309|526679037|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045300|NCT03364309|526679038|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
146045301|NCT03364309|526679039|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045302|NCT03364309|526679040|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045303|NCT03364309|526679041|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045304|NCT03364309|526679042|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
146045305|NCT03364309|526679024|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
146045306|NCT03364309|526679025|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
146045307|NCT03364309|526679026|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
146045308|NCT03364309|526679027|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
146045309|NCT03364309|526679028|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
146045310|NCT03364309|526679029|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
146045311|NCT03364309|526679030|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
146045312|NCT03364309|526679031|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
146045313|NCT03364309|526679032|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
146045314|NCT03364309|526679033|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
146045315|NCT03364309|526679034|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
146045316|NCT03364309|526679035|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
146045317|NCT03364309|526679036|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
146045318|NCT03364309|526679037|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
146045319|NCT03364309|526679038|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
146045320|NCT03364309|526679039|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
146045321|NCT03364309|526679040|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
146045322|NCT03364309|526679041|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
146045323|NCT03364309|526679042|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
146045324|NCT03364309|526679024|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045325|NCT03364309|526679025|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045326|NCT03364309|526679026|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045327|NCT03364309|526679027|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045328|NCT03364309|526679028|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045329|NCT03364309|526679029|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045330|NCT03364309|526679030|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045331|NCT03364309|526679031|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045332|NCT03364309|526679032|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045333|NCT03364309|526679033|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146255390|NCT02359552|527448603|FG001|Overall Study|Lost to Follow-up|4|||
146102438|NCT00347360|526893409|FG004|Overall Study|Visits conflicted with new job|0|||
146102439|NCT00347360|526893410|FG005|Overall Study|Visits conflicted with new job|0|||
146102440|NCT00347360|526893411|FG006|Overall Study|Visits conflicted with new job|1|||
146102441|NCT00347360|526893412|FG007|Overall Study|Visits conflicted with new job|0|||
146102442|NCT00347360|526893413|FG008|Overall Study|Visits conflicted with new job|0|||
146102443|NCT00347360|526893414|FG009|Overall Study|Visits conflicted with new job|0|||
146102444|NCT00347360|526893415|FG010|Overall Study|Visits conflicted with new job|0|||
146102445|NCT00347360|526893416|FG011|Overall Study|Visits conflicted with new job|0|||
146102446|NCT00347360|526893417|FG012|Overall Study|Visits conflicted with new job|0|||
146102447|NCT00347360|526893418|FG013|Overall Study|Visits conflicted with new job|0|||
146102448|NCT00347360|526893419|FG014|Overall Study|Visits conflicted with new job|0|||
146102449|NCT01788228|526893427|FG000|Overall Study|Migrated/moved from study area|1|||
146102450|NCT01788228|526893428|FG001|Overall Study|Migrated/moved from study area|0|||
146102451|NCT02187744|526893429|FG000|Study|Participant refused further follow-up|1|||
146102452|NCT02187744|526893430|FG001|Study|Participant refused further follow-up|0|||
146102453|NCT02187744|526893429|FG000|Study|Other|2|||
146102454|NCT02187744|526893430|FG001|Study|Other|1|||
146102455|NCT02187744|526893429|FG000|Study|Lost to Follow-up|0|||
146102456|NCT02187744|526893430|FG001|Study|Lost to Follow-up|2|||
146102457|NCT02187744|526893429|FG000|Study|Related adverse event, not serious|0|||
146102458|NCT02187744|526893430|FG001|Study|Related adverse event, not serious|2|||
146102459|NCT02187744|526893429|FG000|Study|Death|1|||
146102460|NCT02187744|526893430|FG001|Study|Death|0|||
146102461|NCT02187744|526893429|FG000|Study|Related adverse event, serious non-fatal|0|||
146102462|NCT02187744|526893430|FG001|Study|Related adverse event, serious non-fatal|1|||
146102463|NCT02187744|526893429|FG000|Treatment|Death|1|||
146102464|NCT02187744|526893430|FG001|Treatment|Death|0|||
146102465|NCT02187744|526893429|FG000|Treatment|Related adverse event, serious non-fatal|0|||
146102466|NCT02187744|526893430|FG001|Treatment|Related adverse event, serious non-fatal|1|||
146102467|NCT02187744|526893429|FG000|Treatment|Related adverse event, not serious|0|||
146102468|NCT02187744|526893430|FG001|Treatment|Related adverse event, not serious|2|||
146300704|NCT01621542|527617130|FG001|Overall Study|Adverse Event|0|||
146300705|NCT01621542|527617131|FG002|Overall Study|Adverse Event|1|||
146300706|NCT01621542|527617132|FG003|Overall Study|Adverse Event|3|||
146045334|NCT03364309|526679034|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045335|NCT03364309|526679035|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045336|NCT03364309|526679036|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045337|NCT03364309|526679037|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045338|NCT03364309|526679038|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045339|NCT03364309|526679039|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
146045340|NCT03364309|526679040|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
146045341|NCT03364309|526679041|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
146045342|NCT03364309|526679042|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
146045343|NCT03364309|526679024|FG000|Post-Treatment Followup Period|Adverse Event|0|||
146045344|NCT03364309|526679025|FG001|Post-Treatment Followup Period|Adverse Event|0|||
146045345|NCT03364309|526679026|FG002|Post-Treatment Followup Period|Adverse Event|0|||
146045346|NCT03364309|526679027|FG003|Post-Treatment Followup Period|Adverse Event|0|||
146045347|NCT03364309|526679028|FG004|Post-Treatment Followup Period|Adverse Event|0|||
146045348|NCT03364309|526679029|FG005|Post-Treatment Followup Period|Adverse Event|0|||
146045349|NCT03364309|526679030|FG006|Post-Treatment Followup Period|Adverse Event|0|||
146045350|NCT03364309|526679031|FG007|Post-Treatment Followup Period|Adverse Event|0|||
146045351|NCT03364309|526679032|FG008|Post-Treatment Followup Period|Adverse Event|0|||
146045352|NCT03364309|526679033|FG009|Post-Treatment Followup Period|Adverse Event|0|||
146045353|NCT03364309|526679034|FG010|Post-Treatment Followup Period|Adverse Event|0|||
146300707|NCT01621542|527617133|FG004|Overall Study|Adverse Event|0|||
146045354|NCT03364309|526679035|FG011|Post-Treatment Followup Period|Adverse Event|0|||
146045355|NCT03364309|526679036|FG012|Post-Treatment Followup Period|Adverse Event|0|||
146045356|NCT03364309|526679037|FG013|Post-Treatment Followup Period|Adverse Event|0|||
146045357|NCT03364309|526679038|FG014|Post-Treatment Followup Period|Adverse Event|0|||
146045358|NCT03364309|526679039|FG015|Post-Treatment Followup Period|Adverse Event|0|||
146045359|NCT03364309|526679040|FG016|Post-Treatment Followup Period|Adverse Event|2|||
146045360|NCT03364309|526679041|FG017|Post-Treatment Followup Period|Adverse Event|6|||
146045361|NCT03364309|526679042|FG018|Post-Treatment Followup Period|Adverse Event|1|||
146045362|NCT03364309|526679024|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045363|NCT03364309|526679025|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045364|NCT03364309|526679026|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045365|NCT03364309|526679027|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045366|NCT03364309|526679028|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045367|NCT03364309|526679029|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045368|NCT03364309|526679030|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
146102469|NCT02187744|526893429|FG000|Treatment|Lost to Follow-up|0|||
146102470|NCT02187744|526893430|FG001|Treatment|Lost to Follow-up|1|||
146045369|NCT03364309|526679031|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045370|NCT03364309|526679032|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045371|NCT03364309|526679033|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045372|NCT03364309|526679034|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045373|NCT03364309|526679035|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045374|NCT03364309|526679036|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045375|NCT03364309|526679037|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045376|NCT03364309|526679038|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045377|NCT03364309|526679039|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045378|NCT03364309|526679040|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045379|NCT03364309|526679041|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
146045380|NCT03364309|526679042|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
146045381|NCT03364309|526679024|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
146045382|NCT03364309|526679025|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
146045383|NCT03364309|526679026|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
146045384|NCT03364309|526679027|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
146045385|NCT03364309|526679028|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
146045386|NCT03364309|526679029|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
146045387|NCT03364309|526679030|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
146045388|NCT03364309|526679031|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
146045389|NCT03364309|526679032|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
146045390|NCT03364309|526679033|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
146045391|NCT03364309|526679034|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
146045392|NCT03364309|526679035|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
146045393|NCT03364309|526679036|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
146045394|NCT03364309|526679037|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
146045395|NCT03364309|526679038|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
146045396|NCT03364309|526679039|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
146045397|NCT03364309|526679040|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
146045398|NCT03364309|526679041|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
146045399|NCT03364309|526679042|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
146045400|NCT00615992|526679043|FG000|Overall Study|Protocol Violation|67|||
146045401|NCT02328027|526679044|FG000|Overall Study|Withdrawal by Subject|0|||
146045402|NCT02328027|526679045|FG001|Overall Study|Withdrawal by Subject|1|||
146045403|NCT03319212|526679046|FG000|Overall Study|Discontinued as moving out of local area|0|||
146045404|NCT03319212|526679047|FG001|Overall Study|Discontinued as moving out of local area|1|||
146045405|NCT03319212|526679046|FG000|Overall Study|Adverse Event|2|||
146045406|NCT03319212|526679047|FG001|Overall Study|Adverse Event|2|||
146045407|NCT03319212|526679046|FG000|Overall Study|Withdrawal by Subject|0|||
146045408|NCT03319212|526679047|FG001|Overall Study|Withdrawal by Subject|1|||
146045409|NCT03319212|526679046|FG000|Overall Study|Lost to Follow-up|0|||
146045410|NCT03319212|526679047|FG001|Overall Study|Lost to Follow-up|1|||
146045411|NCT03319212|526679046|FG000|Overall Study|Physician Decision|1|||
146045412|NCT03319212|526679047|FG001|Overall Study|Physician Decision|0|||
146045413|NCT01811186|526679049|FG000|Overall Study|Adverse Event|54|||
146045414|NCT01811186|526679050|FG001|Overall Study|Adverse Event|38|||
146045415|NCT01811186|526679049|FG000|Overall Study|Protocol Violation|5|||
146045416|NCT01811186|526679050|FG001|Overall Study|Protocol Violation|6|||
146045417|NCT01811186|526679049|FG000|Overall Study|Withdrawal by Subject|5|||
146045418|NCT01811186|526679050|FG001|Overall Study|Withdrawal by Subject|10|||
146045419|NCT01811186|526679049|FG000|Overall Study|Lack of Efficacy|3|||
146045420|NCT01811186|526679050|FG001|Overall Study|Lack of Efficacy|6|||
146045421|NCT01811186|526679049|FG000|Overall Study|Lost to Follow-up|4|||
146045422|NCT01811186|526679050|FG001|Overall Study|Lost to Follow-up|2|||
146045423|NCT02465203|526679051|FG000|Overall Study|Protocol Violation|1|||
146045424|NCT02465203|526679052|FG001|Overall Study|Protocol Violation|1|||
146045425|NCT02465203|526679053|FG002|Overall Study|Protocol Violation|1|||
146045426|NCT02465203|526679051|FG000|Overall Study|Study terminated by sponsor|50|||
146045427|NCT02465203|526679052|FG001|Overall Study|Study terminated by sponsor|34|||
146045428|NCT02465203|526679053|FG002|Overall Study|Study terminated by sponsor|11|||
146045429|NCT02465203|526679051|FG000|Overall Study|New therapy for study indication|4|||
146045430|NCT02465203|526679052|FG001|Overall Study|New therapy for study indication|0|||
146045431|NCT02465203|526679053|FG002|Overall Study|New therapy for study indication|0|||
146045432|NCT02465203|526679051|FG000|Overall Study|Patient/guardian decision|1|||
146045433|NCT02465203|526679052|FG001|Overall Study|Patient/guardian decision|1|||
146045434|NCT02465203|526679053|FG002|Overall Study|Patient/guardian decision|1|||
146045435|NCT04072887|526679058|FG000|Overall Study|Withdrawal by Subject|3|||
146045436|NCT04072887|526679059|FG001|Overall Study|Withdrawal by Subject|8|||
146045437|NCT04072887|526679060|FG002|Overall Study|Withdrawal by Subject|1|||
146045438|NCT04072887|526679061|FG003|Overall Study|Withdrawal by Subject|3|||
146045439|NCT04072887|526679062|FG004|Overall Study|Withdrawal by Subject|3|||
146045440|NCT04072887|526679063|FG005|Overall Study|Withdrawal by Subject|13|||
146045441|NCT04072887|526679058|FG000|Overall Study|Adverse Event|2|||
146045442|NCT04072887|526679059|FG001|Overall Study|Adverse Event|4|||
146045443|NCT04072887|526679060|FG002|Overall Study|Adverse Event|1|||
146045444|NCT04072887|526679061|FG003|Overall Study|Adverse Event|4|||
146045445|NCT04072887|526679062|FG004|Overall Study|Adverse Event|0|||
146045446|NCT04072887|526679063|FG005|Overall Study|Adverse Event|1|||
146045447|NCT04072887|526679058|FG000|Overall Study|Physician Decision|2|||
146045448|NCT04072887|526679059|FG001|Overall Study|Physician Decision|0|||
146045449|NCT04072887|526679060|FG002|Overall Study|Physician Decision|0|||
146045450|NCT04072887|526679061|FG003|Overall Study|Physician Decision|0|||
146045451|NCT04072887|526679062|FG004|Overall Study|Physician Decision|0|||
146045452|NCT04072887|526679063|FG005|Overall Study|Physician Decision|1|||
146045453|NCT04072887|526679058|FG000|Overall Study|Lost to Follow-up|1|||
146045454|NCT04072887|526679059|FG001|Overall Study|Lost to Follow-up|3|||
146102471|NCT02187744|526893429|FG000|Treatment|Other|2|||
146102472|NCT02187744|526893430|FG001|Treatment|Other|0|||
146102473|NCT02187744|526893429|FG000|Treatment|Participant refused continued treatment|1|||
146102474|NCT02187744|526893430|FG001|Treatment|Participant refused continued treatment|1|||
146102475|NCT01972568|526893431|FG000|Overall Study|Other events|3|||
146102476|NCT01972568|526893432|FG001|Overall Study|Other events|0|||
146102477|NCT01972568|526893433|FG002|Overall Study|Other events|0|||
146102478|NCT01972568|526893431|FG000|Overall Study|Lack of Efficacy|0|||
146102479|NCT01972568|526893432|FG001|Overall Study|Lack of Efficacy|1|||
146102480|NCT01972568|526893433|FG002|Overall Study|Lack of Efficacy|2|||
146102481|NCT01972568|526893431|FG000|Overall Study|Protocol Violation|1|||
146102482|NCT01972568|526893432|FG001|Overall Study|Protocol Violation|2|||
146102483|NCT01972568|526893433|FG002|Overall Study|Protocol Violation|2|||
146102484|NCT01972568|526893431|FG000|Overall Study|Withdrawal by Subject|6|||
146102485|NCT01972568|526893432|FG001|Overall Study|Withdrawal by Subject|3|||
146102486|NCT01972568|526893433|FG002|Overall Study|Withdrawal by Subject|7|||
146102487|NCT01972568|526893431|FG000|Overall Study|Lost to Follow-up|1|||
146102488|NCT01972568|526893432|FG001|Overall Study|Lost to Follow-up|0|||
146102489|NCT01972568|526893433|FG002|Overall Study|Lost to Follow-up|0|||
146102490|NCT01972568|526893431|FG000|Overall Study|Adverse Event|5|||
146102491|NCT01972568|526893432|FG001|Overall Study|Adverse Event|6|||
146102492|NCT01972568|526893433|FG002|Overall Study|Adverse Event|5|||
146102493|NCT01696071|526893448|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
146102494|NCT01696071|526893449|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
146102495|NCT02764697|526893450|FG000|Overall Study|Lack of Efficacy|3|||
146102496|NCT03298867|526893459|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
146102497|NCT03298867|526893460|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
146102498|NCT03298867|526893459|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
146102499|NCT03298867|526893460|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
146102500|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
146102501|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
146102502|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
146102503|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
146102504|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
146102505|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
146102506|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
146102507|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
146102508|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
146102509|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
146102510|NCT03298867|526893459|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
146102511|NCT03298867|526893460|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
146102512|NCT03298867|526893459|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
146102513|NCT03298867|526893460|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
146102514|NCT03730012|526893461|FG000|Overall Study|Adverse Event|0|||
146102515|NCT03730012|526893462|FG001|Overall Study|Adverse Event|1|||
146102516|NCT03730012|526893461|FG000|Overall Study|Lack of Efficacy|1|||
146102517|NCT03730012|526893462|FG001|Overall Study|Lack of Efficacy|5|||
146102518|NCT03730012|526893461|FG000|Overall Study|Withdrawal by Subject|0|||
146102519|NCT03730012|526893462|FG001|Overall Study|Withdrawal by Subject|1|||
146102520|NCT03730012|526893461|FG000|Overall Study|Miscellaneous|2|||
146102521|NCT03730012|526893462|FG001|Overall Study|Miscellaneous|1|||
146102522|NCT01995825|526895243|FG000|Overall Study|Withdrawal by Subject|1|||
146102523|NCT01995825|526895244|FG001|Overall Study|Withdrawal by Subject|0|||
146102524|NCT01798004|526895245|FG000|Overall Study|Death|2|||
146102525|NCT01798004|526895245|FG000|Overall Study|Lack of Efficacy|8|||
146102526|NCT01798004|526895245|FG000|Overall Study|Physician Decision|25|||
146102527|NCT01798004|526895245|FG000|Overall Study|Withdrawal by Subject|4|||
146045455|NCT04072887|526679060|FG002|Overall Study|Lost to Follow-up|0|||
146045456|NCT04072887|526679061|FG003|Overall Study|Lost to Follow-up|0|||
146102528|NCT01798004|526895245|FG000|Overall Study|Ineligible|4|||
146102529|NCT01798004|526895245|FG000|Overall Study|Patient/parent refusal|7|||
146255391|NCT02391116|527448604|FG000|Treatment|Withdrawal by Subject|1|||
146045457|NCT04072887|526679062|FG004|Overall Study|Lost to Follow-up|0|||
146045458|NCT04072887|526679063|FG005|Overall Study|Lost to Follow-up|0|||
146045459|NCT04072887|526679058|FG000|Overall Study|Death|0|||
146045460|NCT04072887|526679059|FG001|Overall Study|Death|2|||
146045461|NCT04072887|526679060|FG002|Overall Study|Death|0|||
146045462|NCT04072887|526679061|FG003|Overall Study|Death|2|||
146045463|NCT04072887|526679062|FG004|Overall Study|Death|3|||
146045464|NCT04072887|526679063|FG005|Overall Study|Death|0|||
146045465|NCT00856297|526679064|FG000|Overall Study|Unable to classify|2|||
146045466|NCT00856297|526679065|FG001|Overall Study|Unable to classify|0|||
146045467|NCT00856297|526679066|FG002|Overall Study|Unable to classify|0|||
146045468|NCT00856297|526679067|FG003|Overall Study|Unable to classify|0|||
146045469|NCT00856297|526679068|FG004|Overall Study|Unable to classify|0|||
146045470|NCT04371666|526679075|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
146045471|NCT04371666|526679076|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
146045472|NCT04371666|526679075|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
146045473|NCT04371666|526679076|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
146045474|NCT04371666|526679075|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
146045475|NCT04371666|526679076|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
146045476|NCT04371666|526679075|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
146045477|NCT04371666|526679076|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
146045478|NCT04371666|526679075|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
146045479|NCT04371666|526679076|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
146045480|NCT04371666|526679075|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
146045481|NCT04371666|526679076|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
146045482|NCT00861471|526679083|FG000|Overall Study|Withdrawal by Subject|1|||
146045483|NCT00861471|526679083|FG000|Overall Study|Adverse Event|2|||
146045484|NCT00861471|526679083|FG000|Overall Study|Lack of Efficacy|3|||
146045485|NCT00861471|526679083|FG000|Overall Study|treatment for lumbar laminectomy|1|||
146045486|NCT00861471|526679083|FG000|Overall Study|Physician Decision|2|||
146045487|NCT02123576|526679084|FG000|Overall Study|Adverse Event|1|||
146045488|NCT02123576|526679085|FG001|Overall Study|Adverse Event|0|||
146045489|NCT00934128|526679086|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
146045490|NCT00934128|526679087|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
146045491|NCT00934128|526679086|FG000|First Intervention (2 Hours)|Adverse Event|4|||
146045492|NCT00934128|526679087|FG001|First Intervention (2 Hours)|Adverse Event|1|||
146045493|NCT00934128|526679086|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
146045494|NCT00934128|526679087|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
146045495|NCT00934128|526679086|FG000|Washout Period (1 Hour)|Patient preference|1|||
146045496|NCT00934128|526679087|FG001|Washout Period (1 Hour)|Patient preference|3|||
146045497|NCT00934128|526679086|FG000|Washout Period (1 Hour)|Pain|1|||
146045498|NCT00934128|526679087|FG001|Washout Period (1 Hour)|Pain|0|||
146045499|NCT00934128|526679086|FG000|Washout Period (1 Hour)|Too tired|1|||
146045500|NCT00934128|526679087|FG001|Washout Period (1 Hour)|Too tired|0|||
146045501|NCT00934128|526679086|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
146045502|NCT00934128|526679087|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
146045503|NCT00934128|526679086|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
146045504|NCT00934128|526679087|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
146045505|NCT03228212|526679088|FG000|Period 1|Adverse Event|1|||
146045506|NCT03228212|526679089|FG001|Period 1|Adverse Event|0|||
146045507|NCT03228212|526679088|FG000|Period 1|no longer meets eligibility criteria|0|||
146045508|NCT03228212|526679089|FG001|Period 1|no longer meets eligibility criteria|1|||
146045509|NCT03228212|526679088|FG000|Period 2|Lost to Follow-up|1|||
146045510|NCT03228212|526679089|FG001|Period 2|Lost to Follow-up|0|||
146045511|NCT02834247|526679090|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
146045512|NCT02834247|526679091|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
146045513|NCT02834247|526679092|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
146045514|NCT02834247|526679093|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
146045515|NCT02834247|526679090|FG000|Dose Escalation Phase|Death|5|||
146045516|NCT02834247|526679091|FG001|Dose Escalation Phase|Death|6|||
146045517|NCT02834247|526679092|FG002|Dose Escalation Phase|Death|5|||
146045518|NCT02834247|526679093|FG003|Dose Escalation Phase|Death|0|||
146045519|NCT02834247|526679090|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
146045520|NCT02834247|526679091|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
146300708|NCT01621542|527617134|FG005|Overall Study|Adverse Event|0|||
146300709|NCT01621542|527617129|FG000|Overall Study|Death|0|||
146045521|NCT02834247|526679092|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
146045522|NCT02834247|526679093|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
146045523|NCT02834247|526679090|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
146045524|NCT02834247|526679091|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
146045525|NCT02834247|526679092|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146045526|NCT02834247|526679093|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146045527|NCT02834247|526679090|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146045528|NCT02834247|526679091|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146045529|NCT02834247|526679092|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
146045530|NCT02834247|526679093|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
146045531|NCT02834247|526679090|FG000|Dose Expansion Phase|Death|0|||
146045532|NCT02834247|526679091|FG001|Dose Expansion Phase|Death|0|||
146045533|NCT02834247|526679092|FG002|Dose Expansion Phase|Death|0|||
146045534|NCT02834247|526679093|FG003|Dose Expansion Phase|Death|8|||
146045535|NCT02834247|526679090|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
146045536|NCT02834247|526679091|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
146045537|NCT02834247|526679092|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
146045538|NCT02834247|526679093|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
146045539|NCT02834247|526679090|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
146045540|NCT02834247|526679091|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
146045541|NCT02834247|526679092|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
146045542|NCT02834247|526679093|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
146045543|NCT01807299|526679094|FG000|Overall Study|Protocol Violation|3|||
146045544|NCT01807299|526679095|FG001|Overall Study|Protocol Violation|1|||
146045545|NCT01807299|526679096|FG002|Overall Study|Protocol Violation|0|||
146045546|NCT01807299|526679097|FG003|Overall Study|Protocol Violation|2|||
146045547|NCT04829916|526680456|FG000|Overall Study|Withdrawal by Subject|1|||
146045548|NCT04829916|526680457|FG001|Overall Study|Withdrawal by Subject|0|||
146045549|NCT03781778|526680459|FG000|Overall Study|Withdrawal by Subject|2|||
146045550|NCT03781778|526680460|FG001|Overall Study|Withdrawal by Subject|2|||
146045551|NCT02287467|526680461|FG000|Overall Study|Protocol Violation|12|||
146045552|NCT02287467|526680462|FG001|Overall Study|Protocol Violation|9|||
146045553|NCT04343755|526680470|FG000|Overall Study|Death|11|||
146045554|NCT04343755|526680470|FG000|Overall Study|Screen Failure|1|||
146045555|NCT03755882|526680471|FG000|Period 1|Protocol Violation|1|||
146045556|NCT03755882|526680472|FG001|Period 1|Protocol Violation|0|||
146045557|NCT03755882|526680471|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
146045558|NCT03755882|526680472|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
146045559|NCT02292446|526680473|FG000|Overall Study|Adverse Event|12|||
146045560|NCT02292446|526680473|FG000|Overall Study|Death|1|||
146045561|NCT02292446|526680473|FG000|Overall Study|Disease progression|2|||
146045562|NCT02292446|526680473|FG000|Overall Study|Subject/guardian decision|2|||
146045563|NCT02292446|526680473|FG000|Overall Study|Withdrawal by Subject|3|||
146045564|NCT02652156|526680475|FG000|Overall Study|Physician Decision|1|||
146045565|NCT02652156|526680476|FG001|Overall Study|Physician Decision|0|||
146045566|NCT02652156|526680477|FG002|Overall Study|Physician Decision|0|||
146045567|NCT00496080|526680481|FG000|Overall Study|Lost to Follow-up|9|||
146045568|NCT00496080|526680481|FG000|Overall Study|Surgical re-intervention|7|||
146045569|NCT00496080|526680481|FG000|Overall Study|Withdrawal by Subject|5|||
146045570|NCT00496080|526680481|FG000|Overall Study|Physician Decision|6|||
146045571|NCT01290757|526680486|FG000|Overall Study|Adverse Event|1|||
146045572|NCT01290757|526680487|FG001|Overall Study|Adverse Event|0|||
146045573|NCT01290757|526680486|FG000|Overall Study|Protocol Violation|1|||
146045574|NCT01290757|526680487|FG001|Overall Study|Protocol Violation|1|||
146045575|NCT01290757|526680486|FG000|Overall Study|Other|0|||
146045576|NCT01290757|526680487|FG001|Overall Study|Other|1|||
146045577|NCT00570310|526680488|FG000|Overall Study|Adverse Event|1|||
146045578|NCT00570310|526680489|FG001|Overall Study|Adverse Event|2|||
146045579|NCT00570310|526680488|FG000|Overall Study|Lack of Efficacy|1|||
146045580|NCT00570310|526680489|FG001|Overall Study|Lack of Efficacy|4|||
146045581|NCT03329846|526680492|FG000|Overall Study|Disease progression|4|||
146045582|NCT03329846|526680493|FG001|Overall Study|Disease progression|6|||
146045583|NCT03329846|526680492|FG000|Overall Study|Study drug toxicity|1|||
146045584|NCT03329846|526680493|FG001|Overall Study|Study drug toxicity|0|||
146045585|NCT03329846|526680492|FG000|Overall Study|Participant request to discontinue treatment|0|||
146045586|NCT03329846|526680493|FG001|Overall Study|Participant request to discontinue treatment|1|||
146045587|NCT03329846|526680492|FG000|Overall Study|Participant withdrew consent|1|||
146045588|NCT03329846|526680493|FG001|Overall Study|Participant withdrew consent|0|||
146300710|NCT01621542|527617130|FG001|Overall Study|Death|1|||
146045589|NCT03329846|526680492|FG000|Overall Study|Other reasons|2|||
146045590|NCT03329846|526680493|FG001|Overall Study|Other reasons|2|||
146045591|NCT00479336|526680494|FG000|Overall Study|Adverse Event|1|||
146045592|NCT00479336|526680495|FG001|Overall Study|Adverse Event|1|||
146045593|NCT00479336|526680496|FG002|Overall Study|Adverse Event|1|||
146045594|NCT00479336|526680497|FG003|Overall Study|Adverse Event|3|||
146045595|NCT00479336|526680494|FG000|Overall Study|Lack of Efficacy|1|||
146045596|NCT00479336|526680495|FG001|Overall Study|Lack of Efficacy|0|||
146045597|NCT00479336|526680496|FG002|Overall Study|Lack of Efficacy|0|||
146045598|NCT00479336|526680497|FG003|Overall Study|Lack of Efficacy|0|||
146045599|NCT00479336|526680494|FG000|Overall Study|Protocol Violation|0|||
146045600|NCT00479336|526680495|FG001|Overall Study|Protocol Violation|1|||
146045601|NCT00479336|526680496|FG002|Overall Study|Protocol Violation|0|||
146045602|NCT00479336|526680497|FG003|Overall Study|Protocol Violation|0|||
146045603|NCT00479336|526680494|FG000|Overall Study|Withdrawal by Subject|1|||
146045604|NCT00479336|526680495|FG001|Overall Study|Withdrawal by Subject|2|||
146045605|NCT00479336|526680496|FG002|Overall Study|Withdrawal by Subject|0|||
146045606|NCT00479336|526680497|FG003|Overall Study|Withdrawal by Subject|0|||
146045607|NCT00479336|526680494|FG000|Overall Study|Physician Decision|0|||
146045608|NCT00479336|526680495|FG001|Overall Study|Physician Decision|1|||
146045609|NCT00479336|526680496|FG002|Overall Study|Physician Decision|0|||
146045610|NCT00479336|526680497|FG003|Overall Study|Physician Decision|2|||
146045611|NCT00479336|526680494|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
146045612|NCT00479336|526680495|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
146045613|NCT00479336|526680496|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
146045614|NCT00479336|526680497|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
146045615|NCT00108862|526680498|FG000|Overall Study|Death|31|||
146045616|NCT00108862|526680499|FG001|Overall Study|Death|37|||
146045617|NCT00108862|526680498|FG000|Overall Study|Withdrawal by Subject|10|||
146045618|NCT00108862|526680499|FG001|Overall Study|Withdrawal by Subject|6|||
146045619|NCT00108862|526680498|FG000|Overall Study|Lost to Follow-up|27|||
146045620|NCT00108862|526680499|FG001|Overall Study|Lost to Follow-up|19|||
146102530|NCT01798004|526895245|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
146102531|NCT01798004|526895245|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
146102532|NCT04680052|526895246|FG000|Overall Study|Ongoing|244|||
146102533|NCT04680052|526895247|FG001|Overall Study|Ongoing|229|||
146102534|NCT04680052|526895248|FG002|Overall Study|Ongoing|39|||
146102535|NCT04680052|526895249|FG003|Overall Study|Ongoing|46|||
146102536|NCT04680052|526895246|FG000|Overall Study|Death|15|||
146102537|NCT04680052|526895247|FG001|Overall Study|Death|22|||
146102538|NCT04680052|526895248|FG002|Overall Study|Death|7|||
146102539|NCT04680052|526895249|FG003|Overall Study|Death|1|||
146045621|NCT03066193|526680500|FG000|Overall Study|Withdrawal by Subject|1|||
146045622|NCT02021643|526680501|FG000|Overall Study|Enrolled but Never Treated|1|||
146045623|NCT02021643|526680502|FG001|Overall Study|Enrolled but Never Treated|0|||
146045624|NCT02021643|526680503|FG002|Overall Study|Enrolled but Never Treated|0|||
146045625|NCT02021643|526680504|FG003|Overall Study|Enrolled but Never Treated|0|||
146045626|NCT02021643|526680501|FG000|Overall Study|Adverse Event|0|||
146045627|NCT02021643|526680502|FG001|Overall Study|Adverse Event|1|||
146045628|NCT02021643|526680503|FG002|Overall Study|Adverse Event|0|||
146045629|NCT02021643|526680504|FG003|Overall Study|Adverse Event|0|||
146045630|NCT02021643|526680501|FG000|Overall Study|Death|0|||
146045631|NCT02021643|526680502|FG001|Overall Study|Death|1|||
146045632|NCT02021643|526680503|FG002|Overall Study|Death|0|||
146045633|NCT02021643|526680504|FG003|Overall Study|Death|0|||
146045634|NCT02021643|526680501|FG000|Overall Study|Investigator's Discretion|1|||
146045635|NCT02021643|526680502|FG001|Overall Study|Investigator's Discretion|0|||
146045636|NCT02021643|526680503|FG002|Overall Study|Investigator's Discretion|0|||
146045637|NCT02021643|526680504|FG003|Overall Study|Investigator's Discretion|0|||
146045638|NCT02021643|526680501|FG000|Overall Study|Lack of Efficacy|7|||
146045639|NCT02021643|526680502|FG001|Overall Study|Lack of Efficacy|6|||
146045640|NCT02021643|526680503|FG002|Overall Study|Lack of Efficacy|0|||
146045641|NCT02021643|526680504|FG003|Overall Study|Lack of Efficacy|12|||
146045642|NCT02021643|526680501|FG000|Overall Study|Lost to Follow-up|0|||
146045643|NCT02021643|526680502|FG001|Overall Study|Lost to Follow-up|1|||
146045644|NCT02021643|526680503|FG002|Overall Study|Lost to Follow-up|0|||
146045645|NCT02021643|526680504|FG003|Overall Study|Lost to Follow-up|0|||
146045646|NCT02021643|526680501|FG000|Overall Study|Withdrew Consent|0|||
146045647|NCT02021643|526680502|FG001|Overall Study|Withdrew Consent|1|||
146045648|NCT02021643|526680503|FG002|Overall Study|Withdrew Consent|0|||
146045649|NCT02021643|526680504|FG003|Overall Study|Withdrew Consent|0|||
146045650|NCT01345188|526680507|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
146045651|NCT01345188|526680507|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
146045652|NCT04181762|526680510|FG000|Overall Study|Adverse Event|1|||
146045653|NCT04181762|526680511|FG001|Overall Study|Adverse Event|3|||
146102540|NCT04680052|526895246|FG000|Overall Study|Lost to Follow-up|3|||
146102541|NCT04680052|526895247|FG001|Overall Study|Lost to Follow-up|2|||
146102542|NCT04680052|526895248|FG002|Overall Study|Lost to Follow-up|0|||
146102543|NCT04680052|526895249|FG003|Overall Study|Lost to Follow-up|1|||
146102544|NCT04680052|526895246|FG000|Overall Study|Withdrawal by Subject|11|||
146102545|NCT04680052|526895247|FG001|Overall Study|Withdrawal by Subject|19|||
146045654|NCT04181762|526680510|FG000|Overall Study|Lost to Follow-up|1|||
146045655|NCT04181762|526680511|FG001|Overall Study|Lost to Follow-up|1|||
146045656|NCT04181762|526680510|FG000|Overall Study|Physician Decision|1|||
146045657|NCT04181762|526680511|FG001|Overall Study|Physician Decision|3|||
146045658|NCT04181762|526680510|FG000|Overall Study|Pregnancy|0|||
146102546|NCT04680052|526895248|FG002|Overall Study|Withdrawal by Subject|7|||
146102547|NCT04680052|526895249|FG003|Overall Study|Withdrawal by Subject|5|||
146102548|NCT04680052|526895246|FG000|Overall Study|Missing|0|||
146045659|NCT04181762|526680511|FG001|Overall Study|Pregnancy|1|||
146045660|NCT04181762|526680510|FG000|Overall Study|Lack of Efficacy|2|||
146045661|NCT04181762|526680511|FG001|Overall Study|Lack of Efficacy|2|||
146045662|NCT04181762|526680510|FG000|Overall Study|Study terminated by sponsor|95|||
146045663|NCT04181762|526680511|FG001|Overall Study|Study terminated by sponsor|97|||
146102549|NCT04680052|526895247|FG001|Overall Study|Missing|1|||
146102550|NCT04680052|526895248|FG002|Overall Study|Missing|0|||
146045664|NCT04181762|526680510|FG000|Overall Study|Subject decision|11|||
146045665|NCT04181762|526680511|FG001|Overall Study|Subject decision|4|||
146045666|NCT04181762|526680510|FG000|Overall Study|Death|1|||
146045667|NCT04181762|526680511|FG001|Overall Study|Death|1|||
146045668|NCT04181762|526680510|FG000|Overall Study|Protocol deviation|1|||
146045669|NCT04181762|526680511|FG001|Overall Study|Protocol deviation|0|||
146045670|NCT04181762|526680510|FG000|Overall Study|Withdrawal of informed consent|1|||
146045671|NCT04181762|526680511|FG001|Overall Study|Withdrawal of informed consent|3|||
146045672|NCT06041919|526680512|FG000|Overall Study|Lost to Follow-up|1|||
146045673|NCT06041919|526680513|FG001|Overall Study|Lost to Follow-up|0|||
146045674|NCT06041919|526680514|FG002|Overall Study|Lost to Follow-up|0|||
146045675|NCT06041919|526680515|FG003|Overall Study|Lost to Follow-up|0|||
146045676|NCT06041919|526680516|FG004|Overall Study|Lost to Follow-up|0|||
146045677|NCT06041919|526680512|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
146045678|NCT06041919|526680513|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
146045679|NCT06041919|526680514|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
146045680|NCT06041919|526680515|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
146045681|NCT06041919|526680516|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
146045682|NCT04526145|526680517|FG000|Overall Study|Withdrawal by Subject|5|||
146045683|NCT00577824|526680521|FG000|Overall Study|Adverse Event|6|||
146045684|NCT00577824|526680522|FG001|Overall Study|Adverse Event|18|||
146045685|NCT00577824|526680523|FG002|Overall Study|Adverse Event|1|||
146045686|NCT00577824|526680521|FG000|Overall Study|Patient decision|0|||
146045687|NCT00577824|526680522|FG001|Overall Study|Patient decision|1|||
146045688|NCT00577824|526680523|FG002|Overall Study|Patient decision|1|||
146045689|NCT00577824|526680521|FG000|Overall Study|Protocol Violation|1|||
146045690|NCT00577824|526680522|FG001|Overall Study|Protocol Violation|1|||
146045691|NCT00577824|526680523|FG002|Overall Study|Protocol Violation|0|||
146045692|NCT01518374|526680524|FG000|Overall Study|Withdrawal by Subject|2|||
146045693|NCT01518374|526680524|FG000|Overall Study|Protocol Violation|3|||
146045694|NCT01518374|526680524|FG000|Overall Study|Lost to Follow-up|2|||
146045695|NCT04607837|526680530|FG000|Overall Study|Adverse Event|8|||
146045696|NCT04607837|526680531|FG001|Overall Study|Adverse Event|2|||
146045697|NCT04607837|526680530|FG000|Overall Study|Withdrawal by Subject|8|||
146045698|NCT04607837|526680531|FG001|Overall Study|Withdrawal by Subject|7|||
146045699|NCT04607837|526680530|FG000|Overall Study|Physician Decision|2|||
146045700|NCT04607837|526680531|FG001|Overall Study|Physician Decision|0|||
146045701|NCT04607837|526680530|FG000|Overall Study|Lack of Efficacy|2|||
146045702|NCT04607837|526680531|FG001|Overall Study|Lack of Efficacy|0|||
146045703|NCT04607837|526680530|FG000|Overall Study|Participant terminated by sponsor|1|||
146045704|NCT04607837|526680531|FG001|Overall Study|Participant terminated by sponsor|0|||
146045705|NCT04607837|526680530|FG000|Overall Study|Disease worsening|36|||
146045706|NCT04607837|526680531|FG001|Overall Study|Disease worsening|36|||
146045707|NCT04607837|526680530|FG000|Overall Study|Other|1|||
146045708|NCT04607837|526680531|FG001|Overall Study|Other|0|||
146045709|NCT02362464|526680532|FG000|Overall Study|Switched to alternative therapy|1|||
146045710|NCT02362464|526680532|FG000|Overall Study|Refused further treatment|1|||
146045711|NCT02362464|526680532|FG000|Overall Study|Physician Decision|4|||
146045712|NCT04209205|526680533|FG000|Overall Study|Adverse Event|2|||
146045713|NCT04209205|526680534|FG001|Overall Study|Adverse Event|3|||
146045714|NCT04209205|526680533|FG000|Overall Study|Lost to Follow-up|3|||
146045715|NCT04209205|526680534|FG001|Overall Study|Lost to Follow-up|1|||
146045716|NCT04209205|526680533|FG000|Overall Study|Physician Decision|1|||
146045717|NCT04209205|526680534|FG001|Overall Study|Physician Decision|1|||
146045718|NCT04209205|526680533|FG000|Overall Study|Subject decision|10|||
146045719|NCT04209205|526680534|FG001|Overall Study|Subject decision|10|||
146045720|NCT04209205|526680533|FG000|Overall Study|Progressive disease|1|||
146045721|NCT04209205|526680534|FG001|Overall Study|Progressive disease|0|||
146045722|NCT04209205|526680533|FG000|Overall Study|Protocol deviation|0|||
146045723|NCT04209205|526680534|FG001|Overall Study|Protocol deviation|1|||
146045724|NCT04209205|526680533|FG000|Overall Study|New therapy for study indication|1|||
146045725|NCT04209205|526680534|FG001|Overall Study|New therapy for study indication|0|||
146045726|NCT04209205|526680533|FG000|Overall Study|Adverse event - placebo not switched|0|||
146045727|NCT04209205|526680534|FG001|Overall Study|Adverse event - placebo not switched|1|||
146045728|NCT04209205|526680533|FG000|Overall Study|Subject decision - placebo not switched|0|||
146045729|NCT04209205|526680534|FG001|Overall Study|Subject decision - placebo not switched|5|||
146045730|NCT04209205|526680533|FG000|Overall Study|Death - placebo not switched|0|||
146045731|NCT04209205|526680534|FG001|Overall Study|Death - placebo not switched|1|||
146045732|NCT05870865|526680535|FG000|Randomized|Did not receive study treatment|2|||
146300711|NCT01621542|527617131|FG002|Overall Study|Death|0|||
146045733|NCT05870865|526680536|FG001|Randomized|Did not receive study treatment|4|||
146045734|NCT05870865|526680537|FG002|Randomized|Did not receive study treatment|4|||
146045735|NCT05870865|526680538|FG003|Randomized|Did not receive study treatment|3|||
146045736|NCT05870865|526680535|FG000|Treatment Period|Adverse Event|1|||
146045737|NCT05870865|526680536|FG001|Treatment Period|Adverse Event|1|||
146045738|NCT05870865|526680537|FG002|Treatment Period|Adverse Event|1|||
146300712|NCT01621542|527617132|FG003|Overall Study|Death|0|||
146045739|NCT05870865|526680538|FG003|Treatment Period|Adverse Event|1|||
146045740|NCT05870865|526680535|FG000|Treatment Period|Lost to Follow-up|0|||
146045741|NCT05870865|526680536|FG001|Treatment Period|Lost to Follow-up|1|||
146045742|NCT05870865|526680537|FG002|Treatment Period|Lost to Follow-up|2|||
146045743|NCT05870865|526680538|FG003|Treatment Period|Lost to Follow-up|0|||
146045744|NCT05870865|526680535|FG000|Treatment Period|Protocol Violation|0|||
146045745|NCT05870865|526680536|FG001|Treatment Period|Protocol Violation|0|||
146045746|NCT05870865|526680537|FG002|Treatment Period|Protocol Violation|0|||
146045747|NCT05870865|526680538|FG003|Treatment Period|Protocol Violation|1|||
146045748|NCT05870865|526680535|FG000|Treatment Period|Withdrawal by Subject|0|||
146045749|NCT05870865|526680536|FG001|Treatment Period|Withdrawal by Subject|1|||
146045750|NCT05870865|526680537|FG002|Treatment Period|Withdrawal by Subject|1|||
146045751|NCT05870865|526680538|FG003|Treatment Period|Withdrawal by Subject|1|||
146045752|NCT03828019|526680543|FG000|Overall Study|Withdrawal by Subject|3|||
146045753|NCT03828019|526680544|FG001|Overall Study|Withdrawal by Subject|8|||
146045754|NCT03828019|526680543|FG000|Overall Study|Lost to Follow-up|1|||
146045755|NCT03828019|526680544|FG001|Overall Study|Lost to Follow-up|6|||
146045756|NCT03828019|526680543|FG000|Overall Study|Incarcerated|1|||
146045757|NCT03828019|526680544|FG001|Overall Study|Incarcerated|0|||
146045758|NCT03828019|526680543|FG000|Overall Study|Adverse Event|0|||
146045759|NCT03828019|526680544|FG001|Overall Study|Adverse Event|1|||
146045760|NCT00048347|526680545|FG000|Overall Study|Screen failure|2|||
146045761|NCT02343406|526680546|FG000|Overall Study|Progressive disease|72|||
146045762|NCT02343406|526680547|FG001|Overall Study|Progressive disease|70|||
146045763|NCT02343406|526680548|FG002|Overall Study|Progressive disease|43|||
146045764|NCT02343406|526680549|FG003|Overall Study|Progressive disease|15|||
146045765|NCT02343406|526680550|FG004|Overall Study|Progressive disease|5|||
146045766|NCT02343406|526680546|FG000|Overall Study|Adverse Event|6|||
146045767|NCT02343406|526680547|FG001|Overall Study|Adverse Event|8|||
146045768|NCT02343406|526680548|FG002|Overall Study|Adverse Event|6|||
146045769|NCT02343406|526680549|FG003|Overall Study|Adverse Event|3|||
146045770|NCT02343406|526680550|FG004|Overall Study|Adverse Event|0|||
146045771|NCT02343406|526680546|FG000|Overall Study|Withdrawal by Subject|6|||
146045772|NCT02343406|526680547|FG001|Overall Study|Withdrawal by Subject|4|||
146045773|NCT02343406|526680548|FG002|Overall Study|Withdrawal by Subject|8|||
146045774|NCT02343406|526680549|FG003|Overall Study|Withdrawal by Subject|3|||
146045775|NCT02343406|526680550|FG004|Overall Study|Withdrawal by Subject|0|||
146045776|NCT02343406|526680546|FG000|Overall Study|Death|2|||
146045777|NCT02343406|526680547|FG001|Overall Study|Death|1|||
146045778|NCT02343406|526680548|FG002|Overall Study|Death|0|||
146045779|NCT02343406|526680549|FG003|Overall Study|Death|0|||
146045780|NCT02343406|526680550|FG004|Overall Study|Death|0|||
146045781|NCT02343406|526680546|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
146045782|NCT02343406|526680547|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
146045783|NCT02343406|526680548|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
146045784|NCT02343406|526680549|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
146045785|NCT02343406|526680550|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
146045786|NCT02343406|526680546|FG000|Overall Study|Other primary malignancy|0|||
146045787|NCT02343406|526680547|FG001|Overall Study|Other primary malignancy|1|||
146045788|NCT02343406|526680548|FG002|Overall Study|Other primary malignancy|0|||
146045789|NCT02343406|526680549|FG003|Overall Study|Other primary malignancy|0|||
146045790|NCT02343406|526680550|FG004|Overall Study|Other primary malignancy|0|||
146045791|NCT02343406|526680546|FG000|Overall Study|Other, not specified|2|||
146045792|NCT02343406|526680547|FG001|Overall Study|Other, not specified|1|||
146045793|NCT02343406|526680548|FG002|Overall Study|Other, not specified|1|||
146045794|NCT02343406|526680549|FG003|Overall Study|Other, not specified|4|||
146045795|NCT02343406|526680550|FG004|Overall Study|Other, not specified|0|||
146045796|NCT01380834|526680551|FG000|Overall Study|Physician Decision|1|||
146045797|NCT01380834|526680552|FG001|Overall Study|Physician Decision|0|||
146045798|NCT03182907|526680555|FG000|Overall Study|Death|3|||
146045799|NCT03182907|526680556|FG001|Overall Study|Death|0|||
146045800|NCT03182907|526680555|FG000|Overall Study|Protocol Violation|4|||
146045801|NCT03182907|526680556|FG001|Overall Study|Protocol Violation|0|||
146045802|NCT03182907|526680555|FG000|Overall Study|Lost to Follow-up|1|||
146045803|NCT03182907|526680556|FG001|Overall Study|Lost to Follow-up|0|||
146045804|NCT03182907|526680555|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146045805|NCT03182907|526680556|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146045806|NCT02058563|526680560|FG000|Overall Study|Lost to Follow-up|26|||
146045807|NCT02058563|526680561|FG001|Overall Study|Lost to Follow-up|22|||
146045808|NCT02058563|526680560|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
146045809|NCT02058563|526680561|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
146045810|NCT02058563|526680560|FG000|Overall Study|Consent Withdrawal|1|||
146045811|NCT02058563|526680561|FG001|Overall Study|Consent Withdrawal|1|||
146045812|NCT02058563|526680560|FG000|Overall Study|Other (patient incarcerated)|0|||
146045813|NCT02058563|526680561|FG001|Overall Study|Other (patient incarcerated)|1|||
146045814|NCT00166439|526680562|FG000|Overall Study|Ineligible|5|||
146045815|NCT04039217|526680565|FG000|Overall Study|Lost to Follow-up|1|||
146102551|NCT04680052|526895249|FG003|Overall Study|Missing|0|||
146102552|NCT04680052|526895246|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146102553|NCT04680052|526895247|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
146102554|NCT04680052|526895248|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146102555|NCT04680052|526895249|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
146102556|NCT04680052|526895246|FG000|Overall Study|Physician Decision|0|||
146102557|NCT04680052|526895247|FG001|Overall Study|Physician Decision|1|||
146102558|NCT04680052|526895248|FG002|Overall Study|Physician Decision|0|||
146102559|NCT04680052|526895249|FG003|Overall Study|Physician Decision|0|||
146102560|NCT06956170|526895250|FG000|Overall Study|Death|2|||
146102561|NCT06956170|526895251|FG001|Overall Study|Death|1|||
146102562|NCT06956170|526895250|FG000|Overall Study|Withdrawal by Subject|1|||
146102563|NCT06956170|526895251|FG001|Overall Study|Withdrawal by Subject|0|||
146102564|NCT06956170|526895250|FG000|Overall Study|Ongoing|7|||
146102565|NCT06956170|526895251|FG001|Overall Study|Ongoing|10|||
146255392|NCT02391116|527448604|FG000|Treatment|Protocol Violation|1|||
146255393|NCT02391116|527448604|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
146045816|NCT00167310|526680566|FG000|Overall Study|Protocol Violation|5|||
146045817|NCT00167310|526680567|FG001|Overall Study|Protocol Violation|3|||
146045818|NCT00167310|526680566|FG000|Overall Study|Withdrawal by Subject|3|||
146045819|NCT00167310|526680567|FG001|Overall Study|Withdrawal by Subject|7|||
146045820|NCT03193736|526680568|FG000|Overall Study|Death|2|||
146045821|NCT03193736|526680568|FG000|Overall Study|Withdrawal by Subject|1|||
146045822|NCT03193736|526680568|FG000|Overall Study|Lost to Follow-up|1|||
146045823|NCT03193736|526680568|FG000|Overall Study|implant not received|1|||
146045824|NCT03369236|526680569|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
146045825|NCT03369236|526680570|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
146045826|NCT03369236|526680569|FG000|Open-label Extension Period|Lack of Efficacy|2|||
146045827|NCT03369236|526680570|FG001|Open-label Extension Period|Lack of Efficacy|1|||
146045828|NCT03369236|526680569|FG000|Open-label Extension Period|Adverse Event|0|||
146045829|NCT03369236|526680570|FG001|Open-label Extension Period|Adverse Event|1|||
146045830|NCT03369236|526680569|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
146045831|NCT03369236|526680570|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
146045832|NCT00423449|526680571|FG000|Overall Study|Clinical Adverse Event|1|||
146045833|NCT00423449|526680572|FG001|Overall Study|Clinical Adverse Event|0|||
146045834|NCT00423449|526680573|FG002|Overall Study|Clinical Adverse Event|1|||
146045835|NCT00423449|526680574|FG003|Overall Study|Clinical Adverse Event|8|||
146045836|NCT00423449|526680575|FG004|Overall Study|Clinical Adverse Event|2|||
146045837|NCT00423449|526680571|FG000|Overall Study|Death|1|||
146045838|NCT00423449|526680572|FG001|Overall Study|Death|0|||
146045839|NCT00423449|526680573|FG002|Overall Study|Death|2|||
146045840|NCT00423449|526680574|FG003|Overall Study|Death|1|||
146045841|NCT00423449|526680575|FG004|Overall Study|Death|1|||
146045842|NCT00423449|526680571|FG000|Overall Study|Progressive Disease|1|||
146045843|NCT00423449|526680572|FG001|Overall Study|Progressive Disease|3|||
146045844|NCT00423449|526680573|FG002|Overall Study|Progressive Disease|8|||
146045845|NCT00423449|526680574|FG003|Overall Study|Progressive Disease|11|||
146045846|NCT00423449|526680575|FG004|Overall Study|Progressive Disease|4|||
146045847|NCT00423449|526680571|FG000|Overall Study|Laboratory Adverse Event|0|||
146045848|NCT00423449|526680572|FG001|Overall Study|Laboratory Adverse Event|1|||
146045849|NCT00423449|526680573|FG002|Overall Study|Laboratory Adverse Event|2|||
146045850|NCT00423449|526680574|FG003|Overall Study|Laboratory Adverse Event|0|||
146045851|NCT00423449|526680575|FG004|Overall Study|Laboratory Adverse Event|0|||
146045852|NCT00423449|526680571|FG000|Overall Study|Other|0|||
146045853|NCT00423449|526680572|FG001|Overall Study|Other|0|||
146045854|NCT00423449|526680573|FG002|Overall Study|Other|0|||
146045855|NCT00423449|526680574|FG003|Overall Study|Other|1|||
146045856|NCT00423449|526680575|FG004|Overall Study|Other|0|||
146045857|NCT00423449|526680571|FG000|Overall Study|Protocol Violation|0|||
146045858|NCT00423449|526680572|FG001|Overall Study|Protocol Violation|0|||
146045859|NCT00423449|526680573|FG002|Overall Study|Protocol Violation|2|||
146045860|NCT00423449|526680574|FG003|Overall Study|Protocol Violation|1|||
146045861|NCT00423449|526680575|FG004|Overall Study|Protocol Violation|0|||
146045862|NCT01153724|526680576|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146045863|NCT01153724|526680576|FG000|Treatment Period 2|Adverse Event|1|||
146045864|NCT01153724|526680576|FG000|Treatment Period 2|Other reason not defined above|1|||
146102566|NCT00825682|526895252|FG000|Overall Study|personal reasons/ inconvenience|13|||
146102567|NCT00825682|526895253|FG001|Overall Study|personal reasons/ inconvenience|5|||
146255394|NCT02391116|527448604|FG000|Treatment|AE with Clinical PD|3|||
146255395|NCT02391116|527448604|FG000|Safety Follow-up|Adverse Event|1|||
146255396|NCT02391116|527448604|FG000|Safety Follow-up|Withdrawal by Subject|4|||
146045865|NCT00367835|526680581|FG000|Overall Study|Adverse Event|14|||
146045866|NCT00367835|526680582|FG001|Overall Study|Adverse Event|1|||
146045867|NCT00367835|526680581|FG000|Overall Study|Protocol Violation|1|||
146045868|NCT00367835|526680582|FG001|Overall Study|Protocol Violation|7|||
146045869|NCT00367835|526680581|FG000|Overall Study|Withdrawal by Subject|7|||
146045870|NCT00367835|526680582|FG001|Overall Study|Withdrawal by Subject|6|||
146255397|NCT02391116|527448604|FG000|Safety Follow-up|Switching to Other Therapy|4|||
146045871|NCT00367835|526680581|FG000|Overall Study|Lost to Follow-up|1|||
146045872|NCT00367835|526680582|FG001|Overall Study|Lost to Follow-up|4|||
146045873|NCT00367835|526680581|FG000|Overall Study|Lack of Efficacy|3|||
146045874|NCT00367835|526680582|FG001|Overall Study|Lack of Efficacy|12|||
146045875|NCT00367835|526680581|FG000|Overall Study|Subject in juvenile detention center|1|||
146045876|NCT00367835|526680582|FG001|Overall Study|Subject in juvenile detention center|0|||
146045877|NCT00367835|526680581|FG000|Overall Study|refused blood collection|1|||
146045878|NCT00367835|526680582|FG001|Overall Study|refused blood collection|0|||
146045879|NCT00367835|526680581|FG000|Overall Study|Did not respond to calls|1|||
146045880|NCT00367835|526680582|FG001|Overall Study|Did not respond to calls|0|||
146045881|NCT00367835|526680581|FG000|Overall Study|History of lead poisoning|0|||
146045882|NCT00367835|526680582|FG001|Overall Study|History of lead poisoning|1|||
146045883|NCT02697435|526680583|FG000|Overall Study|Withdrawal by Subject|1|||
146045884|NCT02697435|526680584|FG001|Overall Study|Withdrawal by Subject|0|||
146045885|NCT02697435|526680583|FG000|Overall Study|Physician Decision|0|||
146045886|NCT02697435|526680584|FG001|Overall Study|Physician Decision|4|||
146045887|NCT00445770|526680589|FG000|Overall Study|Adverse Event|9|||
146045888|NCT00445770|526680590|FG001|Overall Study|Adverse Event|15|||
146045889|NCT00445770|526680591|FG002|Overall Study|Adverse Event|19|||
146045890|NCT00445770|526680589|FG000|Overall Study|Lack of Efficacy|38|||
146045891|NCT00445770|526680590|FG001|Overall Study|Lack of Efficacy|13|||
146045892|NCT00445770|526680591|FG002|Overall Study|Lack of Efficacy|6|||
146045893|NCT00445770|526680589|FG000|Overall Study|Lost to Follow-up|0|||
146045894|NCT00445770|526680590|FG001|Overall Study|Lost to Follow-up|2|||
146045895|NCT00445770|526680591|FG002|Overall Study|Lost to Follow-up|0|||
146045896|NCT00445770|526680589|FG000|Overall Study|Other|6|||
146045897|NCT00445770|526680590|FG001|Overall Study|Other|5|||
146045898|NCT00445770|526680591|FG002|Overall Study|Other|6|||
146045899|NCT00811174|526680593|FG000|Overall Study|Protocol Violation|2|||
146045900|NCT00811174|526680593|FG000|Overall Study|Sponsors Decision|1|||
146045901|NCT00999544|526682092|FG000|Overall Study|Withdrawal by Subject|1|||
146045902|NCT01392547|526682093|FG000|Overall Study|Adverse Event|2|||
146045903|NCT01392547|526682093|FG000|Overall Study|Non-compliance|2|||
146045904|NCT01392547|526682093|FG000|Overall Study|Withdrawal criteria|3|||
146045905|NCT01392547|526682093|FG000|Overall Study|Unclassified|1|||
146045906|NCT02936635|526682095|FG000|Overall Study|Adverse Event|43|||
146045907|NCT02936635|526682096|FG001|Overall Study|Adverse Event|25|||
146045908|NCT02936635|526682095|FG000|Overall Study|Progressive Disease|10|||
146045909|NCT02936635|526682096|FG001|Overall Study|Progressive Disease|18|||
146045910|NCT02936635|526682095|FG000|Overall Study|Sponsor Discretion|10|||
146045911|NCT02936635|526682096|FG001|Overall Study|Sponsor Discretion|16|||
146045912|NCT02936635|526682095|FG000|Overall Study|Death|9|||
146045913|NCT02936635|526682096|FG001|Overall Study|Death|15|||
146045914|NCT02936635|526682095|FG000|Overall Study|Withdrawal by Subject|8|||
146045915|NCT02936635|526682096|FG001|Overall Study|Withdrawal by Subject|15|||
146045916|NCT02936635|526682095|FG000|Overall Study|Physician Decision|2|||
146045917|NCT02936635|526682096|FG001|Overall Study|Physician Decision|9|||
146045918|NCT02936635|526682095|FG000|Overall Study|Lost to Follow-up|1|||
146045919|NCT02936635|526682096|FG001|Overall Study|Lost to Follow-up|2|||
146045920|NCT02936635|526682095|FG000|Overall Study|Protocol Violation|1|||
146045921|NCT02936635|526682096|FG001|Overall Study|Protocol Violation|0|||
146045922|NCT02936635|526682095|FG000|Overall Study|Lack of effect/Entry into other study|31|||
146045923|NCT02936635|526682096|FG001|Overall Study|Lack of effect/Entry into other study|65|||
146045924|NCT02407223|526682097|FG000|Overall Study|Adverse Event|1|||
146045925|NCT02407223|526682098|FG001|Overall Study|Adverse Event|0|||
146045926|NCT02407223|526682099|FG002|Overall Study|Adverse Event|1|||
146045927|NCT02407223|526682097|FG000|Overall Study|Lack of Efficacy|6|||
146045928|NCT02407223|526682098|FG001|Overall Study|Lack of Efficacy|6|||
146045929|NCT02407223|526682099|FG002|Overall Study|Lack of Efficacy|4|||
146045930|NCT02407223|526682097|FG000|Overall Study|Lost to Follow-up|1|||
146045931|NCT02407223|526682098|FG001|Overall Study|Lost to Follow-up|0|||
146045932|NCT02407223|526682099|FG002|Overall Study|Lost to Follow-up|2|||
146045933|NCT02407223|526682097|FG000|Overall Study|Withdrawal by Subject|2|||
146045934|NCT02407223|526682098|FG001|Overall Study|Withdrawal by Subject|4|||
146255398|NCT02391116|527448604|FG000|Safety Follow-up|No Follow Up|1|||
146255399|NCT02391116|527448604|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
146255400|NCT02391116|527448604|FG000|Active Follow-up|Withdrawal by Subject|1|||
146255401|NCT02391116|527448604|FG000|Active Follow-up|Switching to Other Therapy|2|||
146045935|NCT02407223|526682099|FG002|Overall Study|Withdrawal by Subject|4|||
146045936|NCT02407223|526682097|FG000|Overall Study|Study Terminated by Sponsor|77|||
146045937|NCT02407223|526682098|FG001|Overall Study|Study Terminated by Sponsor|80|||
146045938|NCT02407223|526682099|FG002|Overall Study|Study Terminated by Sponsor|86|||
146045939|NCT02407223|526682097|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
146045940|NCT02407223|526682098|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
146102568|NCT00094172|526895256|FG000|Overall Study|Adverse Event|0|||
146255402|NCT02391116|527448604|FG000|Survival Follow-up|Withdrawal by Subject|3|||
146045941|NCT02407223|526682099|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
146255403|NCT02391116|527448604|FG000|Survival Follow-up|Switching to Other Therapy|1|||
146255404|NCT02282917|527448605|FG000|Overall Study|Withdrawal by Subject|1|||
146045942|NCT02407223|526682097|FG000|Overall Study|Other|29|||
146045943|NCT02407223|526682098|FG001|Overall Study|Other|27|||
146045944|NCT02407223|526682099|FG002|Overall Study|Other|25|||
146045945|NCT00447226|526682100|FG000|12-Week Open-label Phase|Adverse Event|0|||
146045946|NCT00447226|526682101|FG001|12-Week Open-label Phase|Adverse Event|3|||
146045947|NCT00447226|526682100|FG000|12-Week Open-label Phase|Protocol Violation|0|||
146045948|NCT00447226|526682101|FG001|12-Week Open-label Phase|Protocol Violation|1|||
146045949|NCT00447226|526682100|FG000|12-Week Open-label Phase|Disease Progression|0|||
146045950|NCT00447226|526682101|FG001|12-Week Open-label Phase|Disease Progression|20|||
146045951|NCT00447226|526682100|FG000|12-Week Open-label Phase|Physician Decision|0|||
146045952|NCT00447226|526682101|FG001|12-Week Open-label Phase|Physician Decision|1|||
146045953|NCT00447226|526682100|FG000|Double-blind Phase|Disease Progression|4|||
146045954|NCT00447226|526682101|FG001|Double-blind Phase|Disease Progression|3|||
146045955|NCT00584012|526682109|FG000|Overall Study|Withdrawal by Subject|1|||
146045956|NCT04404556|526682110|FG000|Intervention|Withdrawal by Subject|15|||
146045957|NCT04404556|526682111|FG001|Intervention|Withdrawal by Subject|3|||
146045958|NCT04404556|526682110|FG000|Intervention|Did not complete all intervention sessions|2|||
146045959|NCT04404556|526682111|FG001|Intervention|Did not complete all intervention sessions|1|||
146045960|NCT04404556|526682110|FG000|Post-Intervention|Missing Data|1|||
146045961|NCT04404556|526682111|FG001|Post-Intervention|Missing Data|2|||
146045962|NCT04404556|526682110|FG000|Follow-up 1|Withdrawal by Subject|5|||
146045963|NCT04404556|526682111|FG001|Follow-up 1|Withdrawal by Subject|1|||
146045964|NCT04404556|526682110|FG000|Follow-up 1|Missing Data|4|||
146045965|NCT04404556|526682111|FG001|Follow-up 1|Missing Data|7|||
146045966|NCT04404556|526682110|FG000|Follow-up 2|Withdrawal by Subject|1|||
146045967|NCT04404556|526682111|FG001|Follow-up 2|Withdrawal by Subject|1|||
146045968|NCT04404556|526682110|FG000|Follow-up 2|Missing Data|6|||
146045969|NCT04404556|526682111|FG001|Follow-up 2|Missing Data|5|||
146045970|NCT00763386|526682113|FG000|Overall Study|Adverse Event|43|||
146045971|NCT00763386|526682114|FG001|Overall Study|Adverse Event|33|||
146045972|NCT00763386|526682113|FG000|Overall Study|Death|1|||
146045973|NCT00763386|526682114|FG001|Overall Study|Death|2|||
146045974|NCT00763386|526682113|FG000|Overall Study|Lost to Follow-up|3|||
146045975|NCT00763386|526682114|FG001|Overall Study|Lost to Follow-up|3|||
146045976|NCT00763386|526682113|FG000|Overall Study|Withdrawal by Subject|0|||
146045977|NCT00763386|526682114|FG001|Overall Study|Withdrawal by Subject|1|||
146045978|NCT00763386|526682113|FG000|Overall Study|CRF missing|0|||
146045979|NCT00763386|526682114|FG001|Overall Study|CRF missing|1|||
146045980|NCT00763386|526682113|FG000|Overall Study|Study Prosthesis Removed|1|||
146045981|NCT00763386|526682114|FG001|Overall Study|Study Prosthesis Removed|0|||
146045982|NCT01402817|526682115|FG000|Overall Study|Withdrawal by Subject|3|||
146045983|NCT01402817|526682115|FG000|Overall Study|Study Suspended by FDA|8|||
146045984|NCT00502671|526682116|FG000|Overall Study|Disease Progression|13|||
146045985|NCT00502671|526682116|FG000|Overall Study|Personal Reasons|22|||
146045986|NCT00502671|526682116|FG000|Overall Study|Lost to Follow-up|7|||
146045987|NCT00502671|526682116|FG000|Overall Study|Protocol Violation|16|||
146045988|NCT00502671|526682116|FG000|Overall Study|Adverse Event|19|||
146045989|NCT00681629|526682117|FG000|Overall Study|Study termination|4|||
146045990|NCT00681629|526682118|FG001|Overall Study|Study termination|2|||
146045991|NCT00681629|526682117|FG000|Overall Study|Adverse Event|1|||
146045992|NCT00681629|526682118|FG001|Overall Study|Adverse Event|0|||
146045993|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
146045994|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146045995|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146045996|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146045997|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146045998|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
146102569|NCT00094172|526895257|FG001|Overall Study|Adverse Event|1|||
146102570|NCT00094172|526895256|FG000|Overall Study|Lost to Follow-up|2|||
146102571|NCT00094172|526895257|FG001|Overall Study|Lost to Follow-up|0|||
146255405|NCT02282917|527448605|FG000|Overall Study|Screen Failure/Not Eligible|1|||
146255406|NCT01747629|527448606|FG000|Overall Study|Adverse Event|1|||
146045999|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146046000|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146046001|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146046002|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146102572|NCT00094172|526895256|FG000|Overall Study|Protocol Violation|0|||
146046003|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
146046004|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146046005|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146102573|NCT00094172|526895257|FG001|Overall Study|Protocol Violation|1|||
146046006|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146046007|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146046008|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
146046009|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146046010|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146046011|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146046012|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146046013|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
146255407|NCT01747629|527448607|FG001|Overall Study|Adverse Event|2|||
146255408|NCT01747629|527448606|FG000|Overall Study|Withdrawal by Subject|2|||
146255409|NCT01747629|527448607|FG001|Overall Study|Withdrawal by Subject|2|||
146255410|NCT01747629|527448606|FG000|Overall Study|Noncompliance|1|||
146255411|NCT01747629|527448607|FG001|Overall Study|Noncompliance|1|||
146255412|NCT01747629|527448606|FG000|Overall Study|Inclusion criteria not met|1|||
146255413|NCT01747629|527448607|FG001|Overall Study|Inclusion criteria not met|0|||
146255414|NCT01747629|527448606|FG000|Overall Study|Not treated|1|||
146255415|NCT01747629|527448607|FG001|Overall Study|Not treated|0|||
146255416|NCT01747629|527448606|FG000|Overall Study|Other|2|||
146255417|NCT01747629|527448607|FG001|Overall Study|Other|1|||
146255418|NCT01770509|527448608|FG000|Overall Study|Injury|0|||
146255419|NCT01770509|527448609|FG001|Overall Study|Injury|1|||
146255420|NCT01770509|527448608|FG000|Overall Study|Lost to Follow-up|1|||
146255421|NCT01770509|527448609|FG001|Overall Study|Lost to Follow-up|2|||
146255422|NCT00794573|527448619|FG000|Overall Study|Death|3|||
146255423|NCT00794573|527448620|FG001|Overall Study|Death|0|||
146255424|NCT00794573|527448619|FG000|Overall Study|Withdrawal by Subject|9|||
146255425|NCT00794573|527448620|FG001|Overall Study|Withdrawal by Subject|12|||
146255426|NCT00794573|527448619|FG000|Overall Study|Lost to Follow-up|26|||
146255427|NCT00794573|527448620|FG001|Overall Study|Lost to Follow-up|33|||
146255428|NCT01332318|527448623|FG000|Overall Study|Adverse Event|0|||
146255429|NCT01332318|527448624|FG001|Overall Study|Adverse Event|3|||
146255430|NCT01332318|527448625|FG002|Overall Study|Adverse Event|0|||
146255431|NCT01332318|527448626|FG003|Overall Study|Adverse Event|0|||
146255432|NCT01332318|527448623|FG000|Overall Study|Withdrawal by Subject|1|||
146255433|NCT01332318|527448624|FG001|Overall Study|Withdrawal by Subject|1|||
146255434|NCT01332318|527448625|FG002|Overall Study|Withdrawal by Subject|0|||
146255435|NCT01332318|527448626|FG003|Overall Study|Withdrawal by Subject|1|||
146255436|NCT01332318|527448623|FG000|Overall Study|Protocol Violation|1|||
146255437|NCT01332318|527448624|FG001|Overall Study|Protocol Violation|0|||
146255438|NCT01332318|527448625|FG002|Overall Study|Protocol Violation|1|||
146255439|NCT01332318|527448626|FG003|Overall Study|Protocol Violation|1|||
146255440|NCT02040532|527448627|FG000|Overall Study|Lost to Follow-up|1|||
146255441|NCT02040532|527448627|FG000|Overall Study|Physician Decision|4|||
146255442|NCT02040532|527448627|FG000|Overall Study|Adverse Event|4|||
146255443|NCT02040532|527448627|FG000|Overall Study|Withdrawal by Subject|3|||
146255444|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
146255445|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
146255446|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
146255447|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
146255448|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
146255449|NCT00500539|527448629|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
146255450|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
146255451|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
146255452|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
146255453|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
146255454|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Death|1|||
146255455|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
146255456|NCT00500539|527448629|FG000|Follow-up Period (16 Weeks)|Missing|3|||
146255457|NCT01524887|527448630|FG000|Overall Study|Withdrawal by Subject|6|||
146255458|NCT01524887|527448631|FG001|Overall Study|Withdrawal by Subject|2|||
146255459|NCT01524887|527448632|FG002|Overall Study|Withdrawal by Subject|3|||
146255460|NCT01524887|527448630|FG000|Overall Study|Adverse Event|5|||
146255461|NCT01524887|527448631|FG001|Overall Study|Adverse Event|1|||
146255462|NCT01524887|527448632|FG002|Overall Study|Adverse Event|1|||
146255463|NCT01524887|527448630|FG000|Overall Study|Protocol Violation|0|||
146255464|NCT01524887|527448631|FG001|Overall Study|Protocol Violation|0|||
146255465|NCT01524887|527448632|FG002|Overall Study|Protocol Violation|1|||
146255466|NCT01524887|527448630|FG000|Overall Study|Study termination|73|||
146255467|NCT01524887|527448631|FG001|Overall Study|Study termination|87|||
146255468|NCT01524887|527448632|FG002|Overall Study|Study termination|79|||
146255469|NCT01524887|527448630|FG000|Overall Study|Withdrawal by Caregiver|0|||
146255470|NCT01524887|527448631|FG001|Overall Study|Withdrawal by Caregiver|0|||
146255471|NCT01524887|527448632|FG002|Overall Study|Withdrawal by Caregiver|2|||
146255472|NCT01524887|527448630|FG000|Overall Study|Use of prohibited medication|1|||
146255473|NCT01524887|527448631|FG001|Overall Study|Use of prohibited medication|0|||
146255474|NCT01524887|527448632|FG002|Overall Study|Use of prohibited medication|0|||
146255475|NCT01808144|527448633|FG000|Overall Study|Death|1|||
146255476|NCT01808144|527448634|FG001|Overall Study|Death|0|||
146255477|NCT01808144|527448633|FG000|Overall Study|Withdrawal by Subject|16|||
146255478|NCT01808144|527448634|FG001|Overall Study|Withdrawal by Subject|23|||
146255479|NCT01808144|527448633|FG000|Overall Study|Lost to Follow-up|6|||
146300713|NCT01621542|527617133|FG004|Overall Study|Death|0|||
146300714|NCT01621542|527617134|FG005|Overall Study|Death|0|||
146300715|NCT01621542|527617129|FG000|Overall Study|Physician Decision|1|||
146300716|NCT01621542|527617130|FG001|Overall Study|Physician Decision|0|||
146300717|NCT01621542|527617131|FG002|Overall Study|Physician Decision|1|||
146300718|NCT01621542|527617132|FG003|Overall Study|Physician Decision|13|||
146300719|NCT01621542|527617133|FG004|Overall Study|Physician Decision|3|||
146300720|NCT01621542|527617134|FG005|Overall Study|Physician Decision|1|||
146300721|NCT01621542|527617129|FG000|Overall Study|Withdrawal by Subject|2|||
146300722|NCT01621542|527617130|FG001|Overall Study|Withdrawal by Subject|0|||
146300723|NCT01621542|527617131|FG002|Overall Study|Withdrawal by Subject|1|||
146300724|NCT01621542|527617132|FG003|Overall Study|Withdrawal by Subject|3|||
146300725|NCT01621542|527617133|FG004|Overall Study|Withdrawal by Subject|3|||
146300726|NCT01621542|527617134|FG005|Overall Study|Withdrawal by Subject|3|||
146300727|NCT01621542|527617129|FG000|Overall Study|progression/treatment failure|2|||
146300728|NCT01621542|527617130|FG001|Overall Study|progression/treatment failure|4|||
146300729|NCT01621542|527617131|FG002|Overall Study|progression/treatment failure|3|||
146300730|NCT01621542|527617132|FG003|Overall Study|progression/treatment failure|7|||
146300731|NCT01621542|527617133|FG004|Overall Study|progression/treatment failure|3|||
146300732|NCT01621542|527617134|FG005|Overall Study|progression/treatment failure|5|||
146300733|NCT01621542|527617129|FG000|Overall Study|Protocol Violation|0|||
146300734|NCT01621542|527617130|FG001|Overall Study|Protocol Violation|0|||
146300735|NCT01621542|527617131|FG002|Overall Study|Protocol Violation|0|||
146300736|NCT01621542|527617132|FG003|Overall Study|Protocol Violation|1|||
146300737|NCT01621542|527617133|FG004|Overall Study|Protocol Violation|0|||
146300738|NCT01621542|527617134|FG005|Overall Study|Protocol Violation|0|||
146300739|NCT01621542|527617129|FG000|Overall Study|study stopped by sponsor|0|||
146300740|NCT01621542|527617130|FG001|Overall Study|study stopped by sponsor|0|||
146300741|NCT01621542|527617131|FG002|Overall Study|study stopped by sponsor|0|||
146300742|NCT01621542|527617132|FG003|Overall Study|study stopped by sponsor|1|||
146300743|NCT01621542|527617133|FG004|Overall Study|study stopped by sponsor|0|||
146300744|NCT01621542|527617134|FG005|Overall Study|study stopped by sponsor|0|||
146300745|NCT01368042|527617135|FG000|Overall Study|Death|14|||
146300746|NCT01368042|527617135|FG000|Overall Study|Protocol Violation|11|||
146300747|NCT01368042|527617135|FG000|Overall Study|Lost to Follow-up|4|||
146300748|NCT01368042|527617135|FG000|Overall Study|Transplanted|1|||
146300749|NCT02632721|527617139|FG000|Overall Study|Adverse Event|0|||
146300750|NCT02632721|527617140|FG001|Overall Study|Adverse Event|0|||
146300751|NCT02632721|527617141|FG002|Overall Study|Adverse Event|2|||
146300752|NCT02632721|527617142|FG003|Overall Study|Adverse Event|5|||
146300753|NCT02632721|527617143|FG004|Overall Study|Adverse Event|3|||
146300754|NCT02632721|527617139|FG000|Overall Study|Dose limiting toxicity|0|||
146300755|NCT02632721|527617140|FG001|Overall Study|Dose limiting toxicity|0|||
146300756|NCT02632721|527617141|FG002|Overall Study|Dose limiting toxicity|0|||
146300757|NCT02632721|527617142|FG003|Overall Study|Dose limiting toxicity|1|||
146300758|NCT02632721|527617143|FG004|Overall Study|Dose limiting toxicity|0|||
146300759|NCT02632721|527617139|FG000|Overall Study|Progressive disease|3|||
146300760|NCT02632721|527617140|FG001|Overall Study|Progressive disease|0|||
146300761|NCT02632721|527617141|FG002|Overall Study|Progressive disease|4|||
146300762|NCT02632721|527617142|FG003|Overall Study|Progressive disease|6|||
146300763|NCT02632721|527617143|FG004|Overall Study|Progressive disease|5|||
146300764|NCT02632721|527617139|FG000|Overall Study|Refused to continue taking trial medication|0|||
146300765|NCT02632721|527617140|FG001|Overall Study|Refused to continue taking trial medication|1|||
146300766|NCT02632721|527617141|FG002|Overall Study|Refused to continue taking trial medication|1|||
146255480|NCT01808144|527448634|FG001|Overall Study|Lost to Follow-up|3|||
146255481|NCT01808144|527448633|FG000|Overall Study|Protocol Violation|6|||
146255482|NCT01808144|527448634|FG001|Overall Study|Protocol Violation|6|||
146255483|NCT01808144|527448633|FG000|Overall Study|Gout flare|0|||
146255484|NCT01808144|527448634|FG001|Overall Study|Gout flare|1|||
146255485|NCT01808144|527448633|FG000|Overall Study|Adverse Event|11|||
146255486|NCT01808144|527448634|FG001|Overall Study|Adverse Event|15|||
146300767|NCT02632721|527617142|FG003|Overall Study|Refused to continue taking trial medication|1|||
146300768|NCT02632721|527617143|FG004|Overall Study|Refused to continue taking trial medication|2|||
146300769|NCT02632721|527617139|FG000|Overall Study|Inadequate clinical condition|0|||
146300770|NCT02632721|527617140|FG001|Overall Study|Inadequate clinical condition|0|||
146300771|NCT02632721|527617141|FG002|Overall Study|Inadequate clinical condition|0|||
146300772|NCT02632721|527617142|FG003|Overall Study|Inadequate clinical condition|0|||
146255487|NCT03993054|527448635|FG000|Overall Study|PI Decision|1|||
146255488|NCT04341584|527448636|FG000|Overall Study|Withdrew consent|0|||
146300773|NCT02632721|527617143|FG004|Overall Study|Inadequate clinical condition|1|||
146300774|NCT02632721|527617139|FG000|Overall Study|No meet eligibility|0|||
146300775|NCT02632721|527617140|FG001|Overall Study|No meet eligibility|0|||
146300776|NCT02632721|527617141|FG002|Overall Study|No meet eligibility|0|||
146300777|NCT02632721|527617142|FG003|Overall Study|No meet eligibility|0|||
146300778|NCT02632721|527617143|FG004|Overall Study|No meet eligibility|1|||
146300779|NCT02632721|527617139|FG000|Overall Study|Allergic reaction|0|||
146255489|NCT04341584|527448637|FG001|Overall Study|Withdrew consent|2|||
146255490|NCT04341584|527448638|FG002|Overall Study|Withdrew consent|2|||
146255491|NCT04341584|527448639|FG003|Overall Study|Withdrew consent|1|||
146255492|NCT00497198|527448641|FG000|Overall Study|Adverse Event|4|||
146102574|NCT00094172|526895256|FG000|Overall Study|Withdrawal by Subject|10|||
146255493|NCT00497198|527448642|FG001|Overall Study|Adverse Event|2|||
146255494|NCT00497198|527448641|FG000|Overall Study|Physician Decision|1|||
146255495|NCT00497198|527448642|FG001|Overall Study|Physician Decision|2|||
146255496|NCT00497198|527448641|FG000|Overall Study|Withdrawal by Subject|0|||
146255497|NCT00497198|527448642|FG001|Overall Study|Withdrawal by Subject|1|||
146255498|NCT04853238|527448643|FG000|Overall Study|Death|4|||
146255499|NCT04853238|527448644|FG001|Overall Study|Death|0|||
146255500|NCT04853238|527448645|FG002|Overall Study|Death|2|||
146255501|NCT04853238|527448643|FG000|Overall Study|Lost to Follow-up|16|||
146255502|NCT04853238|527448644|FG001|Overall Study|Lost to Follow-up|2|||
146255503|NCT04853238|527448645|FG002|Overall Study|Lost to Follow-up|37|||
146255504|NCT04853238|527448643|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
146255505|NCT04853238|527448644|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
146255506|NCT04853238|527448645|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
146255507|NCT04853238|527448643|FG000|Overall Study|Withdrawal by Subject|6|||
146255508|NCT04853238|527448644|FG001|Overall Study|Withdrawal by Subject|0|||
146255509|NCT04853238|527448645|FG002|Overall Study|Withdrawal by Subject|21|||
146255510|NCT04853238|527448643|FG000|Overall Study|Physician Decision|0|||
146255511|NCT04853238|527448644|FG001|Overall Study|Physician Decision|0|||
146255512|NCT04853238|527448645|FG002|Overall Study|Physician Decision|2|||
146255513|NCT04853238|527448643|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
146255514|NCT04853238|527448644|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
146255515|NCT04853238|527448645|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
146255516|NCT03098797|527450511|FG000|Part 2 Open Label Extension|Adverse Event|2|||
146255517|NCT03098797|527450512|FG001|Part 2 Open Label Extension|Adverse Event|0|||
146255518|NCT00509821|527450513|FG000|Study Period 1 (Induction)|Death|0|||
146255519|NCT00509821|527450514|FG001|Study Period 1 (Induction)|Death|1|||
146255520|NCT00509821|527450513|FG000|Study Period 1 (Induction)|Adverse Event|0|||
146255521|NCT00509821|527450514|FG001|Study Period 1 (Induction)|Adverse Event|2|||
146255522|NCT00509821|527450513|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
146255523|NCT00509821|527450514|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
146255524|NCT00552513|527450517|FG000|Overall Study|Lost to Follow-up|5|||
146255525|NCT00552513|527450518|FG001|Overall Study|Lost to Follow-up|1|||
146255526|NCT01816685|527450519|FG000|Overall Study|Lost to Follow-up|7|||
146255527|NCT01816685|527450520|FG001|Overall Study|Lost to Follow-up|9|||
146255528|NCT01816685|527450519|FG000|Overall Study|Surgery Cancelled|3|||
146255529|NCT01816685|527450520|FG001|Overall Study|Surgery Cancelled|2|||
146255530|NCT02720185|527450521|FG000|Overall Study|Lost to Follow-up|1|||
146255531|NCT00371462|527450522|FG000|Overall Study|Withdrawal by Subject|1|||
146255532|NCT00371462|527450523|FG001|Overall Study|Withdrawal by Subject|0|||
146255533|NCT00371462|527450522|FG000|Overall Study|Other|7|||
146255534|NCT00371462|527450523|FG001|Overall Study|Other|8|||
146255535|NCT00349622|527450529|FG000|Overall Study|Death|168|||
146255536|NCT00349622|527450530|FG001|Overall Study|Death|86|||
146255537|NCT00349622|527450529|FG000|Overall Study|Lost to Follow-up|5|||
146255538|NCT00349622|527450530|FG001|Overall Study|Lost to Follow-up|1|||
146255539|NCT00349622|527450529|FG000|Overall Study|Withdrawal by Subject|5|||
146255540|NCT00349622|527450530|FG001|Overall Study|Withdrawal by Subject|9|||
146255541|NCT00508274|527450531|FG000|Overall Study|Adverse Event|5|||
146255542|NCT00508274|527450531|FG000|Overall Study|Death|7|||
146255543|NCT00508274|527450531|FG000|Overall Study|Disease progression|32|||
146255544|NCT00508274|527450531|FG000|Overall Study|Withdrawal by Subject|1|||
146255545|NCT00508274|527450531|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
146255546|NCT00508274|527450531|FG000|Overall Study|Missing|3|||
146255547|NCT03296566|527450532|FG000|Overall Study|Lost to Follow-up|19|||
146255548|NCT03296566|527450533|FG001|Overall Study|Lost to Follow-up|46|||
146255549|NCT03296566|527450532|FG000|Overall Study|Withdrawal by Subject|0|||
146255550|NCT03296566|527450533|FG001|Overall Study|Withdrawal by Subject|3|||
146255551|NCT02229396|527450538|FG000|Overall Study|Adverse Event|6|||
146255552|NCT02229396|527450539|FG001|Overall Study|Adverse Event|12|||
146255553|NCT02229396|527450540|FG002|Overall Study|Adverse Event|12|||
146255554|NCT02229396|527450538|FG000|Overall Study|Death|2|||
146255555|NCT02229396|527450539|FG001|Overall Study|Death|3|||
146255556|NCT02229396|527450540|FG002|Overall Study|Death|1|||
146255557|NCT02229396|527450538|FG000|Overall Study|Lost to Follow-up|14|||
146255558|NCT02229396|527450539|FG001|Overall Study|Lost to Follow-up|14|||
146255559|NCT02229396|527450540|FG002|Overall Study|Lost to Follow-up|21|||
146255560|NCT02229396|527450538|FG000|Overall Study|Protocol Violation|2|||
146255561|NCT02229396|527450539|FG001|Overall Study|Protocol Violation|1|||
146255562|NCT02229396|527450540|FG002|Overall Study|Protocol Violation|0|||
146102575|NCT00094172|526895257|FG001|Overall Study|Withdrawal by Subject|5|||
146255563|NCT02229396|527450538|FG000|Overall Study|Patient Incorrectly Randomized|0|||
146255564|NCT02229396|527450539|FG001|Overall Study|Patient Incorrectly Randomized|0|||
146255565|NCT02229396|527450540|FG002|Overall Study|Patient Incorrectly Randomized|1|||
146255566|NCT02229396|527450538|FG000|Overall Study|Other|10|||
146255567|NCT02229396|527450539|FG001|Overall Study|Other|18|||
146255568|NCT02229396|527450540|FG002|Overall Study|Other|15|||
146255569|NCT02229396|527450538|FG000|Overall Study|Withdrawal by Subject|42|||
146255570|NCT02229396|527450539|FG001|Overall Study|Withdrawal by Subject|28|||
146255571|NCT02229396|527450540|FG002|Overall Study|Withdrawal by Subject|41|||
146255572|NCT02229396|527450538|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
146255573|NCT02229396|527450539|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
146255574|NCT02229396|527450540|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
146255575|NCT02229396|527450538|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
146255576|NCT02229396|527450539|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
146255577|NCT02229396|527450540|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
146255578|NCT01243411|527450541|FG000|Overall Study|Withdrawal by Subject|18|||
146255579|NCT01243411|527450541|FG000|Overall Study|Lost to Follow-up|10|||
146255580|NCT01243411|527450541|FG000|Overall Study|Adverse Event|5|||
146255581|NCT01243411|527450541|FG000|Overall Study|Other|8|||
146255582|NCT00805285|527450544|FG000|Overall Study|Lack of Efficacy|1|||
146255583|NCT00839306|527450545|FG000|Overall Study|Adverse Event|3|||
146255584|NCT00839306|527450546|FG001|Overall Study|Adverse Event|5|||
146255585|NCT00839306|527450545|FG000|Overall Study|Lost to Follow-up|6|||
146255586|NCT00839306|527450546|FG001|Overall Study|Lost to Follow-up|9|||
146255587|NCT00839306|527450545|FG000|Overall Study|Withdrawal by Subject|5|||
146300780|NCT02632721|527617140|FG001|Overall Study|Allergic reaction|0|||
146300781|NCT02632721|527617141|FG002|Overall Study|Allergic reaction|0|||
146300782|NCT02632721|527617142|FG003|Overall Study|Allergic reaction|1|||
146300783|NCT02632721|527617143|FG004|Overall Study|Allergic reaction|0|||
146300784|NCT02632721|527617139|FG000|Overall Study|Receiving Decitabine locally|0|||
146300785|NCT02632721|527617140|FG001|Overall Study|Receiving Decitabine locally|0|||
146300786|NCT02632721|527617141|FG002|Overall Study|Receiving Decitabine locally|1|||
146300787|NCT02632721|527617142|FG003|Overall Study|Receiving Decitabine locally|0|||
146300788|NCT02632721|527617143|FG004|Overall Study|Receiving Decitabine locally|0|||
146300789|NCT02632721|527617139|FG000|Overall Study|No benefit from study treatment|1|||
146300790|NCT02632721|527617140|FG001|Overall Study|No benefit from study treatment|1|||
146300791|NCT02632721|527617141|FG002|Overall Study|No benefit from study treatment|0|||
146300792|NCT02632721|527617142|FG003|Overall Study|No benefit from study treatment|0|||
146300793|NCT02632721|527617143|FG004|Overall Study|No benefit from study treatment|1|||
146300794|NCT02632721|527617139|FG000|Overall Study|Patient wish for other treatment|0|||
146300795|NCT02632721|527617140|FG001|Overall Study|Patient wish for other treatment|1|||
146300796|NCT02632721|527617141|FG002|Overall Study|Patient wish for other treatment|0|||
146300797|NCT02632721|527617142|FG003|Overall Study|Patient wish for other treatment|0|||
146300798|NCT02632721|527617143|FG004|Overall Study|Patient wish for other treatment|0|||
146300799|NCT02632721|527617139|FG000|Overall Study|Relapsed Pneumonia|0|||
146300800|NCT02632721|527617140|FG001|Overall Study|Relapsed Pneumonia|0|||
146300801|NCT02632721|527617141|FG002|Overall Study|Relapsed Pneumonia|0|||
146300802|NCT02632721|527617142|FG003|Overall Study|Relapsed Pneumonia|0|||
146300803|NCT02632721|527617143|FG004|Overall Study|Relapsed Pneumonia|1|||
146300804|NCT02632721|527617139|FG000|Overall Study|Therapy refractory AML|0|||
146300805|NCT02632721|527617140|FG001|Overall Study|Therapy refractory AML|0|||
146300806|NCT02632721|527617141|FG002|Overall Study|Therapy refractory AML|0|||
146300807|NCT02632721|527617142|FG003|Overall Study|Therapy refractory AML|0|||
146300808|NCT02632721|527617143|FG004|Overall Study|Therapy refractory AML|1|||
146300809|NCT02632721|527617139|FG000|Overall Study|Increase of white blood cell count|0|||
146300810|NCT02632721|527617140|FG001|Overall Study|Increase of white blood cell count|0|||
146300811|NCT02632721|527617141|FG002|Overall Study|Increase of white blood cell count|0|||
146300812|NCT02632721|527617142|FG003|Overall Study|Increase of white blood cell count|0|||
146300813|NCT02632721|527617143|FG004|Overall Study|Increase of white blood cell count|1|||
146300814|NCT02632721|527617139|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146300815|NCT02632721|527617140|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146300816|NCT02632721|527617141|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
146255588|NCT00839306|527450546|FG001|Overall Study|Withdrawal by Subject|7|||
146255589|NCT00839306|527450545|FG000|Overall Study|Lack of Efficacy|5|||
146300817|NCT02632721|527617142|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146300818|NCT02632721|527617143|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
146300819|NCT00544648|527617147|FG000|Overall Study|Withdrawal by Subject|1|||
146300820|NCT00544648|527617148|FG001|Overall Study|Withdrawal by Subject|0|||
146300821|NCT00544648|527617147|FG000|Overall Study|Adverse Event|1|||
146300822|NCT00544648|527617148|FG001|Overall Study|Adverse Event|1|||
146300823|NCT00544648|527617147|FG000|Overall Study|progression of disease|1|||
146300824|NCT00544648|527617148|FG001|Overall Study|progression of disease|0|||
146300825|NCT01572675|527617149|FG000|Overall Study|End of prescribed treatment|140|||
146255590|NCT00839306|527450546|FG001|Overall Study|Lack of Efficacy|4|||
146102576|NCT00094172|526895256|FG000|Overall Study|Primary endpoint met.|1|||
146102577|NCT00094172|526895257|FG001|Overall Study|Primary endpoint met.|0|||
146102578|NCT00094172|526895256|FG000|Overall Study|Started other MS therapy due to disease|1|||
146102579|NCT00094172|526895257|FG001|Overall Study|Started other MS therapy due to disease|0|||
146102580|NCT02478632|526895263|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
146102581|NCT02478632|526895264|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
146102582|NCT02478632|526895263|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
146102583|NCT02478632|526895264|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
146255591|NCT00839306|527450545|FG000|Overall Study|Other|6|||
146255592|NCT00839306|527450546|FG001|Overall Study|Other|18|||
146255593|NCT01812707|527450547|FG000|Overall Study|Adverse Event|0|||
146102584|NCT02478632|526895263|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
146102585|NCT02478632|526895264|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
146255594|NCT01812707|527450548|FG001|Overall Study|Adverse Event|0|||
146255595|NCT01812707|527450549|FG002|Overall Study|Adverse Event|0|||
146255596|NCT01812707|527450550|FG003|Overall Study|Adverse Event|2|||
146255597|NCT01812707|527450547|FG000|Overall Study|Poor compliance to protocol|1|||
146255598|NCT01812707|527450548|FG001|Overall Study|Poor compliance to protocol|0|||
146255599|NCT01812707|527450549|FG002|Overall Study|Poor compliance to protocol|0|||
146255600|NCT01812707|527450550|FG003|Overall Study|Poor compliance to protocol|0|||
146255601|NCT01812707|527450547|FG000|Overall Study|Consent withdrawn by participant|1|||
146255602|NCT01812707|527450548|FG001|Overall Study|Consent withdrawn by participant|0|||
146255603|NCT01812707|527450549|FG002|Overall Study|Consent withdrawn by participant|0|||
146255604|NCT01812707|527450550|FG003|Overall Study|Consent withdrawn by participant|0|||
146255605|NCT01066897|527450551|FG000|Overall Study|Withdrawal by Subject|1|||
146255606|NCT01066897|527450552|FG001|Overall Study|Withdrawal by Subject|0|||
146255607|NCT01066897|527450551|FG000|Overall Study|stopped study after developing the flu.|1|||
146255608|NCT01066897|527450552|FG001|Overall Study|stopped study after developing the flu.|0|||
146255609|NCT02396758|527450555|FG000|Overall Study|Withdrawal by Subject|2|||
146255610|NCT02396758|527450556|FG001|Overall Study|Withdrawal by Subject|0|||
146255611|NCT02396758|527450557|FG002|Overall Study|Withdrawal by Subject|0|||
146255612|NCT02396758|527450558|FG003|Overall Study|Withdrawal by Subject|1|||
146255613|NCT02396758|527450555|FG000|Overall Study|Lost to Follow-up|8|||
146255614|NCT02396758|527450556|FG001|Overall Study|Lost to Follow-up|5|||
146255615|NCT02396758|527450557|FG002|Overall Study|Lost to Follow-up|3|||
146255616|NCT02396758|527450558|FG003|Overall Study|Lost to Follow-up|3|||
146255617|NCT02396758|527450555|FG000|Overall Study|Death|1|||
146255618|NCT02396758|527450556|FG001|Overall Study|Death|1|||
146255619|NCT02396758|527450557|FG002|Overall Study|Death|0|||
146255620|NCT02396758|527450558|FG003|Overall Study|Death|1|||
146255621|NCT02396758|527450555|FG000|Overall Study|Randomized but not treated|1|||
146255622|NCT02396758|527450556|FG001|Overall Study|Randomized but not treated|0|||
146255623|NCT02396758|527450557|FG002|Overall Study|Randomized but not treated|1|||
146255624|NCT02396758|527450558|FG003|Overall Study|Randomized but not treated|0|||
146255625|NCT03022045|527450559|FG000|Overall Study|Adverse Event|0|||
146255626|NCT03022045|527450560|FG001|Overall Study|Adverse Event|1|||
146255627|NCT03022045|527450559|FG000|Overall Study|Withdrawal by Subject|1|||
146255628|NCT03022045|527450560|FG001|Overall Study|Withdrawal by Subject|1|||
146255629|NCT00666835|527450561|FG000|Overall Study|Withdrawal by Subject|5|||
146255630|NCT00666835|527450562|FG001|Overall Study|Withdrawal by Subject|2|||
146255631|NCT00666835|527450561|FG000|Overall Study|Lack of Efficacy|0|||
146255632|NCT00666835|527450562|FG001|Overall Study|Lack of Efficacy|1|||
146255633|NCT00666835|527450561|FG000|Overall Study|Incl./excl. not fulfilled|7|||
146255634|NCT00666835|527450562|FG001|Overall Study|Incl./excl. not fulfilled|2|||
146255635|NCT00666835|527450561|FG000|Overall Study|Adverse Event|7|||
146255636|NCT00666835|527450562|FG001|Overall Study|Adverse Event|6|||
146255637|NCT00666835|527450561|FG000|Overall Study|Protocol Violation|2|||
146255638|NCT00666835|527450562|FG001|Overall Study|Protocol Violation|0|||
146255639|NCT00666835|527450561|FG000|Overall Study|Death|15|||
146255640|NCT00666835|527450562|FG001|Overall Study|Death|4|||
146255641|NCT00666835|527450561|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
146255642|NCT00666835|527450562|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
146255643|NCT00666835|527450561|FG000|Overall Study|Hemoglobulin concentration|4|||
146255644|NCT00666835|527450562|FG001|Overall Study|Hemoglobulin concentration|3|||
146255645|NCT00666835|527450561|FG000|Overall Study|Planned operation|2|||
146255646|NCT00666835|527450562|FG001|Overall Study|Planned operation|0|||
146255647|NCT00666835|527450561|FG000|Overall Study|Physician Decision|1|||
146255648|NCT00666835|527450562|FG001|Overall Study|Physician Decision|2|||
146255649|NCT01126879|527450563|FG000|Overall Study|Progressive Disease|3|||
146255650|NCT01126879|527450564|FG001|Overall Study|Progressive Disease|1|||
146255651|NCT01126879|527450563|FG000|Overall Study|Withdrawal by Subject|1|||
146255652|NCT01126879|527450564|FG001|Overall Study|Withdrawal by Subject|0|||
146255653|NCT01126879|527450563|FG000|Overall Study|Adverse Event|0|||
146255654|NCT01126879|527450564|FG001|Overall Study|Adverse Event|1|||
146255655|NCT01126879|527450563|FG000|Overall Study|Physician Decision|1|||
146255656|NCT01126879|527450564|FG001|Overall Study|Physician Decision|0|||
146102586|NCT00002651|526895265|FG000|Induction|Adverse Event|44|||
146102587|NCT00002651|526895266|FG001|Induction|Adverse Event|0|||
146102588|NCT00002651|526895267|FG002|Induction|Adverse Event|0|||
146102589|NCT00002651|526895265|FG000|Induction|Refusal unrelated to adverse event|50|||
146102590|NCT00002651|526895266|FG001|Induction|Refusal unrelated to adverse event|0|||
146102591|NCT00002651|526895267|FG002|Induction|Refusal unrelated to adverse event|0|||
146102592|NCT00002651|526895265|FG000|Induction|Progression/relapse|274|||
146102593|NCT00002651|526895266|FG001|Induction|Progression/relapse|0|||
146102594|NCT00002651|526895267|FG002|Induction|Progression/relapse|0|||
146102595|NCT00002651|526895265|FG000|Induction|Death|62|||
146102596|NCT00002651|526895266|FG001|Induction|Death|0|||
146102597|NCT00002651|526895267|FG002|Induction|Death|0|||
146102598|NCT00002651|526895265|FG000|Induction|Other|823|||
146102599|NCT00002651|526895266|FG001|Induction|Other|0|||
146102600|NCT00002651|526895267|FG002|Induction|Other|0|||
146102601|NCT00002651|526895265|FG000|Induction|not eligible|90|||
146102602|NCT00002651|526895266|FG001|Induction|not eligible|0|||
146102603|NCT00002651|526895267|FG002|Induction|not eligible|0|||
146102604|NCT00002651|526895265|FG000|Consolidation and Randomization|Adverse Event|0|||
146102605|NCT00002651|526895266|FG001|Consolidation and Randomization|Adverse Event|36|||
146102606|NCT00002651|526895267|FG002|Consolidation and Randomization|Adverse Event|14|||
146102607|NCT00002651|526895265|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
146102608|NCT00002651|526895266|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
146102609|NCT00002651|526895267|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
146102610|NCT00002651|526895265|FG000|Consolidation and Randomization|Progression/relapse|0|||
146102611|NCT00002651|526895266|FG001|Consolidation and Randomization|Progression/relapse|295|||
146102612|NCT00002651|526895267|FG002|Consolidation and Randomization|Progression/relapse|298|||
146102613|NCT00002651|526895265|FG000|Consolidation and Randomization|Death|0|||
146102614|NCT00002651|526895266|FG001|Consolidation and Randomization|Death|38|||
146102615|NCT00002651|526895267|FG002|Consolidation and Randomization|Death|48|||
146102616|NCT00002651|526895265|FG000|Consolidation and Randomization|Other|0|||
146102617|NCT00002651|526895266|FG001|Consolidation and Randomization|Other|314|||
146102618|NCT00002651|526895267|FG002|Consolidation and Randomization|Other|313|||
146102619|NCT00002651|526895265|FG000|Consolidation and Randomization|not eligible|0|||
146102620|NCT00002651|526895266|FG001|Consolidation and Randomization|not eligible|102|||
146102621|NCT00002651|526895267|FG002|Consolidation and Randomization|not eligible|112|||
146102622|NCT03750955|526895268|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
146102623|NCT03750955|526895269|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
146102624|NCT03750955|526895268|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
146102625|NCT03750955|526895269|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
146102626|NCT01705730|526895270|FG000|Overall Study|Lack of Efficacy|1|||
146102627|NCT01705730|526895270|FG000|Overall Study|Adverse Event|3|||
146102628|NCT01705730|526895270|FG000|Overall Study|Lost to Follow-up|1|||
146102629|NCT01705730|526895270|FG000|Overall Study|Reason not Specified|4|||
146255657|NCT00899379|527450565|FG000|Overall Study|Adverse Event|2|||
146255658|NCT00899379|527450566|FG001|Overall Study|Adverse Event|2|||
146255659|NCT00899379|527450567|FG002|Overall Study|Adverse Event|1|||
146255660|NCT00899379|527450568|FG003|Overall Study|Adverse Event|1|||
146255661|NCT00899379|527450569|FG004|Overall Study|Adverse Event|2|||
146255662|NCT00899379|527450565|FG000|Overall Study|Lack of Efficacy|0|||
146255663|NCT00899379|527450566|FG001|Overall Study|Lack of Efficacy|4|||
146255664|NCT00899379|527450567|FG002|Overall Study|Lack of Efficacy|3|||
146255665|NCT00899379|527450568|FG003|Overall Study|Lack of Efficacy|0|||
146255666|NCT00899379|527450569|FG004|Overall Study|Lack of Efficacy|1|||
146255667|NCT00899379|527450565|FG000|Overall Study|Lost to Follow-up|9|||
146255668|NCT00899379|527450566|FG001|Overall Study|Lost to Follow-up|3|||
146255669|NCT00899379|527450567|FG002|Overall Study|Lost to Follow-up|0|||
146255670|NCT00899379|527450568|FG003|Overall Study|Lost to Follow-up|6|||
146255671|NCT00899379|527450569|FG004|Overall Study|Lost to Follow-up|2|||
146255672|NCT00899379|527450565|FG000|Overall Study|Protocol Violation|0|||
146255673|NCT00899379|527450566|FG001|Overall Study|Protocol Violation|0|||
146255674|NCT00899379|527450567|FG002|Overall Study|Protocol Violation|1|||
146255675|NCT00899379|527450568|FG003|Overall Study|Protocol Violation|1|||
146255676|NCT00899379|527450569|FG004|Overall Study|Protocol Violation|0|||
146255677|NCT00899379|527450565|FG000|Overall Study|Withdrawal by Subject|2|||
146255678|NCT00899379|527450566|FG001|Overall Study|Withdrawal by Subject|4|||
146255679|NCT00899379|527450567|FG002|Overall Study|Withdrawal by Subject|2|||
146300826|NCT01572675|527617150|FG001|Overall Study|End of prescribed treatment|118|||
146102630|NCT01773733|526895271|FG000|Overall Study|Adverse Event|3286|||
146102631|NCT01773733|526895272|FG001|Overall Study|Adverse Event|540|||
146102632|NCT01773733|526895271|FG000|Overall Study|Pregnancy|28|||
146102633|NCT01773733|526895272|FG001|Overall Study|Pregnancy|0|||
146102634|NCT01773733|526895271|FG000|Overall Study|Other different categories of not compl|55415|||
146102635|NCT01773733|526895272|FG001|Overall Study|Other different categories of not compl|7781|||
146102636|NCT00880542|526895277|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
146255680|NCT00899379|527450568|FG003|Overall Study|Withdrawal by Subject|3|||
146300827|NCT01572675|527617149|FG000|Overall Study|Recovery|16|||
146300828|NCT01572675|527617150|FG001|Overall Study|Recovery|23|||
146300829|NCT01572675|527617149|FG000|Overall Study|Lack of Efficacy|31|||
146300830|NCT01572675|527617150|FG001|Overall Study|Lack of Efficacy|31|||
146300831|NCT01572675|527617149|FG000|Overall Study|Intolerance|6|||
146300832|NCT01572675|527617150|FG001|Overall Study|Intolerance|5|||
146300833|NCT01572675|527617149|FG000|Overall Study|Improved symptoms|8|||
146300834|NCT01572675|527617150|FG001|Overall Study|Improved symptoms|2|||
146300835|NCT01572675|527617149|FG000|Overall Study|Surgical intervention|3|||
146300836|NCT01572675|527617150|FG001|Overall Study|Surgical intervention|6|||
146300837|NCT01572675|527617149|FG000|Overall Study|Withdrawal by Subject|5|||
146300838|NCT01572675|527617150|FG001|Overall Study|Withdrawal by Subject|1|||
146300839|NCT01572675|527617149|FG000|Overall Study|Physician Decision|2|||
146300840|NCT01572675|527617150|FG001|Overall Study|Physician Decision|2|||
146300841|NCT01572675|527617149|FG000|Overall Study|Death unrelated to coxibs|1|||
146300842|NCT01572675|527617150|FG001|Overall Study|Death unrelated to coxibs|1|||
146300843|NCT01572675|527617149|FG000|Overall Study|Other disease detected|1|||
146300844|NCT01572675|527617150|FG001|Overall Study|Other disease detected|1|||
146300845|NCT01572675|527617149|FG000|Overall Study|Unknown reason|1|||
146300846|NCT01572675|527617150|FG001|Overall Study|Unknown reason|1|||
146300847|NCT01572675|527617149|FG000|Overall Study|Rheumatologist new evaluation|0|||
146300848|NCT01572675|527617150|FG001|Overall Study|Rheumatologist new evaluation|1|||
146300849|NCT01572675|527617149|FG000|Overall Study|Missing data|1|||
146300850|NCT01572675|527617150|FG001|Overall Study|Missing data|4|||
146300851|NCT01572675|527617149|FG000|Overall Study|Lost to Follow-up|22|||
146046014|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146046015|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146046016|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146046017|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146046018|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
146046019|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146046020|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146046021|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146046022|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146046023|NCT01173601|526682120|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
146046024|NCT01173601|526682121|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146046025|NCT01173601|526682122|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146046026|NCT01173601|526682123|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146046027|NCT01173601|526682124|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146046028|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146046029|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
146046030|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
146046031|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
146046032|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
146046033|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146046034|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
146046035|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
146046036|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
146046037|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
146046038|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146046039|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
146046040|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146046041|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
146046042|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
146046043|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146046044|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146046045|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146046046|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146046047|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146046048|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146046049|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
146046050|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146046051|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
146046052|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146046053|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146046054|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146300852|NCT01572675|527617150|FG001|Overall Study|Lost to Follow-up|27|||
146300853|NCT03346057|527617151|FG000|Overall Study|Death|1|||
146300854|NCT03346057|527617152|FG001|Overall Study|Death|2|||
146300855|NCT03346057|527617153|FG002|Overall Study|Death|0|||
146102637|NCT00880542|526895277|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
146102638|NCT00880542|526895277|FG000|REP: Surgical Resection|progressive disease|1|||
146102639|NCT00762385|526895278|FG000|First Intervention|Lens Issue|1|||
146102640|NCT00762385|526895279|FG001|First Intervention|Lens Issue|1|||
146102641|NCT00762385|526895278|FG000|First Intervention|Lost to Follow-up|0|||
146102642|NCT00762385|526895279|FG001|First Intervention|Lost to Follow-up|2|||
146102643|NCT00762385|526895278|FG000|First Intervention|Ineligible|1|||
146102644|NCT00762385|526895279|FG001|First Intervention|Ineligible|0|||
146102645|NCT00762385|526895278|FG000|First Intervention|Protocol Violation|0|||
146102646|NCT00762385|526895279|FG001|First Intervention|Protocol Violation|1|||
146102647|NCT00762385|526895278|FG000|Second Intervention|Protocol Violation|3|||
146102648|NCT00762385|526895279|FG001|Second Intervention|Protocol Violation|3|||
146102649|NCT01781975|526895280|FG000|Overall Study|Death|1|||
146102650|NCT01781975|526895281|FG001|Overall Study|Death|0|||
146102651|NCT01781975|526895280|FG000|Overall Study|Withdrawal by Subject|1|||
146102652|NCT01781975|526895281|FG001|Overall Study|Withdrawal by Subject|1|||
146255681|NCT00899379|527450569|FG004|Overall Study|Withdrawal by Subject|6|||
146255682|NCT00899379|527450565|FG000|Overall Study|Pregnancy|0|||
146046055|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
146046056|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
146046057|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
146046058|NCT01173601|526682120|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146046059|NCT01173601|526682121|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146046060|NCT01173601|526682122|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146046061|NCT01173601|526682123|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146046062|NCT01173601|526682124|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
146046063|NCT02274792|526682125|FG000|Overall Study|Withdrawal by Subject|13|||
146046064|NCT02274792|526682125|FG000|Overall Study|Lost to Follow-up|8|||
146046065|NCT02274792|526682125|FG000|Overall Study|Protocol Specified Criteria|2|||
146046066|NCT02274792|526682125|FG000|Overall Study|Sponsor Decision|2|||
146046067|NCT01510158|526682126|FG000|Overall Study|Adverse Event|7|||
146046068|NCT01510158|526682127|FG001|Overall Study|Adverse Event|8|||
146046069|NCT01510158|526682128|FG002|Overall Study|Adverse Event|5|||
146046070|NCT01510158|526682126|FG000|Overall Study|Gout flare|1|||
146046071|NCT01510158|526682127|FG001|Overall Study|Gout flare|0|||
146046072|NCT01510158|526682128|FG002|Overall Study|Gout flare|0|||
146046073|NCT01510158|526682126|FG000|Overall Study|Protocol Violation|17|||
146046074|NCT01510158|526682127|FG001|Overall Study|Protocol Violation|16|||
146046075|NCT01510158|526682128|FG002|Overall Study|Protocol Violation|24|||
146046076|NCT01510158|526682126|FG000|Overall Study|Sponsor terminated study.|2|||
146046077|NCT01510158|526682127|FG001|Overall Study|Sponsor terminated study.|0|||
146046078|NCT01510158|526682128|FG002|Overall Study|Sponsor terminated study.|2|||
146046079|NCT01510158|526682126|FG000|Overall Study|Lost to Follow-up|13|||
146046080|NCT01510158|526682127|FG001|Overall Study|Lost to Follow-up|16|||
146046081|NCT01510158|526682128|FG002|Overall Study|Lost to Follow-up|9|||
146046082|NCT01510158|526682126|FG000|Overall Study|Withdrawal by Subject|10|||
146046083|NCT01510158|526682127|FG001|Overall Study|Withdrawal by Subject|13|||
146046084|NCT01510158|526682128|FG002|Overall Study|Withdrawal by Subject|10|||
146046085|NCT01510158|526682126|FG000|Overall Study|Death|1|||
146046086|NCT01510158|526682127|FG001|Overall Study|Death|0|||
146046087|NCT01510158|526682128|FG002|Overall Study|Death|0|||
146046088|NCT05258149|526682129|FG000|Period 1|Protocol Deviation|1|||
146046089|NCT05258149|526682130|FG001|Period 1|Protocol Deviation|0|||
146046090|NCT05258149|526682129|FG000|Period 1|Adverse Event|0|||
146046091|NCT05258149|526682130|FG001|Period 1|Adverse Event|1|||
146046092|NCT05258149|526682129|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
146046093|NCT05258149|526682130|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
146046094|NCT05258149|526682129|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146046095|NCT05258149|526682130|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146102653|NCT02329080|526895282|FG000|Overall Study|Adverse Event|1|||
146102654|NCT02329080|526895282|FG000|Overall Study|Death|4|||
146102655|NCT02329080|526895282|FG000|Overall Study|Lack of Efficacy|22|||
146102656|NCT02329080|526895282|FG000|Overall Study|Lost to Follow-up|1|||
146102657|NCT02329080|526895282|FG000|Overall Study|Physician Decision|2|||
146102658|NCT02329080|526895282|FG000|Overall Study|Partial response|4|||
146046096|NCT05258149|526682129|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
146046097|NCT05258149|526682130|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
146046098|NCT00832416|526682137|FG000|Overall Study|Lack of Efficacy|17|||
146046099|NCT00832416|526682138|FG001|Overall Study|Lack of Efficacy|15|||
146102659|NCT02329080|526895282|FG000|Overall Study|Complete response|4|||
146102660|NCT04545060|526895283|FG000|Overall Study|Adverse Event|0|||
146102661|NCT04545060|526895284|FG001|Overall Study|Adverse Event|1|||
146102662|NCT04545060|526895283|FG000|Overall Study|Death|0|||
146102663|NCT04545060|526895284|FG001|Overall Study|Death|5|||
146102664|NCT04545060|526895283|FG000|Overall Study|Lost to Follow-up|10|||
146255683|NCT00899379|527450566|FG001|Overall Study|Pregnancy|0|||
146255684|NCT00899379|527450567|FG002|Overall Study|Pregnancy|1|||
146046100|NCT00832416|526682139|FG002|Overall Study|Lack of Efficacy|13|||
146046101|NCT00832416|526682140|FG003|Overall Study|Lack of Efficacy|52|||
146046102|NCT00832416|526682137|FG000|Overall Study|Withdrawal by Subject|5|||
146046103|NCT00832416|526682138|FG001|Overall Study|Withdrawal by Subject|7|||
146046104|NCT00832416|526682139|FG002|Overall Study|Withdrawal by Subject|2|||
146046105|NCT00832416|526682140|FG003|Overall Study|Withdrawal by Subject|10|||
146046106|NCT00832416|526682137|FG000|Overall Study|Physician Decision|2|||
146046107|NCT00832416|526682138|FG001|Overall Study|Physician Decision|12|||
146046108|NCT00832416|526682139|FG002|Overall Study|Physician Decision|5|||
146046109|NCT00832416|526682140|FG003|Overall Study|Physician Decision|10|||
146046110|NCT00832416|526682137|FG000|Overall Study|Administrative|0|||
146046111|NCT00832416|526682138|FG001|Overall Study|Administrative|0|||
146046112|NCT00832416|526682139|FG002|Overall Study|Administrative|0|||
146046113|NCT00832416|526682140|FG003|Overall Study|Administrative|1|||
146046114|NCT00832416|526682137|FG000|Overall Study|Adverse Event|21|||
146046115|NCT00832416|526682138|FG001|Overall Study|Adverse Event|19|||
146046116|NCT00832416|526682139|FG002|Overall Study|Adverse Event|41|||
146046117|NCT00832416|526682140|FG003|Overall Study|Adverse Event|10|||
146046118|NCT00832416|526682137|FG000|Overall Study|Death|1|||
146046119|NCT00832416|526682138|FG001|Overall Study|Death|0|||
146046120|NCT00832416|526682139|FG002|Overall Study|Death|0|||
146046121|NCT00832416|526682140|FG003|Overall Study|Death|0|||
146046122|NCT02114606|526682141|FG000|Overall Study|Unable to swallow Cytosponge|6|||
146046123|NCT05786508|526682151|FG000|Overall Study|Withdrawal by Subject|2|||
146046124|NCT05786508|526682152|FG001|Overall Study|Withdrawal by Subject|0|||
146046125|NCT04426318|526682153|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
146046126|NCT04426318|526682154|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
146046127|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Technical problems|0|||
146046128|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Technical problems|0|||
146046129|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Technical problems|0|||
146046130|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Technical problems|1|||
146046131|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146046132|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
146046133|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146046134|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
146046135|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
146046136|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
146046137|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
146046138|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
146046139|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
146046140|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
146046141|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
146046142|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
146046143|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Death|0|||
146046144|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Death|3|||
146046145|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Death|1|||
146046146|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Death|0|||
146046147|NCT02152761|526682157|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
146046148|NCT02152761|526682158|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
146046149|NCT02152761|526682159|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
146046150|NCT02152761|526682160|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
146046151|NCT02152761|526682157|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
146046152|NCT02152761|526682158|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
146046153|NCT02152761|526682159|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
146046154|NCT02152761|526682160|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
146046155|NCT02152761|526682157|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
146046156|NCT02152761|526682158|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
146046157|NCT02152761|526682159|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
146046158|NCT02152761|526682160|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
146046159|NCT02152761|526682157|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
146046160|NCT02152761|526682158|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146046161|NCT02152761|526682159|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146046162|NCT02152761|526682160|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
146046163|NCT02152761|526682157|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
146046164|NCT02152761|526682158|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
146046165|NCT02152761|526682159|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
146046166|NCT02152761|526682160|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
146046167|NCT01957202|526682161|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046168|NCT01957202|526682162|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
146046169|NCT01957202|526682163|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046170|NCT01957202|526682164|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046171|NCT01957202|526682165|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046172|NCT01957202|526682166|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146102665|NCT04545060|526895284|FG001|Overall Study|Lost to Follow-up|13|||
146102666|NCT04545060|526895283|FG000|Overall Study|Physician Decision|3|||
146102667|NCT04545060|526895284|FG001|Overall Study|Physician Decision|0|||
146102668|NCT04545060|526895283|FG000|Overall Study|Withdrawal by Subject|17|||
146102669|NCT04545060|526895284|FG001|Overall Study|Withdrawal by Subject|22|||
146102670|NCT00973674|526895285|FG000|Overall Study|Protocol Violation|2|||
146046173|NCT01957202|526682167|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046174|NCT01957202|526682168|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046175|NCT01957202|526682169|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046176|NCT01957202|526682170|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046177|NCT01957202|526682171|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046178|NCT01957202|526682172|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046179|NCT01957202|526682173|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046180|NCT01957202|526682174|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046181|NCT01957202|526682175|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046182|NCT01957202|526682176|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046183|NCT01957202|526682177|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
146046184|NCT01957202|526682178|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
146046185|NCT01957202|526682161|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046186|NCT01957202|526682162|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046187|NCT01957202|526682163|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046188|NCT01957202|526682164|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046189|NCT01957202|526682165|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046190|NCT01957202|526682166|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046191|NCT01957202|526682167|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046192|NCT01957202|526682168|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046193|NCT01957202|526682169|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046194|NCT01957202|526682170|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046195|NCT01957202|526682171|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046196|NCT01957202|526682172|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046197|NCT01957202|526682173|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046198|NCT01957202|526682174|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046199|NCT01957202|526682175|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046200|NCT01957202|526682176|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046201|NCT01957202|526682177|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
146046202|NCT01957202|526682178|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
146046203|NCT01456169|526682179|FG000|Overall Study|Adverse Event|1|||
146046204|NCT01456169|526682180|FG001|Overall Study|Adverse Event|2|||
146046205|NCT01456169|526682181|FG002|Overall Study|Adverse Event|7|||
146046206|NCT01456169|526682179|FG000|Overall Study|Major Protocol Deviation|3|||
146046207|NCT01456169|526682180|FG001|Overall Study|Major Protocol Deviation|2|||
146046208|NCT01456169|526682181|FG002|Overall Study|Major Protocol Deviation|3|||
146046209|NCT01456169|526682179|FG000|Overall Study|Voluntary Withdrawal|3|||
146046210|NCT01456169|526682180|FG001|Overall Study|Voluntary Withdrawal|0|||
146046211|NCT01456169|526682181|FG002|Overall Study|Voluntary Withdrawal|2|||
146046212|NCT01456169|526682179|FG000|Overall Study|Lack of Efficacy|2|||
146046213|NCT01456169|526682180|FG001|Overall Study|Lack of Efficacy|0|||
146046214|NCT01456169|526682181|FG002|Overall Study|Lack of Efficacy|0|||
146046215|NCT01456169|526682179|FG000|Overall Study|Other|1|||
146046216|NCT01456169|526682180|FG001|Overall Study|Other|1|||
146046217|NCT01456169|526682181|FG002|Overall Study|Other|0|||
146046218|NCT01397461|526682182|FG000|Overall Study|Withdrawal by Subject|2|||
146046219|NCT01397461|526682183|FG001|Overall Study|Withdrawal by Subject|1|||
146046220|NCT01397461|526682184|FG002|Overall Study|Withdrawal by Subject|0|||
146046221|NCT01397461|526682182|FG000|Overall Study|Lost to Follow-up|0|||
146046222|NCT01397461|526682183|FG001|Overall Study|Lost to Follow-up|2|||
146046223|NCT01397461|526682184|FG002|Overall Study|Lost to Follow-up|1|||
146046224|NCT01397461|526682182|FG000|Overall Study|Lack of Efficacy|0|||
146046225|NCT01397461|526682183|FG001|Overall Study|Lack of Efficacy|3|||
146046226|NCT01397461|526682184|FG002|Overall Study|Lack of Efficacy|0|||
146046227|NCT01397461|526682182|FG000|Overall Study|Not treated|0|||
146046228|NCT01397461|526682183|FG001|Overall Study|Not treated|0|||
146046229|NCT01397461|526682184|FG002|Overall Study|Not treated|1|||
146046230|NCT05729568|526682185|FG000|Overall Study|Still on Study|52|||
146046231|NCT05729568|526682186|FG001|Overall Study|Still on Study|26|||
146102671|NCT00973674|526895286|FG001|Overall Study|Protocol Violation|0|||
146046232|NCT05729568|526682185|FG000|Overall Study|Randomized but Never Treated|3|||
146046233|NCT05729568|526682186|FG001|Overall Study|Randomized but Never Treated|0|||
146046234|NCT05729568|526682185|FG000|Overall Study|Adverse Event|0|||
146046235|NCT05729568|526682186|FG001|Overall Study|Adverse Event|1|||
146046236|NCT05729568|526682185|FG000|Overall Study|Investigator's Discretion|1|||
146046237|NCT05729568|526682186|FG001|Overall Study|Investigator's Discretion|0|||
146046238|NCT01514201|526682196|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
146046239|NCT01514201|526682197|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146046240|NCT01514201|526682198|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146102672|NCT00071396|526895291|FG000|Overall Study|Withdrawal by Subject|1|||
146046241|NCT01514201|526682199|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146046242|NCT01514201|526682196|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146046243|NCT01514201|526682197|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
146046244|NCT01514201|526682198|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
146046245|NCT01514201|526682199|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146046246|NCT01514201|526682196|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
146046247|NCT01514201|526682197|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
146046248|NCT01514201|526682198|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
146046249|NCT01514201|526682199|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146046250|NCT01514201|526682196|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
146046251|NCT01514201|526682197|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
146046252|NCT01514201|526682198|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146046253|NCT01514201|526682199|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146046254|NCT01514201|526682196|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146046255|NCT01514201|526682197|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146046256|NCT01514201|526682198|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
146046257|NCT01514201|526682199|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
146046258|NCT01514201|526682196|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146046259|NCT01514201|526682197|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146046260|NCT01514201|526682198|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
146046261|NCT01514201|526682199|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
146046262|NCT01514201|526682196|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146046263|NCT01514201|526682197|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146046264|NCT01514201|526682198|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
146046265|NCT01514201|526682199|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
146046266|NCT01514201|526682196|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146046267|NCT01514201|526682197|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146046268|NCT01514201|526682198|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
146046269|NCT01514201|526682199|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
146046270|NCT01514201|526682196|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146046271|NCT01514201|526682197|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146046272|NCT01514201|526682198|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
146046273|NCT01514201|526682199|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
146046274|NCT01514201|526682196|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146046275|NCT01514201|526682197|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146046276|NCT01514201|526682198|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
146046277|NCT01514201|526682199|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
146046278|NCT01514201|526682196|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146046279|NCT01514201|526682197|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146046280|NCT01514201|526682198|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
146046281|NCT01514201|526682199|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
146046282|NCT01514201|526682196|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146046283|NCT01514201|526682197|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146046284|NCT01514201|526682198|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
146046285|NCT01514201|526682199|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
146046286|NCT05888181|526682201|FG000|Overall Study|Lost to Follow-up|1|||
146046287|NCT05888181|526682202|FG001|Overall Study|Lost to Follow-up|1|||
146046288|NCT05888181|526682203|FG002|Overall Study|Lost to Follow-up|0|||
146046289|NCT00637416|526682205|FG000|Overall Study|Lost to Follow-up|1|||
146046290|NCT00637416|526682206|FG001|Overall Study|Lost to Follow-up|1|||
146046291|NCT00637416|526682205|FG000|Overall Study|Unable to take study drug|0|||
146046292|NCT00637416|526682206|FG001|Overall Study|Unable to take study drug|1|||
146046293|NCT02534909|526682217|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
146046294|NCT01625000|526682218|FG000|Overall Study|Physician Decision|15|||
146046295|NCT01625000|526682219|FG001|Overall Study|Physician Decision|7|||
146046296|NCT01625000|526682220|FG002|Overall Study|Physician Decision|7|||
146046297|NCT01625000|526682221|FG003|Overall Study|Physician Decision|2|||
146046298|NCT01625000|526682222|FG004|Overall Study|Physician Decision|15|||
146046299|NCT01625000|526682218|FG000|Overall Study|Protocol Violation|3|||
146046300|NCT01625000|526682219|FG001|Overall Study|Protocol Violation|10|||
146046301|NCT01625000|526682220|FG002|Overall Study|Protocol Violation|4|||
146046302|NCT01625000|526682221|FG003|Overall Study|Protocol Violation|1|||
146046303|NCT01625000|526682222|FG004|Overall Study|Protocol Violation|2|||
146046304|NCT01625000|526682218|FG000|Overall Study|Withdrawal by Subject|19|||
146046305|NCT01625000|526682219|FG001|Overall Study|Withdrawal by Subject|16|||
146046306|NCT01625000|526682220|FG002|Overall Study|Withdrawal by Subject|11|||
146046307|NCT01625000|526682221|FG003|Overall Study|Withdrawal by Subject|9|||
146102673|NCT00071396|526895291|FG000|Overall Study|Physician Decision|2|||
146300856|NCT03346057|527617154|FG003|Overall Study|Death|0|||
146102674|NCT03082261|526895292|FG000|Overall Study|Death|4|||
146046308|NCT01625000|526682222|FG004|Overall Study|Withdrawal by Subject|17|||
146046309|NCT01625000|526682218|FG000|Overall Study|Adverse Event (including Death)|15|||
146046310|NCT01625000|526682219|FG001|Overall Study|Adverse Event (including Death)|19|||
146046311|NCT01625000|526682220|FG002|Overall Study|Adverse Event (including Death)|11|||
146046312|NCT01625000|526682221|FG003|Overall Study|Adverse Event (including Death)|7|||
146046313|NCT01625000|526682222|FG004|Overall Study|Adverse Event (including Death)|21|||
146046314|NCT00566852|526682223|FG000|Overall Study|Protocol Violation|22|||
146102675|NCT03082261|526895292|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
146102676|NCT03082261|526895292|FG000|Overall Study|Insurance denial|1|||
146102677|NCT03082261|526895292|FG000|Overall Study|Peripheral lead added|1|||
146102678|NCT03082261|526895292|FG000|Overall Study|Withdrawal by Subject|40|||
146046315|NCT00566852|526682224|FG001|Overall Study|Protocol Violation|24|||
146046316|NCT00566852|526682223|FG000|Overall Study|Death|95|||
146046317|NCT00566852|526682224|FG001|Overall Study|Death|78|||
146046318|NCT00566852|526682223|FG000|Overall Study|Withdrawal by Subject|30|||
146046319|NCT00566852|526682224|FG001|Overall Study|Withdrawal by Subject|25|||
146046320|NCT00566852|526682223|FG000|Overall Study|Patient refusal|37|||
146046321|NCT00566852|526682224|FG001|Overall Study|Patient refusal|37|||
146046322|NCT00566852|526682223|FG000|Overall Study|Not tested due to disability|6|||
146046323|NCT00566852|526682224|FG001|Overall Study|Not tested due to disability|12|||
146046324|NCT00566852|526682223|FG000|Overall Study|Missing reason not specified|1|||
146046325|NCT00566852|526682224|FG001|Overall Study|Missing reason not specified|2|||
146046326|NCT00566852|526682223|FG000|Overall Study|Missing reason not reported|16|||
146046327|NCT00566852|526682224|FG001|Overall Study|Missing reason not reported|20|||
146046328|NCT01147055|526682225|FG000|First Intervention Period|Lost to Follow-up|1|||
146046329|NCT01147055|526682226|FG001|First Intervention Period|Lost to Follow-up|0|||
146046330|NCT00132808|526682227|FG000|Stratum I|Adverse Event|2|||
146046331|NCT00132808|526682228|FG001|Stratum I|Adverse Event|1|||
146046332|NCT00132808|526682229|FG002|Stratum I|Adverse Event|0|||
146046333|NCT00132808|526682227|FG000|Stratum I|Lost to Follow-up|3|||
146046334|NCT00132808|526682228|FG001|Stratum I|Lost to Follow-up|4|||
146046335|NCT00132808|526682229|FG002|Stratum I|Lost to Follow-up|1|||
146046336|NCT00132808|526682227|FG000|Stratum I|Withdrawal by Subject|4|||
146046337|NCT00132808|526682228|FG001|Stratum I|Withdrawal by Subject|7|||
146046338|NCT00132808|526682229|FG002|Stratum I|Withdrawal by Subject|3|||
146046339|NCT00132808|526682227|FG000|Stratum I|Abnormal test procedure result (s)|0|||
146046340|NCT00132808|526682228|FG001|Stratum I|Abnormal test procedure result (s)|0|||
146046341|NCT00132808|526682229|FG002|Stratum I|Abnormal test procedure result (s)|1|||
146046342|NCT00132808|526682227|FG000|Stratum II|Adverse Event|1|||
146046343|NCT00132808|526682228|FG001|Stratum II|Adverse Event|2|||
146046344|NCT00132808|526682229|FG002|Stratum II|Adverse Event|1|||
146046345|NCT00132808|526682227|FG000|Stratum II|Death|1|||
146046346|NCT00132808|526682228|FG001|Stratum II|Death|0|||
146046347|NCT00132808|526682229|FG002|Stratum II|Death|0|||
146046348|NCT00132808|526682227|FG000|Stratum II|Lost to Follow-up|2|||
146046349|NCT00132808|526682228|FG001|Stratum II|Lost to Follow-up|2|||
146046350|NCT00132808|526682229|FG002|Stratum II|Lost to Follow-up|1|||
146046351|NCT00132808|526682227|FG000|Stratum II|Protocol Violation|0|||
146046352|NCT00132808|526682228|FG001|Stratum II|Protocol Violation|2|||
146046353|NCT00132808|526682229|FG002|Stratum II|Protocol Violation|1|||
146046354|NCT00132808|526682227|FG000|Stratum II|Withdrawal by Subject|4|||
146046355|NCT00132808|526682228|FG001|Stratum II|Withdrawal by Subject|9|||
146046356|NCT00132808|526682229|FG002|Stratum II|Withdrawal by Subject|6|||
146102679|NCT03082261|526895292|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
146102680|NCT03082261|526895292|FG000|Overall Study|Subject implanted with device other than study device|1|||
146102681|NCT03082261|526895292|FG000|Overall Study|Lost to Follow-up|14|||
146102682|NCT03082261|526895292|FG000|Overall Study|Subject moved to a different state|1|||
146102683|NCT03082261|526895292|FG000|Overall Study|Subject non-compliance|2|||
146102684|NCT03082261|526895292|FG000|Overall Study|Subject participation terminated by investigator|9|||
146046357|NCT04137731|526682232|FG000|Overall Study|Surgery Cancellation|1|||
146046358|NCT04137731|526682233|FG001|Overall Study|Surgery Cancellation|2|||
146046359|NCT04137731|526682232|FG000|Overall Study|Withdrawal by Subject|2|||
146046360|NCT04137731|526682233|FG001|Overall Study|Withdrawal by Subject|0|||
146046361|NCT04137731|526682232|FG000|Overall Study|Protocol Violation|0|||
146102685|NCT03082261|526895292|FG000|Overall Study|Subject participation terminated by sponsor|4|||
146102686|NCT03082261|526895292|FG000|Overall Study|System explant|19|||
146046362|NCT04137731|526682233|FG001|Overall Study|Protocol Violation|1|||
146102687|NCT03082261|526895292|FG000|Overall Study|Unable to place lead(s)|2|||
146046363|NCT00362648|526682234|FG000|Overall Study|Adverse Event|12|||
146046364|NCT00362648|526682235|FG001|Overall Study|Adverse Event|21|||
146046365|NCT00362648|526682236|FG002|Overall Study|Adverse Event|1|||
146046366|NCT00362648|526682237|FG003|Overall Study|Adverse Event|0|||
146046367|NCT00362648|526682234|FG000|Overall Study|Lost to Follow-up|62|||
146046368|NCT00362648|526682235|FG001|Overall Study|Lost to Follow-up|69|||
146046369|NCT00362648|526682236|FG002|Overall Study|Lost to Follow-up|4|||
146102688|NCT03082261|526895292|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
146255685|NCT00899379|527450568|FG003|Overall Study|Pregnancy|0|||
146255686|NCT00899379|527450569|FG004|Overall Study|Pregnancy|1|||
146255687|NCT00899379|527450565|FG000|Overall Study|Patient Uncooperative|0|||
146046370|NCT00362648|526682237|FG003|Overall Study|Lost to Follow-up|3|||
146255688|NCT00899379|527450566|FG001|Overall Study|Patient Uncooperative|1|||
146255689|NCT00899379|527450567|FG002|Overall Study|Patient Uncooperative|0|||
146255690|NCT00899379|527450568|FG003|Overall Study|Patient Uncooperative|1|||
146255691|NCT00899379|527450569|FG004|Overall Study|Patient Uncooperative|2|||
146255692|NCT00899379|527450565|FG000|Overall Study|Abnormal Baseline ECG|0|||
146255693|NCT00899379|527450566|FG001|Overall Study|Abnormal Baseline ECG|0|||
146255694|NCT00899379|527450567|FG002|Overall Study|Abnormal Baseline ECG|0|||
146255695|NCT00899379|527450568|FG003|Overall Study|Abnormal Baseline ECG|1|||
146255696|NCT00899379|527450569|FG004|Overall Study|Abnormal Baseline ECG|0|||
146255697|NCT00899379|527450565|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146255698|NCT00899379|527450566|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146255699|NCT00899379|527450567|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146255700|NCT00899379|527450568|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255701|NCT00899379|527450569|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255702|NCT00899379|527450565|FG000|Overall Study|Not Completed/Entered Extn|5|||
146255703|NCT00899379|527450566|FG001|Overall Study|Not Completed/Entered Extn|1|||
146255704|NCT00899379|527450567|FG002|Overall Study|Not Completed/Entered Extn|6|||
146255705|NCT00899379|527450568|FG003|Overall Study|Not Completed/Entered Extn|4|||
146255706|NCT00899379|527450569|FG004|Overall Study|Not Completed/Entered Extn|3|||
146255707|NCT00899379|527450565|FG000|Overall Study|Study Terminated|3|||
146255708|NCT00899379|527450566|FG001|Overall Study|Study Terminated|0|||
146255709|NCT00899379|527450567|FG002|Overall Study|Study Terminated|3|||
146255710|NCT00899379|527450568|FG003|Overall Study|Study Terminated|3|||
146255711|NCT00899379|527450569|FG004|Overall Study|Study Terminated|1|||
146255712|NCT00899379|527450565|FG000|Overall Study|Lost to Follow-up|3|||
146255713|NCT00899379|527450566|FG001|Overall Study|Lost to Follow-up|1|||
146255714|NCT00899379|527450567|FG002|Overall Study|Lost to Follow-up|0|||
146255715|NCT00899379|527450568|FG003|Overall Study|Lost to Follow-up|2|||
146255716|NCT00899379|527450569|FG004|Overall Study|Lost to Follow-up|5|||
146255717|NCT00899379|527450565|FG000|Overall Study|Withdrawal by Subject|4|||
146255718|NCT00899379|527450566|FG001|Overall Study|Withdrawal by Subject|7|||
146255719|NCT00899379|527450567|FG002|Overall Study|Withdrawal by Subject|4|||
146255720|NCT00899379|527450568|FG003|Overall Study|Withdrawal by Subject|7|||
146255721|NCT00899379|527450569|FG004|Overall Study|Withdrawal by Subject|2|||
146255722|NCT00899379|527450565|FG000|Overall Study|Pregnancy|1|||
146046371|NCT00362648|526682234|FG000|Overall Study|Protocol Violation|4|||
146046372|NCT00362648|526682235|FG001|Overall Study|Protocol Violation|2|||
146046373|NCT00362648|526682236|FG002|Overall Study|Protocol Violation|2|||
146046374|NCT00362648|526682237|FG003|Overall Study|Protocol Violation|2|||
146046375|NCT00362648|526682234|FG000|Overall Study|Withdrawal by Subject|48|||
146046376|NCT00362648|526682235|FG001|Overall Study|Withdrawal by Subject|42|||
146046377|NCT00362648|526682236|FG002|Overall Study|Withdrawal by Subject|2|||
146046378|NCT00362648|526682237|FG003|Overall Study|Withdrawal by Subject|6|||
146046379|NCT02204072|526682238|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
146046380|NCT02204072|526682239|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
146046381|NCT02204072|526682240|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
146046382|NCT02204072|526682241|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
146046383|NCT02204072|526682242|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
146046384|NCT02204072|526682238|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
146046385|NCT02204072|526682239|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
146046386|NCT02204072|526682240|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
146046387|NCT02204072|526682241|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
146046388|NCT02204072|526682242|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
146046389|NCT02204072|526682238|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
146255723|NCT00899379|527450566|FG001|Overall Study|Pregnancy|0|||
146255724|NCT00899379|527450567|FG002|Overall Study|Pregnancy|0|||
146255725|NCT00899379|527450568|FG003|Overall Study|Pregnancy|0|||
146255726|NCT00899379|527450569|FG004|Overall Study|Pregnancy|0|||
146255727|NCT00899379|527450565|FG000|Overall Study|Patient Uncooperative|0|||
146255728|NCT00899379|527450566|FG001|Overall Study|Patient Uncooperative|0|||
146255729|NCT00899379|527450567|FG002|Overall Study|Patient Uncooperative|0|||
146255730|NCT00899379|527450568|FG003|Overall Study|Patient Uncooperative|1|||
146255731|NCT00899379|527450569|FG004|Overall Study|Patient Uncooperative|0|||
146255732|NCT00899379|527450565|FG000|Overall Study|Abnormal Prestudy Labs|0|||
146255733|NCT00899379|527450566|FG001|Overall Study|Abnormal Prestudy Labs|0|||
146255734|NCT00899379|527450567|FG002|Overall Study|Abnormal Prestudy Labs|0|||
146255735|NCT00899379|527450568|FG003|Overall Study|Abnormal Prestudy Labs|0|||
146255736|NCT00899379|527450569|FG004|Overall Study|Abnormal Prestudy Labs|2|||
146255737|NCT00899379|527450565|FG000|Overall Study|Abnormal Baseline ECG|0|||
146255738|NCT00899379|527450566|FG001|Overall Study|Abnormal Baseline ECG|0|||
146102689|NCT00839852|526895293|FG000|Overall Study|Adverse Event|10|||
146102690|NCT00839852|526895293|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146102691|NCT00839852|526895293|FG000|Overall Study|Protocol Violation|9|||
146102692|NCT00839852|526895293|FG000|Overall Study|Withdrawal of Consent|16|||
146046390|NCT02204072|526682239|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
146046391|NCT02204072|526682240|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
146102693|NCT00839852|526895293|FG000|Overall Study|Lost to Follow-up|7|||
146102694|NCT00839852|526895293|FG000|Overall Study|Lack of Compliance While in Jail|1|||
146102695|NCT00839852|526895293|FG000|Overall Study|Pregnancy|1|||
146102696|NCT04545554|526895294|FG000|Overall Study|Withdrawal by Subject|0|||
146102697|NCT04545554|526895295|FG001|Overall Study|Withdrawal by Subject|0|||
146102698|NCT04545554|526895296|FG002|Overall Study|Withdrawal by Subject|0|||
146102699|NCT04545554|526895297|FG003|Overall Study|Withdrawal by Subject|1|||
146102700|NCT04545554|526895298|FG004|Overall Study|Withdrawal by Subject|0|||
146102701|NCT04545554|526895299|FG005|Overall Study|Withdrawal by Subject|0|||
146102702|NCT00494299|526895300|FG000|Overall Study|Adverse Event|93|||
146102703|NCT00494299|526895301|FG001|Overall Study|Adverse Event|13|||
146102704|NCT00494299|526895300|FG000|Overall Study|Lost to Follow-up|1|||
146102705|NCT00494299|526895301|FG001|Overall Study|Lost to Follow-up|0|||
146102706|NCT00494299|526895300|FG000|Overall Study|Physician Decision|0|||
146102707|NCT00494299|526895301|FG001|Overall Study|Physician Decision|2|||
146102708|NCT00494299|526895300|FG000|Overall Study|Protocol Violation|1|||
146102709|NCT00494299|526895301|FG001|Overall Study|Protocol Violation|2|||
146102710|NCT00494299|526895300|FG000|Overall Study|Withdrawal by Subject|8|||
146102711|NCT00494299|526895301|FG001|Overall Study|Withdrawal by Subject|3|||
146102712|NCT00494299|526895300|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
146102713|NCT00494299|526895301|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
146046392|NCT02204072|526682241|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
146046393|NCT02204072|526682242|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
146046394|NCT02204072|526682238|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146046395|NCT02204072|526682239|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146046396|NCT02204072|526682240|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
146046397|NCT02204072|526682241|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146046398|NCT02204072|526682242|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
146046399|NCT03983304|526682243|FG000|Overall Study|Withdrawal by Subject|5|||
146046400|NCT03983304|526682243|FG000|Overall Study|Lost to Follow-up|2|||
146046401|NCT01587040|526682249|FG000|Overall Study|Protocol Violation|0|||
146046402|NCT01587040|526682250|FG001|Overall Study|Protocol Violation|0|||
146046403|NCT01587040|526682251|FG002|Overall Study|Protocol Violation|1|||
146046404|NCT01587040|526682252|FG003|Overall Study|Protocol Violation|0|||
146046405|NCT01587040|526682249|FG000|Overall Study|Adverse Event|0|||
146046406|NCT01587040|526682250|FG001|Overall Study|Adverse Event|1|||
146046407|NCT01587040|526682251|FG002|Overall Study|Adverse Event|10|||
146046408|NCT01587040|526682252|FG003|Overall Study|Adverse Event|0|||
146046409|NCT01587040|526682249|FG000|Overall Study|Disease progression|12|||
146046410|NCT01587040|526682250|FG001|Overall Study|Disease progression|1|||
146046411|NCT01587040|526682251|FG002|Overall Study|Disease progression|15|||
146046412|NCT01587040|526682252|FG003|Overall Study|Disease progression|3|||
146046413|NCT01587040|526682249|FG000|Overall Study|Other than specified|5|||
146046414|NCT01587040|526682250|FG001|Overall Study|Other than specified|1|||
146046415|NCT01587040|526682251|FG002|Overall Study|Other than specified|11|||
146046416|NCT01587040|526682252|FG003|Overall Study|Other than specified|1|||
146046417|NCT04300309|526682255|FG000|Overall Study|Lost to Follow-up|1|||
146046418|NCT04300309|526682256|FG001|Overall Study|Lost to Follow-up|0|||
146046419|NCT04346654|526682258|FG000|Overall Study|Adverse Event|2|||
146046420|NCT04346654|526682259|FG001|Overall Study|Adverse Event|0|||
146046421|NCT04346654|526682258|FG000|Overall Study|Non-response|1|||
146046422|NCT04346654|526682259|FG001|Overall Study|Non-response|1|||
146046423|NCT04346654|526682258|FG000|Overall Study|Withdrawal by Subject|2|||
146046424|NCT04346654|526682259|FG001|Overall Study|Withdrawal by Subject|0|||
146046425|NCT04346654|526682258|FG000|Overall Study|Lost to Follow-up|0|||
146046426|NCT04346654|526682259|FG001|Overall Study|Lost to Follow-up|1|||
146046427|NCT04346654|526682258|FG000|Overall Study|Pregnancy|0|||
146046428|NCT04346654|526682259|FG001|Overall Study|Pregnancy|1|||
146046429|NCT00858637|526682262|FG000|Active Comparison Phase|Adverse Event|14|||
146102714|NCT00494299|526895300|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
146102715|NCT00494299|526895301|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
146102716|NCT00494299|526895300|FG000|Overall Study|Site Closed by Sponsor|6|||
146102717|NCT00494299|526895301|FG001|Overall Study|Site Closed by Sponsor|0|||
146102718|NCT00494299|526895300|FG000|Overall Study|Protocol Driven Decision Point|11|||
146046430|NCT00858637|526682263|FG001|Active Comparison Phase|Adverse Event|0|||
146046431|NCT00858637|526682264|FG002|Active Comparison Phase|Adverse Event|0|||
146102719|NCT00494299|526895301|FG001|Overall Study|Protocol Driven Decision Point|22|||
146102720|NCT01313312|526895303|FG000|Overall Study|Adverse Event|5|||
146046432|NCT00858637|526682265|FG003|Active Comparison Phase|Adverse Event|9|||
146046433|NCT00858637|526682266|FG004|Active Comparison Phase|Adverse Event|0|||
146046434|NCT00858637|526682267|FG005|Active Comparison Phase|Adverse Event|0|||
146046435|NCT00858637|526682262|FG000|Active Comparison Phase|Death|1|||
146046436|NCT00858637|526682263|FG001|Active Comparison Phase|Death|0|||
146046437|NCT00858637|526682264|FG002|Active Comparison Phase|Death|0|||
146046438|NCT00858637|526682265|FG003|Active Comparison Phase|Death|1|||
146046439|NCT00858637|526682266|FG004|Active Comparison Phase|Death|0|||
146046440|NCT00858637|526682267|FG005|Active Comparison Phase|Death|0|||
146046441|NCT00858637|526682262|FG000|Active Comparison Phase|Physician Decision|1|||
146046442|NCT00858637|526682263|FG001|Active Comparison Phase|Physician Decision|0|||
146046443|NCT00858637|526682264|FG002|Active Comparison Phase|Physician Decision|0|||
146046444|NCT00858637|526682265|FG003|Active Comparison Phase|Physician Decision|1|||
146046445|NCT00858637|526682266|FG004|Active Comparison Phase|Physician Decision|0|||
146046446|NCT00858637|526682267|FG005|Active Comparison Phase|Physician Decision|0|||
146046447|NCT00858637|526682262|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
146046448|NCT00858637|526682263|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
146046449|NCT00858637|526682264|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
146046450|NCT00858637|526682265|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
146046451|NCT00858637|526682266|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
146046452|NCT00858637|526682267|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
146046453|NCT00858637|526682262|FG000|Active Comparison Phase|Other Reasons|1|||
146046454|NCT00858637|526682263|FG001|Active Comparison Phase|Other Reasons|0|||
146046455|NCT00858637|526682264|FG002|Active Comparison Phase|Other Reasons|0|||
146046456|NCT00858637|526682265|FG003|Active Comparison Phase|Other Reasons|1|||
146046457|NCT00858637|526682266|FG004|Active Comparison Phase|Other Reasons|0|||
146046458|NCT00858637|526682267|FG005|Active Comparison Phase|Other Reasons|0|||
146046459|NCT00858637|526682262|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
146046460|NCT00858637|526682263|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
146046461|NCT00858637|526682264|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
146046462|NCT00858637|526682265|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
146046463|NCT00858637|526682266|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
146046464|NCT00858637|526682267|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
146046465|NCT00858637|526682262|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146046466|NCT00858637|526682263|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146046467|NCT00858637|526682264|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146046468|NCT00858637|526682265|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146046469|NCT00858637|526682266|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
146046470|NCT00858637|526682267|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
146046471|NCT04677504|526682268|FG000|Overall Study|Death|51|||
146046472|NCT04677504|526682269|FG001|Overall Study|Death|49|||
146046473|NCT04677504|526682268|FG000|Overall Study|Progressive Disease|1|||
146046474|NCT04677504|526682269|FG001|Overall Study|Progressive Disease|0|||
146046475|NCT04677504|526682268|FG000|Overall Study|Symptomatic Deterioration|1|||
146046476|NCT04677504|526682269|FG001|Overall Study|Symptomatic Deterioration|0|||
146046477|NCT04677504|526682268|FG000|Overall Study|Withdrawal by Subject|2|||
146046478|NCT04677504|526682269|FG001|Overall Study|Withdrawal by Subject|5|||
146046479|NCT04677504|526682268|FG000|Overall Study|Study Terminated By Sponsor|28|||
146046480|NCT04677504|526682269|FG001|Overall Study|Study Terminated By Sponsor|24|||
146046481|NCT04677504|526682268|FG000|Overall Study|Adverse Event|0|||
146046482|NCT04677504|526682269|FG001|Overall Study|Adverse Event|1|||
146046483|NCT03508609|526682270|FG000|Overall Study|Withdrawal by Subject|1|||
146046484|NCT03304873|526682271|FG000|Overall Study|Lost to Follow-up|1|||
146046485|NCT03304873|526682272|FG001|Overall Study|Lost to Follow-up|8|||
146046486|NCT01546688|526682273|FG000|Overall Study|Adverse Event|0|||
146046487|NCT01546688|526682274|FG001|Overall Study|Adverse Event|4|||
146046488|NCT01546688|526682273|FG000|Overall Study|Withdrawal by Subject|2|||
146046489|NCT01546688|526682274|FG001|Overall Study|Withdrawal by Subject|1|||
146046490|NCT01546688|526682273|FG000|Overall Study|Lack of Efficacy|1|||
146046491|NCT01546688|526682274|FG001|Overall Study|Lack of Efficacy|0|||
146046492|NCT00782483|526682278|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
146046493|NCT01868477|526682279|FG000|Overall Study|Adverse Event|2|||
146046494|NCT01868477|526682280|FG001|Overall Study|Adverse Event|4|||
146046495|NCT01868477|526682279|FG000|Overall Study|Disease progression|1|||
146046496|NCT01868477|526682280|FG001|Overall Study|Disease progression|1|||
146046497|NCT01868477|526682279|FG000|Overall Study|Withdrawal by Subject|1|||
146255739|NCT00899379|527450567|FG002|Overall Study|Abnormal Baseline ECG|1|||
146046498|NCT01868477|526682280|FG001|Overall Study|Withdrawal by Subject|0|||
146046499|NCT01052077|526682282|FG000|Phase A|Lost to Follow-up|22|||
146046500|NCT01052077|526682283|FG001|Phase A|Lost to Follow-up|0|||
146046501|NCT01052077|526682284|FG002|Phase A|Lost to Follow-up|0|||
146046502|NCT01052077|526682285|FG003|Phase A|Lost to Follow-up|0|||
146046503|NCT01052077|526682282|FG000|Phase A|Adverse Event|32|||
146046504|NCT01052077|526682283|FG001|Phase A|Adverse Event|0|||
146046505|NCT01052077|526682284|FG002|Phase A|Adverse Event|0|||
146046506|NCT01052077|526682285|FG003|Phase A|Adverse Event|0|||
146255740|NCT00899379|527450568|FG003|Overall Study|Abnormal Baseline ECG|1|||
146046507|NCT01052077|526682282|FG000|Phase A|Met Withdrawal Criteria|26|||
146046508|NCT01052077|526682283|FG001|Phase A|Met Withdrawal Criteria|0|||
146046509|NCT01052077|526682284|FG002|Phase A|Met Withdrawal Criteria|0|||
146046510|NCT01052077|526682285|FG003|Phase A|Met Withdrawal Criteria|0|||
146046511|NCT01052077|526682282|FG000|Phase A|Physician Decision|10|||
146046512|NCT01052077|526682283|FG001|Phase A|Physician Decision|0|||
146046513|NCT01052077|526682284|FG002|Phase A|Physician Decision|0|||
146046514|NCT01052077|526682285|FG003|Phase A|Physician Decision|0|||
146046515|NCT01052077|526682282|FG000|Phase A|Withdrawal by Subject|29|||
146046516|NCT01052077|526682283|FG001|Phase A|Withdrawal by Subject|0|||
146046517|NCT01052077|526682284|FG002|Phase A|Withdrawal by Subject|0|||
146046518|NCT01052077|526682285|FG003|Phase A|Withdrawal by Subject|0|||
146046519|NCT01052077|526682282|FG000|Phase A|Protocol Deviation|27|||
146046520|NCT01052077|526682283|FG001|Phase A|Protocol Deviation|0|||
146046521|NCT01052077|526682284|FG002|Phase A|Protocol Deviation|0|||
146046522|NCT01052077|526682285|FG003|Phase A|Protocol Deviation|0|||
146046523|NCT01052077|526682282|FG000|Phase B|Lost to Follow-up|0|||
146046524|NCT01052077|526682283|FG001|Phase B|Lost to Follow-up|2|||
146046525|NCT01052077|526682284|FG002|Phase B|Lost to Follow-up|3|||
146046526|NCT01052077|526682285|FG003|Phase B|Lost to Follow-up|0|||
146046527|NCT01052077|526682282|FG000|Phase B|Adverse Event|0|||
146046528|NCT01052077|526682283|FG001|Phase B|Adverse Event|9|||
146046529|NCT01052077|526682284|FG002|Phase B|Adverse Event|2|||
146046530|NCT01052077|526682285|FG003|Phase B|Adverse Event|0|||
146046531|NCT01052077|526682282|FG000|Phase B|Met Withdrawal Criteria|0|||
146046532|NCT01052077|526682283|FG001|Phase B|Met Withdrawal Criteria|2|||
146046533|NCT01052077|526682284|FG002|Phase B|Met Withdrawal Criteria|1|||
146046534|NCT01052077|526682285|FG003|Phase B|Met Withdrawal Criteria|0|||
146046535|NCT01052077|526682282|FG000|Phase B|Physician Decision|0|||
146046536|NCT01052077|526682283|FG001|Phase B|Physician Decision|1|||
146046537|NCT01052077|526682284|FG002|Phase B|Physician Decision|1|||
146046538|NCT01052077|526682285|FG003|Phase B|Physician Decision|0|||
146046539|NCT01052077|526682282|FG000|Phase B|Withdrawal by Subject|0|||
146046540|NCT01052077|526682283|FG001|Phase B|Withdrawal by Subject|0|||
146046541|NCT01052077|526682284|FG002|Phase B|Withdrawal by Subject|5|||
146046542|NCT01052077|526682285|FG003|Phase B|Withdrawal by Subject|0|||
146046543|NCT01052077|526682282|FG000|Phase B|Protocol Deviation|0|||
146046544|NCT01052077|526682283|FG001|Phase B|Protocol Deviation|3|||
146046545|NCT01052077|526682284|FG002|Phase B|Protocol Deviation|4|||
146046546|NCT01052077|526682285|FG003|Phase B|Protocol Deviation|0|||
146046547|NCT01052077|526682282|FG000|Phase B|Lack of Efficacy|0|||
146046548|NCT01052077|526682283|FG001|Phase B|Lack of Efficacy|1|||
146046549|NCT01052077|526682284|FG002|Phase B|Lack of Efficacy|0|||
146046550|NCT01052077|526682285|FG003|Phase B|Lack of Efficacy|0|||
146046551|NCT01052077|526682282|FG000|Phase A+|Lost to Follow-up|0|||
146046552|NCT01052077|526682283|FG001|Phase A+|Lost to Follow-up|0|||
146046553|NCT01052077|526682284|FG002|Phase A+|Lost to Follow-up|0|||
146046554|NCT01052077|526682285|FG003|Phase A+|Lost to Follow-up|8|||
146046555|NCT01052077|526682282|FG000|Phase A+|Adverse Event|0|||
146046556|NCT01052077|526682283|FG001|Phase A+|Adverse Event|0|||
146046557|NCT01052077|526682284|FG002|Phase A+|Adverse Event|0|||
146046558|NCT01052077|526682285|FG003|Phase A+|Adverse Event|4|||
146046559|NCT01052077|526682282|FG000|Phase A+|Met Withdrawal Criteria|0|||
146046560|NCT01052077|526682283|FG001|Phase A+|Met Withdrawal Criteria|0|||
146046561|NCT01052077|526682284|FG002|Phase A+|Met Withdrawal Criteria|0|||
146046562|NCT01052077|526682285|FG003|Phase A+|Met Withdrawal Criteria|2|||
146046563|NCT01052077|526682282|FG000|Phase A+|Withdrawal by Subject|0|||
146046564|NCT01052077|526682283|FG001|Phase A+|Withdrawal by Subject|0|||
146046565|NCT01052077|526682284|FG002|Phase A+|Withdrawal by Subject|0|||
146046566|NCT01052077|526682285|FG003|Phase A+|Withdrawal by Subject|7|||
146046567|NCT00042991|526682286|FG000|Overall Study|Adverse Event|1|||
146046568|NCT00042991|526682287|FG001|Overall Study|Adverse Event|4|||
146046569|NCT00042991|526682288|FG002|Overall Study|Adverse Event|2|||
146046570|NCT00042991|526682289|FG003|Overall Study|Adverse Event|0|||
146102721|NCT01313312|526895303|FG000|Overall Study|Withdrawal by Subject|18|||
146046571|NCT00042991|526682290|FG004|Overall Study|Adverse Event|0|||
146046572|NCT00042991|526682291|FG005|Overall Study|Adverse Event|1|||
146046573|NCT00042991|526682292|FG006|Overall Study|Adverse Event|0|||
146046574|NCT00042991|526682286|FG000|Overall Study|Withdrawal by Subject|0|||
146046575|NCT00042991|526682287|FG001|Overall Study|Withdrawal by Subject|7|||
146046576|NCT00042991|526682288|FG002|Overall Study|Withdrawal by Subject|2|||
146046577|NCT00042991|526682289|FG003|Overall Study|Withdrawal by Subject|0|||
146046578|NCT00042991|526682290|FG004|Overall Study|Withdrawal by Subject|1|||
146046579|NCT00042991|526682291|FG005|Overall Study|Withdrawal by Subject|0|||
146046580|NCT00042991|526682292|FG006|Overall Study|Withdrawal by Subject|0|||
146046581|NCT00042991|526682286|FG000|Overall Study|Disease Progression|5|||
146046582|NCT00042991|526682287|FG001|Overall Study|Disease Progression|29|||
146046583|NCT00042991|526682288|FG002|Overall Study|Disease Progression|2|||
146046584|NCT00042991|526682289|FG003|Overall Study|Disease Progression|2|||
146046585|NCT00042991|526682290|FG004|Overall Study|Disease Progression|1|||
146046586|NCT00042991|526682291|FG005|Overall Study|Disease Progression|4|||
146046587|NCT00042991|526682292|FG006|Overall Study|Disease Progression|2|||
146255741|NCT00899379|527450569|FG004|Overall Study|Abnormal Baseline ECG|0|||
146255742|NCT00899379|527450565|FG000|Overall Study|No Attack Pretreatment|3|||
146255743|NCT00899379|527450566|FG001|Overall Study|No Attack Pretreatment|5|||
146255744|NCT00899379|527450567|FG002|Overall Study|No Attack Pretreatment|5|||
146046588|NCT00042991|526682286|FG000|Overall Study|Alternative Therapy|0|||
146046589|NCT00042991|526682287|FG001|Overall Study|Alternative Therapy|0|||
146046590|NCT00042991|526682288|FG002|Overall Study|Alternative Therapy|0|||
146046591|NCT00042991|526682289|FG003|Overall Study|Alternative Therapy|0|||
146046592|NCT00042991|526682290|FG004|Overall Study|Alternative Therapy|1|||
146046593|NCT00042991|526682291|FG005|Overall Study|Alternative Therapy|0|||
146046594|NCT00042991|526682292|FG006|Overall Study|Alternative Therapy|0|||
146046595|NCT01445080|526682293|FG000|Overall Study|Adverse Event|5|||
146046596|NCT01445080|526682294|FG001|Overall Study|Adverse Event|3|||
146046597|NCT01445080|526682295|FG002|Overall Study|Adverse Event|11|||
146046598|NCT01445080|526682296|FG003|Overall Study|Adverse Event|6|||
146046599|NCT01445080|526682297|FG004|Overall Study|Adverse Event|2|||
146046600|NCT01445080|526682298|FG005|Overall Study|Adverse Event|3|||
146046601|NCT01445080|526682299|FG006|Overall Study|Adverse Event|0|||
146046602|NCT01445080|526682300|FG007|Overall Study|Adverse Event|3|||
146046603|NCT01445080|526682301|FG008|Overall Study|Adverse Event|10|||
146046604|NCT01445080|526682293|FG000|Overall Study|Physician Decision|0|||
146046605|NCT01445080|526682294|FG001|Overall Study|Physician Decision|0|||
146046606|NCT01445080|526682295|FG002|Overall Study|Physician Decision|1|||
146046607|NCT01445080|526682296|FG003|Overall Study|Physician Decision|0|||
146046608|NCT01445080|526682297|FG004|Overall Study|Physician Decision|0|||
146046609|NCT01445080|526682298|FG005|Overall Study|Physician Decision|3|||
146046610|NCT01445080|526682299|FG006|Overall Study|Physician Decision|2|||
146046611|NCT01445080|526682300|FG007|Overall Study|Physician Decision|2|||
146046612|NCT01445080|526682301|FG008|Overall Study|Physician Decision|0|||
146046613|NCT01445080|526682293|FG000|Overall Study|Withdrawal by Subject|1|||
146046614|NCT01445080|526682294|FG001|Overall Study|Withdrawal by Subject|0|||
146046615|NCT01445080|526682295|FG002|Overall Study|Withdrawal by Subject|0|||
146046616|NCT01445080|526682296|FG003|Overall Study|Withdrawal by Subject|1|||
146046617|NCT01445080|526682297|FG004|Overall Study|Withdrawal by Subject|0|||
146046618|NCT01445080|526682298|FG005|Overall Study|Withdrawal by Subject|0|||
146046619|NCT01445080|526682299|FG006|Overall Study|Withdrawal by Subject|0|||
146046620|NCT01445080|526682300|FG007|Overall Study|Withdrawal by Subject|0|||
146046621|NCT01445080|526682301|FG008|Overall Study|Withdrawal by Subject|2|||
146046622|NCT01445080|526682293|FG000|Overall Study|Ineligible/Inevaluable|1|||
146046623|NCT01445080|526682294|FG001|Overall Study|Ineligible/Inevaluable|2|||
146046624|NCT01445080|526682295|FG002|Overall Study|Ineligible/Inevaluable|0|||
146046625|NCT01445080|526682296|FG003|Overall Study|Ineligible/Inevaluable|1|||
146046626|NCT01445080|526682297|FG004|Overall Study|Ineligible/Inevaluable|2|||
146046627|NCT01445080|526682298|FG005|Overall Study|Ineligible/Inevaluable|3|||
146046628|NCT01445080|526682299|FG006|Overall Study|Ineligible/Inevaluable|0|||
146046629|NCT01445080|526682300|FG007|Overall Study|Ineligible/Inevaluable|0|||
146046630|NCT01445080|526682301|FG008|Overall Study|Ineligible/Inevaluable|6|||
146046631|NCT01574651|526682302|FG000|Overall Study|Lost to Follow-up|2|||
146046632|NCT01574651|526682303|FG001|Overall Study|Lost to Follow-up|4|||
146046633|NCT01574651|526682302|FG000|Overall Study|Administrative problems|0|||
146046634|NCT01574651|526682303|FG001|Overall Study|Administrative problems|1|||
146255745|NCT00899379|527450568|FG003|Overall Study|No Attack Pretreatment|6|||
146255746|NCT00899379|527450569|FG004|Overall Study|No Attack Pretreatment|4|||
146255747|NCT00899379|527450565|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146255748|NCT00899379|527450566|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255749|NCT00899379|527450567|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255750|NCT00899379|527450568|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255751|NCT00899379|527450569|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146255752|NCT00899379|527450565|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
146255753|NCT00899379|527450566|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
146255754|NCT00899379|527450567|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
146255755|NCT00899379|527450568|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
146255756|NCT00899379|527450569|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
146255757|NCT00498433|527450574|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
146255758|NCT00498433|527450575|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
146255759|NCT00498433|527450576|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
146255760|NCT00498433|527450574|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
146046635|NCT01574651|526682302|FG000|Overall Study|Death|3|||
146046636|NCT01574651|526682303|FG001|Overall Study|Death|3|||
146046637|NCT01574651|526682302|FG000|Overall Study|Patient's inability to use the device|0|||
146046638|NCT01574651|526682303|FG001|Overall Study|Patient's inability to use the device|1|||
146046639|NCT01574651|526682302|FG000|Overall Study|Adverse Event|36|||
146046640|NCT01574651|526682303|FG001|Overall Study|Adverse Event|27|||
146046641|NCT01574651|526682302|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146046642|NCT01574651|526682303|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146046643|NCT01574651|526682302|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146255761|NCT00498433|527450575|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
146255762|NCT00498433|527450576|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
146255763|NCT00498433|527450574|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
146255764|NCT00498433|527450575|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
146255765|NCT00498433|527450576|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
146255766|NCT00498433|527450574|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
146255767|NCT00498433|527450575|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
146255768|NCT00498433|527450576|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
146300857|NCT03346057|527617151|FG000|Overall Study|Lost to Follow-up|0|||
146046644|NCT01574651|526682303|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146046645|NCT01574651|526682302|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146046646|NCT01574651|526682303|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146046647|NCT01574651|526682302|FG000|Overall Study|Protocol Violation|3|||
146046648|NCT01574651|526682303|FG001|Overall Study|Protocol Violation|5|||
146046649|NCT01574651|526682302|FG000|Overall Study|Withdrawal by Subject|9|||
146046650|NCT01574651|526682303|FG001|Overall Study|Withdrawal by Subject|10|||
146046651|NCT03857542|526682304|FG000|Overall Study|Adverse Event|1|||
146046652|NCT03857542|526682305|FG001|Overall Study|Adverse Event|3|||
146046653|NCT03857542|526682304|FG000|Overall Study|Withdrawal by Subject|2|||
146046654|NCT03857542|526682305|FG001|Overall Study|Withdrawal by Subject|1|||
146046655|NCT03857542|526682304|FG000|Overall Study|Lost to Follow-up|2|||
146046656|NCT03857542|526682305|FG001|Overall Study|Lost to Follow-up|1|||
146046657|NCT03857542|526682304|FG000|Overall Study|Reason not Specified|1|||
146046658|NCT03857542|526682305|FG001|Overall Study|Reason not Specified|0|||
146046659|NCT01101035|526684074|FG000|Overall Study|Adverse Event|191|||
146046660|NCT01101035|526684075|FG001|Overall Study|Adverse Event|172|||
146046661|NCT01101035|526684074|FG000|Overall Study|Major Protocol Deviation|52|||
146046662|NCT01101035|526684075|FG001|Overall Study|Major Protocol Deviation|46|||
146046663|NCT01101035|526684074|FG000|Overall Study|Lost to Follow-up|226|||
146046664|NCT01101035|526684075|FG001|Overall Study|Lost to Follow-up|223|||
146046665|NCT01101035|526684074|FG000|Overall Study|Voluntary Withdrawal|595|||
146046666|NCT01101035|526684075|FG001|Overall Study|Voluntary Withdrawal|587|||
146046667|NCT01101035|526684074|FG000|Overall Study|Reason not Specified|333|||
146046668|NCT01101035|526684075|FG001|Overall Study|Reason not Specified|363|||
146046669|NCT02871635|526684076|FG000|Overall Study|Primary lack of efficacy|4|||
146046670|NCT02871635|526684077|FG001|Overall Study|Primary lack of efficacy|4|||
146046671|NCT02871635|526684076|FG000|Overall Study|Protocol Violation|3|||
146046672|NCT02871635|526684077|FG001|Overall Study|Protocol Violation|1|||
146046673|NCT02871635|526684076|FG000|Overall Study|Lost to Follow-up|1|||
146046674|NCT02871635|526684077|FG001|Overall Study|Lost to Follow-up|2|||
146046675|NCT02871635|526684076|FG000|Overall Study|Pregnancy|0|||
146046676|NCT02871635|526684077|FG001|Overall Study|Pregnancy|2|||
146046677|NCT02871635|526684076|FG000|Overall Study|Physician Decision|1|||
146046678|NCT02871635|526684077|FG001|Overall Study|Physician Decision|1|||
146046679|NCT02871635|526684076|FG000|Overall Study|Withdrawal by Subject|3|||
146046680|NCT02871635|526684077|FG001|Overall Study|Withdrawal by Subject|4|||
146046681|NCT02871635|526684076|FG000|Overall Study|Adverse Event|4|||
146046682|NCT02871635|526684077|FG001|Overall Study|Adverse Event|4|||
146046683|NCT02871635|526684076|FG000|Overall Study|Secondary lack of efficacy|2|||
146046684|NCT02871635|526684077|FG001|Overall Study|Secondary lack of efficacy|1|||
146046685|NCT00412893|526684080|FG000|Overall Study|Adverse Event|31|||
146046686|NCT00412893|526684081|FG001|Overall Study|Adverse Event|53|||
146046687|NCT00412893|526684080|FG000|Overall Study|Death|17|||
146046688|NCT00412893|526684081|FG001|Overall Study|Death|21|||
146046689|NCT00412893|526684080|FG000|Overall Study|Insufficient Therapeutic Response|39|||
146046690|NCT00412893|526684081|FG001|Overall Study|Insufficient Therapeutic Response|23|||
146046691|NCT00412893|526684080|FG000|Overall Study|Lost to Follow-up|2|||
146046692|NCT00412893|526684081|FG001|Overall Study|Lost to Follow-up|1|||
146046693|NCT00412893|526684080|FG000|Overall Study|Violation of Selection at Entry|17|||
146046694|NCT00412893|526684081|FG001|Overall Study|Violation of Selection at Entry|10|||
146046695|NCT00412893|526684080|FG000|Overall Study|Other Protocol Violation|10|||
146046696|NCT00412893|526684081|FG001|Overall Study|Other Protocol Violation|6|||
146046697|NCT00412893|526684080|FG000|Overall Study|Did Not Cooperate|12|||
146046698|NCT00412893|526684081|FG001|Overall Study|Did Not Cooperate|9|||
146046699|NCT00412893|526684080|FG000|Overall Study|Administrative Reason|12|||
146300858|NCT03346057|527617152|FG001|Overall Study|Lost to Follow-up|2|||
146300859|NCT03346057|527617153|FG002|Overall Study|Lost to Follow-up|1|||
146046700|NCT00412893|526684081|FG001|Overall Study|Administrative Reason|15|||
146046701|NCT00412893|526684080|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
146046702|NCT00412893|526684081|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
146046703|NCT01797263|526684085|FG000|Overall Study|Withdrawal by Subject|21|||
146046704|NCT01797263|526684086|FG001|Overall Study|Withdrawal by Subject|25|||
146046705|NCT01797263|526684085|FG000|Overall Study|Death|1|||
146046706|NCT01797263|526684086|FG001|Overall Study|Death|0|||
146046707|NCT01797263|526684085|FG000|Overall Study|Lost to Follow-up|15|||
146046708|NCT01797263|526684086|FG001|Overall Study|Lost to Follow-up|15|||
146102722|NCT01313312|526895303|FG000|Overall Study|Lack of Efficacy|3|||
146046709|NCT02342223|526684087|FG000|Overall Study|Lost to Follow-up|1|||
146046710|NCT04098809|526684090|FG000|Overall Study|Withdrawal by Subject|1|||
146046711|NCT04098809|526684091|FG001|Overall Study|Withdrawal by Subject|3|||
146046712|NCT04098809|526684090|FG000|Overall Study|Physician Decision|2|||
146046713|NCT04098809|526684091|FG001|Overall Study|Physician Decision|1|||
146046714|NCT01200368|526684092|FG000|Infant Series|Adverse Event|2|||
146046715|NCT01200368|526684093|FG001|Infant Series|Adverse Event|2|||
146046716|NCT01200368|526684094|FG002|Infant Series|Adverse Event|3|||
146046717|NCT01200368|526684092|FG000|Infant Series|Withdrawal by Subject|0|||
146046718|NCT01200368|526684093|FG001|Infant Series|Withdrawal by Subject|2|||
146046719|NCT01200368|526684094|FG002|Infant Series|Withdrawal by Subject|2|||
146046720|NCT01200368|526684092|FG000|Infant Series|Did not meet entrance criteria|0|||
146046721|NCT01200368|526684093|FG001|Infant Series|Did not meet entrance criteria|1|||
146046722|NCT01200368|526684094|FG002|Infant Series|Did not meet entrance criteria|0|||
146046723|NCT01200368|526684092|FG000|Infant Series|Randomized, not vaccinated|0|||
146046724|NCT01200368|526684093|FG001|Infant Series|Randomized, not vaccinated|1|||
146046725|NCT01200368|526684094|FG002|Infant Series|Randomized, not vaccinated|1|||
146046726|NCT01200368|526684092|FG000|Infant Series|Other|1|||
146046727|NCT01200368|526684093|FG001|Infant Series|Other|0|||
146046728|NCT01200368|526684094|FG002|Infant Series|Other|0|||
146046729|NCT01200368|526684092|FG000|After Infant Series|Adverse Event|6|||
146046730|NCT01200368|526684093|FG001|After Infant Series|Adverse Event|6|||
146046731|NCT01200368|526684094|FG002|After Infant Series|Adverse Event|3|||
146046732|NCT01200368|526684092|FG000|After Infant Series|Withdrawal by Subject|10|||
146046733|NCT01200368|526684093|FG001|After Infant Series|Withdrawal by Subject|8|||
146046734|NCT01200368|526684094|FG002|After Infant Series|Withdrawal by Subject|4|||
146046735|NCT01200368|526684092|FG000|After Infant Series|Lost to Follow-up|1|||
146046736|NCT01200368|526684093|FG001|After Infant Series|Lost to Follow-up|0|||
146046737|NCT01200368|526684094|FG002|After Infant Series|Lost to Follow-up|0|||
146046738|NCT01200368|526684092|FG000|After Infant Series|Other|1|||
146046739|NCT01200368|526684093|FG001|After Infant Series|Other|2|||
146046740|NCT01200368|526684094|FG002|After Infant Series|Other|2|||
146046741|NCT01200368|526684092|FG000|Toddler Dose|Adverse Event|0|||
146046742|NCT01200368|526684093|FG001|Toddler Dose|Adverse Event|3|||
146046743|NCT01200368|526684094|FG002|Toddler Dose|Adverse Event|1|||
146046744|NCT02741596|526684095|FG000|Overall Study|Adverse Event|1|||
146046745|NCT02741596|526684096|FG001|Overall Study|Adverse Event|5|||
146046746|NCT02741596|526684095|FG000|Overall Study|Lost to Follow-up|1|||
146046747|NCT02741596|526684096|FG001|Overall Study|Lost to Follow-up|1|||
146046748|NCT02741596|526684095|FG000|Overall Study|Physician Decision|2|||
146046749|NCT02741596|526684096|FG001|Overall Study|Physician Decision|1|||
146046750|NCT02741596|526684095|FG000|Overall Study|Pregnancy|3|||
146046751|NCT02741596|526684096|FG001|Overall Study|Pregnancy|1|||
146046752|NCT02741596|526684095|FG000|Overall Study|Other (Unspecified)|0|||
146046753|NCT02741596|526684096|FG001|Overall Study|Other (Unspecified)|3|||
146046754|NCT02741596|526684095|FG000|Overall Study|Subject withdrawn-Other|17|||
146046755|NCT02741596|526684096|FG001|Overall Study|Subject withdrawn-Other|4|||
146046756|NCT02741596|526684095|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
146046757|NCT02741596|526684096|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
146046758|NCT04854551|526684099|FG000|Overall Study|Withdrawal by Subject|1|||
146046759|NCT04854551|526684100|FG001|Overall Study|Withdrawal by Subject|1|||
146046760|NCT02859246|526684101|FG000|Overall Study|Screen fails|3|||
146046761|NCT02859246|526684101|FG000|Overall Study|Adverse Event|1|||
146046762|NCT02859246|526684101|FG000|Overall Study|Withdrawal by Subject|1|||
146046763|NCT05280717|526684102|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
146046764|NCT05280717|526684103|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
146046765|NCT05280717|526684104|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
146046766|NCT05280717|526684105|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146046767|NCT05280717|526684106|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146255769|NCT02581189|527450577|FG000|Overall Study|Failure to return|36|||
146255770|NCT02581189|527450577|FG000|Overall Study|Withdrew consent|5|||
146255771|NCT02581189|527450577|FG000|Overall Study|Death|3|||
146046768|NCT05280717|526684107|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146046769|NCT05280717|526684108|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
146046770|NCT05280717|526684102|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
146046771|NCT05280717|526684103|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146046772|NCT05280717|526684104|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146046773|NCT05280717|526684105|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146046774|NCT05280717|526684106|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146046775|NCT05280717|526684107|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146046776|NCT05280717|526684108|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
146255772|NCT02581189|527450577|FG000|Overall Study|Insufficient virological response|2|||
146255773|NCT02581189|527450577|FG000|Overall Study|Other, not specified|7|||
146255774|NCT02253147|527450578|FG000|Overall Study|Protocol Violation|30|||
146255775|NCT02253147|527450578|FG000|Overall Study|Did not consent to study extension|9|||
146046777|NCT05280717|526684102|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046778|NCT05280717|526684103|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
146046779|NCT05280717|526684104|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046780|NCT05280717|526684105|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046781|NCT05280717|526684106|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046782|NCT05280717|526684107|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046783|NCT05280717|526684108|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
146046784|NCT05280717|526684102|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046785|NCT05280717|526684103|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046786|NCT05280717|526684104|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
146046787|NCT05280717|526684105|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046788|NCT05280717|526684106|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046789|NCT05280717|526684107|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046790|NCT05280717|526684108|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
146046791|NCT05280717|526684102|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046792|NCT05280717|526684103|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046793|NCT05280717|526684104|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046794|NCT05280717|526684105|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046795|NCT05280717|526684106|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046796|NCT05280717|526684107|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
146046797|NCT05280717|526684108|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
146046798|NCT05280717|526684102|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046799|NCT05280717|526684103|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046800|NCT05280717|526684104|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046801|NCT05280717|526684105|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046802|NCT05280717|526684106|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046803|NCT05280717|526684107|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
146046804|NCT05280717|526684108|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
146046805|NCT00080301|526684109|FG000|Overall Study|Randomized but Never Treated|5|||
146046806|NCT00080301|526684110|FG001|Overall Study|Randomized but Never Treated|10|||
146046807|NCT00080301|526684109|FG000|Overall Study|Still on Treatment as of CSR date|0|||
146046808|NCT00080301|526684110|FG001|Overall Study|Still on Treatment as of CSR date|1|||
146046809|NCT00181766|526684111|FG000|Overall Study|Lost to Follow-up|6|||
146046810|NCT00181766|526684111|FG000|Overall Study|Adverse Event|4|||
146046811|NCT00181766|526684111|FG000|Overall Study|non-compliance|2|||
146046812|NCT00687804|526684112|FG000|Core Study|Adverse Event|5|||
146046813|NCT00687804|526684113|FG001|Core Study|Adverse Event|3|||
146046814|NCT00687804|526684114|FG002|Core Study|Adverse Event|3|||
146046815|NCT00687804|526684112|FG000|Core Study|Abnormal laboratory value(s)|1|||
146046816|NCT00687804|526684113|FG001|Core Study|Abnormal laboratory value(s)|0|||
146046817|NCT00687804|526684114|FG002|Core Study|Abnormal laboratory value(s)|0|||
146046818|NCT00687804|526684112|FG000|Core Study|Lack of Efficacy|1|||
146102723|NCT01313312|526895303|FG000|Overall Study|Investigator Decision|1|||
146102724|NCT01313312|526895303|FG000|Overall Study|Observational Phase|1|||
146102725|NCT01313312|526895303|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
146102726|NCT01313312|526895303|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
146102727|NCT04295772|526895304|FG000|Overall Study|Protocol Violation|1|||
146102728|NCT04295772|526895305|FG001|Overall Study|Protocol Violation|0|||
146102729|NCT04295772|526895304|FG000|Overall Study|Ongoing for safety monitoring|14|||
146102730|NCT04295772|526895305|FG001|Overall Study|Ongoing for safety monitoring|1|||
146102731|NCT04295772|526895304|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
146102732|NCT04295772|526895305|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
146102733|NCT02846324|526895306|FG000|Overall Study|Other|1|||
146102734|NCT02846324|526895307|FG001|Overall Study|Other|0|||
146102735|NCT02846324|526895308|FG002|Overall Study|Other|0|||
146102736|NCT02846324|526895309|FG003|Overall Study|Other|0|||
146102737|NCT02846324|526895306|FG000|Overall Study|Withdrawal by Subject|1|||
146046819|NCT00687804|526684113|FG001|Core Study|Lack of Efficacy|1|||
146102738|NCT02846324|526895307|FG001|Overall Study|Withdrawal by Subject|0|||
146102739|NCT02846324|526895308|FG002|Overall Study|Withdrawal by Subject|4|||
146102740|NCT02846324|526895309|FG003|Overall Study|Withdrawal by Subject|0|||
146102741|NCT02716805|526895317|FG000|Overall Study|Progressive disease|2|||
146102742|NCT02716805|526895318|FG001|Overall Study|Progressive disease|0|||
146102743|NCT02716805|526895319|FG002|Overall Study|Progressive disease|0|||
146102744|NCT02716805|526895320|FG003|Overall Study|Progressive disease|0|||
146102745|NCT00932126|526895321|FG000|Overall Study|Adverse Event|0|||
146102746|NCT00932126|526895322|FG001|Overall Study|Adverse Event|0|||
146102747|NCT00932126|526895323|FG002|Overall Study|Adverse Event|0|||
146102748|NCT00932126|526895324|FG003|Overall Study|Adverse Event|0|||
146102749|NCT00932126|526895325|FG004|Overall Study|Adverse Event|0|||
146102750|NCT00932126|526895326|FG005|Overall Study|Adverse Event|0|||
146102751|NCT00932126|526895327|FG006|Overall Study|Adverse Event|1|||
146102752|NCT00932126|526895328|FG007|Overall Study|Adverse Event|2|||
146102753|NCT00932126|526895321|FG000|Overall Study|Protocol Violation|0|||
146102754|NCT00932126|526895322|FG001|Overall Study|Protocol Violation|0|||
146102755|NCT00932126|526895323|FG002|Overall Study|Protocol Violation|0|||
146102756|NCT00932126|526895324|FG003|Overall Study|Protocol Violation|0|||
146102757|NCT00932126|526895325|FG004|Overall Study|Protocol Violation|1|||
146102758|NCT00932126|526895326|FG005|Overall Study|Protocol Violation|0|||
146102759|NCT00932126|526895327|FG006|Overall Study|Protocol Violation|0|||
146102760|NCT00932126|526895328|FG007|Overall Study|Protocol Violation|0|||
146102761|NCT00932126|526895321|FG000|Overall Study|Withdrawal by Subject|0|||
146102762|NCT00932126|526895322|FG001|Overall Study|Withdrawal by Subject|0|||
146102763|NCT00932126|526895323|FG002|Overall Study|Withdrawal by Subject|1|||
146102764|NCT00932126|526895324|FG003|Overall Study|Withdrawal by Subject|0|||
146102765|NCT00932126|526895325|FG004|Overall Study|Withdrawal by Subject|0|||
146102766|NCT00932126|526895326|FG005|Overall Study|Withdrawal by Subject|0|||
146102767|NCT00932126|526895327|FG006|Overall Study|Withdrawal by Subject|0|||
146102768|NCT00932126|526895328|FG007|Overall Study|Withdrawal by Subject|1|||
146102769|NCT00932126|526895321|FG000|Overall Study|Objective progression or relapse|3|||
146102770|NCT00932126|526895322|FG001|Overall Study|Objective progression or relapse|3|||
146102771|NCT00932126|526895323|FG002|Overall Study|Objective progression or relapse|2|||
146102772|NCT00932126|526895324|FG003|Overall Study|Objective progression or relapse|3|||
146102773|NCT00932126|526895325|FG004|Overall Study|Objective progression or relapse|3|||
146102774|NCT00932126|526895326|FG005|Overall Study|Objective progression or relapse|3|||
146102775|NCT00932126|526895327|FG006|Overall Study|Objective progression or relapse|3|||
146102776|NCT00932126|526895328|FG007|Overall Study|Objective progression or relapse|5|||
146102777|NCT00932126|526895321|FG000|Overall Study|Other|0|||
146102778|NCT00932126|526895322|FG001|Overall Study|Other|0|||
146102779|NCT00932126|526895323|FG002|Overall Study|Other|0|||
146102780|NCT00932126|526895324|FG003|Overall Study|Other|0|||
146102781|NCT00932126|526895325|FG004|Overall Study|Other|1|||
146102782|NCT00932126|526895326|FG005|Overall Study|Other|0|||
146102783|NCT00932126|526895327|FG006|Overall Study|Other|1|||
146102784|NCT00932126|526895328|FG007|Overall Study|Other|2|||
146102785|NCT00066365|526895329|FG000|Overall Study|Adverse Event|1|||
146102786|NCT00066365|526895330|FG001|Overall Study|Adverse Event|0|||
146102787|NCT00066365|526895329|FG000|Overall Study|Lack of Efficacy|15|||
146102788|NCT00066365|526895330|FG001|Overall Study|Lack of Efficacy|12|||
146102789|NCT00066365|526895329|FG000|Overall Study|Physician Decision|1|||
146102790|NCT00066365|526895330|FG001|Overall Study|Physician Decision|0|||
146102791|NCT00066365|526895329|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
146102792|NCT00066365|526895330|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
146102793|NCT00066365|526895329|FG000|Overall Study|Ineligible|4|||
146102794|NCT00066365|526895330|FG001|Overall Study|Ineligible|2|||
146102795|NCT04203797|526895333|FG000|Overall Study|Adverse Event|1|||
146102796|NCT04203797|526895334|FG001|Overall Study|Adverse Event|0|||
146102797|NCT04203797|526895333|FG000|Overall Study|Did not complete End of Study follow-up|1|||
146102798|NCT04203797|526895334|FG001|Overall Study|Did not complete End of Study follow-up|0|||
146046820|NCT00687804|526684114|FG002|Core Study|Lack of Efficacy|1|||
146046821|NCT00687804|526684112|FG000|Core Study|Withdrawal by Subject|4|||
146046822|NCT00687804|526684113|FG001|Core Study|Withdrawal by Subject|7|||
146046823|NCT00687804|526684114|FG002|Core Study|Withdrawal by Subject|7|||
146046824|NCT00687804|526684112|FG000|Core Study|Lost to Follow-up|0|||
146046825|NCT00687804|526684113|FG001|Core Study|Lost to Follow-up|1|||
146046826|NCT00687804|526684114|FG002|Core Study|Lost to Follow-up|0|||
146046827|NCT00687804|526684112|FG000|Core Study|Death|2|||
146046828|NCT00687804|526684113|FG001|Core Study|Death|2|||
146046829|NCT00687804|526684114|FG002|Core Study|Death|2|||
146046830|NCT00687804|526684112|FG000|Core Study|Protocol Violation|1|||
146046831|NCT00687804|526684113|FG001|Core Study|Protocol Violation|1|||
146046832|NCT00687804|526684114|FG002|Core Study|Protocol Violation|0|||
146046833|NCT00687804|526684112|FG000|Open-Label Extension Study|Adverse Event|2|||
146046834|NCT00687804|526684113|FG001|Open-Label Extension Study|Adverse Event|2|||
146102799|NCT03208127|526895336|FG000|Overall Study|Death|1|||
146102800|NCT00579098|526895337|FG000|Overall Study|Lost to Follow-up|2|||
146102801|NCT00579098|526895338|FG001|Overall Study|Lost to Follow-up|0|||
146102802|NCT00579098|526895337|FG000|Overall Study|Adverse Event|2|||
146102803|NCT00579098|526895338|FG001|Overall Study|Adverse Event|3|||
146102804|NCT00579098|526895337|FG000|Overall Study|Withdrawal by Subject|2|||
146102805|NCT00579098|526895338|FG001|Overall Study|Withdrawal by Subject|3|||
146102806|NCT00579098|526895337|FG000|Overall Study|AF returned after ablation|3|||
146046835|NCT00687804|526684114|FG002|Open-Label Extension Study|Adverse Event|2|||
146046836|NCT00687804|526684112|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
146102807|NCT00579098|526895338|FG001|Overall Study|AF returned after ablation|2|||
146102808|NCT01254331|526895339|FG000|Initial Phase|Adverse Event|3|||
146102809|NCT01254331|526895339|FG000|Initial Phase|Withdrawal by Subject|1|||
146102810|NCT01254331|526895339|FG000|Initial Phase|Pregnancy|1|||
146102811|NCT01254331|526895339|FG000|Extension Phase|Lack of Efficacy|1|||
146255776|NCT02253147|527450578|FG000|Overall Study|Conditional re-treatment at W52|5|||
146255777|NCT02253147|527450578|FG000|Overall Study|Lost to Follow-up|2|||
146046837|NCT00687804|526684113|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
146046838|NCT00687804|526684114|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
146046839|NCT00687804|526684112|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
146046840|NCT00687804|526684113|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
146046841|NCT00687804|526684114|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
146046842|NCT00687804|526684112|FG000|Open-Label Extension Study|Administrative problems|1|||
146046843|NCT00687804|526684113|FG001|Open-Label Extension Study|Administrative problems|1|||
146046844|NCT00687804|526684114|FG002|Open-Label Extension Study|Administrative problems|0|||
146046845|NCT00687804|526684112|FG000|Open-Label Extension Study|Death|2|||
146046846|NCT00687804|526684113|FG001|Open-Label Extension Study|Death|3|||
146046847|NCT00687804|526684114|FG002|Open-Label Extension Study|Death|3|||
146046848|NCT00413218|526684115|FG000|Overall Study|Randomized but didn't receive study drug|2|||
146046849|NCT00413218|526684116|FG001|Overall Study|Randomized but didn't receive study drug|8|||
146046850|NCT00413218|526684115|FG000|Overall Study|Death|57|||
146046851|NCT00413218|526684116|FG001|Overall Study|Death|56|||
146046852|NCT00413218|526684115|FG000|Overall Study|Lost to Follow-up|14|||
146046853|NCT00413218|526684116|FG001|Overall Study|Lost to Follow-up|17|||
146046854|NCT00413218|526684115|FG000|Overall Study|Admin|20|||
146046855|NCT00413218|526684116|FG001|Overall Study|Admin|14|||
146046856|NCT00413218|526684115|FG000|Overall Study|Missing|1|||
146046857|NCT00413218|526684116|FG001|Overall Study|Missing|0|||
146046858|NCT00413218|526684115|FG000|Overall Study|Withdrawal by Subject|9|||
146046859|NCT00413218|526684116|FG001|Overall Study|Withdrawal by Subject|1|||
146046860|NCT04034004|526684118|FG000|Overall Study|Withdrawal by Subject|1|||
146046861|NCT04034004|526684119|FG001|Overall Study|Withdrawal by Subject|2|||
146046862|NCT04034004|526684120|FG002|Overall Study|Withdrawal by Subject|2|||
146046863|NCT04034004|526684121|FG003|Overall Study|Withdrawal by Subject|3|||
146046864|NCT04034004|526684118|FG000|Overall Study|could not find vein to administer IV|2|||
146046865|NCT04034004|526684119|FG001|Overall Study|could not find vein to administer IV|1|||
146046866|NCT04034004|526684120|FG002|Overall Study|could not find vein to administer IV|0|||
146046867|NCT04034004|526684121|FG003|Overall Study|could not find vein to administer IV|0|||
146046868|NCT04034004|526684118|FG000|Overall Study|nurse accidentally unblinded subject|0|||
146046869|NCT04034004|526684119|FG001|Overall Study|nurse accidentally unblinded subject|0|||
146046870|NCT04034004|526684120|FG002|Overall Study|nurse accidentally unblinded subject|0|||
146046871|NCT04034004|526684121|FG003|Overall Study|nurse accidentally unblinded subject|1|||
146046872|NCT04317040|526684122|FG000|Overall Study|Lost to Follow-up|2|||
146046873|NCT04317040|526684123|FG001|Overall Study|Lost to Follow-up|0|||
146046874|NCT04317040|526684122|FG000|Overall Study|Death|16|||
146046875|NCT04317040|526684123|FG001|Overall Study|Death|18|||
146046876|NCT04317040|526684122|FG000|Overall Study|Withdrawal by Subject|0|||
146046877|NCT04317040|526684123|FG001|Overall Study|Withdrawal by Subject|1|||
146046878|NCT04317040|526684122|FG000|Overall Study|Incomplete assessments|0|||
146046879|NCT04317040|526684123|FG001|Overall Study|Incomplete assessments|1|||
146046880|NCT03672292|526684124|FG000|Overall Study|Adverse Event|3|||
146046881|NCT03672292|526684125|FG001|Overall Study|Adverse Event|1|||
146046882|NCT03672292|526684124|FG000|Overall Study|Physician Decision|0|||
146046883|NCT03672292|526684125|FG001|Overall Study|Physician Decision|1|||
146046884|NCT03672292|526684124|FG000|Overall Study|Withdrawal by Subject|1|||
146046885|NCT03672292|526684125|FG001|Overall Study|Withdrawal by Subject|2|||
146046886|NCT00799903|526684126|FG000|Overall Study|Investigator Site Closed|25|||
146046887|NCT00799903|526684127|FG001|Overall Study|Investigator Site Closed|23|||
146046888|NCT00799903|526684126|FG000|Overall Study|Withdrawal by Subject|179|||
146046889|NCT00799903|526684127|FG001|Overall Study|Withdrawal by Subject|175|||
146046890|NCT00799903|526684126|FG000|Overall Study|Lost to Follow-up|69|||
146046891|NCT00799903|526684127|FG001|Overall Study|Lost to Follow-up|80|||
146046892|NCT02518971|526684128|FG000|Overall Study|Lost to Follow-up|0|||
146046893|NCT02518971|526684129|FG001|Overall Study|Lost to Follow-up|1|||
146046894|NCT02518971|526684128|FG000|Overall Study|Physician Decision|6|||
146046895|NCT02518971|526684129|FG001|Overall Study|Physician Decision|6|||
146046896|NCT02518971|526684128|FG000|Overall Study|Protocol Violation|6|||
146102812|NCT01254331|526895339|FG000|Extension Phase|Lost to Follow-up|3|||
146255778|NCT02253147|527450578|FG000|Overall Study|Withdrawal by Subject|1|||
146255779|NCT00396097|527450581|FG000|Overall Study|Withdrawal by Subject|17|||
146046897|NCT02518971|526684129|FG001|Overall Study|Protocol Violation|4|||
146046898|NCT02518971|526684128|FG000|Overall Study|Withdrawal by Subject|4|||
146046899|NCT02518971|526684129|FG001|Overall Study|Withdrawal by Subject|5|||
146046900|NCT02518971|526684128|FG000|Overall Study|Side effects|1|||
146046901|NCT02518971|526684129|FG001|Overall Study|Side effects|0|||
146046902|NCT02518971|526684128|FG000|Overall Study|medication lost in mail|0|||
146102813|NCT00810355|526895344|FG000|Overall Study|Lost to Follow-up|13|||
146046903|NCT02518971|526684129|FG001|Overall Study|medication lost in mail|1|||
146046904|NCT02518971|526684128|FG000|Overall Study|eligibility criteria no longer met|6|||
146046905|NCT02518971|526684129|FG001|Overall Study|eligibility criteria no longer met|3|||
146046906|NCT03088917|526684130|FG000|Overall Study|In care/cured elsewhere|15|||
146046907|NCT03088917|526684130|FG000|Overall Study|Refuse re-evaluation|13|||
146046908|NCT03088917|526684130|FG000|Overall Study|Contact not established|13|||
146046909|NCT03088917|526684130|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
146046910|NCT03088917|526684130|FG000|Overall Study|Moved outside study region|50|||
146046911|NCT00757237|526684131|FG000|Overall Study|Lost to Follow-up|0|||
146046912|NCT00757237|526684132|FG001|Overall Study|Lost to Follow-up|1|||
146046913|NCT00757237|526684131|FG000|Overall Study|Protocol Violation|0|||
146046914|NCT00757237|526684132|FG001|Overall Study|Protocol Violation|2|||
146046915|NCT00757237|526684131|FG000|Overall Study|Physician Decision|2|||
146046916|NCT00757237|526684132|FG001|Overall Study|Physician Decision|3|||
146046917|NCT00757237|526684131|FG000|Overall Study|Withdrawal by Subject|8|||
146046918|NCT00757237|526684132|FG001|Overall Study|Withdrawal by Subject|12|||
146046919|NCT00757237|526684131|FG000|Overall Study|Safety or Tolerability|3|||
146046920|NCT00757237|526684132|FG001|Overall Study|Safety or Tolerability|5|||
146046921|NCT00757237|526684131|FG000|Overall Study|Other|0|||
146046922|NCT00757237|526684132|FG001|Overall Study|Other|2|||
146046923|NCT05150990|526684139|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
146046924|NCT05150990|526684140|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
146046925|NCT05150990|526684139|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
146046926|NCT05150990|526684140|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
146046927|NCT05150990|526684139|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
146046928|NCT05150990|526684140|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
146046929|NCT05150990|526684139|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
146046930|NCT05150990|526684140|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
146046931|NCT05150990|526684139|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
146046932|NCT05150990|526684140|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
146046933|NCT05150990|526684139|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
146046934|NCT05150990|526684140|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
146046935|NCT05150990|526684139|FG000|Overall Study|Death (unrelated to the intervention)|1|||
146046936|NCT05150990|526684140|FG001|Overall Study|Death (unrelated to the intervention)|2|||
146046937|NCT00779025|526684141|FG000|Overall Study|Withdrawal by Subject|1|||
146046938|NCT02735343|526684164|FG000|Overall Study|screen fail|0|||
146046939|NCT02735343|526684165|FG001|Overall Study|screen fail|2|||
146046940|NCT02715609|526684175|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
146046941|NCT02715609|526684176|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
146046942|NCT02715609|526684177|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
146046943|NCT02715609|526684175|FG000|Overall Study|Withdrawal by Subject|0|||
146046944|NCT02715609|526684176|FG001|Overall Study|Withdrawal by Subject|0|||
146046945|NCT02715609|526684177|FG002|Overall Study|Withdrawal by Subject|1|||
146046946|NCT00310817|526684178|FG000|Overall Study|AE or Death|3|||
146046947|NCT00310817|526684179|FG001|Overall Study|AE or Death|1|||
146046948|NCT00310817|526684180|FG002|Overall Study|AE or Death|0|||
146046949|NCT00310817|526684181|FG003|Overall Study|AE or Death|0|||
146046950|NCT00310817|526684178|FG000|Overall Study|Withdrawal by Subject|1|||
146046951|NCT00310817|526684179|FG001|Overall Study|Withdrawal by Subject|4|||
146046952|NCT00310817|526684180|FG002|Overall Study|Withdrawal by Subject|6|||
146046953|NCT00310817|526684181|FG003|Overall Study|Withdrawal by Subject|7|||
146046954|NCT00310817|526684178|FG000|Overall Study|Lost to Follow-up|2|||
146046955|NCT00310817|526684179|FG001|Overall Study|Lost to Follow-up|1|||
146046956|NCT00310817|526684180|FG002|Overall Study|Lost to Follow-up|0|||
146046957|NCT00310817|526684181|FG003|Overall Study|Lost to Follow-up|0|||
146046958|NCT00310817|526684178|FG000|Overall Study|Inappropriate Enrollment|1|||
146046959|NCT00310817|526684179|FG001|Overall Study|Inappropriate Enrollment|0|||
146046960|NCT00310817|526684180|FG002|Overall Study|Inappropriate Enrollment|1|||
146046961|NCT00310817|526684181|FG003|Overall Study|Inappropriate Enrollment|0|||
146046962|NCT00310817|526684178|FG000|Overall Study|Protocol Violation|1|||
146046963|NCT00310817|526684179|FG001|Overall Study|Protocol Violation|1|||
146046964|NCT00310817|526684180|FG002|Overall Study|Protocol Violation|1|||
146046965|NCT00310817|526684181|FG003|Overall Study|Protocol Violation|1|||
146046966|NCT00310817|526684178|FG000|Overall Study|Unable to classify|3|||
146046967|NCT00310817|526684179|FG001|Overall Study|Unable to classify|1|||
146046968|NCT00310817|526684180|FG002|Overall Study|Unable to classify|0|||
146046969|NCT00310817|526684181|FG003|Overall Study|Unable to classify|0|||
146046970|NCT02915978|526684184|FG000|Overall Study|Adverse Event|2|||
146046971|NCT02915978|526684185|FG001|Overall Study|Adverse Event|1|||
146046972|NCT02915978|526684186|FG002|Overall Study|Adverse Event|0|||
146046973|NCT00548145|526684190|FG000|Overall Study|Death|0|||
146046974|NCT00548145|526684191|FG001|Overall Study|Death|1|||
146046975|NCT00548145|526684190|FG000|Overall Study|Withdrawal by Subject|0|||
146046976|NCT00548145|526684191|FG001|Overall Study|Withdrawal by Subject|2|||
146046977|NCT00548145|526684190|FG000|Overall Study|Physician Decision|1|||
146046978|NCT00548145|526684191|FG001|Overall Study|Physician Decision|1|||
146046979|NCT00874848|526684192|FG000|Overall Study|Adverse Event|13|||
146046980|NCT00874848|526684193|FG001|Overall Study|Adverse Event|2|||
146046981|NCT00874848|526684192|FG000|Overall Study|Progressive neoplastic disease|38|||
146046982|NCT00874848|526684193|FG001|Overall Study|Progressive neoplastic disease|18|||
146046983|NCT00874848|526684192|FG000|Overall Study|Withdrawal by Subject|7|||
146046984|NCT00874848|526684193|FG001|Overall Study|Withdrawal by Subject|4|||
146046985|NCT00874848|526684192|FG000|Overall Study|Noncompliance|1|||
146046986|NCT00874848|526684193|FG001|Overall Study|Noncompliance|1|||
146046987|NCT00874848|526684192|FG000|Overall Study|Failure to comply with protocol|0|||
146046988|NCT00874848|526684193|FG001|Overall Study|Failure to comply with protocol|1|||
146046989|NCT00874848|526684192|FG000|Overall Study|Physician Decision|0|||
146046990|NCT00874848|526684193|FG001|Overall Study|Physician Decision|2|||
146046991|NCT04522141|526684198|FG000|Overall Study|Withdrawal by Subject|1|||
146046992|NCT04522141|526684199|FG001|Overall Study|Withdrawal by Subject|0|||
146046993|NCT03052049|526684200|FG000|Overall Study|Withdrawal by Subject|2|||
146046994|NCT00999518|526684204|FG000|Overall Study|Adverse Event|1|||
146046995|NCT00999518|526684205|FG001|Overall Study|Adverse Event|6|||
146046996|NCT00999518|526684206|FG002|Overall Study|Adverse Event|3|||
146046997|NCT00999518|526684207|FG003|Overall Study|Adverse Event|1|||
146046998|NCT00999518|526684208|FG004|Overall Study|Adverse Event|2|||
146046999|NCT00999518|526684204|FG000|Overall Study|Lack of Efficacy|2|||
146047000|NCT00999518|526684205|FG001|Overall Study|Lack of Efficacy|0|||
146047001|NCT00999518|526684206|FG002|Overall Study|Lack of Efficacy|0|||
146047002|NCT00999518|526684207|FG003|Overall Study|Lack of Efficacy|2|||
146047003|NCT00999518|526684208|FG004|Overall Study|Lack of Efficacy|2|||
146047004|NCT00999518|526684204|FG000|Overall Study|Lost to Follow-up|0|||
146047005|NCT00999518|526684205|FG001|Overall Study|Lost to Follow-up|0|||
146047006|NCT00999518|526684206|FG002|Overall Study|Lost to Follow-up|0|||
146047007|NCT00999518|526684207|FG003|Overall Study|Lost to Follow-up|4|||
146047008|NCT00999518|526684208|FG004|Overall Study|Lost to Follow-up|1|||
146047009|NCT00999518|526684204|FG000|Overall Study|Did not meet entrance criteria|0|||
146047010|NCT00999518|526684205|FG001|Overall Study|Did not meet entrance criteria|0|||
146047011|NCT00999518|526684206|FG002|Overall Study|Did not meet entrance criteria|0|||
146047012|NCT00999518|526684207|FG003|Overall Study|Did not meet entrance criteria|0|||
146047013|NCT00999518|526684208|FG004|Overall Study|Did not meet entrance criteria|1|||
146047014|NCT00999518|526684204|FG000|Overall Study|Study terminated by sponsor|10|||
146047015|NCT00999518|526684205|FG001|Overall Study|Study terminated by sponsor|6|||
146047016|NCT00999518|526684206|FG002|Overall Study|Study terminated by sponsor|5|||
146047017|NCT00999518|526684207|FG003|Overall Study|Study terminated by sponsor|5|||
146047018|NCT00999518|526684208|FG004|Overall Study|Study terminated by sponsor|9|||
146047019|NCT00999518|526684204|FG000|Overall Study|Pregnancy|0|||
146047020|NCT00999518|526684205|FG001|Overall Study|Pregnancy|0|||
146047021|NCT00999518|526684206|FG002|Overall Study|Pregnancy|1|||
146047022|NCT00999518|526684207|FG003|Overall Study|Pregnancy|0|||
146047023|NCT00999518|526684208|FG004|Overall Study|Pregnancy|0|||
146047024|NCT00999518|526684204|FG000|Overall Study|Protocol Violation|0|||
146047025|NCT00999518|526684205|FG001|Overall Study|Protocol Violation|1|||
146047026|NCT00999518|526684206|FG002|Overall Study|Protocol Violation|0|||
146047027|NCT00999518|526684207|FG003|Overall Study|Protocol Violation|0|||
146047028|NCT00999518|526684208|FG004|Overall Study|Protocol Violation|2|||
146047029|NCT00999518|526684204|FG000|Overall Study|Withdrawal by Subject|5|||
146047030|NCT00999518|526684205|FG001|Overall Study|Withdrawal by Subject|4|||
146047031|NCT00999518|526684206|FG002|Overall Study|Withdrawal by Subject|10|||
146047032|NCT00999518|526684207|FG003|Overall Study|Withdrawal by Subject|6|||
146047033|NCT00999518|526684208|FG004|Overall Study|Withdrawal by Subject|1|||
146047034|NCT00999518|526684204|FG000|Overall Study|Other|5|||
146047035|NCT00999518|526684205|FG001|Overall Study|Other|7|||
146047036|NCT00999518|526684206|FG002|Overall Study|Other|1|||
146047037|NCT00999518|526684207|FG003|Overall Study|Other|4|||
146047038|NCT00999518|526684208|FG004|Overall Study|Other|5|||
146047039|NCT00999518|526684204|FG000|Overall Study|Randomized but not Treated|1|||
146047040|NCT00999518|526684205|FG001|Overall Study|Randomized but not Treated|1|||
146047041|NCT00999518|526684206|FG002|Overall Study|Randomized but not Treated|2|||
146047042|NCT00999518|526684207|FG003|Overall Study|Randomized but not Treated|0|||
146047043|NCT00999518|526684208|FG004|Overall Study|Randomized but not Treated|1|||
146047044|NCT00250276|526684209|FG000|Overall Study|Serious Adverse Event|0|||
146047045|NCT00250276|526684210|FG001|Overall Study|Serious Adverse Event|0|||
146047046|NCT00250276|526684211|FG002|Overall Study|Serious Adverse Event|1|||
146047047|NCT00250276|526684212|FG003|Overall Study|Serious Adverse Event|0|||
146047048|NCT00250276|526684209|FG000|Overall Study|Non-serious Adverse Event|2|||
146047049|NCT00250276|526684210|FG001|Overall Study|Non-serious Adverse Event|0|||
146047050|NCT00250276|526684211|FG002|Overall Study|Non-serious Adverse Event|0|||
146047051|NCT00250276|526684212|FG003|Overall Study|Non-serious Adverse Event|2|||
146047052|NCT00250276|526684209|FG000|Overall Study|Protocol Violation|0|||
146047053|NCT00250276|526684210|FG001|Overall Study|Protocol Violation|1|||
146047054|NCT00250276|526684211|FG002|Overall Study|Protocol Violation|0|||
146047055|NCT00250276|526684212|FG003|Overall Study|Protocol Violation|0|||
146047056|NCT00250276|526684209|FG000|Overall Study|Withdrawal by Subject|1|||
146047057|NCT00250276|526684210|FG001|Overall Study|Withdrawal by Subject|2|||
146047058|NCT00250276|526684211|FG002|Overall Study|Withdrawal by Subject|3|||
146047059|NCT00250276|526684212|FG003|Overall Study|Withdrawal by Subject|2|||
146047060|NCT00250276|526684209|FG000|Overall Study|Migrated/moved from study area|3|||
146047061|NCT00250276|526684210|FG001|Overall Study|Migrated/moved from study area|0|||
146047062|NCT00250276|526684211|FG002|Overall Study|Migrated/moved from study area|2|||
146047063|NCT00250276|526684212|FG003|Overall Study|Migrated/moved from study area|7|||
146047064|NCT00250276|526684209|FG000|Overall Study|Lost to Follow-up|11|||
146047065|NCT00250276|526684210|FG001|Overall Study|Lost to Follow-up|18|||
146047066|NCT00250276|526684211|FG002|Overall Study|Lost to Follow-up|13|||
146047067|NCT00250276|526684212|FG003|Overall Study|Lost to Follow-up|8|||
146047068|NCT03543137|526684213|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
146047069|NCT03543137|526684214|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
146047070|NCT03543137|526684213|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
146047071|NCT03543137|526684214|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
146047072|NCT03543137|526684213|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
146047073|NCT03543137|526684214|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
146047074|NCT03887221|526684215|FG000|Overall Study|Protocol Violation|1|||
146047075|NCT03887221|526684216|FG001|Overall Study|Protocol Violation|0|||
146047076|NCT02487030|526684217|FG000|Overall Study|Lack of Efficacy|2|||
146047077|NCT02487030|526684218|FG001|Overall Study|Lack of Efficacy|4|||
146047078|NCT02487030|526684219|FG002|Overall Study|Lack of Efficacy|1|||
146047079|NCT02487030|526684220|FG003|Overall Study|Lack of Efficacy|0|||
146047080|NCT02487030|526684221|FG004|Overall Study|Lack of Efficacy|1|||
146047081|NCT02487030|526684222|FG005|Overall Study|Lack of Efficacy|0|||
146047082|NCT02487030|526684223|FG006|Overall Study|Lack of Efficacy|0|||
146047083|NCT02487030|526684217|FG000|Overall Study|Lost to Follow-up|0|||
146047084|NCT02487030|526684218|FG001|Overall Study|Lost to Follow-up|0|||
146047085|NCT02487030|526684219|FG002|Overall Study|Lost to Follow-up|1|||
146047086|NCT02487030|526684220|FG003|Overall Study|Lost to Follow-up|1|||
146047087|NCT02487030|526684221|FG004|Overall Study|Lost to Follow-up|0|||
146047088|NCT02487030|526684222|FG005|Overall Study|Lost to Follow-up|1|||
146047089|NCT02487030|526684223|FG006|Overall Study|Lost to Follow-up|0|||
146047090|NCT02487030|526684217|FG000|Overall Study|Adverse Event|0|||
146047091|NCT02487030|526684218|FG001|Overall Study|Adverse Event|0|||
146047092|NCT02487030|526684219|FG002|Overall Study|Adverse Event|0|||
146047093|NCT02487030|526684220|FG003|Overall Study|Adverse Event|1|||
146047094|NCT02487030|526684221|FG004|Overall Study|Adverse Event|0|||
146047095|NCT02487030|526684222|FG005|Overall Study|Adverse Event|0|||
146047096|NCT02487030|526684223|FG006|Overall Study|Adverse Event|0|||
146047097|NCT02487030|526684217|FG000|Overall Study|Death|0|||
146047098|NCT02487030|526684218|FG001|Overall Study|Death|0|||
146047099|NCT02487030|526684219|FG002|Overall Study|Death|0|||
146047100|NCT02487030|526684220|FG003|Overall Study|Death|0|||
146047101|NCT02487030|526684221|FG004|Overall Study|Death|1|||
146047102|NCT02487030|526684222|FG005|Overall Study|Death|0|||
146047103|NCT02487030|526684223|FG006|Overall Study|Death|0|||
146047104|NCT00947115|526684224|FG000|Overall Study|Missed reporting interval|3|||
146047105|NCT00947115|526684225|FG001|Overall Study|Missed reporting interval|4|||
146047106|NCT00947115|526684226|FG002|Overall Study|Missed reporting interval|2|||
146047107|NCT00947115|526684224|FG000|Overall Study|Physician Decision|0|||
146047108|NCT00947115|526684225|FG001|Overall Study|Physician Decision|2|||
146047109|NCT00947115|526684226|FG002|Overall Study|Physician Decision|0|||
146047110|NCT00947115|526684224|FG000|Overall Study|Death|0|||
146047111|NCT00947115|526684225|FG001|Overall Study|Death|1|||
146047112|NCT00947115|526684226|FG002|Overall Study|Death|1|||
146047113|NCT00947115|526684224|FG000|Overall Study|Migrated from study area|2|||
146047114|NCT00947115|526684225|FG001|Overall Study|Migrated from study area|0|||
146047115|NCT00947115|526684226|FG002|Overall Study|Migrated from study area|0|||
146047116|NCT00947115|526684224|FG000|Overall Study|Withdrawal by Subject|1|||
146047117|NCT00947115|526684225|FG001|Overall Study|Withdrawal by Subject|3|||
146047118|NCT00947115|526684226|FG002|Overall Study|Withdrawal by Subject|4|||
146047119|NCT00947115|526684224|FG000|Overall Study|Lost to Follow-up|11|||
146047120|NCT00947115|526684225|FG001|Overall Study|Lost to Follow-up|12|||
146047121|NCT00947115|526684226|FG002|Overall Study|Lost to Follow-up|8|||
146047122|NCT01594931|526686279|FG000|Overall Study|Adverse Event|3|||
146047123|NCT01594931|526686280|FG001|Overall Study|Adverse Event|1|||
146047124|NCT01594931|526686281|FG002|Overall Study|Adverse Event|1|||
146047125|NCT01594931|526686279|FG000|Overall Study|Withdrawal by Subject|2|||
146047126|NCT01594931|526686280|FG001|Overall Study|Withdrawal by Subject|1|||
146047127|NCT01594931|526686281|FG002|Overall Study|Withdrawal by Subject|1|||
146047128|NCT01594931|526686279|FG000|Overall Study|Lack of Efficacy|7|||
146047129|NCT01594931|526686280|FG001|Overall Study|Lack of Efficacy|2|||
146047130|NCT01594931|526686281|FG002|Overall Study|Lack of Efficacy|2|||
146047131|NCT01594931|526686279|FG000|Overall Study|Lost to Follow-up|4|||
146047132|NCT01594931|526686280|FG001|Overall Study|Lost to Follow-up|3|||
146047133|NCT01594931|526686281|FG002|Overall Study|Lost to Follow-up|3|||
146047134|NCT01594931|526686279|FG000|Overall Study|Protocol Violation|2|||
146047135|NCT01594931|526686280|FG001|Overall Study|Protocol Violation|1|||
146047136|NCT01594931|526686281|FG002|Overall Study|Protocol Violation|0|||
146047137|NCT01594931|526686279|FG000|Overall Study|No defiined|11|||
146047138|NCT01594931|526686280|FG001|Overall Study|No defiined|4|||
146047139|NCT01594931|526686281|FG002|Overall Study|No defiined|7|||
146047140|NCT04864639|526686283|FG000|Overall Study|Death|1|||
146047141|NCT04864639|526686283|FG000|Overall Study|Lost to Follow-up|1|||
146047142|NCT01478971|526686290|FG000|Standard of Care Period|Adverse Event|1|||
146047143|NCT01478971|526686290|FG000|Standard of Care Period|Withdrawal by Subject|3|||
146047144|NCT01478971|526686290|FG000|Standard of Care Period|Death|8|||
146047145|NCT01478971|526686290|FG000|Standard of Care Period|Lost to Follow-up|9|||
146047146|NCT01478971|526686290|FG000|Standard of Care Period|Other|4|||
146047147|NCT01478971|526686290|FG000|Peginesatide Treatment Period|Adverse Event|1|||
146047148|NCT01478971|526686290|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
146047149|NCT01478971|526686290|FG000|Peginesatide Treatment Period|Death|4|||
146047150|NCT01478971|526686290|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
146047151|NCT01478971|526686290|FG000|Peginesatide Treatment Period|Other|4|||
146047152|NCT01525615|526686291|FG000|Overall Study|Adverse Event|11|||
146047153|NCT01525615|526686292|FG001|Overall Study|Adverse Event|7|||
146047154|NCT01525615|526686293|FG002|Overall Study|Adverse Event|5|||
146047155|NCT01525615|526686291|FG000|Overall Study|Lost to Follow-up|1|||
146047156|NCT01525615|526686292|FG001|Overall Study|Lost to Follow-up|0|||
146047157|NCT01525615|526686293|FG002|Overall Study|Lost to Follow-up|0|||
146047158|NCT01525615|526686291|FG000|Overall Study|Withdrawal by Subject|1|||
146047159|NCT01525615|526686292|FG001|Overall Study|Withdrawal by Subject|0|||
146047160|NCT01525615|526686293|FG002|Overall Study|Withdrawal by Subject|0|||
146047161|NCT01525615|526686291|FG000|Overall Study|Other reason not described above|1|||
146047162|NCT01525615|526686292|FG001|Overall Study|Other reason not described above|0|||
146047163|NCT01525615|526686293|FG002|Overall Study|Other reason not described above|1|||
146047164|NCT04050618|526686294|FG000|First Intervention|Withdrawal by Subject|2|||
146047165|NCT04050618|526686295|FG001|First Intervention|Withdrawal by Subject|0|||
146047166|NCT04050618|526686294|FG000|Second Intervention|Withdrawal by Subject|1|||
146047167|NCT04050618|526686295|FG001|Second Intervention|Withdrawal by Subject|0|||
146047168|NCT02451943|526686305|FG000|Overall Study|Withdrawal by Subject|13|||
146047169|NCT02451943|526686306|FG001|Overall Study|Withdrawal by Subject|16|||
146047170|NCT02451943|526686305|FG000|Overall Study|Lost to Follow-up|3|||
146047171|NCT02451943|526686306|FG001|Overall Study|Lost to Follow-up|4|||
146047172|NCT02451943|526686305|FG000|Overall Study|Sponsor Decision|0|||
146047173|NCT02451943|526686306|FG001|Overall Study|Sponsor Decision|4|||
146047174|NCT00217425|526686309|FG000|Overall Study|Never started treatment|2|||
146047175|NCT00217425|526686309|FG000|Overall Study|Patient ineligible|5|||
146047176|NCT00217425|526686309|FG000|Overall Study|Lack of Efficacy|13|||
146047177|NCT00217425|526686309|FG000|Overall Study|Adverse Event|8|||
146047178|NCT00217425|526686309|FG000|Overall Study|Withdrawal by Subject|4|||
146047179|NCT00217425|526686309|FG000|Overall Study|Other complicating disease|1|||
146047180|NCT00217425|526686309|FG000|Overall Study|Other|4|||
146047181|NCT03951077|526686310|FG000|Overall Study|Adverse Event|1|||
146047182|NCT03951077|526686311|FG001|Overall Study|Adverse Event|0|||
146047183|NCT03951077|526686312|FG002|Overall Study|Adverse Event|0|||
146047184|NCT03951077|526686313|FG003|Overall Study|Adverse Event|0|||
146047185|NCT03951077|526686314|FG004|Overall Study|Adverse Event|0|||
146047186|NCT03951077|526686315|FG005|Overall Study|Adverse Event|0|||
146047187|NCT03951077|526686310|FG000|Overall Study|Withdrawal by Subject|3|||
146047188|NCT03951077|526686311|FG001|Overall Study|Withdrawal by Subject|3|||
146047189|NCT03951077|526686312|FG002|Overall Study|Withdrawal by Subject|0|||
146047190|NCT03951077|526686313|FG003|Overall Study|Withdrawal by Subject|3|||
146047191|NCT03951077|526686314|FG004|Overall Study|Withdrawal by Subject|3|||
146047192|NCT03951077|526686315|FG005|Overall Study|Withdrawal by Subject|2|||
146047193|NCT03951077|526686310|FG000|Overall Study|Lost to Follow-up|1|||
146047194|NCT03951077|526686311|FG001|Overall Study|Lost to Follow-up|1|||
146047195|NCT03951077|526686312|FG002|Overall Study|Lost to Follow-up|2|||
146047196|NCT03951077|526686313|FG003|Overall Study|Lost to Follow-up|3|||
146047197|NCT03951077|526686314|FG004|Overall Study|Lost to Follow-up|2|||
146047198|NCT03951077|526686315|FG005|Overall Study|Lost to Follow-up|3|||
146047199|NCT03951077|526686310|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
146255780|NCT00396097|527450582|FG001|Overall Study|Withdrawal by Subject|17|||
146047200|NCT03951077|526686311|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
146255781|NCT00396097|527450581|FG000|Overall Study|Lost to Follow-up|4|||
146255782|NCT00396097|527450582|FG001|Overall Study|Lost to Follow-up|9|||
146047201|NCT03951077|526686312|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
146047202|NCT03951077|526686313|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
146047203|NCT03951077|526686314|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
146047204|NCT03951077|526686315|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
146047205|NCT03951077|526686310|FG000|Overall Study|Other, Not Specified|12|||
146047206|NCT03951077|526686311|FG001|Overall Study|Other, Not Specified|10|||
146047207|NCT03951077|526686312|FG002|Overall Study|Other, Not Specified|10|||
146047208|NCT03951077|526686313|FG003|Overall Study|Other, Not Specified|5|||
146047209|NCT03951077|526686314|FG004|Overall Study|Other, Not Specified|9|||
146047210|NCT03951077|526686315|FG005|Overall Study|Other, Not Specified|6|||
146047211|NCT03951077|526686310|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
146047212|NCT03951077|526686311|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
146047213|NCT03951077|526686312|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
146047214|NCT03951077|526686313|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
146047215|NCT03951077|526686314|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
146047216|NCT03951077|526686315|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
146047217|NCT01473732|526686317|FG000|Overall Study|Adverse Event|1|||
146047218|NCT01473732|526686318|FG001|Overall Study|Adverse Event|0|||
146047219|NCT01473732|526686317|FG000|Overall Study|Death|1|||
146047220|NCT01473732|526686318|FG001|Overall Study|Death|0|||
146047221|NCT01395901|526686319|FG000|Overall Study|Lost to Follow-up|4|||
146047222|NCT01395901|526686320|FG001|Overall Study|Lost to Follow-up|0|||
146047223|NCT01395901|526686319|FG000|Overall Study|Randomized but not received study drug|5|||
146047224|NCT01395901|526686320|FG001|Overall Study|Randomized but not received study drug|4|||
146047225|NCT01395901|526686319|FG000|Overall Study|Adverse Event|0|||
146047226|NCT01395901|526686320|FG001|Overall Study|Adverse Event|1|||
146047227|NCT01395901|526686319|FG000|Overall Study|Withdrawal of consent|1|||
146047228|NCT01395901|526686320|FG001|Overall Study|Withdrawal of consent|0|||
146047229|NCT03579940|526686324|FG000|Period 2|Withdrawal by Subject|0|||
146047230|NCT03579940|526686325|FG001|Period 2|Withdrawal by Subject|0|||
146047231|NCT03579940|526686326|FG002|Period 2|Withdrawal by Subject|1|||
146047232|NCT03579940|526686327|FG003|Period 2|Withdrawal by Subject|0|||
146047233|NCT03579940|526686328|FG004|Period 2|Withdrawal by Subject|0|||
146047234|NCT03579940|526686329|FG005|Period 2|Withdrawal by Subject|0|||
146047235|NCT03579940|526686330|FG006|Period 2|Withdrawal by Subject|0|||
146047236|NCT03579940|526686331|FG007|Period 2|Withdrawal by Subject|0|||
146047237|NCT03579940|526686332|FG008|Period 2|Withdrawal by Subject|0|||
146047238|NCT03579940|526686333|FG009|Period 2|Withdrawal by Subject|0|||
146047239|NCT03579940|526686334|FG010|Period 2|Withdrawal by Subject|0|||
146047240|NCT01217944|526686335|FG000|Overall Study|Protocol Violation|1|||
146047241|NCT01217944|526686336|FG001|Overall Study|Protocol Violation|1|||
146047242|NCT01217944|526686337|FG002|Overall Study|Protocol Violation|0|||
146047243|NCT01217944|526686335|FG000|Overall Study|Lost to Follow-up|3|||
146047244|NCT01217944|526686336|FG001|Overall Study|Lost to Follow-up|1|||
146047245|NCT01217944|526686337|FG002|Overall Study|Lost to Follow-up|0|||
146047246|NCT01217944|526686335|FG000|Overall Study|Withdrawal by Subject|1|||
146047247|NCT01217944|526686336|FG001|Overall Study|Withdrawal by Subject|2|||
146047248|NCT01217944|526686337|FG002|Overall Study|Withdrawal by Subject|0|||
146047249|NCT01217944|526686335|FG000|Overall Study|Lack of Efficacy|1|||
146047250|NCT01217944|526686336|FG001|Overall Study|Lack of Efficacy|0|||
146047251|NCT01217944|526686337|FG002|Overall Study|Lack of Efficacy|0|||
146047252|NCT00671034|526686338|FG000|Overall Study|Adverse Event|5|||
146047253|NCT00671034|526686339|FG001|Overall Study|Adverse Event|7|||
146047254|NCT00671034|526686340|FG002|Overall Study|Adverse Event|1|||
146047255|NCT00671034|526686338|FG000|Overall Study|Death|3|||
146047256|NCT00671034|526686339|FG001|Overall Study|Death|2|||
146047257|NCT00671034|526686340|FG002|Overall Study|Death|1|||
146047258|NCT00671034|526686338|FG000|Overall Study|Physician Decision|12|||
146047259|NCT00671034|526686339|FG001|Overall Study|Physician Decision|4|||
146047260|NCT00671034|526686340|FG002|Overall Study|Physician Decision|5|||
146047261|NCT00671034|526686338|FG000|Overall Study|VHR ALL feature|8|||
146047262|NCT00671034|526686339|FG001|Overall Study|VHR ALL feature|3|||
146047263|NCT00671034|526686340|FG002|Overall Study|VHR ALL feature|5|||
146047264|NCT00671034|526686338|FG000|Overall Study|Refusal|5|||
146047265|NCT00671034|526686339|FG001|Overall Study|Refusal|3|||
146047266|NCT00671034|526686340|FG002|Overall Study|Refusal|5|||
146047267|NCT00671034|526686338|FG000|Overall Study|includes Alternative therapy, etc.|6|||
146047268|NCT00671034|526686339|FG001|Overall Study|includes Alternative therapy, etc.|1|||
146047269|NCT00671034|526686340|FG002|Overall Study|includes Alternative therapy, etc.|7|||
146047270|NCT00853151|526686341|FG000|Overall Study|Adverse Event|1|||
146047271|NCT00853151|526686342|FG001|Overall Study|Adverse Event|4|||
146047272|NCT00853151|526686343|FG002|Overall Study|Adverse Event|2|||
146047273|NCT00853151|526686344|FG003|Overall Study|Adverse Event|0|||
146047274|NCT00853151|526686341|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
146047275|NCT00853151|526686342|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146047276|NCT00853151|526686343|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146047277|NCT00853151|526686344|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146047278|NCT00853151|526686341|FG000|Overall Study|Lost to Follow-up|2|||
146047279|NCT00853151|526686342|FG001|Overall Study|Lost to Follow-up|0|||
146047280|NCT00853151|526686343|FG002|Overall Study|Lost to Follow-up|3|||
146047281|NCT00853151|526686344|FG003|Overall Study|Lost to Follow-up|0|||
146047282|NCT00853151|526686341|FG000|Overall Study|Death|1|||
146047283|NCT00853151|526686342|FG001|Overall Study|Death|0|||
146047284|NCT00853151|526686343|FG002|Overall Study|Death|0|||
146047285|NCT00853151|526686344|FG003|Overall Study|Death|1|||
146047286|NCT00853151|526686341|FG000|Overall Study|Protocol Violation|0|||
146047287|NCT00853151|526686342|FG001|Overall Study|Protocol Violation|0|||
146047288|NCT00853151|526686343|FG002|Overall Study|Protocol Violation|0|||
146047289|NCT00853151|526686344|FG003|Overall Study|Protocol Violation|1|||
146047290|NCT00853151|526686341|FG000|Overall Study|Withdrawal by Subject|5|||
146047291|NCT00853151|526686342|FG001|Overall Study|Withdrawal by Subject|4|||
146047292|NCT00853151|526686343|FG002|Overall Study|Withdrawal by Subject|2|||
146047293|NCT00853151|526686344|FG003|Overall Study|Withdrawal by Subject|1|||
146047294|NCT00853151|526686341|FG000|Overall Study|Physician Decision|0|||
146047295|NCT00853151|526686342|FG001|Overall Study|Physician Decision|2|||
146047296|NCT00853151|526686343|FG002|Overall Study|Physician Decision|1|||
146047297|NCT00853151|526686344|FG003|Overall Study|Physician Decision|0|||
146047298|NCT00853151|526686341|FG000|Overall Study|Sponsor Decision|0|||
146047299|NCT00853151|526686342|FG001|Overall Study|Sponsor Decision|3|||
146047300|NCT00853151|526686343|FG002|Overall Study|Sponsor Decision|0|||
146047301|NCT00853151|526686344|FG003|Overall Study|Sponsor Decision|0|||
146047302|NCT00713544|526686345|FG000|Overall Study|Adverse Event|5|||
146047303|NCT00713544|526686346|FG001|Overall Study|Adverse Event|3|||
146047304|NCT00713544|526686347|FG002|Overall Study|Adverse Event|7|||
146047305|NCT00713544|526686348|FG003|Overall Study|Adverse Event|7|||
146047306|NCT00713544|526686349|FG004|Overall Study|Adverse Event|3|||
146047307|NCT00713544|526686350|FG005|Overall Study|Adverse Event|5|||
146047308|NCT00713544|526686345|FG000|Overall Study|Withdrawal by Subject|2|||
146047309|NCT00713544|526686346|FG001|Overall Study|Withdrawal by Subject|0|||
146047310|NCT00713544|526686347|FG002|Overall Study|Withdrawal by Subject|3|||
146047311|NCT00713544|526686348|FG003|Overall Study|Withdrawal by Subject|2|||
146047312|NCT00713544|526686349|FG004|Overall Study|Withdrawal by Subject|3|||
146047313|NCT00713544|526686350|FG005|Overall Study|Withdrawal by Subject|1|||
146047314|NCT00713544|526686345|FG000|Overall Study|Protocol Violation|0|||
146047315|NCT00713544|526686346|FG001|Overall Study|Protocol Violation|0|||
146047316|NCT00713544|526686347|FG002|Overall Study|Protocol Violation|0|||
146047317|NCT00713544|526686348|FG003|Overall Study|Protocol Violation|0|||
146047318|NCT00713544|526686349|FG004|Overall Study|Protocol Violation|0|||
146047319|NCT00713544|526686350|FG005|Overall Study|Protocol Violation|1|||
146047320|NCT00713544|526686345|FG000|Overall Study|Physician Decision|0|||
146047321|NCT00713544|526686346|FG001|Overall Study|Physician Decision|0|||
146047322|NCT00713544|526686347|FG002|Overall Study|Physician Decision|0|||
146047323|NCT00713544|526686348|FG003|Overall Study|Physician Decision|0|||
146047324|NCT00713544|526686349|FG004|Overall Study|Physician Decision|0|||
146047325|NCT00713544|526686350|FG005|Overall Study|Physician Decision|2|||
146047326|NCT00713544|526686345|FG000|Overall Study|Lack of Efficacy|0|||
146047327|NCT00713544|526686346|FG001|Overall Study|Lack of Efficacy|1|||
146047328|NCT00713544|526686347|FG002|Overall Study|Lack of Efficacy|0|||
146047329|NCT00713544|526686348|FG003|Overall Study|Lack of Efficacy|1|||
146047330|NCT00713544|526686349|FG004|Overall Study|Lack of Efficacy|1|||
146047331|NCT00713544|526686350|FG005|Overall Study|Lack of Efficacy|0|||
146047332|NCT00713544|526686345|FG000|Overall Study|Lost to Follow-up|0|||
146047333|NCT00713544|526686346|FG001|Overall Study|Lost to Follow-up|0|||
146047334|NCT00713544|526686347|FG002|Overall Study|Lost to Follow-up|1|||
146047335|NCT00713544|526686348|FG003|Overall Study|Lost to Follow-up|0|||
146047336|NCT00713544|526686349|FG004|Overall Study|Lost to Follow-up|0|||
146047337|NCT00713544|526686350|FG005|Overall Study|Lost to Follow-up|0|||
146047338|NCT00713544|526686345|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146047339|NCT00713544|526686346|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
146047340|NCT00713544|526686347|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146047341|NCT00713544|526686348|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146047342|NCT00713544|526686349|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146047343|NCT00713544|526686350|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
146047344|NCT00713544|526686345|FG000|Overall Study|Incorrect enrollment|0|||
146047345|NCT00713544|526686346|FG001|Overall Study|Incorrect enrollment|1|||
146047346|NCT00713544|526686347|FG002|Overall Study|Incorrect enrollment|0|||
146102814|NCT00810355|526895345|FG001|Overall Study|Lost to Follow-up|17|||
146102815|NCT00810355|526895346|FG002|Overall Study|Lost to Follow-up|11|||
146102816|NCT00810355|526895344|FG000|Overall Study|Withdrawal by Subject|1|||
146047347|NCT00713544|526686348|FG003|Overall Study|Incorrect enrollment|0|||
146047348|NCT00713544|526686349|FG004|Overall Study|Incorrect enrollment|0|||
146047349|NCT00713544|526686350|FG005|Overall Study|Incorrect enrollment|0|||
146047350|NCT00713544|526686345|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
146047351|NCT00713544|526686346|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
146047352|NCT00713544|526686347|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
146047353|NCT00713544|526686348|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
146047354|NCT00713544|526686349|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
146047355|NCT00713544|526686350|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
146047356|NCT02471014|526686353|FG000|Overall Study|Lost to Follow-up|2|||
146047357|NCT02471014|526686354|FG001|Overall Study|Lost to Follow-up|2|||
146102817|NCT00810355|526895345|FG001|Overall Study|Withdrawal by Subject|0|||
146047358|NCT02380287|526686355|FG000|Overall Study|Adverse Event|0|||
146047359|NCT02380287|526686356|FG001|Overall Study|Adverse Event|0|||
146047360|NCT02380287|526686357|FG002|Overall Study|Adverse Event|1|||
146047361|NCT02380287|526686358|FG003|Overall Study|Adverse Event|0|||
146047362|NCT02380287|526686359|FG004|Overall Study|Adverse Event|0|||
146047363|NCT02380287|526686360|FG005|Overall Study|Adverse Event|0|||
146047364|NCT02380287|526686361|FG006|Overall Study|Adverse Event|0|||
146047365|NCT02380287|526686362|FG007|Overall Study|Adverse Event|0|||
146047366|NCT01751984|526686363|FG000|Overall Study|Adverse Event|5|||
146047367|NCT01751984|526686364|FG001|Overall Study|Adverse Event|3|||
146047368|NCT01751984|526686363|FG000|Overall Study|Withdrawal by Subject|0|||
146047369|NCT01751984|526686364|FG001|Overall Study|Withdrawal by Subject|1|||
146047370|NCT01751984|526686363|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
146047371|NCT01751984|526686364|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
146047372|NCT04473963|526686365|FG000|Overall Study|Withdrawal by Subject|1|||
146047373|NCT04473963|526686366|FG001|Overall Study|Withdrawal by Subject|1|||
146047374|NCT04473963|526686367|FG002|Overall Study|Withdrawal by Subject|0|||
146047375|NCT04473963|526686365|FG000|Overall Study|Not inducible in AF|0|||
146047376|NCT04473963|526686366|FG001|Overall Study|Not inducible in AF|0|||
146047377|NCT04473963|526686367|FG002|Overall Study|Not inducible in AF|2|||
146047378|NCT01641601|526686368|FG000|Overall Study|Study discontinued.|3|||
146047379|NCT01641601|526686369|FG001|Overall Study|Study discontinued.|5|||
146047380|NCT00587158|526686370|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
146047381|NCT00587158|526686371|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
146047382|NCT00587158|526686370|FG000|Overall Study|Physician Decision|0|||
146047383|NCT00587158|526686371|FG001|Overall Study|Physician Decision|1|||
146047384|NCT00587158|526686370|FG000|Overall Study|Lost to Follow-up|1|||
146047385|NCT00587158|526686371|FG001|Overall Study|Lost to Follow-up|2|||
146047386|NCT00587158|526686370|FG000|Overall Study|Death|0|||
146047387|NCT00587158|526686371|FG001|Overall Study|Death|1|||
146047388|NCT00587158|526686370|FG000|Overall Study|Subject did not want to take study med|0|||
146047389|NCT00587158|526686371|FG001|Overall Study|Subject did not want to take study med|1|||
146047390|NCT04390243|526686375|FG000|Overall Study|Death|1|||
146047391|NCT04390243|526686375|FG000|Overall Study|Disease Progression|4|||
146047392|NCT04390243|526686375|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
146047393|NCT01196026|526686382|FG000|Overall Study|Withdrawal by Subject|1|||
146047394|NCT01196026|526686383|FG001|Overall Study|Withdrawal by Subject|4|||
146047395|NCT01196026|526686384|FG002|Overall Study|Withdrawal by Subject|0|||
146047396|NCT01196026|526686385|FG003|Overall Study|Withdrawal by Subject|0|||
146047397|NCT01196026|526686386|FG004|Overall Study|Withdrawal by Subject|0|||
146047398|NCT01196026|526686387|FG005|Overall Study|Withdrawal by Subject|0|||
146047399|NCT01196026|526686382|FG000|Overall Study|Lost to Follow-up|0|||
146047400|NCT01196026|526686383|FG001|Overall Study|Lost to Follow-up|3|||
146047401|NCT01196026|526686384|FG002|Overall Study|Lost to Follow-up|0|||
146047402|NCT01196026|526686385|FG003|Overall Study|Lost to Follow-up|0|||
146047403|NCT01196026|526686386|FG004|Overall Study|Lost to Follow-up|1|||
146047404|NCT01196026|526686387|FG005|Overall Study|Lost to Follow-up|0|||
146047405|NCT01196026|526686382|FG000|Overall Study|Other|0|||
146047406|NCT01196026|526686383|FG001|Overall Study|Other|1|||
146047407|NCT01196026|526686384|FG002|Overall Study|Other|0|||
146047408|NCT01196026|526686385|FG003|Overall Study|Other|0|||
146047409|NCT01196026|526686386|FG004|Overall Study|Other|0|||
146047410|NCT01196026|526686387|FG005|Overall Study|Other|0|||
146047411|NCT01221350|526686391|FG000|Overall Study|Discontinued intervention (GERD)|1|||
146047412|NCT01221350|526686392|FG001|Overall Study|Discontinued intervention (GERD)|0|||
146047413|NCT01221350|526686391|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
146047414|NCT01221350|526686392|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
146047415|NCT01221350|526686391|FG000|Overall Study|Withdrawal by Subject|4|||
146047416|NCT01221350|526686392|FG001|Overall Study|Withdrawal by Subject|2|||
146047417|NCT05236257|526686395|FG000|Overall Study|Ongoing with study treatment|29|||
146047418|NCT05236257|526686396|FG001|Overall Study|Ongoing with study treatment|1|||
146047419|NCT05236257|526686395|FG000|Overall Study|Discontinued study treatment|22|||
146047420|NCT05236257|526686396|FG001|Overall Study|Discontinued study treatment|41|||
146047421|NCT04752332|526686397|FG000|Overall Study|Adverse Event|3|||
146047422|NCT04752332|526686398|FG001|Overall Study|Adverse Event|1|||
146047423|NCT04752332|526686397|FG000|Overall Study|Disease Relapse|1|||
146047424|NCT04752332|526686398|FG001|Overall Study|Disease Relapse|0|||
146047425|NCT04752332|526686397|FG000|Overall Study|Non-compliance With Study Drug|2|||
146047426|NCT04752332|526686398|FG001|Overall Study|Non-compliance With Study Drug|0|||
146047427|NCT04752332|526686397|FG000|Overall Study|Physician Decision|2|||
146102818|NCT00810355|526895346|FG002|Overall Study|Withdrawal by Subject|0|||
146047428|NCT04752332|526686398|FG001|Overall Study|Physician Decision|1|||
146047429|NCT04752332|526686397|FG000|Overall Study|Protocol Violation|1|||
146047430|NCT04752332|526686398|FG001|Overall Study|Protocol Violation|1|||
146047431|NCT04752332|526686397|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
146047432|NCT04752332|526686398|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
146047433|NCT04752332|526686397|FG000|Overall Study|Study Terminated by Sponsor|10|||
146047434|NCT04752332|526686398|FG001|Overall Study|Study Terminated by Sponsor|48|||
146047435|NCT04752332|526686397|FG000|Overall Study|Withdrawal by Subject|11|||
146047436|NCT04752332|526686398|FG001|Overall Study|Withdrawal by Subject|3|||
146047437|NCT00924443|526686399|FG000|Overall Study|Physician Decision|2|||
146047438|NCT00924443|526686399|FG000|Overall Study|Protocol Violation|1|||
146047439|NCT02451124|526686401|FG000|Overall Study|Withdrawal by Subject|1|||
146047440|NCT03301350|526686402|FG000|Overall Study|Withdrawal by Subject|4|||
146047441|NCT03301350|526686402|FG000|Overall Study|Adverse Event|1|||
146047442|NCT03301350|526686402|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
146047443|NCT03301350|526686402|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
146047444|NCT03301350|526686402|FG000|Overall Study|no detail provided|1|||
146047445|NCT01248949|526686403|FG000|Overall Study|Lost to Follow-up|2|||
146047446|NCT01248949|526686404|FG001|Overall Study|Lost to Follow-up|2|||
146047447|NCT01248949|526686405|FG002|Overall Study|Lost to Follow-up|2|||
146047448|NCT01248949|526686406|FG003|Overall Study|Lost to Follow-up|1|||
146047449|NCT01248949|526686407|FG004|Overall Study|Lost to Follow-up|0|||
146047450|NCT01248949|526686403|FG000|Overall Study|Withdrawal by Subject|5|||
146047451|NCT01248949|526686404|FG001|Overall Study|Withdrawal by Subject|3|||
146047452|NCT01248949|526686405|FG002|Overall Study|Withdrawal by Subject|11|||
146047453|NCT01248949|526686406|FG003|Overall Study|Withdrawal by Subject|3|||
146047454|NCT01248949|526686407|FG004|Overall Study|Withdrawal by Subject|1|||
146047455|NCT01248949|526686403|FG000|Overall Study|Death|22|||
146047456|NCT01248949|526686404|FG001|Overall Study|Death|7|||
146047457|NCT01248949|526686405|FG002|Overall Study|Death|21|||
146047458|NCT01248949|526686406|FG003|Overall Study|Death|6|||
146047459|NCT01248949|526686407|FG004|Overall Study|Death|2|||
146047460|NCT01248949|526686403|FG000|Overall Study|Alternative Therapy|1|||
146047461|NCT01248949|526686404|FG001|Overall Study|Alternative Therapy|0|||
146047462|NCT01248949|526686405|FG002|Overall Study|Alternative Therapy|0|||
146047463|NCT01248949|526686406|FG003|Overall Study|Alternative Therapy|0|||
146047464|NCT01248949|526686407|FG004|Overall Study|Alternative Therapy|0|||
146047465|NCT01248949|526686403|FG000|Overall Study|Alternative Therapy.|1|||
146047466|NCT01248949|526686404|FG001|Overall Study|Alternative Therapy.|0|||
146047467|NCT01248949|526686405|FG002|Overall Study|Alternative Therapy.|0|||
146047468|NCT01248949|526686406|FG003|Overall Study|Alternative Therapy.|0|||
146047469|NCT01248949|526686407|FG004|Overall Study|Alternative Therapy.|0|||
146047470|NCT01248949|526686403|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
146047471|NCT01248949|526686404|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
146047472|NCT01248949|526686405|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
146047473|NCT01248949|526686406|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
146047474|NCT01248949|526686407|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
146047475|NCT01248949|526686403|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
146047476|NCT01248949|526686404|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
146047477|NCT01248949|526686405|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
146047478|NCT01248949|526686406|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
146047479|NCT01248949|526686407|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
146047480|NCT01248949|526686403|FG000|Overall Study|Participant Went To Hospice|0|||
146047481|NCT01248949|526686404|FG001|Overall Study|Participant Went To Hospice|0|||
146047482|NCT01248949|526686405|FG002|Overall Study|Participant Went To Hospice|1|||
146047483|NCT01248949|526686406|FG003|Overall Study|Participant Went To Hospice|0|||
146047484|NCT01248949|526686407|FG004|Overall Study|Participant Went To Hospice|0|||
146047485|NCT01248949|526686403|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
146047486|NCT01248949|526686404|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146047487|NCT01248949|526686405|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146047488|NCT01248949|526686406|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146047489|NCT01248949|526686407|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
146047490|NCT01248949|526686403|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
146047491|NCT01248949|526686404|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
146047492|NCT01248949|526686405|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
146047493|NCT01248949|526686406|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
146047494|NCT01248949|526686407|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
146047495|NCT01248949|526686403|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146047496|NCT01248949|526686404|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
146047497|NCT01248949|526686405|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146047498|NCT01248949|526686406|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146047499|NCT01248949|526686407|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
146047500|NCT01248949|526686403|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146047501|NCT01248949|526686404|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146047502|NCT01248949|526686405|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
146047503|NCT01248949|526686406|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146047504|NCT01248949|526686407|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
146047505|NCT00286429|526686408|FG000|Overall Study|Adverse Event|4|||
146047506|NCT00286429|526686409|FG001|Overall Study|Adverse Event|1|||
146047507|NCT00286429|526686410|FG002|Overall Study|Adverse Event|6|||
146047508|NCT00286429|526686408|FG000|Overall Study|Lack of Efficacy|52|||
146047509|NCT00286429|526686409|FG001|Overall Study|Lack of Efficacy|27|||
146047510|NCT00286429|526686410|FG002|Overall Study|Lack of Efficacy|25|||
146047511|NCT00286429|526686408|FG000|Overall Study|Lost to Follow-up|2|||
146047512|NCT00286429|526686409|FG001|Overall Study|Lost to Follow-up|4|||
146047513|NCT00286429|526686410|FG002|Overall Study|Lost to Follow-up|3|||
146047514|NCT00286429|526686408|FG000|Overall Study|Physician Decision|10|||
146047515|NCT00286429|526686409|FG001|Overall Study|Physician Decision|7|||
146047516|NCT00286429|526686410|FG002|Overall Study|Physician Decision|7|||
146047517|NCT00286429|526686408|FG000|Overall Study|Protocol Violation|3|||
146047518|NCT00286429|526686409|FG001|Overall Study|Protocol Violation|5|||
146047519|NCT00286429|526686410|FG002|Overall Study|Protocol Violation|4|||
146047520|NCT00286429|526686408|FG000|Overall Study|Withdrawal by Subject|3|||
146047521|NCT00286429|526686409|FG001|Overall Study|Withdrawal by Subject|2|||
146047522|NCT00286429|526686410|FG002|Overall Study|Withdrawal by Subject|6|||
146047523|NCT00286429|526686408|FG000|Overall Study|Administrative Error|1|||
146047524|NCT00286429|526686409|FG001|Overall Study|Administrative Error|1|||
146047525|NCT00286429|526686410|FG002|Overall Study|Administrative Error|1|||
146047526|NCT00286429|526686408|FG000|Overall Study|Administrative Decision|0|||
146047527|NCT00286429|526686409|FG001|Overall Study|Administrative Decision|1|||
146047528|NCT00286429|526686410|FG002|Overall Study|Administrative Decision|0|||
146047529|NCT01746225|526686413|FG000|Overall Study|Death|1|||
146047530|NCT01746225|526686414|FG001|Overall Study|Death|0|||
146047531|NCT01746225|526686415|FG002|Overall Study|Death|1|||
146047532|NCT01746225|526686413|FG000|Overall Study|Withdrawal by Subject|5|||
146047533|NCT01746225|526686414|FG001|Overall Study|Withdrawal by Subject|15|||
146047534|NCT01746225|526686415|FG002|Overall Study|Withdrawal by Subject|19|||
146047535|NCT01746225|526686413|FG000|Overall Study|Physician Decision|14|||
146047536|NCT01746225|526686414|FG001|Overall Study|Physician Decision|11|||
146047537|NCT01746225|526686415|FG002|Overall Study|Physician Decision|3|||
146047538|NCT01746225|526686413|FG000|Overall Study|Adverse Event|15|||
146047539|NCT01746225|526686414|FG001|Overall Study|Adverse Event|12|||
146047540|NCT01746225|526686415|FG002|Overall Study|Adverse Event|17|||
146047541|NCT01746225|526686413|FG000|Overall Study|Continuing Treatment|5|||
146047542|NCT01746225|526686414|FG001|Overall Study|Continuing Treatment|8|||
146047543|NCT01746225|526686415|FG002|Overall Study|Continuing Treatment|3|||
146047544|NCT03245775|526686418|FG000|Overall Study|Lost to Follow-up|25|||
146047545|NCT03245775|526686419|FG001|Overall Study|Lost to Follow-up|26|||
146047546|NCT03245775|526686420|FG002|Overall Study|Lost to Follow-up|16|||
146047547|NCT03245775|526686421|FG003|Overall Study|Lost to Follow-up|16|||
146047548|NCT02713828|526686424|FG000|Overall Study|Death|2|||
146047549|NCT02713828|526686425|FG001|Overall Study|Death|0|||
146047550|NCT02713828|526686424|FG000|Overall Study|Withdrawal by Subject|1|||
146047551|NCT02713828|526686425|FG001|Overall Study|Withdrawal by Subject|0|||
146047552|NCT02713828|526686424|FG000|Overall Study|study terminated but patient allowed to|2|||
146047553|NCT02713828|526686425|FG001|Overall Study|study terminated but patient allowed to|0|||
146047554|NCT03302247|526686426|FG000|Overall Study|the study has closed prematurely|2|||
146047555|NCT03302247|526686426|FG000|Overall Study|Death|1|||
146047556|NCT03197376|526686427|FG000|Primary and Booster Phase|Adverse Event|0|||
146047557|NCT03197376|526686428|FG001|Primary and Booster Phase|Adverse Event|0|||
146047558|NCT03197376|526686429|FG002|Primary and Booster Phase|Adverse Event|0|||
146047559|NCT03197376|526686430|FG003|Primary and Booster Phase|Adverse Event|1|||
146047560|NCT03197376|526686427|FG000|Primary and Booster Phase|Death|1|||
146047561|NCT03197376|526686428|FG001|Primary and Booster Phase|Death|0|||
146047562|NCT03197376|526686429|FG002|Primary and Booster Phase|Death|0|||
146047563|NCT03197376|526686430|FG003|Primary and Booster Phase|Death|2|||
146047564|NCT03197376|526686427|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
146047565|NCT03197376|526686428|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
146047566|NCT03197376|526686429|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
146047567|NCT03197376|526686430|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
146047568|NCT03197376|526686427|FG000|Primary and Booster Phase|Physician Decision|1|||
146047569|NCT03197376|526686428|FG001|Primary and Booster Phase|Physician Decision|0|||
146047570|NCT03197376|526686429|FG002|Primary and Booster Phase|Physician Decision|1|||
146047571|NCT03197376|526686430|FG003|Primary and Booster Phase|Physician Decision|3|||
146047572|NCT03197376|526686427|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
146047573|NCT03197376|526686428|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
146047574|NCT03197376|526686429|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
146047575|NCT03197376|526686430|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
146047576|NCT03197376|526686427|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
146047577|NCT03197376|526686428|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
146047578|NCT03197376|526686429|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
146047579|NCT03197376|526686430|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
146047580|NCT03197376|526686427|FG000|Primary and Booster Phase|Not vaccine related|1|||
146047581|NCT03197376|526686428|FG001|Primary and Booster Phase|Not vaccine related|2|||
146047582|NCT03197376|526686429|FG002|Primary and Booster Phase|Not vaccine related|0|||
146047583|NCT03197376|526686430|FG003|Primary and Booster Phase|Not vaccine related|6|||
146047584|NCT03197376|526686427|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
146047585|NCT03197376|526686428|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
146047586|NCT03197376|526686429|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
146047587|NCT03197376|526686430|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
146047588|NCT03197376|526686427|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
146047589|NCT03197376|526686428|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
146047590|NCT03197376|526686429|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
146047591|NCT03197376|526686430|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
146047592|NCT03197376|526686427|FG000|Immune Persistence Phase|Not vaccine related|1|||
146047593|NCT03197376|526686428|FG001|Immune Persistence Phase|Not vaccine related|0|||
146047594|NCT03197376|526686429|FG002|Immune Persistence Phase|Not vaccine related|1|||
146047595|NCT03197376|526686430|FG003|Immune Persistence Phase|Not vaccine related|1|||
146047596|NCT01123395|526686432|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
146047597|NCT01123395|526686433|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
146047598|NCT03691571|526686434|FG000|Overall Study|Withdrawal by Subject|9|||
146047599|NCT03691571|526686435|FG001|Overall Study|Withdrawal by Subject|2|||
146047600|NCT02363959|526686439|FG000|Overall Study|Medical instability|1|||
146047601|NCT02363959|526686440|FG001|Overall Study|Medical instability|0|||
146047602|NCT02663622|526686441|FG000|Overall Study|Death|3|||
146047603|NCT02663622|526686442|FG001|Overall Study|Death|1|||
146047604|NCT02663622|526686443|FG002|Overall Study|Death|1|||
146047605|NCT02663622|526686444|FG003|Overall Study|Death|8|||
146047606|NCT02663622|526686441|FG000|Overall Study|Protocol Violation|0|||
146047607|NCT02663622|526686442|FG001|Overall Study|Protocol Violation|0|||
146047608|NCT02663622|526686443|FG002|Overall Study|Protocol Violation|0|||
146047609|NCT02663622|526686444|FG003|Overall Study|Protocol Violation|1|||
146047610|NCT00930930|526686447|FG000|Overall Study|Death|1|||
146047611|NCT00930930|526686448|FG001|Overall Study|Death|0|||
146047612|NCT00930930|526686447|FG000|Overall Study|Physician Decision|1|||
146047613|NCT00930930|526686448|FG001|Overall Study|Physician Decision|0|||
146047614|NCT00930930|526686447|FG000|Overall Study|Adverse Event|13|||
146047615|NCT00930930|526686448|FG001|Overall Study|Adverse Event|3|||
146047616|NCT00930930|526686447|FG000|Overall Study|Withdrawal by Subject|3|||
146047617|NCT00930930|526686448|FG001|Overall Study|Withdrawal by Subject|1|||
146047618|NCT00930930|526686447|FG000|Overall Study|Disease progression|2|||
146047619|NCT00930930|526686448|FG001|Overall Study|Disease progression|3|||
146047620|NCT00930930|526686447|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
146047621|NCT00930930|526686448|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
146047622|NCT00930930|526686447|FG000|Overall Study|patients not compliant|1|||
146047623|NCT00930930|526686448|FG001|Overall Study|patients not compliant|1|||
146047624|NCT04618744|526686449|FG000|Overall Study|Adverse Event|0|||
146047625|NCT04618744|526686450|FG001|Overall Study|Adverse Event|1|||
146047626|NCT04618744|526686449|FG000|Overall Study|Withdrawal by Subject|0|||
146047627|NCT04618744|526686450|FG001|Overall Study|Withdrawal by Subject|1|||
146047628|NCT03937713|526688149|FG000|Overall Study|Withdrawal by Subject|3|||
146047629|NCT03937713|526688150|FG001|Overall Study|Withdrawal by Subject|6|||
146047630|NCT03937713|526688149|FG000|Overall Study|Lost to Follow-up|1|||
146047631|NCT03937713|526688150|FG001|Overall Study|Lost to Follow-up|0|||
146047632|NCT00922623|526688156|FG000|Overall Study|Other|4|||
146047633|NCT00922623|526688156|FG000|Overall Study|Lost to Follow-up|1|||
146047634|NCT02420379|526688157|FG000|Overall Study|Withdrawal by Subject|0|||
146047635|NCT02420379|526688158|FG001|Overall Study|Withdrawal by Subject|3|||
146047636|NCT02420379|526688157|FG000|Overall Study|Unable to complete due to schooling|0|||
146047637|NCT02420379|526688158|FG001|Overall Study|Unable to complete due to schooling|1|||
146047638|NCT02420379|526688157|FG000|Overall Study|Transitioned to commercial drug|1|||
146047639|NCT02420379|526688158|FG001|Overall Study|Transitioned to commercial drug|0|||
146047640|NCT00086047|526688159|FG000|Overall Study|Lost to Follow-up|7|||
146047641|NCT00086047|526688160|FG001|Overall Study|Lost to Follow-up|6|||
146047642|NCT00086047|526688159|FG000|Overall Study|Physician Decision|0|||
146047643|NCT00086047|526688160|FG001|Overall Study|Physician Decision|1|||
146047644|NCT00269919|526688166|FG000|Overall Study|Other|26|||
146047645|NCT00269919|526688166|FG000|Overall Study|Started but not treated|1|||
146047646|NCT00786799|526688167|FG000|Overall Study|Lost to Follow-up|1|||
146047647|NCT00786799|526688168|FG001|Overall Study|Lost to Follow-up|1|||
146047648|NCT00950846|526688171|FG000|Overall Study|Death|6|||
146047649|NCT00950846|526688171|FG000|Overall Study|Lost to Follow-up|3|||
146047650|NCT00950846|526688171|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
146047651|NCT01799226|526688174|FG000|Overall Study|Withdrawal by Subject|1|||
146047652|NCT01799226|526688175|FG001|Overall Study|Withdrawal by Subject|0|||
146047653|NCT01799226|526688174|FG000|Overall Study|Disqualified at Day 14|1|||
146047654|NCT01799226|526688175|FG001|Overall Study|Disqualified at Day 14|0|||
146047655|NCT02178995|526688176|FG000|Double Blind|Adverse Event|0|||
146047656|NCT02178995|526688177|FG001|Double Blind|Adverse Event|0|||
146047657|NCT02178995|526688178|FG002|Double Blind|Adverse Event|0|||
146102819|NCT00003487|526895347|FG000|Overall Study|Not evaluable|2|||
146102820|NCT04154930|526895350|FG000|Overall Study|Withdrawal by Subject|15|||
146102821|NCT04154930|526895351|FG001|Overall Study|Withdrawal by Subject|6|||
146102822|NCT04154930|526895350|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
146102823|NCT04154930|526895351|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
146102824|NCT04154930|526895350|FG000|Overall Study|Lost to Follow-up|14|||
146102825|NCT04154930|526895351|FG001|Overall Study|Lost to Follow-up|6|||
146102826|NCT04154930|526895350|FG000|Overall Study|Other|6|||
146102827|NCT04154930|526895351|FG001|Overall Study|Other|0|||
146102828|NCT02628938|526895352|FG000|Overall Study|Did not attend the follow up recall|2|||
146102829|NCT02628938|526895353|FG001|Overall Study|Did not attend the follow up recall|2|||
146102830|NCT02628938|526895354|FG002|Overall Study|Did not attend the follow up recall|1|||
146102831|NCT02628938|526895352|FG000|Overall Study|Failure to comply with the instructions|3|||
146102832|NCT02628938|526895353|FG001|Overall Study|Failure to comply with the instructions|0|||
146102833|NCT02628938|526895354|FG002|Overall Study|Failure to comply with the instructions|3|||
146102834|NCT02058693|526895355|FG000|Phase 1|Withdrawal by Subject|3|||
146102835|NCT02058693|526895356|FG001|Phase 1|Withdrawal by Subject|2|||
146102836|NCT02058693|526895355|FG000|Phase 1|Adverse Event|0|||
146102837|NCT02058693|526895356|FG001|Phase 1|Adverse Event|1|||
146255783|NCT00396097|527450581|FG000|Overall Study|Other|3|||
146255784|NCT00396097|527450582|FG001|Overall Study|Other|5|||
146255785|NCT00396097|527450581|FG000|Overall Study|Protocol Violation|0|||
146255786|NCT00396097|527450582|FG001|Overall Study|Protocol Violation|6|||
146255787|NCT00396097|527450581|FG000|Overall Study|Adverse Event|1|||
146255788|NCT00396097|527450582|FG001|Overall Study|Adverse Event|5|||
146255789|NCT00396097|527450581|FG000|Overall Study|Insufficient Clinical Response|1|||
146255790|NCT00396097|527450582|FG001|Overall Study|Insufficient Clinical Response|4|||
146255791|NCT03461211|527450583|FG000|Overall Study|Adverse Event|1|||
146255792|NCT03461211|527450584|FG001|Overall Study|Adverse Event|1|||
146255793|NCT03461211|527450583|FG000|Overall Study|Lack of Efficacy|0|||
146255794|NCT03461211|527450584|FG001|Overall Study|Lack of Efficacy|1|||
146255795|NCT03807700|527450585|FG000|Overall Study|Withdrawal by Subject|2|||
146255796|NCT03807700|527450586|FG001|Overall Study|Withdrawal by Subject|1|||
146255797|NCT02720081|527450587|FG000|Overall Study|Adverse Event|0|||
146255798|NCT02720081|527450588|FG001|Overall Study|Adverse Event|3|||
146255799|NCT02720081|527450587|FG000|Overall Study|Protocol Violation|4|||
146255800|NCT02720081|527450588|FG001|Overall Study|Protocol Violation|1|||
146255801|NCT02316847|527450590|FG000|Overall Study|Adverse Event|0|||
146255802|NCT02316847|527450591|FG001|Overall Study|Adverse Event|3|||
146255803|NCT02316847|527450590|FG000|Overall Study|Lost to Follow-up|0|||
146255804|NCT02316847|527450591|FG001|Overall Study|Lost to Follow-up|2|||
146255805|NCT02316847|527450590|FG000|Overall Study|Physician Decision|0|||
146255806|NCT02316847|527450591|FG001|Overall Study|Physician Decision|1|||
146255807|NCT02316847|527450590|FG000|Overall Study|Pregnancy|0|||
146255808|NCT02316847|527450591|FG001|Overall Study|Pregnancy|1|||
146255809|NCT02316847|527450590|FG000|Overall Study|Withdrawal by Subject|2|||
146255810|NCT02316847|527450591|FG001|Overall Study|Withdrawal by Subject|9|||
146255811|NCT02316847|527450590|FG000|Overall Study|Noncompliance with study drug|0|||
146255812|NCT02316847|527450591|FG001|Overall Study|Noncompliance with study drug|3|||
146255813|NCT02316847|527450590|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
146255814|NCT02316847|527450591|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
146255815|NCT03371485|527450594|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
146255816|NCT03371485|527450594|FG000|2-year Follow-up|Death|5|||
146255817|NCT01061775|527450597|FG000|Overall Study|Physician Decision|2|||
146255818|NCT01061775|527450597|FG000|Overall Study|Lost to Follow-up|1|||
146255819|NCT02567227|527450598|FG000|9 Weeks|Adverse Event|5|||
146255820|NCT02567227|527450599|FG001|9 Weeks|Adverse Event|5|||
146255821|NCT02567227|527450598|FG000|9 Weeks|Withdrawal by Subject|18|||
146255822|NCT02567227|527450599|FG001|9 Weeks|Withdrawal by Subject|8|||
146255823|NCT02567227|527450598|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
146255824|NCT02567227|527450599|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
146255825|NCT02567227|527450598|FG000|6 Month|Death|2|||
146255826|NCT02567227|527450599|FG001|6 Month|Death|0|||
146102838|NCT02058693|526895355|FG000|Phase 1|Lack of Efficacy|1|||
146102839|NCT02058693|526895356|FG001|Phase 1|Lack of Efficacy|0|||
146255827|NCT02567227|527450598|FG000|6 Month|Lost to Follow-up|43|||
146255828|NCT02567227|527450599|FG001|6 Month|Lost to Follow-up|40|||
146255829|NCT02567227|527450598|FG000|12 Months|Lost to Follow-up|31|||
146255830|NCT02567227|527450599|FG001|12 Months|Lost to Follow-up|32|||
146255831|NCT02567227|527450598|FG000|12 Months|Death|0|||
146255832|NCT02567227|527450599|FG001|12 Months|Death|2|||
146102840|NCT02058693|526895355|FG000|Phase 1|Physician Decision|1|||
146102841|NCT02058693|526895356|FG001|Phase 1|Physician Decision|1|||
146102842|NCT02058693|526895355|FG000|Phase 2|Withdrawal by Subject|0|||
146102843|NCT02058693|526895356|FG001|Phase 2|Withdrawal by Subject|2|||
146102844|NCT00241358|526895357|FG000|Overall Study|Determined to be not ineligible|0|||
146255833|NCT01026103|527450600|FG000|Overall Study|Physician Decision|1|||
146255834|NCT01026103|527450600|FG000|Overall Study|did not receive study device bc of error|1|||
146255835|NCT02498418|527450601|FG000|Overall Study|Lack of Efficacy|0|||
146047658|NCT02178995|526688179|FG003|Double Blind|Adverse Event|0|||
146047659|NCT02178995|526688180|FG004|Double Blind|Adverse Event|0|||
146047660|NCT02178995|526688181|FG005|Double Blind|Adverse Event|1|||
146047661|NCT02178995|526688182|FG006|Double Blind|Adverse Event|0|||
146047662|NCT02178995|526688183|FG007|Double Blind|Adverse Event|1|||
146047663|NCT02178995|526688184|FG008|Double Blind|Adverse Event|1|||
146047664|NCT02178995|526688176|FG000|Double Blind|Lost to Follow-up|0|||
146047665|NCT02178995|526688177|FG001|Double Blind|Lost to Follow-up|1|||
146047666|NCT02178995|526688178|FG002|Double Blind|Lost to Follow-up|0|||
146047667|NCT02178995|526688179|FG003|Double Blind|Lost to Follow-up|0|||
146047668|NCT02178995|526688180|FG004|Double Blind|Lost to Follow-up|0|||
146047669|NCT02178995|526688181|FG005|Double Blind|Lost to Follow-up|0|||
146047670|NCT02178995|526688182|FG006|Double Blind|Lost to Follow-up|0|||
146047671|NCT02178995|526688183|FG007|Double Blind|Lost to Follow-up|1|||
146047672|NCT02178995|526688184|FG008|Double Blind|Lost to Follow-up|0|||
146047673|NCT02178995|526688176|FG000|Open Label|Adverse Event|2|||
146047674|NCT02178995|526688177|FG001|Open Label|Adverse Event|0|||
146047675|NCT02178995|526688178|FG002|Open Label|Adverse Event|0|||
146047676|NCT02178995|526688179|FG003|Open Label|Adverse Event|0|||
146047677|NCT02178995|526688180|FG004|Open Label|Adverse Event|0|||
146047678|NCT02178995|526688181|FG005|Open Label|Adverse Event|0|||
146047679|NCT02178995|526688182|FG006|Open Label|Adverse Event|0|||
146047680|NCT02178995|526688183|FG007|Open Label|Adverse Event|0|||
146047681|NCT02178995|526688184|FG008|Open Label|Adverse Event|0|||
146047682|NCT00981461|526688185|FG000|Overall Study|Lost to Follow-up|5|||
146047683|NCT00981461|526688186|FG001|Overall Study|Lost to Follow-up|2|||
146047684|NCT03361293|526688189|FG000|Overall Study|Lost to Follow-up|0|||
146047685|NCT03361293|526688190|FG001|Overall Study|Lost to Follow-up|2|||
146047686|NCT03361293|526688189|FG000|Overall Study|Withdrawal by Subject|1|||
146047687|NCT03361293|526688190|FG001|Overall Study|Withdrawal by Subject|3|||
146047688|NCT00483405|526688191|FG000|Overall Study|Adverse Event|8|||
146047689|NCT00483405|526688191|FG000|Overall Study|Lack of Efficacy|14|||
146047690|NCT00483405|526688191|FG000|Overall Study|Death|3|||
146047691|NCT00483405|526688191|FG000|Overall Study|Withdrawal by Subject|2|||
146047692|NCT00483405|526688191|FG000|Overall Study|Other complicating disease|1|||
146047693|NCT00571038|526688192|FG000|Overall Study|Lost to Follow-up|1|||
146047694|NCT00571038|526688193|FG001|Overall Study|Lost to Follow-up|4|||
146047695|NCT00571038|526688192|FG000|Overall Study|Death|7|||
146047696|NCT00571038|526688193|FG001|Overall Study|Death|5|||
146047697|NCT00571038|526688192|FG000|Overall Study|Withdrawal by Subject|1|||
146047698|NCT00571038|526688193|FG001|Overall Study|Withdrawal by Subject|3|||
146047699|NCT00571038|526688192|FG000|Overall Study|Moved out of state|2|||
146047700|NCT00571038|526688193|FG001|Overall Study|Moved out of state|2|||
146047701|NCT01426958|526688194|FG000|Overall Study|Adverse Event|2|||
146047702|NCT02631551|526688195|FG000|Overall Study|Adverse Event|1|||
146047703|NCT02631551|526688196|FG001|Overall Study|Adverse Event|2|||
146047704|NCT02631551|526688197|FG002|Overall Study|Adverse Event|4|||
146047705|NCT02631551|526688198|FG003|Overall Study|Adverse Event|0|||
146047706|NCT02631551|526688195|FG000|Overall Study|Lack of Efficacy|0|||
146047707|NCT02631551|526688196|FG001|Overall Study|Lack of Efficacy|0|||
146047708|NCT02631551|526688197|FG002|Overall Study|Lack of Efficacy|1|||
146047709|NCT02631551|526688198|FG003|Overall Study|Lack of Efficacy|0|||
146047710|NCT02631551|526688195|FG000|Overall Study|Lost to Follow-up|1|||
146047711|NCT02631551|526688196|FG001|Overall Study|Lost to Follow-up|2|||
146255836|NCT02498418|527450602|FG001|Overall Study|Lack of Efficacy|0|||
146047712|NCT02631551|526688197|FG002|Overall Study|Lost to Follow-up|0|||
146047713|NCT02631551|526688198|FG003|Overall Study|Lost to Follow-up|3|||
146047714|NCT02631551|526688195|FG000|Overall Study|Withdrawal by Subject|2|||
146047715|NCT02631551|526688196|FG001|Overall Study|Withdrawal by Subject|2|||
146047716|NCT02631551|526688197|FG002|Overall Study|Withdrawal by Subject|0|||
146047717|NCT02631551|526688198|FG003|Overall Study|Withdrawal by Subject|5|||
146047718|NCT02631551|526688195|FG000|Overall Study|Protocol deviation|3|||
146047719|NCT02631551|526688196|FG001|Overall Study|Protocol deviation|6|||
146047720|NCT02631551|526688197|FG002|Overall Study|Protocol deviation|3|||
146047721|NCT02631551|526688198|FG003|Overall Study|Protocol deviation|0|||
146047722|NCT02631551|526688195|FG000|Overall Study|Non-compliance with study procedures|0|||
146047723|NCT02631551|526688196|FG001|Overall Study|Non-compliance with study procedures|0|||
146047724|NCT02631551|526688197|FG002|Overall Study|Non-compliance with study procedures|1|||
146047725|NCT02631551|526688198|FG003|Overall Study|Non-compliance with study procedures|1|||
146047726|NCT02631551|526688195|FG000|Overall Study|Non-compliance with study drug|1|||
146047727|NCT02631551|526688196|FG001|Overall Study|Non-compliance with study drug|0|||
146047728|NCT02631551|526688197|FG002|Overall Study|Non-compliance with study drug|0|||
146047729|NCT02631551|526688198|FG003|Overall Study|Non-compliance with study drug|0|||
146047730|NCT02631551|526688195|FG000|Overall Study|Other, specific reasons not collected|5|||
146047731|NCT02631551|526688196|FG001|Overall Study|Other, specific reasons not collected|7|||
146047732|NCT02631551|526688197|FG002|Overall Study|Other, specific reasons not collected|2|||
146047733|NCT02631551|526688198|FG003|Overall Study|Other, specific reasons not collected|2|||
146047734|NCT02073682|526688203|FG000|Overall Study|Low Creatinine Clearance|1|||
146255837|NCT02498418|527450603|FG002|Overall Study|Lack of Efficacy|1|||
146102845|NCT00241358|526895358|FG001|Overall Study|Determined to be not ineligible|1|||
146102846|NCT00241358|526895359|FG002|Overall Study|Determined to be not ineligible|1|||
146102847|NCT00843856|526895360|FG000|Overall Study|Lost to Follow-up|1|||
146102848|NCT00843856|526895361|FG001|Overall Study|Lost to Follow-up|2|||
146102849|NCT03855228|526895362|FG000|Overall Study|Adverse Event|2|||
146102850|NCT03855228|526895363|FG001|Overall Study|Adverse Event|4|||
146102851|NCT03855228|526895364|FG002|Overall Study|Adverse Event|4|||
146102852|NCT03855228|526895365|FG003|Overall Study|Adverse Event|8|||
146102853|NCT03855228|526895362|FG000|Overall Study|Treatment Failure|1|||
146102854|NCT03855228|526895363|FG001|Overall Study|Treatment Failure|2|||
146102855|NCT03855228|526895364|FG002|Overall Study|Treatment Failure|1|||
146102856|NCT03855228|526895365|FG003|Overall Study|Treatment Failure|8|||
146102857|NCT03855228|526895362|FG000|Overall Study|Lost to Follow-up|0|||
146102858|NCT03855228|526895363|FG001|Overall Study|Lost to Follow-up|0|||
146102859|NCT03855228|526895364|FG002|Overall Study|Lost to Follow-up|0|||
146102860|NCT03855228|526895365|FG003|Overall Study|Lost to Follow-up|1|||
146102861|NCT03855228|526895362|FG000|Overall Study|Protocol Violation|0|||
146102862|NCT03855228|526895363|FG001|Overall Study|Protocol Violation|1|||
146102863|NCT03855228|526895364|FG002|Overall Study|Protocol Violation|2|||
146102864|NCT03855228|526895365|FG003|Overall Study|Protocol Violation|1|||
146102865|NCT03855228|526895362|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
146102866|NCT03855228|526895363|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
146102867|NCT03855228|526895364|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
146102868|NCT03855228|526895365|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
146102869|NCT00590135|526895366|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
146102870|NCT01449539|526895379|FG000|Overall Study|Withdrawal by Subject|3|||
146102871|NCT01449539|526895379|FG000|Overall Study|Toxicity not study related|1|||
146102872|NCT00806351|526895383|FG000|Overall Study|Death|5|||
146102873|NCT00806351|526895384|FG001|Overall Study|Death|4|||
146102874|NCT00913380|526895387|FG000|Clinical Outcomes|Lost to Follow-up|6|||
146102875|NCT00913380|526895388|FG001|Clinical Outcomes|Lost to Follow-up|6|||
146102876|NCT00957580|526895389|FG000|Overall Study|Ongoing at data cut-off|0|||
146102877|NCT00957580|526895390|FG001|Overall Study|Ongoing at data cut-off|1|||
146102878|NCT00957580|526895391|FG002|Overall Study|Ongoing at data cut-off|0|||
146102879|NCT00957580|526895389|FG000|Overall Study|Enrolled but not treated|0|||
146102880|NCT00957580|526895390|FG001|Overall Study|Enrolled but not treated|1|||
146102881|NCT00957580|526895391|FG002|Overall Study|Enrolled but not treated|0|||
146102882|NCT02699593|526895397|FG000|Period 1|Unsatisfactory Visual Response|0|||
146102883|NCT02699593|526895398|FG001|Period 1|Unsatisfactory Visual Response|1|||
146102884|NCT02699593|526895397|FG000|Period 1|Torn Contact Len|4|||
146102885|NCT02699593|526895398|FG001|Period 1|Torn Contact Len|3|||
146102886|NCT02699593|526895397|FG000|Period 1|Protocol Violation|0|||
146102887|NCT02699593|526895398|FG001|Period 1|Protocol Violation|1|||
146102888|NCT02699593|526895397|FG000|Period 1|Withdrawal by Subject|0|||
146102889|NCT02699593|526895398|FG001|Period 1|Withdrawal by Subject|1|||
146102890|NCT02699593|526895397|FG000|Period 1|Adverse Event|1|||
146102891|NCT02699593|526895398|FG001|Period 1|Adverse Event|1|||
146102892|NCT02699593|526895397|FG000|Period 2|Adverse Event|1|||
146102893|NCT02699593|526895398|FG001|Period 2|Adverse Event|1|||
146102894|NCT02699593|526895397|FG000|Period 2|Lost Contact Lens|0|||
146102895|NCT02699593|526895398|FG001|Period 2|Lost Contact Lens|1|||
146102896|NCT02699593|526895397|FG000|Period 2|Torn Contact Lens|1|||
146102897|NCT02699593|526895398|FG001|Period 2|Torn Contact Lens|0|||
146102898|NCT01681472|526895399|FG000|Overall Study|Adverse Event|0|||
146102899|NCT01681472|526895400|FG001|Overall Study|Adverse Event|1|||
146102900|NCT01681472|526895401|FG002|Overall Study|Adverse Event|0|||
146102901|NCT01681472|526895402|FG003|Overall Study|Adverse Event|0|||
146102902|NCT01999179|526895403|FG000|Overall Study|Adverse Event|1|||
146102903|NCT01999179|526895403|FG000|Overall Study|Lost to Follow-up|1|||
146102904|NCT01999179|526895403|FG000|Overall Study|Change in Therapy|3|||
146102905|NCT01999179|526895403|FG000|Overall Study|New catheter|2|||
146102906|NCT01752985|526895404|FG000|Treatment Period|Subject request to discontinue treatment|1|||
146102907|NCT01752985|526895405|FG001|Treatment Period|Subject request to discontinue treatment|0|||
146300860|NCT03346057|527617154|FG003|Overall Study|Lost to Follow-up|0|||
146102908|NCT01752985|526895406|FG002|Treatment Period|Subject request to discontinue treatment|1|||
146102909|NCT01752985|526895404|FG000|Treatment Period|Subject no longer meets study criteria|0|||
146102910|NCT01752985|526895405|FG001|Treatment Period|Subject no longer meets study criteria|1|||
146102911|NCT01752985|526895406|FG002|Treatment Period|Subject no longer meets study criteria|1|||
146102912|NCT01752985|526895404|FG000|Treatment Period|Adverse Event|2|||
146102913|NCT01752985|526895405|FG001|Treatment Period|Adverse Event|1|||
146102914|NCT01752985|526895406|FG002|Treatment Period|Adverse Event|2|||
146102915|NCT01752985|526895404|FG000|Treatment Period|Withdrawal by Subject|1|||
146102916|NCT01752985|526895405|FG001|Treatment Period|Withdrawal by Subject|1|||
146102917|NCT01752985|526895406|FG002|Treatment Period|Withdrawal by Subject|0|||
146102918|NCT01752985|526895404|FG000|Treatment Period|Lost to Follow-up|0|||
146102919|NCT01752985|526895405|FG001|Treatment Period|Lost to Follow-up|0|||
146102920|NCT01752985|526895406|FG002|Treatment Period|Lost to Follow-up|1|||
146102921|NCT05147428|526895407|FG000|Overall Study|Removed prior to mailing|289|||
146047735|NCT02073682|526688204|FG001|Overall Study|Low Creatinine Clearance|2|||
146047736|NCT02073682|526688203|FG000|Overall Study|Death|86|||
146047737|NCT02073682|526688204|FG001|Overall Study|Death|100|||
146047738|NCT02073682|526688203|FG000|Overall Study|Cancer Cured|10|||
146047739|NCT02073682|526688204|FG001|Overall Study|Cancer Cured|15|||
146047740|NCT02073682|526688203|FG000|Overall Study|ID: Patient Noncompliance|1|||
146047741|NCT02073682|526688204|FG001|Overall Study|ID: Patient Noncompliance|2|||
146047742|NCT02073682|526688203|FG000|Overall Study|ID: Palliative Treatment Only|10|||
146047743|NCT02073682|526688204|FG001|Overall Study|ID: Palliative Treatment Only|7|||
146047744|NCT02073682|526688203|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
146047745|NCT02073682|526688204|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
146047746|NCT02073682|526688203|FG000|Overall Study|Platelet Count <50,000/mL|1|||
146047747|NCT02073682|526688204|FG001|Overall Study|Platelet Count <50,000/mL|2|||
146047748|NCT02073682|526688203|FG000|Overall Study|Surgery/Medical Procedure|3|||
146047749|NCT02073682|526688204|FG001|Overall Study|Surgery/Medical Procedure|1|||
146047750|NCT02073682|526688203|FG000|Overall Study|Withdrawal by Subject|6|||
146047751|NCT02073682|526688204|FG001|Overall Study|Withdrawal by Subject|8|||
146047752|NCT02073682|526688203|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
146047753|NCT02073682|526688204|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
146047754|NCT02073682|526688203|FG000|Overall Study|Cancer Progression|53|||
146047755|NCT02073682|526688204|FG001|Overall Study|Cancer Progression|33|||
146047756|NCT02073682|526688203|FG000|Overall Study|Protocol Violation|1|||
146047757|NCT02073682|526688204|FG001|Overall Study|Protocol Violation|0|||
146047758|NCT02073682|526688203|FG000|Overall Study|Adverse Event|79|||
146047759|NCT02073682|526688204|FG001|Overall Study|Adverse Event|62|||
146047760|NCT02073682|526688203|FG000|Overall Study|No reason provided|11|||
146047761|NCT02073682|526688204|FG001|Overall Study|No reason provided|9|||
146047762|NCT02073682|526688203|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
146047763|NCT02073682|526688204|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
146047764|NCT02073682|526688203|FG000|Overall Study|Lost to Follow-up|1|||
146047765|NCT02073682|526688204|FG001|Overall Study|Lost to Follow-up|1|||
146047766|NCT02073682|526688203|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
146047767|NCT02073682|526688204|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
146047768|NCT01965704|526688205|FG000|Overall Study|Withdrawal by Subject|2|||
146047769|NCT01965704|526688206|FG001|Overall Study|Withdrawal by Subject|2|||
146047770|NCT01965704|526688207|FG002|Overall Study|Withdrawal by Subject|1|||
146047771|NCT01965704|526688208|FG003|Overall Study|Withdrawal by Subject|1|||
146047772|NCT01965704|526688205|FG000|Overall Study|Delivered at home|1|||
146047773|NCT01965704|526688206|FG001|Overall Study|Delivered at home|1|||
146047774|NCT01965704|526688207|FG002|Overall Study|Delivered at home|0|||
146047775|NCT01965704|526688208|FG003|Overall Study|Delivered at home|0|||
146047776|NCT01965704|526688205|FG000|Overall Study|Experienced complications|0|||
146047777|NCT01965704|526688206|FG001|Overall Study|Experienced complications|0|||
146047778|NCT01965704|526688207|FG002|Overall Study|Experienced complications|2|||
146047779|NCT01965704|526688208|FG003|Overall Study|Experienced complications|2|||
146047780|NCT01965704|526688205|FG000|Overall Study|Adverse Event|0|||
146047781|NCT01965704|526688206|FG001|Overall Study|Adverse Event|0|||
146047782|NCT01965704|526688207|FG002|Overall Study|Adverse Event|1|||
146047783|NCT01965704|526688208|FG003|Overall Study|Adverse Event|1|||
146047784|NCT01965704|526688205|FG000|Overall Study|Did not meet inclusion criteria|0|||
146047785|NCT01965704|526688206|FG001|Overall Study|Did not meet inclusion criteria|0|||
146047786|NCT01965704|526688207|FG002|Overall Study|Did not meet inclusion criteria|1|||
146047787|NCT01965704|526688208|FG003|Overall Study|Did not meet inclusion criteria|1|||
146047788|NCT00337207|526688216|FG000|Overall Study|Withdrawal by Subject|3|||
146047789|NCT03188432|526688217|FG000|Overall Study|Death|3|||
146047790|NCT03188432|526688217|FG000|Overall Study|Withdrawal by Subject|15|||
146047791|NCT03188432|526688217|FG000|Overall Study|Did not complete protocol treatment|9|||
146047792|NCT01687296|526688223|FG000|Overall Study|Lack of Efficacy|1|||
146047793|NCT01687296|526688224|FG001|Overall Study|Lack of Efficacy|1|||
146047794|NCT01687296|526688223|FG000|Overall Study|Protocol Violation|0|||
146047795|NCT01687296|526688224|FG001|Overall Study|Protocol Violation|1|||
146047796|NCT01687296|526688223|FG000|Overall Study|Withdrawal by Subject|6|||
146102922|NCT05147428|526895408|FG001|Overall Study|Removed prior to mailing|306|||
146255838|NCT02498418|527450601|FG000|Overall Study|Withdrawal by Subject|2|||
146255839|NCT02498418|527450602|FG001|Overall Study|Withdrawal by Subject|0|||
146047797|NCT01687296|526688224|FG001|Overall Study|Withdrawal by Subject|3|||
146047798|NCT02336230|526688226|FG000|Overall Study|Adverse Event|1|||
146047799|NCT02336230|526688226|FG000|Overall Study|Withdrawal of consent|1|||
146047800|NCT02336230|526688226|FG000|Overall Study|Death|9|||
146047801|NCT02336230|526688226|FG000|Overall Study|Dose not received due to shipping delay|1|||
146047802|NCT02336230|526688226|FG000|Overall Study|Discontinuation of MSC infusion|1|||
146047803|NCT02524171|526688227|FG000|6-month Follow-up|Lost to Follow-up|53|||
146047804|NCT02524171|526688228|FG001|6-month Follow-up|Lost to Follow-up|45|||
146047805|NCT02524171|526688227|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
146047806|NCT02524171|526688228|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
146102923|NCT05147428|526895409|FG002|Overall Study|Removed prior to mailing|270|||
146047807|NCT00216671|526688229|FG000|Overall Study|Adverse Event|4|||
146047808|NCT00216671|526688230|FG001|Overall Study|Adverse Event|9|||
146047809|NCT00216671|526688229|FG000|Overall Study|Pregnancy|0|||
146047810|NCT00216671|526688230|FG001|Overall Study|Pregnancy|1|||
146047811|NCT00216671|526688229|FG000|Overall Study|Withdrawal by Subject|4|||
146047812|NCT00216671|526688230|FG001|Overall Study|Withdrawal by Subject|2|||
146047813|NCT00216671|526688229|FG000|Overall Study|Refused Injections|3|||
146047814|NCT00216671|526688230|FG001|Overall Study|Refused Injections|13|||
146047815|NCT00216671|526688229|FG000|Overall Study|No Need to Continue Medication|1|||
146047816|NCT00216671|526688230|FG001|Overall Study|No Need to Continue Medication|1|||
146047817|NCT00216671|526688229|FG000|Overall Study|Insufficient Response|9|||
146047818|NCT00216671|526688230|FG001|Overall Study|Insufficient Response|4|||
146047819|NCT00216671|526688229|FG000|Overall Study|Lost to Follow-up|3|||
146047820|NCT00216671|526688230|FG001|Overall Study|Lost to Follow-up|5|||
146047821|NCT00216671|526688229|FG000|Overall Study|Non compliant|2|||
146047822|NCT00216671|526688230|FG001|Overall Study|Non compliant|2|||
146047823|NCT00216671|526688229|FG000|Overall Study|Ineligible|0|||
146047824|NCT00216671|526688230|FG001|Overall Study|Ineligible|2|||
146047825|NCT00216671|526688229|FG000|Overall Study|Physician Decision|1|||
146047826|NCT00216671|526688230|FG001|Overall Study|Physician Decision|1|||
146047827|NCT00216671|526688229|FG000|Overall Study|Protocol Violation|3|||
146047828|NCT00216671|526688230|FG001|Overall Study|Protocol Violation|5|||
146047829|NCT00216671|526688229|FG000|Overall Study|Relapse|1|||
146047830|NCT00216671|526688230|FG001|Overall Study|Relapse|0|||
146047831|NCT00216671|526688229|FG000|Overall Study|Investigator Illness|0|||
146047832|NCT00216671|526688230|FG001|Overall Study|Investigator Illness|1|||
146047833|NCT00216671|526688229|FG000|Overall Study|Patient Moved|0|||
146047834|NCT00216671|526688230|FG001|Overall Study|Patient Moved|1|||
146047835|NCT00216671|526688229|FG000|Overall Study|Ineligible, no efficacy data|2|||
146047836|NCT00216671|526688230|FG001|Overall Study|Ineligible, no efficacy data|2|||
146047837|NCT00216671|526688229|FG000|Overall Study|Insufficient Response Adverse Event|2|||
146047838|NCT00216671|526688230|FG001|Overall Study|Insufficient Response Adverse Event|1|||
146047839|NCT01843023|526688231|FG000|Overall Study|Death|1|||
146047840|NCT01843023|526688232|FG001|Overall Study|Death|0|||
146047841|NCT01843023|526688231|FG000|Overall Study|Lost to Follow-up|24|||
146047842|NCT01843023|526688232|FG001|Overall Study|Lost to Follow-up|29|||
146047843|NCT01843023|526688231|FG000|Overall Study|Withdrawal by Subject|8|||
146047844|NCT01843023|526688232|FG001|Overall Study|Withdrawal by Subject|6|||
146047845|NCT00466921|526688233|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
146047846|NCT00466921|526688233|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
146047847|NCT00466921|526688233|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
146047848|NCT00466921|526688233|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
146047849|NCT00466921|526688233|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
146047850|NCT00466921|526688233|FG000|Follow up for a Minimum of 1 Year|Death|6|||
146047851|NCT03305770|526688234|FG000|Overall Study|Physician Decision - prior to dispense|0|||
146047852|NCT03305770|526688235|FG001|Overall Study|Physician Decision - prior to dispense|1|||
146047853|NCT03305770|526688234|FG000|Overall Study|Subject moved|1|||
146047854|NCT03305770|526688235|FG001|Overall Study|Subject moved|0|||
146047855|NCT03539601|526688236|FG000|Overall Study|Withdraw by parent/guardian|1|||
146047856|NCT03539601|526688237|FG001|Overall Study|Withdraw by parent/guardian|0|||
146047857|NCT03539601|526688238|FG002|Overall Study|Withdraw by parent/guardian|1|||
146047858|NCT03539601|526688239|FG003|Overall Study|Withdraw by parent/guardian|0|||
146047859|NCT03539601|526688236|FG000|Overall Study|Adverse Event|0|||
146047860|NCT03539601|526688237|FG001|Overall Study|Adverse Event|2|||
146047861|NCT03539601|526688238|FG002|Overall Study|Adverse Event|0|||
146047862|NCT03539601|526688239|FG003|Overall Study|Adverse Event|0|||
146047863|NCT03539601|526688236|FG000|Overall Study|Lost to Follow-up|2|||
146047864|NCT03539601|526688237|FG001|Overall Study|Lost to Follow-up|4|||
146047865|NCT03539601|526688238|FG002|Overall Study|Lost to Follow-up|5|||
146047866|NCT03539601|526688239|FG003|Overall Study|Lost to Follow-up|0|||
146047867|NCT03539601|526688236|FG000|Overall Study|Withdrawal by Subject|2|||
146047868|NCT03539601|526688237|FG001|Overall Study|Withdrawal by Subject|0|||
146047869|NCT03539601|526688238|FG002|Overall Study|Withdrawal by Subject|0|||
146047870|NCT03539601|526688239|FG003|Overall Study|Withdrawal by Subject|1|||
146047871|NCT03539601|526688236|FG000|Overall Study|Randomized but not treated|1|||
146047872|NCT03539601|526688237|FG001|Overall Study|Randomized but not treated|1|||
146047873|NCT03539601|526688238|FG002|Overall Study|Randomized but not treated|0|||
146047874|NCT03539601|526688239|FG003|Overall Study|Randomized but not treated|0|||
146047875|NCT00226811|526688243|FG000|Overall Study|Death|8|||
146047876|NCT00226811|526688243|FG000|Overall Study|Adverse Event|11|||
146047877|NCT00226811|526688243|FG000|Overall Study|Lack of Efficacy|55|||
146047878|NCT00226811|526688243|FG000|Overall Study|Withdrawal by Subject|2|||
146047879|NCT02741635|526688246|FG000|Overall Study|Withdrawal by Subject|1|||
146047880|NCT01427933|526688250|FG000|Overall Study|Withdrawal by Subject|5|||
146047881|NCT01427933|526688251|FG001|Overall Study|Withdrawal by Subject|8|||
146047882|NCT01427933|526688250|FG000|Overall Study|Lost to Follow-up|1|||
146047883|NCT01427933|526688251|FG001|Overall Study|Lost to Follow-up|5|||
146047884|NCT01427933|526688250|FG000|Overall Study|Other|1|||
146047885|NCT01427933|526688251|FG001|Overall Study|Other|0|||
146047886|NCT01427933|526688250|FG000|Overall Study|Investigator's Decision|1|||
146047887|NCT01427933|526688251|FG001|Overall Study|Investigator's Decision|0|||
146047888|NCT01633541|526688252|FG000|Overall Study|Death|1|||
146047889|NCT01633541|526688253|FG001|Overall Study|Death|0|||
146047890|NCT01010971|526688256|FG000|Overall Study|Adverse Event|2|||
146047891|NCT01010971|526688257|FG001|Overall Study|Adverse Event|4|||
146047892|NCT01010971|526688258|FG002|Overall Study|Adverse Event|3|||
146047893|NCT01010971|526688256|FG000|Overall Study|Withdrawal by Subject|0|||
146047894|NCT01010971|526688257|FG001|Overall Study|Withdrawal by Subject|2|||
146047895|NCT01010971|526688258|FG002|Overall Study|Withdrawal by Subject|5|||
146047896|NCT01010971|526688256|FG000|Overall Study|Lost to Follow-up|0|||
146047897|NCT01010971|526688257|FG001|Overall Study|Lost to Follow-up|2|||
146047898|NCT01010971|526688258|FG002|Overall Study|Lost to Follow-up|3|||
146047899|NCT01010971|526688256|FG000|Overall Study|Other|1|||
146047900|NCT01010971|526688257|FG001|Overall Study|Other|0|||
146047901|NCT01010971|526688258|FG002|Overall Study|Other|2|||
146047902|NCT03472326|526688259|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
146047903|NCT03472326|526688260|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
146047904|NCT03472326|526688261|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
146047905|NCT03472326|526688262|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
146047906|NCT03472326|526688259|FG000|Part 2: Combination Therapy|Pregnancy|0|||
146047907|NCT03472326|526688260|FG001|Part 2: Combination Therapy|Pregnancy|0|||
146047908|NCT03472326|526688261|FG002|Part 2: Combination Therapy|Pregnancy|0|||
146047909|NCT03472326|526688262|FG003|Part 2: Combination Therapy|Pregnancy|1|||
146047910|NCT05447663|526688263|FG000|Overall Study|Study terminated by Sponsor|5|||
146047911|NCT05447663|526688263|FG000|Overall Study|Death|2|||
146047912|NCT05447663|526688263|FG000|Overall Study|Withdrawal by Subject|1|||
146047913|NCT01100320|526688266|FG000|Period 1|Withdrawal by Subject|2|||
146047914|NCT01100320|526688267|FG001|Period 1|Withdrawal by Subject|4|||
146047915|NCT01100320|526688266|FG000|Period 1|Positive Drug Screen|1|||
146047916|NCT01100320|526688267|FG001|Period 1|Positive Drug Screen|1|||
146047917|NCT01100320|526688266|FG000|Period 1|Adverse Event|2|||
146047918|NCT01100320|526688267|FG001|Period 1|Adverse Event|2|||
146047919|NCT01100320|526688266|FG000|Period 2|Withdrawal by Subject|1|||
146047920|NCT01100320|526688267|FG001|Period 2|Withdrawal by Subject|1|||
146047921|NCT04669301|526688268|FG000|Overall Study|Lost to Follow-up|0|||
146047922|NCT04669301|526688269|FG001|Overall Study|Lost to Follow-up|1|||
146047923|NCT04669301|526688270|FG002|Overall Study|Lost to Follow-up|0|||
146047924|NCT04669301|526688268|FG000|Overall Study|Withdrawal by Subject|3|||
146047925|NCT04669301|526688269|FG001|Overall Study|Withdrawal by Subject|2|||
146047926|NCT04669301|526688270|FG002|Overall Study|Withdrawal by Subject|0|||
146047927|NCT02863328|526688272|FG000|Overall Study|Lost to Follow-up|4|||
146047928|NCT02863328|526688273|FG001|Overall Study|Lost to Follow-up|10|||
146047929|NCT02863328|526688272|FG000|Overall Study|Withdrawal by Subject|7|||
146047930|NCT02863328|526688273|FG001|Overall Study|Withdrawal by Subject|12|||
146047931|NCT02863328|526688272|FG000|Overall Study|Died|0|||
146047932|NCT02863328|526688273|FG001|Overall Study|Died|1|||
146047933|NCT01870726|526688274|FG000|Overall Study|Withdrawal of informed consent|0|||
146047934|NCT01870726|526688275|FG001|Overall Study|Withdrawal of informed consent|0|||
146047935|NCT01870726|526688276|FG002|Overall Study|Withdrawal of informed consent|0|||
146047936|NCT01870726|526688277|FG003|Overall Study|Withdrawal of informed consent|1|||
146047937|NCT01870726|526688278|FG004|Overall Study|Withdrawal of informed consent|0|||
146047938|NCT01870726|526688279|FG005|Overall Study|Withdrawal of informed consent|0|||
146047939|NCT01870726|526688280|FG006|Overall Study|Withdrawal of informed consent|0|||
146047940|NCT01870726|526688274|FG000|Overall Study|Withdrawal by Subject|0|||
146047941|NCT01870726|526688275|FG001|Overall Study|Withdrawal by Subject|1|||
146047942|NCT01870726|526688276|FG002|Overall Study|Withdrawal by Subject|0|||
146047943|NCT01870726|526688277|FG003|Overall Study|Withdrawal by Subject|0|||
146047944|NCT01870726|526688278|FG004|Overall Study|Withdrawal by Subject|0|||
146047945|NCT01870726|526688279|FG005|Overall Study|Withdrawal by Subject|0|||
146047946|NCT01870726|526688280|FG006|Overall Study|Withdrawal by Subject|0|||
146047947|NCT01870726|526688274|FG000|Overall Study|Adverse Event|0|||
146047948|NCT01870726|526688275|FG001|Overall Study|Adverse Event|0|||
146047949|NCT01870726|526688276|FG002|Overall Study|Adverse Event|0|||
146047950|NCT01870726|526688277|FG003|Overall Study|Adverse Event|0|||
146047951|NCT01870726|526688278|FG004|Overall Study|Adverse Event|1|||
146047952|NCT01870726|526688279|FG005|Overall Study|Adverse Event|1|||
146047953|NCT01870726|526688280|FG006|Overall Study|Adverse Event|0|||
146047954|NCT01870726|526688274|FG000|Overall Study|Progressive disease|5|||
146047955|NCT01870726|526688275|FG001|Overall Study|Progressive disease|5|||
146047956|NCT01870726|526688276|FG002|Overall Study|Progressive disease|4|||
146047957|NCT01870726|526688277|FG003|Overall Study|Progressive disease|5|||
146047958|NCT01870726|526688278|FG004|Overall Study|Progressive disease|6|||
146047959|NCT01870726|526688279|FG005|Overall Study|Progressive disease|4|||
146047960|NCT01870726|526688280|FG006|Overall Study|Progressive disease|10|||
146047961|NCT00595478|526688281|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
146047962|NCT00595478|526688282|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
146047963|NCT00595478|526688281|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
146047964|NCT00595478|526688282|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
146047965|NCT02978833|526688288|FG000|Overall Study|Study terminated|1|||
146047966|NCT02978833|526688289|FG001|Overall Study|Study terminated|1|||
146047967|NCT00186901|526688291|FG000|Overall Study|Pregnancy|6|||
146047968|NCT00186901|526688292|FG001|Overall Study|Pregnancy|3|||
146047969|NCT00186901|526688293|FG002|Overall Study|Pregnancy|0|||
146047970|NCT00186901|526688291|FG000|Overall Study|Lost to Follow-up|6|||
146047971|NCT00186901|526688292|FG001|Overall Study|Lost to Follow-up|3|||
146047972|NCT00186901|526688293|FG002|Overall Study|Lost to Follow-up|0|||
146047973|NCT00186901|526688291|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
146047974|NCT00186901|526688292|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
146047975|NCT00186901|526688293|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
146047976|NCT00186901|526688291|FG000|Overall Study|ALL relapse or second malignancy|1|||
146047977|NCT00186901|526688292|FG001|Overall Study|ALL relapse or second malignancy|2|||
146047978|NCT00186901|526688293|FG002|Overall Study|ALL relapse or second malignancy|0|||
146047979|NCT00186901|526688291|FG000|Overall Study|Withdrawal by Subject|4|||
146047980|NCT00186901|526688292|FG001|Overall Study|Withdrawal by Subject|5|||
146047981|NCT00186901|526688293|FG002|Overall Study|Withdrawal by Subject|0|||
146047982|NCT00186901|526688291|FG000|Overall Study|Open label|3|||
146047983|NCT00186901|526688292|FG001|Overall Study|Open label|2|||
146047984|NCT00186901|526688293|FG002|Overall Study|Open label|0|||
146047985|NCT00186901|526688291|FG000|Overall Study|Limited adherence to study requirements|20|||
146047986|NCT00186901|526688292|FG001|Overall Study|Limited adherence to study requirements|23|||
146047987|NCT00186901|526688293|FG002|Overall Study|Limited adherence to study requirements|0|||
146047988|NCT00186901|526688291|FG000|Overall Study|Bone Mineral Density > 0|0|||
146047989|NCT00186901|526688292|FG001|Overall Study|Bone Mineral Density > 0|0|||
146047990|NCT00186901|526688293|FG002|Overall Study|Bone Mineral Density > 0|149|||
146047991|NCT00555217|526688294|FG000|Overall Study|Withdrawal by Subject|35|||
146047992|NCT00555217|526688295|FG001|Overall Study|Withdrawal by Subject|31|||
146047993|NCT00555217|526688294|FG000|Overall Study|Lost to Follow-up|19|||
146047994|NCT00555217|526688295|FG001|Overall Study|Lost to Follow-up|20|||
146047995|NCT00555217|526688294|FG000|Overall Study|close out sites|21|||
146047996|NCT00555217|526688295|FG001|Overall Study|close out sites|17|||
146047997|NCT00950248|526688298|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
146047998|NCT00950248|526688299|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
146047999|NCT00950248|526688300|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
146048000|NCT00950248|526688298|FG000|Year 1: Baseline|worsening of symptoms|2|||
146048001|NCT00950248|526688299|FG001|Year 1: Baseline|worsening of symptoms|0|||
146048002|NCT00950248|526688300|FG002|Year 1: Baseline|worsening of symptoms|0|||
146048003|NCT00950248|526688298|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
146048004|NCT00950248|526688299|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
146048005|NCT00950248|526688300|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
146048006|NCT00950248|526688298|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
146048007|NCT00950248|526688299|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
146048008|NCT00950248|526688300|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
146048009|NCT00950248|526688298|FG000|Year 2&3 Treatment Randomization|Death|0|||
146048010|NCT00950248|526688299|FG001|Year 2&3 Treatment Randomization|Death|0|||
146048011|NCT00950248|526688300|FG002|Year 2&3 Treatment Randomization|Death|1|||
146048012|NCT00950248|526688298|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
146048013|NCT00950248|526688299|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
146048014|NCT00950248|526688300|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
146048015|NCT00900029|526688301|FG000|Overall Study|Lost to Follow-up|0|||
146048016|NCT00900029|526688302|FG001|Overall Study|Lost to Follow-up|2|||
146048017|NCT00900029|526688303|FG002|Overall Study|Lost to Follow-up|1|||
146048018|NCT00900029|526688304|FG003|Overall Study|Lost to Follow-up|4|||
146048019|NCT00900029|526688305|FG004|Overall Study|Lost to Follow-up|4|||
146048020|NCT00900029|526688301|FG000|Overall Study|Withdrawal by Subject|2|||
146048021|NCT00900029|526688302|FG001|Overall Study|Withdrawal by Subject|2|||
146048022|NCT00900029|526688303|FG002|Overall Study|Withdrawal by Subject|1|||
146048023|NCT00900029|526688304|FG003|Overall Study|Withdrawal by Subject|1|||
146048024|NCT00900029|526688305|FG004|Overall Study|Withdrawal by Subject|1|||
146048025|NCT00900029|526688301|FG000|Overall Study|Adverse Event|0|||
146048026|NCT00900029|526688302|FG001|Overall Study|Adverse Event|0|||
146048027|NCT00900029|526688303|FG002|Overall Study|Adverse Event|1|||
146048028|NCT00900029|526688304|FG003|Overall Study|Adverse Event|1|||
146048029|NCT00900029|526688305|FG004|Overall Study|Adverse Event|1|||
146048030|NCT00900029|526688301|FG000|Overall Study|Death|1|||
146048031|NCT00900029|526688302|FG001|Overall Study|Death|0|||
146048032|NCT00900029|526688303|FG002|Overall Study|Death|0|||
146048033|NCT00900029|526688304|FG003|Overall Study|Death|1|||
146048034|NCT00900029|526688305|FG004|Overall Study|Death|0|||
146048035|NCT02709330|526688306|FG000|Overall Study|Death|5|||
146048036|NCT02709330|526688307|FG001|Overall Study|Death|0|||
146048037|NCT02709330|526688306|FG000|Overall Study|Lost to Follow-up|2|||
146048038|NCT02709330|526688307|FG001|Overall Study|Lost to Follow-up|0|||
146255840|NCT02498418|527450603|FG002|Overall Study|Withdrawal by Subject|3|||
146255841|NCT02498418|527450601|FG000|Overall Study|Lost to Follow-up|0|||
146255842|NCT02498418|527450602|FG001|Overall Study|Lost to Follow-up|1|||
146255843|NCT02498418|527450603|FG002|Overall Study|Lost to Follow-up|1|||
146255844|NCT02498418|527450601|FG000|Overall Study|Participant taken prohibited medication|0|||
146255845|NCT02498418|527450602|FG001|Overall Study|Participant taken prohibited medication|1|||
146255846|NCT02498418|527450603|FG002|Overall Study|Participant taken prohibited medication|1|||
146255847|NCT00762502|527450605|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
146255848|NCT00762502|527450606|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
146255849|NCT00762502|527450607|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
146255850|NCT00762502|527450605|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
146255851|NCT00762502|527450606|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
146255852|NCT00762502|527450607|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
146255853|NCT00762502|527450605|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
146255854|NCT00762502|527450606|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
146255855|NCT00762502|527450607|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
146255856|NCT02625922|527450609|FG000|Overall Study|Non-availability of IMP|1|||
146255857|NCT02625922|527450610|FG001|Overall Study|Non-availability of IMP|1|||
146255858|NCT02625922|527450609|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
146048039|NCT02709330|526688306|FG000|Overall Study|Physician Decision|2|||
146048040|NCT02709330|526688307|FG001|Overall Study|Physician Decision|0|||
146048041|NCT02709330|526688306|FG000|Overall Study|Withdrawal by Subject|4|||
146048042|NCT02709330|526688307|FG001|Overall Study|Withdrawal by Subject|0|||
146048043|NCT02587819|526688308|FG000|Overall Study|Adverse Event|1|||
146048044|NCT02587819|526688308|FG000|Overall Study|Lost to Follow-up|1|||
146048045|NCT00511238|526688309|FG000|Overall Study|Adverse Event|13|||
146048046|NCT00511238|526688310|FG001|Overall Study|Adverse Event|33|||
146048047|NCT00511238|526688309|FG000|Overall Study|Withdrawal by Subject|2|||
146048048|NCT00511238|526688310|FG001|Overall Study|Withdrawal by Subject|22|||
146048049|NCT00511238|526688309|FG000|Overall Study|Progressive Disease|23|||
146048050|NCT00511238|526688310|FG001|Overall Study|Progressive Disease|157|||
146048051|NCT00511238|526688309|FG000|Overall Study|various reasons|4|||
146048052|NCT00511238|526688310|FG001|Overall Study|various reasons|14|||
146048053|NCT00859547|526689928|FG000|Overall Study|Lost to Follow-up|1|||
146048054|NCT00859547|526689928|FG000|Overall Study|Parent withdrew consent|1|||
146048055|NCT01410890|526689930|FG000|Overall Study|Withdrawal by Subject|0|||
146048056|NCT01410890|526689931|FG001|Overall Study|Withdrawal by Subject|1|||
146048057|NCT00997035|526689935|FG000|3-week Followup Visit|Lost to Follow-up|9|||
146048058|NCT00997035|526689936|FG001|3-week Followup Visit|Lost to Follow-up|6|||
146048059|NCT00997035|526689935|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
146048060|NCT00997035|526689936|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
146048061|NCT02544503|526689942|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
146048062|NCT02544503|526689943|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
146048063|NCT02544503|526689942|FG000|Overall Study|Lost to Follow-up|9|||
146048064|NCT02544503|526689943|FG001|Overall Study|Lost to Follow-up|0|||
146048065|NCT02544503|526689942|FG000|Overall Study|Withdrawal by Subject|1|||
146048066|NCT02544503|526689943|FG001|Overall Study|Withdrawal by Subject|0|||
146048067|NCT00991939|526689946|FG000|Overall Study|Lost to Follow-up|0|||
146048068|NCT00991939|526689947|FG001|Overall Study|Lost to Follow-up|1|||
146048069|NCT00991939|526689946|FG000|Overall Study|Withdrawal by Subject|1|||
146048070|NCT00991939|526689947|FG001|Overall Study|Withdrawal by Subject|0|||
146048071|NCT00991939|526689946|FG000|Overall Study|Entire study terminated|4|||
146048072|NCT00991939|526689947|FG001|Overall Study|Entire study terminated|1|||
146048073|NCT00714415|526689948|FG000|Overall Study|Lack of Efficacy|1|||
146048074|NCT00714415|526689949|FG001|Overall Study|Lack of Efficacy|0|||
146048075|NCT00714415|526689948|FG000|Overall Study|Death|1|||
146048076|NCT00714415|526689949|FG001|Overall Study|Death|0|||
146048077|NCT01461707|526689952|FG000|Overall Study|Withdrawal by Subject|1|||
146048078|NCT01461707|526689953|FG001|Overall Study|Withdrawal by Subject|0|||
146048079|NCT01450761|526689954|FG000|Randomization|Subject no longer meets study criteria|1|||
146048080|NCT01450761|526689955|FG001|Randomization|Subject no longer meets study criteria|2|||
146048081|NCT01450761|526689954|FG000|Randomization|Withdrawal by Subject|2|||
146048082|NCT01450761|526689955|FG001|Randomization|Withdrawal by Subject|0|||
146048083|NCT01450761|526689954|FG000|Randomization|Disease progression|0|||
146048084|NCT01450761|526689955|FG001|Randomization|Disease progression|2|||
146048085|NCT01450761|526689954|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146048086|NCT01450761|526689955|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146048087|NCT01450761|526689954|FG000|Randomization|Other|0|||
146048088|NCT01450761|526689955|FG001|Randomization|Other|1|||
146048089|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Disease progression|33|||
146048090|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Disease progression|32|||
146048091|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
146048092|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
146048093|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
146048094|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
146048095|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
146048096|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
146048097|NCT01450761|526689954|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
146048098|NCT01450761|526689955|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
146048099|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Death|3|||
146048100|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Death|3|||
146048101|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Other|2|||
146048102|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Other|2|||
146048103|NCT01450761|526689954|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
146048104|NCT01450761|526689955|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
146048105|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
146048106|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
146048107|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
146048108|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
146048109|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
146048110|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
146048111|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
146048112|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
146048113|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
146048114|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
146048115|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Death|5|||
146048116|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Death|6|||
146255859|NCT02625922|527450610|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
146255860|NCT01294358|527450614|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146255861|NCT01294358|527450615|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
146255862|NCT01294358|527450616|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146255863|NCT01294358|527450617|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146255864|NCT01294358|527450618|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
146255865|NCT01294358|527450614|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146255866|NCT01294358|527450615|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146255867|NCT01294358|527450616|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
146255868|NCT01294358|527450617|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146255869|NCT01294358|527450618|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
146255870|NCT01294358|527450614|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146255871|NCT01294358|527450615|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146255872|NCT01294358|527450616|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146255873|NCT01294358|527450617|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
146255874|NCT01294358|527450618|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
146255875|NCT01294358|527450614|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146255876|NCT01294358|527450615|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146255877|NCT01294358|527450616|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146255878|NCT01294358|527450617|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
146255879|NCT01294358|527450618|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
146048117|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
146048118|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
146048119|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
146048120|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
146048121|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
146048122|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
146048123|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
146048124|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
146048125|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
146048126|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
146048127|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
146048128|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
146255880|NCT03356145|527450619|FG000|Overall Study|Withdrawal by Subject|2|||
146255881|NCT03356145|527450620|FG001|Overall Study|Withdrawal by Subject|1|||
146255882|NCT03356145|527450619|FG000|Overall Study|Did not meet inclusion criteria|1|||
146255883|NCT03356145|527450620|FG001|Overall Study|Did not meet inclusion criteria|0|||
146300861|NCT03346057|527617151|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
146300862|NCT03346057|527617152|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
146300863|NCT03346057|527617153|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
146300864|NCT03346057|527617154|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
146300865|NCT03346057|527617151|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
146300866|NCT03346057|527617152|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
146300867|NCT03346057|527617153|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
146255884|NCT02963922|527450621|FG000|Overall Study|Adverse Event|15|||
146255885|NCT02963922|527450622|FG001|Overall Study|Adverse Event|6|||
146300868|NCT03346057|527617154|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
146300869|NCT03346057|527617151|FG000|Overall Study|Physician Decision|3|||
146300870|NCT03346057|527617152|FG001|Overall Study|Physician Decision|2|||
146300871|NCT03346057|527617153|FG002|Overall Study|Physician Decision|0|||
146300872|NCT03346057|527617154|FG003|Overall Study|Physician Decision|2|||
146300873|NCT03346057|527617151|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
146300874|NCT03346057|527617152|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
146300875|NCT03346057|527617153|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
146300876|NCT03346057|527617154|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
146300877|NCT03346057|527617151|FG000|Overall Study|Withdrawal by Subject|1|||
146300878|NCT03346057|527617152|FG001|Overall Study|Withdrawal by Subject|0|||
146300879|NCT03346057|527617153|FG002|Overall Study|Withdrawal by Subject|0|||
146300880|NCT03346057|527617154|FG003|Overall Study|Withdrawal by Subject|0|||
146300881|NCT02921269|527617155|FG000|Overall Study|Did not complete DLT period|1|||
146300882|NCT04399122|527617156|FG000|Overall Study|Lost to Follow-up|2|||
146300883|NCT04399122|527617157|FG001|Overall Study|Lost to Follow-up|0|||
146300884|NCT04399122|527617156|FG000|Overall Study|Withdrawal by Subject|1|||
146300885|NCT04399122|527617157|FG001|Overall Study|Withdrawal by Subject|0|||
146300886|NCT02536755|527617158|FG000|Overall Study|Adverse Event|4|||
146300887|NCT02301936|527617160|FG000|Overall Study|Lost to Follow-up|1|||
146300888|NCT02301936|527617161|FG001|Overall Study|Lost to Follow-up|0|||
146300889|NCT01174238|527617162|FG000|Overall Study|Lost to Follow-up|2|||
146300890|NCT02322229|527617164|FG000|Overall Study|Physician Decision|2|||
146300891|NCT03065023|527617165|FG000|Overall Study|Progressive Disease|0|||
146300892|NCT03065023|527617166|FG001|Overall Study|Progressive Disease|1|||
146300893|NCT03065023|527617167|FG002|Overall Study|Progressive Disease|0|||
146300894|NCT03065023|527617168|FG003|Overall Study|Progressive Disease|0|||
146300895|NCT03065023|527617169|FG004|Overall Study|Progressive Disease|0|||
146300896|NCT03065023|527617165|FG000|Overall Study|Death|2|||
146300897|NCT03065023|527617166|FG001|Overall Study|Death|0|||
146300898|NCT03065023|527617167|FG002|Overall Study|Death|1|||
146300899|NCT03065023|527617168|FG003|Overall Study|Death|1|||
146300900|NCT03065023|527617169|FG004|Overall Study|Death|0|||
146300901|NCT03065023|527617165|FG000|Overall Study|Lost to Follow-up|0|||
146300902|NCT03065023|527617166|FG001|Overall Study|Lost to Follow-up|1|||
146048129|NCT01450761|526689954|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
146048130|NCT01450761|526689955|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
146048131|NCT03801174|526689977|FG000|Overall Study|Withdrawal by Subject|14|||
146048132|NCT03801174|526689978|FG001|Overall Study|Withdrawal by Subject|15|||
146048133|NCT03801174|526689977|FG000|Overall Study|Death|1|||
146048134|NCT03801174|526689978|FG001|Overall Study|Death|0|||
146048135|NCT03801174|526689977|FG000|Overall Study|Pregnancy|2|||
146048136|NCT03801174|526689978|FG001|Overall Study|Pregnancy|2|||
146048137|NCT03801174|526689977|FG000|Overall Study|Lost to Follow-up|19|||
146048138|NCT03801174|526689978|FG001|Overall Study|Lost to Follow-up|10|||
146048139|NCT03801174|526689977|FG000|Overall Study|Other|4|||
146048140|NCT03801174|526689978|FG001|Overall Study|Other|3|||
146048141|NCT03801174|526689977|FG000|Overall Study|Lack of Efficacy|4|||
146048142|NCT03801174|526689978|FG001|Overall Study|Lack of Efficacy|0|||
146048143|NCT03801174|526689977|FG000|Overall Study|Unwilling to complete activities|5|||
146048144|NCT03801174|526689978|FG001|Overall Study|Unwilling to complete activities|6|||
146048145|NCT03801174|526689977|FG000|Overall Study|Moved out of area|3|||
146048146|NCT03801174|526689978|FG001|Overall Study|Moved out of area|0|||
146048147|NCT00855816|526689979|FG000|Overall Study|Withdrawal by Subject|22|||
146048148|NCT00855816|526689980|FG001|Overall Study|Withdrawal by Subject|15|||
146048149|NCT00855816|526689979|FG000|Overall Study|Lost to Follow-up|3|||
146048150|NCT00855816|526689980|FG001|Overall Study|Lost to Follow-up|5|||
146048151|NCT00855816|526689979|FG000|Overall Study|Death|1|||
146048152|NCT00855816|526689980|FG001|Overall Study|Death|0|||
146048153|NCT00855816|526689979|FG000|Overall Study|Became ineligible|0|||
146048154|NCT00855816|526689980|FG001|Overall Study|Became ineligible|1|||
146048155|NCT01521507|526689984|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
146255886|NCT02963922|527450621|FG000|Overall Study|Protocol deviation|6|||
146048156|NCT01521507|526689985|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
146255887|NCT02963922|527450622|FG001|Overall Study|Protocol deviation|6|||
146255888|NCT02963922|527450621|FG000|Overall Study|Lack of Efficacy|1|||
146255889|NCT02963922|527450622|FG001|Overall Study|Lack of Efficacy|1|||
146300903|NCT03065023|527617167|FG002|Overall Study|Lost to Follow-up|0|||
146300904|NCT03065023|527617168|FG003|Overall Study|Lost to Follow-up|0|||
146300905|NCT03065023|527617169|FG004|Overall Study|Lost to Follow-up|0|||
146255890|NCT02963922|527450621|FG000|Overall Study|Lost to Follow-up|2|||
146255891|NCT02963922|527450622|FG001|Overall Study|Lost to Follow-up|3|||
146300906|NCT03065023|527617165|FG000|Overall Study|Participant Decision|0|||
146300907|NCT03065023|527617166|FG001|Overall Study|Participant Decision|0|||
146300908|NCT03065023|527617167|FG002|Overall Study|Participant Decision|0|||
146300909|NCT03065023|527617168|FG003|Overall Study|Participant Decision|1|||
146048157|NCT01521507|526689984|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
146048158|NCT01521507|526689985|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
146048159|NCT01521507|526689984|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
146048160|NCT01521507|526689985|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
146048161|NCT01521507|526689984|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
146048162|NCT01521507|526689985|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
146048163|NCT01521507|526689984|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
146048164|NCT01521507|526689985|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
146048165|NCT01521507|526689984|FG000|Stage 2: Observational Design|Physician Decision|1|||
146048166|NCT01521507|526689985|FG001|Stage 2: Observational Design|Physician Decision|0|||
146048167|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
146048168|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
146048169|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
146048170|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
146048171|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
146048172|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
146048173|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
146048174|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
146048175|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
146048176|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
146048177|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
146048178|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
146048179|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
146048180|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
146048181|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
146048182|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
146048183|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
146048184|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
146048185|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
146048186|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
146048187|NCT03573323|526689986|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
146048188|NCT03573323|526689987|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
146048189|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
146048190|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
146048191|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
146048192|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
146048193|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
146048194|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
146048195|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
146048196|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
146048197|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
146048198|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
146048199|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
146048200|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
146048201|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
146048202|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
146048203|NCT03573323|526689986|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
146048204|NCT03573323|526689987|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
146048205|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Progressive disease|50|||
146048206|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Progressive disease|110|||
146048207|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Progressive disease|0|||
146048208|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Progressive disease|0|||
146048209|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146048210|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
146048211|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146048212|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146048213|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Adverse Event|7|||
146048214|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Adverse Event|7|||
146048215|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146048216|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Adverse Event|0|||
146048217|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Other|1|||
146048218|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Other|3|||
146048219|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Other|0|||
146048220|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Other|0|||
146048221|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Physician Decision|6|||
146255892|NCT02963922|527450621|FG000|Overall Study|Other|8|||
146255893|NCT02963922|527450622|FG001|Overall Study|Other|14|||
146255894|NCT03840148|527450632|FG000|Study Drug Disposition|Adverse Event|13|||
146255895|NCT03840148|527450633|FG001|Study Drug Disposition|Adverse Event|2|||
146255896|NCT03840148|527450632|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
146048222|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Physician Decision|3|||
146048223|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Physician Decision|0|||
146048224|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Physician Decision|0|||
146048225|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Death|1|||
146048226|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Death|1|||
146048227|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Death|0|||
146048228|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Death|0|||
146048229|NCT01695135|526689990|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146048230|NCT01695135|526689991|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
146048231|NCT01695135|526689992|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146048232|NCT01695135|526689993|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
146048233|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
146048234|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
146048235|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
146048236|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
146048237|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
146048238|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
146048239|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
146048240|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
146048241|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
146048242|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
146048243|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
146048244|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
146048245|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Other|0|||
146048246|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Other|0|||
146048247|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Other|4|||
146048248|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Other|7|||
146048249|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
146048250|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
146048251|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
146048252|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
146048253|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Death|0|||
146048254|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Death|0|||
146048255|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Death|2|||
146048256|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Death|7|||
146048257|NCT01695135|526689990|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146048258|NCT01695135|526689991|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146048259|NCT01695135|526689992|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
146048260|NCT01695135|526689993|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
146048261|NCT02714569|526689996|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
146048262|NCT02714569|526689997|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
146048263|NCT02714569|526689998|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
146048264|NCT02714569|526689999|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
146048265|NCT02714569|526690000|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
146048266|NCT02714569|526690001|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
146048267|NCT02714569|526690002|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
146048268|NCT02714569|526690003|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
146048269|NCT02714569|526690004|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
146048270|NCT02714569|526690005|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
146048271|NCT02714569|526690006|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
146048272|NCT02714569|526689996|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048273|NCT02714569|526689997|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048274|NCT02714569|526689998|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048275|NCT02714569|526689999|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
146048276|NCT02714569|526690000|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048277|NCT02714569|526690001|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048278|NCT02714569|526690002|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048279|NCT02714569|526690003|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048280|NCT02714569|526690004|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146255897|NCT03840148|527450633|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
146255898|NCT03840148|527450632|FG000|Study Drug Disposition|Lack of Efficacy|3|||
146255899|NCT03840148|527450633|FG001|Study Drug Disposition|Lack of Efficacy|0|||
146048281|NCT02714569|526690005|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048282|NCT02714569|526690006|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
146048283|NCT02714569|526689996|FG000|Part A Third Intervention|Adverse Event|0|||
146048284|NCT02714569|526689997|FG001|Part A Third Intervention|Adverse Event|0|||
146048285|NCT02714569|526689998|FG002|Part A Third Intervention|Adverse Event|1|||
146048286|NCT02714569|526689999|FG003|Part A Third Intervention|Adverse Event|0|||
146048287|NCT02714569|526690000|FG004|Part A Third Intervention|Adverse Event|0|||
146048288|NCT02714569|526690001|FG005|Part A Third Intervention|Adverse Event|0|||
146048289|NCT02714569|526690002|FG006|Part A Third Intervention|Adverse Event|0|||
146048290|NCT02714569|526690003|FG007|Part A Third Intervention|Adverse Event|0|||
146048291|NCT02714569|526690004|FG008|Part A Third Intervention|Adverse Event|0|||
146048292|NCT02714569|526690005|FG009|Part A Third Intervention|Adverse Event|0|||
146048293|NCT02714569|526690006|FG010|Part A Third Intervention|Adverse Event|0|||
146048294|NCT02714569|526689996|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
146048295|NCT02714569|526689997|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048296|NCT02714569|526689998|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048297|NCT02714569|526689999|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048298|NCT02714569|526690000|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048299|NCT02714569|526690001|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
146048300|NCT02714569|526690002|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048301|NCT02714569|526690003|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048302|NCT02714569|526690004|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048303|NCT02714569|526690005|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048304|NCT02714569|526690006|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
146048305|NCT02714569|526689996|FG000|Part B (Overall)|Lost to Follow-up|0|||
146048306|NCT02714569|526689997|FG001|Part B (Overall)|Lost to Follow-up|0|||
146048307|NCT02714569|526689998|FG002|Part B (Overall)|Lost to Follow-up|0|||
146048308|NCT02714569|526689999|FG003|Part B (Overall)|Lost to Follow-up|0|||
146048309|NCT02714569|526690000|FG004|Part B (Overall)|Lost to Follow-up|0|||
146048310|NCT02714569|526690001|FG005|Part B (Overall)|Lost to Follow-up|0|||
146048311|NCT02714569|526690002|FG006|Part B (Overall)|Lost to Follow-up|1|||
146048312|NCT02714569|526690003|FG007|Part B (Overall)|Lost to Follow-up|0|||
146048313|NCT02714569|526690004|FG008|Part B (Overall)|Lost to Follow-up|0|||
146048314|NCT02714569|526690005|FG009|Part B (Overall)|Lost to Follow-up|0|||
146048315|NCT02714569|526690006|FG010|Part B (Overall)|Lost to Follow-up|0|||
146048316|NCT02714569|526689996|FG000|Part B (Overall)|Withdrawal by Subject|0|||
146048317|NCT02714569|526689997|FG001|Part B (Overall)|Withdrawal by Subject|0|||
146048318|NCT02714569|526689998|FG002|Part B (Overall)|Withdrawal by Subject|0|||
146048319|NCT02714569|526689999|FG003|Part B (Overall)|Withdrawal by Subject|0|||
146048320|NCT02714569|526690000|FG004|Part B (Overall)|Withdrawal by Subject|0|||
146048321|NCT02714569|526690001|FG005|Part B (Overall)|Withdrawal by Subject|0|||
146048322|NCT02714569|526690002|FG006|Part B (Overall)|Withdrawal by Subject|0|||
146048323|NCT02714569|526690003|FG007|Part B (Overall)|Withdrawal by Subject|1|||
146048324|NCT02714569|526690004|FG008|Part B (Overall)|Withdrawal by Subject|0|||
146048325|NCT02714569|526690005|FG009|Part B (Overall)|Withdrawal by Subject|1|||
146048326|NCT02714569|526690006|FG010|Part B (Overall)|Withdrawal by Subject|0|||
146048327|NCT02714569|526689996|FG000|Part B (Overall)|Adverse Event|0|||
146048328|NCT02714569|526689997|FG001|Part B (Overall)|Adverse Event|0|||
146048329|NCT02714569|526689998|FG002|Part B (Overall)|Adverse Event|0|||
146048330|NCT02714569|526689999|FG003|Part B (Overall)|Adverse Event|0|||
146048331|NCT02714569|526690000|FG004|Part B (Overall)|Adverse Event|0|||
146048332|NCT02714569|526690001|FG005|Part B (Overall)|Adverse Event|0|||
146048333|NCT02714569|526690002|FG006|Part B (Overall)|Adverse Event|0|||
146048334|NCT02714569|526690003|FG007|Part B (Overall)|Adverse Event|0|||
146048335|NCT02714569|526690004|FG008|Part B (Overall)|Adverse Event|0|||
146048336|NCT02714569|526690005|FG009|Part B (Overall)|Adverse Event|1|||
146048337|NCT02714569|526690006|FG010|Part B (Overall)|Adverse Event|0|||
146048338|NCT01684202|526690007|FG000|Dose-escalation Period|Adverse Event|0|||
146048339|NCT01684202|526690008|FG001|Dose-escalation Period|Adverse Event|1|||
146048340|NCT01684202|526690009|FG002|Dose-escalation Period|Adverse Event|0|||
146048341|NCT01684202|526690010|FG003|Dose-escalation Period|Adverse Event|0|||
146048342|NCT01684202|526690007|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
146048343|NCT01684202|526690008|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
146048344|NCT01684202|526690009|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
146255900|NCT03840148|527450632|FG000|Study Drug Disposition|Physician Decision|2|||
146255901|NCT03840148|527450633|FG001|Study Drug Disposition|Physician Decision|0|||
146255902|NCT03840148|527450632|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
146048345|NCT01684202|526690010|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
146048346|NCT01684202|526690007|FG000|Maintenance Period|Adverse Event|1|||
146048347|NCT01684202|526690008|FG001|Maintenance Period|Adverse Event|1|||
146048348|NCT01684202|526690009|FG002|Maintenance Period|Adverse Event|1|||
146048349|NCT01684202|526690010|FG003|Maintenance Period|Adverse Event|1|||
146048350|NCT01684202|526690007|FG000|Maintenance Period|Physician Decision|0|||
146048351|NCT01684202|526690008|FG001|Maintenance Period|Physician Decision|1|||
146048352|NCT01684202|526690009|FG002|Maintenance Period|Physician Decision|0|||
146048353|NCT01684202|526690010|FG003|Maintenance Period|Physician Decision|0|||
146048354|NCT01684202|526690007|FG000|Maintenance Period|Withdrawal by Subject|0|||
146048355|NCT01684202|526690008|FG001|Maintenance Period|Withdrawal by Subject|1|||
146048356|NCT01684202|526690009|FG002|Maintenance Period|Withdrawal by Subject|0|||
146048357|NCT01684202|526690010|FG003|Maintenance Period|Withdrawal by Subject|0|||
146048358|NCT03386721|526690011|FG000|Overall Study|Death|12|||
146048359|NCT03386721|526690012|FG001|Overall Study|Death|21|||
146048360|NCT03386721|526690013|FG002|Overall Study|Death|2|||
146048361|NCT03386721|526690014|FG003|Overall Study|Death|5|||
146048362|NCT03386721|526690015|FG004|Overall Study|Death|1|||
146048363|NCT03386721|526690016|FG005|Overall Study|Death|12|||
146048364|NCT03386721|526690017|FG006|Overall Study|Death|1|||
146048365|NCT03386721|526690018|FG007|Overall Study|Death|1|||
146048366|NCT03386721|526690019|FG008|Overall Study|Death|12|||
146048367|NCT03386721|526690020|FG009|Overall Study|Death|20|||
146048368|NCT03386721|526690021|FG010|Overall Study|Death|21|||
146048369|NCT03386721|526690022|FG011|Overall Study|Death|21|||
146048370|NCT03386721|526690023|FG012|Overall Study|Death|14|||
146048371|NCT03386721|526690024|FG013|Overall Study|Death|2|||
146048372|NCT03386721|526690025|FG014|Overall Study|Death|1|||
146048373|NCT03386721|526690011|FG000|Overall Study|Lost to Follow-up|1|||
146048374|NCT03386721|526690012|FG001|Overall Study|Lost to Follow-up|3|||
146048375|NCT03386721|526690013|FG002|Overall Study|Lost to Follow-up|0|||
146048376|NCT03386721|526690014|FG003|Overall Study|Lost to Follow-up|0|||
146048377|NCT03386721|526690015|FG004|Overall Study|Lost to Follow-up|0|||
146048378|NCT03386721|526690016|FG005|Overall Study|Lost to Follow-up|2|||
146048379|NCT03386721|526690017|FG006|Overall Study|Lost to Follow-up|1|||
146048380|NCT03386721|526690018|FG007|Overall Study|Lost to Follow-up|0|||
146048381|NCT03386721|526690019|FG008|Overall Study|Lost to Follow-up|1|||
146048382|NCT03386721|526690020|FG009|Overall Study|Lost to Follow-up|2|||
146048383|NCT03386721|526690021|FG010|Overall Study|Lost to Follow-up|1|||
146048384|NCT03386721|526690022|FG011|Overall Study|Lost to Follow-up|0|||
146048385|NCT03386721|526690023|FG012|Overall Study|Lost to Follow-up|0|||
146048386|NCT03386721|526690024|FG013|Overall Study|Lost to Follow-up|0|||
146048387|NCT03386721|526690025|FG014|Overall Study|Lost to Follow-up|0|||
146048388|NCT03386721|526690011|FG000|Overall Study|Reason not specified|3|||
146048389|NCT03386721|526690012|FG001|Overall Study|Reason not specified|0|||
146048390|NCT03386721|526690013|FG002|Overall Study|Reason not specified|0|||
146048391|NCT03386721|526690014|FG003|Overall Study|Reason not specified|0|||
146048392|NCT03386721|526690015|FG004|Overall Study|Reason not specified|0|||
146048393|NCT03386721|526690016|FG005|Overall Study|Reason not specified|3|||
146048394|NCT03386721|526690017|FG006|Overall Study|Reason not specified|1|||
146048395|NCT03386721|526690018|FG007|Overall Study|Reason not specified|0|||
146048396|NCT03386721|526690019|FG008|Overall Study|Reason not specified|0|||
146048397|NCT03386721|526690020|FG009|Overall Study|Reason not specified|1|||
146048398|NCT03386721|526690021|FG010|Overall Study|Reason not specified|2|||
146048399|NCT03386721|526690022|FG011|Overall Study|Reason not specified|6|||
146048400|NCT03386721|526690023|FG012|Overall Study|Reason not specified|1|||
146048401|NCT03386721|526690024|FG013|Overall Study|Reason not specified|0|||
146048402|NCT03386721|526690025|FG014|Overall Study|Reason not specified|0|||
146048403|NCT03386721|526690011|FG000|Overall Study|Progressive Disease|0|||
146048404|NCT03386721|526690012|FG001|Overall Study|Progressive Disease|0|||
146048405|NCT03386721|526690013|FG002|Overall Study|Progressive Disease|1|||
146048406|NCT03386721|526690014|FG003|Overall Study|Progressive Disease|0|||
146048407|NCT03386721|526690015|FG004|Overall Study|Progressive Disease|0|||
146048408|NCT03386721|526690016|FG005|Overall Study|Progressive Disease|1|||
146048409|NCT03386721|526690017|FG006|Overall Study|Progressive Disease|0|||
146048410|NCT03386721|526690018|FG007|Overall Study|Progressive Disease|0|||
146048411|NCT03386721|526690019|FG008|Overall Study|Progressive Disease|2|||
146048412|NCT03386721|526690020|FG009|Overall Study|Progressive Disease|1|||
146048413|NCT03386721|526690021|FG010|Overall Study|Progressive Disease|1|||
146048414|NCT03386721|526690022|FG011|Overall Study|Progressive Disease|0|||
146048415|NCT03386721|526690023|FG012|Overall Study|Progressive Disease|1|||
146048416|NCT03386721|526690024|FG013|Overall Study|Progressive Disease|0|||
146048417|NCT03386721|526690025|FG014|Overall Study|Progressive Disease|0|||
146048418|NCT03386721|526690011|FG000|Overall Study|Site Terminated by Sponsor|5|||
146048419|NCT03386721|526690012|FG001|Overall Study|Site Terminated by Sponsor|5|||
146048420|NCT03386721|526690013|FG002|Overall Study|Site Terminated by Sponsor|0|||
146048421|NCT03386721|526690014|FG003|Overall Study|Site Terminated by Sponsor|0|||
146048422|NCT03386721|526690015|FG004|Overall Study|Site Terminated by Sponsor|1|||
146048423|NCT03386721|526690016|FG005|Overall Study|Site Terminated by Sponsor|3|||
146048424|NCT03386721|526690017|FG006|Overall Study|Site Terminated by Sponsor|0|||
146048425|NCT03386721|526690018|FG007|Overall Study|Site Terminated by Sponsor|1|||
146048426|NCT03386721|526690019|FG008|Overall Study|Site Terminated by Sponsor|4|||
146048427|NCT03386721|526690020|FG009|Overall Study|Site Terminated by Sponsor|5|||
146048428|NCT03386721|526690021|FG010|Overall Study|Site Terminated by Sponsor|3|||
146048429|NCT03386721|526690022|FG011|Overall Study|Site Terminated by Sponsor|11|||
146048430|NCT03386721|526690023|FG012|Overall Study|Site Terminated by Sponsor|6|||
146255903|NCT03840148|527450633|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
146255904|NCT03840148|527450632|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
146255905|NCT03840148|527450633|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
146255906|NCT03840148|527450632|FG000|Study Completion Disposition|Physician Decision|2|||
146255907|NCT03840148|527450633|FG001|Study Completion Disposition|Physician Decision|0|||
146255908|NCT03840148|527450632|FG000|Study Completion Disposition|Covid-19 related|2|||
146255909|NCT03840148|527450633|FG001|Study Completion Disposition|Covid-19 related|0|||
146255910|NCT03840148|527450632|FG000|Study Completion Disposition|Lost to Follow-up|1|||
146255911|NCT03840148|527450633|FG001|Study Completion Disposition|Lost to Follow-up|1|||
146255912|NCT03840148|527450632|FG000|Study Completion Disposition|Death|1|||
146255913|NCT03840148|527450633|FG001|Study Completion Disposition|Death|0|||
146255914|NCT03840148|527450632|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
146255915|NCT03840148|527450633|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
146255916|NCT03615404|527450634|FG000|Overall Study|Death|1|||
146255917|NCT03615404|527450634|FG000|Overall Study|vaccine did not pass quality assurance|1|||
146255918|NCT00257556|527450635|FG000|Overall Study|Adverse Event|1|||
146255919|NCT00257556|527450636|FG001|Overall Study|Adverse Event|4|||
146255920|NCT00257556|527450635|FG000|Overall Study|Physician Decision|6|||
146255921|NCT00257556|527450636|FG001|Overall Study|Physician Decision|0|||
146255922|NCT00257556|527450635|FG000|Overall Study|Did not meet hCG criterion|3|||
146255923|NCT00257556|527450636|FG001|Overall Study|Did not meet hCG criterion|0|||
146255924|NCT00257556|527450635|FG000|Overall Study|other reason|4|||
146255925|NCT00257556|527450636|FG001|Overall Study|other reason|6|||
146255926|NCT00905255|527450638|FG000|Overall Study|Adverse Event|7|||
146255927|NCT00905255|527450639|FG001|Overall Study|Adverse Event|5|||
146255928|NCT00905255|527450638|FG000|Overall Study|Withdrawal by Subject|5|||
146048431|NCT03386721|526690024|FG013|Overall Study|Site Terminated by Sponsor|0|||
146048432|NCT03386721|526690025|FG014|Overall Study|Site Terminated by Sponsor|0|||
146048433|NCT03386721|526690011|FG000|Overall Study|Symptomatic Deterioration|0|||
146048434|NCT03386721|526690012|FG001|Overall Study|Symptomatic Deterioration|0|||
146048435|NCT03386721|526690013|FG002|Overall Study|Symptomatic Deterioration|0|||
146048436|NCT03386721|526690014|FG003|Overall Study|Symptomatic Deterioration|0|||
146048437|NCT03386721|526690015|FG004|Overall Study|Symptomatic Deterioration|0|||
146048438|NCT03386721|526690016|FG005|Overall Study|Symptomatic Deterioration|0|||
146048439|NCT03386721|526690017|FG006|Overall Study|Symptomatic Deterioration|0|||
146048440|NCT03386721|526690018|FG007|Overall Study|Symptomatic Deterioration|0|||
146048441|NCT03386721|526690019|FG008|Overall Study|Symptomatic Deterioration|1|||
146048442|NCT03386721|526690020|FG009|Overall Study|Symptomatic Deterioration|0|||
146048443|NCT03386721|526690021|FG010|Overall Study|Symptomatic Deterioration|0|||
146048444|NCT03386721|526690022|FG011|Overall Study|Symptomatic Deterioration|1|||
146048445|NCT03386721|526690023|FG012|Overall Study|Symptomatic Deterioration|0|||
146048446|NCT03386721|526690024|FG013|Overall Study|Symptomatic Deterioration|0|||
146048447|NCT03386721|526690025|FG014|Overall Study|Symptomatic Deterioration|0|||
146048448|NCT03386721|526690011|FG000|Overall Study|Withdrawal by Subject|1|||
146048449|NCT03386721|526690012|FG001|Overall Study|Withdrawal by Subject|2|||
146048450|NCT03386721|526690013|FG002|Overall Study|Withdrawal by Subject|0|||
146048451|NCT03386721|526690014|FG003|Overall Study|Withdrawal by Subject|0|||
146048452|NCT03386721|526690015|FG004|Overall Study|Withdrawal by Subject|0|||
146048453|NCT03386721|526690016|FG005|Overall Study|Withdrawal by Subject|0|||
146048454|NCT03386721|526690017|FG006|Overall Study|Withdrawal by Subject|0|||
146048455|NCT03386721|526690018|FG007|Overall Study|Withdrawal by Subject|0|||
146048456|NCT03386721|526690019|FG008|Overall Study|Withdrawal by Subject|2|||
146048457|NCT03386721|526690020|FG009|Overall Study|Withdrawal by Subject|1|||
146048458|NCT03386721|526690021|FG010|Overall Study|Withdrawal by Subject|3|||
146255929|NCT00905255|527450639|FG001|Overall Study|Withdrawal by Subject|4|||
146255930|NCT00905255|527450638|FG000|Overall Study|Familial and Personal Reasons|1|||
146255931|NCT00905255|527450639|FG001|Overall Study|Familial and Personal Reasons|0|||
146255932|NCT03849300|527450640|FG000|Overall Study|move out to different area|1|||
146048459|NCT03386721|526690022|FG011|Overall Study|Withdrawal by Subject|2|||
146048460|NCT03386721|526690023|FG012|Overall Study|Withdrawal by Subject|3|||
146048461|NCT03386721|526690024|FG013|Overall Study|Withdrawal by Subject|0|||
146048462|NCT03386721|526690025|FG014|Overall Study|Withdrawal by Subject|0|||
146048463|NCT00700713|526690027|FG000|Overall Study|Protocol Violation|1|||
146048464|NCT00700713|526690028|FG001|Overall Study|Protocol Violation|0|||
146048465|NCT00700713|526690029|FG002|Overall Study|Protocol Violation|1|||
146048466|NCT00700713|526690027|FG000|Overall Study|Withdrawal by Subject|0|||
146048467|NCT00700713|526690028|FG001|Overall Study|Withdrawal by Subject|0|||
146048468|NCT00700713|526690029|FG002|Overall Study|Withdrawal by Subject|1|||
146255933|NCT03849300|527450641|FG001|Overall Study|move out to different area|3|||
146255934|NCT03849300|527450642|FG002|Overall Study|move out to different area|1|||
146255935|NCT03849300|527450643|FG003|Overall Study|move out to different area|4|||
146048469|NCT00550953|526690030|FG000|Overall Study|Adverse Event|4|||
146048470|NCT00550953|526690031|FG001|Overall Study|Adverse Event|3|||
146102924|NCT05147428|526895407|FG000|Overall Study|Died or disenrolled during blackout period|239|||
146102925|NCT05147428|526895408|FG001|Overall Study|Died or disenrolled during blackout period|278|||
146102926|NCT05147428|526895409|FG002|Overall Study|Died or disenrolled during blackout period|273|||
146102927|NCT01367002|526897135|FG000|Overall Study|Withdrawal by Subject|1|||
146102928|NCT01367002|526897136|FG001|Overall Study|Withdrawal by Subject|0|||
146102929|NCT01367002|526897135|FG000|Overall Study|Physician Decision|0|||
146102930|NCT01367002|526897136|FG001|Overall Study|Physician Decision|2|||
146102931|NCT01516437|526897137|FG000|Overall Study|Reason not specified|0|||
146102932|NCT01516437|526897138|FG001|Overall Study|Reason not specified|0|||
146102933|NCT01516437|526897139|FG002|Overall Study|Reason not specified|1|||
146102934|NCT01516437|526897140|FG003|Overall Study|Reason not specified|1|||
146102935|NCT01385566|526897144|FG000|Overall Study|Lost to Follow-up|1|||
146102936|NCT01385566|526897145|FG001|Overall Study|Lost to Follow-up|0|||
146102937|NCT01385566|526897146|FG002|Overall Study|Lost to Follow-up|0|||
146102938|NCT01385566|526897147|FG003|Overall Study|Lost to Follow-up|0|||
146102939|NCT01385566|526897148|FG004|Overall Study|Lost to Follow-up|0|||
146102940|NCT01385566|526897149|FG005|Overall Study|Lost to Follow-up|0|||
146102941|NCT01385566|526897144|FG000|Overall Study|Withdrawal by Subject|0|||
146102942|NCT01385566|526897145|FG001|Overall Study|Withdrawal by Subject|0|||
146102943|NCT01385566|526897146|FG002|Overall Study|Withdrawal by Subject|0|||
146102944|NCT01385566|526897147|FG003|Overall Study|Withdrawal by Subject|1|||
146102945|NCT01385566|526897148|FG004|Overall Study|Withdrawal by Subject|0|||
146102946|NCT01385566|526897149|FG005|Overall Study|Withdrawal by Subject|0|||
146102947|NCT00560105|526897156|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
146102948|NCT00560105|526897157|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
146102949|NCT02400333|526897158|FG000|Overall Study|Withdrawal by Subject|0|||
146102950|NCT02400333|526897159|FG001|Overall Study|Withdrawal by Subject|1|||
146102951|NCT02400333|526897160|FG002|Overall Study|Withdrawal by Subject|0|||
146102952|NCT02400333|526897161|FG003|Overall Study|Withdrawal by Subject|1|||
146102953|NCT02400333|526897158|FG000|Overall Study|Protocol Violation|1|||
146102954|NCT02400333|526897159|FG001|Overall Study|Protocol Violation|0|||
146102955|NCT02400333|526897160|FG002|Overall Study|Protocol Violation|2|||
146102956|NCT02400333|526897161|FG003|Overall Study|Protocol Violation|1|||
146102957|NCT00289133|526897171|FG000|Overall Study|Non-study device implanted|12|||
146102958|NCT00289133|526897172|FG001|Overall Study|Non-study device implanted|0|||
146102959|NCT00289133|526897171|FG000|Overall Study|Protocol Violation|32|||
146102960|NCT00289133|526897172|FG001|Overall Study|Protocol Violation|38|||
146102961|NCT00289133|526897171|FG000|Overall Study|Withdrawal by Subject|9|||
146102962|NCT00289133|526897172|FG001|Overall Study|Withdrawal by Subject|10|||
146102963|NCT00289133|526897171|FG000|Overall Study|Death|5|||
146102964|NCT00289133|526897172|FG001|Overall Study|Death|10|||
146102965|NCT00289133|526897171|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
146102966|NCT00289133|526897172|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
146102967|NCT00289133|526897171|FG000|Overall Study|Physician Decision|41|||
146102968|NCT00289133|526897172|FG001|Overall Study|Physician Decision|45|||
146102969|NCT00289133|526897171|FG000|Overall Study|Revision|8|||
146102970|NCT00289133|526897172|FG001|Overall Study|Revision|6|||
146102971|NCT00289133|526897171|FG000|Overall Study|Lost to Follow-up|92|||
146102972|NCT00289133|526897172|FG001|Overall Study|Lost to Follow-up|115|||
146102973|NCT00541931|526897177|FG000|Overall Study|Adverse Event|1|||
146102974|NCT00541931|526897178|FG001|Overall Study|Adverse Event|0|||
146102975|NCT00541931|526897177|FG000|Overall Study|Lost to Follow-up|3|||
146102976|NCT00541931|526897178|FG001|Overall Study|Lost to Follow-up|3|||
146102977|NCT00541931|526897177|FG000|Overall Study|Withdrawal by Subject|1|||
146102978|NCT00541931|526897178|FG001|Overall Study|Withdrawal by Subject|0|||
146102979|NCT00541931|526897177|FG000|Overall Study|Transportation Issue|0|||
146102980|NCT00541931|526897178|FG001|Overall Study|Transportation Issue|1|||
146102981|NCT01947582|526897179|FG000|Overall Study|Withdrawal by Subject|1|||
146102982|NCT00064337|526897180|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
146102983|NCT00064337|526897180|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
146102984|NCT00064337|526897180|FG000|PBSCC or Induction/PBSCC|Progression|3|||
146102985|NCT00064337|526897180|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
146102986|NCT00064337|526897180|FG000|PBSCC or Induction/PBSCC|Death|2|||
146102987|NCT00064337|526897180|FG000|Transplant|Adverse Event|9|||
146102988|NCT00064337|526897180|FG000|Transplant|Not protocol-specified|5|||
146300910|NCT03065023|527617169|FG004|Overall Study|Participant Decision|0|||
146300911|NCT03065023|527617165|FG000|Overall Study|Withdrawal by Subject|0|||
146102989|NCT00064337|526897180|FG000|Transplant|Death|3|||
146102990|NCT00064337|526897180|FG000|Transplant|Patient Refusal|2|||
146102991|NCT00064337|526897180|FG000|Transplant|Progression|2|||
146102992|NCT00064337|526897180|FG000|Maintenance|Adverse Event|3|||
146102993|NCT00064337|526897180|FG000|Maintenance|Progression|2|||
146102994|NCT00064337|526897180|FG000|Maintenance|On treatment at time of analysis|2|||
146102995|NCT00064337|526897180|FG000|Maintenance|Not protocol-specified|2|||
146102996|NCT00064337|526897180|FG000|Maintenance|Death|1|||
146102997|NCT00612040|526897181|FG000|Overall Study|Adverse Event|0|||
146102998|NCT00612040|526897182|FG001|Overall Study|Adverse Event|2|||
146102999|NCT00612040|526897183|FG002|Overall Study|Adverse Event|1|||
146255936|NCT03849300|527450640|FG000|Overall Study|scheduling/transportation conflict|4|||
146048471|NCT00550953|526690030|FG000|Overall Study|Not able to visit the site|2|||
146048472|NCT00550953|526690031|FG001|Overall Study|Not able to visit the site|3|||
146048473|NCT03797586|526690032|FG000|Overall Study|Lost to Follow-up|3|||
146048474|NCT03797586|526690033|FG001|Overall Study|Lost to Follow-up|6|||
146048475|NCT03797586|526690032|FG000|Overall Study|Death|1|||
146048476|NCT03797586|526690033|FG001|Overall Study|Death|1|||
146048477|NCT03797586|526690032|FG000|Overall Study|Adverse Event|0|||
146048478|NCT03797586|526690033|FG001|Overall Study|Adverse Event|2|||
146048479|NCT04980612|526690034|FG000|Overall Study|Withdrawal by Subject|7|||
146048480|NCT04980612|526690035|FG001|Overall Study|Withdrawal by Subject|5|||
146048481|NCT01502228|526690038|FG000|Overall Study|Death|1|||
146048482|NCT05730387|526690039|FG000|Overall Study|Stillbirth|0|||
146048483|NCT05730387|526690040|FG001|Overall Study|Stillbirth|262|||
146048484|NCT05730387|526690039|FG000|Overall Study|Died during or after delivery|2|||
146048485|NCT05730387|526690040|FG001|Overall Study|Died during or after delivery|85|||
146048486|NCT05730387|526690039|FG000|Overall Study|Died after being admitted|0|||
146048487|NCT05730387|526690040|FG001|Overall Study|Died after being admitted|44|||
146048488|NCT05730387|526690039|FG000|Overall Study|Lost to Follow-up|69|||
146048489|NCT05730387|526690040|FG001|Overall Study|Lost to Follow-up|77|||
146048490|NCT02728089|526690041|FG000|Overall Study|Physician Decision|2|||
146048491|NCT02728089|526690041|FG000|Overall Study|Withdrawal by Subject|1|||
146048492|NCT01219985|526690042|FG000|Overall Study|Physician Decision|20|||
146048493|NCT00596752|526690043|FG000|Overall Study|Other Reason|44|||
146048494|NCT00596752|526690044|FG001|Overall Study|Other Reason|49|||
146048495|NCT00596752|526690043|FG000|Overall Study|Adverse Event|34|||
146048496|NCT00596752|526690044|FG001|Overall Study|Adverse Event|34|||
146048497|NCT00596752|526690043|FG000|Overall Study|Lost to Follow-up|22|||
146048498|NCT00596752|526690044|FG001|Overall Study|Lost to Follow-up|38|||
146048499|NCT00596752|526690043|FG000|Overall Study|Withdrawal by Subject|12|||
146048500|NCT00596752|526690044|FG001|Overall Study|Withdrawal by Subject|9|||
146048501|NCT00596752|526690043|FG000|Overall Study|Unsatisfactory Compliance|9|||
146048502|NCT00596752|526690044|FG001|Overall Study|Unsatisfactory Compliance|6|||
146048503|NCT00596752|526690043|FG000|Overall Study|Lack of Efficacy|4|||
146048504|NCT00596752|526690044|FG001|Overall Study|Lack of Efficacy|7|||
146048505|NCT00596752|526690043|FG000|Overall Study|Protocol Violation|1|||
146048506|NCT00596752|526690044|FG001|Overall Study|Protocol Violation|0|||
146048507|NCT04797780|526690045|FG000|Overall Study|Lost to Follow-up|1|||
146048508|NCT04797780|526690046|FG001|Overall Study|Lost to Follow-up|1|||
146048509|NCT04797780|526690045|FG000|Overall Study|Withdrawal by Subject|14|||
146048510|NCT04797780|526690046|FG001|Overall Study|Withdrawal by Subject|9|||
146048511|NCT04797780|526690045|FG000|Overall Study|Death|49|||
146048512|NCT04797780|526690046|FG001|Overall Study|Death|20|||
146048513|NCT02940496|526690047|FG000|Overall Study|Adverse Event|1|||
146048514|NCT02940496|526690048|FG001|Overall Study|Adverse Event|0|||
146048515|NCT02940496|526690047|FG000|Overall Study|Death|2|||
146048516|NCT02940496|526690048|FG001|Overall Study|Death|0|||
146048517|NCT02940496|526690047|FG000|Overall Study|Hospice Care|1|||
146048518|NCT02940496|526690048|FG001|Overall Study|Hospice Care|0|||
146048519|NCT02940496|526690047|FG000|Overall Study|No MRE Done|1|||
146048520|NCT02940496|526690048|FG001|Overall Study|No MRE Done|0|||
146048521|NCT02940496|526690047|FG000|Overall Study|MRE Failure|1|||
146048522|NCT02940496|526690048|FG001|Overall Study|MRE Failure|0|||
146048523|NCT02586727|526690049|FG000|Overall Study|Lost to Follow-up|1|||
146048524|NCT02586727|526690050|FG001|Overall Study|Lost to Follow-up|0|||
146048525|NCT04089761|526690055|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
146048526|NCT04089761|526690055|FG000|"Run In Phase"|Lost to Follow-up|1|||
146048527|NCT04089761|526690055|FG000|"Treatment Phase"|No evaluable data|5|||
146048528|NCT04089761|526690055|FG000|"Treatment Phase"|Lost to Follow-up|1|||
146048529|NCT02119663|526690056|FG000|Overall Study|Disease progression|26|||
146048530|NCT02119663|526690057|FG001|Overall Study|Disease progression|27|||
146048531|NCT02119663|526690056|FG000|Overall Study|Adverse Event|5|||
146255937|NCT03849300|527450641|FG001|Overall Study|scheduling/transportation conflict|4|||
146048532|NCT02119663|526690057|FG001|Overall Study|Adverse Event|5|||
146048533|NCT02119663|526690056|FG000|Overall Study|Death|3|||
146048534|NCT02119663|526690057|FG001|Overall Study|Death|2|||
146048535|NCT02119663|526690056|FG000|Overall Study|Physician Decision|1|||
146048536|NCT02119663|526690057|FG001|Overall Study|Physician Decision|2|||
146048537|NCT02119663|526690056|FG000|Overall Study|Other unspecified|2|||
146048538|NCT02119663|526690057|FG001|Overall Study|Other unspecified|0|||
146048539|NCT02119663|526690056|FG000|Overall Study|Subject decision|0|||
146048540|NCT02119663|526690057|FG001|Overall Study|Subject decision|1|||
146048541|NCT02119663|526690056|FG000|Overall Study|Study Terminated by the Sponsor|3|||
146255938|NCT03849300|527450642|FG002|Overall Study|scheduling/transportation conflict|3|||
146048542|NCT02119663|526690057|FG001|Overall Study|Study Terminated by the Sponsor|4|||
146048543|NCT00699660|526690058|FG000|Overall Study|Lost to Follow-up|4|||
146048544|NCT00699660|526690059|FG001|Overall Study|Lost to Follow-up|2|||
146048545|NCT00699660|526690058|FG000|Overall Study|missing reports and recording failures|10|||
146048546|NCT00699660|526690059|FG001|Overall Study|missing reports and recording failures|6|||
146048547|NCT00103740|526690064|FG000|Period 1 - Core|Adverse Event|1|||
146048548|NCT00103740|526690065|FG001|Period 1 - Core|Adverse Event|0|||
146048549|NCT00103740|526690064|FG000|Period 1 - Core|Protocol Violation|3|||
146048550|NCT00103740|526690065|FG001|Period 1 - Core|Protocol Violation|2|||
146048551|NCT00103740|526690064|FG000|Period 1 - Core|Patient withdrew consent|3|||
146048552|NCT00103740|526690065|FG001|Period 1 - Core|Patient withdrew consent|2|||
146048553|NCT00103740|526690064|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
146048554|NCT00103740|526690065|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
146048555|NCT00103740|526690064|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
146048556|NCT00103740|526690065|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
146048557|NCT00103740|526690064|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
146048558|NCT00103740|526690065|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
146048559|NCT00103740|526690064|FG000|Period 2 - Extended Observation Period|Death|6|||
146048560|NCT00103740|526690065|FG001|Period 2 - Extended Observation Period|Death|2|||
146048561|NCT00103740|526690064|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
146048562|NCT00103740|526690065|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
146048563|NCT01099397|526690067|FG000|Overall Study|Lost to Follow-up|4|||
146048564|NCT01099397|526690067|FG000|Overall Study|Protocol Violation|4|||
146048565|NCT01099397|526690067|FG000|Overall Study|Withdrawal by Subject|5|||
146048566|NCT00003199|526690068|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
146048567|NCT00003199|526690068|FG000|Overall Study|Lack of insurance clearance|2|||
146048568|NCT00003199|526690068|FG000|Overall Study|Screen fail|15|||
146048569|NCT00940498|526690069|FG000|Overall Study|Death|2|||
146048570|NCT00940498|526690070|FG001|Overall Study|Death|0|||
146048571|NCT00940498|526690071|FG002|Overall Study|Death|0|||
146048572|NCT00940498|526690072|FG003|Overall Study|Death|1|||
146048573|NCT00940498|526690073|FG004|Overall Study|Death|5|||
146048574|NCT00940498|526690074|FG005|Overall Study|Death|0|||
146048575|NCT00940498|526690075|FG006|Overall Study|Death|1|||
146048576|NCT00940498|526690076|FG007|Overall Study|Death|0|||
146048577|NCT00940498|526690069|FG000|Overall Study|Lost to Follow-up|1|||
146048578|NCT00940498|526690070|FG001|Overall Study|Lost to Follow-up|1|||
146048579|NCT00940498|526690071|FG002|Overall Study|Lost to Follow-up|2|||
146048580|NCT00940498|526690072|FG003|Overall Study|Lost to Follow-up|0|||
146048581|NCT00940498|526690073|FG004|Overall Study|Lost to Follow-up|1|||
146048582|NCT00940498|526690074|FG005|Overall Study|Lost to Follow-up|0|||
146048583|NCT00940498|526690075|FG006|Overall Study|Lost to Follow-up|0|||
146048584|NCT00940498|526690076|FG007|Overall Study|Lost to Follow-up|1|||
146048585|NCT00940498|526690069|FG000|Overall Study|Disease Progression|0|||
146048586|NCT00940498|526690070|FG001|Overall Study|Disease Progression|0|||
146048587|NCT00940498|526690071|FG002|Overall Study|Disease Progression|1|||
146048588|NCT00940498|526690072|FG003|Overall Study|Disease Progression|1|||
146048589|NCT00940498|526690073|FG004|Overall Study|Disease Progression|0|||
146048590|NCT00940498|526690074|FG005|Overall Study|Disease Progression|1|||
146048591|NCT00940498|526690075|FG006|Overall Study|Disease Progression|0|||
146048592|NCT00940498|526690076|FG007|Overall Study|Disease Progression|0|||
146048593|NCT00940498|526690069|FG000|Overall Study|Physician Decision|0|||
146048594|NCT00940498|526690070|FG001|Overall Study|Physician Decision|0|||
146048595|NCT00940498|526690071|FG002|Overall Study|Physician Decision|0|||
146255939|NCT03849300|527450643|FG003|Overall Study|scheduling/transportation conflict|2|||
146048596|NCT00940498|526690072|FG003|Overall Study|Physician Decision|0|||
146048597|NCT00940498|526690073|FG004|Overall Study|Physician Decision|2|||
146048598|NCT00940498|526690074|FG005|Overall Study|Physician Decision|0|||
146048599|NCT00940498|526690075|FG006|Overall Study|Physician Decision|0|||
146048600|NCT00940498|526690076|FG007|Overall Study|Physician Decision|0|||
146048601|NCT00940498|526690069|FG000|Overall Study|Not treated due to disease related pain|0|||
146048602|NCT00940498|526690070|FG001|Overall Study|Not treated due to disease related pain|0|||
146103000|NCT00612040|526897181|FG000|Overall Study|Protocol Violation|1|||
146103001|NCT00612040|526897182|FG001|Overall Study|Protocol Violation|2|||
146103002|NCT00612040|526897183|FG002|Overall Study|Protocol Violation|1|||
146103003|NCT00612040|526897181|FG000|Overall Study|Lack of Efficacy|2|||
146103004|NCT00612040|526897182|FG001|Overall Study|Lack of Efficacy|1|||
146103005|NCT00612040|526897183|FG002|Overall Study|Lack of Efficacy|0|||
146103006|NCT00612040|526897181|FG000|Overall Study|Unclassified|2|||
146103007|NCT00612040|526897182|FG001|Overall Study|Unclassified|2|||
146103008|NCT00612040|526897183|FG002|Overall Study|Unclassified|5|||
146103009|NCT00827502|526897186|FG000|Overall Study|randomized but not treated|11|||
146103010|NCT00827502|526897186|FG000|Overall Study|Adverse Event|1|||
146103011|NCT00827502|526897186|FG000|Overall Study|Lost to Follow-up|4|||
146103012|NCT00827502|526897186|FG000|Overall Study|Withdrawal by Subject|5|||
146103013|NCT01397890|526897191|FG000|Overall Study|Withdrawal by Subject|7|||
146103014|NCT01397890|526897192|FG001|Overall Study|Withdrawal by Subject|11|||
146103015|NCT01397890|526897191|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
146103016|NCT01397890|526897192|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
146048603|NCT00940498|526690071|FG002|Overall Study|Not treated due to disease related pain|0|||
146103017|NCT01397890|526897191|FG000|Overall Study|Death|2|||
146255940|NCT01774929|527450644|FG000|Overall Study|Adverse Event|3|||
146255941|NCT04839289|527450645|FG000|Overall Study|Withdrawal by Subject|1|||
146255942|NCT04839289|527450646|FG001|Overall Study|Withdrawal by Subject|0|||
146255943|NCT01544153|527450647|FG000|Overall Study|Under 18|0|||
146255944|NCT01544153|527450648|FG001|Overall Study|Under 18|1|||
146255945|NCT01544153|527450649|FG002|Overall Study|Under 18|0|||
146255946|NCT01544153|527450650|FG003|Overall Study|Under 18|0|||
146255947|NCT01544153|527450647|FG000|Overall Study|Non-smoker|0|||
146255948|NCT01544153|527450648|FG001|Overall Study|Non-smoker|0|||
146255949|NCT01544153|527450649|FG002|Overall Study|Non-smoker|1|||
146255950|NCT01544153|527450650|FG003|Overall Study|Non-smoker|0|||
146255951|NCT00390806|527450655|FG000|Overall Study|Lost to Follow-up|7|||
146255952|NCT00390806|527450656|FG001|Overall Study|Lost to Follow-up|6|||
146255953|NCT00390806|527450655|FG000|Overall Study|Protocol Violation|2|||
146255954|NCT00390806|527450656|FG001|Overall Study|Protocol Violation|2|||
146255955|NCT00390806|527450655|FG000|Overall Study|Withdrawal by Subject|12|||
146255956|NCT00390806|527450656|FG001|Overall Study|Withdrawal by Subject|15|||
146255957|NCT00390806|527450655|FG000|Overall Study|Investigator Decision|4|||
146255958|NCT00390806|527450656|FG001|Overall Study|Investigator Decision|6|||
146255959|NCT00390806|527450655|FG000|Overall Study|Death|1|||
146255960|NCT00390806|527450656|FG001|Overall Study|Death|0|||
146255961|NCT00390806|527450655|FG000|Overall Study|Physician Decision|0|||
146255962|NCT00390806|527450656|FG001|Overall Study|Physician Decision|1|||
146255963|NCT00390806|527450655|FG000|Overall Study|Ongoing|4|||
146255964|NCT00390806|527450656|FG001|Overall Study|Ongoing|2|||
146255965|NCT00884793|527450659|FG000|Overall Study|Withdrawal by Subject|1|||
146255966|NCT03169530|527450660|FG000|Overall Study|Study ended by NIH|15|||
146255967|NCT03169530|527450661|FG001|Overall Study|Study ended by NIH|17|||
146255968|NCT01032200|527450662|FG000|Overall Study|Death|1|||
146255969|NCT01032200|527450663|FG001|Overall Study|Death|1|||
146255970|NCT01032200|527450662|FG000|Overall Study|Withdrawal by Subject|1|||
146255971|NCT01032200|527450663|FG001|Overall Study|Withdrawal by Subject|3|||
146255972|NCT01032200|527450662|FG000|Overall Study|Toxicity|0|||
146255973|NCT01032200|527450663|FG001|Overall Study|Toxicity|2|||
146255974|NCT01032200|527450662|FG000|Overall Study|Progression|1|||
146255975|NCT01032200|527450663|FG001|Overall Study|Progression|0|||
146255976|NCT01032200|527450662|FG000|Overall Study|Multiple|1|||
146255977|NCT01032200|527450663|FG001|Overall Study|Multiple|1|||
146255978|NCT00727259|527450667|FG000|Overall Study|Not all questionnaires completed|1055|||
146255979|NCT01021683|527450668|FG000|Overall Study|Lack of Efficacy|12|||
146255980|NCT01021683|527450668|FG000|Overall Study|Recovery of neutrophil count|51|||
146255981|NCT01021683|527450668|FG000|Overall Study|Other|8|||
146255982|NCT00663923|527450669|FG000|Overall Study|Lost to Follow-up|2|||
146255983|NCT01804140|527450671|FG000|Overall Study|No sampling or biopsy procedures done|114|||
146255984|NCT02785900|527450672|FG000|Overall Study|Study Termination by Sponsor|64|||
146048604|NCT00940498|526690072|FG003|Overall Study|Not treated due to disease related pain|0|||
146048605|NCT00940498|526690073|FG004|Overall Study|Not treated due to disease related pain|1|||
146048606|NCT00940498|526690074|FG005|Overall Study|Not treated due to disease related pain|0|||
146048607|NCT00940498|526690075|FG006|Overall Study|Not treated due to disease related pain|0|||
146048608|NCT00940498|526690076|FG007|Overall Study|Not treated due to disease related pain|0|||
146048609|NCT00650845|526690077|FG000|Overall Study|Withdrawal by Subject|5|||
146048610|NCT00650845|526690078|FG001|Overall Study|Withdrawal by Subject|0|||
146048611|NCT00650845|526690077|FG000|Overall Study|Protocol Violation|0|||
146048612|NCT00650845|526690078|FG001|Overall Study|Protocol Violation|13|||
146048613|NCT03761810|526690079|FG000|Overall Study|Adverse Event|12|||
146048614|NCT03761810|526690080|FG001|Overall Study|Adverse Event|0|||
146048615|NCT03761810|526690079|FG000|Overall Study|Lost to Follow-up|15|||
146048616|NCT03761810|526690080|FG001|Overall Study|Lost to Follow-up|7|||
146048617|NCT03761810|526690079|FG000|Overall Study|Pregnancy|1|||
146048618|NCT03761810|526690080|FG001|Overall Study|Pregnancy|0|||
146048619|NCT03761810|526690079|FG000|Overall Study|Withdrawal by Subject|14|||
146255985|NCT02785900|527450673|FG001|Overall Study|Study Termination by Sponsor|81|||
146255986|NCT02785900|527450672|FG000|Overall Study|Death|46|||
146255987|NCT02785900|527450673|FG001|Overall Study|Death|32|||
146255988|NCT02785900|527450672|FG000|Overall Study|Withdrawal by Subject|4|||
146048620|NCT03761810|526690080|FG001|Overall Study|Withdrawal by Subject|5|||
146255989|NCT02785900|527450673|FG001|Overall Study|Withdrawal by Subject|8|||
146255990|NCT02785900|527450672|FG000|Overall Study|Physician Decision|3|||
146255991|NCT02785900|527450673|FG001|Overall Study|Physician Decision|2|||
146255992|NCT00547300|527450674|FG000|Overall Study|Study was Administratively Terminated|25|||
146255993|NCT00547300|527450675|FG001|Overall Study|Study was Administratively Terminated|24|||
146255994|NCT00547300|527450674|FG000|Overall Study|Did not Meet Entry Criteria|0|||
146255995|NCT00547300|527450675|FG001|Overall Study|Did not Meet Entry Criteria|2|||
146048621|NCT03761810|526690079|FG000|Overall Study|Physician Decision|1|||
146048622|NCT03761810|526690080|FG001|Overall Study|Physician Decision|0|||
146048623|NCT03761810|526690079|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
146255996|NCT04130061|527450678|FG000|Overall Study|OR team forgot to request membrane|1|||
146255997|NCT04130061|527450679|FG001|Overall Study|OR team forgot to request membrane|0|||
146255998|NCT02972242|527452475|FG000|Overall Study|Withdrawal by Subject|1|||
146048624|NCT03761810|526690080|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146255999|NCT02972242|527452476|FG001|Overall Study|Withdrawal by Subject|0|||
146256000|NCT02679079|527452483|FG000|Overall Study|Adverse Event|2|||
146256001|NCT02679079|527452484|FG001|Overall Study|Adverse Event|0|||
146256002|NCT02679079|527452485|FG002|Overall Study|Adverse Event|2|||
146048625|NCT03761810|526690079|FG000|Overall Study|Other Than Specified|1|||
146048626|NCT03761810|526690080|FG001|Overall Study|Other Than Specified|0|||
146048627|NCT03932760|526690081|FG000|Overall Study|Became Ineligible|2|||
146048628|NCT03932760|526690082|FG001|Overall Study|Became Ineligible|5|||
146048629|NCT03932760|526690081|FG000|Overall Study|Withdrawal by Subject|6|||
146048630|NCT03932760|526690082|FG001|Overall Study|Withdrawal by Subject|6|||
146048631|NCT00869518|526690083|FG000|Overall Study|Lost to Follow-up|1|||
146048632|NCT00869518|526690084|FG001|Overall Study|Lost to Follow-up|1|||
146048633|NCT03922620|526690087|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
146048634|NCT03922620|526690088|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
146048635|NCT03772665|526690090|FG000|Overall Study|Protocol Violation|1|||
146048636|NCT03772665|526690091|FG001|Overall Study|Protocol Violation|0|||
146048637|NCT00163020|526690092|FG000|Overall Study|Lost to Follow-up|0|||
146048638|NCT00163020|526690093|FG001|Overall Study|Lost to Follow-up|2|||
146048639|NCT03449758|526691838|FG000|Overall Study|Major protocol deviation|1|||
146048640|NCT03449758|526691838|FG000|Overall Study|Treatment inefficacy|5|||
146048641|NCT03449758|526691838|FG000|Overall Study|Adverse Event|9|||
146048642|NCT03449758|526691838|FG000|Overall Study|Consent withdrawal|1|||
146048643|NCT03449758|526691838|FG000|Overall Study|Other unspecified reason|3|||
146048644|NCT03310723|526691839|FG000|Overall Study|Withdrawal by Subject|0|||
146048645|NCT03310723|526691840|FG001|Overall Study|Withdrawal by Subject|1|||
146048646|NCT03310723|526691839|FG000|Overall Study|Protocol Violation|0|||
146048647|NCT03310723|526691840|FG001|Overall Study|Protocol Violation|2|||
146048648|NCT02098746|526691841|FG000|Overall Study|Changes of Investigator|2|||
146048649|NCT02098746|526691841|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146048650|NCT02098746|526691841|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
146048651|NCT02098746|526691841|FG000|Overall Study|Data Not Available After Treatment|1|||
146048652|NCT00330759|526691842|FG000|Overall Study|Death|316|||
146048653|NCT00330759|526691843|FG001|Overall Study|Death|310|||
146048654|NCT00330759|526691842|FG000|Overall Study|Disease progression|104|||
146048655|NCT00330759|526691843|FG001|Overall Study|Disease progression|126|||
146048656|NCT00330759|526691842|FG000|Overall Study|Withdrawal by Subject|143|||
146048657|NCT00330759|526691843|FG001|Overall Study|Withdrawal by Subject|124|||
146048658|NCT00330759|526691842|FG000|Overall Study|Adverse Event|48|||
146048659|NCT00330759|526691843|FG001|Overall Study|Adverse Event|36|||
146048660|NCT00330759|526691842|FG000|Overall Study|Participant request|31|||
146048661|NCT00330759|526691843|FG001|Overall Study|Participant request|22|||
146048662|NCT00330759|526691842|FG000|Overall Study|Lost to Follow-up|16|||
146048663|NCT00330759|526691843|FG001|Overall Study|Lost to Follow-up|22|||
146048664|NCT00330759|526691842|FG000|Overall Study|Noncompliance|15|||
146048665|NCT00330759|526691843|FG001|Overall Study|Noncompliance|17|||
146048666|NCT00330759|526691842|FG000|Overall Study|Physician Decision|1|||
146048667|NCT00330759|526691843|FG001|Overall Study|Physician Decision|2|||
146048668|NCT00330759|526691842|FG000|Overall Study|Protocol deviation|0|||
146048669|NCT00330759|526691843|FG001|Overall Study|Protocol deviation|2|||
146048670|NCT00330759|526691842|FG000|Overall Study|Ineligibility determined|2|||
146048671|NCT00330759|526691843|FG001|Overall Study|Ineligibility determined|1|||
146048672|NCT00330759|526691842|FG000|Overall Study|Other|36|||
146048673|NCT00330759|526691843|FG001|Overall Study|Other|44|||
146048674|NCT04070989|526691844|FG000|Overall Study|Death|1|||
146048675|NCT04070989|526691845|FG001|Overall Study|Death|0|||
146048676|NCT04070989|526691846|FG002|Overall Study|Death|0|||
146048677|NCT04070989|526691844|FG000|Overall Study|Study Terminated by Sponsor|7|||
146048678|NCT04070989|526691845|FG001|Overall Study|Study Terminated by Sponsor|8|||
146048679|NCT04070989|526691846|FG002|Overall Study|Study Terminated by Sponsor|23|||
146048680|NCT04070989|526691844|FG000|Overall Study|Withdrawal by Subject|0|||
146048681|NCT04070989|526691845|FG001|Overall Study|Withdrawal by Subject|1|||
146048682|NCT04070989|526691846|FG002|Overall Study|Withdrawal by Subject|0|||
146048683|NCT04070989|526691844|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
146048684|NCT04070989|526691845|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
146048685|NCT04070989|526691846|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
146048686|NCT04070989|526691844|FG000|Overall Study|Other|1|||
146048687|NCT04070989|526691845|FG001|Overall Study|Other|1|||
146048688|NCT04070989|526691846|FG002|Overall Study|Other|0|||
146048689|NCT04685798|526691865|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
146256003|NCT02679079|527452483|FG000|Overall Study|Protocol Violation|0|||
146048690|NCT04640311|526691866|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
146048691|NCT04640311|526691867|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048692|NCT04640311|526691868|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048693|NCT04640311|526691869|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146256004|NCT02679079|527452484|FG001|Overall Study|Protocol Violation|1|||
146048694|NCT04640311|526691870|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048695|NCT04640311|526691871|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048696|NCT04640311|526691872|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048697|NCT04640311|526691873|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048698|NCT04640311|526691874|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048699|NCT04640311|526691875|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048700|NCT04640311|526691876|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048701|NCT04640311|526691877|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048702|NCT04640311|526691878|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048703|NCT04640311|526691866|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048704|NCT04640311|526691867|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
146048705|NCT04640311|526691868|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048706|NCT04640311|526691869|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048707|NCT04640311|526691870|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048708|NCT04640311|526691871|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048709|NCT04640311|526691872|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048710|NCT04640311|526691873|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048711|NCT04640311|526691874|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048712|NCT04640311|526691875|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048713|NCT04640311|526691876|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048714|NCT04640311|526691877|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048715|NCT04640311|526691878|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
146048716|NCT04640311|526691866|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048717|NCT04640311|526691867|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
146048718|NCT04640311|526691868|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048719|NCT04640311|526691869|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048720|NCT04640311|526691870|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048721|NCT04640311|526691871|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048722|NCT04640311|526691872|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048723|NCT04640311|526691873|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048724|NCT04640311|526691874|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048725|NCT04640311|526691875|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048726|NCT04640311|526691876|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048727|NCT04640311|526691877|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048728|NCT04640311|526691878|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048729|NCT04640311|526691866|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
146048730|NCT04640311|526691867|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
146048731|NCT04640311|526691868|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
146048732|NCT04640311|526691869|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048733|NCT04640311|526691870|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048734|NCT04640311|526691871|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048735|NCT04640311|526691872|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048736|NCT04640311|526691873|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048737|NCT04640311|526691874|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048738|NCT04640311|526691875|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048739|NCT04640311|526691876|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048740|NCT04640311|526691877|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048741|NCT04640311|526691878|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
146048742|NCT04640311|526691866|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048743|NCT04640311|526691867|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048744|NCT04640311|526691868|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
146048745|NCT04640311|526691869|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048746|NCT04640311|526691870|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048747|NCT04640311|526691871|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146256005|NCT02679079|527452485|FG002|Overall Study|Protocol Violation|0|||
146048748|NCT04640311|526691872|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048749|NCT04640311|526691873|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048750|NCT04640311|526691874|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048751|NCT04640311|526691875|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048752|NCT04640311|526691876|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048753|NCT04640311|526691877|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048754|NCT04640311|526691878|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
146048755|NCT04640311|526691866|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048756|NCT04640311|526691867|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048757|NCT04640311|526691868|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048758|NCT04640311|526691869|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
146048759|NCT04640311|526691870|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048760|NCT04640311|526691871|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048761|NCT04640311|526691872|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
146048762|NCT04640311|526691873|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048763|NCT04640311|526691874|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048764|NCT04640311|526691875|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048765|NCT04640311|526691876|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048766|NCT04640311|526691877|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048767|NCT04640311|526691878|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
146048768|NCT04640311|526691866|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048769|NCT04640311|526691867|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048770|NCT04640311|526691868|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048771|NCT04640311|526691869|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048772|NCT04640311|526691870|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048773|NCT04640311|526691871|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
146048774|NCT04640311|526691872|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048775|NCT04640311|526691873|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048776|NCT04640311|526691874|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
146048777|NCT04640311|526691875|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048778|NCT04640311|526691876|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048779|NCT04640311|526691877|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048780|NCT04640311|526691878|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
146048781|NCT04640311|526691866|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048782|NCT04640311|526691867|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048783|NCT04640311|526691868|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048784|NCT04640311|526691869|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048785|NCT04640311|526691870|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048786|NCT04640311|526691871|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048787|NCT04640311|526691872|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
146048788|NCT04640311|526691873|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048789|NCT04640311|526691874|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048790|NCT04640311|526691875|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048791|NCT04640311|526691876|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
146048792|NCT04640311|526691877|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048793|NCT04640311|526691878|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
146048794|NCT04640311|526691866|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048795|NCT04640311|526691867|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048796|NCT04640311|526691868|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048797|NCT04640311|526691869|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048798|NCT04640311|526691870|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048799|NCT04640311|526691871|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048800|NCT04640311|526691872|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048801|NCT04640311|526691873|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048802|NCT04640311|526691874|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048803|NCT04640311|526691875|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048804|NCT04640311|526691876|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048805|NCT04640311|526691877|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
146048806|NCT04640311|526691878|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
146048807|NCT01388907|526691882|FG000|Overall Study|Adverse Event|2|||
146256006|NCT02679079|527452483|FG000|Overall Study|Withdrawal by Subject|2|||
146256007|NCT02679079|527452484|FG001|Overall Study|Withdrawal by Subject|1|||
146256008|NCT02679079|527452485|FG002|Overall Study|Withdrawal by Subject|0|||
146103018|NCT01397890|526897192|FG001|Overall Study|Death|3|||
146103019|NCT01397890|526897191|FG000|Overall Study|Lost to Follow-up|1|||
146103020|NCT01397890|526897192|FG001|Overall Study|Lost to Follow-up|4|||
146103021|NCT01397890|526897191|FG000|Overall Study|Condition under Investigation Worsened|1|||
146103022|NCT01397890|526897192|FG001|Overall Study|Condition under Investigation Worsened|3|||
146103023|NCT01397890|526897191|FG000|Overall Study|Adverse Event|1|||
146103024|NCT01397890|526897192|FG001|Overall Study|Adverse Event|2|||
146103025|NCT01397890|526897191|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
146103026|NCT01397890|526897192|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
146103027|NCT01397890|526897191|FG000|Overall Study|Others|2|||
146103028|NCT01397890|526897192|FG001|Overall Study|Others|1|||
146103029|NCT02924571|526897193|FG000|Overall Study|Lost to Follow-up|1|||
146103030|NCT02924571|526897194|FG001|Overall Study|Lost to Follow-up|1|||
146103031|NCT02924571|526897195|FG002|Overall Study|Lost to Follow-up|0|||
146103032|NCT00434954|526897199|FG000|Overall Study|Adverse Event|17|||
146103033|NCT00434954|526897200|FG001|Overall Study|Adverse Event|2|||
146103034|NCT00434954|526897199|FG000|Overall Study|Entry criteria not met|14|||
146103035|NCT00434954|526897200|FG001|Overall Study|Entry criteria not met|16|||
146103036|NCT00434954|526897199|FG000|Overall Study|Lost to Follow-up|0|||
146103037|NCT00434954|526897200|FG001|Overall Study|Lost to Follow-up|1|||
146103038|NCT00434954|526897199|FG000|Overall Study|Physician Decision|6|||
146103039|NCT00434954|526897200|FG001|Overall Study|Physician Decision|3|||
146103040|NCT00434954|526897199|FG000|Overall Study|Protocol Violation|36|||
146103041|NCT00434954|526897200|FG001|Overall Study|Protocol Violation|27|||
146103042|NCT00434954|526897199|FG000|Overall Study|Sponsor decision|1|||
146103043|NCT00434954|526897200|FG001|Overall Study|Sponsor decision|0|||
146103044|NCT00434954|526897199|FG000|Overall Study|Subject decision|8|||
146103045|NCT00434954|526897200|FG001|Overall Study|Subject decision|22|||
146103046|NCT03417219|526897209|FG000|Overall Study|Lost to Follow-up|0|||
146103047|NCT03417219|526897210|FG001|Overall Study|Lost to Follow-up|3|||
146103048|NCT03345914|526897211|FG000|Overall Study|Transition to another study at week 16|80|||
146103049|NCT03345914|526897212|FG001|Overall Study|Transition to another study at week 16|86|||
146103050|NCT03345914|526897213|FG002|Overall Study|Transition to another study at week 16|78|||
146103051|NCT03345914|526897211|FG000|Overall Study|Transition to OLE during follow-up|37|||
146048808|NCT01388907|526691883|FG001|Overall Study|Adverse Event|0|||
146048809|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
146048810|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
146048811|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
146048812|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
146048813|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
146048814|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
146048815|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
146048816|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
146256009|NCT03924947|527452486|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146256010|NCT03924947|527452487|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146048817|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
146048818|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
146048819|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
146048820|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
146048821|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
146048822|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
146048823|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
146048824|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
146048825|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
146048826|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
146103052|NCT03345914|526897212|FG001|Overall Study|Transition to OLE during follow-up|33|||
146103053|NCT03345914|526897213|FG002|Overall Study|Transition to OLE during follow-up|39|||
146103054|NCT03345914|526897211|FG000|Overall Study|Physician Decision|0|||
146103055|NCT03345914|526897212|FG001|Overall Study|Physician Decision|1|||
146103056|NCT03345914|526897213|FG002|Overall Study|Physician Decision|1|||
146256011|NCT03924947|527452488|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
146256012|NCT03924947|527452489|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146048827|NCT01910402|526691884|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
146048828|NCT01910402|526691885|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
146048829|NCT01910402|526691886|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
146048830|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
146103057|NCT03345914|526897211|FG000|Overall Study|Withdrawal by Subject|5|||
146103058|NCT03345914|526897212|FG001|Overall Study|Withdrawal by Subject|1|||
146103059|NCT03345914|526897213|FG002|Overall Study|Withdrawal by Subject|2|||
146103060|NCT03345914|526897211|FG000|Overall Study|Other|1|||
146103061|NCT03345914|526897212|FG001|Overall Study|Other|1|||
146103062|NCT03345914|526897213|FG002|Overall Study|Other|1|||
146103063|NCT03345914|526897211|FG000|Overall Study|Ongoing|0|||
146048831|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
146048832|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
146048833|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
146048834|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
146048835|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
146048836|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
146048837|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
146048838|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
146048839|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
146048840|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
146048841|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
146048842|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
146048843|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
146048844|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
146048845|NCT01910402|526691884|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
146048846|NCT01910402|526691885|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
146048847|NCT01910402|526691886|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
146048848|NCT00824473|526691887|FG000|Overall Study|Adverse Event|4|||
146048849|NCT00824473|526691888|FG001|Overall Study|Adverse Event|5|||
146048850|NCT00824473|526691887|FG000|Overall Study|Lack of Efficacy|2|||
146048851|NCT00824473|526691888|FG001|Overall Study|Lack of Efficacy|2|||
146048852|NCT00824473|526691887|FG000|Overall Study|Protocol Violation|2|||
146048853|NCT00824473|526691888|FG001|Overall Study|Protocol Violation|0|||
146048854|NCT00824473|526691887|FG000|Overall Study|Non-Compliance|4|||
146048855|NCT00824473|526691888|FG001|Overall Study|Non-Compliance|2|||
146048856|NCT00824473|526691887|FG000|Overall Study|Withdrawal by Subject|2|||
146048857|NCT00824473|526691888|FG001|Overall Study|Withdrawal by Subject|3|||
146048858|NCT00824473|526691887|FG000|Overall Study|Other|1|||
146048859|NCT00824473|526691888|FG001|Overall Study|Other|1|||
146048860|NCT01359904|526691889|FG000|Overall Study|Withdrawal by Subject|1|||
146048861|NCT01359904|526691890|FG001|Overall Study|Withdrawal by Subject|0|||
146048862|NCT03594773|526691892|FG000|Overall Study|Withdrawal by Subject|3|||
146048863|NCT03594773|526691893|FG001|Overall Study|Withdrawal by Subject|2|||
146048864|NCT03594773|526691892|FG000|Overall Study|Lost to Follow-up|3|||
146048865|NCT03594773|526691893|FG001|Overall Study|Lost to Follow-up|4|||
146048866|NCT01550757|526691896|FG000|Overall Study|Lost to Follow-up|21|||
146048867|NCT01550757|526691897|FG001|Overall Study|Lost to Follow-up|14|||
146048868|NCT01550757|526691898|FG002|Overall Study|Lost to Follow-up|42|||
146048869|NCT01550757|526691899|FG003|Overall Study|Lost to Follow-up|53|||
146048870|NCT01550757|526691896|FG000|Overall Study|Withdrawal by Subject|2|||
146048871|NCT01550757|526691897|FG001|Overall Study|Withdrawal by Subject|0|||
146048872|NCT01550757|526691898|FG002|Overall Study|Withdrawal by Subject|3|||
146048873|NCT01550757|526691899|FG003|Overall Study|Withdrawal by Subject|1|||
146048874|NCT03191630|526691900|FG000|Overall Study|Lost to Follow-up|7|||
146048875|NCT03191630|526691901|FG001|Overall Study|Lost to Follow-up|7|||
146048876|NCT00193206|526691903|FG000|Preoperative Therapy|Lack of Efficacy|2|||
146048877|NCT00193206|526691903|FG000|Preoperative Therapy|Adverse Event|2|||
146048878|NCT00193206|526691903|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
146048879|NCT00193206|526691903|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
146048880|NCT00193206|526691903|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
146048881|NCT00193206|526691903|FG000|Postoperative Therapy|Physician Decision|3|||
146048882|NCT00193206|526691903|FG000|Postoperative Therapy|Intercurrent Illness|2|||
146048883|NCT00193206|526691903|FG000|Postoperative Therapy|Lack of Efficacy|1|||
146048884|NCT00193206|526691903|FG000|Postoperative Therapy|Protocol Violation|1|||
146048885|NCT00740584|526691910|FG000|Overall Study|Withdrawal by Subject|1|||
146048886|NCT03461146|526691913|FG000|Overall Study|Adverse Event|2|||
146048887|NCT03461146|526691913|FG000|Overall Study|Physician Decision|1|||
146048888|NCT02915263|526691918|FG000|Overall Study|Covid|3|||
146048889|NCT02915263|526691919|FG001|Overall Study|Covid|2|||
146048890|NCT01479868|526691925|FG000|Overall Study|Adverse Event|1|||
146048891|NCT01479868|526691925|FG000|Overall Study|Lost to Follow-up|4|||
146048892|NCT01479868|526691925|FG000|Overall Study|Protocol Violation|1|||
146048893|NCT01479868|526691925|FG000|Overall Study|Withdrawal by Subject|1|||
146048894|NCT01479868|526691925|FG000|Overall Study|Sponsor's Decision|1|||
146048895|NCT01479868|526691925|FG000|Overall Study|Initiation of new HCV Therapy|1|||
146048896|NCT01618669|526691926|FG000|Overall Study|Lost to Follow-up|1|||
146048897|NCT01618669|526691927|FG001|Overall Study|Lost to Follow-up|1|||
146048898|NCT01618669|526691926|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
146048899|NCT01618669|526691927|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
146048900|NCT01618669|526691926|FG000|Overall Study|Adverse Event|16|||
146048901|NCT01618669|526691927|FG001|Overall Study|Adverse Event|7|||
146048902|NCT01618669|526691926|FG000|Overall Study|Protocol Violation|5|||
146048903|NCT01618669|526691927|FG001|Overall Study|Protocol Violation|3|||
146103064|NCT03345914|526897212|FG001|Overall Study|Ongoing|0|||
146256013|NCT03924947|527452490|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146256014|NCT03924947|527452491|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
146256015|NCT01441583|527452494|FG000|Overall Study|Withdrawal by Subject|1|||
146256016|NCT01441583|527452495|FG001|Overall Study|Withdrawal by Subject|1|||
146256017|NCT01441583|527452496|FG002|Overall Study|Withdrawal by Subject|1|||
146256018|NCT01441583|527452494|FG000|Overall Study|Death|1|||
146256019|NCT01441583|527452495|FG001|Overall Study|Death|0|||
146256020|NCT01441583|527452496|FG002|Overall Study|Death|4|||
146256021|NCT01441583|527452494|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
146048904|NCT01618669|526691926|FG000|Overall Study|Withdrawal by Subject|9|||
146048905|NCT01618669|526691927|FG001|Overall Study|Withdrawal by Subject|9|||
146048906|NCT01618669|526691926|FG000|Overall Study|Miscellaneous Reason|0|||
146048907|NCT01618669|526691927|FG001|Overall Study|Miscellaneous Reason|1|||
146048908|NCT01177007|526691930|FG000|Overall Study|Lost to Follow-up|2|||
146048909|NCT01177007|526691930|FG000|Overall Study|Death|4|||
146048910|NCT01177007|526691930|FG000|Overall Study|Entered hospice care|5|||
146048911|NCT01177007|526691930|FG000|Overall Study|Required additional Y90 treatment|6|||
146048912|NCT01177007|526691930|FG000|Overall Study|Change in treatment modality|21|||
146048913|NCT03600740|526691932|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
146048914|NCT01702558|526691933|FG000|Overall Study|Withdrawal by Subject|0|||
146048915|NCT01702558|526691934|FG001|Overall Study|Withdrawal by Subject|0|||
146048916|NCT01702558|526691935|FG002|Overall Study|Withdrawal by Subject|0|||
146048917|NCT01702558|526691936|FG003|Overall Study|Withdrawal by Subject|12|||
146048918|NCT01702558|526691937|FG004|Overall Study|Withdrawal by Subject|4|||
146048919|NCT01702558|526691933|FG000|Overall Study|Lost to Follow-up|0|||
146048920|NCT01702558|526691934|FG001|Overall Study|Lost to Follow-up|0|||
146048921|NCT01702558|526691935|FG002|Overall Study|Lost to Follow-up|0|||
146048922|NCT01702558|526691936|FG003|Overall Study|Lost to Follow-up|3|||
146048923|NCT01702558|526691937|FG004|Overall Study|Lost to Follow-up|0|||
146048924|NCT01702558|526691933|FG000|Overall Study|Death|4|||
146048925|NCT01702558|526691934|FG001|Overall Study|Death|3|||
146048926|NCT01702558|526691935|FG002|Overall Study|Death|3|||
146048927|NCT01702558|526691936|FG003|Overall Study|Death|16|||
146048928|NCT01702558|526691937|FG004|Overall Study|Death|20|||
146048929|NCT01702558|526691933|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
146048930|NCT01702558|526691934|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
146048931|NCT01702558|526691935|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
146048932|NCT01702558|526691936|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
146048933|NCT01702558|526691937|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
146048934|NCT01702558|526691933|FG000|Overall Study|Study Terminated by Sponsor|0|||
146048935|NCT01702558|526691934|FG001|Overall Study|Study Terminated by Sponsor|1|||
146048936|NCT01702558|526691935|FG002|Overall Study|Study Terminated by Sponsor|0|||
146048937|NCT01702558|526691936|FG003|Overall Study|Study Terminated by Sponsor|0|||
146048938|NCT01702558|526691937|FG004|Overall Study|Study Terminated by Sponsor|1|||
146048939|NCT01702558|526691933|FG000|Overall Study|Other|0|||
146048940|NCT01702558|526691934|FG001|Overall Study|Other|0|||
146048941|NCT01702558|526691935|FG002|Overall Study|Other|0|||
146048942|NCT01702558|526691936|FG003|Overall Study|Other|16|||
146048943|NCT01702558|526691937|FG004|Overall Study|Other|17|||
146048944|NCT03259087|526691940|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146048945|NCT03259087|526691941|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146048946|NCT03259087|526691942|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146048947|NCT03259087|526691943|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
146048948|NCT03259087|526691944|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
146048949|NCT03259087|526691940|FG000|Period 2 of Part 2|Adverse Event|0|||
146048950|NCT03259087|526691941|FG001|Period 2 of Part 2|Adverse Event|0|||
146048951|NCT03259087|526691942|FG002|Period 2 of Part 2|Adverse Event|0|||
146048952|NCT03259087|526691943|FG003|Period 2 of Part 2|Adverse Event|0|||
146048953|NCT03259087|526691944|FG004|Period 2 of Part 2|Adverse Event|1|||
146048954|NCT04950465|526691945|FG000|Overall Study|Lost to Follow-up|1|||
146048955|NCT04950465|526691946|FG001|Overall Study|Lost to Follow-up|0|||
146048956|NCT04950465|526691947|FG002|Overall Study|Lost to Follow-up|0|||
146048957|NCT02562716|526691963|FG000|Overall Study|Adverse Event|7|||
146048958|NCT02562716|526691964|FG001|Overall Study|Adverse Event|14|||
146048959|NCT02562716|526691963|FG000|Overall Study|Withdrawal unrelated to AE|7|||
146048960|NCT02562716|526691964|FG001|Overall Study|Withdrawal unrelated to AE|1|||
146048961|NCT02562716|526691963|FG000|Overall Study|Progression|8|||
146048962|NCT02562716|526691964|FG001|Overall Study|Progression|10|||
146048963|NCT02562716|526691963|FG000|Overall Study|Death|2|||
146048964|NCT02562716|526691964|FG001|Overall Study|Death|1|||
146048965|NCT02562716|526691963|FG000|Overall Study|Not protocol specified|4|||
146048966|NCT02562716|526691964|FG001|Overall Study|Not protocol specified|2|||
146048967|NCT02753946|526691965|FG000|Overall Study|Adverse Event|7|||
146256022|NCT01441583|527452495|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
146048968|NCT02753946|526691966|FG001|Overall Study|Adverse Event|6|||
146048969|NCT02753946|526691965|FG000|Overall Study|Withdrawal by Subject|6|||
146048970|NCT02753946|526691966|FG001|Overall Study|Withdrawal by Subject|1|||
146048971|NCT02753946|526691965|FG000|Overall Study|Lack of Efficacy|1|||
146048972|NCT02753946|526691966|FG001|Overall Study|Lack of Efficacy|0|||
146048973|NCT02753946|526691965|FG000|Overall Study|Physician Decision|0|||
146048974|NCT02753946|526691966|FG001|Overall Study|Physician Decision|2|||
146048975|NCT04915729|526691967|FG000|Overall Study|Lost to Follow-up|20|||
146048976|NCT04915729|526691968|FG001|Overall Study|Lost to Follow-up|10|||
146048977|NCT04915729|526691967|FG000|Overall Study|Withdrawal by Subject|12|||
146048978|NCT04915729|526691968|FG001|Overall Study|Withdrawal by Subject|5|||
146048979|NCT04915729|526691967|FG000|Overall Study|Death|34|||
146048980|NCT04915729|526691968|FG001|Overall Study|Death|44|||
146048981|NCT04915729|526691967|FG000|Overall Study|not treated|3|||
146048982|NCT04915729|526691968|FG001|Overall Study|not treated|6|||
146048983|NCT04915729|526691967|FG000|Overall Study|Investigator removed subject|1|||
146048984|NCT04915729|526691968|FG001|Overall Study|Investigator removed subject|2|||
146048985|NCT04915729|526691967|FG000|Overall Study|questionnaire result not evaluated|1|||
146048986|NCT04915729|526691968|FG001|Overall Study|questionnaire result not evaluated|0|||
146048987|NCT04915729|526691967|FG000|Overall Study|refuse of hospital visit|1|||
146048988|NCT04915729|526691968|FG001|Overall Study|refuse of hospital visit|3|||
146048989|NCT04915729|526691967|FG000|Overall Study|Subject withdrew|1|||
146048990|NCT04915729|526691968|FG001|Overall Study|Subject withdrew|0|||
146048991|NCT03710642|526691969|FG000|Overall Study|Adverse Event|5|||
146048992|NCT03710642|526691970|FG001|Overall Study|Adverse Event|1|||
146048993|NCT03710642|526691969|FG000|Overall Study|non-site physician recommendation|1|||
146048994|NCT03710642|526691970|FG001|Overall Study|non-site physician recommendation|0|||
146048995|NCT03710642|526691969|FG000|Overall Study|Participant unwilling or unable to participate|1|||
146048996|NCT03710642|526691970|FG001|Overall Study|Participant unwilling or unable to participate|1|||
146048997|NCT03710642|526691969|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
146048998|NCT03710642|526691970|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
146048999|NCT03710642|526691969|FG000|Overall Study|NA-no code provided|1|||
146049000|NCT03710642|526691970|FG001|Overall Study|NA-no code provided|0|||
146049001|NCT03710642|526691969|FG000|Overall Study|Withdrawal by Subject|1|||
146049002|NCT03710642|526691970|FG001|Overall Study|Withdrawal by Subject|0|||
146049003|NCT02864901|526691971|FG000|Overall Study|Withdrawal by Subject|1|||
146049004|NCT02864901|526691972|FG001|Overall Study|Withdrawal by Subject|0|||
146049005|NCT01369784|526691973|FG000|Overall Study|Protocol Violation|12|||
146049006|NCT02446717|526691974|FG000|Overall Study|Adverse Event|0|||
146049007|NCT02446717|526691975|FG001|Overall Study|Adverse Event|0|||
146049008|NCT02446717|526691976|FG002|Overall Study|Adverse Event|1|||
146049009|NCT02446717|526691977|FG003|Overall Study|Adverse Event|0|||
146049010|NCT02446717|526691978|FG004|Overall Study|Adverse Event|0|||
146049011|NCT02446717|526691974|FG000|Overall Study|Lost to Follow-up|0|||
146049012|NCT02446717|526691975|FG001|Overall Study|Lost to Follow-up|1|||
146049013|NCT02446717|526691976|FG002|Overall Study|Lost to Follow-up|1|||
146049014|NCT02446717|526691977|FG003|Overall Study|Lost to Follow-up|0|||
146049015|NCT02446717|526691978|FG004|Overall Study|Lost to Follow-up|1|||
146049016|NCT02446717|526691974|FG000|Overall Study|Withdrew consent|0|||
146049017|NCT02446717|526691975|FG001|Overall Study|Withdrew consent|0|||
146049018|NCT02446717|526691976|FG002|Overall Study|Withdrew consent|0|||
146049019|NCT02446717|526691977|FG003|Overall Study|Withdrew consent|1|||
146049020|NCT02446717|526691978|FG004|Overall Study|Withdrew consent|0|||
146049021|NCT02680665|526691979|FG000|Overall Study|No visit after the first prescription|5|||
146049022|NCT02905266|526691980|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
146049023|NCT02905266|526691981|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
146049024|NCT02905266|526691980|FG000|Treatment Phase Part 1|Disease Progression|6|||
146049025|NCT02905266|526691981|FG001|Treatment Phase Part 1|Disease Progression|7|||
146049026|NCT02905266|526691980|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
146049027|NCT02905266|526691981|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
146049028|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
146049029|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
146049030|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
146049031|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
146049032|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
146049033|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
146049034|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Death|0|||
146049035|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Death|1|||
146049036|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
146049037|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
146049038|NCT02905266|526691980|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
146103065|NCT03345914|526897213|FG002|Overall Study|Ongoing|1|||
146049039|NCT02905266|526691981|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
146049040|NCT02905266|526691980|FG000|Maintenance Phase Part 2|Disease Progression|9|||
146049041|NCT02905266|526691981|FG001|Maintenance Phase Part 2|Disease Progression|2|||
146049042|NCT02905266|526691980|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
146103066|NCT02609828|526897214|FG000|Overall Study|Adverse Event|8|||
146103067|NCT02609828|526897215|FG001|Overall Study|Adverse Event|1|||
146103068|NCT02609828|526897216|FG002|Overall Study|Adverse Event|0|||
146103069|NCT02609828|526897217|FG003|Overall Study|Adverse Event|6|||
146103070|NCT02609828|526897214|FG000|Overall Study|Death|15|||
146103071|NCT02609828|526897215|FG001|Overall Study|Death|1|||
146103072|NCT02609828|526897216|FG002|Overall Study|Death|1|||
146103073|NCT02609828|526897217|FG003|Overall Study|Death|19|||
146103074|NCT02609828|526897214|FG000|Overall Study|Insufficient clinical response|2|||
146103075|NCT02609828|526897215|FG001|Overall Study|Insufficient clinical response|1|||
146103076|NCT02609828|526897216|FG002|Overall Study|Insufficient clinical response|0|||
146103077|NCT02609828|526897217|FG003|Overall Study|Insufficient clinical response|0|||
146103078|NCT02609828|526897214|FG000|Overall Study|Lost to Follow-up|0|||
146103079|NCT02609828|526897215|FG001|Overall Study|Lost to Follow-up|0|||
146103080|NCT02609828|526897216|FG002|Overall Study|Lost to Follow-up|0|||
146103081|NCT02609828|526897217|FG003|Overall Study|Lost to Follow-up|1|||
146103082|NCT02609828|526897214|FG000|Overall Study|Protocol Violation|2|||
146103083|NCT02609828|526897215|FG001|Overall Study|Protocol Violation|0|||
146103084|NCT02609828|526897216|FG002|Overall Study|Protocol Violation|0|||
146103085|NCT02609828|526897217|FG003|Overall Study|Protocol Violation|1|||
146103086|NCT02609828|526897214|FG000|Overall Study|Withdrawal by Subject|12|||
146256023|NCT01441583|527452496|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
146256024|NCT05060237|527452498|FG000|Overall Study|Withdrawal by Subject|4|||
146256025|NCT05060237|527452498|FG000|Overall Study|Screening failure|8|||
146256026|NCT01697592|527452502|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
146256027|NCT01697592|527452503|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256028|NCT01697592|527452504|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256029|NCT01697592|527452505|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146103087|NCT02609828|526897215|FG001|Overall Study|Withdrawal by Subject|1|||
146103088|NCT02609828|526897216|FG002|Overall Study|Withdrawal by Subject|0|||
146103089|NCT02609828|526897217|FG003|Overall Study|Withdrawal by Subject|10|||
146103090|NCT02609828|526897214|FG000|Overall Study|Other|3|||
146103091|NCT02609828|526897215|FG001|Overall Study|Other|0|||
146103092|NCT02609828|526897216|FG002|Overall Study|Other|0|||
146103093|NCT02609828|526897217|FG003|Overall Study|Other|6|||
146256030|NCT01697592|527452506|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256031|NCT01697592|527452507|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256032|NCT01697592|527452508|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256033|NCT01697592|527452509|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256034|NCT01697592|527452510|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256035|NCT01697592|527452511|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
146256036|NCT01697592|527452502|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256037|NCT01697592|527452503|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256038|NCT01697592|527452504|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256039|NCT01697592|527452505|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256040|NCT01697592|527452506|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256041|NCT01697592|527452507|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
146256042|NCT01697592|527452508|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256043|NCT01697592|527452509|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256044|NCT01697592|527452510|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256045|NCT01697592|527452511|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
146256046|NCT01697592|527452502|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
146256047|NCT01697592|527452503|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256048|NCT01697592|527452504|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256049|NCT01697592|527452505|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256050|NCT01697592|527452506|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256051|NCT01697592|527452507|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256052|NCT01697592|527452508|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146103094|NCT02609828|526897214|FG000|Overall Study|Randomized but not treated|1|||
146103095|NCT02609828|526897215|FG001|Overall Study|Randomized but not treated|0|||
146103096|NCT02609828|526897216|FG002|Overall Study|Randomized but not treated|0|||
146103097|NCT02609828|526897217|FG003|Overall Study|Randomized but not treated|0|||
146103098|NCT00319553|526897218|FG000|Overall Study|Protocol Violation|1|||
146103099|NCT00319553|526897219|FG001|Overall Study|Protocol Violation|2|||
146103100|NCT00319553|526897218|FG000|Overall Study|Lost to Follow-up|2|||
146103101|NCT00319553|526897219|FG001|Overall Study|Lost to Follow-up|1|||
146103102|NCT00319553|526897218|FG000|Overall Study|Withdrawal by Subject|1|||
146103103|NCT00319553|526897219|FG001|Overall Study|Withdrawal by Subject|1|||
146103104|NCT01896102|526897220|FG000|Overall Study|Death|1|||
146103105|NCT01896102|526897220|FG000|Overall Study|Participant to receive allogenic transplant|2|||
146103106|NCT00753766|526897223|FG000|Overall Study|Physician Decision|1|||
146103107|NCT00753766|526897224|FG001|Overall Study|Physician Decision|0|||
146103108|NCT01281137|526897229|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
146256053|NCT01697592|527452509|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256054|NCT01697592|527452510|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146256055|NCT01697592|527452511|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
146049043|NCT02905266|526691981|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
146049044|NCT02905266|526691980|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
146049045|NCT02905266|526691981|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
146049046|NCT02292719|526691987|FG000|Overall Study|Withdrawal by Subject|0|||
146049047|NCT02292719|526691988|FG001|Overall Study|Withdrawal by Subject|0|||
146049048|NCT02292719|526691989|FG002|Overall Study|Withdrawal by Subject|0|||
146049049|NCT02292719|526691990|FG003|Overall Study|Withdrawal by Subject|1|||
146049050|NCT02292719|526691991|FG004|Overall Study|Withdrawal by Subject|1|||
146049051|NCT02292719|526691992|FG005|Overall Study|Withdrawal by Subject|0|||
146049052|NCT02292719|526691987|FG000|Overall Study|Subject enrolled in new study.|0|||
146049053|NCT02292719|526691988|FG001|Overall Study|Subject enrolled in new study.|0|||
146049054|NCT02292719|526691989|FG002|Overall Study|Subject enrolled in new study.|1|||
146049055|NCT02292719|526691990|FG003|Overall Study|Subject enrolled in new study.|0|||
146049056|NCT02292719|526691991|FG004|Overall Study|Subject enrolled in new study.|0|||
146049057|NCT02292719|526691992|FG005|Overall Study|Subject enrolled in new study.|0|||
146049058|NCT05973006|526691995|FG000|Overall Study|Early termination|3|||
146049059|NCT05973006|526691996|FG001|Overall Study|Early termination|9|||
146049060|NCT05167825|526691997|FG000|Overall Study|Ongoing|3|||
146049061|NCT02326597|526692002|FG000|Overall Study|Lost to Follow-up|42|||
146049062|NCT02326597|526692003|FG001|Overall Study|Lost to Follow-up|32|||
146049063|NCT00770601|526692006|FG000|Overall Study|Withdrawal by Subject|1|||
146049064|NCT00428948|526692007|FG000|Overall Study|Lost to Follow-up|15|||
146049065|NCT00428948|526692008|FG001|Overall Study|Lost to Follow-up|8|||
146049066|NCT00428948|526692007|FG000|Overall Study|Adverse Event|148|||
146049067|NCT00428948|526692008|FG001|Overall Study|Adverse Event|24|||
146049068|NCT00428948|526692007|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
146049069|NCT00428948|526692008|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
146049070|NCT00428948|526692007|FG000|Overall Study|Investigator Withdrew Subject|3|||
146049071|NCT00428948|526692008|FG001|Overall Study|Investigator Withdrew Subject|4|||
146049072|NCT00428948|526692007|FG000|Overall Study|Subject Withdrew Consent|50|||
146049073|NCT00428948|526692008|FG001|Overall Study|Subject Withdrew Consent|30|||
146049074|NCT00428948|526692007|FG000|Overall Study|Protocol Deviation|1|||
146049075|NCT00428948|526692008|FG001|Overall Study|Protocol Deviation|1|||
146049076|NCT05907395|526692011|FG000|Period 1|No longer met eligibility criteria|0|||
146049077|NCT05907395|526692012|FG001|Period 1|No longer met eligibility criteria|1|||
146049078|NCT05907395|526692013|FG002|Period 1|No longer met eligibility criteria|0|||
146049079|NCT05907395|526692014|FG003|Period 1|No longer met eligibility criteria|0|||
146049080|NCT05907395|526692015|FG004|Period 1|No longer met eligibility criteria|0|||
146049081|NCT05907395|526692016|FG005|Period 1|No longer met eligibility criteria|1|||
146049082|NCT05907395|526692017|FG006|Period 1|No longer met eligibility criteria|1|||
146049083|NCT05907395|526692018|FG007|Period 1|No longer met eligibility criteria|0|||
146103109|NCT01281137|526897230|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
146103110|NCT01281137|526897229|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
146103111|NCT01281137|526897230|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
146103112|NCT01281137|526897229|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
146103113|NCT01281137|526897230|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
146103114|NCT01281137|526897229|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
146103115|NCT01281137|526897230|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
146103116|NCT01281137|526897229|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
146103117|NCT01281137|526897230|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
146103118|NCT01206166|526897235|FG000|Overall Study|No evaluable data|2|||
146103119|NCT01206166|526897236|FG001|Overall Study|No evaluable data|3|||
146103120|NCT00306189|526897244|FG000|Overall Study|Physician Decision|0|||
146103121|NCT00306189|526897245|FG001|Overall Study|Physician Decision|0|||
146103122|NCT00306189|526897246|FG002|Overall Study|Physician Decision|0|||
146103123|NCT00306189|526897247|FG003|Overall Study|Physician Decision|1|||
146103124|NCT00306189|526897244|FG000|Overall Study|Adverse Event|3|||
146103125|NCT00306189|526897245|FG001|Overall Study|Adverse Event|3|||
146103126|NCT00306189|526897246|FG002|Overall Study|Adverse Event|2|||
146103127|NCT00306189|526897247|FG003|Overall Study|Adverse Event|2|||
146103128|NCT00306189|526897244|FG000|Overall Study|Withdrawal by Subject|4|||
146103129|NCT00306189|526897245|FG001|Overall Study|Withdrawal by Subject|2|||
146103130|NCT00306189|526897246|FG002|Overall Study|Withdrawal by Subject|8|||
146103131|NCT00306189|526897247|FG003|Overall Study|Withdrawal by Subject|1|||
146103132|NCT00306189|526897244|FG000|Overall Study|Ineligibility determined|1|||
146103133|NCT00306189|526897245|FG001|Overall Study|Ineligibility determined|1|||
146103134|NCT00306189|526897246|FG002|Overall Study|Ineligibility determined|1|||
146049084|NCT05907395|526692019|FG008|Period 1|No longer met eligibility criteria|0|||
146049085|NCT05907395|526692020|FG009|Period 1|No longer met eligibility criteria|0|||
146256056|NCT01697592|527452502|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146256057|NCT01697592|527452503|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146256058|NCT01697592|527452504|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256059|NCT01697592|527452505|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256060|NCT01697592|527452506|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256061|NCT01697592|527452507|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256062|NCT01697592|527452508|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146256063|NCT01697592|527452509|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256064|NCT01697592|527452510|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
146256065|NCT01697592|527452511|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
146256066|NCT01697592|527452502|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146256067|NCT01697592|527452503|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
146256068|NCT01697592|527452504|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146256069|NCT01697592|527452505|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
146049086|NCT05907395|526692021|FG010|Period 1|No longer met eligibility criteria|0|||
146049087|NCT05907395|526692022|FG011|Period 1|No longer met eligibility criteria|0|||
146049088|NCT05907395|526692011|FG000|Period 2|Adverse Event|0|||
146049089|NCT05907395|526692012|FG001|Period 2|Adverse Event|0|||
146049090|NCT05907395|526692013|FG002|Period 2|Adverse Event|0|||
146049091|NCT05907395|526692014|FG003|Period 2|Adverse Event|1|||
146049092|NCT05907395|526692015|FG004|Period 2|Adverse Event|0|||
146049093|NCT05907395|526692016|FG005|Period 2|Adverse Event|0|||
146049094|NCT05907395|526692017|FG006|Period 2|Adverse Event|0|||
146049095|NCT05907395|526692018|FG007|Period 2|Adverse Event|1|||
146049096|NCT05907395|526692019|FG008|Period 2|Adverse Event|0|||
146049097|NCT05907395|526692020|FG009|Period 2|Adverse Event|0|||
146049098|NCT05907395|526692021|FG010|Period 2|Adverse Event|0|||
146049099|NCT05907395|526692022|FG011|Period 2|Adverse Event|0|||
146049100|NCT05907395|526692011|FG000|Period 2|Personal reason|0|||
146049101|NCT05907395|526692012|FG001|Period 2|Personal reason|0|||
146049102|NCT05907395|526692013|FG002|Period 2|Personal reason|0|||
146049103|NCT05907395|526692014|FG003|Period 2|Personal reason|0|||
146049104|NCT05907395|526692015|FG004|Period 2|Personal reason|0|||
146049105|NCT05907395|526692016|FG005|Period 2|Personal reason|0|||
146049106|NCT05907395|526692017|FG006|Period 2|Personal reason|0|||
146049107|NCT05907395|526692018|FG007|Period 2|Personal reason|0|||
146049108|NCT05907395|526692019|FG008|Period 2|Personal reason|0|||
146049109|NCT05907395|526692020|FG009|Period 2|Personal reason|1|||
146049110|NCT05907395|526692021|FG010|Period 2|Personal reason|0|||
146049111|NCT05907395|526692022|FG011|Period 2|Personal reason|0|||
146049112|NCT05907395|526692011|FG000|Period 3|Adverse Event|0|||
146049113|NCT05907395|526692012|FG001|Period 3|Adverse Event|0|||
146049114|NCT05907395|526692013|FG002|Period 3|Adverse Event|0|||
146049115|NCT05907395|526692014|FG003|Period 3|Adverse Event|0|||
146049116|NCT05907395|526692015|FG004|Period 3|Adverse Event|1|||
146049117|NCT05907395|526692016|FG005|Period 3|Adverse Event|0|||
146049118|NCT05907395|526692017|FG006|Period 3|Adverse Event|0|||
146049119|NCT05907395|526692018|FG007|Period 3|Adverse Event|0|||
146049120|NCT05907395|526692019|FG008|Period 3|Adverse Event|0|||
146049121|NCT05907395|526692020|FG009|Period 3|Adverse Event|0|||
146049122|NCT05907395|526692021|FG010|Period 3|Adverse Event|0|||
146049123|NCT05907395|526692022|FG011|Period 3|Adverse Event|0|||
146049124|NCT04544956|526692023|FG000|Overall Study|Withdrawal by Subject|1|||
146049125|NCT04178720|526692027|FG000|Overall Study|Withdrawal by Subject|2|||
146049126|NCT04178720|526692028|FG001|Overall Study|Withdrawal by Subject|0|||
146049127|NCT04178720|526692027|FG000|Overall Study|Relocation|0|||
146049128|NCT04178720|526692028|FG001|Overall Study|Relocation|1|||
146049129|NCT00983385|526692029|FG000|Observation Period|Not eligible to be dosed|20|||
146049130|NCT00983385|526692029|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
146049131|NCT01223183|526692030|FG000|Imaging Day 1|Physician Decision|0|||
146049132|NCT01223183|526692031|FG001|Imaging Day 1|Physician Decision|1|||
146049133|NCT01223183|526692030|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
146049134|NCT01223183|526692031|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
146049135|NCT01223183|526692030|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
146049136|NCT01223183|526692031|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
146049137|NCT02562235|526695273|FG000|Overall Study|Adverse Event|3|||
146049138|NCT00592904|526695277|FG000|Overall Study|Adverse Event|15|||
146049139|NCT00592904|526695278|FG001|Overall Study|Adverse Event|25|||
146049140|NCT00592904|526695279|FG002|Overall Study|Adverse Event|13|||
146049141|NCT00592904|526695280|FG003|Overall Study|Adverse Event|5|||
146049142|NCT00592904|526695277|FG000|Overall Study|Protocol Violation|1|||
146049143|NCT00592904|526695278|FG001|Overall Study|Protocol Violation|1|||
146049144|NCT00592904|526695279|FG002|Overall Study|Protocol Violation|0|||
146049145|NCT00592904|526695280|FG003|Overall Study|Protocol Violation|1|||
146049146|NCT00592904|526695277|FG000|Overall Study|Withdrawal by Subject|4|||
146049147|NCT00592904|526695278|FG001|Overall Study|Withdrawal by Subject|16|||
146049148|NCT00592904|526695279|FG002|Overall Study|Withdrawal by Subject|1|||
146256070|NCT01697592|527452506|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146256071|NCT01697592|527452507|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146103135|NCT00306189|526897247|FG003|Overall Study|Ineligibility determined|1|||
146103136|NCT00306189|526897244|FG000|Overall Study|Other|1|||
146103137|NCT00306189|526897245|FG001|Overall Study|Other|0|||
146103138|NCT00306189|526897246|FG002|Overall Study|Other|0|||
146103139|NCT00306189|526897247|FG003|Overall Study|Other|0|||
146103140|NCT02059408|526897248|FG000|Overall Study|Did not get tested|0|||
146103141|NCT02059408|526897249|FG001|Overall Study|Did not get tested|330|||
146103142|NCT02059408|526897250|FG002|Overall Study|Did not get tested|358|||
146103143|NCT02993757|526897251|FG000|Overall Study|Non compliance with the protocol|155|||
146103144|NCT02993757|526897252|FG001|Overall Study|Non compliance with the protocol|170|||
146103145|NCT02993757|526897251|FG000|Overall Study|Lost to Follow-up|1|||
146103146|NCT02993757|526897252|FG001|Overall Study|Lost to Follow-up|0|||
146103147|NCT02993757|526897251|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
146103148|NCT02993757|526897252|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
146103149|NCT00672646|526897255|FG000|Overall Study|Lost to Follow-up|0|||
146103150|NCT00672646|526897256|FG001|Overall Study|Lost to Follow-up|1|||
146103151|NCT00672646|526897257|FG002|Overall Study|Lost to Follow-up|2|||
146103152|NCT00672646|526897255|FG000|Overall Study|Withdrawal by Subject|0|||
146103153|NCT00672646|526897256|FG001|Overall Study|Withdrawal by Subject|0|||
146103154|NCT00672646|526897257|FG002|Overall Study|Withdrawal by Subject|1|||
146103155|NCT00289783|526897258|FG000|Primary Phase|Adverse Event|10|||
146103156|NCT00289783|526897259|FG001|Primary Phase|Adverse Event|1|||
146103157|NCT00289783|526897258|FG000|Primary Phase|Protocol Violation|27|||
146103158|NCT00289783|526897259|FG001|Primary Phase|Protocol Violation|6|||
146103159|NCT00289783|526897258|FG000|Primary Phase|Withdrawal by Subject|93|||
146103160|NCT00289783|526897259|FG001|Primary Phase|Withdrawal by Subject|40|||
146103161|NCT00289783|526897258|FG000|Primary Phase|Lost to Follow-up|60|||
146103162|NCT00289783|526897259|FG001|Primary Phase|Lost to Follow-up|14|||
146103163|NCT00289783|526897258|FG000|Primary Phase|Migration from the study area|26|||
146103164|NCT00289783|526897259|FG001|Primary Phase|Migration from the study area|10|||
146103165|NCT00289783|526897258|FG000|Primary Phase|Other|32|||
146103166|NCT00289783|526897259|FG001|Primary Phase|Other|12|||
146103167|NCT00289783|526897258|FG000|Fourth Dose Phase|Adverse Event|1|||
146103168|NCT00289783|526897259|FG001|Fourth Dose Phase|Adverse Event|0|||
146103169|NCT00289783|526897258|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
146103170|NCT00289783|526897259|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
146103171|NCT00289783|526897258|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
146103172|NCT00289783|526897259|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
146103173|NCT00289783|526897258|FG000|Fourth Dose Phase|Migration from the study area|1|||
146103174|NCT00289783|526897259|FG001|Fourth Dose Phase|Migration from the study area|1|||
146103175|NCT00289783|526897258|FG000|Fourth Dose Phase|Other|22|||
146103176|NCT00289783|526897259|FG001|Fourth Dose Phase|Other|10|||
146103177|NCT06934993|526897262|FG000|Overall Study|Withdrawal by Subject|29|||
146103178|NCT06934993|526897262|FG000|Overall Study|elevated postoperative creatinine level|11|||
146103179|NCT06934993|526897262|FG000|Overall Study|Death|3|||
146103180|NCT03128047|526897263|FG000|Overall Study|Withdrawal by Subject|1|||
146103181|NCT00443261|526898692|FG000|Overall Study|Death|1|||
146256072|NCT01697592|527452508|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146256073|NCT01697592|527452509|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146256074|NCT01697592|527452510|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
146103182|NCT01663532|526898693|FG000|Overall Study|Lost to Follow-up|9|||
146103183|NCT01663532|526898694|FG001|Overall Study|Lost to Follow-up|10|||
146103184|NCT01663532|526898693|FG000|Overall Study|Adverse Event|7|||
146103185|NCT01663532|526898694|FG001|Overall Study|Adverse Event|13|||
146103186|NCT01663532|526898693|FG000|Overall Study|Met Withdrawal Criteria|7|||
146103187|NCT01663532|526898694|FG001|Overall Study|Met Withdrawal Criteria|6|||
146103188|NCT01663532|526898693|FG000|Overall Study|Physician Decision|1|||
146103189|NCT01663532|526898694|FG001|Overall Study|Physician Decision|1|||
146103190|NCT01663532|526898693|FG000|Overall Study|Withdrawal by Subject|35|||
146103191|NCT01663532|526898694|FG001|Overall Study|Withdrawal by Subject|17|||
146103192|NCT01663532|526898693|FG000|Overall Study|Lack of Efficacy|15|||
146103193|NCT01663532|526898694|FG001|Overall Study|Lack of Efficacy|60|||
146256075|NCT01697592|527452511|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
146256076|NCT01697592|527452502|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
146256077|NCT01697592|527452503|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256078|NCT01697592|527452504|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256079|NCT01697592|527452505|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
146256080|NCT01697592|527452506|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256081|NCT01697592|527452507|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256082|NCT01697592|527452508|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256083|NCT01697592|527452509|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256084|NCT01697592|527452510|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256085|NCT01697592|527452511|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
146256086|NCT01697592|527452502|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
146256087|NCT01697592|527452503|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256088|NCT01697592|527452504|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146049149|NCT00592904|526695280|FG003|Overall Study|Withdrawal by Subject|2|||
146049150|NCT00592904|526695277|FG000|Overall Study|Lack of Efficacy|2|||
146049151|NCT00592904|526695278|FG001|Overall Study|Lack of Efficacy|7|||
146049152|NCT00592904|526695279|FG002|Overall Study|Lack of Efficacy|2|||
146049153|NCT00592904|526695280|FG003|Overall Study|Lack of Efficacy|3|||
146049154|NCT00592904|526695277|FG000|Overall Study|Physician Decision|0|||
146049155|NCT00592904|526695278|FG001|Overall Study|Physician Decision|3|||
146049156|NCT00592904|526695279|FG002|Overall Study|Physician Decision|1|||
146049157|NCT00592904|526695280|FG003|Overall Study|Physician Decision|0|||
146049158|NCT00592904|526695277|FG000|Overall Study|Other|3|||
146049159|NCT00592904|526695278|FG001|Overall Study|Other|3|||
146049160|NCT00592904|526695279|FG002|Overall Study|Other|0|||
146049161|NCT00592904|526695280|FG003|Overall Study|Other|0|||
146049162|NCT02640547|526695281|FG000|Overall Study|Failure to Return|1|||
146256089|NCT01697592|527452505|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256090|NCT01697592|527452506|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256091|NCT01697592|527452507|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
146256092|NCT01697592|527452508|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256093|NCT01697592|527452509|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
146256094|NCT01697592|527452510|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256095|NCT01697592|527452511|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
146256096|NCT01697592|527452502|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146256097|NCT01697592|527452503|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146256098|NCT01697592|527452504|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146256099|NCT01697592|527452505|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146256100|NCT01697592|527452506|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146256101|NCT01697592|527452507|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146256102|NCT01697592|527452508|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
146256103|NCT01697592|527452509|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146256104|NCT01697592|527452510|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
146256105|NCT01697592|527452511|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
146256106|NCT02499835|527452512|FG000|Overall Study|Withdrawal by Subject|1|||
146256107|NCT02499835|527452513|FG001|Overall Study|Withdrawal by Subject|0|||
146256108|NCT02499835|527452514|FG002|Overall Study|Withdrawal by Subject|0|||
146256109|NCT02499835|527452515|FG003|Overall Study|Withdrawal by Subject|1|||
146256110|NCT02499835|527452512|FG000|Overall Study|Physician Decision|0|||
146256111|NCT02499835|527452513|FG001|Overall Study|Physician Decision|3|||
146256112|NCT02499835|527452514|FG002|Overall Study|Physician Decision|18|||
146256113|NCT02499835|527452515|FG003|Overall Study|Physician Decision|7|||
146256114|NCT02499835|527452512|FG000|Overall Study|Adverse Event|0|||
146256115|NCT02499835|527452513|FG001|Overall Study|Adverse Event|0|||
146256116|NCT02499835|527452514|FG002|Overall Study|Adverse Event|0|||
146256117|NCT02499835|527452515|FG003|Overall Study|Adverse Event|1|||
146256118|NCT02499835|527452512|FG000|Overall Study|Disease progression|2|||
146256119|NCT02499835|527452513|FG001|Overall Study|Disease progression|1|||
146256120|NCT02499835|527452514|FG002|Overall Study|Disease progression|0|||
146256121|NCT02499835|527452515|FG003|Overall Study|Disease progression|7|||
146256122|NCT05109117|527452516|FG000|Overall Study|Lost to Follow-up|1|||
146256123|NCT05109117|527452516|FG000|Overall Study|Discontinued for non-compliance|1|||
146049163|NCT02640547|526695281|FG000|Overall Study|Withdrawal by Subject|1|||
146049164|NCT02640547|526695281|FG000|Overall Study|Death|6|||
146049165|NCT02640547|526695281|FG000|Overall Study|Miscellaneous|3|||
146049166|NCT02525588|526695282|FG000|Overall Study|Death|3|||
146049167|NCT02525588|526695283|FG001|Overall Study|Death|1|||
146049168|NCT02525588|526695282|FG000|Overall Study|Lost to Follow-up|2|||
146049169|NCT02525588|526695283|FG001|Overall Study|Lost to Follow-up|0|||
146049170|NCT02525588|526695282|FG000|Overall Study|Withdrawal by Subject|1|||
146049171|NCT02525588|526695283|FG001|Overall Study|Withdrawal by Subject|1|||
146049172|NCT02525588|526695282|FG000|Overall Study|Adverse Event|0|||
146049173|NCT02525588|526695283|FG001|Overall Study|Adverse Event|1|||
146049174|NCT03018691|526695284|FG000|Overall Study|Adverse Event|1|||
146049175|NCT03018691|526695285|FG001|Overall Study|Adverse Event|1|||
146256124|NCT03972137|527452520|FG000|Overall Study|Lost to Follow-up|2|||
146256125|NCT03972137|527452520|FG000|Overall Study|Withdrawal by Subject|4|||
146256126|NCT03319719|527452522|FG000|Overall Study|Lost to Follow-up|1|||
146256127|NCT00744796|527452523|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
146256128|NCT02973477|527452525|FG000|First Intervention|Lost to Follow-up|0|||
146256129|NCT02973477|527452526|FG001|First Intervention|Lost to Follow-up|2|||
146256130|NCT02973477|527452525|FG000|Washout|Withdrawal by Subject|1|||
146049176|NCT03018691|526695286|FG002|Overall Study|Adverse Event|4|||
146049177|NCT03018691|526695284|FG000|Overall Study|Lack of Efficacy|0|||
146049178|NCT03018691|526695285|FG001|Overall Study|Lack of Efficacy|0|||
146049179|NCT03018691|526695286|FG002|Overall Study|Lack of Efficacy|1|||
146049180|NCT03018691|526695284|FG000|Overall Study|Withdrawal by Subject|0|||
146049181|NCT03018691|526695285|FG001|Overall Study|Withdrawal by Subject|0|||
146049182|NCT03018691|526695286|FG002|Overall Study|Withdrawal by Subject|1|||
146256131|NCT02973477|527452526|FG001|Washout|Withdrawal by Subject|0|||
146256132|NCT02973477|527452525|FG000|Second Intervention|Lost to Follow-up|1|||
146256133|NCT02973477|527452526|FG001|Second Intervention|Lost to Follow-up|0|||
146049183|NCT03018691|526695284|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146049184|NCT03018691|526695285|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146049185|NCT03018691|526695286|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146049186|NCT03369418|526695288|FG000|Overall Study|Withdrawal by Subject|3|||
146049187|NCT03369418|526695289|FG001|Overall Study|Withdrawal by Subject|3|||
146049188|NCT01485094|526695290|FG000|Overall Study|Adverse Event|1|||
146049189|NCT01485094|526695291|FG001|Overall Study|Adverse Event|1|||
146049190|NCT01485094|526695292|FG002|Overall Study|Adverse Event|1|||
146049191|NCT01485094|526695290|FG000|Overall Study|Lost to Follow-up|1|||
146049192|NCT01485094|526695291|FG001|Overall Study|Lost to Follow-up|0|||
146049193|NCT01485094|526695292|FG002|Overall Study|Lost to Follow-up|0|||
146049194|NCT01485094|526695290|FG000|Overall Study|Withdrawal by Subject|1|||
146049195|NCT01485094|526695291|FG001|Overall Study|Withdrawal by Subject|1|||
146049196|NCT01485094|526695292|FG002|Overall Study|Withdrawal by Subject|0|||
146049197|NCT01172535|526695293|FG000|Overall Study|Death|3|||
146049198|NCT01172535|526695293|FG000|Overall Study|Withdrawal by Subject|2|||
146049199|NCT01172535|526695293|FG000|Overall Study|Lost to Follow-up|1|||
146049200|NCT01172535|526695293|FG000|Overall Study|Ineligible at study entry|1|||
146049201|NCT01172535|526695293|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146049202|NCT02698826|526695299|FG000|Overall Study|Death|13|||
146049203|NCT02698826|526695299|FG000|Overall Study|Adverse Event|1|||
146049204|NCT02478463|526695304|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
146049205|NCT02478463|526695304|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
146049206|NCT02478463|526695304|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
146049207|NCT01879683|526695305|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
146256134|NCT02381652|527452533|FG000|Overall Study|Withdrawal by Subject|0|||
146256135|NCT02381652|527452534|FG001|Overall Study|Withdrawal by Subject|0|||
146049208|NCT01508169|526695309|FG000|Overall Study|Adverse Event|1|||
146049209|NCT01508169|526695310|FG001|Overall Study|Adverse Event|0|||
146049210|NCT01508169|526695309|FG000|Overall Study|Withdrawal by Subject|1|||
146049211|NCT01508169|526695310|FG001|Overall Study|Withdrawal by Subject|0|||
146049212|NCT01508169|526695309|FG000|Overall Study|Lost to Follow-up|1|||
146049213|NCT01508169|526695310|FG001|Overall Study|Lost to Follow-up|2|||
146049214|NCT02396212|526695313|FG000|Overall Study|Adverse Event|1|||
146049215|NCT02396212|526695313|FG000|Overall Study|Lack of Efficacy|2|||
146049216|NCT01623115|526695314|FG000|Overall Study|Randomized but not treated|0|||
146049217|NCT01623115|526695315|FG001|Overall Study|Randomized but not treated|1|||
146049218|NCT01623115|526695314|FG000|Overall Study|Physician Decision|1|||
146049219|NCT01623115|526695315|FG001|Overall Study|Physician Decision|0|||
146049220|NCT01623115|526695314|FG000|Overall Study|Participants moved|1|||
146049221|NCT01623115|526695315|FG001|Overall Study|Participants moved|5|||
146049222|NCT01623115|526695314|FG000|Overall Study|Adverse Event|10|||
146049223|NCT01623115|526695315|FG001|Overall Study|Adverse Event|13|||
146049224|NCT01623115|526695314|FG000|Overall Study|Poor compliance to protocol|4|||
146049225|NCT01623115|526695315|FG001|Overall Study|Poor compliance to protocol|10|||
146049226|NCT01623115|526695314|FG000|Overall Study|Consent withdrawn by participant|2|||
146049227|NCT01623115|526695315|FG001|Overall Study|Consent withdrawn by participant|6|||
146049228|NCT01623115|526695314|FG000|Overall Study|Related to study drug administration|0|||
146049229|NCT01623115|526695315|FG001|Overall Study|Related to study drug administration|2|||
146049230|NCT01623115|526695314|FG000|Overall Study|Last visit outside protocol visit window|14|||
146049231|NCT01623115|526695315|FG001|Overall Study|Last visit outside protocol visit window|26|||
146049232|NCT01623115|526695314|FG000|Overall Study|Site closure|1|||
146049233|NCT01623115|526695315|FG001|Overall Study|Site closure|7|||
146049234|NCT01623115|526695314|FG000|Overall Study|Death|0|||
146049235|NCT01623115|526695315|FG001|Overall Study|Death|4|||
146049236|NCT01623115|526695314|FG000|Overall Study|Other than specified above|0|||
146049237|NCT01623115|526695315|FG001|Overall Study|Other than specified above|3|||
146049238|NCT02366195|526695317|FG000|Overall Study|Protocol-specified criteria|3|||
146049239|NCT02366195|526695317|FG000|Overall Study|Withdrawal by Subject|9|||
146049240|NCT02366195|526695317|FG000|Overall Study|Lost to Follow-up|1|||
146256136|NCT02381652|527452535|FG002|Overall Study|Withdrawal by Subject|1|||
146256137|NCT01340300|527452536|FG000|Overall Study|Lost to Follow-up|3|||
146049241|NCT02366195|526695317|FG000|Overall Study|Death|41|||
146049242|NCT01338818|526695320|FG000|Overall Study|Adverse Event|8|||
146049243|NCT01338818|526695320|FG000|Overall Study|Lack of Efficacy|5|||
146049244|NCT01338818|526695320|FG000|Overall Study|no longer require study drug|1|||
146049245|NCT01338818|526695320|FG000|Overall Study|Withdrawal by Subject|11|||
146049246|NCT01338818|526695320|FG000|Overall Study|Lost to Follow-up|4|||
146049247|NCT01338818|526695320|FG000|Overall Study|Administrative problems|3|||
146049248|NCT01338818|526695320|FG000|Overall Study|Protocol Deviation|4|||
146049249|NCT01620086|526695321|FG000|Overall Study|Withdrawal by Subject|3|||
146049250|NCT01620086|526695322|FG001|Overall Study|Withdrawal by Subject|3|||
146049251|NCT01620086|526695323|FG002|Overall Study|Withdrawal by Subject|0|||
146049252|NCT01620086|526695321|FG000|Overall Study|failed study criteria|1|||
146103194|NCT03539081|526898696|FG000|Overall Study|Withdrawal by Subject|2|||
146256138|NCT01340300|527452537|FG001|Overall Study|Lost to Follow-up|0|||
146256139|NCT01340300|527452538|FG002|Overall Study|Lost to Follow-up|5|||
146049253|NCT01620086|526695322|FG001|Overall Study|failed study criteria|4|||
146049254|NCT01620086|526695323|FG002|Overall Study|failed study criteria|0|||
146049255|NCT01620086|526695321|FG000|Overall Study|Physician Decision|1|||
146049256|NCT01620086|526695322|FG001|Overall Study|Physician Decision|0|||
146049257|NCT01620086|526695323|FG002|Overall Study|Physician Decision|0|||
146049258|NCT00580723|526695329|FG000|Overall Study|Did not want to participate in extension|3|||
146049259|NCT00580723|526695329|FG000|Overall Study|Lost to Follow-up|5|||
146049260|NCT05202418|526695330|FG000|Overall Study|Withdrawal by Subject|2|||
146049261|NCT05202418|526695331|FG001|Overall Study|Withdrawal by Subject|1|||
146049262|NCT05202418|526695330|FG000|Overall Study|Lost to Follow-up|1|||
146049263|NCT05202418|526695331|FG001|Overall Study|Lost to Follow-up|1|||
146049264|NCT00684996|526695332|FG000|Overall Study|Adverse Event|1|||
146049265|NCT00684996|526695332|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146049266|NCT00684996|526695332|FG000|Overall Study|Progression/relapse|2|||
146049267|NCT00684996|526695332|FG000|Overall Study|Other reasons not protocol specified|1|||
146049268|NCT00556998|526695333|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
146049269|NCT00556998|526695333|FG000|Voriconazole Intravenous (IV)|Other|4|||
146049270|NCT00556998|526695333|FG000|Voriconazole Oral|Adverse Event|1|||
146049271|NCT00556998|526695333|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
146049272|NCT02519439|526695336|FG000|Overall Study|Study Termination|19|||
146049273|NCT02519439|526695336|FG000|Overall Study|Withdrawal by Subject|1|||
146049274|NCT02519439|526695336|FG000|Overall Study|Adverse Event|1|||
146049275|NCT03030417|526695339|FG000|Dose Expansion|Disease progression before treatment|0|||
146049276|NCT03030417|526695340|FG001|Dose Expansion|Disease progression before treatment|0|||
146049277|NCT03030417|526695341|FG002|Dose Expansion|Disease progression before treatment|0|||
146049278|NCT03030417|526695342|FG003|Dose Expansion|Disease progression before treatment|0|||
146049279|NCT03030417|526695343|FG004|Dose Expansion|Disease progression before treatment|0|||
146049280|NCT03030417|526695344|FG005|Dose Expansion|Disease progression before treatment|0|||
146049281|NCT03030417|526695345|FG006|Dose Expansion|Disease progression before treatment|0|||
146049282|NCT03030417|526695346|FG007|Dose Expansion|Disease progression before treatment|0|||
146049283|NCT03030417|526695347|FG008|Dose Expansion|Disease progression before treatment|0|||
146049284|NCT03030417|526695348|FG009|Dose Expansion|Disease progression before treatment|0|||
146049285|NCT03030417|526695349|FG010|Dose Expansion|Disease progression before treatment|0|||
146049286|NCT03030417|526695350|FG011|Dose Expansion|Disease progression before treatment|0|||
146049287|NCT03030417|526695351|FG012|Dose Expansion|Disease progression before treatment|1|||
146049288|NCT01078441|526695352|FG000|Overall Study|Withdrawal by Subject|1|||
146049289|NCT01425801|526695353|FG000|Period 1|Withdrawal by Subject|0|||
146049290|NCT01425801|526695354|FG001|Period 1|Withdrawal by Subject|0|||
146049291|NCT01425801|526695355|FG002|Period 1|Withdrawal by Subject|0|||
146049292|NCT01425801|526695356|FG003|Period 1|Withdrawal by Subject|0|||
146049293|NCT01425801|526695357|FG004|Period 1|Withdrawal by Subject|1|||
146049294|NCT01425801|526695358|FG005|Period 1|Withdrawal by Subject|0|||
146049295|NCT01425801|526695353|FG000|Period 2|Withdrawal by Subject|0|||
146049296|NCT01425801|526695354|FG001|Period 2|Withdrawal by Subject|0|||
146049297|NCT01425801|526695355|FG002|Period 2|Withdrawal by Subject|0|||
146049298|NCT01425801|526695356|FG003|Period 2|Withdrawal by Subject|0|||
146049299|NCT01425801|526695357|FG004|Period 2|Withdrawal by Subject|1|||
146049300|NCT01425801|526695358|FG005|Period 2|Withdrawal by Subject|0|||
146049301|NCT01425801|526695353|FG000|Period 3|Stability criteria not fullfilled|0|||
146049302|NCT01425801|526695354|FG001|Period 3|Stability criteria not fullfilled|0|||
146049303|NCT01425801|526695355|FG002|Period 3|Stability criteria not fullfilled|1|||
146049304|NCT01425801|526695356|FG003|Period 3|Stability criteria not fullfilled|0|||
146049305|NCT01425801|526695357|FG004|Period 3|Stability criteria not fullfilled|0|||
146049306|NCT01425801|526695358|FG005|Period 3|Stability criteria not fullfilled|0|||
146049307|NCT01425801|526695353|FG000|Period 4|Not able to maintain visit schedule|0|||
146049308|NCT01425801|526695354|FG001|Period 4|Not able to maintain visit schedule|0|||
146049309|NCT01425801|526695355|FG002|Period 4|Not able to maintain visit schedule|1|||
146049310|NCT01425801|526695356|FG003|Period 4|Not able to maintain visit schedule|0|||
146049311|NCT01425801|526695357|FG004|Period 4|Not able to maintain visit schedule|0|||
146049312|NCT01425801|526695358|FG005|Period 4|Not able to maintain visit schedule|0|||
146049313|NCT02868554|526695359|FG000|Overall Study|Lost to Follow-up|3|||
146049314|NCT02868554|526695360|FG001|Overall Study|Lost to Follow-up|0|||
146049315|NCT02868554|526695361|FG002|Overall Study|Lost to Follow-up|1|||
146049316|NCT02175017|526695362|FG000|Overall Study|Did not receive the investigational product|1|||
146049317|NCT02175017|526695363|FG001|Overall Study|Did not receive the investigational product|2|||
146049318|NCT02175017|526695362|FG000|Overall Study|Withdrawal by Subject|6|||
146049319|NCT02175017|526695363|FG001|Overall Study|Withdrawal by Subject|3|||
146256140|NCT01340300|527452539|FG003|Overall Study|Lost to Follow-up|10|||
146049320|NCT02175017|526695362|FG000|Overall Study|Met an exclusion criteria|0|||
146103195|NCT03539081|526898697|FG001|Overall Study|Withdrawal by Subject|3|||
146256141|NCT01340300|527452536|FG000|Overall Study|Withdrawal by Subject|5|||
146049321|NCT02175017|526695363|FG001|Overall Study|Met an exclusion criteria|1|||
146049322|NCT02175017|526695362|FG000|Overall Study|Adverse Event|3|||
146049323|NCT02175017|526695363|FG001|Overall Study|Adverse Event|10|||
146256142|NCT01340300|527452537|FG001|Overall Study|Withdrawal by Subject|6|||
146256143|NCT01340300|527452538|FG002|Overall Study|Withdrawal by Subject|6|||
146256144|NCT01340300|527452539|FG003|Overall Study|Withdrawal by Subject|3|||
146256145|NCT01340300|527452536|FG000|Overall Study|Adverse Event|1|||
146256146|NCT01340300|527452537|FG001|Overall Study|Adverse Event|0|||
146049324|NCT02175017|526695362|FG000|Overall Study|Disease progression|20|||
146049325|NCT02175017|526695363|FG001|Overall Study|Disease progression|27|||
146049326|NCT02175017|526695362|FG000|Overall Study|Other than above reasons|3|||
146049327|NCT02175017|526695363|FG001|Overall Study|Other than above reasons|0|||
146049328|NCT02491983|526695364|FG000|Overall Study|Physician Decision|1|||
146049329|NCT02491983|526695365|FG001|Overall Study|Physician Decision|0|||
146049330|NCT02491983|526695364|FG000|Overall Study|Not meet selection criteria|1|||
146049331|NCT02491983|526695365|FG001|Overall Study|Not meet selection criteria|0|||
146049332|NCT02491983|526695364|FG000|Overall Study|Withdrawal by Subject|0|||
146049333|NCT02491983|526695365|FG001|Overall Study|Withdrawal by Subject|1|||
146049334|NCT04961541|526695366|FG000|Overall Study|Adverse Event|0|||
146049335|NCT04961541|526695367|FG001|Overall Study|Adverse Event|0|||
146049336|NCT04961541|526695368|FG002|Overall Study|Adverse Event|0|||
146049337|NCT04961541|526695369|FG003|Overall Study|Adverse Event|0|||
146049338|NCT04961541|526695370|FG004|Overall Study|Adverse Event|0|||
146049339|NCT04961541|526695371|FG005|Overall Study|Adverse Event|1|||
146049340|NCT04961541|526695372|FG006|Overall Study|Adverse Event|0|||
146049341|NCT04961541|526695373|FG007|Overall Study|Adverse Event|0|||
146049342|NCT04961541|526695374|FG008|Overall Study|Adverse Event|0|||
146049343|NCT04961541|526695375|FG009|Overall Study|Adverse Event|0|||
146049344|NCT04961541|526695376|FG010|Overall Study|Adverse Event|0|||
146049345|NCT04961541|526695377|FG011|Overall Study|Adverse Event|0|||
146049346|NCT04961541|526695378|FG012|Overall Study|Adverse Event|0|||
146049347|NCT04961541|526695379|FG013|Overall Study|Adverse Event|0|||
146049348|NCT04961541|526695366|FG000|Overall Study|Lost to Follow-up|0|||
146049349|NCT04961541|526695367|FG001|Overall Study|Lost to Follow-up|0|||
146049350|NCT04961541|526695368|FG002|Overall Study|Lost to Follow-up|3|||
146049351|NCT04961541|526695369|FG003|Overall Study|Lost to Follow-up|0|||
146049352|NCT04961541|526695370|FG004|Overall Study|Lost to Follow-up|0|||
146049353|NCT04961541|526695371|FG005|Overall Study|Lost to Follow-up|0|||
146049354|NCT04961541|526695372|FG006|Overall Study|Lost to Follow-up|1|||
146049355|NCT04961541|526695373|FG007|Overall Study|Lost to Follow-up|1|||
146049356|NCT04961541|526695374|FG008|Overall Study|Lost to Follow-up|0|||
146049357|NCT04961541|526695375|FG009|Overall Study|Lost to Follow-up|1|||
146049358|NCT04961541|526695376|FG010|Overall Study|Lost to Follow-up|0|||
146049359|NCT04961541|526695377|FG011|Overall Study|Lost to Follow-up|0|||
146049360|NCT04961541|526695378|FG012|Overall Study|Lost to Follow-up|1|||
146049361|NCT04961541|526695379|FG013|Overall Study|Lost to Follow-up|0|||
146049362|NCT04961541|526695366|FG000|Overall Study|Withdrawal by Subject|0|||
146049363|NCT04961541|526695367|FG001|Overall Study|Withdrawal by Subject|0|||
146049364|NCT04961541|526695368|FG002|Overall Study|Withdrawal by Subject|1|||
146049365|NCT04961541|526695369|FG003|Overall Study|Withdrawal by Subject|1|||
146049366|NCT04961541|526695370|FG004|Overall Study|Withdrawal by Subject|0|||
146049367|NCT04961541|526695371|FG005|Overall Study|Withdrawal by Subject|0|||
146049368|NCT04961541|526695372|FG006|Overall Study|Withdrawal by Subject|0|||
146049369|NCT04961541|526695373|FG007|Overall Study|Withdrawal by Subject|0|||
146049370|NCT04961541|526695374|FG008|Overall Study|Withdrawal by Subject|0|||
146049371|NCT04961541|526695375|FG009|Overall Study|Withdrawal by Subject|1|||
146049372|NCT04961541|526695376|FG010|Overall Study|Withdrawal by Subject|0|||
146049373|NCT04961541|526695377|FG011|Overall Study|Withdrawal by Subject|0|||
146049374|NCT04961541|526695378|FG012|Overall Study|Withdrawal by Subject|0|||
146049375|NCT04961541|526695379|FG013|Overall Study|Withdrawal by Subject|0|||
146049376|NCT00191308|526695380|FG000|Overall Study|Adverse Event|1|||
146049377|NCT01970306|526695382|FG000|Overall Study|Not eligible|3|||
146049378|NCT01970306|526695382|FG000|Overall Study|Not able to be treated|9|||
146049379|NCT03066596|526695383|FG000|Overall Study|Withdrawal by Subject|4|||
146049380|NCT03066596|526695384|FG001|Overall Study|Withdrawal by Subject|2|||
146049381|NCT03066596|526695383|FG000|Overall Study|Lost to Follow-up|14|||
146049382|NCT03066596|526695384|FG001|Overall Study|Lost to Follow-up|10|||
146256147|NCT01340300|527452538|FG002|Overall Study|Adverse Event|4|||
146049383|NCT00782717|526695385|FG000|Overall Study|Adverse Event|2|||
146049384|NCT00782717|526695386|FG001|Overall Study|Adverse Event|5|||
146049385|NCT00782717|526695385|FG000|Overall Study|Patient decision unrelated to AE|6|||
146049386|NCT00782717|526695386|FG001|Overall Study|Patient decision unrelated to AE|3|||
146049387|NCT00782717|526695385|FG000|Overall Study|Noncompliance|2|||
146049388|NCT00782717|526695386|FG001|Overall Study|Noncompliance|1|||
146049389|NCT00782717|526695385|FG000|Overall Study|Treatment failure|3|||
146049390|NCT00782717|526695386|FG001|Overall Study|Treatment failure|14|||
146049391|NCT00782717|526695385|FG000|Overall Study|Enrollment close prior to surgery|1|||
146256148|NCT01340300|527452539|FG003|Overall Study|Adverse Event|0|||
146256149|NCT01340300|527452536|FG000|Overall Study|Physician Decision|0|||
146103196|NCT03539081|526898698|FG002|Overall Study|Withdrawal by Subject|0|||
146103197|NCT03539081|526898696|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
146103198|NCT03539081|526898697|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
146103199|NCT03539081|526898698|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
146103200|NCT02025621|526898699|FG000|Overall Study|Withdrawal by Subject|1|||
146103201|NCT02025621|526898700|FG001|Overall Study|Withdrawal by Subject|0|||
146103202|NCT02025621|526898699|FG000|Overall Study|Death|0|||
146103203|NCT02025621|526898700|FG001|Overall Study|Death|1|||
146103204|NCT02025621|526898699|FG000|Overall Study|No longer eligible|10|||
146103205|NCT02025621|526898700|FG001|Overall Study|No longer eligible|15|||
146103206|NCT02025621|526898699|FG000|Overall Study|Surgery initiated before infusion|3|||
146103207|NCT02025621|526898700|FG001|Overall Study|Surgery initiated before infusion|3|||
146103208|NCT00739674|526898701|FG000|Overall Study|Screening failures|19|||
146103209|NCT00739674|526898702|FG001|Overall Study|Screening failures|17|||
146103210|NCT00739674|526898701|FG000|Overall Study|Site 212 removal|19|||
146103211|NCT00739674|526898702|FG001|Overall Study|Site 212 removal|13|||
146103212|NCT00739674|526898701|FG000|Overall Study|No follow-up data|33|||
146103213|NCT00739674|526898702|FG001|Overall Study|No follow-up data|18|||
146103214|NCT00739674|526898701|FG000|Overall Study|Dietician consultation >30 days|1|||
146103215|NCT00739674|526898702|FG001|Overall Study|Dietician consultation >30 days|9|||
146103216|NCT00739674|526898701|FG000|Overall Study|Adverse Event|22|||
146103217|NCT00739674|526898702|FG001|Overall Study|Adverse Event|13|||
146103218|NCT00739674|526898701|FG000|Overall Study|Death|1|||
146103219|NCT00739674|526898702|FG001|Overall Study|Death|0|||
146103220|NCT00739674|526898701|FG000|Overall Study|Lack of Efficacy|1|||
146103221|NCT00739674|526898702|FG001|Overall Study|Lack of Efficacy|0|||
146103222|NCT00739674|526898701|FG000|Overall Study|Lost to Follow-up|52|||
146103223|NCT00739674|526898702|FG001|Overall Study|Lost to Follow-up|30|||
146103224|NCT00739674|526898701|FG000|Overall Study|Protocol Violation|5|||
146103225|NCT00739674|526898702|FG001|Overall Study|Protocol Violation|5|||
146103226|NCT00739674|526898701|FG000|Overall Study|Withdrawal by Subject|9|||
146103227|NCT00739674|526898702|FG001|Overall Study|Withdrawal by Subject|9|||
146103228|NCT00739674|526898701|FG000|Overall Study|Reason missing|2|||
146103229|NCT00739674|526898702|FG001|Overall Study|Reason missing|0|||
146103230|NCT00739674|526898701|FG000|Overall Study|Clinic closed|6|||
146103231|NCT00739674|526898702|FG001|Overall Study|Clinic closed|4|||
146103232|NCT00739674|526898701|FG000|Overall Study|Patient moved|3|||
146103233|NCT00739674|526898702|FG001|Overall Study|Patient moved|2|||
146103234|NCT00739674|526898701|FG000|Overall Study|Non compliant|4|||
146103235|NCT00739674|526898702|FG001|Overall Study|Non compliant|0|||
146103236|NCT00739674|526898701|FG000|Overall Study|Unable to attend visit|3|||
146103237|NCT00739674|526898702|FG001|Overall Study|Unable to attend visit|1|||
146103238|NCT00739674|526898701|FG000|Overall Study|Home monitoring off meds|1|||
146103239|NCT00739674|526898702|FG001|Overall Study|Home monitoring off meds|0|||
146103240|NCT00739674|526898701|FG000|Overall Study|Erectile dysfunction|0|||
146103241|NCT00739674|526898702|FG001|Overall Study|Erectile dysfunction|1|||
146103242|NCT04805541|526898704|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
146103243|NCT00283400|526898707|FG000|Overall Study|Withdrawal by Subject|1|||
146103244|NCT00283400|526898708|FG001|Overall Study|Withdrawal by Subject|1|||
146103245|NCT00283400|526898709|FG002|Overall Study|Withdrawal by Subject|0|||
146103246|NCT00283400|526898710|FG003|Overall Study|Withdrawal by Subject|0|||
146103247|NCT00283400|526898707|FG000|Overall Study|Death|1|||
146103248|NCT00283400|526898708|FG001|Overall Study|Death|0|||
146049392|NCT00782717|526695386|FG001|Overall Study|Enrollment close prior to surgery|0|||
146049393|NCT00782717|526695385|FG000|Overall Study|Did not meet entrance criteria|1|||
146049394|NCT00782717|526695386|FG001|Overall Study|Did not meet entrance criteria|3|||
146049395|NCT00782717|526695385|FG000|Overall Study|Exited in error|0|||
146049396|NCT00782717|526695386|FG001|Overall Study|Exited in error|2|||
146049397|NCT04739436|526695389|FG000|Overall Study|Lost to Follow-up|21|||
146049398|NCT04739436|526695390|FG001|Overall Study|Lost to Follow-up|23|||
146049399|NCT04739436|526695389|FG000|Overall Study|Withdrawal by Subject|4|||
146049400|NCT04739436|526695390|FG001|Overall Study|Withdrawal by Subject|6|||
146049401|NCT04739436|526695389|FG000|Overall Study|not randomized properly|1|||
146049402|NCT04739436|526695390|FG001|Overall Study|not randomized properly|0|||
146049403|NCT03201419|526695392|FG000|Overall Study|Adverse Event|3|||
146049404|NCT03201419|526695393|FG001|Overall Study|Adverse Event|1|||
146049405|NCT03201419|526695394|FG002|Overall Study|Adverse Event|0|||
146049406|NCT03201419|526695395|FG003|Overall Study|Adverse Event|0|||
146049407|NCT03201419|526695396|FG004|Overall Study|Adverse Event|1|||
146049408|NCT03201419|526695397|FG005|Overall Study|Adverse Event|1|||
146103249|NCT00283400|526898709|FG002|Overall Study|Death|1|||
146103250|NCT00283400|526898710|FG003|Overall Study|Death|0|||
146049409|NCT03201419|526695398|FG006|Overall Study|Adverse Event|5|||
146103251|NCT00983437|526898712|FG000|Overall Study|Adverse Event|9|||
146103252|NCT00983437|526898712|FG000|Overall Study|Lack of Efficacy|1|||
146103253|NCT00983437|526898712|FG000|Overall Study|Withdrawal by Subject|8|||
146256150|NCT01340300|527452537|FG001|Overall Study|Physician Decision|1|||
146103254|NCT00983437|526898712|FG000|Overall Study|Noncompliance to Study Procedures|1|||
146103255|NCT00983437|526898712|FG000|Overall Study|Lost to Follow-up|2|||
146103256|NCT00983437|526898712|FG000|Overall Study|Other Reason|26|||
146103257|NCT01020981|526898713|FG000|Overall Study|Did not return mailed survey|74|||
146103258|NCT01020981|526898714|FG001|Overall Study|Did not return mailed survey|58|||
146103259|NCT01020981|526898713|FG000|Overall Study|Survey returned undeliverable|8|||
146103260|NCT01020981|526898714|FG001|Overall Study|Survey returned undeliverable|32|||
146103261|NCT01020981|526898713|FG000|Overall Study|Participant declined to complete survey|2|||
146103262|NCT01020981|526898714|FG001|Overall Study|Participant declined to complete survey|0|||
146103263|NCT03372096|526898715|FG000|Overall Study|Study Closed|8|||
146103264|NCT02555683|526898719|FG000|Overall Study|Physician Decision|1|||
146103265|NCT02555683|526898720|FG001|Overall Study|Physician Decision|0|||
146103266|NCT02555683|526898721|FG002|Overall Study|Physician Decision|2|||
146103267|NCT02555683|526898719|FG000|Overall Study|Lost to Follow-up|2|||
146103268|NCT02555683|526898720|FG001|Overall Study|Lost to Follow-up|1|||
146103269|NCT02555683|526898721|FG002|Overall Study|Lost to Follow-up|2|||
146103270|NCT02555683|526898719|FG000|Overall Study|Technical Problems|1|||
146103271|NCT02555683|526898720|FG001|Overall Study|Technical Problems|1|||
146103272|NCT02555683|526898721|FG002|Overall Study|Technical Problems|0|||
146103273|NCT02555683|526898719|FG000|Overall Study|Protocol deviation|0|||
146103274|NCT02555683|526898720|FG001|Overall Study|Protocol deviation|1|||
146103275|NCT02555683|526898721|FG002|Overall Study|Protocol deviation|0|||
146103276|NCT02555683|526898719|FG000|Overall Study|Lack of Efficacy|2|||
146103277|NCT02555683|526898720|FG001|Overall Study|Lack of Efficacy|0|||
146103278|NCT02555683|526898721|FG002|Overall Study|Lack of Efficacy|0|||
146103279|NCT02555683|526898719|FG000|Overall Study|Death|0|||
146103280|NCT02555683|526898720|FG001|Overall Study|Death|1|||
146103281|NCT02555683|526898721|FG002|Overall Study|Death|2|||
146103282|NCT02555683|526898719|FG000|Overall Study|Adverse Event|1|||
146103283|NCT02555683|526898720|FG001|Overall Study|Adverse Event|0|||
146103284|NCT02555683|526898721|FG002|Overall Study|Adverse Event|1|||
146103285|NCT02555683|526898719|FG000|Overall Study|Subject/guardian decision|12|||
146103286|NCT02555683|526898720|FG001|Overall Study|Subject/guardian decision|12|||
146103287|NCT02555683|526898721|FG002|Overall Study|Subject/guardian decision|22|||
146103288|NCT02555683|526898719|FG000|Overall Study|Death post Treatment/safety period|0|||
146103289|NCT02555683|526898720|FG001|Overall Study|Death post Treatment/safety period|1|||
146103290|NCT02555683|526898721|FG002|Overall Study|Death post Treatment/safety period|0|||
146103291|NCT01153347|526898722|FG000|Overall Study|Withdrawal by Subject|7|||
146103292|NCT01153347|526898723|FG001|Overall Study|Withdrawal by Subject|7|||
146103293|NCT01153347|526898724|FG002|Overall Study|Withdrawal by Subject|7|||
146103294|NCT01153347|526898725|FG003|Overall Study|Withdrawal by Subject|7|||
146103295|NCT01153347|526898722|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146103296|NCT01153347|526898723|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146103297|NCT01153347|526898724|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146103298|NCT01153347|526898725|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146103299|NCT01153347|526898722|FG000|Overall Study|Adverse Event|3|||
146103300|NCT01153347|526898723|FG001|Overall Study|Adverse Event|9|||
146103301|NCT01153347|526898724|FG002|Overall Study|Adverse Event|21|||
146103302|NCT01153347|526898725|FG003|Overall Study|Adverse Event|7|||
146103303|NCT01153347|526898722|FG000|Overall Study|Severe non-compliance to protocol|6|||
146103304|NCT01153347|526898723|FG001|Overall Study|Severe non-compliance to protocol|7|||
146103305|NCT01153347|526898724|FG002|Overall Study|Severe non-compliance to protocol|4|||
146103306|NCT01153347|526898725|FG003|Overall Study|Severe non-compliance to protocol|3|||
146256151|NCT01340300|527452538|FG002|Overall Study|Physician Decision|0|||
146256152|NCT01340300|527452539|FG003|Overall Study|Physician Decision|0|||
146256153|NCT01340300|527452536|FG000|Overall Study|Unrelated sickness|0|||
146256154|NCT01340300|527452537|FG001|Overall Study|Unrelated sickness|2|||
146256155|NCT01340300|527452538|FG002|Overall Study|Unrelated sickness|0|||
146256156|NCT01340300|527452539|FG003|Overall Study|Unrelated sickness|1|||
146256157|NCT02642159|527452541|FG000|Overall Study|Randomized but not treated|1|||
146256158|NCT02642159|527452542|FG001|Overall Study|Randomized but not treated|0|||
146256159|NCT02642159|527452541|FG000|Overall Study|Adverse Event|10|||
146103307|NCT01153347|526898722|FG000|Overall Study|Condition under investigation worsened|1|||
146103308|NCT01153347|526898723|FG001|Overall Study|Condition under investigation worsened|1|||
146103309|NCT01153347|526898724|FG002|Overall Study|Condition under investigation worsened|0|||
146103310|NCT01153347|526898725|FG003|Overall Study|Condition under investigation worsened|0|||
146103311|NCT01153347|526898722|FG000|Overall Study|Lack of Efficacy|2|||
146103312|NCT01153347|526898723|FG001|Overall Study|Lack of Efficacy|2|||
146256160|NCT02642159|527452542|FG001|Overall Study|Adverse Event|4|||
146256161|NCT02642159|527452541|FG000|Overall Study|Withdrawal by Subject|9|||
146103313|NCT01153347|526898724|FG002|Overall Study|Lack of Efficacy|0|||
146103314|NCT01153347|526898725|FG003|Overall Study|Lack of Efficacy|4|||
146103315|NCT01153347|526898722|FG000|Overall Study|Study-specific withdrawal criteria|4|||
146103316|NCT01153347|526898723|FG001|Overall Study|Study-specific withdrawal criteria|3|||
146256162|NCT02642159|527452542|FG001|Overall Study|Withdrawal by Subject|1|||
146256163|NCT02642159|527452541|FG000|Overall Study|Poor compliance to study protocol|1|||
146256164|NCT02642159|527452542|FG001|Overall Study|Poor compliance to study protocol|0|||
146256165|NCT02642159|527452541|FG000|Overall Study|Other than specified above|10|||
146256166|NCT02642159|527452542|FG001|Overall Study|Other than specified above|3|||
146256167|NCT04194541|527452543|FG000|Day 1 Through 13|Lost to Follow-up|3|||
146256168|NCT04194541|527452543|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
146256169|NCT04194541|527452543|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
146256170|NCT03746483|527452544|FG000|Overall Study|Adverse Event|0|||
146256171|NCT03746483|527452545|FG001|Overall Study|Adverse Event|1|||
146256172|NCT03746483|527452544|FG000|Overall Study|Lack of Efficacy|3|||
146256173|NCT03746483|527452545|FG001|Overall Study|Lack of Efficacy|2|||
146256174|NCT03746483|527452544|FG000|Overall Study|Lost to Follow-up|1|||
146049410|NCT03201419|526695399|FG007|Overall Study|Adverse Event|0|||
146049411|NCT03201419|526695400|FG008|Overall Study|Adverse Event|0|||
146049412|NCT03201419|526695392|FG000|Overall Study|Lost to Follow-up|1|||
146049413|NCT03201419|526695393|FG001|Overall Study|Lost to Follow-up|0|||
146049414|NCT03201419|526695394|FG002|Overall Study|Lost to Follow-up|0|||
146049415|NCT03201419|526695395|FG003|Overall Study|Lost to Follow-up|0|||
146049416|NCT03201419|526695396|FG004|Overall Study|Lost to Follow-up|0|||
146049417|NCT03201419|526695397|FG005|Overall Study|Lost to Follow-up|0|||
146049418|NCT03201419|526695398|FG006|Overall Study|Lost to Follow-up|0|||
146049419|NCT03201419|526695399|FG007|Overall Study|Lost to Follow-up|0|||
146049420|NCT03201419|526695400|FG008|Overall Study|Lost to Follow-up|0|||
146049421|NCT03201419|526695392|FG000|Overall Study|Protocol Deviation|0|||
146049422|NCT03201419|526695393|FG001|Overall Study|Protocol Deviation|0|||
146049423|NCT03201419|526695394|FG002|Overall Study|Protocol Deviation|0|||
146049424|NCT03201419|526695395|FG003|Overall Study|Protocol Deviation|0|||
146049425|NCT03201419|526695396|FG004|Overall Study|Protocol Deviation|0|||
146049426|NCT03201419|526695397|FG005|Overall Study|Protocol Deviation|0|||
146049427|NCT03201419|526695398|FG006|Overall Study|Protocol Deviation|1|||
146049428|NCT03201419|526695399|FG007|Overall Study|Protocol Deviation|0|||
146049429|NCT03201419|526695400|FG008|Overall Study|Protocol Deviation|0|||
146049430|NCT03201419|526695392|FG000|Overall Study|Withdrawal by Subject|4|||
146049431|NCT03201419|526695393|FG001|Overall Study|Withdrawal by Subject|2|||
146049432|NCT03201419|526695394|FG002|Overall Study|Withdrawal by Subject|1|||
146049433|NCT03201419|526695395|FG003|Overall Study|Withdrawal by Subject|0|||
146049434|NCT03201419|526695396|FG004|Overall Study|Withdrawal by Subject|0|||
146049435|NCT03201419|526695397|FG005|Overall Study|Withdrawal by Subject|0|||
146049436|NCT03201419|526695398|FG006|Overall Study|Withdrawal by Subject|0|||
146049437|NCT03201419|526695399|FG007|Overall Study|Withdrawal by Subject|1|||
146049438|NCT03201419|526695400|FG008|Overall Study|Withdrawal by Subject|2|||
146049439|NCT03201419|526695392|FG000|Overall Study|Other|0|||
146049440|NCT03201419|526695393|FG001|Overall Study|Other|0|||
146049441|NCT03201419|526695394|FG002|Overall Study|Other|1|||
146049442|NCT03201419|526695395|FG003|Overall Study|Other|0|||
146049443|NCT03201419|526695396|FG004|Overall Study|Other|0|||
146049444|NCT03201419|526695397|FG005|Overall Study|Other|0|||
146049445|NCT03201419|526695398|FG006|Overall Study|Other|0|||
146049446|NCT03201419|526695399|FG007|Overall Study|Other|0|||
146049447|NCT03201419|526695400|FG008|Overall Study|Other|0|||
146049448|NCT02701283|526695401|FG000|Overall Study|Death|25|||
146049449|NCT02701283|526695402|FG001|Overall Study|Death|29|||
146049450|NCT02701283|526695403|FG002|Overall Study|Death|19|||
146049451|NCT02701283|526695401|FG000|Overall Study|Lost to Follow-up|3|||
146049452|NCT02701283|526695402|FG001|Overall Study|Lost to Follow-up|8|||
146049453|NCT02701283|526695403|FG002|Overall Study|Lost to Follow-up|1|||
146049454|NCT02701283|526695401|FG000|Overall Study|Withdrawal by Subject|12|||
146049455|NCT02701283|526695402|FG001|Overall Study|Withdrawal by Subject|41|||
146049456|NCT02701283|526695403|FG002|Overall Study|Withdrawal by Subject|1|||
146049457|NCT02701283|526695401|FG000|Overall Study|Missed 2-year visit|22|||
146049458|NCT02701283|526695402|FG001|Overall Study|Missed 2-year visit|27|||
146049459|NCT02701283|526695403|FG002|Overall Study|Missed 2-year visit|0|||
146049460|NCT02701283|526695401|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
146049461|NCT02701283|526695402|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
146049462|NCT02701283|526695403|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
146049463|NCT00892775|526695404|FG000|Overall Study|Protocol Violation|1|||
146049464|NCT00892775|526695405|FG001|Overall Study|Protocol Violation|0|||
146049465|NCT00892775|526695404|FG000|Overall Study|Subject difficulties with blood drawing|1|||
146049466|NCT00892775|526695405|FG001|Overall Study|Subject difficulties with blood drawing|0|||
146049467|NCT00892775|526695404|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
146049468|NCT00892775|526695405|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
146049469|NCT00892775|526695404|FG000|Overall Study|Migrated/ moved from study area|1|||
146049470|NCT00892775|526695405|FG001|Overall Study|Migrated/ moved from study area|0|||
146049471|NCT00892775|526695404|FG000|Overall Study|Withdrawal by Subject|0|||
146049472|NCT00892775|526695405|FG001|Overall Study|Withdrawal by Subject|1|||
146049473|NCT00892775|526695404|FG000|Overall Study|Lost to Follow-up|1|||
146256175|NCT03746483|527452545|FG001|Overall Study|Lost to Follow-up|0|||
146300912|NCT03065023|527617166|FG001|Overall Study|Withdrawal by Subject|0|||
146049474|NCT00892775|526695405|FG001|Overall Study|Lost to Follow-up|0|||
146049475|NCT00398320|526695406|FG000|Overall Study|Death|1|||
146049476|NCT00398320|526695406|FG000|Overall Study|Adverse Event|4|||
146049477|NCT00398320|526695406|FG000|Overall Study|Physician Decision|1|||
146049478|NCT00064792|526695407|FG000|Overall Study|Withdrawal by Subject|2|||
146049479|NCT00064792|526695408|FG001|Overall Study|Withdrawal by Subject|0|||
146049480|NCT00064792|526695407|FG000|Overall Study|Adverse Event|3|||
146049481|NCT00064792|526695408|FG001|Overall Study|Adverse Event|0|||
146049482|NCT03160898|526695409|FG000|Overall Study|Adverse Event|4|||
146049483|NCT03160898|526695410|FG001|Overall Study|Adverse Event|8|||
146049484|NCT03160898|526695411|FG002|Overall Study|Adverse Event|7|||
146049485|NCT03160898|526695412|FG003|Overall Study|Adverse Event|10|||
146049486|NCT03160898|526695409|FG000|Overall Study|Death|1|||
146049487|NCT03160898|526695410|FG001|Overall Study|Death|0|||
146049488|NCT03160898|526695411|FG002|Overall Study|Death|0|||
146049489|NCT03160898|526695412|FG003|Overall Study|Death|1|||
146049490|NCT03160898|526695409|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
146049491|NCT03160898|526695410|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
146049492|NCT03160898|526695411|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
146049493|NCT03160898|526695412|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
146049494|NCT03160898|526695409|FG000|Overall Study|Lost to Follow-up|1|||
146049495|NCT03160898|526695410|FG001|Overall Study|Lost to Follow-up|1|||
146049496|NCT03160898|526695411|FG002|Overall Study|Lost to Follow-up|1|||
146049497|NCT03160898|526695412|FG003|Overall Study|Lost to Follow-up|2|||
146049498|NCT03160898|526695409|FG000|Overall Study|Physician Decision|1|||
146049499|NCT03160898|526695410|FG001|Overall Study|Physician Decision|0|||
146049500|NCT03160898|526695411|FG002|Overall Study|Physician Decision|0|||
146049501|NCT03160898|526695412|FG003|Overall Study|Physician Decision|1|||
146049502|NCT03160898|526695409|FG000|Overall Study|Progressive Disease|4|||
146049503|NCT03160898|526695410|FG001|Overall Study|Progressive Disease|1|||
146049504|NCT03160898|526695411|FG002|Overall Study|Progressive Disease|2|||
146049505|NCT03160898|526695412|FG003|Overall Study|Progressive Disease|1|||
146049506|NCT03160898|526695409|FG000|Overall Study|Protocol Violation|1|||
146049507|NCT03160898|526695410|FG001|Overall Study|Protocol Violation|0|||
146049508|NCT03160898|526695411|FG002|Overall Study|Protocol Violation|2|||
146049509|NCT03160898|526695412|FG003|Overall Study|Protocol Violation|0|||
146049510|NCT03160898|526695409|FG000|Overall Study|Sponsor Discretion|2|||
146049511|NCT03160898|526695410|FG001|Overall Study|Sponsor Discretion|0|||
146049512|NCT03160898|526695411|FG002|Overall Study|Sponsor Discretion|0|||
146049513|NCT03160898|526695412|FG003|Overall Study|Sponsor Discretion|0|||
146049514|NCT03160898|526695409|FG000|Overall Study|Withdrawal by Subject|1|||
146049515|NCT03160898|526695410|FG001|Overall Study|Withdrawal by Subject|3|||
146049516|NCT03160898|526695411|FG002|Overall Study|Withdrawal by Subject|2|||
146049517|NCT03160898|526695412|FG003|Overall Study|Withdrawal by Subject|1|||
146049518|NCT03160898|526695409|FG000|Overall Study|Other|2|||
146049519|NCT03160898|526695410|FG001|Overall Study|Other|0|||
146049520|NCT03160898|526695411|FG002|Overall Study|Other|2|||
146049521|NCT03160898|526695412|FG003|Overall Study|Other|2|||
146049522|NCT03405818|526695413|FG000|Overall Study|Withdrawal by Subject|4|||
146049523|NCT03405818|526695413|FG000|Overall Study|Lost to Follow-up|4|||
146049524|NCT00291486|526695416|FG000|Overall Study|Adverse Event|0|||
146049525|NCT00291486|526695417|FG001|Overall Study|Adverse Event|3|||
146049526|NCT00291486|526695418|FG002|Overall Study|Adverse Event|0|||
146049527|NCT00291486|526695419|FG003|Overall Study|Adverse Event|1|||
146049528|NCT00291486|526695420|FG004|Overall Study|Adverse Event|0|||
146049529|NCT00291486|526695416|FG000|Overall Study|Withdrawal by Subject|0|||
146049530|NCT00291486|526695417|FG001|Overall Study|Withdrawal by Subject|0|||
146049531|NCT00291486|526695418|FG002|Overall Study|Withdrawal by Subject|0|||
146049532|NCT00291486|526695419|FG003|Overall Study|Withdrawal by Subject|0|||
146049533|NCT00291486|526695420|FG004|Overall Study|Withdrawal by Subject|1|||
146049534|NCT00291486|526695416|FG000|Overall Study|Disease progression|1|||
146049535|NCT00291486|526695417|FG001|Overall Study|Disease progression|0|||
146049536|NCT00291486|526695418|FG002|Overall Study|Disease progression|1|||
146049537|NCT00291486|526695419|FG003|Overall Study|Disease progression|0|||
146049538|NCT00291486|526695420|FG004|Overall Study|Disease progression|0|||
146049539|NCT01045694|526695423|FG000|Overall Study|Withdrawal by Subject|2|||
146049540|NCT01408459|526695424|FG000|Overall Study|Withdrawal by Subject|1|||
146049541|NCT01408459|526695425|FG001|Overall Study|Withdrawal by Subject|1|||
146049542|NCT00992459|526695426|FG000|Overall Study|Withdrawal by Subject|0|||
146049543|NCT00992459|526695427|FG001|Overall Study|Withdrawal by Subject|1|||
146049544|NCT00992459|526695426|FG000|Overall Study|Adverse Event|1|||
146049545|NCT00992459|526695427|FG001|Overall Study|Adverse Event|0|||
146049546|NCT01657292|526695437|FG000|Overall Study|Adverse Event|6|||
146049547|NCT01657292|526695437|FG000|Overall Study|Withdrawal by Subject|2|||
146049548|NCT01657292|526695437|FG000|Overall Study|Violation of eligibility criteria|1|||
146049549|NCT01657292|526695437|FG000|Overall Study|Change of therapy|1|||
146049550|NCT04725500|526695439|FG000|Screening|Screen Failure|26|||
146049551|NCT04725500|526695439|FG000|Screening|Withdrawal by Subject|1|||
146049552|NCT04725500|526695439|FG000|2 Week Take Home|Screen Fail|5|||
146103317|NCT01153347|526898724|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146103318|NCT01153347|526898725|FG003|Overall Study|Study-specific withdrawal criteria|2|||
146103319|NCT01153347|526898722|FG000|Overall Study|Lost to Follow-up|4|||
146103320|NCT01153347|526898723|FG001|Overall Study|Lost to Follow-up|9|||
146103321|NCT01153347|526898724|FG002|Overall Study|Lost to Follow-up|11|||
146103322|NCT01153347|526898725|FG003|Overall Study|Lost to Follow-up|8|||
146103323|NCT01153347|526898722|FG000|Overall Study|Other|5|||
146103324|NCT01153347|526898723|FG001|Overall Study|Other|5|||
146103325|NCT01153347|526898724|FG002|Overall Study|Other|4|||
146103326|NCT01153347|526898725|FG003|Overall Study|Other|0|||
146103327|NCT01153347|526898722|FG000|Overall Study|Death|1|||
146103328|NCT01153347|526898723|FG001|Overall Study|Death|0|||
146103329|NCT01153347|526898724|FG002|Overall Study|Death|0|||
146103330|NCT01153347|526898725|FG003|Overall Study|Death|0|||
146103331|NCT05096221|526898726|FG000|Part 2|Physician Decision|0|||
146103332|NCT05096221|526898727|FG001|Part 2|Physician Decision|1|||
146103333|NCT04678661|526898730|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
146103334|NCT04678661|526898731|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
146103335|NCT04678661|526898730|FG000|Overall Study|Protocol Violation|2|||
146103336|NCT04678661|526898731|FG001|Overall Study|Protocol Violation|0|||
146103337|NCT04678661|526898730|FG000|Overall Study|Withdrawal by Subject|1|||
146103338|NCT04678661|526898731|FG001|Overall Study|Withdrawal by Subject|0|||
146103339|NCT04678661|526898730|FG000|Overall Study|Lost to Follow-up|2|||
146103340|NCT04678661|526898731|FG001|Overall Study|Lost to Follow-up|0|||
146103341|NCT04678661|526898730|FG000|Overall Study|Death|2|||
146103342|NCT04678661|526898731|FG001|Overall Study|Death|0|||
146103343|NCT01086033|526898732|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
146103344|NCT01086033|526898732|FG000|Overall Study|Lost to Follow-up|86|||
146103345|NCT01086033|526898732|FG000|Overall Study|Adverse Event|42|||
146103346|NCT01086033|526898732|FG000|Overall Study|Withdrawal by Subject|41|||
146103347|NCT01086033|526898732|FG000|Overall Study|Other|14|||
146103348|NCT01086033|526898732|FG000|Overall Study|Other|13|||
146103349|NCT01086033|526898732|FG000|Overall Study|AE and Withdrew Consent|5|||
146103350|NCT01086033|526898732|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
146103351|NCT01086033|526898732|FG000|Overall Study|Withdrew consent and Other Reason|4|||
146103352|NCT01086033|526898732|FG000|Overall Study|AE and Lack of Efficacy|4|||
146103353|NCT01086033|526898732|FG000|Overall Study|Death|1|||
146103354|NCT01086033|526898732|FG000|Overall Study|AE and Lost to Follow-up|1|||
146103355|NCT01086033|526898732|FG000|Overall Study|AE and Other Reason|1|||
146103356|NCT01086033|526898732|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
146103357|NCT03094169|526898733|FG000|Overall Study|Lack of Efficacy|0|||
146103358|NCT03094169|526898734|FG001|Overall Study|Lack of Efficacy|0|||
146103359|NCT03094169|526898735|FG002|Overall Study|Lack of Efficacy|0|||
146103360|NCT03094169|526898736|FG003|Overall Study|Lack of Efficacy|0|||
146103361|NCT03094169|526898737|FG004|Overall Study|Lack of Efficacy|0|||
146103362|NCT03094169|526898738|FG005|Overall Study|Lack of Efficacy|0|||
146103363|NCT03094169|526898739|FG006|Overall Study|Lack of Efficacy|0|||
146103364|NCT03094169|526898740|FG007|Overall Study|Lack of Efficacy|21|||
146103365|NCT03094169|526898733|FG000|Overall Study|Adverse Event|0|||
146103366|NCT03094169|526898734|FG001|Overall Study|Adverse Event|0|||
146103367|NCT03094169|526898735|FG002|Overall Study|Adverse Event|0|||
146103368|NCT03094169|526898736|FG003|Overall Study|Adverse Event|0|||
146103369|NCT03094169|526898737|FG004|Overall Study|Adverse Event|0|||
146103370|NCT03094169|526898738|FG005|Overall Study|Adverse Event|0|||
146103371|NCT03094169|526898739|FG006|Overall Study|Adverse Event|0|||
146103372|NCT03094169|526898740|FG007|Overall Study|Adverse Event|2|||
146103373|NCT03094169|526898733|FG000|Overall Study|Withdrawal by Subject|0|||
146103374|NCT03094169|526898734|FG001|Overall Study|Withdrawal by Subject|0|||
146103375|NCT03094169|526898735|FG002|Overall Study|Withdrawal by Subject|0|||
146103376|NCT03094169|526898736|FG003|Overall Study|Withdrawal by Subject|0|||
146256176|NCT03746483|527452544|FG000|Overall Study|Protocol Violation|2|||
146103377|NCT03094169|526898737|FG004|Overall Study|Withdrawal by Subject|0|||
146103378|NCT03094169|526898738|FG005|Overall Study|Withdrawal by Subject|0|||
146103379|NCT03094169|526898739|FG006|Overall Study|Withdrawal by Subject|1|||
146103380|NCT03094169|526898740|FG007|Overall Study|Withdrawal by Subject|1|||
146103381|NCT03094169|526898733|FG000|Overall Study|Trial Termination|0|||
146103382|NCT03094169|526898734|FG001|Overall Study|Trial Termination|0|||
146103383|NCT03094169|526898735|FG002|Overall Study|Trial Termination|0|||
146103384|NCT03094169|526898736|FG003|Overall Study|Trial Termination|0|||
146103385|NCT03094169|526898737|FG004|Overall Study|Trial Termination|0|||
146103386|NCT03094169|526898738|FG005|Overall Study|Trial Termination|0|||
146103387|NCT03094169|526898739|FG006|Overall Study|Trial Termination|0|||
146103388|NCT03094169|526898740|FG007|Overall Study|Trial Termination|1|||
146256177|NCT03746483|527452545|FG001|Overall Study|Protocol Violation|0|||
146103389|NCT04645953|526898741|FG000|Overall Study|Lost to Follow-up|2|||
146103390|NCT04645953|526898742|FG001|Overall Study|Lost to Follow-up|1|||
146103391|NCT04645953|526898743|FG002|Overall Study|Lost to Follow-up|1|||
146103392|NCT04645953|526898741|FG000|Overall Study|Withdrawal by Subject|0|||
146103393|NCT04645953|526898742|FG001|Overall Study|Withdrawal by Subject|1|||
146103394|NCT04645953|526898743|FG002|Overall Study|Withdrawal by Subject|0|||
146103395|NCT04645953|526898741|FG000|Overall Study|Physician Decision|0|||
146103396|NCT04645953|526898742|FG001|Overall Study|Physician Decision|1|||
146103397|NCT04645953|526898743|FG002|Overall Study|Physician Decision|0|||
146103398|NCT04645953|526898741|FG000|Overall Study|Discontinued Prior to Dosing|0|||
146103399|NCT04645953|526898742|FG001|Overall Study|Discontinued Prior to Dosing|0|||
146103400|NCT04645953|526898743|FG002|Overall Study|Discontinued Prior to Dosing|2|||
146103401|NCT00864721|526898744|FG000|Overall Study|Patient request|11|||
146103402|NCT00864721|526898744|FG000|Overall Study|Hospitalized|1|||
146103403|NCT00864721|526898744|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
146103404|NCT00864721|526898744|FG000|Overall Study|Adverse Event|21|||
146103405|NCT02763462|526898747|FG000|Overall Study|Protocol Violation|6|||
146103406|NCT00261807|526898748|FG000|Overall Study|Lost to Follow-up|2|||
146103407|NCT00261807|526898748|FG000|Overall Study|Adverse Event|2|||
146103408|NCT00261807|526898748|FG000|Overall Study|Death|1|||
146103409|NCT00261807|526898748|FG000|Overall Study|Protocol Violation|2|||
146103410|NCT00762229|526898749|FG000|Overall Study|Lost to Follow-up|1|||
146103411|NCT00762229|526898750|FG001|Overall Study|Lost to Follow-up|1|||
146103412|NCT00762229|526898749|FG000|Overall Study|did not recveive intervention|0|||
146103413|NCT00762229|526898750|FG001|Overall Study|did not recveive intervention|1|||
146103414|NCT01751178|526898753|FG000|Overall Study|Adverse Event|2|||
146103415|NCT01751178|526898754|FG001|Overall Study|Adverse Event|0|||
146103416|NCT01751178|526898755|FG002|Overall Study|Adverse Event|0|||
146103417|NCT01751178|526898753|FG000|Overall Study|Other Reason (unknown)|1|||
146103418|NCT01751178|526898754|FG001|Overall Study|Other Reason (unknown)|0|||
146103419|NCT01751178|526898755|FG002|Overall Study|Other Reason (unknown)|2|||
146103420|NCT02747875|526898759|FG000|Overall Study|Physician Decision|1|||
146103421|NCT02747875|526898760|FG001|Overall Study|Physician Decision|0|||
146103422|NCT02747875|526898759|FG000|Overall Study|Adverse Event|0|||
146103423|NCT02747875|526898760|FG001|Overall Study|Adverse Event|1|||
146103424|NCT04891978|526898764|FG000|Baseline|Protocol Violation|2|||
146103425|NCT04891978|526898765|FG001|Baseline|Protocol Violation|1|||
146103426|NCT04891978|526898766|FG002|Baseline|Protocol Violation|0|||
146103427|NCT04891978|526898764|FG000|Baseline|Missing AIRQ|1|||
146103428|NCT04891978|526898765|FG001|Baseline|Missing AIRQ|0|||
146103429|NCT04891978|526898766|FG002|Baseline|Missing AIRQ|0|||
146103430|NCT04891978|526898764|FG000|Baseline|Did not attend a baseline visit|0|||
146103431|NCT04891978|526898765|FG001|Baseline|Did not attend a baseline visit|0|||
146103432|NCT04891978|526898766|FG002|Baseline|Did not attend a baseline visit|9|||
146103433|NCT01776840|526898767|FG000|Overall Study|Lost to Follow-up|12|||
146103434|NCT01776840|526898768|FG001|Overall Study|Lost to Follow-up|7|||
146103435|NCT01776840|526898767|FG000|Overall Study|Withdrawal by Subject|32|||
146103436|NCT01776840|526898768|FG001|Overall Study|Withdrawal by Subject|48|||
146103437|NCT01776840|526898767|FG000|Overall Study|Sponsor decision|89|||
146103438|NCT01776840|526898768|FG001|Overall Study|Sponsor decision|87|||
146103439|NCT03641339|526898771|FG000|Overall Study|Physician Decision|1|||
146103440|NCT03641339|526898772|FG001|Overall Study|Physician Decision|0|||
146103441|NCT03641339|526898773|FG002|Overall Study|Physician Decision|0|||
146103442|NCT03641339|526898774|FG003|Overall Study|Physician Decision|0|||
146103443|NCT03641339|526898775|FG004|Overall Study|Physician Decision|0|||
146103444|NCT03641339|526898776|FG005|Overall Study|Physician Decision|0|||
146103445|NCT03641339|526898771|FG000|Overall Study|Withdrawal by Subject|0|||
146103446|NCT03641339|526898772|FG001|Overall Study|Withdrawal by Subject|2|||
146103447|NCT03641339|526898773|FG002|Overall Study|Withdrawal by Subject|0|||
146103448|NCT03641339|526898774|FG003|Overall Study|Withdrawal by Subject|2|||
146103449|NCT03641339|526898775|FG004|Overall Study|Withdrawal by Subject|0|||
146103450|NCT03641339|526898776|FG005|Overall Study|Withdrawal by Subject|1|||
146103451|NCT02589405|526898777|FG000|Overall Study|Adverse Event|3|||
146103452|NCT02589405|526898777|FG000|Overall Study|Withdrawal by Subject|1|||
146103453|NCT00446251|526898781|FG000|Overall Study|On-study Transplants|2|||
146103454|NCT00446251|526898781|FG000|Overall Study|Rituximab Infusion Reaction|2|||
146103455|NCT00446251|526898781|FG000|Overall Study|Lost to Follow-up|1|||
146103456|NCT02264639|526898786|FG000|Overall Study|Death (after completing single-dose phase)|1|||
146103457|NCT02264639|526898787|FG001|Overall Study|Death (after completing single-dose phase)|0|||
146103458|NCT02264639|526898788|FG002|Overall Study|Death (after completing single-dose phase)|0|||
146103459|NCT02264639|526898789|FG003|Overall Study|Death (after completing single-dose phase)|0|||
146103460|NCT02264639|526898790|FG004|Overall Study|Death (after completing single-dose phase)|0|||
146103461|NCT02264639|526898786|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
146103462|NCT02264639|526898787|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146103463|NCT02264639|526898788|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146103464|NCT02264639|526898789|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146103465|NCT02264639|526898790|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
146103466|NCT02264639|526898786|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146103467|NCT02264639|526898787|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146103468|NCT02264639|526898788|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
146103469|NCT02264639|526898789|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146103470|NCT02264639|526898790|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
146103471|NCT02264639|526898786|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146103472|NCT02264639|526898787|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146103473|NCT02264639|526898788|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146103474|NCT02264639|526898789|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
146103475|NCT02264639|526898790|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
146103476|NCT02693119|526898798|FG000|Open-Label Period|Withdrawal by Subject|0|||
146103477|NCT02693119|526898799|FG001|Open-Label Period|Withdrawal by Subject|1|||
146103478|NCT02319837|526898800|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
146103479|NCT02319837|526898801|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
146103480|NCT02319837|526898802|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
146103481|NCT02319837|526898800|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
146103482|NCT02319837|526898801|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
146103483|NCT02319837|526898802|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
146103484|NCT02319837|526898800|FG000|Study Treatment Phase|Adverse Event|73|||
146103485|NCT02319837|526898801|FG001|Study Treatment Phase|Adverse Event|36|||
146103486|NCT02319837|526898802|FG002|Study Treatment Phase|Adverse Event|63|||
146103487|NCT02319837|526898800|FG000|Study Treatment Phase|Development of castration resistance|0|||
146103488|NCT02319837|526898801|FG001|Study Treatment Phase|Development of castration resistance|2|||
146103489|NCT02319837|526898802|FG002|Study Treatment Phase|Development of castration resistance|0|||
146103490|NCT02319837|526898800|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
146103491|NCT02319837|526898801|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
146103492|NCT02319837|526898802|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
146103493|NCT02319837|526898800|FG000|Study Treatment Phase|Protocol Violation|2|||
146103494|NCT02319837|526898801|FG001|Study Treatment Phase|Protocol Violation|2|||
146103495|NCT02319837|526898802|FG002|Study Treatment Phase|Protocol Violation|1|||
146103496|NCT02319837|526898800|FG000|Study Treatment Phase|Lost to Follow-up|0|||
146103497|NCT02319837|526898801|FG001|Study Treatment Phase|Lost to Follow-up|1|||
146103498|NCT02319837|526898802|FG002|Study Treatment Phase|Lost to Follow-up|0|||
146103499|NCT02319837|526898800|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
146256178|NCT01954771|527452548|FG000|Overall Study|Missing HbA1c of end-point|1|||
146256179|NCT01954771|527452549|FG001|Overall Study|Missing HbA1c of end-point|1|||
146256180|NCT01954771|527452550|FG002|Overall Study|Missing HbA1c of end-point|0|||
146049553|NCT01633788|526697207|FG000|Overall Study|Adverse Event|1|||
146049554|NCT01633788|526697208|FG001|Overall Study|Adverse Event|3|||
146049555|NCT01633788|526697209|FG002|Overall Study|Adverse Event|3|||
146049556|NCT01633788|526697210|FG003|Overall Study|Adverse Event|3|||
146049557|NCT01633788|526697207|FG000|Overall Study|Lost to Follow-up|2|||
146049558|NCT01633788|526697208|FG001|Overall Study|Lost to Follow-up|2|||
146049559|NCT01633788|526697209|FG002|Overall Study|Lost to Follow-up|2|||
146049560|NCT01633788|526697210|FG003|Overall Study|Lost to Follow-up|0|||
146049561|NCT01633788|526697207|FG000|Overall Study|Personal Reasons|3|||
146049562|NCT01633788|526697208|FG001|Overall Study|Personal Reasons|1|||
146049563|NCT01633788|526697209|FG002|Overall Study|Personal Reasons|1|||
146049564|NCT01633788|526697210|FG003|Overall Study|Personal Reasons|3|||
146049565|NCT01633788|526697207|FG000|Overall Study|Protocol Violation|1|||
146049566|NCT01633788|526697208|FG001|Overall Study|Protocol Violation|0|||
146049567|NCT01633788|526697209|FG002|Overall Study|Protocol Violation|1|||
146049568|NCT01633788|526697210|FG003|Overall Study|Protocol Violation|0|||
146049569|NCT01633788|526697207|FG000|Overall Study|Other Reasons|0|||
146049570|NCT01633788|526697208|FG001|Overall Study|Other Reasons|2|||
146049571|NCT01633788|526697209|FG002|Overall Study|Other Reasons|3|||
146049572|NCT01633788|526697210|FG003|Overall Study|Other Reasons|7|||
146049573|NCT01929226|526697211|FG000|Overall Study|Lost to Follow-up|4|||
146049574|NCT01929226|526697212|FG001|Overall Study|Lost to Follow-up|0|||
146049575|NCT01929226|526697211|FG000|Overall Study|Withdrawal by Subject|1|||
146049576|NCT01929226|526697212|FG001|Overall Study|Withdrawal by Subject|1|||
146049577|NCT03553758|526697213|FG000|Overall Study|Lost to Follow-up|1|||
146049578|NCT01467505|526697218|FG000|Overall Study|Adverse Event|1|||
146049579|NCT01467505|526697219|FG001|Overall Study|Adverse Event|0|||
146049580|NCT01467505|526697218|FG000|Overall Study|Withdrawal by Subject|4|||
146049581|NCT01467505|526697219|FG001|Overall Study|Withdrawal by Subject|0|||
146049582|NCT01467505|526697218|FG000|Overall Study|Study Terminated by Sponsor|28|||
146049583|NCT01467505|526697219|FG001|Overall Study|Study Terminated by Sponsor|3|||
146049584|NCT02807623|526697220|FG000|Overall Study|Lost to Follow-up|23|||
146049585|NCT02807623|526697221|FG001|Overall Study|Lost to Follow-up|18|||
146049586|NCT02807623|526697222|FG002|Overall Study|Lost to Follow-up|22|||
146049587|NCT02807623|526697220|FG000|Overall Study|Drug intolerance|0|||
146049588|NCT02807623|526697221|FG001|Overall Study|Drug intolerance|1|||
146049589|NCT02807623|526697222|FG002|Overall Study|Drug intolerance|0|||
146103500|NCT02319837|526898801|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
146103501|NCT02319837|526898802|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
146103502|NCT02319837|526898800|FG000|Study Treatment Phase|Other|0|||
146103503|NCT02319837|526898801|FG001|Study Treatment Phase|Other|1|||
146103504|NCT02319837|526898802|FG002|Study Treatment Phase|Other|0|||
146103505|NCT02319837|526898800|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
146103506|NCT02319837|526898801|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
146103507|NCT02319837|526898802|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
146103508|NCT02319837|526898800|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
146103509|NCT02319837|526898801|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
146103510|NCT02319837|526898802|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
146103511|NCT02319837|526898800|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
146103512|NCT02319837|526898801|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
146103513|NCT02319837|526898802|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
146103514|NCT02319837|526898800|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
146103515|NCT02319837|526898801|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
146103516|NCT02319837|526898802|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
146103517|NCT02319837|526898800|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
146103518|NCT02319837|526898801|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
146103519|NCT02319837|526898802|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
146103520|NCT02319837|526898800|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
146103521|NCT02319837|526898801|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
146103522|NCT02319837|526898802|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
146103523|NCT02319837|526898800|FG000|Long-Term Follow-Up Phase|Death|33|||
146103524|NCT02319837|526898801|FG001|Long-Term Follow-Up Phase|Death|54|||
146103525|NCT02319837|526898802|FG002|Long-Term Follow-Up Phase|Death|42|||
146103526|NCT02805972|526898807|FG000|Washout Period|Lost to Follow-up|3|||
146103527|NCT02805972|526898808|FG001|Washout Period|Lost to Follow-up|0|||
146103528|NCT00939640|526898812|FG000|Overall Study|Physician Decision|1|||
146103529|NCT00239590|526898813|FG000|Randomized|Lost to Follow-up|0|||
146103530|NCT00239590|526898814|FG001|Randomized|Lost to Follow-up|1|||
146103531|NCT00239590|526898813|FG000|Randomized|Withdrawal by Subject|0|||
146103532|NCT00239590|526898814|FG001|Randomized|Withdrawal by Subject|1|||
146103533|NCT00239590|526898813|FG000|Completed Study Protocol|Adverse Event|1|||
146103534|NCT00239590|526898814|FG001|Completed Study Protocol|Adverse Event|1|||
146103535|NCT00239590|526898813|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
146103536|NCT00239590|526898814|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
146103537|NCT02121522|526898816|FG000|Overall Study|Adverse Event|1|||
146103538|NCT00892047|526898821|FG000|Overall Study|Adverse Event|2|||
146103539|NCT00892047|526898822|FG001|Overall Study|Adverse Event|2|||
146103540|NCT00892047|526898821|FG000|Overall Study|subject burden|2|||
146103541|NCT00892047|526898822|FG001|Overall Study|subject burden|3|||
146103542|NCT00892047|526898821|FG000|Overall Study|Lack of Efficacy|0|||
146103543|NCT00892047|526898822|FG001|Overall Study|Lack of Efficacy|2|||
146103544|NCT05306977|526898823|FG000|Overall Study|Withdrawal by Subject|1|||
146103545|NCT00190671|526898824|FG000|Overall Study|Satisfactory Response|4|||
146103546|NCT00190671|526898825|FG001|Overall Study|Satisfactory Response|7|||
146103547|NCT00190671|526898824|FG000|Overall Study|Lack of Efficacy|19|||
146103548|NCT00190671|526898825|FG001|Overall Study|Lack of Efficacy|24|||
146103549|NCT00190671|526898824|FG000|Overall Study|Death from Study Disease|1|||
146103550|NCT00190671|526898825|FG001|Overall Study|Death from Study Disease|1|||
146103551|NCT00190671|526898824|FG000|Overall Study|Adverse Event|3|||
146103552|NCT00190671|526898825|FG001|Overall Study|Adverse Event|2|||
146103553|NCT00190671|526898824|FG000|Overall Study|Clinical Relapse|0|||
146103554|NCT00190671|526898825|FG001|Overall Study|Clinical Relapse|1|||
146103555|NCT00190671|526898824|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
146103556|NCT00190671|526898825|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
146103557|NCT00190671|526898824|FG000|Overall Study|Death from Other Causes|0|||
146103558|NCT00190671|526898825|FG001|Overall Study|Death from Other Causes|2|||
146103559|NCT00190671|526898824|FG000|Overall Study|Protocol Violation|0|||
146103560|NCT00190671|526898825|FG001|Overall Study|Protocol Violation|1|||
146103561|NCT00190671|526898824|FG000|Overall Study|Withdrawal by Subject|0|||
146103562|NCT00190671|526898825|FG001|Overall Study|Withdrawal by Subject|2|||
146103563|NCT04502433|526898826|FG000|Overall Study|Death|2|||
146103564|NCT04502433|526898827|FG001|Overall Study|Death|4|||
146103565|NCT04502433|526898826|FG000|Overall Study|Lost to Follow-up|1|||
146103566|NCT04502433|526898827|FG001|Overall Study|Lost to Follow-up|0|||
146103567|NCT04502433|526898826|FG000|Overall Study|Physician Decision|0|||
146103568|NCT04502433|526898827|FG001|Overall Study|Physician Decision|1|||
146256181|NCT01954771|527452548|FG000|Overall Study|Missing CGMS of end-point|1|||
146256182|NCT01954771|527452549|FG001|Overall Study|Missing CGMS of end-point|1|||
146256183|NCT01954771|527452550|FG002|Overall Study|Missing CGMS of end-point|0|||
146256184|NCT01954771|527452548|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
146256185|NCT01954771|527452549|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
146049590|NCT02807623|526697220|FG000|Overall Study|incomplete blood draw|0|||
146049591|NCT02807623|526697221|FG001|Overall Study|incomplete blood draw|2|||
146049592|NCT02807623|526697222|FG002|Overall Study|incomplete blood draw|1|||
146049593|NCT03811340|526697226|FG000|Overall Study|subjects did not complete the survey.|90|||
146049594|NCT01045967|526697227|FG000|Second Intervention|Protocol Violation|0|||
146049595|NCT01045967|526697228|FG001|Second Intervention|Protocol Violation|1|||
146049596|NCT05104450|526697229|FG000|Overall Study|Death|1|||
146049597|NCT05104450|526697230|FG001|Overall Study|Death|2|||
146049598|NCT05104450|526697229|FG000|Overall Study|Withdrawal by Subject|3|||
146049599|NCT05104450|526697230|FG001|Overall Study|Withdrawal by Subject|1|||
146049600|NCT01380769|526697231|FG000|Overall Study|Withdrawal by Subject|7|||
146049601|NCT01380769|526697232|FG001|Overall Study|Withdrawal by Subject|11|||
146049602|NCT01380769|526697231|FG000|Overall Study|Physician Decision|1|||
146049603|NCT01380769|526697232|FG001|Overall Study|Physician Decision|1|||
146049604|NCT01380769|526697231|FG000|Overall Study|Adverse Event|1|||
146049605|NCT01380769|526697232|FG001|Overall Study|Adverse Event|1|||
146049606|NCT01380769|526697231|FG000|Overall Study|Protocol Violation|0|||
146049607|NCT01380769|526697232|FG001|Overall Study|Protocol Violation|1|||
146049608|NCT01080807|526697235|FG000|Overall Study|Adverse Event|9|||
146049609|NCT01080807|526697236|FG001|Overall Study|Adverse Event|1|||
146049610|NCT01080807|526697235|FG000|Overall Study|Lack of Efficacy|0|||
146049611|NCT01080807|526697236|FG001|Overall Study|Lack of Efficacy|1|||
146049612|NCT01080807|526697235|FG000|Overall Study|Withdrawal by Subject|7|||
146049613|NCT01080807|526697236|FG001|Overall Study|Withdrawal by Subject|2|||
146049614|NCT01080807|526697235|FG000|Overall Study|Protocol Violation|7|||
146049615|NCT01080807|526697236|FG001|Overall Study|Protocol Violation|6|||
146049616|NCT01080807|526697235|FG000|Overall Study|Lost to Follow-up|6|||
146049617|NCT01080807|526697236|FG001|Overall Study|Lost to Follow-up|4|||
146049618|NCT01080807|526697235|FG000|Overall Study|Noncompliance with drug administration|1|||
146049619|NCT01080807|526697236|FG001|Overall Study|Noncompliance with drug administration|1|||
146049620|NCT01080807|526697235|FG000|Overall Study|Noncompliance to study procedures|1|||
146049621|NCT01080807|526697236|FG001|Overall Study|Noncompliance to study procedures|1|||
146049622|NCT01080807|526697235|FG000|Overall Study|Began working day shift|0|||
146049623|NCT01080807|526697236|FG001|Overall Study|Began working day shift|2|||
146049624|NCT01080807|526697235|FG000|Overall Study|Laid off or terminated from job|1|||
146049625|NCT01080807|526697236|FG001|Overall Study|Laid off or terminated from job|2|||
146049626|NCT01080807|526697235|FG000|Overall Study|Stopped working consistent night shifts|0|||
146049627|NCT01080807|526697236|FG001|Overall Study|Stopped working consistent night shifts|1|||
146049628|NCT01080807|526697235|FG000|Overall Study|Work schedule changing|1|||
146049629|NCT01080807|526697236|FG001|Overall Study|Work schedule changing|1|||
146049630|NCT01080807|526697235|FG000|Overall Study|Work schedule and travel|0|||
146049631|NCT01080807|526697236|FG001|Overall Study|Work schedule and travel|1|||
146049632|NCT01080807|526697235|FG000|Overall Study|Switched to first shift|1|||
146049633|NCT01080807|526697236|FG001|Overall Study|Switched to first shift|0|||
146049634|NCT01080807|526697235|FG000|Overall Study|Moved away without notifying center|1|||
146049635|NCT01080807|526697236|FG001|Overall Study|Moved away without notifying center|0|||
146049636|NCT02107703|526697249|FG000|Overall Study|Withdrawal by Subject|46|||
146049637|NCT02107703|526697250|FG001|Overall Study|Withdrawal by Subject|21|||
146049638|NCT02107703|526697249|FG000|Overall Study|Lost to Follow-up|20|||
146049639|NCT02107703|526697250|FG001|Overall Study|Lost to Follow-up|9|||
146049640|NCT02107703|526697249|FG000|Overall Study|On study treatment/follow up|48|||
146049641|NCT02107703|526697250|FG001|Overall Study|On study treatment/follow up|5|||
146049642|NCT03456076|526697255|FG000|Overall Study|Withdrawal by Subject|5|||
146049643|NCT03456076|526697256|FG001|Overall Study|Withdrawal by Subject|9|||
146049644|NCT03456076|526697255|FG000|Overall Study|Protocol deviation|0|||
146049645|NCT03456076|526697256|FG001|Overall Study|Protocol deviation|1|||
146049646|NCT03456076|526697255|FG000|Overall Study|Lost to Follow-up|0|||
146049647|NCT03456076|526697256|FG001|Overall Study|Lost to Follow-up|1|||
146049648|NCT03456076|526697255|FG000|Overall Study|Death|2|||
146049649|NCT03456076|526697256|FG001|Overall Study|Death|5|||
146049650|NCT03456076|526697255|FG000|Overall Study|Study ongoing|123|||
146049651|NCT03456076|526697256|FG001|Overall Study|Study ongoing|111|||
146049652|NCT02045095|526697257|FG000|Overall Study|Other|0|||
146049653|NCT02045095|526697258|FG001|Overall Study|Other|0|||
146049654|NCT02045095|526697259|FG002|Overall Study|Other|1|||
146049655|NCT02045095|526697260|FG003|Overall Study|Other|0|||
146049656|NCT02045095|526697261|FG004|Overall Study|Other|0|||
146049657|NCT02045095|526697262|FG005|Overall Study|Other|2|||
146049658|NCT02045095|526697263|FG006|Overall Study|Other|0|||
146256186|NCT01954771|527452550|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
146049659|NCT02045095|526697257|FG000|Overall Study|Progressive Disease|3|||
146049660|NCT02045095|526697258|FG001|Overall Study|Progressive Disease|3|||
146256187|NCT03635775|527452553|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146256188|NCT03635775|527452554|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146256189|NCT03635775|527452555|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
146256190|NCT03635775|527452556|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
146256191|NCT01675050|527452558|FG000|Period One Treatment|Withdrawal by Subject|1|||
146256192|NCT01675050|527452559|FG001|Period One Treatment|Withdrawal by Subject|0|||
146256193|NCT01820637|527452561|FG000|Overall Study|Death|2|||
146256194|NCT01820637|527452561|FG000|Overall Study|Withdrawal by Subject|1|||
146256195|NCT00583115|527452562|FG000|Overall Study|Death|1|||
146256196|NCT00264498|527452563|FG000|Randomized Treatment|Death|0|||
146300913|NCT03065023|527617167|FG002|Overall Study|Withdrawal by Subject|0|||
146049661|NCT02045095|526697259|FG002|Overall Study|Progressive Disease|2|||
146049662|NCT02045095|526697260|FG003|Overall Study|Progressive Disease|4|||
146049663|NCT02045095|526697261|FG004|Overall Study|Progressive Disease|2|||
146049664|NCT02045095|526697262|FG005|Overall Study|Progressive Disease|4|||
146049665|NCT02045095|526697263|FG006|Overall Study|Progressive Disease|1|||
146049666|NCT02045095|526697257|FG000|Overall Study|Withdrawal by Subject|0|||
146049667|NCT02045095|526697258|FG001|Overall Study|Withdrawal by Subject|0|||
146049668|NCT02045095|526697259|FG002|Overall Study|Withdrawal by Subject|0|||
146049669|NCT02045095|526697260|FG003|Overall Study|Withdrawal by Subject|0|||
146049670|NCT02045095|526697261|FG004|Overall Study|Withdrawal by Subject|3|||
146049671|NCT02045095|526697262|FG005|Overall Study|Withdrawal by Subject|0|||
146049672|NCT02045095|526697263|FG006|Overall Study|Withdrawal by Subject|0|||
146049673|NCT02045095|526697257|FG000|Overall Study|Adverse Event|0|||
146049674|NCT02045095|526697258|FG001|Overall Study|Adverse Event|1|||
146049675|NCT02045095|526697259|FG002|Overall Study|Adverse Event|1|||
146049676|NCT02045095|526697260|FG003|Overall Study|Adverse Event|0|||
146049677|NCT02045095|526697261|FG004|Overall Study|Adverse Event|0|||
146049678|NCT02045095|526697262|FG005|Overall Study|Adverse Event|2|||
146049679|NCT02045095|526697263|FG006|Overall Study|Adverse Event|0|||
146049680|NCT01020786|526697267|FG000|Induction Period|Entry Criteria Not Met|2|||
146049681|NCT01020786|526697267|FG000|Induction Period|Adverse Event|10|||
146049682|NCT01020786|526697267|FG000|Induction Period|Progressive Disease|31|||
146049683|NCT01020786|526697267|FG000|Induction Period|Investigator Decision|3|||
146049684|NCT01020786|526697267|FG000|Induction Period|Withdrawal by Subject|3|||
146049685|NCT01020786|526697267|FG000|Maintenance Period|Adverse Event|8|||
146049686|NCT01020786|526697267|FG000|Maintenance Period|Progressive Disease|43|||
146049687|NCT01020786|526697267|FG000|Maintenance Period|Withdrawal by Subject|8|||
146049688|NCT01020786|526697267|FG000|Maintenance Period|Sponsor Decision|1|||
146049689|NCT01818596|526697268|FG000|Overall Study|Enrolled but Not Treated|4|||
146049690|NCT01818596|526697269|FG001|Overall Study|Enrolled but Not Treated|0|||
146049691|NCT01818596|526697268|FG000|Overall Study|Adverse Event|7|||
146049692|NCT01818596|526697269|FG001|Overall Study|Adverse Event|0|||
146049693|NCT01818596|526697268|FG000|Overall Study|Death|3|||
146049694|NCT01818596|526697269|FG001|Overall Study|Death|0|||
146049695|NCT01818596|526697268|FG000|Overall Study|Investigator's Discretion|4|||
146049696|NCT01818596|526697269|FG001|Overall Study|Investigator's Discretion|0|||
146049697|NCT01818596|526697268|FG000|Overall Study|Protocol Violation|1|||
146049698|NCT01818596|526697269|FG001|Overall Study|Protocol Violation|0|||
146049699|NCT01818596|526697268|FG000|Overall Study|Withdrew Consent|5|||
146049700|NCT01818596|526697269|FG001|Overall Study|Withdrew Consent|0|||
146049701|NCT01818596|526697268|FG000|Overall Study|Lost to Follow-up|7|||
146049702|NCT01818596|526697269|FG001|Overall Study|Lost to Follow-up|0|||
146049703|NCT04435366|526697275|FG000|Year 1 (12 Months)|Adverse Event|3|||
146049704|NCT04435366|526697276|FG001|Year 1 (12 Months)|Adverse Event|0|||
146049705|NCT04435366|526697277|FG002|Year 1 (12 Months)|Adverse Event|2|||
146049706|NCT04435366|526697275|FG000|Year 1 (12 Months)|Death|2|||
146049707|NCT04435366|526697276|FG001|Year 1 (12 Months)|Death|0|||
146049708|NCT04435366|526697277|FG002|Year 1 (12 Months)|Death|1|||
146049709|NCT04435366|526697275|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
146049710|NCT04435366|526697276|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
146049711|NCT04435366|526697277|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
146049712|NCT04435366|526697275|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
146049713|NCT04435366|526697276|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
146049714|NCT04435366|526697277|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
146049715|NCT04435366|526697275|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
146049716|NCT04435366|526697276|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
146049717|NCT04435366|526697277|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
146049718|NCT04435366|526697275|FG000|Year 1 (12 Months)|Not treated|0|||
146049719|NCT04435366|526697276|FG001|Year 1 (12 Months)|Not treated|0|||
146049720|NCT04435366|526697277|FG002|Year 1 (12 Months)|Not treated|1|||
146049721|NCT04435366|526697275|FG000|Year 2 (12 Months)|Death|1|||
146049722|NCT04435366|526697276|FG001|Year 2 (12 Months)|Death|4|||
146049723|NCT04435366|526697277|FG002|Year 2 (12 Months)|Death|6|||
146049724|NCT04435366|526697275|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
146049725|NCT04435366|526697276|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
146049726|NCT04435366|526697277|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
146103569|NCT00660699|526898828|FG000|Overall Study|Withdrawal by Subject|2|||
146103570|NCT01453361|526898837|FG000|Overall Study|Disease Progression|6|||
146103571|NCT01453361|526898837|FG000|Overall Study|Screen-Failures|10|||
146103572|NCT01687998|526900504|FG000|Overall Study|Withdrawal by Subject|49|||
146103573|NCT01687998|526900505|FG001|Overall Study|Withdrawal by Subject|51|||
146103574|NCT01687998|526900504|FG000|Overall Study|Known to be Alive at Study End|54|||
146103575|NCT01687998|526900505|FG001|Overall Study|Known to be Alive at Study End|62|||
146103576|NCT01687998|526900504|FG000|Overall Study|Lost to Follow-up|9|||
146103577|NCT01687998|526900505|FG001|Overall Study|Lost to Follow-up|7|||
146103578|NCT02195583|526900510|FG000|Overall Study|Lost to Follow-up|1|||
146103579|NCT02195583|526900510|FG000|Overall Study|Withdrawal by Subject|4|||
146103580|NCT02195583|526900510|FG000|Overall Study|Adverse Event|2|||
146103581|NCT02195583|526900510|FG000|Overall Study|Other Reason|2|||
146256197|NCT00264498|527452564|FG001|Randomized Treatment|Death|3|||
146256198|NCT00264498|527452563|FG000|Randomized Treatment|Withdrawal by Subject|0|||
146256199|NCT00264498|527452564|FG001|Randomized Treatment|Withdrawal by Subject|1|||
146256200|NCT00264498|527452563|FG000|Randomized Treatment|Objective disease Progression|13|||
146256201|NCT00264498|527452564|FG001|Randomized Treatment|Objective disease Progression|14|||
146256202|NCT00264498|527452563|FG000|Randomized Treatment|Physician Decision|1|||
146103582|NCT01560403|526900511|FG000|Overall Study|Lost to Follow-up|0|||
146103583|NCT01560403|526900512|FG001|Overall Study|Lost to Follow-up|1|||
146103584|NCT00354744|526900513|FG000|Overall Study|Adverse Event|2|||
146103585|NCT00354744|526900513|FG000|Overall Study|Death|2|||
146103586|NCT00354744|526900513|FG000|Overall Study|Lack of Efficacy|11|||
146103587|NCT00354744|526900513|FG000|Overall Study|Lost to Follow-up|2|||
146103588|NCT00354744|526900513|FG000|Overall Study|Physician Decision|11|||
146103589|NCT00354744|526900513|FG000|Overall Study|Withdrawal by Subject|14|||
146103590|NCT00040365|526900519|FG000|Overall Study|Death|1|||
146103591|NCT00040365|526900519|FG000|Overall Study|Progressive disease|7|||
146103592|NCT00040365|526900519|FG000|Overall Study|Lost to Follow-up|3|||
146103593|NCT00680017|526900520|FG000|Overall Study|Adverse Event|13|||
146103594|NCT00680017|526900521|FG001|Overall Study|Adverse Event|7|||
146103595|NCT00680017|526900520|FG000|Overall Study|Withdrawal by Subject|2|||
146103596|NCT00680017|526900521|FG001|Overall Study|Withdrawal by Subject|5|||
146103597|NCT00680017|526900520|FG000|Overall Study|Lost to Follow-up|2|||
146103598|NCT00680017|526900521|FG001|Overall Study|Lost to Follow-up|0|||
146103599|NCT02165215|526900522|FG000|Induction Phase|Adverse Event|1|||
146103600|NCT02165215|526900523|FG001|Induction Phase|Adverse Event|0|||
146103601|NCT02165215|526900524|FG002|Induction Phase|Adverse Event|0|||
146103602|NCT02165215|526900522|FG000|Induction Phase|Withdrawal by Subject|10|||
146103603|NCT02165215|526900523|FG001|Induction Phase|Withdrawal by Subject|0|||
146103604|NCT02165215|526900524|FG002|Induction Phase|Withdrawal by Subject|0|||
146103605|NCT02165215|526900522|FG000|Induction Phase|Protocol Violation|1|||
146103606|NCT02165215|526900523|FG001|Induction Phase|Protocol Violation|0|||
146103607|NCT02165215|526900524|FG002|Induction Phase|Protocol Violation|0|||
146103608|NCT02165215|526900522|FG000|Induction Phase|Physician Decision|1|||
146103609|NCT02165215|526900523|FG001|Induction Phase|Physician Decision|0|||
146103610|NCT02165215|526900524|FG002|Induction Phase|Physician Decision|0|||
146103611|NCT02165215|526900522|FG000|Induction Phase|Lack of Efficacy|2|||
146103612|NCT02165215|526900523|FG001|Induction Phase|Lack of Efficacy|0|||
146103613|NCT02165215|526900524|FG002|Induction Phase|Lack of Efficacy|0|||
146103614|NCT02165215|526900522|FG000|Induction Phase|Non-Compliance|2|||
146103615|NCT02165215|526900523|FG001|Induction Phase|Non-Compliance|0|||
146103616|NCT02165215|526900524|FG002|Induction Phase|Non-Compliance|0|||
146103617|NCT02165215|526900522|FG000|Induction Phase|Lost to Follow-up|6|||
146103618|NCT02165215|526900523|FG001|Induction Phase|Lost to Follow-up|0|||
146103619|NCT02165215|526900524|FG002|Induction Phase|Lost to Follow-up|0|||
146103620|NCT02165215|526900522|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146103621|NCT02165215|526900523|FG001|Maintenance Phase|Withdrawal by Subject|7|||
146300914|NCT03065023|527617168|FG003|Overall Study|Withdrawal by Subject|1|||
146103622|NCT02165215|526900524|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146103623|NCT02165215|526900522|FG000|Maintenance Phase|Multiple reasons|0|||
146103624|NCT02165215|526900523|FG001|Maintenance Phase|Multiple reasons|2|||
146103625|NCT02165215|526900524|FG002|Maintenance Phase|Multiple reasons|1|||
146103626|NCT02165215|526900522|FG000|Maintenance Phase|Lost to Follow-up|0|||
146103627|NCT02165215|526900523|FG001|Maintenance Phase|Lost to Follow-up|2|||
146103628|NCT02165215|526900524|FG002|Maintenance Phase|Lost to Follow-up|0|||
146103629|NCT02165215|526900522|FG000|Maintenance Phase|Adverse Event|0|||
146103630|NCT02165215|526900523|FG001|Maintenance Phase|Adverse Event|1|||
146256203|NCT00264498|527452564|FG001|Randomized Treatment|Physician Decision|0|||
146256204|NCT00264498|527452563|FG000|Randomized Treatment|Incorrectly randomized|1|||
146300915|NCT03065023|527617169|FG004|Overall Study|Withdrawal by Subject|0|||
146103631|NCT02165215|526900524|FG002|Maintenance Phase|Adverse Event|1|||
146103632|NCT05074667|526900525|FG000|Overall Study|Death|1|||
146103633|NCT05074667|526900525|FG000|Overall Study|Withdrawal by Subject|4|||
146103634|NCT05074667|526900525|FG000|Overall Study|Lost to Follow-up|10|||
146103635|NCT02279420|526900526|FG000|Overall Study|Lost to Follow-up|23|||
146103636|NCT03535844|526900529|FG000|Overall Study|Withdrawal by Subject|0|||
146103637|NCT03535844|526900530|FG001|Overall Study|Withdrawal by Subject|1|||
146103638|NCT00297830|526900531|FG000|6 Month Visit|Death|1|||
146103639|NCT00297830|526900532|FG001|6 Month Visit|Death|0|||
146103640|NCT00297830|526900533|FG002|6 Month Visit|Death|2|||
146103641|NCT00297830|526900531|FG000|6 Month Visit|Withdrawal by Subject|2|||
146103642|NCT00297830|526900532|FG001|6 Month Visit|Withdrawal by Subject|1|||
146103643|NCT00297830|526900533|FG002|6 Month Visit|Withdrawal by Subject|1|||
146103644|NCT00297830|526900531|FG000|6 Month Visit|Adverse Event|0|||
146103645|NCT00297830|526900532|FG001|6 Month Visit|Adverse Event|1|||
146103646|NCT00297830|526900533|FG002|6 Month Visit|Adverse Event|0|||
146103647|NCT00297830|526900531|FG000|12 Month Visit|Lost to Follow-up|1|||
146103648|NCT00297830|526900532|FG001|12 Month Visit|Lost to Follow-up|0|||
146103649|NCT00297830|526900533|FG002|12 Month Visit|Lost to Follow-up|0|||
146103650|NCT00297830|526900531|FG000|12 Month Visit|Adverse Event|0|||
146256205|NCT00264498|527452564|FG001|Randomized Treatment|Incorrectly randomized|0|||
146256206|NCT00264498|527452563|FG000|Randomized Treatment|Study Closure|1|||
146256207|NCT00264498|527452564|FG001|Randomized Treatment|Study Closure|0|||
146256208|NCT00264498|527452563|FG000|Randomized Treatment|Protocol Violation|1|||
146256209|NCT00264498|527452564|FG001|Randomized Treatment|Protocol Violation|0|||
146256210|NCT00264498|527452563|FG000|Crossover Treatment|Death|1|||
146256211|NCT00264498|527452564|FG001|Crossover Treatment|Death|3|||
146103651|NCT00297830|526900532|FG001|12 Month Visit|Adverse Event|3|||
146103652|NCT00297830|526900533|FG002|12 Month Visit|Adverse Event|0|||
146103653|NCT00297830|526900531|FG000|12 Month Visit|Withdrawal by Subject|0|||
146103654|NCT00297830|526900532|FG001|12 Month Visit|Withdrawal by Subject|3|||
146103655|NCT00297830|526900533|FG002|12 Month Visit|Withdrawal by Subject|0|||
146103656|NCT02835820|526900534|FG000|Overall Study|Baseline Screen Failure|0|||
146103657|NCT02835820|526900535|FG001|Overall Study|Baseline Screen Failure|3|||
146103658|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
146103659|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
146103660|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
146103661|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
146103662|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103663|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103664|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103665|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103666|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103667|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103668|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
146103669|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
146103670|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
146103671|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
146103672|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
146103673|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103674|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103675|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103676|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103677|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103678|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103679|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
146103680|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
146103681|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
146103682|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
146103683|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
146103684|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103685|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103686|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103687|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103688|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103689|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103690|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
146103691|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103692|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146256212|NCT00264498|527452563|FG000|Crossover Treatment|Objective disease progression|4|||
146256213|NCT00264498|527452564|FG001|Crossover Treatment|Objective disease progression|5|||
146256214|NCT00264498|527452563|FG000|Crossover Treatment|Study closure|0|||
146256215|NCT00264498|527452564|FG001|Crossover Treatment|Study closure|1|||
146256216|NCT00264498|527452563|FG000|Crossover Treatment|Withdrawal by Subject|1|||
146256217|NCT00264498|527452564|FG001|Crossover Treatment|Withdrawal by Subject|0|||
146103693|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103694|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
146103695|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103696|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103697|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103698|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103699|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103700|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103701|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
146103702|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
146103703|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
146103704|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
146103705|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
146103706|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103707|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103708|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103709|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103710|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103711|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103712|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
146103713|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
146103714|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
146103715|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
146103716|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
146103717|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103718|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103719|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103720|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103721|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103722|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103723|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
146103724|NCT01847274|526900541|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
146103725|NCT01847274|526900542|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
146103726|NCT01847274|526900543|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
146103727|NCT01847274|526900544|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
146103728|NCT01847274|526900545|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103729|NCT01847274|526900546|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103730|NCT01847274|526900547|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103731|NCT01847274|526900548|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103732|NCT01847274|526900549|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103733|NCT01847274|526900550|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103734|NCT01847274|526900551|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
146103735|NCT01847274|526900541|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103736|NCT01847274|526900542|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103737|NCT01847274|526900543|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103738|NCT01847274|526900544|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103739|NCT01847274|526900545|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103740|NCT01847274|526900546|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
146103741|NCT01847274|526900547|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103742|NCT01847274|526900548|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103743|NCT01847274|526900549|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103744|NCT01847274|526900550|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103745|NCT01847274|526900551|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
146103746|NCT01847274|526900541|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103747|NCT01847274|526900542|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103748|NCT01847274|526900543|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103749|NCT01847274|526900544|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103750|NCT01847274|526900545|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
146103751|NCT01847274|526900546|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103752|NCT01847274|526900547|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146300916|NCT02281357|527617172|FG000|Overall Study|Adverse Event|2|||
146103753|NCT01847274|526900548|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103754|NCT01847274|526900549|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103755|NCT01847274|526900550|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103756|NCT01847274|526900551|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
146103757|NCT01847274|526900541|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103758|NCT01847274|526900542|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103759|NCT01847274|526900543|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103760|NCT01847274|526900544|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103761|NCT01847274|526900545|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103762|NCT01847274|526900546|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103763|NCT01847274|526900547|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
146103764|NCT01847274|526900548|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103765|NCT01847274|526900549|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103766|NCT01847274|526900550|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103767|NCT01847274|526900551|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
146103768|NCT01847274|526900541|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103769|NCT01847274|526900542|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103770|NCT01847274|526900543|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103771|NCT01847274|526900544|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103772|NCT01847274|526900545|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103773|NCT01847274|526900546|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103774|NCT01847274|526900547|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
146103775|NCT01847274|526900548|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103776|NCT01847274|526900549|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103777|NCT01847274|526900550|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103778|NCT01847274|526900551|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
146103779|NCT01847274|526900541|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103780|NCT01847274|526900542|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103781|NCT01847274|526900543|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103782|NCT01847274|526900544|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103783|NCT01847274|526900545|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103784|NCT01847274|526900546|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103785|NCT01847274|526900547|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
146103786|NCT01847274|526900548|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103787|NCT01847274|526900549|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103788|NCT01847274|526900550|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103789|NCT01847274|526900551|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
146103790|NCT01847274|526900541|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103791|NCT01847274|526900542|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103792|NCT01847274|526900543|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103793|NCT01847274|526900544|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103794|NCT01847274|526900545|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103795|NCT01847274|526900546|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103796|NCT01847274|526900547|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
146103797|NCT01847274|526900548|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
146103798|NCT01847274|526900549|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
146103799|NCT01847274|526900550|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
146103800|NCT01847274|526900551|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
146103801|NCT01847274|526900541|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103802|NCT01847274|526900542|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103803|NCT01847274|526900543|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103804|NCT01847274|526900544|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103805|NCT01847274|526900545|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103806|NCT01847274|526900546|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103807|NCT01847274|526900547|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103808|NCT01847274|526900548|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
146103809|NCT01847274|526900549|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103810|NCT01847274|526900550|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
146103811|NCT01847274|526900551|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
146103812|NCT01847274|526900541|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103813|NCT01847274|526900542|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103814|NCT01847274|526900543|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103815|NCT01847274|526900544|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103816|NCT01847274|526900545|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103817|NCT01847274|526900546|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146300917|NCT02281357|527617173|FG001|Overall Study|Adverse Event|1|||
146103818|NCT01847274|526900547|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103819|NCT01847274|526900548|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
146103820|NCT01847274|526900549|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
146103821|NCT01847274|526900550|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
146103822|NCT01847274|526900551|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
146103823|NCT01847274|526900541|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103824|NCT01847274|526900542|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103825|NCT01847274|526900543|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103826|NCT01847274|526900544|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103827|NCT01847274|526900545|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103828|NCT01847274|526900546|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103829|NCT01847274|526900547|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103830|NCT01847274|526900548|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103831|NCT01847274|526900549|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103832|NCT01847274|526900550|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
146103833|NCT01847274|526900551|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
146103834|NCT01921387|526900552|FG000|Overall Study|Adverse Event|1|||
146103835|NCT03741062|526900553|FG000|Overall Study|Protocol Violation|1|||
146103836|NCT03741062|526900554|FG001|Overall Study|Protocol Violation|0|||
146103837|NCT01706146|526900557|FG000|Overall Study|Withdrawal by Subject|1|||
146103838|NCT01706146|526900557|FG000|Overall Study|Adverse Event|3|||
146103839|NCT01706146|526900557|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
146103840|NCT00675948|526900559|FG000|Overall Study|Adverse Event|23|||
146103841|NCT00675948|526900560|FG001|Overall Study|Adverse Event|1|||
146103842|NCT00675948|526900559|FG000|Overall Study|Lack of Efficacy|3|||
146103843|NCT00675948|526900560|FG001|Overall Study|Lack of Efficacy|0|||
146103844|NCT00675948|526900559|FG000|Overall Study|Withdrawal by Subject|7|||
146103845|NCT00675948|526900560|FG001|Overall Study|Withdrawal by Subject|0|||
146103846|NCT00675948|526900559|FG000|Overall Study|Lost to Follow-up|2|||
146103847|NCT00675948|526900560|FG001|Overall Study|Lost to Follow-up|0|||
146103848|NCT00675948|526900559|FG000|Overall Study|Protocol Violation|1|||
146103849|NCT00675948|526900560|FG001|Overall Study|Protocol Violation|0|||
146103850|NCT00675948|526900559|FG000|Overall Study|Pain under control|1|||
146103851|NCT00675948|526900560|FG001|Overall Study|Pain under control|0|||
146103852|NCT00675948|526900559|FG000|Overall Study|Sponsor decision|0|||
146103853|NCT00675948|526900560|FG001|Overall Study|Sponsor decision|1|||
146103854|NCT00675948|526900559|FG000|Overall Study|Patient died|1|||
146103855|NCT00675948|526900560|FG001|Overall Study|Patient died|0|||
146103856|NCT00675948|526900559|FG000|Overall Study|Patient unable to comply with diaries|1|||
146103857|NCT00675948|526900560|FG001|Overall Study|Patient unable to comply with diaries|0|||
146103858|NCT00675948|526900559|FG000|Overall Study|Patient feels unable to take medication|0|||
146103859|NCT00675948|526900560|FG001|Overall Study|Patient feels unable to take medication|1|||
146103860|NCT02527161|526900561|FG000|Overall Study|Failed MRI|52|||
146103861|NCT02527161|526900561|FG000|Overall Study|Withdrawal by Subject|19|||
146103862|NCT02527161|526900561|FG000|Overall Study|Delay in or unfit for surgery|16|||
146103863|NCT02527161|526900561|FG000|Overall Study|MRI contraindication|6|||
146103864|NCT02527161|526900561|FG000|Overall Study|Consent violation|4|||
146103865|NCT02527161|526900561|FG000|Overall Study|Only Recruited to Part A|27|||
146103866|NCT02527161|526900561|FG000|Overall Study|Physician Decision|1|||
146103867|NCT02527161|526900561|FG000|Overall Study|Adverse Event|1|||
146103868|NCT02527161|526900561|FG000|Overall Study|Lost to Follow-up|6|||
146103869|NCT02100514|526900562|FG000|Treatment Period|Adverse Event|0|||
146103870|NCT02100514|526900563|FG001|Treatment Period|Adverse Event|5|||
146103871|NCT02100514|526900564|FG002|Treatment Period|Adverse Event|0|||
146103872|NCT02100514|526900565|FG003|Treatment Period|Adverse Event|0|||
146103873|NCT02100514|526900566|FG004|Treatment Period|Adverse Event|0|||
146103874|NCT02100514|526900562|FG000|Treatment Period|Death|2|||
146103875|NCT02100514|526900563|FG001|Treatment Period|Death|2|||
146103876|NCT02100514|526900564|FG002|Treatment Period|Death|0|||
146103877|NCT02100514|526900565|FG003|Treatment Period|Death|0|||
146103878|NCT02100514|526900566|FG004|Treatment Period|Death|0|||
146103879|NCT02100514|526900562|FG000|Treatment Period|Lost to Follow-up|5|||
146103880|NCT02100514|526900563|FG001|Treatment Period|Lost to Follow-up|17|||
146103881|NCT02100514|526900564|FG002|Treatment Period|Lost to Follow-up|0|||
146103882|NCT02100514|526900565|FG003|Treatment Period|Lost to Follow-up|0|||
146103883|NCT02100514|526900566|FG004|Treatment Period|Lost to Follow-up|0|||
146103884|NCT02100514|526900562|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
146103885|NCT02100514|526900563|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
146103886|NCT02100514|526900564|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
146103887|NCT02100514|526900565|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
146103888|NCT02100514|526900566|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
146103889|NCT02100514|526900562|FG000|Treatment Period|Protocol Violation|1|||
146103890|NCT02100514|526900563|FG001|Treatment Period|Protocol Violation|1|||
146103891|NCT02100514|526900564|FG002|Treatment Period|Protocol Violation|0|||
146103892|NCT02100514|526900565|FG003|Treatment Period|Protocol Violation|0|||
146103893|NCT02100514|526900566|FG004|Treatment Period|Protocol Violation|0|||
146103894|NCT02100514|526900562|FG000|Treatment Period|Withdrawal by Subject|12|||
146103895|NCT02100514|526900563|FG001|Treatment Period|Withdrawal by Subject|37|||
146103896|NCT02100514|526900564|FG002|Treatment Period|Withdrawal by Subject|0|||
146103897|NCT02100514|526900565|FG003|Treatment Period|Withdrawal by Subject|0|||
146103898|NCT02100514|526900566|FG004|Treatment Period|Withdrawal by Subject|0|||
146103899|NCT02100514|526900562|FG000|Treatment Period|Other|9|||
146103900|NCT02100514|526900563|FG001|Treatment Period|Other|11|||
146103901|NCT02100514|526900564|FG002|Treatment Period|Other|0|||
146103902|NCT02100514|526900565|FG003|Treatment Period|Other|0|||
146103903|NCT02100514|526900566|FG004|Treatment Period|Other|0|||
146103904|NCT02100514|526900562|FG000|Extension Period|Withdrew consent|0|||
146103905|NCT02100514|526900563|FG001|Extension Period|Withdrew consent|0|||
146103906|NCT02100514|526900564|FG002|Extension Period|Withdrew consent|2|||
146103907|NCT02100514|526900565|FG003|Extension Period|Withdrew consent|0|||
146103908|NCT02100514|526900566|FG004|Extension Period|Withdrew consent|0|||
146103909|NCT01786668|526900576|FG000|Overall Study|Adverse Event|0|||
146103910|NCT01786668|526900577|FG001|Overall Study|Adverse Event|1|||
146103911|NCT01786668|526900578|FG002|Overall Study|Adverse Event|1|||
146103912|NCT01786668|526900579|FG003|Overall Study|Adverse Event|2|||
146103913|NCT01786668|526900576|FG000|Overall Study|Withdrawal by Subject|0|||
146103914|NCT01786668|526900577|FG001|Overall Study|Withdrawal by Subject|0|||
146103915|NCT01786668|526900578|FG002|Overall Study|Withdrawal by Subject|3|||
146103916|NCT01786668|526900579|FG003|Overall Study|Withdrawal by Subject|1|||
146103917|NCT01786668|526900576|FG000|Overall Study|Pregnancy|0|||
146103918|NCT01786668|526900577|FG001|Overall Study|Pregnancy|0|||
146103919|NCT01786668|526900578|FG002|Overall Study|Pregnancy|0|||
146103920|NCT01786668|526900579|FG003|Overall Study|Pregnancy|1|||
146103921|NCT01786668|526900576|FG000|Overall Study|Lost to Follow-up|1|||
146103922|NCT01786668|526900577|FG001|Overall Study|Lost to Follow-up|0|||
146103923|NCT01786668|526900578|FG002|Overall Study|Lost to Follow-up|1|||
146103924|NCT01786668|526900579|FG003|Overall Study|Lost to Follow-up|0|||
146103925|NCT03570697|526900580|FG000|Overall Study|Lost to Follow-up|0|||
146103926|NCT03570697|526900581|FG001|Overall Study|Lost to Follow-up|1|||
146103927|NCT03570697|526900580|FG000|Overall Study|Death|2|||
146103928|NCT03570697|526900581|FG001|Overall Study|Death|0|||
146103929|NCT03570697|526900580|FG000|Overall Study|Withdrawal by Subject|4|||
146103930|NCT03570697|526900581|FG001|Overall Study|Withdrawal by Subject|2|||
146103931|NCT03173313|526900583|FG000|Overall Study|Lost to Follow-up|2|||
146103932|NCT03173313|526900584|FG001|Overall Study|Lost to Follow-up|3|||
146103933|NCT03173313|526900583|FG000|Overall Study|Withdrawal by Subject|0|||
146103934|NCT03173313|526900584|FG001|Overall Study|Withdrawal by Subject|1|||
146103935|NCT03173313|526900583|FG000|Overall Study|Death|5|||
146103936|NCT03173313|526900584|FG001|Overall Study|Death|0|||
146103937|NCT03173313|526900583|FG000|Overall Study|Physician Decision|1|||
146103938|NCT03173313|526900584|FG001|Overall Study|Physician Decision|0|||
146103939|NCT03173313|526900583|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
146103940|NCT03173313|526900584|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
146103941|NCT03173313|526900583|FG000|Overall Study|Bone Fracture|1|||
146103942|NCT03173313|526900584|FG001|Overall Study|Bone Fracture|0|||
146103943|NCT01876420|526900585|FG000|Overall Study|Missed 30 day visit|1|||
146103944|NCT05338216|526900588|FG000|Overall Study|Withdrawal by Subject|1|||
146103945|NCT05338216|526900589|FG001|Overall Study|Withdrawal by Subject|1|||
146103946|NCT04457336|526900590|FG000|Period 2: Part A|Withdrawal by Subject|0|||
146103947|NCT04457336|526900591|FG001|Period 2: Part A|Withdrawal by Subject|1|||
146103948|NCT04457336|526900592|FG002|Period 2: Part A|Withdrawal by Subject|1|||
146103949|NCT04457336|526900593|FG003|Period 2: Part A|Withdrawal by Subject|1|||
146103950|NCT04457336|526900594|FG004|Period 2: Part A|Withdrawal by Subject|0|||
146103951|NCT04457336|526900595|FG005|Period 2: Part A|Withdrawal by Subject|0|||
146103952|NCT04457336|526900596|FG006|Period 2: Part A|Withdrawal by Subject|0|||
146103953|NCT04457336|526900597|FG007|Period 2: Part A|Withdrawal by Subject|0|||
146103954|NCT04457336|526900590|FG000|Period 2: Part A|Adverse Event|0|||
146103955|NCT04457336|526900591|FG001|Period 2: Part A|Adverse Event|0|||
146103956|NCT04457336|526900592|FG002|Period 2: Part A|Adverse Event|1|||
146103957|NCT04457336|526900593|FG003|Period 2: Part A|Adverse Event|1|||
146103958|NCT04457336|526900594|FG004|Period 2: Part A|Adverse Event|0|||
146103959|NCT04457336|526900595|FG005|Period 2: Part A|Adverse Event|0|||
146103960|NCT04457336|526900596|FG006|Period 2: Part A|Adverse Event|0|||
146103961|NCT04457336|526900597|FG007|Period 2: Part A|Adverse Event|0|||
146256218|NCT02382406|527452565|FG000|Study Treatment|Disease Progression|8|||
146103962|NCT04457336|526900590|FG000|Period 2: Part A|Study Terminated|0|||
146103963|NCT04457336|526900591|FG001|Period 2: Part A|Study Terminated|0|||
146103964|NCT04457336|526900592|FG002|Period 2: Part A|Study Terminated|1|||
146103965|NCT04457336|526900593|FG003|Period 2: Part A|Study Terminated|0|||
146256219|NCT02382406|527452566|FG001|Study Treatment|Disease Progression|0|||
146103966|NCT04457336|526900594|FG004|Period 2: Part A|Study Terminated|0|||
146103967|NCT04457336|526900595|FG005|Period 2: Part A|Study Terminated|0|||
146103968|NCT04457336|526900596|FG006|Period 2: Part A|Study Terminated|0|||
146256220|NCT02382406|527452567|FG002|Study Treatment|Disease Progression|20|||
146103969|NCT04457336|526900597|FG007|Period 2: Part A|Study Terminated|0|||
146103970|NCT04457336|526900590|FG000|Period 2: Part A|Protocol Violation|0|||
146103971|NCT04457336|526900591|FG001|Period 2: Part A|Protocol Violation|1|||
146103972|NCT04457336|526900592|FG002|Period 2: Part A|Protocol Violation|0|||
146103973|NCT04457336|526900593|FG003|Period 2: Part A|Protocol Violation|0|||
146103974|NCT04457336|526900594|FG004|Period 2: Part A|Protocol Violation|0|||
146103975|NCT04457336|526900595|FG005|Period 2: Part A|Protocol Violation|0|||
146103976|NCT04457336|526900596|FG006|Period 2: Part A|Protocol Violation|0|||
146103977|NCT04457336|526900597|FG007|Period 2: Part A|Protocol Violation|0|||
146103978|NCT04457336|526900590|FG000|Period 2: Part A|Lost to Follow-up|0|||
146103979|NCT04457336|526900591|FG001|Period 2: Part A|Lost to Follow-up|1|||
146103980|NCT04457336|526900592|FG002|Period 2: Part A|Lost to Follow-up|0|||
146103981|NCT04457336|526900593|FG003|Period 2: Part A|Lost to Follow-up|0|||
146103982|NCT04457336|526900594|FG004|Period 2: Part A|Lost to Follow-up|0|||
146103983|NCT04457336|526900595|FG005|Period 2: Part A|Lost to Follow-up|0|||
146103984|NCT04457336|526900596|FG006|Period 2: Part A|Lost to Follow-up|0|||
146103985|NCT04457336|526900597|FG007|Period 2: Part A|Lost to Follow-up|0|||
146103986|NCT04457336|526900590|FG000|Period 2: Part A|Other|0|||
146103987|NCT04457336|526900591|FG001|Period 2: Part A|Other|1|||
146103988|NCT04457336|526900592|FG002|Period 2: Part A|Other|0|||
146103989|NCT04457336|526900593|FG003|Period 2: Part A|Other|0|||
146103990|NCT04457336|526900594|FG004|Period 2: Part A|Other|0|||
146103991|NCT04457336|526900595|FG005|Period 2: Part A|Other|0|||
146103992|NCT04457336|526900596|FG006|Period 2: Part A|Other|0|||
146103993|NCT04457336|526900597|FG007|Period 2: Part A|Other|0|||
146103994|NCT04457336|526900590|FG000|Period 2: Part A|Physician Decision|0|||
146103995|NCT04457336|526900591|FG001|Period 2: Part A|Physician Decision|0|||
146103996|NCT04457336|526900592|FG002|Period 2: Part A|Physician Decision|0|||
146103997|NCT04457336|526900593|FG003|Period 2: Part A|Physician Decision|1|||
146103998|NCT04457336|526900594|FG004|Period 2: Part A|Physician Decision|0|||
146103999|NCT04457336|526900595|FG005|Period 2: Part A|Physician Decision|0|||
146104000|NCT04457336|526900596|FG006|Period 2: Part A|Physician Decision|0|||
146104001|NCT04457336|526900597|FG007|Period 2: Part A|Physician Decision|0|||
146104002|NCT04457336|526900590|FG000|Period 3: Part B|Study Terminated|0|||
146104003|NCT04457336|526900591|FG001|Period 3: Part B|Study Terminated|0|||
146104004|NCT04457336|526900592|FG002|Period 3: Part B|Study Terminated|0|||
146104005|NCT04457336|526900593|FG003|Period 3: Part B|Study Terminated|0|||
146104006|NCT04457336|526900594|FG004|Period 3: Part B|Study Terminated|1|||
146104007|NCT04457336|526900595|FG005|Period 3: Part B|Study Terminated|10|||
146104008|NCT04457336|526900596|FG006|Period 3: Part B|Study Terminated|13|||
146104009|NCT04457336|526900597|FG007|Period 3: Part B|Study Terminated|0|||
146104010|NCT04457336|526900590|FG000|Period 3: Part B|Withdrawal by Subject|0|||
146104011|NCT04457336|526900591|FG001|Period 3: Part B|Withdrawal by Subject|0|||
146104012|NCT04457336|526900592|FG002|Period 3: Part B|Withdrawal by Subject|0|||
146104013|NCT04457336|526900593|FG003|Period 3: Part B|Withdrawal by Subject|0|||
146104014|NCT04457336|526900594|FG004|Period 3: Part B|Withdrawal by Subject|0|||
146104015|NCT04457336|526900595|FG005|Period 3: Part B|Withdrawal by Subject|1|||
146104016|NCT04457336|526900596|FG006|Period 3: Part B|Withdrawal by Subject|2|||
146104017|NCT04457336|526900597|FG007|Period 3: Part B|Withdrawal by Subject|0|||
146104018|NCT04457336|526900590|FG000|Period 4: Part C|Study Terminated|0|||
146104019|NCT04457336|526900591|FG001|Period 4: Part C|Study Terminated|0|||
146104020|NCT04457336|526900592|FG002|Period 4: Part C|Study Terminated|0|||
146104021|NCT04457336|526900593|FG003|Period 4: Part C|Study Terminated|0|||
146104022|NCT04457336|526900594|FG004|Period 4: Part C|Study Terminated|0|||
146104023|NCT04457336|526900595|FG005|Period 4: Part C|Study Terminated|0|||
146104024|NCT04457336|526900596|FG006|Period 4: Part C|Study Terminated|0|||
146104025|NCT04457336|526900597|FG007|Period 4: Part C|Study Terminated|30|||
146104026|NCT04457336|526900590|FG000|Period 4: Part C|Adverse Event|0|||
146104027|NCT04457336|526900591|FG001|Period 4: Part C|Adverse Event|0|||
146104028|NCT04457336|526900592|FG002|Period 4: Part C|Adverse Event|0|||
146104029|NCT04457336|526900593|FG003|Period 4: Part C|Adverse Event|0|||
146104030|NCT04457336|526900594|FG004|Period 4: Part C|Adverse Event|0|||
146104031|NCT04457336|526900595|FG005|Period 4: Part C|Adverse Event|0|||
146104032|NCT04457336|526900596|FG006|Period 4: Part C|Adverse Event|0|||
146104033|NCT04457336|526900597|FG007|Period 4: Part C|Adverse Event|2|||
146104034|NCT04457336|526900590|FG000|Period 4: Part C|Site Terminated|0|||
146104035|NCT04457336|526900591|FG001|Period 4: Part C|Site Terminated|0|||
146104036|NCT04457336|526900592|FG002|Period 4: Part C|Site Terminated|0|||
146104037|NCT04457336|526900593|FG003|Period 4: Part C|Site Terminated|0|||
146104038|NCT04457336|526900594|FG004|Period 4: Part C|Site Terminated|0|||
146104039|NCT04457336|526900595|FG005|Period 4: Part C|Site Terminated|0|||
146104040|NCT04457336|526900596|FG006|Period 4: Part C|Site Terminated|0|||
146104041|NCT04457336|526900597|FG007|Period 4: Part C|Site Terminated|1|||
146104042|NCT04457336|526900590|FG000|Period 4: Part C|Other|0|||
146104043|NCT04457336|526900591|FG001|Period 4: Part C|Other|0|||
146104044|NCT04457336|526900592|FG002|Period 4: Part C|Other|0|||
146104045|NCT04457336|526900593|FG003|Period 4: Part C|Other|0|||
146104046|NCT04457336|526900594|FG004|Period 4: Part C|Other|0|||
146104047|NCT04457336|526900595|FG005|Period 4: Part C|Other|0|||
146104048|NCT04457336|526900596|FG006|Period 4: Part C|Other|0|||
146104049|NCT04457336|526900597|FG007|Period 4: Part C|Other|2|||
146104050|NCT04457336|526900590|FG000|Period 4: Part C|Withdrawal by Subject|0|||
146104051|NCT04457336|526900591|FG001|Period 4: Part C|Withdrawal by Subject|0|||
146104052|NCT04457336|526900592|FG002|Period 4: Part C|Withdrawal by Subject|0|||
146104053|NCT04457336|526900593|FG003|Period 4: Part C|Withdrawal by Subject|0|||
146104054|NCT04457336|526900594|FG004|Period 4: Part C|Withdrawal by Subject|0|||
146104055|NCT04457336|526900595|FG005|Period 4: Part C|Withdrawal by Subject|0|||
146104056|NCT04457336|526900596|FG006|Period 4: Part C|Withdrawal by Subject|0|||
146104057|NCT04457336|526900597|FG007|Period 4: Part C|Withdrawal by Subject|3|||
146104058|NCT03330288|526900604|FG000|Overall Study|Other reason|1|||
146104059|NCT03330288|526900605|FG001|Overall Study|Other reason|1|||
146104060|NCT03330288|526900604|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
146104061|NCT03330288|526900605|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
146104062|NCT03330288|526900604|FG000|Overall Study|Adverse Event|1|||
146104063|NCT03330288|526900605|FG001|Overall Study|Adverse Event|0|||
146104064|NCT03330288|526900604|FG000|Overall Study|Withdrawal by Subject|1|||
146104065|NCT03330288|526900605|FG001|Overall Study|Withdrawal by Subject|0|||
146104066|NCT03330288|526900604|FG000|Overall Study|Lost to Follow-up|26|||
146104067|NCT03330288|526900605|FG001|Overall Study|Lost to Follow-up|7|||
146104068|NCT01042678|526900606|FG000|Overall Study|Physician Decision|1|||
146104069|NCT01042678|526900607|FG001|Overall Study|Physician Decision|0|||
146104070|NCT01042678|526900608|FG002|Overall Study|Physician Decision|0|||
146104071|NCT01042678|526900609|FG003|Overall Study|Physician Decision|0|||
146104072|NCT01042678|526900610|FG004|Overall Study|Physician Decision|0|||
146104073|NCT01042678|526900611|FG005|Overall Study|Physician Decision|0|||
146104074|NCT01416272|526900612|FG000|Overall Study|Unacceptable distance visual acuity|2|||
146104075|NCT01416272|526900612|FG000|Overall Study|Lost to Follow-up|1|||
146104076|NCT01416272|526900612|FG000|Overall Study|Study related complaints|1|||
146104077|NCT01719783|526900615|FG000|Dose 2|Physician Decision|1|||
146104078|NCT01719783|526900616|FG001|Dose 2|Physician Decision|0|||
146104079|NCT01350492|526900617|FG000|Intervention|Lost to Follow-up|2|||
146104080|NCT01350492|526900618|FG001|Intervention|Lost to Follow-up|5|||
146104081|NCT01350492|526900617|FG000|Intervention|Withdrawal by Subject|3|||
146104082|NCT01350492|526900618|FG001|Intervention|Withdrawal by Subject|1|||
146104083|NCT01350492|526900617|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
146256221|NCT02382406|527452565|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
146104084|NCT01350492|526900618|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
146104085|NCT01350492|526900617|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
146104086|NCT01350492|526900618|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
146104087|NCT00205881|526900619|FG000|Overall Study|Withdrawal by Subject|16|||
146104088|NCT00702689|526900620|FG000|Overall Study|Withdrawal by Subject|4|||
146104089|NCT00702689|526900620|FG000|Overall Study|Recurrent malignancy|1|||
146104090|NCT00702689|526900620|FG000|Overall Study|Adverse Event|1|||
146104091|NCT00369824|526900622|FG000|Overall Study|Adverse Event|0|||
146104092|NCT00369824|526900623|FG001|Overall Study|Adverse Event|2|||
146104093|NCT00369824|526900624|FG002|Overall Study|Adverse Event|0|||
146104094|NCT00369824|526900625|FG003|Overall Study|Adverse Event|0|||
146104095|NCT00369824|526900626|FG004|Overall Study|Adverse Event|1|||
146104096|NCT00369824|526900627|FG005|Overall Study|Adverse Event|0|||
146104097|NCT00369824|526900622|FG000|Overall Study|Protocol Violation|0|||
146104098|NCT00369824|526900623|FG001|Overall Study|Protocol Violation|1|||
146104099|NCT00369824|526900624|FG002|Overall Study|Protocol Violation|0|||
146104100|NCT00369824|526900625|FG003|Overall Study|Protocol Violation|1|||
146104101|NCT00369824|526900626|FG004|Overall Study|Protocol Violation|1|||
146104102|NCT00369824|526900627|FG005|Overall Study|Protocol Violation|0|||
146104103|NCT00369824|526900622|FG000|Overall Study|Withdrawal by Subject|9|||
146104104|NCT00369824|526900623|FG001|Overall Study|Withdrawal by Subject|5|||
146104105|NCT00369824|526900624|FG002|Overall Study|Withdrawal by Subject|5|||
146104106|NCT00369824|526900625|FG003|Overall Study|Withdrawal by Subject|4|||
146104107|NCT00369824|526900626|FG004|Overall Study|Withdrawal by Subject|6|||
146104108|NCT00369824|526900627|FG005|Overall Study|Withdrawal by Subject|2|||
146104109|NCT00369824|526900622|FG000|Overall Study|Lost to Follow-up|6|||
146104110|NCT00369824|526900623|FG001|Overall Study|Lost to Follow-up|11|||
146256222|NCT02382406|527452566|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
146104111|NCT00369824|526900624|FG002|Overall Study|Lost to Follow-up|7|||
146104112|NCT00369824|526900625|FG003|Overall Study|Lost to Follow-up|8|||
146104113|NCT00369824|526900626|FG004|Overall Study|Lost to Follow-up|9|||
146104114|NCT00369824|526900627|FG005|Overall Study|Lost to Follow-up|6|||
146256223|NCT02382406|527452567|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
146104115|NCT00369824|526900622|FG000|Overall Study|Other|0|||
146104116|NCT00369824|526900623|FG001|Overall Study|Other|0|||
146104117|NCT00369824|526900624|FG002|Overall Study|Other|0|||
146104118|NCT00369824|526900625|FG003|Overall Study|Other|2|||
146104119|NCT00369824|526900626|FG004|Overall Study|Other|1|||
146104120|NCT00369824|526900627|FG005|Overall Study|Other|3|||
146104121|NCT01443078|526900628|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
146104122|NCT01443078|526900628|FG000|Overall Study|Withdrawal by Subject|1|||
146104123|NCT01443078|526900628|FG000|Overall Study|Patient had brain mets|1|||
146104124|NCT02217878|526900629|FG000|Overall Study|required morphine due to chest pain|1|||
146104125|NCT02217878|526900630|FG001|Overall Study|required morphine due to chest pain|2|||
146104126|NCT02217878|526900629|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
146104127|NCT02217878|526900630|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
146104128|NCT00415168|526900631|FG000|Overall Study|Death|26|||
146104129|NCT00415168|526900631|FG000|Overall Study|Lost to Follow-up|3|||
146104130|NCT00415168|526900631|FG000|Overall Study|Physician Decision|13|||
146104131|NCT00415168|526900631|FG000|Overall Study|Sponsor Decision|4|||
146104132|NCT00415168|526900631|FG000|Overall Study|Withdrawal by Subject|6|||
146104133|NCT02106975|526900634|FG000|Overall Study|Death|25|||
146104134|NCT02106975|526900635|FG001|Overall Study|Death|39|||
146104135|NCT01611155|526900636|FG000|Overall Study|Adverse Event|1|||
146104136|NCT01611155|526900637|FG001|Overall Study|Adverse Event|1|||
146104137|NCT01611155|526900636|FG000|Overall Study|Refused further treatment|6|||
146104138|NCT01611155|526900637|FG001|Overall Study|Refused further treatment|4|||
146104139|NCT01611155|526900636|FG000|Overall Study|Disease progression|1|||
146104140|NCT01611155|526900637|FG001|Overall Study|Disease progression|0|||
146104141|NCT01611155|526900636|FG000|Overall Study|Withdrawal by Subject|1|||
146104142|NCT01611155|526900637|FG001|Overall Study|Withdrawal by Subject|0|||
146104143|NCT01611155|526900636|FG000|Overall Study|Alternative treatment|0|||
146104144|NCT01611155|526900637|FG001|Overall Study|Alternative treatment|1|||
146104145|NCT01611155|526900636|FG000|Overall Study|Ineligible patient|0|||
146104146|NCT01611155|526900637|FG001|Overall Study|Ineligible patient|1|||
146104147|NCT00087607|526900639|FG000|Overall Study|Adverse Event|14|||
146104148|NCT00087607|526900640|FG001|Overall Study|Adverse Event|24|||
146104149|NCT00087607|526900639|FG000|Overall Study|Death|0|||
146104150|NCT00087607|526900640|FG001|Overall Study|Death|1|||
146104151|NCT00087607|526900639|FG000|Overall Study|Insufficient Therapeutic Response|53|||
146104152|NCT00087607|526900640|FG001|Overall Study|Insufficient Therapeutic Response|42|||
146104153|NCT00087607|526900639|FG000|Overall Study|Failure to return|21|||
146104154|NCT00087607|526900640|FG001|Overall Study|Failure to return|17|||
146104155|NCT00087607|526900639|FG000|Overall Study|Withdrew Consent|12|||
146104156|NCT00087607|526900640|FG001|Overall Study|Withdrew Consent|16|||
146104157|NCT00087607|526900639|FG000|Overall Study|Administrative|12|||
146104158|NCT00087607|526900640|FG001|Overall Study|Administrative|12|||
146104159|NCT00087607|526900639|FG000|Overall Study|Refused Treatment|5|||
146104160|NCT00087607|526900640|FG001|Overall Study|Refused Treatment|7|||
146104161|NCT00087607|526900639|FG000|Overall Study|Other Protocol Violation|5|||
146104162|NCT00087607|526900640|FG001|Overall Study|Other Protocol Violation|2|||
146104163|NCT00087607|526900639|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146104164|NCT00087607|526900640|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146104165|NCT02229383|526900641|FG000|Overall Study|Adverse Event|7|||
146104166|NCT02229383|526900642|FG001|Overall Study|Adverse Event|4|||
146104167|NCT02229383|526900641|FG000|Overall Study|Death|0|||
146104168|NCT02229383|526900642|FG001|Overall Study|Death|1|||
146104169|NCT02229383|526900641|FG000|Overall Study|Lost to Follow-up|5|||
146104170|NCT02229383|526900642|FG001|Overall Study|Lost to Follow-up|3|||
146104171|NCT02229383|526900641|FG000|Overall Study|Withdrawal by Subject|4|||
146104172|NCT02229383|526900642|FG001|Overall Study|Withdrawal by Subject|6|||
146104173|NCT02229383|526900641|FG000|Overall Study|Did not receive treatment|1|||
146104174|NCT02229383|526900642|FG001|Overall Study|Did not receive treatment|0|||
146104175|NCT02229383|526900641|FG000|Overall Study|Other|3|||
146104176|NCT02229383|526900642|FG001|Overall Study|Other|8|||
146104177|NCT00873015|526900647|FG000|Overall Study|Withdrawal by Subject|0|||
146104178|NCT00873015|526900648|FG001|Overall Study|Withdrawal by Subject|1|||
146104179|NCT00873015|526900649|FG002|Overall Study|Withdrawal by Subject|0|||
146104180|NCT00873015|526900650|FG003|Overall Study|Withdrawal by Subject|0|||
146104181|NCT00345839|526900651|FG000|Overall Study|Withdrawal by Subject|91|||
146104182|NCT00345839|526900652|FG001|Overall Study|Withdrawal by Subject|98|||
146104183|NCT00345839|526900651|FG000|Overall Study|Lost to Follow-up|58|||
146104184|NCT00345839|526900652|FG001|Overall Study|Lost to Follow-up|61|||
146104185|NCT01594281|526902378|FG000|Interventional Core Phase|Protocol Deviation|1|||
146104186|NCT01594281|526902379|FG001|Interventional Core Phase|Protocol Deviation|0|||
146104187|NCT01594281|526902380|FG002|Interventional Core Phase|Protocol Deviation|0|||
146104188|NCT01594281|526902378|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
146104189|NCT01594281|526902379|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
146104190|NCT01594281|526902380|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
146104191|NCT01594281|526902378|FG000|Interventional Core Phase|Death|1|||
146104192|NCT01594281|526902379|FG001|Interventional Core Phase|Death|1|||
146104193|NCT01594281|526902380|FG002|Interventional Core Phase|Death|2|||
146104194|NCT01594281|526902378|FG000|Interventional Core Phase|Lost to Follow-up|1|||
146104195|NCT01594281|526902379|FG001|Interventional Core Phase|Lost to Follow-up|4|||
146104196|NCT01594281|526902380|FG002|Interventional Core Phase|Lost to Follow-up|1|||
146104197|NCT01594281|526902378|FG000|Interventional Core Phase|Adverse Event|4|||
146104198|NCT01594281|526902379|FG001|Interventional Core Phase|Adverse Event|4|||
146104199|NCT01594281|526902380|FG002|Interventional Core Phase|Adverse Event|4|||
146104200|NCT01594281|526902378|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
146104201|NCT01594281|526902379|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
146104202|NCT01594281|526902380|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
146104203|NCT01594281|526902378|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
146104204|NCT01594281|526902379|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
146104205|NCT01594281|526902380|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
146104206|NCT01594281|526902378|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
146104207|NCT01594281|526902379|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
146104208|NCT01594281|526902380|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
146104209|NCT01871532|526902381|FG000|Overall Study|Withdrawal by Subject|1|||
146104210|NCT01871532|526902382|FG001|Overall Study|Withdrawal by Subject|2|||
146104211|NCT02550106|526902384|FG000|Overall Study|Adverse Event|1|||
146104212|NCT02550106|526902384|FG000|Overall Study|Lack of Efficacy|3|||
146104213|NCT02550106|526902384|FG000|Overall Study|Protocol Violation|6|||
146104214|NCT02550106|526902384|FG000|Overall Study|Withdrawal by Subject|2|||
146104215|NCT01709513|526902385|FG000|Overall Study|Randomized but not treated|0|||
146104216|NCT01709513|526902386|FG001|Overall Study|Randomized but not treated|1|||
146104217|NCT01709513|526902387|FG002|Overall Study|Randomized but not treated|0|||
146104218|NCT01709513|526902385|FG000|Overall Study|Adverse Event|16|||
146104219|NCT01709513|526902386|FG001|Overall Study|Adverse Event|31|||
146104220|NCT01709513|526902387|FG002|Overall Study|Adverse Event|23|||
146104221|NCT01709513|526902385|FG000|Overall Study|Poor compliance to protocol|2|||
146104222|NCT01709513|526902386|FG001|Overall Study|Poor compliance to protocol|0|||
146104223|NCT01709513|526902387|FG002|Overall Study|Poor compliance to protocol|0|||
146104224|NCT01709513|526902385|FG000|Overall Study|Other|3|||
146104225|NCT01709513|526902386|FG001|Overall Study|Other|11|||
146104226|NCT01709513|526902387|FG002|Overall Study|Other|7|||
146104227|NCT01034631|526902388|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
146104228|NCT01034631|526902389|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
146104229|NCT01034631|526902390|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
146104230|NCT01034631|526902388|FG000|Phase II|Not Evaluable per protocol|0|||
146104231|NCT01034631|526902389|FG001|Phase II|Not Evaluable per protocol|0|||
146104232|NCT01034631|526902390|FG002|Phase II|Not Evaluable per protocol|2|||
146104233|NCT01034631|526902388|FG000|Phase II|Determined Ineligible per protocol|0|||
146104234|NCT01034631|526902389|FG001|Phase II|Determined Ineligible per protocol|1|||
146104235|NCT01034631|526902390|FG002|Phase II|Determined Ineligible per protocol|0|||
146104236|NCT01193530|526902393|FG000|Overall Study|Withdrawal by Subject|2|||
146104237|NCT01193530|526902394|FG001|Overall Study|Withdrawal by Subject|2|||
146104238|NCT01193530|526902393|FG000|Overall Study|Began Contraindicated Therapy|1|||
146104239|NCT01193530|526902394|FG001|Overall Study|Began Contraindicated Therapy|0|||
146104240|NCT01193530|526902393|FG000|Overall Study|Lost Light Box|0|||
146104241|NCT01193530|526902394|FG001|Overall Study|Lost Light Box|1|||
146104242|NCT01193530|526902393|FG000|Overall Study|Returned home - out of state|0|||
146104243|NCT01193530|526902394|FG001|Overall Study|Returned home - out of state|1|||
146104244|NCT01193530|526902393|FG000|Overall Study|Non-Compliance|0|||
146104245|NCT01193530|526902394|FG001|Overall Study|Non-Compliance|1|||
146104246|NCT04218695|526902395|FG000|Overall Study|Adverse Event|1|||
146104247|NCT04218695|526902396|FG001|Overall Study|Adverse Event|0|||
146104248|NCT01890473|526902397|FG000|Overall Study|Lost to Follow-up|1|||
146104249|NCT01890473|526902398|FG001|Overall Study|Lost to Follow-up|0|||
146104250|NCT01890473|526902397|FG000|Overall Study|Poor/non-compliance|1|||
146104251|NCT01890473|526902398|FG001|Overall Study|Poor/non-compliance|0|||
146104252|NCT01543958|526902399|FG000|Overall Study|Loss to follow-up|3|||
146104253|NCT01543958|526902399|FG000|Overall Study|ART initiation|1|||
146104254|NCT04019288|526902400|FG000|Overall Study|Death|1|||
146104255|NCT04019288|526902401|FG001|Overall Study|Death|0|||
146104256|NCT04019288|526902402|FG002|Overall Study|Death|0|||
146104257|NCT03166735|526902403|FG000|Overall Study|Not Treated|1|||
146104258|NCT03166735|526902404|FG001|Overall Study|Not Treated|0|||
146104259|NCT03166735|526902405|FG002|Overall Study|Not Treated|0|||
146104260|NCT03166735|526902406|FG003|Overall Study|Not Treated|0|||
146104261|NCT03166735|526902407|FG004|Overall Study|Not Treated|0|||
146104262|NCT03166735|526902403|FG000|Overall Study|follow-up not completed as planned|0|||
146104263|NCT03166735|526902404|FG001|Overall Study|follow-up not completed as planned|1|||
146104264|NCT03166735|526902405|FG002|Overall Study|follow-up not completed as planned|1|||
146104265|NCT03166735|526902406|FG003|Overall Study|follow-up not completed as planned|0|||
146104266|NCT03166735|526902407|FG004|Overall Study|follow-up not completed as planned|1|||
146104267|NCT03166735|526902403|FG000|Overall Study|Withdrawal by Subject|0|||
146104268|NCT03166735|526902404|FG001|Overall Study|Withdrawal by Subject|0|||
146104269|NCT03166735|526902405|FG002|Overall Study|Withdrawal by Subject|1|||
146104270|NCT03166735|526902406|FG003|Overall Study|Withdrawal by Subject|1|||
146104271|NCT03166735|526902407|FG004|Overall Study|Withdrawal by Subject|2|||
146104272|NCT03166735|526902403|FG000|Overall Study|Lost to Follow-up|0|||
146104273|NCT03166735|526902404|FG001|Overall Study|Lost to Follow-up|2|||
146104274|NCT03166735|526902405|FG002|Overall Study|Lost to Follow-up|1|||
146104275|NCT03166735|526902406|FG003|Overall Study|Lost to Follow-up|0|||
146104276|NCT03166735|526902407|FG004|Overall Study|Lost to Follow-up|1|||
146104277|NCT00934089|526902408|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
146104278|NCT00934089|526902409|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
146104279|NCT00934089|526902408|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
146104280|NCT00934089|526902409|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
146104281|NCT01945281|526902411|FG000|Overall Study|Adverse Event|1|||
146104282|NCT01945281|526902412|FG001|Overall Study|Adverse Event|0|||
146104283|NCT01945281|526902411|FG000|Overall Study|Death|3|||
146104284|NCT01945281|526902412|FG001|Overall Study|Death|3|||
146104285|NCT01945281|526902411|FG000|Overall Study|Physician Decision|1|||
146104286|NCT01945281|526902412|FG001|Overall Study|Physician Decision|1|||
146104287|NCT01945281|526902411|FG000|Overall Study|Technical Problems|1|||
146104288|NCT01945281|526902412|FG001|Overall Study|Technical Problems|0|||
146104289|NCT00799383|526902415|FG000|Overall Study|Protocol Violation|1|||
146104290|NCT00799383|526902416|FG001|Overall Study|Protocol Violation|1|||
146104291|NCT00799383|526902415|FG000|Overall Study|Adverse Event|0|||
146104292|NCT00799383|526902416|FG001|Overall Study|Adverse Event|1|||
146104293|NCT00799383|526902415|FG000|Overall Study|Lost to Follow-up|1|||
146104294|NCT00799383|526902416|FG001|Overall Study|Lost to Follow-up|2|||
146104295|NCT00799383|526902415|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
146104296|NCT00799383|526902416|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
146104297|NCT00799383|526902415|FG000|Overall Study|Withdrawal by Subject|0|||
146104298|NCT00799383|526902416|FG001|Overall Study|Withdrawal by Subject|1|||
146104299|NCT00926328|526902417|FG000|Overall Study|Lost to Follow-up|12|||
146104300|NCT00926328|526902418|FG001|Overall Study|Lost to Follow-up|14|||
146104301|NCT00726986|526902419|FG000|Induction Phase|Adverse Event|4|||
146104302|NCT00726986|526902419|FG000|Induction Phase|Withdrawal by Subject|2|||
146104303|NCT00726986|526902419|FG000|Induction Phase|Death|2|||
146104304|NCT00726986|526902419|FG000|Induction Phase|Lack of Efficacy|5|||
146104305|NCT00726986|526902419|FG000|Induction Phase|Secondary Disease|2|||
146104306|NCT00726986|526902419|FG000|Maintenance Phase|Adverse Event|1|||
146104307|NCT00726986|526902419|FG000|Maintenance Phase|Lack of Efficacy|2|||
146104308|NCT01434667|526902427|FG000|Overall Study|Lost to Follow-up|5|||
146104309|NCT01434667|526902428|FG001|Overall Study|Lost to Follow-up|10|||
146104310|NCT01877265|526902431|FG000|Treatment Period 1|Sponsor Decision|0|||
146104311|NCT01877265|526902432|FG001|Treatment Period 1|Sponsor Decision|0|||
146104312|NCT01877265|526902433|FG002|Treatment Period 1|Sponsor Decision|1|||
146104313|NCT01877265|526902434|FG003|Treatment Period 1|Sponsor Decision|0|||
146104314|NCT01877265|526902435|FG004|Treatment Period 1|Sponsor Decision|0|||
146104315|NCT01877265|526902436|FG005|Treatment Period 1|Sponsor Decision|0|||
146104316|NCT01877265|526902431|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146104317|NCT01877265|526902432|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146104318|NCT01877265|526902433|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146104319|NCT01877265|526902434|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146104320|NCT01877265|526902435|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
146104321|NCT01877265|526902436|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
146104322|NCT01877265|526902431|FG000|Treatment Period 3|Lost to Follow-up|1|||
146104323|NCT01877265|526902432|FG001|Treatment Period 3|Lost to Follow-up|0|||
146104324|NCT01877265|526902433|FG002|Treatment Period 3|Lost to Follow-up|0|||
146104325|NCT01877265|526902434|FG003|Treatment Period 3|Lost to Follow-up|0|||
146104326|NCT01877265|526902435|FG004|Treatment Period 3|Lost to Follow-up|0|||
146104327|NCT01877265|526902436|FG005|Treatment Period 3|Lost to Follow-up|0|||
146104328|NCT00003473|526902439|FG000|Overall Study|Three patients were not evaluable.|3|||
146104329|NCT04401423|526902440|FG000|Overall Study|Withdrawal by Subject|3|||
146104330|NCT04401423|526902441|FG001|Overall Study|Withdrawal by Subject|1|||
146104331|NCT04401423|526902440|FG000|Overall Study|Physician Decision|2|||
146104332|NCT04401423|526902441|FG001|Overall Study|Physician Decision|1|||
146256224|NCT02382406|527452565|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
146256225|NCT02382406|527452566|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
146104333|NCT02193867|526902442|FG000|Overall Study|Death|2|||
146104334|NCT02193867|526902442|FG000|Overall Study|Sponsor Study Termination|2|||
146104335|NCT01867424|526902443|FG000|Overall Study|Patient noncompliance|2|||
146104336|NCT01867424|526902444|FG001|Overall Study|Patient noncompliance|1|||
146104337|NCT04613375|526902445|FG000|Overall Study|Death|198|||
146104338|NCT04613375|526902445|FG000|Overall Study|Withdrawal by Subject|3|||
146256226|NCT02382406|527452567|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
146300918|NCT02281357|527617172|FG000|Overall Study|Lost to Follow-up|1|||
146104339|NCT02582983|526902446|FG000|Overall Study|Death|3|||
146104340|NCT02582983|526902446|FG000|Overall Study|Withdrawal by Subject|2|||
146104341|NCT02582983|526902446|FG000|Overall Study|Adverse Event|1|||
146104342|NCT05209360|526902447|FG000|Overall Study|Withdrawal by Subject|0|||
146104343|NCT05209360|526902448|FG001|Overall Study|Withdrawal by Subject|0|||
146104344|NCT05209360|526902449|FG002|Overall Study|Withdrawal by Subject|1|||
146104345|NCT05209360|526902450|FG003|Overall Study|Withdrawal by Subject|0|||
146104346|NCT05209360|526902451|FG004|Overall Study|Withdrawal by Subject|0|||
146104347|NCT05209360|526902452|FG005|Overall Study|Withdrawal by Subject|0|||
146104348|NCT02021331|526902455|FG000|Overall Study|Adverse Event|0|||
146104349|NCT02021331|526902456|FG001|Overall Study|Adverse Event|2|||
146104350|NCT01081678|526902459|FG000|Overall Study|Ineligibility Determined|0|||
146104351|NCT01081678|526902460|FG001|Overall Study|Ineligibility Determined|0|||
146104352|NCT01081678|526902461|FG002|Overall Study|Ineligibility Determined|1|||
146104353|NCT01081678|526902462|FG003|Overall Study|Ineligibility Determined|1|||
146104354|NCT01081678|526902459|FG000|Overall Study|Noncompliance|3|||
146104355|NCT01081678|526902460|FG001|Overall Study|Noncompliance|4|||
146104356|NCT01081678|526902461|FG002|Overall Study|Noncompliance|5|||
146104357|NCT01081678|526902462|FG003|Overall Study|Noncompliance|2|||
146104358|NCT01081678|526902459|FG000|Overall Study|Adverse Event|2|||
146104359|NCT01081678|526902460|FG001|Overall Study|Adverse Event|1|||
146104360|NCT01081678|526902461|FG002|Overall Study|Adverse Event|2|||
146104361|NCT01081678|526902462|FG003|Overall Study|Adverse Event|2|||
146104362|NCT01081678|526902459|FG000|Overall Study|Withdrawal by Subject|15|||
146104363|NCT01081678|526902460|FG001|Overall Study|Withdrawal by Subject|7|||
146104364|NCT01081678|526902461|FG002|Overall Study|Withdrawal by Subject|17|||
146104365|NCT01081678|526902462|FG003|Overall Study|Withdrawal by Subject|14|||
146104366|NCT01081678|526902459|FG000|Overall Study|Administrative Decision|1|||
146104367|NCT01081678|526902460|FG001|Overall Study|Administrative Decision|0|||
146104368|NCT01081678|526902461|FG002|Overall Study|Administrative Decision|0|||
146104369|NCT01081678|526902462|FG003|Overall Study|Administrative Decision|1|||
146104370|NCT01081678|526902459|FG000|Overall Study|Lost to Follow-up|4|||
146104371|NCT01081678|526902460|FG001|Overall Study|Lost to Follow-up|1|||
146104372|NCT01081678|526902461|FG002|Overall Study|Lost to Follow-up|4|||
146104373|NCT01081678|526902462|FG003|Overall Study|Lost to Follow-up|3|||
146104374|NCT01081678|526902459|FG000|Overall Study|Death|2|||
146104375|NCT01081678|526902460|FG001|Overall Study|Death|2|||
146104376|NCT01081678|526902461|FG002|Overall Study|Death|2|||
146104377|NCT01081678|526902462|FG003|Overall Study|Death|6|||
146104378|NCT01081678|526902459|FG000|Overall Study|Other|0|||
146104379|NCT01081678|526902460|FG001|Overall Study|Other|1|||
146104380|NCT01081678|526902461|FG002|Overall Study|Other|0|||
146104381|NCT01081678|526902462|FG003|Overall Study|Other|0|||
146104382|NCT01619423|526902465|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
146104383|NCT01619423|526902466|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
146104384|NCT01619423|526902467|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
146104385|NCT01619423|526902468|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
146104386|NCT01281865|526902469|FG000|Overall Study|Adverse Event|1|||
146104387|NCT01281865|526902470|FG001|Overall Study|Adverse Event|1|||
146104388|NCT01281865|526902469|FG000|Overall Study|Withdrawal by Subject|1|||
146104389|NCT01281865|526902470|FG001|Overall Study|Withdrawal by Subject|0|||
146104390|NCT01281865|526902469|FG000|Overall Study|Lack of Efficacy|1|||
146104391|NCT01281865|526902470|FG001|Overall Study|Lack of Efficacy|0|||
146104392|NCT03478657|526902471|FG000|Overall Study|Withdrawal by Subject|0|||
146104393|NCT03478657|526902472|FG001|Overall Study|Withdrawal by Subject|1|||
146104394|NCT03948581|526902473|FG000|Overall Study|Lost to Follow-up|0|||
146104395|NCT03948581|526902474|FG001|Overall Study|Lost to Follow-up|1|||
146104396|NCT03068455|526902475|FG000|Pre-treatment Period|Disease progression|0|||
146104397|NCT03068455|526902476|FG001|Pre-treatment Period|Disease progression|1|||
146104398|NCT03068455|526902475|FG000|Pre-treatment Period|Participant withdrew consent|1|||
146104399|NCT03068455|526902476|FG001|Pre-treatment Period|Participant withdrew consent|1|||
146104400|NCT03068455|526902475|FG000|Pre-treatment Period|Poor/non-compliance|0|||
146104401|NCT03068455|526902476|FG001|Pre-treatment Period|Poor/non-compliance|1|||
146104402|NCT03068455|526902475|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
146104403|NCT03068455|526902476|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
146104404|NCT03068455|526902475|FG000|Pre-treatment Period|Not reported|2|||
146104405|NCT03068455|526902476|FG001|Pre-treatment Period|Not reported|1|||
146104406|NCT03068455|526902475|FG000|Treatment Period|Disease progression|166|||
146104407|NCT03068455|526902476|FG001|Treatment Period|Disease progression|208|||
146104408|NCT03068455|526902475|FG000|Treatment Period|Study drug toxicity|317|||
146104409|NCT03068455|526902476|FG001|Treatment Period|Study drug toxicity|104|||
146104410|NCT03068455|526902475|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
146104411|NCT03068455|526902476|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
146104412|NCT03068455|526902475|FG000|Treatment Period|Participant request to stop therapy|33|||
146104413|NCT03068455|526902476|FG001|Treatment Period|Participant request to stop therapy|20|||
146104414|NCT03068455|526902475|FG000|Treatment Period|Participant withdrew consent|5|||
146104415|NCT03068455|526902476|FG001|Treatment Period|Participant withdrew consent|10|||
146104416|NCT03068455|526902475|FG000|Treatment Period|Poor/non-compliance|3|||
146104417|NCT03068455|526902476|FG001|Treatment Period|Poor/non-compliance|0|||
146104418|NCT03068455|526902475|FG000|Treatment Period|Participant no longer meets study criteria|1|||
146104419|NCT03068455|526902476|FG001|Treatment Period|Participant no longer meets study criteria|3|||
146104420|NCT03068455|526902475|FG000|Treatment Period|Other reasons|12|||
146104421|NCT03068455|526902476|FG001|Treatment Period|Other reasons|4|||
146104422|NCT00005044|526902486|FG000|Overall Study|Protocol Violation|37|||
146104423|NCT00005044|526902487|FG001|Overall Study|Protocol Violation|46|||
146300919|NCT02281357|527617173|FG001|Overall Study|Lost to Follow-up|0|||
146104424|NCT00005044|526902486|FG000|Overall Study|Withdrawal by Subject|1|||
146104425|NCT00005044|526902487|FG001|Overall Study|Withdrawal by Subject|5|||
146104426|NCT00005044|526902486|FG000|Overall Study|No protocol treatment|0|||
146104427|NCT00005044|526902487|FG001|Overall Study|No protocol treatment|1|||
146104428|NCT00181155|526902488|FG000|Overall Study|Physician Decision|1|||
146104429|NCT00181155|526902489|FG001|Overall Study|Physician Decision|0|||
146104430|NCT00181155|526902488|FG000|Overall Study|Withdrawal by Subject|1|||
146104431|NCT00181155|526902489|FG001|Overall Study|Withdrawal by Subject|0|||
146104432|NCT02572401|526902490|FG000|Overall Study|Lost to Follow-up|5|||
146104433|NCT02572401|526902491|FG001|Overall Study|Lost to Follow-up|8|||
146104434|NCT02572401|526902492|FG002|Overall Study|Lost to Follow-up|9|||
146104435|NCT02572401|526902493|FG003|Overall Study|Lost to Follow-up|9|||
146104436|NCT02572401|526902490|FG000|Overall Study|Death|0|||
146104437|NCT02572401|526902491|FG001|Overall Study|Death|0|||
146104438|NCT02572401|526902492|FG002|Overall Study|Death|0|||
146104439|NCT02572401|526902493|FG003|Overall Study|Death|1|||
146104440|NCT01548287|526902494|FG000|Screening|No reason provided|0|||
146104441|NCT01548287|526902495|FG001|Screening|No reason provided|0|||
146104442|NCT01548287|526902496|FG002|Screening|No reason provided|0|||
146104443|NCT01548287|526902497|FG003|Screening|No reason provided|0|||
146104444|NCT01548287|526902498|FG004|Screening|No reason provided|9|||
146104445|NCT01548287|526902494|FG000|Screening|Did not meet eligibility criteria|0|||
146104446|NCT01548287|526902495|FG001|Screening|Did not meet eligibility criteria|0|||
146104447|NCT01548287|526902496|FG002|Screening|Did not meet eligibility criteria|0|||
146104448|NCT01548287|526902497|FG003|Screening|Did not meet eligibility criteria|0|||
146104449|NCT01548287|526902498|FG004|Screening|Did not meet eligibility criteria|74|||
146104450|NCT01548287|526902494|FG000|Randomized Period|Did not meet inclusion criteria|0|||
146104451|NCT01548287|526902495|FG001|Randomized Period|Did not meet inclusion criteria|0|||
146104452|NCT01548287|526902496|FG002|Randomized Period|Did not meet inclusion criteria|2|||
146104453|NCT01548287|526902497|FG003|Randomized Period|Did not meet inclusion criteria|0|||
146104454|NCT01548287|526902498|FG004|Randomized Period|Did not meet inclusion criteria|0|||
146104455|NCT01548287|526902494|FG000|Randomized Period|Adverse Event|0|||
146104456|NCT01548287|526902495|FG001|Randomized Period|Adverse Event|2|||
146104457|NCT01548287|526902496|FG002|Randomized Period|Adverse Event|5|||
146104458|NCT01548287|526902497|FG003|Randomized Period|Adverse Event|0|||
146104459|NCT01548287|526902498|FG004|Randomized Period|Adverse Event|0|||
146104460|NCT02762578|526902503|FG000|Overall Study|Adverse Event|1|||
146104461|NCT02762578|526902504|FG001|Overall Study|Adverse Event|6|||
146104462|NCT02762578|526902503|FG000|Overall Study|Protocol Violation|4|||
146104463|NCT02762578|526902504|FG001|Overall Study|Protocol Violation|2|||
146104464|NCT02762578|526902503|FG000|Overall Study|Withdrawal by Subject|4|||
146104465|NCT02762578|526902504|FG001|Overall Study|Withdrawal by Subject|2|||
146104466|NCT02762578|526902503|FG000|Overall Study|Unclassified|6|||
146104467|NCT02762578|526902504|FG001|Overall Study|Unclassified|0|||
146104468|NCT00259610|526902505|FG000|Overall Study|Withdrawal by Subject|33|||
146104469|NCT00259610|526902506|FG001|Overall Study|Withdrawal by Subject|25|||
146104470|NCT00259610|526902507|FG002|Overall Study|Withdrawal by Subject|29|||
146104471|NCT00259610|526902508|FG003|Overall Study|Withdrawal by Subject|19|||
146104472|NCT00259610|526902505|FG000|Overall Study|Lost to Follow-up|19|||
146104473|NCT00259610|526902506|FG001|Overall Study|Lost to Follow-up|8|||
146104474|NCT00259610|526902507|FG002|Overall Study|Lost to Follow-up|18|||
146104475|NCT00259610|526902508|FG003|Overall Study|Lost to Follow-up|15|||
146104476|NCT00259610|526902505|FG000|Overall Study|Physician Decision|6|||
146104477|NCT00259610|526902506|FG001|Overall Study|Physician Decision|4|||
146104478|NCT00259610|526902507|FG002|Overall Study|Physician Decision|7|||
146104479|NCT00259610|526902508|FG003|Overall Study|Physician Decision|2|||
146104480|NCT00259610|526902505|FG000|Overall Study|Death|1|||
146104481|NCT00259610|526902506|FG001|Overall Study|Death|1|||
146104482|NCT00259610|526902507|FG002|Overall Study|Death|2|||
146104483|NCT00259610|526902508|FG003|Overall Study|Death|0|||
146104484|NCT00259610|526902505|FG000|Overall Study|non medical reason|6|||
146104485|NCT00259610|526902506|FG001|Overall Study|non medical reason|2|||
146256227|NCT02382406|527452565|FG000|Study Treatment|symptomatic deterioration|1|||
146104486|NCT00259610|526902507|FG002|Overall Study|non medical reason|10|||
146104487|NCT00259610|526902508|FG003|Overall Study|non medical reason|3|||
146104488|NCT00259610|526902505|FG000|Overall Study|Adverse Event|3|||
146256228|NCT02382406|527452566|FG001|Study Treatment|symptomatic deterioration|0|||
146104489|NCT00259610|526902506|FG001|Overall Study|Adverse Event|4|||
146104490|NCT00259610|526902507|FG002|Overall Study|Adverse Event|5|||
146104491|NCT00259610|526902508|FG003|Overall Study|Adverse Event|2|||
146104492|NCT00259610|526902505|FG000|Overall Study|Serious Adverse Event|8|||
146104493|NCT00259610|526902506|FG001|Overall Study|Serious Adverse Event|2|||
146104494|NCT00259610|526902507|FG002|Overall Study|Serious Adverse Event|2|||
146104495|NCT00259610|526902508|FG003|Overall Study|Serious Adverse Event|2|||
146104496|NCT01768286|526902511|FG000|Overall Study|Randomized But Not Treated|0|||
146104497|NCT01768286|526902512|FG001|Overall Study|Randomized But Not Treated|0|||
146104498|NCT01768286|526902513|FG002|Overall Study|Randomized But Not Treated|1|||
146104499|NCT01768286|526902514|FG003|Overall Study|Randomized But Not Treated|0|||
146256229|NCT02382406|527452567|FG002|Study Treatment|symptomatic deterioration|1|||
146256230|NCT02382406|527452565|FG000|Study Treatment|Death|0|||
146256231|NCT02382406|527452566|FG001|Study Treatment|Death|0|||
146256232|NCT02382406|527452567|FG002|Study Treatment|Death|2|||
146256233|NCT02382406|527452565|FG000|Follow up|Death|11|||
146256234|NCT02382406|527452566|FG001|Follow up|Death|0|||
146256235|NCT02382406|527452567|FG002|Follow up|Death|19|||
146256236|NCT02382406|527452565|FG000|Follow up|Symptomatic deterioration|1|||
146256237|NCT02382406|527452566|FG001|Follow up|Symptomatic deterioration|0|||
146256238|NCT02382406|527452567|FG002|Follow up|Symptomatic deterioration|1|||
146256239|NCT02382406|527452565|FG000|Follow up|Patient Refused Follow-up|1|||
146256240|NCT02382406|527452566|FG001|Follow up|Patient Refused Follow-up|0|||
146049727|NCT04435366|526697275|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
146049728|NCT04435366|526697276|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
146104500|NCT01768286|526902511|FG000|Overall Study|Lack of Efficacy|7|||
146104501|NCT01768286|526902512|FG001|Overall Study|Lack of Efficacy|4|||
146104502|NCT01768286|526902513|FG002|Overall Study|Lack of Efficacy|0|||
146104503|NCT01768286|526902514|FG003|Overall Study|Lack of Efficacy|1|||
146104504|NCT01768286|526902511|FG000|Overall Study|Withdrew Consent|0|||
146104505|NCT01768286|526902512|FG001|Overall Study|Withdrew Consent|0|||
146104506|NCT01768286|526902513|FG002|Overall Study|Withdrew Consent|1|||
146104507|NCT01768286|526902514|FG003|Overall Study|Withdrew Consent|0|||
146104508|NCT02083965|526902515|FG000|Treatment Period|Other|1|||
146104509|NCT02083965|526902516|FG001|Treatment Period|Other|0|||
146104510|NCT01201785|526902518|FG000|Overall Study|Lost to Follow-up|16|||
146104511|NCT02151110|526902519|FG000|Overall Study|Withdrawal by Subject|0|||
146104512|NCT02151110|526902520|FG001|Overall Study|Withdrawal by Subject|0|||
146104513|NCT02151110|526902521|FG002|Overall Study|Withdrawal by Subject|0|||
146104514|NCT02151110|526902522|FG003|Overall Study|Withdrawal by Subject|0|||
146256241|NCT02382406|527452567|FG002|Follow up|Patient Refused Follow-up|0|||
146256242|NCT02382406|527452565|FG000|Follow up|Study Terminated|1|||
146256243|NCT02382406|527452566|FG001|Follow up|Study Terminated|0|||
146049729|NCT04435366|526697277|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
146049730|NCT04435366|526697275|FG000|Year 2 (12 Months)|Adverse Event|2|||
146049731|NCT04435366|526697276|FG001|Year 2 (12 Months)|Adverse Event|1|||
146049732|NCT04435366|526697277|FG002|Year 2 (12 Months)|Adverse Event|6|||
146049733|NCT00837213|526697279|FG000|Overall Study|Lost to Follow-up|3|||
146049734|NCT00837213|526697280|FG001|Overall Study|Lost to Follow-up|2|||
146049735|NCT00837213|526697279|FG000|Overall Study|Withdrawal by Subject|2|||
146049736|NCT00837213|526697280|FG001|Overall Study|Withdrawal by Subject|2|||
146049737|NCT00837213|526697279|FG000|Overall Study|not stated|1|||
146049738|NCT00837213|526697280|FG001|Overall Study|not stated|1|||
146049739|NCT04497116|526697283|FG000|Overall Study|Lost to Follow-up|1|||
146049740|NCT04497116|526697284|FG001|Overall Study|Lost to Follow-up|0|||
146049741|NCT04497116|526697285|FG002|Overall Study|Lost to Follow-up|0|||
146049742|NCT04497116|526697286|FG003|Overall Study|Lost to Follow-up|0|||
146049743|NCT04497116|526697287|FG004|Overall Study|Lost to Follow-up|0|||
146049744|NCT04497116|526697288|FG005|Overall Study|Lost to Follow-up|0|||
146049745|NCT04497116|526697289|FG006|Overall Study|Lost to Follow-up|0|||
146049746|NCT04497116|526697290|FG007|Overall Study|Lost to Follow-up|3|||
146049747|NCT04497116|526697291|FG008|Overall Study|Lost to Follow-up|3|||
146049748|NCT04497116|526697292|FG009|Overall Study|Lost to Follow-up|0|||
146049749|NCT04497116|526697293|FG010|Overall Study|Lost to Follow-up|0|||
146049750|NCT04497116|526697294|FG011|Overall Study|Lost to Follow-up|0|||
146049751|NCT04497116|526697295|FG012|Overall Study|Lost to Follow-up|0|||
146049752|NCT04497116|526697296|FG013|Overall Study|Lost to Follow-up|0|||
146049753|NCT04497116|526697297|FG014|Overall Study|Lost to Follow-up|0|||
146049754|NCT04497116|526697298|FG015|Overall Study|Lost to Follow-up|0|||
146049755|NCT04497116|526697299|FG016|Overall Study|Lost to Follow-up|0|||
146049756|NCT04497116|526697300|FG017|Overall Study|Lost to Follow-up|0|||
146049757|NCT04497116|526697301|FG018|Overall Study|Lost to Follow-up|0|||
146049758|NCT04497116|526697302|FG019|Overall Study|Lost to Follow-up|0|||
146049759|NCT04497116|526697303|FG020|Overall Study|Lost to Follow-up|0|||
146049760|NCT04497116|526697304|FG021|Overall Study|Lost to Follow-up|0|||
146049761|NCT04497116|526697305|FG022|Overall Study|Lost to Follow-up|1|||
146049762|NCT04497116|526697306|FG023|Overall Study|Lost to Follow-up|0|||
146049763|NCT04497116|526697307|FG024|Overall Study|Lost to Follow-up|0|||
146104515|NCT02151110|526902523|FG004|Overall Study|Withdrawal by Subject|0|||
146104516|NCT02151110|526902524|FG005|Overall Study|Withdrawal by Subject|0|||
146256244|NCT02382406|527452567|FG002|Follow up|Study Terminated|8|||
146049764|NCT04497116|526697283|FG000|Overall Study|Sponsor decision to terminate study|0|||
146049765|NCT04497116|526697284|FG001|Overall Study|Sponsor decision to terminate study|0|||
146049766|NCT04497116|526697285|FG002|Overall Study|Sponsor decision to terminate study|0|||
146104517|NCT02151110|526902525|FG006|Overall Study|Withdrawal by Subject|0|||
146049767|NCT04497116|526697286|FG003|Overall Study|Sponsor decision to terminate study|0|||
146049768|NCT04497116|526697287|FG004|Overall Study|Sponsor decision to terminate study|0|||
146049769|NCT04497116|526697288|FG005|Overall Study|Sponsor decision to terminate study|0|||
146049770|NCT04497116|526697289|FG006|Overall Study|Sponsor decision to terminate study|1|||
146104518|NCT02151110|526902526|FG007|Overall Study|Withdrawal by Subject|1|||
146104519|NCT02151110|526902519|FG000|Overall Study|Lost to Follow-up|0|||
146104520|NCT02151110|526902520|FG001|Overall Study|Lost to Follow-up|0|||
146104521|NCT02151110|526902521|FG002|Overall Study|Lost to Follow-up|0|||
146104522|NCT02151110|526902522|FG003|Overall Study|Lost to Follow-up|0|||
146104523|NCT02151110|526902523|FG004|Overall Study|Lost to Follow-up|0|||
146104524|NCT02151110|526902524|FG005|Overall Study|Lost to Follow-up|0|||
146104525|NCT02151110|526902525|FG006|Overall Study|Lost to Follow-up|0|||
146104526|NCT02151110|526902526|FG007|Overall Study|Lost to Follow-up|2|||
146104527|NCT02015754|526902527|FG000|Overall Study|Disease progression|5|||
146104528|NCT02015754|526902527|FG000|Overall Study|Change in treatment modality|5|||
146104529|NCT02015754|526902527|FG000|Overall Study|Lost to Follow-up|1|||
146104530|NCT02369016|526902528|FG000|Overall Study|AE associated with clinical disease progression|2|||
146104531|NCT02369016|526902529|FG001|Overall Study|AE associated with clinical disease progression|1|||
146104532|NCT02369016|526902528|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
146256245|NCT02382406|527452565|FG000|Follow up|Withdrawal by Subject|0|||
146256246|NCT02382406|527452566|FG001|Follow up|Withdrawal by Subject|0|||
146256247|NCT02382406|527452567|FG002|Follow up|Withdrawal by Subject|2|||
146256248|NCT04543942|527452568|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
146256249|NCT04543942|527452569|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
146256250|NCT04543942|527452568|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
146256251|NCT04543942|527452569|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
146256252|NCT02506881|527452575|FG000|First Intervention (Day 1)|Protocol Violation|0|||
146256253|NCT02506881|527452576|FG001|First Intervention (Day 1)|Protocol Violation|0|||
146256254|NCT02506881|527452577|FG002|First Intervention (Day 1)|Protocol Violation|1|||
146256255|NCT02506881|527452578|FG003|First Intervention (Day 1)|Protocol Violation|0|||
146256256|NCT02506881|527452575|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
146256257|NCT02506881|527452576|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
146256258|NCT02506881|527452577|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146256259|NCT02506881|527452578|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
146256260|NCT02506881|527452575|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
146256261|NCT02506881|527452576|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
146256262|NCT02506881|527452577|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
146256263|NCT02506881|527452578|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
146256264|NCT02391545|527452579|FG000|Overall Study|Death|0|||
146256265|NCT02391545|527452580|FG001|Overall Study|Death|2|||
146256266|NCT02391545|527452579|FG000|Overall Study|Lost to Follow-up|0|||
146256267|NCT02391545|527452580|FG001|Overall Study|Lost to Follow-up|1|||
146256268|NCT02391545|527452579|FG000|Overall Study|Termination of study by sponsor|20|||
146256269|NCT02391545|527452580|FG001|Overall Study|Termination of study by sponsor|20|||
146256270|NCT02391545|527452579|FG000|Overall Study|Withdrawal by Subject|0|||
146256271|NCT02391545|527452580|FG001|Overall Study|Withdrawal by Subject|1|||
146256272|NCT02391545|527452579|FG000|Overall Study|Other Reasons|6|||
146104533|NCT02369016|526902529|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
146104534|NCT02369016|526902528|FG000|Overall Study|Progressive disease - clinical progression|1|||
146104535|NCT02369016|526902529|FG001|Overall Study|Progressive disease - clinical progression|4|||
146104536|NCT02369016|526902528|FG000|Overall Study|withdrawal by patient|4|||
146104537|NCT02369016|526902529|FG001|Overall Study|withdrawal by patient|0|||
146104538|NCT02369016|526902528|FG000|Overall Study|Progressive disease - radiological progression|6|||
146104539|NCT02369016|526902529|FG001|Overall Study|Progressive disease - radiological progression|2|||
146104540|NCT00939770|526902532|FG000|Overall Study|Adverse Event|1|||
146104541|NCT00939770|526902533|FG001|Overall Study|Adverse Event|1|||
146104542|NCT00939770|526902534|FG002|Overall Study|Adverse Event|0|||
146104543|NCT00939770|526902535|FG003|Overall Study|Adverse Event|0|||
146104544|NCT00939770|526902536|FG004|Overall Study|Adverse Event|6|||
146104545|NCT00939770|526902537|FG005|Overall Study|Adverse Event|2|||
146104546|NCT00939770|526902538|FG006|Overall Study|Adverse Event|1|||
146104547|NCT00939770|526902539|FG007|Overall Study|Adverse Event|1|||
146104548|NCT00939770|526902532|FG000|Overall Study|Lack of Efficacy|4|||
146104549|NCT00939770|526902533|FG001|Overall Study|Lack of Efficacy|6|||
146104550|NCT00939770|526902534|FG002|Overall Study|Lack of Efficacy|13|||
146104551|NCT00939770|526902535|FG003|Overall Study|Lack of Efficacy|9|||
146256273|NCT02391545|527452580|FG001|Overall Study|Other Reasons|4|||
146256274|NCT02016690|527452581|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
146256275|NCT02016690|527452581|FG000|Overall Study|Excluded from SAS: Duplication|2|||
146104552|NCT00939770|526902536|FG004|Overall Study|Lack of Efficacy|16|||
146104553|NCT00939770|526902537|FG005|Overall Study|Lack of Efficacy|8|||
146104554|NCT00939770|526902538|FG006|Overall Study|Lack of Efficacy|11|||
146104555|NCT00939770|526902539|FG007|Overall Study|Lack of Efficacy|1|||
146104556|NCT00939770|526902532|FG000|Overall Study|Lost to Follow-up|0|||
146104557|NCT00939770|526902533|FG001|Overall Study|Lost to Follow-up|0|||
146104558|NCT00939770|526902534|FG002|Overall Study|Lost to Follow-up|0|||
146256276|NCT02016690|527452581|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
146256277|NCT02016690|527452581|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
146104559|NCT00939770|526902535|FG003|Overall Study|Lost to Follow-up|0|||
146256278|NCT02016690|527452581|FG000|Overall Study|Did not meet inclusion criteria|13|||
146256279|NCT02016690|527452581|FG000|Overall Study|Hospitalized for RSV at study start|3|||
146256280|NCT01363297|527452582|FG000|Overall Study|Other|0|||
146256281|NCT01363297|527452583|FG001|Overall Study|Other|0|||
146256282|NCT01363297|527452584|FG002|Overall Study|Other|0|||
146256283|NCT01363297|527452585|FG003|Overall Study|Other|0|||
146256284|NCT01363297|527452586|FG004|Overall Study|Other|1|||
146256285|NCT01363297|527452582|FG000|Overall Study|Death|3|||
146256286|NCT01363297|527452583|FG001|Overall Study|Death|6|||
146256287|NCT01363297|527452584|FG002|Overall Study|Death|6|||
146256288|NCT01363297|527452585|FG003|Overall Study|Death|10|||
146256289|NCT01363297|527452586|FG004|Overall Study|Death|30|||
146256290|NCT00495612|527452587|FG000|Overall Study|Lost to Follow-up|1|||
146256291|NCT00495612|527452588|FG001|Overall Study|Lost to Follow-up|0|||
146256292|NCT00495612|527452587|FG000|Overall Study|Subject's Decision to Withdraw|3|||
146049771|NCT04497116|526697290|FG007|Overall Study|Sponsor decision to terminate study|0|||
146049772|NCT04497116|526697291|FG008|Overall Study|Sponsor decision to terminate study|0|||
146049773|NCT04497116|526697292|FG009|Overall Study|Sponsor decision to terminate study|1|||
146049774|NCT04497116|526697293|FG010|Overall Study|Sponsor decision to terminate study|0|||
146049775|NCT04497116|526697294|FG011|Overall Study|Sponsor decision to terminate study|0|||
146049776|NCT04497116|526697295|FG012|Overall Study|Sponsor decision to terminate study|0|||
146256293|NCT00495612|527452588|FG001|Overall Study|Subject's Decision to Withdraw|0|||
146256294|NCT03340766|527452595|FG000|Overall Study|Withdrawal by Subject|2|||
146256295|NCT03340766|527452596|FG001|Overall Study|Withdrawal by Subject|1|||
146256296|NCT03340766|527452597|FG002|Overall Study|Withdrawal by Subject|3|||
146300920|NCT02281357|527617172|FG000|Overall Study|Withdrawal by Subject|4|||
146300921|NCT02281357|527617173|FG001|Overall Study|Withdrawal by Subject|3|||
146049777|NCT04497116|526697296|FG013|Overall Study|Sponsor decision to terminate study|0|||
146256297|NCT03340766|527452595|FG000|Overall Study|Lost to Follow-up|0|||
146256298|NCT03340766|527452596|FG001|Overall Study|Lost to Follow-up|0|||
146049778|NCT04497116|526697297|FG014|Overall Study|Sponsor decision to terminate study|0|||
146049779|NCT04497116|526697298|FG015|Overall Study|Sponsor decision to terminate study|0|||
146049780|NCT04497116|526697299|FG016|Overall Study|Sponsor decision to terminate study|0|||
146049781|NCT04497116|526697300|FG017|Overall Study|Sponsor decision to terminate study|0|||
146049782|NCT04497116|526697301|FG018|Overall Study|Sponsor decision to terminate study|0|||
146049783|NCT04497116|526697302|FG019|Overall Study|Sponsor decision to terminate study|1|||
146049784|NCT04497116|526697303|FG020|Overall Study|Sponsor decision to terminate study|0|||
146049785|NCT04497116|526697304|FG021|Overall Study|Sponsor decision to terminate study|0|||
146049786|NCT04497116|526697305|FG022|Overall Study|Sponsor decision to terminate study|0|||
146049787|NCT04497116|526697306|FG023|Overall Study|Sponsor decision to terminate study|0|||
146049788|NCT04497116|526697307|FG024|Overall Study|Sponsor decision to terminate study|0|||
146049789|NCT04497116|526697283|FG000|Overall Study|Death|4|||
146049790|NCT04497116|526697284|FG001|Overall Study|Death|5|||
146049791|NCT04497116|526697285|FG002|Overall Study|Death|2|||
146049792|NCT04497116|526697286|FG003|Overall Study|Death|2|||
146049793|NCT04497116|526697287|FG004|Overall Study|Death|1|||
146049794|NCT04497116|526697288|FG005|Overall Study|Death|1|||
146049795|NCT04497116|526697289|FG006|Overall Study|Death|3|||
146049796|NCT04497116|526697290|FG007|Overall Study|Death|10|||
146049797|NCT04497116|526697291|FG008|Overall Study|Death|37|||
146049798|NCT04497116|526697292|FG009|Overall Study|Death|17|||
146049799|NCT04497116|526697293|FG010|Overall Study|Death|2|||
146049800|NCT04497116|526697294|FG011|Overall Study|Death|1|||
146049801|NCT04497116|526697295|FG012|Overall Study|Death|1|||
146049802|NCT04497116|526697296|FG013|Overall Study|Death|3|||
146049803|NCT04497116|526697297|FG014|Overall Study|Death|18|||
146049804|NCT04497116|526697298|FG015|Overall Study|Death|3|||
146049805|NCT04497116|526697299|FG016|Overall Study|Death|2|||
146049806|NCT04497116|526697300|FG017|Overall Study|Death|1|||
146049807|NCT04497116|526697301|FG018|Overall Study|Death|4|||
146049808|NCT04497116|526697302|FG019|Overall Study|Death|17|||
146049809|NCT04497116|526697303|FG020|Overall Study|Death|1|||
146049810|NCT04497116|526697304|FG021|Overall Study|Death|0|||
146049811|NCT04497116|526697305|FG022|Overall Study|Death|3|||
146049812|NCT04497116|526697306|FG023|Overall Study|Death|5|||
146049813|NCT04497116|526697307|FG024|Overall Study|Death|4|||
146049814|NCT04497116|526697283|FG000|Overall Study|Withdrawal by Subject|1|||
146104560|NCT00939770|526902536|FG004|Overall Study|Lost to Follow-up|1|||
146256299|NCT03340766|527452597|FG002|Overall Study|Lost to Follow-up|1|||
146049815|NCT04497116|526697284|FG001|Overall Study|Withdrawal by Subject|0|||
146049816|NCT04497116|526697285|FG002|Overall Study|Withdrawal by Subject|1|||
146049817|NCT04497116|526697286|FG003|Overall Study|Withdrawal by Subject|0|||
146049818|NCT04497116|526697287|FG004|Overall Study|Withdrawal by Subject|0|||
146049819|NCT04497116|526697288|FG005|Overall Study|Withdrawal by Subject|0|||
146049820|NCT04497116|526697289|FG006|Overall Study|Withdrawal by Subject|0|||
146049821|NCT04497116|526697290|FG007|Overall Study|Withdrawal by Subject|7|||
146049822|NCT04497116|526697291|FG008|Overall Study|Withdrawal by Subject|14|||
146256300|NCT03340766|527452595|FG000|Overall Study|Death|6|||
146256301|NCT03340766|527452596|FG001|Overall Study|Death|7|||
146256302|NCT03340766|527452597|FG002|Overall Study|Death|4|||
146256303|NCT02864147|527452598|FG000|Overall Study|Withdrawal by Subject|3|||
146256304|NCT02864147|527452599|FG001|Overall Study|Withdrawal by Subject|2|||
146256305|NCT02864147|527452600|FG002|Overall Study|Withdrawal by Subject|1|||
146256306|NCT02864147|527452598|FG000|Overall Study|Lost to Follow-up|0|||
146256307|NCT02864147|527452599|FG001|Overall Study|Lost to Follow-up|4|||
146256308|NCT02864147|527452600|FG002|Overall Study|Lost to Follow-up|0|||
146256309|NCT02864147|527452598|FG000|Overall Study|Adverse Event|0|||
146256310|NCT02864147|527452599|FG001|Overall Study|Adverse Event|1|||
146256311|NCT02864147|527452600|FG002|Overall Study|Adverse Event|0|||
146256312|NCT02864147|527452598|FG000|Overall Study|Pregnancy|4|||
146256313|NCT02864147|527452599|FG001|Overall Study|Pregnancy|0|||
146256314|NCT02864147|527452600|FG002|Overall Study|Pregnancy|0|||
146256315|NCT02864147|527452598|FG000|Overall Study|Physician Decision|0|||
146256316|NCT02864147|527452599|FG001|Overall Study|Physician Decision|0|||
146256317|NCT02864147|527452600|FG002|Overall Study|Physician Decision|1|||
146256318|NCT02864147|527452598|FG000|Overall Study|Opted for excisional procedures|0|||
146256319|NCT02864147|527452599|FG001|Overall Study|Opted for excisional procedures|0|||
146256320|NCT02864147|527452600|FG002|Overall Study|Opted for excisional procedures|3|||
146256321|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
146256322|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
146256323|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
146256324|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
146256325|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
146256326|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
146256327|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
146256328|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
146256329|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
146256330|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
146256331|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
146256332|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
146256333|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
146256334|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
146256335|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
146256336|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
146256337|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
146256338|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
146256339|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
146256340|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
146256341|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
146256342|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
146256343|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
146256344|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
146256345|NCT02269917|527452601|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
146256346|NCT02269917|527452602|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
146256347|NCT02269917|527452603|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
146256348|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146256349|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
146104561|NCT00939770|526902537|FG005|Overall Study|Lost to Follow-up|0|||
146104562|NCT00939770|526902538|FG006|Overall Study|Lost to Follow-up|0|||
146104563|NCT00939770|526902539|FG007|Overall Study|Lost to Follow-up|0|||
146104564|NCT00939770|526902532|FG000|Overall Study|Physician Decision|0|||
146104565|NCT00939770|526902533|FG001|Overall Study|Physician Decision|0|||
146104566|NCT00939770|526902534|FG002|Overall Study|Physician Decision|2|||
146104567|NCT00939770|526902535|FG003|Overall Study|Physician Decision|0|||
146104568|NCT00939770|526902536|FG004|Overall Study|Physician Decision|7|||
146104569|NCT00939770|526902537|FG005|Overall Study|Physician Decision|1|||
146104570|NCT00939770|526902538|FG006|Overall Study|Physician Decision|0|||
146104571|NCT00939770|526902539|FG007|Overall Study|Physician Decision|6|||
146256350|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
146256351|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146256352|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
146256353|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
146256354|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146256355|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
146104572|NCT00939770|526902532|FG000|Overall Study|Protocol Violation|0|||
146256356|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
146256357|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146256358|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
146104573|NCT00939770|526902533|FG001|Overall Study|Protocol Violation|0|||
146104574|NCT00939770|526902534|FG002|Overall Study|Protocol Violation|0|||
146104575|NCT00939770|526902535|FG003|Overall Study|Protocol Violation|0|||
146104576|NCT00939770|526902536|FG004|Overall Study|Protocol Violation|1|||
146104577|NCT00939770|526902537|FG005|Overall Study|Protocol Violation|0|||
146104578|NCT00939770|526902538|FG006|Overall Study|Protocol Violation|0|||
146104579|NCT00939770|526902539|FG007|Overall Study|Protocol Violation|0|||
146104580|NCT00939770|526902532|FG000|Overall Study|Withdrawal by Subject|0|||
146104581|NCT00939770|526902533|FG001|Overall Study|Withdrawal by Subject|1|||
146104582|NCT00939770|526902534|FG002|Overall Study|Withdrawal by Subject|5|||
146104583|NCT00939770|526902535|FG003|Overall Study|Withdrawal by Subject|2|||
146104584|NCT00939770|526902536|FG004|Overall Study|Withdrawal by Subject|6|||
146104585|NCT00939770|526902537|FG005|Overall Study|Withdrawal by Subject|0|||
146104586|NCT00939770|526902538|FG006|Overall Study|Withdrawal by Subject|2|||
146104587|NCT00939770|526902539|FG007|Overall Study|Withdrawal by Subject|2|||
146104588|NCT01146665|526902540|FG000|Overall Study|Withdrawal by Subject|10|||
146104589|NCT01146665|526902541|FG001|Overall Study|Withdrawal by Subject|16|||
146104590|NCT05248867|526902542|FG000|Double-blind Period|Lost to Follow-up|0|||
146104591|NCT05248867|526902543|FG001|Double-blind Period|Lost to Follow-up|3|||
146104592|NCT05248867|526902544|FG002|Double-blind Period|Lost to Follow-up|0|||
146104593|NCT05248867|526902545|FG003|Double-blind Period|Lost to Follow-up|0|||
146104594|NCT05248867|526902546|FG004|Double-blind Period|Lost to Follow-up|0|||
146104595|NCT05248867|526902547|FG005|Double-blind Period|Lost to Follow-up|0|||
146104596|NCT05248867|526902542|FG000|Double-blind Period|Withdrawal by Subject|5|||
146104597|NCT05248867|526902543|FG001|Double-blind Period|Withdrawal by Subject|14|||
146104598|NCT05248867|526902544|FG002|Double-blind Period|Withdrawal by Subject|0|||
146104599|NCT05248867|526902545|FG003|Double-blind Period|Withdrawal by Subject|0|||
146104600|NCT05248867|526902546|FG004|Double-blind Period|Withdrawal by Subject|0|||
146104601|NCT05248867|526902547|FG005|Double-blind Period|Withdrawal by Subject|0|||
146104602|NCT05248867|526902542|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146104603|NCT05248867|526902543|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
146104604|NCT05248867|526902544|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146104605|NCT05248867|526902545|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146104606|NCT05248867|526902546|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146104607|NCT05248867|526902547|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
146104608|NCT05248867|526902542|FG000|Double-blind Period|Other, not specified|3|||
146104609|NCT05248867|526902543|FG001|Double-blind Period|Other, not specified|8|||
146104610|NCT05248867|526902544|FG002|Double-blind Period|Other, not specified|0|||
146104611|NCT05248867|526902545|FG003|Double-blind Period|Other, not specified|0|||
146104612|NCT05248867|526902546|FG004|Double-blind Period|Other, not specified|0|||
146104613|NCT05248867|526902547|FG005|Double-blind Period|Other, not specified|0|||
146104614|NCT05248867|526902542|FG000|Open-label Period|Withdrawal by Subject|0|||
146104615|NCT05248867|526902543|FG001|Open-label Period|Withdrawal by Subject|0|||
146104616|NCT05248867|526902544|FG002|Open-label Period|Withdrawal by Subject|3|||
146104617|NCT05248867|526902545|FG003|Open-label Period|Withdrawal by Subject|1|||
146104618|NCT05248867|526902546|FG004|Open-label Period|Withdrawal by Subject|7|||
146104619|NCT05248867|526902547|FG005|Open-label Period|Withdrawal by Subject|9|||
146104620|NCT05248867|526902542|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146104621|NCT05248867|526902543|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146104622|NCT05248867|526902544|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146104623|NCT05248867|526902545|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
146104624|NCT05248867|526902546|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146104625|NCT05248867|526902547|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
146104626|NCT05248867|526902542|FG000|Open-label Period|Lost to Follow-up|0|||
146104627|NCT05248867|526902543|FG001|Open-label Period|Lost to Follow-up|0|||
146104628|NCT05248867|526902544|FG002|Open-label Period|Lost to Follow-up|0|||
146104629|NCT05248867|526902545|FG003|Open-label Period|Lost to Follow-up|0|||
146104630|NCT05248867|526902546|FG004|Open-label Period|Lost to Follow-up|5|||
146104631|NCT05248867|526902547|FG005|Open-label Period|Lost to Follow-up|2|||
146104632|NCT05248867|526902542|FG000|Open-label Period|COVID-19 Infection|0|||
146256359|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
146256360|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
146104633|NCT05248867|526902543|FG001|Open-label Period|COVID-19 Infection|0|||
146256361|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
146104634|NCT05248867|526902544|FG002|Open-label Period|COVID-19 Infection|0|||
146256362|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
146104635|NCT05248867|526902545|FG003|Open-label Period|COVID-19 Infection|0|||
146104636|NCT05248867|526902546|FG004|Open-label Period|COVID-19 Infection|1|||
146104637|NCT05248867|526902547|FG005|Open-label Period|COVID-19 Infection|0|||
146104638|NCT05248867|526902542|FG000|Open-label Period|Other, not specified|0|||
146104639|NCT05248867|526902543|FG001|Open-label Period|Other, not specified|0|||
146104640|NCT05248867|526902544|FG002|Open-label Period|Other, not specified|0|||
146104641|NCT05248867|526902545|FG003|Open-label Period|Other, not specified|0|||
146104642|NCT05248867|526902546|FG004|Open-label Period|Other, not specified|4|||
146104643|NCT05248867|526902547|FG005|Open-label Period|Other, not specified|0|||
146256363|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146256364|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
146256365|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
146256366|NCT02269917|527452601|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146256367|NCT02269917|527452602|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
146256368|NCT02269917|527452603|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
146256369|NCT00818519|527452604|FG000|Overall Study|Adverse Event|2|||
146256370|NCT00818519|527452605|FG001|Overall Study|Adverse Event|2|||
146256371|NCT00818519|527452604|FG000|Overall Study|Lost to Follow-up|4|||
146300922|NCT00228566|527617174|FG000|Overall Study|Adverse Event|31|||
146049823|NCT04497116|526697292|FG009|Overall Study|Withdrawal by Subject|3|||
146049824|NCT04497116|526697293|FG010|Overall Study|Withdrawal by Subject|3|||
146049825|NCT04497116|526697294|FG011|Overall Study|Withdrawal by Subject|0|||
146049826|NCT04497116|526697295|FG012|Overall Study|Withdrawal by Subject|1|||
146049827|NCT04497116|526697296|FG013|Overall Study|Withdrawal by Subject|0|||
146049828|NCT04497116|526697297|FG014|Overall Study|Withdrawal by Subject|7|||
146049829|NCT04497116|526697298|FG015|Overall Study|Withdrawal by Subject|1|||
146049830|NCT04497116|526697299|FG016|Overall Study|Withdrawal by Subject|3|||
146049831|NCT04497116|526697300|FG017|Overall Study|Withdrawal by Subject|1|||
146049832|NCT04497116|526697301|FG018|Overall Study|Withdrawal by Subject|1|||
146049833|NCT04497116|526697302|FG019|Overall Study|Withdrawal by Subject|5|||
146049834|NCT04497116|526697303|FG020|Overall Study|Withdrawal by Subject|2|||
146049835|NCT04497116|526697304|FG021|Overall Study|Withdrawal by Subject|2|||
146049836|NCT04497116|526697305|FG022|Overall Study|Withdrawal by Subject|2|||
146049837|NCT04497116|526697306|FG023|Overall Study|Withdrawal by Subject|4|||
146049838|NCT04497116|526697307|FG024|Overall Study|Withdrawal by Subject|3|||
146049839|NCT04497116|526697283|FG000|Overall Study|Physician Decision|0|||
146049840|NCT04497116|526697284|FG001|Overall Study|Physician Decision|0|||
146049841|NCT04497116|526697285|FG002|Overall Study|Physician Decision|0|||
146049842|NCT04497116|526697286|FG003|Overall Study|Physician Decision|0|||
146049843|NCT04497116|526697287|FG004|Overall Study|Physician Decision|0|||
146049844|NCT04497116|526697288|FG005|Overall Study|Physician Decision|0|||
146049845|NCT04497116|526697289|FG006|Overall Study|Physician Decision|0|||
146049846|NCT04497116|526697290|FG007|Overall Study|Physician Decision|0|||
146049847|NCT04497116|526697291|FG008|Overall Study|Physician Decision|0|||
146049848|NCT04497116|526697292|FG009|Overall Study|Physician Decision|0|||
146049849|NCT04497116|526697293|FG010|Overall Study|Physician Decision|0|||
146049850|NCT04497116|526697294|FG011|Overall Study|Physician Decision|0|||
146049851|NCT04497116|526697295|FG012|Overall Study|Physician Decision|0|||
146049852|NCT04497116|526697296|FG013|Overall Study|Physician Decision|0|||
146049853|NCT04497116|526697297|FG014|Overall Study|Physician Decision|0|||
146049854|NCT04497116|526697298|FG015|Overall Study|Physician Decision|0|||
146049855|NCT04497116|526697299|FG016|Overall Study|Physician Decision|0|||
146049856|NCT04497116|526697300|FG017|Overall Study|Physician Decision|0|||
146049857|NCT04497116|526697301|FG018|Overall Study|Physician Decision|0|||
146049858|NCT04497116|526697302|FG019|Overall Study|Physician Decision|0|||
146049859|NCT04497116|526697303|FG020|Overall Study|Physician Decision|0|||
146049860|NCT04497116|526697304|FG021|Overall Study|Physician Decision|0|||
146049861|NCT04497116|526697305|FG022|Overall Study|Physician Decision|0|||
146049862|NCT04497116|526697306|FG023|Overall Study|Physician Decision|1|||
146049863|NCT04497116|526697307|FG024|Overall Study|Physician Decision|0|||
146049864|NCT04497116|526697283|FG000|Overall Study|Clinical Progression Related|0|||
146049865|NCT04497116|526697284|FG001|Overall Study|Clinical Progression Related|0|||
146049866|NCT04497116|526697285|FG002|Overall Study|Clinical Progression Related|0|||
146049867|NCT04497116|526697286|FG003|Overall Study|Clinical Progression Related|0|||
146049868|NCT04497116|526697287|FG004|Overall Study|Clinical Progression Related|0|||
146049869|NCT04497116|526697288|FG005|Overall Study|Clinical Progression Related|0|||
146049870|NCT04497116|526697289|FG006|Overall Study|Clinical Progression Related|0|||
146049871|NCT04497116|526697290|FG007|Overall Study|Clinical Progression Related|0|||
146049872|NCT04497116|526697291|FG008|Overall Study|Clinical Progression Related|0|||
146049873|NCT04497116|526697292|FG009|Overall Study|Clinical Progression Related|1|||
146049874|NCT04497116|526697293|FG010|Overall Study|Clinical Progression Related|0|||
146049875|NCT04497116|526697294|FG011|Overall Study|Clinical Progression Related|0|||
146049876|NCT04497116|526697295|FG012|Overall Study|Clinical Progression Related|0|||
146049877|NCT04497116|526697296|FG013|Overall Study|Clinical Progression Related|0|||
146049878|NCT04497116|526697297|FG014|Overall Study|Clinical Progression Related|0|||
146049879|NCT04497116|526697298|FG015|Overall Study|Clinical Progression Related|0|||
146049880|NCT04497116|526697299|FG016|Overall Study|Clinical Progression Related|0|||
146049881|NCT04497116|526697300|FG017|Overall Study|Clinical Progression Related|0|||
146049882|NCT04497116|526697301|FG018|Overall Study|Clinical Progression Related|0|||
146049883|NCT04497116|526697302|FG019|Overall Study|Clinical Progression Related|0|||
146049884|NCT04497116|526697303|FG020|Overall Study|Clinical Progression Related|0|||
146049885|NCT04497116|526697304|FG021|Overall Study|Clinical Progression Related|0|||
146049886|NCT04497116|526697305|FG022|Overall Study|Clinical Progression Related|0|||
146049887|NCT04497116|526697306|FG023|Overall Study|Clinical Progression Related|0|||
146256372|NCT00818519|527452605|FG001|Overall Study|Lost to Follow-up|6|||
146256373|NCT00818519|527452604|FG000|Overall Study|Protocol Violation|2|||
146256374|NCT00818519|527452605|FG001|Overall Study|Protocol Violation|1|||
146256375|NCT00818519|527452604|FG000|Overall Study|Pregnancy|0|||
146256376|NCT00818519|527452605|FG001|Overall Study|Pregnancy|1|||
146256377|NCT00818519|527452604|FG000|Overall Study|Withdrawal by Subject|4|||
146256378|NCT00818519|527452605|FG001|Overall Study|Withdrawal by Subject|9|||
146256379|NCT00818519|527452604|FG000|Overall Study|participant recovered completely|1|||
146256380|NCT00818519|527452605|FG001|Overall Study|participant recovered completely|0|||
146256381|NCT00818519|527452604|FG000|Overall Study|participant will leave for long tme|1|||
146256382|NCT00818519|527452605|FG001|Overall Study|participant will leave for long tme|0|||
146256383|NCT00655668|527452610|FG000|Overall Study|Adverse Event|6|||
146300923|NCT00228566|527617174|FG000|Overall Study|Lack of Efficacy|14|||
146104644|NCT01064310|526902548|FG000|Period 1|Adverse Event|7|||
146104645|NCT01064310|526902549|FG001|Period 1|Adverse Event|10|||
146104646|NCT01064310|526902550|FG002|Period 1|Adverse Event|0|||
146104647|NCT01064310|526902548|FG000|Period 1|Physician Decision|1|||
146104648|NCT01064310|526902549|FG001|Period 1|Physician Decision|0|||
146104649|NCT01064310|526902550|FG002|Period 1|Physician Decision|0|||
146104650|NCT01064310|526902548|FG000|Period 1|Withdrawal by Subject|2|||
146104651|NCT01064310|526902549|FG001|Period 1|Withdrawal by Subject|2|||
146104652|NCT01064310|526902550|FG002|Period 1|Withdrawal by Subject|0|||
146104653|NCT01064310|526902548|FG000|Period 1|Lack of Efficacy|3|||
146104654|NCT01064310|526902549|FG001|Period 1|Lack of Efficacy|5|||
146104655|NCT01064310|526902550|FG002|Period 1|Lack of Efficacy|0|||
146256384|NCT00655668|527452610|FG000|Overall Study|Death|5|||
146256385|NCT00655668|527452610|FG000|Overall Study|Disease Progression|27|||
146300924|NCT00228566|527617174|FG000|Overall Study|Lost to Follow-up|16|||
146049888|NCT04497116|526697307|FG024|Overall Study|Clinical Progression Related|0|||
146049889|NCT01358825|526697311|FG000|Overall Study|Blood sample not drawn|0|||
146049890|NCT01358825|526697312|FG001|Overall Study|Blood sample not drawn|1|||
146049891|NCT04524858|526697315|FG000|Overall Study|Adverse Event|1|||
146049892|NCT00113841|526697319|FG000|Overall Study|Disease progression|0|||
146049893|NCT00113841|526697320|FG001|Overall Study|Disease progression|2|||
146049894|NCT00113841|526697319|FG000|Overall Study|Non-compliant|1|||
146049895|NCT00113841|526697320|FG001|Overall Study|Non-compliant|0|||
146049896|NCT01788566|526697321|FG000|Overall Study|Death|4|||
146049897|NCT01788566|526697321|FG000|Overall Study|Adverse Event|1|||
146049898|NCT01788566|526697321|FG000|Overall Study|Clinical Progressive Disease|3|||
146049899|NCT01539759|526697324|FG000|Overall Study|Lost to Follow-up|6|||
146049900|NCT01539759|526697325|FG001|Overall Study|Lost to Follow-up|8|||
146049901|NCT01076959|526697326|FG000|Overall Study|Adverse Event|767|||
146049902|NCT01076959|526697326|FG000|Overall Study|Lack of Efficacy|849|||
146049903|NCT01076959|526697326|FG000|Overall Study|Non-compliance|274|||
146049904|NCT01076959|526697326|FG000|Overall Study|Lost to Follow-up|241|||
146049905|NCT01076959|526697326|FG000|Overall Study|Other|119|||
146049906|NCT02330055|526697327|FG000|Overall Study|technical issues|2|||
146049907|NCT02330055|526697328|FG001|Overall Study|technical issues|0|||
146049908|NCT02330055|526697327|FG000|Overall Study|participant forgot to wear device|5|||
146049909|NCT02330055|526697328|FG001|Overall Study|participant forgot to wear device|5|||
146049910|NCT02330055|526697327|FG000|Overall Study|data for less than 60 minutes|3|||
146049911|NCT02330055|526697328|FG001|Overall Study|data for less than 60 minutes|3|||
146049912|NCT02330055|526697327|FG000|Overall Study|participant did not sleep|0|||
146049913|NCT02330055|526697328|FG001|Overall Study|participant did not sleep|1|||
146049914|NCT02959437|526697329|FG000|Overall Study|Death|33|||
146049915|NCT02959437|526697330|FG001|Overall Study|Death|3|||
146049916|NCT02959437|526697331|FG002|Overall Study|Death|0|||
146049917|NCT02959437|526697332|FG003|Overall Study|Death|0|||
146049918|NCT02959437|526697329|FG000|Overall Study|Lost to Follow-up|3|||
146049919|NCT02959437|526697330|FG001|Overall Study|Lost to Follow-up|1|||
146049920|NCT02959437|526697331|FG002|Overall Study|Lost to Follow-up|0|||
146049921|NCT02959437|526697332|FG003|Overall Study|Lost to Follow-up|0|||
146049922|NCT02959437|526697329|FG000|Overall Study|Withdrawal by Subject|11|||
146049923|NCT02959437|526697330|FG001|Overall Study|Withdrawal by Subject|3|||
146049924|NCT02959437|526697331|FG002|Overall Study|Withdrawal by Subject|0|||
146049925|NCT02959437|526697332|FG003|Overall Study|Withdrawal by Subject|0|||
146049926|NCT02959437|526697329|FG000|Overall Study|Progressive Disease|9|||
146049927|NCT02959437|526697330|FG001|Overall Study|Progressive Disease|1|||
146049928|NCT02959437|526697331|FG002|Overall Study|Progressive Disease|0|||
146049929|NCT02959437|526697332|FG003|Overall Study|Progressive Disease|0|||
146049930|NCT02959437|526697329|FG000|Overall Study|Study Terminated by Sponsor|4|||
146049931|NCT02959437|526697330|FG001|Overall Study|Study Terminated by Sponsor|0|||
146049932|NCT02959437|526697331|FG002|Overall Study|Study Terminated by Sponsor|0|||
146049933|NCT02959437|526697332|FG003|Overall Study|Study Terminated by Sponsor|0|||
146049934|NCT02959437|526697329|FG000|Overall Study|Other Unspecified|2|||
146049935|NCT02959437|526697330|FG001|Overall Study|Other Unspecified|0|||
146049936|NCT02959437|526697331|FG002|Overall Study|Other Unspecified|0|||
146049937|NCT02959437|526697332|FG003|Overall Study|Other Unspecified|0|||
146049938|NCT03622814|526697335|FG000|Overall Study|Lost to Follow-up|8|||
146104656|NCT01064310|526902548|FG000|Period 1|Entered Open-label Period|1|||
146256386|NCT00655668|527452610|FG000|Overall Study|Study Terminated|9|||
146256387|NCT00655668|527452610|FG000|Overall Study|Other|1|||
146256388|NCT00655668|527452610|FG000|Overall Study|New Lymphoma Treatment Started|4|||
146256389|NCT00655668|527452610|FG000|Overall Study|Withdrawal by Subject|2|||
146104657|NCT01064310|526902549|FG001|Period 1|Entered Open-label Period|1|||
146104658|NCT01064310|526902550|FG002|Period 1|Entered Open-label Period|0|||
146104659|NCT01064310|526902548|FG000|Period 2|Adverse Event|2|||
146104660|NCT01064310|526902549|FG001|Period 2|Adverse Event|1|||
146104661|NCT01064310|526902550|FG002|Period 2|Adverse Event|0|||
146104662|NCT01064310|526902548|FG000|Period 2|Physician Decision|0|||
146104663|NCT01064310|526902549|FG001|Period 2|Physician Decision|1|||
146104664|NCT01064310|526902550|FG002|Period 2|Physician Decision|0|||
146104665|NCT01064310|526902548|FG000|Period 2|Entered Open-label Period|1|||
146104666|NCT01064310|526902549|FG001|Period 2|Entered Open-label Period|0|||
146104667|NCT01064310|526902550|FG002|Period 2|Entered Open-label Period|0|||
146104668|NCT01064310|526902548|FG000|Period 2|Lack of Efficacy|1|||
146104669|NCT01064310|526902549|FG001|Period 2|Lack of Efficacy|4|||
146104670|NCT01064310|526902550|FG002|Period 2|Lack of Efficacy|0|||
146104671|NCT01064310|526902548|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
146104672|NCT01064310|526902549|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
146104673|NCT01064310|526902550|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
146104674|NCT01064310|526902548|FG000|Open Label Pazopinib|Adverse Event|0|||
146104675|NCT01064310|526902549|FG001|Open Label Pazopinib|Adverse Event|0|||
146104676|NCT01064310|526902550|FG002|Open Label Pazopinib|Adverse Event|12|||
146104677|NCT01064310|526902548|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
146104678|NCT01064310|526902549|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
146104679|NCT01064310|526902550|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
146104680|NCT01064310|526902548|FG000|Open Label Pazopinib|Physician Decision|0|||
146104681|NCT01064310|526902549|FG001|Open Label Pazopinib|Physician Decision|0|||
146104682|NCT01064310|526902550|FG002|Open Label Pazopinib|Physician Decision|20|||
146104683|NCT02639065|526902551|FG000|Study Treatment|Disease Progression|13|||
146104684|NCT02639065|526902551|FG000|Study Treatment|Adverse Event|9|||
146104685|NCT02639065|526902551|FG000|Study Treatment|Withdrawal by Subject|1|||
146104686|NCT02639065|526902551|FG000|Follow up|Subject refused to follow up|1|||
146104687|NCT02639065|526902551|FG000|Follow up|Symptomatic Deterioration|2|||
146104688|NCT02639065|526902551|FG000|Follow up|Death|2|||
146104689|NCT02639065|526902551|FG000|Follow up|Study Terminated|1|||
146104690|NCT02639065|526902551|FG000|Follow up|Disease Progression|3|||
146104691|NCT03128411|526902553|FG000|Treatment Phase|Adverse Event|21|||
146104692|NCT03128411|526902553|FG000|Treatment Phase|Physician Decision|1|||
146104693|NCT03128411|526902553|FG000|Treatment Phase|Other|2|||
146104694|NCT03128411|526902553|FG000|Long Term Follow-up Phase|Death|2|||
146104695|NCT01218113|526903918|FG000|Overall Study|Withdrawal by Subject|1|||
146104696|NCT01218113|526903919|FG001|Overall Study|Withdrawal by Subject|0|||
146104697|NCT01218113|526903920|FG002|Overall Study|Withdrawal by Subject|1|||
146104698|NCT01218113|526903918|FG000|Overall Study|Lost to Follow-up|4|||
146104699|NCT01218113|526903919|FG001|Overall Study|Lost to Follow-up|1|||
146104700|NCT01218113|526903920|FG002|Overall Study|Lost to Follow-up|4|||
146104701|NCT01218113|526903918|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
146104702|NCT01218113|526903919|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
146104703|NCT01218113|526903920|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
146104704|NCT00967668|526903921|FG000|Overall Study|Withdrawal by Subject|13|||
146104705|NCT00967668|526903922|FG001|Overall Study|Withdrawal by Subject|8|||
146104706|NCT00967668|526903923|FG002|Overall Study|Withdrawal by Subject|8|||
146104707|NCT00967668|526903921|FG000|Overall Study|Death|0|||
146104708|NCT00967668|526903922|FG001|Overall Study|Death|2|||
146104709|NCT00967668|526903923|FG002|Overall Study|Death|4|||
146104710|NCT00967668|526903921|FG000|Overall Study|Removed due to behavior|1|||
146104711|NCT00967668|526903922|FG001|Overall Study|Removed due to behavior|1|||
146256390|NCT03873038|527452611|FG000|Part 2|Withdrawal by Subject|0|||
146256391|NCT03873038|527452612|FG001|Part 2|Withdrawal by Subject|0|||
146256392|NCT03873038|527452613|FG002|Part 2|Withdrawal by Subject|0|||
146104712|NCT00967668|526903923|FG002|Overall Study|Removed due to behavior|2|||
146256393|NCT03873038|527452614|FG003|Part 2|Withdrawal by Subject|0|||
146104713|NCT00967668|526903921|FG000|Overall Study|Refused Year 2|11|||
146104714|NCT00967668|526903922|FG001|Overall Study|Refused Year 2|6|||
146104715|NCT00967668|526903923|FG002|Overall Study|Refused Year 2|4|||
146104716|NCT00967668|526903921|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
146104717|NCT00967668|526903922|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
146104718|NCT00967668|526903923|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
146104719|NCT00967668|526903921|FG000|Overall Study|Lost to Follow-up|15|||
146104720|NCT00967668|526903922|FG001|Overall Study|Lost to Follow-up|9|||
146104721|NCT00967668|526903923|FG002|Overall Study|Lost to Follow-up|16|||
146104722|NCT00967668|526903921|FG000|Overall Study|Refused 12-mo assessment|3|||
146104723|NCT00967668|526903922|FG001|Overall Study|Refused 12-mo assessment|1|||
146104724|NCT00967668|526903923|FG002|Overall Study|Refused 12-mo assessment|9|||
146104725|NCT00967668|526903921|FG000|Overall Study|Pregnancy|1|||
146256394|NCT03873038|527452615|FG004|Part 2|Withdrawal by Subject|0|||
146256395|NCT03873038|527452616|FG005|Part 2|Withdrawal by Subject|1|||
146256396|NCT03873038|527452611|FG000|Part 2|Unknon|0|||
146256397|NCT03873038|527452612|FG001|Part 2|Unknon|0|||
146256398|NCT03873038|527452613|FG002|Part 2|Unknon|0|||
146256399|NCT03873038|527452614|FG003|Part 2|Unknon|0|||
146256400|NCT03873038|527452615|FG004|Part 2|Unknon|1|||
146256401|NCT03873038|527452616|FG005|Part 2|Unknon|0|||
146256402|NCT04222088|527452617|FG000|Overall Study|Lost to Follow-up|5|||
146256403|NCT04222088|527452618|FG001|Overall Study|Lost to Follow-up|1|||
146256404|NCT04222088|527452617|FG000|Overall Study|Withdrawal by Subject|4|||
146256405|NCT04222088|527452618|FG001|Overall Study|Withdrawal by Subject|0|||
146256406|NCT00595764|527452619|FG000|Overall Study|Protocol Violation|24|||
146256407|NCT00595764|527452620|FG001|Overall Study|Protocol Violation|19|||
146256408|NCT00595764|527452619|FG000|Overall Study|Missed Medication >1 week|10|||
146256409|NCT00595764|527452620|FG001|Overall Study|Missed Medication >1 week|17|||
146256410|NCT00595764|527452619|FG000|Overall Study|Missed 3 PM visits|1|||
146256411|NCT00595764|527452620|FG001|Overall Study|Missed 3 PM visits|7|||
146256412|NCT00595764|527452619|FG000|Overall Study|Withdrawal by Subject|4|||
146256413|NCT00595764|527452620|FG001|Overall Study|Withdrawal by Subject|0|||
146256414|NCT00464737|527452621|FG000|Overall Study|Adverse Event|12|||
146256415|NCT00464737|527452622|FG001|Overall Study|Adverse Event|17|||
146256416|NCT00464737|527452623|FG002|Overall Study|Adverse Event|33|||
146256417|NCT00464737|527452621|FG000|Overall Study|Lack of Efficacy|7|||
146256418|NCT00464737|527452622|FG001|Overall Study|Lack of Efficacy|7|||
146256419|NCT00464737|527452623|FG002|Overall Study|Lack of Efficacy|4|||
146256420|NCT00464737|527452621|FG000|Overall Study|Withdrawal by Subject|5|||
146256421|NCT00464737|527452622|FG001|Overall Study|Withdrawal by Subject|3|||
146256422|NCT00464737|527452623|FG002|Overall Study|Withdrawal by Subject|5|||
146256423|NCT00464737|527452621|FG000|Overall Study|Protocol Violation|1|||
146256424|NCT00464737|527452622|FG001|Overall Study|Protocol Violation|1|||
146256425|NCT00464737|527452623|FG002|Overall Study|Protocol Violation|5|||
146256426|NCT00464737|527452621|FG000|Overall Study|Non-compliance|0|||
146256427|NCT00464737|527452622|FG001|Overall Study|Non-compliance|1|||
146256428|NCT00464737|527452623|FG002|Overall Study|Non-compliance|1|||
146104726|NCT00967668|526903922|FG001|Overall Study|Pregnancy|0|||
146104727|NCT00967668|526903923|FG002|Overall Study|Pregnancy|0|||
146104728|NCT00259649|526903925|FG000|Overall Study|Lost to Follow-up|7|||
146104729|NCT00259649|526903925|FG000|Overall Study|irregular menses|3|||
146104730|NCT01433991|526903930|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
146104731|NCT01433991|526903931|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146104732|NCT01433991|526903932|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146104733|NCT01433991|526903933|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
146104734|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
146104735|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
146104736|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
146104737|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
146104738|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146104739|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146104740|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
146104741|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
146104742|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
146104743|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
146104744|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
146104745|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
146104746|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
146104747|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
146104748|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
146104749|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
146104750|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
146104751|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
146104752|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
146104753|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
146104754|NCT01433991|526903930|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146256429|NCT00464737|527452621|FG000|Overall Study|Lost to Follow-up|5|||
146256430|NCT00464737|527452622|FG001|Overall Study|Lost to Follow-up|2|||
146256431|NCT00464737|527452623|FG002|Overall Study|Lost to Follow-up|5|||
146256432|NCT00464737|527452621|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
146256433|NCT00464737|527452622|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
146256434|NCT00464737|527452623|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
146104755|NCT01433991|526903931|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146104756|NCT01433991|526903932|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
146104757|NCT01433991|526903933|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
146256435|NCT00464737|527452621|FG000|Overall Study|Other: Subject left town; family illness|1|||
146104758|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
146104759|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
146104760|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
146104761|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
146104762|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
146104763|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
146104764|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
146104765|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
146104766|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
146104767|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
146104768|NCT00787891|526903936|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
146104769|NCT00787891|526903937|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
146104770|NCT00787891|526903936|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
146104771|NCT00787891|526903937|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
146104772|NCT00787891|526903936|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
146104773|NCT00787891|526903937|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
146104774|NCT00787891|526903936|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
146104775|NCT00787891|526903937|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
146104776|NCT00787891|526903936|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
146104777|NCT00787891|526903937|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
146104778|NCT01673867|526903940|FG000|Randomization|Adverse event unrelated to study drug|1|||
146104779|NCT01673867|526903941|FG001|Randomization|Adverse event unrelated to study drug|0|||
146104780|NCT01673867|526903940|FG000|Randomization|Participant request to discontinue study treatment|0|||
146104781|NCT01673867|526903941|FG001|Randomization|Participant request to discontinue study treatment|4|||
146104782|NCT01673867|526903940|FG000|Randomization|Withdrawal by participant|0|||
146104783|NCT01673867|526903941|FG001|Randomization|Withdrawal by participant|12|||
146104784|NCT01673867|526903940|FG000|Randomization|Lost to Follow-up|0|||
146104785|NCT01673867|526903941|FG001|Randomization|Lost to Follow-up|1|||
146104786|NCT01673867|526903940|FG000|Randomization|Participant no longer meets study criteria|4|||
146104787|NCT01673867|526903941|FG001|Randomization|Participant no longer meets study criteria|5|||
146104788|NCT01673867|526903940|FG000|Treatment|Disease Progression|208|||
146104789|NCT01673867|526903941|FG001|Treatment|Disease Progression|178|||
146104790|NCT01673867|526903940|FG000|Treatment|Study Drug Toxicity|23|||
146104791|NCT01673867|526903941|FG001|Treatment|Study Drug Toxicity|43|||
146104792|NCT01673867|526903940|FG000|Treatment|Death|2|||
146104793|NCT01673867|526903941|FG001|Treatment|Death|3|||
146104794|NCT01673867|526903940|FG000|Treatment|Adverse event unrelated to study drug|23|||
146104795|NCT01673867|526903941|FG001|Treatment|Adverse event unrelated to study drug|10|||
146104796|NCT01673867|526903940|FG000|Treatment|Participant request to discontinue study treatment|7|||
146104797|NCT01673867|526903941|FG001|Treatment|Participant request to discontinue study treatment|17|||
146104798|NCT01673867|526903940|FG000|Treatment|Withdrawal by participant|5|||
146104799|NCT01673867|526903941|FG001|Treatment|Withdrawal by participant|5|||
146104800|NCT01673867|526903940|FG000|Treatment|Maximum clinical benefit|1|||
146104801|NCT01673867|526903941|FG001|Treatment|Maximum clinical benefit|10|||
146104802|NCT01673867|526903940|FG000|Treatment|Participant no longer meets study criteria|2|||
146104803|NCT01673867|526903941|FG001|Treatment|Participant no longer meets study criteria|0|||
146104804|NCT01673867|526903940|FG000|Treatment|Administrative reason by sponsor|3|||
146104805|NCT01673867|526903941|FG001|Treatment|Administrative reason by sponsor|0|||
146104806|NCT01673867|526903940|FG000|Treatment|Other reason|11|||
146104807|NCT01673867|526903941|FG001|Treatment|Other reason|2|||
146104808|NCT03486223|526903945|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
146104809|NCT03486223|526903946|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
146104810|NCT01513343|526903949|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
146104811|NCT01513343|526903950|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
146104812|NCT01513343|526903949|FG000|Post Data Collection|Dropped/withdrew from study|7|||
146104813|NCT01513343|526903950|FG001|Post Data Collection|Dropped/withdrew from study|1|||
146104814|NCT01513343|526903949|FG000|Post Data Collection|Lost to Follow-up|10|||
146104815|NCT01513343|526903950|FG001|Post Data Collection|Lost to Follow-up|23|||
146104816|NCT01513343|526903949|FG000|6-month Follow-up|Lost to Follow-up|28|||
146104817|NCT01513343|526903950|FG001|6-month Follow-up|Lost to Follow-up|17|||
146104818|NCT01513343|526903949|FG000|12-month Follow-up|Lost to Follow-up|10|||
146104819|NCT01513343|526903950|FG001|12-month Follow-up|Lost to Follow-up|3|||
146104820|NCT00724932|526903968|FG000|Overall Study|Lost to Follow-up|1|||
146104821|NCT00724932|526903969|FG001|Overall Study|Lost to Follow-up|0|||
146104822|NCT00724932|526903968|FG000|Overall Study|Not treated|4|||
146104823|NCT00724932|526903969|FG001|Overall Study|Not treated|3|||
146104824|NCT03758066|526903971|FG000|Overall Study|Lost to Follow-up|14|||
146104825|NCT02590003|526903972|FG000|Overall Study|Death|1|||
146104826|NCT02590003|526903973|FG001|Overall Study|Death|2|||
146104827|NCT03733470|526903974|FG000|Overall Study|PI Decision|1|||
146104828|NCT03733470|526903975|FG001|Overall Study|PI Decision|1|||
146104829|NCT01849783|526903978|FG000|Overall Study|Adverse Event|5|||
146104830|NCT01849783|526903978|FG000|Overall Study|Death|2|||
146104831|NCT01849783|526903978|FG000|Overall Study|Physician Decision|1|||
146104832|NCT01849783|526903978|FG000|Overall Study|Withdrawal by Subject|1|||
146104833|NCT01849783|526903978|FG000|Overall Study|Unable to comply|2|||
146104834|NCT01849783|526903978|FG000|Overall Study|Disease progression|11|||
146104835|NCT04203498|526903983|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
146104836|NCT04203498|526903984|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
146104837|NCT04203498|526903983|FG000|Overall Study|Withdrawal of patient consent|7|||
146104838|NCT04203498|526903984|FG001|Overall Study|Withdrawal of patient consent|2|||
146104839|NCT04203498|526903983|FG000|Overall Study|Adverse Event|4|||
146104840|NCT04203498|526903984|FG001|Overall Study|Adverse Event|1|||
146104841|NCT04203498|526903983|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
146104842|NCT04203498|526903984|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
146104843|NCT04203498|526903983|FG000|Overall Study|Did not receive IMP|2|||
146104844|NCT04203498|526903984|FG001|Overall Study|Did not receive IMP|0|||
146104845|NCT03988088|526903990|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146104846|NCT03988088|526903991|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
146104847|NCT03988088|526903992|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146104848|NCT03988088|526903993|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
146104849|NCT03988088|526903990|FG000|Open-Label Addendum|Lost to Follow-up|0|||
146104850|NCT03988088|526903991|FG001|Open-Label Addendum|Lost to Follow-up|0|||
146104851|NCT03988088|526903992|FG002|Open-Label Addendum|Lost to Follow-up|1|||
146104852|NCT03988088|526903993|FG003|Open-Label Addendum|Lost to Follow-up|0|||
146104853|NCT03546062|526903994|FG000|Overall Study|Adverse Event|6|||
146104854|NCT03546062|526903995|FG001|Overall Study|Adverse Event|5|||
146104855|NCT03546062|526903996|FG002|Overall Study|Adverse Event|8|||
146104856|NCT00781274|526903997|FG000|Overall Study|Withdrawal by Subject|2|||
146104857|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146104858|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146104859|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146104860|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
146104861|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146104862|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146104863|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
146104864|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
146104865|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104866|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
146104867|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104868|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104869|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104870|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104871|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
146104872|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
146104873|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104874|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104875|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
146104876|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104877|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104878|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104879|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104880|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104881|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Other|0|||
146104882|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Other|0|||
146104883|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Other|1|||
146104884|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Other|1|||
146104885|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Other|2|||
146104886|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Other|0|||
146104887|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Other|0|||
146104888|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Other|0|||
146104889|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104890|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104891|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104892|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104893|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
146104894|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104895|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
146256436|NCT00464737|527452622|FG001|Overall Study|Other: Subject left town; family illness|0|||
146104896|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
146104897|NCT01090492|526903998|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
146104898|NCT01090492|526903999|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
146104899|NCT01090492|526904000|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
146104900|NCT01090492|526904001|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
146104901|NCT01090492|526904002|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
146104902|NCT01090492|526904003|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
146104903|NCT01090492|526904004|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
146104904|NCT01090492|526904005|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
146104905|NCT01090492|526903998|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146104906|NCT01090492|526903999|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146104907|NCT01090492|526904000|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146104908|NCT01090492|526904001|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146104909|NCT01090492|526904002|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146104910|NCT01090492|526904003|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
146104911|NCT01090492|526904004|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146104912|NCT01090492|526904005|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
146104913|NCT01090492|526903998|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104914|NCT01090492|526903999|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
146104915|NCT01090492|526904000|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104916|NCT01090492|526904001|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104917|NCT01090492|526904002|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104918|NCT01090492|526904003|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104919|NCT01090492|526904004|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104920|NCT01090492|526904005|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
146104921|NCT01090492|526903998|FG000|Second Intervention Period (4 Weeks)|Other|0|||
146104922|NCT01090492|526903999|FG001|Second Intervention Period (4 Weeks)|Other|1|||
146104923|NCT01090492|526904000|FG002|Second Intervention Period (4 Weeks)|Other|1|||
146104924|NCT01090492|526904001|FG003|Second Intervention Period (4 Weeks)|Other|0|||
146104925|NCT01090492|526904002|FG004|Second Intervention Period (4 Weeks)|Other|0|||
146104926|NCT01090492|526904003|FG005|Second Intervention Period (4 Weeks)|Other|0|||
146104927|NCT01090492|526904004|FG006|Second Intervention Period (4 Weeks)|Other|0|||
146104928|NCT01090492|526904005|FG007|Second Intervention Period (4 Weeks)|Other|0|||
146104929|NCT01090492|526903998|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146104930|NCT01090492|526903999|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146104931|NCT01090492|526904000|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146104932|NCT01090492|526904001|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
146104933|NCT01090492|526904002|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146104934|NCT01090492|526904003|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146104935|NCT01090492|526904004|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
146104936|NCT01090492|526904005|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
146104937|NCT01090492|526903998|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104938|NCT01090492|526903999|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104939|NCT01090492|526904000|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104940|NCT01090492|526904001|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104941|NCT01090492|526904002|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104942|NCT01090492|526904003|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104943|NCT01090492|526904004|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
146104944|NCT01090492|526904005|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
146104945|NCT00868608|526904006|FG000|Overall Study|Withdrawal by Subject|3|||
146104946|NCT00868608|526904007|FG001|Overall Study|Withdrawal by Subject|1|||
146104947|NCT00868608|526904008|FG002|Overall Study|Withdrawal by Subject|0|||
146104948|NCT00868608|526904006|FG000|Overall Study|Lost to Follow-up|3|||
146104949|NCT00868608|526904007|FG001|Overall Study|Lost to Follow-up|0|||
146104950|NCT00868608|526904008|FG002|Overall Study|Lost to Follow-up|1|||
146104951|NCT00868608|526904006|FG000|Overall Study|Death|16|||
146104952|NCT00868608|526904007|FG001|Overall Study|Death|2|||
146104953|NCT00868608|526904008|FG002|Overall Study|Death|4|||
146104954|NCT00868608|526904006|FG000|Overall Study|Other - Unspecified|1|||
146104955|NCT00868608|526904007|FG001|Overall Study|Other - Unspecified|0|||
146104956|NCT00868608|526904008|FG002|Overall Study|Other - Unspecified|0|||
146104957|NCT02935842|526904009|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
146104958|NCT02935842|526904010|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146104959|NCT02935842|526904011|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146104960|NCT02935842|526904012|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
146104961|NCT02935842|526904009|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
146104962|NCT02935842|526904010|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
146104963|NCT02935842|526904011|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
146256437|NCT00464737|527452623|FG002|Overall Study|Other: Subject left town; family illness|0|||
146104964|NCT02935842|526904012|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
146104965|NCT02935842|526904009|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
146104966|NCT02935842|526904010|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
146104967|NCT02935842|526904011|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
146104968|NCT02935842|526904012|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
146104969|NCT02935842|526904009|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
146104970|NCT02935842|526904010|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
146104971|NCT02935842|526904011|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
146104972|NCT02935842|526904012|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
146104973|NCT02935842|526904009|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146104974|NCT02935842|526904010|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146104975|NCT02935842|526904011|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
146104976|NCT02935842|526904012|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
146104977|NCT00911547|526904013|FG000|Overall Study|Adverse Event|8|||
146104978|NCT00911547|526904014|FG001|Overall Study|Adverse Event|27|||
146104979|NCT00911547|526904015|FG002|Overall Study|Adverse Event|11|||
146104980|NCT00911547|526904016|FG003|Overall Study|Adverse Event|6|||
146104981|NCT00911547|526904013|FG000|Overall Study|Lost to Follow-up|0|||
146104982|NCT00911547|526904014|FG001|Overall Study|Lost to Follow-up|0|||
146104983|NCT00911547|526904015|FG002|Overall Study|Lost to Follow-up|2|||
146104984|NCT00911547|526904016|FG003|Overall Study|Lost to Follow-up|1|||
146104985|NCT00911547|526904013|FG000|Overall Study|Protocol Violation|0|||
146104986|NCT00911547|526904014|FG001|Overall Study|Protocol Violation|5|||
146104987|NCT00911547|526904015|FG002|Overall Study|Protocol Violation|5|||
146104988|NCT00911547|526904016|FG003|Overall Study|Protocol Violation|1|||
146104989|NCT00911547|526904013|FG000|Overall Study|Withdrawal by Subject|3|||
146104990|NCT00911547|526904014|FG001|Overall Study|Withdrawal by Subject|10|||
146104991|NCT00911547|526904015|FG002|Overall Study|Withdrawal by Subject|4|||
146104992|NCT00911547|526904016|FG003|Overall Study|Withdrawal by Subject|8|||
146104993|NCT03344796|526904017|FG000|Overall Study|Lost to Follow-up|0|||
146104994|NCT03344796|526904018|FG001|Overall Study|Lost to Follow-up|0|||
146104995|NCT03344796|526904019|FG002|Overall Study|Lost to Follow-up|0|||
146104996|NCT03344796|526904020|FG003|Overall Study|Lost to Follow-up|0|||
146104997|NCT03344796|526904021|FG004|Overall Study|Lost to Follow-up|0|||
146104998|NCT03344796|526904022|FG005|Overall Study|Lost to Follow-up|2|||
146104999|NCT00001880|526904031|FG000|Overall Study|Death|14|||
146105000|NCT00481078|526904032|FG000|Overall Study|Progression of disease|11|||
146105001|NCT00481078|526904033|FG001|Overall Study|Progression of disease|11|||
146105002|NCT00481078|526904032|FG000|Overall Study|Adverse Event|15|||
146105003|NCT00481078|526904033|FG001|Overall Study|Adverse Event|3|||
146105004|NCT00481078|526904032|FG000|Overall Study|Death|5|||
146105005|NCT00481078|526904033|FG001|Overall Study|Death|3|||
146105006|NCT00481078|526904032|FG000|Overall Study|Intercurrent illness|1|||
146105007|NCT00481078|526904033|FG001|Overall Study|Intercurrent illness|0|||
146105008|NCT00481078|526904032|FG000|Overall Study|Withdrawal by Subject|7|||
146105009|NCT00481078|526904033|FG001|Overall Study|Withdrawal by Subject|1|||
146105010|NCT00481078|526904032|FG000|Overall Study|Information not available|1|||
146105011|NCT00481078|526904033|FG001|Overall Study|Information not available|0|||
146105012|NCT00481078|526904032|FG000|Overall Study|Received other treatment|2|||
146105013|NCT00481078|526904033|FG001|Overall Study|Received other treatment|1|||
146105014|NCT00481078|526904032|FG000|Overall Study|Brain metastasis|0|||
146105015|NCT00481078|526904033|FG001|Overall Study|Brain metastasis|1|||
146105016|NCT05695209|526904038|FG000|3-months|Withdrawal by Subject|2|||
146105017|NCT05695209|526904039|FG001|3-months|Withdrawal by Subject|0|||
146105018|NCT05695209|526904038|FG000|3-months|Unable to contact for 3-month data collection|0|||
146105019|NCT05695209|526904039|FG001|3-months|Unable to contact for 3-month data collection|1|||
146105020|NCT05695209|526904038|FG000|6-months|Lost to Follow-up|1|||
146105021|NCT05695209|526904039|FG001|6-months|Lost to Follow-up|1|||
146105022|NCT05372419|526904040|FG000|Overall Study|Protocol Deviation|1|||
146105023|NCT05372419|526904040|FG000|Overall Study|Withdrawal by Subject|5|||
146105024|NCT05372419|526904040|FG000|Overall Study|Lost to Follow-up|7|||
146105025|NCT04362072|526904043|FG000|Treatment|Adverse Event|1|||
146105026|NCT04362072|526904043|FG000|Treatment|Death|9|||
146105027|NCT04362072|526904043|FG000|Treatment|Physician Decision|2|||
146105028|NCT04362072|526904043|FG000|Treatment|Progressive disease|27|||
146105029|NCT04362072|526904043|FG000|Treatment|Withdrawal by Subject|4|||
146105030|NCT04362072|526904043|FG000|Treatment|Global deterioration of health status|1|||
146105031|NCT04362072|526904043|FG000|Treatment|Switched to commercial Lorlatinib|13|||
146105032|NCT04362072|526904043|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
146105033|NCT04362072|526904043|FG000|Treatment|Other|3|||
146105034|NCT04362072|526904043|FG000|Follow up|Death|2|||
146105035|NCT04362072|526904043|FG000|Follow up|Other|2|||
146105036|NCT04731363|526904044|FG000|Overall Study|Could not obtain samples|0|||
146105037|NCT04731363|526904045|FG001|Overall Study|Could not obtain samples|1|||
146105038|NCT04731363|526904046|FG002|Overall Study|Could not obtain samples|0|||
146105039|NCT04731363|526904047|FG003|Overall Study|Could not obtain samples|0|||
146105040|NCT04731363|526904044|FG000|Overall Study|Physician Decision|0|||
146105041|NCT04731363|526904045|FG001|Overall Study|Physician Decision|1|||
146105042|NCT04731363|526904046|FG002|Overall Study|Physician Decision|0|||
146105043|NCT04731363|526904047|FG003|Overall Study|Physician Decision|0|||
146105044|NCT04560998|526904048|FG000|Overall Study|Withdrawal by Subject|18|||
146105045|NCT04560998|526904049|FG001|Overall Study|Withdrawal by Subject|12|||
146105046|NCT04560998|526904048|FG000|Overall Study|Lost to Follow-up|8|||
146105047|NCT04560998|526904049|FG001|Overall Study|Lost to Follow-up|5|||
146105048|NCT04560998|526904048|FG000|Overall Study|Physician Decision|4|||
146105049|NCT04560998|526904049|FG001|Overall Study|Physician Decision|0|||
146105050|NCT03749447|526905577|FG000|Overall Study|Adverse Event|11|||
146105051|NCT03749447|526905578|FG001|Overall Study|Adverse Event|3|||
146105052|NCT03749447|526905577|FG000|Overall Study|Death|1|||
146105053|NCT03749447|526905578|FG001|Overall Study|Death|1|||
146105054|NCT03749447|526905577|FG000|Overall Study|Lost to Follow-up|2|||
146105055|NCT03749447|526905578|FG001|Overall Study|Lost to Follow-up|2|||
146105056|NCT03749447|526905577|FG000|Overall Study|Reason Not Specified|0|||
146105057|NCT03749447|526905578|FG001|Overall Study|Reason Not Specified|3|||
146105058|NCT03749447|526905577|FG000|Overall Study|Physician Decision|4|||
146105059|NCT03749447|526905578|FG001|Overall Study|Physician Decision|3|||
146105060|NCT03749447|526905577|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
146105061|NCT03749447|526905578|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
146105062|NCT03749447|526905577|FG000|Overall Study|Study Terminated By Sponsor|112|||
146105063|NCT03749447|526905578|FG001|Overall Study|Study Terminated By Sponsor|105|||
146105064|NCT03749447|526905577|FG000|Overall Study|Withdrawal by Subject|12|||
146105065|NCT03749447|526905578|FG001|Overall Study|Withdrawal by Subject|6|||
146105066|NCT03749447|526905577|FG000|Overall Study|Non-compliance With Study Drug|0|||
146105067|NCT03749447|526905578|FG001|Overall Study|Non-compliance With Study Drug|1|||
146105068|NCT00115739|526905579|FG000|Overall Study|Lost to Follow-up|3|||
146105069|NCT00745823|526905580|FG000|Overall Study|Adverse Event|5|||
146105070|NCT00745823|526905581|FG001|Overall Study|Adverse Event|3|||
146105071|NCT00745823|526905580|FG000|Overall Study|Lack of Efficacy|20|||
146105072|NCT00745823|526905581|FG001|Overall Study|Lack of Efficacy|6|||
146105073|NCT00745823|526905580|FG000|Overall Study|Lost to Follow-up|10|||
146105074|NCT00745823|526905581|FG001|Overall Study|Lost to Follow-up|11|||
146105075|NCT00745823|526905580|FG000|Overall Study|Physician Decision|10|||
146105076|NCT00745823|526905581|FG001|Overall Study|Physician Decision|5|||
146105077|NCT00745823|526905580|FG000|Overall Study|Pregnancy|0|||
146105078|NCT00745823|526905581|FG001|Overall Study|Pregnancy|4|||
146105079|NCT00745823|526905580|FG000|Overall Study|Withdrawal by Subject|14|||
146105080|NCT00745823|526905581|FG001|Overall Study|Withdrawal by Subject|8|||
146105081|NCT00745823|526905580|FG000|Overall Study|Study Terminated by Sponsor|326|||
146105082|NCT00745823|526905581|FG001|Overall Study|Study Terminated by Sponsor|349|||
146105083|NCT01819831|526905593|FG000|Overall Study|Withdrawal by Subject|1|||
146105084|NCT02034110|526905594|FG000|Overall Study|Physician Decision|0|||
146105085|NCT02034110|526905595|FG001|Overall Study|Physician Decision|0|||
146105086|NCT02034110|526905596|FG002|Overall Study|Physician Decision|0|||
146105087|NCT02034110|526905597|FG003|Overall Study|Physician Decision|0|||
146105088|NCT02034110|526905598|FG004|Overall Study|Physician Decision|2|||
146105089|NCT02034110|526905599|FG005|Overall Study|Physician Decision|0|||
146105090|NCT02034110|526905600|FG006|Overall Study|Physician Decision|1|||
146105091|NCT02034110|526905601|FG007|Overall Study|Physician Decision|0|||
146105092|NCT02034110|526905594|FG000|Overall Study|Lost to Follow-up|1|||
146105093|NCT02034110|526905595|FG001|Overall Study|Lost to Follow-up|0|||
146105094|NCT02034110|526905596|FG002|Overall Study|Lost to Follow-up|0|||
146105095|NCT02034110|526905597|FG003|Overall Study|Lost to Follow-up|0|||
146105096|NCT02034110|526905598|FG004|Overall Study|Lost to Follow-up|1|||
146105097|NCT02034110|526905599|FG005|Overall Study|Lost to Follow-up|0|||
146105098|NCT02034110|526905600|FG006|Overall Study|Lost to Follow-up|1|||
146105099|NCT02034110|526905601|FG007|Overall Study|Lost to Follow-up|0|||
146256438|NCT00464737|527452621|FG000|Overall Study|Other: Study demands too great|0|||
146256439|NCT00464737|527452622|FG001|Overall Study|Other: Study demands too great|1|||
146105100|NCT02034110|526905594|FG000|Overall Study|Withdrawal by Subject|5|||
146105101|NCT02034110|526905595|FG001|Overall Study|Withdrawal by Subject|7|||
146105102|NCT02034110|526905596|FG002|Overall Study|Withdrawal by Subject|0|||
146105103|NCT02034110|526905597|FG003|Overall Study|Withdrawal by Subject|3|||
146105104|NCT02034110|526905598|FG004|Overall Study|Withdrawal by Subject|7|||
146105105|NCT02034110|526905599|FG005|Overall Study|Withdrawal by Subject|0|||
146105106|NCT02034110|526905600|FG006|Overall Study|Withdrawal by Subject|3|||
146105107|NCT02034110|526905601|FG007|Overall Study|Withdrawal by Subject|1|||
146105108|NCT02034110|526905594|FG000|Overall Study|Study closed by sponsor|6|||
146105109|NCT02034110|526905595|FG001|Overall Study|Study closed by sponsor|2|||
146105110|NCT02034110|526905596|FG002|Overall Study|Study closed by sponsor|0|||
146105111|NCT02034110|526905597|FG003|Overall Study|Study closed by sponsor|6|||
146105112|NCT02034110|526905598|FG004|Overall Study|Study closed by sponsor|7|||
146105113|NCT02034110|526905599|FG005|Overall Study|Study closed by sponsor|0|||
146256440|NCT00464737|527452623|FG002|Overall Study|Other: Study demands too great|0|||
146256441|NCT00464737|527452621|FG000|Overall Study|Other: Personal family reasons|0|||
146105114|NCT02034110|526905600|FG006|Overall Study|Study closed by sponsor|42|||
146256442|NCT00464737|527452622|FG001|Overall Study|Other: Personal family reasons|0|||
146049939|NCT03622814|526697336|FG001|Overall Study|Lost to Follow-up|14|||
146049940|NCT03269994|526697337|FG000|Overall Study|Withdrawal by Subject|4|||
146049941|NCT03269994|526697338|FG001|Overall Study|Withdrawal by Subject|5|||
146049942|NCT03269994|526697337|FG000|Overall Study|Unresectable at surgery|39|||
146049943|NCT03269994|526697338|FG001|Overall Study|Unresectable at surgery|58|||
146049944|NCT03269994|526697337|FG000|Overall Study|Patient canceled surgery|5|||
146049945|NCT03269994|526697338|FG001|Overall Study|Patient canceled surgery|14|||
146049946|NCT03269994|526697337|FG000|Overall Study|Preoperative progression|14|||
146049947|NCT03269994|526697338|FG001|Overall Study|Preoperative progression|9|||
146049948|NCT03269994|526697337|FG000|Overall Study|Preoperative infection|10|||
146049949|NCT03269994|526697338|FG001|Overall Study|Preoperative infection|4|||
146049950|NCT03269994|526697337|FG000|Overall Study|Kidney insufficiency|1|||
146049951|NCT03269994|526697338|FG001|Overall Study|Kidney insufficiency|0|||
146049952|NCT03269994|526697337|FG000|Overall Study|Drug allergy|0|||
146049953|NCT03269994|526697338|FG001|Overall Study|Drug allergy|2|||
146049954|NCT03269994|526697337|FG000|Overall Study|Operation changed to different resection|9|||
146049955|NCT03269994|526697338|FG001|Overall Study|Operation changed to different resection|0|||
146049956|NCT03269994|526697337|FG000|Overall Study|Preoperative steroid|0|||
146049957|NCT03269994|526697338|FG001|Overall Study|Preoperative steroid|3|||
146049958|NCT03269994|526697337|FG000|Overall Study|Accrual Closed|2|||
146049959|NCT03269994|526697338|FG001|Overall Study|Accrual Closed|0|||
146049960|NCT03269994|526697337|FG000|Overall Study|Operation changed to different resection|0|||
146049961|NCT03269994|526697338|FG001|Overall Study|Operation changed to different resection|10|||
146049962|NCT04417361|526697339|FG000|Overall Study|Withdrawal by Subject|1|||
146049963|NCT04417361|526697340|FG001|Overall Study|Withdrawal by Subject|0|||
146049964|NCT04417361|526697339|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
146049965|NCT04417361|526697340|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
146049966|NCT04707469|526697341|FG000|Overall Study|Site closure|0|||
146049967|NCT04707469|526697342|FG001|Overall Study|Site closure|2|||
146049968|NCT04707469|526697343|FG002|Overall Study|Site closure|0|||
146049969|NCT04707469|526697341|FG000|Overall Study|Physician Decision|2|||
146049970|NCT04707469|526697342|FG001|Overall Study|Physician Decision|2|||
146049971|NCT04707469|526697343|FG002|Overall Study|Physician Decision|2|||
146049972|NCT04707469|526697341|FG000|Overall Study|Death|1|||
146049973|NCT04707469|526697342|FG001|Overall Study|Death|6|||
146049974|NCT04707469|526697343|FG002|Overall Study|Death|2|||
146049975|NCT04707469|526697341|FG000|Overall Study|Lost to Follow-up|9|||
146049976|NCT04707469|526697342|FG001|Overall Study|Lost to Follow-up|19|||
146049977|NCT04707469|526697343|FG002|Overall Study|Lost to Follow-up|14|||
146049978|NCT04707469|526697341|FG000|Overall Study|Withdrawal by Subject|17|||
146049979|NCT04707469|526697342|FG001|Overall Study|Withdrawal by Subject|16|||
146049980|NCT04707469|526697343|FG002|Overall Study|Withdrawal by Subject|12|||
146049981|NCT04661150|526697351|FG000|Overall Study|Ongoing in study|19|||
146049982|NCT04661150|526697352|FG001|Overall Study|Ongoing in study|20|||
146049983|NCT04661150|526697351|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
146049984|NCT04661150|526697352|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
146049985|NCT04661150|526697351|FG000|Overall Study|Death|2|||
146049986|NCT04661150|526697352|FG001|Overall Study|Death|0|||
146049987|NCT04965688|526697353|FG000|Overall Study|Withdrawal by Subject|2|||
146049988|NCT03868943|526697354|FG000|Overall Study|Adverse Event|1|||
146049989|NCT02777827|526697355|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
146049990|NCT02777827|526697356|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
146049991|NCT02777827|526697357|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
146049992|NCT02777827|526697358|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
146049993|NCT02777827|526697359|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
146049994|NCT02777827|526697360|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
146049995|NCT04551066|526697361|FG000|Overall Study|Death|5|||
146049996|NCT04551066|526697362|FG001|Overall Study|Death|3|||
146049997|NCT04551066|526697361|FG000|Overall Study|Lost to Follow-up|1|||
146049998|NCT04551066|526697362|FG001|Overall Study|Lost to Follow-up|0|||
146049999|NCT04551066|526697361|FG000|Overall Study|Sponsor Decision|104|||
146050000|NCT04551066|526697362|FG001|Overall Study|Sponsor Decision|117|||
146050001|NCT04551066|526697361|FG000|Overall Study|Withdrawal by Subject|8|||
146050002|NCT04551066|526697362|FG001|Overall Study|Withdrawal by Subject|2|||
146050003|NCT04551066|526697361|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
146050004|NCT04551066|526697362|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
146050005|NCT04551066|526697361|FG000|Overall Study|Adverse Event|2|||
146050006|NCT04551066|526697362|FG001|Overall Study|Adverse Event|0|||
146050007|NCT04551066|526697361|FG000|Overall Study|Physician Decision|2|||
146256443|NCT00464737|527452623|FG002|Overall Study|Other: Personal family reasons|1|||
146050008|NCT04551066|526697362|FG001|Overall Study|Physician Decision|0|||
146050009|NCT04551066|526697361|FG000|Overall Study|Protocol Violation|1|||
146050010|NCT04551066|526697362|FG001|Overall Study|Protocol Violation|0|||
146050011|NCT04551066|526697361|FG000|Overall Study|Lack of Efficacy|0|||
146105115|NCT02034110|526905601|FG007|Overall Study|Study closed by sponsor|0|||
146105116|NCT02587234|526905602|FG000|Overall Study|Withdrawal by Subject|1|||
146105117|NCT02587234|526905603|FG001|Overall Study|Withdrawal by Subject|1|||
146105118|NCT02587234|526905602|FG000|Overall Study|Lost to Follow-up|0|||
146105119|NCT02587234|526905603|FG001|Overall Study|Lost to Follow-up|2|||
146105120|NCT00590720|526905604|FG000|Overall Study|Lost to Follow-up|1|||
146105121|NCT00590720|526905605|FG001|Overall Study|Lost to Follow-up|0|||
146105122|NCT00590720|526905604|FG000|Overall Study|Withdrawal by Subject|0|||
146105123|NCT00590720|526905605|FG001|Overall Study|Withdrawal by Subject|1|||
146105124|NCT01001377|526905607|FG000|Overall Study|Ineligibility determined|2|||
146105125|NCT01001377|526905608|FG001|Overall Study|Ineligibility determined|0|||
146105126|NCT01001377|526905607|FG000|Overall Study|Withdrawal by Subject|19|||
146105127|NCT01001377|526905608|FG001|Overall Study|Withdrawal by Subject|20|||
146105128|NCT01001377|526905607|FG000|Overall Study|Lost to Follow-up|14|||
146105129|NCT01001377|526905608|FG001|Overall Study|Lost to Follow-up|17|||
146105130|NCT01001377|526905607|FG000|Overall Study|Death|391|||
146105131|NCT01001377|526905608|FG001|Overall Study|Death|384|||
146105132|NCT03039283|526905612|FG000|Overall Study|Protocol Violation|2|||
146105133|NCT02732119|526905613|FG000|Phase I|Adverse Event|1|||
146105134|NCT02732119|526905614|FG001|Phase I|Adverse Event|3|||
146105135|NCT02732119|526905615|FG002|Phase I|Adverse Event|1|||
146105136|NCT02732119|526905616|FG003|Phase I|Adverse Event|0|||
146050012|NCT04551066|526697362|FG001|Overall Study|Lack of Efficacy|1|||
146050013|NCT04551066|526697361|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
146050014|NCT04551066|526697362|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
146050015|NCT00369577|526697363|FG000|Overall Study|Withdrawal by Subject|0|||
146050016|NCT00369577|526697364|FG001|Overall Study|Withdrawal by Subject|0|||
146050017|NCT00369577|526697365|FG002|Overall Study|Withdrawal by Subject|1|||
146050018|NCT03915470|526697366|FG000|Overall Study|Death|3|||
146050019|NCT03915470|526697367|FG001|Overall Study|Death|1|||
146105137|NCT02732119|526905617|FG004|Phase I|Adverse Event|0|||
146105138|NCT02732119|526905613|FG000|Phase I|Progressive disease|7|||
146105139|NCT02732119|526905614|FG001|Phase I|Progressive disease|3|||
146105140|NCT02732119|526905615|FG002|Phase I|Progressive disease|2|||
146105141|NCT02732119|526905616|FG003|Phase I|Progressive disease|0|||
146105142|NCT02732119|526905617|FG004|Phase I|Progressive disease|0|||
146105143|NCT02732119|526905613|FG000|Phase I|Protocol deviation|0|||
146105144|NCT02732119|526905614|FG001|Phase I|Protocol deviation|1|||
146105145|NCT02732119|526905615|FG002|Phase I|Protocol deviation|0|||
146105146|NCT02732119|526905616|FG003|Phase I|Protocol deviation|0|||
146105147|NCT02732119|526905617|FG004|Phase I|Protocol deviation|0|||
146105148|NCT02732119|526905613|FG000|Phase I|Physician Decision|0|||
146105149|NCT02732119|526905614|FG001|Phase I|Physician Decision|3|||
146105150|NCT02732119|526905615|FG002|Phase I|Physician Decision|4|||
146105151|NCT02732119|526905616|FG003|Phase I|Physician Decision|0|||
146105152|NCT02732119|526905617|FG004|Phase I|Physician Decision|0|||
146105153|NCT02732119|526905613|FG000|Phase II|Adverse Event|0|||
146105154|NCT02732119|526905614|FG001|Phase II|Adverse Event|0|||
146105155|NCT02732119|526905615|FG002|Phase II|Adverse Event|0|||
146105156|NCT02732119|526905616|FG003|Phase II|Adverse Event|3|||
146105157|NCT02732119|526905617|FG004|Phase II|Adverse Event|3|||
146105158|NCT02732119|526905613|FG000|Phase II|Death|0|||
146105159|NCT02732119|526905614|FG001|Phase II|Death|0|||
146105160|NCT02732119|526905615|FG002|Phase II|Death|0|||
146105161|NCT02732119|526905616|FG003|Phase II|Death|1|||
146105162|NCT02732119|526905617|FG004|Phase II|Death|0|||
146105163|NCT02732119|526905613|FG000|Phase II|Progressive dissease|0|||
146105164|NCT02732119|526905614|FG001|Phase II|Progressive dissease|0|||
146105165|NCT02732119|526905615|FG002|Phase II|Progressive dissease|0|||
146105166|NCT02732119|526905616|FG003|Phase II|Progressive dissease|30|||
146050020|NCT03915470|526697366|FG000|Overall Study|Adverse Event|1|||
146050021|NCT03915470|526697367|FG001|Overall Study|Adverse Event|0|||
146050022|NCT03915470|526697366|FG000|Overall Study|Physician Decision|1|||
146105167|NCT02732119|526905617|FG004|Phase II|Progressive dissease|23|||
146105168|NCT02732119|526905613|FG000|Phase II|Study terminated by sponsor|0|||
146105169|NCT02732119|526905614|FG001|Phase II|Study terminated by sponsor|0|||
146105170|NCT02732119|526905615|FG002|Phase II|Study terminated by sponsor|0|||
146105171|NCT02732119|526905616|FG003|Phase II|Study terminated by sponsor|2|||
146105172|NCT02732119|526905617|FG004|Phase II|Study terminated by sponsor|2|||
146105173|NCT02732119|526905613|FG000|Phase II|Other|0|||
146105174|NCT02732119|526905614|FG001|Phase II|Other|0|||
146105175|NCT02732119|526905615|FG002|Phase II|Other|0|||
146105176|NCT02732119|526905616|FG003|Phase II|Other|2|||
146105177|NCT02732119|526905617|FG004|Phase II|Other|0|||
146105178|NCT02732119|526905613|FG000|Phase II|Physician Decision|0|||
146050023|NCT03915470|526697367|FG001|Overall Study|Physician Decision|0|||
146105179|NCT02732119|526905614|FG001|Phase II|Physician Decision|0|||
146105180|NCT02732119|526905615|FG002|Phase II|Physician Decision|0|||
146105181|NCT02732119|526905616|FG003|Phase II|Physician Decision|8|||
146105182|NCT02732119|526905617|FG004|Phase II|Physician Decision|5|||
146105183|NCT00964860|526905618|FG000|Overall Study|Withdrawal by Subject|0|||
146105184|NCT00964860|526905619|FG001|Overall Study|Withdrawal by Subject|1|||
146105185|NCT00867568|526905620|FG000|Overall Study|Lack of Efficacy|10|||
146105186|NCT00867568|526905620|FG000|Overall Study|Adverse Event|4|||
146105187|NCT00867568|526905620|FG000|Overall Study|Withdrawal by Subject|1|||
146105188|NCT01056653|526905621|FG000|Overall Study|Lost to Follow-up|0|||
146105189|NCT01056653|526905622|FG001|Overall Study|Lost to Follow-up|0|||
146105190|NCT01056653|526905623|FG002|Overall Study|Lost to Follow-up|2|||
146105191|NCT03639935|526905624|FG000|Overall Study|Death|3|||
146105192|NCT03639935|526905624|FG000|Overall Study|Adverse Event|1|||
146105193|NCT03727230|526905626|FG000|Overall Study|Lost to Follow-up|12|||
146105194|NCT02059395|526905628|FG000|Overall Study|Lost to Follow-up|2|||
146105195|NCT02059395|526905629|FG001|Overall Study|Lost to Follow-up|4|||
146105196|NCT04377620|526905630|FG000|Overall Study|Death|42|||
146105197|NCT04377620|526905631|FG001|Overall Study|Death|48|||
146105198|NCT04377620|526905632|FG002|Overall Study|Death|36|||
146105199|NCT04377620|526905630|FG000|Overall Study|Withdrawal by Subject|0|||
146105200|NCT04377620|526905631|FG001|Overall Study|Withdrawal by Subject|2|||
146105201|NCT04377620|526905632|FG002|Overall Study|Withdrawal by Subject|0|||
146105202|NCT00134082|526905633|FG000|Overall Study|Adverse Event|2|||
146105203|NCT00134082|526905633|FG000|Overall Study|Death|1|||
146105204|NCT01606007|526905634|FG000|Overall Study|Reason 'Other' in the protocol|0|||
146105205|NCT01606007|526905635|FG001|Overall Study|Reason 'Other' in the protocol|1|||
146105206|NCT01606007|526905636|FG002|Overall Study|Reason 'Other' in the protocol|1|||
146105207|NCT01606007|526905634|FG000|Overall Study|Pregnancy|0|||
146105208|NCT01606007|526905635|FG001|Overall Study|Pregnancy|1|||
146105209|NCT01606007|526905636|FG002|Overall Study|Pregnancy|1|||
146105210|NCT01606007|526905634|FG000|Overall Study|Withdrawal by Subject|8|||
146105211|NCT01606007|526905635|FG001|Overall Study|Withdrawal by Subject|6|||
146105212|NCT01606007|526905636|FG002|Overall Study|Withdrawal by Subject|1|||
146105213|NCT01606007|526905634|FG000|Overall Study|Adverse Event|0|||
146105214|NCT01606007|526905635|FG001|Overall Study|Adverse Event|1|||
146105215|NCT01606007|526905636|FG002|Overall Study|Adverse Event|1|||
146105216|NCT01606007|526905634|FG000|Overall Study|discontinue study treatment|0|||
146105217|NCT01606007|526905635|FG001|Overall Study|discontinue study treatment|2|||
146105218|NCT01606007|526905636|FG002|Overall Study|discontinue study treatment|1|||
146105219|NCT01606007|526905634|FG000|Overall Study|Lost to Follow-up|6|||
146105220|NCT01606007|526905635|FG001|Overall Study|Lost to Follow-up|8|||
146105221|NCT01606007|526905636|FG002|Overall Study|Lost to Follow-up|5|||
146105222|NCT01606007|526905634|FG000|Overall Study|Poor/Non-compliance|1|||
146105223|NCT01606007|526905635|FG001|Overall Study|Poor/Non-compliance|0|||
146105224|NCT01606007|526905636|FG002|Overall Study|Poor/Non-compliance|0|||
146105225|NCT03095612|526905642|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146105226|NCT03095612|526905643|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
146105227|NCT03095612|526905644|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146105228|NCT03095612|526905645|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146105229|NCT03095612|526905646|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146105230|NCT03095612|526905647|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146300925|NCT00228566|527617174|FG000|Overall Study|Physician Decision|5|||
146300926|NCT00228566|527617174|FG000|Overall Study|Withdrawal by Subject|4|||
146300927|NCT00228566|527617174|FG000|Overall Study|Miscellaneous|1|||
146300928|NCT05975840|527617175|FG000|Overall Study|Other|1|||
146300929|NCT05975840|527617176|FG001|Overall Study|Other|0|||
146300930|NCT05975840|527617177|FG002|Overall Study|Other|0|||
146300931|NCT05975840|527617178|FG003|Overall Study|Other|0|||
146300932|NCT05975840|527617179|FG004|Overall Study|Other|1|||
146300933|NCT05975840|527617180|FG005|Overall Study|Other|0|||
146300934|NCT05975840|527617181|FG006|Overall Study|Other|0|||
146300935|NCT05975840|527617182|FG007|Overall Study|Other|0|||
146300936|NCT05975840|527617175|FG000|Overall Study|Lost to Follow-up|3|||
146300937|NCT05975840|527617176|FG001|Overall Study|Lost to Follow-up|6|||
146300938|NCT05975840|527617177|FG002|Overall Study|Lost to Follow-up|3|||
146300939|NCT05975840|527617178|FG003|Overall Study|Lost to Follow-up|1|||
146300940|NCT05975840|527617179|FG004|Overall Study|Lost to Follow-up|4|||
146300941|NCT05975840|527617180|FG005|Overall Study|Lost to Follow-up|1|||
146300942|NCT05975840|527617181|FG006|Overall Study|Lost to Follow-up|2|||
146300943|NCT05975840|527617182|FG007|Overall Study|Lost to Follow-up|4|||
146300944|NCT05975840|527617175|FG000|Overall Study|Migrated/moved from the study area|1|||
146300945|NCT05975840|527617176|FG001|Overall Study|Migrated/moved from the study area|0|||
146300946|NCT05975840|527617177|FG002|Overall Study|Migrated/moved from the study area|0|||
146300947|NCT05975840|527617178|FG003|Overall Study|Migrated/moved from the study area|0|||
146300948|NCT05975840|527617179|FG004|Overall Study|Migrated/moved from the study area|0|||
146300949|NCT05975840|527617180|FG005|Overall Study|Migrated/moved from the study area|0|||
146105231|NCT03095612|526905648|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
146300950|NCT05975840|527617181|FG006|Overall Study|Migrated/moved from the study area|0|||
146300951|NCT05975840|527617182|FG007|Overall Study|Migrated/moved from the study area|0|||
146300952|NCT05975840|527617175|FG000|Overall Study|Withdrawal by Subject|0|||
146105232|NCT04447794|526905649|FG000|Overall Study|Lost to Follow-up|2|||
146105233|NCT04447794|526905650|FG001|Overall Study|Lost to Follow-up|3|||
146105234|NCT04447794|526905651|FG002|Overall Study|Lost to Follow-up|8|||
146105235|NCT04447794|526905649|FG000|Overall Study|Withdrawal by Subject|1|||
146105236|NCT04447794|526905650|FG001|Overall Study|Withdrawal by Subject|1|||
146105237|NCT04447794|526905651|FG002|Overall Study|Withdrawal by Subject|0|||
146105238|NCT01235689|526905652|FG000|Overall Study|Adverse Event|12|||
146105239|NCT01235689|526905653|FG001|Overall Study|Adverse Event|16|||
146105240|NCT01235689|526905652|FG000|Overall Study|Lack of Efficacy|12|||
146105241|NCT01235689|526905653|FG001|Overall Study|Lack of Efficacy|5|||
146105242|NCT01235689|526905652|FG000|Overall Study|Withdrawal by Subject|3|||
146105243|NCT01235689|526905653|FG001|Overall Study|Withdrawal by Subject|4|||
146105244|NCT01235689|526905652|FG000|Overall Study|Lost to Follow-up|1|||
146105245|NCT01235689|526905653|FG001|Overall Study|Lost to Follow-up|2|||
146105246|NCT01235689|526905652|FG000|Overall Study|Miscellaneous|1|||
146105247|NCT01235689|526905653|FG001|Overall Study|Miscellaneous|5|||
146105248|NCT01390649|526905654|FG000|Overall Study|Physician Decision|1|||
146105249|NCT00389597|526905655|FG000|Overall Study|Lost to Follow-up|8|||
146105250|NCT00389597|526905656|FG001|Overall Study|Lost to Follow-up|6|||
146105251|NCT00389597|526905657|FG002|Overall Study|Lost to Follow-up|4|||
146105252|NCT00389597|526905658|FG003|Overall Study|Lost to Follow-up|6|||
146105253|NCT04431453|526905659|FG000|Overall Study|Withdrew Consent|0|||
146105254|NCT04431453|526905660|FG001|Overall Study|Withdrew Consent|1|||
146105255|NCT04431453|526905661|FG002|Overall Study|Withdrew Consent|0|||
146105256|NCT04431453|526905662|FG003|Overall Study|Withdrew Consent|2|||
146105257|NCT04431453|526905663|FG004|Overall Study|Withdrew Consent|0|||
146105258|NCT04431453|526905664|FG005|Overall Study|Withdrew Consent|0|||
146105259|NCT04431453|526905665|FG006|Overall Study|Withdrew Consent|0|||
146105260|NCT04431453|526905666|FG007|Overall Study|Withdrew Consent|0|||
146105261|NCT04431453|526905659|FG000|Overall Study|Death|1|||
146105262|NCT04431453|526905660|FG001|Overall Study|Death|0|||
146105263|NCT04431453|526905661|FG002|Overall Study|Death|0|||
146105264|NCT04431453|526905662|FG003|Overall Study|Death|0|||
146105265|NCT04431453|526905663|FG004|Overall Study|Death|0|||
146105266|NCT04431453|526905664|FG005|Overall Study|Death|0|||
146105267|NCT04431453|526905665|FG006|Overall Study|Death|0|||
146105268|NCT04431453|526905666|FG007|Overall Study|Death|1|||
146105269|NCT04431453|526905659|FG000|Overall Study|Lost to Follow-up|0|||
146105270|NCT04431453|526905660|FG001|Overall Study|Lost to Follow-up|0|||
146105271|NCT04431453|526905661|FG002|Overall Study|Lost to Follow-up|1|||
146105272|NCT04431453|526905662|FG003|Overall Study|Lost to Follow-up|1|||
146105273|NCT04431453|526905663|FG004|Overall Study|Lost to Follow-up|0|||
146105274|NCT04431453|526905664|FG005|Overall Study|Lost to Follow-up|0|||
146105275|NCT04431453|526905665|FG006|Overall Study|Lost to Follow-up|0|||
146105276|NCT04431453|526905666|FG007|Overall Study|Lost to Follow-up|0|||
146105277|NCT04431453|526905659|FG000|Overall Study|Enrolled but Never Treated|0|||
146105278|NCT04431453|526905660|FG001|Overall Study|Enrolled but Never Treated|0|||
146105279|NCT04431453|526905661|FG002|Overall Study|Enrolled but Never Treated|0|||
146105280|NCT04431453|526905662|FG003|Overall Study|Enrolled but Never Treated|0|||
146105281|NCT04431453|526905663|FG004|Overall Study|Enrolled but Never Treated|1|||
146105282|NCT04431453|526905664|FG005|Overall Study|Enrolled but Never Treated|0|||
146105283|NCT04431453|526905665|FG006|Overall Study|Enrolled but Never Treated|0|||
146105284|NCT04431453|526905666|FG007|Overall Study|Enrolled but Never Treated|0|||
146105285|NCT00622401|526905667|FG000|Overall Study|Disease progression prior to treatment|3|||
146105286|NCT00622401|526905668|FG001|Overall Study|Disease progression prior to treatment|2|||
146105287|NCT00622401|526905669|FG002|Overall Study|Disease progression prior to treatment|0|||
146105288|NCT00282984|526905673|FG000|Overall Study|Death|2|||
146105289|NCT00282984|526905674|FG001|Overall Study|Death|5|||
146105290|NCT00282984|526905673|FG000|Overall Study|Adverse Event|8|||
146105291|NCT00282984|526905674|FG001|Overall Study|Adverse Event|5|||
146105292|NCT00282984|526905673|FG000|Overall Study|Lack of Efficacy|0|||
146105293|NCT00282984|526905674|FG001|Overall Study|Lack of Efficacy|2|||
146105294|NCT00282984|526905673|FG000|Overall Study|Lost to Follow-up|14|||
146105295|NCT00282984|526905674|FG001|Overall Study|Lost to Follow-up|10|||
146105296|NCT00282984|526905673|FG000|Overall Study|Withdrawal by Participant|22|||
146105297|NCT00282984|526905674|FG001|Overall Study|Withdrawal by Participant|34|||
146105298|NCT00282984|526905673|FG000|Overall Study|Participant stopped study medication|2|||
146105299|NCT00282984|526905674|FG001|Overall Study|Participant stopped study medication|2|||
146105300|NCT00282984|526905673|FG000|Overall Study|Participant only allowed phone follow-up|0|||
146105301|NCT00282984|526905674|FG001|Overall Study|Participant only allowed phone follow-up|1|||
146105302|NCT00282984|526905673|FG000|Overall Study|Participant used antipsychosis meds|0|||
146105303|NCT00282984|526905674|FG001|Overall Study|Participant used antipsychosis meds|1|||
146105304|NCT00282984|526905673|FG000|Overall Study|lack of motivation|1|||
146105305|NCT00282984|526905674|FG001|Overall Study|lack of motivation|0|||
146105306|NCT00282984|526905673|FG000|Overall Study|in prison|0|||
146105307|NCT00282984|526905674|FG001|Overall Study|in prison|1|||
146105308|NCT00282984|526905673|FG000|Overall Study|Protocol Violation|2|||
146105309|NCT00282984|526905674|FG001|Overall Study|Protocol Violation|0|||
146105310|NCT00191269|526905675|FG000|Overall Study|Protocol Violation|0|||
146105311|NCT00191269|526905676|FG001|Overall Study|Protocol Violation|2|||
146105312|NCT00191269|526905675|FG000|Overall Study|Adverse Event|1|||
146105313|NCT00191269|526905676|FG001|Overall Study|Adverse Event|4|||
146105314|NCT00191269|526905675|FG000|Overall Study|Progression of Disease|4|||
146105315|NCT00191269|526905676|FG001|Overall Study|Progression of Disease|42|||
146105316|NCT00191269|526905675|FG000|Overall Study|Lack of Efficacy|1|||
146105317|NCT00191269|526905676|FG001|Overall Study|Lack of Efficacy|5|||
146105318|NCT00191269|526905675|FG000|Overall Study|Withdrawal by Subject|0|||
146105319|NCT00191269|526905676|FG001|Overall Study|Withdrawal by Subject|1|||
146105320|NCT00191269|526905675|FG000|Overall Study|Pathologic Aggrevation|0|||
146105321|NCT00191269|526905676|FG001|Overall Study|Pathologic Aggrevation|1|||
146105322|NCT00191269|526905675|FG000|Overall Study|Physician Decision|0|||
146105323|NCT00191269|526905676|FG001|Overall Study|Physician Decision|3|||
146105324|NCT00915278|526905682|FG000|Overall Study|Death|1|||
146105325|NCT00915278|526905683|FG001|Overall Study|Death|0|||
146105326|NCT00915278|526905684|FG002|Overall Study|Death|0|||
146105327|NCT00915278|526905685|FG003|Overall Study|Death|0|||
146105328|NCT00915278|526905686|FG004|Overall Study|Death|0|||
146105329|NCT00915278|526905687|FG005|Overall Study|Death|0|||
146105330|NCT00915278|526905682|FG000|Overall Study|Lost to Follow-up|0|||
146105331|NCT00915278|526905683|FG001|Overall Study|Lost to Follow-up|1|||
146105332|NCT00915278|526905684|FG002|Overall Study|Lost to Follow-up|0|||
146105333|NCT00915278|526905685|FG003|Overall Study|Lost to Follow-up|0|||
146105334|NCT00915278|526905686|FG004|Overall Study|Lost to Follow-up|0|||
146105335|NCT00915278|526905687|FG005|Overall Study|Lost to Follow-up|0|||
146256444|NCT00464737|527452621|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
145939205|NCT01041976|526285854|FG000|Overall Study|Withdrawal by Subject|3|||
145939206|NCT01041976|526285855|FG001|Overall Study|Withdrawal by Subject|0|||
145939207|NCT01041976|526285854|FG000|Overall Study|Incarceration|2|||
145939208|NCT01041976|526285855|FG001|Overall Study|Incarceration|0|||
145939209|NCT01041976|526285854|FG000|Overall Study|Death|0|||
145939210|NCT01041976|526285855|FG001|Overall Study|Death|4|||
145939211|NCT02370667|526285856|FG000|Overall Study|Lost to Follow-up|0|||
145939212|NCT02370667|526285857|FG001|Overall Study|Lost to Follow-up|1|||
145939213|NCT02370667|526285858|FG002|Overall Study|Lost to Follow-up|0|||
145939214|NCT02612610|526285859|FG000|Overall Study|Withdrawal by Subject|1|||
145939215|NCT02612610|526285860|FG001|Overall Study|Withdrawal by Subject|1|||
145939216|NCT02612610|526285861|FG002|Overall Study|Withdrawal by Subject|0|||
145939217|NCT02612610|526285862|FG003|Overall Study|Withdrawal by Subject|2|||
145939218|NCT02612610|526285859|FG000|Overall Study|Adverse Event|2|||
145939219|NCT02612610|526285860|FG001|Overall Study|Adverse Event|2|||
145939220|NCT02612610|526285861|FG002|Overall Study|Adverse Event|3|||
145939221|NCT02612610|526285862|FG003|Overall Study|Adverse Event|10|||
145939222|NCT02612610|526285859|FG000|Overall Study|Lost to Follow-up|0|||
145939223|NCT02612610|526285860|FG001|Overall Study|Lost to Follow-up|1|||
145939224|NCT02612610|526285861|FG002|Overall Study|Lost to Follow-up|0|||
145939225|NCT02612610|526285862|FG003|Overall Study|Lost to Follow-up|0|||
145939226|NCT02612610|526285859|FG000|Overall Study|Protocol Violation|0|||
145939227|NCT02612610|526285860|FG001|Overall Study|Protocol Violation|1|||
145939228|NCT02612610|526285861|FG002|Overall Study|Protocol Violation|1|||
145939229|NCT02612610|526285862|FG003|Overall Study|Protocol Violation|0|||
145939230|NCT02612610|526285859|FG000|Overall Study|Lack of Efficacy|1|||
145939231|NCT02612610|526285860|FG001|Overall Study|Lack of Efficacy|2|||
146256445|NCT00464737|527452622|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
146256446|NCT00464737|527452623|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
146256447|NCT02820298|527452624|FG000|Overall Study|Withdrawal by Subject|0|||
145939232|NCT02612610|526285861|FG002|Overall Study|Lack of Efficacy|0|||
145939233|NCT02612610|526285862|FG003|Overall Study|Lack of Efficacy|1|||
145939234|NCT02612610|526285859|FG000|Overall Study|Physician Decision|0|||
145939235|NCT02612610|526285860|FG001|Overall Study|Physician Decision|1|||
145939236|NCT02612610|526285861|FG002|Overall Study|Physician Decision|0|||
145939237|NCT02612610|526285862|FG003|Overall Study|Physician Decision|0|||
145939238|NCT02612610|526285859|FG000|Overall Study|Noncompliance|1|||
145939239|NCT02612610|526285860|FG001|Overall Study|Noncompliance|0|||
145939240|NCT02612610|526285861|FG002|Overall Study|Noncompliance|0|||
145939241|NCT02612610|526285862|FG003|Overall Study|Noncompliance|0|||
145939242|NCT02612610|526285859|FG000|Overall Study|Cough Improvement|0|||
145939243|NCT02612610|526285860|FG001|Overall Study|Cough Improvement|0|||
145939244|NCT02612610|526285861|FG002|Overall Study|Cough Improvement|1|||
145939245|NCT02612610|526285862|FG003|Overall Study|Cough Improvement|0|||
145939246|NCT00176644|526285863|FG000|Overall Study|Withdrawal by Subject|1|||
145939247|NCT01801280|526285864|FG000|Period 1|Withdrawal by Subject|0|||
145939248|NCT01801280|526285865|FG001|Period 1|Withdrawal by Subject|1|||
145939249|NCT01801280|526285866|FG002|Period 1|Withdrawal by Subject|0|||
145939250|NCT01801280|526285867|FG003|Period 1|Withdrawal by Subject|0|||
145939251|NCT01801280|526285864|FG000|Period 2|Withdrawal by Subject|1|||
145939252|NCT01801280|526285865|FG001|Period 2|Withdrawal by Subject|0|||
145939253|NCT01801280|526285866|FG002|Period 2|Withdrawal by Subject|0|||
145939254|NCT01801280|526285867|FG003|Period 2|Withdrawal by Subject|0|||
146105336|NCT00915278|526905682|FG000|Overall Study|Withdrawal by Subject|0|||
146256448|NCT02820298|527452625|FG001|Overall Study|Withdrawal by Subject|1|||
146256449|NCT02820298|527452624|FG000|Overall Study|Physician Decision|1|||
146256450|NCT02820298|527452625|FG001|Overall Study|Physician Decision|0|||
146256451|NCT02820298|527452624|FG000|Overall Study|Protocol Violation|0|||
146256452|NCT02820298|527452625|FG001|Overall Study|Protocol Violation|1|||
146256453|NCT01894256|527452626|FG000|Part A|Adverse Event|0|||
146256454|NCT01894256|527452627|FG001|Part A|Adverse Event|1|||
146256455|NCT01894256|527452628|FG002|Part A|Adverse Event|0|||
146256456|NCT01894256|527452626|FG000|Part B|Death|0|||
146256457|NCT01894256|527452627|FG001|Part B|Death|1|||
146256458|NCT01894256|527452628|FG002|Part B|Death|1|||
146256459|NCT01894256|527452626|FG000|Part B|Withdrawal by Subject|0|||
146256460|NCT01894256|527452627|FG001|Part B|Withdrawal by Subject|1|||
146256461|NCT01894256|527452628|FG002|Part B|Withdrawal by Subject|0|||
146256462|NCT01894256|527452626|FG000|Part B|Lack of Efficacy|15|||
146256463|NCT01894256|527452627|FG001|Part B|Lack of Efficacy|12|||
146256464|NCT01894256|527452628|FG002|Part B|Lack of Efficacy|13|||
146256465|NCT00141271|527452631|FG000|Overall Study|Adverse Event|31|||
146256466|NCT00141271|527452632|FG001|Overall Study|Adverse Event|19|||
146256467|NCT00141271|527452633|FG002|Overall Study|Adverse Event|17|||
146256468|NCT00141271|527452631|FG000|Overall Study|Laboratory Abnormality|2|||
146256469|NCT00141271|527452632|FG001|Overall Study|Laboratory Abnormality|1|||
146256470|NCT00141271|527452633|FG002|Overall Study|Laboratory Abnormality|1|||
146256471|NCT00141271|527452631|FG000|Overall Study|Lack of Efficacy|7|||
146256472|NCT00141271|527452632|FG001|Overall Study|Lack of Efficacy|7|||
146256473|NCT00141271|527452633|FG002|Overall Study|Lack of Efficacy|3|||
146256474|NCT00141271|527452631|FG000|Overall Study|Lost to Follow-up|15|||
146256475|NCT00141271|527452632|FG001|Overall Study|Lost to Follow-up|15|||
146256476|NCT00141271|527452633|FG002|Overall Study|Lost to Follow-up|21|||
146256477|NCT00141271|527452631|FG000|Overall Study|Withdrawal by Subject|14|||
146256478|NCT00141271|527452632|FG001|Overall Study|Withdrawal by Subject|9|||
146256479|NCT00141271|527452633|FG002|Overall Study|Withdrawal by Subject|10|||
146256480|NCT00141271|527452631|FG000|Overall Study|Other|11|||
146256481|NCT00141271|527452632|FG001|Overall Study|Other|12|||
146256482|NCT00141271|527452633|FG002|Overall Study|Other|5|||
146256483|NCT02133131|527452634|FG000|Overall Study|Adverse Event|0|||
146256484|NCT02133131|527452635|FG001|Overall Study|Adverse Event|0|||
146256485|NCT02133131|527452636|FG002|Overall Study|Adverse Event|0|||
146256486|NCT02133131|527452637|FG003|Overall Study|Adverse Event|1|||
146256487|NCT02133131|527452638|FG004|Overall Study|Adverse Event|0|||
146256488|NCT02133131|527452639|FG005|Overall Study|Adverse Event|0|||
146256489|NCT02133131|527452640|FG006|Overall Study|Adverse Event|0|||
146256490|NCT02133131|527452634|FG000|Overall Study|Lost to Follow-up|1|||
146256491|NCT02133131|527452635|FG001|Overall Study|Lost to Follow-up|0|||
146256492|NCT02133131|527452636|FG002|Overall Study|Lost to Follow-up|0|||
146256493|NCT02133131|527452637|FG003|Overall Study|Lost to Follow-up|1|||
146256494|NCT02133131|527452638|FG004|Overall Study|Lost to Follow-up|0|||
146256495|NCT02133131|527452639|FG005|Overall Study|Lost to Follow-up|0|||
146256496|NCT02133131|527452640|FG006|Overall Study|Lost to Follow-up|0|||
146256497|NCT02133131|527452634|FG000|Overall Study|Status not recorded|4|||
146256498|NCT02133131|527452635|FG001|Overall Study|Status not recorded|5|||
146256499|NCT02133131|527452636|FG002|Overall Study|Status not recorded|1|||
146256500|NCT02133131|527452637|FG003|Overall Study|Status not recorded|4|||
146256501|NCT02133131|527452638|FG004|Overall Study|Status not recorded|0|||
146256502|NCT02133131|527452639|FG005|Overall Study|Status not recorded|0|||
146256503|NCT02133131|527452640|FG006|Overall Study|Status not recorded|0|||
146256504|NCT02133131|527452634|FG000|Overall Study|Ongoing in study|0|||
146256505|NCT02133131|527452635|FG001|Overall Study|Ongoing in study|0|||
146256506|NCT02133131|527452636|FG002|Overall Study|Ongoing in study|0|||
146256507|NCT02133131|527452637|FG003|Overall Study|Ongoing in study|0|||
146256508|NCT02133131|527452638|FG004|Overall Study|Ongoing in study|15|||
146256509|NCT02133131|527452639|FG005|Overall Study|Ongoing in study|14|||
146256510|NCT02133131|527452640|FG006|Overall Study|Ongoing in study|11|||
146256511|NCT02133131|527452634|FG000|Overall Study|Protocol Violation|0|||
145939255|NCT01801280|526285864|FG000|Period 4|Protocol Violation|0|||
146256512|NCT02133131|527452635|FG001|Overall Study|Protocol Violation|0|||
146256513|NCT02133131|527452636|FG002|Overall Study|Protocol Violation|0|||
146256514|NCT02133131|527452637|FG003|Overall Study|Protocol Violation|0|||
145939256|NCT01801280|526285865|FG001|Period 4|Protocol Violation|0|||
145939257|NCT01801280|526285866|FG002|Period 4|Protocol Violation|1|||
146256515|NCT02133131|527452638|FG004|Overall Study|Protocol Violation|0|||
146256516|NCT02133131|527452639|FG005|Overall Study|Protocol Violation|0|||
146256517|NCT02133131|527452640|FG006|Overall Study|Protocol Violation|1|||
146256518|NCT02316171|527452641|FG000|Overall Study|difficulties with urinary catheter|1|||
146256519|NCT02316171|527452642|FG001|Overall Study|difficulties with urinary catheter|0|||
146256520|NCT02316171|527452643|FG002|Overall Study|difficulties with urinary catheter|0|||
146256521|NCT02316171|527452644|FG003|Overall Study|difficulties with urinary catheter|0|||
146282347|NCT01879722|527546472|FG003|Overall Study|Voluntary Withdrawal|0|||
146282348|NCT01879722|527546473|FG004|Overall Study|Voluntary Withdrawal|0|||
146282349|NCT01879722|527546474|FG005|Overall Study|Voluntary Withdrawal|0|||
146282350|NCT01879722|527546475|FG006|Overall Study|Voluntary Withdrawal|0|||
146256522|NCT01772147|527454189|FG000|Overall Study|Adverse Event|13|||
146256523|NCT01772147|527454190|FG001|Overall Study|Adverse Event|10|||
146256524|NCT01772147|527454191|FG002|Overall Study|Adverse Event|6|||
146256525|NCT01772147|527454189|FG000|Overall Study|Withdrew Consent|7|||
146256526|NCT01772147|527454190|FG001|Overall Study|Withdrew Consent|8|||
146256527|NCT01772147|527454191|FG002|Overall Study|Withdrew Consent|4|||
146256528|NCT01772147|527454189|FG000|Overall Study|Lost to Follow-up|1|||
146256529|NCT01772147|527454190|FG001|Overall Study|Lost to Follow-up|0|||
146256530|NCT01772147|527454191|FG002|Overall Study|Lost to Follow-up|1|||
146256531|NCT01772147|527454189|FG000|Overall Study|Protocol Deviation|2|||
146256532|NCT01772147|527454190|FG001|Overall Study|Protocol Deviation|1|||
146256533|NCT01772147|527454191|FG002|Overall Study|Protocol Deviation|1|||
146256534|NCT01772147|527454189|FG000|Overall Study|Lack of Efficacy|8|||
146256535|NCT01772147|527454190|FG001|Overall Study|Lack of Efficacy|6|||
146256536|NCT01772147|527454191|FG002|Overall Study|Lack of Efficacy|6|||
146256537|NCT02093897|527454193|FG000|Overall Study|Physician Decision|1|||
146256538|NCT02093897|527454193|FG000|Overall Study|Planned age group closure - no's reached|17|||
145939258|NCT01801280|526285867|FG003|Period 4|Protocol Violation|0|||
145939259|NCT01866657|526285873|FG000|Overall Study|Surgery canceled|2|||
145939260|NCT01866657|526285874|FG001|Overall Study|Surgery canceled|0|||
145939261|NCT03973918|526285877|FG000|Overall Study|Adverse Event|0|||
145939262|NCT03973918|526285878|FG001|Overall Study|Adverse Event|0|||
145939263|NCT03973918|526285879|FG002|Overall Study|Adverse Event|0|||
145939264|NCT03973918|526285880|FG003|Overall Study|Adverse Event|1|||
145939265|NCT03973918|526285877|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145939266|NCT03973918|526285878|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
146256539|NCT02093897|527454193|FG000|Overall Study|Adverse event, non-fatal|1|||
146256540|NCT04572997|527454197|FG000|Overall Study|Adverse Event|1|||
146256541|NCT02956278|527454198|FG000|Overall Study|Withdrawal by Subject|6|||
146256542|NCT02956278|527454199|FG001|Overall Study|Withdrawal by Subject|2|||
146256543|NCT02956278|527454200|FG002|Overall Study|Withdrawal by Subject|0|||
145939267|NCT03973918|526285879|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145939268|NCT03973918|526285880|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145939269|NCT04351373|526285881|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
145939270|NCT02880865|526285889|FG000|Overall Study|Adverse Event|1|||
145939271|NCT02880865|526285890|FG001|Overall Study|Adverse Event|0|||
145939272|NCT02880865|526285889|FG000|Overall Study|Withdrawal by Subject|0|||
145939273|NCT02880865|526285890|FG001|Overall Study|Withdrawal by Subject|2|||
145939274|NCT02880865|526285889|FG000|Overall Study|Physician Decision|0|||
145939275|NCT02880865|526285890|FG001|Overall Study|Physician Decision|1|||
145939276|NCT03045276|526285891|FG000|Intervention Phase|Withdrawal by Subject|7|||
145939277|NCT03045276|526285892|FG001|Intervention Phase|Withdrawal by Subject|2|||
145939278|NCT03045276|526285893|FG002|Intervention Phase|Withdrawal by Subject|3|||
145939279|NCT03045276|526285894|FG003|Intervention Phase|Withdrawal by Subject|7|||
145939280|NCT03045276|526285891|FG000|Intervention Phase|Developed exclusionary criteria|3|||
146050024|NCT03915470|526697366|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
146256544|NCT01967719|527454201|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
146256545|NCT01967719|527454202|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
146256546|NCT01967719|527454203|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146256547|NCT01967719|527454204|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
146050025|NCT03915470|526697367|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
146050026|NCT00549445|526697373|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
146050027|NCT00549445|526697374|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
146050028|NCT01900652|526697375|FG000|Overall Study|Progressive Disease|1|||
146050029|NCT01900652|526697376|FG001|Overall Study|Progressive Disease|0|||
146050030|NCT01900652|526697375|FG000|Overall Study|Consent withdrawn by subject|1|||
146050031|NCT01900652|526697376|FG001|Overall Study|Consent withdrawn by subject|1|||
146050032|NCT01900652|526697375|FG000|Overall Study|Death|3|||
146050033|NCT01900652|526697376|FG001|Overall Study|Death|0|||
146050034|NCT01900652|526697375|FG000|Overall Study|Adverse Event|2|||
146050035|NCT01900652|526697376|FG001|Overall Study|Adverse Event|1|||
146050036|NCT01900652|526697375|FG000|Overall Study|Physician Decision|1|||
146050037|NCT01900652|526697376|FG001|Overall Study|Physician Decision|1|||
146050038|NCT03566082|526697377|FG000|Overall Study|Death|7|||
146050039|NCT03566082|526697377|FG000|Overall Study|Failures (revision required)|2|||
146050040|NCT03566082|526697377|FG000|Overall Study|Lost to Follow-up|8|||
146050041|NCT01389882|526699096|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
146050042|NCT01389882|526699097|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
146050043|NCT01389882|526699096|FG000|Overall Study|Withdrawal by Subject|0|||
146050044|NCT01389882|526699097|FG001|Overall Study|Withdrawal by Subject|1|||
146256548|NCT01967719|527454201|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
146256549|NCT01967719|527454202|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
146256550|NCT01967719|527454203|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
145939281|NCT03045276|526285892|FG001|Intervention Phase|Developed exclusionary criteria|3|||
145939282|NCT03045276|526285893|FG002|Intervention Phase|Developed exclusionary criteria|0|||
145939283|NCT03045276|526285894|FG003|Intervention Phase|Developed exclusionary criteria|0|||
145939284|NCT03045276|526285891|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
145939285|NCT03045276|526285892|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
145939286|NCT03045276|526285893|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
145939287|NCT03045276|526285894|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
145939288|NCT03045276|526285891|FG000|Follow-Up Phase|Lost to Follow-up|0|||
145939289|NCT03045276|526285892|FG001|Follow-Up Phase|Lost to Follow-up|1|||
145939290|NCT03045276|526285893|FG002|Follow-Up Phase|Lost to Follow-up|0|||
145939291|NCT03045276|526285894|FG003|Follow-Up Phase|Lost to Follow-up|1|||
145939292|NCT03045276|526285891|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
145939293|NCT03045276|526285892|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
145939294|NCT03045276|526285893|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
145939295|NCT03045276|526285894|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
145939296|NCT02375555|526285916|FG000|Induction Period|Adverse Event|7|||
145939297|NCT02375555|526285916|FG000|Induction Period|Withdrawal by Subject|2|||
145939298|NCT02375555|526285916|FG000|Induction Period|Other|1|||
145939299|NCT02375555|526285916|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
145939300|NCT02375555|526285916|FG000|Maintenance Period|Adverse Event|2|||
145939301|NCT02375555|526285916|FG000|Maintenance Period|Withdrawal by Subject|4|||
145939302|NCT02375555|526285916|FG000|Maintenance Period|Death|1|||
145939303|NCT02375555|526285916|FG000|Maintenance Period|Disease Progression|5|||
145939304|NCT02375555|526285916|FG000|Maintenance Period|Patient Non-compliance|1|||
145939305|NCT02375555|526285916|FG000|Maintenance Period|Still on maintenance|16|||
145939306|NCT02548351|526285921|FG000|Overall Study|Withdrawal by Subject|149|||
145939307|NCT02548351|526285922|FG001|Overall Study|Withdrawal by Subject|154|||
145939308|NCT02548351|526285923|FG002|Overall Study|Withdrawal by Subject|152|||
145939309|NCT02548351|526285921|FG000|Overall Study|Death|11|||
145939310|NCT02548351|526285922|FG001|Overall Study|Death|15|||
145939311|NCT02548351|526285923|FG002|Overall Study|Death|12|||
145939312|NCT02548351|526285921|FG000|Overall Study|Adverse Event|22|||
145939313|NCT02548351|526285922|FG001|Overall Study|Adverse Event|56|||
145939314|NCT02548351|526285923|FG002|Overall Study|Adverse Event|36|||
145939315|NCT02548351|526285921|FG000|Overall Study|Study Terminated by Sponsor|549|||
145939316|NCT02548351|526285922|FG001|Overall Study|Study Terminated by Sponsor|509|||
145939317|NCT02548351|526285923|FG002|Overall Study|Study Terminated by Sponsor|528|||
145939318|NCT02548351|526285921|FG000|Overall Study|Site Closure|14|||
145939319|NCT02548351|526285922|FG001|Overall Study|Site Closure|5|||
145939320|NCT02548351|526285923|FG002|Overall Study|Site Closure|7|||
145939321|NCT02548351|526285921|FG000|Overall Study|Non-compliance with Study Drug|4|||
145939322|NCT02548351|526285922|FG001|Overall Study|Non-compliance with Study Drug|2|||
145939323|NCT02548351|526285923|FG002|Overall Study|Non-compliance with Study Drug|0|||
145939324|NCT02548351|526285921|FG000|Overall Study|Protocol Violation|2|||
145939325|NCT02548351|526285922|FG001|Overall Study|Protocol Violation|1|||
145939326|NCT02548351|526285923|FG002|Overall Study|Protocol Violation|2|||
145939327|NCT02548351|526285921|FG000|Overall Study|Physician Decision|11|||
145939328|NCT02548351|526285922|FG001|Overall Study|Physician Decision|18|||
145939329|NCT02548351|526285923|FG002|Overall Study|Physician Decision|11|||
145939330|NCT02548351|526285921|FG000|Overall Study|Lost to Follow-up|43|||
145939331|NCT02548351|526285922|FG001|Overall Study|Lost to Follow-up|50|||
145939332|NCT02548351|526285923|FG002|Overall Study|Lost to Follow-up|57|||
145939333|NCT02548351|526285921|FG000|Overall Study|Other|19|||
145939334|NCT02548351|526285922|FG001|Overall Study|Other|16|||
145939335|NCT02548351|526285923|FG002|Overall Study|Other|20|||
145939336|NCT02548351|526285921|FG000|Overall Study|Missing|1|||
145939337|NCT02548351|526285922|FG001|Overall Study|Missing|1|||
145939338|NCT02548351|526285923|FG002|Overall Study|Missing|0|||
145939339|NCT01744184|526285924|FG000|Overall Study|Adverse Event|1|||
145939340|NCT01744184|526285925|FG001|Overall Study|Adverse Event|0|||
145939341|NCT01744184|526285924|FG000|Overall Study|Withdrawal by Subject|0|||
145939342|NCT01744184|526285925|FG001|Overall Study|Withdrawal by Subject|1|||
145939343|NCT02091986|526285929|FG000|Overall Study|7 rand in error 1 patient decision|2|||
145939344|NCT02091986|526285930|FG001|Overall Study|7 rand in error 1 patient decision|3|||
145939345|NCT02091986|526285931|FG002|Overall Study|7 rand in error 1 patient decision|3|||
145939346|NCT02091986|526285929|FG000|Overall Study|Lost to Follow-up|1|||
145939347|NCT02091986|526285930|FG001|Overall Study|Lost to Follow-up|0|||
145939348|NCT02091986|526285931|FG002|Overall Study|Lost to Follow-up|0|||
145939349|NCT02091986|526285929|FG000|Overall Study|Withdrawal by Subject|4|||
145939350|NCT02091986|526285930|FG001|Overall Study|Withdrawal by Subject|8|||
145939351|NCT02091986|526285931|FG002|Overall Study|Withdrawal by Subject|3|||
145939352|NCT02091986|526285929|FG000|Overall Study|Adverse Event|0|||
145939353|NCT02091986|526285930|FG001|Overall Study|Adverse Event|0|||
145939354|NCT02091986|526285931|FG002|Overall Study|Adverse Event|2|||
145939355|NCT00125242|526285932|FG000|Overall Study|did not qualify|7|||
145939356|NCT00125242|526285933|FG001|Overall Study|did not qualify|2|||
145939357|NCT01664949|526285936|FG000|Overall Study|Adverse Event|11|||
145939358|NCT01664949|526285937|FG001|Overall Study|Adverse Event|12|||
146300953|NCT05975840|527617176|FG001|Overall Study|Withdrawal by Subject|5|||
146050045|NCT03057496|526699098|FG000|Overall Study|Withdrawal by Subject|8|||
146050046|NCT03057496|526699098|FG000|Overall Study|Lost to Follow-up|5|||
146050047|NCT03057496|526699098|FG000|Overall Study|Did not use device during home trial|3|||
146050048|NCT03057496|526699098|FG000|Overall Study|Device failure|2|||
146050049|NCT00280917|526699102|FG000|Overall Study|Adverse Event|1|||
146050050|NCT00280917|526699103|FG001|Overall Study|Adverse Event|1|||
146050051|NCT00280917|526699104|FG002|Overall Study|Adverse Event|4|||
146050052|NCT00280917|526699105|FG003|Overall Study|Adverse Event|1|||
146050053|NCT00280917|526699102|FG000|Overall Study|Change Therapy|1|||
146050054|NCT00280917|526699103|FG001|Overall Study|Change Therapy|2|||
146050055|NCT00280917|526699104|FG002|Overall Study|Change Therapy|0|||
146050056|NCT00280917|526699105|FG003|Overall Study|Change Therapy|0|||
146050057|NCT00280917|526699102|FG000|Overall Study|Withdrawal by Subject|0|||
146050058|NCT00280917|526699103|FG001|Overall Study|Withdrawal by Subject|2|||
146050059|NCT00280917|526699104|FG002|Overall Study|Withdrawal by Subject|0|||
146050060|NCT00280917|526699105|FG003|Overall Study|Withdrawal by Subject|1|||
146050061|NCT00280917|526699102|FG000|Overall Study|Noncompliance|0|||
146050062|NCT00280917|526699103|FG001|Overall Study|Noncompliance|1|||
146050063|NCT00280917|526699104|FG002|Overall Study|Noncompliance|2|||
146050064|NCT00280917|526699105|FG003|Overall Study|Noncompliance|0|||
146050065|NCT03529110|526699106|FG000|Overall Study|Progressive Disease|66|||
146050066|NCT03529110|526699107|FG001|Overall Study|Progressive Disease|158|||
146050067|NCT03529110|526699106|FG000|Overall Study|Clinical Progression|4|||
146050068|NCT03529110|526699107|FG001|Overall Study|Clinical Progression|12|||
146050069|NCT03529110|526699106|FG000|Overall Study|Adverse Event|35|||
146050070|NCT03529110|526699107|FG001|Overall Study|Adverse Event|17|||
146050071|NCT03529110|526699106|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
146050072|NCT03529110|526699107|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
146050073|NCT03529110|526699106|FG000|Overall Study|Lack of Efficacy|3|||
146050074|NCT03529110|526699107|FG001|Overall Study|Lack of Efficacy|3|||
146050075|NCT03529110|526699106|FG000|Overall Study|Physician Decision|2|||
146050076|NCT03529110|526699107|FG001|Overall Study|Physician Decision|8|||
146050077|NCT03529110|526699106|FG000|Overall Study|Miscellaneous|2|||
146050078|NCT03529110|526699107|FG001|Overall Study|Miscellaneous|5|||
146050079|NCT01584232|526699108|FG000|Overall Study|Adverse Event|3|||
146050080|NCT01584232|526699109|FG001|Overall Study|Adverse Event|1|||
146050081|NCT01584232|526699108|FG000|Overall Study|Withdrawal by Subject|2|||
146050082|NCT01584232|526699109|FG001|Overall Study|Withdrawal by Subject|1|||
146050083|NCT01584232|526699108|FG000|Overall Study|Physician Decision|2|||
146050084|NCT01584232|526699109|FG001|Overall Study|Physician Decision|1|||
146050085|NCT01584232|526699108|FG000|Overall Study|Lost to Follow-up|1|||
146050086|NCT01584232|526699109|FG001|Overall Study|Lost to Follow-up|0|||
146050087|NCT02723773|526699111|FG000|Overall Study|Adverse Event|934|||
146050088|NCT02723773|526699112|FG001|Overall Study|Adverse Event|3|||
146050089|NCT02723773|526699113|FG002|Overall Study|Adverse Event|1|||
146050090|NCT02723773|526699114|FG003|Overall Study|Adverse Event|9|||
146050091|NCT02723773|526699111|FG000|Overall Study|Protocol Violation|1|||
146050092|NCT02723773|526699112|FG001|Overall Study|Protocol Violation|0|||
146050093|NCT02723773|526699113|FG002|Overall Study|Protocol Violation|0|||
146050094|NCT02723773|526699114|FG003|Overall Study|Protocol Violation|0|||
146050095|NCT02723773|526699111|FG000|Overall Study|Withdrawal by Subject|360|||
146050096|NCT02723773|526699112|FG001|Overall Study|Withdrawal by Subject|5|||
146050097|NCT02723773|526699113|FG002|Overall Study|Withdrawal by Subject|6|||
146050098|NCT02723773|526699114|FG003|Overall Study|Withdrawal by Subject|10|||
146050099|NCT02723773|526699111|FG000|Overall Study|Migrated/moved from study area|37|||
146050100|NCT02723773|526699112|FG001|Overall Study|Migrated/moved from study area|0|||
146050101|NCT02723773|526699113|FG002|Overall Study|Migrated/moved from study area|0|||
146050102|NCT02723773|526699114|FG003|Overall Study|Migrated/moved from study area|1|||
146050103|NCT02723773|526699111|FG000|Overall Study|Lost to Follow-up|198|||
146050104|NCT02723773|526699112|FG001|Overall Study|Lost to Follow-up|0|||
146050105|NCT02723773|526699113|FG002|Overall Study|Lost to Follow-up|0|||
146050106|NCT02723773|526699114|FG003|Overall Study|Lost to Follow-up|0|||
146050107|NCT02723773|526699111|FG000|Overall Study|Other|189|||
146050108|NCT02723773|526699112|FG001|Overall Study|Other|1|||
146050109|NCT02723773|526699113|FG002|Overall Study|Other|2|||
146050110|NCT02723773|526699114|FG003|Overall Study|Other|2|||
146050111|NCT03654690|526699126|FG000|Overall Study|Withdrawal by Subject|1|||
146050112|NCT03654690|526699127|FG001|Overall Study|Withdrawal by Subject|0|||
146050113|NCT03654690|526699128|FG002|Overall Study|Withdrawal by Subject|0|||
146050114|NCT00742183|526699129|FG000|Overall Study|Adverse Event|2|||
146050115|NCT00742183|526699130|FG001|Overall Study|Adverse Event|2|||
146050116|NCT00742183|526699129|FG000|Overall Study|Death|1|||
146050117|NCT00742183|526699130|FG001|Overall Study|Death|0|||
146050118|NCT00742183|526699129|FG000|Overall Study|Physician Decision|0|||
146050119|NCT00742183|526699130|FG001|Overall Study|Physician Decision|2|||
146050120|NCT00742183|526699129|FG000|Overall Study|Lost to Follow-up|4|||
146050121|NCT00742183|526699130|FG001|Overall Study|Lost to Follow-up|4|||
146050122|NCT00742183|526699129|FG000|Overall Study|Required skin-graft|1|||
145939359|NCT01664949|526285936|FG000|Overall Study|Lack of Efficacy|1|||
145939360|NCT01664949|526285937|FG001|Overall Study|Lack of Efficacy|1|||
145939361|NCT01664949|526285936|FG000|Overall Study|Lost to Follow-up|1|||
145939362|NCT01664949|526285937|FG001|Overall Study|Lost to Follow-up|2|||
145939363|NCT01664949|526285936|FG000|Overall Study|Personal Reasons|3|||
145939364|NCT01664949|526285937|FG001|Overall Study|Personal Reasons|4|||
145939365|NCT01664949|526285936|FG000|Overall Study|Protocol Violation|5|||
145939366|NCT01664949|526285937|FG001|Overall Study|Protocol Violation|5|||
145939367|NCT01664949|526285936|FG000|Overall Study|Other Miscellaneous Reasons|3|||
145939368|NCT01664949|526285937|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145939369|NCT02537431|526285942|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
145939370|NCT00794040|526285943|FG000|Overall Study|Withdrawal by Subject|3|||
145939371|NCT00794040|526285944|FG001|Overall Study|Withdrawal by Subject|4|||
145939372|NCT00794040|526285943|FG000|Overall Study|Physician Decision|0|||
145939373|NCT00794040|526285944|FG001|Overall Study|Physician Decision|1|||
145939374|NCT01263782|526285945|FG000|Overall Study|Death|0|||
145939375|NCT01263782|526285946|FG001|Overall Study|Death|0|||
145939376|NCT01263782|526285947|FG002|Overall Study|Death|1|||
145939377|NCT01263782|526285948|FG003|Overall Study|Death|0|||
145939378|NCT01263782|526285945|FG000|Overall Study|Progressive disease|0|||
145939379|NCT01263782|526285946|FG001|Overall Study|Progressive disease|0|||
145939380|NCT01263782|526285947|FG002|Overall Study|Progressive disease|0|||
145939381|NCT01263782|526285948|FG003|Overall Study|Progressive disease|1|||
145939382|NCT01263782|526285945|FG000|Overall Study|Too early|0|||
145939383|NCT01263782|526285946|FG001|Overall Study|Too early|0|||
145939384|NCT01263782|526285947|FG002|Overall Study|Too early|1|||
145939385|NCT01263782|526285948|FG003|Overall Study|Too early|0|||
145939386|NCT01263782|526285945|FG000|Overall Study|Inevaluable|0|||
145939387|NCT01263782|526285946|FG001|Overall Study|Inevaluable|0|||
145939388|NCT01263782|526285947|FG002|Overall Study|Inevaluable|1|||
145939389|NCT01263782|526285948|FG003|Overall Study|Inevaluable|0|||
145939390|NCT00915876|526285949|FG000|Overall Study|Adverse Event|0|||
145939391|NCT00915876|526285950|FG001|Overall Study|Adverse Event|1|||
145939392|NCT04545567|526285952|FG000|Overall Study|tested positive for SARS-co-V2|1|||
145939393|NCT04545567|526285953|FG001|Overall Study|tested positive for SARS-co-V2|1|||
145939394|NCT04545567|526285952|FG000|Overall Study|Withdrawal by Subject|0|||
145939395|NCT04545567|526285953|FG001|Overall Study|Withdrawal by Subject|1|||
145939396|NCT03626363|526285957|FG000|Overall Study|Protocol Violation|4|||
145939397|NCT03626363|526285958|FG001|Overall Study|Protocol Violation|0|||
145939398|NCT03626363|526285957|FG000|Overall Study|Lost to Follow-up|5|||
145939399|NCT03626363|526285958|FG001|Overall Study|Lost to Follow-up|7|||
145939400|NCT02419612|526285959|FG000|Short-term Treatment Period|Adverse Event|1|||
145939401|NCT02419612|526285960|FG001|Short-term Treatment Period|Adverse Event|1|||
145939402|NCT02419612|526285959|FG000|Short-term Treatment Period|Death|0|||
145939403|NCT02419612|526285960|FG001|Short-term Treatment Period|Death|2|||
145939404|NCT02419612|526285959|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
145939405|NCT02419612|526285960|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
145939406|NCT02419612|526285959|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
145939407|NCT02419612|526285960|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
145939408|NCT02419612|526285959|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
145939409|NCT02419612|526285960|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
145939410|NCT02419612|526285959|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
145939411|NCT02419612|526285960|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
145939412|NCT02419612|526285959|FG000|Short-term Treatment Period|Worsening of liver function|0|||
145939413|NCT02419612|526285960|FG001|Short-term Treatment Period|Worsening of liver function|1|||
146256551|NCT01967719|527454204|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
146256552|NCT00796614|527454206|FG000|Overall Study|Adverse Event|1|||
145939414|NCT02419612|526285959|FG000|Short-term Treatment Period|Subject moved out of state|0|||
145939415|NCT02419612|526285960|FG001|Short-term Treatment Period|Subject moved out of state|1|||
145939416|NCT02419612|526285959|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
145939417|NCT02419612|526285960|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
146256553|NCT00796614|527454207|FG001|Overall Study|Adverse Event|2|||
146256554|NCT00796614|527454208|FG002|Overall Study|Adverse Event|0|||
146256555|NCT00796614|527454209|FG003|Overall Study|Adverse Event|0|||
146256556|NCT00796614|527454206|FG000|Overall Study|Protocol Violation|0|||
146256557|NCT00796614|527454207|FG001|Overall Study|Protocol Violation|0|||
146256558|NCT00796614|527454208|FG002|Overall Study|Protocol Violation|2|||
145939418|NCT02419612|526285959|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
145939419|NCT02419612|526285960|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
145939420|NCT02419612|526285959|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
145939421|NCT02419612|526285960|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
145939422|NCT02419612|526285959|FG000|Long-term Treatment Period|Death|0|||
145939423|NCT02419612|526285960|FG001|Long-term Treatment Period|Death|1|||
146050123|NCT00742183|526699130|FG001|Overall Study|Required skin-graft|1|||
146256559|NCT00796614|527454209|FG003|Overall Study|Protocol Violation|0|||
145939424|NCT02419612|526285959|FG000|Long-term Treatment Period|Adverse Event|0|||
145939425|NCT02419612|526285960|FG001|Long-term Treatment Period|Adverse Event|5|||
145939426|NCT02419612|526285959|FG000|Long-term Treatment Period|Other|4|||
145939427|NCT02419612|526285960|FG001|Long-term Treatment Period|Other|4|||
145939428|NCT02419612|526285959|FG000|Long-term Treatment Period|Subject Decision|2|||
145939429|NCT02419612|526285960|FG001|Long-term Treatment Period|Subject Decision|4|||
145939430|NCT02419612|526285959|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
145939431|NCT02419612|526285960|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
145939432|NCT00533702|526285961|FG000|Overall Study|Withdrawal by Subject|3|||
145939433|NCT00533702|526285962|FG001|Overall Study|Withdrawal by Subject|1|||
145939434|NCT00533702|526285961|FG000|Overall Study|Found ineligible after randomization|2|||
145939435|NCT00533702|526285962|FG001|Overall Study|Found ineligible after randomization|1|||
145939436|NCT01095978|526285963|FG000|Overall Study|Did not take Klacid SR|2|||
145939437|NCT01095978|526285963|FG000|Overall Study|Adverse Event|1|||
145939438|NCT00960986|526285971|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
145939439|NCT00960986|526285972|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
145939440|NCT00960986|526285973|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
145939441|NCT00960986|526285974|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
145939442|NCT00960986|526285971|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
145939443|NCT00960986|526285972|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
145939444|NCT00960986|526285973|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
145939445|NCT00960986|526285974|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
145939446|NCT00960986|526285971|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
145939447|NCT00960986|526285972|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
145939448|NCT00960986|526285973|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
145939449|NCT00960986|526285974|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
145939450|NCT00960986|526285971|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145939451|NCT00960986|526285972|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
145939452|NCT00960986|526285973|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145939453|NCT00960986|526285974|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145939454|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
145939455|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
145939456|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
145939457|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
145939458|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Death|0|||
145939459|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Death|0|||
145939460|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Death|1|||
145939461|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Death|0|||
145939462|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145939463|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145939464|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
145939465|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145939466|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
145939467|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
145939468|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
145939469|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
145939470|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145939471|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145939472|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
145939473|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145939474|NCT00960986|526285971|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
145939475|NCT00960986|526285972|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
145939476|NCT00960986|526285973|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
145939477|NCT00960986|526285974|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
145939478|NCT01984892|526285975|FG000|Overall Study|Progressive disease|7|||
145939479|NCT04464720|526285976|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
145939480|NCT04413552|526285982|FG000|Overall Study|Adverse Event|0|||
145939481|NCT04413552|526285983|FG001|Overall Study|Adverse Event|0|||
145939482|NCT04413552|526285984|FG002|Overall Study|Adverse Event|0|||
145939483|NCT04413552|526285985|FG003|Overall Study|Adverse Event|0|||
145939484|NCT04413552|526285986|FG004|Overall Study|Adverse Event|0|||
145939485|NCT04413552|526285987|FG005|Overall Study|Adverse Event|0|||
145939486|NCT04413552|526285988|FG006|Overall Study|Adverse Event|1|||
145939487|NCT04413552|526285989|FG007|Overall Study|Adverse Event|0|||
145939488|NCT04413552|526285990|FG008|Overall Study|Adverse Event|0|||
145939489|NCT04413552|526285991|FG009|Overall Study|Adverse Event|0|||
145939490|NCT01794793|526285994|FG000|Treatment Period|Withdrawal by Subject|24|||
145939491|NCT01794793|526285994|FG000|Treatment Period|Lack of Efficacy|22|||
145939492|NCT01794793|526285994|FG000|Treatment Period|Adverse Event|17|||
145939493|NCT01794793|526285994|FG000|Treatment Period|Physician Decision|14|||
145939494|NCT01794793|526285994|FG000|Treatment Period|Lost to Follow-up|7|||
145939495|NCT01794793|526285994|FG000|Treatment Period|Death|6|||
146256560|NCT00796614|527454206|FG000|Overall Study|Lost to Follow-up|2|||
146256561|NCT00796614|527454207|FG001|Overall Study|Lost to Follow-up|2|||
146256562|NCT00796614|527454208|FG002|Overall Study|Lost to Follow-up|1|||
146256563|NCT00796614|527454209|FG003|Overall Study|Lost to Follow-up|0|||
146256564|NCT00796614|527454206|FG000|Overall Study|Withdrawal by Subject|1|||
146256565|NCT00796614|527454207|FG001|Overall Study|Withdrawal by Subject|0|||
146256566|NCT00796614|527454208|FG002|Overall Study|Withdrawal by Subject|0|||
146256567|NCT00796614|527454209|FG003|Overall Study|Withdrawal by Subject|1|||
146256568|NCT00796614|527454206|FG000|Overall Study|Other than stated|1|||
146256569|NCT00796614|527454207|FG001|Overall Study|Other than stated|0|||
146256570|NCT00796614|527454208|FG002|Overall Study|Other than stated|0|||
146256571|NCT00796614|527454209|FG003|Overall Study|Other than stated|0|||
146256572|NCT00740597|527454210|FG000|Overall Study|insurance would not cover treatment|1|||
146256573|NCT01157351|527454212|FG000|Overall Study|Adverse Event|5|||
146256574|NCT01157351|527454213|FG001|Overall Study|Adverse Event|4|||
146256575|NCT01157351|527454212|FG000|Overall Study|Death|1|||
146256576|NCT01157351|527454213|FG001|Overall Study|Death|0|||
146256577|NCT01157351|527454212|FG000|Overall Study|Lost to Follow-up|53|||
146256578|NCT01157351|527454213|FG001|Overall Study|Lost to Follow-up|55|||
146256579|NCT01157351|527454212|FG000|Overall Study|Withdrawal by Subject|37|||
146256580|NCT01157351|527454213|FG001|Overall Study|Withdrawal by Subject|27|||
145939496|NCT01794793|526285994|FG000|Treatment Period|Protocol Violation|5|||
145939497|NCT01794793|526285994|FG000|Treatment Period|administrative problem|3|||
145939498|NCT01794793|526285994|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
145939499|NCT01794793|526285994|FG000|Post-treatment Follow-up|Adverse Event|8|||
145939500|NCT01794793|526285994|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
145939501|NCT01794793|526285994|FG000|Post-treatment Follow-up|administrative problem|5|||
145939502|NCT01794793|526285994|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
145939503|NCT01794793|526285994|FG000|Post-treatment Follow-up|Protocol Violation|3|||
145939504|NCT04852679|526285995|FG000|Main Intervention Period|Withdrawal by Subject|3|||
145939505|NCT04852679|526285995|FG000|Main Intervention Period|Adverse Event|1|||
145939506|NCT04852679|526285995|FG000|Main Intervention Period|Progressive Disease|16|||
145939507|NCT04852679|526285995|FG000|Main Intervention Period|Refused study visit|1|||
145939508|NCT04852679|526285995|FG000|Independent Injection Period|Missed study visit|1|||
145939509|NCT05072106|526288014|FG000|Overall Study|Progressive disease|3|||
145939510|NCT05072106|526288015|FG001|Overall Study|Progressive disease|3|||
145939511|NCT05072106|526288014|FG000|Overall Study|Compassionate use|3|||
145939512|NCT05072106|526288015|FG001|Overall Study|Compassionate use|1|||
145939513|NCT05072106|526288014|FG000|Overall Study|Withdrawal by Subject|1|||
145939514|NCT05072106|526288015|FG001|Overall Study|Withdrawal by Subject|0|||
145939515|NCT04240886|526288020|FG000|Treatment Phase|Death|4|||
145939516|NCT04240886|526288020|FG000|Treatment Phase|Discontinuation by Subject|1|||
145939517|NCT04240886|526288020|FG000|Treatment Phase|Adverse Event|5|||
145939518|NCT04240886|526288020|FG000|Follow-up Phase|Withdrawal by Subject|1|||
145939519|NCT04240886|526288020|FG000|Follow-up Phase|Discontinuation by Subject|1|||
145939520|NCT04240886|526288020|FG000|Follow-up Phase|Death|2|||
145939521|NCT04743804|526288023|FG000|Overall Study|Other|1|||
145939522|NCT04743804|526288024|FG001|Overall Study|Other|0|||
145939523|NCT04743804|526288023|FG000|Overall Study|Withdrawal by Subject|0|||
145939524|NCT04743804|526288024|FG001|Overall Study|Withdrawal by Subject|1|||
145939525|NCT04743804|526288023|FG000|Overall Study|Study Terminated by Sponsor|1|||
145939526|NCT04743804|526288024|FG001|Overall Study|Study Terminated by Sponsor|4|||
145939527|NCT04743804|526288023|FG000|Overall Study|Physician Decision|0|||
145939528|NCT04743804|526288024|FG001|Overall Study|Physician Decision|1|||
145939529|NCT04743804|526288023|FG000|Overall Study|Death|3|||
145939530|NCT04743804|526288024|FG001|Overall Study|Death|0|||
145939531|NCT01944670|526288027|FG000|Overall Study|Lost to Follow-up|2|||
145939532|NCT04542499|526288028|FG000|Overall Study|Adverse Event|23|||
146256581|NCT01157351|527454212|FG000|Overall Study|Physician Decision|5|||
146256582|NCT01157351|527454213|FG001|Overall Study|Physician Decision|4|||
146256583|NCT01157351|527454212|FG000|Overall Study|Protocol Violation|0|||
146256584|NCT01157351|527454213|FG001|Overall Study|Protocol Violation|1|||
146256585|NCT01157351|527454212|FG000|Overall Study|Other|32|||
146256586|NCT01157351|527454213|FG001|Overall Study|Other|36|||
145939533|NCT04542499|526288029|FG001|Overall Study|Adverse Event|43|||
145939534|NCT04542499|526288028|FG000|Overall Study|Lack of Efficacy|5|||
145939535|NCT04542499|526288029|FG001|Overall Study|Lack of Efficacy|2|||
145939536|NCT04542499|526288028|FG000|Overall Study|Lost to Follow-up|3|||
145939537|NCT04542499|526288029|FG001|Overall Study|Lost to Follow-up|4|||
145939538|NCT04542499|526288028|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
145939539|NCT04542499|526288029|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
145939540|NCT04542499|526288028|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
145939541|NCT04542499|526288029|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
146256587|NCT01157351|527454212|FG000|Overall Study|Noncompliance with Study Drug|0|||
146256588|NCT01157351|527454213|FG001|Overall Study|Noncompliance with Study Drug|3|||
146256589|NCT01157351|527454212|FG000|Overall Study|Randomized but not Treated|4|||
146256590|NCT01157351|527454213|FG001|Overall Study|Randomized but not Treated|2|||
145939542|NCT04542499|526288028|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145939543|NCT04542499|526288029|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145939544|NCT04542499|526288028|FG000|Overall Study|Physician Decision|0|||
145939545|NCT04542499|526288029|FG001|Overall Study|Physician Decision|1|||
145939546|NCT04542499|526288028|FG000|Overall Study|Site Terminated by Sponsor|3|||
145939547|NCT04542499|526288029|FG001|Overall Study|Site Terminated by Sponsor|5|||
145939548|NCT04542499|526288028|FG000|Overall Study|Withdrawal by Subject|12|||
145939549|NCT04542499|526288029|FG001|Overall Study|Withdrawal by Subject|33|||
145939550|NCT04542499|526288028|FG000|Overall Study|Other|2|||
145939551|NCT04542499|526288029|FG001|Overall Study|Other|2|||
145939552|NCT04035434|526288033|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939553|NCT04035434|526288034|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939554|NCT04035434|526288035|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939555|NCT04035434|526288036|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
145939556|NCT04035434|526288037|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939557|NCT04035434|526288038|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939558|NCT04035434|526288039|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939559|NCT04035434|526288040|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939560|NCT04035434|526288041|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939561|NCT04035434|526288042|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939562|NCT04035434|526288043|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939563|NCT04035434|526288044|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939564|NCT04035434|526288045|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939565|NCT04035434|526288033|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145939566|NCT04035434|526288034|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145939567|NCT04035434|526288035|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
145939568|NCT04035434|526288036|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145939569|NCT04035434|526288037|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
145939570|NCT04035434|526288038|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145939571|NCT04035434|526288039|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
145939572|NCT04035434|526288040|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145939573|NCT04035434|526288041|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145939574|NCT04035434|526288042|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
145939575|NCT04035434|526288043|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145939576|NCT04035434|526288044|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
145939577|NCT04035434|526288045|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145939578|NCT04035434|526288033|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939579|NCT04035434|526288034|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145939580|NCT04035434|526288035|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145939581|NCT04035434|526288036|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939582|NCT04035434|526288037|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145939583|NCT04035434|526288038|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145939584|NCT04035434|526288039|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939585|NCT04035434|526288040|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939586|NCT04035434|526288041|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145939587|NCT04035434|526288042|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145939588|NCT04035434|526288043|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939589|NCT04035434|526288044|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145939590|NCT04035434|526288045|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
145939591|NCT04035434|526288033|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939592|NCT04035434|526288034|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939593|NCT04035434|526288035|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939594|NCT04035434|526288036|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
145939595|NCT04035434|526288037|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939596|NCT04035434|526288038|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939597|NCT04035434|526288039|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939598|NCT04035434|526288040|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939599|NCT04035434|526288041|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939600|NCT04035434|526288042|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939601|NCT04035434|526288043|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939602|NCT04035434|526288044|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939603|NCT04035434|526288045|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145939604|NCT04035434|526288033|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939605|NCT04035434|526288034|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939606|NCT04035434|526288035|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939607|NCT04035434|526288036|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939608|NCT04035434|526288037|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939609|NCT04035434|526288038|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
145939610|NCT04035434|526288039|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
145939611|NCT04035434|526288040|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939612|NCT04035434|526288041|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939613|NCT04035434|526288042|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939614|NCT04035434|526288043|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939615|NCT04035434|526288044|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939616|NCT04035434|526288045|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145939617|NCT04035434|526288033|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939618|NCT04035434|526288034|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939619|NCT04035434|526288035|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939620|NCT04035434|526288036|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939621|NCT04035434|526288037|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939622|NCT04035434|526288038|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939623|NCT04035434|526288039|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145939624|NCT04035434|526288040|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939625|NCT04035434|526288041|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939626|NCT04035434|526288042|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939627|NCT04035434|526288043|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939628|NCT04035434|526288044|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939629|NCT04035434|526288045|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145939630|NCT04035434|526288033|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939631|NCT04035434|526288034|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939632|NCT04035434|526288035|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939633|NCT04035434|526288036|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939634|NCT04035434|526288037|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939635|NCT04035434|526288038|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
145939636|NCT04035434|526288039|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
145939637|NCT04035434|526288040|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939638|NCT04035434|526288041|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939639|NCT04035434|526288042|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939640|NCT04035434|526288043|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939641|NCT04035434|526288044|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939642|NCT04035434|526288045|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145939643|NCT04488497|526288046|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
145939644|NCT04488497|526288047|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
145939645|NCT04488497|526288046|FG000|Intervention|Physician Decision|2|||
145939646|NCT04488497|526288047|FG001|Intervention|Physician Decision|1|||
145939647|NCT04488497|526288046|FG000|Intervention|Withdrawal by Subject|5|||
145939648|NCT04488497|526288047|FG001|Intervention|Withdrawal by Subject|6|||
145939649|NCT04488497|526288046|FG000|Intervention|Lost to Follow-up|2|||
145939650|NCT04488497|526288047|FG001|Intervention|Lost to Follow-up|0|||
145939651|NCT04488497|526288046|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
145939652|NCT04488497|526288047|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
145939653|NCT04488497|526288046|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
145939654|NCT04488497|526288047|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
145939655|NCT04063657|526288052|FG000|Overall Study|Lost to Follow-up|1|||
145939656|NCT04063657|526288053|FG001|Overall Study|Lost to Follow-up|0|||
145939657|NCT03408444|526288054|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
145939658|NCT03408444|526288055|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145939659|NCT03408444|526288056|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145939660|NCT03408444|526288057|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145939661|NCT03408444|526288054|FG000|Overall Study|Lens Discomfort|0|||
145939662|NCT03408444|526288055|FG001|Overall Study|Lens Discomfort|1|||
145939663|NCT03408444|526288056|FG002|Overall Study|Lens Discomfort|0|||
145939664|NCT03408444|526288057|FG003|Overall Study|Lens Discomfort|0|||
145939665|NCT03408444|526288054|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
145939666|NCT03408444|526288055|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
146256591|NCT00746785|527454214|FG000|Overall Study|Lost to Follow-up|29|||
146256592|NCT00746785|527454215|FG001|Overall Study|Lost to Follow-up|25|||
146256593|NCT00746785|527454216|FG002|Overall Study|Lost to Follow-up|27|||
146256594|NCT01231464|527454217|FG000|Overall Study|Adverse Event|0|||
146256595|NCT01231464|527454218|FG001|Overall Study|Adverse Event|1|||
146256596|NCT01231464|527454217|FG000|Overall Study|Protocol Violation|1|||
146256597|NCT01231464|527454218|FG001|Overall Study|Protocol Violation|2|||
146256598|NCT01231464|527454217|FG000|Overall Study|Lost to Follow-up|1|||
146256599|NCT01231464|527454218|FG001|Overall Study|Lost to Follow-up|2|||
146256600|NCT01231464|527454217|FG000|Overall Study|Withdrawal by Subject|3|||
146256601|NCT01231464|527454218|FG001|Overall Study|Withdrawal by Subject|2|||
146256602|NCT01960348|527454223|FG000|Overall Study|Adverse event, not serious|2|||
146256603|NCT01960348|527454224|FG001|Overall Study|Adverse event, not serious|2|||
146256604|NCT01960348|527454223|FG000|Overall Study|Adverse event, serious fatal|6|||
146256605|NCT01960348|527454224|FG001|Overall Study|Adverse event, serious fatal|5|||
146256606|NCT01960348|527454223|FG000|Overall Study|Adverse event, serious non-fatal|0|||
146256607|NCT01960348|527454224|FG001|Overall Study|Adverse event, serious non-fatal|3|||
146256608|NCT01960348|527454223|FG000|Overall Study|Withdrawal by Subject|1|||
146256609|NCT01960348|527454224|FG001|Overall Study|Withdrawal by Subject|11|||
146256610|NCT01960348|527454223|FG000|Overall Study|Physician Decision|0|||
146256611|NCT01960348|527454224|FG001|Overall Study|Physician Decision|1|||
146256612|NCT01960348|527454223|FG000|Overall Study|Protocol Violation|1|||
146256613|NCT01960348|527454224|FG001|Overall Study|Protocol Violation|0|||
146256614|NCT01580995|527454225|FG000|Overall Study|Lost to Follow-up|2|||
146256615|NCT01580995|527454226|FG001|Overall Study|Lost to Follow-up|2|||
146256616|NCT02916706|527454227|FG000|Overall Study|Adverse Event|0|||
146256617|NCT02916706|527454228|FG001|Overall Study|Adverse Event|1|||
146256618|NCT02916706|527454227|FG000|Overall Study|Lost to Follow-up|0|||
146256619|NCT02916706|527454228|FG001|Overall Study|Lost to Follow-up|1|||
146256620|NCT02916706|527454227|FG000|Overall Study|Physician Decision|1|||
146256621|NCT02916706|527454228|FG001|Overall Study|Physician Decision|0|||
146256622|NCT02916706|527454227|FG000|Overall Study|Protocol Violation|3|||
146256623|NCT02916706|527454228|FG001|Overall Study|Protocol Violation|1|||
146256624|NCT02916706|527454227|FG000|Overall Study|Withdrawal by Subject|6|||
146256625|NCT02916706|527454228|FG001|Overall Study|Withdrawal by Subject|9|||
146256626|NCT02916706|527454227|FG000|Overall Study|Other|5|||
146256627|NCT02916706|527454228|FG001|Overall Study|Other|19|||
146256628|NCT01902381|527454231|FG000|Overall Study|Withdrawal by Subject|1|||
146256629|NCT04140266|527454232|FG000|Overall Study|Physician Decision|2|||
146256630|NCT04140266|527454233|FG001|Overall Study|Physician Decision|0|||
146256631|NCT04140266|527454232|FG000|Overall Study|Withdrawal by Subject|4|||
146256632|NCT04140266|527454233|FG001|Overall Study|Withdrawal by Subject|2|||
146256633|NCT03511378|527454236|FG000|Overall Study|Withdrawal by Subject|2|||
146256634|NCT03511378|527454237|FG001|Overall Study|Withdrawal by Subject|2|||
146256635|NCT03511378|527454236|FG000|Overall Study|Patient not coming or schedule visit|1|||
146256636|NCT03511378|527454237|FG001|Overall Study|Patient not coming or schedule visit|0|||
146256637|NCT02762500|527454238|FG000|Overall Study|Lack of Efficacy|1|||
146256638|NCT02762500|527454239|FG001|Overall Study|Lack of Efficacy|0|||
146256639|NCT02762500|527454238|FG000|Overall Study|Withdrawal by Subject|1|||
146256640|NCT02762500|527454239|FG001|Overall Study|Withdrawal by Subject|1|||
146256641|NCT02762500|527454238|FG000|Overall Study|Adverse Event|0|||
146256642|NCT02762500|527454239|FG001|Overall Study|Adverse Event|2|||
146256643|NCT00730847|527454241|FG000|Overall Study|Adverse Event|1|||
146256644|NCT00730847|527454241|FG000|Overall Study|Protocol Violation|2|||
146256645|NCT00730847|527454241|FG000|Overall Study|Withdrawal by Subject|16|||
146256646|NCT00730847|527454241|FG000|Overall Study|Lost to Follow-up|67|||
146256647|NCT00730847|527454241|FG000|Overall Study|Unknown completion status|21|||
146256648|NCT00730847|527454241|FG000|Overall Study|Other|24|||
146256649|NCT00280683|527454242|FG000|Overall Study|Withdrawal by Subject|1|||
146256650|NCT00280683|527454243|FG001|Overall Study|Withdrawal by Subject|2|||
146256651|NCT00280683|527454242|FG000|Overall Study|Adverse Event|1|||
146256652|NCT00280683|527454243|FG001|Overall Study|Adverse Event|1|||
146256653|NCT00329550|527454247|FG000|Overall Study|Adverse Event|3|||
145939667|NCT03408444|526288056|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145939668|NCT03408444|526288057|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
145939669|NCT03408444|526288054|FG000|Overall Study|Withdrawal by Subject|0|||
145939670|NCT03408444|526288055|FG001|Overall Study|Withdrawal by Subject|2|||
146256654|NCT00329550|527454248|FG001|Overall Study|Adverse Event|4|||
146256655|NCT00329550|527454249|FG002|Overall Study|Adverse Event|2|||
146256656|NCT00329550|527454247|FG000|Overall Study|Withdrawal of Consent|1|||
146256657|NCT00329550|527454248|FG001|Overall Study|Withdrawal of Consent|0|||
146256658|NCT00329550|527454249|FG002|Overall Study|Withdrawal of Consent|1|||
146256659|NCT00329550|527454247|FG000|Overall Study|Due to Relocation|0|||
146256660|NCT00329550|527454248|FG001|Overall Study|Due to Relocation|0|||
146256661|NCT00329550|527454249|FG002|Overall Study|Due to Relocation|1|||
146256662|NCT00111839|527454253|FG000|Overall Study|Disease Progression|30|||
146256663|NCT00111839|527454254|FG001|Overall Study|Disease Progression|33|||
146256664|NCT00111839|527454255|FG002|Overall Study|Disease Progression|33|||
146256665|NCT00111839|527454253|FG000|Overall Study|Adverse Event|5|||
146256666|NCT00111839|527454254|FG001|Overall Study|Adverse Event|3|||
145939671|NCT03408444|526288056|FG002|Overall Study|Withdrawal by Subject|3|||
146256667|NCT00111839|527454255|FG002|Overall Study|Adverse Event|1|||
146256668|NCT00111839|527454253|FG000|Overall Study|Protocol Violation|2|||
146256669|NCT00111839|527454254|FG001|Overall Study|Protocol Violation|4|||
146256670|NCT00111839|527454255|FG002|Overall Study|Protocol Violation|2|||
146256671|NCT00111839|527454253|FG000|Overall Study|Death|1|||
146300954|NCT05975840|527617177|FG002|Overall Study|Withdrawal by Subject|2|||
146300955|NCT05975840|527617178|FG003|Overall Study|Withdrawal by Subject|2|||
146050124|NCT00742183|526699129|FG000|Overall Study|Withdrawal by Subject|1|||
146050125|NCT00742183|526699130|FG001|Overall Study|Withdrawal by Subject|0|||
146050126|NCT00742183|526699129|FG000|Overall Study|Lack of Efficacy|0|||
146050127|NCT00742183|526699130|FG001|Overall Study|Lack of Efficacy|3|||
146050128|NCT03922581|526699131|FG000|Overall Study|Lost to Follow-up|20|||
146050129|NCT03922581|526699132|FG001|Overall Study|Lost to Follow-up|9|||
146050130|NCT03922581|526699131|FG000|Overall Study|Physician Decision|1|||
146050131|NCT03922581|526699132|FG001|Overall Study|Physician Decision|1|||
146050132|NCT03922581|526699131|FG000|Overall Study|Withdrawal by Subject|1|||
146050133|NCT03922581|526699132|FG001|Overall Study|Withdrawal by Subject|0|||
146050134|NCT00764699|526699133|FG000|Overall Study|PI left and study terminated|3|||
146050135|NCT01508312|526699134|FG000|Overall Study|Lost to Follow-up|1|||
146050136|NCT01508312|526699135|FG001|Overall Study|Lost to Follow-up|0|||
146050137|NCT01508312|526699136|FG002|Overall Study|Lost to Follow-up|0|||
146050138|NCT01508312|526699137|FG003|Overall Study|Lost to Follow-up|0|||
146050139|NCT01508312|526699134|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146050140|NCT01508312|526699135|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
146050141|NCT01508312|526699136|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146050142|NCT01508312|526699137|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
146050143|NCT01508312|526699134|FG000|Overall Study|Adverse Event|0|||
146050144|NCT01508312|526699135|FG001|Overall Study|Adverse Event|0|||
146050145|NCT01508312|526699136|FG002|Overall Study|Adverse Event|2|||
146050146|NCT01508312|526699137|FG003|Overall Study|Adverse Event|0|||
146050147|NCT01508312|526699134|FG000|Overall Study|Lack of Efficacy|0|||
146050148|NCT01508312|526699135|FG001|Overall Study|Lack of Efficacy|0|||
146050149|NCT01508312|526699136|FG002|Overall Study|Lack of Efficacy|1|||
146050150|NCT01508312|526699137|FG003|Overall Study|Lack of Efficacy|0|||
146050151|NCT01508312|526699134|FG000|Overall Study|Withdrawal by Subject|0|||
146050152|NCT01508312|526699135|FG001|Overall Study|Withdrawal by Subject|0|||
146050153|NCT01508312|526699136|FG002|Overall Study|Withdrawal by Subject|1|||
146050154|NCT01508312|526699137|FG003|Overall Study|Withdrawal by Subject|0|||
146050155|NCT02223715|526699138|FG000|Overall Study|Death|31|||
146050156|NCT02223715|526699138|FG000|Overall Study|Lost to Follow-up|73|||
146050157|NCT03906071|526699141|FG000|Overall Study|Death|180|||
146050158|NCT03906071|526699142|FG001|Overall Study|Death|185|||
146050159|NCT03906071|526699141|FG000|Overall Study|Lost to Follow-up|3|||
146050160|NCT03906071|526699142|FG001|Overall Study|Lost to Follow-up|3|||
146050161|NCT03906071|526699141|FG000|Overall Study|Withdrawal by Subject|15|||
146050162|NCT03906071|526699142|FG001|Overall Study|Withdrawal by Subject|27|||
146050163|NCT03906071|526699141|FG000|Overall Study|Other|2|||
146050164|NCT03906071|526699142|FG001|Overall Study|Other|1|||
146050165|NCT00466440|526699143|FG000|Overall Study|Adverse Event|0|||
146050166|NCT00466440|526699144|FG001|Overall Study|Adverse Event|3|||
146050167|NCT00466440|526699145|FG002|Overall Study|Adverse Event|1|||
146050168|NCT00466440|526699143|FG000|Overall Study|Death|1|||
146050169|NCT00466440|526699144|FG001|Overall Study|Death|1|||
146050170|NCT00466440|526699145|FG002|Overall Study|Death|0|||
146050171|NCT00466440|526699143|FG000|Overall Study|Progressive disease|13|||
146050172|NCT00466440|526699144|FG001|Overall Study|Progressive disease|5|||
146050173|NCT00466440|526699145|FG002|Overall Study|Progressive disease|4|||
146050174|NCT00466440|526699143|FG000|Overall Study|Lost to Follow-up|0|||
146050175|NCT00466440|526699144|FG001|Overall Study|Lost to Follow-up|1|||
146050176|NCT00466440|526699145|FG002|Overall Study|Lost to Follow-up|0|||
146050177|NCT00466440|526699143|FG000|Overall Study|Physician Decision|0|||
146050178|NCT00466440|526699144|FG001|Overall Study|Physician Decision|1|||
146050179|NCT00466440|526699145|FG002|Overall Study|Physician Decision|2|||
146050180|NCT00466440|526699143|FG000|Overall Study|Protocol entry criteria not met|0|||
146050181|NCT00466440|526699144|FG001|Overall Study|Protocol entry criteria not met|0|||
146050182|NCT00466440|526699145|FG002|Overall Study|Protocol entry criteria not met|4|||
146050183|NCT00466440|526699143|FG000|Overall Study|Withdrawal by Subject|0|||
146050184|NCT00466440|526699144|FG001|Overall Study|Withdrawal by Subject|1|||
146050185|NCT00466440|526699145|FG002|Overall Study|Withdrawal by Subject|0|||
146050186|NCT00466440|526699143|FG000|Overall Study|Sponsor decision|0|||
146050187|NCT00466440|526699144|FG001|Overall Study|Sponsor decision|0|||
146050188|NCT00466440|526699145|FG002|Overall Study|Sponsor decision|1|||
146300956|NCT05975840|527617179|FG004|Overall Study|Withdrawal by Subject|0|||
146050189|NCT03187132|526699146|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
146050190|NCT03187132|526699147|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
146050191|NCT03187132|526699146|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
146050192|NCT03187132|526699147|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
146050193|NCT03187132|526699146|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
146050194|NCT03187132|526699147|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
146050195|NCT03187132|526699146|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
146050196|NCT03187132|526699147|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
146256672|NCT00111839|527454254|FG001|Overall Study|Death|1|||
146256673|NCT00111839|527454255|FG002|Overall Study|Death|6|||
146256674|NCT00111839|527454253|FG000|Overall Study|Withdrawal by Subject|2|||
146256675|NCT00111839|527454254|FG001|Overall Study|Withdrawal by Subject|2|||
146256676|NCT00111839|527454255|FG002|Overall Study|Withdrawal by Subject|2|||
146256677|NCT00111839|527454253|FG000|Overall Study|Lost to Follow-up|1|||
146256678|NCT00111839|527454254|FG001|Overall Study|Lost to Follow-up|0|||
145939672|NCT03408444|526288057|FG003|Overall Study|Withdrawal by Subject|0|||
145939673|NCT03408444|526288054|FG000|Overall Study|Lost to Follow-up|0|||
145939674|NCT03408444|526288055|FG001|Overall Study|Lost to Follow-up|0|||
145939675|NCT03408444|526288056|FG002|Overall Study|Lost to Follow-up|1|||
145939676|NCT03408444|526288057|FG003|Overall Study|Lost to Follow-up|0|||
145939677|NCT03408444|526288054|FG000|Overall Study|Adverse Event|0|||
145939678|NCT03408444|526288055|FG001|Overall Study|Adverse Event|0|||
145939679|NCT03408444|526288056|FG002|Overall Study|Adverse Event|0|||
145939680|NCT03408444|526288057|FG003|Overall Study|Adverse Event|1|||
145939681|NCT03408444|526288054|FG000|Overall Study|Lens Handling Difficulties|0|||
145939682|NCT03408444|526288055|FG001|Overall Study|Lens Handling Difficulties|0|||
146256679|NCT00111839|527454255|FG002|Overall Study|Lost to Follow-up|0|||
146256680|NCT00111839|527454253|FG000|Overall Study|Logistical Constraint|1|||
145939683|NCT03408444|526288056|FG002|Overall Study|Lens Handling Difficulties|1|||
145939684|NCT03408444|526288057|FG003|Overall Study|Lens Handling Difficulties|0|||
145939685|NCT03408444|526288054|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145939686|NCT03408444|526288055|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145939687|NCT03408444|526288056|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145939688|NCT03408444|526288057|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
145939689|NCT04984681|526288058|FG000|Overall Study|Lost to Follow-up|3|||
145939690|NCT04984681|526288059|FG001|Overall Study|Lost to Follow-up|1|||
145939691|NCT01214252|526288060|FG000|Overall Study|Not eligible per protocol|82|||
145939692|NCT01473394|526288061|FG000|Overall Study|Adverse Event|13|||
145939693|NCT01473394|526288062|FG001|Overall Study|Adverse Event|16|||
145939694|NCT01473394|526288061|FG000|Overall Study|Insufficient Therapeutic Response|4|||
145939695|NCT01473394|526288062|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145939696|NCT01473394|526288061|FG000|Overall Study|Protocol Violation|7|||
145939697|NCT01473394|526288062|FG001|Overall Study|Protocol Violation|5|||
145939698|NCT01473394|526288061|FG000|Overall Study|Withdrew Consent|12|||
145939699|NCT01473394|526288062|FG001|Overall Study|Withdrew Consent|10|||
145939700|NCT01473394|526288061|FG000|Overall Study|Lost to Follow-up|9|||
145939701|NCT01473394|526288062|FG001|Overall Study|Lost to Follow-up|11|||
145939702|NCT00552032|526288063|FG000|Overall Study|Withdrawal by Subject|2|||
145939703|NCT00552032|526288064|FG001|Overall Study|Withdrawal by Subject|2|||
145939704|NCT00552032|526288063|FG000|Overall Study|Protocol Violation|7|||
145939705|NCT00552032|526288064|FG001|Overall Study|Protocol Violation|12|||
145939706|NCT00552032|526288063|FG000|Overall Study|Lost to Follow-up|8|||
145939707|NCT00552032|526288064|FG001|Overall Study|Lost to Follow-up|5|||
145939708|NCT04430738|526288065|FG000|Phase 1: Dose Escalation|Death|1|||
145939709|NCT04430738|526288066|FG001|Phase 1: Dose Escalation|Death|4|||
145939710|NCT04430738|526288067|FG002|Phase 1: Dose Escalation|Death|4|||
145939711|NCT04430738|526288068|FG003|Phase 1: Dose Escalation|Death|1|||
145939712|NCT04430738|526288069|FG004|Phase 1: Dose Escalation|Death|6|||
145939713|NCT04430738|526288070|FG005|Phase 1: Dose Escalation|Death|0|||
145939714|NCT04430738|526288065|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
145939715|NCT04430738|526288066|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145939716|NCT04430738|526288067|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
145939717|NCT04430738|526288068|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145939718|NCT04430738|526288069|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145939719|NCT04430738|526288070|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
145939720|NCT04430738|526288065|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145939721|NCT04430738|526288066|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
145939722|NCT04430738|526288067|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145939723|NCT04430738|526288068|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
145939724|NCT04430738|526288069|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
146256681|NCT00111839|527454254|FG001|Overall Study|Logistical Constraint|0|||
146256682|NCT00111839|527454255|FG002|Overall Study|Logistical Constraint|0|||
145939725|NCT04430738|526288070|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145939726|NCT04430738|526288065|FG000|Phase 1: Dose Escalation|Other|1|||
145939727|NCT04430738|526288066|FG001|Phase 1: Dose Escalation|Other|0|||
145939728|NCT04430738|526288067|FG002|Phase 1: Dose Escalation|Other|0|||
145939729|NCT04430738|526288068|FG003|Phase 1: Dose Escalation|Other|0|||
145939730|NCT04430738|526288069|FG004|Phase 1: Dose Escalation|Other|0|||
145939731|NCT04430738|526288070|FG005|Phase 1: Dose Escalation|Other|0|||
145939732|NCT04430738|526288065|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
146256683|NCT00111839|527454253|FG000|Overall Study|Other|6|||
146256684|NCT00111839|527454254|FG001|Overall Study|Other|3|||
146256685|NCT00111839|527454255|FG002|Overall Study|Other|3|||
145939733|NCT04430738|526288066|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145939734|NCT04430738|526288067|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145939735|NCT04430738|526288068|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145939736|NCT04430738|526288069|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145939737|NCT04430738|526288070|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
145939738|NCT04430738|526288065|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145939739|NCT04430738|526288066|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145939740|NCT04430738|526288067|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145939741|NCT04430738|526288068|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145939742|NCT04430738|526288069|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145939743|NCT04430738|526288070|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
145939744|NCT04777201|526288074|FG000|Main Study|Withdrawal by Subject|19|||
145939745|NCT04777201|526288075|FG001|Main Study|Withdrawal by Subject|27|||
145939746|NCT04777201|526288076|FG002|Main Study|Withdrawal by Subject|0|||
145939747|NCT04777201|526288074|FG000|Main Study|Death|13|||
145939748|NCT04777201|526288075|FG001|Main Study|Death|27|||
145939749|NCT04777201|526288076|FG002|Main Study|Death|0|||
145939750|NCT04777201|526288074|FG000|Main Study|Subject missed the safety follow-up visit|9|||
145939751|NCT04777201|526288075|FG001|Main Study|Subject missed the safety follow-up visit|10|||
145939752|NCT04777201|526288076|FG002|Main Study|Subject missed the safety follow-up visit|0|||
145939753|NCT04777201|526288074|FG000|Main Study|Physician Decision|8|||
145939754|NCT04777201|526288075|FG001|Main Study|Physician Decision|10|||
145939755|NCT04777201|526288076|FG002|Main Study|Physician Decision|0|||
145939756|NCT04777201|526288074|FG000|Main Study|Adverse Event|8|||
145939757|NCT04777201|526288075|FG001|Main Study|Adverse Event|8|||
145939758|NCT04777201|526288076|FG002|Main Study|Adverse Event|0|||
145939759|NCT04777201|526288074|FG000|Main Study|Lost to Follow-up|9|||
145939760|NCT04777201|526288075|FG001|Main Study|Lost to Follow-up|4|||
145939761|NCT04777201|526288076|FG002|Main Study|Lost to Follow-up|0|||
145939762|NCT04777201|526288074|FG000|Main Study|Reason not specified|3|||
145939763|NCT04777201|526288075|FG001|Main Study|Reason not specified|3|||
145939764|NCT04777201|526288076|FG002|Main Study|Reason not specified|0|||
145939765|NCT04777201|526288074|FG000|Main Study|Lack of Efficacy|1|||
145939766|NCT04777201|526288075|FG001|Main Study|Lack of Efficacy|1|||
145939767|NCT04777201|526288076|FG002|Main Study|Lack of Efficacy|0|||
145939768|NCT04777201|526288074|FG000|Main Study|Protocol Violation|1|||
145939769|NCT04777201|526288075|FG001|Main Study|Protocol Violation|0|||
145939770|NCT04777201|526288076|FG002|Main Study|Protocol Violation|0|||
145939771|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
145939772|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
145939773|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
145939774|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
145939775|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
145939776|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
145939777|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
145939778|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
145939779|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
145939780|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
145939781|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
145939782|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
145939783|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
145939784|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
145939785|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
145939786|NCT04777201|526288074|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
145939787|NCT04777201|526288075|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
145939788|NCT04777201|526288076|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
145939789|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Adverse Event|6|||
145939790|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Adverse Event|14|||
145939791|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Death|3|||
145939792|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Death|1|||
145939793|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
145939794|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
146256686|NCT00111839|527454253|FG000|Overall Study|Randomized but Not Treated|0|||
145939795|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
145939796|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
145939797|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
145939798|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
145939799|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
145939800|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
145939801|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
145939802|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
145939803|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Physician Decision|2|||
145939804|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Physician Decision|4|||
145939805|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Pregnancy|2|||
145939806|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Pregnancy|1|||
145939807|NCT02275780|526288077|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
145939808|NCT02275780|526288078|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
145939809|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
145939810|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
145939811|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
145939812|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
145939813|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
145939814|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
145939815|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
145939816|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
145939817|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
145939818|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
145939819|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
145939820|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
145939821|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
145939822|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
145939823|NCT02275780|526288077|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
145939824|NCT02275780|526288078|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
145939825|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
145939826|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
145939827|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
145939828|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
145939829|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
145939830|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
145939831|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
145939832|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
145939833|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
145939834|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
145939835|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
145939836|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
145939837|NCT02275780|526288077|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
145939838|NCT02275780|526288078|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
145939839|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
145939840|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
145939841|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
145939842|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
145939843|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
145939844|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
145939845|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
145939846|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
145939847|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
145939848|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
145939849|NCT02275780|526288077|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
145939850|NCT02275780|526288078|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
145939851|NCT01054300|526288081|FG000|Period 1|Adverse Event|1|||
145939852|NCT01054300|526288082|FG001|Period 1|Adverse Event|0|||
145939853|NCT01054300|526288083|FG002|Period 1|Adverse Event|0|||
145939854|NCT01054300|526288084|FG003|Period 1|Adverse Event|0|||
145939855|NCT01054300|526288081|FG000|Period 2|Withdrawal by Subject|0|||
145939856|NCT01054300|526288082|FG001|Period 2|Withdrawal by Subject|0|||
145939857|NCT01054300|526288083|FG002|Period 2|Withdrawal by Subject|1|||
145939858|NCT01054300|526288084|FG003|Period 2|Withdrawal by Subject|0|||
145939859|NCT00738881|526288088|FG000|Overall Study|Withdrawal by Subject|0|||
145939860|NCT00738881|526288089|FG001|Overall Study|Withdrawal by Subject|2|||
145939861|NCT00348790|526288090|FG000|Completed Treatment|Withdrawal by Subject|4|||
145939862|NCT00348790|526288090|FG000|Completed Treatment|Disease progression|14|||
145939863|NCT00348790|526288090|FG000|Completed Treatment|Adverse Event|4|||
145939864|NCT00348790|526288090|FG000|Completed Treatment|Required surgery|2|||
145939865|NCT00348790|526288090|FG000|Completed Treatment|Unable to travel to study site|1|||
145939866|NCT04186806|526288091|FG000|Period 1: 7 Days|Adverse Event|1|||
146256687|NCT00111839|527454254|FG001|Overall Study|Randomized but Not Treated|0|||
145939867|NCT04186806|526288092|FG001|Period 1: 7 Days|Adverse Event|0|||
145939868|NCT03409107|526288093|FG000|Overall Study|Withdrawal by Subject|4|||
146050197|NCT03187132|526699146|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
146256688|NCT00111839|527454255|FG002|Overall Study|Randomized but Not Treated|2|||
146256689|NCT00588341|527454261|FG000|Overall Study|Withdrawal by Subject|3|||
146256690|NCT00588341|527454261|FG000|Overall Study|Not treated due to metastatic disease|1|||
146256691|NCT00588341|527454261|FG000|Overall Study|Patient ineligible|1|||
146256692|NCT03280108|527454262|FG000|Overall Study|Lost to Follow-up|2|||
146256693|NCT03280108|527454263|FG001|Overall Study|Lost to Follow-up|0|||
146256694|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
146256695|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146256696|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146050198|NCT03187132|526699147|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
146050199|NCT03187132|526699146|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
146050200|NCT03187132|526699147|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
146050201|NCT03187132|526699146|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
146050202|NCT03187132|526699147|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
146050203|NCT03187132|526699146|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
146050204|NCT03187132|526699147|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
146050205|NCT03187132|526699146|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
146050206|NCT03187132|526699147|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
146050207|NCT03187132|526699146|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
146050208|NCT03187132|526699147|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
146050209|NCT03187132|526699146|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
146050210|NCT03187132|526699147|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
146050211|NCT00965081|526699148|FG000|Overall Study|Adverse Event|14|||
146050212|NCT00965081|526699149|FG001|Overall Study|Adverse Event|9|||
146050213|NCT00965081|526699148|FG000|Overall Study|Lack of Efficacy|2|||
146050214|NCT00965081|526699149|FG001|Overall Study|Lack of Efficacy|5|||
146050215|NCT00965081|526699148|FG000|Overall Study|Lost to Follow-up|4|||
146050216|NCT00965081|526699149|FG001|Overall Study|Lost to Follow-up|5|||
146050217|NCT00965081|526699148|FG000|Overall Study|Physician Decision|2|||
146050218|NCT00965081|526699149|FG001|Overall Study|Physician Decision|0|||
146050219|NCT00965081|526699148|FG000|Overall Study|Protocol Violation|2|||
146050220|NCT00965081|526699149|FG001|Overall Study|Protocol Violation|5|||
146050221|NCT00965081|526699148|FG000|Overall Study|Sponsor Decision|1|||
146050222|NCT00965081|526699149|FG001|Overall Study|Sponsor Decision|0|||
146050223|NCT00965081|526699148|FG000|Overall Study|Withdrawal by Subject|4|||
146050224|NCT00965081|526699149|FG001|Overall Study|Withdrawal by Subject|7|||
146050225|NCT00965081|526699148|FG000|Overall Study|Switched to Rescue Arm|5|||
146050226|NCT00965081|526699149|FG001|Overall Study|Switched to Rescue Arm|12|||
146050227|NCT01367834|526699152|FG000|Overall Study|Withdrawal by Subject|2|||
146050228|NCT01367834|526699153|FG001|Overall Study|Withdrawal by Subject|2|||
146050229|NCT01367834|526699152|FG000|Overall Study|Study was ended.|0|||
146050230|NCT01367834|526699153|FG001|Overall Study|Study was ended.|1|||
146050231|NCT00988598|526699154|FG000|Overall Study|Withdrawal by Subject|2|||
146050232|NCT00988598|526699155|FG001|Overall Study|Withdrawal by Subject|0|||
146050233|NCT01141712|526699161|FG000|Overall Study|Disease progression|3|||
146050234|NCT04112810|526699172|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
146050235|NCT05963022|526699173|FG000|Overall Study|Adverse Event|0|||
146050236|NCT05963022|526699174|FG001|Overall Study|Adverse Event|1|||
146050237|NCT05963022|526699175|FG002|Overall Study|Adverse Event|1|||
146050238|NCT05963022|526699176|FG003|Overall Study|Adverse Event|0|||
146050239|NCT05963022|526699173|FG000|Overall Study|Protocol Violation|0|||
146050240|NCT05963022|526699174|FG001|Overall Study|Protocol Violation|3|||
146050241|NCT05963022|526699175|FG002|Overall Study|Protocol Violation|0|||
146050242|NCT05963022|526699176|FG003|Overall Study|Protocol Violation|0|||
146050243|NCT05963022|526699173|FG000|Overall Study|Pregnancy|0|||
146050244|NCT05963022|526699174|FG001|Overall Study|Pregnancy|1|||
146050245|NCT05963022|526699175|FG002|Overall Study|Pregnancy|1|||
146050246|NCT05963022|526699176|FG003|Overall Study|Pregnancy|1|||
146050247|NCT05963022|526699173|FG000|Overall Study|Withdrawal by Subject|0|||
146050248|NCT05963022|526699174|FG001|Overall Study|Withdrawal by Subject|0|||
146050249|NCT05963022|526699175|FG002|Overall Study|Withdrawal by Subject|2|||
146050250|NCT05963022|526699176|FG003|Overall Study|Withdrawal by Subject|1|||
146050251|NCT05963022|526699173|FG000|Overall Study|Lost to Follow-up|0|||
146256697|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146256698|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
146050252|NCT05963022|526699174|FG001|Overall Study|Lost to Follow-up|0|||
146050253|NCT05963022|526699175|FG002|Overall Study|Lost to Follow-up|0|||
146050254|NCT05963022|526699176|FG003|Overall Study|Lost to Follow-up|1|||
146050255|NCT05963022|526699173|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146050256|NCT05963022|526699174|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146050257|NCT05963022|526699175|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
146050258|NCT05963022|526699176|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
146050259|NCT01012258|526699177|FG000|Overall Study|Death|14|||
146050260|NCT01012258|526699177|FG000|Overall Study|Lost to Follow-up|1|||
146256699|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
145939869|NCT03409107|526288094|FG001|Overall Study|Withdrawal by Subject|2|||
145939870|NCT03409107|526288093|FG000|Overall Study|Physician Decision|1|||
145939871|NCT03409107|526288094|FG001|Overall Study|Physician Decision|0|||
145939872|NCT03409107|526288093|FG000|Overall Study|Lost to Follow-up|7|||
145939873|NCT03409107|526288094|FG001|Overall Study|Lost to Follow-up|2|||
145939874|NCT03409107|526288093|FG000|Overall Study|Adverse Event|5|||
145939875|NCT03409107|526288094|FG001|Overall Study|Adverse Event|3|||
145939876|NCT00916344|526288095|FG000|Overall Study|Death|2|||
145939877|NCT00916344|526288095|FG000|Overall Study|ICD upgrade|1|||
145939878|NCT00916344|526288095|FG000|Overall Study|Drop-out|5|||
145939879|NCT03687372|526288100|FG000|Overall Study|Lost to Follow-up|12|||
145939880|NCT03687372|526288101|FG001|Overall Study|Lost to Follow-up|21|||
145939881|NCT03687372|526288100|FG000|Overall Study|Withdrawal by Subject|4|||
145939882|NCT03687372|526288101|FG001|Overall Study|Withdrawal by Subject|17|||
145939883|NCT03687372|526288100|FG000|Overall Study|Investigator Decision|1|||
145939884|NCT03687372|526288101|FG001|Overall Study|Investigator Decision|1|||
145939885|NCT03602391|526288104|FG000|Overall Study|COVID-19|7|||
145939886|NCT03602391|526288105|FG001|Overall Study|COVID-19|6|||
145939887|NCT00705718|526288116|FG000|Overall Study|Death|6|||
145939888|NCT00705718|526288117|FG001|Overall Study|Death|6|||
145939889|NCT00705718|526288116|FG000|Overall Study|Not due for Visit|0|||
145939890|NCT00705718|526288117|FG001|Overall Study|Not due for Visit|12|||
145939891|NCT00705718|526288116|FG000|Overall Study|Follow up not done|1|||
145939892|NCT00705718|526288117|FG001|Overall Study|Follow up not done|4|||
145939893|NCT02954653|526288118|FG000|Overall Study|Death|3|||
145939894|NCT02954653|526288119|FG001|Overall Study|Death|1|||
145939895|NCT02954653|526288120|FG002|Overall Study|Death|0|||
145939896|NCT02954653|526288121|FG003|Overall Study|Death|0|||
145939897|NCT02954653|526288122|FG004|Overall Study|Death|0|||
145939898|NCT02954653|526288123|FG005|Overall Study|Death|0|||
145939899|NCT02954653|526288124|FG006|Overall Study|Death|0|||
145939900|NCT02954653|526288125|FG007|Overall Study|Death|0|||
145939901|NCT02954653|526288126|FG008|Overall Study|Death|0|||
145939902|NCT02954653|526288118|FG000|Overall Study|Randomized but did not receive treatment|1|||
145939903|NCT02954653|526288119|FG001|Overall Study|Randomized but did not receive treatment|0|||
145939904|NCT02954653|526288120|FG002|Overall Study|Randomized but did not receive treatment|0|||
145939905|NCT02954653|526288121|FG003|Overall Study|Randomized but did not receive treatment|0|||
145939906|NCT02954653|526288122|FG004|Overall Study|Randomized but did not receive treatment|0|||
145939907|NCT02954653|526288123|FG005|Overall Study|Randomized but did not receive treatment|0|||
145939908|NCT02954653|526288124|FG006|Overall Study|Randomized but did not receive treatment|0|||
145939909|NCT02954653|526288125|FG007|Overall Study|Randomized but did not receive treatment|0|||
145939910|NCT02954653|526288126|FG008|Overall Study|Randomized but did not receive treatment|0|||
145939911|NCT02954653|526288118|FG000|Overall Study|Started another anti-cancer therapy|0|||
145939912|NCT02954653|526288119|FG001|Overall Study|Started another anti-cancer therapy|1|||
145939913|NCT02954653|526288120|FG002|Overall Study|Started another anti-cancer therapy|0|||
145939914|NCT02954653|526288121|FG003|Overall Study|Started another anti-cancer therapy|0|||
145939915|NCT02954653|526288122|FG004|Overall Study|Started another anti-cancer therapy|0|||
145939916|NCT02954653|526288123|FG005|Overall Study|Started another anti-cancer therapy|0|||
145939917|NCT02954653|526288124|FG006|Overall Study|Started another anti-cancer therapy|0|||
145939918|NCT02954653|526288125|FG007|Overall Study|Started another anti-cancer therapy|0|||
145939919|NCT02954653|526288126|FG008|Overall Study|Started another anti-cancer therapy|0|||
145939920|NCT02954653|526288118|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
145939921|NCT02954653|526288119|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
145939922|NCT02954653|526288120|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
146256700|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146256701|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145939923|NCT02954653|526288121|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
145939924|NCT02954653|526288122|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
145939925|NCT02954653|526288123|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
145939926|NCT02954653|526288124|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
145939927|NCT02954653|526288125|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
146256702|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
146256703|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145939928|NCT02954653|526288126|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
145939929|NCT03054064|526288127|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
145939930|NCT03054064|526288127|FG000|Overall Study|Investigator Decision|2|||
145939931|NCT03054064|526288127|FG000|Overall Study|Bladder Issue|1|||
145939932|NCT03054064|526288127|FG000|Overall Study|High Blood Pressure|1|||
145939933|NCT03054064|526288127|FG000|Overall Study|Change in Status|1|||
145939934|NCT01459718|526288130|FG000|Overall Study|Physician Decision|1|||
145939935|NCT01459718|526288130|FG000|Overall Study|Lost to Follow-up|1|||
145939936|NCT01459718|526288130|FG000|Overall Study|Adverse Event|1|||
145939937|NCT00581542|526288131|FG000|Overall Study|they met an exclusion criteria|2|||
145939938|NCT00581542|526288132|FG001|Overall Study|they met an exclusion criteria|2|||
146256704|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
146256705|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146256706|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146256707|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146256708|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
146256709|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
146256710|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146256711|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146300957|NCT05975840|527617180|FG005|Overall Study|Withdrawal by Subject|2|||
146300958|NCT05975840|527617181|FG006|Overall Study|Withdrawal by Subject|2|||
146300959|NCT05975840|527617182|FG007|Overall Study|Withdrawal by Subject|1|||
146300960|NCT05975840|527617175|FG000|Overall Study|Protocol Violation|0|||
146300961|NCT05975840|527617176|FG001|Overall Study|Protocol Violation|1|||
146300962|NCT05975840|527617177|FG002|Overall Study|Protocol Violation|0|||
146300963|NCT05975840|527617178|FG003|Overall Study|Protocol Violation|0|||
146300964|NCT05975840|527617179|FG004|Overall Study|Protocol Violation|0|||
146300965|NCT05975840|527617180|FG005|Overall Study|Protocol Violation|0|||
146300966|NCT05975840|527617181|FG006|Overall Study|Protocol Violation|0|||
146300967|NCT05975840|527617182|FG007|Overall Study|Protocol Violation|0|||
146300968|NCT05975840|527617175|FG000|Overall Study|Adverse Event|0|||
146300969|NCT05975840|527617176|FG001|Overall Study|Adverse Event|0|||
146300970|NCT05975840|527617177|FG002|Overall Study|Adverse Event|0|||
146300971|NCT05975840|527617178|FG003|Overall Study|Adverse Event|1|||
146300972|NCT05975840|527617179|FG004|Overall Study|Adverse Event|0|||
146300973|NCT05975840|527617180|FG005|Overall Study|Adverse Event|0|||
146300974|NCT05975840|527617181|FG006|Overall Study|Adverse Event|0|||
146300975|NCT05975840|527617182|FG007|Overall Study|Adverse Event|0|||
146300976|NCT05975840|527617175|FG000|Overall Study|Death|0|||
146300977|NCT05975840|527617176|FG001|Overall Study|Death|1|||
146300978|NCT05975840|527617177|FG002|Overall Study|Death|0|||
146300979|NCT05975840|527617178|FG003|Overall Study|Death|0|||
146300980|NCT05975840|527617179|FG004|Overall Study|Death|0|||
146300981|NCT05975840|527617180|FG005|Overall Study|Death|0|||
146300982|NCT05975840|527617181|FG006|Overall Study|Death|0|||
146300983|NCT05975840|527617182|FG007|Overall Study|Death|1|||
146300984|NCT02877927|527617185|FG000|Overall Study|Adverse Event|1|||
146300985|NCT02877927|527617186|FG001|Overall Study|Adverse Event|0|||
146300986|NCT02877927|527617185|FG000|Overall Study|Lost to Follow-up|37|||
146300987|NCT02877927|527617186|FG001|Overall Study|Lost to Follow-up|38|||
146300988|NCT02877927|527617185|FG000|Overall Study|Withdrawal by Subject|11|||
146300989|NCT02877927|527617186|FG001|Overall Study|Withdrawal by Subject|12|||
146300990|NCT02877927|527617185|FG000|Overall Study|Physician Decision|0|||
146300991|NCT02877927|527617186|FG001|Overall Study|Physician Decision|1|||
146300992|NCT02877927|527617185|FG000|Overall Study|Missed EOT/PTE Visit|5|||
146300993|NCT02877927|527617186|FG001|Overall Study|Missed EOT/PTE Visit|6|||
146300994|NCT00601250|527617187|FG000|Overall Study|Adverse Event|3|||
146300995|NCT00601250|527617188|FG001|Overall Study|Adverse Event|9|||
146300996|NCT00601250|527617187|FG000|Overall Study|Protocol Violation|3|||
146300997|NCT00601250|527617188|FG001|Overall Study|Protocol Violation|2|||
146300998|NCT00601250|527617187|FG000|Overall Study|Lost to Follow-up|2|||
146300999|NCT00601250|527617188|FG001|Overall Study|Lost to Follow-up|6|||
146301000|NCT00601250|527617187|FG000|Overall Study|Withdrawal by Subject|4|||
146301001|NCT00601250|527617188|FG001|Overall Study|Withdrawal by Subject|13|||
146301002|NCT00601250|527617187|FG000|Overall Study|Other incl. lack of efficacy|2|||
146301003|NCT00601250|527617188|FG001|Overall Study|Other incl. lack of efficacy|9|||
146301004|NCT01810016|527617189|FG000|Overall Study|Progressive disease|1|||
146301005|NCT01810016|527617190|FG001|Overall Study|Progressive disease|1|||
146301006|NCT01810016|527617191|FG002|Overall Study|Progressive disease|0|||
146301007|NCT01810016|527617189|FG000|Overall Study|Death|0|||
146301008|NCT01810016|527617190|FG001|Overall Study|Death|0|||
146301009|NCT01810016|527617191|FG002|Overall Study|Death|1|||
146301010|NCT01791803|527617196|FG000|Overall Study|Withdrawal by Subject|0|||
146301011|NCT01791803|527617197|FG001|Overall Study|Withdrawal by Subject|0|||
146301012|NCT01791803|527617198|FG002|Overall Study|Withdrawal by Subject|0|||
146301013|NCT01791803|527617199|FG003|Overall Study|Withdrawal by Subject|2|||
146301014|NCT01791803|527617196|FG000|Overall Study|Physician Decision|0|||
146301015|NCT01791803|527617197|FG001|Overall Study|Physician Decision|2|||
145939939|NCT00581542|526288131|FG000|Overall Study|Lost to Follow-up|9|||
146301016|NCT01791803|527617198|FG002|Overall Study|Physician Decision|0|||
146301017|NCT01791803|527617199|FG003|Overall Study|Physician Decision|1|||
146301018|NCT01791803|527617196|FG000|Overall Study|Death|0|||
146301019|NCT01791803|527617197|FG001|Overall Study|Death|0|||
145939940|NCT00581542|526288132|FG001|Overall Study|Lost to Follow-up|21|||
145939941|NCT01546571|526288133|FG000|Overall Study|Adverse Event|1|||
146301020|NCT01791803|527617198|FG002|Overall Study|Death|2|||
146301021|NCT01791803|527617199|FG003|Overall Study|Death|2|||
146301022|NCT00972777|527617200|FG000|Overall Study|Adverse Event|3|||
146301023|NCT00972777|527617201|FG001|Overall Study|Adverse Event|2|||
146301024|NCT00972777|527617200|FG000|Overall Study|Lost to Follow-up|0|||
145939942|NCT01546571|526288134|FG001|Overall Study|Adverse Event|0|||
145939943|NCT01546571|526288135|FG002|Overall Study|Adverse Event|0|||
145939944|NCT01546571|526288136|FG003|Overall Study|Adverse Event|1|||
145939945|NCT01546571|526288137|FG004|Overall Study|Adverse Event|0|||
145939946|NCT01546571|526288133|FG000|Overall Study|assigned placebo in Part A|0|||
145939947|NCT01546571|526288134|FG001|Overall Study|assigned placebo in Part A|0|||
145939948|NCT01546571|526288135|FG002|Overall Study|assigned placebo in Part A|22|||
145939949|NCT01546571|526288136|FG003|Overall Study|assigned placebo in Part A|0|||
145939950|NCT01546571|526288137|FG004|Overall Study|assigned placebo in Part A|0|||
145939951|NCT01546571|526288133|FG000|Overall Study|Death|0|||
145939952|NCT01546571|526288134|FG001|Overall Study|Death|1|||
145939953|NCT01546571|526288135|FG002|Overall Study|Death|0|||
145939954|NCT01546571|526288136|FG003|Overall Study|Death|0|||
145939955|NCT01546571|526288137|FG004|Overall Study|Death|0|||
145939956|NCT01546571|526288133|FG000|Overall Study|Lost to Follow-up|0|||
145939957|NCT01546571|526288134|FG001|Overall Study|Lost to Follow-up|0|||
145939958|NCT01546571|526288135|FG002|Overall Study|Lost to Follow-up|2|||
145939959|NCT01546571|526288136|FG003|Overall Study|Lost to Follow-up|2|||
145939960|NCT01546571|526288137|FG004|Overall Study|Lost to Follow-up|3|||
145939961|NCT01546571|526288133|FG000|Overall Study|Pregnancy|0|||
145939962|NCT01546571|526288134|FG001|Overall Study|Pregnancy|0|||
145939963|NCT01546571|526288135|FG002|Overall Study|Pregnancy|0|||
145939964|NCT01546571|526288136|FG003|Overall Study|Pregnancy|1|||
145939965|NCT01546571|526288137|FG004|Overall Study|Pregnancy|0|||
145939966|NCT01546571|526288133|FG000|Overall Study|Disease Progression|20|||
145939967|NCT01546571|526288134|FG001|Overall Study|Disease Progression|18|||
145939968|NCT01546571|526288135|FG002|Overall Study|Disease Progression|15|||
145939969|NCT01546571|526288136|FG003|Overall Study|Disease Progression|73|||
145939970|NCT01546571|526288137|FG004|Overall Study|Disease Progression|37|||
145939971|NCT01546571|526288133|FG000|Overall Study|Withdrawal by Subject|1|||
145939972|NCT01546571|526288134|FG001|Overall Study|Withdrawal by Subject|2|||
145939973|NCT01546571|526288135|FG002|Overall Study|Withdrawal by Subject|4|||
145939974|NCT01546571|526288136|FG003|Overall Study|Withdrawal by Subject|9|||
145939975|NCT01546571|526288137|FG004|Overall Study|Withdrawal by Subject|2|||
145939976|NCT01546571|526288133|FG000|Overall Study|Intercurrent Illness|1|||
145939977|NCT01546571|526288134|FG001|Overall Study|Intercurrent Illness|2|||
145939978|NCT01546571|526288135|FG002|Overall Study|Intercurrent Illness|0|||
145939979|NCT01546571|526288136|FG003|Overall Study|Intercurrent Illness|0|||
145939980|NCT01546571|526288137|FG004|Overall Study|Intercurrent Illness|0|||
145939981|NCT01546571|526288133|FG000|Overall Study|Other Cancers|0|||
145939982|NCT01546571|526288134|FG001|Overall Study|Other Cancers|0|||
145939983|NCT01546571|526288135|FG002|Overall Study|Other Cancers|0|||
145939984|NCT01546571|526288136|FG003|Overall Study|Other Cancers|3|||
145939985|NCT01546571|526288137|FG004|Overall Study|Other Cancers|1|||
145939986|NCT01546571|526288133|FG000|Overall Study|Other|0|||
145939987|NCT01546571|526288134|FG001|Overall Study|Other|0|||
145939988|NCT01546571|526288135|FG002|Overall Study|Other|3|||
145939989|NCT01546571|526288136|FG003|Overall Study|Other|0|||
145939990|NCT01546571|526288137|FG004|Overall Study|Other|0|||
145939991|NCT01880086|526288140|FG000|Overall Study|Lost to Follow-up|1|||
145939992|NCT01880086|526288141|FG001|Overall Study|Lost to Follow-up|1|||
145939993|NCT05174949|526288147|FG000|Overall Study|Physician Decision|1|||
145939994|NCT05174949|526288148|FG001|Overall Study|Physician Decision|2|||
145939995|NCT05174949|526288149|FG002|Overall Study|Physician Decision|0|||
145939996|NCT05174949|526288150|FG003|Overall Study|Physician Decision|1|||
145939997|NCT05174949|526288151|FG004|Overall Study|Physician Decision|0|||
145939998|NCT05174949|526288152|FG005|Overall Study|Physician Decision|0|||
145939999|NCT05174949|526288147|FG000|Overall Study|Withdrawal by Subject|0|||
145940000|NCT05174949|526288148|FG001|Overall Study|Withdrawal by Subject|1|||
145940001|NCT05174949|526288149|FG002|Overall Study|Withdrawal by Subject|0|||
145940002|NCT05174949|526288150|FG003|Overall Study|Withdrawal by Subject|0|||
145940003|NCT05174949|526288151|FG004|Overall Study|Withdrawal by Subject|0|||
145940004|NCT05174949|526288152|FG005|Overall Study|Withdrawal by Subject|0|||
145940005|NCT05174949|526288147|FG000|Overall Study|Lost to Follow-up|0|||
145940006|NCT05174949|526288148|FG001|Overall Study|Lost to Follow-up|0|||
145940007|NCT05174949|526288149|FG002|Overall Study|Lost to Follow-up|0|||
145940008|NCT05174949|526288150|FG003|Overall Study|Lost to Follow-up|1|||
145940009|NCT05174949|526288151|FG004|Overall Study|Lost to Follow-up|0|||
145940010|NCT05174949|526288152|FG005|Overall Study|Lost to Follow-up|0|||
145940011|NCT01123941|526288155|FG000|Overall Study|Lost to Follow-up|2|||
145940012|NCT01123941|526288156|FG001|Overall Study|Lost to Follow-up|1|||
145940013|NCT05083923|526288164|FG000|Overall Study|Adverse Event|2|||
145940014|NCT05083923|526288165|FG001|Overall Study|Adverse Event|0|||
145940015|NCT05083923|526288164|FG000|Overall Study|Lack of Efficacy|1|||
145940016|NCT05083923|526288165|FG001|Overall Study|Lack of Efficacy|3|||
145940017|NCT05083923|526288164|FG000|Overall Study|Withdrawal by Subject|2|||
145940018|NCT05083923|526288165|FG001|Overall Study|Withdrawal by Subject|6|||
145940019|NCT05083923|526288164|FG000|Overall Study|Reason Not Specified|0|||
145940020|NCT05083923|526288165|FG001|Overall Study|Reason Not Specified|1|||
145940021|NCT03099694|526288168|FG000|Overall Study|Withdrawal by Subject|11|||
146256712|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146256713|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
146256714|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
146256715|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146256716|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146256717|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146256718|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
146256719|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
146256720|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146256721|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146256722|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146256723|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
146256724|NCT01187407|527454264|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
146256725|NCT01187407|527454265|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146256726|NCT01187407|527454266|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146256727|NCT01187407|527454267|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146256728|NCT01187407|527454268|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
146256729|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
146256730|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
146256731|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
146256732|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
146256733|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
146256734|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
146256735|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
146256736|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
146256737|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
146256738|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
146256739|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
146256740|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
146256741|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
146256742|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
146256743|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
146256744|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146256745|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146256746|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
146256747|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
146256748|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
146256749|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
146256750|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
146256751|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
146256752|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
146256753|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
146256754|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
146256755|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146256756|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
146256757|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
146256758|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
146256759|NCT01187407|527454264|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
146256760|NCT01187407|527454265|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146256761|NCT01187407|527454266|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146256762|NCT01187407|527454267|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
146256763|NCT01187407|527454268|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
146256764|NCT01713998|527454269|FG000|Overall Study|Lost to Follow-up|2|||
146256765|NCT01713998|527454270|FG001|Overall Study|Lost to Follow-up|0|||
146256766|NCT01713998|527454271|FG002|Overall Study|Lost to Follow-up|2|||
146256767|NCT01713998|527454269|FG000|Overall Study|Withdrawal by Subject|1|||
146256768|NCT01713998|527454270|FG001|Overall Study|Withdrawal by Subject|0|||
146256769|NCT01713998|527454271|FG002|Overall Study|Withdrawal by Subject|0|||
146256770|NCT03638258|527454272|FG000|Overall Study|Adverse Event|1|||
146256771|NCT03638258|527454273|FG001|Overall Study|Adverse Event|0|||
146256772|NCT03638258|527454274|FG002|Overall Study|Adverse Event|2|||
146256773|NCT03638258|527454272|FG000|Overall Study|Lost to Follow-up|2|||
146256774|NCT03638258|527454273|FG001|Overall Study|Lost to Follow-up|4|||
146256775|NCT03638258|527454274|FG002|Overall Study|Lost to Follow-up|5|||
146050261|NCT01012258|526699177|FG000|Overall Study|Adverse Event|1|||
146050262|NCT01012258|526699177|FG000|Overall Study|Progressive Disease (PD)|18|||
146050263|NCT01012258|526699177|FG000|Overall Study|Symptomatic Deterioration|1|||
146256776|NCT03638258|527454272|FG000|Overall Study|Pregnancy|0|||
146256777|NCT03638258|527454273|FG001|Overall Study|Pregnancy|0|||
146256778|NCT03638258|527454274|FG002|Overall Study|Pregnancy|1|||
146256779|NCT03638258|527454272|FG000|Overall Study|Protocol Violation|0|||
146256780|NCT03638258|527454273|FG001|Overall Study|Protocol Violation|0|||
146256781|NCT03638258|527454274|FG002|Overall Study|Protocol Violation|1|||
146256782|NCT03638258|527454272|FG000|Overall Study|Withdrawal by Subject|4|||
146256783|NCT03638258|527454273|FG001|Overall Study|Withdrawal by Subject|5|||
146256784|NCT03638258|527454274|FG002|Overall Study|Withdrawal by Subject|12|||
146256785|NCT03638258|527454272|FG000|Overall Study|Lack of Efficacy|0|||
146256786|NCT03638258|527454273|FG001|Overall Study|Lack of Efficacy|0|||
146256787|NCT03638258|527454274|FG002|Overall Study|Lack of Efficacy|2|||
146256788|NCT01287416|527454275|FG000|Pre-post Training|Withdrawal by Subject|17|||
146256789|NCT01287416|527454276|FG001|Pre-post Training|Withdrawal by Subject|24|||
146256790|NCT01287416|527454275|FG000|Pre-post Training|Lost to Follow-up|5|||
146256791|NCT01287416|527454276|FG001|Pre-post Training|Lost to Follow-up|1|||
146256792|NCT01287416|527454275|FG000|6 Month Follow-up|Lost to Follow-up|3|||
145940022|NCT03099694|526288169|FG001|Overall Study|Withdrawal by Subject|13|||
145940023|NCT03099694|526288168|FG000|Overall Study|Lost to Follow-up|9|||
145940024|NCT03099694|526288169|FG001|Overall Study|Lost to Follow-up|5|||
145940025|NCT02291601|526288170|FG000|Abdomen|Did not qualify|333|||
145940026|NCT02291601|526288171|FG001|Abdomen|Did not qualify|54|||
145940027|NCT02291601|526288172|FG002|Abdomen|Did not qualify|339|||
145940028|NCT02291601|526288170|FG000|Groin|Did not qualify|183|||
145940029|NCT02291601|526288171|FG001|Groin|Did not qualify|30|||
145940030|NCT02291601|526288172|FG002|Groin|Did not qualify|177|||
145940031|NCT03379753|526288173|FG000|Overall Study|Withdrawal by Subject|2|||
145940032|NCT03379753|526288174|FG001|Overall Study|Withdrawal by Subject|1|||
145940033|NCT03379753|526288173|FG000|Overall Study|not having correct procedure|1|||
145940034|NCT03379753|526288174|FG001|Overall Study|not having correct procedure|2|||
145940035|NCT03379753|526288173|FG000|Overall Study|No primary outcome|12|||
145940036|NCT03379753|526288174|FG001|Overall Study|No primary outcome|22|||
145940037|NCT04017832|526288179|FG000|Overall Study|Withdrawal by Subject|13|||
145940038|NCT04017832|526288180|FG001|Overall Study|Withdrawal by Subject|12|||
145940039|NCT04017832|526288181|FG002|Overall Study|Withdrawal by Subject|21|||
145940040|NCT04017832|526288182|FG003|Overall Study|Withdrawal by Subject|7|||
145940041|NCT04017832|526288179|FG000|Overall Study|Lost to Follow-up|0|||
145940042|NCT04017832|526288180|FG001|Overall Study|Lost to Follow-up|3|||
145940043|NCT04017832|526288181|FG002|Overall Study|Lost to Follow-up|3|||
145940044|NCT04017832|526288182|FG003|Overall Study|Lost to Follow-up|1|||
145940045|NCT04017832|526288179|FG000|Overall Study|Physician Decision|1|||
145940046|NCT04017832|526288180|FG001|Overall Study|Physician Decision|1|||
145940047|NCT04017832|526288181|FG002|Overall Study|Physician Decision|1|||
145940048|NCT04017832|526288182|FG003|Overall Study|Physician Decision|1|||
145940049|NCT04017832|526288179|FG000|Overall Study|Death|2|||
145940050|NCT04017832|526288180|FG001|Overall Study|Death|2|||
145940051|NCT04017832|526288181|FG002|Overall Study|Death|1|||
145940052|NCT04017832|526288182|FG003|Overall Study|Death|0|||
145940053|NCT01419080|526288185|FG000|Overall Study|Withdrawal by Subject|75|||
145940054|NCT01419080|526288185|FG000|Overall Study|Death|30|||
145940055|NCT01419080|526288185|FG000|Overall Study|Lost to Follow-up|23|||
145940056|NCT01419080|526288185|FG000|Overall Study|Too Ill|3|||
145940057|NCT01294696|526288197|FG000|Overall Study|Screening failures|7|||
145940058|NCT01294696|526288197|FG000|Overall Study|Protocol Violation|8|||
145940059|NCT01294696|526288197|FG000|Overall Study|Missing BPI Response|7|||
145940060|NCT01294696|526288197|FG000|Overall Study|Site closure|52|||
145940061|NCT02417961|526289872|FG000|Overall Study|Adverse Event|1|||
145940062|NCT02417961|526289872|FG000|Overall Study|Lost to Follow-up|1|||
145940063|NCT02417961|526289872|FG000|Overall Study|Withdrawal by Subject|2|||
145940064|NCT05079750|526289873|FG000|Overall Study|Lost to Follow-up|0|||
146256793|NCT01287416|527454276|FG001|6 Month Follow-up|Lost to Follow-up|2|||
146256794|NCT00607789|527454278|FG000|Overall Study|Adverse Event|3|||
146256795|NCT00607789|527454279|FG001|Overall Study|Adverse Event|0|||
146256796|NCT00607789|527454278|FG000|Overall Study|Lack of Efficacy|0|||
146256797|NCT00607789|527454279|FG001|Overall Study|Lack of Efficacy|1|||
145940065|NCT05079750|526289874|FG001|Overall Study|Lost to Follow-up|0|||
145940066|NCT05079750|526289875|FG002|Overall Study|Lost to Follow-up|1|||
145940067|NCT05091346|526289876|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
145940068|NCT05091346|526289877|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
145940069|NCT05091346|526289878|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
145940070|NCT05091346|526289879|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
145940071|NCT05091346|526289880|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
146256798|NCT00607789|527454278|FG000|Overall Study|Inadequate adherence|3|||
145940072|NCT05091346|526289876|FG000|Overall Study|Death|6|||
145940073|NCT05091346|526289877|FG001|Overall Study|Death|5|||
145940074|NCT05091346|526289878|FG002|Overall Study|Death|8|||
145940075|NCT05091346|526289879|FG003|Overall Study|Death|16|||
145940076|NCT05091346|526289880|FG004|Overall Study|Death|26|||
145940077|NCT05091346|526289876|FG000|Overall Study|Lost to Follow-up|0|||
146256799|NCT00607789|527454279|FG001|Overall Study|Inadequate adherence|0|||
146256800|NCT00607789|527454278|FG000|Overall Study|Lost to Follow-up|0|||
146256801|NCT00607789|527454279|FG001|Overall Study|Lost to Follow-up|5|||
146256802|NCT00607789|527454278|FG000|Overall Study|Withdrawal by Subject|1|||
146256803|NCT00607789|527454279|FG001|Overall Study|Withdrawal by Subject|0|||
146256804|NCT01313299|527454280|FG000|Overall Study|Adverse Event|3|||
146256805|NCT01313299|527454281|FG001|Overall Study|Adverse Event|1|||
146256806|NCT01313299|527454282|FG002|Overall Study|Adverse Event|1|||
146256807|NCT01313299|527454280|FG000|Overall Study|Lost to Follow-up|1|||
146256808|NCT01313299|527454281|FG001|Overall Study|Lost to Follow-up|0|||
146256809|NCT01313299|527454282|FG002|Overall Study|Lost to Follow-up|0|||
146256810|NCT01313299|527454280|FG000|Overall Study|Protocol Violation|2|||
146256811|NCT01313299|527454281|FG001|Overall Study|Protocol Violation|0|||
146256812|NCT01313299|527454282|FG002|Overall Study|Protocol Violation|0|||
146256813|NCT01313299|527454280|FG000|Overall Study|Withdrawal by Subject|1|||
146256814|NCT01313299|527454281|FG001|Overall Study|Withdrawal by Subject|0|||
146256815|NCT01313299|527454282|FG002|Overall Study|Withdrawal by Subject|2|||
146256816|NCT01313299|527454280|FG000|Overall Study|Family reason and moved out of state|0|||
146050264|NCT01012258|526699177|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
146050265|NCT01012258|526699177|FG000|Overall Study|Another Tumor Discovered|1|||
146050266|NCT01012258|526699177|FG000|Overall Study|Ongoing|29|||
146050267|NCT03081884|526699184|FG000|Overall Study|deferred prostate cancer treatment|1|||
146050268|NCT03081884|526699184|FG000|Overall Study|metastasis managed with systemic therapy|3|||
146050269|NCT03948334|526699185|FG000|Overall Study|Adverse Event|1|||
146050270|NCT03948334|526699186|FG001|Overall Study|Adverse Event|4|||
146050271|NCT03948334|526699185|FG000|Overall Study|Lack of Efficacy|2|||
146050272|NCT03948334|526699186|FG001|Overall Study|Lack of Efficacy|0|||
146050273|NCT03948334|526699185|FG000|Overall Study|Lost to Follow-up|1|||
146050274|NCT03948334|526699186|FG001|Overall Study|Lost to Follow-up|0|||
146050275|NCT03948334|526699185|FG000|Overall Study|Physician Decision|1|||
146050276|NCT03948334|526699186|FG001|Overall Study|Physician Decision|0|||
146050277|NCT03948334|526699185|FG000|Overall Study|Pregnancy|0|||
146050278|NCT03948334|526699186|FG001|Overall Study|Pregnancy|1|||
146050279|NCT03948334|526699185|FG000|Overall Study|Protocol Deviation|1|||
146050280|NCT03948334|526699186|FG001|Overall Study|Protocol Deviation|0|||
146050281|NCT03948334|526699185|FG000|Overall Study|Study terminated by Sponsor|50|||
146050282|NCT03948334|526699186|FG001|Overall Study|Study terminated by Sponsor|51|||
146050283|NCT03948334|526699185|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
146050284|NCT03948334|526699186|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
146050285|NCT03575403|526699187|FG000|Overall Study|Adverse Event|1|||
146050286|NCT03575403|526699188|FG001|Overall Study|Adverse Event|0|||
146050287|NCT03575403|526699189|FG002|Overall Study|Adverse Event|0|||
146050288|NCT03575403|526699187|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
146050289|NCT03575403|526699188|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
146050290|NCT03575403|526699189|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
146050291|NCT00773513|526699190|FG000|Overall Study|Renal Transplant|254|||
146050292|NCT00773513|526699191|FG001|Overall Study|Renal Transplant|263|||
146050293|NCT00773513|526699190|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
146050294|NCT00773513|526699191|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
146050295|NCT00773513|526699190|FG000|Overall Study|Withdrew Consent|68|||
146050296|NCT00773513|526699191|FG001|Overall Study|Withdrew Consent|69|||
146050297|NCT00773513|526699190|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
146050298|NCT00773513|526699191|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
146050299|NCT00773513|526699190|FG000|Overall Study|Failure to Return|22|||
146050300|NCT00773513|526699191|FG001|Overall Study|Failure to Return|8|||
146050301|NCT00773513|526699190|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146050302|NCT00773513|526699191|FG001|Overall Study|Insufficient Therapeutic Response|18|||
146050303|NCT00773513|526699190|FG000|Overall Study|Reason Not Specified|159|||
146050304|NCT00773513|526699191|FG001|Overall Study|Reason Not Specified|126|||
146050305|NCT00773513|526699190|FG000|Overall Study|Death|531|||
146050306|NCT00773513|526699191|FG001|Overall Study|Death|545|||
146050307|NCT04445662|526699199|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
146050308|NCT04445662|526699200|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
146050309|NCT04445662|526699199|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
146050310|NCT04445662|526699200|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
146050311|NCT04445662|526699199|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
146050312|NCT04445662|526699200|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
146050313|NCT04445662|526699199|FG000|Post-treatment (12-24 weeks)|Death|1|||
146050314|NCT04445662|526699200|FG001|Post-treatment (12-24 weeks)|Death|0|||
146050315|NCT01332994|526699201|FG000|Overall Study|Adverse Event|34|||
146050316|NCT01332994|526699201|FG000|Overall Study|Death|1|||
146050317|NCT01332994|526699201|FG000|Overall Study|Lack of Efficacy|1|||
146256817|NCT01313299|527454281|FG001|Overall Study|Family reason and moved out of state|2|||
146256818|NCT01313299|527454282|FG002|Overall Study|Family reason and moved out of state|0|||
146256819|NCT01313299|527454280|FG000|Overall Study|Lack of subject compliance|0|||
146256820|NCT01313299|527454281|FG001|Overall Study|Lack of subject compliance|0|||
146256821|NCT01313299|527454282|FG002|Overall Study|Lack of subject compliance|1|||
146256822|NCT01919398|527454283|FG000|Overall Study|Progressive Disease|0|||
146256823|NCT01919398|527454284|FG001|Overall Study|Progressive Disease|0|||
146256824|NCT01919398|527454285|FG002|Overall Study|Progressive Disease|4|||
146256825|NCT01222078|527454288|FG000|Overall Study|Early termination of the study|1|||
146256826|NCT00240097|527454294|FG000|Part I|Adverse Event|1|||
146256827|NCT00240097|527454294|FG000|Part I|Death|1|||
146256828|NCT00240097|527454294|FG000|Part I|histology|1|||
146256829|NCT00240097|527454294|FG000|Part I|unevaluable|1|||
146256830|NCT00240097|527454294|FG000|Part II|did not continue from Part I|23|||
146256831|NCT02383927|527454295|FG000|Overall Study|Disease Progression|8|||
146256832|NCT02383927|527454296|FG001|Overall Study|Disease Progression|8|||
146256833|NCT02383927|527454297|FG002|Overall Study|Disease Progression|15|||
146256834|NCT02383927|527454298|FG003|Overall Study|Disease Progression|4|||
146256835|NCT02383927|527454295|FG000|Overall Study|Physician Decision|0|||
146256836|NCT02383927|527454296|FG001|Overall Study|Physician Decision|0|||
146256837|NCT02383927|527454297|FG002|Overall Study|Physician Decision|2|||
146256838|NCT02383927|527454298|FG003|Overall Study|Physician Decision|0|||
146256839|NCT02383927|527454295|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
146256840|NCT02383927|527454296|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
146256841|NCT02383927|527454297|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
146256842|NCT02383927|527454298|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
146256843|NCT02383927|527454295|FG000|Overall Study|Adverse Event|4|||
146256844|NCT02383927|527454296|FG001|Overall Study|Adverse Event|1|||
146256845|NCT02383927|527454297|FG002|Overall Study|Adverse Event|3|||
146256846|NCT02383927|527454298|FG003|Overall Study|Adverse Event|5|||
146256847|NCT02383927|527454295|FG000|Overall Study|Miscellaneous|1|||
146256848|NCT02383927|527454296|FG001|Overall Study|Miscellaneous|0|||
146256849|NCT02383927|527454297|FG002|Overall Study|Miscellaneous|0|||
146256850|NCT02383927|527454298|FG003|Overall Study|Miscellaneous|1|||
146256851|NCT02383927|527454295|FG000|Overall Study|Withdrawal by Subject|0|||
146256852|NCT02383927|527454296|FG001|Overall Study|Withdrawal by Subject|1|||
146256853|NCT02383927|527454297|FG002|Overall Study|Withdrawal by Subject|4|||
146256854|NCT02383927|527454298|FG003|Overall Study|Withdrawal by Subject|0|||
146256855|NCT00981578|527454299|FG000|Overall Study|Death|1|||
146256856|NCT00981578|527454299|FG000|Overall Study|Withdrawal by Subject|2|||
146256857|NCT02865135|527454300|FG000|Overall Study|Death|0|||
146256858|NCT02865135|527454301|FG001|Overall Study|Death|1|||
146256859|NCT02865135|527454302|FG002|Overall Study|Death|0|||
146256860|NCT02865135|527454300|FG000|Overall Study|Progression|6|||
146256861|NCT02865135|527454301|FG001|Overall Study|Progression|2|||
146256862|NCT02865135|527454302|FG002|Overall Study|Progression|2|||
146256863|NCT01180790|527454305|FG000|Overall Study|Adverse Event|1|||
146256864|NCT01180790|527454306|FG001|Overall Study|Adverse Event|1|||
146256865|NCT01180790|527454307|FG002|Overall Study|Adverse Event|2|||
146256866|NCT01180790|527454308|FG003|Overall Study|Adverse Event|0|||
145940078|NCT05091346|526289877|FG001|Overall Study|Lost to Follow-up|0|||
145940079|NCT05091346|526289878|FG002|Overall Study|Lost to Follow-up|0|||
145940080|NCT05091346|526289879|FG003|Overall Study|Lost to Follow-up|1|||
145940081|NCT05091346|526289880|FG004|Overall Study|Lost to Follow-up|0|||
145940082|NCT05091346|526289876|FG000|Overall Study|Withdrawal by Subject|0|||
145940083|NCT05091346|526289877|FG001|Overall Study|Withdrawal by Subject|1|||
145940084|NCT05091346|526289878|FG002|Overall Study|Withdrawal by Subject|2|||
145940085|NCT05091346|526289879|FG003|Overall Study|Withdrawal by Subject|2|||
145940086|NCT05091346|526289880|FG004|Overall Study|Withdrawal by Subject|1|||
146256867|NCT01180790|527454309|FG004|Overall Study|Adverse Event|1|||
146256868|NCT01180790|527454310|FG005|Overall Study|Adverse Event|3|||
146256869|NCT01180790|527454311|FG006|Overall Study|Adverse Event|0|||
146256870|NCT01180790|527454305|FG000|Overall Study|Withdrawal by Subject|3|||
146256871|NCT01180790|527454306|FG001|Overall Study|Withdrawal by Subject|0|||
146256872|NCT01180790|527454307|FG002|Overall Study|Withdrawal by Subject|5|||
146256873|NCT01180790|527454308|FG003|Overall Study|Withdrawal by Subject|0|||
146256874|NCT01180790|527454309|FG004|Overall Study|Withdrawal by Subject|2|||
146256875|NCT01180790|527454310|FG005|Overall Study|Withdrawal by Subject|1|||
145940087|NCT00197002|526289881|FG000|Overall Study|Adverse Event|0|||
146256876|NCT01180790|527454311|FG006|Overall Study|Withdrawal by Subject|0|||
146256877|NCT01180790|527454305|FG000|Overall Study|Lost to Follow-up|3|||
145940088|NCT00197002|526289882|FG001|Overall Study|Adverse Event|1|||
146256878|NCT01180790|527454306|FG001|Overall Study|Lost to Follow-up|1|||
146256879|NCT01180790|527454307|FG002|Overall Study|Lost to Follow-up|0|||
146256880|NCT01180790|527454308|FG003|Overall Study|Lost to Follow-up|2|||
146256881|NCT01180790|527454309|FG004|Overall Study|Lost to Follow-up|1|||
146256882|NCT01180790|527454310|FG005|Overall Study|Lost to Follow-up|0|||
145940089|NCT00197002|526289883|FG002|Overall Study|Adverse Event|0|||
146256883|NCT01180790|527454311|FG006|Overall Study|Lost to Follow-up|1|||
146256884|NCT01180790|527454305|FG000|Overall Study|Physician Decision|1|||
146256885|NCT01180790|527454306|FG001|Overall Study|Physician Decision|0|||
146256886|NCT01180790|527454307|FG002|Overall Study|Physician Decision|0|||
146256887|NCT01180790|527454308|FG003|Overall Study|Physician Decision|1|||
146256888|NCT01180790|527454309|FG004|Overall Study|Physician Decision|0|||
146256889|NCT01180790|527454310|FG005|Overall Study|Physician Decision|0|||
146256890|NCT01180790|527454311|FG006|Overall Study|Physician Decision|0|||
146256891|NCT01180790|527454305|FG000|Overall Study|Lack of Efficacy|1|||
146256892|NCT01180790|527454306|FG001|Overall Study|Lack of Efficacy|2|||
146256893|NCT01180790|527454307|FG002|Overall Study|Lack of Efficacy|5|||
146256894|NCT01180790|527454308|FG003|Overall Study|Lack of Efficacy|6|||
146256895|NCT01180790|527454309|FG004|Overall Study|Lack of Efficacy|1|||
146256896|NCT01180790|527454310|FG005|Overall Study|Lack of Efficacy|3|||
146050318|NCT01332994|526699201|FG000|Overall Study|Lost to Follow-up|4|||
146050319|NCT01332994|526699201|FG000|Overall Study|Protocol Violation|6|||
146050320|NCT01332994|526699201|FG000|Overall Study|Withdrawal by Subject|15|||
146050321|NCT01332994|526699201|FG000|Overall Study|Administrative Problem|2|||
146050322|NCT01332994|526699201|FG000|Overall Study|Other|8|||
146050323|NCT04170543|526699202|FG000|Overall Study|Death|1|||
146050324|NCT04170543|526699203|FG001|Overall Study|Death|1|||
146050325|NCT04170543|526699204|FG002|Overall Study|Death|1|||
146050326|NCT04170543|526699205|FG003|Overall Study|Death|1|||
146050327|NCT04170543|526699206|FG004|Overall Study|Death|1|||
146050328|NCT04170543|526699202|FG000|Overall Study|Lost to Follow-up|3|||
146050329|NCT04170543|526699203|FG001|Overall Study|Lost to Follow-up|3|||
146050330|NCT04170543|526699204|FG002|Overall Study|Lost to Follow-up|0|||
146050331|NCT04170543|526699205|FG003|Overall Study|Lost to Follow-up|3|||
146050332|NCT04170543|526699206|FG004|Overall Study|Lost to Follow-up|1|||
146050333|NCT04170543|526699202|FG000|Overall Study|Withdrawal by Subject|13|||
146050334|NCT04170543|526699203|FG001|Overall Study|Withdrawal by Subject|6|||
146050335|NCT04170543|526699204|FG002|Overall Study|Withdrawal by Subject|5|||
146050336|NCT04170543|526699205|FG003|Overall Study|Withdrawal by Subject|4|||
146050337|NCT04170543|526699206|FG004|Overall Study|Withdrawal by Subject|9|||
146050338|NCT04170543|526699202|FG000|Overall Study|Not able to transition to phase 2b|8|||
146050339|NCT04170543|526699203|FG001|Overall Study|Not able to transition to phase 2b|0|||
146050340|NCT04170543|526699204|FG002|Overall Study|Not able to transition to phase 2b|10|||
146050341|NCT04170543|526699205|FG003|Overall Study|Not able to transition to phase 2b|0|||
146050342|NCT04170543|526699206|FG004|Overall Study|Not able to transition to phase 2b|6|||
146050343|NCT04170543|526699202|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
146050344|NCT04170543|526699203|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
146050345|NCT04170543|526699204|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
146050346|NCT04170543|526699205|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
146050347|NCT04170543|526699206|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
146050348|NCT04170543|526699202|FG000|Overall Study|Not Treated|0|||
146050349|NCT04170543|526699203|FG001|Overall Study|Not Treated|0|||
146050350|NCT04170543|526699204|FG002|Overall Study|Not Treated|0|||
146050351|NCT04170543|526699205|FG003|Overall Study|Not Treated|0|||
146050352|NCT04170543|526699206|FG004|Overall Study|Not Treated|2|||
146050353|NCT04170543|526699202|FG000|Overall Study|(CRF)|16|||
146050354|NCT04170543|526699203|FG001|Overall Study|(CRF)|15|||
146050355|NCT04170543|526699204|FG002|Overall Study|(CRF)|12|||
146050356|NCT04170543|526699205|FG003|Overall Study|(CRF)|17|||
146050357|NCT04170543|526699206|FG004|Overall Study|(CRF)|17|||
146050358|NCT04170543|526699202|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
146050359|NCT04170543|526699203|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
146050360|NCT04170543|526699204|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
146050361|NCT04170543|526699205|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
146050362|NCT04170543|526699206|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
146050363|NCT04628780|526699207|FG000|Overall Study|Death|0|||
146050364|NCT04628780|526699208|FG001|Overall Study|Death|1|||
146050365|NCT04628780|526699209|FG002|Overall Study|Death|0|||
146050366|NCT04628780|526699210|FG003|Overall Study|Death|0|||
146050367|NCT04628780|526699211|FG004|Overall Study|Death|1|||
146050368|NCT04628780|526699212|FG005|Overall Study|Death|0|||
146050369|NCT04628780|526699207|FG000|Overall Study|Physician Decision|2|||
146050370|NCT04628780|526699208|FG001|Overall Study|Physician Decision|0|||
146050371|NCT04628780|526699209|FG002|Overall Study|Physician Decision|0|||
146050372|NCT04628780|526699210|FG003|Overall Study|Physician Decision|0|||
146050373|NCT04628780|526699211|FG004|Overall Study|Physician Decision|2|||
146050374|NCT04628780|526699212|FG005|Overall Study|Physician Decision|0|||
146050375|NCT04628780|526699207|FG000|Overall Study|Progressive disease|2|||
146050376|NCT04628780|526699208|FG001|Overall Study|Progressive disease|2|||
146050377|NCT04628780|526699209|FG002|Overall Study|Progressive disease|2|||
146050378|NCT04628780|526699210|FG003|Overall Study|Progressive disease|3|||
146050379|NCT04628780|526699211|FG004|Overall Study|Progressive disease|9|||
146050380|NCT04628780|526699212|FG005|Overall Study|Progressive disease|4|||
146050381|NCT04628780|526699207|FG000|Overall Study|Withdrawal by Subject|0|||
146050382|NCT04628780|526699208|FG001|Overall Study|Withdrawal by Subject|1|||
146050383|NCT04628780|526699209|FG002|Overall Study|Withdrawal by Subject|2|||
146256897|NCT01180790|527454311|FG006|Overall Study|Lack of Efficacy|0|||
146256898|NCT01180790|527454305|FG000|Overall Study|compliance|0|||
146256899|NCT01180790|527454306|FG001|Overall Study|compliance|1|||
146256900|NCT01180790|527454307|FG002|Overall Study|compliance|0|||
146256901|NCT01180790|527454308|FG003|Overall Study|compliance|0|||
146256902|NCT01180790|527454309|FG004|Overall Study|compliance|0|||
146256903|NCT01180790|527454310|FG005|Overall Study|compliance|0|||
146256904|NCT01180790|527454311|FG006|Overall Study|compliance|0|||
146256905|NCT01180790|527454305|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256906|NCT01180790|527454306|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256907|NCT01180790|527454307|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
146256908|NCT01180790|527454308|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256909|NCT01180790|527454309|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256910|NCT01180790|527454310|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256911|NCT01180790|527454311|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
146256912|NCT02335242|527454312|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
146256913|NCT02335242|527454313|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
146256914|NCT02335242|527454312|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
146256915|NCT02335242|527454313|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
146256916|NCT02335242|527454312|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
146050384|NCT04628780|526699210|FG003|Overall Study|Withdrawal by Subject|0|||
146050385|NCT04628780|526699211|FG004|Overall Study|Withdrawal by Subject|3|||
146050386|NCT04628780|526699212|FG005|Overall Study|Withdrawal by Subject|1|||
146050387|NCT04628780|526699207|FG000|Overall Study|Global deterioration of health status|0|||
146050388|NCT04628780|526699208|FG001|Overall Study|Global deterioration of health status|0|||
146050389|NCT04628780|526699209|FG002|Overall Study|Global deterioration of health status|0|||
146050390|NCT04628780|526699210|FG003|Overall Study|Global deterioration of health status|0|||
146050391|NCT04628780|526699211|FG004|Overall Study|Global deterioration of health status|1|||
146050392|NCT04628780|526699212|FG005|Overall Study|Global deterioration of health status|1|||
146050393|NCT04303559|526699214|FG000|Overall Study|Study closed due to poor enrollment.|1|||
146050394|NCT04378270|526699219|FG000|Overall Study|Lack of Efficacy|1|||
146050395|NCT04378270|526699219|FG000|Overall Study|Withdrawal by Subject|1|||
146050396|NCT04378270|526699219|FG000|Overall Study|Screen Failure|1|||
146050397|NCT04378270|526699219|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
146050398|NCT01327599|526699220|FG000|Overall Study|Adverse Event|1|||
146050399|NCT01327599|526699220|FG000|Overall Study|Could Not Attend Visit|1|||
146050400|NCT01327599|526699220|FG000|Overall Study|Withdrawal of Consent|1|||
146050401|NCT01156714|526699221|FG000|Overall Study|Withdrawal by Subject|9|||
146050402|NCT01156714|526699222|FG001|Overall Study|Withdrawal by Subject|4|||
146050403|NCT01156714|526699223|FG002|Overall Study|Withdrawal by Subject|3|||
146050404|NCT01132313|526699224|FG000|Overall Study|Lack of Efficacy|1|||
146050405|NCT01132313|526699225|FG001|Overall Study|Lack of Efficacy|0|||
146050406|NCT01132313|526699226|FG002|Overall Study|Lack of Efficacy|0|||
146050407|NCT01132313|526699227|FG003|Overall Study|Lack of Efficacy|0|||
146050408|NCT01132313|526699228|FG004|Overall Study|Lack of Efficacy|0|||
146050409|NCT01132313|526699229|FG005|Overall Study|Lack of Efficacy|0|||
146050410|NCT01132313|526699230|FG006|Overall Study|Lack of Efficacy|0|||
146050411|NCT01132313|526699231|FG007|Overall Study|Lack of Efficacy|3|||
146050412|NCT01132313|526699232|FG008|Overall Study|Lack of Efficacy|14|||
146050413|NCT01132313|526699233|FG009|Overall Study|Lack of Efficacy|16|||
146050414|NCT01132313|526699234|FG010|Overall Study|Lack of Efficacy|0|||
146050415|NCT01132313|526699235|FG011|Overall Study|Lack of Efficacy|0|||
146050416|NCT01132313|526699224|FG000|Overall Study|Not treated|2|||
146050417|NCT01132313|526699225|FG001|Overall Study|Not treated|0|||
146050418|NCT01132313|526699226|FG002|Overall Study|Not treated|0|||
146050419|NCT01132313|526699227|FG003|Overall Study|Not treated|0|||
146050420|NCT01132313|526699228|FG004|Overall Study|Not treated|2|||
146050421|NCT01132313|526699229|FG005|Overall Study|Not treated|1|||
146050422|NCT01132313|526699230|FG006|Overall Study|Not treated|3|||
146050423|NCT01132313|526699231|FG007|Overall Study|Not treated|0|||
146050424|NCT01132313|526699232|FG008|Overall Study|Not treated|0|||
146050425|NCT01132313|526699233|FG009|Overall Study|Not treated|0|||
146050426|NCT01132313|526699234|FG010|Overall Study|Not treated|0|||
146050427|NCT01132313|526699235|FG011|Overall Study|Not treated|0|||
146050428|NCT01132313|526699224|FG000|Overall Study|Adverse Event|0|||
146050429|NCT01132313|526699225|FG001|Overall Study|Adverse Event|0|||
146050430|NCT01132313|526699226|FG002|Overall Study|Adverse Event|4|||
146050431|NCT01132313|526699227|FG003|Overall Study|Adverse Event|10|||
146050432|NCT01132313|526699228|FG004|Overall Study|Adverse Event|19|||
146050433|NCT01132313|526699229|FG005|Overall Study|Adverse Event|6|||
146256917|NCT02335242|527454313|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
146050434|NCT01132313|526699230|FG006|Overall Study|Adverse Event|5|||
146050435|NCT01132313|526699231|FG007|Overall Study|Adverse Event|3|||
146050436|NCT01132313|526699232|FG008|Overall Study|Adverse Event|7|||
146256918|NCT00580047|527454321|FG000|Overall Study|Lost to Follow-up|1|||
146256919|NCT00580047|527454322|FG001|Overall Study|Lost to Follow-up|1|||
146256920|NCT00580047|527454323|FG002|Overall Study|Lost to Follow-up|0|||
146050437|NCT01132313|526699233|FG009|Overall Study|Adverse Event|2|||
146050438|NCT01132313|526699234|FG010|Overall Study|Adverse Event|0|||
146050439|NCT01132313|526699235|FG011|Overall Study|Adverse Event|0|||
146050440|NCT01132313|526699224|FG000|Overall Study|Protocol Violation|0|||
146050441|NCT01132313|526699225|FG001|Overall Study|Protocol Violation|0|||
146050442|NCT01132313|526699226|FG002|Overall Study|Protocol Violation|0|||
146050443|NCT01132313|526699227|FG003|Overall Study|Protocol Violation|1|||
146050444|NCT01132313|526699228|FG004|Overall Study|Protocol Violation|0|||
146050445|NCT01132313|526699229|FG005|Overall Study|Protocol Violation|0|||
146050446|NCT01132313|526699230|FG006|Overall Study|Protocol Violation|0|||
146050447|NCT01132313|526699231|FG007|Overall Study|Protocol Violation|0|||
146050448|NCT01132313|526699232|FG008|Overall Study|Protocol Violation|0|||
146050449|NCT01132313|526699233|FG009|Overall Study|Protocol Violation|0|||
146050450|NCT01132313|526699234|FG010|Overall Study|Protocol Violation|0|||
146050451|NCT01132313|526699235|FG011|Overall Study|Protocol Violation|0|||
146050452|NCT01132313|526699224|FG000|Overall Study|Lost to Follow-up|0|||
146050453|NCT01132313|526699225|FG001|Overall Study|Lost to Follow-up|0|||
146050454|NCT01132313|526699226|FG002|Overall Study|Lost to Follow-up|1|||
146050455|NCT01132313|526699227|FG003|Overall Study|Lost to Follow-up|0|||
146050456|NCT01132313|526699228|FG004|Overall Study|Lost to Follow-up|0|||
146050457|NCT01132313|526699229|FG005|Overall Study|Lost to Follow-up|0|||
146050458|NCT01132313|526699230|FG006|Overall Study|Lost to Follow-up|0|||
146050459|NCT01132313|526699231|FG007|Overall Study|Lost to Follow-up|1|||
146050460|NCT01132313|526699232|FG008|Overall Study|Lost to Follow-up|0|||
146050461|NCT01132313|526699233|FG009|Overall Study|Lost to Follow-up|0|||
146050462|NCT01132313|526699234|FG010|Overall Study|Lost to Follow-up|0|||
146050463|NCT01132313|526699235|FG011|Overall Study|Lost to Follow-up|0|||
146050464|NCT01132313|526699224|FG000|Overall Study|Withdrawal by Subject|0|||
146050465|NCT01132313|526699225|FG001|Overall Study|Withdrawal by Subject|0|||
146050466|NCT01132313|526699226|FG002|Overall Study|Withdrawal by Subject|3|||
146050467|NCT01132313|526699227|FG003|Overall Study|Withdrawal by Subject|3|||
145940090|NCT00197002|526289881|FG000|Overall Study|Protocol Violation|1|||
145940091|NCT00197002|526289882|FG001|Overall Study|Protocol Violation|0|||
145940092|NCT00197002|526289883|FG002|Overall Study|Protocol Violation|2|||
145940093|NCT00197002|526289881|FG000|Overall Study|Withdrawal by Subject|9|||
145940094|NCT00197002|526289882|FG001|Overall Study|Withdrawal by Subject|5|||
145940095|NCT00197002|526289883|FG002|Overall Study|Withdrawal by Subject|7|||
145940096|NCT00197002|526289881|FG000|Overall Study|Migrated/moved from study area|3|||
145940097|NCT00197002|526289882|FG001|Overall Study|Migrated/moved from study area|5|||
145940098|NCT00197002|526289883|FG002|Overall Study|Migrated/moved from study area|1|||
145940099|NCT00197002|526289881|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
145940100|NCT00197002|526289882|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
145940101|NCT00197002|526289883|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
145940102|NCT00197002|526289881|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
145940103|NCT00197002|526289882|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
145940104|NCT00197002|526289883|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
145940105|NCT00197002|526289881|FG000|Overall Study|Others|3|||
145940106|NCT00197002|526289882|FG001|Overall Study|Others|1|||
145940107|NCT00197002|526289883|FG002|Overall Study|Others|1|||
145940108|NCT03569293|526289884|FG000|Overall Study|Adverse Event|4|||
145940109|NCT03569293|526289885|FG001|Overall Study|Adverse Event|1|||
145940110|NCT03569293|526289886|FG002|Overall Study|Adverse Event|5|||
145940111|NCT03569293|526289887|FG003|Overall Study|Adverse Event|1|||
145940112|NCT03569293|526289888|FG004|Overall Study|Adverse Event|0|||
145940113|NCT03569293|526289889|FG005|Overall Study|Adverse Event|0|||
145940114|NCT03569293|526289884|FG000|Overall Study|Withdrawal by Subject|16|||
145940115|NCT03569293|526289885|FG001|Overall Study|Withdrawal by Subject|2|||
145940116|NCT03569293|526289886|FG002|Overall Study|Withdrawal by Subject|4|||
145940117|NCT03569293|526289887|FG003|Overall Study|Withdrawal by Subject|1|||
145940118|NCT03569293|526289888|FG004|Overall Study|Withdrawal by Subject|0|||
145940119|NCT03569293|526289889|FG005|Overall Study|Withdrawal by Subject|0|||
145940120|NCT03569293|526289884|FG000|Overall Study|Lost to Follow-up|1|||
145940121|NCT03569293|526289885|FG001|Overall Study|Lost to Follow-up|3|||
145940122|NCT03569293|526289886|FG002|Overall Study|Lost to Follow-up|1|||
145940123|NCT03569293|526289887|FG003|Overall Study|Lost to Follow-up|1|||
145940124|NCT03569293|526289888|FG004|Overall Study|Lost to Follow-up|0|||
145940125|NCT03569293|526289889|FG005|Overall Study|Lost to Follow-up|0|||
145940126|NCT03569293|526289884|FG000|Overall Study|Other|8|||
146050468|NCT01132313|526699228|FG004|Overall Study|Withdrawal by Subject|6|||
146050469|NCT01132313|526699229|FG005|Overall Study|Withdrawal by Subject|0|||
145940127|NCT03569293|526289885|FG001|Overall Study|Other|2|||
145940128|NCT03569293|526289886|FG002|Overall Study|Other|1|||
145940129|NCT03569293|526289887|FG003|Overall Study|Other|1|||
145940130|NCT03569293|526289888|FG004|Overall Study|Other|0|||
145940131|NCT03569293|526289889|FG005|Overall Study|Other|0|||
145940132|NCT03569293|526289884|FG000|Overall Study|Ongoing at Time of Analysis|8|||
146050470|NCT01132313|526699230|FG006|Overall Study|Withdrawal by Subject|1|||
145940133|NCT03569293|526289885|FG001|Overall Study|Ongoing at Time of Analysis|1|||
145940134|NCT03569293|526289886|FG002|Overall Study|Ongoing at Time of Analysis|3|||
145940135|NCT03569293|526289887|FG003|Overall Study|Ongoing at Time of Analysis|0|||
145940136|NCT03569293|526289888|FG004|Overall Study|Ongoing at Time of Analysis|0|||
146256921|NCT00580047|527454321|FG000|Overall Study|Withdrawal by Subject|1|||
146256922|NCT00580047|527454322|FG001|Overall Study|Withdrawal by Subject|1|||
146256923|NCT00580047|527454323|FG002|Overall Study|Withdrawal by Subject|2|||
146256924|NCT00580047|527454321|FG000|Overall Study|Withdrawal by Subject|1|||
146256925|NCT00580047|527454322|FG001|Overall Study|Withdrawal by Subject|0|||
146256926|NCT00580047|527454323|FG002|Overall Study|Withdrawal by Subject|0|||
145940137|NCT03569293|526289889|FG005|Overall Study|Ongoing at Time of Analysis|0|||
145940138|NCT03839459|526289900|FG000|Overall Study|Withdrawal by Subject|2|||
145940139|NCT03839459|526289900|FG000|Overall Study|progression of disease|3|||
145940140|NCT05376241|526289905|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
145940141|NCT05376241|526289905|FG000|Overall Study|103 did not complete the survey|103|||
145940142|NCT05376241|526289905|FG000|Overall Study|17 failed 2 attention check questions|17|||
145940143|NCT02276053|526289908|FG000|Overall Study|Death|2|||
146256927|NCT01064856|527454326|FG000|Double-blind (DB) Period|Adverse Event|1|||
146256928|NCT01064856|527454327|FG001|Double-blind (DB) Period|Adverse Event|0|||
146256929|NCT01064856|527454328|FG002|Double-blind (DB) Period|Adverse Event|0|||
146256930|NCT01064856|527454329|FG003|Double-blind (DB) Period|Adverse Event|0|||
146256931|NCT01064856|527454326|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
146256932|NCT01064856|527454327|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146256933|NCT01064856|527454328|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146256934|NCT01064856|527454329|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
146256935|NCT01064856|527454326|FG000|Open-label (OL) Period|Adverse Event|0|||
146256936|NCT01064856|527454327|FG001|Open-label (OL) Period|Adverse Event|0|||
146256937|NCT01064856|527454328|FG002|Open-label (OL) Period|Adverse Event|12|||
146256938|NCT01064856|527454329|FG003|Open-label (OL) Period|Adverse Event|6|||
146050471|NCT01132313|526699231|FG007|Overall Study|Withdrawal by Subject|0|||
146050472|NCT01132313|526699232|FG008|Overall Study|Withdrawal by Subject|0|||
146050473|NCT01132313|526699233|FG009|Overall Study|Withdrawal by Subject|2|||
146050474|NCT01132313|526699234|FG010|Overall Study|Withdrawal by Subject|0|||
146050475|NCT01132313|526699235|FG011|Overall Study|Withdrawal by Subject|0|||
146050476|NCT01132313|526699224|FG000|Overall Study|Lack of antiviral response|0|||
146050477|NCT01132313|526699225|FG001|Overall Study|Lack of antiviral response|0|||
146050478|NCT01132313|526699226|FG002|Overall Study|Lack of antiviral response|12|||
146050479|NCT01132313|526699227|FG003|Overall Study|Lack of antiviral response|18|||
146050480|NCT01132313|526699228|FG004|Overall Study|Lack of antiviral response|18|||
146050481|NCT01132313|526699229|FG005|Overall Study|Lack of antiviral response|18|||
146050482|NCT01132313|526699230|FG006|Overall Study|Lack of antiviral response|21|||
146050483|NCT01132313|526699231|FG007|Overall Study|Lack of antiviral response|0|||
146050484|NCT01132313|526699232|FG008|Overall Study|Lack of antiviral response|0|||
146050485|NCT01132313|526699233|FG009|Overall Study|Lack of antiviral response|0|||
146050486|NCT01132313|526699234|FG010|Overall Study|Lack of antiviral response|1|||
146050487|NCT01132313|526699235|FG011|Overall Study|Lack of antiviral response|0|||
146050488|NCT01132313|526699224|FG000|Overall Study|Other reason not defined above|0|||
146050489|NCT01132313|526699225|FG001|Overall Study|Other reason not defined above|0|||
146050490|NCT01132313|526699226|FG002|Overall Study|Other reason not defined above|0|||
146050491|NCT01132313|526699227|FG003|Overall Study|Other reason not defined above|0|||
146050492|NCT01132313|526699228|FG004|Overall Study|Other reason not defined above|0|||
146050493|NCT01132313|526699229|FG005|Overall Study|Other reason not defined above|0|||
146050494|NCT01132313|526699230|FG006|Overall Study|Other reason not defined above|0|||
146050495|NCT01132313|526699231|FG007|Overall Study|Other reason not defined above|1|||
146050496|NCT01132313|526699232|FG008|Overall Study|Other reason not defined above|0|||
146050497|NCT01132313|526699233|FG009|Overall Study|Other reason not defined above|0|||
146050498|NCT01132313|526699234|FG010|Overall Study|Other reason not defined above|0|||
146050499|NCT01132313|526699235|FG011|Overall Study|Other reason not defined above|0|||
146050500|NCT01236521|526699236|FG000|Overall Study|Withdrawal by Subject|12|||
146050501|NCT01236521|526699237|FG001|Overall Study|Withdrawal by Subject|17|||
146050502|NCT01236521|526699236|FG000|Overall Study|Death|2|||
146050503|NCT01236521|526699237|FG001|Overall Study|Death|1|||
146050504|NCT01236521|526699236|FG000|Overall Study|Lost to Follow-up|9|||
146050505|NCT01236521|526699237|FG001|Overall Study|Lost to Follow-up|7|||
146050506|NCT04266795|526699243|FG000|Overall Study|Adverse Event|10|||
146050507|NCT04266795|526699244|FG001|Overall Study|Adverse Event|19|||
146050508|NCT04266795|526699243|FG000|Overall Study|Death|7|||
146050509|NCT04266795|526699244|FG001|Overall Study|Death|8|||
146050510|NCT04266795|526699243|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
146050511|NCT04266795|526699244|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
146050512|NCT04266795|526699243|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
146050513|NCT04266795|526699244|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146256939|NCT01064856|527454326|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
146256940|NCT01064856|527454327|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
146050514|NCT04266795|526699243|FG000|Overall Study|Progressive Disease|12|||
146050515|NCT04266795|526699244|FG001|Overall Study|Progressive Disease|9|||
145940144|NCT02276053|526289908|FG000|Overall Study|Adverse Event|5|||
146256941|NCT01064856|527454328|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
145940145|NCT02276053|526289908|FG000|Overall Study|Lack of Efficacy|2|||
145940146|NCT02276053|526289908|FG000|Overall Study|Withdrawal by Subject|1|||
145940147|NCT02276053|526289908|FG000|Overall Study|Patient does not meet selection criteria|3|||
145940148|NCT02276053|526289908|FG000|Overall Study|Patient needs to increase baseline AED|1|||
145940149|NCT01632904|526289909|FG000|Overall Study|Adverse Event|4|||
145940150|NCT01632904|526289910|FG001|Overall Study|Adverse Event|1|||
145940151|NCT01632904|526289909|FG000|Overall Study|Physician Decision|0|||
145940152|NCT01632904|526289910|FG001|Overall Study|Physician Decision|1|||
145940153|NCT01632904|526289909|FG000|Overall Study|Subject decision|3|||
145940154|NCT01632904|526289910|FG001|Overall Study|Subject decision|2|||
145940155|NCT01632904|526289909|FG000|Overall Study|Disease Progression|0|||
145940156|NCT01632904|526289910|FG001|Overall Study|Disease Progression|1|||
145940157|NCT01632904|526289909|FG000|Overall Study|Reason for discontinuation not available|0|||
145940158|NCT01632904|526289910|FG001|Overall Study|Reason for discontinuation not available|1|||
145940159|NCT01668966|526289924|FG000|Overall Study|Withdrawal by Subject|1|||
145940160|NCT01668966|526289924|FG000|Overall Study|Death|1|||
145940161|NCT01668966|526289924|FG000|Overall Study|Not treated|2|||
145940162|NCT00878969|526289934|FG000|Overall Study|Physician Decision|5|||
145940163|NCT00878969|526289935|FG001|Overall Study|Physician Decision|3|||
145940164|NCT00878969|526289936|FG002|Overall Study|Physician Decision|2|||
145940165|NCT00878969|526289934|FG000|Overall Study|Withdrawal by Subject|1|||
145940166|NCT00878969|526289935|FG001|Overall Study|Withdrawal by Subject|6|||
145940167|NCT00878969|526289936|FG002|Overall Study|Withdrawal by Subject|3|||
145940168|NCT00878969|526289934|FG000|Overall Study|kidney transplant|2|||
145940169|NCT00878969|526289935|FG001|Overall Study|kidney transplant|3|||
145940170|NCT00878969|526289936|FG002|Overall Study|kidney transplant|2|||
145940171|NCT00878969|526289934|FG000|Overall Study|Adverse Event|3|||
145940172|NCT00878969|526289935|FG001|Overall Study|Adverse Event|1|||
145940173|NCT00878969|526289936|FG002|Overall Study|Adverse Event|2|||
145940174|NCT00878969|526289934|FG000|Overall Study|Lost to Follow-up|2|||
145940175|NCT00878969|526289935|FG001|Overall Study|Lost to Follow-up|1|||
145940176|NCT00878969|526289936|FG002|Overall Study|Lost to Follow-up|0|||
145940177|NCT00878969|526289934|FG000|Overall Study|Protocol Violation|2|||
145940178|NCT00878969|526289935|FG001|Overall Study|Protocol Violation|0|||
145940179|NCT00878969|526289936|FG002|Overall Study|Protocol Violation|0|||
145940180|NCT00878969|526289934|FG000|Overall Study|Death|0|||
145940181|NCT00878969|526289935|FG001|Overall Study|Death|0|||
145940182|NCT00878969|526289936|FG002|Overall Study|Death|2|||
145940183|NCT00878969|526289934|FG000|Overall Study|Pregnancy|0|||
145940184|NCT00878969|526289935|FG001|Overall Study|Pregnancy|1|||
145940185|NCT00878969|526289936|FG002|Overall Study|Pregnancy|0|||
145940186|NCT00655733|526289937|FG000|Overall Study|Lost to Follow-up|2|||
145940187|NCT00655733|526289938|FG001|Overall Study|Lost to Follow-up|2|||
145940188|NCT00655733|526289937|FG000|Overall Study|Adverse Event|2|||
145940189|NCT00655733|526289938|FG001|Overall Study|Adverse Event|2|||
145940190|NCT00655733|526289937|FG000|Overall Study|Withdrawal by Subject|3|||
145940191|NCT00655733|526289938|FG001|Overall Study|Withdrawal by Subject|3|||
145940192|NCT00655733|526289937|FG000|Overall Study|Physician Decision|0|||
145940193|NCT00655733|526289938|FG001|Overall Study|Physician Decision|1|||
145940194|NCT02035748|526289939|FG000|Overall Study|Adverse Event|5|||
145940195|NCT02035748|526289939|FG000|Overall Study|Death|3|||
145940196|NCT02035748|526289939|FG000|Overall Study|Lost to Follow-up|2|||
145940197|NCT02035748|526289939|FG000|Overall Study|Physician Decision|3|||
145940198|NCT02035748|526289939|FG000|Overall Study|Withdrawal by Subject|6|||
145940199|NCT02035748|526289939|FG000|Overall Study|Progressive Disease|1|||
145940200|NCT01088243|526289941|FG000|Overall Study|Adverse Event|1|||
145940201|NCT01088243|526289942|FG001|Overall Study|Adverse Event|0|||
145940202|NCT00597506|526289943|FG000|Overall Study|Subject is being followed for survival|1|||
145940203|NCT03199612|526289946|FG000|Overall Study|Adverse Event|1|||
145940204|NCT03199612|526289947|FG001|Overall Study|Adverse Event|0|||
146256942|NCT01064856|527454329|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
145940205|NCT02543892|526289952|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
145940206|NCT02543892|526289953|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
146256943|NCT01064856|527454326|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
146256944|NCT01064856|527454327|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
145940207|NCT02543892|526289954|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
145940208|NCT02543892|526289955|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
145940209|NCT02543892|526289956|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
145940210|NCT02543892|526289957|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
145940211|NCT02543892|526289958|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
145940212|NCT02543892|526289959|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
145940213|NCT02543892|526289952|FG000|Received Vaccination 2|Physician Decision|0|||
145940214|NCT02543892|526289953|FG001|Received Vaccination 2|Physician Decision|0|||
145940215|NCT02543892|526289954|FG002|Received Vaccination 2|Physician Decision|0|||
145940216|NCT02543892|526289955|FG003|Received Vaccination 2|Physician Decision|0|||
145940217|NCT02543892|526289956|FG004|Received Vaccination 2|Physician Decision|0|||
145940218|NCT02543892|526289957|FG005|Received Vaccination 2|Physician Decision|1|||
145940219|NCT02543892|526289958|FG006|Received Vaccination 2|Physician Decision|0|||
145940220|NCT02543892|526289959|FG007|Received Vaccination 2|Physician Decision|0|||
146256945|NCT01064856|527454328|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
146256946|NCT01064856|527454329|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
146256947|NCT01064856|527454326|FG000|Open-label (OL) Period|Other|0|||
146256948|NCT01064856|527454327|FG001|Open-label (OL) Period|Other|0|||
146256949|NCT01064856|527454328|FG002|Open-label (OL) Period|Other|7|||
146256950|NCT01064856|527454329|FG003|Open-label (OL) Period|Other|7|||
146256951|NCT01780584|527454330|FG000|Overall Study|Death|1|||
146256952|NCT01780584|527454331|FG001|Overall Study|Death|0|||
146256953|NCT01780584|527454332|FG002|Overall Study|Death|1|||
146256954|NCT01780584|527454330|FG000|Overall Study|Adverse Event|0|||
146256955|NCT01780584|527454331|FG001|Overall Study|Adverse Event|1|||
146256956|NCT01780584|527454332|FG002|Overall Study|Adverse Event|0|||
146256957|NCT01780584|527454330|FG000|Overall Study|Protocol Violation|0|||
146301025|NCT00972777|527617201|FG001|Overall Study|Lost to Follow-up|4|||
146301026|NCT00972777|527617200|FG000|Overall Study|Withdrawal by Subject|4|||
146301027|NCT00972777|527617201|FG001|Overall Study|Withdrawal by Subject|5|||
146301028|NCT00972777|527617200|FG000|Overall Study|Physician Decision|4|||
146301029|NCT00972777|527617201|FG001|Overall Study|Physician Decision|0|||
146301030|NCT00972777|527617200|FG000|Overall Study|Protocol Violation|0|||
146301031|NCT00972777|527617201|FG001|Overall Study|Protocol Violation|2|||
146301032|NCT00972777|527617200|FG000|Overall Study|Screening Failure|2|||
146301033|NCT00972777|527617201|FG001|Overall Study|Screening Failure|1|||
146301034|NCT00972777|527617200|FG000|Overall Study|Missed visit|1|||
146301035|NCT00972777|527617201|FG001|Overall Study|Missed visit|0|||
146301036|NCT01093326|527617202|FG000|Overall Study|Death|0|||
146301037|NCT01093326|527617203|FG001|Overall Study|Death|1|||
146301038|NCT01093326|527617204|FG002|Overall Study|Death|0|||
146301039|NCT01093326|527617202|FG000|Overall Study|Lack of Efficacy|7|||
146301040|NCT01093326|527617203|FG001|Overall Study|Lack of Efficacy|6|||
146301041|NCT01093326|527617204|FG002|Overall Study|Lack of Efficacy|3|||
146301042|NCT01093326|527617202|FG000|Overall Study|Lost to Follow-up|2|||
146301043|NCT01093326|527617203|FG001|Overall Study|Lost to Follow-up|5|||
146301044|NCT01093326|527617204|FG002|Overall Study|Lost to Follow-up|4|||
145940221|NCT02543892|526289952|FG000|Received Vaccination 2|Adverse Event|0|||
145940222|NCT02543892|526289953|FG001|Received Vaccination 2|Adverse Event|1|||
145940223|NCT02543892|526289954|FG002|Received Vaccination 2|Adverse Event|0|||
145940224|NCT02543892|526289955|FG003|Received Vaccination 2|Adverse Event|0|||
145940225|NCT02543892|526289956|FG004|Received Vaccination 2|Adverse Event|0|||
145940226|NCT02543892|526289957|FG005|Received Vaccination 2|Adverse Event|0|||
145940227|NCT02543892|526289958|FG006|Received Vaccination 2|Adverse Event|0|||
145940228|NCT02543892|526289959|FG007|Received Vaccination 2|Adverse Event|0|||
145940229|NCT02543892|526289952|FG000|Had Immunology Data|Withdrawal by Subject|0|||
145940230|NCT02543892|526289953|FG001|Had Immunology Data|Withdrawal by Subject|0|||
145940231|NCT02543892|526289954|FG002|Had Immunology Data|Withdrawal by Subject|0|||
145940232|NCT02543892|526289955|FG003|Had Immunology Data|Withdrawal by Subject|0|||
145940233|NCT02543892|526289956|FG004|Had Immunology Data|Withdrawal by Subject|0|||
145940234|NCT02543892|526289957|FG005|Had Immunology Data|Withdrawal by Subject|0|||
145940235|NCT02543892|526289958|FG006|Had Immunology Data|Withdrawal by Subject|1|||
145940236|NCT02543892|526289959|FG007|Had Immunology Data|Withdrawal by Subject|0|||
145940237|NCT00081731|526289960|FG000|Overall Study|scientific integrity issue|8|||
145940238|NCT00081731|526289961|FG001|Overall Study|scientific integrity issue|8|||
145940239|NCT01500213|526289962|FG000|Overall Study|Adverse Event|35|||
145940240|NCT01500213|526289963|FG001|Overall Study|Adverse Event|35|||
145940241|NCT01500213|526289962|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
145940242|NCT01500213|526289963|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
145940243|NCT01500213|526289962|FG000|Overall Study|Withdrawal by Subject|28|||
145940244|NCT01500213|526289963|FG001|Overall Study|Withdrawal by Subject|37|||
145940245|NCT01500213|526289962|FG000|Overall Study|Death|7|||
145940246|NCT01500213|526289963|FG001|Overall Study|Death|3|||
146256958|NCT01780584|527454331|FG001|Overall Study|Protocol Violation|0|||
146256959|NCT01780584|527454332|FG002|Overall Study|Protocol Violation|1|||
146256960|NCT04783519|527454333|FG000|Overall Study|Withdrawal by Subject|2|||
146256961|NCT04783519|527454334|FG001|Overall Study|Withdrawal by Subject|7|||
146256962|NCT04783519|527454335|FG002|Overall Study|Withdrawal by Subject|3|||
146256963|NCT04783519|527454333|FG000|Overall Study|Lost to Follow-up|9|||
146256964|NCT04783519|527454334|FG001|Overall Study|Lost to Follow-up|7|||
146301045|NCT01093326|527617202|FG000|Overall Study|Physician Decision|3|||
146301046|NCT01093326|527617203|FG001|Overall Study|Physician Decision|1|||
145940247|NCT01500213|526289962|FG000|Overall Study|Disease Progression|13|||
146301047|NCT01093326|527617204|FG002|Overall Study|Physician Decision|3|||
145940248|NCT01500213|526289963|FG001|Overall Study|Disease Progression|21|||
145940249|NCT01500213|526289962|FG000|Overall Study|Protocol Violation|19|||
146301048|NCT01093326|527617202|FG000|Overall Study|Withdrawal by Subject|30|||
146256965|NCT04783519|527454335|FG002|Overall Study|Lost to Follow-up|6|||
146256966|NCT00645099|527454336|FG000|Overall Study|Lack of Efficacy|15|||
146256967|NCT00645099|527454337|FG001|Overall Study|Lack of Efficacy|6|||
146301049|NCT01093326|527617203|FG001|Overall Study|Withdrawal by Subject|27|||
145940250|NCT01500213|526289963|FG001|Overall Study|Protocol Violation|19|||
145940251|NCT01500213|526289962|FG000|Overall Study|Physician Decision|12|||
145940252|NCT01500213|526289963|FG001|Overall Study|Physician Decision|10|||
145940253|NCT01500213|526289962|FG000|Overall Study|Lack of Efficacy|9|||
145940254|NCT01500213|526289963|FG001|Overall Study|Lack of Efficacy|7|||
145940255|NCT01500213|526289962|FG000|Overall Study|Lost to Follow-up|3|||
145940256|NCT01500213|526289963|FG001|Overall Study|Lost to Follow-up|6|||
145940257|NCT01500213|526289962|FG000|Overall Study|Other Reasons|7|||
145940258|NCT01500213|526289963|FG001|Overall Study|Other Reasons|5|||
145940259|NCT00785213|526289964|FG000|Quinine Sulfate Alone|Adverse Event|4|||
145940260|NCT00785213|526289964|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
145940261|NCT02386345|526289965|FG000|Overall Study|Not treated|14|||
145940262|NCT02386345|526289965|FG000|Overall Study|Lost to Follow-up|1|||
145940263|NCT02386345|526289965|FG000|Overall Study|Adverse Event|5|||
145940264|NCT02386345|526289965|FG000|Overall Study|Repeat Procedure|10|||
145940265|NCT02386345|526289965|FG000|Overall Study|Did not complete 12-month follow-up|72|||
145940266|NCT02003963|526289967|FG000|Overall Study|Lost to Follow-up|2|||
145940267|NCT02003963|526289968|FG001|Overall Study|Lost to Follow-up|1|||
145940268|NCT04050124|526289970|FG000|Overall Study|Death|1|||
145940269|NCT04050124|526289971|FG001|Overall Study|Death|0|||
145940270|NCT01537068|526289974|FG000|Overall Study|Lost to Follow-up|2|||
145940271|NCT01537068|526289975|FG001|Overall Study|Lost to Follow-up|1|||
145940272|NCT01537068|526289974|FG000|Overall Study|Adverse Event|0|||
145940273|NCT01537068|526289975|FG001|Overall Study|Adverse Event|1|||
145940274|NCT01537068|526289974|FG000|Overall Study|Withdrawal by Subject|1|||
145940275|NCT01537068|526289975|FG001|Overall Study|Withdrawal by Subject|1|||
145940276|NCT01537068|526289974|FG000|Overall Study|Lack of Efficacy|1|||
145940277|NCT01537068|526289975|FG001|Overall Study|Lack of Efficacy|0|||
145940278|NCT06011161|526289976|FG000|Overall Study|Withdrawal by Subject|2|||
145940279|NCT06011161|526289976|FG000|Overall Study|Lost to Follow-up|5|||
145940280|NCT03802565|526289980|FG000|Overall Study|Adverse Event|0|||
145940281|NCT03802565|526289981|FG001|Overall Study|Adverse Event|1|||
145940282|NCT03802565|526289982|FG002|Overall Study|Adverse Event|2|||
145940283|NCT03802565|526289983|FG003|Overall Study|Adverse Event|1|||
145940284|NCT03802565|526289984|FG004|Overall Study|Adverse Event|1|||
145940285|NCT03802565|526289980|FG000|Overall Study|Withdrawal by Subject|2|||
145940286|NCT03802565|526289981|FG001|Overall Study|Withdrawal by Subject|2|||
145940287|NCT03802565|526289982|FG002|Overall Study|Withdrawal by Subject|2|||
145940288|NCT03802565|526289983|FG003|Overall Study|Withdrawal by Subject|0|||
145940289|NCT03802565|526289984|FG004|Overall Study|Withdrawal by Subject|1|||
145940290|NCT03802565|526289980|FG000|Overall Study|Protocol Violation|2|||
145940291|NCT03802565|526289981|FG001|Overall Study|Protocol Violation|1|||
145940292|NCT03802565|526289982|FG002|Overall Study|Protocol Violation|4|||
145940293|NCT03802565|526289983|FG003|Overall Study|Protocol Violation|5|||
145940294|NCT03802565|526289984|FG004|Overall Study|Protocol Violation|1|||
145940295|NCT03802565|526289980|FG000|Overall Study|Lost to Follow-up|0|||
145940296|NCT03802565|526289981|FG001|Overall Study|Lost to Follow-up|0|||
145940297|NCT03802565|526289982|FG002|Overall Study|Lost to Follow-up|1|||
145940298|NCT03802565|526289983|FG003|Overall Study|Lost to Follow-up|0|||
145940299|NCT03802565|526289984|FG004|Overall Study|Lost to Follow-up|0|||
145940300|NCT03802565|526289980|FG000|Overall Study|Subjects Related to Each Other|1|||
145940301|NCT03802565|526289981|FG001|Overall Study|Subjects Related to Each Other|0|||
145940302|NCT03802565|526289982|FG002|Overall Study|Subjects Related to Each Other|0|||
145940303|NCT03802565|526289983|FG003|Overall Study|Subjects Related to Each Other|2|||
145940304|NCT03802565|526289984|FG004|Overall Study|Subjects Related to Each Other|1|||
145940305|NCT03802565|526289980|FG000|Overall Study|Elevated Enzymes|0|||
145940306|NCT03802565|526289981|FG001|Overall Study|Elevated Enzymes|0|||
145940307|NCT03802565|526289982|FG002|Overall Study|Elevated Enzymes|0|||
145940308|NCT03802565|526289983|FG003|Overall Study|Elevated Enzymes|0|||
145940309|NCT03802565|526289984|FG004|Overall Study|Elevated Enzymes|2|||
145940310|NCT00430352|526289985|FG000|Overall Study|Disease progression|58|||
145940311|NCT00430352|526289985|FG000|Overall Study|Withdrawal by Subject|11|||
145940312|NCT00430352|526289985|FG000|Overall Study|Adverse Event|16|||
145940313|NCT00430352|526289985|FG000|Overall Study|Death|5|||
145940314|NCT00430352|526289985|FG000|Overall Study|Other|48|||
145940315|NCT01597375|526289991|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
145940316|NCT01597375|526289992|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
145940317|NCT01597375|526289991|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
145940318|NCT01597375|526289992|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
145940319|NCT01597375|526289991|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
145940320|NCT01597375|526289992|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
145940321|NCT01597375|526289991|FG000|Washout (2 Weeks)|Adverse Event|1|||
145940322|NCT01597375|526289992|FG001|Washout (2 Weeks)|Adverse Event|0|||
145940323|NCT01597375|526289991|FG000|Second Intervention|Failed to react at both Aspirin|1|||
145940324|NCT01597375|526289992|FG001|Second Intervention|Failed to react at both Aspirin|1|||
145940325|NCT00347919|526289993|FG000|Overall Study|Lost to Follow-up|11|||
145940326|NCT00347919|526289994|FG001|Overall Study|Lost to Follow-up|13|||
145940327|NCT00347919|526289995|FG002|Overall Study|Lost to Follow-up|0|||
146256968|NCT00645099|527454336|FG000|Overall Study|Withdrawal by Subject|30|||
146256969|NCT00645099|527454337|FG001|Overall Study|Withdrawal by Subject|22|||
146256970|NCT00645099|527454336|FG000|Overall Study|Lost to Follow-up|6|||
146256971|NCT00645099|527454337|FG001|Overall Study|Lost to Follow-up|4|||
146256972|NCT00645099|527454336|FG000|Overall Study|Adverse Event|11|||
146256973|NCT00645099|527454337|FG001|Overall Study|Adverse Event|5|||
146256974|NCT00645099|527454336|FG000|Overall Study|Other|9|||
146256975|NCT00645099|527454337|FG001|Overall Study|Other|5|||
146256976|NCT01201915|527454338|FG000|Overall Study|Adverse Event|2|||
146256977|NCT01201915|527454339|FG001|Overall Study|Adverse Event|1|||
146256978|NCT01201915|527454340|FG002|Overall Study|Adverse Event|1|||
146256979|NCT01201915|527454338|FG000|Overall Study|Lost to Follow-up|0|||
146256980|NCT01201915|527454339|FG001|Overall Study|Lost to Follow-up|4|||
146256981|NCT01201915|527454340|FG002|Overall Study|Lost to Follow-up|0|||
146256982|NCT01201915|527454338|FG000|Overall Study|Physician Decision|3|||
146256983|NCT01201915|527454339|FG001|Overall Study|Physician Decision|0|||
146256984|NCT01201915|527454340|FG002|Overall Study|Physician Decision|0|||
146256985|NCT01201915|527454338|FG000|Overall Study|Subject Decision|3|||
146256986|NCT01201915|527454339|FG001|Overall Study|Subject Decision|3|||
146050516|NCT04266795|526699243|FG000|Overall Study|Withdrawal by Patient|5|||
146050517|NCT04266795|526699244|FG001|Overall Study|Withdrawal by Patient|6|||
146050518|NCT04266795|526699243|FG000|Overall Study|Disease Relapse|3|||
146050519|NCT04266795|526699244|FG001|Overall Study|Disease Relapse|6|||
145940328|NCT00347919|526289993|FG000|Overall Study|Withdrawal by Subject|6|||
145940329|NCT00347919|526289994|FG001|Overall Study|Withdrawal by Subject|8|||
145940330|NCT00347919|526289995|FG002|Overall Study|Withdrawal by Subject|0|||
145940331|NCT00347919|526289993|FG000|Overall Study|Physician Decision|1|||
145940332|NCT00347919|526289994|FG001|Overall Study|Physician Decision|1|||
145940333|NCT00347919|526289995|FG002|Overall Study|Physician Decision|0|||
145940334|NCT00347919|526289993|FG000|Overall Study|Sponsor terminated study|15|||
145940335|NCT00347919|526289994|FG001|Overall Study|Sponsor terminated study|10|||
145940336|NCT00347919|526289995|FG002|Overall Study|Sponsor terminated study|16|||
145940337|NCT00347919|526289993|FG000|Overall Study|Death|35|||
145940338|NCT00347919|526289994|FG001|Overall Study|Death|42|||
145940339|NCT00347919|526289995|FG002|Overall Study|Death|19|||
145940340|NCT00347919|526289993|FG000|Overall Study|Par. Started Other Treatment|1|||
145940341|NCT00347919|526289994|FG001|Overall Study|Par. Started Other Treatment|1|||
145940342|NCT00347919|526289995|FG002|Overall Study|Par. Started Other Treatment|1|||
145940343|NCT00347919|526289993|FG000|Overall Study|Missing|2|||
145940344|NCT00347919|526289994|FG001|Overall Study|Missing|1|||
145940345|NCT00347919|526289995|FG002|Overall Study|Missing|2|||
145940346|NCT02225366|526290002|FG000|Overall Study|Lack of Efficacy|1|||
145940347|NCT02225366|526290003|FG001|Overall Study|Lack of Efficacy|0|||
145940348|NCT04713592|526290004|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145940349|NCT04713592|526290005|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
145940350|NCT04713592|526290006|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145940351|NCT04713592|526290007|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145940352|NCT04713592|526290004|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
145940353|NCT04713592|526290005|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
145940354|NCT04713592|526290006|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
146050520|NCT04266795|526699243|FG000|Overall Study|Reason not Specified|12|||
146050521|NCT04266795|526699244|FG001|Overall Study|Reason not Specified|10|||
146050522|NCT04266795|526699243|FG000|Overall Study|Participants Ongoing on Treatment|25|||
146050523|NCT04266795|526699244|FG001|Overall Study|Participants Ongoing on Treatment|23|||
146050524|NCT03043872|526699245|FG000|Overall Study|Withdrawal by Subject|6|||
146050525|NCT03043872|526699246|FG001|Overall Study|Withdrawal by Subject|6|||
146050526|NCT03043872|526699247|FG002|Overall Study|Withdrawal by Subject|15|||
146050527|NCT03043872|526699245|FG000|Overall Study|Lost to Follow-up|2|||
146050528|NCT03043872|526699246|FG001|Overall Study|Lost to Follow-up|1|||
146050529|NCT03043872|526699247|FG002|Overall Study|Lost to Follow-up|1|||
146050530|NCT03043872|526699245|FG000|Overall Study|Death|270|||
146050531|NCT03043872|526699246|FG001|Overall Study|Death|269|||
146050532|NCT03043872|526699247|FG002|Overall Study|Death|296|||
146050533|NCT00434109|526699248|FG000|Overall Study|Physician Decision|9|||
145940355|NCT04713592|526290007|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
145940356|NCT04713592|526290004|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
145940357|NCT04713592|526290005|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
145940358|NCT04713592|526290006|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
146256987|NCT01201915|527454340|FG002|Overall Study|Subject Decision|5|||
146256988|NCT01201915|527454338|FG000|Overall Study|Target Lesion Progression|0|||
146256989|NCT01201915|527454339|FG001|Overall Study|Target Lesion Progression|3|||
146256990|NCT01201915|527454340|FG002|Overall Study|Target Lesion Progression|0|||
146256991|NCT03406507|527454341|FG000|Extension Period|Lack of Efficacy|0|||
146050534|NCT00434109|526699248|FG000|Overall Study|Adverse Event|5|||
146050535|NCT00434109|526699248|FG000|Overall Study|Protocol Violation|1|||
146256992|NCT03406507|527454342|FG001|Extension Period|Lack of Efficacy|1|||
146256993|NCT02329223|527456095|FG000|Overall Study|Withdrawal by Subject|1|||
146050536|NCT00434109|526699248|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
146050537|NCT04186871|526699251|FG000|Overall Study|Lack of Efficacy|0|||
146050538|NCT04186871|526699252|FG001|Overall Study|Lack of Efficacy|1|||
146050539|NCT04186871|526699253|FG002|Overall Study|Lack of Efficacy|0|||
146050540|NCT04186871|526699254|FG003|Overall Study|Lack of Efficacy|0|||
146050541|NCT04186871|526699255|FG004|Overall Study|Lack of Efficacy|1|||
146050542|NCT04186871|526699256|FG005|Overall Study|Lack of Efficacy|1|||
146050543|NCT04186871|526699251|FG000|Overall Study|Adverse Event|1|||
146050544|NCT04186871|526699252|FG001|Overall Study|Adverse Event|1|||
146050545|NCT04186871|526699253|FG002|Overall Study|Adverse Event|0|||
146050546|NCT04186871|526699254|FG003|Overall Study|Adverse Event|0|||
146050547|NCT04186871|526699255|FG004|Overall Study|Adverse Event|0|||
146050548|NCT04186871|526699256|FG005|Overall Study|Adverse Event|2|||
146050549|NCT04186871|526699251|FG000|Overall Study|Study terminated by sponsor|1|||
146050550|NCT04186871|526699252|FG001|Overall Study|Study terminated by sponsor|2|||
146050551|NCT04186871|526699253|FG002|Overall Study|Study terminated by sponsor|0|||
146050552|NCT04186871|526699254|FG003|Overall Study|Study terminated by sponsor|1|||
146050553|NCT04186871|526699255|FG004|Overall Study|Study terminated by sponsor|0|||
146050554|NCT04186871|526699256|FG005|Overall Study|Study terminated by sponsor|0|||
146050555|NCT04186871|526699251|FG000|Overall Study|Other reasons|0|||
146050556|NCT04186871|526699252|FG001|Overall Study|Other reasons|0|||
146050557|NCT04186871|526699253|FG002|Overall Study|Other reasons|0|||
146050558|NCT04186871|526699254|FG003|Overall Study|Other reasons|0|||
146050559|NCT04186871|526699255|FG004|Overall Study|Other reasons|0|||
146050560|NCT04186871|526699256|FG005|Overall Study|Other reasons|1|||
146050561|NCT04186871|526699251|FG000|Overall Study|Withdrawal by Subject|0|||
146050562|NCT04186871|526699252|FG001|Overall Study|Withdrawal by Subject|0|||
146050563|NCT04186871|526699253|FG002|Overall Study|Withdrawal by Subject|0|||
146050564|NCT04186871|526699254|FG003|Overall Study|Withdrawal by Subject|0|||
146050565|NCT04186871|526699255|FG004|Overall Study|Withdrawal by Subject|0|||
146050566|NCT04186871|526699256|FG005|Overall Study|Withdrawal by Subject|1|||
146050567|NCT04186871|526699251|FG000|Overall Study|Lost to Follow-up|0|||
146050568|NCT04186871|526699252|FG001|Overall Study|Lost to Follow-up|0|||
146050569|NCT04186871|526699253|FG002|Overall Study|Lost to Follow-up|0|||
146050570|NCT04186871|526699254|FG003|Overall Study|Lost to Follow-up|0|||
146050571|NCT04186871|526699255|FG004|Overall Study|Lost to Follow-up|0|||
146050572|NCT04186871|526699256|FG005|Overall Study|Lost to Follow-up|1|||
146050573|NCT03790917|526699257|FG000|Overall Study|Death|1|||
146050574|NCT00543387|526699267|FG000|Panel 1 + Panel 2|Adverse Event|0|||
146050575|NCT00543387|526699268|FG001|Panel 1 + Panel 2|Adverse Event|1|||
146050576|NCT00543387|526699269|FG002|Panel 1 + Panel 2|Adverse Event|0|||
146050577|NCT00543387|526699270|FG003|Panel 1 + Panel 2|Adverse Event|0|||
146050578|NCT00543387|526699271|FG004|Panel 1 + Panel 2|Adverse Event|0|||
146050579|NCT00543387|526699272|FG005|Panel 1 + Panel 2|Adverse Event|0|||
146050580|NCT00543387|526699273|FG006|Panel 1 + Panel 2|Adverse Event|0|||
146050581|NCT00543387|526699274|FG007|Panel 1 + Panel 2|Adverse Event|1|||
146050582|NCT00543387|526699275|FG008|Panel 1 + Panel 2|Adverse Event|1|||
146050583|NCT00543387|526699276|FG009|Panel 1 + Panel 2|Adverse Event|0|||
146050584|NCT00543387|526699277|FG010|Panel 1 + Panel 2|Adverse Event|0|||
146050585|NCT00543387|526699267|FG000|Panel 1 + Panel 2|Physician Decision|0|||
146050586|NCT00543387|526699268|FG001|Panel 1 + Panel 2|Physician Decision|0|||
146050587|NCT00543387|526699269|FG002|Panel 1 + Panel 2|Physician Decision|1|||
146050588|NCT00543387|526699270|FG003|Panel 1 + Panel 2|Physician Decision|0|||
146050589|NCT00543387|526699271|FG004|Panel 1 + Panel 2|Physician Decision|0|||
146050590|NCT00543387|526699272|FG005|Panel 1 + Panel 2|Physician Decision|0|||
146050591|NCT00543387|526699273|FG006|Panel 1 + Panel 2|Physician Decision|0|||
146050592|NCT00543387|526699274|FG007|Panel 1 + Panel 2|Physician Decision|1|||
146050593|NCT00543387|526699275|FG008|Panel 1 + Panel 2|Physician Decision|0|||
146050594|NCT00543387|526699276|FG009|Panel 1 + Panel 2|Physician Decision|0|||
146050595|NCT00543387|526699277|FG010|Panel 1 + Panel 2|Physician Decision|0|||
146050596|NCT00543387|526699267|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146050597|NCT00543387|526699268|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
146256994|NCT02329223|527456096|FG001|Overall Study|Withdrawal by Subject|2|||
146256995|NCT02329223|527456097|FG002|Overall Study|Withdrawal by Subject|5|||
146256996|NCT02329223|527456095|FG000|Overall Study|Physician Decision|0|||
146256997|NCT02329223|527456096|FG001|Overall Study|Physician Decision|0|||
146050598|NCT00543387|526699269|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
146050599|NCT00543387|526699270|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146050600|NCT00543387|526699271|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146050601|NCT00543387|526699272|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
146050602|NCT00543387|526699273|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
146050603|NCT00543387|526699274|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
146256998|NCT02329223|527456097|FG002|Overall Study|Physician Decision|1|||
146256999|NCT02329223|527456095|FG000|Overall Study|Adverse Event|0|||
146050604|NCT00543387|526699275|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
146050605|NCT00543387|526699276|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
146257000|NCT02329223|527456096|FG001|Overall Study|Adverse Event|1|||
146257001|NCT02329223|527456097|FG002|Overall Study|Adverse Event|0|||
146257002|NCT03449134|527456106|FG000|52-Week Treatment Period|Death|2|||
146257003|NCT03449134|527456107|FG001|52-Week Treatment Period|Death|1|||
146257004|NCT03449134|527456108|FG002|52-Week Treatment Period|Death|0|||
146257005|NCT03449134|527456106|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
146257006|NCT03449134|527456107|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
146050606|NCT00543387|526699277|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
146050607|NCT00543387|526699267|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050608|NCT00543387|526699268|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050609|NCT00543387|526699269|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050610|NCT00543387|526699270|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050611|NCT00543387|526699271|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050612|NCT00543387|526699272|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050613|NCT00543387|526699273|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
146050614|NCT00543387|526699274|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050615|NCT00543387|526699275|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050616|NCT00543387|526699276|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050617|NCT00543387|526699277|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
146050618|NCT00543387|526699267|FG000|Crossover Participants|Progressive Disease|0|||
146050619|NCT00543387|526699268|FG001|Crossover Participants|Progressive Disease|0|||
146050620|NCT00543387|526699269|FG002|Crossover Participants|Progressive Disease|0|||
146050621|NCT00543387|526699270|FG003|Crossover Participants|Progressive Disease|0|||
146050622|NCT00543387|526699271|FG004|Crossover Participants|Progressive Disease|0|||
146050623|NCT00543387|526699272|FG005|Crossover Participants|Progressive Disease|0|||
146050624|NCT00543387|526699273|FG006|Crossover Participants|Progressive Disease|0|||
146050625|NCT00543387|526699274|FG007|Crossover Participants|Progressive Disease|0|||
146050626|NCT00543387|526699275|FG008|Crossover Participants|Progressive Disease|0|||
146050627|NCT00543387|526699276|FG009|Crossover Participants|Progressive Disease|1|||
146050628|NCT00543387|526699277|FG010|Crossover Participants|Progressive Disease|2|||
146050629|NCT00543387|526699267|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
146050630|NCT00543387|526699268|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
146050631|NCT00543387|526699269|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
146050632|NCT00543387|526699270|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
146050633|NCT00543387|526699271|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
146050634|NCT00543387|526699272|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
146050635|NCT00543387|526699273|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
146050636|NCT00543387|526699274|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
146050637|NCT00543387|526699275|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
146050638|NCT00543387|526699276|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
146050639|NCT00543387|526699277|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
146050640|NCT01792115|526699281|FG000|Overall Study|Lost to Follow-up|0|||
146050641|NCT01792115|526699282|FG001|Overall Study|Lost to Follow-up|1|||
146050642|NCT01792115|526699283|FG002|Overall Study|Lost to Follow-up|0|||
146050643|NCT03790111|526700741|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
146050644|NCT02796677|526700746|FG000|Overall Study|Adverse Event|11|||
146050645|NCT02796677|526700747|FG001|Overall Study|Adverse Event|22|||
146050646|NCT02796677|526700748|FG002|Overall Study|Adverse Event|14|||
146050647|NCT02796677|526700749|FG003|Overall Study|Adverse Event|14|||
146050648|NCT02796677|526700746|FG000|Overall Study|Protocol Violation|7|||
146050649|NCT02796677|526700747|FG001|Overall Study|Protocol Violation|5|||
146050650|NCT02796677|526700748|FG002|Overall Study|Protocol Violation|4|||
146050651|NCT02796677|526700749|FG003|Overall Study|Protocol Violation|8|||
146050652|NCT02796677|526700746|FG000|Overall Study|Lost to Follow-up|1|||
146050653|NCT02796677|526700747|FG001|Overall Study|Lost to Follow-up|5|||
146050654|NCT02796677|526700748|FG002|Overall Study|Lost to Follow-up|2|||
146050655|NCT02796677|526700749|FG003|Overall Study|Lost to Follow-up|2|||
146050656|NCT02796677|526700746|FG000|Overall Study|Lack of Efficacy|7|||
146050657|NCT02796677|526700747|FG001|Overall Study|Lack of Efficacy|9|||
146050658|NCT02796677|526700748|FG002|Overall Study|Lack of Efficacy|14|||
146050659|NCT02796677|526700749|FG003|Overall Study|Lack of Efficacy|20|||
146050660|NCT02796677|526700746|FG000|Overall Study|Withdrawal by Subject|4|||
146050661|NCT02796677|526700747|FG001|Overall Study|Withdrawal by Subject|14|||
146050662|NCT02796677|526700748|FG002|Overall Study|Withdrawal by Subject|6|||
146050663|NCT02796677|526700749|FG003|Overall Study|Withdrawal by Subject|7|||
146050664|NCT02796677|526700746|FG000|Overall Study|Progressive disease|6|||
146050665|NCT02796677|526700747|FG001|Overall Study|Progressive disease|15|||
146050666|NCT02796677|526700748|FG002|Overall Study|Progressive disease|13|||
146257007|NCT03449134|527456108|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
146050667|NCT02796677|526700749|FG003|Overall Study|Progressive disease|18|||
146050668|NCT02796677|526700746|FG000|Overall Study|Reason not mentioned|2|||
146050669|NCT02796677|526700747|FG001|Overall Study|Reason not mentioned|3|||
146257008|NCT03449134|527456106|FG000|52-Week Treatment Period|Physician Decision|2|||
146050670|NCT02796677|526700748|FG002|Overall Study|Reason not mentioned|0|||
146050671|NCT02796677|526700749|FG003|Overall Study|Reason not mentioned|5|||
145940359|NCT04713592|526290007|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
145940360|NCT04713592|526290004|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145940361|NCT04713592|526290005|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145940362|NCT04713592|526290006|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
145940363|NCT04713592|526290007|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
145940364|NCT04713592|526290004|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
145940365|NCT04713592|526290005|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
145940366|NCT04713592|526290006|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
145940367|NCT04713592|526290007|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
145940368|NCT04713592|526290004|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145940369|NCT04713592|526290005|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145940370|NCT04713592|526290006|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145940371|NCT04713592|526290007|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145940372|NCT04713592|526290004|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
146257009|NCT03449134|527456107|FG001|52-Week Treatment Period|Physician Decision|3|||
145940373|NCT04713592|526290005|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
145940374|NCT04713592|526290006|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
145940375|NCT04713592|526290007|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
145940376|NCT01190267|526290008|FG000|Overall Study|Adverse Event|10|||
145940377|NCT01190267|526290009|FG001|Overall Study|Adverse Event|0|||
145940378|NCT01190267|526290008|FG000|Overall Study|Treatment Failure|8|||
145940379|NCT01190267|526290009|FG001|Overall Study|Treatment Failure|2|||
145940380|NCT01190267|526290008|FG000|Overall Study|Lost to Follow-up|2|||
145940381|NCT01190267|526290009|FG001|Overall Study|Lost to Follow-up|0|||
145940382|NCT01190267|526290008|FG000|Overall Study|Withdrawal by Subject|13|||
145940383|NCT01190267|526290009|FG001|Overall Study|Withdrawal by Subject|1|||
145940384|NCT01190267|526290008|FG000|Overall Study|Protocol Violation|8|||
145940385|NCT01190267|526290009|FG001|Overall Study|Protocol Violation|1|||
145940386|NCT01382225|526290012|FG000|Overall Study|Adverse Event|3|||
146257010|NCT03449134|527456108|FG002|52-Week Treatment Period|Physician Decision|3|||
146257011|NCT03449134|527456106|FG000|52-Week Treatment Period|Screen Failure|1|||
146257012|NCT03449134|527456107|FG001|52-Week Treatment Period|Screen Failure|0|||
146257013|NCT03449134|527456108|FG002|52-Week Treatment Period|Screen Failure|1|||
146257014|NCT03449134|527456106|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
146257015|NCT03449134|527456107|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
146257016|NCT03449134|527456108|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
146257017|NCT03449134|527456106|FG000|52-Week Treatment Period|Site Closure|1|||
146257018|NCT03449134|527456107|FG001|52-Week Treatment Period|Site Closure|0|||
146257019|NCT03449134|527456108|FG002|52-Week Treatment Period|Site Closure|0|||
146257020|NCT00957996|527456114|FG000|Overall Study|Death|4|||
146257021|NCT00957996|527456115|FG001|Overall Study|Death|10|||
146257022|NCT00957996|527456114|FG000|Overall Study|Lost to Follow-up|4|||
146257023|NCT00957996|527456115|FG001|Overall Study|Lost to Follow-up|7|||
146257024|NCT00957996|527456114|FG000|Overall Study|Withdrawal by Subject|9|||
146257025|NCT00957996|527456115|FG001|Overall Study|Withdrawal by Subject|2|||
146257026|NCT00957996|527456114|FG000|Overall Study|Adverse Event|2|||
146257027|NCT00957996|527456115|FG001|Overall Study|Adverse Event|1|||
146257028|NCT00957996|527456114|FG000|Overall Study|Physician Decision|1|||
146257029|NCT00957996|527456115|FG001|Overall Study|Physician Decision|1|||
146257030|NCT00957996|527456114|FG000|Overall Study|Influenza-related complication|0|||
146257031|NCT00957996|527456115|FG001|Overall Study|Influenza-related complication|1|||
146257032|NCT00957996|527456114|FG000|Overall Study|Missing|1|||
146257033|NCT00957996|527456115|FG001|Overall Study|Missing|0|||
146257034|NCT00957996|527456114|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
146257035|NCT00957996|527456115|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
146257036|NCT01821729|527456117|FG000|Overall Study|Withdrawal by Subject|1|||
145940387|NCT01382225|526290013|FG001|Overall Study|Adverse Event|2|||
145940388|NCT01382225|526290012|FG000|Overall Study|Protocol Violation|2|||
145940389|NCT01382225|526290013|FG001|Overall Study|Protocol Violation|1|||
145940390|NCT01382225|526290012|FG000|Overall Study|Subject Withdrew Consent|5|||
146257037|NCT00381797|527456123|FG000|Overall Study|Withdrawal by Subject|1|||
146301050|NCT01093326|527617204|FG002|Overall Study|Withdrawal by Subject|26|||
146301051|NCT01093326|527617202|FG000|Overall Study|Adverse Event|2|||
146301052|NCT01093326|527617203|FG001|Overall Study|Adverse Event|1|||
146301053|NCT01093326|527617204|FG002|Overall Study|Adverse Event|4|||
145940391|NCT01382225|526290013|FG001|Overall Study|Subject Withdrew Consent|2|||
145940392|NCT01382225|526290012|FG000|Overall Study|Other|4|||
145940393|NCT01382225|526290013|FG001|Overall Study|Other|2|||
145940394|NCT02484651|526290017|FG000|Overall Study|Patients' data files were corrupted.|1|||
145940395|NCT02484651|526290018|FG001|Overall Study|Patients' data files were corrupted.|1|||
146257038|NCT00381797|527456124|FG001|Overall Study|Withdrawal by Subject|1|||
146257039|NCT00381797|527456125|FG002|Overall Study|Withdrawal by Subject|0|||
146257040|NCT00381797|527456126|FG003|Overall Study|Withdrawal by Subject|0|||
146301054|NCT01093326|527617202|FG000|Overall Study|Other|0|||
145940396|NCT02484651|526290017|FG000|Overall Study|BIS monitoring failed.|1|||
145940397|NCT02484651|526290018|FG001|Overall Study|BIS monitoring failed.|1|||
145940398|NCT02484651|526290017|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
145940399|NCT02484651|526290018|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
145940400|NCT01077739|526290022|FG000|Overall Study|Premature withdrawal|1|||
145940401|NCT01077739|526290023|FG001|Overall Study|Premature withdrawal|3|||
145940402|NCT01077739|526290022|FG000|Overall Study|Withdrawal by Subject|1|||
145940403|NCT01077739|526290023|FG001|Overall Study|Withdrawal by Subject|0|||
145940404|NCT01077739|526290022|FG000|Overall Study|Death|0|||
145940405|NCT01077739|526290023|FG001|Overall Study|Death|3|||
145940406|NCT01077739|526290022|FG000|Overall Study|Unacceptable toxicity|1|||
145940407|NCT01077739|526290023|FG001|Overall Study|Unacceptable toxicity|2|||
145940408|NCT01077739|526290022|FG000|Overall Study|Other|2|||
145940409|NCT01077739|526290023|FG001|Overall Study|Other|2|||
145940410|NCT00877071|526290024|FG000|Overall Study|disease progression|2|||
145940411|NCT05723328|526290025|FG000|Overall Study|Investigator's Decision|5|||
145940412|NCT05723328|526290026|FG001|Overall Study|Investigator's Decision|2|||
145940413|NCT03495154|526290028|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
145940414|NCT03495154|526290028|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
145940415|NCT03495154|526290028|FG000|Overall Study|Screen Failures During Surgery|6|||
145940416|NCT03495154|526290028|FG000|Overall Study|Death|2|||
145940417|NCT03495154|526290028|FG000|Overall Study|Lost to Follow-up|16|||
145940418|NCT03495154|526290028|FG000|Overall Study|Withdrawal by Subject|2|||
145940419|NCT03495154|526290028|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
145940420|NCT05685732|526290029|FG000|Overall Study|Withdrawal by Subject|2|||
145940421|NCT05685732|526290030|FG001|Overall Study|Withdrawal by Subject|0|||
145940422|NCT05685732|526290031|FG002|Overall Study|Withdrawal by Subject|2|||
145940423|NCT05685732|526290032|FG003|Overall Study|Withdrawal by Subject|3|||
145940424|NCT05685732|526290029|FG000|Overall Study|Protocol Violation|1|||
145940425|NCT05685732|526290030|FG001|Overall Study|Protocol Violation|2|||
145940426|NCT05685732|526290031|FG002|Overall Study|Protocol Violation|4|||
145940427|NCT05685732|526290032|FG003|Overall Study|Protocol Violation|1|||
145940428|NCT05685732|526290029|FG000|Overall Study|Lost to Follow-up|5|||
145940429|NCT05685732|526290030|FG001|Overall Study|Lost to Follow-up|1|||
145940430|NCT05685732|526290031|FG002|Overall Study|Lost to Follow-up|3|||
145940431|NCT05685732|526290032|FG003|Overall Study|Lost to Follow-up|1|||
145940432|NCT05685732|526290029|FG000|Overall Study|Adverse Event|2|||
145940433|NCT05685732|526290030|FG001|Overall Study|Adverse Event|1|||
145940434|NCT05685732|526290031|FG002|Overall Study|Adverse Event|0|||
145940435|NCT05685732|526290032|FG003|Overall Study|Adverse Event|0|||
145940436|NCT05685732|526290029|FG000|Overall Study|Physician Decision|1|||
145940437|NCT05685732|526290030|FG001|Overall Study|Physician Decision|0|||
145940438|NCT05685732|526290031|FG002|Overall Study|Physician Decision|0|||
145940439|NCT05685732|526290032|FG003|Overall Study|Physician Decision|0|||
145940440|NCT02640404|526290033|FG000|Overall Study|Protocol Violation|1|||
145940441|NCT02640404|526290034|FG001|Overall Study|Protocol Violation|0|||
145940442|NCT02640404|526290033|FG000|Overall Study|Withdrawal by Subject|1|||
145940443|NCT02640404|526290034|FG001|Overall Study|Withdrawal by Subject|0|||
145940444|NCT04908202|526290036|FG000|Pre-Treatment Period|OTHER REASONS|3|||
145940445|NCT04908202|526290037|FG001|Pre-Treatment Period|OTHER REASONS|1|||
145940446|NCT04908202|526290038|FG002|Pre-Treatment Period|OTHER REASONS|0|||
145940447|NCT04908202|526290039|FG003|Pre-Treatment Period|OTHER REASONS|0|||
145940448|NCT04908202|526290036|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
145940449|NCT04908202|526290037|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940450|NCT04908202|526290038|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940451|NCT04908202|526290039|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940452|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
145940453|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
145940454|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145940455|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145940456|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
145940457|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
145940458|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
145940459|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
145940460|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
145940461|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
145940462|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145940463|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145940464|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
145940465|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
145940466|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940467|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
146050672|NCT03798717|526700750|FG000|Overall Study|Failed Screening|0|||
146257041|NCT00381797|527456127|FG004|Overall Study|Withdrawal by Subject|2|||
146257042|NCT00381797|527456123|FG000|Overall Study|Ineligible|0|||
146257043|NCT00381797|527456124|FG001|Overall Study|Ineligible|0|||
146257044|NCT00381797|527456125|FG002|Overall Study|Ineligible|0|||
146257045|NCT00381797|527456126|FG003|Overall Study|Ineligible|1|||
146257046|NCT00381797|527456127|FG004|Overall Study|Ineligible|0|||
146257047|NCT00684203|527456128|FG000|Overall Study|Adverse Event|6|||
146257048|NCT00684203|527456129|FG001|Overall Study|Adverse Event|4|||
146257049|NCT00684203|527456130|FG002|Overall Study|Adverse Event|8|||
146257050|NCT00684203|527456131|FG003|Overall Study|Adverse Event|0|||
146257051|NCT00684203|527456132|FG004|Overall Study|Adverse Event|0|||
146257052|NCT00684203|527456133|FG005|Overall Study|Adverse Event|0|||
146257053|NCT00684203|527456128|FG000|Overall Study|Protocol-defined clinical event|3|||
146257054|NCT00684203|527456129|FG001|Overall Study|Protocol-defined clinical event|1|||
146257055|NCT00684203|527456130|FG002|Overall Study|Protocol-defined clinical event|0|||
146257056|NCT00684203|527456131|FG003|Overall Study|Protocol-defined clinical event|0|||
146257057|NCT00684203|527456132|FG004|Overall Study|Protocol-defined clinical event|0|||
146257058|NCT00684203|527456133|FG005|Overall Study|Protocol-defined clinical event|0|||
146257059|NCT00684203|527456128|FG000|Overall Study|Withdrawal by Subject|0|||
146257060|NCT00684203|527456129|FG001|Overall Study|Withdrawal by Subject|2|||
146257061|NCT00684203|527456130|FG002|Overall Study|Withdrawal by Subject|1|||
146257062|NCT00684203|527456131|FG003|Overall Study|Withdrawal by Subject|0|||
146257063|NCT00684203|527456132|FG004|Overall Study|Withdrawal by Subject|0|||
146257064|NCT00684203|527456133|FG005|Overall Study|Withdrawal by Subject|0|||
146257065|NCT00684203|527456128|FG000|Overall Study|Did not meet protocol eligibility|0|||
146257066|NCT00684203|527456129|FG001|Overall Study|Did not meet protocol eligibility|1|||
146257067|NCT00684203|527456130|FG002|Overall Study|Did not meet protocol eligibility|0|||
146257068|NCT00684203|527456131|FG003|Overall Study|Did not meet protocol eligibility|0|||
146257069|NCT00684203|527456132|FG004|Overall Study|Did not meet protocol eligibility|0|||
146257070|NCT00684203|527456133|FG005|Overall Study|Did not meet protocol eligibility|0|||
145940468|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145940469|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
146257071|NCT00719212|527456136|FG000|Overall Study|Death|41|||
146257072|NCT00719212|527456136|FG000|Overall Study|Lost to Follow-up|2|||
146257073|NCT00719212|527456136|FG000|Overall Study|Withdrawal by Subject|1|||
146257074|NCT00837096|527456137|FG000|Overall Study|Physician Decision|1|||
146257075|NCT00837096|527456138|FG001|Overall Study|Physician Decision|1|||
146257076|NCT00837096|527456137|FG000|Overall Study|Not reported|9|||
146257077|NCT00837096|527456138|FG001|Overall Study|Not reported|8|||
146257078|NCT01011049|527456139|FG000|Overall Study|Protocol Violation|0|||
146257079|NCT01011049|527456140|FG001|Overall Study|Protocol Violation|0|||
146257080|NCT01011049|527456141|FG002|Overall Study|Protocol Violation|2|||
146257081|NCT01011049|527456142|FG003|Overall Study|Protocol Violation|0|||
146257082|NCT01011049|527456139|FG000|Overall Study|Lost to Follow-up|1|||
146257083|NCT01011049|527456140|FG001|Overall Study|Lost to Follow-up|2|||
146257084|NCT01011049|527456141|FG002|Overall Study|Lost to Follow-up|1|||
146257085|NCT01011049|527456142|FG003|Overall Study|Lost to Follow-up|0|||
146257086|NCT01011049|527456139|FG000|Overall Study|Withdrawal by Subject|0|||
146257087|NCT01011049|527456140|FG001|Overall Study|Withdrawal by Subject|0|||
146257088|NCT01011049|527456141|FG002|Overall Study|Withdrawal by Subject|1|||
146257089|NCT01011049|527456142|FG003|Overall Study|Withdrawal by Subject|0|||
146257090|NCT00352053|527456143|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
146257091|NCT00352053|527456144|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
146257092|NCT00352053|527456143|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
146257093|NCT00352053|527456144|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
145940470|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145940471|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145940472|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145940473|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145940474|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145940475|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145940476|NCT04908202|526290036|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
145940477|NCT04908202|526290037|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
146257094|NCT00352053|527456143|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
145940478|NCT04908202|526290038|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
145940479|NCT04908202|526290039|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
146257095|NCT00352053|527456144|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
146257096|NCT00352053|527456143|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
146257097|NCT00352053|527456144|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
146257098|NCT00352053|527456143|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
146257099|NCT00352053|527456144|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
146257100|NCT00352053|527456143|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
146257101|NCT00352053|527456144|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
146257102|NCT00352053|527456143|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
146257103|NCT00352053|527456144|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
146257104|NCT00352053|527456143|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
146257105|NCT00352053|527456144|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
146257106|NCT00352053|527456143|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
146257107|NCT00352053|527456144|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
146257108|NCT00352053|527456143|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
146257109|NCT00352053|527456144|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
146257110|NCT00352053|527456143|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
146257111|NCT00352053|527456144|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
146257112|NCT00352053|527456143|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
146257113|NCT00352053|527456144|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
146257114|NCT00352053|527456143|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
146257115|NCT00352053|527456144|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
146257116|NCT02435381|527456145|FG000|Overall Study|Lost to Follow-up|2|||
146257117|NCT02435381|527456146|FG001|Overall Study|Lost to Follow-up|1|||
146257118|NCT04150341|527456149|FG000|Overall Study|Physician Decision|0|||
146257119|NCT04150341|527456150|FG001|Overall Study|Physician Decision|0|||
146257120|NCT04150341|527456151|FG002|Overall Study|Physician Decision|1|||
146257121|NCT04150341|527456152|FG003|Overall Study|Physician Decision|0|||
146257122|NCT04150341|527456153|FG004|Overall Study|Physician Decision|0|||
146257123|NCT04150341|527456154|FG005|Overall Study|Physician Decision|0|||
146257124|NCT04150341|527456149|FG000|Overall Study|Adverse Event|0|||
146257125|NCT04150341|527456150|FG001|Overall Study|Adverse Event|0|||
146257126|NCT04150341|527456151|FG002|Overall Study|Adverse Event|0|||
146257127|NCT04150341|527456152|FG003|Overall Study|Adverse Event|0|||
146257128|NCT04150341|527456153|FG004|Overall Study|Adverse Event|1|||
146257129|NCT04150341|527456154|FG005|Overall Study|Adverse Event|0|||
146257130|NCT00875615|527456155|FG000|Overall Study|Withdrawal by Subject|1|||
146257131|NCT00833898|527456161|FG000|Overall Study|Withdrawal by Subject|33|||
146257132|NCT00833898|527456162|FG001|Overall Study|Withdrawal by Subject|27|||
146257133|NCT00833898|527456161|FG000|Overall Study|Lost to Follow-up|7|||
146257134|NCT00833898|527456162|FG001|Overall Study|Lost to Follow-up|7|||
146257135|NCT00833898|527456161|FG000|Overall Study|Patient did not receive transplant|0|||
146257136|NCT00833898|527456162|FG001|Overall Study|Patient did not receive transplant|2|||
146257137|NCT00666198|527456166|FG000|Overall Study|Protocol Violation|10|||
146257138|NCT00666198|527456166|FG000|Overall Study|No Visit After First Day of Treatment|13|||
146257139|NCT00666198|527456166|FG000|Overall Study|Safety Not Assessable|6|||
146257140|NCT00666198|527456166|FG000|Overall Study|No Drug Administration|4|||
146257141|NCT05153499|527456167|FG000|Overall Study|Withdrawal by Subject|1|||
146257142|NCT05153499|527456168|FG001|Overall Study|Withdrawal by Subject|0|||
146257143|NCT05153499|527456167|FG000|Overall Study|Clinical Hold|1|||
146257144|NCT05153499|527456168|FG001|Overall Study|Clinical Hold|0|||
146257145|NCT05153499|527456167|FG000|Overall Study|Study Termination|6|||
146257146|NCT05153499|527456168|FG001|Overall Study|Study Termination|5|||
146257147|NCT03220776|527456174|FG000|Overall Study|Claustrophobia|0|||
145940480|NCT04908202|526290036|FG000|Active Treatment Period|OTHER REASONS|0|||
145940481|NCT04908202|526290037|FG001|Active Treatment Period|OTHER REASONS|0|||
145940482|NCT04908202|526290038|FG002|Active Treatment Period|OTHER REASONS|1|||
145940483|NCT04908202|526290039|FG003|Active Treatment Period|OTHER REASONS|3|||
145940484|NCT04908202|526290036|FG000|Active Treatment Period|Lack of Efficacy|0|||
145940485|NCT04908202|526290037|FG001|Active Treatment Period|Lack of Efficacy|0|||
145940486|NCT04908202|526290038|FG002|Active Treatment Period|Lack of Efficacy|4|||
145940487|NCT04908202|526290039|FG003|Active Treatment Period|Lack of Efficacy|5|||
145940488|NCT04908202|526290036|FG000|Active Treatment Period|Adverse Event|0|||
145940489|NCT04908202|526290037|FG001|Active Treatment Period|Adverse Event|0|||
146257148|NCT03220776|527456175|FG001|Overall Study|Claustrophobia|1|||
146257149|NCT03220776|527456176|FG002|Overall Study|Claustrophobia|1|||
145940490|NCT04908202|526290038|FG002|Active Treatment Period|Adverse Event|5|||
145940491|NCT04908202|526290039|FG003|Active Treatment Period|Adverse Event|8|||
145940492|NCT04908202|526290036|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145940493|NCT04908202|526290037|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
146257150|NCT03220776|527456177|FG003|Overall Study|Claustrophobia|0|||
146257151|NCT03220776|527456178|FG004|Overall Study|Claustrophobia|1|||
146257152|NCT03220776|527456179|FG005|Overall Study|Claustrophobia|0|||
146257153|NCT03220776|527456174|FG000|Overall Study|MRI Equipment Failure|1|||
146257154|NCT03220776|527456175|FG001|Overall Study|MRI Equipment Failure|0|||
146257155|NCT03220776|527456176|FG002|Overall Study|MRI Equipment Failure|0|||
146257156|NCT03220776|527456177|FG003|Overall Study|MRI Equipment Failure|0|||
145940494|NCT04908202|526290038|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
145940495|NCT04908202|526290039|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
146257157|NCT03220776|527456178|FG004|Overall Study|MRI Equipment Failure|0|||
145940496|NCT04908202|526290036|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940497|NCT04908202|526290037|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145940498|NCT04908202|526290038|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
145940499|NCT04908202|526290039|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
145940500|NCT04908202|526290036|FG000|Active Treatment Period|Lost to Follow-up|0|||
145940501|NCT04908202|526290037|FG001|Active Treatment Period|Lost to Follow-up|0|||
145940502|NCT04908202|526290038|FG002|Active Treatment Period|Lost to Follow-up|2|||
145940503|NCT04908202|526290039|FG003|Active Treatment Period|Lost to Follow-up|2|||
145940504|NCT04908202|526290036|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145940505|NCT04908202|526290037|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145940506|NCT04908202|526290038|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
145940507|NCT04908202|526290039|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145940508|NCT04908202|526290036|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145940509|NCT04908202|526290037|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145940510|NCT04908202|526290038|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145940511|NCT04908202|526290039|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145940512|NCT04908202|526290036|FG000|Active Treatment Period|ONGOING Treatment|0|||
145940513|NCT04908202|526290037|FG001|Active Treatment Period|ONGOING Treatment|0|||
145940514|NCT04908202|526290038|FG002|Active Treatment Period|ONGOING Treatment|117|||
145940515|NCT04908202|526290039|FG003|Active Treatment Period|ONGOING Treatment|114|||
145940516|NCT02100670|526290040|FG000|Overall Study|Adverse Event|10|||
145940517|NCT02100670|526290041|FG001|Overall Study|Adverse Event|3|||
145940518|NCT02100670|526290042|FG002|Overall Study|Adverse Event|3|||
145940519|NCT02100670|526290043|FG003|Overall Study|Adverse Event|0|||
145940520|NCT02100670|526290040|FG000|Overall Study|Lost to Follow-up|1|||
145940521|NCT02100670|526290041|FG001|Overall Study|Lost to Follow-up|0|||
145940522|NCT02100670|526290042|FG002|Overall Study|Lost to Follow-up|0|||
145940523|NCT02100670|526290043|FG003|Overall Study|Lost to Follow-up|0|||
145940524|NCT02100670|526290040|FG000|Overall Study|Protocol Violation|0|||
145940525|NCT02100670|526290041|FG001|Overall Study|Protocol Violation|1|||
145940526|NCT02100670|526290042|FG002|Overall Study|Protocol Violation|0|||
145940527|NCT02100670|526290043|FG003|Overall Study|Protocol Violation|1|||
145940528|NCT02100670|526290040|FG000|Overall Study|Withdrawal of Consent|0|||
145940529|NCT02100670|526290041|FG001|Overall Study|Withdrawal of Consent|1|||
145940530|NCT02100670|526290042|FG002|Overall Study|Withdrawal of Consent|1|||
145940531|NCT02100670|526290043|FG003|Overall Study|Withdrawal of Consent|0|||
145940532|NCT02100670|526290040|FG000|Overall Study|No swelling no pain|1|||
145940533|NCT02100670|526290041|FG001|Overall Study|No swelling no pain|0|||
145940534|NCT02100670|526290042|FG002|Overall Study|No swelling no pain|0|||
145940535|NCT02100670|526290043|FG003|Overall Study|No swelling no pain|0|||
145940536|NCT02100670|526290040|FG000|Overall Study|Poor Efficacy|0|||
145940537|NCT02100670|526290041|FG001|Overall Study|Poor Efficacy|1|||
145940538|NCT02100670|526290042|FG002|Overall Study|Poor Efficacy|0|||
145940539|NCT02100670|526290043|FG003|Overall Study|Poor Efficacy|0|||
145940540|NCT02100670|526290040|FG000|Overall Study|Physician Decision|0|||
145940541|NCT02100670|526290041|FG001|Overall Study|Physician Decision|1|||
145940542|NCT02100670|526290042|FG002|Overall Study|Physician Decision|0|||
145940543|NCT02100670|526290043|FG003|Overall Study|Physician Decision|0|||
145940544|NCT02100670|526290040|FG000|Overall Study|Withdrawal by Subject|1|||
145940545|NCT02100670|526290041|FG001|Overall Study|Withdrawal by Subject|0|||
145940546|NCT02100670|526290042|FG002|Overall Study|Withdrawal by Subject|0|||
145940547|NCT02100670|526290043|FG003|Overall Study|Withdrawal by Subject|0|||
145940548|NCT03036098|526291879|FG000|Pre-Treatment|Other Reasons|1|||
145940549|NCT03036098|526291880|FG001|Pre-Treatment|Other Reasons|2|||
145940550|NCT03036098|526291881|FG002|Pre-Treatment|Other Reasons|0|||
145940551|NCT03036098|526291882|FG003|Pre-Treatment|Other Reasons|5|||
145940552|NCT03036098|526291879|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
145940553|NCT03036098|526291880|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
145940554|NCT03036098|526291881|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
145940555|NCT03036098|526291882|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
146257158|NCT03220776|527456179|FG005|Overall Study|MRI Equipment Failure|0|||
146257159|NCT03220776|527456174|FG000|Overall Study|Inclimate Weather|0|||
145940556|NCT03036098|526291879|FG000|Pre-Treatment|Withdrawal by Subject|1|||
145940557|NCT03036098|526291880|FG001|Pre-Treatment|Withdrawal by Subject|14|||
145940558|NCT03036098|526291881|FG002|Pre-Treatment|Withdrawal by Subject|0|||
145940559|NCT03036098|526291882|FG003|Pre-Treatment|Withdrawal by Subject|5|||
145940560|NCT03036098|526291879|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
145940561|NCT03036098|526291880|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
145940562|NCT03036098|526291881|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
145940563|NCT03036098|526291882|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
145940564|NCT03036098|526291879|FG000|Treatment|Disease Progression|130|||
145940565|NCT03036098|526291880|FG001|Treatment|Disease Progression|77|||
145940566|NCT03036098|526291881|FG002|Treatment|Disease Progression|168|||
145940567|NCT03036098|526291882|FG003|Treatment|Disease Progression|50|||
146257160|NCT03220776|527456175|FG001|Overall Study|Inclimate Weather|0|||
146257161|NCT03220776|527456176|FG002|Overall Study|Inclimate Weather|0|||
146257162|NCT03220776|527456177|FG003|Overall Study|Inclimate Weather|0|||
146257163|NCT03220776|527456178|FG004|Overall Study|Inclimate Weather|0|||
146257164|NCT03220776|527456179|FG005|Overall Study|Inclimate Weather|1|||
146257165|NCT03220776|527456174|FG000|Overall Study|Physician Decision|0|||
146257166|NCT03220776|527456175|FG001|Overall Study|Physician Decision|0|||
146257167|NCT03220776|527456176|FG002|Overall Study|Physician Decision|0|||
146257168|NCT03220776|527456177|FG003|Overall Study|Physician Decision|1|||
146257169|NCT03220776|527456178|FG004|Overall Study|Physician Decision|0|||
146257170|NCT03220776|527456179|FG005|Overall Study|Physician Decision|0|||
146257171|NCT03220776|527456174|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146257172|NCT03220776|527456175|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146257173|NCT03220776|527456176|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146257174|NCT03220776|527456177|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
146257175|NCT03220776|527456178|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146257176|NCT03220776|527456179|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
146257177|NCT03220776|527456174|FG000|Overall Study|Protocol Violation|0|||
146257178|NCT03220776|527456175|FG001|Overall Study|Protocol Violation|0|||
146257179|NCT03220776|527456176|FG002|Overall Study|Protocol Violation|0|||
146257180|NCT03220776|527456177|FG003|Overall Study|Protocol Violation|2|||
146257181|NCT03220776|527456178|FG004|Overall Study|Protocol Violation|0|||
146257182|NCT03220776|527456179|FG005|Overall Study|Protocol Violation|1|||
146257183|NCT03220776|527456174|FG000|Overall Study|Withdrawal by Subject|1|||
146257184|NCT03220776|527456175|FG001|Overall Study|Withdrawal by Subject|0|||
146257185|NCT03220776|527456176|FG002|Overall Study|Withdrawal by Subject|0|||
146257186|NCT03220776|527456177|FG003|Overall Study|Withdrawal by Subject|0|||
146257187|NCT03220776|527456178|FG004|Overall Study|Withdrawal by Subject|0|||
146257188|NCT03220776|527456179|FG005|Overall Study|Withdrawal by Subject|0|||
146257189|NCT03226353|527456180|FG000|Overall Study|Withdrawal by Subject|1|||
146257190|NCT03226353|527456180|FG000|Overall Study|Screen Failure|5|||
146257191|NCT03441789|527456181|FG000|Overall Study|Withdrawal by Subject|1|||
146257192|NCT03441789|527456182|FG001|Overall Study|Withdrawal by Subject|1|||
146257193|NCT03441789|527456181|FG000|Overall Study|Adverse Event|0|||
146257194|NCT03441789|527456182|FG001|Overall Study|Adverse Event|1|||
146257195|NCT03441789|527456181|FG000|Overall Study|Protocol Violation|0|||
146257196|NCT03441789|527456182|FG001|Overall Study|Protocol Violation|1|||
146257197|NCT03441789|527456181|FG000|Overall Study|Lost to Follow-up|0|||
146257198|NCT03441789|527456182|FG001|Overall Study|Lost to Follow-up|1|||
146257199|NCT03168425|527456183|FG000|Overall Study|Lost to Follow-up|5|||
146257200|NCT03168425|527456184|FG001|Overall Study|Lost to Follow-up|8|||
146257201|NCT03168425|527456183|FG000|Overall Study|unable to confirm post op opioids|2|||
146257202|NCT03168425|527456184|FG001|Overall Study|unable to confirm post op opioids|3|||
146257203|NCT02166047|527456187|FG000|Overall Study|Withdrawal by Participant|0|||
146257204|NCT02166047|527456188|FG001|Overall Study|Withdrawal by Participant|1|||
146257205|NCT02166047|527456189|FG002|Overall Study|Withdrawal by Participant|2|||
146257206|NCT02166047|527456190|FG003|Overall Study|Withdrawal by Participant|0|||
146257207|NCT02166047|527456191|FG004|Overall Study|Withdrawal by Participant|0|||
146257208|NCT02166047|527456192|FG005|Overall Study|Withdrawal by Participant|0|||
146257209|NCT02166047|527456193|FG006|Overall Study|Withdrawal by Participant|1|||
146257210|NCT02166047|527456194|FG007|Overall Study|Withdrawal by Participant|0|||
146257211|NCT02166047|527456195|FG008|Overall Study|Withdrawal by Participant|0|||
146257212|NCT02166047|527456196|FG009|Overall Study|Withdrawal by Participant|0|||
146257213|NCT02166047|527456197|FG010|Overall Study|Withdrawal by Participant|0|||
146257214|NCT02166047|527456198|FG011|Overall Study|Withdrawal by Participant|0|||
146257215|NCT02166047|527456187|FG000|Overall Study|Adverse Event|0|||
146257216|NCT02166047|527456188|FG001|Overall Study|Adverse Event|0|||
146257217|NCT02166047|527456189|FG002|Overall Study|Adverse Event|0|||
146257218|NCT02166047|527456190|FG003|Overall Study|Adverse Event|0|||
146257219|NCT02166047|527456191|FG004|Overall Study|Adverse Event|1|||
146257220|NCT02166047|527456192|FG005|Overall Study|Adverse Event|0|||
146257221|NCT02166047|527456193|FG006|Overall Study|Adverse Event|1|||
146257222|NCT02166047|527456194|FG007|Overall Study|Adverse Event|0|||
146257223|NCT02166047|527456195|FG008|Overall Study|Adverse Event|0|||
146257224|NCT02166047|527456196|FG009|Overall Study|Adverse Event|0|||
146257225|NCT02166047|527456197|FG010|Overall Study|Adverse Event|2|||
146257226|NCT02166047|527456198|FG011|Overall Study|Adverse Event|0|||
146257227|NCT01960114|527456200|FG000|Overall Study|Adverse Event|1|||
146257228|NCT01960114|527456201|FG001|Overall Study|Adverse Event|0|||
146257229|NCT01960114|527456200|FG000|Overall Study|Could not swallow study medication|0|||
146257230|NCT01960114|527456201|FG001|Overall Study|Could not swallow study medication|1|||
146257231|NCT02490878|527456205|FG000|Overall Study|deemed ineligible|0|||
146257232|NCT02490878|527456206|FG001|Overall Study|deemed ineligible|1|||
146257233|NCT02490878|527456205|FG000|Overall Study|progression prior to treatment|0|||
146257234|NCT02490878|527456206|FG001|Overall Study|progression prior to treatment|1|||
146257235|NCT02490878|527456205|FG000|Overall Study|only submitted baseline QOL|0|||
146257236|NCT02490878|527456206|FG001|Overall Study|only submitted baseline QOL|1|||
146257237|NCT02845375|527456207|FG000|Overall Study|upper airway obstruction|1|||
146050673|NCT03798717|526700751|FG001|Overall Study|Failed Screening|0|||
146050674|NCT03798717|526700752|FG002|Overall Study|Failed Screening|0|||
146050675|NCT03798717|526700753|FG003|Overall Study|Failed Screening|0|||
146050676|NCT03798717|526700754|FG004|Overall Study|Failed Screening|0|||
146050677|NCT03798717|526700755|FG005|Overall Study|Failed Screening|1|||
146050678|NCT03798717|526700750|FG000|Overall Study|Physician Decision|1|||
146050679|NCT03798717|526700751|FG001|Overall Study|Physician Decision|0|||
146257238|NCT02845375|527456208|FG001|Overall Study|upper airway obstruction|2|||
146257239|NCT02845375|527456209|FG002|Overall Study|upper airway obstruction|1|||
146257240|NCT01177137|527456210|FG000|Overall Study|Withdrawal by Subject|10|||
146257241|NCT01177137|527456211|FG001|Overall Study|Withdrawal by Subject|10|||
146257242|NCT01177137|527456212|FG002|Overall Study|Withdrawal by Subject|2|||
146257243|NCT02215954|527456214|FG000|Overall Study|Adverse Event|0|||
146257244|NCT02215954|527456215|FG001|Overall Study|Adverse Event|0|||
146257245|NCT02215954|527456216|FG002|Overall Study|Adverse Event|1|||
146257246|NCT02215954|527456214|FG000|Overall Study|Withdrawal by Subject|0|||
146257247|NCT02215954|527456215|FG001|Overall Study|Withdrawal by Subject|0|||
146257248|NCT02215954|527456216|FG002|Overall Study|Withdrawal by Subject|2|||
146257249|NCT02215954|527456214|FG000|Overall Study|Not exposed|1|||
146257250|NCT02215954|527456215|FG001|Overall Study|Not exposed|1|||
146257251|NCT02215954|527456216|FG002|Overall Study|Not exposed|3|||
146257252|NCT02460562|527456217|FG000|Overall Study|Lost to Follow-up|15|||
146257253|NCT02460562|527456218|FG001|Overall Study|Lost to Follow-up|16|||
146257254|NCT01951261|527456219|FG000|Overall Study|Death|1|||
146257255|NCT01951261|527456220|FG001|Overall Study|Death|0|||
146257256|NCT01951261|527456219|FG000|Overall Study|Lost to Follow-up|4|||
146257257|NCT01951261|527456220|FG001|Overall Study|Lost to Follow-up|3|||
146257258|NCT01951261|527456219|FG000|Overall Study|Protocol Violation|4|||
146257259|NCT01951261|527456220|FG001|Overall Study|Protocol Violation|3|||
146257260|NCT01924806|527456221|FG000|Overall Study|Physician Decision|2|||
146257261|NCT01924806|527456222|FG001|Overall Study|Physician Decision|1|||
146257262|NCT00297778|527456230|FG000|Overall Study|Adverse Event|16|||
146257263|NCT00297778|527456231|FG001|Overall Study|Adverse Event|10|||
146257264|NCT00297778|527456230|FG000|Overall Study|Withdrawal by Subject|1|||
146257265|NCT00297778|527456231|FG001|Overall Study|Withdrawal by Subject|5|||
146257266|NCT00297778|527456230|FG000|Overall Study|Lack of Efficacy|2|||
146257267|NCT00297778|527456231|FG001|Overall Study|Lack of Efficacy|1|||
146257268|NCT00297778|527456230|FG000|Overall Study|Non-compliant with trial protocol|0|||
146257269|NCT00297778|527456231|FG001|Overall Study|Non-compliant with trial protocol|3|||
146257270|NCT00297778|527456230|FG000|Overall Study|Other|0|||
146257271|NCT00297778|527456231|FG001|Overall Study|Other|1|||
146257272|NCT02996097|527456232|FG000|Overall Study|Lost to Follow-up|11|||
146257273|NCT02996097|527456233|FG001|Overall Study|Lost to Follow-up|11|||
146257274|NCT02201771|527456234|FG000|Overall Study|Death|3|||
146257275|NCT02201771|527456235|FG001|Overall Study|Death|2|||
146257276|NCT02201771|527456236|FG002|Overall Study|Death|0|||
146257277|NCT02201771|527456234|FG000|Overall Study|Protocol Violation|10|||
146257278|NCT02201771|527456235|FG001|Overall Study|Protocol Violation|8|||
146257279|NCT02201771|527456236|FG002|Overall Study|Protocol Violation|10|||
146257280|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146257281|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
146257282|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
146257283|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146257284|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146257285|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146257286|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
146257287|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
146257288|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
146257289|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
146257290|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
146257291|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
146257292|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146257293|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146257294|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
146257295|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146257296|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146257297|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
146257298|NCT03569475|527456237|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
146257299|NCT03569475|527456238|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
146257300|NCT03569475|527456239|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
146257301|NCT03569475|527456237|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
146257302|NCT03569475|527456238|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
146257303|NCT03569475|527456239|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
146257304|NCT03569475|527456237|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
146257305|NCT03569475|527456238|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
146257306|NCT03569475|527456239|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
146257307|NCT02109107|527456240|FG000|Overall Study|Lost to Follow-up|2|||
146257308|NCT03078751|527456241|FG000|Overall Study|Adverse Event|4|||
146257309|NCT03078751|527456242|FG001|Overall Study|Adverse Event|0|||
146257310|NCT03078751|527456241|FG000|Overall Study|Physician Decision|1|||
146257311|NCT03078751|527456242|FG001|Overall Study|Physician Decision|0|||
146257312|NCT03078751|527456241|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
146257313|NCT03078751|527456242|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
146257314|NCT03078751|527456241|FG000|Overall Study|Subject/guardian decision|8|||
146257315|NCT03078751|527456242|FG001|Overall Study|Subject/guardian decision|1|||
146257316|NCT03078751|527456241|FG000|Overall Study|Untreated|0|||
146257317|NCT03078751|527456242|FG001|Overall Study|Untreated|4|||
146257318|NCT02515097|527456243|FG000|Overall Study|Lost to Follow-up|4|||
146257319|NCT02515097|527456244|FG001|Overall Study|Lost to Follow-up|2|||
146257320|NCT02515097|527456243|FG000|Overall Study|Withdrawal by Subject|1|||
146257321|NCT02515097|527456244|FG001|Overall Study|Withdrawal by Subject|3|||
146257322|NCT02515097|527456243|FG000|Overall Study|Adverse Event|2|||
145940568|NCT03036098|526291879|FG000|Treatment|Study Drug Toxicity|95|||
145940569|NCT03036098|526291880|FG001|Treatment|Study Drug Toxicity|45|||
145940570|NCT03036098|526291881|FG002|Treatment|Study Drug Toxicity|26|||
146257323|NCT02515097|527456244|FG001|Overall Study|Adverse Event|1|||
146257324|NCT02273180|527456248|FG000|Overall Study|Adverse Event|2|||
146257325|NCT02273180|527456249|FG001|Overall Study|Adverse Event|2|||
146257326|NCT02273180|527456248|FG000|Overall Study|Lack of Efficacy|1|||
146050680|NCT03798717|526700752|FG002|Overall Study|Physician Decision|1|||
145940571|NCT03036098|526291882|FG003|Treatment|Study Drug Toxicity|22|||
145940572|NCT03036098|526291879|FG000|Treatment|Death|9|||
145940573|NCT03036098|526291880|FG001|Treatment|Death|3|||
145940574|NCT03036098|526291881|FG002|Treatment|Death|1|||
145940575|NCT03036098|526291882|FG003|Treatment|Death|2|||
145940576|NCT03036098|526291879|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
145940577|NCT03036098|526291880|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
145940578|NCT03036098|526291881|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
145940579|NCT03036098|526291882|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
145940580|NCT03036098|526291879|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
145940581|NCT03036098|526291880|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
145940582|NCT03036098|526291881|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
145940583|NCT03036098|526291882|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
145940584|NCT03036098|526291879|FG000|Treatment|Withdrawal by Subject|2|||
145940585|NCT03036098|526291880|FG001|Treatment|Withdrawal by Subject|9|||
145940586|NCT03036098|526291881|FG002|Treatment|Withdrawal by Subject|2|||
145940587|NCT03036098|526291882|FG003|Treatment|Withdrawal by Subject|4|||
145940588|NCT03036098|526291879|FG000|Treatment|Maximum Clinical Benefit|6|||
145940589|NCT03036098|526291880|FG001|Treatment|Maximum Clinical Benefit|1|||
145940590|NCT03036098|526291881|FG002|Treatment|Maximum Clinical Benefit|6|||
145940591|NCT03036098|526291882|FG003|Treatment|Maximum Clinical Benefit|10|||
145940592|NCT03036098|526291879|FG000|Treatment|Poor/Non Compliance|1|||
145940593|NCT03036098|526291880|FG001|Treatment|Poor/Non Compliance|2|||
145940594|NCT03036098|526291881|FG002|Treatment|Poor/Non Compliance|0|||
145940595|NCT03036098|526291882|FG003|Treatment|Poor/Non Compliance|1|||
145940596|NCT03036098|526291879|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
145940597|NCT03036098|526291880|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
145940598|NCT03036098|526291881|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
145940599|NCT03036098|526291882|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
145940600|NCT03036098|526291879|FG000|Treatment|Administrative Reason by Sponsor|1|||
145940601|NCT03036098|526291880|FG001|Treatment|Administrative Reason by Sponsor|0|||
145940602|NCT03036098|526291881|FG002|Treatment|Administrative Reason by Sponsor|2|||
145940603|NCT03036098|526291882|FG003|Treatment|Administrative Reason by Sponsor|1|||
145940604|NCT03036098|526291879|FG000|Treatment|Other Reasons|31|||
145940605|NCT03036098|526291880|FG001|Treatment|Other Reasons|5|||
145940606|NCT03036098|526291881|FG002|Treatment|Other Reasons|21|||
145940607|NCT03036098|526291882|FG003|Treatment|Other Reasons|8|||
145940608|NCT03036098|526291879|FG000|Treatment|Ongoing Treatment|0|||
145940609|NCT03036098|526291880|FG001|Treatment|Ongoing Treatment|0|||
145940610|NCT03036098|526291881|FG002|Treatment|Ongoing Treatment|23|||
145940611|NCT03036098|526291882|FG003|Treatment|Ongoing Treatment|0|||
145940612|NCT02059434|526291883|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
145940613|NCT02059434|526291884|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
145940614|NCT02059434|526291885|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
145940615|NCT02059434|526291886|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
146257327|NCT02273180|527456249|FG001|Overall Study|Lack of Efficacy|0|||
146257328|NCT02273180|527456248|FG000|Overall Study|Protocol Violation|1|||
146257329|NCT02273180|527456249|FG001|Overall Study|Protocol Violation|7|||
145940616|NCT02059434|526291887|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
145940617|NCT02059434|526291888|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
145940618|NCT02059434|526291889|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
145940619|NCT02059434|526291890|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
145940620|NCT02059434|526291891|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
145940621|NCT02059434|526291883|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
145940622|NCT02059434|526291884|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
145940623|NCT02059434|526291885|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
145940624|NCT02059434|526291886|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
145940625|NCT02059434|526291887|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
145940626|NCT02059434|526291888|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
145940627|NCT02059434|526291889|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
145940628|NCT02059434|526291890|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
145940629|NCT02059434|526291891|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
145940630|NCT02059434|526291883|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
145940631|NCT02059434|526291884|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
145940632|NCT02059434|526291885|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
145940633|NCT02059434|526291886|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
145940634|NCT02059434|526291887|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
145940635|NCT02059434|526291888|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
145940636|NCT02059434|526291889|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
145940637|NCT02059434|526291890|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
145940638|NCT02059434|526291891|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
145940639|NCT02059434|526291883|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
145940640|NCT02059434|526291884|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
145940641|NCT02059434|526291885|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
145940642|NCT02059434|526291886|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
145940643|NCT02059434|526291887|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
145940644|NCT02059434|526291888|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
145940645|NCT02059434|526291889|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
145940646|NCT02059434|526291890|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
145940647|NCT02059434|526291891|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
145940648|NCT02059434|526291883|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940649|NCT02059434|526291884|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940650|NCT02059434|526291885|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940651|NCT02059434|526291886|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940652|NCT02059434|526291887|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940653|NCT02059434|526291888|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940654|NCT02059434|526291889|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940655|NCT02059434|526291890|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145940656|NCT02059434|526291891|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
145940657|NCT03201874|526291894|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
145940658|NCT03201874|526291895|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
145940659|NCT03201874|526291894|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
145940660|NCT03201874|526291895|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
145940661|NCT02907593|526291898|FG000|Overall Study|Withdrawal by Subject|0|||
145940662|NCT02907593|526291899|FG001|Overall Study|Withdrawal by Subject|0|||
145940663|NCT02907593|526291900|FG002|Overall Study|Withdrawal by Subject|1|||
145940664|NCT02907593|526291901|FG003|Overall Study|Withdrawal by Subject|0|||
145940665|NCT02659514|526291916|FG000|Overall Study|Adverse Event|3|||
145940666|NCT02659514|526291917|FG001|Overall Study|Adverse Event|12|||
145940667|NCT02659514|526291916|FG000|Overall Study|Disease Progression|23|||
145940668|NCT02659514|526291917|FG001|Overall Study|Disease Progression|13|||
145940669|NCT02659514|526291916|FG000|Overall Study|Withdrawal by Subject|0|||
145940670|NCT02659514|526291917|FG001|Overall Study|Withdrawal by Subject|4|||
145940671|NCT02659514|526291916|FG000|Overall Study|Lost to Follow-up|0|||
145940672|NCT02659514|526291917|FG001|Overall Study|Lost to Follow-up|1|||
145940673|NCT02659514|526291916|FG000|Overall Study|Death|6|||
145940674|NCT02659514|526291917|FG001|Overall Study|Death|1|||
145940675|NCT02659514|526291916|FG000|Overall Study|Reason Unspecified|0|||
145940676|NCT02659514|526291917|FG001|Overall Study|Reason Unspecified|3|||
145940677|NCT04495816|526291920|FG000|Overall Study|Lost to Follow-up|10|||
145940678|NCT04495816|526291921|FG001|Overall Study|Lost to Follow-up|4|||
145940679|NCT04495816|526291920|FG000|Overall Study|Withdrawal by Subject|3|||
145940680|NCT04495816|526291921|FG001|Overall Study|Withdrawal by Subject|5|||
145940681|NCT03536949|526291922|FG000|Overall Study|Adverse Event|4|||
145940682|NCT03536949|526291923|FG001|Overall Study|Adverse Event|0|||
145940683|NCT03536949|526291922|FG000|Overall Study|Lost to Follow-up|2|||
145940684|NCT03536949|526291923|FG001|Overall Study|Lost to Follow-up|1|||
145940685|NCT03536949|526291922|FG000|Overall Study|Withdrawal by Subject|6|||
145940686|NCT03536949|526291923|FG001|Overall Study|Withdrawal by Subject|0|||
145940687|NCT03536949|526291922|FG000|Overall Study|Non-compliance|2|||
145940688|NCT03536949|526291923|FG001|Overall Study|Non-compliance|1|||
145940689|NCT06137703|526291925|FG000|Overall Study|Other|0|||
145940690|NCT06137703|526291926|FG001|Overall Study|Other|1|||
145940691|NCT06137703|526291927|FG002|Overall Study|Other|0|||
145940692|NCT06137703|526291928|FG003|Overall Study|Other|0|||
145940693|NCT06137703|526291925|FG000|Overall Study|Adverse Event|0|||
145940694|NCT06137703|526291926|FG001|Overall Study|Adverse Event|0|||
145940695|NCT06137703|526291927|FG002|Overall Study|Adverse Event|1|||
145940696|NCT06137703|526291928|FG003|Overall Study|Adverse Event|0|||
145940697|NCT04329091|526291929|FG000|Overall Study|Physician Decision|5|||
145940698|NCT00741091|526291932|FG000|Overall Study|Death|13|||
145940699|NCT00741091|526291932|FG000|Overall Study|Lost to Follow-up|16|||
145940700|NCT00741091|526291932|FG000|Overall Study|Withdrawal by Subject|6|||
145940701|NCT00741091|526291932|FG000|Overall Study|Missed Visit|22|||
145940702|NCT01801358|526291933|FG000|Overall Study|Adverse Event|0|||
145940703|NCT01801358|526291934|FG001|Overall Study|Adverse Event|2|||
145940704|NCT01801358|526291935|FG002|Overall Study|Adverse Event|1|||
145940705|NCT01801358|526291936|FG003|Overall Study|Adverse Event|0|||
145940706|NCT01801358|526291937|FG004|Overall Study|Adverse Event|0|||
145940707|NCT01801358|526291938|FG005|Overall Study|Adverse Event|1|||
145940708|NCT01801358|526291933|FG000|Overall Study|Physician Decision|0|||
145940709|NCT01801358|526291934|FG001|Overall Study|Physician Decision|0|||
145940710|NCT01801358|526291935|FG002|Overall Study|Physician Decision|1|||
145940711|NCT01801358|526291936|FG003|Overall Study|Physician Decision|0|||
145940712|NCT01801358|526291937|FG004|Overall Study|Physician Decision|0|||
145940713|NCT01801358|526291938|FG005|Overall Study|Physician Decision|0|||
145940714|NCT01801358|526291933|FG000|Overall Study|Progressive Disease|6|||
145940715|NCT01801358|526291934|FG001|Overall Study|Progressive Disease|4|||
145940716|NCT01801358|526291935|FG002|Overall Study|Progressive Disease|4|||
145940717|NCT01801358|526291936|FG003|Overall Study|Progressive Disease|5|||
145940718|NCT01801358|526291937|FG004|Overall Study|Progressive Disease|6|||
145940719|NCT01801358|526291938|FG005|Overall Study|Progressive Disease|5|||
146257330|NCT02273180|527456248|FG000|Overall Study|Randomized but not treated|1|||
146257331|NCT02273180|527456249|FG001|Overall Study|Randomized but not treated|0|||
146050681|NCT03798717|526700753|FG003|Overall Study|Physician Decision|0|||
146050682|NCT03798717|526700754|FG004|Overall Study|Physician Decision|0|||
146050683|NCT03798717|526700755|FG005|Overall Study|Physician Decision|0|||
146050684|NCT03798717|526700750|FG000|Overall Study|Withdrawal by Subject|0|||
146050685|NCT03798717|526700751|FG001|Overall Study|Withdrawal by Subject|0|||
146050686|NCT03798717|526700752|FG002|Overall Study|Withdrawal by Subject|0|||
146050687|NCT03798717|526700753|FG003|Overall Study|Withdrawal by Subject|1|||
146050688|NCT03798717|526700754|FG004|Overall Study|Withdrawal by Subject|0|||
146050689|NCT03798717|526700755|FG005|Overall Study|Withdrawal by Subject|0|||
146050690|NCT03798717|526700750|FG000|Overall Study|Lost to Follow-up|1|||
146050691|NCT03798717|526700751|FG001|Overall Study|Lost to Follow-up|0|||
146050692|NCT03798717|526700752|FG002|Overall Study|Lost to Follow-up|0|||
146050693|NCT03798717|526700753|FG003|Overall Study|Lost to Follow-up|1|||
146050694|NCT03798717|526700754|FG004|Overall Study|Lost to Follow-up|0|||
146050695|NCT03798717|526700755|FG005|Overall Study|Lost to Follow-up|0|||
146050696|NCT03798717|526700750|FG000|Overall Study|Adverse Event|0|||
146050697|NCT03798717|526700751|FG001|Overall Study|Adverse Event|1|||
146050698|NCT03798717|526700752|FG002|Overall Study|Adverse Event|0|||
146050699|NCT03798717|526700753|FG003|Overall Study|Adverse Event|0|||
146050700|NCT03798717|526700754|FG004|Overall Study|Adverse Event|0|||
146050701|NCT03798717|526700755|FG005|Overall Study|Adverse Event|0|||
146257332|NCT02273180|527456248|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
146257333|NCT02273180|527456249|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
146257334|NCT02273180|527456248|FG000|Overall Study|Other than specified above|21|||
146257335|NCT02273180|527456249|FG001|Overall Study|Other than specified above|10|||
146257336|NCT02154516|527456250|FG000|Overall Study|Withdrawal by Subject|0|||
146257337|NCT02154516|527456251|FG001|Overall Study|Withdrawal by Subject|1|||
145940720|NCT01801358|526291933|FG000|Overall Study|Withdrawal by Subject|0|||
145940721|NCT01801358|526291934|FG001|Overall Study|Withdrawal by Subject|0|||
145940722|NCT01801358|526291935|FG002|Overall Study|Withdrawal by Subject|0|||
145940723|NCT01801358|526291936|FG003|Overall Study|Withdrawal by Subject|1|||
146050702|NCT03798717|526700750|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146050703|NCT03798717|526700751|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146050704|NCT03798717|526700752|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146050705|NCT03798717|526700753|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146050706|NCT03798717|526700754|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
145940724|NCT01801358|526291937|FG004|Overall Study|Withdrawal by Subject|0|||
145940725|NCT01801358|526291938|FG005|Overall Study|Withdrawal by Subject|2|||
145940726|NCT03787303|526291939|FG000|Overall Study|Death|1|||
145940727|NCT03787303|526291939|FG000|Overall Study|Premature Termination of Study|1|||
146257338|NCT02154516|527456250|FG000|Overall Study|Lost to Follow-up|1|||
146257339|NCT02154516|527456251|FG001|Overall Study|Lost to Follow-up|0|||
145940728|NCT01527487|526291942|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
145940729|NCT01527487|526291943|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
145940730|NCT01527487|526291942|FG000|Overall Study|Disease Progression|4|||
145940731|NCT01527487|526291943|FG001|Overall Study|Disease Progression|1|||
145940732|NCT01527487|526291942|FG000|Overall Study|Adverse Event|1|||
145940733|NCT01527487|526291943|FG001|Overall Study|Adverse Event|1|||
145940734|NCT01527487|526291942|FG000|Overall Study|Death|0|||
145940735|NCT01527487|526291943|FG001|Overall Study|Death|1|||
145940736|NCT01210495|526291944|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
145940737|NCT01210495|526291945|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
145940738|NCT01210495|526291946|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
145940739|NCT01210495|526291947|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
145940740|NCT01210495|526291944|FG000|Overall Study|Death|14|||
145940741|NCT01210495|526291945|FG001|Overall Study|Death|7|||
145940742|NCT01210495|526291946|FG002|Overall Study|Death|112|||
145940743|NCT01210495|526291947|FG003|Overall Study|Death|54|||
145940744|NCT01210495|526291944|FG000|Overall Study|Study Terminated by Sponsor|0|||
145940745|NCT01210495|526291945|FG001|Overall Study|Study Terminated by Sponsor|0|||
145940746|NCT01210495|526291946|FG002|Overall Study|Study Terminated by Sponsor|4|||
145940747|NCT01210495|526291947|FG003|Overall Study|Study Terminated by Sponsor|11|||
145940748|NCT01210495|526291944|FG000|Overall Study|Lost to Follow-up|0|||
145940749|NCT01210495|526291945|FG001|Overall Study|Lost to Follow-up|0|||
145940750|NCT01210495|526291946|FG002|Overall Study|Lost to Follow-up|1|||
145940751|NCT01210495|526291947|FG003|Overall Study|Lost to Follow-up|1|||
145940752|NCT01210495|526291944|FG000|Overall Study|Other unspecified|0|||
145940753|NCT01210495|526291945|FG001|Overall Study|Other unspecified|0|||
145940754|NCT01210495|526291946|FG002|Overall Study|Other unspecified|6|||
145940755|NCT01210495|526291947|FG003|Overall Study|Other unspecified|0|||
145940756|NCT01384019|526291948|FG000|Overall Study|Withdrawal by Subject|3|||
145940757|NCT01384019|526291949|FG001|Overall Study|Withdrawal by Subject|0|||
145940758|NCT01384019|526291948|FG000|Overall Study|Death|1|||
145940759|NCT01384019|526291949|FG001|Overall Study|Death|0|||
145940760|NCT01384019|526291948|FG000|Overall Study|MRI refusal|6|||
145940761|NCT01384019|526291949|FG001|Overall Study|MRI refusal|6|||
146257340|NCT02154516|527456250|FG000|Overall Study|Removal/revision of device|1|||
146257341|NCT02154516|527456251|FG001|Overall Study|Removal/revision of device|0|||
146257342|NCT02154516|527456250|FG000|Overall Study|Death|2|||
146257343|NCT02154516|527456251|FG001|Overall Study|Death|1|||
146257344|NCT02965599|527456255|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
146257345|NCT02965599|527456256|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
146257346|NCT04435522|527456260|FG000|Overall Study|Withdrawal by Subject|2|||
146257347|NCT02799745|527456263|FG000|Overall Study|Participant moved out of state|1|||
146257348|NCT02799745|527456264|FG001|Overall Study|Participant moved out of state|0|||
146257349|NCT02799745|527456263|FG000|Overall Study|Discontinued due to planned surgery|1|||
146257350|NCT02799745|527456264|FG001|Overall Study|Discontinued due to planned surgery|0|||
146257351|NCT02799745|527456263|FG000|Overall Study|Withdrawal by Subject|16|||
146257352|NCT02799745|527456264|FG001|Overall Study|Withdrawal by Subject|25|||
146257353|NCT02799745|527456263|FG000|Overall Study|Protocol Deviation|4|||
146257354|NCT02799745|527456264|FG001|Overall Study|Protocol Deviation|5|||
146257355|NCT02799745|527456263|FG000|Overall Study|Progressive Disease|28|||
146257356|NCT02799745|527456264|FG001|Overall Study|Progressive Disease|38|||
146257357|NCT02799745|527456263|FG000|Overall Study|Lost to Follow-up|3|||
146257358|NCT02799745|527456264|FG001|Overall Study|Lost to Follow-up|2|||
145940762|NCT00767039|526291952|FG000|Overall Study|Death|5|||
145940763|NCT00767039|526291953|FG001|Overall Study|Death|2|||
145940764|NCT01826370|526291954|FG000|Overall Study|Protocol Violation|6|||
145940765|NCT01826370|526291954|FG000|Overall Study|Lost to Follow-up|12|||
145940766|NCT01826370|526291954|FG000|Overall Study|Other reason not defined above|2|||
145940767|NCT04416737|526291956|FG000|Week 1 (First Injection)|Physician Decision|0|||
145940768|NCT04416737|526291957|FG001|Week 1 (First Injection)|Physician Decision|1|||
146257359|NCT02799745|527456263|FG000|Overall Study|Death|3|||
146257360|NCT02799745|527456264|FG001|Overall Study|Death|0|||
146257361|NCT02799745|527456263|FG000|Overall Study|Adverse Event|0|||
145940769|NCT01472757|526291963|FG000|Overall Study|Withdrawal by Subject|1|||
145940770|NCT01472757|526291964|FG001|Overall Study|Withdrawal by Subject|2|||
145940771|NCT01472757|526291965|FG002|Overall Study|Withdrawal by Subject|2|||
145940772|NCT01472757|526291966|FG003|Overall Study|Withdrawal by Subject|0|||
145940773|NCT01472757|526291963|FG000|Overall Study|Asthma exacerbation|4|||
145940774|NCT01472757|526291964|FG001|Overall Study|Asthma exacerbation|1|||
145940775|NCT01472757|526291965|FG002|Overall Study|Asthma exacerbation|2|||
145940776|NCT01472757|526291966|FG003|Overall Study|Asthma exacerbation|1|||
145940777|NCT01472757|526291963|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
145940778|NCT01472757|526291964|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
146257362|NCT02799745|527456264|FG001|Overall Study|Adverse Event|1|||
146257363|NCT02517528|527457640|FG000|Overall Study|Withdrawal by Subject|1|||
146257364|NCT01093599|527457641|FG000|Overall Study|Lost to Follow-up|32|||
146257365|NCT01093599|527457642|FG001|Overall Study|Lost to Follow-up|46|||
146257366|NCT00630552|527457646|FG000|Overall Study|Adverse Event|0|||
145940779|NCT01472757|526291965|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
145940780|NCT01472757|526291966|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
145940781|NCT01472757|526291963|FG000|Overall Study|Protocol Violation|3|||
145940782|NCT01472757|526291964|FG001|Overall Study|Protocol Violation|2|||
145940783|NCT01472757|526291965|FG002|Overall Study|Protocol Violation|4|||
145940784|NCT01472757|526291966|FG003|Overall Study|Protocol Violation|4|||
145940785|NCT01472757|526291963|FG000|Overall Study|Other reasons|1|||
145940786|NCT01472757|526291964|FG001|Overall Study|Other reasons|0|||
145940787|NCT01472757|526291965|FG002|Overall Study|Other reasons|2|||
145940788|NCT01472757|526291966|FG003|Overall Study|Other reasons|2|||
145940789|NCT04489381|526291971|FG000|Overall Study|Lost to Follow-up|2|||
145940790|NCT04489381|526291972|FG001|Overall Study|Lost to Follow-up|3|||
145940791|NCT04489381|526291971|FG000|Overall Study|Withdrawal by Subject|1|||
145940792|NCT04489381|526291972|FG001|Overall Study|Withdrawal by Subject|0|||
145940793|NCT00526331|526291975|FG000|Overall Study|Sponsor Termination|55|||
145940794|NCT01259375|526291976|FG000|Overall Study|Adverse Event|1|||
145940795|NCT00628095|526291977|FG000|Overall Study|Adverse Event|5|||
145940796|NCT00628095|526291978|FG001|Overall Study|Adverse Event|3|||
145940797|NCT00628095|526291977|FG000|Overall Study|Lack of Efficacy|0|||
145940798|NCT00628095|526291978|FG001|Overall Study|Lack of Efficacy|3|||
145940799|NCT00628095|526291977|FG000|Overall Study|Withdrawal by Subject|2|||
145940800|NCT00628095|526291978|FG001|Overall Study|Withdrawal by Subject|0|||
145940801|NCT00628095|526291977|FG000|Overall Study|Other|0|||
145940802|NCT00628095|526291978|FG001|Overall Study|Other|1|||
145940803|NCT00478699|526291981|FG000|Overall Study|Inclusion Error|1|||
145940804|NCT00478699|526291982|FG001|Overall Study|Inclusion Error|7|||
145940805|NCT00478699|526291981|FG000|Overall Study|Not receive study treatment|6|||
145940806|NCT00478699|526291982|FG001|Overall Study|Not receive study treatment|30|||
145940807|NCT01043705|526291987|FG000|Overall Study|Death|28|||
145940808|NCT01043705|526291988|FG001|Overall Study|Death|60|||
145940809|NCT01043705|526291989|FG002|Overall Study|Death|26|||
145940810|NCT01043705|526291987|FG000|Overall Study|Lost to Follow-up|27|||
145940811|NCT01043705|526291988|FG001|Overall Study|Lost to Follow-up|12|||
145940812|NCT01043705|526291989|FG002|Overall Study|Lost to Follow-up|0|||
145940813|NCT01043705|526291987|FG000|Overall Study|Multiple Reasons|4|||
145940814|NCT01043705|526291988|FG001|Overall Study|Multiple Reasons|7|||
145940815|NCT01043705|526291989|FG002|Overall Study|Multiple Reasons|0|||
145940816|NCT01043705|526291987|FG000|Overall Study|Protocol Violation|2|||
145940817|NCT01043705|526291988|FG001|Overall Study|Protocol Violation|1|||
145940818|NCT01043705|526291989|FG002|Overall Study|Protocol Violation|0|||
145940819|NCT01043705|526291987|FG000|Overall Study|Withdrawal by Subject|8|||
145940820|NCT01043705|526291988|FG001|Overall Study|Withdrawal by Subject|6|||
145940821|NCT01043705|526291989|FG002|Overall Study|Withdrawal by Subject|0|||
145940822|NCT01043705|526291987|FG000|Overall Study|Site Closure|8|||
145940823|NCT01043705|526291988|FG001|Overall Study|Site Closure|0|||
145940824|NCT01043705|526291989|FG002|Overall Study|Site Closure|0|||
145940825|NCT01043705|526291987|FG000|Overall Study|Subsequent Procedure|9|||
145940826|NCT01043705|526291988|FG001|Overall Study|Subsequent Procedure|24|||
145940827|NCT01043705|526291989|FG002|Overall Study|Subsequent Procedure|29|||
145940828|NCT01043705|526291987|FG000|Overall Study|Adverse Event|0|||
145940829|NCT01043705|526291988|FG001|Overall Study|Adverse Event|2|||
145940830|NCT01043705|526291989|FG002|Overall Study|Adverse Event|0|||
145940831|NCT01043705|526291987|FG000|Overall Study|Screen Fail|21|||
145940832|NCT01043705|526291988|FG001|Overall Study|Screen Fail|0|||
145940833|NCT01043705|526291989|FG002|Overall Study|Screen Fail|0|||
145940834|NCT01043705|526291987|FG000|Overall Study|Other|0|||
145940835|NCT01043705|526291988|FG001|Overall Study|Other|19|||
145940836|NCT01043705|526291989|FG002|Overall Study|Other|25|||
145940837|NCT05020366|526291992|FG000|Overall Study|Lost to Follow-up|2|||
145940838|NCT05020366|526291993|FG001|Overall Study|Lost to Follow-up|0|||
145940839|NCT05020366|526291992|FG000|Overall Study|Withdrawal by Subject|2|||
145940840|NCT05020366|526291993|FG001|Overall Study|Withdrawal by Subject|0|||
146257367|NCT00630552|527457647|FG001|Overall Study|Adverse Event|1|||
146257368|NCT00630552|527457648|FG002|Overall Study|Adverse Event|5|||
145940841|NCT00656851|526291999|FG000|Overall Study|Withdrawal by Subject|0|||
145940842|NCT00656851|526292000|FG001|Overall Study|Withdrawal by Subject|4|||
145940843|NCT04601103|526292002|FG000|Overall Study|Needed crown & cleaning|0|||
145940844|NCT04601103|526292003|FG001|Overall Study|Needed crown & cleaning|0|||
145940845|NCT04601103|526292004|FG002|Overall Study|Needed crown & cleaning|1|||
145940846|NCT04601103|526292002|FG000|Overall Study|study was terminated|18|||
145940847|NCT04601103|526292003|FG001|Overall Study|study was terminated|18|||
145940848|NCT04601103|526292004|FG002|Overall Study|study was terminated|16|||
145940849|NCT04442269|526292007|FG000|Overall Study|Adverse Event|1|||
145940850|NCT04442269|526292008|FG001|Overall Study|Adverse Event|0|||
145940851|NCT04442269|526292007|FG000|Overall Study|Death|0|||
145940852|NCT04442269|526292008|FG001|Overall Study|Death|1|||
145940853|NCT04442269|526292007|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
145940854|NCT04442269|526292008|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
145940855|NCT04442269|526292007|FG000|Overall Study|Lost to Follow-up|1|||
146257369|NCT00630552|527457649|FG003|Overall Study|Adverse Event|4|||
145940856|NCT04442269|526292008|FG001|Overall Study|Lost to Follow-up|0|||
145940857|NCT04442269|526292007|FG000|Overall Study|Withdrawal by Subject|3|||
145940858|NCT04442269|526292008|FG001|Overall Study|Withdrawal by Subject|2|||
145940859|NCT04442269|526292007|FG000|Overall Study|Protocol Deviation|0|||
145940860|NCT04442269|526292008|FG001|Overall Study|Protocol Deviation|1|||
145940861|NCT04442269|526292007|FG000|Overall Study|Travel Limitations|1|||
145940862|NCT04442269|526292008|FG001|Overall Study|Travel Limitations|1|||
145940863|NCT04326439|526292009|FG000|Overall Study|Withdrawal by Subject|1|||
145940864|NCT04326439|526292010|FG001|Overall Study|Withdrawal by Subject|0|||
145940865|NCT04326439|526292009|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
145940866|NCT04326439|526292010|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
145940867|NCT04326439|526292009|FG000|Overall Study|Relapse after Induction 2|0|||
146257370|NCT00630552|527457650|FG004|Overall Study|Adverse Event|2|||
146050707|NCT03798717|526700755|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
146050708|NCT04002960|526700757|FG000|Overall Study|Withdrawn prior to Completion|2|||
146050709|NCT00961181|526700758|FG000|Overall Study|Death|2|||
146050710|NCT00961181|526700758|FG000|Overall Study|Withdrawal by Subject|2|||
146050711|NCT00961181|526700758|FG000|Overall Study|Lost to Follow-up|1|||
146050712|NCT03212326|526700759|FG000|Overall Study|Physician Decision|4|||
146050713|NCT01790594|526700769|FG000|Overall Study|Death|1|||
146050714|NCT01790594|526700770|FG001|Overall Study|Death|0|||
146050715|NCT01790594|526700771|FG002|Overall Study|Death|0|||
146050716|NCT01790594|526700769|FG000|Overall Study|Physician Decision|2|||
146050717|NCT01790594|526700770|FG001|Overall Study|Physician Decision|1|||
146050718|NCT01790594|526700771|FG002|Overall Study|Physician Decision|0|||
146050719|NCT01790594|526700769|FG000|Overall Study|Withdrawal by Subject|2|||
146050720|NCT01790594|526700770|FG001|Overall Study|Withdrawal by Subject|0|||
146050721|NCT01790594|526700771|FG002|Overall Study|Withdrawal by Subject|0|||
146050722|NCT01790594|526700769|FG000|Overall Study|Transplant was not done|0|||
146050723|NCT01790594|526700770|FG001|Overall Study|Transplant was not done|0|||
146050724|NCT01790594|526700771|FG002|Overall Study|Transplant was not done|3|||
146050725|NCT01790594|526700769|FG000|Overall Study|Terminated prior to week 76|0|||
146050726|NCT01790594|526700770|FG001|Overall Study|Terminated prior to week 76|2|||
146050727|NCT01790594|526700771|FG002|Overall Study|Terminated prior to week 76|0|||
146050728|NCT00404651|526700773|FG000|Overall Study|Serious Adverse Event|0|||
146050729|NCT00404651|526700774|FG001|Overall Study|Serious Adverse Event|0|||
146050730|NCT00404651|526700775|FG002|Overall Study|Serious Adverse Event|2|||
146050731|NCT00404651|526700776|FG003|Overall Study|Serious Adverse Event|0|||
146050732|NCT00404651|526700773|FG000|Overall Study|Protocol Violation|10|||
146050733|NCT00404651|526700774|FG001|Overall Study|Protocol Violation|5|||
146050734|NCT00404651|526700775|FG002|Overall Study|Protocol Violation|14|||
146050735|NCT00404651|526700776|FG003|Overall Study|Protocol Violation|5|||
146050736|NCT00404651|526700773|FG000|Overall Study|Lost to Follow-up|15|||
146050737|NCT00404651|526700774|FG001|Overall Study|Lost to Follow-up|11|||
146050738|NCT00404651|526700775|FG002|Overall Study|Lost to Follow-up|13|||
146050739|NCT00404651|526700776|FG003|Overall Study|Lost to Follow-up|10|||
146050740|NCT00404651|526700773|FG000|Overall Study|Withdrawal by Subject|14|||
146050741|NCT00404651|526700774|FG001|Overall Study|Withdrawal by Subject|12|||
146050742|NCT00404651|526700775|FG002|Overall Study|Withdrawal by Subject|16|||
146050743|NCT00404651|526700776|FG003|Overall Study|Withdrawal by Subject|6|||
146050744|NCT01121146|526700788|FG000|Overall Study|Death|17|||
146050745|NCT01121146|526700789|FG001|Overall Study|Death|15|||
146050746|NCT01121146|526700788|FG000|Overall Study|Adverse Event|2|||
146050747|NCT01121146|526700789|FG001|Overall Study|Adverse Event|11|||
146050748|NCT01121146|526700788|FG000|Overall Study|Lost to Follow-up|7|||
146050749|NCT01121146|526700789|FG001|Overall Study|Lost to Follow-up|16|||
146050750|NCT05030350|526700795|FG000|Overall Study|Adverse Event|13|||
146050751|NCT05030350|526700795|FG000|Overall Study|Lack of Efficacy|8|||
146050752|NCT05030350|526700795|FG000|Overall Study|Lost to Follow-up|35|||
146050753|NCT05030350|526700795|FG000|Overall Study|Pregnancy|2|||
146050754|NCT05030350|526700795|FG000|Overall Study|Protocol Violation|2|||
146050755|NCT05030350|526700795|FG000|Overall Study|Withdrawal by Subject|60|||
146050756|NCT05030350|526700795|FG000|Overall Study|Study terminated by sponsor|349|||
146050757|NCT05030350|526700795|FG000|Overall Study|Positive Drug Screen|4|||
146050758|NCT05030350|526700795|FG000|Overall Study|Other|8|||
146050759|NCT02711137|526700796|FG000|Overall Study|Death|1|||
146050760|NCT02711137|526700797|FG001|Overall Study|Death|4|||
146050761|NCT02711137|526700798|FG002|Overall Study|Death|5|||
146050762|NCT02711137|526700799|FG003|Overall Study|Death|5|||
146050763|NCT02711137|526700800|FG004|Overall Study|Death|3|||
146257371|NCT00630552|527457646|FG000|Overall Study|Disease progression|5|||
145940868|NCT04326439|526292010|FG001|Overall Study|Relapse after Induction 2|1|||
145940869|NCT04326439|526292009|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
145940870|NCT04326439|526292010|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
146050764|NCT02711137|526700801|FG005|Overall Study|Death|1|||
146050765|NCT02711137|526700802|FG006|Overall Study|Death|61|||
146050766|NCT02711137|526700803|FG007|Overall Study|Death|3|||
146050767|NCT02711137|526700804|FG008|Overall Study|Death|0|||
146050768|NCT02711137|526700805|FG009|Overall Study|Death|1|||
145940871|NCT03932331|526292014|FG000|Overall Study|Death|0|||
145940872|NCT03932331|526292015|FG001|Overall Study|Death|7|||
145940873|NCT03932331|526292016|FG002|Overall Study|Death|2|||
145940874|NCT03932331|526292014|FG000|Overall Study|Withdrawal by Subject|0|||
145940875|NCT03932331|526292015|FG001|Overall Study|Withdrawal by Subject|3|||
145940876|NCT03932331|526292016|FG002|Overall Study|Withdrawal by Subject|0|||
145940877|NCT03932331|526292014|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
145940878|NCT03932331|526292015|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
145940879|NCT03932331|526292016|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
145940880|NCT03932331|526292014|FG000|Overall Study|Progressive disease|3|||
145940881|NCT03932331|526292015|FG001|Overall Study|Progressive disease|0|||
145940882|NCT03932331|526292016|FG002|Overall Study|Progressive disease|0|||
145940883|NCT03932331|526292014|FG000|Overall Study|Lung infection|1|||
145940884|NCT03932331|526292015|FG001|Overall Study|Lung infection|0|||
145940885|NCT03932331|526292016|FG002|Overall Study|Lung infection|0|||
145940886|NCT03932331|526292014|FG000|Overall Study|Other|0|||
145940887|NCT03932331|526292015|FG001|Overall Study|Other|0|||
145940888|NCT03932331|526292016|FG002|Overall Study|Other|58|||
145940889|NCT01032239|526292017|FG000|Overall Study|Lost to Follow-up|3|||
145940890|NCT01032239|526292018|FG001|Overall Study|Lost to Follow-up|2|||
145940891|NCT01032239|526292017|FG000|Overall Study|Withdrawal by Subject|2|||
145940892|NCT01032239|526292018|FG001|Overall Study|Withdrawal by Subject|3|||
145940893|NCT01032239|526292017|FG000|Overall Study|Death|1|||
145940894|NCT01032239|526292018|FG001|Overall Study|Death|0|||
145940895|NCT01032239|526292017|FG000|Overall Study|Protocol Violation|1|||
145940896|NCT01032239|526292018|FG001|Overall Study|Protocol Violation|0|||
145940897|NCT03782298|526292019|FG000|Overall Study|Protocol Deviation|4|||
145940898|NCT01797081|526292020|FG000|Overall Study|Adverse Event|1|||
145940899|NCT01797081|526292021|FG001|Overall Study|Adverse Event|0|||
145940900|NCT01797081|526292022|FG002|Overall Study|Adverse Event|1|||
145940901|NCT01797081|526292023|FG003|Overall Study|Adverse Event|0|||
145940902|NCT01797081|526292020|FG000|Overall Study|Pregnancy|1|||
145940903|NCT01797081|526292021|FG001|Overall Study|Pregnancy|0|||
145940904|NCT01797081|526292022|FG002|Overall Study|Pregnancy|0|||
145940905|NCT01797081|526292023|FG003|Overall Study|Pregnancy|0|||
145940906|NCT01797081|526292020|FG000|Overall Study|Personal Reasons|12|||
145940907|NCT01797081|526292021|FG001|Overall Study|Personal Reasons|4|||
145940908|NCT01797081|526292022|FG002|Overall Study|Personal Reasons|4|||
145940909|NCT01797081|526292023|FG003|Overall Study|Personal Reasons|8|||
145940910|NCT01797081|526292020|FG000|Overall Study|Protocol Violation|0|||
145940911|NCT01797081|526292021|FG001|Overall Study|Protocol Violation|0|||
145940912|NCT01797081|526292022|FG002|Overall Study|Protocol Violation|0|||
145940913|NCT01797081|526292023|FG003|Overall Study|Protocol Violation|1|||
145940914|NCT05513703|526292027|FG000|Overall Study|Death|4|||
145940915|NCT05513703|526292027|FG000|Overall Study|Study terminated by sponsor|5|||
145940916|NCT01793688|526292030|FG000|Overall Study|Protocol Violation|2|||
145940917|NCT03649178|526292031|FG000|Overall Study|Adverse Event|1|||
145940918|NCT03649178|526292032|FG001|Overall Study|Adverse Event|2|||
145940919|NCT03649178|526292031|FG000|Overall Study|Withdrawal by Subject|0|||
145940920|NCT03649178|526292032|FG001|Overall Study|Withdrawal by Subject|2|||
145940921|NCT03649178|526292031|FG000|Overall Study|COVID regulation required halt in protocol|1|||
145940922|NCT03649178|526292032|FG001|Overall Study|COVID regulation required halt in protocol|0|||
145940923|NCT03003494|526292033|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
145940924|NCT05238025|526292034|FG000|Overall Study|Adverse Event|2|||
145940925|NCT05238025|526292035|FG001|Overall Study|Adverse Event|2|||
145940926|NCT05238025|526292034|FG000|Overall Study|Lost to Follow-up|334|||
145940927|NCT05238025|526292035|FG001|Overall Study|Lost to Follow-up|339|||
145940928|NCT05238025|526292034|FG000|Overall Study|Withdrawal by Subject|203|||
146257372|NCT00630552|527457647|FG001|Overall Study|Disease progression|6|||
146257373|NCT00630552|527457648|FG002|Overall Study|Disease progression|27|||
146257374|NCT00630552|527457649|FG003|Overall Study|Disease progression|22|||
146257375|NCT00630552|527457650|FG004|Overall Study|Disease progression|31|||
145940929|NCT05238025|526292035|FG001|Overall Study|Withdrawal by Subject|222|||
145940930|NCT05238025|526292034|FG000|Overall Study|Physician Decision|20|||
145940931|NCT05238025|526292035|FG001|Overall Study|Physician Decision|8|||
145940932|NCT05238025|526292034|FG000|Overall Study|Protocol Violation|6|||
145940933|NCT05238025|526292035|FG001|Overall Study|Protocol Violation|2|||
145940934|NCT05238025|526292034|FG000|Overall Study|Death|38|||
145940935|NCT05238025|526292035|FG001|Overall Study|Death|32|||
145940936|NCT05238025|526292034|FG000|Overall Study|Study terminated by Sponsor|6358|||
145940937|NCT05238025|526292035|FG001|Overall Study|Study terminated by Sponsor|6358|||
145940938|NCT05238025|526292034|FG000|Overall Study|Other Reason|669|||
145940939|NCT05238025|526292035|FG001|Overall Study|Other Reason|690|||
145940940|NCT03814720|526292040|FG000|Overall Study|Lost to Follow-up|0|||
145940941|NCT03814720|526292041|FG001|Overall Study|Lost to Follow-up|1|||
145940942|NCT03814720|526292042|FG002|Overall Study|Lost to Follow-up|0|||
145940943|NCT03814720|526292043|FG003|Overall Study|Lost to Follow-up|0|||
145940944|NCT03814720|526292044|FG004|Overall Study|Lost to Follow-up|0|||
145940945|NCT02135107|526292045|FG000|Treatment Period|Withdrawal by Subject|11|||
146257376|NCT00630552|527457646|FG000|Overall Study|Never received IP|0|||
145940946|NCT02135107|526292046|FG001|Treatment Period|Withdrawal by Subject|0|||
145940947|NCT02135107|526292047|FG002|Treatment Period|Withdrawal by Subject|0|||
145940948|NCT02135107|526292048|FG003|Treatment Period|Withdrawal by Subject|0|||
146257377|NCT00630552|527457647|FG001|Overall Study|Never received IP|0|||
146257378|NCT00630552|527457648|FG002|Overall Study|Never received IP|0|||
146257379|NCT00630552|527457649|FG003|Overall Study|Never received IP|2|||
146257380|NCT00630552|527457650|FG004|Overall Study|Never received IP|2|||
146257381|NCT00630552|527457646|FG000|Overall Study|Ineligibility determined|0|||
146257382|NCT00630552|527457647|FG001|Overall Study|Ineligibility determined|0|||
146257383|NCT00630552|527457648|FG002|Overall Study|Ineligibility determined|0|||
146257384|NCT00630552|527457649|FG003|Overall Study|Ineligibility determined|0|||
146257385|NCT00630552|527457650|FG004|Overall Study|Ineligibility determined|1|||
146257386|NCT00630552|527457646|FG000|Overall Study|Protocol Violation|0|||
146257387|NCT00630552|527457647|FG001|Overall Study|Protocol Violation|0|||
146257388|NCT00630552|527457648|FG002|Overall Study|Protocol Violation|0|||
146257389|NCT00630552|527457649|FG003|Overall Study|Protocol Violation|1|||
146257390|NCT00630552|527457650|FG004|Overall Study|Protocol Violation|0|||
146257391|NCT00630552|527457646|FG000|Overall Study|Physician Decision|0|||
146257392|NCT00630552|527457647|FG001|Overall Study|Physician Decision|0|||
146301055|NCT01093326|527617203|FG001|Overall Study|Other|0|||
146301056|NCT01093326|527617204|FG002|Overall Study|Other|1|||
145940949|NCT02135107|526292045|FG000|Treatment Period|Adverse Event|5|||
145940950|NCT02135107|526292046|FG001|Treatment Period|Adverse Event|2|||
145940951|NCT02135107|526292047|FG002|Treatment Period|Adverse Event|0|||
145940952|NCT02135107|526292048|FG003|Treatment Period|Adverse Event|0|||
145940953|NCT02135107|526292045|FG000|Treatment Period|Pregnancy|1|||
145940954|NCT02135107|526292046|FG001|Treatment Period|Pregnancy|0|||
145940955|NCT02135107|526292047|FG002|Treatment Period|Pregnancy|0|||
145940956|NCT02135107|526292048|FG003|Treatment Period|Pregnancy|0|||
145940957|NCT02135107|526292045|FG000|Treatment Period|Other|115|||
145940958|NCT02135107|526292046|FG001|Treatment Period|Other|24|||
145940959|NCT02135107|526292047|FG002|Treatment Period|Other|0|||
145940960|NCT02135107|526292048|FG003|Treatment Period|Other|0|||
145940961|NCT02135107|526292045|FG000|Maintenance Therapy Period|Adverse Event|0|||
145940962|NCT02135107|526292046|FG001|Maintenance Therapy Period|Adverse Event|0|||
145940963|NCT02135107|526292047|FG002|Maintenance Therapy Period|Adverse Event|3|||
145940964|NCT02135107|526292048|FG003|Maintenance Therapy Period|Adverse Event|7|||
145940965|NCT02135107|526292045|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
145940966|NCT02135107|526292046|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
145940967|NCT02135107|526292047|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
145940968|NCT02135107|526292048|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
145940969|NCT02135107|526292045|FG000|Maintenance Therapy Period|Pregnancy|0|||
145940970|NCT02135107|526292046|FG001|Maintenance Therapy Period|Pregnancy|0|||
145940971|NCT02135107|526292047|FG002|Maintenance Therapy Period|Pregnancy|0|||
145940972|NCT02135107|526292048|FG003|Maintenance Therapy Period|Pregnancy|1|||
145940973|NCT02135107|526292045|FG000|Maintenance Therapy Period|Other|0|||
145940974|NCT02135107|526292046|FG001|Maintenance Therapy Period|Other|0|||
145940975|NCT02135107|526292047|FG002|Maintenance Therapy Period|Other|7|||
145940976|NCT02135107|526292048|FG003|Maintenance Therapy Period|Other|8|||
145940977|NCT02278120|526292056|FG000|Treatment Period|Progressive disease|234|||
145940978|NCT02278120|526292057|FG001|Treatment Period|Progressive disease|260|||
145940979|NCT02278120|526292056|FG000|Treatment Period|Subject/guardian decision|23|||
145940980|NCT02278120|526292057|FG001|Treatment Period|Subject/guardian decision|20|||
145940981|NCT02278120|526292056|FG000|Treatment Period|Adverse Event|16|||
145940982|NCT02278120|526292057|FG001|Treatment Period|Adverse Event|14|||
145940983|NCT02278120|526292056|FG000|Treatment Period|Physician Decision|14|||
145940984|NCT02278120|526292057|FG001|Treatment Period|Physician Decision|27|||
145940985|NCT02278120|526292056|FG000|Treatment Period|Death|3|||
145940986|NCT02278120|526292057|FG001|Treatment Period|Death|3|||
145940987|NCT02278120|526292056|FG000|Treatment Period|Lost to Follow-up|2|||
145940988|NCT02278120|526292057|FG001|Treatment Period|Lost to Follow-up|0|||
145940989|NCT02278120|526292056|FG000|Treatment Period|Protocol deviation|0|||
145940990|NCT02278120|526292057|FG001|Treatment Period|Protocol deviation|2|||
145940991|NCT02278120|526292056|FG000|Treatment Period|Study terminated as per protocol|43|||
145940992|NCT02278120|526292057|FG001|Treatment Period|Study terminated as per protocol|11|||
145940993|NCT02278120|526292056|FG000|Post-treatment Efficacy Follow-up|Death|0|||
145940994|NCT02278120|526292057|FG001|Post-treatment Efficacy Follow-up|Death|1|||
145940995|NCT02278120|526292056|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
145940996|NCT02278120|526292057|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145940997|NCT02278120|526292056|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
145940998|NCT02278120|526292057|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
145940999|NCT02278120|526292056|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
145941000|NCT02278120|526292057|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
146257393|NCT00630552|527457648|FG002|Overall Study|Physician Decision|0|||
146257394|NCT00630552|527457649|FG003|Overall Study|Physician Decision|0|||
146257395|NCT00630552|527457650|FG004|Overall Study|Physician Decision|1|||
145941001|NCT02278120|526292056|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145941002|NCT02278120|526292057|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145941003|NCT03197324|526292058|FG000|Overall Study|Adverse Event|0|||
145941004|NCT03197324|526292059|FG001|Overall Study|Adverse Event|1|||
145941005|NCT00102531|526292060|FG000|Overall Study|Adverse Event|0|||
145941006|NCT00102531|526292061|FG001|Overall Study|Adverse Event|1|||
145941007|NCT00102531|526292060|FG000|Overall Study|Disease Progression|5|||
145941008|NCT00102531|526292061|FG001|Overall Study|Disease Progression|9|||
145941009|NCT00102531|526292060|FG000|Overall Study|Physician Decision|0|||
145941010|NCT00102531|526292061|FG001|Overall Study|Physician Decision|1|||
145941011|NCT00954512|526292063|FG000|Overall Study|Withdrawal by Subject|0|||
145941012|NCT00954512|526292064|FG001|Overall Study|Withdrawal by Subject|0|||
145941013|NCT00954512|526292065|FG002|Overall Study|Withdrawal by Subject|0|||
145941014|NCT00954512|526292066|FG003|Overall Study|Withdrawal by Subject|0|||
145941015|NCT00954512|526292067|FG004|Overall Study|Withdrawal by Subject|0|||
145941016|NCT00954512|526292068|FG005|Overall Study|Withdrawal by Subject|1|||
145941017|NCT00954512|526292063|FG000|Overall Study|Adverse Event|0|||
145941018|NCT00954512|526292064|FG001|Overall Study|Adverse Event|0|||
145941019|NCT00954512|526292065|FG002|Overall Study|Adverse Event|0|||
145941020|NCT00954512|526292066|FG003|Overall Study|Adverse Event|0|||
145941021|NCT00954512|526292067|FG004|Overall Study|Adverse Event|1|||
145941022|NCT00954512|526292068|FG005|Overall Study|Adverse Event|2|||
145941023|NCT00954512|526292063|FG000|Overall Study|Physician Decision|0|||
145941024|NCT00954512|526292064|FG001|Overall Study|Physician Decision|1|||
145941025|NCT00954512|526292065|FG002|Overall Study|Physician Decision|0|||
145941026|NCT00954512|526292066|FG003|Overall Study|Physician Decision|1|||
145941027|NCT00954512|526292067|FG004|Overall Study|Physician Decision|0|||
145941028|NCT00954512|526292068|FG005|Overall Study|Physician Decision|0|||
145941029|NCT00954512|526292063|FG000|Overall Study|Symptomatic Deterioration|0|||
145941030|NCT00954512|526292064|FG001|Overall Study|Symptomatic Deterioration|1|||
145941031|NCT00954512|526292065|FG002|Overall Study|Symptomatic Deterioration|0|||
145941032|NCT00954512|526292066|FG003|Overall Study|Symptomatic Deterioration|0|||
145941033|NCT00954512|526292067|FG004|Overall Study|Symptomatic Deterioration|2|||
145941034|NCT00954512|526292068|FG005|Overall Study|Symptomatic Deterioration|0|||
145941035|NCT00954512|526292063|FG000|Overall Study|Progression of Disease|2|||
145941036|NCT00954512|526292064|FG001|Overall Study|Progression of Disease|1|||
145941037|NCT00954512|526292065|FG002|Overall Study|Progression of Disease|0|||
145941038|NCT00954512|526292066|FG003|Overall Study|Progression of Disease|1|||
145941039|NCT00954512|526292067|FG004|Overall Study|Progression of Disease|1|||
145941040|NCT00954512|526292068|FG005|Overall Study|Progression of Disease|1|||
145941041|NCT05397171|526292069|FG000|Overall Study|Death|2|||
145941042|NCT05397171|526292070|FG001|Overall Study|Death|3|||
145941043|NCT05397171|526292071|FG002|Overall Study|Death|3|||
145941044|NCT05397171|526292069|FG000|Overall Study|Study Terminated By Sponsor|1|||
145941045|NCT05397171|526292070|FG001|Overall Study|Study Terminated By Sponsor|2|||
145941046|NCT05397171|526292071|FG002|Overall Study|Study Terminated By Sponsor|3|||
145941047|NCT05397171|526292069|FG000|Overall Study|Withdrawal by Subject|0|||
145941048|NCT05397171|526292070|FG001|Overall Study|Withdrawal by Subject|1|||
145941049|NCT05397171|526292071|FG002|Overall Study|Withdrawal by Subject|1|||
145941050|NCT01390428|526293770|FG000|Overall Study|Elective Surgery|0|||
145941051|NCT01390428|526293771|FG001|Overall Study|Elective Surgery|0|||
145941052|NCT01390428|526293772|FG002|Overall Study|Elective Surgery|0|||
145941053|NCT01390428|526293773|FG003|Overall Study|Elective Surgery|0|||
145941054|NCT01390428|526293774|FG004|Overall Study|Elective Surgery|1|||
145941055|NCT01390428|526293775|FG005|Overall Study|Elective Surgery|0|||
145941056|NCT01390428|526293770|FG000|Overall Study|Withdrawal by Subject|0|||
145941057|NCT01390428|526293771|FG001|Overall Study|Withdrawal by Subject|0|||
145941058|NCT01390428|526293772|FG002|Overall Study|Withdrawal by Subject|1|||
145941059|NCT01390428|526293773|FG003|Overall Study|Withdrawal by Subject|0|||
146257396|NCT00630552|527457646|FG000|Overall Study|Death|0|||
145941060|NCT01390428|526293774|FG004|Overall Study|Withdrawal by Subject|0|||
145941061|NCT01390428|526293775|FG005|Overall Study|Withdrawal by Subject|0|||
145941062|NCT05897827|526293778|FG000|Overall Study|Lost to Follow-up|33|||
145941063|NCT05897827|526293779|FG001|Overall Study|Lost to Follow-up|14|||
145941064|NCT05897827|526293778|FG000|Overall Study|Withdrawal by Subject|1|||
145941065|NCT05897827|526293779|FG001|Overall Study|Withdrawal by Subject|1|||
145941066|NCT01004406|526293780|FG000|Overall Study|Withdrawal by Subject|2|||
145941067|NCT01004406|526293781|FG001|Overall Study|Withdrawal by Subject|0|||
146257397|NCT00630552|527457647|FG001|Overall Study|Death|0|||
146257398|NCT00630552|527457648|FG002|Overall Study|Death|1|||
145941068|NCT01004406|526293780|FG000|Overall Study|Lost to Follow-up|1|||
145941069|NCT01004406|526293781|FG001|Overall Study|Lost to Follow-up|0|||
145941070|NCT01752634|526293782|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145941071|NCT01752634|526293783|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145941072|NCT01752634|526293784|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145941073|NCT01752634|526293785|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
146257399|NCT00630552|527457649|FG003|Overall Study|Death|2|||
145941074|NCT01752634|526293786|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
145941075|NCT01752634|526293787|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
145941076|NCT01752634|526293782|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145941077|NCT01752634|526293783|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
145941078|NCT01752634|526293784|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145941079|NCT01752634|526293785|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145941080|NCT01752634|526293786|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145941081|NCT01752634|526293787|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145941082|NCT01752634|526293782|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
145941083|NCT01752634|526293783|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
145941084|NCT01752634|526293784|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145941085|NCT01752634|526293785|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145941086|NCT01752634|526293786|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145941087|NCT01752634|526293787|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
145941088|NCT01752634|526293782|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
145941089|NCT01752634|526293783|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145941090|NCT01752634|526293784|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
145941091|NCT01752634|526293785|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145941092|NCT01752634|526293786|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145941093|NCT01752634|526293787|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
145941094|NCT01752634|526293782|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
145941095|NCT01752634|526293783|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
145941096|NCT01752634|526293784|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
145941097|NCT01752634|526293785|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
145941098|NCT01752634|526293786|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
145941099|NCT01752634|526293787|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
145941100|NCT01752634|526293782|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
145941101|NCT01752634|526293783|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
145941102|NCT01752634|526293784|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
145941103|NCT01752634|526293785|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
145941104|NCT01752634|526293786|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
145941105|NCT01752634|526293787|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
145941106|NCT01752634|526293782|FG000|Week 24 to Week 260|Physician Decision|1|||
145941107|NCT01752634|526293783|FG001|Week 24 to Week 260|Physician Decision|2|||
145941108|NCT01752634|526293784|FG002|Week 24 to Week 260|Physician Decision|4|||
145941109|NCT01752634|526293785|FG003|Week 24 to Week 260|Physician Decision|2|||
145941110|NCT01752634|526293786|FG004|Week 24 to Week 260|Physician Decision|1|||
145941111|NCT01752634|526293787|FG005|Week 24 to Week 260|Physician Decision|0|||
145941112|NCT01752634|526293782|FG000|Week 24 to Week 260|Death|0|||
145941113|NCT01752634|526293783|FG001|Week 24 to Week 260|Death|1|||
145941114|NCT01752634|526293784|FG002|Week 24 to Week 260|Death|0|||
145941115|NCT01752634|526293785|FG003|Week 24 to Week 260|Death|0|||
145941116|NCT01752634|526293786|FG004|Week 24 to Week 260|Death|0|||
145941117|NCT01752634|526293787|FG005|Week 24 to Week 260|Death|0|||
145941118|NCT01752634|526293782|FG000|Week 24 to Week 260|Pregnancy|0|||
145941119|NCT01752634|526293783|FG001|Week 24 to Week 260|Pregnancy|0|||
145941120|NCT01752634|526293784|FG002|Week 24 to Week 260|Pregnancy|1|||
145941121|NCT01752634|526293785|FG003|Week 24 to Week 260|Pregnancy|0|||
145941122|NCT01752634|526293786|FG004|Week 24 to Week 260|Pregnancy|0|||
145941123|NCT01752634|526293787|FG005|Week 24 to Week 260|Pregnancy|0|||
145941124|NCT01752634|526293782|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
145941125|NCT01752634|526293783|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
145941126|NCT01752634|526293784|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
145941127|NCT01752634|526293785|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
145941128|NCT01752634|526293786|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
145941129|NCT01752634|526293787|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
145941130|NCT01752634|526293782|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
145941131|NCT01752634|526293783|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
145941132|NCT01752634|526293784|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
145941133|NCT01752634|526293785|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
145941134|NCT01752634|526293786|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
145941135|NCT01752634|526293787|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
145941136|NCT01752634|526293782|FG000|Week 24 to Week 260|Adverse Event|4|||
145941137|NCT01752634|526293783|FG001|Week 24 to Week 260|Adverse Event|8|||
145941138|NCT01752634|526293784|FG002|Week 24 to Week 260|Adverse Event|8|||
145941139|NCT01752634|526293785|FG003|Week 24 to Week 260|Adverse Event|4|||
145941140|NCT01752634|526293786|FG004|Week 24 to Week 260|Adverse Event|2|||
145941141|NCT01752634|526293787|FG005|Week 24 to Week 260|Adverse Event|0|||
145941142|NCT05562934|526293791|FG000|Overall Study|Adverse Event|0|||
145941143|NCT05562934|526293792|FG001|Overall Study|Adverse Event|2|||
145941144|NCT05562934|526293793|FG002|Overall Study|Adverse Event|0|||
145941145|NCT05562934|526293794|FG003|Overall Study|Adverse Event|0|||
145941146|NCT05562934|526293795|FG004|Overall Study|Adverse Event|2|||
146301057|NCT02246582|527618817|FG000|Overall Study|Withdrawal by Subject|3|||
146050769|NCT02711137|526700806|FG010|Overall Study|Death|1|||
146050770|NCT02711137|526700807|FG011|Overall Study|Death|1|||
146050771|NCT02711137|526700808|FG012|Overall Study|Death|0|||
146050772|NCT02711137|526700809|FG013|Overall Study|Death|0|||
146050773|NCT02711137|526700810|FG014|Overall Study|Death|0|||
146050774|NCT02711137|526700796|FG000|Overall Study|Study Terminated by Sponsor|0|||
146050775|NCT02711137|526700797|FG001|Overall Study|Study Terminated by Sponsor|0|||
146050776|NCT02711137|526700798|FG002|Overall Study|Study Terminated by Sponsor|1|||
146050777|NCT02711137|526700799|FG003|Overall Study|Study Terminated by Sponsor|0|||
146050778|NCT02711137|526700800|FG004|Overall Study|Study Terminated by Sponsor|0|||
146050779|NCT02711137|526700801|FG005|Overall Study|Study Terminated by Sponsor|0|||
146050780|NCT02711137|526700802|FG006|Overall Study|Study Terminated by Sponsor|1|||
146050781|NCT02711137|526700803|FG007|Overall Study|Study Terminated by Sponsor|0|||
146050782|NCT02711137|526700804|FG008|Overall Study|Study Terminated by Sponsor|0|||
146050783|NCT02711137|526700805|FG009|Overall Study|Study Terminated by Sponsor|0|||
146050784|NCT02711137|526700806|FG010|Overall Study|Study Terminated by Sponsor|0|||
146050785|NCT02711137|526700807|FG011|Overall Study|Study Terminated by Sponsor|0|||
146050786|NCT02711137|526700808|FG012|Overall Study|Study Terminated by Sponsor|0|||
146050787|NCT02711137|526700809|FG013|Overall Study|Study Terminated by Sponsor|0|||
146050788|NCT02711137|526700810|FG014|Overall Study|Study Terminated by Sponsor|0|||
146050789|NCT02711137|526700796|FG000|Overall Study|Physician Decision|1|||
146050790|NCT02711137|526700797|FG001|Overall Study|Physician Decision|0|||
146050791|NCT02711137|526700798|FG002|Overall Study|Physician Decision|2|||
146050792|NCT02711137|526700799|FG003|Overall Study|Physician Decision|1|||
146050793|NCT02711137|526700800|FG004|Overall Study|Physician Decision|1|||
146050794|NCT02711137|526700801|FG005|Overall Study|Physician Decision|0|||
146050795|NCT02711137|526700802|FG006|Overall Study|Physician Decision|12|||
146050796|NCT02711137|526700803|FG007|Overall Study|Physician Decision|2|||
146050797|NCT02711137|526700804|FG008|Overall Study|Physician Decision|1|||
146050798|NCT02711137|526700805|FG009|Overall Study|Physician Decision|1|||
146050799|NCT02711137|526700806|FG010|Overall Study|Physician Decision|3|||
146050800|NCT02711137|526700807|FG011|Overall Study|Physician Decision|2|||
146050801|NCT02711137|526700808|FG012|Overall Study|Physician Decision|1|||
146050802|NCT02711137|526700809|FG013|Overall Study|Physician Decision|1|||
146050803|NCT02711137|526700810|FG014|Overall Study|Physician Decision|2|||
146050804|NCT02711137|526700796|FG000|Overall Study|Other|0|||
146050805|NCT02711137|526700797|FG001|Overall Study|Other|1|||
146050806|NCT02711137|526700798|FG002|Overall Study|Other|0|||
146050807|NCT02711137|526700799|FG003|Overall Study|Other|0|||
146050808|NCT02711137|526700800|FG004|Overall Study|Other|0|||
146050809|NCT02711137|526700801|FG005|Overall Study|Other|0|||
146050810|NCT02711137|526700802|FG006|Overall Study|Other|3|||
146050811|NCT02711137|526700803|FG007|Overall Study|Other|0|||
146050812|NCT02711137|526700804|FG008|Overall Study|Other|0|||
146050813|NCT02711137|526700805|FG009|Overall Study|Other|0|||
146050814|NCT02711137|526700806|FG010|Overall Study|Other|0|||
146050815|NCT02711137|526700807|FG011|Overall Study|Other|0|||
146050816|NCT02711137|526700808|FG012|Overall Study|Other|0|||
146050817|NCT02711137|526700809|FG013|Overall Study|Other|0|||
146050818|NCT02711137|526700810|FG014|Overall Study|Other|1|||
146050819|NCT02711137|526700796|FG000|Overall Study|Withdrawal by Subject|1|||
146050820|NCT02711137|526700797|FG001|Overall Study|Withdrawal by Subject|0|||
146050821|NCT02711137|526700798|FG002|Overall Study|Withdrawal by Subject|0|||
146050822|NCT02711137|526700799|FG003|Overall Study|Withdrawal by Subject|1|||
146050823|NCT02711137|526700800|FG004|Overall Study|Withdrawal by Subject|1|||
146050824|NCT02711137|526700801|FG005|Overall Study|Withdrawal by Subject|0|||
146050825|NCT02711137|526700802|FG006|Overall Study|Withdrawal by Subject|7|||
146050826|NCT02711137|526700803|FG007|Overall Study|Withdrawal by Subject|0|||
146050827|NCT02711137|526700804|FG008|Overall Study|Withdrawal by Subject|0|||
146050828|NCT02711137|526700805|FG009|Overall Study|Withdrawal by Subject|0|||
146050829|NCT02711137|526700806|FG010|Overall Study|Withdrawal by Subject|0|||
146050830|NCT02711137|526700807|FG011|Overall Study|Withdrawal by Subject|0|||
146050831|NCT02711137|526700808|FG012|Overall Study|Withdrawal by Subject|0|||
146050832|NCT02711137|526700809|FG013|Overall Study|Withdrawal by Subject|1|||
146050833|NCT02711137|526700810|FG014|Overall Study|Withdrawal by Subject|0|||
146050834|NCT02711137|526700796|FG000|Overall Study|Lost to Follow-up|1|||
146050835|NCT02711137|526700797|FG001|Overall Study|Lost to Follow-up|0|||
146050836|NCT02711137|526700798|FG002|Overall Study|Lost to Follow-up|0|||
146050837|NCT02711137|526700799|FG003|Overall Study|Lost to Follow-up|0|||
146050838|NCT02711137|526700800|FG004|Overall Study|Lost to Follow-up|0|||
146050839|NCT02711137|526700801|FG005|Overall Study|Lost to Follow-up|0|||
146050840|NCT02711137|526700802|FG006|Overall Study|Lost to Follow-up|2|||
146050841|NCT02711137|526700803|FG007|Overall Study|Lost to Follow-up|0|||
146050842|NCT02711137|526700804|FG008|Overall Study|Lost to Follow-up|0|||
146050843|NCT02711137|526700805|FG009|Overall Study|Lost to Follow-up|0|||
146050844|NCT02711137|526700806|FG010|Overall Study|Lost to Follow-up|0|||
146050845|NCT02711137|526700807|FG011|Overall Study|Lost to Follow-up|0|||
146050846|NCT02711137|526700808|FG012|Overall Study|Lost to Follow-up|0|||
146050847|NCT02711137|526700809|FG013|Overall Study|Lost to Follow-up|0|||
146050848|NCT02711137|526700810|FG014|Overall Study|Lost to Follow-up|0|||
145941147|NCT05562934|526293791|FG000|Overall Study|Lost to Follow-up|0|||
145941148|NCT05562934|526293792|FG001|Overall Study|Lost to Follow-up|0|||
145941149|NCT05562934|526293793|FG002|Overall Study|Lost to Follow-up|0|||
145941150|NCT05562934|526293794|FG003|Overall Study|Lost to Follow-up|0|||
145941151|NCT05562934|526293795|FG004|Overall Study|Lost to Follow-up|1|||
145941152|NCT05562934|526293791|FG000|Overall Study|Protocol Violation|0|||
145941153|NCT05562934|526293792|FG001|Overall Study|Protocol Violation|0|||
145941154|NCT05562934|526293793|FG002|Overall Study|Protocol Violation|0|||
145941155|NCT05562934|526293794|FG003|Overall Study|Protocol Violation|1|||
145941156|NCT05562934|526293795|FG004|Overall Study|Protocol Violation|1|||
145941157|NCT05562934|526293791|FG000|Overall Study|Withdrawal by Subject|0|||
145941158|NCT05562934|526293792|FG001|Overall Study|Withdrawal by Subject|0|||
145941159|NCT05562934|526293793|FG002|Overall Study|Withdrawal by Subject|1|||
145941160|NCT05562934|526293794|FG003|Overall Study|Withdrawal by Subject|1|||
145941161|NCT05562934|526293795|FG004|Overall Study|Withdrawal by Subject|0|||
145941162|NCT05128773|526293798|FG000|Overall Study|Sponsor decision to terminate study|3|||
145941163|NCT04697056|526293799|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
145941164|NCT04697056|526293800|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
145941165|NCT05741346|526293801|FG000|Overall Study|Withdrawn due to termination of study|28|||
145941166|NCT05906836|526293810|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
145941167|NCT05906836|526293810|FG000|Overall Study|Lost to Follow-up|1|||
145941168|NCT04982575|526293811|FG000|Overall Study|Withdrawal by Subject|2|||
145941169|NCT04982575|526293812|FG001|Overall Study|Withdrawal by Subject|0|||
145941170|NCT04982575|526293813|FG002|Overall Study|Withdrawal by Subject|2|||
145941171|NCT04322539|526293818|FG000|Overall Study|Adverse Event|2|||
145941172|NCT04322539|526293819|FG001|Overall Study|Adverse Event|0|||
145941173|NCT04322539|526293818|FG000|Overall Study|Death|411|||
145941174|NCT04322539|526293819|FG001|Overall Study|Death|203|||
145941175|NCT04322539|526293818|FG000|Overall Study|Lost to Follow-up|3|||
145941176|NCT04322539|526293819|FG001|Overall Study|Lost to Follow-up|1|||
145941177|NCT04322539|526293818|FG000|Overall Study|Withdrawal of consent|14|||
145941178|NCT04322539|526293819|FG001|Overall Study|Withdrawal of consent|8|||
145941179|NCT04322539|526293818|FG000|Overall Study|Radiological Disease Progression|6|||
145941180|NCT04322539|526293819|FG001|Overall Study|Radiological Disease Progression|0|||
145941181|NCT04322539|526293818|FG000|Overall Study|Sponsor Decision|19|||
145941182|NCT04322539|526293819|FG001|Overall Study|Sponsor Decision|14|||
145941183|NCT04322539|526293818|FG000|Overall Study|Other|6|||
145941184|NCT04322539|526293819|FG001|Overall Study|Other|4|||
145941185|NCT01702532|526293820|FG000|Overall Study|Adverse Event|0|||
145941186|NCT01702532|526293821|FG001|Overall Study|Adverse Event|1|||
145941187|NCT03617861|526293822|FG000|Second Intervention (1 Day)|Adverse Event|0|||
145941188|NCT03617861|526293823|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145941189|NCT03617861|526293824|FG002|Second Intervention (1 Day)|Adverse Event|1|||
146257400|NCT00630552|527457650|FG004|Overall Study|Death|2|||
146257401|NCT00630552|527457646|FG000|Overall Study|Withdrawal by Subject|0|||
146257402|NCT00630552|527457647|FG001|Overall Study|Withdrawal by Subject|0|||
145941190|NCT03617861|526293825|FG003|Second Intervention (1 Day)|Adverse Event|0|||
145941191|NCT00623597|526293826|FG000|Overall Study|Failed to return|1|||
145941192|NCT00623597|526293827|FG001|Overall Study|Failed to return|0|||
145941193|NCT01451164|526293828|FG000|Overall Study|Adverse Event|19|||
145941194|NCT01451164|526293829|FG001|Overall Study|Adverse Event|12|||
145941195|NCT01451164|526293830|FG002|Overall Study|Adverse Event|18|||
145941196|NCT01451164|526293831|FG003|Overall Study|Adverse Event|21|||
145941197|NCT01451164|526293828|FG000|Overall Study|Withdrawal Criteria|1|||
145941198|NCT01451164|526293829|FG001|Overall Study|Withdrawal Criteria|1|||
145941199|NCT01451164|526293830|FG002|Overall Study|Withdrawal Criteria|1|||
145941200|NCT01451164|526293831|FG003|Overall Study|Withdrawal Criteria|1|||
145941201|NCT01451164|526293828|FG000|Overall Study|Physician Decision|2|||
145941202|NCT01451164|526293829|FG001|Overall Study|Physician Decision|0|||
145941203|NCT01451164|526293830|FG002|Overall Study|Physician Decision|1|||
145941204|NCT01451164|526293831|FG003|Overall Study|Physician Decision|0|||
146257403|NCT00630552|527457648|FG002|Overall Study|Withdrawal by Subject|0|||
146257404|NCT00630552|527457649|FG003|Overall Study|Withdrawal by Subject|1|||
146257405|NCT00630552|527457650|FG004|Overall Study|Withdrawal by Subject|0|||
145941205|NCT01451164|526293828|FG000|Overall Study|Withdrawal by Subject|14|||
145941206|NCT01451164|526293829|FG001|Overall Study|Withdrawal by Subject|11|||
145941207|NCT01451164|526293830|FG002|Overall Study|Withdrawal by Subject|16|||
145941208|NCT01451164|526293831|FG003|Overall Study|Withdrawal by Subject|17|||
145941209|NCT01451164|526293828|FG000|Overall Study|Protocol Violation|0|||
145941210|NCT01451164|526293829|FG001|Overall Study|Protocol Violation|1|||
145941211|NCT01451164|526293830|FG002|Overall Study|Protocol Violation|0|||
145941212|NCT01451164|526293831|FG003|Overall Study|Protocol Violation|0|||
145941213|NCT01451164|526293828|FG000|Overall Study|Lack of Efficacy|7|||
145941214|NCT01451164|526293829|FG001|Overall Study|Lack of Efficacy|9|||
145941215|NCT01451164|526293830|FG002|Overall Study|Lack of Efficacy|9|||
145941216|NCT01451164|526293831|FG003|Overall Study|Lack of Efficacy|7|||
146257406|NCT00630552|527457646|FG000|Overall Study|Other|0|||
146257407|NCT00630552|527457647|FG001|Overall Study|Other|0|||
146301058|NCT02246582|527618818|FG001|Overall Study|Withdrawal by Subject|4|||
146301059|NCT02229539|527618819|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
146301060|NCT02229539|527618820|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
146301061|NCT02229539|527618821|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
146301062|NCT02229539|527618819|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
146301063|NCT02229539|527618820|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
146301064|NCT02229539|527618821|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
146301065|NCT02229539|527618819|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
146301066|NCT02229539|527618820|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
146301067|NCT02229539|527618821|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
146301068|NCT02229539|527618819|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
146301069|NCT02229539|527618820|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
146301070|NCT02229539|527618821|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
146301071|NCT02229539|527618819|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
146301072|NCT02229539|527618820|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
146301073|NCT02229539|527618821|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
146301074|NCT02229539|527618819|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
146257408|NCT00630552|527457648|FG002|Overall Study|Other|4|||
146257409|NCT00630552|527457649|FG003|Overall Study|Other|2|||
146257410|NCT00630552|527457650|FG004|Overall Study|Other|0|||
146257411|NCT03226106|527457651|FG000|Overall Study|Withdrawal by Subject|2|||
146257412|NCT03226106|527457652|FG001|Overall Study|Withdrawal by Subject|0|||
146257413|NCT03226106|527457651|FG000|Overall Study|Adverse Event|1|||
146257414|NCT03226106|527457652|FG001|Overall Study|Adverse Event|0|||
146257415|NCT03226106|527457651|FG000|Overall Study|Lost to Follow-up|2|||
146257416|NCT03226106|527457652|FG001|Overall Study|Lost to Follow-up|0|||
146257417|NCT01084239|527457653|FG000|28-Day Follow-up|Lost to Follow-up|4|||
146257418|NCT01084239|527457654|FG001|28-Day Follow-up|Lost to Follow-up|9|||
146257419|NCT00721214|527457655|FG000|Overall Study|Chose another center for transplant|1|||
146257420|NCT00721214|527457655|FG000|Overall Study|Death|3|||
146257421|NCT00983905|527457656|FG000|Theophylline Alone|Adverse Event|1|||
146257422|NCT00983905|527457656|FG000|Colchicine Alone|Adverse Event|2|||
146257423|NCT00405912|527457659|FG000|Overall Study|Withdrawal by Subject|12|||
146257424|NCT00405912|527457660|FG001|Overall Study|Withdrawal by Subject|11|||
146257425|NCT00405912|527457661|FG002|Overall Study|Withdrawal by Subject|12|||
146257426|NCT00405912|527457659|FG000|Overall Study|Lost to Follow-up|4|||
146257427|NCT00405912|527457660|FG001|Overall Study|Lost to Follow-up|8|||
145941217|NCT01846221|526293832|FG000|Overall Study|Catheter Failure|2|||
145941218|NCT01846221|526293833|FG001|Overall Study|Catheter Failure|0|||
145941219|NCT01846221|526293832|FG000|Overall Study|Age Exclusion|1|||
145941220|NCT01846221|526293833|FG001|Overall Study|Age Exclusion|0|||
145941221|NCT04599933|526293834|FG000|Overall Study|Adverse Event|4|||
145941222|NCT04599933|526293835|FG001|Overall Study|Adverse Event|1|||
145941223|NCT04599933|526293834|FG000|Overall Study|Withdrawal by Subject|4|||
145941224|NCT04599933|526293835|FG001|Overall Study|Withdrawal by Subject|2|||
145941225|NCT04599933|526293834|FG000|Overall Study|Lost to Follow-up|0|||
145941226|NCT04599933|526293835|FG001|Overall Study|Lost to Follow-up|1|||
145941227|NCT04599933|526293834|FG000|Overall Study|Physician Decision|0|||
145941228|NCT04599933|526293835|FG001|Overall Study|Physician Decision|1|||
145941229|NCT04599933|526293834|FG000|Overall Study|Screen Failure|1|||
146257428|NCT00405912|527457661|FG002|Overall Study|Lost to Follow-up|4|||
146257429|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
146257430|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
146257431|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
146257432|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
146257433|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
146257434|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
146257435|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
146257436|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
146301075|NCT02229539|527618820|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
146301076|NCT02229539|527618821|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
146301077|NCT02060383|527618823|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
146257437|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Death|6|||
145941230|NCT04599933|526293835|FG001|Overall Study|Screen Failure|2|||
145941231|NCT02963558|526293838|FG000|Overall Study|Withdrawn by investigator|1|||
145941232|NCT02963558|526293839|FG001|Overall Study|Withdrawn by investigator|0|||
145941233|NCT02963558|526293838|FG000|Overall Study|Withdrawal by Subject|0|||
145941234|NCT02963558|526293839|FG001|Overall Study|Withdrawal by Subject|1|||
146257438|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Death|2|||
146257439|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Death|2|||
146257440|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Death|9|||
146257441|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
146257442|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146257443|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146257444|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
146257445|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
146257446|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
146257447|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
146257448|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
146257449|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
145941235|NCT02339155|526293840|FG000|Overall Study|Adverse Event|0|||
145941236|NCT02339155|526293841|FG001|Overall Study|Adverse Event|6|||
145941237|NCT02339155|526293840|FG000|Overall Study|Death|1|||
145941238|NCT02339155|526293841|FG001|Overall Study|Death|1|||
145941239|NCT02339155|526293840|FG000|Overall Study|Lost to Follow-up|8|||
145941240|NCT02339155|526293841|FG001|Overall Study|Lost to Follow-up|9|||
145941241|NCT02339155|526293840|FG000|Overall Study|Physician Decision|2|||
145941242|NCT02339155|526293841|FG001|Overall Study|Physician Decision|1|||
145941243|NCT02339155|526293840|FG000|Overall Study|Withdrawal by Subject|4|||
145941244|NCT02339155|526293841|FG001|Overall Study|Withdrawal by Subject|4|||
145941245|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Adverse Event|0|||
145941246|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Adverse Event|1|||
145941247|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Adverse Event|0|||
145941248|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Adverse Event|0|||
145941249|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Adverse Event|0|||
145941250|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Adverse Event|0|||
145941251|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Death|0|||
145941252|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Death|0|||
145941253|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Death|1|||
145941254|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Death|0|||
145941255|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Death|0|||
145941256|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Death|0|||
145941257|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
145941258|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
145941259|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
145941260|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
145941261|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
145941262|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
145941263|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145941264|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145941265|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
145941266|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145941267|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145941268|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145941269|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145941270|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145941271|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145941272|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
145941273|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145941274|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145941275|NCT03226678|526293842|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
145941276|NCT03226678|526293843|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
145941277|NCT03226678|526293844|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145941278|NCT03226678|526293845|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145941279|NCT03226678|526293846|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145941280|NCT03226678|526293847|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145941281|NCT03226678|526293842|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145941282|NCT03226678|526293843|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145941283|NCT03226678|526293844|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145941284|NCT03226678|526293845|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145941285|NCT03226678|526293846|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
145941286|NCT03226678|526293847|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
146257450|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
146257451|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
145941287|NCT03226678|526293842|FG000|Part B (Long-Term Extension Phase)|Death|0|||
145941288|NCT03226678|526293843|FG001|Part B (Long-Term Extension Phase)|Death|0|||
145941289|NCT03226678|526293844|FG002|Part B (Long-Term Extension Phase)|Death|0|||
145941290|NCT03226678|526293845|FG003|Part B (Long-Term Extension Phase)|Death|0|||
145941291|NCT03226678|526293846|FG004|Part B (Long-Term Extension Phase)|Death|0|||
145941292|NCT03226678|526293847|FG005|Part B (Long-Term Extension Phase)|Death|1|||
145941293|NCT03226678|526293842|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145941294|NCT03226678|526293843|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145941295|NCT03226678|526293844|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145941296|NCT03226678|526293845|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145941297|NCT03226678|526293846|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
146257452|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
146257453|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146257454|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
146257455|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
146257456|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
146257457|NCT03730662|527457663|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
146257458|NCT03730662|527457664|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
146257459|NCT03730662|527457665|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
146257460|NCT03730662|527457666|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
146257461|NCT03730662|527457663|FG000|Variable Treatment Period|Adverse Event|1|||
146257462|NCT03730662|527457664|FG001|Variable Treatment Period|Adverse Event|2|||
146257463|NCT03730662|527457665|FG002|Variable Treatment Period|Adverse Event|0|||
146257464|NCT03730662|527457666|FG003|Variable Treatment Period|Adverse Event|7|||
146257465|NCT03730662|527457663|FG000|Variable Treatment Period|Death|9|||
146257466|NCT03730662|527457664|FG001|Variable Treatment Period|Death|0|||
146257467|NCT03730662|527457665|FG002|Variable Treatment Period|Death|6|||
146257468|NCT03730662|527457666|FG003|Variable Treatment Period|Death|26|||
146257469|NCT03730662|527457663|FG000|Variable Treatment Period|Lost to Follow-up|2|||
146257470|NCT03730662|527457664|FG001|Variable Treatment Period|Lost to Follow-up|1|||
146257471|NCT03730662|527457665|FG002|Variable Treatment Period|Lost to Follow-up|4|||
146257472|NCT03730662|527457666|FG003|Variable Treatment Period|Lost to Follow-up|11|||
145941298|NCT03226678|526293847|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
146050849|NCT01745367|526700822|FG000|Overall Study|Death|1|||
146050850|NCT01745367|526700823|FG001|Overall Study|Death|0|||
146050851|NCT01745367|526700822|FG000|Overall Study|Withdrawal by Subject|1|||
145941299|NCT03226678|526293842|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145941300|NCT03226678|526293843|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145941301|NCT03226678|526293844|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145941302|NCT03226678|526293845|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145941303|NCT03226678|526293846|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
145941304|NCT03226678|526293847|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
145941305|NCT03226678|526293842|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145941306|NCT03226678|526293843|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145941307|NCT03226678|526293844|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145941308|NCT03226678|526293845|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145941309|NCT03226678|526293846|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145941310|NCT03226678|526293847|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
145941311|NCT03427268|526293852|FG000|Overall Study|Progressive disease|25|||
145941312|NCT03427268|526293852|FG000|Overall Study|Never treated|2|||
145941313|NCT03427268|526293852|FG000|Overall Study|Compassionate use|1|||
145941314|NCT03427268|526293852|FG000|Overall Study|Withdrawal by Subject|1|||
145941315|NCT03427268|526293852|FG000|Overall Study|Adverse Event|3|||
145941316|NCT00345878|526293856|FG000|Overall Study|Adverse Event|1|||
145941317|NCT00345878|526293857|FG001|Overall Study|Adverse Event|0|||
145941318|NCT00345878|526293856|FG000|Overall Study|Lost to Follow-up|2|||
145941319|NCT00345878|526293857|FG001|Overall Study|Lost to Follow-up|1|||
145941320|NCT00345878|526293856|FG000|Overall Study|Other|1|||
145941321|NCT00345878|526293857|FG001|Overall Study|Other|0|||
145941322|NCT01643798|526293858|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
145941323|NCT01643798|526293859|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
145941324|NCT02045732|526293865|FG000|Overall Study|At the discretion of the investigator|1|||
145941325|NCT02045732|526293866|FG001|Overall Study|At the discretion of the investigator|1|||
145941326|NCT01349322|526293867|FG000|Overall Study|Protocol Violation|45|||
145941327|NCT01349322|526293868|FG001|Overall Study|Protocol Violation|47|||
145941328|NCT01097421|526293870|FG000|Overall Study|Adverse Event|8|||
145941329|NCT01097421|526293870|FG000|Overall Study|Protocol Violation|2|||
145941330|NCT01097421|526293870|FG000|Overall Study|Lost to Follow-up|1|||
145941331|NCT01097421|526293870|FG000|Overall Study|Withdrawal by Subject|3|||
145941332|NCT01120249|526293873|FG000|Overall Study|No protocol treatment received|21|||
145941333|NCT01120249|526293874|FG001|Overall Study|No protocol treatment received|15|||
145941334|NCT01120249|526293873|FG000|Overall Study|Disease recurrence|107|||
145941335|NCT01120249|526293874|FG001|Overall Study|Disease recurrence|57|||
145941336|NCT01120249|526293873|FG000|Overall Study|Death|1|||
145941337|NCT01120249|526293874|FG001|Overall Study|Death|0|||
145941338|NCT01120249|526293873|FG000|Overall Study|Adverse Event|40|||
145941339|NCT01120249|526293874|FG001|Overall Study|Adverse Event|276|||
145941340|NCT01120249|526293873|FG000|Overall Study|Participant refusal|34|||
145941341|NCT01120249|526293874|FG001|Overall Study|Participant refusal|42|||
145941342|NCT01120249|526293873|FG000|Overall Study|Other reasons, not protocol specified|29|||
145941343|NCT01120249|526293874|FG001|Overall Study|Other reasons, not protocol specified|22|||
145941344|NCT01482962|526293875|FG000|Overall Study|Progressive Disease|65|||
145941345|NCT01482962|526293876|FG001|Overall Study|Progressive Disease|53|||
146257473|NCT03730662|527457663|FG000|Variable Treatment Period|Personal Reason|0|||
145941346|NCT01482962|526293875|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
145941347|NCT01482962|526293876|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
145941348|NCT01482962|526293875|FG000|Overall Study|Adverse Event|18|||
145941349|NCT01482962|526293876|FG001|Overall Study|Adverse Event|22|||
145941350|NCT01482962|526293875|FG000|Overall Study|Withdrawal by Participant|8|||
145941351|NCT01482962|526293876|FG001|Overall Study|Withdrawal by Participant|13|||
145941352|NCT01482962|526293875|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
145941353|NCT01482962|526293876|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
145941354|NCT01482962|526293875|FG000|Overall Study|Other Reason|1|||
145941355|NCT01482962|526293876|FG001|Overall Study|Other Reason|5|||
145941356|NCT01482962|526293875|FG000|Overall Study|Study Terminated by Sponsor|5|||
145941357|NCT01482962|526293876|FG001|Overall Study|Study Terminated by Sponsor|2|||
145941358|NCT01482962|526293875|FG000|Overall Study|Did not Receive Study Drug|1|||
145941359|NCT01482962|526293876|FG001|Overall Study|Did not Receive Study Drug|6|||
145941360|NCT02407457|526293877|FG000|1 Month|Death|3|||
145941361|NCT02407457|526293878|FG001|1 Month|Death|0|||
145941362|NCT02407457|526293877|FG000|1 Month|Lost to Follow-up|1|||
145941363|NCT02407457|526293878|FG001|1 Month|Lost to Follow-up|1|||
145941364|NCT02407457|526293877|FG000|1 Month|missed visit|2|||
145941365|NCT02407457|526293878|FG001|1 Month|missed visit|5|||
145941366|NCT02407457|526293877|FG000|6-Month|Death|2|||
145941367|NCT02407457|526293878|FG001|6-Month|Death|8|||
145941368|NCT02407457|526293877|FG000|6-Month|Lost to Follow-up|2|||
145941369|NCT02407457|526293878|FG001|6-Month|Lost to Follow-up|2|||
145941370|NCT02407457|526293877|FG000|6-Month|missed visit|16|||
145941371|NCT02407457|526293878|FG001|6-Month|missed visit|14|||
145941372|NCT02407457|526293877|FG000|6-Month|Open Repair|0|||
145941373|NCT02407457|526293878|FG001|6-Month|Open Repair|1|||
145941374|NCT02407457|526293877|FG000|1 Year|Death|6|||
145941375|NCT02407457|526293878|FG001|1 Year|Death|11|||
145941376|NCT02407457|526293877|FG000|1 Year|Lost to Follow-up|3|||
145941377|NCT02407457|526293878|FG001|1 Year|Lost to Follow-up|2|||
145941378|NCT02407457|526293877|FG000|1 Year|Missed Visit|24|||
145941379|NCT02407457|526293878|FG001|1 Year|Missed Visit|14|||
145941380|NCT02407457|526293877|FG000|1 Year|Open Repair|0|||
145941381|NCT02407457|526293878|FG001|1 Year|Open Repair|1|||
145941382|NCT02407457|526293877|FG000|2-year|Death|14|||
145941383|NCT02407457|526293878|FG001|2-year|Death|8|||
145941384|NCT02407457|526293877|FG000|2-year|Lost to Follow-up|7|||
145941385|NCT02407457|526293878|FG001|2-year|Lost to Follow-up|10|||
145941386|NCT02407457|526293877|FG000|2-year|Missed Visit|13|||
145941387|NCT02407457|526293878|FG001|2-year|Missed Visit|15|||
145941388|NCT02407457|526293877|FG000|2-year|Open Repair|0|||
145941389|NCT02407457|526293878|FG001|2-year|Open Repair|2|||
145941390|NCT02407457|526293877|FG000|3-year|Death|11|||
145941391|NCT02407457|526293878|FG001|3-year|Death|10|||
145941392|NCT02407457|526293877|FG000|3-year|Lost to Follow-up|9|||
145941393|NCT02407457|526293878|FG001|3-year|Lost to Follow-up|10|||
145941394|NCT02407457|526293877|FG000|3-year|Missed Visit|19|||
145941395|NCT02407457|526293878|FG001|3-year|Missed Visit|16|||
145941396|NCT02407457|526293877|FG000|4-year|Death|18|||
145941397|NCT02407457|526293878|FG001|4-year|Death|10|||
145941398|NCT02407457|526293877|FG000|4-year|Lost to Follow-up|10|||
145941399|NCT02407457|526293878|FG001|4-year|Lost to Follow-up|12|||
145941400|NCT02407457|526293877|FG000|4-year|Missed Visit|18|||
145941401|NCT02407457|526293878|FG001|4-year|Missed Visit|16|||
145941402|NCT02407457|526293877|FG000|5-year|Death|10|||
145941403|NCT02407457|526293878|FG001|5-year|Death|3|||
145941404|NCT02407457|526293877|FG000|5-year|Lost to Follow-up|22|||
145941405|NCT02407457|526293878|FG001|5-year|Lost to Follow-up|13|||
145941406|NCT02407457|526293877|FG000|5-year|Missed Visit|9|||
145941407|NCT02407457|526293878|FG001|5-year|Missed Visit|1|||
146257474|NCT03730662|527457664|FG001|Variable Treatment Period|Personal Reason|2|||
146257475|NCT03730662|527457665|FG002|Variable Treatment Period|Personal Reason|1|||
146257476|NCT03730662|527457666|FG003|Variable Treatment Period|Personal Reason|6|||
145941408|NCT03332628|526293881|FG000|Overall Study|Physician Decision|2|||
145941409|NCT02505334|526293884|FG000|Main Treatment Period|Adverse Event|3|||
145941410|NCT02505334|526293885|FG001|Main Treatment Period|Adverse Event|3|||
145941411|NCT02505334|526293884|FG000|Main Treatment Period|Lack of Efficacy|7|||
145941412|NCT02505334|526293885|FG001|Main Treatment Period|Lack of Efficacy|17|||
145941413|NCT02505334|526293884|FG000|Main Treatment Period|Protocol Violation|0|||
145941414|NCT02505334|526293885|FG001|Main Treatment Period|Protocol Violation|1|||
145941415|NCT02505334|526293884|FG000|Main Treatment Period|Withdrawal by Subject|1|||
145941416|NCT02505334|526293885|FG001|Main Treatment Period|Withdrawal by Subject|8|||
145941417|NCT02505334|526293884|FG000|Main Treatment Period|Unclassified|4|||
145941418|NCT02505334|526293885|FG001|Main Treatment Period|Unclassified|10|||
145941419|NCT02505334|526293884|FG000|Extension Treatment Period|Adverse Event|5|||
145941420|NCT02505334|526293885|FG001|Extension Treatment Period|Adverse Event|0|||
145941421|NCT02505334|526293884|FG000|Extension Treatment Period|Lack of Efficacy|4|||
145941422|NCT02505334|526293885|FG001|Extension Treatment Period|Lack of Efficacy|0|||
145941423|NCT02505334|526293884|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
145941424|NCT02505334|526293885|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
146257477|NCT03730662|527457663|FG000|Variable Treatment Period|Physician Decision|0|||
146257478|NCT03730662|527457664|FG001|Variable Treatment Period|Physician Decision|0|||
146257479|NCT03730662|527457665|FG002|Variable Treatment Period|Physician Decision|0|||
146257480|NCT03730662|527457666|FG003|Variable Treatment Period|Physician Decision|3|||
146050852|NCT01745367|526700823|FG001|Overall Study|Withdrawal by Subject|2|||
146050853|NCT01745367|526700822|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
146050854|NCT01745367|526700823|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
146050855|NCT01745367|526700822|FG000|Overall Study|Other Reasons Unspecified|0|||
146050856|NCT01745367|526700823|FG001|Overall Study|Other Reasons Unspecified|2|||
146050857|NCT00354679|526700824|FG000|Overall Study|Patient Not Treated|1|||
146050858|NCT01814527|526700825|FG000|Overall Study|RTP greater than 30 days|6|||
146050859|NCT01814527|526700826|FG001|Overall Study|RTP greater than 30 days|1|||
146050860|NCT03571204|526700827|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
146050861|NCT03571204|526700828|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
146050862|NCT03571204|526700829|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
146050863|NCT03571204|526700827|FG000|Overall Study|Physician Decision|0|||
146050864|NCT03571204|526700828|FG001|Overall Study|Physician Decision|1|||
146050865|NCT03571204|526700829|FG002|Overall Study|Physician Decision|0|||
146050866|NCT05114473|526700830|FG000|Overall Study|Lost to Follow-up|2|||
146050867|NCT05114473|526700831|FG001|Overall Study|Lost to Follow-up|2|||
146050868|NCT05114473|526700832|FG002|Overall Study|Lost to Follow-up|0|||
146050869|NCT03359174|526700835|FG000|Overall Study|Adverse Event|1|||
146050870|NCT00279916|526700836|FG000|Overall Study|Withdrawal by Subject|4|||
146050871|NCT00279916|526700837|FG001|Overall Study|Withdrawal by Subject|3|||
146050872|NCT00279916|526700836|FG000|Overall Study|Lost to Follow-up|3|||
146050873|NCT00279916|526700837|FG001|Overall Study|Lost to Follow-up|2|||
146050874|NCT00731679|526700839|FG000|Overall Study|Adverse Event|7|||
146050875|NCT00731679|526700840|FG001|Overall Study|Adverse Event|8|||
146050876|NCT00731679|526700839|FG000|Overall Study|Withdrawal by Subject|8|||
146050877|NCT00731679|526700840|FG001|Overall Study|Withdrawal by Subject|8|||
146050878|NCT00731679|526700839|FG000|Overall Study|Lost to Follow-up|7|||
146050879|NCT00731679|526700840|FG001|Overall Study|Lost to Follow-up|8|||
146050880|NCT00731679|526700839|FG000|Overall Study|Noncompliance|0|||
146050881|NCT00731679|526700840|FG001|Overall Study|Noncompliance|1|||
146050882|NCT00731679|526700839|FG000|Overall Study|Pregnancy|0|||
146050883|NCT00731679|526700840|FG001|Overall Study|Pregnancy|1|||
146050884|NCT02488005|526700843|FG000|Overall Study|Lost to Follow-up|2|||
146050885|NCT03384940|526700844|FG000|Overall Study|Progressive disease|36|||
146050886|NCT03384940|526700845|FG001|Overall Study|Progressive disease|11|||
146050887|NCT03384940|526700846|FG002|Overall Study|Progressive disease|13|||
146050888|NCT03384940|526700844|FG000|Overall Study|Clinical progression|4|||
146050889|NCT03384940|526700845|FG001|Overall Study|Clinical progression|0|||
146050890|NCT03384940|526700846|FG002|Overall Study|Clinical progression|3|||
146050891|NCT03384940|526700844|FG000|Overall Study|Adverse Event|7|||
146050892|NCT03384940|526700845|FG001|Overall Study|Adverse Event|1|||
146050893|NCT03384940|526700846|FG002|Overall Study|Adverse Event|1|||
146050894|NCT03384940|526700844|FG000|Overall Study|Withdrawal by Subject|3|||
146050895|NCT03384940|526700845|FG001|Overall Study|Withdrawal by Subject|1|||
146050896|NCT03384940|526700846|FG002|Overall Study|Withdrawal by Subject|0|||
146050897|NCT03384940|526700844|FG000|Overall Study|Physician Decision|1|||
146050898|NCT03384940|526700845|FG001|Overall Study|Physician Decision|1|||
146050899|NCT03384940|526700846|FG002|Overall Study|Physician Decision|0|||
146050900|NCT03384940|526700844|FG000|Overall Study|Death|2|||
146050901|NCT03384940|526700845|FG001|Overall Study|Death|1|||
146050902|NCT03384940|526700846|FG002|Overall Study|Death|0|||
146050903|NCT03384940|526700844|FG000|Overall Study|Other|0|||
146050904|NCT03384940|526700845|FG001|Overall Study|Other|0|||
146050905|NCT03384940|526700846|FG002|Overall Study|Other|1|||
146050906|NCT03089580|526700852|FG000|Overall Study|Lost to Follow-up|2|||
146050907|NCT03087513|526700853|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
146050908|NCT01987102|526700854|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
146050909|NCT01987102|526700855|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
146050910|NCT01987102|526700854|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
146050911|NCT01987102|526700855|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
146050912|NCT01987102|526700854|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
146050913|NCT01987102|526700855|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
146050914|NCT01987102|526700854|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
146050915|NCT01987102|526700855|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
146050916|NCT01987102|526700854|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
146050917|NCT01987102|526700855|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
146050918|NCT01987102|526700854|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
146050919|NCT01987102|526700855|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
146050920|NCT01288989|526700856|FG000|Overall Study|Death|0|||
146050921|NCT01288989|526700857|FG001|Overall Study|Death|0|||
146050922|NCT01288989|526700858|FG002|Overall Study|Death|0|||
146050923|NCT01288989|526700859|FG003|Overall Study|Death|1|||
146257481|NCT03730662|527457663|FG000|Variable Treatment Period|Protocol Violation|0|||
146050924|NCT01288989|526700860|FG004|Overall Study|Death|0|||
146050925|NCT01288989|526700856|FG000|Overall Study|Dose limiting toxicity|1|||
146050926|NCT01288989|526700857|FG001|Overall Study|Dose limiting toxicity|0|||
146050927|NCT01288989|526700858|FG002|Overall Study|Dose limiting toxicity|0|||
146050928|NCT01288989|526700859|FG003|Overall Study|Dose limiting toxicity|0|||
146050929|NCT01288989|526700860|FG004|Overall Study|Dose limiting toxicity|0|||
146050930|NCT01288989|526700856|FG000|Overall Study|Adverse Event|0|||
146050931|NCT01288989|526700857|FG001|Overall Study|Adverse Event|0|||
146050932|NCT01288989|526700858|FG002|Overall Study|Adverse Event|0|||
146050933|NCT01288989|526700859|FG003|Overall Study|Adverse Event|0|||
146050934|NCT01288989|526700860|FG004|Overall Study|Adverse Event|2|||
146050935|NCT01288989|526700856|FG000|Overall Study|Physician Decision|0|||
146050936|NCT01288989|526700857|FG001|Overall Study|Physician Decision|0|||
146050937|NCT01288989|526700858|FG002|Overall Study|Physician Decision|0|||
146050938|NCT01288989|526700859|FG003|Overall Study|Physician Decision|0|||
146050939|NCT01288989|526700860|FG004|Overall Study|Physician Decision|1|||
146050940|NCT01288989|526700856|FG000|Overall Study|Withdrawal by Subject|0|||
146050941|NCT01288989|526700857|FG001|Overall Study|Withdrawal by Subject|0|||
146050942|NCT01288989|526700858|FG002|Overall Study|Withdrawal by Subject|0|||
146050943|NCT01288989|526700859|FG003|Overall Study|Withdrawal by Subject|0|||
146050944|NCT01288989|526700860|FG004|Overall Study|Withdrawal by Subject|3|||
146050945|NCT00165672|526700861|FG000|Overall Study|Adverse Event|0|||
146050946|NCT00165672|526700862|FG001|Overall Study|Adverse Event|1|||
146050947|NCT05864586|526700864|FG000|Overall Study|Ineligible|4|||
146050948|NCT05864586|526700865|FG001|Overall Study|Ineligible|12|||
146050949|NCT05864586|526700864|FG000|Overall Study|Pregnancy|0|||
146050950|NCT05864586|526700865|FG001|Overall Study|Pregnancy|1|||
146050951|NCT05864586|526700864|FG000|Overall Study|Withdrawal by Subject|0|||
146050952|NCT05864586|526700865|FG001|Overall Study|Withdrawal by Subject|1|||
146050953|NCT03635424|526700866|FG000|Overall Study|Adverse Event|1|||
146050954|NCT03635424|526700866|FG000|Overall Study|Death|1|||
146050955|NCT03635424|526700866|FG000|Overall Study|Device not implanted|1|||
146050956|NCT05081219|526700867|FG000|Overall Study|Withdrawal by Subject|4|||
146050957|NCT05081219|526700868|FG001|Overall Study|Withdrawal by Subject|0|||
146050958|NCT05081219|526700869|FG002|Overall Study|Withdrawal by Subject|0|||
146050959|NCT05081219|526700870|FG003|Overall Study|Withdrawal by Subject|1|||
146050960|NCT02452424|526700873|FG000|Overall Study|Death|2|||
146050961|NCT02452424|526700874|FG001|Overall Study|Death|2|||
146050962|NCT02452424|526700875|FG002|Overall Study|Death|2|||
146050963|NCT02452424|526700876|FG003|Overall Study|Death|6|||
146050964|NCT02452424|526700877|FG004|Overall Study|Death|2|||
146050965|NCT02452424|526700878|FG005|Overall Study|Death|0|||
146050966|NCT02452424|526700879|FG006|Overall Study|Death|5|||
146050967|NCT02452424|526700880|FG007|Overall Study|Death|1|||
146050968|NCT02452424|526700881|FG008|Overall Study|Death|3|||
146050969|NCT02452424|526700882|FG009|Overall Study|Death|1|||
146050970|NCT02452424|526700883|FG010|Overall Study|Death|0|||
146050971|NCT02452424|526700873|FG000|Overall Study|Lost to Follow-up|0|||
146050972|NCT02452424|526700874|FG001|Overall Study|Lost to Follow-up|1|||
146050973|NCT02452424|526700875|FG002|Overall Study|Lost to Follow-up|1|||
146050974|NCT02452424|526700876|FG003|Overall Study|Lost to Follow-up|0|||
146050975|NCT02452424|526700877|FG004|Overall Study|Lost to Follow-up|0|||
146050976|NCT02452424|526700878|FG005|Overall Study|Lost to Follow-up|0|||
146050977|NCT02452424|526700879|FG006|Overall Study|Lost to Follow-up|0|||
146050978|NCT02452424|526700880|FG007|Overall Study|Lost to Follow-up|0|||
146050979|NCT02452424|526700881|FG008|Overall Study|Lost to Follow-up|0|||
146050980|NCT02452424|526700882|FG009|Overall Study|Lost to Follow-up|0|||
146050981|NCT02452424|526700883|FG010|Overall Study|Lost to Follow-up|0|||
146050982|NCT02452424|526700873|FG000|Overall Study|Withdrawal by Subject|0|||
146050983|NCT02452424|526700874|FG001|Overall Study|Withdrawal by Subject|0|||
146050984|NCT02452424|526700875|FG002|Overall Study|Withdrawal by Subject|3|||
146050985|NCT02452424|526700876|FG003|Overall Study|Withdrawal by Subject|2|||
146050986|NCT02452424|526700877|FG004|Overall Study|Withdrawal by Subject|0|||
146050987|NCT02452424|526700878|FG005|Overall Study|Withdrawal by Subject|0|||
146050988|NCT02452424|526700879|FG006|Overall Study|Withdrawal by Subject|1|||
146050989|NCT02452424|526700880|FG007|Overall Study|Withdrawal by Subject|0|||
146050990|NCT02452424|526700881|FG008|Overall Study|Withdrawal by Subject|1|||
146050991|NCT02452424|526700882|FG009|Overall Study|Withdrawal by Subject|1|||
146050992|NCT02452424|526700883|FG010|Overall Study|Withdrawal by Subject|0|||
146050993|NCT02452424|526700873|FG000|Overall Study|Other|0|||
146050994|NCT02452424|526700874|FG001|Overall Study|Other|0|||
146050995|NCT02452424|526700875|FG002|Overall Study|Other|1|||
146050996|NCT02452424|526700876|FG003|Overall Study|Other|0|||
146050997|NCT02452424|526700877|FG004|Overall Study|Other|0|||
146050998|NCT02452424|526700878|FG005|Overall Study|Other|1|||
146050999|NCT02452424|526700879|FG006|Overall Study|Other|4|||
146051000|NCT02452424|526700880|FG007|Overall Study|Other|3|||
146051001|NCT02452424|526700881|FG008|Overall Study|Other|0|||
146051002|NCT02452424|526700882|FG009|Overall Study|Other|0|||
146051003|NCT02452424|526700883|FG010|Overall Study|Other|1|||
146051004|NCT02452424|526700873|FG000|Overall Study|Progressive disease (per RECIST)|0|||
145941425|NCT02505334|526293884|FG000|Extension Treatment Period|Unclassified|3|||
145941426|NCT02505334|526293885|FG001|Extension Treatment Period|Unclassified|0|||
145941427|NCT01629823|526293889|FG000|Trial Period|Missed visit|11|||
145941428|NCT01629823|526293890|FG001|Trial Period|Missed visit|9|||
145941429|NCT01629823|526293891|FG002|Trial Period|Missed visit|8|||
146257482|NCT03730662|527457664|FG001|Variable Treatment Period|Protocol Violation|1|||
146257483|NCT03730662|527457665|FG002|Variable Treatment Period|Protocol Violation|1|||
146257484|NCT03730662|527457666|FG003|Variable Treatment Period|Protocol Violation|1|||
146257485|NCT03730662|527457663|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
146257486|NCT03730662|527457664|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
146257487|NCT03730662|527457665|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
146257488|NCT03730662|527457666|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
146257489|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
146257490|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
146257491|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
146257492|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
146257493|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Death|0|||
146257494|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Death|1|||
146257495|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
146257496|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
146257497|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
146257498|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
146257499|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
146257500|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
146257501|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
146257502|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
146257503|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
146257504|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
146257505|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
146257506|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
146257507|NCT01309243|527457667|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
145941430|NCT01629823|526293889|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145941431|NCT01629823|526293890|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145941432|NCT01629823|526293891|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145941433|NCT01629823|526293889|FG000|Trial Period|Pregnancy|1|||
145941434|NCT01629823|526293890|FG001|Trial Period|Pregnancy|0|||
145941435|NCT01629823|526293891|FG002|Trial Period|Pregnancy|0|||
145941436|NCT01629823|526293889|FG000|Trial Period|Adverse Event|0|||
145941437|NCT01629823|526293890|FG001|Trial Period|Adverse Event|1|||
145941438|NCT01629823|526293891|FG002|Trial Period|Adverse Event|0|||
145941439|NCT01629823|526293889|FG000|Trial Period|Out-of-window visit|0|||
145941440|NCT01629823|526293890|FG001|Trial Period|Out-of-window visit|2|||
145941441|NCT01629823|526293891|FG002|Trial Period|Out-of-window visit|0|||
145941442|NCT01629823|526293889|FG000|Trial Period|Failed to hold medication|0|||
145941443|NCT01629823|526293890|FG001|Trial Period|Failed to hold medication|0|||
145941444|NCT01629823|526293891|FG002|Trial Period|Failed to hold medication|1|||
145941445|NCT01629823|526293889|FG000|Washout Period|Safety|2|||
145941446|NCT01629823|526293890|FG001|Washout Period|Safety|5|||
145941447|NCT01629823|526293891|FG002|Washout Period|Safety|0|||
145941448|NCT01629823|526293889|FG000|Washout Period|Pregnancy|1|||
145941449|NCT01629823|526293890|FG001|Washout Period|Pregnancy|0|||
145941450|NCT01629823|526293891|FG002|Washout Period|Pregnancy|0|||
145941451|NCT01629823|526293889|FG000|Washout Period|Protocol Violation|0|||
145941452|NCT01629823|526293890|FG001|Washout Period|Protocol Violation|1|||
145941453|NCT01629823|526293891|FG002|Washout Period|Protocol Violation|0|||
145941454|NCT00525902|526293892|FG000|Overall Study|Lack of Efficacy|1|||
145941455|NCT02258542|526293893|FG000|Overall Study|eg. not made to the visit|7|||
145941456|NCT02258542|526293894|FG001|Overall Study|eg. not made to the visit|4|||
145941457|NCT02258542|526293895|FG002|Overall Study|eg. not made to the visit|0|||
145941458|NCT02258542|526293896|FG003|Overall Study|eg. not made to the visit|1|||
145941459|NCT02258542|526293893|FG000|Overall Study|study specific discount. criteria|1|||
145941460|NCT02258542|526293894|FG001|Overall Study|study specific discount. criteria|1|||
145941461|NCT02258542|526293895|FG002|Overall Study|study specific discount. criteria|0|||
146257508|NCT01309243|527457668|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
146257509|NCT01309243|527457667|FG000|Extension Phase|Lost to Follow-up|6|||
146257510|NCT01309243|527457668|FG001|Extension Phase|Lost to Follow-up|0|||
146257511|NCT00632931|527457669|FG000|Part 1, Period 1|Protocol Violation|1|||
145941462|NCT02258542|526293896|FG003|Overall Study|study specific discount. criteria|0|||
145941463|NCT02258542|526293893|FG000|Overall Study|Withdrawal by Subject|20|||
145941464|NCT02258542|526293894|FG001|Overall Study|Withdrawal by Subject|20|||
145941465|NCT02258542|526293895|FG002|Overall Study|Withdrawal by Subject|7|||
145941466|NCT02258542|526293896|FG003|Overall Study|Withdrawal by Subject|1|||
145941467|NCT02258542|526293893|FG000|Overall Study|Lost to Follow-up|5|||
146257512|NCT00632931|527457670|FG001|Part 1, Period 1|Protocol Violation|0|||
146257513|NCT00632931|527457671|FG002|Part 1, Period 1|Protocol Violation|0|||
146257514|NCT00632931|527457669|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
146257515|NCT00632931|527457670|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
146257516|NCT00632931|527457671|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
146257517|NCT00632931|527457669|FG000|Part 2|Adverse Event|0|||
146257518|NCT00632931|527457670|FG001|Part 2|Adverse Event|0|||
146257519|NCT00632931|527457671|FG002|Part 2|Adverse Event|3|||
146257520|NCT00632931|527457669|FG000|Part 2|Death|0|||
146257521|NCT00632931|527457670|FG001|Part 2|Death|0|||
146257522|NCT00632931|527457671|FG002|Part 2|Death|1|||
146257523|NCT00632931|527457669|FG000|Part 2|Lack of Efficacy|0|||
146257524|NCT00632931|527457670|FG001|Part 2|Lack of Efficacy|0|||
146257525|NCT00632931|527457671|FG002|Part 2|Lack of Efficacy|17|||
146257526|NCT00632931|527457669|FG000|Part 2|Withdrawal by Subject|0|||
146257527|NCT00632931|527457670|FG001|Part 2|Withdrawal by Subject|0|||
146257528|NCT00632931|527457671|FG002|Part 2|Withdrawal by Subject|3|||
146257529|NCT01402063|527457672|FG000|Overall Study|Withdrawal by Subject|3|||
146257530|NCT01402063|527457673|FG001|Overall Study|Withdrawal by Subject|3|||
146257531|NCT03712449|527457676|FG000|Overall Study|Withdraw Consent|0|||
146257532|NCT03712449|527457677|FG001|Overall Study|Withdraw Consent|1|||
146257533|NCT04491006|527457680|FG000|Overall Study|Adverse Event|0|||
146257534|NCT04491006|527457681|FG001|Overall Study|Adverse Event|3|||
146257535|NCT04491006|527457682|FG002|Overall Study|Adverse Event|5|||
146257536|NCT04491006|527457680|FG000|Overall Study|Withdrawal by Subject|1|||
146257537|NCT04491006|527457681|FG001|Overall Study|Withdrawal by Subject|0|||
146257538|NCT04491006|527457682|FG002|Overall Study|Withdrawal by Subject|2|||
146257539|NCT00451555|527457690|FG000|Overall Study|Protocol Violation|2|||
146257540|NCT00451555|527457691|FG001|Overall Study|Protocol Violation|2|||
146257541|NCT00451555|527457690|FG000|Overall Study|Adverse Event|3|||
146257542|NCT00451555|527457691|FG001|Overall Study|Adverse Event|1|||
146257543|NCT00451555|527457690|FG000|Overall Study|Withdrawal by Subject|6|||
146257544|NCT00451555|527457691|FG001|Overall Study|Withdrawal by Subject|0|||
146257545|NCT00451555|527457690|FG000|Overall Study|Physician Decision|2|||
146257546|NCT00451555|527457691|FG001|Overall Study|Physician Decision|1|||
146257547|NCT00922441|527457692|FG000|Overall Study|Protocol Violation|0|||
146257548|NCT00922441|527457693|FG001|Overall Study|Protocol Violation|0|||
146257549|NCT00922441|527457694|FG002|Overall Study|Protocol Violation|2|||
146257550|NCT00922441|527457692|FG000|Overall Study|Withdrawal by Subject|0|||
146257551|NCT00922441|527457693|FG001|Overall Study|Withdrawal by Subject|0|||
146257552|NCT00922441|527457694|FG002|Overall Study|Withdrawal by Subject|1|||
146257553|NCT00468858|527457699|FG000|Overall Study|Adverse Event|0|||
146257554|NCT00468858|527457700|FG001|Overall Study|Adverse Event|1|||
146257555|NCT00468858|527457701|FG002|Overall Study|Adverse Event|0|||
146257556|NCT00468858|527457699|FG000|Overall Study|Withdrawal by Subject|7|||
146257557|NCT00468858|527457700|FG001|Overall Study|Withdrawal by Subject|4|||
146257558|NCT00468858|527457701|FG002|Overall Study|Withdrawal by Subject|5|||
146257559|NCT00468858|527457699|FG000|Overall Study|Relocation|1|||
146257560|NCT00468858|527457700|FG001|Overall Study|Relocation|3|||
146257561|NCT00468858|527457701|FG002|Overall Study|Relocation|3|||
146257562|NCT00468858|527457699|FG000|Overall Study|Lost to Follow-up|1|||
146257563|NCT00468858|527457700|FG001|Overall Study|Lost to Follow-up|2|||
146301078|NCT02060383|527618824|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
146301079|NCT02060383|527618825|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
145941468|NCT02258542|526293894|FG001|Overall Study|Lost to Follow-up|12|||
145941469|NCT02258542|526293895|FG002|Overall Study|Lost to Follow-up|1|||
145941470|NCT02258542|526293896|FG003|Overall Study|Lost to Follow-up|2|||
145941471|NCT02258542|526293893|FG000|Overall Study|Death|5|||
145941472|NCT02258542|526293894|FG001|Overall Study|Death|4|||
145941473|NCT02258542|526293895|FG002|Overall Study|Death|0|||
145941474|NCT02258542|526293896|FG003|Overall Study|Death|1|||
145941475|NCT02258542|526293893|FG000|Overall Study|Adverse Event|3|||
145941476|NCT02258542|526293894|FG001|Overall Study|Adverse Event|4|||
145941477|NCT02258542|526293895|FG002|Overall Study|Adverse Event|0|||
145941478|NCT02258542|526293896|FG003|Overall Study|Adverse Event|0|||
145941479|NCT02258542|526293893|FG000|Overall Study|Protocol Violation|1|||
145941480|NCT02258542|526293894|FG001|Overall Study|Protocol Violation|2|||
146301080|NCT02060383|527618826|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
146301081|NCT02060383|527618827|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
145941481|NCT02258542|526293895|FG002|Overall Study|Protocol Violation|0|||
145941482|NCT02258542|526293896|FG003|Overall Study|Protocol Violation|0|||
146257564|NCT00468858|527457701|FG002|Overall Study|Lost to Follow-up|5|||
146257565|NCT00468858|527457699|FG000|Overall Study|Other|0|||
146257566|NCT00468858|527457700|FG001|Overall Study|Other|0|||
146257567|NCT00468858|527457701|FG002|Overall Study|Other|1|||
146257568|NCT01885936|527457704|FG000|Overall Study|Withdrawal by Subject|1|||
146257569|NCT01885936|527457705|FG001|Overall Study|Withdrawal by Subject|0|||
146257570|NCT00317603|527457706|FG000|Overall Study|Progressive Disease|3|||
146257571|NCT00523549|527457709|FG000|Overall Study|Adverse Event|6|||
146257572|NCT00523549|527457710|FG001|Overall Study|Adverse Event|3|||
146257573|NCT00523549|527457709|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146257574|NCT00523549|527457710|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146257575|NCT00523549|527457709|FG000|Overall Study|Protocol Deviation|3|||
145941483|NCT02258542|526293893|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145941484|NCT02258542|526293894|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
145941485|NCT02258542|526293895|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145941486|NCT02258542|526293896|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
145941487|NCT03235115|526293900|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145941488|NCT03235115|526293901|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145941489|NCT03235115|526293902|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145941490|NCT03235115|526293903|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145941491|NCT03235115|526293904|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145941492|NCT03235115|526293905|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
145941493|NCT01698879|526293907|FG000|Overall Study|Withdrawal by Subject|1|||
145941494|NCT01698879|526293908|FG001|Overall Study|Withdrawal by Subject|0|||
145941495|NCT01698879|526293909|FG002|Overall Study|Withdrawal by Subject|0|||
145941496|NCT04972968|526293910|FG000|Overall Study|Adverse Event|3|||
145941497|NCT04972968|526293911|FG001|Overall Study|Adverse Event|1|||
145941498|NCT04972968|526293912|FG002|Overall Study|Adverse Event|1|||
145941499|NCT04972968|526293913|FG003|Overall Study|Adverse Event|7|||
145941500|NCT04972968|526293910|FG000|Overall Study|Lack of Efficacy|2|||
145941501|NCT04972968|526293911|FG001|Overall Study|Lack of Efficacy|1|||
145941502|NCT04972968|526293912|FG002|Overall Study|Lack of Efficacy|0|||
145941503|NCT04972968|526293913|FG003|Overall Study|Lack of Efficacy|0|||
145941504|NCT04972968|526293910|FG000|Overall Study|Withdrawal by Subject|7|||
145941505|NCT04972968|526293911|FG001|Overall Study|Withdrawal by Subject|4|||
145941506|NCT04972968|526293912|FG002|Overall Study|Withdrawal by Subject|3|||
145941507|NCT04972968|526293913|FG003|Overall Study|Withdrawal by Subject|2|||
145941508|NCT04972968|526293910|FG000|Overall Study|Study Terminated by Sponsor|25|||
145941509|NCT04972968|526293911|FG001|Overall Study|Study Terminated by Sponsor|28|||
145941510|NCT04972968|526293912|FG002|Overall Study|Study Terminated by Sponsor|32|||
145941511|NCT04972968|526293913|FG003|Overall Study|Study Terminated by Sponsor|27|||
145941512|NCT04972968|526293910|FG000|Overall Study|Other|1|||
145941513|NCT04972968|526293911|FG001|Overall Study|Other|0|||
145941514|NCT04972968|526293912|FG002|Overall Study|Other|1|||
145941515|NCT04972968|526293913|FG003|Overall Study|Other|1|||
145941516|NCT01317797|526293918|FG000|Overall Study|Other|0|||
145941517|NCT01317797|526293919|FG001|Overall Study|Other|1|||
145941518|NCT01317797|526293920|FG002|Overall Study|Other|0|||
145941519|NCT01317797|526293918|FG000|Overall Study|Withdrawal of Patient|0|||
145941520|NCT01317797|526293919|FG001|Overall Study|Withdrawal of Patient|0|||
145941521|NCT01317797|526293920|FG002|Overall Study|Withdrawal of Patient|1|||
145941522|NCT02928770|526295199|FG000|Overall Study|Withdrawal by Subject|2|||
145941523|NCT04250714|526295204|FG000|Overall Study|Treatment - withdrawal by subject|14|||
145941524|NCT04250714|526295204|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
145941525|NCT04250714|526295204|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
145941526|NCT04250714|526295204|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
145941527|NCT04250714|526295204|FG000|Overall Study|Treatment - Death|1|||
145941528|NCT04250714|526295204|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
145941529|NCT04250714|526295204|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
145941530|NCT04250714|526295204|FG000|Overall Study|Attempt|2|||
145941531|NCT04250714|526295204|FG000|Overall Study|Intent|7|||
145941532|NCT04392167|526295207|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
145941533|NCT00473824|526295208|FG000|Overall Study|Virologic Breakthrough|1|||
145941534|NCT00473824|526295209|FG001|Overall Study|Virologic Breakthrough|0|||
145941535|NCT00473824|526295208|FG000|Overall Study|Adverse Event|1|||
145941536|NCT00473824|526295209|FG001|Overall Study|Adverse Event|0|||
145941537|NCT00473824|526295208|FG000|Overall Study|Death|1|||
145941538|NCT00473824|526295209|FG001|Overall Study|Death|0|||
145941539|NCT00473824|526295208|FG000|Overall Study|Lost to Follow-up|1|||
145941540|NCT00473824|526295209|FG001|Overall Study|Lost to Follow-up|0|||
145941541|NCT00473824|526295208|FG000|Overall Study|Withdrawal by physician|1|||
145941542|NCT00473824|526295209|FG001|Overall Study|Withdrawal by physician|0|||
146257576|NCT00523549|527457710|FG001|Overall Study|Protocol Deviation|1|||
146257577|NCT00523549|527457709|FG000|Overall Study|Patient withdrew consent|7|||
146257578|NCT00523549|527457710|FG001|Overall Study|Patient withdrew consent|6|||
145941543|NCT02560623|526295210|FG000|Overall Study|Unable to swallow sponge|0|||
145941544|NCT02560623|526295211|FG001|Overall Study|Unable to swallow sponge|1|||
145941545|NCT02560623|526295212|FG002|Overall Study|Unable to swallow sponge|0|||
145941546|NCT02560623|526295213|FG003|Overall Study|Unable to swallow sponge|0|||
145941547|NCT02560623|526295210|FG000|Overall Study|Intervention prior to sponge administration|0|||
145941548|NCT02560623|526295211|FG001|Overall Study|Intervention prior to sponge administration|1|||
145941549|NCT02560623|526295212|FG002|Overall Study|Intervention prior to sponge administration|0|||
145941550|NCT02560623|526295213|FG003|Overall Study|Intervention prior to sponge administration|0|||
145941551|NCT05014815|526295216|FG000|Overall Study|Death|63|||
145941552|NCT05014815|526295217|FG001|Overall Study|Death|70|||
145941553|NCT05014815|526295216|FG000|Overall Study|Withdrawal by Subject|10|||
145941554|NCT05014815|526295217|FG001|Overall Study|Withdrawal by Subject|10|||
145941555|NCT05014815|526295216|FG000|Overall Study|Lost to Follow-up|4|||
145941556|NCT05014815|526295217|FG001|Overall Study|Lost to Follow-up|2|||
145941557|NCT05014815|526295216|FG000|Overall Study|Physician Decision|2|||
145941558|NCT05014815|526295217|FG001|Overall Study|Physician Decision|4|||
145941559|NCT04247880|526295218|FG000|Overall Study|Lost to Follow-up|24|||
145941560|NCT04247880|526295219|FG001|Overall Study|Lost to Follow-up|17|||
145941561|NCT04247880|526295218|FG000|Overall Study|Withdrawal by Subject|3|||
145941562|NCT04247880|526295219|FG001|Overall Study|Withdrawal by Subject|0|||
145941563|NCT06303167|526295224|FG000|Overall Study|Ineligible|1|||
145941564|NCT06303167|526295224|FG000|Overall Study|Never start protocol therapy|2|||
145941565|NCT06303167|526295224|FG000|Overall Study|Disease progression|16|||
145941566|NCT04076059|526295227|FG000|Double Blind Phase|Progressive disease|22|||
145941567|NCT04076059|526295228|FG001|Double Blind Phase|Progressive disease|26|||
145941568|NCT04076059|526295229|FG002|Double Blind Phase|Progressive disease|0|||
145941569|NCT04076059|526295227|FG000|Double Blind Phase|Withdrawal by Subject|4|||
145941570|NCT04076059|526295228|FG001|Double Blind Phase|Withdrawal by Subject|11|||
145941571|NCT04076059|526295229|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145941572|NCT04076059|526295227|FG000|Double Blind Phase|Death|1|||
145941573|NCT04076059|526295228|FG001|Double Blind Phase|Death|1|||
145941574|NCT04076059|526295229|FG002|Double Blind Phase|Death|0|||
145941575|NCT04076059|526295227|FG000|Double Blind Phase|Lost to Follow-up|1|||
145941576|NCT04076059|526295228|FG001|Double Blind Phase|Lost to Follow-up|0|||
145941577|NCT04076059|526295229|FG002|Double Blind Phase|Lost to Follow-up|0|||
145941578|NCT04076059|526295227|FG000|Double Blind Phase|Adverse Event|5|||
145941579|NCT04076059|526295228|FG001|Double Blind Phase|Adverse Event|1|||
145941580|NCT04076059|526295229|FG002|Double Blind Phase|Adverse Event|0|||
145941581|NCT04076059|526295227|FG000|Double Blind Phase|Ongoing Participants|82|||
146105337|NCT00915278|526905683|FG001|Overall Study|Withdrawal by Subject|1|||
146105338|NCT00915278|526905684|FG002|Overall Study|Withdrawal by Subject|0|||
146105339|NCT00915278|526905685|FG003|Overall Study|Withdrawal by Subject|0|||
146105340|NCT00915278|526905686|FG004|Overall Study|Withdrawal by Subject|1|||
146105341|NCT00915278|526905687|FG005|Overall Study|Withdrawal by Subject|4|||
146105342|NCT00915278|526905682|FG000|Overall Study|Adverse Event|4|||
146105343|NCT00915278|526905683|FG001|Overall Study|Adverse Event|1|||
146105344|NCT00915278|526905684|FG002|Overall Study|Adverse Event|0|||
146105345|NCT00915278|526905685|FG003|Overall Study|Adverse Event|0|||
146105346|NCT00915278|526905686|FG004|Overall Study|Adverse Event|0|||
146105347|NCT00915278|526905687|FG005|Overall Study|Adverse Event|0|||
146105348|NCT00915278|526905682|FG000|Overall Study|Progressive disease/clinical progression|0|||
146105349|NCT00915278|526905683|FG001|Overall Study|Progressive disease/clinical progression|0|||
146105350|NCT00915278|526905684|FG002|Overall Study|Progressive disease/clinical progression|0|||
146105351|NCT00915278|526905685|FG003|Overall Study|Progressive disease/clinical progression|3|||
146105352|NCT00915278|526905686|FG004|Overall Study|Progressive disease/clinical progression|1|||
146105353|NCT00915278|526905687|FG005|Overall Study|Progressive disease/clinical progression|2|||
146105354|NCT00915278|526905682|FG000|Overall Study|Infusion related AEs|0|||
146105355|NCT00915278|526905683|FG001|Overall Study|Infusion related AEs|0|||
146105356|NCT00915278|526905684|FG002|Overall Study|Infusion related AEs|0|||
146105357|NCT00915278|526905685|FG003|Overall Study|Infusion related AEs|0|||
146105358|NCT00915278|526905686|FG004|Overall Study|Infusion related AEs|0|||
146105359|NCT00915278|526905687|FG005|Overall Study|Infusion related AEs|2|||
146105360|NCT00915278|526905682|FG000|Overall Study|Admission to hospice|0|||
146105361|NCT00915278|526905683|FG001|Overall Study|Admission to hospice|0|||
146105362|NCT00915278|526905684|FG002|Overall Study|Admission to hospice|1|||
146105363|NCT00915278|526905685|FG003|Overall Study|Admission to hospice|0|||
146105364|NCT00915278|526905686|FG004|Overall Study|Admission to hospice|0|||
146105365|NCT00915278|526905687|FG005|Overall Study|Admission to hospice|0|||
146105366|NCT00674362|526905688|FG000|Double Blind|Adverse Event|6|||
146105367|NCT00674362|526905689|FG001|Double Blind|Adverse Event|6|||
146105368|NCT00674362|526905688|FG000|Double Blind|Lack of Efficacy|2|||
146105369|NCT00674362|526905689|FG001|Double Blind|Lack of Efficacy|6|||
146105370|NCT00674362|526905688|FG000|Double Blind|Loss of efficacy|0|||
146257579|NCT00523549|527457709|FG000|Overall Study|Lost to Follow-up|3|||
146257580|NCT00523549|527457710|FG001|Overall Study|Lost to Follow-up|5|||
146257581|NCT00427778|527457715|FG000|First Intervention (4 Weeks)|no longer interested|1|||
146105371|NCT00674362|526905689|FG001|Double Blind|Loss of efficacy|1|||
146105372|NCT00674362|526905688|FG000|Double Blind|Withdrawal by Subject|4|||
146105373|NCT00674362|526905689|FG001|Double Blind|Withdrawal by Subject|3|||
146105374|NCT00674362|526905688|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
146105375|NCT00674362|526905689|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
146105376|NCT00674362|526905688|FG000|Double Blind|Other: Surgery|0|||
146105377|NCT00674362|526905689|FG001|Double Blind|Other: Surgery|1|||
146105378|NCT00674362|526905688|FG000|Open Label|Adverse Event|1|||
146105379|NCT00674362|526905689|FG001|Open Label|Adverse Event|0|||
146105380|NCT00674362|526905688|FG000|Open Label|Other: Subject moved to extension study|1|||
146105381|NCT00674362|526905689|FG001|Open Label|Other: Subject moved to extension study|0|||
146105382|NCT01201850|526905692|FG000|Overall Study|Tumor progression|4|||
146301082|NCT02060383|527618823|FG000|Core Phase|Adverse Event|2|||
146257582|NCT00427778|527457716|FG001|First Intervention (4 Weeks)|no longer interested|0|||
146257583|NCT00427778|527457715|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
146257584|NCT00427778|527457716|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
146257585|NCT00427778|527457715|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
146257586|NCT00427778|527457716|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
146257587|NCT00427778|527457715|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
146257588|NCT00427778|527457716|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
146257589|NCT00439647|527457717|FG000|Overall Study|Withdrawal by Subject|25|||
146257590|NCT00439647|527457718|FG001|Overall Study|Withdrawal by Subject|22|||
146257591|NCT00439647|527457717|FG000|Overall Study|Death|15|||
146257592|NCT00439647|527457718|FG001|Overall Study|Death|18|||
146257593|NCT00439647|527457717|FG000|Overall Study|Adverse Event|11|||
146257594|NCT00439647|527457718|FG001|Overall Study|Adverse Event|11|||
146257595|NCT00439647|527457717|FG000|Overall Study|Lost to Follow-up|4|||
146257596|NCT00439647|527457718|FG001|Overall Study|Lost to Follow-up|12|||
146257597|NCT00439647|527457717|FG000|Overall Study|Protocol Violation|3|||
146257598|NCT00439647|527457718|FG001|Overall Study|Protocol Violation|4|||
146301083|NCT02060383|527618824|FG001|Core Phase|Adverse Event|0|||
146105383|NCT00816595|526905693|FG000|Overall Study|Withdrawal by Subject|2|||
146105384|NCT00816595|526905694|FG001|Overall Study|Withdrawal by Subject|0|||
146105385|NCT00453063|526905695|FG000|Overall Study|Adverse Event|1|||
146105386|NCT00453063|526905696|FG001|Overall Study|Adverse Event|2|||
146105387|NCT00453063|526905695|FG000|Overall Study|Withdrawal by Subject|1|||
146105388|NCT00453063|526905696|FG001|Overall Study|Withdrawal by Subject|1|||
146105389|NCT00453063|526905695|FG000|Overall Study|Protocol Violation|1|||
146105390|NCT00453063|526905696|FG001|Overall Study|Protocol Violation|0|||
146105391|NCT00365508|526905697|FG000|Overall Study|Lost to Follow-up|139|||
146105392|NCT00365508|526905698|FG001|Overall Study|Lost to Follow-up|154|||
146105393|NCT02538029|526905702|FG000|Overall Study|unable to complete cognitive assessments|1|||
146105394|NCT02538029|526905703|FG001|Overall Study|unable to complete cognitive assessments|0|||
146105395|NCT02538029|526905704|FG002|Overall Study|unable to complete cognitive assessments|1|||
146105396|NCT00566995|526905706|FG000|Overall Study|Toxicity|4|||
146105397|NCT00566995|526905706|FG000|Overall Study|Withdrew consent|3|||
146105398|NCT00404235|526905707|FG000|Overall Study|Withdrawal by Subject|1|||
146105399|NCT00404235|526905708|FG001|Overall Study|Withdrawal by Subject|2|||
146105400|NCT01558271|526905709|FG000|Overall Study|Adverse Event|6|||
146105401|NCT01558271|526905710|FG001|Overall Study|Adverse Event|3|||
146105402|NCT01558271|526905711|FG002|Overall Study|Adverse Event|4|||
146105403|NCT01558271|526905709|FG000|Overall Study|Lost to Follow-up|1|||
146105404|NCT01558271|526905710|FG001|Overall Study|Lost to Follow-up|0|||
146105405|NCT01558271|526905711|FG002|Overall Study|Lost to Follow-up|0|||
146105406|NCT01558271|526905709|FG000|Overall Study|Protocol Violation|1|||
146105407|NCT01558271|526905710|FG001|Overall Study|Protocol Violation|0|||
146105408|NCT01558271|526905711|FG002|Overall Study|Protocol Violation|0|||
146105409|NCT01558271|526905709|FG000|Overall Study|Withdrawal by Subject|10|||
146105410|NCT01558271|526905710|FG001|Overall Study|Withdrawal by Subject|6|||
146105411|NCT01558271|526905711|FG002|Overall Study|Withdrawal by Subject|12|||
146105412|NCT01558271|526905709|FG000|Overall Study|Physician Decision|0|||
146105413|NCT01558271|526905710|FG001|Overall Study|Physician Decision|2|||
146105414|NCT01558271|526905711|FG002|Overall Study|Physician Decision|1|||
146105415|NCT00228384|526905712|FG000|Overall Study|Death|9|||
146105416|NCT00228384|526905713|FG001|Overall Study|Death|3|||
146105417|NCT00228384|526905712|FG000|Overall Study|Lost to Follow-up|6|||
146105418|NCT00228384|526905713|FG001|Overall Study|Lost to Follow-up|10|||
146105419|NCT00228384|526905712|FG000|Overall Study|Surgical Intervention (bypass)|5|||
146105420|NCT00228384|526905713|FG001|Overall Study|Surgical Intervention (bypass)|5|||
146105421|NCT00228384|526905712|FG000|Overall Study|Withdrawal by Subject|9|||
146105422|NCT00228384|526905713|FG001|Overall Study|Withdrawal by Subject|10|||
146105423|NCT00228384|526905712|FG000|Overall Study|Physician Decision|0|||
146105424|NCT00228384|526905713|FG001|Overall Study|Physician Decision|1|||
146105425|NCT00873912|526905714|FG000|Overall Study|Withdrawal by Subject|1|||
146105426|NCT00873912|526905715|FG001|Overall Study|Withdrawal by Subject|0|||
146105427|NCT00873912|526905714|FG000|Overall Study|Lost to Follow-up|2|||
146105428|NCT00873912|526905715|FG001|Overall Study|Lost to Follow-up|0|||
146105429|NCT01980940|526905719|FG000|Overall Study|Protocol Violation|0|||
146105430|NCT01980940|526905720|FG001|Overall Study|Protocol Violation|0|||
146105431|NCT01980940|526905721|FG002|Overall Study|Protocol Violation|0|||
146105432|NCT01980940|526905722|FG003|Overall Study|Protocol Violation|0|||
146105433|NCT01980940|526905723|FG004|Overall Study|Protocol Violation|0|||
146105434|NCT01980940|526905724|FG005|Overall Study|Protocol Violation|2|||
146105435|NCT01980940|526905725|FG006|Overall Study|Protocol Violation|0|||
146105436|NCT01980940|526905726|FG007|Overall Study|Protocol Violation|0|||
146105437|NCT05358444|526905730|FG000|Overall Study|Withdrawal by Subject|0|||
146105438|NCT05358444|526905731|FG001|Overall Study|Withdrawal by Subject|1|||
146257599|NCT00439647|527457717|FG000|Overall Study|Lack of Efficacy|0|||
146257600|NCT00439647|527457718|FG001|Overall Study|Lack of Efficacy|4|||
146257601|NCT00843115|527457720|FG000|Overall Study|Death|4|||
146301084|NCT02060383|527618825|FG002|Core Phase|Adverse Event|0|||
146105439|NCT05358444|526905730|FG000|Overall Study|Lost to Follow-up|0|||
146105440|NCT05358444|526905731|FG001|Overall Study|Lost to Follow-up|3|||
146105441|NCT00709761|526907660|FG000|Overall Study|Withdrawal by Subject|8|||
146105442|NCT00709761|526907660|FG000|Overall Study|study closed/terminated|17|||
146105443|NCT00709761|526907660|FG000|Overall Study|Lost to Follow-up|2|||
146105444|NCT02955602|526907664|FG000|Overall Study|Adverse Event|0|||
146105445|NCT02955602|526907665|FG001|Overall Study|Adverse Event|3|||
146105446|NCT02955602|526907666|FG002|Overall Study|Adverse Event|0|||
146105447|NCT02955602|526907664|FG000|Overall Study|Withdrawal of informed consent|1|||
146105448|NCT02955602|526907665|FG001|Overall Study|Withdrawal of informed consent|3|||
146105449|NCT02955602|526907666|FG002|Overall Study|Withdrawal of informed consent|2|||
146105450|NCT02955602|526907664|FG000|Overall Study|Lost to Follow-up|0|||
146301085|NCT02060383|527618826|FG003|Core Phase|Adverse Event|2|||
146301086|NCT02060383|527618827|FG004|Core Phase|Adverse Event|6|||
146105451|NCT02955602|526907665|FG001|Overall Study|Lost to Follow-up|0|||
146105452|NCT02955602|526907666|FG002|Overall Study|Lost to Follow-up|1|||
146105453|NCT02955602|526907664|FG000|Overall Study|Other|0|||
146105454|NCT02955602|526907665|FG001|Overall Study|Other|1|||
146105455|NCT02955602|526907666|FG002|Overall Study|Other|3|||
146105456|NCT00290888|526907667|FG000|Overall Study|Physician Decision|3|||
146105457|NCT00290888|526907668|FG001|Overall Study|Physician Decision|1|||
146105458|NCT01581931|526907669|FG000|Washout|Adverse Event|0|||
146105459|NCT01581931|526907670|FG001|Washout|Adverse Event|1|||
146105460|NCT04160195|526907677|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
146105461|NCT04160195|526907678|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
146105462|NCT03068130|526907679|FG000|Overall Study|Adverse Event|19|||
146105463|NCT03068130|526907679|FG000|Overall Study|Death|14|||
146105464|NCT03068130|526907679|FG000|Overall Study|Lost to Follow-up|4|||
146105465|NCT03068130|526907679|FG000|Overall Study|Withdrawal by Subject|26|||
146105466|NCT03068130|526907679|FG000|Overall Study|Administrative Reasons|3|||
146105467|NCT03068130|526907679|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
146105468|NCT03068130|526907679|FG000|Overall Study|Study terminated by sponsor|194|||
146105469|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Physician Decision|0|||
146105470|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Physician Decision|1|||
146105471|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Physician Decision|0|||
146105472|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
146105473|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
146105474|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
146105475|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
146105476|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
146105477|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
146105478|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Other|4|||
146105479|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Other|4|||
146105480|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Other|0|||
146105481|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
146105482|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
146105483|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
146105484|NCT02585960|526907686|FG000|PK/Safety Assessment Period|Screen Failure|0|||
146105485|NCT02585960|526907687|FG001|PK/Safety Assessment Period|Screen Failure|0|||
146105486|NCT02585960|526907688|FG002|PK/Safety Assessment Period|Screen Failure|1|||
146105487|NCT02585960|526907686|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
146105488|NCT02585960|526907687|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
146105489|NCT02585960|526907688|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
146105490|NCT02585960|526907686|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
146105491|NCT02585960|526907687|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
146105492|NCT02585960|526907688|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
146105493|NCT04930965|526907690|FG000|Overall Study|Lost to Follow-up|7|||
146105494|NCT04930965|526907691|FG001|Overall Study|Lost to Follow-up|5|||
146105495|NCT02849678|526907692|FG000|Overall Study|Protocol Violation|3|||
146105496|NCT02849678|526907693|FG001|Overall Study|Protocol Violation|6|||
146105497|NCT00444912|526907694|FG000|Overall Study|Death|1|||
146105498|NCT00444912|526907695|FG001|Overall Study|Death|2|||
146105499|NCT00444912|526907694|FG000|Overall Study|Lost to Follow-up|1|||
146105500|NCT00444912|526907695|FG001|Overall Study|Lost to Follow-up|0|||
146105501|NCT00444912|526907694|FG000|Overall Study|Participant Failed Mobilization|1|||
146105502|NCT00444912|526907695|FG001|Overall Study|Participant Failed Mobilization|0|||
146105503|NCT02499783|526907696|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
146105504|NCT02499783|526907697|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
146105505|NCT02499783|526907698|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
146105506|NCT02499783|526907696|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
146105507|NCT02499783|526907697|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
146105508|NCT02499783|526907698|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
146105509|NCT02499783|526907696|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
146257602|NCT00843115|527457720|FG000|Overall Study|Adverse Event|30|||
146257603|NCT00843115|527457720|FG000|Overall Study|Lost to Follow-up|4|||
146257604|NCT00843115|527457720|FG000|Overall Study|Withdrawal by Subject|17|||
146257605|NCT00843115|527457720|FG000|Overall Study|Family wanted meds stopped|1|||
146257606|NCT00843115|527457720|FG000|Overall Study|Family does not want continuation|1|||
146257607|NCT00843115|527457720|FG000|Overall Study|Patient forgot to take meds|1|||
146257608|NCT00843115|527457720|FG000|Overall Study|Does not meet entrance criteria|1|||
146257609|NCT00843115|527457720|FG000|Overall Study|Physician Decision|1|||
146257610|NCT00843115|527457720|FG000|Overall Study|Family discontinued meds|1|||
146301087|NCT02060383|527618823|FG000|Core Phase|Administrative problems|0|||
146301088|NCT02060383|527618824|FG001|Core Phase|Administrative problems|1|||
146301089|NCT02060383|527618825|FG002|Core Phase|Administrative problems|0|||
146301090|NCT02060383|527618826|FG003|Core Phase|Administrative problems|0|||
146301091|NCT02060383|527618827|FG004|Core Phase|Administrative problems|0|||
146301092|NCT02060383|527618823|FG000|Core Phase|Protocol Violation|0|||
146301093|NCT02060383|527618824|FG001|Core Phase|Protocol Violation|0|||
146301094|NCT02060383|527618825|FG002|Core Phase|Protocol Violation|0|||
146301095|NCT02060383|527618826|FG003|Core Phase|Protocol Violation|1|||
146301096|NCT02060383|527618827|FG004|Core Phase|Protocol Violation|0|||
146301097|NCT02060383|527618823|FG000|Core Phase|Withdrawal by Subject|0|||
146301098|NCT02060383|527618824|FG001|Core Phase|Withdrawal by Subject|0|||
146301099|NCT02060383|527618825|FG002|Core Phase|Withdrawal by Subject|0|||
146301100|NCT02060383|527618826|FG003|Core Phase|Withdrawal by Subject|4|||
146301101|NCT02060383|527618827|FG004|Core Phase|Withdrawal by Subject|2|||
146301102|NCT02060383|527618823|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
146301103|NCT02060383|527618824|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
146301104|NCT02060383|527618825|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
146301105|NCT02060383|527618826|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
146301106|NCT02060383|527618827|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
146301107|NCT02060383|527618823|FG000|Extension Phase|Adverse Event|1|||
146301108|NCT02060383|527618824|FG001|Extension Phase|Adverse Event|1|||
146301109|NCT02060383|527618825|FG002|Extension Phase|Adverse Event|2|||
146301110|NCT02060383|527618826|FG003|Extension Phase|Adverse Event|0|||
146301111|NCT02060383|527618827|FG004|Extension Phase|Adverse Event|1|||
146301112|NCT02060383|527618823|FG000|Extension Phase|Withdrawal by Subject|0|||
146301113|NCT02060383|527618824|FG001|Extension Phase|Withdrawal by Subject|1|||
146301114|NCT02060383|527618825|FG002|Extension Phase|Withdrawal by Subject|0|||
146301115|NCT02060383|527618826|FG003|Extension Phase|Withdrawal by Subject|0|||
146301116|NCT02060383|527618827|FG004|Extension Phase|Withdrawal by Subject|2|||
146301117|NCT02060383|527618823|FG000|Extension Phase|Administrative problems|1|||
146301118|NCT02060383|527618824|FG001|Extension Phase|Administrative problems|0|||
146301119|NCT02060383|527618825|FG002|Extension Phase|Administrative problems|0|||
146301120|NCT02060383|527618826|FG003|Extension Phase|Administrative problems|0|||
146301121|NCT02060383|527618827|FG004|Extension Phase|Administrative problems|0|||
146301122|NCT02060383|527618823|FG000|Extension Phase|Death|0|||
146301123|NCT02060383|527618824|FG001|Extension Phase|Death|0|||
146301124|NCT02060383|527618825|FG002|Extension Phase|Death|1|||
146301125|NCT02060383|527618826|FG003|Extension Phase|Death|0|||
146301126|NCT02060383|527618827|FG004|Extension Phase|Death|1|||
146301127|NCT02060383|527618823|FG000|Extension Phase|Protocol Violation|0|||
146301128|NCT02060383|527618824|FG001|Extension Phase|Protocol Violation|0|||
146301129|NCT02060383|527618825|FG002|Extension Phase|Protocol Violation|0|||
146301130|NCT02060383|527618826|FG003|Extension Phase|Protocol Violation|0|||
146301131|NCT02060383|527618827|FG004|Extension Phase|Protocol Violation|1|||
146301132|NCT03441334|527618828|FG000|Overall Study|Withdrawal by Subject|1|||
146301133|NCT03441334|527618829|FG001|Overall Study|Withdrawal by Subject|0|||
146301134|NCT05162027|527618838|FG000|Overall Study|Adverse Event|1|||
146301135|NCT05162027|527618839|FG001|Overall Study|Adverse Event|0|||
146301136|NCT02553265|527618840|FG000|Enrollment|Death|0|||
146051005|NCT02452424|526700874|FG001|Overall Study|Progressive disease (per RECIST)|0|||
146301137|NCT02553265|527618841|FG001|Enrollment|Death|0|||
146301138|NCT02553265|527618842|FG002|Enrollment|Death|1|||
146301139|NCT02553265|527618840|FG000|First Intervention (28 Days)|Adverse Event|1|||
146301140|NCT02553265|527618841|FG001|First Intervention (28 Days)|Adverse Event|0|||
146301141|NCT02553265|527618842|FG002|First Intervention (28 Days)|Adverse Event|0|||
146301142|NCT02553265|527618840|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
146301143|NCT02553265|527618841|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
146051006|NCT02452424|526700875|FG002|Overall Study|Progressive disease (per RECIST)|0|||
146051007|NCT02452424|526700876|FG003|Overall Study|Progressive disease (per RECIST)|0|||
146301144|NCT02553265|527618842|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
146301145|NCT02553265|527618840|FG000|Second Intervention (28 Days)|Adverse Event|1|||
146257611|NCT00843115|527457720|FG000|Overall Study|patient took for 2 days then stopped|1|||
146257612|NCT00843115|527457720|FG000|Overall Study|patient never took the medication|1|||
146301146|NCT02553265|527618841|FG001|Second Intervention (28 Days)|Adverse Event|0|||
146301147|NCT02553265|527618842|FG002|Second Intervention (28 Days)|Adverse Event|0|||
146301148|NCT02553265|527618840|FG000|Third Intervention (28 Days)|Adverse Event|1|||
146257613|NCT00843115|527457720|FG000|Overall Study|hospitalized due to deterioration|1|||
146257614|NCT00843115|527457720|FG000|Overall Study|week 12 not done|1|||
146257615|NCT00843115|527457720|FG000|Overall Study|Syndrome De Glissement|1|||
146257616|NCT00225277|527457721|FG000|Overall Study|Adverse Event|30|||
146257617|NCT00225277|527457722|FG001|Overall Study|Adverse Event|34|||
146257618|NCT00225277|527457721|FG000|Overall Study|Lack of Efficacy|4|||
146257619|NCT00225277|527457722|FG001|Overall Study|Lack of Efficacy|1|||
146257620|NCT00225277|527457721|FG000|Overall Study|Lost to Follow-up|4|||
146257621|NCT00225277|527457722|FG001|Overall Study|Lost to Follow-up|6|||
146257622|NCT00225277|527457721|FG000|Overall Study|Physician Decision|6|||
146257623|NCT00225277|527457722|FG001|Overall Study|Physician Decision|8|||
146257624|NCT00225277|527457721|FG000|Overall Study|Protocol Violation|6|||
146105510|NCT02499783|526907697|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
146105511|NCT02499783|526907698|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
146105512|NCT02499783|526907696|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
146105513|NCT02499783|526907697|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
146105514|NCT02499783|526907698|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
146105515|NCT02499783|526907696|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
146105516|NCT02499783|526907697|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
146105517|NCT02499783|526907698|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
146105518|NCT02499783|526907696|FG000|DB Period: Weeks 0-8|Other|1|||
146105519|NCT02499783|526907697|FG001|DB Period: Weeks 0-8|Other|1|||
146105520|NCT02499783|526907698|FG002|DB Period: Weeks 0-8|Other|0|||
146105521|NCT02499783|526907696|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
146105522|NCT02499783|526907697|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
146105523|NCT02499783|526907698|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
146105524|NCT02499783|526907696|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
146105525|NCT02499783|526907697|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
146105526|NCT02499783|526907698|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
146105527|NCT02499783|526907696|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
146105528|NCT02499783|526907697|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
146105529|NCT02499783|526907698|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
146105530|NCT02499783|526907696|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
146105531|NCT02499783|526907697|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
146105532|NCT02499783|526907698|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
146105533|NCT02228460|526907699|FG000|Overall Study|Adverse Event|1|||
146105534|NCT02228460|526907699|FG000|Overall Study|Lost to Follow-up|1|||
146105535|NCT01243892|526907700|FG000|Overall Study|Did not meet eligibility criteria|2|||
146105536|NCT01243892|526907701|FG001|Overall Study|Did not meet eligibility criteria|0|||
146105537|NCT00329238|526907702|FG000|Overall Study|Adverse Event|147|||
146105538|NCT00329238|526907703|FG001|Overall Study|Adverse Event|129|||
146105539|NCT00329238|526907702|FG000|Overall Study|Protocol Violation|23|||
146105540|NCT00329238|526907703|FG001|Overall Study|Protocol Violation|34|||
146105541|NCT00329238|526907702|FG000|Overall Study|Lost to Follow-up|2|||
146105542|NCT00329238|526907703|FG001|Overall Study|Lost to Follow-up|6|||
146105543|NCT00329238|526907702|FG000|Overall Study|Withdrawal by Subject|64|||
146105544|NCT00329238|526907703|FG001|Overall Study|Withdrawal by Subject|58|||
146105545|NCT00329238|526907702|FG000|Overall Study|Other reason (not specified)|40|||
146105546|NCT00329238|526907703|FG001|Overall Study|Other reason (not specified)|54|||
146105547|NCT00801632|526907704|FG000|Overall Study|Re-transplant|1|||
146105548|NCT05379231|526907705|FG000|Home Visit|Withdrawal by Subject|2|||
146105549|NCT05379231|526907705|FG000|In-lab Visit|Withdrawal by Subject|2|||
146105550|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
146105551|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
146105552|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
146105553|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
146105554|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
146105555|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146105556|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
146105557|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
146105558|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146105559|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
146105560|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
146105561|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
146105562|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
146105563|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
146105564|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
146105565|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
146105566|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
146105567|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
146105568|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
146257625|NCT00225277|527457722|FG001|Overall Study|Protocol Violation|3|||
146257626|NCT00225277|527457721|FG000|Overall Study|Withdrawal by Subject|40|||
146105569|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
146105570|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
146105571|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
146105572|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
146105573|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
146105574|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
146105575|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146105576|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146105577|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
146105578|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146105579|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
146105580|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
146105581|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146105582|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146105583|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146105584|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
146105585|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146105586|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
146105587|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146105588|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146105589|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
146105590|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146105591|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
146105592|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146105593|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
146105594|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
146105595|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146105596|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146105597|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
146105598|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146105599|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
146105600|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
146105601|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
146105602|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
146105603|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
146105604|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
146105605|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
146105606|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
146105607|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
146105608|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
146105609|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
146105610|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146105611|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146105612|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146105613|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
146105614|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
146105615|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146105616|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146105617|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
146105618|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146105619|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
146105620|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Change of location|0|||
146105621|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Change of location|0|||
146105622|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Change of location|0|||
146105623|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Change of location|1|||
146105624|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Change of location|0|||
146105625|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
146105626|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
146105627|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
146105628|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
146105629|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
146105630|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146257627|NCT00225277|527457722|FG001|Overall Study|Withdrawal by Subject|34|||
146257628|NCT00225277|527457721|FG000|Overall Study|Other|7|||
146257629|NCT00225277|527457722|FG001|Overall Study|Other|9|||
146051008|NCT02452424|526700877|FG004|Overall Study|Progressive disease (per RECIST)|0|||
146051009|NCT02452424|526700878|FG005|Overall Study|Progressive disease (per RECIST)|0|||
146051010|NCT02452424|526700879|FG006|Overall Study|Progressive disease (per RECIST)|0|||
146051011|NCT02452424|526700880|FG007|Overall Study|Progressive disease (per RECIST)|0|||
146051012|NCT02452424|526700881|FG008|Overall Study|Progressive disease (per RECIST)|2|||
146051013|NCT02452424|526700882|FG009|Overall Study|Progressive disease (per RECIST)|0|||
146051014|NCT02452424|526700883|FG010|Overall Study|Progressive disease (per RECIST)|0|||
146051015|NCT02452424|526700873|FG000|Overall Study|Adverse Event|0|||
146051016|NCT02452424|526700874|FG001|Overall Study|Adverse Event|0|||
146051017|NCT02452424|526700875|FG002|Overall Study|Adverse Event|0|||
146051018|NCT02452424|526700876|FG003|Overall Study|Adverse Event|0|||
146051019|NCT02452424|526700877|FG004|Overall Study|Adverse Event|0|||
146051020|NCT02452424|526700878|FG005|Overall Study|Adverse Event|0|||
146051021|NCT02452424|526700879|FG006|Overall Study|Adverse Event|0|||
146051022|NCT02452424|526700880|FG007|Overall Study|Adverse Event|0|||
146051023|NCT02452424|526700881|FG008|Overall Study|Adverse Event|0|||
146051024|NCT02452424|526700882|FG009|Overall Study|Adverse Event|0|||
146051025|NCT02452424|526700883|FG010|Overall Study|Adverse Event|1|||
146051026|NCT01463306|526700884|FG000|Overall Study|Adverse Event|6|||
146051027|NCT01463306|526700885|FG001|Overall Study|Adverse Event|9|||
146051028|NCT01463306|526700886|FG002|Overall Study|Adverse Event|3|||
146051029|NCT01463306|526700884|FG000|Overall Study|Death|3|||
146051030|NCT01463306|526700885|FG001|Overall Study|Death|3|||
146051031|NCT01463306|526700886|FG002|Overall Study|Death|0|||
146051032|NCT01463306|526700884|FG000|Overall Study|Lack of Efficacy|22|||
146051033|NCT01463306|526700885|FG001|Overall Study|Lack of Efficacy|16|||
146051034|NCT01463306|526700886|FG002|Overall Study|Lack of Efficacy|1|||
146051035|NCT01463306|526700884|FG000|Overall Study|Lost to Follow-up|5|||
146051036|NCT01463306|526700885|FG001|Overall Study|Lost to Follow-up|2|||
146051037|NCT01463306|526700886|FG002|Overall Study|Lost to Follow-up|0|||
146051038|NCT01463306|526700884|FG000|Overall Study|Protocol Violation|4|||
146051039|NCT01463306|526700885|FG001|Overall Study|Protocol Violation|0|||
146051040|NCT01463306|526700886|FG002|Overall Study|Protocol Violation|0|||
146051041|NCT01463306|526700884|FG000|Overall Study|Withdrawal by Subject|19|||
146051042|NCT01463306|526700885|FG001|Overall Study|Withdrawal by Subject|9|||
146051043|NCT01463306|526700886|FG002|Overall Study|Withdrawal by Subject|1|||
146051044|NCT01463306|526700884|FG000|Overall Study|Other|26|||
146051045|NCT01463306|526700885|FG001|Overall Study|Other|13|||
146051046|NCT01463306|526700886|FG002|Overall Study|Other|0|||
146051047|NCT01463306|526700884|FG000|Overall Study|Approval expiry at site|1|||
146051048|NCT01463306|526700885|FG001|Overall Study|Approval expiry at site|0|||
146051049|NCT01463306|526700886|FG002|Overall Study|Approval expiry at site|0|||
146051050|NCT01059318|526700889|FG000|Core Study (26 Week)|Adverse Event|3|||
146051051|NCT01059318|526700889|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
146051052|NCT01059318|526700889|FG000|Extension (36 Week)|Adverse Event|3|||
146051053|NCT00176462|526700897|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
146051054|NCT00176462|526700898|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
146051055|NCT00176462|526700897|FG000|Induction (4 Weeks)|Death|1|||
146051056|NCT00176462|526700898|FG001|Induction (4 Weeks)|Death|2|||
146051057|NCT00176462|526700897|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
146051058|NCT00176462|526700898|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
146051059|NCT00176462|526700897|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
146051060|NCT00176462|526700898|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
146051061|NCT00176462|526700897|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
146051062|NCT00176462|526700898|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
146051063|NCT00176462|526700897|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
146051064|NCT00176462|526700898|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
146051065|NCT00176462|526700897|FG000|Consolidation (12 Weeks)|Not documented|0|||
146051066|NCT00176462|526700898|FG001|Consolidation (12 Weeks)|Not documented|1|||
146051067|NCT00176462|526700897|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
146051068|NCT00176462|526700898|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
146051069|NCT00176462|526700897|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
146051070|NCT00176462|526700898|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
146051071|NCT01150097|526700900|FG000|Months 24 to 36 Post-transplantation|Death|2|||
146051072|NCT01150097|526700901|FG001|Months 24 to 36 Post-transplantation|Death|0|||
146051073|NCT01150097|526700902|FG002|Months 24 to 36 Post-transplantation|Death|0|||
146051074|NCT01150097|526700900|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
146051075|NCT01150097|526700901|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
146051076|NCT01150097|526700902|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
146051077|NCT01150097|526700900|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
146051078|NCT01150097|526700901|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
146051079|NCT01150097|526700902|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
146051080|NCT01150097|526700900|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
146051081|NCT01150097|526700901|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
146051082|NCT01150097|526700902|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
146105631|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146105632|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146105633|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
146105634|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
146105635|NCT00730405|526907712|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
146105636|NCT00730405|526907713|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146105637|NCT00730405|526907714|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146105638|NCT00730405|526907715|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146105639|NCT00730405|526907716|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
146105640|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
146105641|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
146105642|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
146105643|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
146105644|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
146105645|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
146105646|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
146105647|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
146105648|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
146105649|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
146105650|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
146105651|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
146105652|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
146105653|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
146105654|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
146105655|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Death|0|||
146105656|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Death|1|||
146105657|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Death|0|||
146105658|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Death|1|||
146105659|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Death|0|||
146105660|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Change of location|1|||
146105661|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Change of location|1|||
146105662|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Change of location|0|||
146105663|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Change of location|1|||
146105664|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Change of location|0|||
146105665|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
146105666|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
146105667|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
146105668|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
146105669|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
146105670|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146105671|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146105672|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
146105673|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146105674|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
146105675|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146105676|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146105677|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
146105678|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146105679|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
146105680|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146105681|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146105682|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146105683|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
146105684|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
146105685|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
146105686|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146105687|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146105688|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146105689|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
146105690|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146105691|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146105692|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146105693|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
146105694|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
146105695|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146105696|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
146105697|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
146105698|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146105699|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
146105700|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
146105701|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
146105702|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146105703|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146105704|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
146105705|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
146105706|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
146105707|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
146105708|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
146105709|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
146105710|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
146105711|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
146105712|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
146105713|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
146105714|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
146105715|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Missing|0|||
146105716|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Missing|0|||
146105717|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Missing|2|||
146105718|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Missing|0|||
146105719|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Missing|0|||
146105720|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146105721|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146105722|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146105723|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
146105724|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
146105725|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146105726|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146105727|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
146105728|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146105729|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
146105730|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
146105731|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
146105732|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
146105733|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
146105734|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
146105735|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
146105736|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
146105737|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
146105738|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
146105739|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
146105740|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146105741|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146105742|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146105743|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
146105744|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
146105745|NCT00730405|526907712|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
146105746|NCT00730405|526907713|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146105747|NCT00730405|526907714|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146105748|NCT00730405|526907715|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146105749|NCT00730405|526907716|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
146105750|NCT01496807|526907720|FG000|Overall Study|Progressive Disease|21|||
146105751|NCT01496807|526907720|FG000|Overall Study|Participant preference/toxicity|8|||
146105752|NCT01496807|526907720|FG000|Overall Study|Change in diagnosis|1|||
146105753|NCT00334958|526907727|FG000|Overall Study|Medication Noncompliance|0|||
146105754|NCT00334958|526907728|FG001|Overall Study|Medication Noncompliance|3|||
146105755|NCT00334958|526907727|FG000|Overall Study|Protocol Violation|2|||
146105756|NCT00334958|526907728|FG001|Overall Study|Protocol Violation|2|||
146105757|NCT00334958|526907727|FG000|Overall Study|Request of the investigator or sponsor|0|||
146105758|NCT00334958|526907728|FG001|Overall Study|Request of the investigator or sponsor|1|||
146105759|NCT00334958|526907727|FG000|Overall Study|Withdrawal by Subject|7|||
146105760|NCT00334958|526907728|FG001|Overall Study|Withdrawal by Subject|4|||
146105761|NCT00334958|526907727|FG000|Overall Study|Adverse Event|27|||
146105762|NCT00334958|526907728|FG001|Overall Study|Adverse Event|12|||
146105763|NCT00334958|526907727|FG000|Overall Study|Other|1|||
146105764|NCT00334958|526907728|FG001|Overall Study|Other|2|||
146105765|NCT02021773|526907732|FG000|Overall Study|Adverse Event|1|||
146105766|NCT02021773|526907733|FG001|Overall Study|Adverse Event|4|||
146105767|NCT02021773|526907734|FG002|Overall Study|Adverse Event|3|||
146105768|NCT02021773|526907732|FG000|Overall Study|Lack of Efficacy|2|||
146105769|NCT02021773|526907733|FG001|Overall Study|Lack of Efficacy|2|||
146105770|NCT02021773|526907734|FG002|Overall Study|Lack of Efficacy|2|||
146105771|NCT02021773|526907732|FG000|Overall Study|Protocol Violation|2|||
146105772|NCT02021773|526907733|FG001|Overall Study|Protocol Violation|3|||
146105773|NCT02021773|526907734|FG002|Overall Study|Protocol Violation|1|||
146105774|NCT02021773|526907732|FG000|Overall Study|Withdrawal by Subject|3|||
146105775|NCT02021773|526907733|FG001|Overall Study|Withdrawal by Subject|4|||
146105776|NCT02021773|526907734|FG002|Overall Study|Withdrawal by Subject|5|||
146105777|NCT02021773|526907732|FG000|Overall Study|Lost to Follow-up|1|||
146105778|NCT02021773|526907733|FG001|Overall Study|Lost to Follow-up|3|||
146105779|NCT02021773|526907734|FG002|Overall Study|Lost to Follow-up|0|||
146105780|NCT02021773|526907732|FG000|Overall Study|Reason not specified|3|||
146105781|NCT02021773|526907733|FG001|Overall Study|Reason not specified|0|||
146105782|NCT02021773|526907734|FG002|Overall Study|Reason not specified|0|||
146105783|NCT00923156|526907744|FG000|Overall Study|Adverse Event|0|||
146105784|NCT00923156|526907745|FG001|Overall Study|Adverse Event|2|||
146105785|NCT00923156|526907746|FG002|Overall Study|Adverse Event|1|||
146105786|NCT00923156|526907744|FG000|Overall Study|Abnormal laboratory values|0|||
146105787|NCT00923156|526907745|FG001|Overall Study|Abnormal laboratory values|0|||
146105788|NCT00923156|526907746|FG002|Overall Study|Abnormal laboratory values|1|||
146105789|NCT00923156|526907744|FG000|Overall Study|Withdrawal by Subject|0|||
146105790|NCT00923156|526907745|FG001|Overall Study|Withdrawal by Subject|1|||
146105791|NCT00923156|526907746|FG002|Overall Study|Withdrawal by Subject|0|||
146105792|NCT00923156|526907744|FG000|Overall Study|Death|0|||
146105793|NCT00923156|526907745|FG001|Overall Study|Death|1|||
146105794|NCT00923156|526907746|FG002|Overall Study|Death|0|||
146105795|NCT00923156|526907744|FG000|Overall Study|Lack of Efficacy|0|||
146105796|NCT00923156|526907745|FG001|Overall Study|Lack of Efficacy|0|||
146105797|NCT00923156|526907746|FG002|Overall Study|Lack of Efficacy|1|||
146105798|NCT03137537|526907747|FG000|Overall Study|Adverse Event|0|||
146105799|NCT03137537|526907748|FG001|Overall Study|Adverse Event|1|||
146105800|NCT04066023|526907749|FG000|Overall Study|Adverse Event|0|||
146105801|NCT04066023|526907750|FG001|Overall Study|Adverse Event|0|||
146105802|NCT04066023|526907751|FG002|Overall Study|Adverse Event|1|||
146105803|NCT04066023|526907749|FG000|Overall Study|Sponsor decision|3|||
146105804|NCT04066023|526907750|FG001|Overall Study|Sponsor decision|6|||
146105805|NCT04066023|526907751|FG002|Overall Study|Sponsor decision|2|||
146105806|NCT04066023|526907749|FG000|Overall Study|Physician Decision|0|||
146105807|NCT04066023|526907750|FG001|Overall Study|Physician Decision|0|||
146105808|NCT04066023|526907751|FG002|Overall Study|Physician Decision|1|||
146105809|NCT04066023|526907749|FG000|Overall Study|Lost to Follow-up|0|||
146105810|NCT04066023|526907750|FG001|Overall Study|Lost to Follow-up|1|||
146105811|NCT04066023|526907751|FG002|Overall Study|Lost to Follow-up|1|||
146105812|NCT04066023|526907749|FG000|Overall Study|Noncompliance|0|||
146105813|NCT04066023|526907750|FG001|Overall Study|Noncompliance|1|||
146105814|NCT04066023|526907751|FG002|Overall Study|Noncompliance|1|||
146105815|NCT04665856|526907752|FG000|Overall Study|Site Terminated by Sponsor|1|||
146105816|NCT04665856|526907753|FG001|Overall Study|Site Terminated by Sponsor|0|||
146105817|NCT04665856|526907752|FG000|Overall Study|Withdrawal by Subject|2|||
146105818|NCT04665856|526907753|FG001|Overall Study|Withdrawal by Subject|0|||
146105819|NCT04665856|526907752|FG000|Overall Study|Lost to Follow-up|3|||
146105820|NCT04665856|526907753|FG001|Overall Study|Lost to Follow-up|2|||
146105821|NCT04665856|526907752|FG000|Overall Study|Death|39|||
146105822|NCT04665856|526907753|FG001|Overall Study|Death|44|||
146105823|NCT04665856|526907752|FG000|Overall Study|Ongoing in study|17|||
146105824|NCT04665856|526907753|FG001|Overall Study|Ongoing in study|15|||
146105825|NCT01552694|526907754|FG000|Overall Study|Lost to Follow-up|0|||
146105826|NCT01552694|526907755|FG001|Overall Study|Lost to Follow-up|1|||
146105827|NCT01552694|526907754|FG000|Overall Study|Protocol Violation|0|||
146105828|NCT01552694|526907755|FG001|Overall Study|Protocol Violation|1|||
146105829|NCT00191139|526907756|FG000|Overall Study|Adverse Event|2|||
146105830|NCT00191139|526907757|FG001|Overall Study|Adverse Event|6|||
146105831|NCT00191139|526907756|FG000|Overall Study|Death|2|||
146105832|NCT00191139|526907757|FG001|Overall Study|Death|0|||
146105833|NCT00191139|526907756|FG000|Overall Study|Withdrawal by Subject|0|||
146105834|NCT00191139|526907757|FG001|Overall Study|Withdrawal by Subject|3|||
146105835|NCT00191139|526907756|FG000|Overall Study|Disease Progression|0|||
146105836|NCT00191139|526907757|FG001|Overall Study|Disease Progression|1|||
146105837|NCT00191139|526907756|FG000|Overall Study|Other|1|||
146105838|NCT00191139|526907757|FG001|Overall Study|Other|2|||
146105839|NCT03386448|526907759|FG000|Overall Study|Adverse Event|0|||
146105840|NCT03386448|526907760|FG001|Overall Study|Adverse Event|2|||
146105841|NCT03338010|526907761|FG000|Overall Study|Withdrawal by Subject|14|||
146105842|NCT03338010|526907762|FG001|Overall Study|Withdrawal by Subject|8|||
146105843|NCT03338010|526907761|FG000|Overall Study|Lost to Follow-up|4|||
146105844|NCT03338010|526907762|FG001|Overall Study|Lost to Follow-up|2|||
146105845|NCT03338010|526907761|FG000|Overall Study|Adverse Event|3|||
146105846|NCT03338010|526907762|FG001|Overall Study|Adverse Event|2|||
146105847|NCT03338010|526907761|FG000|Overall Study|Physician Decision|2|||
146105848|NCT03338010|526907762|FG001|Overall Study|Physician Decision|2|||
146105849|NCT03338010|526907761|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146105850|NCT03338010|526907762|FG001|Overall Study|Non-Compliance with Study Drug|3|||
146105851|NCT03338010|526907761|FG000|Overall Study|Protocol Violation|0|||
146105852|NCT03338010|526907762|FG001|Overall Study|Protocol Violation|1|||
146105853|NCT02465515|526907765|FG000|Overall Study|Investigator site closed|4|||
146105854|NCT02465515|526907766|FG001|Overall Study|Investigator site closed|5|||
146105855|NCT02465515|526907765|FG000|Overall Study|Withdrawal by Subject|74|||
146105856|NCT02465515|526907766|FG001|Overall Study|Withdrawal by Subject|43|||
146105857|NCT02465515|526907765|FG000|Overall Study|Physician Decision|8|||
146105858|NCT02465515|526907766|FG001|Overall Study|Physician Decision|12|||
146105859|NCT02465515|526907765|FG000|Overall Study|Lost to Follow-up|68|||
146105860|NCT02465515|526907766|FG001|Overall Study|Lost to Follow-up|51|||
146105861|NCT02564796|526907767|FG000|Overall Study|Physician Decision|2|||
146105862|NCT02564796|526907768|FG001|Overall Study|Physician Decision|2|||
146105863|NCT00293033|526907769|FG000|Open-label Titration Period|Adverse Event|10|||
146105864|NCT00293033|526907769|FG000|Open-label Titration Period|Death|3|||
146105865|NCT00293033|526907769|FG000|Open-label Titration Period|Lack of Efficacy|5|||
146105866|NCT00293033|526907769|FG000|Open-label Titration Period|Protocol Violation|2|||
146105867|NCT00293033|526907769|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
146105868|NCT00293033|526907769|FG000|Open-label Titration Period|Noncompliance and other|27|||
146105869|NCT00293033|526907769|FG000|Double-blind Treatment Period|Adverse Event|3|||
146105870|NCT00293033|526907769|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
146105871|NCT00293033|526907769|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
146105872|NCT00293033|526907769|FG000|Double-blind Treatment Period|Noncompliance|4|||
146105873|NCT03583697|526907770|FG000|Overall Study|Withdrawal by Subject|0|||
146105874|NCT03583697|526907771|FG001|Overall Study|Withdrawal by Subject|0|||
146105875|NCT03583697|526907772|FG002|Overall Study|Withdrawal by Subject|1|||
146105876|NCT03583697|526907770|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
146105877|NCT03583697|526907771|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
146105878|NCT03583697|526907772|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
146105879|NCT00114530|526907773|FG000|Overall Study|Death|3|||
146105880|NCT00114530|526907774|FG001|Overall Study|Death|11|||
146105881|NCT00114530|526907773|FG000|Overall Study|Lost to Follow-up|1|||
146105882|NCT00114530|526907774|FG001|Overall Study|Lost to Follow-up|1|||
146105883|NCT00114530|526907773|FG000|Overall Study|Physician Decision|1|||
146105884|NCT00114530|526907774|FG001|Overall Study|Physician Decision|1|||
146105885|NCT00114530|526907773|FG000|Overall Study|Withdrawal by Subject|2|||
146105886|NCT00114530|526907774|FG001|Overall Study|Withdrawal by Subject|6|||
146105887|NCT00114530|526907773|FG000|Overall Study|Breast Cancer|1|||
146105888|NCT00114530|526907774|FG001|Overall Study|Breast Cancer|0|||
146105889|NCT00114530|526907773|FG000|Overall Study|Subject decision after endpoint failure|0|||
146105890|NCT00114530|526907774|FG001|Overall Study|Subject decision after endpoint failure|1|||
146105891|NCT00114530|526907773|FG000|Overall Study|Ineligible|1|||
146105892|NCT00114530|526907774|FG001|Overall Study|Ineligible|0|||
146105893|NCT03724032|526907776|FG000|Overall Study|Physician Decision|1|||
146105894|NCT03724032|526907777|FG001|Overall Study|Physician Decision|0|||
146105895|NCT03724032|526907778|FG002|Overall Study|Physician Decision|0|||
146105896|NCT03724032|526907776|FG000|Overall Study|Protocol Violation|2|||
146105897|NCT03724032|526907777|FG001|Overall Study|Protocol Violation|2|||
146105898|NCT03724032|526907778|FG002|Overall Study|Protocol Violation|1|||
146105899|NCT00751933|526907779|FG000|Overall Study|Withdrawal by Subject|0|||
146105900|NCT00751933|526907780|FG001|Overall Study|Withdrawal by Subject|1|||
146105901|NCT00751933|526907781|FG002|Overall Study|Withdrawal by Subject|0|||
146105902|NCT00751933|526907782|FG003|Overall Study|Withdrawal by Subject|0|||
146105903|NCT00751933|526907779|FG000|Overall Study|Physician Decision|0|||
146105904|NCT00751933|526907780|FG001|Overall Study|Physician Decision|0|||
146105905|NCT00751933|526907781|FG002|Overall Study|Physician Decision|1|||
146105906|NCT00751933|526907782|FG003|Overall Study|Physician Decision|1|||
146105907|NCT01817530|526907784|FG000|Overall Study|Exclusionary Medication Received|0|||
146105908|NCT01817530|526907785|FG001|Overall Study|Exclusionary Medication Received|0|||
146105909|NCT01817530|526907786|FG002|Overall Study|Exclusionary Medication Received|0|||
146105910|NCT01817530|526907787|FG003|Overall Study|Exclusionary Medication Received|0|||
146105911|NCT01817530|526907788|FG004|Overall Study|Exclusionary Medication Received|1|||
146105912|NCT01817530|526907789|FG005|Overall Study|Exclusionary Medication Received|0|||
146105913|NCT01817530|526907790|FG006|Overall Study|Exclusionary Medication Received|0|||
146105914|NCT01817530|526907791|FG007|Overall Study|Exclusionary Medication Received|0|||
146105915|NCT01817530|526907784|FG000|Overall Study|Adverse Event|6|||
146105916|NCT01817530|526907785|FG001|Overall Study|Adverse Event|3|||
146105917|NCT01817530|526907786|FG002|Overall Study|Adverse Event|2|||
146105918|NCT01817530|526907787|FG003|Overall Study|Adverse Event|5|||
146105919|NCT01817530|526907788|FG004|Overall Study|Adverse Event|0|||
146105920|NCT01817530|526907789|FG005|Overall Study|Adverse Event|10|||
146105921|NCT01817530|526907790|FG006|Overall Study|Adverse Event|5|||
146105922|NCT01817530|526907791|FG007|Overall Study|Adverse Event|8|||
146105923|NCT01817530|526907784|FG000|Overall Study|Subject Noncompliant|3|||
146105924|NCT01817530|526907785|FG001|Overall Study|Subject Noncompliant|1|||
146105925|NCT01817530|526907786|FG002|Overall Study|Subject Noncompliant|0|||
146105926|NCT01817530|526907787|FG003|Overall Study|Subject Noncompliant|4|||
146105927|NCT01817530|526907788|FG004|Overall Study|Subject Noncompliant|0|||
146105928|NCT01817530|526907789|FG005|Overall Study|Subject Noncompliant|1|||
146105929|NCT01817530|526907790|FG006|Overall Study|Subject Noncompliant|1|||
146105930|NCT01817530|526907791|FG007|Overall Study|Subject Noncompliant|1|||
146105931|NCT01817530|526907784|FG000|Overall Study|Lack of Efficacy|1|||
146105932|NCT01817530|526907785|FG001|Overall Study|Lack of Efficacy|0|||
146105933|NCT01817530|526907786|FG002|Overall Study|Lack of Efficacy|0|||
146105934|NCT01817530|526907787|FG003|Overall Study|Lack of Efficacy|0|||
146105935|NCT01817530|526907788|FG004|Overall Study|Lack of Efficacy|0|||
146105936|NCT01817530|526907789|FG005|Overall Study|Lack of Efficacy|1|||
146105937|NCT01817530|526907790|FG006|Overall Study|Lack of Efficacy|0|||
146105938|NCT01817530|526907791|FG007|Overall Study|Lack of Efficacy|1|||
146105939|NCT01817530|526907784|FG000|Overall Study|Pregnancy|0|||
146105940|NCT01817530|526907785|FG001|Overall Study|Pregnancy|0|||
146105941|NCT01817530|526907786|FG002|Overall Study|Pregnancy|0|||
146105942|NCT01817530|526907787|FG003|Overall Study|Pregnancy|0|||
146105943|NCT01817530|526907788|FG004|Overall Study|Pregnancy|0|||
146105944|NCT01817530|526907789|FG005|Overall Study|Pregnancy|1|||
146105945|NCT01817530|526907790|FG006|Overall Study|Pregnancy|0|||
146105946|NCT01817530|526907791|FG007|Overall Study|Pregnancy|0|||
146105947|NCT01817530|526907784|FG000|Overall Study|Other|0|||
146105948|NCT01817530|526907785|FG001|Overall Study|Other|1|||
146105949|NCT01817530|526907786|FG002|Overall Study|Other|0|||
146105950|NCT01817530|526907787|FG003|Overall Study|Other|0|||
146105951|NCT01817530|526907788|FG004|Overall Study|Other|1|||
146105952|NCT01817530|526907789|FG005|Overall Study|Other|0|||
146105953|NCT01817530|526907790|FG006|Overall Study|Other|5|||
146105954|NCT01817530|526907791|FG007|Overall Study|Other|0|||
146105955|NCT01817530|526907784|FG000|Overall Study|Surgery or Invasive Intervention|1|||
146105956|NCT01817530|526907785|FG001|Overall Study|Surgery or Invasive Intervention|0|||
146105957|NCT01817530|526907786|FG002|Overall Study|Surgery or Invasive Intervention|0|||
146105958|NCT01817530|526907787|FG003|Overall Study|Surgery or Invasive Intervention|0|||
146105959|NCT01817530|526907788|FG004|Overall Study|Surgery or Invasive Intervention|1|||
146105960|NCT01817530|526907789|FG005|Overall Study|Surgery or Invasive Intervention|1|||
146105961|NCT01817530|526907790|FG006|Overall Study|Surgery or Invasive Intervention|1|||
146105962|NCT01817530|526907791|FG007|Overall Study|Surgery or Invasive Intervention|0|||
146105963|NCT01817530|526907784|FG000|Overall Study|Consent Withdrawn by Subject|3|||
146105964|NCT01817530|526907785|FG001|Overall Study|Consent Withdrawn by Subject|4|||
146105965|NCT01817530|526907786|FG002|Overall Study|Consent Withdrawn by Subject|7|||
146105966|NCT01817530|526907787|FG003|Overall Study|Consent Withdrawn by Subject|3|||
146105967|NCT01817530|526907788|FG004|Overall Study|Consent Withdrawn by Subject|5|||
146105968|NCT01817530|526907789|FG005|Overall Study|Consent Withdrawn by Subject|3|||
146105969|NCT01817530|526907790|FG006|Overall Study|Consent Withdrawn by Subject|3|||
146105970|NCT01817530|526907791|FG007|Overall Study|Consent Withdrawn by Subject|10|||
146105971|NCT01817530|526907784|FG000|Overall Study|Lost to Follow-up|1|||
146105972|NCT01817530|526907785|FG001|Overall Study|Lost to Follow-up|4|||
146105973|NCT01817530|526907786|FG002|Overall Study|Lost to Follow-up|2|||
146105974|NCT01817530|526907787|FG003|Overall Study|Lost to Follow-up|1|||
146105975|NCT01817530|526907788|FG004|Overall Study|Lost to Follow-up|3|||
146105976|NCT01817530|526907789|FG005|Overall Study|Lost to Follow-up|2|||
145941582|NCT04076059|526295228|FG001|Double Blind Phase|Ongoing Participants|18|||
146105977|NCT01817530|526907790|FG006|Overall Study|Lost to Follow-up|8|||
146105978|NCT01817530|526907791|FG007|Overall Study|Lost to Follow-up|4|||
146105979|NCT03846804|526907792|FG000|Overall Study|Refused blood draw|1|||
146105980|NCT03846804|526907792|FG000|Overall Study|Protocol Violation|1|||
146105981|NCT00679432|526907793|FG000|Overall Study|Adverse Event|5|||
146105982|NCT00679432|526907794|FG001|Overall Study|Adverse Event|6|||
146105983|NCT00679432|526907795|FG002|Overall Study|Adverse Event|10|||
146105984|NCT00679432|526907796|FG003|Overall Study|Adverse Event|7|||
146105985|NCT00679432|526907793|FG000|Overall Study|Protocol Violation|1|||
146105986|NCT00679432|526907794|FG001|Overall Study|Protocol Violation|1|||
146105987|NCT00679432|526907795|FG002|Overall Study|Protocol Violation|2|||
146105988|NCT00679432|526907796|FG003|Overall Study|Protocol Violation|1|||
146105989|NCT00679432|526907793|FG000|Overall Study|Withdrawal by Subject|8|||
146105990|NCT00679432|526907794|FG001|Overall Study|Withdrawal by Subject|11|||
146105991|NCT00679432|526907795|FG002|Overall Study|Withdrawal by Subject|10|||
146105992|NCT00679432|526907796|FG003|Overall Study|Withdrawal by Subject|9|||
146105993|NCT00679432|526907793|FG000|Overall Study|Lost to Follow-up|1|||
146105994|NCT00679432|526907794|FG001|Overall Study|Lost to Follow-up|5|||
146105995|NCT00679432|526907795|FG002|Overall Study|Lost to Follow-up|4|||
146105996|NCT00679432|526907796|FG003|Overall Study|Lost to Follow-up|2|||
146105997|NCT00679432|526907793|FG000|Overall Study|Physician Decision|3|||
146105998|NCT00679432|526907794|FG001|Overall Study|Physician Decision|2|||
146105999|NCT00679432|526907795|FG002|Overall Study|Physician Decision|2|||
146106000|NCT00679432|526907796|FG003|Overall Study|Physician Decision|2|||
146106001|NCT00679432|526907793|FG000|Overall Study|Sponsor decision|1|||
146106002|NCT00679432|526907794|FG001|Overall Study|Sponsor decision|0|||
146106003|NCT00679432|526907795|FG002|Overall Study|Sponsor decision|0|||
146106004|NCT00679432|526907796|FG003|Overall Study|Sponsor decision|0|||
146106005|NCT00679432|526907793|FG000|Overall Study|Lack of Efficacy|13|||
146106006|NCT00679432|526907794|FG001|Overall Study|Lack of Efficacy|9|||
146106007|NCT00679432|526907795|FG002|Overall Study|Lack of Efficacy|14|||
146106008|NCT00679432|526907796|FG003|Overall Study|Lack of Efficacy|8|||
146106009|NCT00679432|526907793|FG000|Overall Study|Infectious colitis, normal histology|5|||
146106010|NCT00679432|526907794|FG001|Overall Study|Infectious colitis, normal histology|4|||
146106011|NCT00679432|526907795|FG002|Overall Study|Infectious colitis, normal histology|8|||
146106012|NCT00679432|526907796|FG003|Overall Study|Infectious colitis, normal histology|3|||
146106013|NCT00679432|526907793|FG000|Overall Study|Randomization error, return to prior Rx|0|||
146106014|NCT00679432|526907794|FG001|Overall Study|Randomization error, return to prior Rx|0|||
146106015|NCT00679432|526907795|FG002|Overall Study|Randomization error, return to prior Rx|3|||
146106016|NCT00679432|526907796|FG003|Overall Study|Randomization error, return to prior Rx|0|||
146106017|NCT00824720|526907797|FG000|Overall Study|failed plug insertion|3|||
146106018|NCT00824720|526907798|FG001|Overall Study|failed plug insertion|1|||
146106019|NCT00824720|526907799|FG002|Overall Study|failed plug insertion|0|||
146106020|NCT00824720|526907797|FG000|Overall Study|Protocol Violation|0|||
146106021|NCT00824720|526907798|FG001|Overall Study|Protocol Violation|0|||
146106022|NCT00824720|526907799|FG002|Overall Study|Protocol Violation|1|||
146106023|NCT02339584|526907800|FG000|Overall Study|Adverse Event|11|||
146106024|NCT02339584|526907801|FG001|Overall Study|Adverse Event|7|||
146106025|NCT02339584|526907800|FG000|Overall Study|Lack of Efficacy|0|||
146106026|NCT02339584|526907801|FG001|Overall Study|Lack of Efficacy|1|||
146106027|NCT02339584|526907800|FG000|Overall Study|Physician Decision|1|||
146106028|NCT02339584|526907801|FG001|Overall Study|Physician Decision|2|||
146106029|NCT02339584|526907800|FG000|Overall Study|Protocol Violation|1|||
146106030|NCT02339584|526907801|FG001|Overall Study|Protocol Violation|1|||
146257630|NCT02959177|527457725|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
146257631|NCT02959177|527457726|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
146257632|NCT02959177|527457727|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
146257633|NCT02959177|527457725|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
146106031|NCT02339584|526907800|FG000|Overall Study|Withdrawal by Subject|2|||
146106032|NCT02339584|526907801|FG001|Overall Study|Withdrawal by Subject|4|||
146106033|NCT00743483|526907802|FG000|Baseline Period|Physician Decision|1|||
146106034|NCT00743483|526907802|FG000|Treatment Period|Adverse Event|1|||
146106035|NCT01084083|526907803|FG000|Overall Study|Adverse Event|5|||
146106036|NCT01084083|526907803|FG000|Overall Study|Death|1|||
146106037|NCT01084083|526907803|FG000|Overall Study|Withdrawal by Subject|2|||
146106038|NCT01084083|526907803|FG000|Overall Study|Complicating disease|1|||
146106039|NCT01084083|526907803|FG000|Overall Study|Other|2|||
146106040|NCT01084083|526907803|FG000|Overall Study|Never started assigned therapy|1|||
146257634|NCT02959177|527457726|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
146257635|NCT02959177|527457727|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
146257636|NCT02959177|527457725|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
146257637|NCT02959177|527457726|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
146257638|NCT02959177|527457727|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
146257639|NCT02959177|527457725|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146257640|NCT02959177|527457726|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146257641|NCT02959177|527457727|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146257642|NCT02959177|527457725|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
146257643|NCT02959177|527457726|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
146257644|NCT02959177|527457727|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
146257645|NCT02959177|527457725|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
146257646|NCT02959177|527457726|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
146257647|NCT02959177|527457727|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
146257648|NCT02959177|527457725|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
146257649|NCT02959177|527457726|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
146257650|NCT02959177|527457727|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
146257651|NCT00677092|527457729|FG000|Overall Study|Adverse Event|1|||
146106041|NCT01273597|526907804|FG000|Overall Study|Adverse Event|5|||
146106042|NCT01273597|526907804|FG000|Overall Study|Underwent Kidney Transplantation|2|||
146106043|NCT01273597|526907804|FG000|Overall Study|Reason Not Reported|1|||
146106044|NCT01466153|526907807|FG000|Overall Study|Disease Progression|2|||
146106045|NCT01466153|526907808|FG001|Overall Study|Disease Progression|2|||
146257652|NCT00677092|527457729|FG000|Overall Study|Lost to Follow-up|1|||
146106046|NCT01466153|526907809|FG002|Overall Study|Disease Progression|0|||
146106047|NCT01466153|526907807|FG000|Overall Study|Adverse Event|14|||
146106048|NCT01466153|526907808|FG001|Overall Study|Adverse Event|13|||
146106049|NCT01466153|526907809|FG002|Overall Study|Adverse Event|17|||
146106050|NCT01466153|526907807|FG000|Overall Study|Withdrawal of Consent|2|||
146106051|NCT01466153|526907808|FG001|Overall Study|Withdrawal of Consent|0|||
146106052|NCT01466153|526907809|FG002|Overall Study|Withdrawal of Consent|0|||
146106053|NCT01466153|526907807|FG000|Overall Study|Investigator Discretion|3|||
146106054|NCT01466153|526907808|FG001|Overall Study|Investigator Discretion|2|||
146106055|NCT01466153|526907809|FG002|Overall Study|Investigator Discretion|2|||
146106056|NCT01466153|526907807|FG000|Overall Study|Randomized-Not Treated|2|||
146106057|NCT01466153|526907808|FG001|Overall Study|Randomized-Not Treated|3|||
146106058|NCT01466153|526907809|FG002|Overall Study|Randomized-Not Treated|4|||
146106059|NCT01466153|526907807|FG000|Overall Study|Other-Unspecified|6|||
146106060|NCT01466153|526907808|FG001|Overall Study|Other-Unspecified|4|||
146106061|NCT01466153|526907809|FG002|Overall Study|Other-Unspecified|2|||
146106062|NCT01785069|526907813|FG000|Overall Study|Implanted with nonstudy device|1|||
146106063|NCT01785069|526907814|FG001|Overall Study|Implanted with nonstudy device|2|||
146106064|NCT01785069|526907815|FG002|Overall Study|Implanted with nonstudy device|1|||
146106065|NCT01785069|526907816|FG003|Overall Study|Implanted with nonstudy device|0|||
146106066|NCT01785069|526907813|FG000|Overall Study|Death|0|||
146106067|NCT01785069|526907814|FG001|Overall Study|Death|0|||
146106068|NCT01785069|526907815|FG002|Overall Study|Death|2|||
146106069|NCT01785069|526907816|FG003|Overall Study|Death|0|||
146106070|NCT01785069|526907813|FG000|Overall Study|Subject choice|2|||
146106071|NCT01785069|526907814|FG001|Overall Study|Subject choice|2|||
146106072|NCT01785069|526907815|FG002|Overall Study|Subject choice|0|||
146106073|NCT01785069|526907816|FG003|Overall Study|Subject choice|1|||
146106074|NCT01785069|526907813|FG000|Overall Study|Lost to Follow-up|1|||
146106075|NCT01785069|526907814|FG001|Overall Study|Lost to Follow-up|2|||
146106076|NCT01785069|526907815|FG002|Overall Study|Lost to Follow-up|4|||
146106077|NCT01785069|526907816|FG003|Overall Study|Lost to Follow-up|1|||
146106078|NCT01785069|526907813|FG000|Overall Study|Reason not Specified|1|||
146106079|NCT01785069|526907814|FG001|Overall Study|Reason not Specified|2|||
146106080|NCT01785069|526907815|FG002|Overall Study|Reason not Specified|1|||
146106081|NCT01785069|526907816|FG003|Overall Study|Reason not Specified|4|||
146106082|NCT01785069|526907813|FG000|Overall Study|Not evaluable|7|||
146106083|NCT01785069|526907814|FG001|Overall Study|Not evaluable|4|||
146106084|NCT01785069|526907815|FG002|Overall Study|Not evaluable|5|||
146106085|NCT01785069|526907816|FG003|Overall Study|Not evaluable|8|||
146106086|NCT01088997|526907819|FG000|Overall Study|Physician Decision|1|||
146106087|NCT01088997|526907820|FG001|Overall Study|Physician Decision|1|||
146106088|NCT01088997|526907819|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
146106089|NCT01088997|526907820|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
146106090|NCT01088997|526907819|FG000|Overall Study|Excluded prior to receiving drug|1|||
146106091|NCT01088997|526907820|FG001|Overall Study|Excluded prior to receiving drug|1|||
146106092|NCT05570500|526907825|FG000|Overall Study|Lost to Follow-up|7|||
146106093|NCT05570500|526907826|FG001|Overall Study|Lost to Follow-up|5|||
146106094|NCT04997304|526907827|FG000|Overall Study|Lost to Follow-up|11|||
146106095|NCT04997304|526907827|FG000|Overall Study|Death|1|||
146106096|NCT04997304|526907827|FG000|Overall Study|Withdrawal by Subject|14|||
146106097|NCT00126191|526909926|FG000|Overall Study|Physician Decision|0|||
146106098|NCT00126191|526909927|FG001|Overall Study|Physician Decision|1|||
146106099|NCT00126191|526909926|FG000|Overall Study|Death|0|||
146106100|NCT00126191|526909927|FG001|Overall Study|Death|1|||
146106101|NCT03000439|526909930|FG000|Open Label Part 1|Adverse Event|6|||
146106102|NCT03000439|526909931|FG001|Open Label Part 1|Adverse Event|0|||
146106103|NCT03000439|526909932|FG002|Open Label Part 1|Adverse Event|0|||
146106104|NCT03000439|526909933|FG003|Open Label Part 1|Adverse Event|0|||
146106105|NCT03000439|526909930|FG000|Open Label Part 1|Other|2|||
146106106|NCT03000439|526909931|FG001|Open Label Part 1|Other|0|||
146106107|NCT03000439|526909932|FG002|Open Label Part 1|Other|0|||
146106108|NCT03000439|526909933|FG003|Open Label Part 1|Other|0|||
146257653|NCT00677092|527457729|FG000|Overall Study|Withdrawal by Subject|3|||
146257654|NCT00677092|527457729|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
146106109|NCT03000439|526909930|FG000|Open Label Part 1|Insufficient clinical response|16|||
146106110|NCT03000439|526909931|FG001|Open Label Part 1|Insufficient clinical response|0|||
146106111|NCT03000439|526909932|FG002|Open Label Part 1|Insufficient clinical response|0|||
146106112|NCT03000439|526909933|FG003|Open Label Part 1|Insufficient clinical response|0|||
146106113|NCT03000439|526909930|FG000|Open Label Part 2|Other|0|||
146106114|NCT03000439|526909931|FG001|Open Label Part 2|Other|5|||
146106115|NCT03000439|526909932|FG002|Open Label Part 2|Other|0|||
146106116|NCT03000439|526909933|FG003|Open Label Part 2|Other|0|||
146106117|NCT03000439|526909930|FG000|Open Label Part 2|Insufficient clinical response|0|||
146106118|NCT03000439|526909931|FG001|Open Label Part 2|Insufficient clinical response|12|||
146106119|NCT03000439|526909932|FG002|Open Label Part 2|Insufficient clinical response|0|||
146106120|NCT03000439|526909933|FG003|Open Label Part 2|Insufficient clinical response|0|||
146106121|NCT03000439|526909930|FG000|Double Blind Phase|Adverse Event|0|||
146106122|NCT03000439|526909931|FG001|Double Blind Phase|Adverse Event|0|||
146106123|NCT03000439|526909932|FG002|Double Blind Phase|Adverse Event|2|||
146106124|NCT03000439|526909933|FG003|Double Blind Phase|Adverse Event|1|||
146106125|NCT03000439|526909930|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
146106126|NCT03000439|526909931|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
146106127|NCT03000439|526909932|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
146106128|NCT03000439|526909933|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
146106129|NCT03000439|526909930|FG000|Double Blind Phase|Other|0|||
146106130|NCT03000439|526909931|FG001|Double Blind Phase|Other|0|||
146106131|NCT03000439|526909932|FG002|Double Blind Phase|Other|10|||
146106132|NCT03000439|526909933|FG003|Double Blind Phase|Other|11|||
146106133|NCT03000439|526909930|FG000|Double Blind Phase|Insufficient clinical response|0|||
146106134|NCT03000439|526909931|FG001|Double Blind Phase|Insufficient clinical response|0|||
146106135|NCT03000439|526909932|FG002|Double Blind Phase|Insufficient clinical response|0|||
146106136|NCT03000439|526909933|FG003|Double Blind Phase|Insufficient clinical response|2|||
146106137|NCT02370160|526909936|FG000|Overall Study|Death|3|||
146106138|NCT02370160|526909937|FG001|Overall Study|Death|4|||
146106139|NCT02370160|526909938|FG002|Overall Study|Death|1|||
146106140|NCT02501473|526909943|FG000|Overall Study|Study Terminated|2|||
146106141|NCT02501473|526909944|FG001|Overall Study|Study Terminated|3|||
146106142|NCT02501473|526909945|FG002|Overall Study|Study Terminated|7|||
146106143|NCT02501473|526909946|FG003|Overall Study|Study Terminated|9|||
146106144|NCT02501473|526909947|FG004|Overall Study|Study Terminated|2|||
146106145|NCT02501473|526909948|FG005|Overall Study|Study Terminated|10|||
146106146|NCT02501473|526909949|FG006|Overall Study|Study Terminated|1|||
146106147|NCT02501473|526909950|FG007|Overall Study|Study Terminated|0|||
146106148|NCT02501473|526909943|FG000|Overall Study|Withdrawal by Subject|0|||
146106149|NCT02501473|526909944|FG001|Overall Study|Withdrawal by Subject|0|||
146106150|NCT02501473|526909945|FG002|Overall Study|Withdrawal by Subject|3|||
146106151|NCT02501473|526909946|FG003|Overall Study|Withdrawal by Subject|3|||
146106152|NCT02501473|526909947|FG004|Overall Study|Withdrawal by Subject|2|||
146106153|NCT02501473|526909948|FG005|Overall Study|Withdrawal by Subject|2|||
146106154|NCT02501473|526909949|FG006|Overall Study|Withdrawal by Subject|0|||
146106155|NCT02501473|526909950|FG007|Overall Study|Withdrawal by Subject|0|||
146106156|NCT02501473|526909943|FG000|Overall Study|Death|0|||
146106157|NCT02501473|526909944|FG001|Overall Study|Death|0|||
146106158|NCT02501473|526909945|FG002|Overall Study|Death|1|||
146106159|NCT02501473|526909946|FG003|Overall Study|Death|1|||
146106160|NCT02501473|526909947|FG004|Overall Study|Death|0|||
146106161|NCT02501473|526909948|FG005|Overall Study|Death|1|||
146106162|NCT02501473|526909949|FG006|Overall Study|Death|0|||
146106163|NCT02501473|526909950|FG007|Overall Study|Death|0|||
146106164|NCT02501473|526909943|FG000|Overall Study|Lost to Follow-up|1|||
146106165|NCT02501473|526909944|FG001|Overall Study|Lost to Follow-up|0|||
146106166|NCT02501473|526909945|FG002|Overall Study|Lost to Follow-up|1|||
146106167|NCT02501473|526909946|FG003|Overall Study|Lost to Follow-up|0|||
146106168|NCT02501473|526909947|FG004|Overall Study|Lost to Follow-up|0|||
146106169|NCT02501473|526909948|FG005|Overall Study|Lost to Follow-up|1|||
146106170|NCT02501473|526909949|FG006|Overall Study|Lost to Follow-up|0|||
146106171|NCT02501473|526909950|FG007|Overall Study|Lost to Follow-up|0|||
146106172|NCT02501473|526909943|FG000|Overall Study|Reason not specified|0|||
146106173|NCT02501473|526909944|FG001|Overall Study|Reason not specified|0|||
146106174|NCT02501473|526909945|FG002|Overall Study|Reason not specified|1|||
146106175|NCT02501473|526909946|FG003|Overall Study|Reason not specified|1|||
146106176|NCT02501473|526909947|FG004|Overall Study|Reason not specified|0|||
146106177|NCT02501473|526909948|FG005|Overall Study|Reason not specified|0|||
146106178|NCT02501473|526909949|FG006|Overall Study|Reason not specified|0|||
146106179|NCT02501473|526909950|FG007|Overall Study|Reason not specified|0|||
146106180|NCT05275400|526909953|FG000|Treatment Period|Adverse Event|7|||
146106181|NCT05275400|526909954|FG001|Treatment Period|Adverse Event|1|||
146106182|NCT05275400|526909953|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
146106183|NCT05275400|526909954|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
146106184|NCT05275400|526909953|FG000|Treatment Period|Death|5|||
146106185|NCT05275400|526909954|FG001|Treatment Period|Death|2|||
146106186|NCT05275400|526909953|FG000|Treatment Period|Protocol Violation|1|||
146106187|NCT05275400|526909954|FG001|Treatment Period|Protocol Violation|0|||
146106188|NCT05275400|526909953|FG000|Treatment Period|Physician Decision|5|||
146106189|NCT05275400|526909954|FG001|Treatment Period|Physician Decision|4|||
146106190|NCT05275400|526909953|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
146106191|NCT05275400|526909954|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
146106192|NCT05275400|526909953|FG000|Treatment Period|Withdrawal by Subject|30|||
146106193|NCT05275400|526909954|FG001|Treatment Period|Withdrawal by Subject|12|||
146106194|NCT05275400|526909953|FG000|Treatment Period|Lost to Follow-up|1|||
146106195|NCT05275400|526909954|FG001|Treatment Period|Lost to Follow-up|5|||
146106196|NCT05275400|526909953|FG000|Treatment Period|Lack of Efficacy|1|||
146106197|NCT05275400|526909954|FG001|Treatment Period|Lack of Efficacy|0|||
146106198|NCT05275400|526909953|FG000|Treatment Period|Sponsor Decision|1|||
146106199|NCT05275400|526909954|FG001|Treatment Period|Sponsor Decision|0|||
146106200|NCT05275400|526909953|FG000|Follow-Up Period|Death|2|||
146106201|NCT05275400|526909954|FG001|Follow-Up Period|Death|0|||
146106202|NCT05275400|526909953|FG000|Follow-Up Period|Protocol Violation|1|||
146106203|NCT05275400|526909954|FG001|Follow-Up Period|Protocol Violation|0|||
146301149|NCT02553265|527618841|FG001|Third Intervention (28 Days)|Adverse Event|0|||
146301150|NCT02553265|527618842|FG002|Third Intervention (28 Days)|Adverse Event|0|||
146301151|NCT02553265|527618840|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
146106204|NCT05275400|526909953|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146106205|NCT05275400|526909954|FG001|Follow-Up Period|Withdrawal by Subject|0|||
146106206|NCT06333613|526909955|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
146106207|NCT05587296|526909959|FG000|Overall Study|Adverse Event|15|||
146106208|NCT05587296|526909960|FG001|Overall Study|Adverse Event|7|||
146106209|NCT05587296|526909959|FG000|Overall Study|Lack of Efficacy|2|||
146106210|NCT05587296|526909960|FG001|Overall Study|Lack of Efficacy|0|||
146106211|NCT05587296|526909959|FG000|Overall Study|Lost to Follow-up|1|||
146106212|NCT05587296|526909960|FG001|Overall Study|Lost to Follow-up|0|||
146106213|NCT05587296|526909959|FG000|Overall Study|Withdrawal by Subject|14|||
146106214|NCT05587296|526909960|FG001|Overall Study|Withdrawal by Subject|4|||
146106215|NCT05587296|526909959|FG000|Overall Study|miscellaneous|3|||
146106216|NCT05587296|526909960|FG001|Overall Study|miscellaneous|6|||
146106217|NCT05587296|526909959|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
146106218|NCT05587296|526909960|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
146106219|NCT03478930|526909962|FG000|Overall Study|Adverse Event|0|||
146106220|NCT03478930|526909963|FG001|Overall Study|Adverse Event|1|||
146106221|NCT03478930|526909962|FG000|Overall Study|Lack of Efficacy|3|||
146106222|NCT03478930|526909963|FG001|Overall Study|Lack of Efficacy|3|||
146106223|NCT03478930|526909962|FG000|Overall Study|Withdrawal by Subject|6|||
146106224|NCT03478930|526909963|FG001|Overall Study|Withdrawal by Subject|5|||
146106225|NCT04189081|526909964|FG000|Overall Study|Lost to Follow-up|1|||
146106226|NCT04189081|526909965|FG001|Overall Study|Lost to Follow-up|0|||
146106227|NCT04189081|526909966|FG002|Overall Study|Lost to Follow-up|0|||
146106228|NCT04189081|526909964|FG000|Overall Study|Withdrawal by Subject|0|||
146106229|NCT04189081|526909965|FG001|Overall Study|Withdrawal by Subject|0|||
146106230|NCT04189081|526909966|FG002|Overall Study|Withdrawal by Subject|1|||
146106231|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
146106232|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
146106233|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
146106234|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
146106235|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
146106236|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
146106237|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
146106238|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
146106239|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
146106240|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
146106241|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
146106242|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
146106243|NCT00044083|526909967|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
146106244|NCT00044083|526909968|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
146106245|NCT00044083|526909967|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
146106246|NCT00044083|526909968|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
146106247|NCT00044083|526909967|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
146106248|NCT00044083|526909968|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
146106249|NCT00044083|526909967|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
146106250|NCT00044083|526909968|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
146106251|NCT00288054|526909969|FG000|Overall Study|Protocol Violation|2|||
146106252|NCT00288054|526909969|FG000|Overall Study|Lack of Efficacy|16|||
146106253|NCT00288054|526909969|FG000|Overall Study|Adverse Event|3|||
146106254|NCT00288054|526909969|FG000|Overall Study|Withdrawal by Subject|1|||
146106255|NCT00288054|526909969|FG000|Overall Study|Not protocol specified|2|||
146106256|NCT00289991|526909970|FG000|Overall Study|Death|35|||
146106257|NCT00289991|526909971|FG001|Overall Study|Death|38|||
146106258|NCT00289991|526909970|FG000|Overall Study|Adverse Event|15|||
146106259|NCT00289991|526909971|FG001|Overall Study|Adverse Event|13|||
146106260|NCT00289991|526909970|FG000|Overall Study|Failure of prophylaxis|1|||
146106261|NCT00289991|526909971|FG001|Overall Study|Failure of prophylaxis|1|||
146106262|NCT00289991|526909970|FG000|Overall Study|Fungal breakthrough infection|0|||
146106263|NCT00289991|526909971|FG001|Overall Study|Fungal breakthrough infection|1|||
146106264|NCT00289991|526909970|FG000|Overall Study|Lost to Follow-up|0|||
146106265|NCT00289991|526909971|FG001|Overall Study|Lost to Follow-up|1|||
146106266|NCT00289991|526909970|FG000|Overall Study|Withdrawal by Subject|2|||
146106267|NCT00289991|526909971|FG001|Overall Study|Withdrawal by Subject|12|||
146106268|NCT00289991|526909970|FG000|Overall Study|Other|5|||
146106269|NCT00289991|526909971|FG001|Overall Study|Other|14|||
146301152|NCT02553265|527618841|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
146106270|NCT00851747|526909993|FG000|Overall Study|Physician Decision|6|||
146106271|NCT00851747|526909994|FG001|Overall Study|Physician Decision|6|||
146106272|NCT00851747|526909995|FG002|Overall Study|Physician Decision|6|||
146106273|NCT02340975|526909996|FG000|Overall Study|Death|6|||
146106274|NCT02340975|526909997|FG001|Overall Study|Death|23|||
146106275|NCT02340975|526909998|FG002|Overall Study|Death|21|||
146106276|NCT02340975|526909999|FG003|Overall Study|Death|7|||
146106277|NCT02340975|526910000|FG004|Overall Study|Death|21|||
146106278|NCT02340975|526910001|FG005|Overall Study|Death|13|||
146106279|NCT02340975|526909996|FG000|Overall Study|Lost to Follow-up|0|||
146106280|NCT02340975|526909997|FG001|Overall Study|Lost to Follow-up|0|||
146106281|NCT02340975|526909998|FG002|Overall Study|Lost to Follow-up|0|||
146106282|NCT02340975|526909999|FG003|Overall Study|Lost to Follow-up|0|||
146106283|NCT02340975|526910000|FG004|Overall Study|Lost to Follow-up|2|||
146106284|NCT02340975|526910001|FG005|Overall Study|Lost to Follow-up|0|||
146106285|NCT02340975|526909996|FG000|Overall Study|Withdrawal by Subject|0|||
146106286|NCT02340975|526909997|FG001|Overall Study|Withdrawal by Subject|0|||
146106287|NCT02340975|526909998|FG002|Overall Study|Withdrawal by Subject|3|||
146106288|NCT02340975|526909999|FG003|Overall Study|Withdrawal by Subject|3|||
146106289|NCT02340975|526910000|FG004|Overall Study|Withdrawal by Subject|2|||
146106290|NCT02340975|526910001|FG005|Overall Study|Withdrawal by Subject|0|||
146106291|NCT02340975|526909996|FG000|Overall Study|Other|0|||
146106292|NCT02340975|526909997|FG001|Overall Study|Other|4|||
146106293|NCT02340975|526909998|FG002|Overall Study|Other|0|||
146106294|NCT02340975|526909999|FG003|Overall Study|Other|2|||
146106295|NCT02340975|526910000|FG004|Overall Study|Other|0|||
146106296|NCT02340975|526910001|FG005|Overall Study|Other|6|||
146106297|NCT01007812|526910004|FG000|Period 1, One Week|Lost to Follow-up|0|||
146106298|NCT01007812|526910005|FG001|Period 1, One Week|Lost to Follow-up|1|||
146106299|NCT01007812|526910004|FG000|Period 1, One Week|Discomfort|1|||
146106300|NCT01007812|526910005|FG001|Period 1, One Week|Discomfort|0|||
146106301|NCT01091974|526910008|FG000|Overall Study|Did not start intervention|3|||
146106302|NCT01091974|526910009|FG001|Overall Study|Did not start intervention|1|||
146106303|NCT01091974|526910010|FG002|Overall Study|Did not start intervention|3|||
146106304|NCT01091974|526910011|FG003|Overall Study|Did not start intervention|1|||
146106305|NCT01091974|526910008|FG000|Overall Study|resumed sleep medication|0|||
146106306|NCT01091974|526910009|FG001|Overall Study|resumed sleep medication|0|||
146106307|NCT01091974|526910010|FG002|Overall Study|resumed sleep medication|1|||
146106308|NCT01091974|526910011|FG003|Overall Study|resumed sleep medication|2|||
146106309|NCT01091974|526910008|FG000|Overall Study|Withdrawal by Subject|1|||
146106310|NCT01091974|526910009|FG001|Overall Study|Withdrawal by Subject|3|||
146106311|NCT01091974|526910010|FG002|Overall Study|Withdrawal by Subject|2|||
146106312|NCT01091974|526910011|FG003|Overall Study|Withdrawal by Subject|2|||
146106313|NCT01091974|526910008|FG000|Overall Study|side-effects|1|||
146106314|NCT01091974|526910009|FG001|Overall Study|side-effects|1|||
146106315|NCT01091974|526910010|FG002|Overall Study|side-effects|0|||
146106316|NCT01091974|526910011|FG003|Overall Study|side-effects|2|||
146106317|NCT01866293|526910016|FG000|Overall Study|Adverse Event|2|||
146106318|NCT03066804|526910017|FG000|Overall Study|Physician Decision|0|||
146106319|NCT03066804|526910018|FG001|Overall Study|Physician Decision|4|||
146106320|NCT03066804|526910017|FG000|Overall Study|Death|23|||
146106321|NCT03066804|526910018|FG001|Overall Study|Death|17|||
146106322|NCT03066804|526910017|FG000|Overall Study|Withdrawal by Subject|19|||
146106323|NCT03066804|526910018|FG001|Overall Study|Withdrawal by Subject|25|||
146106324|NCT03066804|526910017|FG000|Overall Study|Lost to Follow-up|2|||
146106325|NCT03066804|526910018|FG001|Overall Study|Lost to Follow-up|0|||
146106326|NCT03066804|526910017|FG000|Overall Study|Adverse Event|2|||
146106327|NCT03066804|526910018|FG001|Overall Study|Adverse Event|3|||
146106328|NCT03066804|526910017|FG000|Overall Study|Technical problems|5|||
146106329|NCT03066804|526910018|FG001|Overall Study|Technical problems|1|||
146106330|NCT00555971|526910020|FG000|Overall Study|Adverse Event|1|||
146106331|NCT00555971|526910021|FG001|Overall Study|Adverse Event|1|||
146106332|NCT03982368|526910022|FG000|Overall Study|Adverse Event|6|||
146106333|NCT03982368|526910023|FG001|Overall Study|Adverse Event|4|||
146106334|NCT03982368|526910024|FG002|Overall Study|Adverse Event|3|||
146257655|NCT00784277|527457730|FG000|IR Treatment|Adverse Event|4|||
146106335|NCT03982368|526910022|FG000|Overall Study|Lost to Follow-up|2|||
146106336|NCT03982368|526910023|FG001|Overall Study|Lost to Follow-up|1|||
146106337|NCT03982368|526910024|FG002|Overall Study|Lost to Follow-up|0|||
146106338|NCT03982368|526910022|FG000|Overall Study|Withdrawal by Subject|1|||
146106339|NCT03982368|526910023|FG001|Overall Study|Withdrawal by Subject|2|||
146106340|NCT03982368|526910024|FG002|Overall Study|Withdrawal by Subject|0|||
146106341|NCT03982368|526910022|FG000|Overall Study|unknow|4|||
146106342|NCT03982368|526910023|FG001|Overall Study|unknow|0|||
146106343|NCT03982368|526910024|FG002|Overall Study|unknow|2|||
146106344|NCT00518284|526910025|FG000|Overall Study|Adverse Event|0|||
146106345|NCT00518284|526910026|FG001|Overall Study|Adverse Event|1|||
146106346|NCT00518284|526910027|FG002|Overall Study|Adverse Event|0|||
146106347|NCT00518284|526910028|FG003|Overall Study|Adverse Event|0|||
146106348|NCT00518284|526910025|FG000|Overall Study|Study Termination|0|||
146106349|NCT00518284|526910026|FG001|Overall Study|Study Termination|2|||
146257656|NCT00784277|527457731|FG001|IR Treatment|Adverse Event|8|||
146257657|NCT00784277|527457732|FG002|IR Treatment|Adverse Event|19|||
146257658|NCT00784277|527457733|FG003|IR Treatment|Adverse Event|35|||
146257659|NCT00784277|527457734|FG004|IR Treatment|Adverse Event|0|||
146257660|NCT00784277|527457735|FG005|IR Treatment|Adverse Event|0|||
146257661|NCT00784277|527457736|FG006|IR Treatment|Adverse Event|0|||
146106350|NCT00518284|526910027|FG002|Overall Study|Study Termination|1|||
146106351|NCT00518284|526910028|FG003|Overall Study|Study Termination|2|||
146106352|NCT03768414|526910029|FG000|Overall Study|Adverse Event or side effects|72|||
146106353|NCT03768414|526910030|FG001|Overall Study|Adverse Event or side effects|28|||
146106354|NCT03768414|526910029|FG000|Overall Study|Refusal unrelated to adverse event|33|||
146106355|NCT03768414|526910030|FG001|Overall Study|Refusal unrelated to adverse event|33|||
146106356|NCT03768414|526910029|FG000|Overall Study|Progression/relapse|132|||
146106357|NCT03768414|526910030|FG001|Overall Study|Progression/relapse|60|||
146106358|NCT03768414|526910029|FG000|Overall Study|Death|9|||
146106359|NCT03768414|526910030|FG001|Overall Study|Death|6|||
146106360|NCT03768414|526910029|FG000|Overall Study|Other - not protocol specified|45|||
146106361|NCT03768414|526910030|FG001|Overall Study|Other - not protocol specified|18|||
146106362|NCT03768414|526910029|FG000|Overall Study|Reason under review|3|||
146106363|NCT03768414|526910030|FG001|Overall Study|Reason under review|2|||
146106364|NCT02571777|526910032|FG000|Overall Study|Subject/guardian decision|34|||
146106365|NCT02571777|526910033|FG001|Overall Study|Subject/guardian decision|26|||
146106366|NCT02571777|526910034|FG002|Overall Study|Subject/guardian decision|26|||
146106367|NCT02571777|526910035|FG003|Overall Study|Subject/guardian decision|25|||
146106368|NCT02571777|526910036|FG004|Overall Study|Subject/guardian decision|27|||
146106369|NCT02571777|526910032|FG000|Overall Study|Protocol Deviation|2|||
146106370|NCT02571777|526910033|FG001|Overall Study|Protocol Deviation|3|||
146106371|NCT02571777|526910034|FG002|Overall Study|Protocol Deviation|4|||
146106372|NCT02571777|526910035|FG003|Overall Study|Protocol Deviation|8|||
146106373|NCT02571777|526910036|FG004|Overall Study|Protocol Deviation|4|||
146106374|NCT02571777|526910032|FG000|Overall Study|Death|1|||
146106375|NCT02571777|526910033|FG001|Overall Study|Death|1|||
146106376|NCT02571777|526910034|FG002|Overall Study|Death|4|||
146106377|NCT02571777|526910035|FG003|Overall Study|Death|0|||
146106378|NCT02571777|526910036|FG004|Overall Study|Death|0|||
146106379|NCT02571777|526910032|FG000|Overall Study|Lost to Follow-up|1|||
146106380|NCT02571777|526910033|FG001|Overall Study|Lost to Follow-up|1|||
146106381|NCT02571777|526910034|FG002|Overall Study|Lost to Follow-up|2|||
146106382|NCT02571777|526910035|FG003|Overall Study|Lost to Follow-up|0|||
146106383|NCT02571777|526910036|FG004|Overall Study|Lost to Follow-up|1|||
146106384|NCT02571777|526910032|FG000|Overall Study|Physician Decision|1|||
146106385|NCT02571777|526910033|FG001|Overall Study|Physician Decision|7|||
146106386|NCT02571777|526910034|FG002|Overall Study|Physician Decision|5|||
146106387|NCT02571777|526910035|FG003|Overall Study|Physician Decision|2|||
146106388|NCT02571777|526910036|FG004|Overall Study|Physician Decision|4|||
146106389|NCT02571777|526910032|FG000|Overall Study|Pregnancy|0|||
146106390|NCT02571777|526910033|FG001|Overall Study|Pregnancy|0|||
146106391|NCT02571777|526910034|FG002|Overall Study|Pregnancy|0|||
146106392|NCT02571777|526910035|FG003|Overall Study|Pregnancy|2|||
146106393|NCT02571777|526910036|FG004|Overall Study|Pregnancy|0|||
146106394|NCT03706079|526910037|FG000|Predecessor Study|Death|0|||
146106395|NCT03706079|526910038|FG001|Predecessor Study|Death|2|||
146106396|NCT03706079|526910039|FG002|Predecessor Study|Death|0|||
146106397|NCT03706079|526910040|FG003|Predecessor Study|Death|1|||
146106398|NCT03706079|526910041|FG004|Predecessor Study|Death|0|||
146106399|NCT03706079|526910042|FG005|Predecessor Study|Death|0|||
146106400|NCT03706079|526910037|FG000|Predecessor Study|Lost to Follow-up|5|||
146106401|NCT03706079|526910038|FG001|Predecessor Study|Lost to Follow-up|2|||
146106402|NCT03706079|526910039|FG002|Predecessor Study|Lost to Follow-up|0|||
146106403|NCT03706079|526910040|FG003|Predecessor Study|Lost to Follow-up|0|||
146106404|NCT03706079|526910041|FG004|Predecessor Study|Lost to Follow-up|1|||
146106405|NCT03706079|526910042|FG005|Predecessor Study|Lost to Follow-up|0|||
146106406|NCT03706079|526910037|FG000|Predecessor Study|Withdrawal by Subject|8|||
146106407|NCT03706079|526910038|FG001|Predecessor Study|Withdrawal by Subject|15|||
146106408|NCT03706079|526910039|FG002|Predecessor Study|Withdrawal by Subject|0|||
146106409|NCT03706079|526910040|FG003|Predecessor Study|Withdrawal by Subject|5|||
146106410|NCT03706079|526910041|FG004|Predecessor Study|Withdrawal by Subject|2|||
146106411|NCT03706079|526910042|FG005|Predecessor Study|Withdrawal by Subject|0|||
146257662|NCT00784277|527457730|FG000|IR Treatment|Lack of Efficacy|4|||
146257663|NCT00784277|527457731|FG001|IR Treatment|Lack of Efficacy|4|||
146257664|NCT00784277|527457732|FG002|IR Treatment|Lack of Efficacy|1|||
146106412|NCT03706079|526910037|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
146106413|NCT03706079|526910038|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
146106414|NCT03706079|526910039|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146106415|NCT03706079|526910040|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146106416|NCT03706079|526910041|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146257665|NCT00784277|527457733|FG003|IR Treatment|Lack of Efficacy|0|||
146257666|NCT00784277|527457734|FG004|IR Treatment|Lack of Efficacy|0|||
146257667|NCT00784277|527457735|FG005|IR Treatment|Lack of Efficacy|0|||
146257668|NCT00784277|527457736|FG006|IR Treatment|Lack of Efficacy|0|||
146257669|NCT00784277|527457730|FG000|IR Treatment|Lost to Follow-up|1|||
146257670|NCT00784277|527457731|FG001|IR Treatment|Lost to Follow-up|0|||
146106417|NCT03706079|526910042|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
146106418|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146106419|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146106420|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146106421|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146106422|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
146106423|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
146106424|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
146106425|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146106426|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
146106427|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146106428|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146106429|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
146106430|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
146106431|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
146106432|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
146106433|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
146106434|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
146106435|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
146106436|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146106437|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146106438|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146106439|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
146106440|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
146106441|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
146106442|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
146106443|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146106444|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146106445|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
146106446|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
146106447|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
146106448|NCT03706079|526910037|FG000|Long Term Extension (DESTINATION)|Death|8|||
146106449|NCT03706079|526910038|FG001|Long Term Extension (DESTINATION)|Death|2|||
146106450|NCT03706079|526910039|FG002|Long Term Extension (DESTINATION)|Death|2|||
146106451|NCT03706079|526910040|FG003|Long Term Extension (DESTINATION)|Death|1|||
146106452|NCT03706079|526910041|FG004|Long Term Extension (DESTINATION)|Death|0|||
146106453|NCT03706079|526910042|FG005|Long Term Extension (DESTINATION)|Death|0|||
146106454|NCT00963937|526910045|FG000|Overall Study|Protocol Violation|1|||
146106455|NCT00963937|526910046|FG001|Overall Study|Protocol Violation|1|||
146106456|NCT00963937|526910047|FG002|Overall Study|Protocol Violation|0|||
146106457|NCT00963937|526910045|FG000|Overall Study|Physician Decision|18|||
146106458|NCT00963937|526910046|FG001|Overall Study|Physician Decision|10|||
146106459|NCT00963937|526910047|FG002|Overall Study|Physician Decision|4|||
146106460|NCT02197520|526910048|FG000|Period 1|Withdrawal by Subject|1|||
146106461|NCT02197520|526910049|FG001|Period 1|Withdrawal by Subject|0|||
146106462|NCT02197520|526910048|FG000|Period 2|Adverse Event|0|||
146106463|NCT02197520|526910049|FG001|Period 2|Adverse Event|2|||
146106464|NCT02197520|526910048|FG000|Period 2|Withdrawal by Subject|1|||
146106465|NCT02197520|526910049|FG001|Period 2|Withdrawal by Subject|0|||
146106466|NCT00913497|526910050|FG000|Overall Study|Adverse Event|1|||
146106467|NCT00913497|526910050|FG000|Overall Study|Withdrawal by Subject|2|||
146257671|NCT00784277|527457732|FG002|IR Treatment|Lost to Follow-up|1|||
146257672|NCT00784277|527457733|FG003|IR Treatment|Lost to Follow-up|0|||
146257673|NCT00784277|527457734|FG004|IR Treatment|Lost to Follow-up|0|||
146257674|NCT00784277|527457735|FG005|IR Treatment|Lost to Follow-up|0|||
146257675|NCT00784277|527457736|FG006|IR Treatment|Lost to Follow-up|0|||
146257676|NCT00784277|527457730|FG000|IR Treatment|Withdrawal by Subject|5|||
146257677|NCT00784277|527457731|FG001|IR Treatment|Withdrawal by Subject|1|||
146257678|NCT00784277|527457732|FG002|IR Treatment|Withdrawal by Subject|4|||
146257679|NCT00784277|527457733|FG003|IR Treatment|Withdrawal by Subject|6|||
146257680|NCT00784277|527457734|FG004|IR Treatment|Withdrawal by Subject|0|||
146257681|NCT00784277|527457735|FG005|IR Treatment|Withdrawal by Subject|0|||
146257682|NCT00784277|527457736|FG006|IR Treatment|Withdrawal by Subject|0|||
146257683|NCT00784277|527457730|FG000|IR Treatment|Resolution Of Pain|0|||
146257684|NCT00784277|527457731|FG001|IR Treatment|Resolution Of Pain|1|||
146051083|NCT01150097|526700900|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
146051084|NCT01150097|526700901|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
146051085|NCT01150097|526700902|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
146051086|NCT01150097|526700900|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
146051087|NCT01150097|526700901|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
146051088|NCT01150097|526700902|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
146051089|NCT01150097|526700900|FG000|Months 24 to 48 Post-transplantation|Death|2|||
146051090|NCT01150097|526700901|FG001|Months 24 to 48 Post-transplantation|Death|0|||
146051091|NCT01150097|526700902|FG002|Months 24 to 48 Post-transplantation|Death|0|||
146051092|NCT01301833|526700903|FG000|Overall Study|Adverse Event|7|||
146051093|NCT01301833|526700904|FG001|Overall Study|Adverse Event|5|||
146051094|NCT01301833|526700905|FG002|Overall Study|Adverse Event|5|||
146051095|NCT01301833|526700906|FG003|Overall Study|Adverse Event|5|||
146051096|NCT01301833|526700903|FG000|Overall Study|Lack of Efficacy|1|||
146051097|NCT01301833|526700904|FG001|Overall Study|Lack of Efficacy|1|||
146051098|NCT01301833|526700905|FG002|Overall Study|Lack of Efficacy|0|||
146051099|NCT01301833|526700906|FG003|Overall Study|Lack of Efficacy|0|||
146051100|NCT01301833|526700903|FG000|Overall Study|Physician Decision|3|||
146051101|NCT01301833|526700904|FG001|Overall Study|Physician Decision|1|||
146051102|NCT01301833|526700905|FG002|Overall Study|Physician Decision|1|||
146051103|NCT01301833|526700906|FG003|Overall Study|Physician Decision|0|||
146051104|NCT01301833|526700903|FG000|Overall Study|Withdrawal by Subject|3|||
146051105|NCT01301833|526700904|FG001|Overall Study|Withdrawal by Subject|1|||
146051106|NCT01301833|526700905|FG002|Overall Study|Withdrawal by Subject|1|||
146051107|NCT01301833|526700906|FG003|Overall Study|Withdrawal by Subject|2|||
146051108|NCT01301833|526700903|FG000|Overall Study|Personal matter|1|||
146051109|NCT01301833|526700904|FG001|Overall Study|Personal matter|0|||
146051110|NCT01301833|526700905|FG002|Overall Study|Personal matter|0|||
146051111|NCT01301833|526700906|FG003|Overall Study|Personal matter|0|||
146051112|NCT02719171|526703262|FG000|Overall Study|Adverse Event|1|||
146051113|NCT02719171|526703263|FG001|Overall Study|Adverse Event|2|||
146051114|NCT02719171|526703264|FG002|Overall Study|Adverse Event|0|||
146051115|NCT02719171|526703265|FG003|Overall Study|Adverse Event|0|||
146051116|NCT02719171|526703266|FG004|Overall Study|Adverse Event|2|||
146051117|NCT02719171|526703262|FG000|Overall Study|Lost to Follow-up|0|||
146051118|NCT02719171|526703263|FG001|Overall Study|Lost to Follow-up|0|||
146051119|NCT02719171|526703264|FG002|Overall Study|Lost to Follow-up|1|||
146051120|NCT02719171|526703265|FG003|Overall Study|Lost to Follow-up|0|||
146051121|NCT02719171|526703266|FG004|Overall Study|Lost to Follow-up|0|||
146051122|NCT02719171|526703262|FG000|Overall Study|Subject Withdrawal|0|||
146051123|NCT02719171|526703263|FG001|Overall Study|Subject Withdrawal|2|||
146051124|NCT02719171|526703264|FG002|Overall Study|Subject Withdrawal|2|||
146051125|NCT02719171|526703265|FG003|Overall Study|Subject Withdrawal|1|||
146051126|NCT02719171|526703266|FG004|Overall Study|Subject Withdrawal|0|||
146051127|NCT02719171|526703262|FG000|Overall Study|Other|0|||
146051128|NCT02719171|526703263|FG001|Overall Study|Other|0|||
146051129|NCT02719171|526703264|FG002|Overall Study|Other|0|||
146051130|NCT02719171|526703265|FG003|Overall Study|Other|1|||
146051131|NCT02719171|526703266|FG004|Overall Study|Other|0|||
146051132|NCT02614729|526703267|FG000|Overall Study|Withdrawal by Subject|1|||
146051133|NCT02614729|526703268|FG001|Overall Study|Withdrawal by Subject|0|||
146051134|NCT00227721|526703269|FG000|Overall Study|On study, but never treated.|1|||
146051135|NCT02539797|526703279|FG000|Overall Study|Lost to Follow-up|0|||
146051136|NCT02539797|526703280|FG001|Overall Study|Lost to Follow-up|1|||
146051137|NCT02539797|526703281|FG002|Overall Study|Lost to Follow-up|0|||
146051138|NCT01777308|526703289|FG000|Overall Study|Withdrawal by Subject|5|||
146051139|NCT01777308|526703290|FG001|Overall Study|Withdrawal by Subject|1|||
146051140|NCT01777308|526703289|FG000|Overall Study|Migrated/moved from study area|1|||
146051141|NCT01777308|526703290|FG001|Overall Study|Migrated/moved from study area|0|||
146051142|NCT01777308|526703289|FG000|Overall Study|Lost to Follow-up|7|||
146051143|NCT01777308|526703290|FG001|Overall Study|Lost to Follow-up|2|||
146051144|NCT01777308|526703289|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
146051145|NCT01777308|526703290|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
146051146|NCT00383786|526703293|FG000|Overall Study|Protocol Violation|2|||
146051147|NCT00383786|526703294|FG001|Overall Study|Protocol Violation|6|||
146051148|NCT00383786|526703293|FG000|Overall Study|Withdrawal by Subject|2|||
146051149|NCT00383786|526703294|FG001|Overall Study|Withdrawal by Subject|5|||
146051150|NCT00383786|526703293|FG000|Overall Study|Physician Decision|0|||
146051151|NCT00383786|526703294|FG001|Overall Study|Physician Decision|1|||
146051152|NCT00985673|526703295|FG000|Overall Study|Lost to Follow-up|6|||
146051153|NCT00985673|526703296|FG001|Overall Study|Lost to Follow-up|7|||
146051154|NCT00985673|526703297|FG002|Overall Study|Lost to Follow-up|6|||
146051155|NCT00985673|526703298|FG003|Overall Study|Lost to Follow-up|10|||
146051156|NCT00985673|526703299|FG004|Overall Study|Lost to Follow-up|5|||
146051157|NCT00985673|526703300|FG005|Overall Study|Lost to Follow-up|3|||
146051158|NCT00985673|526703295|FG000|Overall Study|Withdrawal by Subject|0|||
146051159|NCT00985673|526703296|FG001|Overall Study|Withdrawal by Subject|4|||
146257685|NCT00784277|527457732|FG002|IR Treatment|Resolution Of Pain|0|||
146257686|NCT00784277|527457733|FG003|IR Treatment|Resolution Of Pain|0|||
146257687|NCT00784277|527457734|FG004|IR Treatment|Resolution Of Pain|0|||
146257688|NCT00784277|527457735|FG005|IR Treatment|Resolution Of Pain|0|||
146257689|NCT00784277|527457736|FG006|IR Treatment|Resolution Of Pain|0|||
146257690|NCT00784277|527457730|FG000|IR Treatment|Other|2|||
146257691|NCT00784277|527457731|FG001|IR Treatment|Other|3|||
146257692|NCT00784277|527457732|FG002|IR Treatment|Other|3|||
146257693|NCT00784277|527457733|FG003|IR Treatment|Other|2|||
146257694|NCT00784277|527457734|FG004|IR Treatment|Other|0|||
146257695|NCT00784277|527457735|FG005|IR Treatment|Other|0|||
146257696|NCT00784277|527457736|FG006|IR Treatment|Other|0|||
146257697|NCT00784277|527457730|FG000|ER Treatment|Adverse Event|0|||
146257698|NCT00784277|527457731|FG001|ER Treatment|Adverse Event|0|||
146257699|NCT00784277|527457732|FG002|ER Treatment|Adverse Event|0|||
146257700|NCT00784277|527457733|FG003|ER Treatment|Adverse Event|0|||
146257701|NCT00784277|527457734|FG004|ER Treatment|Adverse Event|1|||
146257702|NCT00784277|527457735|FG005|ER Treatment|Adverse Event|7|||
146257703|NCT00784277|527457736|FG006|ER Treatment|Adverse Event|7|||
146257704|NCT00784277|527457730|FG000|ER Treatment|Lack of Efficacy|0|||
146257705|NCT00784277|527457731|FG001|ER Treatment|Lack of Efficacy|0|||
146257706|NCT00784277|527457732|FG002|ER Treatment|Lack of Efficacy|0|||
146257707|NCT00784277|527457733|FG003|ER Treatment|Lack of Efficacy|0|||
146257708|NCT00784277|527457734|FG004|ER Treatment|Lack of Efficacy|3|||
146257709|NCT00784277|527457735|FG005|ER Treatment|Lack of Efficacy|4|||
146257710|NCT00784277|527457736|FG006|ER Treatment|Lack of Efficacy|0|||
146257711|NCT00784277|527457730|FG000|ER Treatment|Lost to Follow-up|0|||
146257712|NCT00784277|527457731|FG001|ER Treatment|Lost to Follow-up|0|||
146257713|NCT00784277|527457732|FG002|ER Treatment|Lost to Follow-up|0|||
146257714|NCT00784277|527457733|FG003|ER Treatment|Lost to Follow-up|0|||
146257715|NCT00784277|527457734|FG004|ER Treatment|Lost to Follow-up|0|||
146257716|NCT00784277|527457735|FG005|ER Treatment|Lost to Follow-up|2|||
146257717|NCT00784277|527457736|FG006|ER Treatment|Lost to Follow-up|0|||
146257718|NCT00784277|527457730|FG000|ER Treatment|Withdrawal by Subject|0|||
146257719|NCT00784277|527457731|FG001|ER Treatment|Withdrawal by Subject|0|||
146257720|NCT00784277|527457732|FG002|ER Treatment|Withdrawal by Subject|0|||
146257721|NCT00784277|527457733|FG003|ER Treatment|Withdrawal by Subject|0|||
146257722|NCT00784277|527457734|FG004|ER Treatment|Withdrawal by Subject|2|||
146257723|NCT00784277|527457735|FG005|ER Treatment|Withdrawal by Subject|5|||
146257724|NCT00784277|527457736|FG006|ER Treatment|Withdrawal by Subject|3|||
146257725|NCT00784277|527457730|FG000|ER Treatment|Study Medication Non-Compliant|0|||
146257726|NCT00784277|527457731|FG001|ER Treatment|Study Medication Non-Compliant|0|||
146257727|NCT00784277|527457732|FG002|ER Treatment|Study Medication Non-Compliant|0|||
146257728|NCT00784277|527457733|FG003|ER Treatment|Study Medication Non-Compliant|0|||
146257729|NCT00784277|527457734|FG004|ER Treatment|Study Medication Non-Compliant|2|||
146257730|NCT00784277|527457735|FG005|ER Treatment|Study Medication Non-Compliant|3|||
146257731|NCT00784277|527457736|FG006|ER Treatment|Study Medication Non-Compliant|3|||
146257732|NCT00784277|527457730|FG000|ER Treatment|Other|0|||
146257733|NCT00784277|527457731|FG001|ER Treatment|Other|0|||
146257734|NCT00784277|527457732|FG002|ER Treatment|Other|0|||
146257735|NCT00784277|527457733|FG003|ER Treatment|Other|0|||
146257736|NCT00784277|527457734|FG004|ER Treatment|Other|1|||
146257737|NCT00784277|527457735|FG005|ER Treatment|Other|3|||
146257738|NCT00784277|527457736|FG006|ER Treatment|Other|2|||
146257739|NCT01093222|527457737|FG000|Overall Study|Ineligible|6|||
146257740|NCT01093222|527457737|FG000|Overall Study|Adverse Event|7|||
146257741|NCT01093222|527457737|FG000|Overall Study|Progression/relapse|24|||
146257742|NCT01093222|527457737|FG000|Overall Study|Death|2|||
146257743|NCT01093222|527457737|FG000|Overall Study|Not protocol specified|1|||
146257744|NCT00187135|527457740|FG000|Visit One|Withdrawal by Subject|1|||
146257745|NCT00187135|527457741|FG001|Visit One|Withdrawal by Subject|0|||
146257746|NCT00187135|527457742|FG002|Visit One|Withdrawal by Subject|0|||
146257747|NCT00187135|527457743|FG003|Visit One|Withdrawal by Subject|0|||
146257748|NCT00187135|527457744|FG004|Visit One|Withdrawal by Subject|0|||
146301153|NCT02553265|527618842|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
146051160|NCT00985673|526703297|FG002|Overall Study|Withdrawal by Subject|5|||
146051161|NCT00985673|526703298|FG003|Overall Study|Withdrawal by Subject|2|||
146051162|NCT00985673|526703299|FG004|Overall Study|Withdrawal by Subject|2|||
146051163|NCT00985673|526703300|FG005|Overall Study|Withdrawal by Subject|3|||
146257749|NCT00187135|527457745|FG005|Visit One|Withdrawal by Subject|1|||
146257750|NCT00187135|527457740|FG000|Visit One|Physician Decision|3|||
146257751|NCT00187135|527457741|FG001|Visit One|Physician Decision|1|||
146051164|NCT00985673|526703295|FG000|Overall Study|Other|1|||
146257752|NCT00187135|527457742|FG002|Visit One|Physician Decision|0|||
146257753|NCT00187135|527457743|FG003|Visit One|Physician Decision|0|||
146257754|NCT00187135|527457744|FG004|Visit One|Physician Decision|0|||
146257755|NCT00187135|527457745|FG005|Visit One|Physician Decision|1|||
146257756|NCT00187135|527457740|FG000|Visit Two|Death|0|||
146257757|NCT00187135|527457741|FG001|Visit Two|Death|0|||
146257758|NCT00187135|527457742|FG002|Visit Two|Death|0|||
146257759|NCT00187135|527457743|FG003|Visit Two|Death|1|||
146106468|NCT03385564|526910051|FG000|Overall Study|Adverse Event|0|||
146106469|NCT03385564|526910052|FG001|Overall Study|Adverse Event|0|||
146106470|NCT03385564|526910053|FG002|Overall Study|Adverse Event|3|||
146106471|NCT03385564|526910054|FG003|Overall Study|Adverse Event|3|||
146106472|NCT03385564|526910051|FG000|Overall Study|Other than listed|0|||
146106473|NCT03385564|526910052|FG001|Overall Study|Other than listed|0|||
146106474|NCT03385564|526910053|FG002|Overall Study|Other than listed|0|||
146106475|NCT03385564|526910054|FG003|Overall Study|Other than listed|5|||
146106476|NCT03385564|526910051|FG000|Overall Study|Withdrawal by Subject|0|||
146106477|NCT03385564|526910052|FG001|Overall Study|Withdrawal by Subject|1|||
146106478|NCT03385564|526910053|FG002|Overall Study|Withdrawal by Subject|1|||
146106479|NCT03385564|526910054|FG003|Overall Study|Withdrawal by Subject|0|||
146106480|NCT03385564|526910051|FG000|Overall Study|Lack of Efficacy|0|||
146106481|NCT03385564|526910052|FG001|Overall Study|Lack of Efficacy|0|||
146106482|NCT03385564|526910053|FG002|Overall Study|Lack of Efficacy|0|||
146106483|NCT03385564|526910054|FG003|Overall Study|Lack of Efficacy|1|||
146257760|NCT00187135|527457744|FG004|Visit Two|Death|0|||
146257761|NCT00187135|527457745|FG005|Visit Two|Death|1|||
146257762|NCT00187135|527457740|FG000|Visit Two|Physician Decision|1|||
146106484|NCT03385564|526910051|FG000|Overall Study|Death|0|||
146106485|NCT03385564|526910052|FG001|Overall Study|Death|0|||
146106486|NCT03385564|526910053|FG002|Overall Study|Death|1|||
146106487|NCT03385564|526910054|FG003|Overall Study|Death|0|||
146106488|NCT03087643|526910059|FG000|Overall Study|Withdrawal by Subject|2|||
146106489|NCT03087643|526910060|FG001|Overall Study|Withdrawal by Subject|4|||
146106490|NCT03087643|526910059|FG000|Overall Study|Death|2|||
146106491|NCT03087643|526910060|FG001|Overall Study|Death|2|||
146106492|NCT01546883|526910064|FG000|Overall Study|Withdrawal by Subject|3|||
146106493|NCT01546883|526910064|FG000|Overall Study|Adverse Event|4|||
146106494|NCT01546883|526910064|FG000|Overall Study|Lost to Follow-up|2|||
146106495|NCT01546883|526910064|FG000|Overall Study|early closure of study|2|||
146106496|NCT01546883|526910064|FG000|Overall Study|other unrelated illness|1|||
146106497|NCT02256631|526910069|FG000|Overall Study|Lost to Follow-up|1|||
146106498|NCT02256631|526910070|FG001|Overall Study|Lost to Follow-up|1|||
146106499|NCT02256631|526910071|FG002|Overall Study|Lost to Follow-up|0|||
146106500|NCT02256631|526910072|FG003|Overall Study|Lost to Follow-up|2|||
146106501|NCT02256631|526910073|FG004|Overall Study|Lost to Follow-up|0|||
146106502|NCT02256631|526910074|FG005|Overall Study|Lost to Follow-up|4|||
146106503|NCT02256631|526910075|FG006|Overall Study|Lost to Follow-up|1|||
146106504|NCT02256631|526910069|FG000|Overall Study|Withdrawal by Subject|0|||
146106505|NCT02256631|526910070|FG001|Overall Study|Withdrawal by Subject|0|||
146106506|NCT02256631|526910071|FG002|Overall Study|Withdrawal by Subject|0|||
146106507|NCT02256631|526910072|FG003|Overall Study|Withdrawal by Subject|1|||
146106508|NCT02256631|526910073|FG004|Overall Study|Withdrawal by Subject|1|||
146106509|NCT02256631|526910074|FG005|Overall Study|Withdrawal by Subject|0|||
146106510|NCT02256631|526910075|FG006|Overall Study|Withdrawal by Subject|1|||
146106511|NCT02256631|526910069|FG000|Overall Study|Unable to get to clinic|0|||
146106512|NCT02256631|526910070|FG001|Overall Study|Unable to get to clinic|2|||
146106513|NCT02256631|526910071|FG002|Overall Study|Unable to get to clinic|0|||
146106514|NCT02256631|526910072|FG003|Overall Study|Unable to get to clinic|1|||
146106515|NCT02256631|526910073|FG004|Overall Study|Unable to get to clinic|0|||
146106516|NCT02256631|526910074|FG005|Overall Study|Unable to get to clinic|1|||
146106517|NCT02256631|526910075|FG006|Overall Study|Unable to get to clinic|2|||
146106518|NCT01427972|526910076|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106519|NCT01427972|526910077|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106520|NCT01427972|526910078|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106521|NCT01427972|526910079|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106522|NCT01427972|526910080|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106523|NCT01427972|526910081|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146257763|NCT00187135|527457741|FG001|Visit Two|Physician Decision|0|||
146257764|NCT00187135|527457742|FG002|Visit Two|Physician Decision|0|||
146257765|NCT00187135|527457743|FG003|Visit Two|Physician Decision|0|||
146106524|NCT01427972|526910082|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106525|NCT01427972|526910083|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
146106526|NCT01427972|526910084|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106527|NCT01427972|526910085|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146257766|NCT00187135|527457744|FG004|Visit Two|Physician Decision|0|||
146257767|NCT00187135|527457745|FG005|Visit Two|Physician Decision|0|||
146106528|NCT01427972|526910086|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106529|NCT01427972|526910087|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
146106530|NCT01427972|526910076|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106531|NCT01427972|526910077|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106532|NCT01427972|526910078|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106533|NCT01427972|526910079|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106534|NCT01427972|526910080|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146257768|NCT00187135|527457740|FG000|Visit Two|Withdrawal by Subject|1|||
146257769|NCT00187135|527457741|FG001|Visit Two|Withdrawal by Subject|1|||
146106535|NCT01427972|526910081|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
146106536|NCT01427972|526910082|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106537|NCT01427972|526910083|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106538|NCT01427972|526910084|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106539|NCT01427972|526910085|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106540|NCT01427972|526910086|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106541|NCT01427972|526910087|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
146106542|NCT01427972|526910076|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106543|NCT01427972|526910077|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
146106544|NCT01427972|526910078|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106545|NCT01427972|526910079|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106546|NCT01427972|526910080|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106547|NCT01427972|526910081|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106548|NCT01427972|526910082|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106549|NCT01427972|526910083|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106550|NCT01427972|526910084|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106551|NCT01427972|526910085|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106552|NCT01427972|526910086|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106553|NCT01427972|526910087|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
146106554|NCT00530946|526910089|FG000|Overall Study|Adverse Event|1|||
146106555|NCT00530946|526910090|FG001|Overall Study|Adverse Event|2|||
146106556|NCT00530946|526910091|FG002|Overall Study|Adverse Event|1|||
146106557|NCT00530946|526910092|FG003|Overall Study|Adverse Event|1|||
146106558|NCT00530946|526910089|FG000|Overall Study|Protocol Violation|0|||
146106559|NCT00530946|526910090|FG001|Overall Study|Protocol Violation|0|||
146106560|NCT00530946|526910091|FG002|Overall Study|Protocol Violation|0|||
146257770|NCT00187135|527457742|FG002|Visit Two|Withdrawal by Subject|1|||
146257771|NCT00187135|527457743|FG003|Visit Two|Withdrawal by Subject|0|||
146257772|NCT00187135|527457744|FG004|Visit Two|Withdrawal by Subject|1|||
146257773|NCT00187135|527457745|FG005|Visit Two|Withdrawal by Subject|1|||
146257774|NCT00187135|527457740|FG000|Visit Two|Study Discontinued|3|||
146257775|NCT00187135|527457741|FG001|Visit Two|Study Discontinued|2|||
146257776|NCT00187135|527457742|FG002|Visit Two|Study Discontinued|1|||
146257777|NCT00187135|527457743|FG003|Visit Two|Study Discontinued|7|||
146257778|NCT00187135|527457744|FG004|Visit Two|Study Discontinued|5|||
146257779|NCT00187135|527457745|FG005|Visit Two|Study Discontinued|6|||
146257780|NCT00187135|527457740|FG000|Visit Three|Death|0|||
146257781|NCT00187135|527457741|FG001|Visit Three|Death|0|||
146257782|NCT00187135|527457742|FG002|Visit Three|Death|1|||
146257783|NCT00187135|527457743|FG003|Visit Three|Death|0|||
146257784|NCT00187135|527457744|FG004|Visit Three|Death|1|||
146257785|NCT00187135|527457745|FG005|Visit Three|Death|0|||
146257786|NCT00187135|527457740|FG000|Visit Three|Withdrawal by Subject|0|||
146257787|NCT00187135|527457741|FG001|Visit Three|Withdrawal by Subject|1|||
146257788|NCT00187135|527457742|FG002|Visit Three|Withdrawal by Subject|1|||
146257789|NCT00187135|527457743|FG003|Visit Three|Withdrawal by Subject|2|||
146257790|NCT00187135|527457744|FG004|Visit Three|Withdrawal by Subject|0|||
146257791|NCT00187135|527457745|FG005|Visit Three|Withdrawal by Subject|0|||
146257792|NCT00187135|527457740|FG000|Visit Three|Study Discontinued|7|||
146257793|NCT00187135|527457741|FG001|Visit Three|Study Discontinued|6|||
146257794|NCT00187135|527457742|FG002|Visit Three|Study Discontinued|7|||
146257795|NCT00187135|527457743|FG003|Visit Three|Study Discontinued|7|||
146257796|NCT00187135|527457744|FG004|Visit Three|Study Discontinued|7|||
146257797|NCT00187135|527457745|FG005|Visit Three|Study Discontinued|6|||
146257798|NCT03927222|527457746|FG000|Overall Study|Progression|3|||
146257799|NCT03927222|527457746|FG000|Overall Study|CMV testing results inconclusive|1|||
146257800|NCT03927222|527457746|FG000|Overall Study|Unable to generate enough vaccines|1|||
146257801|NCT03927222|527457746|FG000|Overall Study|Early study termination|1|||
146257802|NCT00640042|527457747|FG000|Enrollment|Did not receive study drug|83|||
146257803|NCT00853021|527457768|FG000|Overall Study|Adverse Event|2|||
146257804|NCT00853021|527457768|FG000|Overall Study|Withdrawal by Subject|2|||
146257805|NCT00853021|527457768|FG000|Overall Study|Death|1|||
146257806|NCT03613454|527457769|FG000|Overall Study|Protocol Violation|1|||
146257807|NCT03613454|527457770|FG001|Overall Study|Protocol Violation|0|||
146257808|NCT03613454|527457769|FG000|Overall Study|Protocol Violation|0|||
146257809|NCT03613454|527457770|FG001|Overall Study|Protocol Violation|1|||
146257810|NCT01592383|527457771|FG000|Overall Study|Adverse Event|1|||
146257811|NCT04167085|527457772|FG000|Baseline|Withdrawal by Subject|2|||
146257812|NCT04167085|527457773|FG001|Baseline|Withdrawal by Subject|1|||
146106561|NCT00530946|526910092|FG003|Overall Study|Protocol Violation|1|||
146106562|NCT00530946|526910089|FG000|Overall Study|Noncompliance|1|||
146106563|NCT00530946|526910090|FG001|Overall Study|Noncompliance|0|||
146106564|NCT00530946|526910091|FG002|Overall Study|Noncompliance|0|||
146257813|NCT04167085|527457772|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
146257814|NCT04167085|527457773|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
146257815|NCT00560313|527459156|FG000|Overall Study|Adverse Events or Death|2|||
146257816|NCT00560313|527459156|FG000|Overall Study|Withdrawal by Subject|2|||
146257817|NCT00560313|527459156|FG000|Overall Study|Lost to Follow-up|1|||
146257818|NCT00560313|527459156|FG000|Overall Study|Protocol Violation|1|||
146257819|NCT00853372|527459161|FG000|Overall Study|Death|30|||
146257820|NCT00853372|527459162|FG001|Overall Study|Death|26|||
146257821|NCT00853372|527459161|FG000|Overall Study|Lost to Follow-up|1|||
146257822|NCT00853372|527459162|FG001|Overall Study|Lost to Follow-up|2|||
146051165|NCT00985673|526703296|FG001|Overall Study|Other|0|||
146051166|NCT00985673|526703297|FG002|Overall Study|Other|1|||
146051167|NCT00985673|526703298|FG003|Overall Study|Other|0|||
146051168|NCT00985673|526703299|FG004|Overall Study|Other|1|||
146051169|NCT00985673|526703300|FG005|Overall Study|Other|0|||
146051170|NCT00531284|526703303|FG000|Overall Study|Progressive Disease|1|||
146051171|NCT00531284|526703304|FG001|Overall Study|Progressive Disease|3|||
146051172|NCT00531284|526703305|FG002|Overall Study|Progressive Disease|5|||
146051173|NCT00531284|526703306|FG003|Overall Study|Progressive Disease|42|||
146051174|NCT00531284|526703307|FG004|Overall Study|Progressive Disease|4|||
146051175|NCT00531284|526703308|FG005|Overall Study|Progressive Disease|4|||
146051176|NCT00531284|526703309|FG006|Overall Study|Progressive Disease|3|||
146051177|NCT00531284|526703310|FG007|Overall Study|Progressive Disease|8|||
146051178|NCT00531284|526703311|FG008|Overall Study|Progressive Disease|6|||
146051179|NCT00531284|526703312|FG009|Overall Study|Progressive Disease|3|||
146051180|NCT00531284|526703313|FG010|Overall Study|Progressive Disease|3|||
146051181|NCT00531284|526703314|FG011|Overall Study|Progressive Disease|14|||
146051182|NCT00531284|526703315|FG012|Overall Study|Progressive Disease|2|||
146051183|NCT00531284|526703316|FG013|Overall Study|Progressive Disease|1|||
146051184|NCT00531284|526703317|FG014|Overall Study|Progressive Disease|2|||
146051185|NCT00531284|526703318|FG015|Overall Study|Progressive Disease|11|||
146051186|NCT00531284|526703319|FG016|Overall Study|Progressive Disease|5|||
146051187|NCT00531284|526703303|FG000|Overall Study|Adverse Event|0|||
146051188|NCT00531284|526703304|FG001|Overall Study|Adverse Event|1|||
146051189|NCT00531284|526703305|FG002|Overall Study|Adverse Event|1|||
146051190|NCT00531284|526703306|FG003|Overall Study|Adverse Event|7|||
146051191|NCT00531284|526703307|FG004|Overall Study|Adverse Event|0|||
146051192|NCT00531284|526703308|FG005|Overall Study|Adverse Event|2|||
146051193|NCT00531284|526703309|FG006|Overall Study|Adverse Event|3|||
146051194|NCT00531284|526703310|FG007|Overall Study|Adverse Event|2|||
146051195|NCT00531284|526703311|FG008|Overall Study|Adverse Event|3|||
146051196|NCT00531284|526703312|FG009|Overall Study|Adverse Event|0|||
146051197|NCT00531284|526703313|FG010|Overall Study|Adverse Event|0|||
146051198|NCT00531284|526703314|FG011|Overall Study|Adverse Event|5|||
146051199|NCT00531284|526703315|FG012|Overall Study|Adverse Event|0|||
146051200|NCT00531284|526703316|FG013|Overall Study|Adverse Event|1|||
146051201|NCT00531284|526703317|FG014|Overall Study|Adverse Event|1|||
146051202|NCT00531284|526703318|FG015|Overall Study|Adverse Event|0|||
146051203|NCT00531284|526703319|FG016|Overall Study|Adverse Event|2|||
146051204|NCT00531284|526703303|FG000|Overall Study|Withdrawal by Subject|1|||
146051205|NCT00531284|526703304|FG001|Overall Study|Withdrawal by Subject|0|||
146051206|NCT00531284|526703305|FG002|Overall Study|Withdrawal by Subject|0|||
146051207|NCT00531284|526703306|FG003|Overall Study|Withdrawal by Subject|4|||
146051208|NCT00531284|526703307|FG004|Overall Study|Withdrawal by Subject|0|||
146051209|NCT00531284|526703308|FG005|Overall Study|Withdrawal by Subject|0|||
146051210|NCT00531284|526703309|FG006|Overall Study|Withdrawal by Subject|0|||
146051211|NCT00531284|526703310|FG007|Overall Study|Withdrawal by Subject|0|||
146051212|NCT00531284|526703311|FG008|Overall Study|Withdrawal by Subject|0|||
146051213|NCT00531284|526703312|FG009|Overall Study|Withdrawal by Subject|0|||
146051214|NCT00531284|526703313|FG010|Overall Study|Withdrawal by Subject|0|||
146051215|NCT00531284|526703314|FG011|Overall Study|Withdrawal by Subject|3|||
146051216|NCT00531284|526703315|FG012|Overall Study|Withdrawal by Subject|0|||
146051217|NCT00531284|526703316|FG013|Overall Study|Withdrawal by Subject|1|||
146051218|NCT00531284|526703317|FG014|Overall Study|Withdrawal by Subject|0|||
146051219|NCT00531284|526703318|FG015|Overall Study|Withdrawal by Subject|1|||
146051220|NCT00531284|526703319|FG016|Overall Study|Withdrawal by Subject|1|||
146051221|NCT00531284|526703303|FG000|Overall Study|Other|1|||
146051222|NCT00531284|526703304|FG001|Overall Study|Other|0|||
146051223|NCT00531284|526703305|FG002|Overall Study|Other|0|||
146051224|NCT00531284|526703306|FG003|Overall Study|Other|10|||
146051225|NCT00531284|526703307|FG004|Overall Study|Other|2|||
146051226|NCT00531284|526703308|FG005|Overall Study|Other|1|||
146051227|NCT00531284|526703309|FG006|Overall Study|Other|0|||
146051228|NCT00531284|526703310|FG007|Overall Study|Other|0|||
146051229|NCT00531284|526703311|FG008|Overall Study|Other|2|||
146051230|NCT00531284|526703312|FG009|Overall Study|Other|1|||
146257823|NCT00853372|527459161|FG000|Overall Study|Full Consent Withdrawn|1|||
146051231|NCT00531284|526703313|FG010|Overall Study|Other|0|||
146051232|NCT00531284|526703314|FG011|Overall Study|Other|2|||
146051233|NCT00531284|526703315|FG012|Overall Study|Other|0|||
146051234|NCT00531284|526703316|FG013|Overall Study|Other|0|||
146051235|NCT00531284|526703317|FG014|Overall Study|Other|1|||
146051236|NCT00531284|526703318|FG015|Overall Study|Other|0|||
146051237|NCT00531284|526703319|FG016|Overall Study|Other|0|||
146051238|NCT02219464|526703321|FG000|Overall Study|Withdrawal by Subject|1|||
146257824|NCT00853372|527459162|FG001|Overall Study|Full Consent Withdrawn|1|||
146257825|NCT01268098|527459167|FG000|Overall Study|Adverse Event|1|||
146257826|NCT01268098|527459168|FG001|Overall Study|Adverse Event|0|||
146257827|NCT01703845|527459170|FG000|Overall Study|Adverse Event|1|||
146257828|NCT01703845|527459171|FG001|Overall Study|Adverse Event|0|||
146257829|NCT01703845|527459170|FG000|Overall Study|Protocol Violation|1|||
146257830|NCT01703845|527459171|FG001|Overall Study|Protocol Violation|0|||
146257831|NCT01703845|527459170|FG000|Overall Study|other than stated above|1|||
146257832|NCT01703845|527459171|FG001|Overall Study|other than stated above|0|||
146257833|NCT01644188|527459172|FG000|Overall Study|Adverse Event|44|||
146257834|NCT01644188|527459173|FG001|Overall Study|Adverse Event|20|||
146257835|NCT01644188|527459172|FG000|Overall Study|Poor compliance to protocol|26|||
146257836|NCT01644188|527459173|FG001|Overall Study|Poor compliance to protocol|14|||
146257837|NCT01644188|527459172|FG000|Overall Study|Physician Decision|1|||
146257838|NCT01644188|527459173|FG001|Overall Study|Physician Decision|3|||
146257839|NCT01644188|527459172|FG000|Overall Study|Participant moved|7|||
146257840|NCT01644188|527459173|FG001|Overall Study|Participant moved|2|||
146257841|NCT01644188|527459172|FG000|Overall Study|Related to auto-injector administration|2|||
146257842|NCT01644188|527459173|FG001|Overall Study|Related to auto-injector administration|2|||
146257843|NCT01644188|527459172|FG000|Overall Study|Consent withdrawn by participant|14|||
146257844|NCT01644188|527459173|FG001|Overall Study|Consent withdrawn by participant|7|||
146257845|NCT01644188|527459172|FG000|Overall Study|Selection criteria finally not met|2|||
146257846|NCT01644188|527459173|FG001|Overall Study|Selection criteria finally not met|0|||
146257847|NCT01644188|527459172|FG000|Overall Study|Lost to Follow-up|1|||
146257848|NCT01644188|527459173|FG001|Overall Study|Lost to Follow-up|0|||
146257849|NCT01644188|527459172|FG000|Overall Study|Death|4|||
146257850|NCT01644188|527459173|FG001|Overall Study|Death|3|||
146257851|NCT01644188|527459172|FG000|Overall Study|Last visit outside protocol visit window|14|||
146257852|NCT01644188|527459173|FG001|Overall Study|Last visit outside protocol visit window|16|||
146257853|NCT01644188|527459172|FG000|Overall Study|Site closure|1|||
146257854|NCT01644188|527459173|FG001|Overall Study|Site closure|1|||
146257855|NCT01644188|527459172|FG000|Overall Study|Other than specified above|6|||
146257856|NCT01644188|527459173|FG001|Overall Study|Other than specified above|7|||
146257857|NCT01929876|527459175|FG000|Period 2|Non-Compliance|1|||
146257858|NCT01845649|527459180|FG000|Overall Study|Adverse Event|7|||
146257859|NCT01845649|527459181|FG001|Overall Study|Adverse Event|10|||
146257860|NCT01845649|527459180|FG000|Overall Study|Lack of Efficacy|1|||
146257861|NCT01845649|527459181|FG001|Overall Study|Lack of Efficacy|1|||
146257862|NCT01845649|527459180|FG000|Overall Study|Lost to Follow-up|2|||
146257863|NCT01845649|527459181|FG001|Overall Study|Lost to Follow-up|2|||
146257864|NCT01845649|527459180|FG000|Overall Study|Withdrew Consent|12|||
146257865|NCT01845649|527459181|FG001|Overall Study|Withdrew Consent|4|||
146257866|NCT01845649|527459180|FG000|Overall Study|Protocol Deviation|7|||
146257867|NCT01845649|527459181|FG001|Overall Study|Protocol Deviation|4|||
146257868|NCT01845649|527459180|FG000|Overall Study|Reason not Specified|2|||
146257869|NCT01845649|527459181|FG001|Overall Study|Reason not Specified|1|||
146257870|NCT03991988|527459182|FG000|Overall Study|Withdrawal by Subject|2|||
146257871|NCT03991988|527459183|FG001|Overall Study|Withdrawal by Subject|2|||
146257872|NCT01222533|527459185|FG000|Overall Study|Adverse Event|5|||
146257873|NCT01222533|527459185|FG000|Overall Study|Withdrawal by Subject|5|||
146257874|NCT01222533|527459185|FG000|Overall Study|Other|4|||
146257875|NCT00966979|527459186|FG000|Overall Study|Death|1|||
146257876|NCT00966979|527459186|FG000|Overall Study|Lost to Follow-up|6|||
146257877|NCT00966979|527459186|FG000|Overall Study|Withdrawal by Subject|14|||
146257878|NCT00966979|527459186|FG000|Overall Study|Adverse Event|5|||
146257879|NCT00966979|527459186|FG000|Overall Study|Sponsor terminated early|49|||
146257880|NCT00966979|527459186|FG000|Overall Study|Censored because surgery not done|2|||
146257881|NCT00966979|527459186|FG000|Overall Study|Censored because study device was not implanted|14|||
146257882|NCT00966979|527459186|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
146257883|NCT03713281|527459187|FG000|Overall Study|Lens handling difficuluties|2|||
146257884|NCT03713281|527459187|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
146301154|NCT02460497|527618847|FG000|Overall Study|Participant Requested Withdrawal|4|||
146051239|NCT02219464|526703322|FG001|Overall Study|Withdrawal by Subject|0|||
146051240|NCT02219464|526703321|FG000|Overall Study|case cancelled|1|||
146051241|NCT02219464|526703322|FG001|Overall Study|case cancelled|0|||
146257885|NCT04349644|527459190|FG000|Allocation/Pretest|Lost to pretest|0|||
146257886|NCT04349644|527459191|FG001|Allocation/Pretest|Lost to pretest|3|||
146257887|NCT04349644|527459190|FG000|Posttest|Lost to posttest|0|||
146257888|NCT04349644|527459191|FG001|Posttest|Lost to posttest|8|||
146257889|NCT04349644|527459190|FG000|Posttest|Discontinued intervention|6|||
146257890|NCT04349644|527459191|FG001|Posttest|Discontinued intervention|0|||
146257891|NCT04349644|527459190|FG000|Follow-up|Lost to Follow-up|0|||
146257892|NCT04349644|527459191|FG001|Follow-up|Lost to Follow-up|2|||
146257893|NCT05006417|527459192|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
146257894|NCT01169636|527459193|FG000|Overall Study|Adverse Event|0|||
146257895|NCT01169636|527459194|FG001|Overall Study|Adverse Event|0|||
146257896|NCT01169636|527459195|FG002|Overall Study|Adverse Event|1|||
146257897|NCT01169636|527459196|FG003|Overall Study|Adverse Event|1|||
146051242|NCT02219464|526703321|FG000|Overall Study|catheter malfunction|1|||
146051243|NCT02219464|526703322|FG001|Overall Study|catheter malfunction|0|||
146051244|NCT00984256|526703323|FG000|Overall Study|Withdrawal by Subject|0|||
146051245|NCT00984256|526703324|FG001|Overall Study|Withdrawal by Subject|1|||
146051246|NCT03493945|526703327|FG000|Phase I Dose Escalation|Ineligible|0|||
146051247|NCT03493945|526703328|FG001|Phase I Dose Escalation|Ineligible|0|||
146051248|NCT03493945|526703329|FG002|Phase I Dose Escalation|Ineligible|1|||
146051249|NCT03493945|526703330|FG003|Phase I Dose Escalation|Ineligible|0|||
146051250|NCT03493945|526703331|FG004|Phase I Dose Escalation|Ineligible|0|||
146051251|NCT03493945|526703332|FG005|Phase I Dose Escalation|Ineligible|0|||
146051252|NCT03493945|526703333|FG006|Phase I Dose Escalation|Ineligible|0|||
146106565|NCT00530946|526910092|FG003|Overall Study|Noncompliance|0|||
146106566|NCT01534962|526910093|FG000|Overall Study|Randomized but did not start treatment|2|||
146106567|NCT01534962|526910094|FG001|Overall Study|Randomized but did not start treatment|0|||
146106568|NCT01534962|526910095|FG002|Overall Study|Randomized but did not start treatment|0|||
146106569|NCT01534962|526910096|FG003|Overall Study|Randomized but did not start treatment|1|||
146106570|NCT01534962|526910093|FG000|Overall Study|Discontinued at AF recurrence|35|||
146106571|NCT01534962|526910094|FG001|Overall Study|Discontinued at AF recurrence|26|||
146106572|NCT01534962|526910095|FG002|Overall Study|Discontinued at AF recurrence|24|||
146106573|NCT01534962|526910096|FG003|Overall Study|Discontinued at AF recurrence|31|||
146106574|NCT02243696|526910097|FG000|Overall Study|Death|282|||
146106575|NCT02243696|526910097|FG000|Overall Study|Withdrawal by Subject|79|||
146106576|NCT02243696|526910097|FG000|Overall Study|Lost to Follow-up|57|||
146106577|NCT02243696|526910097|FG000|Overall Study|Subject No Longer has Study System|42|||
146106578|NCT02243696|526910097|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
146106579|NCT02243696|526910097|FG000|Overall Study|Study Terminated for EP PASSION|961|||
146106580|NCT00622284|526910098|FG000|Overall Study|Lack of Efficacy|45|||
146106581|NCT00622284|526910099|FG001|Overall Study|Lack of Efficacy|15|||
146106582|NCT00622284|526910098|FG000|Overall Study|Adverse Event|61|||
146106583|NCT00622284|526910099|FG001|Overall Study|Adverse Event|90|||
146106584|NCT00622284|526910098|FG000|Overall Study|Protocol Violation|12|||
146106585|NCT00622284|526910099|FG001|Overall Study|Protocol Violation|5|||
146106586|NCT00622284|526910098|FG000|Overall Study|Lost to Follow-up|11|||
146106587|NCT00622284|526910099|FG001|Overall Study|Lost to Follow-up|13|||
146106588|NCT00622284|526910098|FG000|Overall Study|Withdrawal by Subject|27|||
146106589|NCT00622284|526910099|FG001|Overall Study|Withdrawal by Subject|24|||
146106590|NCT00622284|526910098|FG000|Overall Study|Other reason (not specified)|33|||
146106591|NCT00622284|526910099|FG001|Overall Study|Other reason (not specified)|24|||
146106592|NCT00457301|526910100|FG000|Overall Study|Withdrawal by Subject|3|||
146106593|NCT00457301|526910101|FG001|Overall Study|Withdrawal by Subject|3|||
146106594|NCT00457301|526910100|FG000|Overall Study|Censored out of the study|15|||
146106595|NCT00457301|526910101|FG001|Overall Study|Censored out of the study|14|||
146106596|NCT00457301|526910100|FG000|Overall Study|Death|5|||
146106597|NCT00457301|526910101|FG001|Overall Study|Death|7|||
146106598|NCT02094677|526910110|FG000|Overall Study|Screening|3|||
146106599|NCT02094677|526910111|FG001|Overall Study|Screening|1|||
146106600|NCT03408483|526910112|FG000|Overall Study|Physician Decision|3|||
146106601|NCT03408483|526910113|FG001|Overall Study|Physician Decision|3|||
146257898|NCT01169636|527459197|FG004|Overall Study|Adverse Event|0|||
146257899|NCT01169636|527459193|FG000|Overall Study|Screen failure|0|||
146257900|NCT01169636|527459194|FG001|Overall Study|Screen failure|0|||
146257901|NCT01169636|527459195|FG002|Overall Study|Screen failure|2|||
146257902|NCT01169636|527459196|FG003|Overall Study|Screen failure|0|||
146257903|NCT01169636|527459197|FG004|Overall Study|Screen failure|0|||
146257904|NCT01169636|527459193|FG000|Overall Study|Withdrawal by Subject|0|||
146257905|NCT01169636|527459194|FG001|Overall Study|Withdrawal by Subject|0|||
146257906|NCT01169636|527459195|FG002|Overall Study|Withdrawal by Subject|0|||
146257907|NCT01169636|527459196|FG003|Overall Study|Withdrawal by Subject|0|||
146257908|NCT01169636|527459197|FG004|Overall Study|Withdrawal by Subject|3|||
146257909|NCT02396953|527459198|FG000|Overall Study|Withdrawal by Subject|0|||
146257910|NCT02396953|527459199|FG001|Overall Study|Withdrawal by Subject|0|||
146257911|NCT02396953|527459200|FG002|Overall Study|Withdrawal by Subject|1|||
146257912|NCT02396953|527459198|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
146301155|NCT02460497|527618847|FG000|Overall Study|Non-Compliance|1|||
146051253|NCT03493945|526703327|FG000|Phase I Dose Escalation|New therapy|0|||
146051254|NCT03493945|526703328|FG001|Phase I Dose Escalation|New therapy|1|||
146051255|NCT03493945|526703329|FG002|Phase I Dose Escalation|New therapy|0|||
146106602|NCT03408483|526910112|FG000|Overall Study|Lost to Follow-up|3|||
146106603|NCT03408483|526910113|FG001|Overall Study|Lost to Follow-up|0|||
146106604|NCT05399641|526910114|FG000|Overall Study|Adverse Event|0|||
146106605|NCT05399641|526910115|FG001|Overall Study|Adverse Event|1|||
146106606|NCT05399641|526910116|FG002|Overall Study|Adverse Event|1|||
146106607|NCT05399641|526910114|FG000|Overall Study|Lost to Follow-up|1|||
146257913|NCT02396953|527459199|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
146257914|NCT02396953|527459200|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
146106608|NCT05399641|526910115|FG001|Overall Study|Lost to Follow-up|2|||
146106609|NCT05399641|526910116|FG002|Overall Study|Lost to Follow-up|2|||
146106610|NCT05399641|526910114|FG000|Overall Study|Physician Decision|1|||
146106611|NCT05399641|526910115|FG001|Overall Study|Physician Decision|3|||
146106612|NCT05399641|526910116|FG002|Overall Study|Physician Decision|3|||
146106613|NCT05399641|526910114|FG000|Overall Study|Withdrawal by Subject|4|||
146106614|NCT05399641|526910115|FG001|Overall Study|Withdrawal by Subject|11|||
146106615|NCT05399641|526910116|FG002|Overall Study|Withdrawal by Subject|7|||
146106616|NCT05399641|526910114|FG000|Overall Study|Reason not defined|3|||
146106617|NCT05399641|526910115|FG001|Overall Study|Reason not defined|5|||
146106618|NCT05399641|526910116|FG002|Overall Study|Reason not defined|6|||
146106619|NCT00478231|526910117|FG000|Overall Study|Death|7|||
146106620|NCT00478231|526910117|FG000|Overall Study|Lack of Efficacy|47|||
146106621|NCT00478231|526910117|FG000|Overall Study|Lost to Follow-up|7|||
146106622|NCT00478231|526910117|FG000|Overall Study|Withdrawal by Subject|6|||
146106623|NCT00478231|526910117|FG000|Overall Study|Other|9|||
146106624|NCT00478231|526910117|FG000|Overall Study|Adverse Event|5|||
146106625|NCT00478231|526910117|FG000|Overall Study|Randomized, not treated|3|||
146106626|NCT01300650|526910118|FG000|Overall Study|Adverse Event|1|||
146106627|NCT01702961|526910119|FG000|Overall Study|Additional treatment|3|||
146106628|NCT01702961|526910119|FG000|Overall Study|Progressive disease|5|||
146106629|NCT01702961|526910119|FG000|Overall Study|Relapse|20|||
146106630|NCT01702961|526910119|FG000|Overall Study|Death|6|||
146106631|NCT01702961|526910119|FG000|Overall Study|Lost to Follow-up|2|||
146106632|NCT01702961|526910119|FG000|Overall Study|Ongoing|11|||
146106633|NCT02610725|526910122|FG000|Overall Study|Lost to Follow-up|197|||
146106634|NCT02610725|526910122|FG000|Overall Study|self-reported contraindication|9|||
146106635|NCT04094883|526910123|FG000|Overall Study|Withdrawal by Subject|1|||
146106636|NCT02302807|526910126|FG000|Overall Study|Withdrawal by Subject|28|||
146106637|NCT02302807|526910127|FG001|Overall Study|Withdrawal by Subject|11|||
146106638|NCT02302807|526910126|FG000|Overall Study|Lost to Follow-up|4|||
146106639|NCT02302807|526910127|FG001|Overall Study|Lost to Follow-up|6|||
146106640|NCT02302807|526910126|FG000|Overall Study|Death|397|||
146106641|NCT02302807|526910127|FG001|Overall Study|Death|385|||
146106642|NCT02302807|526910126|FG000|Overall Study|Study Terminated By Sponsor|35|||
146106643|NCT02302807|526910127|FG001|Overall Study|Study Terminated By Sponsor|64|||
146106644|NCT02302807|526910126|FG000|Overall Study|Physician Decision|0|||
146106645|NCT02302807|526910127|FG001|Overall Study|Physician Decision|1|||
146106646|NCT01133522|526910131|FG000|Overall Study|Withdrawal by Subject|0|||
146106647|NCT01133522|526910132|FG001|Overall Study|Withdrawal by Subject|1|||
146106648|NCT01133522|526910133|FG002|Overall Study|Withdrawal by Subject|0|||
146106649|NCT01133522|526910134|FG003|Overall Study|Withdrawal by Subject|1|||
146106650|NCT01133522|526910135|FG004|Overall Study|Withdrawal by Subject|0|||
146106651|NCT01133522|526910136|FG005|Overall Study|Withdrawal by Subject|0|||
146106652|NCT01133522|526910137|FG006|Overall Study|Withdrawal by Subject|0|||
146106653|NCT01133522|526910138|FG007|Overall Study|Withdrawal by Subject|0|||
146106654|NCT01133522|526910139|FG008|Overall Study|Withdrawal by Subject|0|||
146106655|NCT01133522|526910140|FG009|Overall Study|Withdrawal by Subject|0|||
146106656|NCT01133522|526910131|FG000|Overall Study|Physician Decision|0|||
146106657|NCT01133522|526910132|FG001|Overall Study|Physician Decision|0|||
146106658|NCT01133522|526910133|FG002|Overall Study|Physician Decision|0|||
146106659|NCT01133522|526910134|FG003|Overall Study|Physician Decision|0|||
146106660|NCT01133522|526910135|FG004|Overall Study|Physician Decision|1|||
146106661|NCT01133522|526910136|FG005|Overall Study|Physician Decision|0|||
146106662|NCT01133522|526910137|FG006|Overall Study|Physician Decision|0|||
146106663|NCT01133522|526910138|FG007|Overall Study|Physician Decision|0|||
146106664|NCT01133522|526910139|FG008|Overall Study|Physician Decision|0|||
146106665|NCT01133522|526910140|FG009|Overall Study|Physician Decision|0|||
146106666|NCT00688753|526912248|FG000|Overall Study|Disease progression|55|||
146106667|NCT00688753|526912248|FG000|Overall Study|Missing|1|||
146106668|NCT00688753|526912248|FG000|Overall Study|Death|9|||
146106669|NCT00688753|526912248|FG000|Overall Study|Withdrawal by Subject|3|||
146106670|NCT00688753|526912248|FG000|Overall Study|Adverse Event|20|||
146106671|NCT00688753|526912248|FG000|Overall Study|Protocol Violation|1|||
146106672|NCT00688753|526912248|FG000|Overall Study|Lost to Follow-up|3|||
146106673|NCT05996718|526912249|FG000|Overall Study|Lost to Follow-up|3|||
146106674|NCT03945773|526912250|FG000|Overall Study|Consent Withdrawn|1|||
146106675|NCT03945773|526912251|FG001|Overall Study|Consent Withdrawn|1|||
146106676|NCT03945773|526912250|FG000|Overall Study|Lost to Follow-up|1|||
146106677|NCT03945773|526912251|FG001|Overall Study|Lost to Follow-up|0|||
146106678|NCT03945773|526912250|FG000|Overall Study|Death|46|||
146106679|NCT03945773|526912251|FG001|Overall Study|Death|22|||
146106680|NCT03945773|526912250|FG000|Overall Study|Physician Decision|1|||
146106681|NCT03945773|526912251|FG001|Overall Study|Physician Decision|0|||
146106682|NCT03945773|526912250|FG000|Overall Study|Other|1|||
146106683|NCT03945773|526912251|FG001|Overall Study|Other|0|||
146106684|NCT03945773|526912250|FG000|Overall Study|Ongoing at the time of DCO|4|||
146106685|NCT03945773|526912251|FG001|Overall Study|Ongoing at the time of DCO|3|||
146106686|NCT01713686|526912252|FG000|Overall Study|Lost to Follow-up|9|||
146106687|NCT01713686|526912252|FG000|Overall Study|Withdrawal by Subject|6|||
146106688|NCT03187197|526912256|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
146051256|NCT03493945|526703330|FG003|Phase I Dose Escalation|New therapy|0|||
146051257|NCT03493945|526703331|FG004|Phase I Dose Escalation|New therapy|0|||
146051258|NCT03493945|526703332|FG005|Phase I Dose Escalation|New therapy|0|||
146051259|NCT03493945|526703333|FG006|Phase I Dose Escalation|New therapy|0|||
146051260|NCT03493945|526703327|FG000|Phase II Dose Expansion|Refused further treatment|0|||
146051261|NCT03493945|526703328|FG001|Phase II Dose Expansion|Refused further treatment|0|||
146051262|NCT03493945|526703329|FG002|Phase II Dose Expansion|Refused further treatment|0|||
146051263|NCT03493945|526703330|FG003|Phase II Dose Expansion|Refused further treatment|0|||
146051264|NCT03493945|526703331|FG004|Phase II Dose Expansion|Refused further treatment|1|||
146051265|NCT03493945|526703332|FG005|Phase II Dose Expansion|Refused further treatment|1|||
146051266|NCT03493945|526703333|FG006|Phase II Dose Expansion|Refused further treatment|0|||
146051267|NCT03493945|526703327|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051268|NCT03493945|526703328|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051269|NCT03493945|526703329|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051270|NCT03493945|526703330|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
146051271|NCT03493945|526703331|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051272|NCT03493945|526703332|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051273|NCT03493945|526703333|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
146051274|NCT01517750|526703334|FG000|Overall Study|Lost to Follow-up|1|||
146051275|NCT01517750|526703335|FG001|Overall Study|Lost to Follow-up|2|||
146051276|NCT01517750|526703336|FG002|Overall Study|Lost to Follow-up|4|||
146051277|NCT01517750|526703337|FG003|Overall Study|Lost to Follow-up|1|||
146051278|NCT01307319|526703338|FG000|Overall Study|Adverse Event|2|||
146051279|NCT01307319|526703339|FG001|Overall Study|Adverse Event|2|||
146051280|NCT01307319|526703340|FG002|Overall Study|Adverse Event|1|||
146051281|NCT01307319|526703338|FG000|Overall Study|Lost to Follow-up|1|||
146051282|NCT01307319|526703339|FG001|Overall Study|Lost to Follow-up|0|||
146051283|NCT01307319|526703340|FG002|Overall Study|Lost to Follow-up|1|||
146051284|NCT01307319|526703338|FG000|Overall Study|Protocol Violation|1|||
146051285|NCT01307319|526703339|FG001|Overall Study|Protocol Violation|1|||
146051286|NCT01307319|526703340|FG002|Overall Study|Protocol Violation|0|||
146051287|NCT01307319|526703338|FG000|Overall Study|Withdrawal by Subject|0|||
146051288|NCT01307319|526703339|FG001|Overall Study|Withdrawal by Subject|1|||
146051289|NCT01307319|526703340|FG002|Overall Study|Withdrawal by Subject|2|||
146051290|NCT01307319|526703338|FG000|Overall Study|Other|0|||
146051291|NCT01307319|526703339|FG001|Overall Study|Other|4|||
146051292|NCT01307319|526703340|FG002|Overall Study|Other|3|||
146051293|NCT02735239|526703341|FG000|Overall Study|Adverse Event|0|||
146051294|NCT02735239|526703342|FG001|Overall Study|Adverse Event|0|||
146051295|NCT02735239|526703343|FG002|Overall Study|Adverse Event|4|||
146051296|NCT02735239|526703344|FG003|Overall Study|Adverse Event|0|||
146051297|NCT02735239|526703345|FG004|Overall Study|Adverse Event|0|||
146051298|NCT02735239|526703346|FG005|Overall Study|Adverse Event|0|||
146051299|NCT02735239|526703341|FG000|Overall Study|Death|1|||
146051300|NCT02735239|526703342|FG001|Overall Study|Death|1|||
146051301|NCT02735239|526703343|FG002|Overall Study|Death|0|||
146051302|NCT02735239|526703344|FG003|Overall Study|Death|0|||
146051303|NCT02735239|526703345|FG004|Overall Study|Death|0|||
146051304|NCT02735239|526703346|FG005|Overall Study|Death|0|||
146051305|NCT02735239|526703341|FG000|Overall Study|Physician Decision|0|||
146051306|NCT02735239|526703342|FG001|Overall Study|Physician Decision|0|||
146051307|NCT02735239|526703343|FG002|Overall Study|Physician Decision|1|||
146051308|NCT02735239|526703344|FG003|Overall Study|Physician Decision|0|||
146051309|NCT02735239|526703345|FG004|Overall Study|Physician Decision|0|||
146051310|NCT02735239|526703346|FG005|Overall Study|Physician Decision|0|||
146051311|NCT02735239|526703341|FG000|Overall Study|Progressive disease|3|||
146051312|NCT02735239|526703342|FG001|Overall Study|Progressive disease|1|||
146051313|NCT02735239|526703343|FG002|Overall Study|Progressive disease|3|||
146051314|NCT02735239|526703344|FG003|Overall Study|Progressive disease|0|||
146051315|NCT02735239|526703345|FG004|Overall Study|Progressive disease|0|||
146051316|NCT02735239|526703346|FG005|Overall Study|Progressive disease|2|||
146051317|NCT02735239|526703341|FG000|Overall Study|Withdrawal by Subject|0|||
146051318|NCT02735239|526703342|FG001|Overall Study|Withdrawal by Subject|1|||
146051319|NCT02735239|526703343|FG002|Overall Study|Withdrawal by Subject|0|||
146051320|NCT02735239|526703344|FG003|Overall Study|Withdrawal by Subject|0|||
146051321|NCT02735239|526703345|FG004|Overall Study|Withdrawal by Subject|0|||
146051322|NCT02735239|526703346|FG005|Overall Study|Withdrawal by Subject|0|||
146051323|NCT02152631|526703348|FG000|Overall Study|Adverse Event|32|||
146051324|NCT02152631|526703349|FG001|Overall Study|Adverse Event|4|||
146051325|NCT02152631|526703348|FG000|Overall Study|Withdrawal by Subject|13|||
146051326|NCT02152631|526703349|FG001|Overall Study|Withdrawal by Subject|16|||
146051327|NCT02152631|526703348|FG000|Overall Study|Noncompliance with study drug|1|||
146051328|NCT02152631|526703349|FG001|Overall Study|Noncompliance with study drug|0|||
146051329|NCT02152631|526703348|FG000|Overall Study|Physician Decision|1|||
146051330|NCT02152631|526703349|FG001|Overall Study|Physician Decision|2|||
146051331|NCT02152631|526703348|FG000|Overall Study|Lost to Follow-up|0|||
146051332|NCT02152631|526703349|FG001|Overall Study|Lost to Follow-up|1|||
146051333|NCT02152631|526703348|FG000|Overall Study|On Treatment|19|||
146051334|NCT02152631|526703349|FG001|Overall Study|On Treatment|3|||
146051335|NCT00527735|526703350|FG000|Overall Study|Disease progression|47|||
146051336|NCT00527735|526703351|FG001|Overall Study|Disease progression|61|||
146051337|NCT00527735|526703352|FG002|Overall Study|Disease progression|53|||
146051338|NCT00527735|526703350|FG000|Overall Study|Death|23|||
146051339|NCT00527735|526703351|FG001|Overall Study|Death|13|||
146051340|NCT00527735|526703352|FG002|Overall Study|Death|15|||
146051341|NCT00527735|526703350|FG000|Overall Study|Completed treatment in treatment phase|14|||
146051342|NCT00527735|526703351|FG001|Overall Study|Completed treatment in treatment phase|13|||
146051343|NCT00527735|526703352|FG002|Overall Study|Completed treatment in treatment phase|18|||
146051344|NCT00527735|526703350|FG000|Overall Study|Adverse Event|10|||
146051345|NCT00527735|526703351|FG001|Overall Study|Adverse Event|6|||
146051346|NCT00527735|526703352|FG002|Overall Study|Adverse Event|7|||
146051347|NCT00527735|526703350|FG000|Overall Study|Not identified|5|||
146051348|NCT00527735|526703351|FG001|Overall Study|Not identified|5|||
146051349|NCT00527735|526703352|FG002|Overall Study|Not identified|5|||
146051350|NCT00527735|526703350|FG000|Overall Study|Withdrawal by Subject|5|||
146051351|NCT00527735|526703351|FG001|Overall Study|Withdrawal by Subject|4|||
146051352|NCT00527735|526703352|FG002|Overall Study|Withdrawal by Subject|3|||
146051353|NCT00527735|526703350|FG000|Overall Study|No longer met study criteria|2|||
146051354|NCT00527735|526703351|FG001|Overall Study|No longer met study criteria|2|||
146051355|NCT00527735|526703352|FG002|Overall Study|No longer met study criteria|1|||
146051356|NCT00527735|526703350|FG000|Overall Study|Lost to Follow-up|0|||
146051357|NCT00527735|526703351|FG001|Overall Study|Lost to Follow-up|0|||
146051358|NCT00527735|526703352|FG002|Overall Study|Lost to Follow-up|3|||
146051359|NCT00527735|526703350|FG000|Overall Study|Poor compliance or noncompliance|0|||
146051360|NCT00527735|526703351|FG001|Overall Study|Poor compliance or noncompliance|1|||
146051361|NCT00527735|526703352|FG002|Overall Study|Poor compliance or noncompliance|1|||
146051362|NCT00527735|526703350|FG000|Overall Study|Completed treatment during maintenance|2|||
146051363|NCT00527735|526703351|FG001|Overall Study|Completed treatment during maintenance|2|||
146051364|NCT00527735|526703352|FG002|Overall Study|Completed treatment during maintenance|1|||
146051365|NCT01855412|526703353|FG000|Overall Study|Death|77|||
146051366|NCT01855412|526703354|FG001|Overall Study|Death|123|||
146051367|NCT01855412|526703355|FG002|Overall Study|Death|30|||
146051368|NCT01855412|526703353|FG000|Overall Study|Lost to Follow-up|28|||
146051369|NCT01855412|526703354|FG001|Overall Study|Lost to Follow-up|46|||
146051370|NCT01855412|526703355|FG002|Overall Study|Lost to Follow-up|15|||
146051371|NCT01855412|526703353|FG000|Overall Study|Withdrawal by Subject|77|||
146051372|NCT01855412|526703354|FG001|Overall Study|Withdrawal by Subject|123|||
146051373|NCT01855412|526703355|FG002|Overall Study|Withdrawal by Subject|24|||
146051374|NCT01855412|526703353|FG000|Overall Study|Physician Decision|25|||
146051375|NCT01855412|526703354|FG001|Overall Study|Physician Decision|31|||
146051376|NCT01855412|526703355|FG002|Overall Study|Physician Decision|3|||
146051377|NCT01855412|526703353|FG000|Overall Study|Site Closure|4|||
146051378|NCT01855412|526703354|FG001|Overall Study|Site Closure|18|||
146051379|NCT01855412|526703355|FG002|Overall Study|Site Closure|1|||
146051380|NCT01855412|526703353|FG000|Overall Study|Reason not Specified|1|||
146051381|NCT01855412|526703354|FG001|Overall Study|Reason not Specified|2|||
146051382|NCT01855412|526703355|FG002|Overall Study|Reason not Specified|3|||
146051383|NCT00346216|526703357|FG000|Overall Study|Other|181|||
146051384|NCT00346216|526703358|FG001|Overall Study|Other|231|||
146051385|NCT00346216|526703359|FG002|Overall Study|Other|205|||
146051386|NCT00346216|526703357|FG000|Overall Study|No longer willing to participate|600|||
146051387|NCT00346216|526703358|FG001|Overall Study|No longer willing to participate|606|||
146051388|NCT00346216|526703359|FG002|Overall Study|No longer willing to participate|585|||
146051389|NCT00346216|526703357|FG000|Overall Study|Withdrawal by Subject|661|||
146051390|NCT00346216|526703358|FG001|Overall Study|Withdrawal by Subject|692|||
146051391|NCT00346216|526703359|FG002|Overall Study|Withdrawal by Subject|651|||
146051392|NCT00346216|526703357|FG000|Overall Study|Lost to Follow-up|611|||
146051393|NCT00346216|526703358|FG001|Overall Study|Lost to Follow-up|588|||
146051394|NCT00346216|526703359|FG002|Overall Study|Lost to Follow-up|542|||
146051395|NCT00346216|526703357|FG000|Overall Study|Physician Decision|80|||
146051396|NCT00346216|526703358|FG001|Overall Study|Physician Decision|76|||
146051397|NCT00346216|526703359|FG002|Overall Study|Physician Decision|59|||
146051398|NCT00346216|526703357|FG000|Overall Study|Does not meet entrance criteria|13|||
146051399|NCT00346216|526703358|FG001|Overall Study|Does not meet entrance criteria|10|||
146051400|NCT00346216|526703359|FG002|Overall Study|Does not meet entrance criteria|8|||
146051401|NCT00346216|526703357|FG000|Overall Study|Death|189|||
146106689|NCT03187197|526912257|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
146051402|NCT00346216|526703358|FG001|Overall Study|Death|192|||
146051403|NCT00346216|526703359|FG002|Overall Study|Death|228|||
146051404|NCT00346216|526703357|FG000|Overall Study|Study terminated by sponsor|11|||
146051405|NCT00346216|526703358|FG001|Overall Study|Study terminated by sponsor|4|||
146051406|NCT00346216|526703359|FG002|Overall Study|Study terminated by sponsor|8|||
146051407|NCT00346216|526703357|FG000|Overall Study|Missing Subject Summary Status|62|||
146051408|NCT00346216|526703358|FG001|Overall Study|Missing Subject Summary Status|61|||
146106690|NCT03187197|526912258|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
146106691|NCT03187197|526912256|FG000|Overall Study|Withdrawal by Subject|8|||
146106692|NCT03187197|526912257|FG001|Overall Study|Withdrawal by Subject|63|||
146106693|NCT03187197|526912258|FG002|Overall Study|Withdrawal by Subject|4|||
146106694|NCT03187197|526912256|FG000|Overall Study|Lost to Follow-up|1|||
146106695|NCT03187197|526912257|FG001|Overall Study|Lost to Follow-up|60|||
146106696|NCT03187197|526912258|FG002|Overall Study|Lost to Follow-up|7|||
146106697|NCT03187197|526912256|FG000|Overall Study|Adverse Event|6|||
146106698|NCT03187197|526912257|FG001|Overall Study|Adverse Event|29|||
146106699|NCT03187197|526912258|FG002|Overall Study|Adverse Event|0|||
146106700|NCT03187197|526912256|FG000|Overall Study|Death|0|||
146106701|NCT03187197|526912257|FG001|Overall Study|Death|11|||
146106702|NCT03187197|526912258|FG002|Overall Study|Death|0|||
146106703|NCT03187197|526912256|FG000|Overall Study|Administrative problem|1|||
146106704|NCT03187197|526912257|FG001|Overall Study|Administrative problem|1|||
146106705|NCT03187197|526912258|FG002|Overall Study|Administrative problem|0|||
146106706|NCT03187197|526912256|FG000|Overall Study|Reason not listed|2|||
146106707|NCT03187197|526912257|FG001|Overall Study|Reason not listed|54|||
146106708|NCT03187197|526912258|FG002|Overall Study|Reason not listed|1|||
146106709|NCT03187197|526912256|FG000|Overall Study|Missing|1|||
146106710|NCT03187197|526912257|FG001|Overall Study|Missing|32|||
146106711|NCT03187197|526912258|FG002|Overall Study|Missing|3|||
146106712|NCT03187197|526912256|FG000|Overall Study|Status missing|2|||
146106713|NCT03187197|526912257|FG001|Overall Study|Status missing|33|||
146106714|NCT03187197|526912258|FG002|Overall Study|Status missing|3|||
146106715|NCT03187197|526912256|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
146106716|NCT03187197|526912257|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
146106717|NCT03187197|526912258|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
146106718|NCT02385045|526912259|FG000|Overall Study|Endoscopy could not be completed|4|||
146106719|NCT02200211|526912262|FG000|Overall Study|Lost to Follow-up|7|||
146106720|NCT02200211|526912263|FG001|Overall Study|Lost to Follow-up|7|||
146106721|NCT02200211|526912264|FG002|Overall Study|Lost to Follow-up|1|||
146106722|NCT02200211|526912265|FG003|Overall Study|Lost to Follow-up|2|||
146106723|NCT02200211|526912262|FG000|Overall Study|Withdrawal by Subject|1|||
146106724|NCT02200211|526912263|FG001|Overall Study|Withdrawal by Subject|0|||
146106725|NCT02200211|526912264|FG002|Overall Study|Withdrawal by Subject|0|||
146106726|NCT02200211|526912265|FG003|Overall Study|Withdrawal by Subject|0|||
146106727|NCT00381485|526912266|FG000|Open-Label Run-In Period|Adverse Event|9|||
146106728|NCT00381485|526912267|FG001|Open-Label Run-In Period|Adverse Event|0|||
146106729|NCT00381485|526912268|FG002|Open-Label Run-In Period|Adverse Event|0|||
146106730|NCT00381485|526912269|FG003|Open-Label Run-In Period|Adverse Event|0|||
146106731|NCT00381485|526912266|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
146106732|NCT00381485|526912267|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146106733|NCT00381485|526912268|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146106734|NCT00381485|526912269|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
146106735|NCT00381485|526912266|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
146106736|NCT00381485|526912267|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146106737|NCT00381485|526912268|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146106738|NCT00381485|526912269|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
146106739|NCT00381485|526912266|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
146106740|NCT00381485|526912267|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146106741|NCT00381485|526912268|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146106742|NCT00381485|526912269|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
146106743|NCT00381485|526912266|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
146106744|NCT00381485|526912267|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
146106745|NCT00381485|526912268|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
146106746|NCT00381485|526912269|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
146106747|NCT00381485|526912266|FG000|Open-Label Run-In Period|Treatment failure|1|||
146257915|NCT02396953|527459198|FG000|Overall Study|Personal Reasons|1|||
146257916|NCT02396953|527459199|FG001|Overall Study|Personal Reasons|1|||
146257917|NCT02396953|527459200|FG002|Overall Study|Personal Reasons|0|||
146257918|NCT00510198|527459201|FG000|Overall Study|Withdrawal by Subject|5|||
146257919|NCT00510198|527459202|FG001|Overall Study|Withdrawal by Subject|4|||
146257920|NCT02994784|527459203|FG000|6 Months Follow-up|Lost to Follow-up|3|||
146257921|NCT00494026|527459204|FG000|Overall Study|Sponsor Decision|4|||
146257922|NCT02466243|527459205|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
146106748|NCT00381485|526912267|FG001|Open-Label Run-In Period|Treatment failure|0|||
146257923|NCT02466243|527459206|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
146106749|NCT00381485|526912268|FG002|Open-Label Run-In Period|Treatment failure|0|||
146106750|NCT00381485|526912269|FG003|Open-Label Run-In Period|Treatment failure|0|||
146106751|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146106752|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146257924|NCT02466243|527459205|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
146106753|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Adverse Event|2|||
146106754|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Adverse Event|5|||
146106755|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146106756|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
146106757|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
146106758|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
146106759|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146106760|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
146106761|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
146106762|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
146106763|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
146106764|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
146106765|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
146106766|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
146106767|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
146106768|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146106769|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
146106770|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146106771|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
146106772|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
146106773|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
146106774|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
146106775|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146106776|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146106777|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
146106778|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
146106779|NCT00381485|526912266|FG000|Double-Blind Treatment Period|Administrative|0|||
146106780|NCT00381485|526912267|FG001|Double-Blind Treatment Period|Administrative|1|||
146106781|NCT00381485|526912268|FG002|Double-Blind Treatment Period|Administrative|0|||
146106782|NCT00381485|526912269|FG003|Double-Blind Treatment Period|Administrative|1|||
146106783|NCT01235351|526912270|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
146257925|NCT02466243|527459206|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
146257926|NCT02466243|527459205|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
146106784|NCT01235351|526912271|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
146106785|NCT01918774|526912272|FG000|Overall Study|Lost prior to first CBTw session|4|||
146106786|NCT01918774|526912272|FG000|Overall Study|Lost to Follow-up|1|||
146106787|NCT01606800|526912273|FG000|Overall Study|Adverse Event|3|||
146106788|NCT01606800|526912274|FG001|Overall Study|Adverse Event|1|||
146106789|NCT01606800|526912273|FG000|Overall Study|Participant withdrew consent|0|||
146106790|NCT01606800|526912274|FG001|Overall Study|Participant withdrew consent|1|||
146106791|NCT01606800|526912273|FG000|Overall Study|Missing completion status|2|||
146106792|NCT01606800|526912274|FG001|Overall Study|Missing completion status|0|||
146051409|NCT00346216|526703359|FG002|Overall Study|Missing Subject Summary Status|62|||
146051410|NCT01132807|526703360|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
146051411|NCT01132807|526703361|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
146051412|NCT01132807|526703362|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
146051413|NCT01132807|526703360|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
146051414|NCT01132807|526703361|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
146051415|NCT01132807|526703362|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
146051416|NCT02222558|526703363|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
146051417|NCT02222558|526703364|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
146051418|NCT02222558|526703365|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
146051419|NCT02222558|526703366|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
146051420|NCT02222558|526703367|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
146051421|NCT02222558|526703368|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
146051422|NCT02222558|526703363|FG000|Period 3|Withdrawal by Subject|0|||
146051423|NCT02222558|526703364|FG001|Period 3|Withdrawal by Subject|0|||
146051424|NCT02222558|526703365|FG002|Period 3|Withdrawal by Subject|0|||
146051425|NCT02222558|526703366|FG003|Period 3|Withdrawal by Subject|0|||
146051426|NCT02222558|526703367|FG004|Period 3|Withdrawal by Subject|0|||
146051427|NCT02222558|526703368|FG005|Period 3|Withdrawal by Subject|1|||
146051428|NCT02322281|526703371|FG000|Overall Study|Progressive Disease|42|||
146051429|NCT02322281|526703372|FG001|Overall Study|Progressive Disease|14|||
146051430|NCT02322281|526703373|FG002|Overall Study|Progressive Disease|49|||
146051431|NCT02322281|526703371|FG000|Overall Study|Adverse Event|3|||
146051432|NCT02322281|526703372|FG001|Overall Study|Adverse Event|4|||
146051433|NCT02322281|526703373|FG002|Overall Study|Adverse Event|6|||
146051434|NCT02322281|526703371|FG000|Overall Study|Death|3|||
146051435|NCT02322281|526703372|FG001|Overall Study|Death|3|||
146051436|NCT02322281|526703373|FG002|Overall Study|Death|3|||
146051437|NCT02322281|526703371|FG000|Overall Study|Withdrawal by Subject|1|||
146051438|NCT02322281|526703372|FG001|Overall Study|Withdrawal by Subject|1|||
146051439|NCT02322281|526703373|FG002|Overall Study|Withdrawal by Subject|6|||
146051440|NCT02322281|526703371|FG000|Overall Study|Physician Decision|2|||
146051441|NCT02322281|526703372|FG001|Overall Study|Physician Decision|0|||
146051442|NCT02322281|526703373|FG002|Overall Study|Physician Decision|5|||
146051443|NCT02322281|526703371|FG000|Overall Study|Study Terminated by Sponsor|2|||
146051444|NCT02322281|526703372|FG001|Overall Study|Study Terminated by Sponsor|0|||
146051445|NCT02322281|526703373|FG002|Overall Study|Study Terminated by Sponsor|0|||
146051446|NCT02322281|526703371|FG000|Overall Study|Missing|0|||
146051447|NCT02322281|526703372|FG001|Overall Study|Missing|0|||
146051448|NCT02322281|526703373|FG002|Overall Study|Missing|1|||
146051449|NCT02322281|526703371|FG000|Overall Study|Miscellaneous|0|||
146051450|NCT02322281|526703372|FG001|Overall Study|Miscellaneous|0|||
146051451|NCT02322281|526703373|FG002|Overall Study|Miscellaneous|4|||
146051452|NCT01285401|526703374|FG000|Overall Study|Prematurely withdrawn from the study|17|||
146051453|NCT01285401|526703375|FG001|Overall Study|Prematurely withdrawn from the study|29|||
146051454|NCT00936702|526703379|FG000|Overall Study|Disease progression|34|||
146051455|NCT00936702|526703379|FG000|Overall Study|Adverse Event|8|||
146051456|NCT00936702|526703379|FG000|Overall Study|Withdrawal by Subject|2|||
146051457|NCT00936702|526703379|FG000|Overall Study|Alternative Treatment|1|||
146051458|NCT00936702|526703379|FG000|Overall Study|Other|1|||
146051459|NCT02420093|526703382|FG000|Overall Study|Withdrawal by Subject|1|||
146051460|NCT02420093|526703383|FG001|Overall Study|Withdrawal by Subject|1|||
146051461|NCT03244917|526703386|FG000|Overall Study|Lost to Follow-up|2|||
146051462|NCT03244917|526703387|FG001|Overall Study|Lost to Follow-up|2|||
146051463|NCT03001557|526703389|FG000|Core Phase|Randomized but not treated|0|||
146051464|NCT03001557|526703390|FG001|Core Phase|Randomized but not treated|0|||
146051465|NCT03001557|526703391|FG002|Core Phase|Randomized but not treated|1|||
146051466|NCT03001557|526703392|FG003|Core Phase|Randomized but not treated|0|||
146051467|NCT03001557|526703393|FG004|Core Phase|Randomized but not treated|0|||
146051468|NCT03001557|526703394|FG005|Core Phase|Randomized but not treated|0|||
146051469|NCT03001557|526703395|FG006|Core Phase|Randomized but not treated|0|||
146051470|NCT03001557|526703396|FG007|Core Phase|Randomized but not treated|0|||
146051471|NCT03001557|526703389|FG000|Extension Phase|Adverse Event|0|||
146051472|NCT03001557|526703390|FG001|Extension Phase|Adverse Event|0|||
146051473|NCT03001557|526703391|FG002|Extension Phase|Adverse Event|0|||
146051474|NCT03001557|526703392|FG003|Extension Phase|Adverse Event|0|||
146051475|NCT03001557|526703393|FG004|Extension Phase|Adverse Event|0|||
146051476|NCT03001557|526703394|FG005|Extension Phase|Adverse Event|2|||
146051477|NCT03001557|526703395|FG006|Extension Phase|Adverse Event|0|||
146051478|NCT03001557|526703396|FG007|Extension Phase|Adverse Event|0|||
146051479|NCT03001557|526703389|FG000|Extension Phase|Withdrawal by Subject|0|||
146051480|NCT03001557|526703390|FG001|Extension Phase|Withdrawal by Subject|0|||
146051481|NCT03001557|526703391|FG002|Extension Phase|Withdrawal by Subject|0|||
146051482|NCT03001557|526703392|FG003|Extension Phase|Withdrawal by Subject|0|||
146051483|NCT03001557|526703393|FG004|Extension Phase|Withdrawal by Subject|0|||
146051484|NCT03001557|526703394|FG005|Extension Phase|Withdrawal by Subject|1|||
146051485|NCT03001557|526703395|FG006|Extension Phase|Withdrawal by Subject|5|||
146051486|NCT03001557|526703396|FG007|Extension Phase|Withdrawal by Subject|2|||
146051487|NCT03001557|526703389|FG000|Extension Phase|Lost to Follow-up|0|||
146051488|NCT03001557|526703390|FG001|Extension Phase|Lost to Follow-up|0|||
146051489|NCT03001557|526703391|FG002|Extension Phase|Lost to Follow-up|0|||
146051490|NCT03001557|526703392|FG003|Extension Phase|Lost to Follow-up|0|||
146051491|NCT03001557|526703393|FG004|Extension Phase|Lost to Follow-up|0|||
146051492|NCT03001557|526703394|FG005|Extension Phase|Lost to Follow-up|0|||
146051493|NCT03001557|526703395|FG006|Extension Phase|Lost to Follow-up|2|||
146051494|NCT03001557|526703396|FG007|Extension Phase|Lost to Follow-up|1|||
146051495|NCT03001557|526703389|FG000|Extension Phase|Administrative Reason|0|||
146051496|NCT03001557|526703390|FG001|Extension Phase|Administrative Reason|0|||
146051497|NCT03001557|526703391|FG002|Extension Phase|Administrative Reason|0|||
146051498|NCT03001557|526703392|FG003|Extension Phase|Administrative Reason|0|||
146051499|NCT03001557|526703393|FG004|Extension Phase|Administrative Reason|0|||
146051500|NCT03001557|526703394|FG005|Extension Phase|Administrative Reason|1|||
146051501|NCT03001557|526703395|FG006|Extension Phase|Administrative Reason|3|||
146051502|NCT03001557|526703396|FG007|Extension Phase|Administrative Reason|3|||
146051503|NCT03001557|526703389|FG000|Extension Phase|Loss of caregiver|0|||
146051504|NCT03001557|526703390|FG001|Extension Phase|Loss of caregiver|0|||
146051505|NCT03001557|526703391|FG002|Extension Phase|Loss of caregiver|0|||
146051506|NCT03001557|526703392|FG003|Extension Phase|Loss of caregiver|0|||
146051507|NCT03001557|526703393|FG004|Extension Phase|Loss of caregiver|0|||
146051508|NCT03001557|526703394|FG005|Extension Phase|Loss of caregiver|0|||
146051509|NCT03001557|526703395|FG006|Extension Phase|Loss of caregiver|1|||
146051510|NCT03001557|526703396|FG007|Extension Phase|Loss of caregiver|0|||
146051511|NCT03001557|526703389|FG000|Extension Phase|Others|0|||
146051512|NCT03001557|526703390|FG001|Extension Phase|Others|0|||
146051513|NCT03001557|526703391|FG002|Extension Phase|Others|0|||
146051514|NCT03001557|526703392|FG003|Extension Phase|Others|0|||
146051515|NCT03001557|526703393|FG004|Extension Phase|Others|0|||
146051516|NCT03001557|526703394|FG005|Extension Phase|Others|1|||
146051517|NCT03001557|526703395|FG006|Extension Phase|Others|3|||
146051518|NCT03001557|526703396|FG007|Extension Phase|Others|0|||
146051519|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
146051520|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
146051521|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Death|1|||
146051522|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Death|2|||
146051523|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
146051524|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
146051525|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
146051526|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
146051527|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
146051528|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
146051529|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
146051530|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
146051531|NCT01794000|526703397|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
146051532|NCT01794000|526703398|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
146051533|NCT01794000|526703397|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
146051534|NCT01794000|526703398|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
146051535|NCT01272232|526703401|FG000|Weeks 0-56|Adverse Event|39|||
146051536|NCT01272232|526703402|FG001|Weeks 0-56|Adverse Event|18|||
146051537|NCT01272232|526703403|FG002|Weeks 0-56|Adverse Event|7|||
146051538|NCT01272232|526703401|FG000|Weeks 0-56|Lack of Efficacy|0|||
146051539|NCT01272232|526703402|FG001|Weeks 0-56|Lack of Efficacy|0|||
146051540|NCT01272232|526703403|FG002|Weeks 0-56|Lack of Efficacy|3|||
146051541|NCT01272232|526703401|FG000|Weeks 0-56|Protocol Violation|12|||
146051542|NCT01272232|526703402|FG001|Weeks 0-56|Protocol Violation|8|||
146051543|NCT01272232|526703403|FG002|Weeks 0-56|Protocol Violation|13|||
146051544|NCT01272232|526703401|FG000|Weeks 0-56|Withdrawal criteria|32|||
146051545|NCT01272232|526703402|FG001|Weeks 0-56|Withdrawal criteria|14|||
146051546|NCT01272232|526703403|FG002|Weeks 0-56|Withdrawal criteria|37|||
146051547|NCT01272232|526703401|FG000|Weeks 0-56|Unclassified|16|||
146051548|NCT01272232|526703402|FG001|Weeks 0-56|Unclassified|7|||
146051549|NCT01272232|526703403|FG002|Weeks 0-56|Unclassified|12|||
146051550|NCT01272232|526703401|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
146051551|NCT01272232|526703402|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
146051552|NCT01272232|526703403|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
146051553|NCT01272232|526703401|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
146051554|NCT01272232|526703402|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
146051555|NCT01272232|526703403|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
146051556|NCT01272232|526703401|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
146051557|NCT01272232|526703402|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
146051558|NCT01272232|526703403|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
146051559|NCT01272232|526703401|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
146051560|NCT01272232|526703402|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
146257927|NCT02466243|527459206|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
146257928|NCT02466243|527459205|FG000|Part B Open-label Treatment Period|Missing|2|||
146257929|NCT02466243|527459206|FG001|Part B Open-label Treatment Period|Missing|2|||
146257930|NCT00488319|527459210|FG000|Overall Study|Adverse Event|1|||
146257931|NCT00488319|527459211|FG001|Overall Study|Adverse Event|2|||
146257932|NCT00488319|527459212|FG002|Overall Study|Adverse Event|23|||
146257933|NCT00488319|527459210|FG000|Overall Study|Lack of Efficacy|6|||
146257934|NCT00488319|527459211|FG001|Overall Study|Lack of Efficacy|12|||
146051561|NCT01272232|526703403|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
146051562|NCT01272232|526703401|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
146051563|NCT01272232|526703402|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
146051564|NCT01272232|526703403|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
146051565|NCT02159066|526703404|FG000|Part I|Adverse Event|7|||
146051566|NCT02159066|526703405|FG001|Part I|Adverse Event|5|||
146051567|NCT02159066|526703406|FG002|Part I|Adverse Event|0|||
146051568|NCT02159066|526703407|FG003|Part I|Adverse Event|0|||
146051569|NCT02159066|526703408|FG004|Part I|Adverse Event|0|||
146051570|NCT02159066|526703409|FG005|Part I|Adverse Event|0|||
146051571|NCT02159066|526703404|FG000|Part I|Death|11|||
146051572|NCT02159066|526703405|FG001|Part I|Death|9|||
146051573|NCT02159066|526703406|FG002|Part I|Death|0|||
146051574|NCT02159066|526703407|FG003|Part I|Death|0|||
146051575|NCT02159066|526703408|FG004|Part I|Death|0|||
146051576|NCT02159066|526703409|FG005|Part I|Death|0|||
146051577|NCT02159066|526703404|FG000|Part I|Progressive Disease|37|||
146051578|NCT02159066|526703405|FG001|Part I|Progressive Disease|46|||
146051579|NCT02159066|526703406|FG002|Part I|Progressive Disease|0|||
146051580|NCT02159066|526703407|FG003|Part I|Progressive Disease|0|||
146051581|NCT02159066|526703408|FG004|Part I|Progressive Disease|0|||
146051582|NCT02159066|526703409|FG005|Part I|Progressive Disease|0|||
146051583|NCT02159066|526703404|FG000|Part I|New Therapy for Study Indication|5|||
146051584|NCT02159066|526703405|FG001|Part I|New Therapy for Study Indication|4|||
146051585|NCT02159066|526703406|FG002|Part I|New Therapy for Study Indication|0|||
146051586|NCT02159066|526703407|FG003|Part I|New Therapy for Study Indication|0|||
146051587|NCT02159066|526703408|FG004|Part I|New Therapy for Study Indication|0|||
146051588|NCT02159066|526703409|FG005|Part I|New Therapy for Study Indication|0|||
146051589|NCT02159066|526703404|FG000|Part I|Termination of participants from the study|3|||
146051590|NCT02159066|526703405|FG001|Part I|Termination of participants from the study|3|||
146051591|NCT02159066|526703406|FG002|Part I|Termination of participants from the study|0|||
146051592|NCT02159066|526703407|FG003|Part I|Termination of participants from the study|0|||
146051593|NCT02159066|526703408|FG004|Part I|Termination of participants from the study|0|||
146051594|NCT02159066|526703409|FG005|Part I|Termination of participants from the study|0|||
146051595|NCT02159066|526703404|FG000|Part I|Physician Decision|2|||
146051596|NCT02159066|526703405|FG001|Part I|Physician Decision|9|||
146051597|NCT02159066|526703406|FG002|Part I|Physician Decision|0|||
146051598|NCT02159066|526703407|FG003|Part I|Physician Decision|0|||
146051599|NCT02159066|526703408|FG004|Part I|Physician Decision|0|||
146051600|NCT02159066|526703409|FG005|Part I|Physician Decision|0|||
146051601|NCT02159066|526703404|FG000|Part I|Participant/Guardian Decision|9|||
146051602|NCT02159066|526703405|FG001|Part I|Participant/Guardian Decision|3|||
146051603|NCT02159066|526703406|FG002|Part I|Participant/Guardian Decision|0|||
146051604|NCT02159066|526703407|FG003|Part I|Participant/Guardian Decision|0|||
146051605|NCT02159066|526703408|FG004|Part I|Participant/Guardian Decision|0|||
146051606|NCT02159066|526703409|FG005|Part I|Participant/Guardian Decision|0|||
146051607|NCT02159066|526703404|FG000|Part I|Missing Data|1|||
146051608|NCT02159066|526703405|FG001|Part I|Missing Data|0|||
146051609|NCT02159066|526703406|FG002|Part I|Missing Data|0|||
146051610|NCT02159066|526703407|FG003|Part I|Missing Data|0|||
146051611|NCT02159066|526703408|FG004|Part I|Missing Data|0|||
146051612|NCT02159066|526703409|FG005|Part I|Missing Data|0|||
146051613|NCT02159066|526703404|FG000|Part II|Adverse Event|0|||
146051614|NCT02159066|526703405|FG001|Part II|Adverse Event|0|||
146051615|NCT02159066|526703406|FG002|Part II|Adverse Event|1|||
146051616|NCT02159066|526703407|FG003|Part II|Adverse Event|0|||
146257935|NCT00488319|527459212|FG002|Overall Study|Lack of Efficacy|27|||
146257936|NCT00488319|527459210|FG000|Overall Study|Lost to Follow-up|3|||
146301156|NCT02460497|527618847|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
146051617|NCT02159066|526703408|FG004|Part II|Adverse Event|1|||
146051618|NCT02159066|526703409|FG005|Part II|Adverse Event|1|||
146051619|NCT02159066|526703404|FG000|Part II|Death|0|||
146051620|NCT02159066|526703405|FG001|Part II|Death|0|||
146051621|NCT02159066|526703406|FG002|Part II|Death|1|||
146051622|NCT02159066|526703407|FG003|Part II|Death|0|||
146051623|NCT02159066|526703408|FG004|Part II|Death|2|||
146051624|NCT02159066|526703409|FG005|Part II|Death|1|||
146051625|NCT02159066|526703404|FG000|Part II|Progressive Disease|0|||
146051626|NCT02159066|526703405|FG001|Part II|Progressive Disease|0|||
146051627|NCT02159066|526703406|FG002|Part II|Progressive Disease|35|||
146051628|NCT02159066|526703407|FG003|Part II|Progressive Disease|1|||
146051629|NCT02159066|526703408|FG004|Part II|Progressive Disease|7|||
146051630|NCT02159066|526703409|FG005|Part II|Progressive Disease|4|||
146257937|NCT00488319|527459211|FG001|Overall Study|Lost to Follow-up|5|||
146257938|NCT00488319|527459212|FG002|Overall Study|Lost to Follow-up|16|||
146257939|NCT00488319|527459210|FG000|Overall Study|Withdrawal by Subject|5|||
146257940|NCT00488319|527459211|FG001|Overall Study|Withdrawal by Subject|20|||
146257941|NCT00488319|527459212|FG002|Overall Study|Withdrawal by Subject|44|||
146257942|NCT00488319|527459210|FG000|Overall Study|Other reasons for withdrawal|0|||
146257943|NCT00488319|527459211|FG001|Overall Study|Other reasons for withdrawal|4|||
146257944|NCT00488319|527459212|FG002|Overall Study|Other reasons for withdrawal|12|||
146257945|NCT01649557|527459213|FG000|Overall Study|Lost to Follow-up|5|||
146257946|NCT01649557|527459214|FG001|Overall Study|Lost to Follow-up|0|||
146257947|NCT01649557|527459215|FG002|Overall Study|Lost to Follow-up|3|||
146257948|NCT01649557|527459213|FG000|Overall Study|Adverse Event|7|||
146257949|NCT01649557|527459214|FG001|Overall Study|Adverse Event|5|||
146257950|NCT01649557|527459215|FG002|Overall Study|Adverse Event|1|||
146257951|NCT01649557|527459213|FG000|Overall Study|Met withdrawal criteria|4|||
146257952|NCT01649557|527459214|FG001|Overall Study|Met withdrawal criteria|0|||
146257953|NCT01649557|527459215|FG002|Overall Study|Met withdrawal criteria|0|||
146257954|NCT01649557|527459213|FG000|Overall Study|Physician Decision|8|||
146257955|NCT01649557|527459214|FG001|Overall Study|Physician Decision|2|||
146257956|NCT01649557|527459215|FG002|Overall Study|Physician Decision|1|||
146257957|NCT01649557|527459213|FG000|Overall Study|Withdrawal by Subject|15|||
146257958|NCT01649557|527459214|FG001|Overall Study|Withdrawal by Subject|5|||
146257959|NCT01649557|527459215|FG002|Overall Study|Withdrawal by Subject|4|||
146257960|NCT01649557|527459213|FG000|Overall Study|Protocol deviation|0|||
146257961|NCT01649557|527459214|FG001|Overall Study|Protocol deviation|2|||
146257962|NCT01649557|527459215|FG002|Overall Study|Protocol deviation|0|||
146257963|NCT01649557|527459213|FG000|Overall Study|Lack of Efficacy|5|||
146257964|NCT01649557|527459214|FG001|Overall Study|Lack of Efficacy|0|||
146257965|NCT01649557|527459215|FG002|Overall Study|Lack of Efficacy|0|||
146257966|NCT00809341|527459216|FG000|Overall Study|Physician Decision|0|||
146257967|NCT00809341|527459217|FG001|Overall Study|Physician Decision|1|||
146257968|NCT03891641|527459229|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
146257969|NCT03891641|527459230|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
146257970|NCT00745121|527459235|FG000|Overall Study|Death|3|||
146257971|NCT00745121|527459236|FG001|Overall Study|Death|0|||
146257972|NCT00745121|527459235|FG000|Overall Study|Adverse Event|1|||
146257973|NCT00745121|527459236|FG001|Overall Study|Adverse Event|0|||
146257974|NCT00745121|527459235|FG000|Overall Study|Lost to Follow-up|1|||
146257975|NCT00745121|527459236|FG001|Overall Study|Lost to Follow-up|0|||
146257976|NCT00745121|527459235|FG000|Overall Study|Withdrawal by Subject|4|||
146257977|NCT00745121|527459236|FG001|Overall Study|Withdrawal by Subject|2|||
146257978|NCT03723915|527459246|FG000|Screening|Failed to meet screening requirements.|2|||
146257979|NCT03723915|527459246|FG000|On Treatment|Failed to meet treatment requirements|2|||
146257980|NCT01281917|527459249|FG000|Overall Study|Withdrawal by Subject|1|||
146257981|NCT04016805|527459250|FG000|Overall Study|Sponsor's Discretion|30|||
146257982|NCT04016805|527459251|FG001|Overall Study|Sponsor's Discretion|6|||
146257983|NCT04016805|527459252|FG002|Overall Study|Sponsor's Discretion|5|||
146257984|NCT00740870|527459255|FG000|Overall Study|Not Catheterized|4|||
146257985|NCT00740870|527459255|FG000|Overall Study|Further testing contraindicated implant|17|||
146257986|NCT00607997|527459256|FG000|Overall Study|Lack of Efficacy|6|||
146257987|NCT00607997|527459257|FG001|Overall Study|Lack of Efficacy|20|||
146257988|NCT00607997|527459258|FG002|Overall Study|Lack of Efficacy|14|||
146257989|NCT00607997|527459259|FG003|Overall Study|Lack of Efficacy|10|||
146257990|NCT00607997|527459256|FG000|Overall Study|Death|8|||
146257991|NCT00607997|527459257|FG001|Overall Study|Death|5|||
146257992|NCT00607997|527459258|FG002|Overall Study|Death|2|||
146257993|NCT00607997|527459259|FG003|Overall Study|Death|5|||
146257994|NCT00607997|527459256|FG000|Overall Study|Adverse Event|3|||
146257995|NCT00607997|527459257|FG001|Overall Study|Adverse Event|1|||
146257996|NCT00607997|527459258|FG002|Overall Study|Adverse Event|2|||
146257997|NCT00607997|527459259|FG003|Overall Study|Adverse Event|0|||
146257998|NCT00607997|527459256|FG000|Overall Study|Physician Decision|4|||
146257999|NCT00607997|527459257|FG001|Overall Study|Physician Decision|1|||
146258000|NCT00607997|527459258|FG002|Overall Study|Physician Decision|0|||
146258001|NCT00607997|527459259|FG003|Overall Study|Physician Decision|0|||
146051631|NCT02159066|526703404|FG000|Part II|New Therapy for Study Indication|0|||
146258002|NCT00607997|527459256|FG000|Overall Study|Relapse, recurrent illness|4|||
146258003|NCT00607997|527459257|FG001|Overall Study|Relapse, recurrent illness|0|||
146258004|NCT00607997|527459258|FG002|Overall Study|Relapse, recurrent illness|2|||
146258005|NCT00607997|527459259|FG003|Overall Study|Relapse, recurrent illness|0|||
146258006|NCT00607997|527459256|FG000|Overall Study|Other without explanation|2|||
146258007|NCT00607997|527459257|FG001|Overall Study|Other without explanation|0|||
146258008|NCT00607997|527459258|FG002|Overall Study|Other without explanation|4|||
146258009|NCT00607997|527459259|FG003|Overall Study|Other without explanation|1|||
146258010|NCT04414397|527459263|FG000|Control Period|Withdrawal by Subject|2|||
146258011|NCT04414397|527459264|FG001|Control Period|Withdrawal by Subject|2|||
146258012|NCT04414397|527459263|FG000|Control Period|Lost to Follow-up|0|||
146258013|NCT04414397|527459264|FG001|Control Period|Lost to Follow-up|4|||
146258014|NCT04414397|527459263|FG000|Control Period|Protocol deviation|0|||
146258015|NCT04414397|527459264|FG001|Control Period|Protocol deviation|1|||
146258016|NCT04414397|527459263|FG000|Post-Control Period|Withdrawal by Subject|3|||
146258017|NCT04414397|527459264|FG001|Post-Control Period|Withdrawal by Subject|6|||
146258018|NCT04414397|527459263|FG000|Post-Control Period|Lost to Follow-up|4|||
146301157|NCT02460497|527618847|FG000|Overall Study|Lost to Follow-up|2|||
146301158|NCT02460497|527618847|FG000|Overall Study|Investigator Decision|1|||
146301159|NCT00659529|527618853|FG000|Overall Study|Withdrawal by Subject|4|||
146301160|NCT00659529|527618853|FG000|Overall Study|Protocol Violation|3|||
146301161|NCT00659529|527618853|FG000|Overall Study|Screen failure|9|||
146301162|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
146258019|NCT04414397|527459264|FG001|Post-Control Period|Lost to Follow-up|9|||
146258020|NCT04414397|527459263|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
146258021|NCT04414397|527459264|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
146258022|NCT04414397|527459263|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
146258023|NCT04414397|527459264|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
146258024|NCT03640754|527459265|FG000|Overall Study|Withdrawal by Subject|1|||
146258025|NCT03640754|527459266|FG001|Overall Study|Withdrawal by Subject|0|||
146258026|NCT03640754|527459265|FG000|Overall Study|Lost to Follow-up|0|||
146258027|NCT03640754|527459266|FG001|Overall Study|Lost to Follow-up|1|||
146258028|NCT01204775|527459271|FG000|Overall Study|Poor/non-compliance|0|||
146258029|NCT01204775|527459272|FG001|Overall Study|Poor/non-compliance|1|||
146258030|NCT01204775|527459271|FG000|Overall Study|Withdrawal by Subject|1|||
146258031|NCT01204775|527459272|FG001|Overall Study|Withdrawal by Subject|0|||
146258032|NCT00276016|527459273|FG000|Intervention 1|Withdrawal by Subject|0|||
146258033|NCT00276016|527459274|FG001|Intervention 1|Withdrawal by Subject|1|||
146258034|NCT00276016|527459275|FG002|Intervention 1|Withdrawal by Subject|0|||
146258035|NCT00276016|527459276|FG003|Intervention 1|Withdrawal by Subject|0|||
146258036|NCT00276016|527459277|FG004|Intervention 1|Withdrawal by Subject|0|||
146258037|NCT00276016|527459278|FG005|Intervention 1|Withdrawal by Subject|0|||
146258038|NCT01679613|527459279|FG000|Overall Study|other than stated above|0|||
146258039|NCT01679613|527459280|FG001|Overall Study|other than stated above|1|||
146258040|NCT01679613|527459281|FG002|Overall Study|other than stated above|2|||
146258041|NCT01679613|527459282|FG003|Overall Study|other than stated above|2|||
146258042|NCT01374971|527459283|FG000|Overall Study|Withdrawal by Subject|1|||
146258043|NCT00509925|527459285|FG000|Overall Study|Personal reasons|0|||
146258044|NCT00509925|527459286|FG001|Overall Study|Personal reasons|1|||
146258045|NCT00951171|527459287|FG000|Overall Study|Adverse Event|2|||
146301163|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146301164|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146258046|NCT00951171|527459288|FG001|Overall Study|Adverse Event|0|||
146258047|NCT00919061|527459289|FG000|Overall Study|Adverse Event|1|||
146258048|NCT00919061|527459289|FG000|Overall Study|Withdrawal by Subject|1|||
146258049|NCT00113269|527461325|FG000|Overall Study|Not transplanted, donor issues|4|||
146258050|NCT00113269|527461326|FG001|Overall Study|Not transplanted, donor issues|0|||
146258051|NCT00113269|527461327|FG002|Overall Study|Not transplanted, donor issues|2|||
146258052|NCT00113269|527461328|FG003|Overall Study|Not transplanted, donor issues|2|||
146258053|NCT00113269|527461325|FG000|Overall Study|Not transplanted, recipient issues|2|||
146258054|NCT00113269|527461326|FG001|Overall Study|Not transplanted, recipient issues|1|||
146258055|NCT00113269|527461327|FG002|Overall Study|Not transplanted, recipient issues|7|||
146258056|NCT00113269|527461328|FG003|Overall Study|Not transplanted, recipient issues|4|||
146258057|NCT00113269|527461325|FG000|Overall Study|Early graft loss, technical|0|||
146258058|NCT00113269|527461326|FG001|Overall Study|Early graft loss, technical|0|||
146258059|NCT00113269|527461327|FG002|Overall Study|Early graft loss, technical|2|||
146258060|NCT00113269|527461328|FG003|Overall Study|Early graft loss, technical|0|||
146258061|NCT00113269|527461325|FG000|Overall Study|Death in operating room|0|||
146258062|NCT00113269|527461326|FG001|Overall Study|Death in operating room|0|||
146258063|NCT00113269|527461327|FG002|Overall Study|Death in operating room|0|||
146258064|NCT00113269|527461328|FG003|Overall Study|Death in operating room|1|||
146258065|NCT00113269|527461325|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
146258066|NCT00113269|527461326|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
146258067|NCT00113269|527461327|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
146258068|NCT00113269|527461328|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
146258069|NCT00113269|527461325|FG000|Overall Study|Adverse Event|2|||
146258070|NCT00113269|527461326|FG001|Overall Study|Adverse Event|7|||
146258071|NCT00113269|527461327|FG002|Overall Study|Adverse Event|11|||
146258072|NCT00113269|527461328|FG003|Overall Study|Adverse Event|7|||
146258073|NCT00113269|527461325|FG000|Overall Study|Withdrawal by Subject|4|||
146258074|NCT00113269|527461326|FG001|Overall Study|Withdrawal by Subject|3|||
146258075|NCT00113269|527461327|FG002|Overall Study|Withdrawal by Subject|4|||
146258076|NCT00113269|527461328|FG003|Overall Study|Withdrawal by Subject|2|||
146301165|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146051632|NCT02159066|526703405|FG001|Part II|New Therapy for Study Indication|0|||
146051633|NCT02159066|526703406|FG002|Part II|New Therapy for Study Indication|0|||
146051634|NCT02159066|526703407|FG003|Part II|New Therapy for Study Indication|0|||
146258077|NCT00113269|527461325|FG000|Overall Study|Graft loss|6|||
146258078|NCT00113269|527461326|FG001|Overall Study|Graft loss|6|||
146258079|NCT00113269|527461327|FG002|Overall Study|Graft loss|4|||
146258080|NCT00113269|527461328|FG003|Overall Study|Graft loss|9|||
146258081|NCT00113269|527461325|FG000|Overall Study|Protocol Violation|1|||
146258082|NCT00113269|527461326|FG001|Overall Study|Protocol Violation|0|||
146258083|NCT00113269|527461327|FG002|Overall Study|Protocol Violation|4|||
146258084|NCT00113269|527461328|FG003|Overall Study|Protocol Violation|2|||
146258085|NCT00113269|527461325|FG000|Overall Study|Lost to Follow-up|2|||
146258086|NCT00113269|527461326|FG001|Overall Study|Lost to Follow-up|3|||
146258087|NCT00113269|527461327|FG002|Overall Study|Lost to Follow-up|6|||
146258088|NCT00113269|527461328|FG003|Overall Study|Lost to Follow-up|3|||
146258089|NCT00113269|527461325|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
146258090|NCT00113269|527461326|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
146258091|NCT00113269|527461327|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
146258092|NCT00113269|527461328|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
146258093|NCT00113269|527461325|FG000|Overall Study|Discontinued due to rejection|0|||
146258094|NCT00113269|527461326|FG001|Overall Study|Discontinued due to rejection|0|||
146258095|NCT00113269|527461327|FG002|Overall Study|Discontinued due to rejection|1|||
146258096|NCT00113269|527461328|FG003|Overall Study|Discontinued due to rejection|0|||
146258097|NCT00113269|527461325|FG000|Overall Study|Moved|0|||
146258098|NCT00113269|527461326|FG001|Overall Study|Moved|1|||
146258099|NCT00113269|527461327|FG002|Overall Study|Moved|0|||
146258100|NCT00113269|527461328|FG003|Overall Study|Moved|3|||
146258101|NCT00113269|527461325|FG000|Overall Study|Received pancreas transplant|0|||
146258102|NCT00113269|527461326|FG001|Overall Study|Received pancreas transplant|0|||
146258103|NCT00113269|527461327|FG002|Overall Study|Received pancreas transplant|0|||
146258104|NCT00113269|527461328|FG003|Overall Study|Received pancreas transplant|2|||
146258105|NCT00113269|527461325|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
146258106|NCT00113269|527461326|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
146258107|NCT00113269|527461327|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
146107122|NCT00717197|526912326|FG000|Overall Study|Unable to purchase study drug|5|||
146107123|NCT00717197|526912326|FG000|Overall Study|Tumor Progression|1|||
146107124|NCT00717197|526912326|FG000|Overall Study|Physician Decision|1|||
146107125|NCT00982137|526912327|FG000|Overall Study|Lost to Follow-up|0|||
146107126|NCT00982137|526912328|FG001|Overall Study|Lost to Follow-up|0|||
146107127|NCT00982137|526912329|FG002|Overall Study|Lost to Follow-up|0|||
146107128|NCT00982137|526912330|FG003|Overall Study|Lost to Follow-up|1|||
146107129|NCT00982137|526912327|FG000|Overall Study|Withdrawal by Subject|0|||
146107130|NCT00982137|526912328|FG001|Overall Study|Withdrawal by Subject|1|||
146107131|NCT00982137|526912329|FG002|Overall Study|Withdrawal by Subject|0|||
146107132|NCT00982137|526912330|FG003|Overall Study|Withdrawal by Subject|0|||
146107133|NCT01648101|526912333|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
146107134|NCT01648101|526912334|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
146107135|NCT01648101|526912335|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
146107136|NCT01648101|526912333|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
146107137|NCT01648101|526912334|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
146107138|NCT01648101|526912335|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
146107139|NCT01648101|526912333|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
146107140|NCT01648101|526912334|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
146107141|NCT01648101|526912335|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
146107142|NCT01648101|526912333|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
146107143|NCT01648101|526912334|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
146107144|NCT01648101|526912335|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
146107145|NCT01648101|526912333|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
146107146|NCT01648101|526912334|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
146107147|NCT01648101|526912335|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
146107148|NCT01648101|526912333|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
146107149|NCT01648101|526912334|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
146107150|NCT01648101|526912335|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
146258108|NCT00113269|527461328|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
146258109|NCT00113269|527461325|FG000|Overall Study|Did not meet eligibility criteria|1|||
146107151|NCT01648101|526912333|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
146107152|NCT01648101|526912334|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
146107153|NCT01648101|526912335|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
146107154|NCT01648101|526912333|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
146107155|NCT01648101|526912334|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
146107156|NCT01648101|526912335|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
146107157|NCT01648101|526912333|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
146107158|NCT01648101|526912334|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
146258110|NCT00113269|527461326|FG001|Overall Study|Did not meet eligibility criteria|0|||
146258111|NCT00113269|527461327|FG002|Overall Study|Did not meet eligibility criteria|0|||
146258112|NCT00113269|527461328|FG003|Overall Study|Did not meet eligibility criteria|1|||
146258113|NCT00113269|527461325|FG000|Overall Study|Unable to return for follow up|2|||
146258114|NCT00113269|527461326|FG001|Overall Study|Unable to return for follow up|1|||
146258115|NCT00113269|527461327|FG002|Overall Study|Unable to return for follow up|0|||
146258116|NCT00113269|527461328|FG003|Overall Study|Unable to return for follow up|0|||
146258117|NCT03418493|527461329|FG000|Overall Study|Adverse Event|1|||
146258118|NCT03418493|527461330|FG001|Overall Study|Adverse Event|0|||
146258119|NCT03418493|527461331|FG002|Overall Study|Adverse Event|0|||
146258120|NCT03418493|527461332|FG003|Overall Study|Adverse Event|0|||
146258121|NCT03418493|527461333|FG004|Overall Study|Adverse Event|0|||
146258122|NCT03418493|527461334|FG005|Overall Study|Adverse Event|0|||
146258123|NCT03418493|527461335|FG006|Overall Study|Adverse Event|0|||
146258124|NCT03418493|527461336|FG007|Overall Study|Adverse Event|0|||
146258125|NCT03418493|527461337|FG008|Overall Study|Adverse Event|0|||
146258126|NCT03418493|527461338|FG009|Overall Study|Adverse Event|0|||
146258127|NCT03418493|527461339|FG010|Overall Study|Adverse Event|0|||
146258128|NCT03418493|527461329|FG000|Overall Study|Protocol Violation|0|||
146258129|NCT03418493|527461330|FG001|Overall Study|Protocol Violation|0|||
146258130|NCT03418493|527461331|FG002|Overall Study|Protocol Violation|0|||
146258131|NCT03418493|527461332|FG003|Overall Study|Protocol Violation|0|||
146258132|NCT03418493|527461333|FG004|Overall Study|Protocol Violation|0|||
146258133|NCT03418493|527461334|FG005|Overall Study|Protocol Violation|0|||
146258134|NCT03418493|527461335|FG006|Overall Study|Protocol Violation|0|||
146258135|NCT03418493|527461336|FG007|Overall Study|Protocol Violation|0|||
146258136|NCT03418493|527461337|FG008|Overall Study|Protocol Violation|0|||
146258137|NCT03418493|527461338|FG009|Overall Study|Protocol Violation|1|||
146258138|NCT03418493|527461339|FG010|Overall Study|Protocol Violation|0|||
146258139|NCT01947517|527461340|FG000|Overall Study|Withdrawal by Subject|1|||
146258140|NCT01947517|527461341|FG001|Overall Study|Withdrawal by Subject|1|||
146258141|NCT05446714|527461345|FG000|Overall Study|Lost to Follow-up|1|||
146258142|NCT05446714|527461346|FG001|Overall Study|Lost to Follow-up|3|||
146258143|NCT05446714|527461347|FG002|Overall Study|Lost to Follow-up|2|||
146258144|NCT05446714|527461345|FG000|Overall Study|Protocol Violation|2|||
146258145|NCT05446714|527461346|FG001|Overall Study|Protocol Violation|0|||
146258146|NCT05446714|527461347|FG002|Overall Study|Protocol Violation|0|||
146258147|NCT00526097|527461353|FG000|Overall Study|Adverse Event|6|||
146258148|NCT00526097|527461354|FG001|Overall Study|Adverse Event|44|||
146258149|NCT00526097|527461353|FG000|Overall Study|Protocol Violation|4|||
146258150|NCT00526097|527461354|FG001|Overall Study|Protocol Violation|10|||
146258151|NCT00526097|527461353|FG000|Overall Study|Withdrawal by Subject|3|||
146258152|NCT00526097|527461354|FG001|Overall Study|Withdrawal by Subject|1|||
146258153|NCT00526097|527461353|FG000|Overall Study|Other|2|||
146258154|NCT00526097|527461354|FG001|Overall Study|Other|1|||
146258155|NCT00943618|527461355|FG000|Overall Study|Lost to Follow-up|38|||
146258156|NCT00943618|527461356|FG001|Overall Study|Lost to Follow-up|48|||
146258157|NCT00943618|527461357|FG002|Overall Study|Lost to Follow-up|20|||
146258158|NCT00943618|527461355|FG000|Overall Study|Discontinued Medication|17|||
146258159|NCT00943618|527461356|FG001|Overall Study|Discontinued Medication|29|||
146258160|NCT00943618|527461357|FG002|Overall Study|Discontinued Medication|11|||
146258161|NCT02412111|527461362|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
146258162|NCT02412111|527461363|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
146258163|NCT02412111|527461364|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
146258164|NCT02412111|527461362|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
146258165|NCT02412111|527461363|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
146258166|NCT02412111|527461364|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
146258167|NCT02412111|527461362|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
146258168|NCT02412111|527461363|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
146258169|NCT02412111|527461364|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
146258170|NCT02412111|527461362|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
146258171|NCT02412111|527461363|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
146258172|NCT02412111|527461364|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
146258173|NCT02412111|527461362|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
146258174|NCT02412111|527461363|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
146258175|NCT02412111|527461364|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
146258176|NCT02412111|527461362|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
146258177|NCT02412111|527461363|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
146258178|NCT02412111|527461364|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
146258179|NCT02412111|527461362|FG000|Active Comparator Period (8 Weeks)|Other|0|||
146258180|NCT02412111|527461363|FG001|Active Comparator Period (8 Weeks)|Other|0|||
146258181|NCT02412111|527461364|FG002|Active Comparator Period (8 Weeks)|Other|2|||
146258182|NCT00487552|527461365|FG000|Overall Study|Unsuccessful magnet placements|3|||
146258183|NCT00487552|527461365|FG000|Overall Study|Death due to progressive malignancy|2|||
145941583|NCT04076059|526295229|FG002|Double Blind Phase|Ongoing Participants|0|||
146107159|NCT01648101|526912335|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
146107160|NCT01648101|526912333|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
146107161|NCT01648101|526912334|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
146107162|NCT01648101|526912335|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
146107163|NCT01648101|526912333|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
146107164|NCT01648101|526912334|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
146107165|NCT01648101|526912335|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
146107166|NCT02469298|526912351|FG000|Overall Study|Protocol Violation|0|||
146107167|NCT02469298|526912352|FG001|Overall Study|Protocol Violation|1|||
146107168|NCT02469298|526912353|FG002|Overall Study|Protocol Violation|1|||
146107169|NCT02469298|526912354|FG003|Overall Study|Protocol Violation|0|||
146107170|NCT02469298|526912351|FG000|Overall Study|Lost to Follow-up|1|||
146107171|NCT02469298|526912352|FG001|Overall Study|Lost to Follow-up|0|||
146107172|NCT02469298|526912353|FG002|Overall Study|Lost to Follow-up|1|||
146107173|NCT02469298|526912354|FG003|Overall Study|Lost to Follow-up|0|||
146107174|NCT02469298|526912351|FG000|Overall Study|Physician Decision|0|||
146107175|NCT02469298|526912352|FG001|Overall Study|Physician Decision|0|||
146107176|NCT02469298|526912353|FG002|Overall Study|Physician Decision|0|||
146107177|NCT02469298|526912354|FG003|Overall Study|Physician Decision|1|||
146107178|NCT02469298|526912351|FG000|Overall Study|Withdrawal by Subject|0|||
146107179|NCT02469298|526912352|FG001|Overall Study|Withdrawal by Subject|0|||
146107180|NCT02469298|526912353|FG002|Overall Study|Withdrawal by Subject|0|||
146107181|NCT02469298|526912354|FG003|Overall Study|Withdrawal by Subject|1|||
146107182|NCT00307294|526912355|FG000|Overall Study|Withdrawal by Subject|1|||
146107183|NCT03311724|526912358|FG000|Overall Study|Physician Decision|0|||
146107184|NCT03311724|526912359|FG001|Overall Study|Physician Decision|0|||
146107185|NCT03311724|526912360|FG002|Overall Study|Physician Decision|0|||
146107186|NCT03311724|526912361|FG003|Overall Study|Physician Decision|1|||
146107187|NCT03311724|526912358|FG000|Overall Study|Protocol Violation|1|||
146107188|NCT03311724|526912359|FG001|Overall Study|Protocol Violation|0|||
146107189|NCT03311724|526912360|FG002|Overall Study|Protocol Violation|1|||
146258184|NCT00487552|527461365|FG000|Overall Study|Stent not placed|1|||
146258185|NCT01917006|527461366|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
146258186|NCT01917006|527461367|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
146258187|NCT01917006|527461368|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
146258188|NCT01917006|527461369|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
146258189|NCT01917006|527461370|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
146258190|NCT01917006|527461371|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
146258191|NCT01917006|527461372|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
146258192|NCT01917006|527461373|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
146258193|NCT01917006|527461366|FG000|Randomized-treatment Period|Personal Reasons|0|||
146258194|NCT01917006|527461367|FG001|Randomized-treatment Period|Personal Reasons|0|||
146258195|NCT01917006|527461368|FG002|Randomized-treatment Period|Personal Reasons|0|||
146258196|NCT01917006|527461369|FG003|Randomized-treatment Period|Personal Reasons|0|||
146258197|NCT01917006|527461370|FG004|Randomized-treatment Period|Personal Reasons|0|||
146258198|NCT01917006|527461371|FG005|Randomized-treatment Period|Personal Reasons|1|||
146107190|NCT03311724|526912361|FG003|Overall Study|Protocol Violation|0|||
146107191|NCT03311724|526912358|FG000|Overall Study|Withdrawal by Subject|1|||
146107192|NCT03311724|526912359|FG001|Overall Study|Withdrawal by Subject|1|||
146107193|NCT03311724|526912360|FG002|Overall Study|Withdrawal by Subject|0|||
146107194|NCT03311724|526912361|FG003|Overall Study|Withdrawal by Subject|0|||
146107195|NCT03311724|526912358|FG000|Overall Study|Lost to Follow-up|1|||
146107196|NCT03311724|526912359|FG001|Overall Study|Lost to Follow-up|0|||
146107197|NCT03311724|526912360|FG002|Overall Study|Lost to Follow-up|0|||
146107198|NCT03311724|526912361|FG003|Overall Study|Lost to Follow-up|0|||
146107199|NCT03311724|526912358|FG000|Overall Study|Sponsor Decision|0|||
146107200|NCT03311724|526912359|FG001|Overall Study|Sponsor Decision|0|||
146107201|NCT03311724|526912360|FG002|Overall Study|Sponsor Decision|1|||
146107202|NCT03311724|526912361|FG003|Overall Study|Sponsor Decision|0|||
146107203|NCT02980601|526912368|FG000|Overall Study|Lost to Follow-up|2|||
146107204|NCT02980601|526912369|FG001|Overall Study|Lost to Follow-up|2|||
146107205|NCT02980601|526912368|FG000|Overall Study|Death|0|||
146107206|NCT02980601|526912369|FG001|Overall Study|Death|1|||
146107207|NCT02980601|526912368|FG000|Overall Study|Graft loss|1|||
146258199|NCT01917006|527461372|FG006|Randomized-treatment Period|Personal Reasons|0|||
146107208|NCT02980601|526912369|FG001|Overall Study|Graft loss|0|||
146107209|NCT02980601|526912368|FG000|Overall Study|Failed to sign consent|2|||
146107210|NCT02980601|526912369|FG001|Overall Study|Failed to sign consent|0|||
146107211|NCT01575769|526912370|FG000|Overall Study|Adverse Event|1|||
146107212|NCT01575769|526912370|FG000|Overall Study|Study terminated by sponsor|40|||
146107213|NCT01473836|526912371|FG000|Overall Study|Adverse Event|4|||
146107214|NCT01473836|526912371|FG000|Overall Study|Lack of Efficacy|1|||
146107215|NCT01473836|526912371|FG000|Overall Study|Does not meet entrance criteria|1|||
146107216|NCT02954237|526912377|FG000|Overall Study|Withdrawal by Subject|25|||
146258200|NCT01917006|527461373|FG007|Randomized-treatment Period|Personal Reasons|0|||
146107217|NCT02954237|526912377|FG000|Overall Study|Missed visit|16|||
146107218|NCT02954237|526912377|FG000|Overall Study|Death|2|||
146107219|NCT00599924|526912379|FG000|Overall Study|Lack of Efficacy|3|||
146107220|NCT00599924|526912380|FG001|Overall Study|Lack of Efficacy|5|||
146107221|NCT00599924|526912381|FG002|Overall Study|Lack of Efficacy|1|||
146107222|NCT00599924|526912382|FG003|Overall Study|Lack of Efficacy|2|||
146107223|NCT00599924|526912383|FG004|Overall Study|Lack of Efficacy|3|||
146107224|NCT00599924|526912384|FG005|Overall Study|Lack of Efficacy|2|||
146107225|NCT00599924|526912385|FG006|Overall Study|Lack of Efficacy|0|||
146107226|NCT00599924|526912379|FG000|Overall Study|Adverse Event|0|||
146107227|NCT00599924|526912380|FG001|Overall Study|Adverse Event|0|||
146107228|NCT00599924|526912381|FG002|Overall Study|Adverse Event|0|||
146107229|NCT00599924|526912382|FG003|Overall Study|Adverse Event|2|||
146107230|NCT00599924|526912383|FG004|Overall Study|Adverse Event|0|||
146107231|NCT00599924|526912384|FG005|Overall Study|Adverse Event|0|||
146107232|NCT00599924|526912385|FG006|Overall Study|Adverse Event|2|||
146107233|NCT00599924|526912379|FG000|Overall Study|Death|0|||
146107234|NCT00599924|526912380|FG001|Overall Study|Death|0|||
146107235|NCT00599924|526912381|FG002|Overall Study|Death|0|||
146107236|NCT00599924|526912382|FG003|Overall Study|Death|2|||
146107237|NCT00599924|526912383|FG004|Overall Study|Death|0|||
146107238|NCT00599924|526912384|FG005|Overall Study|Death|2|||
146107239|NCT00599924|526912385|FG006|Overall Study|Death|1|||
146107240|NCT00599924|526912379|FG000|Overall Study|Protocol Violation|0|||
146107241|NCT00599924|526912380|FG001|Overall Study|Protocol Violation|0|||
146107242|NCT00599924|526912381|FG002|Overall Study|Protocol Violation|0|||
146107243|NCT00599924|526912382|FG003|Overall Study|Protocol Violation|1|||
146107244|NCT00599924|526912383|FG004|Overall Study|Protocol Violation|0|||
146107245|NCT00599924|526912384|FG005|Overall Study|Protocol Violation|0|||
146107246|NCT00599924|526912385|FG006|Overall Study|Protocol Violation|0|||
146107247|NCT00599924|526912379|FG000|Overall Study|Withdrawal by Subject|0|||
146107248|NCT00599924|526912380|FG001|Overall Study|Withdrawal by Subject|0|||
146107249|NCT00599924|526912381|FG002|Overall Study|Withdrawal by Subject|1|||
146107250|NCT00599924|526912382|FG003|Overall Study|Withdrawal by Subject|0|||
146107251|NCT00599924|526912383|FG004|Overall Study|Withdrawal by Subject|1|||
146107252|NCT00599924|526912384|FG005|Overall Study|Withdrawal by Subject|0|||
146107253|NCT00599924|526912385|FG006|Overall Study|Withdrawal by Subject|0|||
146107254|NCT00599924|526912379|FG000|Overall Study|Other|0|||
146107255|NCT00599924|526912380|FG001|Overall Study|Other|0|||
146107256|NCT00599924|526912381|FG002|Overall Study|Other|0|||
146107257|NCT00599924|526912382|FG003|Overall Study|Other|1|||
146107258|NCT00599924|526912383|FG004|Overall Study|Other|2|||
146107259|NCT00599924|526912384|FG005|Overall Study|Other|0|||
146107260|NCT00599924|526912385|FG006|Overall Study|Other|2|||
146107261|NCT01806298|526912386|FG000|Overall Study|Adverse Event|3|||
146107262|NCT01806298|526912386|FG000|Overall Study|Protocol Non-compliance|1|||
146107263|NCT01806298|526912386|FG000|Overall Study|Withdrawal by Subject|1|||
146107264|NCT01806298|526912386|FG000|Overall Study|Other|5|||
146107265|NCT00980057|526912391|FG000|Overall Study|Death|13|||
146107266|NCT00980057|526912392|FG001|Overall Study|Death|3|||
146107267|NCT00980057|526912391|FG000|Overall Study|Adverse Event|0|||
146107268|NCT00980057|526912392|FG001|Overall Study|Adverse Event|1|||
146107269|NCT00980057|526912391|FG000|Overall Study|Physician Decision|4|||
146107270|NCT00980057|526912392|FG001|Overall Study|Physician Decision|0|||
146107271|NCT00980057|526912391|FG000|Overall Study|Lost to Follow-up|1|||
146107272|NCT00980057|526912392|FG001|Overall Study|Lost to Follow-up|0|||
146107273|NCT00980057|526912391|FG000|Overall Study|Withdrawal by Subject|1|||
146107274|NCT00980057|526912392|FG001|Overall Study|Withdrawal by Subject|1|||
146107275|NCT04980040|526912393|FG000|Overall Study|Violated the Inclusion Criteria|260|||
146107276|NCT04980040|526912393|FG000|Overall Study|Violated the Administration & Dosage|225|||
146258201|NCT01917006|527461366|FG000|Randomized-treatment Period|Protocol Violation|1|||
146258202|NCT01917006|527461367|FG001|Randomized-treatment Period|Protocol Violation|0|||
146258203|NCT01917006|527461368|FG002|Randomized-treatment Period|Protocol Violation|0|||
146107277|NCT04980040|526912393|FG000|Overall Study|Lost to Safety-Follow-up|4|||
146107278|NCT04980040|526912393|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
146107279|NCT00691015|526912397|FG000|Overall Study|Refused further treatment|1|||
146107280|NCT00592384|526912402|FG000|Overall Study|Withdrawal by Subject|5|||
146107281|NCT00592384|526912403|FG001|Overall Study|Withdrawal by Subject|6|||
146107282|NCT03600818|526912404|FG000|Overall Study|Adverse Event|4|||
146107283|NCT03600818|526912405|FG001|Overall Study|Adverse Event|7|||
146107284|NCT03600818|526912404|FG000|Overall Study|Lack of Efficacy|9|||
146107285|NCT03600818|526912405|FG001|Overall Study|Lack of Efficacy|4|||
146107286|NCT03600818|526912404|FG000|Overall Study|Withdrawal by Subject|4|||
146107287|NCT03600818|526912405|FG001|Overall Study|Withdrawal by Subject|3|||
146107288|NCT03600818|526912404|FG000|Overall Study|Other-unspecified|5|||
146107289|NCT03600818|526912405|FG001|Overall Study|Other-unspecified|3|||
146107290|NCT03600818|526912404|FG000|Overall Study|Randomized and not treated|0|||
146107291|NCT03600818|526912405|FG001|Overall Study|Randomized and not treated|1|||
146107292|NCT01488370|526912406|FG000|Overall Study|Protocol Violation|0|||
146107293|NCT01488370|526912407|FG001|Overall Study|Protocol Violation|1|||
146107294|NCT01488370|526912408|FG002|Overall Study|Protocol Violation|1|||
146107295|NCT01471171|526912409|FG000|Treatment Period 1|Adverse Event|4|||
146107296|NCT01471171|526912410|FG001|Treatment Period 1|Adverse Event|1|||
146107297|NCT01471171|526912409|FG000|Treatment Period 2|Adverse Event|1|||
146107298|NCT01471171|526912410|FG001|Treatment Period 2|Adverse Event|0|||
146107299|NCT00553644|526912413|FG000|Overall Study|Adverse Event|17|||
146107300|NCT00553644|526912413|FG000|Overall Study|Withdrawal by Subject|4|||
146107301|NCT00553644|526912413|FG000|Overall Study|Physician Decision|1|||
146107302|NCT00553644|526912413|FG000|Overall Study|Alternative therapy|6|||
146107303|NCT00705484|526912414|FG000|Overall Study|Adverse Event|28|||
146107304|NCT00705484|526912415|FG001|Overall Study|Adverse Event|27|||
146107305|NCT00705484|526912414|FG000|Overall Study|Lost to Follow-up|169|||
146107306|NCT00705484|526912415|FG001|Overall Study|Lost to Follow-up|250|||
146107307|NCT00705484|526912414|FG000|Overall Study|Withdrawal by Subject|96|||
146107308|NCT00705484|526912415|FG001|Overall Study|Withdrawal by Subject|72|||
146107309|NCT00705484|526912414|FG000|Overall Study|Administrative|89|||
146107310|NCT00705484|526912415|FG001|Overall Study|Administrative|59|||
146107311|NCT00119106|526912416|FG000|Overall Study|HIV infected at baseline|179|||
146107312|NCT00119106|526912417|FG001|Overall Study|HIV infected at baseline|178|||
146107313|NCT01010061|526912418|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
146107314|NCT01010061|526912419|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
146107315|NCT01010061|526912418|FG000|Overall Study|Disease Progression|2|||
146107316|NCT01010061|526912419|FG001|Overall Study|Disease Progression|8|||
146107317|NCT01010061|526912418|FG000|Overall Study|Withdrew Consent|5|||
146107318|NCT01010061|526912419|FG001|Overall Study|Withdrew Consent|1|||
146107319|NCT01010061|526912418|FG000|Overall Study|Death|3|||
146107320|NCT01010061|526912419|FG001|Overall Study|Death|6|||
146107321|NCT01010061|526912418|FG000|Overall Study|Administrative/Other|0|||
146107322|NCT01010061|526912419|FG001|Overall Study|Administrative/Other|1|||
146107323|NCT01010061|526912418|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
146107324|NCT01010061|526912419|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146107325|NCT01010061|526912418|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146107326|NCT01010061|526912419|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146107327|NCT01010061|526912418|FG000|Overall Study|Violation of Selection Criteria|0|||
146107328|NCT01010061|526912419|FG001|Overall Study|Violation of Selection Criteria|1|||
146107329|NCT01010061|526912418|FG000|Overall Study|Did Not Receive Treatment|2|||
146107330|NCT01010061|526912419|FG001|Overall Study|Did Not Receive Treatment|2|||
146107331|NCT03470441|526912423|FG000|Overall Study|Death|0|||
146107332|NCT03470441|526912424|FG001|Overall Study|Death|1|||
146107333|NCT03470441|526912425|FG002|Overall Study|Death|1|||
146107334|NCT03470441|526912426|FG003|Overall Study|Death|0|||
146107335|NCT03470441|526912423|FG000|Overall Study|Adverse Event|0|||
146107336|NCT03470441|526912424|FG001|Overall Study|Adverse Event|0|||
146107337|NCT03470441|526912425|FG002|Overall Study|Adverse Event|0|||
146107338|NCT03470441|526912426|FG003|Overall Study|Adverse Event|1|||
146107339|NCT03470441|526912423|FG000|Overall Study|Withdrawal by Subject|1|||
146107340|NCT03470441|526912424|FG001|Overall Study|Withdrawal by Subject|4|||
146107341|NCT03470441|526912425|FG002|Overall Study|Withdrawal by Subject|1|||
146107342|NCT03470441|526912426|FG003|Overall Study|Withdrawal by Subject|3|||
146107343|NCT01203098|526912429|FG000|Overall Study|Adverse Event|3|||
146107344|NCT01203098|526912430|FG001|Overall Study|Adverse Event|1|||
146107345|NCT01203098|526912431|FG002|Overall Study|Adverse Event|7|||
146107346|NCT01203098|526912429|FG000|Overall Study|Lost to Follow-up|0|||
146107347|NCT01203098|526912430|FG001|Overall Study|Lost to Follow-up|0|||
146107348|NCT01203098|526912431|FG002|Overall Study|Lost to Follow-up|1|||
146107349|NCT01203098|526912429|FG000|Overall Study|Physician Decision|2|||
146107350|NCT01203098|526912430|FG001|Overall Study|Physician Decision|2|||
146107351|NCT01203098|526912431|FG002|Overall Study|Physician Decision|0|||
146107352|NCT01203098|526912429|FG000|Overall Study|Withdrawal by Subject|1|||
146107353|NCT01203098|526912430|FG001|Overall Study|Withdrawal by Subject|1|||
146107354|NCT01203098|526912431|FG002|Overall Study|Withdrawal by Subject|3|||
146107355|NCT03851705|526912436|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
146107356|NCT03851705|526912437|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146107357|NCT03851705|526912438|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146107358|NCT03851705|526912439|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146107359|NCT03851705|526912436|FG000|Part 1: Double-Blind Period|Other reason|1|||
146107360|NCT03851705|526912437|FG001|Part 1: Double-Blind Period|Other reason|0|||
146107361|NCT03851705|526912438|FG002|Part 1: Double-Blind Period|Other reason|0|||
146107362|NCT03851705|526912439|FG003|Part 1: Double-Blind Period|Other reason|0|||
146107363|NCT03851705|526912436|FG000|Part 2: Open-Label Period|Other reason|0|||
146107364|NCT03851705|526912437|FG001|Part 2: Open-Label Period|Other reason|0|||
146107365|NCT03851705|526912438|FG002|Part 2: Open-Label Period|Other reason|0|||
146107366|NCT03851705|526912439|FG003|Part 2: Open-Label Period|Other reason|1|||
146107367|NCT03851705|526912436|FG000|Part 2: Open-Label Period|Death|0|||
146107368|NCT03851705|526912437|FG001|Part 2: Open-Label Period|Death|0|||
146107369|NCT03851705|526912438|FG002|Part 2: Open-Label Period|Death|3|||
146107370|NCT03851705|526912439|FG003|Part 2: Open-Label Period|Death|0|||
146107371|NCT03851705|526912436|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
146258204|NCT01917006|527461369|FG003|Randomized-treatment Period|Protocol Violation|0|||
146258205|NCT01917006|527461370|FG004|Randomized-treatment Period|Protocol Violation|0|||
146258206|NCT01917006|527461371|FG005|Randomized-treatment Period|Protocol Violation|0|||
146258207|NCT01917006|527461372|FG006|Randomized-treatment Period|Protocol Violation|0|||
146258208|NCT01917006|527461373|FG007|Randomized-treatment Period|Protocol Violation|0|||
146258209|NCT01917006|527461366|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146258210|NCT01917006|527461367|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146051635|NCT02159066|526703408|FG004|Part II|New Therapy for Study Indication|1|||
146051636|NCT02159066|526703409|FG005|Part II|New Therapy for Study Indication|0|||
146051637|NCT02159066|526703404|FG000|Part II|Physician Decision|0|||
146051638|NCT02159066|526703405|FG001|Part II|Physician Decision|0|||
146051639|NCT02159066|526703406|FG002|Part II|Physician Decision|1|||
146051640|NCT02159066|526703407|FG003|Part II|Physician Decision|0|||
146051641|NCT02159066|526703408|FG004|Part II|Physician Decision|0|||
146051642|NCT02159066|526703409|FG005|Part II|Physician Decision|0|||
146051643|NCT02159066|526703404|FG000|Part II|Participant/Guardian Decision|0|||
146051644|NCT02159066|526703405|FG001|Part II|Participant/Guardian Decision|0|||
146051645|NCT02159066|526703406|FG002|Part II|Participant/Guardian Decision|0|||
146051646|NCT02159066|526703407|FG003|Part II|Participant/Guardian Decision|0|||
146051647|NCT02159066|526703408|FG004|Part II|Participant/Guardian Decision|2|||
146051648|NCT02159066|526703409|FG005|Part II|Participant/Guardian Decision|0|||
146051649|NCT05470387|526703410|FG000|Overall Study|Protocol Violation|0|||
146051650|NCT05470387|526703411|FG001|Overall Study|Protocol Violation|3|||
146051651|NCT03480152|526703415|FG000|Phase I|Signed consent. Died before treatment.|1|||
146051652|NCT03480152|526703416|FG001|Phase I|Signed consent. Died before treatment.|0|||
146051653|NCT03480152|526703417|FG002|Phase I|Signed consent. Died before treatment.|0|||
146051654|NCT01308736|526703418|FG000|Overall Study|Did not attend a single session|6|||
146051655|NCT01308736|526703419|FG001|Overall Study|Did not attend a single session|5|||
146051656|NCT01946139|526703420|FG000|Overall Study|Withdrawal by Subject|8|||
146051657|NCT01946139|526703420|FG000|Overall Study|ineligible|8|||
146051658|NCT01946139|526703420|FG000|Overall Study|Specimens not available|4|||
146051659|NCT01363700|526703429|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146051660|NCT01363700|526703430|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
146051661|NCT01363700|526703431|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146051662|NCT01363700|526703432|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146051663|NCT01363700|526703433|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
146051664|NCT02721875|526703434|FG000|Overall Study|Progressive disease/relapse|1|||
146051665|NCT02721875|526703435|FG001|Overall Study|Progressive disease/relapse|0|||
146051666|NCT00857285|526703436|FG000|Overall Study|Adverse Event|4|||
146051667|NCT00857285|526703437|FG001|Overall Study|Adverse Event|2|||
146051668|NCT00857285|526703436|FG000|Overall Study|Lack of Efficacy|0|||
146051669|NCT00857285|526703437|FG001|Overall Study|Lack of Efficacy|2|||
146051670|NCT00857285|526703436|FG000|Overall Study|Protocol Violation|3|||
146051671|NCT00857285|526703437|FG001|Overall Study|Protocol Violation|1|||
146051672|NCT00857285|526703436|FG000|Overall Study|Withdrawal by Subject|4|||
146051673|NCT00857285|526703437|FG001|Overall Study|Withdrawal by Subject|0|||
146051674|NCT00857285|526703436|FG000|Overall Study|Randomization criteria not met|1|||
146051675|NCT00857285|526703437|FG001|Overall Study|Randomization criteria not met|1|||
146051676|NCT01329978|526703446|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
146051677|NCT01329978|526703447|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
146051678|NCT01329978|526703448|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146051679|NCT01329978|526703449|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146051680|NCT01329978|526703450|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
146051681|NCT01329978|526703446|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
146051682|NCT01329978|526703447|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
146051683|NCT01329978|526703448|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
146051684|NCT01329978|526703449|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
146051685|NCT01329978|526703450|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
146051686|NCT01329978|526703446|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
146051687|NCT01329978|526703447|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
146051688|NCT01329978|526703448|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
146051689|NCT01329978|526703449|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
146051690|NCT01329978|526703450|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
146051691|NCT01329978|526703446|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146051692|NCT01329978|526703447|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
146258211|NCT01917006|527461368|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146051693|NCT01329978|526703448|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146051694|NCT01329978|526703449|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146051695|NCT01329978|526703450|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
146051696|NCT01329978|526703446|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146258212|NCT01917006|527461369|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146051697|NCT01329978|526703447|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
146051698|NCT01329978|526703448|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146051699|NCT01329978|526703449|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146051700|NCT01329978|526703450|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
146051701|NCT01329978|526703446|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
146051702|NCT01329978|526703447|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
146051703|NCT01329978|526703448|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
146051704|NCT01329978|526703449|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
146051705|NCT01329978|526703450|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
146051706|NCT01329978|526703446|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146051707|NCT01329978|526703447|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146051708|NCT01329978|526703448|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146051709|NCT01329978|526703449|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
146051710|NCT01329978|526703450|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
146051711|NCT03901144|526703451|FG000|Overall Study|Lost to Follow-up|1|||
146051712|NCT03901144|526703452|FG001|Overall Study|Lost to Follow-up|1|||
146051713|NCT03901144|526703453|FG002|Overall Study|Lost to Follow-up|1|||
146051714|NCT03901144|526703454|FG003|Overall Study|Lost to Follow-up|1|||
146051715|NCT01807598|526703455|FG000|Overall Study|Withdrawal by Subject|4|||
146051716|NCT01807598|526703455|FG000|Overall Study|Adverse Event|1|||
146051717|NCT01807598|526703455|FG000|Overall Study|Other Physician Decision|1|||
146051718|NCT04896593|526703459|FG000|Overall Study|Withdrawal by Subject|2|||
146051719|NCT04896593|526703459|FG000|Overall Study|Lost to Follow-up|1|||
146051720|NCT04896593|526703459|FG000|Overall Study|Did not complete onboarding|2|||
146051721|NCT00452790|526703460|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
146051722|NCT00452790|526703461|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
146051723|NCT00452790|526703460|FG000|Infant Series|Parent/legal guardian request|8|||
146051724|NCT00452790|526703461|FG001|Infant Series|Parent/legal guardian request|6|||
146051725|NCT00452790|526703460|FG000|Infant Series|Failed to return|4|||
146051726|NCT00452790|526703461|FG001|Infant Series|Failed to return|1|||
146051727|NCT00452790|526703460|FG000|Infant Series|Protocol Violation|1|||
146051728|NCT00452790|526703461|FG001|Infant Series|Protocol Violation|3|||
146051729|NCT00452790|526703460|FG000|Infant Series|Lost to Follow-up|2|||
146051730|NCT00452790|526703461|FG001|Infant Series|Lost to Follow-up|2|||
146051731|NCT00452790|526703460|FG000|Infant Series|Adverse Event|1|||
146051732|NCT00452790|526703461|FG001|Infant Series|Adverse Event|2|||
146051733|NCT00452790|526703460|FG000|Infant Series|Other reasons|1|||
146051734|NCT00452790|526703461|FG001|Infant Series|Other reasons|2|||
146051735|NCT00452790|526703460|FG000|Infant Series|Investigator request|0|||
146051736|NCT00452790|526703461|FG001|Infant Series|Investigator request|1|||
146051737|NCT00452790|526703460|FG000|Infant Series|Death|0|||
146051738|NCT00452790|526703461|FG001|Infant Series|Death|1|||
146051739|NCT00452790|526703460|FG000|After Infant Series|Investigator request|10|||
146051740|NCT00452790|526703461|FG001|After Infant Series|Investigator request|10|||
146051741|NCT00452790|526703460|FG000|After Infant Series|Adverse Event|4|||
146051742|NCT00452790|526703461|FG001|After Infant Series|Adverse Event|1|||
146051743|NCT00452790|526703460|FG000|After Infant Series|Parent/legal guardian request|1|||
146051744|NCT00452790|526703461|FG001|After Infant Series|Parent/legal guardian request|3|||
146051745|NCT00452790|526703460|FG000|After Infant Series|Lost to Follow-up|4|||
146051746|NCT00452790|526703461|FG001|After Infant Series|Lost to Follow-up|0|||
146051747|NCT00452790|526703460|FG000|After Infant Series|Failed to return|1|||
146051748|NCT00452790|526703461|FG001|After Infant Series|Failed to return|0|||
146051749|NCT00452790|526703460|FG000|After Infant Series|Other reasons|1|||
146051750|NCT00452790|526703461|FG001|After Infant Series|Other reasons|0|||
146051751|NCT00452790|526703460|FG000|Toddler Dose|Failed to return|0|||
146051752|NCT00452790|526703461|FG001|Toddler Dose|Failed to return|1|||
146051753|NCT00452790|526703460|FG000|Toddler Dose|Parent/legal guardian request|0|||
146051754|NCT00452790|526703461|FG001|Toddler Dose|Parent/legal guardian request|1|||
146051755|NCT04177212|526703470|FG000|Overall Study|Withdrawal by Subject|9|||
146051756|NCT04177212|526703471|FG001|Overall Study|Withdrawal by Subject|7|||
146051757|NCT04177212|526703470|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
146051758|NCT04177212|526703471|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
146051759|NCT04177212|526703470|FG000|Overall Study|Physician Decision|1|||
146051760|NCT04177212|526703471|FG001|Overall Study|Physician Decision|0|||
146051761|NCT04177212|526703470|FG000|Overall Study|Lost to Follow-up|0|||
146051762|NCT04177212|526703471|FG001|Overall Study|Lost to Follow-up|3|||
146051763|NCT04177212|526703470|FG000|Overall Study|Adverse Event|0|||
146051764|NCT04177212|526703471|FG001|Overall Study|Adverse Event|1|||
146051765|NCT04177212|526703470|FG000|Overall Study|Other|1|||
146051766|NCT04177212|526703471|FG001|Overall Study|Other|2|||
146051767|NCT01279681|526703472|FG000|Overall Study|Disease Progression|9|||
146051768|NCT01279681|526703473|FG001|Overall Study|Disease Progression|6|||
146051769|NCT01279681|526703472|FG000|Overall Study|Withdrawal by Subject|3|||
146051770|NCT01279681|526703473|FG001|Overall Study|Withdrawal by Subject|4|||
146051771|NCT01279681|526703472|FG000|Overall Study|Adverse Event|2|||
146301166|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
146301167|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
146301168|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146301169|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146301170|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146301171|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
146301172|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
146301173|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146301174|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146301175|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146301176|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
146301177|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
146301178|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146301179|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146301180|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146301181|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
146301182|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
146301183|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146301184|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146301185|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146301186|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
146301187|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
146301188|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146301189|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146301190|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146301191|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
146301192|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
146301193|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146301194|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146301195|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146301196|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
146301197|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
146301198|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146301199|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146301200|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146301201|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
146301202|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
146301203|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146107372|NCT03851705|526912437|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
146107373|NCT03851705|526912438|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
146107374|NCT03851705|526912439|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
145941584|NCT04076059|526295227|FG000|Double Blind Phase|Miscellaneous|3|||
145941585|NCT04076059|526295228|FG001|Double Blind Phase|Miscellaneous|1|||
145941586|NCT04076059|526295229|FG002|Double Blind Phase|Miscellaneous|0|||
145941587|NCT04076059|526295227|FG000|Double Blind Phase|Protocol Deviation|1|||
145941588|NCT04076059|526295228|FG001|Double Blind Phase|Protocol Deviation|1|||
145941589|NCT04076059|526295229|FG002|Double Blind Phase|Protocol Deviation|0|||
145941590|NCT04076059|526295227|FG000|Double Blind Phase|Did not take study drug|1|||
145941591|NCT04076059|526295228|FG001|Double Blind Phase|Did not take study drug|1|||
145941592|NCT04076059|526295229|FG002|Double Blind Phase|Did not take study drug|0|||
145941593|NCT04076059|526295227|FG000|Open Label Phase|Progressive disease|0|||
145941594|NCT04076059|526295228|FG001|Open Label Phase|Progressive disease|0|||
145941595|NCT04076059|526295229|FG002|Open Label Phase|Progressive disease|7|||
145941596|NCT04076059|526295227|FG000|Open Label Phase|Withdrawal by Subject|0|||
145941597|NCT04076059|526295228|FG001|Open Label Phase|Withdrawal by Subject|0|||
145941598|NCT04076059|526295229|FG002|Open Label Phase|Withdrawal by Subject|3|||
145941599|NCT04076059|526295227|FG000|Open Label Phase|Death|0|||
145941600|NCT04076059|526295228|FG001|Open Label Phase|Death|0|||
145941601|NCT04076059|526295229|FG002|Open Label Phase|Death|2|||
145941602|NCT04076059|526295227|FG000|Open Label Phase|Ongoing Participants|0|||
145941603|NCT04076059|526295228|FG001|Open Label Phase|Ongoing Participants|0|||
145941604|NCT04076059|526295229|FG002|Open Label Phase|Ongoing Participants|11|||
145941605|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Death|117|||
145941606|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Death|197|||
145941607|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
146258213|NCT01917006|527461370|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146258214|NCT01917006|527461371|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146258215|NCT01917006|527461372|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
146258216|NCT01917006|527461373|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
146258217|NCT01917006|527461366|FG000|Open-label Period|Adverse Event|0|||
146258218|NCT01917006|527461367|FG001|Open-label Period|Adverse Event|0|||
146258219|NCT01917006|527461368|FG002|Open-label Period|Adverse Event|0|||
146258220|NCT01917006|527461369|FG003|Open-label Period|Adverse Event|0|||
146258221|NCT01917006|527461370|FG004|Open-label Period|Adverse Event|0|||
146258222|NCT01917006|527461371|FG005|Open-label Period|Adverse Event|0|||
146258223|NCT01917006|527461372|FG006|Open-label Period|Adverse Event|0|||
146258224|NCT01917006|527461373|FG007|Open-label Period|Adverse Event|1|||
146258225|NCT01917006|527461366|FG000|Open-label Period|Lost to Follow-up|0|||
146258226|NCT01917006|527461367|FG001|Open-label Period|Lost to Follow-up|0|||
146258227|NCT01917006|527461368|FG002|Open-label Period|Lost to Follow-up|0|||
146258228|NCT01917006|527461369|FG003|Open-label Period|Lost to Follow-up|0|||
146258229|NCT01917006|527461370|FG004|Open-label Period|Lost to Follow-up|0|||
146258230|NCT01917006|527461371|FG005|Open-label Period|Lost to Follow-up|0|||
146258231|NCT01917006|527461372|FG006|Open-label Period|Lost to Follow-up|0|||
146258232|NCT01917006|527461373|FG007|Open-label Period|Lost to Follow-up|1|||
146258233|NCT02158247|527461374|FG000|Overall Study|Invisible vocal cords|5|||
146258234|NCT03029234|527461378|FG000|Overall Study|Sponsor Decision|1|||
146258235|NCT03029234|527461378|FG000|Overall Study|Withdrawal by Subject|5|||
146258236|NCT03029234|527461378|FG000|Overall Study|Death|91|||
146258237|NCT03029234|527461378|FG000|Overall Study|Lost to Follow-up|2|||
146258238|NCT02544113|527461380|FG000|Overall Study|Death|3|||
146258239|NCT02544113|527461381|FG001|Overall Study|Death|4|||
146258240|NCT02847637|527461383|FG000|Overall Study|Withdrawal by Subject|0|||
146258241|NCT02847637|527461384|FG001|Overall Study|Withdrawal by Subject|1|||
146258242|NCT02847637|527461385|FG002|Overall Study|Withdrawal by Subject|1|||
146258243|NCT02847637|527461386|FG003|Overall Study|Withdrawal by Subject|0|||
146258244|NCT02847637|527461383|FG000|Overall Study|Lost to Follow-up|1|||
146258245|NCT02847637|527461384|FG001|Overall Study|Lost to Follow-up|1|||
146107375|NCT00621582|526912443|FG000|Overall Study|Adverse Event|7|||
146107376|NCT00621582|526912443|FG000|Overall Study|Protocol Violation|57|||
146107377|NCT00621582|526912443|FG000|Overall Study|Lost to Follow-up|24|||
146107378|NCT00621582|526912443|FG000|Overall Study|issues not identified by investigators|18|||
146107379|NCT01387932|526912445|FG000|Randomized and Treated|Physician Decision|3|||
146107380|NCT01387932|526912446|FG001|Randomized and Treated|Physician Decision|2|||
146107381|NCT01387932|526912445|FG000|Randomized and Treated|Withdrawal by Subject|4|||
146107382|NCT01387932|526912446|FG001|Randomized and Treated|Withdrawal by Subject|2|||
146107383|NCT01387932|526912445|FG000|Survival Follow-up|Liver Transplant|24|||
146107384|NCT01387932|526912446|FG001|Survival Follow-up|Liver Transplant|28|||
146107385|NCT01387932|526912445|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
146107386|NCT01387932|526912446|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
146107387|NCT01387932|526912445|FG000|Survival Follow-up|Withdrawal by Subject|2|||
146107388|NCT01387932|526912446|FG001|Survival Follow-up|Withdrawal by Subject|4|||
146107389|NCT01387932|526912445|FG000|Survival Follow-up|Lost to Follow-up|6|||
146107390|NCT01387932|526912446|FG001|Survival Follow-up|Lost to Follow-up|5|||
146107391|NCT02591290|526912447|FG000|Overall Study|Withdrawal by Subject|2|||
146107392|NCT02571075|526912448|FG000|Overall Study|Lost to Follow-up|20|||
146107393|NCT02571075|526912449|FG001|Overall Study|Lost to Follow-up|24|||
146107394|NCT01306942|526912455|FG000|Phase I|Adverse Event|2|||
146107395|NCT01306942|526912456|FG001|Phase I|Adverse Event|2|||
146107396|NCT01306942|526912457|FG002|Phase I|Adverse Event|0|||
146107397|NCT01306942|526912458|FG003|Phase I|Adverse Event|0|||
146107398|NCT01306942|526912455|FG000|Phase I|Physician Decision|3|||
146107399|NCT01306942|526912456|FG001|Phase I|Physician Decision|1|||
146107400|NCT01306942|526912457|FG002|Phase I|Physician Decision|0|||
146107401|NCT01306942|526912458|FG003|Phase I|Physician Decision|0|||
146107402|NCT01306942|526912455|FG000|Phase II|Adverse Event|0|||
146107403|NCT01306942|526912456|FG001|Phase II|Adverse Event|0|||
146107404|NCT01306942|526912457|FG002|Phase II|Adverse Event|0|||
146107405|NCT01306942|526912458|FG003|Phase II|Adverse Event|6|||
146107406|NCT01306942|526912455|FG000|Phase II|Physician Decision|2|||
146107407|NCT01306942|526912456|FG001|Phase II|Physician Decision|0|||
146107408|NCT01306942|526912457|FG002|Phase II|Physician Decision|0|||
146107409|NCT01306942|526912458|FG003|Phase II|Physician Decision|5|||
146107410|NCT01306942|526912455|FG000|Phase II|Withdrawal by Subject|0|||
146107411|NCT01306942|526912456|FG001|Phase II|Withdrawal by Subject|0|||
146107412|NCT01306942|526912457|FG002|Phase II|Withdrawal by Subject|0|||
146107413|NCT01306942|526912458|FG003|Phase II|Withdrawal by Subject|2|||
146258246|NCT02847637|527461385|FG002|Overall Study|Lost to Follow-up|0|||
146258247|NCT02847637|527461386|FG003|Overall Study|Lost to Follow-up|0|||
146258248|NCT01746108|527461391|FG000|Overall Study|Migrated /moved from study area|0|||
146258249|NCT01746108|527461392|FG001|Overall Study|Migrated /moved from study area|1|||
146258250|NCT01746108|527461393|FG002|Overall Study|Migrated /moved from study area|0|||
146258251|NCT01746108|527461391|FG000|Overall Study|Adverse event, non-fatal|0|||
146258252|NCT01746108|527461392|FG001|Overall Study|Adverse event, non-fatal|1|||
146258253|NCT01746108|527461393|FG002|Overall Study|Adverse event, non-fatal|0|||
146258254|NCT01746108|527461391|FG000|Overall Study|Withdrawal by Subject|0|||
146258255|NCT01746108|527461392|FG001|Overall Study|Withdrawal by Subject|1|||
146258256|NCT01746108|527461393|FG002|Overall Study|Withdrawal by Subject|0|||
146258257|NCT01746108|527461391|FG000|Overall Study|Lost to Follow-up|0|||
146258258|NCT01746108|527461392|FG001|Overall Study|Lost to Follow-up|1|||
146258259|NCT01746108|527461393|FG002|Overall Study|Lost to Follow-up|0|||
146258260|NCT00797511|527461395|FG000|Overall Study|Withdrawal by Subject|1|||
146051772|NCT01279681|526703473|FG001|Overall Study|Adverse Event|3|||
146051773|NCT01279681|526703472|FG000|Overall Study|Death|0|||
146051774|NCT01279681|526703473|FG001|Overall Study|Death|1|||
146051775|NCT01279681|526703472|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
146051776|NCT01279681|526703473|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
146051777|NCT01279681|526703472|FG000|Overall Study|Physician Decision|1|||
146051778|NCT01279681|526703473|FG001|Overall Study|Physician Decision|0|||
146051779|NCT01279681|526703472|FG000|Overall Study|Other Reason|0|||
146051780|NCT01279681|526703473|FG001|Overall Study|Other Reason|2|||
146051781|NCT02252146|526705333|FG000|Overall Study|Lack of Efficacy|4|||
146051782|NCT02252146|526705333|FG000|Overall Study|Entered hospice care|1|||
146051783|NCT02252146|526705333|FG000|Overall Study|Inability to travel to study site|1|||
146051784|NCT02544321|526705338|FG000|Overall Study|Withdrawal by Subject|1|||
146051785|NCT02544321|526705339|FG001|Overall Study|Withdrawal by Subject|2|||
146051786|NCT02544321|526705338|FG000|Overall Study|Adverse Event|1|||
146051787|NCT02544321|526705339|FG001|Overall Study|Adverse Event|1|||
146051788|NCT02544321|526705338|FG000|Overall Study|Protocol Violation|0|||
146051789|NCT02544321|526705339|FG001|Overall Study|Protocol Violation|1|||
146051790|NCT04388111|526705340|FG000|Overall Study|Lost to Follow-up|5|||
146051791|NCT04388111|526705341|FG001|Overall Study|Lost to Follow-up|3|||
146051792|NCT04388111|526705340|FG000|Overall Study|Adverse Event|1|||
146051793|NCT04388111|526705341|FG001|Overall Study|Adverse Event|1|||
146051794|NCT04388111|526705340|FG000|Overall Study|Protocol Violation|2|||
146051795|NCT04388111|526705341|FG001|Overall Study|Protocol Violation|4|||
146051796|NCT04388111|526705340|FG000|Overall Study|Withdrawal by Subject|1|||
146051797|NCT04388111|526705341|FG001|Overall Study|Withdrawal by Subject|0|||
146051798|NCT02038153|526705344|FG000|Overall Study|Withdrawal by Subject|1|||
146051799|NCT02647281|526705345|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051800|NCT02647281|526705346|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051801|NCT02647281|526705347|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051802|NCT02647281|526705348|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051803|NCT02647281|526705349|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051804|NCT02647281|526705350|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051805|NCT02647281|526705351|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051806|NCT02647281|526705352|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
146051807|NCT02647281|526705353|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
146051808|NCT01050634|526705354|FG000|Overall Study|Enrolled, but Not Treated|56|||
146051809|NCT01050634|526705354|FG000|Overall Study|Death|2|||
146051810|NCT01050634|526705354|FG000|Overall Study|Adverse Event|42|||
146051811|NCT01050634|526705354|FG000|Overall Study|Lost to Follow-up|2|||
146051812|NCT01050634|526705354|FG000|Overall Study|Other|21|||
146051813|NCT01050634|526705354|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
146051814|NCT03347123|526705357|FG000|Overall Study|Death|1|||
146051815|NCT03347123|526705358|FG001|Overall Study|Death|2|||
146051816|NCT03347123|526705359|FG002|Overall Study|Death|0|||
146051817|NCT03347123|526705360|FG003|Overall Study|Death|0|||
146051818|NCT03347123|526705361|FG004|Overall Study|Death|0|||
146051819|NCT03347123|526705362|FG005|Overall Study|Death|0|||
146051820|NCT03347123|526705363|FG006|Overall Study|Death|0|||
146051821|NCT03347123|526705357|FG000|Overall Study|Withdrawal by Subject|1|||
146051822|NCT03347123|526705358|FG001|Overall Study|Withdrawal by Subject|0|||
146051823|NCT03347123|526705359|FG002|Overall Study|Withdrawal by Subject|0|||
146051824|NCT03347123|526705360|FG003|Overall Study|Withdrawal by Subject|0|||
146051825|NCT03347123|526705361|FG004|Overall Study|Withdrawal by Subject|0|||
146051826|NCT03347123|526705362|FG005|Overall Study|Withdrawal by Subject|0|||
146051827|NCT03347123|526705363|FG006|Overall Study|Withdrawal by Subject|0|||
146051828|NCT03347123|526705357|FG000|Overall Study|Reason not Specified|3|||
146051829|NCT03347123|526705358|FG001|Overall Study|Reason not Specified|4|||
146051830|NCT03347123|526705359|FG002|Overall Study|Reason not Specified|0|||
146051831|NCT03347123|526705360|FG003|Overall Study|Reason not Specified|0|||
146051832|NCT03347123|526705361|FG004|Overall Study|Reason not Specified|0|||
146051833|NCT03347123|526705362|FG005|Overall Study|Reason not Specified|0|||
146051834|NCT03347123|526705363|FG006|Overall Study|Reason not Specified|0|||
146107414|NCT01306942|526912455|FG000|Phase II|Death|0|||
146107415|NCT01306942|526912456|FG001|Phase II|Death|0|||
146107416|NCT01306942|526912457|FG002|Phase II|Death|0|||
146107417|NCT01306942|526912458|FG003|Phase II|Death|1|||
146107418|NCT01306942|526912455|FG000|Phase II|Not finished treatment|0|||
146107419|NCT01306942|526912456|FG001|Phase II|Not finished treatment|0|||
146107420|NCT01306942|526912457|FG002|Phase II|Not finished treatment|0|||
146107421|NCT01306942|526912458|FG003|Phase II|Not finished treatment|1|||
146107422|NCT01306942|526912455|FG000|Phase II|Protocol Violation|0|||
146107423|NCT01306942|526912456|FG001|Phase II|Protocol Violation|0|||
146107424|NCT01306942|526912457|FG002|Phase II|Protocol Violation|0|||
146107425|NCT01306942|526912458|FG003|Phase II|Protocol Violation|1|||
146107426|NCT03190915|526912465|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
146107427|NCT03190915|526912465|FG000|Overall Study|Progressive Disease|3|||
146107428|NCT04545385|526912466|FG000|Overall Study|Withdrawal by Subject|2|||
146107429|NCT04545385|526912467|FG001|Overall Study|Withdrawal by Subject|0|||
146107430|NCT04545385|526912466|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
146107431|NCT04545385|526912467|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
146107432|NCT04545385|526912466|FG000|Overall Study|Study termination|10|||
146107433|NCT04545385|526912467|FG001|Overall Study|Study termination|10|||
146107434|NCT04545385|526912466|FG000|Overall Study|Sponsor decision|2|||
146107435|NCT04545385|526912467|FG001|Overall Study|Sponsor decision|2|||
146107436|NCT04545385|526912466|FG000|Overall Study|Other than specified|1|||
146107437|NCT04545385|526912467|FG001|Overall Study|Other than specified|0|||
146107438|NCT01128842|526912468|FG000|Overall Study|Adverse Event|1|||
146107439|NCT01128842|526912468|FG000|Overall Study|Disease Progression|6|||
146107440|NCT04528732|526912469|FG000|Overall Study|Death|1|||
146107441|NCT04528732|526912470|FG001|Overall Study|Death|0|||
146107442|NCT04528732|526912471|FG002|Overall Study|Death|1|||
146107443|NCT04528732|526912469|FG000|Overall Study|Lost to Follow-up|0|||
146107444|NCT04528732|526912470|FG001|Overall Study|Lost to Follow-up|1|||
146107445|NCT04528732|526912471|FG002|Overall Study|Lost to Follow-up|2|||
146107446|NCT00668707|526912472|FG000|Overall Study|Cancer Recurrence|58|||
146107447|NCT00668707|526912473|FG001|Overall Study|Cancer Recurrence|58|||
146107448|NCT00668707|526912472|FG000|Overall Study|Withdrawal by Subject|117|||
146107449|NCT00668707|526912473|FG001|Overall Study|Withdrawal by Subject|100|||
146107450|NCT00668707|526912472|FG000|Overall Study|Lost to Follow-up|3|||
146107451|NCT00668707|526912473|FG001|Overall Study|Lost to Follow-up|6|||
146107452|NCT00668707|526912472|FG000|Overall Study|Protocol Violation|10|||
146107453|NCT00668707|526912473|FG001|Overall Study|Protocol Violation|12|||
146107454|NCT00668707|526912472|FG000|Overall Study|Death|11|||
146107455|NCT00668707|526912473|FG001|Overall Study|Death|4|||
146107456|NCT00826943|526912474|FG000|Overall Study|Withdrawal by Subject|0|||
146107457|NCT00826943|526912475|FG001|Overall Study|Withdrawal by Subject|0|||
146107458|NCT00826943|526912476|FG002|Overall Study|Withdrawal by Subject|0|||
146107459|NCT00826943|526912477|FG003|Overall Study|Withdrawal by Subject|0|||
146107460|NCT00826943|526912478|FG004|Overall Study|Withdrawal by Subject|1|||
146107461|NCT00826943|526912479|FG005|Overall Study|Withdrawal by Subject|0|||
146107462|NCT01382212|526912480|FG000|Overall Study|Kidney transplant|1|||
146107463|NCT01382212|526912480|FG000|Overall Study|Withdrew consent|1|||
146258261|NCT03036150|527461396|FG000|Overall Study|Withdrawal by Subject|8|||
146107464|NCT03192462|526914441|FG000|Overall Study|Death|13|||
146107465|NCT03192462|526914442|FG001|Overall Study|Death|11|||
146107466|NCT03192462|526914443|FG002|Overall Study|Death|10|||
146107467|NCT03192462|526914441|FG000|Overall Study|Lost to Follow-up|0|||
146107468|NCT03192462|526914442|FG001|Overall Study|Lost to Follow-up|1|||
146107469|NCT03192462|526914443|FG002|Overall Study|Lost to Follow-up|0|||
146107470|NCT04840615|526914444|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
146107471|NCT04840615|526914445|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
146107472|NCT04840615|526914446|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
146258262|NCT03036150|527461397|FG001|Overall Study|Withdrawal by Subject|3|||
146258263|NCT03036150|527461396|FG000|Overall Study|Lost to Follow-up|2|||
146258264|NCT03036150|527461397|FG001|Overall Study|Lost to Follow-up|2|||
146258265|NCT00053352|527461401|FG000|Overall Study|Lost to Follow-up|0|||
146258266|NCT00053352|527461402|FG001|Overall Study|Lost to Follow-up|1|||
146258267|NCT00053352|527461401|FG000|Overall Study|Physician Decision|11|||
146258268|NCT00053352|527461402|FG001|Overall Study|Physician Decision|1|||
146107473|NCT01898806|526914449|FG000|Overall Study|Withdrawal by Subject|2|||
146107474|NCT01898806|526914449|FG000|Overall Study|Physician Decision|1|||
146107475|NCT03003390|526914450|FG000|Overall Study|Physician Decision|2|||
146107476|NCT03003390|526914451|FG001|Overall Study|Physician Decision|0|||
146107477|NCT03003390|526914450|FG000|Overall Study|Parent refused intervention|2|||
146107478|NCT03003390|526914451|FG001|Overall Study|Parent refused intervention|0|||
146107479|NCT03156543|526914454|FG000|Overall Study|Withdrawal by Subject|1|||
146107480|NCT03156543|526914455|FG001|Overall Study|Withdrawal by Subject|0|||
146258269|NCT00053352|527461401|FG000|Overall Study|Withdrawal by Subject|1|||
146258270|NCT00053352|527461402|FG001|Overall Study|Withdrawal by Subject|0|||
146107481|NCT00674700|526914458|FG000|Year 1|Adverse Event|17|||
146107482|NCT00674700|526914459|FG001|Year 1|Adverse Event|20|||
146107483|NCT00674700|526914460|FG002|Year 1|Adverse Event|5|||
146107484|NCT00674700|526914458|FG000|Year 1|Withdrawal by Subject|7|||
146107485|NCT00674700|526914459|FG001|Year 1|Withdrawal by Subject|7|||
146107486|NCT00674700|526914460|FG002|Year 1|Withdrawal by Subject|6|||
146107487|NCT00674700|526914458|FG000|Year 1|Any other reason not above-mentioned|7|||
146107488|NCT00674700|526914459|FG001|Year 1|Any other reason not above-mentioned|7|||
146107489|NCT00674700|526914460|FG002|Year 1|Any other reason not above-mentioned|6|||
146107490|NCT00674700|526914458|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
146107491|NCT00674700|526914459|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
146107492|NCT00674700|526914460|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
146107493|NCT00674700|526914458|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
146107494|NCT00674700|526914459|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
146107495|NCT00674700|526914460|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
146107496|NCT00674700|526914458|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
146107497|NCT00674700|526914459|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
146107498|NCT00674700|526914460|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
146107499|NCT00395304|526914461|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146107500|NCT00395304|526914462|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146107501|NCT00395304|526914463|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146107502|NCT00395304|526914464|FG003|Treatment Period 1|Withdrawal by Subject|2|||
146107503|NCT00395304|526914465|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146107504|NCT00395304|526914466|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146107505|NCT00395304|526914461|FG000|Treatment Period 1|Lost to Follow-up|1|||
146107506|NCT00395304|526914462|FG001|Treatment Period 1|Lost to Follow-up|0|||
146107507|NCT00395304|526914463|FG002|Treatment Period 1|Lost to Follow-up|0|||
146107508|NCT00395304|526914464|FG003|Treatment Period 1|Lost to Follow-up|1|||
146107509|NCT00395304|526914465|FG004|Treatment Period 1|Lost to Follow-up|0|||
146107510|NCT00395304|526914466|FG005|Treatment Period 1|Lost to Follow-up|1|||
146107511|NCT00395304|526914461|FG000|Treatment Period 1|Physician Decision|0|||
146107512|NCT00395304|526914462|FG001|Treatment Period 1|Physician Decision|1|||
146107513|NCT00395304|526914463|FG002|Treatment Period 1|Physician Decision|0|||
146107514|NCT00395304|526914464|FG003|Treatment Period 1|Physician Decision|0|||
146107515|NCT00395304|526914465|FG004|Treatment Period 1|Physician Decision|0|||
146107516|NCT00395304|526914466|FG005|Treatment Period 1|Physician Decision|0|||
146107517|NCT00395304|526914461|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146107518|NCT00395304|526914462|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146107519|NCT00395304|526914463|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146107520|NCT00395304|526914464|FG003|Treatment Period 2|Withdrawal by Subject|1|||
146107521|NCT00395304|526914465|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146107522|NCT00395304|526914466|FG005|Treatment Period 2|Withdrawal by Subject|2|||
146107523|NCT00395304|526914461|FG000|Treatment Period 2|Lost to Follow-up|0|||
146107524|NCT00395304|526914462|FG001|Treatment Period 2|Lost to Follow-up|3|||
146107525|NCT00395304|526914463|FG002|Treatment Period 2|Lost to Follow-up|0|||
146107526|NCT00395304|526914464|FG003|Treatment Period 2|Lost to Follow-up|0|||
146107527|NCT00395304|526914465|FG004|Treatment Period 2|Lost to Follow-up|0|||
146107528|NCT00395304|526914466|FG005|Treatment Period 2|Lost to Follow-up|0|||
146107529|NCT00395304|526914461|FG000|Treatment Period 2|Physician Decision|0|||
146107530|NCT00395304|526914462|FG001|Treatment Period 2|Physician Decision|0|||
146107531|NCT00395304|526914463|FG002|Treatment Period 2|Physician Decision|1|||
146107532|NCT00395304|526914464|FG003|Treatment Period 2|Physician Decision|0|||
146107533|NCT00395304|526914465|FG004|Treatment Period 2|Physician Decision|0|||
146107534|NCT00395304|526914466|FG005|Treatment Period 2|Physician Decision|0|||
146107535|NCT00395304|526914461|FG000|Treatment Period 2|Other|0|||
146107536|NCT00395304|526914462|FG001|Treatment Period 2|Other|1|||
146107537|NCT00395304|526914463|FG002|Treatment Period 2|Other|0|||
146107538|NCT00395304|526914464|FG003|Treatment Period 2|Other|0|||
146107539|NCT00395304|526914465|FG004|Treatment Period 2|Other|0|||
146107540|NCT00395304|526914466|FG005|Treatment Period 2|Other|0|||
146107541|NCT00395304|526914461|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146107542|NCT00395304|526914462|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146107543|NCT00395304|526914463|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146107544|NCT00395304|526914464|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146107545|NCT00395304|526914465|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146107546|NCT00395304|526914466|FG005|Treatment Period 3|Withdrawal by Subject|1|||
146107547|NCT00395304|526914461|FG000|Treatment Period 3|Lost to Follow-up|1|||
146107548|NCT00395304|526914462|FG001|Treatment Period 3|Lost to Follow-up|1|||
146107549|NCT00395304|526914463|FG002|Treatment Period 3|Lost to Follow-up|0|||
146107550|NCT00395304|526914464|FG003|Treatment Period 3|Lost to Follow-up|0|||
146107551|NCT00395304|526914465|FG004|Treatment Period 3|Lost to Follow-up|0|||
146107552|NCT00395304|526914466|FG005|Treatment Period 3|Lost to Follow-up|0|||
146107553|NCT00395304|526914461|FG000|Treatment Period 3|Physician Decision|0|||
146107554|NCT00395304|526914462|FG001|Treatment Period 3|Physician Decision|1|||
146258271|NCT00053352|527461401|FG000|Overall Study|Ineligible|8|||
146258272|NCT00053352|527461402|FG001|Overall Study|Ineligible|8|||
146107555|NCT00395304|526914463|FG002|Treatment Period 3|Physician Decision|0|||
146107556|NCT00395304|526914464|FG003|Treatment Period 3|Physician Decision|0|||
146107557|NCT00395304|526914465|FG004|Treatment Period 3|Physician Decision|0|||
146107558|NCT00395304|526914466|FG005|Treatment Period 3|Physician Decision|0|||
146107559|NCT00395304|526914461|FG000|Treatment Period 3|Other|0|||
146107560|NCT00395304|526914462|FG001|Treatment Period 3|Other|0|||
146107561|NCT00395304|526914463|FG002|Treatment Period 3|Other|0|||
146107562|NCT00395304|526914464|FG003|Treatment Period 3|Other|1|||
146107563|NCT00395304|526914465|FG004|Treatment Period 3|Other|0|||
146107564|NCT00395304|526914466|FG005|Treatment Period 3|Other|0|||
146107565|NCT01389817|526914467|FG000|Overall Study|Physician Decision|1|||
146107566|NCT01389817|526914468|FG001|Overall Study|Physician Decision|0|||
146107567|NCT01389817|526914467|FG000|Overall Study|Lost to Follow-up|1|||
146258273|NCT00053352|527461401|FG000|Overall Study|Disease at new site|1|||
146107568|NCT01389817|526914468|FG001|Overall Study|Lost to Follow-up|0|||
146107569|NCT01389817|526914467|FG000|Overall Study|Withdrawal by Subject|2|||
146107570|NCT01389817|526914468|FG001|Overall Study|Withdrawal by Subject|0|||
146107571|NCT02871297|526914476|FG000|Overall Study|Adverse Event|34|||
146107572|NCT02871297|526914476|FG000|Overall Study|Lack of Efficacy|10|||
146107573|NCT02871297|526914476|FG000|Overall Study|Non-compliance with study drug|15|||
146107574|NCT02871297|526914476|FG000|Overall Study|Protocol Violation|3|||
146107575|NCT02871297|526914476|FG000|Overall Study|Withdrawal by Subject|20|||
146107576|NCT02871297|526914476|FG000|Overall Study|Lost to Follow-up|13|||
146107577|NCT02871297|526914476|FG000|Overall Study|Rolled over to 13546A|2|||
146107578|NCT02871297|526914476|FG000|Overall Study|Other than specified|39|||
146107579|NCT02966028|526914477|FG000|Overall Study|Adverse Event|7|||
146107580|NCT02966028|526914478|FG001|Overall Study|Adverse Event|13|||
146107581|NCT02966028|526914479|FG002|Overall Study|Adverse Event|10|||
146107582|NCT02966028|526914477|FG000|Overall Study|Physician Decision|1|||
146107583|NCT02966028|526914478|FG001|Overall Study|Physician Decision|0|||
146107584|NCT02966028|526914479|FG002|Overall Study|Physician Decision|2|||
146107585|NCT02966028|526914477|FG000|Overall Study|Withdrawal by Subject|7|||
146107586|NCT02966028|526914478|FG001|Overall Study|Withdrawal by Subject|5|||
146107587|NCT02966028|526914479|FG002|Overall Study|Withdrawal by Subject|5|||
146107588|NCT02966028|526914477|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
146107589|NCT02966028|526914478|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
146107590|NCT02966028|526914479|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
146107591|NCT01397084|526914480|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
146107592|NCT01397084|526914480|FG000|Overall Study|Protocol Violation|2|||
146107593|NCT01397084|526914480|FG000|Overall Study|Adverse Event|2|||
146107594|NCT01397084|526914480|FG000|Overall Study|Withdrawal by Subject|1|||
146107595|NCT01397084|526914480|FG000|Overall Study|Lost to Follow-up|1|||
146107596|NCT01397084|526914480|FG000|Overall Study|Used other proton pump inhibitor|1|||
146107597|NCT00573469|526914481|FG000|Overall Study|Adverse Event|1|||
146107598|NCT00573469|526914482|FG001|Overall Study|Adverse Event|1|||
146107599|NCT00573469|526914483|FG002|Overall Study|Adverse Event|1|||
146107600|NCT00573469|526914481|FG000|Overall Study|Withdrawal by Subject|0|||
146107601|NCT00573469|526914482|FG001|Overall Study|Withdrawal by Subject|2|||
146107602|NCT00573469|526914483|FG002|Overall Study|Withdrawal by Subject|0|||
146107603|NCT00573469|526914481|FG000|Overall Study|Other|5|||
146107604|NCT00573469|526914482|FG001|Overall Study|Other|1|||
146107605|NCT00573469|526914483|FG002|Overall Study|Other|3|||
146107606|NCT00160693|526914484|FG000|Overall Study|Adverse Event|97|||
146107607|NCT00160693|526914484|FG000|Overall Study|Lack of Efficacy|30|||
146107608|NCT00160693|526914484|FG000|Overall Study|Protocol Violation|24|||
146107609|NCT00160693|526914484|FG000|Overall Study|Lost to Follow-up|15|||
146107610|NCT00160693|526914484|FG000|Overall Study|Withdrawal by Subject|54|||
146107611|NCT00160693|526914484|FG000|Overall Study|Study terminated by sponsor|15|||
146107612|NCT01976338|526914485|FG000|Overall Study|Physician Decision|0|||
146107613|NCT01976338|526914486|FG001|Overall Study|Physician Decision|1|||
146107614|NCT01976338|526914485|FG000|Overall Study|Lost to Follow-up|3|||
146258274|NCT00053352|527461402|FG001|Overall Study|Disease at new site|0|||
146258275|NCT02741713|527461405|FG000|Overall Study|Surgery type changed intra-operatively|2|||
146258276|NCT02741713|527461406|FG001|Overall Study|Surgery type changed intra-operatively|1|||
146258277|NCT01388478|527461407|FG000|Overall Study|Adverse Event|4|||
146258278|NCT01388478|527461407|FG000|Overall Study|Withdrawal by Subject|1|||
146107615|NCT01976338|526914486|FG001|Overall Study|Lost to Follow-up|0|||
146107616|NCT01976338|526914485|FG000|Overall Study|Withdrawal by Subject|5|||
146107617|NCT01976338|526914486|FG001|Overall Study|Withdrawal by Subject|2|||
146258279|NCT01990664|527461410|FG000|Overall Study|Lost to Follow-up|2|||
146107618|NCT01976338|526914485|FG000|Overall Study|Adverse Event|5|||
146107619|NCT01976338|526914486|FG001|Overall Study|Adverse Event|1|||
146107620|NCT02853604|526914487|FG000|Overall Study|Withdrawal by Subject|12|||
146107621|NCT02853604|526914488|FG001|Overall Study|Withdrawal by Subject|35|||
146107622|NCT02853604|526914487|FG000|Overall Study|Lost to Follow-up|4|||
146107623|NCT02853604|526914488|FG001|Overall Study|Lost to Follow-up|8|||
146107624|NCT02853604|526914487|FG000|Overall Study|Death|1|||
146107625|NCT02853604|526914488|FG001|Overall Study|Death|5|||
146107626|NCT02853604|526914487|FG000|Overall Study|Miscellaneous|11|||
146107627|NCT02853604|526914488|FG001|Overall Study|Miscellaneous|2|||
146107628|NCT02853604|526914487|FG000|Overall Study|Progressive Disease|0|||
146107629|NCT02853604|526914488|FG001|Overall Study|Progressive Disease|2|||
146107630|NCT03766581|526914489|FG000|Randomization|Other reasons|2|||
146107631|NCT03766581|526914490|FG001|Randomization|Other reasons|1|||
146107632|NCT03766581|526914491|FG002|Randomization|Other reasons|0|||
146107633|NCT03766581|526914492|FG003|Randomization|Other reasons|1|||
146107634|NCT03766581|526914493|FG004|Randomization|Other reasons|0|||
146107635|NCT03766581|526914494|FG005|Randomization|Other reasons|0|||
146107636|NCT03766581|526914495|FG006|Randomization|Other reasons|0|||
146107637|NCT03766581|526914496|FG007|Randomization|Other reasons|0|||
146107638|NCT03766581|526914489|FG000|Randomization|Participant no longer meets study criteria|5|||
146107639|NCT03766581|526914490|FG001|Randomization|Participant no longer meets study criteria|3|||
146107640|NCT03766581|526914491|FG002|Randomization|Participant no longer meets study criteria|4|||
146107641|NCT03766581|526914492|FG003|Randomization|Participant no longer meets study criteria|0|||
146107642|NCT03766581|526914493|FG004|Randomization|Participant no longer meets study criteria|2|||
146107643|NCT03766581|526914494|FG005|Randomization|Participant no longer meets study criteria|3|||
146107644|NCT03766581|526914495|FG006|Randomization|Participant no longer meets study criteria|0|||
146107645|NCT03766581|526914496|FG007|Randomization|Participant no longer meets study criteria|1|||
146107646|NCT03766581|526914489|FG000|Randomization|Participant request to discontinue study treatment|1|||
146107647|NCT03766581|526914490|FG001|Randomization|Participant request to discontinue study treatment|0|||
146107648|NCT03766581|526914491|FG002|Randomization|Participant request to discontinue study treatment|0|||
146107649|NCT03766581|526914492|FG003|Randomization|Participant request to discontinue study treatment|0|||
146107650|NCT03766581|526914493|FG004|Randomization|Participant request to discontinue study treatment|1|||
146107651|NCT03766581|526914494|FG005|Randomization|Participant request to discontinue study treatment|2|||
146107652|NCT03766581|526914495|FG006|Randomization|Participant request to discontinue study treatment|0|||
146107653|NCT03766581|526914496|FG007|Randomization|Participant request to discontinue study treatment|0|||
146107654|NCT03766581|526914489|FG000|Randomization|Participant withdrew consent|1|||
146107655|NCT03766581|526914490|FG001|Randomization|Participant withdrew consent|0|||
146107656|NCT03766581|526914491|FG002|Randomization|Participant withdrew consent|1|||
146107657|NCT03766581|526914492|FG003|Randomization|Participant withdrew consent|2|||
146107658|NCT03766581|526914493|FG004|Randomization|Participant withdrew consent|1|||
146107659|NCT03766581|526914494|FG005|Randomization|Participant withdrew consent|1|||
146107660|NCT03766581|526914495|FG006|Randomization|Participant withdrew consent|0|||
146107661|NCT03766581|526914496|FG007|Randomization|Participant withdrew consent|0|||
146107662|NCT03766581|526914489|FG000|Treatment|Adverse Event|82|||
146107663|NCT03766581|526914490|FG001|Treatment|Adverse Event|44|||
146107664|NCT03766581|526914491|FG002|Treatment|Adverse Event|47|||
146107665|NCT03766581|526914492|FG003|Treatment|Adverse Event|46|||
146107666|NCT03766581|526914493|FG004|Treatment|Adverse Event|50|||
146107667|NCT03766581|526914494|FG005|Treatment|Adverse Event|77|||
146107668|NCT03766581|526914495|FG006|Treatment|Adverse Event|5|||
146107669|NCT03766581|526914496|FG007|Treatment|Adverse Event|2|||
146107670|NCT03766581|526914489|FG000|Treatment|Participant request to discontinue treatment|34|||
146107671|NCT03766581|526914490|FG001|Treatment|Participant request to discontinue treatment|6|||
146107672|NCT03766581|526914491|FG002|Treatment|Participant request to discontinue treatment|10|||
146107673|NCT03766581|526914492|FG003|Treatment|Participant request to discontinue treatment|10|||
146107674|NCT03766581|526914493|FG004|Treatment|Participant request to discontinue treatment|14|||
146107675|NCT03766581|526914494|FG005|Treatment|Participant request to discontinue treatment|15|||
146107676|NCT03766581|526914495|FG006|Treatment|Participant request to discontinue treatment|0|||
146107677|NCT03766581|526914496|FG007|Treatment|Participant request to discontinue treatment|1|||
146107678|NCT03766581|526914489|FG000|Treatment|Participant withdrew consent|11|||
146107679|NCT03766581|526914490|FG001|Treatment|Participant withdrew consent|4|||
146107680|NCT03766581|526914491|FG002|Treatment|Participant withdrew consent|5|||
146107681|NCT03766581|526914492|FG003|Treatment|Participant withdrew consent|5|||
146107682|NCT03766581|526914493|FG004|Treatment|Participant withdrew consent|4|||
146107683|NCT03766581|526914494|FG005|Treatment|Participant withdrew consent|4|||
146107684|NCT03766581|526914495|FG006|Treatment|Participant withdrew consent|0|||
146107685|NCT03766581|526914496|FG007|Treatment|Participant withdrew consent|0|||
146107686|NCT03766581|526914489|FG000|Treatment|Death|1|||
146107687|NCT03766581|526914490|FG001|Treatment|Death|0|||
146107688|NCT03766581|526914491|FG002|Treatment|Death|0|||
146107689|NCT03766581|526914492|FG003|Treatment|Death|0|||
146107690|NCT03766581|526914493|FG004|Treatment|Death|0|||
146107691|NCT03766581|526914494|FG005|Treatment|Death|0|||
146107692|NCT03766581|526914495|FG006|Treatment|Death|0|||
146107693|NCT03766581|526914496|FG007|Treatment|Death|0|||
146107694|NCT03766581|526914489|FG000|Treatment|Lost to Follow-up|1|||
146107695|NCT03766581|526914490|FG001|Treatment|Lost to Follow-up|0|||
146107696|NCT03766581|526914491|FG002|Treatment|Lost to Follow-up|0|||
146107697|NCT03766581|526914492|FG003|Treatment|Lost to Follow-up|1|||
146107698|NCT03766581|526914493|FG004|Treatment|Lost to Follow-up|0|||
146107699|NCT03766581|526914494|FG005|Treatment|Lost to Follow-up|0|||
146107700|NCT03766581|526914495|FG006|Treatment|Lost to Follow-up|0|||
146107701|NCT03766581|526914496|FG007|Treatment|Lost to Follow-up|0|||
146107702|NCT03766581|526914489|FG000|Treatment|Poor/Non compliance|2|||
146107703|NCT03766581|526914490|FG001|Treatment|Poor/Non compliance|2|||
146107704|NCT03766581|526914491|FG002|Treatment|Poor/Non compliance|1|||
146107705|NCT03766581|526914492|FG003|Treatment|Poor/Non compliance|1|||
146107706|NCT03766581|526914493|FG004|Treatment|Poor/Non compliance|1|||
146107707|NCT03766581|526914494|FG005|Treatment|Poor/Non compliance|1|||
146107708|NCT03766581|526914495|FG006|Treatment|Poor/Non compliance|0|||
146107709|NCT03766581|526914496|FG007|Treatment|Poor/Non compliance|0|||
146107710|NCT03766581|526914489|FG000|Treatment|Participant no longer meets study criteria|9|||
146107711|NCT03766581|526914490|FG001|Treatment|Participant no longer meets study criteria|1|||
146107712|NCT03766581|526914491|FG002|Treatment|Participant no longer meets study criteria|5|||
146107713|NCT03766581|526914492|FG003|Treatment|Participant no longer meets study criteria|4|||
146107714|NCT03766581|526914493|FG004|Treatment|Participant no longer meets study criteria|4|||
146107715|NCT03766581|526914494|FG005|Treatment|Participant no longer meets study criteria|4|||
146107716|NCT03766581|526914495|FG006|Treatment|Participant no longer meets study criteria|2|||
146107717|NCT03766581|526914496|FG007|Treatment|Participant no longer meets study criteria|0|||
146107718|NCT03766581|526914489|FG000|Treatment|Other reasons|13|||
146107719|NCT03766581|526914490|FG001|Treatment|Other reasons|8|||
146107720|NCT03766581|526914491|FG002|Treatment|Other reasons|3|||
146107721|NCT03766581|526914492|FG003|Treatment|Other reasons|7|||
146107722|NCT03766581|526914493|FG004|Treatment|Other reasons|3|||
146107723|NCT03766581|526914494|FG005|Treatment|Other reasons|3|||
146107724|NCT03766581|526914495|FG006|Treatment|Other reasons|0|||
146107725|NCT03766581|526914496|FG007|Treatment|Other reasons|0|||
146107726|NCT03716024|526914497|FG000|Overall Study|Randomized, not Treated|7|||
146107727|NCT03716024|526914498|FG001|Overall Study|Randomized, not Treated|8|||
146107728|NCT03716024|526914497|FG000|Overall Study|Adverse Event|1|||
146107729|NCT03716024|526914498|FG001|Overall Study|Adverse Event|2|||
146107730|NCT03716024|526914497|FG000|Overall Study|Treatment Failure|1|||
146107731|NCT03716024|526914498|FG001|Overall Study|Treatment Failure|0|||
146107732|NCT03716024|526914497|FG000|Overall Study|Lost to Follow-up|2|||
146107733|NCT03716024|526914498|FG001|Overall Study|Lost to Follow-up|6|||
146107734|NCT03716024|526914497|FG000|Overall Study|Withdrawal by Subject|0|||
146107735|NCT03716024|526914498|FG001|Overall Study|Withdrawal by Subject|1|||
146107736|NCT03716024|526914497|FG000|Overall Study|Missing Reason|0|||
146107737|NCT03716024|526914498|FG001|Overall Study|Missing Reason|1|||
146107738|NCT04182763|526914505|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
146107739|NCT04182763|526914506|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
146107740|NCT04182763|526914507|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
146107741|NCT04182763|526914508|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
146107742|NCT04182763|526914509|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
146107743|NCT04182763|526914505|FG000|Double-Blind Period, initial 6 months|Death|0|||
146107744|NCT04182763|526914506|FG001|Double-Blind Period, initial 6 months|Death|1|||
146107745|NCT04182763|526914507|FG002|Double-Blind Period, initial 6 months|Death|0|||
146107746|NCT04182763|526914508|FG003|Double-Blind Period, initial 6 months|Death|0|||
146107747|NCT04182763|526914509|FG004|Double-Blind Period, initial 6 months|Death|0|||
146107748|NCT04182763|526914505|FG000|Open-Label Period, subsequent 18 months|Death|3|||
146107749|NCT04182763|526914506|FG001|Open-Label Period, subsequent 18 months|Death|2|||
146107750|NCT04182763|526914507|FG002|Open-Label Period, subsequent 18 months|Death|2|||
146107751|NCT04182763|526914508|FG003|Open-Label Period, subsequent 18 months|Death|0|||
146107752|NCT04182763|526914509|FG004|Open-Label Period, subsequent 18 months|Death|1|||
146107753|NCT04182763|526914505|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
146107754|NCT04182763|526914506|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
146107755|NCT04182763|526914507|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
146107756|NCT04182763|526914508|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
146107757|NCT04182763|526914509|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
146107758|NCT04182763|526914505|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146107759|NCT04182763|526914506|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
146107760|NCT04182763|526914507|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146107761|NCT04182763|526914508|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
146107762|NCT04182763|526914509|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
146107763|NCT05988619|526914511|FG000|Overall Study|Lost to Follow-up|1|||
146107764|NCT05988619|526914512|FG001|Overall Study|Lost to Follow-up|4|||
146107765|NCT05988619|526914511|FG000|Overall Study|Withdrawal by Subject|2|||
146107766|NCT05988619|526914512|FG001|Overall Study|Withdrawal by Subject|9|||
146107767|NCT03616600|526914515|FG000|Overall Study|Withdrawal by Subject|1|||
146107768|NCT03616600|526914516|FG001|Overall Study|Withdrawal by Subject|0|||
146107769|NCT00587054|526914517|FG000|Overall Study|Patient not treated|9|||
146107770|NCT03984994|526914518|FG000|Overall Study|Withdrawal by Subject|2|||
146107771|NCT03984994|526914519|FG001|Overall Study|Withdrawal by Subject|1|||
146107772|NCT03010176|526914521|FG000|Overall Study|Death|21|||
146258280|NCT01990664|527461411|FG001|Overall Study|Lost to Follow-up|6|||
146258281|NCT01990664|527461410|FG000|Overall Study|Withdrawal by Subject|2|||
146258282|NCT01990664|527461411|FG001|Overall Study|Withdrawal by Subject|3|||
146051835|NCT01276639|526705371|FG000|Week 0 to 16|Death|1|||
146051836|NCT01276639|526705372|FG001|Week 0 to 16|Death|0|||
146051837|NCT01276639|526705373|FG002|Week 0 to 16|Death|0|||
146051838|NCT01276639|526705374|FG003|Week 0 to 16|Death|0|||
146051839|NCT01276639|526705375|FG004|Week 0 to 16|Death|0|||
146051840|NCT01276639|526705371|FG000|Week 0 to 16|Adverse Event|11|||
146051841|NCT01276639|526705372|FG001|Week 0 to 16|Adverse Event|8|||
146051842|NCT01276639|526705373|FG002|Week 0 to 16|Adverse Event|11|||
146051843|NCT01276639|526705374|FG003|Week 0 to 16|Adverse Event|0|||
146051844|NCT01276639|526705375|FG004|Week 0 to 16|Adverse Event|0|||
146051845|NCT01276639|526705371|FG000|Week 0 to 16|Lack of Efficacy|20|||
146051846|NCT01276639|526705372|FG001|Week 0 to 16|Lack of Efficacy|15|||
146051847|NCT01276639|526705373|FG002|Week 0 to 16|Lack of Efficacy|25|||
146051848|NCT01276639|526705374|FG003|Week 0 to 16|Lack of Efficacy|0|||
146051849|NCT01276639|526705375|FG004|Week 0 to 16|Lack of Efficacy|0|||
146051850|NCT01276639|526705371|FG000|Week 0 to 16|Lost to Follow-up|3|||
146051851|NCT01276639|526705372|FG001|Week 0 to 16|Lost to Follow-up|5|||
146051852|NCT01276639|526705373|FG002|Week 0 to 16|Lost to Follow-up|3|||
146051853|NCT01276639|526705374|FG003|Week 0 to 16|Lost to Follow-up|0|||
146051854|NCT01276639|526705375|FG004|Week 0 to 16|Lost to Follow-up|0|||
146051855|NCT01276639|526705371|FG000|Week 0 to 16|Withdrawal by Subject|8|||
146051856|NCT01276639|526705372|FG001|Week 0 to 16|Withdrawal by Subject|5|||
146051857|NCT01276639|526705373|FG002|Week 0 to 16|Withdrawal by Subject|4|||
146051858|NCT01276639|526705374|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146051859|NCT01276639|526705375|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146051860|NCT01276639|526705371|FG000|Week 0 to 16|Other|7|||
146051861|NCT01276639|526705372|FG001|Week 0 to 16|Other|7|||
146051862|NCT01276639|526705373|FG002|Week 0 to 16|Other|2|||
146051863|NCT01276639|526705374|FG003|Week 0 to 16|Other|0|||
146051864|NCT01276639|526705375|FG004|Week 0 to 16|Other|0|||
146051865|NCT01276639|526705371|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
146051866|NCT01276639|526705372|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
146051867|NCT01276639|526705373|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
146051868|NCT01276639|526705374|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
146051869|NCT01276639|526705375|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
146051870|NCT01276639|526705371|FG000|Week 16 to 52|Death|1|||
146051871|NCT01276639|526705372|FG001|Week 16 to 52|Death|0|||
146051872|NCT01276639|526705373|FG002|Week 16 to 52|Death|0|||
146051873|NCT01276639|526705374|FG003|Week 16 to 52|Death|0|||
146051874|NCT01276639|526705375|FG004|Week 16 to 52|Death|0|||
146051875|NCT01276639|526705371|FG000|Week 16 to 52|Adverse Event|10|||
146051876|NCT01276639|526705372|FG001|Week 16 to 52|Adverse Event|13|||
146051877|NCT01276639|526705373|FG002|Week 16 to 52|Adverse Event|0|||
146051878|NCT01276639|526705374|FG003|Week 16 to 52|Adverse Event|1|||
146051879|NCT01276639|526705375|FG004|Week 16 to 52|Adverse Event|3|||
146051880|NCT01276639|526705371|FG000|Week 16 to 52|Lack of Efficacy|99|||
146051881|NCT01276639|526705372|FG001|Week 16 to 52|Lack of Efficacy|71|||
146051882|NCT01276639|526705373|FG002|Week 16 to 52|Lack of Efficacy|0|||
146051883|NCT01276639|526705374|FG003|Week 16 to 52|Lack of Efficacy|14|||
146051884|NCT01276639|526705375|FG004|Week 16 to 52|Lack of Efficacy|13|||
146051885|NCT01276639|526705371|FG000|Week 16 to 52|Lost to Follow-up|3|||
146051886|NCT01276639|526705372|FG001|Week 16 to 52|Lost to Follow-up|1|||
146051887|NCT01276639|526705373|FG002|Week 16 to 52|Lost to Follow-up|0|||
146051888|NCT01276639|526705374|FG003|Week 16 to 52|Lost to Follow-up|0|||
146051889|NCT01276639|526705375|FG004|Week 16 to 52|Lost to Follow-up|1|||
146051890|NCT01276639|526705371|FG000|Week 16 to 52|Withdrawal by Subject|4|||
146051891|NCT01276639|526705372|FG001|Week 16 to 52|Withdrawal by Subject|4|||
146051892|NCT01276639|526705373|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146051893|NCT01276639|526705374|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146051894|NCT01276639|526705375|FG004|Week 16 to 52|Withdrawal by Subject|1|||
146051895|NCT01276639|526705371|FG000|Week 16 to 52|Other|10|||
146051896|NCT01276639|526705372|FG001|Week 16 to 52|Other|12|||
146051897|NCT01276639|526705373|FG002|Week 16 to 52|Other|0|||
146051898|NCT01276639|526705374|FG003|Week 16 to 52|Other|1|||
146051899|NCT01276639|526705375|FG004|Week 16 to 52|Other|3|||
146051900|NCT03431441|526705376|FG000|Overall Study|Withdrawal by Subject|2|||
146051901|NCT03431441|526705376|FG000|Overall Study|Adverse Event|2|||
146051902|NCT03431441|526705376|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
146051903|NCT03985761|526705379|FG000|Overall Study|Withdrawal by Subject|2|||
146051904|NCT03985761|526705380|FG001|Overall Study|Withdrawal by Subject|3|||
146051905|NCT03956550|526705381|FG000|Overall Study|Sponsor decision|65|||
146051906|NCT03956550|526705382|FG001|Overall Study|Sponsor decision|66|||
146051907|NCT03956550|526705383|FG002|Overall Study|Sponsor decision|64|||
146051908|NCT03956550|526705381|FG000|Overall Study|Adverse Event|0|||
146051909|NCT03956550|526705382|FG001|Overall Study|Adverse Event|1|||
146051910|NCT03956550|526705383|FG002|Overall Study|Adverse Event|0|||
146051911|NCT03956550|526705381|FG000|Overall Study|Withdrawal by Subject|5|||
146051912|NCT03956550|526705382|FG001|Overall Study|Withdrawal by Subject|5|||
146107773|NCT03010176|526914522|FG001|Overall Study|Death|35|||
146107774|NCT03010176|526914523|FG002|Overall Study|Death|19|||
146107775|NCT03010176|526914524|FG003|Overall Study|Death|19|||
146107776|NCT03010176|526914525|FG004|Overall Study|Death|14|||
146107777|NCT03010176|526914526|FG005|Overall Study|Death|0|||
146107778|NCT03010176|526914521|FG000|Overall Study|Lost to Follow-up|0|||
146107779|NCT03010176|526914522|FG001|Overall Study|Lost to Follow-up|0|||
146107780|NCT03010176|526914523|FG002|Overall Study|Lost to Follow-up|0|||
146107781|NCT03010176|526914524|FG003|Overall Study|Lost to Follow-up|0|||
146107782|NCT03010176|526914525|FG004|Overall Study|Lost to Follow-up|1|||
146107783|NCT03010176|526914526|FG005|Overall Study|Lost to Follow-up|0|||
146107784|NCT03010176|526914521|FG000|Overall Study|Physician Decision|0|||
146107785|NCT03010176|526914522|FG001|Overall Study|Physician Decision|4|||
146107786|NCT03010176|526914523|FG002|Overall Study|Physician Decision|0|||
146107787|NCT03010176|526914524|FG003|Overall Study|Physician Decision|1|||
146107788|NCT03010176|526914525|FG004|Overall Study|Physician Decision|0|||
146107789|NCT03010176|526914526|FG005|Overall Study|Physician Decision|0|||
146107790|NCT03010176|526914521|FG000|Overall Study|Sponsor Decision|0|||
146107791|NCT03010176|526914522|FG001|Overall Study|Sponsor Decision|4|||
146107792|NCT03010176|526914523|FG002|Overall Study|Sponsor Decision|4|||
146107793|NCT03010176|526914524|FG003|Overall Study|Sponsor Decision|1|||
146107794|NCT03010176|526914525|FG004|Overall Study|Sponsor Decision|6|||
146107795|NCT03010176|526914526|FG005|Overall Study|Sponsor Decision|0|||
146107796|NCT03010176|526914521|FG000|Overall Study|Withdrawal by Subject|11|||
146107797|NCT03010176|526914522|FG001|Overall Study|Withdrawal by Subject|9|||
146107798|NCT03010176|526914523|FG002|Overall Study|Withdrawal by Subject|3|||
146107799|NCT03010176|526914524|FG003|Overall Study|Withdrawal by Subject|0|||
146107800|NCT03010176|526914525|FG004|Overall Study|Withdrawal by Subject|4|||
146107801|NCT03010176|526914526|FG005|Overall Study|Withdrawal by Subject|0|||
146107802|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Death|0|||
146107803|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Death|0|||
146107804|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Death|0|||
146107805|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Death|0|||
146107806|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Death|1|||
146107807|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Death|0|||
146107808|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Death|0|||
146107809|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Death|0|||
146107810|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
146107811|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
146107812|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
146107813|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
146107814|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
146107815|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
146107816|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
146107817|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
146107818|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
146107819|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146107820|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146107821|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
146107822|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146107823|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
146107824|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146107825|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
146107826|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
146107827|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
146107828|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
146107829|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
146107830|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
146107831|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
146107832|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
146107833|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
146258283|NCT01990664|527461410|FG000|Overall Study|Protocol Violation|1|||
146107834|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
146107835|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146107836|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146258284|NCT01990664|527461411|FG001|Overall Study|Protocol Violation|0|||
146107837|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
146258285|NCT01990664|527461410|FG000|Overall Study|Lens Discomfort|1|||
146258286|NCT01990664|527461411|FG001|Overall Study|Lens Discomfort|1|||
146258287|NCT01990664|527461410|FG000|Overall Study|Lens Handling Difficulties|1|||
146107838|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
146107839|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
146258288|NCT01990664|527461411|FG001|Overall Study|Lens Handling Difficulties|0|||
146258289|NCT01990664|527461410|FG000|Overall Study|Unsatisfactory Visual Response|0|||
146258290|NCT01990664|527461411|FG001|Overall Study|Unsatisfactory Visual Response|1|||
146258291|NCT01037413|527461412|FG000|Part A: Skin Testing|Adverse Event|1|||
146258292|NCT01037413|527461413|FG001|Part A: Skin Testing|Adverse Event|0|||
146258293|NCT01037413|527461412|FG000|Part A: Skin Testing|Protocol Violation|1|||
146258294|NCT01037413|527461413|FG001|Part A: Skin Testing|Protocol Violation|0|||
146258295|NCT01037413|527461412|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
146258296|NCT01037413|527461413|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
146258297|NCT01037413|527461412|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
146258298|NCT01037413|527461413|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
146258299|NCT00619983|527461417|FG000|Test Drug Alone|Withdrawal by Subject|1|||
146258300|NCT00619983|527461418|FG001|Test Drug Alone|Withdrawal by Subject|0|||
146258301|NCT00619983|527461419|FG002|Test Drug Alone|Withdrawal by Subject|0|||
146258302|NCT00619983|527461420|FG003|Test Drug Alone|Withdrawal by Subject|1|||
146051913|NCT03956550|526705383|FG002|Overall Study|Withdrawal by Subject|6|||
146051914|NCT03400852|526705384|FG000|Blinded Treatment Period|Physician Decision|0|||
146051915|NCT03400852|526705385|FG001|Blinded Treatment Period|Physician Decision|1|||
146051916|NCT03400852|526705386|FG002|Blinded Treatment Period|Physician Decision|0|||
146051917|NCT03400852|526705384|FG000|Blinded Treatment Period|Adverse Event|1|||
146051918|NCT03400852|526705385|FG001|Blinded Treatment Period|Adverse Event|1|||
146051919|NCT03400852|526705386|FG002|Blinded Treatment Period|Adverse Event|0|||
146051920|NCT03400852|526705384|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
146051921|NCT03400852|526705385|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
146051922|NCT03400852|526705386|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
146051923|NCT03400852|526705384|FG000|Open Label Period|Physician Decision|0|||
146051924|NCT03400852|526705385|FG001|Open Label Period|Physician Decision|0|||
146051925|NCT03400852|526705386|FG002|Open Label Period|Physician Decision|1|||
146051926|NCT03400852|526705384|FG000|Open Label Period|Study terminated by sponsor|0|||
146051927|NCT03400852|526705385|FG001|Open Label Period|Study terminated by sponsor|0|||
146051928|NCT03400852|526705386|FG002|Open Label Period|Study terminated by sponsor|21|||
146051929|NCT02366312|526705387|FG000|Overall Study|Lost to Follow-up|0|||
146051930|NCT02366312|526705388|FG001|Overall Study|Lost to Follow-up|1|||
146051931|NCT02532465|526705389|FG000|Overall Study|Protocol Violation|1|||
146051932|NCT02532465|526705390|FG001|Overall Study|Protocol Violation|0|||
146051933|NCT02532465|526705389|FG000|Overall Study|Lack of Efficacy|0|||
146051934|NCT02532465|526705390|FG001|Overall Study|Lack of Efficacy|1|||
146051935|NCT03719131|526705392|FG000|Overall Study|Death|1|||
146051936|NCT03719131|526705393|FG001|Overall Study|Death|2|||
146051937|NCT01544920|526705394|FG000|Overall Study|Adverse Event|0|||
146051938|NCT01544920|526705395|FG001|Overall Study|Adverse Event|3|||
146051939|NCT01544920|526705394|FG000|Overall Study|Death|0|||
146051940|NCT01544920|526705395|FG001|Overall Study|Death|1|||
146051941|NCT01544920|526705394|FG000|Overall Study|Lost to Follow-up|11|||
146051942|NCT01544920|526705395|FG001|Overall Study|Lost to Follow-up|12|||
146051943|NCT01544920|526705394|FG000|Overall Study|Protocol Violation|0|||
146051944|NCT01544920|526705395|FG001|Overall Study|Protocol Violation|2|||
146051945|NCT01544920|526705394|FG000|Overall Study|Physician Decision|4|||
146051946|NCT01544920|526705395|FG001|Overall Study|Physician Decision|1|||
146051947|NCT01544920|526705394|FG000|Overall Study|Withdrawal by Subject|4|||
146051948|NCT01544920|526705395|FG001|Overall Study|Withdrawal by Subject|4|||
146051949|NCT00796666|526705400|FG000|Overall Study|Death|2|||
146051950|NCT00796666|526705401|FG001|Overall Study|Death|4|||
146051951|NCT00796666|526705400|FG000|Overall Study|Withdrawal by Subject|2|||
146051952|NCT00796666|526705401|FG001|Overall Study|Withdrawal by Subject|0|||
146051953|NCT00796666|526705400|FG000|Overall Study|Adverse Event|7|||
146051954|NCT00796666|526705401|FG001|Overall Study|Adverse Event|5|||
146051955|NCT00796666|526705400|FG000|Overall Study|Protocol Violation|1|||
146051956|NCT00796666|526705401|FG001|Overall Study|Protocol Violation|0|||
146051957|NCT00796666|526705400|FG000|Overall Study|Other|1|||
146051958|NCT00796666|526705401|FG001|Overall Study|Other|0|||
146051959|NCT00796666|526705400|FG000|Overall Study|Terminated by sponsor|53|||
146051960|NCT00796666|526705401|FG001|Overall Study|Terminated by sponsor|55|||
146051961|NCT00796666|526705400|FG000|Overall Study|Randomized and not treated|1|||
146051962|NCT00796666|526705401|FG001|Overall Study|Randomized and not treated|0|||
146051963|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146051964|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146051965|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146051966|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051967|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051968|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051969|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051970|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051971|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146258303|NCT00619983|527461417|FG000|Test Drug Alone|Failure of daily diary device|1|||
146258304|NCT00619983|527461418|FG001|Test Drug Alone|Failure of daily diary device|1|||
146258305|NCT00619983|527461419|FG002|Test Drug Alone|Failure of daily diary device|2|||
146107840|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
146107841|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
146107842|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
146107843|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146107844|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146107845|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
146107846|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
146107847|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
146107848|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146107849|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
146107850|NCT00726232|526914529|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
146107851|NCT00726232|526914530|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107852|NCT00726232|526914531|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107853|NCT00726232|526914532|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107854|NCT00726232|526914533|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107855|NCT00726232|526914534|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107856|NCT00726232|526914535|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107857|NCT00726232|526914536|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
146107858|NCT00726232|526914529|FG000|Expansion Phase|Death|0|||
146107859|NCT00726232|526914530|FG001|Expansion Phase|Death|0|||
146107860|NCT00726232|526914531|FG002|Expansion Phase|Death|0|||
146107861|NCT00726232|526914532|FG003|Expansion Phase|Death|0|||
146107862|NCT00726232|526914533|FG004|Expansion Phase|Death|0|||
146107863|NCT00726232|526914534|FG005|Expansion Phase|Death|0|||
146107864|NCT00726232|526914535|FG006|Expansion Phase|Death|0|||
146107865|NCT00726232|526914536|FG007|Expansion Phase|Death|1|||
146107866|NCT00726232|526914529|FG000|Expansion Phase|Adverse Event|0|||
146107867|NCT00726232|526914530|FG001|Expansion Phase|Adverse Event|0|||
146107868|NCT00726232|526914531|FG002|Expansion Phase|Adverse Event|0|||
146107869|NCT00726232|526914532|FG003|Expansion Phase|Adverse Event|0|||
146107870|NCT00726232|526914533|FG004|Expansion Phase|Adverse Event|0|||
146107871|NCT00726232|526914534|FG005|Expansion Phase|Adverse Event|0|||
146107872|NCT00726232|526914535|FG006|Expansion Phase|Adverse Event|6|||
146107873|NCT00726232|526914536|FG007|Expansion Phase|Adverse Event|11|||
146107874|NCT00726232|526914529|FG000|Expansion Phase|Withdrawal by Subject|0|||
146107875|NCT00726232|526914530|FG001|Expansion Phase|Withdrawal by Subject|0|||
146107876|NCT00726232|526914531|FG002|Expansion Phase|Withdrawal by Subject|0|||
146107877|NCT00726232|526914532|FG003|Expansion Phase|Withdrawal by Subject|0|||
146107878|NCT00726232|526914533|FG004|Expansion Phase|Withdrawal by Subject|0|||
146107879|NCT00726232|526914534|FG005|Expansion Phase|Withdrawal by Subject|0|||
146107880|NCT00726232|526914535|FG006|Expansion Phase|Withdrawal by Subject|2|||
146107881|NCT00726232|526914536|FG007|Expansion Phase|Withdrawal by Subject|3|||
146107882|NCT00726232|526914529|FG000|Expansion Phase|Disease progression|0|||
146107883|NCT00726232|526914530|FG001|Expansion Phase|Disease progression|0|||
146107884|NCT00726232|526914531|FG002|Expansion Phase|Disease progression|0|||
146107885|NCT00726232|526914532|FG003|Expansion Phase|Disease progression|0|||
146107886|NCT00726232|526914533|FG004|Expansion Phase|Disease progression|0|||
146107887|NCT00726232|526914534|FG005|Expansion Phase|Disease progression|0|||
146107888|NCT00726232|526914535|FG006|Expansion Phase|Disease progression|4|||
146107889|NCT00726232|526914536|FG007|Expansion Phase|Disease progression|0|||
146107890|NCT00726232|526914529|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
146107891|NCT00726232|526914530|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
146107892|NCT00726232|526914531|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
146107893|NCT00726232|526914532|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
146107894|NCT00726232|526914533|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
146107895|NCT00726232|526914534|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
146107896|NCT00726232|526914535|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
146107897|NCT00726232|526914536|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
146107898|NCT00726232|526914529|FG000|Expansion Phase|Per Investigator: lack of response|0|||
146107899|NCT00726232|526914530|FG001|Expansion Phase|Per Investigator: lack of response|0|||
146107900|NCT00726232|526914531|FG002|Expansion Phase|Per Investigator: lack of response|0|||
146051972|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051973|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051974|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051975|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
146051976|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051977|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
146051978|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051979|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146051980|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051981|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146107901|NCT00726232|526914532|FG003|Expansion Phase|Per Investigator: lack of response|0|||
146107902|NCT00726232|526914533|FG004|Expansion Phase|Per Investigator: lack of response|0|||
146107903|NCT00726232|526914534|FG005|Expansion Phase|Per Investigator: lack of response|0|||
146107904|NCT00726232|526914535|FG006|Expansion Phase|Per Investigator: lack of response|1|||
146107905|NCT00726232|526914536|FG007|Expansion Phase|Per Investigator: lack of response|7|||
146107906|NCT00726232|526914529|FG000|Expansion Phase|Unspecified reason|0|||
146107907|NCT00726232|526914530|FG001|Expansion Phase|Unspecified reason|0|||
146107908|NCT00726232|526914531|FG002|Expansion Phase|Unspecified reason|0|||
146107909|NCT00726232|526914532|FG003|Expansion Phase|Unspecified reason|0|||
146107910|NCT00726232|526914533|FG004|Expansion Phase|Unspecified reason|0|||
146107911|NCT00726232|526914534|FG005|Expansion Phase|Unspecified reason|0|||
146107912|NCT00726232|526914535|FG006|Expansion Phase|Unspecified reason|1|||
146107913|NCT00726232|526914536|FG007|Expansion Phase|Unspecified reason|0|||
146107914|NCT01651039|526914542|FG000|Overall Study|Non-evaluables|5|||
146107915|NCT01651039|526914542|FG000|Overall Study|Physician Decision|2|||
146107916|NCT01651039|526914542|FG000|Overall Study|Withdrawal by Subject|1|||
146107917|NCT01651039|526914542|FG000|Overall Study|Progressive Disease|22|||
146107918|NCT05393895|526914545|FG000|Overall Study|Adverse Event|2|||
146107919|NCT05393895|526914546|FG001|Overall Study|Adverse Event|3|||
146107920|NCT05393895|526914545|FG000|Overall Study|Lost to Follow-up|4|||
146107921|NCT05393895|526914546|FG001|Overall Study|Lost to Follow-up|3|||
146107922|NCT05393895|526914545|FG000|Overall Study|Protocol Violation|1|||
146107923|NCT05393895|526914546|FG001|Overall Study|Protocol Violation|0|||
146107924|NCT05393895|526914545|FG000|Overall Study|Withdrawal by Subject|1|||
146107925|NCT05393895|526914546|FG001|Overall Study|Withdrawal by Subject|4|||
146107926|NCT00968513|526914547|FG000|Overall Study|Death|4|||
146107927|NCT00968513|526914548|FG001|Overall Study|Death|10|||
146107928|NCT00968513|526914549|FG002|Overall Study|Death|15|||
146107929|NCT02002091|526914554|FG000|Screening|Lost to Follow-up|10|||
146107930|NCT02002091|526914555|FG001|Screening|Lost to Follow-up|12|||
146107931|NCT02002091|526914554|FG000|Screening|Death|3|||
146107932|NCT02002091|526914555|FG001|Screening|Death|2|||
146107933|NCT02083783|526914564|FG000|Overall Study|Withdrawal by Subject|1|||
146107934|NCT02083783|526914565|FG001|Overall Study|Withdrawal by Subject|0|||
146107935|NCT04967443|526914566|FG000|Open Label Treatment|Death|1|||
146107936|NCT04967443|526914567|FG001|Open Label Treatment|Death|0|||
146107937|NCT04967443|526914568|FG002|Open Label Treatment|Death|0|||
146107938|NCT04967443|526914569|FG003|Open Label Treatment|Death|0|||
146107939|NCT04967443|526914570|FG004|Open Label Treatment|Death|0|||
146107940|NCT04967443|526914571|FG005|Open Label Treatment|Death|0|||
146107941|NCT04967443|526914572|FG006|Open Label Treatment|Death|0|||
146107942|NCT04967443|526914573|FG007|Open Label Treatment|Death|0|||
146107943|NCT04967443|526914566|FG000|Open Label Treatment|Lost to Follow-up|0|||
146107944|NCT04967443|526914567|FG001|Open Label Treatment|Lost to Follow-up|0|||
146107945|NCT04967443|526914568|FG002|Open Label Treatment|Lost to Follow-up|1|||
146107946|NCT04967443|526914569|FG003|Open Label Treatment|Lost to Follow-up|0|||
146107947|NCT04967443|526914570|FG004|Open Label Treatment|Lost to Follow-up|0|||
146107948|NCT04967443|526914571|FG005|Open Label Treatment|Lost to Follow-up|0|||
146107949|NCT04967443|526914572|FG006|Open Label Treatment|Lost to Follow-up|0|||
146107950|NCT04967443|526914573|FG007|Open Label Treatment|Lost to Follow-up|0|||
146107951|NCT04967443|526914566|FG000|Open Label Treatment|Withdrawal by Subject|0|||
146107952|NCT04967443|526914567|FG001|Open Label Treatment|Withdrawal by Subject|1|||
146107953|NCT04967443|526914568|FG002|Open Label Treatment|Withdrawal by Subject|0|||
146107954|NCT04967443|526914569|FG003|Open Label Treatment|Withdrawal by Subject|1|||
146107955|NCT04967443|526914570|FG004|Open Label Treatment|Withdrawal by Subject|0|||
146107956|NCT04967443|526914571|FG005|Open Label Treatment|Withdrawal by Subject|1|||
146107957|NCT04967443|526914572|FG006|Open Label Treatment|Withdrawal by Subject|2|||
146107958|NCT04967443|526914573|FG007|Open Label Treatment|Withdrawal by Subject|3|||
146107959|NCT04967443|526914566|FG000|Follow-Up|Death|1|||
146107960|NCT04967443|526914567|FG001|Follow-Up|Death|0|||
146107961|NCT04967443|526914568|FG002|Follow-Up|Death|0|||
146107962|NCT04967443|526914569|FG003|Follow-Up|Death|0|||
146107963|NCT04967443|526914570|FG004|Follow-Up|Death|0|||
146107964|NCT04967443|526914571|FG005|Follow-Up|Death|0|||
146107965|NCT04967443|526914572|FG006|Follow-Up|Death|0|||
146107966|NCT04967443|526914573|FG007|Follow-Up|Death|0|||
146107967|NCT04967443|526914566|FG000|Follow-Up|Lost to Follow-up|0|||
146107968|NCT04967443|526914567|FG001|Follow-Up|Lost to Follow-up|0|||
146107969|NCT04967443|526914568|FG002|Follow-Up|Lost to Follow-up|1|||
146107970|NCT04967443|526914569|FG003|Follow-Up|Lost to Follow-up|1|||
146301204|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146107971|NCT04967443|526914570|FG004|Follow-Up|Lost to Follow-up|0|||
146107972|NCT04967443|526914571|FG005|Follow-Up|Lost to Follow-up|0|||
146107973|NCT04967443|526914572|FG006|Follow-Up|Lost to Follow-up|0|||
146107974|NCT04967443|526914573|FG007|Follow-Up|Lost to Follow-up|0|||
146107975|NCT04967443|526914566|FG000|Follow-Up|Withdrawal by Subject|0|||
146107976|NCT04967443|526914567|FG001|Follow-Up|Withdrawal by Subject|1|||
146107977|NCT04967443|526914568|FG002|Follow-Up|Withdrawal by Subject|0|||
146107978|NCT04967443|526914569|FG003|Follow-Up|Withdrawal by Subject|1|||
146258306|NCT00619983|527461420|FG003|Test Drug Alone|Failure of daily diary device|2|||
146258307|NCT00931918|527461421|FG000|Overall Study|Adverse Event|4|||
146258308|NCT00931918|527461422|FG001|Overall Study|Adverse Event|6|||
146258309|NCT00931918|527461421|FG000|Overall Study|Progressive Disease|2|||
146258310|NCT00931918|527461422|FG001|Overall Study|Progressive Disease|1|||
146258311|NCT00931918|527461421|FG000|Overall Study|Symptomatic Deterioration|1|||
146258312|NCT00931918|527461422|FG001|Overall Study|Symptomatic Deterioration|0|||
146258313|NCT00931918|527461421|FG000|Overall Study|Withdrawal by Patient|3|||
146258314|NCT00931918|527461422|FG001|Overall Study|Withdrawal by Patient|4|||
146258315|NCT00931918|527461421|FG000|Overall Study|Other Reason not Specified|4|||
146051982|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
146051983|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146051984|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
146051985|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
146051986|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051987|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146051988|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051989|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051990|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
146051991|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
146051992|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
146051993|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
146051994|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
146051995|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
146051996|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
146051997|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
146051998|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
146051999|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
146052000|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
146052001|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
146052002|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
146052003|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
146052004|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
146052005|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
146052006|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
146052007|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
146052008|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146052009|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052010|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052011|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146052012|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052013|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052014|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052015|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052016|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052017|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052018|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
146052019|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052020|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052021|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052022|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
146052023|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052024|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052025|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052026|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052027|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052028|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052029|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052030|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052031|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052032|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052033|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052034|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052035|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052036|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
146052037|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
146052038|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146258316|NCT00931918|527461422|FG001|Overall Study|Other Reason not Specified|4|||
146258317|NCT00931918|527461421|FG000|Overall Study|Did not receive study drug|3|||
146258318|NCT00931918|527461422|FG001|Overall Study|Did not receive study drug|2|||
146258319|NCT00570921|527461424|FG000|Overall Study|Protocol Violation|1|||
146258320|NCT00570921|527461424|FG000|Overall Study|Physician Decision|1|||
146258321|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
146258322|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
146258323|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
146258324|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
146258325|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
146258326|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
146258327|NCT03201900|527461427|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
146258328|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
146258329|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
146258330|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
146258331|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
146258332|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
146258333|NCT03201900|527461427|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
146258334|NCT02971228|527461428|FG000|Overall Study|Withdrawal by Subject|1|||
146258335|NCT02971228|527461429|FG001|Overall Study|Withdrawal by Subject|1|||
146258336|NCT02971228|527461430|FG002|Overall Study|Withdrawal by Subject|0|||
146258337|NCT02971228|527461431|FG003|Overall Study|Withdrawal by Subject|0|||
146258338|NCT02971228|527461432|FG004|Overall Study|Withdrawal by Subject|0|||
146258339|NCT02971228|527461428|FG000|Overall Study|Logistical challenges|0|||
146258340|NCT02971228|527461429|FG001|Overall Study|Logistical challenges|1|||
146258341|NCT02971228|527461430|FG002|Overall Study|Logistical challenges|0|||
146258342|NCT02971228|527461431|FG003|Overall Study|Logistical challenges|0|||
146258343|NCT02971228|527461432|FG004|Overall Study|Logistical challenges|0|||
146258344|NCT02560389|527461433|FG000|Overall Study|Lost to Follow-up|1|||
146258345|NCT02560389|527461434|FG001|Overall Study|Lost to Follow-up|2|||
146258346|NCT02560389|527461435|FG002|Overall Study|Lost to Follow-up|2|||
146258347|NCT02560389|527461433|FG000|Overall Study|Tested positive for illicit substance|0|||
146258348|NCT02560389|527461434|FG001|Overall Study|Tested positive for illicit substance|1|||
146258349|NCT02560389|527461435|FG002|Overall Study|Tested positive for illicit substance|0|||
146258350|NCT02716298|527461436|FG000|First Intervention (1 Month)|Lens discomfort|1|||
146258351|NCT02716298|527461437|FG001|First Intervention (1 Month)|Lens discomfort|1|||
146258352|NCT00550446|527461438|FG000|Up To Week 12|Adverse Event|2|||
146258353|NCT00550446|527461439|FG001|Up To Week 12|Adverse Event|2|||
146258354|NCT00550446|527461440|FG002|Up To Week 12|Adverse Event|0|||
146258355|NCT00550446|527461441|FG003|Up To Week 12|Adverse Event|0|||
146258356|NCT00550446|527461442|FG004|Up To Week 12|Adverse Event|2|||
146258357|NCT00550446|527461443|FG005|Up To Week 12|Adverse Event|2|||
146258358|NCT00550446|527461444|FG006|Up To Week 12|Adverse Event|1|||
146258359|NCT00550446|527461445|FG007|Up To Week 12|Adverse Event|0|||
146258360|NCT00550446|527461446|FG008|Up To Week 12|Adverse Event|0|||
146258361|NCT00550446|527461447|FG009|Up To Week 12|Adverse Event|0|||
146052039|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052040|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052041|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
146052042|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052043|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052044|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052045|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052046|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052047|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052048|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
146052049|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052050|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052051|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052052|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
146052053|NCT01147666|526705402|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052054|NCT01147666|526705403|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052055|NCT01147666|526705404|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052056|NCT01147666|526705405|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052057|NCT01147666|526705406|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052058|NCT01147666|526705407|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052059|NCT01147666|526705408|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052060|NCT01147666|526705409|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052061|NCT01147666|526705410|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146258362|NCT00550446|527461448|FG010|Up To Week 12|Adverse Event|0|||
146258363|NCT00550446|527461438|FG000|Up To Week 12|Lack of Efficacy|3|||
146258364|NCT00550446|527461439|FG001|Up To Week 12|Lack of Efficacy|1|||
146107979|NCT04967443|526914570|FG004|Follow-Up|Withdrawal by Subject|0|||
146107980|NCT04967443|526914571|FG005|Follow-Up|Withdrawal by Subject|1|||
146258365|NCT00550446|527461440|FG002|Up To Week 12|Lack of Efficacy|0|||
146258366|NCT00550446|527461441|FG003|Up To Week 12|Lack of Efficacy|1|||
146258367|NCT00550446|527461442|FG004|Up To Week 12|Lack of Efficacy|0|||
146258368|NCT00550446|527461443|FG005|Up To Week 12|Lack of Efficacy|3|||
146258369|NCT00550446|527461444|FG006|Up To Week 12|Lack of Efficacy|3|||
146258370|NCT00550446|527461445|FG007|Up To Week 12|Lack of Efficacy|0|||
146258371|NCT00550446|527461446|FG008|Up To Week 12|Lack of Efficacy|0|||
146258372|NCT00550446|527461447|FG009|Up To Week 12|Lack of Efficacy|0|||
146258373|NCT00550446|527461448|FG010|Up To Week 12|Lack of Efficacy|0|||
146258374|NCT00550446|527461438|FG000|Up To Week 12|Lost to Follow-up|0|||
146258375|NCT00550446|527461439|FG001|Up To Week 12|Lost to Follow-up|1|||
146258376|NCT00550446|527461440|FG002|Up To Week 12|Lost to Follow-up|0|||
146258377|NCT00550446|527461441|FG003|Up To Week 12|Lost to Follow-up|0|||
146258378|NCT00550446|527461442|FG004|Up To Week 12|Lost to Follow-up|1|||
146258379|NCT00550446|527461443|FG005|Up To Week 12|Lost to Follow-up|1|||
146258380|NCT00550446|527461444|FG006|Up To Week 12|Lost to Follow-up|2|||
146258381|NCT00550446|527461445|FG007|Up To Week 12|Lost to Follow-up|0|||
146258382|NCT00550446|527461446|FG008|Up To Week 12|Lost to Follow-up|0|||
146258383|NCT00550446|527461447|FG009|Up To Week 12|Lost to Follow-up|0|||
146258384|NCT00550446|527461448|FG010|Up To Week 12|Lost to Follow-up|0|||
146258385|NCT00550446|527461438|FG000|Up To Week 12|Withdrawal by Subject|2|||
146258386|NCT00550446|527461439|FG001|Up To Week 12|Withdrawal by Subject|0|||
146258387|NCT00550446|527461440|FG002|Up To Week 12|Withdrawal by Subject|3|||
146258388|NCT00550446|527461441|FG003|Up To Week 12|Withdrawal by Subject|2|||
146258389|NCT00550446|527461442|FG004|Up To Week 12|Withdrawal by Subject|0|||
146258390|NCT00550446|527461443|FG005|Up To Week 12|Withdrawal by Subject|1|||
146258391|NCT00550446|527461444|FG006|Up To Week 12|Withdrawal by Subject|3|||
146258392|NCT00550446|527461445|FG007|Up To Week 12|Withdrawal by Subject|0|||
146258393|NCT00550446|527461446|FG008|Up To Week 12|Withdrawal by Subject|0|||
146258394|NCT00550446|527461447|FG009|Up To Week 12|Withdrawal by Subject|0|||
146258395|NCT00550446|527461448|FG010|Up To Week 12|Withdrawal by Subject|0|||
146258396|NCT00550446|527461438|FG000|Up To Week 12|Other|3|||
146258397|NCT00550446|527461439|FG001|Up To Week 12|Other|0|||
146258398|NCT00550446|527461440|FG002|Up To Week 12|Other|0|||
146258399|NCT00550446|527461441|FG003|Up To Week 12|Other|0|||
146258400|NCT00550446|527461442|FG004|Up To Week 12|Other|0|||
146258401|NCT00550446|527461443|FG005|Up To Week 12|Other|1|||
146258402|NCT00550446|527461444|FG006|Up To Week 12|Other|4|||
146258403|NCT00550446|527461445|FG007|Up To Week 12|Other|0|||
146258404|NCT00550446|527461446|FG008|Up To Week 12|Other|0|||
146258405|NCT00550446|527461447|FG009|Up To Week 12|Other|0|||
146107981|NCT04967443|526914572|FG006|Follow-Up|Withdrawal by Subject|2|||
146107982|NCT04967443|526914573|FG007|Follow-Up|Withdrawal by Subject|3|||
146107983|NCT01654536|526914574|FG000|Overall Study|Lost to Follow-up|5|||
146107984|NCT01654536|526914575|FG001|Overall Study|Lost to Follow-up|5|||
146107985|NCT01654536|526914574|FG000|Overall Study|Physician Decision|12|||
146107986|NCT01654536|526914575|FG001|Overall Study|Physician Decision|8|||
146107987|NCT01654536|526914574|FG000|Overall Study|Withdrawal by Subject|27|||
146107988|NCT01654536|526914575|FG001|Overall Study|Withdrawal by Subject|25|||
146107989|NCT03943147|526914576|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
146107990|NCT03943147|526914577|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
146107991|NCT03943147|526914576|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
146107992|NCT03943147|526914577|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
146107993|NCT03943147|526914576|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
146107994|NCT03943147|526914577|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
146258406|NCT00550446|527461448|FG010|Up To Week 12|Other|0|||
146258407|NCT00550446|527461438|FG000|Up To Week 12|Randomized not treated|0|||
146258408|NCT00550446|527461439|FG001|Up To Week 12|Randomized not treated|1|||
146107995|NCT03943147|526914576|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
146107996|NCT03943147|526914577|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
146107997|NCT03943147|526914576|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
146107998|NCT03943147|526914577|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
146107999|NCT03943147|526914576|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
146258409|NCT00550446|527461440|FG002|Up To Week 12|Randomized not treated|1|||
146258410|NCT00550446|527461441|FG003|Up To Week 12|Randomized not treated|0|||
146258411|NCT00550446|527461442|FG004|Up To Week 12|Randomized not treated|0|||
146108000|NCT03943147|526914577|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
146258412|NCT00550446|527461443|FG005|Up To Week 12|Randomized not treated|0|||
146108001|NCT00629707|526914580|FG000|Overall Study|Withdrawal by Subject|0|||
146108002|NCT00629707|526914581|FG001|Overall Study|Withdrawal by Subject|1|||
146108003|NCT00629707|526914580|FG000|Overall Study|Physician Decision|0|||
146258413|NCT00550446|527461444|FG006|Up To Week 12|Randomized not treated|0|||
146258414|NCT00550446|527461445|FG007|Up To Week 12|Randomized not treated|0|||
146258415|NCT00550446|527461446|FG008|Up To Week 12|Randomized not treated|0|||
146258416|NCT00550446|527461447|FG009|Up To Week 12|Randomized not treated|0|||
146052062|NCT01147666|526705411|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052063|NCT01147666|526705412|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052064|NCT01147666|526705413|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146052065|NCT01147666|526705414|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146052066|NCT01147666|526705415|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
146052067|NCT01147666|526705416|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
146052068|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
146052069|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
146052070|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
146052071|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
146052072|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
146052073|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
146052074|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
146052075|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
146052076|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
146052077|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
146052078|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
146052079|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
146052080|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
146052081|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
146052082|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
146052083|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052084|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052085|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052086|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052087|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
146052088|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146052089|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146052090|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146052091|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052092|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146052093|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052094|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052095|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
146052096|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
146052097|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
146052098|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052099|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052100|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052101|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
146052102|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052103|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052104|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052105|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052106|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052107|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052108|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052109|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052110|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052111|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052112|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
146052113|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052114|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052115|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052116|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052117|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146052118|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146052119|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052120|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146052121|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052122|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146052123|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052124|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052125|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052126|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
146052127|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
146052128|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146301205|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146301206|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
146301207|NCT03627767|527618859|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
146301208|NCT03627767|527618860|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146301209|NCT03627767|527618861|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146301210|NCT03627767|527618862|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146301211|NCT03627767|527618863|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
146301212|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
146301213|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
146301214|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
146301215|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
146301216|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
146301217|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146301218|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146301219|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
146301220|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
146301221|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146301222|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
146301223|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
146301224|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
146301225|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
146301226|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
146301227|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146301228|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
146052129|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052130|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052131|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
146052132|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146258417|NCT00550446|527461448|FG010|Up To Week 12|Randomized not treated|0|||
146258418|NCT00550446|527461438|FG000|Post Week 12|Adverse Event|2|||
146258419|NCT00550446|527461439|FG001|Post Week 12|Adverse Event|1|||
146258420|NCT00550446|527461440|FG002|Post Week 12|Adverse Event|1|||
146258421|NCT00550446|527461441|FG003|Post Week 12|Adverse Event|1|||
146258422|NCT00550446|527461442|FG004|Post Week 12|Adverse Event|1|||
146258423|NCT00550446|527461443|FG005|Post Week 12|Adverse Event|1|||
146258424|NCT00550446|527461444|FG006|Post Week 12|Adverse Event|0|||
146258425|NCT00550446|527461445|FG007|Post Week 12|Adverse Event|0|||
146258426|NCT00550446|527461446|FG008|Post Week 12|Adverse Event|0|||
146258427|NCT00550446|527461447|FG009|Post Week 12|Adverse Event|4|||
146258428|NCT00550446|527461448|FG010|Post Week 12|Adverse Event|0|||
146258429|NCT00550446|527461438|FG000|Post Week 12|Lack of Efficacy|0|||
146258430|NCT00550446|527461439|FG001|Post Week 12|Lack of Efficacy|0|||
146258431|NCT00550446|527461440|FG002|Post Week 12|Lack of Efficacy|1|||
146258432|NCT00550446|527461441|FG003|Post Week 12|Lack of Efficacy|0|||
146258433|NCT00550446|527461442|FG004|Post Week 12|Lack of Efficacy|0|||
146258434|NCT00550446|527461443|FG005|Post Week 12|Lack of Efficacy|0|||
146258435|NCT00550446|527461444|FG006|Post Week 12|Lack of Efficacy|0|||
146258436|NCT00550446|527461445|FG007|Post Week 12|Lack of Efficacy|1|||
146258437|NCT00550446|527461446|FG008|Post Week 12|Lack of Efficacy|1|||
146258438|NCT00550446|527461447|FG009|Post Week 12|Lack of Efficacy|2|||
146258439|NCT00550446|527461448|FG010|Post Week 12|Lack of Efficacy|1|||
146258440|NCT00550446|527461438|FG000|Post Week 12|Lost to Follow-up|0|||
146258441|NCT00550446|527461439|FG001|Post Week 12|Lost to Follow-up|0|||
146258442|NCT00550446|527461440|FG002|Post Week 12|Lost to Follow-up|1|||
146258443|NCT00550446|527461441|FG003|Post Week 12|Lost to Follow-up|1|||
146258444|NCT00550446|527461442|FG004|Post Week 12|Lost to Follow-up|0|||
146258445|NCT00550446|527461443|FG005|Post Week 12|Lost to Follow-up|0|||
146258446|NCT00550446|527461444|FG006|Post Week 12|Lost to Follow-up|1|||
146258447|NCT00550446|527461445|FG007|Post Week 12|Lost to Follow-up|0|||
146258448|NCT00550446|527461446|FG008|Post Week 12|Lost to Follow-up|0|||
146258449|NCT00550446|527461447|FG009|Post Week 12|Lost to Follow-up|0|||
146258450|NCT00550446|527461448|FG010|Post Week 12|Lost to Follow-up|0|||
146258451|NCT00550446|527461438|FG000|Post Week 12|Withdrawal by Subject|0|||
146258452|NCT00550446|527461439|FG001|Post Week 12|Withdrawal by Subject|0|||
146258453|NCT00550446|527461440|FG002|Post Week 12|Withdrawal by Subject|0|||
146258454|NCT00550446|527461441|FG003|Post Week 12|Withdrawal by Subject|0|||
146108004|NCT00629707|526914581|FG001|Overall Study|Physician Decision|1|||
146258455|NCT00550446|527461442|FG004|Post Week 12|Withdrawal by Subject|1|||
146258456|NCT00550446|527461443|FG005|Post Week 12|Withdrawal by Subject|0|||
146258457|NCT00550446|527461444|FG006|Post Week 12|Withdrawal by Subject|0|||
146258458|NCT00550446|527461445|FG007|Post Week 12|Withdrawal by Subject|0|||
146258459|NCT00550446|527461446|FG008|Post Week 12|Withdrawal by Subject|0|||
146258460|NCT00550446|527461447|FG009|Post Week 12|Withdrawal by Subject|0|||
146258461|NCT00550446|527461448|FG010|Post Week 12|Withdrawal by Subject|0|||
146258462|NCT00550446|527461438|FG000|Post Week 12|Other|1|||
146258463|NCT00550446|527461439|FG001|Post Week 12|Other|1|||
146258464|NCT00550446|527461440|FG002|Post Week 12|Other|0|||
146258465|NCT00550446|527461441|FG003|Post Week 12|Other|1|||
146258466|NCT00550446|527461442|FG004|Post Week 12|Other|0|||
146258467|NCT00550446|527461443|FG005|Post Week 12|Other|0|||
146258468|NCT00550446|527461444|FG006|Post Week 12|Other|1|||
146258469|NCT00550446|527461445|FG007|Post Week 12|Other|0|||
146258470|NCT00550446|527461446|FG008|Post Week 12|Other|1|||
146258471|NCT00550446|527461447|FG009|Post Week 12|Other|1|||
146258472|NCT00550446|527461448|FG010|Post Week 12|Other|0|||
146258473|NCT04081389|527461450|FG000|Overall Study|Withdrawal by Subject|0|||
146258474|NCT04081389|527461451|FG001|Overall Study|Withdrawal by Subject|0|||
146258475|NCT04081389|527461452|FG002|Overall Study|Withdrawal by Subject|1|||
146258476|NCT04081389|527461453|FG003|Overall Study|Withdrawal by Subject|0|||
146258477|NCT01670188|527461454|FG000|Overall Study|Death|0|||
146258478|NCT01670188|527461455|FG001|Overall Study|Death|1|||
146258479|NCT00866918|527461456|FG000|Overall Study|Death|1|||
146258480|NCT00866918|527461457|FG001|Overall Study|Death|5|||
146258481|NCT00866918|527461456|FG000|Overall Study|Lack of Efficacy|1|||
146258482|NCT00866918|527461457|FG001|Overall Study|Lack of Efficacy|1|||
146258483|NCT00866918|527461456|FG000|Overall Study|Physician Decision|10|||
146258484|NCT00866918|527461457|FG001|Overall Study|Physician Decision|2|||
146258485|NCT00866918|527461456|FG000|Overall Study|Ineligible|2|||
146258486|NCT00866918|527461457|FG001|Overall Study|Ineligible|4|||
146258487|NCT00866918|527461456|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
146258488|NCT00866918|527461457|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
146258489|NCT00866918|527461456|FG000|Overall Study|Secondary malignancy|1|||
146258490|NCT00866918|527461457|FG001|Overall Study|Secondary malignancy|0|||
146258491|NCT00802438|527461458|FG000|Overall Study|Screen Failure|20|||
146258492|NCT00802438|527461458|FG000|Overall Study|Withdrawal by Subject|7|||
146258493|NCT00802438|527461458|FG000|Overall Study|Physician Decision|1|||
146258494|NCT02101268|527461461|FG000|Randomized Treatment Phase|Subject Decision|8|||
146258495|NCT02101268|527461462|FG001|Randomized Treatment Phase|Subject Decision|4|||
146258496|NCT02101268|527461463|FG002|Randomized Treatment Phase|Subject Decision|0|||
146258497|NCT02101268|527461464|FG003|Randomized Treatment Phase|Subject Decision|0|||
146258498|NCT02101268|527461461|FG000|Randomized Treatment Phase|Physician Decision|4|||
146258499|NCT02101268|527461462|FG001|Randomized Treatment Phase|Physician Decision|1|||
146258500|NCT02101268|527461463|FG002|Randomized Treatment Phase|Physician Decision|0|||
146258501|NCT02101268|527461464|FG003|Randomized Treatment Phase|Physician Decision|0|||
146258502|NCT02101268|527461461|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146258503|NCT02101268|527461462|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
146258504|NCT02101268|527461463|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146258505|NCT02101268|527461464|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
146258506|NCT02101268|527461461|FG000|Randomized Treatment Phase|Adverse Event|6|||
146258507|NCT02101268|527461462|FG001|Randomized Treatment Phase|Adverse Event|0|||
146258508|NCT02101268|527461463|FG002|Randomized Treatment Phase|Adverse Event|0|||
146258509|NCT02101268|527461464|FG003|Randomized Treatment Phase|Adverse Event|0|||
146258510|NCT02101268|527461461|FG000|Randomized Treatment Phase|Death|5|||
146258511|NCT02101268|527461462|FG001|Randomized Treatment Phase|Death|4|||
146258512|NCT02101268|527461463|FG002|Randomized Treatment Phase|Death|0|||
146258513|NCT02101268|527461464|FG003|Randomized Treatment Phase|Death|0|||
146258514|NCT02101268|527461461|FG000|Randomized Treatment Phase|Disease Progression|4|||
146258515|NCT02101268|527461462|FG001|Randomized Treatment Phase|Disease Progression|1|||
146258516|NCT02101268|527461463|FG002|Randomized Treatment Phase|Disease Progression|0|||
146258517|NCT02101268|527461464|FG003|Randomized Treatment Phase|Disease Progression|0|||
146258518|NCT02101268|527461461|FG000|Extended Treatment Phase|Subject Decision|0|||
146258519|NCT02101268|527461462|FG001|Extended Treatment Phase|Subject Decision|0|||
146258520|NCT02101268|527461463|FG002|Extended Treatment Phase|Subject Decision|3|||
146258521|NCT02101268|527461464|FG003|Extended Treatment Phase|Subject Decision|2|||
146258522|NCT02101268|527461461|FG000|Extended Treatment Phase|Physician Decision|0|||
146258523|NCT02101268|527461462|FG001|Extended Treatment Phase|Physician Decision|0|||
146258524|NCT02101268|527461463|FG002|Extended Treatment Phase|Physician Decision|5|||
146258525|NCT02101268|527461464|FG003|Extended Treatment Phase|Physician Decision|2|||
146258526|NCT02101268|527461461|FG000|Extended Treatment Phase|Adverse Event|0|||
146258527|NCT02101268|527461462|FG001|Extended Treatment Phase|Adverse Event|0|||
146258528|NCT02101268|527461463|FG002|Extended Treatment Phase|Adverse Event|14|||
146258529|NCT02101268|527461464|FG003|Extended Treatment Phase|Adverse Event|18|||
146258530|NCT02101268|527461461|FG000|Extended Treatment Phase|Death|0|||
146258531|NCT02101268|527461462|FG001|Extended Treatment Phase|Death|0|||
146258532|NCT02101268|527461463|FG002|Extended Treatment Phase|Death|5|||
146258533|NCT02101268|527461464|FG003|Extended Treatment Phase|Death|1|||
146258534|NCT02101268|527461461|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
146258535|NCT02101268|527461462|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
146258536|NCT02101268|527461463|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
146258537|NCT02101268|527461464|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
146258538|NCT02101268|527461461|FG000|Extended Treatment Phase|Disease Progression|0|||
146258539|NCT02101268|527461462|FG001|Extended Treatment Phase|Disease Progression|0|||
146258540|NCT02101268|527461463|FG002|Extended Treatment Phase|Disease Progression|13|||
146258541|NCT02101268|527461464|FG003|Extended Treatment Phase|Disease Progression|6|||
146258542|NCT02101268|527461461|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
146258543|NCT02101268|527461462|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
146258544|NCT02101268|527461463|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
146258545|NCT02101268|527461464|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
146258546|NCT00819013|527461466|FG000|Overall Study|Not meeting continuing study eligibility|2|||
146258547|NCT00819013|527461467|FG001|Overall Study|Not meeting continuing study eligibility|1|||
146258548|NCT00819013|527461468|FG002|Overall Study|Not meeting continuing study eligibility|2|||
146258549|NCT00819013|527461469|FG003|Overall Study|Not meeting continuing study eligibility|1|||
146258550|NCT00819013|527461466|FG000|Overall Study|Adverse Event|0|||
146258551|NCT00819013|527461467|FG001|Overall Study|Adverse Event|0|||
146258552|NCT00819013|527461468|FG002|Overall Study|Adverse Event|1|||
146258553|NCT00819013|527461469|FG003|Overall Study|Adverse Event|0|||
146258554|NCT00819013|527461466|FG000|Overall Study|Withdrawal by Subject|1|||
146258555|NCT00819013|527461467|FG001|Overall Study|Withdrawal by Subject|0|||
146258556|NCT00819013|527461468|FG002|Overall Study|Withdrawal by Subject|1|||
146258557|NCT00819013|527461469|FG003|Overall Study|Withdrawal by Subject|0|||
146258558|NCT00819013|527461466|FG000|Overall Study|Lost to Follow-up|0|||
146258559|NCT00819013|527461467|FG001|Overall Study|Lost to Follow-up|0|||
146258560|NCT00819013|527461468|FG002|Overall Study|Lost to Follow-up|1|||
146258561|NCT00819013|527461469|FG003|Overall Study|Lost to Follow-up|2|||
146258562|NCT00819013|527461466|FG000|Overall Study|Death|0|||
146258563|NCT00819013|527461467|FG001|Overall Study|Death|0|||
146258564|NCT00819013|527461468|FG002|Overall Study|Death|0|||
146258565|NCT00819013|527461469|FG003|Overall Study|Death|1|||
146258566|NCT00839332|527461473|FG000|Phase 1|Disease Progression|38|||
146258567|NCT00839332|527461474|FG001|Phase 1|Disease Progression|0|||
146258568|NCT00839332|527461475|FG002|Phase 1|Disease Progression|0|||
146258569|NCT00839332|527461473|FG000|Phase 1|Adverse Event|6|||
146258570|NCT00839332|527461474|FG001|Phase 1|Adverse Event|0|||
146258571|NCT00839332|527461475|FG002|Phase 1|Adverse Event|0|||
146258572|NCT00839332|527461473|FG000|Phase 1|Withdrawal by Subject|4|||
146258573|NCT00839332|527461474|FG001|Phase 1|Withdrawal by Subject|0|||
146258574|NCT00839332|527461475|FG002|Phase 1|Withdrawal by Subject|0|||
146258575|NCT00839332|527461473|FG000|Phase 1|Physician Decision|2|||
146258576|NCT00839332|527461474|FG001|Phase 1|Physician Decision|0|||
146258577|NCT00839332|527461475|FG002|Phase 1|Physician Decision|0|||
146258578|NCT00839332|527461473|FG000|Phase 2|Protocol Violation|0|||
146258579|NCT00839332|527461474|FG001|Phase 2|Protocol Violation|1|||
146258580|NCT00839332|527461475|FG002|Phase 2|Protocol Violation|0|||
146258581|NCT00839332|527461473|FG000|Phase 2|Disease Progression|0|||
146258582|NCT00839332|527461474|FG001|Phase 2|Disease Progression|46|||
146258583|NCT00839332|527461475|FG002|Phase 2|Disease Progression|21|||
146258584|NCT00839332|527461473|FG000|Phase 2|Adverse Event|0|||
146258585|NCT00839332|527461474|FG001|Phase 2|Adverse Event|8|||
146258586|NCT00839332|527461475|FG002|Phase 2|Adverse Event|6|||
146258587|NCT00839332|527461473|FG000|Phase 2|Death|0|||
146258588|NCT00839332|527461474|FG001|Phase 2|Death|4|||
146258589|NCT00839332|527461475|FG002|Phase 2|Death|2|||
146258590|NCT00839332|527461473|FG000|Phase 2|Withdrawal by Subject|0|||
146258591|NCT00839332|527461474|FG001|Phase 2|Withdrawal by Subject|5|||
146258592|NCT00839332|527461475|FG002|Phase 2|Withdrawal by Subject|8|||
146258593|NCT00839332|527461473|FG000|Phase 2|Physician Decision|0|||
146258594|NCT00839332|527461474|FG001|Phase 2|Physician Decision|4|||
146258595|NCT00839332|527461475|FG002|Phase 2|Physician Decision|1|||
146258596|NCT00839332|527461473|FG000|Phase 2|Lost to Follow-up|0|||
146258597|NCT00839332|527461474|FG001|Phase 2|Lost to Follow-up|0|||
146258598|NCT00839332|527461475|FG002|Phase 2|Lost to Follow-up|1|||
146258599|NCT01200485|527461476|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
146258600|NCT01200485|527461477|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
146258601|NCT01200485|527461478|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
146258602|NCT01200485|527461476|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
146258603|NCT01200485|527461477|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
146258604|NCT01200485|527461478|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
146258605|NCT06080438|527461479|FG000|Overall Study|Lost to Follow-up|2|||
146258606|NCT03589300|527461481|FG000|Overall Study|Adverse Event|2|||
146258607|NCT03589300|527461481|FG000|Overall Study|Death|4|||
146258608|NCT03589300|527461481|FG000|Overall Study|Lost to Follow-up|12|||
146258609|NCT03589300|527461481|FG000|Overall Study|Withdrawal by Subject|5|||
146258610|NCT01678898|527461484|FG000|PB-102-F01|Adverse Event|0|||
146258611|NCT01678898|527461485|FG001|PB-102-F01|Adverse Event|1|||
146258612|NCT01678898|527461486|FG002|PB-102-F01|Adverse Event|0|||
146258613|NCT01678898|527461484|FG000|PB-102-F01|Physician Decision|0|||
146108005|NCT00968201|526914584|FG000|Base Study - (Period II)|Adverse Event|8|||
146108006|NCT00968201|526914585|FG001|Base Study - (Period II)|Adverse Event|0|||
146108007|NCT00968201|526914586|FG002|Base Study - (Period II)|Adverse Event|16|||
146108008|NCT00968201|526914584|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
146108009|NCT00968201|526914585|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
146108010|NCT00968201|526914586|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
146108011|NCT00968201|526914584|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
146108012|NCT00968201|526914585|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
146108013|NCT00968201|526914586|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
146108014|NCT00968201|526914584|FG000|Base Study - (Period II)|Protocol Violation|12|||
146108015|NCT00968201|526914585|FG001|Base Study - (Period II)|Protocol Violation|0|||
146108016|NCT00968201|526914586|FG002|Base Study - (Period II)|Protocol Violation|12|||
146108017|NCT00968201|526914584|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
146108018|NCT00968201|526914585|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
146108019|NCT00968201|526914586|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
146108020|NCT00968201|526914584|FG000|Base Study - (Period II)|Site Error|0|||
146108021|NCT00968201|526914585|FG001|Base Study - (Period II)|Site Error|0|||
146108022|NCT00968201|526914586|FG002|Base Study - (Period II)|Site Error|1|||
146108023|NCT00968201|526914584|FG000|Extension Study - (Period III)|Adverse Event|0|||
146108024|NCT00968201|526914585|FG001|Extension Study - (Period III)|Adverse Event|5|||
146108025|NCT00968201|526914586|FG002|Extension Study - (Period III)|Adverse Event|22|||
146108026|NCT00968201|526914584|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
146108027|NCT00968201|526914585|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
146108028|NCT00968201|526914586|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
146108029|NCT00968201|526914584|FG000|Extension Study - (Period III)|Protocol Violation|0|||
146108030|NCT00968201|526914585|FG001|Extension Study - (Period III)|Protocol Violation|17|||
146108031|NCT00968201|526914586|FG002|Extension Study - (Period III)|Protocol Violation|14|||
146108032|NCT00968201|526914584|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
146108033|NCT00968201|526914585|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
146108034|NCT00968201|526914586|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
146108035|NCT00968201|526914584|FG000|Extension Study - (Period III)|Patient Relocated|0|||
146108036|NCT00968201|526914585|FG001|Extension Study - (Period III)|Patient Relocated|1|||
146108037|NCT00968201|526914586|FG002|Extension Study - (Period III)|Patient Relocated|1|||
146108038|NCT00968201|526914584|FG000|Extension Study - (Period III)|Noncompliance|0|||
146108039|NCT00968201|526914585|FG001|Extension Study - (Period III)|Noncompliance|0|||
146108040|NCT00968201|526914586|FG002|Extension Study - (Period III)|Noncompliance|3|||
146108041|NCT00968201|526914584|FG000|Extension Study - (Period III)|Other|0|||
146108042|NCT00968201|526914585|FG001|Extension Study - (Period III)|Other|0|||
146108043|NCT00968201|526914586|FG002|Extension Study - (Period III)|Other|2|||
146108044|NCT00968201|526914584|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
146108045|NCT00968201|526914585|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
146108046|NCT00968201|526914586|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
146108047|NCT02619175|526914587|FG000|Overall Study|Withdrawal by Subject|1|||
146108048|NCT02619175|526914588|FG001|Overall Study|Withdrawal by Subject|0|||
146108049|NCT02619175|526914587|FG000|Overall Study|foot pain|1|||
146108050|NCT02619175|526914588|FG001|Overall Study|foot pain|0|||
146108051|NCT02657369|526914589|FG000|Overall Study|Death|27|||
146108052|NCT02657369|526914589|FG000|Overall Study|Study terminated by sponsor|7|||
146108053|NCT00361569|526914590|FG000|Overall Study|Protocol Violation|3|||
146108054|NCT00361569|526914591|FG001|Overall Study|Protocol Violation|2|||
146108055|NCT00361569|526914592|FG002|Overall Study|Protocol Violation|4|||
146108056|NCT00361569|526914593|FG003|Overall Study|Protocol Violation|2|||
146108057|NCT00361569|526914590|FG000|Overall Study|Withdrawal by Subject|2|||
146108058|NCT00361569|526914591|FG001|Overall Study|Withdrawal by Subject|1|||
146108059|NCT00361569|526914592|FG002|Overall Study|Withdrawal by Subject|9|||
146108060|NCT00361569|526914593|FG003|Overall Study|Withdrawal by Subject|14|||
146108061|NCT00361569|526914590|FG000|Overall Study|Adverse Event|3|||
146108062|NCT00361569|526914591|FG001|Overall Study|Adverse Event|5|||
146108063|NCT00361569|526914592|FG002|Overall Study|Adverse Event|2|||
146108064|NCT00361569|526914593|FG003|Overall Study|Adverse Event|2|||
146108065|NCT00361569|526914590|FG000|Overall Study|Lost to Follow-up|2|||
146258614|NCT01678898|527461485|FG001|PB-102-F01|Physician Decision|1|||
146258615|NCT01678898|527461486|FG002|PB-102-F01|Physician Decision|0|||
146258616|NCT00776984|527461487|FG000|Overall Study|Adverse Event|8|||
146258617|NCT00776984|527461488|FG001|Overall Study|Adverse Event|2|||
146108066|NCT00361569|526914591|FG001|Overall Study|Lost to Follow-up|3|||
146108067|NCT00361569|526914592|FG002|Overall Study|Lost to Follow-up|3|||
146108068|NCT00361569|526914593|FG003|Overall Study|Lost to Follow-up|2|||
146108069|NCT00361569|526914590|FG000|Overall Study|Not specified by investigator|2|||
146108070|NCT00361569|526914591|FG001|Overall Study|Not specified by investigator|0|||
146258618|NCT00776984|527461487|FG000|Overall Study|Protocol Violation|4|||
146258619|NCT00776984|527461488|FG001|Overall Study|Protocol Violation|2|||
146108071|NCT00361569|526914592|FG002|Overall Study|Not specified by investigator|0|||
146108072|NCT00361569|526914593|FG003|Overall Study|Not specified by investigator|1|||
146108073|NCT02605824|526914594|FG000|Overall Study|Physician Decision|1|||
146108074|NCT02605824|526914595|FG001|Overall Study|Physician Decision|0|||
146108075|NCT01095731|526914596|FG000|Overall Study|Protocol Violation|1|||
146108076|NCT01095731|526914597|FG001|Overall Study|Protocol Violation|1|||
146108077|NCT01095731|526914596|FG000|Overall Study|Withdrawal by Subject|0|||
146108078|NCT01095731|526914597|FG001|Overall Study|Withdrawal by Subject|1|||
146108079|NCT01446289|526914598|FG000|Overall Study|Withdrawal by Subject|1|||
146108080|NCT01446289|526914599|FG001|Overall Study|Withdrawal by Subject|0|||
146108081|NCT01446289|526914600|FG002|Overall Study|Withdrawal by Subject|1|||
146108082|NCT01446289|526914601|FG003|Overall Study|Withdrawal by Subject|0|||
146108083|NCT03329573|526914602|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146108084|NCT03329573|526914603|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
146108085|NCT03329573|526914604|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146108086|NCT03329573|526914605|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
146108087|NCT03329573|526914602|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146108088|NCT03329573|526914603|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
146108089|NCT03329573|526914604|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146108090|NCT03329573|526914605|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146108091|NCT03329573|526914602|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
146108092|NCT03329573|526914603|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146108093|NCT03329573|526914604|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146108094|NCT03329573|526914605|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
146108095|NCT03329573|526914602|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146108096|NCT03329573|526914603|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
146108097|NCT03329573|526914604|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146108098|NCT03329573|526914605|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
146108099|NCT02777333|526914608|FG000|Overall Study|Withdrawal by Subject|0|||
146108100|NCT02777333|526914609|FG001|Overall Study|Withdrawal by Subject|1|||
146108101|NCT02777333|526914608|FG000|Overall Study|Lost to Follow-up|0|||
146108102|NCT02777333|526914609|FG001|Overall Study|Lost to Follow-up|1|||
146108103|NCT00837811|526914610|FG000|Overall Study|Adverse Event|4|||
146108104|NCT00837811|526914611|FG001|Overall Study|Adverse Event|6|||
146108105|NCT00837811|526914612|FG002|Overall Study|Adverse Event|0|||
146108106|NCT00837811|526914610|FG000|Overall Study|Death|1|||
146108107|NCT00837811|526914611|FG001|Overall Study|Death|1|||
146108108|NCT00837811|526914612|FG002|Overall Study|Death|0|||
146108109|NCT00837811|526914610|FG000|Overall Study|Lack of Efficacy|0|||
146108110|NCT00837811|526914611|FG001|Overall Study|Lack of Efficacy|11|||
146108111|NCT00837811|526914612|FG002|Overall Study|Lack of Efficacy|0|||
146108112|NCT00837811|526914610|FG000|Overall Study|Lost to Follow-up|1|||
146108113|NCT00837811|526914611|FG001|Overall Study|Lost to Follow-up|3|||
146108114|NCT00837811|526914612|FG002|Overall Study|Lost to Follow-up|0|||
146108115|NCT00837811|526914610|FG000|Overall Study|Physician Decision|0|||
146108116|NCT00837811|526914611|FG001|Overall Study|Physician Decision|2|||
146108117|NCT00837811|526914612|FG002|Overall Study|Physician Decision|1|||
146108118|NCT00837811|526914610|FG000|Overall Study|Withdrawal by Subject|1|||
146108119|NCT00837811|526914611|FG001|Overall Study|Withdrawal by Subject|9|||
146108120|NCT00837811|526914612|FG002|Overall Study|Withdrawal by Subject|0|||
146108121|NCT00837811|526914610|FG000|Overall Study|Sponsor Decision|0|||
146108122|NCT00837811|526914611|FG001|Overall Study|Sponsor Decision|2|||
146108123|NCT00837811|526914612|FG002|Overall Study|Sponsor Decision|0|||
146108124|NCT03307967|526914613|FG000|Overall Study|Lost to Follow-up|4|||
146108125|NCT02578316|526914614|FG000|Extension Phase|Progression of disease|6|||
146108126|NCT05243641|526914618|FG000|Overall Study|Adverse Event|3|||
146108127|NCT05243641|526914619|FG001|Overall Study|Adverse Event|0|||
146108128|NCT05243641|526914620|FG002|Overall Study|Adverse Event|0|||
146108129|NCT05243641|526914621|FG003|Overall Study|Adverse Event|1|||
146108130|NCT05243641|526914622|FG004|Overall Study|Adverse Event|0|||
146108131|NCT05243641|526914623|FG005|Overall Study|Adverse Event|0|||
146108132|NCT05243641|526914618|FG000|Overall Study|Disease progression|4|||
146108133|NCT05243641|526914619|FG001|Overall Study|Disease progression|0|||
146108134|NCT05243641|526914620|FG002|Overall Study|Disease progression|0|||
146108135|NCT05243641|526914621|FG003|Overall Study|Disease progression|2|||
146108136|NCT05243641|526914622|FG004|Overall Study|Disease progression|0|||
146258620|NCT00776984|527461487|FG000|Overall Study|Lost to Follow-up|2|||
146258621|NCT00776984|527461488|FG001|Overall Study|Lost to Follow-up|0|||
146258622|NCT00776984|527461487|FG000|Overall Study|Withdrawal by Subject|12|||
146258623|NCT00776984|527461488|FG001|Overall Study|Withdrawal by Subject|7|||
146108137|NCT05243641|526914623|FG005|Overall Study|Disease progression|0|||
146258624|NCT00776984|527461487|FG000|Overall Study|Lack of Efficacy|0|||
146258625|NCT00776984|527461488|FG001|Overall Study|Lack of Efficacy|1|||
146108138|NCT03268954|526914625|FG000|Overall Study|Withdrawal by Subject|27|||
146108139|NCT03268954|526914626|FG001|Overall Study|Withdrawal by Subject|17|||
146108140|NCT03268954|526914625|FG000|Overall Study|Lost to Follow-up|2|||
146108141|NCT03268954|526914626|FG001|Overall Study|Lost to Follow-up|3|||
146108142|NCT03268954|526914625|FG000|Overall Study|Reason Not Specified|3|||
146108143|NCT03268954|526914626|FG001|Overall Study|Reason Not Specified|8|||
146108144|NCT04698187|526914631|FG000|Overall Study|Withdrawal by Subject|7|||
146108145|NCT04698187|526914631|FG000|Overall Study|Death|21|||
146108146|NCT04698187|526914631|FG000|Overall Study|Sponsor Decision|15|||
146108147|NCT04698187|526914631|FG000|Overall Study|In-transit Disease|1|||
146108148|NCT03820986|526914632|FG000|Overall Study|Death|201|||
146108149|NCT03820986|526914633|FG001|Overall Study|Death|175|||
146108150|NCT03820986|526914632|FG000|Overall Study|Lost to Follow-up|1|||
146108151|NCT03820986|526914633|FG001|Overall Study|Lost to Follow-up|1|||
146108152|NCT03820986|526914632|FG000|Overall Study|Physician Decision|1|||
146108153|NCT03820986|526914633|FG001|Overall Study|Physician Decision|0|||
146108154|NCT03820986|526914632|FG000|Overall Study|Sponsor Decision|122|||
146108155|NCT03820986|526914633|FG001|Overall Study|Sponsor Decision|160|||
146108156|NCT03820986|526914632|FG000|Overall Study|Withdrawal by Subject|9|||
146108157|NCT03820986|526914633|FG001|Overall Study|Withdrawal by Subject|4|||
146108158|NCT02993146|526914634|FG000|Overall Study|Withdrawal by Subject|0|||
146108159|NCT02993146|526914635|FG001|Overall Study|Withdrawal by Subject|0|||
146108160|NCT02993146|526914636|FG002|Overall Study|Withdrawal by Subject|1|||
146108161|NCT02993146|526914637|FG003|Overall Study|Withdrawal by Subject|1|||
146108162|NCT02513394|526914640|FG000|Overall Study|Withdrawal by Subject|11|||
146108163|NCT02513394|526914641|FG001|Overall Study|Withdrawal by Subject|23|||
146108164|NCT02513394|526914640|FG000|Overall Study|Ineligible|1|||
146108165|NCT02513394|526914641|FG001|Overall Study|Ineligible|0|||
146108166|NCT00612690|526916547|FG000|Overall Study|Lost to Follow-up|72|||
146108167|NCT00612690|526916548|FG001|Overall Study|Lost to Follow-up|98|||
146108168|NCT00612690|526916547|FG000|Overall Study|Withdrawal by Subject|32|||
146108169|NCT00612690|526916548|FG001|Overall Study|Withdrawal by Subject|20|||
146108170|NCT00612690|526916547|FG000|Overall Study|Withdrawal by Site|11|||
146108171|NCT00612690|526916548|FG001|Overall Study|Withdrawal by Site|0|||
146108172|NCT03364023|526916551|FG000|Overall Study|Lost to Follow-up|3|||
146108173|NCT03364023|526916551|FG000|Overall Study|Death|14|||
146108174|NCT03797014|526916555|FG000|Overall Study|Withdrawal by Subject|1|||
146108175|NCT03797014|526916555|FG000|Overall Study|Lost to Follow-up|1|||
146108176|NCT03797014|526916555|FG000|Overall Study|Protocol Violation|1|||
146108177|NCT01970397|526916556|FG000|Overall Study|Adverse Event|0|||
146108178|NCT01970397|526916557|FG001|Overall Study|Adverse Event|1|||
146108179|NCT01970397|526916556|FG000|Overall Study|Lost to Follow-up|0|||
146108180|NCT01970397|526916557|FG001|Overall Study|Lost to Follow-up|1|||
146108181|NCT01970397|526916556|FG000|Overall Study|Personal Reasons|1|||
146108182|NCT01970397|526916557|FG001|Overall Study|Personal Reasons|2|||
146108183|NCT01970397|526916556|FG000|Overall Study|Protocol Violation|1|||
146108184|NCT01970397|526916557|FG001|Overall Study|Protocol Violation|1|||
146108185|NCT03305575|526916566|FG000|Overall Study|Physician Decision|1|||
146108186|NCT03305575|526916567|FG001|Overall Study|Physician Decision|0|||
146108187|NCT00105469|526916568|FG000|Overall Study|Adverse Event|9|||
146108188|NCT00105469|526916569|FG001|Overall Study|Adverse Event|8|||
146108189|NCT00105469|526916568|FG000|Overall Study|Protocol Violation|4|||
146108190|NCT00105469|526916569|FG001|Overall Study|Protocol Violation|0|||
146108191|NCT00105469|526916568|FG000|Overall Study|Withdrawal by Subject|2|||
146108192|NCT00105469|526916569|FG001|Overall Study|Withdrawal by Subject|3|||
146108193|NCT00105469|526916568|FG000|Overall Study|Lost to Follow-up|1|||
146108194|NCT00105469|526916569|FG001|Overall Study|Lost to Follow-up|0|||
146108195|NCT00105469|526916568|FG000|Overall Study|Lack of Efficacy|2|||
146108196|NCT00105469|526916569|FG001|Overall Study|Lack of Efficacy|0|||
146108197|NCT00105469|526916568|FG000|Overall Study|Other Reason|4|||
146108198|NCT00105469|526916569|FG001|Overall Study|Other Reason|0|||
146108199|NCT01749137|526916570|FG000|Overall Study|Adverse Event|4|||
146108200|NCT01749137|526916571|FG001|Overall Study|Adverse Event|4|||
146108201|NCT01749137|526916570|FG000|Overall Study|Lost to Follow-up|2|||
146108202|NCT01749137|526916571|FG001|Overall Study|Lost to Follow-up|3|||
146108203|NCT01749137|526916570|FG000|Overall Study|Physician Decision|1|||
146108204|NCT01749137|526916571|FG001|Overall Study|Physician Decision|0|||
146108205|NCT01749137|526916570|FG000|Overall Study|Withdrawal by Subject|8|||
146108206|NCT01749137|526916571|FG001|Overall Study|Withdrawal by Subject|4|||
146108207|NCT04115839|526916576|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
146108208|NCT04115839|526916577|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
146108209|NCT04115839|526916578|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
146108210|NCT04115839|526916579|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146108211|NCT04115839|526916580|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146108212|NCT04115839|526916581|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146108213|NCT04115839|526916582|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
146108214|NCT04115839|526916576|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
146108215|NCT04115839|526916577|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
146108216|NCT04115839|526916578|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
146108217|NCT04115839|526916579|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146108218|NCT04115839|526916580|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146108219|NCT04115839|526916581|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146108220|NCT04115839|526916582|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
146108221|NCT04115839|526916576|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
146108222|NCT04115839|526916577|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146108223|NCT04115839|526916578|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146258626|NCT00776984|527461487|FG000|Overall Study|Other|5|||
146258627|NCT00776984|527461488|FG001|Overall Study|Other|9|||
146258628|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
146258629|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
146258630|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
146258631|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Other|1|||
146258632|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Other|0|||
146258633|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Other|0|||
146258634|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Physician Decision|3|||
146258635|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Physician Decision|0|||
146258636|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Physician Decision|0|||
146258637|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
146258638|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
146258639|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
146258640|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
146258641|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
146258642|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
146258643|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Adverse Event|18|||
146258644|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Adverse Event|0|||
146258645|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Adverse Event|0|||
146258646|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
146258647|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
146258648|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
146258649|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
146258650|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
146258651|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
146258652|NCT03030599|527461489|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
146258653|NCT03030599|527461490|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
146258654|NCT03030599|527461491|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
146258655|NCT03030599|527461489|FG000|Stable Dose|Protocol deviation|3|||
146258656|NCT03030599|527461490|FG001|Stable Dose|Protocol deviation|0|||
146258657|NCT03030599|527461491|FG002|Stable Dose|Protocol deviation|0|||
146258658|NCT03030599|527461489|FG000|Stable Dose|Adverse Event|1|||
146258659|NCT03030599|527461490|FG001|Stable Dose|Adverse Event|0|||
146258660|NCT03030599|527461491|FG002|Stable Dose|Adverse Event|0|||
146258661|NCT03030599|527461489|FG000|Stable Dose|Lost to Follow-up|1|||
146258662|NCT03030599|527461490|FG001|Stable Dose|Lost to Follow-up|0|||
146258663|NCT03030599|527461491|FG002|Stable Dose|Lost to Follow-up|0|||
146258664|NCT03030599|527461489|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
146258665|NCT03030599|527461490|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
146258666|NCT03030599|527461491|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
146258667|NCT03030599|527461489|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
146258668|NCT03030599|527461490|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
146258669|NCT03030599|527461491|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
146258670|NCT03030599|527461489|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
146258671|NCT03030599|527461490|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
146258672|NCT03030599|527461491|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
146258673|NCT03030599|527461489|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
146258674|NCT03030599|527461490|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
146258675|NCT03030599|527461491|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
146258676|NCT03030599|527461489|FG000|Open-label Extension|Adverse Event|3|||
146258677|NCT03030599|527461490|FG001|Open-label Extension|Adverse Event|0|||
146258678|NCT03030599|527461491|FG002|Open-label Extension|Adverse Event|0|||
146258679|NCT03030599|527461489|FG000|Open-label Extension|Lost to Follow-up|2|||
146258680|NCT03030599|527461490|FG001|Open-label Extension|Lost to Follow-up|0|||
146258681|NCT03030599|527461491|FG002|Open-label Extension|Lost to Follow-up|0|||
146258682|NCT03030599|527461489|FG000|Open-label Extension|Lack of Efficacy|1|||
146258683|NCT03030599|527461490|FG001|Open-label Extension|Lack of Efficacy|0|||
146258684|NCT03030599|527461491|FG002|Open-label Extension|Lack of Efficacy|0|||
145941608|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
146108224|NCT04115839|526916579|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146258685|NCT03030599|527461489|FG000|Open-label Extension|Other Reason|1|||
146258686|NCT03030599|527461490|FG001|Open-label Extension|Other Reason|0|||
146258687|NCT03030599|527461491|FG002|Open-label Extension|Other Reason|0|||
146258688|NCT00230971|527461493|FG000|Randomization|No study drug administered|3|||
146258689|NCT00230971|527461494|FG001|Randomization|No study drug administered|3|||
146258690|NCT00230971|527461493|FG000|Baseline Participants|Lost to Follow-up|5|||
146301229|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
146301230|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
146301231|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146052133|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052134|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052135|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052136|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052137|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052138|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
146052139|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052140|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052141|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052142|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
146052143|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052144|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052145|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052146|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052147|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052148|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052149|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052150|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052151|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052152|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052153|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052154|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052155|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
146052156|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052157|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
146052158|NCT01147666|526705402|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052159|NCT01147666|526705403|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052160|NCT01147666|526705404|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052161|NCT01147666|526705405|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052162|NCT01147666|526705406|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052163|NCT01147666|526705407|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052164|NCT01147666|526705408|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052165|NCT01147666|526705409|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052166|NCT01147666|526705410|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052167|NCT01147666|526705411|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052168|NCT01147666|526705412|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052169|NCT01147666|526705413|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052170|NCT01147666|526705414|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
146052171|NCT01147666|526705415|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
146052172|NCT01147666|526705416|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
146052173|NCT00474955|526705418|FG000|Overall Study|Adverse Event|2|||
146052174|NCT00474955|526705418|FG000|Overall Study|Drug unavailability|1|||
146052175|NCT00474955|526705418|FG000|Overall Study|Personal reasons|5|||
146052176|NCT02576639|526705419|FG000|Overall Study|Withdrawal by Subject|1|||
146052177|NCT02576639|526705420|FG001|Overall Study|Withdrawal by Subject|2|||
146052178|NCT02576639|526705421|FG002|Overall Study|Withdrawal by Subject|1|||
146052179|NCT02576639|526705422|FG003|Overall Study|Withdrawal by Subject|0|||
146052180|NCT02576639|526705423|FG004|Overall Study|Withdrawal by Subject|1|||
146052181|NCT02576639|526705419|FG000|Overall Study|Adverse Event|1|||
146052182|NCT02576639|526705420|FG001|Overall Study|Adverse Event|0|||
146052183|NCT02576639|526705421|FG002|Overall Study|Adverse Event|1|||
146052184|NCT02576639|526705422|FG003|Overall Study|Adverse Event|1|||
146052185|NCT02576639|526705423|FG004|Overall Study|Adverse Event|2|||
146052186|NCT02576639|526705419|FG000|Overall Study|Physician Decision|0|||
146052187|NCT02576639|526705420|FG001|Overall Study|Physician Decision|0|||
146052188|NCT02576639|526705421|FG002|Overall Study|Physician Decision|0|||
146052189|NCT02576639|526705422|FG003|Overall Study|Physician Decision|0|||
146052190|NCT02576639|526705423|FG004|Overall Study|Physician Decision|1|||
146052191|NCT01135134|526705424|FG000|Overall Study|Adverse Event|1|||
146052192|NCT01135134|526705425|FG001|Overall Study|Adverse Event|1|||
146052193|NCT01135134|526705424|FG000|Overall Study|Did not meet protocol eligibility|1|||
146108225|NCT04115839|526916580|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146108226|NCT04115839|526916581|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146052194|NCT01135134|526705425|FG001|Overall Study|Did not meet protocol eligibility|0|||
146052195|NCT00255190|526705430|FG000|Overall Study|Adverse Event|17|||
146052196|NCT00255190|526705431|FG001|Overall Study|Adverse Event|36|||
146052197|NCT00255190|526705430|FG000|Overall Study|Protocol Violation|2|||
146108227|NCT04115839|526916582|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
146108228|NCT04115839|526916576|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108229|NCT04115839|526916577|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108230|NCT04115839|526916578|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
146108231|NCT04115839|526916579|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108232|NCT04115839|526916580|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108233|NCT04115839|526916581|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108234|NCT04115839|526916582|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
146108235|NCT04115839|526916576|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146108236|NCT04115839|526916577|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146108237|NCT04115839|526916578|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
146108238|NCT04115839|526916579|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
146108239|NCT04115839|526916580|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
146108240|NCT04115839|526916581|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
146108241|NCT04115839|526916582|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
146108242|NCT04115839|526916576|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146108243|NCT04115839|526916577|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146108244|NCT04115839|526916578|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146108245|NCT04115839|526916579|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
146108246|NCT04115839|526916580|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
146108247|NCT04115839|526916581|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146108248|NCT04115839|526916582|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
146108249|NCT00621985|526916583|FG000|Dexamethasone Admission|Adverse Event|1|||
146108250|NCT03808545|526916584|FG000|Overall Study|Withdrawal by Subject|1|||
146108251|NCT03808545|526916585|FG001|Overall Study|Withdrawal by Subject|1|||
146108252|NCT01408485|526916586|FG000|Overall Study|Withdrawal by Subject|21|||
146108253|NCT01338792|526916587|FG000|Overall Study|Adverse Event|2|||
146108254|NCT01338792|526916587|FG000|Overall Study|Death|1|||
146108255|NCT01338792|526916587|FG000|Overall Study|Withdrawal by Subject|1|||
146108256|NCT00618072|526916588|FG000|Overall Study|Lost to Follow-up|2|||
146108257|NCT00618072|526916589|FG001|Overall Study|Lost to Follow-up|0|||
146108258|NCT00618072|526916590|FG002|Overall Study|Lost to Follow-up|3|||
146108259|NCT00618072|526916588|FG000|Overall Study|Physician Decision|0|||
146108260|NCT00618072|526916589|FG001|Overall Study|Physician Decision|1|||
146108261|NCT00618072|526916590|FG002|Overall Study|Physician Decision|1|||
146108262|NCT00684593|526916592|FG000|Overall Study|Adverse Event|0|||
146108263|NCT00684593|526916593|FG001|Overall Study|Adverse Event|2|||
146108264|NCT00617773|526916594|FG000|Overall Study|Physician Decision|1|||
146108265|NCT00617773|526916594|FG000|Overall Study|Lack of compliance with the protocol|1|||
146108266|NCT00617773|526916594|FG000|Overall Study|Withdrawal by Subject|1|||
146108267|NCT00617773|526916594|FG000|Overall Study|Death|1|||
146108268|NCT00617773|526916594|FG000|Overall Study|Progressive disease|19|||
146108269|NCT00617773|526916594|FG000|Overall Study|Protocol Violation|1|||
146108270|NCT03130257|526916598|FG000|Overall Study|Withdrawal by Subject|1|||
146108271|NCT03130257|526916599|FG001|Overall Study|Withdrawal by Subject|0|||
146108272|NCT03130257|526916600|FG002|Overall Study|Withdrawal by Subject|2|||
146108273|NCT05526716|526916602|FG000|Overall Study|Death|1|||
146108274|NCT05526716|526916603|FG001|Overall Study|Death|2|||
146108275|NCT05526716|526916602|FG000|Overall Study|Lost to Follow-up|17|||
146108276|NCT05526716|526916603|FG001|Overall Study|Lost to Follow-up|15|||
146108277|NCT05526716|526916602|FG000|Overall Study|Physician Decision|0|||
146108278|NCT05526716|526916603|FG001|Overall Study|Physician Decision|1|||
146108279|NCT05526716|526916602|FG000|Overall Study|Randomized by mistake without study treatment|0|||
146108280|NCT05526716|526916603|FG001|Overall Study|Randomized by mistake without study treatment|1|||
146108281|NCT05526716|526916602|FG000|Overall Study|Withdrawal by Subject|12|||
146108282|NCT05526716|526916603|FG001|Overall Study|Withdrawal by Subject|12|||
146108283|NCT05526716|526916602|FG000|Overall Study|Not reported|0|||
146108284|NCT05526716|526916603|FG001|Overall Study|Not reported|2|||
146108285|NCT01751867|526916604|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
146108286|NCT01751867|526916605|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
146108287|NCT01751867|526916604|FG000|Overall Study|Diease Progression|4|||
146108288|NCT01751867|526916605|FG001|Overall Study|Diease Progression|18|||
146108289|NCT01751867|526916604|FG000|Overall Study|Adverse Event|8|||
146108290|NCT01751867|526916605|FG001|Overall Study|Adverse Event|15|||
146108291|NCT01751867|526916604|FG000|Overall Study|Poor Compliance|0|||
146108292|NCT01751867|526916605|FG001|Overall Study|Poor Compliance|5|||
146108293|NCT01751867|526916604|FG000|Overall Study|Withdrawal by Subject|3|||
146108294|NCT01751867|526916605|FG001|Overall Study|Withdrawal by Subject|1|||
146108295|NCT01751867|526916604|FG000|Overall Study|Physician Decision|4|||
146108296|NCT01751867|526916605|FG001|Overall Study|Physician Decision|7|||
146108297|NCT01751867|526916604|FG000|Overall Study|Protocol Violation|0|||
146108298|NCT01751867|526916605|FG001|Overall Study|Protocol Violation|2|||
146108299|NCT01751867|526916604|FG000|Overall Study|Death|0|||
146108300|NCT01751867|526916605|FG001|Overall Study|Death|5|||
146108301|NCT01751867|526916604|FG000|Overall Study|Other|11|||
146258691|NCT00230971|527461494|FG001|Baseline Participants|Lost to Follow-up|12|||
146258692|NCT00230971|527461493|FG000|Baseline Participants|Death|6|||
146258693|NCT00230971|527461494|FG001|Baseline Participants|Death|5|||
146258694|NCT00230971|527461493|FG000|Baseline Participants|Withdrawal by Subject|7|||
146258695|NCT00230971|527461494|FG001|Baseline Participants|Withdrawal by Subject|1|||
146258696|NCT00230971|527461493|FG000|Baseline Participants|Adverse Event|1|||
146258697|NCT00230971|527461494|FG001|Baseline Participants|Adverse Event|0|||
146258698|NCT00230971|527461493|FG000|Baseline Participants|No bacteria observed|1|||
146258699|NCT00230971|527461494|FG001|Baseline Participants|No bacteria observed|0|||
146258700|NCT00230971|527461493|FG000|Baseline Participants|Failure to return|1|||
146258701|NCT00230971|527461494|FG001|Baseline Participants|Failure to return|1|||
146258702|NCT00230971|527461493|FG000|Baseline Participants|Reintervention|1|||
146258703|NCT00230971|527461494|FG001|Baseline Participants|Reintervention|0|||
146258704|NCT04380688|527461495|FG000|Overall Study|Death|2|||
146258705|NCT04380688|527461496|FG001|Overall Study|Death|2|||
146258706|NCT04380688|527461495|FG000|Overall Study|Lost to Follow-up|2|||
146258707|NCT04380688|527461496|FG001|Overall Study|Lost to Follow-up|4|||
146258708|NCT04380688|527461495|FG000|Overall Study|Withdrawal by Subject|3|||
146258709|NCT04380688|527461496|FG001|Overall Study|Withdrawal by Subject|3|||
146258710|NCT05294328|527461502|FG000|Overall Study|Adverse Event|1|||
146258711|NCT05294328|527461503|FG001|Overall Study|Adverse Event|0|||
146258712|NCT05294328|527461504|FG002|Overall Study|Adverse Event|0|||
146258713|NCT05294328|527461502|FG000|Overall Study|Physician Decision|1|||
146258714|NCT05294328|527461503|FG001|Overall Study|Physician Decision|1|||
146258715|NCT05294328|527461504|FG002|Overall Study|Physician Decision|0|||
146258716|NCT05294328|527461502|FG000|Overall Study|Withdrawal by Subject|0|||
146258717|NCT05294328|527461503|FG001|Overall Study|Withdrawal by Subject|2|||
146258718|NCT05294328|527461504|FG002|Overall Study|Withdrawal by Subject|1|||
146258719|NCT05294328|527461502|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
146258720|NCT05294328|527461503|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
146258721|NCT05294328|527461504|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
146258722|NCT04267393|527461505|FG000|Randomization|Adverse Event|1|||
146258723|NCT04267393|527461506|FG001|Randomization|Adverse Event|0|||
146258724|NCT04267393|527461507|FG002|Randomization|Adverse Event|0|||
146258725|NCT04267393|527461505|FG000|Randomization|Administrative Reasons by Sponsor|0|||
146258726|NCT04267393|527461506|FG001|Randomization|Administrative Reasons by Sponsor|1|||
146258727|NCT04267393|527461507|FG002|Randomization|Administrative Reasons by Sponsor|0|||
146258728|NCT04267393|527461505|FG000|Treatment Period|Adverse Event|0|||
146258729|NCT04267393|527461506|FG001|Treatment Period|Adverse Event|2|||
146258730|NCT04267393|527461507|FG002|Treatment Period|Adverse Event|3|||
146258731|NCT04267393|527461505|FG000|Treatment Period|Participant Withdrew Consent|0|||
146258732|NCT04267393|527461506|FG001|Treatment Period|Participant Withdrew Consent|0|||
146258733|NCT04267393|527461507|FG002|Treatment Period|Participant Withdrew Consent|1|||
146258734|NCT04267393|527461505|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
146258735|NCT04267393|527461506|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
146258736|NCT04267393|527461507|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
146258737|NCT02056873|527461508|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
146258738|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
146258739|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
146258740|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
146258741|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
146258742|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
146258743|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
146258744|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
146258745|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
146258746|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
146258747|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
146258748|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
146258749|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
146258750|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
146258751|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
146258752|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
146258753|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
146258754|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
146258755|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
146258756|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
146258757|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
146301232|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146301233|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146108302|NCT01751867|526916605|FG001|Overall Study|Other|37|||
146258758|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
146108303|NCT01751867|526916604|FG000|Overall Study|Randomized but not treated.|2|||
146108304|NCT01751867|526916605|FG001|Overall Study|Randomized but not treated.|1|||
146108305|NCT04932096|526916606|FG000|Overall Study|Withdrawal by Subject|1|||
146108306|NCT04932096|526916607|FG001|Overall Study|Withdrawal by Subject|1|||
146108307|NCT04932096|526916606|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
146108308|NCT04932096|526916607|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
146108309|NCT01508650|526916608|FG000|Overall Study|Lost to Follow-up|0|||
146108310|NCT01508650|526916609|FG001|Overall Study|Lost to Follow-up|3|||
146108311|NCT02064894|526916610|FG000|Overall Study|Withdrawal by Subject|43|||
146108312|NCT02064894|526916611|FG001|Overall Study|Withdrawal by Subject|102|||
146108313|NCT02064894|526916612|FG002|Overall Study|Withdrawal by Subject|115|||
146108314|NCT01396148|526916613|FG000|Overall Study|Patient Decision|1|||
146108315|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
146108316|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
146108317|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108318|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108319|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108320|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108321|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108322|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
146108323|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
146108324|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
146108325|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108326|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108327|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108328|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108329|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108330|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
146108331|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
146108332|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
146108333|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108334|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108335|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108336|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108337|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108338|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
146108339|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108340|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
146108341|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108342|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108343|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108344|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108345|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108346|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
146108347|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
146108348|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
146108349|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108350|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108351|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108352|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108353|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108354|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
146108355|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
146108356|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108357|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108358|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108359|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108360|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108361|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108362|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
146108363|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
146301234|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
146108364|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
146108365|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146108366|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146258759|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
146258760|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
146258761|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
146258762|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
146258763|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
146258764|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
146258765|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
146258766|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
146258767|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146258768|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146258769|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
146258770|NCT00092521|527463285|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
146258771|NCT00092521|527463286|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146258772|NCT00092521|527463287|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146258773|NCT00092521|527463288|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
146258774|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
146258775|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
146258776|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
146258777|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
146258778|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
146258779|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
146258780|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
146258781|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
146258782|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
146108367|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146108368|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146108369|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146108370|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
146108371|NCT03095066|526916624|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
146108372|NCT03095066|526916625|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
146108373|NCT03095066|526916626|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108374|NCT03095066|526916627|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108375|NCT03095066|526916628|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108376|NCT03095066|526916629|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108377|NCT03095066|526916630|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108378|NCT03095066|526916631|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
146108379|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108380|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108381|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
146108382|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108383|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108384|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108385|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
146108386|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
146108387|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108388|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108389|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
146108390|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108391|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108392|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108393|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
146108394|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
146108395|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108396|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108397|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
146108398|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108399|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108400|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108401|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
146108402|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
146108403|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146108404|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146108405|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
146108406|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146108407|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146108408|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146108409|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
146301235|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146052198|NCT00255190|526705431|FG001|Overall Study|Protocol Violation|2|||
146052199|NCT00255190|526705430|FG000|Overall Study|Lost to Follow-up|10|||
146052200|NCT00255190|526705431|FG001|Overall Study|Lost to Follow-up|27|||
146052201|NCT00255190|526705430|FG000|Overall Study|Withdrew Consent|17|||
146052202|NCT00255190|526705431|FG001|Overall Study|Withdrew Consent|48|||
146052203|NCT00255190|526705430|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146052204|NCT00255190|526705431|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
146052205|NCT00255190|526705430|FG000|Overall Study|Erosive esophagitis not healed|0|||
146052206|NCT00255190|526705431|FG001|Overall Study|Erosive esophagitis not healed|20|||
146052207|NCT00255190|526705430|FG000|Overall Study|Various|4|||
146052208|NCT00255190|526705431|FG001|Overall Study|Various|23|||
146052209|NCT01156480|526705437|FG000|Overall Study|change in diagnosis|0|||
146052210|NCT01156480|526705438|FG001|Overall Study|change in diagnosis|1|||
146052211|NCT04537793|526705439|FG000|Part B (24 Weeks)|Adverse Event|0|||
146052212|NCT04537793|526705440|FG001|Part B (24 Weeks)|Adverse Event|1|||
146052213|NCT01176058|526705442|FG000|Overall Study|Adverse Event|1|||
146052214|NCT01176058|526705443|FG001|Overall Study|Adverse Event|0|||
146052215|NCT01176058|526705442|FG000|Overall Study|Insufficient clinical response|2|||
146052216|NCT01176058|526705443|FG001|Overall Study|Insufficient clinical response|2|||
146052217|NCT01176058|526705442|FG000|Overall Study|Insufficient mycological response|0|||
146052218|NCT01176058|526705443|FG001|Overall Study|Insufficient mycological response|1|||
146052219|NCT01176058|526705442|FG000|Overall Study|Withdrawal by Subject|1|||
146052220|NCT01176058|526705443|FG001|Overall Study|Withdrawal by Subject|0|||
146052221|NCT00256724|526705446|FG000|Overall Study|Physician Decision|2|||
146052222|NCT00256724|526705447|FG001|Overall Study|Physician Decision|5|||
146052223|NCT00256724|526705446|FG000|Overall Study|Protocol Violation|3|||
146052224|NCT00256724|526705447|FG001|Overall Study|Protocol Violation|3|||
146052225|NCT01217463|526705448|FG000|Overall Study|Adverse Event|8|||
146052226|NCT01217463|526705449|FG001|Overall Study|Adverse Event|5|||
146052227|NCT01217463|526705448|FG000|Overall Study|Physician Decision|0|||
146052228|NCT01217463|526705449|FG001|Overall Study|Physician Decision|1|||
146052229|NCT01217463|526705448|FG000|Overall Study|Withdrawal by Subject|3|||
146052230|NCT01217463|526705449|FG001|Overall Study|Withdrawal by Subject|0|||
146052231|NCT01217463|526705448|FG000|Overall Study|Surgery on the Target Limb|0|||
146052232|NCT01217463|526705449|FG001|Overall Study|Surgery on the Target Limb|1|||
146052233|NCT01217463|526705448|FG000|Overall Study|Patient Non-compliant|1|||
146052234|NCT01217463|526705449|FG001|Overall Study|Patient Non-compliant|0|||
146052235|NCT01217463|526705448|FG000|Overall Study|Other|1|||
146052236|NCT01217463|526705449|FG001|Overall Study|Other|1|||
146052237|NCT01858363|526705452|FG000|Overall Study|Death|35|||
146052238|NCT01858363|526705453|FG001|Overall Study|Death|9|||
146052239|NCT01858363|526705452|FG000|Overall Study|Withdrawal by Subject|28|||
146052240|NCT01858363|526705453|FG001|Overall Study|Withdrawal by Subject|14|||
146052241|NCT01858363|526705452|FG000|Overall Study|Lost to Follow-up|13|||
146052242|NCT01858363|526705453|FG001|Overall Study|Lost to Follow-up|3|||
146052243|NCT01569841|526705454|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
146052244|NCT01569841|526705455|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
146052245|NCT00057863|526705465|FG000|Overall Study|Death|1|||
146052246|NCT00057863|526705465|FG000|Overall Study|Withdrawal by Subject|2|||
146052247|NCT00764361|526705466|FG000|Overall Study|Withdrawal by Subject|2|||
146052248|NCT00764361|526705467|FG001|Overall Study|Withdrawal by Subject|3|||
146052249|NCT00764361|526705466|FG000|Overall Study|Adverse Event|0|||
146052250|NCT00764361|526705467|FG001|Overall Study|Adverse Event|1|||
146052251|NCT02090426|526705468|FG000|Overall Study|Lost to Follow-up|12|||
146052252|NCT02090426|526705469|FG001|Overall Study|Lost to Follow-up|6|||
146052253|NCT02079038|526705470|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
146052254|NCT02079038|526705471|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
146052255|NCT02079038|526705470|FG000|Modified Intent to Treat Population|Death|1|||
146052256|NCT02079038|526705471|FG001|Modified Intent to Treat Population|Death|0|||
146052257|NCT02079038|526705470|FG000|Completed 6 Months|Lost to Follow-up|2|||
146052258|NCT02079038|526705471|FG001|Completed 6 Months|Lost to Follow-up|1|||
146052259|NCT03634085|526705472|FG000|Overall Study|Adverse Event|1|||
146052260|NCT03634085|526705473|FG001|Overall Study|Adverse Event|0|||
146052261|NCT03634085|526705472|FG000|Overall Study|Withdrawal by Subject|0|||
146052262|NCT03634085|526705473|FG001|Overall Study|Withdrawal by Subject|2|||
146052263|NCT04276233|526705474|FG000|Overall Study|Adverse Event|1|||
146052264|NCT04276233|526705474|FG000|Overall Study|Lost to Follow-up|3|||
146052265|NCT04276233|526705474|FG000|Overall Study|Physician Decision|4|||
146052266|NCT04276233|526705474|FG000|Overall Study|Withdrawal by Subject|2|||
146052267|NCT00148759|526705477|FG000|Overall Study|Withdrawal by Subject|1|||
146052268|NCT00148759|526705478|FG001|Overall Study|Withdrawal by Subject|1|||
146052269|NCT00148759|526705477|FG000|Overall Study|Lost to Follow-up|1|||
146052270|NCT00148759|526705478|FG001|Overall Study|Lost to Follow-up|0|||
146052271|NCT01454596|526705479|FG000|Overall Study|Death|0|||
146052272|NCT01454596|526705480|FG001|Overall Study|Death|0|||
146052273|NCT01454596|526705481|FG002|Overall Study|Death|0|||
146052274|NCT01454596|526705482|FG003|Overall Study|Death|0|||
146301236|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
146301237|NCT03627767|527618859|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
146301238|NCT03627767|527618860|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
146052275|NCT01454596|526705483|FG004|Overall Study|Death|0|||
146052276|NCT01454596|526705484|FG005|Overall Study|Death|0|||
146052277|NCT01454596|526705485|FG006|Overall Study|Death|0|||
146052278|NCT01454596|526705486|FG007|Overall Study|Death|0|||
146052279|NCT01454596|526705487|FG008|Overall Study|Death|0|||
146052280|NCT01454596|526705488|FG009|Overall Study|Death|1|||
146052281|NCT01454596|526705489|FG010|Overall Study|Death|1|||
146052282|NCT01454596|526705490|FG011|Overall Study|Death|0|||
146052283|NCT02800863|526705499|FG000|Overall Study|Adverse Event|14|||
146052284|NCT02800863|526705499|FG000|Overall Study|Another Device Implanted|1|||
146052285|NCT02800863|526705499|FG000|Overall Study|Device Explanted|1|||
146052286|NCT02800863|526705499|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
146052287|NCT02800863|526705499|FG000|Overall Study|Health Issues|1|||
146052288|NCT02800863|526705499|FG000|Overall Study|Insurance Denial|8|||
146052289|NCT02800863|526705499|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
146052290|NCT02800863|526705499|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
146052291|NCT02800863|526705499|FG000|Overall Study|Screen Failure|1|||
146052292|NCT02800863|526705499|FG000|Overall Study|Sponsor Request|6|||
146052293|NCT02800863|526705499|FG000|Overall Study|Death|3|||
146052294|NCT02800863|526705499|FG000|Overall Study|Subject Implant at Another Facility|1|||
146052295|NCT02800863|526705499|FG000|Overall Study|Lost to Follow-up|26|||
146052296|NCT02800863|526705499|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
146052297|NCT02800863|526705499|FG000|Overall Study|Subject and/or Family Request|64|||
146052298|NCT02800863|526705499|FG000|Overall Study|Trial Failure|81|||
146052299|NCT02800863|526705499|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
146052300|NCT03957551|526705500|FG000|Overall Study|Adverse Event|2|||
146052301|NCT03957551|526705501|FG001|Overall Study|Adverse Event|2|||
146052302|NCT03957551|526705502|FG002|Overall Study|Adverse Event|6|||
146052303|NCT03957551|526705500|FG000|Overall Study|Physician Decision|1|||
146052304|NCT03957551|526705501|FG001|Overall Study|Physician Decision|0|||
146052305|NCT03957551|526705502|FG002|Overall Study|Physician Decision|2|||
146052306|NCT03957551|526705500|FG000|Overall Study|Withdrawal by Subject|1|||
146052307|NCT03957551|526705501|FG001|Overall Study|Withdrawal by Subject|0|||
146052308|NCT03957551|526705502|FG002|Overall Study|Withdrawal by Subject|2|||
146052309|NCT03957551|526705500|FG000|Overall Study|Disease progression|1|||
146052310|NCT03957551|526705501|FG001|Overall Study|Disease progression|0|||
146052311|NCT03957551|526705502|FG002|Overall Study|Disease progression|8|||
146052312|NCT03775486|526705503|FG000|Initial Therapy Phase|Other reason provided|0|||
146052313|NCT03775486|526705504|FG001|Initial Therapy Phase|Other reason provided|15|||
146052314|NCT03775486|526705503|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
146052315|NCT03775486|526705504|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
146052316|NCT03775486|526705503|FG000|Initial Therapy Phase|Protocol Violation|0|||
146052317|NCT03775486|526705504|FG001|Initial Therapy Phase|Protocol Violation|2|||
146052318|NCT03775486|526705503|FG000|Initial Therapy Phase|Adverse Event|0|||
146052319|NCT03775486|526705504|FG001|Initial Therapy Phase|Adverse Event|34|||
146052320|NCT03775486|526705503|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
146052321|NCT03775486|526705504|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
146052322|NCT03775486|526705503|FG000|Maintenance Phase|Withdrawal by Subject|13|||
146052323|NCT03775486|526705504|FG001|Maintenance Phase|Withdrawal by Subject|12|||
146052324|NCT03775486|526705503|FG000|Maintenance Phase|Death|44|||
146052325|NCT03775486|526705504|FG001|Maintenance Phase|Death|45|||
146052326|NCT01572480|526705505|FG000|Participants Enrolled|Withdrawal by Subject|1|||
146052327|NCT01572480|526705505|FG000|Drug Administration|Discontinued drug/Off Study|1|||
146052328|NCT01572480|526705505|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
146052329|NCT01572480|526705505|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
146052330|NCT04194944|526705506|FG000|Overall Study|Lost to Follow-up|3|||
146052331|NCT04194944|526705507|FG001|Overall Study|Lost to Follow-up|0|||
146052332|NCT04194944|526705506|FG000|Overall Study|Withdrawal by Subject|2|||
146052333|NCT04194944|526705507|FG001|Overall Study|Withdrawal by Subject|2|||
146052334|NCT04194944|526705506|FG000|Overall Study|On Treatment|93|||
146052335|NCT04194944|526705507|FG001|Overall Study|On Treatment|30|||
146052336|NCT06235905|526705508|FG000|Overall Study|Adverse Event|1|||
146052337|NCT06235905|526705508|FG000|Overall Study|Non-compliant with protocol procedures|1|||
146052338|NCT00319254|526705509|FG000|Overall Study|Withdrawal by Subject|4|||
146052339|NCT00319254|526705509|FG000|Overall Study|Death|46|||
146052340|NCT00319254|526705509|FG000|Overall Study|Lost to Follow-up|2|||
146052341|NCT00319254|526705509|FG000|Overall Study|Enrolled, Not Treated|2|||
146052342|NCT01859923|526707327|FG000|Overall Study|Adverse Event|0|||
146052343|NCT01859923|526707328|FG001|Overall Study|Adverse Event|0|||
146052344|NCT01859923|526707329|FG002|Overall Study|Adverse Event|1|||
146052345|NCT01859923|526707330|FG003|Overall Study|Adverse Event|1|||
146052346|NCT00296816|526707335|FG000|Overall Study|Disease Progression|37|||
146108410|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
146108411|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108412|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108413|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
146108414|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108415|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108416|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108417|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108418|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
146108419|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108420|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108421|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
146108422|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108423|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108424|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108425|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
146108426|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
146108427|NCT03095066|526916624|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108428|NCT03095066|526916625|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108429|NCT03095066|526916626|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108430|NCT03095066|526916627|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108431|NCT03095066|526916628|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108432|NCT03095066|526916629|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108433|NCT03095066|526916630|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
146108434|NCT03095066|526916631|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
146108435|NCT03095066|526916624|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108436|NCT03095066|526916625|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108437|NCT03095066|526916626|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108438|NCT03095066|526916627|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108439|NCT03095066|526916628|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108440|NCT03095066|526916629|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
146108441|NCT03095066|526916630|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108442|NCT03095066|526916631|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
146108443|NCT03095066|526916624|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108444|NCT03095066|526916625|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108445|NCT03095066|526916626|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108446|NCT03095066|526916627|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108447|NCT03095066|526916628|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
146108448|NCT03095066|526916629|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108449|NCT03095066|526916630|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
146108450|NCT03095066|526916631|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
146108451|NCT03095066|526916624|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108452|NCT03095066|526916625|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108453|NCT03095066|526916626|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108454|NCT03095066|526916627|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108455|NCT03095066|526916628|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
146108456|NCT03095066|526916629|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108457|NCT03095066|526916630|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
146108458|NCT03095066|526916631|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
146108459|NCT03095066|526916624|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108460|NCT03095066|526916625|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108461|NCT03095066|526916626|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108462|NCT03095066|526916627|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108463|NCT03095066|526916628|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
146108464|NCT03095066|526916629|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108465|NCT03095066|526916630|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
146108466|NCT03095066|526916631|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
146108467|NCT03095066|526916624|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146108468|NCT03095066|526916625|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146108469|NCT03095066|526916626|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146108470|NCT03095066|526916627|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
146108471|NCT03095066|526916628|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146108472|NCT03095066|526916629|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
146108473|NCT03095066|526916630|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145941609|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
146108474|NCT03095066|526916631|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
146108475|NCT02170298|526916636|FG000|Overall Study|Withdrawal by Subject|0|||
146108476|NCT02170298|526916637|FG001|Overall Study|Withdrawal by Subject|1|||
146108477|NCT02170298|526916636|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
146108478|NCT02170298|526916637|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
146108479|NCT00777608|526916639|FG000|Overall Study|Lost to Follow-up|1|||
146108480|NCT00777608|526916640|FG001|Overall Study|Lost to Follow-up|1|||
146108481|NCT00777608|526916639|FG000|Overall Study|Withdrawal by Subject|1|||
146108482|NCT00777608|526916640|FG001|Overall Study|Withdrawal by Subject|3|||
146108483|NCT00777608|526916639|FG000|Overall Study|Protocol Violation|1|||
146108484|NCT00777608|526916640|FG001|Overall Study|Protocol Violation|0|||
146108485|NCT00777608|526916639|FG000|Overall Study|Investigator Decision|1|||
146108486|NCT00777608|526916640|FG001|Overall Study|Investigator Decision|2|||
146108487|NCT04213079|526916641|FG000|Overall Study|Lost to Follow-up|0|||
146108488|NCT04213079|526916642|FG001|Overall Study|Lost to Follow-up|2|||
146108489|NCT00520936|526916644|FG000|Overall Study|Physician Decision|0|||
146108490|NCT00520936|526916645|FG001|Overall Study|Physician Decision|2|||
146108491|NCT00520936|526916646|FG002|Overall Study|Physician Decision|1|||
146108492|NCT00520936|526916647|FG003|Overall Study|Physician Decision|0|||
146108493|NCT00520936|526916648|FG004|Overall Study|Physician Decision|0|||
146301239|NCT03627767|527618861|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
146301240|NCT03627767|527618862|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
146301241|NCT03627767|527618863|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
146301242|NCT03627767|527618859|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146301243|NCT03627767|527618860|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146301244|NCT03627767|527618861|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146301245|NCT03627767|527618862|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
146301246|NCT03627767|527618863|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
146301247|NCT03627767|527618859|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146301248|NCT03627767|527618860|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146301249|NCT03627767|527618861|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146301250|NCT03627767|527618862|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
146301251|NCT03627767|527618863|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
146301252|NCT03627767|527618859|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146301253|NCT03627767|527618860|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146301254|NCT03627767|527618861|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146301255|NCT03627767|527618862|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
146301256|NCT03627767|527618863|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
146301257|NCT03627767|527618859|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
146301258|NCT03627767|527618860|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
146301259|NCT03627767|527618861|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
146301260|NCT03627767|527618862|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
146301261|NCT03627767|527618863|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
146301262|NCT00907257|527618864|FG000|Overall Study|Adverse Event|0|||
146052347|NCT00296816|526707335|FG000|Overall Study|Adverse Event|18|||
146052348|NCT00296816|526707335|FG000|Overall Study|Investigator/Participant request|5|||
146052349|NCT00296816|526707335|FG000|Overall Study|Non-compliance|1|||
146052350|NCT00296816|526707335|FG000|Overall Study|Missing for end of treatment|4|||
146052351|NCT00296816|526707335|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
146052352|NCT00296816|526707335|FG000|Overall Study|Poor performance status|1|||
146052353|NCT00296816|526707335|FG000|Overall Study|Relocation to Florida|1|||
146052354|NCT00296816|526707335|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
146052355|NCT00296816|526707335|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
146052356|NCT00296816|526707335|FG000|Overall Study|Neuropathy/patient preference|1|||
146052357|NCT00296816|526707335|FG000|Overall Study|Proteinuria|1|||
146052358|NCT00296816|526707335|FG000|Overall Study|ineligibility due to radiation treatment|1|||
146052359|NCT00985465|526707336|FG000|Overall Study|Withdrawal by Subject|1|||
146052360|NCT00985465|526707337|FG001|Overall Study|Withdrawal by Subject|2|||
146052361|NCT00985465|526707336|FG000|Overall Study|Considered to be part of the other group|0|||
146052362|NCT00985465|526707337|FG001|Overall Study|Considered to be part of the other group|1|||
146052363|NCT01054456|526707338|FG000|Overall Study|Other|1|||
146052364|NCT00687401|526707340|FG000|Overall Study|Protocol Violation|7|||
146052365|NCT00687401|526707340|FG000|Overall Study|Adverse Event|6|||
146052366|NCT00687401|526707340|FG000|Overall Study|Lack of Efficacy|6|||
146052367|NCT00687401|526707340|FG000|Overall Study|Withdrawal by Subject|4|||
146052368|NCT00687401|526707340|FG000|Overall Study|Did not return for visit|3|||
146052369|NCT00687401|526707340|FG000|Overall Study|For reasons different from those above|4|||
146052370|NCT01721161|526707343|FG000|Overall Study|Adverse Event|2|||
146052371|NCT01721161|526707344|FG001|Overall Study|Adverse Event|3|||
146052372|NCT01721161|526707343|FG000|Overall Study|Lost to Follow-up|1|||
146052373|NCT01721161|526707344|FG001|Overall Study|Lost to Follow-up|2|||
146052374|NCT01721161|526707343|FG000|Overall Study|Withdrawal by Subject|1|||
146052375|NCT01721161|526707344|FG001|Overall Study|Withdrawal by Subject|1|||
146052376|NCT01721161|526707343|FG000|Overall Study|Other|0|||
146108494|NCT00520936|526916649|FG005|Overall Study|Physician Decision|0|||
146108495|NCT00520936|526916650|FG006|Overall Study|Physician Decision|0|||
146108496|NCT00520936|526916651|FG007|Overall Study|Physician Decision|0|||
146108497|NCT00520936|526916644|FG000|Overall Study|Withdrawal by Subject|0|||
146108498|NCT00520936|526916645|FG001|Overall Study|Withdrawal by Subject|0|||
146108499|NCT00520936|526916646|FG002|Overall Study|Withdrawal by Subject|0|||
146108500|NCT00520936|526916647|FG003|Overall Study|Withdrawal by Subject|0|||
146108501|NCT00520936|526916648|FG004|Overall Study|Withdrawal by Subject|0|||
146108502|NCT00520936|526916649|FG005|Overall Study|Withdrawal by Subject|0|||
146108503|NCT00520936|526916650|FG006|Overall Study|Withdrawal by Subject|0|||
146108504|NCT00520936|526916651|FG007|Overall Study|Withdrawal by Subject|1|||
146108505|NCT00520936|526916644|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
146108506|NCT00520936|526916645|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
146108507|NCT00520936|526916646|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
146108508|NCT00520936|526916647|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
146108509|NCT00520936|526916648|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
146108510|NCT00520936|526916649|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
146108511|NCT00520936|526916650|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
146108512|NCT00520936|526916651|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
146108513|NCT00520936|526916644|FG000|Overall Study|Death|0|||
146108514|NCT00520936|526916645|FG001|Overall Study|Death|0|||
146108515|NCT00520936|526916646|FG002|Overall Study|Death|0|||
146258783|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
146258784|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
146258785|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
146258786|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Death|2|||
146258787|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Death|0|||
146258788|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Death|1|||
146258789|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Death|0|||
146258790|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
146258791|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
146258792|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
146258793|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
146258794|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
146258795|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
146258796|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
146258797|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
146258798|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
146258799|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
146258800|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
146258801|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
146258802|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Moved|32|||
146258803|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Moved|2|||
146258804|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Moved|28|||
146258805|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Moved|0|||
146258806|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
146258807|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
146258808|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
146258809|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
146258810|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Travel|2|||
146258811|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Travel|0|||
146258812|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Travel|0|||
146258813|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Travel|0|||
146258814|NCT00092521|527463285|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
146258815|NCT00092521|527463286|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
146258816|NCT00092521|527463287|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
146258817|NCT00092521|527463288|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
146258818|NCT00092521|527463285|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146258819|NCT00092521|527463286|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146258820|NCT00092521|527463287|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
146258821|NCT00092521|527463288|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
146258822|NCT00092521|527463285|FG000|Extension Study (Group 4)|Adverse Event|0|||
146258823|NCT00092521|527463286|FG001|Extension Study (Group 4)|Adverse Event|0|||
146108516|NCT00520936|526916647|FG003|Overall Study|Death|0|||
146258824|NCT00092521|527463287|FG002|Extension Study (Group 4)|Adverse Event|0|||
146258825|NCT00092521|527463288|FG003|Extension Study (Group 4)|Adverse Event|2|||
146258826|NCT00092521|527463285|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
146258827|NCT00092521|527463286|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
146258828|NCT00092521|527463287|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
146258829|NCT00092521|527463288|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
146258830|NCT00092521|527463285|FG000|Extension Study (Group 4)|Pregnancy|0|||
146258831|NCT00092521|527463286|FG001|Extension Study (Group 4)|Pregnancy|0|||
146258832|NCT00092521|527463287|FG002|Extension Study (Group 4)|Pregnancy|0|||
146258833|NCT00092521|527463288|FG003|Extension Study (Group 4)|Pregnancy|4|||
146301263|NCT00907257|527618865|FG001|Overall Study|Adverse Event|4|||
146108517|NCT00520936|526916648|FG004|Overall Study|Death|0|||
146108518|NCT00520936|526916649|FG005|Overall Study|Death|0|||
146108519|NCT00520936|526916650|FG006|Overall Study|Death|1|||
146301264|NCT00907257|527618864|FG000|Overall Study|Protocol Violation|1|||
146301265|NCT00907257|527618865|FG001|Overall Study|Protocol Violation|2|||
146301266|NCT00907257|527618864|FG000|Overall Study|Lost to Follow-up|3|||
146108520|NCT00520936|526916651|FG007|Overall Study|Death|0|||
146108521|NCT00520936|526916644|FG000|Overall Study|Protocol Violation|0|||
146108522|NCT00520936|526916645|FG001|Overall Study|Protocol Violation|1|||
146108523|NCT00520936|526916646|FG002|Overall Study|Protocol Violation|1|||
146108524|NCT00520936|526916647|FG003|Overall Study|Protocol Violation|0|||
146108525|NCT00520936|526916648|FG004|Overall Study|Protocol Violation|1|||
146108526|NCT00520936|526916649|FG005|Overall Study|Protocol Violation|0|||
146108527|NCT00520936|526916650|FG006|Overall Study|Protocol Violation|1|||
146108528|NCT00520936|526916651|FG007|Overall Study|Protocol Violation|0|||
146108529|NCT04343261|526916652|FG000|Overall Study|Adverse Event|1|||
146108530|NCT04343261|526916652|FG000|Overall Study|received inadequate amount of antibodies|7|||
146108531|NCT04220866|526916657|FG000|Overall Study|Death|4|||
146108532|NCT04220866|526916658|FG001|Overall Study|Death|5|||
146108533|NCT04220866|526916657|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
146108534|NCT04220866|526916658|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
146108535|NCT04220866|526916657|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
146108536|NCT04220866|526916658|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
146108537|NCT04220866|526916657|FG000|Overall Study|Withdrawal by Subject|0|||
146108538|NCT04220866|526916658|FG001|Overall Study|Withdrawal by Subject|1|||
146108539|NCT03858309|526916659|FG000|Overall Study|Withdrawal by Subject|2|||
146108540|NCT03858309|526916660|FG001|Overall Study|Withdrawal by Subject|3|||
146108541|NCT03897465|526916664|FG000|Overall Study|Lost to Follow-up|2|||
146108542|NCT03897465|526916665|FG001|Overall Study|Lost to Follow-up|1|||
146108543|NCT03897465|526916664|FG000|Overall Study|Adverse Event|2|||
146108544|NCT03897465|526916665|FG001|Overall Study|Adverse Event|0|||
146108545|NCT03897465|526916664|FG000|Overall Study|complete healing by V2|1|||
146108546|NCT03897465|526916665|FG001|Overall Study|complete healing by V2|0|||
146108547|NCT03897465|526916664|FG000|Overall Study|occurence of exclusion criterion|1|||
146108548|NCT03897465|526916665|FG001|Overall Study|occurence of exclusion criterion|1|||
146108549|NCT03897465|526916664|FG000|Overall Study|Other|1|||
146108550|NCT03897465|526916665|FG001|Overall Study|Other|0|||
146108551|NCT02197247|526916668|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
146108552|NCT02197247|526916668|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
146108553|NCT02197247|526916668|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
146108554|NCT02197247|526916668|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
146108555|NCT02197247|526916668|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
146108556|NCT02197247|526916668|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
146108557|NCT02197247|526916668|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
146108558|NCT02197247|526916668|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
146108559|NCT00601458|526916672|FG000|Overall Study|Dosing Error|1|||
146108560|NCT00601458|526916673|FG001|Overall Study|Dosing Error|0|||
146108561|NCT00601458|526916674|FG002|Overall Study|Dosing Error|0|||
146108562|NCT00601458|526916672|FG000|Overall Study|Incomplete Data|0|||
146108563|NCT00601458|526916673|FG001|Overall Study|Incomplete Data|2|||
146108564|NCT00601458|526916674|FG002|Overall Study|Incomplete Data|0|||
146108565|NCT00601458|526916672|FG000|Overall Study|Protocol Violation|3|||
146108566|NCT00601458|526916673|FG001|Overall Study|Protocol Violation|2|||
146108567|NCT00601458|526916674|FG002|Overall Study|Protocol Violation|1|||
146108568|NCT00601458|526916672|FG000|Overall Study|Early Termination|0|||
146108569|NCT00601458|526916673|FG001|Overall Study|Early Termination|1|||
146108570|NCT00601458|526916674|FG002|Overall Study|Early Termination|1|||
146108571|NCT00370032|526916675|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
146108572|NCT00370032|526916676|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
146108573|NCT00370032|526916675|FG000|Washout Period|Withdrawal by Subject|0|||
146108574|NCT00370032|526916676|FG001|Washout Period|Withdrawal by Subject|1|||
146108575|NCT00370032|526916675|FG000|Washout Period|Lost to Follow-up|0|||
146108576|NCT00370032|526916676|FG001|Washout Period|Lost to Follow-up|1|||
146108577|NCT00370032|526916675|FG000|Washout Period|Adverse Event|1|||
146108578|NCT00370032|526916676|FG001|Washout Period|Adverse Event|0|||
146108579|NCT00370032|526916675|FG000|Follow-up Period|Withdrawal by Subject|1|||
146108580|NCT00370032|526916676|FG001|Follow-up Period|Withdrawal by Subject|0|||
146108581|NCT02405780|526916684|FG000|Period I|Adverse Event|8|||
146108582|NCT02405780|526916685|FG001|Period I|Adverse Event|0|||
146108583|NCT02405780|526916686|FG002|Period I|Adverse Event|3|||
146108584|NCT02405780|526916687|FG003|Period I|Adverse Event|7|||
145941610|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
146108585|NCT02405780|526916684|FG000|Period I|Medical reasons|1|||
146108586|NCT02405780|526916685|FG001|Period I|Medical reasons|1|||
146108587|NCT02405780|526916686|FG002|Period I|Medical reasons|0|||
146108588|NCT02405780|526916687|FG003|Period I|Medical reasons|1|||
146108589|NCT02405780|526916684|FG000|Period I|Screening Failure|1|||
146108590|NCT02405780|526916685|FG001|Period I|Screening Failure|0|||
146108591|NCT02405780|526916686|FG002|Period I|Screening Failure|1|||
146108592|NCT02405780|526916687|FG003|Period I|Screening Failure|0|||
146108593|NCT02405780|526916684|FG000|Period I|Withdrawal by Subject|9|||
146108594|NCT02405780|526916685|FG001|Period I|Withdrawal by Subject|1|||
146108595|NCT02405780|526916686|FG002|Period I|Withdrawal by Subject|3|||
146108596|NCT02405780|526916687|FG003|Period I|Withdrawal by Subject|4|||
146108597|NCT02405780|526916684|FG000|Period I|Non-compliance with study procedures|8|||
146108598|NCT02405780|526916685|FG001|Period I|Non-compliance with study procedures|6|||
146108599|NCT02405780|526916686|FG002|Period I|Non-compliance with study procedures|8|||
146108600|NCT02405780|526916687|FG003|Period I|Non-compliance with study procedures|11|||
146108601|NCT02405780|526916684|FG000|Period II|Adverse Event|3|||
146108602|NCT02405780|526916685|FG001|Period II|Adverse Event|5|||
146108603|NCT02405780|526916686|FG002|Period II|Adverse Event|4|||
146108604|NCT02405780|526916687|FG003|Period II|Adverse Event|11|||
146108605|NCT02405780|526916684|FG000|Period II|Medical reason|0|||
146108606|NCT02405780|526916685|FG001|Period II|Medical reason|1|||
146108607|NCT02405780|526916686|FG002|Period II|Medical reason|0|||
146108608|NCT02405780|526916687|FG003|Period II|Medical reason|0|||
146108609|NCT02405780|526916684|FG000|Period II|Pregnancy|0|||
146108610|NCT02405780|526916685|FG001|Period II|Pregnancy|0|||
146108611|NCT02405780|526916686|FG002|Period II|Pregnancy|1|||
146108612|NCT02405780|526916687|FG003|Period II|Pregnancy|0|||
146108613|NCT02405780|526916684|FG000|Period II|Withdrawal by Subject|7|||
146108614|NCT02405780|526916685|FG001|Period II|Withdrawal by Subject|4|||
146108615|NCT02405780|526916686|FG002|Period II|Withdrawal by Subject|0|||
146108616|NCT02405780|526916687|FG003|Period II|Withdrawal by Subject|3|||
146108617|NCT02405780|526916684|FG000|Period II|Non-compliance with study procedures|5|||
146108618|NCT02405780|526916685|FG001|Period II|Non-compliance with study procedures|2|||
146108619|NCT02405780|526916686|FG002|Period II|Non-compliance with study procedures|7|||
146108620|NCT02405780|526916687|FG003|Period II|Non-compliance with study procedures|4|||
146108621|NCT00602797|526916688|FG000|Overall Study|Adverse Event|1|||
146108622|NCT04502693|526916693|FG000|Overall Study|Adverse Event|7|||
146108623|NCT04502693|526916694|FG001|Overall Study|Adverse Event|6|||
146108624|NCT04502693|526916695|FG002|Overall Study|Adverse Event|11|||
146108625|NCT04502693|526916696|FG003|Overall Study|Adverse Event|1|||
146108626|NCT04502693|526916693|FG000|Overall Study|Lost to Follow-up|32|||
146108627|NCT04502693|526916694|FG001|Overall Study|Lost to Follow-up|36|||
146108628|NCT04502693|526916695|FG002|Overall Study|Lost to Follow-up|69|||
146108629|NCT04502693|526916696|FG003|Overall Study|Lost to Follow-up|4|||
146108630|NCT04502693|526916693|FG000|Overall Study|Protocol Violation|8|||
146108631|NCT04502693|526916694|FG001|Overall Study|Protocol Violation|8|||
146108632|NCT04502693|526916695|FG002|Overall Study|Protocol Violation|16|||
146108633|NCT04502693|526916696|FG003|Overall Study|Protocol Violation|1|||
146108634|NCT04502693|526916693|FG000|Overall Study|Withdrawal by Subject|46|||
146108635|NCT04502693|526916694|FG001|Overall Study|Withdrawal by Subject|38|||
146108636|NCT04502693|526916695|FG002|Overall Study|Withdrawal by Subject|54|||
146108637|NCT04502693|526916696|FG003|Overall Study|Withdrawal by Subject|7|||
146108638|NCT04502693|526916693|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
146108639|NCT04502693|526916694|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
146108640|NCT04502693|526916695|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
146108641|NCT04502693|526916696|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146108642|NCT04502693|526916693|FG000|Overall Study|Other|1|||
146108643|NCT04502693|526916694|FG001|Overall Study|Other|0|||
146108644|NCT04502693|526916695|FG002|Overall Study|Other|1|||
146108645|NCT04502693|526916696|FG003|Overall Study|Other|1|||
146108646|NCT03736447|526916699|FG000|Overall Study|Adverse Event|5|||
146108647|NCT03736447|526916700|FG001|Overall Study|Adverse Event|1|||
146108648|NCT03736447|526916699|FG000|Overall Study|Withdrawal by Subject|5|||
146108649|NCT03736447|526916700|FG001|Overall Study|Withdrawal by Subject|1|||
146108650|NCT03736447|526916699|FG000|Overall Study|Lost to Follow-up|1|||
146108651|NCT03736447|526916700|FG001|Overall Study|Lost to Follow-up|0|||
146258834|NCT00092521|527463285|FG000|Extension Study (Group 4)|Protocol Violation|0|||
146258835|NCT00092521|527463286|FG001|Extension Study (Group 4)|Protocol Violation|0|||
146258836|NCT00092521|527463287|FG002|Extension Study (Group 4)|Protocol Violation|0|||
146258837|NCT00092521|527463288|FG003|Extension Study (Group 4)|Protocol Violation|2|||
146258838|NCT00092521|527463285|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
146258839|NCT00092521|527463286|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
146258840|NCT00092521|527463287|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
146258841|NCT00092521|527463288|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
146258842|NCT00092521|527463285|FG000|Extension Study (Group 4)|Moved|0|||
146258843|NCT00092521|527463286|FG001|Extension Study (Group 4)|Moved|0|||
146258844|NCT00092521|527463287|FG002|Extension Study (Group 4)|Moved|0|||
146258845|NCT00092521|527463288|FG003|Extension Study (Group 4)|Moved|16|||
146258846|NCT00092521|527463285|FG000|Extension Study (Group 4)|Site Terminated|0|||
146258847|NCT00092521|527463286|FG001|Extension Study (Group 4)|Site Terminated|0|||
146258848|NCT00092521|527463287|FG002|Extension Study (Group 4)|Site Terminated|0|||
146258849|NCT00092521|527463288|FG003|Extension Study (Group 4)|Site Terminated|4|||
146258850|NCT00092521|527463285|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
146108652|NCT03736447|526916699|FG000|Overall Study|Physician Decision|1|||
146108653|NCT03736447|526916700|FG001|Overall Study|Physician Decision|0|||
146108654|NCT03736447|526916699|FG000|Overall Study|Continued commitment to study treatment|3|||
146108655|NCT03736447|526916700|FG001|Overall Study|Continued commitment to study treatment|0|||
146108656|NCT03736447|526916699|FG000|Overall Study|Taste aversion to study product|0|||
146108657|NCT03736447|526916700|FG001|Overall Study|Taste aversion to study product|1|||
146108658|NCT02784431|526916701|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
146108659|NCT02784431|526916701|FG000|Overall Study|Early Study Termination|19|||
146108660|NCT04875195|526916702|FG000|Overall Study|Death|9|||
146108661|NCT04875195|526916703|FG001|Overall Study|Death|3|||
146108662|NCT04875195|526916702|FG000|Overall Study|Withdrawal by Subject|2|||
146108663|NCT04875195|526916703|FG001|Overall Study|Withdrawal by Subject|1|||
146108664|NCT04875195|526916702|FG000|Overall Study|Ongoing in study|49|||
146108665|NCT04875195|526916703|FG001|Overall Study|Ongoing in study|2|||
146108666|NCT00074152|526916704|FG000|Overall Study|Death|21|||
146108667|NCT00074152|526916705|FG001|Overall Study|Death|9|||
146108668|NCT00074152|526916704|FG000|Overall Study|Lack of Efficacy|34|||
146108669|NCT00074152|526916705|FG001|Overall Study|Lack of Efficacy|24|||
146108670|NCT01594762|526916709|FG000|Overall Study|Withdrawal by Subject|1|||
146108671|NCT01594762|526916710|FG001|Overall Study|Withdrawal by Subject|0|||
146108672|NCT01594762|526916709|FG000|Overall Study|Lost to Follow-up|10|||
146108673|NCT01594762|526916710|FG001|Overall Study|Lost to Follow-up|10|||
146108674|NCT00382252|526916711|FG000|Overall Study|Death|4|||
146108675|NCT00382252|526916711|FG000|Overall Study|Protocol Violation|8|||
146108676|NCT00382252|526916711|FG000|Overall Study|Not treated by RFA|1|||
146108677|NCT03338998|526916712|FG000|Treatment Period|Withdrawal by Subject|1|||
146108678|NCT03338998|526916713|FG001|Treatment Period|Withdrawal by Subject|1|||
146108679|NCT03338998|526916712|FG000|Treatment Period|Adverse Event|0|||
146108680|NCT03338998|526916713|FG001|Treatment Period|Adverse Event|2|||
146108681|NCT03338998|526916712|FG000|Treatment Period|Protocol deviation|1|||
146108682|NCT03338998|526916713|FG001|Treatment Period|Protocol deviation|0|||
146108683|NCT03338998|526916712|FG000|Treatment Period|Physician Decision|2|||
146108684|NCT03338998|526916713|FG001|Treatment Period|Physician Decision|0|||
146108685|NCT03338998|526916712|FG000|Treatment Period|Subject failed swallow test|4|||
146108686|NCT03338998|526916713|FG001|Treatment Period|Subject failed swallow test|0|||
146108687|NCT03338998|526916712|FG000|Safety Follow-Up Period|Adverse Event|0|||
146108688|NCT03338998|526916713|FG001|Safety Follow-Up Period|Adverse Event|1|||
146108689|NCT03338998|526916712|FG000|Safety Follow-Up Period|Protocol deviation|1|||
146108690|NCT03338998|526916713|FG001|Safety Follow-Up Period|Protocol deviation|0|||
146108691|NCT03338998|526916712|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
146108692|NCT03338998|526916713|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
146108693|NCT02612727|526916714|FG000|Overall Study|Parent request|4|||
146108694|NCT02612727|526916715|FG001|Overall Study|Parent request|1|||
146108695|NCT02612727|526916714|FG000|Overall Study|Needed treatment incompatible with PT|1|||
146108696|NCT02612727|526916715|FG001|Overall Study|Needed treatment incompatible with PT|1|||
146108697|NCT02612727|526916714|FG000|Overall Study|Direct hyperbilirubinemia|0|||
146108698|NCT02612727|526916715|FG001|Overall Study|Direct hyperbilirubinemia|2|||
146108699|NCT04526665|526916716|FG000|Overall Study|Withdrawal by Subject|6|||
146108700|NCT04526665|526916717|FG001|Overall Study|Withdrawal by Subject|3|||
146258851|NCT00092521|527463286|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
146258852|NCT00092521|527463287|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
146258853|NCT00092521|527463288|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
146258854|NCT01878383|527463289|FG000|Overall Study|Lost to Follow-up|0|||
146258855|NCT01878383|527463290|FG001|Overall Study|Lost to Follow-up|1499|||
146258856|NCT03464383|527463291|FG000|Overall Study|Lost to Follow-up|1|||
146258857|NCT03464383|527463292|FG001|Overall Study|Lost to Follow-up|0|||
146258858|NCT03464383|527463293|FG002|Overall Study|Lost to Follow-up|0|||
146258859|NCT03464383|527463291|FG000|Overall Study|Withdrawal by Subject|0|||
146258860|NCT03464383|527463292|FG001|Overall Study|Withdrawal by Subject|1|||
146258861|NCT03464383|527463293|FG002|Overall Study|Withdrawal by Subject|0|||
146258862|NCT03475056|527463294|FG000|Overall Study|Lost to Follow-up|0|||
146258863|NCT03475056|527463295|FG001|Overall Study|Lost to Follow-up|1|||
146258864|NCT03475056|527463294|FG000|Overall Study|Moved from Area|0|||
146258865|NCT03475056|527463295|FG001|Overall Study|Moved from Area|2|||
146108701|NCT04526665|526916716|FG000|Overall Study|Adverse Event|4|||
146108702|NCT04526665|526916717|FG001|Overall Study|Adverse Event|1|||
146108703|NCT04526665|526916716|FG000|Overall Study|Physician Decision|2|||
146258866|NCT01904136|527463299|FG000|Overall Study|Physician Decision|0|||
146258867|NCT01904136|527463300|FG001|Overall Study|Physician Decision|0|||
146258868|NCT01904136|527463301|FG002|Overall Study|Physician Decision|0|||
146108704|NCT04526665|526916717|FG001|Overall Study|Physician Decision|2|||
146108705|NCT04526665|526916716|FG000|Overall Study|Death|2|||
146108706|NCT04526665|526916717|FG001|Overall Study|Death|0|||
146108707|NCT04526665|526916716|FG000|Overall Study|Other|0|||
146108708|NCT04526665|526916717|FG001|Overall Study|Other|1|||
146108709|NCT04524689|526916718|FG000|Overall Study|Withdrawal by Subject|1|||
146108710|NCT04524689|526916719|FG001|Overall Study|Withdrawal by Subject|1|||
146108711|NCT04524689|526916720|FG002|Overall Study|Withdrawal by Subject|0|||
146108712|NCT04524689|526916721|FG003|Overall Study|Withdrawal by Subject|0|||
146108713|NCT04524689|526916722|FG004|Overall Study|Withdrawal by Subject|2|||
146108714|NCT04524689|526916723|FG005|Overall Study|Withdrawal by Subject|0|||
146108715|NCT04524689|526916718|FG000|Overall Study|Study terminated by Sponsor|6|||
146108716|NCT04524689|526916719|FG001|Overall Study|Study terminated by Sponsor|0|||
146108717|NCT04524689|526916720|FG002|Overall Study|Study terminated by Sponsor|1|||
146108718|NCT04524689|526916721|FG003|Overall Study|Study terminated by Sponsor|0|||
146108719|NCT04524689|526916722|FG004|Overall Study|Study terminated by Sponsor|4|||
146108720|NCT04524689|526916723|FG005|Overall Study|Study terminated by Sponsor|0|||
146108721|NCT04524689|526916718|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
146108722|NCT04524689|526916719|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
146108723|NCT04524689|526916720|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
146108724|NCT04524689|526916721|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
146108725|NCT04524689|526916722|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
146108726|NCT04524689|526916723|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
146108727|NCT04292743|526916724|FG000|Overall Study|Physician Decision|1|||
146108728|NCT04292743|526916725|FG001|Overall Study|Physician Decision|3|||
146108729|NCT04292743|526916726|FG002|Overall Study|Physician Decision|0|||
146108730|NCT04292743|526916727|FG003|Overall Study|Physician Decision|0|||
146108731|NCT04292743|526916724|FG000|Overall Study|Withdrawal by Subject|0|||
146108732|NCT04292743|526916725|FG001|Overall Study|Withdrawal by Subject|5|||
146108733|NCT04292743|526916726|FG002|Overall Study|Withdrawal by Subject|0|||
146108734|NCT04292743|526916727|FG003|Overall Study|Withdrawal by Subject|0|||
146108735|NCT04292743|526916724|FG000|Overall Study|Death|0|||
146108736|NCT04292743|526916725|FG001|Overall Study|Death|1|||
146108737|NCT04292743|526916726|FG002|Overall Study|Death|0|||
146108738|NCT04292743|526916727|FG003|Overall Study|Death|0|||
146108739|NCT04292743|526916724|FG000|Overall Study|Progression of Disease|2|||
146108740|NCT04292743|526916725|FG001|Overall Study|Progression of Disease|5|||
146108741|NCT04292743|526916726|FG002|Overall Study|Progression of Disease|0|||
146108742|NCT04292743|526916727|FG003|Overall Study|Progression of Disease|0|||
146108743|NCT04292743|526916724|FG000|Overall Study|No Treatment per protocol|0|||
146108744|NCT04292743|526916725|FG001|Overall Study|No Treatment per protocol|2|||
146108745|NCT04292743|526916726|FG002|Overall Study|No Treatment per protocol|0|||
146108746|NCT04292743|526916727|FG003|Overall Study|No Treatment per protocol|0|||
146108747|NCT05766423|526916728|FG000|Overall Study|Withdrawal by Subject|1|||
146108748|NCT05766423|526916729|FG001|Overall Study|Withdrawal by Subject|0|||
146108749|NCT05766423|526916728|FG000|Overall Study|Consented, not scheduled|3|||
146108750|NCT05766423|526916729|FG001|Overall Study|Consented, not scheduled|5|||
146108751|NCT00844831|526918825|FG000|Overall Study|Withdrawal by Subject|4|||
146108752|NCT00844831|526918825|FG000|Overall Study|Adverse Event|1|||
146108753|NCT00844831|526918825|FG000|Overall Study|Physician Decision|1|||
146108754|NCT05255068|526918826|FG000|Overall Study|Lost to Follow-up|0|||
146108755|NCT05255068|526918827|FG001|Overall Study|Lost to Follow-up|1|||
146108756|NCT00540514|526918829|FG000|Overall Study|Still on treatment|3|||
146108757|NCT00540514|526918830|FG001|Overall Study|Still on treatment|0|||
146108758|NCT00540514|526918829|FG000|Overall Study|Unacceptable Toxicity|61|||
146108759|NCT00540514|526918830|FG001|Overall Study|Unacceptable Toxicity|62|||
146108760|NCT00540514|526918829|FG000|Overall Study|Adverse Event|20|||
146108761|NCT00540514|526918830|FG001|Overall Study|Adverse Event|24|||
146108762|NCT00540514|526918829|FG000|Overall Study|Physician Decision|86|||
146108763|NCT00540514|526918830|FG001|Overall Study|Physician Decision|99|||
146108764|NCT00540514|526918829|FG000|Overall Study|Protocol Deviation|3|||
146108765|NCT00540514|526918830|FG001|Overall Study|Protocol Deviation|4|||
146108766|NCT00540514|526918829|FG000|Overall Study|Lost to Follow-up|1|||
146108767|NCT00540514|526918830|FG001|Overall Study|Lost to Follow-up|1|||
146108768|NCT00540514|526918829|FG000|Overall Study|Withdrawal by Subject|65|||
146258869|NCT01904136|527463302|FG003|Overall Study|Physician Decision|0|||
146258870|NCT01904136|527463303|FG004|Overall Study|Physician Decision|0|||
146052377|NCT01721161|526707344|FG001|Overall Study|Other|1|||
146052378|NCT02888106|526707352|FG000|Overall Study|Withdrawal by Subject|1|||
146052379|NCT02888106|526707353|FG001|Overall Study|Withdrawal by Subject|2|||
146052380|NCT02888106|526707354|FG002|Overall Study|Withdrawal by Subject|0|||
146052381|NCT02888106|526707355|FG003|Overall Study|Withdrawal by Subject|1|||
146052382|NCT02888106|526707356|FG004|Overall Study|Withdrawal by Subject|0|||
146052383|NCT02888106|526707357|FG005|Overall Study|Withdrawal by Subject|0|||
146052384|NCT02888106|526707352|FG000|Overall Study|Lost to Follow-up|1|||
146052385|NCT02888106|526707353|FG001|Overall Study|Lost to Follow-up|0|||
146052386|NCT02888106|526707354|FG002|Overall Study|Lost to Follow-up|0|||
146052387|NCT02888106|526707355|FG003|Overall Study|Lost to Follow-up|1|||
146052388|NCT02888106|526707356|FG004|Overall Study|Lost to Follow-up|0|||
146052389|NCT02888106|526707357|FG005|Overall Study|Lost to Follow-up|1|||
146052390|NCT02888106|526707352|FG000|Overall Study|Adverse Event|2|||
146052391|NCT02888106|526707353|FG001|Overall Study|Adverse Event|0|||
146052392|NCT02888106|526707354|FG002|Overall Study|Adverse Event|0|||
146052393|NCT02888106|526707355|FG003|Overall Study|Adverse Event|0|||
146052394|NCT02888106|526707356|FG004|Overall Study|Adverse Event|0|||
146301267|NCT00907257|527618865|FG001|Overall Study|Lost to Follow-up|3|||
146301268|NCT00907257|527618864|FG000|Overall Study|Withdrawal by Subject|1|||
146301269|NCT00907257|527618865|FG001|Overall Study|Withdrawal by Subject|2|||
146301270|NCT00907257|527618864|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
146301271|NCT00907257|527618865|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
146301272|NCT00907257|527618864|FG000|Overall Study|Moved|1|||
146301273|NCT00907257|527618865|FG001|Overall Study|Moved|0|||
146301274|NCT00907257|527618864|FG000|Overall Study|Personal Reasons|6|||
146301275|NCT00907257|527618865|FG001|Overall Study|Personal Reasons|1|||
146301276|NCT04163900|527618866|FG000|Overall Study|Radiological disease progression|112|||
146301277|NCT04163900|527618867|FG001|Overall Study|Radiological disease progression|127|||
146301278|NCT04163900|527618866|FG000|Overall Study|Study closure|98|||
146301279|NCT04163900|527618867|FG001|Overall Study|Study closure|133|||
146301280|NCT04163900|527618866|FG000|Overall Study|Adverse Event|78|||
146301281|NCT04163900|527618867|FG001|Overall Study|Adverse Event|32|||
146301282|NCT04163900|527618866|FG000|Overall Study|Withdrawal by Subject|37|||
146301283|NCT04163900|527618867|FG001|Overall Study|Withdrawal by Subject|34|||
146301284|NCT04163900|527618866|FG000|Overall Study|Death|29|||
146301285|NCT04163900|527618867|FG001|Overall Study|Death|16|||
146301286|NCT04163900|527618866|FG000|Overall Study|Physician Decision|17|||
146301287|NCT04163900|527618867|FG001|Overall Study|Physician Decision|25|||
146301288|NCT04163900|527618866|FG000|Overall Study|Clinical disease progression|14|||
146301289|NCT04163900|527618867|FG001|Overall Study|Clinical disease progression|13|||
146301290|NCT04163900|527618866|FG000|Overall Study|Protocol Violation|3|||
146301291|NCT04163900|527618867|FG001|Overall Study|Protocol Violation|4|||
146301292|NCT04163900|527618866|FG000|Overall Study|Lost to Follow-up|0|||
146301293|NCT04163900|527618867|FG001|Overall Study|Lost to Follow-up|1|||
146301294|NCT01873417|527618868|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
146301295|NCT01873417|527618868|FG000|Overall Study|Adverse Event|24|||
146301296|NCT01873417|527618868|FG000|Overall Study|Lost to Follow-up|2|||
146301297|NCT01873417|527618868|FG000|Overall Study|Withdrawal by Subject|2|||
146301298|NCT01873417|527618868|FG000|Overall Study|Physician Decision|3|||
146301299|NCT00785044|527618869|FG000|Overall Study|Dosed at non-participating sites|152|||
146301300|NCT00785044|527618869|FG000|Overall Study|Death|77|||
146301301|NCT00785044|527618869|FG000|Overall Study|Lost to Follow-up|266|||
146301302|NCT00785044|527618869|FG000|Overall Study|Withdrawal by Subject|1|||
146301303|NCT01628107|527618870|FG000|Overall Study|Withdrawal by Subject|17|||
146301304|NCT01628107|527618870|FG000|Overall Study|Lost to Follow-up|4|||
146301305|NCT01628107|527618870|FG000|Overall Study|Adverse Event|33|||
146301306|NCT01628107|527618870|FG000|Overall Study|Physician Decision|2|||
146301307|NCT01628107|527618870|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
146301308|NCT01628107|527618870|FG000|Overall Study|Non-compliant with Study Procedures|10|||
146301309|NCT01628107|527618870|FG000|Overall Study|Not Treated|8|||
146301310|NCT01628107|527618870|FG000|Overall Study|Sponsor Decision|11|||
146301311|NCT01628107|527618870|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
146301312|NCT01628107|527618870|FG000|Overall Study|Relocated|8|||
146301313|NCT01628107|527618870|FG000|Overall Study|Kidney Transplant|9|||
146301314|NCT01628107|527618870|FG000|Overall Study|Use of Standard of Care|9|||
146301315|NCT04196803|527618871|FG000|Overall Study|Withdrawal by Subject|1|||
146301316|NCT04196803|527618872|FG001|Overall Study|Withdrawal by Subject|3|||
146301317|NCT04196803|527618871|FG000|Overall Study|Adverse Event|4|||
146301318|NCT04196803|527618872|FG001|Overall Study|Adverse Event|2|||
146301319|NCT04196803|527618871|FG000|Overall Study|Lost to Follow-up|0|||
146301320|NCT04196803|527618872|FG001|Overall Study|Lost to Follow-up|1|||
146301321|NCT01022996|527618873|FG000|Overall Study|Adverse Event|14|||
146301322|NCT01022996|527618873|FG000|Overall Study|Withdrawal by Subject|3|||
146301323|NCT01022996|527618873|FG000|Overall Study|Lost to Follow-up|1|||
146301324|NCT01022996|527618873|FG000|Overall Study|Administrative problems|6|||
146301325|NCT01022996|527618873|FG000|Overall Study|Disease Progression|32|||
146301326|NCT01022996|527618873|FG000|Overall Study|Protocol Violation|1|||
146301327|NCT00930722|527618874|FG000|Overall Study|Lost to Follow-up|16|||
146301328|NCT00930722|527618874|FG000|Overall Study|No longer willing to participate|9|||
146301329|NCT00930722|527618874|FG000|Overall Study|Study terminated by sponsor|2|||
146301330|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Adverse Event|2|||
146301331|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Adverse Event|2|||
146301332|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Adverse Event|4|||
146301333|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Adverse Event|0|||
146301334|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Adverse Event|0|||
146301335|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Progressive disease|0|||
146301336|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Progressive disease|0|||
146301337|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Progressive disease|1|||
146301338|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Progressive disease|0|||
146301339|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Progressive disease|0|||
146301340|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
146301341|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
146301342|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
146301343|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
146301344|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
146108769|NCT00540514|526918830|FG001|Overall Study|Withdrawal by Subject|67|||
146108770|NCT00540514|526918829|FG000|Overall Study|Excluded prior to treatment|7|||
146108771|NCT00540514|526918830|FG001|Overall Study|Excluded prior to treatment|7|||
146108772|NCT00540514|526918829|FG000|Overall Study|Paclitaxel not available|0|||
146108773|NCT00540514|526918830|FG001|Overall Study|Paclitaxel not available|2|||
146108774|NCT04487730|526918831|FG000|Overall Study|Withdrawal by Subject|3|||
146108775|NCT04487730|526918832|FG001|Overall Study|Withdrawal by Subject|1|||
146108776|NCT04487730|526918831|FG000|Overall Study|Lost to Follow-up|0|||
146108777|NCT04487730|526918832|FG001|Overall Study|Lost to Follow-up|1|||
146108778|NCT04487730|526918831|FG000|Overall Study|Physician Decision|0|||
146108779|NCT04487730|526918832|FG001|Overall Study|Physician Decision|1|||
146108780|NCT00907777|526918833|FG000|Overall Study|Withdrawal by Subject|0|||
146108781|NCT00907777|526918834|FG001|Overall Study|Withdrawal by Subject|1|||
146108782|NCT02891850|526918835|FG000|Overall Study|Adverse Event|3|||
146108783|NCT02891850|526918836|FG001|Overall Study|Adverse Event|0|||
146108784|NCT02891850|526918835|FG000|Overall Study|Death|0|||
146108785|NCT02891850|526918836|FG001|Overall Study|Death|4|||
146108786|NCT02891850|526918835|FG000|Overall Study|Physician Decision|1|||
146108787|NCT02891850|526918836|FG001|Overall Study|Physician Decision|0|||
146108788|NCT02891850|526918835|FG000|Overall Study|Pregnancy|1|||
146108789|NCT02891850|526918836|FG001|Overall Study|Pregnancy|0|||
146108790|NCT02891850|526918835|FG000|Overall Study|Withdrawal by Subject|2|||
146108791|NCT02891850|526918836|FG001|Overall Study|Withdrawal by Subject|3|||
146108792|NCT00790023|526918837|FG000|Overall Study|Adverse Event|2|||
146108793|NCT00790023|526918838|FG001|Overall Study|Adverse Event|1|||
146108794|NCT00790023|526918839|FG002|Overall Study|Adverse Event|4|||
146108795|NCT00790023|526918837|FG000|Overall Study|Protocol Violation|2|||
146108796|NCT00790023|526918838|FG001|Overall Study|Protocol Violation|4|||
146108797|NCT00790023|526918839|FG002|Overall Study|Protocol Violation|2|||
146108798|NCT00790023|526918837|FG000|Overall Study|Withdrawal by Subject|2|||
146108799|NCT00790023|526918838|FG001|Overall Study|Withdrawal by Subject|0|||
146108800|NCT00790023|526918839|FG002|Overall Study|Withdrawal by Subject|6|||
146108801|NCT00790023|526918837|FG000|Overall Study|Lost to Follow-up|0|||
146108802|NCT00790023|526918838|FG001|Overall Study|Lost to Follow-up|0|||
146108803|NCT00790023|526918839|FG002|Overall Study|Lost to Follow-up|1|||
146108804|NCT00790023|526918837|FG000|Overall Study|Other|5|||
146108805|NCT00790023|526918838|FG001|Overall Study|Other|5|||
146108806|NCT00790023|526918839|FG002|Overall Study|Other|8|||
146108807|NCT02468414|526918840|FG000|Overall Study|Early Study Termination by Sponsor|1|||
146108808|NCT02468414|526918841|FG001|Overall Study|Early Study Termination by Sponsor|0|||
146108809|NCT02468414|526918840|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
146108810|NCT02468414|526918841|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
146108811|NCT02468414|526918840|FG000|Overall Study|Screen Failure|1|||
146108812|NCT02468414|526918841|FG001|Overall Study|Screen Failure|0|||
146108813|NCT02151591|526918842|FG000|Overall Study|Lost to Follow-up|6|||
146108814|NCT02151591|526918843|FG001|Overall Study|Lost to Follow-up|3|||
146108815|NCT03555591|526918846|FG000|Overall Study|Protocol Violation|77|||
146108816|NCT03633695|526918847|FG000|Overall Study|Lost to Follow-up|4|||
146108817|NCT03633695|526918848|FG001|Overall Study|Lost to Follow-up|5|||
146108818|NCT03633695|526918847|FG000|Overall Study|Discontinued|8|||
146108819|NCT03633695|526918848|FG001|Overall Study|Discontinued|4|||
146108820|NCT01438957|526918858|FG000|Overall Study|Physician Decision|1|||
146108821|NCT01438957|526918859|FG001|Overall Study|Physician Decision|1|||
146108822|NCT01438957|526918860|FG002|Overall Study|Physician Decision|0|||
146108823|NCT01438957|526918861|FG003|Overall Study|Physician Decision|1|||
146108824|NCT01438957|526918862|FG004|Overall Study|Physician Decision|0|||
146108825|NCT00407797|526918863|FG000|Overall Study|Lost to Follow-up|2|||
146108826|NCT00407797|526918863|FG000|Overall Study|Adverse Event|6|||
146108827|NCT00407797|526918863|FG000|Overall Study|Other|7|||
146108828|NCT00407797|526918863|FG000|Overall Study|Withdrawal by Subject|3|||
146108829|NCT01812174|526918864|FG000|Overall Study|Death|1|||
146108830|NCT01812174|526918865|FG001|Overall Study|Death|0|||
146108831|NCT01812174|526918864|FG000|Overall Study|Protocol Violation|2|||
146108832|NCT01812174|526918865|FG001|Overall Study|Protocol Violation|0|||
146108833|NCT00518986|526918869|FG000|Overall Study|Adverse Event|12|||
146108834|NCT00518986|526918870|FG001|Overall Study|Adverse Event|7|||
146108835|NCT00518986|526918869|FG000|Overall Study|Lack of Efficacy|0|||
146108836|NCT00518986|526918870|FG001|Overall Study|Lack of Efficacy|2|||
146108837|NCT00518986|526918869|FG000|Overall Study|Lost to Follow-up|3|||
146108838|NCT00518986|526918870|FG001|Overall Study|Lost to Follow-up|2|||
146108839|NCT00518986|526918869|FG000|Overall Study|Physician Decision|0|||
146108840|NCT00518986|526918870|FG001|Overall Study|Physician Decision|3|||
146108841|NCT00518986|526918869|FG000|Overall Study|Protocol Violation|5|||
146108842|NCT00518986|526918870|FG001|Overall Study|Protocol Violation|7|||
146108843|NCT00518986|526918869|FG000|Overall Study|Withdrawal by Subject|4|||
146108844|NCT00518986|526918870|FG001|Overall Study|Withdrawal by Subject|4|||
146108845|NCT00518986|526918869|FG000|Overall Study|Non-Specific|2|||
146108846|NCT00518986|526918870|FG001|Overall Study|Non-Specific|1|||
146258871|NCT01904136|527463304|FG005|Overall Study|Physician Decision|1|||
146258872|NCT01904136|527463305|FG006|Overall Study|Physician Decision|0|||
146258873|NCT01904136|527463306|FG007|Overall Study|Physician Decision|0|||
146258874|NCT01904136|527463307|FG008|Overall Study|Physician Decision|0|||
146258875|NCT02418845|527463310|FG000|Overall Study|Lost to Follow-up|7|||
146258876|NCT02418845|527463311|FG001|Overall Study|Lost to Follow-up|2|||
146258877|NCT02418845|527463310|FG000|Overall Study|Lack of Efficacy|0|||
146258878|NCT02418845|527463311|FG001|Overall Study|Lack of Efficacy|3|||
146258879|NCT02418845|527463310|FG000|Overall Study|Physician Decision|5|||
146258880|NCT02418845|527463311|FG001|Overall Study|Physician Decision|5|||
146258881|NCT02418845|527463310|FG000|Overall Study|Protocol Violation|1|||
146258882|NCT02418845|527463311|FG001|Overall Study|Protocol Violation|0|||
146258883|NCT02418845|527463310|FG000|Overall Study|Withdrawal by Subject|3|||
146258884|NCT02418845|527463311|FG001|Overall Study|Withdrawal by Subject|2|||
146258885|NCT00460564|527463312|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
146108861|NCT05683249|526918873|FG000|Overall Study|Adverse Event|3|||
146108862|NCT05683249|526918874|FG001|Overall Study|Adverse Event|1|||
146108863|NCT05683249|526918873|FG000|Overall Study|Lack of Efficacy|0|||
146108864|NCT05683249|526918874|FG001|Overall Study|Lack of Efficacy|2|||
146108865|NCT05683249|526918873|FG000|Overall Study|Lost to Follow-up|6|||
146108866|NCT05683249|526918874|FG001|Overall Study|Lost to Follow-up|5|||
146108867|NCT05683249|526918873|FG000|Overall Study|Non-compliance with Study Drug|2|||
146108868|NCT05683249|526918874|FG001|Overall Study|Non-compliance with Study Drug|0|||
146108869|NCT05683249|526918873|FG000|Overall Study|Protocol Violation|6|||
146108870|NCT05683249|526918874|FG001|Overall Study|Protocol Violation|3|||
146108871|NCT05683249|526918873|FG000|Overall Study|Withdrawal by Subject|9|||
146108872|NCT05683249|526918874|FG001|Overall Study|Withdrawal by Subject|8|||
146108873|NCT05683249|526918873|FG000|Overall Study|Other|0|||
146108874|NCT05683249|526918874|FG001|Overall Study|Other|2|||
146108875|NCT05469178|526918875|FG000|Overall Study|Death|1|||
146108876|NCT05469178|526918876|FG001|Overall Study|Death|1|||
146108877|NCT05469178|526918877|FG002|Overall Study|Death|3|||
146108878|NCT05469178|526918878|FG003|Overall Study|Death|6|||
146108879|NCT05469178|526918875|FG000|Overall Study|Lack of Efficacy|2|||
146108880|NCT05469178|526918876|FG001|Overall Study|Lack of Efficacy|2|||
146108881|NCT05469178|526918877|FG002|Overall Study|Lack of Efficacy|1|||
146108882|NCT05469178|526918878|FG003|Overall Study|Lack of Efficacy|10|||
146108883|NCT01328431|526918879|FG000|Baseline|Protocol Violation|0|||
146108884|NCT01328431|526918880|FG001|Baseline|Protocol Violation|2|||
146108885|NCT01328431|526918879|FG000|1 Month (1M)|Lost to Follow-up|55|||
146108886|NCT01328431|526918880|FG001|1 Month (1M)|Lost to Follow-up|58|||
146108887|NCT01328431|526918879|FG000|3 Month (3M)|Death|2|||
146108888|NCT01328431|526918880|FG001|3 Month (3M)|Death|2|||
146108889|NCT01328431|526918879|FG000|3 Month (3M)|Lost to Follow-up|75|||
146108890|NCT01328431|526918880|FG001|3 Month (3M)|Lost to Follow-up|70|||
146108891|NCT01328431|526918879|FG000|12 Month (12M)|Death|2|||
146108892|NCT01328431|526918880|FG001|12 Month (12M)|Death|6|||
146108893|NCT01328431|526918879|FG000|12 Month (12M)|Lost to Follow-up|82|||
146108894|NCT01328431|526918880|FG001|12 Month (12M)|Lost to Follow-up|91|||
146108895|NCT03617185|526918886|FG000|Baseline|Lost to Follow-up|0|||
146108896|NCT03617185|526918887|FG001|Baseline|Lost to Follow-up|2|||
146108897|NCT03617185|526918888|FG002|Baseline|Lost to Follow-up|1|||
146108898|NCT03617185|526918889|FG003|Baseline|Lost to Follow-up|1|||
146108899|NCT03617185|526918886|FG000|Baseline|Withdrawal by Subject|0|||
146108900|NCT03617185|526918887|FG001|Baseline|Withdrawal by Subject|1|||
146108901|NCT03617185|526918888|FG002|Baseline|Withdrawal by Subject|0|||
146108902|NCT03617185|526918889|FG003|Baseline|Withdrawal by Subject|1|||
146108903|NCT03617185|526918886|FG000|Baseline|Driving Distance/Travel|0|||
146108904|NCT03617185|526918887|FG001|Baseline|Driving Distance/Travel|0|||
146108905|NCT03617185|526918888|FG002|Baseline|Driving Distance/Travel|2|||
146108906|NCT03617185|526918889|FG003|Baseline|Driving Distance/Travel|0|||
146108907|NCT03617185|526918886|FG000|Baseline|Family Obligations|0|||
146108908|NCT03617185|526918887|FG001|Baseline|Family Obligations|0|||
146108909|NCT03617185|526918888|FG002|Baseline|Family Obligations|0|||
146108910|NCT03617185|526918889|FG003|Baseline|Family Obligations|1|||
146108911|NCT03617185|526918886|FG000|3 Months|Lost to Follow-up|4|||
146258886|NCT00460564|527463313|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
146108912|NCT03617185|526918887|FG001|3 Months|Lost to Follow-up|1|||
146258887|NCT00460564|527463314|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146258888|NCT00460564|527463315|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146108913|NCT03617185|526918888|FG002|3 Months|Lost to Follow-up|0|||
146108914|NCT03617185|526918889|FG003|3 Months|Lost to Follow-up|2|||
146108915|NCT03617185|526918886|FG000|3 Months|Withdrawal by Subject|1|||
146108916|NCT03617185|526918887|FG001|3 Months|Withdrawal by Subject|3|||
146258889|NCT00460564|527463316|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146108917|NCT03617185|526918888|FG002|3 Months|Withdrawal by Subject|0|||
146108918|NCT03617185|526918889|FG003|3 Months|Withdrawal by Subject|0|||
146108919|NCT03617185|526918886|FG000|3 Months|Driving Distance/Travel|1|||
146108920|NCT03617185|526918887|FG001|3 Months|Driving Distance/Travel|0|||
146108921|NCT03617185|526918888|FG002|3 Months|Driving Distance/Travel|0|||
146108922|NCT03617185|526918889|FG003|3 Months|Driving Distance/Travel|0|||
146258890|NCT00460564|527463317|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146108923|NCT03617185|526918886|FG000|3 Months|Family Obligations|0|||
146108924|NCT03617185|526918887|FG001|3 Months|Family Obligations|0|||
146108925|NCT03617185|526918888|FG002|3 Months|Family Obligations|0|||
146108926|NCT03617185|526918889|FG003|3 Months|Family Obligations|1|||
146108927|NCT03617185|526918886|FG000|12 Months|Lost to Follow-up|3|||
146108928|NCT03617185|526918887|FG001|12 Months|Lost to Follow-up|1|||
146108929|NCT03617185|526918888|FG002|12 Months|Lost to Follow-up|3|||
146108930|NCT03617185|526918889|FG003|12 Months|Lost to Follow-up|0|||
146108931|NCT03617185|526918886|FG000|12 Months|Withdrawal by Subject|0|||
146108932|NCT03617185|526918887|FG001|12 Months|Withdrawal by Subject|0|||
146108933|NCT03617185|526918888|FG002|12 Months|Withdrawal by Subject|0|||
146108934|NCT03617185|526918889|FG003|12 Months|Withdrawal by Subject|1|||
146108935|NCT03617185|526918886|FG000|12 Months|Driving Distance/Travel|0|||
146108936|NCT03617185|526918887|FG001|12 Months|Driving Distance/Travel|0|||
146108937|NCT03617185|526918888|FG002|12 Months|Driving Distance/Travel|1|||
146108938|NCT03617185|526918889|FG003|12 Months|Driving Distance/Travel|0|||
146108939|NCT01964430|526918890|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
146108940|NCT01964430|526918891|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
146108941|NCT01964430|526918890|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
146108942|NCT01964430|526918891|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
146108943|NCT01964430|526918890|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
146108944|NCT01964430|526918891|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
146108945|NCT01964430|526918890|FG000|Treatment Period|Adverse Event|71|||
146108946|NCT01964430|526918891|FG001|Treatment Period|Adverse Event|37|||
146108947|NCT01964430|526918890|FG000|Treatment Period|Withdrawal by Subject|36|||
146108948|NCT01964430|526918891|FG001|Treatment Period|Withdrawal by Subject|27|||
146108949|NCT01964430|526918890|FG000|Treatment Period|Death|1|||
146108950|NCT01964430|526918891|FG001|Treatment Period|Death|3|||
146108951|NCT01964430|526918890|FG000|Treatment Period|Protocol Deviation|0|||
146108952|NCT01964430|526918891|FG001|Treatment Period|Protocol Deviation|1|||
146108953|NCT01964430|526918890|FG000|Treatment Period|Physician Decision|5|||
146108954|NCT01964430|526918891|FG001|Treatment Period|Physician Decision|4|||
146108955|NCT01964430|526918890|FG000|Treatment Period|Disease Relapse|28|||
146108956|NCT01964430|526918891|FG001|Treatment Period|Disease Relapse|38|||
146108957|NCT01964430|526918890|FG000|Treatment Period|Other reasons|1|||
146108958|NCT01964430|526918891|FG001|Treatment Period|Other reasons|3|||
146108959|NCT02801396|526918892|FG000|Period 1|Withdrawal by Subject|0|||
146108960|NCT02801396|526918893|FG001|Period 1|Withdrawal by Subject|0|||
146108961|NCT02801396|526918894|FG002|Period 1|Withdrawal by Subject|0|||
146108962|NCT02801396|526918895|FG003|Period 1|Withdrawal by Subject|0|||
146108963|NCT02801396|526918896|FG004|Period 1|Withdrawal by Subject|1|||
146108964|NCT02801396|526918897|FG005|Period 1|Withdrawal by Subject|0|||
146108965|NCT03310021|526918902|FG000|Overall Study|Withdrawal by Subject|0|||
146108966|NCT03310021|526918903|FG001|Overall Study|Withdrawal by Subject|0|||
146108967|NCT03310021|526918904|FG002|Overall Study|Withdrawal by Subject|0|||
146108968|NCT03310021|526918905|FG003|Overall Study|Withdrawal by Subject|0|||
146108969|NCT03310021|526918906|FG004|Overall Study|Withdrawal by Subject|0|||
146108970|NCT03310021|526918907|FG005|Overall Study|Withdrawal by Subject|0|||
146108971|NCT03310021|526918908|FG006|Overall Study|Withdrawal by Subject|1|||
146108972|NCT03310021|526918909|FG007|Overall Study|Withdrawal by Subject|0|||
146108973|NCT03310021|526918910|FG008|Overall Study|Withdrawal by Subject|0|||
146108974|NCT03310021|526918911|FG009|Overall Study|Withdrawal by Subject|0|||
146108975|NCT03310021|526918912|FG010|Overall Study|Withdrawal by Subject|0|||
146108976|NCT03310021|526918913|FG011|Overall Study|Withdrawal by Subject|0|||
146108977|NCT03310021|526918914|FG012|Overall Study|Withdrawal by Subject|0|||
146108978|NCT03310021|526918915|FG013|Overall Study|Withdrawal by Subject|0|||
146108979|NCT03310021|526918916|FG014|Overall Study|Withdrawal by Subject|0|||
146108980|NCT03310021|526918917|FG015|Overall Study|Withdrawal by Subject|0|||
146108981|NCT03310021|526918918|FG016|Overall Study|Withdrawal by Subject|0|||
146108982|NCT03310021|526918919|FG017|Overall Study|Withdrawal by Subject|0|||
146108983|NCT03310021|526918920|FG018|Overall Study|Withdrawal by Subject|0|||
146258891|NCT00460564|527463318|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146258892|NCT00460564|527463319|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
146258893|NCT00460564|527463312|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
146258894|NCT00460564|527463313|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146108984|NCT03310021|526918921|FG019|Overall Study|Withdrawal by Subject|0|||
146108985|NCT03310021|526918902|FG000|Overall Study|Lost to Follow-up|0|||
146108986|NCT03310021|526918903|FG001|Overall Study|Lost to Follow-up|0|||
146108987|NCT03310021|526918904|FG002|Overall Study|Lost to Follow-up|0|||
146258895|NCT00460564|527463314|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146108988|NCT03310021|526918905|FG003|Overall Study|Lost to Follow-up|0|||
146108989|NCT03310021|526918906|FG004|Overall Study|Lost to Follow-up|0|||
146108990|NCT03310021|526918907|FG005|Overall Study|Lost to Follow-up|0|||
146108991|NCT03310021|526918908|FG006|Overall Study|Lost to Follow-up|0|||
146108992|NCT03310021|526918909|FG007|Overall Study|Lost to Follow-up|0|||
146108993|NCT03310021|526918910|FG008|Overall Study|Lost to Follow-up|0|||
146108994|NCT03310021|526918911|FG009|Overall Study|Lost to Follow-up|0|||
146258896|NCT00460564|527463315|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146258897|NCT00460564|527463316|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146258898|NCT00460564|527463317|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146258899|NCT00460564|527463318|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146052395|NCT02888106|526707357|FG005|Overall Study|Adverse Event|0|||
146052396|NCT02888106|526707352|FG000|Overall Study|Withdrawal of consent|0|||
146052397|NCT02888106|526707353|FG001|Overall Study|Withdrawal of consent|0|||
146052398|NCT02888106|526707354|FG002|Overall Study|Withdrawal of consent|0|||
146052399|NCT02888106|526707355|FG003|Overall Study|Withdrawal of consent|0|||
146052400|NCT02888106|526707356|FG004|Overall Study|Withdrawal of consent|1|||
146258900|NCT00460564|527463319|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
146258901|NCT00460564|527463312|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146052401|NCT02888106|526707357|FG005|Overall Study|Withdrawal of consent|0|||
146052402|NCT02888106|526707352|FG000|Overall Study|Pregnancy|1|||
146052403|NCT02888106|526707353|FG001|Overall Study|Pregnancy|0|||
146052404|NCT02888106|526707354|FG002|Overall Study|Pregnancy|0|||
146052405|NCT02888106|526707355|FG003|Overall Study|Pregnancy|0|||
146052406|NCT02888106|526707356|FG004|Overall Study|Pregnancy|0|||
146052407|NCT02888106|526707357|FG005|Overall Study|Pregnancy|0|||
146052408|NCT00430716|526707362|FG000|Double Blind Phase|Death|1|||
146052409|NCT00430716|526707363|FG001|Double Blind Phase|Death|0|||
146052410|NCT00430716|526707364|FG002|Double Blind Phase|Death|0|||
146052411|NCT00430716|526707362|FG000|Double Blind Phase|No longer willing to participate|2|||
146052412|NCT00430716|526707363|FG001|Double Blind Phase|No longer willing to participate|1|||
146052413|NCT00430716|526707364|FG002|Double Blind Phase|No longer willing to participate|1|||
146052414|NCT00430716|526707362|FG000|Double Blind Phase|Other|0|||
146052415|NCT00430716|526707363|FG001|Double Blind Phase|Other|2|||
146052416|NCT00430716|526707364|FG002|Double Blind Phase|Other|0|||
146052417|NCT00430716|526707362|FG000|Double Blind Phase|Study terminated by sponsor|1|||
146052418|NCT00430716|526707363|FG001|Double Blind Phase|Study terminated by sponsor|1|||
146052419|NCT00430716|526707364|FG002|Double Blind Phase|Study terminated by sponsor|2|||
146052420|NCT00430716|526707362|FG000|Double Blind Phase|Adverse Event|1|||
146052421|NCT00430716|526707363|FG001|Double Blind Phase|Adverse Event|1|||
146052422|NCT00430716|526707364|FG002|Double Blind Phase|Adverse Event|3|||
146052423|NCT00430716|526707362|FG000|Double Blind Phase|Not treated|1|||
146052424|NCT00430716|526707363|FG001|Double Blind Phase|Not treated|0|||
146052425|NCT00430716|526707364|FG002|Double Blind Phase|Not treated|0|||
146052426|NCT00430716|526707362|FG000|Open Label Phase|Lost to Follow-up|1|||
146052427|NCT00430716|526707363|FG001|Open Label Phase|Lost to Follow-up|0|||
146052428|NCT00430716|526707364|FG002|Open Label Phase|Lost to Follow-up|1|||
146052429|NCT00430716|526707362|FG000|Open Label Phase|No longer willing to participate|0|||
146052430|NCT00430716|526707363|FG001|Open Label Phase|No longer willing to participate|1|||
146052431|NCT00430716|526707364|FG002|Open Label Phase|No longer willing to participate|1|||
146052432|NCT00430716|526707362|FG000|Open Label Phase|Other|3|||
146052433|NCT00430716|526707363|FG001|Open Label Phase|Other|1|||
146052434|NCT00430716|526707364|FG002|Open Label Phase|Other|1|||
146052435|NCT00430716|526707362|FG000|Open Label Phase|Protocol Violation|1|||
146052436|NCT00430716|526707363|FG001|Open Label Phase|Protocol Violation|0|||
146052437|NCT00430716|526707364|FG002|Open Label Phase|Protocol Violation|0|||
146052438|NCT00430716|526707362|FG000|Open Label Phase|Study terminated by sponsor|4|||
146052439|NCT00430716|526707363|FG001|Open Label Phase|Study terminated by sponsor|5|||
146052440|NCT00430716|526707364|FG002|Open Label Phase|Study terminated by sponsor|4|||
146052441|NCT01433172|526707370|FG000|Overall Study|Withdrawal by Subject|0|||
146052442|NCT01433172|526707371|FG001|Overall Study|Withdrawal by Subject|1|||
146052443|NCT01433172|526707372|FG002|Overall Study|Withdrawal by Subject|0|||
146052444|NCT01433172|526707370|FG000|Overall Study|Disease Progression|0|||
146052445|NCT01433172|526707371|FG001|Overall Study|Disease Progression|0|||
146052446|NCT01433172|526707372|FG002|Overall Study|Disease Progression|1|||
146052447|NCT01433172|526707370|FG000|Overall Study|Death|0|||
146052448|NCT01433172|526707371|FG001|Overall Study|Death|2|||
146052449|NCT01433172|526707372|FG002|Overall Study|Death|0|||
146052450|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
146052451|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
146052452|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
146052453|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
146052454|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
146258902|NCT00460564|527463313|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146258903|NCT00460564|527463314|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146052455|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
146052456|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Death|7|||
146052457|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Death|5|||
146052458|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Death|6|||
146052459|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
146052460|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
146052461|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
146052462|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
146052463|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
146052464|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
146052465|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Other|1|||
146052466|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Other|0|||
146052467|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Other|0|||
146052468|NCT00104650|526707373|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
146052469|NCT00104650|526707374|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
146052470|NCT00104650|526707375|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
146052471|NCT00104650|526707373|FG000|Follow-up Period|Physician Decision|1|||
146052472|NCT00104650|526707374|FG001|Follow-up Period|Physician Decision|1|||
146052473|NCT00104650|526707375|FG002|Follow-up Period|Physician Decision|0|||
146052474|NCT00104650|526707373|FG000|Follow-up Period|Adverse Event|1|||
146052475|NCT00104650|526707374|FG001|Follow-up Period|Adverse Event|0|||
146052476|NCT00104650|526707375|FG002|Follow-up Period|Adverse Event|1|||
146052477|NCT00104650|526707373|FG000|Follow-up Period|Withdrawal by Subject|0|||
146052478|NCT00104650|526707374|FG001|Follow-up Period|Withdrawal by Subject|3|||
146052479|NCT00104650|526707375|FG002|Follow-up Period|Withdrawal by Subject|3|||
146052480|NCT00104650|526707373|FG000|Follow-up Period|Death|6|||
146052481|NCT00104650|526707374|FG001|Follow-up Period|Death|6|||
146052482|NCT00104650|526707375|FG002|Follow-up Period|Death|4|||
146052483|NCT00104650|526707373|FG000|Follow-up Period|Disease progression|3|||
146052484|NCT00104650|526707374|FG001|Follow-up Period|Disease progression|1|||
146052485|NCT00104650|526707375|FG002|Follow-up Period|Disease progression|0|||
146052486|NCT00104650|526707373|FG000|Follow-up Period|Lost to Follow-up|0|||
146052487|NCT00104650|526707374|FG001|Follow-up Period|Lost to Follow-up|1|||
146052488|NCT00104650|526707375|FG002|Follow-up Period|Lost to Follow-up|2|||
146052489|NCT00104650|526707373|FG000|Follow-up Period|Other|0|||
146052490|NCT00104650|526707374|FG001|Follow-up Period|Other|1|||
146052491|NCT00104650|526707375|FG002|Follow-up Period|Other|0|||
146052492|NCT02294058|526707376|FG000|Overall Study|Adverse Event|16|||
146052493|NCT02294058|526707377|FG001|Overall Study|Adverse Event|7|||
146052494|NCT02294058|526707378|FG002|Overall Study|Adverse Event|13|||
146052495|NCT02294058|526707376|FG000|Overall Study|Lack of Efficacy|3|||
146052496|NCT02294058|526707377|FG001|Overall Study|Lack of Efficacy|3|||
146052497|NCT02294058|526707378|FG002|Overall Study|Lack of Efficacy|0|||
146052498|NCT02294058|526707376|FG000|Overall Study|Lost to Follow-up|1|||
146052499|NCT02294058|526707377|FG001|Overall Study|Lost to Follow-up|0|||
146052500|NCT02294058|526707378|FG002|Overall Study|Lost to Follow-up|2|||
146052501|NCT02294058|526707376|FG000|Overall Study|Withdrawal by Subject|10|||
146052502|NCT02294058|526707377|FG001|Overall Study|Withdrawal by Subject|14|||
146052503|NCT02294058|526707378|FG002|Overall Study|Withdrawal by Subject|13|||
146052504|NCT02294058|526707376|FG000|Overall Study|Physician Decision|2|||
146052505|NCT02294058|526707377|FG001|Overall Study|Physician Decision|1|||
146052506|NCT02294058|526707378|FG002|Overall Study|Physician Decision|0|||
146052507|NCT02294058|526707376|FG000|Overall Study|Miscellaneous|4|||
146052508|NCT02294058|526707377|FG001|Overall Study|Miscellaneous|1|||
146258904|NCT00460564|527463315|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146258905|NCT00460564|527463316|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
146258906|NCT00460564|527463317|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
146258907|NCT00460564|527463318|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
146258908|NCT00460564|527463319|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
146258909|NCT00460564|527463312|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258910|NCT00460564|527463313|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258911|NCT00460564|527463314|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258912|NCT00460564|527463315|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258913|NCT00460564|527463316|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
146258914|NCT00460564|527463317|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
146258915|NCT00460564|527463318|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258916|NCT00460564|527463319|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
146258917|NCT00460564|527463312|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258918|NCT00460564|527463313|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258919|NCT00460564|527463314|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258920|NCT00460564|527463315|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258921|NCT00460564|527463316|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
146258922|NCT00460564|527463317|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258923|NCT00460564|527463318|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258924|NCT00460564|527463319|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
146258925|NCT01990313|527463325|FG000|Overall Study|Lost to Follow-up|1|||
146258926|NCT03119688|527463326|FG000|Overall Study|Adverse Event|4|||
146052509|NCT02294058|526707378|FG002|Overall Study|Miscellaneous|1|||
146052510|NCT01894607|526707379|FG000|Overall Study|Ineligible|1|||
146052511|NCT03084796|526707382|FG000|Overall Study|Adverse Event|4|||
146052512|NCT03084796|526707383|FG001|Overall Study|Adverse Event|5|||
146052513|NCT03084796|526707384|FG002|Overall Study|Adverse Event|6|||
146052514|NCT03084796|526707385|FG003|Overall Study|Adverse Event|2|||
146301345|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
146052515|NCT03084796|526707386|FG004|Overall Study|Adverse Event|3|||
146052516|NCT03084796|526707387|FG005|Overall Study|Adverse Event|5|||
146052517|NCT03084796|526707382|FG000|Overall Study|Withdrawal by Subject|3|||
146052518|NCT03084796|526707383|FG001|Overall Study|Withdrawal by Subject|5|||
146052519|NCT03084796|526707384|FG002|Overall Study|Withdrawal by Subject|2|||
146052520|NCT03084796|526707385|FG003|Overall Study|Withdrawal by Subject|1|||
146052521|NCT03084796|526707386|FG004|Overall Study|Withdrawal by Subject|3|||
146052522|NCT03084796|526707387|FG005|Overall Study|Withdrawal by Subject|0|||
146052523|NCT03084796|526707382|FG000|Overall Study|Protocol Violation|0|||
146052524|NCT03084796|526707383|FG001|Overall Study|Protocol Violation|0|||
146052525|NCT03084796|526707384|FG002|Overall Study|Protocol Violation|1|||
146052526|NCT03084796|526707385|FG003|Overall Study|Protocol Violation|0|||
146052527|NCT03084796|526707386|FG004|Overall Study|Protocol Violation|1|||
146052528|NCT03084796|526707387|FG005|Overall Study|Protocol Violation|1|||
146052529|NCT03084796|526707382|FG000|Overall Study|Lack of Efficacy|0|||
146052530|NCT03084796|526707383|FG001|Overall Study|Lack of Efficacy|0|||
146052531|NCT03084796|526707384|FG002|Overall Study|Lack of Efficacy|1|||
146052532|NCT03084796|526707385|FG003|Overall Study|Lack of Efficacy|0|||
146052533|NCT03084796|526707386|FG004|Overall Study|Lack of Efficacy|1|||
146052534|NCT03084796|526707387|FG005|Overall Study|Lack of Efficacy|0|||
146052535|NCT03084796|526707382|FG000|Overall Study|Lost to Follow-up|0|||
146052536|NCT03084796|526707383|FG001|Overall Study|Lost to Follow-up|0|||
146052537|NCT03084796|526707384|FG002|Overall Study|Lost to Follow-up|1|||
146052538|NCT03084796|526707385|FG003|Overall Study|Lost to Follow-up|1|||
146052539|NCT03084796|526707386|FG004|Overall Study|Lost to Follow-up|3|||
146052540|NCT03084796|526707387|FG005|Overall Study|Lost to Follow-up|1|||
146052541|NCT03084796|526707382|FG000|Overall Study|Randomization error|0|||
146052542|NCT03084796|526707383|FG001|Overall Study|Randomization error|0|||
146052543|NCT03084796|526707384|FG002|Overall Study|Randomization error|1|||
146052544|NCT03084796|526707385|FG003|Overall Study|Randomization error|0|||
146052545|NCT03084796|526707386|FG004|Overall Study|Randomization error|0|||
146052546|NCT03084796|526707387|FG005|Overall Study|Randomization error|0|||
146052547|NCT03259555|526707392|FG000|Overall Study|Adverse Event|6|||
146052548|NCT03259555|526707393|FG001|Overall Study|Adverse Event|4|||
146052549|NCT03259555|526707392|FG000|Overall Study|Lack of Efficacy|6|||
146052550|NCT03259555|526707393|FG001|Overall Study|Lack of Efficacy|4|||
146052551|NCT03259555|526707392|FG000|Overall Study|Lost to Follow-up|0|||
146052552|NCT03259555|526707393|FG001|Overall Study|Lost to Follow-up|2|||
146052553|NCT03259555|526707392|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146052554|NCT03259555|526707393|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146052555|NCT03259555|526707392|FG000|Overall Study|Progressive Disease|0|||
146052556|NCT03259555|526707393|FG001|Overall Study|Progressive Disease|2|||
146052557|NCT03259555|526707392|FG000|Overall Study|Withdrawal by Subject|19|||
146052558|NCT03259555|526707393|FG001|Overall Study|Withdrawal by Subject|16|||
146052559|NCT03259555|526707392|FG000|Overall Study|Physician Decision|1|||
146052560|NCT03259555|526707393|FG001|Overall Study|Physician Decision|2|||
146052561|NCT03259555|526707392|FG000|Overall Study|Other|1|||
146052562|NCT03259555|526707393|FG001|Overall Study|Other|0|||
146052563|NCT00607087|526707394|FG000|Overall Study|Withdrawal by Subject|9|||
146052564|NCT00607087|526707395|FG001|Overall Study|Withdrawal by Subject|4|||
146052565|NCT00607087|526707396|FG002|Overall Study|Withdrawal by Subject|4|||
146052566|NCT00607087|526707394|FG000|Overall Study|Adverse Event|3|||
146052567|NCT00607087|526707395|FG001|Overall Study|Adverse Event|2|||
146052568|NCT00607087|526707396|FG002|Overall Study|Adverse Event|3|||
146052569|NCT00607087|526707394|FG000|Overall Study|Other reason|1|||
146052570|NCT00607087|526707395|FG001|Overall Study|Other reason|5|||
146052571|NCT00607087|526707396|FG002|Overall Study|Other reason|2|||
146052572|NCT00607087|526707394|FG000|Overall Study|Poor compliance to protocol|1|||
146052573|NCT00607087|526707395|FG001|Overall Study|Poor compliance to protocol|0|||
146052574|NCT00607087|526707396|FG002|Overall Study|Poor compliance to protocol|1|||
146052575|NCT00607087|526707394|FG000|Overall Study|Lost to Follow-up|1|||
146052576|NCT00607087|526707395|FG001|Overall Study|Lost to Follow-up|0|||
146052577|NCT00607087|526707396|FG002|Overall Study|Lost to Follow-up|0|||
146052578|NCT00607087|526707394|FG000|Period 1|Withdrawal by Subject|7|||
146052579|NCT00607087|526707395|FG001|Period 1|Withdrawal by Subject|2|||
146052580|NCT00607087|526707396|FG002|Period 1|Withdrawal by Subject|3|||
146052581|NCT00607087|526707394|FG000|Period 1|Adverse Event|3|||
146052582|NCT00607087|526707395|FG001|Period 1|Adverse Event|0|||
146052583|NCT00607087|526707396|FG002|Period 1|Adverse Event|0|||
146052584|NCT00607087|526707394|FG000|Period 1|Poor compliance to protocol|1|||
146052585|NCT00607087|526707395|FG001|Period 1|Poor compliance to protocol|0|||
146052586|NCT00607087|526707396|FG002|Period 1|Poor compliance to protocol|0|||
146052587|NCT00607087|526707394|FG000|Period 1|Lost to Follow-up|1|||
146052588|NCT00607087|526707395|FG001|Period 1|Lost to Follow-up|0|||
146052589|NCT00607087|526707396|FG002|Period 1|Lost to Follow-up|0|||
146052590|NCT00607087|526707394|FG000|Period 1|Other reason|0|||
146108995|NCT03310021|526918912|FG010|Overall Study|Lost to Follow-up|1|||
146108996|NCT03310021|526918913|FG011|Overall Study|Lost to Follow-up|0|||
146108997|NCT03310021|526918914|FG012|Overall Study|Lost to Follow-up|0|||
146108998|NCT03310021|526918915|FG013|Overall Study|Lost to Follow-up|0|||
146108999|NCT03310021|526918916|FG014|Overall Study|Lost to Follow-up|0|||
146109000|NCT03310021|526918917|FG015|Overall Study|Lost to Follow-up|0|||
146109001|NCT03310021|526918918|FG016|Overall Study|Lost to Follow-up|0|||
146109002|NCT03310021|526918919|FG017|Overall Study|Lost to Follow-up|0|||
146109003|NCT03310021|526918920|FG018|Overall Study|Lost to Follow-up|0|||
146109004|NCT03310021|526918921|FG019|Overall Study|Lost to Follow-up|0|||
146109005|NCT00702923|526918924|FG000|Overall Study|Adverse Event|1|||
146258927|NCT02624869|527463327|FG000|Overall Study|Lost to Follow-up|0|||
146258928|NCT02624869|527463328|FG001|Overall Study|Lost to Follow-up|0|||
146258929|NCT02624869|527463329|FG002|Overall Study|Lost to Follow-up|1|||
146258930|NCT02624869|527463327|FG000|Overall Study|Withdrawal by Subject|1|||
146258931|NCT02624869|527463328|FG001|Overall Study|Withdrawal by Subject|3|||
146258932|NCT02624869|527463329|FG002|Overall Study|Withdrawal by Subject|1|||
146258933|NCT02705625|527463330|FG000|Overall Study|Protocol Violation|1|||
146258934|NCT02705625|527463331|FG001|Overall Study|Protocol Violation|0|||
146258935|NCT02705625|527463332|FG002|Overall Study|Protocol Violation|0|||
146258936|NCT02705625|527463330|FG000|Overall Study|Adverse Event|6|||
146258937|NCT02705625|527463331|FG001|Overall Study|Adverse Event|5|||
146258938|NCT02705625|527463332|FG002|Overall Study|Adverse Event|2|||
146258939|NCT02705625|527463330|FG000|Overall Study|Death|0|||
146258940|NCT02705625|527463331|FG001|Overall Study|Death|0|||
146258941|NCT02705625|527463332|FG002|Overall Study|Death|1|||
146258942|NCT02705625|527463330|FG000|Overall Study|Withdrawal by Subject|1|||
146258943|NCT02705625|527463331|FG001|Overall Study|Withdrawal by Subject|4|||
146258944|NCT02705625|527463332|FG002|Overall Study|Withdrawal by Subject|5|||
146258945|NCT02705625|527463330|FG000|Overall Study|Lost to Follow-up|0|||
146258946|NCT02705625|527463331|FG001|Overall Study|Lost to Follow-up|0|||
146258947|NCT02705625|527463332|FG002|Overall Study|Lost to Follow-up|1|||
146258948|NCT02705625|527463330|FG000|Overall Study|Non-compliance|0|||
146258949|NCT02705625|527463331|FG001|Overall Study|Non-compliance|1|||
146258950|NCT02705625|527463332|FG002|Overall Study|Non-compliance|1|||
146258951|NCT02705625|527463330|FG000|Overall Study|Overdosing|0|||
146258952|NCT02705625|527463331|FG001|Overall Study|Overdosing|0|||
146258953|NCT02705625|527463332|FG002|Overall Study|Overdosing|1|||
146258954|NCT00863798|527463333|FG000|Overall Study|Adverse Event|5|||
146258955|NCT00863798|527463334|FG001|Overall Study|Adverse Event|2|||
146258956|NCT00863798|527463335|FG002|Overall Study|Adverse Event|4|||
146258957|NCT00863798|527463333|FG000|Overall Study|Participant failed to return|2|||
146258958|NCT00863798|527463334|FG001|Overall Study|Participant failed to return|1|||
146258959|NCT00863798|527463335|FG002|Overall Study|Participant failed to return|0|||
146258960|NCT00863798|527463333|FG000|Overall Study|Investigator request|1|||
146258961|NCT00863798|527463334|FG001|Overall Study|Investigator request|2|||
146258962|NCT00863798|527463335|FG002|Overall Study|Investigator request|1|||
146258963|NCT00863798|527463333|FG000|Overall Study|Lack of Efficacy|4|||
146258964|NCT00863798|527463334|FG001|Overall Study|Lack of Efficacy|3|||
146258965|NCT00863798|527463335|FG002|Overall Study|Lack of Efficacy|6|||
146258966|NCT00863798|527463333|FG000|Overall Study|Lost to Follow-up|6|||
146258967|NCT00863798|527463334|FG001|Overall Study|Lost to Follow-up|9|||
146258968|NCT00863798|527463335|FG002|Overall Study|Lost to Follow-up|5|||
146258969|NCT00863798|527463333|FG000|Overall Study|Other|2|||
146109006|NCT03322631|526918934|FG000|Overall Study|Withdrawal by Subject|0|||
146109007|NCT03322631|526918935|FG001|Overall Study|Withdrawal by Subject|1|||
146109008|NCT03322631|526918936|FG002|Overall Study|Withdrawal by Subject|0|||
146109009|NCT03322631|526918937|FG003|Overall Study|Withdrawal by Subject|0|||
146109010|NCT03322631|526918934|FG000|Overall Study|Adverse Event|0|||
146109011|NCT03322631|526918935|FG001|Overall Study|Adverse Event|0|||
146109012|NCT03322631|526918936|FG002|Overall Study|Adverse Event|1|||
146109013|NCT03322631|526918937|FG003|Overall Study|Adverse Event|0|||
146258970|NCT00863798|527463334|FG001|Overall Study|Other|3|||
146258971|NCT00863798|527463335|FG002|Overall Study|Other|1|||
146258972|NCT00863798|527463333|FG000|Overall Study|Protocol Violation|0|||
146109014|NCT02412618|526918938|FG000|Overall Study|Withdrawal by Subject|1|||
146109015|NCT02412618|526918939|FG001|Overall Study|Withdrawal by Subject|1|||
146258973|NCT00863798|527463334|FG001|Overall Study|Protocol Violation|1|||
146258974|NCT00863798|527463335|FG002|Overall Study|Protocol Violation|1|||
146109016|NCT02412618|526918938|FG000|Overall Study|Expulsion|1|||
146109017|NCT02412618|526918939|FG001|Overall Study|Expulsion|1|||
146109018|NCT02378961|526918941|FG000|Overall Study|Lack of Efficacy|4|||
146258975|NCT00863798|527463333|FG000|Overall Study|Withdrawal by Subject|8|||
146258976|NCT00863798|527463334|FG001|Overall Study|Withdrawal by Subject|7|||
146258977|NCT00863798|527463335|FG002|Overall Study|Withdrawal by Subject|4|||
146258978|NCT00863798|527463333|FG000|Overall Study|Randomized not treated|4|||
146258979|NCT00863798|527463334|FG001|Overall Study|Randomized not treated|2|||
146258980|NCT00863798|527463335|FG002|Overall Study|Randomized not treated|3|||
146258981|NCT04238520|527463337|FG000|Overall Study|Withdrawal by Subject|1|||
146258982|NCT04238520|527463338|FG001|Overall Study|Withdrawal by Subject|1|||
146258983|NCT04238520|527463337|FG000|Overall Study|Lost to Follow-up|1|||
146258984|NCT04238520|527463338|FG001|Overall Study|Lost to Follow-up|2|||
146258985|NCT04238520|527463337|FG000|Overall Study|Death|0|||
146258986|NCT04238520|527463338|FG001|Overall Study|Death|2|||
146258987|NCT04238520|527463337|FG000|Overall Study|Unsafe home environment for research staff|0|||
146258988|NCT04238520|527463338|FG001|Overall Study|Unsafe home environment for research staff|1|||
146258989|NCT01470599|527463339|FG000|Overall Study|Did not meet entrance criteria|1|||
146258990|NCT01470599|527463340|FG001|Overall Study|Did not meet entrance criteria|0|||
146258991|NCT01470599|527463339|FG000|Overall Study|Lost to Follow-up|2|||
146258992|NCT01470599|527463340|FG001|Overall Study|Lost to Follow-up|1|||
146258993|NCT01470599|527463339|FG000|Overall Study|Withdrawal by Subject|3|||
146258994|NCT01470599|527463340|FG001|Overall Study|Withdrawal by Subject|4|||
146258995|NCT01470599|527463339|FG000|Overall Study|Other|1|||
146258996|NCT01470599|527463340|FG001|Overall Study|Other|0|||
146258997|NCT01470599|527463339|FG000|Overall Study|Protocol Violation|3|||
146258998|NCT01470599|527463340|FG001|Overall Study|Protocol Violation|1|||
146258999|NCT01470599|527463339|FG000|Overall Study|Adverse event related to study drug|2|||
146259000|NCT01470599|527463340|FG001|Overall Study|Adverse event related to study drug|5|||
146259001|NCT01470599|527463339|FG000|Overall Study|Insufficient clinical response|6|||
146259002|NCT01470599|527463340|FG001|Overall Study|Insufficient clinical response|27|||
146259003|NCT01470599|527463339|FG000|Overall Study|Adverse event not related to study drug|1|||
146259004|NCT01470599|527463340|FG001|Overall Study|Adverse event not related to study drug|5|||
146259005|NCT00195442|527463341|FG000|Overall Study|Less than expected therapeutic effect|38|||
146259006|NCT00195442|527463341|FG000|Overall Study|Lost to Follow-up|27|||
146259007|NCT00195442|527463341|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
146259008|NCT00195442|527463341|FG000|Overall Study|Intermittent product shortage|21|||
146259009|NCT00195442|527463341|FG000|Overall Study|Death|7|||
146259010|NCT00195442|527463341|FG000|Overall Study|No reason specified|4|||
146109019|NCT02378961|526918942|FG001|Overall Study|Lack of Efficacy|2|||
146109020|NCT02378961|526918943|FG002|Overall Study|Lack of Efficacy|0|||
146109021|NCT02378961|526918944|FG003|Overall Study|Lack of Efficacy|1|||
146109022|NCT02378961|526918941|FG000|Overall Study|Death|0|||
146109023|NCT02378961|526918942|FG001|Overall Study|Death|0|||
146109024|NCT02378961|526918943|FG002|Overall Study|Death|1|||
146109025|NCT02378961|526918944|FG003|Overall Study|Death|0|||
146109026|NCT01253408|526918945|FG000|Overall Study|Adverse Event|0|||
146109027|NCT01253408|526918946|FG001|Overall Study|Adverse Event|1|||
146109028|NCT01253408|526918947|FG002|Overall Study|Adverse Event|0|||
146109029|NCT00393029|526918951|FG000|Overall Study|Not treated|0|||
146109030|NCT00393029|526918952|FG001|Overall Study|Not treated|1|||
146109031|NCT03715530|526918953|FG000|Overall Study|Lost to Follow-up|3|||
146109032|NCT03715530|526918954|FG001|Overall Study|Lost to Follow-up|1|||
146109033|NCT03715530|526918955|FG002|Overall Study|Lost to Follow-up|2|||
146109034|NCT00039130|526918957|FG000|Overall Study|Adverse Event|11|||
146109035|NCT00039130|526918957|FG000|Overall Study|Death|9|||
146109036|NCT00039130|526918957|FG000|Overall Study|Withdrawal by Subject|3|||
146109037|NCT00039130|526918957|FG000|Overall Study|Progression|2|||
146109038|NCT00039130|526918957|FG000|Overall Study|Subsequent treatment|2|||
146109039|NCT00039130|526918957|FG000|Overall Study|Physician Decision|3|||
146109040|NCT03288129|526918958|FG000|Overall Study|Adverse Event|10|||
146109041|NCT03288129|526918958|FG000|Overall Study|Lost to Follow-up|3|||
146109042|NCT03288129|526918958|FG000|Overall Study|Withdrawal by Subject|3|||
146109043|NCT03288129|526918958|FG000|Overall Study|Withdrawal of consent/assent|1|||
146109044|NCT03288129|526918958|FG000|Overall Study|Other|5|||
146109045|NCT01744197|526918964|FG000|Overall Study|Received 1 patch|2|||
146109046|NCT01744197|526918965|FG001|Overall Study|Received 1 patch|1|||
146109047|NCT01744197|526918964|FG000|Overall Study|No patch received|2|||
146109048|NCT01744197|526918965|FG001|Overall Study|No patch received|2|||
146109049|NCT01949506|526918966|FG000|Overall Study|Physician Decision|1|||
146109050|NCT02915016|526918967|FG000|Overall Study|Lost to Follow-up|4|||
146109051|NCT02915016|526918968|FG001|Overall Study|Lost to Follow-up|2|||
146109052|NCT02915016|526918969|FG002|Overall Study|Lost to Follow-up|5|||
146109053|NCT02915016|526918970|FG003|Overall Study|Lost to Follow-up|3|||
146109054|NCT02915016|526918971|FG004|Overall Study|Lost to Follow-up|5|||
146109055|NCT02915016|526918972|FG005|Overall Study|Lost to Follow-up|2|||
146109056|NCT02915016|526918973|FG006|Overall Study|Lost to Follow-up|8|||
146109057|NCT02915016|526918974|FG007|Overall Study|Lost to Follow-up|2|||
146109058|NCT02915016|526918967|FG000|Overall Study|Physician Decision|0|||
146259011|NCT00195442|527463341|FG000|Overall Study|Poor cooperation|2|||
146259012|NCT00195442|527463341|FG000|Overall Study|Other|14|||
146259013|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
146259014|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
146259015|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
146109059|NCT02915016|526918968|FG001|Overall Study|Physician Decision|0|||
146109060|NCT02915016|526918969|FG002|Overall Study|Physician Decision|1|||
146109061|NCT02915016|526918970|FG003|Overall Study|Physician Decision|0|||
146109062|NCT02915016|526918971|FG004|Overall Study|Physician Decision|0|||
146109063|NCT02915016|526918972|FG005|Overall Study|Physician Decision|1|||
146109064|NCT02915016|526918973|FG006|Overall Study|Physician Decision|2|||
146109065|NCT02915016|526918974|FG007|Overall Study|Physician Decision|0|||
146109066|NCT02915016|526918967|FG000|Overall Study|Withdrawal by Subject|2|||
146109067|NCT02915016|526918968|FG001|Overall Study|Withdrawal by Subject|0|||
146109068|NCT02915016|526918969|FG002|Overall Study|Withdrawal by Subject|1|||
146109069|NCT02915016|526918970|FG003|Overall Study|Withdrawal by Subject|0|||
146109070|NCT02915016|526918971|FG004|Overall Study|Withdrawal by Subject|1|||
146109071|NCT02915016|526918972|FG005|Overall Study|Withdrawal by Subject|3|||
146109072|NCT02915016|526918973|FG006|Overall Study|Withdrawal by Subject|1|||
146109073|NCT02915016|526918974|FG007|Overall Study|Withdrawal by Subject|1|||
146109074|NCT02915016|526918967|FG000|Overall Study|Elected not to continue|0|||
146109075|NCT02915016|526918968|FG001|Overall Study|Elected not to continue|0|||
146109076|NCT02915016|526918969|FG002|Overall Study|Elected not to continue|0|||
146109077|NCT02915016|526918970|FG003|Overall Study|Elected not to continue|1|||
146109078|NCT02915016|526918971|FG004|Overall Study|Elected not to continue|0|||
146109079|NCT02915016|526918972|FG005|Overall Study|Elected not to continue|0|||
146109080|NCT02915016|526918973|FG006|Overall Study|Elected not to continue|1|||
146109081|NCT02915016|526918974|FG007|Overall Study|Elected not to continue|0|||
146109082|NCT02915016|526918967|FG000|Overall Study|HIV infection|1|||
146109083|NCT02915016|526918968|FG001|Overall Study|HIV infection|1|||
146109084|NCT02915016|526918969|FG002|Overall Study|HIV infection|1|||
146109085|NCT02915016|526918970|FG003|Overall Study|HIV infection|0|||
146109086|NCT02915016|526918971|FG004|Overall Study|HIV infection|1|||
146109087|NCT02915016|526918972|FG005|Overall Study|HIV infection|0|||
146109088|NCT02915016|526918973|FG006|Overall Study|HIV infection|0|||
146109089|NCT02915016|526918974|FG007|Overall Study|HIV infection|0|||
146109090|NCT02915016|526918967|FG000|Overall Study|Participant unable to adhere|0|||
146109091|NCT02915016|526918968|FG001|Overall Study|Participant unable to adhere|0|||
146109092|NCT02915016|526918969|FG002|Overall Study|Participant unable to adhere|0|||
146109093|NCT02915016|526918970|FG003|Overall Study|Participant unable to adhere|0|||
146109094|NCT02915016|526918971|FG004|Overall Study|Participant unable to adhere|0|||
146109095|NCT02915016|526918972|FG005|Overall Study|Participant unable to adhere|0|||
146109096|NCT02915016|526918973|FG006|Overall Study|Participant unable to adhere|0|||
146109097|NCT02915016|526918974|FG007|Overall Study|Participant unable to adhere|1|||
146109098|NCT02166905|526918975|FG000|Overall Study|Withdrawal by Subject|1|||
146109099|NCT02166905|526918976|FG001|Overall Study|Withdrawal by Subject|0|||
146109100|NCT02166905|526918977|FG002|Overall Study|Withdrawal by Subject|0|||
146109101|NCT02166905|526918978|FG003|Overall Study|Withdrawal by Subject|0|||
146109102|NCT02617628|526918979|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
146109103|NCT02617628|526918980|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
146109104|NCT03278873|526918981|FG000|Overall Study|Withdrawal by Subject|0|||
146109105|NCT03278873|526918982|FG001|Overall Study|Withdrawal by Subject|1|||
146109106|NCT03278873|526918983|FG002|Overall Study|Withdrawal by Subject|0|||
146109107|NCT03278873|526918984|FG003|Overall Study|Withdrawal by Subject|0|||
146109108|NCT03278873|526918981|FG000|Overall Study|Sponsor's decision|0|||
146109109|NCT03278873|526918982|FG001|Overall Study|Sponsor's decision|1|||
146109110|NCT03278873|526918983|FG002|Overall Study|Sponsor's decision|0|||
146109111|NCT03278873|526918984|FG003|Overall Study|Sponsor's decision|0|||
146109112|NCT03278873|526918981|FG000|Overall Study|Early Termination|2|||
146109113|NCT03278873|526918982|FG001|Overall Study|Early Termination|6|||
146109114|NCT03278873|526918983|FG002|Overall Study|Early Termination|0|||
146109115|NCT03278873|526918984|FG003|Overall Study|Early Termination|4|||
146109116|NCT03278873|526918981|FG000|Overall Study|Lost to Follow-up|0|||
146109117|NCT03278873|526918982|FG001|Overall Study|Lost to Follow-up|0|||
146109118|NCT03278873|526918983|FG002|Overall Study|Lost to Follow-up|2|||
146109119|NCT03278873|526918984|FG003|Overall Study|Lost to Follow-up|0|||
146109120|NCT03278873|526918981|FG000|Overall Study|The patient decided to withdraw via email|1|||
146109121|NCT03278873|526918982|FG001|Overall Study|The patient decided to withdraw via email|0|||
146109122|NCT03278873|526918983|FG002|Overall Study|The patient decided to withdraw via email|0|||
146109123|NCT03278873|526918984|FG003|Overall Study|The patient decided to withdraw via email|0|||
146109124|NCT03278873|526918981|FG000|Overall Study|The patient was unresponsive to contact|0|||
146259016|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
146259017|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
146259018|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
146109125|NCT03278873|526918982|FG001|Overall Study|The patient was unresponsive to contact|0|||
146109126|NCT03278873|526918983|FG002|Overall Study|The patient was unresponsive to contact|0|||
146109127|NCT03278873|526918984|FG003|Overall Study|The patient was unresponsive to contact|4|||
146109128|NCT03278873|526918981|FG000|Overall Study|The patient wished to participate no longer|0|||
146109129|NCT03278873|526918982|FG001|Overall Study|The patient wished to participate no longer|1|||
146109130|NCT03278873|526918983|FG002|Overall Study|The patient wished to participate no longer|0|||
146109131|NCT03278873|526918984|FG003|Overall Study|The patient wished to participate no longer|0|||
146109132|NCT03278873|526918981|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146259019|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
146109133|NCT03278873|526918982|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146109134|NCT03278873|526918983|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
146109135|NCT03278873|526918984|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
146109136|NCT04518306|526918999|FG000|Double-Blind Period|Run in failure|0|||
146109137|NCT04518306|526919000|FG001|Double-Blind Period|Run in failure|0|||
146109138|NCT04518306|526919001|FG002|Double-Blind Period|Run in failure|1|||
146109139|NCT04518306|526918999|FG000|Double-Blind Period|Adverse Event|0|||
146109140|NCT04518306|526919000|FG001|Double-Blind Period|Adverse Event|2|||
146109141|NCT04518306|526919001|FG002|Double-Blind Period|Adverse Event|2|||
146109142|NCT04518306|526918999|FG000|Double-Blind Period|Lost to Follow-up|1|||
146109143|NCT04518306|526919000|FG001|Double-Blind Period|Lost to Follow-up|2|||
146109144|NCT04518306|526919001|FG002|Double-Blind Period|Lost to Follow-up|2|||
146109145|NCT04518306|526918999|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
146109146|NCT04518306|526919000|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
146109147|NCT04518306|526919001|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
146109148|NCT04518306|526918999|FG000|Double-Blind Period|Other|0|||
146109149|NCT04518306|526919000|FG001|Double-Blind Period|Other|2|||
146109150|NCT04518306|526919001|FG002|Double-Blind Period|Other|0|||
146109151|NCT04518306|526918999|FG000|Double-Blind Period|Missing|0|||
146109152|NCT04518306|526919000|FG001|Double-Blind Period|Missing|1|||
146109153|NCT04518306|526919001|FG002|Double-Blind Period|Missing|0|||
146109154|NCT02801331|526919002|FG000|Overall Study|Transferred to another hospital|8|||
146109155|NCT02801331|526919003|FG001|Overall Study|Transferred to another hospital|7|||
146109156|NCT02801331|526919002|FG000|Overall Study|Withdrawal by Subject|0|||
146109157|NCT02801331|526919003|FG001|Overall Study|Withdrawal by Subject|4|||
146109158|NCT02801331|526919002|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
146109159|NCT02801331|526919003|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
146109160|NCT02443987|526919004|FG000|Overall Study|Bladder injury|1|||
146109161|NCT02443987|526919005|FG001|Overall Study|Bladder injury|1|||
146109162|NCT02443987|526919004|FG000|Overall Study|Other|0|||
146109163|NCT02443987|526919005|FG001|Overall Study|Other|1|||
146109164|NCT01397708|526919006|FG000|Overall Study|Withdrawal by Subject|0|||
146109165|NCT01397708|526919007|FG001|Overall Study|Withdrawal by Subject|0|||
146109166|NCT01397708|526919008|FG002|Overall Study|Withdrawal by Subject|1|||
146109167|NCT01397708|526919009|FG003|Overall Study|Withdrawal by Subject|0|||
146109168|NCT01397708|526919010|FG004|Overall Study|Withdrawal by Subject|0|||
146109169|NCT01397708|526919011|FG005|Overall Study|Withdrawal by Subject|0|||
146109170|NCT01397708|526919012|FG006|Overall Study|Withdrawal by Subject|0|||
146109171|NCT01397708|526919013|FG007|Overall Study|Withdrawal by Subject|1|||
146109172|NCT01397708|526919006|FG000|Overall Study|Death|0|||
146109173|NCT01397708|526919007|FG001|Overall Study|Death|0|||
146109174|NCT01397708|526919008|FG002|Overall Study|Death|1|||
146109175|NCT01397708|526919009|FG003|Overall Study|Death|1|||
146109176|NCT01397708|526919010|FG004|Overall Study|Death|0|||
146109177|NCT01397708|526919011|FG005|Overall Study|Death|0|||
146109178|NCT01397708|526919012|FG006|Overall Study|Death|0|||
146109179|NCT01397708|526919013|FG007|Overall Study|Death|0|||
146109180|NCT01397708|526919006|FG000|Overall Study|Lost to Follow-up|0|||
146109181|NCT01397708|526919007|FG001|Overall Study|Lost to Follow-up|0|||
146109182|NCT01397708|526919008|FG002|Overall Study|Lost to Follow-up|0|||
146109183|NCT01397708|526919009|FG003|Overall Study|Lost to Follow-up|0|||
146109184|NCT01397708|526919010|FG004|Overall Study|Lost to Follow-up|1|||
146109185|NCT01397708|526919011|FG005|Overall Study|Lost to Follow-up|0|||
146109186|NCT01397708|526919012|FG006|Overall Study|Lost to Follow-up|0|||
146109187|NCT01397708|526919013|FG007|Overall Study|Lost to Follow-up|0|||
146109188|NCT01397708|526919006|FG000|Overall Study|Other|0|||
146109189|NCT01397708|526919007|FG001|Overall Study|Other|0|||
146109190|NCT01397708|526919008|FG002|Overall Study|Other|0|||
146109191|NCT01397708|526919009|FG003|Overall Study|Other|0|||
146109192|NCT01397708|526919010|FG004|Overall Study|Other|0|||
146109193|NCT01397708|526919011|FG005|Overall Study|Other|0|||
146109194|NCT01397708|526919012|FG006|Overall Study|Other|1|||
146109195|NCT01397708|526919013|FG007|Overall Study|Other|0|||
146109196|NCT01638546|526919016|FG000|Overall Study|Adverse Event|1|||
146259020|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
146259021|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
146259022|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
146109197|NCT01638546|526919017|FG001|Overall Study|Adverse Event|3|||
146109198|NCT05330702|526919018|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
146109199|NCT05330702|526919019|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
146109200|NCT05330702|526919020|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
146109201|NCT01664533|526920286|FG000|Overall Study|Death|42|||
146109202|NCT01664533|526920286|FG000|Overall Study|Lost to Follow-up|3|||
146109203|NCT01664533|526920286|FG000|Overall Study|Study termination|9|||
146109204|NCT01664533|526920286|FG000|Overall Study|Protocol Violation|3|||
146109205|NCT03291808|526920287|FG000|Overall Study|Lost to Follow-up|6|||
146109206|NCT03291808|526920287|FG000|Overall Study|Research burden|4|||
146109207|NCT02674529|526920288|FG000|Overall Study|Lost to Follow-up|1|||
146109208|NCT02674529|526920289|FG001|Overall Study|Lost to Follow-up|2|||
146109209|NCT02674529|526920288|FG000|Overall Study|Withdrawal by Subject|2|||
146109210|NCT02674529|526920289|FG001|Overall Study|Withdrawal by Subject|1|||
146109211|NCT02674529|526920288|FG000|Overall Study|Physician Decision|0|||
146109212|NCT02674529|526920289|FG001|Overall Study|Physician Decision|1|||
146109213|NCT02674529|526920288|FG000|Overall Study|Protocol Violation|0|||
146109214|NCT02674529|526920289|FG001|Overall Study|Protocol Violation|1|||
146109215|NCT02397278|526920300|FG000|Overall Study|Withdrawal by Subject|0|||
146109216|NCT02397278|526920301|FG001|Overall Study|Withdrawal by Subject|2|||
146109217|NCT02397278|526920300|FG000|Overall Study|Deemed ineligible following surgery|1|||
146109218|NCT02397278|526920301|FG001|Overall Study|Deemed ineligible following surgery|1|||
146109219|NCT00062374|526920306|FG000|Overall Study|Not treated|12|||
146109220|NCT02155608|526920307|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
146109221|NCT02155608|526920308|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
146109222|NCT02155608|526920307|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
146109223|NCT02155608|526920308|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
146109224|NCT01532414|526920309|FG000|Overall Study|Lost to Follow-up|3|||
146109225|NCT01532414|526920310|FG001|Overall Study|Lost to Follow-up|0|||
146109226|NCT01532414|526920311|FG002|Overall Study|Lost to Follow-up|1|||
146109227|NCT01532414|526920309|FG000|Overall Study|Withdrawal by Subject|3|||
146109228|NCT01532414|526920310|FG001|Overall Study|Withdrawal by Subject|0|||
146109229|NCT01532414|526920311|FG002|Overall Study|Withdrawal by Subject|0|||
146109230|NCT01532414|526920309|FG000|Overall Study|No V6 semen sample|0|||
146109231|NCT01532414|526920310|FG001|Overall Study|No V6 semen sample|1|||
146109232|NCT01532414|526920311|FG002|Overall Study|No V6 semen sample|0|||
146109233|NCT01532414|526920309|FG000|Overall Study|Adverse Event|0|||
146109234|NCT01532414|526920310|FG001|Overall Study|Adverse Event|1|||
146109235|NCT01532414|526920311|FG002|Overall Study|Adverse Event|1|||
146109236|NCT01532414|526920309|FG000|Overall Study|Unable to complete 24 hour PK|0|||
146109237|NCT01532414|526920310|FG001|Overall Study|Unable to complete 24 hour PK|0|||
146109238|NCT01532414|526920311|FG002|Overall Study|Unable to complete 24 hour PK|1|||
146109239|NCT01532414|526920309|FG000|Overall Study|Withdrawn by sponsor|1|||
146109240|NCT01532414|526920310|FG001|Overall Study|Withdrawn by sponsor|0|||
146109241|NCT01532414|526920311|FG002|Overall Study|Withdrawn by sponsor|0|||
146109242|NCT00187486|526920314|FG000|Overall Study|Protocol Violation|1|||
146109243|NCT02380677|526920315|FG000|Overall Study|Adverse Event|0|||
146109244|NCT02380677|526920316|FG001|Overall Study|Adverse Event|0|||
146109245|NCT02380677|526920317|FG002|Overall Study|Adverse Event|0|||
146109246|NCT02380677|526920318|FG003|Overall Study|Adverse Event|1|||
146109247|NCT02380677|526920319|FG004|Overall Study|Adverse Event|1|||
146109248|NCT02380677|526920320|FG005|Overall Study|Adverse Event|4|||
146109249|NCT02380677|526920321|FG006|Overall Study|Adverse Event|2|||
146109250|NCT02380677|526920322|FG007|Overall Study|Adverse Event|2|||
146109251|NCT02380677|526920323|FG008|Overall Study|Adverse Event|2|||
146109252|NCT02380677|526920324|FG009|Overall Study|Adverse Event|1|||
146109253|NCT02380677|526920325|FG010|Overall Study|Adverse Event|2|||
146109254|NCT02380677|526920326|FG011|Overall Study|Adverse Event|1|||
146109255|NCT02380677|526920315|FG000|Overall Study|Physician Decision|1|||
146109256|NCT02380677|526920316|FG001|Overall Study|Physician Decision|0|||
146109257|NCT02380677|526920317|FG002|Overall Study|Physician Decision|1|||
146109258|NCT02380677|526920318|FG003|Overall Study|Physician Decision|1|||
146109259|NCT02380677|526920319|FG004|Overall Study|Physician Decision|0|||
146109260|NCT02380677|526920320|FG005|Overall Study|Physician Decision|0|||
146109261|NCT02380677|526920321|FG006|Overall Study|Physician Decision|0|||
146109262|NCT02380677|526920322|FG007|Overall Study|Physician Decision|0|||
146109263|NCT02380677|526920323|FG008|Overall Study|Physician Decision|0|||
146109264|NCT02380677|526920324|FG009|Overall Study|Physician Decision|0|||
146052591|NCT00607087|526707395|FG001|Period 1|Other reason|4|||
146052592|NCT00607087|526707396|FG002|Period 1|Other reason|2|||
146052593|NCT00607087|526707394|FG000|Period 2|Withdrawal by Subject|0|||
146052594|NCT00607087|526707395|FG001|Period 2|Withdrawal by Subject|1|||
146052595|NCT00607087|526707396|FG002|Period 2|Withdrawal by Subject|1|||
146052596|NCT00607087|526707394|FG000|Period 2|Other reason|1|||
146052597|NCT00607087|526707395|FG001|Period 2|Other reason|1|||
146052598|NCT00607087|526707396|FG002|Period 2|Other reason|0|||
146052599|NCT00607087|526707394|FG000|Period 2|Adverse Event|0|||
146052600|NCT00607087|526707395|FG001|Period 2|Adverse Event|1|||
146052601|NCT00607087|526707396|FG002|Period 2|Adverse Event|3|||
146052602|NCT00607087|526707394|FG000|Period 2|Poor compliance to protocol|0|||
146109265|NCT02380677|526920325|FG010|Overall Study|Physician Decision|0|||
146109266|NCT02380677|526920326|FG011|Overall Study|Physician Decision|0|||
146109267|NCT02380677|526920315|FG000|Overall Study|Lack of Efficacy|0|||
146109268|NCT02380677|526920316|FG001|Overall Study|Lack of Efficacy|1|||
146109269|NCT02380677|526920317|FG002|Overall Study|Lack of Efficacy|2|||
146052603|NCT00607087|526707395|FG001|Period 2|Poor compliance to protocol|0|||
146052604|NCT00607087|526707396|FG002|Period 2|Poor compliance to protocol|1|||
146109270|NCT02380677|526920318|FG003|Overall Study|Lack of Efficacy|0|||
146109271|NCT02380677|526920319|FG004|Overall Study|Lack of Efficacy|4|||
146109272|NCT02380677|526920320|FG005|Overall Study|Lack of Efficacy|1|||
146109273|NCT02380677|526920321|FG006|Overall Study|Lack of Efficacy|1|||
146109274|NCT02380677|526920322|FG007|Overall Study|Lack of Efficacy|2|||
146109275|NCT02380677|526920323|FG008|Overall Study|Lack of Efficacy|2|||
146109276|NCT02380677|526920324|FG009|Overall Study|Lack of Efficacy|0|||
146109277|NCT02380677|526920325|FG010|Overall Study|Lack of Efficacy|2|||
146109278|NCT02380677|526920326|FG011|Overall Study|Lack of Efficacy|1|||
146109279|NCT02380677|526920315|FG000|Overall Study|Withdrawal by Subject|0|||
146109280|NCT02380677|526920316|FG001|Overall Study|Withdrawal by Subject|0|||
146109281|NCT02380677|526920317|FG002|Overall Study|Withdrawal by Subject|0|||
146109282|NCT02380677|526920318|FG003|Overall Study|Withdrawal by Subject|0|||
146109283|NCT02380677|526920319|FG004|Overall Study|Withdrawal by Subject|0|||
146109284|NCT02380677|526920320|FG005|Overall Study|Withdrawal by Subject|0|||
146109285|NCT02380677|526920321|FG006|Overall Study|Withdrawal by Subject|0|||
146109286|NCT02380677|526920322|FG007|Overall Study|Withdrawal by Subject|0|||
146109287|NCT02380677|526920323|FG008|Overall Study|Withdrawal by Subject|0|||
146109288|NCT02380677|526920324|FG009|Overall Study|Withdrawal by Subject|1|||
146109289|NCT02380677|526920325|FG010|Overall Study|Withdrawal by Subject|0|||
146109290|NCT02380677|526920326|FG011|Overall Study|Withdrawal by Subject|3|||
146109291|NCT02380677|526920315|FG000|Overall Study|Other|0|||
146109292|NCT02380677|526920316|FG001|Overall Study|Other|0|||
146109293|NCT02380677|526920317|FG002|Overall Study|Other|0|||
146109294|NCT02380677|526920318|FG003|Overall Study|Other|1|||
146109295|NCT02380677|526920319|FG004|Overall Study|Other|1|||
146109296|NCT02380677|526920320|FG005|Overall Study|Other|1|||
146109297|NCT02380677|526920321|FG006|Overall Study|Other|0|||
146109298|NCT02380677|526920322|FG007|Overall Study|Other|0|||
146109299|NCT02380677|526920323|FG008|Overall Study|Other|0|||
146109300|NCT02380677|526920324|FG009|Overall Study|Other|0|||
146109301|NCT02380677|526920325|FG010|Overall Study|Other|0|||
146109302|NCT02380677|526920326|FG011|Overall Study|Other|0|||
146109303|NCT02599129|526920332|FG000|Overall Study|Lack of Efficacy|2|||
146109304|NCT02599129|526920333|FG001|Overall Study|Lack of Efficacy|2|||
146109305|NCT02599129|526920332|FG000|Overall Study|Lost to Follow-up|1|||
146109306|NCT02599129|526920333|FG001|Overall Study|Lost to Follow-up|0|||
146109307|NCT02599129|526920332|FG000|Overall Study|Withdrawal by Subject|2|||
146109308|NCT02599129|526920333|FG001|Overall Study|Withdrawal by Subject|1|||
146109309|NCT01029795|526920338|FG000|Overall Study|Entry Criteria Not Met|2|||
146109310|NCT01029795|526920339|FG001|Overall Study|Entry Criteria Not Met|1|||
146109311|NCT01029795|526920338|FG000|Overall Study|Physician Decision|2|||
146109312|NCT01029795|526920339|FG001|Overall Study|Physician Decision|1|||
146109313|NCT01029795|526920338|FG000|Overall Study|Sponsor Decision|11|||
146109314|NCT01029795|526920339|FG001|Overall Study|Sponsor Decision|17|||
146109315|NCT01029795|526920338|FG000|Overall Study|Withdrawal by Subject|1|||
146109316|NCT01029795|526920339|FG001|Overall Study|Withdrawal by Subject|3|||
146109317|NCT03217175|526920340|FG000|Overall Study|Physician Decision|4|||
146109318|NCT03217175|526920341|FG001|Overall Study|Physician Decision|1|||
146109319|NCT05035550|526920349|FG000|Overall Study|Withdrawal by Subject|3|||
146109320|NCT05035550|526920350|FG001|Overall Study|Withdrawal by Subject|0|||
146109321|NCT01806545|526920351|FG000|Overall Study|Adverse Event|2|||
146109322|NCT01806545|526920352|FG001|Overall Study|Adverse Event|3|||
146109323|NCT01806545|526920351|FG000|Overall Study|Lost to Follow-up|1|||
146109324|NCT01806545|526920352|FG001|Overall Study|Lost to Follow-up|0|||
146109325|NCT01806545|526920351|FG000|Overall Study|Withdrawal by Subject|3|||
146109326|NCT01806545|526920352|FG001|Overall Study|Withdrawal by Subject|2|||
146109327|NCT00429273|526920353|FG000|Overall Study|Lost to Follow-up|1|||
146109328|NCT00429273|526920354|FG001|Overall Study|Lost to Follow-up|2|||
146109329|NCT00429273|526920355|FG002|Overall Study|Lost to Follow-up|2|||
146109330|NCT00429273|526920353|FG000|Overall Study|Physician Decision|6|||
146109331|NCT00429273|526920354|FG001|Overall Study|Physician Decision|5|||
146109332|NCT00429273|526920355|FG002|Overall Study|Physician Decision|5|||
146109333|NCT00429273|526920353|FG000|Overall Study|Adverse Event|1|||
146109334|NCT00429273|526920354|FG001|Overall Study|Adverse Event|1|||
146109335|NCT00429273|526920355|FG002|Overall Study|Adverse Event|2|||
146109336|NCT00884312|526920357|FG000|Overall Study|Non-fatal Progressive Disease|0|||
146109337|NCT00884312|526920358|FG001|Overall Study|Non-fatal Progressive Disease|8|||
146109338|NCT00884312|526920357|FG000|Overall Study|Fatal Progressive Disease|0|||
146109339|NCT00884312|526920358|FG001|Overall Study|Fatal Progressive Disease|1|||
146109340|NCT00884312|526920357|FG000|Overall Study|Non-fatal Adverse Event|1|||
146109341|NCT00884312|526920358|FG001|Overall Study|Non-fatal Adverse Event|0|||
146109342|NCT00884312|526920357|FG000|Overall Study|Fatal Adverse Event|1|||
146109343|NCT00884312|526920358|FG001|Overall Study|Fatal Adverse Event|4|||
146109344|NCT00884312|526920357|FG000|Overall Study|Withdrawal by Subject|0|||
146109345|NCT00884312|526920358|FG001|Overall Study|Withdrawal by Subject|6|||
146109346|NCT00884312|526920357|FG000|Overall Study|Physician Decision|0|||
146109347|NCT00884312|526920358|FG001|Overall Study|Physician Decision|1|||
146109348|NCT00884312|526920357|FG000|Overall Study|Other|0|||
146109349|NCT00884312|526920358|FG001|Overall Study|Other|4|||
146109350|NCT00884312|526920357|FG000|Overall Study|Did Not Receive Study Drug|0|||
146109351|NCT00884312|526920358|FG001|Overall Study|Did Not Receive Study Drug|1|||
146109352|NCT00224042|526920359|FG000|Overall Study|Adverse Event|2|||
146109353|NCT00224042|526920360|FG001|Overall Study|Adverse Event|1|||
146109354|NCT00224042|526920359|FG000|Overall Study|Protocol Violation|0|||
146109355|NCT00224042|526920360|FG001|Overall Study|Protocol Violation|1|||
146109356|NCT00224042|526920359|FG000|Overall Study|Physician Decision|0|||
146109357|NCT00224042|526920360|FG001|Overall Study|Physician Decision|1|||
146109358|NCT00224042|526920359|FG000|Overall Study|Did not meet lab incusion criteria|2|||
146109359|NCT00224042|526920360|FG001|Overall Study|Did not meet lab incusion criteria|3|||
146109360|NCT00224042|526920359|FG000|Overall Study|Other|2|||
146109361|NCT00224042|526920360|FG001|Overall Study|Other|0|||
146109362|NCT00840450|526920361|FG000|Overall Study|Adverse Event|1|||
146109363|NCT00840450|526920361|FG000|Overall Study|Lack of Efficacy|2|||
146109364|NCT01061177|526920362|FG000|Overall Study|Adverse Event|117|||
146109365|NCT01061177|526920362|FG000|Overall Study|Withdrawal by Subject|27|||
146109366|NCT01061177|526920362|FG000|Overall Study|Disease progression|17|||
146109367|NCT01061177|526920362|FG000|Overall Study|Protocol Violation|11|||
146109368|NCT01061177|526920362|FG000|Overall Study|Lost to Follow-up|9|||
146109369|NCT01061177|526920362|FG000|Overall Study|New cancer therapy|9|||
146109370|NCT01061177|526920362|FG000|Overall Study|Abnormal laboratory values|6|||
146109371|NCT01061177|526920362|FG000|Overall Study|Abnormal test procedure results|4|||
146109372|NCT01061177|526920362|FG000|Overall Study|Administratie problems|4|||
146109373|NCT01061177|526920362|FG000|Overall Study|Death|4|||
146109374|NCT01854710|526920373|FG000|Overall Study|Withdrawal by Subject|2|||
146109375|NCT01854710|526920374|FG001|Overall Study|Withdrawal by Subject|1|||
146109376|NCT01854710|526920375|FG002|Overall Study|Withdrawal by Subject|0|||
146109377|NCT01854710|526920376|FG003|Overall Study|Withdrawal by Subject|0|||
146109378|NCT01854710|526920377|FG004|Overall Study|Withdrawal by Subject|0|||
146109379|NCT01854710|526920378|FG005|Overall Study|Withdrawal by Subject|0|||
146109380|NCT01854710|526920373|FG000|Overall Study|CRI procedural error|2|||
146109381|NCT01854710|526920374|FG001|Overall Study|CRI procedural error|2|||
146109382|NCT01854710|526920375|FG002|Overall Study|CRI procedural error|2|||
146109383|NCT01854710|526920376|FG003|Overall Study|CRI procedural error|2|||
146109384|NCT01854710|526920377|FG004|Overall Study|CRI procedural error|2|||
146109385|NCT01854710|526920378|FG005|Overall Study|CRI procedural error|2|||
146109386|NCT03132220|526920379|FG000|Overall Study|Lost to Follow-up|17|||
146109387|NCT03132220|526920380|FG001|Overall Study|Lost to Follow-up|8|||
146109388|NCT03132220|526920379|FG000|Overall Study|Withdrawal by Subject|1|||
146109389|NCT03132220|526920380|FG001|Overall Study|Withdrawal by Subject|4|||
146109390|NCT00730132|526920381|FG000|Overall Study|Protocol Violation|154|||
146109391|NCT00730132|526920381|FG000|Overall Study|Death|1|||
146109392|NCT02296320|526920383|FG000|Overall Study|Withdrawal by Subject|4|||
146109393|NCT02296320|526920384|FG001|Overall Study|Withdrawal by Subject|0|||
146109394|NCT02296320|526920385|FG002|Overall Study|Withdrawal by Subject|2|||
146109395|NCT02296320|526920383|FG000|Overall Study|Death|24|||
146109396|NCT02296320|526920384|FG001|Overall Study|Death|3|||
146109397|NCT02296320|526920385|FG002|Overall Study|Death|27|||
146109398|NCT02296320|526920383|FG000|Overall Study|Lost to Follow-up|5|||
146109399|NCT02296320|526920384|FG001|Overall Study|Lost to Follow-up|2|||
146109400|NCT02296320|526920385|FG002|Overall Study|Lost to Follow-up|7|||
146109401|NCT02296320|526920383|FG000|Overall Study|Not treated|2|||
146109402|NCT02296320|526920384|FG001|Overall Study|Not treated|0|||
146109403|NCT02296320|526920385|FG002|Overall Study|Not treated|0|||
146109404|NCT02296320|526920383|FG000|Overall Study|Not - specified|0|||
146109405|NCT02296320|526920384|FG001|Overall Study|Not - specified|0|||
146109406|NCT02296320|526920385|FG002|Overall Study|Not - specified|1|||
146109407|NCT05466682|526920389|FG000|Overall Study|Withdrawal by Subject|0|||
146259023|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
146259024|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
146259025|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
146109408|NCT05466682|526920390|FG001|Overall Study|Withdrawal by Subject|2|||
146109409|NCT05466682|526920389|FG000|Overall Study|Lost to Follow-up|2|||
146109410|NCT05466682|526920390|FG001|Overall Study|Lost to Follow-up|1|||
146109411|NCT01930123|526920391|FG000|Overall Study|Adverse Event|1|||
146109412|NCT01930123|526920392|FG001|Overall Study|Adverse Event|0|||
146109413|NCT01930123|526920391|FG000|Overall Study|Physician Decision|21|||
146109414|NCT01930123|526920392|FG001|Overall Study|Physician Decision|8|||
146109415|NCT01930123|526920391|FG000|Overall Study|Withdrawal by Subject|1|||
146109416|NCT01930123|526920392|FG001|Overall Study|Withdrawal by Subject|0|||
146109417|NCT03208244|526920393|FG000|Overall Study|Death|1|||
146109418|NCT03953820|526920395|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
146109419|NCT03953820|526920396|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
146109420|NCT03953820|526920397|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
146109421|NCT03953820|526920395|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
146109422|NCT03953820|526920396|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
146109423|NCT03953820|526920397|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
146109424|NCT03334539|526920398|FG000|Overall Study|Adverse Event|3|||
146109425|NCT03334539|526920399|FG001|Overall Study|Adverse Event|5|||
146109426|NCT03334539|526920400|FG002|Overall Study|Adverse Event|0|||
146109427|NCT03334539|526920398|FG000|Overall Study|Withdrawal by Subject|0|||
146109428|NCT03334539|526920399|FG001|Overall Study|Withdrawal by Subject|1|||
146109429|NCT03334539|526920400|FG002|Overall Study|Withdrawal by Subject|1|||
146109430|NCT03334539|526920398|FG000|Overall Study|Administrative Reasons|1|||
146109431|NCT03334539|526920399|FG001|Overall Study|Administrative Reasons|0|||
146109432|NCT03334539|526920400|FG002|Overall Study|Administrative Reasons|0|||
146109433|NCT03334539|526920398|FG000|Overall Study|Hypertension Not Controlled|0|||
146109434|NCT03334539|526920399|FG001|Overall Study|Hypertension Not Controlled|1|||
146109435|NCT03334539|526920400|FG002|Overall Study|Hypertension Not Controlled|0|||
146109436|NCT03547583|526920405|FG000|Overall Study|Adverse Event|16|||
146109437|NCT03547583|526920406|FG001|Overall Study|Adverse Event|11|||
146109438|NCT03547583|526920407|FG002|Overall Study|Adverse Event|10|||
146109439|NCT03547583|526920405|FG000|Overall Study|Death|11|||
146109440|NCT03547583|526920406|FG001|Overall Study|Death|7|||
146109441|NCT03547583|526920407|FG002|Overall Study|Death|4|||
146109442|NCT03547583|526920405|FG000|Overall Study|Lost to Follow-up|1|||
146109443|NCT03547583|526920406|FG001|Overall Study|Lost to Follow-up|0|||
146109444|NCT03547583|526920407|FG002|Overall Study|Lost to Follow-up|0|||
146109445|NCT03547583|526920405|FG000|Overall Study|Non-compliance with study drug|0|||
146109446|NCT03547583|526920406|FG001|Overall Study|Non-compliance with study drug|0|||
146109447|NCT03547583|526920407|FG002|Overall Study|Non-compliance with study drug|1|||
146109448|NCT03547583|526920405|FG000|Overall Study|Physician Decision|1|||
146109449|NCT03547583|526920406|FG001|Overall Study|Physician Decision|0|||
146109450|NCT03547583|526920407|FG002|Overall Study|Physician Decision|3|||
146109451|NCT03547583|526920405|FG000|Overall Study|Protocol Violation|2|||
146109452|NCT03547583|526920406|FG001|Overall Study|Protocol Violation|1|||
146109453|NCT03547583|526920407|FG002|Overall Study|Protocol Violation|1|||
146109454|NCT03547583|526920405|FG000|Overall Study|Withdrawal by Subject|12|||
146109455|NCT03547583|526920406|FG001|Overall Study|Withdrawal by Subject|19|||
146109456|NCT03547583|526920407|FG002|Overall Study|Withdrawal by Subject|10|||
146109457|NCT03547583|526920405|FG000|Overall Study|Other|2|||
146109458|NCT03547583|526920406|FG001|Overall Study|Other|2|||
146109459|NCT03547583|526920407|FG002|Overall Study|Other|3|||
146109460|NCT04706091|526920410|FG000|Treatment 2|Withdrawal by Subject|1|||
146109461|NCT04706091|526920411|FG001|Treatment 2|Withdrawal by Subject|0|||
146109462|NCT01063868|526920412|FG000|Overall Study|Adverse Event|9|||
146109463|NCT01063868|526920413|FG001|Overall Study|Adverse Event|7|||
146109464|NCT01063868|526920412|FG000|Overall Study|Withdrawal by Subject|3|||
146109465|NCT01063868|526920413|FG001|Overall Study|Withdrawal by Subject|1|||
146109466|NCT01063868|526920412|FG000|Overall Study|Study Terminated By Sponsor|23|||
146109467|NCT01063868|526920413|FG001|Overall Study|Study Terminated By Sponsor|4|||
146109468|NCT03069378|526920417|FG000|Overall Study|Withdrawal by Subject|1|||
146109469|NCT02881554|526920428|FG000|Overall Study|Withdrawal by Subject|2|||
146109470|NCT02881554|526920429|FG001|Overall Study|Withdrawal by Subject|0|||
146109471|NCT02161731|526921943|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
146109472|NCT02161731|526921944|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
146109473|NCT02161731|526921943|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
146109474|NCT02161731|526921944|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
146109475|NCT01315678|526921949|FG000|Overall Study|Withdrawal by Subject|7|||
146109476|NCT01315678|526921950|FG001|Overall Study|Withdrawal by Subject|3|||
146109477|NCT01315678|526921949|FG000|Overall Study|Adverse Event|3|||
146109478|NCT01315678|526921950|FG001|Overall Study|Adverse Event|1|||
146109479|NCT01315678|526921949|FG000|Overall Study|Lost to Follow-up|1|||
146109480|NCT01315678|526921950|FG001|Overall Study|Lost to Follow-up|0|||
146109481|NCT01315678|526921949|FG000|Overall Study|similar reason to those listed above|3|||
146259026|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
146109482|NCT01315678|526921950|FG001|Overall Study|similar reason to those listed above|2|||
146109483|NCT00331682|526921951|FG000|Overall Study|Adverse Event|1|||
146109484|NCT03292588|526921952|FG000|Overall Study|Death|1|||
146109485|NCT03292588|526921953|FG001|Overall Study|Death|0|||
146109486|NCT03292588|526921952|FG000|Overall Study|Lost to Follow-up|12|||
146109487|NCT03292588|526921953|FG001|Overall Study|Lost to Follow-up|16|||
146109488|NCT03292588|526921952|FG000|Overall Study|Physician Decision|0|||
146259027|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
146259028|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
146109489|NCT03292588|526921953|FG001|Overall Study|Physician Decision|1|||
146109490|NCT03292588|526921952|FG000|Overall Study|Withdrawal by Subject|4|||
146109491|NCT03292588|526921953|FG001|Overall Study|Withdrawal by Subject|4|||
146109492|NCT03292588|526921952|FG000|Overall Study|Move out of town|1|||
146109493|NCT03292588|526921953|FG001|Overall Study|Move out of town|0|||
146109494|NCT03292588|526921952|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
146109495|NCT03292588|526921953|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
146109496|NCT00004978|526921954|FG000|Overall Study|Death|107|||
146109497|NCT00004978|526921955|FG001|Overall Study|Death|116|||
146109498|NCT00004978|526921954|FG000|Overall Study|Lost to Follow-up|101|||
146109499|NCT00004978|526921955|FG001|Overall Study|Lost to Follow-up|108|||
146109500|NCT00004978|526921954|FG000|Overall Study|Withdrawal by Subject|17|||
146109501|NCT00004978|526921955|FG001|Overall Study|Withdrawal by Subject|26|||
146109502|NCT00004978|526921954|FG000|Overall Study|site closure - not in analysis cohort|19|||
146109503|NCT00004978|526921955|FG001|Overall Study|site closure - not in analysis cohort|20|||
146109504|NCT01652703|526921956|FG000|Overall Study|Withdrawal by Subject|0|||
146109505|NCT01652703|526921957|FG001|Overall Study|Withdrawal by Subject|1|||
146109506|NCT01652703|526921958|FG002|Overall Study|Withdrawal by Subject|3|||
146109507|NCT01652703|526921959|FG003|Overall Study|Withdrawal by Subject|1|||
146109508|NCT01652703|526921960|FG004|Overall Study|Withdrawal by Subject|0|||
146109509|NCT01652703|526921961|FG005|Overall Study|Withdrawal by Subject|1|||
146109510|NCT01652703|526921956|FG000|Overall Study|Other|0|||
146109511|NCT01652703|526921957|FG001|Overall Study|Other|0|||
146109512|NCT01652703|526921958|FG002|Overall Study|Other|0|||
146109513|NCT01652703|526921959|FG003|Overall Study|Other|1|||
146109514|NCT01652703|526921960|FG004|Overall Study|Other|1|||
146109515|NCT01652703|526921961|FG005|Overall Study|Other|1|||
146109516|NCT00617123|526921965|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
146109517|NCT00617123|526921966|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
146109518|NCT00617123|526921965|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
146109519|NCT00617123|526921966|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
146109520|NCT00617123|526921965|FG000|Referral Screening Period|Adverse Event|0|||
146109521|NCT00617123|526921966|FG001|Referral Screening Period|Adverse Event|1|||
146109522|NCT00617123|526921965|FG000|Study Treatment Period|Withdrawal by Subject|8|||
146109523|NCT00617123|526921966|FG001|Study Treatment Period|Withdrawal by Subject|12|||
146109524|NCT00617123|526921965|FG000|Study Treatment Period|Adverse Event|7|||
146109525|NCT00617123|526921966|FG001|Study Treatment Period|Adverse Event|3|||
146109526|NCT00617123|526921965|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
146109527|NCT00617123|526921966|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
146109528|NCT00617123|526921965|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
146109529|NCT00617123|526921966|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
146109530|NCT00133952|526921968|FG000|Overall Study|Adverse Event|1|||
146109531|NCT00133952|526921969|FG001|Overall Study|Adverse Event|2|||
146109532|NCT00133952|526921968|FG000|Overall Study|Death|3|||
146109533|NCT00133952|526921969|FG001|Overall Study|Death|2|||
146109534|NCT00133952|526921968|FG000|Overall Study|Lost to Follow-up|9|||
146109535|NCT00133952|526921969|FG001|Overall Study|Lost to Follow-up|14|||
146109536|NCT00133952|526921968|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
146109537|NCT00133952|526921969|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
146109538|NCT00133952|526921968|FG000|Overall Study|Protocol Violation|1|||
146109539|NCT00133952|526921969|FG001|Overall Study|Protocol Violation|1|||
146109540|NCT00133952|526921968|FG000|Overall Study|Withdrawal by Subject|20|||
146109541|NCT00133952|526921969|FG001|Overall Study|Withdrawal by Subject|4|||
146109542|NCT00133952|526921968|FG000|Overall Study|Physician Decision|4|||
146109543|NCT00133952|526921969|FG001|Overall Study|Physician Decision|3|||
146109544|NCT00133952|526921968|FG000|Overall Study|Sponsor Decision|0|||
146109545|NCT00133952|526921969|FG001|Overall Study|Sponsor Decision|1|||
146109546|NCT03052725|526921970|FG000|Overall Study|Adverse Event|2|||
146109547|NCT03052725|526921971|FG001|Overall Study|Adverse Event|0|||
146109548|NCT03052725|526921970|FG000|Overall Study|Withdrawal by Subject|3|||
146109549|NCT03052725|526921971|FG001|Overall Study|Withdrawal by Subject|4|||
146109550|NCT03052725|526921970|FG000|Overall Study|Pregnancy|0|||
146109551|NCT03052725|526921971|FG001|Overall Study|Pregnancy|1|||
146109552|NCT03052725|526921970|FG000|Overall Study|Site closure|0|||
146109553|NCT03052725|526921971|FG001|Overall Study|Site closure|1|||
146109554|NCT03052725|526921970|FG000|Overall Study|Study terminated by sponsor|143|||
146109555|NCT03052725|526921971|FG001|Overall Study|Study terminated by sponsor|144|||
146109556|NCT03462082|526921977|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109557|NCT03462082|526921978|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109558|NCT03462082|526921979|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109559|NCT03462082|526921980|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109560|NCT03462082|526921981|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109561|NCT03462082|526921982|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
146109562|NCT03462082|526921983|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
146109563|NCT03462082|526921984|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
146109564|NCT00166114|526921987|FG000|Overall Study|Protocol Violation|2|||
146109565|NCT00166114|526921988|FG001|Overall Study|Protocol Violation|1|||
146109566|NCT00166114|526921987|FG000|Overall Study|Withdrawal by Subject|10|||
146109567|NCT00166114|526921988|FG001|Overall Study|Withdrawal by Subject|4|||
146109568|NCT00166114|526921987|FG000|Overall Study|Adverse Event|2|||
146109569|NCT00166114|526921988|FG001|Overall Study|Adverse Event|1|||
146109570|NCT00545168|526921995|FG000|Overall Study|Lost to Follow-up|5|||
146259029|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
146109571|NCT00545168|526921996|FG001|Overall Study|Lost to Follow-up|5|||
146109572|NCT00545168|526921997|FG002|Overall Study|Lost to Follow-up|5|||
146109573|NCT00545168|526921995|FG000|Overall Study|Withdrawal by Subject|9|||
146109574|NCT00545168|526921996|FG001|Overall Study|Withdrawal by Subject|0|||
146109575|NCT00545168|526921997|FG002|Overall Study|Withdrawal by Subject|13|||
146109576|NCT00545168|526921995|FG000|Overall Study|Protocol Violation|1|||
146109577|NCT00545168|526921996|FG001|Overall Study|Protocol Violation|0|||
146109578|NCT00545168|526921997|FG002|Overall Study|Protocol Violation|1|||
146109579|NCT00545168|526921995|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
146109580|NCT00545168|526921996|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
146109581|NCT00545168|526921997|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
146109582|NCT02548650|526922010|FG000|Triple Therapy|Adverse Event|1|||
146109583|NCT02548650|526922011|FG001|Triple Therapy|Adverse Event|0|||
146109584|NCT02548650|526922010|FG000|Triple Therapy|Withdrawal by Subject|0|||
146109585|NCT02548650|526922011|FG001|Triple Therapy|Withdrawal by Subject|4|||
146109586|NCT02548650|526922010|FG000|Double Therapy|Adverse Event|1|||
146109587|NCT02548650|526922011|FG001|Double Therapy|Adverse Event|1|||
146109588|NCT02548650|526922010|FG000|Double Therapy|Withdrawal by Subject|0|||
146109589|NCT02548650|526922011|FG001|Double Therapy|Withdrawal by Subject|1|||
146109590|NCT02128113|526922013|FG000|Overall Study|Withdrawal by Subject|3|||
146109591|NCT02128113|526922014|FG001|Overall Study|Withdrawal by Subject|1|||
146109592|NCT02128113|526922015|FG002|Overall Study|Withdrawal by Subject|0|||
146109593|NCT02128113|526922013|FG000|Overall Study|Protocol Violation|0|||
146109594|NCT02128113|526922014|FG001|Overall Study|Protocol Violation|1|||
146109595|NCT02128113|526922015|FG002|Overall Study|Protocol Violation|0|||
146109596|NCT02128113|526922013|FG000|Overall Study|Surgery cancelled|0|||
146109597|NCT02128113|526922014|FG001|Overall Study|Surgery cancelled|1|||
146109598|NCT02128113|526922015|FG002|Overall Study|Surgery cancelled|0|||
146109599|NCT02128113|526922013|FG000|Overall Study|Adverse Event|0|||
146109600|NCT02128113|526922014|FG001|Overall Study|Adverse Event|0|||
146109601|NCT02128113|526922015|FG002|Overall Study|Adverse Event|1|||
146109602|NCT00299104|526922016|FG000|Treatment Period|Adverse Event|14|||
146109603|NCT00299104|526922017|FG001|Treatment Period|Adverse Event|9|||
146109604|NCT00299104|526922018|FG002|Treatment Period|Adverse Event|7|||
146109605|NCT00299104|526922016|FG000|Treatment Period|Death|1|||
146109606|NCT00299104|526922017|FG001|Treatment Period|Death|1|||
146109607|NCT00299104|526922018|FG002|Treatment Period|Death|1|||
146109608|NCT00299104|526922016|FG000|Treatment Period|Insufficient therapeutic response|34|||
146109609|NCT00299104|526922017|FG001|Treatment Period|Insufficient therapeutic response|13|||
146109610|NCT00299104|526922018|FG002|Treatment Period|Insufficient therapeutic response|8|||
146109611|NCT00299104|526922016|FG000|Treatment Period|Failure to return|9|||
146109612|NCT00299104|526922017|FG001|Treatment Period|Failure to return|8|||
146109613|NCT00299104|526922018|FG002|Treatment Period|Failure to return|8|||
146109614|NCT00299104|526922016|FG000|Treatment Period|Violation of selection criteria|1|||
146109615|NCT00299104|526922017|FG001|Treatment Period|Violation of selection criteria|2|||
146109616|NCT00299104|526922018|FG002|Treatment Period|Violation of selection criteria|0|||
146109617|NCT00299104|526922016|FG000|Treatment Period|Protocol Violation|1|||
146109618|NCT00299104|526922017|FG001|Treatment Period|Protocol Violation|1|||
146109619|NCT00299104|526922018|FG002|Treatment Period|Protocol Violation|0|||
146109620|NCT00299104|526922016|FG000|Treatment Period|Refused treatment|9|||
146109621|NCT00299104|526922017|FG001|Treatment Period|Refused treatment|2|||
146109622|NCT00299104|526922018|FG002|Treatment Period|Refused treatment|2|||
146109623|NCT00299104|526922016|FG000|Treatment Period|Withdrew consent|14|||
146109624|NCT00299104|526922017|FG001|Treatment Period|Withdrew consent|19|||
146109625|NCT00299104|526922018|FG002|Treatment Period|Withdrew consent|9|||
146109626|NCT00299104|526922016|FG000|Treatment Period|Administrative reasons|106|||
146109627|NCT00299104|526922017|FG001|Treatment Period|Administrative reasons|120|||
146109628|NCT00299104|526922018|FG002|Treatment Period|Administrative reasons|137|||
146109629|NCT00299104|526922016|FG000|Safety Follow-Up (SFU) Period|Death|3|||
146109630|NCT00299104|526922017|FG001|Safety Follow-Up (SFU) Period|Death|2|||
146109631|NCT00299104|526922018|FG002|Safety Follow-Up (SFU) Period|Death|1|||
146109632|NCT00299104|526922016|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
146109633|NCT00299104|526922017|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
146109634|NCT00299104|526922018|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
146109635|NCT00299104|526922016|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
146109636|NCT00299104|526922017|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
146109637|NCT00299104|526922018|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
146259030|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
146109638|NCT00299104|526922016|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
146109639|NCT00299104|526922017|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
146109640|NCT00299104|526922018|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
146109641|NCT00299104|526922016|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
146109642|NCT00299104|526922017|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
146109643|NCT00299104|526922018|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
146109644|NCT00299104|526922016|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146259031|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
146259032|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
146259033|NCT02637856|527463349|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
146259034|NCT02637856|527463350|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
146259035|NCT02637856|527463349|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
146259036|NCT02637856|527463350|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
146259037|NCT02637856|527463349|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
146259038|NCT02637856|527463350|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
146259039|NCT02509312|527463351|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
146259040|NCT02509312|527463352|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
146259041|NCT02509312|527463351|FG000|Overall Study|Obstetrician refusal|0|||
146259042|NCT02509312|527463352|FG001|Overall Study|Obstetrician refusal|1|||
146259043|NCT02509312|527463351|FG000|Overall Study|Patient elected for TOLAC|1|||
146259044|NCT02509312|527463352|FG001|Overall Study|Patient elected for TOLAC|0|||
146259045|NCT02509312|527463351|FG000|Overall Study|Cesarean deemed stat|1|||
146259046|NCT02509312|527463352|FG001|Overall Study|Cesarean deemed stat|0|||
146259047|NCT02509312|527463351|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
146259048|NCT02509312|527463352|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
146259049|NCT02815735|527463355|FG000|First Intervention (4 Weeks)|Discomfort|1|||
146259050|NCT02815735|527463356|FG001|First Intervention (4 Weeks)|Discomfort|0|||
146259051|NCT02815735|527463355|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
146259052|NCT02815735|527463356|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146259053|NCT02815735|527463355|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
146259054|NCT02815735|527463356|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
146259055|NCT02815735|527463355|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
146259056|NCT02815735|527463356|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
146259057|NCT00702650|527463358|FG000|Overall Study|Withdrawal by Subject|9|||
146259058|NCT00702650|527463358|FG000|Overall Study|Non-Compliance of Study Drug|3|||
146259059|NCT00702650|527463358|FG000|Overall Study|Lost to Follow-up|2|||
146259060|NCT00702650|527463358|FG000|Overall Study|Non-Compliance with Site Directives|1|||
146259061|NCT00702650|527463358|FG000|Overall Study|Sponsor Request|1|||
146259062|NCT00702650|527463358|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
146259063|NCT00702650|527463358|FG000|Overall Study|Adverse Event|3|||
146259064|NCT00988533|527463359|FG000|Overall Study|Lost to Follow-up|3|||
146259065|NCT00943722|527463361|FG000|Base Study|Adverse Event|0|||
146259066|NCT00943722|527463362|FG001|Base Study|Adverse Event|0|||
146259067|NCT00943722|527463363|FG002|Base Study|Adverse Event|0|||
146259068|NCT00943722|527463364|FG003|Base Study|Adverse Event|1|||
146259069|NCT00943722|527463365|FG004|Base Study|Adverse Event|0|||
146259070|NCT00943722|527463366|FG005|Base Study|Adverse Event|0|||
146259071|NCT00943722|527463367|FG006|Base Study|Adverse Event|0|||
146259072|NCT00943722|527463361|FG000|Base Study|Lost to Follow-up|12|||
146259073|NCT00943722|527463362|FG001|Base Study|Lost to Follow-up|8|||
146259074|NCT00943722|527463363|FG002|Base Study|Lost to Follow-up|10|||
146259075|NCT00943722|527463364|FG003|Base Study|Lost to Follow-up|8|||
146259076|NCT00943722|527463365|FG004|Base Study|Lost to Follow-up|11|||
146259077|NCT00943722|527463366|FG005|Base Study|Lost to Follow-up|0|||
146259078|NCT00943722|527463367|FG006|Base Study|Lost to Follow-up|0|||
146259079|NCT00943722|527463361|FG000|Base Study|Physician Decision|1|||
146259080|NCT00943722|527463362|FG001|Base Study|Physician Decision|0|||
146259081|NCT00943722|527463363|FG002|Base Study|Physician Decision|0|||
146259082|NCT00943722|527463364|FG003|Base Study|Physician Decision|0|||
146259083|NCT00943722|527463365|FG004|Base Study|Physician Decision|1|||
146109645|NCT00299104|526922017|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146109646|NCT00299104|526922018|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
146109647|NCT00299104|526922016|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
146109648|NCT00299104|526922017|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
146109649|NCT00299104|526922018|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
146109650|NCT00299104|526922016|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
146109651|NCT00299104|526922017|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
146109652|NCT00299104|526922018|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
146109653|NCT05147350|526922030|FG000|Overall Study|Death|2|||
146109654|NCT05147350|526922031|FG001|Overall Study|Death|3|||
146109655|NCT05147350|526922032|FG002|Overall Study|Death|3|||
146109656|NCT05147350|526922033|FG003|Overall Study|Death|2|||
146259084|NCT00943722|527463366|FG005|Base Study|Physician Decision|0|||
146259085|NCT00943722|527463367|FG006|Base Study|Physician Decision|0|||
146259086|NCT00943722|527463361|FG000|Base Study|Pregnancy|0|||
146259087|NCT00943722|527463362|FG001|Base Study|Pregnancy|0|||
146259088|NCT00943722|527463363|FG002|Base Study|Pregnancy|1|||
146259089|NCT00943722|527463364|FG003|Base Study|Pregnancy|0|||
146109657|NCT05147350|526922034|FG004|Overall Study|Death|2|||
146109658|NCT05147350|526922035|FG005|Overall Study|Death|1|||
146109659|NCT05147350|526922036|FG006|Overall Study|Death|1|||
146109660|NCT05147350|526922037|FG007|Overall Study|Death|3|||
146109661|NCT05147350|526922030|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
146109662|NCT05147350|526922031|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
146109663|NCT05147350|526922032|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
146109664|NCT05147350|526922033|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
146109665|NCT05147350|526922034|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
146109666|NCT05147350|526922035|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
146109667|NCT05147350|526922036|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
146109668|NCT05147350|526922037|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
146109669|NCT05147350|526922030|FG000|Overall Study|Withdrawal by Subject|0|||
146109670|NCT05147350|526922031|FG001|Overall Study|Withdrawal by Subject|0|||
146109671|NCT05147350|526922032|FG002|Overall Study|Withdrawal by Subject|3|||
146109672|NCT05147350|526922033|FG003|Overall Study|Withdrawal by Subject|1|||
146109673|NCT05147350|526922034|FG004|Overall Study|Withdrawal by Subject|1|||
146109674|NCT05147350|526922035|FG005|Overall Study|Withdrawal by Subject|0|||
146109675|NCT05147350|526922036|FG006|Overall Study|Withdrawal by Subject|1|||
146109676|NCT05147350|526922037|FG007|Overall Study|Withdrawal by Subject|0|||
146109677|NCT05147350|526922030|FG000|Overall Study|Other Reasons|0|||
146109678|NCT05147350|526922031|FG001|Overall Study|Other Reasons|0|||
146109679|NCT05147350|526922032|FG002|Overall Study|Other Reasons|2|||
146109680|NCT05147350|526922033|FG003|Overall Study|Other Reasons|0|||
146109681|NCT05147350|526922034|FG004|Overall Study|Other Reasons|0|||
146109682|NCT05147350|526922035|FG005|Overall Study|Other Reasons|2|||
146109683|NCT05147350|526922036|FG006|Overall Study|Other Reasons|1|||
146109684|NCT05147350|526922037|FG007|Overall Study|Other Reasons|1|||
146109685|NCT01539538|526922038|FG000|Overall Study|Adverse Event|13|||
146109686|NCT01539538|526922039|FG001|Overall Study|Adverse Event|18|||
146109687|NCT01539538|526922038|FG000|Overall Study|Lack of Efficacy|13|||
146109688|NCT01539538|526922039|FG001|Overall Study|Lack of Efficacy|16|||
146109689|NCT01539538|526922038|FG000|Overall Study|Withdrawal by Subject|2|||
146109690|NCT01539538|526922039|FG001|Overall Study|Withdrawal by Subject|3|||
146109691|NCT01539538|526922038|FG000|Overall Study|PCA no longer required or PCA problem|3|||
146109692|NCT01539538|526922039|FG001|Overall Study|PCA no longer required or PCA problem|7|||
146109693|NCT00847379|526922040|FG000|Overall Study|Study terminated by Sponsor|59|||
146109694|NCT00847379|526922041|FG001|Overall Study|Study terminated by Sponsor|57|||
146109695|NCT00847379|526922042|FG002|Overall Study|Study terminated by Sponsor|57|||
146109696|NCT00521014|526922043|FG000|Overall Study|Inevaluable, not treated|1|||
146109697|NCT04390191|526922044|FG000|Overall Study|Withdrawal by Subject|1|||
146109698|NCT04390191|526922045|FG001|Overall Study|Withdrawal by Subject|0|||
146109699|NCT03978832|526922046|FG000|Overall Study|Adverse Event|1|||
146109700|NCT03978832|526922046|FG000|Overall Study|Lost to Follow-up|1|||
146109701|NCT03978832|526922046|FG000|Overall Study|Withdrawal by Subject|6|||
146109702|NCT03978832|526922046|FG000|Overall Study|Physician Decision|2|||
146109703|NCT03978832|526922046|FG000|Overall Study|did not pass screening criteria|44|||
146109704|NCT00003499|526922047|FG000|Overall Study|Not evaluable|8|||
146109705|NCT02864498|526922052|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
146109706|NCT02864498|526922053|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
146109707|NCT02864498|526922054|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
146109708|NCT02864498|526922052|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
146109709|NCT02864498|526922053|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
146109710|NCT02864498|526922054|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
146109711|NCT02864498|526922052|FG000|Overall Study|Investigator Discretion|0|||
146109712|NCT02864498|526922053|FG001|Overall Study|Investigator Discretion|2|||
146109713|NCT02864498|526922054|FG002|Overall Study|Investigator Discretion|1|||
146109714|NCT02864498|526922052|FG000|Overall Study|Lost to Follow-up|8|||
146109715|NCT02864498|526922053|FG001|Overall Study|Lost to Follow-up|6|||
146109716|NCT02864498|526922054|FG002|Overall Study|Lost to Follow-up|3|||
146109717|NCT02864498|526922052|FG000|Overall Study|Lack of Efficacy|5|||
146109718|NCT02864498|526922053|FG001|Overall Study|Lack of Efficacy|3|||
146109719|NCT02864498|526922054|FG002|Overall Study|Lack of Efficacy|3|||
146109720|NCT02864498|526922052|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
146109721|NCT02864498|526922053|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
146109722|NCT02864498|526922054|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
146109723|NCT02864498|526922052|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
146109724|NCT02864498|526922053|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
146109725|NCT02864498|526922054|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
146109726|NCT02864498|526922052|FG000|Overall Study|Subject moved out of the country.|0|||
146109727|NCT02864498|526922053|FG001|Overall Study|Subject moved out of the country.|0|||
146109728|NCT02864498|526922054|FG002|Overall Study|Subject moved out of the country.|1|||
146109729|NCT01256008|526922055|FG000|Overall Study|Lost to Follow-up|6|||
146109730|NCT01256008|526922056|FG001|Overall Study|Lost to Follow-up|4|||
146109731|NCT01256008|526922057|FG002|Overall Study|Lost to Follow-up|11|||
146109732|NCT01256008|526922055|FG000|Overall Study|Withdrawal by Subject|2|||
146052605|NCT00607087|526707394|FG000|Period 3|Withdrawal by Subject|2|||
146052606|NCT00607087|526707395|FG001|Period 3|Withdrawal by Subject|1|||
146052607|NCT00607087|526707396|FG002|Period 3|Withdrawal by Subject|0|||
146052608|NCT00607087|526707394|FG000|Period 3|Adverse Event|0|||
146052609|NCT00607087|526707395|FG001|Period 3|Adverse Event|1|||
146052610|NCT00607087|526707396|FG002|Period 3|Adverse Event|0|||
146052611|NCT02717494|526707398|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
146052612|NCT02717494|526707399|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
146052613|NCT02717494|526707400|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
146052614|NCT02717494|526707398|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
146052615|NCT02717494|526707399|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
146052616|NCT02717494|526707400|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
146052617|NCT02717494|526707398|FG000|First Intervention (Step 1)|Death|0|||
146052618|NCT02717494|526707399|FG001|First Intervention (Step 1)|Death|0|||
146052619|NCT02717494|526707400|FG002|First Intervention (Step 1)|Death|1|||
146052620|NCT02717494|526707398|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
146052621|NCT02717494|526707399|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
146052622|NCT02717494|526707400|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
146052623|NCT03370718|526707408|FG000|Overall Study|Withdrawal by Subject|1|||
146052624|NCT05477485|526707415|FG000|Overall Study|Lost to Follow-up|0|||
146052625|NCT05477485|526707416|FG001|Overall Study|Lost to Follow-up|4|||
146052626|NCT06172348|526707417|FG000|Treatment Period 2|Adverse Event|0|||
146052627|NCT06172348|526707418|FG001|Treatment Period 2|Adverse Event|0|||
146052628|NCT06172348|526707419|FG002|Treatment Period 2|Adverse Event|1|||
146052629|NCT06172348|526707420|FG003|Treatment Period 2|Adverse Event|0|||
146052630|NCT06172348|526707421|FG004|Treatment Period 2|Adverse Event|0|||
146052631|NCT06172348|526707422|FG005|Treatment Period 2|Adverse Event|0|||
146052632|NCT03116685|526707423|FG000|Overall Study|Physician Decision|0|||
146052633|NCT03116685|526707424|FG001|Overall Study|Physician Decision|1|||
146052634|NCT00801216|526707425|FG000|Overall Study|Screening Failure|2|||
146052635|NCT05274958|526707426|FG000|Overall Study|Only completed 1 set of PROMs|22|||
146052636|NCT05274958|526707427|FG001|Overall Study|Only completed 1 set of PROMs|35|||
146052637|NCT05214768|526707428|FG000|Induction Period|Withdrawal by Subject|1|||
146052638|NCT05214768|526707429|FG001|Induction Period|Withdrawal by Subject|0|||
146052639|NCT05214768|526707430|FG002|Induction Period|Withdrawal by Subject|0|||
146052640|NCT05214768|526707431|FG003|Induction Period|Withdrawal by Subject|0|||
146052641|NCT05214768|526707432|FG004|Induction Period|Withdrawal by Subject|0|||
146052642|NCT05214768|526707433|FG005|Induction Period|Withdrawal by Subject|0|||
146052643|NCT05214768|526707428|FG000|Induction Period|Physician Decision|1|||
146052644|NCT05214768|526707429|FG001|Induction Period|Physician Decision|0|||
146052645|NCT05214768|526707430|FG002|Induction Period|Physician Decision|0|||
146052646|NCT05214768|526707431|FG003|Induction Period|Physician Decision|0|||
146052647|NCT05214768|526707432|FG004|Induction Period|Physician Decision|0|||
146052648|NCT05214768|526707433|FG005|Induction Period|Physician Decision|0|||
146052649|NCT05214768|526707428|FG000|Maintenance Period|Other Reasons|0|||
146052650|NCT05214768|526707429|FG001|Maintenance Period|Other Reasons|0|||
146052651|NCT05214768|526707430|FG002|Maintenance Period|Other Reasons|1|||
146052652|NCT05214768|526707431|FG003|Maintenance Period|Other Reasons|1|||
146052653|NCT05214768|526707432|FG004|Maintenance Period|Other Reasons|0|||
146052654|NCT05214768|526707433|FG005|Maintenance Period|Other Reasons|0|||
146052655|NCT05214768|526707428|FG000|Maintenance Period|Withdrawal by Subject|0|||
146052656|NCT05214768|526707429|FG001|Maintenance Period|Withdrawal by Subject|0|||
146052657|NCT05214768|526707430|FG002|Maintenance Period|Withdrawal by Subject|0|||
146052658|NCT05214768|526707431|FG003|Maintenance Period|Withdrawal by Subject|1|||
146052659|NCT05214768|526707432|FG004|Maintenance Period|Withdrawal by Subject|0|||
146052660|NCT05214768|526707433|FG005|Maintenance Period|Withdrawal by Subject|0|||
146052661|NCT05214768|526707428|FG000|Maintenance Period|Lack of Efficacy|0|||
146052662|NCT05214768|526707429|FG001|Maintenance Period|Lack of Efficacy|0|||
146052663|NCT05214768|526707430|FG002|Maintenance Period|Lack of Efficacy|1|||
146052664|NCT05214768|526707431|FG003|Maintenance Period|Lack of Efficacy|0|||
146052665|NCT05214768|526707432|FG004|Maintenance Period|Lack of Efficacy|1|||
146052666|NCT05214768|526707433|FG005|Maintenance Period|Lack of Efficacy|0|||
146052667|NCT05214768|526707428|FG000|Open Label Extension Period|Physician Decision|0|||
146052668|NCT05214768|526707429|FG001|Open Label Extension Period|Physician Decision|0|||
146052669|NCT05214768|526707430|FG002|Open Label Extension Period|Physician Decision|0|||
146052670|NCT05214768|526707431|FG003|Open Label Extension Period|Physician Decision|0|||
146052671|NCT05214768|526707432|FG004|Open Label Extension Period|Physician Decision|0|||
146052672|NCT05214768|526707433|FG005|Open Label Extension Period|Physician Decision|1|||
146052673|NCT05214768|526707428|FG000|Open Label Extension Period|Lack of Efficacy|0|||
146052674|NCT05214768|526707429|FG001|Open Label Extension Period|Lack of Efficacy|0|||
146052675|NCT05214768|526707430|FG002|Open Label Extension Period|Lack of Efficacy|0|||
146052676|NCT05214768|526707431|FG003|Open Label Extension Period|Lack of Efficacy|0|||
146052677|NCT05214768|526707432|FG004|Open Label Extension Period|Lack of Efficacy|0|||
146109733|NCT01256008|526922056|FG001|Overall Study|Withdrawal by Subject|3|||
146109734|NCT01256008|526922057|FG002|Overall Study|Withdrawal by Subject|10|||
146109735|NCT02244606|526922058|FG000|Overall Study|Adverse Event|0|||
146109736|NCT02244606|526922059|FG001|Overall Study|Adverse Event|1|||
146109737|NCT02244606|526922060|FG002|Overall Study|Adverse Event|1|||
146109738|NCT02244606|526922061|FG003|Overall Study|Adverse Event|0|||
146109739|NCT02244606|526922058|FG000|Overall Study|Lost to Follow-up|2|||
146109740|NCT02244606|526922059|FG001|Overall Study|Lost to Follow-up|2|||
146109741|NCT02244606|526922060|FG002|Overall Study|Lost to Follow-up|1|||
146109742|NCT02244606|526922061|FG003|Overall Study|Lost to Follow-up|0|||
146109743|NCT02244606|526922058|FG000|Overall Study|Protocol Violation|0|||
146109744|NCT02244606|526922059|FG001|Overall Study|Protocol Violation|0|||
146109745|NCT02244606|526922060|FG002|Overall Study|Protocol Violation|0|||
146109746|NCT02244606|526922061|FG003|Overall Study|Protocol Violation|1|||
146109747|NCT02244606|526922058|FG000|Overall Study|Withdrawal by Subject|1|||
146109748|NCT02244606|526922059|FG001|Overall Study|Withdrawal by Subject|1|||
146109749|NCT02244606|526922060|FG002|Overall Study|Withdrawal by Subject|0|||
146109750|NCT02244606|526922061|FG003|Overall Study|Withdrawal by Subject|0|||
146109751|NCT02244606|526922058|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
146109752|NCT02244606|526922059|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
146109753|NCT02244606|526922060|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
146109754|NCT02244606|526922061|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
146109755|NCT00378378|526922066|FG000|Overall Study|Withdrawal by Subject|0|||
146109756|NCT00378378|526922067|FG001|Overall Study|Withdrawal by Subject|1|||
146109757|NCT00378378|526922068|FG002|Overall Study|Withdrawal by Subject|0|||
146109758|NCT00378378|526922066|FG000|Overall Study|Treatment Failure|0|||
146109759|NCT00378378|526922067|FG001|Overall Study|Treatment Failure|0|||
146109760|NCT00378378|526922068|FG002|Overall Study|Treatment Failure|1|||
146109761|NCT00378378|526922066|FG000|Overall Study|Non-compliance with protocol|0|||
146109762|NCT00378378|526922067|FG001|Overall Study|Non-compliance with protocol|0|||
146109763|NCT00378378|526922068|FG002|Overall Study|Non-compliance with protocol|1|||
146109764|NCT01402492|526922069|FG000|Overall Study|Withdrawal by Subject|17|||
146109765|NCT01402492|526922070|FG001|Overall Study|Withdrawal by Subject|11|||
146109766|NCT01402492|526922071|FG002|Overall Study|Withdrawal by Subject|11|||
146109767|NCT01402492|526922069|FG000|Overall Study|Adverse Event|2|||
146109768|NCT01402492|526922070|FG001|Overall Study|Adverse Event|3|||
146109769|NCT01402492|526922071|FG002|Overall Study|Adverse Event|4|||
146109770|NCT01402492|526922069|FG000|Overall Study|Physician Decision|0|||
146109771|NCT01402492|526922070|FG001|Overall Study|Physician Decision|3|||
146109772|NCT01402492|526922071|FG002|Overall Study|Physician Decision|0|||
146109773|NCT01402492|526922069|FG000|Overall Study|Incarcerated (N=3)|2|||
146109774|NCT01402492|526922070|FG001|Overall Study|Incarcerated (N=3)|0|||
146109775|NCT01402492|526922071|FG002|Overall Study|Incarcerated (N=3)|1|||
146109776|NCT01336764|526922073|FG000|Overall Study|Withdrawal by Subject|5|||
146109777|NCT01336764|526922074|FG001|Overall Study|Withdrawal by Subject|5|||
146109778|NCT05537883|526922075|FG000|Overall Study|revisional surgery|4|||
146109779|NCT05537883|526922076|FG001|Overall Study|revisional surgery|2|||
146109780|NCT05537883|526922075|FG000|Overall Study|surgeries were cancelled|0|||
146109781|NCT05537883|526922076|FG001|Overall Study|surgeries were cancelled|2|||
146109782|NCT05537883|526922075|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
146109783|NCT05537883|526922076|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
146109784|NCT02099708|526922077|FG000|Overall Study|Data Not Available|30|||
146109785|NCT02099708|526922077|FG000|Overall Study|Lost to Follow-up|141|||
146109786|NCT02099708|526922077|FG000|Overall Study|Other|29|||
146109787|NCT01049308|526922078|FG000|Pill Counts|Withdrawal by Subject|83|||
146109788|NCT03845985|526922079|FG000|Overall Study|Lost to Follow-up|2|||
146109789|NCT03845985|526922080|FG001|Overall Study|Lost to Follow-up|1|||
146109790|NCT03845985|526922079|FG000|Overall Study|Physician Decision|1|||
146109791|NCT03845985|526922080|FG001|Overall Study|Physician Decision|0|||
146109792|NCT03845985|526922079|FG000|Overall Study|Withdrawal by Subject|4|||
146109793|NCT03845985|526922080|FG001|Overall Study|Withdrawal by Subject|1|||
146109794|NCT01318993|526922081|FG000|Overall Study|Adverse Event|53|||
146109795|NCT01318993|526922081|FG000|Overall Study|Lack of Efficacy|121|||
146109796|NCT01318993|526922081|FG000|Overall Study|Protocol Violation|3|||
146109797|NCT01318993|526922081|FG000|Overall Study|Protocol based stopping criteria|6|||
146109798|NCT01318993|526922081|FG000|Overall Study|Study closed or terminated|174|||
146109799|NCT01318993|526922081|FG000|Overall Study|Lost to Follow-up|4|||
146109800|NCT01318993|526922081|FG000|Overall Study|Physician Decision|13|||
146109801|NCT01318993|526922081|FG000|Overall Study|Withdrawal by Subject|24|||
146109802|NCT04974697|526922082|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
146109803|NCT04974697|526922082|FG000|Overall Study|Lens discomfort|1|||
146109804|NCT03706456|526922083|FG000|Overall Study|Adverse Event|1|||
146109805|NCT03706456|526922083|FG000|Overall Study|Lack of Efficacy|2|||
146109806|NCT03302234|526922084|FG000|Overall Study|Death|191|||
146109807|NCT03302234|526922085|FG001|Overall Study|Death|192|||
146109808|NCT03302234|526922084|FG000|Overall Study|Withdrawal by Subject|2|||
146109809|NCT03302234|526922085|FG001|Overall Study|Withdrawal by Subject|2|||
146109810|NCT03302234|526922084|FG000|Overall Study|Sponsor Decision|90|||
146109811|NCT03302234|526922085|FG001|Overall Study|Sponsor Decision|89|||
146109812|NCT03302234|526922084|FG000|Overall Study|Laryngeal carcinoma|0|||
146109813|NCT03302234|526922085|FG001|Overall Study|Laryngeal carcinoma|1|||
146109814|NCT03302234|526922084|FG000|Overall Study|Not Reported|1|||
146109815|NCT03302234|526922085|FG001|Overall Study|Not Reported|0|||
146109816|NCT02795832|526922088|FG000|Overall Study|Adverse Event|0|||
146109817|NCT02795832|526922089|FG001|Overall Study|Adverse Event|0|||
146109818|NCT02795832|526922090|FG002|Overall Study|Adverse Event|0|||
146109819|NCT02795832|526922091|FG003|Overall Study|Adverse Event|0|||
146109820|NCT02795832|526922092|FG004|Overall Study|Adverse Event|0|||
146109821|NCT02795832|526922093|FG005|Overall Study|Adverse Event|3|||
146109822|NCT01845831|526922094|FG000|Inpatient Phase|Withdrawal by Subject|1|||
146109823|NCT01845831|526922095|FG001|Inpatient Phase|Withdrawal by Subject|1|||
146109824|NCT01845831|526922096|FG002|Inpatient Phase|Withdrawal by Subject|0|||
146109825|NCT01845831|526922097|FG003|Inpatient Phase|Withdrawal by Subject|0|||
146109826|NCT01845831|526922098|FG004|Inpatient Phase|Withdrawal by Subject|0|||
146109827|NCT00221403|526922099|FG000|Overall Study|Protocol Violation|1|||
146109828|NCT00221403|526922100|FG001|Overall Study|Protocol Violation|0|||
146109829|NCT00221403|526922101|FG002|Overall Study|Protocol Violation|0|||
146109830|NCT00221403|526922099|FG000|Overall Study|Physician Decision|1|||
146109831|NCT00221403|526922100|FG001|Overall Study|Physician Decision|0|||
146109832|NCT00221403|526922101|FG002|Overall Study|Physician Decision|0|||
146109833|NCT00221403|526922099|FG000|Overall Study|Withdrawal by Subject|0|||
146109834|NCT00221403|526922100|FG001|Overall Study|Withdrawal by Subject|3|||
146109835|NCT00221403|526922101|FG002|Overall Study|Withdrawal by Subject|0|||
146109836|NCT00221403|526922099|FG000|Overall Study|Lack of Efficacy|0|||
146109837|NCT00221403|526922100|FG001|Overall Study|Lack of Efficacy|1|||
146109838|NCT00221403|526922101|FG002|Overall Study|Lack of Efficacy|0|||
146109839|NCT00221403|526922099|FG000|Overall Study|Adverse Event|0|||
146109840|NCT00221403|526922100|FG001|Overall Study|Adverse Event|1|||
146109841|NCT00221403|526922101|FG002|Overall Study|Adverse Event|0|||
146109842|NCT02695329|526922102|FG000|Overall Study|Adverse Event|1|||
146109843|NCT02695329|526922103|FG001|Overall Study|Adverse Event|0|||
146109844|NCT02695329|526922102|FG000|Overall Study|Poor X-ray quality for measurement|4|||
146109845|NCT02695329|526922103|FG001|Overall Study|Poor X-ray quality for measurement|5|||
146109846|NCT01348165|526922104|FG000|Overall Study|Adverse Event|0|||
146109847|NCT01348165|526922105|FG001|Overall Study|Adverse Event|0|||
146109848|NCT01348165|526922106|FG002|Overall Study|Adverse Event|0|||
146109849|NCT01348165|526922107|FG003|Overall Study|Adverse Event|0|||
146109850|NCT01348165|526922108|FG004|Overall Study|Adverse Event|0|||
146109851|NCT01348165|526922109|FG005|Overall Study|Adverse Event|0|||
146109852|NCT01348165|526922110|FG006|Overall Study|Adverse Event|1|||
146109853|NCT01929343|526922111|FG000|Overall Study|Physician Decision|0|||
146109854|NCT01929343|526922112|FG001|Overall Study|Physician Decision|2|||
146109855|NCT01929343|526922113|FG002|Overall Study|Physician Decision|0|||
146109856|NCT01929343|526922111|FG000|Overall Study|Withdrawal by Subject|1|||
146109857|NCT01929343|526922112|FG001|Overall Study|Withdrawal by Subject|0|||
146109858|NCT01929343|526922113|FG002|Overall Study|Withdrawal by Subject|0|||
146109859|NCT01892293|526923814|FG000|Overall Study|Apheresed but not treated|4|||
146109860|NCT03602482|526923815|FG000|Overall Study|Withdrawal by Subject|6|||
146109861|NCT03602482|526923816|FG001|Overall Study|Withdrawal by Subject|7|||
146109862|NCT03602482|526923817|FG002|Overall Study|Withdrawal by Subject|0|||
146109863|NCT03602482|526923818|FG003|Overall Study|Withdrawal by Subject|0|||
146109864|NCT02601469|526923821|FG000|Overall Study|Enrolled in Error|1|||
146109865|NCT02601469|526923822|FG001|Overall Study|Enrolled in Error|0|||
146109866|NCT01411774|526923827|FG000|Overall Study|Withdrawal by Subject|0|||
146109867|NCT01411774|526923828|FG001|Overall Study|Withdrawal by Subject|3|||
146109868|NCT00056316|526923829|FG000|Overall Study|Withdrawal by Subject|2|||
146109869|NCT00056316|526923830|FG001|Overall Study|Withdrawal by Subject|2|||
146109870|NCT00056316|526923829|FG000|Overall Study|Death/NH placement of pt|1|||
146109871|NCT00056316|526923830|FG001|Overall Study|Death/NH placement of pt|1|||
146109872|NCT02820753|526923831|FG000|2 Month|Withdrawal by Subject|3|||
146109873|NCT02820753|526923832|FG001|2 Month|Withdrawal by Subject|3|||
146109874|NCT02820753|526923831|FG000|2 Month|Lost to Follow-up|24|||
146109875|NCT02820753|526923832|FG001|2 Month|Lost to Follow-up|26|||
146109876|NCT02820753|526923831|FG000|2 Month|Stopped per NIH Hold|51|||
146109877|NCT02820753|526923832|FG001|2 Month|Stopped per NIH Hold|13|||
146109878|NCT02820753|526923831|FG000|6 Month|Withdrawal by Subject|2|||
146109879|NCT02820753|526923832|FG001|6 Month|Withdrawal by Subject|2|||
146109880|NCT02820753|526923831|FG000|6 Month|Lost to Follow-up|20|||
146109881|NCT02820753|526923832|FG001|6 Month|Lost to Follow-up|27|||
146109882|NCT02820753|526923831|FG000|6 Month|Stopped per NIH Hold|81|||
146109883|NCT02820753|526923832|FG001|6 Month|Stopped per NIH Hold|81|||
146109884|NCT02820753|526923831|FG000|6 Month|Death|0|||
146109885|NCT02820753|526923832|FG001|6 Month|Death|1|||
146109886|NCT05048784|526923840|FG000|Period 1|Adverse Event|3|||
146109887|NCT05048784|526923841|FG001|Period 1|Adverse Event|1|||
146109888|NCT05048784|526923842|FG002|Period 1|Adverse Event|0|||
146109889|NCT05048784|526923843|FG003|Period 1|Adverse Event|0|||
146109890|NCT05048784|526923840|FG000|Period 2|Lost to Follow-up|0|||
146109891|NCT05048784|526923841|FG001|Period 2|Lost to Follow-up|1|||
146109892|NCT05048784|526923842|FG002|Period 2|Lost to Follow-up|0|||
146109893|NCT05048784|526923843|FG003|Period 2|Lost to Follow-up|0|||
146109894|NCT02269241|526923846|FG000|Overall Study|Lost to Follow-up|269|||
146109895|NCT02269241|526923846|FG000|Overall Study|Withdrawal by Subject|155|||
146109896|NCT02269241|526923846|FG000|Overall Study|Protocol Violation|1|||
146109897|NCT02269241|526923846|FG000|Overall Study|Physician Decision|7|||
146259090|NCT00943722|527463365|FG004|Base Study|Pregnancy|2|||
146109898|NCT02269241|526923846|FG000|Overall Study|Pregnancy|15|||
146109899|NCT02269241|526923846|FG000|Overall Study|Wish for pregnancy|5|||
146109900|NCT02269241|526923846|FG000|Overall Study|Development of an exclusion criteria|16|||
146109901|NCT02269241|526923846|FG000|Overall Study|Adverse Event|113|||
146109902|NCT02269241|526923846|FG000|Overall Study|At the specific request of the sponsor|20|||
146109903|NCT02269241|526923846|FG000|Overall Study|Several reasons not classified|53|||
146109904|NCT02269241|526923846|FG000|Overall Study|Screening failures|546|||
146109905|NCT03020160|526923847|FG000|Overall Study|Withdrawal by Subject|1|||
146109906|NCT03020160|526923848|FG001|Overall Study|Withdrawal by Subject|0|||
146109907|NCT02270957|526923849|FG000|Overall Study|Lack of Efficacy|2|||
146109908|NCT02270957|526923850|FG001|Overall Study|Lack of Efficacy|4|||
146109909|NCT02270957|526923849|FG000|Overall Study|Adverse Event|2|||
146109910|NCT02270957|526923850|FG001|Overall Study|Adverse Event|0|||
146109911|NCT01513473|526923851|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
146109912|NCT01513473|526923852|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
146109913|NCT01513473|526923851|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
146109914|NCT01513473|526923852|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
146109915|NCT01513473|526923851|FG000|Main Trial (26 Weeks)|Unclassified|0|||
146109916|NCT01513473|526923852|FG001|Main Trial (26 Weeks)|Unclassified|2|||
146109917|NCT01513473|526923851|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
146109918|NCT01513473|526923852|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
146109919|NCT01513473|526923851|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
146109920|NCT01513473|526923852|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
146109921|NCT01218204|526923854|FG000|Part B Washout|Adverse Event|0|||
146109922|NCT01218204|526923855|FG001|Part B Washout|Adverse Event|1|||
146109923|NCT01218204|526923856|FG002|Part B Washout|Adverse Event|0|||
146109924|NCT01218204|526923857|FG003|Part B Washout|Adverse Event|0|||
146109925|NCT01218204|526923854|FG000|Part B Washout|Lost to Follow-up|0|||
146109926|NCT01218204|526923855|FG001|Part B Washout|Lost to Follow-up|2|||
146109927|NCT01218204|526923856|FG002|Part B Washout|Lost to Follow-up|0|||
146109928|NCT01218204|526923857|FG003|Part B Washout|Lost to Follow-up|0|||
146109929|NCT01218204|526923854|FG000|Part B Washout|Physician Decision|0|||
146109930|NCT01218204|526923855|FG001|Part B Washout|Physician Decision|14|||
146109931|NCT01218204|526923856|FG002|Part B Washout|Physician Decision|0|||
146109932|NCT01218204|526923857|FG003|Part B Washout|Physician Decision|0|||
146109933|NCT01218204|526923854|FG000|Part B Washout|Withdrawal by Subject|0|||
146109934|NCT01218204|526923855|FG001|Part B Washout|Withdrawal by Subject|14|||
146109935|NCT01218204|526923856|FG002|Part B Washout|Withdrawal by Subject|0|||
146109936|NCT01218204|526923857|FG003|Part B Washout|Withdrawal by Subject|0|||
146109937|NCT01218204|526923854|FG000|Part B Washout|Reached defined stopping criteria|0|||
146109938|NCT01218204|526923855|FG001|Part B Washout|Reached defined stopping criteria|2|||
146109939|NCT01218204|526923856|FG002|Part B Washout|Reached defined stopping criteria|0|||
146109940|NCT01218204|526923857|FG003|Part B Washout|Reached defined stopping criteria|0|||
146109941|NCT01218204|526923854|FG000|Part B Washout|Did not meet continuation criteria|0|||
146109942|NCT01218204|526923855|FG001|Part B Washout|Did not meet continuation criteria|112|||
146109943|NCT01218204|526923856|FG002|Part B Washout|Did not meet continuation criteria|0|||
146109944|NCT01218204|526923857|FG003|Part B Washout|Did not meet continuation criteria|0|||
146109945|NCT01218204|526923854|FG000|Part B Run-in|Adverse Event|0|||
146259091|NCT00943722|527463366|FG005|Base Study|Pregnancy|0|||
146259092|NCT00943722|527463367|FG006|Base Study|Pregnancy|0|||
146259093|NCT00943722|527463361|FG000|Base Study|Protocol Violation|0|||
146259094|NCT00943722|527463362|FG001|Base Study|Protocol Violation|1|||
146259095|NCT00943722|527463363|FG002|Base Study|Protocol Violation|0|||
146259096|NCT00943722|527463364|FG003|Base Study|Protocol Violation|0|||
146259097|NCT00943722|527463365|FG004|Base Study|Protocol Violation|2|||
146259098|NCT00943722|527463366|FG005|Base Study|Protocol Violation|0|||
146259099|NCT00943722|527463367|FG006|Base Study|Protocol Violation|0|||
146259100|NCT00943722|527463361|FG000|Base Study|Withdrawal by Subject|12|||
146259101|NCT00943722|527463362|FG001|Base Study|Withdrawal by Subject|13|||
146259102|NCT00943722|527463363|FG002|Base Study|Withdrawal by Subject|2|||
146109946|NCT01218204|526923855|FG001|Part B Run-in|Adverse Event|0|||
146109947|NCT01218204|526923856|FG002|Part B Run-in|Adverse Event|1|||
146109948|NCT01218204|526923857|FG003|Part B Run-in|Adverse Event|0|||
146109949|NCT01218204|526923854|FG000|Part B Run-in|Protocol Violation|0|||
146109950|NCT01218204|526923855|FG001|Part B Run-in|Protocol Violation|0|||
146259103|NCT00943722|527463364|FG003|Base Study|Withdrawal by Subject|13|||
146259104|NCT00943722|527463365|FG004|Base Study|Withdrawal by Subject|8|||
146109951|NCT01218204|526923856|FG002|Part B Run-in|Protocol Violation|2|||
146109952|NCT01218204|526923857|FG003|Part B Run-in|Protocol Violation|0|||
146109953|NCT01218204|526923854|FG000|Part B Run-in|Withdrawal by Subject|0|||
146109954|NCT01218204|526923855|FG001|Part B Run-in|Withdrawal by Subject|0|||
146109955|NCT01218204|526923856|FG002|Part B Run-in|Withdrawal by Subject|3|||
146109956|NCT01218204|526923857|FG003|Part B Run-in|Withdrawal by Subject|0|||
146109957|NCT01218204|526923854|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
146109958|NCT01218204|526923855|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
146109959|NCT01218204|526923856|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
146109960|NCT01218204|526923857|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
146109961|NCT01218204|526923854|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
146109962|NCT01218204|526923855|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
146109963|NCT01218204|526923856|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
146109964|NCT01218204|526923857|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
146109965|NCT00743340|526923858|FG000|Overall Study|Study medication non-compliance|1|||
146109966|NCT00743340|526923858|FG000|Overall Study|Lost to Follow-up|1|||
146109967|NCT00743340|526923858|FG000|Overall Study|Withdrawal from the Study|5|||
146109968|NCT00743340|526923858|FG000|Overall Study|Protocol Violation|1|||
146109969|NCT00743340|526923858|FG000|Overall Study|Virologic failure|8|||
146109970|NCT00743340|526923858|FG000|Overall Study|Pregnancy|1|||
146109971|NCT00743340|526923858|FG000|Overall Study|Rolled over to other Gilead Study|23|||
146109972|NCT00743340|526923858|FG000|Overall Study|Participant Relocated|1|||
146109973|NCT02321800|526923859|FG000|Overall Study|Withdrawal by Subject|3|||
146109974|NCT02321800|526923860|FG001|Overall Study|Withdrawal by Subject|3|||
146109975|NCT02321800|526923859|FG000|Overall Study|Death|1|||
146109976|NCT02321800|526923860|FG001|Overall Study|Death|0|||
146109977|NCT02321800|526923859|FG000|Overall Study|Protocol Violation|1|||
146109978|NCT02321800|526923860|FG001|Overall Study|Protocol Violation|0|||
146109979|NCT02321800|526923859|FG000|Overall Study|Lost to Follow-up|10|||
146109980|NCT02321800|526923860|FG001|Overall Study|Lost to Follow-up|4|||
146109981|NCT02321800|526923859|FG000|Overall Study|Adverse Event|2|||
146109982|NCT02321800|526923860|FG001|Overall Study|Adverse Event|3|||
146109983|NCT02321800|526923859|FG000|Overall Study|Other, Miscellaneous|3|||
146109984|NCT02321800|526923860|FG001|Overall Study|Other, Miscellaneous|1|||
146109985|NCT00982878|526923861|FG000|Overall Study|Physician Decision|1|||
146109986|NCT01051323|526923866|FG000|Overall Study|Discontinuation of treatment|103|||
146109987|NCT01051323|526923866|FG000|Overall Study|Transplantation|28|||
146109988|NCT01051323|526923866|FG000|Overall Study|Dialysis dependency|22|||
146109989|NCT01051323|526923866|FG000|Overall Study|Withdrawal by Subject|13|||
146109990|NCT01051323|526923866|FG000|Overall Study|Lost to Follow-up|31|||
146109991|NCT01051323|526923866|FG000|Overall Study|Death|129|||
146109992|NCT01051323|526923866|FG000|Overall Study|Hospitalization|28|||
146109993|NCT01051323|526923866|FG000|Overall Study|Other|148|||
146109994|NCT01051323|526923866|FG000|Overall Study|Missing|37|||
146109995|NCT01626391|526923867|FG000|Overall Study|Physician Decision|1|||
146109996|NCT01626391|526923868|FG001|Overall Study|Physician Decision|0|||
146109997|NCT01626391|526923867|FG000|Overall Study|Withdrawal by Subject|1|||
146109998|NCT01626391|526923868|FG001|Overall Study|Withdrawal by Subject|0|||
146109999|NCT02573311|526923869|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
146110000|NCT02573311|526923870|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
146110001|NCT02573311|526923869|FG000|Disposition for Part 2|Physician Decision|25|||
146110002|NCT02573311|526923870|FG001|Disposition for Part 2|Physician Decision|7|||
146110003|NCT02573311|526923869|FG000|Disposition for Part 2|Adverse Event|36|||
146110004|NCT02573311|526923870|FG001|Disposition for Part 2|Adverse Event|5|||
146110005|NCT02573311|526923869|FG000|Disposition for Part 2|Lost to Follow-up|76|||
146110006|NCT02573311|526923870|FG001|Disposition for Part 2|Lost to Follow-up|7|||
146110007|NCT02573311|526923869|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
146110008|NCT02573311|526923870|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
146110009|NCT02573311|526923869|FG000|Disposition for Part 2|Investigator decision|0|||
146110010|NCT02573311|526923870|FG001|Disposition for Part 2|Investigator decision|1|||
146110011|NCT02573311|526923869|FG000|Disposition for Part 2|Other than specified above|13|||
146110012|NCT02573311|526923870|FG001|Disposition for Part 2|Other than specified above|3|||
146110013|NCT05229406|526923872|FG000|Overall Study|Withdrawal by Subject|1|||
146110014|NCT05229406|526923873|FG001|Overall Study|Withdrawal by Subject|2|||
146110015|NCT01697566|526923874|FG000|Overall Study|Withdrawal by Subject|0|||
146110016|NCT01697566|526923875|FG001|Overall Study|Withdrawal by Subject|0|||
146110017|NCT01697566|526923876|FG002|Overall Study|Withdrawal by Subject|1|||
146110018|NCT01697566|526923877|FG003|Overall Study|Withdrawal by Subject|1|||
146110019|NCT01697566|526923874|FG000|Overall Study|Final biopsy not obtained|0|||
146110020|NCT01697566|526923875|FG001|Overall Study|Final biopsy not obtained|0|||
146110021|NCT01697566|526923876|FG002|Overall Study|Final biopsy not obtained|1|||
146110022|NCT01697566|526923877|FG003|Overall Study|Final biopsy not obtained|0|||
146110023|NCT00036270|526923880|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
146110024|NCT00036270|526923881|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
146110025|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
146110026|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
146110027|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
146259105|NCT00943722|527463366|FG005|Base Study|Withdrawal by Subject|0|||
146110028|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
146110029|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
146301346|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146110030|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
146110031|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Other|277|||
146110032|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Other|288|||
146110033|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
146110034|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
146110035|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
146110036|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
146110037|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
146110038|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
146110039|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
146110040|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
146110041|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
146110042|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
146110043|NCT00036270|526923880|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
146110044|NCT00036270|526923881|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
146110045|NCT02516163|526923882|FG000|Overall Study|Withdrawal by Subject|1|||
146110046|NCT02516163|526923882|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
146110047|NCT02516163|526923882|FG000|Overall Study|Unfit/delay in surgery|3|||
146110048|NCT02516163|526923882|FG000|Overall Study|Use of incorrect measurement technique|5|||
146110049|NCT02516163|526923882|FG000|Overall Study|Data not recorded|2|||
146110050|NCT02516163|526923882|FG000|Overall Study|MRI contraindication exclusion|6|||
146110051|NCT01370356|526923883|FG000|Overall Study|Death|1|||
146110052|NCT01370356|526923884|FG001|Overall Study|Death|0|||
146110053|NCT01370356|526923883|FG000|Overall Study|Lack of Efficacy|6|||
146110054|NCT01370356|526923884|FG001|Overall Study|Lack of Efficacy|28|||
146110055|NCT01370356|526923883|FG000|Overall Study|Lost to Follow-up|76|||
146110056|NCT01370356|526923884|FG001|Overall Study|Lost to Follow-up|81|||
146110057|NCT01370356|526923883|FG000|Overall Study|Withdrawal by Subject|54|||
146110058|NCT01370356|526923884|FG001|Overall Study|Withdrawal by Subject|59|||
146110059|NCT01370356|526923883|FG000|Overall Study|Reason not specified|39|||
146110060|NCT01370356|526923884|FG001|Overall Study|Reason not specified|43|||
146110061|NCT01370356|526923883|FG000|Overall Study|Protocol Violation|3|||
146110062|NCT01370356|526923884|FG001|Overall Study|Protocol Violation|3|||
146110063|NCT01370356|526923883|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
146110064|NCT01370356|526923884|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
146110065|NCT01370356|526923883|FG000|Overall Study|AE Not Related to Study Drug|1|||
146110066|NCT01370356|526923884|FG001|Overall Study|AE Not Related to Study Drug|4|||
146110067|NCT01658072|526923885|FG000|Overall Study|Protocol Violation|4|||
146110068|NCT01658072|526923886|FG001|Overall Study|Protocol Violation|2|||
146110069|NCT00040664|526923889|FG000|Overall Study|Adverse Event|12|||
146110070|NCT00040664|526923890|FG001|Overall Study|Adverse Event|3|||
146110071|NCT00040664|526923891|FG002|Overall Study|Adverse Event|2|||
146110072|NCT00040664|526923892|FG003|Overall Study|Adverse Event|7|||
146110073|NCT00040664|526923889|FG000|Overall Study|Lack of Efficacy|9|||
146110074|NCT00040664|526923890|FG001|Overall Study|Lack of Efficacy|2|||
146110075|NCT00040664|526923891|FG002|Overall Study|Lack of Efficacy|3|||
146110076|NCT00040664|526923892|FG003|Overall Study|Lack of Efficacy|4|||
146110077|NCT00040664|526923889|FG000|Overall Study|Insufficient CD4 response|1|||
146110078|NCT00040664|526923890|FG001|Overall Study|Insufficient CD4 response|0|||
146110079|NCT00040664|526923891|FG002|Overall Study|Insufficient CD4 response|1|||
146110080|NCT00040664|526923892|FG003|Overall Study|Insufficient CD4 response|0|||
146110081|NCT00040664|526923889|FG000|Overall Study|Lost to Follow-up|4|||
146110082|NCT00040664|526923890|FG001|Overall Study|Lost to Follow-up|2|||
146110083|NCT00040664|526923891|FG002|Overall Study|Lost to Follow-up|0|||
146110084|NCT00040664|526923892|FG003|Overall Study|Lost to Follow-up|2|||
146110085|NCT00040664|526923889|FG000|Overall Study|Protocol Violation|2|||
146110086|NCT00040664|526923890|FG001|Overall Study|Protocol Violation|1|||
146110087|NCT00040664|526923891|FG002|Overall Study|Protocol Violation|0|||
146110088|NCT00040664|526923892|FG003|Overall Study|Protocol Violation|1|||
146110089|NCT00040664|526923889|FG000|Overall Study|Withdrawal by Subject|7|||
146110090|NCT00040664|526923890|FG001|Overall Study|Withdrawal by Subject|0|||
146110091|NCT00040664|526923891|FG002|Overall Study|Withdrawal by Subject|3|||
146110092|NCT00040664|526923892|FG003|Overall Study|Withdrawal by Subject|4|||
146110093|NCT00040664|526923889|FG000|Overall Study|Pregnancy|3|||
146110094|NCT00040664|526923890|FG001|Overall Study|Pregnancy|0|||
146110095|NCT00040664|526923891|FG002|Overall Study|Pregnancy|0|||
146110096|NCT00040664|526923892|FG003|Overall Study|Pregnancy|3|||
146110097|NCT00040664|526923889|FG000|Overall Study|Medication adherence/compliance problems|8|||
146110098|NCT00040664|526923890|FG001|Overall Study|Medication adherence/compliance problems|2|||
146110099|NCT00040664|526923891|FG002|Overall Study|Medication adherence/compliance problems|1|||
146301347|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146052678|NCT05214768|526707433|FG005|Open Label Extension Period|Lack of Efficacy|1|||
146052679|NCT05214768|526707428|FG000|Open Label Extension Period|Ongoing Study|0|||
146052680|NCT05214768|526707429|FG001|Open Label Extension Period|Ongoing Study|0|||
146052681|NCT05214768|526707430|FG002|Open Label Extension Period|Ongoing Study|0|||
146052682|NCT05214768|526707431|FG003|Open Label Extension Period|Ongoing Study|0|||
146052683|NCT05214768|526707432|FG004|Open Label Extension Period|Ongoing Study|0|||
146052684|NCT05214768|526707433|FG005|Open Label Extension Period|Ongoing Study|42|||
146052685|NCT05481359|526707434|FG000|Overall Study|Lost to Follow-up|3|||
146052686|NCT05481359|526707434|FG000|Overall Study|Withdrawal by Subject|1|||
146052687|NCT05579977|526707439|FG000|Treatment Phase|Other|0|||
146052688|NCT05579977|526707440|FG001|Treatment Phase|Other|0|||
146052689|NCT05579977|526707441|FG002|Treatment Phase|Other|0|||
146052690|NCT05579977|526707442|FG003|Treatment Phase|Other|2|||
146052691|NCT05579977|526707443|FG004|Treatment Phase|Other|1|||
146052692|NCT05579977|526707444|FG005|Treatment Phase|Other|2|||
146052693|NCT05579977|526707445|FG006|Treatment Phase|Other|1|||
146052694|NCT05579977|526707446|FG007|Treatment Phase|Other|2|||
146052695|NCT05579977|526707447|FG008|Treatment Phase|Other|2|||
146052696|NCT05579977|526707448|FG009|Treatment Phase|Other|1|||
146052697|NCT05579977|526707449|FG010|Treatment Phase|Other|0|||
146052698|NCT05579977|526707450|FG011|Treatment Phase|Other|0|||
146052699|NCT05579977|526707451|FG012|Treatment Phase|Other|3|||
146052700|NCT05579977|526707439|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
146052701|NCT05579977|526707440|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
146052702|NCT05579977|526707441|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
146052703|NCT05579977|526707442|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
146052704|NCT05579977|526707443|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
146052705|NCT05579977|526707444|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
146052706|NCT05579977|526707445|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
146052707|NCT05579977|526707446|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
146052708|NCT05579977|526707447|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
146052709|NCT05579977|526707448|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
146052710|NCT05579977|526707449|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
146052711|NCT05579977|526707450|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
146052712|NCT05579977|526707451|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
146052713|NCT05579977|526707439|FG000|Treatment Phase|Withdrawal by Subject|2|||
146052714|NCT05579977|526707440|FG001|Treatment Phase|Withdrawal by Subject|0|||
146052715|NCT05579977|526707441|FG002|Treatment Phase|Withdrawal by Subject|0|||
146052716|NCT05579977|526707442|FG003|Treatment Phase|Withdrawal by Subject|1|||
146052717|NCT05579977|526707443|FG004|Treatment Phase|Withdrawal by Subject|2|||
146052718|NCT05579977|526707444|FG005|Treatment Phase|Withdrawal by Subject|0|||
146052719|NCT05579977|526707445|FG006|Treatment Phase|Withdrawal by Subject|1|||
146052720|NCT05579977|526707446|FG007|Treatment Phase|Withdrawal by Subject|8|||
146052721|NCT05579977|526707447|FG008|Treatment Phase|Withdrawal by Subject|3|||
146052722|NCT05579977|526707448|FG009|Treatment Phase|Withdrawal by Subject|3|||
146052723|NCT05579977|526707449|FG010|Treatment Phase|Withdrawal by Subject|5|||
146052724|NCT05579977|526707450|FG011|Treatment Phase|Withdrawal by Subject|1|||
146052725|NCT05579977|526707451|FG012|Treatment Phase|Withdrawal by Subject|3|||
146052726|NCT05579977|526707439|FG000|Treatment Phase|Study terminated by sponsor|70|||
146052727|NCT05579977|526707440|FG001|Treatment Phase|Study terminated by sponsor|70|||
146052728|NCT05579977|526707441|FG002|Treatment Phase|Study terminated by sponsor|61|||
146052729|NCT05579977|526707442|FG003|Treatment Phase|Study terminated by sponsor|59|||
146052730|NCT05579977|526707443|FG004|Treatment Phase|Study terminated by sponsor|63|||
146052731|NCT05579977|526707444|FG005|Treatment Phase|Study terminated by sponsor|53|||
146052732|NCT05579977|526707445|FG006|Treatment Phase|Study terminated by sponsor|66|||
146052733|NCT05579977|526707446|FG007|Treatment Phase|Study terminated by sponsor|48|||
146052734|NCT05579977|526707447|FG008|Treatment Phase|Study terminated by sponsor|47|||
146052735|NCT05579977|526707448|FG009|Treatment Phase|Study terminated by sponsor|37|||
146052736|NCT05579977|526707449|FG010|Treatment Phase|Study terminated by sponsor|44|||
146052737|NCT05579977|526707450|FG011|Treatment Phase|Study terminated by sponsor|36|||
146052738|NCT05579977|526707451|FG012|Treatment Phase|Study terminated by sponsor|32|||
146052739|NCT05579977|526707439|FG000|Treatment Phase|Pregnancy|0|||
146052740|NCT05579977|526707440|FG001|Treatment Phase|Pregnancy|0|||
146052741|NCT05579977|526707441|FG002|Treatment Phase|Pregnancy|0|||
146052742|NCT05579977|526707442|FG003|Treatment Phase|Pregnancy|0|||
146052743|NCT05579977|526707443|FG004|Treatment Phase|Pregnancy|0|||
146259106|NCT00943722|527463367|FG006|Base Study|Withdrawal by Subject|0|||
146259107|NCT00943722|527463361|FG000|Base Study|Month 12 visit not completed|0|||
146052744|NCT05579977|526707444|FG005|Treatment Phase|Pregnancy|0|||
146259108|NCT00943722|527463362|FG001|Base Study|Month 12 visit not completed|0|||
146259109|NCT00943722|527463363|FG002|Base Study|Month 12 visit not completed|0|||
146052745|NCT05579977|526707445|FG006|Treatment Phase|Pregnancy|0|||
146052746|NCT05579977|526707446|FG007|Treatment Phase|Pregnancy|0|||
146052747|NCT05579977|526707447|FG008|Treatment Phase|Pregnancy|0|||
146052748|NCT05579977|526707448|FG009|Treatment Phase|Pregnancy|1|||
146052749|NCT05579977|526707449|FG010|Treatment Phase|Pregnancy|0|||
146052750|NCT05579977|526707450|FG011|Treatment Phase|Pregnancy|0|||
146052751|NCT05579977|526707451|FG012|Treatment Phase|Pregnancy|0|||
146052752|NCT05579977|526707439|FG000|Treatment Phase|Physician Decision|0|||
146052753|NCT05579977|526707440|FG001|Treatment Phase|Physician Decision|0|||
146052754|NCT05579977|526707441|FG002|Treatment Phase|Physician Decision|0|||
146052755|NCT05579977|526707442|FG003|Treatment Phase|Physician Decision|0|||
146052756|NCT05579977|526707443|FG004|Treatment Phase|Physician Decision|0|||
146052757|NCT05579977|526707444|FG005|Treatment Phase|Physician Decision|0|||
146052758|NCT05579977|526707445|FG006|Treatment Phase|Physician Decision|0|||
146052759|NCT05579977|526707446|FG007|Treatment Phase|Physician Decision|0|||
146052760|NCT05579977|526707447|FG008|Treatment Phase|Physician Decision|0|||
146052761|NCT05579977|526707448|FG009|Treatment Phase|Physician Decision|0|||
146052762|NCT05579977|526707449|FG010|Treatment Phase|Physician Decision|0|||
146052763|NCT05579977|526707450|FG011|Treatment Phase|Physician Decision|1|||
146052764|NCT05579977|526707451|FG012|Treatment Phase|Physician Decision|0|||
146052765|NCT05579977|526707439|FG000|Treatment Phase|Lost to Follow-up|0|||
146052766|NCT05579977|526707440|FG001|Treatment Phase|Lost to Follow-up|0|||
146052767|NCT05579977|526707441|FG002|Treatment Phase|Lost to Follow-up|0|||
146052768|NCT05579977|526707442|FG003|Treatment Phase|Lost to Follow-up|1|||
146052769|NCT05579977|526707443|FG004|Treatment Phase|Lost to Follow-up|1|||
146052770|NCT05579977|526707444|FG005|Treatment Phase|Lost to Follow-up|1|||
146052771|NCT05579977|526707445|FG006|Treatment Phase|Lost to Follow-up|0|||
146052772|NCT05579977|526707446|FG007|Treatment Phase|Lost to Follow-up|1|||
146052773|NCT05579977|526707447|FG008|Treatment Phase|Lost to Follow-up|2|||
146052774|NCT05579977|526707448|FG009|Treatment Phase|Lost to Follow-up|2|||
146052775|NCT05579977|526707449|FG010|Treatment Phase|Lost to Follow-up|1|||
146052776|NCT05579977|526707450|FG011|Treatment Phase|Lost to Follow-up|4|||
146052777|NCT05579977|526707451|FG012|Treatment Phase|Lost to Follow-up|3|||
146052778|NCT05579977|526707439|FG000|Treatment Phase|Death|1|||
146052779|NCT05579977|526707440|FG001|Treatment Phase|Death|0|||
146052780|NCT05579977|526707441|FG002|Treatment Phase|Death|0|||
146052781|NCT05579977|526707442|FG003|Treatment Phase|Death|0|||
146052782|NCT05579977|526707443|FG004|Treatment Phase|Death|0|||
146052783|NCT05579977|526707444|FG005|Treatment Phase|Death|0|||
146052784|NCT05579977|526707445|FG006|Treatment Phase|Death|0|||
146052785|NCT05579977|526707446|FG007|Treatment Phase|Death|0|||
146052786|NCT05579977|526707447|FG008|Treatment Phase|Death|0|||
146052787|NCT05579977|526707448|FG009|Treatment Phase|Death|0|||
146052788|NCT05579977|526707449|FG010|Treatment Phase|Death|0|||
146052789|NCT05579977|526707450|FG011|Treatment Phase|Death|0|||
146052790|NCT05579977|526707451|FG012|Treatment Phase|Death|0|||
146052791|NCT05579977|526707439|FG000|Treatment Phase|Adverse Event|0|||
146052792|NCT05579977|526707440|FG001|Treatment Phase|Adverse Event|3|||
146052793|NCT05579977|526707441|FG002|Treatment Phase|Adverse Event|11|||
146052794|NCT05579977|526707442|FG003|Treatment Phase|Adverse Event|10|||
146052795|NCT05579977|526707443|FG004|Treatment Phase|Adverse Event|5|||
146052796|NCT05579977|526707444|FG005|Treatment Phase|Adverse Event|17|||
146052797|NCT05579977|526707445|FG006|Treatment Phase|Adverse Event|5|||
146052798|NCT05579977|526707446|FG007|Treatment Phase|Adverse Event|5|||
146052799|NCT05579977|526707447|FG008|Treatment Phase|Adverse Event|12|||
146052800|NCT05579977|526707448|FG009|Treatment Phase|Adverse Event|20|||
146052801|NCT05579977|526707449|FG010|Treatment Phase|Adverse Event|15|||
146052802|NCT05579977|526707450|FG011|Treatment Phase|Adverse Event|24|||
146052803|NCT05579977|526707451|FG012|Treatment Phase|Adverse Event|23|||
146052804|NCT05579977|526707439|FG000|Treatment Phase|Randomized not treated|0|||
146052805|NCT05579977|526707440|FG001|Treatment Phase|Randomized not treated|0|||
146052806|NCT05579977|526707441|FG002|Treatment Phase|Randomized not treated|0|||
146052807|NCT05579977|526707442|FG003|Treatment Phase|Randomized not treated|0|||
146052808|NCT05579977|526707443|FG004|Treatment Phase|Randomized not treated|1|||
146052809|NCT05579977|526707444|FG005|Treatment Phase|Randomized not treated|0|||
146052810|NCT05579977|526707445|FG006|Treatment Phase|Randomized not treated|0|||
146052811|NCT05579977|526707446|FG007|Treatment Phase|Randomized not treated|0|||
146052812|NCT05579977|526707447|FG008|Treatment Phase|Randomized not treated|0|||
146052813|NCT05579977|526707448|FG009|Treatment Phase|Randomized not treated|0|||
146052814|NCT05579977|526707449|FG010|Treatment Phase|Randomized not treated|0|||
146052815|NCT05579977|526707450|FG011|Treatment Phase|Randomized not treated|0|||
146052816|NCT05579977|526707451|FG012|Treatment Phase|Randomized not treated|0|||
146052817|NCT05579977|526707439|FG000|Follow up|Death|1|||
146052818|NCT05579977|526707440|FG001|Follow up|Death|0|||
146052819|NCT05579977|526707441|FG002|Follow up|Death|0|||
146052820|NCT05579977|526707442|FG003|Follow up|Death|0|||
146052821|NCT05579977|526707443|FG004|Follow up|Death|0|||
146052822|NCT05579977|526707444|FG005|Follow up|Death|0|||
146301348|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146301349|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
146052823|NCT05579977|526707445|FG006|Follow up|Death|0|||
146052824|NCT05579977|526707446|FG007|Follow up|Death|0|||
146052825|NCT05579977|526707447|FG008|Follow up|Death|0|||
146052826|NCT05579977|526707448|FG009|Follow up|Death|0|||
146052827|NCT05579977|526707449|FG010|Follow up|Death|0|||
146052828|NCT05579977|526707450|FG011|Follow up|Death|0|||
146259110|NCT00943722|527463364|FG003|Base Study|Month 12 visit not completed|0|||
146259111|NCT00943722|527463365|FG004|Base Study|Month 12 visit not completed|2|||
146052829|NCT05579977|526707451|FG012|Follow up|Death|0|||
146052830|NCT05579977|526707439|FG000|Follow up|Lost to Follow-up|0|||
146052831|NCT05579977|526707440|FG001|Follow up|Lost to Follow-up|0|||
146052832|NCT05579977|526707441|FG002|Follow up|Lost to Follow-up|0|||
146052833|NCT05579977|526707442|FG003|Follow up|Lost to Follow-up|1|||
146052834|NCT05579977|526707443|FG004|Follow up|Lost to Follow-up|1|||
146052835|NCT05579977|526707444|FG005|Follow up|Lost to Follow-up|2|||
146052836|NCT05579977|526707445|FG006|Follow up|Lost to Follow-up|1|||
146052837|NCT05579977|526707446|FG007|Follow up|Lost to Follow-up|1|||
146052838|NCT05579977|526707447|FG008|Follow up|Lost to Follow-up|3|||
146052839|NCT05579977|526707448|FG009|Follow up|Lost to Follow-up|2|||
146052840|NCT05579977|526707449|FG010|Follow up|Lost to Follow-up|2|||
146052841|NCT05579977|526707450|FG011|Follow up|Lost to Follow-up|4|||
146052842|NCT05579977|526707451|FG012|Follow up|Lost to Follow-up|4|||
146052843|NCT05579977|526707439|FG000|Follow up|Withdrawal by Subject|2|||
146052844|NCT05579977|526707440|FG001|Follow up|Withdrawal by Subject|0|||
146052845|NCT05579977|526707441|FG002|Follow up|Withdrawal by Subject|0|||
146052846|NCT05579977|526707442|FG003|Follow up|Withdrawal by Subject|0|||
146052847|NCT05579977|526707443|FG004|Follow up|Withdrawal by Subject|1|||
146052848|NCT05579977|526707444|FG005|Follow up|Withdrawal by Subject|0|||
146052849|NCT05579977|526707445|FG006|Follow up|Withdrawal by Subject|1|||
146052850|NCT05579977|526707446|FG007|Follow up|Withdrawal by Subject|4|||
146052851|NCT05579977|526707447|FG008|Follow up|Withdrawal by Subject|2|||
146052852|NCT05579977|526707448|FG009|Follow up|Withdrawal by Subject|3|||
146052853|NCT05579977|526707449|FG010|Follow up|Withdrawal by Subject|3|||
146052854|NCT05579977|526707450|FG011|Follow up|Withdrawal by Subject|1|||
146052855|NCT05579977|526707451|FG012|Follow up|Withdrawal by Subject|3|||
146052856|NCT01611194|526707453|FG000|Overall Study|Lost to Follow-up|0|||
146052857|NCT01611194|526707454|FG001|Overall Study|Lost to Follow-up|1|||
146052858|NCT01611194|526707453|FG000|Overall Study|Withdrawal by Subject|0|||
146052859|NCT01611194|526707454|FG001|Overall Study|Withdrawal by Subject|1|||
146052860|NCT01611194|526707453|FG000|Overall Study|drug use|0|||
146052861|NCT01611194|526707454|FG001|Overall Study|drug use|1|||
146052862|NCT00348673|526707455|FG000|Stage 1|Randomized but not Treated|0|||
146052863|NCT00348673|526707456|FG001|Stage 1|Randomized but not Treated|0|||
146052864|NCT00348673|526707457|FG002|Stage 1|Randomized but not Treated|1|||
146052865|NCT00348673|526707458|FG003|Stage 1|Randomized but not Treated|0|||
146052866|NCT00348673|526707459|FG004|Stage 1|Randomized but not Treated|0|||
146052867|NCT00348673|526707460|FG005|Stage 1|Randomized but not Treated|0|||
146052868|NCT00348673|526707461|FG006|Stage 1|Randomized but not Treated|0|||
146052869|NCT00348673|526707462|FG007|Stage 1|Randomized but not Treated|0|||
146052870|NCT00348673|526707463|FG008|Stage 1|Randomized but not Treated|0|||
146052871|NCT01712204|526707465|FG000|Overall Study|Adverse Event|3|||
146052872|NCT01712204|526707466|FG001|Overall Study|Adverse Event|1|||
146052873|NCT01712204|526707465|FG000|Overall Study|Withdrawal by Subject|3|||
146052874|NCT01712204|526707466|FG001|Overall Study|Withdrawal by Subject|3|||
146052875|NCT01712204|526707465|FG000|Overall Study|Lost to Follow-up|1|||
146052876|NCT01712204|526707466|FG001|Overall Study|Lost to Follow-up|0|||
146052877|NCT01712204|526707465|FG000|Overall Study|Protocol Violation|1|||
146052878|NCT01712204|526707466|FG001|Overall Study|Protocol Violation|1|||
146052879|NCT02679287|526707467|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
146052880|NCT02679287|526707468|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
146052881|NCT02679287|526707467|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
146052882|NCT02679287|526707468|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
146052883|NCT02679287|526707467|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
146052884|NCT02679287|526707468|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
146052885|NCT02679287|526707467|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
146052886|NCT02679287|526707468|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
146052887|NCT02679287|526707467|FG000|Period 2|Work/Scheduling Conflict|1|||
146052888|NCT02679287|526707468|FG001|Period 2|Work/Scheduling Conflict|0|||
146052889|NCT02679287|526707467|FG000|Period 2|Disliked Mobile System|2|||
146052890|NCT02679287|526707468|FG001|Period 2|Disliked Mobile System|0|||
146052891|NCT02679287|526707467|FG000|Period 3|Work/Scheduling Conflict|0|||
146052892|NCT02679287|526707468|FG001|Period 3|Work/Scheduling Conflict|1|||
146259112|NCT00943722|527463366|FG005|Base Study|Month 12 visit not completed|0|||
146052893|NCT01114828|526707469|FG000|Overall Study|Adverse Event|1|||
146052894|NCT01114828|526707470|FG001|Overall Study|Adverse Event|1|||
146052895|NCT01114828|526707469|FG000|Overall Study|Lack of Efficacy|0|||
146052896|NCT01114828|526707470|FG001|Overall Study|Lack of Efficacy|2|||
146052897|NCT01114828|526707469|FG000|Overall Study|Protocol Violation|2|||
146052898|NCT01114828|526707470|FG001|Overall Study|Protocol Violation|0|||
146052899|NCT01114828|526707469|FG000|Overall Study|Withdrawal by Subject|0|||
146052900|NCT01114828|526707470|FG001|Overall Study|Withdrawal by Subject|1|||
146052901|NCT00794950|526707471|FG000|BCG Induction|Withdrawal by Subject|2|||
146259113|NCT00943722|527463367|FG006|Base Study|Month 12 visit not completed|0|||
146052902|NCT00794950|526707471|FG000|BCG Induction|ineligible|3|||
146052903|NCT00794950|526707471|FG000|BCG Induction|noncompliant w. BCG|1|||
146052904|NCT00794950|526707471|FG000|BCG Induction|Adverse Event|1|||
146052905|NCT00794950|526707471|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
146052906|NCT00794950|526707471|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
146052907|NCT00794950|526707471|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
146052908|NCT00794950|526707471|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
146052909|NCT02485704|526707472|FG000|Overall Study|Lost to Follow-up|4|||
146052910|NCT02485704|526707473|FG001|Overall Study|Lost to Follow-up|5|||
146052911|NCT02485704|526707472|FG000|Overall Study|Withdrawal by Subject|0|||
146052912|NCT02485704|526707473|FG001|Overall Study|Withdrawal by Subject|3|||
146052913|NCT02485704|526707472|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
146052914|NCT02485704|526707473|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
146052915|NCT01777776|526707474|FG000|Overall Study|Adverse Event|2|||
146052916|NCT01777776|526707475|FG001|Overall Study|Adverse Event|4|||
146052917|NCT01777776|526707476|FG002|Overall Study|Adverse Event|0|||
146052918|NCT01777776|526707477|FG003|Overall Study|Adverse Event|0|||
146052919|NCT01777776|526707474|FG000|Overall Study|Disease Progression|4|||
146052920|NCT01777776|526707475|FG001|Overall Study|Disease Progression|8|||
146052921|NCT01777776|526707476|FG002|Overall Study|Disease Progression|6|||
146052922|NCT01777776|526707477|FG003|Overall Study|Disease Progression|3|||
146052923|NCT01777776|526707474|FG000|Overall Study|Withdrawal by Subject|0|||
146052924|NCT01777776|526707475|FG001|Overall Study|Withdrawal by Subject|0|||
146052925|NCT01777776|526707476|FG002|Overall Study|Withdrawal by Subject|0|||
146052926|NCT01777776|526707477|FG003|Overall Study|Withdrawal by Subject|1|||
146052927|NCT01943591|526707480|FG000|Overall Study|Lost to Follow-up|3|||
146052928|NCT01943591|526707481|FG001|Overall Study|Lost to Follow-up|4|||
146052929|NCT01943591|526707480|FG000|Overall Study|Death|2|||
146052930|NCT01943591|526707481|FG001|Overall Study|Death|7|||
146052931|NCT05473026|526709986|FG000|Overall Study|Lost to Follow-up|5|||
146052932|NCT05473026|526709987|FG001|Overall Study|Lost to Follow-up|2|||
146052933|NCT00248495|526709993|FG000|Overall Study|Withdrawal by Subject|1|||
146052934|NCT03812380|526709994|FG000|Overall Study|Protocol Violation|3|||
146052935|NCT03812380|526709995|FG001|Overall Study|Protocol Violation|3|||
146052936|NCT03812380|526709994|FG000|Overall Study|Withdrawal by Subject|5|||
146052937|NCT03812380|526709995|FG001|Overall Study|Withdrawal by Subject|4|||
146052938|NCT03812380|526709994|FG000|Overall Study|Early termination of study|14|||
146052939|NCT03812380|526709995|FG001|Overall Study|Early termination of study|14|||
146052940|NCT00981149|526709996|FG000|Overall Study|Lost to Follow-up|1|||
146052941|NCT00981149|526709997|FG001|Overall Study|Lost to Follow-up|2|||
146052942|NCT00981149|526709996|FG000|Overall Study|Withdrawal by Subject|1|||
146052943|NCT00981149|526709997|FG001|Overall Study|Withdrawal by Subject|1|||
146052944|NCT04244253|526710003|FG000|Overall Study|Adverse Event|2|||
146052945|NCT04244253|526710004|FG001|Overall Study|Adverse Event|2|||
146052946|NCT04244253|526710005|FG002|Overall Study|Adverse Event|4|||
146052947|NCT04244253|526710003|FG000|Overall Study|Protocol Violation|1|||
146052948|NCT04244253|526710004|FG001|Overall Study|Protocol Violation|2|||
146052949|NCT04244253|526710005|FG002|Overall Study|Protocol Violation|1|||
146052950|NCT04244253|526710003|FG000|Overall Study|Withdrawal by Subject|0|||
146052951|NCT04244253|526710004|FG001|Overall Study|Withdrawal by Subject|1|||
146052952|NCT04244253|526710005|FG002|Overall Study|Withdrawal by Subject|6|||
146052953|NCT04244253|526710003|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146052954|NCT04244253|526710004|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146052955|NCT04244253|526710005|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146052956|NCT00619515|526710006|FG000|Overall Study|Study Termination by IRB|73|||
146052957|NCT03294590|526710009|FG000|Overall Study|Lost to Follow-up|105|||
146052958|NCT03294590|526710010|FG001|Overall Study|Lost to Follow-up|107|||
146052959|NCT00628030|526710015|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
146052960|NCT00628030|526710016|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
146052961|NCT00628030|526710015|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
146052962|NCT00628030|526710016|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
146052963|NCT00628030|526710015|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
146052964|NCT00628030|526710016|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
146052965|NCT01255423|526710017|FG000|Overall Study|Abnormal Laboratory value|3|||
146052966|NCT01255423|526710018|FG001|Overall Study|Abnormal Laboratory value|2|||
146052967|NCT01255423|526710017|FG000|Overall Study|Use of prohibited medications|0|||
146052968|NCT01255423|526710018|FG001|Overall Study|Use of prohibited medications|1|||
146259114|NCT00943722|527463361|FG000|First Extension Study: EXT 1|Adverse Event|0|||
146052969|NCT03367858|526710019|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
146052970|NCT03367858|526710020|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
146052971|NCT03367858|526710019|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
146052972|NCT03367858|526710020|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
146052973|NCT03367858|526710019|FG000|3 Month Follow Up|Lost to Follow-up|8|||
146052974|NCT03367858|526710020|FG001|3 Month Follow Up|Lost to Follow-up|3|||
146259115|NCT00943722|527463362|FG001|First Extension Study: EXT 1|Adverse Event|0|||
146052975|NCT03367858|526710019|FG000|3 Month Follow Up|Moved out of study area|2|||
146052976|NCT03367858|526710020|FG001|3 Month Follow Up|Moved out of study area|6|||
146052977|NCT03367858|526710019|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
146052978|NCT03367858|526710020|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
146052979|NCT03367858|526710019|FG000|3 Month Follow Up|MRI contraindication|2|||
146052980|NCT03367858|526710020|FG001|3 Month Follow Up|MRI contraindication|1|||
146052981|NCT03367858|526710019|FG000|3 Month Follow Up|Incarcerated|0|||
146052982|NCT03367858|526710020|FG001|3 Month Follow Up|Incarcerated|1|||
146052983|NCT03367858|526710019|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
146052984|NCT03367858|526710020|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
146052985|NCT03367858|526710019|FG000|6 Month Follow Up|Lost to Follow-up|5|||
146052986|NCT03367858|526710020|FG001|6 Month Follow Up|Lost to Follow-up|2|||
146052987|NCT03367858|526710019|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
146052988|NCT03367858|526710020|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
146052989|NCT03367858|526710019|FG000|12 Month Follow Up|Lost to Follow-up|3|||
146052990|NCT03367858|526710020|FG001|12 Month Follow Up|Lost to Follow-up|3|||
146052991|NCT03367858|526710019|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
146052992|NCT03367858|526710020|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
146052993|NCT04154943|526710023|FG000|Overall Study|Study Ongoing|68|||
146052994|NCT04154943|526710023|FG000|Overall Study|Lost to Follow-up|1|||
146052995|NCT04154943|526710023|FG000|Overall Study|Decision by the Investigator|1|||
146052996|NCT04154943|526710023|FG000|Overall Study|Death|5|||
146052997|NCT04154943|526710023|FG000|Overall Study|Withdrawal by Subject|4|||
146052998|NCT00101686|526710024|FG000|Overall Study|Progressive Disease|37|||
146052999|NCT00101686|526710025|FG001|Overall Study|Progressive Disease|28|||
146053000|NCT00101686|526710026|FG002|Overall Study|Progressive Disease|37|||
146053001|NCT00101686|526710027|FG003|Overall Study|Progressive Disease|38|||
146053002|NCT00101686|526710028|FG004|Overall Study|Progressive Disease|28|||
146053003|NCT00101686|526710029|FG005|Overall Study|Progressive Disease|25|||
146053004|NCT00101686|526710030|FG006|Overall Study|Progressive Disease|5|||
146053005|NCT00101686|526710031|FG007|Overall Study|Progressive Disease|7|||
146053006|NCT00101686|526710032|FG008|Overall Study|Progressive Disease|10|||
146053007|NCT00101686|526710033|FG009|Overall Study|Progressive Disease|8|||
146053008|NCT00101686|526710024|FG000|Overall Study|initiation other anti-cancer treatment|4|||
146053009|NCT00101686|526710025|FG001|Overall Study|initiation other anti-cancer treatment|3|||
146053010|NCT00101686|526710026|FG002|Overall Study|initiation other anti-cancer treatment|4|||
146053011|NCT00101686|526710027|FG003|Overall Study|initiation other anti-cancer treatment|3|||
146053012|NCT00101686|526710028|FG004|Overall Study|initiation other anti-cancer treatment|1|||
146053013|NCT00101686|526710029|FG005|Overall Study|initiation other anti-cancer treatment|1|||
146053014|NCT00101686|526710030|FG006|Overall Study|initiation other anti-cancer treatment|2|||
146053015|NCT00101686|526710031|FG007|Overall Study|initiation other anti-cancer treatment|2|||
146053016|NCT00101686|526710032|FG008|Overall Study|initiation other anti-cancer treatment|3|||
146053017|NCT00101686|526710033|FG009|Overall Study|initiation other anti-cancer treatment|3|||
146053018|NCT00101686|526710024|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
146053019|NCT00101686|526710025|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
146053020|NCT00101686|526710026|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
146053021|NCT00101686|526710027|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
146053022|NCT00101686|526710028|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
146053023|NCT00101686|526710029|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
146053024|NCT00101686|526710030|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
146053025|NCT00101686|526710031|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
146053026|NCT00101686|526710032|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
146053027|NCT00101686|526710033|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
146053028|NCT00101686|526710024|FG000|Overall Study|unacceptable toxicity|3|||
146053029|NCT00101686|526710025|FG001|Overall Study|unacceptable toxicity|9|||
146053030|NCT00101686|526710026|FG002|Overall Study|unacceptable toxicity|10|||
146053031|NCT00101686|526710027|FG003|Overall Study|unacceptable toxicity|6|||
146053032|NCT00101686|526710028|FG004|Overall Study|unacceptable toxicity|16|||
146053033|NCT00101686|526710029|FG005|Overall Study|unacceptable toxicity|10|||
146053034|NCT00101686|526710030|FG006|Overall Study|unacceptable toxicity|4|||
146053035|NCT00101686|526710031|FG007|Overall Study|unacceptable toxicity|2|||
146053036|NCT00101686|526710032|FG008|Overall Study|unacceptable toxicity|1|||
146053037|NCT00101686|526710033|FG009|Overall Study|unacceptable toxicity|4|||
146053038|NCT00101686|526710024|FG000|Overall Study|Randomized but did not receive treament|1|||
146053039|NCT00101686|526710025|FG001|Overall Study|Randomized but did not receive treament|6|||
146053040|NCT00101686|526710026|FG002|Overall Study|Randomized but did not receive treament|2|||
146053041|NCT00101686|526710027|FG003|Overall Study|Randomized but did not receive treament|2|||
146053042|NCT00101686|526710028|FG004|Overall Study|Randomized but did not receive treament|2|||
146053043|NCT00101686|526710029|FG005|Overall Study|Randomized but did not receive treament|2|||
146053044|NCT00101686|526710030|FG006|Overall Study|Randomized but did not receive treament|0|||
146053045|NCT00101686|526710031|FG007|Overall Study|Randomized but did not receive treament|1|||
146053046|NCT00101686|526710032|FG008|Overall Study|Randomized but did not receive treament|0|||
146053047|NCT00101686|526710033|FG009|Overall Study|Randomized but did not receive treament|1|||
146053048|NCT00101686|526710024|FG000|Overall Study|intercurrent non-cancer related illness|0|||
146053049|NCT00101686|526710025|FG001|Overall Study|intercurrent non-cancer related illness|0|||
146053050|NCT00101686|526710026|FG002|Overall Study|intercurrent non-cancer related illness|2|||
146053051|NCT00101686|526710027|FG003|Overall Study|intercurrent non-cancer related illness|0|||
146053052|NCT00101686|526710028|FG004|Overall Study|intercurrent non-cancer related illness|1|||
146259116|NCT00943722|527463363|FG002|First Extension Study: EXT 1|Adverse Event|0|||
146259117|NCT00943722|527463364|FG003|First Extension Study: EXT 1|Adverse Event|0|||
146259118|NCT00943722|527463365|FG004|First Extension Study: EXT 1|Adverse Event|0|||
146053053|NCT00101686|526710029|FG005|Overall Study|intercurrent non-cancer related illness|3|||
146053054|NCT00101686|526710030|FG006|Overall Study|intercurrent non-cancer related illness|1|||
146053055|NCT00101686|526710031|FG007|Overall Study|intercurrent non-cancer related illness|0|||
146053056|NCT00101686|526710032|FG008|Overall Study|intercurrent non-cancer related illness|1|||
146053057|NCT00101686|526710033|FG009|Overall Study|intercurrent non-cancer related illness|1|||
146053058|NCT00101686|526710024|FG000|Overall Study|Physician Decision|10|||
146053059|NCT00101686|526710025|FG001|Overall Study|Physician Decision|13|||
146053060|NCT00101686|526710026|FG002|Overall Study|Physician Decision|6|||
146053061|NCT00101686|526710027|FG003|Overall Study|Physician Decision|7|||
146053062|NCT00101686|526710028|FG004|Overall Study|Physician Decision|8|||
146053063|NCT00101686|526710029|FG005|Overall Study|Physician Decision|9|||
146053064|NCT00101686|526710030|FG006|Overall Study|Physician Decision|5|||
146053065|NCT00101686|526710031|FG007|Overall Study|Physician Decision|5|||
146053066|NCT00101686|526710032|FG008|Overall Study|Physician Decision|1|||
146053067|NCT00101686|526710033|FG009|Overall Study|Physician Decision|1|||
146053068|NCT00101686|526710024|FG000|Overall Study|Other|1|||
146053069|NCT00101686|526710025|FG001|Overall Study|Other|4|||
146053070|NCT00101686|526710026|FG002|Overall Study|Other|1|||
146053071|NCT00101686|526710027|FG003|Overall Study|Other|6|||
146053072|NCT00101686|526710028|FG004|Overall Study|Other|2|||
146053073|NCT00101686|526710029|FG005|Overall Study|Other|12|||
146053074|NCT00101686|526710030|FG006|Overall Study|Other|1|||
146053075|NCT00101686|526710031|FG007|Overall Study|Other|5|||
146053076|NCT00101686|526710032|FG008|Overall Study|Other|3|||
146053077|NCT00101686|526710033|FG009|Overall Study|Other|3|||
146053078|NCT00101686|526710024|FG000|Overall Study|Withdrawal by Subject|9|||
146053079|NCT00101686|526710025|FG001|Overall Study|Withdrawal by Subject|8|||
146053080|NCT00101686|526710026|FG002|Overall Study|Withdrawal by Subject|6|||
146053081|NCT00101686|526710027|FG003|Overall Study|Withdrawal by Subject|8|||
146053082|NCT00101686|526710028|FG004|Overall Study|Withdrawal by Subject|8|||
146053083|NCT00101686|526710029|FG005|Overall Study|Withdrawal by Subject|7|||
146053084|NCT00101686|526710030|FG006|Overall Study|Withdrawal by Subject|7|||
146053085|NCT00101686|526710031|FG007|Overall Study|Withdrawal by Subject|7|||
146053086|NCT00101686|526710032|FG008|Overall Study|Withdrawal by Subject|8|||
146053087|NCT00101686|526710033|FG009|Overall Study|Withdrawal by Subject|9|||
146053088|NCT01292187|526710034|FG000|Overall Study|Adverse Event|10|||
146053089|NCT01292187|526710035|FG001|Overall Study|Adverse Event|5|||
146053090|NCT01292187|526710034|FG000|Overall Study|Withdrawal by Subject|6|||
146053091|NCT01292187|526710035|FG001|Overall Study|Withdrawal by Subject|5|||
146053092|NCT01292187|526710034|FG000|Overall Study|All other reasons|1|||
146053093|NCT01292187|526710035|FG001|Overall Study|All other reasons|3|||
146053094|NCT03827655|526710036|FG000|Overall Study|Death|0|||
146053095|NCT03827655|526710037|FG001|Overall Study|Death|0|||
146053096|NCT03827655|526710038|FG002|Overall Study|Death|0|||
146053097|NCT03827655|526710039|FG003|Overall Study|Death|0|||
146053098|NCT03827655|526710040|FG004|Overall Study|Death|1|||
146053099|NCT03827655|526710036|FG000|Overall Study|Protocol Deviation|1|||
146053100|NCT03827655|526710037|FG001|Overall Study|Protocol Deviation|0|||
146053101|NCT03827655|526710038|FG002|Overall Study|Protocol Deviation|1|||
146053102|NCT03827655|526710039|FG003|Overall Study|Protocol Deviation|1|||
146053103|NCT03827655|526710040|FG004|Overall Study|Protocol Deviation|0|||
146053104|NCT03827655|526710036|FG000|Overall Study|Withdrawal by Subject|3|||
146053105|NCT03827655|526710037|FG001|Overall Study|Withdrawal by Subject|2|||
146053106|NCT03827655|526710038|FG002|Overall Study|Withdrawal by Subject|2|||
146053107|NCT03827655|526710039|FG003|Overall Study|Withdrawal by Subject|0|||
146053108|NCT03827655|526710040|FG004|Overall Study|Withdrawal by Subject|1|||
146053109|NCT03827655|526710036|FG000|Overall Study|Reason not Specified|3|||
146053110|NCT03827655|526710037|FG001|Overall Study|Reason not Specified|1|||
146053111|NCT03827655|526710038|FG002|Overall Study|Reason not Specified|1|||
146053112|NCT03827655|526710039|FG003|Overall Study|Reason not Specified|1|||
146053113|NCT03827655|526710040|FG004|Overall Study|Reason not Specified|1|||
146053114|NCT02520726|526710041|FG000|Overall Study|Lost to Follow-up|3|||
146053115|NCT02520726|526710042|FG001|Overall Study|Lost to Follow-up|2|||
146053116|NCT03649217|526710043|FG000|Overall Study|subject had severe ataxia not initially found|1|||
146053117|NCT03649217|526710043|FG000|Overall Study|subject had cognitive issues not initially found|1|||
146053118|NCT01092728|526710044|FG000|Overall Study|Withdrawal by Subject|2|||
146053119|NCT01092728|526710045|FG001|Overall Study|Withdrawal by Subject|0|||
146259119|NCT00943722|527463366|FG005|First Extension Study: EXT 1|Adverse Event|1|||
146053120|NCT01092728|526710044|FG000|Overall Study|Adverse Event|0|||
146053121|NCT01092728|526710045|FG001|Overall Study|Adverse Event|1|||
146053122|NCT01092728|526710044|FG000|Overall Study|Disease Progression|1|||
146053123|NCT01092728|526710045|FG001|Overall Study|Disease Progression|13|||
146053124|NCT01092728|526710044|FG000|Overall Study|Prohibited Concomitant Medications|1|||
146053125|NCT01092728|526710045|FG001|Overall Study|Prohibited Concomitant Medications|0|||
146053126|NCT02336607|526710046|FG000|Overall Study|Physician Decision|1|||
146053127|NCT02336607|526710047|FG001|Overall Study|Physician Decision|4|||
146053128|NCT02336607|526710048|FG002|Overall Study|Physician Decision|3|||
146053129|NCT02336607|526710049|FG003|Overall Study|Physician Decision|15|||
146053130|NCT02336607|526710046|FG000|Overall Study|Lack of Efficacy|1|||
146053131|NCT02336607|526710047|FG001|Overall Study|Lack of Efficacy|0|||
146053132|NCT02336607|526710048|FG002|Overall Study|Lack of Efficacy|0|||
146053133|NCT02336607|526710049|FG003|Overall Study|Lack of Efficacy|2|||
146053134|NCT02336607|526710046|FG000|Overall Study|Lost to Follow-up|2|||
146053135|NCT02336607|526710047|FG001|Overall Study|Lost to Follow-up|1|||
146053136|NCT02336607|526710048|FG002|Overall Study|Lost to Follow-up|0|||
146053137|NCT02336607|526710049|FG003|Overall Study|Lost to Follow-up|21|||
146053138|NCT02336607|526710046|FG000|Overall Study|Protocol Violation|0|||
146053139|NCT02336607|526710047|FG001|Overall Study|Protocol Violation|1|||
146053140|NCT02336607|526710048|FG002|Overall Study|Protocol Violation|1|||
146053141|NCT02336607|526710049|FG003|Overall Study|Protocol Violation|3|||
146053142|NCT02336607|526710046|FG000|Overall Study|Adverse Event|0|||
146053143|NCT02336607|526710047|FG001|Overall Study|Adverse Event|2|||
146053144|NCT02336607|526710048|FG002|Overall Study|Adverse Event|2|||
146053145|NCT02336607|526710049|FG003|Overall Study|Adverse Event|26|||
146053146|NCT02336607|526710046|FG000|Overall Study|Withdrawal by Subject|0|||
146053147|NCT02336607|526710047|FG001|Overall Study|Withdrawal by Subject|2|||
146053148|NCT02336607|526710048|FG002|Overall Study|Withdrawal by Subject|0|||
146053149|NCT02336607|526710049|FG003|Overall Study|Withdrawal by Subject|20|||
146053150|NCT02552966|526710052|FG000|Overall Study|Lost to Follow-up|2|||
146053151|NCT02552966|526710052|FG000|Overall Study|Withdrawal by Subject|3|||
146053152|NCT00721396|526710054|FG000|Overall Study|Adverse Event|4|||
146053153|NCT00721396|526710055|FG001|Overall Study|Adverse Event|7|||
146053154|NCT00721396|526710056|FG002|Overall Study|Adverse Event|2|||
146053155|NCT00721396|526710057|FG003|Overall Study|Adverse Event|0|||
146053156|NCT00721396|526710054|FG000|Overall Study|Withdrawal by Subject|12|||
146053157|NCT00721396|526710055|FG001|Overall Study|Withdrawal by Subject|15|||
146053158|NCT00721396|526710056|FG002|Overall Study|Withdrawal by Subject|3|||
146053159|NCT00721396|526710057|FG003|Overall Study|Withdrawal by Subject|7|||
146053160|NCT00721396|526710054|FG000|Overall Study|Lost to Follow-up|7|||
146053161|NCT00721396|526710055|FG001|Overall Study|Lost to Follow-up|9|||
146053162|NCT00721396|526710056|FG002|Overall Study|Lost to Follow-up|3|||
146053163|NCT00721396|526710057|FG003|Overall Study|Lost to Follow-up|3|||
146053164|NCT00721396|526710054|FG000|Overall Study|Protocol Violation|4|||
146053165|NCT00721396|526710055|FG001|Overall Study|Protocol Violation|3|||
146110100|NCT00040664|526923892|FG003|Overall Study|Medication adherence/compliance problems|5|||
146110101|NCT00040664|526923889|FG000|Overall Study|Poor taste|2|||
146110102|NCT00040664|526923890|FG001|Overall Study|Poor taste|0|||
146110103|NCT00040664|526923891|FG002|Overall Study|Poor taste|2|||
146110104|NCT00040664|526923892|FG003|Overall Study|Poor taste|0|||
146110105|NCT00040664|526923889|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
146110106|NCT00040664|526923890|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
146110107|NCT00040664|526923891|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
146110108|NCT00040664|526923892|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
146110109|NCT00040664|526923889|FG000|Overall Study|Change of formulation|2|||
146301350|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
146053166|NCT00721396|526710056|FG002|Overall Study|Protocol Violation|1|||
146053167|NCT00721396|526710057|FG003|Overall Study|Protocol Violation|0|||
146053168|NCT00721396|526710054|FG000|Overall Study|Inappropriate enrollment|0|||
146053169|NCT00721396|526710055|FG001|Overall Study|Inappropriate enrollment|2|||
146053170|NCT00721396|526710056|FG002|Overall Study|Inappropriate enrollment|0|||
146053171|NCT00721396|526710057|FG003|Overall Study|Inappropriate enrollment|0|||
146053172|NCT00721396|526710054|FG000|Overall Study|Administrative reason|3|||
146053173|NCT00721396|526710055|FG001|Overall Study|Administrative reason|0|||
146053174|NCT00721396|526710056|FG002|Overall Study|Administrative reason|1|||
146053175|NCT00721396|526710057|FG003|Overall Study|Administrative reason|0|||
146053176|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053177|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053178|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053179|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
146053180|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053181|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053182|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146110110|NCT00040664|526923890|FG001|Overall Study|Change of formulation|2|||
146110111|NCT00040664|526923891|FG002|Overall Study|Change of formulation|0|||
146053183|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053184|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053185|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
146053186|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
146053187|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
146053188|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146053189|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
146053190|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
146053191|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
146053192|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146053193|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146053194|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146053195|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
146053196|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
146053197|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146053198|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146053199|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146053200|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
146053201|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
146110112|NCT00040664|526923892|FG003|Overall Study|Change of formulation|0|||
146110113|NCT00040664|526923889|FG000|Overall Study|Non-viability of oral suspension|1|||
146110114|NCT00040664|526923890|FG001|Overall Study|Non-viability of oral suspension|0|||
146110115|NCT00040664|526923891|FG002|Overall Study|Non-viability of oral suspension|1|||
146110116|NCT00040664|526923892|FG003|Overall Study|Non-viability of oral suspension|0|||
146110117|NCT01709162|526923893|FG000|Overall Study|Disease progression|3|||
146110118|NCT01709162|526923894|FG001|Overall Study|Disease progression|3|||
146110119|NCT01709162|526923893|FG000|Overall Study|Study drug toxicity|2|||
146110120|NCT01709162|526923894|FG001|Overall Study|Study drug toxicity|0|||
146110121|NCT01709162|526923893|FG000|Overall Study|Administrative reason by sponsor|0|||
146110122|NCT01709162|526923894|FG001|Overall Study|Administrative reason by sponsor|1|||
146110123|NCT01709162|526923893|FG000|Overall Study|Other|1|||
146110124|NCT01709162|526923894|FG001|Overall Study|Other|0|||
146110125|NCT01709162|526923893|FG000|Overall Study|Withdrawal by Subject|0|||
146110126|NCT01709162|526923894|FG001|Overall Study|Withdrawal by Subject|1|||
146110127|NCT01874054|526923895|FG000|Overall Study|Withdrawal by Subject|3|||
146110128|NCT01874054|526923895|FG000|Overall Study|Study Termination by Sponsor|42|||
146110129|NCT01874054|526923895|FG000|Overall Study|Lost to Follow-up|5|||
146110130|NCT01874054|526923895|FG000|Overall Study|Death|5|||
146110131|NCT01233258|526923898|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
146110132|NCT01233258|526923899|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
146110133|NCT01233258|526923900|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
146110134|NCT01233258|526923901|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
146110135|NCT01233258|526923902|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
146110136|NCT01233258|526923903|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
146110137|NCT01233258|526923898|FG000|First Intervention (6 Months)|Protocol Violation|0|||
146110138|NCT01233258|526923899|FG001|First Intervention (6 Months)|Protocol Violation|0|||
146110139|NCT01233258|526923900|FG002|First Intervention (6 Months)|Protocol Violation|1|||
146110140|NCT01233258|526923901|FG003|First Intervention (6 Months)|Protocol Violation|0|||
146110141|NCT01233258|526923902|FG004|First Intervention (6 Months)|Protocol Violation|0|||
146110142|NCT01233258|526923903|FG005|First Intervention (6 Months)|Protocol Violation|0|||
146110143|NCT01233258|526923898|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
146110144|NCT01233258|526923899|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
146110145|NCT01233258|526923900|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
146301351|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
146053202|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146053203|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146110146|NCT01233258|526923901|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
146110147|NCT01233258|526923902|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
146110148|NCT01233258|526923903|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
146110149|NCT00799422|526923907|FG000|First Week of Wear|Lost to Follow-up|0|||
146110150|NCT00799422|526923908|FG001|First Week of Wear|Lost to Follow-up|0|||
146110151|NCT00799422|526923909|FG002|First Week of Wear|Lost to Follow-up|1|||
146110152|NCT00799422|526923910|FG003|First Week of Wear|Lost to Follow-up|0|||
146110153|NCT00799422|526923911|FG004|First Week of Wear|Lost to Follow-up|0|||
146110154|NCT00799422|526923912|FG005|First Week of Wear|Lost to Follow-up|0|||
146110155|NCT00799422|526923907|FG000|First Week of Wear|Adverse Event|0|||
146110156|NCT00799422|526923908|FG001|First Week of Wear|Adverse Event|0|||
146110157|NCT00799422|526923909|FG002|First Week of Wear|Adverse Event|0|||
146110158|NCT00799422|526923910|FG003|First Week of Wear|Adverse Event|1|||
146110159|NCT00799422|526923911|FG004|First Week of Wear|Adverse Event|0|||
146110160|NCT00799422|526923912|FG005|First Week of Wear|Adverse Event|0|||
146110161|NCT00880009|526923913|FG000|Overall Study|Study terminated by sponsor|14|||
146110162|NCT00880009|526923913|FG000|Overall Study|Withdrawal by Subject|1|||
146110163|NCT00880009|526923913|FG000|Overall Study|Protocol Violation|1|||
146110164|NCT04112784|526923917|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
146110165|NCT04112784|526923917|FG000|Overall Study|Screen Failures|4|||
146110166|NCT02010775|526923919|FG000|Overall Study|Adverse Event|0|||
146110167|NCT02010775|526923920|FG001|Overall Study|Adverse Event|0|||
146110168|NCT02010775|526923921|FG002|Overall Study|Adverse Event|0|||
146110169|NCT02010775|526923922|FG003|Overall Study|Adverse Event|0|||
146110170|NCT02010775|526923923|FG004|Overall Study|Adverse Event|1|||
146110171|NCT02010775|526923919|FG000|Overall Study|Pregnancy|0|||
146110172|NCT02010775|526923920|FG001|Overall Study|Pregnancy|0|||
146110173|NCT02010775|526923921|FG002|Overall Study|Pregnancy|2|||
146110174|NCT02010775|526923922|FG003|Overall Study|Pregnancy|0|||
146110175|NCT02010775|526923923|FG004|Overall Study|Pregnancy|0|||
146110176|NCT02010775|526923919|FG000|Overall Study|Lost to Follow-up|2|||
146110177|NCT02010775|526923920|FG001|Overall Study|Lost to Follow-up|0|||
146110178|NCT02010775|526923921|FG002|Overall Study|Lost to Follow-up|0|||
146110179|NCT02010775|526923922|FG003|Overall Study|Lost to Follow-up|1|||
146110180|NCT02010775|526923923|FG004|Overall Study|Lost to Follow-up|1|||
146110181|NCT02010775|526923919|FG000|Overall Study|Personal Reasons|3|||
146110182|NCT02010775|526923920|FG001|Overall Study|Personal Reasons|3|||
146110183|NCT02010775|526923921|FG002|Overall Study|Personal Reasons|1|||
146110184|NCT02010775|526923922|FG003|Overall Study|Personal Reasons|2|||
146110185|NCT02010775|526923923|FG004|Overall Study|Personal Reasons|4|||
146110186|NCT00256750|526923924|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
146110187|NCT00256750|526923925|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
146110188|NCT00256750|526923926|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
146110189|NCT00256750|526923924|FG000|Transplanted Pre-Treatment|Other|2|||
146110190|NCT00256750|526923925|FG001|Transplanted Pre-Treatment|Other|0|||
146110191|NCT00256750|526923926|FG002|Transplanted Pre-Treatment|Other|0|||
146110192|NCT00256750|526923924|FG000|Transplanted Pre-Treatment|Death|1|||
146110193|NCT00256750|526923925|FG001|Transplanted Pre-Treatment|Death|0|||
146110194|NCT00256750|526923926|FG002|Transplanted Pre-Treatment|Death|0|||
146110195|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
146110196|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
146110197|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
146110198|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Death|3|||
146110199|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Death|2|||
146110200|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Death|4|||
146110201|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
146110202|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
146110203|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
146110204|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
146110205|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
146110206|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
146110207|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Other|5|||
146110208|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Other|4|||
146110209|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Other|2|||
146110210|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
146110211|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
146110212|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
146110213|NCT00256750|526923924|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
146110214|NCT00256750|526923925|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
146110215|NCT00256750|526923926|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
146110216|NCT00256750|526923924|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
146110217|NCT00256750|526923925|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
146110218|NCT00256750|526923926|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
146110219|NCT00256750|526923924|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
146110220|NCT00256750|526923925|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
146259120|NCT00943722|527463367|FG006|First Extension Study: EXT 1|Adverse Event|0|||
146259121|NCT00943722|527463361|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
146259122|NCT00943722|527463362|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
146259123|NCT00943722|527463363|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
146259124|NCT00943722|527463364|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
146259125|NCT00943722|527463365|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
146259126|NCT00943722|527463366|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
146259127|NCT00943722|527463367|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
146259128|NCT00943722|527463361|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146259129|NCT00943722|527463362|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146259130|NCT00943722|527463363|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146110221|NCT00256750|526923926|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
146110222|NCT00256750|526923924|FG000|Post-Transplant Treated (24 Months)|Death|3|||
146110223|NCT00256750|526923925|FG001|Post-Transplant Treated (24 Months)|Death|0|||
146110224|NCT00256750|526923926|FG002|Post-Transplant Treated (24 Months)|Death|0|||
146110225|NCT00256750|526923924|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
146110226|NCT00256750|526923925|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
146110227|NCT00256750|526923926|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
146110228|NCT00256750|526923924|FG000|Post-Transplant Treated (24 Months)|Other|2|||
146110229|NCT00256750|526923925|FG001|Post-Transplant Treated (24 Months)|Other|0|||
146110230|NCT00256750|526923926|FG002|Post-Transplant Treated (24 Months)|Other|1|||
146110231|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
146110232|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
146110233|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
146110234|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
146110235|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
146110236|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
146110237|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Death|0|||
146110238|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Death|2|||
146110239|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Death|1|||
146110240|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
146110241|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
146110242|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
146110243|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
146110244|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
146110245|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
146110246|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
146110247|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
146110248|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
146110249|NCT00256750|526923924|FG000|Post-Transplant Treated (36 Months)|Other|0|||
146110250|NCT00256750|526923925|FG001|Post-Transplant Treated (36 Months)|Other|1|||
146110251|NCT00256750|526923926|FG002|Post-Transplant Treated (36 Months)|Other|1|||
146110252|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
146110253|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
146110254|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
146110255|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
146110256|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
146110257|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
146110258|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
146110259|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
146110260|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
146110261|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
146110262|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
146110263|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
146053204|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146053205|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
146053206|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
146053207|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053208|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
146053209|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053210|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
146053211|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
146053212|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053213|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053214|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053215|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
146053216|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
146053217|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146053218|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
146053219|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146053220|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
146053221|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146110264|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
146110265|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
146110266|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
146110267|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
146110268|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
146301352|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
146053222|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146301353|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
146053223|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146301354|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
146301355|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
146301356|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
146301357|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
146301358|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
146301359|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
146301360|NCT03523728|527618875|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
146301361|NCT03523728|527618876|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
146301362|NCT03523728|527618877|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
146301363|NCT03523728|527618878|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
146301364|NCT03523728|527618879|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
146301365|NCT03523728|527618875|FG000|Stage 2 (24 Months)|Adverse Event|0|||
146301366|NCT03523728|527618876|FG001|Stage 2 (24 Months)|Adverse Event|0|||
146301367|NCT03523728|527618877|FG002|Stage 2 (24 Months)|Adverse Event|0|||
146301368|NCT03523728|527618878|FG003|Stage 2 (24 Months)|Adverse Event|1|||
146301369|NCT03523728|527618879|FG004|Stage 2 (24 Months)|Adverse Event|2|||
146301370|NCT03523728|527618875|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146301371|NCT03523728|527618876|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146301372|NCT03523728|527618877|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146301373|NCT03523728|527618878|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
146301374|NCT03523728|527618879|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
146301375|NCT03523728|527618875|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146301376|NCT03523728|527618876|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146301377|NCT03523728|527618877|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
146053224|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146053225|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
146053226|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146053227|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053228|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053229|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053230|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146053231|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
146053232|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053233|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053234|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053235|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
146053236|NCT02365649|526710061|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053237|NCT02365649|526710062|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053238|NCT02365649|526710063|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
146053239|NCT02365649|526710064|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053240|NCT02365649|526710065|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053241|NCT02365649|526710066|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053242|NCT02365649|526710067|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053243|NCT02365649|526710068|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053244|NCT02365649|526710069|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053245|NCT02365649|526710070|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
146053246|NCT02365649|526710061|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053247|NCT02365649|526710062|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053248|NCT02365649|526710063|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053249|NCT02365649|526710064|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053250|NCT02365649|526710065|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053251|NCT02365649|526710066|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053252|NCT02365649|526710067|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
146053253|NCT02365649|526710068|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053254|NCT02365649|526710069|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053255|NCT02365649|526710070|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
146053256|NCT02365649|526710061|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053257|NCT02365649|526710062|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053258|NCT02365649|526710063|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053259|NCT02365649|526710064|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053260|NCT02365649|526710065|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053261|NCT02365649|526710066|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053262|NCT02365649|526710067|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
146053263|NCT02365649|526710068|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
146053264|NCT02365649|526710069|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
146301378|NCT03523728|527618878|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
146301379|NCT03523728|527618879|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
146053265|NCT02365649|526710070|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
146053266|NCT02365649|526710061|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053267|NCT02365649|526710062|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053268|NCT02365649|526710063|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053269|NCT02365649|526710064|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053270|NCT02365649|526710065|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053271|NCT02365649|526710066|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
146053272|NCT02365649|526710067|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
146053273|NCT02365649|526710068|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
146053274|NCT02365649|526710069|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
146053275|NCT02365649|526710070|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
146053276|NCT02365649|526710061|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053277|NCT02365649|526710062|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053278|NCT02365649|526710063|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053279|NCT02365649|526710064|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053280|NCT02365649|526710065|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053281|NCT02365649|526710066|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053282|NCT02365649|526710067|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
146053283|NCT02365649|526710068|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
146053284|NCT02365649|526710069|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
146053285|NCT02365649|526710070|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
146053286|NCT02365649|526710061|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053287|NCT02365649|526710062|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053288|NCT02365649|526710063|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053289|NCT02365649|526710064|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053290|NCT02365649|526710065|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053291|NCT02365649|526710066|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053292|NCT02365649|526710067|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
146053293|NCT02365649|526710068|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053294|NCT02365649|526710069|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
146053295|NCT02365649|526710070|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
146053296|NCT02021565|526710082|FG000|Baseline Through Intervention|Death|0|||
146053297|NCT02021565|526710083|FG001|Baseline Through Intervention|Death|1|||
146053298|NCT02021565|526710082|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
146053299|NCT02021565|526710083|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
146110269|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
146110270|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
146110271|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
146110272|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
146110273|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
146110274|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
146110275|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
146110276|NCT00256750|526923924|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
146110277|NCT00256750|526923925|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
146110278|NCT00256750|526923926|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
146110279|NCT04659161|526923927|FG000|Overall Study|Adverse Event|10|||
146110280|NCT04659161|526923928|FG001|Overall Study|Adverse Event|6|||
146110281|NCT04659161|526923927|FG000|Overall Study|Withdrawal by Subject|13|||
146259131|NCT00943722|527463364|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146259132|NCT00943722|527463365|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
146259133|NCT00943722|527463366|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
146259134|NCT00943722|527463367|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
146259135|NCT00943722|527463361|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
146259136|NCT00943722|527463362|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
146259137|NCT00943722|527463363|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
146259138|NCT00943722|527463364|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
146259139|NCT00943722|527463365|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
146259140|NCT00943722|527463366|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
146259141|NCT00943722|527463367|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
146259142|NCT00943722|527463361|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
146259143|NCT00943722|527463362|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
146259144|NCT00943722|527463363|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
146259145|NCT00943722|527463364|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
146259146|NCT00943722|527463365|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
146110282|NCT04659161|526923928|FG001|Overall Study|Withdrawal by Subject|12|||
146110283|NCT04659161|526923927|FG000|Overall Study|Other|9|||
146110284|NCT04659161|526923928|FG001|Overall Study|Other|8|||
146301380|NCT03523728|527618875|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
146301381|NCT03523728|527618876|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
146110285|NCT02197130|526923932|FG000|Overall Study|Adverse Event|13|||
146110286|NCT02197130|526923933|FG001|Overall Study|Adverse Event|4|||
146110287|NCT02197130|526923934|FG002|Overall Study|Adverse Event|23|||
146110288|NCT02197130|526923932|FG000|Overall Study|Death|0|||
146110289|NCT02197130|526923933|FG001|Overall Study|Death|1|||
146110290|NCT02197130|526923934|FG002|Overall Study|Death|0|||
146053300|NCT02021565|526710082|FG000|Baseline Through Intervention|Protocol Violation|0|||
146053301|NCT02021565|526710083|FG001|Baseline Through Intervention|Protocol Violation|7|||
146053302|NCT02021565|526710082|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
146053303|NCT02021565|526710083|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
146053304|NCT02021565|526710082|FG000|3-month Follow-up|Death|3|||
146053305|NCT02021565|526710083|FG001|3-month Follow-up|Death|0|||
146053306|NCT02021565|526710082|FG000|3-month Follow-up|Withdrawal by Subject|4|||
146053307|NCT02021565|526710083|FG001|3-month Follow-up|Withdrawal by Subject|0|||
146053308|NCT02021565|526710082|FG000|3-month Follow-up|Protocol Violation|3|||
146053309|NCT02021565|526710083|FG001|3-month Follow-up|Protocol Violation|2|||
146110291|NCT02197130|526923932|FG000|Overall Study|Lost to Follow-up|2|||
146110292|NCT02197130|526923933|FG001|Overall Study|Lost to Follow-up|0|||
146110293|NCT02197130|526923934|FG002|Overall Study|Lost to Follow-up|1|||
146110294|NCT02197130|526923932|FG000|Overall Study|Does not meet entrance criteria|0|||
146053310|NCT01188772|526710084|FG000|Overall Study|Randomized but Not Treated|0|||
146053311|NCT01188772|526710085|FG001|Overall Study|Randomized but Not Treated|1|||
146259147|NCT00943722|527463366|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
146259148|NCT00943722|527463367|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
146259149|NCT00943722|527463361|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146259150|NCT00943722|527463362|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146259151|NCT00943722|527463363|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146259152|NCT00943722|527463364|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146259153|NCT00943722|527463365|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
146259154|NCT00943722|527463366|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
146259155|NCT00943722|527463367|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
146259156|NCT00943722|527463361|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
146259157|NCT00943722|527463362|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
146259158|NCT00943722|527463363|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
146259159|NCT00943722|527463364|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
146259160|NCT00943722|527463365|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
146259161|NCT00943722|527463366|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
146259162|NCT00943722|527463367|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
146259163|NCT00943722|527463361|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
146259164|NCT00943722|527463362|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
146259165|NCT00943722|527463363|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
146259166|NCT00943722|527463364|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
146259167|NCT00943722|527463365|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
146259168|NCT00943722|527463366|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
146259169|NCT00943722|527463367|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
146259170|NCT00943722|527463361|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146259171|NCT00943722|527463362|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146259172|NCT00943722|527463363|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146259173|NCT00943722|527463364|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146259174|NCT00943722|527463365|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
146259175|NCT00943722|527463366|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
146053312|NCT01188772|526710086|FG002|Overall Study|Randomized but Not Treated|0|||
146053313|NCT01188772|526710087|FG003|Overall Study|Randomized but Not Treated|0|||
146110295|NCT02197130|526923933|FG001|Overall Study|Does not meet entrance criteria|0|||
146110296|NCT02197130|526923934|FG002|Overall Study|Does not meet entrance criteria|1|||
146110297|NCT02197130|526923932|FG000|Overall Study|Withdrawal by Subject|0|||
146259176|NCT00943722|527463367|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
146259177|NCT01036165|527463368|FG000|Overall Study|Adverse Event|6|||
146259178|NCT01036165|527463368|FG000|Overall Study|Lost to Follow-up|2|||
146259179|NCT01036165|527463368|FG000|Overall Study|Withdrawal by Subject|3|||
146301382|NCT03523728|527618877|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
146053314|NCT01188772|526710084|FG000|Overall Study|Adverse Event|0|||
146110298|NCT02197130|526923933|FG001|Overall Study|Withdrawal by Subject|3|||
146110299|NCT02197130|526923934|FG002|Overall Study|Withdrawal by Subject|4|||
146259180|NCT01036165|527463368|FG000|Overall Study|Device Related Issues|3|||
146259181|NCT01036165|527463368|FG000|Overall Study|Problems finding proper area to inject|1|||
146259182|NCT00307164|527463371|FG000|Overall Study|Death|1|||
146110300|NCT02197130|526923932|FG000|Overall Study|Other|1|||
146259183|NCT00307164|527463372|FG001|Overall Study|Death|0|||
146053315|NCT01188772|526710085|FG001|Overall Study|Adverse Event|1|||
146110301|NCT02197130|526923933|FG001|Overall Study|Other|0|||
146053316|NCT01188772|526710086|FG002|Overall Study|Adverse Event|2|||
146053317|NCT01188772|526710087|FG003|Overall Study|Adverse Event|0|||
146053318|NCT01188772|526710084|FG000|Overall Study|Lost to Follow-up|4|||
146053319|NCT01188772|526710085|FG001|Overall Study|Lost to Follow-up|1|||
146053320|NCT01188772|526710086|FG002|Overall Study|Lost to Follow-up|1|||
146053321|NCT01188772|526710087|FG003|Overall Study|Lost to Follow-up|1|||
146053322|NCT01188772|526710084|FG000|Overall Study|Non-responder|0|||
146053323|NCT01188772|526710085|FG001|Overall Study|Non-responder|0|||
146053324|NCT01188772|526710086|FG002|Overall Study|Non-responder|3|||
146053325|NCT01188772|526710087|FG003|Overall Study|Non-responder|0|||
146053326|NCT01188772|526710084|FG000|Overall Study|Physician Decision|0|||
146053327|NCT01188772|526710085|FG001|Overall Study|Physician Decision|0|||
146053328|NCT01188772|526710086|FG002|Overall Study|Physician Decision|1|||
146053329|NCT01188772|526710087|FG003|Overall Study|Physician Decision|0|||
146053330|NCT01188772|526710084|FG000|Overall Study|Terminated by Sponsor|0|||
146110302|NCT02197130|526923934|FG002|Overall Study|Other|3|||
146110303|NCT02615145|526923935|FG000|Overall Study|Did Not Start Treatment|0|||
146110304|NCT02615145|526923936|FG001|Overall Study|Did Not Start Treatment|0|||
146110305|NCT02615145|526923937|FG002|Overall Study|Did Not Start Treatment|1|||
146110306|NCT02615145|526923938|FG003|Overall Study|Did Not Start Treatment|1|||
146110307|NCT02615145|526923935|FG000|Overall Study|Failure to Return|20|||
146110308|NCT02615145|526923936|FG001|Overall Study|Failure to Return|10|||
146110309|NCT02615145|526923937|FG002|Overall Study|Failure to Return|7|||
146110310|NCT02615145|526923938|FG003|Overall Study|Failure to Return|0|||
146110311|NCT02615145|526923935|FG000|Overall Study|Death|2|||
146110312|NCT02615145|526923936|FG001|Overall Study|Death|3|||
146110313|NCT02615145|526923937|FG002|Overall Study|Death|0|||
146110314|NCT02615145|526923938|FG003|Overall Study|Death|0|||
146110315|NCT02615145|526923935|FG000|Overall Study|Other, Not Specified|5|||
146110316|NCT02615145|526923936|FG001|Overall Study|Other, Not Specified|2|||
146110317|NCT02615145|526923937|FG002|Overall Study|Other, Not Specified|0|||
146110318|NCT02615145|526923938|FG003|Overall Study|Other, Not Specified|0|||
146110319|NCT01269463|526923945|FG000|First Intervention|Withdrawal by Subject|1|||
146301383|NCT03523728|527618878|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
146301384|NCT03523728|527618879|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
146301385|NCT03523728|527618875|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
146301386|NCT03523728|527618876|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
146301387|NCT03523728|527618877|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
146301388|NCT03523728|527618878|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
146301389|NCT03523728|527618879|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
146301390|NCT00621751|527618880|FG000|Overall Study|Adverse Event|0|||
146301391|NCT00621751|527618881|FG001|Overall Study|Adverse Event|1|||
146301392|NCT00419120|527618883|FG000|Long Term Follow up Period|study ongoing|10|||
146301393|NCT01069120|527618884|FG000|Overall Study|Study prematurely terminated|27|||
146301394|NCT00763971|527618885|FG000|Overall Study|Adverse Event|5|||
146301395|NCT00763971|527618886|FG001|Overall Study|Adverse Event|2|||
146301396|NCT00763971|527618887|FG002|Overall Study|Adverse Event|4|||
146301397|NCT00763971|527618885|FG000|Overall Study|Protocol Violation|3|||
146301398|NCT00763971|527618886|FG001|Overall Study|Protocol Violation|3|||
146301399|NCT00763971|527618887|FG002|Overall Study|Protocol Violation|2|||
146301400|NCT00763971|527618885|FG000|Overall Study|Withdrawal by Subject|4|||
146301401|NCT00763971|527618886|FG001|Overall Study|Withdrawal by Subject|5|||
146301402|NCT00763971|527618887|FG002|Overall Study|Withdrawal by Subject|5|||
146301403|NCT00763971|527618885|FG000|Overall Study|Lost to Follow-up|0|||
146301404|NCT00763971|527618886|FG001|Overall Study|Lost to Follow-up|1|||
146301405|NCT00763971|527618887|FG002|Overall Study|Lost to Follow-up|0|||
146301406|NCT00763971|527618885|FG000|Overall Study|Lack of Efficacy|11|||
146301407|NCT00763971|527618886|FG001|Overall Study|Lack of Efficacy|22|||
146301408|NCT00763971|527618887|FG002|Overall Study|Lack of Efficacy|54|||
146301409|NCT00763971|527618885|FG000|Overall Study|Unable to swallow capsule|2|||
146301410|NCT00763971|527618886|FG001|Overall Study|Unable to swallow capsule|1|||
146301411|NCT00763971|527618887|FG002|Overall Study|Unable to swallow capsule|1|||
146301412|NCT00763971|527618885|FG000|Overall Study|Personal reason|3|||
146301413|NCT00763971|527618886|FG001|Overall Study|Personal reason|0|||
146301414|NCT00763971|527618887|FG002|Overall Study|Personal reason|0|||
146301415|NCT00763971|527618885|FG000|Overall Study|Exclusion criteria met|1|||
146301416|NCT00763971|527618886|FG001|Overall Study|Exclusion criteria met|0|||
146053331|NCT01188772|526710085|FG001|Overall Study|Terminated by Sponsor|0|||
146053332|NCT01188772|526710086|FG002|Overall Study|Terminated by Sponsor|1|||
146110320|NCT01269463|526923946|FG001|First Intervention|Withdrawal by Subject|0|||
146110321|NCT01269463|526923945|FG000|First Intervention|Adverse Event|1|||
146110322|NCT01269463|526923946|FG001|First Intervention|Adverse Event|0|||
146053333|NCT01188772|526710087|FG003|Overall Study|Terminated by Sponsor|0|||
146053334|NCT01188772|526710084|FG000|Overall Study|Treatment Failure|0|||
146053335|NCT01188772|526710085|FG001|Overall Study|Treatment Failure|0|||
146053336|NCT01188772|526710086|FG002|Overall Study|Treatment Failure|1|||
146110323|NCT01269463|526923945|FG000|First Intervention|Lack of Efficacy|0|||
146110324|NCT01269463|526923946|FG001|First Intervention|Lack of Efficacy|1|||
146110325|NCT01269463|526923945|FG000|First Intervention|Physician Decision|0|||
146110326|NCT01269463|526923946|FG001|First Intervention|Physician Decision|1|||
146110327|NCT04404361|526923950|FG000|Overall Study|Death|12|||
146110328|NCT04404361|526923951|FG001|Overall Study|Death|12|||
146110329|NCT04404361|526923950|FG000|Overall Study|Withdrawal by Subject|13|||
146110330|NCT04404361|526923951|FG001|Overall Study|Withdrawal by Subject|5|||
146110331|NCT04404361|526923950|FG000|Overall Study|Lost to Follow-up|6|||
146110332|NCT04404361|526923951|FG001|Overall Study|Lost to Follow-up|3|||
146110333|NCT04404361|526923950|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
146110334|NCT04404361|526923951|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
146110335|NCT00558558|526923952|FG000|Overall Study|Unable to swallow|1|||
146110336|NCT00558558|526923952|FG000|Overall Study|Withdrawal by Subject|1|||
146110337|NCT00558558|526923952|FG000|Overall Study|Lack of Efficacy|4|||
146110338|NCT02549937|526923954|FG000|Overall Study|Death|0|||
146110339|NCT02549937|526923955|FG001|Overall Study|Death|1|||
146053337|NCT01188772|526710087|FG003|Overall Study|Treatment Failure|0|||
146053338|NCT01188772|526710084|FG000|Overall Study|Virologic Failure|1|||
146110340|NCT02549937|526923956|FG002|Overall Study|Death|0|||
146110341|NCT02549937|526923957|FG003|Overall Study|Death|1|||
146110342|NCT02549937|526923958|FG004|Overall Study|Death|0|||
146110343|NCT02549937|526923959|FG005|Overall Study|Death|8|||
146110344|NCT02549937|526923960|FG006|Overall Study|Death|0|||
146110345|NCT02549937|526923961|FG007|Overall Study|Death|0|||
146110346|NCT02549937|526923962|FG008|Overall Study|Death|19|||
146259184|NCT00307164|527463371|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146053339|NCT01188772|526710085|FG001|Overall Study|Virologic Failure|0|||
146053340|NCT01188772|526710086|FG002|Overall Study|Virologic Failure|0|||
146053341|NCT01188772|526710087|FG003|Overall Study|Virologic Failure|0|||
146053342|NCT01188772|526710084|FG000|Overall Study|Withdrawal by Subject|0|||
146053343|NCT01188772|526710085|FG001|Overall Study|Withdrawal by Subject|0|||
146053344|NCT01188772|526710086|FG002|Overall Study|Withdrawal by Subject|2|||
146053345|NCT01188772|526710087|FG003|Overall Study|Withdrawal by Subject|0|||
146053346|NCT00154297|526710099|FG000|Overall Study|Death|5|||
146053347|NCT00154297|526710100|FG001|Overall Study|Death|2|||
146053348|NCT00154297|526710099|FG000|Overall Study|Withdrawal by Subject|0|||
146053349|NCT00154297|526710100|FG001|Overall Study|Withdrawal by Subject|5|||
146053350|NCT00154297|526710099|FG000|Overall Study|Lost to Follow-up|3|||
146053351|NCT00154297|526710100|FG001|Overall Study|Lost to Follow-up|0|||
146053352|NCT00650767|526710101|FG000|Overall Study|Adverse Event|0|||
146053353|NCT00650767|526710102|FG001|Overall Study|Adverse Event|3|||
146053354|NCT00650767|526710103|FG002|Overall Study|Adverse Event|10|||
146053355|NCT00650767|526710104|FG003|Overall Study|Adverse Event|8|||
146053356|NCT00650767|526710101|FG000|Overall Study|Death|1|||
146053357|NCT00650767|526710102|FG001|Overall Study|Death|0|||
146259185|NCT00307164|527463372|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146259186|NCT00307164|527463371|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
146259187|NCT00307164|527463372|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
146259188|NCT00307164|527463371|FG000|Overall Study|Withdrawal by Subject|1|||
146259189|NCT00307164|527463372|FG001|Overall Study|Withdrawal by Subject|8|||
146259190|NCT00307164|527463371|FG000|Overall Study|Not compliant with requirements|4|||
146259191|NCT00307164|527463372|FG001|Overall Study|Not compliant with requirements|4|||
146259192|NCT00307164|527463371|FG000|Overall Study|Lost to Follow-up|6|||
146259193|NCT00307164|527463372|FG001|Overall Study|Lost to Follow-up|1|||
146259194|NCT01649297|527463373|FG000|Overall Study|Adverse Event|5|||
146259195|NCT01649297|527463374|FG001|Overall Study|Adverse Event|5|||
146259196|NCT01649297|527463375|FG002|Overall Study|Adverse Event|4|||
146259197|NCT01649297|527463376|FG003|Overall Study|Adverse Event|13|||
146259198|NCT01649297|527463377|FG004|Overall Study|Adverse Event|1|||
146259199|NCT01649297|527463373|FG000|Overall Study|Lack of Efficacy|0|||
146259200|NCT01649297|527463374|FG001|Overall Study|Lack of Efficacy|0|||
146259201|NCT01649297|527463375|FG002|Overall Study|Lack of Efficacy|0|||
146259202|NCT01649297|527463376|FG003|Overall Study|Lack of Efficacy|0|||
146053358|NCT00650767|526710103|FG002|Overall Study|Death|0|||
146053359|NCT00650767|526710104|FG003|Overall Study|Death|0|||
146053360|NCT00650767|526710101|FG000|Overall Study|Withdrawal by Subject|2|||
146110347|NCT02549937|526923954|FG000|Overall Study|No follow up required|3|||
146110348|NCT02549937|526923955|FG001|Overall Study|No follow up required|6|||
146259203|NCT01649297|527463377|FG004|Overall Study|Lack of Efficacy|1|||
146259204|NCT01649297|527463373|FG000|Overall Study|Non compliant with Protocol|1|||
146259205|NCT01649297|527463374|FG001|Overall Study|Non compliant with Protocol|0|||
146053361|NCT00650767|526710102|FG001|Overall Study|Withdrawal by Subject|4|||
146053362|NCT00650767|526710103|FG002|Overall Study|Withdrawal by Subject|3|||
146053363|NCT00650767|526710104|FG003|Overall Study|Withdrawal by Subject|3|||
146053364|NCT00650767|526710101|FG000|Overall Study|Lost to Follow-up|1|||
146053365|NCT00650767|526710102|FG001|Overall Study|Lost to Follow-up|1|||
146110349|NCT02549937|526923956|FG002|Overall Study|No follow up required|3|||
146110350|NCT02549937|526923957|FG003|Overall Study|No follow up required|8|||
146110351|NCT02549937|526923958|FG004|Overall Study|No follow up required|12|||
146110352|NCT02549937|526923959|FG005|Overall Study|No follow up required|21|||
146110353|NCT02549937|526923960|FG006|Overall Study|No follow up required|9|||
146110354|NCT02549937|526923961|FG007|Overall Study|No follow up required|11|||
146110355|NCT02549937|526923962|FG008|Overall Study|No follow up required|0|||
146110356|NCT02549937|526923954|FG000|Overall Study|Other|0|||
146110357|NCT02549937|526923955|FG001|Overall Study|Other|0|||
146110358|NCT02549937|526923956|FG002|Overall Study|Other|0|||
146110359|NCT02549937|526923957|FG003|Overall Study|Other|0|||
146110360|NCT02549937|526923958|FG004|Overall Study|Other|1|||
146110361|NCT02549937|526923959|FG005|Overall Study|Other|0|||
146110362|NCT02549937|526923960|FG006|Overall Study|Other|3|||
146110363|NCT02549937|526923961|FG007|Overall Study|Other|2|||
146110364|NCT02549937|526923962|FG008|Overall Study|Other|3|||
146110365|NCT02549937|526923954|FG000|Overall Study|Lost to Follow-up|0|||
146110366|NCT02549937|526923955|FG001|Overall Study|Lost to Follow-up|0|||
146110367|NCT02549937|526923956|FG002|Overall Study|Lost to Follow-up|0|||
146110368|NCT02549937|526923957|FG003|Overall Study|Lost to Follow-up|0|||
146110369|NCT02549937|526923958|FG004|Overall Study|Lost to Follow-up|0|||
146110370|NCT02549937|526923959|FG005|Overall Study|Lost to Follow-up|0|||
146110371|NCT02549937|526923960|FG006|Overall Study|Lost to Follow-up|0|||
146110372|NCT02549937|526923961|FG007|Overall Study|Lost to Follow-up|0|||
146110373|NCT02549937|526923962|FG008|Overall Study|Lost to Follow-up|3|||
146110374|NCT02549937|526923954|FG000|Overall Study|Withdrawal by Subject|0|||
146110375|NCT02549937|526923955|FG001|Overall Study|Withdrawal by Subject|0|||
146110376|NCT02549937|526923956|FG002|Overall Study|Withdrawal by Subject|0|||
146110377|NCT02549937|526923957|FG003|Overall Study|Withdrawal by Subject|0|||
146110378|NCT02549937|526923958|FG004|Overall Study|Withdrawal by Subject|0|||
146110379|NCT02549937|526923959|FG005|Overall Study|Withdrawal by Subject|1|||
146110380|NCT02549937|526923960|FG006|Overall Study|Withdrawal by Subject|4|||
146110381|NCT02549937|526923961|FG007|Overall Study|Withdrawal by Subject|3|||
146110382|NCT02549937|526923962|FG008|Overall Study|Withdrawal by Subject|2|||
146110383|NCT02549937|526923954|FG000|Overall Study|Sponsor Decision|0|||
146110384|NCT02549937|526923955|FG001|Overall Study|Sponsor Decision|0|||
146110385|NCT02549937|526923956|FG002|Overall Study|Sponsor Decision|0|||
146110386|NCT02549937|526923957|FG003|Overall Study|Sponsor Decision|0|||
146110387|NCT02549937|526923958|FG004|Overall Study|Sponsor Decision|0|||
146110388|NCT02549937|526923959|FG005|Overall Study|Sponsor Decision|0|||
146110389|NCT02549937|526923960|FG006|Overall Study|Sponsor Decision|0|||
146110390|NCT02549937|526923961|FG007|Overall Study|Sponsor Decision|0|||
146110391|NCT02549937|526923962|FG008|Overall Study|Sponsor Decision|6|||
146110392|NCT00317356|526923963|FG000|Overall Study|Adverse Event|0|||
146110393|NCT00317356|526923964|FG001|Overall Study|Adverse Event|0|||
146110394|NCT00317356|526923965|FG002|Overall Study|Adverse Event|1|||
146110395|NCT00317356|526923966|FG003|Overall Study|Adverse Event|0|||
146110396|NCT00317356|526923963|FG000|Overall Study|Lack of Efficacy|1|||
146110397|NCT00317356|526923964|FG001|Overall Study|Lack of Efficacy|1|||
146110398|NCT00317356|526923965|FG002|Overall Study|Lack of Efficacy|0|||
146110399|NCT00317356|526923966|FG003|Overall Study|Lack of Efficacy|3|||
146110400|NCT00317356|526923963|FG000|Overall Study|Physician Decision|0|||
146110401|NCT00317356|526923964|FG001|Overall Study|Physician Decision|1|||
146110402|NCT00317356|526923965|FG002|Overall Study|Physician Decision|0|||
146110403|NCT00317356|526923966|FG003|Overall Study|Physician Decision|0|||
146110404|NCT03199274|526923967|FG000|Overall Study|Withdrawal by Subject|4|||
146110405|NCT03199274|526923968|FG001|Overall Study|Withdrawal by Subject|0|||
146110406|NCT03199274|526923967|FG000|Overall Study|Lost to Follow-up|0|||
146110407|NCT03199274|526923968|FG001|Overall Study|Lost to Follow-up|1|||
146110408|NCT03199274|526923967|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
146110409|NCT03199274|526923968|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
146110410|NCT05980182|526923969|FG000|Overall Study|Lost to Follow-up|10|||
146110411|NCT00638378|526925823|FG000|Overall Study|Death|2|||
146110412|NCT00638378|526925823|FG000|Overall Study|Adverse Event|1|||
146110413|NCT00638378|526925823|FG000|Overall Study|Disease progression|15|||
146110414|NCT00638378|526925823|FG000|Overall Study|Physician Decision|4|||
146301417|NCT00763971|527618887|FG002|Overall Study|Exclusion criteria met|0|||
146301418|NCT00763971|527618885|FG000|Overall Study|Sponsor decision|1|||
146110415|NCT03761277|526925831|FG000|Enrollment to Implant|Screen Failure|17|||
146110416|NCT03761277|526925831|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
146110417|NCT03761277|526925831|FG000|Enrollment to Implant|Physician Decision|2|||
146301419|NCT00763971|527618886|FG001|Overall Study|Sponsor decision|0|||
146110418|NCT03761277|526925831|FG000|Enrollment to Implant|Site Closure|3|||
146110419|NCT03761277|526925831|FG000|Enrollment to Implant|Sponsor Request|2|||
146110420|NCT03761277|526925831|FG000|Post-Implant to 6 Months|Adverse Event|2|||
146110421|NCT03761277|526925831|FG000|Post-Implant to 6 Months|Death|1|||
146110422|NCT03761277|526925831|FG000|Post-Implant to 6 Months|Site Closure|2|||
146110423|NCT03761277|526925831|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
146110424|NCT03761277|526925831|FG000|6 Months to 12 Months|Physician Decision|2|||
146110425|NCT03761277|526925831|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
146110426|NCT00684307|526925832|FG000|Overall Study|Adverse Event|11|||
146110427|NCT00684307|526925833|FG001|Overall Study|Adverse Event|6|||
146110428|NCT00684307|526925834|FG002|Overall Study|Adverse Event|15|||
146110429|NCT00684307|526925835|FG003|Overall Study|Adverse Event|16|||
146110430|NCT00684307|526925836|FG004|Overall Study|Adverse Event|8|||
146110431|NCT00684307|526925832|FG000|Overall Study|Development of increasing Liver Function|0|||
146110432|NCT00684307|526925833|FG001|Overall Study|Development of increasing Liver Function|2|||
146259206|NCT01649297|527463375|FG002|Overall Study|Non compliant with Protocol|3|||
146259207|NCT01649297|527463376|FG003|Overall Study|Non compliant with Protocol|2|||
146110433|NCT00684307|526925834|FG002|Overall Study|Development of increasing Liver Function|0|||
146110434|NCT00684307|526925835|FG003|Overall Study|Development of increasing Liver Function|1|||
146110435|NCT00684307|526925836|FG004|Overall Study|Development of increasing Liver Function|0|||
146110436|NCT00684307|526925832|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
146110437|NCT00684307|526925833|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
146110438|NCT00684307|526925834|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
146110439|NCT00684307|526925835|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
146110440|NCT00684307|526925836|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
146110441|NCT00684307|526925832|FG000|Overall Study|Incorrect enrolment or randomization|4|||
146110442|NCT00684307|526925833|FG001|Overall Study|Incorrect enrolment or randomization|0|||
146110443|NCT00684307|526925834|FG002|Overall Study|Incorrect enrolment or randomization|0|||
146110444|NCT00684307|526925835|FG003|Overall Study|Incorrect enrolment or randomization|0|||
146110445|NCT00684307|526925836|FG004|Overall Study|Incorrect enrolment or randomization|0|||
146110446|NCT00684307|526925832|FG000|Overall Study|Interupted IP for more than 7 days|0|||
146110447|NCT00684307|526925833|FG001|Overall Study|Interupted IP for more than 7 days|4|||
146110448|NCT00684307|526925834|FG002|Overall Study|Interupted IP for more than 7 days|1|||
146110449|NCT00684307|526925835|FG003|Overall Study|Interupted IP for more than 7 days|3|||
146110450|NCT00684307|526925836|FG004|Overall Study|Interupted IP for more than 7 days|3|||
146110451|NCT00684307|526925832|FG000|Overall Study|Severe non compliance to protocol|1|||
146110452|NCT00684307|526925833|FG001|Overall Study|Severe non compliance to protocol|0|||
146110453|NCT00684307|526925834|FG002|Overall Study|Severe non compliance to protocol|0|||
146110454|NCT00684307|526925835|FG003|Overall Study|Severe non compliance to protocol|1|||
146110455|NCT00684307|526925836|FG004|Overall Study|Severe non compliance to protocol|2|||
146110456|NCT00684307|526925832|FG000|Overall Study|Participant not willing to continue|7|||
146110457|NCT00684307|526925833|FG001|Overall Study|Participant not willing to continue|10|||
146110458|NCT00684307|526925834|FG002|Overall Study|Participant not willing to continue|11|||
146110459|NCT00684307|526925835|FG003|Overall Study|Participant not willing to continue|5|||
146110460|NCT00684307|526925836|FG004|Overall Study|Participant not willing to continue|8|||
146110461|NCT00684307|526925832|FG000|Overall Study|Criteria from the CSR|0|||
146110462|NCT00684307|526925833|FG001|Overall Study|Criteria from the CSR|0|||
146110463|NCT00684307|526925834|FG002|Overall Study|Criteria from the CSR|1|||
146110464|NCT00684307|526925835|FG003|Overall Study|Criteria from the CSR|3|||
146110465|NCT00684307|526925836|FG004|Overall Study|Criteria from the CSR|3|||
146110466|NCT00543140|526925837|FG000|Overall Study|Lost to Follow-up|33|||
146053366|NCT00650767|526710103|FG002|Overall Study|Lost to Follow-up|1|||
146053367|NCT00650767|526710104|FG003|Overall Study|Lost to Follow-up|0|||
146053368|NCT00650767|526710101|FG000|Overall Study|Other|1|||
146053369|NCT00650767|526710102|FG001|Overall Study|Other|1|||
146053370|NCT00650767|526710103|FG002|Overall Study|Other|0|||
146053371|NCT00650767|526710104|FG003|Overall Study|Other|0|||
146053372|NCT01774799|526710105|FG000|Overall Study|Lost to Follow-up|1|||
146053373|NCT01774799|526710106|FG001|Overall Study|Lost to Follow-up|1|||
146053374|NCT01774799|526710107|FG002|Overall Study|Lost to Follow-up|0|||
146053375|NCT01774799|526710108|FG003|Overall Study|Lost to Follow-up|0|||
146053376|NCT04393493|526710109|FG000|First 4 Days of Intervention|Early improvement|5|||
146053377|NCT04393493|526710110|FG001|First 4 Days of Intervention|Early improvement|7|||
146053378|NCT02910466|526710111|FG000|Overall Study|Adverse Event|1|||
146053379|NCT02910466|526710111|FG000|Overall Study|Withdrawal by Subject|3|||
146053380|NCT02910466|526710111|FG000|Overall Study|Lost to Follow-up|5|||
146053381|NCT02910466|526710111|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
146110467|NCT00543140|526925837|FG000|Overall Study|Withdrawal by Subject|13|||
146110468|NCT00543140|526925837|FG000|Overall Study|Protocol Violation|10|||
146110469|NCT00543140|526925837|FG000|Overall Study|Insufficient weight loss|10|||
146110470|NCT00543140|526925837|FG000|Overall Study|SAE leading to explant of SAGB|3|||
146110471|NCT00543140|526925837|FG000|Overall Study|Death|1|||
146110472|NCT00543140|526925837|FG000|Overall Study|Subject moved|1|||
146110473|NCT00543140|526925837|FG000|Overall Study|Conversion to different procedure|1|||
146110474|NCT00578812|526925838|FG000|Overall Study|Not treated|6|||
146110475|NCT00578812|526925839|FG001|Overall Study|Not treated|7|||
146110476|NCT04532164|526925840|FG000|Overall Study|Adverse Event|1|||
146053382|NCT02910466|526710111|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
146053383|NCT01125800|526710112|FG000|Phase I|Protocol Violation|0|||
146053384|NCT01125800|526710113|FG001|Phase I|Protocol Violation|3|||
146053385|NCT01125800|526710114|FG002|Phase I|Protocol Violation|1|||
146110477|NCT04532164|526925840|FG000|Overall Study|Protocol Violation|5|||
146110478|NCT04532164|526925840|FG000|Overall Study|Lost to Follow-up|1|||
146053386|NCT01125800|526710115|FG003|Phase I|Protocol Violation|1|||
146053387|NCT01125800|526710116|FG004|Phase I|Protocol Violation|0|||
146053388|NCT01125800|526710112|FG000|Phase I|Adverse Event|2|||
146053389|NCT01125800|526710113|FG001|Phase I|Adverse Event|2|||
146053390|NCT01125800|526710114|FG002|Phase I|Adverse Event|1|||
146053391|NCT01125800|526710115|FG003|Phase I|Adverse Event|7|||
146053392|NCT01125800|526710116|FG004|Phase I|Adverse Event|0|||
146053393|NCT01125800|526710112|FG000|Phase I|Administrative problems|1|||
146053394|NCT01125800|526710113|FG001|Phase I|Administrative problems|0|||
146053395|NCT01125800|526710114|FG002|Phase I|Administrative problems|0|||
146053396|NCT01125800|526710115|FG003|Phase I|Administrative problems|0|||
146053397|NCT01125800|526710116|FG004|Phase I|Administrative problems|0|||
146053398|NCT01125800|526710112|FG000|Phase I|Withdrawal by Subject|0|||
146053399|NCT01125800|526710113|FG001|Phase I|Withdrawal by Subject|0|||
146053400|NCT01125800|526710114|FG002|Phase I|Withdrawal by Subject|1|||
146053401|NCT01125800|526710115|FG003|Phase I|Withdrawal by Subject|0|||
146053402|NCT01125800|526710116|FG004|Phase I|Withdrawal by Subject|0|||
146053403|NCT01125800|526710112|FG000|Phase I|Disease progression|5|||
146053404|NCT01125800|526710113|FG001|Phase I|Disease progression|4|||
146053405|NCT01125800|526710114|FG002|Phase I|Disease progression|1|||
146053406|NCT01125800|526710115|FG003|Phase I|Disease progression|3|||
146053407|NCT01125800|526710116|FG004|Phase I|Disease progression|0|||
146053408|NCT01125800|526710112|FG000|Phase II|Protocol Violation|0|||
146053409|NCT01125800|526710113|FG001|Phase II|Protocol Violation|0|||
146053410|NCT01125800|526710114|FG002|Phase II|Protocol Violation|0|||
146053411|NCT01125800|526710115|FG003|Phase II|Protocol Violation|0|||
146053412|NCT01125800|526710116|FG004|Phase II|Protocol Violation|1|||
146053413|NCT01125800|526710112|FG000|Phase II|Adverse Event|0|||
146053414|NCT01125800|526710113|FG001|Phase II|Adverse Event|0|||
146053415|NCT01125800|526710114|FG002|Phase II|Adverse Event|0|||
146053416|NCT01125800|526710115|FG003|Phase II|Adverse Event|0|||
146053417|NCT01125800|526710116|FG004|Phase II|Adverse Event|2|||
146053418|NCT01125800|526710112|FG000|Phase II|Disease progression|0|||
146053419|NCT01125800|526710113|FG001|Phase II|Disease progression|0|||
146053420|NCT01125800|526710114|FG002|Phase II|Disease progression|0|||
146053421|NCT01125800|526710115|FG003|Phase II|Disease progression|1|||
146053422|NCT01125800|526710116|FG004|Phase II|Disease progression|8|||
146053423|NCT00141102|526710117|FG000|Overall Study|Adverse Event|233|||
146053424|NCT00141102|526710118|FG001|Overall Study|Adverse Event|305|||
146053425|NCT00141102|526710117|FG000|Overall Study|Laboratory Abnormality|9|||
146053426|NCT00141102|526710118|FG001|Overall Study|Laboratory Abnormality|33|||
146053427|NCT00141102|526710117|FG000|Overall Study|Lack of Efficacy|21|||
146053428|NCT00141102|526710118|FG001|Overall Study|Lack of Efficacy|26|||
146053429|NCT00141102|526710117|FG000|Overall Study|Lost to Follow-up|29|||
146053430|NCT00141102|526710118|FG001|Overall Study|Lost to Follow-up|32|||
146053431|NCT00141102|526710117|FG000|Overall Study|Other|87|||
146053432|NCT00141102|526710118|FG001|Overall Study|Other|76|||
146053433|NCT00141102|526710117|FG000|Overall Study|Withdrawal by Subject|112|||
146053434|NCT00141102|526710118|FG001|Overall Study|Withdrawal by Subject|142|||
146053435|NCT00141102|526710117|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
146053436|NCT00141102|526710118|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
146053437|NCT00141102|526710117|FG000|Overall Study|Death|2|||
146053438|NCT00141102|526710118|FG001|Overall Study|Death|2|||
146053439|NCT03061201|526710119|FG000|Overall Study|Participants Terminated at Month 36|0|||
146053440|NCT03061201|526710120|FG001|Overall Study|Participants Terminated at Month 36|1|||
146053441|NCT03061201|526710121|FG002|Overall Study|Participants Terminated at Month 36|0|||
146053442|NCT03061201|526710122|FG003|Overall Study|Participants Terminated at Month 36|1|||
146053443|NCT03061201|526710119|FG000|Overall Study|Lost to Follow-up|1|||
146053444|NCT03061201|526710120|FG001|Overall Study|Lost to Follow-up|0|||
146053445|NCT03061201|526710121|FG002|Overall Study|Lost to Follow-up|0|||
146053446|NCT03061201|526710122|FG003|Overall Study|Lost to Follow-up|0|||
146053447|NCT04037891|526710123|FG000|Open-label Period|Withdrawal by Subject|1|||
146053448|NCT04037891|526710124|FG001|Open-label Period|Withdrawal by Subject|0|||
146053449|NCT04037891|526710125|FG002|Open-label Period|Withdrawal by Subject|0|||
146053450|NCT04037891|526710123|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
146053451|NCT04037891|526710124|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
146053452|NCT04037891|526710125|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
146053453|NCT03446313|526710127|FG000|Overall Study|Lost to Follow-up|1|||
146053454|NCT03446313|526710128|FG001|Overall Study|Lost to Follow-up|2|||
146053455|NCT03446313|526710127|FG000|Overall Study|Failed primary screening|3|||
146053456|NCT03446313|526710128|FG001|Overall Study|Failed primary screening|0|||
146053457|NCT03446313|526710127|FG000|Overall Study|Diagnosed with terminal cancer|1|||
146053458|NCT03446313|526710128|FG001|Overall Study|Diagnosed with terminal cancer|0|||
146053459|NCT03446313|526710127|FG000|Overall Study|Excluded from analysis|1|||
146053460|NCT03446313|526710128|FG001|Overall Study|Excluded from analysis|1|||
146053461|NCT00866814|526710134|FG000|Overall Study|Lost to Follow-up|12|||
146053462|NCT00866814|526710134|FG000|Overall Study|Adverse Event|2|||
146053463|NCT00866814|526710134|FG000|Overall Study|Physician Decision|1|||
146053464|NCT00866814|526710134|FG000|Overall Study|Death|1|||
146053465|NCT00866814|526710134|FG000|Overall Study|No longer wished to participate|1|||
146053466|NCT00866814|526710134|FG000|Overall Study|Unable to meet follow-up requirements|2|||
146053467|NCT00866814|526710134|FG000|Overall Study|Moved to area without study site|1|||
146053468|NCT04491136|526710135|FG000|Overall Study|Patient withdraw informed consent|9|||
146053469|NCT04491136|526710135|FG000|Overall Study|Adverse Event|2|||
146053470|NCT04491136|526710135|FG000|Overall Study|Death|3|||
146053471|NCT04491136|526710135|FG000|Overall Study|Lost to Follow-up|3|||
146053472|NCT04491136|526710135|FG000|Overall Study|Physician Decision|45|||
146053473|NCT04491136|526710135|FG000|Overall Study|sponsor terminated the study early|16|||
146053474|NCT04491136|526710135|FG000|Overall Study|Patient/guardian's decision|1|||
146053475|NCT01505374|526710140|FG000|Overall Study|Lost to Follow-up|1|||
146053476|NCT01505374|526710141|FG001|Overall Study|Lost to Follow-up|0|||
146053477|NCT02360228|526710142|FG000|Overall Study|Withdrawal by Subject|1|||
146053478|NCT02360228|526710143|FG001|Overall Study|Withdrawal by Subject|0|||
146053479|NCT02360228|526710144|FG002|Overall Study|Withdrawal by Subject|0|||
146053480|NCT02360228|526710142|FG000|Overall Study|Self-discontinued medication|0|||
146053481|NCT02360228|526710143|FG001|Overall Study|Self-discontinued medication|1|||
146053482|NCT02360228|526710144|FG002|Overall Study|Self-discontinued medication|0|||
146053483|NCT02360228|526710142|FG000|Overall Study|Unstable symptoms during screening|0|||
146053484|NCT02360228|526710143|FG001|Overall Study|Unstable symptoms during screening|0|||
146053485|NCT02360228|526710144|FG002|Overall Study|Unstable symptoms during screening|1|||
146053486|NCT02464410|526710147|FG000|Overall Study|Death|3|||
146053487|NCT02464410|526710148|FG001|Overall Study|Death|4|||
146053488|NCT02464410|526710147|FG000|Overall Study|Lost to Follow-up|7|||
146053489|NCT02464410|526710148|FG001|Overall Study|Lost to Follow-up|9|||
146053490|NCT02464410|526710147|FG000|Overall Study|Withdrawal by Subject|12|||
146053491|NCT02464410|526710148|FG001|Overall Study|Withdrawal by Subject|3|||
146053492|NCT00851786|526710151|FG000|Overall Study|Withdrawal by Subject|0|||
146053493|NCT00851786|526710152|FG001|Overall Study|Withdrawal by Subject|1|||
146053494|NCT00851786|526710151|FG000|Overall Study|Protocol Violation|0|||
146053495|NCT00851786|526710152|FG001|Overall Study|Protocol Violation|1|||
146053496|NCT00851786|526710151|FG000|Overall Study|Lost to Follow-up|1|||
146053497|NCT00851786|526710152|FG001|Overall Study|Lost to Follow-up|0|||
146053498|NCT00851786|526710151|FG000|Overall Study|Incarceration|1|||
146053499|NCT00851786|526710152|FG001|Overall Study|Incarceration|0|||
146053500|NCT00851786|526710151|FG000|Overall Study|Site Closure|1|||
146053501|NCT00851786|526710152|FG001|Overall Study|Site Closure|0|||
146053502|NCT00851786|526710151|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
146053503|NCT00851786|526710152|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
146053504|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146053505|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
146053506|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146053507|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146053508|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
146053509|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
146053510|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
146053511|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146053512|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146053513|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
146053514|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
146053515|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
146053516|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146053517|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146053518|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
146053519|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
146053520|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
146053521|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146053522|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146053523|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
146053524|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
146259208|NCT01649297|527463377|FG004|Overall Study|Non compliant with Protocol|1|||
146053525|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
146053526|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146053527|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146053528|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
146053529|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
146053530|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
146053531|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146053532|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146259209|NCT01649297|527463373|FG000|Overall Study|Lost to Follow-up|1|||
146053533|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
146053534|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
146053535|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
146053536|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146053537|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146053538|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
146053539|NCT02831764|526711541|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146053540|NCT02831764|526711542|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
146053541|NCT02831764|526711543|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146053542|NCT02831764|526711544|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146053543|NCT02831764|526711545|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
146053544|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146053545|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146053546|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
146053547|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
146053548|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146053549|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146053550|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146053551|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
146053552|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146053553|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146053554|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146053555|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146053556|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
146053557|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
146053558|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146053559|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146053560|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146053561|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
146053562|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146053563|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
146053564|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146053565|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146053566|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
146053567|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
146053568|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146053569|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146053570|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146053571|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
146053572|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
146053573|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146053574|NCT02831764|526711541|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146053575|NCT02831764|526711542|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146053576|NCT02831764|526711543|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
146053577|NCT02831764|526711544|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
146053578|NCT02831764|526711545|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146053579|NCT02831764|526711541|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146053580|NCT02831764|526711542|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146053581|NCT02831764|526711543|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146053582|NCT02831764|526711544|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146053583|NCT02831764|526711545|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
146053584|NCT02831764|526711541|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146053585|NCT02831764|526711542|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146053586|NCT02831764|526711543|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146053587|NCT02831764|526711544|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146053588|NCT02831764|526711545|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
146053589|NCT02831764|526711541|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146053590|NCT02831764|526711542|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146053591|NCT02831764|526711543|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146053592|NCT02831764|526711544|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146053593|NCT02831764|526711545|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
146110479|NCT04532164|526925840|FG000|Overall Study|Found to be Ineligible|3|||
146053594|NCT02831764|526711541|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146053595|NCT02831764|526711542|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146053596|NCT02831764|526711543|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146053597|NCT02831764|526711544|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146053598|NCT02831764|526711545|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
146053599|NCT00865345|526711546|FG000|Overall Study|Withdrawal by Subject|2|||
146053600|NCT03737123|526711547|FG000|Study Treatment|Adverse Event|2|||
146053601|NCT03737123|526711548|FG001|Study Treatment|Adverse Event|0|||
146053602|NCT03737123|526711547|FG000|Study Treatment|Disease Progression|2|||
146053603|NCT03737123|526711548|FG001|Study Treatment|Disease Progression|0|||
146053604|NCT03737123|526711547|FG000|Study Treatment|Withdrawal by Subject|2|||
146053605|NCT03737123|526711548|FG001|Study Treatment|Withdrawal by Subject|0|||
146053606|NCT03737123|526711547|FG000|Follow up|Death|1|||
146053607|NCT03737123|526711548|FG001|Follow up|Death|0|||
146053608|NCT03737123|526711547|FG000|Follow up|Withdrawal by Subject|1|||
146053609|NCT03737123|526711548|FG001|Follow up|Withdrawal by Subject|0|||
146053610|NCT03737123|526711547|FG000|Follow up|Termination of study|4|||
146053611|NCT03737123|526711548|FG001|Follow up|Termination of study|0|||
146053612|NCT01519323|526711549|FG000|Overall Study|Death|3|||
146053613|NCT01519323|526711550|FG001|Overall Study|Death|2|||
146053614|NCT01519323|526711549|FG000|Overall Study|Study terminated by sponsor|0|||
146053615|NCT01519323|526711550|FG001|Overall Study|Study terminated by sponsor|1|||
146053616|NCT03858049|526711565|FG000|Overall Study|Adverse Event|16|||
146053617|NCT03858049|526711566|FG001|Overall Study|Adverse Event|9|||
146053618|NCT03858049|526711565|FG000|Overall Study|Other|1|||
146053619|NCT03858049|526711566|FG001|Overall Study|Other|1|||
146053620|NCT02079740|526711567|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
146053621|NCT02079740|526711568|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
146053622|NCT02079740|526711569|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
146053623|NCT02079740|526711570|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
146053624|NCT02079740|526711571|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
146053625|NCT02079740|526711572|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
146053626|NCT02079740|526711573|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
146053627|NCT02079740|526711574|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
146053628|NCT02079740|526711575|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
146053629|NCT02079740|526711576|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
146053630|NCT02079740|526711577|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
146053631|NCT02079740|526711578|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
146053632|NCT02079740|526711579|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
146053633|NCT02079740|526711567|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
146053634|NCT02079740|526711568|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
146053635|NCT02079740|526711569|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
146053636|NCT02079740|526711570|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
146053637|NCT02079740|526711571|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
146053638|NCT02079740|526711572|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
146053639|NCT02079740|526711573|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
146053640|NCT02079740|526711574|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
146053641|NCT02079740|526711575|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
146053642|NCT02079740|526711576|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
146053643|NCT02079740|526711577|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
146053644|NCT02079740|526711578|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
146053645|NCT02079740|526711579|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
146110480|NCT04532164|526925840|FG000|Overall Study|Withdrawal by Subject|14|||
146110481|NCT02483520|526925841|FG000|Overall Study|Lost to Follow-up|3|||
146110482|NCT02483520|526925842|FG001|Overall Study|Lost to Follow-up|4|||
146110483|NCT02483520|526925841|FG000|Overall Study|Withdrawal by Subject|4|||
146110484|NCT02483520|526925842|FG001|Overall Study|Withdrawal by Subject|14|||
146301420|NCT00763971|527618887|FG002|Overall Study|Sponsor decision|0|||
146053646|NCT02079740|526711567|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053647|NCT02079740|526711568|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053648|NCT02079740|526711569|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053649|NCT02079740|526711570|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053650|NCT02079740|526711571|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053651|NCT02079740|526711572|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053652|NCT02079740|526711573|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053653|NCT02079740|526711574|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
146053654|NCT02079740|526711575|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053655|NCT02079740|526711576|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053656|NCT02079740|526711577|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
146110485|NCT02483520|526925841|FG000|Overall Study|Hospitalized|2|||
146301421|NCT00763971|527618885|FG000|Overall Study|Due to holiday season|2|||
146053657|NCT02079740|526711578|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
146053658|NCT02079740|526711579|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
146110486|NCT02483520|526925842|FG001|Overall Study|Hospitalized|3|||
146110487|NCT02483520|526925841|FG000|Overall Study|Moved to LTC|2|||
146110488|NCT02483520|526925842|FG001|Overall Study|Moved to LTC|3|||
146110489|NCT01104493|526925843|FG000|Overall Study|Lost to Follow-up|0|||
146110490|NCT01104493|526925844|FG001|Overall Study|Lost to Follow-up|2|||
146110491|NCT00489541|526925854|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
146110492|NCT00489541|526925855|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
146110493|NCT00489541|526925854|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
146110494|NCT00489541|526925855|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
146110495|NCT00489541|526925854|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
146110496|NCT00489541|526925855|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
146110497|NCT00489541|526925854|FG000|12-Month Clinical Follow-up|Death|3|||
146110498|NCT00489541|526925855|FG001|12-Month Clinical Follow-up|Death|2|||
146110499|NCT00489541|526925854|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
146110500|NCT00489541|526925855|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
146110501|NCT00489541|526925854|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
146110502|NCT00489541|526925855|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
146110503|NCT00003479|526925856|FG000|Overall Study|Not evaluable|3|||
146110504|NCT02042183|526925859|FG000|Overall Study|Physician Decision|7|||
146110505|NCT02042183|526925860|FG001|Overall Study|Physician Decision|2|||
146110506|NCT02042183|526925859|FG000|Overall Study|Lack of Efficacy|4|||
146110507|NCT02042183|526925860|FG001|Overall Study|Lack of Efficacy|3|||
146110508|NCT02042183|526925859|FG000|Overall Study|Non-compliance with Study Drug|2|||
146110509|NCT02042183|526925860|FG001|Overall Study|Non-compliance with Study Drug|3|||
146110510|NCT02042183|526925859|FG000|Overall Study|Adverse Event|17|||
146110511|NCT02042183|526925860|FG001|Overall Study|Adverse Event|6|||
146110512|NCT02042183|526925859|FG000|Overall Study|Other|3|||
146110513|NCT02042183|526925860|FG001|Overall Study|Other|3|||
146110514|NCT02042183|526925859|FG000|Overall Study|Withdrawal by Subject|21|||
146110515|NCT02042183|526925860|FG001|Overall Study|Withdrawal by Subject|16|||
146110516|NCT02042183|526925859|FG000|Overall Study|Site Terminated by Sponsor|2|||
146110517|NCT02042183|526925860|FG001|Overall Study|Site Terminated by Sponsor|1|||
146110518|NCT02042183|526925859|FG000|Overall Study|Lost to Follow-up|9|||
146110519|NCT02042183|526925860|FG001|Overall Study|Lost to Follow-up|2|||
146110520|NCT01192516|526925863|FG000|Overall Study|Lost to Follow-up|7|||
146110521|NCT01192516|526925864|FG001|Overall Study|Lost to Follow-up|10|||
146110522|NCT01192516|526925865|FG002|Overall Study|Lost to Follow-up|7|||
146110523|NCT01192516|526925863|FG000|Overall Study|Withdrawal by Subject|4|||
146110524|NCT01192516|526925864|FG001|Overall Study|Withdrawal by Subject|4|||
146110525|NCT01192516|526925865|FG002|Overall Study|Withdrawal by Subject|1|||
146110526|NCT01192516|526925863|FG000|Overall Study|started new treatment|5|||
146110527|NCT01192516|526925864|FG001|Overall Study|started new treatment|1|||
146110528|NCT01192516|526925865|FG002|Overall Study|started new treatment|0|||
146110529|NCT01192516|526925863|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
146110530|NCT01192516|526925864|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
146110531|NCT01192516|526925865|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
146110532|NCT04605484|526925869|FG000|Overall Study|Lost to Follow-up|0|||
146110533|NCT04605484|526925870|FG001|Overall Study|Lost to Follow-up|1|||
146110534|NCT04605484|526925871|FG002|Overall Study|Lost to Follow-up|1|||
146110535|NCT04605484|526925869|FG000|Overall Study|Other|0|||
146110536|NCT04605484|526925870|FG001|Overall Study|Other|1|||
146110537|NCT04605484|526925871|FG002|Overall Study|Other|0|||
146110538|NCT04171531|526925872|FG000|Overall Study|Lost to Follow-up|4|||
146110539|NCT04171531|526925873|FG001|Overall Study|Lost to Follow-up|5|||
146110540|NCT04171531|526925872|FG000|Overall Study|Consent only through 6 months|1|||
146110541|NCT04171531|526925873|FG001|Overall Study|Consent only through 6 months|1|||
146110542|NCT04171531|526925872|FG000|Overall Study|Insurance did not cover procedure|0|||
146110543|NCT04171531|526925873|FG001|Overall Study|Insurance did not cover procedure|1|||
146110544|NCT04171531|526925872|FG000|Overall Study|Physician Decision|0|||
146110545|NCT04171531|526925873|FG001|Overall Study|Physician Decision|3|||
146110546|NCT04171531|526925872|FG000|Overall Study|Withdrawal by Subject|1|||
146110547|NCT04171531|526925873|FG001|Overall Study|Withdrawal by Subject|5|||
146110548|NCT04862585|526925877|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
146110549|NCT04862585|526925878|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
146110550|NCT04862585|526925877|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
146110551|NCT04862585|526925878|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
146110552|NCT04862585|526925877|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
146110553|NCT04862585|526925878|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
146110554|NCT04862585|526925877|FG000|Overall Study|one withdrew without providing a reason|0|||
146110555|NCT04862585|526925878|FG001|Overall Study|one withdrew without providing a reason|1|||
146110556|NCT03366337|526925881|FG000|Overall Study|Lost to Follow-up|1|||
146110557|NCT03366337|526925882|FG001|Overall Study|Lost to Follow-up|0|||
146110558|NCT03366337|526925883|FG002|Overall Study|Lost to Follow-up|1|||
146110559|NCT03366337|526925884|FG003|Overall Study|Lost to Follow-up|0|||
146110560|NCT03366337|526925881|FG000|Overall Study|Withdrawal by Subject|2|||
146110561|NCT03366337|526925882|FG001|Overall Study|Withdrawal by Subject|0|||
146110562|NCT03366337|526925883|FG002|Overall Study|Withdrawal by Subject|1|||
146110563|NCT03366337|526925884|FG003|Overall Study|Withdrawal by Subject|1|||
146110564|NCT05288062|526925885|FG000|Overall Study|Ineligible|0|||
146110565|NCT05288062|526925886|FG001|Overall Study|Ineligible|0|||
146110566|NCT05288062|526925887|FG002|Overall Study|Ineligible|1|||
146110567|NCT05288062|526925888|FG003|Overall Study|Ineligible|0|||
146110568|NCT05288062|526925885|FG000|Overall Study|Withdrawal by Subject|0|||
146110569|NCT05288062|526925886|FG001|Overall Study|Withdrawal by Subject|0|||
146110570|NCT05288062|526925887|FG002|Overall Study|Withdrawal by Subject|1|||
146110571|NCT05288062|526925888|FG003|Overall Study|Withdrawal by Subject|0|||
146110572|NCT01025752|526925892|FG000|Overall Study|Lost to Follow-up|7|||
146110573|NCT01025752|526925893|FG001|Overall Study|Lost to Follow-up|10|||
146110574|NCT01025752|526925892|FG000|Overall Study|Physician Decision|1|||
146110575|NCT01025752|526925893|FG001|Overall Study|Physician Decision|3|||
146110576|NCT01537393|526925896|FG000|Overall Study|Exclude prior to study|32|||
146110577|NCT01537393|526925897|FG001|Overall Study|Exclude prior to study|44|||
146110578|NCT01537393|526925896|FG000|Overall Study|Death|20|||
146110579|NCT01537393|526925897|FG001|Overall Study|Death|32|||
146110580|NCT01537393|526925896|FG000|Overall Study|Withdrawal by Subject|18|||
146110581|NCT01537393|526925897|FG001|Overall Study|Withdrawal by Subject|17|||
146110582|NCT01537393|526925896|FG000|Overall Study|Lost to Follow-up|53|||
146110583|NCT01537393|526925897|FG001|Overall Study|Lost to Follow-up|48|||
146110584|NCT01537393|526925896|FG000|Overall Study|Failure - Regrafted|28|||
146110585|NCT01537393|526925897|FG001|Overall Study|Failure - Regrafted|43|||
146110586|NCT01537393|526925896|FG000|Overall Study|Failure - Not regrafted|2|||
146110587|NCT01537393|526925897|FG001|Overall Study|Failure - Not regrafted|6|||
146110588|NCT01537393|526925896|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
146110589|NCT01537393|526925897|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
146110590|NCT00459953|526925898|FG000|Overall Study|not analyzed-household member in study|1|||
146110591|NCT00459953|526925899|FG001|Overall Study|not analyzed-household member in study|1|||
146110592|NCT01447433|526925900|FG000|Overall Study|Lost to Follow-up|0|||
146110593|NCT01447433|526925901|FG001|Overall Study|Lost to Follow-up|2|||
146110594|NCT01447433|526925900|FG000|Overall Study|Withdrawal by Subject|3|||
146110595|NCT01447433|526925901|FG001|Overall Study|Withdrawal by Subject|3|||
146110596|NCT01447433|526925900|FG000|Overall Study|Protocol Violation|1|||
146110597|NCT01447433|526925901|FG001|Overall Study|Protocol Violation|1|||
146110598|NCT01578187|526925902|FG000|Usability Phase|Withdrawal by Subject|1|||
146110599|NCT01217801|526925907|FG000|Period 1|Protocol Violation|1|||
146110600|NCT01217801|526925908|FG001|Period 1|Protocol Violation|1|||
146110601|NCT01217801|526925907|FG000|Period 1|Withdrawal by Subject|0|||
146110602|NCT01217801|526925908|FG001|Period 1|Withdrawal by Subject|1|||
146110603|NCT04584645|526925909|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
146110604|NCT04584645|526925910|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
146110605|NCT00390468|526925911|FG000|Overall Study|Protocol Violation|2|||
146110606|NCT00390468|526925911|FG000|Overall Study|Lack of Efficacy|1|||
146110607|NCT03926169|526925918|FG000|Period A|Adverse Event|2|||
146110608|NCT03926169|526925919|FG001|Period A|Adverse Event|2|||
146110609|NCT03926169|526925920|FG002|Period A|Adverse Event|1|||
146110610|NCT03926169|526925918|FG000|Period A|Withdrawal by Subject|2|||
146110611|NCT03926169|526925919|FG001|Period A|Withdrawal by Subject|2|||
146110612|NCT03926169|526925920|FG002|Period A|Withdrawal by Subject|2|||
146110613|NCT03926169|526925918|FG000|Period A|Lost to Follow-up|3|||
146110614|NCT03926169|526925919|FG001|Period A|Lost to Follow-up|1|||
146110615|NCT03926169|526925920|FG002|Period A|Lost to Follow-up|0|||
146110616|NCT03926169|526925918|FG000|Period A|Lack of Efficacy|0|||
146110617|NCT03926169|526925919|FG001|Period A|Lack of Efficacy|2|||
146110618|NCT03926169|526925920|FG002|Period A|Lack of Efficacy|2|||
146110619|NCT03926169|526925918|FG000|Period A|COVID-19 Infection|0|||
146110620|NCT03926169|526925919|FG001|Period A|COVID-19 Infection|1|||
146110621|NCT03926169|526925920|FG002|Period A|COVID-19 Infection|0|||
146110622|NCT03926169|526925918|FG000|Period A|COVID-19 Logistical Restrictions|0|||
146110623|NCT03926169|526925919|FG001|Period A|COVID-19 Logistical Restrictions|2|||
146110624|NCT03926169|526925920|FG002|Period A|COVID-19 Logistical Restrictions|1|||
146110625|NCT03926169|526925918|FG000|Period A|Other, Not Specified|1|||
146110626|NCT03926169|526925919|FG001|Period A|Other, Not Specified|0|||
146110627|NCT03926169|526925920|FG002|Period A|Other, Not Specified|0|||
146110628|NCT03926169|526925918|FG000|Period B|Adverse Event|3|||
146110629|NCT03926169|526925919|FG001|Period B|Adverse Event|1|||
146110630|NCT03926169|526925920|FG002|Period B|Adverse Event|1|||
146110631|NCT03926169|526925918|FG000|Period B|Withdrawal by Subject|1|||
146110632|NCT03926169|526925919|FG001|Period B|Withdrawal by Subject|3|||
146110633|NCT03926169|526925920|FG002|Period B|Withdrawal by Subject|0|||
146110634|NCT03926169|526925918|FG000|Period B|Lack of Efficacy|3|||
146110635|NCT03926169|526925919|FG001|Period B|Lack of Efficacy|1|||
146110636|NCT03926169|526925920|FG002|Period B|Lack of Efficacy|1|||
146053659|NCT02079740|526711567|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053660|NCT02079740|526711568|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053661|NCT02079740|526711569|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053662|NCT02079740|526711570|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053663|NCT02079740|526711571|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053664|NCT02079740|526711572|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053665|NCT02079740|526711573|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053666|NCT02079740|526711574|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
146053667|NCT02079740|526711575|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053668|NCT02079740|526711576|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053669|NCT02079740|526711577|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053670|NCT02079740|526711578|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053671|NCT02079740|526711579|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
146053672|NCT02079740|526711567|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053673|NCT02079740|526711568|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053674|NCT02079740|526711569|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053675|NCT02079740|526711570|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053676|NCT02079740|526711571|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053677|NCT02079740|526711572|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053678|NCT02079740|526711573|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053679|NCT02079740|526711574|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053680|NCT02079740|526711575|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053681|NCT02079740|526711576|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
146053682|NCT02079740|526711577|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
146053683|NCT02079740|526711578|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
146053684|NCT02079740|526711579|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
146053685|NCT04617782|526711580|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
146053686|NCT04617782|526711580|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
146053687|NCT04617782|526711580|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
146053688|NCT04617782|526711580|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
146053689|NCT04617782|526711580|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
146053690|NCT04617782|526711580|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
146053691|NCT01131507|526711581|FG000|Overall Study|Adverse Event|1|||
146053692|NCT01131507|526711581|FG000|Overall Study|Lost to Follow-up|1|||
146053693|NCT01131507|526711581|FG000|Overall Study|Withdrawal by Subject|1|||
146053694|NCT01474317|526711585|FG000|Overall Study|Adverse Event|1|||
146053695|NCT01474317|526711585|FG000|Overall Study|Subject ineligible for study|1|||
146053696|NCT00387881|526711588|FG000|Overall Study|Lost to Follow-up|23|||
146053697|NCT00387881|526711589|FG001|Overall Study|Lost to Follow-up|23|||
146053698|NCT00387881|526711588|FG000|Overall Study|Protocol Violation|2|||
146053699|NCT00387881|526711589|FG001|Overall Study|Protocol Violation|12|||
146053700|NCT00387881|526711588|FG000|Overall Study|Withdrawal by Subject|15|||
146053701|NCT00387881|526711589|FG001|Overall Study|Withdrawal by Subject|18|||
146053702|NCT00387881|526711588|FG000|Overall Study|Sponsor terminated Study|0|||
146053703|NCT00387881|526711589|FG001|Overall Study|Sponsor terminated Study|1|||
146053704|NCT00387881|526711588|FG000|Overall Study|Not eligible|6|||
146053705|NCT00387881|526711589|FG001|Overall Study|Not eligible|7|||
146053706|NCT00387881|526711588|FG000|Overall Study|No opportunity to treat headache|32|||
146053707|NCT00387881|526711589|FG001|Overall Study|No opportunity to treat headache|34|||
146053708|NCT00387881|526711588|FG000|Overall Study|Not otherwise specified|11|||
146053709|NCT00387881|526711589|FG001|Overall Study|Not otherwise specified|7|||
146053710|NCT00453154|526711590|FG000|Double BIind Maintenance|Adverse Event|0|||
146053711|NCT00453154|526711591|FG001|Double BIind Maintenance|Adverse Event|0|||
146053712|NCT00453154|526711592|FG002|Double BIind Maintenance|Adverse Event|3|||
146053713|NCT00453154|526711593|FG003|Double BIind Maintenance|Adverse Event|12|||
146053714|NCT00453154|526711590|FG000|Double BIind Maintenance|Death|0|||
146053715|NCT00453154|526711591|FG001|Double BIind Maintenance|Death|0|||
146053716|NCT00453154|526711592|FG002|Double BIind Maintenance|Death|2|||
146053717|NCT00453154|526711593|FG003|Double BIind Maintenance|Death|1|||
146053718|NCT00453154|526711590|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
146053719|NCT00453154|526711591|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
146053720|NCT00453154|526711592|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
146053721|NCT00453154|526711593|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
146053722|NCT00453154|526711590|FG000|Double BIind Maintenance|Progression|0|||
146053723|NCT00453154|526711591|FG001|Double BIind Maintenance|Progression|0|||
146053724|NCT00453154|526711592|FG002|Double BIind Maintenance|Progression|29|||
146053725|NCT00453154|526711593|FG003|Double BIind Maintenance|Progression|26|||
146053726|NCT00453154|526711590|FG000|Double BIind Maintenance|Medical Issues|0|||
146053727|NCT00453154|526711591|FG001|Double BIind Maintenance|Medical Issues|0|||
146053728|NCT00453154|526711592|FG002|Double BIind Maintenance|Medical Issues|3|||
146053729|NCT00453154|526711593|FG003|Double BIind Maintenance|Medical Issues|1|||
146053730|NCT00453154|526711590|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
146053731|NCT00453154|526711591|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
146053732|NCT00453154|526711592|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
146053733|NCT00453154|526711593|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
146053734|NCT03629886|526711594|FG000|Overall Study|Migrated / moved from the study area|0|||
146053735|NCT03629886|526711595|FG001|Overall Study|Migrated / moved from the study area|55|||
146053736|NCT03629886|526711594|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
146053737|NCT03629886|526711595|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
146053738|NCT03629886|526711594|FG000|Overall Study|Study vaccine not administrated|0|||
146053739|NCT03629886|526711595|FG001|Overall Study|Study vaccine not administrated|3|||
146053740|NCT03629886|526711594|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
146053741|NCT03629886|526711595|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
146053742|NCT03629886|526711594|FG000|Overall Study|Refused vaccination step of the study|0|||
146053743|NCT03629886|526711595|FG001|Overall Study|Refused vaccination step of the study|44|||
146053744|NCT03291067|526711596|FG000|Overall Study|Adverse Event|0|||
146053745|NCT03291067|526711597|FG001|Overall Study|Adverse Event|2|||
146053746|NCT03291067|526711598|FG002|Overall Study|Adverse Event|17|||
146053747|NCT03291067|526711599|FG003|Overall Study|Adverse Event|3|||
146110637|NCT03926169|526925918|FG000|Period B|Lost to Follow-up|1|||
146110638|NCT03926169|526925919|FG001|Period B|Lost to Follow-up|1|||
146110639|NCT03926169|526925920|FG002|Period B|Lost to Follow-up|4|||
146110640|NCT03926169|526925918|FG000|Period B|Other, Not Specified|62|||
146110641|NCT03926169|526925919|FG001|Period B|Other, Not Specified|57|||
146110642|NCT03926169|526925920|FG002|Period B|Other, Not Specified|65|||
146110643|NCT03708328|526925923|FG000|Overall Study|Death|3|||
146110644|NCT03708328|526925924|FG001|Overall Study|Death|3|||
146110645|NCT03708328|526925925|FG002|Overall Study|Death|4|||
146110646|NCT03708328|526925926|FG003|Overall Study|Death|2|||
146110647|NCT03708328|526925927|FG004|Overall Study|Death|2|||
146110648|NCT03708328|526925928|FG005|Overall Study|Death|13|||
146110649|NCT03708328|526925929|FG006|Overall Study|Death|26|||
146110650|NCT03708328|526925930|FG007|Overall Study|Death|18|||
146110651|NCT03708328|526925931|FG008|Overall Study|Death|13|||
146110652|NCT03708328|526925932|FG009|Overall Study|Death|8|||
146110653|NCT03708328|526925923|FG000|Overall Study|Lost to Follow-up|0|||
146110654|NCT03708328|526925924|FG001|Overall Study|Lost to Follow-up|1|||
146053748|NCT03291067|526711596|FG000|Overall Study|Lost to Follow-up|2|||
146053749|NCT03291067|526711597|FG001|Overall Study|Lost to Follow-up|1|||
146053750|NCT03291067|526711598|FG002|Overall Study|Lost to Follow-up|0|||
146053751|NCT03291067|526711599|FG003|Overall Study|Lost to Follow-up|1|||
146053752|NCT03291067|526711596|FG000|Overall Study|Physician Decision|0|||
146053753|NCT03291067|526711597|FG001|Overall Study|Physician Decision|0|||
146053754|NCT03291067|526711598|FG002|Overall Study|Physician Decision|1|||
146053755|NCT03291067|526711599|FG003|Overall Study|Physician Decision|0|||
146053756|NCT03291067|526711596|FG000|Overall Study|Protocol Violation|5|||
146053757|NCT03291067|526711597|FG001|Overall Study|Protocol Violation|3|||
146053758|NCT03291067|526711598|FG002|Overall Study|Protocol Violation|4|||
146053759|NCT03291067|526711599|FG003|Overall Study|Protocol Violation|2|||
146053760|NCT03291067|526711596|FG000|Overall Study|Withdrawal by Subject|3|||
146053761|NCT03291067|526711597|FG001|Overall Study|Withdrawal by Subject|4|||
146053762|NCT03291067|526711598|FG002|Overall Study|Withdrawal by Subject|7|||
146053763|NCT03291067|526711599|FG003|Overall Study|Withdrawal by Subject|5|||
146053764|NCT03291067|526711596|FG000|Overall Study|Other|0|||
146053765|NCT03291067|526711597|FG001|Overall Study|Other|4|||
146053766|NCT03291067|526711598|FG002|Overall Study|Other|4|||
146053767|NCT03291067|526711599|FG003|Overall Study|Other|6|||
146053768|NCT03683173|526711600|FG000|Completed Follow-up|Unavailable|235|||
146053769|NCT03683173|526711601|FG001|Completed Follow-up|Unavailable|217|||
146053770|NCT03683173|526711600|FG000|Completed Follow-up|Refused|69|||
146053771|NCT03683173|526711601|FG001|Completed Follow-up|Refused|59|||
146053772|NCT03683173|526711600|FG000|Completed Follow-up|Disconnected phone|65|||
146053773|NCT03683173|526711601|FG001|Completed Follow-up|Disconnected phone|95|||
146053774|NCT03683173|526711600|FG000|Completed Follow-up|Health issue/deceased|10|||
146053775|NCT03683173|526711601|FG001|Completed Follow-up|Health issue/deceased|4|||
146053776|NCT03683173|526711600|FG000|Completed Follow-up|Moved away|8|||
146053777|NCT03683173|526711601|FG001|Completed Follow-up|Moved away|1|||
146053778|NCT03016312|526711602|FG000|Overall Study|discontinued before the treatment started|0|||
146053779|NCT03016312|526711603|FG001|Overall Study|discontinued before the treatment started|1|||
146053780|NCT03016312|526711602|FG000|Overall Study|Withdrawal by Subject|37|||
146053781|NCT03016312|526711603|FG001|Overall Study|Withdrawal by Subject|44|||
146053782|NCT03016312|526711602|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
146110655|NCT03708328|526925925|FG002|Overall Study|Lost to Follow-up|0|||
146110656|NCT03708328|526925926|FG003|Overall Study|Lost to Follow-up|1|||
146110657|NCT03708328|526925927|FG004|Overall Study|Lost to Follow-up|0|||
146110658|NCT03708328|526925928|FG005|Overall Study|Lost to Follow-up|3|||
146110659|NCT03708328|526925929|FG006|Overall Study|Lost to Follow-up|3|||
146053783|NCT03016312|526711603|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
146053784|NCT03016312|526711602|FG000|Overall Study|Physician Decision|1|||
146053785|NCT03016312|526711603|FG001|Overall Study|Physician Decision|3|||
146053786|NCT03016312|526711602|FG000|Overall Study|Lost to Follow-up|12|||
146053787|NCT03016312|526711603|FG001|Overall Study|Lost to Follow-up|12|||
146053788|NCT03016312|526711602|FG000|Overall Study|Death|210|||
146053789|NCT03016312|526711603|FG001|Overall Study|Death|184|||
146053790|NCT03016312|526711602|FG000|Overall Study|loss to contact|1|||
146053791|NCT03016312|526711603|FG001|Overall Study|loss to contact|0|||
146053792|NCT03016312|526711602|FG000|Overall Study|started a new cancer therapy|1|||
146053793|NCT03016312|526711603|FG001|Overall Study|started a new cancer therapy|0|||
146053794|NCT00496015|526711604|FG000|Overall Study|Other|1|||
146053795|NCT00496015|526711605|FG001|Overall Study|Other|0|||
146053796|NCT00496015|526711606|FG002|Overall Study|Other|0|||
146053797|NCT00496015|526711607|FG003|Overall Study|Other|1|||
146053798|NCT00496015|526711608|FG004|Overall Study|Other|0|||
146053799|NCT01535807|526711610|FG000|Overall Study|Withdrawal by Subject|1|||
146053800|NCT01535807|526711611|FG001|Overall Study|Withdrawal by Subject|1|||
146053801|NCT01535807|526711610|FG000|Overall Study|Data collection error|1|||
146053802|NCT01535807|526711611|FG001|Overall Study|Data collection error|1|||
146053803|NCT02730728|526711614|FG000|Overall Study|Withdrawal by Subject|0|||
146053804|NCT02730728|526711615|FG001|Overall Study|Withdrawal by Subject|1|||
146053805|NCT02730728|526711616|FG002|Overall Study|Withdrawal by Subject|0|||
146053806|NCT02730728|526711614|FG000|Overall Study|Lack of Efficacy|0|||
146053807|NCT02730728|526711615|FG001|Overall Study|Lack of Efficacy|1|||
146053808|NCT02730728|526711616|FG002|Overall Study|Lack of Efficacy|1|||
146053809|NCT01702844|526711628|FG000|Overall Study|Adverse Event|9|||
146053810|NCT01702844|526711628|FG000|Overall Study|Death|1|||
146053811|NCT01702844|526711628|FG000|Overall Study|Withdrawal by Subject|3|||
146053812|NCT01702844|526711628|FG000|Overall Study|Physician Decision|6|||
146053813|NCT02193776|526711629|FG000|Overall Study|Consent withdrawn|1|||
146053814|NCT02193776|526711630|FG001|Overall Study|Consent withdrawn|0|||
146053815|NCT02193776|526711631|FG002|Overall Study|Consent withdrawn|0|||
146053816|NCT02193776|526711632|FG003|Overall Study|Consent withdrawn|0|||
146053817|NCT02193776|526711629|FG000|Overall Study|Failure to comply with protocol|0|||
146053818|NCT02193776|526711630|FG001|Overall Study|Failure to comply with protocol|1|||
146053819|NCT02193776|526711631|FG002|Overall Study|Failure to comply with protocol|0|||
146053820|NCT02193776|526711632|FG003|Overall Study|Failure to comply with protocol|0|||
146053821|NCT02193776|526711629|FG000|Overall Study|Investigator/Sponsor decision|1|||
146053822|NCT02193776|526711630|FG001|Overall Study|Investigator/Sponsor decision|1|||
146053823|NCT02193776|526711631|FG002|Overall Study|Investigator/Sponsor decision|0|||
146053824|NCT02193776|526711632|FG003|Overall Study|Investigator/Sponsor decision|0|||
146053825|NCT02193776|526711629|FG000|Overall Study|Death|1|||
146053826|NCT02193776|526711630|FG001|Overall Study|Death|0|||
146053827|NCT02193776|526711631|FG002|Overall Study|Death|0|||
146053828|NCT02193776|526711632|FG003|Overall Study|Death|0|||
146053829|NCT02193776|526711629|FG000|Overall Study|Adverse event/Specific toxicity|5|||
146053830|NCT02193776|526711630|FG001|Overall Study|Adverse event/Specific toxicity|5|||
146053831|NCT02193776|526711631|FG002|Overall Study|Adverse event/Specific toxicity|2|||
146053832|NCT02193776|526711632|FG003|Overall Study|Adverse event/Specific toxicity|2|||
146053833|NCT02123134|526711633|FG000|Overall Study|Withdrawal of consent|3|||
146053834|NCT02123134|526711634|FG001|Overall Study|Withdrawal of consent|2|||
146053835|NCT02123134|526711633|FG000|Overall Study|Administrative decision|0|||
146053836|NCT02123134|526711634|FG001|Overall Study|Administrative decision|1|||
146053837|NCT01731912|526711640|FG000|Overall Study|noncompliance|2|||
146053838|NCT02043938|526711641|FG000|Overall Study|Withdrawal by Subject|7|||
146053839|NCT02043938|526711641|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
146053840|NCT02043938|526711641|FG000|Overall Study|No show by subject|1|||
146053841|NCT02043938|526711641|FG000|Overall Study|Investigator decision|1|||
146053842|NCT03010527|526711642|FG000|Overall Study|Death|0|||
146053843|NCT03010527|526711643|FG001|Overall Study|Death|0|||
146053844|NCT03010527|526711644|FG002|Overall Study|Death|1|||
146053845|NCT03010527|526711642|FG000|Overall Study|Adverse Event|0|||
146053846|NCT03010527|526711643|FG001|Overall Study|Adverse Event|4|||
146053847|NCT03010527|526711644|FG002|Overall Study|Adverse Event|2|||
146053848|NCT03010527|526711642|FG000|Overall Study|Protocol Violation|0|||
146053849|NCT03010527|526711643|FG001|Overall Study|Protocol Violation|1|||
146110660|NCT03708328|526925930|FG007|Overall Study|Lost to Follow-up|0|||
146110661|NCT03708328|526925931|FG008|Overall Study|Lost to Follow-up|0|||
146053850|NCT03010527|526711644|FG002|Overall Study|Protocol Violation|0|||
146053851|NCT03010527|526711642|FG000|Overall Study|Lost to Follow-up|0|||
146053852|NCT03010527|526711643|FG001|Overall Study|Lost to Follow-up|2|||
146110662|NCT03708328|526925932|FG009|Overall Study|Lost to Follow-up|1|||
146053853|NCT03010527|526711644|FG002|Overall Study|Lost to Follow-up|1|||
146053854|NCT03010527|526711642|FG000|Overall Study|Withdrawal by Subject|0|||
146053855|NCT03010527|526711643|FG001|Overall Study|Withdrawal by Subject|3|||
146053856|NCT03010527|526711644|FG002|Overall Study|Withdrawal by Subject|4|||
146053857|NCT03010527|526711642|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
146053858|NCT03010527|526711643|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
146053859|NCT03010527|526711644|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
146053860|NCT03010527|526711642|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
146053861|NCT03010527|526711643|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
146053862|NCT03010527|526711644|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
146053863|NCT03010527|526711642|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
146053864|NCT03010527|526711643|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
146053865|NCT03010527|526711644|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
146053866|NCT01458639|526711645|FG000|Overall Study|Physician Decision|4|||
146053867|NCT01458639|526711645|FG000|Overall Study|Equipment issue|1|||
146053868|NCT01458639|526711645|FG000|Overall Study|Inability to obtain subject blood sample|1|||
146053869|NCT02656017|526711646|FG000|Overall Study|Study burden|3|||
146053870|NCT02656017|526711647|FG001|Overall Study|Study burden|3|||
146053871|NCT02656017|526711646|FG000|Overall Study|Adverse Event|2|||
146053872|NCT02656017|526711647|FG001|Overall Study|Adverse Event|1|||
146053873|NCT02656017|526711646|FG000|Overall Study|Unable/unwilling to take study medication|2|||
146053874|NCT02656017|526711647|FG001|Overall Study|Unable/unwilling to take study medication|1|||
146053875|NCT02656017|526711646|FG000|Overall Study|Began Tolvaptan|1|||
146053876|NCT02656017|526711647|FG001|Overall Study|Began Tolvaptan|1|||
146053877|NCT02656017|526711646|FG000|Overall Study|Withdrawal by Subject|1|||
146053878|NCT02656017|526711647|FG001|Overall Study|Withdrawal by Subject|0|||
146053879|NCT01755234|526711648|FG000|Overall Study|Lost to Follow-up|11|||
146053880|NCT01755234|526711649|FG001|Overall Study|Lost to Follow-up|6|||
146053881|NCT01755234|526711648|FG000|Overall Study|Change in surgical case|2|||
146053882|NCT01755234|526711649|FG001|Overall Study|Change in surgical case|1|||
146053883|NCT01755234|526711648|FG000|Overall Study|case cancelled|1|||
146053884|NCT01755234|526711649|FG001|Overall Study|case cancelled|0|||
146053885|NCT01755234|526711648|FG000|Overall Study|Withdrawal by Subject|0|||
146053886|NCT01755234|526711649|FG001|Overall Study|Withdrawal by Subject|1|||
146053887|NCT01755234|526711648|FG000|Overall Study|unblinded|1|||
146110663|NCT03708328|526925923|FG000|Overall Study|Physician Decision|0|||
146110664|NCT03708328|526925924|FG001|Overall Study|Physician Decision|0|||
146110665|NCT03708328|526925925|FG002|Overall Study|Physician Decision|0|||
146110666|NCT03708328|526925926|FG003|Overall Study|Physician Decision|0|||
146110667|NCT03708328|526925927|FG004|Overall Study|Physician Decision|0|||
146110668|NCT03708328|526925928|FG005|Overall Study|Physician Decision|1|||
146110669|NCT03708328|526925929|FG006|Overall Study|Physician Decision|0|||
146110670|NCT03708328|526925930|FG007|Overall Study|Physician Decision|0|||
146110671|NCT03708328|526925931|FG008|Overall Study|Physician Decision|0|||
146110672|NCT03708328|526925932|FG009|Overall Study|Physician Decision|0|||
146110673|NCT03708328|526925923|FG000|Overall Study|Withdrawal by Subject|0|||
146110674|NCT03708328|526925924|FG001|Overall Study|Withdrawal by Subject|0|||
146110675|NCT03708328|526925925|FG002|Overall Study|Withdrawal by Subject|0|||
146110676|NCT03708328|526925926|FG003|Overall Study|Withdrawal by Subject|0|||
146110677|NCT03708328|526925927|FG004|Overall Study|Withdrawal by Subject|1|||
146110678|NCT03708328|526925928|FG005|Overall Study|Withdrawal by Subject|0|||
146110679|NCT03708328|526925929|FG006|Overall Study|Withdrawal by Subject|2|||
146110680|NCT03708328|526925930|FG007|Overall Study|Withdrawal by Subject|4|||
146110681|NCT03708328|526925931|FG008|Overall Study|Withdrawal by Subject|1|||
146110682|NCT03708328|526925932|FG009|Overall Study|Withdrawal by Subject|5|||
146110683|NCT03708328|526925923|FG000|Overall Study|Study Closed Locally|0|||
146110684|NCT03708328|526925924|FG001|Overall Study|Study Closed Locally|0|||
146110685|NCT03708328|526925925|FG002|Overall Study|Study Closed Locally|0|||
146110686|NCT03708328|526925926|FG003|Overall Study|Study Closed Locally|0|||
146110687|NCT03708328|526925927|FG004|Overall Study|Study Closed Locally|0|||
146110688|NCT03708328|526925928|FG005|Overall Study|Study Closed Locally|0|||
146110689|NCT03708328|526925929|FG006|Overall Study|Study Closed Locally|0|||
146110690|NCT03708328|526925930|FG007|Overall Study|Study Closed Locally|1|||
146110691|NCT03708328|526925931|FG008|Overall Study|Study Closed Locally|0|||
146110692|NCT03708328|526925932|FG009|Overall Study|Study Closed Locally|0|||
146110693|NCT03708328|526925923|FG000|Overall Study|Study Ended By Sponsor|0|||
146110694|NCT03708328|526925924|FG001|Overall Study|Study Ended By Sponsor|0|||
146301422|NCT00763971|527618886|FG001|Overall Study|Due to holiday season|0|||
146110695|NCT03708328|526925925|FG002|Overall Study|Study Ended By Sponsor|0|||
146110696|NCT03708328|526925926|FG003|Overall Study|Study Ended By Sponsor|0|||
146110697|NCT03708328|526925927|FG004|Overall Study|Study Ended By Sponsor|0|||
146110698|NCT03708328|526925928|FG005|Overall Study|Study Ended By Sponsor|1|||
146053888|NCT01755234|526711649|FG001|Overall Study|unblinded|0|||
146053889|NCT00622505|526711650|FG000|Overall Study|Adverse Event|9|||
146053890|NCT00622505|526711651|FG001|Overall Study|Adverse Event|7|||
146053891|NCT00622505|526711650|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
146053892|NCT00622505|526711651|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
146053893|NCT00622505|526711650|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146053894|NCT00622505|526711651|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146053895|NCT00622505|526711650|FG000|Overall Study|Withdrawal by Subject|12|||
146110699|NCT03708328|526925929|FG006|Overall Study|Study Ended By Sponsor|0|||
146053896|NCT00622505|526711651|FG001|Overall Study|Withdrawal by Subject|5|||
146053897|NCT00622505|526711650|FG000|Overall Study|Administrative Problems|2|||
146053898|NCT00622505|526711651|FG001|Overall Study|Administrative Problems|4|||
146053899|NCT00622505|526711650|FG000|Overall Study|Death|2|||
146110700|NCT03708328|526925930|FG007|Overall Study|Study Ended By Sponsor|1|||
146110701|NCT03708328|526925931|FG008|Overall Study|Study Ended By Sponsor|0|||
146053900|NCT00622505|526711651|FG001|Overall Study|Death|2|||
146053901|NCT01216202|526711662|FG000|Overall Study|Withdrawal by Subject|8|||
146053902|NCT01216202|526711663|FG001|Overall Study|Withdrawal by Subject|0|||
146053903|NCT01216202|526711662|FG000|Overall Study|Death|0|||
146053904|NCT01216202|526711663|FG001|Overall Study|Death|2|||
146053905|NCT01216202|526711662|FG000|Overall Study|Lost to Follow-up|14|||
146053906|NCT01216202|526711663|FG001|Overall Study|Lost to Follow-up|0|||
146053907|NCT00614380|526711667|FG000|Overall Study|Adverse Event|14|||
146053908|NCT00614380|526711668|FG001|Overall Study|Adverse Event|4|||
146053909|NCT00614380|526711669|FG002|Overall Study|Adverse Event|0|||
146053910|NCT00614380|526711670|FG003|Overall Study|Adverse Event|0|||
146110702|NCT03708328|526925932|FG009|Overall Study|Study Ended By Sponsor|0|||
146110703|NCT03708328|526925923|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110704|NCT03708328|526925924|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110705|NCT03708328|526925925|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110706|NCT03708328|526925926|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110707|NCT03708328|526925927|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110708|NCT03708328|526925928|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110709|NCT03708328|526925929|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110710|NCT03708328|526925930|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110711|NCT03708328|526925931|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
146053911|NCT00614380|526711667|FG000|Overall Study|Lost to Follow-up|6|||
146053912|NCT00614380|526711668|FG001|Overall Study|Lost to Follow-up|1|||
146053913|NCT00614380|526711669|FG002|Overall Study|Lost to Follow-up|0|||
146053914|NCT00614380|526711670|FG003|Overall Study|Lost to Follow-up|0|||
146053915|NCT00614380|526711667|FG000|Overall Study|Non compliant with the protocol|12|||
146053916|NCT00614380|526711668|FG001|Overall Study|Non compliant with the protocol|2|||
146053917|NCT00614380|526711669|FG002|Overall Study|Non compliant with the protocol|1|||
146053918|NCT00614380|526711670|FG003|Overall Study|Non compliant with the protocol|2|||
146053919|NCT00614380|526711667|FG000|Overall Study|Consent withdrawn|3|||
146053920|NCT00614380|526711668|FG001|Overall Study|Consent withdrawn|1|||
146110712|NCT03708328|526925932|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
146110713|NCT04523220|526925933|FG000|Main Treatment Period|Physician Decision|1|||
146110714|NCT04523220|526925934|FG001|Main Treatment Period|Physician Decision|1|||
146110715|NCT04523220|526925935|FG002|Main Treatment Period|Physician Decision|0|||
146110716|NCT04523220|526925933|FG000|Main Treatment Period|Other|5|||
146110717|NCT04523220|526925934|FG001|Main Treatment Period|Other|2|||
146110718|NCT04523220|526925935|FG002|Main Treatment Period|Other|4|||
146110719|NCT04523220|526925933|FG000|Main Treatment Period|Subject Decision|5|||
146110720|NCT04523220|526925934|FG001|Main Treatment Period|Subject Decision|7|||
146110721|NCT04523220|526925935|FG002|Main Treatment Period|Subject Decision|3|||
146110722|NCT04523220|526925933|FG000|Main Treatment Period|Death|5|||
146110723|NCT04523220|526925934|FG001|Main Treatment Period|Death|11|||
146110724|NCT04523220|526925935|FG002|Main Treatment Period|Death|4|||
146110725|NCT04523220|526925933|FG000|Main Treatment Period|Adverse Event|11|||
146053921|NCT00614380|526711669|FG002|Overall Study|Consent withdrawn|0|||
146053922|NCT00614380|526711670|FG003|Overall Study|Consent withdrawn|0|||
146053923|NCT01506271|526711671|FG000|Overall Study|Progressive disease|0|||
146053924|NCT01506271|526711672|FG001|Overall Study|Progressive disease|1|||
146053925|NCT01506271|526711673|FG002|Overall Study|Progressive disease|0|||
146053926|NCT01506271|526711671|FG000|Overall Study|Protocol Violation|3|||
146053927|NCT01506271|526711672|FG001|Overall Study|Protocol Violation|1|||
146053928|NCT01506271|526711673|FG002|Overall Study|Protocol Violation|0|||
146053929|NCT01506271|526711671|FG000|Overall Study|Death|0|||
146053930|NCT01506271|526711672|FG001|Overall Study|Death|1|||
146053931|NCT01506271|526711673|FG002|Overall Study|Death|0|||
146110726|NCT04523220|526925934|FG001|Main Treatment Period|Adverse Event|9|||
146110727|NCT04523220|526925935|FG002|Main Treatment Period|Adverse Event|9|||
146259210|NCT01649297|527463374|FG001|Overall Study|Lost to Follow-up|1|||
146110728|NCT04523220|526925933|FG000|Main Treatment Period|Withdrawal by Subject|3|||
146259211|NCT01649297|527463375|FG002|Overall Study|Lost to Follow-up|4|||
146259212|NCT01649297|527463376|FG003|Overall Study|Lost to Follow-up|3|||
146053932|NCT01506271|526711671|FG000|Overall Study|Adverse Event|0|||
146053933|NCT01506271|526711672|FG001|Overall Study|Adverse Event|2|||
146053934|NCT01506271|526711673|FG002|Overall Study|Adverse Event|0|||
146053935|NCT01506271|526711671|FG000|Overall Study|Insufficient supply of study drug|1|||
146053936|NCT01506271|526711672|FG001|Overall Study|Insufficient supply of study drug|0|||
146053937|NCT01506271|526711673|FG002|Overall Study|Insufficient supply of study drug|0|||
146053938|NCT01506271|526711671|FG000|Overall Study|Withdrawal by Subject|0|||
146053939|NCT01506271|526711672|FG001|Overall Study|Withdrawal by Subject|1|||
146053940|NCT01506271|526711673|FG002|Overall Study|Withdrawal by Subject|1|||
146053941|NCT01506271|526711671|FG000|Overall Study|Lost to Follow-up|0|||
146053942|NCT01506271|526711672|FG001|Overall Study|Lost to Follow-up|1|||
146053943|NCT01506271|526711673|FG002|Overall Study|Lost to Follow-up|2|||
146053944|NCT01808196|526711680|FG000|Overall Study|Lost to Follow-up|1|||
146053945|NCT01670721|526711683|FG000|Overall Study|Participant's decision|15|||
146053946|NCT01670721|526711683|FG000|Overall Study|Other than specified above|38|||
146053947|NCT00479713|526711684|FG000|Overall Study|Adverse Event|8|||
146053948|NCT00479713|526711685|FG001|Overall Study|Adverse Event|6|||
146053949|NCT00479713|526711684|FG000|Overall Study|Death|1|||
146053950|NCT00479713|526711685|FG001|Overall Study|Death|0|||
146053951|NCT00479713|526711684|FG000|Overall Study|Lost to Follow-up|0|||
146053952|NCT00479713|526711685|FG001|Overall Study|Lost to Follow-up|1|||
146053953|NCT00479713|526711684|FG000|Overall Study|Protocol Violation|0|||
146053954|NCT00479713|526711685|FG001|Overall Study|Protocol Violation|1|||
146053955|NCT00479713|526711684|FG000|Overall Study|Withdrawal by Subject|4|||
146053956|NCT00479713|526711685|FG001|Overall Study|Withdrawal by Subject|1|||
146053957|NCT01232868|526713207|FG000|Overall Study|Lost to Follow-up|2|||
146053958|NCT01232868|526713208|FG001|Overall Study|Lost to Follow-up|4|||
146053959|NCT04481243|526713209|FG000|Overall Study|Withdrawal by Subject|4|||
146053960|NCT04564846|526713210|FG000|Overall Study|Withdrawal by Subject|2|||
146053961|NCT04564846|526713211|FG001|Overall Study|Withdrawal by Subject|1|||
146053962|NCT04564846|526713210|FG000|Overall Study|Physician Decision|0|||
146053963|NCT04564846|526713211|FG001|Overall Study|Physician Decision|1|||
146053964|NCT04564846|526713210|FG000|Overall Study|Lost to Follow-up|0|||
146053965|NCT04564846|526713211|FG001|Overall Study|Lost to Follow-up|1|||
146053966|NCT04564846|526713210|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
146053967|NCT04564846|526713211|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
146053968|NCT04564846|526713210|FG000|Overall Study|Subject non-compliance|1|||
146053969|NCT04564846|526713211|FG001|Overall Study|Subject non-compliance|0|||
146053970|NCT01342913|526713212|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
146053971|NCT01342913|526713213|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146053972|NCT01342913|526713214|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
146053973|NCT01342913|526713212|FG000|2-week Run-in Period|Physician Decision|6|||
146053974|NCT01342913|526713213|FG001|2-week Run-in Period|Physician Decision|0|||
146053975|NCT01342913|526713214|FG002|2-week Run-in Period|Physician Decision|0|||
146053976|NCT01342913|526713212|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
146053977|NCT01342913|526713213|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146053978|NCT01342913|526713214|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146053979|NCT01342913|526713212|FG000|2-week Run-in Period|Adverse Event|2|||
146053980|NCT01342913|526713213|FG001|2-week Run-in Period|Adverse Event|0|||
146053981|NCT01342913|526713214|FG002|2-week Run-in Period|Adverse Event|0|||
146053982|NCT01342913|526713212|FG000|2-week Run-in Period|Protocol Violation|5|||
146053983|NCT01342913|526713213|FG001|2-week Run-in Period|Protocol Violation|0|||
146053984|NCT01342913|526713214|FG002|2-week Run-in Period|Protocol Violation|0|||
146053985|NCT01342913|526713212|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
146053986|NCT01342913|526713213|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146053987|NCT01342913|526713214|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146053988|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146053989|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Adverse Event|3|||
146053990|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Adverse Event|6|||
146053991|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
146053992|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
146053993|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
146053994|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146053995|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
146053996|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
146053997|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146053998|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146053999|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
146054000|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Physician Decision|0|||
146054001|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Physician Decision|2|||
146054002|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Physician Decision|0|||
146054003|NCT01342913|526713212|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146054004|NCT01342913|526713213|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146054005|NCT01342913|526713214|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
146054006|NCT05482308|526713217|FG000|Overall Study|Withdrawal by Subject|1|||
146054007|NCT05482308|526713218|FG001|Overall Study|Withdrawal by Subject|0|||
146054008|NCT05482308|526713217|FG000|Overall Study|No longer meets eligibility criteria|0|||
146054009|NCT05482308|526713218|FG001|Overall Study|No longer meets eligibility criteria|1|||
146054010|NCT04319198|526713219|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
146054011|NCT04319198|526713220|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
146259213|NCT01649297|527463377|FG004|Overall Study|Lost to Follow-up|0|||
146054012|NCT04319198|526713221|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
146054013|NCT04319198|526713219|FG000|Overall Study|Death|0|||
146054014|NCT04319198|526713220|FG001|Overall Study|Death|3|||
146054015|NCT04319198|526713221|FG002|Overall Study|Death|3|||
146054016|NCT04319198|526713219|FG000|Overall Study|Reason Not Specified|0|||
146054017|NCT04319198|526713220|FG001|Overall Study|Reason Not Specified|2|||
146054018|NCT04319198|526713221|FG002|Overall Study|Reason Not Specified|4|||
146054019|NCT04319198|526713219|FG000|Overall Study|Withdrawal of Consent|0|||
146054020|NCT04319198|526713220|FG001|Overall Study|Withdrawal of Consent|0|||
146054021|NCT04319198|526713221|FG002|Overall Study|Withdrawal of Consent|5|||
146054022|NCT04319198|526713219|FG000|Overall Study|Site Terminated by Sponsor|0|||
146054023|NCT04319198|526713220|FG001|Overall Study|Site Terminated by Sponsor|1|||
146054024|NCT04319198|526713221|FG002|Overall Study|Site Terminated by Sponsor|0|||
146054025|NCT05801991|526713222|FG000|Overall Study|Lost to Follow-up|1|||
146054026|NCT05801991|526713223|FG001|Overall Study|Lost to Follow-up|0|||
146054027|NCT03489863|526713227|FG000|Overall Study|Withdrawal by Subject|0|||
146054028|NCT03489863|526713228|FG001|Overall Study|Withdrawal by Subject|1|||
146054029|NCT02995980|526713229|FG000|Overall Study|Lost to Follow-up|14|||
146054030|NCT01169103|526713231|FG000|Overall Study|Lost to Follow-up|3|||
146054031|NCT01169103|526713232|FG001|Overall Study|Lost to Follow-up|3|||
146054032|NCT01169103|526713231|FG000|Overall Study|Withdrawal by Subject|3|||
146054033|NCT01169103|526713232|FG001|Overall Study|Withdrawal by Subject|1|||
146054034|NCT02634333|526713233|FG000|Overall Study|Completed out of Window|3|||
146054035|NCT02634333|526713234|FG001|Overall Study|Completed out of Window|2|||
146054036|NCT02634333|526713233|FG000|Overall Study|Missed Visit|5|||
146054037|NCT02634333|526713234|FG001|Overall Study|Missed Visit|2|||
146054038|NCT02634333|526713233|FG000|Overall Study|Lost to Follow-up|12|||
146054039|NCT02634333|526713234|FG001|Overall Study|Lost to Follow-up|7|||
146054040|NCT02634333|526713233|FG000|Overall Study|Withdrawal by Subject|9|||
146054041|NCT02634333|526713234|FG001|Overall Study|Withdrawal by Subject|13|||
146054042|NCT02634333|526713233|FG000|Overall Study|Death|11|||
146054043|NCT02634333|526713234|FG001|Overall Study|Death|8|||
146054044|NCT02611479|526713235|FG000|Baseline Enrollment|Exited study|13|||
146054045|NCT02611479|526713235|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
146054046|NCT02611479|526713235|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
146054047|NCT02611479|526713235|FG000|Data Cleaning|No baseline function or pain metrics|2|||
146054048|NCT03275740|526713239|FG000|Overall Study|Adverse Event|0|||
146054049|NCT03275740|526713240|FG001|Overall Study|Adverse Event|0|||
146054050|NCT03275740|526713241|FG002|Overall Study|Adverse Event|0|||
146054051|NCT03275740|526713242|FG003|Overall Study|Adverse Event|0|||
146054052|NCT03275740|526713243|FG004|Overall Study|Adverse Event|1|||
146054053|NCT03275740|526713244|FG005|Overall Study|Adverse Event|0|||
146054054|NCT03275740|526713245|FG006|Overall Study|Adverse Event|0|||
146054055|NCT03275740|526713246|FG007|Overall Study|Adverse Event|0|||
146054056|NCT03275740|526713247|FG008|Overall Study|Adverse Event|0|||
146054057|NCT03275740|526713248|FG009|Overall Study|Adverse Event|0|||
146054058|NCT03275740|526713249|FG010|Overall Study|Adverse Event|0|||
146054059|NCT03275740|526713250|FG011|Overall Study|Adverse Event|0|||
146054060|NCT03275740|526713239|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054061|NCT03275740|526713240|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054062|NCT03275740|526713241|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054063|NCT03275740|526713242|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054064|NCT03275740|526713243|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054065|NCT03275740|526713244|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
146054066|NCT03275740|526713245|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054067|NCT03275740|526713246|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054068|NCT03275740|526713247|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054069|NCT03275740|526713248|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054070|NCT03275740|526713249|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054071|NCT03275740|526713250|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
146054072|NCT03275740|526713239|FG000|Overall Study|Withdrawal by Subject|0|||
146054073|NCT03275740|526713240|FG001|Overall Study|Withdrawal by Subject|0|||
146054074|NCT03275740|526713241|FG002|Overall Study|Withdrawal by Subject|0|||
146054075|NCT03275740|526713242|FG003|Overall Study|Withdrawal by Subject|0|||
146054076|NCT03275740|526713243|FG004|Overall Study|Withdrawal by Subject|0|||
146054077|NCT03275740|526713244|FG005|Overall Study|Withdrawal by Subject|0|||
146054078|NCT03275740|526713245|FG006|Overall Study|Withdrawal by Subject|0|||
146054079|NCT03275740|526713246|FG007|Overall Study|Withdrawal by Subject|0|||
146054080|NCT03275740|526713247|FG008|Overall Study|Withdrawal by Subject|1|||
146054081|NCT03275740|526713248|FG009|Overall Study|Withdrawal by Subject|1|||
146054082|NCT03275740|526713249|FG010|Overall Study|Withdrawal by Subject|0|||
146054083|NCT03275740|526713250|FG011|Overall Study|Withdrawal by Subject|0|||
146054084|NCT00890825|526713251|FG000|Overall Study|Withdrawal by Subject|1|||
146054085|NCT00890825|526713252|FG001|Overall Study|Withdrawal by Subject|0|||
146054086|NCT00890825|526713251|FG000|Overall Study|Alive at data cut off (DCO)|13|||
146054087|NCT00890825|526713252|FG001|Overall Study|Alive at data cut off (DCO)|14|||
146054088|NCT04701333|526713253|FG000|Overall Study|Lost to Follow-up|3|||
146054089|NCT04701333|526713254|FG001|Overall Study|Lost to Follow-up|7|||
146054090|NCT04701333|526713253|FG000|Overall Study|Withdrawal by Subject|0|||
146054091|NCT04701333|526713254|FG001|Overall Study|Withdrawal by Subject|1|||
146054092|NCT02920892|526713255|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
146054093|NCT02920892|526713256|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
146054094|NCT02920892|526713257|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
146054095|NCT02920892|526713255|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
146054096|NCT02920892|526713256|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
146054097|NCT02920892|526713257|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
146054098|NCT02920892|526713255|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
146054099|NCT02920892|526713256|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
146054100|NCT02920892|526713257|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
146054101|NCT02920892|526713255|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
146054102|NCT02920892|526713256|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
146054103|NCT02920892|526713257|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
146054104|NCT02920892|526713255|FG000|Placebo-Controlled Period|Physician Decision|0|||
146054105|NCT02920892|526713256|FG001|Placebo-Controlled Period|Physician Decision|0|||
146054106|NCT02920892|526713257|FG002|Placebo-Controlled Period|Physician Decision|1|||
146054107|NCT02920892|526713255|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
146054108|NCT02920892|526713256|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
146054109|NCT02920892|526713257|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
146054110|NCT02920892|526713255|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146054111|NCT02920892|526713256|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
146054112|NCT02920892|526713257|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146054113|NCT02920892|526713255|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
146054114|NCT02920892|526713256|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
146054115|NCT02920892|526713257|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
146054116|NCT00377520|526713266|FG000|Overall Study|Ineligible (Prior radiation)|1|||
146054117|NCT00660192|526713267|FG000|Overall Study|Lost to Follow-up|2|||
146054118|NCT00660192|526713268|FG001|Overall Study|Lost to Follow-up|3|||
146054119|NCT04908397|526713269|FG000|Overall Study|Withdrawal by Subject|2|||
146054120|NCT00462306|526713270|FG000|Overall Study|insufficient data|0|||
146054121|NCT00462306|526713271|FG001|Overall Study|insufficient data|13|||
146054122|NCT01391663|526713272|FG000|Overall Study|Withdrawal by Subject|0|||
146054123|NCT01391663|526713273|FG001|Overall Study|Withdrawal by Subject|0|||
146054124|NCT01391663|526713274|FG002|Overall Study|Withdrawal by Subject|1|||
146054125|NCT01391663|526713275|FG003|Overall Study|Withdrawal by Subject|0|||
146054126|NCT03515824|526713276|FG000|Overall Study|Death|3|||
146054127|NCT03515824|526713277|FG001|Overall Study|Death|2|||
146054128|NCT03515824|526713278|FG002|Overall Study|Death|6|||
146054129|NCT03515824|526713279|FG003|Overall Study|Death|0|||
146054130|NCT03515824|526713276|FG000|Overall Study|Lost to Follow-up|0|||
146054131|NCT03515824|526713277|FG001|Overall Study|Lost to Follow-up|1|||
146054132|NCT03515824|526713278|FG002|Overall Study|Lost to Follow-up|1|||
146054133|NCT03515824|526713279|FG003|Overall Study|Lost to Follow-up|0|||
146054134|NCT03515824|526713276|FG000|Overall Study|Study terminated by sponsor|0|||
146054135|NCT03515824|526713277|FG001|Overall Study|Study terminated by sponsor|1|||
146054136|NCT03515824|526713278|FG002|Overall Study|Study terminated by sponsor|6|||
146054137|NCT03515824|526713279|FG003|Overall Study|Study terminated by sponsor|0|||
146054138|NCT03515824|526713276|FG000|Overall Study|Status not recorded|0|||
146054139|NCT03515824|526713277|FG001|Overall Study|Status not recorded|0|||
146054140|NCT03515824|526713278|FG002|Overall Study|Status not recorded|2|||
146054141|NCT03515824|526713279|FG003|Overall Study|Status not recorded|0|||
146054142|NCT00920855|526713280|FG000|Overall Study|Adverse Event|1|||
146054143|NCT00920855|526713281|FG001|Overall Study|Adverse Event|1|||
146054144|NCT00920855|526713282|FG002|Overall Study|Adverse Event|4|||
146054145|NCT00920855|526713280|FG000|Overall Study|Withdrawal by Subject|2|||
146054146|NCT00920855|526713281|FG001|Overall Study|Withdrawal by Subject|1|||
146054147|NCT00920855|526713282|FG002|Overall Study|Withdrawal by Subject|6|||
146054148|NCT00920855|526713280|FG000|Overall Study|Disease progression|2|||
146054149|NCT00920855|526713281|FG001|Overall Study|Disease progression|1|||
146054150|NCT00920855|526713282|FG002|Overall Study|Disease progression|10|||
146054151|NCT00920855|526713280|FG000|Overall Study|Noncompliance to study medication|0|||
146054152|NCT00920855|526713281|FG001|Overall Study|Noncompliance to study medication|0|||
146054153|NCT00920855|526713282|FG002|Overall Study|Noncompliance to study medication|1|||
146054154|NCT00920855|526713280|FG000|Overall Study|Response plateau; started maintenance|0|||
146054155|NCT00920855|526713281|FG001|Overall Study|Response plateau; started maintenance|0|||
146054156|NCT00920855|526713282|FG002|Overall Study|Response plateau; started maintenance|1|||
146054157|NCT00510835|526713286|FG000|Overall Study|Withdrawal by Subject|6|||
146054158|NCT00510835|526713287|FG001|Overall Study|Withdrawal by Subject|2|||
146054159|NCT00510835|526713288|FG002|Overall Study|Withdrawal by Subject|2|||
146054160|NCT05470985|526713289|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
146054161|NCT05470985|526713290|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
146054162|NCT05470985|526713289|FG000|Double Blind Treatment Period|Physician Decision|0|||
146054163|NCT05470985|526713290|FG001|Double Blind Treatment Period|Physician Decision|1|||
146054164|NCT05470985|526713289|FG000|Long Term Extension|Adverse Event|0|||
146054165|NCT05470985|526713290|FG001|Long Term Extension|Adverse Event|1|||
146054166|NCT05470985|526713289|FG000|Long Term Extension|Study terminated by sponsor|2|||
146054167|NCT05470985|526713290|FG001|Long Term Extension|Study terminated by sponsor|0|||
146054168|NCT01917747|526713291|FG000|Overall Study|Withdrawal by Subject|1|||
146054169|NCT01917747|526713292|FG001|Overall Study|Withdrawal by Subject|2|||
146054170|NCT01917747|526713291|FG000|Overall Study|Lost to Follow-up|18|||
146054171|NCT01917747|526713292|FG001|Overall Study|Lost to Follow-up|9|||
146054172|NCT02741245|526713294|FG000|Overall Study|Adverse Event|0|||
146054173|NCT02741245|526713295|FG001|Overall Study|Adverse Event|0|||
146054174|NCT02741245|526713296|FG002|Overall Study|Adverse Event|0|||
146054175|NCT02741245|526713297|FG003|Overall Study|Adverse Event|2|||
146054176|NCT02741245|526713298|FG004|Overall Study|Adverse Event|2|||
146054177|NCT02741245|526713294|FG000|Overall Study|Protocol Violation|0|||
146054178|NCT02741245|526713295|FG001|Overall Study|Protocol Violation|1|||
146054179|NCT02741245|526713296|FG002|Overall Study|Protocol Violation|0|||
146054180|NCT02741245|526713297|FG003|Overall Study|Protocol Violation|1|||
146054181|NCT02741245|526713298|FG004|Overall Study|Protocol Violation|0|||
146054182|NCT02741245|526713294|FG000|Overall Study|Withdrawal by Subject|0|||
146054183|NCT02741245|526713295|FG001|Overall Study|Withdrawal by Subject|0|||
146054184|NCT02741245|526713296|FG002|Overall Study|Withdrawal by Subject|0|||
146054185|NCT02741245|526713297|FG003|Overall Study|Withdrawal by Subject|1|||
146054186|NCT02741245|526713298|FG004|Overall Study|Withdrawal by Subject|0|||
146054187|NCT01787461|526713300|FG000|Overall Study|Adverse Event|4|||
146054188|NCT01787461|526713301|FG001|Overall Study|Adverse Event|3|||
146054189|NCT01787461|526713300|FG000|Overall Study|Lost to Follow-up|3|||
146054190|NCT01787461|526713301|FG001|Overall Study|Lost to Follow-up|2|||
146054191|NCT01787461|526713300|FG000|Overall Study|No longer met eligibility criteria|1|||
146054192|NCT01787461|526713301|FG001|Overall Study|No longer met eligibility criteria|0|||
146054193|NCT01787461|526713300|FG000|Overall Study|Withdrawal by Subject|3|||
146054194|NCT01787461|526713301|FG001|Overall Study|Withdrawal by Subject|4|||
146054195|NCT01787461|526713300|FG000|Overall Study|Protocol Violation|3|||
146054196|NCT01787461|526713301|FG001|Overall Study|Protocol Violation|0|||
146054197|NCT00152503|526713302|FG000|Overall Study|Adverse Event|4|||
146054198|NCT03253679|526713303|FG000|Overall Study|Screen Failure|1|||
146054199|NCT04816214|526713304|FG000|Overall Study|Progressive Disease|4|||
146054200|NCT04816214|526713305|FG001|Overall Study|Progressive Disease|0|||
146054201|NCT04816214|526713306|FG002|Overall Study|Progressive Disease|0|||
146054202|NCT04816214|526713304|FG000|Overall Study|Death|1|||
146054203|NCT04816214|526713305|FG001|Overall Study|Death|0|||
146054204|NCT04816214|526713306|FG002|Overall Study|Death|0|||
146054205|NCT04816214|526713304|FG000|Overall Study|Study Terminated by Sponsor|1|||
146054206|NCT04816214|526713305|FG001|Overall Study|Study Terminated by Sponsor|0|||
146054207|NCT04816214|526713306|FG002|Overall Study|Study Terminated by Sponsor|0|||
146054208|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
146054209|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
146054210|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
146054211|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
146054212|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
146054213|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
146054214|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
146054215|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
146054216|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
146054217|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
146054218|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
146054219|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
146054220|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
146054221|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
146054222|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
146054223|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
146054224|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
146054225|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
146054226|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
146054227|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
146054228|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
146054229|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
146259214|NCT01649297|527463373|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
146054230|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
146054231|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
146054232|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
146054233|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
146054234|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
146054235|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
146054236|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
146054237|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
146054238|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
146054239|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
146054240|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
146054241|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
146054242|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
146054243|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
146054244|NCT02586623|526713307|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
146054245|NCT02586623|526713308|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
146054246|NCT02586623|526713309|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
146054247|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
146054248|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
146054249|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
146054250|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
146054251|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
146054252|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
146054253|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
146054254|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
146054255|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
146054256|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
146054257|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
146054258|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
146054259|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
146054260|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
146054261|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
146054262|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
146054263|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
146054264|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
146054265|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
146054266|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
146054267|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
146054268|NCT02586623|526713307|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
146054269|NCT02586623|526713308|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
146054270|NCT02586623|526713309|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
146054271|NCT05051579|526713313|FG000|Overall Study|Withdrawal by Subject|3|||
146054272|NCT05051579|526713314|FG001|Overall Study|Withdrawal by Subject|5|||
146054273|NCT05051579|526713315|FG002|Overall Study|Withdrawal by Subject|2|||
146054274|NCT05051579|526713316|FG003|Overall Study|Withdrawal by Subject|1|||
146054275|NCT05051579|526713317|FG004|Overall Study|Withdrawal by Subject|4|||
146054276|NCT05051579|526713318|FG005|Overall Study|Withdrawal by Subject|0|||
146054277|NCT05051579|526713319|FG006|Overall Study|Withdrawal by Subject|4|||
146054278|NCT05051579|526713313|FG000|Overall Study|Lost to Follow-up|1|||
146054279|NCT05051579|526713314|FG001|Overall Study|Lost to Follow-up|0|||
146054280|NCT05051579|526713315|FG002|Overall Study|Lost to Follow-up|0|||
146054281|NCT05051579|526713316|FG003|Overall Study|Lost to Follow-up|0|||
146054282|NCT05051579|526713317|FG004|Overall Study|Lost to Follow-up|1|||
146054283|NCT05051579|526713318|FG005|Overall Study|Lost to Follow-up|0|||
146054284|NCT05051579|526713319|FG006|Overall Study|Lost to Follow-up|1|||
146054285|NCT05051579|526713313|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054286|NCT05051579|526713314|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054287|NCT05051579|526713315|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054288|NCT05051579|526713316|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054289|NCT05051579|526713317|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054290|NCT05051579|526713318|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
146054291|NCT05051579|526713319|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
146054292|NCT05051579|526713313|FG000|Overall Study|Adverse Event|2|||
146054293|NCT05051579|526713314|FG001|Overall Study|Adverse Event|1|||
146054294|NCT05051579|526713315|FG002|Overall Study|Adverse Event|0|||
146054295|NCT05051579|526713316|FG003|Overall Study|Adverse Event|4|||
146054296|NCT05051579|526713317|FG004|Overall Study|Adverse Event|1|||
146054297|NCT05051579|526713318|FG005|Overall Study|Adverse Event|2|||
146054298|NCT05051579|526713319|FG006|Overall Study|Adverse Event|0|||
146054299|NCT05051579|526713313|FG000|Overall Study|Inadvertent Enrollment|0|||
146054300|NCT05051579|526713314|FG001|Overall Study|Inadvertent Enrollment|0|||
146054301|NCT05051579|526713315|FG002|Overall Study|Inadvertent Enrollment|0|||
146054302|NCT05051579|526713316|FG003|Overall Study|Inadvertent Enrollment|0|||
146054303|NCT05051579|526713317|FG004|Overall Study|Inadvertent Enrollment|0|||
146054304|NCT05051579|526713318|FG005|Overall Study|Inadvertent Enrollment|0|||
146110729|NCT04523220|526925934|FG001|Main Treatment Period|Withdrawal by Subject|3|||
146110730|NCT04523220|526925935|FG002|Main Treatment Period|Withdrawal by Subject|4|||
146110731|NCT04523220|526925933|FG000|Main Treatment Period|Study drug never adminstered|10|||
146110732|NCT04523220|526925934|FG001|Main Treatment Period|Study drug never adminstered|3|||
146110733|NCT04523220|526925935|FG002|Main Treatment Period|Study drug never adminstered|5|||
146301423|NCT00763971|527618887|FG002|Overall Study|Due to holiday season|1|||
146110734|NCT04523220|526925933|FG000|Extension Treatment Period|Physician Decision|1|||
146110735|NCT04523220|526925934|FG001|Extension Treatment Period|Physician Decision|0|||
146110736|NCT04523220|526925935|FG002|Extension Treatment Period|Physician Decision|3|||
146110737|NCT04523220|526925933|FG000|Extension Treatment Period|Other|2|||
146110738|NCT04523220|526925934|FG001|Extension Treatment Period|Other|6|||
146110739|NCT04523220|526925935|FG002|Extension Treatment Period|Other|6|||
146110740|NCT04523220|526925933|FG000|Extension Treatment Period|Subject Decision|5|||
146110741|NCT04523220|526925934|FG001|Extension Treatment Period|Subject Decision|2|||
146110742|NCT04523220|526925935|FG002|Extension Treatment Period|Subject Decision|4|||
146110743|NCT04523220|526925933|FG000|Extension Treatment Period|Death|6|||
146110744|NCT04523220|526925934|FG001|Extension Treatment Period|Death|4|||
146110745|NCT04523220|526925935|FG002|Extension Treatment Period|Death|7|||
146110746|NCT04523220|526925933|FG000|Extension Treatment Period|Adverse Event|6|||
146301424|NCT00763971|527618885|FG000|Overall Study|Randomization error|0|||
146301425|NCT00763971|527618886|FG001|Overall Study|Randomization error|0|||
146301426|NCT00763971|527618887|FG002|Overall Study|Randomization error|1|||
146301427|NCT00763971|527618885|FG000|Overall Study|Medical monitor decision|0|||
146301428|NCT00763971|527618886|FG001|Overall Study|Medical monitor decision|0|||
146301429|NCT00763971|527618887|FG002|Overall Study|Medical monitor decision|1|||
146054305|NCT05051579|526713319|FG006|Overall Study|Inadvertent Enrollment|1|||
146054306|NCT05051579|526713313|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054307|NCT05051579|526713314|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
146054308|NCT05051579|526713315|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054309|NCT05051579|526713316|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054310|NCT05051579|526713317|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054311|NCT05051579|526713318|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054312|NCT05051579|526713319|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
146054313|NCT05051579|526713313|FG000|Overall Study|Sponsor Decision|0|||
146054314|NCT05051579|526713314|FG001|Overall Study|Sponsor Decision|0|||
146054315|NCT05051579|526713315|FG002|Overall Study|Sponsor Decision|0|||
146054316|NCT05051579|526713316|FG003|Overall Study|Sponsor Decision|0|||
146054317|NCT05051579|526713317|FG004|Overall Study|Sponsor Decision|1|||
146054318|NCT05051579|526713318|FG005|Overall Study|Sponsor Decision|0|||
146054319|NCT05051579|526713319|FG006|Overall Study|Sponsor Decision|0|||
146054320|NCT05051579|526713313|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054321|NCT05051579|526713314|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054322|NCT05051579|526713315|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054323|NCT05051579|526713316|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054324|NCT05051579|526713317|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
146054325|NCT05051579|526713318|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054326|NCT05051579|526713319|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
146054327|NCT04332107|526713325|FG000|Day 3|Lost to Follow-up|23|||
146054328|NCT04332107|526713326|FG001|Day 3|Lost to Follow-up|14|||
146054329|NCT04332107|526713325|FG000|Day 3|Missing outcome data|3|||
146054330|NCT04332107|526713326|FG001|Day 3|Missing outcome data|6|||
146054331|NCT04332107|526713325|FG000|Day 14|Lost to Follow-up|13|||
146054332|NCT04332107|526713326|FG001|Day 14|Lost to Follow-up|4|||
146054333|NCT04332107|526713325|FG000|Day 14|Missing outcome data|4|||
146054334|NCT04332107|526713326|FG001|Day 14|Missing outcome data|4|||
146054335|NCT04332107|526713325|FG000|Day 21|Lost to Follow-up|10|||
146054336|NCT04332107|526713326|FG001|Day 21|Lost to Follow-up|2|||
146054337|NCT00717249|526713327|FG000|Overall Study|Lens Discomfort|4|||
146054338|NCT00717249|526713328|FG001|Overall Study|Lens Discomfort|1|||
146301430|NCT00763971|527618885|FG000|Overall Study|Moved to another country|0|||
146054339|NCT00717249|526713327|FG000|Overall Study|Unsatisfactory visual Response|0|||
146054340|NCT00717249|526713328|FG001|Overall Study|Unsatisfactory visual Response|2|||
146054341|NCT00717249|526713327|FG000|Overall Study|Adverse Event|4|||
146054342|NCT00717249|526713328|FG001|Overall Study|Adverse Event|2|||
146110747|NCT04523220|526925934|FG001|Extension Treatment Period|Adverse Event|7|||
146110748|NCT04523220|526925935|FG002|Extension Treatment Period|Adverse Event|9|||
146110749|NCT04523220|526925933|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
146110750|NCT04523220|526925934|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
146110751|NCT04523220|526925935|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
146301431|NCT00763971|527618886|FG001|Overall Study|Moved to another country|1|||
146301432|NCT00763971|527618887|FG002|Overall Study|Moved to another country|0|||
146054343|NCT00717249|526713327|FG000|Overall Study|Lost to Follow-up|2|||
146054344|NCT00717249|526713328|FG001|Overall Study|Lost to Follow-up|0|||
146054345|NCT00717249|526713327|FG000|Overall Study|Withdrawal by Subject|1|||
146054346|NCT00717249|526713328|FG001|Overall Study|Withdrawal by Subject|2|||
146054347|NCT00717249|526713327|FG000|Overall Study|Pregnancy|6|||
146054348|NCT00717249|526713328|FG001|Overall Study|Pregnancy|3|||
146054349|NCT00717249|526713327|FG000|Overall Study|Protocol Violation|0|||
146054350|NCT00717249|526713328|FG001|Overall Study|Protocol Violation|2|||
146054351|NCT00717249|526713327|FG000|Overall Study|Subject became Ineligible|1|||
146054352|NCT00717249|526713328|FG001|Overall Study|Subject became Ineligible|1|||
146054353|NCT00717249|526713327|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
146054354|NCT00717249|526713328|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
146054355|NCT00717249|526713327|FG000|Overall Study|Gastric Surgery|0|||
146054356|NCT00717249|526713328|FG001|Overall Study|Gastric Surgery|1|||
146054357|NCT00717249|526713327|FG000|Overall Study|Diagnosed with Diabetes|1|||
146054358|NCT00717249|526713328|FG001|Overall Study|Diagnosed with Diabetes|0|||
146054359|NCT00717249|526713327|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
146054360|NCT00717249|526713328|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
146054361|NCT00717249|526713327|FG000|Overall Study|Subject relocated|1|||
146054362|NCT00717249|526713328|FG001|Overall Study|Subject relocated|0|||
146054363|NCT00717249|526713327|FG000|Overall Study|Headaches|1|||
146054364|NCT00717249|526713328|FG001|Overall Study|Headaches|0|||
146054365|NCT00871871|526713329|FG000|Part I|Adverse Event|0|||
146054366|NCT00871871|526713330|FG001|Part I|Adverse Event|2|||
146054367|NCT00871871|526713331|FG002|Part I|Adverse Event|0|||
146054368|NCT00871871|526713332|FG003|Part I|Adverse Event|0|||
146054369|NCT00871871|526713329|FG000|Part I|Withdrawal by Subject|3|||
146054370|NCT00871871|526713330|FG001|Part I|Withdrawal by Subject|0|||
146054371|NCT00871871|526713331|FG002|Part I|Withdrawal by Subject|0|||
146054372|NCT00871871|526713332|FG003|Part I|Withdrawal by Subject|0|||
146054373|NCT00871871|526713329|FG000|Part I|Laboratory abnormality|0|||
146054374|NCT00871871|526713330|FG001|Part I|Laboratory abnormality|1|||
146054375|NCT00871871|526713331|FG002|Part I|Laboratory abnormality|0|||
146054376|NCT00871871|526713332|FG003|Part I|Laboratory abnormality|0|||
146054377|NCT00871871|526713329|FG000|Part II|Lack of Efficacy|0|||
146054378|NCT00871871|526713330|FG001|Part II|Lack of Efficacy|0|||
146054379|NCT00871871|526713331|FG002|Part II|Lack of Efficacy|1|||
146054380|NCT00871871|526713332|FG003|Part II|Lack of Efficacy|0|||
146054381|NCT00871871|526713329|FG000|Part II|Withdrawal by Subject|0|||
146054382|NCT00871871|526713330|FG001|Part II|Withdrawal by Subject|0|||
146054383|NCT00871871|526713331|FG002|Part II|Withdrawal by Subject|2|||
146054384|NCT00871871|526713332|FG003|Part II|Withdrawal by Subject|1|||
146054385|NCT00871871|526713329|FG000|Part II|Adverse Event|0|||
146054386|NCT00871871|526713330|FG001|Part II|Adverse Event|0|||
146054387|NCT00871871|526713331|FG002|Part II|Adverse Event|1|||
146054388|NCT00871871|526713332|FG003|Part II|Adverse Event|2|||
146054389|NCT00871871|526713329|FG000|Part II|Protocol Violation|0|||
146054390|NCT00871871|526713330|FG001|Part II|Protocol Violation|0|||
146054391|NCT00871871|526713331|FG002|Part II|Protocol Violation|0|||
146054392|NCT00871871|526713332|FG003|Part II|Protocol Violation|1|||
146054393|NCT03863509|526713333|FG000|Overall Study|COVID-19 shutdown period|0|||
146054394|NCT03863509|526713334|FG001|Overall Study|COVID-19 shutdown period|4|||
146054395|NCT03863509|526713335|FG002|Overall Study|COVID-19 shutdown period|0|||
146054396|NCT03863509|526713333|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
146054397|NCT03863509|526713334|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
146054398|NCT03863509|526713335|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
146054399|NCT03863509|526713333|FG000|Overall Study|Lost to Follow-up|8|||
146054400|NCT03863509|526713334|FG001|Overall Study|Lost to Follow-up|0|||
146054401|NCT03863509|526713335|FG002|Overall Study|Lost to Follow-up|2|||
146054402|NCT03863509|526713333|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
146054403|NCT03863509|526713334|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
146054404|NCT03863509|526713335|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
146054405|NCT03863509|526713333|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
146110752|NCT04523220|526925933|FG000|Extension Treatment Period|Study drug never administered|0|||
146110753|NCT04523220|526925934|FG001|Extension Treatment Period|Study drug never administered|1|||
146110754|NCT04523220|526925935|FG002|Extension Treatment Period|Study drug never administered|0|||
146054406|NCT03863509|526713334|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
146054407|NCT03863509|526713335|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
146054408|NCT03799341|526713336|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
146054409|NCT03799341|526713337|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
146259215|NCT01649297|527463374|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
146054410|NCT03799341|526713338|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
146054411|NCT03799341|526713336|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
146054412|NCT03799341|526713337|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
146054413|NCT03799341|526713338|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
146054414|NCT03799341|526713336|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
146054415|NCT03799341|526713337|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
146054416|NCT03799341|526713338|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
146054417|NCT03799341|526713336|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
146054418|NCT03799341|526713337|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
146054419|NCT03799341|526713338|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
146054420|NCT03799341|526713336|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
146054421|NCT03799341|526713337|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
146054422|NCT03799341|526713338|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
146054423|NCT03799341|526713336|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
146054424|NCT03799341|526713337|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
146054425|NCT03799341|526713338|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
146054426|NCT00990106|526713339|FG000|Overall Study|"too busy to continue"|1|||
146054427|NCT00990106|526713340|FG001|Overall Study|"too busy to continue"|2|||
146054428|NCT00990106|526713339|FG000|Overall Study|Lost to Follow-up|1|||
146054429|NCT00990106|526713340|FG001|Overall Study|Lost to Follow-up|3|||
146054430|NCT00990106|526713339|FG000|Overall Study|Withdrawal by Subject|2|||
146054431|NCT00990106|526713340|FG001|Overall Study|Withdrawal by Subject|1|||
146054432|NCT00990106|526713339|FG000|Overall Study|opted for open label prazosin|1|||
146054433|NCT00990106|526713340|FG001|Overall Study|opted for open label prazosin|1|||
146054434|NCT00990106|526713339|FG000|Overall Study|relocation/deployment|4|||
146054435|NCT00990106|526713340|FG001|Overall Study|relocation/deployment|1|||
146054436|NCT00990106|526713339|FG000|Overall Study|started exclusionary medication|0|||
146054437|NCT00990106|526713340|FG001|Overall Study|started exclusionary medication|1|||
146054438|NCT00990106|526713339|FG000|Overall Study|planned major surgery|0|||
146054439|NCT00990106|526713340|FG001|Overall Study|planned major surgery|1|||
146054440|NCT00990106|526713339|FG000|Overall Study|scheduling conflicts|0|||
146054441|NCT00990106|526713340|FG001|Overall Study|scheduling conflicts|2|||
146054442|NCT03100149|526713341|FG000|Overall Study|Adverse Event|0|||
146054443|NCT03100149|526713342|FG001|Overall Study|Adverse Event|1|||
146054444|NCT03100149|526713343|FG002|Overall Study|Adverse Event|0|||
146054445|NCT03100149|526713341|FG000|Overall Study|Participant Moved out of Country|0|||
146054446|NCT03100149|526713342|FG001|Overall Study|Participant Moved out of Country|0|||
146054447|NCT03100149|526713343|FG002|Overall Study|Participant Moved out of Country|1|||
146054448|NCT03100149|526713341|FG000|Overall Study|Withdrawal by Subject|0|||
146054449|NCT03100149|526713342|FG001|Overall Study|Withdrawal by Subject|3|||
146054450|NCT03100149|526713343|FG002|Overall Study|Withdrawal by Subject|1|||
146054451|NCT01871519|526713344|FG000|Overall Study|Death|26|||
146054452|NCT01871519|526713344|FG000|Overall Study|Lost to Follow-up|15|||
146054453|NCT01871519|526713344|FG000|Overall Study|Withdrawal by Subject|49|||
146054454|NCT00320515|526713345|FG000|Overall Study|Death|33|||
146054455|NCT00320515|526713345|FG000|Overall Study|Lost to Follow-up|6|||
146054456|NCT00320515|526713345|FG000|Overall Study|Physician Decision|2|||
146054457|NCT00320515|526713345|FG000|Overall Study|Withdrawal by Subject|8|||
146054458|NCT00445549|526714377|FG000|Overall Study|progressive disease|12|||
146054459|NCT01405768|526714384|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
146054460|NCT01405768|526714385|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
146054461|NCT02792231|526714388|FG000|Overall Study|Patient/guardian decision|32|||
146054462|NCT02792231|526714389|FG001|Overall Study|Patient/guardian decision|42|||
146054463|NCT02792231|526714388|FG000|Overall Study|Adverse Event|15|||
146054464|NCT02792231|526714389|FG001|Overall Study|Adverse Event|11|||
146054465|NCT02792231|526714388|FG000|Overall Study|Physician Decision|14|||
146054466|NCT02792231|526714389|FG001|Overall Study|Physician Decision|12|||
146054467|NCT02792231|526714388|FG000|Overall Study|Lack of Efficacy|7|||
146054468|NCT02792231|526714389|FG001|Overall Study|Lack of Efficacy|9|||
146054469|NCT02792231|526714388|FG000|Overall Study|Lost to Follow-up|9|||
146054470|NCT02792231|526714389|FG001|Overall Study|Lost to Follow-up|5|||
146054471|NCT02792231|526714388|FG000|Overall Study|Pregnancy|1|||
146054472|NCT02792231|526714389|FG001|Overall Study|Pregnancy|3|||
146054473|NCT02792231|526714388|FG000|Overall Study|Non-compliance with study treatment|2|||
146054474|NCT02792231|526714389|FG001|Overall Study|Non-compliance with study treatment|1|||
146054475|NCT02792231|526714388|FG000|Overall Study|Protocol deviation|2|||
146054476|NCT02792231|526714389|FG001|Overall Study|Protocol deviation|0|||
146054477|NCT02792231|526714388|FG000|Overall Study|Technical problems|0|||
146054478|NCT02792231|526714389|FG001|Overall Study|Technical problems|1|||
146110755|NCT00571948|526925936|FG000|Overall Study|Lost to Follow-up|2|||
146054479|NCT05196828|526714390|FG000|Overall Study|Withdrawal by Subject|2|||
146259216|NCT01649297|527463375|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
146259217|NCT01649297|527463376|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
146054480|NCT05196828|526714391|FG001|Overall Study|Withdrawal by Subject|0|||
146054481|NCT05196828|526714390|FG000|Overall Study|Lost to Follow-up|0|||
146054482|NCT05196828|526714391|FG001|Overall Study|Lost to Follow-up|4|||
146054483|NCT05196828|526714390|FG000|Overall Study|Adverse Event|1|||
146054484|NCT05196828|526714391|FG001|Overall Study|Adverse Event|0|||
146054485|NCT04073186|526714392|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
146054486|NCT04073186|526714392|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
146054487|NCT04073186|526714392|FG000|First Wearing Cycle|Protocol Violation|1|||
146054488|NCT04073186|526714392|FG000|First Wearing Cycle|Lens Discomfort|2|||
146054489|NCT04073186|526714392|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
146054490|NCT04073186|526714392|FG000|Second Wearing Cycle|Adverse Event|1|||
146054491|NCT00473434|526714393|FG000|Overall Study|Physician Decision|3|||
146054492|NCT00473434|526714393|FG000|Overall Study|Withdrawal by Subject|9|||
146054493|NCT00473434|526714393|FG000|Overall Study|Compliance|3|||
146054494|NCT00473434|526714393|FG000|Overall Study|Lack of Efficacy|3|||
146054495|NCT00473434|526714393|FG000|Overall Study|Adverse Event|3|||
146054496|NCT00473434|526714393|FG000|Overall Study|Patient was selling medication to others|1|||
146054497|NCT00473434|526714393|FG000|Overall Study|Safety evaluation|1|||
146054498|NCT00473434|526714393|FG000|Overall Study|Reason not specified|6|||
146054499|NCT00473434|526714393|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
146054500|NCT00473434|526714393|FG000|Overall Study|Switching to trial medication|1|||
146054501|NCT00473434|526714393|FG000|Overall Study|No longer required|1|||
146054502|NCT00423657|526714394|FG000|Overall Study|Withdrew consent|10|||
146054503|NCT00423657|526714395|FG001|Overall Study|Withdrew consent|8|||
146054504|NCT00423657|526714394|FG000|Overall Study|Non-compliance|0|||
146054505|NCT00423657|526714395|FG001|Overall Study|Non-compliance|1|||
146054506|NCT00423657|526714394|FG000|Overall Study|Other|15|||
146054507|NCT00423657|526714395|FG001|Overall Study|Other|16|||
146054508|NCT00423657|526714394|FG000|Overall Study|Request of sponsor/investigator|1|||
146054509|NCT00423657|526714395|FG001|Overall Study|Request of sponsor/investigator|0|||
146054510|NCT02748863|526714396|FG000|Treatment Period 1|Adverse Event|0|||
146054511|NCT02748863|526714397|FG001|Treatment Period 1|Adverse Event|1|||
146054512|NCT02748863|526714398|FG002|Treatment Period 1|Adverse Event|0|||
146054513|NCT02748863|526714399|FG003|Treatment Period 1|Adverse Event|0|||
146054514|NCT02748863|526714400|FG004|Treatment Period 1|Adverse Event|0|||
146054515|NCT02748863|526714396|FG000|Treatment Period 1|Lack of Efficacy|0|||
146054516|NCT02748863|526714397|FG001|Treatment Period 1|Lack of Efficacy|0|||
146054517|NCT02748863|526714398|FG002|Treatment Period 1|Lack of Efficacy|1|||
146054518|NCT02748863|526714399|FG003|Treatment Period 1|Lack of Efficacy|0|||
146054519|NCT02748863|526714400|FG004|Treatment Period 1|Lack of Efficacy|0|||
146054520|NCT02748863|526714396|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146054521|NCT02748863|526714397|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146054522|NCT02748863|526714398|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146054523|NCT02748863|526714399|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146054524|NCT02748863|526714400|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146054525|NCT02748863|526714396|FG000|Treatment Period 2|Lost to Follow-up|2|||
146054526|NCT02748863|526714397|FG001|Treatment Period 2|Lost to Follow-up|0|||
146054527|NCT02748863|526714398|FG002|Treatment Period 2|Lost to Follow-up|0|||
146054528|NCT02748863|526714399|FG003|Treatment Period 2|Lost to Follow-up|0|||
146054529|NCT02748863|526714400|FG004|Treatment Period 2|Lost to Follow-up|0|||
146054530|NCT02748863|526714396|FG000|Treatment Period 2|Adverse Event|3|||
146054531|NCT02748863|526714397|FG001|Treatment Period 2|Adverse Event|2|||
146054532|NCT02748863|526714398|FG002|Treatment Period 2|Adverse Event|0|||
146054533|NCT02748863|526714399|FG003|Treatment Period 2|Adverse Event|2|||
146054534|NCT02748863|526714400|FG004|Treatment Period 2|Adverse Event|0|||
146054535|NCT02748863|526714396|FG000|Treatment Period 2|Lack of Efficacy|0|||
146054536|NCT02748863|526714397|FG001|Treatment Period 2|Lack of Efficacy|1|||
146054537|NCT02748863|526714398|FG002|Treatment Period 2|Lack of Efficacy|0|||
146054538|NCT02748863|526714399|FG003|Treatment Period 2|Lack of Efficacy|0|||
146054539|NCT02748863|526714400|FG004|Treatment Period 2|Lack of Efficacy|0|||
146054540|NCT02748863|526714396|FG000|Treatment Period 2|Pregnancy|0|||
146259218|NCT01649297|527463377|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
146259219|NCT01649297|527463373|FG000|Overall Study|For other reason|4|||
146259220|NCT01649297|527463374|FG001|Overall Study|For other reason|1|||
146259221|NCT01649297|527463375|FG002|Overall Study|For other reason|2|||
146054541|NCT02748863|526714397|FG001|Treatment Period 2|Pregnancy|0|||
146054542|NCT02748863|526714398|FG002|Treatment Period 2|Pregnancy|0|||
146054543|NCT02748863|526714399|FG003|Treatment Period 2|Pregnancy|0|||
146054544|NCT02748863|526714400|FG004|Treatment Period 2|Pregnancy|1|||
146054545|NCT02422498|526714401|FG000|Overall Study|Inevaluable|4|||
146054546|NCT03206216|526714402|FG000|Overall Study|Withdrawal by Subject|0|||
146054547|NCT03206216|526714403|FG001|Overall Study|Withdrawal by Subject|1|||
146054548|NCT00657046|526714404|FG000|Overall Study|Adverse Event|1|||
146259222|NCT01649297|527463376|FG003|Overall Study|For other reason|0|||
146259223|NCT01649297|527463377|FG004|Overall Study|For other reason|0|||
146054549|NCT00657046|526714405|FG001|Overall Study|Adverse Event|1|||
146054550|NCT00657046|526714406|FG002|Overall Study|Adverse Event|0|||
146054551|NCT00657046|526714404|FG000|Overall Study|Protocol Violation|2|||
146054552|NCT00657046|526714405|FG001|Overall Study|Protocol Violation|2|||
146054553|NCT00657046|526714406|FG002|Overall Study|Protocol Violation|0|||
146054554|NCT00657046|526714404|FG000|Overall Study|Withdrawal by Subject|1|||
146054555|NCT00657046|526714405|FG001|Overall Study|Withdrawal by Subject|0|||
146054556|NCT00657046|526714406|FG002|Overall Study|Withdrawal by Subject|0|||
146054557|NCT00657046|526714404|FG000|Overall Study|Death|0|||
146054558|NCT00657046|526714405|FG001|Overall Study|Death|0|||
146054559|NCT00657046|526714406|FG002|Overall Study|Death|1|||
146054560|NCT00657046|526714404|FG000|Overall Study|Surgery|0|||
146054561|NCT00657046|526714405|FG001|Overall Study|Surgery|0|||
146054562|NCT00657046|526714406|FG002|Overall Study|Surgery|1|||
146054563|NCT06237049|526714407|FG000|Overall Study|Death|0|||
146054564|NCT06237049|526714408|FG001|Overall Study|Death|0|||
146054565|NCT06237049|526714409|FG002|Overall Study|Death|0|||
146054566|NCT06237049|526714410|FG003|Overall Study|Death|1|||
146054567|NCT06237049|526714407|FG000|Overall Study|Lost to Follow-up|11|||
146054568|NCT06237049|526714408|FG001|Overall Study|Lost to Follow-up|5|||
146054569|NCT06237049|526714409|FG002|Overall Study|Lost to Follow-up|8|||
146054570|NCT06237049|526714410|FG003|Overall Study|Lost to Follow-up|8|||
146054571|NCT06237049|526714407|FG000|Overall Study|Protocol Violation|0|||
146054572|NCT06237049|526714408|FG001|Overall Study|Protocol Violation|1|||
146054573|NCT06237049|526714409|FG002|Overall Study|Protocol Violation|0|||
146054574|NCT06237049|526714410|FG003|Overall Study|Protocol Violation|1|||
146054575|NCT06237049|526714407|FG000|Overall Study|Withdrawal by Subject|4|||
146054576|NCT06237049|526714408|FG001|Overall Study|Withdrawal by Subject|2|||
146054577|NCT06237049|526714409|FG002|Overall Study|Withdrawal by Subject|1|||
146110756|NCT00571948|526925937|FG001|Overall Study|Lost to Follow-up|0|||
146110757|NCT00571948|526925936|FG000|Overall Study|Withdrawal by Subject|1|||
146054578|NCT06237049|526714410|FG003|Overall Study|Withdrawal by Subject|0|||
146110758|NCT00571948|526925937|FG001|Overall Study|Withdrawal by Subject|2|||
146110759|NCT00571948|526925936|FG000|Overall Study|Protocol Violation|3|||
146110760|NCT00571948|526925937|FG001|Overall Study|Protocol Violation|3|||
146110761|NCT00571948|526925936|FG000|Overall Study|infant refused study meal|3|||
146110762|NCT00571948|526925937|FG001|Overall Study|infant refused study meal|4|||
146110763|NCT00571948|526925936|FG000|Overall Study|Parent were afraid of blood colection|2|||
146110764|NCT00571948|526925937|FG001|Overall Study|Parent were afraid of blood colection|5|||
146110765|NCT02030041|526925939|FG000|Overall Study|Withdrawal by Subject|2|||
146110766|NCT02030041|526925940|FG001|Overall Study|Withdrawal by Subject|2|||
146110767|NCT02030041|526925941|FG002|Overall Study|Withdrawal by Subject|1|||
146110768|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
146110769|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
146110770|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146110771|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146110772|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146110773|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
146110774|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
146110775|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
146110776|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146259224|NCT01685047|527463378|FG000|Overall Study|Withdrawal by Subject|20|||
146259225|NCT01685047|527463378|FG000|Overall Study|Death|26|||
146259226|NCT01685047|527463378|FG000|Overall Study|Lost to Follow-up|8|||
146054579|NCT02525471|526714411|FG000|Overall Study|Screen Failure|6|||
146054580|NCT02525471|526714411|FG000|Overall Study|Withdrawal by Subject|4|||
146054581|NCT02525471|526714411|FG000|Overall Study|Death|1|||
146054582|NCT00844376|526714412|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
146054583|NCT00844376|526714413|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
146054584|NCT00988884|526714414|FG000|Overall Study|Adverse Event|0|||
146259227|NCT01685047|527463378|FG000|Overall Study|Physician Decision|25|||
146259228|NCT01685047|527463378|FG000|Overall Study|Adverse Event|5|||
146259229|NCT01685047|527463378|FG000|Overall Study|patient withdrawn by sponsor|1|||
146259230|NCT01049984|527463380|FG000|Overall Study|Withdrawal by Subject|1|||
146259231|NCT01049984|527463381|FG001|Overall Study|Withdrawal by Subject|5|||
146054585|NCT00988884|526714415|FG001|Overall Study|Adverse Event|1|||
146054586|NCT00988884|526714414|FG000|Overall Study|Lost to Follow-up|20|||
146054587|NCT00988884|526714415|FG001|Overall Study|Lost to Follow-up|16|||
146259232|NCT01049984|527463380|FG000|Overall Study|Protocol Violation|3|||
146259233|NCT01049984|527463381|FG001|Overall Study|Protocol Violation|4|||
146259234|NCT01049984|527463380|FG000|Overall Study|Lost to Follow-up|2|||
146054588|NCT00988884|526714414|FG000|Overall Study|Protocol Violation|0|||
146054589|NCT00988884|526714415|FG001|Overall Study|Protocol Violation|1|||
146054590|NCT00988884|526714414|FG000|Overall Study|Withdrawal by Subject|15|||
146054591|NCT00988884|526714415|FG001|Overall Study|Withdrawal by Subject|18|||
146054592|NCT00468299|526714422|FG000|Overall Study|Withdrawal by Subject|0|||
146054593|NCT00468299|526714423|FG001|Overall Study|Withdrawal by Subject|1|||
146054594|NCT03546621|526714424|FG000|Overall Study|Withdrawal by Subject|0|||
146054595|NCT03546621|526714425|FG001|Overall Study|Withdrawal by Subject|1|||
146054596|NCT03546621|526714426|FG002|Overall Study|Withdrawal by Subject|2|||
146054597|NCT03546621|526714427|FG003|Overall Study|Withdrawal by Subject|1|||
146054598|NCT03546621|526714424|FG000|Overall Study|Lost to Follow-up|0|||
146054599|NCT03546621|526714425|FG001|Overall Study|Lost to Follow-up|1|||
146054600|NCT03546621|526714426|FG002|Overall Study|Lost to Follow-up|0|||
146054601|NCT03546621|526714427|FG003|Overall Study|Lost to Follow-up|0|||
146054602|NCT03546621|526714424|FG000|Overall Study|Adverse Event|0|||
146054603|NCT03546621|526714425|FG001|Overall Study|Adverse Event|1|||
146054604|NCT03546621|526714426|FG002|Overall Study|Adverse Event|0|||
146054605|NCT03546621|526714427|FG003|Overall Study|Adverse Event|1|||
146054606|NCT03546621|526714424|FG000|Overall Study|Progressive disease|0|||
146054607|NCT03546621|526714425|FG001|Overall Study|Progressive disease|0|||
146054608|NCT03546621|526714426|FG002|Overall Study|Progressive disease|0|||
146054609|NCT03546621|526714427|FG003|Overall Study|Progressive disease|1|||
146054610|NCT03318549|526714434|FG000|Overall Study|Withdrawal by Subject|5|||
146054611|NCT03318549|526714435|FG001|Overall Study|Withdrawal by Subject|19|||
146054612|NCT03318549|526714436|FG002|Overall Study|Withdrawal by Subject|2|||
146054613|NCT03318549|526714437|FG003|Overall Study|Withdrawal by Subject|0|||
146054614|NCT03318549|526714438|FG004|Overall Study|Withdrawal by Subject|0|||
146054615|NCT03318549|526714439|FG005|Overall Study|Withdrawal by Subject|0|||
146054616|NCT03318549|526714440|FG006|Overall Study|Withdrawal by Subject|0|||
146054617|NCT03318549|526714434|FG000|Overall Study|Physician Decision|0|||
146054618|NCT03318549|526714435|FG001|Overall Study|Physician Decision|4|||
146054619|NCT03318549|526714436|FG002|Overall Study|Physician Decision|1|||
146054620|NCT03318549|526714437|FG003|Overall Study|Physician Decision|0|||
146054621|NCT03318549|526714438|FG004|Overall Study|Physician Decision|0|||
146054622|NCT03318549|526714439|FG005|Overall Study|Physician Decision|0|||
146054623|NCT03318549|526714440|FG006|Overall Study|Physician Decision|0|||
146054624|NCT03318549|526714434|FG000|Overall Study|Lost to Follow-up|0|||
146054625|NCT03318549|526714435|FG001|Overall Study|Lost to Follow-up|3|||
146054626|NCT03318549|526714436|FG002|Overall Study|Lost to Follow-up|3|||
146054627|NCT03318549|526714437|FG003|Overall Study|Lost to Follow-up|0|||
146054628|NCT03318549|526714438|FG004|Overall Study|Lost to Follow-up|0|||
146054629|NCT03318549|526714439|FG005|Overall Study|Lost to Follow-up|0|||
146054630|NCT03318549|526714440|FG006|Overall Study|Lost to Follow-up|0|||
146054631|NCT00539994|526714441|FG000|Overall Study|Lost to Follow-up|2|||
146054632|NCT00539994|526714442|FG001|Overall Study|Lost to Follow-up|1|||
146054633|NCT00539994|526714443|FG002|Overall Study|Lost to Follow-up|0|||
146054634|NCT00539994|526714441|FG000|Overall Study|Withdrawal by Subject|1|||
146054635|NCT00539994|526714442|FG001|Overall Study|Withdrawal by Subject|0|||
146054636|NCT00539994|526714443|FG002|Overall Study|Withdrawal by Subject|1|||
146054637|NCT00539994|526714441|FG000|Overall Study|Physician Decision|0|||
146054638|NCT00539994|526714442|FG001|Overall Study|Physician Decision|0|||
146054639|NCT00539994|526714443|FG002|Overall Study|Physician Decision|1|||
146054640|NCT03649074|526714449|FG000|Overall Study|Lost to Follow-up|2|||
146054641|NCT03649074|526714450|FG001|Overall Study|Lost to Follow-up|1|||
146054642|NCT03649074|526714449|FG000|Overall Study|Adverse Event|1|||
146054643|NCT03649074|526714450|FG001|Overall Study|Adverse Event|0|||
146054644|NCT03649074|526714449|FG000|Overall Study|Physician Decision|1|||
146054645|NCT03649074|526714450|FG001|Overall Study|Physician Decision|0|||
146054646|NCT03649074|526714449|FG000|Overall Study|Withdrawal by Subject|0|||
146054647|NCT03649074|526714450|FG001|Overall Study|Withdrawal by Subject|2|||
146054648|NCT03649074|526714449|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
146054649|NCT03649074|526714450|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
146054650|NCT03649074|526714449|FG000|Overall Study|Other|1|||
146054651|NCT03649074|526714450|FG001|Overall Study|Other|0|||
146054652|NCT03861273|526714457|FG000|Screening Phase (3 Weeks)|Other|1|||
146054653|NCT03861273|526714457|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
146054654|NCT03861273|526714457|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
146054655|NCT03861273|526714457|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
146054656|NCT03861273|526714457|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
146054657|NCT00191334|526714460|FG000|Overall Study|Adverse Event|4|||
146054658|NCT00191334|526714460|FG000|Overall Study|Disease Progression or Relapse|8|||
146054659|NCT00191334|526714460|FG000|Overall Study|Physician Decision|1|||
146054660|NCT00191334|526714460|FG000|Overall Study|Withdrawal by Subject|4|||
146054661|NCT01116648|526714461|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
146054662|NCT01116648|526714462|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
146054663|NCT01116648|526714463|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
146054664|NCT01116648|526714464|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
146054665|NCT01116648|526714465|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
146054666|NCT01116648|526714466|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
146054667|NCT01116648|526714467|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
146054668|NCT01116648|526714468|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
146259235|NCT01049984|527463381|FG001|Overall Study|Lost to Follow-up|1|||
146054669|NCT01116648|526714469|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
146054670|NCT01116648|526714470|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
146054671|NCT01116648|526714471|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
146054672|NCT01116648|526714472|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
146054673|NCT01116648|526714473|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
146054674|NCT01116648|526714474|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
146054675|NCT01116648|526714475|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
146054676|NCT04539938|526714476|FG000|Overall Study|Death|30|||
146054677|NCT04539938|526714476|FG000|Overall Study|Withdrawal by Subject|4|||
146054678|NCT03064490|526714477|FG000|Overall Study|Physician Decision|5|||
146054679|NCT02926638|526714483|FG000|Overall Study|Progression|2|||
146054680|NCT02926638|526714484|FG001|Overall Study|Progression|5|||
146054681|NCT02926638|526714483|FG000|Overall Study|Ineligible|1|||
146054682|NCT02926638|526714484|FG001|Overall Study|Ineligible|0|||
146054683|NCT02926638|526714483|FG000|Overall Study|Not protocol specified|1|||
146054684|NCT02926638|526714484|FG001|Overall Study|Not protocol specified|0|||
146054685|NCT01063153|526714485|FG000|Overall Study|Found Ineligible During Screening|2|||
146054686|NCT01063153|526714486|FG001|Overall Study|Found Ineligible During Screening|0|||
146054687|NCT01063153|526714485|FG000|Overall Study|Lost to Follow-up|0|||
146054688|NCT01063153|526714486|FG001|Overall Study|Lost to Follow-up|7|||
146054689|NCT01063153|526714485|FG000|Overall Study|Withdrawal by Subject|0|||
146054690|NCT01063153|526714486|FG001|Overall Study|Withdrawal by Subject|1|||
146054691|NCT01063153|526714485|FG000|Overall Study|Physician Decision|0|||
146054692|NCT01063153|526714486|FG001|Overall Study|Physician Decision|4|||
146054693|NCT00350844|526714487|FG000|Overall Study|Lost to Follow-up|1|||
146054694|NCT01420926|526714488|FG000|Overall Study|Adverse Event|6|||
146054695|NCT01420926|526714489|FG001|Overall Study|Adverse Event|4|||
146054696|NCT01420926|526714488|FG000|Overall Study|Death|18|||
146054697|NCT01420926|526714489|FG001|Overall Study|Death|17|||
146054698|NCT01420926|526714488|FG000|Overall Study|Withdrawal by Subject|11|||
146054699|NCT01420926|526714489|FG001|Overall Study|Withdrawal by Subject|17|||
146054700|NCT01420926|526714488|FG000|Overall Study|Non-protocol treatment|17|||
146054701|NCT01420926|526714489|FG001|Overall Study|Non-protocol treatment|20|||
146054702|NCT01420926|526714488|FG000|Overall Study|Physician Decision|8|||
146054703|NCT01420926|526714489|FG001|Overall Study|Physician Decision|5|||
146054704|NCT00882440|526716064|FG000|Overall Study|Adverse Event|2|||
146054705|NCT00882440|526716065|FG001|Overall Study|Adverse Event|2|||
146054706|NCT00882440|526716066|FG002|Overall Study|Adverse Event|2|||
146054707|NCT00882440|526716067|FG003|Overall Study|Adverse Event|1|||
146054708|NCT00882440|526716068|FG004|Overall Study|Adverse Event|1|||
146054709|NCT00882440|526716069|FG005|Overall Study|Adverse Event|4|||
146054710|NCT00882440|526716070|FG006|Overall Study|Adverse Event|2|||
146054711|NCT00882440|526716064|FG000|Overall Study|Lack of Efficacy|3|||
146054712|NCT00882440|526716065|FG001|Overall Study|Lack of Efficacy|5|||
146054713|NCT00882440|526716066|FG002|Overall Study|Lack of Efficacy|2|||
146054714|NCT00882440|526716067|FG003|Overall Study|Lack of Efficacy|0|||
146054715|NCT00882440|526716068|FG004|Overall Study|Lack of Efficacy|0|||
146054716|NCT00882440|526716069|FG005|Overall Study|Lack of Efficacy|3|||
146054717|NCT00882440|526716070|FG006|Overall Study|Lack of Efficacy|0|||
146054718|NCT00882440|526716064|FG000|Overall Study|Lost to Follow-up|2|||
146054719|NCT00882440|526716065|FG001|Overall Study|Lost to Follow-up|0|||
146054720|NCT00882440|526716066|FG002|Overall Study|Lost to Follow-up|1|||
146054721|NCT00882440|526716067|FG003|Overall Study|Lost to Follow-up|1|||
146054722|NCT00882440|526716068|FG004|Overall Study|Lost to Follow-up|1|||
146054723|NCT00882440|526716069|FG005|Overall Study|Lost to Follow-up|0|||
146054724|NCT00882440|526716070|FG006|Overall Study|Lost to Follow-up|1|||
146054725|NCT00882440|526716064|FG000|Overall Study|Protocol Violation|0|||
146054726|NCT00882440|526716065|FG001|Overall Study|Protocol Violation|0|||
146054727|NCT00882440|526716066|FG002|Overall Study|Protocol Violation|1|||
146054728|NCT00882440|526716067|FG003|Overall Study|Protocol Violation|1|||
146054729|NCT00882440|526716068|FG004|Overall Study|Protocol Violation|1|||
146054730|NCT00882440|526716069|FG005|Overall Study|Protocol Violation|0|||
146054731|NCT00882440|526716070|FG006|Overall Study|Protocol Violation|0|||
146054732|NCT00882440|526716064|FG000|Overall Study|Withdrawal by Subject|2|||
146054733|NCT00882440|526716065|FG001|Overall Study|Withdrawal by Subject|1|||
146054734|NCT00882440|526716066|FG002|Overall Study|Withdrawal by Subject|1|||
146054735|NCT00882440|526716067|FG003|Overall Study|Withdrawal by Subject|0|||
146054736|NCT00882440|526716068|FG004|Overall Study|Withdrawal by Subject|6|||
146054737|NCT00882440|526716069|FG005|Overall Study|Withdrawal by Subject|0|||
146054738|NCT00882440|526716070|FG006|Overall Study|Withdrawal by Subject|1|||
146054739|NCT00882440|526716064|FG000|Overall Study|Patient Uncooperative|2|||
146054740|NCT00882440|526716065|FG001|Overall Study|Patient Uncooperative|0|||
146054741|NCT00882440|526716066|FG002|Overall Study|Patient Uncooperative|0|||
146054742|NCT00882440|526716067|FG003|Overall Study|Patient Uncooperative|0|||
146054743|NCT00882440|526716068|FG004|Overall Study|Patient Uncooperative|1|||
146054744|NCT00882440|526716069|FG005|Overall Study|Patient Uncooperative|0|||
146259236|NCT01049984|527463380|FG000|Overall Study|Adverse Event|13|||
146054745|NCT00882440|526716070|FG006|Overall Study|Patient Uncooperative|0|||
146054746|NCT01381016|526716072|FG000|Overall Study|Lost to Follow-up|1|||
146054747|NCT01381016|526716073|FG001|Overall Study|Lost to Follow-up|1|||
146054748|NCT01381016|526716072|FG000|Overall Study|Screen Failure|2|||
146054749|NCT01381016|526716073|FG001|Overall Study|Screen Failure|2|||
146054750|NCT01381016|526716072|FG000|Overall Study|Withdrawal by Subject|0|||
146054751|NCT01381016|526716073|FG001|Overall Study|Withdrawal by Subject|1|||
146054752|NCT01381016|526716072|FG000|Overall Study|Physician Decision|0|||
146054753|NCT01381016|526716073|FG001|Overall Study|Physician Decision|2|||
146054754|NCT01451723|526716083|FG000|Overall Study|study halted|6|||
146054755|NCT01451723|526716084|FG001|Overall Study|study halted|5|||
146054756|NCT01329263|526716085|FG000|Overall Study|Lost to Follow-up|4|||
146054757|NCT01329263|526716086|FG001|Overall Study|Lost to Follow-up|21|||
146054758|NCT01329263|526716085|FG000|Overall Study|Withdrawal by Subject|1|||
146054759|NCT01329263|526716086|FG001|Overall Study|Withdrawal by Subject|2|||
146054760|NCT01631435|526716088|FG000|Overall Study|Adverse Event|2|||
146054761|NCT01631435|526716088|FG000|Overall Study|Withdrawal by Subject|2|||
146054762|NCT01631435|526716088|FG000|Overall Study|incomplete study procedure|5|||
146054763|NCT00833040|526716089|FG000|Overall Study|Adverse Event|0|||
146054764|NCT00833040|526716090|FG001|Overall Study|Adverse Event|0|||
146054765|NCT00833040|526716091|FG002|Overall Study|Adverse Event|0|||
146054766|NCT00833040|526716092|FG003|Overall Study|Adverse Event|0|||
146054767|NCT00833040|526716093|FG004|Overall Study|Adverse Event|0|||
146054768|NCT00833040|526716094|FG005|Overall Study|Adverse Event|1|||
146110777|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146110778|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146110779|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
146110780|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
146110781|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
146110782|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146110783|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146110784|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146110785|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
146110786|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
146110787|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
146110788|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146110789|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146110790|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146110791|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
146110792|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
146110793|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
146110794|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146054769|NCT00416624|526716097|FG000|Overall Study|Withdrawal by Subject|1|||
146054770|NCT00416624|526716098|FG001|Overall Study|Withdrawal by Subject|6|||
146054771|NCT00416624|526716099|FG002|Overall Study|Withdrawal by Subject|4|||
146054772|NCT00416624|526716100|FG003|Overall Study|Withdrawal by Subject|9|||
146054773|NCT00416624|526716097|FG000|Overall Study|Death|4|||
146054774|NCT00416624|526716098|FG001|Overall Study|Death|7|||
146054775|NCT00416624|526716099|FG002|Overall Study|Death|7|||
146054776|NCT00416624|526716100|FG003|Overall Study|Death|1|||
146054777|NCT00416624|526716097|FG000|Overall Study|Adverse Event|8|||
146054778|NCT00416624|526716098|FG001|Overall Study|Adverse Event|3|||
146054779|NCT00416624|526716099|FG002|Overall Study|Adverse Event|2|||
146054780|NCT00416624|526716100|FG003|Overall Study|Adverse Event|2|||
146110795|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146110796|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146110797|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
146110798|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146110799|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
146110800|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146110801|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146110802|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146110803|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
146110804|NCT00843024|526925942|FG000|Single-blind Placebo Run-In Phase|Other|0|||
146110805|NCT00843024|526925943|FG001|Single-blind Placebo Run-In Phase|Other|1|||
146054781|NCT00416624|526716097|FG000|Overall Study|Other|8|||
146054782|NCT00416624|526716098|FG001|Overall Study|Other|11|||
146054783|NCT00416624|526716099|FG002|Overall Study|Other|5|||
146110806|NCT00843024|526925944|FG002|Single-blind Placebo Run-In Phase|Other|0|||
146110807|NCT00843024|526925945|FG003|Single-blind Placebo Run-In Phase|Other|0|||
146110808|NCT00843024|526925946|FG004|Single-blind Placebo Run-In Phase|Other|0|||
146110809|NCT00843024|526925947|FG005|Single-blind Placebo Run-In Phase|Other|0|||
146110810|NCT00843024|526925942|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
146054784|NCT00416624|526716100|FG003|Overall Study|Other|5|||
146054785|NCT00416624|526716097|FG000|Overall Study|Cancel|1|||
146054786|NCT00416624|526716098|FG001|Overall Study|Cancel|0|||
146054787|NCT00416624|526716099|FG002|Overall Study|Cancel|0|||
146054788|NCT00416624|526716100|FG003|Overall Study|Cancel|0|||
146054789|NCT01005251|526716101|FG000|Overall Study|Withdrawal by Subject|2|||
146054790|NCT01005251|526716102|FG001|Overall Study|Withdrawal by Subject|5|||
146054791|NCT01005251|526716103|FG002|Overall Study|Withdrawal by Subject|3|||
146054792|NCT01005251|526716104|FG003|Overall Study|Withdrawal by Subject|4|||
146054793|NCT01005251|526716105|FG004|Overall Study|Withdrawal by Subject|9|||
146054794|NCT01005251|526716101|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
146054795|NCT01005251|526716102|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146054796|NCT01005251|526716103|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
146054797|NCT01005251|526716104|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146054798|NCT01005251|526716105|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146054799|NCT01005251|526716101|FG000|Overall Study|Adverse Event|2|||
146054800|NCT01005251|526716102|FG001|Overall Study|Adverse Event|6|||
146054801|NCT01005251|526716103|FG002|Overall Study|Adverse Event|8|||
146054802|NCT01005251|526716104|FG003|Overall Study|Adverse Event|5|||
146054803|NCT01005251|526716105|FG004|Overall Study|Adverse Event|4|||
146054804|NCT01005251|526716101|FG000|Overall Study|Protocol Violation|1|||
146054805|NCT01005251|526716102|FG001|Overall Study|Protocol Violation|0|||
146054806|NCT01005251|526716103|FG002|Overall Study|Protocol Violation|0|||
146054807|NCT01005251|526716104|FG003|Overall Study|Protocol Violation|0|||
146054808|NCT01005251|526716105|FG004|Overall Study|Protocol Violation|2|||
146054809|NCT01005251|526716101|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
146054810|NCT01005251|526716102|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
146054811|NCT01005251|526716103|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
146054812|NCT01005251|526716104|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
146054813|NCT01005251|526716105|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
146054814|NCT01005251|526716101|FG000|Overall Study|Lost to Follow-up|1|||
146054815|NCT01005251|526716102|FG001|Overall Study|Lost to Follow-up|4|||
146054816|NCT01005251|526716103|FG002|Overall Study|Lost to Follow-up|2|||
146054817|NCT01005251|526716104|FG003|Overall Study|Lost to Follow-up|0|||
146054818|NCT01005251|526716105|FG004|Overall Study|Lost to Follow-up|0|||
146054819|NCT01005251|526716101|FG000|Overall Study|Physician Decision|0|||
146054820|NCT01005251|526716102|FG001|Overall Study|Physician Decision|0|||
146054821|NCT01005251|526716103|FG002|Overall Study|Physician Decision|0|||
146054822|NCT01005251|526716104|FG003|Overall Study|Physician Decision|0|||
146054823|NCT01005251|526716105|FG004|Overall Study|Physician Decision|2|||
146054824|NCT01005251|526716101|FG000|Overall Study|Patient moved|1|||
146054825|NCT01005251|526716102|FG001|Overall Study|Patient moved|0|||
146054826|NCT01005251|526716103|FG002|Overall Study|Patient moved|0|||
146054827|NCT01005251|526716104|FG003|Overall Study|Patient moved|0|||
146054828|NCT01005251|526716105|FG004|Overall Study|Patient moved|0|||
146054829|NCT01005251|526716101|FG000|Overall Study|Wrong drug dispensed|0|||
146054830|NCT01005251|526716102|FG001|Overall Study|Wrong drug dispensed|1|||
146054831|NCT01005251|526716103|FG002|Overall Study|Wrong drug dispensed|0|||
146054832|NCT01005251|526716104|FG003|Overall Study|Wrong drug dispensed|0|||
146054833|NCT01005251|526716105|FG004|Overall Study|Wrong drug dispensed|0|||
146054834|NCT01005251|526716101|FG000|Overall Study|Randomized in error|0|||
146054835|NCT01005251|526716102|FG001|Overall Study|Randomized in error|0|||
146054836|NCT01005251|526716103|FG002|Overall Study|Randomized in error|1|||
146054837|NCT01005251|526716104|FG003|Overall Study|Randomized in error|1|||
146054838|NCT01005251|526716105|FG004|Overall Study|Randomized in error|0|||
146054839|NCT01005251|526716101|FG000|Overall Study|Lack of Efficacy|0|||
146054840|NCT01005251|526716102|FG001|Overall Study|Lack of Efficacy|0|||
146054841|NCT01005251|526716103|FG002|Overall Study|Lack of Efficacy|1|||
146054842|NCT01005251|526716104|FG003|Overall Study|Lack of Efficacy|1|||
146054843|NCT01005251|526716105|FG004|Overall Study|Lack of Efficacy|0|||
146054844|NCT00962208|526716107|FG000|Overall Study|Could not achieve good vision|9|||
146054845|NCT00962208|526716108|FG001|Overall Study|Could not achieve good vision|0|||
146054846|NCT00962208|526716107|FG000|Overall Study|Contraindicated to continue study|5|||
146054847|NCT00962208|526716108|FG001|Overall Study|Contraindicated to continue study|1|||
146054848|NCT00962208|526716107|FG000|Overall Study|Lost to Follow-up|0|||
146054849|NCT00962208|526716108|FG001|Overall Study|Lost to Follow-up|9|||
146054850|NCT00657540|526716109|FG000|Overall Study|Lost to Follow-up|1|||
146054851|NCT00657540|526716110|FG001|Overall Study|Lost to Follow-up|4|||
146054852|NCT04245111|526716113|FG000|Overall Study|Lost to Follow-up|5|||
146054853|NCT04245111|526716114|FG001|Overall Study|Lost to Follow-up|1|||
146054854|NCT04245111|526716115|FG002|Overall Study|Lost to Follow-up|1|||
146054855|NCT06039579|526716118|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054856|NCT06039579|526716119|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054857|NCT06039579|526716120|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054858|NCT06039579|526716121|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054859|NCT06039579|526716122|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054860|NCT06039579|526716123|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054861|NCT06039579|526716124|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
146054862|NCT06039579|526716125|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
146054863|NCT02469623|526716130|FG000|Overall Study|Not consented for long-term follow-up|4|||
146054864|NCT02469623|526716130|FG000|Overall Study|Lost to Follow-up|4|||
146054865|NCT02469623|526716130|FG000|Overall Study|Withdrawal by Subject|2|||
146054866|NCT02469623|526716130|FG000|Overall Study|Death|3|||
146054867|NCT03309878|526716131|FG000|Overall Study|Adverse Event|1|||
146054868|NCT03309878|526716132|FG001|Overall Study|Adverse Event|0|||
146054869|NCT03309878|526716133|FG002|Overall Study|Adverse Event|0|||
146054870|NCT03309878|526716134|FG003|Overall Study|Adverse Event|0|||
146054871|NCT03309878|526716131|FG000|Overall Study|Did not maintain eligibility|2|||
146054872|NCT03309878|526716132|FG001|Overall Study|Did not maintain eligibility|1|||
146054873|NCT03309878|526716133|FG002|Overall Study|Did not maintain eligibility|0|||
146054874|NCT03309878|526716134|FG003|Overall Study|Did not maintain eligibility|0|||
146054875|NCT03309878|526716131|FG000|Overall Study|Withdrawal by Subject|0|||
146054876|NCT03309878|526716132|FG001|Overall Study|Withdrawal by Subject|1|||
146054877|NCT03309878|526716133|FG002|Overall Study|Withdrawal by Subject|0|||
146054878|NCT03309878|526716134|FG003|Overall Study|Withdrawal by Subject|0|||
146054879|NCT01096316|526716135|FG000|Overall Study|Lost to Follow-up|15|||
146054880|NCT01096316|526716136|FG001|Overall Study|Lost to Follow-up|9|||
146054881|NCT01884077|526716137|FG000|Overall Study|screen fail|0|||
146054882|NCT01884077|526716138|FG001|Overall Study|screen fail|2|||
146054883|NCT01884077|526716137|FG000|Overall Study|canceled surgery|2|||
146054884|NCT01884077|526716138|FG001|Overall Study|canceled surgery|0|||
146054885|NCT01884077|526716137|FG000|Overall Study|Lost to Follow-up|0|||
146054886|NCT01884077|526716138|FG001|Overall Study|Lost to Follow-up|4|||
146054887|NCT01884077|526716137|FG000|Overall Study|study closed|6|||
146054888|NCT01884077|526716138|FG001|Overall Study|study closed|4|||
146054889|NCT02836652|526716139|FG000|Overall Study|Death|3|||
146054890|NCT02836652|526716140|FG001|Overall Study|Death|3|||
146054891|NCT02836652|526716139|FG000|Overall Study|Transplant/Explant|3|||
146054892|NCT02836652|526716140|FG001|Overall Study|Transplant/Explant|4|||
146054893|NCT02836652|526716139|FG000|Overall Study|Withdrawn|9|||
146054894|NCT02836652|526716140|FG001|Overall Study|Withdrawn|9|||
146054895|NCT02836652|526716139|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
146054896|NCT02836652|526716140|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
146054897|NCT02349633|526716141|FG000|Overall Study|Death|0|||
146054898|NCT02349633|526716142|FG001|Overall Study|Death|1|||
146054899|NCT02349633|526716143|FG002|Overall Study|Death|0|||
146054900|NCT02349633|526716144|FG003|Overall Study|Death|0|||
146054901|NCT02349633|526716145|FG004|Overall Study|Death|0|||
146054902|NCT02349633|526716146|FG005|Overall Study|Death|1|||
146054903|NCT02349633|526716147|FG006|Overall Study|Death|1|||
146054904|NCT02349633|526716148|FG007|Overall Study|Death|1|||
146054905|NCT02349633|526716149|FG008|Overall Study|Death|0|||
146054906|NCT02349633|526716150|FG009|Overall Study|Death|1|||
146054907|NCT02349633|526716151|FG010|Overall Study|Death|0|||
146054908|NCT02349633|526716152|FG011|Overall Study|Death|0|||
146054909|NCT02349633|526716153|FG012|Overall Study|Death|0|||
146054910|NCT02349633|526716154|FG013|Overall Study|Death|0|||
146054911|NCT02349633|526716141|FG000|Overall Study|Withdrawal by Subject|0|||
146054912|NCT02349633|526716142|FG001|Overall Study|Withdrawal by Subject|0|||
146054913|NCT02349633|526716143|FG002|Overall Study|Withdrawal by Subject|0|||
146054914|NCT02349633|526716144|FG003|Overall Study|Withdrawal by Subject|1|||
146054915|NCT02349633|526716145|FG004|Overall Study|Withdrawal by Subject|0|||
146054916|NCT02349633|526716146|FG005|Overall Study|Withdrawal by Subject|0|||
146054917|NCT02349633|526716147|FG006|Overall Study|Withdrawal by Subject|0|||
146054918|NCT02349633|526716148|FG007|Overall Study|Withdrawal by Subject|2|||
146054919|NCT02349633|526716149|FG008|Overall Study|Withdrawal by Subject|2|||
146054920|NCT02349633|526716150|FG009|Overall Study|Withdrawal by Subject|1|||
146054921|NCT02349633|526716151|FG010|Overall Study|Withdrawal by Subject|0|||
146054922|NCT02349633|526716152|FG011|Overall Study|Withdrawal by Subject|0|||
146054923|NCT02349633|526716153|FG012|Overall Study|Withdrawal by Subject|0|||
146054924|NCT02349633|526716154|FG013|Overall Study|Withdrawal by Subject|0|||
146054925|NCT02349633|526716141|FG000|Overall Study|Withdrawal of informed consent|0|||
146054926|NCT02349633|526716142|FG001|Overall Study|Withdrawal of informed consent|0|||
146054927|NCT02349633|526716143|FG002|Overall Study|Withdrawal of informed consent|0|||
146054928|NCT02349633|526716144|FG003|Overall Study|Withdrawal of informed consent|1|||
146054929|NCT02349633|526716145|FG004|Overall Study|Withdrawal of informed consent|1|||
146054930|NCT02349633|526716146|FG005|Overall Study|Withdrawal of informed consent|0|||
146110811|NCT00843024|526925943|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
146054931|NCT02349633|526716147|FG006|Overall Study|Withdrawal of informed consent|0|||
146054932|NCT02349633|526716148|FG007|Overall Study|Withdrawal of informed consent|3|||
146054933|NCT02349633|526716149|FG008|Overall Study|Withdrawal of informed consent|0|||
146054934|NCT02349633|526716150|FG009|Overall Study|Withdrawal of informed consent|0|||
146054935|NCT02349633|526716151|FG010|Overall Study|Withdrawal of informed consent|0|||
146054936|NCT02349633|526716152|FG011|Overall Study|Withdrawal of informed consent|0|||
146054937|NCT02349633|526716153|FG012|Overall Study|Withdrawal of informed consent|0|||
146054938|NCT02349633|526716154|FG013|Overall Study|Withdrawal of informed consent|0|||
146054939|NCT02349633|526716141|FG000|Overall Study|Transition to compassionate use|0|||
146054940|NCT02349633|526716142|FG001|Overall Study|Transition to compassionate use|0|||
146054941|NCT02349633|526716143|FG002|Overall Study|Transition to compassionate use|0|||
146259237|NCT01049984|527463381|FG001|Overall Study|Adverse Event|7|||
146259238|NCT01049984|527463380|FG000|Overall Study|Treatment failure|0|||
146259239|NCT01049984|527463381|FG001|Overall Study|Treatment failure|2|||
146259240|NCT01040403|527463382|FG000|Overall Study|Adverse Event|10|||
146259241|NCT01040403|527463382|FG000|Overall Study|Protocol Violation|2|||
146259242|NCT01040403|527463382|FG000|Overall Study|Lost to Follow-up|1|||
146259243|NCT01040403|527463382|FG000|Overall Study|Not treated|1|||
146259244|NCT01040403|527463382|FG000|Overall Study|Other reason not defined above|6|||
146259245|NCT01233999|527463385|FG000|Overall Study|Withdrawal by Subject|1|||
146259246|NCT01233999|527463385|FG000|Overall Study|Lost to Follow-up|1|||
146259247|NCT01321723|527463386|FG000|Overall Study|Adverse Event|3|||
146259248|NCT01321723|527463387|FG001|Overall Study|Adverse Event|5|||
146259249|NCT01321723|527463388|FG002|Overall Study|Adverse Event|2|||
146259250|NCT01321723|527463386|FG000|Overall Study|Withdrawal by Subject|2|||
146259251|NCT01321723|527463387|FG001|Overall Study|Withdrawal by Subject|0|||
146259252|NCT01321723|527463388|FG002|Overall Study|Withdrawal by Subject|2|||
146259253|NCT02246218|527463389|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146259254|NCT02246218|527463390|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146259255|NCT02246218|527463389|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
146259256|NCT02246218|527463390|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
146259257|NCT02246218|527463389|FG000|Overall Study|Adverse Event|1|||
146259258|NCT02246218|527463390|FG001|Overall Study|Adverse Event|1|||
146259259|NCT02246218|527463389|FG000|Overall Study|Lost to Follow-up|1|||
146259260|NCT02246218|527463390|FG001|Overall Study|Lost to Follow-up|0|||
146259261|NCT04952701|527463391|FG000|Control Lens|Physician Decision|4|||
146259262|NCT04952701|527463391|FG000|Test Lens|Physician Decision|1|||
146259263|NCT00827775|527463397|FG000|Overall Study|Withdrawal by Subject|0|||
146259264|NCT00827775|527463398|FG001|Overall Study|Withdrawal by Subject|5|||
146259265|NCT02212301|527463402|FG000|Period 1|Lost to Follow-up|0|||
146259266|NCT02212301|527463403|FG001|Period 1|Lost to Follow-up|1|||
146259267|NCT00578318|527463408|FG000|Overall Study|Lost to Follow-up|2|||
146259268|NCT00578318|527463409|FG001|Overall Study|Lost to Follow-up|0|||
146259269|NCT00578318|527463408|FG000|Overall Study|Physician Decision|1|||
146259270|NCT00578318|527463409|FG001|Overall Study|Physician Decision|0|||
146259271|NCT02025985|527463410|FG000|Overall Study|Consent withdrawn|0|||
146259272|NCT02025985|527463411|FG001|Overall Study|Consent withdrawn|0|||
146259273|NCT02025985|527463412|FG002|Overall Study|Consent withdrawn|1|||
146259274|NCT02025985|527463413|FG003|Overall Study|Consent withdrawn|0|||
146259275|NCT02025985|527463414|FG004|Overall Study|Consent withdrawn|0|||
146259276|NCT02025985|527463410|FG000|Overall Study|Termination of study by Sponsor|4|||
146259277|NCT02025985|527463411|FG001|Overall Study|Termination of study by Sponsor|3|||
146259278|NCT02025985|527463412|FG002|Overall Study|Termination of study by Sponsor|1|||
146259279|NCT02025985|527463413|FG003|Overall Study|Termination of study by Sponsor|1|||
146259280|NCT02025985|527463414|FG004|Overall Study|Termination of study by Sponsor|3|||
146259281|NCT02025985|527463410|FG000|Overall Study|Death|21|||
146259282|NCT02025985|527463411|FG001|Overall Study|Death|20|||
146259283|NCT02025985|527463412|FG002|Overall Study|Death|23|||
146259284|NCT02025985|527463413|FG003|Overall Study|Death|20|||
146259285|NCT02025985|527463414|FG004|Overall Study|Death|17|||
146259286|NCT03041701|527463415|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
146259287|NCT03041701|527463416|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
146259288|NCT03041701|527463417|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
146259289|NCT03041701|527463415|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
146259290|NCT03041701|527463416|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
146259291|NCT03041701|527463417|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
146259292|NCT00527514|527463418|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
146259293|NCT00527514|527463418|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
146259294|NCT00527514|527463418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
146259295|NCT00527514|527463418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
146259296|NCT00527514|527463418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
146259297|NCT00527514|527463418|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
146259298|NCT00527514|527463418|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
146259299|NCT03175198|527463419|FG000|Overall Study|Adverse Event|480|||
146259300|NCT03175198|527463419|FG000|Overall Study|No actual visit|120|||
146259301|NCT03175198|527463419|FG000|Overall Study|Registration rule not followed|4|||
146259302|NCT03175198|527463419|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
146259303|NCT03175198|527463419|FG000|Overall Study|Other personal reason|509|||
146259304|NCT03175198|527463419|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
146259305|NCT03175198|527463419|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
146259306|NCT03175198|527463419|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
146259307|NCT03175198|527463419|FG000|Overall Study|To conduct invasive treatment of operation|53|||
146259308|NCT03175198|527463419|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
146259309|NCT02630706|527463420|FG000|Overall Study|Adverse Event|2|||
146054942|NCT02349633|526716144|FG003|Overall Study|Transition to compassionate use|0|||
146110812|NCT00843024|526925944|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
146110813|NCT00843024|526925945|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
146110814|NCT00843024|526925946|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
146110815|NCT00843024|526925947|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
146054943|NCT02349633|526716145|FG004|Overall Study|Transition to compassionate use|1|||
146054944|NCT02349633|526716146|FG005|Overall Study|Transition to compassionate use|0|||
146054945|NCT02349633|526716147|FG006|Overall Study|Transition to compassionate use|0|||
146054946|NCT02349633|526716148|FG007|Overall Study|Transition to compassionate use|3|||
146054947|NCT02349633|526716149|FG008|Overall Study|Transition to compassionate use|0|||
146054948|NCT02349633|526716150|FG009|Overall Study|Transition to compassionate use|1|||
146054949|NCT02349633|526716151|FG010|Overall Study|Transition to compassionate use|0|||
146054950|NCT02349633|526716152|FG011|Overall Study|Transition to compassionate use|0|||
146054951|NCT02349633|526716153|FG012|Overall Study|Transition to compassionate use|0|||
146054952|NCT02349633|526716154|FG013|Overall Study|Transition to compassionate use|0|||
146054953|NCT02349633|526716141|FG000|Overall Study|Early termination of survival follow-up|0|||
146054954|NCT02349633|526716142|FG001|Overall Study|Early termination of survival follow-up|0|||
146054955|NCT02349633|526716143|FG002|Overall Study|Early termination of survival follow-up|0|||
146054956|NCT02349633|526716144|FG003|Overall Study|Early termination of survival follow-up|0|||
146054957|NCT02349633|526716145|FG004|Overall Study|Early termination of survival follow-up|0|||
146054958|NCT02349633|526716146|FG005|Overall Study|Early termination of survival follow-up|0|||
146054959|NCT02349633|526716147|FG006|Overall Study|Early termination of survival follow-up|0|||
146054960|NCT02349633|526716148|FG007|Overall Study|Early termination of survival follow-up|4|||
146054961|NCT02349633|526716149|FG008|Overall Study|Early termination of survival follow-up|0|||
146054962|NCT02349633|526716150|FG009|Overall Study|Early termination of survival follow-up|0|||
146054963|NCT02349633|526716151|FG010|Overall Study|Early termination of survival follow-up|0|||
146054964|NCT02349633|526716152|FG011|Overall Study|Early termination of survival follow-up|0|||
146054965|NCT02349633|526716153|FG012|Overall Study|Early termination of survival follow-up|0|||
146054966|NCT02349633|526716154|FG013|Overall Study|Early termination of survival follow-up|0|||
146054967|NCT02349633|526716141|FG000|Overall Study|Termination by sponsor|0|||
146054968|NCT02349633|526716142|FG001|Overall Study|Termination by sponsor|0|||
146054969|NCT02349633|526716143|FG002|Overall Study|Termination by sponsor|0|||
146054970|NCT02349633|526716144|FG003|Overall Study|Termination by sponsor|0|||
146054971|NCT02349633|526716145|FG004|Overall Study|Termination by sponsor|0|||
146054972|NCT02349633|526716146|FG005|Overall Study|Termination by sponsor|0|||
146054973|NCT02349633|526716147|FG006|Overall Study|Termination by sponsor|0|||
146054974|NCT02349633|526716148|FG007|Overall Study|Termination by sponsor|1|||
146054975|NCT02349633|526716149|FG008|Overall Study|Termination by sponsor|0|||
146054976|NCT02349633|526716150|FG009|Overall Study|Termination by sponsor|2|||
146054977|NCT02349633|526716151|FG010|Overall Study|Termination by sponsor|0|||
146054978|NCT02349633|526716152|FG011|Overall Study|Termination by sponsor|0|||
146054979|NCT02349633|526716153|FG012|Overall Study|Termination by sponsor|0|||
146054980|NCT02349633|526716154|FG013|Overall Study|Termination by sponsor|0|||
146054981|NCT02349633|526716141|FG000|Overall Study|Other|0|||
146054982|NCT02349633|526716142|FG001|Overall Study|Other|0|||
146054983|NCT02349633|526716143|FG002|Overall Study|Other|0|||
146054984|NCT02349633|526716144|FG003|Overall Study|Other|0|||
146054985|NCT02349633|526716145|FG004|Overall Study|Other|0|||
146054986|NCT02349633|526716146|FG005|Overall Study|Other|0|||
146054987|NCT02349633|526716147|FG006|Overall Study|Other|0|||
146054988|NCT02349633|526716148|FG007|Overall Study|Other|2|||
146054989|NCT02349633|526716149|FG008|Overall Study|Other|0|||
146054990|NCT02349633|526716150|FG009|Overall Study|Other|0|||
146054991|NCT02349633|526716151|FG010|Overall Study|Other|0|||
146054992|NCT02349633|526716152|FG011|Overall Study|Other|0|||
146054993|NCT02349633|526716153|FG012|Overall Study|Other|0|||
146054994|NCT02349633|526716154|FG013|Overall Study|Other|0|||
146259310|NCT02630706|527463421|FG001|Overall Study|Adverse Event|1|||
146054995|NCT00667628|526716161|FG000|Overall Study|Lost to Follow-up|1|||
146054996|NCT00667628|526716162|FG001|Overall Study|Lost to Follow-up|0|||
146054997|NCT00667628|526716161|FG000|Overall Study|Death|6|||
146110816|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146110817|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
146110818|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
146110819|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
146110820|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
146110821|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
146110822|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146110823|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146259311|NCT02630706|527463422|FG002|Overall Study|Adverse Event|1|||
146054998|NCT00667628|526716162|FG001|Overall Study|Death|6|||
146054999|NCT00667628|526716161|FG000|Overall Study|Investigator Considers in Best Interest|1|||
146055000|NCT00667628|526716162|FG001|Overall Study|Investigator Considers in Best Interest|0|||
146110824|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146110825|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
146110826|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146110827|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
146110828|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146110829|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
146110830|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
146110831|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
146110832|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
146110833|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
146110834|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Physician Decision|0|||
146110835|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Physician Decision|0|||
146110836|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Physician Decision|0|||
146110837|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Physician Decision|3|||
146110838|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Physician Decision|1|||
146110839|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Physician Decision|1|||
146110840|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146110841|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146110842|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Adverse Event|0|||
146110843|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Adverse Event|0|||
146110844|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Adverse Event|1|||
146110845|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Adverse Event|1|||
146110846|NCT00843024|526925942|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146110847|NCT00843024|526925943|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
146110848|NCT00843024|526925944|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
146110849|NCT00843024|526925945|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
146110850|NCT00843024|526925946|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
146110851|NCT00843024|526925947|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
146110852|NCT01032837|526925948|FG000|Overall Study|Adverse event/internal illness|0|||
146110853|NCT01032837|526925949|FG001|Overall Study|Adverse event/internal illness|1|||
146110854|NCT01032837|526925950|FG002|Overall Study|Adverse event/internal illness|0|||
146110855|NCT01032837|526925951|FG003|Overall Study|Adverse event/internal illness|1|||
146110856|NCT01032837|526925948|FG000|Overall Study|Withdrew consent|0|||
146110857|NCT01032837|526925949|FG001|Overall Study|Withdrew consent|2|||
146110858|NCT01032837|526925950|FG002|Overall Study|Withdrew consent|0|||
146110859|NCT01032837|526925951|FG003|Overall Study|Withdrew consent|1|||
146110860|NCT01032837|526925948|FG000|Overall Study|Failed to return|0|||
146110861|NCT01032837|526925949|FG001|Overall Study|Failed to return|0|||
146110862|NCT01032837|526925950|FG002|Overall Study|Failed to return|1|||
146110863|NCT01032837|526925951|FG003|Overall Study|Failed to return|0|||
146110864|NCT01032837|526925948|FG000|Overall Study|Refused treatment|0|||
146110865|NCT01032837|526925949|FG001|Overall Study|Refused treatment|0|||
146110866|NCT01032837|526925950|FG002|Overall Study|Refused treatment|0|||
146110867|NCT01032837|526925951|FG003|Overall Study|Refused treatment|1|||
146110868|NCT05201703|526925952|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
146110869|NCT05201703|526925953|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
146110870|NCT05201703|526925952|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
146110871|NCT05201703|526925953|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
146301433|NCT00763971|527618885|FG000|Overall Study|Subject wanted dose reduction|0|||
146055001|NCT00667628|526716161|FG000|Overall Study|Sponsor Terminated Study|17|||
146055002|NCT00667628|526716162|FG001|Overall Study|Sponsor Terminated Study|21|||
146055003|NCT04663321|526716163|FG000|Overall Study|Study terminated by Sponsor|2|||
146055004|NCT04663321|526716164|FG001|Overall Study|Study terminated by Sponsor|1|||
146055005|NCT04663321|526716165|FG002|Overall Study|Study terminated by Sponsor|2|||
146055006|NCT04663321|526716163|FG000|Overall Study|Withdrawal by Subject|10|||
146055007|NCT04663321|526716164|FG001|Overall Study|Withdrawal by Subject|3|||
146055008|NCT04663321|526716165|FG002|Overall Study|Withdrawal by Subject|2|||
146055009|NCT04663321|526716163|FG000|Overall Study|Not provided|0|||
146055010|NCT04663321|526716164|FG001|Overall Study|Not provided|0|||
146055011|NCT04663321|526716165|FG002|Overall Study|Not provided|1|||
146055012|NCT03360682|526716166|FG000|Overall Study|Adverse Event|3|||
146055013|NCT01962441|526716169|FG000|Randomized Period|Randomized but Never Treated|4|||
146055014|NCT01962441|526716170|FG001|Randomized Period|Randomized but Never Treated|2|||
146055015|NCT01962441|526716171|FG002|Randomized Period|Randomized but Never Treated|3|||
146055016|NCT01962441|526716169|FG000|Randomized Period|Lost to Follow-up|2|||
146055017|NCT01962441|526716170|FG001|Randomized Period|Lost to Follow-up|4|||
146055018|NCT01962441|526716171|FG002|Randomized Period|Lost to Follow-up|4|||
146055019|NCT01962441|526716169|FG000|Randomized Period|Withdrew Consent|3|||
146055020|NCT01962441|526716170|FG001|Randomized Period|Withdrew Consent|3|||
146055021|NCT01962441|526716171|FG002|Randomized Period|Withdrew Consent|2|||
146301434|NCT00763971|527618886|FG001|Overall Study|Subject wanted dose reduction|1|||
146301435|NCT00763971|527618887|FG002|Overall Study|Subject wanted dose reduction|0|||
146301436|NCT00763971|527618885|FG000|Overall Study|Lack of availability|0|||
146301437|NCT00763971|527618886|FG001|Overall Study|Lack of availability|1|||
146301438|NCT00763971|527618887|FG002|Overall Study|Lack of availability|0|||
146301439|NCT00763971|527618885|FG000|Overall Study|Performed final visit on phone|0|||
146301440|NCT00763971|527618886|FG001|Overall Study|Performed final visit on phone|1|||
146301441|NCT00763971|527618887|FG002|Overall Study|Performed final visit on phone|0|||
146301442|NCT00763971|527618885|FG000|Overall Study|Participation in 489-326 required|1|||
146301443|NCT00763971|527618886|FG001|Overall Study|Participation in 489-326 required|0|||
146301444|NCT00763971|527618887|FG002|Overall Study|Participation in 489-326 required|0|||
146301445|NCT00710879|527618888|FG000|Overall Study|Lost to Follow-up|2|||
146301446|NCT00710879|527618889|FG001|Overall Study|Lost to Follow-up|1|||
146301447|NCT00710879|527618888|FG000|Overall Study|Protocol Violation|0|||
146301448|NCT00710879|527618889|FG001|Overall Study|Protocol Violation|3|||
146301449|NCT01809132|527618890|FG000|Overall Study|Withdrawal by Subject|0|||
146301450|NCT01809132|527618891|FG001|Overall Study|Withdrawal by Subject|0|||
146301451|NCT01809132|527618892|FG002|Overall Study|Withdrawal by Subject|1|||
146301452|NCT03383289|527618894|FG000|Overall Study|Death|83|||
146301453|NCT03383289|527618895|FG001|Overall Study|Death|78|||
146301454|NCT03383289|527618894|FG000|Overall Study|discharge from facility|84|||
146301455|NCT03383289|527618895|FG001|Overall Study|discharge from facility|84|||
146301456|NCT03383289|527618894|FG000|Overall Study|Withdrawal by Subject|4|||
146301457|NCT03383289|527618895|FG001|Overall Study|Withdrawal by Subject|1|||
146301458|NCT03583450|527618896|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
146301459|NCT03583450|527618897|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
146301460|NCT01446016|527618898|FG000|Overall Study|Lost to Follow-up|3|||
146301461|NCT01446016|527618898|FG000|Overall Study|Withdrawal by Subject|1|||
146301462|NCT01446016|527618898|FG000|Overall Study|Toxicity|3|||
146301463|NCT00698204|527618901|FG000|Overall Study|Withdrawal by Subject|1|||
146301464|NCT00698204|527618902|FG001|Overall Study|Withdrawal by Subject|0|||
146301465|NCT01179672|527618903|FG000|Overall Study|Adverse Event|17|||
146301466|NCT01179672|527618904|FG001|Overall Study|Adverse Event|8|||
146301467|NCT01179672|527618903|FG000|Overall Study|Withdrawal by Subject|10|||
146301468|NCT01179672|527618904|FG001|Overall Study|Withdrawal by Subject|12|||
146301469|NCT01179672|527618903|FG000|Overall Study|Entry Criteria Not Met|0|||
146301470|NCT01179672|527618904|FG001|Overall Study|Entry Criteria Not Met|2|||
146301471|NCT01179672|527618903|FG000|Overall Study|Lost to Follow-up|0|||
146301472|NCT01179672|527618904|FG001|Overall Study|Lost to Follow-up|1|||
146301473|NCT01179672|527618903|FG000|Overall Study|Protocol Violation|2|||
146301474|NCT01179672|527618904|FG001|Overall Study|Protocol Violation|2|||
146301475|NCT01179672|527618903|FG000|Overall Study|Physician Decision|1|||
146301476|NCT01179672|527618904|FG001|Overall Study|Physician Decision|1|||
146301477|NCT01949155|527618906|FG000|Overall Study|Lost to Follow-up|1|||
146301478|NCT01949155|527618907|FG001|Overall Study|Lost to Follow-up|0|||
146301479|NCT01949155|527618906|FG000|Overall Study|Protocol Violation|1|||
146301480|NCT01949155|527618907|FG001|Overall Study|Protocol Violation|0|||
146110872|NCT02006719|526925954|FG000|Overall Study|Withdrawal by Subject|10|||
146259312|NCT02630706|527463420|FG000|Overall Study|Lost to Follow-up|0|||
146259313|NCT02630706|527463421|FG001|Overall Study|Lost to Follow-up|1|||
146259314|NCT02630706|527463422|FG002|Overall Study|Lost to Follow-up|2|||
146259315|NCT02630706|527463420|FG000|Overall Study|Physician Decision|1|||
146259316|NCT02630706|527463421|FG001|Overall Study|Physician Decision|1|||
146259317|NCT02630706|527463422|FG002|Overall Study|Physician Decision|0|||
146259318|NCT02630706|527463420|FG000|Overall Study|Pregnancy|0|||
146259319|NCT02630706|527463421|FG001|Overall Study|Pregnancy|1|||
146259320|NCT02630706|527463422|FG002|Overall Study|Pregnancy|0|||
146259321|NCT02630706|527463420|FG000|Overall Study|Withdrawal by Subject|4|||
146259322|NCT02630706|527463421|FG001|Overall Study|Withdrawal by Subject|5|||
146259323|NCT02630706|527463422|FG002|Overall Study|Withdrawal by Subject|7|||
146259324|NCT01544309|527463427|FG000|Overall Study|Withdrawal by Subject|12|||
146259325|NCT01544309|527463428|FG001|Overall Study|Withdrawal by Subject|7|||
146259326|NCT01544309|527463427|FG000|Overall Study|Protocol Violation|2|||
146259327|NCT01544309|527463428|FG001|Overall Study|Protocol Violation|1|||
146259328|NCT01544309|527463427|FG000|Overall Study|Physician Decision|4|||
146301481|NCT00314249|527618908|FG000|Overall Study|Adverse Event|73|||
146301482|NCT00314249|527618909|FG001|Overall Study|Adverse Event|94|||
146301483|NCT00314249|527618908|FG000|Overall Study|Lack of Efficacy|33|||
146301484|NCT00314249|527618909|FG001|Overall Study|Lack of Efficacy|24|||
146301485|NCT00314249|527618908|FG000|Overall Study|Withdrawal by Subject|21|||
146301486|NCT00314249|527618909|FG001|Overall Study|Withdrawal by Subject|28|||
146110873|NCT02006719|526925955|FG001|Overall Study|Withdrawal by Subject|2|||
146259329|NCT01544309|527463428|FG001|Overall Study|Physician Decision|1|||
146301487|NCT00314249|527618908|FG000|Overall Study|Lost to Follow-up|15|||
146301488|NCT00314249|527618909|FG001|Overall Study|Lost to Follow-up|9|||
146301489|NCT00314249|527618908|FG000|Overall Study|Physician Decision|1|||
146259330|NCT01544309|527463427|FG000|Overall Study|Not performed pre-dose examination|1|||
146259331|NCT01544309|527463428|FG001|Overall Study|Not performed pre-dose examination|2|||
146301490|NCT00314249|527618909|FG001|Overall Study|Physician Decision|1|||
146110874|NCT02006719|526925954|FG000|Overall Study|Lost to Follow-up|5|||
146110875|NCT02006719|526925955|FG001|Overall Study|Lost to Follow-up|1|||
146110876|NCT02006719|526925954|FG000|Overall Study|Protocol Violation|2|||
146110877|NCT02006719|526925955|FG001|Overall Study|Protocol Violation|0|||
146110878|NCT02006719|526925954|FG000|Overall Study|Adverse Event|1|||
146110879|NCT02006719|526925955|FG001|Overall Study|Adverse Event|1|||
146110880|NCT02006719|526925954|FG000|Overall Study|Other/Unknown|0|||
146110881|NCT02006719|526925955|FG001|Overall Study|Other/Unknown|1|||
146110882|NCT02439138|526925957|FG000|Overall Study|Adverse Event|1|||
146110883|NCT02439138|526925957|FG000|Overall Study|PI decision to terminate the study|2|||
146110884|NCT03727347|526925962|FG000|Overall Study|Withdrawal by Subject|2|||
146110885|NCT03727347|526925962|FG000|Overall Study|Lost to Follow-up|1|||
146110886|NCT00006237|526925963|FG000|Overall Study|Adverse Event|39|||
146110887|NCT00006237|526925964|FG001|Overall Study|Adverse Event|29|||
146110888|NCT00006237|526925963|FG000|Overall Study|Death|1|||
146110889|NCT00006237|526925964|FG001|Overall Study|Death|0|||
146110890|NCT00006237|526925963|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
146110891|NCT00006237|526925964|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
146110892|NCT00006237|526925963|FG000|Overall Study|Progression/relapse|54|||
146110893|NCT00006237|526925964|FG001|Overall Study|Progression/relapse|2|||
146110894|NCT00006237|526925963|FG000|Overall Study|Not eligible|9|||
146110895|NCT00006237|526925964|FG001|Overall Study|Not eligible|20|||
146110896|NCT00006237|526925963|FG000|Overall Study|Withdrawal by Subject|0|||
146110897|NCT00006237|526925964|FG001|Overall Study|Withdrawal by Subject|1|||
146110898|NCT00006237|526925963|FG000|Overall Study|Not protocol specified|14|||
146110899|NCT00006237|526925964|FG001|Overall Study|Not protocol specified|5|||
146110900|NCT01846416|526925967|FG000|Treatment Phase|Death|2|||
146110901|NCT01846416|526925968|FG001|Treatment Phase|Death|9|||
146110902|NCT01846416|526925969|FG002|Treatment Phase|Death|1|||
146110903|NCT01846416|526925967|FG000|Treatment Phase|Withdrawal by Subject|2|||
146110904|NCT01846416|526925968|FG001|Treatment Phase|Withdrawal by Subject|4|||
146110905|NCT01846416|526925969|FG002|Treatment Phase|Withdrawal by Subject|2|||
146110906|NCT01846416|526925967|FG000|Treatment Phase|Other|1|||
146110907|NCT01846416|526925968|FG001|Treatment Phase|Other|5|||
146110908|NCT01846416|526925969|FG002|Treatment Phase|Other|1|||
146110909|NCT01846416|526925967|FG000|Treatment Phase|Physician Decision|1|||
146110910|NCT01846416|526925968|FG001|Treatment Phase|Physician Decision|2|||
146110911|NCT01846416|526925969|FG002|Treatment Phase|Physician Decision|0|||
146110912|NCT01846416|526925967|FG000|Treatment Phase|Adverse Event|3|||
146110913|NCT01846416|526925968|FG001|Treatment Phase|Adverse Event|4|||
146110914|NCT01846416|526925969|FG002|Treatment Phase|Adverse Event|0|||
146110915|NCT01846416|526925967|FG000|Treatment Phase|Non-compliance|0|||
146110916|NCT01846416|526925968|FG001|Treatment Phase|Non-compliance|2|||
146110917|NCT01846416|526925969|FG002|Treatment Phase|Non-compliance|0|||
146110918|NCT01846416|526925967|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
146110919|NCT01846416|526925968|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
146110920|NCT01846416|526925969|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
146110921|NCT01846416|526925967|FG000|Treatment Phase|Progressive Disease|21|||
146110922|NCT01846416|526925968|FG001|Treatment Phase|Progressive Disease|63|||
146110923|NCT01846416|526925969|FG002|Treatment Phase|Progressive Disease|9|||
146110924|NCT01846416|526925967|FG000|Survival Follow-up|Death|21|||
146110925|NCT01846416|526925968|FG001|Survival Follow-up|Death|62|||
146055022|NCT01962441|526716169|FG000|Randomized Period|Adverse Event|1|||
146055023|NCT01962441|526716170|FG001|Randomized Period|Adverse Event|1|||
146055024|NCT01962441|526716171|FG002|Randomized Period|Adverse Event|0|||
146055025|NCT01962441|526716169|FG000|Randomized Period|Death|0|||
146055026|NCT01962441|526716170|FG001|Randomized Period|Death|0|||
146055027|NCT01962441|526716171|FG002|Randomized Period|Death|2|||
146055028|NCT01962441|526716169|FG000|Randomized Period|Protocol Violation|0|||
146110926|NCT01846416|526925969|FG002|Survival Follow-up|Death|9|||
146110927|NCT01846416|526925967|FG000|Survival Follow-up|Lost to Follow-up|0|||
146110928|NCT01846416|526925968|FG001|Survival Follow-up|Lost to Follow-up|2|||
146110929|NCT01846416|526925969|FG002|Survival Follow-up|Lost to Follow-up|2|||
146110930|NCT01846416|526925967|FG000|Survival Follow-up|Withdrawal by Subject|2|||
146110931|NCT01846416|526925968|FG001|Survival Follow-up|Withdrawal by Subject|7|||
146110932|NCT01846416|526925969|FG002|Survival Follow-up|Withdrawal by Subject|0|||
146110933|NCT01846416|526925967|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
146110934|NCT01846416|526925968|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
146110935|NCT01846416|526925969|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
146055029|NCT01962441|526716170|FG001|Randomized Period|Protocol Violation|1|||
146055030|NCT01962441|526716171|FG002|Randomized Period|Protocol Violation|0|||
146055031|NCT01962441|526716169|FG000|Retreatment Substudy|Lack of Efficacy|1|||
146055032|NCT01962441|526716170|FG001|Retreatment Substudy|Lack of Efficacy|0|||
146110936|NCT01846416|526925967|FG000|Survival Follow-up|Other|3|||
146110937|NCT01846416|526925968|FG001|Survival Follow-up|Other|1|||
146110938|NCT01846416|526925969|FG002|Survival Follow-up|Other|1|||
146110939|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110940|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146110941|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110942|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146110943|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
146110944|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110945|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110946|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110947|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110948|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110949|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110950|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110951|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110952|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110953|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
146110954|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
146110955|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
146110956|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
146110957|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110958|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110959|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110960|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110961|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110962|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110963|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110964|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110965|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110966|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110967|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110968|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
146110969|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110970|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110971|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110972|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
146110973|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110974|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110975|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110976|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110977|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110978|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110979|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110980|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110981|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110982|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110983|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
146110984|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110985|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
146110986|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110987|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110988|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110989|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110990|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110991|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110992|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110993|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110994|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110995|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110996|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110997|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110998|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
146110999|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111000|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111001|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111002|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111003|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
146111004|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111005|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111006|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111007|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111008|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111009|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111010|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111011|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111012|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111013|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
146111014|NCT01737697|526925972|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111015|NCT01737697|526925973|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146111016|NCT01737697|526925974|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146111017|NCT01737697|526925975|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
146111018|NCT01737697|526925976|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
146111019|NCT01737697|526925977|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111020|NCT01737697|526925978|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111021|NCT01737697|526925979|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111022|NCT01737697|526925980|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111023|NCT01737697|526925981|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111024|NCT01737697|526925982|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111025|NCT01737697|526925983|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111026|NCT01737697|526925984|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111027|NCT01737697|526925985|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111028|NCT01737697|526925986|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
146111029|NCT01737697|526925972|FG000|Subacute Phase|Adverse Event|0|||
146111030|NCT01737697|526925973|FG001|Subacute Phase|Adverse Event|0|||
146111031|NCT01737697|526925974|FG002|Subacute Phase|Adverse Event|0|||
146111032|NCT01737697|526925975|FG003|Subacute Phase|Adverse Event|0|||
146111033|NCT01737697|526925976|FG004|Subacute Phase|Adverse Event|0|||
146111034|NCT01737697|526925977|FG005|Subacute Phase|Adverse Event|1|||
146111035|NCT01737697|526925978|FG006|Subacute Phase|Adverse Event|1|||
146111036|NCT01737697|526925979|FG007|Subacute Phase|Adverse Event|1|||
146111037|NCT01737697|526925980|FG008|Subacute Phase|Adverse Event|1|||
146111038|NCT01737697|526925981|FG009|Subacute Phase|Adverse Event|1|||
146111039|NCT01737697|526925982|FG010|Subacute Phase|Adverse Event|4|||
146111040|NCT01737697|526925983|FG011|Subacute Phase|Adverse Event|1|||
146111041|NCT01737697|526925984|FG012|Subacute Phase|Adverse Event|1|||
146111042|NCT01737697|526925985|FG013|Subacute Phase|Adverse Event|0|||
146111043|NCT01737697|526925986|FG014|Subacute Phase|Adverse Event|0|||
146111044|NCT01737697|526925972|FG000|Subacute Phase|Withdrawal by Subject|0|||
146111045|NCT01737697|526925973|FG001|Subacute Phase|Withdrawal by Subject|0|||
146111046|NCT01737697|526925974|FG002|Subacute Phase|Withdrawal by Subject|0|||
146111047|NCT01737697|526925975|FG003|Subacute Phase|Withdrawal by Subject|0|||
146111048|NCT01737697|526925976|FG004|Subacute Phase|Withdrawal by Subject|0|||
146111049|NCT01737697|526925977|FG005|Subacute Phase|Withdrawal by Subject|1|||
146111050|NCT01737697|526925978|FG006|Subacute Phase|Withdrawal by Subject|0|||
146111051|NCT01737697|526925979|FG007|Subacute Phase|Withdrawal by Subject|2|||
146111052|NCT01737697|526925980|FG008|Subacute Phase|Withdrawal by Subject|0|||
146111053|NCT01737697|526925981|FG009|Subacute Phase|Withdrawal by Subject|1|||
146111054|NCT01737697|526925982|FG010|Subacute Phase|Withdrawal by Subject|0|||
146111055|NCT01737697|526925983|FG011|Subacute Phase|Withdrawal by Subject|1|||
146111056|NCT01737697|526925984|FG012|Subacute Phase|Withdrawal by Subject|1|||
146111057|NCT01737697|526925985|FG013|Subacute Phase|Withdrawal by Subject|1|||
146111058|NCT01737697|526925986|FG014|Subacute Phase|Withdrawal by Subject|0|||
146111059|NCT01737697|526925972|FG000|Subacute Phase|Lost to Follow-up|0|||
146111060|NCT01737697|526925973|FG001|Subacute Phase|Lost to Follow-up|0|||
146111061|NCT01737697|526925974|FG002|Subacute Phase|Lost to Follow-up|0|||
146111062|NCT01737697|526925975|FG003|Subacute Phase|Lost to Follow-up|0|||
146111063|NCT01737697|526925976|FG004|Subacute Phase|Lost to Follow-up|0|||
146111064|NCT01737697|526925977|FG005|Subacute Phase|Lost to Follow-up|0|||
146111065|NCT01737697|526925978|FG006|Subacute Phase|Lost to Follow-up|0|||
146111066|NCT01737697|526925979|FG007|Subacute Phase|Lost to Follow-up|0|||
146111067|NCT01737697|526925980|FG008|Subacute Phase|Lost to Follow-up|0|||
146111068|NCT01737697|526925981|FG009|Subacute Phase|Lost to Follow-up|0|||
146111069|NCT01737697|526925982|FG010|Subacute Phase|Lost to Follow-up|0|||
146111070|NCT01737697|526925983|FG011|Subacute Phase|Lost to Follow-up|0|||
146111071|NCT01737697|526925984|FG012|Subacute Phase|Lost to Follow-up|0|||
146111072|NCT01737697|526925985|FG013|Subacute Phase|Lost to Follow-up|0|||
146111073|NCT01737697|526925986|FG014|Subacute Phase|Lost to Follow-up|1|||
146111074|NCT01737697|526925972|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
146111075|NCT01737697|526925973|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
146111076|NCT01737697|526925974|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
146111077|NCT01737697|526925975|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
146111078|NCT01737697|526925976|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
146111079|NCT01737697|526925977|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
146111080|NCT01737697|526925978|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
146111081|NCT01737697|526925979|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
146111082|NCT01737697|526925980|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
146111083|NCT01737697|526925981|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
146111084|NCT01737697|526925982|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
146111085|NCT01737697|526925983|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
146111086|NCT01737697|526925984|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
146111087|NCT01737697|526925985|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
146111088|NCT01737697|526925986|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
146111089|NCT01737697|526925972|FG000|Subacute Phase|Protocol Violation|0|||
146111090|NCT01737697|526925973|FG001|Subacute Phase|Protocol Violation|0|||
146111091|NCT01737697|526925974|FG002|Subacute Phase|Protocol Violation|0|||
146111092|NCT01737697|526925975|FG003|Subacute Phase|Protocol Violation|0|||
146111093|NCT01737697|526925976|FG004|Subacute Phase|Protocol Violation|0|||
146111094|NCT01737697|526925977|FG005|Subacute Phase|Protocol Violation|1|||
146111095|NCT01737697|526925978|FG006|Subacute Phase|Protocol Violation|0|||
146111096|NCT01737697|526925979|FG007|Subacute Phase|Protocol Violation|0|||
146111097|NCT01737697|526925980|FG008|Subacute Phase|Protocol Violation|0|||
146111098|NCT01737697|526925981|FG009|Subacute Phase|Protocol Violation|0|||
146111099|NCT01737697|526925982|FG010|Subacute Phase|Protocol Violation|1|||
146111100|NCT01737697|526925983|FG011|Subacute Phase|Protocol Violation|0|||
146111101|NCT01737697|526925984|FG012|Subacute Phase|Protocol Violation|0|||
146111102|NCT01737697|526925985|FG013|Subacute Phase|Protocol Violation|0|||
146111103|NCT01737697|526925986|FG014|Subacute Phase|Protocol Violation|0|||
146111104|NCT01737697|526925972|FG000|Subacute Phase|Physician Decision|0|||
146111105|NCT01737697|526925973|FG001|Subacute Phase|Physician Decision|0|||
146111106|NCT01737697|526925974|FG002|Subacute Phase|Physician Decision|0|||
146111107|NCT01737697|526925975|FG003|Subacute Phase|Physician Decision|0|||
146111108|NCT01737697|526925976|FG004|Subacute Phase|Physician Decision|0|||
146111109|NCT01737697|526925977|FG005|Subacute Phase|Physician Decision|0|||
146111110|NCT01737697|526925978|FG006|Subacute Phase|Physician Decision|0|||
146111111|NCT01737697|526925979|FG007|Subacute Phase|Physician Decision|0|||
146111112|NCT01737697|526925980|FG008|Subacute Phase|Physician Decision|1|||
146111113|NCT01737697|526925981|FG009|Subacute Phase|Physician Decision|0|||
146111114|NCT01737697|526925982|FG010|Subacute Phase|Physician Decision|0|||
146111115|NCT01737697|526925983|FG011|Subacute Phase|Physician Decision|0|||
146111116|NCT01737697|526925984|FG012|Subacute Phase|Physician Decision|0|||
146111117|NCT01737697|526925985|FG013|Subacute Phase|Physician Decision|0|||
146111118|NCT01737697|526925986|FG014|Subacute Phase|Physician Decision|0|||
146111119|NCT01737697|526925972|FG000|Subacute Phase|Death|0|||
146111120|NCT01737697|526925973|FG001|Subacute Phase|Death|0|||
146111121|NCT01737697|526925974|FG002|Subacute Phase|Death|0|||
146111122|NCT01737697|526925975|FG003|Subacute Phase|Death|0|||
146111123|NCT01737697|526925976|FG004|Subacute Phase|Death|0|||
146111124|NCT01737697|526925977|FG005|Subacute Phase|Death|0|||
146111125|NCT01737697|526925978|FG006|Subacute Phase|Death|0|||
146111126|NCT01737697|526925979|FG007|Subacute Phase|Death|0|||
146111127|NCT01737697|526925980|FG008|Subacute Phase|Death|0|||
146111128|NCT01737697|526925981|FG009|Subacute Phase|Death|0|||
146111129|NCT01737697|526925982|FG010|Subacute Phase|Death|1|||
146111130|NCT01737697|526925983|FG011|Subacute Phase|Death|0|||
146111131|NCT01737697|526925984|FG012|Subacute Phase|Death|0|||
146111132|NCT01737697|526925985|FG013|Subacute Phase|Death|0|||
146111133|NCT01737697|526925986|FG014|Subacute Phase|Death|0|||
146111134|NCT03648983|526925988|FG000|Overall Study|Study was terminated due to PI departure|95|||
146111135|NCT01866930|526925989|FG000|Treatment Period|Other|1|||
146111136|NCT01866930|526925990|FG001|Treatment Period|Other|0|||
146111137|NCT01866930|526925989|FG000|Treatment Period|Death|0|||
146111138|NCT01866930|526925990|FG001|Treatment Period|Death|2|||
146111139|NCT01866930|526925989|FG000|Treatment Period|Poor/non compliance|0|||
146111140|NCT01866930|526925990|FG001|Treatment Period|Poor/non compliance|2|||
146111141|NCT01866930|526925989|FG000|Treatment Period|No longer meets study criteria|0|||
146111142|NCT01866930|526925990|FG001|Treatment Period|No longer meets study criteria|1|||
146111143|NCT01866930|526925989|FG000|Treatment Period|Withdrawal by Subject|2|||
146111144|NCT01866930|526925990|FG001|Treatment Period|Withdrawal by Subject|8|||
146111145|NCT01866930|526925989|FG000|Treatment Period|Lack of Efficacy|1|||
146111146|NCT01866930|526925990|FG001|Treatment Period|Lack of Efficacy|9|||
146111147|NCT01866930|526925989|FG000|Treatment Period|Adverse Event|4|||
146111148|NCT01866930|526925990|FG001|Treatment Period|Adverse Event|12|||
146111149|NCT01866930|526925989|FG000|Treatment Period|Lost to Follow-up|1|||
146111150|NCT01866930|526925990|FG001|Treatment Period|Lost to Follow-up|1|||
146111151|NCT01866930|526925989|FG000|Follow-up Period|Lost to Follow-up|1|||
146111152|NCT01866930|526925990|FG001|Follow-up Period|Lost to Follow-up|1|||
146111153|NCT01866930|526925989|FG000|Follow-up Period|Other|1|||
146111154|NCT01866930|526925990|FG001|Follow-up Period|Other|5|||
146111155|NCT01866930|526925989|FG000|Follow-up Period|No longer required per protocol|1|||
146111156|NCT01866930|526925990|FG001|Follow-up Period|No longer required per protocol|0|||
146111157|NCT01866930|526925989|FG000|Follow-up Period|Withdrawal by Subject|3|||
146111158|NCT01866930|526925990|FG001|Follow-up Period|Withdrawal by Subject|3|||
146111159|NCT00279305|526925995|FG000|Overall Study|Pregnancy|1|||
146111160|NCT00279305|526925996|FG001|Overall Study|Pregnancy|0|||
146111161|NCT00279305|526925995|FG000|Overall Study|Withdrawal by Subject|2|||
146111162|NCT00279305|526925996|FG001|Overall Study|Withdrawal by Subject|0|||
146111163|NCT00279305|526925995|FG000|Overall Study|Dificulting establishing IV|1|||
146111164|NCT00279305|526925996|FG001|Overall Study|Dificulting establishing IV|0|||
146111165|NCT00279305|526925995|FG000|Overall Study|FDA Safety Alert|4|||
146111166|NCT00279305|526925996|FG001|Overall Study|FDA Safety Alert|1|||
146111167|NCT02521870|526925999|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111168|NCT02521870|526926000|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
146111169|NCT02521870|526926001|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111170|NCT02521870|526926002|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111171|NCT02521870|526926003|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111172|NCT02521870|526926004|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111173|NCT02521870|526926005|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111174|NCT02521870|526926006|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111175|NCT02521870|526926007|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111176|NCT02521870|526926008|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111177|NCT02521870|526926009|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111178|NCT02521870|526926010|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146111179|NCT02521870|526925999|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
146111180|NCT02521870|526926000|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
146111181|NCT02521870|526926001|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
146111182|NCT02521870|526926002|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
146111183|NCT02521870|526926003|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
146111184|NCT02521870|526926004|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
146111185|NCT02521870|526926005|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
146111186|NCT02521870|526926006|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
146111187|NCT02521870|526926007|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
146111188|NCT02521870|526926008|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
146111189|NCT02521870|526926009|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
146111190|NCT02521870|526926010|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
146111191|NCT02521870|526925999|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
146111192|NCT02521870|526926000|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
146111193|NCT02521870|526926001|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
146111194|NCT02521870|526926002|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
146111195|NCT02521870|526926003|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
146111196|NCT02521870|526926004|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
146111197|NCT02521870|526926005|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
146111198|NCT02521870|526926006|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
146111199|NCT02521870|526926007|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
146111200|NCT02521870|526926008|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
146111201|NCT02521870|526926009|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
146111202|NCT02521870|526926010|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
146111203|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111204|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111205|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111206|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111207|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
146111208|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146111209|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146111210|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111211|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146111212|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
146111213|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
146111214|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146111215|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
146111216|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
146111217|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
146111218|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
146111219|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
146111220|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
146111221|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
146111222|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
146111223|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
146111224|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
146111225|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
146111226|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
146111227|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
146259332|NCT01544309|527463427|FG000|Overall Study|Administered prohibit prior medication|1|||
146111228|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
146111229|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
146111230|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
146111231|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
146111232|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
146111233|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
146111234|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
146111235|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
146111236|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
146111237|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
146111238|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
146111239|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Death|0|||
146111240|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Death|0|||
146111241|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Death|0|||
146111242|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Death|0|||
146111243|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Death|1|||
146111244|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Death|1|||
146111245|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Death|3|||
146111246|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Death|1|||
146111247|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Death|1|||
146111248|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Death|5|||
146111249|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Death|2|||
146111250|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Death|2|||
146111251|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Other|0|||
146111252|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Other|0|||
146111253|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Other|0|||
146111254|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Other|0|||
146111255|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Other|10|||
146111256|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Other|3|||
146111257|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Other|2|||
146111258|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Other|0|||
146111259|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Other|10|||
146111260|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Other|5|||
146111261|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Other|1|||
146111262|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Other|7|||
146111263|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111264|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111265|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111266|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111267|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
146111268|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111269|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111270|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111271|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111272|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111273|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111274|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146111275|NCT02521870|526925999|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111276|NCT02521870|526926000|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111277|NCT02521870|526926001|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111278|NCT02521870|526926002|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111279|NCT02521870|526926003|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
146111280|NCT02521870|526926004|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111281|NCT02521870|526926005|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111282|NCT02521870|526926006|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111283|NCT02521870|526926007|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111284|NCT02521870|526926008|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111285|NCT02521870|526926009|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111286|NCT02521870|526926010|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
146111287|NCT02862171|526926011|FG000|Overall Study|Death|1|||
146111288|NCT02862171|526926011|FG000|Overall Study|Lost to Follow-up|13|||
146111289|NCT02862171|526926011|FG000|Overall Study|Withdrawal by Subject|57|||
146111290|NCT02862171|526926011|FG000|Overall Study|Non-compliance|4|||
146111291|NCT02862171|526926011|FG000|Overall Study|HIV-1 seroconversion|18|||
146111292|NCT03930797|526926012|FG000|Overall Study|Lost to Follow-up|3|||
146111293|NCT03930797|526926013|FG001|Overall Study|Lost to Follow-up|10|||
146111294|NCT00662012|526926014|FG000|Overall Study|Lost to Follow-up|85|||
146111295|NCT00662012|526926014|FG000|Overall Study|Death|1|||
146111296|NCT00662012|526926014|FG000|Overall Study|Withdrawal by Subject|1|||
146111297|NCT04656691|526926018|FG000|Overall Study|Adverse Event|1|||
146111298|NCT04023526|526927390|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
146111299|NCT04023526|526927391|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
146111300|NCT04023526|526927390|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
146111301|NCT04023526|526927391|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
146111302|NCT02324569|526927396|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
146111303|NCT02324569|526927397|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146111304|NCT02324569|526927396|FG000|Overall Study|Voluntary Withdrawal|3|||
146111305|NCT02324569|526927397|FG001|Overall Study|Voluntary Withdrawal|6|||
146111306|NCT02324569|526927396|FG000|Overall Study|Lack of Efficacy|2|||
146111307|NCT02324569|526927397|FG001|Overall Study|Lack of Efficacy|3|||
146111308|NCT02324569|526927396|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
146111309|NCT02324569|526927397|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
146111310|NCT02324569|526927396|FG000|Overall Study|Inconvenient Schedule|2|||
146111311|NCT02324569|526927397|FG001|Overall Study|Inconvenient Schedule|0|||
146301491|NCT00314249|527618908|FG000|Overall Study|Withdrawn for other reasons|4|||
146301492|NCT00314249|527618909|FG001|Overall Study|Withdrawn for other reasons|1|||
146301493|NCT00314249|527618908|FG000|Overall Study|Non-Compliant|5|||
146055033|NCT01962441|526716171|FG002|Retreatment Substudy|Lack of Efficacy|0|||
146055034|NCT01962441|526716169|FG000|Retreatment Substudy|Lost to Follow-up|1|||
146055035|NCT01962441|526716170|FG001|Retreatment Substudy|Lost to Follow-up|0|||
146055036|NCT01962441|526716171|FG002|Retreatment Substudy|Lost to Follow-up|0|||
146055037|NCT04862065|526716172|FG000|Screening|Protocol Violation|54|||
146055038|NCT04862065|526716173|FG001|Screening|Protocol Violation|0|||
146055039|NCT04862065|526716174|FG002|Screening|Protocol Violation|0|||
146055040|NCT04862065|526716172|FG000|Screening|Insufficient Sample|1|||
146055041|NCT04862065|526716173|FG001|Screening|Insufficient Sample|0|||
146055042|NCT04862065|526716174|FG002|Screening|Insufficient Sample|0|||
146055043|NCT04862065|526716172|FG000|Follow-Up|Lost to Follow-up|3|||
146055044|NCT04862065|526716173|FG001|Follow-Up|Lost to Follow-up|0|||
146055045|NCT04862065|526716174|FG002|Follow-Up|Lost to Follow-up|0|||
146055046|NCT02055898|526716175|FG000|First Intervention (5 Days)|Physician Decision|2|||
146055047|NCT02055898|526716176|FG001|First Intervention (5 Days)|Physician Decision|0|||
146055048|NCT02055898|526716175|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
146055049|NCT02055898|526716176|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
146055050|NCT01453140|526716177|FG000|Overall Study|Adverse Event|3|||
146055051|NCT00743249|526716178|FG000|Overall Study|Adverse Event|0|||
146055052|NCT00743249|526716179|FG001|Overall Study|Adverse Event|4|||
146055053|NCT00743249|526716178|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
146055054|NCT00743249|526716179|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
146055055|NCT00743249|526716178|FG000|Overall Study|Unsuccessful insertion of stent|2|||
146055056|NCT00743249|526716179|FG001|Overall Study|Unsuccessful insertion of stent|1|||
146055057|NCT00718510|526716180|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146055058|NCT00718510|526716181|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146055059|NCT00718510|526716180|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146055060|NCT00718510|526716181|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146055061|NCT02653326|526716185|FG000|Overall Study|Lost to Follow-up|10|||
146055062|NCT02653326|526716186|FG001|Overall Study|Lost to Follow-up|7|||
146055063|NCT00231777|526716189|FG000|Overall Study|Lost to Follow-up|3|||
146055064|NCT00231777|526716190|FG001|Overall Study|Lost to Follow-up|0|||
146055065|NCT00231777|526716189|FG000|Overall Study|Other|3|||
146055066|NCT00231777|526716190|FG001|Overall Study|Other|2|||
146055067|NCT01239381|526716193|FG000|Overall Study|Protocol Violation|1|||
146055068|NCT01239381|526716193|FG000|Overall Study|Withdrawal by Subject|1|||
146055069|NCT00867165|526716194|FG000|Overall Study|Adverse Event|3|||
146055070|NCT00867165|526716195|FG001|Overall Study|Adverse Event|0|||
146055071|NCT00867165|526716194|FG000|Overall Study|Withdrawal by Subject|1|||
146055072|NCT00867165|526716195|FG001|Overall Study|Withdrawal by Subject|0|||
146055073|NCT04678115|526716196|FG000|Overall Study|Lost to Follow-up|1|||
146055074|NCT04678115|526716197|FG001|Overall Study|Lost to Follow-up|0|||
146055075|NCT02738008|526716198|FG000|Overall Study|Study Terminated by Sponsor|1|||
146055076|NCT02738008|526716199|FG001|Overall Study|Study Terminated by Sponsor|5|||
146055077|NCT02738008|526716200|FG002|Overall Study|Study Terminated by Sponsor|3|||
146055078|NCT02738008|526716198|FG000|Overall Study|Adverse Event|0|||
146055079|NCT02738008|526716199|FG001|Overall Study|Adverse Event|1|||
146055080|NCT02738008|526716200|FG002|Overall Study|Adverse Event|2|||
146055081|NCT04621448|526716201|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
146055082|NCT04621448|526716202|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
146055083|NCT04621448|526716203|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
146055084|NCT04621448|526716204|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
146055085|NCT04621448|526716201|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
146055086|NCT04621448|526716202|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
146055087|NCT04621448|526716203|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
146055088|NCT04621448|526716204|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
146055089|NCT04621448|526716201|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
146055090|NCT04621448|526716202|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
146055091|NCT04621448|526716203|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
146055092|NCT04621448|526716204|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
146055093|NCT04621448|526716201|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
146055094|NCT04621448|526716202|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
146055095|NCT04621448|526716203|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
146055096|NCT04621448|526716204|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
146055097|NCT03550378|526716207|FG000|Overall Study|Death|0|||
146055098|NCT03550378|526716208|FG001|Overall Study|Death|1|||
146055099|NCT04486235|526716209|FG000|Overall Study|Pregnancy|1|||
146055100|NCT04486235|526716210|FG001|Overall Study|Pregnancy|0|||
146055101|NCT04486235|526716209|FG000|Overall Study|Lost to Follow-up|1|||
146055102|NCT04486235|526716210|FG001|Overall Study|Lost to Follow-up|0|||
146055103|NCT04590014|526716211|FG000|Overall Study|Withdrawal by Subject|1|||
146055104|NCT04590014|526716212|FG001|Overall Study|Withdrawal by Subject|0|||
146301494|NCT00314249|527618909|FG001|Overall Study|Non-Compliant|6|||
146055105|NCT03935126|526716213|FG000|Overall Study|Study termination by sponsor|3|||
146111312|NCT01943292|526927398|FG000|Overall Study|Withdrawal by Subject|1|||
146111313|NCT01943292|526927399|FG001|Overall Study|Withdrawal by Subject|0|||
146111314|NCT01943292|526927400|FG002|Overall Study|Withdrawal by Subject|0|||
146111315|NCT00996216|526927401|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
146111316|NCT00996216|526927401|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
146111317|NCT00996216|526927401|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
146111318|NCT00903695|526927407|FG000|Overall Study|medical exclusion after 1st testing|1|||
146111319|NCT00903695|526927408|FG001|Overall Study|medical exclusion after 1st testing|0|||
146111320|NCT00903695|526927407|FG000|Overall Study|lung cancer|1|||
146111321|NCT00903695|526927408|FG001|Overall Study|lung cancer|0|||
146111322|NCT02495168|526927423|FG000|Overall Study|Other than Specified|18|||
146111323|NCT02495168|526927424|FG001|Overall Study|Other than Specified|22|||
146111324|NCT02495168|526927425|FG002|Overall Study|Other than Specified|5|||
146111325|NCT02495168|526927423|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
146111326|NCT02495168|526927424|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
146111327|NCT02495168|526927425|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
146111328|NCT02495168|526927423|FG000|Overall Study|Physician Decision|1|||
146111329|NCT02495168|526927424|FG001|Overall Study|Physician Decision|1|||
146111330|NCT02495168|526927425|FG002|Overall Study|Physician Decision|0|||
146111331|NCT02495168|526927423|FG000|Overall Study|Lost to Follow-up|10|||
146111332|NCT02495168|526927424|FG001|Overall Study|Lost to Follow-up|6|||
146111333|NCT02495168|526927425|FG002|Overall Study|Lost to Follow-up|1|||
146111334|NCT02495168|526927423|FG000|Overall Study|Withdrawal by Subject|1|||
146111335|NCT02495168|526927424|FG001|Overall Study|Withdrawal by Subject|4|||
146111336|NCT02495168|526927425|FG002|Overall Study|Withdrawal by Subject|2|||
146111337|NCT02495168|526927423|FG000|Overall Study|Protocol Violation|0|||
146111338|NCT02495168|526927424|FG001|Overall Study|Protocol Violation|10|||
146111339|NCT02495168|526927425|FG002|Overall Study|Protocol Violation|1|||
146111340|NCT02495168|526927423|FG000|Overall Study|Adverse Event|4|||
146111341|NCT02495168|526927424|FG001|Overall Study|Adverse Event|8|||
146111342|NCT02495168|526927425|FG002|Overall Study|Adverse Event|3|||
146111343|NCT02495168|526927423|FG000|Overall Study|Lack of Efficacy|0|||
146111344|NCT02495168|526927424|FG001|Overall Study|Lack of Efficacy|0|||
146111345|NCT02495168|526927425|FG002|Overall Study|Lack of Efficacy|3|||
146111346|NCT03521934|526927426|FG000|Overall Study|Death|65|||
146111347|NCT03521934|526927427|FG001|Overall Study|Death|73|||
146111348|NCT03521934|526927426|FG000|Overall Study|Withdrawal by Subject|18|||
146111349|NCT03521934|526927427|FG001|Overall Study|Withdrawal by Subject|23|||
146111350|NCT03521934|526927426|FG000|Overall Study|Site Terminated by Sponsor|39|||
146111351|NCT03521934|526927427|FG001|Overall Study|Site Terminated by Sponsor|35|||
146111352|NCT03521934|526927426|FG000|Overall Study|Study Terminated by Sponsor|483|||
146111353|NCT03521934|526927427|FG001|Overall Study|Study Terminated by Sponsor|477|||
146111354|NCT03521934|526927426|FG000|Overall Study|Reason not Specified|3|||
146111355|NCT03521934|526927427|FG001|Overall Study|Reason not Specified|6|||
146111356|NCT00727025|526927428|FG000|Overall Study|Physician Decision|23|||
146111357|NCT02101060|526927429|FG000|Overall Study|Adverse Event|1|||
146111358|NCT02101060|526927430|FG001|Overall Study|Adverse Event|0|||
146111359|NCT02101060|526927429|FG000|Overall Study|Withdrawal by Subject|1|||
146111360|NCT02101060|526927430|FG001|Overall Study|Withdrawal by Subject|1|||
146111361|NCT02101060|526927429|FG000|Overall Study|Lost to Follow-up|3|||
146111362|NCT02101060|526927430|FG001|Overall Study|Lost to Follow-up|3|||
146111363|NCT04166435|526927431|FG000|Overall Study|2 patients ineligible for response|2|||
146111364|NCT00127660|526927436|FG000|Overall Study|Protocol Violation|3|||
146111365|NCT00127660|526927437|FG001|Overall Study|Protocol Violation|3|||
146111366|NCT00127660|526927438|FG002|Overall Study|Protocol Violation|5|||
146111367|NCT00127660|526927439|FG003|Overall Study|Protocol Violation|0|||
146111368|NCT05131646|526927440|FG000|Overall Study|Withdrawal by Subject|1|||
146111369|NCT05131646|526927441|FG001|Overall Study|Withdrawal by Subject|0|||
146111370|NCT05131646|526927442|FG002|Overall Study|Withdrawal by Subject|0|||
146111371|NCT03454997|526927443|FG000|Overall Study|Staff Coach - Left Oranization|1|||
146111372|NCT03454997|526927444|FG001|Overall Study|Staff Coach - Left Oranization|1|||
146111373|NCT03454997|526927443|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
146111374|NCT03454997|526927444|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
146111375|NCT03454997|526927443|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
146111376|NCT03454997|526927444|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
146111377|NCT03454997|526927443|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
146111378|NCT03454997|526927444|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
146111379|NCT03454997|526927443|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
146111380|NCT03454997|526927444|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
146111381|NCT03454997|526927443|FG000|Overall Study|Client with SMI - Left organization|0|||
146111382|NCT03454997|526927444|FG001|Overall Study|Client with SMI - Left organization|1|||
146111383|NCT03454997|526927443|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
146111384|NCT03454997|526927444|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
146111385|NCT01191801|526927447|FG000|Overall Study|Death|36|||
146111386|NCT01191801|526927448|FG001|Overall Study|Death|12|||
146111387|NCT01191801|526927447|FG000|Overall Study|Lack of Efficacy|176|||
146301495|NCT00210184|527618910|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
146301496|NCT02316340|527618911|FG000|First Progression|Clinical progression|2|||
146301497|NCT02316340|527618912|FG001|First Progression|Clinical progression|1|||
146301498|NCT02316340|527618911|FG000|First Progression|Withdrawal by Subject|1|||
146301499|NCT02316340|527618912|FG001|First Progression|Withdrawal by Subject|0|||
146301500|NCT01835015|527618913|FG000|Overall Study|Adverse Event|0|||
146055106|NCT00399516|526716214|FG000|Overall Study|Lost to Follow-up|2|||
146055107|NCT01091675|526716215|FG000|Overall Study|Adverse Event|7|||
146055108|NCT01091675|526716215|FG000|Overall Study|Lack of Efficacy|27|||
146055109|NCT03040141|526716216|FG000|Overall Study|Death|1|||
146055110|NCT03040141|526716217|FG001|Overall Study|Death|2|||
146055111|NCT03040141|526716218|FG002|Overall Study|Death|3|||
146055112|NCT03040141|526716216|FG000|Overall Study|Withdrawal by Subject|3|||
146055113|NCT03040141|526716217|FG001|Overall Study|Withdrawal by Subject|1|||
146055114|NCT03040141|526716218|FG002|Overall Study|Withdrawal by Subject|1|||
146055115|NCT03040141|526716216|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
146055116|NCT03040141|526716217|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
146055117|NCT03040141|526716218|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
146055118|NCT03040141|526716216|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
146055119|NCT03040141|526716217|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
146055120|NCT03040141|526716218|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
146055121|NCT04879628|526716219|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146055122|NCT04879628|526716220|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146055123|NCT04879628|526716221|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
146055124|NCT04879628|526716222|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
146055125|NCT04879628|526716219|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146055126|NCT04879628|526716220|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146055127|NCT04879628|526716221|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
146055128|NCT04879628|526716222|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146055129|NCT04879628|526716219|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146055130|NCT04879628|526716220|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146055131|NCT04879628|526716221|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
146055132|NCT04879628|526716222|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
146055133|NCT04879628|526716219|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
146055134|NCT04879628|526716220|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
146055135|NCT04879628|526716221|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
146055136|NCT04879628|526716222|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
146055137|NCT02775916|526716223|FG000|Overall Study|Adverse Event|1|||
146055138|NCT02775916|526716224|FG001|Overall Study|Adverse Event|0|||
146055139|NCT02775916|526716223|FG000|Overall Study|Subject/Guardian Decision|2|||
146055140|NCT02775916|526716224|FG001|Overall Study|Subject/Guardian Decision|0|||
146055141|NCT02426580|526717916|FG000|Overall Study|Death|2|||
146055142|NCT02426580|526717917|FG001|Overall Study|Death|2|||
146055143|NCT02426580|526717916|FG000|Overall Study|Lost to Follow-up|0|||
146055144|NCT02426580|526717917|FG001|Overall Study|Lost to Follow-up|9|||
146055145|NCT02426580|526717916|FG000|Overall Study|transfer to hemodialysis|5|||
146055146|NCT02426580|526717917|FG001|Overall Study|transfer to hemodialysis|5|||
146055147|NCT02426580|526717916|FG000|Overall Study|Kidney transplant|3|||
146055148|NCT02426580|526717917|FG001|Overall Study|Kidney transplant|0|||
146055149|NCT02426580|526717916|FG000|Overall Study|Allergic to egg white|1|||
146055150|NCT02426580|526717917|FG001|Overall Study|Allergic to egg white|0|||
146055151|NCT00383552|526717918|FG000|Overall Study|Adverse Event|7|||
146055152|NCT00383552|526717919|FG001|Overall Study|Adverse Event|6|||
146055153|NCT00383552|526717920|FG002|Overall Study|Adverse Event|9|||
146055154|NCT00383552|526717921|FG003|Overall Study|Adverse Event|6|||
146055155|NCT00383552|526717918|FG000|Overall Study|Lack of Efficacy|4|||
146055156|NCT00383552|526717919|FG001|Overall Study|Lack of Efficacy|13|||
146055157|NCT00383552|526717920|FG002|Overall Study|Lack of Efficacy|29|||
146055158|NCT00383552|526717921|FG003|Overall Study|Lack of Efficacy|42|||
146055159|NCT00383552|526717918|FG000|Overall Study|Lost to Follow-up|0|||
146055160|NCT00383552|526717919|FG001|Overall Study|Lost to Follow-up|1|||
146055161|NCT00383552|526717920|FG002|Overall Study|Lost to Follow-up|5|||
146055162|NCT00383552|526717921|FG003|Overall Study|Lost to Follow-up|1|||
146055163|NCT00383552|526717918|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
146055164|NCT00383552|526717919|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
146055165|NCT00383552|526717920|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
146055166|NCT00383552|526717921|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
146055167|NCT00383552|526717918|FG000|Overall Study|Did not wish to continue (related)|1|||
146111388|NCT01191801|526927448|FG001|Overall Study|Lack of Efficacy|258|||
146111389|NCT01191801|526927447|FG000|Overall Study|Adverse Event|9|||
146111390|NCT01191801|526927448|FG001|Overall Study|Adverse Event|8|||
146111391|NCT01191801|526927447|FG000|Overall Study|Protocol Violation|2|||
146111392|NCT01191801|526927448|FG001|Overall Study|Protocol Violation|4|||
146111393|NCT01191801|526927447|FG000|Overall Study|Physician Decision|47|||
146111394|NCT01191801|526927448|FG001|Overall Study|Physician Decision|24|||
146111395|NCT01191801|526927447|FG000|Overall Study|Withdrawal by Subject|1|||
146111396|NCT01191801|526927448|FG001|Overall Study|Withdrawal by Subject|4|||
146111397|NCT01191801|526927447|FG000|Overall Study|Not Provided|45|||
146111398|NCT01191801|526927448|FG001|Overall Study|Not Provided|27|||
146111399|NCT02794883|526927451|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
146111400|NCT02794883|526927452|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
146111401|NCT02794883|526927453|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
146111402|NCT02794883|526927451|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
146111403|NCT02794883|526927452|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
146111404|NCT02794883|526927453|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
146111405|NCT02794883|526927451|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
146111406|NCT02794883|526927452|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
146111407|NCT02794883|526927453|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
146111408|NCT02794883|526927451|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
146111409|NCT02794883|526927452|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
146111410|NCT02794883|526927453|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
146111411|NCT02794883|526927451|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
146111412|NCT02794883|526927452|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
146111413|NCT02794883|526927453|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
146111414|NCT02794883|526927451|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
146111415|NCT02794883|526927452|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
146111416|NCT02794883|526927453|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
146111417|NCT02794883|526927451|FG000|Follow-up Period (up to 2 Years)|Death|12|||
146111418|NCT02794883|526927452|FG001|Follow-up Period (up to 2 Years)|Death|10|||
146111419|NCT02794883|526927453|FG002|Follow-up Period (up to 2 Years)|Death|10|||
146111420|NCT01727297|526927458|FG000|Overall Study|Death|13|||
146111421|NCT01727297|526927459|FG001|Overall Study|Death|0|||
146111422|NCT01727297|526927458|FG000|Overall Study|Protocol Violation|1|||
146111423|NCT01727297|526927459|FG001|Overall Study|Protocol Violation|10|||
146111424|NCT01727297|526927458|FG000|Overall Study|Adverse Event|3|||
146111425|NCT01727297|526927459|FG001|Overall Study|Adverse Event|1|||
146111426|NCT01727297|526927458|FG000|Overall Study|Lost to Follow-up|11|||
146111427|NCT01727297|526927459|FG001|Overall Study|Lost to Follow-up|0|||
146111428|NCT01727297|526927458|FG000|Overall Study|Withdrawal by Subject|26|||
146111429|NCT01727297|526927459|FG001|Overall Study|Withdrawal by Subject|27|||
146111430|NCT01727297|526927458|FG000|Overall Study|Physician Decision|19|||
146111431|NCT01727297|526927459|FG001|Overall Study|Physician Decision|5|||
146111432|NCT01727297|526927458|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
146111433|NCT01727297|526927459|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
146111434|NCT03018704|526927472|FG000|Overall Study|Lost to Follow-up|1|||
146111435|NCT03018704|526927473|FG001|Overall Study|Lost to Follow-up|1|||
146111436|NCT04448171|526927474|FG000|Overall Study|Procedure Cancelled|1|||
146055168|NCT00383552|526717919|FG001|Overall Study|Did not wish to continue (related)|0|||
146055169|NCT00383552|526717920|FG002|Overall Study|Did not wish to continue (related)|2|||
146055170|NCT00383552|526717921|FG003|Overall Study|Did not wish to continue (related)|3|||
146055171|NCT00383552|526717918|FG000|Overall Study|Noncompliance with the protocol|11|||
146055172|NCT00383552|526717919|FG001|Overall Study|Noncompliance with the protocol|6|||
146055173|NCT00383552|526717920|FG002|Overall Study|Noncompliance with the protocol|8|||
146055174|NCT00383552|526717921|FG003|Overall Study|Noncompliance with the protocol|10|||
146055175|NCT00383552|526717918|FG000|Overall Study|Did not meet protocol eligibility|8|||
146055176|NCT00383552|526717919|FG001|Overall Study|Did not meet protocol eligibility|6|||
146055177|NCT00383552|526717920|FG002|Overall Study|Did not meet protocol eligibility|2|||
146055178|NCT00383552|526717921|FG003|Overall Study|Did not meet protocol eligibility|3|||
146055179|NCT00383552|526717918|FG000|Overall Study|Administrative|1|||
146055180|NCT00383552|526717919|FG001|Overall Study|Administrative|0|||
146055181|NCT00383552|526717920|FG002|Overall Study|Administrative|1|||
146055182|NCT00383552|526717921|FG003|Overall Study|Administrative|1|||
146055183|NCT00966654|526717922|FG000|Overall Study|Study was terminated,PI left institution|12|||
146055184|NCT01600326|526717925|FG000|Overall Study|Lost to Follow-up|1|||
146055185|NCT01600326|526717926|FG001|Overall Study|Lost to Follow-up|1|||
146055186|NCT04456504|526717927|FG000|Overall Study|Lost to Follow-up|2|||
146111437|NCT04448171|526927475|FG001|Overall Study|Procedure Cancelled|0|||
146111438|NCT04448171|526927474|FG000|Overall Study|Protocol Violation|1|||
146111439|NCT04448171|526927475|FG001|Overall Study|Protocol Violation|0|||
146111440|NCT00211809|526927480|FG000|Overall Study|Lack of Efficacy|1|||
146111441|NCT00211809|526927480|FG000|Overall Study|Lost to Follow-up|2|||
146111442|NCT00211809|526927480|FG000|Overall Study|Pregnancy|1|||
146111443|NCT00211809|526927480|FG000|Overall Study|side effects|2|||
146111444|NCT01417234|526927481|FG000|Overall Study|Subject non-compliant|3|||
146055187|NCT01393158|526717928|FG000|Overall Study|Adverse Event|1|||
146055188|NCT01393158|526717929|FG001|Overall Study|Adverse Event|0|||
146055189|NCT02173769|526717931|FG000|Overall Study|Protocol Violation|4|||
146055190|NCT02869633|526717932|FG000|Overall Study|Death|2|||
146055191|NCT02869633|526717933|FG001|Overall Study|Death|1|||
146055192|NCT02869633|526717932|FG000|Overall Study|Patient refused follow-up|1|||
146055193|NCT02869633|526717933|FG001|Overall Study|Patient refused follow-up|0|||
146055194|NCT02869633|526717932|FG000|Overall Study|Provider discretion|1|||
146055195|NCT02869633|526717933|FG001|Overall Study|Provider discretion|0|||
146055196|NCT02869633|526717932|FG000|Overall Study|Investigator decision|1|||
146055197|NCT02869633|526717933|FG001|Overall Study|Investigator decision|0|||
146055198|NCT02869633|526717932|FG000|Overall Study|Lost to Follow-up|0|||
146055199|NCT02869633|526717933|FG001|Overall Study|Lost to Follow-up|1|||
146055200|NCT02869633|526717932|FG000|Overall Study|Not eligible|6|||
146055201|NCT02869633|526717933|FG001|Overall Study|Not eligible|1|||
146055202|NCT02869633|526717932|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
146055203|NCT02869633|526717933|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
146055204|NCT02869633|526717932|FG000|Overall Study|Withdrawal by Subject|0|||
146055205|NCT02869633|526717933|FG001|Overall Study|Withdrawal by Subject|1|||
146055206|NCT04024891|526717934|FG000|Overall Study|Pregnancy|0|||
146055207|NCT04024891|526717935|FG001|Overall Study|Pregnancy|1|||
146055208|NCT01693029|526717936|FG000|Overall Study|Withdrawal by Subject|15|||
146055209|NCT01693029|526717937|FG001|Overall Study|Withdrawal by Subject|22|||
146055210|NCT01693029|526717936|FG000|Overall Study|Kidney transplantation|7|||
146055211|NCT01693029|526717937|FG001|Overall Study|Kidney transplantation|7|||
146055212|NCT01693029|526717936|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
146055213|NCT01693029|526717937|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
146055214|NCT01693029|526717936|FG000|Overall Study|Protocol Violation|6|||
146055215|NCT01693029|526717937|FG001|Overall Study|Protocol Violation|7|||
146055216|NCT01693029|526717936|FG000|Overall Study|Change in dialysis modality|2|||
146055217|NCT01693029|526717937|FG001|Overall Study|Change in dialysis modality|1|||
146055218|NCT01693029|526717936|FG000|Overall Study|Physician Decision|0|||
146055219|NCT01693029|526717937|FG001|Overall Study|Physician Decision|2|||
146055220|NCT01693029|526717936|FG000|Overall Study|Lost to Follow-up|0|||
146055221|NCT01693029|526717937|FG001|Overall Study|Lost to Follow-up|1|||
146055222|NCT01693029|526717936|FG000|Overall Study|Adverse Event|1|||
146055223|NCT01693029|526717937|FG001|Overall Study|Adverse Event|6|||
146055224|NCT01693029|526717936|FG000|Overall Study|Death|5|||
146055225|NCT01693029|526717937|FG001|Overall Study|Death|8|||
146055226|NCT01693029|526717936|FG000|Overall Study|Non-compliance|2|||
146055227|NCT01693029|526717937|FG001|Overall Study|Non-compliance|1|||
146055228|NCT00308139|526717938|FG000|Overall Study|Adverse Event|20|||
146055229|NCT00308139|526717939|FG001|Overall Study|Adverse Event|14|||
146055230|NCT00308139|526717938|FG000|Overall Study|Lost to Follow-up|13|||
146055231|NCT00308139|526717939|FG001|Overall Study|Lost to Follow-up|8|||
146055232|NCT00308139|526717938|FG000|Overall Study|Protocol Violation|3|||
146055233|NCT00308139|526717939|FG001|Overall Study|Protocol Violation|2|||
146055234|NCT00308139|526717938|FG000|Overall Study|Withdrawal of Consent|40|||
146055235|NCT00308139|526717939|FG001|Overall Study|Withdrawal of Consent|42|||
146055236|NCT00308139|526717938|FG000|Overall Study|Investigator Decision|11|||
146055237|NCT00308139|526717939|FG001|Overall Study|Investigator Decision|10|||
146055238|NCT00308139|526717938|FG000|Overall Study|Loss of Glucose Control|5|||
146055239|NCT00308139|526717939|FG001|Overall Study|Loss of Glucose Control|7|||
146055240|NCT00308139|526717938|FG000|Overall Study|Administrative|1|||
146055241|NCT00308139|526717939|FG001|Overall Study|Administrative|4|||
146055242|NCT00308139|526717938|FG000|Overall Study|Other|1|||
146055243|NCT00308139|526717939|FG001|Overall Study|Other|0|||
146055244|NCT02313766|526717942|FG000|Overall Study|surgery cancelled|1|||
146055245|NCT02313766|526717943|FG001|Overall Study|surgery cancelled|0|||
146055246|NCT02313766|526717944|FG002|Overall Study|surgery cancelled|0|||
146055247|NCT02313766|526717942|FG000|Overall Study|Lost to Follow-up|0|||
146055248|NCT02313766|526717943|FG001|Overall Study|Lost to Follow-up|2|||
146055249|NCT02313766|526717944|FG002|Overall Study|Lost to Follow-up|0|||
146055250|NCT02313766|526717942|FG000|Overall Study|Adverse Event|0|||
146055251|NCT02313766|526717943|FG001|Overall Study|Adverse Event|1|||
146055252|NCT02313766|526717944|FG002|Overall Study|Adverse Event|0|||
146055253|NCT00791388|526717948|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146055254|NCT00791388|526717949|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
146055255|NCT00791388|526717950|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146055256|NCT00791388|526717951|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146055257|NCT00791388|526717952|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
146055258|NCT00791388|526717948|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
146055259|NCT00791388|526717949|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146055260|NCT00791388|526717950|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146055261|NCT00791388|526717951|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146055262|NCT00791388|526717952|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
146055263|NCT00791388|526717948|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146055264|NCT00791388|526717949|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146055265|NCT00791388|526717950|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146055266|NCT00791388|526717951|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
146055267|NCT00791388|526717952|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
146055268|NCT00141453|526717960|FG000|Overall Study|Protocol Violation|6|||
146055269|NCT00141453|526717961|FG001|Overall Study|Protocol Violation|5|||
146055270|NCT00443040|526717962|FG000|Overall Study|Withdrawal by Subject|1|||
146055271|NCT00443040|526717963|FG001|Overall Study|Withdrawal by Subject|0|||
146055272|NCT00443040|526717964|FG002|Overall Study|Withdrawal by Subject|0|||
146055273|NCT00443040|526717962|FG000|Overall Study|Converted to an open laparotomy|3|||
146055274|NCT00443040|526717963|FG001|Overall Study|Converted to an open laparotomy|0|||
146055275|NCT00443040|526717964|FG002|Overall Study|Converted to an open laparotomy|1|||
146055276|NCT02763644|526717967|FG000|Overall Study|Patient/guardian decision|1|||
146055277|NCT02763644|526717968|FG001|Overall Study|Patient/guardian decision|0|||
146055278|NCT02763644|526717967|FG000|Overall Study|Death|1|||
146055279|NCT02763644|526717968|FG001|Overall Study|Death|1|||
146055280|NCT02763644|526717967|FG000|Overall Study|Adverse Event|1|||
146055281|NCT02763644|526717968|FG001|Overall Study|Adverse Event|1|||
146055282|NCT02648204|526717969|FG000|Overall Study|Withdrawal by Subject|12|||
146055283|NCT02648204|526717970|FG001|Overall Study|Withdrawal by Subject|8|||
146055284|NCT02648204|526717971|FG002|Overall Study|Withdrawal by Subject|2|||
146055285|NCT02648204|526717972|FG003|Overall Study|Withdrawal by Subject|6|||
146055286|NCT02648204|526717969|FG000|Overall Study|Lost to Follow-up|5|||
146055287|NCT02648204|526717970|FG001|Overall Study|Lost to Follow-up|8|||
146055288|NCT02648204|526717971|FG002|Overall Study|Lost to Follow-up|4|||
146055289|NCT02648204|526717972|FG003|Overall Study|Lost to Follow-up|6|||
146055290|NCT02648204|526717969|FG000|Overall Study|Missing follow-up information|4|||
146055291|NCT02648204|526717970|FG001|Overall Study|Missing follow-up information|4|||
146055292|NCT02648204|526717971|FG002|Overall Study|Missing follow-up information|4|||
146055293|NCT02648204|526717972|FG003|Overall Study|Missing follow-up information|2|||
146055294|NCT02648204|526717969|FG000|Overall Study|Death|1|||
146055295|NCT02648204|526717970|FG001|Overall Study|Death|1|||
146055296|NCT02648204|526717971|FG002|Overall Study|Death|2|||
146055297|NCT02648204|526717972|FG003|Overall Study|Death|2|||
146055298|NCT02648204|526717969|FG000|Overall Study|Adverse Event|0|||
146055299|NCT02648204|526717970|FG001|Overall Study|Adverse Event|0|||
146055300|NCT02648204|526717971|FG002|Overall Study|Adverse Event|1|||
146055301|NCT02648204|526717972|FG003|Overall Study|Adverse Event|0|||
146055302|NCT01220167|526717977|FG000|Period 3|Urine positive for substance abuse|0|||
146055303|NCT01220167|526717978|FG001|Period 3|Urine positive for substance abuse|1|||
146055304|NCT01220167|526717979|FG002|Period 3|Urine positive for substance abuse|0|||
146055305|NCT01008943|526717980|FG000|Overall Study|Withdrawal by Subject|1|||
146055306|NCT02356159|526717981|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146055307|NCT02356159|526717982|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146055308|NCT02356159|526717983|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146055309|NCT02356159|526717984|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146055310|NCT02356159|526717985|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
146055311|NCT02356159|526717986|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
146055312|NCT06418152|526717987|FG000|Overall Study|Frequent DBS setting changes|1|||
146055313|NCT06418152|526717987|FG000|Overall Study|Withdrawal by Subject|2|||
146055314|NCT05789745|526717988|FG000|Overall Study|Withdrawal by Subject|0|||
146055315|NCT05789745|526717989|FG001|Overall Study|Withdrawal by Subject|0|||
146055316|NCT05789745|526717990|FG002|Overall Study|Withdrawal by Subject|0|||
146055317|NCT05789745|526717991|FG003|Overall Study|Withdrawal by Subject|0|||
146055318|NCT05789745|526717992|FG004|Overall Study|Withdrawal by Subject|1|||
146055319|NCT02201524|526717998|FG000|Overall Study|Adverse Event|0|||
146055320|NCT02201524|526717999|FG001|Overall Study|Adverse Event|2|||
146055321|NCT02201524|526718000|FG002|Overall Study|Adverse Event|1|||
146055322|NCT02201524|526718001|FG003|Overall Study|Adverse Event|0|||
146055323|NCT02201524|526717998|FG000|Overall Study|Insufficient clinical response|1|||
146055324|NCT02201524|526717999|FG001|Overall Study|Insufficient clinical response|0|||
146055325|NCT02201524|526718000|FG002|Overall Study|Insufficient clinical response|0|||
146055326|NCT02201524|526718001|FG003|Overall Study|Insufficient clinical response|0|||
146055327|NCT02201524|526717998|FG000|Overall Study|Lost to Follow-up|0|||
146055328|NCT02201524|526717999|FG001|Overall Study|Lost to Follow-up|0|||
146055329|NCT02201524|526718000|FG002|Overall Study|Lost to Follow-up|2|||
146055330|NCT02201524|526718001|FG003|Overall Study|Lost to Follow-up|0|||
146055331|NCT02201524|526717998|FG000|Overall Study|No longer meets eligibility criteria|0|||
146055332|NCT02201524|526717999|FG001|Overall Study|No longer meets eligibility criteria|0|||
146055333|NCT02201524|526718000|FG002|Overall Study|No longer meets eligibility criteria|0|||
146055334|NCT02201524|526718001|FG003|Overall Study|No longer meets eligibility criteria|2|||
146055335|NCT02201524|526717998|FG000|Overall Study|Protocol Violation|0|||
146055336|NCT02201524|526717999|FG001|Overall Study|Protocol Violation|0|||
146055337|NCT02201524|526718000|FG002|Overall Study|Protocol Violation|0|||
146055338|NCT02201524|526718001|FG003|Overall Study|Protocol Violation|1|||
146055339|NCT02201524|526717998|FG000|Overall Study|Withdrawal by Subject|0|||
146055340|NCT02201524|526717999|FG001|Overall Study|Withdrawal by Subject|0|||
146055341|NCT02201524|526718000|FG002|Overall Study|Withdrawal by Subject|1|||
146055342|NCT02201524|526718001|FG003|Overall Study|Withdrawal by Subject|1|||
146055343|NCT02201524|526717998|FG000|Overall Study|Other|1|||
146055344|NCT02201524|526717999|FG001|Overall Study|Other|1|||
146055345|NCT02201524|526718000|FG002|Overall Study|Other|0|||
146055346|NCT02201524|526718001|FG003|Overall Study|Other|0|||
146055347|NCT02314052|526718002|FG000|Cycle One|Adverse Event|0|||
146055348|NCT02314052|526718003|FG001|Cycle One|Adverse Event|0|||
146055349|NCT02314052|526718004|FG002|Cycle One|Adverse Event|0|||
146055350|NCT02314052|526718005|FG003|Cycle One|Adverse Event|1|||
146055351|NCT02314052|526718006|FG004|Cycle One|Adverse Event|0|||
146055352|NCT02314052|526718007|FG005|Cycle One|Adverse Event|0|||
146055353|NCT01960140|526718013|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
146055354|NCT00686777|526718019|FG000|Overall Study|Adverse Event|2|||
146055355|NCT00686777|526718019|FG000|Overall Study|Pregnancy|1|||
146055356|NCT00686777|526718019|FG000|Overall Study|Withdrawal by Subject|2|||
146055357|NCT00686777|526718019|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
146055358|NCT00686777|526718019|FG000|Overall Study|No Visit|1|||
146055359|NCT00499681|526718020|FG000|Overall Study|toxicity|0|||
146055360|NCT00499681|526718021|FG001|Overall Study|toxicity|1|||
146055361|NCT00499681|526718020|FG000|Overall Study|disease progression|0|||
146055362|NCT00499681|526718021|FG001|Overall Study|disease progression|1|||
146055363|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
146055364|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
146055365|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Disease progression|75|||
146055366|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Disease progression|59|||
146055367|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Adverse Event|16|||
146055368|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Adverse Event|16|||
146055369|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Death|2|||
146055370|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Death|3|||
146055371|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
146055372|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
146055373|NCT00883779|526718022|FG000|Primary Study Treatment Phase|Other|3|||
146055374|NCT00883779|526718023|FG001|Primary Study Treatment Phase|Other|0|||
146055375|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Adverse Event|2|||
146055376|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Adverse Event|3|||
146055377|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Death|1|||
146055378|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Death|3|||
146055379|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
146055380|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
146055381|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
146055382|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
146055383|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Disease progression|103|||
146055384|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Disease progression|122|||
146055385|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Other|3|||
146055386|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Other|0|||
146055387|NCT00883779|526718022|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
146055388|NCT00883779|526718023|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
146055389|NCT00883779|526718022|FG000|Off-study Phase|Death|185|||
146055390|NCT00883779|526718023|FG001|Off-study Phase|Death|174|||
146055391|NCT00883779|526718022|FG000|Off-study Phase|Refused treatment|1|||
146055392|NCT00883779|526718023|FG001|Off-study Phase|Refused treatment|1|||
146055393|NCT00883779|526718022|FG000|Off-study Phase|Failure to return|5|||
146055394|NCT00883779|526718023|FG001|Off-study Phase|Failure to return|6|||
146055395|NCT00883779|526718022|FG000|Off-study Phase|Other|18|||
146055396|NCT00883779|526718023|FG001|Off-study Phase|Other|21|||
146055397|NCT00739401|526718028|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
146055398|NCT00739401|526718028|FG000|Overall Study|Death|3|||
146055399|NCT00739401|526718028|FG000|Overall Study|Withdrawal by Subject|4|||
146055400|NCT04575155|526718029|FG000|2 Month|Withdrawal by Subject|1|||
146055401|NCT04575155|526718030|FG001|2 Month|Withdrawal by Subject|1|||
146055402|NCT04575155|526718029|FG000|2 Month|Lost to Follow-up|5|||
146055403|NCT04575155|526718030|FG001|2 Month|Lost to Follow-up|3|||
146055404|NCT04575155|526718029|FG000|2 Month|Ineligible|1|||
146055405|NCT04575155|526718030|FG001|2 Month|Ineligible|0|||
146055406|NCT03915717|526718033|FG000|Overall Study|EchoMark Not Implanted|6|||
146055407|NCT03748823|526718035|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
146055408|NCT03748823|526718036|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
146055409|NCT03748823|526718035|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
146055410|NCT03748823|526718036|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
146055411|NCT03748823|526718035|FG000|Extension Period|Withdrawal by Subject|9|||
146055412|NCT03748823|526718036|FG001|Extension Period|Withdrawal by Subject|12|||
146055413|NCT03748823|526718035|FG000|Extension Period|Death|2|||
146055414|NCT03748823|526718036|FG001|Extension Period|Death|2|||
146111445|NCT00023764|526927482|FG000|Overall Study|Other|1|||
146111446|NCT00023764|526927482|FG000|Overall Study|Adverse Event|4|||
146111447|NCT00023764|526927482|FG000|Overall Study|Withdrawal by Subject|1|||
146111448|NCT00023764|526927482|FG000|Overall Study|Progression of disease|6|||
146111449|NCT00023764|526927482|FG000|Overall Study|patient received other treatment|1|||
146111450|NCT00023764|526927482|FG000|Overall Study|delay in obtaining staging images|1|||
146111451|NCT02756013|526927486|FG000|Overall Study|Adverse Event|1|||
146111452|NCT02756013|526927486|FG000|Overall Study|Hypersensitivity|1|||
146111453|NCT00211510|526927487|FG000|Overall Study|Physician Decision|3|||
146111454|NCT00211510|526927488|FG001|Overall Study|Physician Decision|1|||
146111455|NCT00211510|526927487|FG000|Overall Study|Withdrawal by Subject|3|||
146111456|NCT00211510|526927488|FG001|Overall Study|Withdrawal by Subject|1|||
146111457|NCT01962896|526927489|FG000|Overall Study|Lack of Efficacy|4|||
146111458|NCT01487200|526927490|FG000|Overall Study|Withdrawal by Subject|0|||
146111459|NCT01487200|526927491|FG001|Overall Study|Withdrawal by Subject|1|||
146111460|NCT01487200|526927492|FG002|Overall Study|Withdrawal by Subject|0|||
146111461|NCT01487200|526927493|FG003|Overall Study|Withdrawal by Subject|0|||
146111462|NCT02837783|526927494|FG000|Overall Study|Adverse Event|1|||
146111463|NCT02837783|526927495|FG001|Overall Study|Adverse Event|0|||
146111464|NCT02837783|526927494|FG000|Overall Study|Other, Not Specified|1|||
146111465|NCT02837783|526927495|FG001|Overall Study|Other, Not Specified|2|||
146111466|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
146111467|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
146111468|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
146111469|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111470|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111471|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111472|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111473|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111474|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111475|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111476|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
146111477|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
146111478|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111479|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
146111480|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111481|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111482|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111483|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111484|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111485|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111486|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111487|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
146111488|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
146111489|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
146111490|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
146111491|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111492|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111493|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111494|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111495|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111496|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111497|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111498|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
146111499|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
146111500|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
146111501|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111502|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111503|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111504|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111505|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111506|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111507|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111508|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111509|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
146111510|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
146111511|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
146111512|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
146111513|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111514|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111515|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111516|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111517|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111518|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111519|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111520|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
146111521|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111522|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
146111523|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
146111524|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111525|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111526|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111527|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111528|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111529|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111530|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111531|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
146111532|NCT02207244|526927500|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111533|NCT02207244|526927501|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
146111534|NCT02207244|526927502|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111535|NCT02207244|526927503|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111536|NCT02207244|526927504|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111537|NCT02207244|526927505|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111538|NCT02207244|526927506|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111539|NCT02207244|526927507|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111540|NCT02207244|526927508|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111541|NCT02207244|526927509|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111542|NCT02207244|526927510|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
146111543|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111544|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111545|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111546|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111547|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
146111548|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
146111549|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111550|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111551|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111552|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111553|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
146111554|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111555|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111556|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111557|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111558|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111559|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
146111560|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111561|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111562|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111563|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111564|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
146111565|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111566|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111567|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111568|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
146111569|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
146111570|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
146111571|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111572|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111573|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111574|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111575|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
146111576|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111577|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111578|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111579|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
146111580|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
146111581|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
146111582|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111583|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111584|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111585|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111586|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
146111587|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111588|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111589|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111590|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
146111591|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111592|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
146111593|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111594|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111595|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111596|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111597|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
146111598|NCT02207244|526927500|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111599|NCT02207244|526927501|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111600|NCT02207244|526927502|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111601|NCT02207244|526927503|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
146111602|NCT02207244|526927504|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111603|NCT02207244|526927505|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111604|NCT02207244|526927506|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111605|NCT02207244|526927507|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111606|NCT02207244|526927508|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111607|NCT02207244|526927509|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111608|NCT02207244|526927510|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
146111609|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111610|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111611|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111612|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111613|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111614|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111615|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
146111616|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
146111617|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
146111618|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
146111619|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
146111620|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111621|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111622|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111623|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111624|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111625|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111626|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111627|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
146111628|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111629|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111630|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
146111631|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146111632|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146111633|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146111634|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146111635|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146301501|NCT01835015|527618914|FG001|Overall Study|Adverse Event|0|||
146301502|NCT01835015|527618915|FG002|Overall Study|Adverse Event|1|||
146301503|NCT01835015|527618916|FG003|Overall Study|Adverse Event|0|||
146111636|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146111637|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
146111638|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
146111639|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
146111640|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
146111641|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
146301504|NCT01835015|527618917|FG004|Overall Study|Adverse Event|0|||
146259333|NCT01544309|527463428|FG001|Overall Study|Administered prohibit prior medication|0|||
146259334|NCT02551692|527463433|FG000|Overall Study|Lost to Follow-up|0|||
146259335|NCT02551692|527463434|FG001|Overall Study|Lost to Follow-up|1|||
146259336|NCT02551692|527463435|FG002|Overall Study|Lost to Follow-up|4|||
146259337|NCT02551692|527463433|FG000|Overall Study|Withdrawal by Subject|1|||
146055415|NCT03748823|526718035|FG000|Extension Period|Other than Specified|0|||
146055416|NCT03748823|526718036|FG001|Extension Period|Other than Specified|1|||
146055417|NCT03748823|526718035|FG000|Extension Period|Protocol Violation|1|||
146055418|NCT03748823|526718036|FG001|Extension Period|Protocol Violation|0|||
146055419|NCT03748823|526718035|FG000|Extension Period|Lost to Follow-up|0|||
146055420|NCT03748823|526718036|FG001|Extension Period|Lost to Follow-up|1|||
146055421|NCT03748823|526718035|FG000|Extension Period|Lack of Efficacy|0|||
146055422|NCT03748823|526718036|FG001|Extension Period|Lack of Efficacy|1|||
146055423|NCT03748823|526718035|FG000|Extension Period|Physician Decision|1|||
146055424|NCT03748823|526718036|FG001|Extension Period|Physician Decision|2|||
146055425|NCT02903160|526718037|FG000|Overall Study|Adverse Event|2|||
146055426|NCT02903160|526718037|FG000|Overall Study|Death|1|||
146055427|NCT02903160|526718037|FG000|Overall Study|Lost to Follow-up|2|||
146055428|NCT02903160|526718037|FG000|Overall Study|Withdrawal by Subject|1|||
146055429|NCT02903160|526718037|FG000|Overall Study|Medical Insurance Barriers|1|||
146055430|NCT01664910|526718040|FG000|Overall Study|Adverse Event|0|||
146055431|NCT01664910|526718041|FG001|Overall Study|Adverse Event|0|||
146055432|NCT01664910|526718042|FG002|Overall Study|Adverse Event|1|||
146055433|NCT00982735|526718047|FG000|Overall Study|Lost to Follow-up|6|||
146055434|NCT00982735|526718047|FG000|Overall Study|Patient ineligible for trial|224|||
146055435|NCT02734693|526718048|FG000|Overall Study|Adverse Event|1|||
146055436|NCT02734693|526718049|FG001|Overall Study|Adverse Event|3|||
146055437|NCT02734693|526718050|FG002|Overall Study|Adverse Event|3|||
146055438|NCT02734693|526718048|FG000|Overall Study|Lack of Efficacy|1|||
146055439|NCT02734693|526718049|FG001|Overall Study|Lack of Efficacy|0|||
146055440|NCT02734693|526718050|FG002|Overall Study|Lack of Efficacy|0|||
146055441|NCT02734693|526718048|FG000|Overall Study|Lost to Follow-up|2|||
146055442|NCT02734693|526718049|FG001|Overall Study|Lost to Follow-up|0|||
146055443|NCT02734693|526718050|FG002|Overall Study|Lost to Follow-up|0|||
146055444|NCT02734693|526718048|FG000|Overall Study|Protocol Violation|1|||
146055445|NCT02734693|526718049|FG001|Overall Study|Protocol Violation|0|||
146055446|NCT02734693|526718050|FG002|Overall Study|Protocol Violation|0|||
146055447|NCT02734693|526718048|FG000|Overall Study|Withdrawal by Subject|1|||
146055448|NCT02734693|526718049|FG001|Overall Study|Withdrawal by Subject|0|||
146055449|NCT02734693|526718050|FG002|Overall Study|Withdrawal by Subject|0|||
146055450|NCT01384734|526718056|FG000|Overall Study|Adverse Event|0|||
146055451|NCT01384734|526718057|FG001|Overall Study|Adverse Event|3|||
146055452|NCT01384734|526718058|FG002|Overall Study|Adverse Event|0|||
146055453|NCT01384734|526718059|FG003|Overall Study|Adverse Event|2|||
146055454|NCT01384734|526718060|FG004|Overall Study|Adverse Event|7|||
146055455|NCT01384734|526718056|FG000|Overall Study|Death|1|||
146055456|NCT01384734|526718057|FG001|Overall Study|Death|0|||
146055457|NCT01384734|526718058|FG002|Overall Study|Death|1|||
146055458|NCT01384734|526718059|FG003|Overall Study|Death|0|||
146055459|NCT01384734|526718060|FG004|Overall Study|Death|0|||
146055460|NCT01384734|526718056|FG000|Overall Study|Continuation criteria not met|0|||
146055461|NCT01384734|526718057|FG001|Overall Study|Continuation criteria not met|0|||
146055462|NCT01384734|526718058|FG002|Overall Study|Continuation criteria not met|1|||
146055463|NCT01384734|526718059|FG003|Overall Study|Continuation criteria not met|1|||
146055464|NCT01384734|526718060|FG004|Overall Study|Continuation criteria not met|0|||
146055465|NCT01384734|526718056|FG000|Overall Study|Lack of Efficacy|3|||
146055466|NCT01384734|526718057|FG001|Overall Study|Lack of Efficacy|7|||
146055467|NCT01384734|526718058|FG002|Overall Study|Lack of Efficacy|4|||
146055468|NCT01384734|526718059|FG003|Overall Study|Lack of Efficacy|4|||
146055469|NCT01384734|526718060|FG004|Overall Study|Lack of Efficacy|2|||
146055470|NCT01384734|526718056|FG000|Overall Study|Lost to Follow-up|5|||
146055471|NCT01384734|526718057|FG001|Overall Study|Lost to Follow-up|3|||
146055472|NCT01384734|526718058|FG002|Overall Study|Lost to Follow-up|3|||
146055473|NCT01384734|526718059|FG003|Overall Study|Lost to Follow-up|8|||
146055474|NCT01384734|526718060|FG004|Overall Study|Lost to Follow-up|5|||
146055475|NCT01384734|526718056|FG000|Overall Study|Non-compliance with study drug|1|||
146055476|NCT01384734|526718057|FG001|Overall Study|Non-compliance with study drug|2|||
146055477|NCT01384734|526718058|FG002|Overall Study|Non-compliance with study drug|6|||
146055478|NCT01384734|526718059|FG003|Overall Study|Non-compliance with study drug|0|||
146055479|NCT01384734|526718060|FG004|Overall Study|Non-compliance with study drug|2|||
146055480|NCT01384734|526718056|FG000|Overall Study|Pregnancy|0|||
146055481|NCT01384734|526718057|FG001|Overall Study|Pregnancy|1|||
146259338|NCT02551692|527463434|FG001|Overall Study|Withdrawal by Subject|0|||
146259339|NCT02551692|527463435|FG002|Overall Study|Withdrawal by Subject|1|||
146055482|NCT01384734|526718058|FG002|Overall Study|Pregnancy|0|||
146055483|NCT01384734|526718059|FG003|Overall Study|Pregnancy|0|||
146055484|NCT01384734|526718060|FG004|Overall Study|Pregnancy|1|||
146055485|NCT01384734|526718056|FG000|Overall Study|Sponsor terminated|0|||
146259340|NCT01091519|527463436|FG000|Overall Study|Adverse Event|12|||
146301505|NCT03334409|527618920|FG000|Overall Study|Did not meet inclusion criteria|1|||
146301506|NCT03334409|527618921|FG001|Overall Study|Did not meet inclusion criteria|0|||
146301507|NCT00975715|527618922|FG000|Titration Period|Adverse Event|6|||
146301508|NCT00975715|527618923|FG001|Titration Period|Adverse Event|0|||
146301509|NCT00975715|527618922|FG000|Titration Period|Protocol Violation|1|||
146301510|NCT00975715|527618923|FG001|Titration Period|Protocol Violation|0|||
146301511|NCT00975715|527618922|FG000|Maintenance Period|Adverse Event|2|||
146301512|NCT00975715|527618923|FG001|Maintenance Period|Adverse Event|1|||
146301513|NCT01241552|527618924|FG000|Overall Study|Lack of Efficacy|1|||
146301514|NCT01241552|527618925|FG001|Overall Study|Lack of Efficacy|0|||
146301515|NCT01241552|527618926|FG002|Overall Study|Lack of Efficacy|0|||
146301516|NCT01241552|527618927|FG003|Overall Study|Lack of Efficacy|0|||
146301517|NCT01241552|527618924|FG000|Overall Study|Death|26|||
146301518|NCT01241552|527618925|FG001|Overall Study|Death|30|||
146301519|NCT01241552|527618926|FG002|Overall Study|Death|20|||
146301520|NCT01241552|527618927|FG003|Overall Study|Death|25|||
146301521|NCT01241552|527618924|FG000|Overall Study|Adverse Event|1|||
146301522|NCT01241552|527618925|FG001|Overall Study|Adverse Event|1|||
146301523|NCT01241552|527618926|FG002|Overall Study|Adverse Event|0|||
146301524|NCT01241552|527618927|FG003|Overall Study|Adverse Event|0|||
146301525|NCT01241552|527618924|FG000|Overall Study|Technical Problems|2|||
146301526|NCT01241552|527618925|FG001|Overall Study|Technical Problems|0|||
146301527|NCT01241552|527618926|FG002|Overall Study|Technical Problems|2|||
146301528|NCT01241552|527618927|FG003|Overall Study|Technical Problems|2|||
146301529|NCT01241552|527618924|FG000|Overall Study|Progressive Disease|0|||
146301530|NCT01241552|527618925|FG001|Overall Study|Progressive Disease|0|||
146301531|NCT01241552|527618926|FG002|Overall Study|Progressive Disease|1|||
146301532|NCT01241552|527618927|FG003|Overall Study|Progressive Disease|2|||
146301533|NCT01241552|527618924|FG000|Overall Study|Protocol Violation|0|||
146301534|NCT01241552|527618925|FG001|Overall Study|Protocol Violation|2|||
146301535|NCT01241552|527618926|FG002|Overall Study|Protocol Violation|6|||
146301536|NCT01241552|527618927|FG003|Overall Study|Protocol Violation|1|||
146301537|NCT01241552|527618924|FG000|Overall Study|Withdrawal by Subject|7|||
146301538|NCT01241552|527618925|FG001|Overall Study|Withdrawal by Subject|15|||
146301539|NCT01241552|527618926|FG002|Overall Study|Withdrawal by Subject|14|||
146301540|NCT01241552|527618927|FG003|Overall Study|Withdrawal by Subject|15|||
146301541|NCT01241552|527618924|FG000|Overall Study|Physician Decision|2|||
146301542|NCT01241552|527618925|FG001|Overall Study|Physician Decision|4|||
146301543|NCT01241552|527618926|FG002|Overall Study|Physician Decision|2|||
146259341|NCT01091519|527463437|FG001|Overall Study|Adverse Event|16|||
146259342|NCT01091519|527463436|FG000|Overall Study|Death|1|||
146259343|NCT01091519|527463437|FG001|Overall Study|Death|0|||
146259344|NCT01091519|527463436|FG000|Overall Study|Lack of Efficacy|16|||
146259345|NCT01091519|527463437|FG001|Overall Study|Lack of Efficacy|19|||
146259346|NCT01091519|527463436|FG000|Overall Study|Lost to Follow-up|14|||
146259347|NCT01091519|527463437|FG001|Overall Study|Lost to Follow-up|24|||
146259348|NCT01091519|527463436|FG000|Overall Study|Withdrawal by Subject|2|||
146259349|NCT01091519|527463437|FG001|Overall Study|Withdrawal by Subject|2|||
146259350|NCT01091519|527463436|FG000|Overall Study|Other|6|||
146259351|NCT01091519|527463437|FG001|Overall Study|Other|8|||
146301544|NCT01241552|527618927|FG003|Overall Study|Physician Decision|3|||
146301545|NCT01241552|527618924|FG000|Overall Study|Lost to Follow-up|2|||
146301546|NCT01241552|527618925|FG001|Overall Study|Lost to Follow-up|11|||
146301547|NCT01241552|527618926|FG002|Overall Study|Lost to Follow-up|15|||
146301548|NCT01241552|527618927|FG003|Overall Study|Lost to Follow-up|16|||
146301549|NCT04004429|527618930|FG000|Overall Study|Protocol Violation|1|||
146301550|NCT04004429|527618931|FG001|Overall Study|Protocol Violation|0|||
146301551|NCT04004429|527618932|FG002|Overall Study|Protocol Violation|0|||
146301552|NCT04004429|527618930|FG000|Overall Study|Physician Decision|0|||
146301553|NCT04004429|527618931|FG001|Overall Study|Physician Decision|1|||
146301554|NCT04004429|527618932|FG002|Overall Study|Physician Decision|1|||
146301555|NCT04004429|527618930|FG000|Overall Study|Withdrawal by Subject|1|||
146301556|NCT04004429|527618931|FG001|Overall Study|Withdrawal by Subject|1|||
146301557|NCT04004429|527618932|FG002|Overall Study|Withdrawal by Subject|1|||
146301558|NCT02663271|527618937|FG000|Overall Study|Withdrawal by Subject|5|||
146301559|NCT02663271|527618937|FG000|Overall Study|Lack of Efficacy|1|||
146301560|NCT04166383|527618938|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
146301561|NCT04166383|527618938|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
146301562|NCT04166383|527618938|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
146301563|NCT03044886|527618940|FG000|Overall Study|Lost to Follow-up|15|||
146301564|NCT03044886|527618941|FG001|Overall Study|Lost to Follow-up|10|||
146301565|NCT03044886|527618942|FG002|Overall Study|Lost to Follow-up|12|||
146301566|NCT01624259|527618952|FG000|Overall Study|Adverse Event|18|||
146259352|NCT01091519|527463436|FG000|Overall Study|Randomized not treated|4|||
146301567|NCT01624259|527618953|FG001|Overall Study|Adverse Event|18|||
146301568|NCT01624259|527618952|FG000|Overall Study|Protocol Violation|1|||
146259353|NCT01091519|527463437|FG001|Overall Study|Randomized not treated|4|||
146259354|NCT01196741|527463440|FG000|Overall Study|Disease progression|34|||
146301569|NCT01624259|527618953|FG001|Overall Study|Protocol Violation|2|||
146055486|NCT01384734|526718057|FG001|Overall Study|Sponsor terminated|0|||
146055487|NCT01384734|526718058|FG002|Overall Study|Sponsor terminated|0|||
146055488|NCT01384734|526718059|FG003|Overall Study|Sponsor terminated|0|||
146055489|NCT01384734|526718060|FG004|Overall Study|Sponsor terminated|1|||
146055490|NCT01384734|526718056|FG000|Overall Study|Withdrawal by Subject|5|||
146055491|NCT01384734|526718057|FG001|Overall Study|Withdrawal by Subject|5|||
146055492|NCT01384734|526718058|FG002|Overall Study|Withdrawal by Subject|6|||
146055493|NCT01384734|526718059|FG003|Overall Study|Withdrawal by Subject|7|||
146055494|NCT01384734|526718060|FG004|Overall Study|Withdrawal by Subject|9|||
146055495|NCT01384734|526718056|FG000|Overall Study|Investigator relocating|0|||
146055496|NCT01384734|526718057|FG001|Overall Study|Investigator relocating|2|||
146055497|NCT01384734|526718058|FG002|Overall Study|Investigator relocating|0|||
146055498|NCT01384734|526718059|FG003|Overall Study|Investigator relocating|3|||
146055499|NCT01384734|526718060|FG004|Overall Study|Investigator relocating|1|||
146055500|NCT01384734|526718056|FG000|Overall Study|Unable to come back for visit|1|||
146055501|NCT01384734|526718057|FG001|Overall Study|Unable to come back for visit|0|||
146055502|NCT01384734|526718058|FG002|Overall Study|Unable to come back for visit|1|||
146055503|NCT01384734|526718059|FG003|Overall Study|Unable to come back for visit|1|||
146055504|NCT01384734|526718060|FG004|Overall Study|Unable to come back for visit|0|||
146055505|NCT01384734|526718056|FG000|Overall Study|Prison|0|||
146055506|NCT01384734|526718057|FG001|Overall Study|Prison|0|||
146055507|NCT01384734|526718058|FG002|Overall Study|Prison|1|||
146055508|NCT01384734|526718059|FG003|Overall Study|Prison|0|||
146055509|NCT01384734|526718060|FG004|Overall Study|Prison|0|||
146055510|NCT01384734|526718056|FG000|Overall Study|As per Exclusion criteria|0|||
146055511|NCT01384734|526718057|FG001|Overall Study|As per Exclusion criteria|1|||
146055512|NCT01384734|526718058|FG002|Overall Study|As per Exclusion criteria|0|||
146055513|NCT01384734|526718059|FG003|Overall Study|As per Exclusion criteria|0|||
146055514|NCT01384734|526718060|FG004|Overall Study|As per Exclusion criteria|0|||
146055515|NCT01384734|526718056|FG000|Overall Study|Missed End of treatment visit|0|||
146055516|NCT01384734|526718057|FG001|Overall Study|Missed End of treatment visit|0|||
146055517|NCT01384734|526718058|FG002|Overall Study|Missed End of treatment visit|0|||
146055518|NCT01384734|526718059|FG003|Overall Study|Missed End of treatment visit|1|||
146055519|NCT01384734|526718060|FG004|Overall Study|Missed End of treatment visit|0|||
146055520|NCT01384734|526718056|FG000|Overall Study|Adhesion problem|0|||
146055521|NCT01384734|526718057|FG001|Overall Study|Adhesion problem|0|||
146055522|NCT01384734|526718058|FG002|Overall Study|Adhesion problem|0|||
146055523|NCT01384734|526718059|FG003|Overall Study|Adhesion problem|1|||
146111642|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111643|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111644|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111645|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111646|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111647|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111648|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
146111649|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
146111650|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111651|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
146111652|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
146111653|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111654|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111655|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111656|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111657|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111658|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111659|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146111660|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
146111661|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146111662|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
146111663|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
146111664|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111665|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111666|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146259355|NCT01196741|527463441|FG001|Overall Study|Disease progression|14|||
146259356|NCT01196741|527463440|FG000|Overall Study|Adverse Event|10|||
146259357|NCT01196741|527463441|FG001|Overall Study|Adverse Event|6|||
146259358|NCT01196741|527463440|FG000|Overall Study|Serious Adverse Event|3|||
146259359|NCT01196741|527463441|FG001|Overall Study|Serious Adverse Event|1|||
146055524|NCT01384734|526718060|FG004|Overall Study|Adhesion problem|0|||
146055525|NCT01384734|526718056|FG000|Overall Study|Early termination|0|||
146055526|NCT01384734|526718057|FG001|Overall Study|Early termination|0|||
146301570|NCT01624259|527618952|FG000|Overall Study|Withdrawal by Subject|5|||
146301571|NCT01624259|527618953|FG001|Overall Study|Withdrawal by Subject|7|||
146301572|NCT01624259|527618952|FG000|Overall Study|Physician Decision|1|||
146301573|NCT01624259|527618953|FG001|Overall Study|Physician Decision|1|||
146301574|NCT01624259|527618952|FG000|Overall Study|Lost to Follow-up|2|||
146301575|NCT01624259|527618953|FG001|Overall Study|Lost to Follow-up|3|||
146301576|NCT01624259|527618952|FG000|Overall Study|Abnormal laboratory measure|3|||
146301577|NCT01624259|527618953|FG001|Overall Study|Abnormal laboratory measure|0|||
146301578|NCT04854434|527620038|FG000|Overall Study|Death|1|||
146301579|NCT04854434|527620039|FG001|Overall Study|Death|3|||
146301580|NCT04854434|527620040|FG002|Overall Study|Death|4|||
146301581|NCT04854434|527620038|FG000|Overall Study|Study Terminated by Sponsor|2|||
146301582|NCT04854434|527620039|FG001|Overall Study|Study Terminated by Sponsor|0|||
146301583|NCT04854434|527620040|FG002|Overall Study|Study Terminated by Sponsor|0|||
146301584|NCT04854434|527620038|FG000|Overall Study|Other|1|||
146301585|NCT04854434|527620039|FG001|Overall Study|Other|1|||
146301586|NCT04854434|527620040|FG002|Overall Study|Other|0|||
146301587|NCT03349775|527620041|FG000|Overall Study|Side Effects|1|||
146301588|NCT03349775|527620042|FG001|Overall Study|Side Effects|2|||
146301589|NCT03349775|527620041|FG000|Overall Study|Withdrawal by Subject|1|||
146301590|NCT03349775|527620042|FG001|Overall Study|Withdrawal by Subject|1|||
146301591|NCT03349775|527620041|FG000|Overall Study|No primary outcome measurements|0|||
146301592|NCT03349775|527620042|FG001|Overall Study|No primary outcome measurements|1|||
146301593|NCT00791258|527620043|FG000|Overall Study|Adverse Event|87|||
146301594|NCT00791258|527620043|FG000|Overall Study|Lost to Follow-up|18|||
146301595|NCT00791258|527620043|FG000|Overall Study|Protocol Violation|109|||
146301596|NCT00791258|527620043|FG000|Overall Study|Withdrawal by Subject|40|||
146301597|NCT00791258|527620043|FG000|Overall Study|Did not take medication for >3 days|1|||
146301598|NCT00791258|527620043|FG000|Overall Study|subject left area|2|||
146301599|NCT00791258|527620043|FG000|Overall Study|non-compliance|3|||
146301600|NCT00791258|527620043|FG000|Overall Study|Subject incarcerated|1|||
146301601|NCT00791258|527620043|FG000|Overall Study|Subject required restricted medication|1|||
146301602|NCT00791258|527620043|FG000|Overall Study|Lack of Efficacy|1|||
146301603|NCT04667377|527620044|FG000|Dose Escalation Period|Other not specified below|3|||
146301604|NCT04667377|527620045|FG001|Dose Escalation Period|Other not specified below|3|||
146301605|NCT04667377|527620046|FG002|Dose Escalation Period|Other not specified below|2|||
146301606|NCT04667377|527620047|FG003|Dose Escalation Period|Other not specified below|1|||
146301607|NCT04667377|527620048|FG004|Dose Escalation Period|Other not specified below|3|||
146301608|NCT04667377|527620044|FG000|Dose Escalation Period|Protocol Violation|2|||
146301609|NCT04667377|527620045|FG001|Dose Escalation Period|Protocol Violation|2|||
146301610|NCT04667377|527620046|FG002|Dose Escalation Period|Protocol Violation|0|||
146301611|NCT04667377|527620047|FG003|Dose Escalation Period|Protocol Violation|2|||
146301612|NCT04667377|527620048|FG004|Dose Escalation Period|Protocol Violation|1|||
146301613|NCT04667377|527620044|FG000|Dose Escalation Period|Burden of study procedures|2|||
146301614|NCT04667377|527620045|FG001|Dose Escalation Period|Burden of study procedures|1|||
146301615|NCT04667377|527620046|FG002|Dose Escalation Period|Burden of study procedures|1|||
146301616|NCT04667377|527620047|FG003|Dose Escalation Period|Burden of study procedures|1|||
146301617|NCT04667377|527620048|FG004|Dose Escalation Period|Burden of study procedures|5|||
146301618|NCT04667377|527620044|FG000|Dose Escalation Period|Change of residence|0|||
146301619|NCT04667377|527620045|FG001|Dose Escalation Period|Change of residence|0|||
146301620|NCT04667377|527620046|FG002|Dose Escalation Period|Change of residence|1|||
146301621|NCT04667377|527620047|FG003|Dose Escalation Period|Change of residence|0|||
146301622|NCT04667377|527620048|FG004|Dose Escalation Period|Change of residence|0|||
146301623|NCT04667377|527620044|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
146301624|NCT04667377|527620045|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
146301625|NCT04667377|527620046|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
146301626|NCT04667377|527620047|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
146301627|NCT04667377|527620048|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
146301628|NCT04667377|527620044|FG000|Dose Escalation Period|Adverse Event|9|||
146301629|NCT04667377|527620045|FG001|Dose Escalation Period|Adverse Event|10|||
146301630|NCT04667377|527620046|FG002|Dose Escalation Period|Adverse Event|12|||
146301631|NCT04667377|527620047|FG003|Dose Escalation Period|Adverse Event|17|||
146301632|NCT04667377|527620048|FG004|Dose Escalation Period|Adverse Event|3|||
146301633|NCT04667377|527620044|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
146301634|NCT04667377|527620045|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
146301635|NCT04667377|527620046|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
146301636|NCT04667377|527620047|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
146301637|NCT04667377|527620048|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
146301638|NCT04667377|527620044|FG000|Dose Escalation Period|Not treated|1|||
146301639|NCT04667377|527620045|FG001|Dose Escalation Period|Not treated|0|||
146301640|NCT04667377|527620046|FG002|Dose Escalation Period|Not treated|0|||
146301641|NCT04667377|527620047|FG003|Dose Escalation Period|Not treated|0|||
146301642|NCT04667377|527620048|FG004|Dose Escalation Period|Not treated|0|||
146301643|NCT04667377|527620044|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
146111667|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111668|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146259360|NCT01196741|527463440|FG000|Overall Study|Dose limiting Adverse Event|2|||
146259361|NCT01196741|527463441|FG001|Overall Study|Dose limiting Adverse Event|1|||
146259362|NCT01196741|527463440|FG000|Overall Study|Withdrawal by Subject|3|||
146055527|NCT01384734|526718058|FG002|Overall Study|Early termination|0|||
146055528|NCT01384734|526718059|FG003|Overall Study|Early termination|0|||
146055529|NCT01384734|526718060|FG004|Overall Study|Early termination|1|||
146055530|NCT01384734|526718056|FG000|Overall Study|Physician Decision|1|||
146055531|NCT01384734|526718057|FG001|Overall Study|Physician Decision|0|||
146055532|NCT01384734|526718058|FG002|Overall Study|Physician Decision|0|||
146055533|NCT01384734|526718059|FG003|Overall Study|Physician Decision|0|||
146055534|NCT01384734|526718060|FG004|Overall Study|Physician Decision|0|||
146055535|NCT01300234|526718061|FG000|Overall Study|Adverse Event|1|||
146055536|NCT01300234|526718062|FG001|Overall Study|Adverse Event|1|||
146055537|NCT01300234|526718061|FG000|Overall Study|Protocol Violation|2|||
146055538|NCT01300234|526718062|FG001|Overall Study|Protocol Violation|3|||
146055539|NCT01300234|526718061|FG000|Overall Study|Withdrawal by Subject|5|||
146055540|NCT01300234|526718062|FG001|Overall Study|Withdrawal by Subject|9|||
146055541|NCT01300234|526718061|FG000|Overall Study|Lost to Follow-up|14|||
146055542|NCT01300234|526718062|FG001|Overall Study|Lost to Follow-up|12|||
146055543|NCT01300234|526718061|FG000|Overall Study|Pregnancy|2|||
146055544|NCT01300234|526718062|FG001|Overall Study|Pregnancy|1|||
146055545|NCT01300234|526718061|FG000|Overall Study|Participant reached stopping critera|2|||
146055546|NCT01300234|526718062|FG001|Overall Study|Participant reached stopping critera|0|||
146055547|NCT01300234|526718061|FG000|Overall Study|Participant stopped medication|1|||
146055548|NCT01300234|526718062|FG001|Overall Study|Participant stopped medication|1|||
146055549|NCT01300234|526718061|FG000|Overall Study|Participant refused return to hospital|1|||
146055550|NCT01300234|526718062|FG001|Overall Study|Participant refused return to hospital|0|||
146055551|NCT04158583|526718063|FG000|Overall Study|Withdrawal by Subject|1|||
146055552|NCT04158583|526718064|FG001|Overall Study|Withdrawal by Subject|1|||
146055553|NCT04158583|526718065|FG002|Overall Study|Withdrawal by Subject|0|||
146055554|NCT04158583|526718066|FG003|Overall Study|Withdrawal by Subject|0|||
146055555|NCT04158583|526718067|FG004|Overall Study|Withdrawal by Subject|1|||
146055556|NCT04158583|526718068|FG005|Overall Study|Withdrawal by Subject|0|||
146055557|NCT04158583|526718069|FG006|Overall Study|Withdrawal by Subject|0|||
146055558|NCT04158583|526718070|FG007|Overall Study|Withdrawal by Subject|0|||
146055559|NCT04158583|526718071|FG008|Overall Study|Withdrawal by Subject|2|||
146055560|NCT04158583|526718072|FG009|Overall Study|Withdrawal by Subject|0|||
146055561|NCT04158583|526718063|FG000|Overall Study|Study Terminated by Sponsor|0|||
146055562|NCT04158583|526718064|FG001|Overall Study|Study Terminated by Sponsor|0|||
146055563|NCT04158583|526718065|FG002|Overall Study|Study Terminated by Sponsor|0|||
146055564|NCT04158583|526718066|FG003|Overall Study|Study Terminated by Sponsor|1|||
146055565|NCT04158583|526718067|FG004|Overall Study|Study Terminated by Sponsor|0|||
146055566|NCT04158583|526718068|FG005|Overall Study|Study Terminated by Sponsor|0|||
146055567|NCT04158583|526718069|FG006|Overall Study|Study Terminated by Sponsor|0|||
146055568|NCT04158583|526718070|FG007|Overall Study|Study Terminated by Sponsor|0|||
146055569|NCT04158583|526718071|FG008|Overall Study|Study Terminated by Sponsor|0|||
146055570|NCT04158583|526718072|FG009|Overall Study|Study Terminated by Sponsor|0|||
146055571|NCT04158583|526718063|FG000|Overall Study|Progressive Disease|1|||
146055572|NCT04158583|526718064|FG001|Overall Study|Progressive Disease|0|||
146055573|NCT04158583|526718065|FG002|Overall Study|Progressive Disease|3|||
146055574|NCT04158583|526718066|FG003|Overall Study|Progressive Disease|5|||
146055575|NCT04158583|526718067|FG004|Overall Study|Progressive Disease|0|||
146055576|NCT04158583|526718068|FG005|Overall Study|Progressive Disease|1|||
146055577|NCT04158583|526718069|FG006|Overall Study|Progressive Disease|6|||
146055578|NCT04158583|526718070|FG007|Overall Study|Progressive Disease|2|||
146055579|NCT04158583|526718071|FG008|Overall Study|Progressive Disease|1|||
146055580|NCT04158583|526718072|FG009|Overall Study|Progressive Disease|2|||
146055581|NCT04158583|526718063|FG000|Overall Study|Lost to Follow-up|0|||
146055582|NCT04158583|526718064|FG001|Overall Study|Lost to Follow-up|0|||
146055583|NCT04158583|526718065|FG002|Overall Study|Lost to Follow-up|1|||
146055584|NCT04158583|526718066|FG003|Overall Study|Lost to Follow-up|1|||
146055585|NCT04158583|526718067|FG004|Overall Study|Lost to Follow-up|1|||
146055586|NCT04158583|526718068|FG005|Overall Study|Lost to Follow-up|0|||
146055587|NCT04158583|526718069|FG006|Overall Study|Lost to Follow-up|0|||
146055588|NCT04158583|526718070|FG007|Overall Study|Lost to Follow-up|0|||
146055589|NCT04158583|526718071|FG008|Overall Study|Lost to Follow-up|0|||
146055590|NCT04158583|526718072|FG009|Overall Study|Lost to Follow-up|0|||
146055591|NCT04158583|526718063|FG000|Overall Study|Due To Patient Status|0|||
146055592|NCT04158583|526718064|FG001|Overall Study|Due To Patient Status|0|||
146055593|NCT04158583|526718065|FG002|Overall Study|Due To Patient Status|0|||
146055594|NCT04158583|526718066|FG003|Overall Study|Due To Patient Status|0|||
146055595|NCT04158583|526718067|FG004|Overall Study|Due To Patient Status|0|||
146055596|NCT04158583|526718068|FG005|Overall Study|Due To Patient Status|0|||
146055597|NCT04158583|526718069|FG006|Overall Study|Due To Patient Status|0|||
146259363|NCT01196741|527463441|FG001|Overall Study|Withdrawal by Subject|0|||
146111669|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111670|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146259364|NCT01196741|527463440|FG000|Overall Study|Other reason|3|||
146259365|NCT01196741|527463441|FG001|Overall Study|Other reason|3|||
146259366|NCT01196741|527463440|FG000|Overall Study|Other|3|||
146259367|NCT01196741|527463441|FG001|Overall Study|Other|2|||
146259368|NCT01196741|527463440|FG000|Overall Study|Protocol Violation|2|||
146259369|NCT01196741|527463441|FG001|Overall Study|Protocol Violation|1|||
146259370|NCT01227928|527463442|FG000|Overall Study|Lost to Follow-up|4|||
146259371|NCT01227928|527463443|FG001|Overall Study|Lost to Follow-up|2|||
146259372|NCT01227928|527463442|FG000|Overall Study|Withdrawal by Subject|4|||
146259373|NCT01227928|527463443|FG001|Overall Study|Withdrawal by Subject|3|||
146259374|NCT01227928|527463442|FG000|Overall Study|Death|14|||
146259375|NCT01227928|527463443|FG001|Overall Study|Death|12|||
146259376|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
146259377|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
146259378|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
146259379|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
146259380|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
146259381|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
146259382|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
146259383|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
146259384|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
146259385|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
146259386|NCT01772823|527465173|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
146259387|NCT01772823|527465174|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
146259388|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
146259389|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
146259390|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
146259391|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
146259392|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
146259393|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
146259394|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
146259395|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
146259396|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
146259397|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
146259398|NCT01772823|527465173|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
146259399|NCT01772823|527465174|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
146259400|NCT01772823|527465173|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
146259401|NCT01772823|527465174|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
146259402|NCT01772823|527465173|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
146259403|NCT01772823|527465174|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
146259404|NCT01772823|527465173|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
146259405|NCT01772823|527465174|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
146259406|NCT01772823|527465173|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
146259407|NCT01772823|527465174|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
146259408|NCT02895360|527465179|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
146259409|NCT02895360|527465180|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146259410|NCT02895360|527465181|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146259411|NCT02895360|527465182|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146259412|NCT02895360|527465183|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146259413|NCT02895360|527465184|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
146259414|NCT02895360|527465179|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146259415|NCT02895360|527465180|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
146259416|NCT02895360|527465181|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146259417|NCT02895360|527465182|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146259418|NCT02895360|527465183|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146259419|NCT02895360|527465184|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
146259420|NCT02895360|527465179|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146259421|NCT02895360|527465180|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146259422|NCT02895360|527465181|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
146259423|NCT02895360|527465182|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146259424|NCT02895360|527465183|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146111671|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
146259425|NCT02895360|527465184|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
146259426|NCT02895360|527465179|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146111672|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
146111673|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111674|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
146111675|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111676|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111677|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111678|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111679|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111680|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111681|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111682|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111683|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
146111684|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146301644|NCT04667377|527620045|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
146055598|NCT04158583|526718070|FG007|Overall Study|Due To Patient Status|0|||
146055599|NCT04158583|526718071|FG008|Overall Study|Due To Patient Status|1|||
146055600|NCT04158583|526718072|FG009|Overall Study|Due To Patient Status|0|||
146055601|NCT04158583|526718063|FG000|Overall Study|Death|3|||
146055602|NCT04158583|526718064|FG001|Overall Study|Death|4|||
146055603|NCT04158583|526718065|FG002|Overall Study|Death|2|||
146055604|NCT04158583|526718066|FG003|Overall Study|Death|2|||
146055605|NCT04158583|526718067|FG004|Overall Study|Death|4|||
146055606|NCT04158583|526718068|FG005|Overall Study|Death|3|||
146055607|NCT04158583|526718069|FG006|Overall Study|Death|5|||
146055608|NCT04158583|526718070|FG007|Overall Study|Death|2|||
146055609|NCT04158583|526718071|FG008|Overall Study|Death|0|||
146055610|NCT04158583|526718072|FG009|Overall Study|Death|1|||
146055611|NCT04158583|526718063|FG000|Overall Study|Clinical Progression Disease|0|||
146055612|NCT04158583|526718064|FG001|Overall Study|Clinical Progression Disease|0|||
146055613|NCT04158583|526718065|FG002|Overall Study|Clinical Progression Disease|0|||
146055614|NCT04158583|526718066|FG003|Overall Study|Clinical Progression Disease|1|||
146055615|NCT04158583|526718067|FG004|Overall Study|Clinical Progression Disease|0|||
146055616|NCT04158583|526718068|FG005|Overall Study|Clinical Progression Disease|0|||
146055617|NCT04158583|526718069|FG006|Overall Study|Clinical Progression Disease|0|||
146055618|NCT04158583|526718070|FG007|Overall Study|Clinical Progression Disease|0|||
146055619|NCT04158583|526718071|FG008|Overall Study|Clinical Progression Disease|0|||
146055620|NCT04158583|526718072|FG009|Overall Study|Clinical Progression Disease|0|||
146055621|NCT04158583|526718063|FG000|Overall Study|Clinical Progression|0|||
146055622|NCT04158583|526718064|FG001|Overall Study|Clinical Progression|0|||
146055623|NCT04158583|526718065|FG002|Overall Study|Clinical Progression|0|||
146055624|NCT04158583|526718066|FG003|Overall Study|Clinical Progression|0|||
146055625|NCT04158583|526718067|FG004|Overall Study|Clinical Progression|1|||
146055626|NCT04158583|526718068|FG005|Overall Study|Clinical Progression|0|||
146055627|NCT04158583|526718069|FG006|Overall Study|Clinical Progression|2|||
146055628|NCT04158583|526718070|FG007|Overall Study|Clinical Progression|0|||
146055629|NCT04158583|526718071|FG008|Overall Study|Clinical Progression|0|||
146055630|NCT04158583|526718072|FG009|Overall Study|Clinical Progression|0|||
146055631|NCT04158583|526718063|FG000|Overall Study|Clinical Deterioration|0|||
146055632|NCT04158583|526718064|FG001|Overall Study|Clinical Deterioration|0|||
146055633|NCT04158583|526718065|FG002|Overall Study|Clinical Deterioration|0|||
146055634|NCT04158583|526718066|FG003|Overall Study|Clinical Deterioration|1|||
146055635|NCT04158583|526718067|FG004|Overall Study|Clinical Deterioration|0|||
146055636|NCT04158583|526718068|FG005|Overall Study|Clinical Deterioration|0|||
146055637|NCT04158583|526718069|FG006|Overall Study|Clinical Deterioration|0|||
146055638|NCT04158583|526718070|FG007|Overall Study|Clinical Deterioration|0|||
146055639|NCT04158583|526718071|FG008|Overall Study|Clinical Deterioration|0|||
146055640|NCT04158583|526718072|FG009|Overall Study|Clinical Deterioration|1|||
146055641|NCT00948064|526719456|FG000|Phase I|No treatment received|1|||
146055642|NCT00948064|526719457|FG001|Phase I|No treatment received|0|||
146055643|NCT00948064|526719458|FG002|Phase I|No treatment received|0|||
146055644|NCT00948064|526719456|FG000|Phase II|Physician Decision|0|||
146055645|NCT00948064|526719457|FG001|Phase II|Physician Decision|0|||
146055646|NCT00948064|526719458|FG002|Phase II|Physician Decision|1|||
146055647|NCT00948064|526719456|FG000|Phase II|Withdrawal by Subject|0|||
146055648|NCT00948064|526719457|FG001|Phase II|Withdrawal by Subject|1|||
146055649|NCT00948064|526719458|FG002|Phase II|Withdrawal by Subject|0|||
146055650|NCT00644423|526719460|FG000|Overall Study|Lost to Follow-up|1|||
146055651|NCT00644423|526719461|FG001|Overall Study|Lost to Follow-up|1|||
146055652|NCT03096834|526719462|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
146055653|NCT03096834|526719463|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
146055654|NCT03096834|526719464|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
146055655|NCT03096834|526719465|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
146055656|NCT03096834|526719462|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
146055657|NCT03096834|526719463|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
146055658|NCT03096834|526719464|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
146111685|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
146111686|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111687|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111688|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111689|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111690|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111691|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111692|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111693|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
146111694|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111695|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111696|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
146111697|NCT02207244|526927500|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111698|NCT02207244|526927501|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111699|NCT02207244|526927502|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111700|NCT02207244|526927503|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111701|NCT02207244|526927504|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111702|NCT02207244|526927505|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111703|NCT02207244|526927506|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
146111704|NCT02207244|526927507|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111705|NCT02207244|526927508|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111706|NCT02207244|526927509|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111707|NCT02207244|526927510|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
146111708|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111709|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111710|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111711|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111712|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111713|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111714|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111715|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111716|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
146111717|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
146111718|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
146111719|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111720|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111721|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111722|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111723|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111724|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111725|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111726|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111727|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
146111728|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
146111729|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
146111730|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111731|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111732|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111733|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111734|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111735|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111736|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111737|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111738|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
146111739|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
146111740|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
146111741|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111742|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111743|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111744|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111745|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111746|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146259427|NCT02895360|527465180|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146259428|NCT02895360|527465181|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
146111747|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111748|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111749|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
146111750|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
146111751|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
146111752|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
146111753|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
146111754|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
146111755|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
146111756|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
146111757|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
146111758|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
146111759|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
146111760|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
146111761|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
146111762|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
146111763|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
146111764|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
146111765|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
146111766|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
146111767|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
146111768|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
146111769|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
146111770|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
146111771|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
146111772|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
146111773|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
146111774|NCT02207244|526927500|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111775|NCT02207244|526927501|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111776|NCT02207244|526927502|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111777|NCT02207244|526927503|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111778|NCT02207244|526927504|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111779|NCT02207244|526927505|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111780|NCT02207244|526927506|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111781|NCT02207244|526927507|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146111782|NCT02207244|526927508|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146259429|NCT02895360|527465182|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146259430|NCT02895360|527465183|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146259431|NCT02895360|527465184|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
146259432|NCT02895360|527465179|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146259433|NCT02895360|527465180|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146259434|NCT02895360|527465181|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146259435|NCT02895360|527465182|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
146259436|NCT02895360|527465183|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146259437|NCT02895360|527465184|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
146259438|NCT02895360|527465179|FG000|Phase 2a|Adverse Event|0|||
146259439|NCT02895360|527465180|FG001|Phase 2a|Adverse Event|0|||
146259440|NCT02895360|527465181|FG002|Phase 2a|Adverse Event|0|||
146259441|NCT02895360|527465182|FG003|Phase 2a|Adverse Event|0|||
146259442|NCT02895360|527465183|FG004|Phase 2a|Adverse Event|0|||
146259443|NCT02895360|527465184|FG005|Phase 2a|Adverse Event|1|||
146259444|NCT02895360|527465179|FG000|Phase 2a|Progressive disease|0|||
146259445|NCT02895360|527465180|FG001|Phase 2a|Progressive disease|0|||
146259446|NCT02895360|527465181|FG002|Phase 2a|Progressive disease|0|||
146259447|NCT02895360|527465182|FG003|Phase 2a|Progressive disease|0|||
146259448|NCT02895360|527465183|FG004|Phase 2a|Progressive disease|11|||
146259449|NCT02895360|527465184|FG005|Phase 2a|Progressive disease|11|||
146259450|NCT01732926|527465186|FG000|Overall Study|Study Terminated by Sponsor|168|||
146259451|NCT01732926|527465187|FG001|Overall Study|Study Terminated by Sponsor|80|||
146259452|NCT01732926|527465186|FG000|Overall Study|Withdrawal by Subject|46|||
146259453|NCT01732926|527465187|FG001|Overall Study|Withdrawal by Subject|8|||
146259454|NCT01732926|527465186|FG000|Overall Study|Physician Decision|24|||
146259455|NCT01732926|527465187|FG001|Overall Study|Physician Decision|11|||
146259456|NCT01732926|527465186|FG000|Overall Study|Other Reason|21|||
146259457|NCT01732926|527465187|FG001|Overall Study|Other Reason|4|||
146259458|NCT01732926|527465186|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
146259459|NCT01732926|527465187|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
146301645|NCT04667377|527620046|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
146111783|NCT02207244|526927509|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
146259460|NCT01732926|527465186|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
146259461|NCT01732926|527465187|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
146259462|NCT02262364|527465192|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
146259463|NCT00337285|527465195|FG000|Overall Study|Withdrawal by Subject|42|||
146259464|NCT00337285|527465195|FG000|Overall Study|Lost to Follow-up|41|||
146111784|NCT02207244|526927510|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
146111785|NCT02144012|526927513|FG000|Overall Study|Adverse Event|1|||
146111786|NCT02144012|526927514|FG001|Overall Study|Adverse Event|0|||
146111787|NCT02144012|526927513|FG000|Overall Study|Death|1|||
146111788|NCT02144012|526927514|FG001|Overall Study|Death|0|||
146111789|NCT02144012|526927513|FG000|Overall Study|Withdrawal by Subject|11|||
146111790|NCT02144012|526927514|FG001|Overall Study|Withdrawal by Subject|3|||
146111791|NCT02144012|526927513|FG000|Overall Study|Study Terminated by Sponsor|18|||
146111792|NCT02144012|526927514|FG001|Overall Study|Study Terminated by Sponsor|12|||
146111793|NCT02144012|526927513|FG000|Overall Study|Other|3|||
146111794|NCT02144012|526927514|FG001|Overall Study|Other|0|||
146111795|NCT02846779|526927517|FG000|Overall Study|Lost Enrollment|83|||
146111796|NCT02846779|526927518|FG001|Overall Study|Lost Enrollment|82|||
146111797|NCT02846779|526927519|FG002|Overall Study|Lost Enrollment|86|||
146111798|NCT02846779|526927517|FG000|Overall Study|Less than 31 days of follow-up|56|||
146111799|NCT02846779|526927518|FG001|Overall Study|Less than 31 days of follow-up|45|||
146111800|NCT02846779|526927519|FG002|Overall Study|Less than 31 days of follow-up|52|||
146111801|NCT00887978|526927522|FG000|Overall Study|Adverse Event|18|||
146111802|NCT00887978|526927523|FG001|Overall Study|Adverse Event|5|||
146111803|NCT00887978|526927522|FG000|Overall Study|Clinical Worsening|4|||
146111804|NCT00887978|526927523|FG001|Overall Study|Clinical Worsening|4|||
146111805|NCT00887978|526927522|FG000|Overall Study|Death|2|||
146111806|NCT00887978|526927523|FG001|Overall Study|Death|3|||
146111807|NCT00887978|526927522|FG000|Overall Study|Withdrawal by Subject|1|||
146111808|NCT00887978|526927523|FG001|Overall Study|Withdrawal by Subject|2|||
146111809|NCT00887978|526927522|FG000|Overall Study|Lost to Follow-up|0|||
146111810|NCT00887978|526927523|FG001|Overall Study|Lost to Follow-up|1|||
146111811|NCT00911820|526928923|FG000|Overall Study|RECIST progression|12|||
146111812|NCT00911820|526928924|FG001|Overall Study|RECIST progression|8|||
146111813|NCT00911820|526928923|FG000|Overall Study|Adverse Event|8|||
146111814|NCT00911820|526928924|FG001|Overall Study|Adverse Event|8|||
146111815|NCT00911820|526928923|FG000|Overall Study|Clinical Progression|7|||
146111816|NCT00911820|526928924|FG001|Overall Study|Clinical Progression|5|||
146111817|NCT00911820|526928923|FG000|Overall Study|Physician Decision|5|||
146111818|NCT00911820|526928924|FG001|Overall Study|Physician Decision|9|||
146111819|NCT00911820|526928923|FG000|Overall Study|Decline in Performance Status|4|||
146111820|NCT00911820|526928924|FG001|Overall Study|Decline in Performance Status|2|||
146111821|NCT00911820|526928923|FG000|Overall Study|Withdrawal by Subject|3|||
146111822|NCT00911820|526928924|FG001|Overall Study|Withdrawal by Subject|4|||
146111823|NCT00911820|526928923|FG000|Overall Study|Death|1|||
146111824|NCT00911820|526928924|FG001|Overall Study|Death|2|||
146111825|NCT00911820|526928923|FG000|Overall Study|Pursue surgery|1|||
146111826|NCT00911820|526928924|FG001|Overall Study|Pursue surgery|1|||
146111827|NCT00911820|526928923|FG000|Overall Study|Pursue Radiation|1|||
146111828|NCT00911820|526928924|FG001|Overall Study|Pursue Radiation|0|||
146111829|NCT00911820|526928923|FG000|Overall Study|Still on Therapy|2|||
146111830|NCT00911820|526928924|FG001|Overall Study|Still on Therapy|2|||
146111831|NCT00911820|526928923|FG000|Overall Study|Pathology Not Confirmed|1|||
146111832|NCT00911820|526928924|FG001|Overall Study|Pathology Not Confirmed|0|||
146111833|NCT00911820|526928923|FG000|Overall Study|Withdraw before Receive Treatment|0|||
146111834|NCT00911820|526928924|FG001|Overall Study|Withdraw before Receive Treatment|2|||
146111835|NCT00963547|526928931|FG000|Overall Study|Adverse Event|0|||
146111836|NCT00963547|526928932|FG001|Overall Study|Adverse Event|1|||
146111837|NCT00963547|526928933|FG002|Overall Study|Adverse Event|0|||
146111838|NCT00963547|526928934|FG003|Overall Study|Adverse Event|1|||
146111839|NCT00963547|526928935|FG004|Overall Study|Adverse Event|0|||
146111840|NCT00963547|526928936|FG005|Overall Study|Adverse Event|0|||
146111841|NCT00963547|526928937|FG006|Overall Study|Adverse Event|0|||
146111842|NCT00963547|526928931|FG000|Overall Study|Physician Decision|1|||
146111843|NCT00963547|526928932|FG001|Overall Study|Physician Decision|1|||
146111844|NCT00963547|526928933|FG002|Overall Study|Physician Decision|0|||
146111845|NCT00963547|526928934|FG003|Overall Study|Physician Decision|0|||
146111846|NCT00963547|526928935|FG004|Overall Study|Physician Decision|0|||
146111847|NCT00963547|526928936|FG005|Overall Study|Physician Decision|0|||
146111848|NCT00963547|526928937|FG006|Overall Study|Physician Decision|0|||
146111849|NCT00963547|526928931|FG000|Overall Study|Progressive Disease|3|||
146111850|NCT00963547|526928932|FG001|Overall Study|Progressive Disease|8|||
146259465|NCT00337285|527465195|FG000|Overall Study|Adverse Event|28|||
146111851|NCT00963547|526928933|FG002|Overall Study|Progressive Disease|9|||
146111852|NCT00963547|526928934|FG003|Overall Study|Progressive Disease|5|||
146111853|NCT00963547|526928935|FG004|Overall Study|Progressive Disease|0|||
146111854|NCT00963547|526928936|FG005|Overall Study|Progressive Disease|0|||
146111855|NCT00963547|526928937|FG006|Overall Study|Progressive Disease|0|||
146111856|NCT00963547|526928931|FG000|Overall Study|Withdrawal by Subject|0|||
146111857|NCT00963547|526928932|FG001|Overall Study|Withdrawal by Subject|0|||
146111858|NCT00963547|526928933|FG002|Overall Study|Withdrawal by Subject|3|||
146111859|NCT00963547|526928934|FG003|Overall Study|Withdrawal by Subject|0|||
146111860|NCT00963547|526928935|FG004|Overall Study|Withdrawal by Subject|0|||
146111861|NCT00963547|526928936|FG005|Overall Study|Withdrawal by Subject|0|||
146301646|NCT04667377|527620047|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
146301647|NCT04667377|527620048|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
146301648|NCT04667377|527620044|FG000|Dose Escalation Period|Lost to Follow-up|0|||
146301649|NCT04667377|527620045|FG001|Dose Escalation Period|Lost to Follow-up|1|||
146301650|NCT04667377|527620046|FG002|Dose Escalation Period|Lost to Follow-up|0|||
146301651|NCT04667377|527620047|FG003|Dose Escalation Period|Lost to Follow-up|0|||
146301652|NCT04667377|527620048|FG004|Dose Escalation Period|Lost to Follow-up|0|||
146301653|NCT04667377|527620044|FG000|Maintenance Period|Perceived lack of efficacy|0|||
146301654|NCT04667377|527620045|FG001|Maintenance Period|Perceived lack of efficacy|2|||
146301655|NCT04667377|527620046|FG002|Maintenance Period|Perceived lack of efficacy|1|||
146301656|NCT04667377|527620047|FG003|Maintenance Period|Perceived lack of efficacy|0|||
146301657|NCT04667377|527620048|FG004|Maintenance Period|Perceived lack of efficacy|1|||
146301658|NCT04667377|527620044|FG000|Maintenance Period|Adverse Event|2|||
146301659|NCT04667377|527620045|FG001|Maintenance Period|Adverse Event|8|||
146301660|NCT04667377|527620046|FG002|Maintenance Period|Adverse Event|5|||
146301661|NCT04667377|527620047|FG003|Maintenance Period|Adverse Event|4|||
146301662|NCT04667377|527620048|FG004|Maintenance Period|Adverse Event|1|||
146301663|NCT04667377|527620044|FG000|Maintenance Period|Adverse event: COVID infection|0|||
146301664|NCT04667377|527620045|FG001|Maintenance Period|Adverse event: COVID infection|1|||
146301665|NCT04667377|527620046|FG002|Maintenance Period|Adverse event: COVID infection|0|||
146301666|NCT04667377|527620047|FG003|Maintenance Period|Adverse event: COVID infection|0|||
146301667|NCT04667377|527620048|FG004|Maintenance Period|Adverse event: COVID infection|0|||
146301668|NCT04667377|527620044|FG000|Maintenance Period|COVID-related|0|||
146301669|NCT04667377|527620045|FG001|Maintenance Period|COVID-related|0|||
146301670|NCT04667377|527620046|FG002|Maintenance Period|COVID-related|1|||
146301671|NCT04667377|527620047|FG003|Maintenance Period|COVID-related|1|||
146301672|NCT04667377|527620048|FG004|Maintenance Period|COVID-related|0|||
146301673|NCT04667377|527620044|FG000|Maintenance Period|Protocol Violation|1|||
146301674|NCT04667377|527620045|FG001|Maintenance Period|Protocol Violation|0|||
146301675|NCT04667377|527620046|FG002|Maintenance Period|Protocol Violation|0|||
146301676|NCT04667377|527620047|FG003|Maintenance Period|Protocol Violation|0|||
146301677|NCT04667377|527620048|FG004|Maintenance Period|Protocol Violation|1|||
146301678|NCT04667377|527620044|FG000|Maintenance Period|Burden of study procedures|1|||
146301679|NCT04667377|527620045|FG001|Maintenance Period|Burden of study procedures|2|||
146301680|NCT04667377|527620046|FG002|Maintenance Period|Burden of study procedures|0|||
146301681|NCT04667377|527620047|FG003|Maintenance Period|Burden of study procedures|1|||
146301682|NCT04667377|527620048|FG004|Maintenance Period|Burden of study procedures|0|||
146301683|NCT04667377|527620044|FG000|Maintenance Period|Change of residence|0|||
146301684|NCT04667377|527620045|FG001|Maintenance Period|Change of residence|1|||
146301685|NCT04667377|527620046|FG002|Maintenance Period|Change of residence|0|||
146301686|NCT04667377|527620047|FG003|Maintenance Period|Change of residence|0|||
146301687|NCT04667377|527620048|FG004|Maintenance Period|Change of residence|1|||
146301688|NCT04667377|527620044|FG000|Maintenance Period|Missing|1|||
146301689|NCT04667377|527620045|FG001|Maintenance Period|Missing|0|||
146301690|NCT04667377|527620046|FG002|Maintenance Period|Missing|0|||
146301691|NCT04667377|527620047|FG003|Maintenance Period|Missing|0|||
146301692|NCT04667377|527620048|FG004|Maintenance Period|Missing|0|||
146301693|NCT04667377|527620044|FG000|Maintenance Period|Other than listed above|2|||
146301694|NCT04667377|527620045|FG001|Maintenance Period|Other than listed above|0|||
146301695|NCT04667377|527620046|FG002|Maintenance Period|Other than listed above|3|||
146301696|NCT04667377|527620047|FG003|Maintenance Period|Other than listed above|2|||
146301697|NCT04667377|527620048|FG004|Maintenance Period|Other than listed above|6|||
146301698|NCT04667377|527620044|FG000|Maintenance Period|Withdrawal by Subject|0|||
146301699|NCT04667377|527620045|FG001|Maintenance Period|Withdrawal by Subject|1|||
146301700|NCT04667377|527620046|FG002|Maintenance Period|Withdrawal by Subject|0|||
146301701|NCT04667377|527620047|FG003|Maintenance Period|Withdrawal by Subject|0|||
146301702|NCT04667377|527620048|FG004|Maintenance Period|Withdrawal by Subject|0|||
146301703|NCT04667377|527620044|FG000|Maintenance Period|Lost to Follow-up|1|||
146301704|NCT04667377|527620045|FG001|Maintenance Period|Lost to Follow-up|0|||
146111862|NCT00963547|526928937|FG006|Overall Study|Withdrawal by Subject|0|||
146111863|NCT00963547|526928931|FG000|Overall Study|Reason Unknown|0|||
146111864|NCT00963547|526928932|FG001|Overall Study|Reason Unknown|1|||
146111865|NCT00963547|526928933|FG002|Overall Study|Reason Unknown|0|||
146111866|NCT00963547|526928934|FG003|Overall Study|Reason Unknown|0|||
146301705|NCT04667377|527620046|FG002|Maintenance Period|Lost to Follow-up|1|||
146301706|NCT04667377|527620047|FG003|Maintenance Period|Lost to Follow-up|0|||
146301707|NCT04667377|527620048|FG004|Maintenance Period|Lost to Follow-up|1|||
146301708|NCT05215262|527620049|FG000|Overall Study|Lost to Follow-up|12|||
146111867|NCT00963547|526928935|FG004|Overall Study|Reason Unknown|0|||
146111868|NCT00963547|526928936|FG005|Overall Study|Reason Unknown|0|||
146301709|NCT05215262|527620050|FG001|Overall Study|Lost to Follow-up|0|||
146111869|NCT00963547|526928937|FG006|Overall Study|Reason Unknown|0|||
146301710|NCT00239226|527620052|FG000|Overall Study|permAF during stabilization period|0|||
146301711|NCT00239226|527620053|FG001|Overall Study|permAF during stabilization period|0|||
146301712|NCT00239226|527620054|FG002|Overall Study|permAF during stabilization period|0|||
146055659|NCT03096834|526719465|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
146055660|NCT03096834|526719462|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
146055661|NCT03096834|526719463|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
146055662|NCT03096834|526719464|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
146055663|NCT03096834|526719465|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
146055664|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
146055665|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
146055666|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
146055667|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
146055668|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
146055669|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
146055670|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
146055671|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
146055672|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
146055673|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
146055674|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
146055675|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
146055676|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
146055677|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
146055678|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
146055679|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
146055680|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
146055681|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
146055682|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
146055683|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
146055684|NCT03096834|526719462|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
146055685|NCT03096834|526719463|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
146055686|NCT03096834|526719464|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
146055687|NCT03096834|526719465|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
146055688|NCT03096834|526719462|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
146055689|NCT03096834|526719463|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
146055690|NCT03096834|526719464|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
146055691|NCT03096834|526719465|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
146055692|NCT03096834|526719462|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
146055693|NCT03096834|526719463|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
146055694|NCT03096834|526719464|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
146055695|NCT03096834|526719465|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
146055696|NCT03096834|526719462|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146055697|NCT03096834|526719463|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146055698|NCT03096834|526719464|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
146055699|NCT03096834|526719465|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
146055700|NCT04233801|526719470|FG000|Overall Study|Other than listed|0|||
146055701|NCT04233801|526719471|FG001|Overall Study|Other than listed|0|||
146055702|NCT04233801|526719472|FG002|Overall Study|Other than listed|1|||
146055703|NCT04233801|526719470|FG000|Overall Study|Withdrawal by Subject|0|||
146055704|NCT04233801|526719471|FG001|Overall Study|Withdrawal by Subject|2|||
146055705|NCT04233801|526719472|FG002|Overall Study|Withdrawal by Subject|3|||
146055706|NCT00762359|526719473|FG000|Overall Study|Adverse Event|20|||
146055707|NCT00762359|526719474|FG001|Overall Study|Adverse Event|23|||
146055708|NCT00762359|526719473|FG000|Overall Study|Protocol Violation|21|||
146055709|NCT00762359|526719474|FG001|Overall Study|Protocol Violation|13|||
146055710|NCT00762359|526719473|FG000|Overall Study|Withdrawal by Subject|13|||
146055711|NCT00762359|526719474|FG001|Overall Study|Withdrawal by Subject|10|||
146055712|NCT00762359|526719473|FG000|Overall Study|Lack of Efficacy|0|||
146055713|NCT00762359|526719474|FG001|Overall Study|Lack of Efficacy|4|||
146055714|NCT00762359|526719473|FG000|Overall Study|Institution closed|2|||
146055715|NCT00762359|526719474|FG001|Overall Study|Institution closed|3|||
146055716|NCT00762359|526719473|FG000|Overall Study|Physician Decision|2|||
146055717|NCT00762359|526719474|FG001|Overall Study|Physician Decision|3|||
146055718|NCT00762359|526719473|FG000|Overall Study|Removal|0|||
146055719|NCT00762359|526719474|FG001|Overall Study|Removal|1|||
146055720|NCT00762359|526719473|FG000|Overall Study|Withdrew consent|1|||
146055721|NCT00762359|526719474|FG001|Overall Study|Withdrew consent|0|||
146055722|NCT01690052|526719479|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
146055723|NCT01690052|526719480|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
146055724|NCT02421172|526719481|FG000|Period 1|Adverse Event|1|||
146055725|NCT02421172|526719482|FG001|Period 1|Adverse Event|0|||
146055726|NCT02421172|526719483|FG002|Period 1|Adverse Event|0|||
146055727|NCT02421172|526719484|FG003|Period 1|Adverse Event|0|||
146055728|NCT02421172|526719485|FG004|Period 1|Adverse Event|0|||
146055729|NCT02421172|526719481|FG000|Period 1|Lost to Follow-up|3|||
146055730|NCT02421172|526719482|FG001|Period 1|Lost to Follow-up|1|||
146055731|NCT02421172|526719483|FG002|Period 1|Lost to Follow-up|0|||
146055732|NCT02421172|526719484|FG003|Period 1|Lost to Follow-up|0|||
146111870|NCT00759031|526928938|FG000|First Intervention (1 Day)|Physician Decision|1|||
146111871|NCT00759031|526928939|FG001|First Intervention (1 Day)|Physician Decision|0|||
146111872|NCT00759031|526928938|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146111873|NCT00759031|526928939|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146111874|NCT00759031|526928938|FG000|First Intervention (1 Day)|Screening failure|1|||
146111875|NCT00759031|526928939|FG001|First Intervention (1 Day)|Screening failure|0|||
146111876|NCT02430311|526928940|FG000|Part A|Adverse Event|0|||
146111877|NCT02430311|526928941|FG001|Part A|Adverse Event|1|||
146111878|NCT02430311|526928940|FG000|Part A|Withdrawal by Subject|1|||
146111879|NCT02430311|526928941|FG001|Part A|Withdrawal by Subject|0|||
146111880|NCT02430311|526928940|FG000|Part B|Meet study-specific withdrawal criteria|6|||
146111881|NCT02430311|526928941|FG001|Part B|Meet study-specific withdrawal criteria|6|||
146111882|NCT02430311|526928940|FG000|Part B|Withdrawal by Subject|2|||
146111883|NCT02430311|526928941|FG001|Part B|Withdrawal by Subject|2|||
146111884|NCT02430311|526928940|FG000|Part B|Adverse Event|1|||
146111885|NCT02430311|526928941|FG001|Part B|Adverse Event|0|||
146111886|NCT02430311|526928940|FG000|Part B|Death|1|||
146111887|NCT02430311|526928941|FG001|Part B|Death|0|||
146111888|NCT00309387|526928942|FG000|Overall Study|Death|72|||
146111889|NCT00309387|526928943|FG001|Overall Study|Death|73|||
146111890|NCT00309387|526928942|FG000|Overall Study|Lost to Follow-up|70|||
146111891|NCT00309387|526928943|FG001|Overall Study|Lost to Follow-up|86|||
146111892|NCT01342796|526928944|FG000|Overall Study|Withdrawal by Subject|2|||
146111893|NCT01342796|526928945|FG001|Overall Study|Withdrawal by Subject|0|||
146111894|NCT01342796|526928944|FG000|Overall Study|Lost to Follow-up|0|||
146111895|NCT01342796|526928945|FG001|Overall Study|Lost to Follow-up|3|||
146111896|NCT01342796|526928944|FG000|Overall Study|Inappropriate enrollment|1|||
146111897|NCT01342796|526928945|FG001|Overall Study|Inappropriate enrollment|0|||
146111898|NCT01599234|526928946|FG000|Overall Study|Adverse Event|9|||
146111899|NCT01599234|526928947|FG001|Overall Study|Adverse Event|5|||
146111900|NCT01599234|526928946|FG000|Overall Study|Withdrawal by Subject|2|||
146111901|NCT01599234|526928947|FG001|Overall Study|Withdrawal by Subject|1|||
146111902|NCT01599234|526928946|FG000|Overall Study|Lost to Follow-up|1|||
146111903|NCT01599234|526928947|FG001|Overall Study|Lost to Follow-up|2|||
146111904|NCT01599234|526928946|FG000|Overall Study|Lack of Efficacy|2|||
146111905|NCT01599234|526928947|FG001|Overall Study|Lack of Efficacy|4|||
146111906|NCT01599234|526928946|FG000|Overall Study|Unable to operate spray|1|||
146111907|NCT01599234|526928947|FG001|Overall Study|Unable to operate spray|0|||
146111908|NCT01599234|526928946|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
146111909|NCT01599234|526928947|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
146111910|NCT01599234|526928946|FG000|Overall Study|Death|1|||
146111911|NCT01599234|526928947|FG001|Overall Study|Death|0|||
146111912|NCT01599234|526928946|FG000|Overall Study|Patient would not stop driving|1|||
146111913|NCT01599234|526928947|FG001|Overall Study|Patient would not stop driving|0|||
146111914|NCT01599234|526928946|FG000|Overall Study|Contra-indication discovered|0|||
146111915|NCT01599234|526928947|FG001|Overall Study|Contra-indication discovered|1|||
146111916|NCT01599234|526928946|FG000|Overall Study|Pregnancy|0|||
146111917|NCT01599234|526928947|FG001|Overall Study|Pregnancy|1|||
146111918|NCT04492618|526928950|FG000|Overall Study|Withdrawal by Subject|1|||
146111919|NCT03489720|526928951|FG000|Overall Study|Withdrawal by Subject|2|||
146111920|NCT03489720|526928952|FG001|Overall Study|Withdrawal by Subject|0|||
146111921|NCT00085631|526928959|FG000|Overall Study|Missing Data|4|||
146111922|NCT00085631|526928960|FG001|Overall Study|Missing Data|11|||
146111923|NCT00085631|526928961|FG002|Overall Study|Missing Data|7|||
146111924|NCT03902574|526928962|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
146111925|NCT03902574|526928963|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
146111926|NCT03902574|526928964|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
146111927|NCT01987505|526928976|FG000|Overall Study|Other|9|||
146111928|NCT01987505|526928976|FG000|Overall Study|Withdrawal by Subject|2|||
146111929|NCT01987505|526928976|FG000|Overall Study|Other Reason|2|||
146111930|NCT01987505|526928976|FG000|Overall Study|Lost to Follow-up|15|||
146111931|NCT01987505|526928976|FG000|Overall Study|Investigator Decision|2|||
146111932|NCT01987505|526928976|FG000|Overall Study|Death|4|||
146111933|NCT01425281|526928977|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
146111934|NCT01425281|526928978|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
146111935|NCT01425281|526928977|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
146111936|NCT01425281|526928978|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
146111937|NCT01425281|526928977|FG000|At 180-day Clinical Follow-up|Death|0|||
146111938|NCT01425281|526928978|FG001|At 180-day Clinical Follow-up|Death|1|||
146111939|NCT01425281|526928977|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
146111940|NCT01425281|526928978|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
146111941|NCT01425281|526928977|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
146111942|NCT01425281|526928978|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
146111943|NCT01425281|526928977|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
146111944|NCT01425281|526928978|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
146111945|NCT01425281|526928977|FG000|At 2-year Clinical Follow-up|Death|2|||
146301713|NCT00239226|527620055|FG003|Overall Study|permAF during stabilization period|3|||
146301714|NCT00239226|527620052|FG000|Overall Study|Lost to Follow-up|1|||
146301715|NCT00239226|527620053|FG001|Overall Study|Lost to Follow-up|0|||
146055733|NCT02421172|526719485|FG004|Period 1|Lost to Follow-up|0|||
146055734|NCT02421172|526719481|FG000|Period 1|Patient/guardian decision|0|||
146055735|NCT02421172|526719482|FG001|Period 1|Patient/guardian decision|1|||
146055736|NCT02421172|526719483|FG002|Period 1|Patient/guardian decision|0|||
146055737|NCT02421172|526719484|FG003|Period 1|Patient/guardian decision|0|||
146055738|NCT02421172|526719485|FG004|Period 1|Patient/guardian decision|0|||
146055739|NCT02421172|526719481|FG000|Period 2|Adverse Event|0|||
146055740|NCT02421172|526719482|FG001|Period 2|Adverse Event|0|||
146055741|NCT02421172|526719483|FG002|Period 2|Adverse Event|4|||
146055742|NCT02421172|526719484|FG003|Period 2|Adverse Event|0|||
146055743|NCT02421172|526719485|FG004|Period 2|Adverse Event|0|||
146055744|NCT02421172|526719481|FG000|Period 2|Lost to Follow-up|0|||
146055745|NCT02421172|526719482|FG001|Period 2|Lost to Follow-up|0|||
146055746|NCT02421172|526719483|FG002|Period 2|Lost to Follow-up|0|||
146055747|NCT02421172|526719484|FG003|Period 2|Lost to Follow-up|1|||
146055748|NCT02421172|526719485|FG004|Period 2|Lost to Follow-up|0|||
146055749|NCT02421172|526719481|FG000|Period 2|Patient/guardian decision|0|||
146055750|NCT02421172|526719482|FG001|Period 2|Patient/guardian decision|0|||
146055751|NCT02421172|526719483|FG002|Period 2|Patient/guardian decision|3|||
146055752|NCT02421172|526719484|FG003|Period 2|Patient/guardian decision|2|||
146055753|NCT02421172|526719485|FG004|Period 2|Patient/guardian decision|1|||
146055754|NCT00928486|526719486|FG000|Overall Study|Adverse Event|2|||
146055755|NCT00928486|526719486|FG000|Overall Study|Disease Progression|7|||
146055756|NCT00928486|526719486|FG000|Overall Study|Withdrawal by Subject|1|||
146055757|NCT00683878|526719491|FG000|Overall Study|Lack of Efficacy|3|||
146055758|NCT00683878|526719492|FG001|Overall Study|Lack of Efficacy|0|||
146055759|NCT00683878|526719493|FG002|Overall Study|Lack of Efficacy|1|||
146055760|NCT00683878|526719491|FG000|Overall Study|Adverse Event|4|||
146055761|NCT00683878|526719492|FG001|Overall Study|Adverse Event|3|||
146055762|NCT00683878|526719493|FG002|Overall Study|Adverse Event|3|||
146055763|NCT00683878|526719491|FG000|Overall Study|Withdrawal by Subject|9|||
146055764|NCT00683878|526719492|FG001|Overall Study|Withdrawal by Subject|8|||
146055765|NCT00683878|526719493|FG002|Overall Study|Withdrawal by Subject|6|||
146055766|NCT00683878|526719491|FG000|Overall Study|Death|0|||
146055767|NCT00683878|526719492|FG001|Overall Study|Death|1|||
146055768|NCT00683878|526719493|FG002|Overall Study|Death|0|||
146055769|NCT00683878|526719491|FG000|Overall Study|Lost to Follow-up|4|||
146055770|NCT00683878|526719492|FG001|Overall Study|Lost to Follow-up|2|||
146055771|NCT00683878|526719493|FG002|Overall Study|Lost to Follow-up|4|||
146055772|NCT00683878|526719491|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
146055773|NCT00683878|526719492|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
146055774|NCT00683878|526719493|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
146055775|NCT02891174|526719515|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
146055776|NCT02891174|526719516|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
146055777|NCT02891174|526719515|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
146055778|NCT02891174|526719516|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
146055779|NCT02891174|526719515|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
146055780|NCT02891174|526719516|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
146055781|NCT02891174|526719515|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
146055782|NCT02891174|526719516|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
146055783|NCT02891174|526719515|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
146055784|NCT02891174|526719516|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
146055785|NCT02891174|526719515|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
146055786|NCT02891174|526719516|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
146055787|NCT02891174|526719515|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
146055788|NCT02891174|526719516|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
146055789|NCT04235140|526719517|FG000|Overall Study|Adverse Event|2|||
146055790|NCT04235140|526719517|FG000|Overall Study|Lost to Follow-up|1|||
146055791|NCT04235140|526719517|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
146055792|NCT04235140|526719517|FG000|Overall Study|Commercial drug is available for participants|7|||
146055793|NCT02210000|526719518|FG000|Overall Study|Study Terminated|11|||
146055794|NCT02210000|526719519|FG001|Overall Study|Study Terminated|12|||
146055795|NCT02210000|526719518|FG000|Overall Study|Withdrawal by Subject|7|||
146055796|NCT02210000|526719519|FG001|Overall Study|Withdrawal by Subject|1|||
146055797|NCT02210000|526719518|FG000|Overall Study|Adverse Event|1|||
146055798|NCT02210000|526719519|FG001|Overall Study|Adverse Event|5|||
146055799|NCT02210000|526719518|FG000|Overall Study|Lost to Follow-up|0|||
146055800|NCT02210000|526719519|FG001|Overall Study|Lost to Follow-up|2|||
146055801|NCT02210000|526719518|FG000|Overall Study|Physician Decision|0|||
146259466|NCT00337285|527465195|FG000|Overall Study|Protocol Violation|27|||
146259467|NCT00337285|527465195|FG000|Overall Study|Lack of Efficacy|11|||
146259468|NCT00337285|527465195|FG000|Overall Study|Death|1|||
146259469|NCT00337285|527465195|FG000|Overall Study|Physician Decision|1|||
146259470|NCT00337285|527465195|FG000|Overall Study|Lack of protocol compliance|7|||
146259471|NCT01004185|527465197|FG000|Overall Study|Adverse Event|1|||
146259472|NCT01004185|527465198|FG001|Overall Study|Adverse Event|1|||
146259473|NCT01004185|527465197|FG000|Overall Study|Lost to Follow-up|0|||
146259474|NCT01004185|527465198|FG001|Overall Study|Lost to Follow-up|1|||
146259475|NCT01004185|527465197|FG000|Overall Study|Lack of Efficacy|2|||
146259476|NCT01004185|527465198|FG001|Overall Study|Lack of Efficacy|1|||
146259477|NCT01004185|527465197|FG000|Overall Study|Sponsor Terminated Study|4|||
146259478|NCT01004185|527465198|FG001|Overall Study|Sponsor Terminated Study|5|||
146259479|NCT01004185|527465197|FG000|Overall Study|Withdrawal by Subject|2|||
146259480|NCT01004185|527465198|FG001|Overall Study|Withdrawal by Subject|1|||
146259481|NCT03214250|527465199|FG000|Overall Study|Death|5|||
146259482|NCT03214250|527465200|FG001|Overall Study|Death|5|||
146259483|NCT03214250|527465201|FG002|Overall Study|Death|7|||
146259484|NCT03214250|527465202|FG003|Overall Study|Death|4|||
146259485|NCT03214250|527465203|FG004|Overall Study|Death|23|||
146259486|NCT03214250|527465204|FG005|Overall Study|Death|23|||
146259487|NCT03214250|527465205|FG006|Overall Study|Death|24|||
146259488|NCT03214250|527465199|FG000|Overall Study|Lost to Follow-up|0|||
146259489|NCT03214250|527465200|FG001|Overall Study|Lost to Follow-up|0|||
146259490|NCT03214250|527465201|FG002|Overall Study|Lost to Follow-up|0|||
146259491|NCT03214250|527465202|FG003|Overall Study|Lost to Follow-up|1|||
146259492|NCT03214250|527465203|FG004|Overall Study|Lost to Follow-up|1|||
146259493|NCT03214250|527465204|FG005|Overall Study|Lost to Follow-up|2|||
146259494|NCT03214250|527465205|FG006|Overall Study|Lost to Follow-up|0|||
146259495|NCT03214250|527465199|FG000|Overall Study|Other|0|||
146259496|NCT03214250|527465200|FG001|Overall Study|Other|0|||
146259497|NCT03214250|527465201|FG002|Overall Study|Other|0|||
146259498|NCT03214250|527465202|FG003|Overall Study|Other|0|||
146259499|NCT03214250|527465203|FG004|Overall Study|Other|1|||
146259500|NCT03214250|527465204|FG005|Overall Study|Other|1|||
146259501|NCT03214250|527465205|FG006|Overall Study|Other|2|||
146259502|NCT03214250|527465199|FG000|Overall Study|Remains on Study|2|||
146259503|NCT03214250|527465200|FG001|Overall Study|Remains on Study|2|||
146259504|NCT03214250|527465201|FG002|Overall Study|Remains on Study|0|||
146259505|NCT03214250|527465202|FG003|Overall Study|Remains on Study|1|||
146259506|NCT03214250|527465203|FG004|Overall Study|Remains on Study|7|||
146259507|NCT03214250|527465204|FG005|Overall Study|Remains on Study|5|||
146259508|NCT03214250|527465205|FG006|Overall Study|Remains on Study|3|||
146259509|NCT03214250|527465199|FG000|Overall Study|Withdrawal by Subject|0|||
146259510|NCT03214250|527465200|FG001|Overall Study|Withdrawal by Subject|0|||
146259511|NCT03214250|527465201|FG002|Overall Study|Withdrawal by Subject|1|||
146259512|NCT03214250|527465202|FG003|Overall Study|Withdrawal by Subject|2|||
146259513|NCT03214250|527465203|FG004|Overall Study|Withdrawal by Subject|5|||
146259514|NCT03214250|527465204|FG005|Overall Study|Withdrawal by Subject|0|||
146259515|NCT03214250|527465205|FG006|Overall Study|Withdrawal by Subject|2|||
146259516|NCT00292981|527465214|FG000|Overall Study|Adverse Event|1|||
146259517|NCT00292981|527465214|FG000|Overall Study|Lost to Follow-up|13|||
146301716|NCT00239226|527620054|FG002|Overall Study|Lost to Follow-up|1|||
146055802|NCT02210000|526719519|FG001|Overall Study|Physician Decision|1|||
146055803|NCT01421017|526719520|FG000|Overall Study|Withdrawal by Subject|2|||
146055804|NCT01421017|526719521|FG001|Overall Study|Withdrawal by Subject|0|||
146055805|NCT01421017|526719522|FG002|Overall Study|Withdrawal by Subject|0|||
146055806|NCT01421017|526719520|FG000|Overall Study|POD|0|||
146055807|NCT01421017|526719521|FG001|Overall Study|POD|6|||
146055808|NCT01421017|526719522|FG002|Overall Study|POD|3|||
146055809|NCT00866177|526719527|FG000|Overall Study|Withdrawal by Subject|1|||
146055810|NCT00866177|526719527|FG000|Overall Study|Not Treated|151|||
146055811|NCT03585660|526719528|FG000|Overall Study|operator error|1|||
146055812|NCT03585660|526719528|FG000|Overall Study|technical error|2|||
146055813|NCT03585660|526719528|FG000|Overall Study|hip prosthesis|2|||
146055814|NCT03585660|526719528|FG000|Overall Study|did not undergo biopsy|8|||
146055815|NCT03585660|526719528|FG000|Overall Study|scanner problem|2|||
146055816|NCT05635461|526719529|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146055817|NCT05635461|526719530|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146055818|NCT05635461|526719531|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146055819|NCT05635461|526719532|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146055820|NCT05635461|526719533|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
146055821|NCT05635461|526719534|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
146055822|NCT05635461|526719529|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146055823|NCT05635461|526719530|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
146055824|NCT05635461|526719531|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146055825|NCT05635461|526719532|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146055826|NCT05635461|526719533|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146055827|NCT05635461|526719534|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
146111946|NCT01425281|526928978|FG001|At 2-year Clinical Follow-up|Death|0|||
146111947|NCT01425281|526928977|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
146111948|NCT01425281|526928978|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
146111949|NCT01425281|526928977|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
146111950|NCT01425281|526928978|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
146111951|NCT01425281|526928977|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
146111952|NCT01425281|526928978|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
146111953|NCT01425281|526928977|FG000|At 3-year Clinical Follow-up|Death|2|||
146111954|NCT01425281|526928978|FG001|At 3-year Clinical Follow-up|Death|3|||
146111955|NCT01425281|526928977|FG000|At 4-year Clinical Follow-up|Death|7|||
146111956|NCT01425281|526928978|FG001|At 4-year Clinical Follow-up|Death|3|||
146111957|NCT01425281|526928977|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
146111958|NCT01425281|526928978|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
146111959|NCT01425281|526928977|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
146111960|NCT01425281|526928978|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
146111961|NCT01425281|526928977|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
146111962|NCT01425281|526928978|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
146111963|NCT01425281|526928977|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
146111964|NCT01425281|526928978|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
146111965|NCT01425281|526928977|FG000|At 5-year Clinical Follow-up|Death|2|||
146111966|NCT01425281|526928978|FG001|At 5-year Clinical Follow-up|Death|0|||
146111967|NCT01425281|526928977|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
146111968|NCT01425281|526928978|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
146111969|NCT01425281|526928977|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
146111970|NCT01425281|526928978|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
146111971|NCT01425281|526928977|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
146111972|NCT01425281|526928978|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
146111973|NCT01833520|526928979|FG000|Overall Study|Lack of Efficacy|3|||
146111974|NCT01833520|526928980|FG001|Overall Study|Lack of Efficacy|3|||
146111975|NCT01833520|526928981|FG002|Overall Study|Lack of Efficacy|8|||
146111976|NCT01833520|526928982|FG003|Overall Study|Lack of Efficacy|3|||
146111977|NCT03266107|526928983|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
146111978|NCT03266107|526928983|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
146111979|NCT03266107|526928983|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
146111980|NCT03266107|526928983|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
146111981|NCT02266225|526928984|FG000|Overall Study|Lost to Follow-up|2|||
146111982|NCT02266225|526928984|FG000|Overall Study|Death|1|||
146259518|NCT00292981|527465214|FG000|Overall Study|Withdrawal by Subject|22|||
146259519|NCT00292981|527465214|FG000|Overall Study|Other|3|||
146259520|NCT00594178|527465217|FG000|Overall Study|Physician Decision|5|||
146259521|NCT04191148|527465223|FG000|Overall Study|Withdrawal by Subject|1|||
146259522|NCT04191148|527465224|FG001|Overall Study|Withdrawal by Subject|0|||
146259523|NCT04191148|527465223|FG000|Overall Study|Adverse Event|1|||
146259524|NCT04191148|527465224|FG001|Overall Study|Adverse Event|0|||
146301717|NCT00239226|527620055|FG003|Overall Study|Lost to Follow-up|0|||
146301718|NCT00646906|527620056|FG000|Crossover Period 1|Withdrawal by Subject|1|||
146111983|NCT02266225|526928984|FG000|Overall Study|Withdrawal by Subject|13|||
146259525|NCT01874665|527465225|FG000|Overall Study|Adverse Event|6|||
146259526|NCT01874665|527465226|FG001|Overall Study|Adverse Event|2|||
146259527|NCT01874665|527465225|FG000|Overall Study|Withdrawal by Subject|4|||
146301719|NCT00646906|527620057|FG001|Crossover Period 1|Withdrawal by Subject|0|||
146055828|NCT05635461|526719529|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146055829|NCT05635461|526719530|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146055830|NCT05635461|526719531|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146055831|NCT05635461|526719532|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
146055832|NCT05635461|526719533|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146055833|NCT05635461|526719534|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
146055834|NCT00861705|526719535|FG000|Overall Study|Never Began Treatment|7|||
146055835|NCT00861705|526719536|FG001|Overall Study|Never Began Treatment|3|||
146055836|NCT00861705|526719537|FG002|Overall Study|Never Began Treatment|0|||
146055837|NCT00861705|526719538|FG003|Overall Study|Never Began Treatment|1|||
146055838|NCT00472108|526719539|FG000|Overall Study|Lost to Follow-up|0|||
146055839|NCT00472108|526719540|FG001|Overall Study|Lost to Follow-up|1|||
146111984|NCT00320411|526928985|FG000|Overall Study|No investigational product admin.|4|||
146111985|NCT02088047|526928988|FG000|Overall Study|Withdrawal by Subject|1|||
146111986|NCT02088047|526928989|FG001|Overall Study|Withdrawal by Subject|0|||
146111987|NCT00660309|526928990|FG000|Overall Study|Adverse Event|2|||
146111988|NCT00660309|526928991|FG001|Overall Study|Adverse Event|0|||
146055840|NCT00005906|526719541|FG000|Overall Study|Lack of Efficacy|3|||
146055841|NCT04551989|526719542|FG000|Overall Study|Adverse Event|4|||
146111989|NCT00660309|526928990|FG000|Overall Study|Withdrawal by Subject|0|||
146259528|NCT01874665|527465226|FG001|Overall Study|Withdrawal by Subject|1|||
146259529|NCT01874665|527465225|FG000|Overall Study|Physician Decision|3|||
146111990|NCT00660309|526928991|FG001|Overall Study|Withdrawal by Subject|3|||
146111991|NCT01217814|526928995|FG000|Overall Study|Adverse Event|1|||
146111992|NCT01217814|526928996|FG001|Overall Study|Adverse Event|1|||
146111993|NCT01217814|526928997|FG002|Overall Study|Adverse Event|0|||
146111994|NCT01217814|526928995|FG000|Overall Study|Lack of Efficacy|0|||
146111995|NCT01217814|526928996|FG001|Overall Study|Lack of Efficacy|0|||
146111996|NCT01217814|526928997|FG002|Overall Study|Lack of Efficacy|1|||
146111997|NCT01218243|526928998|FG000|Overall Study|Lack of Efficacy|1|||
146111998|NCT01218243|526928999|FG001|Overall Study|Lack of Efficacy|1|||
146111999|NCT01218243|526928998|FG000|Overall Study|Lost to Follow-up|3|||
146112000|NCT01218243|526928999|FG001|Overall Study|Lost to Follow-up|3|||
146112001|NCT01218243|526928998|FG000|Overall Study|Protocol Violation|5|||
146112002|NCT01218243|526928999|FG001|Overall Study|Protocol Violation|10|||
146112003|NCT01844518|526929001|FG000|Overall Study|Adverse Event|7|||
146112004|NCT01844518|526929002|FG001|Overall Study|Adverse Event|1|||
146112005|NCT01844518|526929001|FG000|Overall Study|Lack of Efficacy|17|||
146112006|NCT01844518|526929002|FG001|Overall Study|Lack of Efficacy|5|||
146112007|NCT01844518|526929001|FG000|Overall Study|Participant's request to discontinue|4|||
146112008|NCT01844518|526929002|FG001|Overall Study|Participant's request to discontinue|1|||
146112009|NCT01844518|526929001|FG000|Overall Study|Poor/Non-compliance|1|||
146112010|NCT01844518|526929002|FG001|Overall Study|Poor/Non-compliance|0|||
146112011|NCT01844518|526929001|FG000|Overall Study|No Longer Met Study Criteria|2|||
146112012|NCT01844518|526929002|FG001|Overall Study|No Longer Met Study Criteria|0|||
146112013|NCT01844518|526929001|FG000|Overall Study|Withdrawal by Subject|9|||
146112014|NCT01844518|526929002|FG001|Overall Study|Withdrawal by Subject|0|||
146112015|NCT01844518|526929001|FG000|Overall Study|Pregnancy|1|||
146112016|NCT01844518|526929002|FG001|Overall Study|Pregnancy|0|||
146112017|NCT03129100|526929005|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
146112018|NCT03129100|526929006|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
146112019|NCT03129100|526929007|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
146112020|NCT03129100|526929008|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
146112021|NCT03129100|526929009|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
146112022|NCT03129100|526929010|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
146112023|NCT03129100|526929011|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
146112024|NCT03129100|526929012|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
146112025|NCT03129100|526929013|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
146112026|NCT03129100|526929014|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
146112027|NCT03129100|526929015|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
146112028|NCT03129100|526929016|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
146112029|NCT03129100|526929017|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
146112030|NCT03129100|526929018|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
146112031|NCT03129100|526929019|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
146112032|NCT03129100|526929020|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
146112033|NCT03129100|526929021|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
146112034|NCT03129100|526929022|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
146112035|NCT03129100|526929023|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
146112036|NCT03129100|526929024|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
146112037|NCT03129100|526929025|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
146112038|NCT03129100|526929026|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
146112039|NCT03129100|526929027|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
146112040|NCT03129100|526929028|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
146112041|NCT03129100|526929029|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
146112042|NCT03129100|526929030|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
146112043|NCT03129100|526929005|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
146112044|NCT03129100|526929006|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112045|NCT03129100|526929007|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112046|NCT03129100|526929008|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112047|NCT03129100|526929009|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112048|NCT03129100|526929010|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112049|NCT03129100|526929011|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112050|NCT03129100|526929012|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112051|NCT03129100|526929013|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112052|NCT03129100|526929014|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112053|NCT03129100|526929015|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112054|NCT03129100|526929016|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112055|NCT03129100|526929017|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112056|NCT03129100|526929018|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112057|NCT03129100|526929019|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112058|NCT03129100|526929020|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112059|NCT03129100|526929021|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112060|NCT03129100|526929022|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112061|NCT03129100|526929023|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112062|NCT03129100|526929024|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112063|NCT03129100|526929025|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112064|NCT03129100|526929026|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112065|NCT03129100|526929027|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146259530|NCT01874665|527465226|FG001|Overall Study|Physician Decision|0|||
146055842|NCT04551989|526719542|FG000|Overall Study|Protocol Violation|3|||
146055843|NCT04551989|526719542|FG000|Overall Study|Lost to Follow-up|1|||
146055844|NCT04551989|526719542|FG000|Overall Study|Physician Decision|3|||
146055845|NCT00088530|526719543|FG000|Overall Study|Progressive/Relapsed Disease|28|||
146055846|NCT00088530|526719544|FG001|Overall Study|Progressive/Relapsed Disease|39|||
146055847|NCT00088530|526719543|FG000|Overall Study|Adverse Event|15|||
146055848|NCT00088530|526719544|FG001|Overall Study|Adverse Event|9|||
146055849|NCT00088530|526719543|FG000|Overall Study|Withdrawal by Subject|2|||
146055850|NCT00088530|526719544|FG001|Overall Study|Withdrawal by Subject|5|||
146055851|NCT00088530|526719543|FG000|Overall Study|Lost to Follow-up|2|||
146055852|NCT00088530|526719544|FG001|Overall Study|Lost to Follow-up|0|||
146055853|NCT00088530|526719543|FG000|Overall Study|Physician Decision|2|||
146055854|NCT00088530|526719544|FG001|Overall Study|Physician Decision|0|||
146055855|NCT00088530|526719543|FG000|Overall Study|Sponsor decision|0|||
146055856|NCT00088530|526719544|FG001|Overall Study|Sponsor decision|1|||
146055857|NCT00088530|526719543|FG000|Overall Study|Patient never treated|1|||
146055858|NCT00088530|526719544|FG001|Overall Study|Patient never treated|0|||
146055859|NCT02694744|526719545|FG000|Overall Study|Adverse Event|2|||
146055860|NCT02694744|526719546|FG001|Overall Study|Adverse Event|1|||
146055861|NCT02694744|526719545|FG000|Overall Study|Withdrawal by Subject|2|||
146055862|NCT02694744|526719546|FG001|Overall Study|Withdrawal by Subject|1|||
146055863|NCT02694744|526719545|FG000|Overall Study|Physician Decision|1|||
146055864|NCT02694744|526719546|FG001|Overall Study|Physician Decision|2|||
146055865|NCT02694744|526719545|FG000|Overall Study|Lost to Follow-up|1|||
146055866|NCT02694744|526719546|FG001|Overall Study|Lost to Follow-up|0|||
146055867|NCT02694744|526719545|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
146055868|NCT02694744|526719546|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
146055869|NCT01945021|526719547|FG000|Overall Study|Adverse Event|1|||
146055870|NCT01945021|526719547|FG000|Overall Study|Withdrawal of consent|12|||
146055871|NCT01945021|526719547|FG000|Overall Study|Lost to Follow-up|5|||
146055872|NCT01945021|526719547|FG000|Overall Study|Death|65|||
146055873|NCT02163902|526719548|FG000|Overall Study|Subject's Request|3|||
146055874|NCT02163902|526719549|FG001|Overall Study|Subject's Request|4|||
146112066|NCT03129100|526929028|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112067|NCT03129100|526929029|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112068|NCT03129100|526929030|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
146112069|NCT03129100|526929005|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
146112070|NCT03129100|526929006|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
146112071|NCT03129100|526929007|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112072|NCT03129100|526929008|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112073|NCT03129100|526929009|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112074|NCT03129100|526929010|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112075|NCT03129100|526929011|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112076|NCT03129100|526929012|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112077|NCT03129100|526929013|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112078|NCT03129100|526929014|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112079|NCT03129100|526929015|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112080|NCT03129100|526929016|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112081|NCT03129100|526929017|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112082|NCT03129100|526929018|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112083|NCT03129100|526929019|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112084|NCT03129100|526929020|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112085|NCT03129100|526929021|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112086|NCT03129100|526929022|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112087|NCT03129100|526929023|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112088|NCT03129100|526929024|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112089|NCT03129100|526929025|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112090|NCT03129100|526929026|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112091|NCT03129100|526929027|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146259531|NCT01874665|527465225|FG000|Overall Study|Clinical Progressive Disease|4|||
146259532|NCT01874665|527465226|FG001|Overall Study|Clinical Progressive Disease|3|||
146112092|NCT03129100|526929028|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146259533|NCT01874665|527465225|FG000|Overall Study|Study Terminated by Sponsor|0|||
146055875|NCT02163902|526719548|FG000|Overall Study|Lost to Follow-up|6|||
146055876|NCT02163902|526719549|FG001|Overall Study|Lost to Follow-up|7|||
146055877|NCT02163902|526719548|FG000|Overall Study|Administrative Decision|2|||
146055878|NCT02163902|526719549|FG001|Overall Study|Administrative Decision|2|||
146055879|NCT00079040|526719550|FG000|Overall Study|Withdrew before treatment|1|||
146055880|NCT00079040|526719550|FG000|Overall Study|Ineligible|1|||
146055881|NCT02898454|526719551|FG000|Overall Study|Adverse Event|4|||
146055882|NCT02898454|526719552|FG001|Overall Study|Adverse Event|1|||
146055883|NCT02898454|526719553|FG002|Overall Study|Adverse Event|2|||
146055884|NCT02898454|526719551|FG000|Overall Study|Protocol Violation|1|||
146112093|NCT03129100|526929029|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112094|NCT03129100|526929030|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
146112095|NCT03129100|526929005|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
146112096|NCT03129100|526929006|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
146112097|NCT03129100|526929007|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112098|NCT03129100|526929008|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112099|NCT03129100|526929009|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112100|NCT03129100|526929010|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112101|NCT03129100|526929011|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112102|NCT03129100|526929012|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112103|NCT03129100|526929013|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112104|NCT03129100|526929014|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112105|NCT03129100|526929015|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112106|NCT03129100|526929016|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112107|NCT03129100|526929017|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146259534|NCT01874665|527465226|FG001|Overall Study|Study Terminated by Sponsor|2|||
146259535|NCT01874665|527465225|FG000|Overall Study|Documented Progressive Disease|11|||
146259536|NCT01874665|527465226|FG001|Overall Study|Documented Progressive Disease|7|||
146259537|NCT01874665|527465225|FG000|Overall Study|Other|2|||
146259538|NCT01874665|527465226|FG001|Overall Study|Other|0|||
146259539|NCT04582669|527465227|FG000|Overall Study|Subject missed appointment(s).|1|||
146259540|NCT04582669|527465228|FG001|Overall Study|Subject missed appointment(s).|0|||
146259541|NCT04582669|527465229|FG002|Overall Study|Subject missed appointment(s).|1|||
146259542|NCT04582669|527465230|FG003|Overall Study|Subject missed appointment(s).|2|||
146259543|NCT04582669|527465227|FG000|Overall Study|Protocol Violation|0|||
146259544|NCT04582669|527465228|FG001|Overall Study|Protocol Violation|1|||
146259545|NCT04582669|527465229|FG002|Overall Study|Protocol Violation|1|||
146259546|NCT04582669|527465230|FG003|Overall Study|Protocol Violation|0|||
146259547|NCT02647788|527465233|FG000|Overall Study|Lost to Follow-up|13|||
146259548|NCT02647788|527465234|FG001|Overall Study|Lost to Follow-up|11|||
146259549|NCT02647788|527465233|FG000|Overall Study|Did not want opiate|0|||
146259550|NCT02647788|527465234|FG001|Overall Study|Did not want opiate|1|||
146259551|NCT02647788|527465233|FG000|Overall Study|Withdrawal by Subject|1|||
146259552|NCT02647788|527465234|FG001|Overall Study|Withdrawal by Subject|0|||
146259553|NCT02647788|527465233|FG000|Overall Study|Felt itchy with assigned medication|1|||
146259554|NCT02647788|527465234|FG001|Overall Study|Felt itchy with assigned medication|0|||
146259555|NCT02647788|527465233|FG000|Overall Study|Felt nauseous with assigned medication|1|||
146259556|NCT02647788|527465234|FG001|Overall Study|Felt nauseous with assigned medication|1|||
146259557|NCT01274559|527465235|FG000|Overall Study|Adverse Event|57|||
146259558|NCT01274559|527465236|FG001|Overall Study|Adverse Event|13|||
146259559|NCT01274559|527465235|FG000|Overall Study|Death|1|||
146259560|NCT01274559|527465236|FG001|Overall Study|Death|1|||
146259561|NCT01274559|527465235|FG000|Overall Study|Lost to Follow-up|3|||
146259562|NCT01274559|527465236|FG001|Overall Study|Lost to Follow-up|3|||
146259563|NCT01274559|527465235|FG000|Overall Study|Non-compliance with Study Drug|2|||
146259564|NCT01274559|527465236|FG001|Overall Study|Non-compliance with Study Drug|4|||
146259565|NCT01274559|527465235|FG000|Overall Study|Physician Decision|2|||
146259566|NCT01274559|527465236|FG001|Overall Study|Physician Decision|1|||
146259567|NCT01274559|527465235|FG000|Overall Study|Protocol Violation|28|||
146259568|NCT01274559|527465236|FG001|Overall Study|Protocol Violation|23|||
146259569|NCT01274559|527465235|FG000|Overall Study|Study Terminated by Sponsor|79|||
146259570|NCT01274559|527465236|FG001|Overall Study|Study Terminated by Sponsor|87|||
146259571|NCT01274559|527465235|FG000|Overall Study|Withdrawal by Subject|25|||
146259572|NCT01274559|527465236|FG001|Overall Study|Withdrawal by Subject|13|||
146259573|NCT03245619|527465237|FG000|Part A (Up to Day 22)|Physician Decision|4|||
146259574|NCT03245619|527465238|FG001|Part A (Up to Day 22)|Physician Decision|6|||
146259575|NCT03245619|527465239|FG002|Part A (Up to Day 22)|Physician Decision|6|||
146259576|NCT03245619|527465240|FG003|Part A (Up to Day 22)|Physician Decision|0|||
146259577|NCT03245619|527465241|FG004|Part A (Up to Day 22)|Physician Decision|0|||
146259578|NCT03245619|527465242|FG005|Part A (Up to Day 22)|Physician Decision|0|||
146259579|NCT03245619|527465243|FG006|Part A (Up to Day 22)|Physician Decision|0|||
146259580|NCT03245619|527465244|FG007|Part A (Up to Day 22)|Physician Decision|0|||
146259581|NCT03245619|527465245|FG008|Part A (Up to Day 22)|Physician Decision|0|||
146259582|NCT03245619|527465246|FG009|Part A (Up to Day 22)|Physician Decision|0|||
146112108|NCT03129100|526929018|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112109|NCT03129100|526929019|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146259583|NCT03245619|527465247|FG010|Part A (Up to Day 22)|Physician Decision|0|||
146259584|NCT03245619|527465248|FG011|Part A (Up to Day 22)|Physician Decision|0|||
146259585|NCT03245619|527465249|FG012|Part A (Up to Day 22)|Physician Decision|0|||
146259586|NCT03245619|527465250|FG013|Part A (Up to Day 22)|Physician Decision|0|||
146259587|NCT03245619|527465251|FG014|Part A (Up to Day 22)|Physician Decision|0|||
146259588|NCT03245619|527465252|FG015|Part A (Up to Day 22)|Physician Decision|0|||
146259589|NCT03245619|527465253|FG016|Part A (Up to Day 22)|Physician Decision|0|||
146259590|NCT00776659|527465270|FG000|Overall Study|Lost to Follow-up|15|||
146259591|NCT00776659|527465270|FG000|Overall Study|Withdrawal by Subject|10|||
146112110|NCT03129100|526929020|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112111|NCT03129100|526929021|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112112|NCT03129100|526929022|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112113|NCT03129100|526929023|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112114|NCT03129100|526929024|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112115|NCT03129100|526929025|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112116|NCT03129100|526929026|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112117|NCT03129100|526929027|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112118|NCT03129100|526929028|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112119|NCT03129100|526929029|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112120|NCT03129100|526929030|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
146112121|NCT03129100|526929005|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112122|NCT03129100|526929006|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
146112123|NCT03129100|526929007|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112124|NCT03129100|526929008|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112125|NCT03129100|526929009|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112126|NCT03129100|526929010|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112127|NCT03129100|526929011|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112128|NCT03129100|526929012|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112129|NCT03129100|526929013|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112130|NCT03129100|526929014|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112131|NCT03129100|526929015|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112132|NCT03129100|526929016|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112133|NCT03129100|526929017|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112134|NCT03129100|526929018|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112135|NCT03129100|526929019|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112136|NCT03129100|526929020|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112137|NCT03129100|526929021|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112138|NCT03129100|526929022|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112139|NCT03129100|526929023|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112140|NCT03129100|526929024|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112141|NCT03129100|526929025|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112142|NCT03129100|526929026|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112143|NCT03129100|526929027|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
146259592|NCT00776659|527465270|FG000|Overall Study|Study Terminated by Sponsor|1|||
146055885|NCT02898454|526719552|FG001|Overall Study|Protocol Violation|0|||
146055886|NCT02898454|526719553|FG002|Overall Study|Protocol Violation|1|||
146055887|NCT02898454|526719551|FG000|Overall Study|Lack of Efficacy|4|||
146055888|NCT02898454|526719552|FG001|Overall Study|Lack of Efficacy|1|||
146055889|NCT02898454|526719553|FG002|Overall Study|Lack of Efficacy|0|||
146055890|NCT02898454|526719551|FG000|Overall Study|Withdrawal by Subject|6|||
146055891|NCT02898454|526719552|FG001|Overall Study|Withdrawal by Subject|3|||
146055892|NCT02898454|526719553|FG002|Overall Study|Withdrawal by Subject|3|||
146055893|NCT02898454|526719551|FG000|Overall Study|Lost to Follow-up|1|||
146259593|NCT01167192|527465273|FG000|Overall Study|Adverse Event|1|||
146259594|NCT01167192|527465273|FG000|Overall Study|Death|1|||
146259595|NCT01167192|527465273|FG000|Overall Study|Withdrawal by Subject|1|||
146259596|NCT01167192|527465273|FG000|Overall Study|Insurance denial|1|||
146259597|NCT01336205|527465274|FG000|Overall Study|Other|22|||
146259598|NCT01336205|527465275|FG001|Overall Study|Other|9|||
146259599|NCT01336205|527465274|FG000|Overall Study|Lost to Follow-up|40|||
146259600|NCT01336205|527465275|FG001|Overall Study|Lost to Follow-up|20|||
146259601|NCT01336205|527465274|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
146259602|NCT01336205|527465275|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
146259603|NCT01336205|527465274|FG000|Overall Study|Lack of Efficacy|4|||
146259604|NCT01336205|527465275|FG001|Overall Study|Lack of Efficacy|0|||
146259605|NCT01336205|527465274|FG000|Overall Study|Severe noncompliance with protocol|9|||
146055894|NCT02898454|526719552|FG001|Overall Study|Lost to Follow-up|0|||
146055895|NCT02898454|526719553|FG002|Overall Study|Lost to Follow-up|0|||
146055896|NCT02898454|526719551|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
146055897|NCT02898454|526719552|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
146055898|NCT02898454|526719553|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
146055899|NCT00689390|526719554|FG000|Overall Study|Adverse Event|19|||
146055900|NCT00689390|526719555|FG001|Overall Study|Adverse Event|0|||
146259606|NCT01336205|527465275|FG001|Overall Study|Severe noncompliance with protocol|2|||
146259607|NCT01336205|527465274|FG000|Overall Study|Adverse Event|56|||
146259608|NCT01336205|527465275|FG001|Overall Study|Adverse Event|6|||
146259609|NCT01336205|527465274|FG000|Overall Study|Death|1|||
146055901|NCT00689390|526719554|FG000|Overall Study|Lost to Follow-up|179|||
146055902|NCT00689390|526719555|FG001|Overall Study|Lost to Follow-up|7|||
146055903|NCT00689390|526719554|FG000|Overall Study|Withdrawal by Subject|117|||
146055904|NCT00689390|526719555|FG001|Overall Study|Withdrawal by Subject|3|||
146055905|NCT00689390|526719554|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
146055906|NCT00689390|526719555|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
146055907|NCT00689390|526719554|FG000|Overall Study|Non-Compliance With Protocol|21|||
146055908|NCT00689390|526719555|FG001|Overall Study|Non-Compliance With Protocol|0|||
146055909|NCT00689390|526719554|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
146055910|NCT00689390|526719555|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
146055911|NCT00689390|526719554|FG000|Overall Study|Administrative|37|||
146055912|NCT00689390|526719555|FG001|Overall Study|Administrative|0|||
146055913|NCT02343263|526719556|FG000|Overall Study|Physician Decision|5|||
146055914|NCT02343263|526719557|FG001|Overall Study|Physician Decision|3|||
146055915|NCT02343263|526719558|FG002|Overall Study|Physician Decision|1|||
146055916|NCT04264442|526719562|FG000|Overall Study|Lack of Efficacy|6|||
146055917|NCT04264442|526719562|FG000|Overall Study|Lost to Follow-up|2|||
146055918|NCT04264442|526719562|FG000|Overall Study|Sponsor Decision|23|||
146055919|NCT04264442|526719562|FG000|Overall Study|Withdrawal by Subject|11|||
146055920|NCT04264442|526719562|FG000|Overall Study|Study Termination|5|||
146055921|NCT01290523|526719564|FG000|Overall Study|Death|3|||
146055922|NCT03071263|526719565|FG000|Overall Study|Adverse Event|1|||
146055923|NCT03071263|526719566|FG001|Overall Study|Adverse Event|3|||
146055924|NCT03071263|526719565|FG000|Overall Study|Withdrawal by Subject|1|||
146055925|NCT03071263|526719566|FG001|Overall Study|Withdrawal by Subject|3|||
146055926|NCT03071263|526719565|FG000|Overall Study|Physician Decision|1|||
146055927|NCT03071263|526719566|FG001|Overall Study|Physician Decision|0|||
146055928|NCT03071263|526719565|FG000|Overall Study|Participant moved to another city|0|||
146055929|NCT03071263|526719566|FG001|Overall Study|Participant moved to another city|1|||
146055930|NCT02922725|526719568|FG000|Overall Study|Withdrawal by Subject|1|||
146055931|NCT02922725|526719569|FG001|Overall Study|Withdrawal by Subject|0|||
146055932|NCT02922725|526719570|FG002|Overall Study|Withdrawal by Subject|0|||
146055933|NCT00360412|526719571|FG000|Overall Study|Adverse Event|37|||
146055934|NCT00360412|526719572|FG001|Overall Study|Adverse Event|65|||
146112144|NCT03129100|526929028|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112145|NCT03129100|526929029|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112146|NCT03129100|526929030|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
146112147|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112148|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112149|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
146112150|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
146112151|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112152|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
146112153|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112154|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112155|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112156|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112157|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112158|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112159|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112160|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112161|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112162|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112163|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112164|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112165|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112166|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112167|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112168|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112169|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112170|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112171|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112172|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
146112173|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Death|0|||
146112174|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Death|0|||
146112175|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Death|1|||
146112176|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Death|0|||
146112177|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Death|0|||
146112178|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Death|0|||
146112179|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Death|0|||
146112180|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Death|0|||
146055935|NCT00360412|526719571|FG000|Overall Study|Protocol Violation|2|||
146055936|NCT00360412|526719572|FG001|Overall Study|Protocol Violation|5|||
146055937|NCT00360412|526719571|FG000|Overall Study|Patient withdrew consent|27|||
146055938|NCT00360412|526719572|FG001|Overall Study|Patient withdrew consent|52|||
146055939|NCT00360412|526719571|FG000|Overall Study|Lack of therapeutic efficacy|46|||
146055940|NCT00360412|526719572|FG001|Overall Study|Lack of therapeutic efficacy|61|||
146112181|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Death|0|||
146112182|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Death|0|||
146112183|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Death|0|||
146112184|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Death|0|||
146112185|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Death|0|||
146112186|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Death|0|||
146112187|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Death|0|||
146112188|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Death|0|||
146112189|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Death|0|||
146112190|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Death|0|||
146112191|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Death|0|||
146112192|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Death|0|||
146112193|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Death|0|||
146112194|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Death|0|||
146112195|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Death|0|||
146112196|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Death|0|||
146112197|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Death|0|||
146112198|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Death|0|||
146112199|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112200|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112201|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
146112202|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
146112203|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
146112204|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
146112205|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
146112206|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112207|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112208|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112209|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112210|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112211|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112212|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112213|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112214|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112215|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112216|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146259610|NCT01336205|527465275|FG001|Overall Study|Death|1|||
146055941|NCT00360412|526719571|FG000|Overall Study|Physician Decision|2|||
146055942|NCT00360412|526719572|FG001|Overall Study|Physician Decision|4|||
146055943|NCT00360412|526719571|FG000|Overall Study|Other|5|||
146055944|NCT00360412|526719572|FG001|Overall Study|Other|6|||
146055945|NCT00360412|526719571|FG000|Overall Study|Study termination by Sponsor|214|||
146055946|NCT00360412|526719572|FG001|Overall Study|Study termination by Sponsor|469|||
146055947|NCT04612725|526719573|FG000|Overall Study|Adverse Event|1|||
146055948|NCT04612725|526719574|FG001|Overall Study|Adverse Event|3|||
146055949|NCT04612725|526719575|FG002|Overall Study|Adverse Event|1|||
146055950|NCT04612725|526719576|FG003|Overall Study|Adverse Event|0|||
146055951|NCT04612725|526719577|FG004|Overall Study|Adverse Event|1|||
146055952|NCT04612725|526719573|FG000|Overall Study|Lost to Follow-up|0|||
146055953|NCT04612725|526719574|FG001|Overall Study|Lost to Follow-up|1|||
146055954|NCT04612725|526719575|FG002|Overall Study|Lost to Follow-up|0|||
146055955|NCT04612725|526719576|FG003|Overall Study|Lost to Follow-up|0|||
146055956|NCT04612725|526719577|FG004|Overall Study|Lost to Follow-up|0|||
146055957|NCT04612725|526719573|FG000|Overall Study|Physician Decision|2|||
146055958|NCT04612725|526719574|FG001|Overall Study|Physician Decision|0|||
146055959|NCT04612725|526719575|FG002|Overall Study|Physician Decision|0|||
146055960|NCT04612725|526719576|FG003|Overall Study|Physician Decision|0|||
146055961|NCT04612725|526719577|FG004|Overall Study|Physician Decision|0|||
146055962|NCT04612725|526719573|FG000|Overall Study|Study terminated by sponsor|3|||
146055963|NCT04612725|526719574|FG001|Overall Study|Study terminated by sponsor|1|||
146055964|NCT04612725|526719575|FG002|Overall Study|Study terminated by sponsor|2|||
146055965|NCT04612725|526719576|FG003|Overall Study|Study terminated by sponsor|4|||
146055966|NCT04612725|526719577|FG004|Overall Study|Study terminated by sponsor|5|||
146055967|NCT04612725|526719573|FG000|Overall Study|Withdrawal by Subject|8|||
146055968|NCT04612725|526719574|FG001|Overall Study|Withdrawal by Subject|3|||
146055969|NCT04612725|526719575|FG002|Overall Study|Withdrawal by Subject|5|||
146055970|NCT04612725|526719576|FG003|Overall Study|Withdrawal by Subject|1|||
146055971|NCT04612725|526719577|FG004|Overall Study|Withdrawal by Subject|9|||
146055972|NCT04612725|526719573|FG000|Overall Study|Other|0|||
146055973|NCT04612725|526719574|FG001|Overall Study|Other|0|||
146055974|NCT04612725|526719575|FG002|Overall Study|Other|0|||
146055975|NCT04612725|526719576|FG003|Overall Study|Other|0|||
146055976|NCT04612725|526719577|FG004|Overall Study|Other|1|||
146055977|NCT02354235|526719578|FG000|Overall Study|Adverse Event|2|||
146055978|NCT02354235|526719579|FG001|Overall Study|Adverse Event|2|||
146055979|NCT02354235|526719578|FG000|Overall Study|Physician Decision|0|||
146055980|NCT02354235|526719579|FG001|Overall Study|Physician Decision|1|||
146055981|NCT02354235|526719578|FG000|Overall Study|Withdrawal by Subject|1|||
146055982|NCT02354235|526719579|FG001|Overall Study|Withdrawal by Subject|3|||
146055983|NCT02354235|526719578|FG000|Overall Study|Conflict with the stopping criteria|0|||
146055984|NCT02354235|526719579|FG001|Overall Study|Conflict with the stopping criteria|1|||
146055985|NCT03069352|526719580|FG000|Overall Study|Ongoing|12|||
146055986|NCT03069352|526719581|FG001|Overall Study|Ongoing|40|||
146055987|NCT02621424|526719582|FG000|Overall Study|Withdrawal by Subject|1|||
146055988|NCT02621424|526719583|FG001|Overall Study|Withdrawal by Subject|2|||
146055989|NCT05148234|526719585|FG000|Phase I|Ineligible|0|||
146055990|NCT05148234|526719586|FG001|Phase I|Ineligible|0|||
146055991|NCT05148234|526719587|FG002|Phase I|Ineligible|0|||
146055992|NCT05148234|526719588|FG003|Phase I|Ineligible|0|||
146055993|NCT05148234|526719589|FG004|Phase I|Ineligible|0|||
146055994|NCT05148234|526719590|FG005|Phase I|Ineligible|0|||
146055995|NCT05148234|526719591|FG006|Phase I|Ineligible|0|||
146055996|NCT05148234|526719592|FG007|Phase I|Ineligible|1|||
146055997|NCT05148234|526719585|FG000|Phase I|Company closed the trial.|0|||
146055998|NCT05148234|526719586|FG001|Phase I|Company closed the trial.|1|||
146055999|NCT05148234|526719587|FG002|Phase I|Company closed the trial.|0|||
146056000|NCT05148234|526719588|FG003|Phase I|Company closed the trial.|0|||
146056001|NCT05148234|526719589|FG004|Phase I|Company closed the trial.|0|||
146056002|NCT05148234|526719590|FG005|Phase I|Company closed the trial.|0|||
146056003|NCT05148234|526719591|FG006|Phase I|Company closed the trial.|0|||
146056004|NCT05148234|526719592|FG007|Phase I|Company closed the trial.|0|||
146056005|NCT01928927|526719593|FG000|Overall Study|Lost to Follow-up|1|||
146056006|NCT01928927|526719594|FG001|Overall Study|Lost to Follow-up|0|||
146056007|NCT01928927|526719593|FG000|Overall Study|Withdrawal by Subject|1|||
146056008|NCT01928927|526719594|FG001|Overall Study|Withdrawal by Subject|1|||
146056009|NCT03409796|526721061|FG000|Overall Study|Adverse Event|2|||
146056010|NCT03409796|526721062|FG001|Overall Study|Adverse Event|0|||
146056011|NCT03409796|526721061|FG000|Overall Study|Other|0|||
146056012|NCT03409796|526721062|FG001|Overall Study|Other|1|||
146056013|NCT01453049|526721076|FG000|Overall Study|Protocol Violation|2|||
146056014|NCT01453049|526721077|FG001|Overall Study|Protocol Violation|5|||
146056015|NCT01453049|526721076|FG000|Overall Study|Lost to Follow-up|2|||
146056016|NCT01453049|526721077|FG001|Overall Study|Lost to Follow-up|1|||
146056017|NCT01453049|526721076|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
146056018|NCT01453049|526721077|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
146056019|NCT01453049|526721076|FG000|Overall Study|Withdrawal by Subject|1|||
146056020|NCT01453049|526721077|FG001|Overall Study|Withdrawal by Subject|0|||
146056021|NCT01453049|526721076|FG000|Overall Study|Randomized in Error|1|||
146056022|NCT01453049|526721077|FG001|Overall Study|Randomized in Error|0|||
146056023|NCT03287791|526721082|FG000|Overall Study|Insufficient Therapeutic Response|0|||
146056024|NCT03287791|526721083|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146056025|NCT03287791|526721084|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146056026|NCT03287791|526721082|FG000|Overall Study|Adverse Event|0|||
146056027|NCT03287791|526721083|FG001|Overall Study|Adverse Event|4|||
146056028|NCT03287791|526721084|FG002|Overall Study|Adverse Event|3|||
146056029|NCT03287791|526721082|FG000|Overall Study|Withdrawal by Subject|12|||
146056030|NCT03287791|526721083|FG001|Overall Study|Withdrawal by Subject|12|||
146056031|NCT03287791|526721084|FG002|Overall Study|Withdrawal by Subject|17|||
146056032|NCT03287791|526721082|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
146056033|NCT03287791|526721083|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
146056034|NCT03287791|526721084|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
146056035|NCT03287791|526721082|FG000|Overall Study|Lost to Follow-up|8|||
146056036|NCT03287791|526721083|FG001|Overall Study|Lost to Follow-up|14|||
146056037|NCT03287791|526721084|FG002|Overall Study|Lost to Follow-up|11|||
146259611|NCT01336205|527465274|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
146259612|NCT01336205|527465275|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
146056038|NCT03287791|526721082|FG000|Overall Study|Protocol Violation|7|||
146056039|NCT03287791|526721083|FG001|Overall Study|Protocol Violation|2|||
146056040|NCT03287791|526721084|FG002|Overall Study|Protocol Violation|1|||
146056041|NCT03287791|526721082|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
146056042|NCT03287791|526721083|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
146056043|NCT03287791|526721084|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
146056044|NCT03287791|526721082|FG000|Overall Study|Too much time between 2 visits|0|||
146056045|NCT03287791|526721083|FG001|Overall Study|Too much time between 2 visits|1|||
146056046|NCT03287791|526721084|FG002|Overall Study|Too much time between 2 visits|0|||
146056047|NCT03287791|526721082|FG000|Overall Study|Non-compliance|0|||
146056048|NCT03287791|526721083|FG001|Overall Study|Non-compliance|1|||
146056049|NCT03287791|526721084|FG002|Overall Study|Non-compliance|0|||
146056050|NCT03287791|526721082|FG000|Overall Study|Did not meet inclusion criteria|1|||
146056051|NCT03287791|526721083|FG001|Overall Study|Did not meet inclusion criteria|0|||
146056052|NCT03287791|526721084|FG002|Overall Study|Did not meet inclusion criteria|0|||
146056053|NCT03095651|526721086|FG000|Overall Study|Lost to Follow-up|1|||
146056054|NCT03095651|526721087|FG001|Overall Study|Lost to Follow-up|1|||
146056055|NCT03095651|526721088|FG002|Overall Study|Lost to Follow-up|0|||
146056056|NCT03095651|526721089|FG003|Overall Study|Lost to Follow-up|1|||
146056057|NCT03095651|526721090|FG004|Overall Study|Lost to Follow-up|0|||
146056058|NCT03095651|526721091|FG005|Overall Study|Lost to Follow-up|0|||
146056059|NCT03095651|526721092|FG006|Overall Study|Lost to Follow-up|0|||
146056060|NCT03095651|526721093|FG007|Overall Study|Lost to Follow-up|0|||
146056061|NCT03095651|526721086|FG000|Overall Study|Withdrawal by Subject|0|||
146056062|NCT03095651|526721087|FG001|Overall Study|Withdrawal by Subject|0|||
146056063|NCT03095651|526721088|FG002|Overall Study|Withdrawal by Subject|0|||
146056064|NCT03095651|526721089|FG003|Overall Study|Withdrawal by Subject|0|||
146056065|NCT03095651|526721090|FG004|Overall Study|Withdrawal by Subject|0|||
146056066|NCT03095651|526721091|FG005|Overall Study|Withdrawal by Subject|1|||
146056067|NCT03095651|526721092|FG006|Overall Study|Withdrawal by Subject|0|||
146056068|NCT03095651|526721093|FG007|Overall Study|Withdrawal by Subject|0|||
146056069|NCT00768989|526721094|FG000|Prior to Week 24|Withdrawal by Subject|1|||
146056070|NCT00768989|526721095|FG001|Prior to Week 24|Withdrawal by Subject|0|||
146056071|NCT00768989|526721094|FG000|Prior to Week 24|Adverse Event|3|||
146056072|NCT00768989|526721095|FG001|Prior to Week 24|Adverse Event|0|||
146056073|NCT00768989|526721094|FG000|Prior to Week 24|Lost to Follow-up|0|||
146056074|NCT00768989|526721095|FG001|Prior to Week 24|Lost to Follow-up|1|||
146056075|NCT00768989|526721094|FG000|Prior to Week 24|Protocol Violation|0|||
146056076|NCT00768989|526721095|FG001|Prior to Week 24|Protocol Violation|2|||
146056077|NCT00768989|526721094|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
146056078|NCT00768989|526721095|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
146056079|NCT00768989|526721094|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
146112217|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112218|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112219|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112220|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112221|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112222|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112223|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112224|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
146112225|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112226|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112227|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
146112228|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112229|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112230|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112231|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112232|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112233|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112234|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112235|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112236|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112237|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112238|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112239|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112240|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112241|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112242|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112243|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112244|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112245|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112246|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112247|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112248|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112249|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146112250|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
146056080|NCT00768989|526721095|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
146056081|NCT00768989|526721094|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
146056082|NCT00768989|526721095|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
146056083|NCT00768989|526721094|FG000|On or After Week 36|Lack of Efficacy|1|||
146056084|NCT00768989|526721095|FG001|On or After Week 36|Lack of Efficacy|0|||
146056085|NCT00768989|526721094|FG000|On or After Week 36|Adverse Event|0|||
146301720|NCT00646906|527620058|FG002|Crossover Period 1|Withdrawal by Subject|0|||
146301721|NCT00646906|527620059|FG003|Crossover Period 1|Withdrawal by Subject|0|||
146301722|NCT00646906|527620060|FG004|Crossover Period 1|Withdrawal by Subject|0|||
146112251|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112252|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112253|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
146112254|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112255|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112256|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112257|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112258|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112259|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112260|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112261|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112262|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112263|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112264|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112265|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112266|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112267|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112268|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112269|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112270|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112271|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112272|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112273|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112274|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112275|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112276|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
146112277|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112278|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112279|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
146112280|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112281|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112282|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112283|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112284|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112285|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112286|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112287|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112288|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112289|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112290|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112291|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112292|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112293|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112294|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112295|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112296|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112297|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112298|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112299|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112300|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146259613|NCT01336205|527465274|FG000|Overall Study|Withdrawal by Subject|72|||
146259614|NCT01336205|527465275|FG001|Overall Study|Withdrawal by Subject|38|||
146259615|NCT01336205|527465274|FG000|Overall Study|Did not receive treatment|4|||
146259616|NCT01336205|527465275|FG001|Overall Study|Did not receive treatment|0|||
146259617|NCT00129649|527465288|FG000|Overall Study|Withdrawal by Subject|76|||
146259618|NCT00129649|527465289|FG001|Overall Study|Withdrawal by Subject|65|||
146259619|NCT02482935|527465293|FG000|Period 1|Withdrawal by Subject|1|||
146259620|NCT02482935|527465294|FG001|Period 1|Withdrawal by Subject|0|||
146301723|NCT00646906|527620061|FG005|Crossover Period 1|Withdrawal by Subject|1|||
146301724|NCT00646906|527620062|FG006|Crossover Period 1|Withdrawal by Subject|0|||
146301725|NCT00646906|527620056|FG000|Crossover Period 2|Withdrawal by Subject|0|||
146301726|NCT00646906|527620057|FG001|Crossover Period 2|Withdrawal by Subject|1|||
146301727|NCT00646906|527620058|FG002|Crossover Period 2|Withdrawal by Subject|2|||
146112301|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112302|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
146112303|NCT03129100|526929005|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112304|NCT03129100|526929006|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112305|NCT03129100|526929007|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112306|NCT03129100|526929008|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112307|NCT03129100|526929009|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
146112308|NCT03129100|526929010|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
146112309|NCT03129100|526929011|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
146112310|NCT03129100|526929012|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112311|NCT03129100|526929013|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112312|NCT03129100|526929014|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112313|NCT03129100|526929015|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112314|NCT03129100|526929016|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112315|NCT03129100|526929017|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112316|NCT03129100|526929018|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112317|NCT03129100|526929019|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112318|NCT03129100|526929020|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112319|NCT03129100|526929021|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112320|NCT03129100|526929022|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112321|NCT03129100|526929023|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112322|NCT03129100|526929024|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112323|NCT03129100|526929025|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112324|NCT03129100|526929026|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112325|NCT03129100|526929027|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112326|NCT03129100|526929028|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112327|NCT03129100|526929029|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112328|NCT03129100|526929030|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
146112329|NCT03129100|526929005|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112330|NCT03129100|526929006|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112331|NCT03129100|526929007|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112332|NCT03129100|526929008|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112333|NCT03129100|526929009|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112334|NCT03129100|526929010|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112335|NCT03129100|526929011|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112336|NCT03129100|526929012|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112337|NCT03129100|526929013|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112338|NCT03129100|526929014|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
146112339|NCT03129100|526929015|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112340|NCT03129100|526929016|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112341|NCT03129100|526929017|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112342|NCT03129100|526929018|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112343|NCT03129100|526929019|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112344|NCT03129100|526929020|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112345|NCT03129100|526929021|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112346|NCT03129100|526929022|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112347|NCT03129100|526929023|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112348|NCT03129100|526929024|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112349|NCT03129100|526929025|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112350|NCT03129100|526929026|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112351|NCT03129100|526929027|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112352|NCT03129100|526929028|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112353|NCT03129100|526929029|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112354|NCT03129100|526929030|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
146112355|NCT03129100|526929005|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112356|NCT03129100|526929006|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146259621|NCT03503162|527465295|FG000|Overall Study|did not meet eligibility|1|||
146259622|NCT02835092|527465296|FG000|Overall Study|Withdrawal by Subject|3|||
146259623|NCT02835092|527465297|FG001|Overall Study|Withdrawal by Subject|6|||
146259624|NCT02835092|527465298|FG002|Overall Study|Withdrawal by Subject|3|||
146259625|NCT02835092|527465296|FG000|Overall Study|Lost to Follow-up|0|||
146259626|NCT02835092|527465297|FG001|Overall Study|Lost to Follow-up|2|||
146259627|NCT02835092|527465298|FG002|Overall Study|Lost to Follow-up|0|||
146301728|NCT00646906|527620059|FG003|Crossover Period 2|Withdrawal by Subject|1|||
146301729|NCT00646906|527620060|FG004|Crossover Period 2|Withdrawal by Subject|0|||
146301730|NCT00646906|527620061|FG005|Crossover Period 2|Withdrawal by Subject|0|||
146301731|NCT00646906|527620062|FG006|Crossover Period 2|Withdrawal by Subject|0|||
146301732|NCT00646906|527620056|FG000|Crossover Period 2|Physician Decision|0|||
146301733|NCT00646906|527620057|FG001|Crossover Period 2|Physician Decision|0|||
146301734|NCT00646906|527620058|FG002|Crossover Period 2|Physician Decision|0|||
146301735|NCT00646906|527620059|FG003|Crossover Period 2|Physician Decision|0|||
146301736|NCT00646906|527620060|FG004|Crossover Period 2|Physician Decision|0|||
146301737|NCT00646906|527620061|FG005|Crossover Period 2|Physician Decision|0|||
146301738|NCT00646906|527620062|FG006|Crossover Period 2|Physician Decision|1|||
146301739|NCT02448225|527620064|FG000|Overall Study|Withdrawal by Subject|1|||
146301740|NCT02448225|527620064|FG000|Overall Study|Did not get FSPG scan|18|||
146301741|NCT02448225|527620064|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
146301742|NCT04060563|527620065|FG000|Overall Study|Lost to Follow-up|1|||
146301743|NCT04060563|527620066|FG001|Overall Study|Lost to Follow-up|1|||
146301744|NCT04060563|527620065|FG000|Overall Study|Physician Decision|0|||
146301745|NCT04060563|527620066|FG001|Overall Study|Physician Decision|1|||
146301746|NCT00851682|527620069|FG000|Overall Study|screen failure|5|||
146301747|NCT00851682|527620070|FG001|Overall Study|screen failure|0|||
146301748|NCT01379573|527620075|FG000|Overall Study|Lost to Follow-up|1|||
146301749|NCT01379573|527620075|FG000|Overall Study|Screen Failure|10|||
146301750|NCT00962390|527620076|FG000|Overall Study|Adverse Event|0|||
146301751|NCT00962390|527620077|FG001|Overall Study|Adverse Event|0|||
146301752|NCT00962390|527620078|FG002|Overall Study|Adverse Event|3|||
146301753|NCT00962390|527620079|FG003|Overall Study|Adverse Event|1|||
146301754|NCT00962390|527620076|FG000|Overall Study|Lost to Follow-up|2|||
146301755|NCT00962390|527620077|FG001|Overall Study|Lost to Follow-up|2|||
146301756|NCT00962390|527620078|FG002|Overall Study|Lost to Follow-up|0|||
146301757|NCT00962390|527620079|FG003|Overall Study|Lost to Follow-up|0|||
146301758|NCT00962390|527620076|FG000|Overall Study|Protocol Violation|1|||
146301759|NCT00962390|527620077|FG001|Overall Study|Protocol Violation|0|||
146301760|NCT00962390|527620078|FG002|Overall Study|Protocol Violation|0|||
146301761|NCT00962390|527620079|FG003|Overall Study|Protocol Violation|0|||
146301762|NCT00962390|527620076|FG000|Overall Study|Withdrawal by Subject|1|||
146301763|NCT00962390|527620077|FG001|Overall Study|Withdrawal by Subject|1|||
146301764|NCT00962390|527620078|FG002|Overall Study|Withdrawal by Subject|1|||
146301765|NCT00962390|527620079|FG003|Overall Study|Withdrawal by Subject|0|||
146301766|NCT02613884|527620080|FG000|Overall Study|Death|1|||
146301767|NCT02613884|527620080|FG000|Overall Study|Lost to Follow-up|1|||
146301768|NCT04422990|527620081|FG000|Overall Study|Withdrawal by Subject|0|||
146301769|NCT04422990|527620082|FG001|Overall Study|Withdrawal by Subject|1|||
146301770|NCT04422990|527620081|FG000|Overall Study|Travel|3|||
146301771|NCT04422990|527620082|FG001|Overall Study|Travel|0|||
146301772|NCT02844920|527620085|FG000|Overall Study|Lost to Follow-up|2|||
146301773|NCT02486653|527620088|FG000|Overall Study|Withdrawal by Subject|1|||
146301774|NCT02486653|527620089|FG001|Overall Study|Withdrawal by Subject|3|||
146301775|NCT02486653|527620088|FG000|Overall Study|Protocol Violation|1|||
146301776|NCT02486653|527620089|FG001|Overall Study|Protocol Violation|0|||
146259628|NCT00025506|527465299|FG000|Overall Study|Ineligible: clerical error|1|||
146259629|NCT00025506|527465299|FG000|Overall Study|Ineligible: wrong cell type|5|||
146259630|NCT00025506|527465299|FG000|Overall Study|Ineligible: inadequate pathology|2|||
146259631|NCT00025506|527465299|FG000|Overall Study|Never Treated|2|||
146259632|NCT00713206|527465300|FG000|Overall Study|Lost to Follow-up|4|||
146259633|NCT00713206|527465301|FG001|Overall Study|Lost to Follow-up|4|||
146259634|NCT00713206|527465300|FG000|Overall Study|Death|1|||
146259635|NCT00713206|527465301|FG001|Overall Study|Death|0|||
146259636|NCT00920699|527465304|FG000|Overall Study|Withdrawal by Subject|2|||
146259637|NCT00920699|527465305|FG001|Overall Study|Withdrawal by Subject|0|||
146112357|NCT03129100|526929007|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112358|NCT03129100|526929008|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112359|NCT03129100|526929009|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112360|NCT03129100|526929010|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112361|NCT03129100|526929011|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112362|NCT03129100|526929012|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146259638|NCT00920699|527465306|FG002|Overall Study|Withdrawal by Subject|2|||
146259639|NCT00920699|527465304|FG000|Overall Study|no longer met eligibility|0|||
146259640|NCT00920699|527465305|FG001|Overall Study|no longer met eligibility|1|||
146259641|NCT00920699|527465306|FG002|Overall Study|no longer met eligibility|0|||
146301777|NCT02486653|527620088|FG000|Overall Study|surgery cancelled|4|||
146259642|NCT00920699|527465304|FG000|Overall Study|Lost to Follow-up|0|||
146259643|NCT00920699|527465305|FG001|Overall Study|Lost to Follow-up|0|||
146259644|NCT00920699|527465306|FG002|Overall Study|Lost to Follow-up|2|||
146301778|NCT02486653|527620089|FG001|Overall Study|surgery cancelled|1|||
146301779|NCT00131469|527620096|FG000|Overall Study|Withdrawal by Subject|3|||
146301780|NCT00131469|527620097|FG001|Overall Study|Withdrawal by Subject|4|||
146301781|NCT00131469|527620096|FG000|Overall Study|Protocol Violation|3|||
146259645|NCT00001941|527465307|FG000|Overall Study|not treated- rapidly progressing disease|0|||
146259646|NCT00001941|527465308|FG001|Overall Study|not treated- rapidly progressing disease|0|||
146259647|NCT00001941|527465309|FG002|Overall Study|not treated- rapidly progressing disease|0|||
146259648|NCT00001941|527465310|FG003|Overall Study|not treated- rapidly progressing disease|0|||
146259649|NCT00001941|527465311|FG004|Overall Study|not treated- rapidly progressing disease|1|||
146259650|NCT01527500|527465313|FG000|Part A|Administrative|11|||
146259651|NCT01527500|527465314|FG001|Part A|Administrative|7|||
146259652|NCT01527500|527465313|FG000|Part A|Adverse Event|4|||
146259653|NCT01527500|527465314|FG001|Part A|Adverse Event|2|||
146259654|NCT01527500|527465313|FG000|Part A|Death|4|||
146259655|NCT01527500|527465314|FG001|Part A|Death|1|||
146259656|NCT01527500|527465313|FG000|Part A|Lost to Follow-up|0|||
146259657|NCT01527500|527465314|FG001|Part A|Lost to Follow-up|1|||
146259658|NCT01527500|527465313|FG000|Part A|Protocol Deviation|9|||
146259659|NCT01527500|527465314|FG001|Part A|Protocol Deviation|2|||
146259660|NCT01527500|527465313|FG000|Part A|Withdrawal by Subject|2|||
146259661|NCT01527500|527465314|FG001|Part A|Withdrawal by Subject|0|||
146259662|NCT01527500|527465313|FG000|Part B|Adverse Event|1|||
146259663|NCT01527500|527465314|FG001|Part B|Adverse Event|0|||
146259664|NCT02864342|527465315|FG000|Overall Study|Eligibility Criteria Deviation|2|||
146259665|NCT02864342|527465316|FG001|Overall Study|Eligibility Criteria Deviation|3|||
146259666|NCT02864342|527465315|FG000|Overall Study|Withdrawal by Subject|4|||
146259667|NCT02864342|527465316|FG001|Overall Study|Withdrawal by Subject|2|||
146259668|NCT02864342|527465315|FG000|Overall Study|Device Technology Issue|6|||
146112363|NCT03129100|526929013|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112364|NCT03129100|526929014|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112365|NCT03129100|526929015|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112366|NCT03129100|526929016|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
146112367|NCT03129100|526929017|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112368|NCT03129100|526929018|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112369|NCT03129100|526929019|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112370|NCT03129100|526929020|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112371|NCT03129100|526929021|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112372|NCT03129100|526929022|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112373|NCT03129100|526929023|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112374|NCT03129100|526929024|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112375|NCT03129100|526929025|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112376|NCT03129100|526929026|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112377|NCT03129100|526929027|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112378|NCT03129100|526929028|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112379|NCT03129100|526929029|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112380|NCT03129100|526929030|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
146112381|NCT03129100|526929005|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112382|NCT03129100|526929006|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112383|NCT03129100|526929007|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112384|NCT03129100|526929008|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112385|NCT03129100|526929009|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112386|NCT03129100|526929010|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112387|NCT03129100|526929011|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112388|NCT03129100|526929012|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112389|NCT03129100|526929013|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112390|NCT03129100|526929014|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112391|NCT03129100|526929015|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112392|NCT03129100|526929016|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
146112393|NCT03129100|526929017|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
146112394|NCT03129100|526929018|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
146112395|NCT03129100|526929019|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
146112396|NCT03129100|526929020|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112397|NCT03129100|526929021|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112398|NCT03129100|526929022|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112399|NCT03129100|526929023|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112400|NCT03129100|526929024|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112401|NCT03129100|526929025|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112402|NCT03129100|526929026|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146259669|NCT02864342|527465316|FG001|Overall Study|Device Technology Issue|7|||
146259670|NCT02864342|527465315|FG000|Overall Study|Death|0|||
146259671|NCT02864342|527465316|FG001|Overall Study|Death|1|||
146259672|NCT02864342|527465315|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
146259673|NCT02864342|527465316|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
146112403|NCT03129100|526929027|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112404|NCT03129100|526929028|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112405|NCT03129100|526929029|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112406|NCT03129100|526929030|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
146112407|NCT03129100|526929005|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112408|NCT03129100|526929006|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112409|NCT03129100|526929007|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112410|NCT03129100|526929008|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112411|NCT03129100|526929009|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112412|NCT03129100|526929010|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112413|NCT03129100|526929011|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112414|NCT03129100|526929012|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112415|NCT03129100|526929013|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112416|NCT03129100|526929014|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112417|NCT03129100|526929015|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112418|NCT03129100|526929016|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146112419|NCT03129100|526929017|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112420|NCT03129100|526929018|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146112421|NCT03129100|526929019|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
146112422|NCT03129100|526929020|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112423|NCT03129100|526929021|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112424|NCT03129100|526929022|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112425|NCT03129100|526929023|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112426|NCT03129100|526929024|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112427|NCT03129100|526929025|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112428|NCT03129100|526929026|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112429|NCT03129100|526929027|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112430|NCT03129100|526929028|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112431|NCT03129100|526929029|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112432|NCT03129100|526929030|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
146112433|NCT03129100|526929005|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112434|NCT03129100|526929006|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112435|NCT03129100|526929007|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112436|NCT03129100|526929008|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112437|NCT03129100|526929009|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112438|NCT03129100|526929010|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112439|NCT03129100|526929011|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112440|NCT03129100|526929012|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112441|NCT03129100|526929013|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112442|NCT03129100|526929014|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112443|NCT03129100|526929015|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112444|NCT03129100|526929016|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112445|NCT03129100|526929017|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112446|NCT03129100|526929018|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112447|NCT03129100|526929019|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112448|NCT03129100|526929020|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
146112449|NCT03129100|526929021|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112450|NCT03129100|526929022|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112451|NCT03129100|526929023|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112452|NCT03129100|526929024|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112453|NCT03129100|526929025|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112454|NCT03129100|526929026|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112455|NCT03129100|526929027|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112456|NCT03129100|526929028|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112457|NCT03129100|526929029|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112458|NCT03129100|526929030|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
146112459|NCT03129100|526929005|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112460|NCT03129100|526929006|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112461|NCT03129100|526929007|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146259674|NCT02864342|527465315|FG000|Overall Study|Lost to Follow-up|1|||
146259675|NCT02864342|527465316|FG001|Overall Study|Lost to Follow-up|5|||
146259676|NCT02864342|527465315|FG000|Overall Study|Lost Device|1|||
146259677|NCT02864342|527465316|FG001|Overall Study|Lost Device|0|||
146259678|NCT02864342|527465315|FG000|Overall Study|Adverse Event|1|||
146259679|NCT02864342|527465316|FG001|Overall Study|Adverse Event|0|||
146259680|NCT02573883|527465317|FG000|Six Month Follow Up|Lost to Follow-up|1|||
146259681|NCT02573883|527465318|FG001|Six Month Follow Up|Lost to Follow-up|0|||
146259682|NCT02573883|527465319|FG002|Six Month Follow Up|Lost to Follow-up|0|||
146259683|NCT02573883|527465320|FG003|Six Month Follow Up|Lost to Follow-up|0|||
146259684|NCT02573883|527465317|FG000|One Year Follow Up|Lost to Follow-up|2|||
146259685|NCT02573883|527465318|FG001|One Year Follow Up|Lost to Follow-up|1|||
146259686|NCT02573883|527465319|FG002|One Year Follow Up|Lost to Follow-up|0|||
146259687|NCT02573883|527465320|FG003|One Year Follow Up|Lost to Follow-up|0|||
146259688|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
146259689|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
146259690|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
146259691|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
146259692|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
146259693|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
146259694|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
146259695|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
146259696|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
146259697|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
146259698|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
146259699|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
146259700|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
146259701|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
146259702|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
146259703|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
146259704|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
146259705|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
146259706|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
146259707|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
146259708|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
146259709|NCT01125566|527465326|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
146259710|NCT01125566|527465327|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
146259711|NCT01125566|527465328|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
146259712|NCT01125566|527465326|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
146259713|NCT01125566|527465327|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
146259714|NCT01125566|527465328|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
146259715|NCT01125566|527465326|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
146259716|NCT01125566|527465327|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
146259717|NCT01125566|527465328|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
146259718|NCT01125566|527465326|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
146259719|NCT01125566|527465327|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
146259720|NCT01125566|527465328|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
146259721|NCT01125566|527465326|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
146259722|NCT01125566|527465327|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
146259723|NCT01125566|527465328|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
146259724|NCT01560585|527465329|FG000|Overall Study|Physician Decision|3|||
146259725|NCT00519285|527465330|FG000|Overall Study|Adverse Event|127|||
146259726|NCT00519285|527465331|FG001|Overall Study|Adverse Event|266|||
146259727|NCT00519285|527465330|FG000|Overall Study|Disease progression|334|||
146259728|NCT00519285|527465331|FG001|Overall Study|Disease progression|186|||
146259729|NCT00519285|527465330|FG000|Overall Study|Physician Decision|75|||
146259730|NCT00519285|527465331|FG001|Overall Study|Physician Decision|47|||
146259731|NCT00519285|527465330|FG000|Overall Study|Participant's request|53|||
146259732|NCT00519285|527465331|FG001|Overall Study|Participant's request|84|||
146259733|NCT00519285|527465330|FG000|Overall Study|Consent withdrawn|4|||
146112462|NCT03129100|526929008|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112463|NCT03129100|526929009|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112464|NCT03129100|526929010|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112465|NCT03129100|526929011|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112466|NCT03129100|526929012|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112467|NCT03129100|526929013|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112468|NCT03129100|526929014|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112469|NCT03129100|526929015|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112470|NCT03129100|526929016|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112471|NCT03129100|526929017|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
146112472|NCT03129100|526929018|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112473|NCT03129100|526929019|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
146112474|NCT03129100|526929020|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
146259734|NCT00519285|527465331|FG001|Overall Study|Consent withdrawn|5|||
146259735|NCT00519285|527465330|FG000|Overall Study|Poor compliance to protocol|5|||
146259736|NCT00519285|527465331|FG001|Overall Study|Poor compliance to protocol|7|||
146259737|NCT00519285|527465330|FG000|Overall Study|Reason unspecified|5|||
146259738|NCT00519285|527465331|FG001|Overall Study|Reason unspecified|8|||
146259739|NCT00519285|527465330|FG000|Overall Study|Not treated|8|||
146259740|NCT00519285|527465331|FG001|Overall Study|Not treated|7|||
146259741|NCT00519285|527465330|FG000|Overall Study|Treatment ongoing|1|||
146259742|NCT00519285|527465331|FG001|Overall Study|Treatment ongoing|2|||
146259743|NCT02970305|527465332|FG000|Overall Study|Adverse Event|10|||
146259744|NCT02970305|527465333|FG001|Overall Study|Adverse Event|6|||
146259745|NCT02970305|527465332|FG000|Overall Study|Lack of Efficacy|1|||
146259746|NCT02970305|527465333|FG001|Overall Study|Lack of Efficacy|1|||
146259747|NCT02970305|527465332|FG000|Overall Study|Noncompliance with study drug|2|||
146259748|NCT02970305|527465333|FG001|Overall Study|Noncompliance with study drug|4|||
146259749|NCT02970305|527465332|FG000|Overall Study|Protocol Violation|2|||
146259750|NCT02970305|527465333|FG001|Overall Study|Protocol Violation|2|||
146259751|NCT02970305|527465332|FG000|Overall Study|Withdrawal by Subject|12|||
146259752|NCT02970305|527465333|FG001|Overall Study|Withdrawal by Subject|11|||
146259753|NCT02970305|527465332|FG000|Overall Study|Not further specified|1|||
146259754|NCT02970305|527465333|FG001|Overall Study|Not further specified|2|||
146259755|NCT02970305|527465332|FG000|Overall Study|Lost to Follow-up|1|||
146259756|NCT02970305|527465333|FG001|Overall Study|Lost to Follow-up|2|||
146259757|NCT01813305|527465335|FG000|Overall Study|Withdrawal by Subject|12|||
146259758|NCT01813305|527465336|FG001|Overall Study|Withdrawal by Subject|5|||
146259759|NCT01813305|527465335|FG000|Overall Study|Safety Concern|4|||
146259760|NCT01813305|527465336|FG001|Overall Study|Safety Concern|0|||
146259761|NCT01813305|527465335|FG000|Overall Study|Ulcer became worse|4|||
146259762|NCT01813305|527465336|FG001|Overall Study|Ulcer became worse|0|||
146259763|NCT01813305|527465335|FG000|Overall Study|Physician Decision|4|||
146259764|NCT01813305|527465336|FG001|Overall Study|Physician Decision|0|||
146259765|NCT01813305|527465335|FG000|Overall Study|Lost to Follow-up|3|||
146259766|NCT01813305|527465336|FG001|Overall Study|Lost to Follow-up|1|||
146259767|NCT01813305|527465335|FG000|Overall Study|Protocol Violation|1|||
146259768|NCT01813305|527465336|FG001|Overall Study|Protocol Violation|0|||
146259769|NCT01813305|527465335|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
146259770|NCT01813305|527465336|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
146259771|NCT00988117|527465337|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
146259772|NCT00988117|527465337|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
146259773|NCT04088500|527465338|FG000|Overall Study|Reason unknown|1|||
146259774|NCT04088500|527465338|FG000|Overall Study|Participant withdrew consent|1|||
146259775|NCT04088500|527465338|FG000|Overall Study|Disease progression|3|||
146259776|NCT02930837|527465342|FG000|Overall Study|Adverse Event|6|||
146259777|NCT02930837|527465342|FG000|Overall Study|Lost to Follow-up|5|||
146259778|NCT02930837|527465342|FG000|Overall Study|Withdrawal by Subject|1|||
146259779|NCT04582864|527465343|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
146259780|NCT04582864|527465343|FG000|Overall Study|Death|1|||
146259781|NCT00006436|527465344|FG000|Overall Study|Refused further treatment|2|||
146259782|NCT00006436|527465344|FG000|Overall Study|Declined to participate (before treatment started)|1|||
146259783|NCT01071317|527465345|FG000|Overall Study|Lost to Follow-up|2|||
146259784|NCT01071317|527465346|FG001|Overall Study|Lost to Follow-up|2|||
146259785|NCT01502371|527465353|FG000|Overall Study|Withdrawal by Subject|1|||
146259786|NCT01502371|527465354|FG001|Overall Study|Withdrawal by Subject|2|||
146259787|NCT01502371|527465355|FG002|Overall Study|Withdrawal by Subject|1|||
146259788|NCT01502371|527465356|FG003|Overall Study|Withdrawal by Subject|1|||
146259789|NCT01502371|527465357|FG004|Overall Study|Withdrawal by Subject|1|||
146259790|NCT01502371|527465353|FG000|Overall Study|Adverse Event|2|||
146259791|NCT01502371|527465354|FG001|Overall Study|Adverse Event|1|||
146259792|NCT01502371|527465355|FG002|Overall Study|Adverse Event|0|||
146259793|NCT01502371|527465356|FG003|Overall Study|Adverse Event|4|||
146259794|NCT01502371|527465357|FG004|Overall Study|Adverse Event|3|||
146259795|NCT01502371|527465353|FG000|Overall Study|Treatment Failure|22|||
146259796|NCT01502371|527465354|FG001|Overall Study|Treatment Failure|20|||
146259797|NCT01502371|527465355|FG002|Overall Study|Treatment Failure|12|||
146259798|NCT01502371|527465356|FG003|Overall Study|Treatment Failure|19|||
146259799|NCT01502371|527465357|FG004|Overall Study|Treatment Failure|30|||
146259800|NCT01502371|527465353|FG000|Overall Study|Lack of Efficacy|3|||
146259801|NCT01502371|527465354|FG001|Overall Study|Lack of Efficacy|3|||
146259802|NCT01502371|527465355|FG002|Overall Study|Lack of Efficacy|2|||
146259803|NCT01502371|527465356|FG003|Overall Study|Lack of Efficacy|2|||
146259804|NCT01502371|527465357|FG004|Overall Study|Lack of Efficacy|4|||
146259805|NCT01502371|527465353|FG000|Overall Study|Physician Decision|3|||
146259806|NCT01502371|527465354|FG001|Overall Study|Physician Decision|0|||
146259807|NCT01502371|527465355|FG002|Overall Study|Physician Decision|0|||
146259808|NCT01502371|527465356|FG003|Overall Study|Physician Decision|0|||
146259809|NCT01502371|527465357|FG004|Overall Study|Physician Decision|1|||
146259810|NCT01502371|527465353|FG000|Overall Study|Noncompliance with Study Drug|0|||
146259811|NCT01502371|527465354|FG001|Overall Study|Noncompliance with Study Drug|0|||
146259812|NCT01502371|527465355|FG002|Overall Study|Noncompliance with Study Drug|1|||
146259813|NCT01502371|527465356|FG003|Overall Study|Noncompliance with Study Drug|2|||
146112475|NCT03129100|526929021|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112476|NCT03129100|526929022|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112477|NCT03129100|526929023|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112478|NCT03129100|526929024|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112479|NCT03129100|526929025|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112480|NCT03129100|526929026|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112481|NCT03129100|526929027|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112482|NCT03129100|526929028|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112483|NCT03129100|526929029|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112484|NCT03129100|526929030|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
146112485|NCT03129100|526929005|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112486|NCT03129100|526929006|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112487|NCT03129100|526929007|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112488|NCT03129100|526929008|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112489|NCT03129100|526929009|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112490|NCT03129100|526929010|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112491|NCT03129100|526929011|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112492|NCT03129100|526929012|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112493|NCT03129100|526929013|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112494|NCT03129100|526929014|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112495|NCT03129100|526929015|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112496|NCT03129100|526929016|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112497|NCT03129100|526929017|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112498|NCT03129100|526929018|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112499|NCT03129100|526929019|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112500|NCT03129100|526929020|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112501|NCT03129100|526929021|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112502|NCT03129100|526929022|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
146112503|NCT03129100|526929023|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112504|NCT03129100|526929024|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
146112505|NCT03129100|526929025|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112506|NCT03129100|526929026|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112507|NCT03129100|526929027|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112508|NCT03129100|526929028|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112509|NCT03129100|526929029|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112510|NCT03129100|526929030|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
146112511|NCT03129100|526929005|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112512|NCT03129100|526929006|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112513|NCT03129100|526929007|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112514|NCT03129100|526929008|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112515|NCT03129100|526929009|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112516|NCT03129100|526929010|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112517|NCT03129100|526929011|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112518|NCT03129100|526929012|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112519|NCT03129100|526929013|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112520|NCT03129100|526929014|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112521|NCT03129100|526929015|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112522|NCT03129100|526929016|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112523|NCT03129100|526929017|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112524|NCT03129100|526929018|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112525|NCT03129100|526929019|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112526|NCT03129100|526929020|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112527|NCT03129100|526929021|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112528|NCT03129100|526929022|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112529|NCT03129100|526929023|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112530|NCT03129100|526929024|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112531|NCT03129100|526929025|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
146112532|NCT03129100|526929026|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146259814|NCT01502371|527465357|FG004|Overall Study|Noncompliance with Study Drug|1|||
146112533|NCT03129100|526929027|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112534|NCT03129100|526929028|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112535|NCT03129100|526929029|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146112536|NCT03129100|526929030|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
146259815|NCT01502371|527465353|FG000|Overall Study|Technical Problems|1|||
146259816|NCT01502371|527465354|FG001|Overall Study|Technical Problems|0|||
146259817|NCT01502371|527465355|FG002|Overall Study|Technical Problems|2|||
146259818|NCT01502371|527465356|FG003|Overall Study|Technical Problems|4|||
146259819|NCT01502371|527465357|FG004|Overall Study|Technical Problems|1|||
146259820|NCT01502371|527465353|FG000|Overall Study|Protocol Violation|9|||
146259821|NCT01502371|527465354|FG001|Overall Study|Protocol Violation|5|||
146259822|NCT01502371|527465355|FG002|Overall Study|Protocol Violation|6|||
146259823|NCT01502371|527465356|FG003|Overall Study|Protocol Violation|5|||
146259824|NCT01502371|527465357|FG004|Overall Study|Protocol Violation|10|||
146259825|NCT01502371|527465353|FG000|Overall Study|Excluded Medication|0|||
146259826|NCT01502371|527465354|FG001|Overall Study|Excluded Medication|1|||
146259827|NCT01502371|527465355|FG002|Overall Study|Excluded Medication|1|||
146259828|NCT01502371|527465356|FG003|Overall Study|Excluded Medication|0|||
146259829|NCT01502371|527465357|FG004|Overall Study|Excluded Medication|1|||
146259830|NCT02598934|527465363|FG000|Overall Study|Adverse Event|11|||
146259831|NCT02598934|527465364|FG001|Overall Study|Adverse Event|13|||
146259832|NCT02598934|527465363|FG000|Overall Study|Failure to Return|3|||
146259833|NCT02598934|527465364|FG001|Overall Study|Failure to Return|3|||
146259834|NCT02598934|527465363|FG000|Overall Study|Withdrawal by Subject|2|||
146259835|NCT02598934|527465364|FG001|Overall Study|Withdrawal by Subject|3|||
146259836|NCT02598934|527465363|FG000|Overall Study|Administrative|2|||
146259837|NCT02598934|527465364|FG001|Overall Study|Administrative|1|||
146259838|NCT02598934|527465363|FG000|Overall Study|Protocol Violation|1|||
146259839|NCT02598934|527465364|FG001|Overall Study|Protocol Violation|2|||
146259840|NCT02481934|527465365|FG000|Overall Study|Death|2|||
146259841|NCT03749616|527465369|FG000|Overall Study|Lost to Follow-up|4|||
146259842|NCT03749616|527465370|FG001|Overall Study|Lost to Follow-up|7|||
146259843|NCT03749616|527465369|FG000|Overall Study|Screen Failure|1|||
146259844|NCT03749616|527465370|FG001|Overall Study|Screen Failure|1|||
146259845|NCT03749616|527465369|FG000|Overall Study|Withdrawal by Subject|2|||
146259846|NCT03749616|527465370|FG001|Overall Study|Withdrawal by Subject|0|||
146259847|NCT03302559|527465373|FG000|Overall Study|Adverse Event|2|||
146259848|NCT03302559|527465373|FG000|Overall Study|Lost to Follow-up|1|||
146259849|NCT03302559|527465373|FG000|Overall Study|Withdrew Consent|3|||
146259850|NCT00605566|527467162|FG000|Overall Study|Adverse Event|1|||
146259851|NCT00605566|527467162|FG000|Overall Study|Clinical deterioration|1|||
146259852|NCT00605566|527467162|FG000|Overall Study|Poor compliance in run-in period|1|||
146259853|NCT03864341|527467165|FG000|Overall Study|Withdrawal by Subject|1|||
146259854|NCT01066936|527467166|FG000|Overall Study|Death|2|||
146259855|NCT01066936|527467166|FG000|Overall Study|Device revised/removed|1|||
146259856|NCT01066936|527467166|FG000|Overall Study|Lost to Follow-up|3|||
146259857|NCT01066936|527467166|FG000|Overall Study|Withdrawal by Subject|4|||
146259858|NCT00695136|527467167|FG000|Overall Study|Withdrawal by Subject|1|||
146259859|NCT00695136|527467167|FG000|Overall Study|unrelated adverse event|1|||
146259860|NCT01726049|527467169|FG000|Overall Study|Death|1|||
146259861|NCT01726049|527467170|FG001|Overall Study|Death|1|||
146259862|NCT01726049|527467169|FG000|Overall Study|Adverse Event|4|||
146259863|NCT01726049|527467170|FG001|Overall Study|Adverse Event|1|||
146259864|NCT01726049|527467169|FG000|Overall Study|refused second HC|0|||
146259865|NCT01726049|527467170|FG001|Overall Study|refused second HC|2|||
146259866|NCT02202109|527467173|FG000|Overall Study|Lost to Follow-up|88|||
146259867|NCT02202109|527467174|FG001|Overall Study|Lost to Follow-up|87|||
146259868|NCT02202109|527467173|FG000|Overall Study|Withdrawal by Subject|2|||
146259869|NCT02202109|527467174|FG001|Overall Study|Withdrawal by Subject|0|||
146259870|NCT04156399|527467181|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
146259871|NCT04156399|527467181|FG000|Overall Study|study suspension due to COVID pandemic|3|||
146259872|NCT01333111|527467184|FG000|Overall Study|patient undergoing major surgery|0|||
146259873|NCT01333111|527467185|FG001|Overall Study|patient undergoing major surgery|2|||
146259874|NCT01333111|527467186|FG002|Overall Study|patient undergoing major surgery|0|||
146259875|NCT01333111|527467184|FG000|Overall Study|personal reasons|0|||
146259876|NCT01333111|527467185|FG001|Overall Study|personal reasons|0|||
146259877|NCT01333111|527467186|FG002|Overall Study|personal reasons|1|||
146259878|NCT01333111|527467184|FG000|Overall Study|unclassified|1|||
146259879|NCT01333111|527467185|FG001|Overall Study|unclassified|0|||
146259880|NCT01333111|527467186|FG002|Overall Study|unclassified|0|||
146301782|NCT00131469|527620097|FG001|Overall Study|Protocol Violation|1|||
146301783|NCT00131469|527620096|FG000|Overall Study|Death|0|||
146259881|NCT01333111|527467184|FG000|Overall Study|withdrawal criteria|0|||
146259882|NCT01333111|527467185|FG001|Overall Study|withdrawal criteria|1|||
146259883|NCT01333111|527467186|FG002|Overall Study|withdrawal criteria|0|||
146259884|NCT01333111|527467184|FG000|Overall Study|Non-compliance|1|||
146259885|NCT01333111|527467185|FG001|Overall Study|Non-compliance|0|||
146259886|NCT01333111|527467186|FG002|Overall Study|Non-compliance|0|||
146259887|NCT01333111|527467184|FG000|Overall Study|Ineffective therapy|0|||
146259888|NCT01333111|527467185|FG001|Overall Study|Ineffective therapy|0|||
146259889|NCT01333111|527467186|FG002|Overall Study|Ineffective therapy|1|||
146259890|NCT00320398|527467196|FG000|Overall Study|Adverse Event|1|||
146259891|NCT00320398|527467197|FG001|Overall Study|Adverse Event|4|||
146259892|NCT00320398|527467196|FG000|Overall Study|Other|1|||
146259893|NCT00320398|527467197|FG001|Overall Study|Other|0|||
146301784|NCT00131469|527620097|FG001|Overall Study|Death|1|||
146301785|NCT00131469|527620096|FG000|Overall Study|Lost to Follow-up|0|||
146301786|NCT00131469|527620097|FG001|Overall Study|Lost to Follow-up|1|||
146301787|NCT00131469|527620096|FG000|Overall Study|scan not analyzable|3|||
146112537|NCT03129100|526929005|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
146112538|NCT03129100|526929006|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
146112539|NCT03129100|526929007|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
146112540|NCT03129100|526929008|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
146112541|NCT03129100|526929009|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
146112542|NCT03129100|526929010|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
146112543|NCT03129100|526929011|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
146112544|NCT03129100|526929012|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
146112545|NCT03129100|526929013|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
146112546|NCT03129100|526929014|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
146112547|NCT03129100|526929015|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
146112548|NCT03129100|526929016|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
146112549|NCT03129100|526929017|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
146112550|NCT03129100|526929018|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
146112551|NCT03129100|526929019|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
146112552|NCT03129100|526929020|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
146112553|NCT03129100|526929021|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
146112554|NCT03129100|526929022|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
146112555|NCT03129100|526929023|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
146112556|NCT03129100|526929024|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
146112557|NCT03129100|526929025|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
146112558|NCT03129100|526929026|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
146112559|NCT03129100|526929027|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
146112560|NCT03129100|526929028|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
146112561|NCT03129100|526929029|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
146112562|NCT03129100|526929030|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
146112563|NCT03129100|526929005|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112564|NCT03129100|526929006|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112565|NCT03129100|526929007|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112566|NCT03129100|526929008|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112567|NCT03129100|526929009|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112568|NCT03129100|526929010|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112569|NCT03129100|526929011|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112570|NCT03129100|526929012|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112571|NCT03129100|526929013|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112572|NCT03129100|526929014|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112573|NCT03129100|526929015|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112574|NCT03129100|526929016|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112575|NCT03129100|526929017|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112576|NCT03129100|526929018|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112577|NCT03129100|526929019|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112578|NCT03129100|526929020|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112579|NCT03129100|526929021|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112580|NCT03129100|526929022|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112581|NCT03129100|526929023|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112582|NCT03129100|526929024|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112583|NCT03129100|526929025|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
146112584|NCT03129100|526929026|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112585|NCT03129100|526929027|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112586|NCT03129100|526929028|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112587|NCT03129100|526929029|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112588|NCT03129100|526929030|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
146112589|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
146112590|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
146112591|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
146112592|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
146112593|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
146112594|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
146112595|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
146301788|NCT00131469|527620097|FG001|Overall Study|scan not analyzable|6|||
146112596|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
146112597|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
146112598|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
146112599|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
146112600|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
146112601|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
146112602|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
146301789|NCT02871778|527620098|FG000|Part A: Treatment Period 1|Adverse Event|1|||
146301790|NCT02871778|527620099|FG001|Part A: Treatment Period 1|Adverse Event|1|||
146112603|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
146112604|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
146112605|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
146112606|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
146112607|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
146112608|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
146112609|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
146112610|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
146112611|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
146112612|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
146112613|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
146112614|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
146112615|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112616|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112617|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112618|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112619|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112620|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112621|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112622|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112623|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112624|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112625|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112626|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112627|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112628|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112629|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112630|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112631|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112632|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112633|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112634|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112635|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112636|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112637|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112638|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
146112639|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
146112640|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
146112641|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112642|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112643|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112644|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112645|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112646|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112647|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112648|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112649|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112650|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112651|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112652|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112653|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112654|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112655|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112656|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112657|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112658|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112659|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112660|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112661|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112662|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112663|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
146112664|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
146112665|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
146112666|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
146259894|NCT04190225|527467198|FG000|Overall Study|Lost to Follow-up|2|||
146259895|NCT04190225|527467199|FG001|Overall Study|Lost to Follow-up|3|||
146259896|NCT04190225|527467198|FG000|Overall Study|Withdrawal by Subject|3|||
146259897|NCT04190225|527467199|FG001|Overall Study|Withdrawal by Subject|2|||
146259898|NCT04190225|527467198|FG000|Overall Study|Unrelated health condition|2|||
146259899|NCT04190225|527467199|FG001|Overall Study|Unrelated health condition|0|||
146259900|NCT00847132|527467202|FG000|Overall Study|Death|1|||
146259901|NCT00847132|527467203|FG001|Overall Study|Death|1|||
146259902|NCT01057251|527467204|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
146259903|NCT01057251|527467205|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
146259904|NCT01057251|527467204|FG000|Overall Study|Adverse Event|4|||
146259905|NCT01057251|527467205|FG001|Overall Study|Adverse Event|2|||
146112667|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112668|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112669|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112670|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112671|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112672|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112673|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112674|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112675|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112676|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112677|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112678|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112679|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112680|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112681|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112682|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112683|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112684|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112685|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112686|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112687|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112688|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112689|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112690|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112691|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
146112692|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
146112693|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112694|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112695|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112696|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112697|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112698|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112699|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112700|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112701|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112702|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112703|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112704|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112705|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112706|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112707|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112708|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112709|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112710|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112711|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112712|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112713|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112714|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112715|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112716|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112717|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
146112718|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
146112719|NCT03129100|526929005|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
146112720|NCT03129100|526929006|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
146112721|NCT03129100|526929007|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
146259906|NCT01057251|527467204|FG000|Overall Study|Lack of Efficacy|2|||
146259907|NCT01057251|527467205|FG001|Overall Study|Lack of Efficacy|11|||
146301791|NCT02871778|527620100|FG002|Part A: Treatment Period 1|Adverse Event|1|||
146301792|NCT02871778|527620101|FG003|Part A: Treatment Period 1|Adverse Event|0|||
146301793|NCT02871778|527620102|FG004|Part A: Treatment Period 1|Adverse Event|0|||
146259908|NCT01057251|527467204|FG000|Overall Study|Protocol Violation|6|||
146259909|NCT01057251|527467205|FG001|Overall Study|Protocol Violation|2|||
146112722|NCT03129100|526929008|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
146112723|NCT03129100|526929009|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
146112724|NCT03129100|526929010|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
146112725|NCT03129100|526929011|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
146112726|NCT03129100|526929012|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
146112727|NCT03129100|526929013|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
146112728|NCT03129100|526929014|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
146112729|NCT03129100|526929015|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
146112730|NCT03129100|526929016|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
146112731|NCT03129100|526929017|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
146112732|NCT03129100|526929018|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
146112733|NCT03129100|526929019|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
146112734|NCT03129100|526929020|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
146112735|NCT03129100|526929021|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
146112736|NCT03129100|526929022|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
146112737|NCT03129100|526929023|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
146112738|NCT03129100|526929024|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
146112739|NCT03129100|526929025|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
146112740|NCT03129100|526929026|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
146112741|NCT03129100|526929027|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
146112742|NCT03129100|526929028|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
146112743|NCT03129100|526929029|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
146112744|NCT03129100|526929030|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
146112745|NCT01587001|526929031|FG000|Overall Study|Lost to Follow-up|2|||
146112746|NCT01587001|526929032|FG001|Overall Study|Lost to Follow-up|0|||
146112747|NCT01587001|526929031|FG000|Overall Study|Insufficient samples to complete testing|4|||
146112748|NCT01587001|526929032|FG001|Overall Study|Insufficient samples to complete testing|1|||
146112749|NCT01197560|526929033|FG000|Overall Study|Adverse Event|6|||
146112750|NCT01197560|526929034|FG001|Overall Study|Adverse Event|8|||
146112751|NCT01197560|526929033|FG000|Overall Study|Death|3|||
146112752|NCT01197560|526929034|FG001|Overall Study|Death|5|||
146112753|NCT01197560|526929033|FG000|Overall Study|Withdrawal by Subject|1|||
146112754|NCT01197560|526929034|FG001|Overall Study|Withdrawal by Subject|1|||
146112755|NCT01197560|526929033|FG000|Overall Study|Disease progression|40|||
146112756|NCT01197560|526929034|FG001|Overall Study|Disease progression|35|||
146112757|NCT01197560|526929033|FG000|Overall Study|Miscellaneous|4|||
146112758|NCT01197560|526929034|FG001|Overall Study|Miscellaneous|3|||
146112759|NCT01197560|526929033|FG000|Overall Study|Missing|0|||
146112760|NCT01197560|526929034|FG001|Overall Study|Missing|1|||
146112761|NCT00496054|526929035|FG000|Overall Study|Adverse Event|1|||
146112762|NCT00496054|526929035|FG000|Overall Study|Lost to Follow-up|7|||
146112763|NCT02216591|526929036|FG000|Overall Study|Lost to Follow-up|0|||
146112764|NCT02216591|526929037|FG001|Overall Study|Lost to Follow-up|1|||
146112765|NCT01950741|526929040|FG000|Overall Study|Lost to Follow-up|1|||
146112766|NCT01950741|526929040|FG000|Overall Study|Death|1|||
146112767|NCT01950741|526929040|FG000|Overall Study|Withdrawal by Subject|1|||
146112768|NCT02854631|526929043|FG000|Overall Study|Adverse Event|1|||
146112769|NCT02854631|526929044|FG001|Overall Study|Adverse Event|2|||
146112770|NCT02854631|526929043|FG000|Overall Study|Withdrew Consent|3|||
146112771|NCT02854631|526929044|FG001|Overall Study|Withdrew Consent|2|||
146112772|NCT02854631|526929043|FG000|Overall Study|Investigator's Discretion|2|||
146112773|NCT02854631|526929044|FG001|Overall Study|Investigator's Discretion|0|||
146112774|NCT02854631|526929043|FG000|Overall Study|Death|12|||
146112775|NCT02854631|526929044|FG001|Overall Study|Death|8|||
146112776|NCT02854631|526929043|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
146112777|NCT02854631|526929044|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
146112778|NCT02854631|526929043|FG000|Overall Study|Protocol Violation|0|||
146259910|NCT01057251|527467204|FG000|Overall Study|Withdrawal by Subject|4|||
146259911|NCT01057251|527467205|FG001|Overall Study|Withdrawal by Subject|5|||
146259912|NCT01057251|527467204|FG000|Overall Study|Lost to Follow-up|7|||
146259913|NCT01057251|527467205|FG001|Overall Study|Lost to Follow-up|6|||
146259914|NCT01057251|527467204|FG000|Overall Study|Other Reason|1|||
146259915|NCT01057251|527467205|FG001|Overall Study|Other Reason|1|||
146112779|NCT02854631|526929044|FG001|Overall Study|Protocol Violation|1|||
146112780|NCT02854631|526929043|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
146112781|NCT02854631|526929044|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
146112782|NCT02854631|526929043|FG000|Overall Study|Lost to Follow-up|4|||
146259916|NCT04544865|527467206|FG000|Overall Study|Death|0|||
146112783|NCT02854631|526929044|FG001|Overall Study|Lost to Follow-up|2|||
146112784|NCT02233647|526929045|FG000|Overall Study|Adverse Event|1|||
146112785|NCT00753415|526929049|FG000|Part A|Disease progression|1|||
146112786|NCT00753415|526929050|FG001|Part A|Disease progression|0|||
146112787|NCT00753415|526929051|FG002|Part A|Disease progression|1|||
146112788|NCT00753415|526929052|FG003|Part A|Disease progression|2|||
146112789|NCT00753415|526929053|FG004|Part A|Disease progression|0|||
146112790|NCT00753415|526929054|FG005|Part A|Disease progression|0|||
146112791|NCT00753415|526929055|FG006|Part A|Disease progression|0|||
146112792|NCT00753415|526929056|FG007|Part A|Disease progression|0|||
146112793|NCT00753415|526929057|FG008|Part A|Disease progression|0|||
146112794|NCT00753415|526929058|FG009|Part A|Disease progression|0|||
146112795|NCT00753415|526929049|FG000|Part A|Withdrawal by Subject|0|||
146112796|NCT00753415|526929050|FG001|Part A|Withdrawal by Subject|0|||
146112797|NCT00753415|526929051|FG002|Part A|Withdrawal by Subject|1|||
146112798|NCT00753415|526929052|FG003|Part A|Withdrawal by Subject|0|||
146112799|NCT00753415|526929053|FG004|Part A|Withdrawal by Subject|0|||
146112800|NCT00753415|526929054|FG005|Part A|Withdrawal by Subject|0|||
146112801|NCT00753415|526929055|FG006|Part A|Withdrawal by Subject|0|||
146112802|NCT00753415|526929056|FG007|Part A|Withdrawal by Subject|0|||
146112803|NCT00753415|526929057|FG008|Part A|Withdrawal by Subject|0|||
146112804|NCT00753415|526929058|FG009|Part A|Withdrawal by Subject|0|||
146112805|NCT00753415|526929049|FG000|Part B|Lost to Follow-up|0|||
146112806|NCT00753415|526929050|FG001|Part B|Lost to Follow-up|0|||
146112807|NCT00753415|526929051|FG002|Part B|Lost to Follow-up|0|||
146112808|NCT00753415|526929052|FG003|Part B|Lost to Follow-up|0|||
146112809|NCT00753415|526929053|FG004|Part B|Lost to Follow-up|0|||
146112810|NCT00753415|526929054|FG005|Part B|Lost to Follow-up|0|||
146112811|NCT00753415|526929055|FG006|Part B|Lost to Follow-up|0|||
146112812|NCT00753415|526929056|FG007|Part B|Lost to Follow-up|1|||
146112813|NCT00753415|526929057|FG008|Part B|Lost to Follow-up|1|||
146112814|NCT00753415|526929058|FG009|Part B|Lost to Follow-up|0|||
146112815|NCT00753415|526929049|FG000|Part B|Disease progression|0|||
146112816|NCT00753415|526929050|FG001|Part B|Disease progression|0|||
146112817|NCT00753415|526929051|FG002|Part B|Disease progression|0|||
146112818|NCT00753415|526929052|FG003|Part B|Disease progression|0|||
146112819|NCT00753415|526929053|FG004|Part B|Disease progression|0|||
146112820|NCT00753415|526929054|FG005|Part B|Disease progression|0|||
146112821|NCT00753415|526929055|FG006|Part B|Disease progression|0|||
146112822|NCT00753415|526929056|FG007|Part B|Disease progression|0|||
146112823|NCT00753415|526929057|FG008|Part B|Disease progression|2|||
146112824|NCT00753415|526929058|FG009|Part B|Disease progression|1|||
146112825|NCT00621153|526929059|FG000|Overall Study|Safety Reason|8|||
146112826|NCT00621153|526929060|FG001|Overall Study|Safety Reason|7|||
146112827|NCT00621153|526929059|FG000|Overall Study|Adverse Event|3|||
146112828|NCT00621153|526929060|FG001|Overall Study|Adverse Event|2|||
146112829|NCT00621153|526929059|FG000|Overall Study|Lost to Follow-up|5|||
146112830|NCT00621153|526929060|FG001|Overall Study|Lost to Follow-up|1|||
146112831|NCT00621153|526929059|FG000|Overall Study|Withdrawal by Subject|4|||
146112832|NCT00621153|526929060|FG001|Overall Study|Withdrawal by Subject|5|||
146112833|NCT04212650|526929061|FG000|Overall Study|Withdrawal by Subject|1|||
146112834|NCT04212650|526929062|FG001|Overall Study|Withdrawal by Subject|0|||
146112835|NCT00679302|526929064|FG000|Overall Study|Lost to Follow-up|8|||
146112836|NCT00679302|526929065|FG001|Overall Study|Lost to Follow-up|4|||
146112837|NCT01753856|526929066|FG000|Overall Study|Adverse Event|1|||
146112838|NCT01753856|526929067|FG001|Overall Study|Adverse Event|0|||
146112839|NCT01753856|526929066|FG000|Overall Study|Withdrawal by Subject|0|||
146112840|NCT01753856|526929067|FG001|Overall Study|Withdrawal by Subject|2|||
146112841|NCT01753856|526929066|FG000|Overall Study|Sponsor Decision|2|||
146112842|NCT01753856|526929067|FG001|Overall Study|Sponsor Decision|0|||
146112843|NCT01852110|526931393|FG000|Overall Study|Adverse Event|12|||
146112844|NCT01852110|526931394|FG001|Overall Study|Adverse Event|5|||
146112845|NCT01852110|526931395|FG002|Overall Study|Adverse Event|0|||
146112846|NCT01852110|526931396|FG003|Overall Study|Adverse Event|0|||
146112847|NCT01852110|526931397|FG004|Overall Study|Adverse Event|0|||
146112848|NCT01852110|526931398|FG005|Overall Study|Adverse Event|0|||
146112849|NCT01852110|526931393|FG000|Overall Study|Lost to Follow-up|1|||
146112850|NCT01852110|526931394|FG001|Overall Study|Lost to Follow-up|3|||
146112851|NCT01852110|526931395|FG002|Overall Study|Lost to Follow-up|0|||
146112852|NCT01852110|526931396|FG003|Overall Study|Lost to Follow-up|0|||
146112853|NCT01852110|526931397|FG004|Overall Study|Lost to Follow-up|0|||
146112854|NCT01852110|526931398|FG005|Overall Study|Lost to Follow-up|0|||
146112855|NCT01852110|526931393|FG000|Overall Study|Non-compliance with Study Drug|2|||
146112856|NCT01852110|526931394|FG001|Overall Study|Non-compliance with Study Drug|1|||
146112857|NCT01852110|526931395|FG002|Overall Study|Non-compliance with Study Drug|0|||
146112858|NCT01852110|526931396|FG003|Overall Study|Non-compliance with Study Drug|0|||
146112859|NCT01852110|526931397|FG004|Overall Study|Non-compliance with Study Drug|0|||
146112860|NCT01852110|526931398|FG005|Overall Study|Non-compliance with Study Drug|0|||
146112861|NCT01852110|526931393|FG000|Overall Study|Physician Decision|1|||
146112862|NCT01852110|526931394|FG001|Overall Study|Physician Decision|0|||
146112863|NCT01852110|526931395|FG002|Overall Study|Physician Decision|0|||
146112864|NCT01852110|526931396|FG003|Overall Study|Physician Decision|0|||
146112865|NCT01852110|526931397|FG004|Overall Study|Physician Decision|0|||
146112866|NCT01852110|526931398|FG005|Overall Study|Physician Decision|0|||
146112867|NCT01852110|526931393|FG000|Overall Study|Protocol Violation|0|||
146112868|NCT01852110|526931394|FG001|Overall Study|Protocol Violation|1|||
146112869|NCT01852110|526931395|FG002|Overall Study|Protocol Violation|0|||
146112870|NCT01852110|526931396|FG003|Overall Study|Protocol Violation|0|||
146112871|NCT01852110|526931397|FG004|Overall Study|Protocol Violation|0|||
146301794|NCT02871778|527620103|FG005|Part A: Treatment Period 1|Adverse Event|0|||
146112872|NCT01852110|526931398|FG005|Overall Study|Protocol Violation|0|||
146112873|NCT01852110|526931393|FG000|Overall Study|Study Terminated by Sponsor|30|||
146112874|NCT01852110|526931394|FG001|Overall Study|Study Terminated by Sponsor|32|||
146112875|NCT01852110|526931395|FG002|Overall Study|Study Terminated by Sponsor|0|||
146112876|NCT01852110|526931396|FG003|Overall Study|Study Terminated by Sponsor|0|||
146112877|NCT01852110|526931397|FG004|Overall Study|Study Terminated by Sponsor|0|||
146112878|NCT01852110|526931398|FG005|Overall Study|Study Terminated by Sponsor|0|||
146112879|NCT01852110|526931393|FG000|Overall Study|Withdrawal by Subject|4|||
146112880|NCT01852110|526931394|FG001|Overall Study|Withdrawal by Subject|4|||
146112881|NCT01852110|526931395|FG002|Overall Study|Withdrawal by Subject|0|||
146112882|NCT01852110|526931396|FG003|Overall Study|Withdrawal by Subject|0|||
146112883|NCT01852110|526931397|FG004|Overall Study|Withdrawal by Subject|0|||
146112884|NCT01852110|526931398|FG005|Overall Study|Withdrawal by Subject|0|||
146112885|NCT02141282|526931399|FG000|Overall Study|Adverse event, not related to progression|8|||
146112886|NCT02141282|526931400|FG001|Overall Study|Adverse event, not related to progression|1|||
146112887|NCT02141282|526931401|FG002|Overall Study|Adverse event, not related to progression|3|||
146112888|NCT02141282|526931402|FG003|Overall Study|Adverse event, not related to progression|1|||
146112889|NCT02141282|526931399|FG000|Overall Study|Adverse event, related to progression|1|||
146112890|NCT02141282|526931400|FG001|Overall Study|Adverse event, related to progression|0|||
146112891|NCT02141282|526931401|FG002|Overall Study|Adverse event, related to progression|2|||
146112892|NCT02141282|526931402|FG003|Overall Study|Adverse event, related to progression|0|||
146112893|NCT02141282|526931399|FG000|Overall Study|COVID-19 infection|1|||
146112894|NCT02141282|526931400|FG001|Overall Study|COVID-19 infection|0|||
146112895|NCT02141282|526931401|FG002|Overall Study|COVID-19 infection|0|||
146112896|NCT02141282|526931402|FG003|Overall Study|COVID-19 infection|0|||
146112897|NCT02141282|526931399|FG000|Overall Study|Lost to Follow-up|0|||
146112898|NCT02141282|526931400|FG001|Overall Study|Lost to Follow-up|0|||
146112899|NCT02141282|526931401|FG002|Overall Study|Lost to Follow-up|4|||
146112900|NCT02141282|526931402|FG003|Overall Study|Lost to Follow-up|2|||
146112901|NCT02141282|526931399|FG000|Overall Study|Other, not specified|14|||
146112902|NCT02141282|526931400|FG001|Overall Study|Other, not specified|11|||
146112903|NCT02141282|526931401|FG002|Overall Study|Other, not specified|23|||
146112904|NCT02141282|526931402|FG003|Overall Study|Other, not specified|9|||
146112905|NCT02141282|526931399|FG000|Overall Study|Progressive disease, Richter's|4|||
146112906|NCT02141282|526931400|FG001|Overall Study|Progressive disease, Richter's|1|||
146112907|NCT02141282|526931401|FG002|Overall Study|Progressive disease, Richter's|1|||
146112908|NCT02141282|526931402|FG003|Overall Study|Progressive disease, Richter's|1|||
146112909|NCT02141282|526931399|FG000|Overall Study|Progressive disease per protocol|12|||
146112910|NCT02141282|526931400|FG001|Overall Study|Progressive disease per protocol|7|||
146112911|NCT02141282|526931401|FG002|Overall Study|Progressive disease per protocol|9|||
146112912|NCT02141282|526931402|FG003|Overall Study|Progressive disease per protocol|2|||
146112913|NCT02141282|526931399|FG000|Overall Study|Stem cell transplant|1|||
146112914|NCT02141282|526931400|FG001|Overall Study|Stem cell transplant|0|||
146112915|NCT02141282|526931401|FG002|Overall Study|Stem cell transplant|1|||
146112916|NCT02141282|526931402|FG003|Overall Study|Stem cell transplant|0|||
146112917|NCT02141282|526931399|FG000|Overall Study|Study terminated by Sponsor|0|||
146112918|NCT02141282|526931400|FG001|Overall Study|Study terminated by Sponsor|1|||
146112919|NCT02141282|526931401|FG002|Overall Study|Study terminated by Sponsor|0|||
146112920|NCT02141282|526931402|FG003|Overall Study|Study terminated by Sponsor|0|||
146112921|NCT02141282|526931399|FG000|Overall Study|Subject non-compliance|0|||
146112922|NCT02141282|526931400|FG001|Overall Study|Subject non-compliance|0|||
146112923|NCT02141282|526931401|FG002|Overall Study|Subject non-compliance|1|||
146112924|NCT02141282|526931402|FG003|Overall Study|Subject non-compliance|0|||
146112925|NCT02141282|526931399|FG000|Overall Study|Withdrew consent|2|||
146112926|NCT02141282|526931400|FG001|Overall Study|Withdrew consent|0|||
146112927|NCT02141282|526931401|FG002|Overall Study|Withdrew consent|4|||
146112928|NCT02141282|526931402|FG003|Overall Study|Withdrew consent|0|||
146112929|NCT01752907|526931404|FG000|Overall Study|Withdrawal by Subject|4|||
146112930|NCT01752907|526931405|FG001|Overall Study|Withdrawal by Subject|10|||
146112931|NCT01752907|526931404|FG000|Overall Study|Lost to Follow-up|2|||
146112932|NCT01752907|526931405|FG001|Overall Study|Lost to Follow-up|1|||
146112933|NCT01752907|526931404|FG000|Overall Study|Decision by Sponsor|6|||
146112934|NCT01752907|526931405|FG001|Overall Study|Decision by Sponsor|9|||
146112935|NCT03098550|526931406|FG000|Overall Study|Disease Progression|30|||
146112936|NCT03098550|526931407|FG001|Overall Study|Disease Progression|19|||
146112937|NCT03098550|526931408|FG002|Overall Study|Disease Progression|41|||
146112938|NCT03098550|526931406|FG000|Overall Study|Study Drug Toxicity|2|||
146112939|NCT03098550|526931407|FG001|Overall Study|Study Drug Toxicity|1|||
146112940|NCT03098550|526931408|FG002|Overall Study|Study Drug Toxicity|0|||
146112941|NCT03098550|526931406|FG000|Overall Study|Death|1|||
146112942|NCT03098550|526931407|FG001|Overall Study|Death|0|||
146112943|NCT03098550|526931408|FG002|Overall Study|Death|0|||
146112944|NCT03098550|526931406|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
146112945|NCT03098550|526931407|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
146112946|NCT03098550|526931408|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
146112947|NCT03098550|526931406|FG000|Overall Study|Administrative reason by sponsor|0|||
146112948|NCT03098550|526931407|FG001|Overall Study|Administrative reason by sponsor|0|||
146112949|NCT03098550|526931408|FG002|Overall Study|Administrative reason by sponsor|1|||
146112950|NCT03098550|526931406|FG000|Overall Study|Other reasons|2|||
146112951|NCT03098550|526931407|FG001|Overall Study|Other reasons|0|||
146112952|NCT03098550|526931408|FG002|Overall Study|Other reasons|0|||
146112953|NCT01384760|526931410|FG000|Overall Study|Lost to Follow-up|0|||
146112954|NCT01384760|526931411|FG001|Overall Study|Lost to Follow-up|6|||
146112955|NCT01384760|526931410|FG000|Overall Study|Protocol Violation|16|||
146112956|NCT01384760|526931411|FG001|Overall Study|Protocol Violation|0|||
146112957|NCT00630396|526931412|FG000|Overall Study|Death|4|||
146112958|NCT00630396|526931412|FG000|Overall Study|Lost to Follow-up|3|||
146112959|NCT02989194|526931417|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
146112960|NCT02989194|526931418|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
146112961|NCT02989194|526931419|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
146112962|NCT02989194|526931417|FG000|Overall Study|Lost to Follow-up|0|||
146112963|NCT02989194|526931418|FG001|Overall Study|Lost to Follow-up|1|||
146112964|NCT02989194|526931419|FG002|Overall Study|Lost to Follow-up|0|||
146112965|NCT02989194|526931417|FG000|Overall Study|Withdrawal by Subject|0|||
146112966|NCT02989194|526931418|FG001|Overall Study|Withdrawal by Subject|1|||
146112967|NCT02989194|526931419|FG002|Overall Study|Withdrawal by Subject|0|||
146112968|NCT04160091|526931422|FG000|Overall Study|Terminated by Sponsor|7|||
146112969|NCT04160091|526931423|FG001|Overall Study|Terminated by Sponsor|3|||
146112970|NCT04160091|526931424|FG002|Overall Study|Terminated by Sponsor|5|||
146112971|NCT04160091|526931425|FG003|Overall Study|Terminated by Sponsor|2|||
146112972|NCT04160091|526931422|FG000|Overall Study|Noncompliance|0|||
146112973|NCT04160091|526931423|FG001|Overall Study|Noncompliance|0|||
146112974|NCT04160091|526931424|FG002|Overall Study|Noncompliance|0|||
146112975|NCT04160091|526931425|FG003|Overall Study|Noncompliance|1|||
146112976|NCT04160091|526931422|FG000|Overall Study|Withdrawal by Subject|0|||
146112977|NCT04160091|526931423|FG001|Overall Study|Withdrawal by Subject|0|||
146112978|NCT04160091|526931424|FG002|Overall Study|Withdrawal by Subject|0|||
146112979|NCT04160091|526931425|FG003|Overall Study|Withdrawal by Subject|1|||
146112980|NCT00381095|526931427|FG000|Overall Study|Death|3|||
146112981|NCT00381095|526931428|FG001|Overall Study|Death|4|||
146112982|NCT00381095|526931427|FG000|Overall Study|Lack of Efficacy|2|||
146112983|NCT00381095|526931428|FG001|Overall Study|Lack of Efficacy|4|||
146112984|NCT00381095|526931427|FG000|Overall Study|Other|2|||
146112985|NCT00381095|526931428|FG001|Overall Study|Other|2|||
146112986|NCT00381095|526931427|FG000|Overall Study|Protocol Violation|1|||
146112987|NCT00381095|526931428|FG001|Overall Study|Protocol Violation|1|||
146112988|NCT00381095|526931427|FG000|Overall Study|Withdrawal by Subject|3|||
146112989|NCT00381095|526931428|FG001|Overall Study|Withdrawal by Subject|3|||
146112990|NCT00381095|526931427|FG000|Overall Study|Adverse Event|2|||
146112991|NCT00381095|526931428|FG001|Overall Study|Adverse Event|7|||
146112992|NCT02485301|526931430|FG000|Overall Study|Serious Adverse Events|2|||
146112993|NCT02485301|526931431|FG001|Overall Study|Serious Adverse Events|1|||
146112994|NCT02485301|526931430|FG000|Overall Study|Protocol Violation|0|||
146112995|NCT02485301|526931431|FG001|Overall Study|Protocol Violation|1|||
146112996|NCT02485301|526931430|FG000|Overall Study|Withdrawal by Subject|6|||
146112997|NCT02485301|526931431|FG001|Overall Study|Withdrawal by Subject|7|||
146112998|NCT02485301|526931430|FG000|Overall Study|Migrated/moved from study area|10|||
146112999|NCT02485301|526931431|FG001|Overall Study|Migrated/moved from study area|19|||
146113000|NCT02485301|526931430|FG000|Overall Study|Lost to Follow-up|17|||
146113001|NCT02485301|526931431|FG001|Overall Study|Lost to Follow-up|17|||
146113002|NCT02485301|526931430|FG000|Overall Study|Other|3|||
146113003|NCT02485301|526931431|FG001|Overall Study|Other|4|||
146113004|NCT02041286|526931432|FG000|Overall Study|Adverse Event|1|||
146113005|NCT03138889|526931437|FG000|Overall Study|Withdrawal by Subject|5|||
146113006|NCT03138889|526931438|FG001|Overall Study|Withdrawal by Subject|5|||
146113007|NCT03138889|526931439|FG002|Overall Study|Withdrawal by Subject|0|||
146113008|NCT03138889|526931440|FG003|Overall Study|Withdrawal by Subject|2|||
146113009|NCT03138889|526931441|FG004|Overall Study|Withdrawal by Subject|1|||
146113010|NCT03138889|526931442|FG005|Overall Study|Withdrawal by Subject|3|||
146113011|NCT03138889|526931443|FG006|Overall Study|Withdrawal by Subject|0|||
146113012|NCT03138889|526931444|FG007|Overall Study|Withdrawal by Subject|1|||
146113013|NCT00411645|526931445|FG000|Overall Study|Consent Withdrawn|13|||
146301795|NCT02871778|527620104|FG006|Part A: Treatment Period 1|Adverse Event|0|||
146301796|NCT02871778|527620105|FG007|Part A: Treatment Period 1|Adverse Event|0|||
146113014|NCT00411645|526931446|FG001|Overall Study|Consent Withdrawn|22|||
146113015|NCT00411645|526931445|FG000|Overall Study|Death|56|||
146113016|NCT00411645|526931446|FG001|Overall Study|Death|135|||
146113017|NCT00411645|526931445|FG000|Overall Study|Investigator/Sponsor Decision|10|||
146113018|NCT00411645|526931446|FG001|Overall Study|Investigator/Sponsor Decision|7|||
146113019|NCT00411645|526931445|FG000|Overall Study|Lost to Follow-up|2|||
146301797|NCT02871778|527620098|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146259917|NCT04544865|527467207|FG001|Overall Study|Death|2|||
146259918|NCT04544865|527467206|FG000|Overall Study|Lost to Follow-up|11|||
146259919|NCT04544865|527467207|FG001|Overall Study|Lost to Follow-up|7|||
146259920|NCT04544865|527467206|FG000|Overall Study|Withdrawal by Subject|0|||
146259921|NCT04544865|527467207|FG001|Overall Study|Withdrawal by Subject|1|||
146259922|NCT04544865|527467206|FG000|Overall Study|Other|0|||
146259923|NCT04544865|527467207|FG001|Overall Study|Other|1|||
146259924|NCT02973802|527467208|FG000|Overall Study|Lost to Follow-up|1|||
146259925|NCT02973802|527467208|FG000|Overall Study|Withdrawal by Subject|1|||
146259926|NCT01850823|527467209|FG000|Overall Study|Early Visit Window|0|||
146259927|NCT01850823|527467210|FG001|Overall Study|Early Visit Window|1|||
146259928|NCT01850823|527467211|FG002|Overall Study|Early Visit Window|4|||
146259929|NCT01850823|527467209|FG000|Overall Study|Enrolled in Error|0|||
146259930|NCT01850823|527467210|FG001|Overall Study|Enrolled in Error|1|||
146259931|NCT01850823|527467211|FG002|Overall Study|Enrolled in Error|2|||
146259932|NCT01850823|527467209|FG000|Overall Study|Lack of Efficacy|1|||
146259933|NCT01850823|527467210|FG001|Overall Study|Lack of Efficacy|0|||
146259934|NCT01850823|527467211|FG002|Overall Study|Lack of Efficacy|0|||
146259935|NCT01850823|527467209|FG000|Overall Study|Lost to Follow-up|0|||
146259936|NCT01850823|527467210|FG001|Overall Study|Lost to Follow-up|0|||
146259937|NCT01850823|527467211|FG002|Overall Study|Lost to Follow-up|1|||
146259938|NCT01850823|527467209|FG000|Overall Study|Restricted Medication|0|||
146259939|NCT01850823|527467210|FG001|Overall Study|Restricted Medication|0|||
146259940|NCT01850823|527467211|FG002|Overall Study|Restricted Medication|2|||
146259941|NCT01850823|527467209|FG000|Overall Study|Significant worstening of SAR|0|||
146259942|NCT01850823|527467210|FG001|Overall Study|Significant worstening of SAR|1|||
146259943|NCT01850823|527467211|FG002|Overall Study|Significant worstening of SAR|0|||
146259944|NCT01850823|527467209|FG000|Overall Study|Withdrawal by Subject|2|||
146259945|NCT01850823|527467210|FG001|Overall Study|Withdrawal by Subject|0|||
146259946|NCT01850823|527467211|FG002|Overall Study|Withdrawal by Subject|1|||
146259947|NCT01751165|527467212|FG000|Overall Study|Adverse event, serious fatal|1|||
146259948|NCT01751165|527467213|FG001|Overall Study|Adverse event, serious fatal|0|||
146259949|NCT01751165|527467214|FG002|Overall Study|Adverse event, serious fatal|1|||
146259950|NCT01751165|527467212|FG000|Overall Study|Withdrawal by Subject|0|||
146259951|NCT01751165|527467213|FG001|Overall Study|Withdrawal by Subject|0|||
146259952|NCT01751165|527467214|FG002|Overall Study|Withdrawal by Subject|1|||
146259953|NCT01751165|527467212|FG000|Overall Study|Serious adverse event|0|||
146259954|NCT01751165|527467213|FG001|Overall Study|Serious adverse event|2|||
146259955|NCT01751165|527467214|FG002|Overall Study|Serious adverse event|0|||
146259956|NCT01751165|527467212|FG000|Overall Study|Lost to Follow-up|1|||
146259957|NCT01751165|527467213|FG001|Overall Study|Lost to Follow-up|1|||
146259958|NCT01751165|527467214|FG002|Overall Study|Lost to Follow-up|1|||
146259959|NCT00913523|527467218|FG000|Overall Study|Withdrawal by Subject|3|||
146259960|NCT00913523|527467219|FG001|Overall Study|Withdrawal by Subject|2|||
146259961|NCT00913523|527467220|FG002|Overall Study|Withdrawal by Subject|2|||
146259962|NCT00913523|527467218|FG000|Overall Study|Lost to Follow-up|1|||
146259963|NCT00913523|527467219|FG001|Overall Study|Lost to Follow-up|1|||
146259964|NCT00913523|527467220|FG002|Overall Study|Lost to Follow-up|1|||
146259965|NCT00913523|527467218|FG000|Overall Study|Adverse Event|1|||
146259966|NCT00913523|527467219|FG001|Overall Study|Adverse Event|0|||
146259967|NCT00913523|527467220|FG002|Overall Study|Adverse Event|0|||
146259968|NCT00913523|527467218|FG000|Overall Study|Protocol Violation|5|||
146259969|NCT00913523|527467219|FG001|Overall Study|Protocol Violation|8|||
146259970|NCT00913523|527467220|FG002|Overall Study|Protocol Violation|8|||
146259971|NCT00913523|527467218|FG000|Overall Study|Pregnancy|1|||
146259972|NCT00913523|527467219|FG001|Overall Study|Pregnancy|3|||
146259973|NCT00913523|527467220|FG002|Overall Study|Pregnancy|0|||
146259974|NCT00913523|527467218|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
146259975|NCT00913523|527467219|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
146259976|NCT00913523|527467220|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
146259977|NCT01202409|527467221|FG000|Overall Study|Adverse Event|1|||
146259978|NCT01202409|527467221|FG000|Overall Study|Ineligible - KRAS mutants|7|||
146259979|NCT01774019|527467222|FG000|Overall Study|No longer meets protocol criteria|2|||
146259980|NCT01774019|527467223|FG001|Overall Study|No longer meets protocol criteria|0|||
146259981|NCT01774019|527467222|FG000|Overall Study|Withdrawal by Subject|1|||
146259982|NCT01774019|527467223|FG001|Overall Study|Withdrawal by Subject|0|||
146259983|NCT01774019|527467222|FG000|Overall Study|Surgery delayed > 120 days|1|||
146259984|NCT01774019|527467223|FG001|Overall Study|Surgery delayed > 120 days|0|||
146259985|NCT01774019|527467222|FG000|Overall Study|Patient refused surgery|1|||
146259986|NCT01774019|527467223|FG001|Overall Study|Patient refused surgery|1|||
146259987|NCT01774019|527467222|FG000|Overall Study|Unable to implant study device|1|||
146259988|NCT01774019|527467223|FG001|Overall Study|Unable to implant study device|0|||
146259989|NCT01774019|527467222|FG000|Overall Study|Lost to Follow-up|0|||
146259990|NCT01774019|527467223|FG001|Overall Study|Lost to Follow-up|3|||
146259991|NCT00553605|527467224|FG000|Overall Study|Did not meet entrance criteria|1|||
146259992|NCT00553605|527467225|FG001|Overall Study|Did not meet entrance criteria|3|||
146259993|NCT00553605|527467224|FG000|Overall Study|Did not receive full dose|1|||
146113020|NCT00411645|526931446|FG001|Overall Study|Lost to Follow-up|0|||
146113021|NCT00284050|526931449|FG000|Overall Study|Adverse Event|1|||
146113022|NCT00284050|526931450|FG001|Overall Study|Adverse Event|1|||
146113023|NCT00284050|526931451|FG002|Overall Study|Adverse Event|1|||
146113024|NCT00284050|526931449|FG000|Overall Study|Lack of Efficacy|0|||
146113025|NCT00284050|526931450|FG001|Overall Study|Lack of Efficacy|1|||
146113026|NCT00284050|526931451|FG002|Overall Study|Lack of Efficacy|3|||
146113027|NCT00284050|526931449|FG000|Overall Study|Protocol Violation|0|||
146113028|NCT00284050|526931450|FG001|Overall Study|Protocol Violation|1|||
146113029|NCT00284050|526931451|FG002|Overall Study|Protocol Violation|2|||
146113030|NCT00284050|526931449|FG000|Overall Study|Withdrawal by Subject|2|||
146113031|NCT00284050|526931450|FG001|Overall Study|Withdrawal by Subject|2|||
146113032|NCT00284050|526931451|FG002|Overall Study|Withdrawal by Subject|2|||
146113033|NCT00284050|526931449|FG000|Overall Study|Lost to Follow-up|1|||
146113034|NCT00284050|526931450|FG001|Overall Study|Lost to Follow-up|0|||
146113035|NCT00284050|526931451|FG002|Overall Study|Lost to Follow-up|1|||
146113036|NCT00284050|526931449|FG000|Overall Study|Death|1|||
146113037|NCT00284050|526931450|FG001|Overall Study|Death|0|||
146113038|NCT00284050|526931451|FG002|Overall Study|Death|0|||
146113039|NCT02573350|526931452|FG000|Overall Study|Lost to Follow-up|2|||
146113040|NCT02573350|526931453|FG001|Overall Study|Lost to Follow-up|1|||
146113041|NCT02573350|526931452|FG000|Overall Study|Adverse Event|3|||
146113042|NCT02573350|526931453|FG001|Overall Study|Adverse Event|4|||
146113043|NCT02573350|526931452|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
146113044|NCT02573350|526931453|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
146113045|NCT02573350|526931452|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
146113046|NCT02573350|526931453|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
146113047|NCT02573350|526931452|FG000|Overall Study|Subject withdrew consent to participate|6|||
146113048|NCT02573350|526931453|FG001|Overall Study|Subject withdrew consent to participate|1|||
146113049|NCT02573350|526931452|FG000|Overall Study|Protocol Deviation|1|||
146113050|NCT02573350|526931453|FG001|Overall Study|Protocol Deviation|1|||
146113051|NCT02708121|526931454|FG000|Overall Study|Withdrawn by Study Team|1|||
146113052|NCT02708121|526931455|FG001|Overall Study|Withdrawn by Study Team|1|||
146113053|NCT02708121|526931454|FG000|Overall Study|Withdrawal by Subject|0|||
146113054|NCT02708121|526931455|FG001|Overall Study|Withdrawal by Subject|4|||
146113055|NCT01111149|526931456|FG000|Overall Study|Protocol Violation|1|||
146113056|NCT01111149|526931457|FG001|Overall Study|Protocol Violation|1|||
146113057|NCT01111149|526931458|FG002|Overall Study|Protocol Violation|2|||
146113058|NCT01111149|526931456|FG000|Overall Study|Withdrawal by Subject|1|||
146113059|NCT01111149|526931457|FG001|Overall Study|Withdrawal by Subject|0|||
146259994|NCT00553605|527467225|FG001|Overall Study|Did not receive full dose|0|||
146259995|NCT00553605|527467224|FG000|Overall Study|Randomized but not treated|2|||
146259996|NCT00553605|527467225|FG001|Overall Study|Randomized but not treated|0|||
146259997|NCT01085812|527467228|FG000|Open-Label Period|Adverse Event|0|||
146259998|NCT01085812|527467229|FG001|Open-Label Period|Adverse Event|80|||
146259999|NCT01085812|527467228|FG000|Open-Label Period|Lack of Efficacy|0|||
146260000|NCT01085812|527467229|FG001|Open-Label Period|Lack of Efficacy|26|||
146260001|NCT01085812|527467228|FG000|Open-Label Period|Protocol Violation|0|||
146260002|NCT01085812|527467229|FG001|Open-Label Period|Protocol Violation|39|||
146260003|NCT01085812|527467228|FG000|Open-Label Period|Withdrawal by Subject|0|||
146260004|NCT01085812|527467229|FG001|Open-Label Period|Withdrawal by Subject|53|||
146260005|NCT01085812|527467228|FG000|Open-Label Period|Lost to Follow-up|0|||
146260006|NCT01085812|527467229|FG001|Open-Label Period|Lost to Follow-up|42|||
146260007|NCT01085812|527467228|FG000|Double-Blind Period|Adverse Event|3|||
146260008|NCT01085812|527467229|FG001|Double-Blind Period|Adverse Event|8|||
146260009|NCT01085812|527467228|FG000|Double-Blind Period|Protocol Violation|2|||
146260010|NCT01085812|527467229|FG001|Double-Blind Period|Protocol Violation|7|||
146260011|NCT01085812|527467228|FG000|Double-Blind Period|Withdrawal by Subject|11|||
146260012|NCT01085812|527467229|FG001|Double-Blind Period|Withdrawal by Subject|24|||
146260013|NCT01085812|527467228|FG000|Double-Blind Period|Lost to Follow-up|5|||
146260014|NCT01085812|527467229|FG001|Double-Blind Period|Lost to Follow-up|17|||
146260015|NCT01085812|527467228|FG000|Double-Blind Period|Other Reasons|0|||
146113060|NCT01111149|526931458|FG002|Overall Study|Withdrawal by Subject|2|||
146113061|NCT03765918|526931463|FG000|Overall Study|Death|109|||
146113062|NCT03765918|526931464|FG001|Overall Study|Death|127|||
146113063|NCT03765918|526931463|FG000|Overall Study|Lost to Follow-up|2|||
146113064|NCT03765918|526931464|FG001|Overall Study|Lost to Follow-up|3|||
146113065|NCT03765918|526931463|FG000|Overall Study|Withdrawal by Subject|12|||
146113066|NCT03765918|526931464|FG001|Overall Study|Withdrawal by Subject|16|||
146113067|NCT03765918|526931463|FG000|Overall Study|Participants Ongoing|240|||
146113068|NCT03765918|526931464|FG001|Overall Study|Participants Ongoing|205|||
146113069|NCT04202965|526931465|FG000|Overall Study|Adverse Event|3|||
146113070|NCT04202965|526931465|FG000|Overall Study|Did not meet inclusion criteria|1|||
146260016|NCT01085812|527467229|FG001|Double-Blind Period|Other Reasons|2|||
146260017|NCT01085812|527467228|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
146260018|NCT01085812|527467229|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
146301798|NCT02871778|527620099|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146301799|NCT02871778|527620100|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146301800|NCT02871778|527620101|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
146301801|NCT02871778|527620102|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146301802|NCT02871778|527620103|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146301803|NCT02871778|527620104|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146301804|NCT02871778|527620105|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
146301805|NCT02871778|527620098|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146301806|NCT02871778|527620099|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146301807|NCT02871778|527620100|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
146301808|NCT02871778|527620101|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146301809|NCT02871778|527620102|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146301810|NCT02871778|527620103|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146113071|NCT01484197|526931469|FG000|Treatment Period 1|Adverse Event|1|||
146113072|NCT01484197|526931470|FG001|Treatment Period 1|Adverse Event|0|||
146113073|NCT01484197|526931471|FG002|Treatment Period 1|Adverse Event|0|||
146260019|NCT01085812|527467228|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
146260020|NCT01085812|527467229|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
146260021|NCT01085812|527467228|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
146260022|NCT01085812|527467229|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
146260023|NCT01085812|527467228|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
146260024|NCT01085812|527467229|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
146260025|NCT01085812|527467228|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
146260026|NCT01085812|527467229|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
146260027|NCT00496626|527467230|FG000|Overall Study|Lost to Follow-up|0|||
146260028|NCT00496626|527467231|FG001|Overall Study|Lost to Follow-up|1|||
146260029|NCT00496626|527467230|FG000|Overall Study|Protocol Violation|1|||
146260030|NCT00496626|527467231|FG001|Overall Study|Protocol Violation|0|||
146260031|NCT00496626|527467230|FG000|Overall Study|Withdrawal by Subject|5|||
146260032|NCT00496626|527467231|FG001|Overall Study|Withdrawal by Subject|4|||
146260033|NCT00496626|527467230|FG000|Overall Study|Relocated|0|||
146260034|NCT00496626|527467231|FG001|Overall Study|Relocated|1|||
146260035|NCT02561806|527467232|FG000|Induction Period|Adverse Event|0|||
146260036|NCT02561806|527467233|FG001|Induction Period|Adverse Event|2|||
146260037|NCT02561806|527467232|FG000|Induction Period|Lack of Efficacy|1|||
146260038|NCT02561806|527467233|FG001|Induction Period|Lack of Efficacy|0|||
146260039|NCT02561806|527467232|FG000|Induction Period|Withdrawal by Subject|0|||
146260040|NCT02561806|527467233|FG001|Induction Period|Withdrawal by Subject|2|||
146260041|NCT02561806|527467232|FG000|Induction Period|Site staff became unblinded|1|||
146260042|NCT02561806|527467233|FG001|Induction Period|Site staff became unblinded|0|||
146260043|NCT02561806|527467232|FG000|Induction Period|Randomized but not treated|0|||
146260044|NCT02561806|527467233|FG001|Induction Period|Randomized but not treated|1|||
146260045|NCT02561806|527467232|FG000|Maintenance Period|Adverse Event|2|||
146260046|NCT02561806|527467233|FG001|Maintenance Period|Adverse Event|1|||
146260047|NCT02561806|527467232|FG000|Maintenance Period|Lack of Efficacy|3|||
146260048|NCT02561806|527467233|FG001|Maintenance Period|Lack of Efficacy|1|||
146260049|NCT02561806|527467232|FG000|Maintenance Period|Lost to Follow-up|2|||
146260050|NCT02561806|527467233|FG001|Maintenance Period|Lost to Follow-up|2|||
146260051|NCT02561806|527467232|FG000|Maintenance Period|Protocol Violation|1|||
146260052|NCT02561806|527467233|FG001|Maintenance Period|Protocol Violation|0|||
146260053|NCT02561806|527467232|FG000|Maintenance Period|Withdrawal by Subject|5|||
146260054|NCT02561806|527467233|FG001|Maintenance Period|Withdrawal by Subject|3|||
146260055|NCT02561806|527467232|FG000|Maintenance Period|Site staff became unblinded|0|||
146260056|NCT02561806|527467233|FG001|Maintenance Period|Site staff became unblinded|1|||
146260057|NCT02561806|527467232|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
146260058|NCT02561806|527467233|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
146260059|NCT02561806|527467232|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
146260060|NCT02561806|527467233|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
146260061|NCT02547441|527467234|FG000|Double-Blind Study Period|Adverse Event|4|||
146301811|NCT02871778|527620104|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146113074|NCT01484197|526931472|FG003|Treatment Period 1|Adverse Event|0|||
146113075|NCT01484197|526931469|FG000|Treatment Period 2|Subject withdrew consent|0|||
146113076|NCT01484197|526931470|FG001|Treatment Period 2|Subject withdrew consent|0|||
146113077|NCT01484197|526931471|FG002|Treatment Period 2|Subject withdrew consent|0|||
146260062|NCT02547441|527467235|FG001|Double-Blind Study Period|Adverse Event|9|||
146260063|NCT02547441|527467234|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
146260064|NCT02547441|527467235|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
146260065|NCT02547441|527467234|FG000|Double-Blind Study Period|Physician Decision|1|||
146260066|NCT02547441|527467235|FG001|Double-Blind Study Period|Physician Decision|0|||
146113078|NCT01484197|526931472|FG003|Treatment Period 2|Subject withdrew consent|1|||
146113079|NCT00814164|526931473|FG000|Overall Study|Progression|7|||
146113080|NCT00814164|526931473|FG000|Overall Study|not stated|7|||
146113081|NCT00814164|526931473|FG000|Overall Study|Death|5|||
146113082|NCT01980992|526931474|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
146113083|NCT01980992|526931475|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
146113084|NCT01980992|526931474|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
146113085|NCT01980992|526931475|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
146113086|NCT01980992|526931474|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
146113087|NCT01980992|526931475|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
146113088|NCT01980992|526931474|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
146113089|NCT01980992|526931475|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
146113090|NCT01980992|526931474|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
146113091|NCT01980992|526931475|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
146113092|NCT01980992|526931474|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
146113093|NCT01980992|526931475|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
146113094|NCT00299975|526931476|FG000|Overall Study|Adverse Event|1|||
146113095|NCT00299975|526931477|FG001|Overall Study|Adverse Event|0|||
146113096|NCT00299975|526931478|FG002|Overall Study|Adverse Event|2|||
146113097|NCT00299975|526931476|FG000|Overall Study|Pregnancy|0|||
146113098|NCT00299975|526931477|FG001|Overall Study|Pregnancy|0|||
146113099|NCT00299975|526931478|FG002|Overall Study|Pregnancy|1|||
146113100|NCT00299975|526931476|FG000|Overall Study|Lack of Efficacy|1|||
146113101|NCT00299975|526931477|FG001|Overall Study|Lack of Efficacy|0|||
146113102|NCT00299975|526931478|FG002|Overall Study|Lack of Efficacy|1|||
146113103|NCT00299975|526931476|FG000|Overall Study|Lost to Follow-up|1|||
146113104|NCT00299975|526931477|FG001|Overall Study|Lost to Follow-up|0|||
146113105|NCT00299975|526931478|FG002|Overall Study|Lost to Follow-up|0|||
146113106|NCT00299975|526931476|FG000|Overall Study|Withdrawal by Subject|0|||
146113107|NCT00299975|526931477|FG001|Overall Study|Withdrawal by Subject|1|||
146113108|NCT00299975|526931478|FG002|Overall Study|Withdrawal by Subject|3|||
146113109|NCT00299975|526931476|FG000|Overall Study|Physician Decision|0|||
146113110|NCT00299975|526931477|FG001|Overall Study|Physician Decision|0|||
146113111|NCT00299975|526931478|FG002|Overall Study|Physician Decision|1|||
146113112|NCT01169493|526931487|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
146113113|NCT01169493|526931488|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
146113114|NCT01169493|526931489|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
146113115|NCT01169493|526931490|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
146113116|NCT01169493|526931491|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
146113117|NCT01169493|526931492|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
146113118|NCT01169493|526931487|FG000|Period 3 (6 Months)|Adverse Event|0|||
146113119|NCT01169493|526931488|FG001|Period 3 (6 Months)|Adverse Event|1|||
146113120|NCT01169493|526931489|FG002|Period 3 (6 Months)|Adverse Event|0|||
146113121|NCT01169493|526931490|FG003|Period 3 (6 Months)|Adverse Event|0|||
146113122|NCT01169493|526931491|FG004|Period 3 (6 Months)|Adverse Event|0|||
146056086|NCT00768989|526721095|FG001|On or After Week 36|Adverse Event|1|||
146056087|NCT00768989|526721094|FG000|On or After Week 36|Lost to Follow-up|1|||
146056088|NCT00768989|526721095|FG001|On or After Week 36|Lost to Follow-up|0|||
146056089|NCT00768989|526721094|FG000|On or After Week 36|Poor Compliance|1|||
146056090|NCT00768989|526721095|FG001|On or After Week 36|Poor Compliance|0|||
146056091|NCT00768989|526721094|FG000|On or After Week 36|Protocol Violation|1|||
146056092|NCT00768989|526721095|FG001|On or After Week 36|Protocol Violation|0|||
146056093|NCT00768989|526721094|FG000|On or After Week 36|Did not attend termination visit|2|||
146056094|NCT00768989|526721095|FG001|On or After Week 36|Did not attend termination visit|0|||
146056095|NCT00768989|526721094|FG000|On or After Week 36|Sponsor Termination|45|||
146056096|NCT00768989|526721095|FG001|On or After Week 36|Sponsor Termination|26|||
146056097|NCT00117637|526721099|FG000|First Intervention (Period 1)|Adverse Event|11|||
146056098|NCT00117637|526721100|FG001|First Intervention (Period 1)|Adverse Event|16|||
146056099|NCT00117637|526721099|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
146056100|NCT00117637|526721100|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
146056101|NCT00117637|526721099|FG000|First Intervention (Period 1)|Protocol Violation|1|||
146056102|NCT00117637|526721100|FG001|First Intervention (Period 1)|Protocol Violation|0|||
146056103|NCT00117637|526721099|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
146056104|NCT00117637|526721100|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
146056105|NCT00117637|526721099|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
146056106|NCT00117637|526721100|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
146056107|NCT00117637|526721099|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
146056108|NCT00117637|526721100|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
146056109|NCT00117637|526721099|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
146056110|NCT00117637|526721100|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
146056111|NCT00117637|526721099|FG000|First Intervention (Period 1)|reason not reported|0|||
146056112|NCT00117637|526721100|FG001|First Intervention (Period 1)|reason not reported|1|||
146113123|NCT01169493|526931492|FG005|Period 3 (6 Months)|Adverse Event|0|||
146113124|NCT01169493|526931487|FG000|Period 3 (6 Months)|Physician Decision|0|||
146113125|NCT01169493|526931488|FG001|Period 3 (6 Months)|Physician Decision|1|||
146113126|NCT01169493|526931489|FG002|Period 3 (6 Months)|Physician Decision|1|||
146113127|NCT01169493|526931490|FG003|Period 3 (6 Months)|Physician Decision|0|||
146113128|NCT01169493|526931491|FG004|Period 3 (6 Months)|Physician Decision|0|||
146113129|NCT01169493|526931492|FG005|Period 3 (6 Months)|Physician Decision|0|||
146113130|NCT05228132|526931493|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
146113131|NCT05228132|526931493|FG000|Overall Study|Adverse Event|3|||
146113132|NCT05228132|526931493|FG000|Overall Study|Lost to Follow-up|1|||
146113133|NCT05228132|526931493|FG000|Overall Study|Arteriovenous-fistula mature|1|||
146113134|NCT03167411|526931494|FG000|Overall Study|Adverse Event|0|||
146113135|NCT03167411|526931495|FG001|Overall Study|Adverse Event|1|||
146113136|NCT02627144|526931498|FG000|Overall Study|Serious adverse event|32|||
146113137|NCT02627144|526931498|FG000|Overall Study|Cancer progression|171|||
146113138|NCT02627144|526931498|FG000|Overall Study|Death from cancer|20|||
146113139|NCT02627144|526931498|FG000|Overall Study|Death from other cause|8|||
146113140|NCT02627144|526931498|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
146113141|NCT02627144|526931498|FG000|Overall Study|Administrative reasons|65|||
146113142|NCT02627144|526931498|FG000|Overall Study|Lost to Follow-up|8|||
146113143|NCT02627144|526931498|FG000|Overall Study|Enrolled, not treated|6|||
146113144|NCT02627144|526931498|FG000|Overall Study|Other|17|||
146113145|NCT00420927|526931503|FG000|Period 1|Adverse Event|19|||
146113146|NCT00420927|526931504|FG001|Period 1|Adverse Event|15|||
146113147|NCT00420927|526931505|FG002|Period 1|Adverse Event|0|||
146113148|NCT00420927|526931506|FG003|Period 1|Adverse Event|0|||
146113149|NCT00420927|526931507|FG004|Period 1|Adverse Event|0|||
146113150|NCT00420927|526931508|FG005|Period 1|Adverse Event|0|||
146113151|NCT00420927|526931509|FG006|Period 1|Adverse Event|0|||
146113152|NCT00420927|526931503|FG000|Period 1|Withdrawal by Subject|7|||
146113153|NCT00420927|526931504|FG001|Period 1|Withdrawal by Subject|12|||
146113154|NCT00420927|526931505|FG002|Period 1|Withdrawal by Subject|0|||
146113155|NCT00420927|526931506|FG003|Period 1|Withdrawal by Subject|0|||
146113156|NCT00420927|526931507|FG004|Period 1|Withdrawal by Subject|0|||
146113157|NCT00420927|526931508|FG005|Period 1|Withdrawal by Subject|0|||
146113158|NCT00420927|526931509|FG006|Period 1|Withdrawal by Subject|0|||
146113159|NCT00420927|526931503|FG000|Period 1|Lost to Follow-up|8|||
146113160|NCT00420927|526931504|FG001|Period 1|Lost to Follow-up|6|||
146113161|NCT00420927|526931505|FG002|Period 1|Lost to Follow-up|0|||
146113162|NCT00420927|526931506|FG003|Period 1|Lost to Follow-up|0|||
146113163|NCT00420927|526931507|FG004|Period 1|Lost to Follow-up|0|||
146113164|NCT00420927|526931508|FG005|Period 1|Lost to Follow-up|0|||
146113165|NCT00420927|526931509|FG006|Period 1|Lost to Follow-up|0|||
146113166|NCT00420927|526931503|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
146113167|NCT00420927|526931504|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
146113168|NCT00420927|526931505|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
146113169|NCT00420927|526931506|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
146113170|NCT00420927|526931507|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
146113171|NCT00420927|526931508|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
146113172|NCT00420927|526931509|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
146113173|NCT00420927|526931503|FG000|Period 1|Death|2|||
146113174|NCT00420927|526931504|FG001|Period 1|Death|0|||
146113175|NCT00420927|526931505|FG002|Period 1|Death|0|||
146113176|NCT00420927|526931506|FG003|Period 1|Death|0|||
146113177|NCT00420927|526931507|FG004|Period 1|Death|0|||
146113178|NCT00420927|526931508|FG005|Period 1|Death|0|||
146113179|NCT00420927|526931509|FG006|Period 1|Death|0|||
146113180|NCT00420927|526931503|FG000|Period 1|Subject moved/relocated|0|||
146113181|NCT00420927|526931504|FG001|Period 1|Subject moved/relocated|2|||
146113182|NCT00420927|526931505|FG002|Period 1|Subject moved/relocated|0|||
146113183|NCT00420927|526931506|FG003|Period 1|Subject moved/relocated|0|||
146113184|NCT00420927|526931507|FG004|Period 1|Subject moved/relocated|0|||
146113185|NCT00420927|526931508|FG005|Period 1|Subject moved/relocated|0|||
146113186|NCT00420927|526931509|FG006|Period 1|Subject moved/relocated|0|||
146113187|NCT00420927|526931503|FG000|Period 1|Noncompliant with study drug|1|||
146113188|NCT00420927|526931504|FG001|Period 1|Noncompliant with study drug|1|||
146113189|NCT00420927|526931505|FG002|Period 1|Noncompliant with study drug|0|||
146113190|NCT00420927|526931506|FG003|Period 1|Noncompliant with study drug|0|||
146113191|NCT00420927|526931507|FG004|Period 1|Noncompliant with study drug|0|||
146113192|NCT00420927|526931508|FG005|Period 1|Noncompliant with study drug|0|||
146113193|NCT00420927|526931509|FG006|Period 1|Noncompliant with study drug|0|||
146113194|NCT00420927|526931503|FG000|Period 1|Randomization error|1|||
146113195|NCT00420927|526931504|FG001|Period 1|Randomization error|0|||
146113196|NCT00420927|526931505|FG002|Period 1|Randomization error|0|||
146113197|NCT00420927|526931506|FG003|Period 1|Randomization error|0|||
146113198|NCT00420927|526931507|FG004|Period 1|Randomization error|0|||
146113199|NCT00420927|526931508|FG005|Period 1|Randomization error|0|||
146113200|NCT00420927|526931509|FG006|Period 1|Randomization error|0|||
146113201|NCT00420927|526931503|FG000|Period 1|Suspected tuberculosis/positive test|1|||
146113202|NCT00420927|526931504|FG001|Period 1|Suspected tuberculosis/positive test|1|||
146113203|NCT00420927|526931505|FG002|Period 1|Suspected tuberculosis/positive test|0|||
146113204|NCT00420927|526931506|FG003|Period 1|Suspected tuberculosis/positive test|0|||
146113205|NCT00420927|526931507|FG004|Period 1|Suspected tuberculosis/positive test|0|||
146113206|NCT00420927|526931508|FG005|Period 1|Suspected tuberculosis/positive test|0|||
146113207|NCT00420927|526931509|FG006|Period 1|Suspected tuberculosis/positive test|0|||
146113208|NCT00420927|526931503|FG000|Period 1|Study site closure|0|||
146113209|NCT00420927|526931504|FG001|Period 1|Study site closure|1|||
146113210|NCT00420927|526931505|FG002|Period 1|Study site closure|0|||
146113211|NCT00420927|526931506|FG003|Period 1|Study site closure|0|||
146113212|NCT00420927|526931507|FG004|Period 1|Study site closure|0|||
146113213|NCT00420927|526931508|FG005|Period 1|Study site closure|0|||
146113214|NCT00420927|526931509|FG006|Period 1|Study site closure|0|||
146113215|NCT00420927|526931503|FG000|Period 1|Subject received new diagnosis|0|||
146113216|NCT00420927|526931504|FG001|Period 1|Subject received new diagnosis|2|||
146113217|NCT00420927|526931505|FG002|Period 1|Subject received new diagnosis|0|||
146113218|NCT00420927|526931506|FG003|Period 1|Subject received new diagnosis|0|||
146113219|NCT00420927|526931507|FG004|Period 1|Subject received new diagnosis|0|||
146113220|NCT00420927|526931508|FG005|Period 1|Subject received new diagnosis|0|||
146113221|NCT00420927|526931509|FG006|Period 1|Subject received new diagnosis|0|||
146113222|NCT00420927|526931503|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
146113223|NCT00420927|526931504|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
146113224|NCT00420927|526931505|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
146113225|NCT00420927|526931506|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
146113226|NCT00420927|526931507|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
146113227|NCT00420927|526931508|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
146113228|NCT00420927|526931509|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
146113229|NCT00420927|526931503|FG000|Period 1|Failed to meet entry criteria|8|||
146113230|NCT00420927|526931504|FG001|Period 1|Failed to meet entry criteria|7|||
146113231|NCT00420927|526931505|FG002|Period 1|Failed to meet entry criteria|0|||
146113232|NCT00420927|526931506|FG003|Period 1|Failed to meet entry criteria|0|||
146113233|NCT00420927|526931507|FG004|Period 1|Failed to meet entry criteria|0|||
146113234|NCT00420927|526931508|FG005|Period 1|Failed to meet entry criteria|0|||
146113235|NCT00420927|526931509|FG006|Period 1|Failed to meet entry criteria|0|||
146113236|NCT00420927|526931503|FG000|Period 1|Took prohibited medication|1|||
146113237|NCT00420927|526931504|FG001|Period 1|Took prohibited medication|3|||
146113238|NCT00420927|526931505|FG002|Period 1|Took prohibited medication|0|||
146113239|NCT00420927|526931506|FG003|Period 1|Took prohibited medication|0|||
146113240|NCT00420927|526931507|FG004|Period 1|Took prohibited medication|0|||
146113241|NCT00420927|526931508|FG005|Period 1|Took prohibited medication|0|||
146113242|NCT00420927|526931509|FG006|Period 1|Took prohibited medication|0|||
146113243|NCT00420927|526931503|FG000|Period 2|Adverse Event|0|||
146113244|NCT00420927|526931504|FG001|Period 2|Adverse Event|0|||
146113245|NCT00420927|526931505|FG002|Period 2|Adverse Event|7|||
146113246|NCT00420927|526931506|FG003|Period 2|Adverse Event|3|||
146113247|NCT00420927|526931507|FG004|Period 2|Adverse Event|17|||
146113248|NCT00420927|526931508|FG005|Period 2|Adverse Event|6|||
146113249|NCT00420927|526931509|FG006|Period 2|Adverse Event|20|||
146113250|NCT00420927|526931503|FG000|Period 2|Withdrawal by Subject|0|||
146113251|NCT00420927|526931504|FG001|Period 2|Withdrawal by Subject|0|||
146113252|NCT00420927|526931505|FG002|Period 2|Withdrawal by Subject|1|||
146113253|NCT00420927|526931506|FG003|Period 2|Withdrawal by Subject|3|||
146113254|NCT00420927|526931507|FG004|Period 2|Withdrawal by Subject|11|||
146113255|NCT00420927|526931508|FG005|Period 2|Withdrawal by Subject|2|||
146113256|NCT00420927|526931509|FG006|Period 2|Withdrawal by Subject|12|||
146113257|NCT00420927|526931503|FG000|Period 2|Lost to Follow-up|0|||
146113258|NCT00420927|526931504|FG001|Period 2|Lost to Follow-up|0|||
146113259|NCT00420927|526931505|FG002|Period 2|Lost to Follow-up|2|||
146113260|NCT00420927|526931506|FG003|Period 2|Lost to Follow-up|2|||
146113261|NCT00420927|526931507|FG004|Period 2|Lost to Follow-up|6|||
146113262|NCT00420927|526931508|FG005|Period 2|Lost to Follow-up|3|||
146113263|NCT00420927|526931509|FG006|Period 2|Lost to Follow-up|9|||
146113264|NCT00420927|526931503|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
146113265|NCT00420927|526931504|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
146113266|NCT00420927|526931505|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
146113267|NCT00420927|526931506|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
146113268|NCT00420927|526931507|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
146260067|NCT02547441|527467234|FG000|Double-Blind Study Period|Protocol Violation|1|||
146113269|NCT00420927|526931508|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
146260068|NCT02547441|527467235|FG001|Double-Blind Study Period|Protocol Violation|2|||
146113270|NCT00420927|526931509|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
146113271|NCT00420927|526931503|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
146113272|NCT00420927|526931504|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
146260069|NCT02547441|527467234|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
146113273|NCT00420927|526931505|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
146260070|NCT02547441|527467235|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
146301812|NCT02871778|527620105|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
146301813|NCT02871778|527620098|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301814|NCT02871778|527620099|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301815|NCT02871778|527620100|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
146301816|NCT02871778|527620101|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301817|NCT02871778|527620102|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301818|NCT02871778|527620103|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301819|NCT02871778|527620104|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301820|NCT02871778|527620105|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
146301821|NCT02871778|527620098|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301822|NCT02871778|527620099|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
146301823|NCT02871778|527620100|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301824|NCT02871778|527620101|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301825|NCT02871778|527620102|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301826|NCT02871778|527620103|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
146113274|NCT00420927|526931506|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
146301827|NCT02871778|527620104|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301828|NCT02871778|527620105|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
146301829|NCT02871778|527620098|FG000|Part A: Treatment Period 2|Adverse Event|2|||
146301830|NCT02871778|527620099|FG001|Part A: Treatment Period 2|Adverse Event|2|||
146301831|NCT02871778|527620100|FG002|Part A: Treatment Period 2|Adverse Event|0|||
146301832|NCT02871778|527620101|FG003|Part A: Treatment Period 2|Adverse Event|0|||
146301833|NCT02871778|527620102|FG004|Part A: Treatment Period 2|Adverse Event|0|||
146301834|NCT02871778|527620103|FG005|Part A: Treatment Period 2|Adverse Event|0|||
146301835|NCT02871778|527620104|FG006|Part A: Treatment Period 2|Adverse Event|0|||
146301836|NCT02871778|527620105|FG007|Part A: Treatment Period 2|Adverse Event|0|||
146301837|NCT02871778|527620098|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301838|NCT02871778|527620099|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301839|NCT02871778|527620100|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301840|NCT02871778|527620101|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
146301841|NCT02871778|527620102|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301842|NCT02871778|527620103|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301843|NCT02871778|527620104|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301844|NCT02871778|527620105|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
146301845|NCT02871778|527620098|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
146301846|NCT02871778|527620099|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301847|NCT02871778|527620100|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
146301848|NCT02871778|527620101|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301849|NCT02871778|527620102|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301850|NCT02871778|527620103|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301851|NCT02871778|527620104|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301852|NCT02871778|527620105|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
146301853|NCT02871778|527620098|FG000|Part B: Treatment Period 3|Adverse Event|0|||
146301854|NCT02871778|527620099|FG001|Part B: Treatment Period 3|Adverse Event|0|||
146301855|NCT02871778|527620100|FG002|Part B: Treatment Period 3|Adverse Event|0|||
146301856|NCT02871778|527620101|FG003|Part B: Treatment Period 3|Adverse Event|0|||
146301857|NCT02871778|527620102|FG004|Part B: Treatment Period 3|Adverse Event|1|||
146301858|NCT02871778|527620103|FG005|Part B: Treatment Period 3|Adverse Event|1|||
146301859|NCT02871778|527620104|FG006|Part B: Treatment Period 3|Adverse Event|1|||
146301860|NCT02871778|527620105|FG007|Part B: Treatment Period 3|Adverse Event|0|||
146301861|NCT01230554|527620106|FG000|Overall Study|Lost to Follow-up|2|||
146301862|NCT01230554|527620106|FG000|Overall Study|Inability to maintain visit schedule|1|||
146301863|NCT02653300|527620107|FG000|Overall Study|Withdrawal by Subject|2|||
146301864|NCT01910116|527620108|FG000|Overall Study|Adverse Event|0|||
146301865|NCT01910116|527620109|FG001|Overall Study|Adverse Event|3|||
146301866|NCT01910116|527620108|FG000|Overall Study|Lack of Efficacy|3|||
146301867|NCT01910116|527620109|FG001|Overall Study|Lack of Efficacy|4|||
146301868|NCT01910116|527620108|FG000|Overall Study|Lost to Follow-up|1|||
146301869|NCT01910116|527620109|FG001|Overall Study|Lost to Follow-up|0|||
146301870|NCT01910116|527620108|FG000|Overall Study|Protocol Violation|1|||
146113275|NCT00420927|526931507|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
146113276|NCT00420927|526931508|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
146113277|NCT00420927|526931509|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
146113278|NCT00420927|526931503|FG000|Period 2|Subject unable to find transportation|0|||
146113279|NCT00420927|526931504|FG001|Period 2|Subject unable to find transportation|0|||
146113280|NCT00420927|526931505|FG002|Period 2|Subject unable to find transportation|0|||
146113281|NCT00420927|526931506|FG003|Period 2|Subject unable to find transportation|0|||
146113282|NCT00420927|526931507|FG004|Period 2|Subject unable to find transportation|0|||
146113283|NCT00420927|526931508|FG005|Period 2|Subject unable to find transportation|0|||
146113284|NCT00420927|526931509|FG006|Period 2|Subject unable to find transportation|1|||
146113285|NCT00420927|526931503|FG000|Period 2|Physician Decision|0|||
146113286|NCT00420927|526931504|FG001|Period 2|Physician Decision|0|||
146113287|NCT00420927|526931505|FG002|Period 2|Physician Decision|0|||
146113288|NCT00420927|526931506|FG003|Period 2|Physician Decision|0|||
146113289|NCT00420927|526931507|FG004|Period 2|Physician Decision|1|||
146113290|NCT00420927|526931508|FG005|Period 2|Physician Decision|1|||
146113291|NCT00420927|526931509|FG006|Period 2|Physician Decision|0|||
146113292|NCT00420927|526931503|FG000|Period 2|Sponsor decision|0|||
146113293|NCT00420927|526931504|FG001|Period 2|Sponsor decision|0|||
146113294|NCT00420927|526931505|FG002|Period 2|Sponsor decision|1|||
146113295|NCT00420927|526931506|FG003|Period 2|Sponsor decision|0|||
146260071|NCT02547441|527467234|FG000|Double-Blind Study Period|Sponsor Decision|1|||
146260072|NCT02547441|527467235|FG001|Double-Blind Study Period|Sponsor Decision|0|||
146260073|NCT02547441|527467234|FG000|Open-Label Study Period|Adverse Event|10|||
146260074|NCT02547441|527467235|FG001|Open-Label Study Period|Adverse Event|11|||
146260075|NCT02547441|527467234|FG000|Open-Label Study Period|Lack of Efficacy|3|||
146260076|NCT02547441|527467235|FG001|Open-Label Study Period|Lack of Efficacy|2|||
146113296|NCT00420927|526931507|FG004|Period 2|Sponsor decision|0|||
146113297|NCT00420927|526931508|FG005|Period 2|Sponsor decision|0|||
146113298|NCT00420927|526931509|FG006|Period 2|Sponsor decision|1|||
146113299|NCT00420927|526931503|FG000|Period 2|Randomization error|0|||
146113300|NCT00420927|526931504|FG001|Period 2|Randomization error|0|||
146113301|NCT00420927|526931505|FG002|Period 2|Randomization error|0|||
146113302|NCT00420927|526931506|FG003|Period 2|Randomization error|0|||
146113303|NCT00420927|526931507|FG004|Period 2|Randomization error|1|||
146113304|NCT00420927|526931508|FG005|Period 2|Randomization error|1|||
146113305|NCT00420927|526931509|FG006|Period 2|Randomization error|0|||
146113306|NCT00420927|526931503|FG000|Period 2|Noncompliant with study drug|0|||
146113307|NCT00420927|526931504|FG001|Period 2|Noncompliant with study drug|0|||
146113308|NCT00420927|526931505|FG002|Period 2|Noncompliant with study drug|0|||
146113309|NCT00420927|526931506|FG003|Period 2|Noncompliant with study drug|1|||
146113310|NCT00420927|526931507|FG004|Period 2|Noncompliant with study drug|0|||
146113311|NCT00420927|526931508|FG005|Period 2|Noncompliant with study drug|0|||
146113312|NCT00420927|526931509|FG006|Period 2|Noncompliant with study drug|2|||
146113313|NCT00420927|526931503|FG000|Period 2|Methotrexate intolerance|0|||
146113314|NCT00420927|526931504|FG001|Period 2|Methotrexate intolerance|0|||
146113315|NCT00420927|526931505|FG002|Period 2|Methotrexate intolerance|0|||
146113316|NCT00420927|526931506|FG003|Period 2|Methotrexate intolerance|0|||
146113317|NCT00420927|526931507|FG004|Period 2|Methotrexate intolerance|0|||
146113318|NCT00420927|526931508|FG005|Period 2|Methotrexate intolerance|0|||
146113319|NCT00420927|526931509|FG006|Period 2|Methotrexate intolerance|1|||
146113320|NCT00420927|526931503|FG000|Period 2|Took prohibited medication|0|||
146113321|NCT00420927|526931504|FG001|Period 2|Took prohibited medication|0|||
146113322|NCT00420927|526931505|FG002|Period 2|Took prohibited medication|0|||
146113323|NCT00420927|526931506|FG003|Period 2|Took prohibited medication|0|||
146113324|NCT00420927|526931507|FG004|Period 2|Took prohibited medication|1|||
146113325|NCT00420927|526931508|FG005|Period 2|Took prohibited medication|0|||
146113326|NCT00420927|526931509|FG006|Period 2|Took prohibited medication|0|||
146113327|NCT00642460|526931510|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
146113328|NCT00642460|526931511|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
146113329|NCT00642460|526931512|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
146260077|NCT02547441|527467234|FG000|Open-Label Study Period|Lost to Follow-up|7|||
146260078|NCT02547441|527467235|FG001|Open-Label Study Period|Lost to Follow-up|8|||
146260079|NCT02547441|527467234|FG000|Open-Label Study Period|Physician Decision|1|||
146260080|NCT02547441|527467235|FG001|Open-Label Study Period|Physician Decision|0|||
146260081|NCT02547441|527467234|FG000|Open-Label Study Period|Protocol Violation|2|||
146260082|NCT02547441|527467235|FG001|Open-Label Study Period|Protocol Violation|0|||
146260083|NCT02547441|527467234|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
146260084|NCT02547441|527467235|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
146260085|NCT02547441|527467234|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
146260086|NCT02547441|527467235|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
146260087|NCT01322009|527467236|FG000|Overall Study|Death|0|||
146113330|NCT00642460|526931513|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
146113331|NCT00642460|526931514|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
146113332|NCT00642460|526931515|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
146113333|NCT00642460|526931510|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
146260088|NCT01322009|527467237|FG001|Overall Study|Death|1|||
146301871|NCT01910116|527620109|FG001|Overall Study|Protocol Violation|2|||
146301872|NCT01910116|527620108|FG000|Overall Study|Withdrawal by Subject|8|||
146113334|NCT00642460|526931511|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146113335|NCT00642460|526931512|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146113336|NCT00642460|526931513|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146113337|NCT00642460|526931514|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146113338|NCT00642460|526931515|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
146113339|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
146260089|NCT01322009|527467236|FG000|Overall Study|Adverse Event|0|||
146260090|NCT01322009|527467237|FG001|Overall Study|Adverse Event|1|||
146113340|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
146113341|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146113342|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146113343|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146113344|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
146113345|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Death|0|||
146113346|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Death|1|||
146113347|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Death|0|||
146113348|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Death|2|||
146113349|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Death|0|||
146113350|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Death|0|||
146113351|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
146113352|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
146113353|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146113354|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146113355|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146113356|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
146113357|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
146113358|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
146113359|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146113360|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146113361|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146113362|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
146113363|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
146113364|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
146113365|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
146113366|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
146113367|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
146113368|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
146113369|NCT00642460|526931510|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146113370|NCT00642460|526931511|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146113371|NCT00642460|526931512|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146113372|NCT00642460|526931513|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
146113373|NCT00642460|526931514|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146113374|NCT00642460|526931515|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
146113375|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146113376|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146113377|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146113378|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
146113379|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
146113380|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
146113381|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146113382|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146113383|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146113384|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
146113385|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
146113386|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
146113387|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146113388|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146113389|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146113390|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
146113391|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
146113392|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
146113393|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146113394|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146113395|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146113396|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
146113397|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
146113398|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
146113399|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Other|0|||
146260091|NCT01322009|527467236|FG000|Overall Study|ng tube discontinued|0|||
146260092|NCT01322009|527467237|FG001|Overall Study|ng tube discontinued|1|||
146260093|NCT01657877|527467238|FG000|Overall Study|Withdrawal by Subject|4|||
146260094|NCT01657877|527467238|FG000|Overall Study|Protocol Violation|6|||
146260095|NCT01657877|527467238|FG000|Overall Study|Adverse Event|2|||
146260096|NCT01657877|527467238|FG000|Overall Study|Other Reason|2|||
146260097|NCT00905034|527467240|FG000|Overall Study|Withdrawal by Subject|1|||
146113400|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Other|0|||
146113401|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Other|0|||
146113402|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Other|0|||
146113403|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Other|2|||
146113404|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Other|2|||
146113405|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Death|0|||
146113406|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Death|0|||
146113407|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Death|0|||
146113408|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Death|0|||
146113409|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Death|0|||
146113410|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Death|3|||
146113411|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146113412|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146113413|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146113414|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146113415|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
146113416|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
146113417|NCT00642460|526931510|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146113418|NCT00642460|526931511|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146113419|NCT00642460|526931512|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146113420|NCT00642460|526931513|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
146113421|NCT00642460|526931514|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
146113422|NCT00642460|526931515|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
146113423|NCT00496470|526931518|FG000|Overall Study|Adverse Event|8|||
146113424|NCT00496470|526931519|FG001|Overall Study|Adverse Event|10|||
146113425|NCT00496470|526931518|FG000|Overall Study|Withdrawal by Subject|5|||
146113426|NCT00496470|526931519|FG001|Overall Study|Withdrawal by Subject|12|||
146113427|NCT00496470|526931518|FG000|Overall Study|Incorrectly enrolled|13|||
146113428|NCT00496470|526931519|FG001|Overall Study|Incorrectly enrolled|5|||
146113429|NCT00496470|526931518|FG000|Overall Study|Other reason|0|||
146113430|NCT00496470|526931519|FG001|Overall Study|Other reason|2|||
146113431|NCT00729651|526931521|FG000|Overall Study|Withdrawal by Subject|5|||
146113432|NCT00729651|526931522|FG001|Overall Study|Withdrawal by Subject|6|||
146113433|NCT00729651|526931521|FG000|Overall Study|Lost to Follow-up|5|||
146113434|NCT00729651|526931522|FG001|Overall Study|Lost to Follow-up|4|||
146113435|NCT00729651|526931521|FG000|Overall Study|Protocol Violation|0|||
146113436|NCT00729651|526931522|FG001|Overall Study|Protocol Violation|1|||
146113437|NCT00729651|526931521|FG000|Overall Study|Adverse Event|7|||
146113438|NCT00729651|526931522|FG001|Overall Study|Adverse Event|3|||
146113439|NCT00729651|526931521|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
146113440|NCT00729651|526931522|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
146113441|NCT00729651|526931521|FG000|Overall Study|Subject's private reason|2|||
146113442|NCT00729651|526931522|FG001|Overall Study|Subject's private reason|0|||
146113443|NCT00291577|526931523|FG000|Overall Study|Adverse Event|1|||
146113444|NCT00291577|526931523|FG000|Overall Study|Other|4|||
146113445|NCT00291577|526931523|FG000|Overall Study|Withdrawal by Subject|2|||
146113446|NCT00291577|526931523|FG000|Overall Study|Lack of Efficacy|14|||
146113447|NCT00833794|526931530|FG000|Open-label Phase|Adverse Event|225|||
146113448|NCT00833794|526931531|FG001|Open-label Phase|Adverse Event|0|||
146113449|NCT00833794|526931530|FG000|Open-label Phase|Lack of Efficacy|28|||
146113450|NCT00833794|526931531|FG001|Open-label Phase|Lack of Efficacy|0|||
146113451|NCT00833794|526931530|FG000|Open-label Phase|Withdrawal by Subject|48|||
146113452|NCT00833794|526931531|FG001|Open-label Phase|Withdrawal by Subject|0|||
146113453|NCT00833794|526931530|FG000|Open-label Phase|Physician Decision|20|||
146113454|NCT00833794|526931531|FG001|Open-label Phase|Physician Decision|0|||
146113455|NCT00833794|526931530|FG000|Open-label Phase|Administrative reason|1|||
146113456|NCT00833794|526931531|FG001|Open-label Phase|Administrative reason|0|||
146113457|NCT00833794|526931530|FG000|Open-label Phase|Protocol Violation|47|||
146113458|NCT00833794|526931531|FG001|Open-label Phase|Protocol Violation|0|||
146113459|NCT00833794|526931530|FG000|Open-label Phase|Did not complete wash-out period|12|||
146113460|NCT00833794|526931531|FG001|Open-label Phase|Did not complete wash-out period|0|||
146113461|NCT00833794|526931530|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
146113462|NCT00833794|526931531|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
146113463|NCT00833794|526931530|FG000|Double-blind Phase|Adverse Event|44|||
146113464|NCT00833794|526931531|FG001|Double-blind Phase|Adverse Event|11|||
146113465|NCT00833794|526931530|FG000|Double-blind Phase|Lack of Efficacy|34|||
146113466|NCT00833794|526931531|FG001|Double-blind Phase|Lack of Efficacy|22|||
146113467|NCT00833794|526931530|FG000|Double-blind Phase|Withdrawal by Subject|23|||
146113468|NCT00833794|526931531|FG001|Double-blind Phase|Withdrawal by Subject|6|||
146113469|NCT00833794|526931530|FG000|Double-blind Phase|Physician Decision|4|||
146113470|NCT00833794|526931531|FG001|Double-blind Phase|Physician Decision|7|||
146113471|NCT00833794|526931530|FG000|Double-blind Phase|Administrative reason|1|||
146113472|NCT00833794|526931531|FG001|Double-blind Phase|Administrative reason|3|||
146113473|NCT00471328|526931532|FG000|Core Phase|Adverse Event|18|||
146113474|NCT00471328|526931533|FG001|Core Phase|Adverse Event|6|||
146260098|NCT00394589|527467241|FG000|Overall Study|Adverse Event|2|||
146260099|NCT00394589|527467242|FG001|Overall Study|Adverse Event|1|||
146260100|NCT00394589|527467243|FG002|Overall Study|Adverse Event|2|||
146260101|NCT00394589|527467241|FG000|Overall Study|Lack of Efficacy|2|||
146260102|NCT00394589|527467242|FG001|Overall Study|Lack of Efficacy|2|||
146260103|NCT00394589|527467243|FG002|Overall Study|Lack of Efficacy|3|||
146260104|NCT00394589|527467241|FG000|Overall Study|Protocol Violation|4|||
146260105|NCT00394589|527467242|FG001|Overall Study|Protocol Violation|0|||
146260106|NCT00394589|527467243|FG002|Overall Study|Protocol Violation|2|||
146260107|NCT03409731|527467245|FG000|Overall Study|Withdrawal by Subject|17|||
146260108|NCT03409731|527467245|FG000|Overall Study|Death|4|||
146260109|NCT01114672|527467246|FG000|Overall Study|Death|0|||
146260110|NCT01114672|527467247|FG001|Overall Study|Death|1|||
146260111|NCT01114672|527467246|FG000|Overall Study|Withdrawal by Subject|2|||
146260112|NCT01114672|527467247|FG001|Overall Study|Withdrawal by Subject|1|||
146260113|NCT01114672|527467246|FG000|Overall Study|Lost to Follow-up|1|||
146260114|NCT01114672|527467247|FG001|Overall Study|Lost to Follow-up|0|||
146113475|NCT00471328|526931532|FG000|Core Phase|Death|8|||
146113476|NCT00471328|526931533|FG001|Core Phase|Death|4|||
146113477|NCT00471328|526931532|FG000|Core Phase|Withdrawal by Subject|2|||
146113478|NCT00471328|526931533|FG001|Core Phase|Withdrawal by Subject|2|||
146113479|NCT00471328|526931532|FG000|Core Phase|Abnormal laboratory value|1|||
146113480|NCT00471328|526931533|FG001|Core Phase|Abnormal laboratory value|0|||
146113481|NCT00471328|526931532|FG000|Core Phase|Disease Progression|78|||
146113482|NCT00471328|526931533|FG001|Core Phase|Disease Progression|53|||
146113483|NCT00471328|526931532|FG000|Core Phase|Administrative Problem|0|||
146113484|NCT00471328|526931533|FG001|Core Phase|Administrative Problem|1|||
146113485|NCT00471328|526931532|FG000|Core Phase|Protocol Deviation|0|||
146113486|NCT00471328|526931533|FG001|Core Phase|Protocol Deviation|1|||
146113487|NCT00471328|526931532|FG000|Extension Phase|Adverse Event|3|||
146113488|NCT00471328|526931533|FG001|Extension Phase|Adverse Event|12|||
146113489|NCT00471328|526931532|FG000|Extension Phase|Withdrawal by Subject|0|||
146113490|NCT00471328|526931533|FG001|Extension Phase|Withdrawal by Subject|2|||
146113491|NCT00471328|526931532|FG000|Extension Phase|Death|1|||
146113492|NCT00471328|526931533|FG001|Extension Phase|Death|7|||
146113493|NCT00471328|526931532|FG000|Extension Phase|Protocol Deviation|3|||
146113494|NCT00471328|526931533|FG001|Extension Phase|Protocol Deviation|1|||
146113495|NCT00471328|526931532|FG000|Extension Phase|Treatment duration as per protocol|0|||
146113496|NCT00471328|526931533|FG001|Extension Phase|Treatment duration as per protocol|1|||
146113497|NCT00471328|526931532|FG000|Extension Phase|Disease Progression|32|||
146113498|NCT00471328|526931533|FG001|Extension Phase|Disease Progression|44|||
146113499|NCT00471328|526931532|FG000|Extension Phase|New cancer Therapy|1|||
146113500|NCT00471328|526931533|FG001|Extension Phase|New cancer Therapy|0|||
146113501|NCT00471328|526931532|FG000|Extension Phase|Administrative Problem|1|||
146113502|NCT00471328|526931533|FG001|Extension Phase|Administrative Problem|0|||
146113503|NCT00519831|526931534|FG000|Overall Study|Adverse Event|3|||
146113504|NCT04051008|526931535|FG000|Overall Study|Withdrawal by Subject|2|||
146113505|NCT04051008|526931536|FG001|Overall Study|Withdrawal by Subject|0|||
146113506|NCT04051008|526931537|FG002|Overall Study|Withdrawal by Subject|1|||
146113507|NCT03200860|526931538|FG000|Overall Study|Withdrawal by Subject|1|||
146113508|NCT03200860|526931539|FG001|Overall Study|Withdrawal by Subject|0|||
146113509|NCT00844896|526931540|FG000|Overall Study|Lost to Follow-up|12|||
146113510|NCT00844896|526931541|FG001|Overall Study|Lost to Follow-up|16|||
146113511|NCT00844896|526931540|FG000|Overall Study|Parents did not have time to complete|0|||
146113512|NCT00844896|526931541|FG001|Overall Study|Parents did not have time to complete|1|||
146113513|NCT00458211|526931545|FG000|Overall Study|Lack of Efficacy|12|||
146113514|NCT00458211|526931545|FG000|Overall Study|Withdrawal by Subject|2|||
146113515|NCT00458211|526931545|FG000|Overall Study|Protocol Violation|2|||
146113516|NCT04342897|526931546|FG000|Overall Study|Death|7|||
146113517|NCT04342897|526931547|FG001|Overall Study|Death|4|||
146113518|NCT04342897|526931546|FG000|Overall Study|Lost to Follow-up|6|||
146113519|NCT04342897|526931547|FG001|Overall Study|Lost to Follow-up|6|||
146113520|NCT04342897|526931546|FG000|Overall Study|Withdrawal by Subject|1|||
146113521|NCT04342897|526931547|FG001|Overall Study|Withdrawal by Subject|2|||
146113522|NCT02634320|526931552|FG000|Overall Study|Adverse Event|2|||
146113523|NCT02634320|526931552|FG000|Overall Study|Lost to Follow-up|3|||
146113524|NCT02634320|526931552|FG000|Overall Study|Moved out of area|2|||
146113525|NCT02634320|526931552|FG000|Overall Study|Out of window for study visits|1|||
146113526|NCT02634320|526931552|FG000|Overall Study|Protocol Violation|1|||
146113527|NCT02634320|526931552|FG000|Overall Study|Withdrawal by Subject|5|||
146113528|NCT02634320|526931552|FG000|Overall Study|Lack of Efficacy|2|||
146113529|NCT00838578|526931557|FG000|Overall Study|Protocol Violation|2|||
146113530|NCT00598832|526931558|FG000|Overall Study|Lack of Efficacy|3|||
146113531|NCT00598832|526931559|FG001|Overall Study|Lack of Efficacy|7|||
146113532|NCT00598832|526931558|FG000|Overall Study|Adverse Event|6|||
146113533|NCT00598832|526931559|FG001|Overall Study|Adverse Event|2|||
146113534|NCT00598832|526931558|FG000|Overall Study|Withdrawal by Subject|25|||
146260115|NCT01114672|527467246|FG000|Overall Study|transplanted|1|||
146260116|NCT01114672|527467247|FG001|Overall Study|transplanted|0|||
146113535|NCT00598832|526931559|FG001|Overall Study|Withdrawal by Subject|36|||
146113536|NCT00598832|526931558|FG000|Overall Study|Protocol Violation|0|||
146113537|NCT00598832|526931559|FG001|Overall Study|Protocol Violation|2|||
146113538|NCT00598832|526931558|FG000|Overall Study|Lost to Follow-up|24|||
146113539|NCT00598832|526931559|FG001|Overall Study|Lost to Follow-up|29|||
146113540|NCT00598832|526931558|FG000|Overall Study|Pregnancy|2|||
146113541|NCT00598832|526931559|FG001|Overall Study|Pregnancy|2|||
146113542|NCT00598832|526931558|FG000|Overall Study|Physician Decision|1|||
146113543|NCT00598832|526931559|FG001|Overall Study|Physician Decision|4|||
146113544|NCT00598832|526931558|FG000|Overall Study|Non compliance|1|||
146113545|NCT00598832|526931559|FG001|Overall Study|Non compliance|0|||
146113546|NCT00357968|526931563|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
146113547|NCT00357968|526931564|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
146113548|NCT00357968|526931563|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
146113549|NCT00357968|526931564|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
146113550|NCT03919799|526931569|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
146113551|NCT03919799|526931570|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
146113552|NCT03919799|526931571|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
146113553|NCT03919799|526931572|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
146113554|NCT03919799|526931573|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
146113555|NCT03919799|526931569|FG000|DB Period (28 Weeks)|Adverse Event|1|||
146113556|NCT03919799|526931570|FG001|DB Period (28 Weeks)|Adverse Event|1|||
146113557|NCT03919799|526931571|FG002|DB Period (28 Weeks)|Adverse Event|1|||
146113558|NCT03919799|526931572|FG003|DB Period (28 Weeks)|Adverse Event|0|||
146113559|NCT03919799|526931573|FG004|DB Period (28 Weeks)|Adverse Event|0|||
146113560|NCT03919799|526931569|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146113561|NCT03919799|526931570|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
146113562|NCT03919799|526931571|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146113563|NCT03919799|526931572|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146113564|NCT03919799|526931573|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
146113565|NCT03919799|526931569|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146113566|NCT03919799|526931570|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
146113567|NCT03919799|526931571|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146113568|NCT03919799|526931572|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146113569|NCT03919799|526931573|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
146113570|NCT03919799|526931569|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
146113571|NCT03919799|526931570|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
146113572|NCT03919799|526931571|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
146113573|NCT03919799|526931572|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
146113574|NCT03919799|526931573|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
146113575|NCT02142959|526931575|FG000|Overall Study|Adverse Event|1|||
146113576|NCT02142959|526931576|FG001|Overall Study|Adverse Event|0|||
146113577|NCT02142959|526931577|FG002|Overall Study|Adverse Event|0|||
146113578|NCT02142959|526931575|FG000|Overall Study|Death|0|||
146113579|NCT02142959|526931576|FG001|Overall Study|Death|1|||
146113580|NCT02142959|526931577|FG002|Overall Study|Death|0|||
146113581|NCT02142959|526931575|FG000|Overall Study|Withdrawal by Subject|3|||
146113582|NCT02142959|526931576|FG001|Overall Study|Withdrawal by Subject|1|||
146113583|NCT02142959|526931577|FG002|Overall Study|Withdrawal by Subject|3|||
146113584|NCT02142959|526931575|FG000|Overall Study|Administrative Reasons|1|||
146113585|NCT02142959|526931576|FG001|Overall Study|Administrative Reasons|0|||
146113586|NCT02142959|526931577|FG002|Overall Study|Administrative Reasons|1|||
146113587|NCT02142959|526931575|FG000|Overall Study|Missing|0|||
146113588|NCT02142959|526931576|FG001|Overall Study|Missing|1|||
146113589|NCT02142959|526931577|FG002|Overall Study|Missing|0|||
146113590|NCT02142959|526931575|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
146113591|NCT02142959|526931576|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
146113592|NCT02142959|526931577|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
146301873|NCT01910116|527620109|FG001|Overall Study|Withdrawal by Subject|3|||
146301874|NCT01910116|527620108|FG000|Overall Study|uncertain allocation|1|||
146301875|NCT01910116|527620109|FG001|Overall Study|uncertain allocation|3|||
146301876|NCT01910116|527620108|FG000|Overall Study|incomplete data|0|||
146301877|NCT01910116|527620109|FG001|Overall Study|incomplete data|1|||
146301878|NCT01849497|527620110|FG000|Overall Study|Withdrawal by Subject|1|||
146301879|NCT01849497|527620111|FG001|Overall Study|Withdrawal by Subject|2|||
146301880|NCT01849497|527620110|FG000|Overall Study|Sponsor Decision|0|||
146301881|NCT01849497|527620111|FG001|Overall Study|Sponsor Decision|1|||
146301882|NCT01849497|527620110|FG000|Overall Study|Lost to Follow-up|0|||
146301883|NCT01849497|527620111|FG001|Overall Study|Lost to Follow-up|1|||
146301884|NCT00911625|527620112|FG000|Overall Study|Lost to Follow-up|7|||
146113593|NCT02142959|526931575|FG000|Overall Study|Patient didn't complete end of study visit|0|||
146113594|NCT02142959|526931576|FG001|Overall Study|Patient didn't complete end of study visit|0|||
146113595|NCT02142959|526931577|FG002|Overall Study|Patient didn't complete end of study visit|1|||
146113596|NCT03547687|526931578|FG000|Overall Study|Withdrawal by Subject|1|||
146301885|NCT00911625|527620113|FG001|Overall Study|Lost to Follow-up|0|||
146301886|NCT01289821|527620114|FG000|Treatment Period|Withdrawal by Subject|1|||
146301887|NCT01289821|527620114|FG000|Treatment Period|Physician Decision|3|||
146301888|NCT01289821|527620114|FG000|Treatment Period|Adverse Event|4|||
146301889|NCT01289821|527620114|FG000|Treatment Period|Radiological Progression|43|||
146301890|NCT01289821|527620114|FG000|Treatment Period|Clinical Progression|2|||
146301891|NCT01289821|527620114|FG000|Treatment Period|Therapeutic procedure required|1|||
146301892|NCT01289821|527620114|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
146301893|NCT01289821|527620114|FG000|Safety Follow-up Period|Protocol Violation|3|||
146301894|NCT01289821|527620114|FG000|Safety Follow-up Period|Unspecified reason|1|||
146301895|NCT01289821|527620114|FG000|Survival Follow-up Period|Protocol Violation|1|||
146301896|NCT01289821|527620114|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
146301897|NCT01289821|527620114|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
146301898|NCT02729740|527620119|FG000|Overall Study|Early Termination|130|||
146301899|NCT02729740|527620119|FG000|Overall Study|Other|1|||
146301900|NCT03061175|527620136|FG000|Baseline|Participant was deemed ineligible|1|||
146113597|NCT03547687|526931578|FG000|Overall Study|Death|1|||
146113598|NCT05425745|526931581|FG000|Overall Study|Withdrawal of Consent|3|||
146113599|NCT05425745|526931582|FG001|Overall Study|Withdrawal of Consent|3|||
146113600|NCT05425745|526931581|FG000|Overall Study|Death|2|||
146113601|NCT05425745|526931582|FG001|Overall Study|Death|3|||
146113602|NCT05425745|526931581|FG000|Overall Study|Lost to Follow-up|1|||
146113603|NCT05425745|526931582|FG001|Overall Study|Lost to Follow-up|2|||
146113604|NCT05425745|526931581|FG000|Overall Study|Adverse Event|0|||
146113605|NCT05425745|526931582|FG001|Overall Study|Adverse Event|1|||
146113606|NCT05425745|526931581|FG000|Overall Study|Did not return for end of study visit|0|||
146113607|NCT05425745|526931582|FG001|Overall Study|Did not return for end of study visit|1|||
146113608|NCT05425745|526931581|FG000|Overall Study|End of study visit completed by phone|1|||
146113609|NCT05425745|526931582|FG001|Overall Study|End of study visit completed by phone|0|||
146113610|NCT05425745|526931581|FG000|Overall Study|Subject decision|1|||
146113611|NCT05425745|526931582|FG001|Overall Study|Subject decision|0|||
146113612|NCT02700815|526932731|FG000|Overall Study|Adverse Event|0|||
146113613|NCT02700815|526932732|FG001|Overall Study|Adverse Event|6|||
146113614|NCT02700815|526932733|FG002|Overall Study|Adverse Event|2|||
146113615|NCT02700815|526932734|FG003|Overall Study|Adverse Event|3|||
146113616|NCT02700815|526932731|FG000|Overall Study|Lack of Efficacy|0|||
146113617|NCT02700815|526932732|FG001|Overall Study|Lack of Efficacy|0|||
146113618|NCT02700815|526932733|FG002|Overall Study|Lack of Efficacy|1|||
146113619|NCT02700815|526932734|FG003|Overall Study|Lack of Efficacy|2|||
146113620|NCT02700815|526932731|FG000|Overall Study|Lost to Follow-up|1|||
146113621|NCT02700815|526932732|FG001|Overall Study|Lost to Follow-up|0|||
146113622|NCT02700815|526932733|FG002|Overall Study|Lost to Follow-up|0|||
146113623|NCT02700815|526932734|FG003|Overall Study|Lost to Follow-up|1|||
146113624|NCT02700815|526932731|FG000|Overall Study|Refusal to continue medication|0|||
146113625|NCT02700815|526932732|FG001|Overall Study|Refusal to continue medication|1|||
146113626|NCT02700815|526932733|FG002|Overall Study|Refusal to continue medication|0|||
146113627|NCT02700815|526932734|FG003|Overall Study|Refusal to continue medication|1|||
146113628|NCT02700815|526932731|FG000|Overall Study|Withdrawal by Subject|0|||
146113629|NCT02700815|526932732|FG001|Overall Study|Withdrawal by Subject|0|||
146113630|NCT02700815|526932733|FG002|Overall Study|Withdrawal by Subject|1|||
146113631|NCT02700815|526932734|FG003|Overall Study|Withdrawal by Subject|0|||
146113632|NCT02239978|526932736|FG000|Overall Study|Withdrawal by Subject|2|||
146113633|NCT02239978|526932737|FG001|Overall Study|Withdrawal by Subject|0|||
146113634|NCT00793403|526932738|FG000|Overall Study|Other|73|||
146113635|NCT02990910|526932744|FG000|Overall Study|Lack of Efficacy|6|||
146113636|NCT02990910|526932745|FG001|Overall Study|Lack of Efficacy|10|||
146113637|NCT03506815|526932751|FG000|Overall Study|Adverse Event|8|||
146113638|NCT03506815|526932752|FG001|Overall Study|Adverse Event|0|||
146113639|NCT03506815|526932751|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
146113640|NCT03506815|526932752|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
146113641|NCT03506815|526932751|FG000|Overall Study|Protocol Violation|1|||
146113642|NCT03506815|526932752|FG001|Overall Study|Protocol Violation|0|||
146113643|NCT03506815|526932751|FG000|Overall Study|Elective Surgery|1|||
146113644|NCT03506815|526932752|FG001|Overall Study|Elective Surgery|0|||
146113645|NCT02692716|526932756|FG000|Overall Study|Lost to Follow-up|2|||
146113646|NCT02692716|526932757|FG001|Overall Study|Lost to Follow-up|5|||
146113647|NCT02692716|526932756|FG000|Overall Study|Withdrawal by Subject|3|||
146113648|NCT02692716|526932757|FG001|Overall Study|Withdrawal by Subject|1|||
146113649|NCT00856284|526932762|FG000|Overall Study|Hyperglycemic rescue|231|||
146113650|NCT00856284|526932763|FG001|Overall Study|Hyperglycemic rescue|201|||
146113651|NCT00856284|526932764|FG002|Overall Study|Hyperglycemic rescue|235|||
146113652|NCT00856284|526932762|FG000|Overall Study|Adverse Event|60|||
146113653|NCT00856284|526932763|FG001|Overall Study|Adverse Event|74|||
146113654|NCT00856284|526932764|FG002|Overall Study|Adverse Event|82|||
146113655|NCT00856284|526932762|FG000|Overall Study|Major protocol deviation|24|||
146113656|NCT00856284|526932763|FG001|Overall Study|Major protocol deviation|16|||
146301901|NCT03061175|527620137|FG001|Baseline|Participant was deemed ineligible|0|||
146113657|NCT00856284|526932764|FG002|Overall Study|Major protocol deviation|15|||
146113658|NCT00856284|526932762|FG000|Overall Study|Lost to Follow-up|20|||
146113659|NCT00856284|526932763|FG001|Overall Study|Lost to Follow-up|22|||
146113660|NCT00856284|526932764|FG002|Overall Study|Lost to Follow-up|28|||
146113661|NCT00856284|526932762|FG000|Overall Study|Voluntary withdrawal|48|||
146113662|NCT00856284|526932763|FG001|Overall Study|Voluntary withdrawal|52|||
146113663|NCT00856284|526932764|FG002|Overall Study|Voluntary withdrawal|62|||
146113664|NCT00856284|526932762|FG000|Overall Study|Pregnancy|1|||
146113665|NCT00856284|526932763|FG001|Overall Study|Pregnancy|2|||
146113666|NCT00856284|526932764|FG002|Overall Study|Pregnancy|0|||
146113667|NCT00856284|526932762|FG000|Overall Study|Investigator discretion|9|||
146113668|NCT00856284|526932763|FG001|Overall Study|Investigator discretion|8|||
146113669|NCT00856284|526932764|FG002|Overall Study|Investigator discretion|10|||
146113670|NCT00856284|526932762|FG000|Overall Study|Other|15|||
146113671|NCT00856284|526932763|FG001|Overall Study|Other|17|||
146113672|NCT00856284|526932764|FG002|Overall Study|Other|14|||
146113673|NCT00856284|526932762|FG000|Overall Study|Randomized in error|0|||
146113674|NCT00856284|526932763|FG001|Overall Study|Randomized in error|0|||
146113675|NCT00856284|526932764|FG002|Overall Study|Randomized in error|1|||
146113676|NCT02511184|526932767|FG000|Overall Study|Death|1|||
146113677|NCT02511184|526932768|FG001|Overall Study|Death|0|||
146113678|NCT02511184|526932767|FG000|Overall Study|Lost to Follow-up|0|||
146113679|NCT02511184|526932768|FG001|Overall Study|Lost to Follow-up|1|||
146113680|NCT02511184|526932767|FG000|Overall Study|Study terminated by sponsor|1|||
146113681|NCT02511184|526932768|FG001|Overall Study|Study terminated by sponsor|5|||
146113682|NCT02511184|526932767|FG000|Overall Study|Withdrawal by Subject|0|||
146113683|NCT02511184|526932768|FG001|Overall Study|Withdrawal by Subject|1|||
146113684|NCT04271605|526932770|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
146113685|NCT00105482|526932771|FG000|Overall Study|Adverse Event|1|||
146113686|NCT00105482|526932772|FG001|Overall Study|Adverse Event|1|||
146113687|NCT00105482|526932771|FG000|Overall Study|Lost to Follow-up|26|||
146113688|NCT00105482|526932772|FG001|Overall Study|Lost to Follow-up|17|||
146113689|NCT00105482|526932771|FG000|Overall Study|Withdrawal by Subject|0|||
146113690|NCT00105482|526932772|FG001|Overall Study|Withdrawal by Subject|1|||
146113691|NCT00105482|526932771|FG000|Overall Study|Lost Interest|29|||
146113692|NCT00105482|526932772|FG001|Overall Study|Lost Interest|32|||
146113693|NCT00105482|526932771|FG000|Overall Study|Scheduling Conflict|2|||
146113694|NCT00105482|526932772|FG001|Overall Study|Scheduling Conflict|3|||
146113695|NCT00105482|526932771|FG000|Overall Study|Withdrawn by PI|1|||
146113696|NCT00105482|526932772|FG001|Overall Study|Withdrawn by PI|1|||
146113697|NCT01349790|526932773|FG000|Overall Study|Investigator Judgement|3|||
146113698|NCT01349790|526932773|FG000|Overall Study|Death|2|||
146113699|NCT01349790|526932773|FG000|Overall Study|Withdrawal by Patient|2|||
146113700|NCT01349790|526932773|FG000|Overall Study|Adverse Event|1|||
146113701|NCT01349790|526932773|FG000|Overall Study|Lost to Follow-up|1|||
146113702|NCT04016285|526932774|FG000|Overall Study|Did not progress to surgery|2|||
146113703|NCT04016285|526932775|FG001|Overall Study|Did not progress to surgery|5|||
146113704|NCT04016285|526932774|FG000|Overall Study|Failed to collect outcome data|5|||
146113705|NCT04016285|526932775|FG001|Overall Study|Failed to collect outcome data|3|||
146113706|NCT02547649|526932778|FG000|Overall Study|Lost to Follow-up|3|||
146113707|NCT02547649|526932779|FG001|Overall Study|Lost to Follow-up|1|||
146113708|NCT02547649|526932780|FG002|Overall Study|Lost to Follow-up|1|||
146113709|NCT02547649|526932778|FG000|Overall Study|Not vaccinated|0|||
146113710|NCT02547649|526932779|FG001|Overall Study|Not vaccinated|0|||
146113711|NCT02547649|526932780|FG002|Overall Study|Not vaccinated|1|||
146113712|NCT02547649|526932778|FG000|Overall Study|Withdrawal by Subject|0|||
146113713|NCT02547649|526932779|FG001|Overall Study|Withdrawal by Subject|4|||
146113714|NCT02547649|526932780|FG002|Overall Study|Withdrawal by Subject|2|||
146113715|NCT01750242|526932786|FG000|Overall Study|Unreadable Images|3|||
146113716|NCT00006903|526932787|FG000|Overall Study|Still receiving treatment|0|||
146113717|NCT00006903|526932788|FG001|Overall Study|Still receiving treatment|0|||
146113718|NCT00006903|526932789|FG002|Overall Study|Still receiving treatment|1|||
146113719|NCT00006903|526932787|FG000|Overall Study|Refused further treatment|0|||
146113720|NCT00006903|526932788|FG001|Overall Study|Refused further treatment|2|||
146113721|NCT00006903|526932789|FG002|Overall Study|Refused further treatment|1|||
146113722|NCT00006903|526932787|FG000|Overall Study|Adverse Event|0|||
146113723|NCT00006903|526932788|FG001|Overall Study|Adverse Event|0|||
146113724|NCT00006903|526932789|FG002|Overall Study|Adverse Event|1|||
146113725|NCT00006903|526932787|FG000|Overall Study|Death|0|||
146113726|NCT00006903|526932788|FG001|Overall Study|Death|1|||
146113727|NCT00006903|526932789|FG002|Overall Study|Death|0|||
146113728|NCT00006903|526932787|FG000|Overall Study|Patient never treated|0|||
146113729|NCT00006903|526932788|FG001|Overall Study|Patient never treated|0|||
146113730|NCT00006903|526932789|FG002|Overall Study|Patient never treated|1|||
146113731|NCT00006903|526932787|FG000|Overall Study|Ineligible|10|||
146113732|NCT00006903|526932788|FG001|Overall Study|Ineligible|1|||
146113733|NCT00006903|526932789|FG002|Overall Study|Ineligible|2|||
146113734|NCT01909674|526932790|FG000|Overall Study|Withdrawal by Subject|5|||
146113735|NCT01909674|526932791|FG001|Overall Study|Withdrawal by Subject|2|||
146113736|NCT02969369|526932792|FG000|Study|Adverse Event|1|||
146260117|NCT01710800|527467250|FG000|Overall Study|Withdrawal by Subject|21|||
146260118|NCT01710800|527467250|FG000|Overall Study|Protocol Violation|1|||
146260119|NCT02427958|527467251|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
146260120|NCT02427958|527467251|FG000|Overall Study|Lost to Follow-up|6|||
146260121|NCT02427958|527467251|FG000|Overall Study|Withdrawal by Subject|14|||
146260122|NCT02427958|527467251|FG000|Overall Study|Lack of Efficacy|1|||
146260123|NCT02287883|527467257|FG000|Overall Study|Death|8|||
146260124|NCT02287883|527467258|FG001|Overall Study|Death|7|||
146260125|NCT02287883|527467257|FG000|Overall Study|No longer eligible|222|||
146260126|NCT02287883|527467258|FG001|Overall Study|No longer eligible|182|||
146260127|NCT02287883|527467257|FG000|Overall Study|Non-response to survey|229|||
146260128|NCT02287883|527467258|FG001|Overall Study|Non-response to survey|237|||
146260129|NCT00545571|527467262|FG000|Overall Study|Administrative Reasons|1|||
146260130|NCT00545571|527467262|FG000|Overall Study|Adverse Event|2|||
146260131|NCT00545571|527467262|FG000|Overall Study|Death|5|||
146113737|NCT02969369|526932793|FG001|Study|Adverse Event|6|||
146113738|NCT02969369|526932792|FG000|Study|Lack of Efficacy|0|||
146113739|NCT02969369|526932793|FG001|Study|Lack of Efficacy|1|||
146113740|NCT02969369|526932792|FG000|Study|Lost to Follow-up|0|||
146113741|NCT02969369|526932793|FG001|Study|Lost to Follow-up|1|||
146113742|NCT02969369|526932792|FG000|Study|Withdrawal by Subject|3|||
146113743|NCT02969369|526932793|FG001|Study|Withdrawal by Subject|5|||
146113744|NCT02969369|526932792|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
146113745|NCT02969369|526932793|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
146113746|NCT02969369|526932792|FG000|Double-blind Period|Adverse Event|1|||
146113747|NCT02969369|526932793|FG001|Double-blind Period|Adverse Event|5|||
146113748|NCT02969369|526932792|FG000|Double-blind Period|Lost to Follow-up|0|||
146113749|NCT02969369|526932793|FG001|Double-blind Period|Lost to Follow-up|1|||
146113750|NCT02969369|526932792|FG000|Double-blind Period|Withdrawal by Subject|2|||
146113751|NCT02969369|526932793|FG001|Double-blind Period|Withdrawal by Subject|3|||
146113752|NCT02969369|526932792|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
146113753|NCT02969369|526932793|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
146113754|NCT02969369|526932792|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
146113755|NCT02969369|526932793|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
146113756|NCT02969369|526932792|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
146113757|NCT02969369|526932793|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
146113758|NCT02969369|526932792|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
146113759|NCT02969369|526932793|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
146113760|NCT02651922|526932795|FG000|Overall Study|due to exclusion criteria|2|||
146113761|NCT01366209|526932796|FG000|Overall Study|Adverse Event|6|||
146113762|NCT01366209|526932797|FG001|Overall Study|Adverse Event|7|||
146113763|NCT01366209|526932796|FG000|Overall Study|Withdrawal by Subject|4|||
146113764|NCT01366209|526932797|FG001|Overall Study|Withdrawal by Subject|4|||
146113765|NCT01366209|526932796|FG000|Overall Study|Death|12|||
146113766|NCT01366209|526932797|FG001|Overall Study|Death|19|||
146113767|NCT01366209|526932796|FG000|Overall Study|Lung transplantation|6|||
146113768|NCT01366209|526932797|FG001|Overall Study|Lung transplantation|1|||
146113769|NCT01366209|526932796|FG000|Overall Study|Lost to Follow-up|2|||
146113770|NCT01366209|526932797|FG001|Overall Study|Lost to Follow-up|1|||
146113771|NCT01366209|526932796|FG000|Overall Study|Physician Decision|1|||
146113772|NCT01366209|526932797|FG001|Overall Study|Physician Decision|0|||
146113773|NCT01366209|526932796|FG000|Overall Study|Sponsors decision|0|||
146113774|NCT01366209|526932797|FG001|Overall Study|Sponsors decision|1|||
146113775|NCT01366209|526932796|FG000|Overall Study|Withdrew consent|4|||
146113776|NCT01366209|526932797|FG001|Overall Study|Withdrew consent|3|||
146113777|NCT01053221|526932798|FG000|Overall Study|The study was closed prematurely|5|||
146113778|NCT01053221|526932799|FG001|Overall Study|The study was closed prematurely|9|||
146113779|NCT01465997|526932800|FG000|Overall Study|Adverse Event|12|||
146113780|NCT01465997|526932801|FG001|Overall Study|Adverse Event|22|||
146113781|NCT01465997|526932800|FG000|Overall Study|Lack of Efficacy|13|||
146113782|NCT01465997|526932801|FG001|Overall Study|Lack of Efficacy|1|||
146113783|NCT01465997|526932800|FG000|Overall Study|Protocol Violation|1|||
146113784|NCT01465997|526932801|FG001|Overall Study|Protocol Violation|4|||
146113785|NCT01465997|526932800|FG000|Overall Study|Lost to Follow-up|6|||
146260132|NCT00545571|527467262|FG000|Overall Study|Lack of Efficacy|1|||
146260133|NCT00545571|527467262|FG000|Overall Study|Protocol Violation|2|||
146260134|NCT00545571|527467262|FG000|Overall Study|Refused Treatment|1|||
146113786|NCT01465997|526932801|FG001|Overall Study|Lost to Follow-up|9|||
146113787|NCT01465997|526932800|FG000|Overall Study|Withdrawal by Subject|32|||
146113788|NCT01465997|526932801|FG001|Overall Study|Withdrawal by Subject|35|||
146113789|NCT01465997|526932800|FG000|Overall Study|investigator's decision|1|||
146113790|NCT01465997|526932801|FG001|Overall Study|investigator's decision|1|||
146113791|NCT01465997|526932800|FG000|Overall Study|Death|0|||
146113792|NCT01465997|526932801|FG001|Overall Study|Death|1|||
146113793|NCT01465997|526932800|FG000|Overall Study|sponsor's decision|1|||
146113794|NCT01465997|526932801|FG001|Overall Study|sponsor's decision|1|||
146260135|NCT00545571|527467262|FG000|Overall Study|Screen Failure|16|||
146113795|NCT01465997|526932800|FG000|Overall Study|subject withdrew consent|1|||
146113796|NCT01465997|526932801|FG001|Overall Study|subject withdrew consent|0|||
146113797|NCT01465997|526932800|FG000|Overall Study|local lab unblinded site|1|||
146113798|NCT01465997|526932801|FG001|Overall Study|local lab unblinded site|0|||
146113799|NCT01465997|526932800|FG000|Overall Study|withdrew before follow-up|0|||
146113800|NCT01465997|526932801|FG001|Overall Study|withdrew before follow-up|13|||
146113801|NCT01465997|526932800|FG000|Overall Study|decision by site staff|0|||
146113802|NCT01465997|526932801|FG001|Overall Study|decision by site staff|1|||
146113803|NCT01465997|526932800|FG000|Overall Study|subject left participation SP0993|0|||
146113804|NCT01465997|526932801|FG001|Overall Study|subject left participation SP0993|1|||
146113805|NCT02246660|526932802|FG000|Overall Study|Withdrawal by Subject|0|||
146113806|NCT02246660|526932803|FG001|Overall Study|Withdrawal by Subject|1|||
146113807|NCT02246660|526932804|FG002|Overall Study|Withdrawal by Subject|0|||
146113808|NCT02246660|526932802|FG000|Overall Study|Death|0|||
146113809|NCT02246660|526932803|FG001|Overall Study|Death|0|||
146113810|NCT02246660|526932804|FG002|Overall Study|Death|1|||
146113811|NCT02557646|526932807|FG000|Overall Study|Adverse Event|40|||
146113812|NCT02557646|526932807|FG000|Overall Study|Death|1|||
146113813|NCT02557646|526932807|FG000|Overall Study|Lack of Efficacy|186|||
146113814|NCT02557646|526932807|FG000|Overall Study|Withdrawal by Subject|18|||
146113815|NCT02557646|526932807|FG000|Overall Study|Lost to Follow-up|17|||
146113816|NCT02557646|526932807|FG000|Overall Study|Other|14|||
146113817|NCT01637272|526932810|FG000|Overall Study|Adverse Event|6|||
146113818|NCT01637272|526932810|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146113819|NCT01637272|526932810|FG000|Overall Study|Withdrawal by Subject|3|||
146113820|NCT01637272|526932810|FG000|Overall Study|Lost to Follow-up|2|||
146113821|NCT01637272|526932810|FG000|Overall Study|completed core, did not enter ext. phase|4|||
146113822|NCT01637272|526932810|FG000|Overall Study|Administrative problems|1|||
146113823|NCT01637272|526932810|FG000|Overall Study|Protocol Violation|2|||
146113824|NCT01496612|526932811|FG000|1st Intervention|Adverse Event|1|||
146113825|NCT01496612|526932812|FG001|1st Intervention|Adverse Event|0|||
146113826|NCT01496612|526932811|FG000|1st Intervention|Withdrawal by Subject|1|||
146113827|NCT01496612|526932812|FG001|1st Intervention|Withdrawal by Subject|0|||
146113828|NCT01666782|526932813|FG000|Overall Study|Received 2 doses of vaccine|0|||
146113829|NCT01666782|526932814|FG001|Overall Study|Received 2 doses of vaccine|1|||
146113830|NCT01666782|526932813|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
146113831|NCT01666782|526932814|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
146113832|NCT01482884|526932836|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
146113833|NCT01482884|526932837|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
146113834|NCT01482884|526932836|FG000|Overall Study|Protocol Violation|1|||
146113835|NCT01482884|526932837|FG001|Overall Study|Protocol Violation|0|||
146113836|NCT01482884|526932836|FG000|Overall Study|Lost to Follow-up|2|||
146113837|NCT01482884|526932837|FG001|Overall Study|Lost to Follow-up|2|||
146113838|NCT01482884|526932836|FG000|Overall Study|Lack of Efficacy|0|||
146113839|NCT01482884|526932837|FG001|Overall Study|Lack of Efficacy|1|||
146113840|NCT01482884|526932836|FG000|Overall Study|Adverse Event|2|||
146113841|NCT01482884|526932837|FG001|Overall Study|Adverse Event|1|||
146113842|NCT01482884|526932836|FG000|Overall Study|Withdrawal by Subject|8|||
146113843|NCT01482884|526932837|FG001|Overall Study|Withdrawal by Subject|13|||
146113844|NCT00439244|526932840|FG000|Overall Study|Adverse Event|5|||
146113845|NCT00439244|526932841|FG001|Overall Study|Adverse Event|2|||
146113846|NCT00439244|526932842|FG002|Overall Study|Adverse Event|3|||
146113847|NCT00439244|526932840|FG000|Overall Study|Withdrawal by Subject|3|||
146113848|NCT00439244|526932841|FG001|Overall Study|Withdrawal by Subject|1|||
146113849|NCT00439244|526932842|FG002|Overall Study|Withdrawal by Subject|2|||
146113850|NCT00439244|526932840|FG000|Overall Study|Lost to Follow-up|2|||
146113851|NCT00439244|526932841|FG001|Overall Study|Lost to Follow-up|1|||
146113852|NCT00439244|526932842|FG002|Overall Study|Lost to Follow-up|2|||
146113853|NCT00439244|526932840|FG000|Overall Study|Death|0|||
146113854|NCT00439244|526932841|FG001|Overall Study|Death|1|||
146113855|NCT00439244|526932842|FG002|Overall Study|Death|0|||
146113856|NCT00439244|526932840|FG000|Overall Study|Protocol Violation|0|||
146113857|NCT00439244|526932841|FG001|Overall Study|Protocol Violation|1|||
146113858|NCT00439244|526932842|FG002|Overall Study|Protocol Violation|0|||
146113859|NCT00439244|526932840|FG000|Overall Study|Administrative problems|1|||
146113860|NCT00439244|526932841|FG001|Overall Study|Administrative problems|0|||
146113861|NCT00439244|526932842|FG002|Overall Study|Administrative problems|0|||
146113862|NCT01774968|526932847|FG000|Overall Study|Adverse Event|4|||
146113863|NCT01774968|526932848|FG001|Overall Study|Adverse Event|4|||
146113864|NCT01774968|526932847|FG000|Overall Study|Death|0|||
146113865|NCT01774968|526932848|FG001|Overall Study|Death|1|||
146113866|NCT01774968|526932847|FG000|Overall Study|Lost to Follow-up|1|||
146113867|NCT01774968|526932848|FG001|Overall Study|Lost to Follow-up|3|||
146113868|NCT01774968|526932847|FG000|Overall Study|Physician Decision|5|||
146113869|NCT01774968|526932848|FG001|Overall Study|Physician Decision|1|||
146113870|NCT01774968|526932847|FG000|Overall Study|Protocol Violation|14|||
146113871|NCT01774968|526932848|FG001|Overall Study|Protocol Violation|13|||
146113872|NCT01774968|526932847|FG000|Overall Study|Sponsor Decision|0|||
146260136|NCT00545571|527467262|FG000|Overall Study|Transfusion|12|||
146260137|NCT00545571|527467262|FG000|Overall Study|Early Termination of Study|24|||
146260138|NCT00545571|527467262|FG000|Overall Study|Kidney Transplantation|3|||
146260139|NCT01978236|527467263|FG000|Overall Study|Discontinued due to study close|2|||
146260140|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
146260141|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
146260142|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
146260143|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
146260144|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
146260145|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
146260146|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Rejections|0|||
146260147|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Rejections|0|||
146260148|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Rejections|55|||
146260149|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
146260150|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
146260151|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
146260152|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
146260153|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
146260154|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
146260155|NCT00634920|527467265|FG000|Period 1 - Pre-Randomization|Other issues|0|||
146260156|NCT00634920|527467266|FG001|Period 1 - Pre-Randomization|Other issues|0|||
146260157|NCT00634920|527467267|FG002|Period 1 - Pre-Randomization|Other issues|6|||
146260158|NCT00634920|527467265|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
146260159|NCT00634920|527467266|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
146260160|NCT00634920|527467267|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
146260161|NCT00634920|527467265|FG000|Period 2 - Post-Randomization|Rejection|11|||
146260162|NCT00634920|527467266|FG001|Period 2 - Post-Randomization|Rejection|5|||
146260163|NCT00634920|527467267|FG002|Period 2 - Post-Randomization|Rejection|0|||
146260164|NCT00634920|527467265|FG000|Period 2 - Post-Randomization|Death|2|||
146260165|NCT00634920|527467266|FG001|Period 2 - Post-Randomization|Death|5|||
146260166|NCT00634920|527467267|FG002|Period 2 - Post-Randomization|Death|0|||
146260167|NCT00634920|527467265|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
146260168|NCT00634920|527467266|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
146260169|NCT00634920|527467267|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
146260170|NCT00634920|527467265|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
146260171|NCT00634920|527467266|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
146260172|NCT00634920|527467267|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
146260173|NCT01193218|527467268|FG000|0-12 Weeks|Adverse Event|6|||
146260174|NCT01193218|527467269|FG001|0-12 Weeks|Adverse Event|0|||
146260175|NCT01193218|527467270|FG002|0-12 Weeks|Adverse Event|1|||
146260176|NCT01193218|527467271|FG003|0-12 Weeks|Adverse Event|0|||
146260177|NCT01193218|527467272|FG004|0-12 Weeks|Adverse Event|0|||
146260178|NCT01193218|527467273|FG005|0-12 Weeks|Adverse Event|2|||
146260179|NCT01193218|527467274|FG006|0-12 Weeks|Adverse Event|2|||
146260180|NCT01193218|527467275|FG007|0-12 Weeks|Adverse Event|0|||
146260181|NCT01193218|527467268|FG000|0-12 Weeks|Protocol Violation|0|||
146260182|NCT01193218|527467269|FG001|0-12 Weeks|Protocol Violation|0|||
146260183|NCT01193218|527467270|FG002|0-12 Weeks|Protocol Violation|0|||
146260184|NCT01193218|527467271|FG003|0-12 Weeks|Protocol Violation|0|||
146260185|NCT01193218|527467272|FG004|0-12 Weeks|Protocol Violation|1|||
146260186|NCT01193218|527467273|FG005|0-12 Weeks|Protocol Violation|1|||
146260187|NCT01193218|527467274|FG006|0-12 Weeks|Protocol Violation|0|||
146260188|NCT01193218|527467275|FG007|0-12 Weeks|Protocol Violation|0|||
146260189|NCT01193218|527467268|FG000|0-12 Weeks|Withdrawal by Subject|3|||
146260190|NCT01193218|527467269|FG001|0-12 Weeks|Withdrawal by Subject|0|||
146260191|NCT01193218|527467270|FG002|0-12 Weeks|Withdrawal by Subject|2|||
146260192|NCT01193218|527467271|FG003|0-12 Weeks|Withdrawal by Subject|0|||
146260193|NCT01193218|527467272|FG004|0-12 Weeks|Withdrawal by Subject|0|||
146260194|NCT01193218|527467273|FG005|0-12 Weeks|Withdrawal by Subject|0|||
146260195|NCT01193218|527467274|FG006|0-12 Weeks|Withdrawal by Subject|1|||
146260196|NCT01193218|527467275|FG007|0-12 Weeks|Withdrawal by Subject|0|||
146260197|NCT01193218|527467268|FG000|12-52 Weeks|Adverse Event|1|||
146260198|NCT01193218|527467269|FG001|12-52 Weeks|Adverse Event|0|||
146260199|NCT01193218|527467270|FG002|12-52 Weeks|Adverse Event|1|||
146260200|NCT01193218|527467271|FG003|12-52 Weeks|Adverse Event|2|||
146260201|NCT01193218|527467272|FG004|12-52 Weeks|Adverse Event|3|||
146260202|NCT01193218|527467273|FG005|12-52 Weeks|Adverse Event|3|||
146260203|NCT01193218|527467274|FG006|12-52 Weeks|Adverse Event|1|||
146260204|NCT01193218|527467275|FG007|12-52 Weeks|Adverse Event|2|||
146260205|NCT01193218|527467268|FG000|12-52 Weeks|Lack of Efficacy|0|||
146260206|NCT01193218|527467269|FG001|12-52 Weeks|Lack of Efficacy|0|||
146260207|NCT01193218|527467270|FG002|12-52 Weeks|Lack of Efficacy|0|||
146260208|NCT01193218|527467271|FG003|12-52 Weeks|Lack of Efficacy|0|||
146260209|NCT01193218|527467272|FG004|12-52 Weeks|Lack of Efficacy|0|||
146260210|NCT01193218|527467273|FG005|12-52 Weeks|Lack of Efficacy|0|||
146260211|NCT01193218|527467274|FG006|12-52 Weeks|Lack of Efficacy|1|||
146260212|NCT01193218|527467275|FG007|12-52 Weeks|Lack of Efficacy|0|||
146260213|NCT01193218|527467268|FG000|12-52 Weeks|Withdrawal by Subject|3|||
146260214|NCT01193218|527467269|FG001|12-52 Weeks|Withdrawal by Subject|0|||
146260215|NCT01193218|527467270|FG002|12-52 Weeks|Withdrawal by Subject|3|||
146260216|NCT01193218|527467271|FG003|12-52 Weeks|Withdrawal by Subject|0|||
146260217|NCT01193218|527467272|FG004|12-52 Weeks|Withdrawal by Subject|0|||
146260218|NCT01193218|527467273|FG005|12-52 Weeks|Withdrawal by Subject|2|||
146260219|NCT01193218|527467274|FG006|12-52 Weeks|Withdrawal by Subject|1|||
146260220|NCT01193218|527467275|FG007|12-52 Weeks|Withdrawal by Subject|2|||
146260221|NCT01193218|527467268|FG000|12-52 Weeks|Other reason than above|1|||
146260222|NCT01193218|527467269|FG001|12-52 Weeks|Other reason than above|0|||
146260223|NCT01193218|527467270|FG002|12-52 Weeks|Other reason than above|0|||
146260224|NCT01193218|527467271|FG003|12-52 Weeks|Other reason than above|1|||
146260225|NCT01193218|527467272|FG004|12-52 Weeks|Other reason than above|1|||
146260226|NCT01193218|527467273|FG005|12-52 Weeks|Other reason than above|0|||
146260227|NCT01193218|527467274|FG006|12-52 Weeks|Other reason than above|0|||
146260228|NCT01193218|527467275|FG007|12-52 Weeks|Other reason than above|0|||
146260229|NCT00363649|527467276|FG000|Overall Study|Withdrawal by Subject|1|||
146260230|NCT00363649|527467277|FG001|Overall Study|Withdrawal by Subject|1|||
146260231|NCT00363649|527467276|FG000|Overall Study|Adverse Event|6|||
146260232|NCT00363649|527467277|FG001|Overall Study|Adverse Event|0|||
146260233|NCT01013740|527467278|FG000|Overall Study|Lost to Follow-up|3|||
146260234|NCT01013740|527467279|FG001|Overall Study|Lost to Follow-up|5|||
146260235|NCT01013740|527467278|FG000|Overall Study|Physician Decision|2|||
146260236|NCT01013740|527467279|FG001|Overall Study|Physician Decision|0|||
146260237|NCT01013740|527467278|FG000|Overall Study|Withdrawal by Subject|2|||
146260238|NCT01013740|527467279|FG001|Overall Study|Withdrawal by Subject|10|||
146260239|NCT01013740|527467278|FG000|Overall Study|study close / terminated : done in error|2|||
146260240|NCT01013740|527467279|FG001|Overall Study|study close / terminated : done in error|1|||
146260241|NCT01013740|527467278|FG000|Overall Study|Missing|2|||
146260242|NCT01013740|527467279|FG001|Overall Study|Missing|1|||
146260243|NCT01013740|527467278|FG000|Overall Study|Ongoing: Study records not completed|0|||
146260244|NCT01013740|527467279|FG001|Overall Study|Ongoing: Study records not completed|2|||
146260245|NCT03811834|527467282|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
146260246|NCT00576823|527467283|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
146260247|NCT00576823|527467284|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
146260248|NCT00576823|527467285|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
146260249|NCT00576823|527467283|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
146260250|NCT00576823|527467284|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
146260251|NCT00576823|527467285|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
146260252|NCT01242371|527467286|FG000|Overall Study|Withdrawal by Subject|2|||
146260253|NCT01242371|527467287|FG001|Overall Study|Withdrawal by Subject|2|||
146260254|NCT01242371|527467286|FG000|Overall Study|Protocol Violation|0|||
146260255|NCT01242371|527467287|FG001|Overall Study|Protocol Violation|3|||
146260256|NCT00510146|527467288|FG000|Double-Blind Treatment|Adverse Event|30|||
146260257|NCT00510146|527467289|FG001|Double-Blind Treatment|Adverse Event|13|||
146260258|NCT00510146|527467288|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
146260259|NCT00510146|527467289|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
146260260|NCT00510146|527467288|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
146260261|NCT00510146|527467289|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
146260262|NCT00510146|527467288|FG000|Double-Blind Treatment|Physician Decision|6|||
146260263|NCT00510146|527467289|FG001|Double-Blind Treatment|Physician Decision|0|||
146260264|NCT00510146|527467288|FG000|Double-Blind Treatment|Protocol Violation|1|||
146260265|NCT00510146|527467289|FG001|Double-Blind Treatment|Protocol Violation|2|||
146260266|NCT00510146|527467288|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
146260267|NCT00510146|527467289|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
146260268|NCT00510146|527467288|FG000|Double-Blind Treatment|Clinical Relapse|0|||
146260269|NCT00510146|527467289|FG001|Double-Blind Treatment|Clinical Relapse|1|||
146113873|NCT01774968|526932848|FG001|Overall Study|Sponsor Decision|2|||
146260270|NCT00510146|527467288|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
146260271|NCT00510146|527467289|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
146260272|NCT00510146|527467288|FG000|Open-Label Treatment|Adverse Event|22|||
146260273|NCT00510146|527467289|FG001|Open-Label Treatment|Adverse Event|8|||
146260274|NCT00510146|527467288|FG000|Open-Label Treatment|Death|1|||
146260275|NCT00510146|527467289|FG001|Open-Label Treatment|Death|1|||
146260276|NCT00510146|527467288|FG000|Open-Label Treatment|Lack of Efficacy|4|||
146260277|NCT00510146|527467289|FG001|Open-Label Treatment|Lack of Efficacy|0|||
146260278|NCT00510146|527467288|FG000|Open-Label Treatment|Lost to Follow-up|10|||
146260279|NCT00510146|527467289|FG001|Open-Label Treatment|Lost to Follow-up|1|||
146260280|NCT00510146|527467288|FG000|Open-Label Treatment|Physician Decision|3|||
146260281|NCT00510146|527467289|FG001|Open-Label Treatment|Physician Decision|1|||
146260282|NCT00510146|527467288|FG000|Open-Label Treatment|Protocol Violation|4|||
146260283|NCT00510146|527467289|FG001|Open-Label Treatment|Protocol Violation|2|||
146260284|NCT00510146|527467288|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
146260285|NCT00510146|527467289|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
146260286|NCT00510146|527467288|FG000|Open-Label Treatment|Clinical Relapse|1|||
146113874|NCT01774968|526932847|FG000|Overall Study|Withdrawal by Subject|6|||
146113875|NCT01774968|526932848|FG001|Overall Study|Withdrawal by Subject|11|||
146113876|NCT04600921|526932851|FG000|Overall Study|Withdrawal by Subject|3|||
146113877|NCT04600921|526932852|FG001|Overall Study|Withdrawal by Subject|5|||
146113878|NCT04600921|526932851|FG000|Overall Study|Death|0|||
146113879|NCT04600921|526932852|FG001|Overall Study|Death|1|||
146113880|NCT04847557|526932853|FG000|Overall Study|Adverse Event|1|||
146113881|NCT04847557|526932854|FG001|Overall Study|Adverse Event|0|||
146113882|NCT04847557|526932853|FG000|Overall Study|Death|19|||
146113883|NCT04847557|526932854|FG001|Overall Study|Death|15|||
146113884|NCT04847557|526932853|FG000|Overall Study|Lost to Follow-up|3|||
146113885|NCT04847557|526932854|FG001|Overall Study|Lost to Follow-up|6|||
146113886|NCT04847557|526932853|FG000|Overall Study|Physician Decision|1|||
146113887|NCT04847557|526932854|FG001|Overall Study|Physician Decision|0|||
146113888|NCT04847557|526932853|FG000|Overall Study|Protocol Violation|0|||
146113889|NCT04847557|526932854|FG001|Overall Study|Protocol Violation|1|||
146113890|NCT04847557|526932853|FG000|Overall Study|Withdrawal by Subject|8|||
146113891|NCT04847557|526932854|FG001|Overall Study|Withdrawal by Subject|14|||
146113892|NCT01955733|526935382|FG000|Period 1|Lost to Follow-up|1|||
146113893|NCT01955733|526935383|FG001|Period 1|Lost to Follow-up|0|||
146113894|NCT01955733|526935384|FG002|Period 1|Lost to Follow-up|0|||
146113895|NCT01955733|526935382|FG000|Period 2|Adverse Event|1|||
146113896|NCT01955733|526935383|FG001|Period 2|Adverse Event|0|||
146113897|NCT01955733|526935384|FG002|Period 2|Adverse Event|0|||
146113898|NCT01955733|526935382|FG000|Period 2|Physician Decision|0|||
146113899|NCT01955733|526935383|FG001|Period 2|Physician Decision|0|||
146113900|NCT01955733|526935384|FG002|Period 2|Physician Decision|1|||
146113901|NCT01955733|526935382|FG000|Period 2|Withdrawal by Subject|1|||
146113902|NCT01955733|526935383|FG001|Period 2|Withdrawal by Subject|3|||
146113903|NCT01955733|526935384|FG002|Period 2|Withdrawal by Subject|2|||
146113904|NCT01955733|526935382|FG000|Period 2|Study terminated by sponsor|8|||
146113905|NCT01955733|526935383|FG001|Period 2|Study terminated by sponsor|14|||
146113906|NCT01955733|526935384|FG002|Period 2|Study terminated by sponsor|16|||
146113907|NCT01955733|526935382|FG000|Period 2|Lost to Follow-up|2|||
146113908|NCT01955733|526935383|FG001|Period 2|Lost to Follow-up|0|||
146113909|NCT01955733|526935384|FG002|Period 2|Lost to Follow-up|0|||
146113910|NCT01955733|526935382|FG000|Period 2|Other not defined above|0|||
146113911|NCT01955733|526935383|FG001|Period 2|Other not defined above|2|||
146113912|NCT01955733|526935384|FG002|Period 2|Other not defined above|2|||
146113913|NCT00793598|526935385|FG000|Overall Study|Patient Request|0|||
146113914|NCT00793598|526935386|FG001|Overall Study|Patient Request|1|||
146113915|NCT00793598|526935387|FG002|Overall Study|Patient Request|0|||
146260287|NCT00510146|527467289|FG001|Open-Label Treatment|Clinical Relapse|1|||
146260288|NCT00510146|527467288|FG000|Open-Label Treatment|Sponsor Decision|2|||
146113916|NCT00793598|526935388|FG003|Overall Study|Patient Request|0|||
146113917|NCT00793598|526935389|FG004|Overall Study|Patient Request|0|||
146113918|NCT00793598|526935390|FG005|Overall Study|Patient Request|0|||
146113919|NCT00793598|526935391|FG006|Overall Study|Patient Request|0|||
146113920|NCT00793598|526935392|FG007|Overall Study|Patient Request|0|||
146113921|NCT00793598|526935385|FG000|Overall Study|Protocol Violation|0|||
146113922|NCT00793598|526935386|FG001|Overall Study|Protocol Violation|0|||
146113923|NCT00793598|526935387|FG002|Overall Study|Protocol Violation|0|||
146113924|NCT00793598|526935388|FG003|Overall Study|Protocol Violation|0|||
146113925|NCT00793598|526935389|FG004|Overall Study|Protocol Violation|0|||
146113926|NCT00793598|526935390|FG005|Overall Study|Protocol Violation|0|||
146113927|NCT00793598|526935391|FG006|Overall Study|Protocol Violation|0|||
146113928|NCT00793598|526935392|FG007|Overall Study|Protocol Violation|1|||
146113929|NCT00793598|526935385|FG000|Overall Study|Subject not dosed|0|||
146113930|NCT00793598|526935386|FG001|Overall Study|Subject not dosed|0|||
146113931|NCT00793598|526935387|FG002|Overall Study|Subject not dosed|0|||
146113932|NCT00793598|526935388|FG003|Overall Study|Subject not dosed|0|||
146113933|NCT00793598|526935389|FG004|Overall Study|Subject not dosed|0|||
146113934|NCT00793598|526935390|FG005|Overall Study|Subject not dosed|1|||
146113935|NCT00793598|526935391|FG006|Overall Study|Subject not dosed|0|||
146113936|NCT00793598|526935392|FG007|Overall Study|Subject not dosed|0|||
146113937|NCT02762266|526935393|FG000|Overall Study|Physician Decision|2|||
146113938|NCT02762266|526935394|FG001|Overall Study|Physician Decision|0|||
146113939|NCT02961751|526935409|FG000|Overall Study|Lost to Follow-up|11|||
146113940|NCT02961751|526935409|FG000|Overall Study|Physician Decision|2|||
146113941|NCT02961751|526935409|FG000|Overall Study|Not Eligible at Enrollment|1|||
146113942|NCT02961751|526935409|FG000|Overall Study|Protocol Violation|1|||
146113943|NCT00842712|526935410|FG000|Safety Run-in Part|Adverse Event|0|||
146113944|NCT00842712|526935411|FG001|Safety Run-in Part|Adverse Event|1|||
146113945|NCT00842712|526935412|FG002|Safety Run-in Part|Adverse Event|0|||
146113946|NCT00842712|526935413|FG003|Safety Run-in Part|Adverse Event|0|||
146113947|NCT00842712|526935414|FG004|Safety Run-in Part|Adverse Event|0|||
146113948|NCT00842712|526935415|FG005|Safety Run-in Part|Adverse Event|0|||
146113949|NCT00842712|526935416|FG006|Safety Run-in Part|Adverse Event|0|||
146113950|NCT00842712|526935410|FG000|Safety Run-in Part|Progressive disease|3|||
146113951|NCT00842712|526935411|FG001|Safety Run-in Part|Progressive disease|1|||
146260289|NCT00510146|527467289|FG001|Open-Label Treatment|Sponsor Decision|0|||
146301902|NCT03061175|527620136|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
146301903|NCT03061175|527620137|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
146301904|NCT03061175|527620136|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
146301905|NCT03061175|527620137|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
146301906|NCT03061175|527620136|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
146301907|NCT03061175|527620137|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
146301908|NCT03044249|527620138|FG000|Overall Study|Adverse Event|4|||
146301909|NCT03044249|527620139|FG001|Overall Study|Adverse Event|9|||
146301910|NCT03044249|527620138|FG000|Overall Study|Lost to Follow-up|1|||
146301911|NCT03044249|527620139|FG001|Overall Study|Lost to Follow-up|0|||
146301912|NCT03044249|527620138|FG000|Overall Study|Non-compliance with Study Drug|1|||
146301913|NCT03044249|527620139|FG001|Overall Study|Non-compliance with Study Drug|0|||
146301914|NCT03044249|527620138|FG000|Overall Study|Study Terminated by Sponsor|2|||
146301915|NCT03044249|527620139|FG001|Overall Study|Study Terminated by Sponsor|0|||
146301916|NCT03044249|527620138|FG000|Overall Study|Withdrawal by Subject|2|||
146301917|NCT03044249|527620139|FG001|Overall Study|Withdrawal by Subject|5|||
146301918|NCT00760669|527620140|FG000|Overall Study|Not assessed for overall improvement|18|||
146301919|NCT00760669|527620140|FG000|Overall Study|Participants missing efficacy assessment|6|||
146301920|NCT00760669|527620140|FG000|Overall Study|Participants with overlapping cases|1|||
146301921|NCT00760669|527620140|FG000|Overall Study|Took drug before entering in contract|5|||
146301922|NCT00504153|527620146|FG000|Overall Study|Withdrawal by Subject|1|||
146301923|NCT00504153|527620146|FG000|Overall Study|Adverse Event|4|||
146301924|NCT00504153|527620146|FG000|Overall Study|Death|1|||
146301925|NCT00732251|527620149|FG000|Overall Study|Lost to Follow-up|3|||
146301926|NCT00732251|527620149|FG000|Overall Study|Withdrawal by Subject|3|||
146301927|NCT00732251|527620149|FG000|Overall Study|Early Term due to Site Closure|1|||
146301928|NCT00805025|527620150|FG000|Overall Study|Screened but not enrolled/treated|42|||
146301929|NCT00805025|527620150|FG000|Overall Study|Adverse Event|4|||
146301930|NCT00805025|527620150|FG000|Overall Study|Withdrawal by Subject|2|||
146301931|NCT00805025|527620150|FG000|Overall Study|Physician Decision|1|||
146301932|NCT04029961|527620151|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
146301933|NCT04029961|527620152|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
146301934|NCT04029961|527620151|FG000|Overall Study|Change in Treatment Course|0|||
146301935|NCT04029961|527620152|FG001|Overall Study|Change in Treatment Course|1|||
146301936|NCT03007979|527620156|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
146301937|NCT00232141|527620157|FG000|Overall Study|Adverse Event|9|||
146301938|NCT00232141|527620158|FG001|Overall Study|Adverse Event|4|||
146301939|NCT00232141|527620157|FG000|Overall Study|Lack of Efficacy|0|||
146301940|NCT00232141|527620158|FG001|Overall Study|Lack of Efficacy|3|||
146301941|NCT00232141|527620157|FG000|Overall Study|Lost to Follow-up|9|||
146301942|NCT00232141|527620158|FG001|Overall Study|Lost to Follow-up|6|||
146301943|NCT00232141|527620157|FG000|Overall Study|Other|8|||
146301944|NCT00232141|527620158|FG001|Overall Study|Other|10|||
146301945|NCT00232141|527620157|FG000|Overall Study|Withdrawal by Subject|5|||
146301946|NCT00232141|527620158|FG001|Overall Study|Withdrawal by Subject|3|||
146301947|NCT02273726|527620159|FG000|Overall Study|Death|70|||
146301948|NCT02273726|527620160|FG001|Overall Study|Death|62|||
146301949|NCT02273726|527620159|FG000|Overall Study|Withdrawal by Subject|41|||
146301950|NCT02273726|527620160|FG001|Overall Study|Withdrawal by Subject|29|||
146301951|NCT02273726|527620159|FG000|Overall Study|Kidney transplant|31|||
146301952|NCT02273726|527620160|FG001|Overall Study|Kidney transplant|39|||
146301953|NCT02273726|527620159|FG000|Overall Study|Physician Decision|30|||
146301954|NCT02273726|527620160|FG001|Overall Study|Physician Decision|15|||
146301955|NCT02273726|527620159|FG000|Overall Study|Adverse Event|27|||
146301956|NCT02273726|527620160|FG001|Overall Study|Adverse Event|9|||
146301957|NCT02273726|527620159|FG000|Overall Study|Lost to Follow-up|6|||
146301958|NCT02273726|527620160|FG001|Overall Study|Lost to Follow-up|3|||
146301959|NCT02273726|527620159|FG000|Overall Study|Lack of Efficacy|6|||
146301960|NCT02273726|527620160|FG001|Overall Study|Lack of Efficacy|1|||
146301961|NCT02273726|527620159|FG000|Overall Study|Protocol Violation|4|||
146301962|NCT02273726|527620160|FG001|Overall Study|Protocol Violation|0|||
146301963|NCT02273726|527620159|FG000|Overall Study|Other than specified|28|||
146301964|NCT02273726|527620160|FG001|Overall Study|Other than specified|30|||
146301965|NCT01479829|527620161|FG000|Overall Study|Withdrawal by Subject|8|||
146301966|NCT01479829|527620162|FG001|Overall Study|Withdrawal by Subject|10|||
146301967|NCT04263896|527620164|FG000|Overall Study|Withdrawal by Subject|2|||
146301968|NCT04263896|527620165|FG001|Overall Study|Withdrawal by Subject|4|||
146301969|NCT04263896|527620164|FG000|Overall Study|converted to open procedure|0|||
146301970|NCT04263896|527620165|FG001|Overall Study|converted to open procedure|1|||
146301971|NCT04263896|527620164|FG000|Overall Study|Lost to Follow-up|9|||
146301972|NCT04263896|527620165|FG001|Overall Study|Lost to Follow-up|11|||
146301973|NCT04263896|527620164|FG000|Overall Study|surveys lost in mail|5|||
146301974|NCT04263896|527620165|FG001|Overall Study|surveys lost in mail|3|||
146301975|NCT04263896|527620164|FG000|Overall Study|excluded from analysis|1|||
146301976|NCT04263896|527620165|FG001|Overall Study|excluded from analysis|0|||
146301977|NCT00088907|527621611|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
146301978|NCT00088907|527621612|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
146301979|NCT00088907|527621611|FG000|Randomized Study (Step 1)|Adverse Event|14|||
146301980|NCT00088907|527621612|FG001|Randomized Study (Step 1)|Adverse Event|19|||
146301981|NCT00088907|527621611|FG000|Randomized Study (Step 1)|Death|11|||
146301982|NCT00088907|527621612|FG001|Randomized Study (Step 1)|Death|12|||
146301983|NCT00088907|527621611|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
146301984|NCT00088907|527621612|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
146301985|NCT00088907|527621611|FG000|Randomized Study (Step 1)|complicating disease|3|||
146301986|NCT00088907|527621612|FG001|Randomized Study (Step 1)|complicating disease|1|||
146301987|NCT00088907|527621611|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
146301988|NCT00088907|527621612|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
146301989|NCT00088907|527621611|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
146301990|NCT00088907|527621612|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
146301991|NCT00088907|527621611|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
146301992|NCT00088907|527621612|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
146301993|NCT00088907|527621611|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
146301994|NCT00088907|527621612|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
146301995|NCT00088907|527621611|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
146301996|NCT00088907|527621612|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
146301997|NCT00088907|527621611|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
146301998|NCT00088907|527621612|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
146301999|NCT03426787|527621613|FG000|Overall Study|Withdrawal by Subject|6|||
146302000|NCT03426787|527621613|FG000|Overall Study|Lost to Follow-up|7|||
146302001|NCT03426787|527621613|FG000|Overall Study|Unrelated to intervention death|1|||
146302002|NCT04050670|527621614|FG000|Period 3|Physician Decision|0|||
146302003|NCT04050670|527621615|FG001|Period 3|Physician Decision|1|||
146302004|NCT04050670|527621616|FG002|Period 3|Physician Decision|0|||
146302005|NCT00880555|527621618|FG000|Overall Study|Physician Decision|0|||
146260290|NCT03188536|527467292|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
146260291|NCT03188536|527467292|FG000|Overall Study|Not participated/met inclusion criteria|1|||
146260292|NCT01930214|527467293|FG000|Overall Study|Death|4|||
146260293|NCT01930214|527467294|FG001|Overall Study|Death|4|||
146260294|NCT01930214|527467295|FG002|Overall Study|Death|11|||
146260295|NCT01930214|527467293|FG000|Overall Study|Lost to Follow-up|12|||
146260296|NCT01930214|527467294|FG001|Overall Study|Lost to Follow-up|13|||
146260297|NCT01930214|527467295|FG002|Overall Study|Lost to Follow-up|12|||
146260298|NCT01930214|527467293|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
146260299|NCT01930214|527467294|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
146260300|NCT01930214|527467295|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
146260301|NCT01930214|527467293|FG000|Overall Study|Physician Decision|2|||
146260302|NCT01930214|527467294|FG001|Overall Study|Physician Decision|0|||
146260303|NCT01930214|527467295|FG002|Overall Study|Physician Decision|0|||
146260304|NCT00025662|527467296|FG000|Overall Study|Withdrawal by Subject|2|||
146260305|NCT00025662|527467296|FG000|Overall Study|Technical failure of manipulation|1|||
146260306|NCT02132117|527467299|FG000|Overall Study|Adverse Event|6|||
146260307|NCT02132117|527467300|FG001|Overall Study|Adverse Event|1|||
146260308|NCT02132117|527467299|FG000|Overall Study|Lost to Follow-up|2|||
146260309|NCT02132117|527467300|FG001|Overall Study|Lost to Follow-up|2|||
146260310|NCT02132117|527467299|FG000|Overall Study|Personal Reasons|1|||
146260311|NCT02132117|527467300|FG001|Overall Study|Personal Reasons|2|||
146260312|NCT02132117|527467299|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146260313|NCT02132117|527467300|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146260314|NCT04947436|527467301|FG000|Overall Study|Lost to Follow-up|3|||
146260315|NCT04947436|527467302|FG001|Overall Study|Lost to Follow-up|7|||
146260316|NCT04947436|527467303|FG002|Overall Study|Lost to Follow-up|5|||
146260317|NCT04947436|527467301|FG000|Overall Study|Death|1|||
146260318|NCT04947436|527467302|FG001|Overall Study|Death|1|||
146302006|NCT00880555|527621619|FG001|Overall Study|Physician Decision|8|||
146302007|NCT00880555|527621620|FG002|Overall Study|Physician Decision|0|||
146260319|NCT04947436|527467303|FG002|Overall Study|Death|1|||
146260320|NCT02161185|527467307|FG000|Treatment Phase|Administrative/Other|7|||
146260321|NCT00372255|527467308|FG000|Overall Study|Withdrawn for other reasons|2|||
146260322|NCT00372255|527467309|FG001|Overall Study|Withdrawn for other reasons|1|||
146260323|NCT00582114|527467313|FG000|Overall Study|Death|4|||
146260324|NCT00582114|527467314|FG001|Overall Study|Death|4|||
146260325|NCT00582114|527467313|FG000|Overall Study|Kidney Transplant|3|||
146260326|NCT00582114|527467314|FG001|Overall Study|Kidney Transplant|1|||
146260327|NCT00582114|527467313|FG000|Overall Study|Lost to Follow-up|7|||
146260328|NCT00582114|527467314|FG001|Overall Study|Lost to Follow-up|6|||
146260329|NCT00582114|527467313|FG000|Overall Study|Withdrawal by Subject|8|||
146260330|NCT00582114|527467314|FG001|Overall Study|Withdrawal by Subject|16|||
146260331|NCT00582114|527467313|FG000|Overall Study|Adverse Event|1|||
146260332|NCT00582114|527467314|FG001|Overall Study|Adverse Event|1|||
146260333|NCT00582114|527467313|FG000|Overall Study|Physician Decision|0|||
146302008|NCT00880555|527621621|FG003|Overall Study|Physician Decision|2|||
146302009|NCT00880555|527621622|FG004|Overall Study|Physician Decision|1|||
146302010|NCT00880555|527621623|FG005|Overall Study|Physician Decision|0|||
146302011|NCT00880555|527621618|FG000|Overall Study|Withdrawal by Subject|1|||
146302012|NCT00880555|527621619|FG001|Overall Study|Withdrawal by Subject|1|||
146302013|NCT00880555|527621620|FG002|Overall Study|Withdrawal by Subject|0|||
146302014|NCT00880555|527621621|FG003|Overall Study|Withdrawal by Subject|0|||
146302015|NCT00880555|527621622|FG004|Overall Study|Withdrawal by Subject|0|||
146302016|NCT00880555|527621623|FG005|Overall Study|Withdrawal by Subject|0|||
146302017|NCT00880555|527621618|FG000|Overall Study|Lack of resources (hired rater)|9|||
146302018|NCT00880555|527621619|FG001|Overall Study|Lack of resources (hired rater)|7|||
146302019|NCT00880555|527621620|FG002|Overall Study|Lack of resources (hired rater)|5|||
146302020|NCT00880555|527621621|FG003|Overall Study|Lack of resources (hired rater)|0|||
146302021|NCT00880555|527621622|FG004|Overall Study|Lack of resources (hired rater)|0|||
146302022|NCT00880555|527621623|FG005|Overall Study|Lack of resources (hired rater)|0|||
146302023|NCT00880555|527621618|FG000|Overall Study|Death|0|||
146302024|NCT00880555|527621619|FG001|Overall Study|Death|0|||
146302025|NCT00880555|527621620|FG002|Overall Study|Death|0|||
146302026|NCT00880555|527621621|FG003|Overall Study|Death|0|||
146302027|NCT00880555|527621622|FG004|Overall Study|Death|0|||
146302028|NCT00880555|527621623|FG005|Overall Study|Death|1|||
146302029|NCT00880555|527621618|FG000|Overall Study|Lost to Follow-up|0|||
146302030|NCT00880555|527621619|FG001|Overall Study|Lost to Follow-up|1|||
146302031|NCT00880555|527621620|FG002|Overall Study|Lost to Follow-up|0|||
146302032|NCT00880555|527621621|FG003|Overall Study|Lost to Follow-up|0|||
146113952|NCT00842712|526935412|FG002|Safety Run-in Part|Progressive disease|0|||
146113953|NCT00842712|526935413|FG003|Safety Run-in Part|Progressive disease|1|||
146113954|NCT00842712|526935414|FG004|Safety Run-in Part|Progressive disease|0|||
146113955|NCT00842712|526935415|FG005|Safety Run-in Part|Progressive disease|0|||
146113956|NCT00842712|526935416|FG006|Safety Run-in Part|Progressive disease|0|||
146113957|NCT00842712|526935410|FG000|Randomized Part|Randomized but not treated|0|||
146113958|NCT00842712|526935411|FG001|Randomized Part|Randomized but not treated|0|||
146113959|NCT00842712|526935412|FG002|Randomized Part|Randomized but not treated|0|||
146113960|NCT00842712|526935413|FG003|Randomized Part|Randomized but not treated|0|||
146113961|NCT00842712|526935414|FG004|Randomized Part|Randomized but not treated|0|||
146113962|NCT00842712|526935415|FG005|Randomized Part|Randomized but not treated|1|||
146113963|NCT00842712|526935416|FG006|Randomized Part|Randomized but not treated|4|||
146302033|NCT00880555|527621622|FG004|Overall Study|Lost to Follow-up|0|||
146302034|NCT00880555|527621623|FG005|Overall Study|Lost to Follow-up|0|||
146302035|NCT02767323|527621625|FG000|Overall Study|Withdrawal by Subject|17|||
146302036|NCT02767323|527621626|FG001|Overall Study|Withdrawal by Subject|5|||
146113964|NCT00842712|526935410|FG000|Randomized Part|Ongoing at cut-off date|0|||
146302037|NCT02767323|527621627|FG002|Overall Study|Withdrawal by Subject|13|||
146302038|NCT02767323|527621628|FG003|Overall Study|Withdrawal by Subject|0|||
146302039|NCT02767323|527621625|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
146302040|NCT02767323|527621626|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
146302041|NCT02767323|527621627|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
146302042|NCT02767323|527621628|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
146302043|NCT02230254|527621629|FG000|Overall Study|Lost to Follow-up|3|||
146302044|NCT02023242|527621630|FG000|Overall Study|Lost to Follow-up|3|||
146302045|NCT02023242|527621631|FG001|Overall Study|Lost to Follow-up|1|||
146302046|NCT02023242|527621630|FG000|Overall Study|Death|0|||
146302047|NCT02023242|527621631|FG001|Overall Study|Death|1|||
146302048|NCT02667275|527621637|FG000|Overall Study|Protocol Violation|11|||
146302049|NCT02667275|527621638|FG001|Overall Study|Protocol Violation|7|||
146302050|NCT02667275|527621637|FG000|Overall Study|Lost to Follow-up|0|||
146302051|NCT02667275|527621638|FG001|Overall Study|Lost to Follow-up|2|||
146302052|NCT02667275|527621637|FG000|Overall Study|Withdrawal by Subject|0|||
146302053|NCT02667275|527621638|FG001|Overall Study|Withdrawal by Subject|5|||
146302054|NCT02667275|527621637|FG000|Overall Study|Discontinued early without completing|0|||
146302055|NCT02667275|527621638|FG001|Overall Study|Discontinued early without completing|1|||
146302056|NCT01756040|527621639|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
146302057|NCT01756040|527621639|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
146302058|NCT01756040|527621639|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
146302059|NCT01274715|527621640|FG000|Overall Study|Lost to Follow-up|1|||
146302060|NCT01274715|527621640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146302061|NCT01274715|527621640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146113965|NCT00842712|526935411|FG001|Randomized Part|Ongoing at cut-off date|0|||
146113966|NCT00842712|526935412|FG002|Randomized Part|Ongoing at cut-off date|0|||
146302062|NCT01274715|527621640|FG000|Overall Study|After consent, met exclusion criteria.|1|||
146302063|NCT04479436|527621641|FG000|Overall Study|Progressive disease|26|||
146302064|NCT04479436|527621642|FG001|Overall Study|Progressive disease|1|||
146113967|NCT00842712|526935413|FG003|Randomized Part|Ongoing at cut-off date|0|||
146113968|NCT00842712|526935414|FG004|Randomized Part|Ongoing at cut-off date|0|||
146113969|NCT00842712|526935415|FG005|Randomized Part|Ongoing at cut-off date|0|||
146113970|NCT00842712|526935416|FG006|Randomized Part|Ongoing at cut-off date|2|||
146113971|NCT00410046|526935418|FG000|Overall Study|Adverse Event|3|||
146113972|NCT00410046|526935418|FG000|Overall Study|Withdrawal by Subject|1|||
146113973|NCT00410046|526935418|FG000|Overall Study|Lost to Follow-up|1|||
146302065|NCT04479436|527621641|FG000|Overall Study|Adverse Event|6|||
146302066|NCT04479436|527621642|FG001|Overall Study|Adverse Event|0|||
146302067|NCT04479436|527621641|FG000|Overall Study|Withdrawal by Subject|5|||
146302068|NCT04479436|527621642|FG001|Overall Study|Withdrawal by Subject|0|||
146302069|NCT04479436|527621641|FG000|Overall Study|Clinical progression|1|||
146302070|NCT04479436|527621642|FG001|Overall Study|Clinical progression|0|||
146302071|NCT04479436|527621641|FG000|Overall Study|Physician Decision|1|||
146302072|NCT04479436|527621642|FG001|Overall Study|Physician Decision|0|||
146302073|NCT02713542|527621643|FG000|Overall Study|Use of prohibited medication|14|||
146302074|NCT02713542|527621644|FG001|Overall Study|Use of prohibited medication|5|||
146302075|NCT02713542|527621643|FG000|Overall Study|Withdrawal by Subject|4|||
146302076|NCT02713542|527621644|FG001|Overall Study|Withdrawal by Subject|1|||
146302077|NCT02357134|527621645|FG000|Overall Study|Lost to Follow-up|1|||
146302078|NCT02357134|527621646|FG001|Overall Study|Lost to Follow-up|0|||
146302079|NCT02357134|527621647|FG002|Overall Study|Lost to Follow-up|0|||
146302080|NCT02357134|527621648|FG003|Overall Study|Lost to Follow-up|0|||
146302081|NCT05097716|527621649|FG000|Period 1|Adverse Event|1|||
146302082|NCT05097716|527621649|FG000|Period 1|Close contact with highly-transmissible infection|1|||
146302083|NCT00467779|527621652|FG000|Stage 1|Adverse Event|1|||
146302084|NCT00467779|527621653|FG001|Stage 1|Adverse Event|0|||
146302085|NCT00467779|527621654|FG002|Stage 1|Adverse Event|0|||
146302086|NCT00467779|527621655|FG003|Stage 1|Adverse Event|0|||
146113974|NCT03909295|526935426|FG000|Overall Study|Adverse Event|2|||
146113975|NCT03909295|526935426|FG000|Overall Study|Study terminated by sponsor|50|||
146113976|NCT03312933|526935433|FG000|Overall Study|Protocol Violation|15|||
146113977|NCT03312933|526935433|FG000|Overall Study|Lost to Follow-up|36|||
146113978|NCT03312933|526935433|FG000|Overall Study|Withdrawal by Subject|3|||
146113979|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146113980|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146113981|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146113982|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
146113983|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
146113984|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
146113985|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146113986|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146113987|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146113988|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
146113989|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|Other|1|||
146260334|NCT00582114|527467314|FG001|Overall Study|Physician Decision|6|||
146260335|NCT00582114|527467313|FG000|Overall Study|Stopped by data safety monitoring board|19|||
146260336|NCT00582114|527467314|FG001|Overall Study|Stopped by data safety monitoring board|20|||
146113990|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|Other|1|||
146113991|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|Other|0|||
146113992|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|Other|0|||
146113993|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|Other|0|||
146113994|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146113995|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146113996|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
146260337|NCT00118703|527467315|FG000|Overall Study|Protocol Violation|1|||
146260338|NCT00118703|527467316|FG001|Overall Study|Protocol Violation|0|||
146260339|NCT00118703|527467315|FG000|Overall Study|Adverse Event|1|||
146260340|NCT00118703|527467316|FG001|Overall Study|Adverse Event|1|||
146260341|NCT00118703|527467315|FG000|Overall Study|Participant took two different treatment|0|||
146260342|NCT00118703|527467316|FG001|Overall Study|Participant took two different treatment|1|||
146260343|NCT00118703|527467315|FG000|Overall Study|Withdrawal by Subject|2|||
146260344|NCT00118703|527467316|FG001|Overall Study|Withdrawal by Subject|5|||
146260345|NCT00118703|527467315|FG000|Overall Study|Lost to Follow-up|1|||
146113997|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
146113998|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
146113999|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146114000|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146114001|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146114002|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
146114003|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
146114004|NCT02310568|526935434|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146114005|NCT02310568|526935435|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146114006|NCT02310568|526935436|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146260346|NCT00118703|527467316|FG001|Overall Study|Lost to Follow-up|2|||
146260347|NCT01215032|527467321|FG000|Overall Study|Adverse Event|3|||
146302087|NCT00467779|527621656|FG004|Stage 1|Adverse Event|0|||
146302088|NCT00467779|527621657|FG005|Stage 1|Adverse Event|1|||
146302089|NCT00467779|527621658|FG006|Stage 1|Adverse Event|2|||
146114007|NCT02310568|526935437|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
146114008|NCT02310568|526935438|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
146114009|NCT02310568|526935434|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
146114010|NCT02310568|526935435|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146114011|NCT02310568|526935436|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146114012|NCT02310568|526935437|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
146114013|NCT02310568|526935438|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
146114014|NCT02310568|526935434|FG000|Stage 2 (4 Weeks)|Other|0|||
146114015|NCT02310568|526935435|FG001|Stage 2 (4 Weeks)|Other|1|||
146114016|NCT02310568|526935436|FG002|Stage 2 (4 Weeks)|Other|1|||
146114017|NCT02310568|526935437|FG003|Stage 2 (4 Weeks)|Other|0|||
146114018|NCT02310568|526935438|FG004|Stage 2 (4 Weeks)|Other|0|||
146114019|NCT02310568|526935434|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
146114020|NCT02310568|526935435|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
146114021|NCT02310568|526935436|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
146114022|NCT02310568|526935437|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
146114023|NCT02310568|526935438|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
146114024|NCT02310568|526935434|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
146114025|NCT02310568|526935435|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
146114026|NCT02310568|526935436|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
146114027|NCT02310568|526935437|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
146114028|NCT02310568|526935438|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
146114029|NCT02310568|526935434|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146114030|NCT02310568|526935435|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146114031|NCT02310568|526935436|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146114032|NCT02310568|526935437|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
146114033|NCT02310568|526935438|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
146114034|NCT01549860|526935445|FG000|Overall Study|Withdrawal by Subject|1|||
146114035|NCT01549860|526935446|FG001|Overall Study|Withdrawal by Subject|0|||
146114036|NCT01549860|526935445|FG000|Overall Study|Physician Decision|1|||
146114037|NCT01549860|526935446|FG001|Overall Study|Physician Decision|1|||
146114038|NCT01366521|526935447|FG000|Overall Study|Adverse Event|1|||
146114039|NCT01366521|526935448|FG001|Overall Study|Adverse Event|0|||
146114040|NCT01366521|526935449|FG002|Overall Study|Adverse Event|0|||
146114041|NCT01366521|526935450|FG003|Overall Study|Adverse Event|0|||
146114042|NCT01366521|526935447|FG000|Overall Study|Protocol Violation|0|||
146114043|NCT01366521|526935448|FG001|Overall Study|Protocol Violation|0|||
146114044|NCT01366521|526935449|FG002|Overall Study|Protocol Violation|1|||
146114045|NCT01366521|526935450|FG003|Overall Study|Protocol Violation|0|||
146114046|NCT01366521|526935447|FG000|Overall Study|Physician Decision|0|||
146114047|NCT01366521|526935448|FG001|Overall Study|Physician Decision|0|||
146114048|NCT01366521|526935449|FG002|Overall Study|Physician Decision|1|||
146114049|NCT01366521|526935450|FG003|Overall Study|Physician Decision|0|||
146114050|NCT01366521|526935447|FG000|Overall Study|Withdrawal by Subject|0|||
146114051|NCT01366521|526935448|FG001|Overall Study|Withdrawal by Subject|1|||
146114052|NCT01366521|526935449|FG002|Overall Study|Withdrawal by Subject|0|||
146114053|NCT01366521|526935450|FG003|Overall Study|Withdrawal by Subject|0|||
146114054|NCT00660023|526935451|FG000|Overall Study|Adverse Event|2|||
146114055|NCT00660023|526935451|FG000|Overall Study|Death|8|||
146114056|NCT00660023|526935451|FG000|Overall Study|Blood Transfusion|5|||
146114057|NCT00660023|526935451|FG000|Overall Study|Renal Transplantation|3|||
146114058|NCT00660023|526935451|FG000|Overall Study|Withdrawal by Subject|1|||
146114059|NCT00660023|526935451|FG000|Overall Study|Missed Pregnancy Test|1|||
146114060|NCT00660023|526935451|FG000|Overall Study|Other Screening Failure|9|||
146114061|NCT04180488|526935452|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146114062|NCT04180488|526935453|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
146114063|NCT04180488|526935454|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
146114064|NCT04180488|526935455|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
146114065|NCT04180488|526935456|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146114066|NCT04180488|526935457|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
146260348|NCT01215032|527467321|FG000|Overall Study|Lack of Efficacy|17|||
146260349|NCT01932762|527468665|FG000|Overall Study|Withdrawal by Subject|1|||
146260350|NCT01932762|527468666|FG001|Overall Study|Withdrawal by Subject|2|||
146114067|NCT04180488|526935452|FG000|Overall Study|Withdrawal by Subject|8|||
146114068|NCT04180488|526935453|FG001|Overall Study|Withdrawal by Subject|4|||
146114069|NCT04180488|526935454|FG002|Overall Study|Withdrawal by Subject|5|||
146114070|NCT04180488|526935455|FG003|Overall Study|Withdrawal by Subject|2|||
146114071|NCT04180488|526935456|FG004|Overall Study|Withdrawal by Subject|8|||
146114072|NCT04180488|526935457|FG005|Overall Study|Withdrawal by Subject|6|||
146114073|NCT04180488|526935452|FG000|Overall Study|Adverse Event|3|||
146114074|NCT04180488|526935453|FG001|Overall Study|Adverse Event|2|||
146114075|NCT04180488|526935454|FG002|Overall Study|Adverse Event|0|||
146114076|NCT04180488|526935455|FG003|Overall Study|Adverse Event|0|||
146114077|NCT04180488|526935456|FG004|Overall Study|Adverse Event|0|||
146114078|NCT04180488|526935457|FG005|Overall Study|Adverse Event|0|||
146114079|NCT04180488|526935452|FG000|Overall Study|Poor compliance to protocol|0|||
146114080|NCT04180488|526935453|FG001|Overall Study|Poor compliance to protocol|0|||
146114081|NCT04180488|526935454|FG002|Overall Study|Poor compliance to protocol|1|||
146114082|NCT04180488|526935455|FG003|Overall Study|Poor compliance to protocol|0|||
146114083|NCT04180488|526935456|FG004|Overall Study|Poor compliance to protocol|0|||
146114084|NCT04180488|526935457|FG005|Overall Study|Poor compliance to protocol|0|||
146114085|NCT02899988|526935462|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
146114086|NCT02899988|526935463|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
146114087|NCT02899988|526935464|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114088|NCT02899988|526935465|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114089|NCT02899988|526935466|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114090|NCT02899988|526935467|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114091|NCT02899988|526935468|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114092|NCT02899988|526935469|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145941611|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
145941612|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
145941613|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
145941614|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
145941615|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
145941616|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
145941617|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
146114093|NCT02899988|526935470|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114094|NCT02899988|526935471|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114095|NCT02899988|526935472|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146114096|NCT02899988|526935462|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
146114097|NCT02899988|526935463|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
146114098|NCT02899988|526935464|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146114099|NCT02899988|526935465|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
146114100|NCT02899988|526935466|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146114101|NCT02899988|526935467|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
146114102|NCT02899988|526935468|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
146114103|NCT02899988|526935469|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
146114104|NCT02899988|526935470|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
146114105|NCT02899988|526935471|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
146114106|NCT02899988|526935472|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
146114107|NCT02899988|526935462|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
146114108|NCT02899988|526935463|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
146114109|NCT02899988|526935464|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
146114110|NCT02899988|526935465|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
146114111|NCT02899988|526935466|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
146114112|NCT02899988|526935467|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
146114113|NCT02899988|526935468|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
146114114|NCT02899988|526935469|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
146114115|NCT02899988|526935470|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
146114116|NCT02899988|526935471|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
146114117|NCT02899988|526935472|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
146114118|NCT02899988|526935462|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
146114119|NCT02899988|526935463|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
146114120|NCT02899988|526935464|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
146114121|NCT02899988|526935465|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
146114122|NCT02899988|526935466|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
146114123|NCT02899988|526935467|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
146114124|NCT02899988|526935468|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
146114125|NCT02899988|526935469|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
146114126|NCT02899988|526935470|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
146114127|NCT02899988|526935471|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
146114128|NCT02899988|526935472|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
146114129|NCT02899988|526935462|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114130|NCT02899988|526935463|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114131|NCT02899988|526935464|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114132|NCT02899988|526935465|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114133|NCT02899988|526935466|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114134|NCT02899988|526935467|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
146114135|NCT02899988|526935468|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114136|NCT02899988|526935469|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
146114137|NCT02899988|526935470|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114138|NCT02899988|526935471|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114139|NCT02899988|526935472|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
146114140|NCT02899988|526935462|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146114141|NCT02899988|526935463|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146114142|NCT02899988|526935464|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146260351|NCT01932762|527468667|FG002|Overall Study|Withdrawal by Subject|0|||
146260352|NCT01932762|527468668|FG003|Overall Study|Withdrawal by Subject|0|||
146260353|NCT01932762|527468665|FG000|Overall Study|Lost to Follow-up|4|||
146260354|NCT01932762|527468666|FG001|Overall Study|Lost to Follow-up|0|||
146260355|NCT01932762|527468667|FG002|Overall Study|Lost to Follow-up|0|||
146260356|NCT01932762|527468668|FG003|Overall Study|Lost to Follow-up|1|||
146260357|NCT01932762|527468665|FG000|Overall Study|Physician Decision|1|||
146260358|NCT01932762|527468666|FG001|Overall Study|Physician Decision|0|||
146260359|NCT01932762|527468667|FG002|Overall Study|Physician Decision|0|||
146260360|NCT01932762|527468668|FG003|Overall Study|Physician Decision|0|||
146260361|NCT00664105|527468669|FG000|Overall Study|Death|3|||
146260362|NCT00664105|527468669|FG000|Overall Study|Withdrawal by Subject|5|||
146260363|NCT00664105|527468669|FG000|Overall Study|Adverse Event|9|||
146260364|NCT00664105|527468669|FG000|Overall Study|Disease progression|7|||
146260365|NCT01468077|527468676|FG000|Overall Study|Adverse Event|2|||
146260366|NCT01468077|527468677|FG001|Overall Study|Adverse Event|2|||
146260367|NCT01468077|527468676|FG000|Overall Study|Lack of Efficacy|1|||
146260368|NCT01468077|527468677|FG001|Overall Study|Lack of Efficacy|1|||
146260369|NCT01468077|527468676|FG000|Overall Study|Physician Decision|1|||
146260370|NCT01468077|527468677|FG001|Overall Study|Physician Decision|0|||
146260371|NCT04843579|527468678|FG000|Overall Study|Adverse Event|1|||
146260372|NCT04843579|527468678|FG000|Overall Study|Disease Progression|1|||
146260373|NCT03834623|527468679|FG000|Overall Study|Progression|0|||
146260374|NCT03834623|527468680|FG001|Overall Study|Progression|1|||
146260375|NCT03024996|527468682|FG000|Overall Study|Death|57|||
146260376|NCT03024996|527468683|FG001|Overall Study|Death|55|||
146260377|NCT03024996|527468682|FG000|Overall Study|Disease relapse|1|||
146260378|NCT03024996|527468683|FG001|Overall Study|Disease relapse|0|||
146260379|NCT03024996|527468682|FG000|Overall Study|Lost to Follow-up|5|||
146260380|NCT03024996|527468683|FG001|Overall Study|Lost to Follow-up|10|||
146260381|NCT03024996|527468682|FG000|Overall Study|Other|3|||
146260382|NCT03024996|527468683|FG001|Overall Study|Other|3|||
146260383|NCT03024996|527468682|FG000|Overall Study|Physician Decision|0|||
146260384|NCT03024996|527468683|FG001|Overall Study|Physician Decision|1|||
146260385|NCT03024996|527468682|FG000|Overall Study|Study terminated by sponsor|303|||
146260386|NCT03024996|527468683|FG001|Overall Study|Study terminated by sponsor|283|||
146260387|NCT03024996|527468682|FG000|Overall Study|Withdrawal by Subject|21|||
146260388|NCT03024996|527468683|FG001|Overall Study|Withdrawal by Subject|36|||
146260389|NCT00478647|527468684|FG000|Overall Study|Adverse Event|1|||
146260390|NCT00478647|527468684|FG000|Overall Study|Withdrawal by Subject|1|||
146260391|NCT00477464|527468688|FG000|Overall Study|Lost to Follow-up|1|||
146260392|NCT00477464|527468688|FG000|Overall Study|Death|36|||
146260393|NCT00477464|527468688|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
146260394|NCT00639769|527468689|FG000|Overall Study|Death|2|||
146260395|NCT00639769|527468689|FG000|Overall Study|Adverse Event|7|||
146260396|NCT00639769|527468689|FG000|Overall Study|Lack of Efficacy|1|||
146260397|NCT00639769|527468689|FG000|Overall Study|Disease progression|26|||
146260398|NCT00639769|527468689|FG000|Overall Study|Withdrawal by Subject|4|||
146260399|NCT00784147|527468690|FG000|Overall Study|Lost to Follow-up|2|||
146260400|NCT00784147|527468691|FG001|Overall Study|Lost to Follow-up|4|||
146260401|NCT00784147|527468690|FG000|Overall Study|Withdrawal by Subject|1|||
146260402|NCT00784147|527468691|FG001|Overall Study|Withdrawal by Subject|3|||
146260403|NCT00784147|527468690|FG000|Overall Study|Physician Decision|2|||
146260404|NCT00784147|527468691|FG001|Overall Study|Physician Decision|1|||
146260405|NCT00784147|527468690|FG000|Overall Study|Protocol Violation|1|||
146260406|NCT00784147|527468691|FG001|Overall Study|Protocol Violation|1|||
146260407|NCT00784147|527468690|FG000|Overall Study|Death|2|||
146260408|NCT00784147|527468691|FG001|Overall Study|Death|0|||
146260409|NCT00130728|527468696|FG000|Overall Study|Death|258|||
146260410|NCT00130728|527468697|FG001|Overall Study|Death|258|||
146260411|NCT00130728|527468696|FG000|Overall Study|Lost to Follow-up|4|||
146260412|NCT00130728|527468697|FG001|Overall Study|Lost to Follow-up|0|||
146260413|NCT00130728|527468696|FG000|Overall Study|Withdrawal by Subject|0|||
146260414|NCT00130728|527468697|FG001|Overall Study|Withdrawal by Subject|2|||
146260415|NCT01209286|527468699|FG000|Overall Study|Adverse Event|4|||
146260416|NCT01209286|527468700|FG001|Overall Study|Adverse Event|3|||
146260417|NCT01209286|527468701|FG002|Overall Study|Adverse Event|1|||
146260418|NCT01209286|527468699|FG000|Overall Study|Hematological Relapse After Remission|0|||
146260419|NCT01209286|527468700|FG001|Overall Study|Hematological Relapse After Remission|1|||
146260420|NCT01209286|527468701|FG002|Overall Study|Hematological Relapse After Remission|1|||
146260421|NCT01209286|527468699|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
146260422|NCT01209286|527468700|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
146260423|NCT01209286|527468701|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
146260424|NCT01209286|527468699|FG000|Overall Study|Physician Decision|0|||
146260425|NCT01209286|527468700|FG001|Overall Study|Physician Decision|2|||
146260426|NCT01209286|527468701|FG002|Overall Study|Physician Decision|0|||
146260427|NCT01209286|527468699|FG000|Overall Study|Other|0|||
146260428|NCT01209286|527468700|FG001|Overall Study|Other|1|||
146260429|NCT01209286|527468701|FG002|Overall Study|Other|0|||
146260430|NCT01349036|527468702|FG000|Overall Study|Disease progression|13|||
146114143|NCT02899988|526935465|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146114144|NCT02899988|526935466|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
146114145|NCT02899988|526935467|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146114146|NCT02899988|526935468|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
146114147|NCT02899988|526935469|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
146114148|NCT02899988|526935470|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
146114149|NCT02899988|526935471|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
146114150|NCT02899988|526935472|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
146114151|NCT01327885|526935476|FG000|Overall Study|Disease progression-according to RECIST|173|||
146114152|NCT01327885|526935477|FG001|Overall Study|Disease progression-according to RECIST|165|||
146114153|NCT01327885|526935476|FG000|Overall Study|Clinical progression|24|||
146114154|NCT01327885|526935477|FG001|Overall Study|Clinical progression|27|||
146114155|NCT01327885|526935476|FG000|Overall Study|Adverse Event|14|||
146114156|NCT01327885|526935477|FG001|Overall Study|Adverse Event|10|||
146114157|NCT01327885|526935476|FG000|Overall Study|Subject choice|5|||
146114158|NCT01327885|526935477|FG001|Overall Study|Subject choice|10|||
146114159|NCT01327885|526935476|FG000|Overall Study|Other|8|||
146114160|NCT01327885|526935477|FG001|Overall Study|Other|6|||
146114161|NCT01327885|526935476|FG000|Overall Study|Withdrawal of consent from study|3|||
146114162|NCT01327885|526935477|FG001|Overall Study|Withdrawal of consent from study|4|||
146114163|NCT01327885|526935476|FG000|Overall Study|Not treated|1|||
146114164|NCT01327885|526935477|FG001|Overall Study|Not treated|1|||
146114165|NCT01327885|526935476|FG000|Overall Study|Administrative decision|0|||
146114166|NCT01327885|526935477|FG001|Overall Study|Administrative decision|1|||
146114167|NCT03824912|526935481|FG000|Overall Study|Lost to Follow-up|18|||
146114168|NCT03824912|526935482|FG001|Overall Study|Lost to Follow-up|15|||
146114169|NCT03824912|526935483|FG002|Overall Study|Lost to Follow-up|8|||
146114170|NCT03824912|526935481|FG000|Overall Study|Negative Baseline Culture Result|118|||
146114171|NCT03824912|526935482|FG001|Overall Study|Negative Baseline Culture Result|112|||
146114172|NCT03824912|526935483|FG002|Overall Study|Negative Baseline Culture Result|57|||
146114173|NCT03824912|526935481|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146114174|NCT03824912|526935482|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146114175|NCT03824912|526935483|FG002|Overall Study|Non-Compliance with Study Drug|1|||
146114176|NCT03824912|526935481|FG000|Overall Study|Protocol Violation|1|||
146114177|NCT03824912|526935482|FG001|Overall Study|Protocol Violation|4|||
146114178|NCT03824912|526935483|FG002|Overall Study|Protocol Violation|1|||
146114179|NCT03824912|526935481|FG000|Overall Study|Withdrawal by Subject|3|||
146114180|NCT03824912|526935482|FG001|Overall Study|Withdrawal by Subject|2|||
146114181|NCT03824912|526935483|FG002|Overall Study|Withdrawal by Subject|1|||
146114182|NCT03824912|526935481|FG000|Overall Study|Participation in another study|0|||
146114183|NCT03824912|526935482|FG001|Overall Study|Participation in another study|1|||
146114184|NCT03824912|526935483|FG002|Overall Study|Participation in another study|0|||
146114185|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114186|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114187|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114188|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114189|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114190|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
146114191|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
146114192|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146114193|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146114194|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146114195|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146260431|NCT01349036|527468703|FG001|Overall Study|Disease progression|22|||
146260432|NCT01349036|527468702|FG000|Overall Study|Other|1|||
146260433|NCT01349036|527468703|FG001|Overall Study|Other|0|||
146260434|NCT01349036|527468702|FG000|Overall Study|Withdrawal by Subject|0|||
146260435|NCT01349036|527468703|FG001|Overall Study|Withdrawal by Subject|2|||
146260436|NCT03796208|527468704|FG000|Overall Study|Withdrawal by Subject|3|||
146260437|NCT03796208|527468705|FG001|Overall Study|Withdrawal by Subject|0|||
146260438|NCT03796208|527468704|FG000|Overall Study|Loss of pregnancy|1|||
146260439|NCT03796208|527468705|FG001|Overall Study|Loss of pregnancy|1|||
146260440|NCT03796208|527468704|FG000|Overall Study|Changed prenatal clinics|0|||
146114196|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146114197|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
146114198|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
146260441|NCT03796208|527468705|FG001|Overall Study|Changed prenatal clinics|5|||
146114199|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
146260442|NCT03796208|527468704|FG000|Overall Study|Lost to Follow-up|20|||
146260443|NCT03796208|527468705|FG001|Overall Study|Lost to Follow-up|16|||
146260444|NCT02725008|527468707|FG000|Overall Study|Lost to Follow-up|7|||
146260445|NCT02725008|527468708|FG001|Overall Study|Lost to Follow-up|9|||
146114200|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
146260446|NCT02725008|527468707|FG000|Overall Study|Withdrawal by Subject|2|||
146260447|NCT02725008|527468708|FG001|Overall Study|Withdrawal by Subject|2|||
146260448|NCT02725008|527468707|FG000|Overall Study|Admitted to hospital|0|||
146260449|NCT02725008|527468708|FG001|Overall Study|Admitted to hospital|1|||
146260450|NCT00983892|527468711|FG000|Overall Study|Withdrawal by Subject|10|||
146260451|NCT00983892|527468712|FG001|Overall Study|Withdrawal by Subject|12|||
146260452|NCT03028012|527468713|FG000|Overall Study|Lost to Follow-up|2|||
146260453|NCT03028012|527468714|FG001|Overall Study|Lost to Follow-up|3|||
146260454|NCT03028012|527468715|FG002|Overall Study|Lost to Follow-up|3|||
146260455|NCT01424189|527468727|FG000|Overall Study|Adverse Event|1|||
146260456|NCT01424189|527468728|FG001|Overall Study|Adverse Event|0|||
146260457|NCT01424189|527468727|FG000|Overall Study|Lost to Follow-up|4|||
146260458|NCT01424189|527468728|FG001|Overall Study|Lost to Follow-up|1|||
146260459|NCT01424189|527468727|FG000|Overall Study|Withdrawal by Subject|4|||
146260460|NCT01424189|527468728|FG001|Overall Study|Withdrawal by Subject|4|||
146260461|NCT01424189|527468727|FG000|Overall Study|Subject moved|1|||
146260462|NCT01424189|527468728|FG001|Overall Study|Subject moved|0|||
146260463|NCT01424189|527468727|FG000|Overall Study|Death|3|||
146260464|NCT01424189|527468728|FG001|Overall Study|Death|1|||
146260465|NCT04688086|527468729|FG000|Overall Study|Lost to Follow-up|164|||
146260466|NCT04688086|527468729|FG000|Overall Study|Imaging error;|64|||
146260467|NCT03120949|527468730|FG000|Overall Study|randomized in error|1|||
146260468|NCT03120949|527468731|FG001|Overall Study|randomized in error|0|||
146114201|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
146114202|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
146114203|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
146114204|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
146114205|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
146114206|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114207|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114208|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114209|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114210|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114211|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
146114212|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
146114213|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
146114214|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
146114215|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
146114216|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
146260469|NCT03120949|527468730|FG000|Overall Study|Death|13|||
146260470|NCT03120949|527468731|FG001|Overall Study|Death|13|||
146260471|NCT03120949|527468730|FG000|Overall Study|Lost to Follow-up|23|||
146260472|NCT03120949|527468731|FG001|Overall Study|Lost to Follow-up|13|||
146260473|NCT03120949|527468730|FG000|Overall Study|Withdrawal by Subject|139|||
146260474|NCT03120949|527468731|FG001|Overall Study|Withdrawal by Subject|124|||
146260475|NCT03120949|527468730|FG000|Overall Study|Covid-19|43|||
146260476|NCT03120949|527468731|FG001|Overall Study|Covid-19|34|||
146260477|NCT03120949|527468730|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
146260478|NCT03120949|527468731|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
146260479|NCT03120949|527468730|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
146260480|NCT03120949|527468731|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
146260481|NCT03120949|527468730|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
146260482|NCT03120949|527468731|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
146260483|NCT03120949|527468730|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
146260484|NCT03120949|527468731|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
146260485|NCT03120949|527468730|FG000|Overall Study|Site was closed|2|||
146260486|NCT03120949|527468731|FG001|Overall Study|Site was closed|3|||
146260487|NCT03120949|527468730|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
146260488|NCT03120949|527468731|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
146114217|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
146114218|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
146114219|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
146114220|NCT01059825|526935487|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
146114221|NCT01059825|526935488|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
146114222|NCT01059825|526935489|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
146260489|NCT03120949|527468730|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
146260490|NCT03120949|527468731|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
146302090|NCT00467779|527621659|FG007|Stage 1|Adverse Event|1|||
146302091|NCT00467779|527621660|FG008|Stage 1|Adverse Event|0|||
146302092|NCT00467779|527621661|FG009|Stage 1|Adverse Event|0|||
146302093|NCT00467779|527621662|FG010|Stage 1|Adverse Event|0|||
146302094|NCT00467779|527621663|FG011|Stage 1|Adverse Event|0|||
146302095|NCT00467779|527621664|FG012|Stage 1|Adverse Event|0|||
146302096|NCT00467779|527621665|FG013|Stage 1|Adverse Event|0|||
146302097|NCT00467779|527621666|FG014|Stage 1|Adverse Event|0|||
146302098|NCT00467779|527621652|FG000|Stage 1|Disease Progression|2|||
146302099|NCT00467779|527621653|FG001|Stage 1|Disease Progression|2|||
146302100|NCT00467779|527621654|FG002|Stage 1|Disease Progression|2|||
146302101|NCT00467779|527621655|FG003|Stage 1|Disease Progression|3|||
146302102|NCT00467779|527621656|FG004|Stage 1|Disease Progression|2|||
146302103|NCT00467779|527621657|FG005|Stage 1|Disease Progression|2|||
146302104|NCT00467779|527621658|FG006|Stage 1|Disease Progression|4|||
146302105|NCT00467779|527621659|FG007|Stage 1|Disease Progression|5|||
146302106|NCT00467779|527621660|FG008|Stage 1|Disease Progression|0|||
146302107|NCT00467779|527621661|FG009|Stage 1|Disease Progression|0|||
146302108|NCT00467779|527621662|FG010|Stage 1|Disease Progression|0|||
146302109|NCT00467779|527621663|FG011|Stage 1|Disease Progression|0|||
146302110|NCT00467779|527621664|FG012|Stage 1|Disease Progression|0|||
146302111|NCT00467779|527621665|FG013|Stage 1|Disease Progression|0|||
146302112|NCT00467779|527621666|FG014|Stage 1|Disease Progression|0|||
146302113|NCT00467779|527621652|FG000|Stage 1|Unspecified Reason|1|||
146302114|NCT00467779|527621653|FG001|Stage 1|Unspecified Reason|0|||
146302115|NCT00467779|527621654|FG002|Stage 1|Unspecified Reason|1|||
146302116|NCT00467779|527621655|FG003|Stage 1|Unspecified Reason|0|||
146302117|NCT00467779|527621656|FG004|Stage 1|Unspecified Reason|1|||
146302118|NCT00467779|527621657|FG005|Stage 1|Unspecified Reason|2|||
146302119|NCT00467779|527621658|FG006|Stage 1|Unspecified Reason|0|||
146302120|NCT00467779|527621659|FG007|Stage 1|Unspecified Reason|0|||
146302121|NCT00467779|527621660|FG008|Stage 1|Unspecified Reason|0|||
146302122|NCT00467779|527621661|FG009|Stage 1|Unspecified Reason|0|||
146302123|NCT00467779|527621662|FG010|Stage 1|Unspecified Reason|0|||
146302124|NCT00467779|527621663|FG011|Stage 1|Unspecified Reason|0|||
146302125|NCT00467779|527621664|FG012|Stage 1|Unspecified Reason|0|||
146302126|NCT00467779|527621665|FG013|Stage 1|Unspecified Reason|0|||
146302127|NCT00467779|527621666|FG014|Stage 1|Unspecified Reason|0|||
146302128|NCT00467779|527621652|FG000|Stage 1|Physician Decision|0|||
146302129|NCT00467779|527621653|FG001|Stage 1|Physician Decision|1|||
146302130|NCT00467779|527621654|FG002|Stage 1|Physician Decision|0|||
146302131|NCT00467779|527621655|FG003|Stage 1|Physician Decision|0|||
146302132|NCT00467779|527621656|FG004|Stage 1|Physician Decision|0|||
146302133|NCT00467779|527621657|FG005|Stage 1|Physician Decision|0|||
146302134|NCT00467779|527621658|FG006|Stage 1|Physician Decision|0|||
146302135|NCT00467779|527621659|FG007|Stage 1|Physician Decision|0|||
146302136|NCT00467779|527621660|FG008|Stage 1|Physician Decision|0|||
146302137|NCT00467779|527621661|FG009|Stage 1|Physician Decision|0|||
146302138|NCT00467779|527621662|FG010|Stage 1|Physician Decision|0|||
146302139|NCT00467779|527621663|FG011|Stage 1|Physician Decision|0|||
146302140|NCT00467779|527621664|FG012|Stage 1|Physician Decision|0|||
146302141|NCT00467779|527621665|FG013|Stage 1|Physician Decision|0|||
146302142|NCT00467779|527621666|FG014|Stage 1|Physician Decision|0|||
146302143|NCT00467779|527621652|FG000|Stage 1|Withdrawal by Subject|0|||
146302144|NCT00467779|527621653|FG001|Stage 1|Withdrawal by Subject|0|||
146302145|NCT00467779|527621654|FG002|Stage 1|Withdrawal by Subject|0|||
146302146|NCT00467779|527621655|FG003|Stage 1|Withdrawal by Subject|0|||
146302147|NCT00467779|527621656|FG004|Stage 1|Withdrawal by Subject|0|||
146302148|NCT00467779|527621657|FG005|Stage 1|Withdrawal by Subject|0|||
146302149|NCT00467779|527621658|FG006|Stage 1|Withdrawal by Subject|1|||
146302150|NCT00467779|527621659|FG007|Stage 1|Withdrawal by Subject|1|||
146302151|NCT00467779|527621660|FG008|Stage 1|Withdrawal by Subject|0|||
146302152|NCT00467779|527621661|FG009|Stage 1|Withdrawal by Subject|0|||
146302153|NCT00467779|527621662|FG010|Stage 1|Withdrawal by Subject|0|||
146302154|NCT00467779|527621663|FG011|Stage 1|Withdrawal by Subject|0|||
146302155|NCT00467779|527621664|FG012|Stage 1|Withdrawal by Subject|0|||
146302156|NCT00467779|527621665|FG013|Stage 1|Withdrawal by Subject|0|||
146302157|NCT00467779|527621666|FG014|Stage 1|Withdrawal by Subject|0|||
146302158|NCT00467779|527621652|FG000|Stage 1A|Adverse Event|0|||
146302159|NCT00467779|527621653|FG001|Stage 1A|Adverse Event|0|||
146302160|NCT00467779|527621654|FG002|Stage 1A|Adverse Event|0|||
146302161|NCT00467779|527621655|FG003|Stage 1A|Adverse Event|0|||
146302162|NCT00467779|527621656|FG004|Stage 1A|Adverse Event|0|||
146302163|NCT00467779|527621657|FG005|Stage 1A|Adverse Event|0|||
146302164|NCT00467779|527621658|FG006|Stage 1A|Adverse Event|0|||
146302165|NCT00467779|527621659|FG007|Stage 1A|Adverse Event|0|||
146302166|NCT00467779|527621660|FG008|Stage 1A|Adverse Event|0|||
146302167|NCT00467779|527621661|FG009|Stage 1A|Adverse Event|0|||
146302168|NCT00467779|527621662|FG010|Stage 1A|Adverse Event|0|||
146302169|NCT00467779|527621663|FG011|Stage 1A|Adverse Event|0|||
146302170|NCT00467779|527621664|FG012|Stage 1A|Adverse Event|1|||
146302171|NCT00467779|527621665|FG013|Stage 1A|Adverse Event|0|||
146302172|NCT00467779|527621666|FG014|Stage 1A|Adverse Event|0|||
146302173|NCT00467779|527621652|FG000|Stage 1A|Death|0|||
146114223|NCT01059825|526935490|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
146114224|NCT01059825|526935491|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
146114225|NCT01059825|526935492|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
146114226|NCT01059825|526935493|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
146114227|NCT01059825|526935487|FG000|Treatment Period|Lost to Follow-up|2|||
146114228|NCT01059825|526935488|FG001|Treatment Period|Lost to Follow-up|1|||
146114229|NCT01059825|526935489|FG002|Treatment Period|Lost to Follow-up|0|||
146114230|NCT01059825|526935490|FG003|Treatment Period|Lost to Follow-up|1|||
146114231|NCT01059825|526935491|FG004|Treatment Period|Lost to Follow-up|2|||
146114232|NCT01059825|526935492|FG005|Treatment Period|Lost to Follow-up|0|||
146114233|NCT01059825|526935493|FG006|Treatment Period|Lost to Follow-up|0|||
146114234|NCT01059825|526935487|FG000|Treatment Period|Withdrawal by Subject|3|||
146114235|NCT01059825|526935488|FG001|Treatment Period|Withdrawal by Subject|0|||
146114236|NCT01059825|526935489|FG002|Treatment Period|Withdrawal by Subject|1|||
146114237|NCT01059825|526935490|FG003|Treatment Period|Withdrawal by Subject|5|||
146114238|NCT01059825|526935491|FG004|Treatment Period|Withdrawal by Subject|4|||
146114239|NCT01059825|526935492|FG005|Treatment Period|Withdrawal by Subject|1|||
146114240|NCT01059825|526935493|FG006|Treatment Period|Withdrawal by Subject|0|||
146114241|NCT01059825|526935487|FG000|Treatment Period|Other reason not specified|1|||
146114242|NCT01059825|526935488|FG001|Treatment Period|Other reason not specified|2|||
146114243|NCT01059825|526935489|FG002|Treatment Period|Other reason not specified|1|||
146114244|NCT01059825|526935490|FG003|Treatment Period|Other reason not specified|2|||
146114245|NCT01059825|526935491|FG004|Treatment Period|Other reason not specified|0|||
146114246|NCT01059825|526935492|FG005|Treatment Period|Other reason not specified|0|||
146114247|NCT01059825|526935493|FG006|Treatment Period|Other reason not specified|0|||
146114248|NCT01059825|526935487|FG000|Treatment Period|Protocol Violation|0|||
146114249|NCT01059825|526935488|FG001|Treatment Period|Protocol Violation|0|||
146114250|NCT01059825|526935489|FG002|Treatment Period|Protocol Violation|1|||
146114251|NCT01059825|526935490|FG003|Treatment Period|Protocol Violation|1|||
146114252|NCT01059825|526935491|FG004|Treatment Period|Protocol Violation|1|||
146114253|NCT01059825|526935492|FG005|Treatment Period|Protocol Violation|1|||
146114254|NCT01059825|526935493|FG006|Treatment Period|Protocol Violation|0|||
146114255|NCT01059825|526935487|FG000|Treatment Period|Adverse event related to study drug|1|||
146114256|NCT01059825|526935488|FG001|Treatment Period|Adverse event related to study drug|0|||
146114257|NCT01059825|526935489|FG002|Treatment Period|Adverse event related to study drug|1|||
146114258|NCT01059825|526935490|FG003|Treatment Period|Adverse event related to study drug|1|||
146114259|NCT01059825|526935491|FG004|Treatment Period|Adverse event related to study drug|0|||
146114260|NCT01059825|526935492|FG005|Treatment Period|Adverse event related to study drug|0|||
146114261|NCT01059825|526935493|FG006|Treatment Period|Adverse event related to study drug|0|||
146114262|NCT01059825|526935487|FG000|Treatment Period|Insufficient clinical response|3|||
146114263|NCT01059825|526935488|FG001|Treatment Period|Insufficient clinical response|0|||
146114264|NCT01059825|526935489|FG002|Treatment Period|Insufficient clinical response|0|||
146114265|NCT01059825|526935490|FG003|Treatment Period|Insufficient clinical response|0|||
146114266|NCT01059825|526935491|FG004|Treatment Period|Insufficient clinical response|0|||
146114267|NCT01059825|526935492|FG005|Treatment Period|Insufficient clinical response|0|||
146114268|NCT01059825|526935493|FG006|Treatment Period|Insufficient clinical response|0|||
146114269|NCT01059825|526935487|FG000|Treatment Period|Adverse event not related to study drug|0|||
146114270|NCT01059825|526935488|FG001|Treatment Period|Adverse event not related to study drug|1|||
146114271|NCT01059825|526935489|FG002|Treatment Period|Adverse event not related to study drug|2|||
146114272|NCT01059825|526935490|FG003|Treatment Period|Adverse event not related to study drug|1|||
146114273|NCT01059825|526935491|FG004|Treatment Period|Adverse event not related to study drug|1|||
146114274|NCT01059825|526935492|FG005|Treatment Period|Adverse event not related to study drug|1|||
146114275|NCT01059825|526935493|FG006|Treatment Period|Adverse event not related to study drug|0|||
146114276|NCT03342690|526935498|FG000|Overall Study|Missing Information|9|||
146260491|NCT03120949|527468730|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
146260492|NCT03120949|527468731|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
146260493|NCT03120949|527468730|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
146260494|NCT03120949|527468731|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
146260495|NCT03120949|527468730|FG000|Overall Study|Other: Adverse Event|0|||
146260496|NCT03120949|527468731|FG001|Overall Study|Other: Adverse Event|1|||
146260497|NCT03120949|527468730|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
146302174|NCT00467779|527621653|FG001|Stage 1A|Death|0|||
146114277|NCT03342690|526935498|FG000|Overall Study|Protocol Violation|16|||
146114278|NCT01749514|526935499|FG000|Overall Study|Lost to Follow-up|0|||
146114279|NCT01749514|526935500|FG001|Overall Study|Lost to Follow-up|0|||
146114280|NCT01749514|526935501|FG002|Overall Study|Lost to Follow-up|0|||
146114281|NCT01749514|526935502|FG003|Overall Study|Lost to Follow-up|0|||
146114282|NCT01749514|526935503|FG004|Overall Study|Lost to Follow-up|0|||
146114283|NCT01749514|526935504|FG005|Overall Study|Lost to Follow-up|0|||
146114284|NCT01749514|526935505|FG006|Overall Study|Lost to Follow-up|0|||
146114285|NCT01749514|526935506|FG007|Overall Study|Lost to Follow-up|1|||
146114286|NCT01749514|526935499|FG000|Overall Study|Withdrawal by Subject|0|||
146114287|NCT01749514|526935500|FG001|Overall Study|Withdrawal by Subject|0|||
146114288|NCT01749514|526935501|FG002|Overall Study|Withdrawal by Subject|0|||
146114289|NCT01749514|526935502|FG003|Overall Study|Withdrawal by Subject|0|||
146114290|NCT01749514|526935503|FG004|Overall Study|Withdrawal by Subject|0|||
146114291|NCT01749514|526935504|FG005|Overall Study|Withdrawal by Subject|1|||
146114292|NCT01749514|526935505|FG006|Overall Study|Withdrawal by Subject|0|||
146114293|NCT01749514|526935506|FG007|Overall Study|Withdrawal by Subject|1|||
146114294|NCT01749514|526935499|FG000|Overall Study|Not Reported|0|||
146114295|NCT01749514|526935500|FG001|Overall Study|Not Reported|0|||
146114296|NCT01749514|526935501|FG002|Overall Study|Not Reported|0|||
146114297|NCT01749514|526935502|FG003|Overall Study|Not Reported|0|||
146114298|NCT01749514|526935503|FG004|Overall Study|Not Reported|0|||
146114299|NCT01749514|526935504|FG005|Overall Study|Not Reported|0|||
146114300|NCT01749514|526935505|FG006|Overall Study|Not Reported|0|||
146114301|NCT01749514|526935506|FG007|Overall Study|Not Reported|5|||
146114302|NCT02509156|526935507|FG000|Randomized Phase|Death|1|||
146114303|NCT02509156|526935508|FG001|Randomized Phase|Death|0|||
146114304|NCT02509156|526935507|FG000|Randomized Phase|Withdrawal by Subject|1|||
146114305|NCT02509156|526935508|FG001|Randomized Phase|Withdrawal by Subject|1|||
146114306|NCT03042533|526935509|FG000|Overall Study|MD left program|1|||
146114307|NCT03042533|526935510|FG001|Overall Study|MD left program|4|||
146114308|NCT03042533|526935511|FG002|Overall Study|MD left program|1|||
146114309|NCT01906008|526935518|FG000|Overall Study|Lost to Follow-up|2|||
146114310|NCT01906008|526935519|FG001|Overall Study|Lost to Follow-up|0|||
146114311|NCT01906008|526935518|FG000|Overall Study|Oxaliplatin toxicity|2|||
146114312|NCT01906008|526935519|FG001|Overall Study|Oxaliplatin toxicity|0|||
146114313|NCT01906008|526935518|FG000|Overall Study|Protocol Violation|0|||
146114314|NCT01906008|526935519|FG001|Overall Study|Protocol Violation|1|||
146114315|NCT01906008|526935518|FG000|Overall Study|Withdrawal by Subject|1|||
146114316|NCT01906008|526935519|FG001|Overall Study|Withdrawal by Subject|5|||
146114317|NCT01906008|526935518|FG000|Overall Study|Did not start study med|3|||
146114318|NCT01906008|526935519|FG001|Overall Study|Did not start study med|4|||
146114319|NCT01906008|526935518|FG000|Overall Study|Oxaliplatin stops|10|||
146114320|NCT01906008|526935519|FG001|Overall Study|Oxaliplatin stops|8|||
146114321|NCT01906008|526935518|FG000|Overall Study|Hospice|1|||
146114322|NCT01906008|526935519|FG001|Overall Study|Hospice|0|||
146114323|NCT01906008|526935518|FG000|Overall Study|Physician Decision|3|||
146114324|NCT01906008|526935519|FG001|Overall Study|Physician Decision|3|||
146114325|NCT01906008|526935518|FG000|Overall Study|Lack of compliance of study med|5|||
146114326|NCT01906008|526935519|FG001|Overall Study|Lack of compliance of study med|3|||
146114327|NCT01906008|526935518|FG000|Overall Study|Adverse Event|0|||
146114328|NCT01906008|526935519|FG001|Overall Study|Adverse Event|3|||
146114329|NCT02117648|526935520|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
146114330|NCT02117648|526935520|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
146114331|NCT02117648|526935520|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
146114332|NCT02117648|526935520|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
146114333|NCT02117648|526935520|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
146114334|NCT02117648|526935520|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
146114335|NCT02117648|526935520|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
146114336|NCT02117648|526935520|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
146114337|NCT02117648|526935520|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
146114338|NCT02117648|526935520|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
146114339|NCT02117648|526935520|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
146114340|NCT00171730|526935522|FG000|Overall Study|Adverse Event|3|||
146114341|NCT00171730|526935522|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146114342|NCT00171730|526935522|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
146114343|NCT00171730|526935522|FG000|Overall Study|Withdrawal by Subject|3|||
146114344|NCT05025241|526935523|FG000|Screening|Failed Screening|5|||
146114345|NCT05025241|526935523|FG000|Treatment and Follow Up|Adverse Event|3|||
146114346|NCT02220205|526935524|FG000|Overall Study|Withdrawal by Subject|1|||
146114347|NCT02220205|526935525|FG001|Overall Study|Withdrawal by Subject|0|||
146114348|NCT04294472|526935526|FG000|Overall Study|Adverse Event|0|||
146114349|NCT04294472|526935527|FG001|Overall Study|Adverse Event|1|||
146114350|NCT04294472|526935528|FG002|Overall Study|Adverse Event|1|||
146114351|NCT04294472|526935526|FG000|Overall Study|Randomized but not treated|0|||
146114352|NCT04294472|526935527|FG001|Overall Study|Randomized but not treated|1|||
146114353|NCT04294472|526935528|FG002|Overall Study|Randomized but not treated|1|||
146114354|NCT02268084|526935529|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
146114355|NCT02268084|526935530|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
146114356|NCT02268084|526935529|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
146114357|NCT02268084|526935530|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
146168161|NCT02496767|527128086|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
146114358|NCT05227027|526935531|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
146114359|NCT05227027|526935532|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
146114360|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146114361|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
146114362|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146114363|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146114364|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146114365|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
146114366|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
146114367|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
146114368|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
146114369|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
146114370|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
146114371|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
146114372|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
146114373|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146114374|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
146114375|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146114376|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
146114377|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
146114378|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146114379|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146114380|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146114381|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146114382|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
146114383|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
146114384|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146114385|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
146114386|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146114387|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146114388|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146114389|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
146114390|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
146114391|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146114392|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146114393|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
146114394|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
146114395|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
146114396|NCT02603419|526935533|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146114397|NCT02603419|526935534|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146114398|NCT02603419|526935535|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146114399|NCT02603419|526935536|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
146114400|NCT02603419|526935537|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146114401|NCT02603419|526935538|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
146114402|NCT02603419|526935533|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146114403|NCT02603419|526935534|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146114404|NCT02603419|526935535|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146114405|NCT02603419|526935536|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146114406|NCT02603419|526935537|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
146114407|NCT02603419|526935538|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
146114408|NCT02603419|526935533|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146114409|NCT02603419|526935534|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146114410|NCT02603419|526935535|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146114411|NCT02603419|526935536|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146114412|NCT02603419|526935537|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
146114413|NCT02603419|526935538|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
146114414|NCT02603419|526935533|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146114415|NCT02603419|526935534|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146114416|NCT02603419|526935535|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146114417|NCT02603419|526935536|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146114418|NCT02603419|526935537|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
146114419|NCT02603419|526935538|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
146114420|NCT03552198|526935539|FG000|Overall Study|Lost to Follow-up|42|||
146302175|NCT00467779|527621654|FG002|Stage 1A|Death|0|||
146302176|NCT00467779|527621655|FG003|Stage 1A|Death|0|||
146302177|NCT00467779|527621656|FG004|Stage 1A|Death|0|||
146302178|NCT00467779|527621657|FG005|Stage 1A|Death|0|||
146302179|NCT00467779|527621658|FG006|Stage 1A|Death|0|||
146302180|NCT00467779|527621659|FG007|Stage 1A|Death|0|||
146302181|NCT00467779|527621660|FG008|Stage 1A|Death|0|||
146302182|NCT00467779|527621661|FG009|Stage 1A|Death|0|||
146302183|NCT00467779|527621662|FG010|Stage 1A|Death|0|||
146302184|NCT00467779|527621663|FG011|Stage 1A|Death|1|||
146302185|NCT00467779|527621664|FG012|Stage 1A|Death|1|||
146302186|NCT00467779|527621665|FG013|Stage 1A|Death|0|||
146302187|NCT00467779|527621666|FG014|Stage 1A|Death|0|||
146302188|NCT00467779|527621652|FG000|Stage 1A|Disease Progression|0|||
146302189|NCT00467779|527621653|FG001|Stage 1A|Disease Progression|0|||
146302190|NCT00467779|527621654|FG002|Stage 1A|Disease Progression|0|||
146302191|NCT00467779|527621655|FG003|Stage 1A|Disease Progression|0|||
146302192|NCT00467779|527621656|FG004|Stage 1A|Disease Progression|0|||
146302193|NCT00467779|527621657|FG005|Stage 1A|Disease Progression|0|||
146302194|NCT00467779|527621658|FG006|Stage 1A|Disease Progression|0|||
146302195|NCT00467779|527621659|FG007|Stage 1A|Disease Progression|0|||
146302196|NCT00467779|527621660|FG008|Stage 1A|Disease Progression|0|||
146302197|NCT00467779|527621661|FG009|Stage 1A|Disease Progression|2|||
146302198|NCT00467779|527621662|FG010|Stage 1A|Disease Progression|2|||
146302199|NCT00467779|527621663|FG011|Stage 1A|Disease Progression|5|||
146302200|NCT00467779|527621664|FG012|Stage 1A|Disease Progression|2|||
146302201|NCT00467779|527621665|FG013|Stage 1A|Disease Progression|0|||
146302202|NCT00467779|527621666|FG014|Stage 1A|Disease Progression|0|||
146302203|NCT00467779|527621652|FG000|Stage 1A|Physician Decision|0|||
146302204|NCT00467779|527621653|FG001|Stage 1A|Physician Decision|0|||
146302205|NCT00467779|527621654|FG002|Stage 1A|Physician Decision|0|||
146302206|NCT00467779|527621655|FG003|Stage 1A|Physician Decision|0|||
146302207|NCT00467779|527621656|FG004|Stage 1A|Physician Decision|0|||
146302208|NCT00467779|527621657|FG005|Stage 1A|Physician Decision|0|||
146302209|NCT00467779|527621658|FG006|Stage 1A|Physician Decision|0|||
146302210|NCT00467779|527621659|FG007|Stage 1A|Physician Decision|0|||
146302211|NCT00467779|527621660|FG008|Stage 1A|Physician Decision|0|||
146302212|NCT00467779|527621661|FG009|Stage 1A|Physician Decision|1|||
146302213|NCT00467779|527621662|FG010|Stage 1A|Physician Decision|0|||
146302214|NCT00467779|527621663|FG011|Stage 1A|Physician Decision|0|||
146302215|NCT00467779|527621664|FG012|Stage 1A|Physician Decision|0|||
146302216|NCT00467779|527621665|FG013|Stage 1A|Physician Decision|0|||
146302217|NCT00467779|527621666|FG014|Stage 1A|Physician Decision|0|||
146302218|NCT00467779|527621652|FG000|Stage 1A|Withdrawal by Subject|0|||
146302219|NCT00467779|527621653|FG001|Stage 1A|Withdrawal by Subject|0|||
146302220|NCT00467779|527621654|FG002|Stage 1A|Withdrawal by Subject|0|||
146302221|NCT00467779|527621655|FG003|Stage 1A|Withdrawal by Subject|0|||
146302222|NCT00467779|527621656|FG004|Stage 1A|Withdrawal by Subject|0|||
146302223|NCT00467779|527621657|FG005|Stage 1A|Withdrawal by Subject|0|||
146114421|NCT03552198|526935540|FG001|Overall Study|Lost to Follow-up|48|||
146114422|NCT03552198|526935541|FG002|Overall Study|Lost to Follow-up|15|||
146114423|NCT03552198|526935542|FG003|Overall Study|Lost to Follow-up|19|||
146114424|NCT03552198|526935539|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
146114425|NCT03552198|526935540|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
146114426|NCT03552198|526935541|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
146114427|NCT03552198|526935542|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
146114428|NCT03552198|526935539|FG000|Overall Study|Did not receive air alerts|1|||
146114429|NCT03552198|526935540|FG001|Overall Study|Did not receive air alerts|0|||
146114430|NCT03552198|526935541|FG002|Overall Study|Did not receive air alerts|0|||
146114431|NCT03552198|526935542|FG003|Overall Study|Did not receive air alerts|1|||
146114432|NCT06149247|526935546|FG000|Overall Study|Adverse Event|0|||
146114433|NCT06149247|526935547|FG001|Overall Study|Adverse Event|1|||
146114434|NCT00855920|526935548|FG000|Overall Study|Protocol Violation|0|||
146114435|NCT00855920|526935549|FG001|Overall Study|Protocol Violation|0|||
146302224|NCT00467779|527621658|FG006|Stage 1A|Withdrawal by Subject|0|||
146302225|NCT00467779|527621659|FG007|Stage 1A|Withdrawal by Subject|0|||
146302226|NCT00467779|527621660|FG008|Stage 1A|Withdrawal by Subject|0|||
146302227|NCT00467779|527621661|FG009|Stage 1A|Withdrawal by Subject|0|||
146302228|NCT00467779|527621662|FG010|Stage 1A|Withdrawal by Subject|1|||
146114436|NCT00855920|526935550|FG002|Overall Study|Protocol Violation|2|||
146302229|NCT00467779|527621663|FG011|Stage 1A|Withdrawal by Subject|1|||
146302230|NCT00467779|527621664|FG012|Stage 1A|Withdrawal by Subject|1|||
146302231|NCT00467779|527621665|FG013|Stage 1A|Withdrawal by Subject|0|||
146302232|NCT00467779|527621666|FG014|Stage 1A|Withdrawal by Subject|0|||
146302233|NCT00467779|527621652|FG000|Stage 1A|Unspecified Reason|0|||
146302234|NCT00467779|527621653|FG001|Stage 1A|Unspecified Reason|0|||
146302235|NCT00467779|527621654|FG002|Stage 1A|Unspecified Reason|0|||
146302236|NCT00467779|527621655|FG003|Stage 1A|Unspecified Reason|0|||
146302237|NCT00467779|527621656|FG004|Stage 1A|Unspecified Reason|0|||
146302238|NCT00467779|527621657|FG005|Stage 1A|Unspecified Reason|0|||
146302239|NCT00467779|527621658|FG006|Stage 1A|Unspecified Reason|0|||
146302240|NCT00467779|527621659|FG007|Stage 1A|Unspecified Reason|0|||
146114437|NCT00855920|526935548|FG000|Overall Study|Adverse Event|2|||
146114438|NCT00855920|526935549|FG001|Overall Study|Adverse Event|1|||
146114439|NCT00855920|526935550|FG002|Overall Study|Adverse Event|1|||
146114440|NCT00855920|526935548|FG000|Overall Study|Lack of Efficacy|2|||
146114441|NCT00855920|526935549|FG001|Overall Study|Lack of Efficacy|2|||
146114442|NCT00855920|526935550|FG002|Overall Study|Lack of Efficacy|2|||
146114443|NCT00855920|526935548|FG000|Overall Study|Withdrawal by Subject|2|||
146114444|NCT00855920|526935549|FG001|Overall Study|Withdrawal by Subject|3|||
146114445|NCT00855920|526935550|FG002|Overall Study|Withdrawal by Subject|2|||
146114446|NCT00855920|526935548|FG000|Overall Study|Lost to Follow-up|1|||
146114447|NCT00855920|526935549|FG001|Overall Study|Lost to Follow-up|0|||
146114448|NCT00855920|526935550|FG002|Overall Study|Lost to Follow-up|2|||
146114449|NCT00855920|526935548|FG000|Overall Study|Death|0|||
146114450|NCT00855920|526935549|FG001|Overall Study|Death|1|||
146114451|NCT00855920|526935550|FG002|Overall Study|Death|0|||
146114452|NCT00855920|526935548|FG000|Overall Study|Decision by the sponsor|0|||
146114453|NCT00855920|526935549|FG001|Overall Study|Decision by the sponsor|1|||
146114454|NCT00855920|526935550|FG002|Overall Study|Decision by the sponsor|1|||
146114455|NCT00855920|526935548|FG000|Overall Study|Other than specified above|1|||
146114456|NCT00855920|526935549|FG001|Overall Study|Other than specified above|1|||
146114457|NCT00855920|526935550|FG002|Overall Study|Other than specified above|1|||
146114458|NCT01756898|526935553|FG000|Overall Study|Adverse Event|7|||
146114459|NCT01756898|526935554|FG001|Overall Study|Adverse Event|1|||
146114460|NCT01756898|526935555|FG002|Overall Study|Adverse Event|0|||
146114461|NCT01756898|526935556|FG003|Overall Study|Adverse Event|0|||
146114462|NCT01756898|526935553|FG000|Overall Study|Lack of Efficacy|4|||
146114463|NCT01756898|526935554|FG001|Overall Study|Lack of Efficacy|7|||
146114464|NCT01756898|526935555|FG002|Overall Study|Lack of Efficacy|6|||
146114465|NCT01756898|526935556|FG003|Overall Study|Lack of Efficacy|6|||
146114466|NCT01756898|526935553|FG000|Overall Study|Lost to Follow-up|2|||
146114467|NCT01756898|526935554|FG001|Overall Study|Lost to Follow-up|4|||
146114468|NCT01756898|526935555|FG002|Overall Study|Lost to Follow-up|2|||
146114469|NCT01756898|526935556|FG003|Overall Study|Lost to Follow-up|3|||
146114470|NCT01756898|526935553|FG000|Overall Study|Protocol Violation|1|||
146114471|NCT01756898|526935554|FG001|Overall Study|Protocol Violation|2|||
146114472|NCT01756898|526935555|FG002|Overall Study|Protocol Violation|2|||
146114473|NCT01756898|526935556|FG003|Overall Study|Protocol Violation|1|||
146114474|NCT01756898|526935553|FG000|Overall Study|Withdrew Consent|5|||
146114475|NCT01756898|526935554|FG001|Overall Study|Withdrew Consent|3|||
146114476|NCT01756898|526935555|FG002|Overall Study|Withdrew Consent|5|||
146114477|NCT01756898|526935556|FG003|Overall Study|Withdrew Consent|6|||
146114478|NCT01756898|526935553|FG000|Overall Study|Other|0|||
146114479|NCT01756898|526935554|FG001|Overall Study|Other|2|||
146114480|NCT01756898|526935555|FG002|Overall Study|Other|2|||
146260498|NCT03120949|527468731|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
146260499|NCT03120949|527468730|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
146260500|NCT03120949|527468731|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
146260501|NCT03120949|527468730|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
146260502|NCT03120949|527468731|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
146260503|NCT03120949|527468730|FG000|Overall Study|Personal Reasons|0|||
146260504|NCT03120949|527468731|FG001|Overall Study|Personal Reasons|1|||
146260505|NCT03120949|527468730|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
146260506|NCT03120949|527468731|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
146260507|NCT03120949|527468730|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
146260508|NCT03120949|527468731|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
146260509|NCT03120949|527468730|FG000|Overall Study|Compliance With Medication|0|||
146260510|NCT03120949|527468731|FG001|Overall Study|Compliance With Medication|1|||
146260511|NCT03120949|527468730|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
146260512|NCT03120949|527468731|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
146114481|NCT01756898|526935556|FG003|Overall Study|Other|0|||
146114482|NCT01500694|526935557|FG000|Overall Study|Adverse Event|4|||
146114483|NCT01500694|526935558|FG001|Overall Study|Adverse Event|3|||
146114484|NCT01500694|526935557|FG000|Overall Study|Protocol Violation|0|||
146114485|NCT01500694|526935558|FG001|Overall Study|Protocol Violation|1|||
146114486|NCT01500694|526935557|FG000|Overall Study|Withdrawal by Subject|23|||
146114487|NCT01500694|526935558|FG001|Overall Study|Withdrawal by Subject|14|||
146114488|NCT01500694|526935557|FG000|Overall Study|Lost to Follow-up|2|||
146114489|NCT01500694|526935558|FG001|Overall Study|Lost to Follow-up|3|||
146114490|NCT01500694|526935557|FG000|Overall Study|Lack of Efficacy|14|||
146114491|NCT01500694|526935558|FG001|Overall Study|Lack of Efficacy|5|||
146114492|NCT01500694|526935557|FG000|Overall Study|Other|9|||
146114493|NCT01500694|526935558|FG001|Overall Study|Other|3|||
146114494|NCT02007109|526935559|FG000|Overall Study|Diary not returned or excluded|102|||
146114495|NCT02007109|526935559|FG000|Overall Study|Excluded - Age<7yo|9|||
146114496|NCT03572062|526935560|FG000|Overall Study|Adverse Event|0|||
146114497|NCT03572062|526935561|FG001|Overall Study|Adverse Event|0|||
146114498|NCT03572062|526935562|FG002|Overall Study|Adverse Event|0|||
146114499|NCT03572062|526935563|FG003|Overall Study|Adverse Event|0|||
146114500|NCT03572062|526935564|FG004|Overall Study|Adverse Event|0|||
146114501|NCT03572062|526935565|FG005|Overall Study|Adverse Event|0|||
146114502|NCT03572062|526935566|FG006|Overall Study|Adverse Event|0|||
146114503|NCT03572062|526935567|FG007|Overall Study|Adverse Event|0|||
146114504|NCT03572062|526935568|FG008|Overall Study|Adverse Event|1|||
146114505|NCT03572062|526935569|FG009|Overall Study|Adverse Event|3|||
146114506|NCT03572062|526935560|FG000|Overall Study|Death|0|||
146114507|NCT03572062|526935561|FG001|Overall Study|Death|0|||
146114508|NCT03572062|526935562|FG002|Overall Study|Death|0|||
146114509|NCT03572062|526935563|FG003|Overall Study|Death|0|||
146114510|NCT03572062|526935564|FG004|Overall Study|Death|0|||
146114511|NCT03572062|526935565|FG005|Overall Study|Death|1|||
146114512|NCT03572062|526935566|FG006|Overall Study|Death|0|||
146114513|NCT03572062|526935567|FG007|Overall Study|Death|0|||
146114514|NCT03572062|526935568|FG008|Overall Study|Death|0|||
146114515|NCT03572062|526935569|FG009|Overall Study|Death|0|||
146114516|NCT03572062|526935560|FG000|Overall Study|Lost to Follow-up|0|||
146114517|NCT03572062|526935561|FG001|Overall Study|Lost to Follow-up|0|||
146114518|NCT03572062|526935562|FG002|Overall Study|Lost to Follow-up|0|||
146114519|NCT03572062|526935563|FG003|Overall Study|Lost to Follow-up|0|||
146114520|NCT03572062|526935564|FG004|Overall Study|Lost to Follow-up|0|||
146114521|NCT03572062|526935565|FG005|Overall Study|Lost to Follow-up|1|||
146114522|NCT03572062|526935566|FG006|Overall Study|Lost to Follow-up|1|||
146114523|NCT03572062|526935567|FG007|Overall Study|Lost to Follow-up|0|||
146114524|NCT03572062|526935568|FG008|Overall Study|Lost to Follow-up|0|||
146114525|NCT03572062|526935569|FG009|Overall Study|Lost to Follow-up|0|||
146114526|NCT03572062|526935560|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114527|NCT03572062|526935561|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114528|NCT03572062|526935562|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114529|NCT03572062|526935563|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114530|NCT03572062|526935564|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114531|NCT03572062|526935565|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114532|NCT03572062|526935566|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114533|NCT03572062|526935567|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114534|NCT03572062|526935568|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
146114535|NCT03572062|526935569|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
146114536|NCT03572062|526935560|FG000|Overall Study|Study Terminated By Sponsor|0|||
146114537|NCT03572062|526935561|FG001|Overall Study|Study Terminated By Sponsor|0|||
146114538|NCT03572062|526935562|FG002|Overall Study|Study Terminated By Sponsor|0|||
146114539|NCT03572062|526935563|FG003|Overall Study|Study Terminated By Sponsor|0|||
146114540|NCT03572062|526935564|FG004|Overall Study|Study Terminated By Sponsor|0|||
146114541|NCT03572062|526935565|FG005|Overall Study|Study Terminated By Sponsor|0|||
146114542|NCT03572062|526935566|FG006|Overall Study|Study Terminated By Sponsor|0|||
146114543|NCT03572062|526935567|FG007|Overall Study|Study Terminated By Sponsor|0|||
146114544|NCT03572062|526935568|FG008|Overall Study|Study Terminated By Sponsor|29|||
146114545|NCT03572062|526935569|FG009|Overall Study|Study Terminated By Sponsor|27|||
146114546|NCT03572062|526935560|FG000|Overall Study|Physician Decision|0|||
146114547|NCT03572062|526935561|FG001|Overall Study|Physician Decision|0|||
146114548|NCT03572062|526935562|FG002|Overall Study|Physician Decision|0|||
146114549|NCT03572062|526935563|FG003|Overall Study|Physician Decision|0|||
146114550|NCT03572062|526935564|FG004|Overall Study|Physician Decision|0|||
146114551|NCT03572062|526935565|FG005|Overall Study|Physician Decision|0|||
146114552|NCT03572062|526935566|FG006|Overall Study|Physician Decision|0|||
146114553|NCT03572062|526935567|FG007|Overall Study|Physician Decision|0|||
146302241|NCT00467779|527621660|FG008|Stage 1A|Unspecified Reason|0|||
146302242|NCT00467779|527621661|FG009|Stage 1A|Unspecified Reason|0|||
146302243|NCT00467779|527621662|FG010|Stage 1A|Unspecified Reason|0|||
146302244|NCT00467779|527621663|FG011|Stage 1A|Unspecified Reason|1|||
146114554|NCT03572062|526935568|FG008|Overall Study|Physician Decision|1|||
146114555|NCT03572062|526935569|FG009|Overall Study|Physician Decision|0|||
146114556|NCT03572062|526935560|FG000|Overall Study|Withdrawal by Subject|0|||
146114557|NCT03572062|526935561|FG001|Overall Study|Withdrawal by Subject|0|||
146114558|NCT03572062|526935562|FG002|Overall Study|Withdrawal by Subject|0|||
146114559|NCT03572062|526935563|FG003|Overall Study|Withdrawal by Subject|0|||
146114560|NCT03572062|526935564|FG004|Overall Study|Withdrawal by Subject|0|||
146114561|NCT03572062|526935565|FG005|Overall Study|Withdrawal by Subject|0|||
146114562|NCT03572062|526935566|FG006|Overall Study|Withdrawal by Subject|0|||
146114563|NCT03572062|526935567|FG007|Overall Study|Withdrawal by Subject|0|||
146114564|NCT03572062|526935568|FG008|Overall Study|Withdrawal by Subject|0|||
146114565|NCT03572062|526935569|FG009|Overall Study|Withdrawal by Subject|1|||
146114566|NCT03572062|526935560|FG000|Overall Study|Randomized But Not Treated|0|||
146114567|NCT03572062|526935561|FG001|Overall Study|Randomized But Not Treated|0|||
146302245|NCT00467779|527621664|FG012|Stage 1A|Unspecified Reason|1|||
146114568|NCT03572062|526935562|FG002|Overall Study|Randomized But Not Treated|0|||
146114569|NCT03572062|526935563|FG003|Overall Study|Randomized But Not Treated|0|||
146114570|NCT03572062|526935564|FG004|Overall Study|Randomized But Not Treated|1|||
146302246|NCT00467779|527621665|FG013|Stage 1A|Unspecified Reason|0|||
146302247|NCT00467779|527621666|FG014|Stage 1A|Unspecified Reason|0|||
146302248|NCT00467779|527621652|FG000|Stage 2|Adverse Event|0|||
146302249|NCT00467779|527621653|FG001|Stage 2|Adverse Event|0|||
146302250|NCT00467779|527621654|FG002|Stage 2|Adverse Event|0|||
146302251|NCT00467779|527621655|FG003|Stage 2|Adverse Event|0|||
146302252|NCT00467779|527621656|FG004|Stage 2|Adverse Event|0|||
146302253|NCT00467779|527621657|FG005|Stage 2|Adverse Event|0|||
146302254|NCT00467779|527621658|FG006|Stage 2|Adverse Event|0|||
146302255|NCT00467779|527621659|FG007|Stage 2|Adverse Event|0|||
146302256|NCT00467779|527621660|FG008|Stage 2|Adverse Event|1|||
146302257|NCT00467779|527621661|FG009|Stage 2|Adverse Event|0|||
146302258|NCT00467779|527621662|FG010|Stage 2|Adverse Event|0|||
146302259|NCT00467779|527621663|FG011|Stage 2|Adverse Event|0|||
146302260|NCT00467779|527621664|FG012|Stage 2|Adverse Event|0|||
146302261|NCT00467779|527621665|FG013|Stage 2|Adverse Event|0|||
146302262|NCT00467779|527621666|FG014|Stage 2|Adverse Event|0|||
146302263|NCT00467779|527621652|FG000|Stage 2|Death|0|||
146302264|NCT00467779|527621653|FG001|Stage 2|Death|0|||
146302265|NCT00467779|527621654|FG002|Stage 2|Death|0|||
146302266|NCT00467779|527621655|FG003|Stage 2|Death|0|||
146302267|NCT00467779|527621656|FG004|Stage 2|Death|0|||
146302268|NCT00467779|527621657|FG005|Stage 2|Death|0|||
146302269|NCT00467779|527621658|FG006|Stage 2|Death|0|||
146302270|NCT00467779|527621659|FG007|Stage 2|Death|0|||
146302271|NCT00467779|527621660|FG008|Stage 2|Death|1|||
146302272|NCT00467779|527621661|FG009|Stage 2|Death|0|||
146302273|NCT00467779|527621662|FG010|Stage 2|Death|0|||
146302274|NCT00467779|527621663|FG011|Stage 2|Death|0|||
146302275|NCT00467779|527621664|FG012|Stage 2|Death|0|||
146302276|NCT00467779|527621665|FG013|Stage 2|Death|0|||
146302277|NCT00467779|527621666|FG014|Stage 2|Death|0|||
146302278|NCT00467779|527621652|FG000|Stage 2|Disease Progression|0|||
146302279|NCT00467779|527621653|FG001|Stage 2|Disease Progression|0|||
146302280|NCT00467779|527621654|FG002|Stage 2|Disease Progression|0|||
146302281|NCT00467779|527621655|FG003|Stage 2|Disease Progression|0|||
146302282|NCT00467779|527621656|FG004|Stage 2|Disease Progression|0|||
146302283|NCT00467779|527621657|FG005|Stage 2|Disease Progression|0|||
146302284|NCT00467779|527621658|FG006|Stage 2|Disease Progression|0|||
146302285|NCT00467779|527621659|FG007|Stage 2|Disease Progression|0|||
146302286|NCT00467779|527621660|FG008|Stage 2|Disease Progression|16|||
146302287|NCT00467779|527621661|FG009|Stage 2|Disease Progression|0|||
146302288|NCT00467779|527621662|FG010|Stage 2|Disease Progression|0|||
146302289|NCT00467779|527621663|FG011|Stage 2|Disease Progression|0|||
146302290|NCT00467779|527621664|FG012|Stage 2|Disease Progression|0|||
146114571|NCT03572062|526935565|FG005|Overall Study|Randomized But Not Treated|2|||
146114572|NCT03572062|526935566|FG006|Overall Study|Randomized But Not Treated|0|||
146114573|NCT03572062|526935567|FG007|Overall Study|Randomized But Not Treated|1|||
146114574|NCT03572062|526935568|FG008|Overall Study|Randomized But Not Treated|0|||
146114575|NCT03572062|526935569|FG009|Overall Study|Randomized But Not Treated|0|||
146114576|NCT01691781|526935570|FG000|Overall Study|Withdrawal by Subject|4|||
146114577|NCT01691781|526935571|FG001|Overall Study|Withdrawal by Subject|3|||
146114578|NCT01691781|526935570|FG000|Overall Study|Physician Decision|1|||
146114579|NCT01691781|526935571|FG001|Overall Study|Physician Decision|1|||
146114580|NCT01691781|526935570|FG000|Overall Study|Protocol Violation|2|||
146114581|NCT01691781|526935571|FG001|Overall Study|Protocol Violation|2|||
146114582|NCT01691781|526935570|FG000|Overall Study|Adverse Event|0|||
146302291|NCT00467779|527621665|FG013|Stage 2|Disease Progression|0|||
146302292|NCT00467779|527621666|FG014|Stage 2|Disease Progression|0|||
146302293|NCT00467779|527621652|FG000|Stage 2|Unspecified Reason|0|||
146114583|NCT01691781|526935571|FG001|Overall Study|Adverse Event|1|||
146302294|NCT00467779|527621653|FG001|Stage 2|Unspecified Reason|0|||
146302295|NCT00467779|527621654|FG002|Stage 2|Unspecified Reason|0|||
146114584|NCT01605877|526935572|FG000|Overall Study|Withdrawal by Subject|1|||
146114585|NCT01918085|526935573|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
146114586|NCT01918085|526935574|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
146302296|NCT00467779|527621655|FG003|Stage 2|Unspecified Reason|0|||
146302297|NCT00467779|527621656|FG004|Stage 2|Unspecified Reason|0|||
146302298|NCT00467779|527621657|FG005|Stage 2|Unspecified Reason|0|||
146302299|NCT00467779|527621658|FG006|Stage 2|Unspecified Reason|0|||
146302300|NCT00467779|527621659|FG007|Stage 2|Unspecified Reason|0|||
146114587|NCT02132130|526935575|FG000|Overall Study|Lost to Follow-up|0|||
146114588|NCT02132130|526935576|FG001|Overall Study|Lost to Follow-up|2|||
146302301|NCT00467779|527621660|FG008|Stage 2|Unspecified Reason|3|||
146302302|NCT00467779|527621661|FG009|Stage 2|Unspecified Reason|0|||
146302303|NCT00467779|527621662|FG010|Stage 2|Unspecified Reason|0|||
146302304|NCT00467779|527621663|FG011|Stage 2|Unspecified Reason|0|||
146302305|NCT00467779|527621664|FG012|Stage 2|Unspecified Reason|0|||
146302306|NCT00467779|527621665|FG013|Stage 2|Unspecified Reason|0|||
146302307|NCT00467779|527621666|FG014|Stage 2|Unspecified Reason|0|||
146302308|NCT00467779|527621652|FG000|Stage 2A|Adverse Event|0|||
146302309|NCT00467779|527621653|FG001|Stage 2A|Adverse Event|0|||
146302310|NCT00467779|527621654|FG002|Stage 2A|Adverse Event|0|||
146114589|NCT02132130|526935577|FG002|Overall Study|Lost to Follow-up|0|||
146114590|NCT02132130|526935578|FG003|Overall Study|Lost to Follow-up|0|||
146114591|NCT02132130|526935575|FG000|Overall Study|Withdrawal by Subject|0|||
146114592|NCT02132130|526935576|FG001|Overall Study|Withdrawal by Subject|0|||
146114593|NCT02132130|526935577|FG002|Overall Study|Withdrawal by Subject|0|||
146114594|NCT02132130|526935578|FG003|Overall Study|Withdrawal by Subject|1|||
146114595|NCT02760069|526935581|FG000|Overall Study|Withdrawal by Subject|0|||
146114596|NCT02760069|526935582|FG001|Overall Study|Withdrawal by Subject|1|||
146114597|NCT02760069|526935583|FG002|Overall Study|Withdrawal by Subject|1|||
146114598|NCT00646776|526935591|FG000|Overall Study|Adverse Event|1|||
146114599|NCT00646776|526935592|FG001|Overall Study|Adverse Event|9|||
146114600|NCT00646776|526935591|FG000|Overall Study|Investigator discretion|0|||
146114601|NCT00646776|526935592|FG001|Overall Study|Investigator discretion|4|||
146114602|NCT00600483|526935596|FG000|Overall Study|Lost to Follow-up|26|||
146114603|NCT00600483|526935597|FG001|Overall Study|Lost to Follow-up|47|||
146114604|NCT00600483|526935596|FG000|Overall Study|Randomized but not treated|10|||
146114605|NCT00600483|526935597|FG001|Overall Study|Randomized but not treated|0|||
146114606|NCT03031678|526935603|FG000|Overall Study|Study closed prior to completion|1|||
146114607|NCT04557371|526935606|FG000|Overall Study|Covid-19-related|0|||
146114608|NCT04557371|526935607|FG001|Overall Study|Covid-19-related|1|||
146114609|NCT04557371|526935608|FG002|Overall Study|Covid-19-related|0|||
146114610|NCT04557371|526935606|FG000|Overall Study|Withdrawal by Subject|0|||
146114611|NCT04557371|526935607|FG001|Overall Study|Withdrawal by Subject|1|||
146114612|NCT04557371|526935608|FG002|Overall Study|Withdrawal by Subject|0|||
146114613|NCT04557371|526935606|FG000|Overall Study|Adverse Event|1|||
146114614|NCT04557371|526935607|FG001|Overall Study|Adverse Event|0|||
146114615|NCT04557371|526935608|FG002|Overall Study|Adverse Event|0|||
146114616|NCT04419714|526935611|FG000|Overall Study|Technical Fault|5|||
146114617|NCT04419714|526935611|FG000|Overall Study|Protocol Deviation|2|||
146114618|NCT04419714|526935611|FG000|Overall Study|Withdrawal by Subject|1|||
146114619|NCT01325584|526935612|FG000|Overall Study|Death|1|||
146114620|NCT00524368|526937091|FG000|Overall Study|Adverse Event|10|||
146114621|NCT00524368|526937092|FG001|Overall Study|Adverse Event|12|||
146114622|NCT00524368|526937091|FG000|Overall Study|Lost to Follow-up|9|||
146114623|NCT00524368|526937092|FG001|Overall Study|Lost to Follow-up|13|||
146114624|NCT00524368|526937091|FG000|Overall Study|Withdrawal by Subject|4|||
146114625|NCT00524368|526937092|FG001|Overall Study|Withdrawal by Subject|5|||
146114626|NCT00524368|526937091|FG000|Overall Study|Non-compliant|8|||
146114627|NCT00524368|526937092|FG001|Overall Study|Non-compliant|9|||
146114628|NCT00524368|526937091|FG000|Overall Study|Reached a Virologic Endpoint|3|||
146114629|NCT00524368|526937092|FG001|Overall Study|Reached a Virologic Endpoint|2|||
146114630|NCT00524368|526937091|FG000|Overall Study|Sponsor's Decision|2|||
146114631|NCT00524368|526937092|FG001|Overall Study|Sponsor's Decision|0|||
146114632|NCT00524368|526937091|FG000|Overall Study|Ineligible to Continue the study|2|||
146114633|NCT00524368|526937092|FG001|Overall Study|Ineligible to Continue the study|5|||
146114634|NCT00524368|526937091|FG000|Overall Study|Other|3|||
146114635|NCT00524368|526937092|FG001|Overall Study|Other|2|||
146114636|NCT02154490|526937093|FG000|Overall Study|No tissue submitted|23|||
146114637|NCT02154490|526937093|FG000|Overall Study|No biomarker results|167|||
146114638|NCT02154490|526937093|FG000|Overall Study|Not assigned to a sub-study|270|||
146114639|NCT02154490|526937093|FG000|Overall Study|Did not register to a sub-study|749|||
146114640|NCT02373202|526937094|FG000|Overall Study|Adverse Event|2|||
146114641|NCT02373202|526937095|FG001|Overall Study|Adverse Event|5|||
146114642|NCT02373202|526937096|FG002|Overall Study|Adverse Event|2|||
146114643|NCT02373202|526937097|FG003|Overall Study|Adverse Event|1|||
146114644|NCT02373202|526937094|FG000|Overall Study|Lack of Efficacy|0|||
146114645|NCT02373202|526937095|FG001|Overall Study|Lack of Efficacy|0|||
146114646|NCT02373202|526937096|FG002|Overall Study|Lack of Efficacy|1|||
146114647|NCT02373202|526937097|FG003|Overall Study|Lack of Efficacy|0|||
146114648|NCT02373202|526937094|FG000|Overall Study|Other|0|||
146114649|NCT02373202|526937095|FG001|Overall Study|Other|1|||
146114650|NCT02373202|526937096|FG002|Overall Study|Other|0|||
146114651|NCT02373202|526937097|FG003|Overall Study|Other|0|||
146114652|NCT00418314|526937100|FG000|Overall Study|Withdrawal by Subject|1|||
146114653|NCT00418314|526937101|FG001|Overall Study|Withdrawal by Subject|2|||
146114654|NCT02289690|526937106|FG000|Overall Study|Adverse Event Related to Progression|0|||
146114655|NCT02289690|526937107|FG001|Overall Study|Adverse Event Related to Progression|1|||
146114656|NCT02289690|526937108|FG002|Overall Study|Adverse Event Related to Progression|1|||
146114657|NCT02289690|526937109|FG003|Overall Study|Adverse Event Related to Progression|0|||
146114658|NCT02289690|526937110|FG004|Overall Study|Adverse Event Related to Progression|1|||
146114659|NCT02289690|526937111|FG005|Overall Study|Adverse Event Related to Progression|0|||
146114660|NCT02289690|526937112|FG006|Overall Study|Adverse Event Related to Progression|1|||
146114661|NCT02289690|526937113|FG007|Overall Study|Adverse Event Related to Progression|0|||
146114662|NCT02289690|526937114|FG008|Overall Study|Adverse Event Related to Progression|0|||
146114663|NCT02289690|526937115|FG009|Overall Study|Adverse Event Related to Progression|0|||
146114664|NCT02289690|526937106|FG000|Overall Study|Withdrawal by Subject|1|||
146114665|NCT02289690|526937107|FG001|Overall Study|Withdrawal by Subject|0|||
146114666|NCT02289690|526937108|FG002|Overall Study|Withdrawal by Subject|0|||
146114667|NCT02289690|526937109|FG003|Overall Study|Withdrawal by Subject|0|||
146114668|NCT02289690|526937110|FG004|Overall Study|Withdrawal by Subject|1|||
146114669|NCT02289690|526937111|FG005|Overall Study|Withdrawal by Subject|1|||
146114670|NCT02289690|526937112|FG006|Overall Study|Withdrawal by Subject|0|||
146114671|NCT02289690|526937113|FG007|Overall Study|Withdrawal by Subject|0|||
146114672|NCT02289690|526937114|FG008|Overall Study|Withdrawal by Subject|4|||
146114673|NCT02289690|526937115|FG009|Overall Study|Withdrawal by Subject|2|||
146114674|NCT02289690|526937106|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
146114675|NCT02289690|526937107|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
146114676|NCT02289690|526937108|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
146114677|NCT02289690|526937109|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
146114678|NCT02289690|526937110|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
146114679|NCT02289690|526937111|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
146114680|NCT02289690|526937112|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
146114681|NCT02289690|526937113|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
146114682|NCT02289690|526937114|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
146114683|NCT02289690|526937115|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
146114684|NCT02289690|526937106|FG000|Overall Study|Lost to Follow-up|0|||
146114685|NCT02289690|526937107|FG001|Overall Study|Lost to Follow-up|0|||
146114686|NCT02289690|526937108|FG002|Overall Study|Lost to Follow-up|0|||
146114687|NCT02289690|526937109|FG003|Overall Study|Lost to Follow-up|0|||
146114688|NCT02289690|526937110|FG004|Overall Study|Lost to Follow-up|0|||
146114689|NCT02289690|526937111|FG005|Overall Study|Lost to Follow-up|0|||
146114690|NCT02289690|526937112|FG006|Overall Study|Lost to Follow-up|0|||
146114691|NCT02289690|526937113|FG007|Overall Study|Lost to Follow-up|1|||
146114692|NCT02289690|526937114|FG008|Overall Study|Lost to Follow-up|0|||
146114693|NCT02289690|526937115|FG009|Overall Study|Lost to Follow-up|2|||
146114694|NCT02289690|526937106|FG000|Overall Study|Death|0|||
146114695|NCT02289690|526937107|FG001|Overall Study|Death|0|||
146114696|NCT02289690|526937108|FG002|Overall Study|Death|0|||
146114697|NCT02289690|526937109|FG003|Overall Study|Death|0|||
146114698|NCT02289690|526937110|FG004|Overall Study|Death|0|||
146114699|NCT02289690|526937111|FG005|Overall Study|Death|0|||
146114700|NCT02289690|526937112|FG006|Overall Study|Death|0|||
146114701|NCT02289690|526937113|FG007|Overall Study|Death|49|||
146114702|NCT02289690|526937114|FG008|Overall Study|Death|45|||
146114703|NCT02289690|526937115|FG009|Overall Study|Death|41|||
146114704|NCT02289690|526937106|FG000|Overall Study|Sponsor Discontinued Study|0|||
146114705|NCT02289690|526937107|FG001|Overall Study|Sponsor Discontinued Study|0|||
146114706|NCT02289690|526937108|FG002|Overall Study|Sponsor Discontinued Study|0|||
146114707|NCT02289690|526937109|FG003|Overall Study|Sponsor Discontinued Study|0|||
146114708|NCT02289690|526937110|FG004|Overall Study|Sponsor Discontinued Study|0|||
146114709|NCT02289690|526937111|FG005|Overall Study|Sponsor Discontinued Study|0|||
146114710|NCT02289690|526937112|FG006|Overall Study|Sponsor Discontinued Study|0|||
146114711|NCT02289690|526937113|FG007|Overall Study|Sponsor Discontinued Study|9|||
146114712|NCT02289690|526937114|FG008|Overall Study|Sponsor Discontinued Study|7|||
146114713|NCT02289690|526937115|FG009|Overall Study|Sponsor Discontinued Study|15|||
146114714|NCT02289690|526937106|FG000|Overall Study|Other|0|||
146114715|NCT02289690|526937107|FG001|Overall Study|Other|0|||
146114716|NCT02289690|526937108|FG002|Overall Study|Other|0|||
146114717|NCT02289690|526937109|FG003|Overall Study|Other|1|||
146114718|NCT02289690|526937110|FG004|Overall Study|Other|1|||
146114719|NCT02289690|526937111|FG005|Overall Study|Other|0|||
146114720|NCT02289690|526937112|FG006|Overall Study|Other|1|||
146114721|NCT02289690|526937113|FG007|Overall Study|Other|2|||
146114722|NCT02289690|526937114|FG008|Overall Study|Other|3|||
146114723|NCT02289690|526937115|FG009|Overall Study|Other|1|||
146114724|NCT02085785|526937118|FG000|Overall Study|Withdrawal by Subject|2|||
146114725|NCT02085785|526937119|FG001|Overall Study|Withdrawal by Subject|1|||
146114726|NCT02085785|526937118|FG000|Overall Study|Lost to Follow-up|0|||
146114727|NCT02085785|526937119|FG001|Overall Study|Lost to Follow-up|1|||
146114728|NCT00779467|526937120|FG000|Overall Study|Lack of Efficacy|11|||
146302311|NCT00467779|527621655|FG003|Stage 2A|Adverse Event|0|||
146114729|NCT00779467|526937121|FG001|Overall Study|Lack of Efficacy|2|||
146114730|NCT00779467|526937122|FG002|Overall Study|Lack of Efficacy|6|||
146114731|NCT00779467|526937123|FG003|Overall Study|Lack of Efficacy|11|||
146114732|NCT00779467|526937120|FG000|Overall Study|failed inclusion criteria|3|||
146114733|NCT00779467|526937121|FG001|Overall Study|failed inclusion criteria|3|||
146114734|NCT00779467|526937122|FG002|Overall Study|failed inclusion criteria|1|||
146114735|NCT00779467|526937123|FG003|Overall Study|failed inclusion criteria|2|||
146114736|NCT00779467|526937120|FG000|Overall Study|missing data|1|||
146114737|NCT00779467|526937121|FG001|Overall Study|missing data|0|||
146114738|NCT00779467|526937122|FG002|Overall Study|missing data|1|||
146114739|NCT00779467|526937123|FG003|Overall Study|missing data|4|||
146114740|NCT00779467|526937120|FG000|Overall Study|technical issue|0|||
146114741|NCT00779467|526937121|FG001|Overall Study|technical issue|0|||
146302312|NCT00467779|527621656|FG004|Stage 2A|Adverse Event|0|||
146114742|NCT00779467|526937122|FG002|Overall Study|technical issue|2|||
146302313|NCT00467779|527621657|FG005|Stage 2A|Adverse Event|0|||
146260513|NCT03120949|527468730|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
146260514|NCT03120949|527468731|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
146260515|NCT03120949|527468730|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
146260516|NCT03120949|527468731|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
146260517|NCT01329419|527468734|FG000|Overall Study|Protocol Violation|235|||
146260518|NCT04522778|527468735|FG000|Overall Study|Patient did not want to wear the device|1|||
146260519|NCT04522778|527468736|FG001|Overall Study|Patient did not want to wear the device|0|||
146260520|NCT04522778|527468735|FG000|Overall Study|Lost to Follow-up|0|||
146260521|NCT04522778|527468736|FG001|Overall Study|Lost to Follow-up|1|||
146260522|NCT00069277|527468739|FG000|Overall Study|Adverse Event|3|||
146260523|NCT00069277|527468739|FG000|Overall Study|Withdrawal by Subject|1|||
146260524|NCT00069277|527468739|FG000|Overall Study|Progressive Disease|15|||
146260525|NCT00069277|527468739|FG000|Overall Study|Physician Decision|2|||
146260526|NCT02230306|527468740|FG000|Overall Study|Did not receive study treatment|1|||
146260527|NCT01225159|527468741|FG000|Overall Study|Change operation|1|||
146260528|NCT01225159|527468742|FG001|Overall Study|Change operation|0|||
146260529|NCT00312845|527468746|FG000|Overall Study|Adverse Event|19|||
146260530|NCT00312845|527468747|FG001|Overall Study|Adverse Event|5|||
146260531|NCT00312845|527468746|FG000|Overall Study|Death|2|||
146260532|NCT00312845|527468747|FG001|Overall Study|Death|2|||
146260533|NCT00312845|527468746|FG000|Overall Study|Withdrawal by Subject|14|||
146260534|NCT00312845|527468747|FG001|Overall Study|Withdrawal by Subject|6|||
146260535|NCT00312845|527468746|FG000|Overall Study|Disease Progression|56|||
146260536|NCT00312845|527468747|FG001|Overall Study|Disease Progression|77|||
146260537|NCT00312845|527468746|FG000|Overall Study|Lost to Follow-up|2|||
146260538|NCT00312845|527468747|FG001|Overall Study|Lost to Follow-up|0|||
146260539|NCT00312845|527468746|FG000|Overall Study|Other|6|||
146260540|NCT00312845|527468747|FG001|Overall Study|Other|5|||
146260541|NCT03512288|527468748|FG000|Overall Study|Adverse Event|1|||
146260542|NCT03512288|527468749|FG001|Overall Study|Adverse Event|0|||
146260543|NCT03512288|527468748|FG000|Overall Study|Lost to Follow-up|12|||
146260544|NCT03512288|527468749|FG001|Overall Study|Lost to Follow-up|15|||
146260545|NCT03512288|527468748|FG000|Overall Study|Physician Decision|0|||
146260546|NCT03512288|527468749|FG001|Overall Study|Physician Decision|2|||
146260547|NCT03512288|527468748|FG000|Overall Study|Protocol Violation|6|||
146260548|NCT03512288|527468749|FG001|Overall Study|Protocol Violation|4|||
146260549|NCT03512288|527468748|FG000|Overall Study|Medication error without associated adverse event|1|||
146260550|NCT03512288|527468749|FG001|Overall Study|Medication error without associated adverse event|0|||
146260551|NCT03512288|527468748|FG000|Overall Study|No longer met eligibility criteria|5|||
146260552|NCT03512288|527468749|FG001|Overall Study|No longer met eligibility criteria|2|||
146260553|NCT03512288|527468748|FG000|Overall Study|Withdrawal by parent/guardian|14|||
146260554|NCT03512288|527468749|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146260555|NCT03512288|527468748|FG000|Overall Study|Other|1|||
146260556|NCT03512288|527468749|FG001|Overall Study|Other|1|||
146260557|NCT03512288|527468748|FG000|Overall Study|Randomized but not treated|1|||
146260558|NCT03512288|527468749|FG001|Overall Study|Randomized but not treated|1|||
146260559|NCT01078584|527468750|FG000|Overall Study|Final Status Unknown|1073|||
146260560|NCT01078584|527468750|FG000|Overall Study|Lost to Follow-up|670|||
146260561|NCT01078584|527468750|FG000|Overall Study|Non-serious Adverse Event|577|||
146260562|NCT01078584|527468750|FG000|Overall Study|Withdrawal of Consent|244|||
146260563|NCT01078584|527468750|FG000|Overall Study|Physician Withdrew from Study|90|||
146260564|NCT01078584|527468750|FG000|Overall Study|Non-compliance|67|||
146260565|NCT01078584|527468750|FG000|Overall Study|Blood Pressure Controlled|49|||
146260566|NCT01078584|527468750|FG000|Overall Study|Physician Switched Medication|26|||
146260567|NCT01078584|527468750|FG000|Overall Study|Physician Discontinued Patient|12|||
146260568|NCT01078584|527468750|FG000|Overall Study|Lack of Efficacy|98|||
146260569|NCT01078584|527468750|FG000|Overall Study|Protocol Violation|75|||
146260570|NCT01078584|527468750|FG000|Overall Study|Serious Adverse Event|27|||
146260571|NCT01078584|527468750|FG000|Overall Study|Multiple Reasons|2|||
146260572|NCT01208870|527468751|FG000|Overall Study|Lost to Follow-up|2|||
146260573|NCT01208870|527468752|FG001|Overall Study|Lost to Follow-up|8|||
146260574|NCT01121185|527468753|FG000|Overall Study|Not infused|0|||
146260575|NCT01121185|527468754|FG001|Overall Study|Not infused|1|||
146260576|NCT01121185|527468753|FG000|Overall Study|Not transplanted|1|||
146260577|NCT01121185|527468754|FG001|Overall Study|Not transplanted|0|||
146260578|NCT00424177|527468755|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
146260579|NCT00424177|527468755|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
146260580|NCT00424177|527468755|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
146260581|NCT00424177|527468755|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
146260582|NCT00424177|527468755|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
146260583|NCT00424177|527468755|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
146260584|NCT00424177|527468755|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
146260585|NCT00424177|527468755|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
146260586|NCT00424177|527468755|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
146260587|NCT00424177|527468755|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
146114743|NCT00779467|526937123|FG003|Overall Study|technical issue|1|||
146114744|NCT00779467|526937120|FG000|Overall Study|unavailable research staff|0|||
146114745|NCT00779467|526937121|FG001|Overall Study|unavailable research staff|0|||
146114746|NCT00779467|526937122|FG002|Overall Study|unavailable research staff|0|||
146114747|NCT00779467|526937123|FG003|Overall Study|unavailable research staff|1|||
146114748|NCT04626297|526937124|FG000|Overall Study|Adverse Event|5|||
146114749|NCT04626297|526937125|FG001|Overall Study|Adverse Event|3|||
146114750|NCT04626297|526937124|FG000|Overall Study|Lost to Follow-up|7|||
146114751|NCT04626297|526937125|FG001|Overall Study|Lost to Follow-up|3|||
146114752|NCT04626297|526937124|FG000|Overall Study|Protocol Violation|5|||
146114753|NCT04626297|526937125|FG001|Overall Study|Protocol Violation|1|||
146114754|NCT04626297|526937124|FG000|Overall Study|Withdrawal by Subject|20|||
146114755|NCT04626297|526937125|FG001|Overall Study|Withdrawal by Subject|6|||
146114756|NCT04626297|526937124|FG000|Overall Study|Sponsor decision|2|||
146114757|NCT04626297|526937125|FG001|Overall Study|Sponsor decision|1|||
146114758|NCT04118166|526937126|FG000|Overall Study|Adverse Event|1|||
146114759|NCT02254486|526937127|FG000|Overall Study|Adverse Event|1|||
146114760|NCT02254486|526937128|FG001|Overall Study|Adverse Event|1|||
146114761|NCT02254486|526937127|FG000|Overall Study|Lack of Efficacy|1|||
146114762|NCT02254486|526937128|FG001|Overall Study|Lack of Efficacy|0|||
146114763|NCT02254486|526937127|FG000|Overall Study|Lost to Follow-up|2|||
146114764|NCT02254486|526937128|FG001|Overall Study|Lost to Follow-up|4|||
146114765|NCT02254486|526937127|FG000|Overall Study|Protocol Violation|1|||
146114766|NCT02254486|526937128|FG001|Overall Study|Protocol Violation|2|||
146114767|NCT02254486|526937127|FG000|Overall Study|Withdrawal by Subject|17|||
146114768|NCT02254486|526937128|FG001|Overall Study|Withdrawal by Subject|15|||
146114769|NCT02254486|526937127|FG000|Overall Study|GFR<60mL/min|16|||
146114770|NCT02254486|526937128|FG001|Overall Study|GFR<60mL/min|21|||
146114771|NCT02254486|526937127|FG000|Overall Study|Various|12|||
146114772|NCT02254486|526937128|FG001|Overall Study|Various|12|||
146114773|NCT01350414|526937135|FG000|Overall Study|Lost to Follow-up|13|||
146114774|NCT01350414|526937135|FG000|Overall Study|Withdrawal by Subject|4|||
146114775|NCT01350414|526937135|FG000|Overall Study|Physician Decision|2|||
146114776|NCT00865124|526937136|FG000|Overall Study|Physician Decision|2|||
146114777|NCT00865124|526937137|FG001|Overall Study|Physician Decision|1|||
146114778|NCT00865124|526937138|FG002|Overall Study|Physician Decision|0|||
146114779|NCT00865124|526937136|FG000|Overall Study|Withdrawn consent|2|||
146114780|NCT00865124|526937137|FG001|Overall Study|Withdrawn consent|0|||
146114781|NCT00865124|526937138|FG002|Overall Study|Withdrawn consent|0|||
146114782|NCT02743520|526937139|FG000|Overall Study|Withdrawal by Subject|1|||
146114783|NCT03247530|526937140|FG000|Overall Study|Withdrawal by caregiver|19|||
146114784|NCT03247530|526937141|FG001|Overall Study|Withdrawal by caregiver|8|||
146114785|NCT03247530|526937142|FG002|Overall Study|Withdrawal by caregiver|10|||
146114786|NCT03247530|526937140|FG000|Overall Study|Lost to Follow-up|3|||
146114787|NCT03247530|526937141|FG001|Overall Study|Lost to Follow-up|9|||
146114788|NCT03247530|526937142|FG002|Overall Study|Lost to Follow-up|6|||
146114789|NCT03247530|526937140|FG000|Overall Study|Adverse Event|2|||
146114790|NCT03247530|526937141|FG001|Overall Study|Adverse Event|5|||
146114791|NCT03247530|526937142|FG002|Overall Study|Adverse Event|2|||
146114792|NCT03247530|526937140|FG000|Overall Study|Failure to follow procedure|1|||
146114793|NCT03247530|526937141|FG001|Overall Study|Failure to follow procedure|1|||
146114794|NCT03247530|526937142|FG002|Overall Study|Failure to follow procedure|1|||
146114795|NCT03247530|526937140|FG000|Overall Study|Withdrawal by Subject|1|||
146114796|NCT03247530|526937141|FG001|Overall Study|Withdrawal by Subject|1|||
146114797|NCT03247530|526937142|FG002|Overall Study|Withdrawal by Subject|0|||
146114798|NCT03247530|526937140|FG000|Overall Study|Study medication misuse|0|||
146114799|NCT03247530|526937141|FG001|Overall Study|Study medication misuse|1|||
146114800|NCT03247530|526937142|FG002|Overall Study|Study medication misuse|0|||
146114801|NCT03247530|526937140|FG000|Overall Study|Other, multiple categories|1|||
146114802|NCT03247530|526937141|FG001|Overall Study|Other, multiple categories|3|||
146114803|NCT03247530|526937142|FG002|Overall Study|Other, multiple categories|1|||
146114804|NCT02551731|526937146|FG000|Overall Study|Withdrawal by Subject|2|||
146114805|NCT00010374|526937147|FG000|Overall Study|False positive phrenic nerve test|1|||
146114806|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
146114807|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
146114808|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
146114809|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
146114810|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
146114811|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
146114812|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
146114813|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
146114814|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Patient Request|1|||
146114815|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Patient Request|0|||
146114816|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
146114817|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
146114818|NCT04649060|526937148|FG000|Arm A/Arm B Treatment|Other|1|||
146114819|NCT04649060|526937149|FG001|Arm A/Arm B Treatment|Other|0|||
146114820|NCT04649060|526937148|FG000|Crossover (Arm B)|Adverse Event|0|||
146114821|NCT04649060|526937149|FG001|Crossover (Arm B)|Adverse Event|1|||
146114822|NCT04649060|526937148|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
146114823|NCT04649060|526937149|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
146114824|NCT02706691|526937150|FG000|Overall Study|Adverse Event|1|||
146114825|NCT03944954|526937151|FG000|Overall Study|Withdrawal by Subject|22|||
146114826|NCT03944954|526937152|FG001|Overall Study|Withdrawal by Subject|4|||
146114827|NCT03944954|526937151|FG000|Overall Study|Lost to Follow-up|18|||
146114828|NCT03944954|526937152|FG001|Overall Study|Lost to Follow-up|0|||
146114829|NCT03944954|526937151|FG000|Overall Study|Failed Medical Screening|7|||
146114830|NCT03944954|526937152|FG001|Overall Study|Failed Medical Screening|0|||
146114831|NCT02289417|526937156|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
146114832|NCT02289417|526937157|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114833|NCT02289417|526937158|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
146114834|NCT02289417|526937159|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114835|NCT02289417|526937160|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114836|NCT02289417|526937161|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114837|NCT02289417|526937162|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114838|NCT02289417|526937163|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114839|NCT02289417|526937164|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
146114840|NCT02289417|526937156|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
146114841|NCT02289417|526937157|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
146114842|NCT02289417|526937158|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
146114843|NCT02289417|526937159|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114844|NCT02289417|526937160|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114845|NCT02289417|526937161|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114846|NCT02289417|526937162|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114847|NCT02289417|526937163|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114848|NCT02289417|526937164|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
146114849|NCT02289417|526937156|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114850|NCT02289417|526937157|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
146114851|NCT02289417|526937158|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114852|NCT02289417|526937159|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114853|NCT02289417|526937160|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114854|NCT02289417|526937161|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114855|NCT02289417|526937162|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114856|NCT02289417|526937163|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114857|NCT02289417|526937164|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
146114858|NCT02289417|526937156|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
146114859|NCT02289417|526937157|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114860|NCT02289417|526937158|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114861|NCT02289417|526937159|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114862|NCT02289417|526937160|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114863|NCT02289417|526937161|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114864|NCT02289417|526937162|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114865|NCT02289417|526937163|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114866|NCT02289417|526937164|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
146114867|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146114868|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
146260588|NCT00316589|527468758|FG000|Overall Study|Withdrawal by Subject|0|||
146260589|NCT00316589|527468759|FG001|Overall Study|Withdrawal by Subject|5|||
146260590|NCT00316589|527468760|FG002|Overall Study|Withdrawal by Subject|0|||
146260591|NCT00316589|527468761|FG003|Overall Study|Withdrawal by Subject|1|||
146260592|NCT00316589|527468758|FG000|Overall Study|Subject unwilling/unable to comply|0|||
146260593|NCT00316589|527468759|FG001|Overall Study|Subject unwilling/unable to comply|6|||
146260594|NCT00316589|527468760|FG002|Overall Study|Subject unwilling/unable to comply|0|||
146260595|NCT00316589|527468761|FG003|Overall Study|Subject unwilling/unable to comply|2|||
146260596|NCT00316589|527468758|FG000|Overall Study|Adverse Event|1|||
146260597|NCT00316589|527468759|FG001|Overall Study|Adverse Event|0|||
146260598|NCT00316589|527468760|FG002|Overall Study|Adverse Event|0|||
146260599|NCT00316589|527468761|FG003|Overall Study|Adverse Event|1|||
146260600|NCT00316589|527468758|FG000|Overall Study|Physician Decision|0|||
146114869|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
146114870|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
146114871|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
146114872|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
146260601|NCT00316589|527468759|FG001|Overall Study|Physician Decision|1|||
146260602|NCT00316589|527468760|FG002|Overall Study|Physician Decision|0|||
146260603|NCT00316589|527468761|FG003|Overall Study|Physician Decision|0|||
146260604|NCT00316589|527468758|FG000|Overall Study|Other reason|0|||
146260605|NCT00316589|527468759|FG001|Overall Study|Other reason|12|||
146114873|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146114874|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146114875|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
146114876|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114877|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114878|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
146114879|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114880|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114881|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114882|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114883|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114884|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
146114885|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146114886|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
146114887|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
146114888|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
146114889|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
146114890|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
146114891|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146114892|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146114893|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
146114894|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114895|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114896|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146114897|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114898|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146114899|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
146114900|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114901|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114902|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
146114903|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114904|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114905|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114906|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114907|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114908|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114909|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
146114910|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114911|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
146114912|NCT02289417|526937156|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114913|NCT02289417|526937157|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114914|NCT02289417|526937158|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114915|NCT02289417|526937159|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
146114916|NCT02289417|526937160|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114917|NCT02289417|526937161|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114918|NCT02289417|526937162|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
146114919|NCT02289417|526937163|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114920|NCT02289417|526937164|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
146114921|NCT02289417|526937156|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
146114922|NCT02289417|526937157|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
146114923|NCT02289417|526937158|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
146114924|NCT02289417|526937159|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
146114925|NCT02289417|526937160|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
146114926|NCT02289417|526937161|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
146114927|NCT02289417|526937162|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
146114928|NCT02289417|526937163|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
146114929|NCT02289417|526937164|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
146114930|NCT02289417|526937156|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114931|NCT02289417|526937157|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114932|NCT02289417|526937158|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114933|NCT02289417|526937159|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114934|NCT02289417|526937160|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114935|NCT02289417|526937161|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114936|NCT02289417|526937162|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
146114937|NCT02289417|526937163|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
146114938|NCT02289417|526937164|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
146114939|NCT02289417|526937156|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114940|NCT02289417|526937157|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114941|NCT02289417|526937158|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114942|NCT02289417|526937159|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114943|NCT02289417|526937160|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114944|NCT02289417|526937161|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114945|NCT02289417|526937162|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
146114946|NCT02289417|526937163|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
146114947|NCT02289417|526937164|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
146114948|NCT02289417|526937156|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114949|NCT02289417|526937157|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114950|NCT02289417|526937158|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114951|NCT02289417|526937159|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114952|NCT02289417|526937160|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114953|NCT02289417|526937161|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114954|NCT02289417|526937162|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114955|NCT02289417|526937163|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
146114956|NCT02289417|526937164|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
146114957|NCT02725710|526937165|FG000|Overall Study|Lost to Follow-up|1|||
146114958|NCT02725710|526937166|FG001|Overall Study|Lost to Follow-up|0|||
146114959|NCT04786990|526937167|FG000|Overall Study|Withdrawal by Subject|1|||
146114960|NCT04786990|526937167|FG000|Overall Study|Adverse Event|1|||
146114961|NCT04786990|526937167|FG000|Overall Study|Lost to Follow-up|1|||
146114962|NCT04786990|526937167|FG000|Overall Study|Noncompliance|1|||
146114963|NCT04786990|526937167|FG000|Overall Study|Unable to complete site visits|1|||
146114964|NCT04786990|526937167|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146114965|NCT01782222|526937168|FG000|Overall Study|Adverse Event|4|||
146114966|NCT01782222|526937169|FG001|Overall Study|Adverse Event|5|||
146114967|NCT01782222|526937170|FG002|Overall Study|Adverse Event|3|||
146114968|NCT01782222|526937168|FG000|Overall Study|Lack of Efficacy|2|||
146114969|NCT01782222|526937169|FG001|Overall Study|Lack of Efficacy|1|||
146114970|NCT01782222|526937170|FG002|Overall Study|Lack of Efficacy|0|||
146114971|NCT01782222|526937168|FG000|Overall Study|Protocol Violation|1|||
146114972|NCT01782222|526937169|FG001|Overall Study|Protocol Violation|0|||
146114973|NCT01782222|526937170|FG002|Overall Study|Protocol Violation|0|||
146114974|NCT01782222|526937168|FG000|Overall Study|Withdrawal by Subject|1|||
146114975|NCT01782222|526937169|FG001|Overall Study|Withdrawal by Subject|4|||
146114976|NCT01782222|526937170|FG002|Overall Study|Withdrawal by Subject|1|||
146114977|NCT01782222|526937168|FG000|Overall Study|Moved to other state|0|||
146114978|NCT01782222|526937169|FG001|Overall Study|Moved to other state|1|||
146114979|NCT01782222|526937170|FG002|Overall Study|Moved to other state|0|||
146114980|NCT01858389|526937175|FG000|Overall Study|Death|1|||
146114981|NCT01858389|526937176|FG001|Overall Study|Death|3|||
146114982|NCT01858389|526937175|FG000|Overall Study|Study terminated by sponsor|0|||
146114983|NCT01858389|526937176|FG001|Overall Study|Study terminated by sponsor|2|||
146114984|NCT01858389|526937175|FG000|Overall Study|Withdrawal by Subject|0|||
146114985|NCT01858389|526937176|FG001|Overall Study|Withdrawal by Subject|1|||
146114986|NCT01858389|526937175|FG000|Overall Study|Progressive disease|10|||
146114987|NCT01858389|526937176|FG001|Overall Study|Progressive disease|11|||
146114988|NCT01858389|526937175|FG000|Overall Study|Other|2|||
146114989|NCT01858389|526937176|FG001|Overall Study|Other|4|||
146114990|NCT01858389|526937175|FG000|Overall Study|Adverse Event|3|||
146114991|NCT01858389|526937176|FG001|Overall Study|Adverse Event|1|||
146114992|NCT01858389|526937175|FG000|Overall Study|Did not receive treatment|0|||
146114993|NCT01858389|526937176|FG001|Overall Study|Did not receive treatment|3|||
146114994|NCT03978520|526937177|FG000|Overall Study|Adverse Event|2|||
146114995|NCT03978520|526937178|FG001|Overall Study|Adverse Event|5|||
146114996|NCT03978520|526937179|FG002|Overall Study|Adverse Event|3|||
146114997|NCT03978520|526937180|FG003|Overall Study|Adverse Event|5|||
146114998|NCT03978520|526937181|FG004|Overall Study|Adverse Event|6|||
146114999|NCT03978520|526937177|FG000|Overall Study|Withdrawal by Subject|10|||
146115000|NCT03978520|526937178|FG001|Overall Study|Withdrawal by Subject|4|||
146115001|NCT03978520|526937179|FG002|Overall Study|Withdrawal by Subject|5|||
146115002|NCT03978520|526937180|FG003|Overall Study|Withdrawal by Subject|6|||
146115003|NCT03978520|526937181|FG004|Overall Study|Withdrawal by Subject|5|||
146115004|NCT03978520|526937177|FG000|Overall Study|Lost to Follow-up|2|||
146115005|NCT03978520|526937178|FG001|Overall Study|Lost to Follow-up|2|||
146115006|NCT03978520|526937179|FG002|Overall Study|Lost to Follow-up|2|||
146115007|NCT03978520|526937180|FG003|Overall Study|Lost to Follow-up|0|||
146115008|NCT03978520|526937181|FG004|Overall Study|Lost to Follow-up|1|||
146115009|NCT03978520|526937177|FG000|Overall Study|COVID-19 infection|0|||
146115010|NCT03978520|526937178|FG001|Overall Study|COVID-19 infection|1|||
146115011|NCT03978520|526937179|FG002|Overall Study|COVID-19 infection|0|||
146115012|NCT03978520|526937180|FG003|Overall Study|COVID-19 infection|0|||
146115013|NCT03978520|526937181|FG004|Overall Study|COVID-19 infection|0|||
146115014|NCT03978520|526937177|FG000|Overall Study|Other, not specified|9|||
146115015|NCT03978520|526937178|FG001|Overall Study|Other, not specified|4|||
146115016|NCT03978520|526937179|FG002|Overall Study|Other, not specified|1|||
146115017|NCT03978520|526937180|FG003|Overall Study|Other, not specified|1|||
146115018|NCT03978520|526937181|FG004|Overall Study|Other, not specified|2|||
146115019|NCT03978520|526937177|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
146115020|NCT03978520|526937178|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
146115021|NCT03978520|526937179|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
146115022|NCT03978520|526937180|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
146115023|NCT03978520|526937181|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
146115024|NCT00687323|526937186|FG000|Overall Study|Death|25|||
146115025|NCT00687323|526937186|FG000|Overall Study|Withdrawal by Subject|1|||
146115026|NCT00687323|526937186|FG000|Overall Study|Excluded from efficacy evaluations|6|||
146115027|NCT00687323|526937186|FG000|Overall Study|Screen failure|148|||
146115028|NCT02547454|526937196|FG000|Overall Study|Due to hemodialysis|53|||
146115029|NCT02547454|526937196|FG000|Overall Study|Due to transplantation|1|||
146115030|NCT02547454|526937196|FG000|Overall Study|Due to no further need to treat|4|||
146115031|NCT02547454|526937196|FG000|Overall Study|Death|38|||
146115032|NCT02547454|526937196|FG000|Overall Study|Lost to Follow-up|26|||
146115033|NCT02547454|526937196|FG000|Overall Study|Other|39|||
146115034|NCT02547454|526937196|FG000|Overall Study|No data|11|||
146115035|NCT00580606|526937197|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
146115036|NCT00580606|526937198|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
146115037|NCT00580606|526937197|FG000|Open Label (OL)|Withdrawal by Subject|4|||
146115038|NCT00580606|526937198|FG001|Open Label (OL)|Withdrawal by Subject|6|||
146115039|NCT00580606|526937197|FG000|Open Label (OL)|Dosing Symptoms|0|||
146115040|NCT00580606|526937198|FG001|Open Label (OL)|Dosing Symptoms|1|||
146115041|NCT00580606|526937197|FG000|Open Label (OL)|Lost to Follow-up|0|||
146115042|NCT00580606|526937198|FG001|Open Label (OL)|Lost to Follow-up|1|||
146115043|NCT00580606|526937197|FG000|Open Label (OL)|Pregnancy|0|||
146115044|NCT00580606|526937198|FG001|Open Label (OL)|Pregnancy|1|||
146115045|NCT00580606|526937197|FG000|Open Label (OL)|Non-compliance|2|||
146115046|NCT00580606|526937198|FG001|Open Label (OL)|Non-compliance|0|||
146115047|NCT00580606|526937197|FG000|Open Label (OL)|Physician Decision|1|||
146115048|NCT00580606|526937198|FG001|Open Label (OL)|Physician Decision|1|||
146115049|NCT00580606|526937197|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
146115050|NCT00580606|526937198|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
146115051|NCT03655691|526937200|FG000|Overall Study|Adverse Event|0|||
146115052|NCT03655691|526937201|FG001|Overall Study|Adverse Event|0|||
146115053|NCT03655691|526937202|FG002|Overall Study|Adverse Event|1|||
146115054|NCT03655691|526937200|FG000|Overall Study|Lost to Follow-up|1|||
146115055|NCT03655691|526937201|FG001|Overall Study|Lost to Follow-up|1|||
146115056|NCT03655691|526937202|FG002|Overall Study|Lost to Follow-up|2|||
146115057|NCT03655691|526937200|FG000|Overall Study|Protocol Violation|0|||
146115058|NCT03655691|526937201|FG001|Overall Study|Protocol Violation|1|||
146115059|NCT03655691|526937202|FG002|Overall Study|Protocol Violation|0|||
146115060|NCT03655691|526937200|FG000|Overall Study|Withdrawal by Subject|1|||
146115061|NCT03655691|526937201|FG001|Overall Study|Withdrawal by Subject|1|||
146115062|NCT03655691|526937202|FG002|Overall Study|Withdrawal by Subject|0|||
146115063|NCT03694821|526937205|FG000|Overall Study|Study terminated|4|||
146115064|NCT03694821|526937206|FG001|Overall Study|Study terminated|8|||
146115065|NCT03694821|526937207|FG002|Overall Study|Study terminated|4|||
146115066|NCT04102020|526937208|FG000|Overall Study|Adverse Event|1|||
146115067|NCT04102020|526937209|FG001|Overall Study|Adverse Event|0|||
146115068|NCT04102020|526937210|FG002|Overall Study|Adverse Event|0|||
146115069|NCT04102020|526937211|FG003|Overall Study|Adverse Event|1|||
146115070|NCT04102020|526937212|FG004|Overall Study|Adverse Event|0|||
146115071|NCT04102020|526937208|FG000|Overall Study|Withdrawal by Subject|0|||
146115072|NCT04102020|526937209|FG001|Overall Study|Withdrawal by Subject|1|||
146115073|NCT04102020|526937210|FG002|Overall Study|Withdrawal by Subject|1|||
146115074|NCT04102020|526937211|FG003|Overall Study|Withdrawal by Subject|1|||
146115075|NCT04102020|526937212|FG004|Overall Study|Withdrawal by Subject|1|||
146115076|NCT04102020|526937208|FG000|Overall Study|Death|1|||
146115077|NCT04102020|526937209|FG001|Overall Study|Death|4|||
146115078|NCT04102020|526937210|FG002|Overall Study|Death|1|||
146115079|NCT04102020|526937211|FG003|Overall Study|Death|1|||
146115080|NCT04102020|526937212|FG004|Overall Study|Death|0|||
146115081|NCT04102020|526937208|FG000|Overall Study|Physician Decision|1|||
146115082|NCT04102020|526937209|FG001|Overall Study|Physician Decision|2|||
146115083|NCT04102020|526937210|FG002|Overall Study|Physician Decision|2|||
146115084|NCT04102020|526937211|FG003|Overall Study|Physician Decision|0|||
146260606|NCT00316589|527468760|FG002|Overall Study|Other reason|1|||
146260607|NCT00316589|527468761|FG003|Overall Study|Other reason|1|||
146115085|NCT04102020|526937212|FG004|Overall Study|Physician Decision|1|||
146115086|NCT04102020|526937208|FG000|Overall Study|COVID-19 Infection|1|||
146115087|NCT04102020|526937209|FG001|Overall Study|COVID-19 Infection|0|||
146115088|NCT04102020|526937210|FG002|Overall Study|COVID-19 Infection|0|||
146115089|NCT04102020|526937211|FG003|Overall Study|COVID-19 Infection|0|||
146115090|NCT04102020|526937212|FG004|Overall Study|COVID-19 Infection|0|||
146115091|NCT04102020|526937208|FG000|Overall Study|Not disclosed|5|||
146115092|NCT04102020|526937209|FG001|Overall Study|Not disclosed|3|||
146115093|NCT04102020|526937210|FG002|Overall Study|Not disclosed|8|||
146115094|NCT04102020|526937211|FG003|Overall Study|Not disclosed|0|||
146115095|NCT04102020|526937212|FG004|Overall Study|Not disclosed|1|||
146115096|NCT04102020|526937208|FG000|Overall Study|MIssing|1|||
146115097|NCT04102020|526937209|FG001|Overall Study|MIssing|0|||
146115098|NCT04102020|526937210|FG002|Overall Study|MIssing|1|||
146115099|NCT04102020|526937211|FG003|Overall Study|MIssing|1|||
146115100|NCT04102020|526937212|FG004|Overall Study|MIssing|1|||
146115101|NCT04102020|526937208|FG000|Overall Study|Continuing in ongoing study|13|||
146115102|NCT04102020|526937209|FG001|Overall Study|Continuing in ongoing study|13|||
146115103|NCT04102020|526937210|FG002|Overall Study|Continuing in ongoing study|7|||
146115104|NCT04102020|526937211|FG003|Overall Study|Continuing in ongoing study|26|||
146115105|NCT04102020|526937212|FG004|Overall Study|Continuing in ongoing study|12|||
146115106|NCT05109442|526937213|FG000|Overall Study|Withdrawal by Subject|0|||
146115107|NCT05109442|526937214|FG001|Overall Study|Withdrawal by Subject|0|||
146115108|NCT05109442|526937215|FG002|Overall Study|Withdrawal by Subject|1|||
146115109|NCT05109442|526937216|FG003|Overall Study|Withdrawal by Subject|0|||
146115110|NCT05109442|526937217|FG004|Overall Study|Withdrawal by Subject|0|||
146115111|NCT05109442|526937218|FG005|Overall Study|Withdrawal by Subject|0|||
146115112|NCT05109442|526937213|FG000|Overall Study|Adverse Event|0|||
146115113|NCT05109442|526937214|FG001|Overall Study|Adverse Event|1|||
146115114|NCT05109442|526937215|FG002|Overall Study|Adverse Event|5|||
146115115|NCT05109442|526937216|FG003|Overall Study|Adverse Event|0|||
146115116|NCT05109442|526937217|FG004|Overall Study|Adverse Event|0|||
146115117|NCT05109442|526937218|FG005|Overall Study|Adverse Event|2|||
146115118|NCT05109442|526937213|FG000|Overall Study|Death|0|||
146115119|NCT05109442|526937214|FG001|Overall Study|Death|0|||
146115120|NCT05109442|526937215|FG002|Overall Study|Death|4|||
146115121|NCT05109442|526937216|FG003|Overall Study|Death|0|||
146115122|NCT05109442|526937217|FG004|Overall Study|Death|0|||
146115123|NCT05109442|526937218|FG005|Overall Study|Death|1|||
146115124|NCT05109442|526937213|FG000|Overall Study|Physician Decision|1|||
146115125|NCT05109442|526937214|FG001|Overall Study|Physician Decision|0|||
146115126|NCT05109442|526937215|FG002|Overall Study|Physician Decision|1|||
146115127|NCT05109442|526937216|FG003|Overall Study|Physician Decision|0|||
146115128|NCT05109442|526937217|FG004|Overall Study|Physician Decision|0|||
146115129|NCT05109442|526937218|FG005|Overall Study|Physician Decision|2|||
146115130|NCT05109442|526937213|FG000|Overall Study|Other than listed|0|||
146115131|NCT05109442|526937214|FG001|Overall Study|Other than listed|0|||
146115132|NCT05109442|526937215|FG002|Overall Study|Other than listed|9|||
146115133|NCT05109442|526937216|FG003|Overall Study|Other than listed|2|||
146115134|NCT05109442|526937217|FG004|Overall Study|Other than listed|0|||
146115135|NCT05109442|526937218|FG005|Overall Study|Other than listed|8|||
146115136|NCT05109442|526937213|FG000|Overall Study|Lack of Efficacy|3|||
146115137|NCT05109442|526937214|FG001|Overall Study|Lack of Efficacy|5|||
146115138|NCT05109442|526937215|FG002|Overall Study|Lack of Efficacy|29|||
146115139|NCT05109442|526937216|FG003|Overall Study|Lack of Efficacy|10|||
146115140|NCT05109442|526937217|FG004|Overall Study|Lack of Efficacy|11|||
146115141|NCT05109442|526937218|FG005|Overall Study|Lack of Efficacy|17|||
146115142|NCT03918447|526937223|FG000|Overall Study|Death|1|||
146115143|NCT03918447|526937224|FG001|Overall Study|Death|0|||
146115144|NCT03918447|526937223|FG000|Overall Study|Lost to Follow-up|13|||
146115145|NCT03918447|526937224|FG001|Overall Study|Lost to Follow-up|6|||
146115146|NCT03918447|526937223|FG000|Overall Study|Withdrawal by Subject|19|||
146115147|NCT03918447|526937224|FG001|Overall Study|Withdrawal by Subject|17|||
146115148|NCT03918447|526937223|FG000|Overall Study|Study Terminated by Sponsor|195|||
146115149|NCT03918447|526937224|FG001|Overall Study|Study Terminated by Sponsor|197|||
146115150|NCT03918447|526937223|FG000|Overall Study|Reason not Specified|0|||
146115151|NCT03918447|526937224|FG001|Overall Study|Reason not Specified|1|||
146115152|NCT03278613|526937225|FG000|Overall Study|Lost to Follow-up|3|||
146115153|NCT03278613|526937226|FG001|Overall Study|Lost to Follow-up|1|||
146115154|NCT01405456|526937227|FG000|Overall Study|Lost to Follow-up|2|||
146115155|NCT01405456|526937228|FG001|Overall Study|Lost to Follow-up|1|||
146115156|NCT01405456|526937227|FG000|Overall Study|Physician Decision|1|||
146115157|NCT01405456|526937228|FG001|Overall Study|Physician Decision|0|||
146115158|NCT05475236|526937230|FG000|Overall Study|Withdrawal by Subject|0|||
146115159|NCT05475236|526937231|FG001|Overall Study|Withdrawal by Subject|1|||
146115160|NCT00477971|526937232|FG000|Overall Study|Disease progression|6|||
146115161|NCT00477971|526937233|FG001|Overall Study|Disease progression|0|||
146115162|NCT00477971|526937232|FG000|Overall Study|Withdrawal by Subject|3|||
146115163|NCT00477971|526937233|FG001|Overall Study|Withdrawal by Subject|1|||
146115164|NCT00477971|526937232|FG000|Overall Study|Adverse Event|3|||
146115165|NCT00477971|526937233|FG001|Overall Study|Adverse Event|0|||
146115166|NCT00477971|526937232|FG000|Overall Study|Death|2|||
146115167|NCT00477971|526937233|FG001|Overall Study|Death|4|||
146115168|NCT00477971|526937232|FG000|Overall Study|Alternative treatment|3|||
146260608|NCT01283971|527468764|FG000|Overall Study|Adverse Event|3|||
146260609|NCT01283971|527468765|FG001|Overall Study|Adverse Event|5|||
146115169|NCT00477971|526937233|FG001|Overall Study|Alternative treatment|1|||
146115170|NCT05355805|526937234|FG000|Overall Study|Lost to Follow-up|6|||
146115171|NCT05355805|526937235|FG001|Overall Study|Lost to Follow-up|11|||
146115172|NCT05355805|526937236|FG002|Overall Study|Lost to Follow-up|10|||
146115173|NCT05355805|526937237|FG003|Overall Study|Lost to Follow-up|6|||
146115174|NCT05355805|526937234|FG000|Overall Study|Decision by Sponsor|0|||
146115175|NCT05355805|526937235|FG001|Overall Study|Decision by Sponsor|0|||
146115176|NCT05355805|526937236|FG002|Overall Study|Decision by Sponsor|1|||
146115177|NCT05355805|526937237|FG003|Overall Study|Decision by Sponsor|0|||
146115178|NCT05355805|526937234|FG000|Overall Study|Withdrawal by Subject|7|||
146115179|NCT05355805|526937235|FG001|Overall Study|Withdrawal by Subject|14|||
146115180|NCT05355805|526937236|FG002|Overall Study|Withdrawal by Subject|15|||
146115181|NCT05355805|526937237|FG003|Overall Study|Withdrawal by Subject|13|||
146115182|NCT05353985|526937238|FG000|Overall Study|Adverse Event|5|||
146115183|NCT05353985|526937239|FG001|Overall Study|Adverse Event|7|||
146115184|NCT05353985|526937238|FG000|Overall Study|Lost to Follow-up|1|||
146115185|NCT05353985|526937239|FG001|Overall Study|Lost to Follow-up|1|||
146115186|NCT05353985|526937238|FG000|Overall Study|Protocol Violation|1|||
146115187|NCT05353985|526937239|FG001|Overall Study|Protocol Violation|0|||
146115188|NCT05353985|526937238|FG000|Overall Study|Withdrawal by Subject|13|||
146115189|NCT05353985|526937239|FG001|Overall Study|Withdrawal by Subject|17|||
146115190|NCT05353985|526937238|FG000|Overall Study|Reason Not Specified|1|||
146115191|NCT05353985|526937239|FG001|Overall Study|Reason Not Specified|0|||
146115192|NCT05353985|526937238|FG000|Overall Study|Randomized in Error & Not Treated|0|||
146115193|NCT05353985|526937239|FG001|Overall Study|Randomized in Error & Not Treated|1|||
146168162|NCT02496767|527128087|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168163|NCT02496767|527128088|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168164|NCT02496767|527128089|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168165|NCT02496767|527128090|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168166|NCT02496767|527128091|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168167|NCT02496767|527128092|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
146168168|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146168169|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
146168170|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
146168171|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
146168172|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
146168173|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146168174|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146168175|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146168176|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146168177|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
146168178|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
146168179|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
146168180|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
146168181|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146168182|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146168183|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
146168184|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
146168185|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
146168186|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
146168187|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
146168188|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
146168189|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
146168190|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
146168191|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
146168192|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
146168193|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
146168194|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
146168195|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
146168196|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
146168197|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
146168198|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
146260610|NCT01283971|527468764|FG000|Overall Study|Insufficient therapeutic responses|3|||
146260611|NCT01283971|527468765|FG001|Overall Study|Insufficient therapeutic responses|3|||
146260612|NCT01283971|527468764|FG000|Overall Study|Protocol Violation|5|||
146260613|NCT01283971|527468765|FG001|Overall Study|Protocol Violation|1|||
146168199|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
146168200|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146168201|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
146168202|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
146168203|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
146168204|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
146260614|NCT01283971|527468764|FG000|Overall Study|Refused treatment|3|||
146260615|NCT01283971|527468765|FG001|Overall Study|Refused treatment|1|||
146260616|NCT01283971|527468764|FG000|Overall Study|Failure to return|0|||
146115194|NCT04221009|526938690|FG000|Overall Study|Withdrawal by Subject|4|||
146115195|NCT00482612|526938693|FG000|In-treatment Period|No study medication administered|0|||
146115196|NCT00482612|526938694|FG001|In-treatment Period|No study medication administered|0|||
146115197|NCT00482612|526938695|FG002|In-treatment Period|No study medication administered|1|||
146115198|NCT00482612|526938696|FG003|In-treatment Period|No study medication administered|0|||
146115199|NCT00482612|526938693|FG000|Follow-up Period|Other|4|||
146115200|NCT00482612|526938694|FG001|Follow-up Period|Other|2|||
146115201|NCT00482612|526938695|FG002|Follow-up Period|Other|1|||
146115202|NCT00482612|526938696|FG003|Follow-up Period|Other|2|||
146115203|NCT00482612|526938693|FG000|Follow-up Period|Lack of compliance|0|||
146115204|NCT00482612|526938694|FG001|Follow-up Period|Lack of compliance|0|||
146115205|NCT00482612|526938695|FG002|Follow-up Period|Lack of compliance|1|||
146115206|NCT00482612|526938696|FG003|Follow-up Period|Lack of compliance|0|||
146115207|NCT00482612|526938693|FG000|Follow-up Period|Lost to Follow-up|0|||
146115208|NCT00482612|526938694|FG001|Follow-up Period|Lost to Follow-up|4|||
146115209|NCT00482612|526938695|FG002|Follow-up Period|Lost to Follow-up|2|||
146115210|NCT00482612|526938696|FG003|Follow-up Period|Lost to Follow-up|1|||
146115211|NCT00482612|526938693|FG000|Follow-up Period|Adverse Event|4|||
146115212|NCT00482612|526938694|FG001|Follow-up Period|Adverse Event|7|||
146115213|NCT00482612|526938695|FG002|Follow-up Period|Adverse Event|9|||
146115214|NCT00482612|526938696|FG003|Follow-up Period|Adverse Event|0|||
146115215|NCT00482612|526938693|FG000|Follow-up Period|Lack of Efficacy|2|||
146115216|NCT00482612|526938694|FG001|Follow-up Period|Lack of Efficacy|0|||
146115217|NCT00482612|526938695|FG002|Follow-up Period|Lack of Efficacy|1|||
146115218|NCT00482612|526938696|FG003|Follow-up Period|Lack of Efficacy|0|||
146115219|NCT00482612|526938693|FG000|Follow-up Period|Withdrawal by Subject|3|||
146115220|NCT00482612|526938694|FG001|Follow-up Period|Withdrawal by Subject|5|||
146115221|NCT00482612|526938695|FG002|Follow-up Period|Withdrawal by Subject|7|||
146115222|NCT00482612|526938696|FG003|Follow-up Period|Withdrawal by Subject|2|||
146115223|NCT00482612|526938693|FG000|Follow-up Period|Reasons not related to trial|1|||
146115224|NCT00482612|526938694|FG001|Follow-up Period|Reasons not related to trial|0|||
146115225|NCT00482612|526938695|FG002|Follow-up Period|Reasons not related to trial|1|||
146115226|NCT00482612|526938696|FG003|Follow-up Period|Reasons not related to trial|3|||
146115227|NCT00464087|526938699|FG000|Overall Study|No PCI per inclusion criteria|0|||
146115228|NCT00464087|526938700|FG001|Overall Study|No PCI per inclusion criteria|0|||
146115229|NCT00464087|526938701|FG002|Overall Study|No PCI per inclusion criteria|29|||
146115230|NCT01224431|526938703|FG000|Overall Study|not randomized|0|||
146115231|NCT01224431|526938704|FG001|Overall Study|not randomized|4|||
146115232|NCT01224431|526938703|FG000|Overall Study|no video record|0|||
146115233|NCT01224431|526938704|FG001|Overall Study|no video record|1|||
146115234|NCT02057406|526938705|FG000|Overall Study|Physician Decision|0|||
146115235|NCT02057406|526938706|FG001|Overall Study|Physician Decision|0|||
146115236|NCT02057406|526938707|FG002|Overall Study|Physician Decision|2|||
146115237|NCT02057406|526938705|FG000|Overall Study|Withdrawal by Subject|0|||
146115238|NCT02057406|526938706|FG001|Overall Study|Withdrawal by Subject|2|||
146115239|NCT02057406|526938707|FG002|Overall Study|Withdrawal by Subject|0|||
146115240|NCT02057406|526938705|FG000|Overall Study|Lost to Follow-up|0|||
146115241|NCT02057406|526938706|FG001|Overall Study|Lost to Follow-up|0|||
146115242|NCT02057406|526938707|FG002|Overall Study|Lost to Follow-up|1|||
146115243|NCT02057406|526938705|FG000|Overall Study|Death|1|||
146115244|NCT02057406|526938706|FG001|Overall Study|Death|0|||
146115245|NCT02057406|526938707|FG002|Overall Study|Death|0|||
146115246|NCT02057406|526938705|FG000|Overall Study|Protocol Violation|0|||
146115247|NCT02057406|526938706|FG001|Overall Study|Protocol Violation|1|||
146115248|NCT02057406|526938707|FG002|Overall Study|Protocol Violation|0|||
146115249|NCT02057406|526938705|FG000|Overall Study|Patient transportation issues|0|||
146115250|NCT02057406|526938706|FG001|Overall Study|Patient transportation issues|0|||
146115251|NCT02057406|526938707|FG002|Overall Study|Patient transportation issues|1|||
146115252|NCT03654651|526938709|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
146260617|NCT01283971|527468765|FG001|Overall Study|Failure to return|1|||
146260618|NCT01283971|527468764|FG000|Overall Study|Administrative reasons|1|||
146115253|NCT03654651|526938710|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
146115254|NCT01401283|526938711|FG000|Overall Study|surgery cancelled|5|||
146115255|NCT01401283|526938712|FG001|Overall Study|surgery cancelled|8|||
146115256|NCT01401283|526938711|FG000|Overall Study|preoperative arrhythmia|5|||
146115257|NCT01401283|526938712|FG001|Overall Study|preoperative arrhythmia|0|||
146115258|NCT01401283|526938711|FG000|Overall Study|no central venous access|0|||
146115259|NCT01401283|526938712|FG001|Overall Study|no central venous access|1|||
146115260|NCT01401283|526938711|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
146115261|NCT01401283|526938712|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
146115262|NCT02433483|526938713|FG000|Overall Study|Unacceptable toxicity|1|||
146115263|NCT02433483|526938713|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
146115264|NCT02904512|526938715|FG000|Overall Study|Withdrawal by Subject|1|||
146115265|NCT02904512|526938716|FG001|Overall Study|Withdrawal by Subject|0|||
146115266|NCT02904512|526938715|FG000|Overall Study|Transferred to ICU|1|||
146115267|NCT02904512|526938716|FG001|Overall Study|Transferred to ICU|0|||
146115268|NCT02904512|526938715|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
146115269|NCT02904512|526938716|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
146115270|NCT01963403|526938721|FG000|Overall Study|Lost to Follow-up|2|||
146115271|NCT01963403|526938722|FG001|Overall Study|Lost to Follow-up|3|||
146115272|NCT01963403|526938721|FG000|Overall Study|Implant removal|0|||
146115273|NCT01963403|526938722|FG001|Overall Study|Implant removal|1|||
146115274|NCT00549302|526938727|FG000|Double-Blind|Death|2|||
146115275|NCT00549302|526938728|FG001|Double-Blind|Death|9|||
146115276|NCT00549302|526938729|FG002|Double-Blind|Death|0|||
146115277|NCT00549302|526938727|FG000|Double-Blind|Adverse Event|3|||
146115278|NCT00549302|526938728|FG001|Double-Blind|Adverse Event|16|||
146115279|NCT00549302|526938729|FG002|Double-Blind|Adverse Event|0|||
146115280|NCT00549302|526938727|FG000|Double-Blind|Withdrawal by Subject|3|||
146115281|NCT00549302|526938728|FG001|Double-Blind|Withdrawal by Subject|8|||
146115282|NCT00549302|526938729|FG002|Double-Blind|Withdrawal by Subject|0|||
146115283|NCT00549302|526938727|FG000|Double-Blind|Investigator Decision|1|||
146115284|NCT00549302|526938728|FG001|Double-Blind|Investigator Decision|5|||
146115285|NCT00549302|526938729|FG002|Double-Blind|Investigator Decision|0|||
146115286|NCT00549302|526938727|FG000|Double-Blind|Sponsor Decision|0|||
146115287|NCT00549302|526938728|FG001|Double-Blind|Sponsor Decision|1|||
146115288|NCT00549302|526938729|FG002|Double-Blind|Sponsor Decision|0|||
146115289|NCT00549302|526938727|FG000|Double-Blind|Lost to Follow-up|1|||
146115290|NCT00549302|526938728|FG001|Double-Blind|Lost to Follow-up|2|||
146115291|NCT00549302|526938729|FG002|Double-Blind|Lost to Follow-up|0|||
146115292|NCT00549302|526938727|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
146115293|NCT00549302|526938728|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
146115294|NCT00549302|526938729|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
146115295|NCT00549302|526938727|FG000|Double-Blind|New condition or starts new therapy|0|||
146115296|NCT00549302|526938728|FG001|Double-Blind|New condition or starts new therapy|2|||
146115297|NCT00549302|526938729|FG002|Double-Blind|New condition or starts new therapy|0|||
146115298|NCT00549302|526938727|FG000|Open-Label|Adverse Event|0|||
146115299|NCT00549302|526938728|FG001|Open-Label|Adverse Event|0|||
146115300|NCT00549302|526938729|FG002|Open-Label|Adverse Event|11|||
146115301|NCT00549302|526938727|FG000|Open-Label|Death|0|||
146115302|NCT00549302|526938728|FG001|Open-Label|Death|0|||
146115303|NCT00549302|526938729|FG002|Open-Label|Death|40|||
146115304|NCT00549302|526938727|FG000|Open-Label|Investigator Decision|0|||
146115305|NCT00549302|526938728|FG001|Open-Label|Investigator Decision|0|||
146115306|NCT00549302|526938729|FG002|Open-Label|Investigator Decision|5|||
146115307|NCT00549302|526938727|FG000|Open-Label|Lost to Follow-up|0|||
146115308|NCT00549302|526938728|FG001|Open-Label|Lost to Follow-up|0|||
146115309|NCT00549302|526938729|FG002|Open-Label|Lost to Follow-up|2|||
146115310|NCT00549302|526938727|FG000|Open-Label|Other|0|||
146115311|NCT00549302|526938728|FG001|Open-Label|Other|0|||
146115312|NCT00549302|526938729|FG002|Open-Label|Other|3|||
146115313|NCT00549302|526938727|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
146115314|NCT00549302|526938728|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
146115315|NCT00549302|526938729|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
146115316|NCT00549302|526938727|FG000|Open-Label|Withdrawal by Subject|0|||
146115317|NCT00549302|526938728|FG001|Open-Label|Withdrawal by Subject|0|||
146115318|NCT00549302|526938729|FG002|Open-Label|Withdrawal by Subject|6|||
146115319|NCT03585504|526938730|FG000|Overall Study|Lost to Follow-up|26|||
146115320|NCT03585504|526938731|FG001|Overall Study|Lost to Follow-up|29|||
146115321|NCT01414114|526938732|FG000|Overall Study|Adverse Event|2|||
146115322|NCT01414114|526938732|FG000|Overall Study|Withdrawal by Subject|1|||
146260619|NCT01283971|527468765|FG001|Overall Study|Administrative reasons|1|||
146115323|NCT01414114|526938732|FG000|Overall Study|Other|2|||
146115324|NCT05620563|526938733|FG000|Overall Study|Adverse Event|3|||
146115325|NCT05620563|526938734|FG001|Overall Study|Adverse Event|1|||
146115326|NCT05620563|526938733|FG000|Overall Study|Lost to Follow-up|0|||
146115327|NCT05620563|526938734|FG001|Overall Study|Lost to Follow-up|2|||
146115328|NCT05620563|526938733|FG000|Overall Study|Protocol Deviation|1|||
146260620|NCT03325608|527468766|FG000|Overall Study|Lost to Follow-up|23|||
146260621|NCT03325608|527468767|FG001|Overall Study|Lost to Follow-up|23|||
146260622|NCT03325608|527468768|FG002|Overall Study|Lost to Follow-up|30|||
146260623|NCT03325608|527468769|FG003|Overall Study|Lost to Follow-up|30|||
146115329|NCT05620563|526938734|FG001|Overall Study|Protocol Deviation|2|||
146115330|NCT05620563|526938733|FG000|Overall Study|Withdrawal by Subject|3|||
146115331|NCT05620563|526938734|FG001|Overall Study|Withdrawal by Subject|3|||
146115332|NCT05620563|526938733|FG000|Overall Study|Physician Decision|0|||
146115333|NCT05620563|526938734|FG001|Overall Study|Physician Decision|1|||
146115334|NCT03590041|526938738|FG000|Overall Study|Protocol Violation|4|||
146115335|NCT03590041|526938739|FG001|Overall Study|Protocol Violation|3|||
146115336|NCT03590041|526938738|FG000|Overall Study|No session data recorded|14|||
146260624|NCT03325608|527468766|FG000|Overall Study|Death of Caregiver|0|||
146115337|NCT03590041|526938739|FG001|Overall Study|No session data recorded|2|||
146115338|NCT02692703|526938740|FG000|Overall Study|Lost to Follow-up|1|||
146115339|NCT02692703|526938740|FG000|Overall Study|Other|1|||
146260625|NCT03325608|527468767|FG001|Overall Study|Death of Caregiver|0|||
146260626|NCT03325608|527468768|FG002|Overall Study|Death of Caregiver|2|||
146260627|NCT03325608|527468769|FG003|Overall Study|Death of Caregiver|2|||
146260628|NCT03325608|527468766|FG000|Overall Study|Death of Care Recipient|34|||
146260629|NCT03325608|527468767|FG001|Overall Study|Death of Care Recipient|34|||
146260630|NCT03325608|527468768|FG002|Overall Study|Death of Care Recipient|28|||
146260631|NCT03325608|527468769|FG003|Overall Study|Death of Care Recipient|28|||
146260632|NCT03325608|527468766|FG000|Overall Study|Withdrawal by Subject|49|||
146260633|NCT03325608|527468767|FG001|Overall Study|Withdrawal by Subject|49|||
146260634|NCT03325608|527468768|FG002|Overall Study|Withdrawal by Subject|35|||
146260635|NCT03325608|527468769|FG003|Overall Study|Withdrawal by Subject|35|||
146260636|NCT03325608|527468766|FG000|Overall Study|Ineligible|7|||
146260637|NCT03325608|527468767|FG001|Overall Study|Ineligible|7|||
146260638|NCT03325608|527468768|FG002|Overall Study|Ineligible|5|||
146260639|NCT03325608|527468769|FG003|Overall Study|Ineligible|5|||
146260640|NCT02154347|527468770|FG000|Double-blind Period|Adverse Event|1|||
146260641|NCT02154347|527468771|FG001|Double-blind Period|Adverse Event|2|||
146260642|NCT02154347|527468770|FG000|Double-blind Period|Lack of Efficacy|1|||
146260643|NCT02154347|527468771|FG001|Double-blind Period|Lack of Efficacy|0|||
146260644|NCT02154347|527468770|FG000|Double-blind Period|Physician Decision|0|||
146260645|NCT02154347|527468771|FG001|Double-blind Period|Physician Decision|1|||
146260646|NCT02154347|527468770|FG000|Double-blind Period|Withdrawal by Subject|1|||
146260647|NCT02154347|527468771|FG001|Double-blind Period|Withdrawal by Subject|1|||
146260648|NCT02154347|527468770|FG000|Open-label Period|Adverse Event|3|||
146260649|NCT02154347|527468771|FG001|Open-label Period|Adverse Event|4|||
146260650|NCT02154347|527468770|FG000|Open-label Period|Lack of Efficacy|4|||
146260651|NCT02154347|527468771|FG001|Open-label Period|Lack of Efficacy|19|||
146260652|NCT02154347|527468770|FG000|Open-label Period|Protocol Violation|0|||
146260653|NCT02154347|527468771|FG001|Open-label Period|Protocol Violation|1|||
146260654|NCT02154347|527468770|FG000|Open-label Period|Withdrawal by Subject|0|||
146260655|NCT02154347|527468771|FG001|Open-label Period|Withdrawal by Subject|1|||
146260656|NCT02188784|527468772|FG000|Overall Study|Death|3|||
146260657|NCT02188784|527468773|FG001|Overall Study|Death|1|||
146260658|NCT02188784|527468772|FG000|Overall Study|Lost to Follow-up|1|||
146260659|NCT02188784|527468773|FG001|Overall Study|Lost to Follow-up|0|||
146260660|NCT02188784|527468772|FG000|Overall Study|Withdrawal by Subject|3|||
146260661|NCT02188784|527468773|FG001|Overall Study|Withdrawal by Subject|9|||
146260662|NCT02188784|527468772|FG000|Overall Study|Physician Decision|2|||
146260663|NCT02188784|527468773|FG001|Overall Study|Physician Decision|3|||
146260664|NCT05041439|527468774|FG000|Overall Study|Withdrawal by Subject|1|||
146260665|NCT05041439|527468775|FG001|Overall Study|Withdrawal by Subject|1|||
146260666|NCT05041439|527468774|FG000|Overall Study|Death|1|||
146260667|NCT05041439|527468775|FG001|Overall Study|Death|0|||
146260668|NCT02250183|527468776|FG000|Overall Study|Withdrawal by Subject|2|||
146260669|NCT02250183|527468776|FG000|Overall Study|Adverse Event|5|||
146260670|NCT02250183|527468776|FG000|Overall Study|Lost to Follow-up|1|||
146260671|NCT03282799|527468777|FG000|Overall Study|Pregnancy|1|||
146260672|NCT03282799|527468778|FG001|Overall Study|Pregnancy|0|||
146260673|NCT03282799|527468777|FG000|Overall Study|Physician Decision|1|||
146260674|NCT03282799|527468778|FG001|Overall Study|Physician Decision|0|||
146260675|NCT03614676|527470724|FG000|Overall Study|Delivery before planned visit|2|||
146260676|NCT03614676|527470725|FG001|Overall Study|Delivery before planned visit|0|||
146260677|NCT03614676|527470724|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
146260678|NCT03614676|527470725|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
146260679|NCT03614676|527470724|FG000|Overall Study|Migrated / moved from the study area|30|||
146260680|NCT03614676|527470725|FG001|Overall Study|Migrated / moved from the study area|22|||
146260681|NCT03614676|527470724|FG000|Overall Study|Lost to Follow-up|17|||
146260682|NCT03614676|527470725|FG001|Overall Study|Lost to Follow-up|42|||
146260683|NCT03614676|527470724|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
146260684|NCT03614676|527470725|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
146260685|NCT03614676|527470724|FG000|Overall Study|Other|16|||
146260686|NCT03614676|527470725|FG001|Overall Study|Other|47|||
146115340|NCT00644995|526938743|FG000|Overall Study|Lost to Follow-up|1|||
146115341|NCT00644995|526938744|FG001|Overall Study|Lost to Follow-up|4|||
146115342|NCT00644995|526938743|FG000|Overall Study|Refused|1|||
146260687|NCT03614676|527470724|FG000|Overall Study|Protocol Violation|0|||
146260688|NCT03614676|527470725|FG001|Overall Study|Protocol Violation|2|||
146260689|NCT03614676|527470724|FG000|Overall Study|Neonatal event of interest|0|||
146260690|NCT03614676|527470725|FG001|Overall Study|Neonatal event of interest|6|||
146115343|NCT00644995|526938744|FG001|Overall Study|Refused|0|||
146115344|NCT03519932|526938745|FG000|First Intervention|Adverse Event|1|||
146260691|NCT03614676|527470724|FG000|Overall Study|Death in infant greater than 28 days old|0|||
146260692|NCT03614676|527470725|FG001|Overall Study|Death in infant greater than 28 days old|12|||
146260693|NCT03614676|527470724|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
146302314|NCT00467779|527621658|FG006|Stage 2A|Adverse Event|0|||
146115345|NCT03519932|526938746|FG001|First Intervention|Adverse Event|3|||
146302315|NCT00467779|527621659|FG007|Stage 2A|Adverse Event|0|||
146302316|NCT00467779|527621660|FG008|Stage 2A|Adverse Event|0|||
146302317|NCT00467779|527621661|FG009|Stage 2A|Adverse Event|0|||
146302318|NCT00467779|527621662|FG010|Stage 2A|Adverse Event|0|||
146302319|NCT00467779|527621663|FG011|Stage 2A|Adverse Event|0|||
146302320|NCT00467779|527621664|FG012|Stage 2A|Adverse Event|0|||
146302321|NCT00467779|527621665|FG013|Stage 2A|Adverse Event|2|||
146302322|NCT00467779|527621666|FG014|Stage 2A|Adverse Event|0|||
146302323|NCT00467779|527621652|FG000|Stage 2A|Death|0|||
146302324|NCT00467779|527621653|FG001|Stage 2A|Death|0|||
146302325|NCT00467779|527621654|FG002|Stage 2A|Death|0|||
146302326|NCT00467779|527621655|FG003|Stage 2A|Death|0|||
146302327|NCT00467779|527621656|FG004|Stage 2A|Death|0|||
146302328|NCT00467779|527621657|FG005|Stage 2A|Death|0|||
146302329|NCT00467779|527621658|FG006|Stage 2A|Death|0|||
146302330|NCT00467779|527621659|FG007|Stage 2A|Death|0|||
146302331|NCT00467779|527621660|FG008|Stage 2A|Death|0|||
146302332|NCT00467779|527621661|FG009|Stage 2A|Death|0|||
146302333|NCT00467779|527621662|FG010|Stage 2A|Death|0|||
146302334|NCT00467779|527621663|FG011|Stage 2A|Death|0|||
146302335|NCT00467779|527621664|FG012|Stage 2A|Death|0|||
146302336|NCT00467779|527621665|FG013|Stage 2A|Death|1|||
146302337|NCT00467779|527621666|FG014|Stage 2A|Death|0|||
146302338|NCT00467779|527621652|FG000|Stage 2A|Disease Progression|0|||
146302339|NCT00467779|527621653|FG001|Stage 2A|Disease Progression|0|||
146302340|NCT00467779|527621654|FG002|Stage 2A|Disease Progression|0|||
146302341|NCT00467779|527621655|FG003|Stage 2A|Disease Progression|0|||
146302342|NCT00467779|527621656|FG004|Stage 2A|Disease Progression|0|||
146302343|NCT00467779|527621657|FG005|Stage 2A|Disease Progression|0|||
146302344|NCT00467779|527621658|FG006|Stage 2A|Disease Progression|0|||
146302345|NCT00467779|527621659|FG007|Stage 2A|Disease Progression|0|||
146302346|NCT00467779|527621660|FG008|Stage 2A|Disease Progression|0|||
146302347|NCT00467779|527621661|FG009|Stage 2A|Disease Progression|0|||
146115346|NCT00372112|526938751|FG000|Overall Study|Adverse Event|0|||
146115347|NCT00372112|526938752|FG001|Overall Study|Adverse Event|1|||
146115348|NCT00372112|526938753|FG002|Overall Study|Adverse Event|1|||
146115349|NCT00372112|526938754|FG003|Overall Study|Adverse Event|1|||
146115350|NCT00372112|526938751|FG000|Overall Study|Withdrawal by Subject|0|||
146115351|NCT00372112|526938752|FG001|Overall Study|Withdrawal by Subject|0|||
146115352|NCT00372112|526938753|FG002|Overall Study|Withdrawal by Subject|2|||
146115353|NCT00372112|526938754|FG003|Overall Study|Withdrawal by Subject|1|||
146115354|NCT00372112|526938751|FG000|Overall Study|Exacerbation|0|||
146115355|NCT00372112|526938752|FG001|Overall Study|Exacerbation|0|||
146115356|NCT00372112|526938753|FG002|Overall Study|Exacerbation|0|||
146115357|NCT00372112|526938754|FG003|Overall Study|Exacerbation|1|||
146115358|NCT00372112|526938751|FG000|Overall Study|PR >240 at Visit 3|0|||
146115359|NCT00372112|526938752|FG001|Overall Study|PR >240 at Visit 3|0|||
146115360|NCT00372112|526938753|FG002|Overall Study|PR >240 at Visit 3|0|||
146115361|NCT00372112|526938754|FG003|Overall Study|PR >240 at Visit 3|1|||
146115362|NCT00372112|526938751|FG000|Overall Study|Hepatitis B|1|||
146115363|NCT00372112|526938752|FG001|Overall Study|Hepatitis B|0|||
146115364|NCT00372112|526938753|FG002|Overall Study|Hepatitis B|0|||
146115365|NCT00372112|526938754|FG003|Overall Study|Hepatitis B|0|||
146115366|NCT00372112|526938751|FG000|Overall Study|Other-protocol violation|0|||
146115367|NCT00372112|526938752|FG001|Overall Study|Other-protocol violation|0|||
146115368|NCT00372112|526938753|FG002|Overall Study|Other-protocol violation|1|||
146115369|NCT00372112|526938754|FG003|Overall Study|Other-protocol violation|0|||
146115370|NCT01678911|526938755|FG000|Second Intervention|Lost to Follow-up|2|||
146115371|NCT01678911|526938756|FG001|Second Intervention|Lost to Follow-up|0|||
146115372|NCT00356369|526938757|FG000|Active Phase|Withdrawal by Subject|2|||
146115373|NCT00356369|526938758|FG001|Active Phase|Withdrawal by Subject|1|||
146115374|NCT01985867|526938761|FG000|Overall Study|Lost to Follow-up|3|||
146115375|NCT01985867|526938762|FG001|Overall Study|Lost to Follow-up|4|||
146115376|NCT01985867|526938761|FG000|Overall Study|Adverse Event|3|||
146115377|NCT01985867|526938762|FG001|Overall Study|Adverse Event|2|||
146115378|NCT01985867|526938761|FG000|Overall Study|Lack of Efficacy|1|||
146115379|NCT01985867|526938762|FG001|Overall Study|Lack of Efficacy|0|||
146115380|NCT02670837|526938763|FG000|Overall Study|Death|2|||
146115381|NCT02670837|526938764|FG001|Overall Study|Death|0|||
146115382|NCT02670837|526938765|FG002|Overall Study|Death|0|||
146115383|NCT02205814|526938771|FG000|Overall Study|Lost to Follow-up|0|||
146115384|NCT02205814|526938772|FG001|Overall Study|Lost to Follow-up|0|||
146115385|NCT02205814|526938773|FG002|Overall Study|Lost to Follow-up|0|||
146115386|NCT02205814|526938774|FG003|Overall Study|Lost to Follow-up|1|||
146302348|NCT00467779|527621662|FG010|Stage 2A|Disease Progression|0|||
146302349|NCT00467779|527621663|FG011|Stage 2A|Disease Progression|0|||
146302350|NCT00467779|527621664|FG012|Stage 2A|Disease Progression|0|||
146302351|NCT00467779|527621665|FG013|Stage 2A|Disease Progression|10|||
146302352|NCT00467779|527621666|FG014|Stage 2A|Disease Progression|0|||
146115387|NCT02205814|526938771|FG000|Overall Study|Lack of Efficacy|1|||
146302353|NCT00467779|527621652|FG000|Stage 2A|Unspecified Reason|0|||
146302354|NCT00467779|527621653|FG001|Stage 2A|Unspecified Reason|0|||
146302355|NCT00467779|527621654|FG002|Stage 2A|Unspecified Reason|0|||
146302356|NCT00467779|527621655|FG003|Stage 2A|Unspecified Reason|0|||
146115388|NCT02205814|526938772|FG001|Overall Study|Lack of Efficacy|0|||
146115389|NCT02205814|526938773|FG002|Overall Study|Lack of Efficacy|1|||
146115390|NCT02205814|526938774|FG003|Overall Study|Lack of Efficacy|1|||
146115391|NCT02205814|526938771|FG000|Overall Study|Physician Decision|0|||
146115392|NCT02205814|526938772|FG001|Overall Study|Physician Decision|0|||
146115393|NCT02205814|526938773|FG002|Overall Study|Physician Decision|1|||
146115394|NCT02205814|526938774|FG003|Overall Study|Physician Decision|0|||
146115395|NCT02205814|526938771|FG000|Overall Study|Protocol Violation|1|||
146115396|NCT02205814|526938772|FG001|Overall Study|Protocol Violation|0|||
146115397|NCT02205814|526938773|FG002|Overall Study|Protocol Violation|0|||
146115398|NCT02205814|526938774|FG003|Overall Study|Protocol Violation|1|||
146115399|NCT02205814|526938771|FG000|Overall Study|Withdrawal by Subject|0|||
146115400|NCT02205814|526938772|FG001|Overall Study|Withdrawal by Subject|1|||
146115401|NCT02205814|526938773|FG002|Overall Study|Withdrawal by Subject|2|||
146115402|NCT02205814|526938774|FG003|Overall Study|Withdrawal by Subject|1|||
146115403|NCT02205814|526938771|FG000|Overall Study|not compliant with study procedures|0|||
146115404|NCT02205814|526938772|FG001|Overall Study|not compliant with study procedures|0|||
146115405|NCT02205814|526938773|FG002|Overall Study|not compliant with study procedures|1|||
146115406|NCT02205814|526938774|FG003|Overall Study|not compliant with study procedures|0|||
146115407|NCT01426373|526938775|FG000|Overall Study|Adverse Event|6|||
146115408|NCT01426373|526938775|FG000|Overall Study|Lost to Follow-up|14|||
146115409|NCT01426373|526938775|FG000|Overall Study|Participant Convenience|10|||
146115410|NCT01426373|526938775|FG000|Overall Study|Miscellaneous Reasons|4|||
146115411|NCT00143403|526938776|FG000|Overall Study|Adverse Event|3|||
146115412|NCT00143403|526938777|FG001|Overall Study|Adverse Event|8|||
146115413|NCT00143403|526938776|FG000|Overall Study|Death|1|||
146115414|NCT00143403|526938777|FG001|Overall Study|Death|0|||
146115415|NCT00143403|526938776|FG000|Overall Study|Withdrawal by Subject|3|||
146115416|NCT00143403|526938777|FG001|Overall Study|Withdrawal by Subject|12|||
146115417|NCT00143403|526938776|FG000|Overall Study|Relapse|15|||
146115418|NCT00143403|526938777|FG001|Overall Study|Relapse|7|||
146115419|NCT00143403|526938776|FG000|Overall Study|Protocol Violation|2|||
146115420|NCT00143403|526938777|FG001|Overall Study|Protocol Violation|2|||
146115421|NCT00143403|526938776|FG000|Overall Study|specified by site|4|||
146115422|NCT00143403|526938777|FG001|Overall Study|specified by site|9|||
146115423|NCT00143403|526938776|FG000|Overall Study|Randomized Not Treated|7|||
146115424|NCT00143403|526938777|FG001|Overall Study|Randomized Not Treated|8|||
146115425|NCT01574326|526938778|FG000|Overall Study|Randomized but not treated|0|||
146115426|NCT01574326|526938779|FG001|Overall Study|Randomized but not treated|1|||
146115427|NCT01574326|526938778|FG000|Overall Study|Withdrawal by Participant|2|||
146115428|NCT01574326|526938779|FG001|Overall Study|Withdrawal by Participant|4|||
146115429|NCT01574326|526938778|FG000|Overall Study|Physician Decision|5|||
146115430|NCT01574326|526938779|FG001|Overall Study|Physician Decision|3|||
146115431|NCT01574326|526938778|FG000|Overall Study|Adverse Event|1|||
146115432|NCT01574326|526938779|FG001|Overall Study|Adverse Event|3|||
146115433|NCT01574326|526938778|FG000|Overall Study|Other: Mainly kidney transplant|8|||
146115434|NCT01574326|526938779|FG001|Overall Study|Other: Mainly kidney transplant|8|||
146115435|NCT01919723|526938780|FG000|Overall Study|Blood Samples Hemolyzed|2|||
146115436|NCT01919723|526938781|FG001|Overall Study|Blood Samples Hemolyzed|2|||
146115437|NCT04502589|526938782|FG000|Overall Study|Physician Decision|1|||
146115438|NCT04502589|526938783|FG001|Overall Study|Physician Decision|0|||
146115439|NCT00137046|526938789|FG000|Overall Study|Death|2|||
146115440|NCT00137046|526938790|FG001|Overall Study|Death|1|||
146115441|NCT00137046|526938789|FG000|Overall Study|Adverse Event|16|||
146115442|NCT00137046|526938790|FG001|Overall Study|Adverse Event|5|||
146115443|NCT00137046|526938789|FG000|Overall Study|Laboratory Abnormality|2|||
146115444|NCT00137046|526938790|FG001|Overall Study|Laboratory Abnormality|0|||
146115445|NCT00137046|526938789|FG000|Overall Study|Lack of Efficacy|13|||
146115446|NCT00137046|526938790|FG001|Overall Study|Lack of Efficacy|1|||
146115447|NCT00137046|526938789|FG000|Overall Study|Lost to Follow-up|8|||
146115448|NCT00137046|526938790|FG001|Overall Study|Lost to Follow-up|24|||
146115449|NCT00137046|526938789|FG000|Overall Study|Other|23|||
146115450|NCT00137046|526938790|FG001|Overall Study|Other|19|||
146115451|NCT00137046|526938789|FG000|Overall Study|Withdrawal by Subject|33|||
146115452|NCT00137046|526938790|FG001|Overall Study|Withdrawal by Subject|42|||
146115453|NCT00137046|526938789|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
146115454|NCT00137046|526938790|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
146115455|NCT00137046|526938789|FG000|Overall Study|Withdrew prior to study treatment|1|||
146115456|NCT00137046|526938790|FG001|Overall Study|Withdrew prior to study treatment|1|||
146115457|NCT02532972|526938792|FG000|Overall Study|Withdrawal by Subject|1|||
146115458|NCT02859454|526938795|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
146115459|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
146115460|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
146115461|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
146115462|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
146115463|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
146115464|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146115465|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
146115466|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
146115467|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Other|1|||
146115468|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Other|4|||
146115469|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Other|3|||
146115470|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Other|6|||
146115471|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
146115472|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
146115473|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
146115474|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
146115475|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
146115476|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
146115477|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
146115478|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
146115479|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
146115480|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
146115481|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
146115482|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
146115483|NCT02925494|526938796|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
146115484|NCT02925494|526938797|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
146115485|NCT02925494|526938798|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
146115486|NCT02925494|526938799|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
146115487|NCT03334448|526938800|FG000|Washout|Personal Reason|0|||
146115488|NCT03334448|526938801|FG001|Washout|Personal Reason|1|||
146115489|NCT03334448|526938802|FG002|Washout|Personal Reason|0|||
146115490|NCT03334448|526938803|FG003|Washout|Personal Reason|0|||
146115491|NCT03334448|526938800|FG000|Washout|Protocol Violation|0|||
146115492|NCT03334448|526938801|FG001|Washout|Protocol Violation|0|||
146115493|NCT03334448|526938802|FG002|Washout|Protocol Violation|0|||
146115494|NCT03334448|526938803|FG003|Washout|Protocol Violation|1|||
146115495|NCT02496611|526938809|FG000|Overall Study|Lost to Follow-up|2|||
146115496|NCT02496611|526938810|FG001|Overall Study|Lost to Follow-up|1|||
146115497|NCT02496611|526938809|FG000|Overall Study|Withdrawal by Subject|5|||
146115498|NCT02496611|526938810|FG001|Overall Study|Withdrawal by Subject|2|||
146115499|NCT02850965|526938811|FG000|Overall Study|Other than listed|3|||
146115500|NCT02850965|526938812|FG001|Overall Study|Other than listed|4|||
146115501|NCT02850965|526938811|FG000|Overall Study|Protocol Violation|0|||
146115502|NCT02850965|526938812|FG001|Overall Study|Protocol Violation|2|||
146115503|NCT02850965|526938811|FG000|Overall Study|Lost to Follow-up|5|||
146115504|NCT02850965|526938812|FG001|Overall Study|Lost to Follow-up|3|||
146115505|NCT02850965|526938811|FG000|Overall Study|Lack of Efficacy|4|||
146115506|NCT02850965|526938812|FG001|Overall Study|Lack of Efficacy|8|||
146115507|NCT02850965|526938811|FG000|Overall Study|Adverse Event|3|||
146115508|NCT02850965|526938812|FG001|Overall Study|Adverse Event|2|||
146115509|NCT02850965|526938811|FG000|Overall Study|Withdrawal by Subject|3|||
146115510|NCT02850965|526938812|FG001|Overall Study|Withdrawal by Subject|4|||
146115511|NCT02850965|526938811|FG000|Overall Study|Physician Decision|0|||
146115512|NCT02850965|526938812|FG001|Overall Study|Physician Decision|1|||
146115513|NCT02850965|526938811|FG000|Overall Study|Randomized but not treated|0|||
146115514|NCT02850965|526938812|FG001|Overall Study|Randomized but not treated|1|||
146115515|NCT02788357|526938816|FG000|Overall Study|Lost to Follow-up|3|||
146115516|NCT02788357|526938817|FG001|Overall Study|Lost to Follow-up|0|||
146115517|NCT01365910|526938818|FG000|Overall Study|Withdrawal by Subject|7|||
146115518|NCT01365910|526938818|FG000|Overall Study|disease progression|18|||
146115519|NCT01365910|526938818|FG000|Overall Study|Adverse Event|3|||
146115520|NCT01365910|526938818|FG000|Overall Study|other complicating disease|1|||
146115521|NCT01365910|526938818|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
146115522|NCT00371137|526938819|FG000|Overall Study|Adverse Event|20|||
146115523|NCT00371137|526938820|FG001|Overall Study|Adverse Event|35|||
146115524|NCT00371137|526938821|FG002|Overall Study|Adverse Event|42|||
146115525|NCT00371137|526938819|FG000|Overall Study|Withdrawal by Subject|11|||
146115526|NCT00371137|526938820|FG001|Overall Study|Withdrawal by Subject|10|||
146115527|NCT00371137|526938821|FG002|Overall Study|Withdrawal by Subject|15|||
146115528|NCT00371137|526938819|FG000|Overall Study|Lost to Follow-up|6|||
146302357|NCT00467779|527621656|FG004|Stage 2A|Unspecified Reason|0|||
146115529|NCT00371137|526938820|FG001|Overall Study|Lost to Follow-up|3|||
146115530|NCT00371137|526938821|FG002|Overall Study|Lost to Follow-up|5|||
146115531|NCT00371137|526938819|FG000|Overall Study|Lack of Efficacy|30|||
146115532|NCT00371137|526938820|FG001|Overall Study|Lack of Efficacy|12|||
146115533|NCT00371137|526938821|FG002|Overall Study|Lack of Efficacy|13|||
146115534|NCT00371137|526938819|FG000|Overall Study|Sponsor Decision|2|||
146115535|NCT00371137|526938820|FG001|Overall Study|Sponsor Decision|1|||
146115536|NCT00371137|526938821|FG002|Overall Study|Sponsor Decision|2|||
146115537|NCT00371137|526938819|FG000|Overall Study|Physician Decision|1|||
146115538|NCT00371137|526938820|FG001|Overall Study|Physician Decision|1|||
146302358|NCT00467779|527621657|FG005|Stage 2A|Unspecified Reason|0|||
146302359|NCT00467779|527621658|FG006|Stage 2A|Unspecified Reason|0|||
146115539|NCT00371137|526938821|FG002|Overall Study|Physician Decision|1|||
146115540|NCT00371137|526938819|FG000|Overall Study|Protocol Violation|2|||
146115541|NCT00371137|526938820|FG001|Overall Study|Protocol Violation|1|||
146115542|NCT00371137|526938821|FG002|Overall Study|Protocol Violation|1|||
146115543|NCT02013791|526938822|FG000|Period 1|Lost to Follow-up|0|||
146115544|NCT02013791|526938823|FG001|Period 1|Lost to Follow-up|0|||
146115545|NCT02013791|526938824|FG002|Period 1|Lost to Follow-up|0|||
146115546|NCT02013791|526938825|FG003|Period 1|Lost to Follow-up|1|||
146115547|NCT02013791|526938826|FG004|Period 1|Lost to Follow-up|0|||
146115548|NCT02013791|526938827|FG005|Period 1|Lost to Follow-up|0|||
146115549|NCT02013791|526938828|FG006|Period 1|Lost to Follow-up|1|||
146115550|NCT02013791|526938829|FG007|Period 1|Lost to Follow-up|1|||
146115551|NCT02013791|526938830|FG008|Period 1|Lost to Follow-up|0|||
146115552|NCT02013791|526938822|FG000|Period 1|Other Miscellaneous Reasons|0|||
146115553|NCT02013791|526938823|FG001|Period 1|Other Miscellaneous Reasons|2|||
146115554|NCT02013791|526938824|FG002|Period 1|Other Miscellaneous Reasons|0|||
146115555|NCT02013791|526938825|FG003|Period 1|Other Miscellaneous Reasons|0|||
146115556|NCT02013791|526938826|FG004|Period 1|Other Miscellaneous Reasons|0|||
146115557|NCT02013791|526938827|FG005|Period 1|Other Miscellaneous Reasons|0|||
146115558|NCT02013791|526938828|FG006|Period 1|Other Miscellaneous Reasons|0|||
146115559|NCT02013791|526938829|FG007|Period 1|Other Miscellaneous Reasons|0|||
146115560|NCT02013791|526938830|FG008|Period 1|Other Miscellaneous Reasons|0|||
146115561|NCT02170051|526938831|FG000|Overall Study|Withdrawal by Subject|10|||
146115562|NCT02170051|526938832|FG001|Overall Study|Withdrawal by Subject|10|||
146115563|NCT02170051|526938831|FG000|Overall Study|Lost to Follow-up|1|||
146115564|NCT02170051|526938832|FG001|Overall Study|Lost to Follow-up|3|||
146115565|NCT03798483|526938833|FG000|Overall Study|Lost to Follow-up|2|||
146115566|NCT00276744|526938834|FG000|PART A|Reason unknown|98|||
146115567|NCT01835587|526938841|FG000|Overall Study|Disease Recurrence or Relapse|0|||
146115568|NCT01835587|526938842|FG001|Overall Study|Disease Recurrence or Relapse|3|||
146115569|NCT01835587|526938843|FG002|Overall Study|Disease Recurrence or Relapse|0|||
146115570|NCT01835587|526938844|FG003|Overall Study|Disease Recurrence or Relapse|3|||
146115571|NCT01835587|526938841|FG000|Overall Study|Withdrawal by Subject|2|||
146115572|NCT01835587|526938842|FG001|Overall Study|Withdrawal by Subject|0|||
146115573|NCT01835587|526938843|FG002|Overall Study|Withdrawal by Subject|0|||
146115574|NCT01835587|526938844|FG003|Overall Study|Withdrawal by Subject|3|||
146115575|NCT01835587|526938841|FG000|Overall Study|Adverse Event|0|||
146115576|NCT01835587|526938842|FG001|Overall Study|Adverse Event|0|||
146115577|NCT01835587|526938843|FG002|Overall Study|Adverse Event|2|||
146115578|NCT01835587|526938844|FG003|Overall Study|Adverse Event|2|||
146115579|NCT01835587|526938841|FG000|Overall Study|Death|0|||
146115580|NCT01835587|526938842|FG001|Overall Study|Death|0|||
146115581|NCT01835587|526938843|FG002|Overall Study|Death|0|||
146115582|NCT01835587|526938844|FG003|Overall Study|Death|1|||
146115583|NCT01835587|526938841|FG000|Overall Study|Miscellaneous|0|||
146115584|NCT01835587|526938842|FG001|Overall Study|Miscellaneous|1|||
146115585|NCT01835587|526938843|FG002|Overall Study|Miscellaneous|0|||
146115586|NCT01835587|526938844|FG003|Overall Study|Miscellaneous|0|||
146115587|NCT03310775|526938848|FG000|Overall Study|Lost to Follow-up|2|||
146115588|NCT03310775|526938849|FG001|Overall Study|Lost to Follow-up|3|||
146115589|NCT03310775|526938848|FG000|Overall Study|aggravation of depression|0|||
146115590|NCT03310775|526938849|FG001|Overall Study|aggravation of depression|1|||
146115591|NCT00126568|526938850|FG000|Overall Study|Death|2|||
146115592|NCT03064451|526938851|FG000|Overall Study|Lost to Follow-up|1|||
146115593|NCT03064451|526938851|FG000|Overall Study|Mapping Failure|4|||
146115594|NCT03064451|526938851|FG000|Overall Study|Exited prior to procedure|8|||
146115595|NCT03064451|526938851|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
146115596|NCT00750204|526938852|FG000|Overall Study|study halted prematurely|1|||
146115597|NCT00750204|526938853|FG001|Overall Study|study halted prematurely|1|||
146115598|NCT03010254|526940657|FG000|Overall Study|Adverse Event|0|||
146115599|NCT03010254|526940658|FG001|Overall Study|Adverse Event|1|||
146115600|NCT03010254|526940657|FG000|Overall Study|Lost to Follow-up|4|||
146115601|NCT03010254|526940658|FG001|Overall Study|Lost to Follow-up|0|||
146115602|NCT03010254|526940657|FG000|Overall Study|Withdrawal by Subject|1|||
146260694|NCT03614676|527470725|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
146260695|NCT02080403|527470726|FG000|Overall Study|Adverse Event|5|||
146260696|NCT02080403|527470727|FG001|Overall Study|Adverse Event|1|||
146260697|NCT02080403|527470726|FG000|Overall Study|Death|0|||
146115603|NCT03010254|526940658|FG001|Overall Study|Withdrawal by Subject|1|||
146115604|NCT03010254|526940657|FG000|Overall Study|Other|2|||
146115605|NCT03010254|526940658|FG001|Overall Study|Other|3|||
146115606|NCT01404325|526940659|FG000|Overall Study|Lost to Follow-up|1|||
146115607|NCT01404325|526940660|FG001|Overall Study|Lost to Follow-up|0|||
146115608|NCT01404325|526940659|FG000|Overall Study|Death|2|||
146115609|NCT01404325|526940660|FG001|Overall Study|Death|0|||
146115610|NCT01404325|526940659|FG000|Overall Study|Graft loss/Retransplantation|1|||
146115611|NCT01404325|526940660|FG001|Overall Study|Graft loss/Retransplantation|0|||
146115612|NCT01404325|526940659|FG000|Overall Study|non-specified reason|0|||
146115613|NCT01404325|526940660|FG001|Overall Study|non-specified reason|2|||
146115614|NCT01411228|526940663|FG000|Overall Study|Lost to Follow-up|0|||
146115615|NCT01411228|526940664|FG001|Overall Study|Lost to Follow-up|0|||
146115616|NCT01411228|526940665|FG002|Overall Study|Lost to Follow-up|1|||
146115617|NCT01411228|526940663|FG000|Overall Study|Withdrawal by Subject|1|||
146115618|NCT01411228|526940664|FG001|Overall Study|Withdrawal by Subject|0|||
146115619|NCT01411228|526940665|FG002|Overall Study|Withdrawal by Subject|0|||
146115620|NCT01986855|526940666|FG000|Overall Study|Adverse Event|1|||
146115621|NCT01986855|526940667|FG001|Overall Study|Adverse Event|0|||
146115622|NCT01986855|526940668|FG002|Overall Study|Adverse Event|0|||
146115623|NCT01986855|526940666|FG000|Overall Study|Death|3|||
146115624|NCT01986855|526940667|FG001|Overall Study|Death|4|||
146115625|NCT01986855|526940668|FG002|Overall Study|Death|4|||
146115626|NCT01986855|526940666|FG000|Overall Study|Lost to Follow-up|2|||
146115627|NCT01986855|526940667|FG001|Overall Study|Lost to Follow-up|1|||
146115628|NCT01986855|526940668|FG002|Overall Study|Lost to Follow-up|0|||
146115629|NCT01986855|526940666|FG000|Overall Study|Screen Failure|0|||
146115630|NCT01986855|526940667|FG001|Overall Study|Screen Failure|1|||
146115631|NCT01986855|526940668|FG002|Overall Study|Screen Failure|0|||
146115632|NCT01986855|526940666|FG000|Overall Study|Participant Moved|0|||
146115633|NCT01986855|526940667|FG001|Overall Study|Participant Moved|0|||
146115634|NCT01986855|526940668|FG002|Overall Study|Participant Moved|2|||
146115635|NCT01986855|526940666|FG000|Overall Study|Withdrawal by Subject|7|||
146115636|NCT01986855|526940667|FG001|Overall Study|Withdrawal by Subject|8|||
146115637|NCT01986855|526940668|FG002|Overall Study|Withdrawal by Subject|5|||
146115638|NCT02064868|526940672|FG000|Overall Study|Lost to Follow-up|14|||
146115639|NCT02064868|526940673|FG001|Overall Study|Lost to Follow-up|8|||
146115640|NCT02064868|526940672|FG000|Overall Study|Physician Decision|1|||
146115641|NCT02064868|526940673|FG001|Overall Study|Physician Decision|0|||
146115642|NCT02064868|526940672|FG000|Overall Study|Withdrawal by Subject|14|||
146115643|NCT02064868|526940673|FG001|Overall Study|Withdrawal by Subject|3|||
146115644|NCT02064868|526940672|FG000|Overall Study|Technical Problems or Missing|5|||
146115645|NCT02064868|526940673|FG001|Overall Study|Technical Problems or Missing|2|||
146115646|NCT02670083|526940674|FG000|Overall Study|Adverse Event|16|||
146115647|NCT02670083|526940675|FG001|Overall Study|Adverse Event|13|||
146115648|NCT02670083|526940674|FG000|Overall Study|Death|4|||
146115649|NCT02670083|526940675|FG001|Overall Study|Death|6|||
146115650|NCT02670083|526940674|FG000|Overall Study|Lost to Follow-up|2|||
146115651|NCT02670083|526940675|FG001|Overall Study|Lost to Follow-up|2|||
146115652|NCT02670083|526940674|FG000|Overall Study|Multiple Reasons|9|||
146115653|NCT02670083|526940675|FG001|Overall Study|Multiple Reasons|9|||
146115654|NCT02670083|526940674|FG000|Overall Study|Physician Decision|0|||
146115655|NCT02670083|526940675|FG001|Overall Study|Physician Decision|2|||
146115656|NCT02670083|526940674|FG000|Overall Study|Study Terminated By Sponsor|257|||
146115657|NCT02670083|526940675|FG001|Overall Study|Study Terminated By Sponsor|254|||
146115658|NCT02670083|526940674|FG000|Overall Study|Symptomatic Deterioration|0|||
146115659|NCT02670083|526940675|FG001|Overall Study|Symptomatic Deterioration|2|||
146115660|NCT02670083|526940674|FG000|Overall Study|Withdrawal by Subject|32|||
146115661|NCT02670083|526940675|FG001|Overall Study|Withdrawal by Subject|31|||
146115662|NCT02670083|526940674|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146115663|NCT02670083|526940675|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146115664|NCT02425046|526940681|FG000|Overall Study|Lost to Follow-up|52|||
146115665|NCT02425046|526940682|FG001|Overall Study|Lost to Follow-up|50|||
146115666|NCT02425046|526940683|FG002|Overall Study|Lost to Follow-up|56|||
146115667|NCT02425046|526940681|FG000|Overall Study|Withdrawal by Subject|16|||
146115668|NCT02425046|526940682|FG001|Overall Study|Withdrawal by Subject|12|||
146115669|NCT02425046|526940683|FG002|Overall Study|Withdrawal by Subject|0|||
146115670|NCT02782780|526940684|FG000|Overall Study|dropped out after randomization.|7|||
146115671|NCT02782780|526940685|FG001|Overall Study|dropped out after randomization.|5|||
146115672|NCT02782780|526940684|FG000|Overall Study|Protocol Violation|0|||
146115673|NCT02782780|526940685|FG001|Overall Study|Protocol Violation|2|||
146115674|NCT03562481|526940686|FG000|First Intervention|Lost to Follow-up|1|||
146115675|NCT03562481|526940687|FG001|First Intervention|Lost to Follow-up|0|||
146115676|NCT01413191|526940688|FG000|Overall Study|Lost to Follow-up|5|||
146115677|NCT01413191|526940688|FG000|Overall Study|Disease Progression|5|||
146115678|NCT01413191|526940688|FG000|Overall Study|Death|1|||
146115679|NCT00267046|526940702|FG000|Overall Study|Disease progression|4|||
146115680|NCT00267046|526940703|FG001|Overall Study|Disease progression|2|||
146115681|NCT00267046|526940702|FG000|Overall Study|Chemotoxicity|2|||
146115682|NCT00267046|526940703|FG001|Overall Study|Chemotoxicity|0|||
146115683|NCT00267046|526940702|FG000|Overall Study|Open-label palifermin|2|||
146115684|NCT00267046|526940703|FG001|Overall Study|Open-label palifermin|7|||
146115685|NCT00267046|526940702|FG000|Overall Study|Surgery|3|||
146115686|NCT00267046|526940703|FG001|Overall Study|Surgery|1|||
146115687|NCT00267046|526940702|FG000|Overall Study|Withdrawal by Subject|1|||
146115688|NCT00267046|526940703|FG001|Overall Study|Withdrawal by Subject|0|||
146115689|NCT00267046|526940702|FG000|Overall Study|Radiation|0|||
146115690|NCT00267046|526940703|FG001|Overall Study|Radiation|1|||
146115691|NCT00460408|526940704|FG000|Overall Study|Adverse Event|1|||
146115692|NCT00460408|526940705|FG001|Overall Study|Adverse Event|0|||
146115693|NCT00460408|526940706|FG002|Overall Study|Adverse Event|0|||
146115694|NCT00460408|526940707|FG003|Overall Study|Adverse Event|0|||
146115695|NCT00460408|526940704|FG000|Overall Study|Death|7|||
146115696|NCT00460408|526940705|FG001|Overall Study|Death|0|||
146115697|NCT00460408|526940706|FG002|Overall Study|Death|0|||
146115698|NCT00460408|526940707|FG003|Overall Study|Death|0|||
146115699|NCT00460408|526940704|FG000|Overall Study|Lost to Follow-up|11|||
146115700|NCT00460408|526940705|FG001|Overall Study|Lost to Follow-up|0|||
146115701|NCT00460408|526940706|FG002|Overall Study|Lost to Follow-up|1|||
146115702|NCT00460408|526940707|FG003|Overall Study|Lost to Follow-up|0|||
146115703|NCT00460408|526940704|FG000|Overall Study|Withdrawal by Subject|31|||
146115704|NCT00460408|526940705|FG001|Overall Study|Withdrawal by Subject|0|||
146115705|NCT00460408|526940706|FG002|Overall Study|Withdrawal by Subject|0|||
146115706|NCT00460408|526940707|FG003|Overall Study|Withdrawal by Subject|0|||
146115707|NCT00460408|526940704|FG000|Overall Study|Insufficient clinical response|5|||
146115708|NCT00460408|526940705|FG001|Overall Study|Insufficient clinical response|1|||
146115709|NCT00460408|526940706|FG002|Overall Study|Insufficient clinical response|5|||
146115710|NCT00460408|526940707|FG003|Overall Study|Insufficient clinical response|0|||
146115711|NCT00460408|526940704|FG000|Overall Study|Other|12|||
146115712|NCT00460408|526940705|FG001|Overall Study|Other|2|||
146115713|NCT00460408|526940706|FG002|Overall Study|Other|0|||
146115714|NCT00460408|526940707|FG003|Overall Study|Other|0|||
146115715|NCT01979016|526940708|FG000|Overall Study|Withdrawal by Subject|2|||
146115716|NCT01979016|526940709|FG001|Overall Study|Withdrawal by Subject|0|||
146115717|NCT01979016|526940708|FG000|Overall Study|Adverse Event|0|||
146115718|NCT01979016|526940709|FG001|Overall Study|Adverse Event|1|||
146115719|NCT04983264|526940710|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
146115720|NCT04983264|526940711|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
146115721|NCT04983264|526940712|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
146115722|NCT04983264|526940710|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
146115723|NCT04983264|526940711|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
146115724|NCT04983264|526940712|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
146115725|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
146115726|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
146115727|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
146115728|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
146115729|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
146115730|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
146115731|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
146115732|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
146302360|NCT00467779|527621659|FG007|Stage 2A|Unspecified Reason|0|||
146302361|NCT00467779|527621660|FG008|Stage 2A|Unspecified Reason|0|||
146302362|NCT00467779|527621661|FG009|Stage 2A|Unspecified Reason|0|||
146302363|NCT00467779|527621662|FG010|Stage 2A|Unspecified Reason|0|||
146302364|NCT00467779|527621663|FG011|Stage 2A|Unspecified Reason|0|||
146302365|NCT00467779|527621664|FG012|Stage 2A|Unspecified Reason|0|||
146302366|NCT00467779|527621665|FG013|Stage 2A|Unspecified Reason|7|||
146302367|NCT00467779|527621666|FG014|Stage 2A|Unspecified Reason|0|||
146302368|NCT00467779|527621652|FG000|Stage 2A|Withdrawal by Subject|0|||
146302369|NCT00467779|527621653|FG001|Stage 2A|Withdrawal by Subject|0|||
146302370|NCT00467779|527621654|FG002|Stage 2A|Withdrawal by Subject|0|||
146302371|NCT00467779|527621655|FG003|Stage 2A|Withdrawal by Subject|0|||
146302372|NCT00467779|527621656|FG004|Stage 2A|Withdrawal by Subject|0|||
146302373|NCT00467779|527621657|FG005|Stage 2A|Withdrawal by Subject|0|||
146302374|NCT00467779|527621658|FG006|Stage 2A|Withdrawal by Subject|0|||
146302375|NCT00467779|527621659|FG007|Stage 2A|Withdrawal by Subject|0|||
146302376|NCT00467779|527621660|FG008|Stage 2A|Withdrawal by Subject|0|||
146115733|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
146302377|NCT00467779|527621661|FG009|Stage 2A|Withdrawal by Subject|0|||
146302378|NCT00467779|527621662|FG010|Stage 2A|Withdrawal by Subject|0|||
146302379|NCT00467779|527621663|FG011|Stage 2A|Withdrawal by Subject|0|||
146302380|NCT00467779|527621664|FG012|Stage 2A|Withdrawal by Subject|0|||
146302381|NCT00467779|527621665|FG013|Stage 2A|Withdrawal by Subject|1|||
146302382|NCT00467779|527621666|FG014|Stage 2A|Withdrawal by Subject|0|||
146302383|NCT00467779|527621652|FG000|Stage 3|Adverse Event|0|||
146302384|NCT00467779|527621653|FG001|Stage 3|Adverse Event|0|||
146302385|NCT00467779|527621654|FG002|Stage 3|Adverse Event|0|||
146115734|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
146115735|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
146115736|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
146115737|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
146115738|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
146302386|NCT00467779|527621655|FG003|Stage 3|Adverse Event|0|||
146302387|NCT00467779|527621656|FG004|Stage 3|Adverse Event|0|||
146302388|NCT00467779|527621657|FG005|Stage 3|Adverse Event|0|||
146302389|NCT00467779|527621658|FG006|Stage 3|Adverse Event|0|||
146115739|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
146115740|NCT01124422|526940713|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
146115741|NCT01124422|526940714|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
146115742|NCT01124422|526940715|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
146115743|NCT01124422|526940713|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
146115744|NCT01124422|526940714|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
146115745|NCT01124422|526940715|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
146115746|NCT01124422|526940713|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
146115747|NCT01124422|526940714|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
146115748|NCT01124422|526940715|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
146115749|NCT01124422|526940713|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
146115750|NCT01124422|526940714|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
146115751|NCT01124422|526940715|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
146115752|NCT01124422|526940713|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
146115753|NCT01124422|526940714|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
146115754|NCT01124422|526940715|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
146115755|NCT00938639|526940716|FG000|Overall Study|Moved away from study area|0|||
146115756|NCT00938639|526940717|FG001|Overall Study|Moved away from study area|1|||
146115757|NCT00938639|526940716|FG000|Overall Study|Lost to Follow-up|1|||
146115758|NCT00938639|526940717|FG001|Overall Study|Lost to Follow-up|2|||
146115759|NCT00938639|526940716|FG000|Overall Study|Family issues|1|||
146115760|NCT00938639|526940717|FG001|Overall Study|Family issues|1|||
146115761|NCT00938639|526940716|FG000|Overall Study|Participant noncompliance|1|||
146115762|NCT00938639|526940717|FG001|Overall Study|Participant noncompliance|0|||
146115763|NCT04326231|526940723|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
146115764|NCT03303079|526940724|FG000|Overall Study|Adverse Event|0|||
146115765|NCT03303079|526940725|FG001|Overall Study|Adverse Event|1|||
146115766|NCT03303079|526940726|FG002|Overall Study|Adverse Event|3|||
146115767|NCT03303079|526940724|FG000|Overall Study|Protocol Violation|5|||
146115768|NCT03303079|526940725|FG001|Overall Study|Protocol Violation|4|||
146115769|NCT03303079|526940726|FG002|Overall Study|Protocol Violation|7|||
146115770|NCT03303079|526940724|FG000|Overall Study|Withdrawal by Subject|2|||
146115771|NCT03303079|526940725|FG001|Overall Study|Withdrawal by Subject|4|||
146115772|NCT03303079|526940726|FG002|Overall Study|Withdrawal by Subject|2|||
146115773|NCT03303079|526940724|FG000|Overall Study|Other than specified|0|||
146115774|NCT03303079|526940725|FG001|Overall Study|Other than specified|2|||
146115775|NCT03303079|526940726|FG002|Overall Study|Other than specified|0|||
146115776|NCT00587639|526940749|FG000|Overall Study|Withdrawal by Subject|1|||
146115777|NCT00160251|526940754|FG000|Prior to Amendment 2|Adverse Event|2|||
146115778|NCT00160251|526940755|FG001|Prior to Amendment 2|Adverse Event|1|||
146115779|NCT00160251|526940756|FG002|Prior to Amendment 2|Adverse Event|3|||
146115780|NCT00160251|526940757|FG003|Prior to Amendment 2|Adverse Event|1|||
146115781|NCT00160251|526940758|FG004|Prior to Amendment 2|Adverse Event|1|||
146115782|NCT00160251|526940759|FG005|Prior to Amendment 2|Adverse Event|1|||
146115783|NCT00160251|526940760|FG006|Prior to Amendment 2|Adverse Event|1|||
146115784|NCT00160251|526940761|FG007|Prior to Amendment 2|Adverse Event|0|||
146115785|NCT00160251|526940754|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
146115786|NCT00160251|526940755|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
146115787|NCT00160251|526940756|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
146115788|NCT00160251|526940757|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
146115789|NCT00160251|526940758|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
146115790|NCT00160251|526940759|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
146115791|NCT00160251|526940760|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
146115792|NCT00160251|526940761|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
146115793|NCT00160251|526940754|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
146115794|NCT00160251|526940755|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
146115795|NCT00160251|526940756|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
146115796|NCT00160251|526940757|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
146115797|NCT00160251|526940758|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
146115798|NCT00160251|526940759|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
146115799|NCT00160251|526940760|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
146115800|NCT00160251|526940761|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
146115801|NCT00160251|526940754|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
146115802|NCT00160251|526940755|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
146115803|NCT00160251|526940756|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
146115804|NCT00160251|526940757|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
146115805|NCT00160251|526940758|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
146115806|NCT00160251|526940759|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
146115807|NCT00160251|526940760|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
146115808|NCT00160251|526940761|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
146115809|NCT00160251|526940754|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
146302390|NCT00467779|527621659|FG007|Stage 3|Adverse Event|0|||
146302391|NCT00467779|527621660|FG008|Stage 3|Adverse Event|0|||
146115810|NCT00160251|526940755|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
146115811|NCT00160251|526940756|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
146115812|NCT00160251|526940757|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
146115813|NCT00160251|526940758|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
146115814|NCT00160251|526940759|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
146115815|NCT00160251|526940760|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
146115816|NCT00160251|526940761|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
146115817|NCT00160251|526940754|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
146115818|NCT00160251|526940755|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
146115819|NCT00160251|526940756|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
146115820|NCT00160251|526940757|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
146115821|NCT00160251|526940758|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
146115822|NCT00160251|526940759|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
146115823|NCT00160251|526940760|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
146115824|NCT00160251|526940761|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
146115825|NCT00160251|526940754|FG000|Post-amendment 2|Adverse Event|0|||
146115826|NCT00160251|526940755|FG001|Post-amendment 2|Adverse Event|0|||
146115827|NCT00160251|526940756|FG002|Post-amendment 2|Adverse Event|0|||
146115828|NCT00160251|526940757|FG003|Post-amendment 2|Adverse Event|0|||
146115829|NCT00160251|526940758|FG004|Post-amendment 2|Adverse Event|0|||
146115830|NCT00160251|526940759|FG005|Post-amendment 2|Adverse Event|0|||
146115831|NCT00160251|526940760|FG006|Post-amendment 2|Adverse Event|0|||
146115832|NCT00160251|526940761|FG007|Post-amendment 2|Adverse Event|20|||
146115833|NCT00160251|526940754|FG000|Post-amendment 2|Lack of Efficacy|0|||
146115834|NCT00160251|526940755|FG001|Post-amendment 2|Lack of Efficacy|0|||
146115835|NCT00160251|526940756|FG002|Post-amendment 2|Lack of Efficacy|0|||
146115836|NCT00160251|526940757|FG003|Post-amendment 2|Lack of Efficacy|0|||
146115837|NCT00160251|526940758|FG004|Post-amendment 2|Lack of Efficacy|0|||
146115838|NCT00160251|526940759|FG005|Post-amendment 2|Lack of Efficacy|0|||
146115839|NCT00160251|526940760|FG006|Post-amendment 2|Lack of Efficacy|0|||
146115840|NCT00160251|526940761|FG007|Post-amendment 2|Lack of Efficacy|24|||
146115841|NCT00160251|526940754|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115842|NCT00160251|526940755|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115843|NCT00160251|526940756|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115844|NCT00160251|526940757|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115845|NCT00160251|526940758|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115846|NCT00160251|526940759|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115847|NCT00160251|526940760|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
146115848|NCT00160251|526940761|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
146115849|NCT01574612|526940764|FG000|Overall Study|Adverse Event|3|||
146115850|NCT01574612|526940764|FG000|Overall Study|non compliant with drug|2|||
146115851|NCT01574612|526940764|FG000|Overall Study|Withdrawal by Subject|1|||
146115852|NCT01574612|526940764|FG000|Overall Study|Lost to Follow-up|2|||
146115853|NCT00582166|526940765|FG000|Overall Study|Death|1|||
146115854|NCT00582166|526940765|FG000|Overall Study|Ineligible pathology|1|||
146115855|NCT01606436|526940766|FG000|Overall Study|Withdrawal by Subject|0|||
146115856|NCT01606436|526940767|FG001|Overall Study|Withdrawal by Subject|0|||
146115857|NCT01606436|526940768|FG002|Overall Study|Withdrawal by Subject|1|||
146115858|NCT01606436|526940769|FG003|Overall Study|Withdrawal by Subject|1|||
146115859|NCT01606436|526940770|FG004|Overall Study|Withdrawal by Subject|1|||
146115860|NCT01606436|526940771|FG005|Overall Study|Withdrawal by Subject|0|||
146115861|NCT01606436|526940766|FG000|Overall Study|Adverse Event|0|||
146115862|NCT01606436|526940767|FG001|Overall Study|Adverse Event|0|||
146115863|NCT01606436|526940768|FG002|Overall Study|Adverse Event|1|||
146115864|NCT01606436|526940769|FG003|Overall Study|Adverse Event|0|||
146115865|NCT01606436|526940770|FG004|Overall Study|Adverse Event|0|||
146115866|NCT01606436|526940771|FG005|Overall Study|Adverse Event|0|||
146115867|NCT01606436|526940766|FG000|Overall Study|Sponsor Decision|0|||
146115868|NCT01606436|526940767|FG001|Overall Study|Sponsor Decision|0|||
146115869|NCT01606436|526940768|FG002|Overall Study|Sponsor Decision|0|||
146115870|NCT01606436|526940769|FG003|Overall Study|Sponsor Decision|1|||
146115871|NCT01606436|526940770|FG004|Overall Study|Sponsor Decision|0|||
146115872|NCT01606436|526940771|FG005|Overall Study|Sponsor Decision|0|||
146115873|NCT00110149|526940772|FG000|Overall Study|Physician Decision|3|||
146115874|NCT01922089|526940775|FG000|Overall Study|Adverse Event|18|||
146115875|NCT01922089|526940776|FG001|Overall Study|Adverse Event|13|||
146115876|NCT01922089|526940775|FG000|Overall Study|Protocol Deviation|10|||
146115877|NCT01922089|526940776|FG001|Overall Study|Protocol Deviation|7|||
146115878|NCT01922089|526940775|FG000|Overall Study|Withdrawal by Subject|3|||
146115879|NCT01922089|526940776|FG001|Overall Study|Withdrawal by Subject|4|||
146115880|NCT01922089|526940775|FG000|Overall Study|administrative problems|4|||
146115881|NCT01922089|526940776|FG001|Overall Study|administrative problems|1|||
146115882|NCT01922089|526940775|FG000|Overall Study|Physician Decision|2|||
146115883|NCT01922089|526940776|FG001|Overall Study|Physician Decision|3|||
146115884|NCT01922089|526940775|FG000|Overall Study|Death|2|||
146115885|NCT01922089|526940776|FG001|Overall Study|Death|1|||
146115886|NCT01922089|526940775|FG000|Overall Study|Lost to Follow-up|0|||
146115887|NCT01922089|526940776|FG001|Overall Study|Lost to Follow-up|1|||
146115888|NCT00434330|526940781|FG000|Overall Study|Adverse Event|0|||
146115889|NCT00434330|526940782|FG001|Overall Study|Adverse Event|0|||
146115890|NCT00434330|526940783|FG002|Overall Study|Adverse Event|1|||
146115891|NCT00434330|526940784|FG003|Overall Study|Adverse Event|0|||
146115892|NCT00434330|526940785|FG004|Overall Study|Adverse Event|0|||
146115893|NCT00434330|526940786|FG005|Overall Study|Adverse Event|0|||
146115894|NCT00434330|526940781|FG000|Overall Study|Death|1|||
146115895|NCT00434330|526940782|FG001|Overall Study|Death|0|||
146115896|NCT00434330|526940783|FG002|Overall Study|Death|0|||
146115897|NCT00434330|526940784|FG003|Overall Study|Death|0|||
146115898|NCT00434330|526940785|FG004|Overall Study|Death|1|||
146115899|NCT00434330|526940786|FG005|Overall Study|Death|1|||
146260698|NCT02080403|527470727|FG001|Overall Study|Death|2|||
146260699|NCT02080403|527470726|FG000|Overall Study|Lost to Follow-up|2|||
146260700|NCT02080403|527470727|FG001|Overall Study|Lost to Follow-up|0|||
146260701|NCT02080403|527470726|FG000|Overall Study|Pregnancy|0|||
146260702|NCT02080403|527470727|FG001|Overall Study|Pregnancy|1|||
146260703|NCT02080403|527470726|FG000|Overall Study|Protocol Violation|3|||
146260704|NCT02080403|527470727|FG001|Overall Study|Protocol Violation|7|||
146260705|NCT02080403|527470726|FG000|Overall Study|Withdrawal by Subject|5|||
146260706|NCT02080403|527470727|FG001|Overall Study|Withdrawal by Subject|1|||
146260707|NCT01999972|527470728|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
146260708|NCT01999972|527470729|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
146260709|NCT01999972|527470730|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
146260710|NCT01999972|527470731|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
146260711|NCT01999972|527470732|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
146260712|NCT01999972|527470733|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
146260713|NCT01999972|527470728|FG000|Dose Escalation Part|Death|0|||
146260714|NCT01999972|527470729|FG001|Dose Escalation Part|Death|1|||
146260715|NCT01999972|527470730|FG002|Dose Escalation Part|Death|0|||
146260716|NCT01999972|527470731|FG003|Dose Escalation Part|Death|0|||
146260717|NCT01999972|527470732|FG004|Dose Escalation Part|Death|0|||
146260718|NCT01999972|527470733|FG005|Dose Escalation Part|Death|0|||
146260719|NCT01999972|527470728|FG000|Dose Escalation Part|Enrolled but not treated|0|||
146260720|NCT01999972|527470729|FG001|Dose Escalation Part|Enrolled but not treated|0|||
146260721|NCT01999972|527470730|FG002|Dose Escalation Part|Enrolled but not treated|1|||
146260722|NCT01999972|527470731|FG003|Dose Escalation Part|Enrolled but not treated|1|||
146260723|NCT01999972|527470732|FG004|Dose Escalation Part|Enrolled but not treated|0|||
146260724|NCT01999972|527470733|FG005|Dose Escalation Part|Enrolled but not treated|0|||
146260725|NCT01999972|527470728|FG000|Dose Escalation Part|Disease progression|3|||
146260726|NCT01999972|527470729|FG001|Dose Escalation Part|Disease progression|2|||
146260727|NCT01999972|527470730|FG002|Dose Escalation Part|Disease progression|3|||
146260728|NCT01999972|527470731|FG003|Dose Escalation Part|Disease progression|6|||
146260729|NCT01999972|527470732|FG004|Dose Escalation Part|Disease progression|0|||
146260730|NCT01999972|527470733|FG005|Dose Escalation Part|Disease progression|0|||
146260731|NCT01999972|527470728|FG000|Dose Escalation Part|Adverse Event|0|||
146260732|NCT01999972|527470729|FG001|Dose Escalation Part|Adverse Event|0|||
146260733|NCT01999972|527470730|FG002|Dose Escalation Part|Adverse Event|0|||
146260734|NCT01999972|527470731|FG003|Dose Escalation Part|Adverse Event|2|||
146260735|NCT01999972|527470732|FG004|Dose Escalation Part|Adverse Event|0|||
146260736|NCT01999972|527470733|FG005|Dose Escalation Part|Adverse Event|0|||
146260737|NCT01999972|527470728|FG000|Dose Escalation Part|Global deterioration of health status|1|||
146260738|NCT01999972|527470729|FG001|Dose Escalation Part|Global deterioration of health status|0|||
146260739|NCT01999972|527470730|FG002|Dose Escalation Part|Global deterioration of health status|0|||
146260740|NCT01999972|527470731|FG003|Dose Escalation Part|Global deterioration of health status|1|||
146260741|NCT01999972|527470732|FG004|Dose Escalation Part|Global deterioration of health status|0|||
146260742|NCT01999972|527470733|FG005|Dose Escalation Part|Global deterioration of health status|0|||
146260743|NCT01999972|527470728|FG000|Dose Expansion Part|Death|0|||
146260744|NCT01999972|527470729|FG001|Dose Expansion Part|Death|0|||
146260745|NCT01999972|527470730|FG002|Dose Expansion Part|Death|0|||
146260746|NCT01999972|527470731|FG003|Dose Expansion Part|Death|0|||
146260747|NCT01999972|527470732|FG004|Dose Expansion Part|Death|2|||
146260748|NCT01999972|527470733|FG005|Dose Expansion Part|Death|1|||
146260749|NCT01999972|527470728|FG000|Dose Expansion Part|Disease progression|0|||
146260750|NCT01999972|527470729|FG001|Dose Expansion Part|Disease progression|0|||
146260751|NCT01999972|527470730|FG002|Dose Expansion Part|Disease progression|0|||
146260752|NCT01999972|527470731|FG003|Dose Expansion Part|Disease progression|0|||
146260753|NCT01999972|527470732|FG004|Dose Expansion Part|Disease progression|9|||
146260754|NCT01999972|527470733|FG005|Dose Expansion Part|Disease progression|3|||
146260755|NCT01999972|527470728|FG000|Dose Expansion Part|Sponsor decision|0|||
146260756|NCT01999972|527470729|FG001|Dose Expansion Part|Sponsor decision|0|||
146302392|NCT00467779|527621661|FG009|Stage 3|Adverse Event|0|||
146302393|NCT00467779|527621662|FG010|Stage 3|Adverse Event|0|||
146115900|NCT00434330|526940781|FG000|Overall Study|Withdrawal by Subject|0|||
146115901|NCT00434330|526940782|FG001|Overall Study|Withdrawal by Subject|0|||
146115902|NCT00434330|526940783|FG002|Overall Study|Withdrawal by Subject|1|||
146115903|NCT00434330|526940784|FG003|Overall Study|Withdrawal by Subject|1|||
146115904|NCT00434330|526940785|FG004|Overall Study|Withdrawal by Subject|0|||
146115905|NCT00434330|526940786|FG005|Overall Study|Withdrawal by Subject|0|||
146115906|NCT00434330|526940781|FG000|Overall Study|Renal transplant|0|||
146115907|NCT00434330|526940782|FG001|Overall Study|Renal transplant|0|||
146115908|NCT00434330|526940783|FG002|Overall Study|Renal transplant|0|||
146115909|NCT00434330|526940784|FG003|Overall Study|Renal transplant|1|||
146115910|NCT00434330|526940785|FG004|Overall Study|Renal transplant|0|||
146115911|NCT00434330|526940786|FG005|Overall Study|Renal transplant|0|||
146115912|NCT00434330|526940781|FG000|Overall Study|Subject Not Compliant With Study|0|||
146115913|NCT00434330|526940782|FG001|Overall Study|Subject Not Compliant With Study|0|||
146115914|NCT00434330|526940783|FG002|Overall Study|Subject Not Compliant With Study|1|||
146115915|NCT00434330|526940784|FG003|Overall Study|Subject Not Compliant With Study|0|||
146115916|NCT00434330|526940785|FG004|Overall Study|Subject Not Compliant With Study|0|||
146115917|NCT00434330|526940786|FG005|Overall Study|Subject Not Compliant With Study|0|||
146115918|NCT01428453|526940787|FG000|Overall Study|Adverse Event|2|||
146115919|NCT01428453|526940788|FG001|Overall Study|Adverse Event|7|||
146115920|NCT01428453|526940787|FG000|Overall Study|Protocol Violation|1|||
146115921|NCT01428453|526940788|FG001|Overall Study|Protocol Violation|0|||
146115922|NCT01428453|526940787|FG000|Overall Study|Lost to Follow-up|0|||
146115923|NCT01428453|526940788|FG001|Overall Study|Lost to Follow-up|1|||
146115924|NCT01428453|526940787|FG000|Overall Study|Withdrawal by Subject|3|||
146115925|NCT01428453|526940788|FG001|Overall Study|Withdrawal by Subject|1|||
146115926|NCT01996709|526940789|FG000|Overall Study|Withdrawal by Subject|1|||
146115927|NCT01996709|526940790|FG001|Overall Study|Withdrawal by Subject|0|||
146115928|NCT01996709|526940789|FG000|Overall Study|Lost to Follow-up|3|||
146115929|NCT01996709|526940790|FG001|Overall Study|Lost to Follow-up|0|||
146115930|NCT01996709|526940789|FG000|Overall Study|Subject Non-Compliant|1|||
146115931|NCT01996709|526940790|FG001|Overall Study|Subject Non-Compliant|0|||
146115932|NCT01996709|526940789|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
146115933|NCT01996709|526940790|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
146115934|NCT04853225|526940793|FG000|Overall Study|Withdrawal by Subject|81|||
146115935|NCT04853225|526940794|FG001|Overall Study|Withdrawal by Subject|4|||
146115936|NCT04853225|526940795|FG002|Overall Study|Withdrawal by Subject|1|||
146115937|NCT04853225|526940793|FG000|Overall Study|Physician Decision|12|||
146115938|NCT04853225|526940794|FG001|Overall Study|Physician Decision|4|||
146115939|NCT04853225|526940795|FG002|Overall Study|Physician Decision|1|||
146115940|NCT04853225|526940793|FG000|Overall Study|Lost to Follow-up|50|||
146115941|NCT04853225|526940794|FG001|Overall Study|Lost to Follow-up|0|||
146115942|NCT04853225|526940795|FG002|Overall Study|Lost to Follow-up|0|||
146115943|NCT04853225|526940793|FG000|Overall Study|Other|102|||
146115944|NCT04853225|526940794|FG001|Overall Study|Other|11|||
146115945|NCT04853225|526940795|FG002|Overall Study|Other|5|||
146115946|NCT04853225|526940793|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
146115947|NCT04853225|526940794|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
146115948|NCT04853225|526940795|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
146115949|NCT04853225|526940793|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
146115950|NCT04853225|526940794|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
146115951|NCT04853225|526940795|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
146115952|NCT00850564|526940796|FG000|Overall Study|Withdrawal by Subject|2|||
146115953|NCT00848081|526942692|FG000|Overall Study|Adverse Event|6|||
146115954|NCT00848081|526942693|FG001|Overall Study|Adverse Event|7|||
146115955|NCT00848081|526942692|FG000|Overall Study|Protocol Violation|8|||
146302394|NCT00467779|527621663|FG011|Stage 3|Adverse Event|0|||
146302395|NCT00467779|527621664|FG012|Stage 3|Adverse Event|0|||
146302396|NCT00467779|527621665|FG013|Stage 3|Adverse Event|0|||
146115956|NCT00848081|526942693|FG001|Overall Study|Protocol Violation|5|||
146115957|NCT00848081|526942692|FG000|Overall Study|Lost to Follow-up|1|||
146115958|NCT00848081|526942693|FG001|Overall Study|Lost to Follow-up|0|||
146115959|NCT00848081|526942692|FG000|Overall Study|Physician Decision|0|||
146115960|NCT00848081|526942693|FG001|Overall Study|Physician Decision|3|||
146115961|NCT00848081|526942692|FG000|Overall Study|Withdrawal by Subject|5|||
146115962|NCT00848081|526942693|FG001|Overall Study|Withdrawal by Subject|3|||
146115963|NCT00609492|526942694|FG000|Overall Study|Withdrawal by Subject|0|||
146302397|NCT00467779|527621666|FG014|Stage 3|Adverse Event|2|||
146302398|NCT00467779|527621652|FG000|Stage 3|Death|0|||
146302399|NCT00467779|527621653|FG001|Stage 3|Death|0|||
146302400|NCT00467779|527621654|FG002|Stage 3|Death|0|||
146302401|NCT00467779|527621655|FG003|Stage 3|Death|0|||
146115964|NCT00609492|526942695|FG001|Overall Study|Withdrawal by Subject|2|||
146115965|NCT00609492|526942696|FG002|Overall Study|Withdrawal by Subject|3|||
146302402|NCT00467779|527621656|FG004|Stage 3|Death|0|||
146115966|NCT00609492|526942694|FG000|Overall Study|Lost to Follow-up|1|||
146115967|NCT00609492|526942695|FG001|Overall Study|Lost to Follow-up|1|||
146115968|NCT00609492|526942696|FG002|Overall Study|Lost to Follow-up|4|||
146115969|NCT00720434|526942697|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146115970|NCT00720434|526942698|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
146115971|NCT00720434|526942699|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146115972|NCT00720434|526942700|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
146115973|NCT00720434|526942697|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
146115974|NCT00720434|526942698|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
146115975|NCT00720434|526942699|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
146115976|NCT00720434|526942700|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
146115977|NCT00720434|526942697|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
146115978|NCT00720434|526942698|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146115979|NCT00720434|526942699|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146115980|NCT00720434|526942700|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
146115981|NCT00720434|526942697|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
146115982|NCT00720434|526942698|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
146115983|NCT00720434|526942699|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
146115984|NCT00720434|526942700|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
146115985|NCT00720434|526942697|FG000|Open-Label Period (Week 5-72)|Other|4|||
146115986|NCT00720434|526942698|FG001|Open-Label Period (Week 5-72)|Other|3|||
146115987|NCT00720434|526942699|FG002|Open-Label Period (Week 5-72)|Other|3|||
146115988|NCT00720434|526942700|FG003|Open-Label Period (Week 5-72)|Other|2|||
146115989|NCT00142584|526942701|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
146115990|NCT00142584|526942702|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
146115991|NCT00142584|526942701|FG000|Overall Study|Withdrawal by Subject|30|||
146115992|NCT00142584|526942702|FG001|Overall Study|Withdrawal by Subject|16|||
146115993|NCT00142584|526942701|FG000|Overall Study|Lost to Follow-up|22|||
146115994|NCT00142584|526942702|FG001|Overall Study|Lost to Follow-up|12|||
146115995|NCT00142584|526942701|FG000|Overall Study|Adverse Event|14|||
146115996|NCT00142584|526942702|FG001|Overall Study|Adverse Event|5|||
146115997|NCT00142584|526942701|FG000|Overall Study|Protocol Violation|4|||
146115998|NCT00142584|526942702|FG001|Overall Study|Protocol Violation|7|||
146115999|NCT00142584|526942701|FG000|Overall Study|Treatment Failure|2|||
146116000|NCT00142584|526942702|FG001|Overall Study|Treatment Failure|0|||
146116001|NCT00759954|526942706|FG000|Overall Study|Personal reason|1|||
146116002|NCT00759954|526942707|FG001|Overall Study|Personal reason|0|||
146116003|NCT00759954|526942706|FG000|Overall Study|Adverse Event|1|||
146116004|NCT00759954|526942707|FG001|Overall Study|Adverse Event|2|||
146116005|NCT03315208|526942708|FG000|Overall Study|Lost to Follow-up|11|||
146116006|NCT03315208|526942709|FG001|Overall Study|Lost to Follow-up|6|||
146116007|NCT03315208|526942708|FG000|Overall Study|Withdrawal by Subject|2|||
146116008|NCT03315208|526942709|FG001|Overall Study|Withdrawal by Subject|0|||
146116009|NCT02875860|526942712|FG000|Overall Study|Withdrawal by Subject|0|||
146116010|NCT02875860|526942713|FG001|Overall Study|Withdrawal by Subject|1|||
146116011|NCT01156311|526942723|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
146116012|NCT01156311|526942724|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
146116013|NCT01156311|526942725|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
146116014|NCT01156311|526942726|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
146116015|NCT01156311|526942723|FG000|2-Month Monotherapy Period|Physician Decision|0|||
146116016|NCT01156311|526942724|FG001|2-Month Monotherapy Period|Physician Decision|1|||
146116017|NCT01156311|526942725|FG002|2-Month Monotherapy Period|Physician Decision|0|||
146116018|NCT01156311|526942726|FG003|2-Month Monotherapy Period|Physician Decision|0|||
146116019|NCT01156311|526942723|FG000|2-Month Monotherapy Period|Other|1|||
146116020|NCT01156311|526942724|FG001|2-Month Monotherapy Period|Other|0|||
146116021|NCT01156311|526942725|FG002|2-Month Monotherapy Period|Other|0|||
146116022|NCT01156311|526942726|FG003|2-Month Monotherapy Period|Other|0|||
146302403|NCT00467779|527621657|FG005|Stage 3|Death|0|||
146302404|NCT00467779|527621658|FG006|Stage 3|Death|0|||
146302405|NCT00467779|527621659|FG007|Stage 3|Death|0|||
146116023|NCT01156311|526942723|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
146302406|NCT00467779|527621660|FG008|Stage 3|Death|0|||
146302407|NCT00467779|527621661|FG009|Stage 3|Death|0|||
146302408|NCT00467779|527621662|FG010|Stage 3|Death|0|||
146302409|NCT00467779|527621663|FG011|Stage 3|Death|0|||
146302410|NCT00467779|527621664|FG012|Stage 3|Death|0|||
146302411|NCT00467779|527621665|FG013|Stage 3|Death|0|||
146116024|NCT01156311|526942724|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
146116025|NCT01156311|526942725|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
146116026|NCT01156311|526942726|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
146116027|NCT01156311|526942723|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146116028|NCT01156311|526942724|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146116029|NCT01156311|526942725|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
146302412|NCT00467779|527621666|FG014|Stage 3|Death|1|||
146302413|NCT00467779|527621652|FG000|Stage 3|Disease Progression|0|||
146302414|NCT00467779|527621653|FG001|Stage 3|Disease Progression|0|||
146116030|NCT01156311|526942726|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
146116031|NCT01156311|526942723|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
146116032|NCT01156311|526942724|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
146116033|NCT01156311|526942725|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
146116034|NCT01156311|526942726|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
146116035|NCT01156311|526942723|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
146116036|NCT01156311|526942724|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
146116037|NCT01156311|526942725|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
146116038|NCT01156311|526942726|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
146116039|NCT01156311|526942723|FG000|6-month Add-on Therapy Period|Other|0|||
146116040|NCT01156311|526942724|FG001|6-month Add-on Therapy Period|Other|0|||
146116041|NCT01156311|526942725|FG002|6-month Add-on Therapy Period|Other|1|||
146116042|NCT01156311|526942726|FG003|6-month Add-on Therapy Period|Other|2|||
146116043|NCT01741701|526942729|FG000|Overall Study|Adverse Event|5|||
146116044|NCT01741701|526942730|FG001|Overall Study|Adverse Event|1|||
146116045|NCT01741701|526942729|FG000|Overall Study|Withdrawal by Subject|0|||
146116046|NCT01741701|526942730|FG001|Overall Study|Withdrawal by Subject|1|||
146116047|NCT03033394|526942731|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
146116048|NCT03033394|526942731|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
146116049|NCT03033394|526942731|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
146116050|NCT03033394|526942731|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
146116051|NCT03033394|526942731|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
146116052|NCT02927431|526942733|FG000|Overall Study|Withdrawal by Subject|0|||
146116053|NCT02927431|526942734|FG001|Overall Study|Withdrawal by Subject|0|||
146116054|NCT02927431|526942735|FG002|Overall Study|Withdrawal by Subject|1|||
146116055|NCT01830972|526942736|FG000|Part II|Withdrawal by Subject|2|||
146116056|NCT01830972|526942737|FG001|Part II|Withdrawal by Subject|2|||
146116057|NCT01830972|526942736|FG000|Part III|Withdrawal by Subject|1|||
146116058|NCT01830972|526942737|FG001|Part III|Withdrawal by Subject|0|||
146116059|NCT01830972|526942736|FG000|Part III|Noncompliance|1|||
146116060|NCT01830972|526942737|FG001|Part III|Noncompliance|0|||
146116061|NCT01830972|526942736|FG000|Part IV|Withdrawal by Subject|2|||
146116062|NCT01830972|526942737|FG001|Part IV|Withdrawal by Subject|1|||
146116063|NCT01830972|526942736|FG000|Part IV|Non-Compliance|1|||
146116064|NCT01830972|526942737|FG001|Part IV|Non-Compliance|0|||
146116065|NCT00673465|526942738|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116066|NCT00673465|526942739|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116067|NCT00673465|526942740|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116068|NCT00673465|526942741|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116069|NCT00673465|526942742|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
146116070|NCT00673465|526942743|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
146116071|NCT00673465|526942744|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116072|NCT00673465|526942745|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116073|NCT00673465|526942746|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116074|NCT00673465|526942747|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116075|NCT00673465|526942748|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116076|NCT00673465|526942749|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
146116077|NCT00673465|526942738|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116078|NCT00673465|526942739|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116079|NCT00673465|526942740|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116080|NCT00673465|526942741|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116081|NCT00673465|526942742|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
146116082|NCT00673465|526942743|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116083|NCT00673465|526942744|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116084|NCT00673465|526942745|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116085|NCT00673465|526942746|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116086|NCT00673465|526942747|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116087|NCT00673465|526942748|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116088|NCT00673465|526942749|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
146116089|NCT01829191|526942750|FG000|Overall Study|Relocation|0|||
146116090|NCT01829191|526942751|FG001|Overall Study|Relocation|1|||
146116091|NCT01829191|526942750|FG000|Overall Study|Lens discomfort|0|||
146116092|NCT01829191|526942751|FG001|Overall Study|Lens discomfort|3|||
146116093|NCT01829191|526942750|FG000|Overall Study|Lens handling difficulty|1|||
146116094|NCT01829191|526942751|FG001|Overall Study|Lens handling difficulty|4|||
146116095|NCT01829191|526942750|FG000|Overall Study|Protocol Violation|4|||
146116096|NCT01829191|526942751|FG001|Overall Study|Protocol Violation|1|||
146116097|NCT01829191|526942750|FG000|Overall Study|Withdrawal by Subject|2|||
146116098|NCT01829191|526942751|FG001|Overall Study|Withdrawal by Subject|3|||
146116099|NCT01829191|526942750|FG000|Overall Study|Lost to Follow-up|0|||
146116100|NCT01829191|526942751|FG001|Overall Study|Lost to Follow-up|1|||
146302415|NCT00467779|527621654|FG002|Stage 3|Disease Progression|0|||
146302416|NCT00467779|527621655|FG003|Stage 3|Disease Progression|0|||
146302417|NCT00467779|527621656|FG004|Stage 3|Disease Progression|0|||
146302418|NCT00467779|527621657|FG005|Stage 3|Disease Progression|0|||
146302419|NCT00467779|527621658|FG006|Stage 3|Disease Progression|0|||
146302420|NCT00467779|527621659|FG007|Stage 3|Disease Progression|0|||
146302421|NCT00467779|527621660|FG008|Stage 3|Disease Progression|0|||
146302422|NCT00467779|527621661|FG009|Stage 3|Disease Progression|0|||
146302423|NCT00467779|527621662|FG010|Stage 3|Disease Progression|0|||
146302424|NCT00467779|527621663|FG011|Stage 3|Disease Progression|0|||
146302425|NCT00467779|527621664|FG012|Stage 3|Disease Progression|0|||
146302426|NCT00467779|527621665|FG013|Stage 3|Disease Progression|0|||
146302427|NCT00467779|527621666|FG014|Stage 3|Disease Progression|9|||
146302428|NCT00467779|527621652|FG000|Stage 3|Unspecified Reason|0|||
146302429|NCT00467779|527621653|FG001|Stage 3|Unspecified Reason|0|||
146302430|NCT00467779|527621654|FG002|Stage 3|Unspecified Reason|0|||
146302431|NCT00467779|527621655|FG003|Stage 3|Unspecified Reason|0|||
146302432|NCT00467779|527621656|FG004|Stage 3|Unspecified Reason|0|||
146302433|NCT00467779|527621657|FG005|Stage 3|Unspecified Reason|0|||
146302434|NCT00467779|527621658|FG006|Stage 3|Unspecified Reason|0|||
146302435|NCT00467779|527621659|FG007|Stage 3|Unspecified Reason|0|||
146302436|NCT00467779|527621660|FG008|Stage 3|Unspecified Reason|0|||
146302437|NCT00467779|527621661|FG009|Stage 3|Unspecified Reason|0|||
146302438|NCT00467779|527621662|FG010|Stage 3|Unspecified Reason|0|||
146302439|NCT00467779|527621663|FG011|Stage 3|Unspecified Reason|0|||
146302440|NCT00467779|527621664|FG012|Stage 3|Unspecified Reason|0|||
146302441|NCT00467779|527621665|FG013|Stage 3|Unspecified Reason|0|||
146302442|NCT00467779|527621666|FG014|Stage 3|Unspecified Reason|5|||
146302443|NCT01509079|527621667|FG000|Overall Study|Lack of Efficacy|0|||
146302444|NCT01509079|527621668|FG001|Overall Study|Lack of Efficacy|2|||
146302445|NCT01509079|527621667|FG000|Overall Study|started an excluded medication|0|||
146302446|NCT01509079|527621668|FG001|Overall Study|started an excluded medication|1|||
146302447|NCT05111041|527621669|FG000|Overall Study|Lost to Follow-up|6|||
146302448|NCT05111041|527621670|FG001|Overall Study|Lost to Follow-up|7|||
146302449|NCT05111041|527621669|FG000|Overall Study|Withdrawal by Subject|1|||
146302450|NCT05111041|527621670|FG001|Overall Study|Withdrawal by Subject|0|||
146302451|NCT00041080|527621671|FG000|Overall Study|Adverse Event|21|||
146302452|NCT00041080|527621672|FG001|Overall Study|Adverse Event|1|||
146302453|NCT00041080|527621671|FG000|Overall Study|Withdrawal by Subject|6|||
146302454|NCT00041080|527621672|FG001|Overall Study|Withdrawal by Subject|6|||
146302455|NCT00041080|527621671|FG000|Overall Study|Concommitant Illness/Other|1|||
146302456|NCT00041080|527621672|FG001|Overall Study|Concommitant Illness/Other|2|||
146302457|NCT00041080|527621671|FG000|Overall Study|Did not start therapy|1|||
146302458|NCT00041080|527621672|FG001|Overall Study|Did not start therapy|1|||
146302459|NCT00041080|527621671|FG000|Overall Study|Ineligible|1|||
146302460|NCT00041080|527621672|FG001|Overall Study|Ineligible|0|||
146302461|NCT00436618|527621673|FG000|Overall Study|Withdrawal by Subject|5|||
146302462|NCT00436618|527621674|FG001|Overall Study|Withdrawal by Subject|8|||
146302463|NCT00436618|527621675|FG002|Overall Study|Withdrawal by Subject|11|||
146302464|NCT00436618|527621673|FG000|Overall Study|Adverse Event|8|||
146302465|NCT00436618|527621674|FG001|Overall Study|Adverse Event|8|||
146302466|NCT00436618|527621675|FG002|Overall Study|Adverse Event|9|||
146302467|NCT00436618|527621673|FG000|Overall Study|Alternate Treatment|3|||
146302468|NCT00436618|527621674|FG001|Overall Study|Alternate Treatment|4|||
146302469|NCT00436618|527621675|FG002|Overall Study|Alternate Treatment|12|||
146302470|NCT00436618|527621673|FG000|Overall Study|Other Medical Problems|3|||
146116101|NCT01829191|526942750|FG000|Overall Study|Subject was fit for ortho - k|0|||
146302471|NCT00436618|527621674|FG001|Overall Study|Other Medical Problems|1|||
146302472|NCT00436618|527621675|FG002|Overall Study|Other Medical Problems|7|||
146302473|NCT00436618|527621673|FG000|Overall Study|Death|4|||
146302474|NCT00436618|527621674|FG001|Overall Study|Death|2|||
146302475|NCT00436618|527621675|FG002|Overall Study|Death|3|||
146302476|NCT00436618|527621673|FG000|Overall Study|New Primary or Other Reasons|6|||
146302477|NCT00436618|527621674|FG001|Overall Study|New Primary or Other Reasons|2|||
146302478|NCT00436618|527621675|FG002|Overall Study|New Primary or Other Reasons|12|||
146302479|NCT00436618|527621673|FG000|Overall Study|Still on treatment|1|||
146302480|NCT00436618|527621674|FG001|Overall Study|Still on treatment|2|||
146302481|NCT00436618|527621675|FG002|Overall Study|Still on treatment|7|||
146302482|NCT01011439|527621676|FG000|Overall Study|Death|37|||
146302483|NCT01011439|527621676|FG000|Overall Study|Lost to Follow-up|4|||
146302484|NCT01011439|527621676|FG000|Overall Study|Withdrawal by Subject|1|||
146302485|NCT01011439|527621676|FG000|Overall Study|Sponsor's decision|15|||
146302486|NCT05418673|527621677|FG000|Overall Study|Study Terminated by Sponsor|2|||
146302487|NCT05418673|527621678|FG001|Overall Study|Study Terminated by Sponsor|4|||
146302488|NCT05418673|527621677|FG000|Overall Study|Lost to Follow-up|1|||
146302489|NCT05418673|527621678|FG001|Overall Study|Lost to Follow-up|0|||
146302490|NCT01986920|527621679|FG000|A- 101 25%|Withdrawal by Subject|1|||
146302491|NCT01986920|527621680|FG001|A- 101 25%|Withdrawal by Subject|0|||
146302492|NCT01986920|527621681|FG002|A- 101 25%|Withdrawal by Subject|0|||
146116102|NCT01829191|526942751|FG001|Overall Study|Subject was fit for ortho - k|1|||
146116103|NCT01276353|526942752|FG000|Double-blind|Adverse Event|2|||
146116104|NCT01276353|526942753|FG001|Double-blind|Adverse Event|0|||
146116105|NCT01276353|526942752|FG000|Double-blind|Withdrawal by Subject|1|||
146116106|NCT01276353|526942753|FG001|Double-blind|Withdrawal by Subject|0|||
146116107|NCT01276353|526942752|FG000|Extension|Adverse Event|2|||
146116108|NCT01276353|526942753|FG001|Extension|Adverse Event|5|||
146116109|NCT01276353|526942752|FG000|Extension|Withdrawal by Subject|1|||
146116110|NCT01276353|526942753|FG001|Extension|Withdrawal by Subject|2|||
146116111|NCT01276353|526942752|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
146116112|NCT01276353|526942753|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
146116113|NCT01276353|526942752|FG000|Extension|Physician Decision|1|||
146116114|NCT01276353|526942753|FG001|Extension|Physician Decision|0|||
146116115|NCT01276353|526942752|FG000|Extension|Prohibited concomitant medications|0|||
146116116|NCT01276353|526942753|FG001|Extension|Prohibited concomitant medications|1|||
146116117|NCT00553514|526942754|FG000|Overall Study|Protocol deviation|0|||
146116118|NCT00553514|526942755|FG001|Overall Study|Protocol deviation|0|||
146116119|NCT00553514|526942756|FG002|Overall Study|Protocol deviation|0|||
146116120|NCT00553514|526942757|FG003|Overall Study|Protocol deviation|1|||
146116121|NCT00553514|526942758|FG004|Overall Study|Protocol deviation|0|||
146116122|NCT00553514|526942754|FG000|Overall Study|Lack of ovarian response|4|||
146116123|NCT00553514|526942755|FG001|Overall Study|Lack of ovarian response|5|||
146116124|NCT00553514|526942756|FG002|Overall Study|Lack of ovarian response|5|||
146116125|NCT00553514|526942757|FG003|Overall Study|Lack of ovarian response|5|||
146116126|NCT00553514|526942758|FG004|Overall Study|Lack of ovarian response|6|||
146116127|NCT00553514|526942754|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146116128|NCT00553514|526942755|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146116129|NCT00553514|526942756|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146116130|NCT00553514|526942757|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146116131|NCT00553514|526942758|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
146116132|NCT00553514|526942754|FG000|Overall Study|Risk of multiple pregnancy|0|||
146116133|NCT00553514|526942755|FG001|Overall Study|Risk of multiple pregnancy|2|||
146116134|NCT00553514|526942756|FG002|Overall Study|Risk of multiple pregnancy|0|||
146116135|NCT00553514|526942757|FG003|Overall Study|Risk of multiple pregnancy|1|||
146116136|NCT00553514|526942758|FG004|Overall Study|Risk of multiple pregnancy|0|||
146116137|NCT00553514|526942754|FG000|Overall Study|Other|1|||
146116138|NCT00553514|526942755|FG001|Overall Study|Other|1|||
146116139|NCT00553514|526942756|FG002|Overall Study|Other|0|||
146116140|NCT00553514|526942757|FG003|Overall Study|Other|0|||
146116141|NCT00553514|526942758|FG004|Overall Study|Other|1|||
146116142|NCT04952402|526942759|FG000|Overall Study|Lost to Follow-up|1|||
146116143|NCT04952402|526942760|FG001|Overall Study|Lost to Follow-up|3|||
146116144|NCT04952402|526942759|FG000|Overall Study|Lack Of Venous Access|0|||
146116145|NCT04952402|526942760|FG001|Overall Study|Lack Of Venous Access|1|||
146116146|NCT00752232|526942761|FG000|Overall Study|Protocol Violation|0|||
146116147|NCT00752232|526942762|FG001|Overall Study|Protocol Violation|0|||
146116148|NCT00752232|526942763|FG002|Overall Study|Protocol Violation|0|||
146116149|NCT00752232|526942764|FG003|Overall Study|Protocol Violation|0|||
146116150|NCT00752232|526942765|FG004|Overall Study|Protocol Violation|0|||
146116151|NCT00752232|526942766|FG005|Overall Study|Protocol Violation|1|||
146116152|NCT00752232|526942767|FG006|Overall Study|Protocol Violation|0|||
146116153|NCT00752232|526942761|FG000|Overall Study|Caregiver request|2|||
146116154|NCT00752232|526942762|FG001|Overall Study|Caregiver request|0|||
146116155|NCT00752232|526942763|FG002|Overall Study|Caregiver request|0|||
146116156|NCT00752232|526942764|FG003|Overall Study|Caregiver request|0|||
146116157|NCT00752232|526942765|FG004|Overall Study|Caregiver request|1|||
146116158|NCT00752232|526942766|FG005|Overall Study|Caregiver request|0|||
146116159|NCT00752232|526942767|FG006|Overall Study|Caregiver request|0|||
146116160|NCT00752232|526942761|FG000|Overall Study|Investigator request|0|||
146116161|NCT00752232|526942762|FG001|Overall Study|Investigator request|0|||
146116162|NCT00752232|526942763|FG002|Overall Study|Investigator request|0|||
146116163|NCT00752232|526942764|FG003|Overall Study|Investigator request|0|||
146116164|NCT00752232|526942765|FG004|Overall Study|Investigator request|1|||
146116165|NCT00752232|526942766|FG005|Overall Study|Investigator request|0|||
146116166|NCT00752232|526942767|FG006|Overall Study|Investigator request|0|||
146116167|NCT00752232|526942761|FG000|Overall Study|Subject request|0|||
146116168|NCT00752232|526942762|FG001|Overall Study|Subject request|0|||
146116169|NCT00752232|526942763|FG002|Overall Study|Subject request|1|||
146116170|NCT00752232|526942764|FG003|Overall Study|Subject request|0|||
146116171|NCT00752232|526942765|FG004|Overall Study|Subject request|0|||
146116172|NCT00752232|526942766|FG005|Overall Study|Subject request|0|||
146116173|NCT00752232|526942767|FG006|Overall Study|Subject request|0|||
146116174|NCT00752232|526942761|FG000|Overall Study|Group home admission|0|||
146260757|NCT01999972|527470730|FG002|Dose Expansion Part|Sponsor decision|0|||
146116175|NCT00752232|526942762|FG001|Overall Study|Group home admission|0|||
146116176|NCT00752232|526942763|FG002|Overall Study|Group home admission|0|||
146116177|NCT00752232|526942764|FG003|Overall Study|Group home admission|1|||
146302493|NCT01986920|527621682|FG003|A- 101 25%|Withdrawal by Subject|0|||
146116178|NCT00752232|526942765|FG004|Overall Study|Group home admission|0|||
146116179|NCT00752232|526942766|FG005|Overall Study|Group home admission|0|||
146116180|NCT00752232|526942767|FG006|Overall Study|Group home admission|0|||
146116181|NCT00752232|526942761|FG000|Overall Study|Caregiver could not attend the subject|0|||
146116182|NCT00752232|526942762|FG001|Overall Study|Caregiver could not attend the subject|0|||
146116183|NCT00752232|526942763|FG002|Overall Study|Caregiver could not attend the subject|0|||
146116184|NCT00752232|526942764|FG003|Overall Study|Caregiver could not attend the subject|0|||
146116185|NCT00752232|526942765|FG004|Overall Study|Caregiver could not attend the subject|1|||
146116186|NCT00752232|526942766|FG005|Overall Study|Caregiver could not attend the subject|0|||
146116187|NCT00752232|526942767|FG006|Overall Study|Caregiver could not attend the subject|0|||
146116188|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
146116189|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
146116190|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
146116191|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
146116192|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
146116193|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
146116194|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146116195|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
146116196|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146116197|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
146116198|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Death|2|||
146116199|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Death|1|||
146116200|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Death|4|||
146116201|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Death|0|||
146116202|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Death|0|||
146116203|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
146116204|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
146116205|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
146116206|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
146116207|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
146116208|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Other Reason|1|||
146116209|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Other Reason|3|||
146116210|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Other Reason|2|||
146116211|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Other Reason|0|||
146116212|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Other Reason|0|||
146116213|NCT00555321|526942770|FG000|Treatment Phase up to 12-months|Never treated|2|||
146116214|NCT00555321|526942771|FG001|Treatment Phase up to 12-months|Never treated|3|||
146116215|NCT00555321|526942772|FG002|Treatment Phase up to 12-months|Never treated|1|||
146116216|NCT00555321|526942773|FG003|Treatment Phase up to 12-months|Never treated|0|||
146116217|NCT00555321|526942774|FG004|Treatment Phase up to 12-months|Never treated|4|||
146116218|NCT00555321|526942770|FG000|Long-term Extension Phase|Adverse Event|2|||
146116219|NCT00555321|526942771|FG001|Long-term Extension Phase|Adverse Event|5|||
146116220|NCT00555321|526942772|FG002|Long-term Extension Phase|Adverse Event|2|||
146116221|NCT00555321|526942773|FG003|Long-term Extension Phase|Adverse Event|1|||
146116222|NCT00555321|526942774|FG004|Long-term Extension Phase|Adverse Event|0|||
146116223|NCT00555321|526942770|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
146116224|NCT00555321|526942771|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
146116225|NCT00555321|526942772|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
146116226|NCT00555321|526942773|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
146116227|NCT00555321|526942774|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
146116228|NCT00555321|526942770|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
146116229|NCT00555321|526942771|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
146116230|NCT00555321|526942772|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
146116231|NCT00555321|526942773|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
146116232|NCT00555321|526942774|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
146116233|NCT00555321|526942770|FG000|Long-term Extension Phase|Death|2|||
146116234|NCT00555321|526942771|FG001|Long-term Extension Phase|Death|0|||
146116235|NCT00555321|526942772|FG002|Long-term Extension Phase|Death|0|||
146116236|NCT00555321|526942773|FG003|Long-term Extension Phase|Death|3|||
146116237|NCT00555321|526942774|FG004|Long-term Extension Phase|Death|0|||
146116238|NCT00555321|526942770|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
146116239|NCT00555321|526942771|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
146116240|NCT00555321|526942772|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
146116241|NCT00555321|526942773|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
146116242|NCT00555321|526942774|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
146116243|NCT00555321|526942770|FG000|Long-term Extension Phase|Other Reason|1|||
146116244|NCT00555321|526942771|FG001|Long-term Extension Phase|Other Reason|0|||
146116245|NCT00555321|526942772|FG002|Long-term Extension Phase|Other Reason|2|||
146116246|NCT00555321|526942773|FG003|Long-term Extension Phase|Other Reason|0|||
146116247|NCT00555321|526942774|FG004|Long-term Extension Phase|Other Reason|0|||
146116248|NCT00005937|526942775|FG000|Overall Study|Lack of Efficacy|5|||
146116249|NCT01288469|526942776|FG000|Overall Study|Adverse Event|4|||
146116250|NCT01288469|526942777|FG001|Overall Study|Adverse Event|1|||
146116251|NCT01288469|526942778|FG002|Overall Study|Adverse Event|1|||
146116252|NCT01288469|526942776|FG000|Overall Study|Poor compliance to protocol|0|||
146116253|NCT01288469|526942777|FG001|Overall Study|Poor compliance to protocol|1|||
146116254|NCT01288469|526942778|FG002|Overall Study|Poor compliance to protocol|0|||
146116255|NCT01288469|526942776|FG000|Overall Study|Participant Moved|1|||
146116256|NCT01288469|526942777|FG001|Overall Study|Participant Moved|0|||
146116257|NCT01288469|526942778|FG002|Overall Study|Participant Moved|0|||
146116258|NCT01288469|526942776|FG000|Overall Study|Consent withdrawn by subject|1|||
146116259|NCT01288469|526942777|FG001|Overall Study|Consent withdrawn by subject|1|||
146116260|NCT01288469|526942778|FG002|Overall Study|Consent withdrawn by subject|1|||
146116261|NCT01288469|526942776|FG000|Overall Study|Exclusion criteria finally met|1|||
146116262|NCT01288469|526942777|FG001|Overall Study|Exclusion criteria finally met|0|||
146116263|NCT01288469|526942778|FG002|Overall Study|Exclusion criteria finally met|0|||
146116264|NCT00563381|526942779|FG000|Overall Study|Adverse Event|264|||
146116265|NCT00563381|526942780|FG001|Overall Study|Adverse Event|292|||
146116266|NCT00563381|526942779|FG000|Overall Study|Protocol Violation|66|||
146116267|NCT00563381|526942780|FG001|Overall Study|Protocol Violation|74|||
146116268|NCT00563381|526942779|FG000|Overall Study|Lost to Follow-up|7|||
146116269|NCT00563381|526942780|FG001|Overall Study|Lost to Follow-up|15|||
146116270|NCT00563381|526942779|FG000|Overall Study|Withdrawal by Subject|192|||
146116271|NCT00563381|526942780|FG001|Overall Study|Withdrawal by Subject|209|||
146116272|NCT00563381|526942779|FG000|Overall Study|Lack of Efficacy|32|||
146116273|NCT00563381|526942780|FG001|Overall Study|Lack of Efficacy|24|||
146116274|NCT00563381|526942779|FG000|Overall Study|Individual different reasons|24|||
146116275|NCT00563381|526942780|FG001|Overall Study|Individual different reasons|34|||
146116276|NCT02452398|526942783|FG000|Overall Study|Adverse Event|1|||
146116277|NCT02452398|526942783|FG000|Overall Study|Lost to Follow-up|28|||
146116278|NCT02452398|526942783|FG000|Overall Study|Physician Decision|2|||
146116279|NCT02452398|526942783|FG000|Overall Study|Withdrawal by Subject|6|||
146116280|NCT02452398|526942783|FG000|Overall Study|Moved away|4|||
146116281|NCT02407704|526942784|FG000|Overall Study|Lost to Follow-up|0|||
146116282|NCT02407704|526942785|FG001|Overall Study|Lost to Follow-up|0|||
146116283|NCT02407704|526942786|FG002|Overall Study|Lost to Follow-up|0|||
146116284|NCT02407704|526942787|FG003|Overall Study|Lost to Follow-up|2|||
146116285|NCT02407704|526942784|FG000|Overall Study|Protocol Violation|0|||
146116286|NCT02407704|526942785|FG001|Overall Study|Protocol Violation|0|||
146116287|NCT02407704|526942786|FG002|Overall Study|Protocol Violation|0|||
146116288|NCT02407704|526942787|FG003|Overall Study|Protocol Violation|1|||
146116289|NCT02407704|526942784|FG000|Overall Study|Withdrawal by Subject|0|||
146116290|NCT02407704|526942785|FG001|Overall Study|Withdrawal by Subject|0|||
146116291|NCT02407704|526942786|FG002|Overall Study|Withdrawal by Subject|1|||
146116292|NCT02407704|526942787|FG003|Overall Study|Withdrawal by Subject|0|||
146116293|NCT02730455|526942788|FG000|Overall Study|Death|5|||
146116294|NCT02730455|526942789|FG001|Overall Study|Death|6|||
146116295|NCT02730455|526942790|FG002|Overall Study|Death|4|||
146116296|NCT02730455|526942788|FG000|Overall Study|Consent withdrawn|2|||
146116297|NCT02730455|526942789|FG001|Overall Study|Consent withdrawn|4|||
146116298|NCT02730455|526942790|FG002|Overall Study|Consent withdrawn|1|||
146116299|NCT02730455|526942788|FG000|Overall Study|Lost to Follow-up|3|||
146116300|NCT02730455|526942789|FG001|Overall Study|Lost to Follow-up|1|||
146116301|NCT02730455|526942790|FG002|Overall Study|Lost to Follow-up|4|||
146116302|NCT02730455|526942788|FG000|Overall Study|Other|1|||
146116303|NCT02730455|526942789|FG001|Overall Study|Other|1|||
146116304|NCT02730455|526942790|FG002|Overall Study|Other|2|||
146116305|NCT02730455|526942788|FG000|Overall Study|Other|2|||
146116306|NCT02730455|526942789|FG001|Overall Study|Other|2|||
146116307|NCT02730455|526942790|FG002|Overall Study|Other|0|||
146116308|NCT00748033|526942794|FG000|Overall Study|Adverse Event|0|||
146116309|NCT00748033|526942795|FG001|Overall Study|Adverse Event|1|||
146116310|NCT01018186|526942796|FG000|2-week Run-in Period|Protocol Violation|1|||
146116311|NCT01018186|526942797|FG001|2-week Run-in Period|Protocol Violation|0|||
146116312|NCT01018186|526942798|FG002|2-week Run-in Period|Protocol Violation|0|||
146116313|NCT01018186|526942799|FG003|2-week Run-in Period|Protocol Violation|0|||
146116314|NCT01018186|526942796|FG000|2-week Run-in Period|Lost to Follow-up|2|||
146116315|NCT01018186|526942797|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146116316|NCT01018186|526942798|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146116317|NCT01018186|526942799|FG003|2-week Run-in Period|Lost to Follow-up|0|||
146116318|NCT01018186|526942796|FG000|2-week Run-in Period|Physician Decision|3|||
146116319|NCT01018186|526942797|FG001|2-week Run-in Period|Physician Decision|0|||
146116320|NCT01018186|526942798|FG002|2-week Run-in Period|Physician Decision|0|||
146116321|NCT01018186|526942799|FG003|2-week Run-in Period|Physician Decision|0|||
146116322|NCT01018186|526942796|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
146116323|NCT01018186|526942797|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146116324|NCT01018186|526942798|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146116325|NCT01018186|526942799|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
146116326|NCT01018186|526942796|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
146116327|NCT01018186|526942797|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146116328|NCT01018186|526942798|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146116329|NCT01018186|526942799|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146116330|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
146116331|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
146116332|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
146116333|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
146116334|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146116335|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
146116336|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
146116337|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
146116338|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
146116339|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
146116340|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
146116341|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
146116342|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
146116343|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
146116344|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
146116345|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
146116346|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
146116347|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
146116348|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
146116349|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
146116350|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
146116351|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
146116352|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
146116353|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
146116354|NCT01018186|526942796|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146116355|NCT01018186|526942797|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
146116356|NCT01018186|526942798|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
146116357|NCT01018186|526942799|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
146116358|NCT03235154|526942802|FG000|Overall Study|Withdrawal by Subject|1|||
146116359|NCT03235154|526942802|FG000|Overall Study|Adverse Event|1|||
146116360|NCT03235154|526942802|FG000|Overall Study|Lost to Follow-up|2|||
146116361|NCT01683383|526942803|FG000|Overall Study|Infant was not transported|1|||
146116362|NCT01683383|526942804|FG001|Overall Study|Infant was not transported|0|||
146116363|NCT00996307|526942805|FG000|Overall Study|Adverse Event|0|||
146116364|NCT00996307|526942806|FG001|Overall Study|Adverse Event|1|||
146116365|NCT00996307|526942807|FG002|Overall Study|Adverse Event|0|||
146116366|NCT00996307|526942808|FG003|Overall Study|Adverse Event|0|||
146116367|NCT00996307|526942805|FG000|Overall Study|Withdrawal by Subject|3|||
146116368|NCT00996307|526942806|FG001|Overall Study|Withdrawal by Subject|2|||
146116369|NCT00996307|526942807|FG002|Overall Study|Withdrawal by Subject|5|||
146116370|NCT00996307|526942808|FG003|Overall Study|Withdrawal by Subject|5|||
146116371|NCT00996307|526942805|FG000|Overall Study|Lost to Follow-up|13|||
146116372|NCT00996307|526942806|FG001|Overall Study|Lost to Follow-up|13|||
146116373|NCT00996307|526942807|FG002|Overall Study|Lost to Follow-up|7|||
146116374|NCT00996307|526942808|FG003|Overall Study|Lost to Follow-up|15|||
146116375|NCT00996307|526942805|FG000|Overall Study|Administrative reason|0|||
146116376|NCT00996307|526942806|FG001|Overall Study|Administrative reason|1|||
146116377|NCT00996307|526942807|FG002|Overall Study|Administrative reason|0|||
146116378|NCT00996307|526942808|FG003|Overall Study|Administrative reason|0|||
146116379|NCT00996307|526942805|FG000|Overall Study|Unable to classify|4|||
146116380|NCT00996307|526942806|FG001|Overall Study|Unable to classify|0|||
146116381|NCT00996307|526942807|FG002|Overall Study|Unable to classify|2|||
146116382|NCT00996307|526942808|FG003|Overall Study|Unable to classify|1|||
146116383|NCT02326025|526942809|FG000|Overall Study|Adverse Event|3|||
146116384|NCT02326025|526942810|FG001|Overall Study|Adverse Event|0|||
146116385|NCT02326025|526942809|FG000|Overall Study|Physician Decision|1|||
146116386|NCT02326025|526942810|FG001|Overall Study|Physician Decision|2|||
146116387|NCT02326025|526942809|FG000|Overall Study|Physician and Participant Decision|1|||
146116388|NCT02326025|526942810|FG001|Overall Study|Physician and Participant Decision|0|||
146116389|NCT02326025|526942809|FG000|Overall Study|Withdrawal by Subject|0|||
146302494|NCT01986920|527621679|FG000|A-101 32.5%|Withdrawal by Subject|0|||
146116390|NCT02326025|526942810|FG001|Overall Study|Withdrawal by Subject|2|||
146116391|NCT02326025|526942809|FG000|Overall Study|Protocol Violation|0|||
146116392|NCT02326025|526942810|FG001|Overall Study|Protocol Violation|1|||
146116393|NCT00001723|526942811|FG000|Overall Study|Lack of Efficacy|6|||
146116394|NCT00001723|526942812|FG001|Overall Study|Lack of Efficacy|7|||
146116395|NCT00001723|526942811|FG000|Overall Study|Lack of family interest|4|||
146116396|NCT00001723|526942812|FG001|Overall Study|Lack of family interest|5|||
146116397|NCT00001723|526942811|FG000|Overall Study|Lost to Follow-up|2|||
146116398|NCT00001723|526942812|FG001|Overall Study|Lost to Follow-up|2|||
146116399|NCT00001723|526942811|FG000|Overall Study|medication intolerance|1|||
146116400|NCT00001723|526942812|FG001|Overall Study|medication intolerance|2|||
146116401|NCT00536198|526942813|FG000|Overall Study|Lost to Follow-up|15|||
146116402|NCT00536198|526942814|FG001|Overall Study|Lost to Follow-up|14|||
146116403|NCT00536198|526942813|FG000|Overall Study|Withdrawal by Subject|16|||
146116404|NCT00536198|526942814|FG001|Overall Study|Withdrawal by Subject|12|||
146116405|NCT00536198|526942813|FG000|Overall Study|Adverse Event|2|||
146116406|NCT00536198|526942814|FG001|Overall Study|Adverse Event|2|||
146116407|NCT00536198|526942813|FG000|Overall Study|Rescue|3|||
146116408|NCT00536198|526942814|FG001|Overall Study|Rescue|9|||
146116409|NCT00536198|526942813|FG000|Overall Study|Pregnancy|1|||
146116410|NCT00536198|526942814|FG001|Overall Study|Pregnancy|1|||
146116411|NCT00536198|526942813|FG000|Overall Study|Protocol Violation|0|||
146116412|NCT00536198|526942814|FG001|Overall Study|Protocol Violation|1|||
146116413|NCT02643082|526942815|FG000|Period 1|Adverse Event|1|||
146116414|NCT02643082|526942816|FG001|Period 1|Adverse Event|0|||
146116415|NCT00881712|526942817|FG000|Overall Study|Death|1|||
146116416|NCT00881712|526942818|FG001|Overall Study|Death|0|||
146116417|NCT00881712|526942819|FG002|Overall Study|Death|0|||
146116418|NCT00881712|526942817|FG000|Overall Study|Withdrawal by Subject|1|||
146116419|NCT00881712|526942818|FG001|Overall Study|Withdrawal by Subject|0|||
146116420|NCT00881712|526942819|FG002|Overall Study|Withdrawal by Subject|0|||
146116421|NCT01324999|526942820|FG000|Overall Study|Adverse Event|3|||
146116422|NCT01324999|526942820|FG000|Overall Study|Withdrawal by Subject|2|||
146116423|NCT02505867|526942822|FG000|Overall Study|Lack of Efficacy|6|||
146116424|NCT02505867|526942823|FG001|Overall Study|Lack of Efficacy|6|||
146116425|NCT00230607|526942828|FG000|Overall Study|Other|3|||
146116426|NCT02860169|526942829|FG000|Part A|Withdrawal by Subject|1|||
146116427|NCT02860169|526942829|FG000|Part A|Other (Screening failure)|6|||
146116428|NCT02860169|526942829|FG000|Part A|Other (Survey not completed)|3|||
146116429|NCT02860169|526942829|FG000|Part A|Other (did not completed consent)|1|||
146116430|NCT02860169|526942829|FG000|Part B|Other (Screening failure)|10|||
146116431|NCT02860169|526942829|FG000|Part B|Withdrawal by Subject|1|||
146116432|NCT02860169|526942829|FG000|Part C|Other (Screening failure)|1|||
146116433|NCT00165776|526942831|FG000|Overall Study|Lack of Efficacy|0|||
146116434|NCT00165776|526942832|FG001|Overall Study|Lack of Efficacy|0|||
146116435|NCT00165776|526942833|FG002|Overall Study|Lack of Efficacy|0|||
146116436|NCT00165776|526942834|FG003|Overall Study|Lack of Efficacy|1|||
146116437|NCT00165776|526942831|FG000|Overall Study|Withdrawal by Subject|4|||
146116438|NCT00165776|526942832|FG001|Overall Study|Withdrawal by Subject|1|||
146116439|NCT00165776|526942833|FG002|Overall Study|Withdrawal by Subject|2|||
146116440|NCT00165776|526942834|FG003|Overall Study|Withdrawal by Subject|0|||
146116441|NCT00165776|526942831|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
146116442|NCT00165776|526942832|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
146116443|NCT00165776|526942833|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
146116444|NCT00165776|526942834|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
146116445|NCT01648205|526942841|FG000|Placebo|Pregnancy|1|||
146116446|NCT01648205|526942841|FG000|Placebo|Withdrawal by Subject|1|||
146116447|NCT01648205|526942841|FG000|Placebo|Protocol Violation|2|||
146116448|NCT01648205|526942841|FG000|Ranolazine|Death|1|||
146116449|NCT01648205|526942841|FG000|Ranolazine|Withdrawal by Subject|1|||
146116450|NCT01648205|526942841|FG000|Ranolazine|Protocol Violation|3|||
146116451|NCT00203996|526942842|FG000|Overall Study|Lost to Follow-up|0|||
146116452|NCT00203996|526942843|FG001|Overall Study|Lost to Follow-up|0|||
146116453|NCT00203996|526942844|FG002|Overall Study|Lost to Follow-up|0|||
146116454|NCT00203996|526942845|FG003|Overall Study|Lost to Follow-up|1|||
146116455|NCT00203996|526942846|FG004|Overall Study|Lost to Follow-up|0|||
146116456|NCT00203996|526942847|FG005|Overall Study|Lost to Follow-up|0|||
146116457|NCT00203996|526942848|FG006|Overall Study|Lost to Follow-up|0|||
146116458|NCT00203996|526942849|FG007|Overall Study|Lost to Follow-up|0|||
146116459|NCT00203996|526942850|FG008|Overall Study|Lost to Follow-up|0|||
146116460|NCT00203996|526942851|FG009|Overall Study|Lost to Follow-up|0|||
146116461|NCT00203996|526942842|FG000|Overall Study|Protocol Violation|0|||
146116462|NCT00203996|526942843|FG001|Overall Study|Protocol Violation|0|||
146116463|NCT00203996|526942844|FG002|Overall Study|Protocol Violation|0|||
146116464|NCT00203996|526942845|FG003|Overall Study|Protocol Violation|6|||
146116465|NCT00203996|526942846|FG004|Overall Study|Protocol Violation|1|||
146116466|NCT00203996|526942847|FG005|Overall Study|Protocol Violation|0|||
146116467|NCT00203996|526942848|FG006|Overall Study|Protocol Violation|0|||
146116468|NCT00203996|526942849|FG007|Overall Study|Protocol Violation|0|||
146116469|NCT00203996|526942850|FG008|Overall Study|Protocol Violation|0|||
146116470|NCT00203996|526942851|FG009|Overall Study|Protocol Violation|0|||
146116471|NCT00203996|526942842|FG000|Overall Study|Physician Decision|0|||
146116472|NCT00203996|526942843|FG001|Overall Study|Physician Decision|0|||
146116473|NCT00203996|526942844|FG002|Overall Study|Physician Decision|0|||
146116474|NCT00203996|526942845|FG003|Overall Study|Physician Decision|2|||
146116475|NCT00203996|526942846|FG004|Overall Study|Physician Decision|0|||
146302495|NCT01986920|527621680|FG001|A-101 32.5%|Withdrawal by Subject|1|||
146302496|NCT01986920|527621681|FG002|A-101 32.5%|Withdrawal by Subject|0|||
146302497|NCT01986920|527621682|FG003|A-101 32.5%|Withdrawal by Subject|0|||
146302498|NCT01986920|527621679|FG000|A-101 40%|Withdrawal by Subject|0|||
146302499|NCT01986920|527621680|FG001|A-101 40%|Withdrawal by Subject|0|||
146302500|NCT01986920|527621681|FG002|A-101 40%|Withdrawal by Subject|1|||
146302501|NCT01986920|527621682|FG003|A-101 40%|Withdrawal by Subject|0|||
146302502|NCT01986920|527621679|FG000|Placebo|Withdrawal by Subject|0|||
146302503|NCT01986920|527621680|FG001|Placebo|Withdrawal by Subject|0|||
146302504|NCT01986920|527621681|FG002|Placebo|Withdrawal by Subject|0|||
146302505|NCT01986920|527621682|FG003|Placebo|Withdrawal by Subject|1|||
146302506|NCT00874770|527621686|FG000|Overall Study|Lack of Efficacy|2|||
146302507|NCT00874770|527621687|FG001|Overall Study|Lack of Efficacy|0|||
146302508|NCT00874770|527621688|FG002|Overall Study|Lack of Efficacy|0|||
146260758|NCT01999972|527470731|FG003|Dose Expansion Part|Sponsor decision|0|||
146260759|NCT01999972|527470732|FG004|Dose Expansion Part|Sponsor decision|1|||
146260760|NCT01999972|527470733|FG005|Dose Expansion Part|Sponsor decision|0|||
146260761|NCT01999972|527470728|FG000|Dose Expansion Part|Adverse Event|0|||
146260762|NCT01999972|527470729|FG001|Dose Expansion Part|Adverse Event|0|||
146260763|NCT01999972|527470730|FG002|Dose Expansion Part|Adverse Event|0|||
146260764|NCT01999972|527470731|FG003|Dose Expansion Part|Adverse Event|0|||
146260765|NCT01999972|527470732|FG004|Dose Expansion Part|Adverse Event|4|||
146260766|NCT01999972|527470733|FG005|Dose Expansion Part|Adverse Event|2|||
146260767|NCT01999972|527470728|FG000|Dose Expansion Part|Participant's non-compliance|0|||
146260768|NCT01999972|527470729|FG001|Dose Expansion Part|Participant's non-compliance|0|||
146302509|NCT00874770|527621689|FG003|Overall Study|Lack of Efficacy|2|||
146302510|NCT00874770|527621686|FG000|Overall Study|Adverse Event|1|||
146302511|NCT00874770|527621687|FG001|Overall Study|Adverse Event|1|||
146302512|NCT00874770|527621688|FG002|Overall Study|Adverse Event|4|||
146302513|NCT00874770|527621689|FG003|Overall Study|Adverse Event|2|||
146302514|NCT00874770|527621686|FG000|Overall Study|Lost to Follow-up|1|||
146302515|NCT00874770|527621687|FG001|Overall Study|Lost to Follow-up|0|||
146302516|NCT00874770|527621688|FG002|Overall Study|Lost to Follow-up|0|||
146302517|NCT00874770|527621689|FG003|Overall Study|Lost to Follow-up|1|||
146302518|NCT00874770|527621686|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
146302519|NCT00874770|527621687|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
146302520|NCT00874770|527621688|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
146260769|NCT01999972|527470730|FG002|Dose Expansion Part|Participant's non-compliance|0|||
146260770|NCT01999972|527470731|FG003|Dose Expansion Part|Participant's non-compliance|0|||
146260771|NCT01999972|527470732|FG004|Dose Expansion Part|Participant's non-compliance|0|||
146260772|NCT01999972|527470733|FG005|Dose Expansion Part|Participant's non-compliance|1|||
146260773|NCT01999972|527470728|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
146260774|NCT01999972|527470729|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
146260775|NCT01999972|527470730|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
146260776|NCT01999972|527470731|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
146260777|NCT01999972|527470732|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
146260778|NCT01999972|527470733|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
146260779|NCT01999972|527470728|FG000|Dose Expansion Part|Changed to standard of care|0|||
146260780|NCT01999972|527470729|FG001|Dose Expansion Part|Changed to standard of care|0|||
146260781|NCT01999972|527470730|FG002|Dose Expansion Part|Changed to standard of care|0|||
146260782|NCT01999972|527470731|FG003|Dose Expansion Part|Changed to standard of care|0|||
146260783|NCT01999972|527470732|FG004|Dose Expansion Part|Changed to standard of care|1|||
146260784|NCT01999972|527470733|FG005|Dose Expansion Part|Changed to standard of care|0|||
146302521|NCT00874770|527621689|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
146116476|NCT00203996|526942847|FG005|Overall Study|Physician Decision|0|||
146116477|NCT00203996|526942848|FG006|Overall Study|Physician Decision|0|||
146116478|NCT00203996|526942849|FG007|Overall Study|Physician Decision|0|||
146116479|NCT00203996|526942850|FG008|Overall Study|Physician Decision|0|||
146116480|NCT00203996|526942851|FG009|Overall Study|Physician Decision|1|||
146116481|NCT00203996|526942842|FG000|Overall Study|CPAP machine malfunction|0|||
146116482|NCT00203996|526942843|FG001|Overall Study|CPAP machine malfunction|0|||
146116483|NCT00203996|526942844|FG002|Overall Study|CPAP machine malfunction|0|||
146116484|NCT00203996|526942845|FG003|Overall Study|CPAP machine malfunction|1|||
146116485|NCT00203996|526942846|FG004|Overall Study|CPAP machine malfunction|0|||
146116486|NCT00203996|526942847|FG005|Overall Study|CPAP machine malfunction|0|||
146116487|NCT00203996|526942848|FG006|Overall Study|CPAP machine malfunction|0|||
146260785|NCT02210208|527470734|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
146260786|NCT02210208|527470734|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
146260787|NCT02210208|527470734|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
146260788|NCT01171183|527470735|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
146302522|NCT04880447|527621691|FG000|Overall Study|No vaccination information|1|||
146302523|NCT04880447|527621691|FG000|Overall Study|No adverse event information (missing information)|1|||
146302524|NCT04880447|527621691|FG000|Overall Study|Disease not covered in this study|35|||
146116488|NCT00203996|526942849|FG007|Overall Study|CPAP machine malfunction|0|||
146116489|NCT00203996|526942850|FG008|Overall Study|CPAP machine malfunction|0|||
146116490|NCT00203996|526942851|FG009|Overall Study|CPAP machine malfunction|0|||
146116491|NCT00203996|526942842|FG000|Overall Study|Scheduling issue|0|||
146116492|NCT00203996|526942843|FG001|Overall Study|Scheduling issue|0|||
146116493|NCT00203996|526942844|FG002|Overall Study|Scheduling issue|0|||
146116494|NCT00203996|526942845|FG003|Overall Study|Scheduling issue|0|||
146116495|NCT00203996|526942846|FG004|Overall Study|Scheduling issue|0|||
146116496|NCT00203996|526942847|FG005|Overall Study|Scheduling issue|0|||
146116497|NCT00203996|526942848|FG006|Overall Study|Scheduling issue|0|||
146116498|NCT00203996|526942849|FG007|Overall Study|Scheduling issue|2|||
146116499|NCT00203996|526942850|FG008|Overall Study|Scheduling issue|0|||
146116500|NCT00203996|526942851|FG009|Overall Study|Scheduling issue|0|||
146116501|NCT00897104|526942854|FG000|Overall Study|Lost to Follow-up|12|||
146116502|NCT00897104|526942855|FG001|Overall Study|Lost to Follow-up|17|||
146116503|NCT00897104|526942856|FG002|Overall Study|Lost to Follow-up|2|||
146116504|NCT00897104|526942854|FG000|Overall Study|Pregnancy|0|||
146116505|NCT00897104|526942855|FG001|Overall Study|Pregnancy|1|||
146116506|NCT00897104|526942856|FG002|Overall Study|Pregnancy|0|||
146116507|NCT00897104|526942854|FG000|Overall Study|Protocol Violation|0|||
146116508|NCT00897104|526942855|FG001|Overall Study|Protocol Violation|1|||
146116509|NCT00897104|526942856|FG002|Overall Study|Protocol Violation|0|||
146116510|NCT00897104|526942854|FG000|Overall Study|Withdrawal by Subject|23|||
146116511|NCT00897104|526942855|FG001|Overall Study|Withdrawal by Subject|27|||
146116512|NCT00897104|526942856|FG002|Overall Study|Withdrawal by Subject|3|||
146116513|NCT00897104|526942854|FG000|Overall Study|Abnormal Prestudy Labs|2|||
146116514|NCT00897104|526942855|FG001|Overall Study|Abnormal Prestudy Labs|0|||
146116515|NCT00897104|526942856|FG002|Overall Study|Abnormal Prestudy Labs|0|||
146116516|NCT00897104|526942854|FG000|Overall Study|Abnormal Baseline ECG|2|||
146116517|NCT00897104|526942855|FG001|Overall Study|Abnormal Baseline ECG|2|||
146116518|NCT00897104|526942856|FG002|Overall Study|Abnormal Baseline ECG|0|||
146116519|NCT00897104|526942854|FG000|Overall Study|Need for Concom. Med.|0|||
146116520|NCT00897104|526942855|FG001|Overall Study|Need for Concom. Med.|1|||
146116521|NCT00897104|526942856|FG002|Overall Study|Need for Concom. Med.|1|||
146116522|NCT00897104|526942854|FG000|Overall Study|Lack of Migraine Attack|20|||
146116523|NCT00897104|526942855|FG001|Overall Study|Lack of Migraine Attack|22|||
146116524|NCT00897104|526942856|FG002|Overall Study|Lack of Migraine Attack|1|||
146116525|NCT00897104|526942854|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
146116526|NCT00897104|526942855|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146116527|NCT00897104|526942856|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
146116528|NCT00897104|526942854|FG000|Overall Study|Other|3|||
146116529|NCT00897104|526942855|FG001|Overall Study|Other|0|||
146116530|NCT00897104|526942856|FG002|Overall Study|Other|0|||
146116531|NCT00897104|526942854|FG000|Overall Study|Protocol Violation|1|||
146116532|NCT00897104|526942855|FG001|Overall Study|Protocol Violation|0|||
146116533|NCT00897104|526942856|FG002|Overall Study|Protocol Violation|0|||
146116534|NCT00897104|526942854|FG000|Overall Study|Withdrawal by Subject|0|||
146116535|NCT00897104|526942855|FG001|Overall Study|Withdrawal by Subject|0|||
146116536|NCT00897104|526942856|FG002|Overall Study|Withdrawal by Subject|1|||
146116537|NCT01937559|526942857|FG000|Overall Study|Physician Decision|3|||
146116538|NCT01937559|526942858|FG001|Overall Study|Physician Decision|3|||
146116539|NCT01937559|526942859|FG002|Overall Study|Physician Decision|0|||
146116540|NCT01937559|526942857|FG000|Overall Study|Withdrawal by Subject|6|||
146116541|NCT01937559|526942858|FG001|Overall Study|Withdrawal by Subject|4|||
146116542|NCT01937559|526942859|FG002|Overall Study|Withdrawal by Subject|0|||
146116543|NCT01937559|526942857|FG000|Overall Study|screen fail|2|||
146116544|NCT01937559|526942858|FG001|Overall Study|screen fail|4|||
146116545|NCT01937559|526942859|FG002|Overall Study|screen fail|0|||
146260789|NCT01171183|527470736|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
146260790|NCT01171183|527470735|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
146260791|NCT01171183|527470736|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
146260792|NCT01171183|527470735|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
146260793|NCT01171183|527470736|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
146260794|NCT01171183|527470735|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
146260795|NCT01171183|527470736|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
146116546|NCT02167893|526942860|FG000|Overall Study|Investigator transferred|85|||
146116547|NCT02167893|526942860|FG000|Overall Study|Investigator health reasons|10|||
146116548|NCT02167893|526942860|FG000|Overall Study|Case report forms not collected|68|||
146116549|NCT04818840|526942861|FG000|Overall Study|Lost to Follow-up|0|||
146260796|NCT01171183|527470735|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
146260797|NCT01171183|527470736|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
146302525|NCT00718549|527621692|FG000|Induction Phase|Disease Progression|1|||
146116550|NCT04818840|526942862|FG001|Overall Study|Lost to Follow-up|5|||
146116551|NCT04818840|526942861|FG000|Overall Study|Physician Decision|1|||
146116552|NCT04818840|526942862|FG001|Overall Study|Physician Decision|0|||
146116553|NCT04818840|526942861|FG000|Overall Study|Site Terminated by Sponsor|0|||
146116554|NCT04818840|526942862|FG001|Overall Study|Site Terminated by Sponsor|3|||
146116555|NCT04818840|526942861|FG000|Overall Study|Study Terminated by Sponsor|43|||
146116556|NCT04818840|526942862|FG001|Overall Study|Study Terminated by Sponsor|7|||
146116557|NCT04818840|526942861|FG000|Overall Study|Withdrawal by Subject|0|||
146116558|NCT04818840|526942862|FG001|Overall Study|Withdrawal by Subject|1|||
146116559|NCT01438424|526944984|FG000|Overall Study|Continuing treatment|29|||
146116560|NCT01438424|526944984|FG000|Overall Study|Minimal virologic response|95|||
146116561|NCT01438424|526944984|FG000|Overall Study|Not identified|55|||
146116562|NCT01438424|526944984|FG000|Overall Study|Withdrawal by Subject|104|||
146116563|NCT01438424|526944984|FG000|Overall Study|Progression of chronic hepatitis B|22|||
146116564|NCT01438424|526944984|FG000|Overall Study|Death|22|||
146116565|NCT01438424|526944984|FG000|Overall Study|Adverse Event|17|||
146116566|NCT01438424|526944984|FG000|Overall Study|Lost to Follow-up|17|||
146116567|NCT01438424|526944984|FG000|Overall Study|Abnormal laboratory test result|14|||
146116568|NCT01438424|526944984|FG000|Overall Study|Need for drug prohibited by protocol|14|||
146116569|NCT01438424|526944984|FG000|Overall Study|Pregnancy|7|||
146116570|NCT01438424|526944984|FG000|Overall Study|No longer met inclusion criteria|1|||
146116571|NCT01438424|526944984|FG000|Overall Study|Participant noncompliance|20|||
146116572|NCT01320085|526944988|FG000|Overall Study|Disease Progression|26|||
146116573|NCT01320085|526944989|FG001|Overall Study|Disease Progression|93|||
146116574|NCT01320085|526944990|FG002|Overall Study|Disease Progression|17|||
146116575|NCT01320085|526944988|FG000|Overall Study|Adverse Event|12|||
146116576|NCT01320085|526944989|FG001|Overall Study|Adverse Event|20|||
146116577|NCT01320085|526944990|FG002|Overall Study|Adverse Event|5|||
146116578|NCT01320085|526944988|FG000|Overall Study|Withdrawal by Subject|2|||
146116579|NCT01320085|526944989|FG001|Overall Study|Withdrawal by Subject|4|||
146116580|NCT01320085|526944990|FG002|Overall Study|Withdrawal by Subject|1|||
146116581|NCT01320085|526944988|FG000|Overall Study|Protocol Deviation|1|||
146116582|NCT01320085|526944989|FG001|Overall Study|Protocol Deviation|0|||
146116583|NCT01320085|526944990|FG002|Overall Study|Protocol Deviation|1|||
146116584|NCT01320085|526944988|FG000|Overall Study|Administrative problems|0|||
146116585|NCT01320085|526944989|FG001|Overall Study|Administrative problems|0|||
146116586|NCT01320085|526944990|FG002|Overall Study|Administrative problems|1|||
146116587|NCT01702454|526944991|FG000|Overall Study|Consent withdrawal|0|||
146116588|NCT01702454|526944992|FG001|Overall Study|Consent withdrawal|1|||
146116589|NCT01702454|526944991|FG000|Overall Study|Migrated/moved from study area|0|||
146116590|NCT01702454|526944992|FG001|Overall Study|Migrated/moved from study area|1|||
146116591|NCT01702454|526944991|FG000|Overall Study|Lost to Follow-up|3|||
146116592|NCT01702454|526944992|FG001|Overall Study|Lost to Follow-up|6|||
146116593|NCT00710710|526944993|FG000|Overall Study|Consent withdrawn|2|||
146116594|NCT00710710|526944994|FG001|Overall Study|Consent withdrawn|2|||
146116595|NCT00710710|526944993|FG000|Overall Study|Protocol Violation|0|||
146116596|NCT00710710|526944994|FG001|Overall Study|Protocol Violation|1|||
146116597|NCT00710710|526944993|FG000|Overall Study|Adverse Event|3|||
146116598|NCT00710710|526944994|FG001|Overall Study|Adverse Event|3|||
146116599|NCT00710710|526944993|FG000|Overall Study|Progressive disease|40|||
146116600|NCT00710710|526944994|FG001|Overall Study|Progressive disease|38|||
146116601|NCT03510884|526944995|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
146116602|NCT03510884|526944996|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
146116603|NCT03510884|526944997|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
146116604|NCT03510884|526944998|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
146116605|NCT03510884|526944995|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
146116606|NCT03510884|526944996|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
146116607|NCT03510884|526944997|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
146116608|NCT03510884|526944998|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
146116609|NCT03510884|526944995|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146116610|NCT03510884|526944996|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
146116611|NCT03510884|526944997|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146116612|NCT03510884|526944998|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
146116613|NCT03510884|526944995|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146116614|NCT03510884|526944996|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
146116615|NCT03510884|526944997|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146116616|NCT03510884|526944998|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
146116617|NCT03510884|526944995|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
146116618|NCT03510884|526944996|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
146116619|NCT03510884|526944997|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
146116620|NCT03510884|526944998|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
146116621|NCT03510884|526944995|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
146116622|NCT03510884|526944996|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
146116623|NCT03510884|526944997|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
146116624|NCT03510884|526944998|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
146116625|NCT03510884|526944995|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146116626|NCT03510884|526944996|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
146116627|NCT03510884|526944997|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146116628|NCT03510884|526944998|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
146116629|NCT03510884|526944995|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
146116630|NCT03510884|526944996|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
146116631|NCT03510884|526944997|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
146116632|NCT03510884|526944998|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
146116633|NCT03510884|526944995|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146116634|NCT03510884|526944996|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
146116635|NCT03510884|526944997|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146116636|NCT03510884|526944998|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
146116637|NCT03510884|526944995|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
146116638|NCT03510884|526944996|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
146116639|NCT03510884|526944997|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
146116640|NCT03510884|526944998|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
146116641|NCT00589914|526944999|FG000|Overall Study|Adverse Event|19|||
146116642|NCT00589914|526945000|FG001|Overall Study|Adverse Event|10|||
146116643|NCT00589914|526944999|FG000|Overall Study|Death|2|||
146116644|NCT00589914|526945000|FG001|Overall Study|Death|0|||
146116645|NCT00589914|526944999|FG000|Overall Study|Lack of Efficacy|40|||
146116646|NCT00589914|526945000|FG001|Overall Study|Lack of Efficacy|43|||
146116647|NCT00589914|526944999|FG000|Overall Study|Lost to Follow-up|11|||
146116648|NCT00589914|526945000|FG001|Overall Study|Lost to Follow-up|18|||
146116649|NCT00589914|526944999|FG000|Overall Study|Pregnancy|1|||
146116650|NCT00589914|526945000|FG001|Overall Study|Pregnancy|0|||
146116651|NCT00589914|526944999|FG000|Overall Study|Withdrawal by Subject|55|||
146116652|NCT00589914|526945000|FG001|Overall Study|Withdrawal by Subject|49|||
146116653|NCT00589914|526944999|FG000|Overall Study|Other|22|||
146116654|NCT00589914|526945000|FG001|Overall Study|Other|17|||
146116655|NCT02564042|526945006|FG000|Overall Study|Adverse Event|4|||
146116656|NCT02564042|526945007|FG001|Overall Study|Adverse Event|4|||
146116657|NCT02564042|526945008|FG002|Overall Study|Adverse Event|3|||
146116658|NCT02564042|526945009|FG003|Overall Study|Adverse Event|0|||
146116659|NCT02564042|526945010|FG004|Overall Study|Adverse Event|0|||
146116660|NCT02564042|526945011|FG005|Overall Study|Adverse Event|1|||
146116661|NCT02564042|526945006|FG000|Overall Study|Lost to Follow-up|1|||
146116662|NCT02564042|526945007|FG001|Overall Study|Lost to Follow-up|1|||
146116663|NCT02564042|526945008|FG002|Overall Study|Lost to Follow-up|1|||
146116664|NCT02564042|526945009|FG003|Overall Study|Lost to Follow-up|0|||
146116665|NCT02564042|526945010|FG004|Overall Study|Lost to Follow-up|1|||
146116666|NCT02564042|526945011|FG005|Overall Study|Lost to Follow-up|1|||
146116667|NCT02564042|526945006|FG000|Overall Study|Physician Decision|1|||
146116668|NCT02564042|526945007|FG001|Overall Study|Physician Decision|0|||
146116669|NCT02564042|526945008|FG002|Overall Study|Physician Decision|0|||
146116670|NCT02564042|526945009|FG003|Overall Study|Physician Decision|1|||
146116671|NCT02564042|526945010|FG004|Overall Study|Physician Decision|0|||
146116672|NCT02564042|526945011|FG005|Overall Study|Physician Decision|0|||
146116673|NCT02564042|526945006|FG000|Overall Study|Withdrawal by Subject|5|||
146116674|NCT02564042|526945007|FG001|Overall Study|Withdrawal by Subject|3|||
146116675|NCT02564042|526945008|FG002|Overall Study|Withdrawal by Subject|2|||
146116676|NCT02564042|526945009|FG003|Overall Study|Withdrawal by Subject|2|||
146116677|NCT02564042|526945010|FG004|Overall Study|Withdrawal by Subject|10|||
146116678|NCT02564042|526945011|FG005|Overall Study|Withdrawal by Subject|12|||
146116679|NCT01356966|526945012|FG000|Overall Study|Withdrawal by Subject|1|||
146116680|NCT01356966|526945013|FG001|Overall Study|Withdrawal by Subject|2|||
146116681|NCT01356966|526945012|FG000|Overall Study|Physician Decision|1|||
146116682|NCT01356966|526945013|FG001|Overall Study|Physician Decision|0|||
146116683|NCT02289898|526945020|FG000|Overall Study|Death|5|||
146260798|NCT01171183|527470735|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
146260799|NCT01171183|527470736|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
146260800|NCT01101334|527470737|FG000|Overall Study|Adverse Event|9|||
146260801|NCT01101334|527470738|FG001|Overall Study|Adverse Event|4|||
146260802|NCT01101334|527470737|FG000|Overall Study|Death|7|||
146260803|NCT01101334|527470738|FG001|Overall Study|Death|1|||
146260804|NCT01101334|527470737|FG000|Overall Study|Withdrawal by Subject|4|||
146260805|NCT01101334|527470738|FG001|Overall Study|Withdrawal by Subject|3|||
146260806|NCT01101334|527470737|FG000|Overall Study|Withdrawal by Sponsor|1|||
146260807|NCT01101334|527470738|FG001|Overall Study|Withdrawal by Sponsor|1|||
146116684|NCT02289898|526945021|FG001|Overall Study|Death|4|||
146116685|NCT02289898|526945022|FG002|Overall Study|Death|3|||
146116686|NCT02289898|526945020|FG000|Overall Study|Physician Decision|2|||
146116687|NCT02289898|526945021|FG001|Overall Study|Physician Decision|5|||
146116688|NCT02289898|526945022|FG002|Overall Study|Physician Decision|2|||
146116689|NCT02289898|526945020|FG000|Overall Study|Withdrawal by Subject|0|||
146116690|NCT02289898|526945021|FG001|Overall Study|Withdrawal by Subject|4|||
146116691|NCT02289898|526945022|FG002|Overall Study|Withdrawal by Subject|1|||
146116692|NCT02289898|526945020|FG000|Overall Study|Adverse Event|3|||
146116693|NCT02289898|526945021|FG001|Overall Study|Adverse Event|5|||
146116694|NCT02289898|526945022|FG002|Overall Study|Adverse Event|5|||
146116695|NCT02289898|526945020|FG000|Overall Study|Disease progression|34|||
146116696|NCT02289898|526945021|FG001|Overall Study|Disease progression|28|||
146116697|NCT02289898|526945022|FG002|Overall Study|Disease progression|34|||
146116698|NCT02289898|526945020|FG000|Overall Study|Use of another anticancer therapy|0|||
146116699|NCT02289898|526945021|FG001|Overall Study|Use of another anticancer therapy|0|||
146116700|NCT02289898|526945022|FG002|Overall Study|Use of another anticancer therapy|1|||
146116701|NCT02289898|526945020|FG000|Overall Study|Other|8|||
146116702|NCT02289898|526945021|FG001|Overall Study|Other|7|||
146116703|NCT02289898|526945022|FG002|Overall Study|Other|10|||
146116704|NCT00885105|526945023|FG000|Overall Study|Withdrawal by Subject|0|||
146116705|NCT00885105|526945024|FG001|Overall Study|Withdrawal by Subject|8|||
146116706|NCT00885105|526945023|FG000|Overall Study|Adverse Event|1|||
146116707|NCT00885105|526945024|FG001|Overall Study|Adverse Event|0|||
146116708|NCT00885105|526945023|FG000|Overall Study|Protocol Violation|0|||
146116709|NCT00885105|526945024|FG001|Overall Study|Protocol Violation|2|||
146116710|NCT00103142|526945025|FG000|Overall Study|Adverse Event|1|||
146116711|NCT00103142|526945026|FG001|Overall Study|Adverse Event|0|||
146260808|NCT01101334|527470737|FG000|Overall Study|Progressive Disease|22|||
146260809|NCT01101334|527470738|FG001|Overall Study|Progressive Disease|35|||
146260810|NCT01101334|527470737|FG000|Overall Study|Other|2|||
146260811|NCT01101334|527470738|FG001|Overall Study|Other|1|||
146260812|NCT03440047|527470739|FG000|Overall Study|Withdrawal by Subject|2|||
146116712|NCT00103142|526945025|FG000|Overall Study|Progression of disease|2|||
146116713|NCT00103142|526945026|FG001|Overall Study|Progression of disease|1|||
146116714|NCT01402544|526945030|FG000|Overall Study|Withdrawal by Subject|6|||
146116715|NCT01828281|526945031|FG000|Overall Study|Withdrawal by Subject|1|||
146116716|NCT01828281|526945032|FG001|Overall Study|Withdrawal by Subject|0|||
146116717|NCT01442493|526945033|FG000|Overall Study|withdrawn from study|3|||
146116718|NCT01442493|526945034|FG001|Overall Study|withdrawn from study|2|||
146116719|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Death|3|||
146116720|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Death|3|||
146116721|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Death|0|||
146116722|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Death|0|||
146116723|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
146116724|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
146116725|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
146116726|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
146116727|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
146116728|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
146116729|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
146116730|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
146116731|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
146116732|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
146116733|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
146116734|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
146116735|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
146116736|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
146116737|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
146116738|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
146116739|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
146116740|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
146116741|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
146116742|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
146116743|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
146116744|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
146116745|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
146116746|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
146116747|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Other|6|||
146116748|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Other|3|||
146116749|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Other|0|||
146116750|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Other|0|||
146116751|NCT02051608|526945035|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
146116752|NCT02051608|526945036|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
146116753|NCT02051608|526945037|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
146116754|NCT02051608|526945038|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
146116755|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Adverse Event|0|||
146116756|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Adverse Event|0|||
146116757|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Adverse Event|6|||
146116758|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Adverse Event|8|||
146260813|NCT01181609|527470740|FG000|Overall Study|Adverse Event|1|||
146116759|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Death|0|||
146116760|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Death|0|||
146116761|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Death|7|||
146116762|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Death|4|||
146116763|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
146116764|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
146116765|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
146116766|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
146116767|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
146116768|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
146116769|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
146116770|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
146116771|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
146116772|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
146116773|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
146116774|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
146116775|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146116776|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146116777|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
146116778|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
146116779|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Physician Decision|0|||
146116780|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Physician Decision|0|||
146116781|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Physician Decision|8|||
146116782|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Physician Decision|5|||
146116783|NCT02051608|526945035|FG000|Part 2: Open-label Extension|Other|0|||
146116784|NCT02051608|526945036|FG001|Part 2: Open-label Extension|Other|0|||
146116785|NCT02051608|526945037|FG002|Part 2: Open-label Extension|Other|9|||
146116786|NCT02051608|526945038|FG003|Part 2: Open-label Extension|Other|9|||
146116787|NCT01083576|526945039|FG000|Overall Study|Treatment Failure|6|||
146116788|NCT01083576|526945040|FG001|Overall Study|Treatment Failure|1|||
146116789|NCT00726661|526945046|FG000|Overall Study|Lost to Follow-up|36|||
146116790|NCT00726661|526945047|FG001|Overall Study|Lost to Follow-up|11|||
146116791|NCT00726661|526945046|FG000|Overall Study|Withdrawal by Subject|17|||
146116792|NCT00726661|526945047|FG001|Overall Study|Withdrawal by Subject|13|||
146116793|NCT00726661|526945046|FG000|Overall Study|Trial terminated by sponsor|214|||
146116794|NCT00726661|526945047|FG001|Overall Study|Trial terminated by sponsor|187|||
146116795|NCT00726661|526945046|FG000|Overall Study|Death|475|||
146116796|NCT00726661|526945047|FG001|Overall Study|Death|159|||
146116797|NCT00726661|526945046|FG000|Overall Study|Physician Decision|25|||
146116798|NCT00726661|526945047|FG001|Overall Study|Physician Decision|13|||
146116799|NCT00726661|526945046|FG000|Overall Study|Other|47|||
146116800|NCT00726661|526945047|FG001|Overall Study|Other|35|||
146116801|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
146116802|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
146116803|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
146116804|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
146116805|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
146116806|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
146116807|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
146116808|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
146116809|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
146116810|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
146116811|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
146116812|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146116813|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
146116814|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146116815|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
146116816|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
146116817|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
146116818|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
146116819|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
146116820|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
146116821|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146116822|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
146116823|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
146116824|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146116825|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
146260814|NCT01181609|527470740|FG000|Overall Study|Withdrawal by Subject|1|||
146260815|NCT01181609|527470740|FG000|Overall Study|Lost to Follow-up|1|||
146260816|NCT01181609|527470740|FG000|Overall Study|Death|50|||
146302526|NCT00718549|527621693|FG001|Induction Phase|Disease Progression|0|||
146116826|NCT01285310|526945048|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
146116827|NCT01285310|526945049|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146116828|NCT01285310|526945050|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
146116829|NCT01285310|526945051|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146116830|NCT01285310|526945052|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
146116831|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
146116832|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
146116833|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
146116834|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
146116835|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
146116836|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
146116837|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
146116838|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
146116839|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
146116840|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
146116841|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
146116842|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
146116843|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
146116844|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
146116845|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
146116846|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
146116847|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
146116848|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
146116849|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
146116850|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
146116851|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
146116852|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
146116853|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
146116854|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
146116855|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
146116856|NCT01285310|526945048|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
146116857|NCT01285310|526945049|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146116858|NCT01285310|526945050|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146116859|NCT01285310|526945051|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
146116860|NCT01285310|526945052|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
146116861|NCT00514540|526945053|FG000|First-Line Chemo|Withdrawal by Subject|1|||
146116862|NCT00514540|526945053|FG000|First-Line Chemo|Protocol Violation|7|||
146116863|NCT00514540|526945053|FG000|Second-Line|Physician/Patient Decision|31|||
146116864|NCT01996982|526945056|FG000|Overall Study|PI/team left institution|7|||
146116865|NCT01195415|526945077|FG000|Overall Study|No repeat biopsy due to progression|2|||
146116866|NCT00533845|526945080|FG000|Overall Study|Physician Decision|1|||
146116867|NCT00533845|526945081|FG001|Overall Study|Physician Decision|0|||
146116868|NCT01442675|526945096|FG000|Overall Study|Protocol Violation|6|||
146116869|NCT01442675|526945096|FG000|Overall Study|Lost to Follow-up|2|||
146116870|NCT01442675|526945096|FG000|Overall Study|Withdrawal by Subject|4|||
146116871|NCT01957644|526945100|FG000|Overall Study|Adverse Event|4|||
146116872|NCT01957644|526945101|FG001|Overall Study|Adverse Event|2|||
146116873|NCT01957644|526945102|FG002|Overall Study|Adverse Event|0|||
146116874|NCT01957644|526945103|FG003|Overall Study|Adverse Event|0|||
146116875|NCT01957644|526945104|FG004|Overall Study|Adverse Event|1|||
146116876|NCT01957644|526945100|FG000|Overall Study|Progressive disease / relapse|0|||
146116877|NCT01957644|526945101|FG001|Overall Study|Progressive disease / relapse|1|||
146116878|NCT01957644|526945102|FG002|Overall Study|Progressive disease / relapse|0|||
146116879|NCT01957644|526945103|FG003|Overall Study|Progressive disease / relapse|1|||
146116880|NCT01957644|526945104|FG004|Overall Study|Progressive disease / relapse|0|||
146116881|NCT01957644|526945100|FG000|Overall Study|Other reason|1|||
146116882|NCT01957644|526945101|FG001|Overall Study|Other reason|2|||
146116883|NCT01957644|526945102|FG002|Overall Study|Other reason|1|||
146116884|NCT01957644|526945103|FG003|Overall Study|Other reason|1|||
146116885|NCT01957644|526945104|FG004|Overall Study|Other reason|0|||
146116886|NCT01957644|526945100|FG000|Overall Study|Withdrawal by Subject|1|||
146116887|NCT01957644|526945101|FG001|Overall Study|Withdrawal by Subject|0|||
146116888|NCT01957644|526945102|FG002|Overall Study|Withdrawal by Subject|0|||
146116889|NCT01957644|526945103|FG003|Overall Study|Withdrawal by Subject|0|||
146116890|NCT01957644|526945104|FG004|Overall Study|Withdrawal by Subject|0|||
146116891|NCT01957644|526945100|FG000|Overall Study|Protocol Violation|0|||
146116892|NCT01957644|526945101|FG001|Overall Study|Protocol Violation|1|||
146116893|NCT01957644|526945102|FG002|Overall Study|Protocol Violation|0|||
146116894|NCT01957644|526945103|FG003|Overall Study|Protocol Violation|0|||
146116895|NCT01957644|526945104|FG004|Overall Study|Protocol Violation|0|||
146116896|NCT02733367|526945105|FG000|Overall Study|Withdrawal by Subject|6|||
146116897|NCT01348347|526945106|FG000|Overall Study|Withdrawal by Subject|1|||
146116898|NCT01348347|526945107|FG001|Overall Study|Withdrawal by Subject|1|||
146116899|NCT01348347|526945108|FG002|Overall Study|Withdrawal by Subject|1|||
146116900|NCT01348347|526945106|FG000|Overall Study|Progressive disease|2|||
146116901|NCT01348347|526945107|FG001|Overall Study|Progressive disease|5|||
146116902|NCT01348347|526945108|FG002|Overall Study|Progressive disease|5|||
146116903|NCT03049280|526945112|FG000|Overall Study|Physician Decision|1|||
146116904|NCT01867021|526945113|FG000|Overall Study|Adverse Event|0|||
146116905|NCT01867021|526945114|FG001|Overall Study|Adverse Event|1|||
146116906|NCT01867021|526945113|FG000|Overall Study|Not Eligible|0|||
146116907|NCT01867021|526945114|FG001|Overall Study|Not Eligible|1|||
146116908|NCT01867021|526945113|FG000|Overall Study|Death|1|||
146116909|NCT01867021|526945114|FG001|Overall Study|Death|0|||
146116910|NCT01867021|526945113|FG000|Overall Study|Lost to Follow-up|0|||
146116911|NCT01867021|526945114|FG001|Overall Study|Lost to Follow-up|2|||
146116912|NCT01867021|526945113|FG000|Overall Study|Withdrawal by Subject|1|||
146116913|NCT01867021|526945114|FG001|Overall Study|Withdrawal by Subject|6|||
146116914|NCT00640601|526945115|FG000|Overall Study|Adverse Event|43|||
146116915|NCT00640601|526945115|FG000|Overall Study|Withdrawal by Subject|20|||
146116916|NCT00640601|526945115|FG000|Overall Study|Protocol Violation|6|||
146116917|NCT00640601|526945115|FG000|Overall Study|Lack of Efficacy|16|||
146116918|NCT00640601|526945115|FG000|Overall Study|Lost to Follow-up|9|||
146116919|NCT00640601|526945115|FG000|Overall Study|Physician Decision|8|||
146116920|NCT00640601|526945115|FG000|Overall Study|treatment naive, combination therapy|10|||
146116921|NCT03681405|526945116|FG000|Overall Study|Found to be ineligible after randomized|1|||
146116922|NCT03681405|526945117|FG001|Overall Study|Found to be ineligible after randomized|0|||
146116923|NCT01958008|526945120|FG000|Overall Study|Worsening of disease under study|0|||
146116924|NCT01958008|526945121|FG001|Overall Study|Worsening of disease under study|0|||
146116925|NCT01958008|526945122|FG002|Overall Study|Worsening of disease under study|1|||
146116926|NCT01958008|526945123|FG003|Overall Study|Worsening of disease under study|0|||
146116927|NCT01958008|526945120|FG000|Overall Study|Other adverse event|1|||
146116928|NCT01958008|526945121|FG001|Overall Study|Other adverse event|0|||
146116929|NCT01958008|526945122|FG002|Overall Study|Other adverse event|0|||
146116930|NCT01958008|526945123|FG003|Overall Study|Other adverse event|0|||
146116931|NCT03789318|526945124|FG000|Overall Study|Adverse Event|0|||
146116932|NCT03789318|526945125|FG001|Overall Study|Adverse Event|0|||
146116933|NCT03789318|526945126|FG002|Overall Study|Adverse Event|1|||
146116934|NCT03789318|526945127|FG003|Overall Study|Adverse Event|1|||
146116935|NCT03789318|526945128|FG004|Overall Study|Adverse Event|0|||
146116936|NCT03789318|526945124|FG000|Overall Study|Lost to Follow-up|0|||
146116937|NCT03789318|526945125|FG001|Overall Study|Lost to Follow-up|0|||
146116938|NCT03789318|526945126|FG002|Overall Study|Lost to Follow-up|1|||
146116939|NCT03789318|526945127|FG003|Overall Study|Lost to Follow-up|0|||
146116940|NCT03789318|526945128|FG004|Overall Study|Lost to Follow-up|0|||
146116941|NCT03789318|526945124|FG000|Overall Study|Withdrawal by Subject|0|||
146116942|NCT03789318|526945125|FG001|Overall Study|Withdrawal by Subject|0|||
146116943|NCT03789318|526945126|FG002|Overall Study|Withdrawal by Subject|1|||
146116944|NCT03789318|526945127|FG003|Overall Study|Withdrawal by Subject|0|||
146116945|NCT03789318|526945128|FG004|Overall Study|Withdrawal by Subject|0|||
146116946|NCT00733408|526946978|FG000|Overall Study|Adverse Event|4|||
146116947|NCT00531232|526946979|FG000|Overall Study|Investigator decision|0|||
146116948|NCT00531232|526946980|FG001|Overall Study|Investigator decision|0|||
146116949|NCT00531232|526946981|FG002|Overall Study|Investigator decision|4|||
146116950|NCT00531232|526946979|FG000|Overall Study|Participants refused further treatment|0|||
146116951|NCT00531232|526946980|FG001|Overall Study|Participants refused further treatment|1|||
146116952|NCT00531232|526946981|FG002|Overall Study|Participants refused further treatment|2|||
146116953|NCT00531232|526946979|FG000|Overall Study|Adverse events (AEs)|1|||
146116954|NCT00531232|526946980|FG001|Overall Study|Adverse events (AEs)|2|||
146116955|NCT00531232|526946981|FG002|Overall Study|Adverse events (AEs)|2|||
146116956|NCT00531232|526946979|FG000|Overall Study|Treatment failure|1|||
146116957|NCT00531232|526946980|FG001|Overall Study|Treatment failure|3|||
146116958|NCT00531232|526946981|FG002|Overall Study|Treatment failure|7|||
146116959|NCT00531232|526946979|FG000|Overall Study|Disease recurrence|0|||
146116960|NCT00531232|526946980|FG001|Overall Study|Disease recurrence|0|||
146116961|NCT00531232|526946981|FG002|Overall Study|Disease recurrence|1|||
146116962|NCT00531232|526946979|FG000|Overall Study|Deceased|2|||
146116963|NCT00531232|526946980|FG001|Overall Study|Deceased|2|||
146116964|NCT00531232|526946981|FG002|Overall Study|Deceased|2|||
146116965|NCT00531232|526946979|FG000|Overall Study|Withdrawal by Subject|0|||
146116966|NCT00531232|526946980|FG001|Overall Study|Withdrawal by Subject|1|||
146116967|NCT00531232|526946981|FG002|Overall Study|Withdrawal by Subject|2|||
146116968|NCT00531232|526946979|FG000|Overall Study|Other|0|||
146116969|NCT00531232|526946980|FG001|Overall Study|Other|0|||
146116970|NCT00531232|526946981|FG002|Overall Study|Other|5|||
146116971|NCT04232124|526946982|FG000|Overall Study|Lost to Follow-up|3|||
146116972|NCT02329730|526946986|FG000|Overall Study|Protocol Violation|0|||
146116973|NCT02329730|526946987|FG001|Overall Study|Protocol Violation|0|||
146116974|NCT02329730|526946988|FG002|Overall Study|Protocol Violation|0|||
146116975|NCT02329730|526946989|FG003|Overall Study|Protocol Violation|0|||
146116976|NCT02329730|526946990|FG004|Overall Study|Protocol Violation|2|||
146116977|NCT02329730|526946991|FG005|Overall Study|Protocol Violation|2|||
146116978|NCT02329730|526946992|FG006|Overall Study|Protocol Violation|0|||
146116979|NCT02329730|526946993|FG007|Overall Study|Protocol Violation|0|||
146116980|NCT02329730|526946994|FG008|Overall Study|Protocol Violation|0|||
146116981|NCT02329730|526946995|FG009|Overall Study|Protocol Violation|0|||
146116982|NCT02329730|526946996|FG010|Overall Study|Protocol Violation|0|||
146116983|NCT02329730|526946997|FG011|Overall Study|Protocol Violation|0|||
146116984|NCT02329730|526946986|FG000|Overall Study|Withdrawal by Subject|0|||
146116985|NCT02329730|526946987|FG001|Overall Study|Withdrawal by Subject|0|||
146116986|NCT02329730|526946988|FG002|Overall Study|Withdrawal by Subject|0|||
146116987|NCT02329730|526946989|FG003|Overall Study|Withdrawal by Subject|0|||
146116988|NCT02329730|526946990|FG004|Overall Study|Withdrawal by Subject|1|||
146116989|NCT02329730|526946991|FG005|Overall Study|Withdrawal by Subject|0|||
146116990|NCT02329730|526946992|FG006|Overall Study|Withdrawal by Subject|1|||
146116991|NCT02329730|526946993|FG007|Overall Study|Withdrawal by Subject|1|||
146116992|NCT02329730|526946994|FG008|Overall Study|Withdrawal by Subject|1|||
146116993|NCT02329730|526946995|FG009|Overall Study|Withdrawal by Subject|1|||
146116994|NCT02329730|526946996|FG010|Overall Study|Withdrawal by Subject|0|||
146116995|NCT02329730|526946997|FG011|Overall Study|Withdrawal by Subject|0|||
146116996|NCT02345850|526947000|FG000|Overall Study|Not transplanted|10|||
146116997|NCT02345850|526947001|FG001|Overall Study|Not transplanted|5|||
146116998|NCT02345850|526947002|FG002|Overall Study|Not transplanted|4|||
146116999|NCT02345850|526947000|FG000|Overall Study|Lost to Follow-up|2|||
146117000|NCT02345850|526947001|FG001|Overall Study|Lost to Follow-up|3|||
146117001|NCT02345850|526947002|FG002|Overall Study|Lost to Follow-up|2|||
146117002|NCT02345850|526947000|FG000|Overall Study|Withdrawal by Subject|1|||
146117003|NCT02345850|526947001|FG001|Overall Study|Withdrawal by Subject|0|||
146117004|NCT02345850|526947002|FG002|Overall Study|Withdrawal by Subject|0|||
146117005|NCT02392247|526947003|FG000|Overall Study|Withdrawal by Subject|1|||
146117006|NCT02392247|526947003|FG000|Overall Study|Surgery cancelled; no data|1|||
146117007|NCT01991067|526947005|FG000|Overall Study|Lost to Follow-up|6|||
146117008|NCT01991067|526947006|FG001|Overall Study|Lost to Follow-up|5|||
146117009|NCT02068443|526947009|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146117010|NCT02068443|526947010|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
146117011|NCT02068443|526947011|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
146117012|NCT02068443|526947009|FG000|Overall Study|Voluntary Withdrawal|4|||
146117013|NCT02068443|526947010|FG001|Overall Study|Voluntary Withdrawal|0|||
146117014|NCT02068443|526947011|FG002|Overall Study|Voluntary Withdrawal|1|||
146117015|NCT02068443|526947009|FG000|Overall Study|Lack of Efficacy|2|||
146117016|NCT02068443|526947010|FG001|Overall Study|Lack of Efficacy|1|||
146117017|NCT02068443|526947011|FG002|Overall Study|Lack of Efficacy|0|||
146117018|NCT02068443|526947009|FG000|Overall Study|Other Reason Not Specified|1|||
146117019|NCT02068443|526947010|FG001|Overall Study|Other Reason Not Specified|0|||
146117020|NCT02068443|526947011|FG002|Overall Study|Other Reason Not Specified|0|||
146117021|NCT00664742|526947012|FG000|Overall Study|Withdrawn due to adverse events|3|||
146117022|NCT00664742|526947012|FG000|Overall Study|Withdrawal by Subject|31|||
146117023|NCT00664742|526947012|FG000|Overall Study|Lost to Follow-up|92|||
146117024|NCT04317066|526947013|FG000|Overall Study|Sponsor decision|5|||
146117025|NCT04317066|526947013|FG000|Overall Study|Death|2|||
146117026|NCT02014597|526947016|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
146117027|NCT02014597|526947017|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
146117028|NCT02825992|526947018|FG000|Overall Study|Withdrawal by Subject|4|||
146117029|NCT02825992|526947018|FG000|Overall Study|Lost to Follow-up|2|||
146117030|NCT02825992|526947018|FG000|Overall Study|Procedure terminated|2|||
146117031|NCT02279173|526947019|FG000|Overall Study|Protocol-specified Criteria|67|||
146260817|NCT01722045|527470741|FG000|Overall Study|Adverse Event|8|||
146260818|NCT01722045|527470741|FG000|Overall Study|Death|3|||
146260819|NCT01722045|527470741|FG000|Overall Study|Withdrawal by Subject|8|||
146260820|NCT01722045|527470741|FG000|Overall Study|Lost to Follow-up|4|||
146117032|NCT02279173|526947019|FG000|Overall Study|Withdrawal by Subject|20|||
146117033|NCT02279173|526947019|FG000|Overall Study|Decision by Sponsor|4|||
146117034|NCT02279173|526947019|FG000|Overall Study|Lost to Follow-up|3|||
146260821|NCT01722045|527470741|FG000|Overall Study|Protocol Deviation|1|||
146260822|NCT01722045|527470741|FG000|Overall Study|Physician Decision|3|||
146260823|NCT01722045|527470741|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
146117035|NCT01164956|526947020|FG000|Overall Study|Side Effects|1|||
146117036|NCT01164956|526947021|FG001|Overall Study|Side Effects|0|||
146117037|NCT01164956|526947022|FG002|Overall Study|Side Effects|1|||
146117038|NCT00931762|526947023|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
146117039|NCT00931762|526947023|FG000|Overall Study|Administrative Problems|5|||
146117040|NCT00931762|526947023|FG000|Overall Study|Death|1|||
146117041|NCT00931762|526947023|FG000|Overall Study|Disease Progression|3|||
146117042|NCT00931762|526947023|FG000|Overall Study|Adverse Event (s)|11|||
146117043|NCT00931762|526947023|FG000|Overall Study|Subject withdrew consent|13|||
146117044|NCT02282020|526947024|FG000|Overall Study|Objective Disease Progression|128|||
146117045|NCT02282020|526947025|FG001|Overall Study|Objective Disease Progression|30|||
146117046|NCT02282020|526947024|FG000|Overall Study|Adverse Event|18|||
146117047|NCT02282020|526947025|FG001|Overall Study|Adverse Event|15|||
146117048|NCT02282020|526947024|FG000|Overall Study|Withdrawal by Subject|7|||
146117049|NCT02282020|526947025|FG001|Overall Study|Withdrawal by Subject|10|||
146117050|NCT02282020|526947024|FG000|Overall Study|Miscellaneous|5|||
146117051|NCT02282020|526947025|FG001|Overall Study|Miscellaneous|19|||
146117052|NCT02282020|526947024|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
146117053|NCT02282020|526947025|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
146117054|NCT02282020|526947024|FG000|Overall Study|Developed Discontinuation Criteria|0|||
146117055|NCT02282020|526947025|FG001|Overall Study|Developed Discontinuation Criteria|2|||
146117056|NCT02282020|526947024|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
146117057|NCT02282020|526947025|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
146117058|NCT01500629|526947026|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
146117059|NCT01500629|526947027|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
146117060|NCT00849381|526947028|FG000|Overall Study|Adverse Event|1|||
146117061|NCT00849381|526947028|FG000|Overall Study|Lost to Follow-up|129|||
146117062|NCT00849381|526947028|FG000|Overall Study|Protocol Violation|5|||
146117063|NCT00849381|526947028|FG000|Overall Study|Withdrawal by Subject|6|||
146117064|NCT00849381|526947028|FG000|Overall Study|Other|4|||
146117065|NCT04429061|526947032|FG000|Overall Study|Lost to Follow-up|62|||
146117066|NCT04429061|526947033|FG001|Overall Study|Lost to Follow-up|87|||
146117067|NCT04429061|526947032|FG000|Overall Study|Withdrawal by Subject|3|||
146117068|NCT04429061|526947033|FG001|Overall Study|Withdrawal by Subject|4|||
146117069|NCT02618434|526947034|FG000|Overall Study|Withdrawal by Subject|0|||
146117070|NCT02618434|526947035|FG001|Overall Study|Withdrawal by Subject|2|||
146117071|NCT02618434|526947036|FG002|Overall Study|Withdrawal by Subject|3|||
146117072|NCT02618434|526947034|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
146117073|NCT02618434|526947035|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
146117074|NCT02618434|526947036|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
146117075|NCT02618434|526947034|FG000|Overall Study|Lost to Follow-up|3|||
146117076|NCT02618434|526947035|FG001|Overall Study|Lost to Follow-up|1|||
146117077|NCT02618434|526947036|FG002|Overall Study|Lost to Follow-up|3|||
146117078|NCT02618434|526947034|FG000|Overall Study|Adverse Event|1|||
146117079|NCT02618434|526947035|FG001|Overall Study|Adverse Event|0|||
146117080|NCT02618434|526947036|FG002|Overall Study|Adverse Event|12|||
146117081|NCT02618434|526947034|FG000|Overall Study|Physician Decision|0|||
146117082|NCT02618434|526947035|FG001|Overall Study|Physician Decision|1|||
146117083|NCT02618434|526947036|FG002|Overall Study|Physician Decision|0|||
146117084|NCT02618434|526947034|FG000|Overall Study|Protocol Violation|0|||
146117085|NCT02618434|526947035|FG001|Overall Study|Protocol Violation|0|||
146117086|NCT02618434|526947036|FG002|Overall Study|Protocol Violation|1|||
146117087|NCT02618434|526947034|FG000|Overall Study|Other, Multiple categories|1|||
146117088|NCT02618434|526947035|FG001|Overall Study|Other, Multiple categories|1|||
146117089|NCT02618434|526947036|FG002|Overall Study|Other, Multiple categories|1|||
146117090|NCT02066233|526947041|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
146117091|NCT02066233|526947042|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
146117092|NCT02772081|526947043|FG000|Overall Study|Physician Decision|1|||
146117093|NCT02772081|526947044|FG001|Overall Study|Physician Decision|1|||
146117094|NCT02772081|526947043|FG000|Overall Study|Death|1|||
146117095|NCT02772081|526947044|FG001|Overall Study|Death|1|||
146117096|NCT01986985|526947052|FG000|Overall Study|Withdrawal by Subject|4|||
146117097|NCT01986985|526947052|FG000|Overall Study|Scan not completed due to malfunction|3|||
146117098|NCT02005445|526947053|FG000|Overall Study|Dual study enrollment|0|||
146117099|NCT02005445|526947054|FG001|Overall Study|Dual study enrollment|1|||
146117100|NCT02709785|526947055|FG000|Overall Study|Withdrawal by Subject|1|||
146117101|NCT02709785|526947056|FG001|Overall Study|Withdrawal by Subject|2|||
146117102|NCT02709785|526947057|FG002|Overall Study|Withdrawal by Subject|1|||
146117103|NCT01961323|526947058|FG000|Overall Study|Withdrawal by Subject|7|||
146117104|NCT01961323|526947058|FG000|Overall Study|Lost to Follow-up|8|||
146117105|NCT01961323|526947058|FG000|Overall Study|screen failure|34|||
146117106|NCT01881776|526947060|FG000|Overall Study|Lost to Follow-up|1|||
146117107|NCT01881776|526947061|FG001|Overall Study|Lost to Follow-up|2|||
146117108|NCT01881776|526947062|FG002|Overall Study|Lost to Follow-up|1|||
146260824|NCT00612352|527470742|FG000|Overall Study|Adverse Event|1|||
146260825|NCT00612352|527470743|FG001|Overall Study|Adverse Event|0|||
146260826|NCT00612352|527470742|FG000|Overall Study|Withdrawal by Subject|3|||
146117109|NCT01881776|526947060|FG000|Overall Study|Protocol Violation|0|||
146117110|NCT01881776|526947061|FG001|Overall Study|Protocol Violation|2|||
146117111|NCT01881776|526947062|FG002|Overall Study|Protocol Violation|1|||
146117112|NCT02320149|526947063|FG000|Overall Study|Adverse Event|3|||
146117113|NCT02320149|526947064|FG001|Overall Study|Adverse Event|7|||
146260827|NCT00612352|527470743|FG001|Overall Study|Withdrawal by Subject|5|||
146260828|NCT00612352|527470742|FG000|Overall Study|moved out of state|1|||
146117114|NCT02320149|526947063|FG000|Overall Study|Withdrawal of Consent|28|||
146117115|NCT02320149|526947064|FG001|Overall Study|Withdrawal of Consent|32|||
146117116|NCT02320149|526947063|FG000|Overall Study|Lost to Follow-up|21|||
146117117|NCT02320149|526947064|FG001|Overall Study|Lost to Follow-up|34|||
146117118|NCT02320149|526947063|FG000|Overall Study|Protocol Violation|2|||
146117119|NCT02320149|526947064|FG001|Overall Study|Protocol Violation|1|||
146117120|NCT02320149|526947063|FG000|Overall Study|Noncompliance with Study Treatment|7|||
146117121|NCT02320149|526947064|FG001|Overall Study|Noncompliance with Study Treatment|2|||
146117122|NCT02320149|526947063|FG000|Overall Study|Lack of Efficacy|0|||
146117123|NCT02320149|526947064|FG001|Overall Study|Lack of Efficacy|1|||
146117124|NCT02320149|526947063|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146117125|NCT02320149|526947064|FG001|Overall Study|Other Miscellaneous Reasons|3|||
146117126|NCT00022633|526947065|FG000|Overall Study|Adverse Event|11|||
146117127|NCT00022633|526947066|FG001|Overall Study|Adverse Event|1|||
146117128|NCT00022633|526947065|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146117129|NCT00022633|526947066|FG001|Overall Study|Refusal unrelated to adverse event|0|||
146117130|NCT00022633|526947065|FG000|Overall Study|Progression/relapse|9|||
146117131|NCT00022633|526947066|FG001|Overall Study|Progression/relapse|2|||
146117132|NCT00022633|526947065|FG000|Overall Study|Death|4|||
146117133|NCT00022633|526947066|FG001|Overall Study|Death|0|||
146117134|NCT00022633|526947065|FG000|Overall Study|Other - not protocol specified|3|||
146117135|NCT00022633|526947066|FG001|Overall Study|Other - not protocol specified|2|||
146117136|NCT00022633|526947065|FG000|Overall Study|Ineligible|4|||
146117137|NCT00022633|526947066|FG001|Overall Study|Ineligible|0|||
146117138|NCT06133348|526947067|FG000|Overall Study|Death|3|||
146117139|NCT06133348|526947067|FG000|Overall Study|Lost to Follow-up|1|||
146117140|NCT06133348|526947067|FG000|Overall Study|Physician Decision|1|||
146117141|NCT06133348|526947067|FG000|Overall Study|Withdrawal by Subject|5|||
146117142|NCT00487747|526947068|FG000|Overall Study|Adverse Event|1|||
146117143|NCT00487747|526947068|FG000|Overall Study|Lost to Follow-up|9|||
146117144|NCT00487747|526947068|FG000|Overall Study|Lack of Efficacy|1|||
146117145|NCT01359449|526947069|FG000|Overall Study|Lost to Follow-up|1|||
146117146|NCT01359449|526947070|FG001|Overall Study|Lost to Follow-up|0|||
146117147|NCT01359449|526947069|FG000|Overall Study|Protocol Violation|0|||
146117148|NCT01359449|526947070|FG001|Overall Study|Protocol Violation|2|||
146117149|NCT01359449|526947069|FG000|Overall Study|Withdrawal by Subject|3|||
146117150|NCT01359449|526947070|FG001|Overall Study|Withdrawal by Subject|2|||
146117151|NCT02036294|526947072|FG000|Overall Study|Death|7|||
146117152|NCT02036294|526947073|FG001|Overall Study|Death|8|||
146117153|NCT02036294|526947072|FG000|Overall Study|Withdrawal by Subject|2|||
146117154|NCT02036294|526947073|FG001|Overall Study|Withdrawal by Subject|3|||
146117155|NCT00429104|526947076|FG000|Overall Study|Protocol Violation|1|||
146117156|NCT01907815|526947077|FG000|Overall Study|Withdrawal by Subject|1|||
146117157|NCT01907815|526947078|FG001|Overall Study|Withdrawal by Subject|0|||
146117158|NCT04997161|526947081|FG000|Overall Study|Study terminated by sponsor|3|||
146260829|NCT00612352|527470743|FG001|Overall Study|moved out of state|0|||
146260830|NCT00612352|527470742|FG000|Overall Study|didn't return calls/show up on test date|4|||
146260831|NCT00612352|527470743|FG001|Overall Study|didn't return calls/show up on test date|1|||
146260832|NCT02161406|527470744|FG000|Overall Study|Death|2|||
146260833|NCT02161406|527470745|FG001|Overall Study|Death|1|||
146260834|NCT02161406|527470744|FG000|Overall Study|Lost to Follow-up|2|||
146260835|NCT02161406|527470745|FG001|Overall Study|Lost to Follow-up|1|||
146260836|NCT02161406|527470744|FG000|Overall Study|Withdrawal by Subject|2|||
146260837|NCT02161406|527470745|FG001|Overall Study|Withdrawal by Subject|4|||
146260838|NCT02161406|527470744|FG000|Overall Study|investigator withdrew subject|3|||
146260839|NCT02161406|527470745|FG001|Overall Study|investigator withdrew subject|1|||
146260840|NCT02161406|527470744|FG000|Overall Study|Lack of Efficacy|1|||
146117171|NCT02485574|526947091|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
146117172|NCT01408914|526947093|FG000|Overall Study|Could not complete tx in protocol period|5|||
146117173|NCT01408914|526947094|FG001|Overall Study|Could not complete tx in protocol period|5|||
146260841|NCT02161406|527470745|FG001|Overall Study|Lack of Efficacy|1|||
146260842|NCT02161406|527470744|FG000|Overall Study|relocation|0|||
146260843|NCT02161406|527470745|FG001|Overall Study|relocation|1|||
146260844|NCT00263211|527470748|FG000|Overall Study|Death|1|||
146260845|NCT00263211|527470749|FG001|Overall Study|Death|0|||
146260846|NCT00263211|527470748|FG000|Overall Study|Withdrawal by Subject|3|||
146117174|NCT01408914|526947095|FG002|Overall Study|Could not complete tx in protocol period|6|||
146117175|NCT01408914|526947093|FG000|Overall Study|Lost to Follow-up|4|||
146117176|NCT01408914|526947094|FG001|Overall Study|Lost to Follow-up|1|||
146117177|NCT01408914|526947095|FG002|Overall Study|Lost to Follow-up|2|||
146117178|NCT01408914|526947093|FG000|Overall Study|Physician Decision|1|||
146117179|NCT01408914|526947094|FG001|Overall Study|Physician Decision|1|||
146260847|NCT00263211|527470749|FG001|Overall Study|Withdrawal by Subject|0|||
146117180|NCT01408914|526947095|FG002|Overall Study|Physician Decision|0|||
146117181|NCT01408914|526947093|FG000|Overall Study|Withdrawal by Subject|1|||
146117182|NCT01408914|526947094|FG001|Overall Study|Withdrawal by Subject|0|||
146117183|NCT01408914|526947095|FG002|Overall Study|Withdrawal by Subject|1|||
146117184|NCT01408914|526947093|FG000|Overall Study|Moved out of study jurisdiction|1|||
146260848|NCT00263211|527470748|FG000|Overall Study|Protocol Violation|1|||
146260849|NCT00263211|527470749|FG001|Overall Study|Protocol Violation|0|||
146260850|NCT00263211|527470748|FG000|Overall Study|Disease Progression|0|||
146117185|NCT01408914|526947094|FG001|Overall Study|Moved out of study jurisdiction|1|||
146117186|NCT01408914|526947095|FG002|Overall Study|Moved out of study jurisdiction|0|||
146117187|NCT01408914|526947093|FG000|Overall Study|Late exclusion|0|||
146117188|NCT01408914|526947094|FG001|Overall Study|Late exclusion|3|||
146117189|NCT01408914|526947095|FG002|Overall Study|Late exclusion|3|||
146117190|NCT01408914|526947093|FG000|Overall Study|Change in local TB/HIV norms|0|||
146117191|NCT01408914|526947094|FG001|Overall Study|Change in local TB/HIV norms|1|||
146117192|NCT01408914|526947095|FG002|Overall Study|Change in local TB/HIV norms|1|||
146117193|NCT01957553|526947103|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
146117194|NCT01957553|526947104|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
146117195|NCT01957553|526947103|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
146117196|NCT01957553|526947104|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
146117197|NCT01957553|526947103|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
146117198|NCT01957553|526947104|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
146117199|NCT01957553|526947103|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
146117200|NCT01957553|526947104|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
146117201|NCT01957553|526947103|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
146117202|NCT01957553|526947104|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
146117203|NCT01957553|526947103|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
146117204|NCT01957553|526947104|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
146117205|NCT01957553|526947103|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
146117206|NCT01957553|526947104|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
146117207|NCT01957553|526947103|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
146117208|NCT01957553|526947104|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
146117209|NCT01957553|526947103|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
146117210|NCT01957553|526947104|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
146117211|NCT04044716|526947105|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
146117212|NCT04044716|526947106|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
146117213|NCT04044716|526947107|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
146117214|NCT04044716|526947105|FG000|Overall Study|Lost to Follow-up|2|||
146117215|NCT04044716|526947106|FG001|Overall Study|Lost to Follow-up|3|||
146117216|NCT04044716|526947107|FG002|Overall Study|Lost to Follow-up|0|||
146117217|NCT00071513|526947114|FG000|Intervention Component|Withdrawal by Subject|2|||
146117218|NCT00071513|526947115|FG001|Intervention Component|Withdrawal by Subject|3|||
146117219|NCT00071513|526947114|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
146117220|NCT00071513|526947115|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
146117221|NCT03667924|526947116|FG000|Baseline Completed|Lost to Follow-up|0|||
146117222|NCT03667924|526947117|FG001|Baseline Completed|Lost to Follow-up|2|||
146117223|NCT03667924|526947118|FG002|Baseline Completed|Lost to Follow-up|0|||
146117224|NCT03667924|526947116|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
146117225|NCT03667924|526947117|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
146117226|NCT03667924|526947118|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
146117227|NCT03667924|526947116|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
146117228|NCT03667924|526947117|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
146117229|NCT03667924|526947118|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
146117230|NCT03667924|526947116|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
146117231|NCT03667924|526947117|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
146117232|NCT03667924|526947118|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
146117233|NCT03667924|526947116|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
146117234|NCT03667924|526947117|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
146117235|NCT03667924|526947118|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
146117236|NCT03667924|526947116|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
146117237|NCT03667924|526947117|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
146117238|NCT03667924|526947118|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
146117239|NCT03667924|526947116|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
146117240|NCT03667924|526947117|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
146117241|NCT03667924|526947118|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
146117242|NCT03358290|526947119|FG000|Overall Study|Study discontinued by Sponsor|0|||
146117243|NCT03358290|526947120|FG001|Overall Study|Study discontinued by Sponsor|1|||
146117244|NCT03358290|526947121|FG002|Overall Study|Study discontinued by Sponsor|1|||
146117245|NCT03358290|526947122|FG003|Overall Study|Study discontinued by Sponsor|0|||
146117246|NCT03358290|526947123|FG004|Overall Study|Study discontinued by Sponsor|0|||
146117247|NCT03358290|526947119|FG000|Overall Study|Adverse Event|0|||
146117248|NCT03358290|526947120|FG001|Overall Study|Adverse Event|0|||
146117249|NCT03358290|526947121|FG002|Overall Study|Adverse Event|1|||
146117250|NCT03358290|526947122|FG003|Overall Study|Adverse Event|2|||
146117251|NCT03358290|526947123|FG004|Overall Study|Adverse Event|0|||
146117252|NCT03358290|526947119|FG000|Overall Study|Withdrawal by Subject|0|||
146117253|NCT03358290|526947120|FG001|Overall Study|Withdrawal by Subject|0|||
146117254|NCT03358290|526947121|FG002|Overall Study|Withdrawal by Subject|0|||
146117255|NCT03358290|526947122|FG003|Overall Study|Withdrawal by Subject|0|||
146117256|NCT03358290|526947123|FG004|Overall Study|Withdrawal by Subject|1|||
146117257|NCT02743871|526947124|FG000|Overall Study|Lost to Follow-up|0|||
146117258|NCT02743871|526947125|FG001|Overall Study|Lost to Follow-up|0|||
146117259|NCT02743871|526947126|FG002|Overall Study|Lost to Follow-up|0|||
146117260|NCT02743871|526947127|FG003|Overall Study|Lost to Follow-up|1|||
146117261|NCT02743871|526947128|FG004|Overall Study|Lost to Follow-up|0|||
146117262|NCT02743871|526947129|FG005|Overall Study|Lost to Follow-up|0|||
146117263|NCT02743871|526947130|FG006|Overall Study|Lost to Follow-up|1|||
146117264|NCT02743871|526947131|FG007|Overall Study|Lost to Follow-up|0|||
146117265|NCT02743871|526947132|FG008|Overall Study|Lost to Follow-up|0|||
146117266|NCT02743871|526947133|FG009|Overall Study|Lost to Follow-up|0|||
146117267|NCT02743871|526947134|FG010|Overall Study|Lost to Follow-up|0|||
146117268|NCT02743871|526947135|FG011|Overall Study|Lost to Follow-up|2|||
146117269|NCT02743871|526947136|FG012|Overall Study|Lost to Follow-up|0|||
146117270|NCT02743871|526947137|FG013|Overall Study|Lost to Follow-up|0|||
146117271|NCT02743871|526947124|FG000|Overall Study|Withdrawal by Subject|0|||
146117272|NCT02743871|526947125|FG001|Overall Study|Withdrawal by Subject|0|||
146117273|NCT02743871|526947126|FG002|Overall Study|Withdrawal by Subject|0|||
146117274|NCT02743871|526947127|FG003|Overall Study|Withdrawal by Subject|0|||
146117275|NCT02743871|526947128|FG004|Overall Study|Withdrawal by Subject|0|||
146117276|NCT02743871|526947129|FG005|Overall Study|Withdrawal by Subject|0|||
146117277|NCT02743871|526947130|FG006|Overall Study|Withdrawal by Subject|0|||
146117278|NCT02743871|526947131|FG007|Overall Study|Withdrawal by Subject|0|||
146117279|NCT02743871|526947132|FG008|Overall Study|Withdrawal by Subject|0|||
146117280|NCT02743871|526947133|FG009|Overall Study|Withdrawal by Subject|0|||
146117281|NCT02743871|526947134|FG010|Overall Study|Withdrawal by Subject|1|||
146117282|NCT02743871|526947135|FG011|Overall Study|Withdrawal by Subject|0|||
146117283|NCT02743871|526947136|FG012|Overall Study|Withdrawal by Subject|12|||
146117284|NCT02743871|526947137|FG013|Overall Study|Withdrawal by Subject|6|||
146117285|NCT02743871|526947124|FG000|Overall Study|Adverse Event|1|||
146117286|NCT02743871|526947125|FG001|Overall Study|Adverse Event|0|||
146117287|NCT02743871|526947126|FG002|Overall Study|Adverse Event|0|||
146117288|NCT02743871|526947127|FG003|Overall Study|Adverse Event|0|||
146117289|NCT02743871|526947128|FG004|Overall Study|Adverse Event|0|||
146117290|NCT02743871|526947129|FG005|Overall Study|Adverse Event|0|||
146117291|NCT02743871|526947130|FG006|Overall Study|Adverse Event|0|||
146117292|NCT02743871|526947131|FG007|Overall Study|Adverse Event|0|||
146117293|NCT02743871|526947132|FG008|Overall Study|Adverse Event|0|||
146117294|NCT02743871|526947133|FG009|Overall Study|Adverse Event|0|||
146117295|NCT02743871|526947134|FG010|Overall Study|Adverse Event|0|||
146117296|NCT02743871|526947135|FG011|Overall Study|Adverse Event|0|||
146117297|NCT02743871|526947136|FG012|Overall Study|Adverse Event|0|||
146117298|NCT02743871|526947137|FG013|Overall Study|Adverse Event|0|||
146117299|NCT02743871|526947124|FG000|Overall Study|Other|0|||
146117300|NCT02743871|526947125|FG001|Overall Study|Other|0|||
146117301|NCT02743871|526947126|FG002|Overall Study|Other|0|||
146117302|NCT02743871|526947127|FG003|Overall Study|Other|0|||
146117303|NCT02743871|526947128|FG004|Overall Study|Other|0|||
146117304|NCT02743871|526947129|FG005|Overall Study|Other|0|||
146117305|NCT02743871|526947130|FG006|Overall Study|Other|0|||
146117306|NCT02743871|526947131|FG007|Overall Study|Other|0|||
146117307|NCT02743871|526947132|FG008|Overall Study|Other|0|||
146117308|NCT02743871|526947133|FG009|Overall Study|Other|0|||
146117309|NCT02743871|526947134|FG010|Overall Study|Other|0|||
146117310|NCT02743871|526947135|FG011|Overall Study|Other|1|||
146117311|NCT02743871|526947136|FG012|Overall Study|Other|1|||
146117312|NCT02743871|526947137|FG013|Overall Study|Other|1|||
146117313|NCT02743871|526947124|FG000|Overall Study|Protocol Violation|0|||
146117314|NCT02743871|526947125|FG001|Overall Study|Protocol Violation|0|||
146117315|NCT02743871|526947126|FG002|Overall Study|Protocol Violation|0|||
146117316|NCT02743871|526947127|FG003|Overall Study|Protocol Violation|0|||
146117317|NCT02743871|526947128|FG004|Overall Study|Protocol Violation|0|||
146117318|NCT02743871|526947129|FG005|Overall Study|Protocol Violation|0|||
146117319|NCT02743871|526947130|FG006|Overall Study|Protocol Violation|0|||
146117320|NCT02743871|526947131|FG007|Overall Study|Protocol Violation|0|||
146117321|NCT02743871|526947132|FG008|Overall Study|Protocol Violation|0|||
146117322|NCT02743871|526947133|FG009|Overall Study|Protocol Violation|0|||
146117323|NCT02743871|526947134|FG010|Overall Study|Protocol Violation|0|||
146117324|NCT02743871|526947135|FG011|Overall Study|Protocol Violation|0|||
146117325|NCT02743871|526947136|FG012|Overall Study|Protocol Violation|2|||
146117326|NCT02743871|526947137|FG013|Overall Study|Protocol Violation|0|||
146117327|NCT02927080|526949125|FG000|Overall Study|Withdrawal by Subject|0|||
146117328|NCT02927080|526949126|FG001|Overall Study|Withdrawal by Subject|0|||
146117329|NCT02927080|526949127|FG002|Overall Study|Withdrawal by Subject|0|||
146117330|NCT02927080|526949128|FG003|Overall Study|Withdrawal by Subject|0|||
146117331|NCT02927080|526949129|FG004|Overall Study|Withdrawal by Subject|1|||
146117332|NCT02927080|526949130|FG005|Overall Study|Withdrawal by Subject|0|||
146117333|NCT02927080|526949131|FG006|Overall Study|Withdrawal by Subject|1|||
146117334|NCT02927080|526949132|FG007|Overall Study|Withdrawal by Subject|1|||
146117335|NCT02927080|526949133|FG008|Overall Study|Withdrawal by Subject|0|||
146117336|NCT02927080|526949134|FG009|Overall Study|Withdrawal by Subject|2|||
146117337|NCT02927080|526949125|FG000|Overall Study|Willingness to comply with protocol|0|||
146117338|NCT02927080|526949126|FG001|Overall Study|Willingness to comply with protocol|0|||
146117339|NCT02927080|526949127|FG002|Overall Study|Willingness to comply with protocol|0|||
146117340|NCT02927080|526949128|FG003|Overall Study|Willingness to comply with protocol|0|||
146117341|NCT02927080|526949129|FG004|Overall Study|Willingness to comply with protocol|0|||
146117342|NCT02927080|526949130|FG005|Overall Study|Willingness to comply with protocol|0|||
146117343|NCT02927080|526949131|FG006|Overall Study|Willingness to comply with protocol|0|||
146117344|NCT02927080|526949132|FG007|Overall Study|Willingness to comply with protocol|0|||
146117345|NCT02927080|526949133|FG008|Overall Study|Willingness to comply with protocol|0|||
146117346|NCT02927080|526949134|FG009|Overall Study|Willingness to comply with protocol|1|||
146117347|NCT02927080|526949125|FG000|Overall Study|Study terminated by Sponsor|0|||
146117348|NCT02927080|526949126|FG001|Overall Study|Study terminated by Sponsor|0|||
146117349|NCT02927080|526949127|FG002|Overall Study|Study terminated by Sponsor|0|||
146117350|NCT02927080|526949128|FG003|Overall Study|Study terminated by Sponsor|0|||
146117351|NCT02927080|526949129|FG004|Overall Study|Study terminated by Sponsor|0|||
146117352|NCT02927080|526949130|FG005|Overall Study|Study terminated by Sponsor|0|||
146117353|NCT02927080|526949131|FG006|Overall Study|Study terminated by Sponsor|6|||
146117354|NCT02927080|526949132|FG007|Overall Study|Study terminated by Sponsor|7|||
146117355|NCT02927080|526949133|FG008|Overall Study|Study terminated by Sponsor|2|||
146117356|NCT02927080|526949134|FG009|Overall Study|Study terminated by Sponsor|3|||
146117357|NCT02927080|526949125|FG000|Overall Study|Adverse Event|0|||
146117358|NCT02927080|526949126|FG001|Overall Study|Adverse Event|1|||
146117359|NCT02927080|526949127|FG002|Overall Study|Adverse Event|0|||
146117360|NCT02927080|526949128|FG003|Overall Study|Adverse Event|0|||
146117361|NCT02927080|526949129|FG004|Overall Study|Adverse Event|0|||
146117362|NCT02927080|526949130|FG005|Overall Study|Adverse Event|0|||
146117363|NCT02927080|526949131|FG006|Overall Study|Adverse Event|0|||
146117364|NCT02927080|526949132|FG007|Overall Study|Adverse Event|1|||
146117365|NCT02927080|526949133|FG008|Overall Study|Adverse Event|0|||
146117366|NCT02927080|526949134|FG009|Overall Study|Adverse Event|1|||
146117367|NCT02927080|526949125|FG000|Overall Study|Other|0|||
146117368|NCT02927080|526949126|FG001|Overall Study|Other|0|||
146117369|NCT02927080|526949127|FG002|Overall Study|Other|0|||
146117370|NCT02927080|526949128|FG003|Overall Study|Other|0|||
146117371|NCT02927080|526949129|FG004|Overall Study|Other|0|||
146117372|NCT02927080|526949130|FG005|Overall Study|Other|0|||
146117373|NCT02927080|526949131|FG006|Overall Study|Other|1|||
146117374|NCT02927080|526949132|FG007|Overall Study|Other|0|||
146117375|NCT02927080|526949133|FG008|Overall Study|Other|1|||
146117376|NCT02927080|526949134|FG009|Overall Study|Other|0|||
146117377|NCT00224055|526949135|FG000|Overall Study|Adverse Event|9|||
146117378|NCT00224055|526949136|FG001|Overall Study|Adverse Event|3|||
146117379|NCT00224055|526949135|FG000|Overall Study|Lost to Follow-up|1|||
146117380|NCT00224055|526949136|FG001|Overall Study|Lost to Follow-up|2|||
146117381|NCT00224055|526949135|FG000|Overall Study|Protocol Violation|1|||
146117382|NCT00224055|526949136|FG001|Overall Study|Protocol Violation|1|||
146117383|NCT00224055|526949135|FG000|Overall Study|Inclusion Violation|3|||
146117384|NCT00224055|526949136|FG001|Overall Study|Inclusion Violation|6|||
146117385|NCT00224055|526949135|FG000|Overall Study|Withdrawal by Subject|0|||
146117386|NCT00224055|526949136|FG001|Overall Study|Withdrawal by Subject|2|||
146117387|NCT00224055|526949135|FG000|Overall Study|Other|1|||
146117388|NCT00224055|526949136|FG001|Overall Study|Other|0|||
146117389|NCT05126901|526949137|FG000|Overall Study|Withdrawal by Subject|1|||
146117390|NCT05126901|526949138|FG001|Overall Study|Withdrawal by Subject|1|||
146260851|NCT00263211|527470749|FG001|Overall Study|Disease Progression|1|||
146117391|NCT05126901|526949139|FG002|Overall Study|Withdrawal by Subject|4|||
146117392|NCT05126901|526949137|FG000|Overall Study|Adverse Event|0|||
146117393|NCT05126901|526949138|FG001|Overall Study|Adverse Event|0|||
146117394|NCT05126901|526949139|FG002|Overall Study|Adverse Event|1|||
146117395|NCT05126901|526949137|FG000|Overall Study|Lost to Follow-up|0|||
146117396|NCT05126901|526949138|FG001|Overall Study|Lost to Follow-up|2|||
146117397|NCT05126901|526949139|FG002|Overall Study|Lost to Follow-up|0|||
146117398|NCT00754624|526949140|FG000|Overall Study|Adverse Event|16|||
146117399|NCT00754624|526949140|FG000|Overall Study|Death|1|||
146117400|NCT00754624|526949140|FG000|Overall Study|Physician Decision|8|||
146117401|NCT00754624|526949140|FG000|Overall Study|Protocol Violation|1|||
146117402|NCT00754624|526949140|FG000|Overall Study|Withdrawal by Subject|28|||
146117403|NCT00754624|526949140|FG000|Overall Study|Various|12|||
146117404|NCT00754624|526949140|FG000|Overall Study|Lost to Follow-up|3|||
146117405|NCT04067544|526949141|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
146117406|NCT01529346|526949144|FG000|Overall Study|Lost to Follow-up|2|||
146117407|NCT01529346|526949145|FG001|Overall Study|Lost to Follow-up|0|||
146117408|NCT01529346|526949146|FG002|Overall Study|Lost to Follow-up|1|||
146117409|NCT01529346|526949147|FG003|Overall Study|Lost to Follow-up|0|||
146117410|NCT01529346|526949148|FG004|Overall Study|Lost to Follow-up|0|||
146117411|NCT01529346|526949144|FG000|Overall Study|Other|0|||
146117412|NCT01529346|526949145|FG001|Overall Study|Other|1|||
146117413|NCT01529346|526949146|FG002|Overall Study|Other|1|||
146117414|NCT01529346|526949147|FG003|Overall Study|Other|0|||
146117415|NCT01529346|526949148|FG004|Overall Study|Other|0|||
146117416|NCT01499667|526949149|FG000|Overall Study|administrative problems|4|||
146117417|NCT01499667|526949150|FG001|Overall Study|administrative problems|5|||
146117418|NCT01499667|526949151|FG002|Overall Study|administrative problems|5|||
146117419|NCT01499667|526949149|FG000|Overall Study|Protocol Violation|1|||
146117420|NCT01499667|526949150|FG001|Overall Study|Protocol Violation|3|||
146117421|NCT01499667|526949151|FG002|Overall Study|Protocol Violation|2|||
146117422|NCT01499667|526949149|FG000|Overall Study|Adverse Event|0|||
146117423|NCT01499667|526949150|FG001|Overall Study|Adverse Event|2|||
146117424|NCT01499667|526949151|FG002|Overall Study|Adverse Event|2|||
146117425|NCT01499667|526949149|FG000|Overall Study|Withdrawal by Subject|2|||
146117426|NCT01499667|526949150|FG001|Overall Study|Withdrawal by Subject|1|||
146117427|NCT01499667|526949151|FG002|Overall Study|Withdrawal by Subject|1|||
146117428|NCT01499667|526949149|FG000|Overall Study|Lack of Efficacy|2|||
146117429|NCT01499667|526949150|FG001|Overall Study|Lack of Efficacy|0|||
146117430|NCT01499667|526949151|FG002|Overall Study|Lack of Efficacy|0|||
146117431|NCT00460031|526949154|FG000|Overall Study|Adverse Event|5|||
146117432|NCT00460031|526949154|FG000|Overall Study|Withdrawal by Subject|5|||
146117433|NCT00460031|526949154|FG000|Overall Study|Death|1|||
146117434|NCT02506153|526949155|FG000|Overall Study|Adverse Event|359|||
146117435|NCT02506153|526949156|FG001|Overall Study|Adverse Event|114|||
146117436|NCT02506153|526949155|FG000|Overall Study|Refused unrelated to adverse event|127|||
146117437|NCT02506153|526949156|FG001|Overall Study|Refused unrelated to adverse event|18|||
146117438|NCT02506153|526949155|FG000|Overall Study|Progression/relapse|91|||
146117439|NCT02506153|526949156|FG001|Overall Study|Progression/relapse|136|||
146117440|NCT02506153|526949155|FG000|Overall Study|Death|2|||
146117441|NCT02506153|526949156|FG001|Overall Study|Death|1|||
146117442|NCT02506153|526949155|FG000|Overall Study|Other - not protocol specified|23|||
146117443|NCT02506153|526949156|FG001|Overall Study|Other - not protocol specified|12|||
146117444|NCT00311623|526949162|FG000|Overall Study|Physician Decision|0|||
146117445|NCT00311623|526949163|FG001|Overall Study|Physician Decision|0|||
146117446|NCT00311623|526949164|FG002|Overall Study|Physician Decision|2|||
146117447|NCT03103919|526949165|FG000|Overall Study|Adverse Event|2|||
146117448|NCT03103919|526949166|FG001|Overall Study|Adverse Event|2|||
146117449|NCT05682326|526949167|FG000|Overall Study|Withdrawal by Subject|1|||
146117450|NCT05682326|526949168|FG001|Overall Study|Withdrawal by Subject|0|||
146117451|NCT03998189|526949169|FG000|Overall Study|Lack of Efficacy|0|||
146117452|NCT03998189|526949170|FG001|Overall Study|Lack of Efficacy|1|||
146117453|NCT03454893|526949173|FG000|Overall Study|Study Terminated by the Sponsor|5|||
146117454|NCT03454893|526949173|FG000|Overall Study|Did not pass screening|4|||
146117455|NCT03414424|526949174|FG000|Overall Study|Screened out after consent|0|||
146117456|NCT03414424|526949175|FG001|Overall Study|Screened out after consent|2|||
146117457|NCT03414424|526949174|FG000|Overall Study|Lost to Follow-up|0|||
146117458|NCT03414424|526949175|FG001|Overall Study|Lost to Follow-up|1|||
146117459|NCT03070782|526949177|FG000|Overall Study|Adverse Event|3|||
146117460|NCT03070782|526949178|FG001|Overall Study|Adverse Event|0|||
146117461|NCT03070782|526949179|FG002|Overall Study|Adverse Event|3|||
146117462|NCT03070782|526949180|FG003|Overall Study|Adverse Event|1|||
146117463|NCT03070782|526949181|FG004|Overall Study|Adverse Event|6|||
146117464|NCT03070782|526949182|FG005|Overall Study|Adverse Event|2|||
146117465|NCT03070782|526949177|FG000|Overall Study|Withdrawal by Subject|2|||
146117466|NCT03070782|526949178|FG001|Overall Study|Withdrawal by Subject|1|||
146117467|NCT03070782|526949179|FG002|Overall Study|Withdrawal by Subject|1|||
146117468|NCT03070782|526949180|FG003|Overall Study|Withdrawal by Subject|0|||
146117469|NCT03070782|526949181|FG004|Overall Study|Withdrawal by Subject|4|||
146117470|NCT03070782|526949182|FG005|Overall Study|Withdrawal by Subject|3|||
146117471|NCT03070782|526949177|FG000|Overall Study|Reason Not Specified|2|||
146117472|NCT03070782|526949178|FG001|Overall Study|Reason Not Specified|0|||
146117473|NCT03070782|526949179|FG002|Overall Study|Reason Not Specified|0|||
146117474|NCT03070782|526949180|FG003|Overall Study|Reason Not Specified|1|||
146117475|NCT03070782|526949181|FG004|Overall Study|Reason Not Specified|2|||
146117476|NCT03070782|526949182|FG005|Overall Study|Reason Not Specified|1|||
146117477|NCT03070782|526949177|FG000|Overall Study|Ineligibility|0|||
146117478|NCT03070782|526949178|FG001|Overall Study|Ineligibility|0|||
146117479|NCT03070782|526949179|FG002|Overall Study|Ineligibility|0|||
146117480|NCT03070782|526949180|FG003|Overall Study|Ineligibility|1|||
146117481|NCT03070782|526949181|FG004|Overall Study|Ineligibility|0|||
146117482|NCT03070782|526949182|FG005|Overall Study|Ineligibility|1|||
146117483|NCT03070782|526949177|FG000|Overall Study|Pregnancy|0|||
146117484|NCT03070782|526949178|FG001|Overall Study|Pregnancy|0|||
146117485|NCT03070782|526949179|FG002|Overall Study|Pregnancy|0|||
146117486|NCT03070782|526949180|FG003|Overall Study|Pregnancy|1|||
146117487|NCT03070782|526949181|FG004|Overall Study|Pregnancy|0|||
146117488|NCT03070782|526949182|FG005|Overall Study|Pregnancy|0|||
146117489|NCT03070782|526949177|FG000|Overall Study|Investigator Judgement|0|||
146117490|NCT03070782|526949178|FG001|Overall Study|Investigator Judgement|0|||
146117491|NCT03070782|526949179|FG002|Overall Study|Investigator Judgement|0|||
146117492|NCT03070782|526949180|FG003|Overall Study|Investigator Judgement|1|||
146117493|NCT03070782|526949181|FG004|Overall Study|Investigator Judgement|0|||
146117494|NCT03070782|526949182|FG005|Overall Study|Investigator Judgement|0|||
146117495|NCT03527966|526949183|FG000|Overall Study|Lost to Follow-up|3|||
146117496|NCT03527966|526949184|FG001|Overall Study|Lost to Follow-up|0|||
146117497|NCT00558025|526949185|FG000|Overall Study|Adverse Event|1|||
146117498|NCT00558025|526949186|FG001|Overall Study|Adverse Event|1|||
146117499|NCT00558025|526949185|FG000|Overall Study|Withdrawal by Subject|2|||
146117500|NCT00558025|526949186|FG001|Overall Study|Withdrawal by Subject|2|||
146117501|NCT00558025|526949185|FG000|Overall Study|Protocol Violation|1|||
146117502|NCT00558025|526949186|FG001|Overall Study|Protocol Violation|0|||
146117503|NCT02288559|526949187|FG000|Overall Study|Adverse Event|1|||
146117504|NCT02288559|526949188|FG001|Overall Study|Adverse Event|1|||
146117505|NCT02288559|526949189|FG002|Overall Study|Adverse Event|5|||
146117506|NCT02288559|526949190|FG003|Overall Study|Adverse Event|0|||
146117507|NCT02288559|526949187|FG000|Overall Study|Death|0|||
146117508|NCT02288559|526949188|FG001|Overall Study|Death|0|||
146117509|NCT02288559|526949189|FG002|Overall Study|Death|1|||
146117510|NCT02288559|526949190|FG003|Overall Study|Death|0|||
146117511|NCT02288559|526949187|FG000|Overall Study|Lost to Follow-up|0|||
146117512|NCT02288559|526949188|FG001|Overall Study|Lost to Follow-up|0|||
146117513|NCT02288559|526949189|FG002|Overall Study|Lost to Follow-up|0|||
146117514|NCT02288559|526949190|FG003|Overall Study|Lost to Follow-up|1|||
146117515|NCT02288559|526949187|FG000|Overall Study|Withdrawal by Subject|0|||
146117516|NCT02288559|526949188|FG001|Overall Study|Withdrawal by Subject|0|||
146117517|NCT02288559|526949189|FG002|Overall Study|Withdrawal by Subject|2|||
146117518|NCT02288559|526949190|FG003|Overall Study|Withdrawal by Subject|1|||
146117519|NCT02288559|526949187|FG000|Overall Study|Reason Not Specified|0|||
146117520|NCT02288559|526949188|FG001|Overall Study|Reason Not Specified|0|||
146117521|NCT02288559|526949189|FG002|Overall Study|Reason Not Specified|3|||
146117522|NCT02288559|526949190|FG003|Overall Study|Reason Not Specified|0|||
146117523|NCT01314443|526949191|FG000|Overall Study|Withdrawal by Subject|2|||
146117524|NCT01314443|526949192|FG001|Overall Study|Withdrawal by Subject|1|||
146117525|NCT01314443|526949193|FG002|Overall Study|Withdrawal by Subject|1|||
146117526|NCT01314443|526949194|FG003|Overall Study|Withdrawal by Subject|1|||
146117527|NCT01314443|526949191|FG000|Overall Study|Protocol Violation|2|||
146117528|NCT01314443|526949192|FG001|Overall Study|Protocol Violation|2|||
146117529|NCT01314443|526949193|FG002|Overall Study|Protocol Violation|1|||
146117530|NCT01314443|526949194|FG003|Overall Study|Protocol Violation|1|||
146117531|NCT06073119|526949195|FG000|Overall Study|Adverse Event|1|||
146117532|NCT06073119|526949196|FG001|Overall Study|Adverse Event|3|||
146117533|NCT06073119|526949197|FG002|Overall Study|Adverse Event|0|||
146117534|NCT06073119|526949198|FG003|Overall Study|Adverse Event|0|||
146117535|NCT06073119|526949199|FG004|Overall Study|Adverse Event|1|||
146117536|NCT06073119|526949200|FG005|Overall Study|Adverse Event|0|||
146117537|NCT06073119|526949195|FG000|Overall Study|Non-compliance with study schedule|1|||
146117538|NCT06073119|526949196|FG001|Overall Study|Non-compliance with study schedule|0|||
146117539|NCT06073119|526949197|FG002|Overall Study|Non-compliance with study schedule|0|||
146117540|NCT06073119|526949198|FG003|Overall Study|Non-compliance with study schedule|0|||
146117541|NCT06073119|526949199|FG004|Overall Study|Non-compliance with study schedule|1|||
146117542|NCT06073119|526949200|FG005|Overall Study|Non-compliance with study schedule|0|||
146117543|NCT06073119|526949195|FG000|Overall Study|Withdrawal by Subject|4|||
146117544|NCT06073119|526949196|FG001|Overall Study|Withdrawal by Subject|4|||
146117545|NCT06073119|526949197|FG002|Overall Study|Withdrawal by Subject|3|||
146260852|NCT02034162|527470750|FG000|Double-blind|Lost to Follow-up|3|||
146260853|NCT02034162|527470751|FG001|Double-blind|Lost to Follow-up|0|||
146260854|NCT02034162|527470752|FG002|Double-blind|Lost to Follow-up|0|||
146260855|NCT02034162|527470750|FG000|Double-blind|Physician Decision|1|||
146260856|NCT02034162|527470751|FG001|Double-blind|Physician Decision|0|||
146260857|NCT02034162|527470752|FG002|Double-blind|Physician Decision|0|||
146260858|NCT02034162|527470750|FG000|Double-blind|Protocol Violation|0|||
146117546|NCT06073119|526949198|FG003|Overall Study|Withdrawal by Subject|5|||
146117547|NCT06073119|526949199|FG004|Overall Study|Withdrawal by Subject|3|||
146117548|NCT06073119|526949200|FG005|Overall Study|Withdrawal by Subject|1|||
146117549|NCT06073119|526949195|FG000|Overall Study|Other|2|||
146117550|NCT06073119|526949196|FG001|Overall Study|Other|4|||
146117551|NCT06073119|526949197|FG002|Overall Study|Other|1|||
146260859|NCT02034162|527470751|FG001|Double-blind|Protocol Violation|1|||
146260860|NCT02034162|527470752|FG002|Double-blind|Protocol Violation|0|||
146117552|NCT06073119|526949198|FG003|Overall Study|Other|0|||
146117553|NCT06073119|526949199|FG004|Overall Study|Other|1|||
146117554|NCT06073119|526949200|FG005|Overall Study|Other|0|||
146117555|NCT02393547|526949203|FG000|Overall Study|Adverse Event|2|||
146117556|NCT02393547|526949203|FG000|Overall Study|Withdrawal by Subject|3|||
146117557|NCT02393547|526949203|FG000|Overall Study|Lost to Follow-up|1|||
146260861|NCT02034162|527470750|FG000|Double-blind|Withdrawal by Subject|5|||
146260862|NCT02034162|527470751|FG001|Double-blind|Withdrawal by Subject|7|||
146260863|NCT02034162|527470752|FG002|Double-blind|Withdrawal by Subject|0|||
146260864|NCT00760513|527470753|FG000|Overall Study|Withdrawal by Subject|5|||
146260865|NCT00760513|527470754|FG001|Overall Study|Withdrawal by Subject|7|||
146260866|NCT04606199|527470755|FG000|Overall Study|Withdrawal by Subject|2|||
146260867|NCT03596242|527470756|FG000|Overall Study|Lost to Follow-up|2|||
146260868|NCT03596242|527470757|FG001|Overall Study|Lost to Follow-up|2|||
146260869|NCT03357471|527470758|FG000|Overall Study|Adverse Event|1|||
146260870|NCT03357471|527470759|FG001|Overall Study|Adverse Event|0|||
146260871|NCT03357471|527470758|FG000|Overall Study|Lost to Follow-up|1|||
146260872|NCT03357471|527470759|FG001|Overall Study|Lost to Follow-up|0|||
146260873|NCT03294941|527470760|FG000|Overall Study|Withdrawal by Subject|0|||
146260874|NCT03294941|527470761|FG001|Overall Study|Withdrawal by Subject|2|||
146260875|NCT01475461|527470762|FG000|Run-in Period|Not meet eligibility criteria|16|||
146260876|NCT01475461|527470763|FG001|Run-in Period|Not meet eligibility criteria|0|||
146260877|NCT01475461|527470764|FG002|Run-in Period|Not meet eligibility criteria|0|||
146260878|NCT01475461|527470765|FG003|Run-in Period|Not meet eligibility criteria|0|||
146260879|NCT01475461|527470766|FG004|Run-in Period|Not meet eligibility criteria|0|||
146260880|NCT01475461|527470767|FG005|Run-in Period|Not meet eligibility criteria|0|||
146260881|NCT01475461|527470768|FG006|Run-in Period|Not meet eligibility criteria|0|||
146260882|NCT01475461|527470762|FG000|Run-in Period|Lost to Follow-up|7|||
146260883|NCT01475461|527470763|FG001|Run-in Period|Lost to Follow-up|0|||
146260884|NCT01475461|527470764|FG002|Run-in Period|Lost to Follow-up|0|||
146260885|NCT01475461|527470765|FG003|Run-in Period|Lost to Follow-up|0|||
146260886|NCT01475461|527470766|FG004|Run-in Period|Lost to Follow-up|0|||
146260887|NCT01475461|527470767|FG005|Run-in Period|Lost to Follow-up|0|||
146260888|NCT01475461|527470768|FG006|Run-in Period|Lost to Follow-up|0|||
146260889|NCT01475461|527470762|FG000|Run-in Period|Withdrawal by Subject|11|||
146260890|NCT01475461|527470763|FG001|Run-in Period|Withdrawal by Subject|0|||
146260891|NCT01475461|527470764|FG002|Run-in Period|Withdrawal by Subject|0|||
146260892|NCT01475461|527470765|FG003|Run-in Period|Withdrawal by Subject|0|||
146260893|NCT01475461|527470766|FG004|Run-in Period|Withdrawal by Subject|0|||
146260894|NCT01475461|527470767|FG005|Run-in Period|Withdrawal by Subject|0|||
146260895|NCT01475461|527470768|FG006|Run-in Period|Withdrawal by Subject|0|||
146260896|NCT01475461|527470762|FG000|Run-in Period|Other|3|||
146260897|NCT01475461|527470763|FG001|Run-in Period|Other|0|||
146260898|NCT01475461|527470764|FG002|Run-in Period|Other|0|||
146260899|NCT01475461|527470765|FG003|Run-in Period|Other|0|||
146260900|NCT01475461|527470766|FG004|Run-in Period|Other|0|||
146260901|NCT01475461|527470767|FG005|Run-in Period|Other|0|||
146260902|NCT01475461|527470768|FG006|Run-in Period|Other|0|||
146260903|NCT01475461|527470762|FG000|Run-in Period|Protocol Violation|4|||
146260904|NCT01475461|527470763|FG001|Run-in Period|Protocol Violation|0|||
146260905|NCT01475461|527470764|FG002|Run-in Period|Protocol Violation|0|||
146260906|NCT01475461|527470765|FG003|Run-in Period|Protocol Violation|0|||
146260907|NCT01475461|527470766|FG004|Run-in Period|Protocol Violation|0|||
146260908|NCT01475461|527470767|FG005|Run-in Period|Protocol Violation|0|||
146260909|NCT01475461|527470768|FG006|Run-in Period|Protocol Violation|0|||
146260910|NCT01475461|527470762|FG000|Treatment Period|Death|0|||
146260911|NCT01475461|527470763|FG001|Treatment Period|Death|0|||
146260912|NCT01475461|527470764|FG002|Treatment Period|Death|0|||
146260913|NCT01475461|527470765|FG003|Treatment Period|Death|1|||
146260914|NCT01475461|527470766|FG004|Treatment Period|Death|0|||
146260915|NCT01475461|527470767|FG005|Treatment Period|Death|0|||
146260916|NCT01475461|527470768|FG006|Treatment Period|Death|0|||
146260917|NCT01475461|527470762|FG000|Treatment Period|Lost to Follow-up|0|||
146260918|NCT01475461|527470763|FG001|Treatment Period|Lost to Follow-up|3|||
146260919|NCT01475461|527470764|FG002|Treatment Period|Lost to Follow-up|2|||
146260920|NCT01475461|527470765|FG003|Treatment Period|Lost to Follow-up|3|||
146260921|NCT01475461|527470766|FG004|Treatment Period|Lost to Follow-up|1|||
146260922|NCT01475461|527470767|FG005|Treatment Period|Lost to Follow-up|2|||
146260923|NCT01475461|527470768|FG006|Treatment Period|Lost to Follow-up|1|||
146260924|NCT01475461|527470762|FG000|Treatment Period|Withdrawal by Subject|0|||
146260925|NCT01475461|527470763|FG001|Treatment Period|Withdrawal by Subject|2|||
146260926|NCT01475461|527470764|FG002|Treatment Period|Withdrawal by Subject|2|||
146260927|NCT01475461|527470765|FG003|Treatment Period|Withdrawal by Subject|0|||
146260928|NCT01475461|527470766|FG004|Treatment Period|Withdrawal by Subject|2|||
146260929|NCT01475461|527470767|FG005|Treatment Period|Withdrawal by Subject|2|||
146260930|NCT01475461|527470768|FG006|Treatment Period|Withdrawal by Subject|0|||
146260931|NCT01475461|527470762|FG000|Treatment Period|Other|0|||
146260932|NCT01475461|527470763|FG001|Treatment Period|Other|1|||
146260933|NCT01475461|527470764|FG002|Treatment Period|Other|0|||
146260934|NCT01475461|527470765|FG003|Treatment Period|Other|0|||
146260935|NCT01475461|527470766|FG004|Treatment Period|Other|0|||
146260936|NCT01475461|527470767|FG005|Treatment Period|Other|0|||
146260937|NCT01475461|527470768|FG006|Treatment Period|Other|0|||
146260938|NCT01475461|527470762|FG000|Treatment Period|Protocol Violation|0|||
146260939|NCT01475461|527470763|FG001|Treatment Period|Protocol Violation|1|||
146260940|NCT01475461|527470764|FG002|Treatment Period|Protocol Violation|0|||
146260941|NCT01475461|527470765|FG003|Treatment Period|Protocol Violation|0|||
146260942|NCT01475461|527470766|FG004|Treatment Period|Protocol Violation|0|||
146260943|NCT01475461|527470767|FG005|Treatment Period|Protocol Violation|0|||
146260944|NCT01475461|527470768|FG006|Treatment Period|Protocol Violation|1|||
146260945|NCT01475461|527470762|FG000|Treatment Period|Lack of Efficacy|0|||
146260946|NCT01475461|527470763|FG001|Treatment Period|Lack of Efficacy|2|||
146260947|NCT01475461|527470764|FG002|Treatment Period|Lack of Efficacy|0|||
146260948|NCT01475461|527470765|FG003|Treatment Period|Lack of Efficacy|2|||
146260949|NCT01475461|527470766|FG004|Treatment Period|Lack of Efficacy|1|||
146260950|NCT01475461|527470767|FG005|Treatment Period|Lack of Efficacy|1|||
146260951|NCT01475461|527470768|FG006|Treatment Period|Lack of Efficacy|0|||
146260952|NCT01475461|527470762|FG000|Treatment Period|Medication Error|0|||
146260953|NCT01475461|527470763|FG001|Treatment Period|Medication Error|0|||
146260954|NCT01475461|527470764|FG002|Treatment Period|Medication Error|0|||
146260955|NCT01475461|527470765|FG003|Treatment Period|Medication Error|1|||
146260956|NCT01475461|527470766|FG004|Treatment Period|Medication Error|0|||
146260957|NCT01475461|527470767|FG005|Treatment Period|Medication Error|0|||
146260958|NCT01475461|527470768|FG006|Treatment Period|Medication Error|0|||
146260959|NCT01475461|527470762|FG000|Treatment Period|Adverse Event|0|||
146260960|NCT01475461|527470763|FG001|Treatment Period|Adverse Event|0|||
146260961|NCT01475461|527470764|FG002|Treatment Period|Adverse Event|0|||
146260962|NCT01475461|527470765|FG003|Treatment Period|Adverse Event|1|||
146260963|NCT01475461|527470766|FG004|Treatment Period|Adverse Event|0|||
146260964|NCT01475461|527470767|FG005|Treatment Period|Adverse Event|0|||
146260965|NCT01475461|527470768|FG006|Treatment Period|Adverse Event|0|||
146260966|NCT04051242|527470771|FG000|Overall Study|Withdrawal by Subject|1|||
146260967|NCT04051242|527470771|FG000|Overall Study|Physician Decision|1|||
146260968|NCT04545476|527470774|FG000|Overall Study|Lost to Follow-up|1|||
146260969|NCT04545476|527470775|FG001|Overall Study|Lost to Follow-up|1|||
146260970|NCT04545476|527470776|FG002|Overall Study|Lost to Follow-up|0|||
146260971|NCT04545476|527470777|FG003|Overall Study|Lost to Follow-up|0|||
146260972|NCT04035577|527470784|FG000|Overall Study|Lost to Follow-up|1|||
146260973|NCT04035577|527470784|FG000|Overall Study|Withdrawal by Subject|1|||
146260974|NCT00505414|527470786|FG000|Titration Phase|Adverse Event|0|||
146260975|NCT00505414|527470787|FG001|Titration Phase|Adverse Event|0|||
146260976|NCT00505414|527470788|FG002|Titration Phase|Adverse Event|0|||
146260977|NCT00505414|527470789|FG003|Titration Phase|Adverse Event|8|||
146260978|NCT00505414|527470790|FG004|Titration Phase|Adverse Event|3|||
146260979|NCT00505414|527470786|FG000|Titration Phase|Death|0|||
146260980|NCT00505414|527470787|FG001|Titration Phase|Death|0|||
146260981|NCT00505414|527470788|FG002|Titration Phase|Death|0|||
146260982|NCT00505414|527470789|FG003|Titration Phase|Death|2|||
146260983|NCT00505414|527470790|FG004|Titration Phase|Death|0|||
146260984|NCT00505414|527470786|FG000|Titration Phase|Lack of Efficacy|0|||
146260985|NCT00505414|527470787|FG001|Titration Phase|Lack of Efficacy|0|||
146260986|NCT00505414|527470788|FG002|Titration Phase|Lack of Efficacy|0|||
146260987|NCT00505414|527470789|FG003|Titration Phase|Lack of Efficacy|10|||
146260988|NCT00505414|527470790|FG004|Titration Phase|Lack of Efficacy|1|||
146260989|NCT00505414|527470786|FG000|Titration Phase|Protocol Violation|0|||
146260990|NCT00505414|527470787|FG001|Titration Phase|Protocol Violation|0|||
146260991|NCT00505414|527470788|FG002|Titration Phase|Protocol Violation|0|||
146260992|NCT00505414|527470789|FG003|Titration Phase|Protocol Violation|0|||
146260993|NCT00505414|527470790|FG004|Titration Phase|Protocol Violation|1|||
146260994|NCT00505414|527470786|FG000|Titration Phase|Withdrawal by Subject|0|||
146260995|NCT00505414|527470787|FG001|Titration Phase|Withdrawal by Subject|0|||
146260996|NCT00505414|527470788|FG002|Titration Phase|Withdrawal by Subject|0|||
146260997|NCT00505414|527470789|FG003|Titration Phase|Withdrawal by Subject|3|||
146260998|NCT00505414|527470790|FG004|Titration Phase|Withdrawal by Subject|4|||
146260999|NCT00505414|527470786|FG000|Titration Phase|Underlying disease and therapy required|0|||
146261000|NCT00505414|527470787|FG001|Titration Phase|Underlying disease and therapy required|0|||
146261001|NCT00505414|527470788|FG002|Titration Phase|Underlying disease and therapy required|0|||
146261002|NCT00505414|527470789|FG003|Titration Phase|Underlying disease and therapy required|7|||
146117558|NCT02979522|526949204|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
146117559|NCT02979522|526949205|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
146261003|NCT00505414|527470790|FG004|Titration Phase|Underlying disease and therapy required|3|||
146261004|NCT00505414|527470786|FG000|Maintenance Phase|Adverse Event|2|||
146261005|NCT00505414|527470787|FG001|Maintenance Phase|Adverse Event|2|||
146261006|NCT00505414|527470788|FG002|Maintenance Phase|Adverse Event|3|||
146261007|NCT00505414|527470789|FG003|Maintenance Phase|Adverse Event|0|||
146117560|NCT02979522|526949204|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
146261008|NCT00505414|527470790|FG004|Maintenance Phase|Adverse Event|0|||
146261009|NCT00505414|527470786|FG000|Maintenance Phase|Death|2|||
146261010|NCT00505414|527470787|FG001|Maintenance Phase|Death|0|||
146261011|NCT00505414|527470788|FG002|Maintenance Phase|Death|1|||
146261012|NCT00505414|527470789|FG003|Maintenance Phase|Death|0|||
146261013|NCT00505414|527470790|FG004|Maintenance Phase|Death|0|||
146261014|NCT00505414|527470786|FG000|Maintenance Phase|Lack of Efficacy|2|||
146261015|NCT00505414|527470787|FG001|Maintenance Phase|Lack of Efficacy|1|||
146261016|NCT00505414|527470788|FG002|Maintenance Phase|Lack of Efficacy|1|||
146261017|NCT00505414|527470789|FG003|Maintenance Phase|Lack of Efficacy|0|||
146261018|NCT00505414|527470790|FG004|Maintenance Phase|Lack of Efficacy|0|||
146261019|NCT00505414|527470786|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146261020|NCT00505414|527470787|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146261021|NCT00505414|527470788|FG002|Maintenance Phase|Withdrawal by Subject|1|||
146261022|NCT00505414|527470789|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146261023|NCT00505414|527470790|FG004|Maintenance Phase|Withdrawal by Subject|0|||
146261024|NCT00505414|527470786|FG000|Maintenance Phase|underlying disease and therapy required|0|||
146261025|NCT00505414|527470787|FG001|Maintenance Phase|underlying disease and therapy required|2|||
146261026|NCT00505414|527470788|FG002|Maintenance Phase|underlying disease and therapy required|2|||
146261027|NCT00505414|527470789|FG003|Maintenance Phase|underlying disease and therapy required|0|||
146261028|NCT00505414|527470790|FG004|Maintenance Phase|underlying disease and therapy required|0|||
146261029|NCT00846768|527470791|FG000|Overall Study|Adverse Event|0|||
146261030|NCT00846768|527470792|FG001|Overall Study|Adverse Event|1|||
146261031|NCT00846768|527470793|FG002|Overall Study|Adverse Event|0|||
146261032|NCT00846768|527470794|FG003|Overall Study|Adverse Event|0|||
146261033|NCT04353817|527470795|FG000|Overall Study|Adverse Event|0|||
146261034|NCT04353817|527470796|FG001|Overall Study|Adverse Event|1|||
146261035|NCT04358068|527470797|FG000|Overall Study|Did not initiate study treatment|2|||
146261036|NCT04358068|527470798|FG001|Overall Study|Did not initiate study treatment|2|||
146261037|NCT00338949|527470799|FG000|Subject Screening|Screen failures|11|||
146261038|NCT00338949|527470800|FG001|Subject Screening|Screen failures|11|||
146261039|NCT00338949|527470799|FG000|Randomization|Withdrawal by Subject|1|||
146261040|NCT00338949|527470800|FG001|Randomization|Withdrawal by Subject|0|||
146261041|NCT00338949|527470799|FG000|Randomization|Adverse Event|0|||
146261042|NCT00338949|527470800|FG001|Randomization|Adverse Event|5|||
146261043|NCT01841112|527470802|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
146261044|NCT01841112|527470803|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
146261045|NCT01841112|527470804|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
146261046|NCT01841112|527470805|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
146261047|NCT01841112|527470806|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
146261048|NCT00878553|527470807|FG000|Sleep Study|Withdrawal by Subject|2|||
146261049|NCT00878553|527470808|FG001|Sleep Study|Withdrawal by Subject|0|||
146261050|NCT00878553|527470809|FG002|Sleep Study|Withdrawal by Subject|0|||
146261051|NCT00878553|527470810|FG003|Sleep Study|Withdrawal by Subject|0|||
146261052|NCT00878553|527470811|FG004|Sleep Study|Withdrawal by Subject|0|||
146261053|NCT00878553|527470807|FG000|Sleep Study|Lost to Follow-up|1|||
146261054|NCT00878553|527470808|FG001|Sleep Study|Lost to Follow-up|0|||
146261055|NCT00878553|527470809|FG002|Sleep Study|Lost to Follow-up|0|||
146261056|NCT00878553|527470810|FG003|Sleep Study|Lost to Follow-up|0|||
146261057|NCT00878553|527470811|FG004|Sleep Study|Lost to Follow-up|0|||
146261058|NCT00878553|527470807|FG000|Sleep Study|car accident|1|||
146261059|NCT00878553|527470808|FG001|Sleep Study|car accident|0|||
146261060|NCT00878553|527470809|FG002|Sleep Study|car accident|0|||
146261061|NCT00878553|527470810|FG003|Sleep Study|car accident|0|||
146261062|NCT00878553|527470811|FG004|Sleep Study|car accident|0|||
146261063|NCT00878553|527470807|FG000|Sleep Study|family emergency|1|||
146261064|NCT00878553|527470808|FG001|Sleep Study|family emergency|0|||
146261065|NCT00878553|527470809|FG002|Sleep Study|family emergency|0|||
146261066|NCT00878553|527470810|FG003|Sleep Study|family emergency|0|||
146117561|NCT02979522|526949205|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
146117562|NCT05185089|526949206|FG000|First Intervention (4 weeks)|Adverse Event|0|||
146117563|NCT05185089|526949207|FG001|First Intervention (4 weeks)|Adverse Event|0|||
146117564|NCT05185089|526949208|FG002|First Intervention (4 weeks)|Adverse Event|0|||
146117565|NCT05185089|526949209|FG003|First Intervention (4 weeks)|Adverse Event|1|||
146117566|NCT05185089|526949206|FG000|Second Intervention (4 weeks)|Death|0|||
146117567|NCT05185089|526949207|FG001|Second Intervention (4 weeks)|Death|1|||
146117568|NCT05185089|526949208|FG002|Second Intervention (4 weeks)|Death|0|||
146117569|NCT05185089|526949209|FG003|Second Intervention (4 weeks)|Death|0|||
146261067|NCT00878553|527470811|FG004|Sleep Study|family emergency|0|||
146261068|NCT00878553|527470807|FG000|PK Study|Withdrawal by Subject|0|||
146261069|NCT00878553|527470808|FG001|PK Study|Withdrawal by Subject|0|||
146261070|NCT00878553|527470809|FG002|PK Study|Withdrawal by Subject|0|||
146261071|NCT00878553|527470810|FG003|PK Study|Withdrawal by Subject|1|||
146261072|NCT00878553|527470811|FG004|PK Study|Withdrawal by Subject|0|||
146261073|NCT02143063|527470812|FG000|Overall Study|Lost to Follow-up|16|||
146261074|NCT02143063|527470813|FG001|Overall Study|Lost to Follow-up|28|||
146261075|NCT02143063|527470814|FG002|Overall Study|Lost to Follow-up|29|||
146261076|NCT02143063|527470812|FG000|Overall Study|Withdrawal by Subject|0|||
146117570|NCT05185089|526949206|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
146117571|NCT05185089|526949207|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
146117572|NCT05185089|526949208|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
146261077|NCT02143063|527470813|FG001|Overall Study|Withdrawal by Subject|1|||
146261078|NCT02143063|527470814|FG002|Overall Study|Withdrawal by Subject|0|||
146261079|NCT02143063|527470812|FG000|Overall Study|Death|0|||
146261080|NCT02143063|527470813|FG001|Overall Study|Death|1|||
146117573|NCT05185089|526949209|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
146117574|NCT00667368|526949210|FG000|Overall Study|Lost to Follow-up|176|||
146117575|NCT00667368|526949211|FG001|Overall Study|Lost to Follow-up|155|||
146117576|NCT00667368|526949210|FG000|Overall Study|Discontinued early|24|||
146117577|NCT00667368|526949211|FG001|Overall Study|Discontinued early|17|||
146117578|NCT00191789|526949213|FG000|Overall Study|Adverse Event|5|||
146117579|NCT00191789|526949213|FG000|Overall Study|Patient: Satisfactory Response|5|||
146117580|NCT00191789|526949213|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
146117581|NCT00191789|526949213|FG000|Overall Study|Withdrawal by Subject|4|||
146117582|NCT00191789|526949213|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
146117583|NCT00191789|526949213|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
146117584|NCT00191789|526949213|FG000|Overall Study|Death - Not Study-Drug Related|1|||
146117585|NCT05582889|526949214|FG000|Overall Study|Health event|3|||
146117586|NCT05582889|526949215|FG001|Overall Study|Health event|2|||
146117587|NCT05582889|526949214|FG000|Overall Study|Lost to Follow-up|2|||
146117588|NCT05582889|526949215|FG001|Overall Study|Lost to Follow-up|4|||
146117589|NCT06112756|526949216|FG000|Overall Study|Withdrawal by Subject|0|||
146117590|NCT06112756|526949217|FG001|Overall Study|Withdrawal by Subject|2|||
146117591|NCT06112756|526949216|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
146117592|NCT06112756|526949217|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
146117593|NCT06112756|526949216|FG000|Overall Study|Adverse Event|2|||
146117594|NCT06112756|526949217|FG001|Overall Study|Adverse Event|2|||
146117595|NCT04551092|526949218|FG000|Overall Study|Lost to Follow-up|7|||
146117596|NCT04551092|526949218|FG000|Overall Study|Withdrawal by Subject|4|||
146117597|NCT01712490|526949219|FG000|Overall Study|Ongoing|601|||
146117598|NCT01712490|526949220|FG001|Overall Study|Ongoing|586|||
146117599|NCT01712490|526949219|FG000|Overall Study|Other|11|||
146117600|NCT01712490|526949220|FG001|Overall Study|Other|11|||
146261081|NCT02143063|527470814|FG002|Overall Study|Death|1|||
146261082|NCT00461123|527470815|FG000|Overall Study|Adverse Event|1|||
146261083|NCT00461123|527470816|FG001|Overall Study|Adverse Event|0|||
146261084|NCT00461123|527470815|FG000|Overall Study|Lost to Follow-up|1|||
146261085|NCT00461123|527470816|FG001|Overall Study|Lost to Follow-up|1|||
146261086|NCT00461123|527470815|FG000|Overall Study|Protocol Violation|3|||
146261087|NCT00461123|527470816|FG001|Overall Study|Protocol Violation|2|||
146261088|NCT00461123|527470815|FG000|Overall Study|Withdrawal by Subject|1|||
146261089|NCT00461123|527470816|FG001|Overall Study|Withdrawal by Subject|3|||
146261090|NCT03029819|527470818|FG000|Overall Study|Lost to Follow-up|3|||
146261091|NCT03029819|527470819|FG001|Overall Study|Lost to Follow-up|5|||
146261092|NCT03029819|527470818|FG000|Overall Study|Removed due to disruptive behavior|0|||
146261093|NCT03029819|527470819|FG001|Overall Study|Removed due to disruptive behavior|1|||
146261094|NCT01020747|527470822|FG000|Overall Study|Withdrawal by Subject|1|||
146261095|NCT02175745|527470827|FG000|Overall Study|Not Eligible|1|||
146261096|NCT00808899|527470828|FG000|Overall Study|Death|1|||
146261097|NCT00808899|527470828|FG000|Overall Study|Physician Decision|3|||
146261098|NCT01705145|527470829|FG000|Part B|Adverse Event|1|||
146261099|NCT01203956|527470832|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
146261100|NCT01203956|527470833|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
146261101|NCT01220856|527470836|FG000|Overall Study|graft loss|3|||
146261102|NCT01220856|527470837|FG001|Overall Study|graft loss|3|||
146261103|NCT01220856|527470836|FG000|Overall Study|Lost to Follow-up|1|||
146261104|NCT01220856|527470837|FG001|Overall Study|Lost to Follow-up|0|||
146261105|NCT00361842|527470838|FG000|Overall Study|Withdrawal by Subject|2|||
146261106|NCT00361842|527470839|FG001|Overall Study|Withdrawal by Subject|3|||
146261107|NCT00361842|527470838|FG000|Overall Study|Death|2|||
146261108|NCT00361842|527470839|FG001|Overall Study|Death|1|||
146261109|NCT00361842|527470838|FG000|Overall Study|Disease progression|19|||
146261110|NCT00361842|527470839|FG001|Overall Study|Disease progression|20|||
146261111|NCT00361842|527470838|FG000|Overall Study|Adverse Event|2|||
146261112|NCT00361842|527470839|FG001|Overall Study|Adverse Event|3|||
146261113|NCT00361842|527470838|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
146261114|NCT00361842|527470839|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
146261115|NCT00361842|527470838|FG000|Overall Study|Other|1|||
146261116|NCT00361842|527470839|FG001|Overall Study|Other|0|||
146261117|NCT00361842|527470838|FG000|Overall Study|Other|0|||
146261118|NCT00361842|527470839|FG001|Overall Study|Other|2|||
146261119|NCT04206384|527470840|FG000|Overall Study|Withdrawal by Subject|8|||
146261120|NCT04206384|527470840|FG000|Overall Study|Adverse Event|2|||
146261121|NCT02212197|527470841|FG000|Overall Study|Need for radiotherapy|1|||
146261122|NCT02212197|527470842|FG001|Overall Study|Need for radiotherapy|0|||
146261123|NCT02212197|527470843|FG002|Overall Study|Need for radiotherapy|0|||
146261124|NCT03015181|527470845|FG000|Overall Study|Enrolled, but product never administered|1|||
146117601|NCT01712490|526949219|FG000|Overall Study|Withdrawal by Subject|36|||
146117602|NCT01712490|526949220|FG001|Overall Study|Withdrawal by Subject|44|||
146117603|NCT01712490|526949219|FG000|Overall Study|Lost to Follow-up|16|||
146117604|NCT01712490|526949220|FG001|Overall Study|Lost to Follow-up|29|||
146117605|NCT03060629|526949225|FG000|Overall Study|Death|4|||
146117606|NCT03060629|526949226|FG001|Overall Study|Death|5|||
146117607|NCT03060629|526949225|FG000|Overall Study|Withdrawal by Subject|50|||
146117608|NCT03060629|526949226|FG001|Overall Study|Withdrawal by Subject|35|||
146117609|NCT03060629|526949225|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
146117610|NCT03060629|526949226|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
146117611|NCT03060629|526949225|FG000|Overall Study|Participant Relocate|15|||
146117612|NCT03060629|526949226|FG001|Overall Study|Participant Relocate|15|||
146117613|NCT03060629|526949225|FG000|Overall Study|Unable to Contact Participant|34|||
146117614|NCT03060629|526949226|FG001|Overall Study|Unable to Contact Participant|23|||
146117615|NCT03060629|526949225|FG000|Overall Study|Investigator Decision|7|||
146117616|NCT03060629|526949226|FG001|Overall Study|Investigator Decision|7|||
146117617|NCT03060629|526949225|FG000|Overall Study|Study Terminated by Sponsor|1100|||
146117618|NCT03060629|526949226|FG001|Overall Study|Study Terminated by Sponsor|1123|||
146117619|NCT03060629|526949225|FG000|Overall Study|Other|4|||
146117620|NCT03060629|526949226|FG001|Overall Study|Other|4|||
146117621|NCT01862874|526949227|FG000|Overall Study|Randomized not treated|1|||
146117622|NCT01862874|526949228|FG001|Overall Study|Randomized not treated|0|||
146117623|NCT01862874|526949227|FG000|Overall Study|Adverse Event|0|||
146117624|NCT01862874|526949228|FG001|Overall Study|Adverse Event|3|||
146117625|NCT01862874|526949227|FG000|Overall Study|Lost to Follow-up|26|||
146117626|NCT01862874|526949228|FG001|Overall Study|Lost to Follow-up|29|||
146117627|NCT01862874|526949227|FG000|Overall Study|Physician Decision|5|||
146261125|NCT03015181|527470846|FG001|Overall Study|Enrolled, but product never administered|0|||
146261126|NCT03015181|527470847|FG002|Overall Study|Enrolled, but product never administered|0|||
146261127|NCT03015181|527470848|FG003|Overall Study|Enrolled, but product never administered|0|||
146261128|NCT03015181|527470849|FG004|Overall Study|Enrolled, but product never administered|0|||
146261129|NCT03015181|527470850|FG005|Overall Study|Enrolled, but product never administered|0|||
146261130|NCT03015181|527470851|FG006|Overall Study|Enrolled, but product never administered|0|||
146261131|NCT03015181|527470845|FG000|Overall Study|Withdrawal by Subject|0|||
146261132|NCT03015181|527470846|FG001|Overall Study|Withdrawal by Subject|0|||
146261133|NCT03015181|527470847|FG002|Overall Study|Withdrawal by Subject|0|||
146261134|NCT03015181|527470848|FG003|Overall Study|Withdrawal by Subject|0|||
146261135|NCT03015181|527470849|FG004|Overall Study|Withdrawal by Subject|0|||
146261136|NCT03015181|527470850|FG005|Overall Study|Withdrawal by Subject|1|||
146261137|NCT03015181|527470851|FG006|Overall Study|Withdrawal by Subject|0|||
146261138|NCT03015181|527470845|FG000|Overall Study|Physician Decision|0|||
146261139|NCT03015181|527470846|FG001|Overall Study|Physician Decision|0|||
146261140|NCT03015181|527470847|FG002|Overall Study|Physician Decision|0|||
146261141|NCT03015181|527470848|FG003|Overall Study|Physician Decision|0|||
146261142|NCT03015181|527470849|FG004|Overall Study|Physician Decision|0|||
146261143|NCT03015181|527470850|FG005|Overall Study|Physician Decision|0|||
146261144|NCT03015181|527470851|FG006|Overall Study|Physician Decision|1|||
146261145|NCT01077622|527470852|FG000|Overall Study|Physician Decision|2|||
146261146|NCT01077622|527470852|FG000|Overall Study|Withdrawal by Subject|1|||
146261147|NCT01260142|527470853|FG000|Treatment Period 1|Study on hold|1|||
146261148|NCT01260142|527470854|FG001|Treatment Period 1|Study on hold|1|||
146261149|NCT01260142|527470855|FG002|Treatment Period 1|Study on hold|0|||
146261150|NCT01260142|527470856|FG003|Treatment Period 1|Study on hold|0|||
146261151|NCT01260142|527470857|FG004|Treatment Period 1|Study on hold|1|||
146261152|NCT01260142|527470858|FG005|Treatment Period 1|Study on hold|2|||
146261153|NCT01260142|527470853|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
146261154|NCT01260142|527470854|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
146261155|NCT01260142|527470855|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
146261156|NCT01260142|527470856|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
146261157|NCT01260142|527470857|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
146261158|NCT01260142|527470858|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
146261159|NCT01260142|527470853|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146261160|NCT01260142|527470854|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146261161|NCT01260142|527470855|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146261162|NCT01260142|527470856|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146261163|NCT01260142|527470857|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146261164|NCT01260142|527470858|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146261165|NCT00496834|527470867|FG000|Overall Study|Withdrawal by Subject|4|||
146261166|NCT00496834|527470868|FG001|Overall Study|Withdrawal by Subject|6|||
146261167|NCT00496834|527470867|FG000|Overall Study|Contraindicated medication administered|0|||
146261168|NCT00496834|527470868|FG001|Overall Study|Contraindicated medication administered|1|||
146117628|NCT01862874|526949228|FG001|Overall Study|Physician Decision|3|||
146261169|NCT00496834|527470867|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
146117629|NCT01862874|526949227|FG000|Overall Study|Withdrawn by parent/guardian|1|||
146261170|NCT00496834|527470868|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
146261171|NCT00496834|527470867|FG000|Overall Study|Adverse Event|5|||
146261172|NCT00496834|527470868|FG001|Overall Study|Adverse Event|3|||
146261173|NCT00496834|527470867|FG000|Overall Study|IP administration violation|2|||
146261174|NCT00496834|527470868|FG001|Overall Study|IP administration violation|0|||
146261175|NCT00496834|527470867|FG000|Overall Study|Lost to Follow-up|2|||
146117630|NCT01862874|526949228|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146117631|NCT01862874|526949227|FG000|Overall Study|Withdrawal by Subject|46|||
146117632|NCT01862874|526949228|FG001|Overall Study|Withdrawal by Subject|40|||
146117633|NCT01862874|526949227|FG000|Overall Study|Death|0|||
146117634|NCT01862874|526949228|FG001|Overall Study|Death|1|||
146117635|NCT01714635|526949234|FG000|Overall Study|Discontinued|1|||
146117636|NCT01714635|526949235|FG001|Overall Study|Discontinued|0|||
146117637|NCT01714635|526949236|FG002|Overall Study|Discontinued|2|||
146117638|NCT01714635|526949234|FG000|Overall Study|Missed 6-month exam|1|||
146117639|NCT01714635|526949235|FG001|Overall Study|Missed 6-month exam|0|||
146117640|NCT01714635|526949236|FG002|Overall Study|Missed 6-month exam|0|||
146117641|NCT03672747|526949237|FG000|Overall Study|Lost to Follow-up|1|||
146117642|NCT03672747|526949238|FG001|Overall Study|Lost to Follow-up|1|||
146117643|NCT03672747|526949239|FG002|Overall Study|Lost to Follow-up|2|||
146117644|NCT03672747|526949240|FG003|Overall Study|Lost to Follow-up|2|||
146117645|NCT03672747|526949241|FG004|Overall Study|Lost to Follow-up|2|||
146117646|NCT03672747|526949242|FG005|Overall Study|Lost to Follow-up|1|||
146117647|NCT04285879|526949243|FG000|Overall Study|Lost to Follow-up|1|||
146117648|NCT04285879|526949244|FG001|Overall Study|Lost to Follow-up|8|||
146117649|NCT04285879|526949243|FG000|Overall Study|medical/surgical exclusion|16|||
146117650|NCT04285879|526949244|FG001|Overall Study|medical/surgical exclusion|0|||
146117651|NCT01782495|526949251|FG000|Overall Study|Adverse Event|0|||
146117652|NCT01782495|526949252|FG001|Overall Study|Adverse Event|0|||
146117653|NCT01782495|526949253|FG002|Overall Study|Adverse Event|0|||
146117654|NCT01782495|526949254|FG003|Overall Study|Adverse Event|0|||
146117655|NCT01782495|526949255|FG004|Overall Study|Adverse Event|0|||
146117656|NCT01782495|526949256|FG005|Overall Study|Adverse Event|0|||
146117657|NCT01782495|526949257|FG006|Overall Study|Adverse Event|0|||
146117658|NCT01782495|526949258|FG007|Overall Study|Adverse Event|2|||
146117659|NCT01782495|526949259|FG008|Overall Study|Adverse Event|0|||
146117660|NCT01782495|526949260|FG009|Overall Study|Adverse Event|0|||
146117661|NCT01782495|526949261|FG010|Overall Study|Adverse Event|0|||
146117662|NCT01782495|526949251|FG000|Overall Study|Withdrew Consent|0|||
146117663|NCT01782495|526949252|FG001|Overall Study|Withdrew Consent|1|||
146117664|NCT01782495|526949253|FG002|Overall Study|Withdrew Consent|0|||
146117665|NCT01782495|526949254|FG003|Overall Study|Withdrew Consent|0|||
146117666|NCT01782495|526949255|FG004|Overall Study|Withdrew Consent|0|||
146117667|NCT01782495|526949256|FG005|Overall Study|Withdrew Consent|0|||
146117668|NCT01782495|526949257|FG006|Overall Study|Withdrew Consent|0|||
146117669|NCT01782495|526949258|FG007|Overall Study|Withdrew Consent|1|||
146117670|NCT01782495|526949259|FG008|Overall Study|Withdrew Consent|0|||
146117671|NCT01782495|526949260|FG009|Overall Study|Withdrew Consent|0|||
146117672|NCT01782495|526949261|FG010|Overall Study|Withdrew Consent|0|||
146117673|NCT01927367|526949262|FG000|Overall Study|Withdrawal by Subject|7|||
146117674|NCT01927367|526949263|FG001|Overall Study|Withdrawal by Subject|4|||
146117675|NCT01927367|526949262|FG000|Overall Study|No baseline data|0|||
146117676|NCT01927367|526949263|FG001|Overall Study|No baseline data|1|||
146117677|NCT00241280|526949268|FG000|Overall Study|Adverse Event|2|||
146117678|NCT00241280|526949269|FG001|Overall Study|Adverse Event|6|||
146117679|NCT00241280|526949268|FG000|Overall Study|Discomfort|11|||
146117680|NCT00241280|526949269|FG001|Overall Study|Discomfort|16|||
146117681|NCT00241280|526949268|FG000|Overall Study|Pregnancy|1|||
146117682|NCT00241280|526949269|FG001|Overall Study|Pregnancy|5|||
146117683|NCT00241280|526949268|FG000|Overall Study|Lost to Follow-up|5|||
146117684|NCT00241280|526949269|FG001|Overall Study|Lost to Follow-up|8|||
146117685|NCT00241280|526949268|FG000|Overall Study|Withdrawal by Subject|7|||
146117686|NCT00241280|526949269|FG001|Overall Study|Withdrawal by Subject|4|||
146117687|NCT00241280|526949268|FG000|Overall Study|Protocol Violation|4|||
146117688|NCT00241280|526949269|FG001|Overall Study|Protocol Violation|10|||
146117689|NCT00241280|526949268|FG000|Overall Study|Relocation|4|||
146117690|NCT00241280|526949269|FG001|Overall Study|Relocation|4|||
146117691|NCT00241280|526949268|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
146117692|NCT00241280|526949269|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
146117693|NCT00241280|526949268|FG000|Overall Study|Unsatisfactory Visual Response|1|||
146117694|NCT00241280|526949269|FG001|Overall Study|Unsatisfactory Visual Response|1|||
146117695|NCT00241280|526949268|FG000|Overall Study|Diabetic|1|||
146117696|NCT00241280|526949269|FG001|Overall Study|Diabetic|0|||
146117697|NCT00241280|526949268|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
146117698|NCT00241280|526949269|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
146117699|NCT00241280|526949268|FG000|Overall Study|Dispensed incorrect test article|1|||
146117700|NCT00241280|526949269|FG001|Overall Study|Dispensed incorrect test article|2|||
146117701|NCT00241280|526949268|FG000|Overall Study|Unacceptable Fit|0|||
146117702|NCT00241280|526949269|FG001|Overall Study|Unacceptable Fit|1|||
146261176|NCT00496834|527470868|FG001|Overall Study|Lost to Follow-up|0|||
146117703|NCT00241280|526949268|FG000|Overall Study|Scheduling Conflict|0|||
146261177|NCT00496834|527470867|FG000|Overall Study|Blood Pressure control failure|2|||
146117704|NCT00241280|526949269|FG001|Overall Study|Scheduling Conflict|2|||
146117705|NCT00241280|526949268|FG000|Overall Study|History of Ocular Surgery|0|||
146117706|NCT00241280|526949269|FG001|Overall Study|History of Ocular Surgery|1|||
146117707|NCT00241280|526949268|FG000|Overall Study|Coating on Lens|1|||
146117708|NCT00241280|526949269|FG001|Overall Study|Coating on Lens|0|||
146117709|NCT00241280|526949268|FG000|Overall Study|Excessive Dryness|0|||
146117710|NCT00241280|526949269|FG001|Overall Study|Excessive Dryness|1|||
146117711|NCT01634360|526949270|FG000|Overall Study|Adverse Event|10|||
146117712|NCT01634360|526949271|FG001|Overall Study|Adverse Event|34|||
146117713|NCT01634360|526949270|FG000|Overall Study|subject withdrew consent|13|||
146117714|NCT01634360|526949271|FG001|Overall Study|subject withdrew consent|23|||
146117715|NCT01634360|526949270|FG000|Overall Study|Protocol Violation|1|||
146117716|NCT01634360|526949271|FG001|Overall Study|Protocol Violation|1|||
146117717|NCT01634360|526949270|FG000|Overall Study|Lack of Efficacy|4|||
146117718|NCT01634360|526949271|FG001|Overall Study|Lack of Efficacy|14|||
146117719|NCT01634360|526949270|FG000|Overall Study|Other|3|||
146117720|NCT01634360|526949271|FG001|Overall Study|Other|20|||
146117721|NCT01634360|526949270|FG000|Overall Study|Study termination by sponsor|18|||
146117722|NCT01634360|526949271|FG001|Overall Study|Study termination by sponsor|44|||
146117723|NCT02260921|526949278|FG000|Overall Study|Adverse Event|1|||
146117724|NCT02260921|526949279|FG001|Overall Study|Adverse Event|0|||
146117725|NCT02260921|526949278|FG000|Overall Study|Lost to Follow-up|4|||
146117726|NCT02260921|526949279|FG001|Overall Study|Lost to Follow-up|3|||
146117727|NCT02260921|526949278|FG000|Overall Study|Withdraw Consent|4|||
146117728|NCT02260921|526949279|FG001|Overall Study|Withdraw Consent|1|||
146117729|NCT02260921|526949278|FG000|Overall Study|Death|1|||
146117730|NCT02260921|526949279|FG001|Overall Study|Death|0|||
146117731|NCT02260921|526949278|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
146117732|NCT02260921|526949279|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
146117733|NCT01244425|526949280|FG000|Overall Study|Withdrawal by Subject|2|||
146117734|NCT01244425|526949281|FG001|Overall Study|Withdrawal by Subject|2|||
146117735|NCT01244425|526949280|FG000|Overall Study|Adverse Event|1|||
146117736|NCT01244425|526949281|FG001|Overall Study|Adverse Event|1|||
146117737|NCT02999854|526949282|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
146117738|NCT02999854|526949283|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
146117739|NCT02999854|526949282|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
146117740|NCT02999854|526949283|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
146117741|NCT02999854|526949282|FG000|Active Study Phase (up to 18 Months)|Death|7|||
146117742|NCT02999854|526949283|FG001|Active Study Phase (up to 18 Months)|Death|5|||
146117743|NCT02999854|526949282|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
146117744|NCT02999854|526949283|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
146117745|NCT02999854|526949282|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
146117746|NCT02999854|526949283|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
146117747|NCT02999854|526949282|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
146117748|NCT02999854|526949283|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
146117749|NCT02999854|526949282|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
146117750|NCT02999854|526949283|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
146117751|NCT02999854|526949282|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
146117752|NCT02999854|526949283|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
146117753|NCT02848651|526949284|FG000|Overall Study|Death|85|||
146117754|NCT02848651|526949284|FG000|Overall Study|Lost to Follow-up|1|||
146117755|NCT02848651|526949284|FG000|Overall Study|Non-Compliance|1|||
146117756|NCT02848651|526949284|FG000|Overall Study|Symptomatic Deterioration|1|||
146117757|NCT02848651|526949284|FG000|Overall Study|Physician Decision|4|||
146117758|NCT02848651|526949284|FG000|Overall Study|Withdrawal by Subject|14|||
146117759|NCT04140292|526949285|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
146117760|NCT04140292|526949286|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
146117761|NCT02480114|526949287|FG000|Overall Study|Not completing surveys|3|||
146117762|NCT02480114|526949288|FG001|Overall Study|Not completing surveys|2|||
146117763|NCT02480114|526949287|FG000|Overall Study|Withdrawal by Subject|2|||
146117764|NCT02480114|526949288|FG001|Overall Study|Withdrawal by Subject|4|||
146117765|NCT02480114|526949287|FG000|Overall Study|Disease progression|3|||
146117766|NCT02480114|526949288|FG001|Overall Study|Disease progression|0|||
146117767|NCT02480114|526949287|FG000|Overall Study|Improper completion of survey|1|||
146117768|NCT02480114|526949288|FG001|Overall Study|Improper completion of survey|1|||
146117769|NCT02480114|526949287|FG000|Overall Study|Not eligible|0|||
146117770|NCT02480114|526949288|FG001|Overall Study|Not eligible|1|||
146117771|NCT01535053|526949289|FG000|Overall Study|Ineligible|1|||
146117772|NCT01535053|526949290|FG001|Overall Study|Ineligible|2|||
146117773|NCT01031069|526949291|FG000|Overall Study|Serious Adverse Event|0|||
146117774|NCT01031069|526949292|FG001|Overall Study|Serious Adverse Event|1|||
146117775|NCT01031069|526949293|FG002|Overall Study|Serious Adverse Event|0|||
146117776|NCT01031069|526949294|FG003|Overall Study|Serious Adverse Event|0|||
146117777|NCT01031069|526949291|FG000|Overall Study|Withdrawal by Subject|2|||
146261178|NCT00496834|527470868|FG001|Overall Study|Blood Pressure control failure|1|||
146261179|NCT01503164|527470869|FG000|Overall Study|Withdrawal by Subject|2|||
146261180|NCT01503164|527470870|FG001|Overall Study|Withdrawal by Subject|1|||
146261181|NCT04088136|527470873|FG000|Overall Study|Withdrawal by Subject|5|||
146117778|NCT01031069|526949292|FG001|Overall Study|Withdrawal by Subject|3|||
146117779|NCT01031069|526949293|FG002|Overall Study|Withdrawal by Subject|18|||
146117780|NCT01031069|526949294|FG003|Overall Study|Withdrawal by Subject|18|||
146117781|NCT01031069|526949291|FG000|Overall Study|Migrated/moved from study area|1|||
146117782|NCT01031069|526949292|FG001|Overall Study|Migrated/moved from study area|2|||
146117783|NCT01031069|526949293|FG002|Overall Study|Migrated/moved from study area|1|||
146117784|NCT01031069|526949294|FG003|Overall Study|Migrated/moved from study area|1|||
146117785|NCT01031069|526949291|FG000|Overall Study|Lost to Follow-up|9|||
146117786|NCT01031069|526949292|FG001|Overall Study|Lost to Follow-up|5|||
146117787|NCT01031069|526949293|FG002|Overall Study|Lost to Follow-up|21|||
146117788|NCT01031069|526949294|FG003|Overall Study|Lost to Follow-up|15|||
146117789|NCT01031069|526949291|FG000|Overall Study|Other|0|||
146117790|NCT01031069|526949292|FG001|Overall Study|Other|0|||
146117791|NCT01031069|526949293|FG002|Overall Study|Other|1|||
146117792|NCT01031069|526949294|FG003|Overall Study|Other|0|||
146117793|NCT00512707|526949295|FG000|Overall Study|Lost to Follow-up|5|||
146117794|NCT00512707|526949296|FG001|Overall Study|Lost to Follow-up|11|||
146117795|NCT00512707|526949295|FG000|Overall Study|Developed skin irritation|2|||
146117796|NCT00512707|526949296|FG001|Overall Study|Developed skin irritation|1|||
146117797|NCT00512707|526949295|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
146117798|NCT00512707|526949296|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
146117799|NCT00512707|526949295|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
146117800|NCT00512707|526949296|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
146117801|NCT01317160|526949297|FG000|Overall Study|Incorrect inclusion|1|||
146117802|NCT01317160|526949298|FG001|Overall Study|Incorrect inclusion|1|||
146117803|NCT01317160|526949297|FG000|Overall Study|Lost to Follow-up|3|||
146117804|NCT01317160|526949298|FG001|Overall Study|Lost to Follow-up|3|||
146117805|NCT01317160|526949297|FG000|Overall Study|Withdrawal by Subject|0|||
146117806|NCT01317160|526949298|FG001|Overall Study|Withdrawal by Subject|2|||
146117807|NCT03032705|526949304|FG000|Overall Study|Lost to Follow-up|16|||
146117808|NCT03032705|526949305|FG001|Overall Study|Lost to Follow-up|17|||
146117809|NCT03032705|526949304|FG000|Overall Study|did not quality|6|||
146117810|NCT03032705|526949305|FG001|Overall Study|did not quality|6|||
146117811|NCT04405037|526949308|FG000|Overall Study|Withdrawal by Subject|1|||
146117812|NCT04405037|526949309|FG001|Overall Study|Withdrawal by Subject|0|||
146117813|NCT04405037|526949308|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
146117814|NCT04405037|526949309|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
146117815|NCT01853826|526950926|FG000|Overall Study|Patients who switched to commercial drug|11|||
146117816|NCT01853826|526950926|FG000|Overall Study|Patient refused to continue medication|21|||
146117817|NCT01853826|526950926|FG000|Overall Study|Lost to Follow-up|2|||
146117818|NCT01853826|526950926|FG000|Overall Study|Non-compliant with protocol|4|||
146117819|NCT01853826|526950926|FG000|Overall Study|Other adverse events (AE)|62|||
146117820|NCT01853826|526950926|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
146117821|NCT01853826|526950926|FG000|Overall Study|Progressive disease|342|||
146117822|NCT01853826|526950926|FG000|Overall Study|Other than listed|13|||
146117823|NCT01853826|526950926|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
146117824|NCT03653637|526950927|FG000|Overall Study|Death|1|||
146117825|NCT03653637|526950928|FG001|Overall Study|Death|3|||
146117826|NCT03653637|526950927|FG000|Overall Study|Lost to Follow-up|29|||
146117827|NCT03653637|526950928|FG001|Overall Study|Lost to Follow-up|30|||
146117828|NCT03653637|526950927|FG000|Overall Study|Physician Decision|1|||
146117829|NCT03653637|526950928|FG001|Overall Study|Physician Decision|1|||
146117830|NCT03653637|526950927|FG000|Overall Study|Withdrawal by Subject|7|||
146117831|NCT03653637|526950928|FG001|Overall Study|Withdrawal by Subject|4|||
146117832|NCT05661942|526950930|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
146117833|NCT05661942|526950931|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
146117834|NCT02734810|526950933|FG000|Overall Study|Adverse Event|1|||
146117835|NCT02734810|526950934|FG001|Overall Study|Adverse Event|0|||
146117836|NCT02734810|526950933|FG000|Overall Study|Lack of Efficacy|1|||
146117837|NCT02734810|526950934|FG001|Overall Study|Lack of Efficacy|0|||
146117838|NCT00127712|526950935|FG000|Overall Study|Adverse Event|3|||
146117839|NCT00127712|526950936|FG001|Overall Study|Adverse Event|0|||
146117840|NCT00127712|526950935|FG000|Overall Study|Lack of GI access to continue|2|||
146117841|NCT00127712|526950936|FG001|Overall Study|Lack of GI access to continue|0|||
146117842|NCT02664441|526950937|FG000|Randomization|Withdrawal by Subject|0|||
146117843|NCT02664441|526950938|FG001|Randomization|Withdrawal by Subject|1|||
146117844|NCT02664441|526950937|FG000|36-week Randomized Trial|Adverse Event|2|||
146117845|NCT02664441|526950938|FG001|36-week Randomized Trial|Adverse Event|0|||
146117846|NCT02664441|526950937|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
146117847|NCT02664441|526950938|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
146117848|NCT02664441|526950937|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
146117849|NCT02664441|526950938|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
146117850|NCT02664441|526950937|FG000|18-week Open Label Extension|Adverse Event|1|||
146117851|NCT02664441|526950938|FG001|18-week Open Label Extension|Adverse Event|0|||
146117852|NCT02664441|526950937|FG000|18-week Open Label Extension|Physician Decision|1|||
146117853|NCT02664441|526950938|FG001|18-week Open Label Extension|Physician Decision|0|||
146117854|NCT02664441|526950937|FG000|18-week Open Label Extension|Death|1|||
146117855|NCT02664441|526950938|FG001|18-week Open Label Extension|Death|0|||
146117856|NCT02664441|526950937|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
146117857|NCT02664441|526950938|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
146117858|NCT05040386|526950939|FG000|Overall Study|Withdrawal by Subject|1|||
146117859|NCT05040386|526950940|FG001|Overall Study|Withdrawal by Subject|0|||
146117860|NCT05040386|526950941|FG002|Overall Study|Withdrawal by Subject|1|||
146117861|NCT05040386|526950942|FG003|Overall Study|Withdrawal by Subject|0|||
146117862|NCT05040386|526950939|FG000|Overall Study|Lost to Follow-up|0|||
146117863|NCT05040386|526950940|FG001|Overall Study|Lost to Follow-up|0|||
146117864|NCT05040386|526950941|FG002|Overall Study|Lost to Follow-up|1|||
146117865|NCT05040386|526950942|FG003|Overall Study|Lost to Follow-up|0|||
146117866|NCT00715078|526950944|FG000|Overall Study|Death|29|||
146117867|NCT00715078|526950945|FG001|Overall Study|Death|36|||
146117868|NCT00715078|526950946|FG002|Overall Study|Death|36|||
146117869|NCT00715078|526950944|FG000|Overall Study|Withdrawal by Subject|1|||
146117870|NCT00715078|526950945|FG001|Overall Study|Withdrawal by Subject|0|||
146117871|NCT00715078|526950946|FG002|Overall Study|Withdrawal by Subject|1|||
146117872|NCT00715078|526950944|FG000|Overall Study|Unable to start due to disease prog.|0|||
146117873|NCT00715078|526950945|FG001|Overall Study|Unable to start due to disease prog.|0|||
146117874|NCT00715078|526950946|FG002|Overall Study|Unable to start due to disease prog.|1|||
146117875|NCT02892760|526950947|FG000|Overall Study|Withdrawal by Subject|3|||
146117876|NCT00386776|526950950|FG000|Overall Study|Withdrawal by Subject|8|||
146117877|NCT00588848|526950951|FG000|Overall Study|Physician Decision|0|||
146117878|NCT00588848|526950952|FG001|Overall Study|Physician Decision|3|||
146117879|NCT00249444|526950953|FG000|Overall Study|Lost to Follow-up|2|||
146117880|NCT00249444|526950954|FG001|Overall Study|Lost to Follow-up|2|||
146117881|NCT00249444|526950953|FG000|Overall Study|non-compliant|9|||
146117882|NCT00249444|526950954|FG001|Overall Study|non-compliant|11|||
146117883|NCT00249444|526950953|FG000|Overall Study|Adverse Event|1|||
146117884|NCT00249444|526950954|FG001|Overall Study|Adverse Event|1|||
146117885|NCT00249444|526950953|FG000|Overall Study|life event|0|||
146117886|NCT00249444|526950954|FG001|Overall Study|life event|1|||
146117887|NCT02673489|526950955|FG000|Treatment Period|Lost to Follow-up|3|||
146117888|NCT02673489|526950956|FG001|Treatment Period|Lost to Follow-up|0|||
146117889|NCT02673489|526950955|FG000|Treatment Period|Participant request to discontinue|1|||
146117890|NCT02673489|526950956|FG001|Treatment Period|Participant request to discontinue|1|||
146117891|NCT02673489|526950955|FG000|Treatment Period|Participant moved to another province|1|||
146117892|NCT02673489|526950956|FG001|Treatment Period|Participant moved to another province|0|||
146117893|NCT02673489|526950955|FG000|Treatment Period|Participant was incarcerated|0|||
146117894|NCT02673489|526950956|FG001|Treatment Period|Participant was incarcerated|1|||
146117895|NCT02673489|526950955|FG000|Treatment Period|Adverse Event|0|||
146117896|NCT02673489|526950956|FG001|Treatment Period|Adverse Event|1|||
146117897|NCT02673489|526950955|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
146117898|NCT02673489|526950956|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
146117899|NCT02673489|526950955|FG000|Follow Up Period|Unable to return for follow-up|0|||
146117900|NCT02673489|526950956|FG001|Follow Up Period|Unable to return for follow-up|1|||
146117901|NCT00082355|526950957|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
146117902|NCT00082355|526950957|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
146117903|NCT00082355|526950957|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
146117904|NCT00759863|526950958|FG000|Overall Study|Death, moved, or lost contact|20|||
146117905|NCT00759863|526950959|FG001|Overall Study|Death, moved, or lost contact|18|||
146117906|NCT00412854|526950960|FG000|Overall Study|Withdrawn due to adverse events|1|||
146117907|NCT00412854|526950961|FG001|Overall Study|Withdrawn due to adverse events|5|||
146117908|NCT00412854|526950960|FG000|Overall Study|Withdrawn for other reasons|13|||
146117909|NCT00412854|526950961|FG001|Overall Study|Withdrawn for other reasons|11|||
146117910|NCT01084174|526950962|FG000|Overall Study|gastrointestinal symptoms|1|||
146117911|NCT01084174|526950963|FG001|Overall Study|gastrointestinal symptoms|1|||
146117912|NCT01084174|526950962|FG000|Overall Study|Eosinophilic esophagitis|0|||
146117913|NCT01084174|526950963|FG001|Overall Study|Eosinophilic esophagitis|1|||
146117914|NCT01084174|526950962|FG000|Overall Study|Anaphylaxis|0|||
146117915|NCT01084174|526950963|FG001|Overall Study|Anaphylaxis|1|||
146117916|NCT01084174|526950962|FG000|Overall Study|Participant noncompliance|0|||
146117917|NCT01084174|526950963|FG001|Overall Study|Participant noncompliance|1|||
146117918|NCT01594125|526950964|FG000|Overall Study|Withdrawal by Subject|1|||
146261182|NCT04088136|527470874|FG001|Overall Study|Withdrawal by Subject|0|||
146117919|NCT01594125|526950965|FG001|Overall Study|Withdrawal by Subject|0|||
146117920|NCT01594125|526950966|FG002|Overall Study|Withdrawal by Subject|0|||
146117921|NCT01594125|526950967|FG003|Overall Study|Withdrawal by Subject|1|||
146117922|NCT01594125|526950968|FG004|Overall Study|Withdrawal by Subject|0|||
146117923|NCT01594125|526950964|FG000|Overall Study|Progressive Disease|3|||
146117924|NCT01594125|526950965|FG001|Overall Study|Progressive Disease|12|||
146117925|NCT01594125|526950966|FG002|Overall Study|Progressive Disease|3|||
146117926|NCT01594125|526950967|FG003|Overall Study|Progressive Disease|3|||
146117927|NCT01594125|526950968|FG004|Overall Study|Progressive Disease|7|||
146117928|NCT01484873|526950969|FG000|Overall Study|Withdrawal by Subject|2|||
146117929|NCT01549392|526950970|FG000|Overall Study|Withdrawal by Subject|1|||
146117930|NCT01549392|526950971|FG001|Overall Study|Withdrawal by Subject|0|||
146117931|NCT02743806|526950972|FG000|Overall Study|Adverse Event|9|||
146117932|NCT02743806|526950972|FG000|Overall Study|Lost to Follow-up|8|||
146117933|NCT02743806|526950972|FG000|Overall Study|Voluntary Withdrawal|54|||
146117934|NCT02743806|526950972|FG000|Overall Study|Study Termination|65|||
146117935|NCT02743806|526950972|FG000|Overall Study|Pregnancy|6|||
146117936|NCT02743806|526950972|FG000|Overall Study|No Longer Clinically Benefiting|27|||
146117937|NCT02743806|526950972|FG000|Overall Study|Reason Not Specified|12|||
146117938|NCT01988103|526950973|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
146117939|NCT01988103|526950974|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
146117940|NCT01988103|526950975|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
146117941|NCT01988103|526950976|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
146117942|NCT01988103|526950977|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
146117943|NCT01988103|526950973|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
146117944|NCT01988103|526950974|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
146117945|NCT01988103|526950975|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
146117946|NCT01988103|526950976|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
146117947|NCT01988103|526950977|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
146117948|NCT01988103|526950973|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
146117949|NCT01988103|526950974|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
146117950|NCT01988103|526950975|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
146117951|NCT01988103|526950976|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
146117952|NCT01988103|526950977|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
146117953|NCT01988103|526950973|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
146117954|NCT01988103|526950974|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
146117955|NCT01988103|526950975|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
146117956|NCT01988103|526950976|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
146117957|NCT01988103|526950977|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
146117958|NCT01988103|526950973|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146117959|NCT01988103|526950974|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
146117960|NCT01988103|526950975|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
146117961|NCT01988103|526950976|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146117962|NCT01988103|526950977|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
146117963|NCT01988103|526950973|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
146117964|NCT01988103|526950974|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
146117965|NCT01988103|526950975|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
146117966|NCT01988103|526950976|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
146117967|NCT01988103|526950977|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
146117968|NCT01988103|526950973|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
146117969|NCT01988103|526950974|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
146117970|NCT01988103|526950975|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
146117971|NCT01988103|526950976|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
146117972|NCT01988103|526950977|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
146117973|NCT05492942|526950978|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
146168205|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146168206|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146168207|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146168208|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168209|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
146168210|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
146168211|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168212|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168213|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168214|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168215|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146168216|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146168217|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146168218|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146168219|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146168220|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
146117974|NCT05492942|526950979|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
146117975|NCT05492942|526950980|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
146117976|NCT05492942|526950981|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
146117977|NCT02598076|526950984|FG000|Overall Study|Lost to Follow-up|2|||
146117978|NCT02598076|526950985|FG001|Overall Study|Lost to Follow-up|3|||
146117979|NCT01946425|526950987|FG000|Overall Study|Protocol Violation|1|||
146117980|NCT01946425|526950988|FG001|Overall Study|Protocol Violation|0|||
146117981|NCT01946425|526950987|FG000|Overall Study|Withdrawal by Subject|1|||
146117982|NCT01946425|526950988|FG001|Overall Study|Withdrawal by Subject|0|||
146117983|NCT00449540|526950992|FG000|Pretreatment Phase|No migraine experienced|66|||
146117984|NCT00449540|526950993|FG001|Pretreatment Phase|No migraine experienced|0|||
146117985|NCT00449540|526950994|FG002|Pretreatment Phase|No migraine experienced|0|||
146117986|NCT00449540|526950992|FG000|Treatment Phase|did not experience or treat migraine|0|||
146117987|NCT00449540|526950993|FG001|Treatment Phase|did not experience or treat migraine|20|||
146117988|NCT00449540|526950994|FG002|Treatment Phase|did not experience or treat migraine|17|||
146117989|NCT04545866|526950995|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
146117990|NCT04545866|526950996|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
146117991|NCT04545866|526950995|FG000|Overall Study|Withdrawal by Physician|1|||
146117992|NCT04545866|526950996|FG001|Overall Study|Withdrawal by Physician|0|||
146117993|NCT05247866|526950997|FG000|Overall Study|Adverse Event|2|||
146117994|NCT05247866|526950997|FG000|Overall Study|Lack of Efficacy|1|||
146117995|NCT05247866|526950997|FG000|Overall Study|Protocol Violation|1|||
146117996|NCT05247866|526950997|FG000|Overall Study|Withdrawal by Subject|3|||
146117997|NCT04463719|526950998|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
146117998|NCT04463719|526950999|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
146117999|NCT04463719|526951000|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
146118000|NCT00333866|526951003|FG000|Overall Study|Adverse Event|23|||
146118001|NCT00333866|526951004|FG001|Overall Study|Adverse Event|37|||
146118002|NCT00333866|526951005|FG002|Overall Study|Adverse Event|38|||
146118003|NCT00333866|526951006|FG003|Overall Study|Adverse Event|47|||
146118004|NCT00333866|526951003|FG000|Overall Study|Other|3|||
146118005|NCT00333866|526951004|FG001|Overall Study|Other|2|||
146118006|NCT00333866|526951005|FG002|Overall Study|Other|2|||
146118007|NCT00333866|526951006|FG003|Overall Study|Other|2|||
146118008|NCT00333866|526951003|FG000|Overall Study|Lack of Efficacy|8|||
146118009|NCT00333866|526951004|FG001|Overall Study|Lack of Efficacy|6|||
146118010|NCT00333866|526951005|FG002|Overall Study|Lack of Efficacy|3|||
146118011|NCT00333866|526951006|FG003|Overall Study|Lack of Efficacy|5|||
146118012|NCT00333866|526951003|FG000|Overall Study|Lost to Follow-up|1|||
146118013|NCT00333866|526951004|FG001|Overall Study|Lost to Follow-up|2|||
146118014|NCT00333866|526951005|FG002|Overall Study|Lost to Follow-up|2|||
146118015|NCT00333866|526951006|FG003|Overall Study|Lost to Follow-up|2|||
146118016|NCT00333866|526951003|FG000|Overall Study|Withdrawal by Subject|8|||
146118017|NCT00333866|526951004|FG001|Overall Study|Withdrawal by Subject|14|||
146118018|NCT00333866|526951005|FG002|Overall Study|Withdrawal by Subject|4|||
146118019|NCT00333866|526951006|FG003|Overall Study|Withdrawal by Subject|9|||
146118020|NCT00333866|526951003|FG000|Overall Study|Randomized but not Treated|5|||
146118021|NCT00333866|526951004|FG001|Overall Study|Randomized but not Treated|3|||
146118022|NCT00333866|526951005|FG002|Overall Study|Randomized but not Treated|2|||
146118023|NCT00333866|526951006|FG003|Overall Study|Randomized but not Treated|1|||
146118024|NCT01013701|526951007|FG000|Overall Study|study prematurely terminated|7|||
146118025|NCT03241342|526951010|FG000|Overall Study|Adverse Event|5|||
146118026|NCT03241342|526951011|FG001|Overall Study|Adverse Event|8|||
146118027|NCT03241342|526951012|FG002|Overall Study|Adverse Event|4|||
146118028|NCT03241342|526951010|FG000|Overall Study|Lack of Efficacy|0|||
146118029|NCT03241342|526951011|FG001|Overall Study|Lack of Efficacy|0|||
146118030|NCT03241342|526951012|FG002|Overall Study|Lack of Efficacy|1|||
146118031|NCT03241342|526951010|FG000|Overall Study|noncompliance with study drug|2|||
146118032|NCT03241342|526951011|FG001|Overall Study|noncompliance with study drug|1|||
146118033|NCT03241342|526951012|FG002|Overall Study|noncompliance with study drug|1|||
146118034|NCT03241342|526951010|FG000|Overall Study|sponsor decision|0|||
146118035|NCT03241342|526951011|FG001|Overall Study|sponsor decision|1|||
146118036|NCT03241342|526951012|FG002|Overall Study|sponsor decision|2|||
146118037|NCT03241342|526951010|FG000|Overall Study|not reported|15|||
146118038|NCT03241342|526951011|FG001|Overall Study|not reported|21|||
146118039|NCT03241342|526951012|FG002|Overall Study|not reported|19|||
146118040|NCT00556712|526951014|FG000|Overall Study|Adverse Event|7|||
146118041|NCT00556712|526951015|FG001|Overall Study|Adverse Event|19|||
146118042|NCT00556712|526951014|FG000|Overall Study|Death|5|||
146118043|NCT00556712|526951015|FG001|Overall Study|Death|10|||
146118044|NCT00556712|526951014|FG000|Overall Study|Progressive Disease|383|||
146118045|NCT00556712|526951015|FG001|Overall Study|Progressive Disease|320|||
146118046|NCT00556712|526951014|FG000|Overall Study|Protocol Violation|3|||
146118047|NCT00556712|526951015|FG001|Overall Study|Protocol Violation|2|||
146118048|NCT00556712|526951014|FG000|Overall Study|Refused Treatment|17|||
146118049|NCT00556712|526951015|FG001|Overall Study|Refused Treatment|16|||
146118050|NCT00556712|526951014|FG000|Overall Study|Failure to Return|2|||
146118051|NCT00556712|526951015|FG001|Overall Study|Failure to Return|3|||
146118052|NCT00556712|526951014|FG000|Overall Study|Other|2|||
146118053|NCT00556712|526951015|FG001|Overall Study|Other|2|||
146118054|NCT00556712|526951014|FG000|Overall Study|Ongoing at Data Cutoff|32|||
146118055|NCT00556712|526951015|FG001|Overall Study|Ongoing at Data Cutoff|66|||
146118056|NCT01059799|526951018|FG000|Overall Study|Adverse Event|2|||
146118057|NCT01059799|526951019|FG001|Overall Study|Adverse Event|3|||
146118058|NCT01059799|526951018|FG000|Overall Study|Lack of Efficacy|1|||
146118059|NCT01059799|526951019|FG001|Overall Study|Lack of Efficacy|0|||
146118060|NCT01059799|526951018|FG000|Overall Study|Protocol Violation|3|||
146118061|NCT01059799|526951019|FG001|Overall Study|Protocol Violation|2|||
146118062|NCT01059799|526951018|FG000|Overall Study|Withdrawal criteria|13|||
146118063|NCT01059799|526951019|FG001|Overall Study|Withdrawal criteria|2|||
146118064|NCT01059799|526951018|FG000|Overall Study|Other|12|||
146118065|NCT01059799|526951019|FG001|Overall Study|Other|3|||
146118066|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
146118067|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
146118068|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
146118069|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
146118070|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
146118071|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
146118072|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
146118073|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
146118074|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
146118075|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
146118076|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
146118077|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
146118078|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
146118079|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
146118080|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
146118081|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
146118082|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
146118083|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
146118084|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
146118085|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
146118086|NCT01962207|526951022|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
146118087|NCT01962207|526951023|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
146118088|NCT01962207|526951024|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
146118089|NCT01962207|526951025|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
146118090|NCT02671422|526951029|FG000|Overall Study|Lost to Follow-up|1|||
146118091|NCT02671422|526951029|FG000|Overall Study|Adverse Event|68|||
146118092|NCT02671422|526951029|FG000|Overall Study|Lack of Efficacy|1|||
146118093|NCT02671422|526951029|FG000|Overall Study|Lost to Follow-up|4|||
146118094|NCT02671422|526951029|FG000|Overall Study|Withdrawal by Subject|7|||
146118095|NCT02671422|526951029|FG000|Overall Study|Progressive Disease|156|||
146118096|NCT02671422|526951029|FG000|Overall Study|Worsening of Disease|4|||
146118097|NCT02671422|526951029|FG000|Overall Study|Sponsor decision|5|||
146118098|NCT02671422|526951029|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
146118099|NCT02671422|526951029|FG000|Overall Study|Not treated with Vargatef®|3|||
146118100|NCT02671422|526951029|FG000|Overall Study|Other not defined above|3|||
146118101|NCT02289079|526951030|FG000|Overall Study|Physician Decision|2|||
146118102|NCT02289079|526951031|FG001|Overall Study|Physician Decision|0|||
146118103|NCT02289079|526951030|FG000|Overall Study|Lost to Follow-up|0|||
146118104|NCT02289079|526951031|FG001|Overall Study|Lost to Follow-up|1|||
146118105|NCT03036072|526951032|FG000|Overall Study|Death|0|||
146118106|NCT03036072|526951033|FG001|Overall Study|Death|1|||
146118107|NCT03036072|526951032|FG000|Overall Study|Withdrawal by Subject|0|||
146118108|NCT03036072|526951033|FG001|Overall Study|Withdrawal by Subject|1|||
146118109|NCT03036072|526951032|FG000|Overall Study|Physician Decision|0|||
146118110|NCT03036072|526951033|FG001|Overall Study|Physician Decision|1|||
146118111|NCT02484729|526951034|FG000|Overall Study|Failure of IntelliCap Error|0|||
146118112|NCT02484729|526951035|FG001|Overall Study|Failure of IntelliCap Error|0|||
146118113|NCT02484729|526951036|FG002|Overall Study|Failure of IntelliCap Error|0|||
146118114|NCT02484729|526951037|FG003|Overall Study|Failure of IntelliCap Error|0|||
146118115|NCT02484729|526951038|FG004|Overall Study|Failure of IntelliCap Error|0|||
146118116|NCT02484729|526951039|FG005|Overall Study|Failure of IntelliCap Error|0|||
146118117|NCT02484729|526951040|FG006|Overall Study|Failure of IntelliCap Error|0|||
146261183|NCT04088136|527470873|FG000|Overall Study|Lack of Efficacy|0|||
146261184|NCT04088136|527470874|FG001|Overall Study|Lack of Efficacy|1|||
146118118|NCT02484729|526951041|FG007|Overall Study|Failure of IntelliCap Error|0|||
146118119|NCT02484729|526951042|FG008|Overall Study|Failure of IntelliCap Error|0|||
146118120|NCT02484729|526951043|FG009|Overall Study|Failure of IntelliCap Error|1|||
146261185|NCT01177228|527470875|FG000|Overall Study|Positive tuberculosis test|0|||
146261186|NCT01177228|527470876|FG001|Overall Study|Positive tuberculosis test|1|||
146261187|NCT01177228|527470877|FG002|Overall Study|Positive tuberculosis test|0|||
146261188|NCT01177228|527470878|FG003|Overall Study|Positive tuberculosis test|0|||
146261189|NCT01177228|527470875|FG000|Overall Study|Worsening disease activity|1|||
146118121|NCT04772755|526951046|FG000|Overall Study|Withdrawal by Subject|1|||
146118122|NCT04772755|526951047|FG001|Overall Study|Withdrawal by Subject|0|||
146118123|NCT04772755|526951046|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
146118124|NCT04772755|526951047|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
146118125|NCT00662363|526951048|FG000|Overall Study|Withdrawal by Subject|6|||
146118126|NCT00662363|526951049|FG001|Overall Study|Withdrawal by Subject|5|||
146118127|NCT00662363|526951048|FG000|Overall Study|Adverse Event|0|||
146118128|NCT00662363|526951049|FG001|Overall Study|Adverse Event|3|||
146118129|NCT00662363|526951048|FG000|Overall Study|Discharged early from rehab|4|||
146118130|NCT00662363|526951049|FG001|Overall Study|Discharged early from rehab|1|||
146118131|NCT00662363|526951048|FG000|Overall Study|Protocol Violation|1|||
146118132|NCT00662363|526951049|FG001|Overall Study|Protocol Violation|1|||
146118133|NCT01905657|526951050|FG000|Overall Study|Adverse Event|23|||
146118134|NCT01905657|526951051|FG001|Overall Study|Adverse Event|17|||
146118135|NCT01905657|526951052|FG002|Overall Study|Adverse Event|18|||
146118136|NCT01905657|526951050|FG000|Overall Study|Clinical Progression|103|||
146118137|NCT01905657|526951051|FG001|Overall Study|Clinical Progression|78|||
146118138|NCT01905657|526951052|FG002|Overall Study|Clinical Progression|59|||
146118139|NCT01905657|526951050|FG000|Overall Study|Death|40|||
146118140|NCT01905657|526951051|FG001|Overall Study|Death|43|||
146118141|NCT01905657|526951052|FG002|Overall Study|Death|47|||
146118142|NCT01905657|526951050|FG000|Overall Study|Excluded Medication|13|||
146118143|NCT01905657|526951051|FG001|Overall Study|Excluded Medication|16|||
146118144|NCT01905657|526951052|FG002|Overall Study|Excluded Medication|9|||
146118145|NCT01905657|526951050|FG000|Overall Study|Lost to Follow-up|1|||
146118146|NCT01905657|526951051|FG001|Overall Study|Lost to Follow-up|2|||
146118147|NCT01905657|526951052|FG002|Overall Study|Lost to Follow-up|1|||
146118148|NCT01905657|526951050|FG000|Overall Study|Physician Decision|5|||
146118149|NCT01905657|526951051|FG001|Overall Study|Physician Decision|8|||
146118150|NCT01905657|526951052|FG002|Overall Study|Physician Decision|12|||
146118151|NCT01905657|526951050|FG000|Overall Study|Protocol Violation|2|||
146118152|NCT01905657|526951051|FG001|Overall Study|Protocol Violation|1|||
146118153|NCT01905657|526951052|FG002|Overall Study|Protocol Violation|1|||
146118154|NCT01905657|526951050|FG000|Overall Study|Screen Failure|0|||
146118155|NCT01905657|526951051|FG001|Overall Study|Screen Failure|1|||
146118156|NCT01905657|526951052|FG002|Overall Study|Screen Failure|0|||
146118157|NCT01905657|526951050|FG000|Overall Study|Withdrawal by Subject|15|||
146118158|NCT01905657|526951051|FG001|Overall Study|Withdrawal by Subject|21|||
146118159|NCT01905657|526951052|FG002|Overall Study|Withdrawal by Subject|53|||
146118160|NCT01905657|526951050|FG000|Overall Study|Sponsor Decision|1|||
146118161|NCT01905657|526951051|FG001|Overall Study|Sponsor Decision|0|||
146118162|NCT01905657|526951052|FG002|Overall Study|Sponsor Decision|0|||
146118163|NCT04080297|526951053|FG000|Overall Study|Adverse Event|1|||
146118164|NCT04080297|526951054|FG001|Overall Study|Adverse Event|3|||
146118165|NCT04080297|526951053|FG000|Overall Study|concurrent illness|1|||
146118166|NCT04080297|526951054|FG001|Overall Study|concurrent illness|0|||
146118167|NCT02744391|526951055|FG000|Overall Study|Lost to Follow-up|9|||
146118168|NCT02744391|526951055|FG000|Overall Study|Physician Decision|2|||
146118169|NCT02744391|526951055|FG000|Overall Study|Withdrawal by Subject|3|||
146118170|NCT05838742|526951056|FG000|Overall Study|Adverse Event|2|||
146118171|NCT05838742|526951057|FG001|Overall Study|Adverse Event|0|||
146118172|NCT05838742|526951058|FG002|Overall Study|Adverse Event|1|||
146118173|NCT05838742|526951059|FG003|Overall Study|Adverse Event|0|||
146118174|NCT05838742|526951060|FG004|Overall Study|Adverse Event|1|||
146118175|NCT05838742|526951056|FG000|Overall Study|Lost to Follow-up|1|||
146118176|NCT05838742|526951057|FG001|Overall Study|Lost to Follow-up|1|||
146118177|NCT05838742|526951058|FG002|Overall Study|Lost to Follow-up|1|||
146118178|NCT05838742|526951059|FG003|Overall Study|Lost to Follow-up|0|||
146118179|NCT05838742|526951060|FG004|Overall Study|Lost to Follow-up|0|||
146118180|NCT05838742|526951056|FG000|Overall Study|Physician Decision|0|||
146118181|NCT05838742|526951057|FG001|Overall Study|Physician Decision|0|||
146118182|NCT05838742|526951058|FG002|Overall Study|Physician Decision|0|||
146118183|NCT05838742|526951059|FG003|Overall Study|Physician Decision|0|||
146118184|NCT05838742|526951060|FG004|Overall Study|Physician Decision|1|||
146118185|NCT05838742|526951056|FG000|Overall Study|Withdrawal by Subject|8|||
146118186|NCT05838742|526951057|FG001|Overall Study|Withdrawal by Subject|3|||
146261190|NCT01177228|527470876|FG001|Overall Study|Worsening disease activity|0|||
146118187|NCT05838742|526951058|FG002|Overall Study|Withdrawal by Subject|3|||
146118188|NCT05838742|526951059|FG003|Overall Study|Withdrawal by Subject|1|||
146118189|NCT05838742|526951060|FG004|Overall Study|Withdrawal by Subject|4|||
146118190|NCT05838742|526951056|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
146118191|NCT05838742|526951057|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
146118192|NCT05838742|526951058|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
146261191|NCT01177228|527470877|FG002|Overall Study|Worsening disease activity|0|||
146261192|NCT01177228|527470878|FG003|Overall Study|Worsening disease activity|0|||
146261193|NCT01177228|527470875|FG000|Overall Study|Withdrawal by Subject|0|||
146261194|NCT01177228|527470876|FG001|Overall Study|Withdrawal by Subject|1|||
146261195|NCT01177228|527470877|FG002|Overall Study|Withdrawal by Subject|0|||
146261196|NCT01177228|527470878|FG003|Overall Study|Withdrawal by Subject|0|||
146261197|NCT00356759|527470879|FG000|Overall Study|Death|5|||
146261198|NCT00356759|527470880|FG001|Overall Study|Death|2|||
146261199|NCT00356759|527470879|FG000|Overall Study|Withdrawal by Subject|2|||
146261200|NCT00356759|527470880|FG001|Overall Study|Withdrawal by Subject|2|||
146261201|NCT00356759|527470879|FG000|Overall Study|Adverse Event|1|||
146261202|NCT00356759|527470880|FG001|Overall Study|Adverse Event|3|||
146261203|NCT00356759|527470879|FG000|Overall Study|Lost to Follow-up|1|||
146261204|NCT00356759|527470880|FG001|Overall Study|Lost to Follow-up|1|||
146261205|NCT00356759|527470879|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
146261206|NCT00356759|527470880|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
146261207|NCT04159805|527470881|FG000|Overall Study|Withdrawal by Subject|0|||
146261208|NCT04159805|527470882|FG001|Overall Study|Withdrawal by Subject|2|||
146261209|NCT04159805|527470883|FG002|Overall Study|Withdrawal by Subject|2|||
146261210|NCT01393613|527470884|FG000|Overall Study|Adverse Event|11|||
146261211|NCT01393613|527470885|FG001|Overall Study|Adverse Event|11|||
146261212|NCT01393613|527470886|FG002|Overall Study|Adverse Event|13|||
146261213|NCT01393613|527470887|FG003|Overall Study|Adverse Event|22|||
146261214|NCT01393613|527470884|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
146261215|NCT01393613|527470885|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
146261216|NCT01393613|527470886|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
146261217|NCT01393613|527470887|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
146261218|NCT01393613|527470884|FG000|Overall Study|Physician Decision|2|||
146261219|NCT01393613|527470885|FG001|Overall Study|Physician Decision|0|||
146261220|NCT01393613|527470886|FG002|Overall Study|Physician Decision|0|||
146261221|NCT01393613|527470887|FG003|Overall Study|Physician Decision|1|||
146261222|NCT01393613|527470884|FG000|Overall Study|Withdrawal by Subject|15|||
146261223|NCT01393613|527470885|FG001|Overall Study|Withdrawal by Subject|25|||
146261224|NCT01393613|527470886|FG002|Overall Study|Withdrawal by Subject|23|||
146261225|NCT01393613|527470887|FG003|Overall Study|Withdrawal by Subject|21|||
146261226|NCT01393613|527470884|FG000|Overall Study|Protocol Deviation|2|||
146261227|NCT01393613|527470885|FG001|Overall Study|Protocol Deviation|1|||
146261228|NCT01393613|527470886|FG002|Overall Study|Protocol Deviation|0|||
146261229|NCT01393613|527470887|FG003|Overall Study|Protocol Deviation|0|||
146261230|NCT01393613|527470884|FG000|Overall Study|Lack of Efficacy|9|||
146261231|NCT01393613|527470885|FG001|Overall Study|Lack of Efficacy|20|||
146261232|NCT01393613|527470886|FG002|Overall Study|Lack of Efficacy|16|||
146261233|NCT01393613|527470887|FG003|Overall Study|Lack of Efficacy|21|||
146261234|NCT03821064|527470888|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
146261235|NCT00474383|527470893|FG000|Main Study|Adverse Event|11|||
146261236|NCT00474383|527470894|FG001|Main Study|Adverse Event|0|||
146261237|NCT00474383|527470893|FG000|Main Study|Symptomatic Deterioration|1|||
146261238|NCT00474383|527470894|FG001|Main Study|Symptomatic Deterioration|0|||
146261239|NCT00474383|527470893|FG000|Main Study|Progressive Disease|23|||
146261240|NCT00474383|527470894|FG001|Main Study|Progressive Disease|0|||
146261241|NCT00474383|527470893|FG000|Main Study|Other|1|||
146261242|NCT00474383|527470894|FG001|Main Study|Other|0|||
146261243|NCT00474383|527470893|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
146261244|NCT00474383|527470894|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
146261245|NCT00474383|527470893|FG000|Extension|Progressive Disease|0|||
146261246|NCT00474383|527470894|FG001|Extension|Progressive Disease|5|||
146261247|NCT02998918|527470895|FG000|Overall Study|Withdrawal by Subject|1|||
146261248|NCT02998918|527470896|FG001|Overall Study|Withdrawal by Subject|0|||
146261249|NCT01482819|527470897|FG000|Overall Study|Lost to Follow-up|2|||
146261250|NCT00562484|527470900|FG000|Overall Study|Adverse Event|6|||
146261251|NCT00562484|527470901|FG001|Overall Study|Adverse Event|1|||
146261252|NCT00562484|527470900|FG000|Overall Study|Protocol Violation|11|||
146261253|NCT00562484|527470901|FG001|Overall Study|Protocol Violation|2|||
146261254|NCT00562484|527470900|FG000|Overall Study|Withdrawal by Subject|12|||
146261255|NCT00562484|527470901|FG001|Overall Study|Withdrawal by Subject|9|||
146261256|NCT00562484|527470900|FG000|Overall Study|Moved away from the study area|20|||
146261257|NCT00562484|527470901|FG001|Overall Study|Moved away from the study area|9|||
146261258|NCT00562484|527470900|FG000|Overall Study|Lost to Follow-up|132|||
146261259|NCT00562484|527470901|FG001|Overall Study|Lost to Follow-up|71|||
146261260|NCT00562484|527470900|FG000|Overall Study|Reason not provided or not specified|25|||
146261261|NCT00562484|527470901|FG001|Overall Study|Reason not provided or not specified|12|||
146261262|NCT02473913|527470905|FG000|Overall Study|Lost to Follow-up|3|||
146261263|NCT02473913|527470906|FG001|Overall Study|Lost to Follow-up|3|||
146261264|NCT02826798|527472658|FG000|Overall Study|Withdrawal by Subject|0|||
146261265|NCT02826798|527472659|FG001|Overall Study|Withdrawal by Subject|1|||
146261266|NCT02826798|527472660|FG002|Overall Study|Withdrawal by Subject|0|||
146118193|NCT05838742|526951059|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
146118194|NCT05838742|526951060|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
146118195|NCT05838742|526951056|FG000|Overall Study|Lack of Efficacy|0|||
146118196|NCT05838742|526951057|FG001|Overall Study|Lack of Efficacy|0|||
146118197|NCT05838742|526951058|FG002|Overall Study|Lack of Efficacy|0|||
146118198|NCT05838742|526951059|FG003|Overall Study|Lack of Efficacy|1|||
146118199|NCT05838742|526951060|FG004|Overall Study|Lack of Efficacy|0|||
146118200|NCT05838742|526951056|FG000|Overall Study|Randomized, not treated|2|||
146118201|NCT05838742|526951057|FG001|Overall Study|Randomized, not treated|1|||
146118202|NCT05838742|526951058|FG002|Overall Study|Randomized, not treated|0|||
146118203|NCT05838742|526951059|FG003|Overall Study|Randomized, not treated|1|||
146118204|NCT05838742|526951060|FG004|Overall Study|Randomized, not treated|0|||
146118205|NCT05119569|526951065|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
146118206|NCT05119569|526951066|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
146118207|NCT05119569|526951067|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146118208|NCT05119569|526951068|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
146118209|NCT05119569|526951065|FG000|Double Blind Treatment Phase|Adverse Event|6|||
146118210|NCT05119569|526951066|FG001|Double Blind Treatment Phase|Adverse Event|0|||
146118211|NCT05119569|526951067|FG002|Double Blind Treatment Phase|Adverse Event|0|||
146118212|NCT05119569|526951068|FG003|Double Blind Treatment Phase|Adverse Event|0|||
146118213|NCT05119569|526951065|FG000|Open Label Extension Phase|Ongoing in the study|0|||
146118214|NCT05119569|526951066|FG001|Open Label Extension Phase|Ongoing in the study|0|||
146118215|NCT05119569|526951067|FG002|Open Label Extension Phase|Ongoing in the study|65|||
146118216|NCT05119569|526951068|FG003|Open Label Extension Phase|Ongoing in the study|34|||
146118217|NCT02623439|526951071|FG000|Overall Study|Withdrawal by Subject|1|||
146118218|NCT02623439|526951071|FG000|Overall Study|Screen Failure|1|||
146118219|NCT04484142|526951075|FG000|Overall Study|Adverse Event|13|||
146118220|NCT04484142|526951075|FG000|Overall Study|Progressive Disease|87|||
146118221|NCT04484142|526951075|FG000|Overall Study|Clinical Progression|10|||
146118222|NCT04484142|526951075|FG000|Overall Study|Withdrawal by Subject|6|||
146118223|NCT04484142|526951075|FG000|Overall Study|Physician Decision|1|||
146118224|NCT03700671|526951076|FG000|Overall Study|Lack of Efficacy|1|||
146118225|NCT03700671|526951077|FG001|Overall Study|Lack of Efficacy|2|||
146118226|NCT05371509|526951078|FG000|Overall Study|Physician Decision|1|||
146118227|NCT05371509|526951079|FG001|Overall Study|Physician Decision|0|||
146261267|NCT02826798|527472661|FG003|Overall Study|Withdrawal by Subject|1|||
146261268|NCT02826798|527472662|FG004|Overall Study|Withdrawal by Subject|0|||
146261269|NCT02806505|527472663|FG000|Overall Study|Adverse event/intercurrent illness|1|||
146261270|NCT02806505|527472664|FG001|Overall Study|Adverse event/intercurrent illness|3|||
146261271|NCT02806505|527472663|FG000|Overall Study|Death|4|||
146261272|NCT02806505|527472664|FG001|Overall Study|Death|0|||
146261273|NCT02806505|527472663|FG000|Overall Study|Did not cooperate/refused treatment|3|||
146261274|NCT02806505|527472664|FG001|Overall Study|Did not cooperate/refused treatment|3|||
146261275|NCT02806505|527472663|FG000|Overall Study|Failure to return|0|||
146261276|NCT02806505|527472664|FG001|Overall Study|Failure to return|1|||
146261277|NCT02806505|527472663|FG000|Overall Study|Insufficient therapeutic response|2|||
146261278|NCT02806505|527472664|FG001|Overall Study|Insufficient therapeutic response|4|||
146261279|NCT03458728|527472671|FG000|Overall Study|Adverse Event|1|||
146261280|NCT03458728|527472672|FG001|Overall Study|Adverse Event|0|||
146261281|NCT03458728|527472671|FG000|Overall Study|Physician Decision|1|||
146261282|NCT03458728|527472672|FG001|Overall Study|Physician Decision|0|||
146261283|NCT03458728|527472671|FG000|Overall Study|Progressive disease - clinical assessment|1|||
146261284|NCT03458728|527472672|FG001|Overall Study|Progressive disease - clinical assessment|0|||
146261285|NCT03458728|527472671|FG000|Overall Study|Progressive disease - radiological progression|21|||
146261286|NCT03458728|527472672|FG001|Overall Study|Progressive disease - radiological progression|6|||
146261287|NCT03458728|527472671|FG000|Overall Study|Withdrawal by Subject|0|||
146261288|NCT03458728|527472672|FG001|Overall Study|Withdrawal by Subject|1|||
146261289|NCT01755546|527472673|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
146261290|NCT01755546|527472673|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
146261291|NCT01755546|527472673|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
146261292|NCT01755546|527472673|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
146261293|NCT01755546|527472673|FG000|Titration Phase|Adverse Event|11|||
146261294|NCT01755546|527472673|FG000|Titration Phase|Lack of Efficacy|18|||
146261295|NCT01755546|527472673|FG000|Titration Phase|Protocol Violation|9|||
146261296|NCT01755546|527472673|FG000|Titration Phase|Lost to Follow-up|2|||
146261297|NCT01755546|527472673|FG000|Titration Phase|Other and Continuing|22|||
146261298|NCT01755546|527472673|FG000|Titration Phase|Withdrawal by Subject|8|||
146261299|NCT01755546|527472673|FG000|Long Term Treatment|Adverse Event|12|||
146261300|NCT01755546|527472673|FG000|Long Term Treatment|Lack of Efficacy|6|||
146261301|NCT01755546|527472673|FG000|Long Term Treatment|Protocol Violation|10|||
146261302|NCT01755546|527472673|FG000|Long Term Treatment|Withdrawal by Subject|35|||
146261303|NCT01755546|527472673|FG000|Long Term Treatment|Lost to Follow-up|17|||
146261304|NCT01755546|527472673|FG000|Long Term Treatment|other and ongoing|41|||
146261305|NCT04333147|527472678|FG000|Overall Study|Adverse Event|43|||
146261306|NCT04333147|527472679|FG001|Overall Study|Adverse Event|40|||
146261307|NCT04333147|527472678|FG000|Overall Study|Lack of Efficacy|49|||
146261308|NCT04333147|527472679|FG001|Overall Study|Lack of Efficacy|48|||
146261309|NCT04333147|527472678|FG000|Overall Study|Lost to Follow-up|19|||
146261310|NCT04333147|527472679|FG001|Overall Study|Lost to Follow-up|16|||
146261311|NCT04333147|527472678|FG000|Overall Study|Physician Decision|17|||
146261312|NCT04333147|527472679|FG001|Overall Study|Physician Decision|20|||
146261313|NCT04333147|527472678|FG000|Overall Study|Withdrawal by Subject|65|||
146261314|NCT04333147|527472679|FG001|Overall Study|Withdrawal by Subject|68|||
146261315|NCT04333147|527472678|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
146261316|NCT04333147|527472679|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
146261317|NCT04333147|527472678|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
146261318|NCT04333147|527472679|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
146261319|NCT04333147|527472678|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
146261320|NCT04333147|527472679|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
146261321|NCT01114139|527472680|FG000|Overall Study|Adverse Event|3|||
146261322|NCT01114139|527472681|FG001|Overall Study|Adverse Event|2|||
146261323|NCT01114139|527472680|FG000|Overall Study|Lost to Follow-up|15|||
146261324|NCT01114139|527472681|FG001|Overall Study|Lost to Follow-up|3|||
146261325|NCT01114139|527472680|FG000|Overall Study|Withdrawal by Subject|17|||
146261326|NCT01114139|527472681|FG001|Overall Study|Withdrawal by Subject|6|||
146261327|NCT01114139|527472680|FG000|Overall Study|Other-Missed 1 visit|1|||
146261328|NCT01114139|527472681|FG001|Overall Study|Other-Missed 1 visit|0|||
146261329|NCT01114139|527472680|FG000|Overall Study|Other-Protocol Violation|1|||
146261330|NCT01114139|527472681|FG001|Overall Study|Other-Protocol Violation|0|||
146261331|NCT01114139|527472680|FG000|Overall Study|Other-Out of window for study drug dose|1|||
146261332|NCT01114139|527472681|FG001|Overall Study|Other-Out of window for study drug dose|0|||
146261333|NCT01114139|527472680|FG000|Overall Study|Other-Participant falsified records|0|||
146261334|NCT01114139|527472681|FG001|Overall Study|Other-Participant falsified records|1|||
146261335|NCT01114139|527472680|FG000|Overall Study|Other-Participant went on hospice|0|||
146118284|NCT03578367|526951087|FG000|Overall Study|Adverse Event|0|||
146118285|NCT03578367|526951088|FG001|Overall Study|Adverse Event|3|||
146118286|NCT03578367|526951089|FG002|Overall Study|Adverse Event|0|||
146118287|NCT03578367|526951090|FG003|Overall Study|Adverse Event|5|||
146118288|NCT03578367|526951087|FG000|Overall Study|Withdrawal by Subject|2|||
146118289|NCT03578367|526951088|FG001|Overall Study|Withdrawal by Subject|2|||
146118290|NCT03578367|526951089|FG002|Overall Study|Withdrawal by Subject|1|||
146118291|NCT03578367|526951090|FG003|Overall Study|Withdrawal by Subject|3|||
146118292|NCT03578367|526951087|FG000|Overall Study|Physician Decision|0|||
146118293|NCT03578367|526951088|FG001|Overall Study|Physician Decision|0|||
146118294|NCT03578367|526951089|FG002|Overall Study|Physician Decision|14|||
146118295|NCT03578367|526951090|FG003|Overall Study|Physician Decision|0|||
146118296|NCT03578367|526951087|FG000|Overall Study|Death|1|||
146118297|NCT03578367|526951088|FG001|Overall Study|Death|0|||
146118298|NCT03578367|526951089|FG002|Overall Study|Death|0|||
146118299|NCT03578367|526951090|FG003|Overall Study|Death|0|||
146118300|NCT03578367|526951087|FG000|Overall Study|Not treated|0|||
146118301|NCT03578367|526951088|FG001|Overall Study|Not treated|0|||
146118302|NCT03578367|526951089|FG002|Overall Study|Not treated|1|||
146118303|NCT03578367|526951090|FG003|Overall Study|Not treated|0|||
146118304|NCT02081690|526952591|FG000|Overall Study|Death|3|||
146118305|NCT02081690|526952591|FG000|Overall Study|Physician Decision|3|||
146118306|NCT02081690|526952591|FG000|Overall Study|Withdrawal by Subject|1|||
146118307|NCT00982488|526952595|FG000|Overall Study|Administrative reason by sponsor|81|||
146118308|NCT00982488|526952596|FG001|Overall Study|Administrative reason by sponsor|3|||
146118309|NCT00982488|526952597|FG002|Overall Study|Administrative reason by sponsor|11|||
146118310|NCT00982488|526952598|FG003|Overall Study|Administrative reason by sponsor|0|||
146118311|NCT00982488|526952599|FG004|Overall Study|Administrative reason by sponsor|0|||
146118312|NCT00982488|526952595|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146118313|NCT00982488|526952596|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146118314|NCT00982488|526952597|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146118315|NCT00982488|526952598|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146118316|NCT00982488|526952599|FG004|Overall Study|Adverse event unrelated to study drug|0|||
146118317|NCT00982488|526952595|FG000|Overall Study|Death|11|||
146118318|NCT00982488|526952596|FG001|Overall Study|Death|0|||
146118319|NCT00982488|526952597|FG002|Overall Study|Death|2|||
146118320|NCT00982488|526952598|FG003|Overall Study|Death|0|||
146118321|NCT00982488|526952599|FG004|Overall Study|Death|0|||
146118322|NCT00982488|526952595|FG000|Overall Study|Disease progression|30|||
146118323|NCT00982488|526952596|FG001|Overall Study|Disease progression|5|||
146118324|NCT00982488|526952597|FG002|Overall Study|Disease progression|10|||
146118325|NCT00982488|526952598|FG003|Overall Study|Disease progression|1|||
146118326|NCT00982488|526952599|FG004|Overall Study|Disease progression|1|||
146118327|NCT00982488|526952595|FG000|Overall Study|Lost to Follow-up|1|||
146118328|NCT00982488|526952596|FG001|Overall Study|Lost to Follow-up|0|||
146118329|NCT00982488|526952597|FG002|Overall Study|Lost to Follow-up|0|||
146118330|NCT00982488|526952598|FG003|Overall Study|Lost to Follow-up|0|||
146118331|NCT00982488|526952599|FG004|Overall Study|Lost to Follow-up|0|||
146118332|NCT00982488|526952595|FG000|Overall Study|Maximum clinical benefit|1|||
146118333|NCT00982488|526952596|FG001|Overall Study|Maximum clinical benefit|1|||
146118334|NCT00982488|526952597|FG002|Overall Study|Maximum clinical benefit|1|||
146118335|NCT00982488|526952598|FG003|Overall Study|Maximum clinical benefit|0|||
146118336|NCT00982488|526952599|FG004|Overall Study|Maximum clinical benefit|0|||
146118337|NCT00982488|526952595|FG000|Overall Study|Other|15|||
146118338|NCT00982488|526952596|FG001|Overall Study|Other|1|||
146118339|NCT00982488|526952597|FG002|Overall Study|Other|3|||
146118340|NCT00982488|526952598|FG003|Overall Study|Other|1|||
146118341|NCT00982488|526952599|FG004|Overall Study|Other|0|||
146118342|NCT00982488|526952595|FG000|Overall Study|Poor compliance/noncompliance|0|||
146118343|NCT00982488|526952596|FG001|Overall Study|Poor compliance/noncompliance|1|||
146118344|NCT00982488|526952597|FG002|Overall Study|Poor compliance/noncompliance|0|||
146118345|NCT00982488|526952598|FG003|Overall Study|Poor compliance/noncompliance|0|||
146118346|NCT00982488|526952599|FG004|Overall Study|Poor compliance/noncompliance|0|||
146118347|NCT00982488|526952595|FG000|Overall Study|Stem cell transplant|2|||
146118348|NCT00982488|526952596|FG001|Overall Study|Stem cell transplant|0|||
146118349|NCT00982488|526952597|FG002|Overall Study|Stem cell transplant|0|||
146118350|NCT00982488|526952598|FG003|Overall Study|Stem cell transplant|1|||
146118351|NCT00982488|526952599|FG004|Overall Study|Stem cell transplant|0|||
146118352|NCT00982488|526952595|FG000|Overall Study|Study drug toxicity|34|||
146118353|NCT00982488|526952596|FG001|Overall Study|Study drug toxicity|1|||
146118354|NCT00982488|526952597|FG002|Overall Study|Study drug toxicity|6|||
146118355|NCT00982488|526952598|FG003|Overall Study|Study drug toxicity|0|||
146118356|NCT00982488|526952599|FG004|Overall Study|Study drug toxicity|0|||
146118357|NCT00982488|526952595|FG000|Overall Study|Withdrawal by Subject|5|||
146118358|NCT00982488|526952596|FG001|Overall Study|Withdrawal by Subject|1|||
146118359|NCT00982488|526952597|FG002|Overall Study|Withdrawal by Subject|1|||
146118360|NCT00982488|526952598|FG003|Overall Study|Withdrawal by Subject|0|||
146118361|NCT00982488|526952599|FG004|Overall Study|Withdrawal by Subject|0|||
146118362|NCT04203238|526952600|FG000|Overall Study|Withdrawal by Subject|1|||
146118363|NCT04203238|526952601|FG001|Overall Study|Withdrawal by Subject|1|||
146118364|NCT04203238|526952600|FG000|Overall Study|Covid-19|3|||
146118365|NCT04203238|526952601|FG001|Overall Study|Covid-19|0|||
146118366|NCT01134783|526952602|FG000|Overall Study|Pregnancy|16|||
146118367|NCT01134783|526952603|FG001|Overall Study|Pregnancy|8|||
146118368|NCT01134783|526952602|FG000|Overall Study|Withdrawal by Subject|15|||
146118369|NCT01134783|526952603|FG001|Overall Study|Withdrawal by Subject|9|||
146118370|NCT01134783|526952602|FG000|Overall Study|Lost to Follow-up|5|||
146118371|NCT01134783|526952603|FG001|Overall Study|Lost to Follow-up|20|||
146118372|NCT00001596|526952605|FG000|Overall Study|Death|1|||
146118373|NCT00001596|526952606|FG001|Overall Study|Death|0|||
146118374|NCT00001596|526952605|FG000|Overall Study|Withdrawal by Subject|3|||
146118375|NCT00001596|526952606|FG001|Overall Study|Withdrawal by Subject|1|||
146118376|NCT00001596|526952605|FG000|Overall Study|Study Termination|12|||
146118377|NCT00001596|526952606|FG001|Overall Study|Study Termination|9|||
146118378|NCT00001596|526952605|FG000|Overall Study|Adverse Event|1|||
146118379|NCT00001596|526952606|FG001|Overall Study|Adverse Event|0|||
146118380|NCT00180414|526952615|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
146118381|NCT00180414|526952616|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
146118382|NCT00463346|526952618|FG000|Overall Study|Withdrawal by Subject|3|||
146118383|NCT00463346|526952619|FG001|Overall Study|Withdrawal by Subject|3|||
146118384|NCT01572909|526952620|FG000|Overall Study|Adverse Event|7|||
146118385|NCT01572909|526952621|FG001|Overall Study|Adverse Event|2|||
146118386|NCT01572909|526952620|FG000|Overall Study|Death|3|||
146118387|NCT01572909|526952621|FG001|Overall Study|Death|1|||
146118388|NCT01572909|526952620|FG000|Overall Study|Lost to Follow-up|8|||
146118389|NCT01572909|526952621|FG001|Overall Study|Lost to Follow-up|7|||
146118390|NCT01572909|526952620|FG000|Overall Study|Physician Decision|1|||
146118391|NCT01572909|526952621|FG001|Overall Study|Physician Decision|1|||
146118392|NCT01572909|526952620|FG000|Overall Study|Technical Issues|1|||
146118393|NCT01572909|526952621|FG001|Overall Study|Technical Issues|0|||
146118394|NCT01572909|526952620|FG000|Overall Study|Withdrawal by Subject|12|||
146118395|NCT01572909|526952621|FG001|Overall Study|Withdrawal by Subject|11|||
146118396|NCT01572909|526952620|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
146118397|NCT01572909|526952621|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
146118398|NCT03641651|526952626|FG000|Overall Study|organizational issues at one study site|1|||
146118399|NCT04779489|526952627|FG000|Overall Study|Physician Decision|1|||
146118400|NCT00951665|526952628|FG000|Phase 1b|Adverse Event|2|||
146118401|NCT00951665|526952629|FG001|Phase 1b|Adverse Event|1|||
146118402|NCT00951665|526952630|FG002|Phase 1b|Adverse Event|0|||
146118403|NCT00951665|526952631|FG003|Phase 1b|Adverse Event|1|||
146118404|NCT00951665|526952632|FG004|Phase 1b|Adverse Event|0|||
146118405|NCT00951665|526952633|FG005|Phase 1b|Adverse Event|0|||
146118406|NCT00951665|526952628|FG000|Phase 1b|Death|1|||
146118407|NCT00951665|526952629|FG001|Phase 1b|Death|0|||
146118408|NCT00951665|526952630|FG002|Phase 1b|Death|2|||
146118409|NCT00951665|526952631|FG003|Phase 1b|Death|0|||
146118410|NCT00951665|526952632|FG004|Phase 1b|Death|0|||
146118411|NCT00951665|526952633|FG005|Phase 1b|Death|0|||
146118412|NCT00951665|526952628|FG000|Phase 1b|Physician Decision|4|||
146118413|NCT00951665|526952629|FG001|Phase 1b|Physician Decision|0|||
146118414|NCT00951665|526952630|FG002|Phase 1b|Physician Decision|1|||
146118415|NCT00951665|526952631|FG003|Phase 1b|Physician Decision|0|||
146118416|NCT00951665|526952632|FG004|Phase 1b|Physician Decision|0|||
146118417|NCT00951665|526952633|FG005|Phase 1b|Physician Decision|0|||
146118418|NCT00951665|526952628|FG000|Phase 1b|Withdrawal by Subject|0|||
146118419|NCT00951665|526952629|FG001|Phase 1b|Withdrawal by Subject|1|||
146118420|NCT00951665|526952630|FG002|Phase 1b|Withdrawal by Subject|0|||
146118421|NCT00951665|526952631|FG003|Phase 1b|Withdrawal by Subject|0|||
146118422|NCT00951665|526952632|FG004|Phase 1b|Withdrawal by Subject|0|||
146118423|NCT00951665|526952633|FG005|Phase 1b|Withdrawal by Subject|0|||
146118424|NCT00951665|526952628|FG000|Phase 1b|Disease Progression|13|||
146118425|NCT00951665|526952629|FG001|Phase 1b|Disease Progression|2|||
146118426|NCT00951665|526952630|FG002|Phase 1b|Disease Progression|14|||
146118427|NCT00951665|526952631|FG003|Phase 1b|Disease Progression|0|||
146118428|NCT00951665|526952632|FG004|Phase 1b|Disease Progression|0|||
146118429|NCT00951665|526952633|FG005|Phase 1b|Disease Progression|0|||
146118430|NCT00951665|526952628|FG000|Phase 1b|Protocol Violation|2|||
146118431|NCT00951665|526952629|FG001|Phase 1b|Protocol Violation|0|||
146118432|NCT00951665|526952630|FG002|Phase 1b|Protocol Violation|0|||
146118433|NCT00951665|526952631|FG003|Phase 1b|Protocol Violation|0|||
146118434|NCT00951665|526952632|FG004|Phase 1b|Protocol Violation|0|||
146118435|NCT00951665|526952633|FG005|Phase 1b|Protocol Violation|0|||
146118436|NCT00951665|526952628|FG000|Phase 2a|Adverse Event|0|||
146118437|NCT00951665|526952629|FG001|Phase 2a|Adverse Event|0|||
146118438|NCT00951665|526952630|FG002|Phase 2a|Adverse Event|0|||
146118439|NCT00951665|526952631|FG003|Phase 2a|Adverse Event|0|||
146118440|NCT00951665|526952632|FG004|Phase 2a|Adverse Event|2|||
146118441|NCT00951665|526952633|FG005|Phase 2a|Adverse Event|0|||
146118442|NCT00951665|526952628|FG000|Phase 2a|Death|0|||
146118443|NCT00951665|526952629|FG001|Phase 2a|Death|0|||
146118444|NCT00951665|526952630|FG002|Phase 2a|Death|0|||
146118445|NCT00951665|526952631|FG003|Phase 2a|Death|0|||
146118446|NCT00951665|526952632|FG004|Phase 2a|Death|1|||
146118447|NCT00951665|526952633|FG005|Phase 2a|Death|1|||
146118448|NCT00951665|526952628|FG000|Phase 2a|Lost to Follow-up|0|||
146118449|NCT00951665|526952629|FG001|Phase 2a|Lost to Follow-up|0|||
146118450|NCT00951665|526952630|FG002|Phase 2a|Lost to Follow-up|0|||
146118451|NCT00951665|526952631|FG003|Phase 2a|Lost to Follow-up|0|||
146118452|NCT00951665|526952632|FG004|Phase 2a|Lost to Follow-up|1|||
146118453|NCT00951665|526952633|FG005|Phase 2a|Lost to Follow-up|0|||
146118454|NCT00951665|526952628|FG000|Phase 2a|Physician Decision|0|||
146118455|NCT00951665|526952629|FG001|Phase 2a|Physician Decision|0|||
146118456|NCT00951665|526952630|FG002|Phase 2a|Physician Decision|0|||
146118457|NCT00951665|526952631|FG003|Phase 2a|Physician Decision|0|||
146118458|NCT00951665|526952632|FG004|Phase 2a|Physician Decision|0|||
146118459|NCT00951665|526952633|FG005|Phase 2a|Physician Decision|1|||
146118460|NCT00951665|526952628|FG000|Phase 2a|Withdrawal by Subject|0|||
146118461|NCT00951665|526952629|FG001|Phase 2a|Withdrawal by Subject|0|||
146118462|NCT00951665|526952630|FG002|Phase 2a|Withdrawal by Subject|0|||
146118463|NCT00951665|526952631|FG003|Phase 2a|Withdrawal by Subject|0|||
146118464|NCT00951665|526952632|FG004|Phase 2a|Withdrawal by Subject|2|||
146118465|NCT00951665|526952633|FG005|Phase 2a|Withdrawal by Subject|0|||
146118466|NCT00951665|526952628|FG000|Phase 2a|Disease Progression|0|||
146118467|NCT00951665|526952629|FG001|Phase 2a|Disease Progression|0|||
146118468|NCT00951665|526952630|FG002|Phase 2a|Disease Progression|0|||
146118469|NCT00951665|526952631|FG003|Phase 2a|Disease Progression|0|||
146118470|NCT00951665|526952632|FG004|Phase 2a|Disease Progression|6|||
146118471|NCT00951665|526952633|FG005|Phase 2a|Disease Progression|5|||
146118472|NCT02723084|526952636|FG000|Overall Study|Withdrawal by Subject|1|||
146118473|NCT02723084|526952637|FG001|Overall Study|Withdrawal by Subject|1|||
146118474|NCT02723084|526952636|FG000|Overall Study|Lost to Follow-up|3|||
146118475|NCT02723084|526952637|FG001|Overall Study|Lost to Follow-up|0|||
146118476|NCT00415909|526952640|FG000|Overall Study|Withdrawal by Subject|2|||
146118477|NCT00415909|526952640|FG000|Overall Study|Death|1|||
146118478|NCT05024058|526952641|FG000|Treatment|Study terminated by sponsor|5|||
146118479|NCT05024058|526952642|FG001|Treatment|Study terminated by sponsor|6|||
146118480|NCT05024058|526952643|FG002|Treatment|Study terminated by sponsor|4|||
146118481|NCT05024058|526952644|FG003|Treatment|Study terminated by sponsor|2|||
146118482|NCT05024058|526952645|FG004|Treatment|Study terminated by sponsor|3|||
146118483|NCT05024058|526952646|FG005|Treatment|Study terminated by sponsor|3|||
146118484|NCT05024058|526952647|FG006|Treatment|Study terminated by sponsor|1|||
146118485|NCT05024058|526952648|FG007|Treatment|Study terminated by sponsor|3|||
146118486|NCT05024058|526952649|FG008|Treatment|Study terminated by sponsor|6|||
146118487|NCT05024058|526952650|FG009|Treatment|Study terminated by sponsor|6|||
146118488|NCT05024058|526952641|FG000|Follow-up|Withdrawal by Subject|1|||
146118489|NCT05024058|526952642|FG001|Follow-up|Withdrawal by Subject|0|||
146118490|NCT05024058|526952643|FG002|Follow-up|Withdrawal by Subject|1|||
146118491|NCT05024058|526952644|FG003|Follow-up|Withdrawal by Subject|0|||
146118492|NCT05024058|526952645|FG004|Follow-up|Withdrawal by Subject|0|||
146118493|NCT05024058|526952646|FG005|Follow-up|Withdrawal by Subject|0|||
146118494|NCT05024058|526952647|FG006|Follow-up|Withdrawal by Subject|0|||
146118495|NCT05024058|526952648|FG007|Follow-up|Withdrawal by Subject|1|||
146118496|NCT05024058|526952649|FG008|Follow-up|Withdrawal by Subject|0|||
146118497|NCT05024058|526952650|FG009|Follow-up|Withdrawal by Subject|1|||
146118498|NCT00407563|526952656|FG000|Overall Study|Patient continues on treatment|1|||
146118499|NCT02450903|526952657|FG000|Overall Study|Adverse Event|3|||
146118500|NCT02450903|526952657|FG000|Overall Study|Progressive disease|15|||
146118501|NCT02450903|526952657|FG000|Overall Study|Switched to commercial drug|1|||
146118502|NCT02450903|526952657|FG000|Overall Study|Subject/guardian decision|1|||
146118503|NCT00503308|526952666|FG000|Overall Study|Protocol Violation|2|||
146118504|NCT00503308|526952667|FG001|Overall Study|Protocol Violation|1|||
146118505|NCT03263442|526952668|FG000|Inpatient Phase|Death|1|||
146118506|NCT03263442|526952669|FG001|Inpatient Phase|Death|0|||
146118507|NCT03263442|526952668|FG000|Inpatient Phase|Withdrawal by Subject|1|||
146118508|NCT03263442|526952669|FG001|Inpatient Phase|Withdrawal by Subject|0|||
146118509|NCT03263442|526952668|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
146118510|NCT03263442|526952669|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
146118511|NCT03263442|526952668|FG000|1-month Follow-Up|Lost to Follow-up|1|||
146118512|NCT03263442|526952669|FG001|1-month Follow-Up|Lost to Follow-up|0|||
146118513|NCT03263442|526952668|FG000|3-month Follow-Up|Lost to Follow-up|1|||
146118514|NCT03263442|526952669|FG001|3-month Follow-Up|Lost to Follow-up|3|||
146118515|NCT03263442|526952668|FG000|6-month Follow-Up|Lost to Follow-up|2|||
146118516|NCT03263442|526952669|FG001|6-month Follow-Up|Lost to Follow-up|2|||
146118517|NCT01463878|526952670|FG000|Overall Study|no longer met criteria for tube feed|2|||
146118518|NCT01463878|526952671|FG001|Overall Study|no longer met criteria for tube feed|2|||
146118519|NCT03804879|526952672|FG000|Overall Study|Adverse Event|3|||
146118520|NCT03804879|526952673|FG001|Overall Study|Adverse Event|0|||
146118521|NCT03804879|526952672|FG000|Overall Study|Study Terminated By Sponsor|10|||
146118522|NCT03804879|526952673|FG001|Overall Study|Study Terminated By Sponsor|12|||
146118523|NCT03804879|526952672|FG000|Overall Study|Withdrawal by Subject|3|||
146118524|NCT03804879|526952673|FG001|Overall Study|Withdrawal by Subject|1|||
146118525|NCT01034462|526952674|FG000|Overall Study|Adverse Event|7|||
146302527|NCT00718549|527621694|FG002|Induction Phase|Disease Progression|0|||
146302528|NCT00718549|527621692|FG000|Induction Phase|Eligibility Criteria Violation|2|||
146302529|NCT00718549|527621693|FG001|Induction Phase|Eligibility Criteria Violation|0|||
146302530|NCT00718549|527621694|FG002|Induction Phase|Eligibility Criteria Violation|0|||
146302531|NCT00718549|527621692|FG000|Induction Phase|Early Termination - No Additional Info|59|||
146302532|NCT00718549|527621693|FG001|Induction Phase|Early Termination - No Additional Info|0|||
146302533|NCT00718549|527621694|FG002|Induction Phase|Early Termination - No Additional Info|0|||
146302534|NCT00718549|527621692|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
146302535|NCT00718549|527621693|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
146302536|NCT00718549|527621694|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
146302537|NCT00718549|527621692|FG000|Maintenance/ Observation Phase|Death|0|||
146302538|NCT00718549|527621693|FG001|Maintenance/ Observation Phase|Death|1|||
146302539|NCT00718549|527621694|FG002|Maintenance/ Observation Phase|Death|2|||
146302540|NCT00718549|527621692|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
146302541|NCT00718549|527621693|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
146302542|NCT00718549|527621694|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
146302543|NCT00718549|527621692|FG000|Maintenance/ Observation Phase|Progression|0|||
146302544|NCT00718549|527621693|FG001|Maintenance/ Observation Phase|Progression|5|||
146302545|NCT00718549|527621694|FG002|Maintenance/ Observation Phase|Progression|14|||
146302546|NCT00718549|527621692|FG000|Maintenance/ Observation Phase|Relapse|0|||
146302547|NCT00718549|527621693|FG001|Maintenance/ Observation Phase|Relapse|3|||
146302548|NCT00718549|527621694|FG002|Maintenance/ Observation Phase|Relapse|2|||
146302549|NCT01353508|527621695|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146302550|NCT01353508|527621696|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146302551|NCT01353508|527621697|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
146302552|NCT01353508|527621698|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
146302553|NCT01353508|527621695|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
146302554|NCT01353508|527621696|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146118526|NCT01034462|526952675|FG001|Overall Study|Adverse Event|17|||
146118527|NCT01034462|526952674|FG000|Overall Study|Lack of Efficacy|4|||
146118528|NCT01034462|526952675|FG001|Overall Study|Lack of Efficacy|4|||
146302555|NCT01353508|527621697|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146302556|NCT01353508|527621698|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
146302557|NCT01576172|527621699|FG000|Overall Study|Ineligible|2|||
146302558|NCT01576172|527621700|FG001|Overall Study|Ineligible|1|||
146302559|NCT01576172|527621699|FG000|Overall Study|Withdrawal by Subject|2|||
146118529|NCT01034462|526952674|FG000|Overall Study|Protocol Violation|10|||
146118530|NCT01034462|526952675|FG001|Overall Study|Protocol Violation|7|||
146118531|NCT01034462|526952674|FG000|Overall Study|Withdrawal by Subject|9|||
146118532|NCT01034462|526952675|FG001|Overall Study|Withdrawal by Subject|8|||
146118533|NCT01034462|526952674|FG000|Overall Study|Lost to Follow-up|14|||
146118534|NCT01034462|526952675|FG001|Overall Study|Lost to Follow-up|16|||
146118535|NCT01034462|526952674|FG000|Overall Study|Other reasons|1|||
146118536|NCT01034462|526952675|FG001|Overall Study|Other reasons|2|||
146118537|NCT00708643|526952676|FG000|Overall Study|Adverse Event|0|||
146118538|NCT00708643|526952677|FG001|Overall Study|Adverse Event|1|||
146118539|NCT04876274|526952678|FG000|Overall Study|Lost to Follow-up|9|||
146118540|NCT04876274|526952679|FG001|Overall Study|Lost to Follow-up|12|||
146118541|NCT01948050|526952680|FG000|Overall Study|Withdrawal by Subject|0|||
146118542|NCT01948050|526952681|FG001|Overall Study|Withdrawal by Subject|1|||
146118543|NCT06079320|526952684|FG000|Follow up Phase|Lost to Follow-up|1|||
146261336|NCT01114139|527472681|FG001|Overall Study|Other-Participant went on hospice|1|||
146261337|NCT01114139|527472680|FG000|Overall Study|Other-Physician changed treatment|1|||
146261338|NCT01114139|527472681|FG001|Overall Study|Other-Physician changed treatment|0|||
146261339|NCT01114139|527472680|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
146261340|NCT01114139|527472681|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
146261341|NCT02536742|527472683|FG000|Overall Study|Did not start protocol therapy|1|||
146261342|NCT02536742|527472683|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
146261343|NCT00706914|527472684|FG000|Overall Study|Lack of Efficacy|0|||
146261344|NCT00706914|527472685|FG001|Overall Study|Lack of Efficacy|1|||
146261345|NCT00706914|527472686|FG002|Overall Study|Lack of Efficacy|0|||
146261346|NCT00706914|527472684|FG000|Overall Study|Lost to Follow-up|1|||
146261347|NCT00706914|527472685|FG001|Overall Study|Lost to Follow-up|0|||
146261348|NCT00706914|527472686|FG002|Overall Study|Lost to Follow-up|0|||
146261349|NCT00706914|527472684|FG000|Overall Study|Adverse Event|2|||
146261350|NCT00706914|527472685|FG001|Overall Study|Adverse Event|2|||
146261351|NCT00706914|527472686|FG002|Overall Study|Adverse Event|0|||
146261352|NCT00706914|527472684|FG000|Overall Study|Protocol Violation|3|||
146261353|NCT00706914|527472685|FG001|Overall Study|Protocol Violation|1|||
146261354|NCT00706914|527472686|FG002|Overall Study|Protocol Violation|1|||
146261355|NCT04629443|527472687|FG000|Overall Study|Adverse Event|2|||
146261356|NCT04629443|527472688|FG001|Overall Study|Adverse Event|1|||
146261357|NCT04629443|527472689|FG002|Overall Study|Adverse Event|2|||
146261358|NCT04629443|527472687|FG000|Overall Study|Progressive Disease|2|||
146261359|NCT04629443|527472688|FG001|Overall Study|Progressive Disease|3|||
146261360|NCT04629443|527472689|FG002|Overall Study|Progressive Disease|3|||
146261361|NCT04629443|527472687|FG000|Overall Study|Physician Decision|1|||
146261362|NCT04629443|527472688|FG001|Overall Study|Physician Decision|3|||
146261363|NCT04629443|527472689|FG002|Overall Study|Physician Decision|0|||
146261364|NCT00916305|527472696|FG000|Overall Study|Lost to Follow-up|21|||
146261365|NCT00916305|527472697|FG001|Overall Study|Lost to Follow-up|27|||
146261366|NCT00916305|527472696|FG000|Overall Study|Withdrawal by Subject|0|||
146261367|NCT00916305|527472697|FG001|Overall Study|Withdrawal by Subject|1|||
146261368|NCT00858247|527472700|FG000|Baseline Assessment|Withdrawal by Subject|1|||
146261369|NCT00858247|527472701|FG001|Baseline Assessment|Withdrawal by Subject|1|||
146261370|NCT00858247|527472700|FG000|Baseline Assessment|Poor IV access|1|||
146261371|NCT00858247|527472701|FG001|Baseline Assessment|Poor IV access|0|||
146261372|NCT00858247|527472700|FG000|Baseline Assessment|Protocol Violation|0|||
146261373|NCT00858247|527472701|FG001|Baseline Assessment|Protocol Violation|1|||
146261374|NCT00858247|527472700|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
146261375|NCT00858247|527472701|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
146261376|NCT02512861|527472702|FG000|Overall Study|Protocol Violation|3|||
146261377|NCT02512861|527472703|FG001|Overall Study|Protocol Violation|7|||
146261378|NCT02512861|527472702|FG000|Overall Study|Physician Decision|3|||
146261379|NCT02512861|527472703|FG001|Overall Study|Physician Decision|1|||
146261380|NCT02512861|527472702|FG000|Overall Study|Withdrawal by Subject|0|||
146261381|NCT02512861|527472703|FG001|Overall Study|Withdrawal by Subject|1|||
146261382|NCT01172639|527472704|FG000|Overall Study|Death|1|||
146261383|NCT01172639|527472705|FG001|Overall Study|Death|1|||
146261384|NCT01172639|527472706|FG002|Overall Study|Death|0|||
146261385|NCT01172639|527472707|FG003|Overall Study|Death|0|||
146261386|NCT01172639|527472708|FG004|Overall Study|Death|0|||
146261387|NCT01172639|527472704|FG000|Overall Study|Lost to Follow-up|9|||
146261388|NCT01172639|527472705|FG001|Overall Study|Lost to Follow-up|7|||
146261389|NCT01172639|527472706|FG002|Overall Study|Lost to Follow-up|11|||
146118544|NCT06079320|526952685|FG001|Follow up Phase|Lost to Follow-up|0|||
146118545|NCT01129960|526952686|FG000|Overall Study|Withdrawal by Subject|3|||
146261390|NCT01172639|527472707|FG003|Overall Study|Lost to Follow-up|6|||
146261391|NCT01172639|527472708|FG004|Overall Study|Lost to Follow-up|6|||
146118546|NCT01129960|526952687|FG001|Overall Study|Withdrawal by Subject|0|||
146118547|NCT01129960|526952688|FG002|Overall Study|Withdrawal by Subject|3|||
146118548|NCT01129960|526952689|FG003|Overall Study|Withdrawal by Subject|2|||
146261392|NCT01172639|527472704|FG000|Overall Study|Withdrawal by Subject|3|||
146261393|NCT01172639|527472705|FG001|Overall Study|Withdrawal by Subject|3|||
146261394|NCT01172639|527472706|FG002|Overall Study|Withdrawal by Subject|5|||
146261395|NCT01172639|527472707|FG003|Overall Study|Withdrawal by Subject|5|||
146302560|NCT01576172|527621700|FG001|Overall Study|Withdrawal by Subject|0|||
146302561|NCT01576172|527621699|FG000|Overall Study|Insurance issue|1|||
146302562|NCT01576172|527621700|FG001|Overall Study|Insurance issue|0|||
146302563|NCT00433914|527621701|FG000|Overall Study|Withdrawal by Subject|0|||
146302564|NCT00433914|527621702|FG001|Overall Study|Withdrawal by Subject|2|||
146302565|NCT00433914|527621701|FG000|Overall Study|Lost to Follow-up|0|||
146302566|NCT00433914|527621702|FG001|Overall Study|Lost to Follow-up|1|||
146302567|NCT00766090|527621703|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302568|NCT00766090|527621704|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302569|NCT00766090|527621705|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302570|NCT00766090|527621706|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302571|NCT00766090|527621707|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302572|NCT00766090|527621708|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302573|NCT00766090|527621709|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302574|NCT00766090|527621710|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302575|NCT00766090|527621711|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
146302576|NCT00766090|527621712|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302577|NCT00766090|527621713|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302578|NCT00766090|527621714|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
146302579|NCT00766090|527621703|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
146302580|NCT00766090|527621704|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302581|NCT00766090|527621705|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302582|NCT00766090|527621706|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302583|NCT00766090|527621707|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302584|NCT00766090|527621708|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302585|NCT00766090|527621709|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302586|NCT00766090|527621710|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302587|NCT00766090|527621711|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302588|NCT00766090|527621712|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302589|NCT00766090|527621713|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302590|NCT00766090|527621714|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
146302591|NCT00766090|527621703|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146302592|NCT00766090|527621704|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302593|NCT00766090|527621705|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302594|NCT00766090|527621706|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
146302595|NCT00766090|527621707|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302596|NCT00766090|527621708|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302597|NCT00766090|527621709|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302598|NCT00766090|527621710|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302599|NCT00766090|527621711|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302600|NCT00766090|527621712|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302601|NCT00766090|527621713|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302602|NCT00766090|527621714|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
146302603|NCT00766090|527621703|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302604|NCT00766090|527621704|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302605|NCT00766090|527621705|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
146302606|NCT00766090|527621706|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302607|NCT00766090|527621707|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
146118549|NCT01129960|526952686|FG000|Overall Study|Lack of Efficacy|1|||
146118550|NCT01129960|526952687|FG001|Overall Study|Lack of Efficacy|1|||
146118551|NCT01129960|526952688|FG002|Overall Study|Lack of Efficacy|1|||
146118552|NCT01129960|526952689|FG003|Overall Study|Lack of Efficacy|1|||
146118553|NCT01129960|526952686|FG000|Overall Study|Adverse Event|23|||
146118554|NCT01129960|526952687|FG001|Overall Study|Adverse Event|16|||
146118555|NCT01129960|526952688|FG002|Overall Study|Adverse Event|16|||
146118556|NCT01129960|526952689|FG003|Overall Study|Adverse Event|7|||
146302608|NCT00766090|527621708|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302609|NCT00766090|527621709|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302610|NCT00766090|527621710|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302611|NCT00766090|527621711|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302612|NCT00766090|527621712|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302613|NCT00766090|527621713|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302614|NCT00766090|527621714|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
146302615|NCT00766090|527621703|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302616|NCT00766090|527621704|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302617|NCT00766090|527621705|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302618|NCT00766090|527621706|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302619|NCT00766090|527621707|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
146118557|NCT01129960|526952686|FG000|Overall Study|Protocol Violation|1|||
146118558|NCT01129960|526952687|FG001|Overall Study|Protocol Violation|2|||
146118559|NCT01129960|526952688|FG002|Overall Study|Protocol Violation|3|||
146118560|NCT01129960|526952689|FG003|Overall Study|Protocol Violation|0|||
146118561|NCT01129960|526952686|FG000|Overall Study|Lost to Follow-up|0|||
146118562|NCT01129960|526952687|FG001|Overall Study|Lost to Follow-up|2|||
146118563|NCT01129960|526952688|FG002|Overall Study|Lost to Follow-up|3|||
146118564|NCT01129960|526952689|FG003|Overall Study|Lost to Follow-up|3|||
146118565|NCT01129960|526952686|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
146118566|NCT01129960|526952687|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
146118567|NCT01129960|526952688|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
146118568|NCT01129960|526952689|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
146118569|NCT01129960|526952686|FG000|Overall Study|Physician Decision|1|||
146118570|NCT01129960|526952687|FG001|Overall Study|Physician Decision|0|||
146118571|NCT01129960|526952688|FG002|Overall Study|Physician Decision|0|||
146118572|NCT01129960|526952689|FG003|Overall Study|Physician Decision|0|||
146118573|NCT01129960|526952686|FG000|Overall Study|Pregnancy|1|||
146118574|NCT01129960|526952687|FG001|Overall Study|Pregnancy|0|||
146118575|NCT01129960|526952688|FG002|Overall Study|Pregnancy|0|||
146118576|NCT01129960|526952689|FG003|Overall Study|Pregnancy|0|||
146118577|NCT03198234|526952690|FG000|Overall Study|Relapse of primary disease|0|||
146118578|NCT03198234|526952691|FG001|Overall Study|Relapse of primary disease|1|||
146118579|NCT03198234|526952692|FG002|Overall Study|Relapse of primary disease|0|||
146118580|NCT03228537|526952693|FG000|Neoadjuvant|Adverse Event|2|||
146118581|NCT03228537|526952693|FG000|Neoadjuvant|Progression/Relapse|4|||
146118582|NCT03228537|526952693|FG000|Neoadjuvant|Death|1|||
146118583|NCT03228537|526952693|FG000|Surgery|Death|1|||
146118584|NCT03228537|526952693|FG000|Surgery|Other - Not Protocol Specified|2|||
146118585|NCT03228537|526952693|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
146118586|NCT03228537|526952693|FG000|Maintenance|Progression/Relapse|10|||
146118587|NCT02622321|526952694|FG000|Overall Study|Withdrawal by Subject|2|||
146118588|NCT02622321|526952695|FG001|Overall Study|Withdrawal by Subject|0|||
146118589|NCT02622321|526952696|FG002|Overall Study|Withdrawal by Subject|0|||
146118590|NCT02622321|526952697|FG003|Overall Study|Withdrawal by Subject|0|||
146118591|NCT02622321|526952694|FG000|Overall Study|Death|0|||
146118592|NCT02622321|526952695|FG001|Overall Study|Death|0|||
146118593|NCT02622321|526952696|FG002|Overall Study|Death|1|||
146118594|NCT02622321|526952697|FG003|Overall Study|Death|0|||
146118595|NCT02622321|526952694|FG000|Overall Study|Physician Decision|1|||
146118596|NCT02622321|526952695|FG001|Overall Study|Physician Decision|0|||
146118597|NCT02622321|526952696|FG002|Overall Study|Physician Decision|0|||
146118598|NCT02622321|526952697|FG003|Overall Study|Physician Decision|0|||
146118599|NCT00965718|526952699|FG000|Overall Study|Withdrawal by Subject|4|||
146118600|NCT03428360|526952700|FG000|Overall Study|Informed consent withdrawn|5|||
146118601|NCT03428360|526952700|FG000|Overall Study|Withdrawal by Subject|4|||
146118602|NCT03428360|526952700|FG000|Overall Study|Lost to Follow-up|5|||
146118603|NCT03428360|526952700|FG000|Overall Study|Physician Decision|2|||
146118604|NCT03428360|526952700|FG000|Overall Study|Informed consent withdrawn|5|||
146118605|NCT03428360|526952700|FG000|Overall Study|Study terminated by sponsor|10|||
146118606|NCT03428360|526952700|FG000|Overall Study|Non-compliant with study|1|||
146118607|NCT03428360|526952700|FG000|Overall Study|Non-compliant with study drug|3|||
146118608|NCT03428360|526952700|FG000|Overall Study|Death|3|||
146118609|NCT03428360|526952700|FG000|Overall Study|Adverse Event|1|||
146118610|NCT03428360|526952700|FG000|Overall Study|Not on antiepileptic drug|1|||
146118611|NCT01414855|526952703|FG000|Overall Study|Death|17|||
146118612|NCT01414855|526952703|FG000|Overall Study|Lost to Follow-up|5|||
146118613|NCT01414855|526952703|FG000|Overall Study|Withdrawal by Subject|7|||
146118614|NCT04851314|526952704|FG000|Overall Study|Unable to complete research set-up procedures|0|||
146118615|NCT04851314|526952705|FG001|Overall Study|Unable to complete research set-up procedures|2|||
146118616|NCT04851314|526952704|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
146118617|NCT04851314|526952705|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
146118618|NCT03266094|526952706|FG000|Overall Study|Lost to Follow-up|1|||
146118619|NCT03266094|526952706|FG000|Overall Study|Withdrawal by Subject|1|||
146118620|NCT00368355|526952709|FG000|Overall Study|Adverse Event|1|||
146118621|NCT00368355|526952710|FG001|Overall Study|Adverse Event|0|||
146118622|NCT00368355|526952709|FG000|Overall Study|Death|2|||
146118623|NCT00368355|526952710|FG001|Overall Study|Death|4|||
146261396|NCT01172639|527472708|FG004|Overall Study|Withdrawal by Subject|0|||
146118624|NCT00368355|526952709|FG000|Overall Study|Relapse|6|||
146118625|NCT00368355|526952710|FG001|Overall Study|Relapse|10|||
146118626|NCT00368355|526952709|FG000|Overall Study|Subsequent transplant|0|||
146118627|NCT00368355|526952710|FG001|Overall Study|Subsequent transplant|3|||
146118628|NCT00368355|526952709|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
146118629|NCT00368355|526952710|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
146118630|NCT04059094|526952717|FG000|Overall Study|Adverse Event|0|||
146118631|NCT04059094|526952718|FG001|Overall Study|Adverse Event|0|||
146118632|NCT04059094|526952719|FG002|Overall Study|Adverse Event|0|||
146118633|NCT04059094|526952720|FG003|Overall Study|Adverse Event|0|||
146118634|NCT04059094|526952721|FG004|Overall Study|Adverse Event|1|||
146118635|NCT04059094|526952717|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146261397|NCT02447432|527472709|FG000|Epoch 001|Adverse Event|1|||
146118636|NCT04059094|526952718|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
146118637|NCT04059094|526952719|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146118638|NCT04059094|526952720|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146118639|NCT04059094|526952721|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
146118640|NCT01339429|526952722|FG000|Overall Study|Withdrawal by Subject|1|||
146118641|NCT01339429|526952722|FG000|Overall Study|Physician Decision|3|||
146118642|NCT01085591|526952729|FG000|Overall Study|Adverse Event|0|||
146118643|NCT01085591|526952730|FG001|Overall Study|Adverse Event|1|||
146118644|NCT01085591|526952731|FG002|Overall Study|Adverse Event|3|||
146118645|NCT01085591|526952729|FG000|Overall Study|Physician Decision|1|||
146118646|NCT01085591|526952730|FG001|Overall Study|Physician Decision|0|||
146118647|NCT01085591|526952731|FG002|Overall Study|Physician Decision|1|||
146118648|NCT01085591|526952729|FG000|Overall Study|Withdrawal by Subject|0|||
146118649|NCT01085591|526952730|FG001|Overall Study|Withdrawal by Subject|2|||
146118650|NCT01085591|526952731|FG002|Overall Study|Withdrawal by Subject|1|||
146118651|NCT01085591|526952729|FG000|Overall Study|Lost to Follow-up|0|||
146118652|NCT01085591|526952730|FG001|Overall Study|Lost to Follow-up|1|||
146118653|NCT01085591|526952731|FG002|Overall Study|Lost to Follow-up|1|||
146118654|NCT01085591|526952729|FG000|Overall Study|Protocol Violation|1|||
146118655|NCT01085591|526952730|FG001|Overall Study|Protocol Violation|1|||
146118656|NCT01085591|526952731|FG002|Overall Study|Protocol Violation|1|||
146118657|NCT01085591|526952729|FG000|Overall Study|Other|0|||
146118658|NCT01085591|526952730|FG001|Overall Study|Other|1|||
146118659|NCT01085591|526952731|FG002|Overall Study|Other|0|||
146118660|NCT01085591|526952729|FG000|Overall Study|Not Properly Consented|1|||
146118661|NCT01085591|526952730|FG001|Overall Study|Not Properly Consented|0|||
146118662|NCT01085591|526952731|FG002|Overall Study|Not Properly Consented|0|||
146118663|NCT00459667|526952734|FG000|Overall Study|Adverse Event|9|||
146118664|NCT00459667|526952735|FG001|Overall Study|Adverse Event|12|||
146118665|NCT00459667|526952736|FG002|Overall Study|Adverse Event|8|||
146118666|NCT00459667|526952734|FG000|Overall Study|Lost to Follow-up|5|||
146118667|NCT00459667|526952735|FG001|Overall Study|Lost to Follow-up|9|||
146118668|NCT00459667|526952736|FG002|Overall Study|Lost to Follow-up|3|||
146118669|NCT00459667|526952734|FG000|Overall Study|Pregnancy|1|||
146118670|NCT00459667|526952735|FG001|Overall Study|Pregnancy|1|||
146118671|NCT00459667|526952736|FG002|Overall Study|Pregnancy|1|||
146118672|NCT00459667|526952734|FG000|Overall Study|Protocol Violation|1|||
146118673|NCT00459667|526952735|FG001|Overall Study|Protocol Violation|0|||
146118674|NCT00459667|526952736|FG002|Overall Study|Protocol Violation|0|||
146118675|NCT00459667|526952734|FG000|Overall Study|Withdrawal by Subject|3|||
146118676|NCT00459667|526952735|FG001|Overall Study|Withdrawal by Subject|5|||
146118677|NCT00459667|526952736|FG002|Overall Study|Withdrawal by Subject|5|||
146118678|NCT00459667|526952734|FG000|Overall Study|Other disease modifying treatment|1|||
146118679|NCT00459667|526952735|FG001|Overall Study|Other disease modifying treatment|2|||
146118680|NCT00459667|526952736|FG002|Overall Study|Other disease modifying treatment|1|||
146118681|NCT00459667|526952734|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
146118682|NCT00459667|526952735|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
146118683|NCT00459667|526952736|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
146118684|NCT00459667|526952734|FG000|Overall Study|No treatment administered|6|||
146118685|NCT00459667|526952735|FG001|Overall Study|No treatment administered|3|||
146118686|NCT00459667|526952736|FG002|Overall Study|No treatment administered|1|||
146118687|NCT00396591|526952737|FG000|Overall Study|Disease Progression|13|||
146118688|NCT00396591|526952737|FG000|Overall Study|Adverse Event|2|||
146118689|NCT00396591|526952737|FG000|Overall Study|Participant request|1|||
146118690|NCT03851302|526952742|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
146118691|NCT03851302|526952743|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
146118692|NCT03851302|526952744|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
146118693|NCT03851302|526952745|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
146118694|NCT03851302|526952746|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
146118695|NCT03851302|526952747|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
146118696|NCT03851302|526952742|FG000|Screening (1 Day)|Screened out|0|||
146118697|NCT03851302|526952743|FG001|Screening (1 Day)|Screened out|0|||
146118698|NCT03851302|526952744|FG002|Screening (1 Day)|Screened out|1|||
146118699|NCT03851302|526952745|FG003|Screening (1 Day)|Screened out|1|||
146118700|NCT03851302|526952746|FG004|Screening (1 Day)|Screened out|0|||
146118701|NCT03851302|526952747|FG005|Screening (1 Day)|Screened out|0|||
146118702|NCT03851302|526952742|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
146261398|NCT02447432|527472710|FG001|Epoch 001|Adverse Event|1|||
146118703|NCT03851302|526952743|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
146118704|NCT03851302|526952744|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
146118705|NCT03851302|526952745|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
146118706|NCT03851302|526952746|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
146118707|NCT03851302|526952747|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
146118708|NCT04434092|526952748|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
146118709|NCT04434092|526952749|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
146302620|NCT00766090|527621708|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302621|NCT00766090|527621709|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302622|NCT00766090|527621710|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302623|NCT00766090|527621711|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302624|NCT00766090|527621712|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302625|NCT00766090|527621713|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302626|NCT00766090|527621714|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
146302627|NCT00766090|527621703|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146118710|NCT04434092|526952750|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
146118711|NCT04434092|526952748|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
146118712|NCT04434092|526952749|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
146118713|NCT04434092|526952750|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
146118714|NCT04434092|526952748|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
146118715|NCT04434092|526952749|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
146118716|NCT04434092|526952750|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
146118717|NCT04434092|526952748|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
146118718|NCT04434092|526952749|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
146118719|NCT04434092|526952750|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
146118720|NCT04434092|526952748|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
146118721|NCT04434092|526952749|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
146118722|NCT04434092|526952750|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
146118723|NCT04434092|526952748|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
146118724|NCT04434092|526952749|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
146118725|NCT04434092|526952750|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
146118726|NCT04434092|526952748|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
146118727|NCT04434092|526952749|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
146118728|NCT04434092|526952750|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
146261399|NCT02447432|527472709|FG000|Epoch 001|Withdrawal by Subject|0|||
146261400|NCT02447432|527472710|FG001|Epoch 001|Withdrawal by Subject|4|||
146261401|NCT02447432|527472709|FG000|Epoch 001|Migrated/moved from study area|3|||
146261402|NCT02447432|527472710|FG001|Epoch 001|Migrated/moved from study area|5|||
146261403|NCT02447432|527472709|FG000|Epoch 001|Lost to Follow-up|1|||
146261404|NCT02447432|527472710|FG001|Epoch 001|Lost to Follow-up|3|||
146261405|NCT01585298|527472711|FG000|Overall Study|Study completion was not documented.|1|||
146261406|NCT01585298|527472711|FG000|Overall Study|Protocol deviation|1|||
146261407|NCT01585298|527472711|FG000|Overall Study|Administrative problems|4|||
146261408|NCT01585298|527472711|FG000|Overall Study|Lost to Follow-up|2|||
146261409|NCT01585298|527472711|FG000|Overall Study|Withdrawal by Subject|4|||
146261410|NCT01585298|527472711|FG000|Overall Study|Abnormal test procedure results|1|||
146261411|NCT01585298|527472711|FG000|Overall Study|Adverse Event|24|||
146261412|NCT00874497|527472721|FG000|Overall Study|Lost to Follow-up|2|||
146261413|NCT00874497|527472722|FG001|Overall Study|Lost to Follow-up|4|||
146261414|NCT00874497|527472721|FG000|Overall Study|Adverse Event|9|||
146261415|NCT00874497|527472722|FG001|Overall Study|Adverse Event|4|||
146261416|NCT00874497|527472721|FG000|Overall Study|Sponsor Discontinued Trial|7|||
146261417|NCT00874497|527472722|FG001|Overall Study|Sponsor Discontinued Trial|3|||
146261418|NCT00874497|527472721|FG000|Overall Study|Met Withdrawal Criteria|4|||
146261419|NCT00874497|527472722|FG001|Overall Study|Met Withdrawal Criteria|2|||
146261420|NCT00874497|527472721|FG000|Overall Study|Physician Decision|1|||
146261421|NCT00874497|527472722|FG001|Overall Study|Physician Decision|1|||
146261422|NCT00874497|527472721|FG000|Overall Study|Withdrawal by Subject|5|||
146261423|NCT00874497|527472722|FG001|Overall Study|Withdrawal by Subject|4|||
146261424|NCT00644878|527472723|FG000|Overall Study|Adverse Event|2|||
146261425|NCT00644878|527472723|FG000|Overall Study|Abnormal laboratory value|3|||
146261426|NCT00644878|527472723|FG000|Overall Study|Protocol deviation|2|||
146261427|NCT00644878|527472723|FG000|Overall Study|Treatment duration completed as per protocol|11|||
146261428|NCT00770588|527472726|FG000|Overall Study|Adverse Event|9|||
146261429|NCT00770588|527472727|FG001|Overall Study|Adverse Event|2|||
146261430|NCT00770588|527472726|FG000|Overall Study|Death caused by progression of disease|70|||
146261431|NCT00770588|527472727|FG001|Overall Study|Death caused by progression of disease|91|||
146261432|NCT00770588|527472726|FG000|Overall Study|Lost to Follow-up|1|||
146261433|NCT00770588|527472727|FG001|Overall Study|Lost to Follow-up|1|||
146261434|NCT00770588|527472726|FG000|Overall Study|Withdrawal by Subject|1|||
146261435|NCT00770588|527472727|FG001|Overall Study|Withdrawal by Subject|1|||
146261436|NCT00665223|527472728|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
146261437|NCT00665223|527472729|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
146261438|NCT00665223|527472730|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
146261439|NCT00665223|527472728|FG000|Randomized Phase (26 Weeks)|Death|0|||
146261440|NCT00665223|527472729|FG001|Randomized Phase (26 Weeks)|Death|0|||
146261441|NCT00665223|527472730|FG002|Randomized Phase (26 Weeks)|Death|1|||
146261442|NCT00665223|527472728|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
146118729|NCT00157950|526954450|FG000|Overall Study|Death|1|||
146118730|NCT00157950|526954451|FG001|Overall Study|Death|0|||
146118731|NCT01287897|526954455|FG000|Overall Study|Adverse Event|5|||
146118732|NCT01287897|526954456|FG001|Overall Study|Adverse Event|3|||
146118733|NCT01287897|526954457|FG002|Overall Study|Adverse Event|6|||
146118734|NCT01287897|526954458|FG003|Overall Study|Adverse Event|4|||
146118735|NCT01287897|526954455|FG000|Overall Study|Lack of Efficacy|2|||
146118736|NCT01287897|526954456|FG001|Overall Study|Lack of Efficacy|0|||
146118737|NCT01287897|526954457|FG002|Overall Study|Lack of Efficacy|0|||
146118738|NCT01287897|526954458|FG003|Overall Study|Lack of Efficacy|0|||
146118739|NCT01287897|526954455|FG000|Overall Study|Protocol Violation|1|||
146118740|NCT01287897|526954456|FG001|Overall Study|Protocol Violation|1|||
146118741|NCT01287897|526954457|FG002|Overall Study|Protocol Violation|0|||
146118742|NCT01287897|526954458|FG003|Overall Study|Protocol Violation|1|||
146118743|NCT01287897|526954455|FG000|Overall Study|Lost to Follow-up|0|||
146118744|NCT01287897|526954456|FG001|Overall Study|Lost to Follow-up|0|||
146118745|NCT01287897|526954457|FG002|Overall Study|Lost to Follow-up|2|||
146118746|NCT01287897|526954458|FG003|Overall Study|Lost to Follow-up|0|||
146118747|NCT01287897|526954455|FG000|Overall Study|Withdrawal by Subject|1|||
146118748|NCT01287897|526954456|FG001|Overall Study|Withdrawal by Subject|5|||
146118749|NCT01287897|526954457|FG002|Overall Study|Withdrawal by Subject|3|||
146118750|NCT01287897|526954458|FG003|Overall Study|Withdrawal by Subject|2|||
146118751|NCT01287897|526954455|FG000|Overall Study|Not consented properly|0|||
146118752|NCT01287897|526954456|FG001|Overall Study|Not consented properly|1|||
146118753|NCT01287897|526954457|FG002|Overall Study|Not consented properly|0|||
146118754|NCT01287897|526954458|FG003|Overall Study|Not consented properly|0|||
146118755|NCT01287897|526954455|FG000|Overall Study|Not meeting entrance criteria|1|||
146118756|NCT01287897|526954456|FG001|Overall Study|Not meeting entrance criteria|1|||
146118757|NCT01287897|526954457|FG002|Overall Study|Not meeting entrance criteria|0|||
146118758|NCT01287897|526954458|FG003|Overall Study|Not meeting entrance criteria|0|||
146118759|NCT01287897|526954455|FG000|Overall Study|Other|1|||
146118760|NCT01287897|526954456|FG001|Overall Study|Other|0|||
146118761|NCT01287897|526954457|FG002|Overall Study|Other|1|||
146118762|NCT01287897|526954458|FG003|Overall Study|Other|0|||
146118763|NCT02902965|526954463|FG000|Overall Study|Withdrawal by Subject|10|||
146118764|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
146118765|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
146118766|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
146118767|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146118768|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
146118769|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
146118770|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146118771|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146118772|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
146118773|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146118774|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
146118775|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146118776|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
146118777|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
146118778|NCT00293254|526954464|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
146118779|NCT00293254|526954465|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
146118780|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
146118781|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
146118782|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Death|4|||
146118783|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Death|1|||
146118784|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
146118785|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
146118786|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
146118787|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
146261443|NCT00665223|527472729|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
146261444|NCT00665223|527472730|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
146261445|NCT00665223|527472728|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
146261446|NCT00665223|527472729|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
146118788|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
146261447|NCT00665223|527472730|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
146261448|NCT00665223|527472728|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
146118789|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
146118790|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
146118791|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
146118792|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
146118793|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
146261449|NCT00665223|527472729|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
146302628|NCT00766090|527621704|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302629|NCT00766090|527621705|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
146302630|NCT00766090|527621706|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146118794|NCT00293254|526954464|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
146118795|NCT00293254|526954465|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
146118796|NCT00293254|526954464|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
146118797|NCT00293254|526954465|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
146118798|NCT00293254|526954464|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
146118799|NCT00293254|526954465|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
146118800|NCT00293254|526954464|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
146118801|NCT00293254|526954465|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
146118802|NCT00293254|526954464|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
146302631|NCT00766090|527621707|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302632|NCT00766090|527621708|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302633|NCT00766090|527621709|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146118803|NCT00293254|526954465|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
146118804|NCT00293254|526954464|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
146118805|NCT00293254|526954465|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
146118806|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
146118807|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
146118808|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
146118809|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
146118810|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
146118811|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
146118812|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
146302634|NCT00766090|527621710|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302635|NCT00766090|527621711|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302636|NCT00766090|527621712|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302637|NCT00766090|527621713|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302638|NCT00766090|527621714|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
146302639|NCT00766090|527621703|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
146302640|NCT00766090|527621704|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
146302641|NCT00766090|527621705|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
146302642|NCT00766090|527621706|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
146302643|NCT00766090|527621707|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
146302644|NCT00766090|527621708|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
146302645|NCT00766090|527621709|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
146302646|NCT00766090|527621710|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
146302647|NCT00766090|527621711|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
146302648|NCT00766090|527621712|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
146302649|NCT00766090|527621713|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
146302650|NCT00766090|527621714|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
146302651|NCT00766090|527621703|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302652|NCT00766090|527621704|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302653|NCT00766090|527621705|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302654|NCT00766090|527621706|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302655|NCT00766090|527621707|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302656|NCT00766090|527621708|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
146302657|NCT00766090|527621709|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302658|NCT00766090|527621710|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302659|NCT00766090|527621711|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302660|NCT00766090|527621712|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302661|NCT00766090|527621713|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302662|NCT00766090|527621714|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
146302663|NCT00766090|527621703|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302664|NCT00766090|527621704|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146118813|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
146118814|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
146118815|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
146118816|NCT00293254|526954464|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
146118817|NCT00293254|526954465|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
146118818|NCT02259582|526954466|FG000|Overall Study|Physician Decision|0|||
146118819|NCT02259582|526954467|FG001|Overall Study|Physician Decision|1|||
146118820|NCT02259582|526954468|FG002|Overall Study|Physician Decision|0|||
146118821|NCT02259582|526954466|FG000|Overall Study|Death|0|||
146302665|NCT00766090|527621705|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302666|NCT00766090|527621706|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146302667|NCT00766090|527621707|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302668|NCT00766090|527621708|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146118822|NCT02259582|526954467|FG001|Overall Study|Death|0|||
146118823|NCT02259582|526954468|FG002|Overall Study|Death|1|||
146118824|NCT02259582|526954466|FG000|Overall Study|Adverse Event|1|||
146118825|NCT02259582|526954467|FG001|Overall Study|Adverse Event|0|||
146118826|NCT02259582|526954468|FG002|Overall Study|Adverse Event|1|||
146118827|NCT02259582|526954466|FG000|Overall Study|Withdrawal by Subject|0|||
146118828|NCT02259582|526954467|FG001|Overall Study|Withdrawal by Subject|0|||
146118829|NCT02259582|526954468|FG002|Overall Study|Withdrawal by Subject|1|||
146118830|NCT02259582|526954466|FG000|Overall Study|Disease progression|14|||
146118831|NCT02259582|526954467|FG001|Overall Study|Disease progression|15|||
146118832|NCT02259582|526954468|FG002|Overall Study|Disease progression|17|||
146118833|NCT02259582|526954466|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
146118834|NCT02259582|526954467|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
146118835|NCT02259582|526954468|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
146118836|NCT02335489|526954469|FG000|Overall Study|Sponsor terminated study|4|||
146118837|NCT02335489|526954469|FG000|Overall Study|Lost to Follow-up|1|||
146118838|NCT02335489|526954469|FG000|Overall Study|Withdrawal by Subject|2|||
146118839|NCT02335489|526954469|FG000|Overall Study|Physician Decision|2|||
146118840|NCT02335489|526954469|FG000|Overall Study|Lack of Efficacy|1|||
146118841|NCT00531050|526954475|FG000|Part 1: Period 1|Adverse Event|0|||
146118842|NCT00531050|526954476|FG001|Part 1: Period 1|Adverse Event|1|||
146118843|NCT00531050|526954477|FG002|Part 1: Period 1|Adverse Event|0|||
146118844|NCT00531050|526954478|FG003|Part 1: Period 1|Adverse Event|0|||
146118845|NCT00531050|526954479|FG004|Part 1: Period 1|Adverse Event|0|||
146118846|NCT00531050|526954480|FG005|Part 1: Period 1|Adverse Event|0|||
146118847|NCT00531050|526954475|FG000|Part 1: Period 1|Protocol Deviation|0|||
146118848|NCT00531050|526954476|FG001|Part 1: Period 1|Protocol Deviation|0|||
146118849|NCT00531050|526954477|FG002|Part 1: Period 1|Protocol Deviation|0|||
146118850|NCT00531050|526954478|FG003|Part 1: Period 1|Protocol Deviation|1|||
146118851|NCT00531050|526954479|FG004|Part 1: Period 1|Protocol Deviation|0|||
146118852|NCT00531050|526954480|FG005|Part 1: Period 1|Protocol Deviation|0|||
146118853|NCT00531050|526954475|FG000|Part 1: Period 3|Adverse Event|1|||
146118854|NCT00531050|526954476|FG001|Part 1: Period 3|Adverse Event|0|||
146118855|NCT00531050|526954477|FG002|Part 1: Period 3|Adverse Event|0|||
146118856|NCT00531050|526954478|FG003|Part 1: Period 3|Adverse Event|0|||
146118857|NCT00531050|526954479|FG004|Part 1: Period 3|Adverse Event|0|||
146118858|NCT00531050|526954480|FG005|Part 1: Period 3|Adverse Event|0|||
146118859|NCT00531050|526954475|FG000|Part 2: Period 1|Adverse Event|0|||
146118860|NCT00531050|526954476|FG001|Part 2: Period 1|Adverse Event|0|||
146118861|NCT00531050|526954477|FG002|Part 2: Period 1|Adverse Event|0|||
146118862|NCT00531050|526954478|FG003|Part 2: Period 1|Adverse Event|0|||
146118863|NCT00531050|526954479|FG004|Part 2: Period 1|Adverse Event|0|||
146118864|NCT00531050|526954480|FG005|Part 2: Period 1|Adverse Event|1|||
146118865|NCT00531050|526954475|FG000|Part 2: Period 3|Abnormal test procedure|1|||
146118866|NCT00531050|526954476|FG001|Part 2: Period 3|Abnormal test procedure|0|||
146118867|NCT00531050|526954477|FG002|Part 2: Period 3|Abnormal test procedure|0|||
146118868|NCT00531050|526954478|FG003|Part 2: Period 3|Abnormal test procedure|0|||
146118869|NCT00531050|526954479|FG004|Part 2: Period 3|Abnormal test procedure|0|||
146118870|NCT00531050|526954480|FG005|Part 2: Period 3|Abnormal test procedure|1|||
146118871|NCT02233309|526954481|FG000|Overall Study|Physician Decision|5|||
146118872|NCT04481750|526954483|FG000|Period 1 (Fasted)|Adverse Event|0|||
146118873|NCT04481750|526954484|FG001|Period 1 (Fasted)|Adverse Event|0|||
146118874|NCT04481750|526954485|FG002|Period 1 (Fasted)|Adverse Event|1|||
146118875|NCT04481750|526954486|FG003|Period 1 (Fasted)|Adverse Event|0|||
146261450|NCT00665223|527472730|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
146261451|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
146261452|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
146261453|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
146261454|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Death|0|||
146118876|NCT04481750|526954487|FG004|Period 1 (Fasted)|Adverse Event|0|||
146118877|NCT04481750|526954488|FG005|Period 1 (Fasted)|Adverse Event|0|||
146118878|NCT04481750|526954489|FG006|Period 1 (Fasted)|Adverse Event|0|||
146118879|NCT04481750|526954490|FG007|Period 1 (Fasted)|Adverse Event|0|||
146118880|NCT04481750|526954491|FG008|Period 1 (Fasted)|Adverse Event|0|||
146118881|NCT04481750|526954492|FG009|Period 1 (Fasted)|Adverse Event|0|||
146118882|NCT04481750|526954493|FG010|Period 1 (Fasted)|Adverse Event|0|||
146118883|NCT02436889|526954494|FG000|Overall Study|No improvement in symptoms|1|||
146118884|NCT02436889|526954495|FG001|Overall Study|No improvement in symptoms|0|||
146118885|NCT02436889|526954494|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
146118886|NCT02436889|526954495|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
146118887|NCT00227903|526954496|FG000|Overall Study|Withdrawal by Subject|2|||
146118888|NCT00227903|526954497|FG001|Overall Study|Withdrawal by Subject|5|||
146118889|NCT00227903|526954496|FG000|Overall Study|Subject moved out of area|1|||
146261455|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Death|1|||
146261456|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Death|0|||
146118890|NCT00227903|526954497|FG001|Overall Study|Subject moved out of area|2|||
146118891|NCT00227903|526954496|FG000|Overall Study|Lost to Follow-up|1|||
146261457|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
146261458|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
146261459|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
146261460|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
146261461|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
146261462|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
146261463|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
146261464|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
146261465|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
146261466|NCT00665223|527472728|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
146261467|NCT00665223|527472729|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
146261468|NCT00665223|527472730|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
146261469|NCT00591591|527472731|FG000|Overall Study|Withdrawal by Subject|1|||
146261470|NCT00591591|527472732|FG001|Overall Study|Withdrawal by Subject|37|||
146261471|NCT00591591|527472731|FG000|Overall Study|Lack of Efficacy|10|||
146261472|NCT00591591|527472732|FG001|Overall Study|Lack of Efficacy|2|||
146261473|NCT00002597|527472733|FG000|Overall Study|Protocol Violation|19|||
146261474|NCT00002597|527472734|FG001|Overall Study|Protocol Violation|17|||
146261475|NCT00002597|527472733|FG000|Overall Study|Withdrawal by Subject|7|||
146261476|NCT00002597|527472734|FG001|Overall Study|Withdrawal by Subject|6|||
146261477|NCT01426113|527472737|FG000|Overall Study|Study Discontinued|1|||
146261478|NCT01426113|527472738|FG001|Overall Study|Study Discontinued|1|||
146261479|NCT01426113|527472737|FG000|Overall Study|Adverse Event|0|||
146261480|NCT01426113|527472738|FG001|Overall Study|Adverse Event|1|||
146261481|NCT00468130|527472741|FG000|Overall Study|Adverse Event|2|||
146261482|NCT00468130|527472742|FG001|Overall Study|Adverse Event|1|||
146261483|NCT00468130|527472741|FG000|Overall Study|Withdrawal by Subject|0|||
146261484|NCT00468130|527472742|FG001|Overall Study|Withdrawal by Subject|1|||
146261485|NCT00436956|527472743|FG000|Overall Study|Not evaluable|1|||
146261486|NCT00436956|527472744|FG001|Overall Study|Not evaluable|0|||
146261487|NCT02485899|527472745|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
146261488|NCT02485899|527472746|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146261489|NCT02485899|527472745|FG000|Overall Study|Withdrawal by Subject|1|||
146261490|NCT02485899|527472746|FG001|Overall Study|Withdrawal by Subject|0|||
146261491|NCT02485899|527472745|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
146261492|NCT02485899|527472746|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
146261493|NCT03517111|527472749|FG000|Enrolled|Withdrawal by Subject|0|||
146261494|NCT03517111|527472750|FG001|Enrolled|Withdrawal by Subject|1|||
146261495|NCT03517111|527472751|FG002|Enrolled|Withdrawal by Subject|0|||
146261496|NCT03517111|527472749|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
146261497|NCT03517111|527472750|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
146261498|NCT03517111|527472751|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
146261499|NCT03517111|527472749|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
146261500|NCT03517111|527472750|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
146261501|NCT03517111|527472751|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
146261502|NCT03517111|527472749|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
146261503|NCT03517111|527472750|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
146261504|NCT03517111|527472751|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
146261505|NCT03517111|527472749|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
146261506|NCT03517111|527472750|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
146261507|NCT03517111|527472751|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
146261508|NCT00912223|527472752|FG000|Overall Study|Withdrawal by Subject|1|||
146261509|NCT00912223|527472752|FG000|Overall Study|Not transplanted|1|||
146261510|NCT00912223|527472752|FG000|Overall Study|Transformed disease|1|||
146261511|NCT02062645|527472755|FG000|Overall Study|Adverse Event|2|||
146261512|NCT02062645|527472755|FG000|Overall Study|Protocol Violation|8|||
146261513|NCT02062645|527472755|FG000|Overall Study|Lost to Follow-up|5|||
146261514|NCT02604342|527472756|FG000|Overall Study|Death|32|||
146261515|NCT02604342|527472757|FG001|Overall Study|Death|16|||
146261516|NCT02604342|527472756|FG000|Overall Study|Progression of disease|1|||
146261517|NCT02604342|527472757|FG001|Overall Study|Progression of disease|0|||
146261518|NCT02604342|527472756|FG000|Overall Study|Withdrawal by Subject|5|||
146118892|NCT00227903|526954497|FG001|Overall Study|Lost to Follow-up|3|||
146261519|NCT02604342|527472757|FG001|Overall Study|Withdrawal by Subject|6|||
146118893|NCT00227903|526954496|FG000|Overall Study|Miscarriage|1|||
146118894|NCT00227903|526954497|FG001|Overall Study|Miscarriage|0|||
146261520|NCT02604342|527472756|FG000|Overall Study|Other|1|||
146261521|NCT02604342|527472757|FG001|Overall Study|Other|0|||
146261522|NCT02604342|527472756|FG000|Overall Study|Study Termination by Sponsor|1|||
146261523|NCT02604342|527472757|FG001|Overall Study|Study Termination by Sponsor|0|||
146261524|NCT02604342|527472756|FG000|Overall Study|Lost to Follow-up|1|||
146261525|NCT02604342|527472757|FG001|Overall Study|Lost to Follow-up|1|||
146261526|NCT02604342|527472756|FG000|Overall Study|Physician Decision|2|||
146118895|NCT04273217|526954498|FG000|Overall Study|Lost to Follow-up|0|||
146261527|NCT02604342|527472757|FG001|Overall Study|Physician Decision|0|||
146261528|NCT02024750|527472758|FG000|Overall Study|Withdrawal by Subject|2|||
146261529|NCT02024750|527472759|FG001|Overall Study|Withdrawal by Subject|1|||
146261530|NCT02261285|527472760|FG000|Overall Study|Disease progression|0|||
146261531|NCT02261285|527472761|FG001|Overall Study|Disease progression|0|||
146261532|NCT02261285|527472762|FG002|Overall Study|Disease progression|1|||
146261533|NCT01702519|527472763|FG000|Washout Period|Lost to Follow-up|1|||
146261534|NCT01702519|527472764|FG001|Washout Period|Lost to Follow-up|0|||
146261535|NCT01702519|527472763|FG000|Washout Period|Withdrawal by Subject|0|||
146261536|NCT01702519|527472764|FG001|Washout Period|Withdrawal by Subject|2|||
146261537|NCT01891890|527472765|FG000|Overall Study|Lost to Follow-up|0|||
146261538|NCT01891890|527472766|FG001|Overall Study|Lost to Follow-up|0|||
146261539|NCT01891890|527472767|FG002|Overall Study|Lost to Follow-up|1|||
146261540|NCT01891890|527472765|FG000|Overall Study|Study ended before endpoint reached|7|||
146261541|NCT01891890|527472766|FG001|Overall Study|Study ended before endpoint reached|3|||
146261542|NCT01891890|527472767|FG002|Overall Study|Study ended before endpoint reached|6|||
146261543|NCT01161628|527472768|FG000|Overall Study|Death|6|||
146261544|NCT01161628|527472768|FG000|Overall Study|Lack of Efficacy|2|||
146261545|NCT00746356|527472775|FG000|Overall Study|Withdrawal by Subject|2|||
146261546|NCT00746356|527472776|FG001|Overall Study|Withdrawal by Subject|3|||
146261547|NCT00746356|527472775|FG000|Overall Study|Death|7|||
146261548|NCT00746356|527472776|FG001|Overall Study|Death|3|||
146261549|NCT00746356|527472775|FG000|Overall Study|Lost to Follow-up|1|||
146261550|NCT00746356|527472776|FG001|Overall Study|Lost to Follow-up|0|||
146261551|NCT00746356|527472775|FG000|Overall Study|Removal of Device|0|||
146261552|NCT00746356|527472776|FG001|Overall Study|Removal of Device|1|||
146261553|NCT00746356|527472775|FG000|Overall Study|Patient relocated|1|||
146261554|NCT00746356|527472776|FG001|Overall Study|Patient relocated|0|||
146261555|NCT01263925|527472777|FG000|Overall Study|Protocol Violation|1|||
146261556|NCT01263925|527472778|FG001|Overall Study|Protocol Violation|0|||
146261557|NCT01263925|527472777|FG000|Overall Study|Lack of Efficacy|0|||
146261558|NCT01263925|527472778|FG001|Overall Study|Lack of Efficacy|1|||
146261559|NCT01263925|527472777|FG000|Overall Study|Adverse Event|23|||
146261560|NCT01263925|527472778|FG001|Overall Study|Adverse Event|22|||
146261561|NCT01263925|527472777|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
146261562|NCT01263925|527472778|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
146261563|NCT01263925|527472777|FG000|Overall Study|Withdrawal by Subject|6|||
146261564|NCT01263925|527472778|FG001|Overall Study|Withdrawal by Subject|8|||
146261565|NCT01263925|527472777|FG000|Overall Study|Other|4|||
146261566|NCT01263925|527472778|FG001|Overall Study|Other|4|||
146261567|NCT01263925|527472777|FG000|Overall Study|Lost to Follow-up|3|||
146261568|NCT01263925|527472778|FG001|Overall Study|Lost to Follow-up|1|||
146261569|NCT01263925|527472777|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
146261570|NCT01263925|527472778|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
146261571|NCT01263925|527472777|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
146261572|NCT01263925|527472778|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
146261573|NCT01263925|527472777|FG000|Overall Study|AE/ Withdrawal|1|||
146261574|NCT01263925|527472778|FG001|Overall Study|AE/ Withdrawal|4|||
146261575|NCT01263925|527472777|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
146261576|NCT01263925|527472778|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
146261577|NCT01263925|527472777|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
146261578|NCT01263925|527472778|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
146261579|NCT01263925|527472777|FG000|Overall Study|Withdrawal/ Not specified|0|||
146261580|NCT01263925|527472778|FG001|Overall Study|Withdrawal/ Not specified|1|||
146261581|NCT03605368|527472784|FG000|Overall Study|Lost to Follow-up|2|||
146261582|NCT03605368|527472785|FG001|Overall Study|Lost to Follow-up|1|||
146261583|NCT03605368|527472786|FG002|Overall Study|Lost to Follow-up|3|||
146261584|NCT03605368|527472787|FG003|Overall Study|Lost to Follow-up|2|||
146261585|NCT03605368|527472784|FG000|Overall Study|Withdrawal by Subject|0|||
146261586|NCT03605368|527472785|FG001|Overall Study|Withdrawal by Subject|0|||
146261587|NCT03605368|527472786|FG002|Overall Study|Withdrawal by Subject|4|||
146261588|NCT03605368|527472787|FG003|Overall Study|Withdrawal by Subject|3|||
146261589|NCT01726517|527472788|FG000|Overall Study|Withdrawal by Subject|0|||
146261590|NCT01726517|527472789|FG001|Overall Study|Withdrawal by Subject|0|||
146261591|NCT01726517|527472790|FG002|Overall Study|Withdrawal by Subject|1|||
146261592|NCT01726517|527472791|FG003|Overall Study|Withdrawal by Subject|0|||
146261593|NCT01726517|527472792|FG004|Overall Study|Withdrawal by Subject|0|||
146261594|NCT02484547|527472793|FG000|Placebo-Controlled Period|Adverse Event|10|||
146261595|NCT02484547|527472794|FG001|Placebo-Controlled Period|Adverse Event|13|||
146261596|NCT02484547|527472795|FG002|Placebo-Controlled Period|Adverse Event|20|||
146261597|NCT02484547|527472796|FG003|Placebo-Controlled Period|Adverse Event|0|||
146261598|NCT02484547|527472797|FG004|Placebo-Controlled Period|Adverse Event|0|||
146261599|NCT02484547|527472798|FG005|Placebo-Controlled Period|Adverse Event|0|||
146261600|NCT02484547|527472799|FG006|Placebo-Controlled Period|Adverse Event|0|||
146261601|NCT02484547|527472793|FG000|Placebo-Controlled Period|Change of Treatment|0|||
146261602|NCT02484547|527472794|FG001|Placebo-Controlled Period|Change of Treatment|0|||
146302669|NCT00766090|527621709|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302670|NCT00766090|527621710|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302671|NCT00766090|527621711|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302672|NCT00766090|527621712|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146302673|NCT00766090|527621713|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
146118896|NCT04273217|526954499|FG001|Overall Study|Lost to Follow-up|0|||
146118897|NCT04273217|526954500|FG002|Overall Study|Lost to Follow-up|0|||
146118898|NCT04273217|526954501|FG003|Overall Study|Lost to Follow-up|0|||
146118899|NCT04273217|526954502|FG004|Overall Study|Lost to Follow-up|0|||
146118900|NCT04273217|526954503|FG005|Overall Study|Lost to Follow-up|1|||
146118901|NCT04273217|526954498|FG000|Overall Study|Participant non-compliance|0|||
146118902|NCT04273217|526954499|FG001|Overall Study|Participant non-compliance|0|||
146118903|NCT04273217|526954500|FG002|Overall Study|Participant non-compliance|0|||
146118904|NCT04273217|526954501|FG003|Overall Study|Participant non-compliance|0|||
146118905|NCT04273217|526954502|FG004|Overall Study|Participant non-compliance|1|||
146118906|NCT04273217|526954503|FG005|Overall Study|Participant non-compliance|0|||
146118907|NCT04273217|526954498|FG000|Overall Study|Positive urine drug screen|1|||
146118908|NCT04273217|526954499|FG001|Overall Study|Positive urine drug screen|0|||
146118909|NCT04273217|526954500|FG002|Overall Study|Positive urine drug screen|1|||
146118910|NCT04273217|526954501|FG003|Overall Study|Positive urine drug screen|0|||
146118911|NCT04273217|526954502|FG004|Overall Study|Positive urine drug screen|0|||
146118912|NCT04273217|526954503|FG005|Overall Study|Positive urine drug screen|1|||
146118913|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
146118914|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
146118915|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
146118916|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
146118917|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
146118918|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
146118919|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146118920|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146118921|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146118922|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
146118923|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
146118924|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
146118925|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
146118926|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
146118927|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
146118928|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
146118929|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
146118930|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
146118931|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146118932|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146118933|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146118934|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
146118935|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
146118936|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
146118937|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146118938|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
146118939|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
146118940|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146118941|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
146302674|NCT00766090|527621714|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
146302675|NCT00766090|527621703|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302676|NCT00766090|527621704|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302677|NCT00766090|527621705|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302678|NCT00766090|527621706|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146118942|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
146118943|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
146118944|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
146118945|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
146118946|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
146118947|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
146118948|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
146302679|NCT00766090|527621707|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
146302680|NCT00766090|527621708|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302681|NCT00766090|527621709|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302682|NCT00766090|527621710|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302683|NCT00766090|527621711|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302684|NCT00766090|527621712|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146118949|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146118950|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146118951|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146118952|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
146118953|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
146118954|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
146118955|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
146118956|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
146118957|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
146118958|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
146118959|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
146118960|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
146118961|NCT03720470|526954506|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146118962|NCT03720470|526954507|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146118963|NCT03720470|526954508|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146118964|NCT03720470|526954509|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146118965|NCT03720470|526954510|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
146118966|NCT03720470|526954511|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
146118967|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146118968|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146118969|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
146118970|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
146118971|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
146118972|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
146118973|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146118974|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146118975|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
146118976|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146118977|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146118978|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
146118979|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146118980|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146118981|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146118982|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
146118983|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
146118984|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
146118985|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146118986|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146118987|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146118988|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146118989|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
146118990|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
146118991|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146118992|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146118993|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
146118994|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146118995|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146118996|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
146118997|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
146118998|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
146118999|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
146119000|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146119001|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146119002|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
146119003|NCT03720470|526954506|FG000|Treatment Period: Final 4 Weeks|Other|0|||
146119004|NCT03720470|526954507|FG001|Treatment Period: Final 4 Weeks|Other|1|||
146119005|NCT03720470|526954508|FG002|Treatment Period: Final 4 Weeks|Other|0|||
146119006|NCT03720470|526954509|FG003|Treatment Period: Final 4 Weeks|Other|2|||
146119007|NCT03720470|526954510|FG004|Treatment Period: Final 4 Weeks|Other|1|||
146119008|NCT03720470|526954511|FG005|Treatment Period: Final 4 Weeks|Other|0|||
146119009|NCT00498602|526954516|FG000|Overall Study|Death|0|||
146119010|NCT00498602|526954517|FG001|Overall Study|Death|0|||
146119011|NCT00498602|526954518|FG002|Overall Study|Death|0|||
146119012|NCT00498602|526954519|FG003|Overall Study|Death|0|||
146119013|NCT00498602|526954520|FG004|Overall Study|Death|0|||
146119014|NCT00498602|526954521|FG005|Overall Study|Death|1|||
146119015|NCT00498602|526954522|FG006|Overall Study|Death|0|||
146119016|NCT00498602|526954516|FG000|Overall Study|Lack of Efficacy|1|||
146119017|NCT00498602|526954517|FG001|Overall Study|Lack of Efficacy|0|||
146119018|NCT00498602|526954518|FG002|Overall Study|Lack of Efficacy|0|||
146119019|NCT00498602|526954519|FG003|Overall Study|Lack of Efficacy|0|||
146119020|NCT00498602|526954520|FG004|Overall Study|Lack of Efficacy|0|||
146119021|NCT00498602|526954521|FG005|Overall Study|Lack of Efficacy|0|||
146119022|NCT00498602|526954522|FG006|Overall Study|Lack of Efficacy|0|||
146119023|NCT00498602|526954516|FG000|Overall Study|Lost to Follow-up|0|||
146119024|NCT00498602|526954517|FG001|Overall Study|Lost to Follow-up|2|||
146119025|NCT00498602|526954518|FG002|Overall Study|Lost to Follow-up|0|||
146119026|NCT00498602|526954519|FG003|Overall Study|Lost to Follow-up|2|||
146119027|NCT00498602|526954520|FG004|Overall Study|Lost to Follow-up|0|||
146119028|NCT00498602|526954521|FG005|Overall Study|Lost to Follow-up|0|||
146119029|NCT00498602|526954522|FG006|Overall Study|Lost to Follow-up|0|||
146119030|NCT00498602|526954516|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146119031|NCT00498602|526954517|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146119032|NCT00498602|526954518|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
146119033|NCT00498602|526954519|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
146119034|NCT00498602|526954520|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146119035|NCT00498602|526954521|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146119036|NCT00498602|526954522|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146119037|NCT00498602|526954516|FG000|Overall Study|AE not related to Study Drug|1|||
146119038|NCT00498602|526954517|FG001|Overall Study|AE not related to Study Drug|3|||
146119039|NCT00498602|526954518|FG002|Overall Study|AE not related to Study Drug|0|||
146119040|NCT00498602|526954519|FG003|Overall Study|AE not related to Study Drug|0|||
146119041|NCT00498602|526954520|FG004|Overall Study|AE not related to Study Drug|2|||
146119042|NCT00498602|526954521|FG005|Overall Study|AE not related to Study Drug|2|||
146119043|NCT00498602|526954522|FG006|Overall Study|AE not related to Study Drug|1|||
146119044|NCT00498602|526954516|FG000|Overall Study|Caregiver Request|2|||
146119045|NCT00498602|526954517|FG001|Overall Study|Caregiver Request|2|||
146119046|NCT00498602|526954518|FG002|Overall Study|Caregiver Request|2|||
146119047|NCT00498602|526954519|FG003|Overall Study|Caregiver Request|0|||
146119048|NCT00498602|526954520|FG004|Overall Study|Caregiver Request|1|||
146119049|NCT00498602|526954521|FG005|Overall Study|Caregiver Request|2|||
146119050|NCT00498602|526954522|FG006|Overall Study|Caregiver Request|0|||
146119051|NCT00498602|526954516|FG000|Overall Study|Investigator Request|0|||
146119052|NCT00498602|526954517|FG001|Overall Study|Investigator Request|0|||
146119053|NCT00498602|526954518|FG002|Overall Study|Investigator Request|1|||
146119054|NCT00498602|526954519|FG003|Overall Study|Investigator Request|0|||
146119055|NCT00498602|526954520|FG004|Overall Study|Investigator Request|0|||
146119056|NCT00498602|526954521|FG005|Overall Study|Investigator Request|0|||
146119057|NCT00498602|526954522|FG006|Overall Study|Investigator Request|0|||
146119058|NCT00498602|526954516|FG000|Overall Study|Subject Request|3|||
146119059|NCT00498602|526954517|FG001|Overall Study|Subject Request|0|||
146119060|NCT00498602|526954518|FG002|Overall Study|Subject Request|1|||
146119061|NCT00498602|526954519|FG003|Overall Study|Subject Request|1|||
146119062|NCT00498602|526954520|FG004|Overall Study|Subject Request|1|||
146119063|NCT00498602|526954521|FG005|Overall Study|Subject Request|4|||
146119064|NCT00498602|526954522|FG006|Overall Study|Subject Request|1|||
146119065|NCT00498602|526954516|FG000|Overall Study|Other|2|||
146119066|NCT00498602|526954517|FG001|Overall Study|Other|3|||
146119067|NCT00498602|526954518|FG002|Overall Study|Other|1|||
146119068|NCT00498602|526954519|FG003|Overall Study|Other|0|||
146119069|NCT00498602|526954520|FG004|Overall Study|Other|0|||
146119070|NCT00498602|526954521|FG005|Overall Study|Other|3|||
146119071|NCT00498602|526954522|FG006|Overall Study|Other|0|||
146119072|NCT01113801|526954526|FG000|Overall Study|Adverse Event|4|||
146119073|NCT01113801|526954527|FG001|Overall Study|Adverse Event|0|||
146119074|NCT01113801|526954528|FG002|Overall Study|Adverse Event|2|||
146119075|NCT01113801|526954529|FG003|Overall Study|Adverse Event|6|||
146119076|NCT01113801|526954526|FG000|Overall Study|Death|4|||
146119077|NCT01113801|526954527|FG001|Overall Study|Death|5|||
146119078|NCT01113801|526954528|FG002|Overall Study|Death|3|||
146119079|NCT01113801|526954529|FG003|Overall Study|Death|4|||
146119080|NCT01113801|526954526|FG000|Overall Study|Protocol Violation|0|||
146261603|NCT02484547|527472795|FG002|Placebo-Controlled Period|Change of Treatment|1|||
146119081|NCT01113801|526954527|FG001|Overall Study|Protocol Violation|1|||
146119082|NCT01113801|526954528|FG002|Overall Study|Protocol Violation|0|||
146119083|NCT01113801|526954529|FG003|Overall Study|Protocol Violation|0|||
146119084|NCT01113801|526954526|FG000|Overall Study|Withdrawal by Subject|9|||
146119085|NCT01113801|526954527|FG001|Overall Study|Withdrawal by Subject|7|||
146119086|NCT01113801|526954528|FG002|Overall Study|Withdrawal by Subject|7|||
146119087|NCT01113801|526954529|FG003|Overall Study|Withdrawal by Subject|8|||
146119088|NCT01113801|526954526|FG000|Overall Study|Physician Decision|2|||
146119089|NCT01113801|526954527|FG001|Overall Study|Physician Decision|2|||
146119090|NCT01113801|526954528|FG002|Overall Study|Physician Decision|3|||
146119091|NCT01113801|526954529|FG003|Overall Study|Physician Decision|3|||
146119092|NCT01113801|526954526|FG000|Overall Study|Sponsor Decision|15|||
146119093|NCT01113801|526954527|FG001|Overall Study|Sponsor Decision|21|||
146119094|NCT01113801|526954528|FG002|Overall Study|Sponsor Decision|20|||
146119095|NCT01113801|526954529|FG003|Overall Study|Sponsor Decision|15|||
146119096|NCT01113801|526954526|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
146119097|NCT01113801|526954527|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
146119098|NCT01113801|526954528|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
146119099|NCT01113801|526954529|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
146119100|NCT01949051|526954532|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
146119101|NCT01949051|526954533|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146119102|NCT01949051|526954534|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146119103|NCT01949051|526954535|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
146119104|NCT01949051|526954536|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146119105|NCT01949051|526954537|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
146119106|NCT01949051|526954532|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
146119107|NCT01949051|526954533|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146119108|NCT01949051|526954534|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146119109|NCT01949051|526954535|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146119110|NCT01949051|526954536|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146119111|NCT01949051|526954537|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
146119112|NCT01949051|526954532|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146119113|NCT01949051|526954533|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146119114|NCT01949051|526954534|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146119115|NCT01949051|526954535|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146119116|NCT01949051|526954536|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
146119117|NCT01949051|526954537|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
146119118|NCT01949051|526954532|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146119119|NCT01949051|526954533|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
146119120|NCT01949051|526954534|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146119121|NCT01949051|526954535|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146119122|NCT01949051|526954536|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146119123|NCT01949051|526954537|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
146119124|NCT01949051|526954532|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146119125|NCT01949051|526954533|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146119126|NCT01949051|526954534|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
146119127|NCT01949051|526954535|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146119128|NCT01949051|526954536|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146119129|NCT01949051|526954537|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
146119130|NCT03325075|526954539|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
146119131|NCT03325075|526954540|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146119132|NCT03325075|526954541|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146119133|NCT03325075|526954542|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
146119134|NCT03325075|526954539|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146119135|NCT03325075|526954540|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
146119136|NCT03325075|526954541|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146119137|NCT03325075|526954542|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
146119138|NCT03325075|526954539|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
146119139|NCT03325075|526954540|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
146119140|NCT03325075|526954541|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
146119141|NCT03325075|526954542|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
146119142|NCT01585194|526954545|FG000|Overall Study|Withdrawal by Subject|1|||
146119143|NCT01585194|526954545|FG000|Overall Study|Physician Decision|2|||
146119144|NCT01585194|526954545|FG000|Overall Study|Lack of insurance|1|||
146119150|NCT01333059|526954547|FG000|Overall Study|Physician Decision|3|||
146119151|NCT01333059|526954548|FG001|Overall Study|Physician Decision|3|||
146119152|NCT01333059|526954547|FG000|Overall Study|Protocol Violation|3|||
146119153|NCT01333059|526954548|FG001|Overall Study|Protocol Violation|0|||
146119154|NCT03035409|526954560|FG000|Overall Study|Adverse Event|5|||
146119155|NCT03035409|526954560|FG000|Overall Study|Death|2|||
146119156|NCT03035409|526954560|FG000|Overall Study|Withdrawal by Subject|2|||
146119157|NCT03035409|526954560|FG000|Overall Study|Non compliance|4|||
146119158|NCT03035409|526954560|FG000|Overall Study|Patient was jittery|1|||
146119159|NCT03035409|526954560|FG000|Overall Study|Did not like Questionnaire|1|||
146119160|NCT03035409|526954560|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
146119161|NCT03035409|526954560|FG000|Overall Study|Did not like taking drugs|1|||
146119162|NCT01405742|526954563|FG000|Overall Study|Lost to Follow-up|1|||
146119163|NCT01405742|526954564|FG001|Overall Study|Lost to Follow-up|0|||
146119164|NCT02056340|526954566|FG000|Overall Study|Lost to Follow-up|5|||
146119165|NCT02056340|526954567|FG001|Overall Study|Lost to Follow-up|5|||
146119166|NCT02056340|526954566|FG000|Overall Study|Withdrawal by Subject|2|||
146119167|NCT02056340|526954567|FG001|Overall Study|Withdrawal by Subject|6|||
146119168|NCT04900220|526954568|FG000|Overall Study|Lost to Follow-up|1|||
146261604|NCT02484547|527472796|FG003|Placebo-Controlled Period|Change of Treatment|0|||
146261605|NCT02484547|527472797|FG004|Placebo-Controlled Period|Change of Treatment|0|||
146261606|NCT02484547|527472798|FG005|Placebo-Controlled Period|Change of Treatment|0|||
146261607|NCT02484547|527472799|FG006|Placebo-Controlled Period|Change of Treatment|0|||
146261608|NCT02484547|527472793|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
146261609|NCT02484547|527472794|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
146261610|NCT02484547|527472795|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
146261611|NCT02484547|527472796|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
146261612|NCT02484547|527472797|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
146261613|NCT02484547|527472798|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
146261614|NCT02484547|527472799|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
146261615|NCT02484547|527472793|FG000|Placebo-Controlled Period|Death|5|||
146261616|NCT02484547|527472794|FG001|Placebo-Controlled Period|Death|0|||
146261617|NCT02484547|527472795|FG002|Placebo-Controlled Period|Death|6|||
146261618|NCT02484547|527472796|FG003|Placebo-Controlled Period|Death|0|||
146261619|NCT02484547|527472797|FG004|Placebo-Controlled Period|Death|0|||
146261620|NCT02484547|527472798|FG005|Placebo-Controlled Period|Death|0|||
146261621|NCT02484547|527472799|FG006|Placebo-Controlled Period|Death|0|||
146261622|NCT02484547|527472793|FG000|Placebo-Controlled Period|Disease Progression|2|||
146261623|NCT02484547|527472794|FG001|Placebo-Controlled Period|Disease Progression|0|||
146261624|NCT02484547|527472795|FG002|Placebo-Controlled Period|Disease Progression|1|||
146261625|NCT02484547|527472796|FG003|Placebo-Controlled Period|Disease Progression|0|||
146261626|NCT02484547|527472797|FG004|Placebo-Controlled Period|Disease Progression|0|||
146261627|NCT02484547|527472798|FG005|Placebo-Controlled Period|Disease Progression|0|||
146261628|NCT02484547|527472799|FG006|Placebo-Controlled Period|Disease Progression|0|||
146261629|NCT02484547|527472793|FG000|Placebo-Controlled Period|Investigator Decision|2|||
146261630|NCT02484547|527472794|FG001|Placebo-Controlled Period|Investigator Decision|2|||
146261631|NCT02484547|527472795|FG002|Placebo-Controlled Period|Investigator Decision|5|||
146261632|NCT02484547|527472796|FG003|Placebo-Controlled Period|Investigator Decision|0|||
146261633|NCT02484547|527472797|FG004|Placebo-Controlled Period|Investigator Decision|0|||
146261634|NCT02484547|527472798|FG005|Placebo-Controlled Period|Investigator Decision|0|||
146261635|NCT02484547|527472799|FG006|Placebo-Controlled Period|Investigator Decision|0|||
146261636|NCT02484547|527472793|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
146261637|NCT02484547|527472794|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
146261638|NCT02484547|527472795|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
146261639|NCT02484547|527472796|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
146261640|NCT02484547|527472797|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
146261641|NCT02484547|527472798|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
146261642|NCT02484547|527472799|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
146261643|NCT02484547|527472793|FG000|Placebo-Controlled Period|Relocation|1|||
146261644|NCT02484547|527472794|FG001|Placebo-Controlled Period|Relocation|1|||
146261645|NCT02484547|527472795|FG002|Placebo-Controlled Period|Relocation|1|||
146261646|NCT02484547|527472796|FG003|Placebo-Controlled Period|Relocation|0|||
146261647|NCT02484547|527472797|FG004|Placebo-Controlled Period|Relocation|0|||
146261648|NCT02484547|527472798|FG005|Placebo-Controlled Period|Relocation|0|||
146261649|NCT02484547|527472799|FG006|Placebo-Controlled Period|Relocation|0|||
146261650|NCT02484547|527472793|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
146261651|NCT02484547|527472794|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
146261652|NCT02484547|527472795|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
146261653|NCT02484547|527472796|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
146261654|NCT02484547|527472797|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
146261655|NCT02484547|527472798|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
146261656|NCT02484547|527472799|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
146261657|NCT02484547|527472793|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
146261658|NCT02484547|527472794|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146261659|NCT02484547|527472795|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146261660|NCT02484547|527472796|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146261661|NCT02484547|527472797|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146261662|NCT02484547|527472798|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146119169|NCT04900220|526954569|FG001|Overall Study|Lost to Follow-up|1|||
146119170|NCT02028065|526954570|FG000|Randomization Through Start Treatment|Not treated|1|||
146261663|NCT02484547|527472799|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146261664|NCT02484547|527472793|FG000|Placebo-Controlled Period|Reason not Specified|216|||
146261665|NCT02484547|527472794|FG001|Placebo-Controlled Period|Reason not Specified|194|||
146261666|NCT02484547|527472795|FG002|Placebo-Controlled Period|Reason not Specified|183|||
146261667|NCT02484547|527472796|FG003|Placebo-Controlled Period|Reason not Specified|0|||
146261668|NCT02484547|527472797|FG004|Placebo-Controlled Period|Reason not Specified|0|||
146261669|NCT02484547|527472798|FG005|Placebo-Controlled Period|Reason not Specified|0|||
146261670|NCT02484547|527472799|FG006|Placebo-Controlled Period|Reason not Specified|0|||
146119171|NCT02028065|526954571|FG001|Randomization Through Start Treatment|Not treated|3|||
146119172|NCT02028065|526954572|FG002|Randomization Through Start Treatment|Not treated|3|||
146119173|NCT02028065|526954570|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
146119174|NCT02028065|526954571|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
146119175|NCT02028065|526954572|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
146119176|NCT02028065|526954570|FG000|Treatment Through Study Completion|Physician Decision|1|||
146261671|NCT02484547|527472793|FG000|Long-Term Extension Period|Adverse Event|0|||
146119177|NCT02028065|526954571|FG001|Treatment Through Study Completion|Physician Decision|0|||
146119178|NCT02028065|526954572|FG002|Treatment Through Study Completion|Physician Decision|0|||
146119179|NCT02028065|526954570|FG000|Treatment Through Study Completion|Protocol Violation|1|||
146119180|NCT02028065|526954571|FG001|Treatment Through Study Completion|Protocol Violation|4|||
146119181|NCT02028065|526954572|FG002|Treatment Through Study Completion|Protocol Violation|0|||
146119182|NCT02028065|526954570|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
146119183|NCT02028065|526954571|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
146119184|NCT02028065|526954572|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
146119185|NCT02028065|526954570|FG000|Treatment Through Study Completion|Adverse Event|3|||
146119186|NCT02028065|526954571|FG001|Treatment Through Study Completion|Adverse Event|3|||
146119187|NCT02028065|526954572|FG002|Treatment Through Study Completion|Adverse Event|5|||
146119188|NCT02107482|526954576|FG000|Overall Study|inconveinence|2|||
146119189|NCT02107482|526954576|FG000|Overall Study|Lost to Follow-up|1|||
146119190|NCT02107482|526954576|FG000|Overall Study|Lack of Efficacy|1|||
146119191|NCT00867009|526954577|FG000|Induction Period|Nonserious Adverse Event|5|||
146119192|NCT00867009|526954577|FG000|Induction Period|Serious Adverse Event|10|||
146119193|NCT00867009|526954577|FG000|Induction Period|Death due to serious adverse event|6|||
146119194|NCT00867009|526954577|FG000|Induction Period|Death due to Study Disease|4|||
146119195|NCT00867009|526954577|FG000|Induction Period|Protocol Violation|1|||
146119196|NCT00867009|526954577|FG000|Induction Period|Withdrawal by Subject|8|||
146119197|NCT00867009|526954577|FG000|Induction Period|Physician Decision|3|||
146119198|NCT00867009|526954577|FG000|Induction Period|Progressive Disease (PD)|25|||
146119199|NCT00867009|526954577|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
146119200|NCT03128892|526954580|FG000|Overall Study|Withdrawal by Subject|2|||
146119201|NCT03128892|526954580|FG000|Overall Study|Physician Decision|1|||
146119202|NCT01850524|526954583|FG000|Overall Study|Lost to Follow-up|5|||
146119203|NCT01850524|526954584|FG001|Overall Study|Lost to Follow-up|10|||
146119204|NCT01850524|526954583|FG000|Overall Study|Withdrawal by Subject|24|||
146119205|NCT01850524|526954584|FG001|Overall Study|Withdrawal by Subject|22|||
146119206|NCT01850524|526954583|FG000|Overall Study|Reason not Specified|142|||
146119207|NCT01850524|526954584|FG001|Overall Study|Reason not Specified|141|||
146119208|NCT03473808|526954585|FG000|Overall Study|Withdrawal by Subject|1|||
146119209|NCT03171415|526954586|FG000|Overall Study|Lost to Follow-up|0|||
146119210|NCT03171415|526954587|FG001|Overall Study|Lost to Follow-up|0|||
146119211|NCT03171415|526954588|FG002|Overall Study|Lost to Follow-up|0|||
146119212|NCT03171415|526954589|FG003|Overall Study|Lost to Follow-up|0|||
146261672|NCT02484547|527472794|FG001|Long-Term Extension Period|Adverse Event|0|||
146261673|NCT02484547|527472795|FG002|Long-Term Extension Period|Adverse Event|0|||
146119213|NCT03171415|526954590|FG004|Overall Study|Lost to Follow-up|2|||
146119214|NCT00847704|526954594|FG000|Overall Study|Withdrawal by Subject|1|||
146119215|NCT02111850|526954595|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119216|NCT02111850|526954596|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119217|NCT02111850|526954597|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119218|NCT02111850|526954598|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119219|NCT02111850|526954599|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
146119220|NCT02111850|526954600|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119221|NCT02111850|526954601|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119222|NCT02111850|526954602|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119223|NCT02111850|526954603|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119224|NCT02111850|526954604|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119225|NCT02111850|526954605|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
146119226|NCT00397982|526956191|FG000|Overall Study|Withdrawal by Subject|1|||
146119227|NCT00397982|526956191|FG000|Overall Study|Adverse Event|1|||
146261674|NCT02484547|527472796|FG003|Long-Term Extension Period|Adverse Event|0|||
146261675|NCT02484547|527472797|FG004|Long-Term Extension Period|Adverse Event|1|||
146261676|NCT02484547|527472798|FG005|Long-Term Extension Period|Adverse Event|3|||
146119228|NCT00397982|526956191|FG000|Overall Study|noncompliance|1|||
146119229|NCT00397982|526956191|FG000|Overall Study|Unrelated health issues|1|||
146119230|NCT01199289|526956195|FG000|Overall Study|Ineligibility determined|2|||
146119231|NCT01199289|526956196|FG001|Overall Study|Ineligibility determined|1|||
146261677|NCT02484547|527472799|FG006|Long-Term Extension Period|Adverse Event|2|||
146261678|NCT02484547|527472793|FG000|Long-Term Extension Period|Death|0|||
146261679|NCT02484547|527472794|FG001|Long-Term Extension Period|Death|0|||
146302685|NCT00766090|527621713|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302686|NCT00766090|527621714|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
146302687|NCT01390272|527621717|FG000|Overall Study|Death|3|||
146302688|NCT01390272|527621718|FG001|Overall Study|Death|2|||
146302689|NCT01390272|527621717|FG000|Overall Study|Withdrawal by Subject|9|||
146302690|NCT01390272|527621718|FG001|Overall Study|Withdrawal by Subject|5|||
146302691|NCT01390272|527621717|FG000|Overall Study|Patient moved, no longer eligible|5|||
146302692|NCT01390272|527621718|FG001|Overall Study|Patient moved, no longer eligible|8|||
146302693|NCT00955279|527621723|FG000|Overall Study|Other|0|||
146302694|NCT00955279|527621724|FG001|Overall Study|Other|0|||
146302695|NCT00955279|527621725|FG002|Overall Study|Other|3|||
146302696|NCT00955279|527621723|FG000|Overall Study|Death|1|||
146302697|NCT00955279|527621724|FG001|Overall Study|Death|1|||
146302698|NCT00955279|527621725|FG002|Overall Study|Death|1|||
146302699|NCT00955279|527621723|FG000|Overall Study|Lost to Follow-up|0|||
146302700|NCT00955279|527621724|FG001|Overall Study|Lost to Follow-up|3|||
146302701|NCT00955279|527621725|FG002|Overall Study|Lost to Follow-up|1|||
146302702|NCT00955279|527621723|FG000|Overall Study|Withdrawal by Subject|2|||
146302703|NCT00955279|527621724|FG001|Overall Study|Withdrawal by Subject|0|||
146302704|NCT00955279|527621725|FG002|Overall Study|Withdrawal by Subject|3|||
146302705|NCT01235793|527621726|FG000|Overall Study|Death|6|||
146302706|NCT01159912|527621727|FG000|Overall Study|Adverse Event|2|||
146302707|NCT01159912|527621728|FG001|Overall Study|Adverse Event|2|||
146302708|NCT01159912|527621729|FG002|Overall Study|Adverse Event|3|||
146302709|NCT01159912|527621727|FG000|Overall Study|Lack of Efficacy|23|||
146302710|NCT01159912|527621728|FG001|Overall Study|Lack of Efficacy|15|||
146302711|NCT01159912|527621729|FG002|Overall Study|Lack of Efficacy|14|||
146302712|NCT01159912|527621727|FG000|Overall Study|Protocol Violation|1|||
146302713|NCT01159912|527621728|FG001|Overall Study|Protocol Violation|2|||
146302714|NCT01159912|527621729|FG002|Overall Study|Protocol Violation|3|||
146302715|NCT01159912|527621727|FG000|Overall Study|Lost to Follow-up|4|||
146302716|NCT01159912|527621728|FG001|Overall Study|Lost to Follow-up|0|||
146302717|NCT01159912|527621729|FG002|Overall Study|Lost to Follow-up|0|||
146302718|NCT01159912|527621727|FG000|Overall Study|Physician Decision|0|||
146302719|NCT01159912|527621728|FG001|Overall Study|Physician Decision|0|||
146302720|NCT01159912|527621729|FG002|Overall Study|Physician Decision|3|||
146302721|NCT01159912|527621727|FG000|Overall Study|Withdrawal by Subject|10|||
146302722|NCT01159912|527621728|FG001|Overall Study|Withdrawal by Subject|3|||
146302723|NCT01159912|527621729|FG002|Overall Study|Withdrawal by Subject|3|||
146302724|NCT02456662|527621732|FG000|Overall Study|Lost to Follow-up|2|||
146302725|NCT02456662|527621733|FG001|Overall Study|Lost to Follow-up|1|||
146302726|NCT02374021|527621736|FG000|Overall Study|Adverse Event|1|||
146302727|NCT02374021|527621737|FG001|Overall Study|Adverse Event|0|||
146302728|NCT02374021|527621736|FG000|Overall Study|Lost to Follow-up|3|||
146302729|NCT02374021|527621737|FG001|Overall Study|Lost to Follow-up|2|||
146302730|NCT02374021|527621736|FG000|Overall Study|Physician Decision|0|||
146302731|NCT02374021|527621737|FG001|Overall Study|Physician Decision|3|||
146302732|NCT02374021|527621736|FG000|Overall Study|Withdrawal by Subject|6|||
146302733|NCT02374021|527621737|FG001|Overall Study|Withdrawal by Subject|5|||
146302734|NCT02374021|527621736|FG000|Overall Study|Poor Adherence|0|||
146302735|NCT02374021|527621737|FG001|Overall Study|Poor Adherence|1|||
146302736|NCT02374021|527621736|FG000|Overall Study|Scan protocol not followed|0|||
146302737|NCT02374021|527621737|FG001|Overall Study|Scan protocol not followed|1|||
146302738|NCT02374021|527621736|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
146302739|NCT02374021|527621737|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
146302740|NCT04411628|527621739|FG000|Overall Study|Withdrawal by Subject|1|||
146302741|NCT04411628|527621740|FG001|Overall Study|Withdrawal by Subject|1|||
146302742|NCT04411628|527621741|FG002|Overall Study|Withdrawal by Subject|2|||
146302743|NCT04411628|527621742|FG003|Overall Study|Withdrawal by Subject|0|||
146302744|NCT04411628|527621739|FG000|Overall Study|Lost to Follow-up|0|||
146302745|NCT04411628|527621740|FG001|Overall Study|Lost to Follow-up|1|||
146302746|NCT04411628|527621741|FG002|Overall Study|Lost to Follow-up|0|||
146302747|NCT04411628|527621742|FG003|Overall Study|Lost to Follow-up|0|||
146302748|NCT03828292|527621743|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146302749|NCT03828292|527621744|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
146302750|NCT03828292|527621745|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146302751|NCT03828292|527621746|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146302752|NCT03828292|527621747|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146302753|NCT03828292|527621748|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
146302754|NCT03828292|527621743|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146302755|NCT03828292|527621744|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146302756|NCT03828292|527621745|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
146302757|NCT03828292|527621746|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146302758|NCT03828292|527621747|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146302759|NCT03828292|527621748|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
146302760|NCT03828292|527621743|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146119232|NCT01199289|526956197|FG002|Overall Study|Ineligibility determined|0|||
146119233|NCT01199289|526956198|FG003|Overall Study|Ineligibility determined|0|||
146119234|NCT01199289|526956195|FG000|Overall Study|Protocol Violation|1|||
146119235|NCT01199289|526956196|FG001|Overall Study|Protocol Violation|0|||
146119236|NCT01199289|526956197|FG002|Overall Study|Protocol Violation|0|||
146119237|NCT01199289|526956198|FG003|Overall Study|Protocol Violation|1|||
146119238|NCT01199289|526956195|FG000|Overall Study|Noncompliance|1|||
146119239|NCT01199289|526956196|FG001|Overall Study|Noncompliance|0|||
146119240|NCT01199289|526956197|FG002|Overall Study|Noncompliance|2|||
146119241|NCT01199289|526956198|FG003|Overall Study|Noncompliance|0|||
146119242|NCT01199289|526956195|FG000|Overall Study|Adverse Event|0|||
146119243|NCT01199289|526956196|FG001|Overall Study|Adverse Event|3|||
146119244|NCT01199289|526956197|FG002|Overall Study|Adverse Event|1|||
146119245|NCT01199289|526956198|FG003|Overall Study|Adverse Event|4|||
146119246|NCT01199289|526956195|FG000|Overall Study|Full consent withdrawn|2|||
146119247|NCT01199289|526956196|FG001|Overall Study|Full consent withdrawn|2|||
146119248|NCT01199289|526956197|FG002|Overall Study|Full consent withdrawn|2|||
146119249|NCT01199289|526956198|FG003|Overall Study|Full consent withdrawn|3|||
146119250|NCT01199289|526956195|FG000|Overall Study|Administrative decision|0|||
146119251|NCT01199289|526956196|FG001|Overall Study|Administrative decision|0|||
146119252|NCT01199289|526956197|FG002|Overall Study|Administrative decision|0|||
146119253|NCT01199289|526956198|FG003|Overall Study|Administrative decision|1|||
146119254|NCT01199289|526956195|FG000|Overall Study|Lost to Follow-up|0|||
146119255|NCT01199289|526956196|FG001|Overall Study|Lost to Follow-up|0|||
146119256|NCT01199289|526956197|FG002|Overall Study|Lost to Follow-up|0|||
146119257|NCT01199289|526956198|FG003|Overall Study|Lost to Follow-up|1|||
146119258|NCT01199289|526956195|FG000|Overall Study|Protocol-specified criteria|3|||
146119259|NCT01199289|526956196|FG001|Overall Study|Protocol-specified criteria|0|||
146119260|NCT01199289|526956197|FG002|Overall Study|Protocol-specified criteria|0|||
146119261|NCT01199289|526956198|FG003|Overall Study|Protocol-specified criteria|1|||
146119262|NCT01199289|526956195|FG000|Overall Study|Pregnancy|0|||
146119263|NCT01199289|526956196|FG001|Overall Study|Pregnancy|1|||
146119264|NCT01199289|526956197|FG002|Overall Study|Pregnancy|0|||
146119265|NCT01199289|526956198|FG003|Overall Study|Pregnancy|1|||
146119266|NCT03055260|526956199|FG000|Overall Study|Withdrawal by Subject|1|||
146119267|NCT03055260|526956200|FG001|Overall Study|Withdrawal by Subject|0|||
146119268|NCT02507505|526956201|FG000|Overall Study|Withdrawal by Subject|13|||
146261680|NCT02484547|527472795|FG002|Long-Term Extension Period|Death|0|||
146119269|NCT02507505|526956202|FG001|Overall Study|Withdrawal by Subject|11|||
146119270|NCT02507505|526956201|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
146119271|NCT02507505|526956202|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
146119272|NCT02507505|526956201|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
146119273|NCT02507505|526956202|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
146119274|NCT02507505|526956201|FG000|Overall Study|Death before receipt of anesthesia|0|||
146119275|NCT02507505|526956202|FG001|Overall Study|Death before receipt of anesthesia|1|||
146119276|NCT00967798|526956203|FG000|Overall Study|Withdrawal by Subject|5|||
146119277|NCT00967798|526956204|FG001|Overall Study|Withdrawal by Subject|2|||
146119278|NCT00967798|526956203|FG000|Overall Study|Lost to Follow-up|4|||
146119279|NCT00967798|526956204|FG001|Overall Study|Lost to Follow-up|1|||
146119280|NCT01409564|526956205|FG000|Overall Study|low medication compliance|4|||
146119281|NCT01409564|526956206|FG001|Overall Study|low medication compliance|3|||
146119282|NCT01409564|526956205|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
146119283|NCT01409564|526956206|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
146119284|NCT00254540|526956207|FG000|Overall Study|Adverse Event|6|||
146119285|NCT00254540|526956208|FG001|Overall Study|Adverse Event|7|||
146119286|NCT00254540|526956207|FG000|Overall Study|Lack of Efficacy|13|||
146119287|NCT00254540|526956208|FG001|Overall Study|Lack of Efficacy|13|||
146119288|NCT00254540|526956207|FG000|Overall Study|Death|0|||
146119289|NCT00254540|526956208|FG001|Overall Study|Death|1|||
146119290|NCT00254540|526956207|FG000|Overall Study|Laboratory Test Abnormality|0|||
146119291|NCT00254540|526956208|FG001|Overall Study|Laboratory Test Abnormality|1|||
146261681|NCT02484547|527472796|FG003|Long-Term Extension Period|Death|0|||
146261682|NCT02484547|527472797|FG004|Long-Term Extension Period|Death|0|||
146261683|NCT02484547|527472798|FG005|Long-Term Extension Period|Death|3|||
146261684|NCT02484547|527472799|FG006|Long-Term Extension Period|Death|0|||
146261685|NCT02484547|527472793|FG000|Long-Term Extension Period|Disease Progression|0|||
146261686|NCT02484547|527472794|FG001|Long-Term Extension Period|Disease Progression|0|||
146119292|NCT00225251|526956209|FG000|Overall Study|Withdrawal by Subject|1|||
146119293|NCT00225251|526956210|FG001|Overall Study|Withdrawal by Subject|1|||
146119294|NCT03045328|526956211|FG000|Overall Study|Withdrawal by Subject|2|||
146119295|NCT00592839|526956214|FG000|Overall Study|Withdrawal by Subject|1|||
146119296|NCT00592839|526956215|FG001|Overall Study|Withdrawal by Subject|1|||
146119297|NCT00592839|526956216|FG002|Overall Study|Withdrawal by Subject|3|||
146119298|NCT00592839|526956214|FG000|Overall Study|Protocol Violation|1|||
146119299|NCT00592839|526956215|FG001|Overall Study|Protocol Violation|1|||
146119300|NCT00592839|526956216|FG002|Overall Study|Protocol Violation|2|||
146119301|NCT00592839|526956214|FG000|Overall Study|Adverse Event|0|||
146119302|NCT00592839|526956215|FG001|Overall Study|Adverse Event|1|||
146119303|NCT00592839|526956216|FG002|Overall Study|Adverse Event|0|||
146119304|NCT00592839|526956214|FG000|Overall Study|Lost to Follow-up|0|||
146119305|NCT00592839|526956215|FG001|Overall Study|Lost to Follow-up|1|||
146119306|NCT00592839|526956216|FG002|Overall Study|Lost to Follow-up|1|||
146119307|NCT01313767|526956217|FG000|Overall Study|Adverse Event|1|||
146119308|NCT01313767|526956218|FG001|Overall Study|Adverse Event|0|||
146119309|NCT01313767|526956217|FG000|Overall Study|Lost to Follow-up|1|||
146119310|NCT01313767|526956218|FG001|Overall Study|Lost to Follow-up|0|||
146119311|NCT01313767|526956217|FG000|Overall Study|Withdrawal by Subject|2|||
146119312|NCT01313767|526956218|FG001|Overall Study|Withdrawal by Subject|1|||
146119313|NCT01313767|526956217|FG000|Overall Study|Protocol Violation|3|||
146119314|NCT01313767|526956218|FG001|Overall Study|Protocol Violation|1|||
146119315|NCT04483011|526956224|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
146119316|NCT04483011|526956225|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
146119317|NCT00799487|526956226|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
146119318|NCT00799487|526956227|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
146119319|NCT00799487|526956228|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
146119320|NCT00799487|526956226|FG000|Dose Adjustment Period|Adverse Event|2|||
146119321|NCT00799487|526956227|FG001|Dose Adjustment Period|Adverse Event|0|||
146119322|NCT00799487|526956228|FG002|Dose Adjustment Period|Adverse Event|0|||
146261687|NCT02484547|527472795|FG002|Long-Term Extension Period|Disease Progression|0|||
146261688|NCT02484547|527472796|FG003|Long-Term Extension Period|Disease Progression|0|||
146261689|NCT02484547|527472797|FG004|Long-Term Extension Period|Disease Progression|2|||
146261690|NCT02484547|527472798|FG005|Long-Term Extension Period|Disease Progression|4|||
146261691|NCT02484547|527472799|FG006|Long-Term Extension Period|Disease Progression|0|||
146261692|NCT02484547|527472793|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
146261693|NCT02484547|527472794|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
146261694|NCT02484547|527472795|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
146261695|NCT02484547|527472796|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
146261696|NCT02484547|527472797|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
146261697|NCT02484547|527472798|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
146261698|NCT02484547|527472799|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
146261699|NCT02484547|527472793|FG000|Long-Term Extension Period|Loss of Capacity|0|||
146261700|NCT02484547|527472794|FG001|Long-Term Extension Period|Loss of Capacity|0|||
146261701|NCT02484547|527472795|FG002|Long-Term Extension Period|Loss of Capacity|0|||
146261702|NCT02484547|527472796|FG003|Long-Term Extension Period|Loss of Capacity|0|||
146261703|NCT02484547|527472797|FG004|Long-Term Extension Period|Loss of Capacity|1|||
146261704|NCT02484547|527472798|FG005|Long-Term Extension Period|Loss of Capacity|0|||
146261705|NCT02484547|527472799|FG006|Long-Term Extension Period|Loss of Capacity|0|||
146261706|NCT02484547|527472793|FG000|Long-Term Extension Period|Change of Treatment|0|||
146261707|NCT02484547|527472794|FG001|Long-Term Extension Period|Change of Treatment|0|||
146261708|NCT02484547|527472795|FG002|Long-Term Extension Period|Change of Treatment|0|||
146261709|NCT02484547|527472796|FG003|Long-Term Extension Period|Change of Treatment|0|||
146261710|NCT02484547|527472797|FG004|Long-Term Extension Period|Change of Treatment|0|||
146261711|NCT02484547|527472798|FG005|Long-Term Extension Period|Change of Treatment|0|||
146261712|NCT02484547|527472799|FG006|Long-Term Extension Period|Change of Treatment|1|||
146261713|NCT02484547|527472793|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
146261714|NCT02484547|527472794|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
146261715|NCT02484547|527472795|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
146261716|NCT02484547|527472796|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
146261717|NCT02484547|527472797|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
146261718|NCT02484547|527472798|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
146261719|NCT02484547|527472799|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
146261720|NCT02484547|527472793|FG000|Long-Term Extension Period|Investigator Decision|0|||
146261721|NCT02484547|527472794|FG001|Long-Term Extension Period|Investigator Decision|0|||
146261722|NCT02484547|527472795|FG002|Long-Term Extension Period|Investigator Decision|0|||
146261723|NCT02484547|527472796|FG003|Long-Term Extension Period|Investigator Decision|2|||
146261724|NCT02484547|527472797|FG004|Long-Term Extension Period|Investigator Decision|1|||
146261725|NCT02484547|527472798|FG005|Long-Term Extension Period|Investigator Decision|0|||
146261726|NCT02484547|527472799|FG006|Long-Term Extension Period|Investigator Decision|1|||
146261727|NCT02484547|527472793|FG000|Long-Term Extension Period|Relocation|0|||
146261728|NCT02484547|527472794|FG001|Long-Term Extension Period|Relocation|0|||
146261729|NCT02484547|527472795|FG002|Long-Term Extension Period|Relocation|0|||
146261730|NCT02484547|527472796|FG003|Long-Term Extension Period|Relocation|1|||
146261731|NCT02484547|527472797|FG004|Long-Term Extension Period|Relocation|1|||
146261732|NCT02484547|527472798|FG005|Long-Term Extension Period|Relocation|0|||
146119323|NCT00799487|526956226|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
146119324|NCT00799487|526956227|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
146119325|NCT00799487|526956228|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
146119326|NCT00799487|526956226|FG000|Dose Adjustment Period|Investigator Discretion|2|||
146119327|NCT00799487|526956227|FG001|Dose Adjustment Period|Investigator Discretion|0|||
146119328|NCT00799487|526956228|FG002|Dose Adjustment Period|Investigator Discretion|0|||
146119329|NCT00799487|526956226|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
146119330|NCT00799487|526956227|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
146119331|NCT00799487|526956228|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
146119332|NCT00799487|526956226|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
146119333|NCT00799487|526956227|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
146119334|NCT00799487|526956228|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
146119335|NCT00799487|526956226|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
146119336|NCT00799487|526956227|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
146119337|NCT00799487|526956228|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
146119338|NCT00799487|526956226|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
146119339|NCT00799487|526956227|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
146119340|NCT00799487|526956228|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
146119341|NCT00799487|526956226|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
146119342|NCT00799487|526956227|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
146119343|NCT00799487|526956228|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
146119344|NCT00799487|526956226|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
146119345|NCT00799487|526956227|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
146119346|NCT00799487|526956228|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
146119347|NCT00799487|526956226|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
146119348|NCT00799487|526956227|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
146119349|NCT00799487|526956228|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
146119350|NCT00799487|526956226|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
146119351|NCT00799487|526956227|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
146119352|NCT00799487|526956228|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
146119353|NCT00232817|526956229|FG000|Overall Study|Protocol Violation|2|||
146119354|NCT00232817|526956230|FG001|Overall Study|Protocol Violation|1|||
146119355|NCT03518073|526956231|FG000|Overall Study|Adverse Event|2|||
146119356|NCT03518073|526956232|FG001|Overall Study|Adverse Event|4|||
146119357|NCT03518073|526956233|FG002|Overall Study|Adverse Event|2|||
146119358|NCT03518073|526956231|FG000|Overall Study|Death|2|||
146119359|NCT03518073|526956232|FG001|Overall Study|Death|1|||
146119360|NCT03518073|526956233|FG002|Overall Study|Death|3|||
146119361|NCT03518073|526956231|FG000|Overall Study|Lost to Follow-up|1|||
146119362|NCT03518073|526956232|FG001|Overall Study|Lost to Follow-up|0|||
146119363|NCT03518073|526956233|FG002|Overall Study|Lost to Follow-up|1|||
146119364|NCT03518073|526956231|FG000|Overall Study|Physician Decision|5|||
146119365|NCT03518073|526956232|FG001|Overall Study|Physician Decision|0|||
146119366|NCT03518073|526956233|FG002|Overall Study|Physician Decision|2|||
146119367|NCT03518073|526956231|FG000|Overall Study|Progressive disease|1|||
146119368|NCT03518073|526956232|FG001|Overall Study|Progressive disease|1|||
146119369|NCT03518073|526956233|FG002|Overall Study|Progressive disease|1|||
146119370|NCT03518073|526956231|FG000|Overall Study|Protocol Violation|1|||
146119371|NCT03518073|526956232|FG001|Overall Study|Protocol Violation|0|||
146119372|NCT03518073|526956233|FG002|Overall Study|Protocol Violation|0|||
146119373|NCT03518073|526956231|FG000|Overall Study|Withdrawal by Subject|30|||
146119374|NCT03518073|526956232|FG001|Overall Study|Withdrawal by Subject|34|||
146119375|NCT03518073|526956233|FG002|Overall Study|Withdrawal by Subject|29|||
146119376|NCT03518073|526956231|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
146119377|NCT03518073|526956232|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
146119378|NCT03518073|526956233|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
146119379|NCT03518073|526956231|FG000|Overall Study|Covid-19|1|||
146119380|NCT03518073|526956232|FG001|Overall Study|Covid-19|2|||
146119381|NCT03518073|526956233|FG002|Overall Study|Covid-19|1|||
146119382|NCT03045081|526956234|FG000|Overall Study|Withdrawal by Subject|6|||
146119383|NCT03045081|526956235|FG001|Overall Study|Withdrawal by Subject|11|||
146119384|NCT00475176|526956236|FG000|Overall Study|Adverse Event|2|||
146119385|NCT00475176|526956236|FG000|Overall Study|Withdrawal by Subject|1|||
146119386|NCT00475176|526956236|FG000|Overall Study|Protocol Violation|1|||
146119387|NCT00065507|526956239|FG000|Overall Study|Death|16|||
146119388|NCT00065507|526956240|FG001|Overall Study|Death|17|||
146119389|NCT00065507|526956239|FG000|Overall Study|Adverse Event|4|||
146119390|NCT00065507|526956240|FG001|Overall Study|Adverse Event|3|||
146119391|NCT00065507|526956239|FG000|Overall Study|Lack of Efficacy|0|||
146119392|NCT00065507|526956240|FG001|Overall Study|Lack of Efficacy|6|||
146119393|NCT00065507|526956239|FG000|Overall Study|Poor/Non-compliance|3|||
146119394|NCT00065507|526956240|FG001|Overall Study|Poor/Non-compliance|2|||
146119395|NCT00065507|526956239|FG000|Overall Study|Lost to Follow-up|3|||
146119396|NCT00065507|526956240|FG001|Overall Study|Lost to Follow-up|0|||
146119397|NCT00065507|526956239|FG000|Overall Study|Subject Withdrew Consent|2|||
146119398|NCT00065507|526956240|FG001|Overall Study|Subject Withdrew Consent|1|||
146119399|NCT00065507|526956239|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
146119400|NCT00065507|526956240|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
146119401|NCT00100815|526956241|FG000|Overall Study|Progression|24|||
146119402|NCT00100815|526956241|FG000|Overall Study|Adverse Event|18|||
146119403|NCT00100815|526956241|FG000|Overall Study|Death|4|||
146119404|NCT00100815|526956241|FG000|Overall Study|Other|3|||
146119405|NCT00723892|526956242|FG000|Overall Study|Participant not tracked|33|||
146119406|NCT00723892|526956243|FG001|Overall Study|Participant not tracked|35|||
146119407|NCT00723892|526956242|FG000|Overall Study|Virological criterion|24|||
146119408|NCT00723892|526956243|FG001|Overall Study|Virological criterion|9|||
146119409|NCT00723892|526956242|FG000|Overall Study|Withdrawal by Subject|6|||
146119410|NCT00723892|526956243|FG001|Overall Study|Withdrawal by Subject|9|||
146119411|NCT00723892|526956242|FG000|Overall Study|End planned|11|||
146119412|NCT00723892|526956243|FG001|Overall Study|End planned|7|||
146119413|NCT00723892|526956242|FG000|Overall Study|Bad tolerance|5|||
146119414|NCT00723892|526956243|FG001|Overall Study|Bad tolerance|5|||
146119415|NCT00723892|526956242|FG000|Overall Study|Multiple reasons|17|||
146119416|NCT00723892|526956243|FG001|Overall Study|Multiple reasons|12|||
146119417|NCT00723892|526956242|FG000|Overall Study|Other|6|||
146119418|NCT00723892|526956243|FG001|Overall Study|Other|3|||
146119419|NCT00723892|526956242|FG000|Overall Study|Study end|1|||
146119420|NCT00723892|526956243|FG001|Overall Study|Study end|3|||
146119421|NCT00723892|526956242|FG000|Overall Study|Weight loss|1|||
146119422|NCT00723892|526956243|FG001|Overall Study|Weight loss|3|||
146119423|NCT00723892|526956242|FG000|Overall Study|Alcohol abuse|0|||
146119424|NCT00723892|526956243|FG001|Overall Study|Alcohol abuse|1|||
146119425|NCT00723892|526956242|FG000|Overall Study|Intercurrent infection|2|||
146119426|NCT00723892|526956243|FG001|Overall Study|Intercurrent infection|0|||
146119427|NCT00723892|526956242|FG000|Overall Study|Drug addiction|1|||
146119428|NCT00723892|526956243|FG001|Overall Study|Drug addiction|0|||
146119429|NCT04532099|526956244|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
146119430|NCT04532099|526956245|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
146119431|NCT04532099|526956246|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
146119432|NCT01506479|526956247|FG000|Overall Study|Lost to Follow-up|1|||
146119433|NCT01506479|526956248|FG001|Overall Study|Lost to Follow-up|2|||
146119434|NCT01506479|526956249|FG002|Overall Study|Lost to Follow-up|2|||
146119435|NCT01506479|526956247|FG000|Overall Study|Withdrawal by Subject|1|||
146119436|NCT01506479|526956248|FG001|Overall Study|Withdrawal by Subject|2|||
146119437|NCT01506479|526956249|FG002|Overall Study|Withdrawal by Subject|1|||
146119438|NCT01506479|526956247|FG000|Overall Study|Missing assessment|1|||
146119439|NCT01506479|526956248|FG001|Overall Study|Missing assessment|0|||
146119440|NCT01506479|526956249|FG002|Overall Study|Missing assessment|0|||
146119441|NCT01506479|526956247|FG000|Overall Study|Adverse Event|0|||
146119442|NCT01506479|526956248|FG001|Overall Study|Adverse Event|1|||
146119443|NCT01506479|526956249|FG002|Overall Study|Adverse Event|0|||
146119444|NCT01846507|526956250|FG000|Overall Study|Lost to Follow-up|4|||
146119445|NCT01846507|526956250|FG000|Overall Study|Protocol Violation|1|||
146119446|NCT01846507|526956250|FG000|Overall Study|Missing data|2|||
146119447|NCT01782859|526956251|FG000|Overall Study|Protocol Violation|6|||
146119448|NCT01782859|526956252|FG001|Overall Study|Protocol Violation|6|||
146119449|NCT01782859|526956251|FG000|Overall Study|Withdrawal by Subject|0|||
146119450|NCT01782859|526956252|FG001|Overall Study|Withdrawal by Subject|1|||
146119451|NCT00276159|526956259|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
146119452|NCT03402386|526956265|FG000|Overall Study|Adverse Event|3|||
146119453|NCT03402386|526956265|FG000|Overall Study|Physician Decision|1|||
146119454|NCT03402386|526956265|FG000|Overall Study|Difficult to control Hb|2|||
146119455|NCT01896531|526956266|FG000|Overall Study|Death|57|||
146119456|NCT01896531|526956267|FG001|Overall Study|Death|59|||
146119457|NCT01896531|526956266|FG000|Overall Study|Lost to Follow-up|3|||
146119458|NCT01896531|526956267|FG001|Overall Study|Lost to Follow-up|0|||
146119459|NCT01896531|526956266|FG000|Overall Study|Non-compliance|0|||
146119460|NCT01896531|526956267|FG001|Overall Study|Non-compliance|1|||
146119461|NCT01896531|526956266|FG000|Overall Study|Study Ended by Sponsor|7|||
146261733|NCT02484547|527472799|FG006|Long-Term Extension Period|Relocation|0|||
146261734|NCT02484547|527472793|FG000|Long-Term Extension Period|Study Visit Burden|0|||
146261735|NCT02484547|527472794|FG001|Long-Term Extension Period|Study Visit Burden|0|||
146261736|NCT02484547|527472795|FG002|Long-Term Extension Period|Study Visit Burden|0|||
146119462|NCT01896531|526956267|FG001|Overall Study|Study Ended by Sponsor|20|||
146119463|NCT01896531|526956266|FG000|Overall Study|Withdrawal by Subject|3|||
146119464|NCT01896531|526956267|FG001|Overall Study|Withdrawal by Subject|2|||
146119465|NCT01896531|526956266|FG000|Overall Study|Death Prior to Treatment|1|||
146119466|NCT01896531|526956267|FG001|Overall Study|Death Prior to Treatment|0|||
146119467|NCT00268996|526956268|FG000|Overall Study|Adverse Event|11|||
146119468|NCT00268996|526956269|FG001|Overall Study|Adverse Event|7|||
146119469|NCT00268996|526956268|FG000|Overall Study|Lost to Follow-up|3|||
146119470|NCT00268996|526956269|FG001|Overall Study|Lost to Follow-up|1|||
146119471|NCT00268996|526956268|FG000|Overall Study|Withdrawal by Subject|5|||
146261737|NCT02484547|527472796|FG003|Long-Term Extension Period|Study Visit Burden|2|||
146119472|NCT00268996|526956269|FG001|Overall Study|Withdrawal by Subject|11|||
146119473|NCT00268996|526956268|FG000|Overall Study|Non-compliance|1|||
146119474|NCT00268996|526956269|FG001|Overall Study|Non-compliance|0|||
146119475|NCT00268996|526956268|FG000|Overall Study|Other|1|||
146119476|NCT00268996|526956269|FG001|Overall Study|Other|1|||
146119477|NCT02956486|526956270|FG000|Core Phase|Adverse Event|51|||
146119478|NCT02956486|526956271|FG001|Core Phase|Adverse Event|88|||
146119479|NCT02956486|526956272|FG002|Core Phase|Adverse Event|0|||
146119480|NCT02956486|526956270|FG000|Core Phase|Lost to Follow-up|8|||
146119481|NCT02956486|526956271|FG001|Core Phase|Lost to Follow-up|6|||
146119482|NCT02956486|526956272|FG002|Core Phase|Lost to Follow-up|0|||
146119483|NCT02956486|526956270|FG000|Core Phase|Inadequate therapeutic effect|4|||
146119484|NCT02956486|526956271|FG001|Core Phase|Inadequate therapeutic effect|5|||
146119485|NCT02956486|526956272|FG002|Core Phase|Inadequate therapeutic effect|0|||
146119486|NCT02956486|526956270|FG000|Core Phase|Withdrawal by Subject|101|||
146119487|NCT02956486|526956271|FG001|Core Phase|Withdrawal by Subject|104|||
146119488|NCT02956486|526956272|FG002|Core Phase|Withdrawal by Subject|0|||
146119489|NCT02956486|526956270|FG000|Core Phase|Study terminated by sponsor|888|||
146119490|NCT02956486|526956271|FG001|Core Phase|Study terminated by sponsor|848|||
146119491|NCT02956486|526956272|FG002|Core Phase|Study terminated by sponsor|0|||
146119492|NCT02956486|526956270|FG000|Core Phase|Other|27|||
146119493|NCT02956486|526956271|FG001|Core Phase|Other|18|||
146119494|NCT02956486|526956272|FG002|Core Phase|Other|0|||
146119495|NCT02956486|526956270|FG000|Core Phase|Not treated|0|||
146119496|NCT02956486|526956271|FG001|Core Phase|Not treated|3|||
146119497|NCT02956486|526956272|FG002|Core Phase|Not treated|0|||
146119498|NCT02956486|526956270|FG000|Extension Phase|Adverse Event|0|||
146119499|NCT02956486|526956271|FG001|Extension Phase|Adverse Event|0|||
146119500|NCT02956486|526956272|FG002|Extension Phase|Adverse Event|2|||
146119501|NCT02956486|526956270|FG000|Extension Phase|Study terminated by sponsor|0|||
146119502|NCT02956486|526956271|FG001|Extension Phase|Study terminated by sponsor|0|||
146119503|NCT02956486|526956272|FG002|Extension Phase|Study terminated by sponsor|16|||
146119504|NCT02956486|526956270|FG000|Extension Phase|Not Treated|0|||
146119505|NCT02956486|526956271|FG001|Extension Phase|Not Treated|0|||
146119506|NCT02956486|526956272|FG002|Extension Phase|Not Treated|1|||
146119507|NCT00422591|526956275|FG000|Overall Study|Physician Decision|4|||
146119508|NCT00422591|526956275|FG000|Overall Study|Withdrawal by Subject|2|||
146119509|NCT02377466|526956276|FG000|Overall Study|Other: Randomized and not treated|0|||
146119510|NCT02377466|526956277|FG001|Overall Study|Other: Randomized and not treated|2|||
146119511|NCT04210310|526956278|FG000|Overall Study|Lost to Follow-up|32|||
146119512|NCT04210310|526956279|FG001|Overall Study|Lost to Follow-up|1|||
146119513|NCT00330616|526956280|FG000|Overall Study|Adverse Event|13|||
146119514|NCT00330616|526956280|FG000|Overall Study|Lack of Efficacy|1|||
146119515|NCT00330616|526956280|FG000|Overall Study|Lost to Follow-up|2|||
146119516|NCT00330616|526956280|FG000|Overall Study|Withdrawal by Subject|4|||
146119517|NCT00330616|526956280|FG000|Overall Study|Other|1|||
146119518|NCT02617511|526956287|FG000|Overall Study|Withdrawal by Subject|1|||
146119519|NCT02617511|526956288|FG001|Overall Study|Withdrawal by Subject|0|||
146119520|NCT00255047|526956289|FG000|Overall Study|Serious Adverse Events|2|||
146119521|NCT00255047|526956290|FG001|Overall Study|Serious Adverse Events|1|||
146119522|NCT00255047|526956291|FG002|Overall Study|Serious Adverse Events|2|||
146119523|NCT00255047|526956292|FG003|Overall Study|Serious Adverse Events|1|||
146119524|NCT00255047|526956289|FG000|Overall Study|Adverse Event|0|||
146119525|NCT00255047|526956290|FG001|Overall Study|Adverse Event|3|||
146119526|NCT00255047|526956291|FG002|Overall Study|Adverse Event|2|||
146119527|NCT00255047|526956292|FG003|Overall Study|Adverse Event|1|||
146119528|NCT00255047|526956289|FG000|Overall Study|Protocol Violation|13|||
146119529|NCT00255047|526956290|FG001|Overall Study|Protocol Violation|13|||
146119530|NCT00255047|526956291|FG002|Overall Study|Protocol Violation|16|||
146119531|NCT00255047|526956292|FG003|Overall Study|Protocol Violation|20|||
146119532|NCT00255047|526956289|FG000|Overall Study|Lost to Follow-up|9|||
146119533|NCT00255047|526956290|FG001|Overall Study|Lost to Follow-up|8|||
146119534|NCT00255047|526956291|FG002|Overall Study|Lost to Follow-up|5|||
146119535|NCT00255047|526956292|FG003|Overall Study|Lost to Follow-up|6|||
146119536|NCT00255047|526956289|FG000|Overall Study|Withdrawal by Subject|24|||
146119537|NCT00255047|526956290|FG001|Overall Study|Withdrawal by Subject|23|||
146119538|NCT00255047|526956291|FG002|Overall Study|Withdrawal by Subject|25|||
146261738|NCT02484547|527472797|FG004|Long-Term Extension Period|Study Visit Burden|0|||
146261739|NCT02484547|527472798|FG005|Long-Term Extension Period|Study Visit Burden|0|||
146261740|NCT02484547|527472799|FG006|Long-Term Extension Period|Study Visit Burden|3|||
146261741|NCT02484547|527472793|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146261742|NCT02484547|527472794|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146261743|NCT02484547|527472795|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146261744|NCT02484547|527472796|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
146261745|NCT02484547|527472797|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
146261746|NCT02484547|527472798|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
146261747|NCT02484547|527472799|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
146261748|NCT02484547|527472793|FG000|Long-Term Extension Period|Reason not Specified|0|||
146261749|NCT02484547|527472794|FG001|Long-Term Extension Period|Reason not Specified|0|||
146119539|NCT00255047|526956292|FG003|Overall Study|Withdrawal by Subject|18|||
146119540|NCT00811473|526956293|FG000|Overall Study|Adverse Event|3|||
146119541|NCT00811473|526956294|FG001|Overall Study|Adverse Event|12|||
146302761|NCT03828292|527621744|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146302762|NCT03828292|527621745|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146302763|NCT03828292|527621746|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
146302764|NCT03828292|527621747|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146302765|NCT03828292|527621748|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
146302766|NCT03828292|527621743|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146302767|NCT03828292|527621744|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146302768|NCT03828292|527621745|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146302769|NCT03828292|527621746|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
146302770|NCT03828292|527621747|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146302771|NCT03828292|527621748|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
146302772|NCT03828292|527621743|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146302773|NCT03828292|527621744|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146302774|NCT03828292|527621745|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
146302775|NCT03828292|527621746|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
146302776|NCT03828292|527621747|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146302777|NCT03828292|527621748|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
146302778|NCT01444456|527621749|FG000|Overall Study|Withdrawal by Subject|21|||
146302779|NCT01444456|527621749|FG000|Overall Study|Physician Decision|9|||
146302780|NCT01444456|527621749|FG000|Overall Study|Lost to Follow-up|37|||
146302781|NCT01444456|527621749|FG000|Overall Study|Death|73|||
146302782|NCT01444456|527621749|FG000|Overall Study|Ineligibility determined|23|||
146302783|NCT01444456|527621749|FG000|Overall Study|Other|18|||
146302784|NCT01444456|527621749|FG000|Overall Study|Not treated|104|||
146302785|NCT04376827|527621753|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
146302786|NCT04376827|527621754|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
146302787|NCT04376827|527621753|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
146302788|NCT04376827|527621754|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
146302789|NCT04376827|527621753|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
146302790|NCT04376827|527621754|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
146302791|NCT04376827|527621753|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
146302792|NCT04376827|527621754|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
146302793|NCT04376827|527621753|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
146302794|NCT04376827|527621754|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
146302795|NCT00682448|527623969|FG000|Overall Study|Adverse Event|1|||
146302796|NCT00682448|527623970|FG001|Overall Study|Adverse Event|2|||
146302797|NCT00682448|527623969|FG000|Overall Study|Lack of Efficacy|1|||
146302798|NCT00682448|527623970|FG001|Overall Study|Lack of Efficacy|0|||
146302799|NCT00682448|527623969|FG000|Overall Study|Lost to Follow-up|1|||
146302800|NCT00682448|527623970|FG001|Overall Study|Lost to Follow-up|3|||
146302801|NCT00682448|527623969|FG000|Overall Study|Pregnancy|0|||
146302802|NCT00682448|527623970|FG001|Overall Study|Pregnancy|1|||
146302803|NCT00682448|527623969|FG000|Overall Study|Withdrawal by Subject|2|||
146302804|NCT00682448|527623970|FG001|Overall Study|Withdrawal by Subject|0|||
146302805|NCT00761306|527623973|FG000|Overall Study|Adverse Event|5|||
146302806|NCT00761306|527623973|FG000|Overall Study|Lack of Efficacy|4|||
146302807|NCT00761306|527623973|FG000|Overall Study|Protocol Violation|2|||
146302808|NCT00761306|527623973|FG000|Overall Study|Withdrawal of Consent|3|||
146302809|NCT00761306|527623973|FG000|Overall Study|Lost to Follow-up|1|||
146302810|NCT00761306|527623973|FG000|Overall Study|Administrative or Other Reasons|5|||
146119542|NCT00811473|526956293|FG000|Overall Study|Lost to Follow-up|5|||
146119543|NCT00811473|526956294|FG001|Overall Study|Lost to Follow-up|1|||
146119544|NCT00811473|526956293|FG000|Overall Study|Withdrawal by Subject|2|||
146119545|NCT00811473|526956294|FG001|Overall Study|Withdrawal by Subject|4|||
146119546|NCT00811473|526956293|FG000|Overall Study|Severe non-compliance to protocol|2|||
146119547|NCT00811473|526956294|FG001|Overall Study|Severe non-compliance to protocol|4|||
146119548|NCT00811473|526956293|FG000|Overall Study|Lack of therapeutic response|4|||
146119549|NCT00811473|526956294|FG001|Overall Study|Lack of therapeutic response|1|||
146119550|NCT00811473|526956293|FG000|Overall Study|Condition under investigation worsened|1|||
146119551|NCT00811473|526956294|FG001|Overall Study|Condition under investigation worsened|3|||
146302811|NCT00268437|527623974|FG000|Overall Study|Ineligible|1|||
146302812|NCT00525044|527623975|FG000|Overall Study|Lost to Follow-up|0|||
146119552|NCT00811473|526956293|FG000|Overall Study|Other 2|4|||
146302813|NCT00525044|527623976|FG001|Overall Study|Lost to Follow-up|1|||
146302814|NCT02142738|527623977|FG000|Overall Study|Adverse Event|13|||
146302815|NCT02142738|527623978|FG001|Overall Study|Adverse Event|9|||
146302816|NCT02142738|527623977|FG000|Overall Study|Death|92|||
146302817|NCT02142738|527623978|FG001|Overall Study|Death|112|||
146302818|NCT02142738|527623977|FG000|Overall Study|Lost to Follow-up|0|||
146119553|NCT00811473|526956294|FG001|Overall Study|Other 2|1|||
146119554|NCT00811473|526956293|FG000|Overall Study|Incorrect Enrollment|1|||
146119555|NCT00811473|526956294|FG001|Overall Study|Incorrect Enrollment|0|||
146119556|NCT00811473|526956293|FG000|Overall Study|Safety Reasons|1|||
146119557|NCT00811473|526956294|FG001|Overall Study|Safety Reasons|0|||
146119558|NCT04446377|526956304|FG000|Overall Study|Withdrawal by Subject|6|||
146119559|NCT04446377|526956305|FG001|Overall Study|Withdrawal by Subject|1|||
146119560|NCT04446377|526956304|FG000|Overall Study|Physician Decision|1|||
146119561|NCT04446377|526956305|FG001|Overall Study|Physician Decision|1|||
146119562|NCT04446377|526956304|FG000|Overall Study|Lost to Follow-up|0|||
146119563|NCT04446377|526956305|FG001|Overall Study|Lost to Follow-up|2|||
146119564|NCT04446377|526956304|FG000|Overall Study|Not eligible|0|||
146119565|NCT04446377|526956305|FG001|Overall Study|Not eligible|1|||
146119566|NCT01187043|526956307|FG000|Overall Study|Adverse Event|0|||
146119567|NCT01187043|526956308|FG001|Overall Study|Adverse Event|0|||
146119568|NCT01187043|526956309|FG002|Overall Study|Adverse Event|0|||
146119569|NCT01187043|526956310|FG003|Overall Study|Adverse Event|0|||
146119570|NCT01187043|526956311|FG004|Overall Study|Adverse Event|1|||
146119571|NCT01187043|526956307|FG000|Overall Study|Unable to make scheduled visits|1|||
146119572|NCT01187043|526956308|FG001|Overall Study|Unable to make scheduled visits|0|||
146119573|NCT01187043|526956309|FG002|Overall Study|Unable to make scheduled visits|4|||
146119574|NCT01187043|526956310|FG003|Overall Study|Unable to make scheduled visits|0|||
146119575|NCT01187043|526956311|FG004|Overall Study|Unable to make scheduled visits|1|||
146119576|NCT04903626|526956312|FG000|Overall Study|Lost to Follow-up|6|||
146119577|NCT04903626|526956312|FG000|Overall Study|Withdrawal by Subject|1|||
146119578|NCT04903626|526956312|FG000|Overall Study|Other, Not Specified|1|||
146119579|NCT00573534|526956313|FG000|Overall Study|oppositional behavior|3|||
146119580|NCT00927784|526956316|FG000|Overall Study|Death|1|||
146119581|NCT00927784|526956317|FG001|Overall Study|Death|0|||
146119582|NCT00927784|526956316|FG000|Overall Study|Withdrawal by Subject|1|||
146119583|NCT00927784|526956317|FG001|Overall Study|Withdrawal by Subject|0|||
146119584|NCT02457910|526956318|FG000|Overall Study|Withdrawal by Subject|0|||
146119585|NCT02457910|526956319|FG001|Overall Study|Withdrawal by Subject|0|||
146119586|NCT02457910|526956320|FG002|Overall Study|Withdrawal by Subject|0|||
146119587|NCT02457910|526956321|FG003|Overall Study|Withdrawal by Subject|0|||
146119588|NCT02457910|526956322|FG004|Overall Study|Withdrawal by Subject|0|||
146119589|NCT02457910|526956323|FG005|Overall Study|Withdrawal by Subject|1|||
146119590|NCT02457910|526956318|FG000|Overall Study|Adverse Event|0|||
146119591|NCT02457910|526956319|FG001|Overall Study|Adverse Event|2|||
146119592|NCT02457910|526956320|FG002|Overall Study|Adverse Event|1|||
146119593|NCT02457910|526956321|FG003|Overall Study|Adverse Event|1|||
146119594|NCT02457910|526956322|FG004|Overall Study|Adverse Event|1|||
146119595|NCT02457910|526956323|FG005|Overall Study|Adverse Event|3|||
146119596|NCT02457910|526956318|FG000|Overall Study|Disease progression|3|||
146119597|NCT02457910|526956319|FG001|Overall Study|Disease progression|3|||
146119598|NCT02457910|526956320|FG002|Overall Study|Disease progression|1|||
146119599|NCT02457910|526956321|FG003|Overall Study|Disease progression|1|||
146119600|NCT02457910|526956322|FG004|Overall Study|Disease progression|4|||
146119601|NCT02457910|526956323|FG005|Overall Study|Disease progression|6|||
146119602|NCT02457910|526956318|FG000|Overall Study|Other complicating illness|0|||
146119603|NCT02457910|526956319|FG001|Overall Study|Other complicating illness|0|||
146119604|NCT02457910|526956320|FG002|Overall Study|Other complicating illness|0|||
146119605|NCT02457910|526956321|FG003|Overall Study|Other complicating illness|0|||
146119606|NCT02457910|526956322|FG004|Overall Study|Other complicating illness|0|||
146119607|NCT02457910|526956323|FG005|Overall Study|Other complicating illness|1|||
146119608|NCT02457910|526956318|FG000|Overall Study|Death|0|||
146119609|NCT02457910|526956319|FG001|Overall Study|Death|0|||
146119610|NCT02457910|526956320|FG002|Overall Study|Death|1|||
146119611|NCT02457910|526956321|FG003|Overall Study|Death|0|||
146119612|NCT02457910|526956322|FG004|Overall Study|Death|0|||
146119613|NCT02457910|526956323|FG005|Overall Study|Death|0|||
146261750|NCT02484547|527472795|FG002|Long-Term Extension Period|Reason not Specified|0|||
146119614|NCT00467259|526956324|FG000|Overall Study|Adverse Event|24|||
146119615|NCT00467259|526956325|FG001|Overall Study|Adverse Event|90|||
146119616|NCT00467259|526956324|FG000|Overall Study|Protocol Violation|1|||
146261751|NCT02484547|527472796|FG003|Long-Term Extension Period|Reason not Specified|119|||
146119617|NCT00467259|526956325|FG001|Overall Study|Protocol Violation|7|||
146119618|NCT00467259|526956324|FG000|Overall Study|Withdrawal by Subject|34|||
146119619|NCT00467259|526956325|FG001|Overall Study|Withdrawal by Subject|108|||
146119620|NCT00467259|526956324|FG000|Overall Study|Physician Decision|0|||
146119621|NCT00467259|526956325|FG001|Overall Study|Physician Decision|2|||
146119622|NCT00467259|526956324|FG000|Overall Study|Lost to Follow-up|14|||
146119623|NCT00467259|526956325|FG001|Overall Study|Lost to Follow-up|34|||
146119624|NCT00467259|526956324|FG000|Overall Study|Site Closed|2|||
146119625|NCT00467259|526956325|FG001|Overall Study|Site Closed|1|||
146119626|NCT02196558|526956326|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
146119627|NCT02196558|526956327|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
146119628|NCT02196558|526956328|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
146119629|NCT02196558|526956326|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
146119630|NCT02196558|526956327|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
146302819|NCT02142738|527623978|FG001|Overall Study|Lost to Follow-up|3|||
146119631|NCT02196558|526956328|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
146119632|NCT02196558|526956326|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
146119633|NCT02196558|526956327|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
146119634|NCT02196558|526956328|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
146119635|NCT02196558|526956326|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
146119636|NCT02196558|526956327|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
146119637|NCT02196558|526956328|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
146119638|NCT02196558|526956326|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146119639|NCT02196558|526956327|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146119640|NCT02196558|526956328|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
146119641|NCT01846611|526956338|FG000|Overall Study|Lost to Follow-up|4|||
146119642|NCT01846611|526956339|FG001|Overall Study|Lost to Follow-up|6|||
146119643|NCT01846611|526956338|FG000|Overall Study|Withdrawal by Subject|15|||
146119644|NCT01846611|526956339|FG001|Overall Study|Withdrawal by Subject|19|||
146119645|NCT01846611|526956338|FG000|Overall Study|Other|19|||
146119646|NCT01846611|526956339|FG001|Overall Study|Other|18|||
146119647|NCT00680043|526956340|FG000|Overall Study|Withdrawal by Subject|1|||
146119648|NCT00680043|526956341|FG001|Overall Study|Withdrawal by Subject|0|||
146119649|NCT00680043|526956342|FG002|Overall Study|Withdrawal by Subject|0|||
146119650|NCT00680043|526956340|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
146119651|NCT00680043|526956341|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
146119652|NCT00680043|526956342|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
146119653|NCT00680043|526956340|FG000|Overall Study|Renal Transplant|1|||
146119654|NCT00680043|526956341|FG001|Overall Study|Renal Transplant|0|||
146119655|NCT00680043|526956342|FG002|Overall Study|Renal Transplant|4|||
146119656|NCT03061331|526956343|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
146119657|NCT03061331|526956344|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
146119658|NCT01980875|526956345|FG000|Overall Study|Withdrew Consent|1|||
146119659|NCT01980875|526956346|FG001|Overall Study|Withdrew Consent|1|||
146119660|NCT01980875|526956347|FG002|Overall Study|Withdrew Consent|1|||
146119661|NCT01980875|526956345|FG000|Overall Study|Study Terminated by Sponsor|7|||
146119662|NCT01980875|526956346|FG001|Overall Study|Study Terminated by Sponsor|24|||
146119663|NCT01980875|526956347|FG002|Overall Study|Study Terminated by Sponsor|22|||
146119664|NCT01980875|526956345|FG000|Overall Study|Lost to Follow-up|0|||
146119665|NCT01980875|526956346|FG001|Overall Study|Lost to Follow-up|0|||
146119666|NCT01980875|526956347|FG002|Overall Study|Lost to Follow-up|1|||
146119667|NCT00513474|526956348|FG000|Overall Study|Death|6|||
146119668|NCT00513474|526956349|FG001|Overall Study|Death|9|||
146119669|NCT00513474|526956348|FG000|Overall Study|Participant Withdrew Consent|1|||
146119670|NCT00513474|526956349|FG001|Overall Study|Participant Withdrew Consent|0|||
146119671|NCT01686633|526956350|FG000|Overall Study|Lack of Efficacy|33|||
146119672|NCT01686633|526956351|FG001|Overall Study|Lack of Efficacy|13|||
146119673|NCT01686633|526956352|FG002|Overall Study|Lack of Efficacy|11|||
146119674|NCT01686633|526956350|FG000|Overall Study|Withdrawal by Subject|8|||
146119675|NCT01686633|526956351|FG001|Overall Study|Withdrawal by Subject|8|||
146119676|NCT01686633|526956352|FG002|Overall Study|Withdrawal by Subject|5|||
146119677|NCT01686633|526956350|FG000|Overall Study|Physician Decision|3|||
146119678|NCT01686633|526956351|FG001|Overall Study|Physician Decision|4|||
146119679|NCT01686633|526956352|FG002|Overall Study|Physician Decision|4|||
146119680|NCT01686633|526956350|FG000|Overall Study|Adverse Event|4|||
146119681|NCT01686633|526956351|FG001|Overall Study|Adverse Event|3|||
146119682|NCT01686633|526956352|FG002|Overall Study|Adverse Event|3|||
146119683|NCT01686633|526956350|FG000|Overall Study|Protocol Violation|2|||
146119684|NCT01686633|526956351|FG001|Overall Study|Protocol Violation|3|||
146119685|NCT01686633|526956352|FG002|Overall Study|Protocol Violation|0|||
146119686|NCT01686633|526956350|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
146119687|NCT01686633|526956351|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146119688|NCT01686633|526956352|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
146119689|NCT01686633|526956350|FG000|Overall Study|Lost to Follow-up|0|||
146119690|NCT01686633|526956351|FG001|Overall Study|Lost to Follow-up|1|||
146119691|NCT01686633|526956352|FG002|Overall Study|Lost to Follow-up|1|||
146119692|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Adverse Event|82|||
146119693|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Death|6|||
146119694|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
146119695|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
146119696|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
146119697|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
146119698|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
146119699|NCT00195676|526956358|FG000|Period O - Open-label Treatment|Other reasons|68|||
146119700|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
146119701|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
146119702|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
146119703|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
146119704|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
146302820|NCT02142738|527623977|FG000|Overall Study|Withdrawal by Subject|6|||
146302821|NCT02142738|527623978|FG001|Overall Study|Withdrawal by Subject|7|||
146302822|NCT02142738|527623977|FG000|Overall Study|Follow up ended by sponsor|43|||
146302823|NCT02142738|527623978|FG001|Overall Study|Follow up ended by sponsor|20|||
146119705|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
146261752|NCT02484547|527472797|FG004|Long-Term Extension Period|Reason not Specified|117|||
146261753|NCT02484547|527472798|FG005|Long-Term Extension Period|Reason not Specified|223|||
146261754|NCT02484547|527472799|FG006|Long-Term Extension Period|Reason not Specified|231|||
146261755|NCT03765164|527472800|FG000|Pre-intervention|Withdrawal by Subject|5|||
146261756|NCT03765164|527472801|FG001|Pre-intervention|Withdrawal by Subject|6|||
146261757|NCT03448536|527472802|FG000|Overall Study|Protocol Violation|2|||
146261758|NCT03448536|527472803|FG001|Overall Study|Protocol Violation|0|||
146261759|NCT03448536|527472802|FG000|Overall Study|Pregnancy|1|||
146261760|NCT03448536|527472803|FG001|Overall Study|Pregnancy|0|||
146261761|NCT03448536|527472802|FG000|Overall Study|Withdrawal by Subject|1|||
146261762|NCT03448536|527472803|FG001|Overall Study|Withdrawal by Subject|2|||
146261763|NCT03448536|527472802|FG000|Overall Study|Lost to Follow-up|3|||
146261764|NCT03448536|527472803|FG001|Overall Study|Lost to Follow-up|2|||
146261765|NCT03448536|527472802|FG000|Overall Study|Inadequate pain reporter|1|||
146261766|NCT03448536|527472803|FG001|Overall Study|Inadequate pain reporter|0|||
146261767|NCT03448536|527472802|FG000|Overall Study|Other|3|||
146261768|NCT03448536|527472803|FG001|Overall Study|Other|0|||
146261769|NCT03448536|527472802|FG000|Overall Study|Physician Decision|1|||
146261770|NCT03448536|527472803|FG001|Overall Study|Physician Decision|0|||
146261771|NCT01665599|527472804|FG000|Overall Study|Adverse Event|1|||
146261772|NCT01665599|527472804|FG000|Overall Study|Consent Withdrawn|1|||
146261773|NCT01665599|527472804|FG000|Overall Study|Investigator/Sponsor decision|1|||
146261774|NCT01665599|527472804|FG000|Overall Study|Death|1|||
146261775|NCT01665599|527472804|FG000|Overall Study|Lost to Follow-up|2|||
146261776|NCT01665599|527472804|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
146261777|NCT01665599|527472804|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
146261778|NCT01494298|527472805|FG000|Overall Study|Protocol Violation|2|||
146261779|NCT01494298|527472806|FG001|Overall Study|Protocol Violation|8|||
146261780|NCT00702520|527472807|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146261781|NCT00702520|527472808|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
146261782|NCT00702520|527472809|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146261783|NCT00702520|527472810|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
146261784|NCT00702520|527472807|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
146261785|NCT00702520|527472808|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
146261786|NCT00702520|527472809|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
146261787|NCT00702520|527472810|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
146261788|NCT00702520|527472807|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
146261789|NCT00702520|527472808|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
146261790|NCT00702520|527472809|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
146261791|NCT00702520|527472810|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
146261792|NCT00942188|527472811|FG000|Overall Study|Adverse Event|0|||
146261793|NCT00942188|527472812|FG001|Overall Study|Adverse Event|3|||
146261794|NCT00942188|527472813|FG002|Overall Study|Adverse Event|2|||
146261795|NCT00942188|527472814|FG003|Overall Study|Adverse Event|0|||
146261796|NCT00942188|527472811|FG000|Overall Study|Lack of Efficacy|0|||
146261797|NCT00942188|527472812|FG001|Overall Study|Lack of Efficacy|0|||
146261798|NCT00942188|527472813|FG002|Overall Study|Lack of Efficacy|0|||
146261799|NCT00942188|527472814|FG003|Overall Study|Lack of Efficacy|1|||
146261800|NCT00942188|527472811|FG000|Overall Study|Protocol Violation|1|||
146261801|NCT00942188|527472812|FG001|Overall Study|Protocol Violation|1|||
146261802|NCT00942188|527472813|FG002|Overall Study|Protocol Violation|0|||
146261803|NCT00942188|527472814|FG003|Overall Study|Protocol Violation|0|||
146261804|NCT00942188|527472811|FG000|Overall Study|Lost to Follow-up|2|||
146261805|NCT00942188|527472812|FG001|Overall Study|Lost to Follow-up|1|||
146302824|NCT03688880|527623979|FG000|Overall Study|Withdrawal by Subject|0|||
146302825|NCT03688880|527623980|FG001|Overall Study|Withdrawal by Subject|2|||
146119706|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
146119707|NCT00195676|526956358|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
146261806|NCT00942188|527472813|FG002|Overall Study|Lost to Follow-up|2|||
146261807|NCT00942188|527472814|FG003|Overall Study|Lost to Follow-up|0|||
146261808|NCT00942188|527472811|FG000|Overall Study|Withdrawal by Subject|1|||
146261809|NCT00942188|527472812|FG001|Overall Study|Withdrawal by Subject|3|||
146261810|NCT00942188|527472813|FG002|Overall Study|Withdrawal by Subject|4|||
146261811|NCT00942188|527472814|FG003|Overall Study|Withdrawal by Subject|2|||
146261812|NCT00942188|527472811|FG000|Overall Study|Physician Decision|0|||
146261813|NCT00942188|527472812|FG001|Overall Study|Physician Decision|0|||
146261814|NCT00942188|527472813|FG002|Overall Study|Physician Decision|1|||
146261815|NCT00942188|527472814|FG003|Overall Study|Physician Decision|0|||
146261816|NCT00942188|527472811|FG000|Overall Study|Sponsor Decision|0|||
146261817|NCT00942188|527472812|FG001|Overall Study|Sponsor Decision|2|||
146119708|NCT00195676|526956358|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
146119709|NCT00195676|526956358|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
146119710|NCT00195676|526956358|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
146119711|NCT00195676|526956358|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
146119712|NCT00195676|526956358|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
146119713|NCT03334903|526956360|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
146168221|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146302826|NCT03688880|527623979|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
146302827|NCT03688880|527623980|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
146302828|NCT03688880|527623979|FG000|Overall Study|Lost to Follow-up|4|||
146168222|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146168223|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146168224|NCT02496767|527128085|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168225|NCT02496767|527128086|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
146168226|NCT02496767|527128087|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168227|NCT02496767|527128088|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168228|NCT02496767|527128089|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168229|NCT02496767|527128090|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168230|NCT02496767|527128091|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168231|NCT02496767|527128092|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
146168232|NCT02496767|527128085|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168233|NCT02496767|527128086|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168234|NCT02496767|527128087|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168235|NCT02496767|527128088|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168236|NCT02496767|527128089|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168237|NCT02496767|527128090|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
146168238|NCT02496767|527128091|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
146168239|NCT02496767|527128092|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
146168240|NCT02496767|527128085|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
146168241|NCT02496767|527128086|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
146168242|NCT02496767|527128087|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
146168243|NCT02496767|527128088|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
146168244|NCT02496767|527128089|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
146168245|NCT02496767|527128090|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
146168246|NCT02496767|527128091|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
146168247|NCT02496767|527128092|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
146168248|NCT02496767|527128085|FG000|Double-blind, Withdrawal Phase|Death|0|||
146168249|NCT02496767|527128086|FG001|Double-blind, Withdrawal Phase|Death|0|||
146168250|NCT02496767|527128087|FG002|Double-blind, Withdrawal Phase|Death|0|||
146168251|NCT02496767|527128088|FG003|Double-blind, Withdrawal Phase|Death|0|||
146168252|NCT02496767|527128089|FG004|Double-blind, Withdrawal Phase|Death|0|||
146168253|NCT02496767|527128090|FG005|Double-blind, Withdrawal Phase|Death|0|||
146168254|NCT02496767|527128091|FG006|Double-blind, Withdrawal Phase|Death|1|||
146168255|NCT02496767|527128092|FG007|Double-blind, Withdrawal Phase|Death|2|||
146168256|NCT02496767|527128085|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146168257|NCT02496767|527128086|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146168258|NCT02496767|527128087|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146168259|NCT02496767|527128088|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146168260|NCT02496767|527128089|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
146168261|NCT02496767|527128090|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146168262|NCT02496767|527128091|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146168263|NCT02496767|527128092|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
146168264|NCT02889133|527128093|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
146168265|NCT02889133|527128094|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
146168266|NCT02889133|527128093|FG000|Completed Primary Outcome|Manufacturing error|3|||
146168267|NCT02889133|527128094|FG001|Completed Primary Outcome|Manufacturing error|8|||
146168268|NCT02889133|527128093|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
146168269|NCT02889133|527128094|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
146168270|NCT02889133|527128093|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
146168271|NCT02889133|527128094|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
146168272|NCT02889133|527128093|FG000|Completed Primary Outcome|Protocol Violation|1|||
146168273|NCT02889133|527128094|FG001|Completed Primary Outcome|Protocol Violation|0|||
146168274|NCT02889133|527128093|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
146168275|NCT02889133|527128094|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
146168276|NCT02889133|527128093|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
146168277|NCT02889133|527128094|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
146119714|NCT03334903|526956361|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
146119715|NCT03334903|526956360|FG000|Overall Study|Protocol Violation|1|||
146119716|NCT03334903|526956361|FG001|Overall Study|Protocol Violation|3|||
146119717|NCT03334903|526956360|FG000|Overall Study|Surgery postponed|1|||
146119718|NCT03334903|526956361|FG001|Overall Study|Surgery postponed|0|||
146119719|NCT03334903|526956360|FG000|Overall Study|Adverse Event|1|||
146119720|NCT03334903|526956361|FG001|Overall Study|Adverse Event|1|||
146119721|NCT03334903|526956360|FG000|Overall Study|Withdrawal by Subject|0|||
146119722|NCT03334903|526956361|FG001|Overall Study|Withdrawal by Subject|1|||
146261818|NCT00942188|527472813|FG002|Overall Study|Sponsor Decision|0|||
146261819|NCT00942188|527472814|FG003|Overall Study|Sponsor Decision|1|||
146261820|NCT04944784|527472819|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
146261821|NCT04944784|527472820|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
146261822|NCT04944784|527472821|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
146261823|NCT04944784|527472822|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
146261824|NCT04944784|527472819|FG000|Double-blind Period|Adverse Event|20|||
146261825|NCT04944784|527472820|FG001|Double-blind Period|Adverse Event|4|||
146119740|NCT02879305|526956367|FG000|Overall Study|Investigator Site Closed|55|||
146119741|NCT02879305|526956368|FG001|Overall Study|Investigator Site Closed|57|||
146119742|NCT02879305|526956367|FG000|Overall Study|Withdrawal by Subject|44|||
146119743|NCT02879305|526956368|FG001|Overall Study|Withdrawal by Subject|42|||
146119744|NCT02879305|526956367|FG000|Overall Study|Lost to Follow-up|17|||
146119745|NCT02879305|526956368|FG001|Overall Study|Lost to Follow-up|12|||
146119746|NCT02879305|526956367|FG000|Overall Study|Other|1|||
146119747|NCT02879305|526956368|FG001|Overall Study|Other|0|||
146119748|NCT02636868|526958340|FG000|Overall Study|Death|0|||
146119749|NCT02636868|526958341|FG001|Overall Study|Death|1|||
146119750|NCT02636868|526958342|FG002|Overall Study|Death|2|||
146119751|NCT03220217|526958343|FG000|Overall Study|Withdrawal by Subject|0|||
146119752|NCT03220217|526958344|FG001|Overall Study|Withdrawal by Subject|1|||
146119753|NCT03220217|526958345|FG002|Overall Study|Withdrawal by Subject|0|||
146119754|NCT03220217|526958343|FG000|Overall Study|Subject Missed Procedure|0|||
146119755|NCT03220217|526958344|FG001|Overall Study|Subject Missed Procedure|0|||
146119756|NCT03220217|526958345|FG002|Overall Study|Subject Missed Procedure|1|||
146119757|NCT03025542|526958346|FG000|Overall Study|Adverse Event|0|||
146119758|NCT03025542|526958347|FG001|Overall Study|Adverse Event|2|||
146119759|NCT03025542|526958346|FG000|Overall Study|Lost to Follow-up|1|||
146119760|NCT03025542|526958347|FG001|Overall Study|Lost to Follow-up|0|||
146119761|NCT03025542|526958346|FG000|Overall Study|Withdrawal by Subject|1|||
146119762|NCT03025542|526958347|FG001|Overall Study|Withdrawal by Subject|0|||
146119763|NCT00312494|526958348|FG000|Overall Study|Randomized; not treated with study drug|9|||
146119764|NCT00312494|526958349|FG001|Overall Study|Randomized; not treated with study drug|10|||
146119765|NCT00312494|526958350|FG002|Overall Study|Randomized; not treated with study drug|5|||
146119766|NCT00312494|526958348|FG000|Overall Study|Adverse Event|33|||
146119767|NCT00312494|526958349|FG001|Overall Study|Adverse Event|15|||
146119768|NCT00312494|526958350|FG002|Overall Study|Adverse Event|11|||
146119769|NCT00312494|526958348|FG000|Overall Study|Lack of Efficacy|4|||
146119770|NCT00312494|526958349|FG001|Overall Study|Lack of Efficacy|6|||
146119771|NCT00312494|526958350|FG002|Overall Study|Lack of Efficacy|8|||
146119772|NCT00312494|526958348|FG000|Overall Study|Laboratory abnormality|1|||
146119773|NCT00312494|526958349|FG001|Overall Study|Laboratory abnormality|0|||
146119774|NCT00312494|526958350|FG002|Overall Study|Laboratory abnormality|0|||
146119775|NCT00312494|526958348|FG000|Overall Study|Lost to Follow-up|8|||
146119776|NCT00312494|526958349|FG001|Overall Study|Lost to Follow-up|8|||
146119777|NCT00312494|526958350|FG002|Overall Study|Lost to Follow-up|8|||
146119778|NCT00312494|526958348|FG000|Overall Study|Withdrawal by Subject|6|||
146119779|NCT00312494|526958349|FG001|Overall Study|Withdrawal by Subject|9|||
146119780|NCT00312494|526958350|FG002|Overall Study|Withdrawal by Subject|10|||
146119781|NCT00312494|526958348|FG000|Overall Study|Other|10|||
146119782|NCT00312494|526958349|FG001|Overall Study|Other|10|||
146119783|NCT00312494|526958350|FG002|Overall Study|Other|1|||
146119784|NCT00501293|526958351|FG000|Optimization Period|Enrolled in error|1|||
146119785|NCT00501293|526958352|FG001|Optimization Period|Enrolled in error|0|||
146119786|NCT00501293|526958351|FG000|Maintenance Period|Withdrawal by Subject|14|||
146119787|NCT00501293|526958352|FG001|Maintenance Period|Withdrawal by Subject|13|||
146119788|NCT00501293|526958351|FG000|Maintenance Period|Lost to Follow-up|12|||
146119789|NCT00501293|526958352|FG001|Maintenance Period|Lost to Follow-up|7|||
146119790|NCT00501293|526958351|FG000|Maintenance Period|Adverse Event|6|||
146119791|NCT00501293|526958352|FG001|Maintenance Period|Adverse Event|6|||
146119792|NCT00501293|526958351|FG000|Maintenance Period|Protocol Violation|2|||
146119793|NCT00501293|526958352|FG001|Maintenance Period|Protocol Violation|1|||
146119794|NCT00501293|526958351|FG000|Maintenance Period|Lack of Efficacy|4|||
146119795|NCT00501293|526958352|FG001|Maintenance Period|Lack of Efficacy|1|||
146119796|NCT00501293|526958351|FG000|Maintenance Period|Noncompliant with study medication|5|||
146119797|NCT00501293|526958352|FG001|Maintenance Period|Noncompliant with study medication|0|||
146119798|NCT00501293|526958351|FG000|Maintenance Period|Went into rehabilitation|1|||
146119799|NCT00501293|526958352|FG001|Maintenance Period|Went into rehabilitation|0|||
146119800|NCT00501293|526958351|FG000|Maintenance Period|Would not wear patch|1|||
146119801|NCT00501293|526958352|FG001|Maintenance Period|Would not wear patch|0|||
146119802|NCT00501293|526958351|FG000|Maintenance Period|Application site reaction|1|||
146119803|NCT00501293|526958352|FG001|Maintenance Period|Application site reaction|0|||
146119804|NCT00488345|526958353|FG000|Overall Study|Adverse Event|0|||
146119805|NCT00488345|526958354|FG001|Overall Study|Adverse Event|1|||
146119806|NCT00488345|526958355|FG002|Overall Study|Adverse Event|1|||
146119807|NCT00488345|526958353|FG000|Overall Study|Unable to administer antibiotics at home|0|||
146119808|NCT00488345|526958354|FG001|Overall Study|Unable to administer antibiotics at home|1|||
146119809|NCT00488345|526958355|FG002|Overall Study|Unable to administer antibiotics at home|0|||
146119810|NCT00488345|526958353|FG000|Overall Study|Institutional Review Board review|0|||
146119811|NCT00488345|526958354|FG001|Overall Study|Institutional Review Board review|0|||
146119812|NCT00488345|526958355|FG002|Overall Study|Institutional Review Board review|1|||
146119813|NCT00488345|526958353|FG000|Overall Study|Surgical team recommendation|0|||
146119814|NCT00488345|526958354|FG001|Overall Study|Surgical team recommendation|1|||
146119815|NCT00488345|526958355|FG002|Overall Study|Surgical team recommendation|0|||
146119816|NCT00488345|526958353|FG000|Overall Study|Parent/legal guardian request|0|||
146119817|NCT00488345|526958354|FG001|Overall Study|Parent/legal guardian request|1|||
146119818|NCT00488345|526958355|FG002|Overall Study|Parent/legal guardian request|1|||
146119819|NCT00903617|526958358|FG000|Overall Study|Adverse Event|0|||
146119820|NCT00903617|526958359|FG001|Overall Study|Adverse Event|1|||
146119821|NCT00903617|526958360|FG002|Overall Study|Adverse Event|1|||
146119822|NCT00903617|526958361|FG003|Overall Study|Adverse Event|0|||
146119823|NCT00903617|526958358|FG000|Overall Study|Protocol-defined stopping criteria|0|||
146119824|NCT00903617|526958359|FG001|Overall Study|Protocol-defined stopping criteria|2|||
146119825|NCT00903617|526958360|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146119826|NCT00903617|526958361|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146119827|NCT00903617|526958358|FG000|Overall Study|Lost to Follow-up|2|||
146119828|NCT00903617|526958359|FG001|Overall Study|Lost to Follow-up|0|||
146119829|NCT00903617|526958360|FG002|Overall Study|Lost to Follow-up|1|||
146119830|NCT00903617|526958361|FG003|Overall Study|Lost to Follow-up|1|||
146119831|NCT00903617|526958358|FG000|Overall Study|Withdrawal by Subject|1|||
146119832|NCT00903617|526958359|FG001|Overall Study|Withdrawal by Subject|2|||
146119833|NCT00903617|526958360|FG002|Overall Study|Withdrawal by Subject|3|||
146119834|NCT00903617|526958361|FG003|Overall Study|Withdrawal by Subject|0|||
146119835|NCT01104636|526958362|FG000|Overall Study|Lack of Efficacy|43|||
146119836|NCT01104636|526958362|FG000|Overall Study|Lost to Follow-up|24|||
146119837|NCT01104636|526958362|FG000|Overall Study|Withdrawal by Subject|4|||
146119838|NCT01104636|526958362|FG000|Overall Study|Other|43|||
146119839|NCT01104636|526958362|FG000|Overall Study|Study terminated by sponsor|1|||
146119840|NCT01104636|526958362|FG000|Overall Study|Pregnancy|2|||
146119841|NCT01104636|526958362|FG000|Overall Study|Adverse Event|40|||
146119842|NCT01104636|526958362|FG000|Overall Study|Ongoing|21|||
146119843|NCT01853046|526958367|FG000|Overall Study|Withdrawal by Subject|1|||
146119844|NCT01853046|526958368|FG001|Overall Study|Withdrawal by Subject|1|||
146119845|NCT01853046|526958367|FG000|Overall Study|Adverse Event|4|||
146119846|NCT01853046|526958368|FG001|Overall Study|Adverse Event|2|||
146119847|NCT01853046|526958367|FG000|Overall Study|Disease progression|13|||
146119848|NCT01853046|526958368|FG001|Overall Study|Disease progression|3|||
146119849|NCT00708162|526958372|FG000|Randomized Phase|Randomized but Not Treated|7|||
146119850|NCT00708162|526958373|FG001|Randomized Phase|Randomized but Not Treated|5|||
146119851|NCT00708162|526958372|FG000|Randomized Phase|Participant Noncompliance|40|||
146119852|NCT00708162|526958373|FG001|Randomized Phase|Participant Noncompliance|32|||
146119853|NCT00708162|526958372|FG000|Randomized Phase|Lost to Follow-up|34|||
146119854|NCT00708162|526958373|FG001|Randomized Phase|Lost to Follow-up|34|||
146119855|NCT00708162|526958372|FG000|Randomized Phase|Withdrew Consent|31|||
146119856|NCT00708162|526958373|FG001|Randomized Phase|Withdrew Consent|22|||
146119857|NCT00708162|526958372|FG000|Randomized Phase|Lack of Efficacy|14|||
146119858|NCT00708162|526958373|FG001|Randomized Phase|Lack of Efficacy|19|||
146119859|NCT00708162|526958372|FG000|Randomized Phase|Protocol Violation|10|||
146119860|NCT00708162|526958373|FG001|Randomized Phase|Protocol Violation|11|||
146119861|NCT00708162|526958372|FG000|Randomized Phase|Adverse Event|8|||
146119862|NCT00708162|526958373|FG001|Randomized Phase|Adverse Event|12|||
146261826|NCT04944784|527472821|FG002|Double-blind Period|Adverse Event|0|||
146261827|NCT04944784|527472822|FG003|Double-blind Period|Adverse Event|0|||
146261828|NCT04944784|527472819|FG000|Double-blind Period|Withdrawal by Subject|15|||
146302829|NCT03688880|527623980|FG001|Overall Study|Lost to Follow-up|7|||
146302830|NCT03688880|527623979|FG000|Overall Study|Adverse Event|0|||
146302831|NCT03688880|527623980|FG001|Overall Study|Adverse Event|2|||
146302832|NCT03688880|527623979|FG000|Overall Study|Device deficiencies|0|||
146302833|NCT03688880|527623980|FG001|Overall Study|Device deficiencies|2|||
146302834|NCT03688880|527623979|FG000|Overall Study|Other|10|||
146302835|NCT03688880|527623980|FG001|Overall Study|Other|16|||
146302836|NCT01704287|527623981|FG000|Initial Treatment Period|Death|139|||
146302837|NCT01704287|527623982|FG001|Initial Treatment Period|Death|129|||
146302838|NCT01704287|527623983|FG002|Initial Treatment Period|Death|71|||
146302839|NCT01704287|527623984|FG003|Initial Treatment Period|Death|0|||
146302840|NCT01704287|527623985|FG004|Initial Treatment Period|Death|0|||
146302841|NCT01704287|527623981|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
146302842|NCT01704287|527623982|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
146302843|NCT01704287|527623983|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
146302844|NCT01704287|527623984|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
146302845|NCT01704287|527623985|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
146302846|NCT01704287|527623981|FG000|Initial Treatment Period|Lost to Follow-up|5|||
146302847|NCT01704287|527623982|FG001|Initial Treatment Period|Lost to Follow-up|3|||
146302848|NCT01704287|527623983|FG002|Initial Treatment Period|Lost to Follow-up|0|||
146302849|NCT01704287|527623984|FG003|Initial Treatment Period|Lost to Follow-up|0|||
146302850|NCT01704287|527623985|FG004|Initial Treatment Period|Lost to Follow-up|0|||
146302851|NCT01704287|527623981|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
146302852|NCT01704287|527623982|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
146302853|NCT01704287|527623983|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
146302854|NCT01704287|527623984|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
146302855|NCT01704287|527623985|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
146302856|NCT01704287|527623981|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146302857|NCT01704287|527623982|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146302858|NCT01704287|527623983|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
146302859|NCT01704287|527623984|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
146302860|NCT01704287|527623985|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
146302861|NCT01704287|527623981|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
146302862|NCT01704287|527623982|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
146302863|NCT01704287|527623983|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
146302864|NCT01704287|527623984|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
146302865|NCT01704287|527623985|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
146302866|NCT01704287|527623981|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146302867|NCT01704287|527623982|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146302868|NCT01704287|527623983|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146302869|NCT01704287|527623984|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
146302870|NCT01704287|527623985|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
146302871|NCT02615470|527623986|FG000|Overall Study|Lost to Follow-up|21|||
146302872|NCT02615470|527623987|FG001|Overall Study|Lost to Follow-up|32|||
146302873|NCT03713034|527623988|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
146302874|NCT03713034|527623989|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
146302875|NCT02982239|527623992|FG000|Overall Study|Lost to Follow-up|3|||
146302876|NCT02982239|527623993|FG001|Overall Study|Lost to Follow-up|2|||
146302877|NCT04024228|527623999|FG000|Overall Study|Adverse Event|1|||
146302878|NCT04024228|527624000|FG001|Overall Study|Adverse Event|0|||
146302879|NCT04024228|527623999|FG000|Overall Study|Protocol Deviation|0|||
146302880|NCT04024228|527624000|FG001|Overall Study|Protocol Deviation|2|||
146302881|NCT04024228|527623999|FG000|Overall Study|Withdrawal by Subject|3|||
146302882|NCT04024228|527624000|FG001|Overall Study|Withdrawal by Subject|4|||
146302883|NCT02982590|527624003|FG000|Overall Study|Lost to Follow-up|0|||
146302884|NCT02982590|527624004|FG001|Overall Study|Lost to Follow-up|1|||
146302885|NCT02982590|527624003|FG000|Overall Study|Death|4|||
146302886|NCT02982590|527624004|FG001|Overall Study|Death|0|||
146302887|NCT01168973|527624006|FG000|Overall Study|Progressive Disease|341|||
146302888|NCT01168973|527624007|FG001|Overall Study|Progressive Disease|429|||
146302889|NCT01168973|527624006|FG000|Overall Study|Adverse Event|94|||
146302890|NCT01168973|527624007|FG001|Overall Study|Adverse Event|55|||
146302891|NCT01168973|527624006|FG000|Overall Study|Withdrawal by Subject|90|||
146302892|NCT01168973|527624007|FG001|Overall Study|Withdrawal by Subject|53|||
146302893|NCT01168973|527624006|FG000|Overall Study|Death|42|||
146302894|NCT01168973|527624007|FG001|Overall Study|Death|45|||
146302895|NCT01168973|527624006|FG000|Overall Study|Physician Decision|37|||
146302896|NCT01168973|527624007|FG001|Overall Study|Physician Decision|19|||
146302897|NCT01168973|527624006|FG000|Overall Study|Sponsor Decision|2|||
146302898|NCT01168973|527624007|FG001|Overall Study|Sponsor Decision|1|||
146302899|NCT01168973|527624006|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
146302900|NCT01168973|527624007|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
146302901|NCT00709111|527624034|FG000|Overall Study|Withdrawal by Subject|1|||
146302902|NCT00709111|527624034|FG000|Overall Study|Unable to attend clinic visits|1|||
146302903|NCT01301456|527624039|FG000|Stage 1|Withdrawal by Subject|0|||
146302904|NCT01301456|527624040|FG001|Stage 1|Withdrawal by Subject|0|||
146302905|NCT01301456|527624041|FG002|Stage 1|Withdrawal by Subject|1|||
146302906|NCT01301456|527624042|FG003|Stage 1|Withdrawal by Subject|0|||
146302907|NCT01301456|527624043|FG004|Stage 1|Withdrawal by Subject|1|||
146302908|NCT01301456|527624044|FG005|Stage 1|Withdrawal by Subject|0|||
146302909|NCT01301456|527624045|FG006|Stage 1|Withdrawal by Subject|0|||
146302910|NCT01301456|527624046|FG007|Stage 1|Withdrawal by Subject|0|||
146302911|NCT01301456|527624047|FG008|Stage 1|Withdrawal by Subject|0|||
146302912|NCT01301456|527624048|FG009|Stage 1|Withdrawal by Subject|0|||
146302913|NCT01301456|527624049|FG010|Stage 1|Withdrawal by Subject|0|||
146302914|NCT01301456|527624050|FG011|Stage 1|Withdrawal by Subject|0|||
146302915|NCT01301456|527624039|FG000|Stage 1|Randomized but not treated|0|||
146302916|NCT01301456|527624040|FG001|Stage 1|Randomized but not treated|0|||
146302917|NCT01301456|527624041|FG002|Stage 1|Randomized but not treated|0|||
146302918|NCT01301456|527624042|FG003|Stage 1|Randomized but not treated|0|||
146302919|NCT01301456|527624043|FG004|Stage 1|Randomized but not treated|0|||
146302920|NCT01301456|527624044|FG005|Stage 1|Randomized but not treated|0|||
146302921|NCT01301456|527624045|FG006|Stage 1|Randomized but not treated|1|||
146302922|NCT01301456|527624046|FG007|Stage 1|Randomized but not treated|0|||
146302923|NCT01301456|527624047|FG008|Stage 1|Randomized but not treated|0|||
146302924|NCT01301456|527624048|FG009|Stage 1|Randomized but not treated|0|||
146302925|NCT01301456|527624049|FG010|Stage 1|Randomized but not treated|0|||
146302926|NCT01301456|527624050|FG011|Stage 1|Randomized but not treated|0|||
146302927|NCT01301456|527624039|FG000|Stage 2|Adverse Event|0|||
146302928|NCT01301456|527624040|FG001|Stage 2|Adverse Event|0|||
146302929|NCT01301456|527624041|FG002|Stage 2|Adverse Event|0|||
146302930|NCT01301456|527624042|FG003|Stage 2|Adverse Event|0|||
146302931|NCT01301456|527624043|FG004|Stage 2|Adverse Event|0|||
146302932|NCT01301456|527624044|FG005|Stage 2|Adverse Event|0|||
146302933|NCT01301456|527624045|FG006|Stage 2|Adverse Event|0|||
146302934|NCT01301456|527624046|FG007|Stage 2|Adverse Event|0|||
146302935|NCT01301456|527624047|FG008|Stage 2|Adverse Event|0|||
146302936|NCT01301456|527624048|FG009|Stage 2|Adverse Event|0|||
146302937|NCT01301456|527624049|FG010|Stage 2|Adverse Event|1|||
146302938|NCT01301456|527624050|FG011|Stage 2|Adverse Event|0|||
146302939|NCT01383096|527624051|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146302940|NCT01383096|527624052|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146302941|NCT01383096|527624053|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
146302942|NCT01383096|527624051|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146302943|NCT01383096|527624052|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146302944|NCT01383096|527624053|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146302945|NCT01383096|527624051|FG000|Third Intervention (8 Days)|Elevated AST|0|||
146302946|NCT01383096|527624052|FG001|Third Intervention (8 Days)|Elevated AST|1|||
146302947|NCT01383096|527624053|FG002|Third Intervention (8 Days)|Elevated AST|0|||
146302948|NCT01383096|527624051|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
146302949|NCT01383096|527624052|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
146302950|NCT01383096|527624053|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
146302951|NCT01383096|527624051|FG000|Third Intervention (8 Days)|Adverse Event|1|||
146302952|NCT01383096|527624052|FG001|Third Intervention (8 Days)|Adverse Event|0|||
146302953|NCT01383096|527624053|FG002|Third Intervention (8 Days)|Adverse Event|0|||
146119863|NCT00708162|526958372|FG000|Randomized Phase|Investigator's Discretion|7|||
146119864|NCT00708162|526958373|FG001|Randomized Phase|Investigator's Discretion|10|||
146119865|NCT00708162|526958372|FG000|Randomized Phase|Death|2|||
146119866|NCT00708162|526958373|FG001|Randomized Phase|Death|9|||
146119867|NCT00708162|526958372|FG000|Randomized Phase|Pregnancy|3|||
146119868|NCT00708162|526958373|FG001|Randomized Phase|Pregnancy|0|||
146119869|NCT00708162|526958372|FG000|Open-Label Phase|Lost to Follow-up|10|||
146119870|NCT00708162|526958373|FG001|Open-Label Phase|Lost to Follow-up|8|||
146119871|NCT00708162|526958372|FG000|Open-Label Phase|Withdrew Consent|12|||
146119872|NCT00708162|526958373|FG001|Open-Label Phase|Withdrew Consent|6|||
146119873|NCT00708162|526958372|FG000|Open-Label Phase|Participant Noncompliance|7|||
146119874|NCT00708162|526958373|FG001|Open-Label Phase|Participant Noncompliance|7|||
146119875|NCT00708162|526958372|FG000|Open-Label Phase|Lack of Efficacy|7|||
146119876|NCT00708162|526958373|FG001|Open-Label Phase|Lack of Efficacy|4|||
146119877|NCT00708162|526958372|FG000|Open-Label Phase|Investigator's Discretion|3|||
146119878|NCT00708162|526958373|FG001|Open-Label Phase|Investigator's Discretion|2|||
146119879|NCT00708162|526958372|FG000|Open-Label Phase|Death|3|||
146119880|NCT00708162|526958373|FG001|Open-Label Phase|Death|1|||
146119881|NCT00708162|526958372|FG000|Open-Label Phase|Adverse Event|1|||
146119882|NCT00708162|526958373|FG001|Open-Label Phase|Adverse Event|2|||
146119883|NCT00708162|526958372|FG000|Open-Label Phase|Other|1|||
146119884|NCT00708162|526958373|FG001|Open-Label Phase|Other|0|||
146302954|NCT01383096|527624051|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
146302955|NCT01383096|527624052|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
146119885|NCT01710033|526958375|FG000|Stage 2|Adverse Event|0|||
146119886|NCT01710033|526958376|FG001|Stage 2|Adverse Event|0|||
146119887|NCT01710033|526958377|FG002|Stage 2|Adverse Event|0|||
146119888|NCT01710033|526958378|FG003|Stage 2|Adverse Event|0|||
146119889|NCT01710033|526958379|FG004|Stage 2|Adverse Event|1|||
146119890|NCT01475331|526958380|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
146119891|NCT01475331|526958381|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
146119892|NCT01475331|526958380|FG000|Overall Study|excessive main duct communication|1|||
146119893|NCT01475331|526958381|FG001|Overall Study|excessive main duct communication|1|||
146119894|NCT01475331|526958380|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
146119895|NCT01475331|526958381|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
146119896|NCT01475331|526958380|FG000|Overall Study|Sign of malignancy during the procedure|2|||
146119897|NCT01475331|526958381|FG001|Overall Study|Sign of malignancy during the procedure|0|||
146119898|NCT01475331|526958380|FG000|Overall Study|cyst found to be prohibitively small|0|||
146119899|NCT01475331|526958381|FG001|Overall Study|cyst found to be prohibitively small|1|||
146119900|NCT01525550|526958382|FG000|Overall Study|Lost to Follow-up|8|||
146119901|NCT01525550|526958383|FG001|Overall Study|Lost to Follow-up|2|||
146119902|NCT01525550|526958382|FG000|Overall Study|Death|19|||
146119903|NCT01525550|526958383|FG001|Overall Study|Death|28|||
146119904|NCT01525550|526958382|FG000|Overall Study|Other|0|||
146119905|NCT01525550|526958383|FG001|Overall Study|Other|4|||
146119906|NCT01525550|526958382|FG000|Overall Study|Sponsor's Decision|30|||
146119907|NCT01525550|526958383|FG001|Overall Study|Sponsor's Decision|11|||
146119908|NCT01525550|526958382|FG000|Overall Study|Withdrawal by Subject|4|||
146119909|NCT01525550|526958383|FG001|Overall Study|Withdrawal by Subject|0|||
146119910|NCT00462761|526958384|FG000|Overall Study|Adverse Event|6|||
146119911|NCT00462761|526958384|FG000|Overall Study|Withdrawal by Subject|9|||
146119912|NCT00462761|526958384|FG000|Overall Study|Physician Decision|5|||
146119913|NCT00462761|526958384|FG000|Overall Study|Disease progression|43|||
146119914|NCT00462761|526958384|FG000|Overall Study|Death|12|||
146119915|NCT00462761|526958384|FG000|Overall Study|Other|1|||
146119916|NCT02877082|526958385|FG000|Overall Study|Trial was closed early|5|||
146119917|NCT01244906|526958386|FG000|Overall Study|Death|2|||
146119918|NCT01244906|526958386|FG000|Overall Study|Progression of disease post treatment|6|||
146119919|NCT03480750|526958387|FG000|Overall Study|Withdrawal by Subject|0|||
146119920|NCT03480750|526958388|FG001|Overall Study|Withdrawal by Subject|1|||
146119921|NCT03480750|526958389|FG002|Overall Study|Withdrawal by Subject|0|||
146119922|NCT03480750|526958390|FG003|Overall Study|Withdrawal by Subject|0|||
146119923|NCT03480750|526958391|FG004|Overall Study|Withdrawal by Subject|0|||
146119924|NCT03480750|526958392|FG005|Overall Study|Withdrawal by Subject|0|||
146119925|NCT03480750|526958387|FG000|Overall Study|The interruption in Trientine shippment|0|||
146119926|NCT03480750|526958388|FG001|Overall Study|The interruption in Trientine shippment|0|||
146119927|NCT03480750|526958389|FG002|Overall Study|The interruption in Trientine shippment|0|||
146119928|NCT03480750|526958390|FG003|Overall Study|The interruption in Trientine shippment|0|||
146119929|NCT03480750|526958391|FG004|Overall Study|The interruption in Trientine shippment|0|||
146119930|NCT03480750|526958392|FG005|Overall Study|The interruption in Trientine shippment|1|||
146119931|NCT03318315|526958393|FG000|Overall Study|Lost to Follow-up|3|||
146119932|NCT03318315|526958394|FG001|Overall Study|Lost to Follow-up|2|||
146119933|NCT03318315|526958395|FG002|Overall Study|Lost to Follow-up|1|||
146119934|NCT03318315|526958393|FG000|Overall Study|Protocol Violation|1|||
146119935|NCT03318315|526958394|FG001|Overall Study|Protocol Violation|1|||
146119936|NCT03318315|526958395|FG002|Overall Study|Protocol Violation|1|||
146119937|NCT03318315|526958393|FG000|Overall Study|Withdrawal by Subject|0|||
146119938|NCT03318315|526958394|FG001|Overall Study|Withdrawal by Subject|0|||
146119939|NCT03318315|526958395|FG002|Overall Study|Withdrawal by Subject|2|||
146119940|NCT02611778|526958400|FG000|Overall Study|Withdrawal by Subject|2|||
146119941|NCT02611778|526958401|FG001|Overall Study|Withdrawal by Subject|8|||
146119942|NCT02611778|526958400|FG000|Overall Study|Adverse Event|1|||
146119943|NCT02611778|526958401|FG001|Overall Study|Adverse Event|2|||
146119944|NCT02611778|526958400|FG000|Overall Study|Death|2|||
146119945|NCT02611778|526958401|FG001|Overall Study|Death|1|||
146119946|NCT02611778|526958400|FG000|Overall Study|Protocol Violation|1|||
146119947|NCT02611778|526958401|FG001|Overall Study|Protocol Violation|0|||
146119948|NCT02611778|526958400|FG000|Overall Study|Lost to Follow-up|3|||
146119949|NCT02611778|526958401|FG001|Overall Study|Lost to Follow-up|1|||
146119950|NCT02611778|526958400|FG000|Overall Study|Need for alternative treatment|1|||
146119951|NCT02611778|526958401|FG001|Overall Study|Need for alternative treatment|0|||
146119952|NCT02611778|526958400|FG000|Overall Study|Other Reason|2|||
146119953|NCT02611778|526958401|FG001|Overall Study|Other Reason|1|||
146119954|NCT02746874|526958402|FG000|Overall Study|Withdrawal by Subject|0|||
146119955|NCT02746874|526958403|FG001|Overall Study|Withdrawal by Subject|1|||
146119956|NCT02746874|526958402|FG000|Overall Study|Surgery Date Changed|0|||
146119957|NCT02746874|526958403|FG001|Overall Study|Surgery Date Changed|2|||
146119958|NCT03108027|526958416|FG000|Period 1|Subject/Guardian Decision|0|||
146119959|NCT03108027|526958417|FG001|Period 1|Subject/Guardian Decision|0|||
146119960|NCT03108027|526958418|FG002|Period 1|Subject/Guardian Decision|0|||
146119961|NCT03108027|526958419|FG003|Period 1|Subject/Guardian Decision|2|||
146119962|NCT03108027|526958420|FG004|Period 1|Subject/Guardian Decision|0|||
146119963|NCT03108027|526958421|FG005|Period 1|Subject/Guardian Decision|0|||
146119964|NCT03108027|526958416|FG000|Period 3|Adverse Event|0|||
146119965|NCT03108027|526958417|FG001|Period 3|Adverse Event|1|||
146119966|NCT03108027|526958418|FG002|Period 3|Adverse Event|0|||
146119967|NCT03108027|526958419|FG003|Period 3|Adverse Event|0|||
146119968|NCT03108027|526958420|FG004|Period 3|Adverse Event|0|||
146119969|NCT03108027|526958421|FG005|Period 3|Adverse Event|0|||
146119970|NCT02426892|526958422|FG000|Overall Study|Adverse Event|2|||
146119971|NCT02426892|526958422|FG000|Overall Study|Lack of Efficacy|17|||
146119972|NCT02426892|526958422|FG000|Overall Study|Withdrawal by Subject|1|||
146119973|NCT02574247|526958423|FG000|Overall Study|Withdrawal by Subject|1|||
146119974|NCT02574247|526958424|FG001|Overall Study|Withdrawal by Subject|0|||
146119975|NCT02574247|526958425|FG002|Overall Study|Withdrawal by Subject|0|||
146119976|NCT02574247|526958423|FG000|Overall Study|Did not meet inclusion criteria|4|||
146119977|NCT02574247|526958424|FG001|Overall Study|Did not meet inclusion criteria|3|||
146119978|NCT02574247|526958425|FG002|Overall Study|Did not meet inclusion criteria|5|||
146119979|NCT01382446|526958426|FG000|Overall Study|Withdrawal by Subject|0|||
146119980|NCT01382446|526958427|FG001|Overall Study|Withdrawal by Subject|1|||
146119981|NCT01382446|526958426|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
146119982|NCT01382446|526958427|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
146119983|NCT00770289|526958434|FG000|Overall Study|Other|6|||
146119984|NCT02733991|526958435|FG000|Overall Study|Adverse Event|1|||
146119985|NCT02733991|526958436|FG001|Overall Study|Adverse Event|0|||
146119986|NCT02733991|526958435|FG000|Overall Study|Withdrawal by Subject|0|||
146119987|NCT02733991|526958436|FG001|Overall Study|Withdrawal by Subject|5|||
146119988|NCT02659631|526958439|FG000|Overall Study|Lost to Follow-up|0|||
146119989|NCT02659631|526958440|FG001|Overall Study|Lost to Follow-up|0|||
146119990|NCT02659631|526958441|FG002|Overall Study|Lost to Follow-up|2|||
146119991|NCT02659631|526958442|FG003|Overall Study|Lost to Follow-up|0|||
146119992|NCT02659631|526958443|FG004|Overall Study|Lost to Follow-up|0|||
146119993|NCT02659631|526958444|FG005|Overall Study|Lost to Follow-up|1|||
146119994|NCT02659631|526958445|FG006|Overall Study|Lost to Follow-up|0|||
146119995|NCT02659631|526958446|FG007|Overall Study|Lost to Follow-up|0|||
146119996|NCT02659631|526958447|FG008|Overall Study|Lost to Follow-up|0|||
146119997|NCT02659631|526958448|FG009|Overall Study|Lost to Follow-up|0|||
146119998|NCT02659631|526958439|FG000|Overall Study|Withdrawal prior to treatment|0|||
146119999|NCT02659631|526958440|FG001|Overall Study|Withdrawal prior to treatment|0|||
146120000|NCT02659631|526958441|FG002|Overall Study|Withdrawal prior to treatment|0|||
146120001|NCT02659631|526958442|FG003|Overall Study|Withdrawal prior to treatment|0|||
146120002|NCT02659631|526958443|FG004|Overall Study|Withdrawal prior to treatment|1|||
146120003|NCT02659631|526958444|FG005|Overall Study|Withdrawal prior to treatment|0|||
146120004|NCT02659631|526958445|FG006|Overall Study|Withdrawal prior to treatment|0|||
146120005|NCT02659631|526958446|FG007|Overall Study|Withdrawal prior to treatment|0|||
146120006|NCT02659631|526958447|FG008|Overall Study|Withdrawal prior to treatment|0|||
146120007|NCT02659631|526958448|FG009|Overall Study|Withdrawal prior to treatment|0|||
146120008|NCT02659631|526958439|FG000|Overall Study|Participant refused further follow-up|0|||
146120009|NCT02659631|526958440|FG001|Overall Study|Participant refused further follow-up|0|||
146120010|NCT02659631|526958441|FG002|Overall Study|Participant refused further follow-up|0|||
146120011|NCT02659631|526958442|FG003|Overall Study|Participant refused further follow-up|1|||
146120012|NCT02659631|526958443|FG004|Overall Study|Participant refused further follow-up|0|||
146120013|NCT02659631|526958444|FG005|Overall Study|Participant refused further follow-up|0|||
146120014|NCT02659631|526958445|FG006|Overall Study|Participant refused further follow-up|0|||
146120015|NCT02659631|526958446|FG007|Overall Study|Participant refused further follow-up|0|||
146120016|NCT02659631|526958447|FG008|Overall Study|Participant refused further follow-up|1|||
146120017|NCT02659631|526958448|FG009|Overall Study|Participant refused further follow-up|0|||
146120018|NCT02659631|526958439|FG000|Overall Study|Death (follow-up phase)|1|||
146120019|NCT02659631|526958440|FG001|Overall Study|Death (follow-up phase)|2|||
146120020|NCT02659631|526958441|FG002|Overall Study|Death (follow-up phase)|1|||
146120021|NCT02659631|526958442|FG003|Overall Study|Death (follow-up phase)|1|||
146120022|NCT02659631|526958443|FG004|Overall Study|Death (follow-up phase)|3|||
146120023|NCT02659631|526958444|FG005|Overall Study|Death (follow-up phase)|2|||
146120024|NCT02659631|526958445|FG006|Overall Study|Death (follow-up phase)|0|||
146120025|NCT02659631|526958446|FG007|Overall Study|Death (follow-up phase)|3|||
146120026|NCT02659631|526958447|FG008|Overall Study|Death (follow-up phase)|1|||
146120027|NCT02659631|526958448|FG009|Overall Study|Death (follow-up phase)|0|||
146120028|NCT02659631|526958439|FG000|Overall Study|Death (treatment phase)|0|||
146120029|NCT02659631|526958440|FG001|Overall Study|Death (treatment phase)|0|||
146120030|NCT02659631|526958441|FG002|Overall Study|Death (treatment phase)|0|||
146120031|NCT02659631|526958442|FG003|Overall Study|Death (treatment phase)|0|||
146120032|NCT02659631|526958443|FG004|Overall Study|Death (treatment phase)|1|||
146120033|NCT02659631|526958444|FG005|Overall Study|Death (treatment phase)|0|||
146120034|NCT02659631|526958445|FG006|Overall Study|Death (treatment phase)|1|||
146120035|NCT02659631|526958446|FG007|Overall Study|Death (treatment phase)|0|||
146302956|NCT01383096|527624053|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
146302957|NCT01383096|527624051|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
146302958|NCT01383096|527624052|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146302959|NCT01383096|527624053|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146302960|NCT01383096|527624051|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
146302961|NCT01383096|527624052|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146302962|NCT01383096|527624053|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
146302963|NCT01383096|527624051|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
146302964|NCT01383096|527624052|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146302965|NCT01383096|527624053|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
146302966|NCT01383096|527624051|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
146302967|NCT01383096|527624052|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
146302968|NCT01383096|527624053|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
146302969|NCT01383096|527624051|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
146302970|NCT01383096|527624052|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
146302971|NCT01383096|527624053|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
146302972|NCT00616434|527624058|FG000|Overall Study|Adverse Event|5|||
146302973|NCT00616434|527624059|FG001|Overall Study|Adverse Event|2|||
146302974|NCT00616434|527624058|FG000|Overall Study|Physician Decision|0|||
146302975|NCT00616434|527624059|FG001|Overall Study|Physician Decision|4|||
146302976|NCT00616434|527624058|FG000|Overall Study|Withdrawal by Subject|1|||
146302977|NCT00616434|527624059|FG001|Overall Study|Withdrawal by Subject|1|||
146302978|NCT00616434|527624058|FG000|Overall Study|Protocol deviation|0|||
146302979|NCT00616434|527624059|FG001|Overall Study|Protocol deviation|1|||
146302980|NCT01994382|527624060|FG000|Overall Study|Informed consent withdrawn|0|||
146302981|NCT01994382|527624061|FG001|Overall Study|Informed consent withdrawn|0|||
146302982|NCT01994382|527624062|FG002|Overall Study|Informed consent withdrawn|0|||
146302983|NCT01994382|527624063|FG003|Overall Study|Informed consent withdrawn|0|||
146302984|NCT01994382|527624064|FG004|Overall Study|Informed consent withdrawn|0|||
146302985|NCT01994382|527624065|FG005|Overall Study|Informed consent withdrawn|0|||
146302986|NCT01994382|527624066|FG006|Overall Study|Informed consent withdrawn|1|||
146302987|NCT01994382|527624067|FG007|Overall Study|Informed consent withdrawn|0|||
146302988|NCT01994382|527624068|FG008|Overall Study|Informed consent withdrawn|0|||
146302989|NCT01994382|527624069|FG009|Overall Study|Informed consent withdrawn|0|||
146302990|NCT01994382|527624070|FG010|Overall Study|Informed consent withdrawn|0|||
146302991|NCT01994382|527624071|FG011|Overall Study|Informed consent withdrawn|0|||
146302992|NCT01994382|527624072|FG012|Overall Study|Informed consent withdrawn|0|||
146302993|NCT01994382|527624073|FG013|Overall Study|Informed consent withdrawn|0|||
146302994|NCT01994382|527624074|FG014|Overall Study|Informed consent withdrawn|0|||
146302995|NCT01994382|527624075|FG015|Overall Study|Informed consent withdrawn|0|||
146302996|NCT01994382|527624076|FG016|Overall Study|Informed consent withdrawn|0|||
146302997|NCT01994382|527624060|FG000|Overall Study|Progressive disease|3|||
146120036|NCT02659631|526958447|FG008|Overall Study|Death (treatment phase)|0|||
146120037|NCT02659631|526958448|FG009|Overall Study|Death (treatment phase)|0|||
146120038|NCT00495170|526958449|FG000|Overall Study|Lost to Follow-up|9|||
146120039|NCT00495170|526958449|FG000|Overall Study|Withdrawal by Subject|3|||
146120040|NCT00495170|526958449|FG000|Overall Study|Inappropriate staging|8|||
146120041|NCT01119131|526958452|FG000|Overall Study|Adverse Event|1|||
146120042|NCT01119131|526958453|FG001|Overall Study|Adverse Event|1|||
146120043|NCT01119131|526958454|FG002|Overall Study|Adverse Event|1|||
146120044|NCT01119131|526958452|FG000|Overall Study|Non-Compliance|1|||
146120045|NCT01119131|526958453|FG001|Overall Study|Non-Compliance|0|||
146120046|NCT01119131|526958454|FG002|Overall Study|Non-Compliance|4|||
146120047|NCT01119131|526958452|FG000|Overall Study|Physician Decision|0|||
146120048|NCT01119131|526958453|FG001|Overall Study|Physician Decision|0|||
146120049|NCT01119131|526958454|FG002|Overall Study|Physician Decision|1|||
146120050|NCT00732615|526958455|FG000|Overall Study|Withdrawal by Subject|3|||
146120051|NCT00732615|526958456|FG001|Overall Study|Withdrawal by Subject|1|||
146302998|NCT01994382|527624061|FG001|Overall Study|Progressive disease|4|||
146302999|NCT01994382|527624062|FG002|Overall Study|Progressive disease|4|||
146120052|NCT00732615|526958455|FG000|Overall Study|Lost to Follow-up|0|||
146120053|NCT00732615|526958456|FG001|Overall Study|Lost to Follow-up|1|||
146120054|NCT00732615|526958455|FG000|Overall Study|Adverse Event|0|||
146303000|NCT01994382|527624063|FG003|Overall Study|Progressive disease|3|||
146303001|NCT01994382|527624064|FG004|Overall Study|Progressive disease|2|||
146303002|NCT01994382|527624065|FG005|Overall Study|Progressive disease|3|||
146303003|NCT01994382|527624066|FG006|Overall Study|Progressive disease|3|||
146303004|NCT01994382|527624067|FG007|Overall Study|Progressive disease|6|||
146303005|NCT01994382|527624068|FG008|Overall Study|Progressive disease|2|||
146303006|NCT01994382|527624069|FG009|Overall Study|Progressive disease|2|||
146303007|NCT01994382|527624070|FG010|Overall Study|Progressive disease|13|||
146303008|NCT01994382|527624071|FG011|Overall Study|Progressive disease|8|||
146120055|NCT00732615|526958456|FG001|Overall Study|Adverse Event|2|||
146303009|NCT01994382|527624072|FG012|Overall Study|Progressive disease|7|||
146120056|NCT00732615|526958455|FG000|Overall Study|Physician Decision|3|||
146120057|NCT00732615|526958456|FG001|Overall Study|Physician Decision|0|||
146120058|NCT00732615|526958455|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
146120059|NCT00732615|526958456|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
146120060|NCT00993291|526958457|FG000|Overall Study|Withdrawal by Subject|1|||
146120061|NCT00003492|526958458|FG000|Overall Study|Not evaluable|6|||
146120062|NCT03566823|526958459|FG000|Overall Study|Lack of Efficacy|0|||
146120063|NCT03566823|526958460|FG001|Overall Study|Lack of Efficacy|1|||
146120064|NCT03566823|526958461|FG002|Overall Study|Lack of Efficacy|0|||
146120065|NCT03566823|526958459|FG000|Overall Study|Withdrawal by Subject|1|||
146120066|NCT03566823|526958460|FG001|Overall Study|Withdrawal by Subject|2|||
146120067|NCT03566823|526958461|FG002|Overall Study|Withdrawal by Subject|0|||
146120068|NCT03566823|526958459|FG000|Overall Study|Adverse Event|1|||
146120069|NCT03566823|526958460|FG001|Overall Study|Adverse Event|0|||
146120070|NCT03566823|526958461|FG002|Overall Study|Adverse Event|2|||
146120071|NCT01528254|526958462|FG000|Overall Study|Administrative problems|96|||
146120072|NCT01528254|526958463|FG001|Overall Study|Administrative problems|94|||
146120073|NCT01528254|526958462|FG000|Overall Study|Adverse Event|28|||
146120074|NCT01528254|526958463|FG001|Overall Study|Adverse Event|44|||
146120075|NCT01528254|526958462|FG000|Overall Study|Lost to Follow-up|17|||
146120076|NCT01528254|526958463|FG001|Overall Study|Lost to Follow-up|24|||
146120077|NCT01528254|526958462|FG000|Overall Study|Death|13|||
146120078|NCT01528254|526958463|FG001|Overall Study|Death|9|||
146120079|NCT01528254|526958462|FG000|Overall Study|Protocol deviation|9|||
146120080|NCT01528254|526958463|FG001|Overall Study|Protocol deviation|19|||
146120081|NCT01528254|526958462|FG000|Overall Study|New therapy for study indication|8|||
146120082|NCT01528254|526958463|FG001|Overall Study|New therapy for study indication|6|||
146120083|NCT01528254|526958462|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146120084|NCT01528254|526958463|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146120085|NCT01528254|526958462|FG000|Overall Study|Withdrawal by Subject|5|||
146120086|NCT01528254|526958463|FG001|Overall Study|Withdrawal by Subject|4|||
146120087|NCT01528254|526958462|FG000|Overall Study|Abnormal laboratory value(s)|3|||
146120088|NCT01528254|526958463|FG001|Overall Study|Abnormal laboratory value(s)|7|||
146120089|NCT01528254|526958462|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146120090|NCT01528254|526958463|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146120091|NCT01528254|526958462|FG000|Overall Study|No longer requires study drug|1|||
146120092|NCT01528254|526958463|FG001|Overall Study|No longer requires study drug|1|||
146120093|NCT00737282|526958464|FG000|Overall Study|Study prematurely terminated|175|||
146120094|NCT02763189|526958465|FG000|Overall Study|Device failure|0|||
146120095|NCT02763189|526958466|FG001|Overall Study|Device failure|2|||
146120096|NCT02049957|526958467|FG000|Overall Study|Progressive Disease|5|||
146120097|NCT02049957|526958468|FG001|Overall Study|Progressive Disease|4|||
146120098|NCT02049957|526958469|FG002|Overall Study|Progressive Disease|2|||
146120099|NCT02049957|526958470|FG003|Overall Study|Progressive Disease|2|||
146120100|NCT02049957|526958471|FG004|Overall Study|Progressive Disease|6|||
146120101|NCT02049957|526958472|FG005|Overall Study|Progressive Disease|35|||
146120102|NCT02049957|526958473|FG006|Overall Study|Progressive Disease|7|||
146120103|NCT02049957|526958474|FG007|Overall Study|Progressive Disease|26|||
146120104|NCT02049957|526958475|FG008|Overall Study|Progressive Disease|6|||
146120105|NCT02049957|526958467|FG000|Overall Study|Adverse Event|1|||
146120106|NCT02049957|526958468|FG001|Overall Study|Adverse Event|1|||
146120107|NCT02049957|526958469|FG002|Overall Study|Adverse Event|1|||
146120108|NCT02049957|526958470|FG003|Overall Study|Adverse Event|0|||
146120109|NCT02049957|526958471|FG004|Overall Study|Adverse Event|0|||
146120110|NCT02049957|526958472|FG005|Overall Study|Adverse Event|5|||
146120111|NCT02049957|526958473|FG006|Overall Study|Adverse Event|0|||
146120112|NCT02049957|526958474|FG007|Overall Study|Adverse Event|6|||
146120113|NCT02049957|526958475|FG008|Overall Study|Adverse Event|1|||
146120114|NCT02049957|526958467|FG000|Overall Study|Study Terminated by Sponsor|0|||
146120115|NCT02049957|526958468|FG001|Overall Study|Study Terminated by Sponsor|1|||
146261829|NCT04944784|527472820|FG001|Double-blind Period|Withdrawal by Subject|4|||
146120116|NCT02049957|526958469|FG002|Overall Study|Study Terminated by Sponsor|0|||
146120117|NCT02049957|526958470|FG003|Overall Study|Study Terminated by Sponsor|0|||
146120118|NCT02049957|526958471|FG004|Overall Study|Study Terminated by Sponsor|0|||
146120119|NCT02049957|526958472|FG005|Overall Study|Study Terminated by Sponsor|0|||
146120120|NCT02049957|526958473|FG006|Overall Study|Study Terminated by Sponsor|1|||
146120121|NCT02049957|526958474|FG007|Overall Study|Study Terminated by Sponsor|0|||
146120122|NCT02049957|526958475|FG008|Overall Study|Study Terminated by Sponsor|0|||
146120123|NCT02049957|526958467|FG000|Overall Study|Withdrawal by Subject|0|||
146120124|NCT02049957|526958468|FG001|Overall Study|Withdrawal by Subject|0|||
146120125|NCT02049957|526958469|FG002|Overall Study|Withdrawal by Subject|0|||
146120126|NCT02049957|526958470|FG003|Overall Study|Withdrawal by Subject|1|||
146120127|NCT02049957|526958471|FG004|Overall Study|Withdrawal by Subject|0|||
146120128|NCT02049957|526958472|FG005|Overall Study|Withdrawal by Subject|2|||
146120129|NCT02049957|526958473|FG006|Overall Study|Withdrawal by Subject|0|||
146120130|NCT02049957|526958474|FG007|Overall Study|Withdrawal by Subject|3|||
146120131|NCT02049957|526958475|FG008|Overall Study|Withdrawal by Subject|1|||
146120132|NCT02049957|526958467|FG000|Overall Study|Physician Decision|0|||
146120133|NCT02049957|526958468|FG001|Overall Study|Physician Decision|0|||
146120134|NCT02049957|526958469|FG002|Overall Study|Physician Decision|0|||
146120135|NCT02049957|526958470|FG003|Overall Study|Physician Decision|0|||
146120136|NCT02049957|526958471|FG004|Overall Study|Physician Decision|0|||
146120137|NCT02049957|526958472|FG005|Overall Study|Physician Decision|1|||
146120138|NCT02049957|526958473|FG006|Overall Study|Physician Decision|0|||
146120139|NCT02049957|526958474|FG007|Overall Study|Physician Decision|0|||
146120140|NCT02049957|526958475|FG008|Overall Study|Physician Decision|0|||
146120141|NCT01414075|526958476|FG000|Overall Study|Adverse Event|1|||
146120142|NCT01414075|526958477|FG001|Overall Study|Adverse Event|0|||
146120143|NCT01414075|526958478|FG002|Overall Study|Adverse Event|1|||
146120144|NCT01414075|526958479|FG003|Overall Study|Adverse Event|0|||
146120145|NCT01414075|526958476|FG000|Overall Study|Death|1|||
146120146|NCT01414075|526958477|FG001|Overall Study|Death|0|||
146120147|NCT01414075|526958478|FG002|Overall Study|Death|0|||
146120148|NCT01414075|526958479|FG003|Overall Study|Death|1|||
146120149|NCT01414075|526958476|FG000|Overall Study|Withdrawal by Subject|0|||
146120150|NCT01414075|526958477|FG001|Overall Study|Withdrawal by Subject|0|||
146120151|NCT01414075|526958478|FG002|Overall Study|Withdrawal by Subject|0|||
146120152|NCT01414075|526958479|FG003|Overall Study|Withdrawal by Subject|1|||
146120153|NCT01414075|526958476|FG000|Overall Study|Other than specified|1|||
146120154|NCT01414075|526958477|FG001|Overall Study|Other than specified|0|||
146120155|NCT01414075|526958478|FG002|Overall Study|Other than specified|1|||
146120156|NCT01414075|526958479|FG003|Overall Study|Other than specified|0|||
146120157|NCT02810392|526958481|FG000|Overall Study|Subject too ill to continue|1|||
146120158|NCT02810392|526958482|FG001|Overall Study|Subject too ill to continue|0|||
146120159|NCT02810392|526958481|FG000|Overall Study|COVID 19 research restrictions|0|||
146120160|NCT02810392|526958482|FG001|Overall Study|COVID 19 research restrictions|1|||
146120161|NCT00840294|526958483|FG000|Overall Study|Withdrawal by Subject|2|||
146120162|NCT00840294|526958484|FG001|Overall Study|Withdrawal by Subject|1|||
146120163|NCT00840294|526958483|FG000|Overall Study|Protocol Violation|1|||
146120164|NCT00840294|526958484|FG001|Overall Study|Protocol Violation|3|||
146120165|NCT00840294|526958483|FG000|Overall Study|Illness|0|||
146120166|NCT00840294|526958484|FG001|Overall Study|Illness|1|||
146120167|NCT02669433|526958489|FG000|Overall Study|Protocol Violation|0|||
146120168|NCT02669433|526958490|FG001|Overall Study|Protocol Violation|4|||
146120169|NCT02669433|526958491|FG002|Overall Study|Protocol Violation|1|||
146120170|NCT02669433|526958489|FG000|Overall Study|Disease Progression|1|||
146120171|NCT02669433|526958490|FG001|Overall Study|Disease Progression|0|||
146120172|NCT02669433|526958491|FG002|Overall Study|Disease Progression|0|||
146120173|NCT02669433|526958489|FG000|Overall Study|Physician Decision|1|||
146120174|NCT02669433|526958490|FG001|Overall Study|Physician Decision|1|||
146120175|NCT02669433|526958491|FG002|Overall Study|Physician Decision|0|||
146120176|NCT02669433|526958489|FG000|Overall Study|Adverse Event|6|||
146120177|NCT02669433|526958490|FG001|Overall Study|Adverse Event|7|||
146120178|NCT02669433|526958491|FG002|Overall Study|Adverse Event|10|||
146120179|NCT02669433|526958489|FG000|Overall Study|Sponsor Termination|1|||
146120180|NCT02669433|526958490|FG001|Overall Study|Sponsor Termination|0|||
146120181|NCT02669433|526958491|FG002|Overall Study|Sponsor Termination|1|||
146120182|NCT02669433|526958489|FG000|Overall Study|Withdrawal by Subject|5|||
146120183|NCT02669433|526958490|FG001|Overall Study|Withdrawal by Subject|1|||
146120184|NCT02669433|526958491|FG002|Overall Study|Withdrawal by Subject|0|||
146120185|NCT02669433|526958489|FG000|Overall Study|Withdrawal by Caregiver|1|||
146120186|NCT02669433|526958490|FG001|Overall Study|Withdrawal by Caregiver|0|||
146120187|NCT02669433|526958491|FG002|Overall Study|Withdrawal by Caregiver|2|||
146120188|NCT02669433|526958489|FG000|Overall Study|Death|0|||
146120189|NCT02669433|526958490|FG001|Overall Study|Death|1|||
146120190|NCT02669433|526958491|FG002|Overall Study|Death|1|||
146120191|NCT00576927|526958492|FG000|Clinical Assessment|Lack of Efficacy|24|||
146120192|NCT00576927|526958492|FG000|Clinical Assessment|Death|1|||
146120193|NCT00576927|526958492|FG000|Clinical Assessment|Withdrawal by Subject|10|||
146120194|NCT00576927|526958492|FG000|Clinical Assessment|Physician Decision|1|||
146120195|NCT00576927|526958492|FG000|Baseline|Physician Decision|9|||
146120196|NCT00576927|526958492|FG000|Baseline|Medication Change by PCP of subject|1|||
146120197|NCT00576927|526958492|FG000|Baseline|Withdrawal by Subject|3|||
146120198|NCT00576927|526958492|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
146120199|NCT00576927|526958492|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
146120200|NCT00576927|526958492|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
146120201|NCT00576927|526958492|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
146261830|NCT04944784|527472821|FG002|Double-blind Period|Withdrawal by Subject|0|||
146120202|NCT00576927|526958492|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
146120203|NCT00883116|526958493|FG000|Overall Study|Adverse event unrelated to study drug|5|||
146120204|NCT00883116|526958494|FG001|Overall Study|Adverse event unrelated to study drug|10|||
146120205|NCT00883116|526958493|FG000|Overall Study|Death|6|||
146120206|NCT00883116|526958494|FG001|Overall Study|Death|2|||
146120207|NCT00883116|526958493|FG000|Overall Study|Disease progression|130|||
146120208|NCT00883116|526958494|FG001|Overall Study|Disease progression|128|||
146261831|NCT04944784|527472822|FG003|Double-blind Period|Withdrawal by Subject|0|||
146120209|NCT00883116|526958493|FG000|Overall Study|Lost to Follow-up|0|||
146120210|NCT00883116|526958494|FG001|Overall Study|Lost to Follow-up|1|||
146120211|NCT00883116|526958493|FG000|Overall Study|Maximum clinical benefit|13|||
146120212|NCT00883116|526958494|FG001|Overall Study|Maximum clinical benefit|46|||
146120213|NCT00883116|526958493|FG000|Overall Study|Not identified|3|||
146120214|NCT00883116|526958494|FG001|Overall Study|Not identified|6|||
146120215|NCT00883116|526958493|FG000|Overall Study|Study drug toxicity|36|||
146120216|NCT00883116|526958494|FG001|Overall Study|Study drug toxicity|16|||
146120217|NCT00883116|526958493|FG000|Overall Study|Withdrawal by Subject|14|||
146120218|NCT00883116|526958494|FG001|Overall Study|Withdrawal by Subject|8|||
146120219|NCT00883116|526958493|FG000|Overall Study|No longer meets study criteria|2|||
146120220|NCT00883116|526958494|FG001|Overall Study|No longer meets study criteria|2|||
146120221|NCT03715764|526958495|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
146120222|NCT03715764|526958496|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
146120223|NCT03715764|526958495|FG000|3 Month Follow-up|Lost to Follow-up|2|||
146120224|NCT03715764|526958496|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146120225|NCT03715764|526958495|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
146120226|NCT03715764|526958496|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
146120227|NCT03715764|526958495|FG000|6 Month Follow-up|Lost to Follow-up|3|||
146120228|NCT03715764|526958496|FG001|6 Month Follow-up|Lost to Follow-up|0|||
146120229|NCT03715764|526958495|FG000|12 Month Follow-up|Lost to Follow-up|2|||
146120230|NCT03715764|526958496|FG001|12 Month Follow-up|Lost to Follow-up|3|||
146120231|NCT03715764|526958495|FG000|12 Month Follow-up|Pregnancy|0|||
146120232|NCT03715764|526958496|FG001|12 Month Follow-up|Pregnancy|1|||
146120233|NCT03715764|526958495|FG000|12 Month Follow-up|Surgery|2|||
146120234|NCT03715764|526958496|FG001|12 Month Follow-up|Surgery|0|||
146120235|NCT03715764|526958495|FG000|12 Month Follow-up|Wrong address|1|||
146120236|NCT03715764|526958496|FG001|12 Month Follow-up|Wrong address|0|||
146120237|NCT03715764|526958495|FG000|12 Month Follow-up|No symptoms|1|||
146120238|NCT03715764|526958496|FG001|12 Month Follow-up|No symptoms|0|||
146120239|NCT03715764|526958495|FG000|12 Month Follow-up|Changed primary care centre|0|||
146120240|NCT03715764|526958496|FG001|12 Month Follow-up|Changed primary care centre|1|||
146120241|NCT01361464|526958499|FG000|Overall Study|Death|1|||
146120242|NCT01361464|526958499|FG000|Overall Study|Withdrawal by Subject|2|||
146120243|NCT03021265|526958500|FG000|Overall Study|Adverse Event|29|||
146120244|NCT03021265|526958500|FG000|Overall Study|Lack of Efficacy|3|||
146120245|NCT03021265|526958500|FG000|Overall Study|Improved|17|||
146120246|NCT03021265|526958500|FG000|Overall Study|Lost to Follow-up|67|||
146120247|NCT03021265|526958500|FG000|Overall Study|No reason given|2|||
146120248|NCT03021265|526958500|FG000|Overall Study|No visit since the first visit|4|||
146120249|NCT01106898|526958501|FG000|Overall Study|Adverse Event|6|||
146120250|NCT01698801|526958502|FG000|Treatment Phase|Adverse Event|4|||
146120251|NCT01698801|526958502|FG000|Treatment Phase|Protocol Violation|1|||
146120252|NCT01698801|526958502|FG000|Treatment Phase|Other|4|||
146120253|NCT01698801|526958502|FG000|Treatment Phase|Withdrawal by Subject|1|||
146120254|NCT01698801|526958502|FG000|Treatment Phase|Disease progression|1|||
146120255|NCT01698801|526958502|FG000|Follow Up Phase|Withdrawal by Subject|1|||
146120256|NCT01698801|526958502|FG000|Follow Up Phase|Death|4|||
146120257|NCT00541034|526958503|FG000|Overall Study|Non-Compliance|3|||
146120258|NCT01614067|526958505|FG000|Overall Study|Pregnancy|1|||
146120259|NCT01614067|526958506|FG001|Overall Study|Pregnancy|0|||
146120260|NCT01614067|526958505|FG000|Overall Study|Physician Decision|6|||
146120261|NCT01614067|526958506|FG001|Overall Study|Physician Decision|5|||
146120262|NCT01614067|526958505|FG000|Overall Study|Withdrawal by Subject|0|||
146120263|NCT01614067|526958506|FG001|Overall Study|Withdrawal by Subject|1|||
146120264|NCT01614067|526958505|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
146120265|NCT01614067|526958506|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
146120266|NCT01505868|526958507|FG000|Overall Study|Withdrawal by Subject|1|||
146120267|NCT01505868|526958508|FG001|Overall Study|Withdrawal by Subject|0|||
146120268|NCT01505868|526958509|FG002|Overall Study|Withdrawal by Subject|0|||
146120269|NCT01505868|526958510|FG003|Overall Study|Withdrawal by Subject|0|||
146120270|NCT01505868|526958511|FG004|Overall Study|Withdrawal by Subject|0|||
146120271|NCT02625259|526958514|FG000|First Intervention (Day 1)|Other|0|||
146120272|NCT02625259|526958515|FG001|First Intervention (Day 1)|Other|0|||
146120273|NCT02625259|526958516|FG002|First Intervention (Day 1)|Other|1|||
146120274|NCT02625259|526958517|FG003|First Intervention (Day 1)|Other|0|||
146120275|NCT02625259|526958518|FG004|First Intervention (Day 1)|Other|0|||
146120276|NCT02625259|526958514|FG000|First Intervention (Day 1)|Adverse Event|2|||
146120277|NCT02625259|526958515|FG001|First Intervention (Day 1)|Adverse Event|1|||
146261832|NCT04944784|527472819|FG000|Double-blind Period|Death|7|||
146261833|NCT04944784|527472820|FG001|Double-blind Period|Death|2|||
146120278|NCT02625259|526958516|FG002|First Intervention (Day 1)|Adverse Event|0|||
146120279|NCT02625259|526958517|FG003|First Intervention (Day 1)|Adverse Event|0|||
146120280|NCT02625259|526958518|FG004|First Intervention (Day 1)|Adverse Event|0|||
146120281|NCT02625259|526958514|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
146120282|NCT02625259|526958515|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
146120283|NCT02625259|526958516|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
146120284|NCT02625259|526958517|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
146120285|NCT02625259|526958518|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
146120286|NCT02998840|526958519|FG000|Overall Study|Lost to Follow-up|1|||
146120287|NCT02998840|526958520|FG001|Overall Study|Lost to Follow-up|1|||
146120288|NCT02998840|526958521|FG002|Overall Study|Lost to Follow-up|2|||
146120289|NCT02998840|526958522|FG003|Overall Study|Lost to Follow-up|3|||
146120290|NCT02998840|526958519|FG000|Overall Study|Withdrawal by Subject|1|||
146120291|NCT02998840|526958520|FG001|Overall Study|Withdrawal by Subject|1|||
146120292|NCT02998840|526958521|FG002|Overall Study|Withdrawal by Subject|0|||
146120293|NCT02998840|526958522|FG003|Overall Study|Withdrawal by Subject|1|||
146120294|NCT02998840|526958519|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
146120295|NCT02998840|526958520|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
146120296|NCT02998840|526958521|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
146120297|NCT02998840|526958522|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
146120298|NCT00665847|526958523|FG000|Overall Study|Adverse Event|8|||
146120299|NCT00665847|526958523|FG000|Overall Study|Withdrawal by Subject|2|||
146120300|NCT00665847|526958523|FG000|Overall Study|Subject non-compliant|8|||
146120301|NCT00665847|526958523|FG000|Overall Study|Subject reached a virologic endpoint|4|||
146120302|NCT00665847|526958523|FG000|Overall Study|Resistance to TMC125|1|||
146120303|NCT00665847|526958523|FG000|Overall Study|Subject ineligible to continue the trial|1|||
146120304|NCT00665847|526958523|FG000|Overall Study|Switch to Commercial Medication|1|||
146120305|NCT01189812|526958524|FG000|Overall Study|Withdrawal by Subject|2|||
146120306|NCT01189812|526958525|FG001|Overall Study|Withdrawal by Subject|3|||
146120307|NCT01189812|526958524|FG000|Overall Study|Adverse Event|1|||
146120308|NCT01189812|526958525|FG001|Overall Study|Adverse Event|0|||
146120309|NCT01189812|526958524|FG000|Overall Study|Out of Window|4|||
146120310|NCT01189812|526958525|FG001|Overall Study|Out of Window|3|||
146120311|NCT01189812|526958524|FG000|Overall Study|Moved out of State|1|||
146120312|NCT01189812|526958525|FG001|Overall Study|Moved out of State|2|||
146120313|NCT02200445|526958527|FG000|Overall Study|Lack of Efficacy|1|||
146120314|NCT02200445|526958528|FG001|Overall Study|Lack of Efficacy|2|||
146120315|NCT02200445|526958529|FG002|Overall Study|Lack of Efficacy|2|||
146120316|NCT02200445|526958527|FG000|Overall Study|Adverse Event|0|||
146120317|NCT02200445|526958528|FG001|Overall Study|Adverse Event|2|||
146120318|NCT02200445|526958529|FG002|Overall Study|Adverse Event|0|||
146120319|NCT00587561|526961008|FG000|Overall Study|Lost to Follow-up|6|||
146120320|NCT00587561|526961009|FG001|Overall Study|Lost to Follow-up|4|||
146120321|NCT03204981|526961011|FG000|Overall Study|Physician Decision|2|||
146120322|NCT03204981|526961011|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
146120323|NCT04244786|526961014|FG000|Overall Study|Adverse Event|0|||
146120324|NCT04244786|526961015|FG001|Overall Study|Adverse Event|0|||
146120325|NCT04244786|526961016|FG002|Overall Study|Adverse Event|2|||
146120326|NCT04244786|526961014|FG000|Overall Study|Withdrawal by Subject|0|||
146120327|NCT04244786|526961015|FG001|Overall Study|Withdrawal by Subject|0|||
146120328|NCT04244786|526961016|FG002|Overall Study|Withdrawal by Subject|5|||
146120329|NCT03274687|526961017|FG000|Overall Study|Protocol Violation|1|||
146120330|NCT03274687|526961018|FG001|Overall Study|Protocol Violation|1|||
146120331|NCT00613938|526961019|FG000|Overall Study|Withdrawal by Subject|2|||
146120332|NCT00613938|526961020|FG001|Overall Study|Withdrawal by Subject|4|||
146120333|NCT00613938|526961021|FG002|Overall Study|Withdrawal by Subject|9|||
146120334|NCT00613938|526961022|FG003|Overall Study|Withdrawal by Subject|9|||
146120335|NCT00613938|526961019|FG000|Overall Study|Adverse Event|1|||
146120336|NCT00613938|526961020|FG001|Overall Study|Adverse Event|4|||
146120337|NCT00613938|526961021|FG002|Overall Study|Adverse Event|8|||
146120338|NCT00613938|526961022|FG003|Overall Study|Adverse Event|5|||
146120339|NCT00613938|526961019|FG000|Overall Study|Lack of Efficacy|16|||
146120340|NCT00613938|526961020|FG001|Overall Study|Lack of Efficacy|18|||
146261834|NCT04944784|527472821|FG002|Double-blind Period|Death|0|||
146261835|NCT04944784|527472822|FG003|Double-blind Period|Death|0|||
146261836|NCT04944784|527472819|FG000|Double-blind Period|Physician Decision|2|||
146261837|NCT04944784|527472820|FG001|Double-blind Period|Physician Decision|1|||
146120341|NCT00613938|526961021|FG002|Overall Study|Lack of Efficacy|5|||
146120342|NCT00613938|526961022|FG003|Overall Study|Lack of Efficacy|9|||
146120343|NCT00613938|526961019|FG000|Overall Study|Other|1|||
146120344|NCT00613938|526961020|FG001|Overall Study|Other|2|||
146120345|NCT00613938|526961021|FG002|Overall Study|Other|1|||
146120346|NCT00613938|526961022|FG003|Overall Study|Other|3|||
146120347|NCT00623727|526961023|FG000|Double Blind (DB)|Adverse Event|1|||
146261838|NCT04944784|527472821|FG002|Double-blind Period|Physician Decision|0|||
146120348|NCT00623727|526961024|FG001|Double Blind (DB)|Adverse Event|3|||
146120349|NCT00623727|526961023|FG000|Double Blind (DB)|Physician Decision|0|||
146120350|NCT00623727|526961024|FG001|Double Blind (DB)|Physician Decision|1|||
146120351|NCT00623727|526961023|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
146120352|NCT00623727|526961024|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
146120353|NCT00623727|526961023|FG000|Double Blind (DB)|Lack of Efficacy|2|||
146120354|NCT00623727|526961024|FG001|Double Blind (DB)|Lack of Efficacy|2|||
146303010|NCT01994382|527624073|FG013|Overall Study|Progressive disease|3|||
146261839|NCT04944784|527472822|FG003|Double-blind Period|Physician Decision|0|||
146261840|NCT04944784|527472819|FG000|Double-blind Period|Lack of Efficacy|0|||
146261841|NCT04944784|527472820|FG001|Double-blind Period|Lack of Efficacy|1|||
146261842|NCT04944784|527472821|FG002|Double-blind Period|Lack of Efficacy|0|||
146261843|NCT04944784|527472822|FG003|Double-blind Period|Lack of Efficacy|0|||
146120355|NCT00623727|526961023|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
146120356|NCT00623727|526961024|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
146120357|NCT00623727|526961023|FG000|Double Blind (DB)|Lost to Follow-up|1|||
146120358|NCT00623727|526961024|FG001|Double Blind (DB)|Lost to Follow-up|1|||
146120359|NCT00623727|526961023|FG000|Double Blind (DB)|Protocol Violation|2|||
146120360|NCT00623727|526961024|FG001|Double Blind (DB)|Protocol Violation|2|||
146120361|NCT00623727|526961023|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
146120362|NCT00623727|526961024|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
146120363|NCT00623727|526961023|FG000|Open Label Follow-up|Study termination|0|||
146120364|NCT00623727|526961024|FG001|Open Label Follow-up|Study termination|6|||
146120365|NCT00623727|526961023|FG000|Open Label Follow-up|Participant convenience|0|||
146120366|NCT00623727|526961024|FG001|Open Label Follow-up|Participant convenience|1|||
146120367|NCT03745937|526961025|FG000|Overall Study|Withdrawal by Subject|0|||
146120368|NCT03745937|526961026|FG001|Overall Study|Withdrawal by Subject|0|||
146120369|NCT03745937|526961027|FG002|Overall Study|Withdrawal by Subject|0|||
146120370|NCT03745937|526961028|FG003|Overall Study|Withdrawal by Subject|1|||
146120371|NCT03745937|526961025|FG000|Overall Study|Not-specifed|0|||
146120372|NCT03745937|526961026|FG001|Overall Study|Not-specifed|1|||
146120373|NCT03745937|526961027|FG002|Overall Study|Not-specifed|0|||
146120374|NCT03745937|526961028|FG003|Overall Study|Not-specifed|1|||
146120375|NCT01706003|526961034|FG000|Overall Study|Withdrawal by Subject|2|||
146120376|NCT01706003|526961035|FG001|Overall Study|Withdrawal by Subject|0|||
146120377|NCT01706003|526961034|FG000|Overall Study|Not scheduled|3|||
146120378|NCT01706003|526961035|FG001|Overall Study|Not scheduled|0|||
146120379|NCT01706003|526961034|FG000|Overall Study|Lost to Follow-up|6|||
146120380|NCT01706003|526961035|FG001|Overall Study|Lost to Follow-up|4|||
146120381|NCT02699554|526961036|FG000|Overall Study|Lost to Follow-up|9|||
146120382|NCT00788151|526961037|FG000|Overall Study|Other adverse event|0|||
146120383|NCT00788151|526961038|FG001|Overall Study|Other adverse event|2|||
146120384|NCT00788151|526961037|FG000|Overall Study|Protocol Violation|0|||
146120385|NCT00788151|526961038|FG001|Overall Study|Protocol Violation|1|||
146120386|NCT00788151|526961037|FG000|Overall Study|Withdrawal by Subject|13|||
146120387|NCT00788151|526961038|FG001|Overall Study|Withdrawal by Subject|6|||
146120388|NCT00788151|526961037|FG000|Overall Study|Enrolled but not treated|1|||
146120389|NCT00788151|526961038|FG001|Overall Study|Enrolled but not treated|1|||
146120390|NCT00503009|526961039|FG000|Overall Study|Protocol Violation|1|||
146120391|NCT00503009|526961040|FG001|Overall Study|Protocol Violation|0|||
146120392|NCT00503009|526961041|FG002|Overall Study|Protocol Violation|1|||
146120393|NCT00503009|526961039|FG000|Overall Study|Withdrawal by Subject|0|||
146120394|NCT00503009|526961040|FG001|Overall Study|Withdrawal by Subject|1|||
146120395|NCT00503009|526961041|FG002|Overall Study|Withdrawal by Subject|1|||
146120396|NCT00503009|526961039|FG000|Overall Study|Physician Decision|0|||
146120397|NCT00503009|526961040|FG001|Overall Study|Physician Decision|1|||
146120398|NCT00503009|526961041|FG002|Overall Study|Physician Decision|1|||
146120399|NCT02169739|526961042|FG000|Overall Study|Lost to Follow-up|0|||
146120400|NCT02169739|526961043|FG001|Overall Study|Lost to Follow-up|4|||
146120401|NCT03635957|526961044|FG000|Run-In Period|Lost to Follow-up|1|||
146120402|NCT03635957|526961044|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
146120403|NCT00350636|526961045|FG000|Overall Study|Adverse Event|19|||
146120404|NCT00350636|526961046|FG001|Overall Study|Adverse Event|13|||
146120405|NCT00350636|526961045|FG000|Overall Study|Protocol Violation|1|||
146120406|NCT00350636|526961046|FG001|Overall Study|Protocol Violation|3|||
146120407|NCT00350636|526961045|FG000|Overall Study|Withdrawal by Subject|13|||
146120408|NCT00350636|526961046|FG001|Overall Study|Withdrawal by Subject|17|||
146120409|NCT00350636|526961045|FG000|Overall Study|Lost to Follow-up|9|||
146120410|NCT00350636|526961046|FG001|Overall Study|Lost to Follow-up|8|||
146120411|NCT00350636|526961045|FG000|Overall Study|Physician Decision|0|||
146120412|NCT00350636|526961046|FG001|Overall Study|Physician Decision|2|||
146120413|NCT00350636|526961045|FG000|Overall Study|Other|1|||
146261844|NCT04944784|527472819|FG000|Double-blind Period|Sponsor Request|2|||
146120414|NCT00350636|526961046|FG001|Overall Study|Other|2|||
146120415|NCT01647282|526961050|FG000|Overall Study|Physician Decision|7|||
146120416|NCT01647282|526961051|FG001|Overall Study|Physician Decision|5|||
146120417|NCT01163279|526961058|FG000|Overall Study|Withdrawal by Subject|2|||
146120418|NCT01163279|526961059|FG001|Overall Study|Withdrawal by Subject|0|||
146261845|NCT04944784|527472820|FG001|Double-blind Period|Sponsor Request|1|||
146120419|NCT02232425|526961060|FG000|Overall Study|Lost to Follow-up|6|||
146120420|NCT02232425|526961061|FG001|Overall Study|Lost to Follow-up|2|||
146120421|NCT02232425|526961060|FG000|Overall Study|Adverse Event|2|||
146120422|NCT02232425|526961061|FG001|Overall Study|Adverse Event|0|||
146120423|NCT02232425|526961060|FG000|Overall Study|Withdrawal by Subject|5|||
146261846|NCT04944784|527472821|FG002|Double-blind Period|Sponsor Request|0|||
146261847|NCT04944784|527472822|FG003|Double-blind Period|Sponsor Request|0|||
146303011|NCT01994382|527624074|FG014|Overall Study|Progressive disease|6|||
146303012|NCT01994382|527624075|FG015|Overall Study|Progressive disease|44|||
146303013|NCT01994382|527624076|FG016|Overall Study|Progressive disease|28|||
146303014|NCT01994382|527624060|FG000|Overall Study|Physician Decision|0|||
146303015|NCT01994382|527624061|FG001|Overall Study|Physician Decision|1|||
146303016|NCT01994382|527624062|FG002|Overall Study|Physician Decision|0|||
146303017|NCT01994382|527624063|FG003|Overall Study|Physician Decision|0|||
146303018|NCT01994382|527624064|FG004|Overall Study|Physician Decision|0|||
146303019|NCT01994382|527624065|FG005|Overall Study|Physician Decision|0|||
146303020|NCT01994382|527624066|FG006|Overall Study|Physician Decision|0|||
146303021|NCT01994382|527624067|FG007|Overall Study|Physician Decision|0|||
146303022|NCT01994382|527624068|FG008|Overall Study|Physician Decision|0|||
146303023|NCT01994382|527624069|FG009|Overall Study|Physician Decision|0|||
146303024|NCT01994382|527624070|FG010|Overall Study|Physician Decision|3|||
146303025|NCT01994382|527624071|FG011|Overall Study|Physician Decision|1|||
146303026|NCT01994382|527624072|FG012|Overall Study|Physician Decision|1|||
146303027|NCT01994382|527624073|FG013|Overall Study|Physician Decision|0|||
146303028|NCT01994382|527624074|FG014|Overall Study|Physician Decision|1|||
146303029|NCT01994382|527624075|FG015|Overall Study|Physician Decision|4|||
146303030|NCT01994382|527624076|FG016|Overall Study|Physician Decision|2|||
146303031|NCT01994382|527624060|FG000|Overall Study|Death|0|||
146303032|NCT01994382|527624061|FG001|Overall Study|Death|0|||
146303033|NCT01994382|527624062|FG002|Overall Study|Death|0|||
146303034|NCT01994382|527624063|FG003|Overall Study|Death|0|||
146303035|NCT01994382|527624064|FG004|Overall Study|Death|1|||
146303036|NCT01994382|527624065|FG005|Overall Study|Death|0|||
146303037|NCT01994382|527624066|FG006|Overall Study|Death|0|||
146303038|NCT01994382|527624067|FG007|Overall Study|Death|0|||
146303039|NCT01994382|527624068|FG008|Overall Study|Death|1|||
146303040|NCT01994382|527624069|FG009|Overall Study|Death|1|||
146303041|NCT01994382|527624070|FG010|Overall Study|Death|0|||
146303042|NCT01994382|527624071|FG011|Overall Study|Death|0|||
146303043|NCT01994382|527624072|FG012|Overall Study|Death|0|||
146303044|NCT01994382|527624073|FG013|Overall Study|Death|0|||
146303045|NCT01994382|527624074|FG014|Overall Study|Death|0|||
146303046|NCT01994382|527624075|FG015|Overall Study|Death|1|||
146303047|NCT01994382|527624076|FG016|Overall Study|Death|0|||
146303048|NCT01994382|527624060|FG000|Overall Study|Adverse Event|0|||
146303049|NCT01994382|527624061|FG001|Overall Study|Adverse Event|1|||
146303050|NCT01994382|527624062|FG002|Overall Study|Adverse Event|2|||
146303051|NCT01994382|527624063|FG003|Overall Study|Adverse Event|0|||
146303052|NCT01994382|527624064|FG004|Overall Study|Adverse Event|0|||
146303053|NCT01994382|527624065|FG005|Overall Study|Adverse Event|0|||
146303054|NCT01994382|527624066|FG006|Overall Study|Adverse Event|0|||
146303055|NCT01994382|527624067|FG007|Overall Study|Adverse Event|0|||
146303056|NCT01994382|527624068|FG008|Overall Study|Adverse Event|0|||
146303057|NCT01994382|527624069|FG009|Overall Study|Adverse Event|0|||
146303058|NCT01994382|527624070|FG010|Overall Study|Adverse Event|15|||
146303059|NCT01994382|527624071|FG011|Overall Study|Adverse Event|2|||
146303060|NCT01994382|527624072|FG012|Overall Study|Adverse Event|7|||
146120424|NCT02232425|526961061|FG001|Overall Study|Withdrawal by Subject|6|||
146120425|NCT02232425|526961060|FG000|Overall Study|Lack of Efficacy|1|||
146120426|NCT02232425|526961061|FG001|Overall Study|Lack of Efficacy|0|||
146120427|NCT01601626|526961062|FG000|Overall Study|Death|1|||
146120428|NCT01601626|526961063|FG001|Overall Study|Death|1|||
146120429|NCT01601626|526961064|FG002|Overall Study|Death|1|||
146303061|NCT01994382|527624073|FG013|Overall Study|Adverse Event|3|||
146303062|NCT01994382|527624074|FG014|Overall Study|Adverse Event|17|||
146120430|NCT01601626|526961062|FG000|Overall Study|Lost to Follow-up|1|||
146120431|NCT01601626|526961063|FG001|Overall Study|Lost to Follow-up|2|||
146120432|NCT01601626|526961064|FG002|Overall Study|Lost to Follow-up|0|||
146120433|NCT01601626|526961062|FG000|Overall Study|Unable to Get to Clinic|0|||
146303063|NCT01994382|527624075|FG015|Overall Study|Adverse Event|6|||
146303064|NCT01994382|527624076|FG016|Overall Study|Adverse Event|3|||
146303065|NCT01994382|527624060|FG000|Overall Study|Other than specified|0|||
146303066|NCT01994382|527624061|FG001|Overall Study|Other than specified|0|||
146303067|NCT01994382|527624062|FG002|Overall Study|Other than specified|0|||
146303068|NCT01994382|527624063|FG003|Overall Study|Other than specified|0|||
146303069|NCT01994382|527624064|FG004|Overall Study|Other than specified|0|||
146303070|NCT01994382|527624065|FG005|Overall Study|Other than specified|0|||
146303071|NCT01994382|527624066|FG006|Overall Study|Other than specified|0|||
146303072|NCT01994382|527624067|FG007|Overall Study|Other than specified|0|||
146303073|NCT01994382|527624068|FG008|Overall Study|Other than specified|0|||
146303074|NCT01994382|527624069|FG009|Overall Study|Other than specified|0|||
146303075|NCT01994382|527624070|FG010|Overall Study|Other than specified|2|||
146303076|NCT01994382|527624071|FG011|Overall Study|Other than specified|0|||
146303077|NCT01994382|527624072|FG012|Overall Study|Other than specified|2|||
146120434|NCT01601626|526961063|FG001|Overall Study|Unable to Get to Clinic|1|||
146303078|NCT01994382|527624073|FG013|Overall Study|Other than specified|0|||
146303079|NCT01994382|527624074|FG014|Overall Study|Other than specified|0|||
146303080|NCT01994382|527624075|FG015|Overall Study|Other than specified|4|||
146261848|NCT04944784|527472819|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
146261849|NCT04944784|527472820|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
146261850|NCT04944784|527472821|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
146261851|NCT04944784|527472822|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
146261852|NCT04944784|527472819|FG000|Double-blind Period|Participant Choice|1|||
146261853|NCT04944784|527472820|FG001|Double-blind Period|Participant Choice|1|||
146261854|NCT04944784|527472821|FG002|Double-blind Period|Participant Choice|0|||
146261855|NCT04944784|527472822|FG003|Double-blind Period|Participant Choice|0|||
146261856|NCT04944784|527472819|FG000|Double-blind Period|Progressive Disease|2|||
146261857|NCT04944784|527472820|FG001|Double-blind Period|Progressive Disease|2|||
146261858|NCT04944784|527472821|FG002|Double-blind Period|Progressive Disease|0|||
146261859|NCT04944784|527472822|FG003|Double-blind Period|Progressive Disease|0|||
146261860|NCT04944784|527472819|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
146261861|NCT04944784|527472820|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
146261862|NCT04944784|527472821|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
146261863|NCT04944784|527472822|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
146261864|NCT04944784|527472819|FG000|Active Drug Period|Adverse Event|0|||
146261865|NCT04944784|527472820|FG001|Active Drug Period|Adverse Event|0|||
146261866|NCT04944784|527472821|FG002|Active Drug Period|Adverse Event|3|||
146120435|NCT01601626|526961064|FG002|Overall Study|Unable to Get to Clinic|0|||
146120436|NCT01601626|526961062|FG000|Overall Study|Withdrawal by Subject|0|||
146120437|NCT01601626|526961063|FG001|Overall Study|Withdrawal by Subject|1|||
146120438|NCT01601626|526961064|FG002|Overall Study|Withdrawal by Subject|1|||
146120439|NCT01601626|526961062|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
146120440|NCT01601626|526961063|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
146120441|NCT01601626|526961064|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
146120442|NCT03914326|526961065|FG000|Overall Study|Withdrawal by Subject|27|||
146120443|NCT03914326|526961066|FG001|Overall Study|Withdrawal by Subject|34|||
146120444|NCT03914326|526961065|FG000|Overall Study|Lost to Follow-up|43|||
146120445|NCT03914326|526961066|FG001|Overall Study|Lost to Follow-up|51|||
146120446|NCT03914326|526961065|FG000|Overall Study|Randomised more than once|0|||
146120447|NCT03914326|526961066|FG001|Overall Study|Randomised more than once|1|||
146120448|NCT03274440|526961067|FG000|Overall Study|Time commitment too great|1|||
146120449|NCT03274440|526961068|FG001|Overall Study|Time commitment too great|0|||
146120450|NCT03274440|526961069|FG002|Overall Study|Time commitment too great|0|||
146120451|NCT03274440|526961070|FG003|Overall Study|Time commitment too great|1|||
146120452|NCT03274440|526961071|FG004|Overall Study|Time commitment too great|0|||
146120453|NCT03274440|526961072|FG005|Overall Study|Time commitment too great|0|||
146120454|NCT01291173|526961073|FG000|Overall Study|Adverse Event|0|||
146120455|NCT01291173|526961074|FG001|Overall Study|Adverse Event|3|||
146120456|NCT01291173|526961075|FG002|Overall Study|Adverse Event|1|||
146120457|NCT01291173|526961076|FG003|Overall Study|Adverse Event|3|||
146120458|NCT01291173|526961073|FG000|Overall Study|Protocol Violation|7|||
146120459|NCT01291173|526961074|FG001|Overall Study|Protocol Violation|2|||
146120460|NCT01291173|526961075|FG002|Overall Study|Protocol Violation|2|||
146120461|NCT01291173|526961076|FG003|Overall Study|Protocol Violation|5|||
146120462|NCT01291173|526961073|FG000|Overall Study|Withdrawal by Subject|6|||
146120463|NCT01291173|526961074|FG001|Overall Study|Withdrawal by Subject|4|||
146120464|NCT01291173|526961075|FG002|Overall Study|Withdrawal by Subject|4|||
146120465|NCT01291173|526961076|FG003|Overall Study|Withdrawal by Subject|2|||
146120466|NCT01291173|526961073|FG000|Overall Study|Lost to Follow-up|4|||
146120467|NCT01291173|526961074|FG001|Overall Study|Lost to Follow-up|6|||
146120468|NCT01291173|526961075|FG002|Overall Study|Lost to Follow-up|3|||
146120469|NCT01291173|526961076|FG003|Overall Study|Lost to Follow-up|2|||
146120470|NCT01291173|526961073|FG000|Overall Study|Unable to meet visit schedule|0|||
146120471|NCT01291173|526961074|FG001|Overall Study|Unable to meet visit schedule|0|||
146120472|NCT01291173|526961075|FG002|Overall Study|Unable to meet visit schedule|1|||
146120473|NCT01291173|526961076|FG003|Overall Study|Unable to meet visit schedule|0|||
146120474|NCT01291173|526961073|FG000|Overall Study|Lack of compliance|0|||
146120475|NCT01291173|526961074|FG001|Overall Study|Lack of compliance|0|||
146120476|NCT01291173|526961075|FG002|Overall Study|Lack of compliance|0|||
146120477|NCT01291173|526961076|FG003|Overall Study|Lack of compliance|1|||
146120478|NCT01291173|526961073|FG000|Overall Study|Subject was unblinded|0|||
146120479|NCT01291173|526961074|FG001|Overall Study|Subject was unblinded|0|||
146261867|NCT04944784|527472822|FG003|Active Drug Period|Adverse Event|6|||
146261868|NCT04944784|527472819|FG000|Active Drug Period|Withdrawal by Subject|0|||
146120480|NCT01291173|526961075|FG002|Overall Study|Subject was unblinded|1|||
146120481|NCT01291173|526961076|FG003|Overall Study|Subject was unblinded|0|||
146120482|NCT01291173|526961073|FG000|Overall Study|Excluded therapy|0|||
146120483|NCT01291173|526961074|FG001|Overall Study|Excluded therapy|0|||
146120484|NCT01291173|526961075|FG002|Overall Study|Excluded therapy|1|||
146120485|NCT01291173|526961076|FG003|Overall Study|Excluded therapy|0|||
146261869|NCT04944784|527472820|FG001|Active Drug Period|Withdrawal by Subject|0|||
146261870|NCT04944784|527472821|FG002|Active Drug Period|Withdrawal by Subject|4|||
146261871|NCT04944784|527472822|FG003|Active Drug Period|Withdrawal by Subject|7|||
146261872|NCT04944784|527472819|FG000|Active Drug Period|Death|0|||
146120486|NCT00390858|526961077|FG000|Overall Study|Adverse Event|6|||
146120487|NCT00390858|526961078|FG001|Overall Study|Adverse Event|2|||
146120488|NCT00390858|526961077|FG000|Overall Study|Lack of Efficacy|0|||
146120489|NCT00390858|526961078|FG001|Overall Study|Lack of Efficacy|1|||
146120490|NCT00390858|526961077|FG000|Overall Study|Withdrawal by Subject|3|||
146120491|NCT00390858|526961078|FG001|Overall Study|Withdrawal by Subject|4|||
146120492|NCT04984993|526961082|FG000|Overall Study|Withdrawal by Subject|8|||
146120493|NCT04984993|526961083|FG001|Overall Study|Withdrawal by Subject|2|||
146120494|NCT04984993|526961082|FG000|Overall Study|Lost to Follow-up|2|||
146120495|NCT04984993|526961083|FG001|Overall Study|Lost to Follow-up|2|||
146120496|NCT04984993|526961082|FG000|Overall Study|Both patients moved to another country|4|||
146120497|NCT04984993|526961083|FG001|Overall Study|Both patients moved to another country|0|||
146120498|NCT02436356|526961084|FG000|Overall Study|Excluded by MRI Screening|0|||
146120499|NCT02436356|526961085|FG001|Overall Study|Excluded by MRI Screening|0|||
146120500|NCT02436356|526961086|FG002|Overall Study|Excluded by MRI Screening|2|||
146120501|NCT02436356|526961084|FG000|Overall Study|Lost to Follow-up|0|||
146120502|NCT02436356|526961085|FG001|Overall Study|Lost to Follow-up|1|||
146120503|NCT02436356|526961086|FG002|Overall Study|Lost to Follow-up|0|||
146120504|NCT02436356|526961084|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
146120505|NCT02436356|526961085|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
146120506|NCT02436356|526961086|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
146120507|NCT02436356|526961084|FG000|Overall Study|Excluded due to other medical conditions|3|||
146120508|NCT02436356|526961085|FG001|Overall Study|Excluded due to other medical conditions|0|||
146120509|NCT02436356|526961086|FG002|Overall Study|Excluded due to other medical conditions|0|||
146120510|NCT02436356|526961084|FG000|Overall Study|Withdrawal by Subject|1|||
146120511|NCT02436356|526961085|FG001|Overall Study|Withdrawal by Subject|0|||
146120512|NCT02436356|526961086|FG002|Overall Study|Withdrawal by Subject|0|||
146120513|NCT04577118|526961087|FG000|Overall Study|Withdrawal by Subject|4|||
146120514|NCT00810407|526961088|FG000|Overall Study|Protocol Violation|3|||
146120515|NCT00810407|526961088|FG000|Overall Study|No Visit After First Day of Treatment|3|||
146120516|NCT02968563|526961089|FG000|Overall Study|Adverse Event|0|||
146120517|NCT02968563|526961090|FG001|Overall Study|Adverse Event|6|||
146120518|NCT02968563|526961089|FG000|Overall Study|Death|1|||
146120519|NCT02968563|526961090|FG001|Overall Study|Death|1|||
146120520|NCT02968563|526961089|FG000|Overall Study|Lost to Follow-up|0|||
146120521|NCT02968563|526961090|FG001|Overall Study|Lost to Follow-up|1|||
146120522|NCT03287804|526961094|FG000|Overall Study|Death|1|||
146120523|NCT03287804|526961094|FG000|Overall Study|Physician Decision|2|||
146120524|NCT03287804|526961094|FG000|Overall Study|Progressive disease|8|||
146120525|NCT04008030|526961095|FG000|Pre-Treatment|Withdrawal by Subject|0|||
146120526|NCT04008030|526961096|FG001|Pre-Treatment|Withdrawal by Subject|0|||
146120527|NCT04008030|526961097|FG002|Pre-Treatment|Withdrawal by Subject|9|||
146120528|NCT04008030|526961095|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
146120529|NCT04008030|526961096|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
146120530|NCT04008030|526961097|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
146120531|NCT04008030|526961095|FG000|Pre-Treatment|Other reasons|0|||
146120532|NCT04008030|526961096|FG001|Pre-Treatment|Other reasons|1|||
146120533|NCT04008030|526961097|FG002|Pre-Treatment|Other reasons|6|||
146120534|NCT04008030|526961095|FG000|Treatment|Withdrawal by Subject|1|||
146120535|NCT04008030|526961096|FG001|Treatment|Withdrawal by Subject|1|||
146120536|NCT04008030|526961097|FG002|Treatment|Withdrawal by Subject|1|||
146120537|NCT04008030|526961095|FG000|Treatment|Death|2|||
146120538|NCT04008030|526961096|FG001|Treatment|Death|4|||
146120539|NCT04008030|526961097|FG002|Treatment|Death|0|||
146120540|NCT04008030|526961095|FG000|Treatment|Pregnancy|0|||
146120541|NCT04008030|526961096|FG001|Treatment|Pregnancy|1|||
146120542|NCT04008030|526961097|FG002|Treatment|Pregnancy|0|||
146120543|NCT04008030|526961095|FG000|Treatment|Participant no longer meets study criteria|0|||
146120544|NCT04008030|526961096|FG001|Treatment|Participant no longer meets study criteria|1|||
146120545|NCT04008030|526961097|FG002|Treatment|Participant no longer meets study criteria|0|||
146120546|NCT04008030|526961095|FG000|Treatment|Other reasons|5|||
146120547|NCT04008030|526961096|FG001|Treatment|Other reasons|13|||
146120548|NCT04008030|526961097|FG002|Treatment|Other reasons|6|||
146120549|NCT04008030|526961095|FG000|Treatment|Disease Progression|137|||
146120550|NCT04008030|526961096|FG001|Treatment|Disease Progression|82|||
146261873|NCT04944784|527472820|FG001|Active Drug Period|Death|0|||
146261874|NCT04944784|527472821|FG002|Active Drug Period|Death|3|||
146261875|NCT04944784|527472822|FG003|Active Drug Period|Death|4|||
146120551|NCT04008030|526961097|FG002|Treatment|Disease Progression|85|||
146120552|NCT04008030|526961095|FG000|Treatment|Study drug toxicity|28|||
146120553|NCT04008030|526961096|FG001|Treatment|Study drug toxicity|48|||
146120554|NCT04008030|526961097|FG002|Treatment|Study drug toxicity|8|||
146120555|NCT04008030|526961095|FG000|Treatment|Adverse Event unrelated to study drug|28|||
146120556|NCT04008030|526961096|FG001|Treatment|Adverse Event unrelated to study drug|22|||
146120557|NCT04008030|526961097|FG002|Treatment|Adverse Event unrelated to study drug|6|||
146261876|NCT04944784|527472819|FG000|Active Drug Period|Lack of Efficacy|0|||
146261877|NCT04944784|527472820|FG001|Active Drug Period|Lack of Efficacy|0|||
146120558|NCT04008030|526961095|FG000|Treatment|Maximum Clinical Benefit|0|||
146120559|NCT04008030|526961096|FG001|Treatment|Maximum Clinical Benefit|1|||
146120560|NCT04008030|526961097|FG002|Treatment|Maximum Clinical Benefit|9|||
146120561|NCT04008030|526961095|FG000|Treatment|On-going treatment|13|||
146120562|NCT04008030|526961096|FG001|Treatment|On-going treatment|20|||
146120563|NCT04008030|526961097|FG002|Treatment|On-going treatment|0|||
146120564|NCT03178773|526961098|FG000|Overall Study|Death|0|||
146120565|NCT03178773|526961099|FG001|Overall Study|Death|1|||
146120566|NCT03178773|526961098|FG000|Overall Study|Lost to Follow-up|29|||
146120567|NCT03178773|526961099|FG001|Overall Study|Lost to Follow-up|25|||
146120568|NCT03178773|526961098|FG000|Overall Study|Withdrawal by Subject|10|||
146120569|NCT03178773|526961099|FG001|Overall Study|Withdrawal by Subject|14|||
146120570|NCT04191499|526961101|FG000|Overall Study|Adverse Event|1|||
146120571|NCT04191499|526961102|FG001|Overall Study|Adverse Event|0|||
146120572|NCT04191499|526961101|FG000|Overall Study|Death|42|||
146120573|NCT04191499|526961102|FG001|Overall Study|Death|55|||
146120574|NCT04191499|526961101|FG000|Overall Study|Lost to Follow-up|4|||
146120575|NCT04191499|526961102|FG001|Overall Study|Lost to Follow-up|1|||
146120576|NCT04191499|526961101|FG000|Overall Study|Physician Decision|1|||
146120577|NCT04191499|526961102|FG001|Overall Study|Physician Decision|0|||
146120578|NCT04191499|526961101|FG000|Overall Study|Progressive Disease|1|||
146120579|NCT04191499|526961102|FG001|Overall Study|Progressive Disease|0|||
146120580|NCT04191499|526961101|FG000|Overall Study|Symptomatic Deterioration|1|||
146120581|NCT04191499|526961102|FG001|Overall Study|Symptomatic Deterioration|0|||
146120582|NCT04191499|526961101|FG000|Overall Study|Withdrawal by Subject|7|||
146120583|NCT04191499|526961102|FG001|Overall Study|Withdrawal by Subject|11|||
146120584|NCT04191499|526961101|FG000|Overall Study|Ongoing in the study|104|||
146120585|NCT04191499|526961102|FG001|Overall Study|Ongoing in the study|97|||
146120586|NCT00680745|526961103|FG000|Overall Study|Withdrawal by Subject|8|||
146120587|NCT00680745|526961104|FG001|Overall Study|Withdrawal by Subject|3|||
146120588|NCT00680745|526961105|FG002|Overall Study|Withdrawal by Subject|2|||
146120589|NCT00680745|526961106|FG003|Overall Study|Withdrawal by Subject|8|||
146120590|NCT00680745|526961103|FG000|Overall Study|Lost to Follow-up|0|||
146120591|NCT00680745|526961104|FG001|Overall Study|Lost to Follow-up|1|||
146120592|NCT00680745|526961105|FG002|Overall Study|Lost to Follow-up|1|||
146120593|NCT00680745|526961106|FG003|Overall Study|Lost to Follow-up|0|||
146120594|NCT00680745|526961103|FG000|Overall Study|Death|1|||
146120595|NCT00680745|526961104|FG001|Overall Study|Death|0|||
146120596|NCT00680745|526961105|FG002|Overall Study|Death|1|||
146120597|NCT00680745|526961106|FG003|Overall Study|Death|0|||
146120598|NCT00680745|526961103|FG000|Overall Study|Adverse Event|5|||
146120599|NCT00680745|526961104|FG001|Overall Study|Adverse Event|3|||
146120600|NCT00680745|526961105|FG002|Overall Study|Adverse Event|3|||
146120601|NCT00680745|526961106|FG003|Overall Study|Adverse Event|3|||
146120602|NCT00680745|526961103|FG000|Overall Study|Poor/Non-compliance|0|||
146120603|NCT00680745|526961104|FG001|Overall Study|Poor/Non-compliance|3|||
146120604|NCT00680745|526961105|FG002|Overall Study|Poor/Non-compliance|0|||
146120605|NCT00680745|526961106|FG003|Overall Study|Poor/Non-compliance|0|||
146120606|NCT00680745|526961103|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
146120607|NCT00680745|526961104|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146120608|NCT00680745|526961105|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146120609|NCT00680745|526961106|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
146120610|NCT00680745|526961103|FG000|Overall Study|False Treatment|0|||
146120611|NCT00680745|526961104|FG001|Overall Study|False Treatment|1|||
146120612|NCT00680745|526961105|FG002|Overall Study|False Treatment|3|||
146120613|NCT00680745|526961106|FG003|Overall Study|False Treatment|0|||
146120614|NCT01928329|526961109|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
146120615|NCT01928329|526961110|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
146120616|NCT01928329|526961109|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
146120617|NCT01928329|526961110|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
146120618|NCT01928329|526961109|FG000|Overall Study|Adverse Event|5|||
146120619|NCT01928329|526961110|FG001|Overall Study|Adverse Event|3|||
146120620|NCT01928329|526961109|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
146120621|NCT01928329|526961110|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
146120622|NCT01928329|526961109|FG000|Overall Study|Withdrawal by Subject|1|||
146120623|NCT01928329|526961110|FG001|Overall Study|Withdrawal by Subject|5|||
146120624|NCT01928329|526961109|FG000|Overall Study|Physician Decision|1|||
146120625|NCT01928329|526961110|FG001|Overall Study|Physician Decision|1|||
146120626|NCT02141997|526961112|FG000|Overall Study|Adverse Event|0|||
146120627|NCT02141997|526961113|FG001|Overall Study|Adverse Event|2|||
146120628|NCT02141997|526961114|FG002|Overall Study|Adverse Event|0|||
146120629|NCT02141997|526961115|FG003|Overall Study|Adverse Event|1|||
146120630|NCT02141997|526961112|FG000|Overall Study|Participant noncompliance|1|||
146120631|NCT02141997|526961113|FG001|Overall Study|Participant noncompliance|0|||
146120632|NCT02141997|526961114|FG002|Overall Study|Participant noncompliance|0|||
146120633|NCT02141997|526961115|FG003|Overall Study|Participant noncompliance|0|||
146120634|NCT02141997|526961112|FG000|Overall Study|Withdrew consent|1|||
146120635|NCT02141997|526961113|FG001|Overall Study|Withdrew consent|0|||
146120636|NCT02141997|526961114|FG002|Overall Study|Withdrew consent|3|||
146120637|NCT02141997|526961115|FG003|Overall Study|Withdrew consent|0|||
146120638|NCT02141997|526961112|FG000|Overall Study|Other|1|||
146120639|NCT02141997|526961113|FG001|Overall Study|Other|4|||
146120640|NCT02141997|526961114|FG002|Overall Study|Other|0|||
146120641|NCT02141997|526961115|FG003|Overall Study|Other|0|||
146120642|NCT00451321|526961116|FG000|Overall Study|Lost to Follow-up|3|||
146120643|NCT00451321|526961117|FG001|Overall Study|Lost to Follow-up|3|||
146120644|NCT00451321|526961118|FG002|Overall Study|Lost to Follow-up|1|||
146120645|NCT00451321|526961119|FG003|Overall Study|Lost to Follow-up|3|||
146120646|NCT00451321|526961120|FG004|Overall Study|Lost to Follow-up|0|||
146120647|NCT00451321|526961121|FG005|Overall Study|Lost to Follow-up|1|||
146120648|NCT00451321|526961122|FG006|Overall Study|Lost to Follow-up|0|||
146261878|NCT04944784|527472821|FG002|Active Drug Period|Lack of Efficacy|2|||
146261879|NCT04944784|527472822|FG003|Active Drug Period|Lack of Efficacy|2|||
146261880|NCT04944784|527472819|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
146261881|NCT04944784|527472820|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
146261882|NCT04944784|527472821|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
146261883|NCT04944784|527472822|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
146261884|NCT04944784|527472819|FG000|Active Drug Period|Participant Choice|0|||
146261885|NCT04944784|527472820|FG001|Active Drug Period|Participant Choice|0|||
146261886|NCT04944784|527472821|FG002|Active Drug Period|Participant Choice|0|||
146261887|NCT04944784|527472822|FG003|Active Drug Period|Participant Choice|1|||
146261888|NCT04944784|527472819|FG000|Active Drug Period|Progressive Disease|0|||
146261889|NCT04944784|527472820|FG001|Active Drug Period|Progressive Disease|0|||
146261890|NCT04944784|527472821|FG002|Active Drug Period|Progressive Disease|4|||
146261891|NCT04944784|527472822|FG003|Active Drug Period|Progressive Disease|4|||
146261892|NCT04944784|527472819|FG000|Active Drug Period|Lost to Follow-up|0|||
146261893|NCT04944784|527472820|FG001|Active Drug Period|Lost to Follow-up|0|||
146261894|NCT04944784|527472821|FG002|Active Drug Period|Lost to Follow-up|0|||
146261895|NCT04944784|527472822|FG003|Active Drug Period|Lost to Follow-up|1|||
146261896|NCT00908349|527474310|FG000|Overall Study|Adverse Event|10|||
146261897|NCT00908349|527474310|FG000|Overall Study|Withdrawal by Subject|9|||
146261898|NCT00908349|527474310|FG000|Overall Study|Physician Decision|5|||
146261899|NCT00908349|527474310|FG000|Overall Study|Lost to Follow-up|5|||
146261900|NCT00908349|527474310|FG000|Overall Study|Various|6|||
146261901|NCT00511836|527474318|FG000|Double-blind Period|Lost to Follow-up|1|||
146261902|NCT00511836|527474319|FG001|Double-blind Period|Lost to Follow-up|0|||
146261903|NCT00030823|527474320|FG000|Overall Study|Withdrawal by Subject|1|||
146261904|NCT00891046|527474321|FG000|Overall Study|Protocol Violation|1|||
146261905|NCT00891046|527474322|FG001|Overall Study|Protocol Violation|1|||
146261906|NCT00891046|527474323|FG002|Overall Study|Protocol Violation|0|||
146261907|NCT00891046|527474324|FG003|Overall Study|Protocol Violation|0|||
146261908|NCT00891046|527474325|FG004|Overall Study|Protocol Violation|1|||
146261909|NCT00891046|527474321|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
146261910|NCT00891046|527474322|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146261911|NCT00891046|527474323|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
146261912|NCT00891046|527474324|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146261913|NCT00891046|527474325|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
146261914|NCT00891046|527474321|FG000|Overall Study|Administrative problems|0|||
146261915|NCT00891046|527474322|FG001|Overall Study|Administrative problems|0|||
146261916|NCT00891046|527474323|FG002|Overall Study|Administrative problems|0|||
146261917|NCT00891046|527474324|FG003|Overall Study|Administrative problems|0|||
146261918|NCT00891046|527474325|FG004|Overall Study|Administrative problems|1|||
146261919|NCT00891046|527474321|FG000|Overall Study|Participant no longer required drug|0|||
146261920|NCT00891046|527474322|FG001|Overall Study|Participant no longer required drug|2|||
146261921|NCT00891046|527474323|FG002|Overall Study|Participant no longer required drug|0|||
146120649|NCT00451321|526961123|FG007|Overall Study|Lost to Follow-up|0|||
146120650|NCT00451321|526961116|FG000|Overall Study|Withdrawal by Subject|3|||
146120651|NCT00451321|526961117|FG001|Overall Study|Withdrawal by Subject|1|||
146120652|NCT00451321|526961118|FG002|Overall Study|Withdrawal by Subject|0|||
146261922|NCT00891046|527474324|FG003|Overall Study|Participant no longer required drug|0|||
146261923|NCT00891046|527474325|FG004|Overall Study|Participant no longer required drug|1|||
146261924|NCT00891046|527474321|FG000|Overall Study|Adverse Event|4|||
146261925|NCT00891046|527474322|FG001|Overall Study|Adverse Event|3|||
146261926|NCT00891046|527474323|FG002|Overall Study|Adverse Event|2|||
146261927|NCT00891046|527474324|FG003|Overall Study|Adverse Event|0|||
146120653|NCT00451321|526961119|FG003|Overall Study|Withdrawal by Subject|4|||
146261928|NCT00891046|527474325|FG004|Overall Study|Adverse Event|14|||
146261929|NCT00891046|527474321|FG000|Overall Study|Withdrawal by Subject|2|||
146261930|NCT00891046|527474322|FG001|Overall Study|Withdrawal by Subject|1|||
146261931|NCT00891046|527474323|FG002|Overall Study|Withdrawal by Subject|2|||
146120654|NCT00451321|526961120|FG004|Overall Study|Withdrawal by Subject|0|||
146120655|NCT00451321|526961121|FG005|Overall Study|Withdrawal by Subject|0|||
146120656|NCT00451321|526961122|FG006|Overall Study|Withdrawal by Subject|0|||
146120657|NCT00451321|526961123|FG007|Overall Study|Withdrawal by Subject|0|||
146120658|NCT00451321|526961116|FG000|Overall Study|Study closed/terminated|1|||
146120659|NCT00451321|526961117|FG001|Overall Study|Study closed/terminated|1|||
146120660|NCT00451321|526961118|FG002|Overall Study|Study closed/terminated|17|||
146120661|NCT00451321|526961119|FG003|Overall Study|Study closed/terminated|5|||
146120662|NCT00451321|526961120|FG004|Overall Study|Study closed/terminated|7|||
146120663|NCT00451321|526961121|FG005|Overall Study|Study closed/terminated|7|||
146120664|NCT00451321|526961122|FG006|Overall Study|Study closed/terminated|5|||
146120665|NCT00451321|526961123|FG007|Overall Study|Study closed/terminated|3|||
146120666|NCT00451321|526961116|FG000|Overall Study|Sponsor decision to amend protocol|0|||
146120667|NCT00451321|526961117|FG001|Overall Study|Sponsor decision to amend protocol|0|||
146120668|NCT00451321|526961118|FG002|Overall Study|Sponsor decision to amend protocol|0|||
146120669|NCT00451321|526961119|FG003|Overall Study|Sponsor decision to amend protocol|0|||
146120670|NCT00451321|526961120|FG004|Overall Study|Sponsor decision to amend protocol|0|||
146120671|NCT00451321|526961121|FG005|Overall Study|Sponsor decision to amend protocol|1|||
146120672|NCT00451321|526961122|FG006|Overall Study|Sponsor decision to amend protocol|1|||
146120673|NCT00451321|526961123|FG007|Overall Study|Sponsor decision to amend protocol|3|||
146120674|NCT00909389|526961125|FG000|Overall Study|Adverse Event|6|||
146120675|NCT00909389|526961125|FG000|Overall Study|Death|4|||
146120676|NCT00909389|526961125|FG000|Overall Study|Poor Compliance|16|||
146120677|NCT00909389|526961125|FG000|Overall Study|Lost to Follow-up|4|||
146120678|NCT00909389|526961125|FG000|Overall Study|No Information|103|||
146120679|NCT03557151|526961126|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
146120680|NCT03557151|526961127|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
146120681|NCT03557151|526961126|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
146120682|NCT03557151|526961127|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
146120683|NCT03557151|526961126|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
146120684|NCT03557151|526961127|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
146120685|NCT04868890|526961133|FG000|Overall Study|Death|2|||
146120686|NCT04868890|526961134|FG001|Overall Study|Death|1|||
146120687|NCT04868890|526961133|FG000|Overall Study|Withdrawal by Subject|1|||
146120688|NCT04868890|526961134|FG001|Overall Study|Withdrawal by Subject|5|||
146120689|NCT00818662|526961138|FG000|Overall Study|Adverse Event|5|||
146120690|NCT00818662|526961139|FG001|Overall Study|Adverse Event|14|||
146120691|NCT00818662|526961140|FG002|Overall Study|Adverse Event|4|||
146120692|NCT00818662|526961141|FG003|Overall Study|Adverse Event|3|||
146120693|NCT00818662|526961138|FG000|Overall Study|Withdrawal by Subject|5|||
146120694|NCT00818662|526961139|FG001|Overall Study|Withdrawal by Subject|4|||
146120695|NCT00818662|526961140|FG002|Overall Study|Withdrawal by Subject|2|||
146120696|NCT00818662|526961141|FG003|Overall Study|Withdrawal by Subject|2|||
146120697|NCT00818662|526961138|FG000|Overall Study|Death|1|||
146120698|NCT00818662|526961139|FG001|Overall Study|Death|3|||
146120699|NCT00818662|526961140|FG002|Overall Study|Death|0|||
146120700|NCT00818662|526961141|FG003|Overall Study|Death|0|||
146120701|NCT00818662|526961138|FG000|Overall Study|Physician Decision|1|||
146120702|NCT00818662|526961139|FG001|Overall Study|Physician Decision|0|||
146120703|NCT00818662|526961140|FG002|Overall Study|Physician Decision|0|||
146120704|NCT00818662|526961141|FG003|Overall Study|Physician Decision|0|||
146120705|NCT00818662|526961138|FG000|Overall Study|Lost to Follow-up|0|||
146120706|NCT00818662|526961139|FG001|Overall Study|Lost to Follow-up|0|||
146120707|NCT00818662|526961140|FG002|Overall Study|Lost to Follow-up|0|||
146120708|NCT00818662|526961141|FG003|Overall Study|Lost to Follow-up|1|||
146120709|NCT00818662|526961138|FG000|Overall Study|Unwilling or Unable to Participate|4|||
146120710|NCT00818662|526961139|FG001|Overall Study|Unwilling or Unable to Participate|6|||
146120711|NCT00818662|526961140|FG002|Overall Study|Unwilling or Unable to Participate|2|||
146120712|NCT00818662|526961141|FG003|Overall Study|Unwilling or Unable to Participate|4|||
146120713|NCT00818662|526961138|FG000|Overall Study|Protocol Violation|1|||
146120714|NCT00818662|526961139|FG001|Overall Study|Protocol Violation|1|||
146120715|NCT00818662|526961140|FG002|Overall Study|Protocol Violation|0|||
146120716|NCT00818662|526961141|FG003|Overall Study|Protocol Violation|0|||
146120717|NCT00818662|526961138|FG000|Overall Study|Requires a Prohibited Medication|1|||
146120718|NCT00818662|526961139|FG001|Overall Study|Requires a Prohibited Medication|0|||
146120719|NCT00818662|526961140|FG002|Overall Study|Requires a Prohibited Medication|0|||
146120720|NCT00818662|526961141|FG003|Overall Study|Requires a Prohibited Medication|0|||
146120721|NCT00818662|526961138|FG000|Overall Study|Safety Risk|1|||
146120722|NCT00818662|526961139|FG001|Overall Study|Safety Risk|1|||
146120723|NCT00818662|526961140|FG002|Overall Study|Safety Risk|0|||
146120724|NCT00818662|526961141|FG003|Overall Study|Safety Risk|1|||
146120725|NCT00818662|526961138|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
146120726|NCT00818662|526961139|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
146120727|NCT00818662|526961140|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
146120728|NCT00818662|526961141|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
146120729|NCT00818662|526961138|FG000|Overall Study|Participant's health declined|0|||
146120730|NCT00818662|526961139|FG001|Overall Study|Participant's health declined|0|||
146120731|NCT00818662|526961140|FG002|Overall Study|Participant's health declined|0|||
146120732|NCT00818662|526961141|FG003|Overall Study|Participant's health declined|1|||
146120733|NCT00818662|526961138|FG000|Overall Study|Caregiver to pursue other treatment|0|||
146120734|NCT00818662|526961139|FG001|Overall Study|Caregiver to pursue other treatment|1|||
146120735|NCT00818662|526961140|FG002|Overall Study|Caregiver to pursue other treatment|0|||
146120736|NCT00818662|526961141|FG003|Overall Study|Caregiver to pursue other treatment|0|||
146120737|NCT00818662|526961138|FG000|Overall Study|Moving out of state|0|||
146120738|NCT00818662|526961139|FG001|Overall Study|Moving out of state|0|||
146120739|NCT00818662|526961140|FG002|Overall Study|Moving out of state|0|||
146120740|NCT00818662|526961141|FG003|Overall Study|Moving out of state|1|||
146120741|NCT00818662|526961138|FG000|Overall Study|Declined move to another study site|1|||
146120742|NCT00818662|526961139|FG001|Overall Study|Declined move to another study site|0|||
146120743|NCT00818662|526961140|FG002|Overall Study|Declined move to another study site|0|||
146120744|NCT00818662|526961141|FG003|Overall Study|Declined move to another study site|0|||
146120745|NCT00818662|526961138|FG000|Overall Study|Change in living situation|0|||
146120746|NCT00818662|526961139|FG001|Overall Study|Change in living situation|0|||
146120747|NCT00818662|526961140|FG002|Overall Study|Change in living situation|0|||
146120748|NCT00818662|526961141|FG003|Overall Study|Change in living situation|1|||
146120749|NCT00818662|526961138|FG000|Overall Study|Study partner decision|0|||
146120750|NCT00818662|526961139|FG001|Overall Study|Study partner decision|0|||
146120751|NCT00818662|526961140|FG002|Overall Study|Study partner decision|0|||
146120752|NCT00818662|526961141|FG003|Overall Study|Study partner decision|1|||
146120753|NCT00818662|526961138|FG000|Overall Study|Admitted to long term nursing care|0|||
146120754|NCT00818662|526961139|FG001|Overall Study|Admitted to long term nursing care|1|||
146120755|NCT00818662|526961140|FG002|Overall Study|Admitted to long term nursing care|0|||
146120756|NCT00818662|526961141|FG003|Overall Study|Admitted to long term nursing care|0|||
146120757|NCT01722071|526961142|FG000|Overall Study|Protocol Violation|1|||
146120758|NCT01722071|526961143|FG001|Overall Study|Protocol Violation|0|||
146120759|NCT01338493|526961144|FG000|Enrolled|Withdrawal by Subject|1|||
146120760|NCT01338493|526961144|FG000|Enrolled|Patient not implanted|4|||
146120761|NCT01338493|526961144|FG000|Discharge|Death|1|||
146120762|NCT01338493|526961144|FG000|Discharge|Missed visit|1|||
146120763|NCT01338493|526961144|FG000|6 Months Follow up|Lost to Follow-up|11|||
146120764|NCT01338493|526961144|FG000|6 Months Follow up|Missed visit|8|||
146120765|NCT01338493|526961144|FG000|12 Months Follow up|Lost to Follow-up|9|||
146120766|NCT01472081|526961145|FG000|Overall Study|Continuing treatment at time of analysis|1|||
146120767|NCT01472081|526961146|FG001|Overall Study|Continuing treatment at time of analysis|4|||
146120768|NCT01472081|526961147|FG002|Overall Study|Continuing treatment at time of analysis|1|||
146120769|NCT01472081|526961148|FG003|Overall Study|Continuing treatment at time of analysis|8|||
146120770|NCT01472081|526961149|FG004|Overall Study|Continuing treatment at time of analysis|9|||
146120771|NCT01472081|526961150|FG005|Overall Study|Continuing treatment at time of analysis|0|||
146120772|NCT01472081|526961145|FG000|Overall Study|Disease Progression|4|||
146120773|NCT01472081|526961146|FG001|Overall Study|Disease Progression|10|||
146120774|NCT01472081|526961147|FG002|Overall Study|Disease Progression|12|||
146120775|NCT01472081|526961148|FG003|Overall Study|Disease Progression|31|||
146120776|NCT01472081|526961149|FG004|Overall Study|Disease Progression|22|||
146120777|NCT01472081|526961150|FG005|Overall Study|Disease Progression|3|||
146120778|NCT01472081|526961145|FG000|Overall Study|Study drug toxicity|2|||
146120779|NCT01472081|526961146|FG001|Overall Study|Study drug toxicity|9|||
146120780|NCT01472081|526961147|FG002|Overall Study|Study drug toxicity|4|||
146120781|NCT01472081|526961148|FG003|Overall Study|Study drug toxicity|6|||
146120782|NCT01472081|526961149|FG004|Overall Study|Study drug toxicity|13|||
146120783|NCT01472081|526961150|FG005|Overall Study|Study drug toxicity|2|||
146120784|NCT01472081|526961145|FG000|Overall Study|Death|0|||
146120785|NCT01472081|526961146|FG001|Overall Study|Death|0|||
146120786|NCT01472081|526961147|FG002|Overall Study|Death|0|||
146120787|NCT01472081|526961148|FG003|Overall Study|Death|0|||
146120788|NCT01472081|526961149|FG004|Overall Study|Death|1|||
146120789|NCT01472081|526961150|FG005|Overall Study|Death|0|||
146120790|NCT01472081|526961145|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146120791|NCT01472081|526961146|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146120792|NCT01472081|526961147|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146120793|NCT01472081|526961148|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
146120794|NCT01472081|526961149|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
146120795|NCT01472081|526961150|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
146120796|NCT01472081|526961145|FG000|Overall Study|Withdrawal by Subject|0|||
146120797|NCT01472081|526961146|FG001|Overall Study|Withdrawal by Subject|0|||
146120798|NCT01472081|526961147|FG002|Overall Study|Withdrawal by Subject|0|||
146120799|NCT01472081|526961148|FG003|Overall Study|Withdrawal by Subject|0|||
146120800|NCT01472081|526961149|FG004|Overall Study|Withdrawal by Subject|0|||
146120801|NCT01472081|526961150|FG005|Overall Study|Withdrawal by Subject|1|||
146120802|NCT01472081|526961145|FG000|Overall Study|Poor/non-compliance|0|||
146120803|NCT01472081|526961146|FG001|Overall Study|Poor/non-compliance|0|||
146120804|NCT01472081|526961147|FG002|Overall Study|Poor/non-compliance|1|||
146120805|NCT01472081|526961148|FG003|Overall Study|Poor/non-compliance|0|||
146120806|NCT01472081|526961149|FG004|Overall Study|Poor/non-compliance|1|||
146120807|NCT01472081|526961150|FG005|Overall Study|Poor/non-compliance|0|||
146120808|NCT01472081|526961145|FG000|Overall Study|No longer meets study criteria|0|||
146120809|NCT01472081|526961146|FG001|Overall Study|No longer meets study criteria|0|||
146120810|NCT01472081|526961147|FG002|Overall Study|No longer meets study criteria|1|||
146120811|NCT01472081|526961148|FG003|Overall Study|No longer meets study criteria|0|||
146120812|NCT01472081|526961149|FG004|Overall Study|No longer meets study criteria|0|||
146120813|NCT01472081|526961150|FG005|Overall Study|No longer meets study criteria|0|||
146120814|NCT01472081|526961145|FG000|Overall Study|Subject request to discontinue treatment|0|||
146120815|NCT01472081|526961146|FG001|Overall Study|Subject request to discontinue treatment|3|||
146120816|NCT01472081|526961147|FG002|Overall Study|Subject request to discontinue treatment|1|||
146120817|NCT01472081|526961148|FG003|Overall Study|Subject request to discontinue treatment|1|||
146120818|NCT01472081|526961149|FG004|Overall Study|Subject request to discontinue treatment|0|||
146120819|NCT01472081|526961150|FG005|Overall Study|Subject request to discontinue treatment|0|||
146120820|NCT01705652|526961152|FG000|Overall Study|Adverse Event|1|||
146120821|NCT01705652|526961153|FG001|Overall Study|Adverse Event|0|||
146120822|NCT01705652|526961152|FG000|Overall Study|Withdrawal by Subject|1|||
146120823|NCT01705652|526961153|FG001|Overall Study|Withdrawal by Subject|2|||
146120824|NCT01705652|526961152|FG000|Overall Study|non-compliance|1|||
146120825|NCT01705652|526961153|FG001|Overall Study|non-compliance|1|||
146120826|NCT00656474|526961154|FG000|Overall Study|Other Reason|1|||
146120827|NCT03564145|526961158|FG000|Overall Study|Adverse Event|4|||
146120828|NCT03564145|526961158|FG000|Overall Study|Lost to Follow-up|21|||
146120829|NCT03564145|526961158|FG000|Overall Study|Protocol Violation|2|||
146120830|NCT03564145|526961158|FG000|Overall Study|Withdrawal by Subject|48|||
146120831|NCT03564145|526961158|FG000|Overall Study|Study Terminated by Sponsor|146|||
146120832|NCT03564145|526961158|FG000|Overall Study|Physician Decision|1|||
146120833|NCT03564145|526961158|FG000|Overall Study|Other Than Specified|1|||
146120834|NCT03564145|526961158|FG000|Overall Study|Pregnancy|1|||
146120835|NCT04702997|526961159|FG000|Overall Study|Withdrawal by Subject|1|||
146120836|NCT04702997|526961160|FG001|Overall Study|Withdrawal by Subject|1|||
146120837|NCT01386554|526961166|FG000|Overall Study|Lost to Follow-up|0|||
146120838|NCT01386554|526961167|FG001|Overall Study|Lost to Follow-up|0|||
146120839|NCT01386554|526961168|FG002|Overall Study|Lost to Follow-up|1|||
146120840|NCT01386554|526961166|FG000|Overall Study|Adverse Event|2|||
146120841|NCT01386554|526961167|FG001|Overall Study|Adverse Event|5|||
146120842|NCT01386554|526961168|FG002|Overall Study|Adverse Event|2|||
146120843|NCT01386554|526961166|FG000|Overall Study|Progressive disease|1|||
146120844|NCT01386554|526961167|FG001|Overall Study|Progressive disease|2|||
146120845|NCT01386554|526961168|FG002|Overall Study|Progressive disease|2|||
146120846|NCT01386554|526961166|FG000|Overall Study|Administration of live vaccines|0|||
146120847|NCT01386554|526961167|FG001|Overall Study|Administration of live vaccines|1|||
146120848|NCT01386554|526961168|FG002|Overall Study|Administration of live vaccines|0|||
146120849|NCT01386554|526961166|FG000|Overall Study|Investigator discretion|0|||
146120850|NCT01386554|526961167|FG001|Overall Study|Investigator discretion|0|||
146120851|NCT01386554|526961168|FG002|Overall Study|Investigator discretion|1|||
146120852|NCT01386554|526961166|FG000|Overall Study|Reason not collected|0|||
146120853|NCT01386554|526961167|FG001|Overall Study|Reason not collected|1|||
146120854|NCT01386554|526961168|FG002|Overall Study|Reason not collected|0|||
146120855|NCT00353262|526961169|FG000|Overall Study|Adverse Event|8|||
146120856|NCT00353262|526961169|FG000|Overall Study|Withdrawal by Subject|2|||
146120857|NCT00353262|526961169|FG000|Overall Study|Insufficient Therapeutic Response|13|||
146120858|NCT00353262|526961169|FG000|Overall Study|Progression|1|||
146120859|NCT00353262|526961169|FG000|Overall Study|Surgery|4|||
146120860|NCT00353262|526961169|FG000|Overall Study|Break from Chemotherapy|1|||
146261932|NCT00891046|527474324|FG003|Overall Study|Withdrawal by Subject|1|||
146261933|NCT00891046|527474325|FG004|Overall Study|Withdrawal by Subject|1|||
146261934|NCT00891046|527474321|FG000|Overall Study|Lost to Follow-up|0|||
146261935|NCT00891046|527474322|FG001|Overall Study|Lost to Follow-up|0|||
146261936|NCT00891046|527474323|FG002|Overall Study|Lost to Follow-up|0|||
146261937|NCT00891046|527474324|FG003|Overall Study|Lost to Follow-up|0|||
146120861|NCT05286307|526961170|FG000|Overall Study|Incomplete outcome assessments|2|||
146120862|NCT05286307|526961171|FG001|Overall Study|Incomplete outcome assessments|1|||
146120863|NCT05286307|526961170|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
146120864|NCT05286307|526961171|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
146120865|NCT05286307|526961170|FG000|Overall Study|Lost to follow up at 6 months|25|||
146120866|NCT05286307|526961171|FG001|Overall Study|Lost to follow up at 6 months|35|||
146120867|NCT05286307|526961170|FG000|Overall Study|Study medication not available|1|||
146120868|NCT05286307|526961171|FG001|Overall Study|Study medication not available|1|||
146120869|NCT02759471|526961172|FG000|Overall Study|discomfort|2|||
146120870|NCT02554812|526961173|FG000|Overall Study|Adverse Event|2|||
146120871|NCT02554812|526961174|FG001|Overall Study|Adverse Event|5|||
146120872|NCT02554812|526961175|FG002|Overall Study|Adverse Event|3|||
146120873|NCT02554812|526961176|FG003|Overall Study|Adverse Event|0|||
146120874|NCT02554812|526961177|FG004|Overall Study|Adverse Event|5|||
146261938|NCT00891046|527474325|FG004|Overall Study|Lost to Follow-up|1|||
146120875|NCT02554812|526961178|FG005|Overall Study|Adverse Event|0|||
146120876|NCT02554812|526961179|FG006|Overall Study|Adverse Event|1|||
146120877|NCT02554812|526961180|FG007|Overall Study|Adverse Event|6|||
146120878|NCT02554812|526961181|FG008|Overall Study|Adverse Event|2|||
146120879|NCT02554812|526961182|FG009|Overall Study|Adverse Event|2|||
146120880|NCT02554812|526961183|FG010|Overall Study|Adverse Event|1|||
146120881|NCT02554812|526961184|FG011|Overall Study|Adverse Event|2|||
146120882|NCT02554812|526961185|FG012|Overall Study|Adverse Event|0|||
146120883|NCT02554812|526961186|FG013|Overall Study|Adverse Event|3|||
146120884|NCT02554812|526961187|FG014|Overall Study|Adverse Event|2|||
146120885|NCT02554812|526961188|FG015|Overall Study|Adverse Event|1|||
146120886|NCT02554812|526961189|FG016|Overall Study|Adverse Event|0|||
146120887|NCT02554812|526961190|FG017|Overall Study|Adverse Event|1|||
146120888|NCT02554812|526961191|FG018|Overall Study|Adverse Event|0|||
146120889|NCT02554812|526961192|FG019|Overall Study|Adverse Event|0|||
146120890|NCT02554812|526961193|FG020|Overall Study|Adverse Event|0|||
146120891|NCT02554812|526961194|FG021|Overall Study|Adverse Event|2|||
146120892|NCT02554812|526961195|FG022|Overall Study|Adverse Event|1|||
146120893|NCT02554812|526961196|FG023|Overall Study|Adverse Event|1|||
146120894|NCT02554812|526961197|FG024|Overall Study|Adverse Event|1|||
146120895|NCT02554812|526961198|FG025|Overall Study|Adverse Event|2|||
146120896|NCT02554812|526961199|FG026|Overall Study|Adverse Event|1|||
146120897|NCT02554812|526961173|FG000|Overall Study|Death|1|||
146120898|NCT02554812|526961174|FG001|Overall Study|Death|2|||
146120899|NCT02554812|526961175|FG002|Overall Study|Death|2|||
146120900|NCT02554812|526961176|FG003|Overall Study|Death|2|||
146120901|NCT02554812|526961177|FG004|Overall Study|Death|0|||
146120902|NCT02554812|526961178|FG005|Overall Study|Death|1|||
146120903|NCT02554812|526961179|FG006|Overall Study|Death|1|||
146120904|NCT02554812|526961180|FG007|Overall Study|Death|1|||
146120905|NCT02554812|526961181|FG008|Overall Study|Death|0|||
146120906|NCT02554812|526961182|FG009|Overall Study|Death|0|||
146120907|NCT02554812|526961183|FG010|Overall Study|Death|0|||
146120908|NCT02554812|526961184|FG011|Overall Study|Death|0|||
146120909|NCT02554812|526961185|FG012|Overall Study|Death|0|||
146120910|NCT02554812|526961186|FG013|Overall Study|Death|0|||
146120911|NCT02554812|526961187|FG014|Overall Study|Death|1|||
146120912|NCT02554812|526961188|FG015|Overall Study|Death|1|||
146120913|NCT02554812|526961189|FG016|Overall Study|Death|1|||
146120914|NCT02554812|526961190|FG017|Overall Study|Death|0|||
146120915|NCT02554812|526961191|FG018|Overall Study|Death|1|||
146120916|NCT02554812|526961192|FG019|Overall Study|Death|2|||
146120917|NCT02554812|526961193|FG020|Overall Study|Death|0|||
146120918|NCT02554812|526961194|FG021|Overall Study|Death|1|||
146120919|NCT02554812|526961195|FG022|Overall Study|Death|1|||
146120920|NCT02554812|526961196|FG023|Overall Study|Death|0|||
146120921|NCT02554812|526961197|FG024|Overall Study|Death|0|||
146120922|NCT02554812|526961198|FG025|Overall Study|Death|0|||
146120923|NCT02554812|526961199|FG026|Overall Study|Death|0|||
146120924|NCT02554812|526961173|FG000|Overall Study|Lost to Follow-up|0|||
146120925|NCT02554812|526961174|FG001|Overall Study|Lost to Follow-up|1|||
146120926|NCT02554812|526961175|FG002|Overall Study|Lost to Follow-up|0|||
146120927|NCT02554812|526961176|FG003|Overall Study|Lost to Follow-up|0|||
146120928|NCT02554812|526961177|FG004|Overall Study|Lost to Follow-up|0|||
146120929|NCT02554812|526961178|FG005|Overall Study|Lost to Follow-up|0|||
146120930|NCT02554812|526961179|FG006|Overall Study|Lost to Follow-up|0|||
146120931|NCT02554812|526961180|FG007|Overall Study|Lost to Follow-up|0|||
146120932|NCT02554812|526961181|FG008|Overall Study|Lost to Follow-up|0|||
146120933|NCT02554812|526961182|FG009|Overall Study|Lost to Follow-up|0|||
146120934|NCT02554812|526961183|FG010|Overall Study|Lost to Follow-up|0|||
146120935|NCT02554812|526961184|FG011|Overall Study|Lost to Follow-up|0|||
146120936|NCT02554812|526961185|FG012|Overall Study|Lost to Follow-up|0|||
146120937|NCT02554812|526961186|FG013|Overall Study|Lost to Follow-up|0|||
146120938|NCT02554812|526961187|FG014|Overall Study|Lost to Follow-up|0|||
146120939|NCT02554812|526961188|FG015|Overall Study|Lost to Follow-up|0|||
146120940|NCT02554812|526961189|FG016|Overall Study|Lost to Follow-up|0|||
146120941|NCT02554812|526961190|FG017|Overall Study|Lost to Follow-up|0|||
146120942|NCT02554812|526961191|FG018|Overall Study|Lost to Follow-up|0|||
146120943|NCT02554812|526961192|FG019|Overall Study|Lost to Follow-up|0|||
146120944|NCT02554812|526961193|FG020|Overall Study|Lost to Follow-up|0|||
146120945|NCT02554812|526961194|FG021|Overall Study|Lost to Follow-up|0|||
146120946|NCT02554812|526961195|FG022|Overall Study|Lost to Follow-up|0|||
146120947|NCT02554812|526961196|FG023|Overall Study|Lost to Follow-up|0|||
146120948|NCT02554812|526961197|FG024|Overall Study|Lost to Follow-up|0|||
146120949|NCT02554812|526961198|FG025|Overall Study|Lost to Follow-up|0|||
146120950|NCT02554812|526961199|FG026|Overall Study|Lost to Follow-up|0|||
146120951|NCT02554812|526961173|FG000|Overall Study|Global deterioration of health status|4|||
146120952|NCT02554812|526961174|FG001|Overall Study|Global deterioration of health status|3|||
146120953|NCT02554812|526961175|FG002|Overall Study|Global deterioration of health status|3|||
146120954|NCT02554812|526961176|FG003|Overall Study|Global deterioration of health status|2|||
146120955|NCT02554812|526961177|FG004|Overall Study|Global deterioration of health status|5|||
146120956|NCT02554812|526961178|FG005|Overall Study|Global deterioration of health status|0|||
146120957|NCT02554812|526961179|FG006|Overall Study|Global deterioration of health status|2|||
146120958|NCT02554812|526961180|FG007|Overall Study|Global deterioration of health status|1|||
146120959|NCT02554812|526961181|FG008|Overall Study|Global deterioration of health status|1|||
146120960|NCT02554812|526961182|FG009|Overall Study|Global deterioration of health status|1|||
146120961|NCT02554812|526961183|FG010|Overall Study|Global deterioration of health status|2|||
146120962|NCT02554812|526961184|FG011|Overall Study|Global deterioration of health status|1|||
146120963|NCT02554812|526961185|FG012|Overall Study|Global deterioration of health status|0|||
146120964|NCT02554812|526961186|FG013|Overall Study|Global deterioration of health status|0|||
146120965|NCT02554812|526961187|FG014|Overall Study|Global deterioration of health status|0|||
146120966|NCT02554812|526961188|FG015|Overall Study|Global deterioration of health status|1|||
146120967|NCT02554812|526961189|FG016|Overall Study|Global deterioration of health status|0|||
146120968|NCT02554812|526961190|FG017|Overall Study|Global deterioration of health status|0|||
146120969|NCT02554812|526961191|FG018|Overall Study|Global deterioration of health status|0|||
146120970|NCT02554812|526961192|FG019|Overall Study|Global deterioration of health status|0|||
146120971|NCT02554812|526961193|FG020|Overall Study|Global deterioration of health status|0|||
146120972|NCT02554812|526961194|FG021|Overall Study|Global deterioration of health status|0|||
146120973|NCT02554812|526961195|FG022|Overall Study|Global deterioration of health status|0|||
146120974|NCT02554812|526961196|FG023|Overall Study|Global deterioration of health status|0|||
146120975|NCT02554812|526961197|FG024|Overall Study|Global deterioration of health status|0|||
146120976|NCT02554812|526961198|FG025|Overall Study|Global deterioration of health status|0|||
146120977|NCT02554812|526961199|FG026|Overall Study|Global deterioration of health status|0|||
146120978|NCT02554812|526961173|FG000|Overall Study|Progressive disease|20|||
146120979|NCT02554812|526961174|FG001|Overall Study|Progressive disease|16|||
146120980|NCT02554812|526961175|FG002|Overall Study|Progressive disease|19|||
146120981|NCT02554812|526961176|FG003|Overall Study|Progressive disease|18|||
146120982|NCT02554812|526961177|FG004|Overall Study|Progressive disease|21|||
146120983|NCT02554812|526961178|FG005|Overall Study|Progressive disease|15|||
146120984|NCT02554812|526961179|FG006|Overall Study|Progressive disease|6|||
146120985|NCT02554812|526961180|FG007|Overall Study|Progressive disease|13|||
146120986|NCT02554812|526961181|FG008|Overall Study|Progressive disease|6|||
146120987|NCT02554812|526961182|FG009|Overall Study|Progressive disease|6|||
146120988|NCT02554812|526961183|FG010|Overall Study|Progressive disease|8|||
146120989|NCT02554812|526961184|FG011|Overall Study|Progressive disease|8|||
146120990|NCT02554812|526961185|FG012|Overall Study|Progressive disease|6|||
146120991|NCT02554812|526961186|FG013|Overall Study|Progressive disease|10|||
146120992|NCT02554812|526961187|FG014|Overall Study|Progressive disease|20|||
146120993|NCT02554812|526961188|FG015|Overall Study|Progressive disease|6|||
146120994|NCT02554812|526961189|FG016|Overall Study|Progressive disease|3|||
146120995|NCT02554812|526961190|FG017|Overall Study|Progressive disease|3|||
146120996|NCT02554812|526961191|FG018|Overall Study|Progressive disease|11|||
146120997|NCT02554812|526961192|FG019|Overall Study|Progressive disease|7|||
146120998|NCT02554812|526961193|FG020|Overall Study|Progressive disease|11|||
146120999|NCT02554812|526961194|FG021|Overall Study|Progressive disease|6|||
146121000|NCT02554812|526961195|FG022|Overall Study|Progressive disease|9|||
146121001|NCT02554812|526961196|FG023|Overall Study|Progressive disease|9|||
146121002|NCT02554812|526961197|FG024|Overall Study|Progressive disease|4|||
146121003|NCT02554812|526961198|FG025|Overall Study|Progressive disease|5|||
146121004|NCT02554812|526961199|FG026|Overall Study|Progressive disease|5|||
146121005|NCT02554812|526961173|FG000|Overall Study|Other|0|||
146121006|NCT02554812|526961174|FG001|Overall Study|Other|0|||
146121007|NCT02554812|526961175|FG002|Overall Study|Other|2|||
146121008|NCT02554812|526961176|FG003|Overall Study|Other|3|||
146121009|NCT02554812|526961177|FG004|Overall Study|Other|2|||
146121010|NCT02554812|526961178|FG005|Overall Study|Other|1|||
146121011|NCT02554812|526961179|FG006|Overall Study|Other|0|||
146121012|NCT02554812|526961180|FG007|Overall Study|Other|0|||
146121013|NCT02554812|526961181|FG008|Overall Study|Other|1|||
146121014|NCT02554812|526961182|FG009|Overall Study|Other|1|||
146121015|NCT02554812|526961183|FG010|Overall Study|Other|0|||
146121016|NCT02554812|526961184|FG011|Overall Study|Other|0|||
146121017|NCT02554812|526961185|FG012|Overall Study|Other|1|||
146121018|NCT02554812|526961186|FG013|Overall Study|Other|0|||
146121019|NCT02554812|526961187|FG014|Overall Study|Other|1|||
146121020|NCT02554812|526961188|FG015|Overall Study|Other|0|||
146121021|NCT02554812|526961189|FG016|Overall Study|Other|0|||
146121022|NCT02554812|526961190|FG017|Overall Study|Other|0|||
146121023|NCT02554812|526961191|FG018|Overall Study|Other|0|||
146121024|NCT02554812|526961192|FG019|Overall Study|Other|0|||
146121025|NCT02554812|526961193|FG020|Overall Study|Other|0|||
146121026|NCT02554812|526961194|FG021|Overall Study|Other|2|||
146121027|NCT02554812|526961195|FG022|Overall Study|Other|0|||
146121028|NCT02554812|526961196|FG023|Overall Study|Other|0|||
146121029|NCT02554812|526961197|FG024|Overall Study|Other|0|||
146121030|NCT02554812|526961198|FG025|Overall Study|Other|0|||
146121031|NCT02554812|526961199|FG026|Overall Study|Other|0|||
146121032|NCT02554812|526961173|FG000|Overall Study|Withdrawal by Subject|1|||
146121033|NCT02554812|526961174|FG001|Overall Study|Withdrawal by Subject|0|||
146121034|NCT02554812|526961175|FG002|Overall Study|Withdrawal by Subject|0|||
146121035|NCT02554812|526961176|FG003|Overall Study|Withdrawal by Subject|2|||
146121036|NCT02554812|526961177|FG004|Overall Study|Withdrawal by Subject|2|||
146121037|NCT02554812|526961178|FG005|Overall Study|Withdrawal by Subject|3|||
146121038|NCT02554812|526961179|FG006|Overall Study|Withdrawal by Subject|0|||
146121039|NCT02554812|526961180|FG007|Overall Study|Withdrawal by Subject|0|||
146121040|NCT02554812|526961181|FG008|Overall Study|Withdrawal by Subject|1|||
146121041|NCT02554812|526961182|FG009|Overall Study|Withdrawal by Subject|1|||
146121042|NCT02554812|526961183|FG010|Overall Study|Withdrawal by Subject|0|||
146121043|NCT02554812|526961184|FG011|Overall Study|Withdrawal by Subject|1|||
146121044|NCT02554812|526961185|FG012|Overall Study|Withdrawal by Subject|1|||
146121045|NCT02554812|526961186|FG013|Overall Study|Withdrawal by Subject|1|||
146121046|NCT02554812|526961187|FG014|Overall Study|Withdrawal by Subject|1|||
146121047|NCT02554812|526961188|FG015|Overall Study|Withdrawal by Subject|1|||
146121048|NCT02554812|526961189|FG016|Overall Study|Withdrawal by Subject|3|||
146121049|NCT02554812|526961190|FG017|Overall Study|Withdrawal by Subject|1|||
146121050|NCT02554812|526961191|FG018|Overall Study|Withdrawal by Subject|0|||
146121051|NCT02554812|526961192|FG019|Overall Study|Withdrawal by Subject|2|||
146121052|NCT02554812|526961193|FG020|Overall Study|Withdrawal by Subject|0|||
146121053|NCT02554812|526961194|FG021|Overall Study|Withdrawal by Subject|1|||
146121054|NCT02554812|526961195|FG022|Overall Study|Withdrawal by Subject|0|||
146121055|NCT02554812|526961196|FG023|Overall Study|Withdrawal by Subject|1|||
146121056|NCT02554812|526961197|FG024|Overall Study|Withdrawal by Subject|0|||
146121057|NCT02554812|526961198|FG025|Overall Study|Withdrawal by Subject|0|||
146121058|NCT02554812|526961199|FG026|Overall Study|Withdrawal by Subject|1|||
146121059|NCT02554812|526961173|FG000|Overall Study|Physician Decision|1|||
146121060|NCT02554812|526961174|FG001|Overall Study|Physician Decision|0|||
146121061|NCT02554812|526961175|FG002|Overall Study|Physician Decision|0|||
146121062|NCT02554812|526961176|FG003|Overall Study|Physician Decision|1|||
146121063|NCT02554812|526961177|FG004|Overall Study|Physician Decision|0|||
146121064|NCT02554812|526961178|FG005|Overall Study|Physician Decision|1|||
146121065|NCT02554812|526961179|FG006|Overall Study|Physician Decision|0|||
146121066|NCT02554812|526961180|FG007|Overall Study|Physician Decision|0|||
146121067|NCT02554812|526961181|FG008|Overall Study|Physician Decision|0|||
146121068|NCT02554812|526961182|FG009|Overall Study|Physician Decision|0|||
146121069|NCT02554812|526961183|FG010|Overall Study|Physician Decision|1|||
146121070|NCT02554812|526961184|FG011|Overall Study|Physician Decision|0|||
146121071|NCT02554812|526961185|FG012|Overall Study|Physician Decision|0|||
146121072|NCT02554812|526961186|FG013|Overall Study|Physician Decision|0|||
146121073|NCT02554812|526961187|FG014|Overall Study|Physician Decision|0|||
146121074|NCT02554812|526961188|FG015|Overall Study|Physician Decision|0|||
146121075|NCT02554812|526961189|FG016|Overall Study|Physician Decision|1|||
146121076|NCT02554812|526961190|FG017|Overall Study|Physician Decision|1|||
146121077|NCT02554812|526961191|FG018|Overall Study|Physician Decision|0|||
146121078|NCT02554812|526961192|FG019|Overall Study|Physician Decision|1|||
146121079|NCT02554812|526961193|FG020|Overall Study|Physician Decision|1|||
146121080|NCT02554812|526961194|FG021|Overall Study|Physician Decision|0|||
146121081|NCT02554812|526961195|FG022|Overall Study|Physician Decision|1|||
146121082|NCT02554812|526961196|FG023|Overall Study|Physician Decision|0|||
146121083|NCT02554812|526961197|FG024|Overall Study|Physician Decision|0|||
146121084|NCT02554812|526961198|FG025|Overall Study|Physician Decision|0|||
146121085|NCT02554812|526961199|FG026|Overall Study|Physician Decision|0|||
146121086|NCT02554812|526961173|FG000|Overall Study|Study terminated by sponsor|0|||
146121087|NCT02554812|526961174|FG001|Overall Study|Study terminated by sponsor|0|||
146121088|NCT02554812|526961175|FG002|Overall Study|Study terminated by sponsor|0|||
146121089|NCT02554812|526961176|FG003|Overall Study|Study terminated by sponsor|0|||
146121090|NCT02554812|526961177|FG004|Overall Study|Study terminated by sponsor|0|||
146121091|NCT02554812|526961178|FG005|Overall Study|Study terminated by sponsor|0|||
146121092|NCT02554812|526961179|FG006|Overall Study|Study terminated by sponsor|0|||
146121093|NCT02554812|526961180|FG007|Overall Study|Study terminated by sponsor|0|||
146121094|NCT02554812|526961181|FG008|Overall Study|Study terminated by sponsor|0|||
146121095|NCT02554812|526961182|FG009|Overall Study|Study terminated by sponsor|0|||
146121096|NCT02554812|526961183|FG010|Overall Study|Study terminated by sponsor|0|||
146121097|NCT02554812|526961184|FG011|Overall Study|Study terminated by sponsor|0|||
146121098|NCT02554812|526961185|FG012|Overall Study|Study terminated by sponsor|0|||
146121099|NCT02554812|526961186|FG013|Overall Study|Study terminated by sponsor|0|||
146121100|NCT02554812|526961187|FG014|Overall Study|Study terminated by sponsor|0|||
146121101|NCT02554812|526961188|FG015|Overall Study|Study terminated by sponsor|0|||
146121102|NCT02554812|526961189|FG016|Overall Study|Study terminated by sponsor|0|||
146121103|NCT02554812|526961190|FG017|Overall Study|Study terminated by sponsor|0|||
146121104|NCT02554812|526961191|FG018|Overall Study|Study terminated by sponsor|0|||
146121105|NCT02554812|526961192|FG019|Overall Study|Study terminated by sponsor|0|||
146121106|NCT02554812|526961193|FG020|Overall Study|Study terminated by sponsor|0|||
146121107|NCT02554812|526961194|FG021|Overall Study|Study terminated by sponsor|0|||
146121108|NCT02554812|526961195|FG022|Overall Study|Study terminated by sponsor|0|||
146121109|NCT02554812|526961196|FG023|Overall Study|Study terminated by sponsor|0|||
146121110|NCT02554812|526961197|FG024|Overall Study|Study terminated by sponsor|1|||
146121111|NCT02554812|526961198|FG025|Overall Study|Study terminated by sponsor|0|||
146121112|NCT02554812|526961199|FG026|Overall Study|Study terminated by sponsor|0|||
146303081|NCT01994382|527624076|FG016|Overall Study|Other than specified|4|||
146303082|NCT01994382|527624060|FG000|Overall Study|Withdrawal by Subject|0|||
146121113|NCT02554812|526961173|FG000|Overall Study|No longer meets eligibility criteria|0|||
146121114|NCT02554812|526961174|FG001|Overall Study|No longer meets eligibility criteria|1|||
146121115|NCT02554812|526961175|FG002|Overall Study|No longer meets eligibility criteria|0|||
146121116|NCT02554812|526961176|FG003|Overall Study|No longer meets eligibility criteria|0|||
146121117|NCT02554812|526961177|FG004|Overall Study|No longer meets eligibility criteria|0|||
146121118|NCT02554812|526961178|FG005|Overall Study|No longer meets eligibility criteria|0|||
146121119|NCT02554812|526961179|FG006|Overall Study|No longer meets eligibility criteria|0|||
146121120|NCT02554812|526961180|FG007|Overall Study|No longer meets eligibility criteria|0|||
146121121|NCT02554812|526961181|FG008|Overall Study|No longer meets eligibility criteria|0|||
146121122|NCT02554812|526961182|FG009|Overall Study|No longer meets eligibility criteria|0|||
146121123|NCT02554812|526961183|FG010|Overall Study|No longer meets eligibility criteria|0|||
146121124|NCT02554812|526961184|FG011|Overall Study|No longer meets eligibility criteria|0|||
146121125|NCT02554812|526961185|FG012|Overall Study|No longer meets eligibility criteria|0|||
146121126|NCT02554812|526961186|FG013|Overall Study|No longer meets eligibility criteria|0|||
146121127|NCT02554812|526961187|FG014|Overall Study|No longer meets eligibility criteria|0|||
146121128|NCT02554812|526961188|FG015|Overall Study|No longer meets eligibility criteria|0|||
146121129|NCT02554812|526961189|FG016|Overall Study|No longer meets eligibility criteria|0|||
146121130|NCT02554812|526961190|FG017|Overall Study|No longer meets eligibility criteria|0|||
146121131|NCT02554812|526961191|FG018|Overall Study|No longer meets eligibility criteria|0|||
146121132|NCT02554812|526961192|FG019|Overall Study|No longer meets eligibility criteria|0|||
146121133|NCT02554812|526961193|FG020|Overall Study|No longer meets eligibility criteria|0|||
146121134|NCT02554812|526961194|FG021|Overall Study|No longer meets eligibility criteria|0|||
146121135|NCT02554812|526961195|FG022|Overall Study|No longer meets eligibility criteria|0|||
146121136|NCT02554812|526961196|FG023|Overall Study|No longer meets eligibility criteria|0|||
146121137|NCT02554812|526961197|FG024|Overall Study|No longer meets eligibility criteria|0|||
146121138|NCT02554812|526961198|FG025|Overall Study|No longer meets eligibility criteria|0|||
146121139|NCT02554812|526961199|FG026|Overall Study|No longer meets eligibility criteria|0|||
146121140|NCT01103284|526961200|FG000|Overall Study|Death|2|||
146121141|NCT01103284|526961201|FG001|Overall Study|Death|0|||
146121142|NCT01103284|526961200|FG000|Overall Study|Lost to Follow-up|9|||
146121143|NCT01103284|526961201|FG001|Overall Study|Lost to Follow-up|10|||
146121144|NCT01103284|526961200|FG000|Overall Study|Pregnancy|3|||
146121145|NCT01103284|526961201|FG001|Overall Study|Pregnancy|1|||
146121146|NCT01103284|526961200|FG000|Overall Study|Protocol Violation|12|||
146121147|NCT01103284|526961201|FG001|Overall Study|Protocol Violation|5|||
146121148|NCT01103284|526961200|FG000|Overall Study|Adverse Event|0|||
146121149|NCT01103284|526961201|FG001|Overall Study|Adverse Event|5|||
146121150|NCT01103284|526961200|FG000|Overall Study|Withdrawal by Subject|14|||
146121151|NCT01103284|526961201|FG001|Overall Study|Withdrawal by Subject|18|||
146121152|NCT01103284|526961200|FG000|Overall Study|Dermal Hypersensitivity|0|||
146121153|NCT01103284|526961201|FG001|Overall Study|Dermal Hypersensitivity|1|||
146121154|NCT01103284|526961200|FG000|Overall Study|Termination by the Sponsor|0|||
146121155|NCT01103284|526961201|FG001|Overall Study|Termination by the Sponsor|1|||
146121156|NCT01103284|526961200|FG000|Overall Study|Not described|2|||
146121157|NCT01103284|526961201|FG001|Overall Study|Not described|1|||
146121158|NCT01103284|526961200|FG000|Overall Study|Missing CRF entries for study completion|0|||
146121159|NCT01103284|526961201|FG001|Overall Study|Missing CRF entries for study completion|2|||
146121160|NCT03182829|526962975|FG000|Overall Study|Protocol Violation|12|||
146121161|NCT03182829|526962976|FG001|Overall Study|Protocol Violation|12|||
146121162|NCT03182829|526962975|FG000|Overall Study|Other|4|||
146121163|NCT03182829|526962976|FG001|Overall Study|Other|3|||
146121164|NCT03316131|526962977|FG000|Treatment Period 2|Protocol deviation|1|||
146121165|NCT03316131|526962978|FG001|Treatment Period 2|Protocol deviation|0|||
146121166|NCT05608005|526962980|FG000|Overall Study|Adverse Event|2|||
146121167|NCT05608005|526962981|FG001|Overall Study|Adverse Event|1|||
146121168|NCT05608005|526962982|FG002|Overall Study|Adverse Event|3|||
146121169|NCT05608005|526962980|FG000|Overall Study|Protocol Violation|2|||
146121170|NCT05608005|526962981|FG001|Overall Study|Protocol Violation|3|||
146121171|NCT05608005|526962982|FG002|Overall Study|Protocol Violation|0|||
146121172|NCT05608005|526962980|FG000|Overall Study|Withdrawal by Subject|10|||
146121173|NCT05608005|526962981|FG001|Overall Study|Withdrawal by Subject|12|||
146121174|NCT05608005|526962982|FG002|Overall Study|Withdrawal by Subject|4|||
146121175|NCT05608005|526962980|FG000|Overall Study|Lost to Follow-up|25|||
146303083|NCT01994382|527624061|FG001|Overall Study|Withdrawal by Subject|0|||
146303084|NCT01994382|527624062|FG002|Overall Study|Withdrawal by Subject|0|||
146303085|NCT01994382|527624063|FG003|Overall Study|Withdrawal by Subject|0|||
146121176|NCT05608005|526962981|FG001|Overall Study|Lost to Follow-up|27|||
146121177|NCT05608005|526962982|FG002|Overall Study|Lost to Follow-up|15|||
146121178|NCT05608005|526962980|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
146303086|NCT01994382|527624064|FG004|Overall Study|Withdrawal by Subject|0|||
146303087|NCT01994382|527624065|FG005|Overall Study|Withdrawal by Subject|0|||
146121179|NCT05608005|526962981|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
146121180|NCT05608005|526962982|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
146121181|NCT03020407|526962986|FG000|Overall Study|Withdrawal by Subject|2|||
146121182|NCT03020407|526962987|FG001|Overall Study|Withdrawal by Subject|1|||
146121183|NCT03020407|526962986|FG000|Overall Study|Lost to Follow-up|2|||
146121184|NCT03020407|526962987|FG001|Overall Study|Lost to Follow-up|3|||
146121185|NCT03020407|526962986|FG000|Overall Study|Protocol Violation|0|||
146121186|NCT03020407|526962987|FG001|Overall Study|Protocol Violation|1|||
146121187|NCT01585428|526962988|FG000|Overall Study|Death during treatment|1|||
146121188|NCT01585428|526962989|FG001|Overall Study|Death during treatment|0|||
146121189|NCT01349803|526962993|FG000|Overall Study|Adverse Event|0|||
146121190|NCT01349803|526962994|FG001|Overall Study|Adverse Event|0|||
146121191|NCT01349803|526962995|FG002|Overall Study|Adverse Event|0|||
146121192|NCT01349803|526962996|FG003|Overall Study|Adverse Event|2|||
146121193|NCT01349803|526962993|FG000|Overall Study|Withdrawal by Subject|1|||
146121194|NCT01349803|526962994|FG001|Overall Study|Withdrawal by Subject|0|||
146121195|NCT01349803|526962995|FG002|Overall Study|Withdrawal by Subject|0|||
146121196|NCT01349803|526962996|FG003|Overall Study|Withdrawal by Subject|0|||
146121197|NCT01349803|526962993|FG000|Overall Study|Protocol-specified criteria|0|||
146121198|NCT01349803|526962994|FG001|Overall Study|Protocol-specified criteria|1|||
146121199|NCT01349803|526962995|FG002|Overall Study|Protocol-specified criteria|3|||
146121200|NCT01349803|526962996|FG003|Overall Study|Protocol-specified criteria|0|||
146121201|NCT01042236|526962999|FG000|Treatment Period 1|Adverse Event|0|||
146121202|NCT01042236|526963000|FG001|Treatment Period 1|Adverse Event|1|||
146121203|NCT01042236|526963001|FG002|Treatment Period 1|Adverse Event|0|||
146121204|NCT01042236|526963002|FG003|Treatment Period 1|Adverse Event|0|||
146121205|NCT01042236|526963003|FG004|Treatment Period 1|Adverse Event|1|||
146121206|NCT01042236|526963004|FG005|Treatment Period 1|Adverse Event|0|||
146121207|NCT01042236|526962999|FG000|Treatment Period 3|Adverse Event|0|||
146121208|NCT01042236|526963000|FG001|Treatment Period 3|Adverse Event|0|||
146121209|NCT01042236|526963001|FG002|Treatment Period 3|Adverse Event|0|||
146121210|NCT01042236|526963002|FG003|Treatment Period 3|Adverse Event|1|||
146121211|NCT01042236|526963003|FG004|Treatment Period 3|Adverse Event|0|||
146121212|NCT01042236|526963004|FG005|Treatment Period 3|Adverse Event|0|||
146121213|NCT01042236|526962999|FG000|Treatment Period 3|Protocol Violation|0|||
146121214|NCT01042236|526963000|FG001|Treatment Period 3|Protocol Violation|0|||
146121215|NCT01042236|526963001|FG002|Treatment Period 3|Protocol Violation|0|||
146121216|NCT01042236|526963002|FG003|Treatment Period 3|Protocol Violation|1|||
146121217|NCT01042236|526963003|FG004|Treatment Period 3|Protocol Violation|0|||
146121218|NCT01042236|526963004|FG005|Treatment Period 3|Protocol Violation|0|||
146121219|NCT02522286|526963005|FG000|Overall Study|Withdrawal by Subject|3|||
146121220|NCT02522286|526963006|FG001|Overall Study|Withdrawal by Subject|0|||
146121221|NCT02522286|526963007|FG002|Overall Study|Withdrawal by Subject|0|||
146121222|NCT02522286|526963008|FG003|Overall Study|Withdrawal by Subject|3|||
146121223|NCT03683758|526963013|FG000|Overall Study|Non-study commitment conflict|1|||
146121224|NCT03683758|526963014|FG001|Overall Study|Non-study commitment conflict|3|||
146121225|NCT03683758|526963013|FG000|Overall Study|Illness preventing participation|1|||
146121226|NCT03683758|526963014|FG001|Overall Study|Illness preventing participation|0|||
146121227|NCT03683758|526963013|FG000|Overall Study|Adverse Event|1|||
146121228|NCT03683758|526963014|FG001|Overall Study|Adverse Event|0|||
146121229|NCT01172847|526963015|FG000|Overall Study|Withdrawal by Subject|3|||
146121230|NCT02411292|526963017|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
146121231|NCT02411292|526963017|FG000|Overall Study|Death|2|||
146121232|NCT02411292|526963017|FG000|Overall Study|Lost to Follow-up|3|||
146121233|NCT00453921|526963020|FG000|Overall Study|Withdrawal by Subject|1|||
146121234|NCT00453921|526963021|FG001|Overall Study|Withdrawal by Subject|1|||
146121235|NCT00453921|526963022|FG002|Overall Study|Withdrawal by Subject|1|||
146121236|NCT00453921|526963023|FG003|Overall Study|Withdrawal by Subject|1|||
146121237|NCT00453921|526963020|FG000|Overall Study|Lost to Follow-up|0|||
146121238|NCT00453921|526963021|FG001|Overall Study|Lost to Follow-up|0|||
146121239|NCT00453921|526963022|FG002|Overall Study|Lost to Follow-up|1|||
146121240|NCT00453921|526963023|FG003|Overall Study|Lost to Follow-up|0|||
146121241|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
146121242|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
146121243|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
146121244|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
146121245|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
146121246|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
146121247|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
146121248|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
146121249|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Other|4|||
146121250|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Other|1|||
146121251|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
146121252|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
146121253|NCT00303498|526963024|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
146121254|NCT00303498|526963025|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
146121255|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
146121256|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
146121257|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Death|1|||
146121258|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Death|0|||
146121259|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
146121260|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
146121261|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
146121262|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
146121263|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
146121264|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
146121265|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
146121266|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
146121267|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Other|1|||
146121268|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Other|0|||
146121269|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
146121270|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
146121271|NCT00303498|526963024|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
146121272|NCT00303498|526963025|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
146121273|NCT00174915|526963026|FG000|Overall Study|Lost to Follow-up|19|||
146121274|NCT00174915|526963027|FG001|Overall Study|Lost to Follow-up|17|||
146121275|NCT00174915|526963028|FG002|Overall Study|Lost to Follow-up|9|||
146121276|NCT00174915|526963029|FG003|Overall Study|Lost to Follow-up|17|||
146121277|NCT00174915|526963030|FG004|Overall Study|Lost to Follow-up|10|||
146121278|NCT00174915|526963026|FG000|Overall Study|Adverse Event|18|||
146121279|NCT00174915|526963027|FG001|Overall Study|Adverse Event|16|||
146121280|NCT00174915|526963028|FG002|Overall Study|Adverse Event|11|||
146121281|NCT00174915|526963029|FG003|Overall Study|Adverse Event|18|||
146121282|NCT00174915|526963030|FG004|Overall Study|Adverse Event|5|||
146121283|NCT00174915|526963026|FG000|Overall Study|Personal Reason(s)|16|||
146121284|NCT00174915|526963027|FG001|Overall Study|Personal Reason(s)|16|||
146121285|NCT00174915|526963028|FG002|Overall Study|Personal Reason(s)|9|||
146121286|NCT00174915|526963029|FG003|Overall Study|Personal Reason(s)|9|||
146121287|NCT00174915|526963030|FG004|Overall Study|Personal Reason(s)|9|||
146121288|NCT00174915|526963026|FG000|Overall Study|Other|15|||
146121289|NCT00174915|526963027|FG001|Overall Study|Other|8|||
146121290|NCT00174915|526963028|FG002|Overall Study|Other|6|||
146121291|NCT00174915|526963029|FG003|Overall Study|Other|5|||
146121292|NCT00174915|526963030|FG004|Overall Study|Other|3|||
146121293|NCT00174915|526963026|FG000|Overall Study|Gout Flare|13|||
146121294|NCT00174915|526963027|FG001|Overall Study|Gout Flare|6|||
146121295|NCT00174915|526963028|FG002|Overall Study|Gout Flare|8|||
146121296|NCT00174915|526963029|FG003|Overall Study|Gout Flare|1|||
146121297|NCT00174915|526963030|FG004|Overall Study|Gout Flare|0|||
146121298|NCT00174915|526963026|FG000|Overall Study|Protocol Violation|6|||
146121299|NCT00174915|526963027|FG001|Overall Study|Protocol Violation|3|||
146121300|NCT00174915|526963028|FG002|Overall Study|Protocol Violation|3|||
146121301|NCT00174915|526963029|FG003|Overall Study|Protocol Violation|6|||
146121302|NCT00174915|526963030|FG004|Overall Study|Protocol Violation|3|||
146121303|NCT00174915|526963026|FG000|Overall Study|Therapeutic Failure|6|||
146121304|NCT00174915|526963027|FG001|Overall Study|Therapeutic Failure|3|||
146121305|NCT00174915|526963028|FG002|Overall Study|Therapeutic Failure|2|||
146121306|NCT00174915|526963029|FG003|Overall Study|Therapeutic Failure|1|||
146121307|NCT00174915|526963030|FG004|Overall Study|Therapeutic Failure|3|||
146121308|NCT03060447|526963031|FG000|Overall Study|Withdrawal by Subject|2|||
146121309|NCT03060447|526963032|FG001|Overall Study|Withdrawal by Subject|0|||
146121310|NCT00665353|526963033|FG000|Study Step 1|Adverse Event|1|||
146121311|NCT00665353|526963033|FG000|Study Step 1|Withdrawal by Subject|2|||
146121312|NCT00665353|526963033|FG000|Study Step 2|Lost to Follow-up|2|||
146121313|NCT00665353|526963033|FG000|Study Step 2|Lack of Efficacy|12|||
146121314|NCT01870583|526963034|FG000|Overall Study|Protocol Violation|0|||
146121315|NCT01870583|526963035|FG001|Overall Study|Protocol Violation|5|||
146121316|NCT01870583|526963036|FG002|Overall Study|Protocol Violation|3|||
146121317|NCT01870583|526963034|FG000|Overall Study|Lost to Follow-up|11|||
146121318|NCT01870583|526963035|FG001|Overall Study|Lost to Follow-up|13|||
146121319|NCT01870583|526963036|FG002|Overall Study|Lost to Follow-up|5|||
146121320|NCT03045887|526963041|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
146121321|NCT03045887|526963042|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121322|NCT03045887|526963043|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121323|NCT03045887|526963044|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121324|NCT03045887|526963045|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121325|NCT03045887|526963046|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121326|NCT03045887|526963047|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121327|NCT03045887|526963048|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121328|NCT03045887|526963049|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146121329|NCT03045887|526963050|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
146261939|NCT00362375|527474326|FG000|Overall Study|Lost to Follow-up|40|||
146261940|NCT00362375|527474327|FG001|Overall Study|Lost to Follow-up|35|||
146261941|NCT04984239|527474328|FG000|Overall Study|Lost to Follow-up|1|||
146261942|NCT04523207|527474331|FG000|Overall Study|Adverse Event|5|||
146261943|NCT04523207|527474332|FG001|Overall Study|Adverse Event|1|||
146261944|NCT04523207|527474331|FG000|Overall Study|Lost to Follow-up|2|||
146261945|NCT04523207|527474332|FG001|Overall Study|Lost to Follow-up|0|||
146261946|NCT04523207|527474331|FG000|Overall Study|Withdrawal by Subject|2|||
146261947|NCT04523207|527474332|FG001|Overall Study|Withdrawal by Subject|0|||
146261948|NCT04523207|527474331|FG000|Overall Study|Progressive Disease|2|||
146261949|NCT04523207|527474332|FG001|Overall Study|Progressive Disease|1|||
146261950|NCT04523207|527474331|FG000|Overall Study|Other|7|||
146261951|NCT04523207|527474332|FG001|Overall Study|Other|1|||
146261952|NCT03113383|527474333|FG000|Overall Study|Death|4|||
146261953|NCT03113383|527474334|FG001|Overall Study|Death|0|||
146261954|NCT03062449|527474336|FG000|Overall Study|Withdrawal by Subject|7|||
146261955|NCT03062449|527474337|FG001|Overall Study|Withdrawal by Subject|1|||
146261956|NCT04702893|527474339|FG000|Overall Study|Other reasons than listed|11|||
146261957|NCT04702893|527474339|FG000|Overall Study|Withdrawal by Subject|3|||
146261958|NCT04702893|527474339|FG000|Overall Study|Lost to Follow-up|7|||
146261959|NCT04702893|527474339|FG000|Overall Study|Death|10|||
146261960|NCT04702893|527474339|FG000|Overall Study|Not treated|6|||
146261961|NCT00408928|527474340|FG000|Overall Study|Withdrawal by Subject|1|||
146261962|NCT00408928|527474340|FG000|Overall Study|Death|1|||
146261963|NCT00408928|527474340|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
146261964|NCT01951378|527474343|FG000|Overall Study|Study Terminated-Not completed|23|||
146261965|NCT01951378|527474344|FG001|Overall Study|Study Terminated-Not completed|17|||
146261966|NCT00543062|527474345|FG000|Overall Study|Withdrawal by Subject|1|||
146261967|NCT00543062|527474346|FG001|Overall Study|Withdrawal by Subject|0|||
146261968|NCT00543062|527474347|FG002|Overall Study|Withdrawal by Subject|2|||
146261969|NCT00543062|527474348|FG003|Overall Study|Withdrawal by Subject|0|||
146261970|NCT00543062|527474345|FG000|Overall Study|Adverse Event|0|||
146261971|NCT00543062|527474346|FG001|Overall Study|Adverse Event|1|||
146261972|NCT00543062|527474347|FG002|Overall Study|Adverse Event|1|||
146261973|NCT00543062|527474348|FG003|Overall Study|Adverse Event|1|||
146261974|NCT00543062|527474345|FG000|Overall Study|Protocol Violation|1|||
146261975|NCT00543062|527474346|FG001|Overall Study|Protocol Violation|0|||
146261976|NCT00543062|527474347|FG002|Overall Study|Protocol Violation|0|||
146261977|NCT00543062|527474348|FG003|Overall Study|Protocol Violation|0|||
146261978|NCT03927690|527474351|FG000|Overall Study|Withdrawal by Subject|3|||
146261979|NCT03927690|527474352|FG001|Overall Study|Withdrawal by Subject|1|||
146261980|NCT03927690|527474353|FG002|Overall Study|Withdrawal by Subject|1|||
146261981|NCT03927690|527474351|FG000|Overall Study|Adverse Event|1|||
146261982|NCT03927690|527474352|FG001|Overall Study|Adverse Event|0|||
146261983|NCT03927690|527474353|FG002|Overall Study|Adverse Event|0|||
146261984|NCT03927690|527474351|FG000|Overall Study|Death|1|||
146261985|NCT03927690|527474352|FG001|Overall Study|Death|0|||
146261986|NCT03927690|527474353|FG002|Overall Study|Death|0|||
146261987|NCT03927690|527474351|FG000|Overall Study|Lost to Follow-up|2|||
146261988|NCT03927690|527474352|FG001|Overall Study|Lost to Follow-up|2|||
146261989|NCT03927690|527474353|FG002|Overall Study|Lost to Follow-up|1|||
146261990|NCT01844726|527474360|FG000|Overall Study|Withdrawal by Subject|0|||
146261991|NCT01844726|527474361|FG001|Overall Study|Withdrawal by Subject|1|||
146261992|NCT01844726|527474360|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
146261993|NCT01844726|527474361|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
146261994|NCT03898960|527474364|FG000|Overall Study|Death|10|||
146261995|NCT00548847|527474365|FG000|Overall Study|Disease progression|7|||
146261996|NCT01772563|527474375|FG000|Cycle 1|Dose limiting toxicity|2|||
146261997|NCT01772563|527474375|FG000|Cycle 1|Progressive disease|2|||
146261998|NCT01772563|527474375|FG000|Cycle 2 and Beyond|Progressive disease|17|||
146261999|NCT01772563|527474375|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
146262000|NCT01772563|527474375|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
146262001|NCT00832000|527474376|FG000|Overall Study|Adverse Event|2|||
146262002|NCT00832000|527474377|FG001|Overall Study|Adverse Event|0|||
146262003|NCT00832000|527474376|FG000|Overall Study|Withdrawal by Subject|1|||
146262004|NCT00832000|527474377|FG001|Overall Study|Withdrawal by Subject|0|||
146262005|NCT00832000|527474376|FG000|Overall Study|No calls to IVR in either period|1|||
146262006|NCT00832000|527474377|FG001|Overall Study|No calls to IVR in either period|1|||
146262007|NCT00832000|527474376|FG000|Overall Study|No calls to IVR in period 2|2|||
146262008|NCT00832000|527474377|FG001|Overall Study|No calls to IVR in period 2|0|||
146262009|NCT01898442|527474378|FG000|Overall Study|Hemolysis/technical problems|1|||
146262010|NCT01898442|527474379|FG001|Overall Study|Hemolysis/technical problems|2|||
146262011|NCT01898442|527474380|FG002|Overall Study|Hemolysis/technical problems|2|||
146262012|NCT01898442|527474378|FG000|Overall Study|Patient vomited pills|0|||
146262013|NCT01898442|527474379|FG001|Overall Study|Patient vomited pills|0|||
146262014|NCT01898442|527474380|FG002|Overall Study|Patient vomited pills|1|||
146121330|NCT03045887|526963041|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121331|NCT03045887|526963042|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121332|NCT03045887|526963043|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121333|NCT03045887|526963044|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
146121334|NCT03045887|526963045|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121335|NCT03045887|526963046|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121336|NCT03045887|526963047|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121337|NCT03045887|526963048|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121338|NCT03045887|526963049|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121339|NCT03045887|526963050|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
146121340|NCT03045887|526963041|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
146121341|NCT03045887|526963042|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121342|NCT03045887|526963043|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121343|NCT03045887|526963044|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121344|NCT03045887|526963045|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121345|NCT03045887|526963046|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121346|NCT03045887|526963047|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121347|NCT03045887|526963048|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121348|NCT03045887|526963049|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121349|NCT03045887|526963050|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
146121350|NCT03045887|526963041|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121351|NCT03045887|526963042|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121352|NCT03045887|526963043|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
146121353|NCT03045887|526963044|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
146121354|NCT03045887|526963045|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121355|NCT03045887|526963046|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121356|NCT03045887|526963047|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121357|NCT03045887|526963048|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121358|NCT03045887|526963049|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121359|NCT03045887|526963050|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
146121360|NCT03045887|526963041|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121361|NCT03045887|526963042|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121362|NCT03045887|526963043|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121363|NCT03045887|526963044|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
146121364|NCT03045887|526963045|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121365|NCT03045887|526963046|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121366|NCT03045887|526963047|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121367|NCT03045887|526963048|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121368|NCT03045887|526963049|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121369|NCT03045887|526963050|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
146121370|NCT02632552|526963051|FG000|Overall Study|Lost to Follow-up|14|||
146121371|NCT02632552|526963052|FG001|Overall Study|Lost to Follow-up|8|||
146121372|NCT02632552|526963051|FG000|Overall Study|Withdrawal by Subject|2|||
146121373|NCT02632552|526963052|FG001|Overall Study|Withdrawal by Subject|0|||
146121374|NCT02632552|526963051|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
146121375|NCT02632552|526963052|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
146121376|NCT02132767|526963053|FG000|Overall Study|Death|3|||
146121377|NCT02132767|526963054|FG001|Overall Study|Death|2|||
146121378|NCT02132767|526963053|FG000|Overall Study|Withdrawal by Subject|10|||
146121379|NCT02132767|526963054|FG001|Overall Study|Withdrawal by Subject|9|||
146121380|NCT02132767|526963053|FG000|Overall Study|Lost to Follow-up|4|||
146121381|NCT02132767|526963054|FG001|Overall Study|Lost to Follow-up|4|||
146121382|NCT00778700|526963057|FG000|Overall Study|Adverse Event|6|||
146121383|NCT00778700|526963058|FG001|Overall Study|Adverse Event|1|||
146121384|NCT00778700|526963059|FG002|Overall Study|Adverse Event|3|||
146121385|NCT00778700|526963060|FG003|Overall Study|Adverse Event|5|||
146121386|NCT00778700|526963057|FG000|Overall Study|Protocol Violation|1|||
146121387|NCT00778700|526963058|FG001|Overall Study|Protocol Violation|1|||
146121388|NCT00778700|526963059|FG002|Overall Study|Protocol Violation|0|||
146121389|NCT00778700|526963060|FG003|Overall Study|Protocol Violation|0|||
146121390|NCT00778700|526963057|FG000|Overall Study|Subject Withdrew Consent|6|||
146121391|NCT00778700|526963058|FG001|Overall Study|Subject Withdrew Consent|4|||
146121392|NCT00778700|526963059|FG002|Overall Study|Subject Withdrew Consent|1|||
146121393|NCT00778700|526963060|FG003|Overall Study|Subject Withdrew Consent|4|||
146303088|NCT01994382|527624066|FG006|Overall Study|Withdrawal by Subject|0|||
146303089|NCT01994382|527624067|FG007|Overall Study|Withdrawal by Subject|0|||
146303090|NCT01994382|527624068|FG008|Overall Study|Withdrawal by Subject|0|||
146121394|NCT00778700|526963057|FG000|Overall Study|Lost to Follow-up|3|||
146121395|NCT00778700|526963058|FG001|Overall Study|Lost to Follow-up|1|||
146121396|NCT00778700|526963059|FG002|Overall Study|Lost to Follow-up|0|||
146303091|NCT01994382|527624069|FG009|Overall Study|Withdrawal by Subject|0|||
146121397|NCT00778700|526963060|FG003|Overall Study|Lost to Follow-up|1|||
146121398|NCT00778700|526963057|FG000|Overall Study|Reason not Specified|2|||
146121399|NCT00778700|526963058|FG001|Overall Study|Reason not Specified|0|||
146121400|NCT00778700|526963059|FG002|Overall Study|Reason not Specified|1|||
146121401|NCT00778700|526963060|FG003|Overall Study|Reason not Specified|3|||
146121402|NCT00778700|526963057|FG000|Overall Study|Other|0|||
146121403|NCT00778700|526963058|FG001|Overall Study|Other|0|||
146121404|NCT00778700|526963059|FG002|Overall Study|Other|1|||
146121405|NCT00778700|526963060|FG003|Overall Study|Other|0|||
146121406|NCT03227029|526963063|FG000|Overall Study|Child Wheezed (no treatment)|0|||
146121407|NCT03227029|526963064|FG001|Overall Study|Child Wheezed (no treatment)|1|||
146121408|NCT03227029|526963065|FG002|Overall Study|Child Wheezed (no treatment)|0|||
146121409|NCT03227029|526963063|FG000|Overall Study|No post RSV season visit due to COVID|3|||
146121410|NCT03227029|526963064|FG001|Overall Study|No post RSV season visit due to COVID|3|||
146121411|NCT03227029|526963065|FG002|Overall Study|No post RSV season visit due to COVID|2|||
146121412|NCT03227029|526963063|FG000|Overall Study|Not able to get to clinic|0|||
146121413|NCT03227029|526963064|FG001|Overall Study|Not able to get to clinic|0|||
146121414|NCT03227029|526963065|FG002|Overall Study|Not able to get to clinic|1|||
146121415|NCT03227029|526963063|FG000|Overall Study|Withdrawal by Subject|1|||
146121416|NCT03227029|526963064|FG001|Overall Study|Withdrawal by Subject|0|||
146121417|NCT03227029|526963065|FG002|Overall Study|Withdrawal by Subject|0|||
146121418|NCT03227029|526963063|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
146121419|NCT03227029|526963064|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
146121420|NCT03227029|526963065|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
146121421|NCT00450450|526963066|FG000|Overall Study|Death|1|||
146121422|NCT00450450|526963067|FG001|Overall Study|Death|3|||
146121423|NCT00450450|526963066|FG000|Overall Study|Relapse|2|||
146121424|NCT00450450|526963067|FG001|Overall Study|Relapse|0|||
146121425|NCT00450450|526963066|FG000|Overall Study|Missing Data|2|||
146121426|NCT00450450|526963067|FG001|Overall Study|Missing Data|0|||
146121427|NCT01496313|526963068|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
146121428|NCT01496313|526963069|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
146121429|NCT01496313|526963070|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
146121430|NCT01496313|526963071|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
146121431|NCT01496313|526963072|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
146262015|NCT03974100|527474381|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
146262016|NCT03974100|527474382|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
146262017|NCT03974100|527474383|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
146262018|NCT03974100|527474384|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
146262019|NCT03974100|527474385|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
146262020|NCT03974100|527474381|FG000|TP1 - Day 1 to Week 52|Death|1|||
146121432|NCT01496313|526963073|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
146121433|NCT01496313|526963068|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
146121434|NCT01496313|526963069|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
146121435|NCT01496313|526963070|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146121436|NCT01496313|526963071|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146121437|NCT01496313|526963072|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146121438|NCT01496313|526963073|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
146121439|NCT01496313|526963068|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146121440|NCT01496313|526963069|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
146121441|NCT01496313|526963070|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146121442|NCT01496313|526963071|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146121443|NCT01496313|526963072|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146121444|NCT01496313|526963073|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
146121445|NCT01496313|526963068|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
146121446|NCT01496313|526963069|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
146121447|NCT01496313|526963070|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
146121448|NCT01496313|526963071|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
146121449|NCT01496313|526963072|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
146262021|NCT03974100|527474382|FG001|TP1 - Day 1 to Week 52|Death|0|||
146303092|NCT01994382|527624070|FG010|Overall Study|Withdrawal by Subject|6|||
146121450|NCT01496313|526963073|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
146121451|NCT01496313|526963068|FG000|Randomized Period (up to 14 Months)|Other|1|||
146262022|NCT03974100|527474383|FG002|TP1 - Day 1 to Week 52|Death|0|||
146303093|NCT01994382|527624071|FG011|Overall Study|Withdrawal by Subject|0|||
146121452|NCT01496313|526963069|FG001|Randomized Period (up to 14 Months)|Other|2|||
146121453|NCT01496313|526963070|FG002|Randomized Period (up to 14 Months)|Other|0|||
146262023|NCT03974100|527474384|FG003|TP1 - Day 1 to Week 52|Death|0|||
146262024|NCT03974100|527474385|FG004|TP1 - Day 1 to Week 52|Death|0|||
146262025|NCT03974100|527474381|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146121454|NCT01496313|526963071|FG003|Randomized Period (up to 14 Months)|Other|0|||
146121455|NCT01496313|526963072|FG004|Randomized Period (up to 14 Months)|Other|0|||
146121456|NCT01496313|526963073|FG005|Randomized Period (up to 14 Months)|Other|0|||
146121457|NCT01496313|526963068|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146121458|NCT01496313|526963069|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146121459|NCT01496313|526963070|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146121460|NCT01496313|526963071|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146121461|NCT01496313|526963072|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
146121462|NCT01496313|526963073|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
146121463|NCT01496313|526963068|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146121464|NCT01496313|526963069|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146121465|NCT01496313|526963070|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146121466|NCT01496313|526963071|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146121467|NCT01496313|526963072|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
146121468|NCT01496313|526963073|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
146121469|NCT01496313|526963068|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
146121470|NCT01496313|526963069|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
146121471|NCT01496313|526963070|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
146121472|NCT01496313|526963071|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
146121473|NCT01496313|526963072|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
146121474|NCT01496313|526963073|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
146121475|NCT02064166|526963079|FG000|Overall Study|Adverse Event|1|||
146121476|NCT02064166|526963080|FG001|Overall Study|Adverse Event|0|||
146121477|NCT00597766|526963085|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
146121478|NCT00597766|526963086|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
146121479|NCT00597766|526963087|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
146121480|NCT00597766|526963085|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
146121481|NCT00597766|526963086|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
146121482|NCT00597766|526963087|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
146121483|NCT04339296|526963089|FG000|Overall Study|Refuse to participate after allocation|1|||
146121484|NCT04339296|526963090|FG001|Overall Study|Refuse to participate after allocation|1|||
146121485|NCT04339296|526963089|FG000|Overall Study|Withdrew after completion of baseline|2|||
146121486|NCT04339296|526963090|FG001|Overall Study|Withdrew after completion of baseline|1|||
146121487|NCT04339296|526963089|FG000|Overall Study|Lost to Follow-up|0|||
146121488|NCT04339296|526963090|FG001|Overall Study|Lost to Follow-up|4|||
146121489|NCT04339296|526963089|FG000|Overall Study|Discontinued intervention|5|||
146121490|NCT04339296|526963090|FG001|Overall Study|Discontinued intervention|3|||
146121491|NCT02375113|526963095|FG000|Overall Study|Undisclosed Reason(s).|1|||
146121492|NCT02375113|526963096|FG001|Overall Study|Undisclosed Reason(s).|1|||
146121493|NCT02375113|526963095|FG000|Overall Study|Poor adherence (<70%).|1|||
146121494|NCT02375113|526963096|FG001|Overall Study|Poor adherence (<70%).|0|||
146121495|NCT02375113|526963095|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
146121496|NCT02375113|526963096|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
146121497|NCT00877383|526963099|FG000|Overall Study|Adverse Event|13|||
146121498|NCT00877383|526963100|FG001|Overall Study|Adverse Event|14|||
146121499|NCT00877383|526963099|FG000|Overall Study|Lost to Follow-up|5|||
146121500|NCT00877383|526963100|FG001|Overall Study|Lost to Follow-up|3|||
146121501|NCT00877383|526963099|FG000|Overall Study|Subject withdrew consent|3|||
146121502|NCT00877383|526963100|FG001|Overall Study|Subject withdrew consent|12|||
146121503|NCT00877383|526963099|FG000|Overall Study|Subject no longer requires study drug|2|||
146121504|NCT00877383|526963100|FG001|Overall Study|Subject no longer requires study drug|0|||
146121505|NCT00877383|526963099|FG000|Overall Study|Administrative problems|2|||
146121506|NCT00877383|526963100|FG001|Overall Study|Administrative problems|0|||
146121507|NCT00877383|526963099|FG000|Overall Study|Protocol deviation|2|||
146121508|NCT00877383|526963100|FG001|Overall Study|Protocol deviation|6|||
146121509|NCT00877383|526963099|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146121510|NCT00877383|526963100|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146121511|NCT00877383|526963099|FG000|Overall Study|Death|1|||
146121512|NCT00877383|526963100|FG001|Overall Study|Death|2|||
146121513|NCT00459108|526963101|FG000|Overall Study|Withdrawal by Subject|5|||
146121514|NCT00459108|526963101|FG000|Overall Study|Adverse Event|3|||
146121515|NCT00459108|526963101|FG000|Overall Study|Death|2|||
146121516|NCT00459108|526963101|FG000|Overall Study|Progression|1|||
146121517|NCT02157298|526963113|FG000|Overall Study|Adverse Event|1|||
146262026|NCT03974100|527474382|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
146262027|NCT03974100|527474383|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146262028|NCT03974100|527474384|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146262029|NCT03974100|527474385|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
146121518|NCT02157298|526963114|FG001|Overall Study|Adverse Event|0|||
146121519|NCT02157298|526963113|FG000|Overall Study|Subject no longer meets study criteria|1|||
146121520|NCT02157298|526963114|FG001|Overall Study|Subject no longer meets study criteria|2|||
146121521|NCT02157298|526963113|FG000|Overall Study|Poor/Non-compliance|1|||
146121522|NCT02157298|526963114|FG001|Overall Study|Poor/Non-compliance|0|||
146121523|NCT02157298|526963113|FG000|Overall Study|Withdrawal by Subject|1|||
146121524|NCT02157298|526963114|FG001|Overall Study|Withdrawal by Subject|0|||
146121525|NCT02062879|526963119|FG000|Overall Study|Withdrawal by Subject|4|||
146121526|NCT02062879|526963120|FG001|Overall Study|Withdrawal by Subject|1|||
146121527|NCT00511667|526963121|FG000|Overall Study|Adverse Event|1|||
146121528|NCT00511667|526963122|FG001|Overall Study|Adverse Event|0|||
146121529|NCT00511667|526963121|FG000|Overall Study|Protocol Violation|1|||
146121530|NCT00511667|526963122|FG001|Overall Study|Protocol Violation|1|||
146121531|NCT00511667|526963121|FG000|Overall Study|Withdrawal by Subject|2|||
146121532|NCT00511667|526963122|FG001|Overall Study|Withdrawal by Subject|0|||
146121533|NCT00511667|526963121|FG000|Overall Study|Site terminated|6|||
146121534|NCT00511667|526963122|FG001|Overall Study|Site terminated|1|||
146121535|NCT00511667|526963121|FG000|Overall Study|Other|2|||
146262030|NCT03974100|527474381|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
146262031|NCT03974100|527474382|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
146262032|NCT03974100|527474383|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
146262033|NCT03974100|527474384|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
146262034|NCT03974100|527474385|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
146262035|NCT03974100|527474381|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
146262036|NCT03974100|527474382|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
146262037|NCT03974100|527474383|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
146262038|NCT03974100|527474384|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
146262039|NCT03974100|527474385|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
146262040|NCT03974100|527474381|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146262041|NCT03974100|527474382|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146262042|NCT03974100|527474383|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146262043|NCT03974100|527474384|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
146262044|NCT03974100|527474385|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
146262045|NCT03974100|527474381|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
146262046|NCT03974100|527474382|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
146262047|NCT03974100|527474383|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
146262048|NCT03974100|527474384|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
146262049|NCT03974100|527474385|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
146262050|NCT00623363|527474386|FG000|Overall Study|Adverse Event|2|||
146262051|NCT00623363|527474387|FG001|Overall Study|Adverse Event|2|||
146262052|NCT02719743|527474388|FG000|Overall Study|Consent withdrawal|0|||
146262053|NCT02719743|527474389|FG001|Overall Study|Consent withdrawal|2|||
146262054|NCT02719743|527474390|FG002|Overall Study|Consent withdrawal|0|||
146262055|NCT02719743|527474391|FG003|Overall Study|Consent withdrawal|1|||
146262056|NCT02719743|527474392|FG004|Overall Study|Consent withdrawal|0|||
146262057|NCT02719743|527474388|FG000|Overall Study|Migrated/moved from study area|0|||
146262058|NCT02719743|527474389|FG001|Overall Study|Migrated/moved from study area|0|||
146262059|NCT02719743|527474390|FG002|Overall Study|Migrated/moved from study area|0|||
146262060|NCT02719743|527474391|FG003|Overall Study|Migrated/moved from study area|0|||
146262061|NCT02719743|527474392|FG004|Overall Study|Migrated/moved from study area|2|||
146262062|NCT02719743|527474388|FG000|Overall Study|Lost to Follow-up|1|||
146262063|NCT02719743|527474389|FG001|Overall Study|Lost to Follow-up|1|||
146262064|NCT02719743|527474390|FG002|Overall Study|Lost to Follow-up|0|||
146262065|NCT02719743|527474391|FG003|Overall Study|Lost to Follow-up|0|||
146262066|NCT02719743|527474392|FG004|Overall Study|Lost to Follow-up|0|||
146262067|NCT01438840|527474394|FG000|Core Study|Adverse Event|0|||
146262068|NCT01438840|527474395|FG001|Core Study|Adverse Event|3|||
146262069|NCT01438840|527474396|FG002|Core Study|Adverse Event|0|||
146262070|NCT01438840|527474394|FG000|Core Study|Lack of Efficacy|15|||
146262071|NCT01438840|527474395|FG001|Core Study|Lack of Efficacy|7|||
146262072|NCT01438840|527474396|FG002|Core Study|Lack of Efficacy|0|||
146262073|NCT01438840|527474394|FG000|Core Study|Withdrawal of consent|1|||
146262074|NCT01438840|527474395|FG001|Core Study|Withdrawal of consent|0|||
146262075|NCT01438840|527474396|FG002|Core Study|Withdrawal of consent|0|||
146262076|NCT01438840|527474394|FG000|Extension Phase|Adverse Event|0|||
146262077|NCT01438840|527474395|FG001|Extension Phase|Adverse Event|0|||
146262078|NCT01438840|527474396|FG002|Extension Phase|Adverse Event|3|||
146262079|NCT01438840|527474394|FG000|Extension Phase|Lost to Follow-up|0|||
146262080|NCT01438840|527474395|FG001|Extension Phase|Lost to Follow-up|0|||
146262081|NCT01438840|527474396|FG002|Extension Phase|Lost to Follow-up|1|||
146121536|NCT00511667|526963122|FG001|Overall Study|Other|1|||
146121537|NCT00056407|526963123|FG000|Overall Study|Adverse Event|282|||
146121538|NCT00056407|526963124|FG001|Overall Study|Adverse Event|364|||
146121539|NCT00056407|526963123|FG000|Overall Study|Withdrawal by Subject|377|||
146121540|NCT00056407|526963124|FG001|Overall Study|Withdrawal by Subject|361|||
146121541|NCT00056407|526963123|FG000|Overall Study|Lost to Follow-up|123|||
146121542|NCT00056407|526963124|FG001|Overall Study|Lost to Follow-up|113|||
146121543|NCT00056407|526963123|FG000|Overall Study|Protocol Violation|104|||
146262082|NCT01438840|527474394|FG000|Extension Phase|Withdrawal by Subject|0|||
146262083|NCT01438840|527474395|FG001|Extension Phase|Withdrawal by Subject|0|||
146262084|NCT01438840|527474396|FG002|Extension Phase|Withdrawal by Subject|3|||
146121544|NCT00056407|526963124|FG001|Overall Study|Protocol Violation|95|||
146121545|NCT00056407|526963123|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
146121546|NCT00056407|526963124|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
146121547|NCT00056407|526963123|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
146121548|NCT00056407|526963124|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
146121549|NCT00056407|526963123|FG000|Overall Study|Missing|25|||
146121550|NCT00056407|526963124|FG001|Overall Study|Missing|34|||
146121551|NCT00616655|526963125|FG000|Overall Study|Adverse Event|10|||
146121552|NCT00616655|526963126|FG001|Overall Study|Adverse Event|7|||
146121553|NCT00616655|526963127|FG002|Overall Study|Adverse Event|12|||
146121554|NCT00616655|526963125|FG000|Overall Study|Lack of Efficacy|5|||
146121555|NCT00616655|526963126|FG001|Overall Study|Lack of Efficacy|5|||
146121556|NCT00616655|526963127|FG002|Overall Study|Lack of Efficacy|5|||
146121557|NCT00616655|526963125|FG000|Overall Study|Lost to Follow-up|3|||
146121558|NCT00616655|526963126|FG001|Overall Study|Lost to Follow-up|12|||
146121559|NCT00616655|526963127|FG002|Overall Study|Lost to Follow-up|10|||
146121560|NCT00616655|526963125|FG000|Overall Study|Protocol Violation|2|||
146121561|NCT00616655|526963126|FG001|Overall Study|Protocol Violation|4|||
146121562|NCT00616655|526963127|FG002|Overall Study|Protocol Violation|3|||
146121563|NCT00616655|526963125|FG000|Overall Study|Withdrawal by Subject|9|||
146121564|NCT00616655|526963126|FG001|Overall Study|Withdrawal by Subject|7|||
146121565|NCT00616655|526963127|FG002|Overall Study|Withdrawal by Subject|11|||
146121566|NCT00616655|526963125|FG000|Overall Study|Does not meet in/ex criteria|0|||
146121567|NCT00616655|526963126|FG001|Overall Study|Does not meet in/ex criteria|0|||
146121568|NCT00616655|526963127|FG002|Overall Study|Does not meet in/ex criteria|2|||
146121569|NCT00616655|526963125|FG000|Overall Study|Other|6|||
146121570|NCT00616655|526963126|FG001|Overall Study|Other|6|||
146121571|NCT00616655|526963127|FG002|Overall Study|Other|5|||
146121572|NCT03605303|526963128|FG000|Period 1|Study Terminated|2|||
146121573|NCT03605303|526963129|FG001|Period 1|Study Terminated|1|||
146121574|NCT00309842|526963130|FG000|Overall Study|Lost to Follow-up|1|||
146121575|NCT00696696|526964119|FG000|Overall Study|Adverse Event|5|||
146121576|NCT00696696|526964119|FG000|Overall Study|Withdrawal by Subject|8|||
146121577|NCT00696696|526964119|FG000|Overall Study|Physician Decision|2|||
146121578|NCT00696696|526964119|FG000|Overall Study|Death|3|||
146121579|NCT02642614|526964120|FG000|Overall Study|Adverse Event|1|||
146121580|NCT02642614|526964121|FG001|Overall Study|Adverse Event|1|||
146121581|NCT02642614|526964122|FG002|Overall Study|Adverse Event|2|||
146121582|NCT02642614|526964123|FG003|Overall Study|Adverse Event|2|||
146121583|NCT02642614|526964120|FG000|Overall Study|Lost to Follow-up|1|||
146121584|NCT02642614|526964121|FG001|Overall Study|Lost to Follow-up|0|||
146121585|NCT02642614|526964122|FG002|Overall Study|Lost to Follow-up|0|||
146121586|NCT02642614|526964123|FG003|Overall Study|Lost to Follow-up|0|||
146121587|NCT02642614|526964120|FG000|Overall Study|Withdrawal by Subject|1|||
146121588|NCT02642614|526964121|FG001|Overall Study|Withdrawal by Subject|1|||
146121589|NCT02642614|526964122|FG002|Overall Study|Withdrawal by Subject|0|||
146121590|NCT02642614|526964123|FG003|Overall Study|Withdrawal by Subject|0|||
146121591|NCT00936910|526964124|FG000|Overall Study|Lack of Efficacy|3|||
146121592|NCT01485640|526964125|FG000|Overall Study|Adverse Event|10|||
146121593|NCT01485640|526964125|FG000|Overall Study|Lack of Efficacy|2|||
146121594|NCT01485640|526964125|FG000|Overall Study|Protocol Violation|1|||
146121595|NCT01485640|526964125|FG000|Overall Study|Withdrawal by Subject|14|||
146121596|NCT01485640|526964125|FG000|Overall Study|Terminated by Sponsor|95|||
146121597|NCT02057198|526964128|FG000|Overall Study|Death|0|||
146121598|NCT02057198|526964129|FG001|Overall Study|Death|0|||
146121599|NCT02057198|526964130|FG002|Overall Study|Death|1|||
146121600|NCT02057198|526964128|FG000|Overall Study|Discharged early; lost to followup|0|||
146121601|NCT02057198|526964129|FG001|Overall Study|Discharged early; lost to followup|1|||
146121602|NCT02057198|526964130|FG002|Overall Study|Discharged early; lost to followup|0|||
146121603|NCT02355691|526964131|FG000|Overall Study|Loss of Research Personnel|7|||
146121604|NCT02355691|526964132|FG001|Overall Study|Loss of Research Personnel|9|||
146121605|NCT03232281|526964134|FG000|Overall Study|Adverse Event|1|||
146121606|NCT03232281|526964135|FG001|Overall Study|Adverse Event|1|||
146121607|NCT03232281|526964134|FG000|Overall Study|Withdrawal by Subject|5|||
146121608|NCT03232281|526964135|FG001|Overall Study|Withdrawal by Subject|4|||
146121609|NCT03232281|526964134|FG000|Overall Study|Protocol Deviation|1|||
146121610|NCT03232281|526964135|FG001|Overall Study|Protocol Deviation|1|||
146121611|NCT02345811|526964137|FG000|First Intervention|Withdrawal by Subject|1|||
146121612|NCT02345811|526964138|FG001|First Intervention|Withdrawal by Subject|1|||
146121613|NCT02489344|526964140|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
146121614|NCT02489344|526964140|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
146121615|NCT02489344|526964140|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
146121616|NCT02489344|526964140|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
146121617|NCT00605813|526964141|FG000|Overall Study|Protocol Violation|25|||
146121618|NCT00573755|526964146|FG000|Overall Study|Still receiving treatment|1|||
146121619|NCT00573755|526964147|FG001|Overall Study|Still receiving treatment|0|||
146121620|NCT00546637|526964152|FG000|Overall Study|Adverse Event|46|||
146121621|NCT00546637|526964153|FG001|Overall Study|Adverse Event|20|||
146121622|NCT00546637|526964152|FG000|Overall Study|Lack of Efficacy|5|||
146121623|NCT00546637|526964153|FG001|Overall Study|Lack of Efficacy|5|||
146121624|NCT00546637|526964152|FG000|Overall Study|Lost to Follow-up|2|||
146121625|NCT00546637|526964153|FG001|Overall Study|Lost to Follow-up|2|||
146121626|NCT00546637|526964152|FG000|Overall Study|Other|10|||
146121627|NCT00546637|526964153|FG001|Overall Study|Other|12|||
146121628|NCT00546637|526964152|FG000|Overall Study|Withdrawal by Subject|7|||
146121629|NCT00546637|526964153|FG001|Overall Study|Withdrawal by Subject|9|||
146121630|NCT00546637|526964152|FG000|Overall Study|Randomized, but not treated|3|||
146121631|NCT00546637|526964153|FG001|Overall Study|Randomized, but not treated|1|||
146121632|NCT02024867|526964156|FG000|Overall Study|Protocol Violation|3|||
146121633|NCT02024867|526964157|FG001|Overall Study|Protocol Violation|3|||
146121634|NCT02024867|526964156|FG000|Overall Study|Lost to Follow-up|6|||
146121635|NCT02024867|526964157|FG001|Overall Study|Lost to Follow-up|4|||
146121636|NCT02865187|526964158|FG000|Overall Study|Lost to Follow-up|12|||
146121637|NCT02865187|526964159|FG001|Overall Study|Lost to Follow-up|7|||
146121638|NCT02865187|526964158|FG000|Overall Study|Adverse Event|1|||
146121639|NCT02865187|526964159|FG001|Overall Study|Adverse Event|0|||
146121640|NCT04267133|526964160|FG000|Overall Study|Withdrawal by Subject|1|||
146121641|NCT04267133|526964160|FG000|Overall Study|Adverse Event|4|||
146121642|NCT01110707|526964161|FG000|Overall Study|Protocol Violation|0|||
146121643|NCT01110707|526964162|FG001|Overall Study|Protocol Violation|3|||
146121644|NCT02369341|526964164|FG000|Overall Study|Migrated/moved from study area|1|||
146121645|NCT02369341|526964165|FG001|Overall Study|Migrated/moved from study area|0|||
146121646|NCT00674661|526964166|FG000|Overall Study|Other|5|||
146121647|NCT00674661|526964167|FG001|Overall Study|Other|7|||
146121648|NCT00674661|526964166|FG000|Overall Study|Lost to Follow-up|6|||
146121649|NCT00674661|526964167|FG001|Overall Study|Lost to Follow-up|3|||
146121650|NCT00674661|526964166|FG000|Overall Study|Withdrawal by Subject|0|||
146121651|NCT00674661|526964167|FG001|Overall Study|Withdrawal by Subject|5|||
146121652|NCT00003901|526964168|FG000|Overall Study|Adverse Event|1|||
146121653|NCT00003901|526964168|FG000|Overall Study|Withdrawal by Subject|1|||
146121654|NCT00003901|526964168|FG000|Overall Study|Ineligible|6|||
146121655|NCT00003901|526964168|FG000|Overall Study|CT Scan not within protocol requirement|2|||
146121656|NCT00003901|526964168|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
146121657|NCT00003901|526964168|FG000|Overall Study|Medical problems|6|||
146121658|NCT02707991|526964169|FG000|Overall Study|Protocol Violation|1|||
146121659|NCT02707991|526964170|FG001|Overall Study|Protocol Violation|0|||
146121660|NCT02707991|526964169|FG000|Overall Study|Became ineligible|0|||
146121661|NCT02707991|526964170|FG001|Overall Study|Became ineligible|1|||
146121662|NCT02268864|526964171|FG000|Overall Study|Withdrawal by Subject|2|||
146121663|NCT02268864|526964172|FG001|Overall Study|Withdrawal by Subject|0|||
146121664|NCT02268864|526964173|FG002|Overall Study|Withdrawal by Subject|0|||
146121665|NCT02268864|526964171|FG000|Overall Study|Death|0|||
146121666|NCT02268864|526964172|FG001|Overall Study|Death|1|||
146121667|NCT02268864|526964173|FG002|Overall Study|Death|0|||
146121668|NCT00857220|526964176|FG000|Overall Study|Adverse Event|35|||
146121669|NCT00857220|526964176|FG000|Overall Study|Death|1|||
146121670|NCT00857220|526964176|FG000|Overall Study|Lack of Efficacy|11|||
146121671|NCT00857220|526964176|FG000|Overall Study|Lost to Follow-up|30|||
146121672|NCT00857220|526964176|FG000|Overall Study|Physician Decision|4|||
146121673|NCT00857220|526964176|FG000|Overall Study|Protocol Violation|16|||
146121674|NCT00857220|526964176|FG000|Overall Study|Withdrawal by Subject|67|||
146121675|NCT00857220|526964176|FG000|Overall Study|Clinical Hold|6|||
146121676|NCT00857220|526964176|FG000|Overall Study|Site Closed|5|||
146121677|NCT00857220|526964176|FG000|Overall Study|Miscellaneous|8|||
146121678|NCT02612428|526964177|FG000|VTL-308|Death|14|||
146121679|NCT02612428|526964178|FG001|VTL-308|Death|16|||
146303094|NCT01994382|527624072|FG012|Overall Study|Withdrawal by Subject|2|||
146303095|NCT01994382|527624073|FG013|Overall Study|Withdrawal by Subject|0|||
146303096|NCT01994382|527624074|FG014|Overall Study|Withdrawal by Subject|4|||
146303097|NCT01994382|527624075|FG015|Overall Study|Withdrawal by Subject|3|||
146121680|NCT02612428|526964177|FG000|VTL-308|Withdrawal by Subject|0|||
146121681|NCT02612428|526964178|FG001|VTL-308|Withdrawal by Subject|1|||
146121682|NCT02612428|526964177|FG000|VTL-308E|Death|9|||
146121683|NCT02612428|526964178|FG001|VTL-308E|Death|7|||
146121684|NCT02612428|526964177|FG000|VTL-308E|Lost to Follow-up|2|||
146121685|NCT02612428|526964178|FG001|VTL-308E|Lost to Follow-up|0|||
146121686|NCT03187262|526964179|FG000|Induction|Lack of Efficacy|2|||
146121687|NCT03187262|526964179|FG000|Induction|Progressive Disease|4|||
146121688|NCT03187262|526964179|FG000|Consolidation|Progressive Disease|5|||
146121689|NCT01166763|526964182|FG000|Overall Study|Withdrawal by Subject|3|||
146121690|NCT01909479|526964183|FG000|From Baseline to Week 26|Adverse Event|3|||
146121691|NCT01909479|526964184|FG001|From Baseline to Week 26|Adverse Event|2|||
146121692|NCT01909479|526964183|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
146121693|NCT01909479|526964184|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
146121694|NCT01909479|526964183|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
146121695|NCT01909479|526964184|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
146121696|NCT01909479|526964183|FG000|26 - 52 Weeks|Adverse Event|0|||
146121697|NCT01909479|526964184|FG001|26 - 52 Weeks|Adverse Event|1|||
146121698|NCT01909479|526964183|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
146121699|NCT01909479|526964184|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
146121700|NCT01909479|526964183|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
146121701|NCT01909479|526964184|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
146121702|NCT01909479|526964183|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
146121703|NCT01909479|526964184|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
146121704|NCT01909479|526964183|FG000|52 Weeks to End of Study|Adverse Event|2|||
146121705|NCT01909479|526964184|FG001|52 Weeks to End of Study|Adverse Event|1|||
146121706|NCT01909479|526964183|FG000|52 Weeks to End of Study|Death|0|||
146121707|NCT01909479|526964184|FG001|52 Weeks to End of Study|Death|1|||
146121708|NCT01909479|526964183|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
146121709|NCT01909479|526964184|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
146121710|NCT01909479|526964183|FG000|52 Weeks to End of Study|Protocol Violation|1|||
146121711|NCT01909479|526964184|FG001|52 Weeks to End of Study|Protocol Violation|0|||
146121712|NCT01909479|526964183|FG000|52 Weeks to End of Study|Progressive disease|1|||
146121713|NCT01909479|526964184|FG001|52 Weeks to End of Study|Progressive disease|1|||
146121714|NCT01909479|526964183|FG000|52 Weeks to End of Study|Personal reasons|2|||
146121715|NCT01909479|526964184|FG001|52 Weeks to End of Study|Personal reasons|1|||
146121716|NCT01909479|526964183|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
146121717|NCT01909479|526964184|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
146121718|NCT01909479|526964183|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
146121719|NCT01909479|526964184|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
146121720|NCT01909479|526964183|FG000|52 Weeks to End of Study|Lack of contact|1|||
146121721|NCT01909479|526964184|FG001|52 Weeks to End of Study|Lack of contact|0|||
146121722|NCT01909479|526964183|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
146121723|NCT01909479|526964184|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
146121724|NCT01909479|526964183|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
146121725|NCT01909479|526964184|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
146121726|NCT00416078|526964188|FG000|Overall Study|Death|3|||
146121727|NCT00416078|526964189|FG001|Overall Study|Death|4|||
146121728|NCT00416078|526964188|FG000|Overall Study|Withdrawal by Subject|3|||
146121729|NCT00416078|526964189|FG001|Overall Study|Withdrawal by Subject|2|||
146121730|NCT00416078|526964188|FG000|Overall Study|Physician Decision|1|||
146121731|NCT00416078|526964189|FG001|Overall Study|Physician Decision|0|||
146121732|NCT00416078|526964188|FG000|Overall Study|Lost to Follow-up|4|||
146121733|NCT00416078|526964189|FG001|Overall Study|Lost to Follow-up|2|||
146121734|NCT01829230|526964190|FG000|Overall Study|Protocol Violation|0|||
146121735|NCT01829230|526964191|FG001|Overall Study|Protocol Violation|2|||
146121736|NCT01829230|526964190|FG000|Overall Study|Withdrawal by Subject|0|||
146121737|NCT01829230|526964191|FG001|Overall Study|Withdrawal by Subject|1|||
146121738|NCT01829230|526964190|FG000|Overall Study|Lost to Follow-up|1|||
146121739|NCT01829230|526964191|FG001|Overall Study|Lost to Follow-up|1|||
146121740|NCT04128267|526964193|FG000|Overall Study|Withdrawal by Subject|6|||
146121741|NCT04128267|526964193|FG000|Overall Study|Death|2|||
146121742|NCT04128267|526964193|FG000|Overall Study|Disease progression|1|||
146121743|NCT04128267|526964193|FG000|Overall Study|Participant had other medical issues|4|||
146121744|NCT04128267|526964193|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
146121745|NCT00553150|526964194|FG000|Overall Study|Withdrawal by Subject|0|||
146121746|NCT00553150|526964195|FG001|Overall Study|Withdrawal by Subject|0|||
146121747|NCT00553150|526964196|FG002|Overall Study|Withdrawal by Subject|0|||
146121748|NCT00553150|526964197|FG003|Overall Study|Withdrawal by Subject|2|||
146121749|NCT00553150|526964194|FG000|Overall Study|Protocol Violation|0|||
146121750|NCT00553150|526964195|FG001|Overall Study|Protocol Violation|0|||
146121751|NCT00553150|526964196|FG002|Overall Study|Protocol Violation|0|||
146121752|NCT00553150|526964197|FG003|Overall Study|Protocol Violation|1|||
146121753|NCT00553150|526964194|FG000|Overall Study|Ineligible|0|||
146121754|NCT00553150|526964195|FG001|Overall Study|Ineligible|0|||
146121755|NCT00553150|526964196|FG002|Overall Study|Ineligible|0|||
146303098|NCT01994382|527624076|FG016|Overall Study|Withdrawal by Subject|0|||
146303099|NCT01994382|527624060|FG000|Overall Study|Lost to Follow-up|0|||
146303100|NCT01994382|527624061|FG001|Overall Study|Lost to Follow-up|0|||
146121756|NCT00553150|526964197|FG003|Overall Study|Ineligible|1|||
146121757|NCT03761147|526964198|FG000|Overall Study|Withdrawal by Subject|6|||
146121758|NCT03761147|526964199|FG001|Overall Study|Withdrawal by Subject|1|||
146121759|NCT03761147|526964198|FG000|Overall Study|Adverse Event|1|||
146121760|NCT03761147|526964199|FG001|Overall Study|Adverse Event|3|||
146303101|NCT01994382|527624062|FG002|Overall Study|Lost to Follow-up|0|||
146303102|NCT01994382|527624063|FG003|Overall Study|Lost to Follow-up|0|||
146121761|NCT01026792|526964202|FG000|Overall Study|Protocol Violation|1|||
146121762|NCT02626520|526964203|FG000|Overall Study|Physician Decision|1|||
146121763|NCT02626520|526964204|FG001|Overall Study|Physician Decision|1|||
146121764|NCT02626520|526964203|FG000|Overall Study|Adverse Event|0|||
146121765|NCT02626520|526964204|FG001|Overall Study|Adverse Event|4|||
146121766|NCT02626520|526964203|FG000|Overall Study|Lack of Efficacy|0|||
146121767|NCT02626520|526964204|FG001|Overall Study|Lack of Efficacy|2|||
146303103|NCT01994382|527624064|FG004|Overall Study|Lost to Follow-up|0|||
146303104|NCT01994382|527624065|FG005|Overall Study|Lost to Follow-up|0|||
146303105|NCT01994382|527624066|FG006|Overall Study|Lost to Follow-up|0|||
146303106|NCT01994382|527624067|FG007|Overall Study|Lost to Follow-up|0|||
146303107|NCT01994382|527624068|FG008|Overall Study|Lost to Follow-up|0|||
146303108|NCT01994382|527624069|FG009|Overall Study|Lost to Follow-up|0|||
146303109|NCT01994382|527624070|FG010|Overall Study|Lost to Follow-up|1|||
146303110|NCT01994382|527624071|FG011|Overall Study|Lost to Follow-up|0|||
146303111|NCT01994382|527624072|FG012|Overall Study|Lost to Follow-up|0|||
146303112|NCT01994382|527624073|FG013|Overall Study|Lost to Follow-up|0|||
146303113|NCT01994382|527624074|FG014|Overall Study|Lost to Follow-up|0|||
146303114|NCT01994382|527624075|FG015|Overall Study|Lost to Follow-up|0|||
146303115|NCT01994382|527624076|FG016|Overall Study|Lost to Follow-up|0|||
146303116|NCT01994382|527624060|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303117|NCT01994382|527624061|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303118|NCT01994382|527624062|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303119|NCT01994382|527624063|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303120|NCT01994382|527624064|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303121|NCT01994382|527624065|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146121768|NCT02626520|526964203|FG000|Overall Study|Did not start protocol therapy|0|||
146121769|NCT02626520|526964204|FG001|Overall Study|Did not start protocol therapy|2|||
146121770|NCT02626520|526964203|FG000|Overall Study|Study terminated|0|||
146121771|NCT02626520|526964204|FG001|Overall Study|Study terminated|1|||
146121772|NCT00492115|526964205|FG000|Overall Study|Withdrawal by Subject|3|||
146121773|NCT00492115|526964206|FG001|Overall Study|Withdrawal by Subject|4|||
146121774|NCT02045797|526964209|FG000|Overall Study|Adverse Event|3|||
146121775|NCT02045797|526964210|FG001|Overall Study|Adverse Event|1|||
146121776|NCT02045797|526964211|FG002|Overall Study|Adverse Event|0|||
146121777|NCT02045797|526964209|FG000|Overall Study|Lack of Efficacy|1|||
146121778|NCT02045797|526964210|FG001|Overall Study|Lack of Efficacy|0|||
146121779|NCT02045797|526964211|FG002|Overall Study|Lack of Efficacy|0|||
146121780|NCT02045797|526964209|FG000|Overall Study|Lost to Follow-up|2|||
146121781|NCT02045797|526964210|FG001|Overall Study|Lost to Follow-up|3|||
146121782|NCT02045797|526964211|FG002|Overall Study|Lost to Follow-up|1|||
146121783|NCT02045797|526964209|FG000|Overall Study|Physician Decision|0|||
146121784|NCT02045797|526964210|FG001|Overall Study|Physician Decision|1|||
146121785|NCT02045797|526964211|FG002|Overall Study|Physician Decision|0|||
146121786|NCT02045797|526964209|FG000|Overall Study|Withdrawal by Subject|1|||
146121787|NCT02045797|526964210|FG001|Overall Study|Withdrawal by Subject|2|||
146121788|NCT02045797|526964211|FG002|Overall Study|Withdrawal by Subject|0|||
146121789|NCT05407675|526965958|FG000|Overall Study|Withdrawal by Subject|0|||
146121790|NCT05407675|526965959|FG001|Overall Study|Withdrawal by Subject|2|||
146121791|NCT05407675|526965960|FG002|Overall Study|Withdrawal by Subject|3|||
146121792|NCT05407675|526965961|FG003|Overall Study|Withdrawal by Subject|5|||
146121793|NCT05407675|526965962|FG004|Overall Study|Withdrawal by Subject|0|||
146121794|NCT05407675|526965963|FG005|Overall Study|Withdrawal by Subject|2|||
146121795|NCT05407675|526965964|FG006|Overall Study|Withdrawal by Subject|0|||
146121796|NCT05407675|526965965|FG007|Overall Study|Withdrawal by Subject|0|||
146121797|NCT05407675|526965966|FG008|Overall Study|Withdrawal by Subject|2|||
146121798|NCT05407675|526965967|FG009|Overall Study|Withdrawal by Subject|0|||
146121799|NCT05407675|526965968|FG010|Overall Study|Withdrawal by Subject|1|||
146121800|NCT05407675|526965969|FG011|Overall Study|Withdrawal by Subject|0|||
146121801|NCT05407675|526965970|FG012|Overall Study|Withdrawal by Subject|0|||
146121802|NCT05407675|526965958|FG000|Overall Study|Site terminated by sponsor|0|||
146121803|NCT05407675|526965959|FG001|Overall Study|Site terminated by sponsor|0|||
146121804|NCT05407675|526965960|FG002|Overall Study|Site terminated by sponsor|1|||
146121805|NCT05407675|526965961|FG003|Overall Study|Site terminated by sponsor|0|||
146121806|NCT05407675|526965962|FG004|Overall Study|Site terminated by sponsor|2|||
146121807|NCT05407675|526965963|FG005|Overall Study|Site terminated by sponsor|0|||
146121808|NCT05407675|526965964|FG006|Overall Study|Site terminated by sponsor|1|||
146121809|NCT05407675|526965965|FG007|Overall Study|Site terminated by sponsor|0|||
146121810|NCT05407675|526965966|FG008|Overall Study|Site terminated by sponsor|0|||
146121811|NCT05407675|526965967|FG009|Overall Study|Site terminated by sponsor|2|||
146121812|NCT05407675|526965968|FG010|Overall Study|Site terminated by sponsor|2|||
146121813|NCT05407675|526965969|FG011|Overall Study|Site terminated by sponsor|2|||
146121814|NCT05407675|526965970|FG012|Overall Study|Site terminated by sponsor|1|||
146121815|NCT05407675|526965958|FG000|Overall Study|Disease Progression|0|||
146121816|NCT05407675|526965959|FG001|Overall Study|Disease Progression|0|||
146121817|NCT05407675|526965960|FG002|Overall Study|Disease Progression|0|||
146121818|NCT05407675|526965961|FG003|Overall Study|Disease Progression|0|||
146121819|NCT05407675|526965962|FG004|Overall Study|Disease Progression|0|||
146121820|NCT05407675|526965963|FG005|Overall Study|Disease Progression|0|||
146121821|NCT05407675|526965964|FG006|Overall Study|Disease Progression|0|||
146303122|NCT01994382|527624066|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303123|NCT01994382|527624067|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146121822|NCT05407675|526965965|FG007|Overall Study|Disease Progression|0|||
146121823|NCT05407675|526965966|FG008|Overall Study|Disease Progression|0|||
146121824|NCT05407675|526965967|FG009|Overall Study|Disease Progression|0|||
146121825|NCT05407675|526965968|FG010|Overall Study|Disease Progression|1|||
146121826|NCT05407675|526965969|FG011|Overall Study|Disease Progression|0|||
146121827|NCT05407675|526965970|FG012|Overall Study|Disease Progression|0|||
146121828|NCT05407675|526965958|FG000|Overall Study|Physician Decision|0|||
146121829|NCT05407675|526965959|FG001|Overall Study|Physician Decision|0|||
146121830|NCT05407675|526965960|FG002|Overall Study|Physician Decision|0|||
146121831|NCT05407675|526965961|FG003|Overall Study|Physician Decision|0|||
146121832|NCT05407675|526965962|FG004|Overall Study|Physician Decision|0|||
146121833|NCT05407675|526965963|FG005|Overall Study|Physician Decision|0|||
146121834|NCT05407675|526965964|FG006|Overall Study|Physician Decision|0|||
146121835|NCT05407675|526965965|FG007|Overall Study|Physician Decision|0|||
146121836|NCT05407675|526965966|FG008|Overall Study|Physician Decision|0|||
146121837|NCT05407675|526965967|FG009|Overall Study|Physician Decision|0|||
146121838|NCT05407675|526965968|FG010|Overall Study|Physician Decision|1|||
146121839|NCT05407675|526965969|FG011|Overall Study|Physician Decision|0|||
146121840|NCT05407675|526965970|FG012|Overall Study|Physician Decision|0|||
146121841|NCT05407675|526965958|FG000|Overall Study|Other reasons|0|||
146121842|NCT05407675|526965959|FG001|Overall Study|Other reasons|0|||
146121843|NCT05407675|526965960|FG002|Overall Study|Other reasons|0|||
146121844|NCT05407675|526965961|FG003|Overall Study|Other reasons|0|||
146121845|NCT05407675|526965962|FG004|Overall Study|Other reasons|0|||
146121846|NCT05407675|526965963|FG005|Overall Study|Other reasons|0|||
146121847|NCT05407675|526965964|FG006|Overall Study|Other reasons|0|||
146121848|NCT05407675|526965965|FG007|Overall Study|Other reasons|0|||
146121849|NCT05407675|526965966|FG008|Overall Study|Other reasons|1|||
146121850|NCT05407675|526965967|FG009|Overall Study|Other reasons|1|||
146121851|NCT05407675|526965968|FG010|Overall Study|Other reasons|1|||
146121852|NCT05407675|526965969|FG011|Overall Study|Other reasons|1|||
146121853|NCT05407675|526965970|FG012|Overall Study|Other reasons|0|||
146121854|NCT05407675|526965958|FG000|Overall Study|Death|3|||
146121855|NCT05407675|526965959|FG001|Overall Study|Death|4|||
146121856|NCT05407675|526965960|FG002|Overall Study|Death|3|||
146121857|NCT05407675|526965961|FG003|Overall Study|Death|6|||
146121858|NCT05407675|526965962|FG004|Overall Study|Death|0|||
146121859|NCT05407675|526965963|FG005|Overall Study|Death|2|||
146121860|NCT05407675|526965964|FG006|Overall Study|Death|4|||
146121861|NCT05407675|526965965|FG007|Overall Study|Death|2|||
146121862|NCT05407675|526965966|FG008|Overall Study|Death|2|||
146121863|NCT05407675|526965967|FG009|Overall Study|Death|4|||
146121864|NCT05407675|526965968|FG010|Overall Study|Death|2|||
146121865|NCT05407675|526965969|FG011|Overall Study|Death|1|||
146121866|NCT05407675|526965970|FG012|Overall Study|Death|0|||
146121867|NCT05407675|526965958|FG000|Overall Study|Adverse Event|0|||
146121868|NCT05407675|526965959|FG001|Overall Study|Adverse Event|0|||
146121869|NCT05407675|526965960|FG002|Overall Study|Adverse Event|0|||
146121870|NCT05407675|526965961|FG003|Overall Study|Adverse Event|0|||
146121871|NCT05407675|526965962|FG004|Overall Study|Adverse Event|1|||
146121872|NCT05407675|526965963|FG005|Overall Study|Adverse Event|0|||
146121873|NCT05407675|526965964|FG006|Overall Study|Adverse Event|0|||
146121874|NCT05407675|526965965|FG007|Overall Study|Adverse Event|0|||
146121875|NCT05407675|526965966|FG008|Overall Study|Adverse Event|0|||
146121876|NCT05407675|526965967|FG009|Overall Study|Adverse Event|0|||
146121877|NCT05407675|526965968|FG010|Overall Study|Adverse Event|0|||
146121878|NCT05407675|526965969|FG011|Overall Study|Adverse Event|1|||
146121879|NCT05407675|526965970|FG012|Overall Study|Adverse Event|0|||
146121880|NCT05407675|526965958|FG000|Overall Study|Ongoing Treatment|0|||
146262085|NCT01438840|527474394|FG000|Extension Phase|Lack of Efficacy|0|||
146262086|NCT01438840|527474395|FG001|Extension Phase|Lack of Efficacy|0|||
146262087|NCT01438840|527474396|FG002|Extension Phase|Lack of Efficacy|2|||
146262088|NCT01438840|527474394|FG000|Extension Phase|Other|0|||
146262089|NCT01438840|527474395|FG001|Extension Phase|Other|0|||
146121881|NCT05407675|526965959|FG001|Overall Study|Ongoing Treatment|0|||
146121882|NCT05407675|526965960|FG002|Overall Study|Ongoing Treatment|0|||
146121883|NCT05407675|526965961|FG003|Overall Study|Ongoing Treatment|0|||
146121884|NCT05407675|526965962|FG004|Overall Study|Ongoing Treatment|0|||
146121885|NCT05407675|526965963|FG005|Overall Study|Ongoing Treatment|0|||
146121886|NCT05407675|526965964|FG006|Overall Study|Ongoing Treatment|0|||
146121887|NCT05407675|526965965|FG007|Overall Study|Ongoing Treatment|0|||
146121888|NCT05407675|526965966|FG008|Overall Study|Ongoing Treatment|1|||
146121889|NCT05407675|526965967|FG009|Overall Study|Ongoing Treatment|0|||
146121890|NCT05407675|526965968|FG010|Overall Study|Ongoing Treatment|0|||
146121891|NCT05407675|526965969|FG011|Overall Study|Ongoing Treatment|0|||
146121892|NCT05407675|526965970|FG012|Overall Study|Ongoing Treatment|0|||
146121893|NCT03698994|526965971|FG000|Overall Study|Adverse Event|2|||
146121894|NCT03698994|526965971|FG000|Overall Study|Death|1|||
146121895|NCT03698994|526965971|FG000|Overall Study|Physician Decision|1|||
146121896|NCT03698994|526965971|FG000|Overall Study|Withdrawal by Subject|3|||
146121897|NCT03698994|526965971|FG000|Overall Study|Progressive Disease|12|||
146121898|NCT00742001|526965972|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
146121899|NCT00742001|526965973|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
146121900|NCT00742001|526965974|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
146121901|NCT00137423|526965975|FG000|Overall Study|Adverse Event|7|||
146121902|NCT00137423|526965976|FG001|Overall Study|Adverse Event|9|||
146121903|NCT00137423|526965975|FG000|Overall Study|consent withdrawn|1|||
146121904|NCT00137423|526965976|FG001|Overall Study|consent withdrawn|1|||
146121905|NCT00137423|526965975|FG000|Overall Study|Lack of Efficacy|31|||
146121906|NCT00137423|526965976|FG001|Overall Study|Lack of Efficacy|33|||
146121907|NCT00137423|526965975|FG000|Overall Study|Death|0|||
146121908|NCT00137423|526965976|FG001|Overall Study|Death|1|||
146121909|NCT04105998|526965978|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
146121910|NCT04105998|526965979|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
146121911|NCT01050257|526965980|FG000|Overall Study|Adverse Event|4|||
146121912|NCT01050257|526965981|FG001|Overall Study|Adverse Event|4|||
146121913|NCT01050257|526965982|FG002|Overall Study|Adverse Event|2|||
146121914|NCT01050257|526965980|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
146121915|NCT01050257|526965981|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
146121916|NCT01050257|526965982|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
146121917|NCT01050257|526965980|FG000|Overall Study|Withdrawal by Subject|0|||
146121918|NCT01050257|526965981|FG001|Overall Study|Withdrawal by Subject|3|||
146121919|NCT01050257|526965982|FG002|Overall Study|Withdrawal by Subject|0|||
146121920|NCT01050257|526965980|FG000|Overall Study|No reason specified|0|||
146121921|NCT01050257|526965981|FG001|Overall Study|No reason specified|0|||
146121922|NCT01050257|526965982|FG002|Overall Study|No reason specified|2|||
146121923|NCT01050257|526965980|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
146121924|NCT01050257|526965981|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
146121925|NCT01050257|526965982|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
146121926|NCT01050257|526965980|FG000|Overall Study|Violation criteria|0|||
146121927|NCT01050257|526965981|FG001|Overall Study|Violation criteria|1|||
146262090|NCT01438840|527474396|FG002|Extension Phase|Other|1|||
146262091|NCT00927901|527474399|FG000|Treatment Period 1|Subject withdrew consent|0|||
146262092|NCT00927901|527474400|FG001|Treatment Period 1|Subject withdrew consent|0|||
146262093|NCT00927901|527474401|FG002|Treatment Period 1|Subject withdrew consent|1|||
146262094|NCT00927901|527474402|FG003|Treatment Period 1|Subject withdrew consent|0|||
146262095|NCT00927901|527474399|FG000|Treatment Period 4|Adverse Event|0|||
146262096|NCT00927901|527474400|FG001|Treatment Period 4|Adverse Event|0|||
146262097|NCT00927901|527474401|FG002|Treatment Period 4|Adverse Event|0|||
146262098|NCT00927901|527474402|FG003|Treatment Period 4|Adverse Event|1|||
146262099|NCT00927901|527474399|FG000|Treatment Period 4|Subject withdrew consent|0|||
146262100|NCT00927901|527474400|FG001|Treatment Period 4|Subject withdrew consent|0|||
146262101|NCT00927901|527474401|FG002|Treatment Period 4|Subject withdrew consent|1|||
146262102|NCT00927901|527474402|FG003|Treatment Period 4|Subject withdrew consent|0|||
146262103|NCT02344173|527474403|FG000|Procedure|Ablation Procedure Not Performed|7|||
146262104|NCT02344173|527474403|FG000|12-month Visit|Death|8|||
146262105|NCT02344173|527474403|FG000|12-month Visit|Withdrawal by Subject|30|||
146262106|NCT02344173|527474403|FG000|12-month Visit|Lost to Follow-up|58|||
146262107|NCT03738397|527474404|FG000|Overall Study|Adverse Event|3|||
146262108|NCT03738397|527474405|FG001|Overall Study|Adverse Event|7|||
146262109|NCT03738397|527474404|FG000|Overall Study|Withdrawal by Subject|8|||
146262110|NCT03738397|527474405|FG001|Overall Study|Withdrawal by Subject|11|||
146262111|NCT03738397|527474404|FG000|Overall Study|Lost to Follow-up|7|||
146262112|NCT03738397|527474405|FG001|Overall Study|Lost to Follow-up|5|||
146262113|NCT03738397|527474404|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
146262114|NCT03738397|527474405|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146262115|NCT03738397|527474404|FG000|Overall Study|Other|4|||
146262116|NCT03738397|527474405|FG001|Overall Study|Other|6|||
146262117|NCT02881047|527474406|FG000|Overall Study|Adverse Event|1|||
146262118|NCT02881047|527474406|FG000|Overall Study|Withdrawal by Subject|1|||
146262119|NCT04814992|527474416|FG000|Overall Study|Withdrawal by Subject|6|||
146303124|NCT01994382|527624068|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303125|NCT01994382|527624069|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146262120|NCT04814992|527474417|FG001|Overall Study|Withdrawal by Subject|3|||
146262121|NCT04814992|527474416|FG000|Overall Study|Lost to Follow-up|1|||
146121928|NCT01050257|526965982|FG002|Overall Study|Violation criteria|0|||
146121929|NCT01050257|526965980|FG000|Overall Study|Failure to return|0|||
146121930|NCT01050257|526965981|FG001|Overall Study|Failure to return|2|||
146262122|NCT04814992|527474417|FG001|Overall Study|Lost to Follow-up|4|||
146262123|NCT01831726|527474422|FG000|Overall Study|Adverse Event|16|||
146262124|NCT01831726|527474422|FG000|Overall Study|Death|7|||
146262125|NCT01831726|527474422|FG000|Overall Study|Disease Progression|49|||
146262126|NCT01831726|527474422|FG000|Overall Study|Physician Decision|1|||
146121931|NCT01050257|526965982|FG002|Overall Study|Failure to return|0|||
146121932|NCT01050257|526965980|FG000|Overall Study|Death|0|||
146121933|NCT01050257|526965981|FG001|Overall Study|Death|0|||
146121934|NCT01050257|526965982|FG002|Overall Study|Death|1|||
146121935|NCT00171223|526965983|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
146121936|NCT00171223|526965984|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
146121937|NCT00171223|526965985|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
146121938|NCT00171223|526965983|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
146121939|NCT00171223|526965984|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
146121940|NCT00171223|526965985|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
146121941|NCT00171223|526965983|FG000|Overall Study|Abnormal Procedure|1|||
146121942|NCT00171223|526965984|FG001|Overall Study|Abnormal Procedure|0|||
146121943|NCT00171223|526965985|FG002|Overall Study|Abnormal Procedure|0|||
146121944|NCT00171223|526965983|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
146121945|NCT00171223|526965984|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
146121946|NCT00171223|526965985|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
146121947|NCT00171223|526965983|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
146121948|NCT00171223|526965984|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
146121949|NCT00171223|526965985|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
146121950|NCT00171223|526965983|FG000|Overall Study|Protocol Violation|2|||
146121951|NCT00171223|526965984|FG001|Overall Study|Protocol Violation|2|||
146121952|NCT00171223|526965985|FG002|Overall Study|Protocol Violation|3|||
146121953|NCT00171223|526965983|FG000|Overall Study|Participant Withdrew Consent|12|||
146121954|NCT00171223|526965984|FG001|Overall Study|Participant Withdrew Consent|21|||
146121955|NCT00171223|526965985|FG002|Overall Study|Participant Withdrew Consent|15|||
146121956|NCT00171223|526965983|FG000|Overall Study|Lost to Follow-up|5|||
146121957|NCT00171223|526965984|FG001|Overall Study|Lost to Follow-up|2|||
146121958|NCT00171223|526965985|FG002|Overall Study|Lost to Follow-up|3|||
146121959|NCT00171223|526965983|FG000|Overall Study|Administrative Problems|4|||
146262127|NCT01831726|527474422|FG000|Overall Study|Subject/guardian decision|7|||
146262128|NCT00514813|527474425|FG000|Overall Study|Study terminated|14|||
146262129|NCT00514813|527474426|FG001|Overall Study|Study terminated|74|||
146262130|NCT00514813|527474427|FG002|Overall Study|Study terminated|40|||
146262131|NCT00514813|527474428|FG003|Overall Study|Study terminated|2|||
146262132|NCT00514813|527474425|FG000|Overall Study|Adverse Event|0|||
146262133|NCT00514813|527474426|FG001|Overall Study|Adverse Event|2|||
146262134|NCT00514813|527474427|FG002|Overall Study|Adverse Event|2|||
146262135|NCT00514813|527474428|FG003|Overall Study|Adverse Event|0|||
146262136|NCT00514813|527474425|FG000|Overall Study|Protocol Violation|1|||
146262137|NCT00514813|527474426|FG001|Overall Study|Protocol Violation|0|||
146262138|NCT00514813|527474427|FG002|Overall Study|Protocol Violation|0|||
146262139|NCT00514813|527474428|FG003|Overall Study|Protocol Violation|0|||
146262140|NCT00514813|527474425|FG000|Overall Study|Withdrawal by Subject|0|||
146262141|NCT00514813|527474426|FG001|Overall Study|Withdrawal by Subject|1|||
146262142|NCT00514813|527474427|FG002|Overall Study|Withdrawal by Subject|0|||
146262143|NCT00514813|527474428|FG003|Overall Study|Withdrawal by Subject|0|||
146262144|NCT00514813|527474425|FG000|Overall Study|Lack of Efficacy|0|||
146262145|NCT00514813|527474426|FG001|Overall Study|Lack of Efficacy|1|||
146262146|NCT00514813|527474427|FG002|Overall Study|Lack of Efficacy|0|||
146262147|NCT00514813|527474428|FG003|Overall Study|Lack of Efficacy|0|||
146262148|NCT00514813|527474425|FG000|Overall Study|Kidney transplant|0|||
146262149|NCT00514813|527474426|FG001|Overall Study|Kidney transplant|6|||
146262150|NCT00514813|527474427|FG002|Overall Study|Kidney transplant|2|||
146262151|NCT00514813|527474428|FG003|Overall Study|Kidney transplant|0|||
146262152|NCT00514813|527474425|FG000|Overall Study|Death|0|||
146262153|NCT00514813|527474426|FG001|Overall Study|Death|2|||
146262154|NCT00514813|527474427|FG002|Overall Study|Death|3|||
146262155|NCT00514813|527474428|FG003|Overall Study|Death|2|||
146262156|NCT02979613|527474429|FG000|Double-Blind Phase|Withdrew Consent|2|||
146262157|NCT02979613|527474430|FG001|Double-Blind Phase|Withdrew Consent|4|||
146262158|NCT02979613|527474429|FG000|Double-Blind Phase|Pregnancy|2|||
146262159|NCT02979613|527474430|FG001|Double-Blind Phase|Pregnancy|2|||
146262160|NCT02979613|527474429|FG000|Double-Blind Phase|Adverse Event|2|||
146262161|NCT02979613|527474430|FG001|Double-Blind Phase|Adverse Event|0|||
146262162|NCT02979613|527474429|FG000|Double-Blind Phase|Lost to Follow-up|1|||
146262163|NCT02979613|527474430|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146262164|NCT02979613|527474429|FG000|Double-Blind Phase|Protocol Violation|1|||
146262165|NCT02979613|527474430|FG001|Double-Blind Phase|Protocol Violation|1|||
146262166|NCT02979613|527474429|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
146262167|NCT02979613|527474430|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
146262168|NCT02979613|527474429|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
146262169|NCT02979613|527474430|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
146262170|NCT02979613|527474429|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
146262171|NCT02979613|527474430|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146121960|NCT00171223|526965984|FG001|Overall Study|Administrative Problems|7|||
146262172|NCT02979613|527474429|FG000|Open-Label Extension (OLE) Phase|Death|0|||
146262173|NCT02979613|527474430|FG001|Open-Label Extension (OLE) Phase|Death|1|||
146262174|NCT02979613|527474429|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
146121961|NCT00171223|526965985|FG002|Overall Study|Administrative Problems|6|||
146262175|NCT02979613|527474430|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
146262176|NCT01075100|527474433|FG000|Overall Study|Adverse Event|15|||
146121962|NCT00171223|526965983|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
146121963|NCT00171223|526965984|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
146121964|NCT00171223|526965985|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
146121965|NCT00171223|526965983|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
146121966|NCT00171223|526965984|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
146121967|NCT00171223|526965985|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
146121968|NCT02604212|526965987|FG000|Overall Study|Study Terminated by Sponsor|2|||
146121969|NCT02604212|526965988|FG001|Overall Study|Study Terminated by Sponsor|1|||
146121970|NCT02604212|526965989|FG002|Overall Study|Study Terminated by Sponsor|3|||
146121971|NCT02604212|526965990|FG003|Overall Study|Study Terminated by Sponsor|3|||
146121972|NCT02604212|526965987|FG000|Overall Study|Withdrawal by Subject|0|||
146121973|NCT02604212|526965988|FG001|Overall Study|Withdrawal by Subject|0|||
146121974|NCT02604212|526965989|FG002|Overall Study|Withdrawal by Subject|1|||
146121975|NCT02604212|526965990|FG003|Overall Study|Withdrawal by Subject|0|||
146121976|NCT00278109|526965991|FG000|Overall Study|Adverse Event|3|||
146121977|NCT00278109|526965991|FG000|Overall Study|social circumstances|1|||
146121978|NCT02580357|526965992|FG000|Overall Study|Lost to Follow-up|2|||
146121979|NCT02580357|526965993|FG001|Overall Study|Lost to Follow-up|0|||
146121980|NCT02580357|526965994|FG002|Overall Study|Lost to Follow-up|0|||
146121981|NCT02580357|526965992|FG000|Overall Study|Protocol Violation|1|||
146121982|NCT02580357|526965993|FG001|Overall Study|Protocol Violation|0|||
146121983|NCT02580357|526965994|FG002|Overall Study|Protocol Violation|0|||
146121984|NCT00383149|526966002|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
146121985|NCT00383149|526966002|FG000|Overall Study|Death|2|||
146121986|NCT00383149|526966002|FG000|Overall Study|Disease Progression|38|||
146121987|NCT00383149|526966002|FG000|Overall Study|Lost to Follow-up|1|||
146121988|NCT00383149|526966002|FG000|Overall Study|Other|1|||
146121989|NCT00383149|526966002|FG000|Overall Study|Study Drug Toxicity|4|||
146121990|NCT00383149|526966002|FG000|Overall Study|Request to Discontinue Treatment|4|||
146121991|NCT00383149|526966002|FG000|Overall Study|Participant Withdrew Consent|1|||
146121992|NCT00453544|526966011|FG000|Overall Study|Withdrawal by Subject|1|||
146121993|NCT00453544|526966012|FG001|Overall Study|Withdrawal by Subject|0|||
146121994|NCT00453544|526966013|FG002|Overall Study|Withdrawal by Subject|0|||
146121995|NCT00453544|526966014|FG003|Overall Study|Withdrawal by Subject|0|||
146121996|NCT00453544|526966011|FG000|Overall Study|Primary outcome measure not completed|1|||
146121997|NCT00453544|526966012|FG001|Overall Study|Primary outcome measure not completed|1|||
146121998|NCT00453544|526966013|FG002|Overall Study|Primary outcome measure not completed|0|||
146121999|NCT00453544|526966014|FG003|Overall Study|Primary outcome measure not completed|1|||
146122000|NCT03721276|526966017|FG000|Overall Study|Lost to Follow-up|5|||
146122001|NCT03721276|526966018|FG001|Overall Study|Lost to Follow-up|3|||
146122002|NCT03721276|526966017|FG000|Overall Study|Adverse Event|0|||
146122003|NCT03721276|526966018|FG001|Overall Study|Adverse Event|1|||
146122004|NCT00450333|526966019|FG000|Overall Study|Study terminated|47|||
146122005|NCT00450333|526966020|FG001|Overall Study|Study terminated|54|||
146122006|NCT00450333|526966021|FG002|Overall Study|Study terminated|16|||
146122007|NCT00450333|526966022|FG003|Overall Study|Study terminated|21|||
146122008|NCT00450333|526966019|FG000|Overall Study|Adverse Event|1|||
146122009|NCT00450333|526966020|FG001|Overall Study|Adverse Event|7|||
146122010|NCT00450333|526966021|FG002|Overall Study|Adverse Event|2|||
146122011|NCT00450333|526966022|FG003|Overall Study|Adverse Event|2|||
146122012|NCT00450333|526966019|FG000|Overall Study|Protocol Violation|1|||
146122013|NCT00450333|526966020|FG001|Overall Study|Protocol Violation|0|||
146122014|NCT00450333|526966021|FG002|Overall Study|Protocol Violation|1|||
146122015|NCT00450333|526966022|FG003|Overall Study|Protocol Violation|0|||
146122016|NCT00450333|526966019|FG000|Overall Study|Withdrawal by Subject|1|||
146122017|NCT00450333|526966020|FG001|Overall Study|Withdrawal by Subject|0|||
146122018|NCT00450333|526966021|FG002|Overall Study|Withdrawal by Subject|3|||
146122019|NCT00450333|526966022|FG003|Overall Study|Withdrawal by Subject|0|||
146122020|NCT00450333|526966019|FG000|Overall Study|Kidney transplant|1|||
146122021|NCT00450333|526966020|FG001|Overall Study|Kidney transplant|0|||
146122022|NCT00450333|526966021|FG002|Overall Study|Kidney transplant|1|||
146262177|NCT01075100|527474434|FG001|Overall Study|Adverse Event|18|||
146262178|NCT01075100|527474433|FG000|Overall Study|Patient Request|4|||
146262179|NCT01075100|527474434|FG001|Overall Study|Patient Request|4|||
146262180|NCT01075100|527474433|FG000|Overall Study|Investigator Request|2|||
146262181|NCT01075100|527474434|FG001|Overall Study|Investigator Request|1|||
146122023|NCT00450333|526966022|FG003|Overall Study|Kidney transplant|3|||
146122024|NCT00450333|526966019|FG000|Overall Study|Death|3|||
146262182|NCT01075100|527474433|FG000|Overall Study|Disease Progression|25|||
146122025|NCT00450333|526966020|FG001|Overall Study|Death|2|||
146122026|NCT00450333|526966021|FG002|Overall Study|Death|2|||
146122027|NCT00450333|526966022|FG003|Overall Study|Death|2|||
146122028|NCT01340898|526966027|FG000|Primary Phase|Serious Adverse Events|0|||
146122029|NCT01340898|526966028|FG001|Primary Phase|Serious Adverse Events|0|||
146122030|NCT01340898|526966029|FG002|Primary Phase|Serious Adverse Events|1|||
146122031|NCT01340898|526966027|FG000|Primary Phase|Withdrawal by Subject|8|||
146262183|NCT01075100|527474434|FG001|Overall Study|Disease Progression|29|||
146122032|NCT01340898|526966028|FG001|Primary Phase|Withdrawal by Subject|7|||
146122033|NCT01340898|526966029|FG002|Primary Phase|Withdrawal by Subject|5|||
146122034|NCT01340898|526966027|FG000|Primary Phase|Migrated/moved from study area|4|||
146122035|NCT01340898|526966028|FG001|Primary Phase|Migrated/moved from study area|1|||
146122036|NCT01340898|526966029|FG002|Primary Phase|Migrated/moved from study area|0|||
146122037|NCT01340898|526966027|FG000|Primary Phase|Lost to Follow-up|4|||
146122038|NCT01340898|526966028|FG001|Primary Phase|Lost to Follow-up|1|||
146122039|NCT01340898|526966029|FG002|Primary Phase|Lost to Follow-up|0|||
146122040|NCT01340898|526966027|FG000|Booster Phase|Withdrawal by Subject|3|||
146122041|NCT01340898|526966028|FG001|Booster Phase|Withdrawal by Subject|0|||
146122042|NCT01340898|526966029|FG002|Booster Phase|Withdrawal by Subject|4|||
146122043|NCT01340898|526966027|FG000|Booster Phase|Migrated/moved from study area|3|||
146122044|NCT01340898|526966028|FG001|Booster Phase|Migrated/moved from study area|0|||
146122045|NCT01340898|526966029|FG002|Booster Phase|Migrated/moved from study area|0|||
146122046|NCT01340898|526966027|FG000|Booster Phase|Lost to Follow-up|4|||
146122047|NCT01340898|526966028|FG001|Booster Phase|Lost to Follow-up|2|||
146122048|NCT01340898|526966029|FG002|Booster Phase|Lost to Follow-up|3|||
146122049|NCT01214629|526966031|FG000|Overall Study|Progressive Disease|1|||
146122050|NCT01214629|526966032|FG001|Overall Study|Progressive Disease|1|||
146122051|NCT01214629|526966033|FG002|Overall Study|Progressive Disease|0|||
146122052|NCT01214629|526966034|FG003|Overall Study|Progressive Disease|1|||
146122053|NCT01214629|526966035|FG004|Overall Study|Progressive Disease|2|||
146122054|NCT01214629|526966036|FG005|Overall Study|Progressive Disease|3|||
146122055|NCT01214629|526966037|FG006|Overall Study|Progressive Disease|1|||
146122056|NCT01214629|526966038|FG007|Overall Study|Progressive Disease|1|||
146122057|NCT01214629|526966039|FG008|Overall Study|Progressive Disease|1|||
146122058|NCT01214629|526966040|FG009|Overall Study|Progressive Disease|5|||
146122059|NCT01214629|526966041|FG010|Overall Study|Progressive Disease|1|||
146122060|NCT01214629|526966031|FG000|Overall Study|Adverse Event|0|||
146122061|NCT01214629|526966032|FG001|Overall Study|Adverse Event|0|||
146122062|NCT01214629|526966033|FG002|Overall Study|Adverse Event|0|||
146122063|NCT01214629|526966034|FG003|Overall Study|Adverse Event|1|||
146122064|NCT01214629|526966035|FG004|Overall Study|Adverse Event|0|||
146122065|NCT01214629|526966036|FG005|Overall Study|Adverse Event|1|||
146122066|NCT01214629|526966037|FG006|Overall Study|Adverse Event|0|||
146122067|NCT01214629|526966038|FG007|Overall Study|Adverse Event|0|||
146122068|NCT01214629|526966039|FG008|Overall Study|Adverse Event|0|||
146122069|NCT01214629|526966040|FG009|Overall Study|Adverse Event|1|||
146122070|NCT01214629|526966041|FG010|Overall Study|Adverse Event|0|||
146122071|NCT01214629|526966031|FG000|Overall Study|Physician Decision|0|||
146122072|NCT01214629|526966032|FG001|Overall Study|Physician Decision|0|||
146122073|NCT01214629|526966033|FG002|Overall Study|Physician Decision|0|||
146122074|NCT01214629|526966034|FG003|Overall Study|Physician Decision|0|||
146122075|NCT01214629|526966035|FG004|Overall Study|Physician Decision|0|||
146122076|NCT01214629|526966036|FG005|Overall Study|Physician Decision|0|||
146122077|NCT01214629|526966037|FG006|Overall Study|Physician Decision|0|||
146122078|NCT01214629|526966038|FG007|Overall Study|Physician Decision|0|||
146122079|NCT01214629|526966039|FG008|Overall Study|Physician Decision|0|||
146122080|NCT01214629|526966040|FG009|Overall Study|Physician Decision|0|||
146122081|NCT01214629|526966041|FG010|Overall Study|Physician Decision|1|||
146122082|NCT01214629|526966031|FG000|Overall Study|Withdrawal by Subject|0|||
146122083|NCT01214629|526966032|FG001|Overall Study|Withdrawal by Subject|0|||
146122084|NCT01214629|526966033|FG002|Overall Study|Withdrawal by Subject|0|||
146122085|NCT01214629|526966034|FG003|Overall Study|Withdrawal by Subject|0|||
146122086|NCT01214629|526966035|FG004|Overall Study|Withdrawal by Subject|0|||
146122087|NCT01214629|526966036|FG005|Overall Study|Withdrawal by Subject|0|||
146122088|NCT01214629|526966037|FG006|Overall Study|Withdrawal by Subject|0|||
146122089|NCT01214629|526966038|FG007|Overall Study|Withdrawal by Subject|0|||
146122090|NCT01214629|526966039|FG008|Overall Study|Withdrawal by Subject|0|||
146122091|NCT01214629|526966040|FG009|Overall Study|Withdrawal by Subject|1|||
146122092|NCT01214629|526966041|FG010|Overall Study|Withdrawal by Subject|0|||
146122093|NCT00461682|526966044|FG000|Overall Study|Protocol Violation|1|||
146122094|NCT04501666|526966051|FG000|Overall Study|Physician Decision|0|||
146122095|NCT04501666|526966052|FG001|Overall Study|Physician Decision|1|||
146122096|NCT04501666|526966051|FG000|Overall Study|Adverse Event|12|||
146122097|NCT04501666|526966052|FG001|Overall Study|Adverse Event|4|||
146122098|NCT04501666|526966051|FG000|Overall Study|Subject's request|10|||
146122099|NCT04501666|526966052|FG001|Overall Study|Subject's request|6|||
146122100|NCT04501666|526966051|FG000|Overall Study|Protocol Deviation|2|||
146122101|NCT04501666|526966052|FG001|Overall Study|Protocol Deviation|1|||
146122102|NCT04501666|526966051|FG000|Overall Study|Other-- site permanently closing|0|||
146122103|NCT04501666|526966052|FG001|Overall Study|Other-- site permanently closing|1|||
146122104|NCT03204305|526966053|FG000|Overall Study|Lost to Follow-up|6|||
146122105|NCT03204305|526966054|FG001|Overall Study|Lost to Follow-up|4|||
146122106|NCT03204305|526966055|FG002|Overall Study|Lost to Follow-up|0|||
146122107|NCT03204305|526966056|FG003|Overall Study|Lost to Follow-up|0|||
146122108|NCT03204305|526966053|FG000|Overall Study|Physician Decision|1|||
146122109|NCT03204305|526966054|FG001|Overall Study|Physician Decision|0|||
146122110|NCT03204305|526966055|FG002|Overall Study|Physician Decision|0|||
146122111|NCT03204305|526966056|FG003|Overall Study|Physician Decision|0|||
146122112|NCT03204305|526966053|FG000|Overall Study|failure to place arterial line|2|||
146122113|NCT03204305|526966054|FG001|Overall Study|failure to place arterial line|1|||
146122114|NCT03204305|526966055|FG002|Overall Study|failure to place arterial line|0|||
146122115|NCT03204305|526966056|FG003|Overall Study|failure to place arterial line|0|||
146122116|NCT03204305|526966053|FG000|Overall Study|Withdrawal by Subject|2|||
146122117|NCT03204305|526966054|FG001|Overall Study|Withdrawal by Subject|0|||
146122118|NCT03204305|526966055|FG002|Overall Study|Withdrawal by Subject|0|||
146122119|NCT03204305|526966056|FG003|Overall Study|Withdrawal by Subject|0|||
146122120|NCT01165554|526966057|FG000|Overall Study|Withdrawal by Subject|23|||
146122121|NCT00535223|526966061|FG000|Overall Study|Withdrawal by Subject|4|||
146122122|NCT00535223|526966062|FG001|Overall Study|Withdrawal by Subject|1|||
146122123|NCT02953314|526966063|FG000|Overall Study|Adverse Event|0|||
146122124|NCT02953314|526966064|FG001|Overall Study|Adverse Event|1|||
146122125|NCT02953314|526966063|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
146122126|NCT02953314|526966064|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
146122127|NCT00101907|526966068|FG000|Overall Study|Adverse Event|1|||
146122128|NCT00101907|526966069|FG001|Overall Study|Adverse Event|0|||
146122129|NCT00101907|526966070|FG002|Overall Study|Adverse Event|0|||
146122130|NCT00101907|526966071|FG003|Overall Study|Adverse Event|0|||
146122131|NCT00101907|526966072|FG004|Overall Study|Adverse Event|0|||
146122132|NCT00101907|526966073|FG005|Overall Study|Adverse Event|0|||
146122133|NCT00101907|526966068|FG000|Overall Study|Death|0|||
146122134|NCT00101907|526966069|FG001|Overall Study|Death|1|||
146122135|NCT00101907|526966070|FG002|Overall Study|Death|0|||
146122136|NCT00101907|526966071|FG003|Overall Study|Death|0|||
146122137|NCT00101907|526966072|FG004|Overall Study|Death|3|||
146122138|NCT00101907|526966073|FG005|Overall Study|Death|0|||
146122139|NCT00101907|526966068|FG000|Overall Study|Physician Decision|0|||
146122140|NCT00101907|526966069|FG001|Overall Study|Physician Decision|0|||
146122141|NCT00101907|526966070|FG002|Overall Study|Physician Decision|0|||
146122142|NCT00101907|526966071|FG003|Overall Study|Physician Decision|1|||
146122143|NCT00101907|526966072|FG004|Overall Study|Physician Decision|1|||
146122144|NCT00101907|526966073|FG005|Overall Study|Physician Decision|0|||
146122145|NCT00101907|526966068|FG000|Overall Study|Withdrawal by Subject|1|||
146122146|NCT00101907|526966069|FG001|Overall Study|Withdrawal by Subject|0|||
146122147|NCT00101907|526966070|FG002|Overall Study|Withdrawal by Subject|1|||
146122148|NCT00101907|526966071|FG003|Overall Study|Withdrawal by Subject|0|||
146122149|NCT00101907|526966072|FG004|Overall Study|Withdrawal by Subject|1|||
146122150|NCT00101907|526966073|FG005|Overall Study|Withdrawal by Subject|0|||
146122151|NCT01765153|526966074|FG000|Training Phase 1|Format of intervention differed|1|||
146122152|NCT01765153|526966075|FG001|Training Phase 1|Format of intervention differed|0|||
146122153|NCT01765153|526966074|FG000|Training Phase 1|Poor participation in intervention|0|||
146122154|NCT01765153|526966075|FG001|Training Phase 1|Poor participation in intervention|1|||
146122155|NCT01765153|526966074|FG000|Rest Phase 1|Withdrawal by Subject|0|||
146122156|NCT01765153|526966075|FG001|Rest Phase 1|Withdrawal by Subject|1|||
146122157|NCT01765153|526966074|FG000|Training Phase 2|Withdrawal by Subject|0|||
146122158|NCT01765153|526966075|FG001|Training Phase 2|Withdrawal by Subject|1|||
146122159|NCT01765153|526966074|FG000|Rest Phase 2|Lost to Follow-up|2|||
146122160|NCT01765153|526966075|FG001|Rest Phase 2|Lost to Follow-up|1|||
146122161|NCT03915496|526966078|FG000|Overall Study|Adverse Event|2|||
146122162|NCT03915496|526966079|FG001|Overall Study|Adverse Event|1|||
146122163|NCT03915496|526966080|FG002|Overall Study|Adverse Event|2|||
146122164|NCT02663674|526966081|FG000|Overall Study|Lost to Follow-up|5|||
146122165|NCT02663674|526966082|FG001|Overall Study|Lost to Follow-up|4|||
146122166|NCT02663674|526966081|FG000|Overall Study|Withdrawal by Subject|1|||
146122167|NCT02663674|526966082|FG001|Overall Study|Withdrawal by Subject|4|||
146122168|NCT02663674|526966081|FG000|Overall Study|Physician Decision|1|||
146122169|NCT02663674|526966082|FG001|Overall Study|Physician Decision|1|||
146122170|NCT02663674|526966081|FG000|Overall Study|Other Event (Health Related)|0|||
146122171|NCT02663674|526966082|FG001|Overall Study|Other Event (Health Related)|1|||
146122172|NCT02472795|526966083|FG000|Overall Study|Adverse Event|0|||
146122173|NCT02472795|526966084|FG001|Overall Study|Adverse Event|1|||
146122174|NCT02472795|526966085|FG002|Overall Study|Adverse Event|0|||
146122175|NCT02472795|526966086|FG003|Overall Study|Adverse Event|0|||
146122176|NCT02472795|526966087|FG004|Overall Study|Adverse Event|2|||
146122177|NCT02472795|526966083|FG000|Overall Study|Withdrawal by Subject|0|||
146122178|NCT02472795|526966084|FG001|Overall Study|Withdrawal by Subject|0|||
146122179|NCT02472795|526966085|FG002|Overall Study|Withdrawal by Subject|0|||
146262184|NCT01075100|527474433|FG000|Overall Study|Other|3|||
146122180|NCT02472795|526966086|FG003|Overall Study|Withdrawal by Subject|0|||
146122181|NCT02472795|526966087|FG004|Overall Study|Withdrawal by Subject|1|||
146122182|NCT04166513|526966088|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
146122183|NCT04166513|526966089|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
146122184|NCT04166513|526966090|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
146122185|NCT04166513|526966091|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
146262185|NCT01075100|527474434|FG001|Overall Study|Other|1|||
146122186|NCT04166513|526966088|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
146122187|NCT04166513|526966089|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
146122188|NCT04166513|526966090|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
146122189|NCT04166513|526966091|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
146122190|NCT04166513|526966088|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
146122191|NCT04166513|526966089|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
146122192|NCT04166513|526966090|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
146122193|NCT04166513|526966091|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
146122194|NCT04166513|526966088|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
146122195|NCT04166513|526966089|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
146122196|NCT04166513|526966090|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
146122197|NCT04166513|526966091|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
146122198|NCT04166513|526966088|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
146122199|NCT04166513|526966089|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
146122200|NCT04166513|526966090|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
146122201|NCT04166513|526966091|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
146122202|NCT04219891|526966093|FG000|Overall Study|Lost to Follow-up|3|||
146122203|NCT04219891|526966093|FG000|Overall Study|Withdrawal by Subject|2|||
146122204|NCT00597012|526966094|FG000|Overall Study|Death|1|||
146122205|NCT00597012|526966095|FG001|Overall Study|Death|1|||
146122206|NCT00597012|526966094|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
146122207|NCT00597012|526966095|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
146122208|NCT00597012|526966094|FG000|Overall Study|Withdrawal by Subject|7|||
146122209|NCT00597012|526966095|FG001|Overall Study|Withdrawal by Subject|4|||
146122210|NCT00597012|526966094|FG000|Overall Study|Ineligible|2|||
146122211|NCT00597012|526966095|FG001|Overall Study|Ineligible|0|||
146122212|NCT00597012|526966094|FG000|Overall Study|Lost to Follow-up|0|||
146122213|NCT00597012|526966095|FG001|Overall Study|Lost to Follow-up|2|||
146122214|NCT00670800|526967085|FG000|Overall Study|2 controls were insulin resistant|0|||
146122215|NCT00670800|526967086|FG001|Overall Study|2 controls were insulin resistant|2|||
146122216|NCT01786629|526967087|FG000|Overall Study|Lack of Efficacy|0|||
146122217|NCT01786629|526967088|FG001|Overall Study|Lack of Efficacy|4|||
146122218|NCT01786629|526967087|FG000|Overall Study|Adverse Event|0|||
146122219|NCT01786629|526967088|FG001|Overall Study|Adverse Event|1|||
146122220|NCT00410761|526967089|FG000|Randomized Treatment Period|Adverse Event|34|||
146122221|NCT00410761|526967090|FG001|Randomized Treatment Period|Adverse Event|3|||
146122222|NCT00410761|526967089|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
146262186|NCT01568112|527474439|FG000|Overall Study|Randomized But Not Treated|0|||
146262187|NCT01568112|527474440|FG001|Overall Study|Randomized But Not Treated|1|||
145941618|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
145941619|NCT02677896|526295230|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
145941620|NCT02677896|526295231|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
145941621|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
145941622|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
145941623|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
145941624|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
145941625|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
145941626|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
145941627|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
145941628|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
145941629|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
145941630|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
145941631|NCT02677896|526295230|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
145941632|NCT02677896|526295231|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
145941633|NCT03385304|526295236|FG000|Overall Study|Death|19|||
145941634|NCT03385304|526295237|FG001|Overall Study|Death|7|||
145941635|NCT03385304|526295236|FG000|Overall Study|Lost to Follow-up|17|||
145941636|NCT03385304|526295237|FG001|Overall Study|Lost to Follow-up|14|||
145941637|NCT03385304|526295236|FG000|Overall Study|Withdrawal by Subject|3|||
145941638|NCT03385304|526295237|FG001|Overall Study|Withdrawal by Subject|2|||
146262188|NCT01568112|527474441|FG002|Overall Study|Randomized But Not Treated|0|||
145941639|NCT03385304|526295236|FG000|Overall Study|Incarceration|2|||
145941640|NCT03385304|526295237|FG001|Overall Study|Incarceration|3|||
145941641|NCT01701193|526295238|FG000|Overall Study|Withdrawal by Subject|2|||
145941642|NCT01701193|526295239|FG001|Overall Study|Withdrawal by Subject|2|||
146262189|NCT01568112|527474442|FG003|Overall Study|Randomized But Not Treated|0|||
146262190|NCT01568112|527474439|FG000|Overall Study|Withdrew due to Adverse Event|2|||
146262191|NCT01568112|527474440|FG001|Overall Study|Withdrew due to Adverse Event|4|||
145941643|NCT01701193|526295240|FG002|Overall Study|Withdrawal by Subject|1|||
145941644|NCT01701193|526295241|FG003|Overall Study|Withdrawal by Subject|2|||
145941645|NCT01701193|526295238|FG000|Overall Study|Adverse Event|1|||
145941646|NCT01701193|526295239|FG001|Overall Study|Adverse Event|0|||
145941647|NCT01701193|526295240|FG002|Overall Study|Adverse Event|0|||
145941648|NCT01701193|526295241|FG003|Overall Study|Adverse Event|0|||
145941649|NCT02720744|526295242|FG000|Overall Study|Protocol Violation|0|||
145941650|NCT02720744|526295243|FG001|Overall Study|Protocol Violation|2|||
145941651|NCT02720744|526295242|FG000|Overall Study|Pregnancy|2|||
145941652|NCT02720744|526295243|FG001|Overall Study|Pregnancy|0|||
145941653|NCT02720744|526295242|FG000|Overall Study|Lack of Efficacy|2|||
145941654|NCT02720744|526295243|FG001|Overall Study|Lack of Efficacy|8|||
145941655|NCT02720744|526295242|FG000|Overall Study|Adverse Event|21|||
145941656|NCT02720744|526295243|FG001|Overall Study|Adverse Event|3|||
145941657|NCT02720744|526295242|FG000|Overall Study|Withdrawal by Subject|11|||
145941658|NCT02720744|526295243|FG001|Overall Study|Withdrawal by Subject|11|||
145941659|NCT02720744|526295242|FG000|Overall Study|Lost to follow up|2|||
145941660|NCT02720744|526295243|FG001|Overall Study|Lost to follow up|0|||
145941661|NCT02720744|526295242|FG000|Overall Study|Non Compliance with Investigational Product|0|||
145941662|NCT02720744|526295243|FG001|Overall Study|Non Compliance with Investigational Product|1|||
145941663|NCT02720744|526295242|FG000|Overall Study|Excluded Concomitant Medication|0|||
145941664|NCT02720744|526295243|FG001|Overall Study|Excluded Concomitant Medication|1|||
145941665|NCT03181503|526295258|FG000|Overall Study|Adverse Event|2|||
145941666|NCT03181503|526295259|FG001|Overall Study|Adverse Event|2|||
145941667|NCT03181503|526295258|FG000|Overall Study|Protocol Violation|1|||
145941668|NCT03181503|526295259|FG001|Overall Study|Protocol Violation|0|||
145941669|NCT03181503|526295258|FG000|Overall Study|Withdrawal by Subject|3|||
145941670|NCT03181503|526295259|FG001|Overall Study|Withdrawal by Subject|0|||
145941671|NCT03181503|526295258|FG000|Overall Study|Lost to Follow-up|1|||
145941672|NCT03181503|526295259|FG001|Overall Study|Lost to Follow-up|1|||
146122223|NCT00410761|526967090|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
146122224|NCT00410761|526967089|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
146122225|NCT00410761|526967090|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
146122226|NCT00410761|526967089|FG000|Randomized Treatment Period|Other|69|||
146122227|NCT00410761|526967090|FG001|Randomized Treatment Period|Other|21|||
146122228|NCT00410761|526967089|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
146122229|NCT00410761|526967090|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
146122230|NCT00410761|526967089|FG000|Open-Label Treatment Period|Adverse Event|13|||
146122231|NCT00410761|526967090|FG001|Open-Label Treatment Period|Adverse Event|15|||
146122232|NCT00410761|526967089|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
146122233|NCT00410761|526967090|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
145941673|NCT01892085|526295262|FG000|Overall Study|Death|4|||
145941674|NCT01892085|526295263|FG001|Overall Study|Death|1|||
145941675|NCT01892085|526295264|FG002|Overall Study|Death|3|||
145941676|NCT01892085|526295262|FG000|Overall Study|Withdrawal by Subject|2|||
145941677|NCT01892085|526295263|FG001|Overall Study|Withdrawal by Subject|0|||
145941678|NCT01892085|526295264|FG002|Overall Study|Withdrawal by Subject|2|||
145941679|NCT01549041|526295265|FG000|Overall Study|Lack of Efficacy|2|||
145941680|NCT01549041|526295266|FG001|Overall Study|Lack of Efficacy|4|||
145941681|NCT01549041|526295265|FG000|Overall Study|Adverse Event|0|||
145941682|NCT01549041|526295266|FG001|Overall Study|Adverse Event|4|||
145941683|NCT01199822|526295271|FG000|Overall Study|Investigator discontinued therapy|0|||
145941684|NCT01199822|526295272|FG001|Overall Study|Investigator discontinued therapy|1|||
146122234|NCT00410761|526967089|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
146122235|NCT00410761|526967090|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
146122236|NCT00410761|526967089|FG000|Open-Label Treatment Period|Other|18|||
146122237|NCT00410761|526967090|FG001|Open-Label Treatment Period|Other|9|||
146122238|NCT04708886|526967094|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
146122239|NCT04708886|526967094|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
146122240|NCT01372501|526967100|FG000|Overall Study|Adverse Event|4|||
146122241|NCT01372501|526967100|FG000|Overall Study|Device migration|1|||
146122242|NCT05333900|526967101|FG000|Overall Study|Protocol Violation|0|||
146122243|NCT05333900|526967102|FG001|Overall Study|Protocol Violation|1|||
146122244|NCT05333900|526967101|FG000|Overall Study|Withdrawal by Subject|0|||
146122245|NCT05333900|526967102|FG001|Overall Study|Withdrawal by Subject|1|||
146332889|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145941685|NCT01199822|526295273|FG002|Overall Study|Investigator discontinued therapy|0|||
146122246|NCT05333900|526967101|FG000|Overall Study|COVID-19 Pandemic|1|||
146122247|NCT05333900|526967102|FG001|Overall Study|COVID-19 Pandemic|1|||
146122248|NCT01277523|526967103|FG000|Overall Study|Adverse Event|1|||
146122249|NCT01277523|526967104|FG001|Overall Study|Adverse Event|0|||
146122250|NCT01277523|526967105|FG002|Overall Study|Adverse Event|0|||
146122251|NCT01277523|526967103|FG000|Overall Study|Protocol Violation|2|||
146122252|NCT01277523|526967104|FG001|Overall Study|Protocol Violation|0|||
146122253|NCT01277523|526967105|FG002|Overall Study|Protocol Violation|0|||
146122254|NCT01277523|526967103|FG000|Overall Study|Other Reason not Defined|0|||
146122255|NCT01277523|526967104|FG001|Overall Study|Other Reason not Defined|1|||
146122256|NCT01277523|526967105|FG002|Overall Study|Other Reason not Defined|0|||
146122257|NCT03724812|526967108|FG000|Overall Study|Missed Visit|1|||
146122258|NCT03724812|526967108|FG000|Overall Study|Death|2|||
146122259|NCT03724812|526967108|FG000|Overall Study|Withdrawal by Subject|1|||
145941686|NCT00480493|526295274|FG000|Overall Study|moved|2|||
146122260|NCT01851720|526967109|FG000|Overall Study|Lost to Follow-up|0|||
146122261|NCT01851720|526967110|FG001|Overall Study|Lost to Follow-up|1|||
146122262|NCT02389998|526967113|FG000|Overall Study|car accident|1|||
146122263|NCT02389998|526967114|FG001|Overall Study|car accident|0|||
146122264|NCT03525574|526967115|FG000|Overall Study|Adverse Event|15|||
146122265|NCT03525574|526967116|FG001|Overall Study|Adverse Event|0|||
146122266|NCT03525574|526967115|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
146122267|NCT03525574|526967116|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146122268|NCT03525574|526967115|FG000|Overall Study|Lost to Follow-up|4|||
146122269|NCT03525574|526967116|FG001|Overall Study|Lost to Follow-up|0|||
146122270|NCT03525574|526967115|FG000|Overall Study|Commercial drug is Available for participant|48|||
146122271|NCT03525574|526967116|FG001|Overall Study|Commercial drug is Available for participant|0|||
146122272|NCT03525574|526967115|FG000|Overall Study|Death|1|||
146122273|NCT03525574|526967116|FG001|Overall Study|Death|0|||
146122274|NCT03525574|526967115|FG000|Overall Study|Other non-compliance|2|||
146122275|NCT03525574|526967116|FG001|Overall Study|Other non-compliance|0|||
146122276|NCT03525574|526967115|FG000|Overall Study|Physician Decision|6|||
146122277|NCT03525574|526967116|FG001|Overall Study|Physician Decision|0|||
146122278|NCT03525574|526967115|FG000|Overall Study|Other|58|||
146122279|NCT03525574|526967116|FG001|Overall Study|Other|0|||
146122280|NCT03525574|526967115|FG000|Overall Study|Enrolled but never dosed|1|||
146122281|NCT03525574|526967116|FG001|Overall Study|Enrolled but never dosed|0|||
146122282|NCT03525574|526967115|FG000|Overall Study|Not enrolled in 105 study|0|||
146122283|NCT03525574|526967116|FG001|Overall Study|Not enrolled in 105 study|3|||
146122284|NCT01770379|526967119|FG000|Overall Study|Technical issues|1|||
146122285|NCT01770379|526967120|FG001|Overall Study|Technical issues|0|||
146122286|NCT01770379|526967121|FG002|Overall Study|Technical issues|0|||
146122287|NCT01770379|526967119|FG000|Overall Study|Withdrawal by Subject|7|||
146122288|NCT01770379|526967120|FG001|Overall Study|Withdrawal by Subject|10|||
146122289|NCT01770379|526967121|FG002|Overall Study|Withdrawal by Subject|7|||
146122290|NCT01770379|526967119|FG000|Overall Study|study terminated by sponsor|22|||
146122291|NCT01770379|526967120|FG001|Overall Study|study terminated by sponsor|23|||
146122292|NCT01770379|526967121|FG002|Overall Study|study terminated by sponsor|22|||
146122293|NCT01770379|526967119|FG000|Overall Study|Protocol Violation|0|||
146122294|NCT01770379|526967120|FG001|Overall Study|Protocol Violation|1|||
146122295|NCT01770379|526967121|FG002|Overall Study|Protocol Violation|1|||
146122296|NCT01770379|526967119|FG000|Overall Study|Physician Decision|0|||
146122297|NCT01770379|526967120|FG001|Overall Study|Physician Decision|1|||
146122298|NCT01770379|526967121|FG002|Overall Study|Physician Decision|2|||
146122299|NCT01770379|526967119|FG000|Overall Study|Lost to Follow-up|0|||
146122300|NCT01770379|526967120|FG001|Overall Study|Lost to Follow-up|0|||
146122301|NCT01770379|526967121|FG002|Overall Study|Lost to Follow-up|2|||
146122302|NCT01770379|526967119|FG000|Overall Study|Lack of Efficacy|8|||
145941687|NCT00480493|526295275|FG001|Overall Study|moved|7|||
145941688|NCT04027075|526295276|FG000|Overall Study|Lost to Follow-up|41|||
145941689|NCT04027075|526295277|FG001|Overall Study|Lost to Follow-up|22|||
145941690|NCT02844907|526295278|FG000|With Dexamethasone|No IV access|1|||
145941691|NCT00550862|526295279|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
145941692|NCT00550862|526295280|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
145941693|NCT00550862|526295281|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
145941694|NCT00550862|526295282|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
145941695|NCT00550862|526295283|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
145941696|NCT00550862|526295279|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
146122303|NCT01770379|526967120|FG001|Overall Study|Lack of Efficacy|6|||
146122304|NCT01770379|526967121|FG002|Overall Study|Lack of Efficacy|6|||
146122305|NCT01770379|526967119|FG000|Overall Study|Adverse Event|1|||
146122306|NCT01770379|526967120|FG001|Overall Study|Adverse Event|3|||
146122307|NCT01770379|526967121|FG002|Overall Study|Adverse Event|2|||
146262192|NCT01568112|527474441|FG002|Overall Study|Withdrew due to Adverse Event|6|||
146262193|NCT01568112|527474442|FG003|Overall Study|Withdrew due to Adverse Event|3|||
146262194|NCT01568112|527474439|FG000|Overall Study|Lost to Follow-up|0|||
146122308|NCT01074450|526967130|FG000|First Intervention|Emesis in Dosing Interval|0|||
145941697|NCT00550862|526295280|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145941698|NCT00550862|526295281|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
145941699|NCT00550862|526295282|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145941700|NCT00550862|526295283|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145941701|NCT00550862|526295279|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145941702|NCT00550862|526295280|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145941703|NCT00550862|526295281|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
146122309|NCT01074450|526967131|FG001|First Intervention|Emesis in Dosing Interval|2|||
146122310|NCT01074450|526967130|FG000|Second Intervention|Protocol Violation|1|||
146122311|NCT01074450|526967131|FG001|Second Intervention|Protocol Violation|0|||
146122312|NCT01074450|526967130|FG000|Second Intervention|Physician Decision|0|||
146122313|NCT01074450|526967131|FG001|Second Intervention|Physician Decision|1|||
146122314|NCT02728895|526967132|FG000|Overall Study|Other|1|||
146122315|NCT02728895|526967133|FG001|Overall Study|Other|2|||
146122316|NCT02728895|526967132|FG000|Overall Study|Withdrawal by Subject|0|||
146122317|NCT02728895|526967133|FG001|Overall Study|Withdrawal by Subject|3|||
146122318|NCT02769247|526967134|FG000|Overall Study|Withdrawal by Subject|1|||
146122319|NCT02769247|526967135|FG001|Overall Study|Withdrawal by Subject|0|||
146122320|NCT02769247|526967136|FG002|Overall Study|Withdrawal by Subject|0|||
146122321|NCT02769247|526967137|FG003|Overall Study|Withdrawal by Subject|1|||
146122322|NCT02769247|526967134|FG000|Overall Study|Protocol Violation|0|||
146122323|NCT02769247|526967135|FG001|Overall Study|Protocol Violation|0|||
146122324|NCT02769247|526967136|FG002|Overall Study|Protocol Violation|1|||
146122325|NCT02769247|526967137|FG003|Overall Study|Protocol Violation|0|||
146122326|NCT02769247|526967134|FG000|Overall Study|Physician Decision|1|||
146122327|NCT02769247|526967135|FG001|Overall Study|Physician Decision|0|||
146122328|NCT02769247|526967136|FG002|Overall Study|Physician Decision|0|||
146122329|NCT02769247|526967137|FG003|Overall Study|Physician Decision|0|||
146122330|NCT02150954|526967138|FG000|Overall Study|Protocol Violation|1|||
145941704|NCT00550862|526295282|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145941705|NCT00550862|526295283|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145941706|NCT00550862|526295279|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145941707|NCT00550862|526295280|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145941708|NCT00550862|526295281|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
145941709|NCT00550862|526295282|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145941710|NCT00550862|526295283|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145941711|NCT00550862|526295279|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145941712|NCT00550862|526295280|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
145941713|NCT00550862|526295281|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145941714|NCT00550862|526295282|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145941715|NCT00550862|526295283|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145941716|NCT00550862|526295279|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145941717|NCT00550862|526295280|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145941718|NCT00550862|526295281|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145941719|NCT00550862|526295282|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145941720|NCT00550862|526295283|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
145941721|NCT00550862|526295279|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145941722|NCT00550862|526295280|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145941723|NCT00550862|526295281|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145941724|NCT00550862|526295282|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145941725|NCT00550862|526295283|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
145941726|NCT00550862|526295279|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145941727|NCT00550862|526295280|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145941728|NCT00550862|526295281|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145941729|NCT00550862|526295282|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145941730|NCT00550862|526295283|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
145941731|NCT00550862|526295279|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
145941732|NCT00550862|526295280|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
146122331|NCT02150954|526967139|FG001|Overall Study|Protocol Violation|0|||
146122332|NCT03164928|526967146|FG000|Overall Study|Lost to Follow-up|1|||
146122333|NCT03164928|526967147|FG001|Overall Study|Lost to Follow-up|0|||
146122334|NCT01998737|526967148|FG000|Overall Study|Corrupted database|23|||
146122335|NCT01998737|526967149|FG001|Overall Study|Corrupted database|0|||
146122336|NCT00326950|526967150|FG000|Overall Study|Progressive Disease|1|||
146122337|NCT01275833|526967154|FG000|Overall Study|Study terminated|1|||
146122338|NCT01275833|526967155|FG001|Overall Study|Study terminated|1|||
146122339|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146122340|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
146122341|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146262195|NCT01568112|527474440|FG001|Overall Study|Lost to Follow-up|0|||
146262196|NCT01568112|527474441|FG002|Overall Study|Lost to Follow-up|0|||
146262197|NCT01568112|527474442|FG003|Overall Study|Lost to Follow-up|1|||
146122342|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146122343|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146122344|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146122345|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
146122346|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146262198|NCT01568112|527474439|FG000|Overall Study|Withdrawal by Subject|2|||
146122347|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
146122348|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
146262199|NCT01568112|527474440|FG001|Overall Study|Withdrawal by Subject|3|||
146262200|NCT01568112|527474441|FG002|Overall Study|Withdrawal by Subject|0|||
146122349|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146122350|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
146122351|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
146122352|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
146122353|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
146122354|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
146122355|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
146122356|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
146122357|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
146122358|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
146122359|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
146122360|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146122361|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
145941733|NCT00550862|526295281|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
145941734|NCT00550862|526295282|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
145941735|NCT00550862|526295283|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
145941736|NCT00550862|526295279|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145941737|NCT00550862|526295280|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145941738|NCT00550862|526295281|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145941739|NCT00550862|526295282|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145941740|NCT00550862|526295283|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
145941741|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
145941742|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
145941743|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
145941744|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
145941745|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
145941746|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
145941747|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
145941748|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
145941749|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
145941750|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
145941751|NCT00455520|526295284|FG000|Open Label Tapentadol Extended Release|All other|33|||
145941752|NCT00455520|526295285|FG001|Open Label Tapentadol Extended Release|All other|0|||
145941753|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
145941754|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
145941755|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
145941756|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
145941757|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
145941758|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
145941759|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
145941760|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
146122362|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146122363|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146122364|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146122365|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
146122366|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
146122367|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
146122368|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
146122369|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
146122370|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
146122371|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
146122372|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
146122373|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
146122374|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122375|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122376|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122377|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122378|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122379|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
146262201|NCT01568112|527474442|FG003|Overall Study|Withdrawal by Subject|7|||
146262202|NCT01568112|527474439|FG000|Overall Study|Withdrawal by Physician|1|||
146262203|NCT01568112|527474440|FG001|Overall Study|Withdrawal by Physician|0|||
146122380|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
146122381|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146122382|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146122383|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146122384|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146122385|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
146122386|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
146122387|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
146122388|NCT03742037|526967163|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122389|NCT03742037|526967164|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122390|NCT03742037|526967165|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122391|NCT03742037|526967166|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122392|NCT03742037|526967167|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122393|NCT03742037|526967168|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
146122394|NCT03742037|526967169|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
146122395|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
145941761|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
145941762|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
145941763|NCT00455520|526295284|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
145941764|NCT00455520|526295285|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
145941765|NCT00986986|526295288|FG000|Overall Study|Lost to Follow-up|0|||
145941766|NCT00986986|526295289|FG001|Overall Study|Lost to Follow-up|1|||
145941767|NCT00955968|526295293|FG000|Overall Study|Death|2|||
145941768|NCT00955968|526295294|FG001|Overall Study|Death|4|||
145941769|NCT00955968|526295293|FG000|Overall Study|Withdrawal by Subject|35|||
145941770|NCT00955968|526295294|FG001|Overall Study|Withdrawal by Subject|31|||
145941771|NCT00955968|526295293|FG000|Overall Study|Lost to Follow-up|45|||
145941772|NCT00955968|526295294|FG001|Overall Study|Lost to Follow-up|39|||
145941773|NCT00955968|526295293|FG000|Overall Study|Site closed|55|||
145941774|NCT00955968|526295294|FG001|Overall Study|Site closed|52|||
145941775|NCT01785849|526295296|FG000|Overall Study|Death|7|||
145941776|NCT01785849|526295297|FG001|Overall Study|Death|9|||
145941777|NCT01785849|526295296|FG000|Overall Study|Protocol Specified Criteria|29|||
145941778|NCT01785849|526295297|FG001|Overall Study|Protocol Specified Criteria|1|||
145941779|NCT01785849|526295296|FG000|Overall Study|Withdrawal by Subject|15|||
145941780|NCT01785849|526295297|FG001|Overall Study|Withdrawal by Subject|12|||
145941781|NCT01785849|526295296|FG000|Overall Study|Sponsor Decision|0|||
145941782|NCT01785849|526295297|FG001|Overall Study|Sponsor Decision|1|||
145941783|NCT01785849|526295296|FG000|Overall Study|Lost to Follow-up|10|||
145941784|NCT01785849|526295297|FG001|Overall Study|Lost to Follow-up|11|||
145941785|NCT01940900|526295298|FG000|Overall Study|Physician Decision|4|||
145941786|NCT01940900|526295299|FG001|Overall Study|Physician Decision|0|||
145941787|NCT01940900|526295298|FG000|Overall Study|Adverse Event|10|||
145941788|NCT01940900|526295299|FG001|Overall Study|Adverse Event|15|||
145941789|NCT01940900|526295298|FG000|Overall Study|Withdrawal by Subject|11|||
145941790|NCT01940900|526295299|FG001|Overall Study|Withdrawal by Subject|15|||
145941791|NCT01940900|526295298|FG000|Overall Study|Lost to Follow-up|1|||
145941792|NCT01940900|526295299|FG001|Overall Study|Lost to Follow-up|0|||
145941793|NCT01940900|526295298|FG000|Overall Study|Sponsor Decision|1|||
145941794|NCT01940900|526295299|FG001|Overall Study|Sponsor Decision|0|||
145941795|NCT01940900|526295298|FG000|Overall Study|subject non-compliance|1|||
145941796|NCT01940900|526295299|FG001|Overall Study|subject non-compliance|1|||
145941797|NCT01940900|526295298|FG000|Overall Study|other|1|||
145941798|NCT01940900|526295299|FG001|Overall Study|other|0|||
145941799|NCT00742508|526295302|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
145941800|NCT00742508|526295303|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
145941801|NCT00742508|526295302|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
145941802|NCT00742508|526295303|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
146303126|NCT01994382|527624070|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
146303127|NCT01994382|527624071|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145941803|NCT00742508|526295302|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
145941804|NCT00742508|526295303|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
146303128|NCT01994382|527624072|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
146303129|NCT01994382|527624073|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145941805|NCT00742508|526295302|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
145941806|NCT00742508|526295303|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
145941807|NCT00742508|526295302|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
145941808|NCT00742508|526295303|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
145941809|NCT02431806|526295304|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
145941810|NCT02431806|526295305|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
145941811|NCT02431806|526295306|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
145941812|NCT02431806|526295307|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
145941813|NCT02431806|526295304|FG000|Double-blind Treatment Period|Adverse Event|4|||
145941814|NCT02431806|526295305|FG001|Double-blind Treatment Period|Adverse Event|7|||
145941815|NCT02431806|526295306|FG002|Double-blind Treatment Period|Adverse Event|11|||
145941816|NCT02431806|526295307|FG003|Double-blind Treatment Period|Adverse Event|7|||
145941817|NCT02431806|526295304|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
145941818|NCT02431806|526295305|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145941819|NCT02431806|526295306|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
145941820|NCT02431806|526295307|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
145941821|NCT02431806|526295304|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
145941822|NCT02431806|526295305|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
145941823|NCT02431806|526295306|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
145941824|NCT02431806|526295307|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
145941825|NCT02431806|526295304|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
145941826|NCT02431806|526295305|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
145941827|NCT02431806|526295306|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
145941828|NCT02431806|526295307|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
145941829|NCT02431806|526295304|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
145941830|NCT02431806|526295305|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
145941831|NCT02431806|526295306|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
145941832|NCT02431806|526295307|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
145941833|NCT02431806|526295304|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
145941834|NCT02431806|526295305|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
145941835|NCT02431806|526295306|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
145941836|NCT02431806|526295307|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
145941837|NCT04450407|526295310|FG000|Overall Study|Withdrawal by Subject|10|||
145941838|NCT04450407|526295311|FG001|Overall Study|Withdrawal by Subject|1|||
145941839|NCT04450407|526295312|FG002|Overall Study|Withdrawal by Subject|4|||
145941840|NCT04450407|526295310|FG000|Overall Study|Adverse Event|0|||
145941841|NCT04450407|526295311|FG001|Overall Study|Adverse Event|0|||
145941842|NCT04450407|526295312|FG002|Overall Study|Adverse Event|1|||
145941843|NCT04450407|526295310|FG000|Overall Study|Lost to Follow-up|1|||
145941844|NCT04450407|526295311|FG001|Overall Study|Lost to Follow-up|0|||
145941845|NCT04450407|526295312|FG002|Overall Study|Lost to Follow-up|0|||
145941846|NCT04450407|526295310|FG000|Overall Study|Physician Decision|0|||
145941847|NCT04450407|526295311|FG001|Overall Study|Physician Decision|0|||
145941848|NCT04450407|526295312|FG002|Overall Study|Physician Decision|1|||
145941849|NCT04450407|526295310|FG000|Overall Study|Pregnancy|1|||
145941850|NCT04450407|526295311|FG001|Overall Study|Pregnancy|0|||
145941851|NCT04450407|526295312|FG002|Overall Study|Pregnancy|0|||
145941852|NCT04450407|526295310|FG000|Overall Study|Protocol Violation|2|||
145941853|NCT04450407|526295311|FG001|Overall Study|Protocol Violation|0|||
145941854|NCT04450407|526295312|FG002|Overall Study|Protocol Violation|0|||
145941855|NCT04450407|526295310|FG000|Overall Study|Investigational site terminated by sponsor|3|||
145941856|NCT04450407|526295311|FG001|Overall Study|Investigational site terminated by sponsor|0|||
145941857|NCT04450407|526295312|FG002|Overall Study|Investigational site terminated by sponsor|2|||
145941858|NCT00474045|526295313|FG000|Overall Study|Adverse Event|18|||
145941859|NCT00474045|526295314|FG001|Overall Study|Adverse Event|8|||
145941860|NCT00474045|526295313|FG000|Overall Study|Unclassified|1|||
145941861|NCT00474045|526295314|FG001|Overall Study|Unclassified|3|||
145941862|NCT00474045|526295313|FG000|Overall Study|Lack of Efficacy|0|||
145941863|NCT00474045|526295314|FG001|Overall Study|Lack of Efficacy|9|||
145941864|NCT00474045|526295313|FG000|Overall Study|Lost to Follow-up|1|||
145941865|NCT00474045|526295314|FG001|Overall Study|Lost to Follow-up|1|||
145941866|NCT00474045|526295313|FG000|Overall Study|Protocol Violation|10|||
145941867|NCT00474045|526295314|FG001|Overall Study|Protocol Violation|12|||
145941868|NCT00474045|526295313|FG000|Overall Study|Withdrawal by Subject|16|||
145941869|NCT00474045|526295314|FG001|Overall Study|Withdrawal by Subject|18|||
145941870|NCT00474045|526295313|FG000|Overall Study|Withdrawal criteria|60|||
145941871|NCT00474045|526295314|FG001|Overall Study|Withdrawal criteria|50|||
145941872|NCT02009397|526295317|FG000|Overall Study|Protocol Violation|6|||
145941873|NCT02009397|526295317|FG000|Overall Study|Death|8|||
145941874|NCT02009397|526295317|FG000|Overall Study|Lost to Follow-up|6|||
145941875|NCT01645891|526295321|FG000|Overall Study|Adverse Event|6|||
145941876|NCT01645891|526295322|FG001|Overall Study|Adverse Event|10|||
145941877|NCT01645891|526295321|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
146122396|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
146122397|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
146122398|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
146122399|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
146122400|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
146122401|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
146122402|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146122403|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146122404|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
146122405|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
146122406|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
145941878|NCT01645891|526295322|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
145941879|NCT01645891|526295321|FG000|Overall Study|Withdrawal by Subject|3|||
145941880|NCT01645891|526295322|FG001|Overall Study|Withdrawal by Subject|3|||
145941881|NCT01645891|526295321|FG000|Overall Study|Protocol Violation|4|||
145941882|NCT01645891|526295322|FG001|Overall Study|Protocol Violation|0|||
145941883|NCT01645891|526295321|FG000|Overall Study|Lost to Follow-up|4|||
145941884|NCT01645891|526295322|FG001|Overall Study|Lost to Follow-up|1|||
145941885|NCT01645891|526295321|FG000|Overall Study|Death|0|||
145941886|NCT01645891|526295322|FG001|Overall Study|Death|2|||
145941887|NCT01173055|526295325|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
145941888|NCT01173055|526295326|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
145941889|NCT01173055|526295325|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
145941890|NCT01173055|526295326|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
145941891|NCT04814368|526295327|FG000|Overall Study|Study Terminated by Sponsor|0|||
146122407|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
146122408|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
146122409|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146122410|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
146122411|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
146122412|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146122413|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146122414|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146122415|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
146122416|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
146122417|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146122418|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146122419|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146122420|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146122421|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
146122422|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
146122423|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146122424|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
146122425|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
146122426|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
146122427|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146122428|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
146122429|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
146122430|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
146122431|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146122432|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
146122433|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146122434|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146122435|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
146122436|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
146122437|NCT03742037|526967163|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122438|NCT03742037|526967164|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122439|NCT03742037|526967165|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
146122440|NCT03742037|526967166|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122441|NCT03742037|526967167|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122442|NCT03742037|526967168|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122443|NCT03742037|526967169|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
146122444|NCT04447755|526967170|FG000|Overall Study|Death|9|||
146122445|NCT04447755|526967171|FG001|Overall Study|Death|16|||
146122446|NCT04447755|526967172|FG002|Overall Study|Death|8|||
146122447|NCT04447755|526967173|FG003|Overall Study|Death|9|||
146122448|NCT04447755|526967174|FG004|Overall Study|Death|8|||
146122449|NCT04447755|526967175|FG005|Overall Study|Death|9|||
146122450|NCT04447755|526967176|FG006|Overall Study|Death|55|||
146122451|NCT04447755|526967170|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146262204|NCT01568112|527474441|FG002|Overall Study|Withdrawal by Physician|1|||
146122452|NCT04447755|526967171|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146122453|NCT04447755|526967172|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145941892|NCT04814368|526295328|FG001|Overall Study|Study Terminated by Sponsor|3|||
145941893|NCT04814368|526295329|FG002|Overall Study|Study Terminated by Sponsor|0|||
145941894|NCT04814368|526295330|FG003|Overall Study|Study Terminated by Sponsor|2|||
145941895|NCT04814368|526295327|FG000|Overall Study|Subject Decision|1|||
145941896|NCT04814368|526295328|FG001|Overall Study|Subject Decision|2|||
145941897|NCT04814368|526295329|FG002|Overall Study|Subject Decision|0|||
145941898|NCT04814368|526295330|FG003|Overall Study|Subject Decision|0|||
145941899|NCT04823130|526296890|FG000|Overall Study|Withdrawal by Subject|2|||
145941900|NCT04823130|526296891|FG001|Overall Study|Withdrawal by Subject|3|||
145941901|NCT04823130|526296890|FG000|Overall Study|Failure to meet inclusion criteria|6|||
145941902|NCT04823130|526296891|FG001|Overall Study|Failure to meet inclusion criteria|4|||
145941903|NCT04823130|526296890|FG000|Overall Study|Other-unspecified|1|||
145941904|NCT04823130|526296891|FG001|Overall Study|Other-unspecified|0|||
145941905|NCT03315455|526296892|FG000|Overall Study|Ongoing in the Study|13|||
145941906|NCT03315455|526296893|FG001|Overall Study|Ongoing in the Study|24|||
145941907|NCT03315455|526296894|FG002|Overall Study|Ongoing in the Study|17|||
145941908|NCT03315455|526296895|FG003|Overall Study|Ongoing in the Study|15|||
145941909|NCT03315455|526296892|FG000|Overall Study|Withdrawal by Subject|0|||
145941910|NCT03315455|526296893|FG001|Overall Study|Withdrawal by Subject|1|||
145941911|NCT03315455|526296894|FG002|Overall Study|Withdrawal by Subject|0|||
145941912|NCT03315455|526296895|FG003|Overall Study|Withdrawal by Subject|0|||
145941913|NCT04439357|526296896|FG000|Overall Study|Disease Progression|4|||
145941914|NCT01458951|526296899|FG000|Overall Study|Other|1|||
145941915|NCT01458951|526296900|FG001|Overall Study|Other|0|||
145941916|NCT01458951|526296901|FG002|Overall Study|Other|0|||
145941917|NCT01458951|526296899|FG000|Overall Study|Protocol Violation|5|||
145941918|NCT01458951|526296900|FG001|Overall Study|Protocol Violation|1|||
145941919|NCT01458951|526296901|FG002|Overall Study|Protocol Violation|0|||
145941920|NCT01458951|526296899|FG000|Overall Study|Withdrawal by Subject|2|||
145941921|NCT01458951|526296900|FG001|Overall Study|Withdrawal by Subject|0|||
145941922|NCT01458951|526296901|FG002|Overall Study|Withdrawal by Subject|2|||
145941923|NCT01458951|526296899|FG000|Overall Study|Adverse Event|7|||
145941924|NCT01458951|526296900|FG001|Overall Study|Adverse Event|0|||
145941925|NCT01458951|526296901|FG002|Overall Study|Adverse Event|2|||
146122454|NCT04447755|526967173|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146122455|NCT04447755|526967174|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146122456|NCT04447755|526967175|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146122457|NCT04447755|526967176|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
146122458|NCT04447755|526967170|FG000|Overall Study|Sponsor Decision|0|||
146122459|NCT04447755|526967171|FG001|Overall Study|Sponsor Decision|0|||
146122460|NCT04447755|526967172|FG002|Overall Study|Sponsor Decision|0|||
146122461|NCT04447755|526967173|FG003|Overall Study|Sponsor Decision|0|||
146122462|NCT04447755|526967174|FG004|Overall Study|Sponsor Decision|1|||
146122463|NCT04447755|526967175|FG005|Overall Study|Sponsor Decision|0|||
146262205|NCT01568112|527474442|FG003|Overall Study|Withdrawal by Physician|1|||
145941926|NCT01458951|526296899|FG000|Overall Study|Insufficient Clinical Response|17|||
145941927|NCT01458951|526296900|FG001|Overall Study|Insufficient Clinical Response|0|||
145941928|NCT01458951|526296901|FG002|Overall Study|Insufficient Clinical Response|11|||
145941929|NCT03117881|526296910|FG000|Baseline|Withdrawal by Subject|21|||
145941930|NCT03117881|526296911|FG001|Baseline|Withdrawal by Subject|10|||
145941931|NCT03117881|526296912|FG002|Baseline|Withdrawal by Subject|0|||
145941932|NCT03117881|526296910|FG000|Baseline|Lost to Follow-up|22|||
145941933|NCT03117881|526296911|FG001|Baseline|Lost to Follow-up|25|||
145941934|NCT03117881|526296912|FG002|Baseline|Lost to Follow-up|0|||
145941935|NCT03117881|526296910|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
145941936|NCT03117881|526296911|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
146262206|NCT02388347|527476353|FG000|Overall Study|Withdrawal by Subject|0|||
146262207|NCT02388347|527476354|FG001|Overall Study|Withdrawal by Subject|0|||
146262208|NCT02388347|527476355|FG002|Overall Study|Withdrawal by Subject|1|||
146262209|NCT02388347|527476356|FG003|Overall Study|Withdrawal by Subject|0|||
145941937|NCT03117881|526296912|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
145941938|NCT03117881|526296910|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
145941939|NCT03117881|526296911|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
145941940|NCT03117881|526296912|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
145941941|NCT03117881|526296910|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
145941942|NCT03117881|526296911|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
146262210|NCT02388347|527476357|FG004|Overall Study|Withdrawal by Subject|0|||
146262211|NCT00497874|527476358|FG000|Overall Study|Withdrawal by Subject|48|||
145941943|NCT03117881|526296912|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
145941944|NCT03117881|526296910|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
145941945|NCT03117881|526296911|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
145941946|NCT03117881|526296912|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
145941947|NCT03117881|526296910|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
145941948|NCT03117881|526296911|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
145941949|NCT03117881|526296912|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
145941950|NCT03117881|526296910|FG000|6-Month Follow-Up|Did not complete test|53|||
145941951|NCT03117881|526296911|FG001|6-Month Follow-Up|Did not complete test|25|||
145941952|NCT03117881|526296912|FG002|6-Month Follow-Up|Did not complete test|7|||
145941953|NCT03117881|526296910|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
145941954|NCT03117881|526296911|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
145941955|NCT03117881|526296912|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
145941956|NCT03117881|526296910|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
145941957|NCT03117881|526296911|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
145941958|NCT03117881|526296912|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
145941959|NCT03117881|526296910|FG000|12-Month Follow-Up|Did not complete test|40|||
145941960|NCT03117881|526296911|FG001|12-Month Follow-Up|Did not complete test|0|||
145941961|NCT03117881|526296912|FG002|12-Month Follow-Up|Did not complete test|0|||
145941962|NCT00308750|526296915|FG000|Overall Study|Adverse Event|9|||
145941963|NCT00308750|526296916|FG001|Overall Study|Adverse Event|9|||
145941964|NCT00308750|526296917|FG002|Overall Study|Adverse Event|13|||
145941965|NCT00308750|526296915|FG000|Overall Study|Withdrawal by Subject|6|||
145941966|NCT00308750|526296916|FG001|Overall Study|Withdrawal by Subject|2|||
145941967|NCT00308750|526296917|FG002|Overall Study|Withdrawal by Subject|3|||
145941968|NCT00308750|526296915|FG000|Overall Study|Physician Decision|3|||
145941969|NCT00308750|526296916|FG001|Overall Study|Physician Decision|4|||
145941970|NCT00308750|526296917|FG002|Overall Study|Physician Decision|3|||
145941971|NCT00308750|526296915|FG000|Overall Study|Sponsor Decision|1|||
145941972|NCT00308750|526296916|FG001|Overall Study|Sponsor Decision|0|||
145941973|NCT00308750|526296917|FG002|Overall Study|Sponsor Decision|0|||
145941974|NCT00308750|526296915|FG000|Overall Study|Disease Progression|47|||
145941975|NCT00308750|526296916|FG001|Overall Study|Disease Progression|24|||
145941976|NCT00308750|526296917|FG002|Overall Study|Disease Progression|28|||
145941977|NCT00308750|526296915|FG000|Overall Study|Unrelated Complication|3|||
145941978|NCT00308750|526296916|FG001|Overall Study|Unrelated Complication|0|||
145941979|NCT00308750|526296917|FG002|Overall Study|Unrelated Complication|1|||
145941980|NCT00308750|526296915|FG000|Overall Study|Death|1|||
145941981|NCT00308750|526296916|FG001|Overall Study|Death|0|||
145941982|NCT00308750|526296917|FG002|Overall Study|Death|1|||
145941983|NCT00308750|526296915|FG000|Overall Study|Protocol Violation|1|||
145941984|NCT00308750|526296916|FG001|Overall Study|Protocol Violation|0|||
145941985|NCT00308750|526296917|FG002|Overall Study|Protocol Violation|0|||
145941986|NCT00308750|526296915|FG000|Overall Study|New Primary Disease Identified|1|||
145941987|NCT00308750|526296916|FG001|Overall Study|New Primary Disease Identified|1|||
145941988|NCT00308750|526296917|FG002|Overall Study|New Primary Disease Identified|0|||
145941989|NCT03605849|526296918|FG000|Overall Study|Adverse Event|20|||
145941990|NCT03605849|526296919|FG001|Overall Study|Adverse Event|21|||
145941991|NCT03605849|526296920|FG002|Overall Study|Adverse Event|29|||
145941992|NCT03605849|526296921|FG003|Overall Study|Adverse Event|11|||
145941993|NCT03605849|526296918|FG000|Overall Study|Lack of Efficacy|4|||
145941994|NCT03605849|526296919|FG001|Overall Study|Lack of Efficacy|7|||
145941995|NCT03605849|526296920|FG002|Overall Study|Lack of Efficacy|9|||
145941996|NCT03605849|526296921|FG003|Overall Study|Lack of Efficacy|2|||
145941997|NCT03605849|526296918|FG000|Overall Study|Lost to Follow-up|8|||
145941998|NCT03605849|526296919|FG001|Overall Study|Lost to Follow-up|8|||
145941999|NCT03605849|526296920|FG002|Overall Study|Lost to Follow-up|14|||
145942000|NCT03605849|526296921|FG003|Overall Study|Lost to Follow-up|11|||
145942001|NCT03605849|526296918|FG000|Overall Study|Non-compliance With IMP|6|||
145942002|NCT03605849|526296919|FG001|Overall Study|Non-compliance With IMP|5|||
145942003|NCT03605849|526296920|FG002|Overall Study|Non-compliance With IMP|2|||
145942004|NCT03605849|526296921|FG003|Overall Study|Non-compliance With IMP|1|||
145942005|NCT03605849|526296918|FG000|Overall Study|Protocol Deviation|1|||
146303130|NCT01994382|527624074|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
146303131|NCT01994382|527624075|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
146303132|NCT01994382|527624076|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
145942006|NCT03605849|526296919|FG001|Overall Study|Protocol Deviation|2|||
146303133|NCT01994382|527624060|FG000|Overall Study|Protocol violation/noncompliance|0|||
146303134|NCT01994382|527624061|FG001|Overall Study|Protocol violation/noncompliance|0|||
146303135|NCT01994382|527624062|FG002|Overall Study|Protocol violation/noncompliance|0|||
145942007|NCT03605849|526296920|FG002|Overall Study|Protocol Deviation|1|||
145942008|NCT03605849|526296921|FG003|Overall Study|Protocol Deviation|3|||
145942009|NCT03605849|526296918|FG000|Overall Study|Withdrawal by Subject|33|||
145942010|NCT03605849|526296919|FG001|Overall Study|Withdrawal by Subject|28|||
145942011|NCT03605849|526296920|FG002|Overall Study|Withdrawal by Subject|30|||
145942012|NCT03605849|526296921|FG003|Overall Study|Withdrawal by Subject|28|||
145942013|NCT03605849|526296918|FG000|Overall Study|Site Terminated by Sponsor|0|||
145942014|NCT03605849|526296919|FG001|Overall Study|Site Terminated by Sponsor|0|||
145942015|NCT03605849|526296920|FG002|Overall Study|Site Terminated by Sponsor|0|||
145942016|NCT03605849|526296921|FG003|Overall Study|Site Terminated by Sponsor|1|||
145942017|NCT03605849|526296918|FG000|Overall Study|Physician Decision|2|||
145942018|NCT03605849|526296919|FG001|Overall Study|Physician Decision|1|||
145942019|NCT03605849|526296920|FG002|Overall Study|Physician Decision|2|||
145942020|NCT03605849|526296921|FG003|Overall Study|Physician Decision|1|||
145942021|NCT03605849|526296918|FG000|Overall Study|Enrolled, but not Treated|2|||
145942022|NCT03605849|526296919|FG001|Overall Study|Enrolled, but not Treated|2|||
145942023|NCT03605849|526296920|FG002|Overall Study|Enrolled, but not Treated|3|||
145942024|NCT03605849|526296921|FG003|Overall Study|Enrolled, but not Treated|2|||
145942025|NCT03605849|526296918|FG000|Overall Study|Other (COVID-19 Related)|0|||
145942026|NCT03605849|526296919|FG001|Overall Study|Other (COVID-19 Related)|1|||
145942027|NCT03605849|526296920|FG002|Overall Study|Other (COVID-19 Related)|1|||
145942028|NCT03605849|526296921|FG003|Overall Study|Other (COVID-19 Related)|0|||
145942029|NCT03605849|526296918|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
145942030|NCT03605849|526296919|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
145942031|NCT03605849|526296920|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
145942032|NCT03605849|526296921|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
145942033|NCT02304380|526296922|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145942034|NCT02304380|526296923|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145942035|NCT02304380|526296924|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145942036|NCT02304380|526296925|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
145942037|NCT02304380|526296926|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145942038|NCT02304380|526296927|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145942039|NCT00985426|526296928|FG000|Overall Study|Adverse Event|0|||
145942040|NCT00985426|526296929|FG001|Overall Study|Adverse Event|1|||
145942041|NCT00985426|526296928|FG000|Overall Study|Subject Non-Compliance|3|||
145942042|NCT00985426|526296929|FG001|Overall Study|Subject Non-Compliance|3|||
145942043|NCT00985426|526296928|FG000|Overall Study|Withdrawal by Subject|12|||
145942044|NCT00985426|526296929|FG001|Overall Study|Withdrawal by Subject|16|||
145942045|NCT00985426|526296928|FG000|Overall Study|Lost to Follow-up|8|||
145942046|NCT00985426|526296929|FG001|Overall Study|Lost to Follow-up|10|||
145942047|NCT00985426|526296928|FG000|Overall Study|Death|7|||
145942048|NCT00985426|526296929|FG001|Overall Study|Death|3|||
145942049|NCT00985426|526296928|FG000|Overall Study|Protocol Violation|2|||
145942050|NCT00985426|526296929|FG001|Overall Study|Protocol Violation|0|||
145942051|NCT00985426|526296928|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
145942052|NCT00985426|526296929|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
145942053|NCT02052596|526296930|FG000|Active Phase|Adverse Event|3|||
145942054|NCT02052596|526296931|FG001|Active Phase|Adverse Event|2|||
145942055|NCT02052596|526296930|FG000|Active Phase|Lost to Follow-up|8|||
145942056|NCT02052596|526296931|FG001|Active Phase|Lost to Follow-up|11|||
145942057|NCT02052596|526296930|FG000|Active Phase|Protocol Violation|1|||
145942058|NCT02052596|526296931|FG001|Active Phase|Protocol Violation|2|||
145942059|NCT02052596|526296930|FG000|Active Phase|Withdrawal by Subject|3|||
145942060|NCT02052596|526296931|FG001|Active Phase|Withdrawal by Subject|4|||
145942061|NCT02052596|526296930|FG000|Active Phase|Enrolled in error|1|||
145942062|NCT02052596|526296931|FG001|Active Phase|Enrolled in error|0|||
145942063|NCT02052596|526296930|FG000|Active Phase|Lost due to Crohn's disease|0|||
145942064|NCT02052596|526296931|FG001|Active Phase|Lost due to Crohn's disease|1|||
145942065|NCT02052596|526296930|FG000|Safety Phase|Adverse Event|6|||
145942066|NCT02052596|526296931|FG001|Safety Phase|Adverse Event|3|||
145942067|NCT02052596|526296930|FG000|Safety Phase|Lost to Follow-up|11|||
145942068|NCT02052596|526296931|FG001|Safety Phase|Lost to Follow-up|18|||
145942069|NCT02052596|526296930|FG000|Safety Phase|Protocol Violation|1|||
145942070|NCT02052596|526296931|FG001|Safety Phase|Protocol Violation|2|||
145942071|NCT02052596|526296930|FG000|Safety Phase|Withdrawal by Subject|8|||
145942072|NCT02052596|526296931|FG001|Safety Phase|Withdrawal by Subject|11|||
145942073|NCT02052596|526296930|FG000|Safety Phase|Enrolled in error|1|||
145942074|NCT02052596|526296931|FG001|Safety Phase|Enrolled in error|0|||
145942075|NCT02052596|526296930|FG000|Safety Phase|Lost due to Crohn's disease|0|||
145942076|NCT02052596|526296931|FG001|Safety Phase|Lost due to Crohn's disease|1|||
145942077|NCT00558896|526296932|FG000|Overall Study|Adverse Event|1|||
145942078|NCT00558896|526296933|FG001|Overall Study|Adverse Event|1|||
145942079|NCT00558896|526296934|FG002|Overall Study|Adverse Event|1|||
145942080|NCT00558896|526296935|FG003|Overall Study|Adverse Event|3|||
145942081|NCT00558896|526296936|FG004|Overall Study|Adverse Event|4|||
145942082|NCT00558896|526296937|FG005|Overall Study|Adverse Event|10|||
145942083|NCT00558896|526296938|FG006|Overall Study|Adverse Event|3|||
145942084|NCT00558896|526296932|FG000|Overall Study|Death|3|||
145942085|NCT00558896|526296933|FG001|Overall Study|Death|0|||
145942086|NCT00558896|526296934|FG002|Overall Study|Death|2|||
145942087|NCT00558896|526296935|FG003|Overall Study|Death|3|||
145942088|NCT00558896|526296936|FG004|Overall Study|Death|2|||
145942089|NCT00558896|526296937|FG005|Overall Study|Death|2|||
145942090|NCT00558896|526296938|FG006|Overall Study|Death|6|||
145942091|NCT00558896|526296932|FG000|Overall Study|Withdrawal by Subject|2|||
145942092|NCT00558896|526296933|FG001|Overall Study|Withdrawal by Subject|1|||
145942093|NCT00558896|526296934|FG002|Overall Study|Withdrawal by Subject|1|||
145942094|NCT00558896|526296935|FG003|Overall Study|Withdrawal by Subject|1|||
145942095|NCT00558896|526296936|FG004|Overall Study|Withdrawal by Subject|1|||
145942096|NCT00558896|526296937|FG005|Overall Study|Withdrawal by Subject|5|||
145942097|NCT00558896|526296938|FG006|Overall Study|Withdrawal by Subject|5|||
145942098|NCT00558896|526296932|FG000|Overall Study|Alternative Treatment|2|||
145942099|NCT00558896|526296933|FG001|Overall Study|Alternative Treatment|2|||
145942100|NCT00558896|526296934|FG002|Overall Study|Alternative Treatment|0|||
145942101|NCT00558896|526296935|FG003|Overall Study|Alternative Treatment|2|||
145942102|NCT00558896|526296936|FG004|Overall Study|Alternative Treatment|6|||
145942103|NCT00558896|526296937|FG005|Overall Study|Alternative Treatment|7|||
145942104|NCT00558896|526296938|FG006|Overall Study|Alternative Treatment|1|||
145942105|NCT00558896|526296932|FG000|Overall Study|Physician discretion|3|||
145942106|NCT00558896|526296933|FG001|Overall Study|Physician discretion|2|||
145942107|NCT00558896|526296934|FG002|Overall Study|Physician discretion|1|||
145942108|NCT00558896|526296935|FG003|Overall Study|Physician discretion|2|||
145942109|NCT00558896|526296936|FG004|Overall Study|Physician discretion|1|||
145942110|NCT00558896|526296937|FG005|Overall Study|Physician discretion|3|||
145942111|NCT00558896|526296938|FG006|Overall Study|Physician discretion|3|||
145942112|NCT00558896|526296932|FG000|Overall Study|Continues on treatment|10|||
145942113|NCT00558896|526296933|FG001|Overall Study|Continues on treatment|1|||
145942114|NCT00558896|526296934|FG002|Overall Study|Continues on treatment|0|||
145942115|NCT00558896|526296935|FG003|Overall Study|Continues on treatment|1|||
145942116|NCT00558896|526296936|FG004|Overall Study|Continues on treatment|9|||
145942117|NCT00558896|526296937|FG005|Overall Study|Continues on treatment|25|||
146122464|NCT04447755|526967176|FG006|Overall Study|Sponsor Decision|10|||
146122465|NCT04447755|526967170|FG000|Overall Study|Lost to Follow-up|0|||
146122466|NCT04447755|526967171|FG001|Overall Study|Lost to Follow-up|0|||
146122467|NCT04447755|526967172|FG002|Overall Study|Lost to Follow-up|0|||
146122468|NCT04447755|526967173|FG003|Overall Study|Lost to Follow-up|0|||
146122469|NCT04447755|526967174|FG004|Overall Study|Lost to Follow-up|0|||
145942118|NCT00558896|526296938|FG006|Overall Study|Continues on treatment|6|||
145942119|NCT00250458|526296942|FG000|Overall Study|Lost to Follow-up|4|||
145942120|NCT00250458|526296943|FG001|Overall Study|Lost to Follow-up|2|||
145942121|NCT00250458|526296942|FG000|Overall Study|Protocol Violation|0|||
145942122|NCT00250458|526296943|FG001|Overall Study|Protocol Violation|1|||
145942123|NCT00250458|526296942|FG000|Overall Study|Withdrawal by Subject|4|||
145942124|NCT00250458|526296943|FG001|Overall Study|Withdrawal by Subject|2|||
145942125|NCT00250458|526296942|FG000|Overall Study|Lack of Migraine Attack|20|||
145942126|NCT00250458|526296943|FG001|Overall Study|Lack of Migraine Attack|9|||
145942127|NCT00250458|526296942|FG000|Overall Study|Qualifying migraine but did not treat|3|||
145942128|NCT00250458|526296943|FG001|Overall Study|Qualifying migraine but did not treat|3|||
145942129|NCT00250458|526296942|FG000|Overall Study|Other|1|||
145942130|NCT00250458|526296943|FG001|Overall Study|Other|0|||
145942131|NCT00723190|526296947|FG000|Overall Study|Withdrawal by Subject|45|||
145942132|NCT00723190|526296947|FG000|Overall Study|Lost to Follow-up|37|||
145942133|NCT00723190|526296947|FG000|Overall Study|Adverse Event|18|||
145942134|NCT00723190|526296947|FG000|Overall Study|Lack of Efficacy|16|||
145942135|NCT00723190|526296947|FG000|Overall Study|Protocol Violation|15|||
145942136|NCT00723190|526296947|FG000|Overall Study|Other-Premature Discontinuation|9|||
145942137|NCT00723190|526296947|FG000|Overall Study|Other-Not included in safety population|2|||
145942138|NCT00454818|526296948|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
145942139|NCT00454818|526296949|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145942140|NCT00454818|526296950|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145942141|NCT00454818|526296951|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145942142|NCT00454818|526296952|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145942143|NCT00454818|526296948|FG000|Phase I: Open-label Dose-escalation|Death|0|||
145942144|NCT00454818|526296949|FG001|Phase I: Open-label Dose-escalation|Death|1|||
145942145|NCT00454818|526296950|FG002|Phase I: Open-label Dose-escalation|Death|0|||
145942146|NCT00454818|526296951|FG003|Phase I: Open-label Dose-escalation|Death|0|||
145942147|NCT00454818|526296952|FG004|Phase I: Open-label Dose-escalation|Death|0|||
145942148|NCT00454818|526296948|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145942149|NCT00454818|526296949|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145942150|NCT00454818|526296950|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
146262212|NCT00497874|527476359|FG001|Overall Study|Withdrawal by Subject|17|||
145942151|NCT00454818|526296951|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
145942152|NCT00454818|526296952|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145942153|NCT00454818|526296948|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145942154|NCT00454818|526296949|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
146262213|NCT00497874|527476358|FG000|Overall Study|Illness|8|||
146262214|NCT00497874|527476359|FG001|Overall Study|Illness|4|||
145942155|NCT00454818|526296950|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145942156|NCT00454818|526296951|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
146122470|NCT04447755|526967175|FG005|Overall Study|Lost to Follow-up|0|||
146262215|NCT00497874|527476358|FG000|Overall Study|Death|2|||
145942157|NCT00454818|526296952|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145942158|NCT00454818|526296948|FG000|Phase 2: Randomized Double-blind|Death|0|||
145942159|NCT00454818|526296949|FG001|Phase 2: Randomized Double-blind|Death|1|||
145942160|NCT00454818|526296950|FG002|Phase 2: Randomized Double-blind|Death|0|||
145942161|NCT00454818|526296951|FG003|Phase 2: Randomized Double-blind|Death|0|||
145942162|NCT00454818|526296952|FG004|Phase 2: Randomized Double-blind|Death|1|||
145942163|NCT00454818|526296948|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145942164|NCT00454818|526296949|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145942165|NCT00454818|526296950|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
145942166|NCT00454818|526296951|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145942167|NCT00454818|526296952|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
145942168|NCT00454818|526296948|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145942169|NCT00454818|526296949|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145942170|NCT00454818|526296950|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
145942171|NCT00454818|526296951|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145942172|NCT00454818|526296952|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
145942173|NCT03448939|526296953|FG000|Overall Study|Adverse Event|5|||
145942174|NCT03448939|526296954|FG001|Overall Study|Adverse Event|1|||
145942175|NCT03448939|526296953|FG000|Overall Study|Lost to Follow-up|6|||
145942176|NCT03448939|526296954|FG001|Overall Study|Lost to Follow-up|6|||
145942177|NCT03448939|526296953|FG000|Overall Study|Pregnancy|1|||
145942178|NCT03448939|526296954|FG001|Overall Study|Pregnancy|1|||
145942179|NCT03448939|526296953|FG000|Overall Study|Withdrawal by Subject|9|||
145942180|NCT03448939|526296954|FG001|Overall Study|Withdrawal by Subject|3|||
145942181|NCT03488225|526296955|FG000|Overall Study|Off Protocol Therapy|2|||
145942182|NCT03488225|526296955|FG000|Overall Study|Stem Cell Transplant|2|||
145942183|NCT01472965|526296958|FG000|Overall Study|Withdrawal by Subject|1|||
145942184|NCT01472965|526296959|FG001|Overall Study|Withdrawal by Subject|0|||
145942185|NCT04631107|526296962|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
145942186|NCT04631107|526296962|FG000|Second Intervention (1 Night)|Adverse Event|1|||
145942187|NCT04631107|526296962|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
145942188|NCT04631107|526296962|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
145942189|NCT00096993|526296967|FG000|Overall Study|Death|1|||
145942190|NCT00096993|526296968|FG001|Overall Study|Death|0|||
145942191|NCT00096993|526296967|FG000|Overall Study|Disease progression|56|||
145942192|NCT00096993|526296968|FG001|Overall Study|Disease progression|53|||
145942193|NCT00096993|526296967|FG000|Overall Study|Adverse Event|2|||
145942194|NCT00096993|526296968|FG001|Overall Study|Adverse Event|8|||
145942195|NCT00096993|526296967|FG000|Overall Study|Subject's decision|3|||
145942196|NCT00096993|526296968|FG001|Overall Study|Subject's decision|1|||
145942197|NCT00096993|526296967|FG000|Overall Study|Physician Decision|2|||
145942198|NCT00096993|526296968|FG001|Overall Study|Physician Decision|1|||
145942199|NCT00096993|526296967|FG000|Overall Study|Non-compliance|0|||
145942200|NCT00096993|526296968|FG001|Overall Study|Non-compliance|1|||
145942201|NCT00096993|526296967|FG000|Overall Study|Other unspecified|1|||
145942202|NCT00096993|526296968|FG001|Overall Study|Other unspecified|1|||
145942203|NCT05020899|526296971|FG000|8 Week Follow-up|Lost to Follow-up|3|||
145942204|NCT05020899|526296972|FG001|8 Week Follow-up|Lost to Follow-up|6|||
145942205|NCT05020899|526296971|FG000|12 Week Follow-up|Lost to Follow-up|1|||
145942206|NCT05020899|526296972|FG001|12 Week Follow-up|Lost to Follow-up|0|||
145942207|NCT05020899|526296971|FG000|12 Week Follow-up|Death|0|||
145942208|NCT05020899|526296972|FG001|12 Week Follow-up|Death|1|||
145942209|NCT01068626|526296975|FG000|Overall Study|Adverse Event|3|||
145942210|NCT01068626|526296976|FG001|Overall Study|Adverse Event|0|||
145942211|NCT01068626|526296975|FG000|Overall Study|Withdrawal by Subject|0|||
145942212|NCT01068626|526296976|FG001|Overall Study|Withdrawal by Subject|2|||
145942213|NCT00808639|526296978|FG000|Overall Study|Disease progression before surgery.|1|||
145942214|NCT00191282|526296981|FG000|Overall Study|Adverse Event|5|||
145942215|NCT00191282|526296982|FG001|Overall Study|Adverse Event|6|||
145942216|NCT00191282|526296981|FG000|Overall Study|Death|51|||
145942217|NCT00191282|526296982|FG001|Overall Study|Death|51|||
145942218|NCT00191282|526296981|FG000|Overall Study|Lack of Efficacy|11|||
145942219|NCT00191282|526296982|FG001|Overall Study|Lack of Efficacy|6|||
145942220|NCT00191282|526296981|FG000|Overall Study|Noncompliance|14|||
145942221|NCT00191282|526296982|FG001|Overall Study|Noncompliance|17|||
145942222|NCT00191282|526296981|FG000|Overall Study|Patient moved|11|||
145942223|NCT00191282|526296982|FG001|Overall Study|Patient moved|14|||
145942224|NCT00191282|526296981|FG000|Overall Study|Withdrawal by Subject|59|||
145942225|NCT00191282|526296982|FG001|Overall Study|Withdrawal by Subject|44|||
145942226|NCT00191282|526296981|FG000|Overall Study|Physician Decision|18|||
145942227|NCT00191282|526296982|FG001|Overall Study|Physician Decision|15|||
145942228|NCT00191282|526296981|FG000|Overall Study|Protocol entry criteria not met|14|||
145942229|NCT00191282|526296982|FG001|Overall Study|Protocol entry criteria not met|9|||
145942230|NCT00191282|526296981|FG000|Overall Study|Protocol Violation|9|||
145942231|NCT00191282|526296982|FG001|Overall Study|Protocol Violation|12|||
145942232|NCT00191282|526296981|FG000|Overall Study|Severity of outcome|2|||
145942233|NCT00191282|526296982|FG001|Overall Study|Severity of outcome|5|||
145942234|NCT00191282|526296981|FG000|Overall Study|Sponsor's decision|2|||
145942235|NCT00191282|526296982|FG001|Overall Study|Sponsor's decision|2|||
145942236|NCT00191282|526296981|FG000|Overall Study|Lost to Follow-up|24|||
145942237|NCT00191282|526296982|FG001|Overall Study|Lost to Follow-up|31|||
145942238|NCT04756154|526296983|FG000|Overall Study|Did not meet treatment day baseline|30|||
145942239|NCT04756154|526296984|FG001|Overall Study|Did not meet treatment day baseline|28|||
145942240|NCT04756154|526296985|FG002|Overall Study|Did not meet treatment day baseline|7|||
145942241|NCT04756154|526296983|FG000|Overall Study|Did not return for final sample collection|1|||
145942242|NCT04756154|526296984|FG001|Overall Study|Did not return for final sample collection|1|||
145942243|NCT04756154|526296985|FG002|Overall Study|Did not return for final sample collection|0|||
145942244|NCT03589976|526296986|FG000|Overall Study|Death|5|||
145942245|NCT03589976|526296987|FG001|Overall Study|Death|1|||
145942246|NCT03589976|526296986|FG000|Overall Study|Adverse Event|5|||
145942247|NCT03589976|526296987|FG001|Overall Study|Adverse Event|1|||
145942248|NCT03589976|526296986|FG000|Overall Study|Withdrawal by Subject|4|||
145942249|NCT03589976|526296987|FG001|Overall Study|Withdrawal by Subject|1|||
145942250|NCT03589976|526296986|FG000|Overall Study|Lost to Follow-up|1|||
145942251|NCT03589976|526296987|FG001|Overall Study|Lost to Follow-up|0|||
145942252|NCT03589976|526296986|FG000|Overall Study|Other|4|||
145942253|NCT03589976|526296987|FG001|Overall Study|Other|3|||
145942254|NCT02089334|526296988|FG000|Overall Study|Withdrawal by Subject|0|||
145942255|NCT02089334|526296989|FG001|Overall Study|Withdrawal by Subject|0|||
145942256|NCT02089334|526296990|FG002|Overall Study|Withdrawal by Subject|0|||
145942257|NCT02089334|526296991|FG003|Overall Study|Withdrawal by Subject|2|||
145942258|NCT02089334|526296988|FG000|Overall Study|Adverse Event|0|||
145942259|NCT02089334|526296989|FG001|Overall Study|Adverse Event|0|||
145942260|NCT02089334|526296990|FG002|Overall Study|Adverse Event|0|||
145942261|NCT02089334|526296991|FG003|Overall Study|Adverse Event|2|||
145942262|NCT02089334|526296988|FG000|Overall Study|Progressive disease|0|||
145942263|NCT02089334|526296989|FG001|Overall Study|Progressive disease|0|||
145942264|NCT02089334|526296990|FG002|Overall Study|Progressive disease|0|||
145942265|NCT02089334|526296991|FG003|Overall Study|Progressive disease|2|||
145942266|NCT02089334|526296988|FG000|Overall Study|Physician Decision|0|||
145942267|NCT02089334|526296989|FG001|Overall Study|Physician Decision|0|||
145942268|NCT02089334|526296990|FG002|Overall Study|Physician Decision|1|||
145942269|NCT02089334|526296991|FG003|Overall Study|Physician Decision|1|||
145942270|NCT00710684|526296994|FG000|Overall Study|Adverse Event|11|||
145942271|NCT00710684|526296995|FG001|Overall Study|Adverse Event|19|||
145942272|NCT00710684|526296996|FG002|Overall Study|Adverse Event|16|||
145942273|NCT00710684|526296994|FG000|Overall Study|Lack of Efficacy|4|||
145942274|NCT00710684|526296995|FG001|Overall Study|Lack of Efficacy|3|||
145942275|NCT00710684|526296996|FG002|Overall Study|Lack of Efficacy|5|||
145942276|NCT00710684|526296994|FG000|Overall Study|Protocol Violation|5|||
145942277|NCT00710684|526296995|FG001|Overall Study|Protocol Violation|5|||
145942278|NCT00710684|526296996|FG002|Overall Study|Protocol Violation|5|||
145942279|NCT00710684|526296994|FG000|Overall Study|Lost to Follow-up|4|||
145942280|NCT00710684|526296995|FG001|Overall Study|Lost to Follow-up|6|||
145942281|NCT00710684|526296996|FG002|Overall Study|Lost to Follow-up|7|||
145942282|NCT00710684|526296994|FG000|Overall Study|Physician Decision|0|||
145942283|NCT00710684|526296995|FG001|Overall Study|Physician Decision|2|||
145942284|NCT00710684|526296996|FG002|Overall Study|Physician Decision|4|||
145942285|NCT00710684|526296994|FG000|Overall Study|Withdrawal by Subject|24|||
145942286|NCT00710684|526296995|FG001|Overall Study|Withdrawal by Subject|18|||
145942287|NCT00710684|526296996|FG002|Overall Study|Withdrawal by Subject|11|||
145942288|NCT00710684|526296994|FG000|Overall Study|Missing|1|||
145942289|NCT00710684|526296995|FG001|Overall Study|Missing|0|||
145942290|NCT00710684|526296996|FG002|Overall Study|Missing|0|||
145942291|NCT00710684|526296994|FG000|Overall Study|Did not continue after week 24|25|||
145942292|NCT00710684|526296995|FG001|Overall Study|Did not continue after week 24|21|||
145942293|NCT00710684|526296996|FG002|Overall Study|Did not continue after week 24|16|||
145942294|NCT04778059|526296997|FG000|Overall Study|Death|2|||
145942295|NCT04778059|526296998|FG001|Overall Study|Death|2|||
145942296|NCT04778059|526296999|FG002|Overall Study|Death|1|||
145942297|NCT04778059|526297000|FG003|Overall Study|Death|1|||
145942298|NCT04778059|526297001|FG004|Overall Study|Death|1|||
145942299|NCT04778059|526296997|FG000|Overall Study|Lost to Follow-up|0|||
146303136|NCT01994382|527624063|FG003|Overall Study|Protocol violation/noncompliance|0|||
145942300|NCT04778059|526296998|FG001|Overall Study|Lost to Follow-up|0|||
145942301|NCT04778059|526296999|FG002|Overall Study|Lost to Follow-up|0|||
145942302|NCT04778059|526297000|FG003|Overall Study|Lost to Follow-up|0|||
145942303|NCT04778059|526297001|FG004|Overall Study|Lost to Follow-up|1|||
145942304|NCT04778059|526296997|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
145942305|NCT04778059|526296998|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
145942306|NCT04778059|526296999|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
145942307|NCT04778059|526297000|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
145942308|NCT04778059|526297001|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
145942309|NCT02832375|526297002|FG000|Overall Study|Lost to Follow-up|1|||
145942310|NCT02832375|526297003|FG001|Overall Study|Lost to Follow-up|0|||
145942311|NCT02832375|526297002|FG000|Overall Study|Withdrawal of Consent|1|||
145942312|NCT02832375|526297003|FG001|Overall Study|Withdrawal of Consent|0|||
145942313|NCT00514904|526297009|FG000|Overall Study|Withdrawal by Subject|3|||
145942314|NCT00514904|526297010|FG001|Overall Study|Withdrawal by Subject|2|||
145942315|NCT00514904|526297009|FG000|Overall Study|Lost to Follow-up|21|||
145942316|NCT00514904|526297010|FG001|Overall Study|Lost to Follow-up|3|||
145942317|NCT03430895|526297011|FG000|Overall Study|Not Treated|2|||
145942318|NCT03026530|526297017|FG000|Overall Study|Lost to Follow-up|19|||
145942319|NCT03026530|526297018|FG001|Overall Study|Lost to Follow-up|24|||
145942320|NCT03026530|526297017|FG000|Overall Study|Protocol Violation|2|||
145942321|NCT03026530|526297018|FG001|Overall Study|Protocol Violation|5|||
145942322|NCT03301740|526297019|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
145942323|NCT03301740|526297020|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
145942324|NCT03301740|526297019|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
145942325|NCT03301740|526297020|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
145942326|NCT04216589|526297021|FG000|Overall Study|Withdrawal by Subject|2|||
145942327|NCT04216589|526297021|FG000|Overall Study|Protocol Violation|1|||
145942328|NCT04216589|526297021|FG000|Overall Study|Incarceration|1|||
145942329|NCT03721835|526297023|FG000|Overall Study|Participant not able to return|1|||
145942330|NCT03721835|526297023|FG000|Overall Study|Lost to Follow-up|1|||
145942331|NCT03721835|526297023|FG000|Overall Study|Revision of the components of the study device|2|||
145942332|NCT03721835|526297023|FG000|Overall Study|Sponsor terminated study|6|||
145942333|NCT03721835|526297023|FG000|Overall Study|Death|1|||
145942334|NCT03721835|526297023|FG000|Overall Study|Sponsor decision|1|||
145942335|NCT01306045|526297028|FG000|Met General Eligibility Criteria|Screen failures|193|||
145942336|NCT01306045|526297029|FG001|Met General Eligibility Criteria|Screen failures|11|||
145942337|NCT01306045|526297030|FG002|Met General Eligibility Criteria|Screen failures|8|||
145942338|NCT03976323|526297039|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
145942339|NCT03976323|526297040|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145942340|NCT03976323|526297041|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145942341|NCT03976323|526297039|FG000|Induction Phase|Death|80|||
145942342|NCT03976323|526297040|FG001|Induction Phase|Death|0|||
145942343|NCT03976323|526297041|FG002|Induction Phase|Death|0|||
145942344|NCT03976323|526297039|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
145942345|NCT03976323|526297040|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
145942346|NCT03976323|526297041|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
145942347|NCT03976323|526297039|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145942348|NCT03976323|526297040|FG001|Maintenance Phase|Withdrawal by Subject|9|||
145942349|NCT03976323|526297041|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145942350|NCT03976323|526297039|FG000|Maintenance Phase|Physician Decision|0|||
145942351|NCT03976323|526297040|FG001|Maintenance Phase|Physician Decision|0|||
145942352|NCT03976323|526297041|FG002|Maintenance Phase|Physician Decision|1|||
145942353|NCT03976323|526297039|FG000|Maintenance Phase|Death|0|||
145942354|NCT03976323|526297040|FG001|Maintenance Phase|Death|228|||
145942355|NCT03976323|526297041|FG002|Maintenance Phase|Death|234|||
145942356|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
145942357|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
145942358|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
145942359|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
145942360|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
145942361|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
146262216|NCT00497874|527476359|FG001|Overall Study|Death|4|||
146262217|NCT00497874|527476358|FG000|Overall Study|Unable to contact|52|||
146262218|NCT00497874|527476359|FG001|Overall Study|Unable to contact|67|||
146262219|NCT00497874|527476358|FG000|Overall Study|Unable to schedule|37|||
146262220|NCT00497874|527476359|FG001|Overall Study|Unable to schedule|24|||
145942362|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
145942363|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
145942364|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
145942365|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
145942366|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
145942367|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
145942368|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
145942369|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
146262221|NCT02820597|527476360|FG000|Overall Study|Lost to Follow-up|12|||
145942370|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
145942371|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
145942372|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
146122471|NCT04447755|526967176|FG006|Overall Study|Lost to Follow-up|1|||
146262222|NCT01053247|527476361|FG000|Overall Study|Withdrawal by Subject|9|||
146262223|NCT01053247|527476362|FG001|Overall Study|Withdrawal by Subject|4|||
146303137|NCT01994382|527624064|FG004|Overall Study|Protocol violation/noncompliance|0|||
146303138|NCT01994382|527624065|FG005|Overall Study|Protocol violation/noncompliance|0|||
146303139|NCT01994382|527624066|FG006|Overall Study|Protocol violation/noncompliance|0|||
146303140|NCT01994382|527624067|FG007|Overall Study|Protocol violation/noncompliance|0|||
146303141|NCT01994382|527624068|FG008|Overall Study|Protocol violation/noncompliance|0|||
146303142|NCT01994382|527624069|FG009|Overall Study|Protocol violation/noncompliance|0|||
146303143|NCT01994382|527624070|FG010|Overall Study|Protocol violation/noncompliance|0|||
146303144|NCT01994382|527624071|FG011|Overall Study|Protocol violation/noncompliance|1|||
146303145|NCT01994382|527624072|FG012|Overall Study|Protocol violation/noncompliance|0|||
146303146|NCT01994382|527624073|FG013|Overall Study|Protocol violation/noncompliance|0|||
146303147|NCT01994382|527624074|FG014|Overall Study|Protocol violation/noncompliance|0|||
146303148|NCT01994382|527624075|FG015|Overall Study|Protocol violation/noncompliance|0|||
145942373|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
146262224|NCT01053247|527476363|FG002|Overall Study|Withdrawal by Subject|15|||
146262225|NCT01053247|527476361|FG000|Overall Study|Lack of Efficacy|1|||
146262226|NCT01053247|527476362|FG001|Overall Study|Lack of Efficacy|0|||
146262227|NCT01053247|527476363|FG002|Overall Study|Lack of Efficacy|1|||
146262228|NCT01053247|527476361|FG000|Overall Study|Protocol Violation|2|||
146262229|NCT01053247|527476362|FG001|Overall Study|Protocol Violation|1|||
146262230|NCT01053247|527476363|FG002|Overall Study|Protocol Violation|2|||
146262231|NCT01053247|527476361|FG000|Overall Study|Lost to Follow-up|8|||
146262232|NCT01053247|527476362|FG001|Overall Study|Lost to Follow-up|5|||
146262233|NCT01053247|527476363|FG002|Overall Study|Lost to Follow-up|7|||
146262234|NCT01053247|527476361|FG000|Overall Study|Adverse Event|0|||
146262235|NCT01053247|527476362|FG001|Overall Study|Adverse Event|9|||
146262236|NCT01053247|527476363|FG002|Overall Study|Adverse Event|3|||
146262237|NCT03898700|527476366|FG000|Overall Study|Withdrawal by Subject|2|||
146262238|NCT00701909|527476367|FG000|Overall Study|Withdrawal by Subject|0|||
146262239|NCT00701909|527476368|FG001|Overall Study|Withdrawal by Subject|1|||
146262240|NCT00971997|527476369|FG000|Overall Study|Adverse Event|2|||
146262241|NCT00971997|527476369|FG000|Overall Study|Death|1|||
146262242|NCT00971997|527476369|FG000|Overall Study|Protocol Violation|4|||
146262243|NCT00971997|527476369|FG000|Overall Study|Withdrawal by Subject|5|||
146262244|NCT00971997|527476369|FG000|Overall Study|Physician Decision|7|||
146262245|NCT04009629|527476370|FG000|Overall Study|Withdrawal by Subject|2|||
146262246|NCT04009629|527476371|FG001|Overall Study|Withdrawal by Subject|0|||
146262247|NCT00761956|527476372|FG000|Overall Study|Lost to Follow-up|6|||
146262248|NCT00761956|527476373|FG001|Overall Study|Lost to Follow-up|11|||
146262249|NCT00761956|527476372|FG000|Overall Study|Withdrawal by Subject|3|||
146262250|NCT00761956|527476373|FG001|Overall Study|Withdrawal by Subject|8|||
146262251|NCT00761956|527476372|FG000|Overall Study|Death|0|||
146262252|NCT00761956|527476373|FG001|Overall Study|Death|1|||
146262253|NCT00761956|527476372|FG000|Overall Study|Adverse Event|26|||
146262254|NCT00761956|527476373|FG001|Overall Study|Adverse Event|34|||
146262255|NCT04398368|527476379|FG000|Overall Study|Withdrawal by Subject|2|||
146262256|NCT02808975|527476380|FG000|Overall Study|Adverse Event|3|||
146303149|NCT01994382|527624076|FG016|Overall Study|Protocol violation/noncompliance|2|||
146303150|NCT01994382|527624060|FG000|Overall Study|Rolled over to Phase 2a|0|||
146303151|NCT01994382|527624061|FG001|Overall Study|Rolled over to Phase 2a|0|||
145942374|NCT02294461|526297042|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
145942375|NCT02294461|526297043|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
145942376|NCT02294461|526297044|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
145942377|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
145942378|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
145942379|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
145942380|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
145942381|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
145942382|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
145942383|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
145942384|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
145942385|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
145942386|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
145942387|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
146262257|NCT02808975|527476381|FG001|Overall Study|Adverse Event|4|||
146262258|NCT02808975|527476380|FG000|Overall Study|Withdrew consent|9|||
146303152|NCT01994382|527624062|FG002|Overall Study|Rolled over to Phase 2a|1|||
146262259|NCT02808975|527476381|FG001|Overall Study|Withdrew consent|8|||
146262260|NCT02808975|527476380|FG000|Overall Study|Lost to Follow-up|4|||
146262261|NCT02808975|527476381|FG001|Overall Study|Lost to Follow-up|6|||
146303153|NCT01994382|527624063|FG003|Overall Study|Rolled over to Phase 2a|0|||
146262262|NCT02808975|527476380|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
146262263|NCT02808975|527476381|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
146262264|NCT02808975|527476380|FG000|Overall Study|Other, not specified|5|||
146303154|NCT01994382|527624064|FG004|Overall Study|Rolled over to Phase 2a|0|||
145942388|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
145942389|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
145942390|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
145942391|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
145942392|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
145942393|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
145942394|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
145942395|NCT02294461|526297042|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
145942396|NCT02294461|526297043|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
145942397|NCT02294461|526297044|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
145942398|NCT04676412|526298271|FG000|Overall Study|Death|28|||
145942399|NCT04676412|526298272|FG001|Overall Study|Death|31|||
145942400|NCT04676412|526298271|FG000|Overall Study|Lost to Follow-up|1|||
145942401|NCT04676412|526298272|FG001|Overall Study|Lost to Follow-up|2|||
145942402|NCT04676412|526298271|FG000|Overall Study|Sponsor Decision|20|||
145942403|NCT04676412|526298272|FG001|Overall Study|Sponsor Decision|23|||
145942404|NCT04676412|526298271|FG000|Overall Study|Withdrawal by Subject|0|||
145942405|NCT04676412|526298272|FG001|Overall Study|Withdrawal by Subject|2|||
145942406|NCT04550832|526298273|FG000|Overall Study|Adverse Event|0|||
145942407|NCT04550832|526298274|FG001|Overall Study|Adverse Event|0|||
145942408|NCT04550832|526298275|FG002|Overall Study|Adverse Event|2|||
145942409|NCT04550832|526298276|FG003|Overall Study|Adverse Event|0|||
145942410|NCT04550832|526298277|FG004|Overall Study|Adverse Event|1|||
145942411|NCT01573767|526298286|FG000|Overall Study|Adverse Event|0|||
145942412|NCT01573767|526298287|FG001|Overall Study|Adverse Event|1|||
145942413|NCT01573767|526298288|FG002|Overall Study|Adverse Event|0|||
145942414|NCT01573767|526298289|FG003|Overall Study|Adverse Event|1|||
145942415|NCT01573767|526298286|FG000|Overall Study|Lack of Efficacy|18|||
145942416|NCT01573767|526298287|FG001|Overall Study|Lack of Efficacy|15|||
145942417|NCT01573767|526298288|FG002|Overall Study|Lack of Efficacy|12|||
145942418|NCT01573767|526298289|FG003|Overall Study|Lack of Efficacy|17|||
145942419|NCT01573767|526298286|FG000|Overall Study|Protocol Violation|3|||
145942420|NCT01573767|526298287|FG001|Overall Study|Protocol Violation|1|||
145942421|NCT01573767|526298288|FG002|Overall Study|Protocol Violation|1|||
145942422|NCT01573767|526298289|FG003|Overall Study|Protocol Violation|3|||
145942423|NCT01573767|526298286|FG000|Overall Study|Lost to Follow-up|0|||
145942424|NCT01573767|526298287|FG001|Overall Study|Lost to Follow-up|1|||
145942425|NCT01573767|526298288|FG002|Overall Study|Lost to Follow-up|1|||
145942426|NCT01573767|526298289|FG003|Overall Study|Lost to Follow-up|1|||
145942427|NCT01573767|526298286|FG000|Overall Study|Physician Decision|1|||
145942428|NCT01573767|526298287|FG001|Overall Study|Physician Decision|2|||
145942429|NCT01573767|526298288|FG002|Overall Study|Physician Decision|0|||
145942430|NCT01573767|526298289|FG003|Overall Study|Physician Decision|2|||
145942431|NCT01573767|526298286|FG000|Overall Study|Withdrawal by Subject|0|||
145942432|NCT01573767|526298287|FG001|Overall Study|Withdrawal by Subject|1|||
145942433|NCT01573767|526298288|FG002|Overall Study|Withdrawal by Subject|0|||
145942434|NCT01573767|526298289|FG003|Overall Study|Withdrawal by Subject|0|||
145942435|NCT01371877|526298290|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
145942436|NCT01371877|526298291|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
145942437|NCT05932225|526298292|FG000|Overall Study|Lost to Follow-up|0|||
145942438|NCT05932225|526298293|FG001|Overall Study|Lost to Follow-up|1|||
145942439|NCT05932225|526298294|FG002|Overall Study|Lost to Follow-up|0|||
145942440|NCT05932225|526298292|FG000|Overall Study|Withdrawal by Subject|1|||
145942441|NCT05932225|526298293|FG001|Overall Study|Withdrawal by Subject|0|||
145942442|NCT05932225|526298294|FG002|Overall Study|Withdrawal by Subject|0|||
145942443|NCT05932225|526298292|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
145942444|NCT05932225|526298293|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
145942445|NCT05932225|526298294|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
145942446|NCT01358578|526298295|FG000|Induction Period|Adverse Event|2|||
145942447|NCT01358578|526298296|FG001|Induction Period|Adverse Event|4|||
145942448|NCT01358578|526298297|FG002|Induction Period|Adverse Event|2|||
145942449|NCT01358578|526298298|FG003|Induction Period|Adverse Event|6|||
145942450|NCT01358578|526298299|FG004|Induction Period|Adverse Event|0|||
145942451|NCT01358578|526298300|FG005|Induction Period|Adverse Event|0|||
145942452|NCT01358578|526298295|FG000|Induction Period|Lack of Efficacy|0|||
145942453|NCT01358578|526298296|FG001|Induction Period|Lack of Efficacy|0|||
145942454|NCT01358578|526298297|FG002|Induction Period|Lack of Efficacy|9|||
145942455|NCT01358578|526298298|FG003|Induction Period|Lack of Efficacy|1|||
145942456|NCT01358578|526298299|FG004|Induction Period|Lack of Efficacy|0|||
145942457|NCT01358578|526298300|FG005|Induction Period|Lack of Efficacy|0|||
145942458|NCT01358578|526298295|FG000|Induction Period|Lost to Follow-up|0|||
145942459|NCT01358578|526298296|FG001|Induction Period|Lost to Follow-up|0|||
145942460|NCT01358578|526298297|FG002|Induction Period|Lost to Follow-up|1|||
145942461|NCT01358578|526298298|FG003|Induction Period|Lost to Follow-up|4|||
145942462|NCT01358578|526298299|FG004|Induction Period|Lost to Follow-up|0|||
145942463|NCT01358578|526298300|FG005|Induction Period|Lost to Follow-up|0|||
145942464|NCT01358578|526298295|FG000|Induction Period|Physician Decision|2|||
145942465|NCT01358578|526298296|FG001|Induction Period|Physician Decision|1|||
145942466|NCT01358578|526298297|FG002|Induction Period|Physician Decision|2|||
145942467|NCT01358578|526298298|FG003|Induction Period|Physician Decision|0|||
145942468|NCT01358578|526298299|FG004|Induction Period|Physician Decision|0|||
145942469|NCT01358578|526298300|FG005|Induction Period|Physician Decision|0|||
145942470|NCT01358578|526298295|FG000|Induction Period|Protocol Deviation|3|||
145942471|NCT01358578|526298296|FG001|Induction Period|Protocol Deviation|5|||
145942472|NCT01358578|526298297|FG002|Induction Period|Protocol Deviation|0|||
145942473|NCT01358578|526298298|FG003|Induction Period|Protocol Deviation|3|||
145942474|NCT01358578|526298299|FG004|Induction Period|Protocol Deviation|0|||
145942475|NCT01358578|526298300|FG005|Induction Period|Protocol Deviation|0|||
145942476|NCT01358578|526298295|FG000|Induction Period|technical problems|0|||
145942477|NCT01358578|526298296|FG001|Induction Period|technical problems|0|||
145942478|NCT01358578|526298297|FG002|Induction Period|technical problems|1|||
145942479|NCT01358578|526298298|FG003|Induction Period|technical problems|1|||
145942480|NCT01358578|526298299|FG004|Induction Period|technical problems|0|||
145942481|NCT01358578|526298300|FG005|Induction Period|technical problems|0|||
145942482|NCT01358578|526298295|FG000|Induction Period|Withdrawal by Subject|5|||
145942483|NCT01358578|526298296|FG001|Induction Period|Withdrawal by Subject|5|||
145942484|NCT01358578|526298297|FG002|Induction Period|Withdrawal by Subject|10|||
145942485|NCT01358578|526298298|FG003|Induction Period|Withdrawal by Subject|6|||
145942486|NCT01358578|526298299|FG004|Induction Period|Withdrawal by Subject|0|||
146262265|NCT02808975|527476381|FG001|Overall Study|Other, not specified|1|||
146262266|NCT03602586|527476382|FG000|Overall Study|Withdrawal by Subject|3|||
146262267|NCT02106195|527476384|FG000|Overall Study|Adverse Event|2|||
146262268|NCT02106195|527476384|FG000|Overall Study|Protocol Violation|1|||
146262269|NCT03568812|527476385|FG000|Overall Study|Physician Decision|0|||
146262270|NCT03568812|527476386|FG001|Overall Study|Physician Decision|1|||
146262271|NCT03194867|527476390|FG000|Overall Study|Incorrect completion of end of study form|0|||
146262272|NCT03194867|527476391|FG001|Overall Study|Incorrect completion of end of study form|0|||
146262273|NCT03194867|527476392|FG002|Overall Study|Incorrect completion of end of study form|1|||
146262274|NCT03194867|527476393|FG003|Overall Study|Incorrect completion of end of study form|0|||
145942487|NCT01358578|526298300|FG005|Induction Period|Withdrawal by Subject|0|||
145942488|NCT01358578|526298295|FG000|Maintenance Period|Adverse Event|2|||
145942489|NCT01358578|526298296|FG001|Maintenance Period|Adverse Event|7|||
145942490|NCT01358578|526298297|FG002|Maintenance Period|Adverse Event|0|||
145942491|NCT01358578|526298298|FG003|Maintenance Period|Adverse Event|6|||
145942492|NCT01358578|526298299|FG004|Maintenance Period|Adverse Event|4|||
145942493|NCT01358578|526298300|FG005|Maintenance Period|Adverse Event|3|||
145942494|NCT01358578|526298295|FG000|Maintenance Period|Lack of Efficacy|10|||
145942495|NCT01358578|526298296|FG001|Maintenance Period|Lack of Efficacy|2|||
145942496|NCT01358578|526298297|FG002|Maintenance Period|Lack of Efficacy|0|||
145942497|NCT01358578|526298298|FG003|Maintenance Period|Lack of Efficacy|11|||
145942498|NCT01358578|526298299|FG004|Maintenance Period|Lack of Efficacy|3|||
145942499|NCT01358578|526298300|FG005|Maintenance Period|Lack of Efficacy|0|||
145942500|NCT01358578|526298295|FG000|Maintenance Period|Lost to Follow-up|4|||
145942501|NCT01358578|526298296|FG001|Maintenance Period|Lost to Follow-up|0|||
145942502|NCT01358578|526298297|FG002|Maintenance Period|Lost to Follow-up|0|||
145942503|NCT01358578|526298298|FG003|Maintenance Period|Lost to Follow-up|5|||
145942504|NCT01358578|526298299|FG004|Maintenance Period|Lost to Follow-up|1|||
146262275|NCT00634842|527476394|FG000|Overall Study|Adverse Event|2|||
146262276|NCT00634842|527476395|FG001|Overall Study|Adverse Event|3|||
146262277|NCT00634842|527476394|FG000|Overall Study|Protocol Violation|8|||
146262278|NCT00634842|527476395|FG001|Overall Study|Protocol Violation|4|||
146262279|NCT00634842|527476394|FG000|Overall Study|Move to another state|1|||
146262280|NCT00634842|527476395|FG001|Overall Study|Move to another state|0|||
146262281|NCT00634842|527476394|FG000|Overall Study|Inclusion criteria were not met|1|||
146262282|NCT00634842|527476395|FG001|Overall Study|Inclusion criteria were not met|0|||
146262283|NCT00634842|527476394|FG000|Overall Study|Lost to Follow-up|1|||
146262284|NCT00634842|527476395|FG001|Overall Study|Lost to Follow-up|2|||
146262285|NCT00634842|527476394|FG000|Overall Study|Physician Decision|1|||
146262286|NCT00634842|527476395|FG001|Overall Study|Physician Decision|0|||
146262287|NCT00634842|527476394|FG000|Overall Study|Withdrawal by Subject|1|||
146262288|NCT00634842|527476395|FG001|Overall Study|Withdrawal by Subject|3|||
146262289|NCT00634842|527476394|FG000|Overall Study|Lack of time and intolerance to drug|0|||
146262290|NCT00634842|527476395|FG001|Overall Study|Lack of time and intolerance to drug|1|||
146262291|NCT00634842|527476394|FG000|Overall Study|Discontinued due to injection|0|||
146262292|NCT00634842|527476395|FG001|Overall Study|Discontinued due to injection|2|||
146262293|NCT00634842|527476394|FG000|Overall Study|No need of study drug to treat diabetes|0|||
146262294|NCT00634842|527476395|FG001|Overall Study|No need of study drug to treat diabetes|1|||
146262295|NCT00634842|527476394|FG000|Overall Study|No wish to keep taking Avandia|0|||
146262296|NCT00634842|527476395|FG001|Overall Study|No wish to keep taking Avandia|1|||
146262297|NCT00634842|527476394|FG000|Overall Study|Subject off study drug for too long|0|||
145942505|NCT01358578|526298300|FG005|Maintenance Period|Lost to Follow-up|1|||
146303155|NCT01994382|527624065|FG005|Overall Study|Rolled over to Phase 2a|0|||
146303156|NCT01994382|527624066|FG006|Overall Study|Rolled over to Phase 2a|0|||
146303157|NCT01994382|527624067|FG007|Overall Study|Rolled over to Phase 2a|0|||
146303158|NCT01994382|527624068|FG008|Overall Study|Rolled over to Phase 2a|0|||
146303159|NCT01994382|527624069|FG009|Overall Study|Rolled over to Phase 2a|2|||
146303160|NCT01994382|527624070|FG010|Overall Study|Rolled over to Phase 2a|0|||
146303161|NCT01994382|527624071|FG011|Overall Study|Rolled over to Phase 2a|0|||
146303162|NCT01994382|527624072|FG012|Overall Study|Rolled over to Phase 2a|0|||
146303163|NCT01994382|527624073|FG013|Overall Study|Rolled over to Phase 2a|0|||
146303164|NCT01994382|527624074|FG014|Overall Study|Rolled over to Phase 2a|0|||
146303165|NCT01994382|527624075|FG015|Overall Study|Rolled over to Phase 2a|0|||
146303166|NCT01994382|527624076|FG016|Overall Study|Rolled over to Phase 2a|0|||
146303167|NCT02428855|527624077|FG000|Overall Study|Withdrawal by Subject|2|||
146303168|NCT00359021|527624078|FG000|Overall Study|Adverse Event|26|||
146303169|NCT00359021|527624079|FG001|Overall Study|Adverse Event|8|||
146303170|NCT00359021|527624078|FG000|Overall Study|Subject Non-Compliant|1|||
146303171|NCT00359021|527624079|FG001|Overall Study|Subject Non-Compliant|2|||
146303172|NCT00359021|527624078|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
146303173|NCT00359021|527624079|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
146303174|NCT00359021|527624078|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
146303175|NCT00359021|527624079|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
146303176|NCT00359021|527624078|FG000|Overall Study|Withdrawal by Subject|2|||
146303177|NCT00359021|527624079|FG001|Overall Study|Withdrawal by Subject|9|||
146303178|NCT00359021|527624078|FG000|Overall Study|Lost to Follow-up|1|||
146303179|NCT00359021|527624079|FG001|Overall Study|Lost to Follow-up|0|||
146303180|NCT00359021|527624078|FG000|Overall Study|Other|4|||
146303181|NCT00359021|527624079|FG001|Overall Study|Other|1|||
146303182|NCT00359021|527624078|FG000|Overall Study|Pregnancy|1|||
146303183|NCT00359021|527624079|FG001|Overall Study|Pregnancy|0|||
146303184|NCT02066311|527624080|FG000|Overall Study|Adverse Event|4|||
146303185|NCT02066311|527624080|FG000|Overall Study|Withdrawal by Subject|1|||
146303186|NCT04353596|527624081|FG000|Overall Study|Protocol Violation|4|||
146303187|NCT04353596|527624082|FG001|Overall Study|Protocol Violation|4|||
146303188|NCT04353596|527624081|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
146303189|NCT04353596|527624082|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
146303190|NCT03023059|527624083|FG000|Overall Study|Withdrawal by Subject|5|||
146303191|NCT03781323|527624084|FG000|Overall Study|Withdrawal by Subject|1|||
146303192|NCT01338415|527624085|FG000|Core + Extension|Adverse Event|8|||
146303193|NCT01338415|527624086|FG001|Core + Extension|Adverse Event|6|||
146303194|NCT01338415|527624087|FG002|Core + Extension|Adverse Event|0|||
146303195|NCT01338415|527624085|FG000|Core + Extension|Withdrawal by Subject|1|||
146303196|NCT01338415|527624086|FG001|Core + Extension|Withdrawal by Subject|1|||
146303197|NCT01338415|527624087|FG002|Core + Extension|Withdrawal by Subject|0|||
146303198|NCT01338415|527624085|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
146303199|NCT01338415|527624086|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
146303200|NCT01338415|527624087|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
146303201|NCT01338415|527624085|FG000|Core + Extension|Other (administrative reason)|1|||
146303202|NCT01338415|527624086|FG001|Core + Extension|Other (administrative reason)|0|||
146303203|NCT01338415|527624087|FG002|Core + Extension|Other (administrative reason)|0|||
146303204|NCT01338415|527624085|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
146303205|NCT01338415|527624086|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
146303206|NCT01338415|527624087|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
146303207|NCT01338415|527624085|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
145942506|NCT01358578|526298295|FG000|Maintenance Period|Non-compliance with study treatment|3|||
145942507|NCT01358578|526298296|FG001|Maintenance Period|Non-compliance with study treatment|1|||
145942508|NCT01358578|526298297|FG002|Maintenance Period|Non-compliance with study treatment|0|||
145942509|NCT01358578|526298298|FG003|Maintenance Period|Non-compliance with study treatment|2|||
145942510|NCT01358578|526298299|FG004|Maintenance Period|Non-compliance with study treatment|1|||
145942511|NCT01358578|526298300|FG005|Maintenance Period|Non-compliance with study treatment|2|||
145942512|NCT01358578|526298295|FG000|Maintenance Period|Physician Decision|0|||
145942513|NCT01358578|526298296|FG001|Maintenance Period|Physician Decision|1|||
145942514|NCT01358578|526298297|FG002|Maintenance Period|Physician Decision|0|||
146303208|NCT01338415|527624086|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
146303209|NCT01338415|527624087|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
146303210|NCT01338415|527624085|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
146303211|NCT01338415|527624086|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
146303212|NCT01338415|527624087|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
146303213|NCT01338415|527624085|FG000|Exceptional Use Treatment Period|Death|0|||
146303214|NCT01338415|527624086|FG001|Exceptional Use Treatment Period|Death|0|||
146303215|NCT01338415|527624087|FG002|Exceptional Use Treatment Period|Death|1|||
146303216|NCT00233363|527624088|FG000|Overall Study|Adverse Event|1|||
145942515|NCT01358578|526298298|FG003|Maintenance Period|Physician Decision|1|||
146303217|NCT00233363|527624089|FG001|Overall Study|Adverse Event|2|||
146303218|NCT00233363|527624088|FG000|Overall Study|Lack of Efficacy|0|||
146303219|NCT00233363|527624089|FG001|Overall Study|Lack of Efficacy|2|||
146303220|NCT00233363|527624088|FG000|Overall Study|Withdrawal by Subject|1|||
146303221|NCT00233363|527624089|FG001|Overall Study|Withdrawal by Subject|1|||
146303222|NCT00233363|527624088|FG000|Overall Study|Aggravation of complication|1|||
146303223|NCT00233363|527624089|FG001|Overall Study|Aggravation of complication|0|||
146303224|NCT01526551|527624092|FG000|Overall Study|Lack of returned parental consent form|424|||
146303225|NCT01303965|527624097|FG000|Overall Study|Adverse Event|1|||
146303226|NCT01303965|527624098|FG001|Overall Study|Adverse Event|1|||
146303227|NCT01303965|527624097|FG000|Overall Study|Death|0|||
146303228|NCT01303965|527624098|FG001|Overall Study|Death|3|||
146303229|NCT01303965|527624097|FG000|Overall Study|Withdrawal by Subject|1|||
146303230|NCT01303965|527624098|FG001|Overall Study|Withdrawal by Subject|0|||
146303231|NCT01303965|527624097|FG000|Overall Study|Disease Progression|1|||
146303232|NCT01303965|527624098|FG001|Overall Study|Disease Progression|6|||
146303233|NCT04534491|527624100|FG000|Overall Study|Not completed end-of-study interview|24|||
146303234|NCT04534491|527624100|FG000|Overall Study|Non-users|70|||
146303235|NCT04534491|527624100|FG000|Overall Study|Non-verifiable users|58|||
146303236|NCT03024970|527624105|FG000|First Intervention|Adverse Event|1|||
146303237|NCT03024970|527624106|FG001|First Intervention|Adverse Event|0|||
146303238|NCT03024970|527624105|FG000|Second Intervention|Lost to Follow-up|1|||
146303239|NCT03024970|527624106|FG001|Second Intervention|Lost to Follow-up|0|||
146303240|NCT01106027|527624107|FG000|Overall Study|Lost graft early, discontinued|1|||
146303241|NCT02678416|527624117|FG000|Part 1|Withdrawal by Subject|1|||
146303242|NCT02678416|527624117|FG000|Part 2|Adverse Event|2|||
146303243|NCT02678416|527624117|FG000|Part 2|Withdrawal by Subject|1|||
146303244|NCT01848353|527624118|FG000|Phase 1|Withdrawal by Subject|3|||
146303245|NCT01848353|527624119|FG001|Phase 1|Withdrawal by Subject|1|||
146303246|NCT01848353|527624120|FG002|Phase 1|Withdrawal by Subject|0|||
146303247|NCT01848353|527624121|FG003|Phase 1|Withdrawal by Subject|0|||
146303248|NCT01848353|527624118|FG000|Phase 2|Withdrawal by Subject|3|||
146303249|NCT01848353|527624119|FG001|Phase 2|Withdrawal by Subject|2|||
146303250|NCT01848353|527624120|FG002|Phase 2|Withdrawal by Subject|0|||
146303251|NCT01848353|527624121|FG003|Phase 2|Withdrawal by Subject|0|||
146303252|NCT01848353|527624118|FG000|Phase 3|Withdrawal by Subject|1|||
146303253|NCT01848353|527624119|FG001|Phase 3|Withdrawal by Subject|1|||
146303254|NCT01848353|527624120|FG002|Phase 3|Withdrawal by Subject|0|||
146303255|NCT01848353|527624121|FG003|Phase 3|Withdrawal by Subject|0|||
146303256|NCT00935272|527624122|FG000|Overall Study|Lost to Follow-up|10|||
146303257|NCT00935272|527624123|FG001|Overall Study|Lost to Follow-up|3|||
146303258|NCT00935272|527624122|FG000|Overall Study|Withdrawal by Subject|8|||
146303259|NCT00935272|527624123|FG001|Overall Study|Withdrawal by Subject|2|||
146303260|NCT00935272|527624122|FG000|Overall Study|Physician Decision|1|||
146303261|NCT00935272|527624123|FG001|Overall Study|Physician Decision|0|||
146303262|NCT00935272|527624122|FG000|Overall Study|Protocol Violation|0|||
146303263|NCT00935272|527624123|FG001|Overall Study|Protocol Violation|1|||
146303264|NCT01478360|527624129|FG000|Overall Study|Lost to Follow-up|1|||
146303265|NCT01478360|527624130|FG001|Overall Study|Lost to Follow-up|0|||
146303266|NCT01478360|527624129|FG000|Overall Study|Adverse Event|0|||
146303267|NCT01478360|527624130|FG001|Overall Study|Adverse Event|1|||
146303268|NCT01478360|527624129|FG000|Overall Study|Administrative problems|1|||
146303269|NCT01478360|527624130|FG001|Overall Study|Administrative problems|2|||
146303270|NCT02289352|527624131|FG000|Overall Study|Withdrawal by Subject|1|||
146303271|NCT02289352|527624132|FG001|Overall Study|Withdrawal by Subject|1|||
146303272|NCT02289352|527624133|FG002|Overall Study|Withdrawal by Subject|0|||
146303273|NCT01177384|527624134|FG000|Overall Study|Adverse Event|6|||
146303274|NCT01177384|527624135|FG001|Overall Study|Adverse Event|4|||
146303275|NCT01177384|527624134|FG000|Overall Study|Lack of Efficacy|0|||
146303276|NCT01177384|527624135|FG001|Overall Study|Lack of Efficacy|1|||
146303277|NCT01177384|527624134|FG000|Overall Study|Lost to Follow-up|3|||
146303278|NCT01177384|527624135|FG001|Overall Study|Lost to Follow-up|4|||
146303279|NCT01177384|527624134|FG000|Overall Study|Physician Decision|0|||
146303280|NCT01177384|527624135|FG001|Overall Study|Physician Decision|3|||
146303281|NCT01177384|527624134|FG000|Overall Study|Protocol Violation|0|||
146303282|NCT01177384|527624135|FG001|Overall Study|Protocol Violation|2|||
146303283|NCT01177384|527624134|FG000|Overall Study|Withdrawal by Subject|5|||
146303284|NCT01177384|527624135|FG001|Overall Study|Withdrawal by Subject|12|||
146303285|NCT00590044|527624165|FG000|Overall Study|Withdrawal by Subject|2|||
146303286|NCT00590044|527624166|FG001|Overall Study|Withdrawal by Subject|2|||
146303287|NCT00590044|527624165|FG000|Overall Study|wrong insulin arm assigned|1|||
146303288|NCT00590044|527624166|FG001|Overall Study|wrong insulin arm assigned|0|||
146303289|NCT00590044|527624165|FG000|Overall Study|Protocol Violation|1|||
146303290|NCT00590044|527624166|FG001|Overall Study|Protocol Violation|0|||
146303291|NCT00175877|527624169|FG000|Overall Study|Adverse Event|136|||
146303292|NCT00175877|527624169|FG000|Overall Study|Withdrawal by Subject|141|||
146303293|NCT00175877|527624169|FG000|Overall Study|Lost to Follow-up|9|||
146303294|NCT00175877|527624169|FG000|Overall Study|Lack of Efficacy|26|||
146303295|NCT00175877|527624169|FG000|Overall Study|Protocol Violation|15|||
145942516|NCT01358578|526298299|FG004|Maintenance Period|Physician Decision|0|||
145942517|NCT01358578|526298300|FG005|Maintenance Period|Physician Decision|0|||
145942518|NCT01358578|526298295|FG000|Maintenance Period|Pregnancy|1|||
145942519|NCT01358578|526298296|FG001|Maintenance Period|Pregnancy|0|||
145942520|NCT01358578|526298297|FG002|Maintenance Period|Pregnancy|0|||
145942521|NCT01358578|526298298|FG003|Maintenance Period|Pregnancy|0|||
145942522|NCT01358578|526298299|FG004|Maintenance Period|Pregnancy|0|||
145942523|NCT01358578|526298300|FG005|Maintenance Period|Pregnancy|0|||
145942524|NCT01358578|526298295|FG000|Maintenance Period|Protocol deviation|7|||
145942525|NCT01358578|526298296|FG001|Maintenance Period|Protocol deviation|4|||
145942526|NCT01358578|526298297|FG002|Maintenance Period|Protocol deviation|0|||
145942527|NCT01358578|526298298|FG003|Maintenance Period|Protocol deviation|2|||
145942528|NCT01358578|526298299|FG004|Maintenance Period|Protocol deviation|2|||
145942529|NCT01358578|526298300|FG005|Maintenance Period|Protocol deviation|2|||
145942530|NCT01358578|526298295|FG000|Maintenance Period|Withdrawal by Subject|12|||
145942531|NCT01358578|526298296|FG001|Maintenance Period|Withdrawal by Subject|7|||
145942532|NCT01358578|526298297|FG002|Maintenance Period|Withdrawal by Subject|2|||
145942533|NCT01358578|526298298|FG003|Maintenance Period|Withdrawal by Subject|15|||
145942534|NCT01358578|526298299|FG004|Maintenance Period|Withdrawal by Subject|6|||
145942535|NCT01358578|526298300|FG005|Maintenance Period|Withdrawal by Subject|3|||
145942536|NCT01358578|526298295|FG000|Follow-up Period|Adverse Event|1|||
145942537|NCT01358578|526298296|FG001|Follow-up Period|Adverse Event|1|||
145942538|NCT01358578|526298297|FG002|Follow-up Period|Adverse Event|0|||
145942539|NCT01358578|526298298|FG003|Follow-up Period|Adverse Event|0|||
145942540|NCT01358578|526298299|FG004|Follow-up Period|Adverse Event|0|||
145942541|NCT01358578|526298300|FG005|Follow-up Period|Adverse Event|0|||
145942542|NCT01358578|526298295|FG000|Follow-up Period|Lack of Efficacy|3|||
145942543|NCT01358578|526298296|FG001|Follow-up Period|Lack of Efficacy|0|||
145942544|NCT01358578|526298297|FG002|Follow-up Period|Lack of Efficacy|4|||
145942545|NCT01358578|526298298|FG003|Follow-up Period|Lack of Efficacy|1|||
145942546|NCT01358578|526298299|FG004|Follow-up Period|Lack of Efficacy|0|||
145942547|NCT01358578|526298300|FG005|Follow-up Period|Lack of Efficacy|0|||
145942548|NCT01358578|526298295|FG000|Follow-up Period|Lost to Follow-up|0|||
145942549|NCT01358578|526298296|FG001|Follow-up Period|Lost to Follow-up|1|||
145942550|NCT01358578|526298297|FG002|Follow-up Period|Lost to Follow-up|0|||
145942551|NCT01358578|526298298|FG003|Follow-up Period|Lost to Follow-up|4|||
145942552|NCT01358578|526298299|FG004|Follow-up Period|Lost to Follow-up|0|||
145942553|NCT01358578|526298300|FG005|Follow-up Period|Lost to Follow-up|0|||
145942554|NCT01358578|526298295|FG000|Follow-up Period|non- compliance with study treatment|1|||
145942555|NCT01358578|526298296|FG001|Follow-up Period|non- compliance with study treatment|0|||
145942556|NCT01358578|526298297|FG002|Follow-up Period|non- compliance with study treatment|0|||
145942557|NCT01358578|526298298|FG003|Follow-up Period|non- compliance with study treatment|0|||
145942558|NCT01358578|526298299|FG004|Follow-up Period|non- compliance with study treatment|0|||
145942559|NCT01358578|526298300|FG005|Follow-up Period|non- compliance with study treatment|0|||
145942560|NCT01358578|526298295|FG000|Follow-up Period|Pregnancy|1|||
145942561|NCT01358578|526298296|FG001|Follow-up Period|Pregnancy|0|||
145942562|NCT01358578|526298297|FG002|Follow-up Period|Pregnancy|0|||
145942563|NCT01358578|526298298|FG003|Follow-up Period|Pregnancy|0|||
145942564|NCT01358578|526298299|FG004|Follow-up Period|Pregnancy|0|||
145942565|NCT01358578|526298300|FG005|Follow-up Period|Pregnancy|0|||
145942566|NCT01358578|526298295|FG000|Follow-up Period|Withdrawal by Subject|3|||
145942567|NCT01358578|526298296|FG001|Follow-up Period|Withdrawal by Subject|3|||
145942568|NCT01358578|526298297|FG002|Follow-up Period|Withdrawal by Subject|1|||
145942569|NCT01358578|526298298|FG003|Follow-up Period|Withdrawal by Subject|12|||
145942570|NCT01358578|526298299|FG004|Follow-up Period|Withdrawal by Subject|0|||
145942571|NCT01358578|526298300|FG005|Follow-up Period|Withdrawal by Subject|0|||
145942572|NCT01358578|526298295|FG000|Follow-up Period|Physician Decision|1|||
145942573|NCT01358578|526298296|FG001|Follow-up Period|Physician Decision|1|||
145942574|NCT01358578|526298297|FG002|Follow-up Period|Physician Decision|0|||
145942575|NCT01358578|526298298|FG003|Follow-up Period|Physician Decision|2|||
145942576|NCT01358578|526298299|FG004|Follow-up Period|Physician Decision|0|||
145942577|NCT01358578|526298300|FG005|Follow-up Period|Physician Decision|0|||
145942578|NCT01027897|526298301|FG000|Overall Study|Protocol Violation|1|||
145942579|NCT01027897|526298301|FG000|Overall Study|Withdrawal by Subject|1|||
145942580|NCT00328094|526298302|FG000|Overall Study|Physician Decision|3|||
145942581|NCT00328094|526298303|FG001|Overall Study|Physician Decision|3|||
145942582|NCT01911780|526298304|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
145942583|NCT01911780|526298305|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
145942584|NCT01911780|526298304|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
145942585|NCT01911780|526298305|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
145942586|NCT01911780|526298304|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
145942587|NCT01911780|526298305|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
145942588|NCT01911780|526298304|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
145942589|NCT01911780|526298305|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
145942590|NCT01911780|526298304|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
145942591|NCT01911780|526298305|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
145942592|NCT01911780|526298304|FG000|Extension Period (52 Weeks)|Personal reason|1|||
145942593|NCT01911780|526298305|FG001|Extension Period (52 Weeks)|Personal reason|1|||
145942594|NCT02667626|526298306|FG000|Overall Study|Withdrawal by Subject|0|||
145942595|NCT02667626|526298307|FG001|Overall Study|Withdrawal by Subject|1|||
145942596|NCT01661933|526298311|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
145942597|NCT01661933|526298311|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
145942598|NCT01935128|526298315|FG000|Overall Study|Death|1|||
145942599|NCT01935128|526298315|FG000|Overall Study|Adverse Event|6|||
145942600|NCT00435487|526298317|FG000|Overall Study|Death|3|||
145942601|NCT00435487|526298318|FG001|Overall Study|Death|4|||
145942602|NCT00435487|526298317|FG000|Overall Study|Adverse Event|0|||
145942603|NCT00435487|526298318|FG001|Overall Study|Adverse Event|3|||
145942604|NCT00435487|526298317|FG000|Overall Study|Lost to Follow-up|2|||
145942605|NCT00435487|526298318|FG001|Overall Study|Lost to Follow-up|2|||
145942606|NCT00435487|526298317|FG000|Overall Study|Other|5|||
145942607|NCT00435487|526298318|FG001|Overall Study|Other|2|||
145942608|NCT00435487|526298317|FG000|Overall Study|Withdrawal by Subject|2|||
145942609|NCT00435487|526298318|FG001|Overall Study|Withdrawal by Subject|1|||
145942610|NCT00435487|526298317|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
145942611|NCT00435487|526298318|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
145942612|NCT00435487|526298317|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
145942613|NCT00435487|526298318|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
145942614|NCT00835679|526298319|FG000|Overall Study|Withdrawal by Subject|1|||
145942615|NCT00835679|526298320|FG001|Overall Study|Withdrawal by Subject|0|||
145942616|NCT00835679|526298321|FG002|Overall Study|Withdrawal by Subject|0|||
145942617|NCT00835679|526298322|FG003|Overall Study|Withdrawal by Subject|0|||
145942618|NCT00204477|526298326|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
145942619|NCT00204477|526298327|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
145942620|NCT00204477|526298326|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
145942621|NCT00204477|526298327|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
145942622|NCT00150800|526298328|FG000|Overall Study|Adverse Event|89|||
145942623|NCT00150800|526298328|FG000|Overall Study|Death|18|||
145942624|NCT00150800|526298328|FG000|Overall Study|Lack of Efficacy|166|||
145942625|NCT00150800|526298328|FG000|Overall Study|Lost to Follow-up|58|||
145942626|NCT00150800|526298328|FG000|Overall Study|Subject's choice|90|||
145942627|NCT00150800|526298328|FG000|Overall Study|No compliance|18|||
145942628|NCT00150800|526298328|FG000|Overall Study|IP misshandling|1|||
145942629|NCT00150800|526298328|FG000|Overall Study|Site closure|24|||
145942630|NCT00150800|526298328|FG000|Overall Study|Protocol non-adherence|2|||
145942631|NCT00150800|526298328|FG000|Overall Study|Nobody to accompany patient|1|||
145942632|NCT00150800|526298328|FG000|Overall Study|Distance too long for patient|1|||
145942633|NCT00150800|526298328|FG000|Overall Study|Neurosurgery|2|||
145942634|NCT00150800|526298328|FG000|Overall Study|BRV monotherapy|1|||
145942635|NCT00150800|526298328|FG000|Overall Study|Visit refusal|3|||
145942636|NCT00150800|526298328|FG000|Overall Study|Sponsor's request|2|||
145942637|NCT00150800|526298328|FG000|Overall Study|Generalized Epilepsy|1|||
145942638|NCT00150800|526298328|FG000|Overall Study|Moved from area/country|8|||
145942639|NCT00150800|526298328|FG000|Overall Study|PI retiring|2|||
145942640|NCT00150800|526298328|FG000|Overall Study|PI leaving site|2|||
145942641|NCT00150800|526298328|FG000|Overall Study|Patient insurance|1|||
145942642|NCT00150800|526298328|FG000|Overall Study|Surgical intervention|4|||
145942643|NCT00150800|526298328|FG000|Overall Study|Pregnancy planned|1|||
145942644|NCT00150800|526298328|FG000|Overall Study|PI discontinuation request|1|||
145942645|NCT03619902|526298329|FG000|Overall Study|Termination of Study by Investigator|1|||
145942646|NCT03619902|526298329|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
145942647|NCT01966068|526298332|FG000|Overall Study|Withdrawal by Subject|57|||
145942648|NCT01966068|526298332|FG000|Overall Study|Lost to Follow-up|81|||
145942649|NCT01790828|526298334|FG000|Overall Study|Other|34|||
145942650|NCT00084318|526298337|FG000|Overall Study|Withdrawal by Subject|5|||
145942651|NCT00084318|526298338|FG001|Overall Study|Withdrawal by Subject|2|||
145942652|NCT00084318|526298337|FG000|Overall Study|Protocol Violation|15|||
145942653|NCT00084318|526298338|FG001|Overall Study|Protocol Violation|11|||
145942654|NCT00084318|526298337|FG000|Overall Study|No protocol treatment|2|||
145942655|NCT00084318|526298338|FG001|Overall Study|No protocol treatment|0|||
145942656|NCT00138073|526298339|FG000|Overall Study|lack of resources|55|||
145942657|NCT01037127|526298341|FG000|Overall Study|Lost to Follow-up|2|||
145942658|NCT01037127|526298342|FG001|Overall Study|Lost to Follow-up|4|||
145942659|NCT01037127|526298341|FG000|Overall Study|Physician Decision|1|||
145942660|NCT01037127|526298342|FG001|Overall Study|Physician Decision|0|||
145942661|NCT01037127|526298341|FG000|Overall Study|Study Closed Terminated|2|||
145942662|NCT01037127|526298342|FG001|Overall Study|Study Closed Terminated|17|||
145942663|NCT02637713|526298349|FG000|Overall Study|Screen Failure|2|||
145942664|NCT02847182|526298350|FG000|Overall Study|Withdrawal by Subject|0|||
145942665|NCT02847182|526298351|FG001|Overall Study|Withdrawal by Subject|1|||
145942666|NCT02345889|526298352|FG000|Overall Study|Inadequate Bowel Prep|17|||
146122472|NCT03855280|526967186|FG000|Treatment Phase|Adverse Event|1|||
146122473|NCT03855280|526967186|FG000|Treatment Phase|Withdrawal by Subject|1|||
146122474|NCT03855280|526967186|FG000|Continuation Phase|Protocol Violation|1|||
145942667|NCT02345889|526298353|FG001|Overall Study|Inadequate Bowel Prep|16|||
145942668|NCT02345889|526298354|FG002|Overall Study|Inadequate Bowel Prep|18|||
145942669|NCT02345889|526298355|FG003|Overall Study|Inadequate Bowel Prep|14|||
145942670|NCT02345889|526298352|FG000|Overall Study|Polyposis identified during procedure|1|||
145942671|NCT02345889|526298353|FG001|Overall Study|Polyposis identified during procedure|1|||
145942672|NCT02345889|526298354|FG002|Overall Study|Polyposis identified during procedure|0|||
145942673|NCT02345889|526298355|FG003|Overall Study|Polyposis identified during procedure|1|||
145942674|NCT02345889|526298352|FG000|Overall Study|Recognized ineligible post-randomization|1|||
145942675|NCT02345889|526298353|FG001|Overall Study|Recognized ineligible post-randomization|0|||
145942676|NCT02345889|526298354|FG002|Overall Study|Recognized ineligible post-randomization|2|||
145942677|NCT02345889|526298355|FG003|Overall Study|Recognized ineligible post-randomization|1|||
145942678|NCT02345889|526298352|FG000|Overall Study|Ulcerative Colitis identified|1|||
145942679|NCT02345889|526298353|FG001|Overall Study|Ulcerative Colitis identified|0|||
145942680|NCT02345889|526298354|FG002|Overall Study|Ulcerative Colitis identified|0|||
145942681|NCT02345889|526298355|FG003|Overall Study|Ulcerative Colitis identified|0|||
145942682|NCT02345889|526298352|FG000|Overall Study|Cecum not intubated|1|||
145942683|NCT02345889|526298353|FG001|Overall Study|Cecum not intubated|0|||
145942684|NCT02345889|526298354|FG002|Overall Study|Cecum not intubated|0|||
145942685|NCT02345889|526298355|FG003|Overall Study|Cecum not intubated|0|||
145942686|NCT04325698|526298357|FG000|Overall Study|Study Terminated By Sponsor|1|||
145942687|NCT04325698|526298358|FG001|Overall Study|Study Terminated By Sponsor|1|||
145942688|NCT04325698|526298357|FG000|Overall Study|Withdrawal by Subject|0|||
145942689|NCT04325698|526298358|FG001|Overall Study|Withdrawal by Subject|2|||
145942690|NCT04253782|526298359|FG000|Overall Study|Death|2|||
145942691|NCT04253782|526298360|FG001|Overall Study|Death|0|||
145942692|NCT00962091|526298361|FG000|Overall Study|Withdrawal by Subject|1|||
145942693|NCT00962091|526298362|FG001|Overall Study|Withdrawal by Subject|2|||
145942694|NCT00962091|526298363|FG002|Overall Study|Withdrawal by Subject|1|||
145942695|NCT00962091|526298364|FG003|Overall Study|Withdrawal by Subject|1|||
145942696|NCT00962091|526298365|FG004|Overall Study|Withdrawal by Subject|0|||
145942697|NCT00962091|526298366|FG005|Overall Study|Withdrawal by Subject|1|||
145942698|NCT00962091|526298367|FG006|Overall Study|Withdrawal by Subject|0|||
145942699|NCT00962091|526298361|FG000|Overall Study|Adverse Event|0|||
145942700|NCT00962091|526298362|FG001|Overall Study|Adverse Event|0|||
145942701|NCT00962091|526298363|FG002|Overall Study|Adverse Event|0|||
145942702|NCT00962091|526298364|FG003|Overall Study|Adverse Event|0|||
145942703|NCT00962091|526298365|FG004|Overall Study|Adverse Event|0|||
145942704|NCT00962091|526298366|FG005|Overall Study|Adverse Event|0|||
145942705|NCT00962091|526298367|FG006|Overall Study|Adverse Event|1|||
145942706|NCT00778102|526298368|FG000|Overall Study|Adverse Event|8|||
145942707|NCT00778102|526298369|FG001|Overall Study|Adverse Event|5|||
145942708|NCT00778102|526298368|FG000|Overall Study|Death|1|||
145942709|NCT00778102|526298369|FG001|Overall Study|Death|1|||
145942710|NCT00778102|526298368|FG000|Overall Study|Lost to Follow-up|1|||
145942711|NCT00778102|526298369|FG001|Overall Study|Lost to Follow-up|0|||
145942712|NCT00778102|526298368|FG000|Overall Study|Violation of Selection Criteria|1|||
145942713|NCT00778102|526298369|FG001|Overall Study|Violation of Selection Criteria|1|||
145942714|NCT00778102|526298368|FG000|Overall Study|Protocol Violation|0|||
145942715|NCT00778102|526298369|FG001|Overall Study|Protocol Violation|1|||
145942716|NCT00778102|526298368|FG000|Overall Study|Refused Treatment|2|||
145942717|NCT00778102|526298369|FG001|Overall Study|Refused Treatment|3|||
145942718|NCT00778102|526298368|FG000|Overall Study|Withdrawal by Subject|1|||
145942719|NCT00778102|526298369|FG001|Overall Study|Withdrawal by Subject|1|||
145942720|NCT00778102|526298368|FG000|Overall Study|Administrative Reason|7|||
145942721|NCT00778102|526298369|FG001|Overall Study|Administrative Reason|10|||
145942722|NCT01328548|526298370|FG000|Overall Study|Death|3|||
145942723|NCT01328548|526298371|FG001|Overall Study|Death|0|||
145942724|NCT01328548|526298370|FG000|Overall Study|Protocol Violation|1|||
145942725|NCT01328548|526298371|FG001|Overall Study|Protocol Violation|0|||
145942726|NCT04506905|526298374|FG000|Overall Study|Lost to Follow-up|1|||
145942727|NCT04506905|526298375|FG001|Overall Study|Lost to Follow-up|0|||
145942728|NCT04506905|526298376|FG002|Overall Study|Lost to Follow-up|0|||
145942729|NCT04506905|526298377|FG003|Overall Study|Lost to Follow-up|1|||
145942730|NCT04506905|526298378|FG004|Overall Study|Lost to Follow-up|0|||
145942731|NCT04506905|526298379|FG005|Overall Study|Lost to Follow-up|0|||
145942732|NCT04506905|526298380|FG006|Overall Study|Lost to Follow-up|0|||
145942733|NCT04506905|526298381|FG007|Overall Study|Lost to Follow-up|0|||
145942734|NCT04506905|526298382|FG008|Overall Study|Lost to Follow-up|0|||
145942735|NCT04506905|526298374|FG000|Overall Study|Withdrawal by Subject|0|||
146122475|NCT03855280|526967186|FG000|Continuation Phase|Adverse Event|1|||
146122476|NCT03855280|526967186|FG000|Continuation Phase|Sponsor Concluded Study|1|||
146122477|NCT00969150|526967187|FG000|Overall Study|Adverse Event|4|||
146122478|NCT00969150|526967188|FG001|Overall Study|Adverse Event|14|||
146122479|NCT00969150|526967187|FG000|Overall Study|Lack of Efficacy|1|||
146122480|NCT00969150|526967188|FG001|Overall Study|Lack of Efficacy|1|||
146122481|NCT00969150|526967187|FG000|Overall Study|Protocol Violation|9|||
146122482|NCT00969150|526967188|FG001|Overall Study|Protocol Violation|12|||
146122483|NCT00969150|526967187|FG000|Overall Study|Withdrawal by Subject|13|||
146122484|NCT00969150|526967188|FG001|Overall Study|Withdrawal by Subject|9|||
146122485|NCT00969150|526967187|FG000|Overall Study|Lost to Follow-up|5|||
146122486|NCT00969150|526967188|FG001|Overall Study|Lost to Follow-up|4|||
146122487|NCT00969150|526967187|FG000|Overall Study|Other reasons|1|||
146122488|NCT00969150|526967188|FG001|Overall Study|Other reasons|0|||
146122489|NCT00642941|526967194|FG000|Overall Study|Physician Decision|3|||
146122490|NCT00642941|526967195|FG001|Overall Study|Physician Decision|1|||
146122491|NCT00642941|526967196|FG002|Overall Study|Physician Decision|0|||
146122492|NCT00642941|526967197|FG003|Overall Study|Physician Decision|0|||
146122493|NCT00642941|526967198|FG004|Overall Study|Physician Decision|0|||
146122494|NCT00642941|526967199|FG005|Overall Study|Physician Decision|0|||
146122495|NCT00642941|526967200|FG006|Overall Study|Physician Decision|1|||
146122496|NCT00642941|526967201|FG007|Overall Study|Physician Decision|0|||
146262298|NCT00634842|527476395|FG001|Overall Study|Subject off study drug for too long|1|||
146262299|NCT00464945|527476396|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
146122497|NCT00642941|526967202|FG008|Overall Study|Physician Decision|0|||
146122498|NCT00642941|526967203|FG009|Overall Study|Physician Decision|1|||
146122499|NCT00642941|526967204|FG010|Overall Study|Physician Decision|0|||
146122500|NCT00642941|526967205|FG011|Overall Study|Physician Decision|1|||
146122501|NCT00642941|526967194|FG000|Overall Study|Death|4|||
146122502|NCT00642941|526967195|FG001|Overall Study|Death|0|||
146122503|NCT00642941|526967196|FG002|Overall Study|Death|1|||
146122504|NCT00642941|526967197|FG003|Overall Study|Death|1|||
146122505|NCT00642941|526967198|FG004|Overall Study|Death|2|||
146122506|NCT00642941|526967199|FG005|Overall Study|Death|1|||
146122507|NCT00642941|526967200|FG006|Overall Study|Death|0|||
146122508|NCT00642941|526967201|FG007|Overall Study|Death|0|||
146122509|NCT00642941|526967202|FG008|Overall Study|Death|0|||
146122510|NCT00642941|526967203|FG009|Overall Study|Death|0|||
146122511|NCT00642941|526967204|FG010|Overall Study|Death|0|||
146122512|NCT00642941|526967205|FG011|Overall Study|Death|1|||
145942736|NCT04506905|526298375|FG001|Overall Study|Withdrawal by Subject|0|||
145942737|NCT04506905|526298376|FG002|Overall Study|Withdrawal by Subject|0|||
145942738|NCT04506905|526298377|FG003|Overall Study|Withdrawal by Subject|2|||
145942739|NCT04506905|526298378|FG004|Overall Study|Withdrawal by Subject|0|||
145942740|NCT04506905|526298379|FG005|Overall Study|Withdrawal by Subject|0|||
145942741|NCT04506905|526298380|FG006|Overall Study|Withdrawal by Subject|0|||
145942742|NCT04506905|526298381|FG007|Overall Study|Withdrawal by Subject|0|||
146122513|NCT00642941|526967194|FG000|Overall Study|Study closed by Sponsor|0|||
146122514|NCT00642941|526967195|FG001|Overall Study|Study closed by Sponsor|1|||
146122515|NCT00642941|526967196|FG002|Overall Study|Study closed by Sponsor|0|||
146122516|NCT00642941|526967197|FG003|Overall Study|Study closed by Sponsor|0|||
146122517|NCT00642941|526967198|FG004|Overall Study|Study closed by Sponsor|0|||
146122518|NCT00642941|526967199|FG005|Overall Study|Study closed by Sponsor|0|||
146122519|NCT00642941|526967200|FG006|Overall Study|Study closed by Sponsor|0|||
146122520|NCT00642941|526967201|FG007|Overall Study|Study closed by Sponsor|0|||
146122521|NCT00642941|526967202|FG008|Overall Study|Study closed by Sponsor|0|||
146122522|NCT00642941|526967203|FG009|Overall Study|Study closed by Sponsor|0|||
146122523|NCT00642941|526967204|FG010|Overall Study|Study closed by Sponsor|0|||
146122524|NCT00642941|526967205|FG011|Overall Study|Study closed by Sponsor|0|||
146122525|NCT00642941|526967194|FG000|Overall Study|Withdrawal by Subject|1|||
146122526|NCT00642941|526967195|FG001|Overall Study|Withdrawal by Subject|0|||
146122527|NCT00642941|526967196|FG002|Overall Study|Withdrawal by Subject|0|||
146122528|NCT00642941|526967197|FG003|Overall Study|Withdrawal by Subject|2|||
146122529|NCT00642941|526967198|FG004|Overall Study|Withdrawal by Subject|0|||
146122530|NCT00642941|526967199|FG005|Overall Study|Withdrawal by Subject|0|||
146262300|NCT00464945|527476397|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
146262301|NCT00464945|527476396|FG000|Infant Series|Protocol Violation|1|||
146122531|NCT00642941|526967200|FG006|Overall Study|Withdrawal by Subject|2|||
146122532|NCT00642941|526967201|FG007|Overall Study|Withdrawal by Subject|0|||
146122533|NCT00642941|526967202|FG008|Overall Study|Withdrawal by Subject|1|||
146122534|NCT00642941|526967203|FG009|Overall Study|Withdrawal by Subject|0|||
146262302|NCT00464945|527476397|FG001|Infant Series|Protocol Violation|0|||
146262303|NCT00464945|527476396|FG000|Infant Series|Lost to Follow-up|1|||
146122535|NCT00642941|526967204|FG010|Overall Study|Withdrawal by Subject|0|||
146122536|NCT00642941|526967205|FG011|Overall Study|Withdrawal by Subject|1|||
146262304|NCT00464945|527476397|FG001|Infant Series|Lost to Follow-up|0|||
146262305|NCT00464945|527476396|FG000|After Infant Series|Withdrawal by Subject|0|||
146122537|NCT00642941|526967194|FG000|Overall Study|Protocol Violation|0|||
146122538|NCT00642941|526967195|FG001|Overall Study|Protocol Violation|0|||
146122539|NCT00642941|526967196|FG002|Overall Study|Protocol Violation|0|||
146122540|NCT00642941|526967197|FG003|Overall Study|Protocol Violation|0|||
146122541|NCT00642941|526967198|FG004|Overall Study|Protocol Violation|0|||
146122542|NCT00642941|526967199|FG005|Overall Study|Protocol Violation|0|||
146122543|NCT00642941|526967200|FG006|Overall Study|Protocol Violation|1|||
145942743|NCT04506905|526298382|FG008|Overall Study|Withdrawal by Subject|0|||
145942744|NCT02000882|526300316|FG000|Overall Study|Adverse Event|3|||
145942745|NCT02000882|526300316|FG000|Overall Study|Physician Decision|2|||
145942746|NCT02000882|526300316|FG000|Overall Study|Withdrawal by Subject|1|||
145942747|NCT00549601|526300317|FG000|Randomized|Protocol Violation|0|||
145942748|NCT00549601|526300318|FG001|Randomized|Protocol Violation|0|||
145942749|NCT00549601|526300319|FG002|Randomized|Protocol Violation|1|||
145942750|NCT00549601|526300317|FG000|Randomized|Withdrawal by Subject|0|||
146122544|NCT00642941|526967201|FG007|Overall Study|Protocol Violation|0|||
146122545|NCT00642941|526967202|FG008|Overall Study|Protocol Violation|0|||
146122546|NCT00642941|526967203|FG009|Overall Study|Protocol Violation|0|||
146122547|NCT00642941|526967204|FG010|Overall Study|Protocol Violation|0|||
146122548|NCT00642941|526967205|FG011|Overall Study|Protocol Violation|0|||
146122549|NCT00642941|526967194|FG000|Overall Study|Adverse Event|1|||
146122550|NCT00642941|526967195|FG001|Overall Study|Adverse Event|1|||
146122551|NCT00642941|526967196|FG002|Overall Study|Adverse Event|0|||
146122552|NCT00642941|526967197|FG003|Overall Study|Adverse Event|0|||
146122553|NCT00642941|526967198|FG004|Overall Study|Adverse Event|0|||
146122554|NCT00642941|526967199|FG005|Overall Study|Adverse Event|0|||
146122555|NCT00642941|526967200|FG006|Overall Study|Adverse Event|1|||
146122556|NCT00642941|526967201|FG007|Overall Study|Adverse Event|1|||
146122557|NCT00642941|526967202|FG008|Overall Study|Adverse Event|0|||
146122558|NCT00642941|526967203|FG009|Overall Study|Adverse Event|1|||
146122559|NCT00642941|526967204|FG010|Overall Study|Adverse Event|0|||
146122560|NCT00642941|526967205|FG011|Overall Study|Adverse Event|0|||
146122561|NCT00642941|526967194|FG000|Overall Study|Other|1|||
146122562|NCT00642941|526967195|FG001|Overall Study|Other|1|||
146122563|NCT00642941|526967196|FG002|Overall Study|Other|1|||
146122564|NCT00642941|526967197|FG003|Overall Study|Other|1|||
145942751|NCT00549601|526300318|FG001|Randomized|Withdrawal by Subject|1|||
145942752|NCT00549601|526300319|FG002|Randomized|Withdrawal by Subject|1|||
145942753|NCT00549601|526300317|FG000|Received Study Drug|Adverse Event|2|||
145942754|NCT00549601|526300318|FG001|Received Study Drug|Adverse Event|5|||
145942755|NCT00549601|526300319|FG002|Received Study Drug|Adverse Event|1|||
145942756|NCT00549601|526300317|FG000|Received Study Drug|Death|0|||
145942757|NCT00549601|526300318|FG001|Received Study Drug|Death|1|||
145942758|NCT00549601|526300319|FG002|Received Study Drug|Death|0|||
146122565|NCT00642941|526967198|FG004|Overall Study|Other|0|||
146122566|NCT00642941|526967199|FG005|Overall Study|Other|1|||
146122567|NCT00642941|526967200|FG006|Overall Study|Other|0|||
146122568|NCT00642941|526967201|FG007|Overall Study|Other|1|||
146122569|NCT00642941|526967202|FG008|Overall Study|Other|0|||
146122570|NCT00642941|526967203|FG009|Overall Study|Other|0|||
146122571|NCT00642941|526967204|FG010|Overall Study|Other|0|||
146122572|NCT00642941|526967205|FG011|Overall Study|Other|1|||
146122573|NCT00642941|526967194|FG000|Overall Study|Disease progression|60|||
146122574|NCT00642941|526967195|FG001|Overall Study|Disease progression|50|||
146122575|NCT00642941|526967196|FG002|Overall Study|Disease progression|5|||
146122576|NCT00642941|526967197|FG003|Overall Study|Disease progression|36|||
146122577|NCT00642941|526967198|FG004|Overall Study|Disease progression|23|||
146122578|NCT00642941|526967199|FG005|Overall Study|Disease progression|39|||
146122579|NCT00642941|526967200|FG006|Overall Study|Disease progression|18|||
146122580|NCT00642941|526967201|FG007|Overall Study|Disease progression|12|||
145942759|NCT00549601|526300317|FG000|Received Study Drug|Lost to Follow-up|0|||
145942760|NCT00549601|526300318|FG001|Received Study Drug|Lost to Follow-up|1|||
145942761|NCT00549601|526300319|FG002|Received Study Drug|Lost to Follow-up|1|||
145942762|NCT00549601|526300317|FG000|Received Study Drug|Protocol Violation|3|||
145942763|NCT00549601|526300318|FG001|Received Study Drug|Protocol Violation|4|||
145942764|NCT00549601|526300319|FG002|Received Study Drug|Protocol Violation|1|||
145942765|NCT00549601|526300317|FG000|Received Study Drug|Withdrawal by Subject|2|||
145942766|NCT00549601|526300318|FG001|Received Study Drug|Withdrawal by Subject|0|||
145942767|NCT00549601|526300319|FG002|Received Study Drug|Withdrawal by Subject|1|||
145942768|NCT00224406|526300323|FG000|Overall Study|Re-transplant|0|||
146122581|NCT00642941|526967202|FG008|Overall Study|Disease progression|10|||
146122582|NCT00642941|526967203|FG009|Overall Study|Disease progression|7|||
146122583|NCT00642941|526967204|FG010|Overall Study|Disease progression|12|||
146122584|NCT00642941|526967205|FG011|Overall Study|Disease progression|7|||
146122585|NCT03712904|526968528|FG000|Overall Study|Death|0|||
146122586|NCT03712904|526968529|FG001|Overall Study|Death|1|||
146262306|NCT00464945|527476397|FG001|After Infant Series|Withdrawal by Subject|2|||
146262307|NCT00464945|527476396|FG000|Toddler Dose|Lost to Follow-up|0|||
146262308|NCT00464945|527476397|FG001|Toddler Dose|Lost to Follow-up|1|||
146262309|NCT03021551|527476399|FG000|Overall Study|Equipment Issues|2|||
146262310|NCT03021551|527476399|FG000|Overall Study|Protocol Violation|1|||
146262311|NCT00551135|527476404|FG000|Overall Study|Adverse Event|1|||
146262312|NCT00551135|527476405|FG001|Overall Study|Adverse Event|0|||
146262313|NCT00551135|527476406|FG002|Overall Study|Adverse Event|1|||
146262314|NCT00551135|527476407|FG003|Overall Study|Adverse Event|1|||
146262315|NCT00551135|527476404|FG000|Overall Study|Lost to Follow-up|0|||
146262316|NCT00551135|527476405|FG001|Overall Study|Lost to Follow-up|0|||
146262317|NCT00551135|527476406|FG002|Overall Study|Lost to Follow-up|0|||
146262318|NCT00551135|527476407|FG003|Overall Study|Lost to Follow-up|1|||
145942769|NCT00224406|526300324|FG001|Overall Study|Re-transplant|2|||
145942770|NCT00224406|526300323|FG000|Overall Study|Death|0|||
145942771|NCT00224406|526300324|FG001|Overall Study|Death|1|||
145942772|NCT00224406|526300323|FG000|Overall Study|Transplant cancelled|0|||
145942773|NCT00224406|526300324|FG001|Overall Study|Transplant cancelled|4|||
145942774|NCT00224406|526300323|FG000|Overall Study|Drug not delivered|2|||
145942775|NCT00224406|526300324|FG001|Overall Study|Drug not delivered|0|||
145942776|NCT00224406|526300323|FG000|Overall Study|Other|4|||
145942777|NCT00224406|526300324|FG001|Overall Study|Other|0|||
145942778|NCT00224406|526300323|FG000|Overall Study|Transplant cancelled|3|||
146303296|NCT00175877|527624169|FG000|Overall Study|Other Reason|20|||
146303297|NCT00175877|527624169|FG000|Overall Study|AE & Other|1|||
146303298|NCT00175877|527624169|FG000|Overall Study|Withdrawal by subject & Other|1|||
146303299|NCT00257166|527625722|FG000|Overall Study|Adverse Event|18|||
146303300|NCT00257166|527625723|FG001|Overall Study|Adverse Event|13|||
146303301|NCT00257166|527625722|FG000|Overall Study|Laboratory abnormality|1|||
146303302|NCT00257166|527625723|FG001|Overall Study|Laboratory abnormality|0|||
145942779|NCT00224406|526300324|FG001|Overall Study|Transplant cancelled|0|||
145942780|NCT01556997|526300325|FG000|Overall Study|Adverse Event|10|||
145942781|NCT01556997|526300326|FG001|Overall Study|Adverse Event|12|||
145942782|NCT01556997|526300327|FG002|Overall Study|Adverse Event|12|||
145942783|NCT01556997|526300325|FG000|Overall Study|Lost to Follow-up|6|||
146122587|NCT03712904|526968528|FG000|Overall Study|Withdrawal by Subject|0|||
146122588|NCT03712904|526968529|FG001|Overall Study|Withdrawal by Subject|1|||
146122589|NCT03712904|526968528|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
146122590|NCT03712904|526968529|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
146122591|NCT01852942|526968530|FG000|Overall Study|Physician Decision|1|||
146122592|NCT01852942|526968531|FG001|Overall Study|Physician Decision|0|||
146122593|NCT01852942|526968530|FG000|Overall Study|Death|1|||
146122594|NCT01852942|526968531|FG001|Overall Study|Death|1|||
146122595|NCT01852942|526968530|FG000|Overall Study|Withdrawal by Subject|2|||
146122596|NCT01852942|526968531|FG001|Overall Study|Withdrawal by Subject|3|||
146122597|NCT01852942|526968530|FG000|Overall Study|Lost to Follow-up|1|||
146122598|NCT01852942|526968531|FG001|Overall Study|Lost to Follow-up|2|||
146122599|NCT04568590|526968533|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
146122600|NCT00202644|526968536|FG000|Overall Study|Adverse Event|12|||
146122601|NCT00202644|526968537|FG001|Overall Study|Adverse Event|13|||
146122602|NCT00202644|526968536|FG000|Overall Study|Withdrawal by Subject|8|||
146122603|NCT00202644|526968537|FG001|Overall Study|Withdrawal by Subject|6|||
146122604|NCT00202644|526968536|FG000|Overall Study|Lack of Efficacy|6|||
145942784|NCT01556997|526300326|FG001|Overall Study|Lost to Follow-up|6|||
145942785|NCT01556997|526300327|FG002|Overall Study|Lost to Follow-up|4|||
145942786|NCT01556997|526300325|FG000|Overall Study|Physician Decision|1|||
145942787|NCT01556997|526300326|FG001|Overall Study|Physician Decision|1|||
145942788|NCT01556997|526300327|FG002|Overall Study|Physician Decision|1|||
145942789|NCT01556997|526300325|FG000|Overall Study|Withdrawal by Subject|7|||
145942790|NCT01556997|526300326|FG001|Overall Study|Withdrawal by Subject|6|||
145942791|NCT01556997|526300327|FG002|Overall Study|Withdrawal by Subject|8|||
145942792|NCT01556997|526300325|FG000|Overall Study|Other|2|||
145942793|NCT01556997|526300326|FG001|Overall Study|Other|3|||
145942794|NCT01556997|526300327|FG002|Overall Study|Other|7|||
145942795|NCT01250171|526300331|FG000|Overall Study|Administrative reasons|1|||
145942796|NCT01250171|526300332|FG001|Overall Study|Administrative reasons|0|||
145942797|NCT01250171|526300333|FG002|Overall Study|Administrative reasons|0|||
145942798|NCT02949908|526300334|FG000|Overall Study|Study termination|2|||
145942799|NCT02607280|526300337|FG000|Overall Study|Adverse Event|4|||
145942800|NCT02607280|526300338|FG001|Overall Study|Adverse Event|0|||
145942801|NCT02607280|526300337|FG000|Overall Study|Decrease in CrCl <15|0|||
145942802|NCT02607280|526300338|FG001|Overall Study|Decrease in CrCl <15|1|||
145942803|NCT00590538|526300339|FG000|Overall Study|Study terminated before completed|2|||
145942804|NCT02309723|526300340|FG000|Overall Study|Withdrawal by Subject|24|||
145942805|NCT02309723|526300341|FG001|Overall Study|Withdrawal by Subject|23|||
145942806|NCT02309723|526300342|FG002|Overall Study|Withdrawal by Subject|24|||
145942807|NCT01125813|526300343|FG000|Overall Study|Death|1|||
145942808|NCT01125813|526300343|FG000|Overall Study|Withdrawal by Subject|1|||
145942809|NCT01125813|526300343|FG000|Overall Study|Screen Failures|4|||
146303303|NCT00257166|527625722|FG000|Overall Study|Lost to Follow-up|8|||
145942810|NCT02539134|526300344|FG000|Overall Study|Lost to Follow-up|1|||
145942811|NCT02539134|526300345|FG001|Overall Study|Lost to Follow-up|0|||
145942812|NCT02539134|526300346|FG002|Overall Study|Lost to Follow-up|0|||
146303304|NCT00257166|527625723|FG001|Overall Study|Lost to Follow-up|1|||
146303305|NCT00257166|527625722|FG000|Overall Study|Withdrawal by Subject|9|||
146303306|NCT00257166|527625723|FG001|Overall Study|Withdrawal by Subject|2|||
145942813|NCT02539134|526300347|FG003|Overall Study|Lost to Follow-up|0|||
145942814|NCT02539134|526300348|FG004|Overall Study|Lost to Follow-up|0|||
145942815|NCT02539134|526300349|FG005|Overall Study|Lost to Follow-up|0|||
145942816|NCT02453282|526300350|FG000|Overall Study|Death|275|||
145942817|NCT02453282|526300351|FG001|Overall Study|Death|277|||
146122605|NCT00202644|526968537|FG001|Overall Study|Lack of Efficacy|6|||
146262319|NCT00551135|527476404|FG000|Overall Study|Other|3|||
146262320|NCT00551135|527476405|FG001|Overall Study|Other|2|||
145942818|NCT02453282|526300352|FG002|Overall Study|Death|296|||
145942819|NCT02453282|526300350|FG000|Overall Study|Lost to Follow-up|1|||
145942820|NCT02453282|526300351|FG001|Overall Study|Lost to Follow-up|0|||
145942821|NCT02453282|526300352|FG002|Overall Study|Lost to Follow-up|2|||
145942822|NCT02453282|526300350|FG000|Overall Study|Withdrawal by Subject|12|||
145942823|NCT02453282|526300351|FG001|Overall Study|Withdrawal by Subject|10|||
145942824|NCT02453282|526300352|FG002|Overall Study|Withdrawal by Subject|11|||
145942825|NCT02453282|526300350|FG000|Overall Study|Participants ongoing at data cut-off|85|||
145942826|NCT02453282|526300351|FG001|Overall Study|Participants ongoing at data cut-off|84|||
145942827|NCT02453282|526300352|FG002|Overall Study|Participants ongoing at data cut-off|62|||
145942828|NCT02453282|526300350|FG000|Overall Study|Other|1|||
145942829|NCT02453282|526300351|FG001|Overall Study|Other|1|||
145942830|NCT02453282|526300352|FG002|Overall Study|Other|1|||
145942831|NCT01143064|526300353|FG000|Overall Study|Death|109|||
145942832|NCT01143064|526300354|FG001|Overall Study|Death|91|||
145942833|NCT01143064|526300353|FG000|Overall Study|Adverse Event|0|||
145942834|NCT01143064|526300354|FG001|Overall Study|Adverse Event|1|||
145942835|NCT01143064|526300353|FG000|Overall Study|Withdrawal by Subject|7|||
145942836|NCT01143064|526300354|FG001|Overall Study|Withdrawal by Subject|5|||
145942837|NCT01143064|526300353|FG000|Overall Study|Lost to Follow-up|17|||
145942838|NCT01143064|526300354|FG001|Overall Study|Lost to Follow-up|14|||
145942839|NCT01143064|526300353|FG000|Overall Study|Physician Decision|0|||
145942840|NCT01143064|526300354|FG001|Overall Study|Physician Decision|4|||
145942841|NCT02327013|526300355|FG000|Overall Study|Adverse Event|4|||
145942842|NCT02327013|526300356|FG001|Overall Study|Adverse Event|4|||
145942843|NCT02327013|526300357|FG002|Overall Study|Adverse Event|3|||
145942844|NCT02327013|526300358|FG003|Overall Study|Adverse Event|0|||
145942845|NCT02327013|526300359|FG004|Overall Study|Adverse Event|1|||
145942846|NCT02327013|526300355|FG000|Overall Study|Lack of Efficacy|2|||
145942847|NCT02327013|526300356|FG001|Overall Study|Lack of Efficacy|0|||
145942848|NCT02327013|526300357|FG002|Overall Study|Lack of Efficacy|5|||
145942849|NCT02327013|526300358|FG003|Overall Study|Lack of Efficacy|0|||
145942850|NCT02327013|526300359|FG004|Overall Study|Lack of Efficacy|1|||
145942851|NCT02327013|526300355|FG000|Overall Study|Non-compliance with IMP|1|||
145942852|NCT02327013|526300356|FG001|Overall Study|Non-compliance with IMP|2|||
145942853|NCT02327013|526300357|FG002|Overall Study|Non-compliance with IMP|7|||
145942854|NCT02327013|526300358|FG003|Overall Study|Non-compliance with IMP|0|||
145942855|NCT02327013|526300359|FG004|Overall Study|Non-compliance with IMP|0|||
145942856|NCT02327013|526300355|FG000|Overall Study|Withdrawal of Consent|1|||
145942857|NCT02327013|526300356|FG001|Overall Study|Withdrawal of Consent|0|||
145942858|NCT02327013|526300357|FG002|Overall Study|Withdrawal of Consent|3|||
145942859|NCT02327013|526300358|FG003|Overall Study|Withdrawal of Consent|0|||
145942860|NCT02327013|526300359|FG004|Overall Study|Withdrawal of Consent|0|||
145942861|NCT02327013|526300355|FG000|Overall Study|Lost to Follow-up|2|||
145942862|NCT02327013|526300356|FG001|Overall Study|Lost to Follow-up|4|||
145942863|NCT02327013|526300357|FG002|Overall Study|Lost to Follow-up|5|||
145942864|NCT02327013|526300358|FG003|Overall Study|Lost to Follow-up|0|||
145942865|NCT02327013|526300359|FG004|Overall Study|Lost to Follow-up|0|||
145942866|NCT02327013|526300355|FG000|Overall Study|Administrative or other reason(s)|1|||
145942867|NCT02327013|526300356|FG001|Overall Study|Administrative or other reason(s)|5|||
145942868|NCT02327013|526300357|FG002|Overall Study|Administrative or other reason(s)|11|||
145942869|NCT02327013|526300358|FG003|Overall Study|Administrative or other reason(s)|1|||
145942870|NCT02327013|526300359|FG004|Overall Study|Administrative or other reason(s)|1|||
145942871|NCT02327013|526300355|FG000|Overall Study|Protocol Violation|0|||
145942872|NCT02327013|526300356|FG001|Overall Study|Protocol Violation|0|||
145942873|NCT02327013|526300357|FG002|Overall Study|Protocol Violation|3|||
145942874|NCT02327013|526300358|FG003|Overall Study|Protocol Violation|0|||
145942875|NCT02327013|526300359|FG004|Overall Study|Protocol Violation|1|||
145942876|NCT02327013|526300355|FG000|Overall Study|Withdrawal before treatment|2|||
145942877|NCT02327013|526300356|FG001|Overall Study|Withdrawal before treatment|1|||
145942878|NCT02327013|526300357|FG002|Overall Study|Withdrawal before treatment|5|||
145942879|NCT02327013|526300358|FG003|Overall Study|Withdrawal before treatment|0|||
145942880|NCT02327013|526300359|FG004|Overall Study|Withdrawal before treatment|0|||
145942881|NCT02380859|526300362|FG000|Overall Study|Withdrawal by Subject|2|||
145942882|NCT02380859|526300363|FG001|Overall Study|Withdrawal by Subject|0|||
145942883|NCT01565668|526300364|FG000|Overall Study|Death|2|||
145942884|NCT01565668|526300365|FG001|Overall Study|Death|1|||
145942885|NCT01565668|526300364|FG000|Overall Study|Lack of Efficacy|4|||
145942886|NCT01565668|526300365|FG001|Overall Study|Lack of Efficacy|2|||
145942887|NCT01565668|526300364|FG000|Overall Study|Participant went on Hospice Care|1|||
145942888|NCT01565668|526300365|FG001|Overall Study|Participant went on Hospice Care|0|||
145942889|NCT01565668|526300364|FG000|Overall Study|Adverse Event|6|||
145942890|NCT01565668|526300365|FG001|Overall Study|Adverse Event|1|||
145942891|NCT01565668|526300364|FG000|Overall Study|Randomized, but never received drug|0|||
145942892|NCT01565668|526300365|FG001|Overall Study|Randomized, but never received drug|2|||
145942893|NCT01565668|526300364|FG000|Overall Study|Progressive disease|13|||
145942894|NCT01565668|526300365|FG001|Overall Study|Progressive disease|14|||
145942895|NCT01565668|526300364|FG000|Overall Study|Withdrawal by Subject|1|||
145942896|NCT01565668|526300365|FG001|Overall Study|Withdrawal by Subject|3|||
145942897|NCT01565668|526300364|FG000|Overall Study|HSCT Transplant|11|||
145942898|NCT01565668|526300365|FG001|Overall Study|HSCT Transplant|15|||
145942899|NCT04258254|526300366|FG000|Overall Study|Withdrawal by Subject|0|||
145942900|NCT04258254|526300367|FG001|Overall Study|Withdrawal by Subject|1|||
145942901|NCT04258254|526300368|FG002|Overall Study|Withdrawal by Subject|0|||
145942902|NCT02255552|526300369|FG000|Overall Study|Participants enrolled into another study|0|||
145942903|NCT02255552|526300370|FG001|Overall Study|Participants enrolled into another study|11|||
145942904|NCT02255552|526300369|FG000|Overall Study|Withdrawal by Subject|1|||
145942905|NCT02255552|526300370|FG001|Overall Study|Withdrawal by Subject|4|||
145942906|NCT01447446|526300371|FG000|Overall Study|Death|6|||
145942907|NCT01447446|526300372|FG001|Overall Study|Death|3|||
145942908|NCT01447446|526300373|FG002|Overall Study|Death|2|||
145942909|NCT01447446|526300374|FG003|Overall Study|Death|1|||
146122606|NCT00202644|526968536|FG000|Overall Study|Lost to Follow-up|0|||
146122607|NCT00202644|526968537|FG001|Overall Study|Lost to Follow-up|1|||
146122608|NCT00202644|526968536|FG000|Overall Study|Other|9|||
146122609|NCT00202644|526968537|FG001|Overall Study|Other|1|||
146122610|NCT02750592|526968538|FG000|Overall Study|Adverse Event|3|||
146122611|NCT02750592|526968538|FG000|Overall Study|Lack of Efficacy|2|||
146122612|NCT02981342|526968541|FG000|Overall Study|Adverse Event|0|||
146122613|NCT02981342|526968542|FG001|Overall Study|Adverse Event|0|||
146122614|NCT02981342|526968543|FG002|Overall Study|Adverse Event|0|||
146122615|NCT02981342|526968544|FG003|Overall Study|Adverse Event|1|||
146122616|NCT02981342|526968541|FG000|Overall Study|Death|0|||
146122617|NCT02981342|526968542|FG001|Overall Study|Death|9|||
146122618|NCT02981342|526968543|FG002|Overall Study|Death|9|||
146122619|NCT02981342|526968544|FG003|Overall Study|Death|4|||
146122620|NCT02981342|526968541|FG000|Overall Study|Withdrawal by Subject|0|||
146122621|NCT02981342|526968542|FG001|Overall Study|Withdrawal by Subject|0|||
146122622|NCT02981342|526968543|FG002|Overall Study|Withdrawal by Subject|3|||
146122623|NCT02981342|526968544|FG003|Overall Study|Withdrawal by Subject|1|||
146122624|NCT02981342|526968541|FG000|Overall Study|Study closed by sponsor|0|||
146122625|NCT02981342|526968542|FG001|Overall Study|Study closed by sponsor|0|||
146122626|NCT02981342|526968543|FG002|Overall Study|Study closed by sponsor|1|||
146122627|NCT02981342|526968544|FG003|Overall Study|Study closed by sponsor|1|||
146122628|NCT02981342|526968541|FG000|Overall Study|Randomized, Never Treated|0|||
146122629|NCT02981342|526968542|FG001|Overall Study|Randomized, Never Treated|1|||
146122630|NCT02981342|526968543|FG002|Overall Study|Randomized, Never Treated|0|||
146122631|NCT02981342|526968544|FG003|Overall Study|Randomized, Never Treated|7|||
146122632|NCT02981342|526968541|FG000|Overall Study|Lost to Follow-up|0|||
146122633|NCT02981342|526968542|FG001|Overall Study|Lost to Follow-up|1|||
146122634|NCT02981342|526968543|FG002|Overall Study|Lost to Follow-up|0|||
146122635|NCT02981342|526968544|FG003|Overall Study|Lost to Follow-up|0|||
146122636|NCT01132482|526968545|FG000|Overall Study|Adverse Event|1|||
146122637|NCT01132482|526968546|FG001|Overall Study|Adverse Event|0|||
146122638|NCT01394523|526968547|FG000|Overall Study|Unable to place block|1|||
146122639|NCT01394523|526968548|FG001|Overall Study|Unable to place block|0|||
146122640|NCT01394523|526968549|FG002|Overall Study|Unable to place block|0|||
146122641|NCT00469092|526968553|FG000|Overall Study|Adverse Event|5|||
146122642|NCT00469092|526968554|FG001|Overall Study|Adverse Event|4|||
146122643|NCT00469092|526968553|FG000|Overall Study|Lack of Efficacy|1|||
146122644|NCT00469092|526968554|FG001|Overall Study|Lack of Efficacy|0|||
146122645|NCT00469092|526968553|FG000|Overall Study|Lost to Follow-up|1|||
146122646|NCT00469092|526968554|FG001|Overall Study|Lost to Follow-up|2|||
146122647|NCT00469092|526968553|FG000|Overall Study|Protocol Violation|3|||
146122648|NCT00469092|526968554|FG001|Overall Study|Protocol Violation|3|||
146122649|NCT00469092|526968553|FG000|Overall Study|Withdrawal by Subject|4|||
146122650|NCT00469092|526968554|FG001|Overall Study|Withdrawal by Subject|4|||
146122651|NCT00469092|526968553|FG000|Overall Study|Withdrawal Criteria|3|||
146122652|NCT00469092|526968554|FG001|Overall Study|Withdrawal Criteria|4|||
146122653|NCT00469092|526968553|FG000|Overall Study|Incorrectly Randomised|4|||
146122654|NCT00469092|526968554|FG001|Overall Study|Incorrectly Randomised|3|||
146122655|NCT00469092|526968553|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
146122656|NCT00469092|526968554|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
146122657|NCT00469092|526968553|FG000|Overall Study|Use of lipid lowering drug|1|||
145942910|NCT01447446|526300375|FG004|Overall Study|Death|7|||
146122658|NCT00469092|526968554|FG001|Overall Study|Use of lipid lowering drug|0|||
146122659|NCT00469092|526968553|FG000|Overall Study|Hypoglycaemic Episodes|1|||
146122660|NCT00469092|526968554|FG001|Overall Study|Hypoglycaemic Episodes|1|||
146122661|NCT00469092|526968553|FG000|Overall Study|Abnormal lab value|1|||
146122662|NCT00469092|526968554|FG001|Overall Study|Abnormal lab value|0|||
146122663|NCT00469092|526968553|FG000|Overall Study|Use of Corticosteroid|1|||
146122664|NCT00469092|526968554|FG001|Overall Study|Use of Corticosteroid|0|||
146122665|NCT01086540|526968556|FG000|Overall Study|Death|3|||
146122666|NCT01086540|526968557|FG001|Overall Study|Death|1|||
146122667|NCT01086540|526968556|FG000|Overall Study|Physician Decision|2|||
146122668|NCT01086540|526968557|FG001|Overall Study|Physician Decision|1|||
146122669|NCT01086540|526968556|FG000|Overall Study|Addition of new therapy for PAH|1|||
146122670|NCT01086540|526968557|FG001|Overall Study|Addition of new therapy for PAH|0|||
146122671|NCT05811234|526968567|FG000|Overall Study|Loss of Effectiveness|2|||
146122672|NCT05811234|526968567|FG000|Overall Study|Adverse Event|4|||
146122673|NCT05811234|526968567|FG000|Overall Study|Pregnancy|1|||
146122674|NCT05811234|526968567|FG000|Overall Study|Disease progression|1|||
146122675|NCT05811234|526968567|FG000|Overall Study|Withdrawal by Subject|4|||
146122676|NCT05811234|526968567|FG000|Overall Study|Lost to Follow-up|13|||
146122677|NCT05811234|526968567|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
146122678|NCT04499781|526968568|FG000|Overall Study|Lost to Follow-up|2|||
146122679|NCT04499781|526968569|FG001|Overall Study|Lost to Follow-up|3|||
146122680|NCT04499781|526968568|FG000|Overall Study|Withdrawal by Subject|2|||
146122681|NCT04499781|526968569|FG001|Overall Study|Withdrawal by Subject|0|||
146122682|NCT00227305|526968570|FG000|Overall Study|Adverse Event|40|||
146122683|NCT00227305|526968570|FG000|Overall Study|Withdrawal by Subject|42|||
146122684|NCT00227305|526968570|FG000|Overall Study|Lost to Follow-up|33|||
146122685|NCT00227305|526968570|FG000|Overall Study|Study specific discontinuation|13|||
146122686|NCT00227305|526968570|FG000|Overall Study|MOVED OUT OF AREA|3|||
146122687|NCT00227305|526968570|FG000|Overall Study|Lack of Efficacy|7|||
146122688|NCT00227305|526968570|FG000|Overall Study|Physician Decision|3|||
146122689|NCT00227305|526968570|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
146122690|NCT00227305|526968570|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
146122691|NCT00227305|526968570|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
146122692|NCT02118012|526968571|FG000|Overall Study|Adverse Event|0|||
146122693|NCT02118012|526968572|FG001|Overall Study|Adverse Event|1|||
146122694|NCT02118012|526968571|FG000|Overall Study|Physician Decision|0|||
146122695|NCT02118012|526968572|FG001|Overall Study|Physician Decision|1|||
146122696|NCT04519645|526968576|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
146122697|NCT04519645|526968577|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
146122698|NCT04519645|526968578|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
146122699|NCT04519645|526968576|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
146122700|NCT04519645|526968577|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
146122701|NCT04519645|526968578|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
146122702|NCT04519645|526968576|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
146122703|NCT04519645|526968577|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
146122704|NCT04519645|526968578|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
146122705|NCT04519645|526968576|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
146122706|NCT04519645|526968577|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
146122707|NCT04519645|526968578|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
146122708|NCT00619801|526968579|FG000|Overall Study|Lack of Efficacy|0|||
146122709|NCT00619801|526968580|FG001|Overall Study|Lack of Efficacy|1|||
146122710|NCT00619801|526968579|FG000|Overall Study|Withdrawal by Subject|1|||
146122711|NCT00619801|526968580|FG001|Overall Study|Withdrawal by Subject|1|||
146122712|NCT00619801|526968579|FG000|Overall Study|Loss of efficacy|0|||
146122713|NCT00619801|526968580|FG001|Overall Study|Loss of efficacy|1|||
146122714|NCT03051607|526968581|FG000|Overall Study|Adverse Event|66|||
146122715|NCT03338855|526968583|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
146122716|NCT03338855|526968584|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
146122717|NCT00455429|526968585|FG000|Overall Study|Study Terminated by Sponsor|0|||
146122718|NCT00455429|526968586|FG001|Overall Study|Study Terminated by Sponsor|0|||
146122719|NCT00455429|526968587|FG002|Overall Study|Study Terminated by Sponsor|0|||
146122720|NCT00455429|526968588|FG003|Overall Study|Study Terminated by Sponsor|3|||
146122721|NCT00455429|526968585|FG000|Overall Study|Lost to Follow-up|1|||
146122722|NCT00455429|526968586|FG001|Overall Study|Lost to Follow-up|0|||
146122723|NCT00455429|526968587|FG002|Overall Study|Lost to Follow-up|0|||
146122724|NCT00455429|526968588|FG003|Overall Study|Lost to Follow-up|3|||
146122725|NCT00455429|526968585|FG000|Overall Study|Withdrawal by Subject|0|||
146122726|NCT00455429|526968586|FG001|Overall Study|Withdrawal by Subject|1|||
146122727|NCT00455429|526968587|FG002|Overall Study|Withdrawal by Subject|1|||
146122728|NCT00455429|526968588|FG003|Overall Study|Withdrawal by Subject|0|||
146122729|NCT00455429|526968585|FG000|Overall Study|Lack of Efficacy|0|||
145942911|NCT01447446|526300376|FG005|Overall Study|Death|0|||
146122730|NCT00455429|526968586|FG001|Overall Study|Lack of Efficacy|1|||
146122731|NCT00455429|526968587|FG002|Overall Study|Lack of Efficacy|0|||
146122732|NCT00455429|526968588|FG003|Overall Study|Lack of Efficacy|1|||
146122733|NCT00455429|526968585|FG000|Overall Study|Adverse Event|0|||
146122734|NCT00455429|526968586|FG001|Overall Study|Adverse Event|1|||
146122735|NCT00455429|526968587|FG002|Overall Study|Adverse Event|0|||
146122736|NCT00455429|526968588|FG003|Overall Study|Adverse Event|3|||
146122737|NCT00455429|526968585|FG000|Overall Study|Randomly assigned but not treated|0|||
146122738|NCT00455429|526968586|FG001|Overall Study|Randomly assigned but not treated|0|||
146122739|NCT00455429|526968587|FG002|Overall Study|Randomly assigned but not treated|0|||
146122740|NCT00455429|526968588|FG003|Overall Study|Randomly assigned but not treated|2|||
146122741|NCT00455429|526968585|FG000|Overall Study|Personal Reason|1|||
146122742|NCT00455429|526968586|FG001|Overall Study|Personal Reason|0|||
146122743|NCT00455429|526968587|FG002|Overall Study|Personal Reason|0|||
146122744|NCT00455429|526968588|FG003|Overall Study|Personal Reason|0|||
146122745|NCT00455429|526968585|FG000|Overall Study|Non-compliance|0|||
146122746|NCT00455429|526968586|FG001|Overall Study|Non-compliance|0|||
146122747|NCT00455429|526968587|FG002|Overall Study|Non-compliance|0|||
146122748|NCT00455429|526968588|FG003|Overall Study|Non-compliance|1|||
146122749|NCT00455429|526968585|FG000|Overall Study|Other|0|||
146122750|NCT00455429|526968586|FG001|Overall Study|Other|2|||
146122751|NCT00455429|526968587|FG002|Overall Study|Other|0|||
146122752|NCT00455429|526968588|FG003|Overall Study|Other|1|||
146122753|NCT04948450|526968589|FG000|Overall Study|Return home|1|||
146122754|NCT04948450|526968590|FG001|Overall Study|Return home|3|||
146122755|NCT03658538|526968600|FG000|Overall Study|Death|2|||
146122756|NCT03658538|526968601|FG001|Overall Study|Death|1|||
146262321|NCT00551135|527476406|FG002|Overall Study|Other|1|||
146262322|NCT00551135|527476407|FG003|Overall Study|Other|2|||
146262323|NCT00551135|527476404|FG000|Overall Study|Withdrawal by Subject|1|||
146262324|NCT00551135|527476405|FG001|Overall Study|Withdrawal by Subject|0|||
146122757|NCT03658538|526968600|FG000|Overall Study|Cancer diagnosis|1|||
146122758|NCT03658538|526968601|FG001|Overall Study|Cancer diagnosis|0|||
146122759|NCT03658538|526968600|FG000|Overall Study|Change residence|1|||
146122760|NCT03658538|526968601|FG001|Overall Study|Change residence|2|||
146122761|NCT03658538|526968600|FG000|Overall Study|Lost to Follow-up|3|||
146122762|NCT03658538|526968601|FG001|Overall Study|Lost to Follow-up|3|||
146122763|NCT03658538|526968600|FG000|Overall Study|Unblinded|2|||
146122764|NCT03658538|526968601|FG001|Overall Study|Unblinded|3|||
146122765|NCT03658538|526968600|FG000|Overall Study|Physician Decision|0|||
146122766|NCT03658538|526968601|FG001|Overall Study|Physician Decision|1|||
146122767|NCT03658538|526968600|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
146122768|NCT03658538|526968601|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
146122769|NCT03658538|526968600|FG000|Overall Study|Evicted from home|1|||
146122770|NCT03658538|526968601|FG001|Overall Study|Evicted from home|0|||
146122771|NCT02588833|526968602|FG000|Part 1|Withdrawal by Subject|1|||
146122772|NCT02588833|526968603|FG001|Part 1|Withdrawal by Subject|0|||
146122773|NCT02588833|526968602|FG000|Part 2A|Physician Decision|0|||
146122774|NCT02588833|526968603|FG001|Part 2A|Physician Decision|1|||
146122775|NCT02588833|526968602|FG000|Part 2A|Withdrawal by Subject|0|||
146122776|NCT02588833|526968603|FG001|Part 2A|Withdrawal by Subject|1|||
146122777|NCT02588833|526968602|FG000|Part 2B|Adverse Event|0|||
146122778|NCT02588833|526968603|FG001|Part 2B|Adverse Event|1|||
146122779|NCT02588833|526968602|FG000|Part 2C|Adverse Event|0|||
146122780|NCT02588833|526968603|FG001|Part 2C|Adverse Event|1|||
146122781|NCT02588833|526968602|FG000|Part 2C|Withdrawal by Subject|0|||
146122782|NCT02588833|526968603|FG001|Part 2C|Withdrawal by Subject|1|||
146122783|NCT02588833|526968602|FG000|Part 3 (Safety Follow-up)|Other|0|||
146122784|NCT02588833|526968603|FG001|Part 3 (Safety Follow-up)|Other|2|||
146122785|NCT03649711|526968606|FG000|Overall Study|Adverse Event|0|||
146122786|NCT03649711|526968607|FG001|Overall Study|Adverse Event|1|||
146122787|NCT03649711|526968608|FG002|Overall Study|Adverse Event|0|||
146122788|NCT03649711|526968606|FG000|Overall Study|Kidney Transplant|1|||
146122789|NCT03649711|526968607|FG001|Overall Study|Kidney Transplant|0|||
146122790|NCT03649711|526968608|FG002|Overall Study|Kidney Transplant|0|||
146122791|NCT02921776|526968609|FG000|Overall Study|patient deterioration, fatigue|2|||
146122792|NCT02921776|526968610|FG001|Overall Study|patient deterioration, fatigue|6|||
146122793|NCT02921776|526968611|FG002|Overall Study|patient deterioration, fatigue|0|||
146122794|NCT02921776|526968612|FG003|Overall Study|patient deterioration, fatigue|0|||
146122795|NCT02921776|526968613|FG004|Overall Study|patient deterioration, fatigue|0|||
146122796|NCT02921776|526968614|FG005|Overall Study|patient deterioration, fatigue|0|||
146122797|NCT02921776|526968615|FG006|Overall Study|patient deterioration, fatigue|0|||
146262325|NCT00551135|527476406|FG002|Overall Study|Withdrawal by Subject|3|||
146262326|NCT00551135|527476407|FG003|Overall Study|Withdrawal by Subject|1|||
146262327|NCT04799418|527476408|FG000|Overall Study|Death|1|||
146262328|NCT04799418|527476409|FG001|Overall Study|Death|1|||
146122798|NCT02921776|526968616|FG007|Overall Study|patient deterioration, fatigue|0|||
146122799|NCT02921776|526968609|FG000|Overall Study|Withdrawal by Subject|0|||
146122800|NCT02921776|526968610|FG001|Overall Study|Withdrawal by Subject|2|||
146122801|NCT02921776|526968611|FG002|Overall Study|Withdrawal by Subject|0|||
146122802|NCT02921776|526968612|FG003|Overall Study|Withdrawal by Subject|1|||
146122803|NCT02921776|526968613|FG004|Overall Study|Withdrawal by Subject|1|||
146122804|NCT02921776|526968614|FG005|Overall Study|Withdrawal by Subject|0|||
146122805|NCT02921776|526968615|FG006|Overall Study|Withdrawal by Subject|8|||
146122806|NCT02921776|526968616|FG007|Overall Study|Withdrawal by Subject|1|||
146122807|NCT02921776|526968609|FG000|Overall Study|Death|0|||
146122808|NCT02921776|526968610|FG001|Overall Study|Death|0|||
146122809|NCT02921776|526968611|FG002|Overall Study|Death|0|||
146122810|NCT02921776|526968612|FG003|Overall Study|Death|2|||
146122811|NCT02921776|526968613|FG004|Overall Study|Death|0|||
146122812|NCT02921776|526968614|FG005|Overall Study|Death|0|||
146122813|NCT02921776|526968615|FG006|Overall Study|Death|0|||
146122814|NCT02921776|526968616|FG007|Overall Study|Death|0|||
146122815|NCT02921776|526968609|FG000|Overall Study|extubation or early discharge|0|||
146122816|NCT02921776|526968610|FG001|Overall Study|extubation or early discharge|0|||
146122817|NCT02921776|526968611|FG002|Overall Study|extubation or early discharge|0|||
146122818|NCT02921776|526968612|FG003|Overall Study|extubation or early discharge|5|||
146122819|NCT02921776|526968613|FG004|Overall Study|extubation or early discharge|5|||
146122820|NCT02921776|526968614|FG005|Overall Study|extubation or early discharge|0|||
146122821|NCT02921776|526968615|FG006|Overall Study|extubation or early discharge|0|||
146122822|NCT02921776|526968616|FG007|Overall Study|extubation or early discharge|0|||
146122823|NCT02921776|526968609|FG000|Overall Study|Lost to Follow-up|0|||
146122824|NCT02921776|526968610|FG001|Overall Study|Lost to Follow-up|0|||
146122825|NCT02921776|526968611|FG002|Overall Study|Lost to Follow-up|0|||
146122826|NCT02921776|526968612|FG003|Overall Study|Lost to Follow-up|0|||
146122827|NCT02921776|526968613|FG004|Overall Study|Lost to Follow-up|0|||
146122828|NCT02921776|526968614|FG005|Overall Study|Lost to Follow-up|2|||
146122829|NCT02921776|526968615|FG006|Overall Study|Lost to Follow-up|3|||
146122830|NCT02921776|526968616|FG007|Overall Study|Lost to Follow-up|6|||
146122831|NCT00296374|526968618|FG000|Overall Study|Adverse Event|14|||
146122832|NCT00296374|526968619|FG001|Overall Study|Adverse Event|10|||
146122833|NCT00296374|526968620|FG002|Overall Study|Adverse Event|7|||
146122834|NCT00296374|526968618|FG000|Overall Study|Withdrawal by Subject|3|||
146122835|NCT00296374|526968619|FG001|Overall Study|Withdrawal by Subject|5|||
146122836|NCT00296374|526968620|FG002|Overall Study|Withdrawal by Subject|11|||
146122837|NCT00296374|526968618|FG000|Overall Study|Incorrect enrollment|3|||
146122838|NCT00296374|526968619|FG001|Overall Study|Incorrect enrollment|3|||
146122839|NCT00296374|526968620|FG002|Overall Study|Incorrect enrollment|4|||
146122840|NCT00296374|526968618|FG000|Overall Study|Protocol Violation|1|||
146122841|NCT00296374|526968619|FG001|Overall Study|Protocol Violation|2|||
146122842|NCT00296374|526968620|FG002|Overall Study|Protocol Violation|3|||
146122843|NCT00296374|526968618|FG000|Overall Study|Lost to Follow-up|3|||
146122844|NCT00296374|526968619|FG001|Overall Study|Lost to Follow-up|1|||
146122845|NCT00296374|526968620|FG002|Overall Study|Lost to Follow-up|1|||
146122846|NCT00296374|526968618|FG000|Overall Study|Relocated to another state|1|||
146122847|NCT00296374|526968619|FG001|Overall Study|Relocated to another state|0|||
146122848|NCT00296374|526968620|FG002|Overall Study|Relocated to another state|0|||
146122849|NCT00296374|526968618|FG000|Overall Study|Stopped drug before end of study visit|0|||
146122850|NCT00296374|526968619|FG001|Overall Study|Stopped drug before end of study visit|1|||
146122851|NCT00296374|526968620|FG002|Overall Study|Stopped drug before end of study visit|0|||
146122852|NCT00296374|526968618|FG000|Overall Study|Nephrologist introduced ACE|0|||
146122853|NCT00296374|526968619|FG001|Overall Study|Nephrologist introduced ACE|1|||
146122854|NCT00296374|526968620|FG002|Overall Study|Nephrologist introduced ACE|0|||
146122855|NCT00296374|526968618|FG000|Overall Study|Pregnancy|0|||
146122856|NCT00296374|526968619|FG001|Overall Study|Pregnancy|0|||
146122857|NCT00296374|526968620|FG002|Overall Study|Pregnancy|2|||
146122858|NCT00296374|526968618|FG000|Overall Study|Other|0|||
146122859|NCT00296374|526968619|FG001|Overall Study|Other|0|||
146122860|NCT00296374|526968620|FG002|Overall Study|Other|1|||
146122861|NCT01721330|526968621|FG000|Overall Study|Withdrawal by Subject|0|||
146122862|NCT01721330|526968622|FG001|Overall Study|Withdrawal by Subject|1|||
146122863|NCT04318080|526970602|FG000|Overall Study|Study closed by sponsor|10|||
146122864|NCT04318080|526970603|FG001|Overall Study|Study closed by sponsor|22|||
146122865|NCT04318080|526970602|FG000|Overall Study|Death|3|||
146122866|NCT04318080|526970603|FG001|Overall Study|Death|9|||
146122867|NCT04318080|526970602|FG000|Overall Study|Withdrawal by Subject|1|||
146122868|NCT04318080|526970603|FG001|Overall Study|Withdrawal by Subject|0|||
146122869|NCT04318080|526970602|FG000|Overall Study|Protocol Deviation|1|||
146122870|NCT04318080|526970603|FG001|Overall Study|Protocol Deviation|0|||
146122871|NCT06308822|526970604|FG000|Overall Study|Mutation Status Not Confirmed|17|||
146122872|NCT06308822|526970604|FG000|Overall Study|Adverse Event|1|||
146122873|NCT06308822|526970604|FG000|Overall Study|Death|5|||
146122874|NCT06308822|526970604|FG000|Overall Study|Disease progression|8|||
146122875|NCT06308822|526970604|FG000|Overall Study|Withdrawal by Subject|1|||
146122876|NCT06308822|526970604|FG000|Overall Study|Physician Decision|3|||
146122877|NCT00542919|526970612|FG000|Overall Study|Adverse Event|1|||
146122878|NCT00542919|526970613|FG001|Overall Study|Adverse Event|5|||
146122879|NCT00542919|526970614|FG002|Overall Study|Adverse Event|1|||
146122880|NCT00542919|526970612|FG000|Overall Study|Withdrawal by Subject|1|||
146122881|NCT00542919|526970613|FG001|Overall Study|Withdrawal by Subject|0|||
146122882|NCT00542919|526970614|FG002|Overall Study|Withdrawal by Subject|3|||
146122883|NCT00542919|526970612|FG000|Overall Study|Physician Decision|2|||
146122884|NCT00542919|526970613|FG001|Overall Study|Physician Decision|2|||
146122885|NCT00542919|526970614|FG002|Overall Study|Physician Decision|1|||
146122886|NCT00542919|526970612|FG000|Overall Study|Sponsor Decision|1|||
146122887|NCT00542919|526970613|FG001|Overall Study|Sponsor Decision|0|||
146122888|NCT00542919|526970614|FG002|Overall Study|Sponsor Decision|0|||
146122889|NCT00542919|526970612|FG000|Overall Study|Lost to Follow-up|2|||
146122890|NCT00542919|526970613|FG001|Overall Study|Lost to Follow-up|0|||
146122891|NCT00542919|526970614|FG002|Overall Study|Lost to Follow-up|1|||
146122892|NCT04788953|526970617|FG000|Overall Study|Adverse Event|1|||
146122893|NCT04788953|526970618|FG001|Overall Study|Adverse Event|1|||
146122894|NCT04788953|526970617|FG000|Overall Study|Withdrawal by Subject|1|||
146122895|NCT04788953|526970618|FG001|Overall Study|Withdrawal by Subject|0|||
146122896|NCT04788953|526970617|FG000|Overall Study|Protocol Violation|0|||
146122897|NCT04788953|526970618|FG001|Overall Study|Protocol Violation|1|||
146122898|NCT02278263|526970619|FG000|Overall Study|Protocol Violation|7|||
146122899|NCT02278263|526970620|FG001|Overall Study|Protocol Violation|0|||
146122900|NCT02278263|526970621|FG002|Overall Study|Protocol Violation|9|||
146122901|NCT02092662|526970622|FG000|Overall Study|Lost to Follow-up|13|||
146122902|NCT02092662|526970623|FG001|Overall Study|Lost to Follow-up|0|||
146122903|NCT02710045|526970624|FG000|Overall Study|Death|1|||
146122904|NCT02710045|526970625|FG001|Overall Study|Death|2|||
146122905|NCT02710045|526970626|FG002|Overall Study|Death|0|||
146122906|NCT02710045|526970624|FG000|Overall Study|Withdrawal by Subject|6|||
146122907|NCT02710045|526970625|FG001|Overall Study|Withdrawal by Subject|6|||
146122908|NCT02710045|526970626|FG002|Overall Study|Withdrawal by Subject|2|||
146122909|NCT02710045|526970624|FG000|Overall Study|Protocol Violation|1|||
146122910|NCT02710045|526970625|FG001|Overall Study|Protocol Violation|2|||
146122911|NCT02710045|526970626|FG002|Overall Study|Protocol Violation|3|||
146122912|NCT02710045|526970624|FG000|Overall Study|Lost to Follow-up|3|||
146122913|NCT02710045|526970625|FG001|Overall Study|Lost to Follow-up|6|||
146122914|NCT02710045|526970626|FG002|Overall Study|Lost to Follow-up|7|||
146122915|NCT02710045|526970624|FG000|Overall Study|Physician Decision|0|||
146122916|NCT02710045|526970625|FG001|Overall Study|Physician Decision|0|||
146122917|NCT02710045|526970626|FG002|Overall Study|Physician Decision|1|||
146122918|NCT02710045|526970624|FG000|Overall Study|Poor Attendance|0|||
146122919|NCT02710045|526970625|FG001|Overall Study|Poor Attendance|1|||
146122920|NCT02710045|526970626|FG002|Overall Study|Poor Attendance|0|||
146122921|NCT03424265|526970630|FG000|Overall Study|screening failure|1|||
146122922|NCT03424265|526970631|FG001|Overall Study|screening failure|0|||
146122923|NCT03424265|526970630|FG000|Overall Study|Withdrawal by Subject|0|||
146122924|NCT03424265|526970631|FG001|Overall Study|Withdrawal by Subject|2|||
146122925|NCT03447990|526970642|FG000|Overall Study|Withdrawal by Subject|0|||
146122926|NCT03447990|526970643|FG001|Overall Study|Withdrawal by Subject|0|||
146122927|NCT03447990|526970644|FG002|Overall Study|Withdrawal by Subject|0|||
146122928|NCT03447990|526970645|FG003|Overall Study|Withdrawal by Subject|0|||
146122929|NCT03447990|526970646|FG004|Overall Study|Withdrawal by Subject|0|||
146122930|NCT03447990|526970647|FG005|Overall Study|Withdrawal by Subject|0|||
146122931|NCT03447990|526970648|FG006|Overall Study|Withdrawal by Subject|1|||
146122932|NCT03251079|526970649|FG000|Overall Study|Withdrawal by Subject|1|||
146122933|NCT01603459|526970661|FG000|Overall Study|Adverse Event|5|||
146122934|NCT01603459|526970661|FG000|Overall Study|Withdrawal by Subject|5|||
146122935|NCT01603459|526970661|FG000|Overall Study|Lost to Follow-up|3|||
146122936|NCT01603459|526970661|FG000|Overall Study|Predefined discontinuation criteria|3|||
146122937|NCT01603459|526970661|FG000|Overall Study|Non-compliance|1|||
146122938|NCT01603459|526970661|FG000|Overall Study|Administrative reason|1|||
146122939|NCT00399360|526970662|FG000|Overall Study|Lost to Follow-up|2|||
146122940|NCT00399360|526970663|FG001|Overall Study|Lost to Follow-up|1|||
146122941|NCT00399360|526970664|FG002|Overall Study|Lost to Follow-up|2|||
146122942|NCT00399360|526970665|FG003|Overall Study|Lost to Follow-up|4|||
146122943|NCT00399360|526970662|FG000|Overall Study|Adverse Event|0|||
146262329|NCT04799418|527476408|FG000|Overall Study|Lack of Efficacy|14|||
146262330|NCT04799418|527476409|FG001|Overall Study|Lack of Efficacy|14|||
146262331|NCT04799418|527476408|FG000|Overall Study|Withdrawal by Subject|10|||
146262332|NCT04799418|527476409|FG001|Overall Study|Withdrawal by Subject|7|||
146262333|NCT04799418|527476408|FG000|Overall Study|Adverse Event|3|||
146262334|NCT04799418|527476409|FG001|Overall Study|Adverse Event|2|||
146262335|NCT01379703|527476410|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
146122944|NCT00399360|526970663|FG001|Overall Study|Adverse Event|0|||
146122945|NCT00399360|526970664|FG002|Overall Study|Adverse Event|1|||
146122946|NCT00399360|526970665|FG003|Overall Study|Adverse Event|0|||
145942912|NCT01447446|526300371|FG000|Overall Study|Adverse Event|3|||
145942913|NCT01447446|526300372|FG001|Overall Study|Adverse Event|0|||
146303307|NCT00257166|527625722|FG000|Overall Study|Other|16|||
145942914|NCT01447446|526300373|FG002|Overall Study|Adverse Event|1|||
145942915|NCT01447446|526300374|FG003|Overall Study|Adverse Event|0|||
146262336|NCT01379703|527476411|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
146262337|NCT01379703|527476412|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
146122947|NCT00399360|526970662|FG000|Overall Study|Withdrawal by Subject|0|||
146122948|NCT00399360|526970663|FG001|Overall Study|Withdrawal by Subject|2|||
146122949|NCT00399360|526970664|FG002|Overall Study|Withdrawal by Subject|0|||
146122950|NCT00399360|526970665|FG003|Overall Study|Withdrawal by Subject|2|||
146122951|NCT01288287|526970669|FG000|Overall Study|Lost to Follow-up|8|||
146122952|NCT01288287|526970669|FG000|Overall Study|Withdrawal by Subject|4|||
146122953|NCT01288287|526970669|FG000|Overall Study|Lack of Efficacy|13|||
146122954|NCT01288287|526970669|FG000|Overall Study|Other Reason|13|||
146262338|NCT01379703|527476410|FG000|Study Start Through 9 Months|Adverse Event|0|||
146303308|NCT00257166|527625723|FG001|Overall Study|Other|21|||
146303309|NCT00257166|527625722|FG000|Overall Study|Randomized, but not treated|1|||
146303310|NCT00257166|527625723|FG001|Overall Study|Randomized, but not treated|0|||
146303311|NCT01641237|527625733|FG000|Period II|Withdrawal by Subject|1|||
145942916|NCT01447446|526300375|FG004|Overall Study|Adverse Event|2|||
145942917|NCT01447446|526300376|FG005|Overall Study|Adverse Event|0|||
145942918|NCT01447446|526300371|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
145942919|NCT01447446|526300372|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
146303312|NCT01641237|527625734|FG001|Period II|Withdrawal by Subject|0|||
146303313|NCT01641237|527625735|FG002|Period II|Withdrawal by Subject|0|||
146303314|NCT01641237|527625736|FG003|Period II|Withdrawal by Subject|0|||
146303315|NCT01641237|527625733|FG000|Period III|Lost to Follow-up|1|||
146303316|NCT01641237|527625734|FG001|Period III|Lost to Follow-up|0|||
146303317|NCT01641237|527625735|FG002|Period III|Lost to Follow-up|0|||
146303318|NCT01641237|527625736|FG003|Period III|Lost to Follow-up|0|||
146303319|NCT02716675|527625737|FG000|Overall Study|Death|2|||
146303320|NCT02716675|527625738|FG001|Overall Study|Death|3|||
146303321|NCT02716675|527625739|FG002|Overall Study|Death|0|||
145942920|NCT01447446|526300373|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
145942921|NCT01447446|526300374|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
145942922|NCT01447446|526300375|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
145942923|NCT01447446|526300376|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
145942924|NCT01447446|526300371|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
145942925|NCT01447446|526300372|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
145942926|NCT01447446|526300373|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
145942927|NCT01447446|526300374|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
145942928|NCT01447446|526300375|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
145942929|NCT01447446|526300376|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
145942930|NCT01447446|526300371|FG000|Overall Study|Administrative/Other|34|||
145942931|NCT01447446|526300372|FG001|Overall Study|Administrative/Other|9|||
145942932|NCT01447446|526300373|FG002|Overall Study|Administrative/Other|10|||
145942933|NCT01447446|526300374|FG003|Overall Study|Administrative/Other|2|||
145942934|NCT01447446|526300375|FG004|Overall Study|Administrative/Other|33|||
145942935|NCT01447446|526300376|FG005|Overall Study|Administrative/Other|4|||
145942936|NCT01447446|526300371|FG000|Overall Study|SVR12 Assessment|13|||
145942937|NCT01447446|526300372|FG001|Overall Study|SVR12 Assessment|1|||
145942938|NCT01447446|526300373|FG002|Overall Study|SVR12 Assessment|2|||
145942939|NCT01447446|526300374|FG003|Overall Study|SVR12 Assessment|1|||
145942940|NCT01447446|526300375|FG004|Overall Study|SVR12 Assessment|5|||
145942941|NCT01447446|526300376|FG005|Overall Study|SVR12 Assessment|5|||
145942942|NCT01447446|526300371|FG000|Overall Study|New Treatment Started|8|||
145942943|NCT01447446|526300372|FG001|Overall Study|New Treatment Started|2|||
145942944|NCT01447446|526300373|FG002|Overall Study|New Treatment Started|1|||
145942945|NCT01447446|526300374|FG003|Overall Study|New Treatment Started|0|||
145942946|NCT01447446|526300375|FG004|Overall Study|New Treatment Started|2|||
145942947|NCT01447446|526300376|FG005|Overall Study|New Treatment Started|0|||
145942948|NCT01447446|526300371|FG000|Overall Study|Reason not Specified|1|||
145942949|NCT01447446|526300372|FG001|Overall Study|Reason not Specified|1|||
145942950|NCT01447446|526300373|FG002|Overall Study|Reason not Specified|1|||
145942951|NCT01447446|526300374|FG003|Overall Study|Reason not Specified|1|||
145942952|NCT01447446|526300375|FG004|Overall Study|Reason not Specified|1|||
145942953|NCT01447446|526300376|FG005|Overall Study|Reason not Specified|0|||
145942954|NCT03747302|526300379|FG000|Overall Study|Withdrawal by Subject|1|||
145942955|NCT03747302|526300380|FG001|Overall Study|Withdrawal by Subject|2|||
145942956|NCT01032070|526300381|FG000|Overall Study|Disease progression|13|||
145942957|NCT01032070|526300382|FG001|Overall Study|Disease progression|8|||
145942958|NCT01032070|526300381|FG000|Overall Study|Medical or ethical reasons|0|||
145942959|NCT01032070|526300382|FG001|Overall Study|Medical or ethical reasons|2|||
145942960|NCT01032070|526300381|FG000|Overall Study|Withdrawal by Subject|0|||
145942961|NCT01032070|526300382|FG001|Overall Study|Withdrawal by Subject|2|||
146303322|NCT02716675|527625737|FG000|Overall Study|Physician Decision|2|||
146303323|NCT02716675|527625738|FG001|Overall Study|Physician Decision|1|||
145942962|NCT02772276|526300385|FG000|Overall Study|Lost to Follow-up|0|||
145942963|NCT02772276|526300386|FG001|Overall Study|Lost to Follow-up|0|||
146303324|NCT02716675|527625739|FG002|Overall Study|Physician Decision|1|||
146303325|NCT02716675|527625737|FG000|Overall Study|Lost to Follow-up|100|||
146303326|NCT02716675|527625738|FG001|Overall Study|Lost to Follow-up|87|||
146303327|NCT02716675|527625739|FG002|Overall Study|Lost to Follow-up|99|||
145942964|NCT02772276|526300387|FG002|Overall Study|Lost to Follow-up|0|||
145942965|NCT02772276|526300388|FG003|Overall Study|Lost to Follow-up|0|||
145942966|NCT02772276|526300389|FG004|Overall Study|Lost to Follow-up|0|||
145942967|NCT02772276|526300390|FG005|Overall Study|Lost to Follow-up|0|||
145942968|NCT02772276|526300391|FG006|Overall Study|Lost to Follow-up|1|||
145942969|NCT02772276|526300392|FG007|Overall Study|Lost to Follow-up|0|||
145942970|NCT02772276|526300393|FG008|Overall Study|Lost to Follow-up|0|||
145942971|NCT02772276|526300394|FG009|Overall Study|Lost to Follow-up|0|||
146303328|NCT02716675|527625737|FG000|Overall Study|Withdrawal by Subject|22|||
145942972|NCT02772276|526300395|FG010|Overall Study|Lost to Follow-up|0|||
145942973|NCT02772276|526300396|FG011|Overall Study|Lost to Follow-up|0|||
145942974|NCT02772276|526300397|FG012|Overall Study|Lost to Follow-up|0|||
145942975|NCT02772276|526300385|FG000|Overall Study|Withdrew consent|0|||
145942976|NCT02772276|526300386|FG001|Overall Study|Withdrew consent|0|||
145942977|NCT02772276|526300387|FG002|Overall Study|Withdrew consent|0|||
145942978|NCT02772276|526300388|FG003|Overall Study|Withdrew consent|0|||
145942979|NCT02772276|526300389|FG004|Overall Study|Withdrew consent|0|||
145942980|NCT02772276|526300390|FG005|Overall Study|Withdrew consent|0|||
145942981|NCT02772276|526300391|FG006|Overall Study|Withdrew consent|0|||
145942982|NCT02772276|526300392|FG007|Overall Study|Withdrew consent|1|||
145942983|NCT02772276|526300393|FG008|Overall Study|Withdrew consent|0|||
145942984|NCT02772276|526300394|FG009|Overall Study|Withdrew consent|0|||
145942985|NCT02772276|526300395|FG010|Overall Study|Withdrew consent|0|||
145942986|NCT02772276|526300396|FG011|Overall Study|Withdrew consent|0|||
145942987|NCT02772276|526300397|FG012|Overall Study|Withdrew consent|0|||
145942988|NCT00738062|526300398|FG000|Open Label Treatment|Lack of Efficacy|5|||
145942989|NCT00738062|526300399|FG001|Open Label Treatment|Lack of Efficacy|0|||
145942990|NCT00738062|526300400|FG002|Open Label Treatment|Lack of Efficacy|0|||
145942991|NCT00738062|526300398|FG000|Open Label Treatment|Adverse Event|11|||
145942992|NCT00738062|526300399|FG001|Open Label Treatment|Adverse Event|0|||
145942993|NCT00738062|526300400|FG002|Open Label Treatment|Adverse Event|0|||
145942994|NCT00738062|526300398|FG000|Open Label Treatment|Protocol Violation|2|||
146122955|NCT01288287|526970669|FG000|Overall Study|Unknown Reason|1|||
146122956|NCT01288287|526970669|FG000|Overall Study|Unknown Status|7|||
146122957|NCT03519347|526970670|FG000|Interventional Crossover Period 1|Death|0|||
146122958|NCT03519347|526970671|FG001|Interventional Crossover Period 1|Death|0|||
145942995|NCT00738062|526300399|FG001|Open Label Treatment|Protocol Violation|0|||
145942996|NCT00738062|526300400|FG002|Open Label Treatment|Protocol Violation|0|||
145942997|NCT00738062|526300398|FG000|Open Label Treatment|Withdrawal by Subject|9|||
145942998|NCT00738062|526300399|FG001|Open Label Treatment|Withdrawal by Subject|0|||
145942999|NCT00738062|526300400|FG002|Open Label Treatment|Withdrawal by Subject|0|||
145943000|NCT00738062|526300398|FG000|Open Label Treatment|Investigator Decision|1|||
145943001|NCT00738062|526300399|FG001|Open Label Treatment|Investigator Decision|0|||
145943002|NCT00738062|526300400|FG002|Open Label Treatment|Investigator Decision|0|||
145943003|NCT00738062|526300398|FG000|Open-Label Extension|Adverse Event|5|||
145943004|NCT00738062|526300399|FG001|Open-Label Extension|Adverse Event|0|||
145943005|NCT00738062|526300400|FG002|Open-Label Extension|Adverse Event|0|||
145943006|NCT00738062|526300398|FG000|Open-Label Extension|Physician Decision|1|||
145943007|NCT00738062|526300399|FG001|Open-Label Extension|Physician Decision|0|||
145943008|NCT00738062|526300400|FG002|Open-Label Extension|Physician Decision|0|||
145943009|NCT00738062|526300398|FG000|Open-Label Extension|Lack of Efficacy|2|||
145943010|NCT00738062|526300399|FG001|Open-Label Extension|Lack of Efficacy|0|||
146122959|NCT03519347|526970672|FG002|Interventional Crossover Period 1|Death|0|||
146122960|NCT03519347|526970673|FG003|Interventional Crossover Period 1|Death|1|||
146122961|NCT01641692|526970679|FG000|Treatment Period 1|Adverse Event|1|||
146122962|NCT01641692|526970680|FG001|Treatment Period 1|Adverse Event|0|||
145943011|NCT00738062|526300400|FG002|Open-Label Extension|Lack of Efficacy|0|||
145943012|NCT00738062|526300398|FG000|Open-Label Extension|Withdrawal by Subject|6|||
145943013|NCT00738062|526300399|FG001|Open-Label Extension|Withdrawal by Subject|0|||
145943014|NCT00738062|526300400|FG002|Open-Label Extension|Withdrawal by Subject|0|||
145943015|NCT00738062|526300398|FG000|Open-Label Extension|Protocol Violation|1|||
145943016|NCT00738062|526300399|FG001|Open-Label Extension|Protocol Violation|0|||
145943017|NCT00738062|526300400|FG002|Open-Label Extension|Protocol Violation|0|||
145943018|NCT00738062|526300398|FG000|Open-Label Extension|Study Terminated|2|||
145943019|NCT00738062|526300399|FG001|Open-Label Extension|Study Terminated|0|||
145943020|NCT00738062|526300400|FG002|Open-Label Extension|Study Terminated|0|||
145943021|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
145943022|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
145943023|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
145943024|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
145943025|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Death|1|||
145943026|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Death|1|||
145943027|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
145943028|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
145943029|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
145943030|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
145943031|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
145943032|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
145943033|NCT00033657|526300401|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
145943034|NCT00033657|526300402|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
145943035|NCT00033657|526300401|FG000|Surgical Resection|not complete resection|0|||
145943036|NCT00033657|526300402|FG001|Surgical Resection|not complete resection|3|||
145943037|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
145943038|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
145943039|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
145943040|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
145943041|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|Death|2|||
145943042|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|Death|1|||
145943043|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
145943044|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
145943045|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
145943046|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
145943047|NCT00033657|526300401|FG000|Adjuvant Chemotherapy|Other|0|||
145943048|NCT00033657|526300402|FG001|Adjuvant Chemotherapy|Other|2|||
145943049|NCT02248974|526300403|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
145943050|NCT02248974|526300404|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
145943051|NCT02248974|526300403|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
145943052|NCT02248974|526300404|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
145943053|NCT02248974|526300403|FG000|1-Day Follow-Up|Enrolled in another study|1|||
145943054|NCT02248974|526300404|FG001|1-Day Follow-Up|Enrolled in another study|0|||
145943055|NCT02248974|526300403|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
145943056|NCT02248974|526300404|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
145943057|NCT02248974|526300403|FG000|1-Week Follow-Up|Enrolled in another study|1|||
145943058|NCT02248974|526300404|FG001|1-Week Follow-Up|Enrolled in another study|1|||
145943059|NCT02248974|526300403|FG000|1-Week Follow-Up|Transferred to another facility|1|||
145943060|NCT02248974|526300404|FG001|1-Week Follow-Up|Transferred to another facility|0|||
145943061|NCT02248974|526300403|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
146262339|NCT01379703|527476411|FG001|Study Start Through 9 Months|Adverse Event|14|||
146262340|NCT01379703|527476412|FG002|Study Start Through 9 Months|Adverse Event|10|||
146262341|NCT01379703|527476410|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
146262342|NCT01379703|527476411|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
145943062|NCT02248974|526300404|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
145943063|NCT02248974|526300403|FG000|1-Week Follow-Up|Death|1|||
145943064|NCT02248974|526300404|FG001|1-Week Follow-Up|Death|1|||
145943065|NCT02248974|526300403|FG000|1-Week Follow-Up|Excluded because of age|0|||
145943066|NCT02248974|526300404|FG001|1-Week Follow-Up|Excluded because of age|1|||
145943067|NCT02248974|526300403|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
145943068|NCT02248974|526300404|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
145943069|NCT02248974|526300403|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
145943070|NCT02248974|526300404|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
145943071|NCT02248974|526300403|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
145943072|NCT02248974|526300404|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
145943073|NCT02248974|526300403|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
145943074|NCT02248974|526300404|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
145943075|NCT02248974|526300403|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
145943076|NCT02248974|526300404|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
145943077|NCT02332239|526300405|FG000|Overall Study|Lost to Follow-up|4|||
145943078|NCT02332239|526300406|FG001|Overall Study|Lost to Follow-up|6|||
145943079|NCT00894790|526300407|FG000|Overall Study|Protocol Violation|0|||
146122963|NCT01641692|526970681|FG002|Treatment Period 1|Adverse Event|0|||
146122964|NCT01641692|526970682|FG003|Treatment Period 1|Adverse Event|0|||
146122965|NCT01641692|526970683|FG004|Treatment Period 1|Adverse Event|0|||
146122966|NCT01641692|526970684|FG005|Treatment Period 1|Adverse Event|0|||
146122967|NCT01641692|526970685|FG006|Treatment Period 1|Adverse Event|0|||
146122968|NCT01641692|526970686|FG007|Treatment Period 1|Adverse Event|0|||
145943080|NCT00894790|526300408|FG001|Overall Study|Protocol Violation|1|||
145943081|NCT00894790|526300407|FG000|Overall Study|Lost to Follow-up|0|||
145943082|NCT00894790|526300408|FG001|Overall Study|Lost to Follow-up|1|||
145943083|NCT00894790|526300407|FG000|Overall Study|Did not meet entrance criteria|1|||
145943084|NCT00894790|526300408|FG001|Overall Study|Did not meet entrance criteria|0|||
145943085|NCT04093492|526300409|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
145943086|NCT04093492|526300410|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
145943087|NCT04093492|526300411|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
145943088|NCT04093492|526300412|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
145943089|NCT04093492|526300409|FG000|25 Weeks Gestational Age (GA)|No response|5|||
145943090|NCT04093492|526300410|FG001|25 Weeks Gestational Age (GA)|No response|5|||
145943091|NCT04093492|526300411|FG002|25 Weeks Gestational Age (GA)|No response|5|||
145943092|NCT04093492|526300412|FG003|25 Weeks Gestational Age (GA)|No response|2|||
145943093|NCT04093492|526300409|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145943094|NCT04093492|526300410|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145943095|NCT04093492|526300411|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145943096|NCT04093492|526300412|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
145943097|NCT04093492|526300409|FG000|30 Weeks GA|Delivered before assessment|1|||
145943098|NCT04093492|526300410|FG001|30 Weeks GA|Delivered before assessment|2|||
145943099|NCT04093492|526300411|FG002|30 Weeks GA|Delivered before assessment|0|||
145943100|NCT04093492|526300412|FG003|30 Weeks GA|Delivered before assessment|0|||
145943101|NCT04093492|526300409|FG000|30 Weeks GA|No response|7|||
145943102|NCT04093492|526300410|FG001|30 Weeks GA|No response|5|||
145943103|NCT04093492|526300411|FG002|30 Weeks GA|No response|5|||
145943104|NCT04093492|526300412|FG003|30 Weeks GA|No response|2|||
145943105|NCT04093492|526300409|FG000|30 Weeks GA|Lost to Follow-up|0|||
145943106|NCT04093492|526300410|FG001|30 Weeks GA|Lost to Follow-up|1|||
145943107|NCT04093492|526300411|FG002|30 Weeks GA|Lost to Follow-up|0|||
145943108|NCT04093492|526300412|FG003|30 Weeks GA|Lost to Follow-up|0|||
146122969|NCT01641692|526970679|FG000|Treatment Period 1|Lack of Efficacy|0|||
146122970|NCT01641692|526970680|FG001|Treatment Period 1|Lack of Efficacy|0|||
146122971|NCT01641692|526970681|FG002|Treatment Period 1|Lack of Efficacy|0|||
146122972|NCT01641692|526970682|FG003|Treatment Period 1|Lack of Efficacy|0|||
146122973|NCT01641692|526970683|FG004|Treatment Period 1|Lack of Efficacy|0|||
146122974|NCT01641692|526970684|FG005|Treatment Period 1|Lack of Efficacy|0|||
146122975|NCT01641692|526970685|FG006|Treatment Period 1|Lack of Efficacy|0|||
146262343|NCT01379703|527476412|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
145943109|NCT04093492|526300409|FG000|34 Weeks GA|Delivered before assessment|6|||
145943110|NCT04093492|526300410|FG001|34 Weeks GA|Delivered before assessment|3|||
145943111|NCT04093492|526300411|FG002|34 Weeks GA|Delivered before assessment|0|||
145943112|NCT04093492|526300412|FG003|34 Weeks GA|Delivered before assessment|0|||
145943113|NCT04093492|526300409|FG000|34 Weeks GA|No response|0|||
145943114|NCT04093492|526300410|FG001|34 Weeks GA|No response|7|||
145943115|NCT04093492|526300411|FG002|34 Weeks GA|No response|5|||
145943116|NCT04093492|526300412|FG003|34 Weeks GA|No response|3|||
145943117|NCT04093492|526300409|FG000|34 Weeks GA|Lost to Follow-up|0|||
145943118|NCT04093492|526300410|FG001|34 Weeks GA|Lost to Follow-up|1|||
145943119|NCT04093492|526300411|FG002|34 Weeks GA|Lost to Follow-up|0|||
145943120|NCT04093492|526300412|FG003|34 Weeks GA|Lost to Follow-up|0|||
145943121|NCT00006305|526300418|FG000|Overall Study|Withdrawal by Subject|17|||
145943122|NCT00006305|526300419|FG001|Overall Study|Withdrawal by Subject|10|||
145943123|NCT00006305|526300420|FG002|Overall Study|Withdrawal by Subject|15|||
145943124|NCT00006305|526300421|FG003|Overall Study|Withdrawal by Subject|14|||
145943125|NCT00662558|526300422|FG000|Overall Study|Adverse Event|21|||
145943126|NCT00662558|526300423|FG001|Overall Study|Adverse Event|59|||
145943127|NCT00662558|526300422|FG000|Overall Study|Lack of Efficacy|4|||
145943128|NCT00662558|526300423|FG001|Overall Study|Lack of Efficacy|7|||
145943129|NCT00662558|526300422|FG000|Overall Study|Lost to Follow-up|13|||
145943130|NCT00662558|526300423|FG001|Overall Study|Lost to Follow-up|10|||
145943131|NCT00662558|526300422|FG000|Overall Study|Other|9|||
145943132|NCT00662558|526300423|FG001|Overall Study|Other|14|||
145943133|NCT00662558|526300422|FG000|Overall Study|Withdrawal by Subject|7|||
145943134|NCT00662558|526300423|FG001|Overall Study|Withdrawal by Subject|12|||
145943135|NCT00662558|526300422|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
145943136|NCT00662558|526300423|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
145943137|NCT00783224|526300426|FG000|Overall Study|Adverse Event|0|||
145943138|NCT00783224|526300427|FG001|Overall Study|Adverse Event|0|||
145943139|NCT00783224|526300428|FG002|Overall Study|Adverse Event|1|||
145943140|NCT00783224|526300429|FG003|Overall Study|Adverse Event|0|||
145943141|NCT00783224|526300426|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
146262344|NCT01379703|527476410|FG000|Study Start Through 9 Months|Treatment Failure|0|||
146262345|NCT01379703|527476411|FG001|Study Start Through 9 Months|Treatment Failure|2|||
146262346|NCT01379703|527476412|FG002|Study Start Through 9 Months|Treatment Failure|2|||
146262347|NCT01379703|527476410|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
146262348|NCT01379703|527476411|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
146262349|NCT01379703|527476412|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
146262350|NCT01379703|527476410|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
146262351|NCT01379703|527476411|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
146262352|NCT01379703|527476412|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
146262353|NCT01379703|527476410|FG000|Study Start Through 9 Months|Medication not available|0|||
146262354|NCT01379703|527476411|FG001|Study Start Through 9 Months|Medication not available|2|||
146262355|NCT01379703|527476412|FG002|Study Start Through 9 Months|Medication not available|1|||
145943142|NCT00783224|526300427|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
145943143|NCT00783224|526300428|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
145943144|NCT00783224|526300429|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
145943145|NCT00783224|526300426|FG000|Overall Study|Inappropriate as a study subject|0|||
145943146|NCT00783224|526300427|FG001|Overall Study|Inappropriate as a study subject|0|||
145943147|NCT00783224|526300428|FG002|Overall Study|Inappropriate as a study subject|0|||
145943148|NCT00783224|526300429|FG003|Overall Study|Inappropriate as a study subject|1|||
145943149|NCT01711619|526300430|FG000|Overall Study|Early study termination|10|||
145943150|NCT01711619|526300431|FG001|Overall Study|Early study termination|14|||
145943151|NCT01711619|526300430|FG000|Overall Study|Withdrawal by Subject|3|||
145943152|NCT01711619|526300431|FG001|Overall Study|Withdrawal by Subject|7|||
145943153|NCT01711619|526300430|FG000|Overall Study|Protocol Violation|2|||
145943154|NCT01711619|526300431|FG001|Overall Study|Protocol Violation|3|||
146262356|NCT01379703|527476410|FG000|Study Start Through 9 Months|Poor general condition|0|||
146262357|NCT01379703|527476411|FG001|Study Start Through 9 Months|Poor general condition|1|||
145943155|NCT01711619|526300430|FG000|Overall Study|Adverse Event|2|||
145943156|NCT01711619|526300431|FG001|Overall Study|Adverse Event|0|||
145943157|NCT01711619|526300430|FG000|Overall Study|Lost to Follow-up|1|||
145943158|NCT01711619|526300431|FG001|Overall Study|Lost to Follow-up|0|||
146122976|NCT01641692|526970686|FG007|Treatment Period 1|Lack of Efficacy|1|||
146122977|NCT01641692|526970679|FG000|Treatment Period 1|Protocol Violation|1|||
146122978|NCT01641692|526970680|FG001|Treatment Period 1|Protocol Violation|0|||
146122979|NCT01641692|526970681|FG002|Treatment Period 1|Protocol Violation|0|||
146122980|NCT01641692|526970682|FG003|Treatment Period 1|Protocol Violation|0|||
146122981|NCT01641692|526970683|FG004|Treatment Period 1|Protocol Violation|2|||
146122982|NCT01641692|526970684|FG005|Treatment Period 1|Protocol Violation|0|||
146122983|NCT01641692|526970685|FG006|Treatment Period 1|Protocol Violation|0|||
146122984|NCT01641692|526970686|FG007|Treatment Period 1|Protocol Violation|0|||
146122985|NCT01641692|526970679|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122986|NCT01641692|526970680|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122987|NCT01641692|526970681|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122988|NCT01641692|526970682|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122989|NCT01641692|526970683|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
146122990|NCT01641692|526970684|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122991|NCT01641692|526970685|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
146122992|NCT01641692|526970686|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
146122993|NCT01641692|526970679|FG000|Treatment Period 1|Lost to Follow-up|0|||
146122994|NCT01641692|526970680|FG001|Treatment Period 1|Lost to Follow-up|0|||
146122995|NCT01641692|526970681|FG002|Treatment Period 1|Lost to Follow-up|1|||
146122996|NCT01641692|526970682|FG003|Treatment Period 1|Lost to Follow-up|0|||
146122997|NCT01641692|526970683|FG004|Treatment Period 1|Lost to Follow-up|0|||
146122998|NCT01641692|526970684|FG005|Treatment Period 1|Lost to Follow-up|0|||
146122999|NCT01641692|526970685|FG006|Treatment Period 1|Lost to Follow-up|0|||
146123000|NCT01641692|526970686|FG007|Treatment Period 1|Lost to Follow-up|0|||
146123001|NCT01641692|526970679|FG000|Treatment Period 1|Physician Decision|0|||
146123002|NCT01641692|526970680|FG001|Treatment Period 1|Physician Decision|0|||
146123003|NCT01641692|526970681|FG002|Treatment Period 1|Physician Decision|0|||
146123004|NCT01641692|526970682|FG003|Treatment Period 1|Physician Decision|0|||
146123005|NCT01641692|526970683|FG004|Treatment Period 1|Physician Decision|1|||
146123006|NCT01641692|526970684|FG005|Treatment Period 1|Physician Decision|0|||
146123007|NCT01641692|526970685|FG006|Treatment Period 1|Physician Decision|0|||
146123008|NCT01641692|526970686|FG007|Treatment Period 1|Physician Decision|0|||
146123009|NCT01641692|526970679|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146123010|NCT01641692|526970680|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146123011|NCT01641692|526970681|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146123012|NCT01641692|526970682|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146123013|NCT01641692|526970683|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146123014|NCT01641692|526970684|FG005|Treatment Period 1|Withdrawal by Subject|2|||
146123015|NCT01641692|526970685|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146123016|NCT01641692|526970686|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146123017|NCT01641692|526970679|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
146123018|NCT01641692|526970680|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123019|NCT01641692|526970681|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123020|NCT01641692|526970682|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145943159|NCT00503997|526300439|FG000|Overall Study|disease progression|1|||
145943160|NCT00503997|526300439|FG000|Overall Study|Adverse Event|5|||
145943161|NCT00503997|526300439|FG000|Overall Study|Death|1|||
145943162|NCT00503997|526300439|FG000|Overall Study|Withdrawal by Subject|1|||
145943163|NCT01935700|526300442|FG000|Overall Study|Withdrawal by Subject|1|||
145943164|NCT01935700|526300443|FG001|Overall Study|Withdrawal by Subject|0|||
145943165|NCT01935700|526300442|FG000|Overall Study|Physician Decision|4|||
145943166|NCT01935700|526300443|FG001|Overall Study|Physician Decision|0|||
145943167|NCT01440569|526300447|FG000|Main Study|Enrolled but not treated|1|||
145943168|NCT01440569|526300448|FG001|Main Study|Enrolled but not treated|0|||
145943169|NCT01440569|526300447|FG000|Main Study|Adverse Event|9|||
145943170|NCT01440569|526300448|FG001|Main Study|Adverse Event|0|||
145943171|NCT01440569|526300447|FG000|Main Study|Pregnancy|1|||
145943172|NCT01440569|526300448|FG001|Main Study|Pregnancy|0|||
145943173|NCT01440569|526300447|FG000|Main Study|Investigator's Discretion|1|||
145943174|NCT01440569|526300448|FG001|Main Study|Investigator's Discretion|1|||
145943175|NCT01440569|526300447|FG000|Main Study|Withdrew Consent|7|||
145943176|NCT01440569|526300448|FG001|Main Study|Withdrew Consent|1|||
145943177|NCT01440569|526300447|FG000|Main Study|Lost to Follow-up|13|||
145943178|NCT01440569|526300448|FG001|Main Study|Lost to Follow-up|2|||
146123021|NCT01641692|526970683|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123022|NCT01641692|526970684|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123023|NCT01641692|526970685|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123024|NCT01641692|526970686|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
146123025|NCT01641692|526970679|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123026|NCT01641692|526970680|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145943179|NCT01440569|526300447|FG000|Main Study|Subject Non-Compliance|3|||
145943180|NCT01440569|526300448|FG001|Main Study|Subject Non-Compliance|0|||
145943181|NCT01440569|526300447|FG000|Main Study|Protocol Violation|1|||
145943182|NCT01440569|526300448|FG001|Main Study|Protocol Violation|0|||
145943183|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Adverse Event|3|||
145943184|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Adverse Event|0|||
145943185|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Pregnancy|1|||
145943186|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Pregnancy|0|||
145943187|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
145943188|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
145943189|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
145943190|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
145943191|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
145943192|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
145943193|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
145943194|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
145943195|NCT01440569|526300447|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
145943196|NCT01440569|526300448|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
145943197|NCT00483704|526300456|FG000|Randomization|Withdrawal by Subject|19|||
145943198|NCT00483704|526300457|FG001|Randomization|Withdrawal by Subject|28|||
145943199|NCT00483704|526300458|FG002|Randomization|Withdrawal by Subject|18|||
145943200|NCT00483704|526300456|FG000|Randomization|Protocol Violation|14|||
145943201|NCT00483704|526300457|FG001|Randomization|Protocol Violation|25|||
145943202|NCT00483704|526300458|FG002|Randomization|Protocol Violation|22|||
145943203|NCT00483704|526300456|FG000|Randomization|Lost to Follow-up|14|||
145943204|NCT00483704|526300457|FG001|Randomization|Lost to Follow-up|14|||
146123027|NCT01641692|526970681|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123028|NCT01641692|526970682|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123029|NCT01641692|526970683|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123030|NCT01641692|526970684|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123031|NCT01641692|526970685|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146123032|NCT01641692|526970686|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146123033|NCT01641692|526970679|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146123034|NCT01641692|526970680|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123035|NCT01641692|526970681|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146123036|NCT01641692|526970682|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146123037|NCT01641692|526970683|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146123038|NCT01641692|526970684|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123039|NCT01641692|526970685|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123040|NCT01641692|526970686|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146123041|NCT01641692|526970679|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146123042|NCT01641692|526970680|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146123043|NCT01641692|526970681|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146123044|NCT01641692|526970682|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146123045|NCT01641692|526970683|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146123046|NCT01641692|526970684|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146123047|NCT01641692|526970685|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146123048|NCT01641692|526970686|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146123049|NCT01641692|526970679|FG000|Treatment Period 2|Lack of Efficacy|1|||
146123050|NCT01641692|526970680|FG001|Treatment Period 2|Lack of Efficacy|0|||
146123051|NCT01641692|526970681|FG002|Treatment Period 2|Lack of Efficacy|0|||
146123052|NCT01641692|526970682|FG003|Treatment Period 2|Lack of Efficacy|0|||
146123053|NCT01641692|526970683|FG004|Treatment Period 2|Lack of Efficacy|0|||
146123054|NCT01641692|526970684|FG005|Treatment Period 2|Lack of Efficacy|0|||
146123055|NCT01641692|526970685|FG006|Treatment Period 2|Lack of Efficacy|0|||
146123056|NCT01641692|526970686|FG007|Treatment Period 2|Lack of Efficacy|0|||
146123057|NCT01641692|526970679|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
146123058|NCT01641692|526970680|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123059|NCT01641692|526970681|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123060|NCT01641692|526970682|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123061|NCT01641692|526970683|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123062|NCT01641692|526970684|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123063|NCT01641692|526970685|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123064|NCT01641692|526970686|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
146123065|NCT01641692|526970679|FG000|Treatment Period 2|Lost to Follow-up|0|||
146123066|NCT01641692|526970680|FG001|Treatment Period 2|Lost to Follow-up|0|||
146123067|NCT01641692|526970681|FG002|Treatment Period 2|Lost to Follow-up|0|||
146123068|NCT01641692|526970682|FG003|Treatment Period 2|Lost to Follow-up|0|||
146123069|NCT01641692|526970683|FG004|Treatment Period 2|Lost to Follow-up|0|||
146123070|NCT01641692|526970684|FG005|Treatment Period 2|Lost to Follow-up|1|||
146123071|NCT01641692|526970685|FG006|Treatment Period 2|Lost to Follow-up|0|||
146123072|NCT01641692|526970686|FG007|Treatment Period 2|Lost to Follow-up|0|||
146123073|NCT01641692|526970679|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146123074|NCT01641692|526970680|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146123075|NCT01641692|526970681|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146123076|NCT01641692|526970682|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146123077|NCT01641692|526970683|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146123078|NCT01641692|526970684|FG005|Treatment Period 2|Withdrawal by Subject|1|||
146123079|NCT01641692|526970685|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146123080|NCT01641692|526970686|FG007|Treatment Period 2|Withdrawal by Subject|1|||
146123081|NCT01641692|526970679|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123082|NCT01641692|526970680|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123083|NCT01641692|526970681|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123084|NCT01641692|526970682|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123085|NCT01641692|526970683|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
146123086|NCT01641692|526970684|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123087|NCT01641692|526970685|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
146123088|NCT01641692|526970686|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
146123089|NCT01641692|526970679|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146123090|NCT01641692|526970680|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146123091|NCT01641692|526970681|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146123092|NCT01641692|526970682|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146123093|NCT01641692|526970683|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146123094|NCT01641692|526970684|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146123095|NCT01641692|526970685|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146123096|NCT01641692|526970686|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146123097|NCT01641692|526970679|FG000|Treatment Period 3|Adverse Event|0|||
146123098|NCT01641692|526970680|FG001|Treatment Period 3|Adverse Event|0|||
146123099|NCT01641692|526970681|FG002|Treatment Period 3|Adverse Event|0|||
146123100|NCT01641692|526970682|FG003|Treatment Period 3|Adverse Event|0|||
146123101|NCT01641692|526970683|FG004|Treatment Period 3|Adverse Event|0|||
146123102|NCT01641692|526970684|FG005|Treatment Period 3|Adverse Event|0|||
146123103|NCT01641692|526970685|FG006|Treatment Period 3|Adverse Event|1|||
146123104|NCT01641692|526970686|FG007|Treatment Period 3|Adverse Event|0|||
146123105|NCT01641692|526970679|FG000|Treatment Period 3|Protocol Violation|0|||
146123106|NCT01641692|526970680|FG001|Treatment Period 3|Protocol Violation|0|||
146123107|NCT01641692|526970681|FG002|Treatment Period 3|Protocol Violation|1|||
146123108|NCT01641692|526970682|FG003|Treatment Period 3|Protocol Violation|0|||
146123109|NCT01641692|526970683|FG004|Treatment Period 3|Protocol Violation|0|||
146123110|NCT01641692|526970684|FG005|Treatment Period 3|Protocol Violation|0|||
146123111|NCT01641692|526970685|FG006|Treatment Period 3|Protocol Violation|0|||
146123112|NCT01641692|526970686|FG007|Treatment Period 3|Protocol Violation|0|||
146123113|NCT01641692|526970679|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123114|NCT01641692|526970680|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123115|NCT01641692|526970681|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123116|NCT01641692|526970682|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123117|NCT01641692|526970683|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123118|NCT01641692|526970684|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123119|NCT01641692|526970685|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
146123120|NCT01641692|526970686|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
146123121|NCT01641692|526970679|FG000|Treatment Period 3|Lost to Follow-up|0|||
146123122|NCT01641692|526970680|FG001|Treatment Period 3|Lost to Follow-up|1|||
146123123|NCT01641692|526970681|FG002|Treatment Period 3|Lost to Follow-up|0|||
146123124|NCT01641692|526970682|FG003|Treatment Period 3|Lost to Follow-up|0|||
146123125|NCT01641692|526970683|FG004|Treatment Period 3|Lost to Follow-up|0|||
146123126|NCT01641692|526970684|FG005|Treatment Period 3|Lost to Follow-up|0|||
146123127|NCT01641692|526970685|FG006|Treatment Period 3|Lost to Follow-up|0|||
146123128|NCT01641692|526970686|FG007|Treatment Period 3|Lost to Follow-up|0|||
146262358|NCT01379703|527476412|FG002|Study Start Through 9 Months|Poor general condition|0|||
146262359|NCT01379703|527476410|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
146262360|NCT01379703|527476411|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
146262361|NCT01379703|527476412|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
146262362|NCT01379703|527476410|FG000|Study Start Through 9 Months|Reason unknown|2|||
146262363|NCT01379703|527476411|FG001|Study Start Through 9 Months|Reason unknown|31|||
146123129|NCT01641692|526970679|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123130|NCT01641692|526970680|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123131|NCT01641692|526970681|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123132|NCT01641692|526970682|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123133|NCT01641692|526970683|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123134|NCT01641692|526970684|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
146123135|NCT01641692|526970685|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
146262364|NCT01379703|527476412|FG002|Study Start Through 9 Months|Reason unknown|24|||
146262365|NCT01379703|527476410|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
146262366|NCT01379703|527476411|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
146262367|NCT01379703|527476412|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
146262368|NCT01379703|527476410|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
146262369|NCT01379703|527476411|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
146262370|NCT01379703|527476412|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
146262371|NCT01379703|527476410|FG000|9 Months Through 18 Months|Adverse Event|0|||
146262372|NCT01379703|527476411|FG001|9 Months Through 18 Months|Adverse Event|6|||
146262373|NCT01379703|527476412|FG002|9 Months Through 18 Months|Adverse Event|0|||
146262374|NCT01379703|527476410|FG000|9 Months Through 18 Months|Treatment failure|0|||
146262375|NCT01379703|527476411|FG001|9 Months Through 18 Months|Treatment failure|5|||
146262376|NCT01379703|527476412|FG002|9 Months Through 18 Months|Treatment failure|0|||
146262377|NCT01379703|527476410|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
146262378|NCT01379703|527476411|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
146262379|NCT01379703|527476412|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
146262380|NCT01379703|527476410|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
146262381|NCT01379703|527476411|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
146262382|NCT01379703|527476412|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
146262383|NCT01379703|527476410|FG000|9 Months Through 18 Months|Fatigue|0|||
146262384|NCT01379703|527476411|FG001|9 Months Through 18 Months|Fatigue|1|||
146262385|NCT01379703|527476412|FG002|9 Months Through 18 Months|Fatigue|0|||
146262386|NCT01379703|527476410|FG000|9 Months Through 18 Months|Reason Unknown|0|||
146262387|NCT01379703|527476411|FG001|9 Months Through 18 Months|Reason Unknown|23|||
146262388|NCT01379703|527476412|FG002|9 Months Through 18 Months|Reason Unknown|0|||
146303329|NCT02716675|527625738|FG001|Overall Study|Withdrawal by Subject|25|||
146303330|NCT02716675|527625739|FG002|Overall Study|Withdrawal by Subject|20|||
146123136|NCT01641692|526970686|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
146123137|NCT01641692|526970679|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146123138|NCT01641692|526970680|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146123139|NCT01641692|526970681|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146123140|NCT01641692|526970682|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146123141|NCT01641692|526970683|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146123142|NCT01641692|526970684|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146123143|NCT01641692|526970685|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
146123144|NCT01641692|526970686|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
146123145|NCT02515045|526970691|FG000|Overall Study|Adverse Event|0|||
146123146|NCT02515045|526970692|FG001|Overall Study|Adverse Event|3|||
146123147|NCT02515045|526970693|FG002|Overall Study|Adverse Event|3|||
146123148|NCT02515045|526970691|FG000|Overall Study|Lost to Follow-up|0|||
146123149|NCT02515045|526970692|FG001|Overall Study|Lost to Follow-up|1|||
146123150|NCT02515045|526970693|FG002|Overall Study|Lost to Follow-up|1|||
146123151|NCT01412021|526970694|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
146123152|NCT01412021|526970694|FG000|Overall Study|Treatment Prior to Approval|3|||
146123153|NCT01412021|526970694|FG000|Overall Study|Transferred to Other Hospital|9|||
146123154|NCT00238121|526970695|FG000|Overall Study|Withdrawal by Subject|1|||
146123155|NCT00238121|526970696|FG001|Overall Study|Withdrawal by Subject|1|||
146123156|NCT00238121|526970695|FG000|Overall Study|Adverse Event|2|||
146123157|NCT00238121|526970696|FG001|Overall Study|Adverse Event|1|||
146123158|NCT00484939|526970699|FG000|Overall Study|Death|9|||
146123159|NCT00484939|526970700|FG001|Overall Study|Death|13|||
146123160|NCT00484939|526970699|FG000|Overall Study|Adverse Event|22|||
146123161|NCT00484939|526970700|FG001|Overall Study|Adverse Event|12|||
146123162|NCT00484939|526970699|FG000|Overall Study|Patient Withdrew Consent|19|||
146123163|NCT00484939|526970700|FG001|Overall Study|Patient Withdrew Consent|10|||
146123164|NCT00484939|526970699|FG000|Overall Study|Protocol Violation|3|||
146123165|NCT00484939|526970700|FG001|Overall Study|Protocol Violation|3|||
146123166|NCT00484939|526970699|FG000|Overall Study|Lost to Follow-up|0|||
146123167|NCT00484939|526970700|FG001|Overall Study|Lost to Follow-up|3|||
146123168|NCT00484939|526970699|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
146123169|NCT00484939|526970700|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
146123170|NCT00484939|526970699|FG000|Overall Study|Disease progression|67|||
146262389|NCT03463577|527476413|FG000|Overall Study|Lost to Follow-up|238|||
146303331|NCT02716675|527625737|FG000|Overall Study|Protocol Violation|0|||
146123171|NCT00484939|526970700|FG001|Overall Study|Disease progression|88|||
146123172|NCT00484939|526970699|FG000|Overall Study|Screen Failure|2|||
146123173|NCT00484939|526970700|FG001|Overall Study|Screen Failure|2|||
146123174|NCT00484939|526970699|FG000|Overall Study|Reason Not Specified|11|||
146262390|NCT03463577|527476414|FG001|Overall Study|Lost to Follow-up|435|||
146123175|NCT00484939|526970700|FG001|Overall Study|Reason Not Specified|6|||
146123176|NCT00449644|526970703|FG000|Overall Study|Adverse Event|0|||
146123177|NCT00449644|526970704|FG001|Overall Study|Adverse Event|0|||
146123178|NCT00449644|526970705|FG002|Overall Study|Adverse Event|3|||
146262391|NCT03463577|527476415|FG002|Overall Study|Lost to Follow-up|0|||
146123179|NCT00449644|526970706|FG003|Overall Study|Adverse Event|5|||
146123180|NCT00449644|526970703|FG000|Overall Study|Death|1|||
146123181|NCT00449644|526970704|FG001|Overall Study|Death|0|||
146123182|NCT00449644|526970705|FG002|Overall Study|Death|6|||
146123183|NCT00449644|526970706|FG003|Overall Study|Death|1|||
146123184|NCT00449644|526970703|FG000|Overall Study|Lost to Follow-up|1|||
146123185|NCT00449644|526970704|FG001|Overall Study|Lost to Follow-up|1|||
146123186|NCT00449644|526970705|FG002|Overall Study|Lost to Follow-up|5|||
146123187|NCT00449644|526970706|FG003|Overall Study|Lost to Follow-up|3|||
146123188|NCT00449644|526970703|FG000|Overall Study|Pregnancy|0|||
146123189|NCT00449644|526970704|FG001|Overall Study|Pregnancy|0|||
146123190|NCT00449644|526970705|FG002|Overall Study|Pregnancy|3|||
146123191|NCT00449644|526970706|FG003|Overall Study|Pregnancy|2|||
146123192|NCT00449644|526970703|FG000|Overall Study|Protocol Violation|4|||
146123193|NCT00449644|526970704|FG001|Overall Study|Protocol Violation|4|||
146123194|NCT00449644|526970705|FG002|Overall Study|Protocol Violation|3|||
146123195|NCT00449644|526970706|FG003|Overall Study|Protocol Violation|7|||
146123196|NCT00449644|526970703|FG000|Overall Study|Withdrawal by Subject|3|||
146123197|NCT00449644|526970704|FG001|Overall Study|Withdrawal by Subject|4|||
146123198|NCT00449644|526970705|FG002|Overall Study|Withdrawal by Subject|6|||
146123199|NCT00449644|526970706|FG003|Overall Study|Withdrawal by Subject|7|||
146123200|NCT00449644|526970703|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
146123201|NCT00449644|526970704|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
146123202|NCT00449644|526970705|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
146123203|NCT00449644|526970706|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
146123204|NCT00449644|526970703|FG000|Overall Study|Other|1|||
146123205|NCT00449644|526970704|FG001|Overall Study|Other|4|||
146123206|NCT00449644|526970705|FG002|Overall Study|Other|1|||
146123207|NCT00449644|526970706|FG003|Overall Study|Other|0|||
146123208|NCT00449644|526970703|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
146123209|NCT00449644|526970704|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
146123210|NCT00449644|526970705|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
146123211|NCT00449644|526970706|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
146123212|NCT00529542|526970707|FG000|Overall Study|Withdrawal by Subject|1|||
146123213|NCT00529542|526970708|FG001|Overall Study|Withdrawal by Subject|0|||
146123214|NCT00529542|526970707|FG000|Overall Study|Lost to Follow-up|0|||
146123215|NCT00529542|526970708|FG001|Overall Study|Lost to Follow-up|1|||
146123216|NCT01474876|526970713|FG000|Overall Study|Adverse Event|11|||
146123217|NCT01474876|526970714|FG001|Overall Study|Adverse Event|5|||
146123218|NCT01474876|526970715|FG002|Overall Study|Adverse Event|0|||
146123219|NCT01474876|526970713|FG000|Overall Study|Serious Adverse Event|2|||
146123220|NCT01474876|526970714|FG001|Overall Study|Serious Adverse Event|3|||
146123221|NCT01474876|526970715|FG002|Overall Study|Serious Adverse Event|0|||
146123222|NCT01474876|526970713|FG000|Overall Study|Lost to Follow-up|5|||
146123223|NCT01474876|526970714|FG001|Overall Study|Lost to Follow-up|4|||
146123224|NCT01474876|526970715|FG002|Overall Study|Lost to Follow-up|0|||
146123225|NCT01474876|526970713|FG000|Overall Study|Investigator's decision|28|||
146123226|NCT01474876|526970714|FG001|Overall Study|Investigator's decision|6|||
146123227|NCT01474876|526970715|FG002|Overall Study|Investigator's decision|0|||
146123228|NCT01474876|526970713|FG000|Overall Study|Patient's request|19|||
146123229|NCT01474876|526970714|FG001|Overall Study|Patient's request|5|||
146123230|NCT01474876|526970715|FG002|Overall Study|Patient's request|0|||
146123231|NCT01474876|526970713|FG000|Overall Study|Investigator's decision and pt request|1|||
146123232|NCT01474876|526970714|FG001|Overall Study|Investigator's decision and pt request|0|||
146123233|NCT01474876|526970715|FG002|Overall Study|Investigator's decision and pt request|0|||
146123234|NCT02291055|526970718|FG000|Overall Study|Death|2|||
146123235|NCT02291055|526970719|FG001|Overall Study|Death|2|||
146123236|NCT02291055|526970720|FG002|Overall Study|Death|5|||
146123237|NCT02291055|526970721|FG003|Overall Study|Death|8|||
146123238|NCT02291055|526970722|FG004|Overall Study|Death|12|||
146123239|NCT02291055|526970718|FG000|Overall Study|Lost to Follow-up|0|||
146123240|NCT02291055|526970719|FG001|Overall Study|Lost to Follow-up|0|||
146303332|NCT02716675|527625738|FG001|Overall Study|Protocol Violation|3|||
146123241|NCT02291055|526970720|FG002|Overall Study|Lost to Follow-up|0|||
146123242|NCT02291055|526970721|FG003|Overall Study|Lost to Follow-up|1|||
146303333|NCT02716675|527625739|FG002|Overall Study|Protocol Violation|1|||
146123243|NCT02291055|526970722|FG004|Overall Study|Lost to Follow-up|2|||
146123244|NCT02291055|526970718|FG000|Overall Study|Withdrawal by Subject|3|||
146123245|NCT02291055|526970719|FG001|Overall Study|Withdrawal by Subject|1|||
146123246|NCT02291055|526970720|FG002|Overall Study|Withdrawal by Subject|1|||
146123247|NCT02291055|526970721|FG003|Overall Study|Withdrawal by Subject|5|||
146123248|NCT02291055|526970722|FG004|Overall Study|Withdrawal by Subject|10|||
146123249|NCT02291055|526970718|FG000|Overall Study|Progressive Disease|0|||
146123250|NCT02291055|526970719|FG001|Overall Study|Progressive Disease|0|||
146123251|NCT02291055|526970720|FG002|Overall Study|Progressive Disease|1|||
146123252|NCT02291055|526970721|FG003|Overall Study|Progressive Disease|4|||
146123253|NCT02291055|526970722|FG004|Overall Study|Progressive Disease|2|||
146123254|NCT02291055|526970718|FG000|Overall Study|Study Terminated by Sponsor|0|||
146123255|NCT02291055|526970719|FG001|Overall Study|Study Terminated by Sponsor|0|||
146123256|NCT02291055|526970720|FG002|Overall Study|Study Terminated by Sponsor|0|||
146123257|NCT02291055|526970721|FG003|Overall Study|Study Terminated by Sponsor|5|||
146123258|NCT02291055|526970722|FG004|Overall Study|Study Terminated by Sponsor|1|||
146123259|NCT02291055|526970718|FG000|Overall Study|Other|0|||
146123260|NCT02291055|526970719|FG001|Overall Study|Other|2|||
146123261|NCT02291055|526970720|FG002|Overall Study|Other|1|||
146123262|NCT02291055|526970721|FG003|Overall Study|Other|4|||
146123263|NCT02291055|526970722|FG004|Overall Study|Other|0|||
146123264|NCT01523886|526970723|FG000|Overall Study|surgery cancelled|0|||
146123265|NCT01523886|526970724|FG001|Overall Study|surgery cancelled|1|||
146123266|NCT00733746|526970738|FG000|Overall Study|Ineligible|5|||
146123267|NCT01173718|526970739|FG000|Overall Study|Death|17|||
146123268|NCT01173718|526970739|FG000|Overall Study|Abandonment of study graft|27|||
146123269|NCT01367158|526970740|FG000|Overall Study|Withdrew consent|0|||
146123270|NCT01367158|526970741|FG001|Overall Study|Withdrew consent|2|||
146123271|NCT01367158|526970742|FG002|Overall Study|Withdrew consent|1|||
146123272|NCT01367158|526970743|FG003|Overall Study|Withdrew consent|0|||
146123273|NCT01367158|526970744|FG004|Overall Study|Withdrew consent|2|||
146123274|NCT01367158|526970745|FG005|Overall Study|Withdrew consent|0|||
146123275|NCT01367158|526970746|FG006|Overall Study|Withdrew consent|0|||
146123276|NCT01367158|526970747|FG007|Overall Study|Withdrew consent|1|||
146123277|NCT01367158|526970748|FG008|Overall Study|Withdrew consent|0|||
146123278|NCT01367158|526970749|FG009|Overall Study|Withdrew consent|0|||
146262392|NCT03463577|527476416|FG003|Overall Study|Lost to Follow-up|0|||
146262393|NCT03463577|527476417|FG004|Overall Study|Lost to Follow-up|0|||
146123279|NCT01367158|526970750|FG010|Overall Study|Withdrew consent|0|||
146123280|NCT01367158|526970740|FG000|Overall Study|Lost to Follow-up|0|||
146123281|NCT01367158|526970741|FG001|Overall Study|Lost to Follow-up|0|||
146123282|NCT01367158|526970742|FG002|Overall Study|Lost to Follow-up|0|||
146123283|NCT01367158|526970743|FG003|Overall Study|Lost to Follow-up|1|||
146123284|NCT01367158|526970744|FG004|Overall Study|Lost to Follow-up|0|||
146123285|NCT01367158|526970745|FG005|Overall Study|Lost to Follow-up|2|||
146123286|NCT01367158|526970746|FG006|Overall Study|Lost to Follow-up|0|||
146123287|NCT01367158|526970747|FG007|Overall Study|Lost to Follow-up|1|||
146123288|NCT01367158|526970748|FG008|Overall Study|Lost to Follow-up|0|||
146123289|NCT01367158|526970749|FG009|Overall Study|Lost to Follow-up|0|||
146123290|NCT01367158|526970750|FG010|Overall Study|Lost to Follow-up|1|||
146123291|NCT01367158|526970740|FG000|Overall Study|Protocol Violation|0|||
146123292|NCT01367158|526970741|FG001|Overall Study|Protocol Violation|1|||
146123293|NCT01367158|526970742|FG002|Overall Study|Protocol Violation|0|||
146123294|NCT01367158|526970743|FG003|Overall Study|Protocol Violation|0|||
146123295|NCT01367158|526970744|FG004|Overall Study|Protocol Violation|0|||
146123296|NCT01367158|526970745|FG005|Overall Study|Protocol Violation|0|||
146123297|NCT01367158|526970746|FG006|Overall Study|Protocol Violation|0|||
146123298|NCT01367158|526970747|FG007|Overall Study|Protocol Violation|0|||
146123299|NCT01367158|526970748|FG008|Overall Study|Protocol Violation|0|||
146123300|NCT01367158|526970749|FG009|Overall Study|Protocol Violation|0|||
146123301|NCT01367158|526970750|FG010|Overall Study|Protocol Violation|0|||
146123302|NCT02226003|526970751|FG000|Overall Study|Lost to Follow-up|2|||
146123303|NCT02226003|526970752|FG001|Overall Study|Lost to Follow-up|1|||
146262394|NCT03463577|527476418|FG005|Overall Study|Lost to Follow-up|0|||
146262395|NCT03463577|527476413|FG000|Overall Study|With unknown pregnancy outcome|0|||
146123304|NCT02226003|526970753|FG002|Overall Study|Lost to Follow-up|3|||
146262396|NCT03463577|527476414|FG001|Overall Study|With unknown pregnancy outcome|5|||
146262397|NCT03463577|527476415|FG002|Overall Study|With unknown pregnancy outcome|0|||
146262398|NCT03463577|527476416|FG003|Overall Study|With unknown pregnancy outcome|0|||
146262399|NCT03463577|527476417|FG004|Overall Study|With unknown pregnancy outcome|0|||
146262400|NCT03463577|527476418|FG005|Overall Study|With unknown pregnancy outcome|0|||
146262401|NCT03463577|527476413|FG000|Overall Study|Maternal death|2|||
146262402|NCT03463577|527476414|FG001|Overall Study|Maternal death|0|||
146262403|NCT03463577|527476415|FG002|Overall Study|Maternal death|0|||
146262404|NCT03463577|527476416|FG003|Overall Study|Maternal death|0|||
146123305|NCT02226003|526970751|FG000|Overall Study|Withdrawal by Subject|0|||
146123306|NCT02226003|526970752|FG001|Overall Study|Withdrawal by Subject|0|||
146123307|NCT02226003|526970753|FG002|Overall Study|Withdrawal by Subject|3|||
146123308|NCT01499563|526970756|FG000|Overall Study|Withdrawal by Subject|10|||
146262405|NCT03463577|527476417|FG004|Overall Study|Maternal death|0|||
146262406|NCT03463577|527476418|FG005|Overall Study|Maternal death|0|||
146123309|NCT01499563|526970757|FG001|Overall Study|Withdrawal by Subject|11|||
146123310|NCT01499563|526970758|FG002|Overall Study|Withdrawal by Subject|7|||
146123311|NCT01499563|526970759|FG003|Overall Study|Withdrawal by Subject|8|||
146123312|NCT01499563|526970756|FG000|Overall Study|Physician Decision|2|||
146123313|NCT01499563|526970757|FG001|Overall Study|Physician Decision|1|||
146123314|NCT01499563|526970758|FG002|Overall Study|Physician Decision|3|||
146123315|NCT01499563|526970759|FG003|Overall Study|Physician Decision|0|||
146123316|NCT01499563|526970756|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
146123317|NCT01499563|526970757|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
146262407|NCT03463577|527476413|FG000|Overall Study|Neonatal death|0|||
146123318|NCT01499563|526970758|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
146123319|NCT01499563|526970759|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
146123320|NCT01499563|526970756|FG000|Overall Study|Adverse Event|2|||
146123321|NCT01499563|526970757|FG001|Overall Study|Adverse Event|0|||
146123322|NCT01499563|526970758|FG002|Overall Study|Adverse Event|1|||
146123323|NCT01499563|526970759|FG003|Overall Study|Adverse Event|3|||
146123324|NCT01499563|526970756|FG000|Overall Study|Lack of Efficacy|0|||
146123325|NCT01499563|526970757|FG001|Overall Study|Lack of Efficacy|1|||
146123326|NCT01499563|526970758|FG002|Overall Study|Lack of Efficacy|6|||
146123327|NCT01499563|526970759|FG003|Overall Study|Lack of Efficacy|3|||
146123328|NCT01499563|526970756|FG000|Overall Study|Other|8|||
146123329|NCT01499563|526970757|FG001|Overall Study|Other|6|||
146123330|NCT01499563|526970758|FG002|Overall Study|Other|6|||
146123331|NCT01499563|526970759|FG003|Overall Study|Other|4|||
146123332|NCT03279692|526970760|FG000|Overall Study|Withdrawal by Subject|1|||
146123333|NCT05198843|526970763|FG000|Overall Study|Lack of Efficacy|1|||
146123334|NCT03333044|526970767|FG000|Overall Study|Pregnancy|1|||
146123335|NCT03333044|526970768|FG001|Overall Study|Pregnancy|0|||
146123336|NCT03333044|526970769|FG002|Overall Study|Pregnancy|0|||
146123337|NCT03333044|526970767|FG000|Overall Study|Lost to Follow-up|0|||
146123338|NCT03333044|526970768|FG001|Overall Study|Lost to Follow-up|14|||
146123339|NCT03333044|526970769|FG002|Overall Study|Lost to Follow-up|6|||
146123340|NCT04537234|526970770|FG000|Overall Study|Withdrawal by Subject|2|||
146123341|NCT04537234|526970771|FG001|Overall Study|Withdrawal by Subject|0|||
146123342|NCT07114198|526970772|FG000|Overall Study|Protocol Violation|1|||
146123343|NCT07114198|526970773|FG001|Overall Study|Protocol Violation|1|||
146123344|NCT04734652|526972942|FG000|Overall Study|Withdrawal by Subject|2|||
146123345|NCT04734652|526972943|FG001|Overall Study|Withdrawal by Subject|0|||
146123346|NCT04734652|526972942|FG000|Overall Study|Death|0|||
146123347|NCT04734652|526972943|FG001|Overall Study|Death|1|||
146123348|NCT01921179|526972945|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
146123349|NCT01921179|526972946|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
146123350|NCT01921179|526972945|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
146123351|NCT01921179|526972946|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
146123352|NCT01190254|526972949|FG000|Overall Study|Adverse Event|3|||
146123353|NCT01190254|526972950|FG001|Overall Study|Adverse Event|6|||
146123354|NCT01190254|526972951|FG002|Overall Study|Adverse Event|8|||
146123355|NCT01190254|526972949|FG000|Overall Study|Lack of Efficacy|7|||
146123356|NCT01190254|526972950|FG001|Overall Study|Lack of Efficacy|4|||
146123357|NCT01190254|526972951|FG002|Overall Study|Lack of Efficacy|5|||
146123358|NCT01190254|526972949|FG000|Overall Study|Lost to Follow-up|4|||
146123359|NCT01190254|526972950|FG001|Overall Study|Lost to Follow-up|2|||
146123360|NCT01190254|526972951|FG002|Overall Study|Lost to Follow-up|0|||
146123361|NCT01190254|526972949|FG000|Overall Study|Withdrawal by Subject|4|||
146123362|NCT01190254|526972950|FG001|Overall Study|Withdrawal by Subject|5|||
146123363|NCT01190254|526972951|FG002|Overall Study|Withdrawal by Subject|7|||
146123364|NCT01190254|526972949|FG000|Overall Study|Protocol Violation|2|||
146123365|NCT01190254|526972950|FG001|Overall Study|Protocol Violation|0|||
146123366|NCT01190254|526972951|FG002|Overall Study|Protocol Violation|2|||
146123367|NCT01190254|526972949|FG000|Overall Study|Did not meet protocol eligibility|1|||
146123368|NCT01190254|526972950|FG001|Overall Study|Did not meet protocol eligibility|0|||
146123369|NCT01190254|526972951|FG002|Overall Study|Did not meet protocol eligibility|0|||
146123370|NCT04146545|526972952|FG000|Overall Study|deemed ineligible after randomization|1|||
146123371|NCT04146545|526972953|FG001|Overall Study|deemed ineligible after randomization|0|||
146123372|NCT01729754|526972954|FG000|Part 1|Adverse Event|2|||
146123373|NCT01729754|526972955|FG001|Part 1|Adverse Event|0|||
146123374|NCT01729754|526972956|FG002|Part 1|Adverse Event|0|||
146123375|NCT01729754|526972957|FG003|Part 1|Adverse Event|1|||
146123376|NCT01729754|526972958|FG004|Part 1|Adverse Event|0|||
146123377|NCT01729754|526972959|FG005|Part 1|Adverse Event|0|||
146123378|NCT01729754|526972960|FG006|Part 1|Adverse Event|2|||
146123379|NCT01729754|526972961|FG007|Part 1|Adverse Event|0|||
146123380|NCT01729754|526972962|FG008|Part 1|Adverse Event|0|||
146123381|NCT01729754|526972963|FG009|Part 1|Adverse Event|5|||
146123382|NCT01729754|526972954|FG000|Part 1|Lack of Efficacy|1|||
146123383|NCT01729754|526972955|FG001|Part 1|Lack of Efficacy|0|||
146123384|NCT01729754|526972956|FG002|Part 1|Lack of Efficacy|0|||
146123385|NCT01729754|526972957|FG003|Part 1|Lack of Efficacy|0|||
146123386|NCT01729754|526972958|FG004|Part 1|Lack of Efficacy|0|||
146123387|NCT01729754|526972959|FG005|Part 1|Lack of Efficacy|0|||
146123388|NCT01729754|526972960|FG006|Part 1|Lack of Efficacy|2|||
146123389|NCT01729754|526972961|FG007|Part 1|Lack of Efficacy|0|||
146123390|NCT01729754|526972962|FG008|Part 1|Lack of Efficacy|0|||
146123391|NCT01729754|526972963|FG009|Part 1|Lack of Efficacy|0|||
146123392|NCT01729754|526972954|FG000|Part 1|Lost to Follow-up|1|||
146123393|NCT01729754|526972955|FG001|Part 1|Lost to Follow-up|0|||
146123394|NCT01729754|526972956|FG002|Part 1|Lost to Follow-up|0|||
146123395|NCT01729754|526972957|FG003|Part 1|Lost to Follow-up|2|||
146123396|NCT01729754|526972958|FG004|Part 1|Lost to Follow-up|0|||
146123397|NCT01729754|526972959|FG005|Part 1|Lost to Follow-up|0|||
146123398|NCT01729754|526972960|FG006|Part 1|Lost to Follow-up|3|||
146123399|NCT01729754|526972961|FG007|Part 1|Lost to Follow-up|0|||
146123400|NCT01729754|526972962|FG008|Part 1|Lost to Follow-up|0|||
146123401|NCT01729754|526972963|FG009|Part 1|Lost to Follow-up|3|||
146123402|NCT01729754|526972954|FG000|Part 1|Non-compliance with Study Drug|1|||
146123403|NCT01729754|526972955|FG001|Part 1|Non-compliance with Study Drug|0|||
146123404|NCT01729754|526972956|FG002|Part 1|Non-compliance with Study Drug|0|||
146123405|NCT01729754|526972957|FG003|Part 1|Non-compliance with Study Drug|0|||
146123406|NCT01729754|526972958|FG004|Part 1|Non-compliance with Study Drug|0|||
146123407|NCT01729754|526972959|FG005|Part 1|Non-compliance with Study Drug|0|||
146123408|NCT01729754|526972960|FG006|Part 1|Non-compliance with Study Drug|0|||
146123409|NCT01729754|526972961|FG007|Part 1|Non-compliance with Study Drug|0|||
146123410|NCT01729754|526972962|FG008|Part 1|Non-compliance with Study Drug|0|||
146123411|NCT01729754|526972963|FG009|Part 1|Non-compliance with Study Drug|0|||
146123412|NCT01729754|526972954|FG000|Part 1|Physician Decision|0|||
146123413|NCT01729754|526972955|FG001|Part 1|Physician Decision|0|||
146123414|NCT01729754|526972956|FG002|Part 1|Physician Decision|0|||
146123415|NCT01729754|526972957|FG003|Part 1|Physician Decision|0|||
146123416|NCT01729754|526972958|FG004|Part 1|Physician Decision|0|||
146123417|NCT01729754|526972959|FG005|Part 1|Physician Decision|0|||
146123418|NCT01729754|526972960|FG006|Part 1|Physician Decision|0|||
146123419|NCT01729754|526972961|FG007|Part 1|Physician Decision|0|||
146123420|NCT01729754|526972962|FG008|Part 1|Physician Decision|0|||
146123421|NCT01729754|526972963|FG009|Part 1|Physician Decision|4|||
146123422|NCT01729754|526972954|FG000|Part 1|Pregnancy|0|||
146123423|NCT01729754|526972955|FG001|Part 1|Pregnancy|0|||
146123424|NCT01729754|526972956|FG002|Part 1|Pregnancy|0|||
146123425|NCT01729754|526972957|FG003|Part 1|Pregnancy|1|||
146123426|NCT01729754|526972958|FG004|Part 1|Pregnancy|0|||
146123427|NCT01729754|526972959|FG005|Part 1|Pregnancy|0|||
146123428|NCT01729754|526972960|FG006|Part 1|Pregnancy|0|||
146123429|NCT01729754|526972961|FG007|Part 1|Pregnancy|0|||
146123430|NCT01729754|526972962|FG008|Part 1|Pregnancy|0|||
146123431|NCT01729754|526972963|FG009|Part 1|Pregnancy|1|||
146123432|NCT01729754|526972954|FG000|Part 1|Progressive Disease|0|||
146123433|NCT01729754|526972955|FG001|Part 1|Progressive Disease|0|||
146123434|NCT01729754|526972956|FG002|Part 1|Progressive Disease|0|||
146123435|NCT01729754|526972957|FG003|Part 1|Progressive Disease|0|||
146123436|NCT01729754|526972958|FG004|Part 1|Progressive Disease|0|||
146123437|NCT01729754|526972959|FG005|Part 1|Progressive Disease|0|||
146123438|NCT01729754|526972960|FG006|Part 1|Progressive Disease|0|||
146123439|NCT01729754|526972961|FG007|Part 1|Progressive Disease|0|||
146123440|NCT01729754|526972962|FG008|Part 1|Progressive Disease|0|||
146123441|NCT01729754|526972963|FG009|Part 1|Progressive Disease|1|||
146123442|NCT01729754|526972954|FG000|Part 1|Protocol Violation|2|||
146123443|NCT01729754|526972955|FG001|Part 1|Protocol Violation|0|||
146123444|NCT01729754|526972956|FG002|Part 1|Protocol Violation|0|||
146123445|NCT01729754|526972957|FG003|Part 1|Protocol Violation|1|||
146123446|NCT01729754|526972958|FG004|Part 1|Protocol Violation|0|||
146123447|NCT01729754|526972959|FG005|Part 1|Protocol Violation|0|||
146123448|NCT01729754|526972960|FG006|Part 1|Protocol Violation|1|||
146123449|NCT01729754|526972961|FG007|Part 1|Protocol Violation|0|||
146123450|NCT01729754|526972962|FG008|Part 1|Protocol Violation|0|||
146123451|NCT01729754|526972963|FG009|Part 1|Protocol Violation|0|||
146123452|NCT01729754|526972954|FG000|Part 1|Withdrawal by Subject|5|||
146123453|NCT01729754|526972955|FG001|Part 1|Withdrawal by Subject|0|||
146123454|NCT01729754|526972956|FG002|Part 1|Withdrawal by Subject|0|||
146123455|NCT01729754|526972957|FG003|Part 1|Withdrawal by Subject|7|||
146123456|NCT01729754|526972958|FG004|Part 1|Withdrawal by Subject|0|||
146123457|NCT01729754|526972959|FG005|Part 1|Withdrawal by Subject|0|||
146123458|NCT01729754|526972960|FG006|Part 1|Withdrawal by Subject|5|||
146123459|NCT01729754|526972961|FG007|Part 1|Withdrawal by Subject|0|||
146123460|NCT01729754|526972962|FG008|Part 1|Withdrawal by Subject|0|||
146123461|NCT01729754|526972963|FG009|Part 1|Withdrawal by Subject|6|||
146123462|NCT01729754|526972954|FG000|Part 1|Other Protocol Specified Criteria|2|||
146123463|NCT01729754|526972955|FG001|Part 1|Other Protocol Specified Criteria|0|||
146123464|NCT01729754|526972956|FG002|Part 1|Other Protocol Specified Criteria|0|||
146123465|NCT01729754|526972957|FG003|Part 1|Other Protocol Specified Criteria|0|||
146123466|NCT01729754|526972958|FG004|Part 1|Other Protocol Specified Criteria|0|||
146123467|NCT01729754|526972959|FG005|Part 1|Other Protocol Specified Criteria|0|||
146123468|NCT01729754|526972960|FG006|Part 1|Other Protocol Specified Criteria|1|||
146123469|NCT01729754|526972961|FG007|Part 1|Other Protocol Specified Criteria|0|||
146123470|NCT01729754|526972962|FG008|Part 1|Other Protocol Specified Criteria|0|||
146123471|NCT01729754|526972963|FG009|Part 1|Other Protocol Specified Criteria|4|||
146123472|NCT01729754|526972954|FG000|Part 2|Adverse Event|2|||
146123473|NCT01729754|526972955|FG001|Part 2|Adverse Event|0|||
146123474|NCT01729754|526972956|FG002|Part 2|Adverse Event|0|||
146123475|NCT01729754|526972957|FG003|Part 2|Adverse Event|0|||
146123476|NCT01729754|526972958|FG004|Part 2|Adverse Event|0|||
146123477|NCT01729754|526972959|FG005|Part 2|Adverse Event|0|||
146123478|NCT01729754|526972960|FG006|Part 2|Adverse Event|0|||
146123479|NCT01729754|526972961|FG007|Part 2|Adverse Event|0|||
146123480|NCT01729754|526972962|FG008|Part 2|Adverse Event|1|||
146123481|NCT01729754|526972963|FG009|Part 2|Adverse Event|2|||
146123482|NCT01729754|526972954|FG000|Part 2|Lack of Efficacy|0|||
146123483|NCT01729754|526972955|FG001|Part 2|Lack of Efficacy|0|||
146123484|NCT01729754|526972956|FG002|Part 2|Lack of Efficacy|0|||
146123485|NCT01729754|526972957|FG003|Part 2|Lack of Efficacy|0|||
146123486|NCT01729754|526972958|FG004|Part 2|Lack of Efficacy|0|||
146123487|NCT01729754|526972959|FG005|Part 2|Lack of Efficacy|0|||
146123488|NCT01729754|526972960|FG006|Part 2|Lack of Efficacy|0|||
146123489|NCT01729754|526972961|FG007|Part 2|Lack of Efficacy|0|||
146123490|NCT01729754|526972962|FG008|Part 2|Lack of Efficacy|2|||
146123491|NCT01729754|526972963|FG009|Part 2|Lack of Efficacy|2|||
146123492|NCT01729754|526972954|FG000|Part 2|Lost to Follow-up|0|||
146123493|NCT01729754|526972955|FG001|Part 2|Lost to Follow-up|0|||
146123494|NCT01729754|526972956|FG002|Part 2|Lost to Follow-up|0|||
146123495|NCT01729754|526972957|FG003|Part 2|Lost to Follow-up|2|||
146123496|NCT01729754|526972958|FG004|Part 2|Lost to Follow-up|0|||
146123497|NCT01729754|526972959|FG005|Part 2|Lost to Follow-up|0|||
146123498|NCT01729754|526972960|FG006|Part 2|Lost to Follow-up|0|||
146123499|NCT01729754|526972961|FG007|Part 2|Lost to Follow-up|1|||
146123500|NCT01729754|526972962|FG008|Part 2|Lost to Follow-up|0|||
146123501|NCT01729754|526972963|FG009|Part 2|Lost to Follow-up|2|||
146123502|NCT01729754|526972954|FG000|Part 2|Non-Compliance with Study Drug|0|||
146123503|NCT01729754|526972955|FG001|Part 2|Non-Compliance with Study Drug|0|||
146123504|NCT01729754|526972956|FG002|Part 2|Non-Compliance with Study Drug|0|||
146123505|NCT01729754|526972957|FG003|Part 2|Non-Compliance with Study Drug|0|||
146123506|NCT01729754|526972958|FG004|Part 2|Non-Compliance with Study Drug|0|||
146123507|NCT01729754|526972959|FG005|Part 2|Non-Compliance with Study Drug|0|||
146123508|NCT01729754|526972960|FG006|Part 2|Non-Compliance with Study Drug|0|||
146123509|NCT01729754|526972961|FG007|Part 2|Non-Compliance with Study Drug|0|||
146123510|NCT01729754|526972962|FG008|Part 2|Non-Compliance with Study Drug|0|||
146123511|NCT01729754|526972963|FG009|Part 2|Non-Compliance with Study Drug|1|||
146123512|NCT01729754|526972954|FG000|Part 2|Pregnancy|0|||
146123513|NCT01729754|526972955|FG001|Part 2|Pregnancy|0|||
146123514|NCT01729754|526972956|FG002|Part 2|Pregnancy|0|||
146123515|NCT01729754|526972957|FG003|Part 2|Pregnancy|1|||
146123516|NCT01729754|526972958|FG004|Part 2|Pregnancy|0|||
146123517|NCT01729754|526972959|FG005|Part 2|Pregnancy|0|||
146123518|NCT01729754|526972960|FG006|Part 2|Pregnancy|0|||
146123519|NCT01729754|526972961|FG007|Part 2|Pregnancy|0|||
146123520|NCT01729754|526972962|FG008|Part 2|Pregnancy|0|||
146123521|NCT01729754|526972963|FG009|Part 2|Pregnancy|1|||
146123522|NCT01729754|526972954|FG000|Part 2|Withdrawal by Subject|3|||
146123523|NCT01729754|526972955|FG001|Part 2|Withdrawal by Subject|0|||
146123524|NCT01729754|526972956|FG002|Part 2|Withdrawal by Subject|0|||
146123525|NCT01729754|526972957|FG003|Part 2|Withdrawal by Subject|2|||
146123526|NCT01729754|526972958|FG004|Part 2|Withdrawal by Subject|0|||
146123527|NCT01729754|526972959|FG005|Part 2|Withdrawal by Subject|0|||
146123528|NCT01729754|526972960|FG006|Part 2|Withdrawal by Subject|0|||
146123529|NCT01729754|526972961|FG007|Part 2|Withdrawal by Subject|1|||
146123530|NCT01729754|526972962|FG008|Part 2|Withdrawal by Subject|1|||
146123531|NCT01729754|526972963|FG009|Part 2|Withdrawal by Subject|4|||
146123532|NCT01729754|526972954|FG000|Part 2|Other Protocol Specified Criteria|1|||
146123533|NCT01729754|526972955|FG001|Part 2|Other Protocol Specified Criteria|0|||
146123534|NCT01729754|526972956|FG002|Part 2|Other Protocol Specified Criteria|0|||
146123535|NCT01729754|526972957|FG003|Part 2|Other Protocol Specified Criteria|0|||
146123536|NCT01729754|526972958|FG004|Part 2|Other Protocol Specified Criteria|0|||
146123537|NCT01729754|526972959|FG005|Part 2|Other Protocol Specified Criteria|0|||
146123538|NCT01729754|526972960|FG006|Part 2|Other Protocol Specified Criteria|0|||
146123539|NCT01729754|526972961|FG007|Part 2|Other Protocol Specified Criteria|1|||
146123540|NCT01729754|526972962|FG008|Part 2|Other Protocol Specified Criteria|0|||
146123541|NCT01729754|526972963|FG009|Part 2|Other Protocol Specified Criteria|0|||
146123542|NCT01729754|526972954|FG000|Part 3|Adverse Event|0|||
146123543|NCT01729754|526972955|FG001|Part 3|Adverse Event|0|||
146123544|NCT01729754|526972956|FG002|Part 3|Adverse Event|1|||
146123545|NCT01729754|526972957|FG003|Part 3|Adverse Event|0|||
146123546|NCT01729754|526972958|FG004|Part 3|Adverse Event|0|||
146123547|NCT01729754|526972959|FG005|Part 3|Adverse Event|5|||
146123548|NCT01729754|526972960|FG006|Part 3|Adverse Event|0|||
146123549|NCT01729754|526972961|FG007|Part 3|Adverse Event|0|||
146123550|NCT01729754|526972962|FG008|Part 3|Adverse Event|0|||
146123551|NCT01729754|526972963|FG009|Part 3|Adverse Event|3|||
146123552|NCT01729754|526972954|FG000|Part 3|Death|0|||
146123553|NCT01729754|526972955|FG001|Part 3|Death|0|||
146123554|NCT01729754|526972956|FG002|Part 3|Death|0|||
146123555|NCT01729754|526972957|FG003|Part 3|Death|0|||
146123556|NCT01729754|526972958|FG004|Part 3|Death|0|||
146123557|NCT01729754|526972959|FG005|Part 3|Death|2|||
146123558|NCT01729754|526972960|FG006|Part 3|Death|0|||
146123559|NCT01729754|526972961|FG007|Part 3|Death|0|||
146123560|NCT01729754|526972962|FG008|Part 3|Death|0|||
146123561|NCT01729754|526972963|FG009|Part 3|Death|0|||
146123562|NCT01729754|526972954|FG000|Part 3|Lack of Efficacy|0|||
146123563|NCT01729754|526972955|FG001|Part 3|Lack of Efficacy|0|||
146123564|NCT01729754|526972956|FG002|Part 3|Lack of Efficacy|0|||
146123565|NCT01729754|526972957|FG003|Part 3|Lack of Efficacy|0|||
146123566|NCT01729754|526972958|FG004|Part 3|Lack of Efficacy|2|||
146123567|NCT01729754|526972959|FG005|Part 3|Lack of Efficacy|0|||
146123568|NCT01729754|526972960|FG006|Part 3|Lack of Efficacy|0|||
146123569|NCT01729754|526972961|FG007|Part 3|Lack of Efficacy|0|||
146123570|NCT01729754|526972962|FG008|Part 3|Lack of Efficacy|0|||
146123571|NCT01729754|526972963|FG009|Part 3|Lack of Efficacy|4|||
146123572|NCT01729754|526972954|FG000|Part 3|Lost to Follow-up|0|||
146123573|NCT01729754|526972955|FG001|Part 3|Lost to Follow-up|1|||
146123574|NCT01729754|526972956|FG002|Part 3|Lost to Follow-up|2|||
146123575|NCT01729754|526972957|FG003|Part 3|Lost to Follow-up|0|||
146123576|NCT01729754|526972958|FG004|Part 3|Lost to Follow-up|0|||
146123577|NCT01729754|526972959|FG005|Part 3|Lost to Follow-up|3|||
146123578|NCT01729754|526972960|FG006|Part 3|Lost to Follow-up|0|||
146123579|NCT01729754|526972961|FG007|Part 3|Lost to Follow-up|0|||
146123580|NCT01729754|526972962|FG008|Part 3|Lost to Follow-up|1|||
146123581|NCT01729754|526972963|FG009|Part 3|Lost to Follow-up|0|||
146123582|NCT01729754|526972954|FG000|Part 3|Physician Decision|0|||
146123583|NCT01729754|526972955|FG001|Part 3|Physician Decision|0|||
146123584|NCT01729754|526972956|FG002|Part 3|Physician Decision|1|||
146123585|NCT01729754|526972957|FG003|Part 3|Physician Decision|0|||
146123586|NCT01729754|526972958|FG004|Part 3|Physician Decision|0|||
146123587|NCT01729754|526972959|FG005|Part 3|Physician Decision|0|||
146123588|NCT01729754|526972960|FG006|Part 3|Physician Decision|0|||
146123589|NCT01729754|526972961|FG007|Part 3|Physician Decision|0|||
146123590|NCT01729754|526972962|FG008|Part 3|Physician Decision|0|||
146123591|NCT01729754|526972963|FG009|Part 3|Physician Decision|0|||
146123592|NCT01729754|526972954|FG000|Part 3|Withdrawal by Subject|0|||
146123593|NCT01729754|526972955|FG001|Part 3|Withdrawal by Subject|4|||
146123594|NCT01729754|526972956|FG002|Part 3|Withdrawal by Subject|1|||
146123595|NCT01729754|526972957|FG003|Part 3|Withdrawal by Subject|0|||
146123596|NCT01729754|526972958|FG004|Part 3|Withdrawal by Subject|2|||
146123597|NCT01729754|526972959|FG005|Part 3|Withdrawal by Subject|1|||
146123598|NCT01729754|526972960|FG006|Part 3|Withdrawal by Subject|0|||
146123599|NCT01729754|526972961|FG007|Part 3|Withdrawal by Subject|2|||
146123600|NCT01729754|526972962|FG008|Part 3|Withdrawal by Subject|0|||
146123601|NCT01729754|526972963|FG009|Part 3|Withdrawal by Subject|0|||
146123602|NCT01729754|526972954|FG000|Part 3|Other Protocol Specified Criteria|0|||
146123603|NCT01729754|526972955|FG001|Part 3|Other Protocol Specified Criteria|0|||
146123604|NCT01729754|526972956|FG002|Part 3|Other Protocol Specified Criteria|0|||
146123605|NCT01729754|526972957|FG003|Part 3|Other Protocol Specified Criteria|0|||
146123606|NCT01729754|526972958|FG004|Part 3|Other Protocol Specified Criteria|0|||
146123607|NCT01729754|526972959|FG005|Part 3|Other Protocol Specified Criteria|2|||
146123608|NCT01729754|526972960|FG006|Part 3|Other Protocol Specified Criteria|0|||
146123609|NCT01729754|526972961|FG007|Part 3|Other Protocol Specified Criteria|1|||
146123610|NCT01729754|526972962|FG008|Part 3|Other Protocol Specified Criteria|0|||
146123611|NCT01729754|526972963|FG009|Part 3|Other Protocol Specified Criteria|0|||
146123612|NCT00773292|526972964|FG000|Treatment 48 Weeks|Adverse Event|1|||
146123613|NCT00773292|526972964|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
146123614|NCT04729127|526972965|FG000|Overall Study|Suspended/Terminated EI Services|4|||
146123615|NCT04729127|526972966|FG001|Overall Study|Suspended/Terminated EI Services|0|||
146123616|NCT04729127|526972967|FG002|Overall Study|Suspended/Terminated EI Services|4|||
146123617|NCT04729127|526972968|FG003|Overall Study|Suspended/Terminated EI Services|6|||
146123618|NCT04729127|526972969|FG004|Overall Study|Suspended/Terminated EI Services|0|||
146123619|NCT04729127|526972970|FG005|Overall Study|Suspended/Terminated EI Services|6|||
146123620|NCT04729127|526972971|FG006|Overall Study|Suspended/Terminated EI Services|2|||
146123621|NCT04729127|526972972|FG007|Overall Study|Suspended/Terminated EI Services|0|||
146123622|NCT04729127|526972973|FG008|Overall Study|Suspended/Terminated EI Services|2|||
146123623|NCT04729127|526972965|FG000|Overall Study|Withdrawal by Subject|1|||
146123624|NCT04729127|526972966|FG001|Overall Study|Withdrawal by Subject|0|||
146123625|NCT04729127|526972967|FG002|Overall Study|Withdrawal by Subject|1|||
146123626|NCT04729127|526972968|FG003|Overall Study|Withdrawal by Subject|0|||
146123627|NCT04729127|526972969|FG004|Overall Study|Withdrawal by Subject|0|||
146123628|NCT04729127|526972970|FG005|Overall Study|Withdrawal by Subject|0|||
146123629|NCT04729127|526972971|FG006|Overall Study|Withdrawal by Subject|0|||
146123630|NCT04729127|526972972|FG007|Overall Study|Withdrawal by Subject|0|||
146123631|NCT04729127|526972973|FG008|Overall Study|Withdrawal by Subject|0|||
146123632|NCT04729127|526972965|FG000|Overall Study|Switched Agency/Setting|1|||
146123633|NCT04729127|526972966|FG001|Overall Study|Switched Agency/Setting|0|||
146123634|NCT04729127|526972967|FG002|Overall Study|Switched Agency/Setting|1|||
146123635|NCT04729127|526972968|FG003|Overall Study|Switched Agency/Setting|1|||
146123636|NCT04729127|526972969|FG004|Overall Study|Switched Agency/Setting|0|||
146123637|NCT04729127|526972970|FG005|Overall Study|Switched Agency/Setting|1|||
146123638|NCT04729127|526972971|FG006|Overall Study|Switched Agency/Setting|1|||
146123639|NCT04729127|526972972|FG007|Overall Study|Switched Agency/Setting|0|||
146123640|NCT04729127|526972973|FG008|Overall Study|Switched Agency/Setting|1|||
146123641|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Death|3|||
146123642|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Death|2|||
146123643|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Death|4|||
146123644|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Death|3|||
146123645|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Death|0|||
146123646|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Death|0|||
146123647|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146123648|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
146123649|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
146123650|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146123651|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146123652|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
146123653|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
146123654|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146123655|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146123656|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146123657|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146123658|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
146123659|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
146123660|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146123661|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
146123662|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
146123663|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146123664|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
146123665|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146123666|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146123667|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
146123668|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
146123669|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146123670|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
146123671|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
146123672|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
146123673|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
146123674|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
146123675|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
146123676|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
146123677|NCT02432846|526972976|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146123678|NCT02432846|526972977|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146123679|NCT02432846|526972978|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
146123680|NCT02432846|526972979|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146123681|NCT02432846|526972980|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146123682|NCT02432846|526972981|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
146123683|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
146123684|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
146123685|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
146123686|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
146123687|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
146123688|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
146123689|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146123690|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146123691|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146123692|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
146123693|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
146123694|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
146123695|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146123696|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146123697|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146123698|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146123699|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
146123700|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
146123701|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146123702|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146123703|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146123704|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
146123705|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
146123706|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
146123707|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146123708|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146123709|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146123710|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
146123711|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
146123712|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
146262408|NCT03463577|527476414|FG001|Overall Study|Neonatal death|0|||
146123713|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146123714|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146123715|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146123716|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
146123717|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
146123718|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
146123719|NCT02432846|526972976|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146123720|NCT02432846|526972977|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146123721|NCT02432846|526972978|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146123722|NCT02432846|526972979|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146123723|NCT02432846|526972980|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
146123724|NCT02432846|526972981|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
146123725|NCT01912287|526972982|FG000|Overall Study|Ineligible|1|||
146123726|NCT01912287|526972983|FG001|Overall Study|Ineligible|0|||
146123727|NCT01912287|526972984|FG002|Overall Study|Ineligible|1|||
146123728|NCT01912287|526972982|FG000|Overall Study|No-show|0|||
146123729|NCT01912287|526972983|FG001|Overall Study|No-show|0|||
146123730|NCT01912287|526972984|FG002|Overall Study|No-show|1|||
146123731|NCT01912287|526972982|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
146123732|NCT01912287|526972983|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
146123733|NCT01912287|526972984|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
146123734|NCT01912287|526972982|FG000|Overall Study|Felt treatment no longer needed|0|||
146123735|NCT01912287|526972983|FG001|Overall Study|Felt treatment no longer needed|1|||
146123736|NCT01912287|526972984|FG002|Overall Study|Felt treatment no longer needed|0|||
146123737|NCT01912287|526972982|FG000|Overall Study|Life circumstances|4|||
146123738|NCT01912287|526972983|FG001|Overall Study|Life circumstances|2|||
146123739|NCT01912287|526972984|FG002|Overall Study|Life circumstances|0|||
146123740|NCT01912287|526972982|FG000|Overall Study|Lost Interest|1|||
146123741|NCT01912287|526972983|FG001|Overall Study|Lost Interest|0|||
146123742|NCT01912287|526972984|FG002|Overall Study|Lost Interest|0|||
146123743|NCT01912287|526972982|FG000|Overall Study|Uknown reason - subject drop out|5|||
146123744|NCT01912287|526972983|FG001|Overall Study|Uknown reason - subject drop out|7|||
146123745|NCT01912287|526972984|FG002|Overall Study|Uknown reason - subject drop out|3|||
146123746|NCT01912287|526972982|FG000|Overall Study|Missed Assesment|1|||
146123747|NCT01912287|526972983|FG001|Overall Study|Missed Assesment|1|||
146123748|NCT01912287|526972984|FG002|Overall Study|Missed Assesment|1|||
146123749|NCT01912287|526972982|FG000|Overall Study|Scheduling/change in availability|17|||
146123750|NCT01912287|526972983|FG001|Overall Study|Scheduling/change in availability|10|||
146123751|NCT01912287|526972984|FG002|Overall Study|Scheduling/change in availability|8|||
146123752|NCT03226392|526972985|FG000|Overall Study|Protocol Deviation|1|||
146123753|NCT03226392|526972986|FG001|Overall Study|Protocol Deviation|0|||
146123754|NCT03226392|526972985|FG000|Overall Study|Physician Decision|1|||
146123755|NCT03226392|526972986|FG001|Overall Study|Physician Decision|0|||
146123756|NCT03226392|526972985|FG000|Overall Study|Lost to Follow-up|1|||
146123757|NCT03226392|526972986|FG001|Overall Study|Lost to Follow-up|0|||
146123758|NCT03226392|526972985|FG000|Overall Study|Adverse Event|1|||
146123759|NCT03226392|526972986|FG001|Overall Study|Adverse Event|0|||
146123760|NCT03226392|526972985|FG000|Overall Study|Technical Problems|0|||
146123761|NCT03226392|526972986|FG001|Overall Study|Technical Problems|2|||
146123762|NCT03226392|526972985|FG000|Overall Study|Subject/Guardian Decision|7|||
146123763|NCT03226392|526972986|FG001|Overall Study|Subject/Guardian Decision|6|||
146123764|NCT00937157|526972987|FG000|Overall Study|Pregnancy|1|||
146123765|NCT00937157|526972987|FG000|Overall Study|Lost to Follow-up|3|||
146123766|NCT01998633|526972988|FG000|Overall Study|Death|1|||
146123767|NCT02631850|526972989|FG000|Treatment Period|Lost to Follow-up|0|||
146123768|NCT02631850|526972990|FG001|Treatment Period|Lost to Follow-up|1|||
146123769|NCT02631850|526972991|FG002|Treatment Period|Lost to Follow-up|0|||
146123770|NCT02631850|526972992|FG003|Treatment Period|Lost to Follow-up|0|||
146123771|NCT02631850|526972989|FG000|Treatment Period|Protocol Violation|1|||
146123772|NCT02631850|526972990|FG001|Treatment Period|Protocol Violation|0|||
146123773|NCT02631850|526972991|FG002|Treatment Period|Protocol Violation|0|||
146123774|NCT02631850|526972992|FG003|Treatment Period|Protocol Violation|0|||
146123775|NCT02631850|526972989|FG000|Treatment Period|Withdrawal by Subject|0|||
146123776|NCT02631850|526972990|FG001|Treatment Period|Withdrawal by Subject|5|||
146123777|NCT02631850|526972991|FG002|Treatment Period|Withdrawal by Subject|2|||
146123778|NCT02631850|526972992|FG003|Treatment Period|Withdrawal by Subject|2|||
146123779|NCT02631850|526972989|FG000|Treatment Period|Adverse Event|1|||
146123780|NCT02631850|526972990|FG001|Treatment Period|Adverse Event|0|||
146123781|NCT02631850|526972991|FG002|Treatment Period|Adverse Event|2|||
146123782|NCT02631850|526972992|FG003|Treatment Period|Adverse Event|3|||
146123783|NCT02631850|526972989|FG000|Treatment Period|Family medical issue|1|||
146123784|NCT02631850|526972990|FG001|Treatment Period|Family medical issue|0|||
146123785|NCT02631850|526972991|FG002|Treatment Period|Family medical issue|0|||
146123786|NCT02631850|526972992|FG003|Treatment Period|Family medical issue|0|||
146123787|NCT02631850|526972989|FG000|6 Month Follow up|Lost to Follow-up|5|||
146123788|NCT02631850|526972990|FG001|6 Month Follow up|Lost to Follow-up|8|||
146123789|NCT02631850|526972991|FG002|6 Month Follow up|Lost to Follow-up|3|||
146123790|NCT02631850|526972992|FG003|6 Month Follow up|Lost to Follow-up|5|||
146123791|NCT02631850|526972989|FG000|6 Month Follow up|Withdrawal by Subject|1|||
146123792|NCT02631850|526972990|FG001|6 Month Follow up|Withdrawal by Subject|0|||
146123793|NCT02631850|526972991|FG002|6 Month Follow up|Withdrawal by Subject|0|||
146123794|NCT02631850|526972992|FG003|6 Month Follow up|Withdrawal by Subject|2|||
146123795|NCT02631850|526972989|FG000|6 Month Follow up|Adverse Event|1|||
146123796|NCT02631850|526972990|FG001|6 Month Follow up|Adverse Event|4|||
146123797|NCT02631850|526972991|FG002|6 Month Follow up|Adverse Event|1|||
146123798|NCT02631850|526972992|FG003|6 Month Follow up|Adverse Event|3|||
146123799|NCT02631850|526972989|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
146123800|NCT02631850|526972990|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
146123801|NCT02631850|526972991|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
146123802|NCT02631850|526972992|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
146123803|NCT01462084|526972994|FG000|Overall Study|Withdrawal by Subject|1|||
146123804|NCT01462084|526972995|FG001|Overall Study|Withdrawal by Subject|0|||
146123805|NCT01462084|526972994|FG000|Overall Study|Protocol Violation|1|||
146123806|NCT01462084|526972995|FG001|Overall Study|Protocol Violation|1|||
146123807|NCT03992781|526972996|FG000|Overall Study|Lost to Follow-up|5|||
146123808|NCT03992781|526972996|FG000|Overall Study|Adverse Event|1|||
146123809|NCT03992781|526972996|FG000|Overall Study|Lack of Efficacy|5|||
146123810|NCT00695396|526972997|FG000|Overall Study|Study Closed Prematurely|5|||
146123811|NCT00695396|526972998|FG001|Overall Study|Study Closed Prematurely|6|||
146123812|NCT00695396|526972999|FG002|Overall Study|Study Closed Prematurely|8|||
146123813|NCT00695396|526972997|FG000|Overall Study|Withdrawal by Subject|2|||
146123814|NCT00695396|526972998|FG001|Overall Study|Withdrawal by Subject|2|||
146123815|NCT00695396|526972999|FG002|Overall Study|Withdrawal by Subject|0|||
146123816|NCT00518323|526973001|FG000|Overall Study|Lack of Efficacy|14|||
146123817|NCT00518323|526973002|FG001|Overall Study|Lack of Efficacy|2|||
146123818|NCT00518323|526973003|FG002|Overall Study|Lack of Efficacy|4|||
146123819|NCT00518323|526973004|FG003|Overall Study|Lack of Efficacy|20|||
146123820|NCT00518323|526973001|FG000|Overall Study|Withdrawal by Subject|1|||
146123821|NCT00518323|526973002|FG001|Overall Study|Withdrawal by Subject|2|||
146123822|NCT00518323|526973003|FG002|Overall Study|Withdrawal by Subject|4|||
146123823|NCT00518323|526973004|FG003|Overall Study|Withdrawal by Subject|2|||
146123824|NCT00518323|526973001|FG000|Overall Study|Lost to Follow-up|0|||
146123825|NCT00518323|526973002|FG001|Overall Study|Lost to Follow-up|2|||
146123826|NCT00518323|526973003|FG002|Overall Study|Lost to Follow-up|1|||
146123827|NCT00518323|526973004|FG003|Overall Study|Lost to Follow-up|3|||
146123828|NCT00518323|526973001|FG000|Overall Study|Adverse Event|1|||
146123829|NCT00518323|526973002|FG001|Overall Study|Adverse Event|1|||
146123830|NCT00518323|526973003|FG002|Overall Study|Adverse Event|1|||
146123831|NCT00518323|526973004|FG003|Overall Study|Adverse Event|0|||
146123832|NCT00518323|526973001|FG000|Overall Study|Prohibited medication and others|3|||
146123833|NCT00518323|526973002|FG001|Overall Study|Prohibited medication and others|1|||
146123834|NCT00518323|526973003|FG002|Overall Study|Prohibited medication and others|1|||
146123835|NCT00518323|526973004|FG003|Overall Study|Prohibited medication and others|0|||
146123836|NCT03880019|526973006|FG000|Overall Study|Competing disease|1|||
146123837|NCT01514760|526973007|FG000|Overall Study|Lost to Follow-up|2|||
146123838|NCT01132547|526973008|FG000|Overall Study|Withdrawal by Subject|3|||
146123839|NCT01132547|526973009|FG001|Overall Study|Withdrawal by Subject|1|||
146123840|NCT01132547|526973008|FG000|Overall Study|Death|1|||
146123841|NCT01132547|526973009|FG001|Overall Study|Death|0|||
146123842|NCT02337907|526973012|FG000|Overall Study|Other than listed|1|||
146123843|NCT02337907|526973013|FG001|Overall Study|Other than listed|0|||
146123844|NCT02337907|526973014|FG002|Overall Study|Other than listed|0|||
146123845|NCT02337907|526973015|FG003|Overall Study|Other than listed|1|||
146123846|NCT02337907|526973016|FG004|Overall Study|Other than listed|1|||
146123847|NCT02337907|526973017|FG005|Overall Study|Other than listed|0|||
146123848|NCT02337907|526973012|FG000|Overall Study|Withdrawal by Subject|2|||
146123849|NCT02337907|526973013|FG001|Overall Study|Withdrawal by Subject|3|||
146123850|NCT02337907|526973014|FG002|Overall Study|Withdrawal by Subject|0|||
146123851|NCT02337907|526973015|FG003|Overall Study|Withdrawal by Subject|2|||
146123852|NCT02337907|526973016|FG004|Overall Study|Withdrawal by Subject|5|||
146123853|NCT02337907|526973017|FG005|Overall Study|Withdrawal by Subject|0|||
146123854|NCT02337907|526973012|FG000|Overall Study|Lost to Follow-up|0|||
146123855|NCT02337907|526973013|FG001|Overall Study|Lost to Follow-up|0|||
146123856|NCT02337907|526973014|FG002|Overall Study|Lost to Follow-up|0|||
146123857|NCT02337907|526973015|FG003|Overall Study|Lost to Follow-up|0|||
146123858|NCT02337907|526973016|FG004|Overall Study|Lost to Follow-up|0|||
146123859|NCT02337907|526973017|FG005|Overall Study|Lost to Follow-up|1|||
146123860|NCT02337907|526973012|FG000|Overall Study|Adverse Event|1|||
146123861|NCT02337907|526973013|FG001|Overall Study|Adverse Event|1|||
146123862|NCT02337907|526973014|FG002|Overall Study|Adverse Event|1|||
146123863|NCT02337907|526973015|FG003|Overall Study|Adverse Event|1|||
146123864|NCT02337907|526973016|FG004|Overall Study|Adverse Event|4|||
146123865|NCT02337907|526973017|FG005|Overall Study|Adverse Event|0|||
146123866|NCT01592344|526973018|FG000|Overall Study|Adverse Event|1|||
146123867|NCT01592344|526973019|FG001|Overall Study|Adverse Event|1|||
146123868|NCT01592344|526973018|FG000|Overall Study|Lack of Efficacy|1|||
146123869|NCT01592344|526973019|FG001|Overall Study|Lack of Efficacy|0|||
146123870|NCT01592344|526973018|FG000|Overall Study|not available at primary outcome visit|2|||
146123871|NCT01592344|526973019|FG001|Overall Study|not available at primary outcome visit|4|||
146123872|NCT03311659|526973025|FG000|Overall Study|Protocol Violation|1|||
146123873|NCT04327388|526973028|FG000|Overall Study|Adverse Event|17|||
146123874|NCT04327388|526973029|FG001|Overall Study|Adverse Event|18|||
146123875|NCT04327388|526973030|FG002|Overall Study|Adverse Event|9|||
146123876|NCT04327388|526973028|FG000|Overall Study|Other|1|||
146123877|NCT04327388|526973029|FG001|Overall Study|Other|2|||
146123878|NCT04327388|526973030|FG002|Overall Study|Other|0|||
146123879|NCT04327388|526973028|FG000|Overall Study|Randomized and not treated|2|||
146123880|NCT04327388|526973029|FG001|Overall Study|Randomized and not treated|0|||
146123881|NCT04327388|526973030|FG002|Overall Study|Randomized and not treated|2|||
146123882|NCT04053023|526973031|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
146123883|NCT04053023|526973032|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
146123884|NCT00071760|526973033|FG000|Overall Study|Adverse Event|2|||
146123885|NCT00071760|526973034|FG001|Overall Study|Adverse Event|1|||
146123886|NCT00071760|526973033|FG000|Overall Study|Lost to Follow-up|0|||
146123887|NCT00071760|526973034|FG001|Overall Study|Lost to Follow-up|3|||
146123888|NCT00071760|526973033|FG000|Overall Study|Protocol Violation|1|||
146123889|NCT00071760|526973034|FG001|Overall Study|Protocol Violation|0|||
146123890|NCT00071760|526973033|FG000|Overall Study|Withdrawal by Subject|0|||
146123891|NCT00071760|526973034|FG001|Overall Study|Withdrawal by Subject|1|||
146123892|NCT00071760|526973033|FG000|Overall Study|Insufficient Viral Load Response|1|||
146123893|NCT00071760|526973034|FG001|Overall Study|Insufficient Viral Load Response|1|||
146123894|NCT00071760|526973033|FG000|Overall Study|Lack of availability of RTV|1|||
146123895|NCT00071760|526973034|FG001|Overall Study|Lack of availability of RTV|0|||
146123896|NCT00071760|526973033|FG000|Overall Study|Physician Decision|2|||
146123897|NCT00071760|526973034|FG001|Overall Study|Physician Decision|1|||
146123898|NCT00071760|526973033|FG000|Overall Study|Relocation|0|||
146123899|NCT00071760|526973034|FG001|Overall Study|Relocation|1|||
146123900|NCT02073279|526973035|FG000|Double-blind Period|Adverse Event|1|||
146123901|NCT02073279|526973036|FG001|Double-blind Period|Adverse Event|1|||
146123902|NCT02073279|526973035|FG000|Double-blind Period|Switched to another treatment|1|||
146123903|NCT02073279|526973036|FG001|Double-blind Period|Switched to another treatment|2|||
146123904|NCT02073279|526973035|FG000|Double-blind Period|Protocol Violation|0|||
146123905|NCT02073279|526973036|FG001|Double-blind Period|Protocol Violation|1|||
146123906|NCT02073279|526973035|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
146123907|NCT02073279|526973036|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
146123908|NCT02073279|526973035|FG000|Double-blind Period|Withdrawal by Subject|2|||
146123909|NCT02073279|526973036|FG001|Double-blind Period|Withdrawal by Subject|2|||
146123910|NCT02073279|526973035|FG000|Open-label Extension Period|Adverse Event|1|||
146123911|NCT02073279|526973036|FG001|Open-label Extension Period|Adverse Event|0|||
146123912|NCT02073279|526973035|FG000|Open-label Extension Period|Lack of Efficacy|1|||
146123913|NCT02073279|526973036|FG001|Open-label Extension Period|Lack of Efficacy|0|||
146123914|NCT02073279|526973035|FG000|Open-label Extension Period|Lost to Follow-up|0|||
146123915|NCT02073279|526973036|FG001|Open-label Extension Period|Lost to Follow-up|4|||
146123916|NCT02073279|526973035|FG000|Open-label Extension Period|Switched to another treatment|1|||
146123917|NCT02073279|526973036|FG001|Open-label Extension Period|Switched to another treatment|4|||
146123918|NCT02073279|526973035|FG000|Open-label Extension Period|Protocol Violation|0|||
146123919|NCT02073279|526973036|FG001|Open-label Extension Period|Protocol Violation|1|||
146123920|NCT02073279|526973035|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
146123921|NCT02073279|526973036|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
146123922|NCT02073279|526973035|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
146123923|NCT02073279|526973036|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
146123924|NCT01558752|526973042|FG000|Overall Study|Physician Decision|2|||
146123925|NCT01558752|526973043|FG001|Overall Study|Physician Decision|0|||
146123926|NCT04387435|526973050|FG000|Overall Study|Physician Decision|1|||
146262409|NCT03463577|527476415|FG002|Overall Study|Neonatal death|0|||
146262410|NCT03463577|527476416|FG003|Overall Study|Neonatal death|15|||
146123927|NCT00391274|526973057|FG000|Overall Study|Death Due to Study Disease|55|||
146123928|NCT00391274|526973058|FG001|Overall Study|Death Due to Study Disease|45|||
146123929|NCT00391274|526973057|FG000|Overall Study|Lost to Follow-up|0|||
146123930|NCT00391274|526973058|FG001|Overall Study|Lost to Follow-up|3|||
146123931|NCT00391274|526973057|FG000|Overall Study|Physician Decision|4|||
146262411|NCT03463577|527476417|FG004|Overall Study|Neonatal death|17|||
146262412|NCT03463577|527476418|FG005|Overall Study|Neonatal death|0|||
146123932|NCT00391274|526973058|FG001|Overall Study|Physician Decision|2|||
146123933|NCT00391274|526973057|FG000|Overall Study|Withdrawal by Subject|0|||
146123934|NCT00391274|526973058|FG001|Overall Study|Withdrawal by Subject|3|||
146123935|NCT00391274|526973057|FG000|Overall Study|Death Due to Adverse Event|1|||
146262413|NCT00236184|527476419|FG000|Overall Study|Adverse Event|5|||
146123936|NCT00391274|526973058|FG001|Overall Study|Death Due to Adverse Event|3|||
146123937|NCT00391274|526973057|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
146123938|NCT00391274|526973058|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
146123939|NCT00391274|526973057|FG000|Overall Study|Death Not Study Related|0|||
146123940|NCT00391274|526973058|FG001|Overall Study|Death Not Study Related|1|||
146123941|NCT00894322|526973059|FG000|Overall Study|Withdrawal by Subject|1|||
146123942|NCT00894322|526973060|FG001|Overall Study|Withdrawal by Subject|0|||
146123943|NCT00894322|526973061|FG002|Overall Study|Withdrawal by Subject|0|||
146123944|NCT03559257|526973065|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
146123945|NCT03559257|526973066|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146123946|NCT03559257|526973065|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146123947|NCT03559257|526973066|FG001|Double Blind Treatment Period|Protocol Violation|4|||
146123948|NCT03559257|526973065|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
146123949|NCT03559257|526973066|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
146123950|NCT03559257|526973065|FG000|Double Blind Treatment Period|Adverse Event|0|||
146123951|NCT03559257|526973066|FG001|Double Blind Treatment Period|Adverse Event|1|||
146123952|NCT03559257|526973065|FG000|Double Blind Treatment Period|Screen Failure|0|||
146123953|NCT03559257|526973066|FG001|Double Blind Treatment Period|Screen Failure|1|||
146123954|NCT03559257|526973065|FG000|Open-label Treatment Period|Adverse Event|1|||
146123955|NCT03559257|526973066|FG001|Open-label Treatment Period|Adverse Event|4|||
146123956|NCT03559257|526973065|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
146123957|NCT03559257|526973066|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
146123958|NCT03559257|526973065|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
146123959|NCT03559257|526973066|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
146123960|NCT03559257|526973065|FG000|Open-label Treatment Period|Protocol Violation|2|||
146123961|NCT03559257|526973066|FG001|Open-label Treatment Period|Protocol Violation|0|||
146123962|NCT03559257|526973065|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
146123963|NCT03559257|526973066|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
146123964|NCT03559257|526973065|FG000|Open-label Treatment Period|Physician Decision|0|||
146123965|NCT03559257|526973066|FG001|Open-label Treatment Period|Physician Decision|1|||
146123966|NCT02738450|526973067|FG000|Overall Study|Withdrawal by Subject|0|||
146123967|NCT02738450|526973068|FG001|Overall Study|Withdrawal by Subject|2|||
146123968|NCT02738450|526973069|FG002|Overall Study|Withdrawal by Subject|0|||
146123969|NCT01387347|526973071|FG000|Overall Study|Lost to Follow-up|2|||
146123970|NCT01387347|526973072|FG001|Overall Study|Lost to Follow-up|1|||
146123971|NCT00423150|526973078|FG000|Overall Study|Adverse Event|11|||
146123972|NCT00423150|526973078|FG000|Overall Study|Progression of disease being studied|69|||
146123973|NCT00423150|526973078|FG000|Overall Study|Withdrawal by Subject|1|||
146123974|NCT00423150|526973078|FG000|Overall Study|Non-compliance with protocol|1|||
146123975|NCT00423150|526973078|FG000|Overall Study|Administrative|4|||
146123976|NCT02335099|526973079|FG000|Treatment|Withdrawal by Subject|1|||
146123977|NCT02335099|526973080|FG001|Treatment|Withdrawal by Subject|3|||
146123978|NCT02335099|526973079|FG000|Treatment|Lost to Follow-up|2|||
146123979|NCT02335099|526973080|FG001|Treatment|Lost to Follow-up|0|||
146123980|NCT02335099|526973079|FG000|Treatment|Death|1|||
146123981|NCT02335099|526973080|FG001|Treatment|Death|0|||
146123982|NCT02335099|526973079|FG000|Treatment|Adverse Event|1|||
146123983|NCT02335099|526973080|FG001|Treatment|Adverse Event|2|||
146123984|NCT02335099|526973079|FG000|Follow-up|Death|0|||
146123985|NCT02335099|526973080|FG001|Follow-up|Death|1|||
146123986|NCT01092182|526973081|FG000|Overall Study|Death|0|||
146123987|NCT01092182|526973082|FG001|Overall Study|Death|5|||
146123988|NCT01092182|526973083|FG002|Overall Study|Death|3|||
146123989|NCT01092182|526973081|FG000|Overall Study|participant safety|1|||
146123990|NCT01092182|526973082|FG001|Overall Study|participant safety|2|||
146123991|NCT01092182|526973083|FG002|Overall Study|participant safety|0|||
146123992|NCT01092182|526973081|FG000|Overall Study|Physician Decision|0|||
146123993|NCT01092182|526973082|FG001|Overall Study|Physician Decision|6|||
146123994|NCT01092182|526973083|FG002|Overall Study|Physician Decision|0|||
146123995|NCT01092182|526973081|FG000|Overall Study|Did not meet criteria|0|||
146262414|NCT00236184|527476420|FG001|Overall Study|Adverse Event|2|||
146262415|NCT00236184|527476419|FG000|Overall Study|Lack of Efficacy|0|||
146123996|NCT01092182|526973082|FG001|Overall Study|Did not meet criteria|0|||
146123997|NCT01092182|526973083|FG002|Overall Study|Did not meet criteria|25|||
146123998|NCT01092182|526973081|FG000|Overall Study|Non-compliance|0|||
146123999|NCT01092182|526973082|FG001|Overall Study|Non-compliance|3|||
146124000|NCT01092182|526973083|FG002|Overall Study|Non-compliance|0|||
146124001|NCT01092182|526973081|FG000|Overall Study|Participant refused follow-up|0|||
146124002|NCT01092182|526973082|FG001|Overall Study|Participant refused follow-up|2|||
146124003|NCT01092182|526973083|FG002|Overall Study|Participant refused follow-up|0|||
146124004|NCT03255382|526973085|FG000|Overall Study|Adverse Event|3|||
146124005|NCT03255382|526973086|FG001|Overall Study|Adverse Event|0|||
146124006|NCT03255382|526973085|FG000|Overall Study|Lost to Follow-up|2|||
146124007|NCT03255382|526973086|FG001|Overall Study|Lost to Follow-up|0|||
146124008|NCT03255382|526973085|FG000|Overall Study|Withdrawal by Subject|2|||
146124009|NCT03255382|526973086|FG001|Overall Study|Withdrawal by Subject|0|||
146124010|NCT03255382|526973085|FG000|Overall Study|Other|6|||
146124011|NCT03255382|526973086|FG001|Overall Study|Other|0|||
146124012|NCT02221284|526973087|FG000|Overall Study|Case Report Forms Uncollected|56|||
146124013|NCT02221284|526973087|FG000|Overall Study|Protocol Deviation|5|||
146124014|NCT01166178|526973088|FG000|Overall Study|Withdrawal by Subject|1|||
146124015|NCT01166178|526973089|FG001|Overall Study|Withdrawal by Subject|0|||
146124016|NCT01166178|526973088|FG000|Overall Study|Study was terminated|20|||
146124017|NCT01166178|526973089|FG001|Overall Study|Study was terminated|8|||
146124018|NCT02113956|526973090|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
146124019|NCT02113956|526973091|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
146124020|NCT02113956|526973090|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
146124021|NCT02113956|526973091|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
146124022|NCT02113956|526973090|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
146124023|NCT02113956|526973091|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
146124024|NCT02446990|526973092|FG000|Overall Study|Death|485|||
146124025|NCT02446990|526973093|FG001|Overall Study|Death|458|||
146124026|NCT02446990|526973092|FG000|Overall Study|Lost to Follow-up|3|||
146124027|NCT02446990|526973093|FG001|Overall Study|Lost to Follow-up|1|||
146124028|NCT02446990|526973092|FG000|Overall Study|Physician Decision|1|||
146124029|NCT02446990|526973093|FG001|Overall Study|Physician Decision|0|||
146124030|NCT02446990|526973092|FG000|Overall Study|Withdrawal by Subject|231|||
146124031|NCT02446990|526973093|FG001|Overall Study|Withdrawal by Subject|199|||
146124032|NCT01064401|526973094|FG000|Overall Study|Adverse Event|47|||
146124033|NCT01064401|526973095|FG001|Overall Study|Adverse Event|56|||
146124034|NCT01064401|526973094|FG000|Overall Study|Lack of Efficacy|46|||
146124035|NCT01064401|526973095|FG001|Overall Study|Lack of Efficacy|23|||
146124036|NCT01064401|526973094|FG000|Overall Study|Lost to Follow-up|12|||
146124037|NCT01064401|526973095|FG001|Overall Study|Lost to Follow-up|9|||
146124038|NCT01064401|526973094|FG000|Overall Study|Consent Withdrawn|98|||
146124039|NCT01064401|526973095|FG001|Overall Study|Consent Withdrawn|80|||
146124040|NCT01064401|526973094|FG000|Overall Study|Investigator Decision|4|||
146124041|NCT01064401|526973095|FG001|Overall Study|Investigator Decision|6|||
146124042|NCT01064401|526973094|FG000|Overall Study|Death|4|||
146124043|NCT01064401|526973095|FG001|Overall Study|Death|0|||
146124044|NCT01064401|526973094|FG000|Overall Study|Pregnancy|4|||
146124045|NCT01064401|526973095|FG001|Overall Study|Pregnancy|7|||
146124046|NCT01064401|526973094|FG000|Overall Study|Noncompliance|7|||
146124047|NCT01064401|526973095|FG001|Overall Study|Noncompliance|8|||
146124048|NCT01064401|526973094|FG000|Overall Study|Site Closure|4|||
146124049|NCT01064401|526973095|FG001|Overall Study|Site Closure|5|||
146124050|NCT01064401|526973094|FG000|Overall Study|Other|2|||
146124051|NCT01064401|526973095|FG001|Overall Study|Other|1|||
146124052|NCT03158051|526973096|FG000|Overall Study|Lost to Follow-up|41|||
146124053|NCT03158051|526973097|FG001|Overall Study|Lost to Follow-up|47|||
146124054|NCT03158051|526973096|FG000|Overall Study|Physician Decision|6|||
146124055|NCT03158051|526973097|FG001|Overall Study|Physician Decision|7|||
146124056|NCT03158051|526973096|FG000|Overall Study|Withdrawal by Subject|24|||
146124057|NCT03158051|526973097|FG001|Overall Study|Withdrawal by Subject|15|||
146124058|NCT03158051|526973096|FG000|Overall Study|Death|0|||
146124059|NCT03158051|526973097|FG001|Overall Study|Death|1|||
146124060|NCT02738151|526973098|FG000|Overall Study|Randomized but not treated|4|||
146124061|NCT02738151|526973099|FG001|Overall Study|Randomized but not treated|1|||
146124062|NCT02738151|526973098|FG000|Overall Study|Adverse Event|4|||
146124063|NCT02738151|526973099|FG001|Overall Study|Adverse Event|5|||
146124064|NCT02738151|526973098|FG000|Overall Study|Hypoglycemia|0|||
146124065|NCT02738151|526973099|FG001|Overall Study|Hypoglycemia|1|||
146124066|NCT02738151|526973098|FG000|Overall Study|Poor Compliance to Protocol|4|||
146124067|NCT02738151|526973099|FG001|Overall Study|Poor Compliance to Protocol|3|||
146124068|NCT02738151|526973098|FG000|Overall Study|Other than specified above|11|||
146124069|NCT02738151|526973099|FG001|Overall Study|Other than specified above|21|||
146124070|NCT02926924|526974613|FG000|Overall Study|withdrawal - reason unknown|0|||
146124071|NCT02926924|526974614|FG001|Overall Study|withdrawal - reason unknown|1|||
146124072|NCT02385266|526974615|FG000|Overall Study|Withdrawal by Subject|1|||
146124073|NCT02385266|526974616|FG001|Overall Study|Withdrawal by Subject|3|||
146262416|NCT00236184|527476420|FG001|Overall Study|Lack of Efficacy|1|||
146262417|NCT00236184|527476419|FG000|Overall Study|Lost to Follow-up|3|||
146124074|NCT03662542|526974619|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
146124075|NCT03662542|526974620|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124076|NCT03662542|526974621|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124077|NCT03662542|526974622|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124078|NCT03662542|526974623|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124079|NCT03662542|526974624|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124080|NCT03662542|526974625|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124081|NCT03662542|526974626|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146124082|NCT03662542|526974627|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
146262418|NCT00236184|527476420|FG001|Overall Study|Lost to Follow-up|4|||
146124083|NCT03662542|526974619|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124084|NCT03662542|526974620|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
146124085|NCT03662542|526974621|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124086|NCT03662542|526974622|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124087|NCT03662542|526974623|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124088|NCT03662542|526974624|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124089|NCT03662542|526974625|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124090|NCT03662542|526974626|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124091|NCT03662542|526974627|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
146124092|NCT03662542|526974619|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
146124093|NCT03662542|526974620|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
146124094|NCT03662542|526974621|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
146124095|NCT03662542|526974622|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
146124096|NCT03662542|526974623|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
146124097|NCT03662542|526974624|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
146124098|NCT03662542|526974625|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
146124099|NCT03662542|526974626|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
146124100|NCT03662542|526974627|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
146124101|NCT03662542|526974619|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
146124102|NCT03662542|526974620|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124103|NCT03662542|526974621|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124104|NCT03662542|526974622|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124105|NCT03662542|526974623|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124106|NCT03662542|526974624|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124107|NCT03662542|526974625|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124108|NCT03662542|526974626|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124109|NCT03662542|526974627|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
146124110|NCT03662542|526974619|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124111|NCT03662542|526974620|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124112|NCT03662542|526974621|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124113|NCT03662542|526974622|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124114|NCT03662542|526974623|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124115|NCT03662542|526974624|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
146124116|NCT03662542|526974625|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124117|NCT03662542|526974626|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124118|NCT03662542|526974627|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
146124119|NCT03662542|526974619|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124120|NCT03662542|526974620|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124121|NCT03662542|526974621|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124122|NCT03662542|526974622|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
146124123|NCT03662542|526974623|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
146124124|NCT03662542|526974624|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124125|NCT03662542|526974625|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124126|NCT03662542|526974626|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124127|NCT03662542|526974627|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
146124128|NCT03662542|526974619|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124129|NCT03662542|526974620|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124130|NCT03662542|526974621|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124131|NCT03662542|526974622|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
146262419|NCT00236184|527476419|FG000|Overall Study|Physician Decision|1|||
146262420|NCT00236184|527476420|FG001|Overall Study|Physician Decision|1|||
146124132|NCT03662542|526974623|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
146124133|NCT03662542|526974624|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
146124134|NCT03662542|526974625|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124135|NCT03662542|526974626|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124136|NCT03662542|526974627|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
146124137|NCT03662542|526974619|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124138|NCT03662542|526974620|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124139|NCT03662542|526974621|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124140|NCT03662542|526974622|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124141|NCT03662542|526974623|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
146124142|NCT03662542|526974624|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
146124143|NCT03662542|526974625|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124144|NCT03662542|526974626|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124145|NCT03662542|526974627|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
146124146|NCT03662542|526974619|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124147|NCT03662542|526974620|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124148|NCT03662542|526974621|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146262421|NCT00236184|527476419|FG000|Overall Study|Withdrawal by Subject|3|||
146262422|NCT00236184|527476420|FG001|Overall Study|Withdrawal by Subject|0|||
146262423|NCT00236184|527476419|FG000|Overall Study|Protocol Violation|3|||
146262424|NCT00236184|527476420|FG001|Overall Study|Protocol Violation|0|||
146262425|NCT00236184|527476419|FG000|Overall Study|non-compliance with study drug|2|||
146124149|NCT03662542|526974622|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124150|NCT03662542|526974623|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124151|NCT03662542|526974624|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
146124152|NCT03662542|526974625|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124153|NCT03662542|526974626|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124154|NCT03662542|526974627|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
146124155|NCT03662542|526974619|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124156|NCT03662542|526974620|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124157|NCT03662542|526974621|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124158|NCT03662542|526974622|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124159|NCT03662542|526974623|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124160|NCT03662542|526974624|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124161|NCT03662542|526974625|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124162|NCT03662542|526974626|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
146124163|NCT03662542|526974627|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
146124164|NCT03662542|526974619|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124165|NCT03662542|526974620|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124166|NCT03662542|526974621|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124167|NCT03662542|526974622|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124168|NCT03662542|526974623|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124169|NCT03662542|526974624|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124170|NCT03662542|526974625|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
146124171|NCT03662542|526974626|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
146124172|NCT03662542|526974627|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
146124173|NCT03662542|526974619|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124174|NCT03662542|526974620|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124175|NCT03662542|526974621|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124176|NCT03662542|526974622|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124177|NCT03662542|526974623|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124178|NCT03662542|526974624|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124179|NCT03662542|526974625|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
146124180|NCT03662542|526974626|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
146124181|NCT03662542|526974627|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
146124182|NCT03662542|526974619|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124183|NCT03662542|526974620|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124184|NCT03662542|526974621|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124185|NCT03662542|526974622|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124186|NCT03662542|526974623|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124187|NCT03662542|526974624|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
146124188|NCT03662542|526974625|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
146124189|NCT03662542|526974626|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
146124190|NCT03662542|526974627|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
146124191|NCT01217060|526974629|FG000|Overall Study|Withdrawal by Subject|1|||
146124192|NCT03388138|526974638|FG000|Overall Study|Protocol Violation|1|||
146124193|NCT03388138|526974639|FG001|Overall Study|Protocol Violation|0|||
146124194|NCT01528072|526974640|FG000|Overall Study|Withdrawal by Subject|5|||
146124195|NCT01528072|526974640|FG000|Overall Study|Physician Decision|1|||
146124196|NCT01528072|526974640|FG000|Overall Study|Determined not eligible by AEAC|1|||
146124197|NCT01528072|526974640|FG000|Overall Study|Missed Visit|2|||
146124198|NCT01528072|526974640|FG000|Overall Study|Lost to Follow-up|5|||
146124199|NCT01528072|526974640|FG000|Overall Study|Explanted|2|||
146124200|NCT01528072|526974640|FG000|Overall Study|Site Closure|4|||
146124201|NCT01528072|526974640|FG000|Overall Study|Death|2|||
146124202|NCT01528072|526974640|FG000|Overall Study|Early Termination of Study|52|||
146124203|NCT01859494|526974643|FG000|Overall Study|Adverse Event|1|||
146124204|NCT04014075|526974646|FG000|Overall Study|Progressive Disease|53|||
146124205|NCT04014075|526974646|FG000|Overall Study|Adverse Event|15|||
146124206|NCT04014075|526974646|FG000|Overall Study|Clinical Progression|4|||
146124207|NCT04014075|526974646|FG000|Overall Study|Death|2|||
146124208|NCT04014075|526974646|FG000|Overall Study|Withdrawal by Subject|2|||
146124209|NCT04014075|526974646|FG000|Overall Study|Miscellaneous|2|||
146124210|NCT04014075|526974646|FG000|Overall Study|Physician Decision|1|||
146124211|NCT04741074|526974651|FG000|Overall Study|Withdrawal by Subject|1|||
146124212|NCT04741074|526974652|FG001|Overall Study|Withdrawal by Subject|1|||
146124213|NCT04741074|526974651|FG000|Overall Study|Study terminated prematurely|1|||
146124214|NCT04741074|526974652|FG001|Overall Study|Study terminated prematurely|0|||
146124215|NCT02357901|526974657|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
146124216|NCT02357901|526974658|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146124217|NCT02357901|526974659|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146262426|NCT00236184|527476420|FG001|Overall Study|non-compliance with study drug|1|||
146124218|NCT02357901|526974660|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
146124219|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
146124220|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
146124221|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
146124222|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
146124223|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
146124224|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
146124225|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
146124226|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
146124227|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
146124228|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
146124229|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
146124230|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
146124231|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
146124232|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
146124233|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
146124234|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
146124235|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
146124236|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
146124237|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
146124238|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
146124239|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
146124240|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
146124241|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
146124242|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
146124243|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
146124244|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
146124245|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
146124246|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
146124247|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
146124248|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
146124249|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
146124250|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
146124251|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
146124252|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
146124253|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
146124254|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
146124255|NCT02357901|526974657|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
146124256|NCT02357901|526974658|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
146124257|NCT02357901|526974659|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
146124258|NCT02357901|526974660|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
146124259|NCT00491387|526974669|FG000|Overall Study|study terminated|20|||
146124260|NCT00413192|526974672|FG000|Overall Study|Disease progression|26|||
146124261|NCT00413192|526974673|FG001|Overall Study|Disease progression|31|||
146124262|NCT00413192|526974674|FG002|Overall Study|Disease progression|16|||
146262427|NCT00236184|527476419|FG000|Overall Study|other|1|||
146262428|NCT00236184|527476420|FG001|Overall Study|other|2|||
146262429|NCT01101997|527476421|FG000|Overall Study|Withdrawal by Subject|2|||
146262430|NCT00469456|527476422|FG000|Overall Study|Adverse Event|4|||
146262431|NCT00469456|527476423|FG001|Overall Study|Adverse Event|3|||
146262432|NCT00469456|527476422|FG000|Overall Study|Protocol Violation|1|||
146262433|NCT00469456|527476423|FG001|Overall Study|Protocol Violation|0|||
146262434|NCT00469456|527476422|FG000|Overall Study|Withdrawal by Subject|4|||
146124263|NCT00413192|526974675|FG003|Overall Study|Disease progression|25|||
146124264|NCT00413192|526974672|FG000|Overall Study|Toxicity|3|||
146124265|NCT00413192|526974673|FG001|Overall Study|Toxicity|2|||
146124266|NCT00413192|526974674|FG002|Overall Study|Toxicity|2|||
146124267|NCT00413192|526974675|FG003|Overall Study|Toxicity|2|||
146124268|NCT00413192|526974672|FG000|Overall Study|Withdrawal by Subject|3|||
146124269|NCT00413192|526974673|FG001|Overall Study|Withdrawal by Subject|5|||
146124270|NCT00413192|526974674|FG002|Overall Study|Withdrawal by Subject|0|||
146124271|NCT00413192|526974675|FG003|Overall Study|Withdrawal by Subject|1|||
146124272|NCT00413192|526974672|FG000|Overall Study|Intercurrent illness|0|||
146124273|NCT00413192|526974673|FG001|Overall Study|Intercurrent illness|0|||
146124274|NCT00413192|526974674|FG002|Overall Study|Intercurrent illness|0|||
146124275|NCT00413192|526974675|FG003|Overall Study|Intercurrent illness|1|||
146124276|NCT00413192|526974672|FG000|Overall Study|Intercurrent death|0|||
146124277|NCT00413192|526974673|FG001|Overall Study|Intercurrent death|1|||
146124278|NCT00413192|526974674|FG002|Overall Study|Intercurrent death|0|||
146124279|NCT00413192|526974675|FG003|Overall Study|Intercurrent death|0|||
146124280|NCT00413192|526974672|FG000|Overall Study|Other|5|||
146124281|NCT00413192|526974673|FG001|Overall Study|Other|1|||
146124282|NCT00413192|526974674|FG002|Overall Study|Other|1|||
146124283|NCT00413192|526974675|FG003|Overall Study|Other|2|||
146124284|NCT00413192|526974672|FG000|Overall Study|Not treated|0|||
146124285|NCT00413192|526974673|FG001|Overall Study|Not treated|0|||
146124286|NCT00413192|526974674|FG002|Overall Study|Not treated|0|||
146124287|NCT00413192|526974675|FG003|Overall Study|Not treated|1|||
146124288|NCT03814746|526974676|FG000|Overall Study|Participant decision|9|||
146124289|NCT03814746|526974677|FG001|Overall Study|Participant decision|6|||
146124290|NCT03814746|526974678|FG002|Overall Study|Participant decision|15|||
146124291|NCT03814746|526974676|FG000|Overall Study|Physician Decision|2|||
146124292|NCT03814746|526974677|FG001|Overall Study|Physician Decision|2|||
146124293|NCT03814746|526974678|FG002|Overall Study|Physician Decision|4|||
146124294|NCT03814746|526974676|FG000|Overall Study|Death|2|||
146124295|NCT03814746|526974677|FG001|Overall Study|Death|2|||
146124296|NCT03814746|526974678|FG002|Overall Study|Death|2|||
146124297|NCT03814746|526974676|FG000|Overall Study|Adverse Event|2|||
146124298|NCT03814746|526974677|FG001|Overall Study|Adverse Event|2|||
146124299|NCT03814746|526974678|FG002|Overall Study|Adverse Event|1|||
146124300|NCT03814746|526974676|FG000|Overall Study|Lost to Follow-up|2|||
146124301|NCT03814746|526974677|FG001|Overall Study|Lost to Follow-up|1|||
146124302|NCT03814746|526974678|FG002|Overall Study|Lost to Follow-up|2|||
146124303|NCT03814746|526974676|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146124304|NCT03814746|526974677|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146124305|NCT03814746|526974678|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146124306|NCT03814746|526974676|FG000|Overall Study|Pregnancy|0|||
146124307|NCT03814746|526974677|FG001|Overall Study|Pregnancy|1|||
146124308|NCT03814746|526974678|FG002|Overall Study|Pregnancy|1|||
146124309|NCT03814746|526974676|FG000|Overall Study|Protocol Violation|1|||
146124310|NCT03814746|526974677|FG001|Overall Study|Protocol Violation|0|||
146124311|NCT03814746|526974678|FG002|Overall Study|Protocol Violation|0|||
146124312|NCT05089682|526974679|FG000|Overall Study|Withdrawal by Subject|2|||
146124313|NCT01996826|526974682|FG000|Overall Study|Lost to Follow-up|6|||
146124314|NCT01996826|526974683|FG001|Overall Study|Lost to Follow-up|2|||
146124315|NCT01996826|526974682|FG000|Overall Study|Physician Decision|1|||
146124316|NCT01996826|526974683|FG001|Overall Study|Physician Decision|1|||
146124317|NCT01266460|526974684|FG000|Overall Study|Adverse Event|3|||
146124318|NCT01266460|526974684|FG000|Overall Study|Withdrawal by Subject|5|||
146124319|NCT01266460|526974684|FG000|Overall Study|Disease Progression|18|||
146124320|NCT01266460|526974684|FG000|Overall Study|Not otherwise specified|8|||
146124321|NCT00483379|526974689|FG000|Treatment Period|Adverse Event|1|||
146124322|NCT00483379|526974690|FG001|Treatment Period|Adverse Event|0|||
146124323|NCT00483379|526974689|FG000|Treatment Period|Withdrawal by Subject|1|||
146124324|NCT00483379|526974690|FG001|Treatment Period|Withdrawal by Subject|0|||
146124325|NCT00536107|526974691|FG000|Overall Study|Death|5|||
146124326|NCT00536107|526974692|FG001|Overall Study|Death|1|||
146124327|NCT00536107|526974691|FG000|Overall Study|Incorrect enrolment|1|||
146124328|NCT00536107|526974692|FG001|Overall Study|Incorrect enrolment|0|||
146124329|NCT00536107|526974691|FG000|Overall Study|Withdrawal by Subject|0|||
146124330|NCT00536107|526974692|FG001|Overall Study|Withdrawal by Subject|1|||
146124331|NCT00536107|526974691|FG000|Overall Study|Study Termination|2|||
146124332|NCT00536107|526974692|FG001|Overall Study|Study Termination|4|||
146124333|NCT00371254|526974694|FG000|Overall Study|Disease progression|13|||
146124334|NCT00371254|526974695|FG001|Overall Study|Disease progression|13|||
146124335|NCT00371254|526974694|FG000|Overall Study|Study drug toxicity|3|||
146124336|NCT00371254|526974695|FG001|Overall Study|Study drug toxicity|5|||
146124337|NCT00371254|526974694|FG000|Overall Study|Subject request|5|||
146124338|NCT00371254|526974695|FG001|Overall Study|Subject request|0|||
146124339|NCT00371254|526974694|FG000|Overall Study|Investigator Decision|2|||
146124340|NCT00371254|526974695|FG001|Overall Study|Investigator Decision|0|||
146124341|NCT00371254|526974694|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146124342|NCT00371254|526974695|FG001|Overall Study|Adverse event unrelated to study drug|1|||
146262435|NCT00469456|527476423|FG001|Overall Study|Withdrawal by Subject|1|||
146262436|NCT02669407|527476426|FG000|Overall Study|Physician Decision|3|||
146124343|NCT00371254|526974694|FG000|Overall Study|Lost to Follow-up|0|||
146124344|NCT00371254|526974695|FG001|Overall Study|Lost to Follow-up|1|||
146124345|NCT00371254|526974694|FG000|Overall Study|Withdrawal by Subject|0|||
146124346|NCT00371254|526974695|FG001|Overall Study|Withdrawal by Subject|1|||
146124347|NCT03329690|526974698|FG000|Overall Study|Progressive disease per RECIST|85|||
146124348|NCT03329690|526974699|FG001|Overall Study|Progressive disease per RECIST|44|||
146124349|NCT03329690|526974700|FG002|Overall Study|Progressive disease per RECIST|6|||
146262437|NCT00704171|527476427|FG000|Overall Study|Withdrawal by Subject|1|||
146262438|NCT00704171|527476428|FG001|Overall Study|Withdrawal by Subject|0|||
146124350|NCT03329690|526974701|FG003|Overall Study|Progressive disease per RECIST|16|||
146124351|NCT03329690|526974702|FG004|Overall Study|Progressive disease per RECIST|20|||
146124352|NCT03329690|526974698|FG000|Overall Study|Clinical progression|7|||
146124353|NCT03329690|526974699|FG001|Overall Study|Clinical progression|4|||
146303334|NCT02716675|527625737|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
146303335|NCT02716675|527625738|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
146303336|NCT02716675|527625739|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
146303337|NCT02716675|527625737|FG000|Overall Study|Other|38|||
146303338|NCT02716675|527625738|FG001|Overall Study|Other|47|||
146303339|NCT02716675|527625739|FG002|Overall Study|Other|48|||
146303340|NCT00290290|527625740|FG000|Overall Study|Death|3|||
146303341|NCT00290290|527625741|FG001|Overall Study|Death|4|||
146303342|NCT00290290|527625740|FG000|Overall Study|Withdrawal by Subject|2|||
146303343|NCT00290290|527625741|FG001|Overall Study|Withdrawal by Subject|2|||
146124354|NCT03329690|526974700|FG002|Overall Study|Clinical progression|1|||
146124355|NCT03329690|526974701|FG003|Overall Study|Clinical progression|1|||
146124356|NCT03329690|526974702|FG004|Overall Study|Clinical progression|1|||
146124357|NCT03329690|526974698|FG000|Overall Study|Adverse Event|22|||
146124358|NCT03329690|526974699|FG001|Overall Study|Adverse Event|4|||
146124359|NCT03329690|526974700|FG002|Overall Study|Adverse Event|0|||
146124360|NCT03329690|526974701|FG003|Overall Study|Adverse Event|1|||
146124361|NCT03329690|526974702|FG004|Overall Study|Adverse Event|2|||
146124362|NCT03329690|526974698|FG000|Overall Study|Death|2|||
146124363|NCT03329690|526974699|FG001|Overall Study|Death|0|||
146124364|NCT03329690|526974700|FG002|Overall Study|Death|0|||
146124365|NCT03329690|526974701|FG003|Overall Study|Death|1|||
146124366|NCT03329690|526974702|FG004|Overall Study|Death|0|||
146124367|NCT03329690|526974698|FG000|Overall Study|Withdrawal by Subject|2|||
146124368|NCT03329690|526974699|FG001|Overall Study|Withdrawal by Subject|3|||
146262439|NCT03634839|527476429|FG000|First Intervention (2 Hours)|Adverse Event|0|||
146262440|NCT03634839|527476430|FG001|First Intervention (2 Hours)|Adverse Event|2|||
146262441|NCT01588366|527476438|FG000|Overall Study|Adverse Event|0|||
146262442|NCT01588366|527476439|FG001|Overall Study|Adverse Event|1|||
146262443|NCT01588366|527476440|FG002|Overall Study|Adverse Event|0|||
146262444|NCT01588366|527476441|FG003|Overall Study|Adverse Event|1|||
146262445|NCT01588366|527476442|FG004|Overall Study|Adverse Event|0|||
146262446|NCT01588366|527476443|FG005|Overall Study|Adverse Event|2|||
146262447|NCT00719043|527476444|FG000|Overall Study|Adverse Event|5|||
146262448|NCT00719043|527476445|FG001|Overall Study|Adverse Event|1|||
146262449|NCT00719043|527476446|FG002|Overall Study|Adverse Event|2|||
146262450|NCT00719043|527476447|FG003|Overall Study|Adverse Event|2|||
146262451|NCT00719043|527476448|FG004|Overall Study|Adverse Event|1|||
146262452|NCT00719043|527476449|FG005|Overall Study|Adverse Event|4|||
146262453|NCT00719043|527476450|FG006|Overall Study|Adverse Event|4|||
146262454|NCT00719043|527476444|FG000|Overall Study|Lost to Follow-up|14|||
146262455|NCT00719043|527476445|FG001|Overall Study|Lost to Follow-up|10|||
146262456|NCT00719043|527476446|FG002|Overall Study|Lost to Follow-up|8|||
146262457|NCT00719043|527476447|FG003|Overall Study|Lost to Follow-up|9|||
146262458|NCT00719043|527476448|FG004|Overall Study|Lost to Follow-up|10|||
146262459|NCT00719043|527476449|FG005|Overall Study|Lost to Follow-up|9|||
146262460|NCT00719043|527476450|FG006|Overall Study|Lost to Follow-up|9|||
146262461|NCT00719043|527476444|FG000|Overall Study|Protocol Violation|0|||
146262462|NCT00719043|527476445|FG001|Overall Study|Protocol Violation|0|||
146262463|NCT00719043|527476446|FG002|Overall Study|Protocol Violation|0|||
146262464|NCT00719043|527476447|FG003|Overall Study|Protocol Violation|0|||
146262465|NCT00719043|527476448|FG004|Overall Study|Protocol Violation|0|||
146262466|NCT00719043|527476449|FG005|Overall Study|Protocol Violation|1|||
146262467|NCT00719043|527476450|FG006|Overall Study|Protocol Violation|0|||
146262468|NCT00719043|527476444|FG000|Overall Study|Other|1|||
146262469|NCT00719043|527476445|FG001|Overall Study|Other|0|||
146262470|NCT00719043|527476446|FG002|Overall Study|Other|1|||
146124369|NCT03329690|526974700|FG002|Overall Study|Withdrawal by Subject|0|||
146124370|NCT03329690|526974701|FG003|Overall Study|Withdrawal by Subject|1|||
146124371|NCT03329690|526974702|FG004|Overall Study|Withdrawal by Subject|0|||
146262471|NCT00719043|527476447|FG003|Overall Study|Other|2|||
146262472|NCT00719043|527476448|FG004|Overall Study|Other|0|||
146262473|NCT00719043|527476449|FG005|Overall Study|Other|2|||
146262474|NCT00719043|527476450|FG006|Overall Study|Other|1|||
146262475|NCT00719043|527476444|FG000|Overall Study|Withdrawal by Subject|12|||
146262476|NCT00719043|527476445|FG001|Overall Study|Withdrawal by Subject|14|||
146262477|NCT00719043|527476446|FG002|Overall Study|Withdrawal by Subject|9|||
146262478|NCT00719043|527476447|FG003|Overall Study|Withdrawal by Subject|10|||
146262479|NCT00719043|527476448|FG004|Overall Study|Withdrawal by Subject|16|||
146262480|NCT00719043|527476449|FG005|Overall Study|Withdrawal by Subject|18|||
146262481|NCT00719043|527476450|FG006|Overall Study|Withdrawal by Subject|14|||
146262482|NCT00302159|527476451|FG000|Overall Study|pt declined before treatment started|1|||
146303344|NCT00290290|527625740|FG000|Overall Study|Underwent clean surgical procedure|13|||
146262483|NCT00302159|527476451|FG000|Overall Study|pt started Avastin|1|||
146262484|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
146262485|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
146262486|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
146262487|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
146303345|NCT00290290|527625741|FG001|Overall Study|Underwent clean surgical procedure|12|||
146124372|NCT03329690|526974698|FG000|Overall Study|Physician Decision|1|||
146124373|NCT03329690|526974699|FG001|Overall Study|Physician Decision|0|||
146124374|NCT03329690|526974700|FG002|Overall Study|Physician Decision|0|||
146124375|NCT03329690|526974701|FG003|Overall Study|Physician Decision|0|||
146124376|NCT03329690|526974702|FG004|Overall Study|Physician Decision|1|||
146124377|NCT03329690|526974698|FG000|Overall Study|Miscellaneous|6|||
146124378|NCT03329690|526974699|FG001|Overall Study|Miscellaneous|0|||
146124379|NCT03329690|526974700|FG002|Overall Study|Miscellaneous|0|||
146124380|NCT03329690|526974701|FG003|Overall Study|Miscellaneous|0|||
146124381|NCT03329690|526974702|FG004|Overall Study|Miscellaneous|0|||
146124382|NCT03329690|526974698|FG000|Overall Study|Did not receive treatment|1|||
146124383|NCT03329690|526974699|FG001|Overall Study|Did not receive treatment|0|||
146124384|NCT03329690|526974700|FG002|Overall Study|Did not receive treatment|0|||
146124385|NCT03329690|526974701|FG003|Overall Study|Did not receive treatment|1|||
146124386|NCT03329690|526974702|FG004|Overall Study|Did not receive treatment|0|||
146124387|NCT01817725|526974703|FG000|Overall Study|Withdrawal by Subject|1|||
146124388|NCT03165110|526974704|FG000|Overall Study|Anroid phone software incompatibility|1|||
146124389|NCT00730912|526974709|FG000|Overall Study|Discontinued|0|||
146124390|NCT00730912|526974710|FG001|Overall Study|Discontinued|0|||
146124391|NCT00730912|526974711|FG002|Overall Study|Discontinued|1|||
146124392|NCT00613015|526974717|FG000|Overall Study|Lost to Follow-up|0|||
146124393|NCT00613015|526974718|FG001|Overall Study|Lost to Follow-up|1|||
146124394|NCT00613015|526974719|FG002|Overall Study|Lost to Follow-up|3|||
146124395|NCT00613015|526974720|FG003|Overall Study|Lost to Follow-up|3|||
146124396|NCT00613015|526974721|FG004|Overall Study|Lost to Follow-up|2|||
146124397|NCT00613015|526974722|FG005|Overall Study|Lost to Follow-up|3|||
146124398|NCT01179477|526974723|FG000|Overall Study|Death|542|||
146124399|NCT01179477|526974723|FG000|Overall Study|Unsuccessful implant|80|||
146124400|NCT01179477|526974723|FG000|Overall Study|Non-death withdrawal|438|||
146124401|NCT01179477|526974723|FG000|Overall Study|Did not complete final visit|27|||
146124402|NCT03630120|526974725|FG000|Overall Study|Disease progression|0|||
146124403|NCT03630120|526974726|FG001|Overall Study|Disease progression|1|||
146124404|NCT03630120|526974727|FG002|Overall Study|Disease progression|1|||
146124405|NCT03630120|526974728|FG003|Overall Study|Disease progression|1|||
146124406|NCT01519960|526974729|FG000|Overall Study|Withdrawal from the study|26|||
146124407|NCT01519960|526974730|FG001|Overall Study|Withdrawal from the study|22|||
146124408|NCT01519960|526974731|FG002|Overall Study|Withdrawal from the study|5|||
146124409|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
146124410|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
146124411|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
146124412|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
146124413|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
146124414|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
146124415|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
146124416|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
146124417|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
146124418|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
146124419|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
146262488|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
146262489|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
146262490|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
146262491|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
146262492|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
146262493|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
146262494|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
146262495|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
146262496|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
146262497|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
146262498|NCT01664923|527476452|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
146262499|NCT01664923|527476453|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
146262500|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
146262501|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
146262502|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
146124420|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
146124421|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
146124422|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
146124423|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
146262503|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
145943205|NCT00483704|526300458|FG002|Randomization|Lost to Follow-up|19|||
146124424|NCT00561080|526974732|FG000|Vaccination Period (up to Month 4)|Other|0|||
146124425|NCT00561080|526974733|FG001|Vaccination Period (up to Month 4)|Other|2|||
146262504|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
146124426|NCT00561080|526974734|FG002|Vaccination Period (up to Month 4)|Other|1|||
146124427|NCT00561080|526974732|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
146124428|NCT00561080|526974733|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
146124429|NCT00561080|526974734|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
146124430|NCT00561080|526974732|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
146124431|NCT00561080|526974733|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
146124432|NCT00561080|526974734|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
146124433|NCT00561080|526974732|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
146124434|NCT00561080|526974733|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
146124435|NCT00561080|526974734|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
146124436|NCT00561080|526974732|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
146124437|NCT00561080|526974733|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
146124438|NCT00561080|526974734|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
146124439|NCT02951156|526974735|FG000|Overall Study|Death|3|||
146124440|NCT02951156|526974736|FG001|Overall Study|Death|8|||
146124441|NCT02951156|526974737|FG002|Overall Study|Death|5|||
146124442|NCT02951156|526974735|FG000|Overall Study|Progressive disease|1|||
146124443|NCT02951156|526974736|FG001|Overall Study|Progressive disease|0|||
146124444|NCT02951156|526974737|FG002|Overall Study|Progressive disease|1|||
146124445|NCT02951156|526974735|FG000|Overall Study|Withdrawal by Subject|0|||
146124446|NCT02951156|526974736|FG001|Overall Study|Withdrawal by Subject|0|||
146124447|NCT02951156|526974737|FG002|Overall Study|Withdrawal by Subject|1|||
146124448|NCT02951156|526974735|FG000|Overall Study|Study terminated by sponsor|0|||
146124449|NCT02951156|526974736|FG001|Overall Study|Study terminated by sponsor|0|||
146124450|NCT02951156|526974737|FG002|Overall Study|Study terminated by sponsor|1|||
146124451|NCT02951156|526974735|FG000|Overall Study|Other|5|||
146124452|NCT02951156|526974736|FG001|Overall Study|Other|1|||
146124453|NCT02951156|526974737|FG002|Overall Study|Other|2|||
146124454|NCT02005250|526974741|FG000|Overall Study|Lost to Follow-up|15|||
146124455|NCT02005250|526974742|FG001|Overall Study|Lost to Follow-up|5|||
146124456|NCT00378209|526974745|FG000|Overall Study|Progressive disease|11|||
146124457|NCT00378209|526974745|FG000|Overall Study|Adverse Event|3|||
146124458|NCT00378209|526974745|FG000|Overall Study|Initiation of non-protocol therapy|3|||
146124459|NCT00378209|526974745|FG000|Overall Study|Physician Decision|3|||
146124460|NCT00378209|526974745|FG000|Overall Study|Death|1|||
146124461|NCT00378209|526974745|FG000|Overall Study|Treatment delay|1|||
146124462|NCT01252940|526974746|FG000|Main Study Phase|Randomized but not treated|4|||
146124463|NCT01252940|526974747|FG001|Main Study Phase|Randomized but not treated|2|||
146124464|NCT01252940|526974746|FG000|Main Study Phase|Adverse Event|3|||
146124465|NCT01252940|526974747|FG001|Main Study Phase|Adverse Event|1|||
146124466|NCT01252940|526974746|FG000|Main Study Phase|Lack of Efficacy|1|||
146124467|NCT01252940|526974747|FG001|Main Study Phase|Lack of Efficacy|0|||
146124468|NCT01252940|526974746|FG000|Main Study Phase|Lost to Follow-up|6|||
146124469|NCT01252940|526974747|FG001|Main Study Phase|Lost to Follow-up|1|||
146124470|NCT01252940|526974746|FG000|Main Study Phase|Physician Decision|1|||
146124471|NCT01252940|526974747|FG001|Main Study Phase|Physician Decision|0|||
146124472|NCT01252940|526974746|FG000|Main Study Phase|Protocol Violation|4|||
146124473|NCT01252940|526974747|FG001|Main Study Phase|Protocol Violation|2|||
146124474|NCT01252940|526974746|FG000|Main Study Phase|Withdrawal by Subject|6|||
146124475|NCT01252940|526974747|FG001|Main Study Phase|Withdrawal by Subject|5|||
146124476|NCT01252940|526974746|FG000|Main Study Phase|Subject Non-compliance|1|||
146124477|NCT01252940|526974747|FG001|Main Study Phase|Subject Non-compliance|1|||
146124478|NCT01252940|526974746|FG000|Extension Phase|Adverse Event|2|||
146124479|NCT01252940|526974747|FG001|Extension Phase|Adverse Event|1|||
146124480|NCT01252940|526974746|FG000|Extension Phase|Lack of Efficacy|1|||
146124481|NCT01252940|526974747|FG001|Extension Phase|Lack of Efficacy|0|||
146124482|NCT01252940|526974746|FG000|Extension Phase|Lost to Follow-up|5|||
146124483|NCT01252940|526974747|FG001|Extension Phase|Lost to Follow-up|0|||
146124484|NCT01252940|526974746|FG000|Extension Phase|Physician Decision|0|||
146124485|NCT01252940|526974747|FG001|Extension Phase|Physician Decision|1|||
146124486|NCT01252940|526974746|FG000|Extension Phase|Subject Non-compliance|1|||
146124487|NCT01252940|526974747|FG001|Extension Phase|Subject Non-compliance|0|||
146124488|NCT01252940|526974746|FG000|Extension Phase|Withdrawal by Subject|1|||
146124489|NCT01252940|526974747|FG001|Extension Phase|Withdrawal by Subject|1|||
146124490|NCT04199117|526974748|FG000|Overall Study|Withdrawal by Subject|3|||
146124491|NCT04199117|526974749|FG001|Overall Study|Withdrawal by Subject|0|||
146124492|NCT04199117|526974750|FG002|Overall Study|Withdrawal by Subject|0|||
145943206|NCT00483704|526300456|FG000|Randomization|Pregnancy|1|||
146124493|NCT04199117|526974751|FG003|Overall Study|Withdrawal by Subject|1|||
146124494|NCT04199117|526974752|FG004|Overall Study|Withdrawal by Subject|1|||
146124495|NCT04199117|526974753|FG005|Overall Study|Withdrawal by Subject|0|||
146124496|NCT04199117|526974754|FG006|Overall Study|Withdrawal by Subject|0|||
146124497|NCT04199117|526974755|FG007|Overall Study|Withdrawal by Subject|2|||
146124498|NCT04199117|526974756|FG008|Overall Study|Withdrawal by Subject|0|||
146124499|NCT04199117|526974757|FG009|Overall Study|Withdrawal by Subject|0|||
146124500|NCT04199117|526974758|FG010|Overall Study|Withdrawal by Subject|1|||
146124501|NCT04199117|526974759|FG011|Overall Study|Withdrawal by Subject|1|||
146124502|NCT04199117|526974760|FG012|Overall Study|Withdrawal by Subject|2|||
146124503|NCT04199117|526974761|FG013|Overall Study|Withdrawal by Subject|1|||
146124504|NCT04199117|526974762|FG014|Overall Study|Withdrawal by Subject|1|||
146124505|NCT04199117|526974763|FG015|Overall Study|Withdrawal by Subject|1|||
146124506|NCT04199117|526974748|FG000|Overall Study|Death|1|||
146124507|NCT04199117|526974749|FG001|Overall Study|Death|1|||
146124508|NCT04199117|526974750|FG002|Overall Study|Death|0|||
146124509|NCT04199117|526974751|FG003|Overall Study|Death|0|||
146124510|NCT04199117|526974752|FG004|Overall Study|Death|0|||
146124511|NCT04199117|526974753|FG005|Overall Study|Death|0|||
146124512|NCT04199117|526974754|FG006|Overall Study|Death|0|||
146124513|NCT04199117|526974755|FG007|Overall Study|Death|0|||
146124514|NCT04199117|526974756|FG008|Overall Study|Death|0|||
146124515|NCT04199117|526974757|FG009|Overall Study|Death|0|||
146124516|NCT04199117|526974758|FG010|Overall Study|Death|0|||
146124517|NCT04199117|526974759|FG011|Overall Study|Death|1|||
146124518|NCT04199117|526974760|FG012|Overall Study|Death|0|||
146124519|NCT04199117|526974761|FG013|Overall Study|Death|1|||
146124520|NCT04199117|526974762|FG014|Overall Study|Death|0|||
146124521|NCT04199117|526974763|FG015|Overall Study|Death|0|||
146124522|NCT04199117|526974748|FG000|Overall Study|Withdrawal by PI|0|||
146124523|NCT04199117|526974749|FG001|Overall Study|Withdrawal by PI|0|||
146124524|NCT04199117|526974750|FG002|Overall Study|Withdrawal by PI|0|||
146124525|NCT04199117|526974751|FG003|Overall Study|Withdrawal by PI|0|||
146124526|NCT04199117|526974752|FG004|Overall Study|Withdrawal by PI|0|||
146124527|NCT04199117|526974753|FG005|Overall Study|Withdrawal by PI|0|||
146124528|NCT04199117|526974754|FG006|Overall Study|Withdrawal by PI|0|||
146124529|NCT04199117|526974755|FG007|Overall Study|Withdrawal by PI|0|||
146124530|NCT04199117|526974756|FG008|Overall Study|Withdrawal by PI|0|||
146124531|NCT04199117|526974757|FG009|Overall Study|Withdrawal by PI|0|||
146124532|NCT04199117|526974758|FG010|Overall Study|Withdrawal by PI|0|||
146124533|NCT04199117|526974759|FG011|Overall Study|Withdrawal by PI|0|||
146124534|NCT04199117|526974760|FG012|Overall Study|Withdrawal by PI|1|||
146124535|NCT04199117|526974761|FG013|Overall Study|Withdrawal by PI|0|||
146124536|NCT04199117|526974762|FG014|Overall Study|Withdrawal by PI|0|||
146124537|NCT04199117|526974763|FG015|Overall Study|Withdrawal by PI|0|||
146124538|NCT00380978|526977046|FG000|Overall Study|Refused allocated intervention|0|||
146124539|NCT00380978|526977047|FG001|Overall Study|Refused allocated intervention|6|||
146124540|NCT00380978|526977046|FG000|Overall Study|Wrong study envelope|0|||
146124541|NCT00380978|526977047|FG001|Overall Study|Wrong study envelope|2|||
146124542|NCT00380978|526977046|FG000|Overall Study|Allocation prior to analgesia request|1|||
146124543|NCT00380978|526977047|FG001|Overall Study|Allocation prior to analgesia request|2|||
146124544|NCT00380978|526977046|FG000|Overall Study|Parous patient|1|||
146124545|NCT00380978|526977047|FG001|Overall Study|Parous patient|0|||
146124546|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
146124547|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
146124548|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
146124549|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
146124550|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
146124551|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
146124552|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
146124553|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
146124554|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
146124555|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
146262505|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
146262506|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
146262507|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
146262508|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
146262509|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
146262510|NCT01664923|527476452|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
146262511|NCT01664923|527476453|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
146262512|NCT01086384|527476454|FG000|2-week Run-in Period|Adverse Event|1|||
145943207|NCT00483704|526300457|FG001|Randomization|Pregnancy|0|||
146124556|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
146124557|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
146124558|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
146124559|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
146124560|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
146124561|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
146124562|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
146124563|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
146124564|NCT00887354|526977048|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
146262513|NCT01086384|527476455|FG001|2-week Run-in Period|Adverse Event|0|||
146124565|NCT00887354|526977049|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
146262514|NCT01086384|527476456|FG002|2-week Run-in Period|Adverse Event|0|||
146262515|NCT01086384|527476454|FG000|2-week Run-in Period|Protocol Violation|1|||
146262516|NCT01086384|527476455|FG001|2-week Run-in Period|Protocol Violation|0|||
146262517|NCT01086384|527476456|FG002|2-week Run-in Period|Protocol Violation|0|||
146262518|NCT01086384|527476454|FG000|2-week Run-in Period|Lost to Follow-up|1|||
146262519|NCT01086384|527476455|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146262520|NCT01086384|527476456|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146262521|NCT01086384|527476454|FG000|2-week Run-in Period|Physician Decision|6|||
146262522|NCT01086384|527476455|FG001|2-week Run-in Period|Physician Decision|0|||
146262523|NCT01086384|527476456|FG002|2-week Run-in Period|Physician Decision|0|||
146262524|NCT01086384|527476454|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
146262525|NCT01086384|527476455|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146262526|NCT01086384|527476456|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146262527|NCT01086384|527476454|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
146262528|NCT01086384|527476455|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
146262529|NCT01086384|527476456|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
146262530|NCT01086384|527476454|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
146124566|NCT00887354|526977048|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
146124567|NCT00887354|526977049|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
146124568|NCT00887354|526977048|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
146124569|NCT00887354|526977049|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
146124570|NCT00887354|526977048|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
146124571|NCT00887354|526977049|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
146124572|NCT00887354|526977048|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
146124573|NCT00887354|526977049|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
146124574|NCT00887354|526977048|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
146124575|NCT00887354|526977049|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
146124576|NCT01466348|526977052|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
146124577|NCT01466348|526977053|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
146124578|NCT03970733|526977054|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146124579|NCT03970733|526977055|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
146124580|NCT03970733|526977056|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
146124581|NCT03970733|526977057|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146124582|NCT03970733|526977058|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
146124583|NCT03970733|526977054|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
146124584|NCT03970733|526977055|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
146124585|NCT03970733|526977056|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
146124586|NCT03970733|526977057|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
146124587|NCT03970733|526977058|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
146124588|NCT03970733|526977054|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
146124589|NCT03970733|526977055|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
146124590|NCT03970733|526977056|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
146124591|NCT03970733|526977057|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
146124592|NCT03970733|526977058|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
146124593|NCT03970733|526977054|FG000|Main Study Phase (18 Months)|Other|1|||
146124594|NCT03970733|526977055|FG001|Main Study Phase (18 Months)|Other|1|||
146124595|NCT03970733|526977056|FG002|Main Study Phase (18 Months)|Other|0|||
146124596|NCT03970733|526977057|FG003|Main Study Phase (18 Months)|Other|0|||
146262531|NCT01086384|527476455|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
146262532|NCT01086384|527476456|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
146262533|NCT01086384|527476454|FG000|2-week Run-in Period|Randomized in Error|1|||
146262534|NCT01086384|527476455|FG001|2-week Run-in Period|Randomized in Error|0|||
146262535|NCT01086384|527476456|FG002|2-week Run-in Period|Randomized in Error|0|||
146262536|NCT01086384|527476454|FG000|Treatment Period|Withdrawal by Subject|0|||
146262537|NCT01086384|527476455|FG001|Treatment Period|Withdrawal by Subject|53|||
146262538|NCT01086384|527476456|FG002|Treatment Period|Withdrawal by Subject|55|||
146262539|NCT01086384|527476454|FG000|Treatment Period|Protocol Violation|0|||
146262540|NCT01086384|527476455|FG001|Treatment Period|Protocol Violation|26|||
146262541|NCT01086384|527476456|FG002|Treatment Period|Protocol Violation|17|||
146262542|NCT01086384|527476454|FG000|Treatment Period|Lack of Efficacy|0|||
146262543|NCT01086384|527476455|FG001|Treatment Period|Lack of Efficacy|22|||
146262544|NCT01086384|527476456|FG002|Treatment Period|Lack of Efficacy|13|||
146262545|NCT01086384|527476454|FG000|Treatment Period|Adverse Event|0|||
146262546|NCT01086384|527476455|FG001|Treatment Period|Adverse Event|19|||
146262547|NCT01086384|527476456|FG002|Treatment Period|Adverse Event|15|||
146262548|NCT01086384|527476454|FG000|Treatment Period|Lost to Follow-up|0|||
146262549|NCT01086384|527476455|FG001|Treatment Period|Lost to Follow-up|11|||
146262550|NCT01086384|527476456|FG002|Treatment Period|Lost to Follow-up|9|||
146262551|NCT01086384|527476454|FG000|Treatment Period|Physician Decision|0|||
146262552|NCT01086384|527476455|FG001|Treatment Period|Physician Decision|9|||
146262553|NCT01086384|527476456|FG002|Treatment Period|Physician Decision|6|||
146124597|NCT03970733|526977058|FG004|Main Study Phase (18 Months)|Other|0|||
146124598|NCT03970733|526977054|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146124599|NCT03970733|526977055|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146124600|NCT03970733|526977056|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146124601|NCT03970733|526977057|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
146124602|NCT03970733|526977058|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
146124603|NCT01955161|526977062|FG000|Overall Study|Withdrawal before treatment|2|||
146124604|NCT01955161|526977063|FG001|Overall Study|Withdrawal before treatment|0|||
146124605|NCT01955161|526977064|FG002|Overall Study|Withdrawal before treatment|1|||
146124606|NCT01955161|526977062|FG000|Overall Study|Adverse Event|10|||
146124607|NCT01955161|526977063|FG001|Overall Study|Adverse Event|14|||
146124608|NCT01955161|526977064|FG002|Overall Study|Adverse Event|15|||
146124609|NCT01955161|526977062|FG000|Overall Study|Death|1|||
146124610|NCT01955161|526977063|FG001|Overall Study|Death|1|||
146124611|NCT01955161|526977064|FG002|Overall Study|Death|3|||
146124612|NCT01955161|526977062|FG000|Overall Study|Withdrawal by Subject|9|||
146124613|NCT01955161|526977063|FG001|Overall Study|Withdrawal by Subject|8|||
146124614|NCT01955161|526977064|FG002|Overall Study|Withdrawal by Subject|12|||
146124615|NCT01955161|526977062|FG000|Overall Study|Protocol Violation|2|||
146124616|NCT01955161|526977063|FG001|Overall Study|Protocol Violation|0|||
146124617|NCT01955161|526977064|FG002|Overall Study|Protocol Violation|0|||
146124618|NCT01955161|526977062|FG000|Overall Study|Other reason: physician decision|0|||
146124619|NCT01955161|526977063|FG001|Overall Study|Other reason: physician decision|1|||
146124620|NCT01955161|526977064|FG002|Overall Study|Other reason: physician decision|1|||
146124621|NCT01955161|526977062|FG000|Overall Study|Other reason: disallowed medication|1|||
146124622|NCT01955161|526977063|FG001|Overall Study|Other reason: disallowed medication|0|||
146124623|NCT01955161|526977064|FG002|Overall Study|Other reason: disallowed medication|1|||
146124624|NCT01955161|526977062|FG000|Overall Study|Other reason: caregiver unavailable|1|||
146124625|NCT01955161|526977063|FG001|Overall Study|Other reason: caregiver unavailable|0|||
146124626|NCT01955161|526977064|FG002|Overall Study|Other reason: caregiver unavailable|0|||
146124627|NCT01955161|526977062|FG000|Overall Study|Other reason: moved to nursing home|0|||
146124628|NCT01955161|526977063|FG001|Overall Study|Other reason: moved to nursing home|1|||
146124629|NCT01955161|526977064|FG002|Overall Study|Other reason: moved to nursing home|0|||
146124630|NCT01955161|526977062|FG000|Overall Study|Other reason: insufficient compliance|0|||
146124631|NCT01955161|526977063|FG001|Overall Study|Other reason: insufficient compliance|0|||
146124632|NCT01955161|526977064|FG002|Overall Study|Other reason: insufficient compliance|1|||
146124633|NCT01955161|526977062|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
146124634|NCT01955161|526977063|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
146124635|NCT01955161|526977064|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
146124636|NCT01955161|526977062|FG000|Overall Study|Other reason: patient's will|0|||
146124637|NCT01955161|526977063|FG001|Overall Study|Other reason: patient's will|0|||
146124638|NCT01955161|526977064|FG002|Overall Study|Other reason: patient's will|1|||
146124639|NCT02784821|526977065|FG000|Overall Study|Death|0|||
146124640|NCT02784821|526977066|FG001|Overall Study|Death|5|||
146124641|NCT02784821|526977067|FG002|Overall Study|Death|4|||
146124642|NCT02784821|526977068|FG003|Overall Study|Death|5|||
146124643|NCT01139450|526977069|FG000|Overall Study|Withdrawal by Subject|7|||
146124644|NCT01139450|526977070|FG001|Overall Study|Withdrawal by Subject|10|||
146124645|NCT01139450|526977071|FG002|Overall Study|Withdrawal by Subject|13|||
146124646|NCT01139450|526977069|FG000|Overall Study|Lack of Efficacy|3|||
146124647|NCT01139450|526977070|FG001|Overall Study|Lack of Efficacy|1|||
146124648|NCT01139450|526977071|FG002|Overall Study|Lack of Efficacy|8|||
146124649|NCT01139450|526977069|FG000|Overall Study|Protocol Violation|6|||
146124650|NCT01139450|526977070|FG001|Overall Study|Protocol Violation|5|||
146124651|NCT01139450|526977071|FG002|Overall Study|Protocol Violation|2|||
146124652|NCT01139450|526977069|FG000|Overall Study|Lost to Follow-up|9|||
146124653|NCT01139450|526977070|FG001|Overall Study|Lost to Follow-up|7|||
146124654|NCT01139450|526977071|FG002|Overall Study|Lost to Follow-up|11|||
146124655|NCT01139450|526977069|FG000|Overall Study|Administrative|0|||
146124656|NCT01139450|526977070|FG001|Overall Study|Administrative|0|||
146124657|NCT01139450|526977071|FG002|Overall Study|Administrative|1|||
146262554|NCT01086384|527476454|FG000|Treatment Period|Study Closed/Terminated|0|||
146124658|NCT01139450|526977069|FG000|Overall Study|Adverse Event|2|||
146124659|NCT01139450|526977070|FG001|Overall Study|Adverse Event|2|||
146124660|NCT01139450|526977071|FG002|Overall Study|Adverse Event|3|||
146124661|NCT02794103|526977072|FG000|Overall Study|Loss to follow up due to high sedation|3|||
146124662|NCT02608268|526977084|FG000|Overall Study|Adverse Event|0|||
146124663|NCT02608268|526977085|FG001|Overall Study|Adverse Event|0|||
146262555|NCT01086384|527476455|FG001|Treatment Period|Study Closed/Terminated|7|||
146124664|NCT02608268|526977086|FG002|Overall Study|Adverse Event|1|||
146124665|NCT02608268|526977087|FG003|Overall Study|Adverse Event|0|||
146124666|NCT02608268|526977088|FG004|Overall Study|Adverse Event|0|||
146124667|NCT02608268|526977089|FG005|Overall Study|Adverse Event|0|||
146124668|NCT02608268|526977090|FG006|Overall Study|Adverse Event|0|||
146262556|NCT01086384|527476456|FG002|Treatment Period|Study Closed/Terminated|8|||
146124669|NCT02608268|526977091|FG007|Overall Study|Adverse Event|0|||
146124670|NCT02608268|526977092|FG008|Overall Study|Adverse Event|0|||
146124671|NCT02608268|526977093|FG009|Overall Study|Adverse Event|0|||
146124672|NCT02608268|526977094|FG010|Overall Study|Adverse Event|0|||
146124673|NCT02608268|526977095|FG011|Overall Study|Adverse Event|0|||
146124674|NCT02608268|526977096|FG012|Overall Study|Adverse Event|2|||
146124675|NCT02608268|526977097|FG013|Overall Study|Adverse Event|0|||
146124676|NCT02608268|526977098|FG014|Overall Study|Adverse Event|0|||
146303346|NCT00915772|527625744|FG000|Overall Study|Adverse Event|12|||
146124677|NCT02608268|526977099|FG015|Overall Study|Adverse Event|0|||
146124678|NCT02608268|526977100|FG016|Overall Study|Adverse Event|0|||
146124679|NCT02608268|526977101|FG017|Overall Study|Adverse Event|0|||
146124680|NCT02608268|526977102|FG018|Overall Study|Adverse Event|0|||
146124681|NCT02608268|526977103|FG019|Overall Study|Adverse Event|0|||
146124682|NCT02608268|526977104|FG020|Overall Study|Adverse Event|1|||
146124683|NCT02608268|526977105|FG021|Overall Study|Adverse Event|1|||
146124684|NCT02608268|526977106|FG022|Overall Study|Adverse Event|0|||
146124685|NCT02608268|526977107|FG023|Overall Study|Adverse Event|0|||
146124686|NCT02608268|526977108|FG024|Overall Study|Adverse Event|1|||
146124687|NCT02608268|526977109|FG025|Overall Study|Adverse Event|0|||
146124688|NCT02608268|526977110|FG026|Overall Study|Adverse Event|0|||
146124689|NCT02608268|526977111|FG027|Overall Study|Adverse Event|0|||
146124690|NCT02608268|526977112|FG028|Overall Study|Adverse Event|1|||
146124691|NCT02608268|526977113|FG029|Overall Study|Adverse Event|0|||
146124692|NCT02608268|526977084|FG000|Overall Study|Death|1|||
146124693|NCT02608268|526977085|FG001|Overall Study|Death|0|||
146124694|NCT02608268|526977086|FG002|Overall Study|Death|0|||
146124695|NCT02608268|526977087|FG003|Overall Study|Death|0|||
146124696|NCT02608268|526977088|FG004|Overall Study|Death|0|||
146124697|NCT02608268|526977089|FG005|Overall Study|Death|0|||
146124698|NCT02608268|526977090|FG006|Overall Study|Death|0|||
146124699|NCT02608268|526977091|FG007|Overall Study|Death|0|||
146124700|NCT02608268|526977092|FG008|Overall Study|Death|1|||
146124701|NCT02608268|526977093|FG009|Overall Study|Death|1|||
146124702|NCT02608268|526977094|FG010|Overall Study|Death|0|||
146124703|NCT02608268|526977095|FG011|Overall Study|Death|0|||
146124704|NCT02608268|526977096|FG012|Overall Study|Death|0|||
146124705|NCT02608268|526977097|FG013|Overall Study|Death|0|||
146124706|NCT02608268|526977098|FG014|Overall Study|Death|0|||
146124707|NCT02608268|526977099|FG015|Overall Study|Death|1|||
146124708|NCT02608268|526977100|FG016|Overall Study|Death|0|||
146124709|NCT02608268|526977101|FG017|Overall Study|Death|1|||
146124710|NCT02608268|526977102|FG018|Overall Study|Death|0|||
146124711|NCT02608268|526977103|FG019|Overall Study|Death|1|||
146124712|NCT02608268|526977104|FG020|Overall Study|Death|1|||
146124713|NCT02608268|526977105|FG021|Overall Study|Death|0|||
146124714|NCT02608268|526977106|FG022|Overall Study|Death|0|||
146124715|NCT02608268|526977107|FG023|Overall Study|Death|0|||
146124716|NCT02608268|526977108|FG024|Overall Study|Death|1|||
146124717|NCT02608268|526977109|FG025|Overall Study|Death|2|||
146124718|NCT02608268|526977110|FG026|Overall Study|Death|0|||
146124719|NCT02608268|526977111|FG027|Overall Study|Death|1|||
146124720|NCT02608268|526977112|FG028|Overall Study|Death|4|||
146124721|NCT02608268|526977113|FG029|Overall Study|Death|0|||
146124722|NCT02608268|526977084|FG000|Overall Study|Physician Decision|0|||
146124723|NCT02608268|526977085|FG001|Overall Study|Physician Decision|0|||
146124724|NCT02608268|526977086|FG002|Overall Study|Physician Decision|0|||
146124725|NCT02608268|526977087|FG003|Overall Study|Physician Decision|0|||
146124726|NCT02608268|526977088|FG004|Overall Study|Physician Decision|0|||
146124727|NCT02608268|526977089|FG005|Overall Study|Physician Decision|0|||
146124728|NCT02608268|526977090|FG006|Overall Study|Physician Decision|0|||
146124729|NCT02608268|526977091|FG007|Overall Study|Physician Decision|0|||
146124730|NCT02608268|526977092|FG008|Overall Study|Physician Decision|0|||
146124731|NCT02608268|526977093|FG009|Overall Study|Physician Decision|0|||
146124732|NCT02608268|526977094|FG010|Overall Study|Physician Decision|1|||
146124733|NCT02608268|526977095|FG011|Overall Study|Physician Decision|0|||
146124734|NCT02608268|526977096|FG012|Overall Study|Physician Decision|0|||
146124735|NCT02608268|526977097|FG013|Overall Study|Physician Decision|1|||
146124736|NCT02608268|526977098|FG014|Overall Study|Physician Decision|0|||
146124737|NCT02608268|526977099|FG015|Overall Study|Physician Decision|0|||
146124738|NCT02608268|526977100|FG016|Overall Study|Physician Decision|0|||
146124739|NCT02608268|526977101|FG017|Overall Study|Physician Decision|0|||
146124740|NCT02608268|526977102|FG018|Overall Study|Physician Decision|0|||
146124741|NCT02608268|526977103|FG019|Overall Study|Physician Decision|0|||
146124742|NCT02608268|526977104|FG020|Overall Study|Physician Decision|0|||
146124743|NCT02608268|526977105|FG021|Overall Study|Physician Decision|0|||
146124744|NCT02608268|526977106|FG022|Overall Study|Physician Decision|1|||
146124745|NCT02608268|526977107|FG023|Overall Study|Physician Decision|1|||
146124746|NCT02608268|526977108|FG024|Overall Study|Physician Decision|1|||
146124747|NCT02608268|526977109|FG025|Overall Study|Physician Decision|0|||
146124748|NCT02608268|526977110|FG026|Overall Study|Physician Decision|0|||
146124749|NCT02608268|526977111|FG027|Overall Study|Physician Decision|2|||
146124750|NCT02608268|526977112|FG028|Overall Study|Physician Decision|1|||
146303347|NCT00915772|527625745|FG001|Overall Study|Adverse Event|13|||
146262557|NCT01086384|527476454|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
146262558|NCT01086384|527476455|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
146262559|NCT01086384|527476456|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
146262560|NCT01086384|527476454|FG000|Treatment Period|Received Treatment in Error|0|||
146262561|NCT01086384|527476455|FG001|Treatment Period|Received Treatment in Error|1|||
146262562|NCT01086384|527476456|FG002|Treatment Period|Received Treatment in Error|0|||
146262563|NCT02872311|527476463|FG000|Overall Study|Death|2|||
146262564|NCT02872311|527476464|FG001|Overall Study|Death|0|||
146262565|NCT02872311|527476465|FG002|Overall Study|Death|0|||
146262566|NCT02872311|527476466|FG003|Overall Study|Death|0|||
146262567|NCT02872311|527476467|FG004|Overall Study|Death|0|||
146262568|NCT02872311|527476463|FG000|Overall Study|Lost to Follow-up|2|||
146262569|NCT02872311|527476464|FG001|Overall Study|Lost to Follow-up|0|||
146262570|NCT02872311|527476465|FG002|Overall Study|Lost to Follow-up|0|||
146124751|NCT02608268|526977113|FG029|Overall Study|Physician Decision|1|||
146124752|NCT02608268|526977084|FG000|Overall Study|Progressive disease|12|||
146124753|NCT02608268|526977085|FG001|Overall Study|Progressive disease|8|||
146124754|NCT02608268|526977086|FG002|Overall Study|Progressive disease|13|||
146124755|NCT02608268|526977087|FG003|Overall Study|Progressive disease|5|||
146124756|NCT02608268|526977088|FG004|Overall Study|Progressive disease|2|||
146124757|NCT02608268|526977089|FG005|Overall Study|Progressive disease|4|||
146124758|NCT02608268|526977090|FG006|Overall Study|Progressive disease|6|||
146124759|NCT02608268|526977091|FG007|Overall Study|Progressive disease|2|||
146124760|NCT02608268|526977092|FG008|Overall Study|Progressive disease|5|||
146124761|NCT02608268|526977093|FG009|Overall Study|Progressive disease|6|||
146124762|NCT02608268|526977094|FG010|Overall Study|Progressive disease|5|||
146124763|NCT02608268|526977095|FG011|Overall Study|Progressive disease|5|||
146124764|NCT02608268|526977096|FG012|Overall Study|Progressive disease|4|||
146124765|NCT02608268|526977097|FG013|Overall Study|Progressive disease|11|||
146124766|NCT02608268|526977098|FG014|Overall Study|Progressive disease|6|||
146124767|NCT02608268|526977099|FG015|Overall Study|Progressive disease|3|||
146124768|NCT02608268|526977100|FG016|Overall Study|Progressive disease|5|||
146124769|NCT02608268|526977101|FG017|Overall Study|Progressive disease|5|||
146124770|NCT02608268|526977102|FG018|Overall Study|Progressive disease|5|||
146124771|NCT02608268|526977103|FG019|Overall Study|Progressive disease|2|||
146124772|NCT02608268|526977104|FG020|Overall Study|Progressive disease|10|||
146124773|NCT02608268|526977105|FG021|Overall Study|Progressive disease|4|||
146124774|NCT02608268|526977106|FG022|Overall Study|Progressive disease|5|||
146124775|NCT02608268|526977107|FG023|Overall Study|Progressive disease|5|||
146124776|NCT02608268|526977108|FG024|Overall Study|Progressive disease|3|||
146124777|NCT02608268|526977109|FG025|Overall Study|Progressive disease|11|||
146124778|NCT02608268|526977110|FG026|Overall Study|Progressive disease|16|||
146124779|NCT02608268|526977111|FG027|Overall Study|Progressive disease|11|||
146124780|NCT02608268|526977112|FG028|Overall Study|Progressive disease|10|||
146124781|NCT02608268|526977113|FG029|Overall Study|Progressive disease|15|||
146124782|NCT02608268|526977084|FG000|Overall Study|Subject/guardian decision|1|||
146124783|NCT02608268|526977085|FG001|Overall Study|Subject/guardian decision|1|||
146124784|NCT02608268|526977086|FG002|Overall Study|Subject/guardian decision|2|||
146124785|NCT02608268|526977087|FG003|Overall Study|Subject/guardian decision|0|||
146124786|NCT02608268|526977088|FG004|Overall Study|Subject/guardian decision|0|||
146124787|NCT02608268|526977089|FG005|Overall Study|Subject/guardian decision|0|||
146124788|NCT02608268|526977090|FG006|Overall Study|Subject/guardian decision|0|||
146124789|NCT02608268|526977091|FG007|Overall Study|Subject/guardian decision|0|||
146124790|NCT02608268|526977092|FG008|Overall Study|Subject/guardian decision|2|||
146124791|NCT02608268|526977093|FG009|Overall Study|Subject/guardian decision|2|||
146124792|NCT02608268|526977094|FG010|Overall Study|Subject/guardian decision|0|||
146262571|NCT02872311|527476466|FG003|Overall Study|Lost to Follow-up|0|||
146262572|NCT02872311|527476467|FG004|Overall Study|Lost to Follow-up|0|||
146262573|NCT02872311|527476463|FG000|Overall Study|Protocol Violation|0|||
146262574|NCT02872311|527476464|FG001|Overall Study|Protocol Violation|2|||
146124793|NCT02608268|526977095|FG011|Overall Study|Subject/guardian decision|1|||
146124794|NCT02608268|526977096|FG012|Overall Study|Subject/guardian decision|0|||
146124795|NCT02608268|526977097|FG013|Overall Study|Subject/guardian decision|1|||
146124796|NCT02608268|526977098|FG014|Overall Study|Subject/guardian decision|0|||
146124797|NCT02608268|526977099|FG015|Overall Study|Subject/guardian decision|1|||
146124798|NCT02608268|526977100|FG016|Overall Study|Subject/guardian decision|0|||
146124799|NCT02608268|526977101|FG017|Overall Study|Subject/guardian decision|0|||
146124800|NCT02608268|526977102|FG018|Overall Study|Subject/guardian decision|1|||
146124801|NCT02608268|526977103|FG019|Overall Study|Subject/guardian decision|0|||
146262575|NCT02872311|527476465|FG002|Overall Study|Protocol Violation|1|||
146262576|NCT02872311|527476466|FG003|Overall Study|Protocol Violation|0|||
146262577|NCT02872311|527476467|FG004|Overall Study|Protocol Violation|0|||
146124802|NCT02608268|526977104|FG020|Overall Study|Subject/guardian decision|0|||
146124803|NCT02608268|526977105|FG021|Overall Study|Subject/guardian decision|0|||
146124804|NCT02608268|526977106|FG022|Overall Study|Subject/guardian decision|1|||
146124805|NCT02608268|526977107|FG023|Overall Study|Subject/guardian decision|0|||
146124806|NCT02608268|526977108|FG024|Overall Study|Subject/guardian decision|0|||
146262578|NCT02725567|527476469|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
146124807|NCT02608268|526977109|FG025|Overall Study|Subject/guardian decision|1|||
146124808|NCT02608268|526977110|FG026|Overall Study|Subject/guardian decision|1|||
146124809|NCT02608268|526977111|FG027|Overall Study|Subject/guardian decision|1|||
146124810|NCT02608268|526977112|FG028|Overall Study|Subject/guardian decision|1|||
146124811|NCT02608268|526977113|FG029|Overall Study|Subject/guardian decision|0|||
146124812|NCT01030523|526977114|FG000|Initial Study (5 Years)|Death|1|||
146124813|NCT01030523|526977115|FG001|Initial Study (5 Years)|Death|0|||
146124814|NCT01030523|526977114|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
146124815|NCT01030523|526977115|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
146124816|NCT01030523|526977114|FG000|Initial Study (5 Years)|Implant failure|1|||
146124817|NCT01030523|526977115|FG001|Initial Study (5 Years)|Implant failure|0|||
146124818|NCT01030523|526977114|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
146124819|NCT01030523|526977115|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
146124820|NCT01030523|526977114|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
146124821|NCT01030523|526977115|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
146124822|NCT01030523|526977114|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
146124823|NCT01030523|526977115|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
146124824|NCT00772707|526977126|FG000|Overall Study|Withdrawn|3|||
146124825|NCT01454570|526977127|FG000|Overall Study|Withdrawal by Subject|2|||
146124826|NCT01454570|526977127|FG000|Overall Study|Screen Failure|7|||
146124827|NCT00909779|526977129|FG000|Overall Study|Adverse Event|53|||
146124828|NCT00909779|526977130|FG001|Overall Study|Adverse Event|55|||
146124829|NCT00909779|526977129|FG000|Overall Study|Lack of Efficacy|7|||
146124830|NCT00909779|526977130|FG001|Overall Study|Lack of Efficacy|4|||
146124831|NCT00909779|526977129|FG000|Overall Study|Lost to Follow-up|19|||
146124832|NCT00909779|526977130|FG001|Overall Study|Lost to Follow-up|15|||
146124833|NCT00909779|526977129|FG000|Overall Study|Physician Decision|8|||
146124834|NCT00909779|526977130|FG001|Overall Study|Physician Decision|2|||
146124835|NCT00909779|526977129|FG000|Overall Study|Protocol Violation|2|||
146124836|NCT00909779|526977130|FG001|Overall Study|Protocol Violation|5|||
146124837|NCT00909779|526977129|FG000|Overall Study|Withdrawal by Subject|116|||
146124838|NCT00909779|526977130|FG001|Overall Study|Withdrawal by Subject|80|||
146124839|NCT00909779|526977129|FG000|Overall Study|Site Ceasing Operation|2|||
146124840|NCT00909779|526977130|FG001|Overall Study|Site Ceasing Operation|2|||
146124841|NCT00909779|526977129|FG000|Overall Study|Medical Monitor Decision|1|||
146124842|NCT00909779|526977130|FG001|Overall Study|Medical Monitor Decision|0|||
146124843|NCT00909779|526977129|FG000|Overall Study|Noncompliance|1|||
146124844|NCT00909779|526977130|FG001|Overall Study|Noncompliance|1|||
146124845|NCT00909779|526977129|FG000|Overall Study|Randomized in error|1|||
146124846|NCT00909779|526977130|FG001|Overall Study|Randomized in error|1|||
146124847|NCT04829318|526977133|FG000|Overall Study|Adverse Event|6|||
146124848|NCT04829318|526977133|FG000|Overall Study|Death|1|||
146124849|NCT04829318|526977133|FG000|Overall Study|Lost to Follow-up|1|||
146124850|NCT04829318|526977133|FG000|Overall Study|Physician Decision|1|||
146124851|NCT04829318|526977133|FG000|Overall Study|Withdrawal by Subject|19|||
146124852|NCT04829318|526977133|FG000|Overall Study|Site terminated by sponsor|1|||
146124853|NCT04829318|526977133|FG000|Overall Study|Sponsor decision|5|||
146124854|NCT04829318|526977133|FG000|Overall Study|Other|1|||
146124855|NCT00728130|526977134|FG000|Overall Study|Withdrawal by Subject|1|||
146124856|NCT00728130|526977134|FG000|Overall Study|Paperwork not completed in time|1|||
146124857|NCT00728130|526977134|FG000|Overall Study|Physician Decision|1|||
146124858|NCT01994629|526977137|FG000|Overall Study|Withdrawal by Subject|1|||
146124859|NCT01994629|526977138|FG001|Overall Study|Withdrawal by Subject|0|||
146124860|NCT01994629|526977137|FG000|Overall Study|Lost to Follow-up|0|||
146124861|NCT01994629|526977138|FG001|Overall Study|Lost to Follow-up|3|||
146124862|NCT03338062|526977139|FG000|Overall Study|Alternative Therapy|1|||
146124863|NCT03338062|526977140|FG001|Overall Study|Alternative Therapy|0|||
146124864|NCT04340362|526977144|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
146124865|NCT00975481|526977147|FG000|Second Intervention Period|Adverse Event|2|||
146124866|NCT00975481|526977148|FG001|Second Intervention Period|Adverse Event|1|||
146262579|NCT02725567|527476470|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
146262580|NCT02725567|527476469|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
146262581|NCT02725567|527476470|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
146124867|NCT00975481|526977149|FG002|Second Intervention Period|Adverse Event|0|||
146124868|NCT00975481|526977150|FG003|Second Intervention Period|Adverse Event|0|||
146124869|NCT00975481|526977151|FG004|Second Intervention Period|Adverse Event|0|||
146124870|NCT00975481|526977152|FG005|Second Intervention Period|Adverse Event|0|||
146124871|NCT00975481|526977147|FG000|Second Intervention Period|Withdrawal by Subject|0|||
146124872|NCT00975481|526977148|FG001|Second Intervention Period|Withdrawal by Subject|0|||
146124873|NCT00975481|526977149|FG002|Second Intervention Period|Withdrawal by Subject|1|||
146124874|NCT00975481|526977150|FG003|Second Intervention Period|Withdrawal by Subject|0|||
146124875|NCT00975481|526977151|FG004|Second Intervention Period|Withdrawal by Subject|0|||
146124876|NCT00975481|526977152|FG005|Second Intervention Period|Withdrawal by Subject|0|||
146124877|NCT00975481|526977147|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
146124878|NCT00975481|526977148|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
146124879|NCT00975481|526977149|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
146124880|NCT00975481|526977150|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
146124881|NCT00975481|526977151|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
146124882|NCT00975481|526977152|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
146124883|NCT00975481|526977147|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
146124884|NCT00975481|526977148|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
146124885|NCT00975481|526977149|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
146124886|NCT00975481|526977150|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
146124887|NCT00975481|526977151|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
146124888|NCT00975481|526977152|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
146124889|NCT04351087|526977154|FG000|Overall Study|Lost to Follow-up|7|||
146124890|NCT04351087|526977155|FG001|Overall Study|Lost to Follow-up|3|||
146124891|NCT04351087|526977154|FG000|Overall Study|Withdrawal by Subject|3|||
146124892|NCT04351087|526977155|FG001|Overall Study|Withdrawal by Subject|4|||
146124893|NCT04351087|526977154|FG000|Overall Study|Lack of Efficacy|3|||
146124894|NCT04351087|526977155|FG001|Overall Study|Lack of Efficacy|2|||
146124895|NCT05517382|526977156|FG000|Overall Study|Lost to Follow-up|0|||
146124896|NCT05517382|526977157|FG001|Overall Study|Lost to Follow-up|1|||
146124897|NCT01374087|526977162|FG000|Overall Study|Adverse Event|1|||
146124898|NCT01374087|526977163|FG001|Overall Study|Adverse Event|0|||
146124899|NCT01374087|526977162|FG000|Overall Study|Disease progression|2|||
146124900|NCT01374087|526977163|FG001|Overall Study|Disease progression|2|||
146124901|NCT01374087|526977162|FG000|Overall Study|Study discontinued|13|||
146124902|NCT01374087|526977163|FG001|Overall Study|Study discontinued|13|||
146124903|NCT00271947|526977166|FG000|Overall Study|Lost to Follow-up|1|||
146124904|NCT01522365|526977169|FG000|Overall Study|Withdrawal by Subject|1|||
146124905|NCT01522365|526977170|FG001|Overall Study|Withdrawal by Subject|1|||
146124906|NCT01522365|526977169|FG000|Overall Study|Lost to Follow-up|1|||
146124907|NCT01522365|526977170|FG001|Overall Study|Lost to Follow-up|1|||
146124908|NCT00651755|526977171|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
146124909|NCT00651755|526977172|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
146124910|NCT00651755|526977171|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
146124911|NCT00651755|526977172|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
146124912|NCT00624052|526977173|FG000|Overall Study|Adverse Event|7|||
146124913|NCT00624052|526977174|FG001|Overall Study|Adverse Event|6|||
146124914|NCT00624052|526977175|FG002|Overall Study|Adverse Event|0|||
146124915|NCT00624052|526977176|FG003|Overall Study|Adverse Event|3|||
146124916|NCT00624052|526977173|FG000|Overall Study|Lack of Efficacy|1|||
146124917|NCT00624052|526977174|FG001|Overall Study|Lack of Efficacy|1|||
146124918|NCT00624052|526977175|FG002|Overall Study|Lack of Efficacy|0|||
146124919|NCT00624052|526977176|FG003|Overall Study|Lack of Efficacy|0|||
146124920|NCT00624052|526977173|FG000|Overall Study|Lost to Follow-up|2|||
146124921|NCT00624052|526977174|FG001|Overall Study|Lost to Follow-up|3|||
146124922|NCT00624052|526977175|FG002|Overall Study|Lost to Follow-up|1|||
146124923|NCT00624052|526977176|FG003|Overall Study|Lost to Follow-up|0|||
146124924|NCT00624052|526977173|FG000|Overall Study|Non compliant with the protocol|2|||
146124925|NCT00624052|526977174|FG001|Overall Study|Non compliant with the protocol|1|||
146124926|NCT00624052|526977175|FG002|Overall Study|Non compliant with the protocol|1|||
146124927|NCT00624052|526977176|FG003|Overall Study|Non compliant with the protocol|1|||
146124928|NCT00624052|526977173|FG000|Overall Study|Consent withdrawn|3|||
146124929|NCT00624052|526977174|FG001|Overall Study|Consent withdrawn|1|||
146124930|NCT00624052|526977175|FG002|Overall Study|Consent withdrawn|1|||
146124931|NCT00624052|526977176|FG003|Overall Study|Consent withdrawn|0|||
146124932|NCT00624052|526977173|FG000|Overall Study|Changed job/ran out if meds|0|||
146124933|NCT00624052|526977174|FG001|Overall Study|Changed job/ran out if meds|2|||
146124934|NCT00624052|526977175|FG002|Overall Study|Changed job/ran out if meds|0|||
146124935|NCT00624052|526977176|FG003|Overall Study|Changed job/ran out if meds|0|||
146124936|NCT02466555|526977177|FG000|Overall Study|Lost to Follow-up|2|||
146262582|NCT02725567|527476469|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
146262583|NCT02725567|527476470|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
146262584|NCT01129115|527476471|FG000|Overall Study|Adverse Event|1|||
146262585|NCT01129115|527476472|FG001|Overall Study|Adverse Event|2|||
146262586|NCT01129115|527476473|FG002|Overall Study|Adverse Event|3|||
146262587|NCT01129115|527476474|FG003|Overall Study|Adverse Event|3|||
146124937|NCT04170348|526977178|FG000|Overall Study|Lost to Follow-up|2|||
146124938|NCT04170348|526977179|FG001|Overall Study|Lost to Follow-up|2|||
146124939|NCT04170348|526977178|FG000|Overall Study|Withdrawal by Subject|1|||
146124940|NCT04170348|526977179|FG001|Overall Study|Withdrawal by Subject|5|||
146124941|NCT04170348|526977178|FG000|Overall Study|Non-adherence|1|||
146124942|NCT04170348|526977179|FG001|Overall Study|Non-adherence|1|||
146124943|NCT04170348|526977178|FG000|Overall Study|Adverse Event|1|||
146124944|NCT04170348|526977179|FG001|Overall Study|Adverse Event|0|||
146124945|NCT01120756|526977180|FG000|Overall Study|Withdrawal by Subject|1|||
146262588|NCT01129115|527476471|FG000|Overall Study|Withdrawal by Subject|1|||
146124946|NCT01120756|526977181|FG001|Overall Study|Withdrawal by Subject|1|||
146124947|NCT03839212|526977190|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
146262589|NCT01129115|527476472|FG001|Overall Study|Withdrawal by Subject|3|||
146124948|NCT00679263|526977191|FG000|Visit 2/Dose 1|Adverse Event|1|||
146124949|NCT00679263|526977192|FG001|Visit 2/Dose 1|Adverse Event|0|||
146124950|NCT00679263|526977193|FG002|Visit 2/Dose 1|Adverse Event|0|||
146124951|NCT00679263|526977191|FG000|Visit 2/Dose 1|subject not compliance|1|||
146124952|NCT00679263|526977192|FG001|Visit 2/Dose 1|subject not compliance|1|||
146124953|NCT00679263|526977193|FG002|Visit 2/Dose 1|subject not compliance|0|||
146124954|NCT05104567|526977194|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124955|NCT05104567|526977195|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
146124956|NCT05104567|526977196|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124957|NCT05104567|526977197|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124958|NCT05104567|526977198|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124959|NCT05104567|526977199|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124960|NCT05104567|526977200|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
146124961|NCT05104567|526977194|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
146124962|NCT05104567|526977195|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
146124963|NCT05104567|526977196|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
146124964|NCT05104567|526977197|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
146124965|NCT05104567|526977198|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
146124966|NCT05104567|526977199|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
146124967|NCT05104567|526977200|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
146124968|NCT05104567|526977194|FG000|Overall Study|Progressive disease|3|||
146124969|NCT05104567|526977195|FG001|Overall Study|Progressive disease|13|||
146124970|NCT05104567|526977196|FG002|Overall Study|Progressive disease|13|||
146124971|NCT05104567|526977197|FG003|Overall Study|Progressive disease|17|||
146124972|NCT05104567|526977198|FG004|Overall Study|Progressive disease|17|||
146124973|NCT05104567|526977199|FG005|Overall Study|Progressive disease|28|||
146124974|NCT05104567|526977200|FG006|Overall Study|Progressive disease|24|||
146124975|NCT05104567|526977194|FG000|Overall Study|Withdrawal by Subject|1|||
146124976|NCT05104567|526977195|FG001|Overall Study|Withdrawal by Subject|1|||
146124977|NCT05104567|526977196|FG002|Overall Study|Withdrawal by Subject|2|||
146124978|NCT05104567|526977197|FG003|Overall Study|Withdrawal by Subject|0|||
146124979|NCT05104567|526977198|FG004|Overall Study|Withdrawal by Subject|0|||
146124980|NCT05104567|526977199|FG005|Overall Study|Withdrawal by Subject|0|||
146124981|NCT05104567|526977200|FG006|Overall Study|Withdrawal by Subject|0|||
146124982|NCT05104567|526977194|FG000|Overall Study|Other|1|||
146124983|NCT05104567|526977195|FG001|Overall Study|Other|1|||
146124984|NCT05104567|526977196|FG002|Overall Study|Other|1|||
146124985|NCT05104567|526977197|FG003|Overall Study|Other|0|||
146124986|NCT05104567|526977198|FG004|Overall Study|Other|0|||
146124987|NCT05104567|526977199|FG005|Overall Study|Other|0|||
146124988|NCT05104567|526977200|FG006|Overall Study|Other|0|||
146124989|NCT01464346|526977204|FG000|Overall Study|Withdrawal by Subject|0|||
146124990|NCT01464346|526977205|FG001|Overall Study|Withdrawal by Subject|0|||
146124991|NCT01464346|526977206|FG002|Overall Study|Withdrawal by Subject|1|||
146124992|NCT02295995|526977207|FG000|Overall Study|Lost to Follow-up|5|||
146124993|NCT02295995|526977208|FG001|Overall Study|Lost to Follow-up|1|||
146124994|NCT01498458|526977210|FG000|Overall Study|Adverse Event|4|||
146124995|NCT01498458|526977210|FG000|Overall Study|Physician Decision|3|||
146124996|NCT03188094|526977215|FG000|Overall Study|Screen failure|1|||
146124997|NCT03188094|526977216|FG001|Overall Study|Screen failure|0|||
146124998|NCT03188094|526977217|FG002|Overall Study|Screen failure|0|||
146124999|NCT03188094|526977215|FG000|Overall Study|Pregnancy|3|||
146125000|NCT03188094|526977216|FG001|Overall Study|Pregnancy|0|||
146125001|NCT03188094|526977217|FG002|Overall Study|Pregnancy|0|||
146125002|NCT03188094|526977215|FG000|Overall Study|Ineligible|1|||
146125003|NCT03188094|526977216|FG001|Overall Study|Ineligible|0|||
146125004|NCT03188094|526977217|FG002|Overall Study|Ineligible|0|||
146125005|NCT03188094|526977215|FG000|Overall Study|Lost to Follow-up|0|||
146125006|NCT03188094|526977216|FG001|Overall Study|Lost to Follow-up|0|||
146125007|NCT03188094|526977217|FG002|Overall Study|Lost to Follow-up|17|||
146125008|NCT04007094|526977218|FG000|Overall Study|Lost to Follow-up|1|||
146125009|NCT04007094|526977219|FG001|Overall Study|Lost to Follow-up|1|||
146125010|NCT04350788|526977225|FG000|Overall Study|Lost to Follow-up|6|||
146125011|NCT04350788|526977226|FG001|Overall Study|Lost to Follow-up|2|||
146125012|NCT04350788|526977225|FG000|Overall Study|Withdrawal by Subject|2|||
146125013|NCT04350788|526977226|FG001|Overall Study|Withdrawal by Subject|4|||
146125014|NCT04350788|526977225|FG000|Overall Study|Protocol Violation|4|||
146125015|NCT04350788|526977226|FG001|Overall Study|Protocol Violation|0|||
146125016|NCT01581307|526977227|FG000|Overall Study|Withdrawal by Subject|1|||
146125017|NCT02070744|526977230|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146125018|NCT02070744|526977231|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146125019|NCT02070744|526977232|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146125020|NCT02070744|526977233|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
146125021|NCT02070744|526977234|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
146125022|NCT02070744|526977230|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146125023|NCT02070744|526977231|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146125024|NCT02070744|526977232|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146125025|NCT02070744|526977233|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
146125026|NCT02070744|526977234|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
146125027|NCT02070744|526977230|FG000|OLE Phase (48 Weeks)|Other|0|||
146125028|NCT02070744|526977231|FG001|OLE Phase (48 Weeks)|Other|0|||
146125029|NCT02070744|526977232|FG002|OLE Phase (48 Weeks)|Other|0|||
146125030|NCT02070744|526977233|FG003|OLE Phase (48 Weeks)|Other|0|||
146125031|NCT02070744|526977234|FG004|OLE Phase (48 Weeks)|Other|1|||
146125032|NCT01894581|526977235|FG000|Overall Study|Withdrawal by Subject|2|||
146125033|NCT01894581|526977236|FG001|Overall Study|Withdrawal by Subject|3|||
146125034|NCT01894581|526977235|FG000|Overall Study|Screen Failure|3|||
146125035|NCT01894581|526977236|FG001|Overall Study|Screen Failure|4|||
146125036|NCT03795298|526977240|FG000|Overall Study|Death|34|||
146125037|NCT03795298|526977241|FG001|Overall Study|Death|29|||
146125038|NCT03795298|526977240|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
146125039|NCT03795298|526977241|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
146125040|NCT03795298|526977240|FG000|Overall Study|Lost to Follow-up|28|||
146125041|NCT03795298|526977241|FG001|Overall Study|Lost to Follow-up|17|||
146125042|NCT03795298|526977240|FG000|Overall Study|Physician Decision|5|||
146125043|NCT03795298|526977241|FG001|Overall Study|Physician Decision|4|||
146125044|NCT03795298|526977240|FG000|Overall Study|Withdrawal by Subject|43|||
146125045|NCT03795298|526977241|FG001|Overall Study|Withdrawal by Subject|28|||
146125046|NCT03795298|526977240|FG000|Overall Study|Reason not reported|7|||
146125047|NCT03795298|526977241|FG001|Overall Study|Reason not reported|9|||
146125048|NCT04383743|526977242|FG000|Overall Study|Withdrawal by Subject|1|||
146125049|NCT04383743|526977242|FG000|Overall Study|Adverse Event|1|||
146125050|NCT05478252|526977245|FG000|Overall Study|Withdrawal by Subject|2|||
146125051|NCT05478252|526977246|FG001|Overall Study|Withdrawal by Subject|3|||
146125052|NCT05478252|526977245|FG000|Overall Study|Lost to Follow-up|4|||
146125053|NCT05478252|526977246|FG001|Overall Study|Lost to Follow-up|2|||
146125054|NCT05478252|526977245|FG000|Overall Study|Physician Decision|1|||
146125055|NCT05478252|526977246|FG001|Overall Study|Physician Decision|1|||
146125056|NCT05478252|526977245|FG000|Overall Study|Death|1|||
146125057|NCT05478252|526977246|FG001|Overall Study|Death|0|||
146125058|NCT03482791|526977251|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
146125059|NCT03482791|526977252|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
146125060|NCT01536379|526978524|FG000|Overall Study|Adverse Event|1|||
146125061|NCT01536379|526978525|FG001|Overall Study|Adverse Event|2|||
146125062|NCT01536379|526978524|FG000|Overall Study|Withdrawal by Subject|1|||
146125063|NCT01536379|526978525|FG001|Overall Study|Withdrawal by Subject|1|||
146125064|NCT04439253|526978534|FG000|Overall Study|Adverse Event|1|||
146125065|NCT04439253|526978534|FG000|Overall Study|Disease progression|2|||
146125066|NCT04439253|526978534|FG000|Overall Study|Complicating disease|1|||
146125067|NCT03971695|526978535|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125068|NCT03971695|526978536|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125069|NCT03971695|526978537|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125070|NCT03971695|526978538|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
146125071|NCT03971695|526978539|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
146125072|NCT03971695|526978540|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125073|NCT03971695|526978541|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125074|NCT03971695|526978542|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125075|NCT03971695|526978543|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
146125076|NCT03971695|526978544|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
146125077|NCT03971695|526978545|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146125078|NCT03971695|526978546|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146125079|NCT03971695|526978547|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
146125080|NCT00939809|526978548|FG000|Overall Study|Adverse Event|2|||
146125081|NCT00939809|526978548|FG000|Overall Study|Death|1|||
146303348|NCT00915772|527625746|FG002|Overall Study|Adverse Event|11|||
146125082|NCT04447417|526978549|FG000|Overall Study|Withdrawal by Subject|1|||
146125083|NCT04447417|526978550|FG001|Overall Study|Withdrawal by Subject|0|||
146125084|NCT04447417|526978549|FG000|Overall Study|Failure to meet inclusion criteria|1|||
146125085|NCT04447417|526978550|FG001|Overall Study|Failure to meet inclusion criteria|0|||
146125086|NCT04447417|526978549|FG000|Overall Study|Lost to Follow-up|1|||
146125087|NCT04447417|526978550|FG001|Overall Study|Lost to Follow-up|0|||
146125088|NCT00858442|526978555|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
146125089|NCT00858442|526978556|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
146125090|NCT02016625|526978559|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
146125091|NCT02016625|526978560|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
146303349|NCT00915772|527625744|FG000|Overall Study|Protocol Violation|4|||
146125092|NCT02016625|526978559|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
146125093|NCT02016625|526978560|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
146125094|NCT02016625|526978559|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
146125095|NCT02016625|526978560|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
146125096|NCT02155738|526978561|FG000|Overall Study|Missing critical information|1|||
146125097|NCT02155738|526978562|FG001|Overall Study|Missing critical information|0|||
146125098|NCT02155738|526978563|FG002|Overall Study|Missing critical information|0|||
146125099|NCT02155738|526978564|FG003|Overall Study|Missing critical information|1|||
146125100|NCT02356783|526978566|FG000|Overall Study|Lost to Follow-up|1|||
146125101|NCT02356783|526978567|FG001|Overall Study|Lost to Follow-up|3|||
146125102|NCT02603809|526978568|FG000|Overall Study|Withdrawal by Subject|4|||
146125103|NCT02603809|526978569|FG001|Overall Study|Withdrawal by Subject|1|||
146125104|NCT02603809|526978570|FG002|Overall Study|Withdrawal by Subject|2|||
146125105|NCT02603809|526978571|FG003|Overall Study|Withdrawal by Subject|3|||
146125106|NCT02603809|526978572|FG004|Overall Study|Withdrawal by Subject|3|||
146125107|NCT02603809|526978573|FG005|Overall Study|Withdrawal by Subject|4|||
146125108|NCT02603809|526978568|FG000|Overall Study|Lost to Follow-up|2|||
146125109|NCT02603809|526978569|FG001|Overall Study|Lost to Follow-up|3|||
146125110|NCT02603809|526978570|FG002|Overall Study|Lost to Follow-up|1|||
146125111|NCT02603809|526978571|FG003|Overall Study|Lost to Follow-up|4|||
146125112|NCT02603809|526978572|FG004|Overall Study|Lost to Follow-up|2|||
146125113|NCT02603809|526978573|FG005|Overall Study|Lost to Follow-up|2|||
146125114|NCT02603809|526978568|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
146125115|NCT02603809|526978569|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
146125116|NCT02603809|526978570|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
146125117|NCT02603809|526978571|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
146125118|NCT02603809|526978572|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
146125119|NCT02603809|526978573|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
146125120|NCT02603809|526978568|FG000|Overall Study|Physician Decision|0|||
146125121|NCT02603809|526978569|FG001|Overall Study|Physician Decision|0|||
146125122|NCT02603809|526978570|FG002|Overall Study|Physician Decision|0|||
146125123|NCT02603809|526978571|FG003|Overall Study|Physician Decision|1|||
146125124|NCT02603809|526978572|FG004|Overall Study|Physician Decision|2|||
146125125|NCT02603809|526978573|FG005|Overall Study|Physician Decision|1|||
146125126|NCT02603809|526978568|FG000|Overall Study|Adverse Event|3|||
146125127|NCT02603809|526978569|FG001|Overall Study|Adverse Event|0|||
146125128|NCT02603809|526978570|FG002|Overall Study|Adverse Event|2|||
146125129|NCT02603809|526978571|FG003|Overall Study|Adverse Event|2|||
146125130|NCT02603809|526978572|FG004|Overall Study|Adverse Event|1|||
146125131|NCT02603809|526978573|FG005|Overall Study|Adverse Event|1|||
146125132|NCT02603809|526978568|FG000|Overall Study|Lack of Efficacy|0|||
146125133|NCT02603809|526978569|FG001|Overall Study|Lack of Efficacy|1|||
146125134|NCT02603809|526978570|FG002|Overall Study|Lack of Efficacy|0|||
146125135|NCT02603809|526978571|FG003|Overall Study|Lack of Efficacy|0|||
146125136|NCT02603809|526978572|FG004|Overall Study|Lack of Efficacy|0|||
146125137|NCT02603809|526978573|FG005|Overall Study|Lack of Efficacy|1|||
146125138|NCT04608500|526978576|FG000|Overall Study|Adverse Event|2|||
146125139|NCT04608500|526978577|FG001|Overall Study|Adverse Event|0|||
146125140|NCT04608500|526978576|FG000|Overall Study|Lost to Follow-up|15|||
146125141|NCT04608500|526978577|FG001|Overall Study|Lost to Follow-up|9|||
146125142|NCT04608500|526978576|FG000|Overall Study|Participant request|11|||
146125143|NCT04608500|526978577|FG001|Overall Study|Participant request|7|||
146125144|NCT04608500|526978576|FG000|Overall Study|Protocol Violation|1|||
146125145|NCT04608500|526978577|FG001|Overall Study|Protocol Violation|0|||
146125146|NCT04608500|526978576|FG000|Overall Study|Other|6|||
146125147|NCT04608500|526978577|FG001|Overall Study|Other|2|||
146125148|NCT01881230|526978578|FG000|Overall Study|Death|2|||
146125149|NCT01881230|526978579|FG001|Overall Study|Death|0|||
146125150|NCT01881230|526978580|FG002|Overall Study|Death|1|||
146125151|NCT01881230|526978578|FG000|Overall Study|Adverse Event|9|||
146125152|NCT01881230|526978579|FG001|Overall Study|Adverse Event|13|||
146125153|NCT01881230|526978580|FG002|Overall Study|Adverse Event|12|||
146125154|NCT01881230|526978578|FG000|Overall Study|Progressive Disease|31|||
146125155|NCT01881230|526978579|FG001|Overall Study|Progressive Disease|35|||
146125156|NCT01881230|526978580|FG002|Overall Study|Progressive Disease|36|||
146125157|NCT01881230|526978578|FG000|Overall Study|Symptomatic Deterioration|3|||
146125158|NCT01881230|526978579|FG001|Overall Study|Symptomatic Deterioration|3|||
146125159|NCT01881230|526978580|FG002|Overall Study|Symptomatic Deterioration|1|||
146125160|NCT01881230|526978578|FG000|Overall Study|Withdrawal by Subject|6|||
146125161|NCT01881230|526978579|FG001|Overall Study|Withdrawal by Subject|4|||
146125162|NCT01881230|526978580|FG002|Overall Study|Withdrawal by Subject|6|||
146125163|NCT01881230|526978578|FG000|Overall Study|Physician Decision|4|||
146125164|NCT01881230|526978579|FG001|Overall Study|Physician Decision|3|||
146125165|NCT01881230|526978580|FG002|Overall Study|Physician Decision|6|||
146125166|NCT01881230|526978578|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146125167|NCT01881230|526978579|FG001|Overall Study|Non-Compliance with Study Drug|2|||
146125168|NCT01881230|526978580|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146125169|NCT01881230|526978578|FG000|Overall Study|Given Commercially Available Drug|0|||
146125170|NCT01881230|526978579|FG001|Overall Study|Given Commercially Available Drug|0|||
146125171|NCT01881230|526978580|FG002|Overall Study|Given Commercially Available Drug|2|||
146125172|NCT01881230|526978578|FG000|Overall Study|Protocol Violation|1|||
146125173|NCT01881230|526978579|FG001|Overall Study|Protocol Violation|1|||
146125174|NCT01881230|526978580|FG002|Overall Study|Protocol Violation|0|||
146125175|NCT01881230|526978578|FG000|Overall Study|Miscellaneous|3|||
146125176|NCT01881230|526978579|FG001|Overall Study|Miscellaneous|3|||
146125177|NCT01881230|526978580|FG002|Overall Study|Miscellaneous|0|||
146125178|NCT01881230|526978578|FG000|Overall Study|Untreated: Other|0|||
146125179|NCT01881230|526978579|FG001|Overall Study|Untreated: Other|0|||
146125180|NCT01881230|526978580|FG002|Overall Study|Untreated: Other|1|||
146125181|NCT01881230|526978578|FG000|Overall Study|Untreated: Death|0|||
146125182|NCT01881230|526978579|FG001|Overall Study|Untreated: Death|0|||
146125183|NCT01881230|526978580|FG002|Overall Study|Untreated: Death|1|||
146125184|NCT01881230|526978578|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
146125185|NCT01881230|526978579|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
146125186|NCT01881230|526978580|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
146125187|NCT00112502|526978581|FG000|Overall Study|Withdrawal by Subject|0|||
146125188|NCT00112502|526978582|FG001|Overall Study|Withdrawal by Subject|1|||
146125189|NCT00112502|526978583|FG002|Overall Study|Withdrawal by Subject|1|||
146125190|NCT00112502|526978584|FG003|Overall Study|Withdrawal by Subject|4|||
146125191|NCT00112502|526978585|FG004|Overall Study|Withdrawal by Subject|2|||
146125192|NCT00112502|526978586|FG005|Overall Study|Withdrawal by Subject|5|||
146125193|NCT00112502|526978587|FG006|Overall Study|Withdrawal by Subject|3|||
146125194|NCT00112502|526978588|FG007|Overall Study|Withdrawal by Subject|7|||
146125195|NCT02747420|526978589|FG000|Overall Study|Lost to Follow-up|4|||
146125196|NCT02747420|526978590|FG001|Overall Study|Lost to Follow-up|2|||
146125197|NCT02747420|526978589|FG000|Overall Study|Withdrawal by Subject|3|||
146125198|NCT02747420|526978590|FG001|Overall Study|Withdrawal by Subject|2|||
146125199|NCT05129488|526978591|FG000|Overall Study|Protocol Violation|3|||
146125200|NCT01290666|526978595|FG000|Overall Study|Lost to Follow-up|11|||
146125201|NCT01290666|526978595|FG000|Overall Study|Withdrawal by Subject|23|||
146125202|NCT01290666|526978595|FG000|Overall Study|Early Termination of Study|4|||
146125203|NCT01652664|526978596|FG000|Overall Study|Treatment Failure|5|||
146125204|NCT01652664|526978597|FG001|Overall Study|Treatment Failure|1|||
146125205|NCT01652664|526978596|FG000|Overall Study|Inadequate IOP control|1|||
146125206|NCT01652664|526978597|FG001|Overall Study|Inadequate IOP control|0|||
146125207|NCT03538158|526978598|FG000|Overall Study|Lost to Follow-up|13|||
146125208|NCT03538158|526978599|FG001|Overall Study|Lost to Follow-up|7|||
146125209|NCT03538158|526978598|FG000|Overall Study|Withdrawal by Subject|2|||
146125210|NCT03538158|526978599|FG001|Overall Study|Withdrawal by Subject|1|||
146125211|NCT02418468|526978603|FG000|Overall Study|Adverse Event|1|||
146125212|NCT02418468|526978604|FG001|Overall Study|Adverse Event|0|||
146125213|NCT02418468|526978603|FG000|Overall Study|Withdrawal of informed consent|1|||
146125214|NCT02418468|526978604|FG001|Overall Study|Withdrawal of informed consent|1|||
146125215|NCT02914769|526978605|FG000|Overall Study|Protocol Violation|3|||
146125216|NCT02914769|526978606|FG001|Overall Study|Protocol Violation|2|||
146125217|NCT02914769|526978605|FG000|Overall Study|Withdrawal by Subject|0|||
146125218|NCT02914769|526978606|FG001|Overall Study|Withdrawal by Subject|1|||
146125219|NCT04356963|526978610|FG000|First Session|Withdrawal by Subject|1|||
146125220|NCT04356963|526978610|FG000|Second Session|Withdrawal by Subject|3|||
146125221|NCT04356963|526978610|FG000|Second Session|Lost to Follow-up|1|||
146125222|NCT04356963|526978610|FG000|Third Session|Lost to Follow-up|6|||
146125223|NCT04356963|526978610|FG000|Third Session|Withdrawal by Subject|1|||
146125224|NCT00099437|526978611|FG000|Overall Study|Lost to Follow-up|30|||
146125225|NCT00099437|526978612|FG001|Overall Study|Lost to Follow-up|33|||
146125226|NCT00099437|526978611|FG000|Overall Study|Death|293|||
146125227|NCT00099437|526978612|FG001|Overall Study|Death|261|||
146125228|NCT00099437|526978611|FG000|Overall Study|Withdrawal by Subject|6|||
146125229|NCT00099437|526978612|FG001|Overall Study|Withdrawal by Subject|10|||
146125230|NCT00099437|526978611|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
146125231|NCT00099437|526978612|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
146125232|NCT02410954|526978613|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
146125233|NCT02410954|526978614|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
146125234|NCT02410954|526978613|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
146262590|NCT01129115|527476473|FG002|Overall Study|Withdrawal by Subject|1|||
146262591|NCT01129115|527476474|FG003|Overall Study|Withdrawal by Subject|4|||
146125235|NCT02410954|526978614|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
146125236|NCT02738333|526978615|FG000|Overall Study|Death|1|||
146125237|NCT02738333|526978616|FG001|Overall Study|Death|0|||
146262592|NCT01129115|527476471|FG000|Overall Study|Protocol Violation|0|||
146262593|NCT01129115|527476472|FG001|Overall Study|Protocol Violation|2|||
146125238|NCT02738333|526978617|FG002|Overall Study|Death|0|||
146125239|NCT02738333|526978615|FG000|Overall Study|Lost to Follow-up|1|||
146125240|NCT02738333|526978616|FG001|Overall Study|Lost to Follow-up|0|||
146125241|NCT02738333|526978617|FG002|Overall Study|Lost to Follow-up|0|||
146125242|NCT00791518|526978618|FG000|Overall Study|Protocol Violation|93|||
146125243|NCT02809677|526978620|FG000|Overall Study|Withdrawal by Subject|8|||
146125244|NCT04969224|526978625|FG000|Overall Study|Adverse Event|1|||
146125245|NCT04969224|526978625|FG000|Overall Study|Enrolled but never dosed|1|||
146125246|NCT01498952|526978626|FG000|Overall Study|Death|2|||
146125247|NCT01498952|526978627|FG001|Overall Study|Death|2|||
146125248|NCT01498952|526978628|FG002|Overall Study|Death|0|||
146125249|NCT01498952|526978629|FG003|Overall Study|Death|0|||
146125250|NCT01498952|526978630|FG004|Overall Study|Death|0|||
146125251|NCT02726074|526978631|FG000|Overall Study|Withdrawal by Subject|4|||
146125252|NCT02726074|526978631|FG000|Overall Study|Adverse Event|14|||
146125253|NCT02726074|526978631|FG000|Overall Study|Protocol Violation|3|||
146125254|NCT02726074|526978631|FG000|Overall Study|Lost to Follow-up|2|||
146125255|NCT02726074|526978631|FG000|Overall Study|Others|3|||
146125256|NCT01679002|526978632|FG000|Overall Study|Adverse Event|1|||
146125257|NCT01679002|526978633|FG001|Overall Study|Adverse Event|1|||
146125258|NCT01679002|526978634|FG002|Overall Study|Adverse Event|0|||
146125259|NCT05172544|526978635|FG000|Overall Study|Withdrawal by Subject|1|||
146125260|NCT05172544|526978636|FG001|Overall Study|Withdrawal by Subject|0|||
146125261|NCT05172544|526978637|FG002|Overall Study|Withdrawal by Subject|0|||
146125262|NCT05172544|526978635|FG000|Overall Study|Physician Decision|0|||
146125263|NCT05172544|526978636|FG001|Overall Study|Physician Decision|0|||
146125264|NCT05172544|526978637|FG002|Overall Study|Physician Decision|1|||
146125265|NCT00454987|526978638|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
146125266|NCT00454987|526978639|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
146125267|NCT00454987|526978640|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
146125268|NCT00454987|526978638|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
146125269|NCT00454987|526978639|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
146125270|NCT00454987|526978640|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
146125271|NCT00454987|526978638|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
146125272|NCT00454987|526978639|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
146125273|NCT00454987|526978640|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
146125274|NCT01176266|526978641|FG000|Overall Study|Death|6|||
146125275|NCT01176266|526978641|FG000|Overall Study|Withdrawal by Subject|3|||
146125276|NCT02642432|526978642|FG000|Overall Study|Adverse Event|2|||
146125277|NCT02642432|526978642|FG000|Overall Study|Withdrew Consent|1|||
146125278|NCT02642432|526978642|FG000|Overall Study|Lost to Follow-up|2|||
146125279|NCT02642432|526978642|FG000|Overall Study|Other|3|||
146125280|NCT03999892|526978643|FG000|Overall Study|Lost to Follow-up|1|||
146125281|NCT01848756|526978644|FG000|Overall Study|Adverse Event|1|||
146125282|NCT01848756|526978644|FG000|Overall Study|Withdrawal by Subject|1|||
146262594|NCT01129115|527476473|FG002|Overall Study|Protocol Violation|2|||
146125283|NCT01848756|526978644|FG000|Overall Study|Enrolled in Error|1|||
146125284|NCT03245008|526978645|FG000|Overall Study|Adverse Event|15|||
146125285|NCT03245008|526978646|FG001|Overall Study|Adverse Event|18|||
146125286|NCT03245008|526978647|FG002|Overall Study|Adverse Event|15|||
146125287|NCT03245008|526978648|FG003|Overall Study|Adverse Event|0|||
146125288|NCT03245008|526978649|FG004|Overall Study|Adverse Event|1|||
146125289|NCT03245008|526978645|FG000|Overall Study|Lack of Efficacy|0|||
146125290|NCT03245008|526978646|FG001|Overall Study|Lack of Efficacy|1|||
146125291|NCT03245008|526978647|FG002|Overall Study|Lack of Efficacy|0|||
146125292|NCT03245008|526978648|FG003|Overall Study|Lack of Efficacy|0|||
146125293|NCT03245008|526978649|FG004|Overall Study|Lack of Efficacy|0|||
146125294|NCT03245008|526978645|FG000|Overall Study|Lost to Follow-up|4|||
146125295|NCT03245008|526978646|FG001|Overall Study|Lost to Follow-up|1|||
146125296|NCT03245008|526978647|FG002|Overall Study|Lost to Follow-up|0|||
146125297|NCT03245008|526978648|FG003|Overall Study|Lost to Follow-up|0|||
146125298|NCT03245008|526978649|FG004|Overall Study|Lost to Follow-up|1|||
146125299|NCT03245008|526978645|FG000|Overall Study|Physician Decision|1|||
146125300|NCT03245008|526978646|FG001|Overall Study|Physician Decision|3|||
146125301|NCT03245008|526978647|FG002|Overall Study|Physician Decision|4|||
146125302|NCT03245008|526978648|FG003|Overall Study|Physician Decision|0|||
146125303|NCT03245008|526978649|FG004|Overall Study|Physician Decision|0|||
146125304|NCT03245008|526978645|FG000|Overall Study|Protocol Violation|0|||
146125305|NCT03245008|526978646|FG001|Overall Study|Protocol Violation|1|||
146125306|NCT03245008|526978647|FG002|Overall Study|Protocol Violation|0|||
146125307|NCT03245008|526978648|FG003|Overall Study|Protocol Violation|0|||
146125308|NCT03245008|526978649|FG004|Overall Study|Protocol Violation|0|||
146125309|NCT03245008|526978645|FG000|Overall Study|Withdrawal by Subject|20|||
146125310|NCT03245008|526978646|FG001|Overall Study|Withdrawal by Subject|19|||
146125311|NCT03245008|526978647|FG002|Overall Study|Withdrawal by Subject|11|||
146125312|NCT03245008|526978648|FG003|Overall Study|Withdrawal by Subject|0|||
146125313|NCT03245008|526978649|FG004|Overall Study|Withdrawal by Subject|0|||
146125314|NCT03245008|526978645|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146125315|NCT03245008|526978646|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146125316|NCT03245008|526978647|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
146125317|NCT03245008|526978648|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
146125318|NCT03245008|526978649|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
146125319|NCT03245008|526978645|FG000|Overall Study|Failure to meet randomization criteria|0|||
146125320|NCT03245008|526978646|FG001|Overall Study|Failure to meet randomization criteria|1|||
146125321|NCT03245008|526978647|FG002|Overall Study|Failure to meet randomization criteria|0|||
146125322|NCT03245008|526978648|FG003|Overall Study|Failure to meet randomization criteria|1|||
146125323|NCT03245008|526978649|FG004|Overall Study|Failure to meet randomization criteria|0|||
146125324|NCT02075658|526978650|FG000|Overall Study|Physician Decision|2|||
146125325|NCT02075658|526978651|FG001|Overall Study|Physician Decision|2|||
146125326|NCT01286012|526978652|FG000|Overall Study|Adverse Event|3|||
146125327|NCT01286012|526978653|FG001|Overall Study|Adverse Event|3|||
146125328|NCT01286012|526978652|FG000|Overall Study|Death|2|||
146125329|NCT01286012|526978653|FG001|Overall Study|Death|3|||
146125330|NCT01286012|526978652|FG000|Overall Study|Protocol Violation|1|||
146125331|NCT01286012|526978653|FG001|Overall Study|Protocol Violation|1|||
146125332|NCT01286012|526978652|FG000|Overall Study|Withdrawal by Subject|4|||
146125333|NCT01286012|526978653|FG001|Overall Study|Withdrawal by Subject|4|||
146125334|NCT01286012|526978652|FG000|Overall Study|Physician Decision|2|||
146125335|NCT01286012|526978653|FG001|Overall Study|Physician Decision|0|||
146125336|NCT01286012|526978652|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
146125337|NCT01286012|526978653|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
146125338|NCT01602380|526978657|FG000|Overall Study|Death|147|||
146125339|NCT01602380|526978658|FG001|Overall Study|Death|145|||
146125340|NCT01602380|526978657|FG000|Overall Study|Withdrawal by Subject|39|||
146125341|NCT01602380|526978658|FG001|Overall Study|Withdrawal by Subject|41|||
146125342|NCT01602380|526978657|FG000|Overall Study|Lost to Follow-up|15|||
146125343|NCT01602380|526978658|FG001|Overall Study|Lost to Follow-up|12|||
146125344|NCT01602380|526978657|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146125345|NCT01602380|526978658|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
146125346|NCT01602380|526978657|FG000|Overall Study|Other|2|||
146125347|NCT01602380|526978658|FG001|Overall Study|Other|0|||
146125348|NCT01816893|526978664|FG000|Washout Period|Withdrawal by Subject|2|||
146125349|NCT01816893|526978665|FG001|Washout Period|Withdrawal by Subject|0|||
146125350|NCT01239368|526980570|FG000|Overall Study|Principal investigator discretion|1|||
146125351|NCT01239368|526980571|FG001|Overall Study|Principal investigator discretion|0|||
146125352|NCT01239368|526980572|FG002|Overall Study|Principal investigator discretion|0|||
146125353|NCT01239368|526980573|FG003|Overall Study|Principal investigator discretion|0|||
146125354|NCT01239368|526980574|FG004|Overall Study|Principal investigator discretion|1|||
146125355|NCT01239368|526980575|FG005|Overall Study|Principal investigator discretion|2|||
146125356|NCT01239368|526980576|FG006|Overall Study|Principal investigator discretion|0|||
146125357|NCT01239368|526980577|FG007|Overall Study|Principal investigator discretion|0|||
146125358|NCT01239368|526980578|FG008|Overall Study|Principal investigator discretion|0|||
146125359|NCT01239368|526980579|FG009|Overall Study|Principal investigator discretion|1|||
146125360|NCT01239368|526980570|FG000|Overall Study|Disease progression on study|1|||
146125361|NCT01239368|526980571|FG001|Overall Study|Disease progression on study|1|||
146125362|NCT01239368|526980572|FG002|Overall Study|Disease progression on study|1|||
146125363|NCT01239368|526980573|FG003|Overall Study|Disease progression on study|1|||
146125364|NCT01239368|526980574|FG004|Overall Study|Disease progression on study|4|||
146125365|NCT01239368|526980575|FG005|Overall Study|Disease progression on study|2|||
146125366|NCT01239368|526980576|FG006|Overall Study|Disease progression on study|5|||
146125367|NCT01239368|526980577|FG007|Overall Study|Disease progression on study|0|||
146125368|NCT01239368|526980578|FG008|Overall Study|Disease progression on study|0|||
146125369|NCT01239368|526980579|FG009|Overall Study|Disease progression on study|2|||
146125370|NCT01239368|526980570|FG000|Overall Study|Refused further treatment|0|||
146125371|NCT01239368|526980571|FG001|Overall Study|Refused further treatment|0|||
146125372|NCT01239368|526980572|FG002|Overall Study|Refused further treatment|0|||
146125373|NCT01239368|526980573|FG003|Overall Study|Refused further treatment|0|||
146125374|NCT01239368|526980574|FG004|Overall Study|Refused further treatment|0|||
146125375|NCT01239368|526980575|FG005|Overall Study|Refused further treatment|0|||
146125376|NCT01239368|526980576|FG006|Overall Study|Refused further treatment|0|||
146125377|NCT01239368|526980577|FG007|Overall Study|Refused further treatment|0|||
146125378|NCT01239368|526980578|FG008|Overall Study|Refused further treatment|0|||
146125379|NCT01239368|526980579|FG009|Overall Study|Refused further treatment|1|||
146125380|NCT01239368|526980570|FG000|Overall Study|Death|0|||
146125381|NCT01239368|526980571|FG001|Overall Study|Death|0|||
146125382|NCT01239368|526980572|FG002|Overall Study|Death|0|||
146125383|NCT01239368|526980573|FG003|Overall Study|Death|0|||
146125384|NCT01239368|526980574|FG004|Overall Study|Death|0|||
146125385|NCT01239368|526980575|FG005|Overall Study|Death|0|||
146125386|NCT01239368|526980576|FG006|Overall Study|Death|1|||
146125387|NCT01239368|526980577|FG007|Overall Study|Death|0|||
146125388|NCT01239368|526980578|FG008|Overall Study|Death|0|||
146125389|NCT01239368|526980579|FG009|Overall Study|Death|0|||
146125390|NCT04709575|526980580|FG000|Overall Study|Withdrawal by Subject|6|||
146125391|NCT04709575|526980581|FG001|Overall Study|Withdrawal by Subject|2|||
146125392|NCT04709575|526980580|FG000|Overall Study|Lost to Follow-up|2|||
146125393|NCT04709575|526980581|FG001|Overall Study|Lost to Follow-up|2|||
146125394|NCT04709575|526980580|FG000|Overall Study|Adverse Event|1|||
146125395|NCT04709575|526980581|FG001|Overall Study|Adverse Event|0|||
146125396|NCT04709575|526980580|FG000|Overall Study|Protocol Violation|1|||
146125397|NCT04709575|526980581|FG001|Overall Study|Protocol Violation|1|||
146125398|NCT03181399|526980582|FG000|6 Months on Treatment|Protocol non-compliance|7|||
146125399|NCT03181399|526980582|FG000|6 Months on Treatment|Adverse Event|4|||
146125400|NCT03181399|526980582|FG000|6 Months on Treatment|Tried alternative treatment|2|||
146125401|NCT03181399|526980582|FG000|6 Months on Treatment|Lost to Follow-up|2|||
146125402|NCT03181399|526980582|FG000|6 Months on Treatment|Personal reasons|1|||
146125403|NCT03181399|526980582|FG000|3 Months Off-treatment|Parent unable to travel|1|||
146125404|NCT00702403|526980583|FG000|From Consent to Engraftment|Progressive leukemia|6|||
146125405|NCT00702403|526980583|FG000|From Consent to Engraftment|Critically ill|2|||
146125406|NCT00702403|526980583|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
146125407|NCT00702403|526980583|FG000|From Consent to Engraftment|Myocardial infarction|1|||
146125408|NCT00702403|526980583|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
146125409|NCT00702403|526980583|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
146125410|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
146125411|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
146125412|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Non-compliance|2|||
146125413|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
146125414|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
146125415|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Suicide|1|||
146125416|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
146125417|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
146125418|NCT00702403|526980583|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
146125419|NCT01254227|526980584|FG000|Overall Study|Withdrawal by Subject|6|||
146125420|NCT01254227|526980584|FG000|Overall Study|Lost to Follow-up|6|||
146125421|NCT01254227|526980584|FG000|Overall Study|Adverse Event|5|||
146125422|NCT01254227|526980584|FG000|Overall Study|Abnormal test procedure result|5|||
146125423|NCT01254227|526980584|FG000|Overall Study|Administrative problems|2|||
146125424|NCT01254227|526980584|FG000|Overall Study|Death|1|||
146125425|NCT01254227|526980584|FG000|Overall Study|Protocol deviation|1|||
146125426|NCT00192504|526980587|FG000|Overall Study|Lost to Follow-up|1|||
146125427|NCT00192504|526980588|FG001|Overall Study|Lost to Follow-up|0|||
146125428|NCT00192504|526980589|FG002|Overall Study|Lost to Follow-up|0|||
146125429|NCT00192504|526980590|FG003|Overall Study|Lost to Follow-up|0|||
146125430|NCT00192504|526980587|FG000|Overall Study|Dosing window missed|0|||
146125431|NCT00192504|526980588|FG001|Overall Study|Dosing window missed|0|||
146125432|NCT00192504|526980589|FG002|Overall Study|Dosing window missed|1|||
146125433|NCT00192504|526980590|FG003|Overall Study|Dosing window missed|0|||
146125434|NCT03989440|526980591|FG000|Overall Study|COVID-19 travel restrictions|0|||
146125435|NCT03989440|526980592|FG001|Overall Study|COVID-19 travel restrictions|0|||
146125436|NCT03989440|526980593|FG002|Overall Study|COVID-19 travel restrictions|1|||
146125437|NCT03989440|526980594|FG003|Overall Study|COVID-19 travel restrictions|0|||
146125438|NCT03989440|526980595|FG004|Overall Study|COVID-19 travel restrictions|0|||
146125439|NCT03989440|526980596|FG005|Overall Study|COVID-19 travel restrictions|0|||
146125440|NCT03989440|526980591|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
146125441|NCT03989440|526980592|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
146125442|NCT03989440|526980593|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
146125443|NCT03989440|526980594|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
146125444|NCT03989440|526980595|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
146125445|NCT03989440|526980596|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
146125446|NCT02189473|526980597|FG000|Overall Study|Death|22|||
146125447|NCT02189473|526980598|FG001|Overall Study|Death|23|||
146125448|NCT02189473|526980597|FG000|Overall Study|Lost to Follow-up|1|||
146125449|NCT02189473|526980598|FG001|Overall Study|Lost to Follow-up|2|||
146125450|NCT05123222|526980599|FG000|Overall Study|Lost to Follow-up|2|||
146125451|NCT05123222|526980600|FG001|Overall Study|Lost to Follow-up|0|||
146125452|NCT05123222|526980601|FG002|Overall Study|Lost to Follow-up|0|||
146125453|NCT05123222|526980602|FG003|Overall Study|Lost to Follow-up|0|||
146125454|NCT05123222|526980599|FG000|Overall Study|Protocol Violation|0|||
146125455|NCT05123222|526980600|FG001|Overall Study|Protocol Violation|0|||
146125456|NCT05123222|526980601|FG002|Overall Study|Protocol Violation|1|||
146125457|NCT05123222|526980602|FG003|Overall Study|Protocol Violation|0|||
146125458|NCT00914810|526980605|FG000|Overall Study|Withdrawal by Subject|1|||
146125459|NCT00914810|526980606|FG001|Overall Study|Withdrawal by Subject|0|||
146125460|NCT00914810|526980605|FG000|Overall Study|Relocated out of state|1|||
146125461|NCT00914810|526980606|FG001|Overall Study|Relocated out of state|0|||
146125462|NCT00914810|526980605|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
146125463|NCT00914810|526980606|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
146262595|NCT01129115|527476474|FG003|Overall Study|Protocol Violation|2|||
146262596|NCT01747837|527476476|FG000|Overall Study|Lost to Follow-up|5|||
146125464|NCT00265343|526980607|FG000|Overall Study|Adverse Event|10|||
146125465|NCT00265343|526980608|FG001|Overall Study|Adverse Event|7|||
146125466|NCT00265343|526980607|FG000|Overall Study|Withdrawal by Subject|3|||
146125467|NCT00265343|526980608|FG001|Overall Study|Withdrawal by Subject|9|||
146125468|NCT00265343|526980607|FG000|Overall Study|Other|8|||
146125469|NCT00265343|526980608|FG001|Overall Study|Other|3|||
146125470|NCT00706641|526980613|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
146125471|NCT00706641|526980613|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
146125472|NCT00706641|526980613|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
146125473|NCT04782856|526980617|FG000|Overall Study|Withdrawal by Subject|0|||
146125474|NCT04782856|526980618|FG001|Overall Study|Withdrawal by Subject|1|||
146125475|NCT02535741|526980619|FG000|Overall Study|Adverse Event|3|||
146125476|NCT02535741|526980619|FG000|Overall Study|Withdrawal by Subject|9|||
146125477|NCT02535741|526980619|FG000|Overall Study|Lost to Follow-up|10|||
146125478|NCT02535741|526980619|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
146125479|NCT02535741|526980619|FG000|Overall Study|Missing data|6|||
146125480|NCT00798369|526980620|FG000|Overall Study|Subject withdrew consent|0|||
146125481|NCT00798369|526980621|FG001|Overall Study|Subject withdrew consent|0|||
146125482|NCT00798369|526980622|FG002|Overall Study|Subject withdrew consent|1|||
146125483|NCT00798369|526980623|FG003|Overall Study|Subject withdrew consent|1|||
146125484|NCT00798369|526980624|FG004|Overall Study|Subject withdrew consent|0|||
146125485|NCT00798369|526980625|FG005|Overall Study|Subject withdrew consent|2|||
146125486|NCT00798369|526980620|FG000|Overall Study|Lost to Follow-up|1|||
146125487|NCT00798369|526980621|FG001|Overall Study|Lost to Follow-up|1|||
146125488|NCT00798369|526980622|FG002|Overall Study|Lost to Follow-up|1|||
146125489|NCT00798369|526980623|FG003|Overall Study|Lost to Follow-up|0|||
146125490|NCT00798369|526980624|FG004|Overall Study|Lost to Follow-up|1|||
146125491|NCT00798369|526980625|FG005|Overall Study|Lost to Follow-up|0|||
146125492|NCT00798369|526980620|FG000|Overall Study|Adminstrative problems|0|||
146125493|NCT00798369|526980621|FG001|Overall Study|Adminstrative problems|0|||
146125494|NCT00798369|526980622|FG002|Overall Study|Adminstrative problems|0|||
146125495|NCT00798369|526980623|FG003|Overall Study|Adminstrative problems|0|||
146125496|NCT00798369|526980624|FG004|Overall Study|Adminstrative problems|0|||
146125497|NCT00798369|526980625|FG005|Overall Study|Adminstrative problems|1|||
146125498|NCT04475588|526980626|FG000|Overall Study|Adverse Event|2|||
146125499|NCT04475588|526980627|FG001|Overall Study|Adverse Event|0|||
146125500|NCT01327300|526980628|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
146125501|NCT01327300|526980629|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
146125502|NCT03020823|526980630|FG000|Overall Study|Physician Decision|4|||
146125503|NCT03020823|526980630|FG000|Overall Study|Lack of Efficacy|4|||
146125504|NCT03020823|526980630|FG000|Overall Study|Adverse Event|2|||
146125505|NCT03739112|526980631|FG000|Overall Study|Adverse Event|2|||
146125506|NCT03739112|526980632|FG001|Overall Study|Adverse Event|2|||
146125507|NCT03739112|526980631|FG000|Overall Study|Withdrawal by Subject|38|||
146125508|NCT03739112|526980632|FG001|Overall Study|Withdrawal by Subject|19|||
146125509|NCT03739112|526980631|FG000|Overall Study|Lost to Follow-up|31|||
146125510|NCT03739112|526980632|FG001|Overall Study|Lost to Follow-up|33|||
146125511|NCT03739112|526980631|FG000|Overall Study|Protocol Deviation|12|||
146125512|NCT03739112|526980632|FG001|Overall Study|Protocol Deviation|9|||
146125513|NCT03739112|526980631|FG000|Overall Study|Physician Decision|1|||
146125514|NCT03739112|526980632|FG001|Overall Study|Physician Decision|0|||
146125515|NCT03739112|526980631|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
146125516|NCT03739112|526980632|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
146125517|NCT03739112|526980631|FG000|Overall Study|Site went on hold|65|||
146125518|NCT03739112|526980632|FG001|Overall Study|Site went on hold|67|||
146125519|NCT03739112|526980631|FG000|Overall Study|Other than specified|8|||
146125520|NCT03739112|526980632|FG001|Overall Study|Other than specified|5|||
146125521|NCT03739112|526980631|FG000|Overall Study|Randomized but not vaccinated|31|||
146125522|NCT03739112|526980632|FG001|Overall Study|Randomized but not vaccinated|25|||
146125523|NCT00588822|526980634|FG000|Overall Study|progression of disease|8|||
146125524|NCT02082210|526980636|FG000|Overall Study|Death|0|||
146125525|NCT02082210|526980637|FG001|Overall Study|Death|0|||
146125526|NCT02082210|526980638|FG002|Overall Study|Death|1|||
146125527|NCT02082210|526980639|FG003|Overall Study|Death|1|||
146125528|NCT02082210|526980640|FG004|Overall Study|Death|1|||
146125529|NCT02082210|526980641|FG005|Overall Study|Death|0|||
146125530|NCT02082210|526980636|FG000|Overall Study|Withdrawal by Subject|0|||
146125531|NCT02082210|526980637|FG001|Overall Study|Withdrawal by Subject|0|||
146125532|NCT02082210|526980638|FG002|Overall Study|Withdrawal by Subject|0|||
146125533|NCT02082210|526980639|FG003|Overall Study|Withdrawal by Subject|1|||
146125534|NCT02082210|526980640|FG004|Overall Study|Withdrawal by Subject|2|||
146125535|NCT02082210|526980641|FG005|Overall Study|Withdrawal by Subject|2|||
146125536|NCT02082210|526980636|FG000|Overall Study|Clinical Progression|0|||
146262597|NCT01747837|527476477|FG001|Overall Study|Lost to Follow-up|2|||
146125537|NCT02082210|526980637|FG001|Overall Study|Clinical Progression|0|||
146125538|NCT02082210|526980638|FG002|Overall Study|Clinical Progression|0|||
146125539|NCT02082210|526980639|FG003|Overall Study|Clinical Progression|1|||
146125540|NCT02082210|526980640|FG004|Overall Study|Clinical Progression|0|||
146125541|NCT02082210|526980641|FG005|Overall Study|Clinical Progression|0|||
146125542|NCT02082210|526980636|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
146125543|NCT02082210|526980637|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
146125544|NCT02082210|526980638|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
146125545|NCT02082210|526980639|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
146125546|NCT02082210|526980640|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
146125547|NCT02082210|526980641|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
146125548|NCT02082210|526980636|FG000|Overall Study|Physician Decision|0|||
146125549|NCT02082210|526980637|FG001|Overall Study|Physician Decision|0|||
146125550|NCT02082210|526980638|FG002|Overall Study|Physician Decision|1|||
146125551|NCT02082210|526980639|FG003|Overall Study|Physician Decision|1|||
146125552|NCT02082210|526980640|FG004|Overall Study|Physician Decision|0|||
146125553|NCT02082210|526980641|FG005|Overall Study|Physician Decision|0|||
146125554|NCT04762680|526980642|FG000|Phase 2|Adverse Event|0|||
146125555|NCT04762680|526980643|FG001|Phase 2|Adverse Event|1|||
146125556|NCT04762680|526980644|FG002|Phase 2|Adverse Event|0|||
146125557|NCT04762680|526980645|FG003|Phase 2|Adverse Event|0|||
146125558|NCT04762680|526980646|FG004|Phase 2|Adverse Event|0|||
146125559|NCT04762680|526980647|FG005|Phase 2|Adverse Event|0|||
146125560|NCT04762680|526980648|FG006|Phase 2|Adverse Event|0|||
146125561|NCT04762680|526980649|FG007|Phase 2|Adverse Event|0|||
146125562|NCT04762680|526980650|FG008|Phase 2|Adverse Event|0|||
146125563|NCT04762680|526980651|FG009|Phase 2|Adverse Event|0|||
146125564|NCT04762680|526980652|FG010|Phase 2|Adverse Event|0|||
146125565|NCT04762680|526980653|FG011|Phase 2|Adverse Event|0|||
146125566|NCT04762680|526980654|FG012|Phase 2|Adverse Event|0|||
146125567|NCT04762680|526980655|FG013|Phase 2|Adverse Event|0|||
146125568|NCT04762680|526980656|FG014|Phase 2|Adverse Event|0|||
146125569|NCT04762680|526980657|FG015|Phase 2|Adverse Event|0|||
146125570|NCT04762680|526980658|FG016|Phase 2|Adverse Event|0|||
146125571|NCT04762680|526980659|FG017|Phase 2|Adverse Event|0|||
146125572|NCT04762680|526980660|FG018|Phase 2|Adverse Event|0|||
146125573|NCT04762680|526980661|FG019|Phase 2|Adverse Event|0|||
146125574|NCT04762680|526980662|FG020|Phase 2|Adverse Event|0|||
146125575|NCT04762680|526980663|FG021|Phase 2|Adverse Event|0|||
146125576|NCT04762680|526980642|FG000|Phase 2|Protocol Violation|5|||
146125577|NCT04762680|526980643|FG001|Phase 2|Protocol Violation|5|||
146125578|NCT04762680|526980644|FG002|Phase 2|Protocol Violation|1|||
146125579|NCT04762680|526980645|FG003|Phase 2|Protocol Violation|0|||
146125580|NCT04762680|526980646|FG004|Phase 2|Protocol Violation|0|||
146125581|NCT04762680|526980647|FG005|Phase 2|Protocol Violation|0|||
146125582|NCT04762680|526980648|FG006|Phase 2|Protocol Violation|0|||
146125583|NCT04762680|526980649|FG007|Phase 2|Protocol Violation|0|||
146125584|NCT04762680|526980650|FG008|Phase 2|Protocol Violation|0|||
146125585|NCT04762680|526980651|FG009|Phase 2|Protocol Violation|0|||
146125586|NCT04762680|526980652|FG010|Phase 2|Protocol Violation|0|||
146125587|NCT04762680|526980653|FG011|Phase 2|Protocol Violation|0|||
146125588|NCT04762680|526980654|FG012|Phase 2|Protocol Violation|0|||
146125589|NCT04762680|526980655|FG013|Phase 2|Protocol Violation|0|||
146125590|NCT04762680|526980656|FG014|Phase 2|Protocol Violation|0|||
146125591|NCT04762680|526980657|FG015|Phase 2|Protocol Violation|0|||
146125592|NCT04762680|526980658|FG016|Phase 2|Protocol Violation|0|||
146125593|NCT04762680|526980659|FG017|Phase 2|Protocol Violation|0|||
146125594|NCT04762680|526980660|FG018|Phase 2|Protocol Violation|0|||
146125595|NCT04762680|526980661|FG019|Phase 2|Protocol Violation|0|||
146125596|NCT04762680|526980662|FG020|Phase 2|Protocol Violation|0|||
146125597|NCT04762680|526980663|FG021|Phase 2|Protocol Violation|0|||
146125598|NCT04762680|526980642|FG000|Phase 2|Withdrawal by Subject|23|||
146125599|NCT04762680|526980643|FG001|Phase 2|Withdrawal by Subject|21|||
146125600|NCT04762680|526980644|FG002|Phase 2|Withdrawal by Subject|28|||
146125601|NCT04762680|526980645|FG003|Phase 2|Withdrawal by Subject|0|||
146262598|NCT01747837|527476476|FG000|Overall Study|Death|4|||
146262599|NCT01747837|527476477|FG001|Overall Study|Death|4|||
146125602|NCT04762680|526980646|FG004|Phase 2|Withdrawal by Subject|0|||
146125603|NCT04762680|526980647|FG005|Phase 2|Withdrawal by Subject|0|||
146262600|NCT00817336|527476479|FG000|Overall Study|Withdrawal by Subject|1|||
146262601|NCT00817336|527476480|FG001|Overall Study|Withdrawal by Subject|1|||
146125604|NCT04762680|526980648|FG006|Phase 2|Withdrawal by Subject|0|||
146125605|NCT04762680|526980649|FG007|Phase 2|Withdrawal by Subject|0|||
146125606|NCT04762680|526980650|FG008|Phase 2|Withdrawal by Subject|0|||
146125607|NCT04762680|526980651|FG009|Phase 2|Withdrawal by Subject|0|||
146262602|NCT01435798|527476481|FG000|Overall Study|Withdrawal by Subject|1|||
146262603|NCT00690378|527476488|FG000|Overall Study|Adverse Event|1|||
146125608|NCT04762680|526980652|FG010|Phase 2|Withdrawal by Subject|0|||
146125609|NCT04762680|526980653|FG011|Phase 2|Withdrawal by Subject|0|||
146125610|NCT04762680|526980654|FG012|Phase 2|Withdrawal by Subject|0|||
146125611|NCT04762680|526980655|FG013|Phase 2|Withdrawal by Subject|0|||
146125612|NCT04762680|526980656|FG014|Phase 2|Withdrawal by Subject|0|||
146125613|NCT04762680|526980657|FG015|Phase 2|Withdrawal by Subject|0|||
146125614|NCT04762680|526980658|FG016|Phase 2|Withdrawal by Subject|0|||
146262604|NCT00690378|527476489|FG001|Overall Study|Adverse Event|0|||
146125615|NCT04762680|526980659|FG017|Phase 2|Withdrawal by Subject|0|||
146125616|NCT04762680|526980660|FG018|Phase 2|Withdrawal by Subject|0|||
146125617|NCT04762680|526980661|FG019|Phase 2|Withdrawal by Subject|0|||
146125618|NCT04762680|526980662|FG020|Phase 2|Withdrawal by Subject|0|||
146125619|NCT04762680|526980663|FG021|Phase 2|Withdrawal by Subject|0|||
146125620|NCT04762680|526980642|FG000|Phase 2|Lost to Follow-up|14|||
146125621|NCT04762680|526980643|FG001|Phase 2|Lost to Follow-up|8|||
146125622|NCT04762680|526980644|FG002|Phase 2|Lost to Follow-up|9|||
146125623|NCT04762680|526980645|FG003|Phase 2|Lost to Follow-up|0|||
146125624|NCT04762680|526980646|FG004|Phase 2|Lost to Follow-up|0|||
146125625|NCT04762680|526980647|FG005|Phase 2|Lost to Follow-up|0|||
146125626|NCT04762680|526980648|FG006|Phase 2|Lost to Follow-up|0|||
146125627|NCT04762680|526980649|FG007|Phase 2|Lost to Follow-up|0|||
146125628|NCT04762680|526980650|FG008|Phase 2|Lost to Follow-up|0|||
146125629|NCT04762680|526980651|FG009|Phase 2|Lost to Follow-up|0|||
146125630|NCT04762680|526980652|FG010|Phase 2|Lost to Follow-up|0|||
146125631|NCT04762680|526980653|FG011|Phase 2|Lost to Follow-up|0|||
146125632|NCT04762680|526980654|FG012|Phase 2|Lost to Follow-up|0|||
146125633|NCT04762680|526980655|FG013|Phase 2|Lost to Follow-up|0|||
146125634|NCT04762680|526980656|FG014|Phase 2|Lost to Follow-up|0|||
146125635|NCT04762680|526980657|FG015|Phase 2|Lost to Follow-up|0|||
146125636|NCT04762680|526980658|FG016|Phase 2|Lost to Follow-up|0|||
146125637|NCT04762680|526980659|FG017|Phase 2|Lost to Follow-up|0|||
146125638|NCT04762680|526980660|FG018|Phase 2|Lost to Follow-up|0|||
146125639|NCT04762680|526980661|FG019|Phase 2|Lost to Follow-up|0|||
146125640|NCT04762680|526980662|FG020|Phase 2|Lost to Follow-up|0|||
146125641|NCT04762680|526980663|FG021|Phase 2|Lost to Follow-up|0|||
146125642|NCT04762680|526980642|FG000|Phase 3|Adverse Event|0|||
146125643|NCT04762680|526980643|FG001|Phase 3|Adverse Event|0|||
146125644|NCT04762680|526980644|FG002|Phase 3|Adverse Event|0|||
146125645|NCT04762680|526980645|FG003|Phase 3|Adverse Event|1|||
146125646|NCT04762680|526980646|FG004|Phase 3|Adverse Event|0|||
146125647|NCT04762680|526980647|FG005|Phase 3|Adverse Event|0|||
146125648|NCT04762680|526980648|FG006|Phase 3|Adverse Event|0|||
146125649|NCT04762680|526980649|FG007|Phase 3|Adverse Event|0|||
146125650|NCT04762680|526980650|FG008|Phase 3|Adverse Event|0|||
146125651|NCT04762680|526980651|FG009|Phase 3|Adverse Event|0|||
146125652|NCT04762680|526980652|FG010|Phase 3|Adverse Event|0|||
146125653|NCT04762680|526980653|FG011|Phase 3|Adverse Event|0|||
146125654|NCT04762680|526980654|FG012|Phase 3|Adverse Event|0|||
146125655|NCT04762680|526980655|FG013|Phase 3|Adverse Event|0|||
146125656|NCT04762680|526980656|FG014|Phase 3|Adverse Event|0|||
146125657|NCT04762680|526980657|FG015|Phase 3|Adverse Event|0|||
146125658|NCT04762680|526980658|FG016|Phase 3|Adverse Event|0|||
146125659|NCT04762680|526980659|FG017|Phase 3|Adverse Event|3|||
146125660|NCT04762680|526980660|FG018|Phase 3|Adverse Event|0|||
146125661|NCT04762680|526980661|FG019|Phase 3|Adverse Event|0|||
146125662|NCT04762680|526980662|FG020|Phase 3|Adverse Event|0|||
146125663|NCT04762680|526980663|FG021|Phase 3|Adverse Event|0|||
146125664|NCT04762680|526980642|FG000|Phase 3|Protocol Violation|0|||
146125665|NCT04762680|526980643|FG001|Phase 3|Protocol Violation|0|||
146125666|NCT04762680|526980644|FG002|Phase 3|Protocol Violation|0|||
146125667|NCT04762680|526980645|FG003|Phase 3|Protocol Violation|4|||
146125668|NCT04762680|526980646|FG004|Phase 3|Protocol Violation|1|||
146125669|NCT04762680|526980647|FG005|Phase 3|Protocol Violation|5|||
146125670|NCT04762680|526980648|FG006|Phase 3|Protocol Violation|1|||
146125671|NCT04762680|526980649|FG007|Phase 3|Protocol Violation|0|||
146125672|NCT04762680|526980650|FG008|Phase 3|Protocol Violation|0|||
146125673|NCT04762680|526980651|FG009|Phase 3|Protocol Violation|0|||
146125674|NCT04762680|526980652|FG010|Phase 3|Protocol Violation|0|||
146125675|NCT04762680|526980653|FG011|Phase 3|Protocol Violation|2|||
146125676|NCT04762680|526980654|FG012|Phase 3|Protocol Violation|3|||
146125677|NCT04762680|526980655|FG013|Phase 3|Protocol Violation|0|||
146125678|NCT04762680|526980656|FG014|Phase 3|Protocol Violation|0|||
146125679|NCT04762680|526980657|FG015|Phase 3|Protocol Violation|1|||
146125680|NCT04762680|526980658|FG016|Phase 3|Protocol Violation|0|||
146125681|NCT04762680|526980659|FG017|Phase 3|Protocol Violation|10|||
146125682|NCT04762680|526980660|FG018|Phase 3|Protocol Violation|0|||
146125683|NCT04762680|526980661|FG019|Phase 3|Protocol Violation|0|||
146125684|NCT04762680|526980662|FG020|Phase 3|Protocol Violation|0|||
146125685|NCT04762680|526980663|FG021|Phase 3|Protocol Violation|0|||
146125686|NCT04762680|526980642|FG000|Phase 3|Withdrawal by Subject|0|||
146125687|NCT04762680|526980643|FG001|Phase 3|Withdrawal by Subject|0|||
146125688|NCT04762680|526980644|FG002|Phase 3|Withdrawal by Subject|0|||
146125689|NCT04762680|526980645|FG003|Phase 3|Withdrawal by Subject|13|||
146125690|NCT04762680|526980646|FG004|Phase 3|Withdrawal by Subject|17|||
146125691|NCT04762680|526980647|FG005|Phase 3|Withdrawal by Subject|12|||
146125692|NCT04762680|526980648|FG006|Phase 3|Withdrawal by Subject|8|||
146125693|NCT04762680|526980649|FG007|Phase 3|Withdrawal by Subject|3|||
146125694|NCT04762680|526980650|FG008|Phase 3|Withdrawal by Subject|2|||
146125695|NCT04762680|526980651|FG009|Phase 3|Withdrawal by Subject|4|||
146125696|NCT04762680|526980652|FG010|Phase 3|Withdrawal by Subject|3|||
146125697|NCT04762680|526980653|FG011|Phase 3|Withdrawal by Subject|1|||
146125698|NCT04762680|526980654|FG012|Phase 3|Withdrawal by Subject|3|||
146125699|NCT04762680|526980655|FG013|Phase 3|Withdrawal by Subject|2|||
146125700|NCT04762680|526980656|FG014|Phase 3|Withdrawal by Subject|1|||
146125701|NCT04762680|526980657|FG015|Phase 3|Withdrawal by Subject|4|||
146125702|NCT04762680|526980658|FG016|Phase 3|Withdrawal by Subject|6|||
146125703|NCT04762680|526980659|FG017|Phase 3|Withdrawal by Subject|32|||
146125704|NCT04762680|526980660|FG018|Phase 3|Withdrawal by Subject|0|||
146125705|NCT04762680|526980661|FG019|Phase 3|Withdrawal by Subject|0|||
146125706|NCT04762680|526980662|FG020|Phase 3|Withdrawal by Subject|0|||
146125707|NCT04762680|526980663|FG021|Phase 3|Withdrawal by Subject|0|||
146125708|NCT04762680|526980642|FG000|Phase 3|Lost to Follow-up|0|||
146125709|NCT04762680|526980643|FG001|Phase 3|Lost to Follow-up|0|||
146125710|NCT04762680|526980644|FG002|Phase 3|Lost to Follow-up|0|||
146125711|NCT04762680|526980645|FG003|Phase 3|Lost to Follow-up|9|||
146125712|NCT04762680|526980646|FG004|Phase 3|Lost to Follow-up|22|||
146125713|NCT04762680|526980647|FG005|Phase 3|Lost to Follow-up|24|||
146125714|NCT04762680|526980648|FG006|Phase 3|Lost to Follow-up|2|||
146125715|NCT04762680|526980649|FG007|Phase 3|Lost to Follow-up|4|||
146125716|NCT04762680|526980650|FG008|Phase 3|Lost to Follow-up|6|||
146125717|NCT04762680|526980651|FG009|Phase 3|Lost to Follow-up|4|||
146125718|NCT04762680|526980652|FG010|Phase 3|Lost to Follow-up|3|||
146125719|NCT04762680|526980653|FG011|Phase 3|Lost to Follow-up|0|||
146125720|NCT04762680|526980654|FG012|Phase 3|Lost to Follow-up|5|||
146125721|NCT04762680|526980655|FG013|Phase 3|Lost to Follow-up|4|||
146125722|NCT04762680|526980656|FG014|Phase 3|Lost to Follow-up|6|||
146125723|NCT04762680|526980657|FG015|Phase 3|Lost to Follow-up|1|||
146125724|NCT04762680|526980658|FG016|Phase 3|Lost to Follow-up|1|||
146125725|NCT04762680|526980659|FG017|Phase 3|Lost to Follow-up|66|||
146125726|NCT04762680|526980660|FG018|Phase 3|Lost to Follow-up|0|||
146125727|NCT04762680|526980661|FG019|Phase 3|Lost to Follow-up|0|||
146125728|NCT04762680|526980662|FG020|Phase 3|Lost to Follow-up|0|||
146125729|NCT04762680|526980663|FG021|Phase 3|Lost to Follow-up|0|||
146125730|NCT04762680|526980642|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125731|NCT04762680|526980643|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125732|NCT04762680|526980644|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125733|NCT04762680|526980645|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125734|NCT04762680|526980646|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125735|NCT04762680|526980647|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125736|NCT04762680|526980648|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125737|NCT04762680|526980649|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125738|NCT04762680|526980650|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125739|NCT04762680|526980651|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125740|NCT04762680|526980652|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125741|NCT04762680|526980653|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125742|NCT04762680|526980654|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125743|NCT04762680|526980655|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125744|NCT04762680|526980656|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125745|NCT04762680|526980657|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125746|NCT04762680|526980658|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125747|NCT04762680|526980659|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125748|NCT04762680|526980660|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125749|NCT04762680|526980661|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125750|NCT04762680|526980662|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
146125751|NCT04762680|526980663|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
146125752|NCT04762680|526980642|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125753|NCT04762680|526980643|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125754|NCT04762680|526980644|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125755|NCT04762680|526980645|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125756|NCT04762680|526980646|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125757|NCT04762680|526980647|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125758|NCT04762680|526980648|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125759|NCT04762680|526980649|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125760|NCT04762680|526980650|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125761|NCT04762680|526980651|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125762|NCT04762680|526980652|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125763|NCT04762680|526980653|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125764|NCT04762680|526980654|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125765|NCT04762680|526980655|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125766|NCT04762680|526980656|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125767|NCT04762680|526980657|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125768|NCT04762680|526980658|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125769|NCT04762680|526980659|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125770|NCT04762680|526980660|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125771|NCT04762680|526980661|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
146125772|NCT04762680|526980662|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125773|NCT04762680|526980663|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
146125774|NCT01727141|526980668|FG000|Overall Study|Physician Decision|0|||
146125775|NCT01727141|526980669|FG001|Overall Study|Physician Decision|1|||
146125776|NCT01727141|526980670|FG002|Overall Study|Physician Decision|0|||
146125777|NCT01727141|526980671|FG003|Overall Study|Physician Decision|2|||
146125778|NCT01727141|526980668|FG000|Overall Study|Lost to Follow-up|0|||
146125779|NCT01727141|526980669|FG001|Overall Study|Lost to Follow-up|2|||
146125780|NCT01727141|526980670|FG002|Overall Study|Lost to Follow-up|0|||
146125781|NCT01727141|526980671|FG003|Overall Study|Lost to Follow-up|0|||
146125782|NCT01727141|526980668|FG000|Overall Study|Death|0|||
146125783|NCT01727141|526980669|FG001|Overall Study|Death|1|||
146125784|NCT01727141|526980670|FG002|Overall Study|Death|1|||
146125785|NCT01727141|526980671|FG003|Overall Study|Death|1|||
146125786|NCT01727141|526980668|FG000|Overall Study|Protocol deviation|1|||
146125787|NCT01727141|526980669|FG001|Overall Study|Protocol deviation|1|||
146125788|NCT01727141|526980670|FG002|Overall Study|Protocol deviation|0|||
146125789|NCT01727141|526980671|FG003|Overall Study|Protocol deviation|1|||
146125790|NCT01727141|526980668|FG000|Overall Study|Withdrawal by Subject|4|||
146125791|NCT01727141|526980669|FG001|Overall Study|Withdrawal by Subject|4|||
146125792|NCT01727141|526980670|FG002|Overall Study|Withdrawal by Subject|2|||
146125793|NCT01727141|526980671|FG003|Overall Study|Withdrawal by Subject|11|||
146125794|NCT02584504|526980672|FG000|Double-blind Treatment|Participant withdrew consent|0|||
146125795|NCT02584504|526980673|FG001|Double-blind Treatment|Participant withdrew consent|0|||
146125796|NCT02584504|526980674|FG002|Double-blind Treatment|Participant withdrew consent|1|||
146125797|NCT02584504|526980672|FG000|Double-blind Treatment|Adverse Event|0|||
146125798|NCT02584504|526980673|FG001|Double-blind Treatment|Adverse Event|1|||
146125799|NCT02584504|526980674|FG002|Double-blind Treatment|Adverse Event|0|||
146125800|NCT02584504|526980672|FG000|Double-blind Treatment|Family Matter|0|||
146125801|NCT02584504|526980673|FG001|Double-blind Treatment|Family Matter|1|||
146125802|NCT02584504|526980674|FG002|Double-blind Treatment|Family Matter|0|||
146125803|NCT02584504|526980672|FG000|Open-label Treatment|Participant withdrew consent|0|||
146125804|NCT02584504|526980673|FG001|Open-label Treatment|Participant withdrew consent|0|||
146125805|NCT02584504|526980674|FG002|Open-label Treatment|Participant withdrew consent|4|||
146125806|NCT02584504|526980672|FG000|Open-label Treatment|Adverse Event|2|||
146125807|NCT02584504|526980673|FG001|Open-label Treatment|Adverse Event|2|||
146125808|NCT02584504|526980674|FG002|Open-label Treatment|Adverse Event|3|||
146125809|NCT02584504|526980672|FG000|Open-label Treatment|Physician Decision|0|||
146125810|NCT02584504|526980673|FG001|Open-label Treatment|Physician Decision|1|||
146125811|NCT02584504|526980674|FG002|Open-label Treatment|Physician Decision|0|||
146125812|NCT02584504|526980672|FG000|Open-label Treatment|Entered but not treated|0|||
146125813|NCT02584504|526980673|FG001|Open-label Treatment|Entered but not treated|1|||
146125814|NCT02584504|526980674|FG002|Open-label Treatment|Entered but not treated|1|||
146125815|NCT03425331|526980675|FG000|Overall Study|Withdrawal by Subject|1|||
146125816|NCT03425331|526980675|FG000|Overall Study|Death|1|||
146125817|NCT03425331|526980675|FG000|Overall Study|Adverse Event|1|||
146125818|NCT03425331|526980675|FG000|Overall Study|Disease Progression|2|||
146125819|NCT01413360|526980678|FG000|Overall Study|Lost to Follow-up|2|||
146125820|NCT01413360|526980678|FG000|Overall Study|Adverse Event|1|||
146125821|NCT02246673|526980679|FG000|Overall Study|Sponsor Decision|1|||
146125822|NCT02246673|526980680|FG001|Overall Study|Sponsor Decision|0|||
146125823|NCT02246673|526980681|FG002|Overall Study|Sponsor Decision|0|||
146125824|NCT02246673|526980682|FG003|Overall Study|Sponsor Decision|0|||
146125825|NCT02246673|526980683|FG004|Overall Study|Sponsor Decision|0|||
146125826|NCT02246673|526980679|FG000|Overall Study|Withdrawal by Subject|0|||
146125827|NCT02246673|526980680|FG001|Overall Study|Withdrawal by Subject|0|||
146125828|NCT02246673|526980681|FG002|Overall Study|Withdrawal by Subject|0|||
146125829|NCT02246673|526980682|FG003|Overall Study|Withdrawal by Subject|0|||
146125830|NCT02246673|526980683|FG004|Overall Study|Withdrawal by Subject|1|||
146125831|NCT02246673|526980679|FG000|Overall Study|Lost to Follow-up|0|||
146125832|NCT02246673|526980680|FG001|Overall Study|Lost to Follow-up|0|||
146125833|NCT02246673|526980681|FG002|Overall Study|Lost to Follow-up|0|||
146125834|NCT02246673|526980682|FG003|Overall Study|Lost to Follow-up|1|||
146125835|NCT02246673|526980683|FG004|Overall Study|Lost to Follow-up|0|||
146125836|NCT02246673|526980679|FG000|Overall Study|Protocol Violation|0|||
146125837|NCT02246673|526980680|FG001|Overall Study|Protocol Violation|0|||
146125838|NCT02246673|526980681|FG002|Overall Study|Protocol Violation|0|||
146125839|NCT02246673|526980682|FG003|Overall Study|Protocol Violation|1|||
146125840|NCT02246673|526980683|FG004|Overall Study|Protocol Violation|0|||
146125841|NCT02488681|526980685|FG000|Overall Study|Implant unsuccessful|7|||
146125842|NCT05413369|526980686|FG000|Overall Study|Adverse Event|1|||
146125843|NCT05413369|526980687|FG001|Overall Study|Adverse Event|1|||
146125844|NCT05413369|526980686|FG000|Overall Study|Withdrawal by Subject|13|||
146125845|NCT05413369|526980687|FG001|Overall Study|Withdrawal by Subject|4|||
146125846|NCT05413369|526980686|FG000|Overall Study|Non-compliance with study schedule|2|||
146125847|NCT05413369|526980687|FG001|Overall Study|Non-compliance with study schedule|1|||
146125848|NCT05413369|526980686|FG000|Overall Study|Other|1|||
146125849|NCT05413369|526980687|FG001|Overall Study|Other|1|||
146125850|NCT00720057|526980688|FG000|Overall Study|Lost to Follow-up|0|||
146125851|NCT00720057|526980689|FG001|Overall Study|Lost to Follow-up|2|||
146125852|NCT00720057|526980688|FG000|Overall Study|Protocol Violation|1|||
146125853|NCT00720057|526980689|FG001|Overall Study|Protocol Violation|0|||
146125854|NCT00720057|526980688|FG000|Overall Study|Withdrawal by Subject|0|||
146125855|NCT00720057|526980689|FG001|Overall Study|Withdrawal by Subject|1|||
146125856|NCT00579826|526980694|FG000|Overall Study|Withdrawal by Subject|5|||
146262605|NCT00690378|527476488|FG000|Overall Study|Withdrawal by Subject|2|||
146262606|NCT00690378|527476489|FG001|Overall Study|Withdrawal by Subject|0|||
146262607|NCT00690378|527476488|FG000|Overall Study|Protocol Violation|1|||
146262608|NCT00690378|527476489|FG001|Overall Study|Protocol Violation|0|||
146262609|NCT00690378|527476488|FG000|Overall Study|Lost to Follow-up|2|||
146262610|NCT00690378|527476489|FG001|Overall Study|Lost to Follow-up|3|||
146262611|NCT00690378|527476488|FG000|Overall Study|Did not meet inc/exc criteria|13|||
146262612|NCT00690378|527476489|FG001|Overall Study|Did not meet inc/exc criteria|11|||
146262613|NCT00690378|527476488|FG000|Overall Study|Social problem|1|||
146262614|NCT00690378|527476489|FG001|Overall Study|Social problem|0|||
146262615|NCT02019641|527476490|FG000|10-Week Follow up|Withdrawal by investigator|2|||
146262616|NCT02019641|527476491|FG001|10-Week Follow up|Withdrawal by investigator|0|||
146262617|NCT02019641|527476492|FG002|10-Week Follow up|Withdrawal by investigator|0|||
146262618|NCT02019641|527476490|FG000|10-Week Follow up|Withdrawal by Subject|1|||
146262619|NCT02019641|527476491|FG001|10-Week Follow up|Withdrawal by Subject|1|||
146262620|NCT02019641|527476492|FG002|10-Week Follow up|Withdrawal by Subject|0|||
146262621|NCT02019641|527476490|FG000|20-Week Follow up|Withdrawal by investigator|0|||
146262622|NCT02019641|527476491|FG001|20-Week Follow up|Withdrawal by investigator|0|||
146262623|NCT02019641|527476492|FG002|20-Week Follow up|Withdrawal by investigator|1|||
146262624|NCT00935259|527476493|FG000|Period 1|Administrative (scheduling conflict)|1|||
146262625|NCT00935259|527476494|FG001|Period 1|Administrative (scheduling conflict)|1|||
146262626|NCT03318783|527476495|FG000|Overall Study|Withdrawal by Subject|0|||
146262627|NCT03318783|527476496|FG001|Overall Study|Withdrawal by Subject|1|||
146262628|NCT03318783|527476495|FG000|Overall Study|Death|0|||
146125857|NCT00579826|526980695|FG001|Overall Study|Withdrawal by Subject|3|||
146125858|NCT00304356|526980697|FG000|Nitazoxanide|Physician Decision|5|||
146125859|NCT00304356|526980697|FG000|Nitazoxanide|Physician Decision|1|||
146125860|NCT00304356|526980697|FG000|Nitazoxanide|number is 0|1|||
146125861|NCT00304356|526980697|FG000|Nitazoxanide|Physician Decision|1|||
146125862|NCT00304356|526980697|FG000|Nitazoxanide|Physician Decision|1|||
146125863|NCT00304356|526980697|FG000|Nitazoxanide|Physician Decision|1|||
146125864|NCT04120974|526980701|FG000|Overall Study|Death|1|||
146125865|NCT04120974|526980701|FG000|Overall Study|Physician Decision|1|||
146125866|NCT04120974|526980701|FG000|Overall Study|Lost to Follow-up|6|||
146125867|NCT00973479|526980704|FG000|Overall Study|Lost to Follow-up|0|||
146125868|NCT00973479|526980705|FG001|Overall Study|Lost to Follow-up|3|||
146125869|NCT00973479|526980704|FG000|Overall Study|Death|2|||
146125870|NCT00973479|526980705|FG001|Overall Study|Death|2|||
146125871|NCT00973479|526980704|FG000|Overall Study|Withdrawal by Subject|15|||
146125872|NCT00973479|526980705|FG001|Overall Study|Withdrawal by Subject|16|||
146125873|NCT00973479|526980704|FG000|Overall Study|Lack of Efficacy|5|||
146125874|NCT00973479|526980705|FG001|Overall Study|Lack of Efficacy|7|||
146125875|NCT00973479|526980704|FG000|Overall Study|Adverse Event|12|||
146125876|NCT00973479|526980705|FG001|Overall Study|Adverse Event|32|||
146125877|NCT00973479|526980704|FG000|Overall Study|Protocol Violation|2|||
146125878|NCT00973479|526980705|FG001|Overall Study|Protocol Violation|2|||
146125879|NCT00973479|526980704|FG000|Overall Study|Other|1|||
146125880|NCT00973479|526980705|FG001|Overall Study|Other|7|||
146125881|NCT05075850|526980706|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
146125882|NCT04256785|526980707|FG000|Overall Study|Adverse Event|8|||
146125883|NCT04256785|526980708|FG001|Overall Study|Adverse Event|6|||
146125884|NCT04256785|526980707|FG000|Overall Study|Lack of Efficacy|3|||
146125885|NCT04256785|526980708|FG001|Overall Study|Lack of Efficacy|4|||
146125886|NCT04256785|526980707|FG000|Overall Study|Lost to Follow-up|7|||
146125887|NCT04256785|526980708|FG001|Overall Study|Lost to Follow-up|7|||
146125888|NCT04256785|526980707|FG000|Overall Study|Protocol Violation|1|||
146125889|NCT04256785|526980708|FG001|Overall Study|Protocol Violation|0|||
146125890|NCT04256785|526980707|FG000|Overall Study|Withdrawal by Subject|4|||
146262629|NCT03318783|527476496|FG001|Overall Study|Death|1|||
146262630|NCT03856047|527476499|FG000|Overall Study|Withdrawal by Subject|0|||
146125891|NCT04256785|526980708|FG001|Overall Study|Withdrawal by Subject|1|||
146125892|NCT04256785|526980707|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
146125893|NCT04256785|526980708|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
146125894|NCT01265849|526980709|FG000|Overall Study|Randomized//Treatment not initiated|1|||
146262631|NCT03856047|527476500|FG001|Overall Study|Withdrawal by Subject|1|||
146262632|NCT03856047|527476501|FG002|Overall Study|Withdrawal by Subject|1|||
146125895|NCT01265849|526980710|FG001|Overall Study|Randomized//Treatment not initiated|4|||
146125896|NCT01265849|526980711|FG002|Overall Study|Randomized//Treatment not initiated|0|||
146125897|NCT01265849|526980709|FG000|Overall Study|Physician Decision|1|||
146262633|NCT03856047|527476502|FG003|Overall Study|Withdrawal by Subject|0|||
146262634|NCT03856047|527476503|FG004|Overall Study|Withdrawal by Subject|3|||
146262635|NCT03856047|527476504|FG005|Overall Study|Withdrawal by Subject|0|||
146262636|NCT03856047|527476505|FG006|Overall Study|Withdrawal by Subject|2|||
146262637|NCT03856047|527476499|FG000|Overall Study|Lost to Follow-up|4|||
146262638|NCT03856047|527476500|FG001|Overall Study|Lost to Follow-up|2|||
146303350|NCT00915772|527625745|FG001|Overall Study|Protocol Violation|1|||
146262639|NCT03856047|527476501|FG002|Overall Study|Lost to Follow-up|3|||
146262640|NCT03856047|527476502|FG003|Overall Study|Lost to Follow-up|1|||
146262641|NCT03856047|527476503|FG004|Overall Study|Lost to Follow-up|4|||
146262642|NCT03856047|527476504|FG005|Overall Study|Lost to Follow-up|4|||
146262643|NCT03856047|527476505|FG006|Overall Study|Lost to Follow-up|4|||
146125898|NCT01265849|526980710|FG001|Overall Study|Physician Decision|2|||
146125899|NCT01265849|526980711|FG002|Overall Study|Physician Decision|0|||
146125900|NCT01265849|526980709|FG000|Overall Study|Lost to Follow-up|18|||
146125901|NCT01265849|526980710|FG001|Overall Study|Lost to Follow-up|15|||
146125902|NCT01265849|526980711|FG002|Overall Study|Lost to Follow-up|5|||
146125903|NCT01265849|526980709|FG000|Overall Study|Not otherwise specified|1|||
146125904|NCT01265849|526980710|FG001|Overall Study|Not otherwise specified|6|||
146125905|NCT01265849|526980711|FG002|Overall Study|Not otherwise specified|1|||
146125906|NCT01265849|526980709|FG000|Overall Study|Withdrawal by Subject|25|||
146125907|NCT01265849|526980710|FG001|Overall Study|Withdrawal by Subject|34|||
146125908|NCT01265849|526980711|FG002|Overall Study|Withdrawal by Subject|13|||
146125909|NCT01170091|526980713|FG000|Overall Study|Missing efficacy evaluation|3|||
146125910|NCT01170091|526980713|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
146125911|NCT03194321|526980714|FG000|Overall Study|Withdrawal by Subject|1|||
146262644|NCT03410108|527476506|FG000|Overall Study|Ongoing|41|||
146125912|NCT03194321|526980714|FG000|Overall Study|Lost to Follow-up|1|||
146125913|NCT03194321|526980714|FG000|Overall Study|Travel for Follow-up|1|||
146125914|NCT00271609|526980715|FG000|Overall Study|Adverse Event|11|||
146125915|NCT00271609|526980716|FG001|Overall Study|Adverse Event|3|||
146125916|NCT00271609|526980715|FG000|Overall Study|Withdrawal by Subject|2|||
146125917|NCT00271609|526980716|FG001|Overall Study|Withdrawal by Subject|0|||
146125918|NCT02188589|526980717|FG000|Overall Study|Withdrawal by Subject|5|||
146125919|NCT03341533|526980718|FG000|Overall Study|Withdrawal by Subject|1|||
146125920|NCT03341533|526980719|FG001|Overall Study|Withdrawal by Subject|1|||
146125921|NCT03341533|526980718|FG000|Overall Study|Not eligible after randomization|2|||
146125922|NCT03341533|526980719|FG001|Overall Study|Not eligible after randomization|1|||
146125923|NCT01675128|526980720|FG000|Overall Study|Disease progression on study|1|||
146125924|NCT01675128|526980721|FG001|Overall Study|Disease progression on study|1|||
146125925|NCT01675128|526980722|FG002|Overall Study|Disease progression on study|1|||
146125926|NCT01675128|526980720|FG000|Overall Study|Refused further treatment|1|||
146125927|NCT01675128|526980721|FG001|Overall Study|Refused further treatment|0|||
146125928|NCT01675128|526980722|FG002|Overall Study|Refused further treatment|0|||
146125929|NCT01675128|526980720|FG000|Overall Study|Pulmonary complication; off study|0|||
146125930|NCT01675128|526980721|FG001|Overall Study|Pulmonary complication; off study|1|||
146125931|NCT01675128|526980722|FG002|Overall Study|Pulmonary complication; off study|0|||
146125932|NCT03526458|526980723|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
146125933|NCT03526458|526980724|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
146125934|NCT03526458|526980723|FG000|Overall Study|Stone passed, surgery cancelled|2|||
146125935|NCT03526458|526980724|FG001|Overall Study|Stone passed, surgery cancelled|1|||
146125936|NCT03526458|526980723|FG000|Overall Study|Withdrawal by Subject|1|||
146125937|NCT03526458|526980724|FG001|Overall Study|Withdrawal by Subject|0|||
146125938|NCT03526458|526980723|FG000|Overall Study|Physician Decision|2|||
146125939|NCT03526458|526980724|FG001|Overall Study|Physician Decision|1|||
146125940|NCT03526458|526980723|FG000|Overall Study|Lack of equipment|1|||
146125941|NCT03526458|526980724|FG001|Overall Study|Lack of equipment|1|||
146125942|NCT03011307|526980725|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
146125943|NCT03011307|526980726|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
146125944|NCT03011307|526980725|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
146125945|NCT03011307|526980726|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
146125946|NCT03011307|526980725|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
146125947|NCT03011307|526980726|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
146125948|NCT01782664|526980727|FG000|Overall Study|Adverse Event|2|||
146125949|NCT01782664|526980728|FG001|Overall Study|Adverse Event|2|||
146125950|NCT01782664|526980729|FG002|Overall Study|Adverse Event|2|||
146125951|NCT01782664|526980730|FG003|Overall Study|Adverse Event|2|||
146262645|NCT03410108|527476506|FG000|Overall Study|Adverse Event|4|||
146125952|NCT01782664|526980731|FG004|Overall Study|Adverse Event|0|||
146125953|NCT01782664|526980732|FG005|Overall Study|Adverse Event|0|||
146125954|NCT01782664|526980727|FG000|Overall Study|Lack of Efficacy|2|||
146125955|NCT01782664|526980728|FG001|Overall Study|Lack of Efficacy|0|||
146125956|NCT01782664|526980729|FG002|Overall Study|Lack of Efficacy|2|||
146262646|NCT03410108|527476506|FG000|Overall Study|Progressive Disease|58|||
146262647|NCT03410108|527476506|FG000|Overall Study|Withdrawal by Subject|1|||
146262648|NCT01721746|527476511|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
146262649|NCT01721746|527476512|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
146262650|NCT01721746|527476511|FG000|Pre-Treatment|Withdrawal by Subject|1|||
146262651|NCT01721746|527476512|FG001|Pre-Treatment|Withdrawal by Subject|16|||
146262652|NCT01721746|527476511|FG000|Pre-Treatment|Poor/Non-compliance|1|||
146125957|NCT01782664|526980730|FG003|Overall Study|Lack of Efficacy|2|||
146125958|NCT01782664|526980731|FG004|Overall Study|Lack of Efficacy|0|||
146125959|NCT01782664|526980732|FG005|Overall Study|Lack of Efficacy|0|||
146125960|NCT01782664|526980727|FG000|Overall Study|Protocol Violation|0|||
146125961|NCT01782664|526980728|FG001|Overall Study|Protocol Violation|1|||
146125962|NCT01782664|526980729|FG002|Overall Study|Protocol Violation|0|||
146125963|NCT01782664|526980730|FG003|Overall Study|Protocol Violation|1|||
146125964|NCT01782664|526980731|FG004|Overall Study|Protocol Violation|0|||
146125965|NCT01782664|526980732|FG005|Overall Study|Protocol Violation|0|||
146125966|NCT01782664|526980727|FG000|Overall Study|Withdrawal by Subject|2|||
146125967|NCT01782664|526980728|FG001|Overall Study|Withdrawal by Subject|2|||
146125968|NCT01782664|526980729|FG002|Overall Study|Withdrawal by Subject|0|||
146125969|NCT01782664|526980730|FG003|Overall Study|Withdrawal by Subject|0|||
146262653|NCT01721746|527476512|FG001|Pre-Treatment|Poor/Non-compliance|0|||
146262654|NCT01721746|527476511|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
146262655|NCT01721746|527476512|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
146262656|NCT01721746|527476511|FG000|Treatment|Disease Progression|192|||
146262657|NCT01721746|527476512|FG001|Treatment|Disease Progression|74|||
146262658|NCT01721746|527476511|FG000|Treatment|Study Drug Toxicity|19|||
146262659|NCT01721746|527476512|FG001|Treatment|Study Drug Toxicity|11|||
146262660|NCT01721746|527476511|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
146303351|NCT00915772|527625746|FG002|Overall Study|Protocol Violation|2|||
146303352|NCT00915772|527625744|FG000|Overall Study|Lost to Follow-up|1|||
146303353|NCT00915772|527625745|FG001|Overall Study|Lost to Follow-up|2|||
146125970|NCT01782664|526980731|FG004|Overall Study|Withdrawal by Subject|0|||
146125971|NCT01782664|526980732|FG005|Overall Study|Withdrawal by Subject|0|||
146125972|NCT00698581|526980735|FG000|Overall Study|Lack of Efficacy|23|||
146125973|NCT00698581|526980736|FG001|Overall Study|Lack of Efficacy|11|||
146125974|NCT00698581|526980735|FG000|Overall Study|Withdrawal by Subject|6|||
146125975|NCT00698581|526980736|FG001|Overall Study|Withdrawal by Subject|0|||
146125976|NCT00698581|526980735|FG000|Overall Study|Other reason|9|||
146125977|NCT00698581|526980736|FG001|Overall Study|Other reason|1|||
146125978|NCT00698581|526980735|FG000|Overall Study|SAE, non-fatal|1|||
146125979|NCT00698581|526980736|FG001|Overall Study|SAE, non-fatal|0|||
146125980|NCT00698581|526980735|FG000|Overall Study|AE, non-serious non-fatal|4|||
146125981|NCT00698581|526980736|FG001|Overall Study|AE, non-serious non-fatal|0|||
146125982|NCT00698581|526980735|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146125983|NCT00698581|526980736|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146125984|NCT00698581|526980735|FG000|Overall Study|AE of unknown type|1|||
146125985|NCT00698581|526980736|FG001|Overall Study|AE of unknown type|0|||
146125986|NCT03760146|526980737|FG000|Overall Study|Adverse Event|11|||
146125987|NCT03760146|526980738|FG001|Overall Study|Adverse Event|8|||
146125988|NCT03760146|526980739|FG002|Overall Study|Adverse Event|0|||
146125989|NCT03760146|526980740|FG003|Overall Study|Adverse Event|0|||
146125990|NCT03760146|526980741|FG004|Overall Study|Adverse Event|0|||
146125991|NCT03760146|526980742|FG005|Overall Study|Adverse Event|0|||
146125992|NCT03760146|526980737|FG000|Overall Study|Death|1|||
146125993|NCT03760146|526980738|FG001|Overall Study|Death|0|||
146125994|NCT03760146|526980739|FG002|Overall Study|Death|0|||
146125995|NCT03760146|526980740|FG003|Overall Study|Death|0|||
146125996|NCT03760146|526980741|FG004|Overall Study|Death|0|||
146125997|NCT03760146|526980742|FG005|Overall Study|Death|0|||
146125998|NCT03760146|526980737|FG000|Overall Study|Lost to Follow-up|41|||
146125999|NCT03760146|526980738|FG001|Overall Study|Lost to Follow-up|28|||
146126000|NCT03760146|526980739|FG002|Overall Study|Lost to Follow-up|9|||
146126001|NCT03760146|526980740|FG003|Overall Study|Lost to Follow-up|2|||
146126002|NCT03760146|526980741|FG004|Overall Study|Lost to Follow-up|14|||
146126003|NCT03760146|526980742|FG005|Overall Study|Lost to Follow-up|8|||
146126004|NCT03760146|526980737|FG000|Overall Study|No longer met eligibility criteria|3|||
146262661|NCT01721746|527476512|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
146262662|NCT01721746|527476511|FG000|Treatment|Participant request to discontinue Study treatment|26|||
146126005|NCT03760146|526980738|FG001|Overall Study|No longer met eligibility criteria|9|||
146126006|NCT03760146|526980739|FG002|Overall Study|No longer met eligibility criteria|0|||
146126007|NCT03760146|526980740|FG003|Overall Study|No longer met eligibility criteria|0|||
146262663|NCT01721746|527476512|FG001|Treatment|Participant request to discontinue Study treatment|7|||
146262664|NCT01721746|527476511|FG000|Treatment|Participant withdrew consent|4|||
146262665|NCT01721746|527476512|FG001|Treatment|Participant withdrew consent|2|||
146126008|NCT03760146|526980741|FG004|Overall Study|No longer met eligibility criteria|1|||
146126009|NCT03760146|526980742|FG005|Overall Study|No longer met eligibility criteria|0|||
146126010|NCT03760146|526980737|FG000|Overall Study|Protocol Violation|21|||
146126011|NCT03760146|526980738|FG001|Overall Study|Protocol Violation|13|||
146126012|NCT03760146|526980739|FG002|Overall Study|Protocol Violation|1|||
146126013|NCT03760146|526980740|FG003|Overall Study|Protocol Violation|0|||
146262666|NCT01721746|527476511|FG000|Treatment|Maximum Clinical Benefit|9|||
146262667|NCT01721746|527476512|FG001|Treatment|Maximum Clinical Benefit|3|||
146126014|NCT03760146|526980741|FG004|Overall Study|Protocol Violation|1|||
146126015|NCT03760146|526980742|FG005|Overall Study|Protocol Violation|0|||
146303354|NCT00915772|527625746|FG002|Overall Study|Lost to Follow-up|2|||
146262668|NCT01721746|527476511|FG000|Treatment|Poor/Non-compliance|2|||
146262669|NCT01721746|527476512|FG001|Treatment|Poor/Non-compliance|0|||
146126016|NCT03760146|526980737|FG000|Overall Study|Withdrawal by Subject|19|||
146126017|NCT03760146|526980738|FG001|Overall Study|Withdrawal by Subject|20|||
146126018|NCT03760146|526980739|FG002|Overall Study|Withdrawal by Subject|1|||
146126019|NCT03760146|526980740|FG003|Overall Study|Withdrawal by Subject|0|||
146126020|NCT03760146|526980741|FG004|Overall Study|Withdrawal by Subject|1|||
146126021|NCT03760146|526980742|FG005|Overall Study|Withdrawal by Subject|0|||
146126022|NCT01082965|526980743|FG000|Overall Study|Protocol Violation|0|||
146126023|NCT01082965|526980744|FG001|Overall Study|Protocol Violation|1|||
146126024|NCT01082965|526980743|FG000|Overall Study|Other|1|||
146126025|NCT01082965|526980744|FG001|Overall Study|Other|1|||
146126026|NCT02587065|526980745|FG000|Overall Study|Adverse Event|14|||
146126027|NCT02587065|526980745|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
146126028|NCT02587065|526980745|FG000|Overall Study|Non-adherence to the Protocol|3|||
146126029|NCT02587065|526980745|FG000|Overall Study|Discontinuation of Study Medication|2|||
146126030|NCT02587065|526980745|FG000|Overall Study|Reason not Specified|3|||
146126031|NCT04307446|526982800|FG000|Overall Study|Lost to Follow-up|2|||
146126032|NCT04307446|526982801|FG001|Overall Study|Lost to Follow-up|0|||
146126033|NCT01063764|526982805|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
146126034|NCT01063764|526982805|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
146126035|NCT01063764|526982805|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
146126036|NCT01063764|526982805|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
146126037|NCT01063764|526982805|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
146126038|NCT01063764|526982805|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
146126039|NCT01063764|526982805|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
146126040|NCT00697515|526982806|FG000|Dose Optimization Period|Adverse Event|4|||
146126041|NCT00697515|526982807|FG001|Dose Optimization Period|Adverse Event|0|||
146126042|NCT00697515|526982806|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
146126043|NCT00697515|526982807|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
146126044|NCT00697515|526982806|FG000|Dose Optimization Period|Lost to Follow-up|2|||
146126045|NCT00697515|526982807|FG001|Dose Optimization Period|Lost to Follow-up|0|||
146126046|NCT00697515|526982806|FG000|Dose Optimization Period|sponsor request|2|||
146126047|NCT00697515|526982807|FG001|Dose Optimization Period|sponsor request|0|||
146126048|NCT00697515|526982806|FG000|Dose Optimization Period|called to active duty|1|||
146126049|NCT00697515|526982807|FG001|Dose Optimization Period|called to active duty|0|||
146126050|NCT00697515|526982806|FG000|Dose Optimization Period|elevated QTc|1|||
146126051|NCT00697515|526982807|FG001|Dose Optimization Period|elevated QTc|0|||
146126052|NCT00697515|526982806|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
146126053|NCT00697515|526982807|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
146126054|NCT00697515|526982806|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
146126055|NCT00697515|526982807|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
146126056|NCT00697515|526982806|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
146126057|NCT00697515|526982807|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
146126058|NCT00697515|526982806|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
146126059|NCT00697515|526982807|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
146126060|NCT02436759|526982808|FG000|Overall Study|Adverse Event|3|||
146126061|NCT02436759|526982809|FG001|Overall Study|Adverse Event|0|||
146126062|NCT02436759|526982808|FG000|Overall Study|Protocol Violation|1|||
146126063|NCT02436759|526982809|FG001|Overall Study|Protocol Violation|0|||
146126064|NCT02436759|526982808|FG000|Overall Study|Withdrawal by Subject|0|||
146126065|NCT02436759|526982809|FG001|Overall Study|Withdrawal by Subject|1|||
146126066|NCT02603432|526982812|FG000|Overall Study|Adverse Event|1|||
146126067|NCT02603432|526982813|FG001|Overall Study|Adverse Event|0|||
146126068|NCT02603432|526982812|FG000|Overall Study|Death|221|||
146126069|NCT02603432|526982813|FG001|Overall Study|Death|242|||
146126070|NCT02603432|526982812|FG000|Overall Study|Lost to Follow-up|3|||
146126071|NCT02603432|526982813|FG001|Overall Study|Lost to Follow-up|9|||
146126072|NCT02603432|526982812|FG000|Overall Study|Progressive Disease|7|||
146126073|NCT02603432|526982813|FG001|Overall Study|Progressive Disease|5|||
146126074|NCT02603432|526982812|FG000|Overall Study|Withdrawal by Subject|12|||
146126075|NCT02603432|526982813|FG001|Overall Study|Withdrawal by Subject|18|||
146126076|NCT02603432|526982812|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
146126077|NCT02603432|526982813|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146126078|NCT02603432|526982812|FG000|Overall Study|Study terminated by sponsor|74|||
146126079|NCT02603432|526982813|FG001|Overall Study|Study terminated by sponsor|75|||
146126080|NCT02603432|526982812|FG000|Overall Study|Other|13|||
146262670|NCT01721746|527476511|FG000|Treatment|Participant no longer met Study criteria|4|||
146126081|NCT02603432|526982813|FG001|Overall Study|Other|0|||
146126082|NCT00297037|526982816|FG000|Overall Study|Withdrawal by Subject|2|||
146126083|NCT00297037|526982817|FG001|Overall Study|Withdrawal by Subject|0|||
146126084|NCT00581776|526982818|FG000|Overall Study|Disease progression or no response|3|||
146126085|NCT05352815|526982821|FG000|Overall Study|Withdrawal by Subject|28|||
146303355|NCT00915772|527625744|FG000|Overall Study|Lack of Efficacy|9|||
146126086|NCT05352815|526982822|FG001|Overall Study|Withdrawal by Subject|24|||
146126087|NCT05352815|526982821|FG000|Overall Study|Lost to Follow-up|4|||
146126088|NCT05352815|526982822|FG001|Overall Study|Lost to Follow-up|7|||
146126089|NCT05352815|526982821|FG000|Overall Study|Death|2|||
146126090|NCT05352815|526982822|FG001|Overall Study|Death|3|||
146126091|NCT05352815|526982821|FG000|Overall Study|Site closure|1|||
146126092|NCT05352815|526982822|FG001|Overall Study|Site closure|0|||
146126093|NCT02759120|526982825|FG000|Overall Study|Death|34|||
146126094|NCT02759120|526982826|FG001|Overall Study|Death|36|||
146126095|NCT02759120|526982825|FG000|Overall Study|Lost to Follow-up|4|||
146126096|NCT02759120|526982826|FG001|Overall Study|Lost to Follow-up|7|||
146126097|NCT02759120|526982825|FG000|Overall Study|Physician Decision|3|||
146126098|NCT02759120|526982826|FG001|Overall Study|Physician Decision|0|||
146126099|NCT02759120|526982825|FG000|Overall Study|Withdrawal by Subject|28|||
146126100|NCT02759120|526982826|FG001|Overall Study|Withdrawal by Subject|15|||
146126101|NCT02759120|526982825|FG000|Overall Study|Moved out of area|3|||
146126102|NCT02759120|526982826|FG001|Overall Study|Moved out of area|4|||
146126103|NCT02759120|526982825|FG000|Overall Study|Lung transplant|3|||
146126104|NCT02759120|526982826|FG001|Overall Study|Lung transplant|5|||
146126105|NCT02759120|526982825|FG000|Overall Study|Other reason not completed|10|||
146126106|NCT02759120|526982826|FG001|Overall Study|Other reason not completed|12|||
146126107|NCT02063854|526982828|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
146126108|NCT02063854|526982829|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146126109|NCT02063854|526982830|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
146126110|NCT02063854|526982831|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
146126111|NCT02063854|526982832|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
146126112|NCT02063854|526982833|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
146126113|NCT02063854|526982834|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
146126114|NCT02063854|526982828|FG000|Overall Study|Major Protocol Deviation|0|||
146126115|NCT02063854|526982829|FG001|Overall Study|Major Protocol Deviation|0|||
146126116|NCT02063854|526982830|FG002|Overall Study|Major Protocol Deviation|3|||
146126117|NCT02063854|526982831|FG003|Overall Study|Major Protocol Deviation|0|||
146126118|NCT02063854|526982832|FG004|Overall Study|Major Protocol Deviation|0|||
146126119|NCT02063854|526982833|FG005|Overall Study|Major Protocol Deviation|0|||
146126120|NCT02063854|526982834|FG006|Overall Study|Major Protocol Deviation|0|||
146126121|NCT02063854|526982828|FG000|Overall Study|Voluntary Withdrawal|2|||
146126122|NCT02063854|526982829|FG001|Overall Study|Voluntary Withdrawal|0|||
146126123|NCT02063854|526982830|FG002|Overall Study|Voluntary Withdrawal|8|||
146126124|NCT02063854|526982831|FG003|Overall Study|Voluntary Withdrawal|1|||
146126125|NCT02063854|526982832|FG004|Overall Study|Voluntary Withdrawal|3|||
146126126|NCT02063854|526982833|FG005|Overall Study|Voluntary Withdrawal|6|||
146126127|NCT02063854|526982834|FG006|Overall Study|Voluntary Withdrawal|1|||
146126128|NCT02063854|526982828|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
146126129|NCT02063854|526982829|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
146126130|NCT02063854|526982830|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
146126131|NCT02063854|526982831|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
146126132|NCT02063854|526982832|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
146126133|NCT02063854|526982833|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
146126134|NCT02063854|526982834|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
146126135|NCT02063854|526982828|FG000|Overall Study|Reason Not Specified|1|||
146126136|NCT02063854|526982829|FG001|Overall Study|Reason Not Specified|0|||
146126137|NCT02063854|526982830|FG002|Overall Study|Reason Not Specified|0|||
146126138|NCT02063854|526982831|FG003|Overall Study|Reason Not Specified|0|||
146126139|NCT02063854|526982832|FG004|Overall Study|Reason Not Specified|0|||
146126140|NCT02063854|526982833|FG005|Overall Study|Reason Not Specified|0|||
146126141|NCT02063854|526982834|FG006|Overall Study|Reason Not Specified|0|||
146126142|NCT02063854|526982828|FG000|Overall Study|Did Not Receive Study Drug|0|||
146126143|NCT02063854|526982829|FG001|Overall Study|Did Not Receive Study Drug|0|||
146126144|NCT02063854|526982830|FG002|Overall Study|Did Not Receive Study Drug|0|||
146126145|NCT02063854|526982831|FG003|Overall Study|Did Not Receive Study Drug|0|||
146126146|NCT02063854|526982832|FG004|Overall Study|Did Not Receive Study Drug|0|||
146126147|NCT02063854|526982833|FG005|Overall Study|Did Not Receive Study Drug|1|||
146126148|NCT02063854|526982834|FG006|Overall Study|Did Not Receive Study Drug|0|||
146126149|NCT00930579|526982837|FG000|Overall Study|Withdrawal by Subject|1|||
146126150|NCT00930579|526982837|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
146126151|NCT02255981|526982838|FG000|Overall Study|Lost to Follow-up|3|||
146126152|NCT02255981|526982838|FG000|Overall Study|Withdrawal by Subject|1|||
146126153|NCT01046682|526982839|FG000|Overall Study|Adverse Event|2|||
146126154|NCT01046682|526982840|FG001|Overall Study|Adverse Event|0|||
146126155|NCT00949325|526982846|FG000|Overall Study|Adverse Event|0|||
146126156|NCT00949325|526982847|FG001|Overall Study|Adverse Event|2|||
146126157|NCT00949325|526982848|FG002|Overall Study|Adverse Event|0|||
146126158|NCT05533632|526982849|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
146126159|NCT05533632|526982849|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
146126160|NCT05533632|526982849|FG000|Overall Study|Lost to Follow-up|1|||
146126161|NCT05533632|526982849|FG000|Overall Study|Withdrawal by Subject|4|||
146126162|NCT05533632|526982849|FG000|Overall Study|Adverse Event|4|||
146126163|NCT02205333|526982853|FG000|Overall Study|Death|5|||
146126164|NCT02205333|526982854|FG001|Overall Study|Death|6|||
146126165|NCT02205333|526982855|FG002|Overall Study|Death|2|||
146126166|NCT02205333|526982856|FG003|Overall Study|Death|6|||
146126167|NCT02205333|526982857|FG004|Overall Study|Death|5|||
146126168|NCT02205333|526982858|FG005|Overall Study|Death|3|||
146126169|NCT02205333|526982859|FG006|Overall Study|Death|3|||
146126170|NCT02205333|526982860|FG007|Overall Study|Death|2|||
146126171|NCT02205333|526982861|FG008|Overall Study|Death|0|||
146126172|NCT02205333|526982853|FG000|Overall Study|Withdrawal by Subject|1|||
146126173|NCT02205333|526982854|FG001|Overall Study|Withdrawal by Subject|0|||
146126174|NCT02205333|526982855|FG002|Overall Study|Withdrawal by Subject|0|||
146126175|NCT02205333|526982856|FG003|Overall Study|Withdrawal by Subject|1|||
146126176|NCT02205333|526982857|FG004|Overall Study|Withdrawal by Subject|0|||
146126177|NCT02205333|526982858|FG005|Overall Study|Withdrawal by Subject|0|||
146126178|NCT02205333|526982859|FG006|Overall Study|Withdrawal by Subject|2|||
146126179|NCT02205333|526982860|FG007|Overall Study|Withdrawal by Subject|0|||
146126180|NCT02205333|526982861|FG008|Overall Study|Withdrawal by Subject|0|||
146126181|NCT03054870|526982862|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
146126182|NCT03054870|526982862|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
146126183|NCT00643682|526982865|FG000|Overall Study|did not keep appointment|522|||
146126184|NCT00643682|526982866|FG001|Overall Study|did not keep appointment|509|||
146126185|NCT03755414|526982868|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
146126186|NCT03755414|526982869|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
146126187|NCT03755414|526982870|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
146126188|NCT03755414|526982868|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
146126189|NCT03755414|526982869|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
146126190|NCT03755414|526982870|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
146126191|NCT03755414|526982868|FG000|Overall Study|Non-compliance|0|||
146126192|NCT03755414|526982869|FG001|Overall Study|Non-compliance|1|||
146126193|NCT03755414|526982870|FG002|Overall Study|Non-compliance|0|||
146126194|NCT02153112|526982871|FG000|Overall Study|Adverse Event|0|||
146126195|NCT02153112|526982872|FG001|Overall Study|Adverse Event|0|||
146126196|NCT02153112|526982873|FG002|Overall Study|Adverse Event|1|||
146126197|NCT02153112|526982874|FG003|Overall Study|Adverse Event|0|||
146126198|NCT02153112|526982875|FG004|Overall Study|Adverse Event|0|||
146126199|NCT02153112|526982876|FG005|Overall Study|Adverse Event|0|||
146126200|NCT02153112|526982877|FG006|Overall Study|Adverse Event|0|||
146126201|NCT02153112|526982878|FG007|Overall Study|Adverse Event|0|||
146126202|NCT02153112|526982879|FG008|Overall Study|Adverse Event|0|||
146126203|NCT02153112|526982880|FG009|Overall Study|Adverse Event|0|||
146126204|NCT02153112|526982871|FG000|Overall Study|Lost to Follow-up|1|||
146126205|NCT02153112|526982872|FG001|Overall Study|Lost to Follow-up|1|||
146126206|NCT02153112|526982873|FG002|Overall Study|Lost to Follow-up|0|||
146126207|NCT02153112|526982874|FG003|Overall Study|Lost to Follow-up|0|||
146126208|NCT02153112|526982875|FG004|Overall Study|Lost to Follow-up|2|||
146126209|NCT02153112|526982876|FG005|Overall Study|Lost to Follow-up|1|||
146126210|NCT02153112|526982877|FG006|Overall Study|Lost to Follow-up|1|||
146262671|NCT01721746|527476512|FG001|Treatment|Participant no longer met Study criteria|0|||
146262672|NCT01721746|527476511|FG000|Treatment|Other reasons|6|||
146262673|NCT01721746|527476512|FG001|Treatment|Other reasons|2|||
146262674|NCT02601209|527476515|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146262675|NCT02601209|527476516|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146262676|NCT02601209|527476517|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
146262677|NCT02601209|527476518|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262678|NCT02601209|527476519|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262679|NCT02601209|527476520|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262680|NCT02601209|527476521|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262681|NCT02601209|527476522|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262682|NCT02601209|527476523|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
146262683|NCT02601209|527476515|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262684|NCT02601209|527476516|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262685|NCT02601209|527476517|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262686|NCT02601209|527476518|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262687|NCT02601209|527476519|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
146126211|NCT02153112|526982878|FG007|Overall Study|Lost to Follow-up|0|||
146126212|NCT02153112|526982879|FG008|Overall Study|Lost to Follow-up|1|||
146126213|NCT02153112|526982880|FG009|Overall Study|Lost to Follow-up|1|||
146126214|NCT02153112|526982871|FG000|Overall Study|Withdrawal by Subject|3|||
146126215|NCT02153112|526982872|FG001|Overall Study|Withdrawal by Subject|1|||
146126216|NCT02153112|526982873|FG002|Overall Study|Withdrawal by Subject|2|||
146126217|NCT02153112|526982874|FG003|Overall Study|Withdrawal by Subject|2|||
146126218|NCT02153112|526982875|FG004|Overall Study|Withdrawal by Subject|1|||
146126219|NCT02153112|526982876|FG005|Overall Study|Withdrawal by Subject|1|||
146126220|NCT02153112|526982877|FG006|Overall Study|Withdrawal by Subject|7|||
146126221|NCT02153112|526982878|FG007|Overall Study|Withdrawal by Subject|2|||
146126222|NCT02153112|526982879|FG008|Overall Study|Withdrawal by Subject|13|||
146126223|NCT02153112|526982880|FG009|Overall Study|Withdrawal by Subject|12|||
146126224|NCT02153112|526982871|FG000|Overall Study|Reason not Specified|0|||
146126225|NCT02153112|526982872|FG001|Overall Study|Reason not Specified|0|||
146126226|NCT02153112|526982873|FG002|Overall Study|Reason not Specified|0|||
146126227|NCT02153112|526982874|FG003|Overall Study|Reason not Specified|0|||
146126228|NCT02153112|526982875|FG004|Overall Study|Reason not Specified|0|||
146126229|NCT02153112|526982876|FG005|Overall Study|Reason not Specified|0|||
146126230|NCT02153112|526982877|FG006|Overall Study|Reason not Specified|0|||
146126231|NCT02153112|526982878|FG007|Overall Study|Reason not Specified|0|||
146126232|NCT02153112|526982879|FG008|Overall Study|Reason not Specified|1|||
146126233|NCT02153112|526982880|FG009|Overall Study|Reason not Specified|1|||
146126234|NCT00003641|526982886|FG000|Overall Study|Withdrawal by Subject|0|||
146126235|NCT00003641|526982887|FG001|Overall Study|Withdrawal by Subject|100|||
146126236|NCT00003641|526982886|FG000|Overall Study|Adverse Event|0|||
146126237|NCT00003641|526982887|FG001|Overall Study|Adverse Event|38|||
146126238|NCT00003641|526982886|FG000|Overall Study|Disease progression|0|||
146126239|NCT00003641|526982887|FG001|Overall Study|Disease progression|2|||
146126240|NCT00003641|526982886|FG000|Overall Study|Unknown/missing|0|||
146126241|NCT00003641|526982887|FG001|Overall Study|Unknown/missing|22|||
146126242|NCT00003641|526982886|FG000|Overall Study|Should not receive interferon therapy|2|||
146126243|NCT00003641|526982887|FG001|Overall Study|Should not receive interferon therapy|0|||
146126244|NCT00003641|526982886|FG000|Overall Study|Never started interferon|567|||
146126245|NCT00003641|526982887|FG001|Overall Study|Never started interferon|12|||
146126246|NCT02154581|526982891|FG000|Overall Study|Lost to Follow-up|7|||
146126247|NCT02154581|526982892|FG001|Overall Study|Lost to Follow-up|8|||
146126248|NCT02068222|526982895|FG000|Overall Study|Lost to Follow-up|1|||
146126249|NCT00281684|526982898|FG000|Overall Study|Lost to Follow-up|0|||
146126250|NCT00281684|526982899|FG001|Overall Study|Lost to Follow-up|0|||
146126251|NCT00281684|526982900|FG002|Overall Study|Lost to Follow-up|1|||
146126252|NCT00281684|526982901|FG003|Overall Study|Lost to Follow-up|0|||
146126253|NCT00281684|526982898|FG000|Overall Study|Withdrawal by Subject|1|||
146126254|NCT00281684|526982899|FG001|Overall Study|Withdrawal by Subject|0|||
146126255|NCT00281684|526982900|FG002|Overall Study|Withdrawal by Subject|0|||
146126256|NCT00281684|526982901|FG003|Overall Study|Withdrawal by Subject|0|||
146126257|NCT03642717|526982904|FG000|Overall Study|Lost to Follow-up|2|||
146262688|NCT02601209|527476520|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
146262689|NCT02601209|527476521|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
146262690|NCT02601209|527476522|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262691|NCT02601209|527476523|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
146262692|NCT01185171|527476526|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
146262693|NCT01185171|527476526|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
146262694|NCT01185171|527476526|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
146262695|NCT01185171|527476526|FG000|Maintenance|Elevated liver transaminases|3|||
146262696|NCT01185171|527476526|FG000|Maintenance|Rush|2|||
146262697|NCT01185171|527476526|FG000|Maintenance|Diarrhea|1|||
146262698|NCT01185171|527476526|FG000|Maintenance|Xerostomia|1|||
146262699|NCT01185171|527476526|FG000|Maintenance|Nausea|1|||
146126258|NCT03642717|526982904|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
146126259|NCT03642717|526982904|FG000|Overall Study|Taken study drug prior to contract date|3|||
146126260|NCT01559012|526982905|FG000|Overall Study|Withdrawal by Subject|0|||
146126261|NCT01559012|526982906|FG001|Overall Study|Withdrawal by Subject|1|||
146126262|NCT00302458|526982907|FG000|Overall Study|Lost to Follow-up|1|||
146126263|NCT00302458|526982907|FG000|Overall Study|Ineligible after screening|1|||
146126264|NCT00302458|526982907|FG000|Overall Study|Withdrawal by Subject|1|||
146126265|NCT00853723|526982909|FG000|Overall Study|Adverse Event|3|||
146126266|NCT00853723|526982910|FG001|Overall Study|Adverse Event|4|||
146126267|NCT00853723|526982911|FG002|Overall Study|Adverse Event|1|||
146126268|NCT00853723|526982909|FG000|Overall Study|Withdrawal by Subject|2|||
146126269|NCT00853723|526982910|FG001|Overall Study|Withdrawal by Subject|1|||
146262700|NCT01185171|527476526|FG000|Maintenance|Comorbid Illness|2|||
146262701|NCT01185171|527476526|FG000|Maintenance|Withdrawal by Subject|1|||
146262702|NCT01185171|527476526|FG000|Maintenance|Disease Recurrence|1|||
146262703|NCT00573651|527476530|FG000|Overall Study|Lost to Follow-up|3|||
146262704|NCT00573651|527476530|FG000|Overall Study|Withdrawal by Subject|1|||
146262705|NCT01837797|527476531|FG000|Period 1|Adverse Event|9|||
146262706|NCT01837797|527476532|FG001|Period 1|Adverse Event|0|||
146262707|NCT01837797|527476533|FG002|Period 1|Adverse Event|0|||
146262708|NCT01837797|527476534|FG003|Period 1|Adverse Event|0|||
146262709|NCT01837797|527476535|FG004|Period 1|Adverse Event|0|||
146126270|NCT00853723|526982911|FG002|Overall Study|Withdrawal by Subject|0|||
146126271|NCT00853723|526982909|FG000|Overall Study|Protocol Violation|1|||
146126272|NCT00853723|526982910|FG001|Overall Study|Protocol Violation|2|||
146126273|NCT00853723|526982911|FG002|Overall Study|Protocol Violation|1|||
146126274|NCT00445965|526982912|FG000|Overall Study|Adverse Event|2|||
146126275|NCT00445965|526982912|FG000|Overall Study|Physician Decision|1|||
146126276|NCT00445965|526982912|FG000|Overall Study|Enrolled but not treated|1|||
146126277|NCT00445965|526982912|FG000|Overall Study|Removed due to progressive disease|29|||
146126278|NCT02447081|526982913|FG000|Overall Study|Death|161|||
146126279|NCT02447081|526982913|FG000|Overall Study|Lost to Follow-up|36|||
146126280|NCT02447081|526982913|FG000|Overall Study|Visit not completed|17|||
146126281|NCT02447081|526982913|FG000|Overall Study|unsuccessful implant procedure|10|||
146126282|NCT05778786|526982916|FG000|Period 1|COVID-19 Related|3|||
146126283|NCT05778786|526982917|FG001|Period 1|COVID-19 Related|3|||
146126284|NCT05778786|526982916|FG000|Period 1|Withdrew Consent during Study|1|||
146126285|NCT05778786|526982917|FG001|Period 1|Withdrew Consent during Study|0|||
146126286|NCT05778786|526982916|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
146126287|NCT05778786|526982917|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
146126288|NCT05778786|526982916|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
146126289|NCT05778786|526982917|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
146126290|NCT02867709|526982918|FG000|Treatment Period|Adverse Event|1|||
146126291|NCT02867709|526982919|FG001|Treatment Period|Adverse Event|1|||
146126292|NCT02867709|526982920|FG002|Treatment Period|Adverse Event|2|||
146126293|NCT02867709|526982918|FG000|Treatment Period|Withdrawal of Consent|7|||
146126294|NCT02867709|526982919|FG001|Treatment Period|Withdrawal of Consent|9|||
146126295|NCT02867709|526982920|FG002|Treatment Period|Withdrawal of Consent|8|||
146126296|NCT02867709|526982918|FG000|Treatment Period|Lost to Follow-up|17|||
146126297|NCT02867709|526982919|FG001|Treatment Period|Lost to Follow-up|20|||
146126298|NCT02867709|526982920|FG002|Treatment Period|Lost to Follow-up|20|||
146126299|NCT02867709|526982918|FG000|Treatment Period|Lack of Qualifying Event|42|||
146126300|NCT02867709|526982919|FG001|Treatment Period|Lack of Qualifying Event|55|||
146126301|NCT02867709|526982920|FG002|Treatment Period|Lack of Qualifying Event|42|||
146126302|NCT02867709|526982918|FG000|Treatment Period|Protocol Violation|3|||
146126303|NCT02867709|526982919|FG001|Treatment Period|Protocol Violation|2|||
146126304|NCT02867709|526982920|FG002|Treatment Period|Protocol Violation|3|||
146126305|NCT02867709|526982918|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
146126306|NCT02867709|526982919|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
146126307|NCT02867709|526982920|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
146126308|NCT02867709|526982918|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
146126309|NCT02867709|526982919|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
146126310|NCT02867709|526982920|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
146126311|NCT02867709|526982918|FG000|Safety Follow-up Period|Pregnancy|0|||
146126312|NCT02867709|526982919|FG001|Safety Follow-up Period|Pregnancy|1|||
146126313|NCT02867709|526982920|FG002|Safety Follow-up Period|Pregnancy|0|||
146126314|NCT02867709|526982918|FG000|Safety Follow-up Period|Protocol Violation|0|||
146126315|NCT02867709|526982919|FG001|Safety Follow-up Period|Protocol Violation|1|||
146126316|NCT02867709|526982920|FG002|Safety Follow-up Period|Protocol Violation|1|||
146126317|NCT04056195|526982923|FG000|Overall Study|Adverse Event|1|||
146126318|NCT04056195|526982924|FG001|Overall Study|Adverse Event|0|||
146126319|NCT04056195|526982925|FG002|Overall Study|Adverse Event|0|||
146126320|NCT04056195|526982923|FG000|Overall Study|Withdrawal by Subject|0|||
146126321|NCT04056195|526982924|FG001|Overall Study|Withdrawal by Subject|1|||
146126322|NCT04056195|526982925|FG002|Overall Study|Withdrawal by Subject|1|||
146126323|NCT04056195|526982923|FG000|Overall Study|Physician Decision|1|||
146126324|NCT04056195|526982924|FG001|Overall Study|Physician Decision|1|||
146126325|NCT04056195|526982925|FG002|Overall Study|Physician Decision|1|||
146126326|NCT02406651|526982926|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
146126327|NCT00718328|526982931|FG000|Overall Study|Lost to Follow-up|1|||
146126328|NCT00718328|526982932|FG001|Overall Study|Lost to Follow-up|0|||
146126329|NCT02865915|526982933|FG000|Overall Study|Pregnancy|1|||
146126330|NCT02865915|526982934|FG001|Overall Study|Pregnancy|0|||
146126331|NCT02865915|526982933|FG000|Overall Study|Withdrawal by Subject|1|||
146126332|NCT02865915|526982934|FG001|Overall Study|Withdrawal by Subject|1|||
146126333|NCT02865915|526982933|FG000|Overall Study|Adverse Event|0|||
146126334|NCT02865915|526982934|FG001|Overall Study|Adverse Event|4|||
146126335|NCT02865915|526982933|FG000|Overall Study|Lost to Follow-up|0|||
146126336|NCT02865915|526982934|FG001|Overall Study|Lost to Follow-up|1|||
146126337|NCT02865915|526982933|FG000|Overall Study|Protocol Violation|0|||
146126338|NCT02865915|526982934|FG001|Overall Study|Protocol Violation|1|||
146126339|NCT02865915|526982933|FG000|Overall Study|Study terminated by sponsor|23|||
146126340|NCT02865915|526982934|FG001|Overall Study|Study terminated by sponsor|18|||
146126341|NCT02865915|526982933|FG000|Overall Study|Dosing group discontinued|0|||
146126342|NCT02865915|526982934|FG001|Overall Study|Dosing group discontinued|5|||
146126343|NCT00663052|526982935|FG000|Overall Study|Adverse Event|6|||
146126344|NCT00663052|526982936|FG001|Overall Study|Adverse Event|3|||
146126345|NCT00663052|526982935|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
146126346|NCT00663052|526982936|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146126347|NCT00663052|526982935|FG000|Overall Study|Protocol Violation|1|||
146126348|NCT00663052|526982936|FG001|Overall Study|Protocol Violation|0|||
146126349|NCT00663052|526982935|FG000|Overall Study|Withdrawal by Subject|2|||
146126350|NCT00663052|526982936|FG001|Overall Study|Withdrawal by Subject|5|||
146126351|NCT00663052|526982935|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
146126352|NCT00663052|526982936|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
146126353|NCT00663052|526982935|FG000|Overall Study|Other|0|||
146126354|NCT00663052|526982936|FG001|Overall Study|Other|1|||
146126355|NCT05497284|526982941|FG000|Overall Study|Adverse Event|1|||
146126356|NCT05497284|526982942|FG001|Overall Study|Adverse Event|0|||
146126357|NCT05497284|526982941|FG000|Overall Study|Physician Decision|0|||
146126358|NCT05497284|526982942|FG001|Overall Study|Physician Decision|1|||
146126359|NCT05497284|526982941|FG000|Overall Study|Study terminated by sponsor|7|||
146126360|NCT05497284|526982942|FG001|Overall Study|Study terminated by sponsor|4|||
146126361|NCT05497284|526982941|FG000|Overall Study|Subject Decision|0|||
146126362|NCT05497284|526982942|FG001|Overall Study|Subject Decision|1|||
146126363|NCT05760300|526982943|FG000|Overall Study|Adverse Event|0|||
146126364|NCT05760300|526982944|FG001|Overall Study|Adverse Event|0|||
146126365|NCT05760300|526982945|FG002|Overall Study|Adverse Event|1|||
146126366|NCT05760300|526982946|FG003|Overall Study|Adverse Event|0|||
146126367|NCT05760300|526982943|FG000|Overall Study|Participant Decision|1|||
146126368|NCT05760300|526982944|FG001|Overall Study|Participant Decision|0|||
146126369|NCT05760300|526982945|FG002|Overall Study|Participant Decision|0|||
146126370|NCT05760300|526982946|FG003|Overall Study|Participant Decision|0|||
146126371|NCT03878446|526982947|FG000|Overall Study|Withdrawn by parent or guardian|1|||
146126372|NCT03878446|526982948|FG001|Overall Study|Withdrawn by parent or guardian|0|||
146126373|NCT03878446|526982949|FG002|Overall Study|Withdrawn by parent or guardian|0|||
146126374|NCT03878446|526982950|FG003|Overall Study|Withdrawn by parent or guardian|0|||
146126375|NCT03878446|526982951|FG004|Overall Study|Withdrawn by parent or guardian|0|||
146126376|NCT03615105|526982954|FG000|Overall Study|Protocol Violation|1|||
146126377|NCT03615105|526982955|FG001|Overall Study|Protocol Violation|0|||
146126378|NCT03615105|526982956|FG002|Overall Study|Protocol Violation|0|||
146126379|NCT03615105|526982954|FG000|Overall Study|Death|0|||
146126380|NCT03615105|526982955|FG001|Overall Study|Death|2|||
146126381|NCT03615105|526982956|FG002|Overall Study|Death|0|||
146126382|NCT05041322|526982957|FG000|Baseline|Withdrawal by Subject|1|||
146126383|NCT05041322|526982958|FG001|Baseline|Withdrawal by Subject|0|||
146126384|NCT05041322|526982957|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
146126385|NCT05041322|526982958|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
146126386|NCT05041322|526982957|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
146126387|NCT05041322|526982958|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
146126388|NCT03313804|526982959|FG000|Treatment|Death|5|||
146126389|NCT03313804|526982959|FG000|Treatment|still on treatment|2|||
146126390|NCT03313804|526982959|FG000|Follow Up|still on follow up|3|||
146126391|NCT01502423|526982960|FG000|Overall Study|Withdrawal by Subject|0|||
146126392|NCT01502423|526982961|FG001|Overall Study|Withdrawal by Subject|1|||
146126393|NCT04814433|526982962|FG000|Overall Study|Survey not returned|4|||
146126394|NCT04814433|526982963|FG001|Overall Study|Survey not returned|8|||
146126395|NCT04814433|526982964|FG002|Overall Study|Survey not returned|4|||
146126396|NCT04814433|526982965|FG003|Overall Study|Survey not returned|5|||
146126397|NCT01545817|526984581|FG000|Pazopanib|Disease progression|51|||
146126398|NCT01545817|526984582|FG001|Pazopanib|Disease progression|0|||
146126399|NCT01545817|526984581|FG000|Pazopanib|Adverse Event|19|||
146126400|NCT01545817|526984582|FG001|Pazopanib|Adverse Event|0|||
146126401|NCT01545817|526984581|FG000|Pazopanib|Other reason|4|||
146126402|NCT01545817|526984582|FG001|Pazopanib|Other reason|0|||
146126403|NCT01545817|526984581|FG000|Everolimus|Other reason|0|||
146126404|NCT01545817|526984582|FG001|Everolimus|Other reason|7|||
146126405|NCT01545817|526984581|FG000|Everolimus|Disease progression|0|||
146262710|NCT01837797|527476531|FG000|Period 1|Withdrawal by Subject|6|||
146262711|NCT01837797|527476532|FG001|Period 1|Withdrawal by Subject|0|||
146262712|NCT01837797|527476533|FG002|Period 1|Withdrawal by Subject|0|||
146262713|NCT01837797|527476534|FG003|Period 1|Withdrawal by Subject|0|||
146262714|NCT01837797|527476535|FG004|Period 1|Withdrawal by Subject|0|||
146126406|NCT01545817|526984582|FG001|Everolimus|Disease progression|25|||
146126407|NCT01545817|526984581|FG000|Everolimus|Adverse Event|0|||
146126408|NCT01545817|526984582|FG001|Everolimus|Adverse Event|6|||
146126409|NCT02967692|526984583|FG000|Overall Study|Progressive disease|3|||
146126410|NCT02967692|526984584|FG001|Overall Study|Progressive disease|15|||
146126411|NCT02967692|526984585|FG002|Overall Study|Progressive disease|114|||
146126412|NCT02967692|526984586|FG003|Overall Study|Progressive disease|151|||
146126413|NCT02967692|526984583|FG000|Overall Study|Subject/guardian decision|1|||
146126414|NCT02967692|526984584|FG001|Overall Study|Subject/guardian decision|1|||
146262715|NCT01837797|527476531|FG000|Period 1|Administrative reasons|76|||
146126415|NCT02967692|526984585|FG002|Overall Study|Subject/guardian decision|14|||
146262716|NCT01837797|527476532|FG001|Period 1|Administrative reasons|0|||
146126416|NCT02967692|526984586|FG003|Overall Study|Subject/guardian decision|22|||
146126417|NCT02967692|526984583|FG000|Overall Study|Death|0|||
146126418|NCT02967692|526984584|FG001|Overall Study|Death|1|||
146126419|NCT02967692|526984585|FG002|Overall Study|Death|13|||
146126420|NCT02967692|526984586|FG003|Overall Study|Death|13|||
146126421|NCT02967692|526984583|FG000|Overall Study|Protocol deviation|1|||
146126422|NCT02967692|526984584|FG001|Overall Study|Protocol deviation|0|||
146126423|NCT02967692|526984585|FG002|Overall Study|Protocol deviation|1|||
146126424|NCT02967692|526984586|FG003|Overall Study|Protocol deviation|1|||
146126425|NCT02967692|526984583|FG000|Overall Study|Lost to Follow-up|0|||
146126426|NCT02967692|526984584|FG001|Overall Study|Lost to Follow-up|0|||
146126427|NCT02967692|526984585|FG002|Overall Study|Lost to Follow-up|1|||
146126428|NCT02967692|526984586|FG003|Overall Study|Lost to Follow-up|0|||
146126429|NCT02967692|526984583|FG000|Overall Study|Physician Decision|0|||
146126430|NCT02967692|526984584|FG001|Overall Study|Physician Decision|0|||
146126431|NCT02967692|526984585|FG002|Overall Study|Physician Decision|22|||
146126432|NCT02967692|526984586|FG003|Overall Study|Physician Decision|13|||
146126433|NCT02967692|526984583|FG000|Overall Study|Adverse Event|2|||
146126434|NCT02967692|526984584|FG001|Overall Study|Adverse Event|9|||
146126435|NCT02967692|526984585|FG002|Overall Study|Adverse Event|60|||
146126436|NCT02967692|526984586|FG003|Overall Study|Adverse Event|28|||
146126437|NCT02967692|526984583|FG000|Overall Study|Study terminated by sponsor|2|||
146126438|NCT02967692|526984584|FG001|Overall Study|Study terminated by sponsor|1|||
146126439|NCT02967692|526984585|FG002|Overall Study|Study terminated by sponsor|42|||
146126440|NCT02967692|526984586|FG003|Overall Study|Study terminated by sponsor|37|||
146126441|NCT00066066|526984589|FG000|Overall Study|Lost to Follow-up|6|||
146126442|NCT00066066|526984590|FG001|Overall Study|Lost to Follow-up|4|||
146126443|NCT00066066|526984591|FG002|Overall Study|Lost to Follow-up|7|||
146126444|NCT00066066|526984592|FG003|Overall Study|Lost to Follow-up|4|||
146126445|NCT00066066|526984593|FG004|Overall Study|Lost to Follow-up|3|||
146126446|NCT00066066|526984594|FG005|Overall Study|Lost to Follow-up|5|||
146126447|NCT03257631|526984603|FG000|Overall Study|Death|1|||
146126448|NCT03257631|526984604|FG001|Overall Study|Death|0|||
146126449|NCT03257631|526984605|FG002|Overall Study|Death|1|||
146126450|NCT03257631|526984606|FG003|Overall Study|Death|1|||
146126451|NCT03257631|526984603|FG000|Overall Study|Progressive Disease|10|||
146126452|NCT03257631|526984604|FG001|Overall Study|Progressive Disease|9|||
146126453|NCT03257631|526984605|FG002|Overall Study|Progressive Disease|17|||
146126454|NCT03257631|526984606|FG003|Overall Study|Progressive Disease|8|||
146126455|NCT03257631|526984603|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146126456|NCT03257631|526984604|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146126457|NCT03257631|526984605|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
146126458|NCT03257631|526984606|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
146126459|NCT03257631|526984603|FG000|Overall Study|Adverse Event|0|||
146126460|NCT03257631|526984604|FG001|Overall Study|Adverse Event|0|||
146126461|NCT03257631|526984605|FG002|Overall Study|Adverse Event|2|||
146126462|NCT03257631|526984606|FG003|Overall Study|Adverse Event|0|||
146126463|NCT02529137|526984607|FG000|Overall Study|Discontinuation for different reasons|8|||
146126464|NCT01649375|526984608|FG000|Up to Week 16|Adverse Event|2|||
146126465|NCT01649375|526984609|FG001|Up to Week 16|Adverse Event|5|||
146126466|NCT01649375|526984610|FG002|Up to Week 16|Adverse Event|4|||
146126467|NCT01649375|526984611|FG003|Up to Week 16|Adverse Event|0|||
146126468|NCT01649375|526984612|FG004|Up to Week 16|Adverse Event|0|||
146126469|NCT01649375|526984608|FG000|Up to Week 16|Lack of Efficacy|0|||
146126470|NCT01649375|526984609|FG001|Up to Week 16|Lack of Efficacy|0|||
146126471|NCT01649375|526984610|FG002|Up to Week 16|Lack of Efficacy|1|||
146126472|NCT01649375|526984611|FG003|Up to Week 16|Lack of Efficacy|0|||
146126473|NCT01649375|526984612|FG004|Up to Week 16|Lack of Efficacy|0|||
146126474|NCT01649375|526984608|FG000|Up to Week 16|Physician Decision|0|||
146126475|NCT01649375|526984609|FG001|Up to Week 16|Physician Decision|0|||
146126476|NCT01649375|526984610|FG002|Up to Week 16|Physician Decision|1|||
146126477|NCT01649375|526984611|FG003|Up to Week 16|Physician Decision|0|||
146126478|NCT01649375|526984612|FG004|Up to Week 16|Physician Decision|0|||
146126479|NCT01649375|526984608|FG000|Up to Week 16|Withdrawal by Subject|2|||
146126480|NCT01649375|526984609|FG001|Up to Week 16|Withdrawal by Subject|1|||
146126481|NCT01649375|526984610|FG002|Up to Week 16|Withdrawal by Subject|2|||
146126482|NCT01649375|526984611|FG003|Up to Week 16|Withdrawal by Subject|0|||
146126483|NCT01649375|526984612|FG004|Up to Week 16|Withdrawal by Subject|0|||
146126484|NCT01649375|526984608|FG000|Up to Week 16|Death|1|||
146126485|NCT01649375|526984609|FG001|Up to Week 16|Death|0|||
146126486|NCT01649375|526984610|FG002|Up to Week 16|Death|0|||
146126487|NCT01649375|526984611|FG003|Up to Week 16|Death|0|||
146126488|NCT01649375|526984612|FG004|Up to Week 16|Death|0|||
146126489|NCT01649375|526984608|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
146126490|NCT01649375|526984609|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
146126491|NCT01649375|526984610|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
146126492|NCT01649375|526984611|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
146126493|NCT01649375|526984612|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
146126494|NCT01649375|526984608|FG000|Week 16 up to Week 260|Non-compliance|0|||
146126495|NCT01649375|526984609|FG001|Week 16 up to Week 260|Non-compliance|1|||
146126496|NCT01649375|526984610|FG002|Week 16 up to Week 260|Non-compliance|0|||
146262717|NCT01837797|527476533|FG002|Period 1|Administrative reasons|0|||
146262718|NCT01837797|527476534|FG003|Period 1|Administrative reasons|0|||
146126497|NCT01649375|526984611|FG003|Week 16 up to Week 260|Non-compliance|1|||
146126498|NCT01649375|526984612|FG004|Week 16 up to Week 260|Non-compliance|0|||
146126499|NCT01649375|526984608|FG000|Week 16 up to Week 260|Physician Decision|0|||
146126500|NCT01649375|526984609|FG001|Week 16 up to Week 260|Physician Decision|2|||
146126501|NCT01649375|526984610|FG002|Week 16 up to Week 260|Physician Decision|0|||
146126502|NCT01649375|526984611|FG003|Week 16 up to Week 260|Physician Decision|0|||
146126503|NCT01649375|526984612|FG004|Week 16 up to Week 260|Physician Decision|0|||
146126504|NCT01649375|526984608|FG000|Week 16 up to Week 260|Technical issues|0|||
146126505|NCT01649375|526984609|FG001|Week 16 up to Week 260|Technical issues|1|||
146126506|NCT01649375|526984610|FG002|Week 16 up to Week 260|Technical issues|0|||
146126507|NCT01649375|526984611|FG003|Week 16 up to Week 260|Technical issues|1|||
146126508|NCT01649375|526984612|FG004|Week 16 up to Week 260|Technical issues|0|||
146126509|NCT01649375|526984608|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
146126510|NCT01649375|526984609|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
146126511|NCT01649375|526984610|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
146126512|NCT01649375|526984611|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
146126513|NCT01649375|526984612|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
146126514|NCT01649375|526984608|FG000|Week 16 up to Week 260|Death|1|||
146126515|NCT01649375|526984609|FG001|Week 16 up to Week 260|Death|1|||
146126516|NCT01649375|526984610|FG002|Week 16 up to Week 260|Death|0|||
146126517|NCT01649375|526984611|FG003|Week 16 up to Week 260|Death|0|||
146126518|NCT01649375|526984612|FG004|Week 16 up to Week 260|Death|0|||
146126519|NCT01649375|526984608|FG000|Week 16 up to Week 260|Adverse Event|5|||
146126520|NCT01649375|526984609|FG001|Week 16 up to Week 260|Adverse Event|2|||
146126521|NCT01649375|526984610|FG002|Week 16 up to Week 260|Adverse Event|0|||
146126522|NCT01649375|526984611|FG003|Week 16 up to Week 260|Adverse Event|3|||
146126523|NCT01649375|526984612|FG004|Week 16 up to Week 260|Adverse Event|2|||
146126524|NCT01124604|526984615|FG000|Overall Study|Adverse Event|10|||
146126525|NCT01124604|526984616|FG001|Overall Study|Adverse Event|1|||
146126526|NCT01124604|526984615|FG000|Overall Study|Lack of Efficacy|1|||
146126527|NCT01124604|526984616|FG001|Overall Study|Lack of Efficacy|0|||
146126528|NCT01124604|526984615|FG000|Overall Study|Withdrawal by Subject|4|||
146126529|NCT01124604|526984616|FG001|Overall Study|Withdrawal by Subject|0|||
146126530|NCT01124604|526984615|FG000|Overall Study|Disease Progression|0|||
146126531|NCT01124604|526984616|FG001|Overall Study|Disease Progression|1|||
146126532|NCT03102918|526984617|FG000|Overall Study|Protocol Violation|1|||
146126533|NCT03102918|526984618|FG001|Overall Study|Protocol Violation|0|||
146126534|NCT00952341|526984622|FG000|Cycle 1|Adverse Event|4|||
146126535|NCT00952341|526984623|FG001|Cycle 1|Adverse Event|1|||
146126536|NCT00952341|526984622|FG000|Cycle 1|Withdrawal by Subject|3|||
146126537|NCT00952341|526984623|FG001|Cycle 1|Withdrawal by Subject|8|||
146126538|NCT00952341|526984622|FG000|Cycle 1|Protocol Violation|2|||
146126539|NCT00952341|526984623|FG001|Cycle 1|Protocol Violation|1|||
146126540|NCT00952341|526984622|FG000|Cycle 1|Lost to Follow-up|11|||
146126541|NCT00952341|526984623|FG001|Cycle 1|Lost to Follow-up|2|||
146126542|NCT00952341|526984622|FG000|Cycle 1|Physician Decision|0|||
146126543|NCT00952341|526984623|FG001|Cycle 1|Physician Decision|1|||
146126544|NCT00952341|526984622|FG000|Cycle 2|Withdrawal by Subject|1|||
146126545|NCT00952341|526984623|FG001|Cycle 2|Withdrawal by Subject|1|||
146126546|NCT00952341|526984622|FG000|Cycle 2|Protocol Violation|1|||
146126547|NCT00952341|526984623|FG001|Cycle 2|Protocol Violation|0|||
146126548|NCT00952341|526984622|FG000|Cycle 2|Lost to Follow-up|6|||
146126549|NCT00952341|526984623|FG001|Cycle 2|Lost to Follow-up|9|||
146126550|NCT00952341|526984622|FG000|Cycle 2|Physician Decision|1|||
146126551|NCT00952341|526984623|FG001|Cycle 2|Physician Decision|1|||
146126552|NCT00952341|526984622|FG000|Cycle 2|Progressive Disease|0|||
146126553|NCT00952341|526984623|FG001|Cycle 2|Progressive Disease|1|||
146126554|NCT02066467|526984626|FG000|Overall Study|Did not undergo implant procedure|24|||
146126555|NCT02066467|526984626|FG000|Overall Study|Attempted to implant withoput success|43|||
146126556|NCT02066467|526984626|FG000|Overall Study|Consent ineligible|1|||
146126557|NCT02066467|526984626|FG000|Overall Study|Death|54|||
146126558|NCT02066467|526984626|FG000|Overall Study|Lost to Follow-up|51|||
146126559|NCT02066467|526984626|FG000|Overall Study|Adverse Event|20|||
146126560|NCT02066467|526984626|FG000|Overall Study|Withdrawal by Subject|16|||
146126561|NCT02066467|526984626|FG000|Overall Study|Physician Decision|2|||
146126562|NCT02066467|526984626|FG000|Overall Study|Not defined|4|||
146126563|NCT03056755|526984627|FG000|Treatment- Core Phase|Progressive disease|89|||
146126564|NCT03056755|526984628|FG001|Treatment- Core Phase|Progressive disease|88|||
146126565|NCT03056755|526984629|FG002|Treatment- Core Phase|Progressive disease|90|||
146126566|NCT03056755|526984627|FG000|Treatment- Core Phase|Adverse Event|20|||
146126567|NCT03056755|526984628|FG001|Treatment- Core Phase|Adverse Event|14|||
146126568|NCT03056755|526984629|FG002|Treatment- Core Phase|Adverse Event|13|||
146126569|NCT03056755|526984627|FG000|Treatment- Core Phase|Physician Decision|7|||
146126570|NCT03056755|526984628|FG001|Treatment- Core Phase|Physician Decision|13|||
146126571|NCT03056755|526984629|FG002|Treatment- Core Phase|Physician Decision|5|||
146262719|NCT01837797|527476535|FG004|Period 1|Administrative reasons|0|||
146126572|NCT03056755|526984627|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
146126573|NCT03056755|526984628|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
146303356|NCT00915772|527625745|FG001|Overall Study|Lack of Efficacy|15|||
146303357|NCT00915772|527625746|FG002|Overall Study|Lack of Efficacy|3|||
146303358|NCT00915772|527625744|FG000|Overall Study|Refused to continue trial medication|6|||
146303359|NCT00915772|527625745|FG001|Overall Study|Refused to continue trial medication|8|||
146303360|NCT00915772|527625746|FG002|Overall Study|Refused to continue trial medication|4|||
146126574|NCT03056755|526984629|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
146126575|NCT03056755|526984627|FG000|Treatment- Core Phase|Death|3|||
146126576|NCT03056755|526984628|FG001|Treatment- Core Phase|Death|2|||
146126577|NCT03056755|526984629|FG002|Treatment- Core Phase|Death|4|||
146126578|NCT03056755|526984627|FG000|Treatment- Core Phase|Protocol deviation|1|||
146126579|NCT03056755|526984628|FG001|Treatment- Core Phase|Protocol deviation|1|||
146126580|NCT03056755|526984629|FG002|Treatment- Core Phase|Protocol deviation|0|||
146126581|NCT03056755|526984627|FG000|Treatment- Core Phase|Technical problems|1|||
146126582|NCT03056755|526984628|FG001|Treatment- Core Phase|Technical problems|0|||
146126583|NCT03056755|526984629|FG002|Treatment- Core Phase|Technical problems|0|||
146126584|NCT03056755|526984627|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
146126585|NCT03056755|526984628|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
146126586|NCT03056755|526984629|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
146126587|NCT03056755|526984627|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
146126588|NCT03056755|526984628|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
146126589|NCT03056755|526984629|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
146126590|NCT03056755|526984627|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
146126591|NCT03056755|526984628|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
146126592|NCT03056755|526984629|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
146126593|NCT03056755|526984627|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
146126594|NCT03056755|526984628|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
146126595|NCT03056755|526984629|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
146126596|NCT04461015|526984632|FG000|Overall Study|IV access lost during the study|0|||
146126597|NCT04461015|526984633|FG001|Overall Study|IV access lost during the study|1|||
146126598|NCT04461015|526984632|FG000|Overall Study|Withdrawal by Subject|0|||
146126599|NCT04461015|526984633|FG001|Overall Study|Withdrawal by Subject|1|||
146126600|NCT00464568|526984634|FG000|Overall Study|Adverse Event|2|||
146126601|NCT02864251|526984648|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
146126602|NCT02864251|526984649|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
146126603|NCT02864251|526984650|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
146126604|NCT02864251|526984648|FG000|Pre-Treatment|Withdrawal by Participant|0|||
146126605|NCT02864251|526984649|FG001|Pre-Treatment|Withdrawal by Participant|0|||
146126606|NCT02864251|526984650|FG002|Pre-Treatment|Withdrawal by Participant|4|||
146126607|NCT02864251|526984648|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
146126608|NCT02864251|526984649|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
146126609|NCT02864251|526984650|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
146126610|NCT02864251|526984648|FG000|Pre-Treatment|Other Reasons|0|||
146126611|NCT02864251|526984649|FG001|Pre-Treatment|Other Reasons|1|||
146126612|NCT02864251|526984650|FG002|Pre-Treatment|Other Reasons|1|||
146126613|NCT02864251|526984648|FG000|Treatment|Disease Progression|109|||
146126614|NCT02864251|526984649|FG001|Treatment|Disease Progression|52|||
146126615|NCT02864251|526984650|FG002|Treatment|Disease Progression|101|||
146126616|NCT02864251|526984648|FG000|Treatment|Study Drug Toxicity|9|||
146126617|NCT02864251|526984649|FG001|Treatment|Study Drug Toxicity|4|||
146126618|NCT02864251|526984650|FG002|Treatment|Study Drug Toxicity|10|||
146126619|NCT02864251|526984648|FG000|Treatment|Death|0|||
146126620|NCT02864251|526984649|FG001|Treatment|Death|2|||
146126621|NCT02864251|526984650|FG002|Treatment|Death|3|||
146126622|NCT02864251|526984648|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
146126623|NCT02864251|526984649|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
146126624|NCT02864251|526984650|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
146126625|NCT02864251|526984648|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
146126626|NCT02864251|526984649|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
146126627|NCT02864251|526984650|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
146126628|NCT02864251|526984648|FG000|Treatment|Withdrawal by Participant|8|||
146126629|NCT02864251|526984649|FG001|Treatment|Withdrawal by Participant|5|||
146126630|NCT02864251|526984650|FG002|Treatment|Withdrawal by Participant|13|||
146126631|NCT02864251|526984648|FG000|Treatment|Maximum Clinical Benefit|1|||
146126632|NCT02864251|526984649|FG001|Treatment|Maximum Clinical Benefit|0|||
146126633|NCT02864251|526984650|FG002|Treatment|Maximum Clinical Benefit|1|||
146126634|NCT02864251|526984648|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
146126635|NCT02864251|526984649|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
146126636|NCT02864251|526984650|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
146126637|NCT02864251|526984648|FG000|Treatment|Other Reasons|1|||
146126638|NCT02864251|526984649|FG001|Treatment|Other Reasons|1|||
146126639|NCT02864251|526984650|FG002|Treatment|Other Reasons|4|||
146303361|NCT00915772|527625744|FG000|Overall Study|Any other reason|4|||
146126640|NCT02864251|526984648|FG000|Treatment|Administrative Reason by Sponsor|1|||
146126641|NCT02864251|526984649|FG001|Treatment|Administrative Reason by Sponsor|0|||
146126642|NCT02864251|526984650|FG002|Treatment|Administrative Reason by Sponsor|0|||
146126643|NCT03506373|526984651|FG000|Overall Study|Adverse Event|6|||
146126644|NCT03506373|526984651|FG000|Overall Study|Withdrawal by Subject|2|||
146126645|NCT03506373|526984651|FG000|Overall Study|Disease progression|5|||
146126646|NCT03506373|526984651|FG000|Overall Study|Other|3|||
146126647|NCT00885755|526984652|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
146126648|NCT00885755|526984653|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
146126649|NCT00885755|526984654|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
146126650|NCT00885755|526984652|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
146126651|NCT00885755|526984653|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
146126652|NCT00885755|526984654|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
146126653|NCT00885755|526984652|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
146126654|NCT00885755|526984653|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
146126655|NCT00885755|526984654|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
146126656|NCT00885755|526984652|FG000|Part I: Trastuzumab+Taxane|Death|0|||
146126657|NCT00885755|526984653|FG001|Part I: Trastuzumab+Taxane|Death|0|||
146126658|NCT00885755|526984654|FG002|Part I: Trastuzumab+Taxane|Death|1|||
146126659|NCT00885755|526984652|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
146126660|NCT00885755|526984653|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
146126661|NCT00885755|526984654|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
146126662|NCT00107198|526984655|FG000|Overall Study|Lack of Efficacy|28|||
146126663|NCT00107198|526984655|FG000|Overall Study|Lost to Follow-up|12|||
146126664|NCT00107198|526984655|FG000|Overall Study|Protocol Violation|1|||
146126665|NCT00107198|526984655|FG000|Overall Study|Withdrawal by Subject|6|||
146126666|NCT00107198|526984655|FG000|Overall Study|Ineligible|5|||
146126667|NCT02120950|526984661|FG000|Overall Study|Adverse Event|5|||
146126668|NCT02120950|526984662|FG001|Overall Study|Adverse Event|4|||
146126669|NCT02120950|526984663|FG002|Overall Study|Adverse Event|3|||
146126670|NCT02120950|526984661|FG000|Overall Study|Death|3|||
146126671|NCT02120950|526984662|FG001|Overall Study|Death|0|||
146126672|NCT02120950|526984663|FG002|Overall Study|Death|1|||
146126673|NCT02120950|526984661|FG000|Overall Study|Withdrawal by Subject|6|||
146126674|NCT02120950|526984662|FG001|Overall Study|Withdrawal by Subject|3|||
146126675|NCT02120950|526984663|FG002|Overall Study|Withdrawal by Subject|2|||
146126676|NCT02120950|526984661|FG000|Overall Study|Protocol Violation|1|||
146126677|NCT02120950|526984662|FG001|Overall Study|Protocol Violation|1|||
146126678|NCT02120950|526984663|FG002|Overall Study|Protocol Violation|7|||
146126679|NCT02120950|526984661|FG000|Overall Study|Other reasons|5|||
146126680|NCT02120950|526984662|FG001|Overall Study|Other reasons|4|||
146126681|NCT02120950|526984663|FG002|Overall Study|Other reasons|1|||
146126682|NCT02120950|526984661|FG000|Overall Study|Lost to Follow-up|0|||
146126683|NCT02120950|526984662|FG001|Overall Study|Lost to Follow-up|2|||
146126684|NCT02120950|526984663|FG002|Overall Study|Lost to Follow-up|1|||
146126685|NCT02625090|526984666|FG000|Overall Study|Participant wants to be pregnant|2|||
146126686|NCT02625090|526984666|FG000|Overall Study|For the Promoter|1|||
146126687|NCT02625090|526984666|FG000|Overall Study|Sponsor's Decision|9|||
146126688|NCT02625090|526984666|FG000|Overall Study|Somnolence|1|||
146126689|NCT02625090|526984666|FG000|Overall Study|Study terminated by Sponsor|7|||
146126690|NCT02625090|526984666|FG000|Overall Study|Negative Benefit/Risk|1|||
146126691|NCT02625090|526984666|FG000|Overall Study|Protocol Deviation|2|||
146126692|NCT02625090|526984666|FG000|Overall Study|Lack of Efficacy|16|||
146126693|NCT02625090|526984666|FG000|Overall Study|Adverse Event|3|||
146126694|NCT02250443|526984667|FG000|Overall Study|Administrative problems|7|||
146126695|NCT02250443|526984667|FG000|Overall Study|Adverse Event|3|||
146126696|NCT01549964|526984668|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
146126697|NCT01549964|526984669|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
146126698|NCT01549964|526984670|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
146126699|NCT01549964|526984671|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
146126700|NCT01549964|526984668|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
146126701|NCT01549964|526984669|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
146262720|NCT01837797|527476531|FG000|Period 1|Withdrawal of consent before treatment|1|||
146262721|NCT01837797|527476532|FG001|Period 1|Withdrawal of consent before treatment|0|||
146262722|NCT01837797|527476533|FG002|Period 1|Withdrawal of consent before treatment|0|||
146262723|NCT01837797|527476534|FG003|Period 1|Withdrawal of consent before treatment|0|||
146262724|NCT01837797|527476535|FG004|Period 1|Withdrawal of consent before treatment|0|||
146262725|NCT01837797|527476531|FG000|Period 1|Other|10|||
146126702|NCT01549964|526984670|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
146126703|NCT01549964|526984671|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
146126704|NCT01549964|526984668|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
146126705|NCT01549964|526984669|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146126706|NCT01549964|526984670|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146126707|NCT01549964|526984671|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
146126708|NCT01549964|526984668|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
146126709|NCT01549964|526984669|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
146126710|NCT01549964|526984670|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
146126711|NCT01549964|526984671|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
146126712|NCT01549964|526984668|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
146126713|NCT01549964|526984669|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
146126714|NCT01549964|526984670|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
146126715|NCT01549964|526984671|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
146126716|NCT01549964|526984668|FG000|24-Week Treatment Period|Other|1|||
146126717|NCT01549964|526984669|FG001|24-Week Treatment Period|Other|0|||
146126718|NCT01549964|526984670|FG002|24-Week Treatment Period|Other|1|||
146126719|NCT01549964|526984671|FG003|24-Week Treatment Period|Other|0|||
146126720|NCT01549964|526984668|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146126721|NCT01549964|526984669|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146126722|NCT01549964|526984670|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
146126723|NCT01549964|526984671|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
146126724|NCT01549964|526984668|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
146126725|NCT01549964|526984669|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
146126726|NCT01549964|526984670|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
146126727|NCT01549964|526984671|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
146126728|NCT01549964|526984668|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
146126729|NCT01549964|526984669|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
146126730|NCT01549964|526984670|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
146126731|NCT01549964|526984671|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
146126732|NCT01549964|526984668|FG000|80-Week Extension Period|Pregnancy|0|||
146126733|NCT01549964|526984669|FG001|80-Week Extension Period|Pregnancy|0|||
146126734|NCT01549964|526984670|FG002|80-Week Extension Period|Pregnancy|1|||
146126735|NCT01549964|526984671|FG003|80-Week Extension Period|Pregnancy|0|||
146126736|NCT01549964|526984668|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
146126737|NCT01549964|526984669|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
146126738|NCT01549964|526984670|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
146126739|NCT01549964|526984671|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
146126740|NCT01549964|526984668|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
146126741|NCT01549964|526984669|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
146126742|NCT01549964|526984670|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
146126743|NCT01549964|526984671|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
146126744|NCT01549964|526984668|FG000|80-Week Extension Period|Lost to Follow-up|1|||
146126745|NCT01549964|526984669|FG001|80-Week Extension Period|Lost to Follow-up|0|||
146126746|NCT01549964|526984670|FG002|80-Week Extension Period|Lost to Follow-up|2|||
146126747|NCT01549964|526984671|FG003|80-Week Extension Period|Lost to Follow-up|1|||
146126748|NCT01549964|526984668|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
146126749|NCT01549964|526984669|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
146126750|NCT01549964|526984670|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
146126751|NCT01549964|526984671|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
146126752|NCT01520363|526984677|FG000|Overall Study|Withdrawal by Subject|2|||
146126753|NCT01520363|526984678|FG001|Overall Study|Withdrawal by Subject|0|||
146126754|NCT00751348|526984682|FG000|Overall Study|Withdrawal by Subject|5|||
146126755|NCT00751348|526984683|FG001|Overall Study|Withdrawal by Subject|2|||
146126756|NCT00751348|526984682|FG000|Overall Study|Migration from study area|1|||
146126757|NCT00751348|526984683|FG001|Overall Study|Migration from study area|0|||
146126758|NCT04191382|526984687|FG000|Overall Study|Withdrawal by Subject|1|||
146126759|NCT04191382|526984688|FG001|Overall Study|Withdrawal by Subject|0|||
146126760|NCT04191382|526984689|FG002|Overall Study|Withdrawal by Subject|0|||
146126761|NCT05237206|526984690|FG000|Overall Study|screen failure-did not receive treatment|8|||
146126762|NCT05237206|526984690|FG000|Overall Study|did not receive treatment|3|||
146126763|NCT01476696|526984695|FG000|Overall Study|Sponsor decision|2|||
146126764|NCT01476696|526984696|FG001|Overall Study|Sponsor decision|1|||
146126765|NCT01476696|526984697|FG002|Overall Study|Sponsor decision|0|||
146126766|NCT01476696|526984695|FG000|Overall Study|Withdrawal by Subject|1|||
146126767|NCT01476696|526984696|FG001|Overall Study|Withdrawal by Subject|0|||
146126768|NCT01476696|526984697|FG002|Overall Study|Withdrawal by Subject|0|||
146126769|NCT02009046|526984699|FG000|Overall Study|Lost to Follow-up|256|||
146126770|NCT02009046|526984700|FG001|Overall Study|Lost to Follow-up|206|||
146126771|NCT01154218|526984706|FG000|Third Intervention Period|Adverse Event|0|||
146126772|NCT01154218|526984707|FG001|Third Intervention Period|Adverse Event|1|||
146126773|NCT01154218|526984708|FG002|Third Intervention Period|Adverse Event|0|||
146126774|NCT01154218|526984709|FG003|Third Intervention Period|Adverse Event|0|||
146126775|NCT01154218|526984706|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146126776|NCT01154218|526984707|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146126777|NCT01154218|526984708|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
146126778|NCT01154218|526984709|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
146126779|NCT01154218|526984706|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
146126780|NCT01154218|526984707|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
146126781|NCT01154218|526984708|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
146126782|NCT01154218|526984709|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
146126783|NCT00362115|526984710|FG000|Overall Study|Adverse Event|0|||
146126784|NCT00362115|526984711|FG001|Overall Study|Adverse Event|1|||
146126785|NCT00362115|526984712|FG002|Overall Study|Adverse Event|1|||
146126786|NCT00362115|526984713|FG003|Overall Study|Adverse Event|1|||
146126787|NCT00362115|526984714|FG004|Overall Study|Adverse Event|2|||
146126788|NCT00362115|526984715|FG005|Overall Study|Adverse Event|2|||
146126789|NCT00362115|526984716|FG006|Overall Study|Adverse Event|1|||
146126790|NCT00362115|526984710|FG000|Overall Study|Protocol Violation|0|||
146126791|NCT00362115|526984711|FG001|Overall Study|Protocol Violation|0|||
146126792|NCT00362115|526984712|FG002|Overall Study|Protocol Violation|0|||
146126793|NCT00362115|526984713|FG003|Overall Study|Protocol Violation|0|||
146126794|NCT00362115|526984714|FG004|Overall Study|Protocol Violation|0|||
146126795|NCT00362115|526984715|FG005|Overall Study|Protocol Violation|1|||
146126796|NCT00362115|526984716|FG006|Overall Study|Protocol Violation|0|||
146126797|NCT00362115|526984710|FG000|Overall Study|Lost to Follow-up|0|||
146126798|NCT00362115|526984711|FG001|Overall Study|Lost to Follow-up|1|||
146126799|NCT00362115|526984712|FG002|Overall Study|Lost to Follow-up|0|||
146126800|NCT00362115|526984713|FG003|Overall Study|Lost to Follow-up|0|||
146126801|NCT00362115|526984714|FG004|Overall Study|Lost to Follow-up|2|||
146126802|NCT00362115|526984715|FG005|Overall Study|Lost to Follow-up|0|||
146126803|NCT00362115|526984716|FG006|Overall Study|Lost to Follow-up|1|||
146126804|NCT00362115|526984710|FG000|Overall Study|Withdrawal by Subject|1|||
146126805|NCT00362115|526984711|FG001|Overall Study|Withdrawal by Subject|3|||
146126806|NCT00362115|526984712|FG002|Overall Study|Withdrawal by Subject|1|||
146126807|NCT00362115|526984713|FG003|Overall Study|Withdrawal by Subject|0|||
146126808|NCT00362115|526984714|FG004|Overall Study|Withdrawal by Subject|1|||
146126809|NCT00362115|526984715|FG005|Overall Study|Withdrawal by Subject|3|||
146126810|NCT00362115|526984716|FG006|Overall Study|Withdrawal by Subject|4|||
146126811|NCT00362115|526984710|FG000|Overall Study|Lack of Efficacy|1|||
146126812|NCT00362115|526984711|FG001|Overall Study|Lack of Efficacy|0|||
146126813|NCT00362115|526984712|FG002|Overall Study|Lack of Efficacy|5|||
146126814|NCT00362115|526984713|FG003|Overall Study|Lack of Efficacy|2|||
146126815|NCT00362115|526984714|FG004|Overall Study|Lack of Efficacy|2|||
146126816|NCT00362115|526984715|FG005|Overall Study|Lack of Efficacy|0|||
146126817|NCT00362115|526984716|FG006|Overall Study|Lack of Efficacy|3|||
146126818|NCT00362115|526984710|FG000|Overall Study|Physician Decision|0|||
146126819|NCT00362115|526984711|FG001|Overall Study|Physician Decision|0|||
146126820|NCT00362115|526984712|FG002|Overall Study|Physician Decision|0|||
146126821|NCT00362115|526984713|FG003|Overall Study|Physician Decision|0|||
146126822|NCT00362115|526984714|FG004|Overall Study|Physician Decision|0|||
146126823|NCT00362115|526984715|FG005|Overall Study|Physician Decision|0|||
146126824|NCT00362115|526984716|FG006|Overall Study|Physician Decision|3|||
146126825|NCT00362115|526984710|FG000|Overall Study|Other|0|||
146126826|NCT00362115|526984711|FG001|Overall Study|Other|1|||
146126827|NCT00362115|526984712|FG002|Overall Study|Other|0|||
146126828|NCT00362115|526984713|FG003|Overall Study|Other|1|||
146126829|NCT00362115|526984714|FG004|Overall Study|Other|0|||
146126830|NCT00362115|526984715|FG005|Overall Study|Other|1|||
146126831|NCT00362115|526984716|FG006|Overall Study|Other|0|||
146126832|NCT03965962|526984717|FG000|Overall Study|Adverse Event|1|||
146126833|NCT03965962|526984718|FG001|Overall Study|Adverse Event|0|||
146126834|NCT03965962|526984719|FG002|Overall Study|Adverse Event|0|||
146126835|NCT03965962|526984720|FG003|Overall Study|Adverse Event|0|||
146126836|NCT03965962|526984717|FG000|Overall Study|Protocol Violation|21|||
146126837|NCT03965962|526984718|FG001|Overall Study|Protocol Violation|4|||
146126838|NCT03965962|526984719|FG002|Overall Study|Protocol Violation|10|||
146126839|NCT03965962|526984720|FG003|Overall Study|Protocol Violation|5|||
146126840|NCT03965962|526984717|FG000|Overall Study|Lost to Follow-up|0|||
146126841|NCT03965962|526984718|FG001|Overall Study|Lost to Follow-up|1|||
146126842|NCT03965962|526984719|FG002|Overall Study|Lost to Follow-up|0|||
146126843|NCT03965962|526984720|FG003|Overall Study|Lost to Follow-up|0|||
146126844|NCT03965962|526984717|FG000|Overall Study|Withdrawal by Subject|3|||
146126845|NCT03965962|526984718|FG001|Overall Study|Withdrawal by Subject|0|||
146126846|NCT03965962|526984719|FG002|Overall Study|Withdrawal by Subject|0|||
146126847|NCT03965962|526984720|FG003|Overall Study|Withdrawal by Subject|1|||
146126848|NCT00741039|526984721|FG000|Overall Study|Patient non-compliance|2|||
146126849|NCT00741039|526984722|FG001|Overall Study|Patient non-compliance|0|||
146126850|NCT00878709|526984723|FG000|Overall Study|Withdrawal by Subject|197|||
146126851|NCT00878709|526984724|FG001|Overall Study|Withdrawal by Subject|120|||
146126852|NCT00878709|526984723|FG000|Overall Study|Lost to Follow-up|35|||
146126853|NCT00878709|526984724|FG001|Overall Study|Lost to Follow-up|33|||
146126854|NCT00878709|526984723|FG000|Overall Study|Other Reasons|93|||
146126855|NCT00878709|526984724|FG001|Overall Study|Other Reasons|84|||
146126856|NCT01712854|526984725|FG000|Overall Study|Physician Decision|1|||
146126857|NCT02225743|526984726|FG000|Overall Study|Withdrawal by Subject|18|||
146126858|NCT03886220|526984729|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
146262726|NCT01837797|527476532|FG001|Period 1|Other|0|||
146262727|NCT01837797|527476533|FG002|Period 1|Other|0|||
146126859|NCT03886220|526984730|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
146126860|NCT03886220|526984729|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
146126861|NCT03886220|526984730|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146126862|NCT03886220|526984729|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146126863|NCT03886220|526984730|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146126864|NCT00768300|526984731|FG000|Overall Study|Randomized but not treated|1|||
146126865|NCT00768300|526984732|FG001|Overall Study|Randomized but not treated|1|||
146126866|NCT00768300|526984731|FG000|Overall Study|Adverse Event|10|||
146126867|NCT00768300|526984732|FG001|Overall Study|Adverse Event|2|||
146126868|NCT00768300|526984731|FG000|Overall Study|Protocol Violation|6|||
146126869|NCT00768300|526984732|FG001|Overall Study|Protocol Violation|1|||
146126870|NCT00768300|526984731|FG000|Overall Study|Withdrawal by Subject|13|||
146126871|NCT00768300|526984732|FG001|Overall Study|Withdrawal by Subject|7|||
146126872|NCT00768300|526984731|FG000|Overall Study|Physician Decision|2|||
146126873|NCT00768300|526984732|FG001|Overall Study|Physician Decision|3|||
146126874|NCT00768300|526984731|FG000|Overall Study|Study discontinued by Sponsor|271|||
146126875|NCT00768300|526984732|FG001|Overall Study|Study discontinued by Sponsor|140|||
146126876|NCT00768300|526984731|FG000|Overall Study|Death|21|||
146126877|NCT00768300|526984732|FG001|Overall Study|Death|5|||
146126878|NCT00768300|526984731|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
146126879|NCT00768300|526984732|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
146126880|NCT00768300|526984731|FG000|Overall Study|Screen failure following randomization|1|||
146126881|NCT00768300|526984732|FG001|Overall Study|Screen failure following randomization|0|||
146126882|NCT00768300|526984731|FG000|Overall Study|Received lung transplant|1|||
146126883|NCT00768300|526984732|FG001|Overall Study|Received lung transplant|1|||
146126884|NCT00768300|526984731|FG000|Overall Study|Lost to Follow-up|0|||
146126885|NCT00768300|526984732|FG001|Overall Study|Lost to Follow-up|1|||
146126886|NCT00768300|526984731|FG000|Overall Study|Began prohibited concomitant medication|0|||
146126887|NCT00768300|526984732|FG001|Overall Study|Began prohibited concomitant medication|1|||
146126888|NCT00768300|526984731|FG000|Overall Study|Treated but never dosed with Study drug|1|||
146126889|NCT00768300|526984732|FG001|Overall Study|Treated but never dosed with Study drug|0|||
146126890|NCT00768300|526984731|FG000|Overall Study|Missing data|1|||
146126891|NCT00768300|526984732|FG001|Overall Study|Missing data|0|||
146126892|NCT00322842|526984733|FG000|Overall Study|Withdrawal by Subject|0|||
146126893|NCT00322842|526984734|FG001|Overall Study|Withdrawal by Subject|1|||
146126894|NCT00322842|526984733|FG000|Overall Study|Lost to Follow-up|0|||
146126895|NCT00322842|526984734|FG001|Overall Study|Lost to Follow-up|1|||
146126896|NCT00322842|526984733|FG000|Overall Study|Refused transplant|1|||
146126897|NCT00322842|526984734|FG001|Overall Study|Refused transplant|0|||
146126898|NCT00322842|526984733|FG000|Overall Study|Death|1|||
146126899|NCT00322842|526984734|FG001|Overall Study|Death|0|||
146126900|NCT03082599|526984737|FG000|Overall Study|Lost to Follow-up|1|||
146126901|NCT03082599|526984738|FG001|Overall Study|Lost to Follow-up|0|||
146126902|NCT00946712|526984749|FG000|Overall Study|Adverse Event|118|||
146126903|NCT00946712|526984750|FG001|Overall Study|Adverse Event|124|||
146126904|NCT00946712|526984749|FG000|Overall Study|Disease progression|308|||
146126905|NCT00946712|526984750|FG001|Overall Study|Disease progression|404|||
146126906|NCT00946712|526984749|FG000|Overall Study|Death|21|||
146126907|NCT00946712|526984750|FG001|Overall Study|Death|22|||
146126908|NCT00946712|526984749|FG000|Overall Study|No treatment given|25|||
146126909|NCT00946712|526984750|FG001|Overall Study|No treatment given|29|||
146126910|NCT00946712|526984749|FG000|Overall Study|Other reasons|61|||
146126911|NCT00946712|526984750|FG001|Overall Study|Other reasons|73|||
146126912|NCT00946712|526984749|FG000|Overall Study|On Treatment|0|||
146126913|NCT00946712|526984750|FG001|Overall Study|On Treatment|4|||
146126914|NCT00946712|526984749|FG000|Overall Study|Ineligible|14|||
146126915|NCT00946712|526984750|FG001|Overall Study|Ineligible|6|||
146126916|NCT00156533|526985925|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
146126917|NCT00156533|526985926|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
146126918|NCT00156533|526985927|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
146262728|NCT01837797|527476534|FG003|Period 1|Other|0|||
146126919|NCT00156533|526985928|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
146126920|NCT00156533|526985925|FG000|Overall Study|Withdrawal by Subject|1|||
146126921|NCT00156533|526985926|FG001|Overall Study|Withdrawal by Subject|0|||
146126922|NCT00156533|526985927|FG002|Overall Study|Withdrawal by Subject|0|||
146126923|NCT00156533|526985928|FG003|Overall Study|Withdrawal by Subject|1|||
146126924|NCT00156533|526985925|FG000|Overall Study|Failed Screening|1|||
146126925|NCT00156533|526985926|FG001|Overall Study|Failed Screening|0|||
146126926|NCT00156533|526985927|FG002|Overall Study|Failed Screening|1|||
146126927|NCT00156533|526985928|FG003|Overall Study|Failed Screening|1|||
146126928|NCT01541969|526985931|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
146126929|NCT01541969|526985932|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
146126930|NCT01541969|526985931|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
146262729|NCT01837797|527476535|FG004|Period 1|Other|0|||
146262730|NCT01837797|527476531|FG000|Period 2|Administrative or other reasons|0|||
146262731|NCT01837797|527476532|FG001|Period 2|Administrative or other reasons|5|||
146262732|NCT01837797|527476533|FG002|Period 2|Administrative or other reasons|2|||
146262733|NCT01837797|527476534|FG003|Period 2|Administrative or other reasons|4|||
146126931|NCT01541969|526985932|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
146126932|NCT01541969|526985931|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
146126933|NCT01541969|526985932|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
146126934|NCT01541969|526985931|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
146126935|NCT01541969|526985932|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
146126936|NCT01541969|526985931|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
146126937|NCT01541969|526985932|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
146126938|NCT01541969|526985931|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
146126939|NCT01541969|526985932|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
146126940|NCT01541969|526985931|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
146126941|NCT01541969|526985932|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
146126942|NCT01541969|526985931|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
146126943|NCT01541969|526985932|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
146126944|NCT01541969|526985931|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
146126945|NCT01541969|526985932|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
146126946|NCT01541969|526985931|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
146126947|NCT01541969|526985932|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
146126948|NCT01365507|526985933|FG000|Overall Study|Withdrawal Criteria|8|||
146126949|NCT01365507|526985934|FG001|Overall Study|Withdrawal Criteria|5|||
146126950|NCT01365507|526985933|FG000|Overall Study|Unclassified|1|||
146126951|NCT01365507|526985934|FG001|Overall Study|Unclassified|4|||
146126952|NCT03265249|526985937|FG000|Overall Study|Withdrawal by Subject|0|||
146126953|NCT03265249|526985938|FG001|Overall Study|Withdrawal by Subject|1|||
146126954|NCT01614990|526985939|FG000|Overall Study|Protocol Violation|1|||
146126955|NCT01614990|526985940|FG001|Overall Study|Protocol Violation|1|||
146126956|NCT02255500|526985947|FG000|Overall Study|Withdrawal by Subject|1|||
146126957|NCT02255500|526985948|FG001|Overall Study|Withdrawal by Subject|0|||
146126958|NCT01012622|526985949|FG000|Overall Study|Withdrawal by Subject|6|||
146126959|NCT01012622|526985949|FG000|Overall Study|Lost to Follow-up|5|||
146126960|NCT01012622|526985949|FG000|Overall Study|Adverse Event|7|||
146126961|NCT01012622|526985949|FG000|Overall Study|non-compliance with the drug|9|||
146126962|NCT01012622|526985949|FG000|Overall Study|Other|1|||
146126963|NCT01012622|526985949|FG000|Overall Study|screening failure|1|||
146126964|NCT01012622|526985949|FG000|Overall Study|withdrawal of consent by a parent|2|||
146126965|NCT04254978|526985950|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
146126966|NCT04254978|526985950|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
146126967|NCT04254978|526985950|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
146126968|NCT04254978|526985950|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
146126969|NCT04254978|526985950|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
146126970|NCT04254978|526985950|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
146126971|NCT02515942|526985951|FG000|Overall Study|Adverse Event|5|||
146126972|NCT02515942|526985952|FG001|Overall Study|Adverse Event|0|||
146126973|NCT02515942|526985953|FG002|Overall Study|Adverse Event|0|||
146126974|NCT02515942|526985951|FG000|Overall Study|Death|0|||
146126975|NCT02515942|526985952|FG001|Overall Study|Death|0|||
146126976|NCT02515942|526985953|FG002|Overall Study|Death|1|||
146126977|NCT02515942|526985951|FG000|Overall Study|Lack of Efficacy|0|||
146126978|NCT02515942|526985952|FG001|Overall Study|Lack of Efficacy|0|||
146126979|NCT02515942|526985953|FG002|Overall Study|Lack of Efficacy|1|||
146126980|NCT02515942|526985951|FG000|Overall Study|Lost to Follow-up|2|||
146126981|NCT02515942|526985952|FG001|Overall Study|Lost to Follow-up|0|||
146126982|NCT02515942|526985953|FG002|Overall Study|Lost to Follow-up|0|||
146126983|NCT02515942|526985951|FG000|Overall Study|Withdrawal by Subject|0|||
146126984|NCT02515942|526985952|FG001|Overall Study|Withdrawal by Subject|3|||
146126985|NCT02515942|526985953|FG002|Overall Study|Withdrawal by Subject|2|||
146126986|NCT04765358|526985954|FG000|Overall Study|Withdrawal by Subject|1|||
146126987|NCT03406858|526985956|FG000|Overall Study|Failure to receive treatment drug.|1|||
146262734|NCT01837797|527476535|FG004|Period 2|Administrative or other reasons|0|||
146262735|NCT01837797|527476531|FG000|Period 2|Adverse Event|0|||
146262736|NCT01837797|527476532|FG001|Period 2|Adverse Event|0|||
146126988|NCT03406858|526985956|FG000|Overall Study|ineligible|1|||
146126989|NCT00405587|526985957|FG000|Overall Study|Death|0|||
146126990|NCT00405587|526985958|FG001|Overall Study|Death|0|||
146126991|NCT00405587|526985959|FG002|Overall Study|Death|0|||
146126992|NCT00405587|526985960|FG003|Overall Study|Death|1|||
146126993|NCT00405587|526985957|FG000|Overall Study|Disease Progression|22|||
146126994|NCT00405587|526985958|FG001|Overall Study|Disease Progression|23|||
146126995|NCT00405587|526985959|FG002|Overall Study|Disease Progression|21|||
146126996|NCT00405587|526985960|FG003|Overall Study|Disease Progression|17|||
146126997|NCT00405587|526985957|FG000|Overall Study|Physician Decision|3|||
146126998|NCT00405587|526985958|FG001|Overall Study|Physician Decision|2|||
146126999|NCT00405587|526985959|FG002|Overall Study|Physician Decision|0|||
146127000|NCT00405587|526985960|FG003|Overall Study|Physician Decision|0|||
146127001|NCT00405587|526985957|FG000|Overall Study|Adverse Event|1|||
146127002|NCT00405587|526985958|FG001|Overall Study|Adverse Event|0|||
146127003|NCT00405587|526985959|FG002|Overall Study|Adverse Event|0|||
146127004|NCT00405587|526985960|FG003|Overall Study|Adverse Event|0|||
146127005|NCT00405587|526985957|FG000|Overall Study|Lost to Follow-up|0|||
146127006|NCT00405587|526985958|FG001|Overall Study|Lost to Follow-up|1|||
146127007|NCT00405587|526985959|FG002|Overall Study|Lost to Follow-up|1|||
146127008|NCT00405587|526985960|FG003|Overall Study|Lost to Follow-up|0|||
146127009|NCT00405587|526985957|FG000|Overall Study|Radiation induced necrosis|0|||
146127010|NCT00405587|526985958|FG001|Overall Study|Radiation induced necrosis|1|||
146127011|NCT00405587|526985959|FG002|Overall Study|Radiation induced necrosis|0|||
146127012|NCT00405587|526985960|FG003|Overall Study|Radiation induced necrosis|0|||
146127013|NCT00405587|526985957|FG000|Overall Study|Withdrawal by Subject|0|||
146127014|NCT00405587|526985958|FG001|Overall Study|Withdrawal by Subject|0|||
146127015|NCT00405587|526985959|FG002|Overall Study|Withdrawal by Subject|0|||
146127016|NCT00405587|526985960|FG003|Overall Study|Withdrawal by Subject|2|||
146127017|NCT00405587|526985957|FG000|Overall Study|Participant not dosed|0|||
146127018|NCT00405587|526985958|FG001|Overall Study|Participant not dosed|1|||
146127019|NCT00405587|526985959|FG002|Overall Study|Participant not dosed|0|||
146127020|NCT00405587|526985960|FG003|Overall Study|Participant not dosed|0|||
146127021|NCT02419742|526985963|FG000|Overall Study|Adverse Event|2|||
146127022|NCT02419742|526985964|FG001|Overall Study|Adverse Event|0|||
146127023|NCT02419742|526985963|FG000|Overall Study|Disease Progression|0|||
146127024|NCT02419742|526985964|FG001|Overall Study|Disease Progression|1|||
146127025|NCT02419742|526985963|FG000|Overall Study|Withdrew Consent|2|||
146127026|NCT02419742|526985964|FG001|Overall Study|Withdrew Consent|1|||
146127027|NCT02419742|526985963|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
146127028|NCT02419742|526985964|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
146127029|NCT00507442|526985967|FG000|Overall Study|Adverse Event|8|||
146127030|NCT00507442|526985968|FG001|Overall Study|Adverse Event|11|||
146127031|NCT00507442|526985969|FG002|Overall Study|Adverse Event|4|||
146127032|NCT00507442|526985970|FG003|Overall Study|Adverse Event|1|||
146127033|NCT00507442|526985967|FG000|Overall Study|Protocol Violation|0|||
146127034|NCT00507442|526985968|FG001|Overall Study|Protocol Violation|1|||
146127035|NCT00507442|526985969|FG002|Overall Study|Protocol Violation|0|||
146262737|NCT01837797|527476533|FG002|Period 2|Adverse Event|0|||
146262738|NCT01837797|527476534|FG003|Period 2|Adverse Event|1|||
146262739|NCT01837797|527476535|FG004|Period 2|Adverse Event|0|||
146262740|NCT01837797|527476531|FG000|Period 3|Adverse Event|0|||
146262741|NCT01837797|527476532|FG001|Period 3|Adverse Event|0|||
146262742|NCT01837797|527476533|FG002|Period 3|Adverse Event|0|||
146262743|NCT01837797|527476534|FG003|Period 3|Adverse Event|0|||
146262744|NCT01837797|527476535|FG004|Period 3|Adverse Event|1|||
146262745|NCT01837797|527476531|FG000|Period 3|Administrative reasons|0|||
146262746|NCT01837797|527476532|FG001|Period 3|Administrative reasons|0|||
146262747|NCT01837797|527476533|FG002|Period 3|Administrative reasons|0|||
146262748|NCT01837797|527476534|FG003|Period 3|Administrative reasons|0|||
146262749|NCT01837797|527476535|FG004|Period 3|Administrative reasons|20|||
146262750|NCT01837797|527476531|FG000|Period 3|Other|0|||
146262751|NCT01837797|527476532|FG001|Period 3|Other|0|||
146262752|NCT01837797|527476533|FG002|Period 3|Other|0|||
146262753|NCT01837797|527476534|FG003|Period 3|Other|0|||
146262754|NCT01837797|527476535|FG004|Period 3|Other|2|||
146262755|NCT03797989|527476536|FG000|VAC069A|Withdrawal by Subject|0|||
146262756|NCT03797989|527476537|FG001|VAC069A|Withdrawal by Subject|0|||
146262757|NCT03797989|527476538|FG002|VAC069A|Withdrawal by Subject|1|||
146262758|NCT03797989|527476539|FG003|VAC069A|Withdrawal by Subject|0|||
146262759|NCT03797989|527476540|FG004|VAC069A|Withdrawal by Subject|0|||
146262760|NCT03797989|527476541|FG005|VAC069A|Withdrawal by Subject|0|||
146262761|NCT03797989|527476542|FG006|VAC069A|Withdrawal by Subject|0|||
146262762|NCT03797989|527476543|FG007|VAC069A|Withdrawal by Subject|0|||
146262763|NCT03797989|527476544|FG008|VAC069A|Withdrawal by Subject|0|||
146262764|NCT03797989|527476545|FG009|VAC069A|Withdrawal by Subject|0|||
146262765|NCT03797989|527476546|FG010|VAC069A|Withdrawal by Subject|0|||
146262766|NCT03797989|527476547|FG011|VAC069A|Withdrawal by Subject|0|||
146262767|NCT04052997|527476548|FG000|Overall Study|Withdrawal by Subject|17|||
146262768|NCT04052997|527476548|FG000|Overall Study|Physician Decision|50|||
146262769|NCT04052997|527476548|FG000|Overall Study|Death|43|||
146262770|NCT04052997|527476548|FG000|Overall Study|Lost to Follow-up|5|||
146262771|NCT04052997|527476548|FG000|Overall Study|Progression of Disease|1|||
146262772|NCT00934700|527476555|FG000|Overall Study|missing scan|5|||
146262773|NCT00934700|527476556|FG001|Overall Study|missing scan|9|||
146262774|NCT00934700|527476555|FG000|Overall Study|Death|8|||
146262775|NCT00934700|527476556|FG001|Overall Study|Death|3|||
146262776|NCT03049306|527476559|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
146262777|NCT03049306|527476560|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
146262778|NCT03151551|527476561|FG000|Open-Label Treatment Period|Adverse Event|0|||
146262779|NCT03151551|527476562|FG001|Open-Label Treatment Period|Adverse Event|2|||
146262780|NCT03151551|527476561|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
146127036|NCT00507442|526985970|FG003|Overall Study|Protocol Violation|0|||
146127037|NCT00507442|526985967|FG000|Overall Study|Lost to Follow-up|0|||
146127038|NCT00507442|526985968|FG001|Overall Study|Lost to Follow-up|0|||
146127039|NCT00507442|526985969|FG002|Overall Study|Lost to Follow-up|1|||
146127040|NCT00507442|526985970|FG003|Overall Study|Lost to Follow-up|0|||
146127041|NCT00507442|526985967|FG000|Overall Study|Physician Decision|0|||
146127042|NCT00507442|526985968|FG001|Overall Study|Physician Decision|2|||
146127043|NCT00507442|526985969|FG002|Overall Study|Physician Decision|4|||
146127044|NCT00507442|526985970|FG003|Overall Study|Physician Decision|1|||
146127045|NCT00507442|526985967|FG000|Overall Study|Progressive Disease|2|||
146127046|NCT00507442|526985968|FG001|Overall Study|Progressive Disease|4|||
146127047|NCT00507442|526985969|FG002|Overall Study|Progressive Disease|2|||
146127048|NCT00507442|526985970|FG003|Overall Study|Progressive Disease|0|||
146127049|NCT00507442|526985967|FG000|Overall Study|Withdrawal by Subject|4|||
146127050|NCT00507442|526985968|FG001|Overall Study|Withdrawal by Subject|4|||
146127051|NCT00507442|526985969|FG002|Overall Study|Withdrawal by Subject|2|||
146127052|NCT00507442|526985970|FG003|Overall Study|Withdrawal by Subject|1|||
146127053|NCT00507442|526985967|FG000|Overall Study|Other|2|||
146127054|NCT00507442|526985968|FG001|Overall Study|Other|5|||
146127055|NCT00507442|526985969|FG002|Overall Study|Other|2|||
146127056|NCT00507442|526985970|FG003|Overall Study|Other|2|||
146127057|NCT02672423|526985972|FG000|Period 1|Adverse Event|0|||
146127058|NCT02672423|526985973|FG001|Period 1|Adverse Event|0|||
146127059|NCT02672423|526985974|FG002|Period 1|Adverse Event|0|||
146127060|NCT02672423|526985975|FG003|Period 1|Adverse Event|0|||
146127061|NCT02672423|526985976|FG004|Period 1|Adverse Event|1|||
146127062|NCT02672423|526985977|FG005|Period 1|Adverse Event|0|||
146127063|NCT02672423|526985978|FG006|Period 1|Adverse Event|0|||
146127064|NCT02672423|526985979|FG007|Period 1|Adverse Event|0|||
146127065|NCT02672423|526985980|FG008|Period 1|Adverse Event|0|||
146127066|NCT02672423|526985981|FG009|Period 1|Adverse Event|0|||
146127067|NCT02672423|526985972|FG000|Period 2|Withdrawal by Subject|0|||
146127068|NCT02672423|526985973|FG001|Period 2|Withdrawal by Subject|0|||
146127069|NCT02672423|526985974|FG002|Period 2|Withdrawal by Subject|1|||
146127070|NCT02672423|526985975|FG003|Period 2|Withdrawal by Subject|0|||
146127071|NCT02672423|526985976|FG004|Period 2|Withdrawal by Subject|0|||
146127072|NCT02672423|526985977|FG005|Period 2|Withdrawal by Subject|0|||
146127073|NCT02672423|526985978|FG006|Period 2|Withdrawal by Subject|0|||
146127074|NCT02672423|526985979|FG007|Period 2|Withdrawal by Subject|0|||
146127075|NCT02672423|526985980|FG008|Period 2|Withdrawal by Subject|0|||
146127076|NCT02672423|526985981|FG009|Period 2|Withdrawal by Subject|0|||
146127077|NCT02672423|526985972|FG000|Period 3|Withdrawal by Subject|0|||
146127078|NCT02672423|526985973|FG001|Period 3|Withdrawal by Subject|0|||
146127079|NCT02672423|526985974|FG002|Period 3|Withdrawal by Subject|0|||
146127080|NCT02672423|526985975|FG003|Period 3|Withdrawal by Subject|0|||
146127081|NCT02672423|526985976|FG004|Period 3|Withdrawal by Subject|0|||
146127082|NCT02672423|526985977|FG005|Period 3|Withdrawal by Subject|0|||
146127083|NCT02672423|526985978|FG006|Period 3|Withdrawal by Subject|0|||
146127084|NCT02672423|526985979|FG007|Period 3|Withdrawal by Subject|1|||
146127085|NCT02672423|526985980|FG008|Period 3|Withdrawal by Subject|0|||
146127086|NCT02672423|526985981|FG009|Period 3|Withdrawal by Subject|0|||
146127087|NCT02672423|526985972|FG000|Period 3|Physician Decision|0|||
146127088|NCT02672423|526985973|FG001|Period 3|Physician Decision|0|||
146127089|NCT02672423|526985974|FG002|Period 3|Physician Decision|0|||
146127090|NCT02672423|526985975|FG003|Period 3|Physician Decision|0|||
146127091|NCT02672423|526985976|FG004|Period 3|Physician Decision|0|||
146127092|NCT02672423|526985977|FG005|Period 3|Physician Decision|1|||
146127093|NCT02672423|526985978|FG006|Period 3|Physician Decision|0|||
146127094|NCT02672423|526985979|FG007|Period 3|Physician Decision|0|||
146127095|NCT02672423|526985980|FG008|Period 3|Physician Decision|0|||
146127096|NCT02672423|526985981|FG009|Period 3|Physician Decision|0|||
146127097|NCT01852812|526985982|FG000|Overall Study|Adverse Event|0|||
146127098|NCT01852812|526985983|FG001|Overall Study|Adverse Event|0|||
146127099|NCT01852812|526985984|FG002|Overall Study|Adverse Event|1|||
146127100|NCT01852812|526985982|FG000|Overall Study|Non-compliance With Study Drug|0|||
146127101|NCT01852812|526985983|FG001|Overall Study|Non-compliance With Study Drug|1|||
146127102|NCT01852812|526985984|FG002|Overall Study|Non-compliance With Study Drug|0|||
146127103|NCT02290821|526985985|FG000|Overall Study|Withdrawal by Subject|1|||
146127104|NCT02290821|526985986|FG001|Overall Study|Withdrawal by Subject|1|||
146127105|NCT02290821|526985985|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
146127106|NCT02290821|526985986|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
146127107|NCT02290821|526985985|FG000|Overall Study|Lost to Follow-up|3|||
146127108|NCT02290821|526985986|FG001|Overall Study|Lost to Follow-up|2|||
146127109|NCT02438722|526985987|FG000|Overall Study|Adverse Event|12|||
146127110|NCT02438722|526985988|FG001|Overall Study|Adverse Event|9|||
146127111|NCT02438722|526985987|FG000|Overall Study|Refusal unrelated to AE|2|||
146127112|NCT02438722|526985988|FG001|Overall Study|Refusal unrelated to AE|5|||
146127113|NCT02438722|526985987|FG000|Overall Study|Disease progression/relapse|46|||
146127114|NCT02438722|526985988|FG001|Overall Study|Disease progression/relapse|51|||
146127115|NCT02438722|526985987|FG000|Overall Study|Death|0|||
146127116|NCT02438722|526985988|FG001|Overall Study|Death|3|||
146127117|NCT02438722|526985987|FG000|Overall Study|Physician Decision|2|||
146127118|NCT02438722|526985988|FG001|Overall Study|Physician Decision|2|||
146127119|NCT02438722|526985987|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
146127120|NCT02438722|526985988|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
146127121|NCT02438722|526985987|FG000|Overall Study|Withdrawal by Subject|0|||
146127122|NCT02438722|526985988|FG001|Overall Study|Withdrawal by Subject|1|||
146127123|NCT02438722|526985987|FG000|Overall Study|On protocol treatment|15|||
146127124|NCT02438722|526985988|FG001|Overall Study|On protocol treatment|14|||
146127125|NCT02438722|526985987|FG000|Overall Study|Did not receive protocol treatment|5|||
146127126|NCT02438722|526985988|FG001|Overall Study|Did not receive protocol treatment|0|||
146127127|NCT00768144|526985992|FG000|Overall Study|Adverse Event|13|||
146127128|NCT00768144|526985992|FG000|Overall Study|Progressive Disease|21|||
146127129|NCT00768144|526985992|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
146127130|NCT00768144|526985992|FG000|Overall Study|Pt Withdrew Consent|1|||
146127131|NCT01150123|526985993|FG000|Overall Study|Withdrawal by Subject|1|||
146127132|NCT01150123|526985994|FG001|Overall Study|Withdrawal by Subject|1|||
146127133|NCT01150123|526985995|FG002|Overall Study|Withdrawal by Subject|2|||
146127134|NCT01150123|526985996|FG003|Overall Study|Withdrawal by Subject|1|||
146127135|NCT01150123|526985997|FG004|Overall Study|Withdrawal by Subject|1|||
146127136|NCT01150123|526985998|FG005|Overall Study|Withdrawal by Subject|1|||
146127137|NCT01150123|526985999|FG006|Overall Study|Withdrawal by Subject|0|||
146127138|NCT01150123|526986000|FG007|Overall Study|Withdrawal by Subject|3|||
146262781|NCT03151551|527476562|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
146262782|NCT03151551|527476561|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
146303362|NCT00915772|527625745|FG001|Overall Study|Any other reason|7|||
146303363|NCT00915772|527625746|FG002|Overall Study|Any other reason|7|||
146303364|NCT01211535|527625747|FG000|Overall Study|Adverse Event|0|||
146303365|NCT01211535|527625748|FG001|Overall Study|Adverse Event|1|||
146303366|NCT00549939|527625754|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
146303367|NCT00549939|527625755|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
146303368|NCT00549939|527625756|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
146303369|NCT00549939|527625754|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
146303370|NCT00549939|527625755|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
146303371|NCT00549939|527625756|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
146303372|NCT00549939|527625754|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
146303373|NCT00549939|527625755|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
146262783|NCT03151551|527476562|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
146303374|NCT00549939|527625756|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
146303375|NCT00549939|527625754|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
146303376|NCT00549939|527625755|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
146303377|NCT00549939|527625756|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
146262784|NCT03151551|527476561|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
146262785|NCT03151551|527476562|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
146262786|NCT03151551|527476561|FG000|Open-Label Treatment Period|Physician Decision|3|||
146262787|NCT03151551|527476562|FG001|Open-Label Treatment Period|Physician Decision|0|||
146262788|NCT03151551|527476561|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
146262789|NCT03151551|527476562|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
146262790|NCT03151551|527476561|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
146262791|NCT03151551|527476562|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
146262792|NCT03151551|527476561|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
146262793|NCT03151551|527476562|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
146262794|NCT03151551|527476561|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
146262795|NCT03151551|527476562|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
146262796|NCT03151551|527476561|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
146262797|NCT03151551|527476562|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
146262798|NCT05896696|527476563|FG000|Overall Study|Screening Failure|7|||
146262799|NCT05896696|527476563|FG000|Overall Study|Withdrawal by Subject|2|||
146262800|NCT00143598|527476564|FG000|Overall Study|Lost to Follow-up|23|||
146262801|NCT00143598|527476565|FG001|Overall Study|Lost to Follow-up|21|||
146262802|NCT00143598|527476564|FG000|Overall Study|Withdrawal by Subject|33|||
146262803|NCT00143598|527476565|FG001|Overall Study|Withdrawal by Subject|37|||
146262804|NCT00143598|527476564|FG000|Overall Study|Death|36|||
146303378|NCT00549939|527625754|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
146303379|NCT00549939|527625755|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
146303380|NCT00549939|527625756|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
146303381|NCT00549939|527625754|FG000|40-week Open Label Treatment Period|Other|0|||
146127139|NCT01150123|526986001|FG008|Overall Study|Withdrawal by Subject|2|||
146127140|NCT01150123|526986002|FG009|Overall Study|Withdrawal by Subject|0|||
146262805|NCT00143598|527476565|FG001|Overall Study|Death|36|||
146262806|NCT03900715|527476566|FG000|Overall Study|Protocol Deviation|1|||
146262807|NCT03900715|527476566|FG000|Overall Study|Lack of Efficacy|1|||
146262808|NCT03900715|527476566|FG000|Overall Study|Progressive Disease|6|||
146127141|NCT01150123|526986003|FG010|Overall Study|Withdrawal by Subject|1|||
146127142|NCT01150123|526986004|FG011|Overall Study|Withdrawal by Subject|0|||
146127143|NCT01150123|526986005|FG012|Overall Study|Withdrawal by Subject|1|||
146127144|NCT01150123|526986006|FG013|Overall Study|Withdrawal by Subject|0|||
146127145|NCT01150123|526986007|FG014|Overall Study|Withdrawal by Subject|0|||
146127146|NCT01150123|526986008|FG015|Overall Study|Withdrawal by Subject|1|||
146127147|NCT01150123|526986009|FG016|Overall Study|Withdrawal by Subject|0|||
146127148|NCT01150123|526986010|FG017|Overall Study|Withdrawal by Subject|1|||
146127149|NCT01150123|526985993|FG000|Overall Study|Lost to Follow-up|2|||
146127150|NCT01150123|526985994|FG001|Overall Study|Lost to Follow-up|1|||
146127151|NCT01150123|526985995|FG002|Overall Study|Lost to Follow-up|2|||
146127152|NCT01150123|526985996|FG003|Overall Study|Lost to Follow-up|2|||
146127153|NCT01150123|526985997|FG004|Overall Study|Lost to Follow-up|2|||
146127154|NCT01150123|526985998|FG005|Overall Study|Lost to Follow-up|5|||
146127155|NCT01150123|526985999|FG006|Overall Study|Lost to Follow-up|0|||
146127156|NCT01150123|526986000|FG007|Overall Study|Lost to Follow-up|0|||
146127157|NCT01150123|526986001|FG008|Overall Study|Lost to Follow-up|3|||
146127158|NCT01150123|526986002|FG009|Overall Study|Lost to Follow-up|1|||
146127159|NCT01150123|526986003|FG010|Overall Study|Lost to Follow-up|1|||
146127160|NCT01150123|526986004|FG011|Overall Study|Lost to Follow-up|1|||
146127161|NCT01150123|526986005|FG012|Overall Study|Lost to Follow-up|2|||
146127162|NCT01150123|526986006|FG013|Overall Study|Lost to Follow-up|0|||
146127163|NCT01150123|526986007|FG014|Overall Study|Lost to Follow-up|0|||
146127164|NCT01150123|526986008|FG015|Overall Study|Lost to Follow-up|0|||
146127165|NCT01150123|526986009|FG016|Overall Study|Lost to Follow-up|0|||
146127166|NCT01150123|526986010|FG017|Overall Study|Lost to Follow-up|0|||
146127167|NCT01466387|526986013|FG000|Overall Study|Adverse Event|0|||
146127168|NCT01466387|526986014|FG001|Overall Study|Adverse Event|0|||
146127169|NCT01466387|526986015|FG002|Overall Study|Adverse Event|1|||
146127170|NCT01466387|526986016|FG003|Overall Study|Adverse Event|1|||
146127171|NCT01466387|526986017|FG004|Overall Study|Adverse Event|0|||
146127172|NCT01466387|526986018|FG005|Overall Study|Adverse Event|0|||
146127173|NCT01466387|526986013|FG000|Overall Study|Lost to Follow-up|0|||
146127174|NCT01466387|526986014|FG001|Overall Study|Lost to Follow-up|0|||
146127175|NCT01466387|526986015|FG002|Overall Study|Lost to Follow-up|0|||
146127176|NCT01466387|526986016|FG003|Overall Study|Lost to Follow-up|0|||
146127177|NCT01466387|526986017|FG004|Overall Study|Lost to Follow-up|0|||
146127178|NCT01466387|526986018|FG005|Overall Study|Lost to Follow-up|1|||
146127179|NCT01466387|526986013|FG000|Overall Study|Protocol Violation|1|||
146127180|NCT01466387|526986014|FG001|Overall Study|Protocol Violation|0|||
146127181|NCT01466387|526986015|FG002|Overall Study|Protocol Violation|0|||
146127182|NCT01466387|526986016|FG003|Overall Study|Protocol Violation|1|||
146127183|NCT01466387|526986017|FG004|Overall Study|Protocol Violation|0|||
146127184|NCT01466387|526986018|FG005|Overall Study|Protocol Violation|0|||
146127185|NCT01319877|526986021|FG000|Overall Study|Lost to Follow-up|100|||
146127186|NCT01319877|526986022|FG001|Overall Study|Lost to Follow-up|37|||
146127187|NCT01319877|526986021|FG000|Overall Study|Physician Decision|2|||
146127188|NCT01319877|526986022|FG001|Overall Study|Physician Decision|0|||
146127189|NCT01319877|526986021|FG000|Overall Study|Disease Progression|2|||
146127190|NCT01319877|526986022|FG001|Overall Study|Disease Progression|2|||
146127191|NCT01319877|526986021|FG000|Overall Study|Withdrawal by Subject|0|||
146127192|NCT01319877|526986022|FG001|Overall Study|Withdrawal by Subject|1|||
146127193|NCT01319877|526986021|FG000|Overall Study|Reason Not Specified|4|||
146127194|NCT01319877|526986022|FG001|Overall Study|Reason Not Specified|5|||
146127195|NCT00832585|526986024|FG000|Overall Study|Withdrawal by Subject|1|||
146127196|NCT00832585|526986024|FG000|Overall Study|Lost to Follow-up|1|||
146127197|NCT02347189|526986025|FG000|Overall Study|No implant attempted of study device|9|||
146127198|NCT02347189|526986025|FG000|Overall Study|No primary outcome data available|2|||
146127199|NCT02677987|526986027|FG000|Overall Study|Withdrawal by Subject|3|||
146127200|NCT02677987|526986028|FG001|Overall Study|Withdrawal by Subject|0|||
146127201|NCT02677987|526986027|FG000|Overall Study|Lost to Follow-up|1|||
146127202|NCT02677987|526986028|FG001|Overall Study|Lost to Follow-up|0|||
146127203|NCT04404855|526986029|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
146262809|NCT03900715|527476566|FG000|Overall Study|Adverse Event|2|||
146127204|NCT04404855|526986030|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
146127205|NCT00673179|526986031|FG000|Overall Study|Toxicity/Complications|3|||
146127206|NCT00673179|526986032|FG001|Overall Study|Toxicity/Complications|0|||
146127207|NCT01531387|526986035|FG000|Overall Study|Early termination of study|11|||
146127208|NCT01531387|526986036|FG001|Overall Study|Early termination of study|11|||
146127209|NCT00567892|526986037|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146127210|NCT00567892|526986038|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146127211|NCT00567892|526986039|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
146262810|NCT03900715|527476566|FG000|Overall Study|Other reasons|11|||
146262811|NCT01639742|527478431|FG000|Overall Study|Study Ongoing|17|||
146262812|NCT01639742|527478431|FG000|Overall Study|Lost to Follow-up|1|||
146282351|NCT01879722|527546476|FG007|Overall Study|Voluntary Withdrawal|0|||
146127212|NCT00567892|526986040|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
146127213|NCT00567892|526986037|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146127214|NCT00567892|526986038|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146127215|NCT00567892|526986039|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
146127216|NCT00567892|526986040|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
146127217|NCT01344161|526986042|FG000|Overall Study|Lost to Follow-up|4|||
146127218|NCT01344161|526986043|FG001|Overall Study|Lost to Follow-up|1|||
146127219|NCT01344161|526986042|FG000|Overall Study|Pregnancy|0|||
146127220|NCT01344161|526986043|FG001|Overall Study|Pregnancy|1|||
146127221|NCT01344161|526986042|FG000|Overall Study|Protocol Violation|1|||
146127222|NCT01344161|526986043|FG001|Overall Study|Protocol Violation|1|||
146127223|NCT04690751|526986044|FG000|Overall Study|Protocol Violation|0|||
146127224|NCT04690751|526986045|FG001|Overall Study|Protocol Violation|1|||
146127225|NCT04690751|526986046|FG002|Overall Study|Protocol Violation|0|||
146127226|NCT04690751|526986047|FG003|Overall Study|Protocol Violation|1|||
146127227|NCT04690751|526986048|FG004|Overall Study|Protocol Violation|2|||
146127228|NCT04690751|526986049|FG005|Overall Study|Protocol Violation|0|||
146127229|NCT04690751|526986044|FG000|Overall Study|Adverse Event|0|||
146127230|NCT04690751|526986045|FG001|Overall Study|Adverse Event|0|||
146127231|NCT04690751|526986046|FG002|Overall Study|Adverse Event|1|||
146127232|NCT04690751|526986047|FG003|Overall Study|Adverse Event|0|||
146127233|NCT04690751|526986048|FG004|Overall Study|Adverse Event|0|||
146127234|NCT04690751|526986049|FG005|Overall Study|Adverse Event|0|||
146127235|NCT04690751|526986044|FG000|Overall Study|Positive urine drug screen test|0|||
146127236|NCT04690751|526986045|FG001|Overall Study|Positive urine drug screen test|0|||
146127237|NCT04690751|526986046|FG002|Overall Study|Positive urine drug screen test|0|||
146127238|NCT04690751|526986047|FG003|Overall Study|Positive urine drug screen test|0|||
146127239|NCT04690751|526986048|FG004|Overall Study|Positive urine drug screen test|1|||
146127240|NCT04690751|526986049|FG005|Overall Study|Positive urine drug screen test|0|||
146127241|NCT04364620|526986050|FG000|Overall Study|Disease Progression|20|||
146127242|NCT04364620|526986050|FG000|Overall Study|Adverse Event|5|||
146127243|NCT04364620|526986050|FG000|Overall Study|Physician Decision|4|||
146127244|NCT04364620|526986050|FG000|Overall Study|Death|3|||
146127245|NCT04364620|526986050|FG000|Overall Study|Other|2|||
146127246|NCT04364620|526986050|FG000|Overall Study|Withdrawal by Subject|1|||
146127247|NCT04439318|526986051|FG000|Overall Study|Ineligible|1|||
146127248|NCT04439318|526986051|FG000|Overall Study|Never Started Treatment|3|||
146127249|NCT04439318|526986051|FG000|Overall Study|Adverse Event|10|||
146127250|NCT04439318|526986051|FG000|Overall Study|Death|2|||
146127251|NCT04439318|526986051|FG000|Overall Study|Disease Progression|25|||
146127252|NCT04439318|526986051|FG000|Overall Study|Other Complicating Disease|2|||
146127253|NCT04439318|526986051|FG000|Overall Study|Withdrawal by Subject|4|||
146127254|NCT04439318|526986051|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
146127255|NCT04439318|526986051|FG000|Overall Study|Non-Compliance|1|||
146127256|NCT04439318|526986051|FG000|Overall Study|Still on Treatment|1|||
146127257|NCT00699972|526987480|FG000|Overall Study|Adverse Event|7|||
146127258|NCT00699972|526987481|FG001|Overall Study|Adverse Event|9|||
146127259|NCT00699972|526987482|FG002|Overall Study|Adverse Event|24|||
146127260|NCT00699972|526987480|FG000|Overall Study|Lost to Follow-up|0|||
146127261|NCT00699972|526987481|FG001|Overall Study|Lost to Follow-up|2|||
146127262|NCT00699972|526987482|FG002|Overall Study|Lost to Follow-up|0|||
146127263|NCT00699972|526987480|FG000|Overall Study|Withdrawal by Subject|3|||
146127264|NCT00699972|526987481|FG001|Overall Study|Withdrawal by Subject|7|||
146127265|NCT00699972|526987482|FG002|Overall Study|Withdrawal by Subject|4|||
146127266|NCT00699972|526987480|FG000|Overall Study|Lack of Efficacy|2|||
146127267|NCT00699972|526987481|FG001|Overall Study|Lack of Efficacy|0|||
146127268|NCT00699972|526987482|FG002|Overall Study|Lack of Efficacy|2|||
146127269|NCT00699972|526987480|FG000|Overall Study|Administrative/Other|3|||
146127270|NCT00699972|526987481|FG001|Overall Study|Administrative/Other|1|||
146127271|NCT00699972|526987482|FG002|Overall Study|Administrative/Other|4|||
146127272|NCT00699972|526987480|FG000|Overall Study|Randomized, Not Treated|1|||
146127273|NCT00699972|526987481|FG001|Overall Study|Randomized, Not Treated|0|||
146127274|NCT00699972|526987482|FG002|Overall Study|Randomized, Not Treated|1|||
146262813|NCT04120376|527478432|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
146127275|NCT00902564|526987483|FG000|Overall Study|Withdrawal by Subject|2|||
146127276|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
146127277|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
146127278|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
146127279|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
146127280|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
146127281|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
146127282|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
146127283|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
146262814|NCT04120376|527478433|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
146127284|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
146262815|NCT00781937|527478438|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
146127285|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
146127286|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
146127287|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
146303382|NCT00549939|527625755|FG001|40-week Open Label Treatment Period|Other|1|||
146303383|NCT00549939|527625756|FG002|40-week Open Label Treatment Period|Other|4|||
146303384|NCT03593850|527625757|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
146303385|NCT03593850|527625758|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
146303386|NCT00058552|527625763|FG000|Overall Study|Died prior to receiving treatment|4|||
146303387|NCT00058552|527625764|FG001|Overall Study|Died prior to receiving treatment|2|||
146303388|NCT00058552|527625763|FG000|Overall Study|Disease progression|52|||
146303389|NCT00058552|527625764|FG001|Overall Study|Disease progression|44|||
146303390|NCT00058552|527625763|FG000|Overall Study|Adverse Event|4|||
146303391|NCT00058552|527625764|FG001|Overall Study|Adverse Event|2|||
146127288|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
146127289|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
146127290|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
146127291|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
146127292|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
146127293|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
146127294|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
146127295|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
146127296|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
146127297|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
146127298|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
146127299|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
146127300|NCT00277212|526987484|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
146127301|NCT00277212|526987485|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
146127302|NCT00277212|526987486|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
146127303|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
146127304|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
146127305|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
146127306|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
146127307|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
146127308|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
146127309|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
146127310|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
146127311|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
146127312|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
146127313|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
146127314|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
146127315|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
146127316|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
146127317|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
146127318|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
146127319|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
146127320|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
146127321|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
146127322|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
146127323|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
146127324|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
146127325|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
146127326|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
146127327|NCT00277212|526987484|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
146127328|NCT00277212|526987485|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
146127329|NCT00277212|526987486|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
146127330|NCT03336216|526987487|FG000|Randomization|Not reported|2|||
146127331|NCT03336216|526987488|FG001|Randomization|Not reported|0|||
146127332|NCT03336216|526987489|FG002|Randomization|Not reported|1|||
146127333|NCT03336216|526987490|FG003|Randomization|Not reported|0|||
146127334|NCT03336216|526987487|FG000|Randomization|Other reasons|1|||
146127335|NCT03336216|526987488|FG001|Randomization|Other reasons|1|||
146127336|NCT03336216|526987489|FG002|Randomization|Other reasons|1|||
146127337|NCT03336216|526987490|FG003|Randomization|Other reasons|0|||
146127338|NCT03336216|526987487|FG000|Randomization|Participant no longer meets study criteria|0|||
146303392|NCT00058552|527625763|FG000|Overall Study|Withdrawal by Subject|3|||
146127339|NCT03336216|526987488|FG001|Randomization|Participant no longer meets study criteria|2|||
146127340|NCT03336216|526987489|FG002|Randomization|Participant no longer meets study criteria|4|||
146127341|NCT03336216|526987490|FG003|Randomization|Participant no longer meets study criteria|1|||
146127342|NCT03336216|526987487|FG000|Randomization|Lost to Follow-up|1|||
146127343|NCT03336216|526987488|FG001|Randomization|Lost to Follow-up|0|||
146127344|NCT03336216|526987489|FG002|Randomization|Lost to Follow-up|0|||
146127345|NCT03336216|526987490|FG003|Randomization|Lost to Follow-up|0|||
146127346|NCT03336216|526987487|FG000|Randomization|Participant withdrew consent|9|||
146127347|NCT03336216|526987488|FG001|Randomization|Participant withdrew consent|1|||
146127348|NCT03336216|526987489|FG002|Randomization|Participant withdrew consent|0|||
146127349|NCT03336216|526987490|FG003|Randomization|Participant withdrew consent|0|||
146127350|NCT03336216|526987487|FG000|Randomization|Adverse Event|1|||
146127351|NCT03336216|526987488|FG001|Randomization|Adverse Event|1|||
146127352|NCT03336216|526987489|FG002|Randomization|Adverse Event|0|||
146127353|NCT03336216|526987490|FG003|Randomization|Adverse Event|0|||
146127354|NCT03336216|526987487|FG000|Treatment|Adverse Event|2|||
146127355|NCT03336216|526987488|FG001|Treatment|Adverse Event|3|||
146127356|NCT03336216|526987489|FG002|Treatment|Adverse Event|4|||
146127357|NCT03336216|526987490|FG003|Treatment|Adverse Event|4|||
146127358|NCT03336216|526987487|FG000|Treatment|Participant request to discontinue treatment|2|||
146127359|NCT03336216|526987488|FG001|Treatment|Participant request to discontinue treatment|1|||
146127360|NCT03336216|526987489|FG002|Treatment|Participant request to discontinue treatment|2|||
146127361|NCT03336216|526987490|FG003|Treatment|Participant request to discontinue treatment|2|||
146127362|NCT03336216|526987487|FG000|Treatment|Participant withdrew consent|7|||
146127363|NCT03336216|526987488|FG001|Treatment|Participant withdrew consent|2|||
146127364|NCT03336216|526987489|FG002|Treatment|Participant withdrew consent|3|||
146127365|NCT03336216|526987490|FG003|Treatment|Participant withdrew consent|2|||
146127366|NCT03336216|526987487|FG000|Treatment|Death|2|||
146127367|NCT03336216|526987488|FG001|Treatment|Death|3|||
146127368|NCT03336216|526987489|FG002|Treatment|Death|3|||
146127369|NCT03336216|526987490|FG003|Treatment|Death|4|||
146127370|NCT03336216|526987487|FG000|Treatment|Participant no longer meets study criteria|0|||
146127371|NCT03336216|526987488|FG001|Treatment|Participant no longer meets study criteria|1|||
146127372|NCT03336216|526987489|FG002|Treatment|Participant no longer meets study criteria|0|||
146127373|NCT03336216|526987490|FG003|Treatment|Participant no longer meets study criteria|0|||
146127374|NCT03336216|526987487|FG000|Treatment|Other reasons|2|||
146127375|NCT03336216|526987488|FG001|Treatment|Other reasons|0|||
146127376|NCT03336216|526987489|FG002|Treatment|Other reasons|0|||
146127377|NCT03336216|526987490|FG003|Treatment|Other reasons|3|||
146127378|NCT03336216|526987487|FG000|Treatment|Disease progression|23|||
146127379|NCT03336216|526987488|FG001|Treatment|Disease progression|34|||
146127380|NCT03336216|526987489|FG002|Treatment|Disease progression|33|||
146127381|NCT03336216|526987490|FG003|Treatment|Disease progression|26|||
146127382|NCT03336216|526987487|FG000|Treatment|Study drug toxicity|0|||
146127383|NCT03336216|526987488|FG001|Treatment|Study drug toxicity|3|||
146127384|NCT03336216|526987489|FG002|Treatment|Study drug toxicity|2|||
146127385|NCT03336216|526987490|FG003|Treatment|Study drug toxicity|0|||
146127386|NCT03336216|526987487|FG000|Treatment|Adverse Event unrelated to study drug|1|||
146127387|NCT03336216|526987488|FG001|Treatment|Adverse Event unrelated to study drug|1|||
146127388|NCT03336216|526987489|FG002|Treatment|Adverse Event unrelated to study drug|1|||
146127389|NCT03336216|526987490|FG003|Treatment|Adverse Event unrelated to study drug|0|||
146127390|NCT03336216|526987487|FG000|Treatment|Disease Recurrence|1|||
146127391|NCT03336216|526987488|FG001|Treatment|Disease Recurrence|0|||
146127392|NCT03336216|526987489|FG002|Treatment|Disease Recurrence|0|||
146127393|NCT03336216|526987490|FG003|Treatment|Disease Recurrence|0|||
146127394|NCT00922766|526987498|FG000|Overall Study|Death|3|||
146127395|NCT00922766|526987498|FG000|Overall Study|Withdrawal by Subject|2|||
146127396|NCT00922766|526987498|FG000|Overall Study|Other|1|||
146127397|NCT00922766|526987498|FG000|Overall Study|Adverse Event|1|||
146127398|NCT00666757|526987504|FG000|Overall Study|Lost to Follow-up|39|||
146127399|NCT00666757|526987505|FG001|Overall Study|Lost to Follow-up|35|||
146303393|NCT00058552|527625764|FG001|Overall Study|Withdrawal by Subject|5|||
146127400|NCT00666757|526987504|FG000|Overall Study|Protocol Violation|23|||
146127401|NCT00666757|526987505|FG001|Overall Study|Protocol Violation|24|||
146127402|NCT00666757|526987504|FG000|Overall Study|Adverse Event|22|||
146127403|NCT00666757|526987505|FG001|Overall Study|Adverse Event|12|||
146127404|NCT00666757|526987504|FG000|Overall Study|Withdrawal by Subject|13|||
146127405|NCT00666757|526987505|FG001|Overall Study|Withdrawal by Subject|17|||
146303394|NCT00058552|527625763|FG000|Overall Study|Physician Decision|2|||
146127406|NCT00666757|526987504|FG000|Overall Study|Lack of Efficacy|3|||
146127407|NCT00666757|526987505|FG001|Overall Study|Lack of Efficacy|6|||
146127408|NCT00666757|526987504|FG000|Overall Study|Physician Decision|0|||
146127409|NCT00666757|526987505|FG001|Overall Study|Physician Decision|2|||
146127410|NCT00666757|526987504|FG000|Overall Study|Sponsor decision|0|||
146127411|NCT00666757|526987505|FG001|Overall Study|Sponsor decision|1|||
146127412|NCT01231581|526987506|FG000|Overall Study|Lost to Follow-up|2|||
146127413|NCT01231581|526987507|FG001|Overall Study|Lost to Follow-up|2|||
146127414|NCT01231581|526987506|FG000|Overall Study|Withdrawal by Subject|6|||
146127415|NCT01231581|526987507|FG001|Overall Study|Withdrawal by Subject|9|||
146127416|NCT01231581|526987506|FG000|Overall Study|Study Closed/Terminated|6|||
146127417|NCT01231581|526987507|FG001|Overall Study|Study Closed/Terminated|5|||
146127418|NCT01231581|526987506|FG000|Overall Study|Death|65|||
146127419|NCT01231581|526987507|FG001|Overall Study|Death|64|||
146127420|NCT01231581|526987506|FG000|Overall Study|Ongoing|1|||
146127421|NCT01231581|526987507|FG001|Overall Study|Ongoing|0|||
146127422|NCT05954052|526987508|FG000|Overall Study|Adverse Event|1|||
146127423|NCT01723163|526987509|FG000|Treatment Phase|Withdrawal by Subject|14|||
146127424|NCT01723163|526987510|FG001|Treatment Phase|Withdrawal by Subject|6|||
146127425|NCT01723163|526987509|FG000|Treatment Phase|Withdrawal by PI|5|||
146127426|NCT01723163|526987510|FG001|Treatment Phase|Withdrawal by PI|1|||
146127427|NCT01723163|526987509|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
146127428|NCT01723163|526987510|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
146127429|NCT01723163|526987509|FG000|3-Month Follow-up|Unable to Contact|12|||
146127430|NCT01723163|526987510|FG001|3-Month Follow-up|Unable to Contact|19|||
146127431|NCT01723163|526987509|FG000|6-Month Follow-up|Death|1|||
146127432|NCT01723163|526987510|FG001|6-Month Follow-up|Death|0|||
146127433|NCT01723163|526987509|FG000|6-Month Follow-up|Unable to Contact|17|||
146127434|NCT01723163|526987510|FG001|6-Month Follow-up|Unable to Contact|15|||
146127435|NCT01723163|526987509|FG000|12-Month Follow-up|Death|1|||
146127436|NCT01723163|526987510|FG001|12-Month Follow-up|Death|0|||
146127437|NCT01723163|526987509|FG000|12-Month Follow-up|Unable to Contact|23|||
146127438|NCT01723163|526987510|FG001|12-Month Follow-up|Unable to Contact|28|||
146127439|NCT02510794|526987511|FG000|Overall Study|Adverse Event|0|||
146127440|NCT02510794|526987512|FG001|Overall Study|Adverse Event|1|||
146127441|NCT02510794|526987513|FG002|Overall Study|Adverse Event|0|||
146127442|NCT02510794|526987514|FG003|Overall Study|Adverse Event|0|||
146127443|NCT02510794|526987511|FG000|Overall Study|Death|1|||
146127444|NCT02510794|526987512|FG001|Overall Study|Death|2|||
146127445|NCT02510794|526987513|FG002|Overall Study|Death|1|||
146127446|NCT02510794|526987514|FG003|Overall Study|Death|1|||
146127447|NCT02510794|526987511|FG000|Overall Study|Lack of Efficacy|3|||
146262816|NCT00781937|527478439|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
146262817|NCT00781937|527478438|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
146262818|NCT00781937|527478439|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
146262819|NCT00781937|527478438|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
146262820|NCT00781937|527478439|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
146262821|NCT00781937|527478438|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
146127448|NCT02510794|526987512|FG001|Overall Study|Lack of Efficacy|1|||
146127449|NCT02510794|526987513|FG002|Overall Study|Lack of Efficacy|1|||
146127450|NCT02510794|526987514|FG003|Overall Study|Lack of Efficacy|0|||
146127451|NCT02510794|526987511|FG000|Overall Study|Participant moved out of the area|0|||
146127452|NCT02510794|526987512|FG001|Overall Study|Participant moved out of the area|0|||
146127453|NCT02510794|526987513|FG002|Overall Study|Participant moved out of the area|0|||
146127454|NCT02510794|526987514|FG003|Overall Study|Participant moved out of the area|1|||
146127455|NCT02510794|526987511|FG000|Overall Study|Physician Decision|3|||
146127456|NCT02510794|526987512|FG001|Overall Study|Physician Decision|0|||
146127457|NCT02510794|526987513|FG002|Overall Study|Physician Decision|0|||
146127458|NCT02510794|526987514|FG003|Overall Study|Physician Decision|0|||
146127459|NCT02510794|526987511|FG000|Overall Study|Protocol Violation|0|||
146127460|NCT02510794|526987512|FG001|Overall Study|Protocol Violation|0|||
146127461|NCT02510794|526987513|FG002|Overall Study|Protocol Violation|1|||
146127462|NCT02510794|526987514|FG003|Overall Study|Protocol Violation|0|||
146127463|NCT02510794|526987511|FG000|Overall Study|Withdrawal by Subject|1|||
146127464|NCT02510794|526987512|FG001|Overall Study|Withdrawal by Subject|2|||
146127465|NCT02510794|526987513|FG002|Overall Study|Withdrawal by Subject|4|||
146127466|NCT02510794|526987514|FG003|Overall Study|Withdrawal by Subject|3|||
146127467|NCT02731729|526987517|FG000|Overall Study|Death|2|||
146127468|NCT02731729|526987518|FG001|Overall Study|Death|2|||
146127469|NCT02731729|526987517|FG000|Overall Study|Study terminated by Sponsor|6|||
146127470|NCT02731729|526987518|FG001|Overall Study|Study terminated by Sponsor|6|||
146127471|NCT02731729|526987517|FG000|Overall Study|Withdrawal by Subject|1|||
146127472|NCT02731729|526987518|FG001|Overall Study|Withdrawal by Subject|0|||
146127473|NCT01344447|526987519|FG000|Overall Study|Adverse Event|1|||
146127474|NCT01344447|526987519|FG000|Overall Study|Protocol Violation|1|||
146127475|NCT01344447|526987519|FG000|Overall Study|Withdrawal by Subject|1|||
146262822|NCT00781937|527478439|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
146127476|NCT01344447|526987519|FG000|Overall Study|The contrast was not seen|1|||
146127477|NCT01344447|526987519|FG000|Overall Study|Physician Decision|1|||
146127478|NCT01344447|526987519|FG000|Overall Study|MRA unsuccessful|1|||
146127479|NCT01344447|526987519|FG000|Overall Study|Bolus tracking failed|1|||
146127480|NCT01344447|526987519|FG000|Overall Study|Error of power injector|1|||
146127481|NCT01660711|526987520|FG000|Overall Study|Adverse Event|7|||
146127482|NCT01660711|526987520|FG000|Overall Study|Withdrawal by Subject|1|||
146127483|NCT01316276|526987521|FG000|Overall Study|Death|1|||
146127484|NCT01316276|526987521|FG000|Overall Study|Adverse Event|19|||
146127485|NCT01316276|526987521|FG000|Overall Study|Withdrawal of consent|24|||
146127486|NCT01316276|526987521|FG000|Overall Study|Lost to Follow-up|1|||
146127487|NCT01316276|526987521|FG000|Overall Study|Other|22|||
146127488|NCT06027866|526987522|FG000|Overall Study|Withdrawal by Subject|2|||
146127489|NCT04343521|526987527|FG000|Overall Study|Adverse Event|0|||
146127490|NCT04343521|526987528|FG001|Overall Study|Adverse Event|2|||
146127491|NCT04343521|526987527|FG000|Overall Study|Death|1|||
146127492|NCT04343521|526987528|FG001|Overall Study|Death|2|||
146127493|NCT04343521|526987527|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
146127494|NCT04343521|526987528|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
146127495|NCT04343521|526987527|FG000|Overall Study|Withdrawal by Subject|70|||
146127496|NCT04343521|526987528|FG001|Overall Study|Withdrawal by Subject|95|||
146127497|NCT04343521|526987527|FG000|Overall Study|Withdrawal by study team|6|||
146127498|NCT04343521|526987528|FG001|Overall Study|Withdrawal by study team|12|||
146127499|NCT02939560|526987531|FG000|Overall Study|Withdrawal by Subject|2|||
146127500|NCT02939560|526987531|FG000|Overall Study|Protocol Violation|1|||
146127501|NCT03340025|526987532|FG000|Overall Study|Lost to Follow-up|2|||
146127502|NCT03340025|526987533|FG001|Overall Study|Lost to Follow-up|2|||
146127503|NCT02420691|526987536|FG000|Overall Study|Adverse Event|3|||
146127504|NCT02420691|526987536|FG000|Overall Study|Withdrawal by Subject|3|||
146127505|NCT03897179|526987539|FG000|Overall Study|Withdrawal by Subject|1|||
146127506|NCT00704535|526987540|FG000|Overall Study|Adverse Event|2|||
146127507|NCT00704535|526987540|FG000|Overall Study|Death|2|||
146127508|NCT00704535|526987540|FG000|Overall Study|Lost to Follow-up|8|||
146127509|NCT00704535|526987540|FG000|Overall Study|Protocol Violation|10|||
146127510|NCT00704535|526987540|FG000|Overall Study|Completed status not on Case Report Form|124|||
146127511|NCT05694546|526987544|FG000|Overall Study|Lost to Follow-up|11|||
146127512|NCT02424383|526987545|FG000|Overall Study|Withdrawal by Subject|32|||
146127513|NCT02424383|526987545|FG000|Overall Study|Death|170|||
146127514|NCT02424383|526987545|FG000|Overall Study|Sponsor's decision|3|||
146127515|NCT02424383|526987545|FG000|Overall Study|Investigator's decision|44|||
146127516|NCT02424383|526987545|FG000|Overall Study|Lost to Follow-up|81|||
146127517|NCT02424383|526987545|FG000|Overall Study|Other|7|||
146127518|NCT02424383|526987545|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
146127519|NCT01251380|526987552|FG000|Overall Study|Other (Not otherwise specified)|12|||
146127520|NCT01251380|526987552|FG000|Overall Study|Withdrawal by Subject|6|||
146127521|NCT01251380|526987552|FG000|Overall Study|Lack of Efficacy|1|||
146127522|NCT01251380|526987552|FG000|Overall Study|Adverse Event|1|||
146127523|NCT01251380|526987552|FG000|Overall Study|Lost to Follow-up|2|||
146127524|NCT02171260|526987559|FG000|Overall Study|Death|0|||
146127525|NCT02171260|526987560|FG001|Overall Study|Death|0|||
146127526|NCT02171260|526987561|FG002|Overall Study|Death|0|||
146127527|NCT02171260|526987562|FG003|Overall Study|Death|1|||
146127528|NCT02171260|526987559|FG000|Overall Study|Physician Decision|1|||
146127529|NCT02171260|526987560|FG001|Overall Study|Physician Decision|0|||
146127530|NCT02171260|526987561|FG002|Overall Study|Physician Decision|1|||
146127531|NCT02171260|526987562|FG003|Overall Study|Physician Decision|0|||
146127532|NCT02171260|526987559|FG000|Overall Study|Withdrawal by Subject|1|||
146127533|NCT02171260|526987560|FG001|Overall Study|Withdrawal by Subject|0|||
146127534|NCT02171260|526987561|FG002|Overall Study|Withdrawal by Subject|0|||
146127535|NCT02171260|526987562|FG003|Overall Study|Withdrawal by Subject|0|||
146127536|NCT02171260|526987559|FG000|Overall Study|Evidence of progressive disease|4|||
146127537|NCT02171260|526987560|FG001|Overall Study|Evidence of progressive disease|6|||
146127538|NCT02171260|526987561|FG002|Overall Study|Evidence of progressive disease|4|||
146127539|NCT02171260|526987562|FG003|Overall Study|Evidence of progressive disease|4|||
146127540|NCT00323492|526987567|FG000|Study Phase 1|Adverse Event|2|||
146127541|NCT00323492|526987568|FG001|Study Phase 1|Adverse Event|0|||
146127542|NCT00323492|526987569|FG002|Study Phase 1|Adverse Event|0|||
146127543|NCT00323492|526987567|FG000|Study Phase 2|Adverse Event|1|||
146127544|NCT00323492|526987568|FG001|Study Phase 2|Adverse Event|0|||
146127545|NCT00323492|526987569|FG002|Study Phase 2|Adverse Event|0|||
146127546|NCT00323492|526987567|FG000|Study Phase 2|Physician Decision|1|||
146127547|NCT00323492|526987568|FG001|Study Phase 2|Physician Decision|0|||
146127548|NCT00323492|526987569|FG002|Study Phase 2|Physician Decision|0|||
146127549|NCT00323492|526987567|FG000|Study Phase 2|Lost to Follow-up|1|||
146127550|NCT00323492|526987568|FG001|Study Phase 2|Lost to Follow-up|0|||
146127551|NCT00323492|526987569|FG002|Study Phase 2|Lost to Follow-up|0|||
146127552|NCT00323492|526987567|FG000|Study Phase 2|Withdrawal by Subject|0|||
146127553|NCT00323492|526987568|FG001|Study Phase 2|Withdrawal by Subject|1|||
146127554|NCT00323492|526987569|FG002|Study Phase 2|Withdrawal by Subject|0|||
146127555|NCT00323492|526987567|FG000|Study Phase 2|Noncompliance with study schedule|0|||
146127556|NCT00323492|526987568|FG001|Study Phase 2|Noncompliance with study schedule|0|||
146127557|NCT00323492|526987569|FG002|Study Phase 2|Noncompliance with study schedule|1|||
146127558|NCT00323492|526987567|FG000|Study Phase 2|Protocol Violation|1|||
146127559|NCT00323492|526987568|FG001|Study Phase 2|Protocol Violation|0|||
146127560|NCT00323492|526987569|FG002|Study Phase 2|Protocol Violation|0|||
146127561|NCT02486042|526987570|FG000|Overall Study|Physician Decision|1|||
146127562|NCT02486042|526987571|FG001|Overall Study|Physician Decision|7|||
146127563|NCT02486042|526987570|FG000|Overall Study|Hospital transfer|2|||
146127564|NCT02486042|526987571|FG001|Overall Study|Hospital transfer|2|||
146127565|NCT02486042|526987570|FG000|Overall Study|Withdrawal by Subject|0|||
146127566|NCT02486042|526987571|FG001|Overall Study|Withdrawal by Subject|2|||
146262823|NCT00781937|527478438|FG000|Main Trial Period Through Week 56|Unclassified|10|||
146262824|NCT00781937|527478439|FG001|Main Trial Period Through Week 56|Unclassified|15|||
146262825|NCT00781937|527478438|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
146262826|NCT00781937|527478439|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
146262827|NCT00781937|527478438|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
146262828|NCT00781937|527478439|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
146262829|NCT01663506|527478441|FG000|Overall Study|Lack of Efficacy|3|||
146127567|NCT00735878|526987574|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
146127568|NCT00735878|526987575|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
146127569|NCT00735878|526987576|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
146127570|NCT03320564|526987577|FG000|Overall Study|Protocol Violation|1|||
146127571|NCT04668950|526987581|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
146127572|NCT04668950|526987582|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
146127573|NCT04668950|526987581|FG000|Overall Study|Could not confirm started study medication|15|||
146127574|NCT04668950|526987582|FG001|Overall Study|Could not confirm started study medication|15|||
146127575|NCT04668950|526987581|FG000|Overall Study|Could not confirm baseline status|6|||
146127576|NCT04668950|526987582|FG001|Overall Study|Could not confirm baseline status|2|||
146127577|NCT04668950|526987581|FG000|Overall Study|Drop out and did not start medication|15|||
146127578|NCT04668950|526987582|FG001|Overall Study|Drop out and did not start medication|17|||
146127579|NCT04668950|526987581|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
146127580|NCT04668950|526987582|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
146127581|NCT04668950|526987581|FG000|Overall Study|Other|2|||
146127582|NCT04668950|526987582|FG001|Overall Study|Other|4|||
146127583|NCT03979638|526987583|FG000|Period 1|Physician Decision|1|||
146127584|NCT03979638|526987584|FG001|Period 1|Physician Decision|1|||
146127585|NCT03979638|526987583|FG000|Period 1|Withdrawal by Subject|4|||
146127586|NCT03979638|526987584|FG001|Period 1|Withdrawal by Subject|3|||
146127587|NCT03979638|526987583|FG000|Period 1|Study terminated by Sponsor|1|||
146127588|NCT03979638|526987584|FG001|Period 1|Study terminated by Sponsor|3|||
146127589|NCT03979638|526987583|FG000|Period 1|Protocol Violation|1|||
146127590|NCT03979638|526987584|FG001|Period 1|Protocol Violation|0|||
146127591|NCT03979638|526987583|FG000|Period 2|Study terminated by Sponsor|1|||
146127592|NCT03979638|526987584|FG001|Period 2|Study terminated by Sponsor|1|||
146127593|NCT04248933|526987587|FG000|Overall Study|Lost to Follow-up|9|||
146127594|NCT04248933|526987587|FG000|Overall Study|Withdrawal by Subject|2|||
146127595|NCT00578942|526987588|FG000|Overall Study|Lost to Follow-up|1|||
146127596|NCT00600938|526987591|FG000|Core Study|Abnormal test procedure result(s)|3|||
146127597|NCT00600938|526987592|FG001|Core Study|Abnormal test procedure result(s)|2|||
146127598|NCT00600938|526987593|FG002|Core Study|Abnormal test procedure result(s)|0|||
146127599|NCT00600938|526987594|FG003|Core Study|Abnormal test procedure result(s)|0|||
146127600|NCT00600938|526987591|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
146127601|NCT00600938|526987592|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
146127602|NCT00600938|526987593|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
146127603|NCT00600938|526987594|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
146127604|NCT00600938|526987591|FG000|Core Study|Patient withdrew consent|7|||
146127605|NCT00600938|526987592|FG001|Core Study|Patient withdrew consent|12|||
146127606|NCT00600938|526987593|FG002|Core Study|Patient withdrew consent|0|||
146127607|NCT00600938|526987594|FG003|Core Study|Patient withdrew consent|0|||
146127608|NCT00600938|526987591|FG000|Core Study|Lost to Follow-up|3|||
146127609|NCT00600938|526987592|FG001|Core Study|Lost to Follow-up|2|||
146127610|NCT00600938|526987593|FG002|Core Study|Lost to Follow-up|0|||
146127611|NCT00600938|526987594|FG003|Core Study|Lost to Follow-up|0|||
146127612|NCT00600938|526987591|FG000|Core Study|Death|1|||
146127613|NCT00600938|526987592|FG001|Core Study|Death|1|||
146127614|NCT00600938|526987593|FG002|Core Study|Death|0|||
146127615|NCT00600938|526987594|FG003|Core Study|Death|0|||
146127616|NCT00600938|526987591|FG000|Core Study|Protocol Violation|1|||
146127617|NCT00600938|526987592|FG001|Core Study|Protocol Violation|2|||
146127618|NCT00600938|526987593|FG002|Core Study|Protocol Violation|0|||
146127619|NCT00600938|526987594|FG003|Core Study|Protocol Violation|0|||
146127620|NCT00600938|526987591|FG000|Extension Study|Adverse Event|1|||
146127621|NCT00600938|526987592|FG001|Extension Study|Adverse Event|0|||
146127622|NCT00600938|526987593|FG002|Extension Study|Adverse Event|2|||
146127623|NCT00600938|526987594|FG003|Extension Study|Adverse Event|0|||
146127624|NCT00600938|526987591|FG000|Extension Study|Abnormal test procedure results|0|||
146127625|NCT00600938|526987592|FG001|Extension Study|Abnormal test procedure results|1|||
146127626|NCT00600938|526987593|FG002|Extension Study|Abnormal test procedure results|1|||
146127627|NCT00600938|526987594|FG003|Extension Study|Abnormal test procedure results|1|||
146127628|NCT00600938|526987591|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
146127629|NCT00600938|526987592|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
146127630|NCT00600938|526987593|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
146127631|NCT00600938|526987594|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
146127632|NCT00600938|526987591|FG000|Extension Study|Withdrawal by Subject|2|||
146127633|NCT00600938|526987592|FG001|Extension Study|Withdrawal by Subject|2|||
146127634|NCT00600938|526987593|FG002|Extension Study|Withdrawal by Subject|3|||
146127635|NCT00600938|526987594|FG003|Extension Study|Withdrawal by Subject|0|||
146127636|NCT00600938|526987591|FG000|Extension Study|Lost to Follow-up|1|||
146127637|NCT00600938|526987592|FG001|Extension Study|Lost to Follow-up|1|||
146127638|NCT00600938|526987593|FG002|Extension Study|Lost to Follow-up|2|||
146127639|NCT00600938|526987594|FG003|Extension Study|Lost to Follow-up|0|||
146127640|NCT00600938|526987591|FG000|Extension Study|Death|1|||
146127641|NCT00600938|526987592|FG001|Extension Study|Death|0|||
146127642|NCT00600938|526987593|FG002|Extension Study|Death|0|||
146127643|NCT00600938|526987594|FG003|Extension Study|Death|0|||
146127644|NCT04220411|526987595|FG000|Overall Study|Adverse Event|0|||
146127645|NCT04220411|526987596|FG001|Overall Study|Adverse Event|0|||
146127646|NCT04220411|526987597|FG002|Overall Study|Adverse Event|0|||
146127647|NCT04220411|526987598|FG003|Overall Study|Adverse Event|1|||
146127648|NCT02680639|526987599|FG000|Screening Period|Screen Failure|7|||
146127649|NCT02680639|526987600|FG001|Screening Period|Screen Failure|0|||
146127650|NCT02680639|526987601|FG002|Screening Period|Screen Failure|0|||
146127651|NCT03200899|526987602|FG000|Overall Study|Lost to Follow-up|10|||
146127652|NCT03200899|526987603|FG001|Overall Study|Lost to Follow-up|23|||
146127653|NCT01400516|526987618|FG000|Primary Trial|Withdrawal by Subject|0|||
146127654|NCT01400516|526987619|FG001|Primary Trial|Withdrawal by Subject|2|||
146127655|NCT00323115|526987625|FG000|Vaccine Administration|Adverse Event|1|||
146127656|NCT00323115|526987625|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
146127657|NCT02946047|526987626|FG000|Overall Study|Adverse Event|1|||
146127658|NCT02946047|526987627|FG001|Overall Study|Adverse Event|0|||
146127659|NCT02946047|526987628|FG002|Overall Study|Adverse Event|0|||
146127660|NCT02946047|526987629|FG003|Overall Study|Adverse Event|0|||
146127661|NCT02496533|526987630|FG000|Overall Study|Lack of data on outcome|3|||
146127662|NCT02496533|526987631|FG001|Overall Study|Lack of data on outcome|0|||
146127663|NCT02496533|526987630|FG000|Overall Study|Patient did not complete all measures|0|||
146127664|NCT02496533|526987631|FG001|Overall Study|Patient did not complete all measures|4|||
146127665|NCT02496533|526987630|FG000|Overall Study|Late for radiologic testing|0|||
146127666|NCT02496533|526987631|FG001|Overall Study|Late for radiologic testing|2|||
146127667|NCT02268409|526989752|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
146127668|NCT02268409|526989752|FG000|Overall Study|Death|1|||
146127669|NCT02268409|526989752|FG000|Overall Study|Lost to Follow-up|1|||
146127670|NCT02268409|526989752|FG000|Overall Study|Protocol Violation|3|||
146127671|NCT02268409|526989752|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
146127672|NCT02268409|526989752|FG000|Overall Study|Withdrawal by Subject|5|||
146127673|NCT04865354|526989753|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
146127674|NCT04865354|526989754|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
146127675|NCT04865354|526989753|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
146127676|NCT04865354|526989754|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
146127677|NCT04865354|526989753|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
146127678|NCT04865354|526989754|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
146127679|NCT03873987|526989755|FG000|Overall Study|Adverse Event|1|||
146127680|NCT03873987|526989756|FG001|Overall Study|Adverse Event|0|||
146127681|NCT03873987|526989755|FG000|Overall Study|staff was unable to start a new IV line|1|||
146127682|NCT03873987|526989756|FG001|Overall Study|staff was unable to start a new IV line|0|||
146127683|NCT03873987|526989755|FG000|Overall Study|Lost to Follow-up|0|||
146127684|NCT03873987|526989756|FG001|Overall Study|Lost to Follow-up|1|||
146127685|NCT01465022|526989757|FG000|Overall Study|Lost to Follow-up|15|||
146127686|NCT01465022|526989758|FG001|Overall Study|Lost to Follow-up|14|||
146127687|NCT01465022|526989759|FG002|Overall Study|Lost to Follow-up|0|||
146127688|NCT01465022|526989757|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
146127689|NCT01465022|526989758|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
146127690|NCT01465022|526989759|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
146127691|NCT01465022|526989757|FG000|Overall Study|Not Randomized|0|||
146127692|NCT01465022|526989758|FG001|Overall Study|Not Randomized|0|||
146127693|NCT01465022|526989759|FG002|Overall Study|Not Randomized|70|||
146262830|NCT01663506|527478441|FG000|Overall Study|Consent Withdrawal by Subject|1|||
146127694|NCT02520011|526989760|FG000|Overall Study|Adverse Event|0|||
146127695|NCT02520011|526989761|FG001|Overall Study|Adverse Event|1|||
146262831|NCT01663506|527478441|FG000|Overall Study|Lost to Follow-up|1|||
146262832|NCT01663506|527478441|FG000|Overall Study|Adverse Event|1|||
146127696|NCT02520011|526989762|FG002|Overall Study|Adverse Event|2|||
146127697|NCT02520011|526989760|FG000|Overall Study|Death|0|||
146127698|NCT02520011|526989761|FG001|Overall Study|Death|8|||
146127699|NCT02520011|526989762|FG002|Overall Study|Death|1|||
146127700|NCT02520011|526989760|FG000|Overall Study|Lack of Efficacy|4|||
146127701|NCT02520011|526989761|FG001|Overall Study|Lack of Efficacy|26|||
146127702|NCT02520011|526989762|FG002|Overall Study|Lack of Efficacy|4|||
146127703|NCT02520011|526989760|FG000|Overall Study|Physician Decision|0|||
146127704|NCT02520011|526989761|FG001|Overall Study|Physician Decision|2|||
146127705|NCT02520011|526989762|FG002|Overall Study|Physician Decision|0|||
146127706|NCT02520011|526989760|FG000|Overall Study|Withdrawal by Subject|1|||
146127707|NCT02520011|526989761|FG001|Overall Study|Withdrawal by Subject|3|||
146127708|NCT02520011|526989762|FG002|Overall Study|Withdrawal by Subject|0|||
146127709|NCT02520011|526989760|FG000|Overall Study|Protocol Deviation|0|||
146127710|NCT02520011|526989761|FG001|Overall Study|Protocol Deviation|1|||
146127711|NCT02520011|526989762|FG002|Overall Study|Protocol Deviation|0|||
146127712|NCT02520011|526989760|FG000|Overall Study|Patient went to hospice|0|||
146127713|NCT02520011|526989761|FG001|Overall Study|Patient went to hospice|1|||
146127714|NCT02520011|526989762|FG002|Overall Study|Patient went to hospice|0|||
146127715|NCT02520011|526989760|FG000|Overall Study|Progressive disease following response|0|||
146127716|NCT02520011|526989761|FG001|Overall Study|Progressive disease following response|4|||
146127717|NCT02520011|526989762|FG002|Overall Study|Progressive disease following response|2|||
146127718|NCT03239470|526989766|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
146127719|NCT03239470|526989767|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
146127720|NCT01957462|526989768|FG000|Test Period 1|Withdrawal by Subject|1|||
146127721|NCT01957462|526989769|FG001|Test Period 1|Withdrawal by Subject|0|||
146127722|NCT01957462|526989768|FG000|Test Period 1|Adverse Event|1|||
146127723|NCT01957462|526989769|FG001|Test Period 1|Adverse Event|0|||
146127724|NCT03616912|526989770|FG000|Overall Study|Adverse Event|17|||
146127725|NCT03616912|526989771|FG001|Overall Study|Adverse Event|21|||
146127726|NCT03616912|526989772|FG002|Overall Study|Adverse Event|9|||
146127727|NCT03616912|526989773|FG003|Overall Study|Adverse Event|0|||
146127728|NCT03616912|526989774|FG004|Overall Study|Adverse Event|0|||
146127729|NCT03616912|526989775|FG005|Overall Study|Adverse Event|0|||
146303395|NCT00058552|527625764|FG001|Overall Study|Physician Decision|5|||
146303396|NCT00058552|527625763|FG000|Overall Study|Clinical disease progression|0|||
146303397|NCT00058552|527625764|FG001|Overall Study|Clinical disease progression|4|||
146303398|NCT03861936|527625765|FG000|Overall Study|Withdrawal by Subject|4|||
146303399|NCT03861936|527625766|FG001|Overall Study|Withdrawal by Subject|1|||
146303400|NCT03861936|527625767|FG002|Overall Study|Withdrawal by Subject|3|||
146303401|NCT03861936|527625765|FG000|Overall Study|Lost to Follow-up|5|||
146303402|NCT03861936|527625766|FG001|Overall Study|Lost to Follow-up|3|||
146303403|NCT03861936|527625767|FG002|Overall Study|Lost to Follow-up|3|||
146303404|NCT03861936|527625765|FG000|Overall Study|Physician Decision|0|||
146303405|NCT03861936|527625766|FG001|Overall Study|Physician Decision|1|||
146303406|NCT03861936|527625767|FG002|Overall Study|Physician Decision|0|||
146303407|NCT03861936|527625765|FG000|Overall Study|Protocol Deviation|0|||
146303408|NCT03861936|527625766|FG001|Overall Study|Protocol Deviation|0|||
146127730|NCT03616912|526989770|FG000|Overall Study|Death|1|||
146127731|NCT03616912|526989771|FG001|Overall Study|Death|1|||
146127732|NCT03616912|526989772|FG002|Overall Study|Death|0|||
146127733|NCT03616912|526989773|FG003|Overall Study|Death|0|||
146127734|NCT03616912|526989774|FG004|Overall Study|Death|0|||
146127735|NCT03616912|526989775|FG005|Overall Study|Death|0|||
146127736|NCT03616912|526989770|FG000|Overall Study|Lack of Efficacy|13|||
146127737|NCT03616912|526989771|FG001|Overall Study|Lack of Efficacy|6|||
146127738|NCT03616912|526989772|FG002|Overall Study|Lack of Efficacy|8|||
146127739|NCT03616912|526989773|FG003|Overall Study|Lack of Efficacy|4|||
146127740|NCT03616912|526989774|FG004|Overall Study|Lack of Efficacy|5|||
146127741|NCT03616912|526989775|FG005|Overall Study|Lack of Efficacy|1|||
146127742|NCT03616912|526989770|FG000|Overall Study|Lost to Follow-up|1|||
146127743|NCT03616912|526989771|FG001|Overall Study|Lost to Follow-up|2|||
146127744|NCT03616912|526989772|FG002|Overall Study|Lost to Follow-up|3|||
146127745|NCT03616912|526989773|FG003|Overall Study|Lost to Follow-up|0|||
146127746|NCT03616912|526989774|FG004|Overall Study|Lost to Follow-up|0|||
146127747|NCT03616912|526989775|FG005|Overall Study|Lost to Follow-up|0|||
146127748|NCT03616912|526989770|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
146127749|NCT03616912|526989771|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
146127750|NCT03616912|526989772|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
146127751|NCT03616912|526989773|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
146127752|NCT03616912|526989774|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
146127753|NCT03616912|526989775|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
146127754|NCT03616912|526989770|FG000|Overall Study|Withdrawal by Subject|12|||
146127755|NCT03616912|526989771|FG001|Overall Study|Withdrawal by Subject|12|||
146127756|NCT03616912|526989772|FG002|Overall Study|Withdrawal by Subject|15|||
146127757|NCT03616912|526989773|FG003|Overall Study|Withdrawal by Subject|2|||
146303409|NCT03861936|527625767|FG002|Overall Study|Protocol Deviation|1|||
146303410|NCT03861936|527625765|FG000|Overall Study|Reason not Specified|5|||
146303411|NCT03861936|527625766|FG001|Overall Study|Reason not Specified|5|||
146127758|NCT03616912|526989774|FG004|Overall Study|Withdrawal by Subject|0|||
146127759|NCT03616912|526989775|FG005|Overall Study|Withdrawal by Subject|2|||
146127760|NCT03616912|526989770|FG000|Overall Study|Study Terminated by Sponsor|0|||
146127761|NCT03616912|526989771|FG001|Overall Study|Study Terminated by Sponsor|0|||
146127762|NCT03616912|526989772|FG002|Overall Study|Study Terminated by Sponsor|0|||
146127763|NCT03616912|526989773|FG003|Overall Study|Study Terminated by Sponsor|10|||
146127764|NCT03616912|526989774|FG004|Overall Study|Study Terminated by Sponsor|9|||
146127765|NCT03616912|526989775|FG005|Overall Study|Study Terminated by Sponsor|11|||
146127766|NCT03616912|526989770|FG000|Overall Study|Protocol Deviation|1|||
146127767|NCT03616912|526989771|FG001|Overall Study|Protocol Deviation|1|||
146127768|NCT03616912|526989772|FG002|Overall Study|Protocol Deviation|0|||
146127769|NCT03616912|526989773|FG003|Overall Study|Protocol Deviation|0|||
146127770|NCT03616912|526989774|FG004|Overall Study|Protocol Deviation|0|||
146127771|NCT03616912|526989775|FG005|Overall Study|Protocol Deviation|0|||
146127772|NCT03616912|526989770|FG000|Overall Study|Pregnancy|1|||
146127773|NCT03616912|526989771|FG001|Overall Study|Pregnancy|0|||
146127774|NCT03616912|526989772|FG002|Overall Study|Pregnancy|4|||
146127775|NCT03616912|526989773|FG003|Overall Study|Pregnancy|0|||
146127776|NCT03616912|526989774|FG004|Overall Study|Pregnancy|0|||
146127777|NCT03616912|526989775|FG005|Overall Study|Pregnancy|0|||
146127778|NCT03616912|526989770|FG000|Overall Study|Protocol Violation|1|||
146127779|NCT03616912|526989771|FG001|Overall Study|Protocol Violation|0|||
146127780|NCT03616912|526989772|FG002|Overall Study|Protocol Violation|2|||
146127781|NCT03616912|526989773|FG003|Overall Study|Protocol Violation|0|||
146127782|NCT03616912|526989774|FG004|Overall Study|Protocol Violation|0|||
146127783|NCT03616912|526989775|FG005|Overall Study|Protocol Violation|0|||
146127784|NCT03616912|526989770|FG000|Overall Study|Physician Decision|2|||
146127785|NCT03616912|526989771|FG001|Overall Study|Physician Decision|0|||
146127786|NCT03616912|526989772|FG002|Overall Study|Physician Decision|0|||
146127787|NCT03616912|526989773|FG003|Overall Study|Physician Decision|0|||
146127788|NCT03616912|526989774|FG004|Overall Study|Physician Decision|1|||
146127789|NCT03616912|526989775|FG005|Overall Study|Physician Decision|0|||
146127790|NCT03616912|526989770|FG000|Overall Study|Randomized But Never Treated|0|||
146127791|NCT03616912|526989771|FG001|Overall Study|Randomized But Never Treated|2|||
146127792|NCT03616912|526989772|FG002|Overall Study|Randomized But Never Treated|0|||
146127793|NCT03616912|526989773|FG003|Overall Study|Randomized But Never Treated|0|||
146127794|NCT03616912|526989774|FG004|Overall Study|Randomized But Never Treated|0|||
146127795|NCT03616912|526989775|FG005|Overall Study|Randomized But Never Treated|0|||
146127796|NCT01856790|526989778|FG000|Closed Loop Control|Withdrawal by Subject|2|||
146127797|NCT01856790|526989778|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
146127798|NCT01921829|526989779|FG000|Overall Study|Withdrawal by Subject|0|||
146127799|NCT01921829|526989780|FG001|Overall Study|Withdrawal by Subject|1|||
146127800|NCT01762943|526989782|FG000|Overall Study|Physician Decision|1|||
146127801|NCT01762943|526989783|FG001|Overall Study|Physician Decision|1|||
146127802|NCT01762943|526989782|FG000|Overall Study|Protocol Violation|1|||
146127803|NCT01762943|526989783|FG001|Overall Study|Protocol Violation|0|||
146127804|NCT01762943|526989782|FG000|Overall Study|Withdrawal by Subject|2|||
146127805|NCT01762943|526989783|FG001|Overall Study|Withdrawal by Subject|1|||
146127806|NCT00539838|526989784|FG000|Overall Study|Fail to return|2|||
146127807|NCT00539838|526989785|FG001|Overall Study|Fail to return|0|||
146127808|NCT00539838|526989786|FG002|Overall Study|Fail to return|0|||
146127809|NCT00539838|526989784|FG000|Overall Study|Withdrawal by Subject|0|||
146127810|NCT00539838|526989785|FG001|Overall Study|Withdrawal by Subject|4|||
146127811|NCT00539838|526989786|FG002|Overall Study|Withdrawal by Subject|0|||
146127812|NCT00539838|526989784|FG000|Overall Study|Death|0|||
146127813|NCT00539838|526989785|FG001|Overall Study|Death|2|||
146127814|NCT00539838|526989786|FG002|Overall Study|Death|0|||
146127815|NCT00539838|526989784|FG000|Overall Study|Did not cooperate|1|||
146127816|NCT00539838|526989785|FG001|Overall Study|Did not cooperate|0|||
146127817|NCT00539838|526989786|FG002|Overall Study|Did not cooperate|1|||
146127818|NCT00539838|526989784|FG000|Overall Study|Administrative|4|||
146127819|NCT00539838|526989785|FG001|Overall Study|Administrative|0|||
146127820|NCT00539838|526989786|FG002|Overall Study|Administrative|8|||
146127821|NCT02658890|526989789|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127822|NCT02658890|526989790|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146262833|NCT01663506|527478441|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
146262834|NCT02094898|527478447|FG000|Overall Study|Clinical Worsening|2|||
146262835|NCT02094898|527478447|FG000|Overall Study|Adverse Event|2|||
146262836|NCT02094898|527478447|FG000|Overall Study|Lack of Efficacy|1|||
146127823|NCT02658890|526989791|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127824|NCT02658890|526989792|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127825|NCT02658890|526989793|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146262837|NCT03520075|527478448|FG000|Phase 1 (Dose Escalation)|Death|2|||
146127826|NCT02658890|526989794|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127827|NCT02658890|526989795|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127828|NCT02658890|526989796|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127829|NCT02658890|526989797|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146127830|NCT02658890|526989798|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127831|NCT02658890|526989799|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127832|NCT02658890|526989800|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127833|NCT02658890|526989801|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127834|NCT02658890|526989802|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127835|NCT02658890|526989803|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127836|NCT02658890|526989804|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127837|NCT02658890|526989805|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127838|NCT02658890|526989806|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127839|NCT02658890|526989807|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127840|NCT02658890|526989808|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127841|NCT02658890|526989809|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127842|NCT02658890|526989810|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127843|NCT02658890|526989811|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127844|NCT02658890|526989812|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127845|NCT02658890|526989813|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127846|NCT02658890|526989814|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127847|NCT02658890|526989815|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146127848|NCT02658890|526989789|FG000|Treatment Phase|Adverse Event|0|||
146127849|NCT02658890|526989790|FG001|Treatment Phase|Adverse Event|1|||
146127850|NCT02658890|526989791|FG002|Treatment Phase|Adverse Event|2|||
146127851|NCT02658890|526989792|FG003|Treatment Phase|Adverse Event|2|||
146127852|NCT02658890|526989793|FG004|Treatment Phase|Adverse Event|1|||
146127853|NCT02658890|526989794|FG005|Treatment Phase|Adverse Event|0|||
146127854|NCT02658890|526989795|FG006|Treatment Phase|Adverse Event|0|||
146127855|NCT02658890|526989796|FG007|Treatment Phase|Adverse Event|2|||
146127856|NCT02658890|526989797|FG008|Treatment Phase|Adverse Event|1|||
146127857|NCT02658890|526989798|FG009|Treatment Phase|Adverse Event|2|||
146127858|NCT02658890|526989799|FG010|Treatment Phase|Adverse Event|3|||
146127859|NCT02658890|526989800|FG011|Treatment Phase|Adverse Event|0|||
146127860|NCT02658890|526989801|FG012|Treatment Phase|Adverse Event|1|||
146127861|NCT02658890|526989802|FG013|Treatment Phase|Adverse Event|4|||
146127862|NCT02658890|526989803|FG014|Treatment Phase|Adverse Event|0|||
146127863|NCT02658890|526989804|FG015|Treatment Phase|Adverse Event|0|||
146127864|NCT02658890|526989805|FG016|Treatment Phase|Adverse Event|0|||
146127865|NCT02658890|526989806|FG017|Treatment Phase|Adverse Event|0|||
146127866|NCT02658890|526989807|FG018|Treatment Phase|Adverse Event|5|||
146127867|NCT02658890|526989808|FG019|Treatment Phase|Adverse Event|1|||
146127868|NCT02658890|526989809|FG020|Treatment Phase|Adverse Event|3|||
146127869|NCT02658890|526989810|FG021|Treatment Phase|Adverse Event|0|||
146127870|NCT02658890|526989811|FG022|Treatment Phase|Adverse Event|5|||
146127871|NCT02658890|526989812|FG023|Treatment Phase|Adverse Event|0|||
146127872|NCT02658890|526989813|FG024|Treatment Phase|Adverse Event|0|||
146127873|NCT02658890|526989814|FG025|Treatment Phase|Adverse Event|2|||
146127874|NCT02658890|526989815|FG026|Treatment Phase|Adverse Event|1|||
146127875|NCT02658890|526989789|FG000|Treatment Phase|Death|0|||
146127876|NCT02658890|526989790|FG001|Treatment Phase|Death|0|||
146127877|NCT02658890|526989791|FG002|Treatment Phase|Death|0|||
146127878|NCT02658890|526989792|FG003|Treatment Phase|Death|0|||
146127879|NCT02658890|526989793|FG004|Treatment Phase|Death|0|||
146262838|NCT03520075|527478449|FG001|Phase 1 (Dose Escalation)|Death|2|||
146262839|NCT03520075|527478450|FG002|Phase 1 (Dose Escalation)|Death|3|||
146262840|NCT03520075|527478451|FG003|Phase 1 (Dose Escalation)|Death|2|||
146262841|NCT03520075|527478452|FG004|Phase 1 (Dose Escalation)|Death|6|||
146262842|NCT03520075|527478453|FG005|Phase 1 (Dose Escalation)|Death|5|||
146262843|NCT03520075|527478454|FG006|Phase 1 (Dose Escalation)|Death|3|||
146262844|NCT03520075|527478455|FG007|Phase 1 (Dose Escalation)|Death|2|||
146262845|NCT03520075|527478456|FG008|Phase 1 (Dose Escalation)|Death|3|||
146262846|NCT03520075|527478457|FG009|Phase 1 (Dose Escalation)|Death|1|||
146262847|NCT03520075|527478458|FG010|Phase 1 (Dose Escalation)|Death|5|||
146262848|NCT03520075|527478459|FG011|Phase 1 (Dose Escalation)|Death|7|||
146262849|NCT03520075|527478460|FG012|Phase 1 (Dose Escalation)|Death|11|||
146262850|NCT03520075|527478461|FG013|Phase 1 (Dose Escalation)|Death|0|||
146262851|NCT03520075|527478462|FG014|Phase 1 (Dose Escalation)|Death|0|||
146262852|NCT03520075|527478463|FG015|Phase 1 (Dose Escalation)|Death|0|||
146262853|NCT03520075|527478464|FG016|Phase 1 (Dose Escalation)|Death|0|||
146262854|NCT03520075|527478465|FG017|Phase 1 (Dose Escalation)|Death|0|||
146262855|NCT03520075|527478466|FG018|Phase 1 (Dose Escalation)|Death|0|||
146262856|NCT03520075|527478448|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146262857|NCT03520075|527478449|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146127880|NCT02658890|526989794|FG005|Treatment Phase|Death|0|||
146127881|NCT02658890|526989795|FG006|Treatment Phase|Death|0|||
146127882|NCT02658890|526989796|FG007|Treatment Phase|Death|0|||
146127883|NCT02658890|526989797|FG008|Treatment Phase|Death|0|||
146127884|NCT02658890|526989798|FG009|Treatment Phase|Death|0|||
146127885|NCT02658890|526989799|FG010|Treatment Phase|Death|0|||
146127886|NCT02658890|526989800|FG011|Treatment Phase|Death|0|||
146127887|NCT02658890|526989801|FG012|Treatment Phase|Death|0|||
146127888|NCT02658890|526989802|FG013|Treatment Phase|Death|0|||
146127889|NCT02658890|526989803|FG014|Treatment Phase|Death|0|||
146127890|NCT02658890|526989804|FG015|Treatment Phase|Death|0|||
146127891|NCT02658890|526989805|FG016|Treatment Phase|Death|0|||
146262858|NCT03520075|527478450|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262859|NCT03520075|527478451|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
146303412|NCT03861936|527625767|FG002|Overall Study|Reason not Specified|3|||
146303413|NCT02319668|527625770|FG000|Overall Study|Other (Not specified)|0|||
146303414|NCT02319668|527625771|FG001|Overall Study|Other (Not specified)|2|||
146303415|NCT01372150|527625776|FG000|Overall Study|Lack of Efficacy|3|||
146303416|NCT01372150|527625777|FG001|Overall Study|Lack of Efficacy|0|||
146303417|NCT01372150|527625778|FG002|Overall Study|Lack of Efficacy|1|||
146303418|NCT01372150|527625776|FG000|Overall Study|Lost to Follow-up|4|||
146303419|NCT01372150|527625777|FG001|Overall Study|Lost to Follow-up|5|||
146303420|NCT01372150|527625778|FG002|Overall Study|Lost to Follow-up|6|||
146303421|NCT01372150|527625776|FG000|Overall Study|Protocol Violation|1|||
146303422|NCT01372150|527625777|FG001|Overall Study|Protocol Violation|0|||
146303423|NCT01372150|527625778|FG002|Overall Study|Protocol Violation|3|||
146303424|NCT01372150|527625776|FG000|Overall Study|Withdrawal by Subject|2|||
146303425|NCT01372150|527625777|FG001|Overall Study|Withdrawal by Subject|7|||
146303426|NCT01372150|527625778|FG002|Overall Study|Withdrawal by Subject|2|||
146303427|NCT01372150|527625776|FG000|Overall Study|Other|1|||
146303428|NCT01372150|527625777|FG001|Overall Study|Other|0|||
146303429|NCT01372150|527625778|FG002|Overall Study|Other|2|||
146303430|NCT01372150|527625776|FG000|Overall Study|Adverse Event|2|||
146303431|NCT01372150|527625777|FG001|Overall Study|Adverse Event|1|||
146303432|NCT01372150|527625778|FG002|Overall Study|Adverse Event|2|||
146303433|NCT01372150|527625776|FG000|Overall Study|Randomized but not treated|0|||
146303434|NCT01372150|527625777|FG001|Overall Study|Randomized but not treated|1|||
146303435|NCT01372150|527625778|FG002|Overall Study|Randomized but not treated|0|||
146303436|NCT03198520|527625779|FG000|Overall Study|Physician Decision|2|||
146303437|NCT03198520|527625779|FG000|Overall Study|Protocol Violation|2|||
146303438|NCT03198520|527625779|FG000|Overall Study|Withdrawal by Subject|1|||
146303439|NCT03198520|527625779|FG000|Overall Study|Study Ended|1|||
146303440|NCT01670539|527625780|FG000|Overall Study|Death|3|||
146303441|NCT01670539|527625781|FG001|Overall Study|Death|5|||
146303442|NCT01670539|527625780|FG000|Overall Study|Withdrawal by Subject|3|||
146303443|NCT01670539|527625781|FG001|Overall Study|Withdrawal by Subject|0|||
146303444|NCT01236573|527625782|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303445|NCT01236573|527625783|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303446|NCT01236573|527625784|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303447|NCT01236573|527625785|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303448|NCT01236573|527625786|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303449|NCT01236573|527625787|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303450|NCT01236573|527625788|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146303451|NCT01236573|527625789|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303452|NCT01236573|527625790|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146303453|NCT01236573|527625791|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
146303454|NCT01236573|527625792|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
146303455|NCT01236573|527625782|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303456|NCT01236573|527625783|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303457|NCT01236573|527625784|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303458|NCT01236573|527625785|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303459|NCT01236573|527625786|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303460|NCT01236573|527625787|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303461|NCT01236573|527625788|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303462|NCT01236573|527625789|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303463|NCT01236573|527625790|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
146303464|NCT01236573|527625791|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303465|NCT01236573|527625792|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
146303466|NCT01236573|527625782|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303467|NCT01236573|527625783|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303468|NCT01236573|527625784|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303469|NCT01236573|527625785|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303470|NCT01236573|527625786|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303471|NCT01236573|527625787|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303472|NCT01236573|527625788|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303473|NCT01236573|527625789|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303474|NCT01236573|527625790|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303475|NCT01236573|527625791|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
146303476|NCT01236573|527625792|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
146303477|NCT00823823|527625795|FG000|Overall Study|Lost to Follow-up|3|||
146303478|NCT00823823|527625796|FG001|Overall Study|Lost to Follow-up|1|||
146303479|NCT00823823|527625795|FG000|Overall Study|Protocol Violation|5|||
146303480|NCT00823823|527625796|FG001|Overall Study|Protocol Violation|5|||
146303481|NCT00536809|527625797|FG000|Phase II|Adverse Event|1|||
146303482|NCT00536809|527625797|FG000|Phase II|Referred for surgical resection|1|||
146303483|NCT00113074|527625816|FG000|Overall Study|Lost to Follow-up|10|||
146127892|NCT02658890|526989806|FG017|Treatment Phase|Death|0|||
146127893|NCT02658890|526989807|FG018|Treatment Phase|Death|1|||
146127894|NCT02658890|526989808|FG019|Treatment Phase|Death|0|||
146127895|NCT02658890|526989809|FG020|Treatment Phase|Death|0|||
146127896|NCT02658890|526989810|FG021|Treatment Phase|Death|0|||
146127897|NCT02658890|526989811|FG022|Treatment Phase|Death|0|||
146127898|NCT02658890|526989812|FG023|Treatment Phase|Death|0|||
146127899|NCT02658890|526989813|FG024|Treatment Phase|Death|0|||
146127900|NCT02658890|526989814|FG025|Treatment Phase|Death|0|||
146127901|NCT02658890|526989815|FG026|Treatment Phase|Death|0|||
146127902|NCT02658890|526989789|FG000|Treatment Phase|Lost to Follow-up|0|||
146127903|NCT02658890|526989790|FG001|Treatment Phase|Lost to Follow-up|0|||
146127904|NCT02658890|526989791|FG002|Treatment Phase|Lost to Follow-up|0|||
146127905|NCT02658890|526989792|FG003|Treatment Phase|Lost to Follow-up|0|||
146127906|NCT02658890|526989793|FG004|Treatment Phase|Lost to Follow-up|0|||
146127907|NCT02658890|526989794|FG005|Treatment Phase|Lost to Follow-up|0|||
146127908|NCT02658890|526989795|FG006|Treatment Phase|Lost to Follow-up|1|||
146127909|NCT02658890|526989796|FG007|Treatment Phase|Lost to Follow-up|0|||
146127910|NCT02658890|526989797|FG008|Treatment Phase|Lost to Follow-up|0|||
146127911|NCT02658890|526989798|FG009|Treatment Phase|Lost to Follow-up|0|||
146127912|NCT02658890|526989799|FG010|Treatment Phase|Lost to Follow-up|0|||
146127913|NCT02658890|526989800|FG011|Treatment Phase|Lost to Follow-up|0|||
146127914|NCT02658890|526989801|FG012|Treatment Phase|Lost to Follow-up|0|||
146127915|NCT02658890|526989802|FG013|Treatment Phase|Lost to Follow-up|0|||
146127916|NCT02658890|526989803|FG014|Treatment Phase|Lost to Follow-up|0|||
146262860|NCT03520075|527478452|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
146262861|NCT03520075|527478453|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
146262862|NCT03520075|527478454|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262863|NCT03520075|527478455|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146262864|NCT03520075|527478456|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262865|NCT03520075|527478457|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
146262866|NCT03520075|527478458|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262867|NCT03520075|527478459|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262868|NCT03520075|527478460|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
146262869|NCT03520075|527478461|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262870|NCT03520075|527478462|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262871|NCT03520075|527478463|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262872|NCT03520075|527478464|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262873|NCT03520075|527478465|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262874|NCT03520075|527478466|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
146262875|NCT03520075|527478448|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262876|NCT03520075|527478449|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146262877|NCT03520075|527478450|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262878|NCT03520075|527478451|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146262879|NCT03520075|527478452|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146262880|NCT03520075|527478453|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262881|NCT03520075|527478454|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262882|NCT03520075|527478455|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262883|NCT03520075|527478456|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262884|NCT03520075|527478457|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262885|NCT03520075|527478458|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146262886|NCT03520075|527478459|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262887|NCT03520075|527478460|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
146262888|NCT03520075|527478461|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262889|NCT03520075|527478462|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262890|NCT03520075|527478463|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262891|NCT03520075|527478464|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262892|NCT03520075|527478465|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262893|NCT03520075|527478466|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
146262894|NCT03520075|527478448|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262895|NCT03520075|527478449|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262896|NCT03520075|527478450|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262897|NCT03520075|527478451|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146127917|NCT02658890|526989804|FG015|Treatment Phase|Lost to Follow-up|0|||
146262898|NCT03520075|527478452|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262899|NCT03520075|527478453|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146127918|NCT02658890|526989805|FG016|Treatment Phase|Lost to Follow-up|0|||
146127919|NCT02658890|526989806|FG017|Treatment Phase|Lost to Follow-up|0|||
146127920|NCT02658890|526989807|FG018|Treatment Phase|Lost to Follow-up|0|||
146127921|NCT02658890|526989808|FG019|Treatment Phase|Lost to Follow-up|0|||
146127922|NCT02658890|526989809|FG020|Treatment Phase|Lost to Follow-up|0|||
146127923|NCT02658890|526989810|FG021|Treatment Phase|Lost to Follow-up|0|||
146127924|NCT02658890|526989811|FG022|Treatment Phase|Lost to Follow-up|0|||
146127925|NCT02658890|526989812|FG023|Treatment Phase|Lost to Follow-up|0|||
146127926|NCT02658890|526989813|FG024|Treatment Phase|Lost to Follow-up|0|||
146127927|NCT02658890|526989814|FG025|Treatment Phase|Lost to Follow-up|0|||
146127928|NCT02658890|526989815|FG026|Treatment Phase|Lost to Follow-up|0|||
146127929|NCT02658890|526989789|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
146127930|NCT02658890|526989790|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
146127931|NCT02658890|526989791|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
146127932|NCT02658890|526989792|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
146127933|NCT02658890|526989793|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
146127934|NCT02658890|526989794|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
146127935|NCT02658890|526989795|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
146127936|NCT02658890|526989796|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
146127937|NCT02658890|526989797|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
146127938|NCT02658890|526989798|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
146127939|NCT02658890|526989799|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
146127940|NCT02658890|526989800|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
146127941|NCT02658890|526989801|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
146127942|NCT02658890|526989802|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
146127943|NCT02658890|526989803|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
146127944|NCT02658890|526989804|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
146127945|NCT02658890|526989805|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
146127946|NCT02658890|526989806|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
146127947|NCT02658890|526989807|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
146127948|NCT02658890|526989808|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
146127949|NCT02658890|526989809|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
146127950|NCT02658890|526989810|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
146127951|NCT02658890|526989811|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
146127952|NCT02658890|526989812|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
146127953|NCT02658890|526989813|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
146127954|NCT02658890|526989814|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
146127955|NCT02658890|526989815|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
146127956|NCT02658890|526989789|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
146127957|NCT02658890|526989790|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
146127958|NCT02658890|526989791|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
146127959|NCT02658890|526989792|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
146127960|NCT02658890|526989793|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
146127961|NCT02658890|526989794|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
146127962|NCT02658890|526989795|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
146127963|NCT02658890|526989796|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
146127964|NCT02658890|526989797|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
146127965|NCT02658890|526989798|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
146127966|NCT02658890|526989799|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
146127967|NCT02658890|526989800|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
146127968|NCT02658890|526989801|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
146127969|NCT02658890|526989802|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
146127970|NCT02658890|526989803|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
146127971|NCT02658890|526989804|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
146127972|NCT02658890|526989805|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
146127973|NCT02658890|526989806|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
146127974|NCT02658890|526989807|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
146127975|NCT02658890|526989808|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
146127976|NCT02658890|526989809|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
146127977|NCT02658890|526989810|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
146127978|NCT02658890|526989811|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
146127979|NCT02658890|526989812|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
146127980|NCT02658890|526989813|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
146127981|NCT02658890|526989814|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
146127982|NCT02658890|526989815|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
146127983|NCT02658890|526989789|FG000|Treatment Phase|Other Reasons|0|||
146127984|NCT02658890|526989790|FG001|Treatment Phase|Other Reasons|0|||
146127985|NCT02658890|526989791|FG002|Treatment Phase|Other Reasons|0|||
146127986|NCT02658890|526989792|FG003|Treatment Phase|Other Reasons|0|||
146127987|NCT02658890|526989793|FG004|Treatment Phase|Other Reasons|0|||
146127988|NCT02658890|526989794|FG005|Treatment Phase|Other Reasons|0|||
146127989|NCT02658890|526989795|FG006|Treatment Phase|Other Reasons|1|||
146127990|NCT02658890|526989796|FG007|Treatment Phase|Other Reasons|0|||
146127991|NCT02658890|526989797|FG008|Treatment Phase|Other Reasons|1|||
146127992|NCT02658890|526989798|FG009|Treatment Phase|Other Reasons|0|||
146127993|NCT02658890|526989799|FG010|Treatment Phase|Other Reasons|0|||
146127994|NCT02658890|526989800|FG011|Treatment Phase|Other Reasons|0|||
146127995|NCT02658890|526989801|FG012|Treatment Phase|Other Reasons|0|||
146127996|NCT02658890|526989802|FG013|Treatment Phase|Other Reasons|2|||
146127997|NCT02658890|526989803|FG014|Treatment Phase|Other Reasons|0|||
146127998|NCT02658890|526989804|FG015|Treatment Phase|Other Reasons|0|||
146127999|NCT02658890|526989805|FG016|Treatment Phase|Other Reasons|0|||
146128000|NCT02658890|526989806|FG017|Treatment Phase|Other Reasons|0|||
146128001|NCT02658890|526989807|FG018|Treatment Phase|Other Reasons|1|||
146128002|NCT02658890|526989808|FG019|Treatment Phase|Other Reasons|0|||
146128003|NCT02658890|526989809|FG020|Treatment Phase|Other Reasons|0|||
146128004|NCT02658890|526989810|FG021|Treatment Phase|Other Reasons|0|||
146128005|NCT02658890|526989811|FG022|Treatment Phase|Other Reasons|0|||
146128006|NCT02658890|526989812|FG023|Treatment Phase|Other Reasons|0|||
146128007|NCT02658890|526989813|FG024|Treatment Phase|Other Reasons|1|||
146128008|NCT02658890|526989814|FG025|Treatment Phase|Other Reasons|0|||
146128009|NCT02658890|526989815|FG026|Treatment Phase|Other Reasons|1|||
146128010|NCT02658890|526989789|FG000|Treatment Phase|Progressive Disease|6|||
146128011|NCT02658890|526989790|FG001|Treatment Phase|Progressive Disease|7|||
146128012|NCT02658890|526989791|FG002|Treatment Phase|Progressive Disease|6|||
146128013|NCT02658890|526989792|FG003|Treatment Phase|Progressive Disease|12|||
146128014|NCT02658890|526989793|FG004|Treatment Phase|Progressive Disease|6|||
146128015|NCT02658890|526989794|FG005|Treatment Phase|Progressive Disease|18|||
146128016|NCT02658890|526989795|FG006|Treatment Phase|Progressive Disease|12|||
146128017|NCT02658890|526989796|FG007|Treatment Phase|Progressive Disease|19|||
146128018|NCT02658890|526989797|FG008|Treatment Phase|Progressive Disease|26|||
146128019|NCT02658890|526989798|FG009|Treatment Phase|Progressive Disease|8|||
146128020|NCT02658890|526989799|FG010|Treatment Phase|Progressive Disease|7|||
146128021|NCT02658890|526989800|FG011|Treatment Phase|Progressive Disease|9|||
146128022|NCT02658890|526989801|FG012|Treatment Phase|Progressive Disease|8|||
146128023|NCT02658890|526989802|FG013|Treatment Phase|Progressive Disease|29|||
146128024|NCT02658890|526989803|FG014|Treatment Phase|Progressive Disease|6|||
146128025|NCT02658890|526989804|FG015|Treatment Phase|Progressive Disease|2|||
146128026|NCT02658890|526989805|FG016|Treatment Phase|Progressive Disease|32|||
146128027|NCT02658890|526989806|FG017|Treatment Phase|Progressive Disease|14|||
146128028|NCT02658890|526989807|FG018|Treatment Phase|Progressive Disease|40|||
146128029|NCT02658890|526989808|FG019|Treatment Phase|Progressive Disease|32|||
146128030|NCT02658890|526989809|FG020|Treatment Phase|Progressive Disease|19|||
146128031|NCT02658890|526989810|FG021|Treatment Phase|Progressive Disease|30|||
146128032|NCT02658890|526989811|FG022|Treatment Phase|Progressive Disease|15|||
146128033|NCT02658890|526989812|FG023|Treatment Phase|Progressive Disease|0|||
146128034|NCT02658890|526989813|FG024|Treatment Phase|Progressive Disease|0|||
146128035|NCT02658890|526989814|FG025|Treatment Phase|Progressive Disease|14|||
146128036|NCT02658890|526989815|FG026|Treatment Phase|Progressive Disease|11|||
146128037|NCT02658890|526989789|FG000|Treatment Phase|Study Drug Toxicity|0|||
146128038|NCT02658890|526989790|FG001|Treatment Phase|Study Drug Toxicity|0|||
146128039|NCT02658890|526989791|FG002|Treatment Phase|Study Drug Toxicity|2|||
146128040|NCT02658890|526989792|FG003|Treatment Phase|Study Drug Toxicity|0|||
146128041|NCT02658890|526989793|FG004|Treatment Phase|Study Drug Toxicity|0|||
146128042|NCT02658890|526989794|FG005|Treatment Phase|Study Drug Toxicity|0|||
146128043|NCT02658890|526989795|FG006|Treatment Phase|Study Drug Toxicity|0|||
146128044|NCT02658890|526989796|FG007|Treatment Phase|Study Drug Toxicity|0|||
146128045|NCT02658890|526989797|FG008|Treatment Phase|Study Drug Toxicity|3|||
146128046|NCT02658890|526989798|FG009|Treatment Phase|Study Drug Toxicity|0|||
146128047|NCT02658890|526989799|FG010|Treatment Phase|Study Drug Toxicity|1|||
146128048|NCT02658890|526989800|FG011|Treatment Phase|Study Drug Toxicity|1|||
146128049|NCT02658890|526989801|FG012|Treatment Phase|Study Drug Toxicity|2|||
146128050|NCT02658890|526989802|FG013|Treatment Phase|Study Drug Toxicity|9|||
146128051|NCT02658890|526989803|FG014|Treatment Phase|Study Drug Toxicity|0|||
146128052|NCT02658890|526989804|FG015|Treatment Phase|Study Drug Toxicity|1|||
146128053|NCT02658890|526989805|FG016|Treatment Phase|Study Drug Toxicity|1|||
146128054|NCT02658890|526989806|FG017|Treatment Phase|Study Drug Toxicity|0|||
146128055|NCT02658890|526989807|FG018|Treatment Phase|Study Drug Toxicity|8|||
146128056|NCT02658890|526989808|FG019|Treatment Phase|Study Drug Toxicity|3|||
146128057|NCT02658890|526989809|FG020|Treatment Phase|Study Drug Toxicity|2|||
146128058|NCT02658890|526989810|FG021|Treatment Phase|Study Drug Toxicity|0|||
146128059|NCT02658890|526989811|FG022|Treatment Phase|Study Drug Toxicity|8|||
146128060|NCT02658890|526989812|FG023|Treatment Phase|Study Drug Toxicity|0|||
146128061|NCT02658890|526989813|FG024|Treatment Phase|Study Drug Toxicity|0|||
146128062|NCT02658890|526989814|FG025|Treatment Phase|Study Drug Toxicity|2|||
146128063|NCT02658890|526989815|FG026|Treatment Phase|Study Drug Toxicity|0|||
146128064|NCT02658890|526989789|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128065|NCT02658890|526989790|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128066|NCT02658890|526989791|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128067|NCT02658890|526989792|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146128068|NCT02658890|526989793|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128069|NCT02658890|526989794|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128070|NCT02658890|526989795|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128071|NCT02658890|526989796|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128072|NCT02658890|526989797|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128073|NCT02658890|526989798|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146303484|NCT00113074|527625817|FG001|Overall Study|Lost to Follow-up|10|||
146128074|NCT02658890|526989799|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128075|NCT02658890|526989800|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128076|NCT02658890|526989801|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128077|NCT02658890|526989802|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128078|NCT02658890|526989803|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128079|NCT02658890|526989804|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128080|NCT02658890|526989805|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146262900|NCT03520075|527478454|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262901|NCT03520075|527478455|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262902|NCT03520075|527478456|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262903|NCT03520075|527478457|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
146262904|NCT03520075|527478458|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262905|NCT03520075|527478459|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262906|NCT03520075|527478460|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
146262907|NCT03520075|527478461|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262908|NCT03520075|527478462|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262909|NCT03520075|527478463|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262910|NCT03520075|527478464|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262911|NCT03520075|527478465|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146262912|NCT03520075|527478466|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
146128081|NCT02658890|526989806|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128082|NCT02658890|526989807|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146128083|NCT02658890|526989808|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128084|NCT02658890|526989809|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128085|NCT02658890|526989810|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128086|NCT02658890|526989811|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
146128087|NCT02658890|526989812|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128088|NCT02658890|526989813|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128089|NCT02658890|526989814|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128090|NCT02658890|526989815|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
146128091|NCT02658890|526989789|FG000|Treatment Phase|Withdrawal by Subject|0|||
146128092|NCT02658890|526989790|FG001|Treatment Phase|Withdrawal by Subject|1|||
146128093|NCT02658890|526989791|FG002|Treatment Phase|Withdrawal by Subject|0|||
146128094|NCT02658890|526989792|FG003|Treatment Phase|Withdrawal by Subject|0|||
146128095|NCT02658890|526989793|FG004|Treatment Phase|Withdrawal by Subject|0|||
146128096|NCT02658890|526989794|FG005|Treatment Phase|Withdrawal by Subject|0|||
146128097|NCT02658890|526989795|FG006|Treatment Phase|Withdrawal by Subject|1|||
146128098|NCT02658890|526989796|FG007|Treatment Phase|Withdrawal by Subject|0|||
146128099|NCT02658890|526989797|FG008|Treatment Phase|Withdrawal by Subject|0|||
146128100|NCT02658890|526989798|FG009|Treatment Phase|Withdrawal by Subject|1|||
146128101|NCT02658890|526989799|FG010|Treatment Phase|Withdrawal by Subject|0|||
146128102|NCT02658890|526989800|FG011|Treatment Phase|Withdrawal by Subject|0|||
146128103|NCT02658890|526989801|FG012|Treatment Phase|Withdrawal by Subject|1|||
146128104|NCT02658890|526989802|FG013|Treatment Phase|Withdrawal by Subject|3|||
146128105|NCT02658890|526989803|FG014|Treatment Phase|Withdrawal by Subject|0|||
146128106|NCT02658890|526989804|FG015|Treatment Phase|Withdrawal by Subject|0|||
146128107|NCT02658890|526989805|FG016|Treatment Phase|Withdrawal by Subject|1|||
146128108|NCT02658890|526989806|FG017|Treatment Phase|Withdrawal by Subject|0|||
146128109|NCT02658890|526989807|FG018|Treatment Phase|Withdrawal by Subject|4|||
146128110|NCT02658890|526989808|FG019|Treatment Phase|Withdrawal by Subject|3|||
146128111|NCT02658890|526989809|FG020|Treatment Phase|Withdrawal by Subject|0|||
146128112|NCT02658890|526989810|FG021|Treatment Phase|Withdrawal by Subject|4|||
146128113|NCT02658890|526989811|FG022|Treatment Phase|Withdrawal by Subject|1|||
146128114|NCT02658890|526989812|FG023|Treatment Phase|Withdrawal by Subject|1|||
146128115|NCT02658890|526989813|FG024|Treatment Phase|Withdrawal by Subject|0|||
146128116|NCT02658890|526989814|FG025|Treatment Phase|Withdrawal by Subject|0|||
146128117|NCT02658890|526989815|FG026|Treatment Phase|Withdrawal by Subject|0|||
146128118|NCT02474199|526989819|FG000|Overall Study|Lost to Follow-up|1|||
146128119|NCT02474199|526989820|FG001|Overall Study|Lost to Follow-up|0|||
146128120|NCT02474199|526989821|FG002|Overall Study|Lost to Follow-up|0|||
146128121|NCT02474199|526989822|FG003|Overall Study|Lost to Follow-up|0|||
146128122|NCT02474199|526989819|FG000|Overall Study|Withdrawal by Subject|1|||
146262913|NCT03520075|527478448|FG000|Phase 2 (Dose Expansion)|Death|0|||
146128123|NCT02474199|526989820|FG001|Overall Study|Withdrawal by Subject|2|||
146128124|NCT02474199|526989821|FG002|Overall Study|Withdrawal by Subject|0|||
146262914|NCT03520075|527478449|FG001|Phase 2 (Dose Expansion)|Death|0|||
146262915|NCT03520075|527478450|FG002|Phase 2 (Dose Expansion)|Death|0|||
146262916|NCT03520075|527478451|FG003|Phase 2 (Dose Expansion)|Death|0|||
146262917|NCT03520075|527478452|FG004|Phase 2 (Dose Expansion)|Death|0|||
145943208|NCT00483704|526300458|FG002|Randomization|Pregnancy|0|||
146128125|NCT02474199|526989822|FG003|Overall Study|Withdrawal by Subject|1|||
146128126|NCT02474199|526989819|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146128127|NCT02474199|526989820|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
146128128|NCT02474199|526989821|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146128129|NCT02474199|526989822|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
146128130|NCT02474199|526989819|FG000|Overall Study|Did not meet eligibility criteria|0|||
146128131|NCT02474199|526989820|FG001|Overall Study|Did not meet eligibility criteria|0|||
146128132|NCT02474199|526989821|FG002|Overall Study|Did not meet eligibility criteria|2|||
146128133|NCT02474199|526989822|FG003|Overall Study|Did not meet eligibility criteria|2|||
146128134|NCT03090100|526989823|FG000|Overall Study|Adverse Event|9|||
146128135|NCT03090100|526989824|FG001|Overall Study|Adverse Event|11|||
146128136|NCT03090100|526989823|FG000|Overall Study|Pregnancy|1|||
146128137|NCT03090100|526989824|FG001|Overall Study|Pregnancy|1|||
146128138|NCT03090100|526989823|FG000|Overall Study|Lack of Efficacy|2|||
146128139|NCT03090100|526989824|FG001|Overall Study|Lack of Efficacy|7|||
146128140|NCT03090100|526989823|FG000|Overall Study|Lost to Follow-up|2|||
146128141|NCT03090100|526989824|FG001|Overall Study|Lost to Follow-up|2|||
146128142|NCT03090100|526989823|FG000|Overall Study|Withdrawal by Subject|7|||
146128143|NCT03090100|526989824|FG001|Overall Study|Withdrawal by Subject|19|||
146128144|NCT03090100|526989823|FG000|Overall Study|Protocol Violation|2|||
146128145|NCT03090100|526989824|FG001|Overall Study|Protocol Violation|6|||
146128146|NCT03090100|526989823|FG000|Overall Study|Non-compliance|2|||
146128147|NCT03090100|526989824|FG001|Overall Study|Non-compliance|0|||
146128148|NCT03090100|526989823|FG000|Overall Study|Other|2|||
146128149|NCT03090100|526989824|FG001|Overall Study|Other|2|||
146128150|NCT00159588|526989825|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
146128151|NCT00159588|526989826|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
146128152|NCT00159588|526989827|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
146128153|NCT03446040|526989828|FG000|Overall Study|Disease progression|3|||
146128154|NCT03446040|526989829|FG001|Overall Study|Disease progression|3|||
146128155|NCT03446040|526989830|FG002|Overall Study|Disease progression|3|||
146128156|NCT03446040|526989831|FG003|Overall Study|Disease progression|4|||
146128157|NCT03446040|526989832|FG004|Overall Study|Disease progression|4|||
146128158|NCT03446040|526989833|FG005|Overall Study|Disease progression|6|||
146128159|NCT03446040|526989834|FG006|Overall Study|Disease progression|3|||
146128160|NCT03446040|526989835|FG007|Overall Study|Disease progression|4|||
146128161|NCT03446040|526989836|FG008|Overall Study|Disease progression|2|||
146128162|NCT03446040|526989837|FG009|Overall Study|Disease progression|4|||
146128163|NCT03446040|526989838|FG010|Overall Study|Disease progression|9|||
146128164|NCT03446040|526989839|FG011|Overall Study|Disease progression|3|||
146128165|NCT03446040|526989840|FG012|Overall Study|Disease progression|7|||
146128166|NCT03446040|526989841|FG013|Overall Study|Disease progression|7|||
146128167|NCT03446040|526989828|FG000|Overall Study|Study drug toxicity|0|||
146128168|NCT03446040|526989829|FG001|Overall Study|Study drug toxicity|0|||
146128169|NCT03446040|526989830|FG002|Overall Study|Study drug toxicity|0|||
146128170|NCT03446040|526989831|FG003|Overall Study|Study drug toxicity|0|||
146128171|NCT03446040|526989832|FG004|Overall Study|Study drug toxicity|0|||
146128172|NCT03446040|526989833|FG005|Overall Study|Study drug toxicity|0|||
146128173|NCT03446040|526989834|FG006|Overall Study|Study drug toxicity|0|||
146128174|NCT03446040|526989835|FG007|Overall Study|Study drug toxicity|0|||
146128175|NCT03446040|526989836|FG008|Overall Study|Study drug toxicity|1|||
146128176|NCT03446040|526989837|FG009|Overall Study|Study drug toxicity|0|||
146128177|NCT03446040|526989838|FG010|Overall Study|Study drug toxicity|0|||
146128178|NCT03446040|526989839|FG011|Overall Study|Study drug toxicity|0|||
146128179|NCT03446040|526989840|FG012|Overall Study|Study drug toxicity|0|||
146128180|NCT03446040|526989841|FG013|Overall Study|Study drug toxicity|0|||
146128181|NCT03446040|526989828|FG000|Overall Study|Adverse Event|0|||
146262918|NCT03520075|527478453|FG005|Phase 2 (Dose Expansion)|Death|0|||
146262919|NCT03520075|527478454|FG006|Phase 2 (Dose Expansion)|Death|0|||
146262920|NCT03520075|527478455|FG007|Phase 2 (Dose Expansion)|Death|0|||
146262921|NCT03520075|527478456|FG008|Phase 2 (Dose Expansion)|Death|0|||
146128182|NCT03446040|526989829|FG001|Overall Study|Adverse Event|0|||
146128183|NCT03446040|526989830|FG002|Overall Study|Adverse Event|0|||
146128184|NCT03446040|526989831|FG003|Overall Study|Adverse Event|0|||
146128185|NCT03446040|526989832|FG004|Overall Study|Adverse Event|0|||
146128186|NCT03446040|526989833|FG005|Overall Study|Adverse Event|2|||
146128187|NCT03446040|526989834|FG006|Overall Study|Adverse Event|0|||
146128188|NCT03446040|526989835|FG007|Overall Study|Adverse Event|0|||
146128189|NCT03446040|526989836|FG008|Overall Study|Adverse Event|1|||
146128190|NCT03446040|526989837|FG009|Overall Study|Adverse Event|0|||
146128191|NCT03446040|526989838|FG010|Overall Study|Adverse Event|0|||
146128192|NCT03446040|526989839|FG011|Overall Study|Adverse Event|0|||
146128193|NCT03446040|526989840|FG012|Overall Study|Adverse Event|0|||
146128194|NCT03446040|526989841|FG013|Overall Study|Adverse Event|0|||
146128195|NCT03446040|526989828|FG000|Overall Study|Death|0|||
146128196|NCT03446040|526989829|FG001|Overall Study|Death|0|||
146262922|NCT03520075|527478457|FG009|Phase 2 (Dose Expansion)|Death|0|||
146262923|NCT03520075|527478458|FG010|Phase 2 (Dose Expansion)|Death|0|||
146262924|NCT03520075|527478459|FG011|Phase 2 (Dose Expansion)|Death|0|||
146128197|NCT03446040|526989830|FG002|Overall Study|Death|0|||
146128198|NCT03446040|526989831|FG003|Overall Study|Death|0|||
146128199|NCT03446040|526989832|FG004|Overall Study|Death|0|||
146128200|NCT03446040|526989833|FG005|Overall Study|Death|0|||
146128201|NCT03446040|526989834|FG006|Overall Study|Death|0|||
146128202|NCT03446040|526989835|FG007|Overall Study|Death|0|||
146128203|NCT03446040|526989836|FG008|Overall Study|Death|0|||
146128204|NCT03446040|526989837|FG009|Overall Study|Death|0|||
146128205|NCT03446040|526989838|FG010|Overall Study|Death|1|||
146128206|NCT03446040|526989839|FG011|Overall Study|Death|0|||
146128207|NCT03446040|526989840|FG012|Overall Study|Death|0|||
146128208|NCT03446040|526989841|FG013|Overall Study|Death|2|||
146128209|NCT03446040|526989828|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146128210|NCT03446040|526989829|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
146128211|NCT03446040|526989830|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146128212|NCT03446040|526989831|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
146128213|NCT03446040|526989832|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
146128214|NCT03446040|526989833|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
146128215|NCT03446040|526989834|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
146128216|NCT03446040|526989835|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
146128217|NCT03446040|526989836|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
146128218|NCT03446040|526989837|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
146128219|NCT03446040|526989838|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
146128220|NCT03446040|526989839|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
146128221|NCT03446040|526989840|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
146128222|NCT03446040|526989841|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
146128223|NCT03446040|526989828|FG000|Overall Study|Participant withdrew consent|0|||
146128224|NCT03446040|526989829|FG001|Overall Study|Participant withdrew consent|0|||
146128225|NCT03446040|526989830|FG002|Overall Study|Participant withdrew consent|0|||
146128226|NCT03446040|526989831|FG003|Overall Study|Participant withdrew consent|0|||
146128227|NCT03446040|526989832|FG004|Overall Study|Participant withdrew consent|0|||
146128228|NCT03446040|526989833|FG005|Overall Study|Participant withdrew consent|1|||
146128229|NCT03446040|526989834|FG006|Overall Study|Participant withdrew consent|0|||
146128230|NCT03446040|526989835|FG007|Overall Study|Participant withdrew consent|1|||
146128231|NCT03446040|526989836|FG008|Overall Study|Participant withdrew consent|0|||
146128232|NCT03446040|526989837|FG009|Overall Study|Participant withdrew consent|0|||
146128233|NCT03446040|526989838|FG010|Overall Study|Participant withdrew consent|0|||
146128234|NCT03446040|526989839|FG011|Overall Study|Participant withdrew consent|0|||
146128235|NCT03446040|526989840|FG012|Overall Study|Participant withdrew consent|0|||
146128236|NCT03446040|526989841|FG013|Overall Study|Participant withdrew consent|0|||
146128237|NCT03446040|526989828|FG000|Overall Study|Not reported|0|||
146128238|NCT03446040|526989829|FG001|Overall Study|Not reported|0|||
146128239|NCT03446040|526989830|FG002|Overall Study|Not reported|1|||
146128240|NCT03446040|526989831|FG003|Overall Study|Not reported|0|||
146128241|NCT03446040|526989832|FG004|Overall Study|Not reported|0|||
146128242|NCT03446040|526989833|FG005|Overall Study|Not reported|0|||
146128243|NCT03446040|526989834|FG006|Overall Study|Not reported|0|||
146128244|NCT03446040|526989835|FG007|Overall Study|Not reported|0|||
146128245|NCT03446040|526989836|FG008|Overall Study|Not reported|0|||
146128246|NCT03446040|526989837|FG009|Overall Study|Not reported|0|||
146128247|NCT03446040|526989838|FG010|Overall Study|Not reported|0|||
146128248|NCT03446040|526989839|FG011|Overall Study|Not reported|0|||
146128249|NCT03446040|526989840|FG012|Overall Study|Not reported|0|||
146128250|NCT03446040|526989841|FG013|Overall Study|Not reported|0|||
146128251|NCT00456521|526989842|FG000|Overall Study|Adverse Event|150|||
146128252|NCT00456521|526989843|FG001|Overall Study|Adverse Event|25|||
146128253|NCT00456521|526989842|FG000|Overall Study|Withdrawal by Subject|43|||
146128254|NCT00456521|526989843|FG001|Overall Study|Withdrawal by Subject|24|||
146128255|NCT00456521|526989842|FG000|Overall Study|Lost to Follow-up|22|||
146128256|NCT00456521|526989843|FG001|Overall Study|Lost to Follow-up|17|||
146128257|NCT00456521|526989842|FG000|Overall Study|Lack of Efficacy|3|||
146128258|NCT00456521|526989843|FG001|Overall Study|Lack of Efficacy|6|||
146128259|NCT00456521|526989842|FG000|Overall Study|Protocol Violation|4|||
146128260|NCT00456521|526989843|FG001|Overall Study|Protocol Violation|0|||
146128261|NCT00456521|526989842|FG000|Overall Study|Pregnancy|1|||
146128262|NCT00456521|526989843|FG001|Overall Study|Pregnancy|1|||
146128263|NCT00456521|526989842|FG000|Overall Study|Drug non-compliance, moved, other|26|||
146128264|NCT00456521|526989843|FG001|Overall Study|Drug non-compliance, moved, other|11|||
146128265|NCT00605475|526989844|FG000|Overall Study|Abnormal Laboratory Values|0|||
146128266|NCT00605475|526989845|FG001|Overall Study|Abnormal Laboratory Values|0|||
146128267|NCT00605475|526989846|FG002|Overall Study|Abnormal Laboratory Values|0|||
146128268|NCT00605475|526989847|FG003|Overall Study|Abnormal Laboratory Values|0|||
146128269|NCT00605475|526989848|FG004|Overall Study|Abnormal Laboratory Values|0|||
146128270|NCT00605475|526989849|FG005|Overall Study|Abnormal Laboratory Values|0|||
146128271|NCT00605475|526989850|FG006|Overall Study|Abnormal Laboratory Values|0|||
146128272|NCT00605475|526989851|FG007|Overall Study|Abnormal Laboratory Values|0|||
146128273|NCT00605475|526989852|FG008|Overall Study|Abnormal Laboratory Values|1|||
146128274|NCT00605475|526989853|FG009|Overall Study|Abnormal Laboratory Values|0|||
146128275|NCT00605475|526989844|FG000|Overall Study|Administrative problems|0|||
146128276|NCT00605475|526989845|FG001|Overall Study|Administrative problems|0|||
146128277|NCT00605475|526989846|FG002|Overall Study|Administrative problems|0|||
146128278|NCT00605475|526989847|FG003|Overall Study|Administrative problems|0|||
146128279|NCT00605475|526989848|FG004|Overall Study|Administrative problems|0|||
146128280|NCT00605475|526989849|FG005|Overall Study|Administrative problems|0|||
146128281|NCT00605475|526989850|FG006|Overall Study|Administrative problems|1|||
146128282|NCT00605475|526989851|FG007|Overall Study|Administrative problems|0|||
146128283|NCT00605475|526989852|FG008|Overall Study|Administrative problems|0|||
146128284|NCT00605475|526989853|FG009|Overall Study|Administrative problems|0|||
146128285|NCT00605475|526989844|FG000|Overall Study|Lost to Follow-up|0|||
146128286|NCT00605475|526989845|FG001|Overall Study|Lost to Follow-up|0|||
146128287|NCT00605475|526989846|FG002|Overall Study|Lost to Follow-up|0|||
146128288|NCT00605475|526989847|FG003|Overall Study|Lost to Follow-up|0|||
146128289|NCT00605475|526989848|FG004|Overall Study|Lost to Follow-up|0|||
146128290|NCT00605475|526989849|FG005|Overall Study|Lost to Follow-up|0|||
146128291|NCT00605475|526989850|FG006|Overall Study|Lost to Follow-up|0|||
146128292|NCT00605475|526989851|FG007|Overall Study|Lost to Follow-up|0|||
146128293|NCT00605475|526989852|FG008|Overall Study|Lost to Follow-up|1|||
146128294|NCT00605475|526989853|FG009|Overall Study|Lost to Follow-up|1|||
146128295|NCT00605475|526989844|FG000|Overall Study|Protocol Violation|0|||
146128296|NCT00605475|526989845|FG001|Overall Study|Protocol Violation|0|||
146128297|NCT00605475|526989846|FG002|Overall Study|Protocol Violation|0|||
146128298|NCT00605475|526989847|FG003|Overall Study|Protocol Violation|0|||
146128299|NCT00605475|526989848|FG004|Overall Study|Protocol Violation|1|||
146128300|NCT00605475|526989849|FG005|Overall Study|Protocol Violation|0|||
146128301|NCT00605475|526989850|FG006|Overall Study|Protocol Violation|0|||
146128302|NCT00605475|526989851|FG007|Overall Study|Protocol Violation|0|||
146128303|NCT00605475|526989852|FG008|Overall Study|Protocol Violation|0|||
146128304|NCT00605475|526989853|FG009|Overall Study|Protocol Violation|0|||
146128305|NCT00605475|526989844|FG000|Overall Study|Withdrawal by Subject|0|||
146128306|NCT00605475|526989845|FG001|Overall Study|Withdrawal by Subject|0|||
146128307|NCT00605475|526989846|FG002|Overall Study|Withdrawal by Subject|0|||
146128308|NCT00605475|526989847|FG003|Overall Study|Withdrawal by Subject|0|||
146128309|NCT00605475|526989848|FG004|Overall Study|Withdrawal by Subject|0|||
146128310|NCT00605475|526989849|FG005|Overall Study|Withdrawal by Subject|2|||
146128311|NCT00605475|526989850|FG006|Overall Study|Withdrawal by Subject|0|||
146128312|NCT00605475|526989851|FG007|Overall Study|Withdrawal by Subject|0|||
146128313|NCT00605475|526989852|FG008|Overall Study|Withdrawal by Subject|0|||
146128314|NCT00605475|526989853|FG009|Overall Study|Withdrawal by Subject|1|||
146128315|NCT02596854|526989854|FG000|Overall Study|Withdrawn|8|||
146128316|NCT00076011|526989858|FG000|Overall Study|Death|1|||
146128317|NCT00076011|526989858|FG000|Overall Study|Adverse Event|10|||
146128318|NCT00076011|526989858|FG000|Overall Study|Lack of Efficacy|25|||
146128319|NCT00076011|526989858|FG000|Overall Study|Withdrawal by Subject|1|||
146128320|NCT00076011|526989858|FG000|Overall Study|Study terminated by sponsor|3|||
146128321|NCT00076011|526989858|FG000|Overall Study|Other|11|||
146128322|NCT00076011|526989858|FG000|Overall Study|Ongoing|1|||
146128323|NCT03615326|526989865|FG000|Overall Study|Death|266|||
146128324|NCT03615326|526989866|FG001|Overall Study|Death|286|||
146128325|NCT03615326|526989867|FG002|Overall Study|Death|14|||
146128326|NCT03615326|526989868|FG003|Overall Study|Death|17|||
146128327|NCT03615326|526989865|FG000|Overall Study|Lost to Follow-up|0|||
146128328|NCT03615326|526989866|FG001|Overall Study|Lost to Follow-up|1|||
146128329|NCT03615326|526989867|FG002|Overall Study|Lost to Follow-up|0|||
146128330|NCT03615326|526989868|FG003|Overall Study|Lost to Follow-up|0|||
146128331|NCT03615326|526989865|FG000|Overall Study|Withdrawal by Subject|1|||
146128332|NCT03615326|526989866|FG001|Overall Study|Withdrawal by Subject|3|||
146128333|NCT03615326|526989867|FG002|Overall Study|Withdrawal by Subject|0|||
146128334|NCT03615326|526989868|FG003|Overall Study|Withdrawal by Subject|0|||
146128335|NCT03615326|526989865|FG000|Overall Study|Participants Ongoing|83|||
146128336|NCT03615326|526989866|FG001|Overall Study|Participants Ongoing|58|||
146128337|NCT03615326|526989867|FG002|Overall Study|Participants Ongoing|6|||
146128338|NCT03615326|526989868|FG003|Overall Study|Participants Ongoing|3|||
146128339|NCT05071183|526989869|FG000|Overall Study|Death|1|||
146128340|NCT05071183|526989870|FG001|Overall Study|Death|2|||
146128341|NCT05071183|526989871|FG002|Overall Study|Death|0|||
146128342|NCT05071183|526989869|FG000|Overall Study|Other Reasons|1|||
146128343|NCT05071183|526989870|FG001|Overall Study|Other Reasons|3|||
146128344|NCT05071183|526989871|FG002|Overall Study|Other Reasons|2|||
146128345|NCT02532647|526989872|FG000|Overall Study|Did not receive trial medication|1|||
146128346|NCT02532647|526989873|FG001|Overall Study|Did not receive trial medication|0|||
146128347|NCT02532647|526989874|FG002|Overall Study|Did not receive trial medication|1|||
146128348|NCT01480076|526989875|FG000|Overall Study|Run-in Failure|52|||
146128349|NCT01480076|526989875|FG000|Overall Study|Adverse Event|39|||
146128350|NCT01480076|526989875|FG000|Overall Study|Death|2|||
146128351|NCT01480076|526989875|FG000|Overall Study|Disease Progression|5|||
146128352|NCT01480076|526989875|FG000|Overall Study|Non-compliance With Study Protocol|15|||
146128353|NCT01480076|526989875|FG000|Overall Study|Withdrawal by Subject|105|||
146128354|NCT01480076|526989875|FG000|Overall Study|Lost to Follow-up|7|||
146128355|NCT01480076|526989875|FG000|Overall Study|Investigator Decision|13|||
146128356|NCT01480076|526989875|FG000|Overall Study|Other|52|||
146128357|NCT02503332|526989876|FG000|Overall Study|Adverse Event|17|||
146128358|NCT02503332|526989877|FG001|Overall Study|Adverse Event|5|||
146128359|NCT02503332|526989878|FG002|Overall Study|Adverse Event|3|||
146128360|NCT02503332|526989879|FG003|Overall Study|Adverse Event|1|||
146128361|NCT02503332|526989876|FG000|Overall Study|Investigator's Decision|5|||
146128362|NCT02503332|526989877|FG001|Overall Study|Investigator's Decision|1|||
146128363|NCT02503332|526989878|FG002|Overall Study|Investigator's Decision|0|||
146128364|NCT02503332|526989879|FG003|Overall Study|Investigator's Decision|0|||
146128365|NCT02503332|526989876|FG000|Overall Study|Sponsor's Decision|1|||
146128366|NCT02503332|526989877|FG001|Overall Study|Sponsor's Decision|0|||
146128367|NCT02503332|526989878|FG002|Overall Study|Sponsor's Decision|0|||
146128368|NCT02503332|526989879|FG003|Overall Study|Sponsor's Decision|1|||
146128369|NCT02503332|526989876|FG000|Overall Study|Subject Request|6|||
146128370|NCT02503332|526989877|FG001|Overall Study|Subject Request|5|||
146128371|NCT02503332|526989878|FG002|Overall Study|Subject Request|2|||
146128372|NCT02503332|526989879|FG003|Overall Study|Subject Request|1|||
146128373|NCT02503332|526989876|FG000|Overall Study|Death|0|||
146128374|NCT02503332|526989877|FG001|Overall Study|Death|2|||
146128375|NCT02503332|526989878|FG002|Overall Study|Death|2|||
146128376|NCT02503332|526989879|FG003|Overall Study|Death|0|||
146128377|NCT02503332|526989876|FG000|Overall Study|Other|5|||
146128378|NCT02503332|526989877|FG001|Overall Study|Other|6|||
146128379|NCT02503332|526989878|FG002|Overall Study|Other|1|||
146128380|NCT02503332|526989879|FG003|Overall Study|Other|1|||
146128381|NCT01589445|526989880|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
146128382|NCT01589445|526989880|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
146128383|NCT01589445|526989880|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
146128384|NCT01589445|526989880|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
146128385|NCT01589445|526989880|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
146128386|NCT01589445|526989880|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
146128387|NCT01589445|526989880|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
146128388|NCT01589445|526989880|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
146128389|NCT01589445|526989880|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
146128390|NCT01589445|526989880|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
146128391|NCT00325754|526989881|FG000|Overall Study|Adverse Event|4|||
146128392|NCT00325754|526989882|FG001|Overall Study|Adverse Event|1|||
146128393|NCT04649164|526989887|FG000|Overall Study|Withdrawal by Subject|1|||
146128394|NCT04649164|526989888|FG001|Overall Study|Withdrawal by Subject|1|||
146128395|NCT04649164|526989889|FG002|Overall Study|Withdrawal by Subject|2|||
146128396|NCT04649164|526989887|FG000|Overall Study|Participant's care recipient expired|0|||
146128397|NCT04649164|526989888|FG001|Overall Study|Participant's care recipient expired|0|||
146128398|NCT04649164|526989889|FG002|Overall Study|Participant's care recipient expired|2|||
146128399|NCT03168464|526989890|FG000|Overall Study|Death|9|||
146128400|NCT03168464|526989890|FG000|Overall Study|Progression of disease|6|||
146128401|NCT00634088|526989893|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
146128402|NCT00634088|526989894|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
146128403|NCT00634088|526989895|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
146128404|NCT00634088|526989896|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
146128405|NCT00634088|526989893|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
146128406|NCT00634088|526989894|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
146128407|NCT00634088|526989895|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
146262925|NCT03520075|527478460|FG012|Phase 2 (Dose Expansion)|Death|0|||
146262926|NCT03520075|527478461|FG013|Phase 2 (Dose Expansion)|Death|20|||
146262927|NCT03520075|527478462|FG014|Phase 2 (Dose Expansion)|Death|13|||
146128408|NCT00634088|526989896|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
146128409|NCT00634088|526989893|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
146128410|NCT00634088|526989894|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
146128411|NCT00634088|526989895|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
146128412|NCT00634088|526989896|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
146128413|NCT00634088|526989893|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
146128414|NCT00634088|526989894|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
146128415|NCT00634088|526989895|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
146128416|NCT00634088|526989896|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
146128417|NCT00634088|526989893|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
146128418|NCT00634088|526989894|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
146128419|NCT00634088|526989895|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
146128420|NCT00634088|526989896|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
146262928|NCT03520075|527478463|FG015|Phase 2 (Dose Expansion)|Death|9|||
146262929|NCT03520075|527478464|FG016|Phase 2 (Dose Expansion)|Death|5|||
146128421|NCT00634088|526989893|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
146128422|NCT00634088|526989894|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
146128423|NCT00634088|526989895|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
146128424|NCT00634088|526989896|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
146128425|NCT00600756|526989899|FG000|Analysis After 6 Months|Adverse Event|43|||
146128426|NCT00600756|526989900|FG001|Analysis After 6 Months|Adverse Event|33|||
146128427|NCT00600756|526989899|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
146128428|NCT00600756|526989900|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
146128429|NCT00600756|526989899|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
146128430|NCT00600756|526989900|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
146128431|NCT00600756|526989899|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
146128432|NCT00600756|526989900|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
146128433|NCT00600756|526989899|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
146128434|NCT00600756|526989900|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
146128435|NCT00600756|526989899|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
146128436|NCT00600756|526989900|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
146128437|NCT00600756|526989899|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
146128438|NCT00600756|526989900|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
146128439|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
146128440|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
146128441|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
146128442|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
146128443|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
146128444|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
146128445|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
146128446|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
146128447|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
146128448|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
146128449|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
146128450|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
146128451|NCT00600756|526989899|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
146128452|NCT00600756|526989900|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
146128453|NCT02063737|526989902|FG000|Overall Study|Lost to Follow-up|11|||
146128454|NCT02063737|526989903|FG001|Overall Study|Lost to Follow-up|4|||
146128455|NCT00439556|526989904|FG000|Overall Study|Patient was taken off study for non-comp|0|||
146128456|NCT00439556|526989905|FG001|Overall Study|Patient was taken off study for non-comp|1|||
146128457|NCT00439556|526989906|FG002|Overall Study|Patient was taken off study for non-comp|0|||
146128458|NCT01358357|526989911|FG000|Open Label Phase|Adverse Event|0|||
146128459|NCT01358357|526989912|FG001|Open Label Phase|Adverse Event|0|||
146128460|NCT01358357|526989913|FG002|Open Label Phase|Adverse Event|59|||
146128461|NCT01358357|526989911|FG000|Open Label Phase|Lack of Efficacy|0|||
146128462|NCT01358357|526989912|FG001|Open Label Phase|Lack of Efficacy|0|||
146128463|NCT01358357|526989913|FG002|Open Label Phase|Lack of Efficacy|107|||
146128464|NCT01358357|526989911|FG000|Open Label Phase|Lost to Follow-up|0|||
146128465|NCT01358357|526989912|FG001|Open Label Phase|Lost to Follow-up|0|||
146128466|NCT01358357|526989913|FG002|Open Label Phase|Lost to Follow-up|76|||
146128467|NCT01358357|526989911|FG000|Open Label Phase|Protocol Violation|0|||
146128468|NCT01358357|526989912|FG001|Open Label Phase|Protocol Violation|0|||
146128469|NCT01358357|526989913|FG002|Open Label Phase|Protocol Violation|45|||
146128470|NCT01358357|526989911|FG000|Open Label Phase|Withdrawal by Subject|0|||
146128471|NCT01358357|526989912|FG001|Open Label Phase|Withdrawal by Subject|0|||
146128472|NCT01358357|526989913|FG002|Open Label Phase|Withdrawal by Subject|112|||
146128473|NCT01358357|526989911|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
146128474|NCT01358357|526989912|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
146128475|NCT01358357|526989913|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
146128476|NCT01358357|526989911|FG000|Open Label Phase|Terminated at study completion|0|||
146128477|NCT01358357|526989912|FG001|Open Label Phase|Terminated at study completion|0|||
146128478|NCT01358357|526989913|FG002|Open Label Phase|Terminated at study completion|5|||
146128479|NCT01358357|526989911|FG000|Open Label Phase|Mood episode|0|||
146128480|NCT01358357|526989912|FG001|Open Label Phase|Mood episode|0|||
146128481|NCT01358357|526989913|FG002|Open Label Phase|Mood episode|42|||
146128482|NCT01358357|526989911|FG000|Double-Blind Phase|Adverse Event|8|||
146128483|NCT01358357|526989912|FG001|Double-Blind Phase|Adverse Event|5|||
146128484|NCT01358357|526989913|FG002|Double-Blind Phase|Adverse Event|0|||
146128485|NCT01358357|526989911|FG000|Double-Blind Phase|Lost to Follow-up|5|||
146128486|NCT01358357|526989912|FG001|Double-Blind Phase|Lost to Follow-up|7|||
146128487|NCT01358357|526989913|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146128488|NCT01358357|526989911|FG000|Double-Blind Phase|Protocol Violation|1|||
146128489|NCT01358357|526989912|FG001|Double-Blind Phase|Protocol Violation|11|||
146128490|NCT01358357|526989913|FG002|Double-Blind Phase|Protocol Violation|0|||
146128491|NCT01358357|526989911|FG000|Double-Blind Phase|Protocol Violation|16|||
146128492|NCT01358357|526989912|FG001|Double-Blind Phase|Protocol Violation|12|||
146128493|NCT01358357|526989913|FG002|Double-Blind Phase|Protocol Violation|0|||
146128494|NCT01358357|526989911|FG000|Double-Blind Phase|Terminated at study completion|2|||
146128495|NCT01358357|526989912|FG001|Double-Blind Phase|Terminated at study completion|0|||
146128496|NCT01358357|526989913|FG002|Double-Blind Phase|Terminated at study completion|0|||
146128497|NCT01358357|526989911|FG000|Double-Blind Phase|Recurrence of mood event|48|||
146128498|NCT01358357|526989912|FG001|Double-Blind Phase|Recurrence of mood event|64|||
146128499|NCT01358357|526989913|FG002|Double-Blind Phase|Recurrence of mood event|0|||
146128500|NCT01358357|526989911|FG000|Double-Blind Phase|Administrative|0|||
146128501|NCT01358357|526989912|FG001|Double-Blind Phase|Administrative|1|||
146128502|NCT01358357|526989913|FG002|Double-Blind Phase|Administrative|0|||
146128503|NCT01826487|526989914|FG000|Overall Study|Adverse Event|1|||
146128504|NCT01826487|526989915|FG001|Overall Study|Adverse Event|1|||
146128505|NCT01826487|526989914|FG000|Overall Study|Lost to Follow-up|1|||
146128506|NCT01826487|526989915|FG001|Overall Study|Lost to Follow-up|0|||
146128507|NCT01826487|526989914|FG000|Overall Study|Withdrawal by Subject|1|||
146128508|NCT01826487|526989915|FG001|Overall Study|Withdrawal by Subject|3|||
146128509|NCT01826487|526989914|FG000|Overall Study|Protocol Violation|1|||
146128510|NCT01826487|526989915|FG001|Overall Study|Protocol Violation|1|||
146128511|NCT00352846|526989922|FG000|Overall Study|Disease progression|0|||
146128512|NCT00352846|526989923|FG001|Overall Study|Disease progression|2|||
146128513|NCT00352846|526989922|FG000|Overall Study|Withdrawal by Subject|3|||
146128514|NCT00352846|526989923|FG001|Overall Study|Withdrawal by Subject|8|||
146128515|NCT00352846|526989922|FG000|Overall Study|Ineligible|3|||
146128516|NCT00352846|526989923|FG001|Overall Study|Ineligible|2|||
146128517|NCT00352846|526989922|FG000|Overall Study|Non-compliance|2|||
146128518|NCT00352846|526989923|FG001|Overall Study|Non-compliance|0|||
146128519|NCT00352846|526989922|FG000|Overall Study|Death|0|||
146128520|NCT00352846|526989923|FG001|Overall Study|Death|1|||
146128521|NCT00788827|526989924|FG000|Overall Study|Lack of Efficacy|2|||
146128522|NCT01527682|526989925|FG000|Overall Study|Protocol Violation|8|||
146128523|NCT00549562|526989929|FG000|Overall Study|Adverse Event|1|||
146128524|NCT00549562|526989929|FG000|Overall Study|Lack of Efficacy|1|||
146128525|NCT00489853|526991331|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
146128526|NCT00489853|526991332|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
146128527|NCT00489853|526991333|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
146128528|NCT00489853|526991331|FG000|Wash-out Period 1|Adverse Event|0|||
146303485|NCT00113074|527625818|FG002|Overall Study|Lost to Follow-up|14|||
146303486|NCT02170779|527625821|FG000|Overall Study|Withdrawal by Subject|1|||
146303487|NCT02170779|527625822|FG001|Overall Study|Withdrawal by Subject|0|||
146303488|NCT02170779|527625821|FG000|Overall Study|Lost to Follow-up|0|||
146303489|NCT02170779|527625822|FG001|Overall Study|Lost to Follow-up|1|||
146303490|NCT00369785|527625823|FG000|Overall Study|Physician Decision|3|||
146303491|NCT00369785|527625824|FG001|Overall Study|Physician Decision|2|||
146303492|NCT00369785|527625823|FG000|Overall Study|Death|1|||
146303493|NCT00369785|527625824|FG001|Overall Study|Death|2|||
146303494|NCT00369785|527625823|FG000|Overall Study|Withdrawal by Subject|7|||
146303495|NCT00369785|527625824|FG001|Overall Study|Withdrawal by Subject|6|||
146303496|NCT00369785|527625823|FG000|Overall Study|Toxicity|6|||
146303497|NCT00369785|527625824|FG001|Overall Study|Toxicity|4|||
146303498|NCT00369785|527625823|FG000|Overall Study|Never started|0|||
146303499|NCT00369785|527625824|FG001|Overall Study|Never started|2|||
146128529|NCT00489853|526991332|FG001|Wash-out Period 1|Adverse Event|1|||
146128530|NCT00489853|526991333|FG002|Wash-out Period 1|Adverse Event|1|||
146128531|NCT00489853|526991331|FG000|Wash-out Period 1|Protocol Violation|0|||
146128532|NCT00489853|526991332|FG001|Wash-out Period 1|Protocol Violation|1|||
146128533|NCT00489853|526991333|FG002|Wash-out Period 1|Protocol Violation|1|||
146128534|NCT00489853|526991331|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
146128535|NCT00489853|526991332|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
146128536|NCT00489853|526991333|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
146128537|NCT00489853|526991331|FG000|Wash-out Period 2|Adverse Event|1|||
146128538|NCT00489853|526991332|FG001|Wash-out Period 2|Adverse Event|1|||
146128539|NCT00489853|526991333|FG002|Wash-out Period 2|Adverse Event|0|||
146128540|NCT00489853|526991331|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
146128541|NCT00489853|526991332|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
146128542|NCT00489853|526991333|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
146128543|NCT00489853|526991331|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
146128544|NCT00489853|526991332|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
146128545|NCT00489853|526991333|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
146128546|NCT00004888|526991339|FG000|Overall Study|Adverse Event|5|||
146128547|NCT00004888|526991340|FG001|Overall Study|Adverse Event|10|||
146303500|NCT00369785|527625823|FG000|Overall Study|Progression|4|||
146303501|NCT00369785|527625824|FG001|Overall Study|Progression|4|||
146303502|NCT00369785|527625823|FG000|Overall Study|Multiple reasons|6|||
146303503|NCT00369785|527625824|FG001|Overall Study|Multiple reasons|5|||
146303504|NCT00800683|527625825|FG000|Overall Study|Adverse Event|11|||
146128548|NCT00004888|526991339|FG000|Overall Study|Withdrawal by Subject|0|||
146128549|NCT00004888|526991340|FG001|Overall Study|Withdrawal by Subject|3|||
146128550|NCT00004888|526991339|FG000|Overall Study|Physician Decision|1|||
146128551|NCT00004888|526991340|FG001|Overall Study|Physician Decision|1|||
146128552|NCT00004888|526991339|FG000|Overall Study|Progressive Disease|4|||
146128553|NCT00004888|526991340|FG001|Overall Study|Progressive Disease|9|||
146128554|NCT00004888|526991339|FG000|Overall Study|Death without progressive disease|0|||
146128555|NCT00004888|526991340|FG001|Overall Study|Death without progressive disease|1|||
146128556|NCT00004888|526991339|FG000|Overall Study|Toxic death|1|||
146128557|NCT00004888|526991340|FG001|Overall Study|Toxic death|0|||
146128558|NCT00136084|526991341|FG000|Overall Study|Death|12|||
146128559|NCT00136084|526991342|FG001|Overall Study|Death|5|||
146128560|NCT00136084|526991341|FG000|Overall Study|Unacceptable toxicity|8|||
146128561|NCT00136084|526991342|FG001|Overall Study|Unacceptable toxicity|11|||
146128562|NCT00136084|526991341|FG000|Overall Study|Relapse|20|||
146128563|NCT00136084|526991342|FG001|Overall Study|Relapse|23|||
146128564|NCT00136084|526991341|FG000|Overall Study|Lost to Follow-up|2|||
146128565|NCT00136084|526991342|FG001|Overall Study|Lost to Follow-up|0|||
146128566|NCT00136084|526991341|FG000|Overall Study|No Response|1|||
146128567|NCT00136084|526991342|FG001|Overall Study|No Response|2|||
146128568|NCT00136084|526991341|FG000|Overall Study|Withdrawal by Subject|5|||
146128569|NCT00136084|526991342|FG001|Overall Study|Withdrawal by Subject|1|||
146128570|NCT02579265|526991343|FG000|Overall Study|Weaned off earlier than 28 days|44|||
146128571|NCT02579265|526991344|FG001|Overall Study|Weaned off earlier than 28 days|43|||
146128572|NCT02579265|526991343|FG000|Overall Study|Adverse Event|2|||
146128573|NCT02579265|526991344|FG001|Overall Study|Adverse Event|0|||
146128574|NCT02579265|526991343|FG000|Overall Study|Any other reason not specified|0|||
146128575|NCT02579265|526991344|FG001|Overall Study|Any other reason not specified|2|||
146128576|NCT02579265|526991343|FG000|Overall Study|Withdrawal by Subject|2|||
146128577|NCT02579265|526991344|FG001|Overall Study|Withdrawal by Subject|0|||
146128578|NCT02579265|526991343|FG000|Overall Study|Physician Decision|1|||
146128579|NCT02579265|526991344|FG001|Overall Study|Physician Decision|0|||
146128580|NCT02579265|526991343|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
146128581|NCT02579265|526991344|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
146128582|NCT02174848|526991345|FG000|Overall Study|Adverse Event|2|||
146128583|NCT02174848|526991346|FG001|Overall Study|Adverse Event|1|||
146128584|NCT02174848|526991345|FG000|Overall Study|Withdrawal by Subject|3|||
146128585|NCT02174848|526991346|FG001|Overall Study|Withdrawal by Subject|3|||
146128586|NCT02174848|526991345|FG000|Overall Study|Lost to Follow-up|0|||
146128587|NCT02174848|526991346|FG001|Overall Study|Lost to Follow-up|1|||
146128588|NCT02174848|526991345|FG000|Overall Study|Worsening of disease|1|||
146128589|NCT02174848|526991346|FG001|Overall Study|Worsening of disease|1|||
146128590|NCT02174848|526991345|FG000|Overall Study|Unable to comply with study requirements|1|||
146128591|NCT02174848|526991346|FG001|Overall Study|Unable to comply with study requirements|0|||
146128592|NCT00644969|526991350|FG000|Treatment Phase|Randomized, not treated|1|||
146128593|NCT00644969|526991351|FG001|Treatment Phase|Randomized, not treated|0|||
146128594|NCT00644969|526991350|FG000|Treatment Phase|Adverse Event|3|||
146128595|NCT00644969|526991351|FG001|Treatment Phase|Adverse Event|0|||
146128596|NCT00644969|526991350|FG000|Treatment Phase|Withdrawal by Subject|4|||
146128597|NCT00644969|526991351|FG001|Treatment Phase|Withdrawal by Subject|0|||
146128598|NCT00644969|526991350|FG000|Treatment Phase|Lost to Follow-up|2|||
146128599|NCT00644969|526991351|FG001|Treatment Phase|Lost to Follow-up|2|||
146128600|NCT00644969|526991350|FG000|Treatment Phase|Other|4|||
146128601|NCT00644969|526991351|FG001|Treatment Phase|Other|1|||
146128602|NCT00644969|526991350|FG000|Post Treatment Phase|Death|1|||
146128603|NCT00644969|526991351|FG001|Post Treatment Phase|Death|0|||
146128604|NCT00644969|526991350|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
146128605|NCT00644969|526991351|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
146128606|NCT00644969|526991350|FG000|Post Treatment Phase|Lost to Follow-up|4|||
146128607|NCT00644969|526991351|FG001|Post Treatment Phase|Lost to Follow-up|1|||
146128608|NCT00644969|526991350|FG000|Post Treatment Phase|Other|1|||
146128609|NCT00644969|526991351|FG001|Post Treatment Phase|Other|0|||
146128610|NCT02449239|526991352|FG000|Induction Phase|Lack of Efficacy|64|||
146128611|NCT02449239|526991352|FG000|Induction Phase|Adverse Event|1|||
146128612|NCT02449239|526991352|FG000|Induction Phase|Lost to Follow-up|1|||
146128613|NCT02449239|526991352|FG000|Induction Phase|Protocol Violation|1|||
146128614|NCT02449239|526991352|FG000|Induction Phase|Physician Decision|1|||
146128615|NCT02449239|526991352|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
146128616|NCT02449239|526991352|FG000|Induction Phase|Withdrawal by Subject|1|||
146128617|NCT02449239|526991352|FG000|Maintenance Month 3|Lack of Efficacy|14|||
146128618|NCT02449239|526991352|FG000|Maintenance Month 6|Lack of Efficacy|10|||
146128619|NCT02449239|526991352|FG000|Maintenance Month 6|Adverse Event|2|||
146128620|NCT02449239|526991352|FG000|Maintenance Month 6|Physician Decision|1|||
146128621|NCT02449239|526991352|FG000|Maintenance Month 9|Lack of Efficacy|2|||
146128622|NCT02449239|526991352|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
146128623|NCT02449239|526991352|FG000|Maintenance Month 12|Lack of Efficacy|5|||
146128624|NCT02449239|526991352|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
146262930|NCT03520075|527478465|FG017|Phase 2 (Dose Expansion)|Death|14|||
146262931|NCT03520075|527478466|FG018|Phase 2 (Dose Expansion)|Death|12|||
146262932|NCT03520075|527478448|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262933|NCT03520075|527478449|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262934|NCT03520075|527478450|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262935|NCT03520075|527478451|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262936|NCT03520075|527478452|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262937|NCT03520075|527478453|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262938|NCT03520075|527478454|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262939|NCT03520075|527478455|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262940|NCT03520075|527478456|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262941|NCT03520075|527478457|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262942|NCT03520075|527478458|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262943|NCT03520075|527478459|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262944|NCT03520075|527478460|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262945|NCT03520075|527478461|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
146262946|NCT03520075|527478462|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
146262947|NCT03520075|527478463|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
146262948|NCT03520075|527478464|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
146262949|NCT03520075|527478465|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
146128625|NCT02449239|526991352|FG000|Maintenance Month 12|Subject moved from area|1|||
146128626|NCT02449239|526991352|FG000|Maintenance Month 15|Lack of Efficacy|1|||
146128627|NCT02449239|526991352|FG000|Maintenance Month 21|Lack of Efficacy|1|||
146128628|NCT02449239|526991352|FG000|Maintenance Month 21|Sponsor decision|1|||
146128629|NCT03509675|526991353|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
146128630|NCT03509675|526991354|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
146128631|NCT03509675|526991353|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
146128632|NCT03509675|526991354|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
146128633|NCT03509675|526991353|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
146128634|NCT03509675|526991354|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
146128635|NCT03509675|526991353|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
146128636|NCT03509675|526991354|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
146128637|NCT05620576|526991357|FG000|Overall Study|Adverse Event|1|||
146128638|NCT05620576|526991358|FG001|Overall Study|Adverse Event|1|||
146128639|NCT05620576|526991357|FG000|Overall Study|Lost to Follow-up|3|||
146128640|NCT05620576|526991358|FG001|Overall Study|Lost to Follow-up|1|||
146128641|NCT05620576|526991357|FG000|Overall Study|Physician Decision|0|||
146128642|NCT05620576|526991358|FG001|Overall Study|Physician Decision|1|||
146128643|NCT05620576|526991357|FG000|Overall Study|Protocol Deviation|1|||
146128644|NCT05620576|526991358|FG001|Overall Study|Protocol Deviation|1|||
146128645|NCT05620576|526991357|FG000|Overall Study|Withdrawal by Subject|2|||
146128646|NCT05620576|526991358|FG001|Overall Study|Withdrawal by Subject|3|||
146128647|NCT02622828|526991359|FG000|Overall Study|participant withdrew|3|||
146128648|NCT04091646|526991360|FG000|Overall Study|Adverse Event|2|||
146128649|NCT04091646|526991361|FG001|Overall Study|Adverse Event|1|||
146128650|NCT04091646|526991360|FG000|Overall Study|Lost to Follow-up|6|||
146128651|NCT04091646|526991361|FG001|Overall Study|Lost to Follow-up|2|||
146128652|NCT04091646|526991360|FG000|Overall Study|Protocol Violation|0|||
146128653|NCT04091646|526991361|FG001|Overall Study|Protocol Violation|1|||
146128654|NCT04091646|526991360|FG000|Overall Study|Withdrawal by Subject|4|||
146128655|NCT04091646|526991361|FG001|Overall Study|Withdrawal by Subject|1|||
146128656|NCT04091646|526991360|FG000|Overall Study|Participant Incarcerated|1|||
146128657|NCT04091646|526991361|FG001|Overall Study|Participant Incarcerated|0|||
146128658|NCT03314584|526991366|FG000|Overall Study|Withdrawal by Subject|3|||
146128659|NCT03314584|526991367|FG001|Overall Study|Withdrawal by Subject|3|||
146128660|NCT03314584|526991366|FG000|Overall Study|Lost to Follow-up|4|||
146128661|NCT03314584|526991367|FG001|Overall Study|Lost to Follow-up|0|||
146128662|NCT02046148|526991373|FG000|Overall Study|Lost to Follow-up|1|||
146128663|NCT02046148|526991374|FG001|Overall Study|Lost to Follow-up|1|||
146128664|NCT02046148|526991373|FG000|Overall Study|Withdrawal by Subject|0|||
146128665|NCT02046148|526991374|FG001|Overall Study|Withdrawal by Subject|2|||
146128666|NCT02439320|526991386|FG000|Overall Study|Adverse Event|0|||
146128667|NCT02439320|526991387|FG001|Overall Study|Adverse Event|2|||
146128668|NCT02439320|526991388|FG002|Overall Study|Adverse Event|0|||
146128669|NCT02439320|526991386|FG000|Overall Study|Lost to Follow-up|37|||
146128670|NCT02439320|526991387|FG001|Overall Study|Lost to Follow-up|34|||
146128671|NCT02439320|526991388|FG002|Overall Study|Lost to Follow-up|42|||
146128672|NCT02439320|526991386|FG000|Overall Study|Death|0|||
146128673|NCT02439320|526991387|FG001|Overall Study|Death|1|||
146262950|NCT03520075|527478466|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
146262951|NCT03520075|527478448|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262952|NCT03520075|527478449|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262953|NCT03520075|527478450|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262954|NCT03520075|527478451|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146303505|NCT00800683|527625826|FG001|Overall Study|Adverse Event|8|||
146128674|NCT02439320|526991388|FG002|Overall Study|Death|0|||
146128675|NCT02439320|526991386|FG000|Overall Study|Noncompliance with Protocol|10|||
146128676|NCT02439320|526991387|FG001|Overall Study|Noncompliance with Protocol|11|||
146128677|NCT02439320|526991388|FG002|Overall Study|Noncompliance with Protocol|7|||
146128678|NCT02439320|526991386|FG000|Overall Study|Pregnancy|0|||
146128679|NCT02439320|526991387|FG001|Overall Study|Pregnancy|1|||
146128680|NCT02439320|526991388|FG002|Overall Study|Pregnancy|1|||
146128681|NCT02439320|526991386|FG000|Overall Study|Withdrawal by Subject|12|||
146128682|NCT02439320|526991387|FG001|Overall Study|Withdrawal by Subject|16|||
146128683|NCT02439320|526991388|FG002|Overall Study|Withdrawal by Subject|14|||
146128684|NCT02439320|526991386|FG000|Overall Study|Physician Decision|2|||
146128685|NCT02439320|526991387|FG001|Overall Study|Physician Decision|1|||
146128686|NCT02439320|526991388|FG002|Overall Study|Physician Decision|0|||
146128687|NCT02439320|526991386|FG000|Overall Study|Sponsor Request|0|||
146128688|NCT02439320|526991387|FG001|Overall Study|Sponsor Request|2|||
146128689|NCT02439320|526991388|FG002|Overall Study|Sponsor Request|1|||
146128690|NCT02439320|526991386|FG000|Overall Study|Randomization Failure|35|||
146128691|NCT02439320|526991387|FG001|Overall Study|Randomization Failure|46|||
146128692|NCT02439320|526991388|FG002|Overall Study|Randomization Failure|34|||
146128693|NCT03343483|526991394|FG000|Overall Study|Death|0|||
146128694|NCT03343483|526991395|FG001|Overall Study|Death|3|||
146128695|NCT03343483|526991394|FG000|Overall Study|Lost to Follow-up|9|||
146128696|NCT03343483|526991395|FG001|Overall Study|Lost to Follow-up|13|||
146128697|NCT03343483|526991394|FG000|Overall Study|Withdrawal by Subject|8|||
146128698|NCT03343483|526991395|FG001|Overall Study|Withdrawal by Subject|17|||
146128699|NCT01505608|526991396|FG000|Phase I|Lack of Efficacy|0|||
146128700|NCT01505608|526991397|FG001|Phase I|Lack of Efficacy|4|||
146128701|NCT01505608|526991396|FG000|Phase I|Adverse Event|0|||
146128702|NCT01505608|526991397|FG001|Phase I|Adverse Event|1|||
146128703|NCT01505608|526991396|FG000|Phase I|Withdrawal by Subject|0|||
146128704|NCT01505608|526991397|FG001|Phase I|Withdrawal by Subject|1|||
146128705|NCT01505608|526991396|FG000|Phase II|Lack of Efficacy|2|||
146128706|NCT01505608|526991397|FG001|Phase II|Lack of Efficacy|1|||
146128707|NCT01505608|526991396|FG000|Phase II|Protocol Violation|0|||
146128708|NCT01505608|526991397|FG001|Phase II|Protocol Violation|1|||
146128709|NCT01488097|526991398|FG000|Overall Study|Lost to Follow-up|1|||
146128710|NCT01293240|526991399|FG000|Overall Study|Noncompliance|2|||
146128711|NCT02404350|526991405|FG000|Overall Study|Adverse Event|2|||
146128712|NCT02404350|526991406|FG001|Overall Study|Adverse Event|2|||
146128713|NCT02404350|526991407|FG002|Overall Study|Adverse Event|3|||
146128714|NCT02404350|526991408|FG003|Overall Study|Adverse Event|9|||
146128715|NCT02404350|526991405|FG000|Overall Study|Lack of Efficacy|3|||
146128716|NCT02404350|526991406|FG001|Overall Study|Lack of Efficacy|1|||
146128717|NCT02404350|526991407|FG002|Overall Study|Lack of Efficacy|0|||
146128718|NCT02404350|526991408|FG003|Overall Study|Lack of Efficacy|3|||
146128719|NCT02404350|526991405|FG000|Overall Study|Lost to Follow-up|2|||
146128720|NCT02404350|526991406|FG001|Overall Study|Lost to Follow-up|0|||
146128721|NCT02404350|526991407|FG002|Overall Study|Lost to Follow-up|0|||
146128722|NCT02404350|526991408|FG003|Overall Study|Lost to Follow-up|1|||
146128723|NCT02404350|526991405|FG000|Overall Study|Physician Decision|1|||
146128724|NCT02404350|526991406|FG001|Overall Study|Physician Decision|0|||
146128725|NCT02404350|526991407|FG002|Overall Study|Physician Decision|0|||
146128726|NCT02404350|526991408|FG003|Overall Study|Physician Decision|2|||
146128727|NCT02404350|526991405|FG000|Overall Study|Pregnancy|0|||
146128728|NCT02404350|526991406|FG001|Overall Study|Pregnancy|0|||
146128729|NCT02404350|526991407|FG002|Overall Study|Pregnancy|0|||
146128730|NCT02404350|526991408|FG003|Overall Study|Pregnancy|1|||
146128731|NCT02404350|526991405|FG000|Overall Study|Withdrawal by Subject|7|||
146303506|NCT00800683|527625825|FG000|Overall Study|Lost to Follow-up|3|||
146303507|NCT00800683|527625826|FG001|Overall Study|Lost to Follow-up|1|||
146303508|NCT00800683|527625825|FG000|Overall Study|Withdrawal by Subject|1|||
146303509|NCT00800683|527625826|FG001|Overall Study|Withdrawal by Subject|7|||
146128732|NCT02404350|526991406|FG001|Overall Study|Withdrawal by Subject|3|||
146128733|NCT02404350|526991407|FG002|Overall Study|Withdrawal by Subject|3|||
146128734|NCT02404350|526991408|FG003|Overall Study|Withdrawal by Subject|19|||
146128735|NCT02404350|526991405|FG000|Overall Study|Due to Non-compliance with treatment|0|||
146128736|NCT02404350|526991406|FG001|Overall Study|Due to Non-compliance with treatment|0|||
146128737|NCT02404350|526991407|FG002|Overall Study|Due to Non-compliance with treatment|0|||
146128738|NCT02404350|526991408|FG003|Overall Study|Due to Non-compliance with treatment|1|||
146128739|NCT02404350|526991405|FG000|Overall Study|Due to Technical problems|0|||
146128740|NCT02404350|526991406|FG001|Overall Study|Due to Technical problems|0|||
146128741|NCT02404350|526991407|FG002|Overall Study|Due to Technical problems|0|||
146303510|NCT00800683|527625825|FG000|Overall Study|Lack of Efficacy|1|||
146128742|NCT02404350|526991408|FG003|Overall Study|Due to Technical problems|1|||
146128743|NCT03969992|526991410|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
146128744|NCT03969992|526991411|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
146128745|NCT03969992|526991412|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
146128746|NCT03969992|526991410|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
146128747|NCT03969992|526991411|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
146128748|NCT03969992|526991412|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
146128749|NCT03969992|526991410|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
146128750|NCT03969992|526991411|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
146128751|NCT03969992|526991412|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
146128752|NCT03969992|526991410|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
146128753|NCT03969992|526991411|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
146128754|NCT03969992|526991412|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
146128755|NCT03969992|526991410|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
146128756|NCT03969992|526991411|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
146128757|NCT03969992|526991412|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
146128758|NCT01324388|526991413|FG000|Part 1 of Study|Adverse Event|2|||
146128759|NCT01324388|526991414|FG001|Part 1 of Study|Adverse Event|0|||
146128760|NCT01324388|526991415|FG002|Part 1 of Study|Adverse Event|0|||
146128761|NCT01324388|526991416|FG003|Part 1 of Study|Adverse Event|0|||
146128762|NCT01324388|526991413|FG000|Part 1 of Study|Protocol Violation|1|||
146128763|NCT01324388|526991414|FG001|Part 1 of Study|Protocol Violation|2|||
146128764|NCT01324388|526991415|FG002|Part 1 of Study|Protocol Violation|0|||
146128765|NCT01324388|526991416|FG003|Part 1 of Study|Protocol Violation|0|||
146128766|NCT01324388|526991413|FG000|Part 1 of Study|Physician Decision|1|||
146128767|NCT01324388|526991414|FG001|Part 1 of Study|Physician Decision|0|||
146128768|NCT01324388|526991415|FG002|Part 1 of Study|Physician Decision|0|||
146128769|NCT01324388|526991416|FG003|Part 1 of Study|Physician Decision|0|||
146128770|NCT01324388|526991413|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
146128771|NCT01324388|526991414|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
146128772|NCT01324388|526991415|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
146128773|NCT01324388|526991416|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
146128774|NCT01324388|526991413|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146128775|NCT01324388|526991414|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146128776|NCT01324388|526991415|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
146128777|NCT01324388|526991416|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
146128778|NCT01405963|526991417|FG000|Overall Study|Moved Away|2|||
146128779|NCT01405963|526991418|FG001|Overall Study|Moved Away|0|||
146128780|NCT01405963|526991417|FG000|Overall Study|Adverse Event|0|||
146128781|NCT01405963|526991418|FG001|Overall Study|Adverse Event|1|||
146128782|NCT01405963|526991417|FG000|Overall Study|Lost to Follow-up|0|||
146128783|NCT01405963|526991418|FG001|Overall Study|Lost to Follow-up|1|||
146128784|NCT01498640|526991419|FG000|Overall Study|Lost to Follow-up|1|||
146128785|NCT01498640|526991419|FG000|Overall Study|Death|1|||
146128786|NCT01498640|526991419|FG000|Overall Study|Other|3|||
146128787|NCT01737047|526991420|FG000|Overall Study|Death|10|||
146128788|NCT01737047|526991421|FG001|Overall Study|Death|0|||
146128789|NCT01737047|526991422|FG002|Overall Study|Death|1|||
146128790|NCT01737047|526991420|FG000|Overall Study|Withdrawal by Subject|17|||
146128791|NCT01737047|526991421|FG001|Overall Study|Withdrawal by Subject|11|||
146128792|NCT01737047|526991422|FG002|Overall Study|Withdrawal by Subject|4|||
146128793|NCT00129129|526991423|FG000|Primary Phase|Adverse Event|2|||
146128794|NCT00129129|526991424|FG001|Primary Phase|Adverse Event|1|||
146128795|NCT00129129|526991425|FG002|Primary Phase|Adverse Event|0|||
146128796|NCT00129129|526991426|FG003|Primary Phase|Adverse Event|0|||
146128797|NCT00129129|526991427|FG004|Primary Phase|Adverse Event|0|||
146128798|NCT00129129|526991423|FG000|Primary Phase|Withdrawal by Subject|12|||
146128799|NCT00129129|526991424|FG001|Primary Phase|Withdrawal by Subject|10|||
146128800|NCT00129129|526991425|FG002|Primary Phase|Withdrawal by Subject|0|||
146128801|NCT00129129|526991426|FG003|Primary Phase|Withdrawal by Subject|0|||
146128802|NCT00129129|526991427|FG004|Primary Phase|Withdrawal by Subject|0|||
146128803|NCT00129129|526991423|FG000|Primary Phase|Migration from study area|1|||
146128804|NCT00129129|526991424|FG001|Primary Phase|Migration from study area|3|||
146128805|NCT00129129|526991425|FG002|Primary Phase|Migration from study area|0|||
146128806|NCT00129129|526991426|FG003|Primary Phase|Migration from study area|0|||
146128807|NCT00129129|526991427|FG004|Primary Phase|Migration from study area|0|||
146128808|NCT00129129|526991423|FG000|Primary Phase|Lost to Follow-up|8|||
146128809|NCT00129129|526991424|FG001|Primary Phase|Lost to Follow-up|6|||
146128810|NCT00129129|526991425|FG002|Primary Phase|Lost to Follow-up|0|||
146128811|NCT00129129|526991426|FG003|Primary Phase|Lost to Follow-up|0|||
146128812|NCT00129129|526991427|FG004|Primary Phase|Lost to Follow-up|0|||
146128813|NCT00129129|526991423|FG000|Primary Phase|Other|2|||
146128814|NCT00129129|526991424|FG001|Primary Phase|Other|5|||
146128815|NCT00129129|526991425|FG002|Primary Phase|Other|0|||
146128816|NCT00129129|526991426|FG003|Primary Phase|Other|0|||
146128817|NCT00129129|526991427|FG004|Primary Phase|Other|0|||
146128818|NCT00129129|526991423|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
146128819|NCT00129129|526991424|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
146128820|NCT00129129|526991425|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
146128821|NCT00129129|526991426|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
146128822|NCT00129129|526991427|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
146128823|NCT00129129|526991423|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
146128824|NCT00129129|526991424|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
146128825|NCT00129129|526991425|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
146128826|NCT00129129|526991426|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
146128827|NCT00129129|526991427|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
146262955|NCT03520075|527478452|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262956|NCT03520075|527478453|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262957|NCT03520075|527478454|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262958|NCT03520075|527478455|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262959|NCT03520075|527478456|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262960|NCT03520075|527478457|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262961|NCT03520075|527478458|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262962|NCT03520075|527478459|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262963|NCT03520075|527478460|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262964|NCT03520075|527478461|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262965|NCT03520075|527478462|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146262966|NCT03520075|527478463|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146262967|NCT03520075|527478464|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262968|NCT03520075|527478465|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
146262969|NCT03520075|527478466|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
146262970|NCT03520075|527478448|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262971|NCT03520075|527478449|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262972|NCT03520075|527478450|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262973|NCT03520075|527478451|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262974|NCT03520075|527478452|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262975|NCT03520075|527478453|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262976|NCT03520075|527478454|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262977|NCT03520075|527478455|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262978|NCT03520075|527478456|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262979|NCT03520075|527478457|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262980|NCT03520075|527478458|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262981|NCT03520075|527478459|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262982|NCT03520075|527478460|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262983|NCT03520075|527478461|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
146262984|NCT03520075|527478462|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146262985|NCT03520075|527478463|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146303511|NCT00800683|527625826|FG001|Overall Study|Lack of Efficacy|1|||
146303512|NCT00800683|527625825|FG000|Overall Study|Other|1|||
146303513|NCT00800683|527625826|FG001|Overall Study|Other|2|||
146128828|NCT00129129|526991423|FG000|Fourth Dose Phase|Migration from study area|0|||
146128829|NCT00129129|526991424|FG001|Fourth Dose Phase|Migration from study area|0|||
146128830|NCT00129129|526991425|FG002|Fourth Dose Phase|Migration from study area|0|||
146128831|NCT00129129|526991426|FG003|Fourth Dose Phase|Migration from study area|0|||
146128832|NCT00129129|526991427|FG004|Fourth Dose Phase|Migration from study area|2|||
146128833|NCT00129129|526991423|FG000|Fourth Dose Phase|Other|0|||
146128834|NCT00129129|526991424|FG001|Fourth Dose Phase|Other|0|||
146128835|NCT00129129|526991425|FG002|Fourth Dose Phase|Other|0|||
146128836|NCT00129129|526991426|FG003|Fourth Dose Phase|Other|1|||
146128837|NCT00129129|526991427|FG004|Fourth Dose Phase|Other|1|||
146128838|NCT00129129|526991423|FG000|Fourth Dose Phase|Protocol Violation|0|||
146128839|NCT00129129|526991424|FG001|Fourth Dose Phase|Protocol Violation|0|||
146128840|NCT00129129|526991425|FG002|Fourth Dose Phase|Protocol Violation|0|||
146128841|NCT00129129|526991426|FG003|Fourth Dose Phase|Protocol Violation|1|||
146128842|NCT00129129|526991427|FG004|Fourth Dose Phase|Protocol Violation|0|||
146128843|NCT03089606|526991428|FG000|Overall Study|Progression after Cycle 1|1|||
146128844|NCT00335972|526991429|FG000|Overall Study|not given treatments|0|||
146128845|NCT00335972|526991430|FG001|Overall Study|not given treatments|3|||
146128846|NCT02802592|526991434|FG000|Overall Study|Study terminated due to loss of funding|4|||
146128847|NCT02882854|526991435|FG000|Overall Study|Lost to Follow-up|1|||
146128848|NCT02882854|526991436|FG001|Overall Study|Lost to Follow-up|2|||
146128849|NCT02882854|526991435|FG000|Overall Study|Physician Decision|0|||
146128850|NCT02882854|526991436|FG001|Overall Study|Physician Decision|1|||
146128851|NCT01408030|526991437|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
146128852|NCT01408030|526991438|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
146262986|NCT03520075|527478464|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
146262987|NCT03520075|527478465|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
146262988|NCT03520075|527478466|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
146303514|NCT00356889|527625828|FG000|Overall Study|Protocol Violation|2|||
146128853|NCT01408030|526991439|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
146128854|NCT01408030|526991440|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
146262989|NCT00328562|527478469|FG000|Overall Study|Disease progression|1|||
146128855|NCT01408030|526991437|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
146128856|NCT01408030|526991438|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
146128857|NCT01408030|526991439|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
146128858|NCT01408030|526991440|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
146128859|NCT01408030|526991437|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
146128860|NCT01408030|526991438|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
146128861|NCT01408030|526991439|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
146128862|NCT01408030|526991440|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
146128863|NCT01408030|526991437|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
146128864|NCT01408030|526991438|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
146128865|NCT01408030|526991439|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
146128866|NCT01408030|526991440|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
146128867|NCT01408030|526991437|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
146128868|NCT01408030|526991438|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
146128869|NCT01408030|526991439|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
146128870|NCT01408030|526991440|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
146128871|NCT01408030|526991437|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
146128872|NCT01408030|526991438|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
146128873|NCT01408030|526991439|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
146128874|NCT01408030|526991440|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
146128875|NCT01408030|526991437|FG000|Observation Phase (Off Drug)|Other|1|||
146128876|NCT01408030|526991438|FG001|Observation Phase (Off Drug)|Other|1|||
146128877|NCT01408030|526991439|FG002|Observation Phase (Off Drug)|Other|1|||
146128878|NCT01408030|526991440|FG003|Observation Phase (Off Drug)|Other|1|||
146128879|NCT02590939|526991441|FG000|Overall Study|Withdrawal by Subject|3|||
146128880|NCT02590939|526991442|FG001|Overall Study|Withdrawal by Subject|1|||
146128881|NCT02590939|526991441|FG000|Overall Study|Failed the nociceptive test|2|||
146128882|NCT02590939|526991442|FG001|Overall Study|Failed the nociceptive test|1|||
146128883|NCT02081079|526991443|FG000|Overall Study|Lack of Efficacy|3|||
146128884|NCT02081079|526991444|FG001|Overall Study|Lack of Efficacy|2|||
146128885|NCT02081079|526991443|FG000|Overall Study|Lost to Follow-up|1|||
146128886|NCT02081079|526991444|FG001|Overall Study|Lost to Follow-up|0|||
146128887|NCT04365556|526991451|FG000|Overall Study|No longer eligible due to treatment plan|1|||
146128888|NCT04365556|526991452|FG001|Overall Study|No longer eligible due to treatment plan|0|||
146128889|NCT04365556|526991451|FG000|Overall Study|Lost to Follow-up|3|||
146128890|NCT04365556|526991452|FG001|Overall Study|Lost to Follow-up|2|||
146128891|NCT04837131|526991453|FG000|Overall Study|Death|1|||
146128892|NCT04837131|526991453|FG000|Overall Study|Withdrawal by Subject|1|||
146128893|NCT04837131|526991453|FG000|Overall Study|Adverse Event|1|||
146128894|NCT04837131|526991453|FG000|Overall Study|Protocol Violation|1|||
146128895|NCT00502697|526992910|FG000|Overall Study|Withdrawal by Subject|3|||
146128896|NCT00502697|526992911|FG001|Overall Study|Withdrawal by Subject|1|||
146128897|NCT00502697|526992910|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
146128898|NCT00502697|526992911|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
146128899|NCT00502697|526992910|FG000|Overall Study|found not to meet eligibility criteria|3|||
146128900|NCT00502697|526992911|FG001|Overall Study|found not to meet eligibility criteria|4|||
146128901|NCT00502697|526992910|FG000|Overall Study|did not meet assignment criteria|4|||
146128902|NCT00502697|526992911|FG001|Overall Study|did not meet assignment criteria|2|||
146128903|NCT05083442|526992917|FG000|Overall Study|Lost to Follow-up|1|||
146128904|NCT05083442|526992918|FG001|Overall Study|Lost to Follow-up|0|||
146128905|NCT05083442|526992917|FG000|Overall Study|Lack of Efficacy|0|||
146128906|NCT05083442|526992918|FG001|Overall Study|Lack of Efficacy|1|||
146128907|NCT05083442|526992917|FG000|Overall Study|Withdrawal by Subject|1|||
146128908|NCT05083442|526992918|FG001|Overall Study|Withdrawal by Subject|3|||
146128909|NCT05083442|526992917|FG000|Overall Study|scheduling difficulties|1|||
146128910|NCT05083442|526992918|FG001|Overall Study|scheduling difficulties|2|||
146262990|NCT03305809|527478470|FG000|Overall Study|Adverse Event|2|||
146262991|NCT03305809|527478471|FG001|Overall Study|Adverse Event|2|||
146262992|NCT03305809|527478472|FG002|Overall Study|Adverse Event|6|||
146262993|NCT03305809|527478473|FG003|Overall Study|Adverse Event|6|||
146262994|NCT03305809|527478470|FG000|Overall Study|Death|0|||
146262995|NCT03305809|527478471|FG001|Overall Study|Death|0|||
146128911|NCT01933048|526992925|FG000|Overall Study|Lost to Follow-up|15|||
146128912|NCT01933048|526992926|FG001|Overall Study|Lost to Follow-up|18|||
146128913|NCT01933048|526992925|FG000|Overall Study|personal reasons|1|||
146128914|NCT01933048|526992926|FG001|Overall Study|personal reasons|1|||
146128915|NCT01933048|526992925|FG000|Overall Study|Protocol Violation|7|||
146128916|NCT01933048|526992926|FG001|Overall Study|Protocol Violation|8|||
146128917|NCT01933048|526992925|FG000|Overall Study|Physician Decision|1|||
146128918|NCT01933048|526992926|FG001|Overall Study|Physician Decision|0|||
146128919|NCT01933048|526992925|FG000|Overall Study|unknown reasons|1|||
146128920|NCT01933048|526992926|FG001|Overall Study|unknown reasons|1|||
146128921|NCT02780804|526992927|FG000|Overall Study|Death|1|||
146128922|NCT02780804|526992928|FG001|Overall Study|Death|0|||
146262996|NCT03305809|527478472|FG002|Overall Study|Death|1|||
146128923|NCT02780804|526992929|FG002|Overall Study|Death|0|||
146128924|NCT02780804|526992927|FG000|Overall Study|Lack of Efficacy|5|||
146128925|NCT02780804|526992928|FG001|Overall Study|Lack of Efficacy|8|||
146128926|NCT02780804|526992929|FG002|Overall Study|Lack of Efficacy|4|||
146128927|NCT02780804|526992927|FG000|Overall Study|Physician Decision|0|||
146128928|NCT02780804|526992928|FG001|Overall Study|Physician Decision|0|||
146128929|NCT02780804|526992929|FG002|Overall Study|Physician Decision|2|||
146128930|NCT02780804|526992927|FG000|Overall Study|Withdrawal by Subject|0|||
146128931|NCT02780804|526992928|FG001|Overall Study|Withdrawal by Subject|1|||
146128932|NCT02780804|526992929|FG002|Overall Study|Withdrawal by Subject|0|||
146128933|NCT02476968|526992930|FG000|Overall Study|Other|0|||
146128934|NCT02476968|526992931|FG001|Overall Study|Other|2|||
146128935|NCT02476968|526992932|FG002|Overall Study|Other|0|||
146128936|NCT02476968|526992930|FG000|Overall Study|Lost to Follow-up|10|||
146128937|NCT02476968|526992931|FG001|Overall Study|Lost to Follow-up|0|||
146128938|NCT02476968|526992932|FG002|Overall Study|Lost to Follow-up|1|||
146128939|NCT02476968|526992930|FG000|Overall Study|Death|48|||
146128940|NCT02476968|526992931|FG001|Overall Study|Death|8|||
146128941|NCT02476968|526992932|FG002|Overall Study|Death|1|||
146128942|NCT02476968|526992930|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146128943|NCT02476968|526992931|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146128944|NCT02476968|526992932|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
146128945|NCT02476968|526992930|FG000|Overall Study|Patient decision|37|||
146128946|NCT02476968|526992931|FG001|Overall Study|Patient decision|8|||
146128947|NCT02476968|526992932|FG002|Overall Study|Patient decision|0|||
146128948|NCT04920123|526992937|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146128949|NCT04920123|526992938|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146128950|NCT04920123|526992939|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
146128951|NCT02586493|526992949|FG000|Overall Study|Adverse Event|4|||
146128952|NCT02586493|526992949|FG000|Overall Study|Protocol Violation|6|||
146128953|NCT02586493|526992949|FG000|Overall Study|Lost to Follow-up|1|||
146128954|NCT02586493|526992949|FG000|Overall Study|Withdrawal by Subject|1|||
146128955|NCT06134817|526992956|FG000|Overall Study|Physician Departure - termination of study|1|||
146128956|NCT00278954|526992957|FG000|Overall Study|Adverse Event|3|||
146128957|NCT00278954|526992957|FG000|Overall Study|Lost to Follow-up|1|||
146128958|NCT00278954|526992957|FG000|Overall Study|Withdrawal by Subject|1|||
146128959|NCT02211131|526992971|FG000|Overall Study|Death|26|||
146128960|NCT02211131|526992972|FG001|Overall Study|Death|16|||
146128961|NCT02211131|526992971|FG000|Overall Study|Lost to Follow-up|4|||
146128962|NCT02211131|526992972|FG001|Overall Study|Lost to Follow-up|3|||
146128963|NCT02211131|526992971|FG000|Overall Study|Decision by Sponsor|1|||
146128964|NCT02211131|526992972|FG001|Overall Study|Decision by Sponsor|1|||
146128965|NCT02211131|526992971|FG000|Overall Study|Withdrawal by Subject|3|||
146128966|NCT02211131|526992972|FG001|Overall Study|Withdrawal by Subject|8|||
146128967|NCT05664490|526992974|FG000|Overall Study|Withdrawal by Subject|0|||
146128968|NCT05664490|526992975|FG001|Overall Study|Withdrawal by Subject|1|||
146128969|NCT05664490|526992974|FG000|Overall Study|Lost to Follow-up|14|||
146128970|NCT05664490|526992975|FG001|Overall Study|Lost to Follow-up|22|||
146128971|NCT05442554|526992976|FG000|Overall Study|Adverse Event|1|||
146128972|NCT01990495|526992980|FG000|Overall Study|Physician Decision|5|||
146128973|NCT01990495|526992981|FG001|Overall Study|Physician Decision|4|||
146128974|NCT01752855|526992984|FG000|Overall Study|Adverse Event|1|||
146128975|NCT01752855|526992985|FG001|Overall Study|Adverse Event|0|||
146128976|NCT01752855|526992984|FG000|Overall Study|Withdrew Consent|0|||
146128977|NCT01752855|526992985|FG001|Overall Study|Withdrew Consent|2|||
146128978|NCT01752855|526992984|FG000|Overall Study|Lack of Efficacy|0|||
146128979|NCT01752855|526992985|FG001|Overall Study|Lack of Efficacy|2|||
146128980|NCT01478321|526992986|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
146128981|NCT01478321|526992986|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
146128982|NCT01478321|526992986|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
146128983|NCT01478321|526992986|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
146303515|NCT00356889|527625828|FG000|Overall Study|Adverse Event|1|||
146303516|NCT03492554|527625833|FG000|Overall Study|Protocol Violation|0|||
146128984|NCT01478321|526992986|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
146128985|NCT01478321|526992986|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
146128986|NCT01478321|526992986|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
146128987|NCT01478321|526992986|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
146128988|NCT01577758|526992987|FG000|Dose Escalation Phase|Adverse Event|0|||
146128989|NCT01577758|526992988|FG001|Dose Escalation Phase|Adverse Event|0|||
146128990|NCT01577758|526992989|FG002|Dose Escalation Phase|Adverse Event|0|||
146128991|NCT01577758|526992990|FG003|Dose Escalation Phase|Adverse Event|0|||
146128992|NCT01577758|526992991|FG004|Dose Escalation Phase|Adverse Event|0|||
146128993|NCT01577758|526992992|FG005|Dose Escalation Phase|Adverse Event|2|||
146128994|NCT01577758|526992993|FG006|Dose Escalation Phase|Adverse Event|1|||
146128995|NCT01577758|526992994|FG007|Dose Escalation Phase|Adverse Event|0|||
146128996|NCT01577758|526992987|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
146128997|NCT01577758|526992988|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
146128998|NCT01577758|526992989|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
146128999|NCT01577758|526992990|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
146129000|NCT01577758|526992991|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
146129001|NCT01577758|526992992|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
146129002|NCT01577758|526992993|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
146129003|NCT01577758|526992994|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
146129004|NCT01577758|526992987|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146129005|NCT01577758|526992988|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146129006|NCT01577758|526992989|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146129007|NCT01577758|526992990|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146129008|NCT01577758|526992991|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
146129009|NCT01577758|526992992|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
146129010|NCT01577758|526992993|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
146129011|NCT01577758|526992994|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
146129012|NCT01577758|526992987|FG000|Dose Escalation Phase|Progression Disease|2|||
146129013|NCT01577758|526992988|FG001|Dose Escalation Phase|Progression Disease|2|||
146129014|NCT01577758|526992989|FG002|Dose Escalation Phase|Progression Disease|1|||
146129015|NCT01577758|526992990|FG003|Dose Escalation Phase|Progression Disease|2|||
146129016|NCT01577758|526992991|FG004|Dose Escalation Phase|Progression Disease|5|||
146129017|NCT01577758|526992992|FG005|Dose Escalation Phase|Progression Disease|0|||
146129018|NCT01577758|526992993|FG006|Dose Escalation Phase|Progression Disease|0|||
146129019|NCT01577758|526992994|FG007|Dose Escalation Phase|Progression Disease|0|||
146129020|NCT01577758|526992987|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129021|NCT01577758|526992988|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129022|NCT01577758|526992989|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129023|NCT01577758|526992990|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129024|NCT01577758|526992991|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129025|NCT01577758|526992992|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129026|NCT01577758|526992993|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
146129027|NCT01577758|526992994|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
146129028|NCT01577758|526992987|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129029|NCT01577758|526992988|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129030|NCT01577758|526992989|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129031|NCT01577758|526992990|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129032|NCT01577758|526992991|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129033|NCT01577758|526992992|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129034|NCT01577758|526992993|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
146129035|NCT01577758|526992994|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
146129036|NCT01577758|526992987|FG000|mCRC Expansion Phase|Progression Disease|0|||
146129037|NCT01577758|526992988|FG001|mCRC Expansion Phase|Progression Disease|0|||
146129038|NCT01577758|526992989|FG002|mCRC Expansion Phase|Progression Disease|0|||
146129039|NCT01577758|526992990|FG003|mCRC Expansion Phase|Progression Disease|0|||
146129040|NCT01577758|526992991|FG004|mCRC Expansion Phase|Progression Disease|0|||
146129041|NCT01577758|526992992|FG005|mCRC Expansion Phase|Progression Disease|0|||
146129042|NCT01577758|526992993|FG006|mCRC Expansion Phase|Progression Disease|0|||
146129043|NCT01577758|526992994|FG007|mCRC Expansion Phase|Progression Disease|19|||
146129044|NCT05389657|526992996|FG000|Overall Study|Lost to Follow-up|7|||
146129045|NCT05389657|526992997|FG001|Overall Study|Lost to Follow-up|8|||
146129046|NCT03261947|526993000|FG000|Overall Study|Death|10|||
146129047|NCT03261947|526993001|FG001|Overall Study|Death|13|||
146129048|NCT03261947|526993002|FG002|Overall Study|Death|17|||
146129049|NCT03261947|526993003|FG003|Overall Study|Death|12|||
146129050|NCT03261947|526993004|FG004|Overall Study|Death|8|||
146129051|NCT03261947|526993000|FG000|Overall Study|Lost to Follow-up|0|||
146129052|NCT03261947|526993001|FG001|Overall Study|Lost to Follow-up|0|||
146129053|NCT03261947|526993002|FG002|Overall Study|Lost to Follow-up|2|||
146129054|NCT03261947|526993003|FG003|Overall Study|Lost to Follow-up|1|||
146129055|NCT03261947|526993004|FG004|Overall Study|Lost to Follow-up|0|||
146129056|NCT03261947|526993000|FG000|Overall Study|Withdrawal by Subject|0|||
146262997|NCT03305809|527478473|FG003|Overall Study|Death|1|||
146262998|NCT03305809|527478470|FG000|Overall Study|Lost to Follow-up|1|||
146129057|NCT03261947|526993001|FG001|Overall Study|Withdrawal by Subject|0|||
146129058|NCT03261947|526993002|FG002|Overall Study|Withdrawal by Subject|3|||
146129059|NCT03261947|526993003|FG003|Overall Study|Withdrawal by Subject|0|||
146129060|NCT03261947|526993004|FG004|Overall Study|Withdrawal by Subject|1|||
146129061|NCT03261947|526993000|FG000|Overall Study|Site Terminated by Sponsor|0|||
146129062|NCT03261947|526993001|FG001|Overall Study|Site Terminated by Sponsor|0|||
146129063|NCT03261947|526993002|FG002|Overall Study|Site Terminated by Sponsor|4|||
146129064|NCT03261947|526993003|FG003|Overall Study|Site Terminated by Sponsor|7|||
146129065|NCT03261947|526993004|FG004|Overall Study|Site Terminated by Sponsor|5|||
146129066|NCT03261947|526993000|FG000|Overall Study|Reason not Specified|2|||
146129067|NCT03261947|526993001|FG001|Overall Study|Reason not Specified|0|||
146129068|NCT03261947|526993002|FG002|Overall Study|Reason not Specified|4|||
146129069|NCT03261947|526993003|FG003|Overall Study|Reason not Specified|1|||
146262999|NCT03305809|527478471|FG001|Overall Study|Lost to Follow-up|2|||
146129070|NCT03261947|526993004|FG004|Overall Study|Reason not Specified|3|||
146129071|NCT02140567|526993007|FG000|Overall Study|Problems with recording equipment|6|||
146129072|NCT02039674|526993008|FG000|Overall Study|Adverse Event|0|||
146129073|NCT02039674|526993009|FG001|Overall Study|Adverse Event|0|||
146129074|NCT02039674|526993010|FG002|Overall Study|Adverse Event|0|||
146129075|NCT02039674|526993011|FG003|Overall Study|Adverse Event|1|||
146129076|NCT02039674|526993012|FG004|Overall Study|Adverse Event|0|||
146129077|NCT02039674|526993013|FG005|Overall Study|Adverse Event|0|||
146129078|NCT02039674|526993014|FG006|Overall Study|Adverse Event|0|||
146129079|NCT02039674|526993015|FG007|Overall Study|Adverse Event|0|||
146129080|NCT02039674|526993016|FG008|Overall Study|Adverse Event|2|||
146129081|NCT02039674|526993017|FG009|Overall Study|Adverse Event|1|||
146129082|NCT02039674|526993018|FG010|Overall Study|Adverse Event|0|||
146129083|NCT02039674|526993019|FG011|Overall Study|Adverse Event|2|||
146129084|NCT02039674|526993020|FG012|Overall Study|Adverse Event|3|||
146129085|NCT02039674|526993021|FG013|Overall Study|Adverse Event|1|||
146129086|NCT02039674|526993008|FG000|Overall Study|Death|2|||
146129087|NCT02039674|526993009|FG001|Overall Study|Death|0|||
146129088|NCT02039674|526993010|FG002|Overall Study|Death|2|||
146129089|NCT02039674|526993011|FG003|Overall Study|Death|3|||
146129090|NCT02039674|526993012|FG004|Overall Study|Death|0|||
146129091|NCT02039674|526993013|FG005|Overall Study|Death|0|||
146129092|NCT02039674|526993014|FG006|Overall Study|Death|1|||
146129093|NCT02039674|526993015|FG007|Overall Study|Death|0|||
146129094|NCT02039674|526993016|FG008|Overall Study|Death|2|||
146129095|NCT02039674|526993017|FG009|Overall Study|Death|0|||
146129096|NCT02039674|526993018|FG010|Overall Study|Death|1|||
146129097|NCT02039674|526993019|FG011|Overall Study|Death|3|||
146129098|NCT02039674|526993020|FG012|Overall Study|Death|2|||
146129099|NCT02039674|526993021|FG013|Overall Study|Death|8|||
146129100|NCT02039674|526993008|FG000|Overall Study|Excluded Medication|1|||
146129101|NCT02039674|526993009|FG001|Overall Study|Excluded Medication|1|||
146129102|NCT02039674|526993010|FG002|Overall Study|Excluded Medication|0|||
146129103|NCT02039674|526993011|FG003|Overall Study|Excluded Medication|1|||
146129104|NCT02039674|526993012|FG004|Overall Study|Excluded Medication|0|||
146129105|NCT02039674|526993013|FG005|Overall Study|Excluded Medication|1|||
146129106|NCT02039674|526993014|FG006|Overall Study|Excluded Medication|0|||
146129107|NCT02039674|526993015|FG007|Overall Study|Excluded Medication|0|||
146129108|NCT02039674|526993016|FG008|Overall Study|Excluded Medication|2|||
146129109|NCT02039674|526993017|FG009|Overall Study|Excluded Medication|3|||
146129110|NCT02039674|526993018|FG010|Overall Study|Excluded Medication|5|||
146129111|NCT02039674|526993019|FG011|Overall Study|Excluded Medication|6|||
146129112|NCT02039674|526993020|FG012|Overall Study|Excluded Medication|8|||
146129113|NCT02039674|526993021|FG013|Overall Study|Excluded Medication|3|||
146129114|NCT02039674|526993008|FG000|Overall Study|Lost to Follow-up|0|||
146129115|NCT02039674|526993009|FG001|Overall Study|Lost to Follow-up|0|||
146129116|NCT02039674|526993010|FG002|Overall Study|Lost to Follow-up|0|||
146129117|NCT02039674|526993011|FG003|Overall Study|Lost to Follow-up|0|||
146129118|NCT02039674|526993012|FG004|Overall Study|Lost to Follow-up|1|||
146129119|NCT02039674|526993013|FG005|Overall Study|Lost to Follow-up|1|||
146129120|NCT02039674|526993014|FG006|Overall Study|Lost to Follow-up|0|||
146129121|NCT02039674|526993015|FG007|Overall Study|Lost to Follow-up|0|||
146263000|NCT03305809|527478472|FG002|Overall Study|Lost to Follow-up|0|||
146263001|NCT03305809|527478473|FG003|Overall Study|Lost to Follow-up|0|||
146263002|NCT03305809|527478470|FG000|Overall Study|Sponsor Decision|1|||
146263003|NCT03305809|527478471|FG001|Overall Study|Sponsor Decision|0|||
146263004|NCT03305809|527478472|FG002|Overall Study|Sponsor Decision|1|||
146263005|NCT03305809|527478473|FG003|Overall Study|Sponsor Decision|8|||
146263006|NCT03305809|527478470|FG000|Overall Study|Physician Decision|0|||
146263007|NCT03305809|527478471|FG001|Overall Study|Physician Decision|0|||
146263008|NCT03305809|527478472|FG002|Overall Study|Physician Decision|2|||
146263009|NCT03305809|527478473|FG003|Overall Study|Physician Decision|4|||
146263010|NCT03305809|527478470|FG000|Overall Study|Progressive Disease|0|||
146263011|NCT03305809|527478471|FG001|Overall Study|Progressive Disease|0|||
146129122|NCT02039674|526993016|FG008|Overall Study|Lost to Follow-up|0|||
146129123|NCT02039674|526993017|FG009|Overall Study|Lost to Follow-up|0|||
146129124|NCT02039674|526993018|FG010|Overall Study|Lost to Follow-up|0|||
146129125|NCT02039674|526993019|FG011|Overall Study|Lost to Follow-up|2|||
146129126|NCT02039674|526993020|FG012|Overall Study|Lost to Follow-up|2|||
146129127|NCT02039674|526993021|FG013|Overall Study|Lost to Follow-up|1|||
146129128|NCT02039674|526993008|FG000|Overall Study|Physician Decision|0|||
146129129|NCT02039674|526993009|FG001|Overall Study|Physician Decision|0|||
146129130|NCT02039674|526993010|FG002|Overall Study|Physician Decision|0|||
146129131|NCT02039674|526993011|FG003|Overall Study|Physician Decision|0|||
146263012|NCT03305809|527478472|FG002|Overall Study|Progressive Disease|1|||
146129132|NCT02039674|526993012|FG004|Overall Study|Physician Decision|0|||
146129133|NCT02039674|526993013|FG005|Overall Study|Physician Decision|0|||
146129134|NCT02039674|526993014|FG006|Overall Study|Physician Decision|0|||
146129135|NCT02039674|526993015|FG007|Overall Study|Physician Decision|0|||
146129136|NCT02039674|526993016|FG008|Overall Study|Physician Decision|0|||
146129137|NCT02039674|526993017|FG009|Overall Study|Physician Decision|0|||
146263013|NCT03305809|527478473|FG003|Overall Study|Progressive Disease|0|||
146263014|NCT03305809|527478470|FG000|Overall Study|Protocol Violation|1|||
146263015|NCT03305809|527478471|FG001|Overall Study|Protocol Violation|0|||
146263016|NCT03305809|527478472|FG002|Overall Study|Protocol Violation|2|||
146263017|NCT03305809|527478473|FG003|Overall Study|Protocol Violation|3|||
146263018|NCT03305809|527478470|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146263019|NCT03305809|527478471|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146263020|NCT03305809|527478472|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
146263021|NCT03305809|527478473|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
146263022|NCT03305809|527478470|FG000|Overall Study|Withdrawal by Subject|2|||
146263023|NCT03305809|527478471|FG001|Overall Study|Withdrawal by Subject|4|||
146263024|NCT03305809|527478472|FG002|Overall Study|Withdrawal by Subject|5|||
146263025|NCT03305809|527478473|FG003|Overall Study|Withdrawal by Subject|2|||
146263026|NCT03305809|527478470|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
146263027|NCT03305809|527478471|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
146263028|NCT03305809|527478472|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
146263029|NCT03305809|527478473|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
146263030|NCT00816556|527478474|FG000|Overall Study|Adverse Event|1|||
146263031|NCT00816556|527478475|FG001|Overall Study|Adverse Event|1|||
146263032|NCT00816556|527478476|FG002|Overall Study|Adverse Event|1|||
146263033|NCT00816556|527478474|FG000|Overall Study|Withdrawal by Subject|1|||
146263034|NCT00816556|527478475|FG001|Overall Study|Withdrawal by Subject|1|||
146263035|NCT00816556|527478476|FG002|Overall Study|Withdrawal by Subject|1|||
146263036|NCT00816556|527478474|FG000|Overall Study|Lost to Follow-up|0|||
146263037|NCT00816556|527478475|FG001|Overall Study|Lost to Follow-up|0|||
146263038|NCT00816556|527478476|FG002|Overall Study|Lost to Follow-up|1|||
146263039|NCT04014790|527478477|FG000|Overall Study|Death|4|||
146263040|NCT04014790|527478477|FG000|Overall Study|Adverse Event|1|||
146263041|NCT04014790|527478477|FG000|Overall Study|Withdrawal by Subject|1|||
146263042|NCT03546816|527478478|FG000|Overall Study|Adverse Event|5|||
146263043|NCT03546816|527478479|FG001|Overall Study|Adverse Event|3|||
146263044|NCT03546816|527478478|FG000|Overall Study|Lack of Efficacy|2|||
146263045|NCT03546816|527478479|FG001|Overall Study|Lack of Efficacy|4|||
146263046|NCT03546816|527478478|FG000|Overall Study|Pregnancy|1|||
146263047|NCT03546816|527478479|FG001|Overall Study|Pregnancy|0|||
146263048|NCT03546816|527478478|FG000|Overall Study|Physician Decision|2|||
146263049|NCT03546816|527478479|FG001|Overall Study|Physician Decision|0|||
146263050|NCT03546816|527478478|FG000|Overall Study|Withdrawal by Subject|8|||
146263051|NCT03546816|527478479|FG001|Overall Study|Withdrawal by Subject|10|||
146263052|NCT03546816|527478478|FG000|Overall Study|Lost to Follow-up|3|||
146263053|NCT03546816|527478479|FG001|Overall Study|Lost to Follow-up|2|||
146263054|NCT02438371|527478480|FG000|Overall Study|Lost to Follow-up|3|||
146263055|NCT02438371|527478481|FG001|Overall Study|Lost to Follow-up|2|||
146263056|NCT02438371|527478480|FG000|Overall Study|Withdrawal by Subject|1|||
146303517|NCT03492554|527625834|FG001|Overall Study|Protocol Violation|14|||
146303518|NCT00736034|527625835|FG000|Overall Study|Adverse Event|2|||
146303519|NCT01514136|527625841|FG000|Test Period 1; Test A|Protocol Violation|1|||
146303520|NCT01514136|527625842|FG001|Test Period 1; Test A|Protocol Violation|0|||
146129138|NCT02039674|526993018|FG010|Overall Study|Physician Decision|0|||
146129139|NCT02039674|526993019|FG011|Overall Study|Physician Decision|1|||
146129140|NCT02039674|526993020|FG012|Overall Study|Physician Decision|1|||
146129141|NCT02039674|526993021|FG013|Overall Study|Physician Decision|0|||
146129142|NCT02039674|526993008|FG000|Overall Study|Progressive Disease|8|||
146129143|NCT02039674|526993009|FG001|Overall Study|Progressive Disease|8|||
146129144|NCT02039674|526993010|FG002|Overall Study|Progressive Disease|6|||
146129145|NCT02039674|526993011|FG003|Overall Study|Progressive Disease|7|||
146129146|NCT02039674|526993012|FG004|Overall Study|Progressive Disease|9|||
146129147|NCT02039674|526993013|FG005|Overall Study|Progressive Disease|10|||
146129148|NCT02039674|526993014|FG006|Overall Study|Progressive Disease|1|||
146129149|NCT02039674|526993015|FG007|Overall Study|Progressive Disease|3|||
146129150|NCT02039674|526993016|FG008|Overall Study|Progressive Disease|6|||
146129151|NCT02039674|526993017|FG009|Overall Study|Progressive Disease|4|||
146263057|NCT02438371|527478481|FG001|Overall Study|Withdrawal by Subject|1|||
146263058|NCT01161446|527478482|FG000|Overall Study|Lost to Follow-up|18|||
146263059|NCT01161446|527478483|FG001|Overall Study|Lost to Follow-up|14|||
146263060|NCT01161446|527478482|FG000|Overall Study|Withdrawal by Subject|0|||
146263061|NCT01161446|527478483|FG001|Overall Study|Withdrawal by Subject|1|||
146263062|NCT00810342|527478486|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
146263063|NCT00810342|527478487|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
146263064|NCT00810342|527478486|FG000|Month 1 Follow-up|Pregnancy|1|||
146263065|NCT00810342|527478487|FG001|Month 1 Follow-up|Pregnancy|0|||
146263066|NCT00810342|527478486|FG000|6-month Follow-up|Lost to Follow-up|18|||
146263067|NCT00810342|527478487|FG001|6-month Follow-up|Lost to Follow-up|6|||
146129152|NCT02039674|526993018|FG010|Overall Study|Progressive Disease|0|||
146129153|NCT02039674|526993019|FG011|Overall Study|Progressive Disease|34|||
146129154|NCT02039674|526993020|FG012|Overall Study|Progressive Disease|34|||
146129155|NCT02039674|526993021|FG013|Overall Study|Progressive Disease|18|||
146129156|NCT02039674|526993008|FG000|Overall Study|Withdrawal by Subject|1|||
146129157|NCT02039674|526993009|FG001|Overall Study|Withdrawal by Subject|2|||
146129158|NCT02039674|526993010|FG002|Overall Study|Withdrawal by Subject|3|||
146129159|NCT02039674|526993011|FG003|Overall Study|Withdrawal by Subject|0|||
146129160|NCT02039674|526993012|FG004|Overall Study|Withdrawal by Subject|1|||
146129161|NCT02039674|526993013|FG005|Overall Study|Withdrawal by Subject|0|||
146129162|NCT02039674|526993014|FG006|Overall Study|Withdrawal by Subject|0|||
146129163|NCT02039674|526993015|FG007|Overall Study|Withdrawal by Subject|0|||
146129164|NCT02039674|526993016|FG008|Overall Study|Withdrawal by Subject|0|||
146129165|NCT02039674|526993017|FG009|Overall Study|Withdrawal by Subject|1|||
146129166|NCT02039674|526993018|FG010|Overall Study|Withdrawal by Subject|1|||
146129167|NCT02039674|526993019|FG011|Overall Study|Withdrawal by Subject|4|||
146129168|NCT02039674|526993020|FG012|Overall Study|Withdrawal by Subject|6|||
146129169|NCT02039674|526993021|FG013|Overall Study|Withdrawal by Subject|2|||
146129170|NCT02039674|526993008|FG000|Overall Study|Clinical Progression|0|||
146129171|NCT02039674|526993009|FG001|Overall Study|Clinical Progression|0|||
146129172|NCT02039674|526993010|FG002|Overall Study|Clinical Progression|0|||
146129173|NCT02039674|526993011|FG003|Overall Study|Clinical Progression|0|||
146129174|NCT02039674|526993012|FG004|Overall Study|Clinical Progression|0|||
146129175|NCT02039674|526993013|FG005|Overall Study|Clinical Progression|0|||
146129176|NCT02039674|526993014|FG006|Overall Study|Clinical Progression|1|||
146129177|NCT02039674|526993015|FG007|Overall Study|Clinical Progression|0|||
146129178|NCT02039674|526993016|FG008|Overall Study|Clinical Progression|0|||
146129179|NCT02039674|526993017|FG009|Overall Study|Clinical Progression|0|||
146129180|NCT02039674|526993018|FG010|Overall Study|Clinical Progression|0|||
146129181|NCT02039674|526993019|FG011|Overall Study|Clinical Progression|0|||
146129182|NCT02039674|526993020|FG012|Overall Study|Clinical Progression|1|||
146129183|NCT02039674|526993021|FG013|Overall Study|Clinical Progression|0|||
146129184|NCT02039674|526993008|FG000|Overall Study|Sponsor Decision|1|||
146129185|NCT02039674|526993009|FG001|Overall Study|Sponsor Decision|1|||
146129186|NCT02039674|526993010|FG002|Overall Study|Sponsor Decision|1|||
146129187|NCT02039674|526993011|FG003|Overall Study|Sponsor Decision|1|||
146129188|NCT02039674|526993012|FG004|Overall Study|Sponsor Decision|1|||
146129189|NCT02039674|526993013|FG005|Overall Study|Sponsor Decision|0|||
146129190|NCT02039674|526993014|FG006|Overall Study|Sponsor Decision|0|||
146129191|NCT02039674|526993015|FG007|Overall Study|Sponsor Decision|0|||
146129192|NCT02039674|526993016|FG008|Overall Study|Sponsor Decision|0|||
146129193|NCT02039674|526993017|FG009|Overall Study|Sponsor Decision|3|||
146129194|NCT02039674|526993018|FG010|Overall Study|Sponsor Decision|0|||
146129195|NCT02039674|526993019|FG011|Overall Study|Sponsor Decision|8|||
146129196|NCT02039674|526993020|FG012|Overall Study|Sponsor Decision|5|||
146129197|NCT02039674|526993021|FG013|Overall Study|Sponsor Decision|0|||
146129198|NCT02039674|526993008|FG000|Overall Study|Other|0|||
146129199|NCT02039674|526993009|FG001|Overall Study|Other|0|||
146129200|NCT02039674|526993010|FG002|Overall Study|Other|0|||
146129201|NCT02039674|526993011|FG003|Overall Study|Other|0|||
146129202|NCT02039674|526993012|FG004|Overall Study|Other|0|||
146129203|NCT02039674|526993013|FG005|Overall Study|Other|0|||
146129204|NCT02039674|526993014|FG006|Overall Study|Other|0|||
146129205|NCT02039674|526993015|FG007|Overall Study|Other|0|||
146129206|NCT02039674|526993016|FG008|Overall Study|Other|0|||
146129207|NCT02039674|526993017|FG009|Overall Study|Other|0|||
146129208|NCT02039674|526993018|FG010|Overall Study|Other|0|||
146129209|NCT02039674|526993019|FG011|Overall Study|Other|0|||
146129210|NCT02039674|526993020|FG012|Overall Study|Other|1|||
146129211|NCT02039674|526993021|FG013|Overall Study|Other|0|||
146129212|NCT03774433|526993023|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
146129213|NCT00108160|526993024|FG000|Overall Study|Lost to Follow-up|25|||
146129214|NCT00108160|526993025|FG001|Overall Study|Lost to Follow-up|12|||
146129215|NCT00108160|526993024|FG000|Overall Study|Death|1|||
146129216|NCT00108160|526993025|FG001|Overall Study|Death|2|||
146129217|NCT00108160|526993024|FG000|Overall Study|Withdrawal by Subject|4|||
146129218|NCT00108160|526993025|FG001|Overall Study|Withdrawal by Subject|2|||
146129219|NCT00108160|526993024|FG000|Overall Study|Protocol Violation|9|||
146129220|NCT00108160|526993025|FG001|Overall Study|Protocol Violation|5|||
146129221|NCT05045144|526993027|FG000|Overall Study|Lost to Follow-up|3|||
146129222|NCT05045144|526993028|FG001|Overall Study|Lost to Follow-up|2|||
146129223|NCT05045144|526993029|FG002|Overall Study|Lost to Follow-up|3|||
146129224|NCT05045144|526993030|FG003|Overall Study|Lost to Follow-up|5|||
146129225|NCT05045144|526993031|FG004|Overall Study|Lost to Follow-up|13|||
146129226|NCT05045144|526993027|FG000|Overall Study|Withdrawal by Subject|0|||
146129227|NCT05045144|526993028|FG001|Overall Study|Withdrawal by Subject|1|||
146263068|NCT00810342|527478486|FG000|6-month Follow-up|Pregnancy|6|||
146129228|NCT05045144|526993029|FG002|Overall Study|Withdrawal by Subject|0|||
146129229|NCT05045144|526993030|FG003|Overall Study|Withdrawal by Subject|0|||
146129230|NCT05045144|526993031|FG004|Overall Study|Withdrawal by Subject|0|||
146129231|NCT05045144|526993027|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146129232|NCT05045144|526993028|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146263069|NCT00810342|527478487|FG001|6-month Follow-up|Pregnancy|2|||
146263070|NCT00810342|527478486|FG000|12-month Followup|Pregnancy|9|||
146263071|NCT00810342|527478487|FG001|12-month Followup|Pregnancy|10|||
146263072|NCT00810342|527478486|FG000|12-month Followup|Lost to Follow-up|3|||
146263073|NCT00810342|527478487|FG001|12-month Followup|Lost to Follow-up|1|||
146263074|NCT03065933|527478488|FG000|Overall Study|study terminated|5|||
146263075|NCT01010204|527478489|FG000|Overall Study|Lost to Follow-up|2|||
146263076|NCT01010204|527478490|FG001|Overall Study|Lost to Follow-up|2|||
146129233|NCT05045144|526993029|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146129234|NCT05045144|526993030|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146129235|NCT05045144|526993031|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146129236|NCT02385084|526993032|FG000|Period 2|Protocol Violation|0|||
146129237|NCT02385084|526993033|FG001|Period 2|Protocol Violation|0|||
146129238|NCT02385084|526993034|FG002|Period 2|Protocol Violation|1|||
146129239|NCT02385084|526993035|FG003|Period 2|Protocol Violation|0|||
146129240|NCT02385084|526993036|FG004|Period 2|Protocol Violation|0|||
146129241|NCT02385084|526993037|FG005|Period 2|Protocol Violation|0|||
146129242|NCT02965703|526993039|FG000|Overall Study|Withdrawal by Subject|6|||
146129243|NCT02965703|526993040|FG001|Overall Study|Withdrawal by Subject|3|||
146129244|NCT02965703|526993041|FG002|Overall Study|Withdrawal by Subject|1|||
146129245|NCT02965703|526993039|FG000|Overall Study|Protocol Violation|1|||
146129246|NCT02965703|526993040|FG001|Overall Study|Protocol Violation|0|||
146129247|NCT02965703|526993041|FG002|Overall Study|Protocol Violation|0|||
146129248|NCT02965703|526993039|FG000|Overall Study|Adverse Event|1|||
146129249|NCT02965703|526993040|FG001|Overall Study|Adverse Event|1|||
146129250|NCT02965703|526993041|FG002|Overall Study|Adverse Event|0|||
146129251|NCT02965703|526993039|FG000|Overall Study|Lost to Follow-up|2|||
146129252|NCT02965703|526993040|FG001|Overall Study|Lost to Follow-up|1|||
146129253|NCT02965703|526993041|FG002|Overall Study|Lost to Follow-up|1|||
146129254|NCT02968979|526993042|FG000|Overall Study|Protocol Violation|7|||
146129255|NCT02968979|526993042|FG000|Overall Study|Withdrawal by Subject|1|||
146129256|NCT01471379|526993043|FG000|Overall Study|Adverse Event|1|||
146129257|NCT01471379|526993044|FG001|Overall Study|Adverse Event|0|||
146129258|NCT01471379|526993045|FG002|Overall Study|Adverse Event|0|||
146129259|NCT01471379|526993043|FG000|Overall Study|Study terminated|0|||
146129260|NCT01471379|526993044|FG001|Overall Study|Study terminated|1|||
146129261|NCT01471379|526993045|FG002|Overall Study|Study terminated|0|||
146129262|NCT00729183|526993046|FG000|Overall Study|Adverse Event|11|||
146129263|NCT00729183|526993047|FG001|Overall Study|Adverse Event|5|||
146129264|NCT00729183|526993046|FG000|Overall Study|Lack of Efficacy|0|||
146129265|NCT00729183|526993047|FG001|Overall Study|Lack of Efficacy|1|||
146129266|NCT00729183|526993046|FG000|Overall Study|Lost to Follow-up|3|||
146129267|NCT00729183|526993047|FG001|Overall Study|Lost to Follow-up|1|||
146129268|NCT00729183|526993046|FG000|Overall Study|Physician Decision|1|||
146129269|NCT00729183|526993047|FG001|Overall Study|Physician Decision|1|||
146263077|NCT01010204|527478489|FG000|Overall Study|Adverse Event|1|||
146263078|NCT01010204|527478490|FG001|Overall Study|Adverse Event|3|||
146263079|NCT01010204|527478489|FG000|Overall Study|Withdrawal by Subject|2|||
146263080|NCT01010204|527478490|FG001|Overall Study|Withdrawal by Subject|3|||
146263081|NCT01010204|527478489|FG000|Overall Study|psychiatric hospitalization|2|||
146263082|NCT01010204|527478490|FG001|Overall Study|psychiatric hospitalization|1|||
146263083|NCT01513330|527478491|FG000|SenSura Mio First,|Adverse Event|2|||
146263084|NCT01513330|527478492|FG001|SenSura Mio First,|Adverse Event|0|||
146263085|NCT01513330|527478491|FG000|SenSura Mio First,|Lack of Efficacy|0|||
146263086|NCT01513330|527478492|FG001|SenSura Mio First,|Lack of Efficacy|1|||
146263087|NCT01513330|527478491|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
146263088|NCT01513330|527478492|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
146263089|NCT01513330|527478491|FG000|SenSura Mio First,|Other|1|||
146263090|NCT01513330|527478492|FG001|SenSura Mio First,|Other|0|||
146263091|NCT01513330|527478491|FG000|Standard Care First,|Lack of Efficacy|2|||
146263092|NCT01513330|527478492|FG001|Standard Care First,|Lack of Efficacy|2|||
146263093|NCT01513330|527478491|FG000|Standard Care First,|Withdrawal by Subject|1|||
146263094|NCT01513330|527478492|FG001|Standard Care First,|Withdrawal by Subject|2|||
146263095|NCT01513330|527478491|FG000|Standard Care First,|Other|1|||
146263096|NCT01513330|527478492|FG001|Standard Care First,|Other|0|||
146263097|NCT01519778|527478493|FG000|Overall Study|Withdrawal by Subject|3|||
146263098|NCT01519778|527478493|FG000|Overall Study|Lost to Follow-up|10|||
146263099|NCT01519778|527478493|FG000|Overall Study|Physician Decision|1|||
146263100|NCT02330562|527478498|FG000|Overall Study|Adverse Event|0|||
146263101|NCT02330562|527478499|FG001|Overall Study|Adverse Event|0|||
146129270|NCT00729183|526993046|FG000|Overall Study|Protocol Violation|1|||
146129271|NCT00729183|526993047|FG001|Overall Study|Protocol Violation|0|||
146129272|NCT00729183|526993046|FG000|Overall Study|Withdrawal by Subject|9|||
146129273|NCT00729183|526993047|FG001|Overall Study|Withdrawal by Subject|7|||
146129274|NCT03745144|526993048|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
146129275|NCT03745144|526993049|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
146129276|NCT03745144|526993050|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
146129277|NCT03745144|526993048|FG000|Period 1|Other|0|||
146129278|NCT03745144|526993049|FG001|Period 1|Other|0|||
146129279|NCT03745144|526993050|FG002|Period 1|Other|1|||
146129280|NCT01359254|526993051|FG000|Overall Study|Death|1|||
146129281|NCT01359254|526993052|FG001|Overall Study|Death|0|||
146129282|NCT01124643|526993063|FG000|Overall Study|Death|1|||
146129283|NCT02678676|526993066|FG000|Overall Study|Death|619|||
146129284|NCT02678676|526993067|FG001|Overall Study|Death|649|||
146129285|NCT02678676|526993066|FG000|Overall Study|Withdrawal by Subject|13|||
146129286|NCT02678676|526993067|FG001|Overall Study|Withdrawal by Subject|5|||
146129287|NCT02678676|526993066|FG000|Overall Study|Lost to Follow-up|171|||
146129288|NCT02678676|526993067|FG001|Overall Study|Lost to Follow-up|151|||
146129289|NCT02678676|526993066|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
146129290|NCT02678676|526993067|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
146129291|NCT00851799|526993068|FG000|Overall Study|Death|1|||
146129292|NCT00851799|526993069|FG001|Overall Study|Death|0|||
146129293|NCT00851799|526993070|FG002|Overall Study|Death|1|||
146129294|NCT00851799|526993068|FG000|Overall Study|Lost to Follow-up|5|||
146129295|NCT00851799|526993069|FG001|Overall Study|Lost to Follow-up|3|||
146129296|NCT00851799|526993070|FG002|Overall Study|Lost to Follow-up|10|||
146129297|NCT00851799|526993068|FG000|Overall Study|Not able to get to clinic|8|||
146129298|NCT00851799|526993069|FG001|Overall Study|Not able to get to clinic|5|||
146129299|NCT00851799|526993070|FG002|Overall Study|Not able to get to clinic|9|||
146129300|NCT00851799|526993068|FG000|Overall Study|Not willing to adhere to requirements|1|||
146129301|NCT00851799|526993069|FG001|Overall Study|Not willing to adhere to requirements|2|||
146129302|NCT00851799|526993070|FG002|Overall Study|Not willing to adhere to requirements|2|||
146129303|NCT00851799|526993068|FG000|Overall Study|Withdrew consent prior study completion|1|||
146129304|NCT00851799|526993069|FG001|Overall Study|Withdrew consent prior study completion|2|||
146129305|NCT00851799|526993070|FG002|Overall Study|Withdrew consent prior study completion|1|||
146129306|NCT00851799|526993068|FG000|Overall Study|Severe Debilitation|0|||
146129307|NCT00851799|526993069|FG001|Overall Study|Severe Debilitation|1|||
146129308|NCT00851799|526993070|FG002|Overall Study|Severe Debilitation|0|||
146129309|NCT00851799|526993068|FG000|Overall Study|Completed protocol due to pregnancy|0|||
146129310|NCT00851799|526993069|FG001|Overall Study|Completed protocol due to pregnancy|0|||
146129311|NCT00851799|526993070|FG002|Overall Study|Completed protocol due to pregnancy|1|||
146129312|NCT01342510|526993071|FG000|Overall Study|Protocol Violation|12|||
146129313|NCT01342510|526993072|FG001|Overall Study|Protocol Violation|6|||
146129314|NCT01342510|526993073|FG002|Overall Study|Protocol Violation|13|||
146129315|NCT01342510|526993074|FG003|Overall Study|Protocol Violation|11|||
146129316|NCT01449526|526993075|FG000|Overall Study|Lost to Follow-up|1|||
146129317|NCT01449526|526993076|FG001|Overall Study|Lost to Follow-up|2|||
146129318|NCT01449526|526993075|FG000|Overall Study|Withdrawal by Subject|1|||
146129319|NCT01449526|526993076|FG001|Overall Study|Withdrawal by Subject|1|||
146129320|NCT01449526|526993075|FG000|Overall Study|Symptoms/complaints|0|||
146129321|NCT01449526|526993076|FG001|Overall Study|Symptoms/complaints|1|||
146129322|NCT01449526|526993075|FG000|Overall Study|Lack of Motivation|0|||
146129323|NCT01449526|526993076|FG001|Overall Study|Lack of Motivation|1|||
146129324|NCT01449526|526993075|FG000|Overall Study|Cannot maintain visits|0|||
146129325|NCT01449526|526993076|FG001|Overall Study|Cannot maintain visits|1|||
146129326|NCT05756790|526993077|FG000|Overall Study|Withdrawal by Subject|1|||
146129327|NCT05756790|526993078|FG001|Overall Study|Withdrawal by Subject|1|||
146129328|NCT05756790|526993079|FG002|Overall Study|Withdrawal by Subject|1|||
146129329|NCT05756790|526993080|FG003|Overall Study|Withdrawal by Subject|1|||
146129330|NCT05756790|526993081|FG004|Overall Study|Withdrawal by Subject|0|||
146129331|NCT05756790|526993082|FG005|Overall Study|Withdrawal by Subject|0|||
146129332|NCT05756790|526993077|FG000|Overall Study|Protocol Violation|0|||
146129333|NCT05756790|526993078|FG001|Overall Study|Protocol Violation|0|||
146129334|NCT05756790|526993079|FG002|Overall Study|Protocol Violation|1|||
146129335|NCT05756790|526993080|FG003|Overall Study|Protocol Violation|1|||
146129336|NCT05756790|526993081|FG004|Overall Study|Protocol Violation|0|||
146129337|NCT05756790|526993082|FG005|Overall Study|Protocol Violation|0|||
146129338|NCT05756790|526993077|FG000|Overall Study|Ineligible|0|||
146129339|NCT05756790|526993078|FG001|Overall Study|Ineligible|0|||
146129340|NCT05756790|526993079|FG002|Overall Study|Ineligible|0|||
146129341|NCT05756790|526993080|FG003|Overall Study|Ineligible|0|||
146129342|NCT05756790|526993081|FG004|Overall Study|Ineligible|2|||
146129343|NCT05756790|526993082|FG005|Overall Study|Ineligible|2|||
146129344|NCT00589108|526994992|FG000|Overall Study|Lost to Follow-up|1|||
146129345|NCT00589108|526994993|FG001|Overall Study|Lost to Follow-up|1|||
146129346|NCT00589108|526994994|FG002|Overall Study|Lost to Follow-up|1|||
146263102|NCT02330562|527478500|FG002|Overall Study|Adverse Event|3|||
146263103|NCT02330562|527478501|FG003|Overall Study|Adverse Event|0|||
146263104|NCT02330562|527478502|FG004|Overall Study|Adverse Event|3|||
146129347|NCT00589108|526994992|FG000|Overall Study|Death|3|||
146129348|NCT00589108|526994993|FG001|Overall Study|Death|3|||
146129349|NCT00589108|526994994|FG002|Overall Study|Death|4|||
146129350|NCT03256552|526994995|FG000|Overall Study|Protocol Violation|1|||
146129351|NCT03256552|526994995|FG000|Overall Study|Physician Decision|1|||
146129352|NCT03256552|526994995|FG000|Overall Study|Adverse Event|1|||
146129353|NCT03256552|526994995|FG000|Overall Study|Withdrawal by Subject|2|||
146129354|NCT01859507|526995000|FG000|Overall Study|left the country|4|||
146129355|NCT04476030|526995001|FG000|Overall Study|Withdrawal by Subject|20|||
146129356|NCT04476030|526995002|FG001|Overall Study|Withdrawal by Subject|16|||
146129357|NCT04476030|526995001|FG000|Overall Study|Adverse Event|10|||
146129358|NCT04476030|526995002|FG001|Overall Study|Adverse Event|11|||
146129359|NCT04476030|526995001|FG000|Overall Study|Lost to Follow-up|7|||
146129360|NCT04476030|526995002|FG001|Overall Study|Lost to Follow-up|4|||
146129361|NCT04476030|526995001|FG000|Overall Study|Physician Decision|1|||
146129362|NCT04476030|526995002|FG001|Overall Study|Physician Decision|1|||
146129363|NCT04476030|526995001|FG000|Overall Study|Protocol Deviation|2|||
146129364|NCT04476030|526995002|FG001|Overall Study|Protocol Deviation|0|||
146129365|NCT04476030|526995001|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
146129366|NCT04476030|526995002|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
146129367|NCT04476030|526995001|FG000|Overall Study|Randomized but not Dosed|2|||
146129368|NCT04476030|526995002|FG001|Overall Study|Randomized but not Dosed|8|||
146129369|NCT02404311|526995003|FG000|Part A: Month 0-18|Death|2|||
146129370|NCT02404311|526995004|FG001|Part A: Month 0-18|Death|0|||
146129371|NCT02404311|526995005|FG002|Part A: Month 0-18|Death|0|||
146129372|NCT02404311|526995006|FG003|Part A: Month 0-18|Death|0|||
146129373|NCT02404311|526995007|FG004|Part A: Month 0-18|Death|0|||
146129374|NCT02404311|526995003|FG000|Part A: Month 0-18|Physician Decision|1|||
146129375|NCT02404311|526995004|FG001|Part A: Month 0-18|Physician Decision|0|||
146129376|NCT02404311|526995005|FG002|Part A: Month 0-18|Physician Decision|0|||
146129377|NCT02404311|526995006|FG003|Part A: Month 0-18|Physician Decision|0|||
146129378|NCT02404311|526995007|FG004|Part A: Month 0-18|Physician Decision|0|||
146129379|NCT02404311|526995003|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
146129380|NCT02404311|526995004|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
146129381|NCT02404311|526995005|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
146129382|NCT02404311|526995006|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
146129383|NCT02404311|526995007|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
146129384|NCT02404311|526995003|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
146129385|NCT02404311|526995004|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
146129386|NCT02404311|526995005|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
146129387|NCT02404311|526995006|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
146129388|NCT02404311|526995007|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
146129389|NCT02404311|526995003|FG000|Part A: Month 0-18|HIV Infection|6|||
146129390|NCT02404311|526995004|FG001|Part A: Month 0-18|HIV Infection|2|||
146129391|NCT02404311|526995005|FG002|Part A: Month 0-18|HIV Infection|0|||
146129392|NCT02404311|526995006|FG003|Part A: Month 0-18|HIV Infection|0|||
146129393|NCT02404311|526995007|FG004|Part A: Month 0-18|HIV Infection|0|||
146129394|NCT02404311|526995003|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
146129395|NCT02404311|526995004|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
146129396|NCT02404311|526995005|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
146129397|NCT02404311|526995006|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
146129398|NCT02404311|526995007|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
146129399|NCT02256891|526995012|FG000|Overall Study|Death|0|||
146129400|NCT02256891|526995013|FG001|Overall Study|Death|2|||
146129401|NCT02256891|526995012|FG000|Overall Study|Lost to Follow-up|0|||
146129402|NCT02256891|526995013|FG001|Overall Study|Lost to Follow-up|3|||
146129403|NCT02256891|526995012|FG000|Overall Study|Physician Decision|7|||
146129404|NCT02256891|526995013|FG001|Overall Study|Physician Decision|3|||
146129405|NCT02256891|526995012|FG000|Overall Study|Screen Fail|5|||
146129406|NCT02256891|526995013|FG001|Overall Study|Screen Fail|4|||
146129407|NCT02256891|526995012|FG000|Overall Study|Equipment Malfunction|0|||
146129408|NCT02256891|526995013|FG001|Overall Study|Equipment Malfunction|1|||
146129409|NCT04171414|526995022|FG000|Overall Study|Death|1|||
146129410|NCT04171414|526995022|FG000|Overall Study|Withdrawal by Subject|1|||
146129411|NCT00218296|526995023|FG000|Overall Study|Lost to Follow-up|9|||
146129412|NCT00218296|526995024|FG001|Overall Study|Lost to Follow-up|7|||
146129413|NCT00218296|526995023|FG000|Overall Study|Withdrawal by Subject|36|||
146129414|NCT00218296|526995024|FG001|Overall Study|Withdrawal by Subject|47|||
146129415|NCT00218296|526995023|FG000|Overall Study|Randomized but did not enter treatment|66|||
146129416|NCT00218296|526995024|FG001|Overall Study|Randomized but did not enter treatment|67|||
146129417|NCT03412084|526995031|FG000|Overall Study|Withdrawal by Subject|2|||
146263105|NCT02330562|527478503|FG005|Overall Study|Adverse Event|1|||
146129418|NCT03412084|526995032|FG001|Overall Study|Withdrawal by Subject|0|||
146129419|NCT03412084|526995031|FG000|Overall Study|Participant moved|1|||
146129420|NCT03412084|526995032|FG001|Overall Study|Participant moved|0|||
146129421|NCT03412084|526995031|FG000|Overall Study|Lost to Follow-up|1|||
146129422|NCT03412084|526995032|FG001|Overall Study|Lost to Follow-up|1|||
146129423|NCT01928862|526995033|FG000|Overall Study|Lost to Follow-up|1|||
146129424|NCT01928862|526995034|FG001|Overall Study|Lost to Follow-up|0|||
146129425|NCT01928862|526995035|FG002|Overall Study|Lost to Follow-up|0|||
146129426|NCT01928862|526995036|FG003|Overall Study|Lost to Follow-up|0|||
146129427|NCT01928862|526995037|FG004|Overall Study|Lost to Follow-up|1|||
146129428|NCT02053753|526995045|FG000|Overall Study|Withdrawal by Subject|2|||
146129429|NCT02053753|526995046|FG001|Overall Study|Withdrawal by Subject|4|||
146129430|NCT02053753|526995045|FG000|Overall Study|Decision by Sponsor|1|||
146129431|NCT02053753|526995046|FG001|Overall Study|Decision by Sponsor|1|||
146129432|NCT02053753|526995045|FG000|Overall Study|Lost to Follow-up|4|||
146129433|NCT02053753|526995046|FG001|Overall Study|Lost to Follow-up|3|||
146129434|NCT02972632|526995047|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146129435|NCT02972632|526995047|FG000|Overall Study|Lost to Follow-up|4|||
146129436|NCT02972632|526995047|FG000|Overall Study|Voluntary Withdrawal|10|||
146129437|NCT02023151|526995048|FG000|Overall Study|Lost to Follow-up|4|||
146129438|NCT04064294|526995049|FG000|Overall Study|Adverse Event|1|||
146129439|NCT04064294|526995050|FG001|Overall Study|Adverse Event|0|||
146129440|NCT04064294|526995051|FG002|Overall Study|Adverse Event|0|||
146129441|NCT03450707|526995052|FG000|Overall Study|Outside enrollment window|4|||
146129442|NCT03450707|526995053|FG001|Overall Study|Outside enrollment window|1|||
146129443|NCT03450707|526995052|FG000|Overall Study|Death|1|||
146129444|NCT03450707|526995053|FG001|Overall Study|Death|0|||
146129445|NCT03450707|526995052|FG000|Overall Study|Indication for thiamine|1|||
146129446|NCT03450707|526995053|FG001|Overall Study|Indication for thiamine|1|||
146129447|NCT03450707|526995052|FG000|Overall Study|Evidence of traumatic brain injury|1|||
146129448|NCT03450707|526995053|FG001|Overall Study|Evidence of traumatic brain injury|0|||
146129449|NCT03450707|526995052|FG000|Overall Study|Following commands|0|||
146129450|NCT03450707|526995053|FG001|Overall Study|Following commands|3|||
146129451|NCT03450707|526995052|FG000|Overall Study|Lactate < 3.5|0|||
146129452|NCT03450707|526995053|FG001|Overall Study|Lactate < 3.5|2|||
146129453|NCT03450707|526995052|FG000|Overall Study|Rearrest with ECMO|0|||
146129454|NCT03450707|526995053|FG001|Overall Study|Rearrest with ECMO|1|||
146129455|NCT03450707|526995052|FG000|Overall Study|Indication for thiamine + head CT results|0|||
146129456|NCT03450707|526995053|FG001|Overall Study|Indication for thiamine + head CT results|1|||
146129457|NCT03450707|526995052|FG000|Overall Study|Family/patient goals of care|0|||
146129458|NCT03450707|526995053|FG001|Overall Study|Family/patient goals of care|1|||
146129459|NCT00337103|526995063|FG000|Overall Study|Progressive Disease|414|||
146129460|NCT00337103|526995064|FG001|Overall Study|Progressive Disease|410|||
146129461|NCT00337103|526995063|FG000|Overall Study|Adverse Event|45|||
146129462|NCT00337103|526995064|FG001|Overall Study|Adverse Event|59|||
146129463|NCT00337103|526995063|FG000|Overall Study|Subject Choice|34|||
146129464|NCT00337103|526995064|FG001|Overall Study|Subject Choice|27|||
146129465|NCT00337103|526995063|FG000|Overall Study|Clinical Progression|27|||
146129466|NCT00337103|526995064|FG001|Overall Study|Clinical Progression|24|||
146129467|NCT00337103|526995063|FG000|Overall Study|Physician Decision|15|||
146129468|NCT00337103|526995064|FG001|Overall Study|Physician Decision|14|||
146129469|NCT00337103|526995063|FG000|Overall Study|Withdrawal by Subject|8|||
146129470|NCT00337103|526995064|FG001|Overall Study|Withdrawal by Subject|5|||
146129471|NCT00337103|526995063|FG000|Overall Study|Other|5|||
146129472|NCT00337103|526995064|FG001|Overall Study|Other|6|||
146129473|NCT00337103|526995063|FG000|Overall Study|Entry Criteria Not Met|4|||
146129474|NCT00337103|526995064|FG001|Overall Study|Entry Criteria Not Met|1|||
146129475|NCT00337103|526995063|FG000|Overall Study|Lost to Follow-up|1|||
146129476|NCT00337103|526995064|FG001|Overall Study|Lost to Follow-up|2|||
146129477|NCT00337103|526995063|FG000|Overall Study|Death|1|||
146129478|NCT00337103|526995064|FG001|Overall Study|Death|0|||
146129479|NCT01289847|526995065|FG000|Overall Study|Patient could not comply with visits|1|||
146129480|NCT03975647|526995078|FG000|Overall Study|Death|71|||
146129481|NCT03975647|526995079|FG001|Overall Study|Death|63|||
146129482|NCT03975647|526995078|FG000|Overall Study|Lost to Follow-up|2|||
146129483|NCT03975647|526995079|FG001|Overall Study|Lost to Follow-up|2|||
146129484|NCT03975647|526995078|FG000|Overall Study|Subject withdrawal of consent|7|||
146129485|NCT03975647|526995079|FG001|Overall Study|Subject withdrawal of consent|11|||
146129486|NCT00228917|526995086|FG000|Overall Study|Migrated/moved from study area|0|||
146129487|NCT00228917|526995087|FG001|Overall Study|Migrated/moved from study area|0|||
146129488|NCT00228917|526995088|FG002|Overall Study|Migrated/moved from study area|0|||
146129489|NCT00228917|526995089|FG003|Overall Study|Migrated/moved from study area|0|||
146129490|NCT00228917|526995090|FG004|Overall Study|Migrated/moved from study area|0|||
146129491|NCT00228917|526995091|FG005|Overall Study|Migrated/moved from study area|2|||
146263106|NCT02330562|527478504|FG006|Overall Study|Adverse Event|0|||
146129492|NCT00228917|526995092|FG006|Overall Study|Migrated/moved from study area|0|||
146129493|NCT00228917|526995093|FG007|Overall Study|Migrated/moved from study area|0|||
146129494|NCT00409617|526995094|FG000|Overall Study|Adverse Event|57|||
146129495|NCT00409617|526995094|FG000|Overall Study|Lack of Efficacy|54|||
146129496|NCT00409617|526995094|FG000|Overall Study|Lost to Follow-up|2|||
146129497|NCT00409617|526995094|FG000|Overall Study|Protocol Violation|24|||
146129498|NCT00409617|526995094|FG000|Overall Study|Withdrawal by Subject|8|||
146129499|NCT00409617|526995094|FG000|Overall Study|Administrative reasons|1|||
146263107|NCT02330562|527478505|FG007|Overall Study|Adverse Event|0|||
146263108|NCT02330562|527478506|FG008|Overall Study|Adverse Event|0|||
146129500|NCT00409617|526995094|FG000|Overall Study|Not described|14|||
146129501|NCT01354496|526995110|FG000|Period 1|Adverse Event|0|||
146129502|NCT01354496|526995111|FG001|Period 1|Adverse Event|0|||
146129503|NCT01354496|526995112|FG002|Period 1|Adverse Event|1|||
146129504|NCT01354496|526995113|FG003|Period 1|Adverse Event|0|||
146129505|NCT01354496|526995114|FG004|Period 1|Adverse Event|0|||
146129506|NCT01354496|526995115|FG005|Period 1|Adverse Event|0|||
146129507|NCT01354496|526995110|FG000|Period 1|Physician Decision|0|||
146129508|NCT01354496|526995111|FG001|Period 1|Physician Decision|0|||
146129509|NCT01354496|526995112|FG002|Period 1|Physician Decision|1|||
146129510|NCT01354496|526995113|FG003|Period 1|Physician Decision|0|||
146129511|NCT01354496|526995114|FG004|Period 1|Physician Decision|0|||
146129512|NCT01354496|526995115|FG005|Period 1|Physician Decision|0|||
146129513|NCT01354496|526995110|FG000|Period 2|Adverse Event|0|||
146129514|NCT01354496|526995111|FG001|Period 2|Adverse Event|0|||
146129515|NCT01354496|526995112|FG002|Period 2|Adverse Event|0|||
146129516|NCT01354496|526995113|FG003|Period 2|Adverse Event|1|||
146129517|NCT01354496|526995114|FG004|Period 2|Adverse Event|0|||
146129518|NCT01354496|526995115|FG005|Period 2|Adverse Event|0|||
146129519|NCT01354496|526995110|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146129520|NCT01354496|526995111|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
146129521|NCT01354496|526995112|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146129522|NCT01354496|526995113|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
146129523|NCT01354496|526995114|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146129524|NCT01354496|526995115|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
146129525|NCT01524692|526995118|FG000|Overall Study|Withdrawal by Subject|3|||
146129526|NCT03190889|526995119|FG000|Overall Study|Lost to Follow-up|7|||
146129527|NCT03190889|526995120|FG001|Overall Study|Lost to Follow-up|7|||
146129528|NCT03190889|526995121|FG002|Overall Study|Lost to Follow-up|3|||
146129529|NCT03190889|526995119|FG000|Overall Study|Withdrawal by Subject|1|||
146129530|NCT03190889|526995120|FG001|Overall Study|Withdrawal by Subject|1|||
146129531|NCT03190889|526995121|FG002|Overall Study|Withdrawal by Subject|2|||
146129532|NCT03190889|526995119|FG000|Overall Study|Did not complete protocol|4|||
146129533|NCT03190889|526995120|FG001|Overall Study|Did not complete protocol|9|||
146129534|NCT03190889|526995121|FG002|Overall Study|Did not complete protocol|0|||
146129535|NCT03190889|526995119|FG000|Overall Study|COVID-19|1|||
146129536|NCT03190889|526995120|FG001|Overall Study|COVID-19|0|||
146129537|NCT03190889|526995121|FG002|Overall Study|COVID-19|2|||
146129538|NCT04007523|526995122|FG000|Overall Study|Withdrawal by Subject|0|||
146129539|NCT04007523|526995123|FG001|Overall Study|Withdrawal by Subject|1|||
146129540|NCT04007523|526995124|FG002|Overall Study|Withdrawal by Subject|1|||
146129541|NCT04007523|526995125|FG003|Overall Study|Withdrawal by Subject|0|||
146129542|NCT04007523|526995122|FG000|Overall Study|ICU Transfer|0|||
146263109|NCT02330562|527478507|FG009|Overall Study|Adverse Event|1|||
146263110|NCT02330562|527478508|FG010|Overall Study|Adverse Event|1|||
146263111|NCT02330562|527478498|FG000|Overall Study|Participant decision|1|||
146263112|NCT02330562|527478499|FG001|Overall Study|Participant decision|0|||
146263113|NCT02330562|527478500|FG002|Overall Study|Participant decision|4|||
146263114|NCT02330562|527478501|FG003|Overall Study|Participant decision|1|||
146263115|NCT02330562|527478502|FG004|Overall Study|Participant decision|5|||
146263116|NCT02330562|527478503|FG005|Overall Study|Participant decision|2|||
146263117|NCT02330562|527478504|FG006|Overall Study|Participant decision|0|||
146263118|NCT02330562|527478505|FG007|Overall Study|Participant decision|0|||
146263119|NCT02330562|527478506|FG008|Overall Study|Participant decision|0|||
146263120|NCT02330562|527478507|FG009|Overall Study|Participant decision|3|||
146263121|NCT02330562|527478508|FG010|Overall Study|Participant decision|0|||
146263122|NCT02330562|527478498|FG000|Overall Study|Disease progression|5|||
146263123|NCT02330562|527478499|FG001|Overall Study|Disease progression|3|||
146263124|NCT02330562|527478500|FG002|Overall Study|Disease progression|20|||
146263125|NCT02330562|527478501|FG003|Overall Study|Disease progression|28|||
146263126|NCT02330562|527478502|FG004|Overall Study|Disease progression|23|||
146263127|NCT02330562|527478503|FG005|Overall Study|Disease progression|7|||
146263128|NCT02330562|527478504|FG006|Overall Study|Disease progression|1|||
146263129|NCT02330562|527478505|FG007|Overall Study|Disease progression|1|||
146263130|NCT02330562|527478506|FG008|Overall Study|Disease progression|1|||
146263131|NCT02330562|527478507|FG009|Overall Study|Disease progression|0|||
146129543|NCT04007523|526995123|FG001|Overall Study|ICU Transfer|1|||
146263132|NCT02330562|527478508|FG010|Overall Study|Disease progression|5|||
146263133|NCT02330562|527478498|FG000|Overall Study|Other reasons|0|||
146263134|NCT02330562|527478499|FG001|Overall Study|Other reasons|0|||
146263135|NCT02330562|527478500|FG002|Overall Study|Other reasons|0|||
146263136|NCT02330562|527478501|FG003|Overall Study|Other reasons|1|||
146263137|NCT02330562|527478502|FG004|Overall Study|Other reasons|0|||
146129544|NCT04007523|526995124|FG002|Overall Study|ICU Transfer|0|||
146129545|NCT04007523|526995125|FG003|Overall Study|ICU Transfer|0|||
146129546|NCT04007523|526995122|FG000|Overall Study|COVID hospital closure|0|||
146129547|NCT04007523|526995123|FG001|Overall Study|COVID hospital closure|0|||
146129548|NCT04007523|526995124|FG002|Overall Study|COVID hospital closure|1|||
146129549|NCT04007523|526995125|FG003|Overall Study|COVID hospital closure|2|||
146129550|NCT04007523|526995122|FG000|Overall Study|Surgery cancelled|0|||
146263138|NCT02330562|527478503|FG005|Overall Study|Other reasons|0|||
146263139|NCT02330562|527478504|FG006|Overall Study|Other reasons|0|||
146263140|NCT02330562|527478505|FG007|Overall Study|Other reasons|0|||
146263141|NCT02330562|527478506|FG008|Overall Study|Other reasons|0|||
146263142|NCT02330562|527478507|FG009|Overall Study|Other reasons|0|||
146129551|NCT04007523|526995123|FG001|Overall Study|Surgery cancelled|0|||
146129552|NCT04007523|526995124|FG002|Overall Study|Surgery cancelled|1|||
146129553|NCT04007523|526995125|FG003|Overall Study|Surgery cancelled|1|||
146129554|NCT02136576|526995126|FG000|Overall Study|Lost to Follow-up|2|||
146129555|NCT02136576|526995127|FG001|Overall Study|Lost to Follow-up|0|||
146129556|NCT02136576|526995128|FG002|Overall Study|Lost to Follow-up|0|||
146129557|NCT02197806|526995129|FG000|Overall Study|Adverse Event|0|||
146129558|NCT02197806|526995130|FG001|Overall Study|Adverse Event|1|||
146129559|NCT02197806|526995131|FG002|Overall Study|Adverse Event|0|||
146129560|NCT02197806|526995132|FG003|Overall Study|Adverse Event|1|||
146129561|NCT00537381|526995134|FG000|Overall Study|Adverse Event|13|||
146129562|NCT00537381|526995135|FG001|Overall Study|Adverse Event|9|||
146129563|NCT00537381|526995134|FG000|Overall Study|Death|3|||
146129564|NCT00537381|526995135|FG001|Overall Study|Death|3|||
146129565|NCT00537381|526995134|FG000|Overall Study|Withdrawal by Subject|5|||
146129566|NCT00537381|526995135|FG001|Overall Study|Withdrawal by Subject|14|||
146129567|NCT00537381|526995134|FG000|Overall Study|Physician Decision|7|||
146129568|NCT00537381|526995135|FG001|Overall Study|Physician Decision|6|||
146129569|NCT00537381|526995134|FG000|Overall Study|Disease Progression|9|||
146129570|NCT00537381|526995135|FG001|Overall Study|Disease Progression|18|||
146129571|NCT00537381|526995134|FG000|Overall Study|Sponsor decision|14|||
146129572|NCT00537381|526995135|FG001|Overall Study|Sponsor decision|9|||
146129573|NCT00537381|526995134|FG000|Overall Study|Other|5|||
146129574|NCT00537381|526995135|FG001|Overall Study|Other|3|||
146129575|NCT00500292|526995142|FG000|Overall Study|Adverse Event|3|||
146129576|NCT00500292|526995143|FG001|Overall Study|Adverse Event|6|||
146129577|NCT00500292|526995144|FG002|Overall Study|Adverse Event|4|||
146129578|NCT00500292|526995142|FG000|Overall Study|Condition under investigation worsened|21|||
146129579|NCT00500292|526995143|FG001|Overall Study|Condition under investigation worsened|23|||
146129580|NCT00500292|526995144|FG002|Overall Study|Condition under investigation worsened|19|||
146129581|NCT00500292|526995142|FG000|Overall Study|Withdrawal by Subject|0|||
146129582|NCT00500292|526995143|FG001|Overall Study|Withdrawal by Subject|1|||
146129583|NCT00500292|526995144|FG002|Overall Study|Withdrawal by Subject|0|||
146129584|NCT00500292|526995142|FG000|Overall Study|Other|1|||
146129585|NCT00500292|526995143|FG001|Overall Study|Other|1|||
146263143|NCT02330562|527478508|FG010|Overall Study|Other reasons|0|||
146263144|NCT02330562|527478498|FG000|Overall Study|Withdrawal by Subject|0|||
146263145|NCT02330562|527478499|FG001|Overall Study|Withdrawal by Subject|0|||
146263146|NCT02330562|527478500|FG002|Overall Study|Withdrawal by Subject|0|||
146263147|NCT02330562|527478501|FG003|Overall Study|Withdrawal by Subject|0|||
146263148|NCT02330562|527478502|FG004|Overall Study|Withdrawal by Subject|0|||
146263149|NCT02330562|527478503|FG005|Overall Study|Withdrawal by Subject|0|||
146263150|NCT02330562|527478504|FG006|Overall Study|Withdrawal by Subject|0|||
146263151|NCT02330562|527478505|FG007|Overall Study|Withdrawal by Subject|0|||
146263152|NCT02330562|527478506|FG008|Overall Study|Withdrawal by Subject|0|||
146263153|NCT02330562|527478507|FG009|Overall Study|Withdrawal by Subject|1|||
146263154|NCT02330562|527478508|FG010|Overall Study|Withdrawal by Subject|0|||
146263155|NCT01547117|527478509|FG000|Overall Study|Physician Decision|0|||
146263156|NCT01547117|527478510|FG001|Overall Study|Physician Decision|1|||
146263157|NCT01547117|527478511|FG002|Overall Study|Physician Decision|1|||
146263158|NCT01547117|527478512|FG003|Overall Study|Physician Decision|3|||
146263159|NCT01547117|527478509|FG000|Overall Study|Withdrawal by Subject|1|||
146263160|NCT01547117|527478510|FG001|Overall Study|Withdrawal by Subject|2|||
146263161|NCT01547117|527478511|FG002|Overall Study|Withdrawal by Subject|1|||
146263162|NCT01547117|527478512|FG003|Overall Study|Withdrawal by Subject|2|||
146263163|NCT00412880|527478517|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
146263164|NCT00412880|527478517|FG000|Overall Study|Consent withdrawn|1|||
146263165|NCT00412880|527478517|FG000|Overall Study|Adverse Event|1|||
146263166|NCT00412880|527478517|FG000|Overall Study|Progressive disease|20|||
146263167|NCT02706951|527478519|FG000|Period 1|Adverse Event|1|||
146263168|NCT02706951|527478520|FG001|Period 1|Adverse Event|5|||
146263169|NCT02706951|527478521|FG002|Period 1|Adverse Event|3|||
146263170|NCT02706951|527478522|FG003|Period 1|Adverse Event|0|||
146263171|NCT02706951|527478523|FG004|Period 1|Adverse Event|0|||
146263172|NCT02706951|527478519|FG000|Period 1|Withdrawal by Subject|10|||
146263173|NCT02706951|527478520|FG001|Period 1|Withdrawal by Subject|6|||
146263174|NCT02706951|527478521|FG002|Period 1|Withdrawal by Subject|6|||
146263175|NCT02706951|527478522|FG003|Period 1|Withdrawal by Subject|0|||
146263176|NCT02706951|527478523|FG004|Period 1|Withdrawal by Subject|0|||
146263177|NCT02706951|527478519|FG000|Period 1|Lost to Follow-up|0|||
146129586|NCT00500292|526995144|FG002|Overall Study|Other|4|||
146129587|NCT03065244|526995145|FG000|Overall Study|Lost to Follow-up|1|||
146129588|NCT03065244|526995146|FG001|Overall Study|Lost to Follow-up|1|||
146129589|NCT03065244|526995145|FG000|Overall Study|Diagnosed with a different disease|1|||
146263178|NCT02706951|527478520|FG001|Period 1|Lost to Follow-up|4|||
146263179|NCT02706951|527478521|FG002|Period 1|Lost to Follow-up|1|||
146263180|NCT02706951|527478522|FG003|Period 1|Lost to Follow-up|0|||
146129590|NCT03065244|526995146|FG001|Overall Study|Diagnosed with a different disease|1|||
146129591|NCT03065244|526995145|FG000|Overall Study|Protocol Violation|0|||
146263181|NCT02706951|527478523|FG004|Period 1|Lost to Follow-up|0|||
146129592|NCT03065244|526995146|FG001|Overall Study|Protocol Violation|1|||
146303521|NCT01514136|527625843|FG002|Test Period 1; Test A|Protocol Violation|0|||
146303522|NCT01514136|527625844|FG003|Test Period 1; Test A|Protocol Violation|0|||
146303523|NCT01514136|527625845|FG004|Test Period 1; Test A|Protocol Violation|0|||
146303524|NCT01514136|527625846|FG005|Test Period 1; Test A|Protocol Violation|0|||
146303525|NCT01514136|527625847|FG006|Test Period 1; Test A|Protocol Violation|0|||
146303526|NCT01514136|527625848|FG007|Test Period 1; Test A|Protocol Violation|0|||
146303527|NCT01514136|527625841|FG000|Test Period 1; Test A|Break from study holiday|2|||
146303528|NCT01514136|527625842|FG001|Test Period 1; Test A|Break from study holiday|0|||
146303529|NCT01514136|527625843|FG002|Test Period 1; Test A|Break from study holiday|0|||
146303530|NCT01514136|527625844|FG003|Test Period 1; Test A|Break from study holiday|0|||
146303531|NCT01514136|527625845|FG004|Test Period 1; Test A|Break from study holiday|0|||
146303532|NCT01514136|527625846|FG005|Test Period 1; Test A|Break from study holiday|0|||
146303533|NCT01514136|527625847|FG006|Test Period 1; Test A|Break from study holiday|0|||
146303534|NCT01514136|527625848|FG007|Test Period 1; Test A|Break from study holiday|0|||
146303535|NCT01514136|527625841|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
146303536|NCT01514136|527625842|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
146303537|NCT01514136|527625843|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
146303538|NCT01514136|527625844|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
146303539|NCT01514136|527625845|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
146303540|NCT01514136|527625846|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
146303541|NCT01514136|527625847|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
146303542|NCT01514136|527625848|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
146303543|NCT01514136|527625841|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
146303544|NCT01514136|527625842|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
146303545|NCT01514136|527625843|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
146129593|NCT03065244|526995145|FG000|Overall Study|Withdrawal by Subject|1|||
146129594|NCT03065244|526995146|FG001|Overall Study|Withdrawal by Subject|1|||
146129595|NCT03717480|526995147|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
146129596|NCT01708174|526995148|FG000|Treatment Period|Withdrawal by Subject|1|||
146129597|NCT01708174|526995149|FG001|Treatment Period|Withdrawal by Subject|0|||
146129598|NCT01708174|526995150|FG002|Treatment Period|Withdrawal by Subject|0|||
146129599|NCT01708174|526995148|FG000|Treatment Period|Progressive disease|0|||
146129600|NCT01708174|526995149|FG001|Treatment Period|Progressive disease|1|||
146129601|NCT01708174|526995150|FG002|Treatment Period|Progressive disease|0|||
146129602|NCT01708174|526995148|FG000|Treatment Period|Death|0|||
146129603|NCT01708174|526995149|FG001|Treatment Period|Death|0|||
146129604|NCT01708174|526995150|FG002|Treatment Period|Death|1|||
146129605|NCT01708174|526995148|FG000|Treatment Period|Adverse Event|0|||
146129606|NCT01708174|526995149|FG001|Treatment Period|Adverse Event|1|||
146129607|NCT01708174|526995150|FG002|Treatment Period|Adverse Event|0|||
146129608|NCT01894152|526995151|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
146129609|NCT00923559|526995152|FG000|Overall Study|Lost to Follow-up|2|||
146129610|NCT00923559|526995153|FG001|Overall Study|Lost to Follow-up|3|||
146129611|NCT00744627|526995158|FG000|Overall Study|Adverse Event|6|||
146129612|NCT00744627|526995159|FG001|Overall Study|Adverse Event|9|||
146129613|NCT00744627|526995158|FG000|Overall Study|Lack of Efficacy|7|||
146129614|NCT00744627|526995159|FG001|Overall Study|Lack of Efficacy|3|||
146129615|NCT00744627|526995158|FG000|Overall Study|Noncompliance|0|||
146129616|NCT00744627|526995159|FG001|Overall Study|Noncompliance|1|||
146129617|NCT00744627|526995158|FG000|Overall Study|Protocol Deviations|0|||
146129618|NCT00744627|526995159|FG001|Overall Study|Protocol Deviations|2|||
146129619|NCT00744627|526995158|FG000|Overall Study|Voluntary Withdrawal|9|||
146129620|NCT00744627|526995159|FG001|Overall Study|Voluntary Withdrawal|6|||
146129621|NCT00744627|526995158|FG000|Overall Study|Lost to Follow-up|2|||
146129622|NCT00744627|526995159|FG001|Overall Study|Lost to Follow-up|1|||
146129623|NCT00744627|526995158|FG000|Overall Study|Other|1|||
146129624|NCT00744627|526995159|FG001|Overall Study|Other|0|||
146129625|NCT01062555|526995161|FG000|Phase 1|Death|10|||
146129626|NCT01062555|526995162|FG001|Phase 1|Death|17|||
146129627|NCT01062555|526995163|FG002|Phase 1|Death|0|||
146129628|NCT01062555|526995164|FG003|Phase 1|Death|0|||
146129629|NCT01062555|526995161|FG000|Phase 1|Graft Failure|12|||
146129630|NCT01062555|526995162|FG001|Phase 1|Graft Failure|8|||
146129631|NCT01062555|526995163|FG002|Phase 1|Graft Failure|0|||
146303546|NCT01514136|527625844|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
146303547|NCT01514136|527625845|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
146129632|NCT01062555|526995164|FG003|Phase 1|Graft Failure|0|||
146129633|NCT01062555|526995161|FG000|Phase 1|Withdrawal by Subject|1|||
146129634|NCT01062555|526995162|FG001|Phase 1|Withdrawal by Subject|1|||
146303548|NCT01514136|527625846|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
146129635|NCT01062555|526995163|FG002|Phase 1|Withdrawal by Subject|0|||
146129636|NCT01062555|526995164|FG003|Phase 1|Withdrawal by Subject|0|||
146129637|NCT01062555|526995161|FG000|Phase 2|Death|0|||
146129638|NCT01062555|526995162|FG001|Phase 2|Death|0|||
146129639|NCT01062555|526995163|FG002|Phase 2|Death|8|||
146129640|NCT01062555|526995164|FG003|Phase 2|Death|3|||
146129641|NCT01062555|526995161|FG000|Phase 2|Graft failure|0|||
146129642|NCT01062555|526995162|FG001|Phase 2|Graft failure|0|||
146129643|NCT01062555|526995163|FG002|Phase 2|Graft failure|7|||
146129644|NCT01062555|526995164|FG003|Phase 2|Graft failure|4|||
146129645|NCT01062555|526995161|FG000|Phase 2|Withdrawal by Subject|0|||
146129646|NCT01062555|526995162|FG001|Phase 2|Withdrawal by Subject|0|||
146129647|NCT01062555|526995163|FG002|Phase 2|Withdrawal by Subject|0|||
146129648|NCT01062555|526995164|FG003|Phase 2|Withdrawal by Subject|7|||
146129649|NCT01062555|526995161|FG000|Phase 2|Protocol Violation|0|||
146129650|NCT01062555|526995162|FG001|Phase 2|Protocol Violation|0|||
146129651|NCT01062555|526995163|FG002|Phase 2|Protocol Violation|0|||
146129652|NCT01062555|526995164|FG003|Phase 2|Protocol Violation|3|||
146129653|NCT01062555|526995161|FG000|Phase 2|Physician Decision|0|||
146129654|NCT01062555|526995162|FG001|Phase 2|Physician Decision|0|||
146129655|NCT01062555|526995163|FG002|Phase 2|Physician Decision|0|||
146129656|NCT01062555|526995164|FG003|Phase 2|Physician Decision|17|||
146129657|NCT03560531|526995165|FG000|Overall Study|Death|4|||
146129658|NCT03560531|526995166|FG001|Overall Study|Death|1|||
146129659|NCT03560531|526995167|FG002|Overall Study|Death|1|||
146129660|NCT03560531|526995168|FG003|Overall Study|Death|2|||
146129661|NCT03560531|526995169|FG004|Overall Study|Death|6|||
146129662|NCT03560531|526995170|FG005|Overall Study|Death|1|||
146129663|NCT03560531|526995171|FG006|Overall Study|Death|4|||
146129664|NCT03560531|526995172|FG007|Overall Study|Death|8|||
146129665|NCT03560531|526995173|FG008|Overall Study|Death|1|||
146129666|NCT03560531|526995174|FG009|Overall Study|Death|3|||
146129667|NCT03560531|526995175|FG010|Overall Study|Death|2|||
146129668|NCT03560531|526995176|FG011|Overall Study|Death|0|||
146129669|NCT03560531|526995177|FG012|Overall Study|Death|4|||
146129670|NCT03560531|526995178|FG013|Overall Study|Death|1|||
146129671|NCT03560531|526995165|FG000|Overall Study|Lost to Follow-up|1|||
146129672|NCT03560531|526995166|FG001|Overall Study|Lost to Follow-up|1|||
146129673|NCT03560531|526995167|FG002|Overall Study|Lost to Follow-up|0|||
146129674|NCT03560531|526995168|FG003|Overall Study|Lost to Follow-up|0|||
146129675|NCT03560531|526995169|FG004|Overall Study|Lost to Follow-up|0|||
146129676|NCT03560531|526995170|FG005|Overall Study|Lost to Follow-up|0|||
146129677|NCT03560531|526995171|FG006|Overall Study|Lost to Follow-up|1|||
146129678|NCT03560531|526995172|FG007|Overall Study|Lost to Follow-up|0|||
146129679|NCT03560531|526995173|FG008|Overall Study|Lost to Follow-up|0|||
146129680|NCT03560531|526995174|FG009|Overall Study|Lost to Follow-up|0|||
146129681|NCT03560531|526995175|FG010|Overall Study|Lost to Follow-up|0|||
146129682|NCT03560531|526995176|FG011|Overall Study|Lost to Follow-up|0|||
146129683|NCT03560531|526995177|FG012|Overall Study|Lost to Follow-up|0|||
146129684|NCT03560531|526995178|FG013|Overall Study|Lost to Follow-up|0|||
146129685|NCT03560531|526995165|FG000|Overall Study|Withdrawal by Subject|1|||
146129686|NCT03560531|526995166|FG001|Overall Study|Withdrawal by Subject|0|||
146129687|NCT03560531|526995167|FG002|Overall Study|Withdrawal by Subject|0|||
146129688|NCT03560531|526995168|FG003|Overall Study|Withdrawal by Subject|0|||
146129689|NCT03560531|526995169|FG004|Overall Study|Withdrawal by Subject|0|||
146129690|NCT03560531|526995170|FG005|Overall Study|Withdrawal by Subject|0|||
146129691|NCT03560531|526995171|FG006|Overall Study|Withdrawal by Subject|0|||
146129692|NCT03560531|526995172|FG007|Overall Study|Withdrawal by Subject|3|||
146129693|NCT03560531|526995173|FG008|Overall Study|Withdrawal by Subject|2|||
146129694|NCT03560531|526995174|FG009|Overall Study|Withdrawal by Subject|0|||
146129695|NCT03560531|526995175|FG010|Overall Study|Withdrawal by Subject|0|||
146129696|NCT03560531|526995176|FG011|Overall Study|Withdrawal by Subject|0|||
146129697|NCT03560531|526995177|FG012|Overall Study|Withdrawal by Subject|2|||
146129698|NCT03560531|526995178|FG013|Overall Study|Withdrawal by Subject|0|||
146129699|NCT03560531|526995165|FG000|Overall Study|Study end per-protocol|1|||
146129700|NCT03560531|526995166|FG001|Overall Study|Study end per-protocol|1|||
146129701|NCT03560531|526995167|FG002|Overall Study|Study end per-protocol|2|||
146129702|NCT03560531|526995168|FG003|Overall Study|Study end per-protocol|0|||
146129703|NCT03560531|526995169|FG004|Overall Study|Study end per-protocol|1|||
146129704|NCT03560531|526995170|FG005|Overall Study|Study end per-protocol|0|||
146129705|NCT03560531|526995171|FG006|Overall Study|Study end per-protocol|0|||
146263182|NCT02706951|527478519|FG000|Period 1|Other|2|||
146129706|NCT03560531|526995172|FG007|Overall Study|Study end per-protocol|0|||
146129707|NCT03560531|526995173|FG008|Overall Study|Study end per-protocol|0|||
146129708|NCT03560531|526995174|FG009|Overall Study|Study end per-protocol|0|||
146129709|NCT03560531|526995175|FG010|Overall Study|Study end per-protocol|0|||
146129710|NCT03560531|526995176|FG011|Overall Study|Study end per-protocol|0|||
146129711|NCT03560531|526995177|FG012|Overall Study|Study end per-protocol|0|||
146129712|NCT03560531|526995178|FG013|Overall Study|Study end per-protocol|0|||
146129713|NCT03560531|526995165|FG000|Overall Study|Early study termination by sponsor|9|||
146129714|NCT03560531|526995166|FG001|Overall Study|Early study termination by sponsor|0|||
146129715|NCT03560531|526995167|FG002|Overall Study|Early study termination by sponsor|0|||
146129716|NCT03560531|526995168|FG003|Overall Study|Early study termination by sponsor|4|||
146129717|NCT03560531|526995169|FG004|Overall Study|Early study termination by sponsor|8|||
146129718|NCT03560531|526995170|FG005|Overall Study|Early study termination by sponsor|2|||
146129719|NCT03560531|526995171|FG006|Overall Study|Early study termination by sponsor|5|||
146263183|NCT02706951|527478520|FG001|Period 1|Other|1|||
146129720|NCT03560531|526995172|FG007|Overall Study|Early study termination by sponsor|64|||
146129721|NCT03560531|526995173|FG008|Overall Study|Early study termination by sponsor|7|||
146129722|NCT03560531|526995174|FG009|Overall Study|Early study termination by sponsor|2|||
146129723|NCT03560531|526995175|FG010|Overall Study|Early study termination by sponsor|16|||
146129724|NCT03560531|526995176|FG011|Overall Study|Early study termination by sponsor|2|||
146129725|NCT03560531|526995177|FG012|Overall Study|Early study termination by sponsor|6|||
146129726|NCT03560531|526995178|FG013|Overall Study|Early study termination by sponsor|2|||
146129727|NCT02028988|526995179|FG000|Overall Study|Withdrawal by Subject|2|||
146129728|NCT01063595|526995180|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
146129729|NCT01063595|526995181|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
146129730|NCT01063595|526995180|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
146129731|NCT01063595|526995181|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
146129732|NCT01063595|526995180|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
146129733|NCT01063595|526995181|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
146129734|NCT01063595|526995180|FG000|First Intervention|Adverse Event|1|||
146129735|NCT01063595|526995181|FG001|First Intervention|Adverse Event|4|||
146129736|NCT01063595|526995180|FG000|First Intervention|Withdrawal by Subject|1|||
146129737|NCT01063595|526995181|FG001|First Intervention|Withdrawal by Subject|0|||
146129738|NCT01063595|526995180|FG000|First Intervention|Reason not Specified|0|||
146129739|NCT01063595|526995181|FG001|First Intervention|Reason not Specified|1|||
146129740|NCT00747435|526995182|FG000|Overall Study|Lost to Follow-up|2|||
146129741|NCT00747435|526995182|FG000|Overall Study|Withdrawal by Subject|3|||
146129742|NCT00747435|526995182|FG000|Overall Study|Still undergoing follow up|1|||
146129743|NCT02181556|526996426|FG000|Overall Study|Withdrawal by Subject|1|||
146129744|NCT01023581|526996431|FG000|Overall Study|Adverse Event|4|||
146129745|NCT01023581|526996432|FG001|Overall Study|Adverse Event|4|||
146129746|NCT01023581|526996433|FG002|Overall Study|Adverse Event|7|||
146129747|NCT01023581|526996434|FG003|Overall Study|Adverse Event|3|||
146129748|NCT01023581|526996435|FG004|Overall Study|Adverse Event|2|||
146129749|NCT01023581|526996436|FG005|Overall Study|Adverse Event|5|||
146129750|NCT01023581|526996437|FG006|Overall Study|Adverse Event|11|||
146129751|NCT01023581|526996431|FG000|Overall Study|Major protocol deviation|2|||
146129752|NCT01023581|526996432|FG001|Overall Study|Major protocol deviation|0|||
146129753|NCT01023581|526996433|FG002|Overall Study|Major protocol deviation|3|||
146129754|NCT01023581|526996434|FG003|Overall Study|Major protocol deviation|0|||
146129755|NCT01023581|526996435|FG004|Overall Study|Major protocol deviation|0|||
146129756|NCT01023581|526996436|FG005|Overall Study|Major protocol deviation|0|||
146129757|NCT01023581|526996437|FG006|Overall Study|Major protocol deviation|0|||
146129758|NCT01023581|526996431|FG000|Overall Study|Lost to Follow-up|4|||
146129759|NCT01023581|526996432|FG001|Overall Study|Lost to Follow-up|8|||
146129760|NCT01023581|526996433|FG002|Overall Study|Lost to Follow-up|7|||
146129761|NCT01023581|526996434|FG003|Overall Study|Lost to Follow-up|2|||
146129762|NCT01023581|526996435|FG004|Overall Study|Lost to Follow-up|5|||
146129763|NCT01023581|526996436|FG005|Overall Study|Lost to Follow-up|2|||
146129764|NCT01023581|526996437|FG006|Overall Study|Lost to Follow-up|2|||
146129765|NCT01023581|526996431|FG000|Overall Study|Withdrawal by Subject|13|||
146129766|NCT01023581|526996432|FG001|Overall Study|Withdrawal by Subject|8|||
146129767|NCT01023581|526996433|FG002|Overall Study|Withdrawal by Subject|16|||
146129768|NCT01023581|526996434|FG003|Overall Study|Withdrawal by Subject|10|||
146129769|NCT01023581|526996435|FG004|Overall Study|Withdrawal by Subject|6|||
146129770|NCT01023581|526996436|FG005|Overall Study|Withdrawal by Subject|8|||
146129771|NCT01023581|526996437|FG006|Overall Study|Withdrawal by Subject|5|||
146129772|NCT01023581|526996431|FG000|Overall Study|Pregnancy|0|||
146129773|NCT01023581|526996432|FG001|Overall Study|Pregnancy|0|||
146129774|NCT01023581|526996433|FG002|Overall Study|Pregnancy|0|||
146129775|NCT01023581|526996434|FG003|Overall Study|Pregnancy|2|||
146129776|NCT01023581|526996435|FG004|Overall Study|Pregnancy|0|||
146129777|NCT01023581|526996436|FG005|Overall Study|Pregnancy|1|||
146129778|NCT01023581|526996437|FG006|Overall Study|Pregnancy|0|||
146129779|NCT01023581|526996431|FG000|Overall Study|Lack of Efficacy|9|||
146129780|NCT01023581|526996432|FG001|Overall Study|Lack of Efficacy|3|||
146129781|NCT01023581|526996433|FG002|Overall Study|Lack of Efficacy|6|||
146129782|NCT01023581|526996434|FG003|Overall Study|Lack of Efficacy|2|||
146129783|NCT01023581|526996435|FG004|Overall Study|Lack of Efficacy|1|||
146129784|NCT01023581|526996436|FG005|Overall Study|Lack of Efficacy|2|||
146129785|NCT01023581|526996437|FG006|Overall Study|Lack of Efficacy|1|||
146129786|NCT01023581|526996431|FG000|Overall Study|Physician Decision|2|||
146129787|NCT01023581|526996432|FG001|Overall Study|Physician Decision|0|||
146129788|NCT01023581|526996433|FG002|Overall Study|Physician Decision|2|||
146129789|NCT01023581|526996434|FG003|Overall Study|Physician Decision|1|||
146129790|NCT01023581|526996435|FG004|Overall Study|Physician Decision|1|||
146129791|NCT01023581|526996436|FG005|Overall Study|Physician Decision|1|||
146129792|NCT01023581|526996437|FG006|Overall Study|Physician Decision|1|||
146129793|NCT01023581|526996431|FG000|Overall Study|Other|1|||
146129794|NCT01023581|526996432|FG001|Overall Study|Other|0|||
146129795|NCT01023581|526996433|FG002|Overall Study|Other|1|||
146129796|NCT01023581|526996434|FG003|Overall Study|Other|0|||
146129797|NCT01023581|526996435|FG004|Overall Study|Other|1|||
146129798|NCT01023581|526996436|FG005|Overall Study|Other|0|||
146129799|NCT01023581|526996437|FG006|Overall Study|Other|0|||
146129800|NCT01176292|526996438|FG000|Overall Study|Lost to Follow-up|2|||
146263184|NCT02706951|527478521|FG002|Period 1|Other|0|||
146263185|NCT02706951|527478522|FG003|Period 1|Other|0|||
146263186|NCT02706951|527478523|FG004|Period 1|Other|0|||
146263187|NCT02706951|527478519|FG000|Period 2|Adverse Event|0|||
146263188|NCT02706951|527478520|FG001|Period 2|Adverse Event|0|||
146263189|NCT02706951|527478521|FG002|Period 2|Adverse Event|0|||
146263190|NCT02706951|527478522|FG003|Period 2|Adverse Event|25|||
146263191|NCT02706951|527478523|FG004|Period 2|Adverse Event|34|||
146263192|NCT02706951|527478519|FG000|Period 2|Withdrawal by Subject|0|||
146263193|NCT02706951|527478520|FG001|Period 2|Withdrawal by Subject|0|||
146263194|NCT02706951|527478521|FG002|Period 2|Withdrawal by Subject|0|||
146263195|NCT02706951|527478522|FG003|Period 2|Withdrawal by Subject|38|||
146263196|NCT02706951|527478523|FG004|Period 2|Withdrawal by Subject|44|||
146263197|NCT02706951|527478519|FG000|Period 2|Lost to Follow-up|0|||
146263198|NCT02706951|527478520|FG001|Period 2|Lost to Follow-up|0|||
146263199|NCT02706951|527478521|FG002|Period 2|Lost to Follow-up|0|||
146263200|NCT02706951|527478522|FG003|Period 2|Lost to Follow-up|17|||
146263201|NCT02706951|527478523|FG004|Period 2|Lost to Follow-up|9|||
146263202|NCT02706951|527478519|FG000|Period 2|COVID-19 Related|0|||
146263203|NCT02706951|527478520|FG001|Period 2|COVID-19 Related|0|||
146263204|NCT02706951|527478521|FG002|Period 2|COVID-19 Related|0|||
146263205|NCT02706951|527478522|FG003|Period 2|COVID-19 Related|1|||
146263206|NCT02706951|527478523|FG004|Period 2|COVID-19 Related|2|||
146263207|NCT02706951|527478519|FG000|Period 2|Other|0|||
146263208|NCT02706951|527478520|FG001|Period 2|Other|0|||
146263209|NCT02706951|527478521|FG002|Period 2|Other|0|||
146263210|NCT02706951|527478522|FG003|Period 2|Other|37|||
146263211|NCT02706951|527478523|FG004|Period 2|Other|31|||
146263212|NCT00813098|527478526|FG000|Overall Study|Adverse Event|2|||
146263213|NCT00813098|527478527|FG001|Overall Study|Adverse Event|4|||
146263214|NCT00813098|527478528|FG002|Overall Study|Adverse Event|1|||
146263215|NCT00813098|527478526|FG000|Overall Study|Withdrawal by Subject|0|||
146129801|NCT01176292|526996439|FG001|Overall Study|Lost to Follow-up|4|||
146129802|NCT01176292|526996438|FG000|Overall Study|Adverse Event|1|||
146129803|NCT01176292|526996439|FG001|Overall Study|Adverse Event|1|||
146129804|NCT01176292|526996438|FG000|Overall Study|Physician Decision|0|||
146129805|NCT01176292|526996439|FG001|Overall Study|Physician Decision|2|||
146129806|NCT01176292|526996438|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
146129807|NCT01176292|526996439|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
146129808|NCT00997503|526996440|FG000|Overall Study|Death|53|||
146129809|NCT00997503|526996440|FG000|Overall Study|Withdrawal by Subject|76|||
146129810|NCT00997503|526996440|FG000|Overall Study|Lost to Follow-up|33|||
146129811|NCT00997503|526996440|FG000|Overall Study|Adverse Event|3|||
146129812|NCT00997503|526996440|FG000|Overall Study|Physician Decision|10|||
146129813|NCT00997503|526996440|FG000|Overall Study|Missed 12-month follow-up|85|||
146129814|NCT00997503|526996440|FG000|Overall Study|Other reason|13|||
146129815|NCT00380393|526996441|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
146129816|NCT00380393|526996442|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
146129817|NCT00380393|526996441|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
146129818|NCT00380393|526996442|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
146129819|NCT00380393|526996441|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
146129820|NCT00380393|526996442|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
146129821|NCT00380393|526996441|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
146129822|NCT00380393|526996442|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
146129823|NCT00380393|526996441|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
146129824|NCT00380393|526996442|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
146129825|NCT00380393|526996441|FG000|Month 14|Withdrawal by Subject|9|||
146263216|NCT00813098|527478527|FG001|Overall Study|Withdrawal by Subject|1|||
146263217|NCT00813098|527478528|FG002|Overall Study|Withdrawal by Subject|0|||
146263218|NCT00813098|527478526|FG000|Overall Study|Inability to complete study procedures|1|||
146263219|NCT00813098|527478527|FG001|Overall Study|Inability to complete study procedures|0|||
146129826|NCT00380393|526996442|FG001|Month 14|Withdrawal by Subject|7|||
146129827|NCT00380393|526996441|FG000|Month 14|Death|1|||
146129828|NCT00380393|526996442|FG001|Month 14|Death|0|||
146129829|NCT00380393|526996441|FG000|Month 14|Lost to Follow-up|0|||
146129830|NCT00380393|526996442|FG001|Month 14|Lost to Follow-up|1|||
146129831|NCT00380393|526996441|FG000|Month 14|Migrated/moved from study area|39|||
146129832|NCT00380393|526996442|FG001|Month 14|Migrated/moved from study area|42|||
146129833|NCT00380393|526996441|FG000|Month 14|Protocol Violation|2|||
146263220|NCT00813098|527478528|FG002|Overall Study|Inability to complete study procedures|0|||
146263221|NCT00813098|527478526|FG000|Overall Study|Lost to Follow-up|0|||
146263222|NCT00813098|527478527|FG001|Overall Study|Lost to Follow-up|1|||
146303549|NCT01514136|527625847|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
146263223|NCT00813098|527478528|FG002|Overall Study|Lost to Follow-up|0|||
146263224|NCT00813098|527478526|FG000|Overall Study|Protocol Violation|0|||
146263225|NCT00813098|527478527|FG001|Overall Study|Protocol Violation|0|||
146129834|NCT00380393|526996442|FG001|Month 14|Protocol Violation|0|||
146129835|NCT00380393|526996441|FG000|Month 14|Others|6|||
146129836|NCT00380393|526996442|FG001|Month 14|Others|6|||
146129837|NCT00481195|526996443|FG000|Overall Study|Adverse Event|16|||
146129838|NCT00481195|526996444|FG001|Overall Study|Adverse Event|11|||
146129839|NCT00481195|526996443|FG000|Overall Study|Lack of Efficacy|1|||
146129840|NCT00481195|526996444|FG001|Overall Study|Lack of Efficacy|3|||
146129841|NCT00481195|526996443|FG000|Overall Study|Lost to Follow-up|4|||
146129842|NCT00481195|526996444|FG001|Overall Study|Lost to Follow-up|6|||
146129843|NCT00481195|526996443|FG000|Overall Study|Physician Decision|3|||
146129844|NCT00481195|526996444|FG001|Overall Study|Physician Decision|1|||
146129845|NCT00481195|526996443|FG000|Overall Study|Protocol Violation|10|||
146129846|NCT00481195|526996444|FG001|Overall Study|Protocol Violation|7|||
146129847|NCT00481195|526996443|FG000|Overall Study|Withdrawal by Subject|3|||
146129848|NCT00481195|526996444|FG001|Overall Study|Withdrawal by Subject|9|||
146129849|NCT00481195|526996443|FG000|Overall Study|Miscellaneous|2|||
146129850|NCT00481195|526996444|FG001|Overall Study|Miscellaneous|2|||
146129851|NCT02932904|526996445|FG000|Overall Study|Reason not Specified|1|||
146129852|NCT02932904|526996446|FG001|Overall Study|Reason not Specified|0|||
146129853|NCT02932904|526996447|FG002|Overall Study|Reason not Specified|2|||
146129854|NCT02932904|526996448|FG003|Overall Study|Reason not Specified|2|||
146129855|NCT02932904|526996445|FG000|Overall Study|Noncompliance with Study Drug|2|||
146129856|NCT02932904|526996446|FG001|Overall Study|Noncompliance with Study Drug|3|||
146129857|NCT02932904|526996447|FG002|Overall Study|Noncompliance with Study Drug|3|||
146129858|NCT02932904|526996448|FG003|Overall Study|Noncompliance with Study Drug|4|||
146129859|NCT02932904|526996445|FG000|Overall Study|Pregnancy|0|||
146129860|NCT02932904|526996446|FG001|Overall Study|Pregnancy|1|||
146129861|NCT02932904|526996447|FG002|Overall Study|Pregnancy|1|||
146129862|NCT02932904|526996448|FG003|Overall Study|Pregnancy|0|||
146129863|NCT02932904|526996445|FG000|Overall Study|Study Termination|0|||
146129864|NCT02932904|526996446|FG001|Overall Study|Study Termination|1|||
146129865|NCT02932904|526996447|FG002|Overall Study|Study Termination|0|||
146129866|NCT02932904|526996448|FG003|Overall Study|Study Termination|0|||
146129867|NCT02932904|526996445|FG000|Overall Study|Voluntary Withdrawal|2|||
146129868|NCT02932904|526996446|FG001|Overall Study|Voluntary Withdrawal|1|||
146129869|NCT02932904|526996447|FG002|Overall Study|Voluntary Withdrawal|4|||
146129870|NCT02932904|526996448|FG003|Overall Study|Voluntary Withdrawal|2|||
146263226|NCT00813098|527478528|FG002|Overall Study|Protocol Violation|1|||
146263227|NCT00813098|527478526|FG000|Overall Study|Principal Investigator decision|0|||
146263228|NCT00813098|527478527|FG001|Overall Study|Principal Investigator decision|1|||
146263229|NCT00813098|527478528|FG002|Overall Study|Principal Investigator decision|0|||
146263230|NCT00813098|527478526|FG000|Overall Study|Withdrew Consent|0|||
146263231|NCT00813098|527478527|FG001|Overall Study|Withdrew Consent|1|||
146263232|NCT00813098|527478528|FG002|Overall Study|Withdrew Consent|0|||
146263233|NCT04962698|527478529|FG000|Motor Imagery|Technical difficulty|1|||
146263234|NCT04962698|527478530|FG001|Motor Imagery|Technical difficulty|0|||
146263235|NCT04962698|527478529|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
146263236|NCT04962698|527478530|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
146263237|NCT04962698|527478529|FG000|Kinesthetic MI|Technical difficulty|1|||
146263238|NCT04962698|527478530|FG001|Kinesthetic MI|Technical difficulty|0|||
146263239|NCT04962698|527478529|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
146263240|NCT04962698|527478530|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
146263241|NCT04962698|527478529|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
146263242|NCT04962698|527478530|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
146263243|NCT04962698|527478529|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
146263244|NCT04962698|527478530|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
146263245|NCT04962698|527478529|FG000|Virtual-hand Interaction|Technical difficulty|1|||
146263246|NCT04962698|527478530|FG001|Virtual-hand Interaction|Technical difficulty|0|||
146129871|NCT02932904|526996445|FG000|Overall Study|Lost to Follow-up|5|||
146129872|NCT02932904|526996446|FG001|Overall Study|Lost to Follow-up|3|||
146129873|NCT02932904|526996447|FG002|Overall Study|Lost to Follow-up|6|||
146129874|NCT02932904|526996448|FG003|Overall Study|Lost to Follow-up|0|||
146129875|NCT02932904|526996445|FG000|Overall Study|Significant Protocol Deviation|2|||
146129876|NCT02932904|526996446|FG001|Overall Study|Significant Protocol Deviation|3|||
146129877|NCT02932904|526996447|FG002|Overall Study|Significant Protocol Deviation|6|||
146129878|NCT02932904|526996448|FG003|Overall Study|Significant Protocol Deviation|1|||
146129879|NCT02932904|526996445|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146129880|NCT02932904|526996446|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
146129881|NCT02932904|526996447|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146303550|NCT01514136|527625848|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
146129882|NCT02932904|526996448|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
146129883|NCT02932904|526996445|FG000|Overall Study|Randomized But Not Treated|1|||
146129884|NCT02932904|526996446|FG001|Overall Study|Randomized But Not Treated|1|||
146129885|NCT02932904|526996447|FG002|Overall Study|Randomized But Not Treated|0|||
146129886|NCT02932904|526996448|FG003|Overall Study|Randomized But Not Treated|2|||
146129887|NCT02016482|526996449|FG000|Period A|Adverse Event|3|||
146129888|NCT02016482|526996450|FG001|Period A|Adverse Event|5|||
146129889|NCT02016482|526996449|FG000|Period A|Withdrawal by Subject|3|||
146129890|NCT02016482|526996450|FG001|Period A|Withdrawal by Subject|4|||
146129891|NCT02016482|526996449|FG000|Period A|Lost to Follow-up|3|||
146129892|NCT02016482|526996450|FG001|Period A|Lost to Follow-up|3|||
146129893|NCT02016482|526996449|FG000|Period A|Lack of Efficacy|2|||
146129894|NCT02016482|526996450|FG001|Period A|Lack of Efficacy|1|||
146129895|NCT02016482|526996449|FG000|Period A|Other|3|||
146129896|NCT02016482|526996450|FG001|Period A|Other|0|||
146129897|NCT02016482|526996449|FG000|Period A|Protocol Violation|0|||
146129898|NCT02016482|526996450|FG001|Period A|Protocol Violation|1|||
146129899|NCT02016482|526996449|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
146129900|NCT02016482|526996450|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
146129901|NCT02016482|526996449|FG000|Period B|Withdrawal by Subject|1|||
146129902|NCT02016482|526996450|FG001|Period B|Withdrawal by Subject|1|||
146129903|NCT02016482|526996449|FG000|Period B|Lost to Follow-up|2|||
146129904|NCT02016482|526996450|FG001|Period B|Lost to Follow-up|0|||
146129905|NCT02016482|526996449|FG000|Period B|Lack of Efficacy|6|||
146129906|NCT02016482|526996450|FG001|Period B|Lack of Efficacy|4|||
146129907|NCT02016482|526996449|FG000|Period B|Other|4|||
146129908|NCT02016482|526996450|FG001|Period B|Other|0|||
146129909|NCT02016482|526996449|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
146129910|NCT02016482|526996450|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
146129911|NCT03161483|526996456|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146129912|NCT03161483|526996457|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
146129913|NCT03161483|526996458|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146129914|NCT03161483|526996459|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
146129915|NCT03161483|526996456|FG000|Treatment Period|Death|1|||
146129916|NCT03161483|526996457|FG001|Treatment Period|Death|0|||
146129917|NCT03161483|526996458|FG002|Treatment Period|Death|0|||
146129918|NCT03161483|526996459|FG003|Treatment Period|Death|0|||
146129919|NCT03161483|526996456|FG000|Treatment Period|Adverse Event|5|||
146129920|NCT03161483|526996457|FG001|Treatment Period|Adverse Event|2|||
146129921|NCT03161483|526996458|FG002|Treatment Period|Adverse Event|1|||
146129922|NCT03161483|526996459|FG003|Treatment Period|Adverse Event|11|||
146129923|NCT03161483|526996456|FG000|Treatment Period|Pregnancy|1|||
146129924|NCT03161483|526996457|FG001|Treatment Period|Pregnancy|0|||
146129925|NCT03161483|526996458|FG002|Treatment Period|Pregnancy|0|||
146129926|NCT03161483|526996459|FG003|Treatment Period|Pregnancy|0|||
146129927|NCT03161483|526996456|FG000|Treatment Period|Lack of Efficacy|0|||
146129928|NCT03161483|526996457|FG001|Treatment Period|Lack of Efficacy|0|||
146129929|NCT03161483|526996458|FG002|Treatment Period|Lack of Efficacy|0|||
146129930|NCT03161483|526996459|FG003|Treatment Period|Lack of Efficacy|1|||
146129931|NCT03161483|526996456|FG000|Treatment Period|Withdrawal by Subject|2|||
146129932|NCT03161483|526996457|FG001|Treatment Period|Withdrawal by Subject|5|||
146129933|NCT03161483|526996458|FG002|Treatment Period|Withdrawal by Subject|2|||
146129934|NCT03161483|526996459|FG003|Treatment Period|Withdrawal by Subject|6|||
146129935|NCT03161483|526996456|FG000|Treatment Period|Lost to Follow-up|0|||
146129936|NCT03161483|526996457|FG001|Treatment Period|Lost to Follow-up|0|||
146129937|NCT03161483|526996458|FG002|Treatment Period|Lost to Follow-up|0|||
146129938|NCT03161483|526996459|FG003|Treatment Period|Lost to Follow-up|1|||
146263247|NCT04962698|527478529|FG000|Robotic Action Observation|Technical difficulty|1|||
146129939|NCT03161483|526996456|FG000|Treatment Period|Protocol Violation|0|||
146129940|NCT03161483|526996457|FG001|Treatment Period|Protocol Violation|0|||
146129941|NCT03161483|526996458|FG002|Treatment Period|Protocol Violation|0|||
146129942|NCT03161483|526996459|FG003|Treatment Period|Protocol Violation|1|||
146129943|NCT03161483|526996456|FG000|Treatment Period|Other reasons|1|||
146129944|NCT03161483|526996457|FG001|Treatment Period|Other reasons|1|||
146129945|NCT03161483|526996458|FG002|Treatment Period|Other reasons|0|||
146129946|NCT03161483|526996459|FG003|Treatment Period|Other reasons|0|||
146263248|NCT04962698|527478530|FG001|Robotic Action Observation|Technical difficulty|0|||
146263249|NCT04962698|527478529|FG000|Rest|Technical difficulty|1|||
146129947|NCT02871739|526996463|FG000|Overall Study|Lost to Follow-up|3|||
146129948|NCT02871739|526996464|FG001|Overall Study|Lost to Follow-up|2|||
146129949|NCT02871739|526996465|FG002|Overall Study|Lost to Follow-up|0|||
146129950|NCT02871739|526996466|FG003|Overall Study|Lost to Follow-up|2|||
146129951|NCT04372602|526996467|FG000|Overall Study|Withdrawal by Subject|1|||
146129952|NCT04372602|526996468|FG001|Overall Study|Withdrawal by Subject|1|||
146129953|NCT04372602|526996467|FG000|Overall Study|Adverse Event|0|||
146129954|NCT04372602|526996468|FG001|Overall Study|Adverse Event|1|||
146129955|NCT04372602|526996467|FG000|Overall Study|Transitioned to comfort care|0|||
146129956|NCT04372602|526996468|FG001|Overall Study|Transitioned to comfort care|1|||
146129957|NCT00594464|526996469|FG000|Overall Study|Withdrawal by Subject|1|||
146129958|NCT00594464|526996469|FG000|Overall Study|Delay in operation|2|||
146129959|NCT02907359|526996470|FG000|Overall Study|Death|234|||
146129960|NCT02907359|526996471|FG001|Overall Study|Death|117|||
146129961|NCT02907359|526996470|FG000|Overall Study|Withdrawal by Subject|6|||
146129962|NCT02907359|526996471|FG001|Overall Study|Withdrawal by Subject|11|||
146129963|NCT02907359|526996470|FG000|Overall Study|Lost to Follow-up|1|||
146129964|NCT02907359|526996471|FG001|Overall Study|Lost to Follow-up|0|||
146129965|NCT01085097|526996472|FG000|Overall Study|Adverse Event|0|||
146129966|NCT01085097|526996473|FG001|Overall Study|Adverse Event|0|||
146129967|NCT01085097|526996474|FG002|Overall Study|Adverse Event|2|||
146129968|NCT01085097|526996472|FG000|Overall Study|Treatment failure|2|||
146129969|NCT01085097|526996473|FG001|Overall Study|Treatment failure|0|||
146129970|NCT01085097|526996474|FG002|Overall Study|Treatment failure|0|||
146129971|NCT06049043|526996483|FG000|Overall Study|Lost to Follow-up|11|||
146129972|NCT06049043|526996484|FG001|Overall Study|Lost to Follow-up|9|||
146129973|NCT02741700|526996486|FG000|Overall Study|Lost to Follow-up|17|||
146129974|NCT02741700|526996487|FG001|Overall Study|Lost to Follow-up|8|||
146129975|NCT02741700|526996486|FG000|Overall Study|Withdrawal by Subject|2|||
146129976|NCT02741700|526996487|FG001|Overall Study|Withdrawal by Subject|5|||
146129977|NCT02741700|526996486|FG000|Overall Study|Physician Decision|3|||
146129978|NCT02741700|526996487|FG001|Overall Study|Physician Decision|0|||
146129979|NCT02741700|526996486|FG000|Overall Study|Moved out of State|0|||
146129980|NCT02741700|526996487|FG001|Overall Study|Moved out of State|1|||
146129981|NCT02741700|526996486|FG000|Overall Study|Death|4|||
146129982|NCT02741700|526996487|FG001|Overall Study|Death|5|||
146129983|NCT01774786|526996488|FG000|Overall Study|Death|300|||
146129984|NCT01774786|526996489|FG001|Overall Study|Death|319|||
146129985|NCT01774786|526996488|FG000|Overall Study|Lost to Follow-up|6|||
146129986|NCT01774786|526996489|FG001|Overall Study|Lost to Follow-up|7|||
146129987|NCT01774786|526996488|FG000|Overall Study|Withdrawal by Subject|18|||
146129988|NCT01774786|526996489|FG001|Overall Study|Withdrawal by Subject|14|||
146129989|NCT01774786|526996488|FG000|Overall Study|Physician Decision|2|||
146129990|NCT01774786|526996489|FG001|Overall Study|Physician Decision|0|||
146129991|NCT01774786|526996488|FG000|Overall Study|Non-compliance|0|||
146129992|NCT01774786|526996489|FG001|Overall Study|Non-compliance|1|||
146129993|NCT01774786|526996488|FG000|Overall Study|Reason Not Specified|2|||
146129994|NCT01774786|526996489|FG001|Overall Study|Reason Not Specified|5|||
146129995|NCT02268812|526996490|FG000|Overall Study|Adverse Event|8|||
146129996|NCT02268812|526996491|FG001|Overall Study|Adverse Event|26|||
146129997|NCT02268812|526996492|FG002|Overall Study|Adverse Event|7|||
146129998|NCT02268812|526996493|FG003|Overall Study|Adverse Event|10|||
146129999|NCT02268812|526996490|FG000|Overall Study|Protocol deviation|0|||
146130000|NCT02268812|526996491|FG001|Overall Study|Protocol deviation|0|||
146130001|NCT02268812|526996492|FG002|Overall Study|Protocol deviation|1|||
146130002|NCT02268812|526996493|FG003|Overall Study|Protocol deviation|0|||
146130003|NCT02268812|526996490|FG000|Overall Study|Withdrawal by Subject|0|||
146130004|NCT02268812|526996491|FG001|Overall Study|Withdrawal by Subject|1|||
146130005|NCT02268812|526996492|FG002|Overall Study|Withdrawal by Subject|0|||
146130006|NCT02268812|526996493|FG003|Overall Study|Withdrawal by Subject|0|||
146130007|NCT02268812|526996490|FG000|Overall Study|Physician Decision|3|||
146130008|NCT02268812|526996491|FG001|Overall Study|Physician Decision|1|||
146130009|NCT02268812|526996492|FG002|Overall Study|Physician Decision|0|||
146130010|NCT02268812|526996493|FG003|Overall Study|Physician Decision|1|||
146130011|NCT02268812|526996490|FG000|Overall Study|Other|5|||
146130012|NCT02268812|526996491|FG001|Overall Study|Other|4|||
146130013|NCT02268812|526996492|FG002|Overall Study|Other|1|||
146130014|NCT02268812|526996493|FG003|Overall Study|Other|3|||
146130015|NCT04544293|526996494|FG000|Double-blind|Adverse Event|2|||
146130016|NCT04544293|526996495|FG001|Double-blind|Adverse Event|1|||
146130017|NCT04544293|526996494|FG000|Double-blind|Pregnancy|0|||
146130018|NCT04544293|526996495|FG001|Double-blind|Pregnancy|1|||
146130019|NCT04544293|526996494|FG000|Double-blind|Lost to Follow-up|0|||
146130020|NCT04544293|526996495|FG001|Double-blind|Lost to Follow-up|1|||
146130021|NCT04544293|526996494|FG000|Open-Label Extension|Study ongoing|79|||
146130022|NCT04544293|526996495|FG001|Open-Label Extension|Study ongoing|81|||
146130023|NCT01951157|526996497|FG000|Overall Study|Progressive Disease|12|||
146130024|NCT01951157|526996498|FG001|Overall Study|Progressive Disease|13|||
146130025|NCT01951157|526996499|FG002|Overall Study|Progressive Disease|10|||
146130026|NCT01951157|526996497|FG000|Overall Study|Treatment-unrelated AE|1|||
146130027|NCT01951157|526996498|FG001|Overall Study|Treatment-unrelated AE|0|||
146130028|NCT01951157|526996499|FG002|Overall Study|Treatment-unrelated AE|3|||
146130029|NCT01951157|526996497|FG000|Overall Study|Study Termination|0|||
146130030|NCT01951157|526996498|FG001|Overall Study|Study Termination|0|||
146130031|NCT01951157|526996499|FG002|Overall Study|Study Termination|1|||
146130032|NCT01951157|526996497|FG000|Overall Study|Physician Decision|5|||
146130033|NCT01951157|526996498|FG001|Overall Study|Physician Decision|3|||
146130034|NCT01951157|526996499|FG002|Overall Study|Physician Decision|2|||
146130035|NCT01951157|526996497|FG000|Overall Study|Non-treatmentrelated death|2|||
146130036|NCT01951157|526996498|FG001|Overall Study|Non-treatmentrelated death|2|||
146130037|NCT01951157|526996499|FG002|Overall Study|Non-treatmentrelated death|2|||
146130038|NCT01951157|526996497|FG000|Overall Study|No treated|0|||
146130039|NCT01951157|526996498|FG001|Overall Study|No treated|1|||
146130040|NCT01951157|526996499|FG002|Overall Study|No treated|0|||
146130041|NCT01951157|526996497|FG000|Overall Study|Treatment-related AE|2|||
146130042|NCT01951157|526996498|FG001|Overall Study|Treatment-related AE|0|||
146130043|NCT01951157|526996499|FG002|Overall Study|Treatment-related AE|4|||
146130044|NCT01951157|526996497|FG000|Overall Study|Consent withdrawn by subject|0|||
146130045|NCT01951157|526996498|FG001|Overall Study|Consent withdrawn by subject|1|||
146130046|NCT01951157|526996499|FG002|Overall Study|Consent withdrawn by subject|3|||
146130047|NCT01951157|526996497|FG000|Overall Study|Treatment-related death|0|||
146130048|NCT01951157|526996498|FG001|Overall Study|Treatment-related death|2|||
146130049|NCT01951157|526996499|FG002|Overall Study|Treatment-related death|0|||
146130050|NCT02268786|526996500|FG000|Overall Study|No Euploid Embryos available|42|||
146130051|NCT02268786|526996501|FG001|Overall Study|No Euploid Embryos available|0|||
146130052|NCT02268786|526996500|FG000|Overall Study|Withdrawal by Subject|7|||
146130053|NCT02268786|526996501|FG001|Overall Study|Withdrawal by Subject|14|||
146130054|NCT02268786|526996500|FG000|Overall Study|Thaw Failure|6|||
146130055|NCT02268786|526996501|FG001|Overall Study|Thaw Failure|4|||
146130056|NCT02268786|526996500|FG000|Overall Study|Protocol Violation|1|||
146130057|NCT02268786|526996501|FG001|Overall Study|Protocol Violation|0|||
146130058|NCT04809220|526996504|FG000|Overall Study|Adverse Event|4|||
146130059|NCT04809220|526996505|FG001|Overall Study|Adverse Event|0|||
146130060|NCT04809220|526996504|FG000|Overall Study|Death|1|||
146130061|NCT04809220|526996505|FG001|Overall Study|Death|0|||
146130062|NCT04809220|526996504|FG000|Overall Study|Lost to Follow-up|3|||
146130063|NCT04809220|526996505|FG001|Overall Study|Lost to Follow-up|0|||
146130064|NCT04809220|526996504|FG000|Overall Study|Physician Decision|0|||
146130065|NCT04809220|526996505|FG001|Overall Study|Physician Decision|1|||
146130066|NCT04809220|526996504|FG000|Overall Study|Withdrawal by Subject|9|||
146130067|NCT04809220|526996505|FG001|Overall Study|Withdrawal by Subject|5|||
146130068|NCT04809220|526996504|FG000|Overall Study|Due to long-term overseas business trips|1|||
146130069|NCT04809220|526996505|FG001|Overall Study|Due to long-term overseas business trips|0|||
146130070|NCT02120794|526996509|FG000|Overall Study|Withdrawal by Subject|43|||
146130071|NCT02120794|526996509|FG000|Overall Study|Adverse Event|10|||
146130072|NCT02120794|526996509|FG000|Overall Study|Physician Decision|4|||
146130073|NCT02120794|526996509|FG000|Overall Study|Due to insurance coverage|1|||
146130074|NCT00994240|526996511|FG000|Overall Study|Lost to Follow-up|3|||
146130075|NCT00994240|526996512|FG001|Overall Study|Lost to Follow-up|2|||
146130076|NCT00994240|526996511|FG000|Overall Study|Withdrawal by Subject|1|||
146130077|NCT00994240|526996512|FG001|Overall Study|Withdrawal by Subject|0|||
146130078|NCT00994240|526996511|FG000|Overall Study|study termination|2|||
146130079|NCT00994240|526996512|FG001|Overall Study|study termination|3|||
146130080|NCT01200797|526996513|FG000|Overall Study|symptomatic deterioration|2|||
146130081|NCT01200797|526996513|FG000|Overall Study|Adverse Event|4|||
146130082|NCT01200797|526996513|FG000|Overall Study|Disease Progression|13|||
146130083|NCT00642668|526996518|FG000|Overall Study|Lost to Follow-up|1|||
146130084|NCT00642668|526996518|FG000|Overall Study|Adverse Event|2|||
146130085|NCT00642668|526996518|FG000|Overall Study|Death|2|||
146130086|NCT00642668|526996518|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146130087|NCT00642668|526996518|FG000|Overall Study|Failure to Return|1|||
146130088|NCT00642668|526996518|FG000|Overall Study|Dialysis Initiation|5|||
146130089|NCT00642668|526996518|FG000|Overall Study|Blood Transfusion|2|||
146130090|NCT03608774|526996519|FG000|Overall Study|Lost to Follow-up|5|||
146130091|NCT03608774|526996520|FG001|Overall Study|Lost to Follow-up|5|||
146130092|NCT03608774|526996519|FG000|Overall Study|Withdrawal by Subject|1|||
146130093|NCT03608774|526996520|FG001|Overall Study|Withdrawal by Subject|0|||
146130094|NCT03608774|526996519|FG000|Overall Study|Protocol Violation|1|||
146130095|NCT03608774|526996520|FG001|Overall Study|Protocol Violation|0|||
146130096|NCT03608774|526996519|FG000|Overall Study|Not eligible at enrollment|0|||
146130097|NCT03608774|526996520|FG001|Overall Study|Not eligible at enrollment|1|||
146130098|NCT03608774|526996519|FG000|Overall Study|Health related event|0|||
146130099|NCT03608774|526996520|FG001|Overall Study|Health related event|1|||
146130100|NCT01586819|526996521|FG000|Overall Study|Withdrawal by Subject|1|||
146130101|NCT01586819|526996522|FG001|Overall Study|Withdrawal by Subject|0|||
146130102|NCT00896337|526996523|FG000|Overall Study|Death|7|||
146130103|NCT00896337|526996523|FG000|Overall Study|Withdrawal by Subject|7|||
146130104|NCT00896337|526996523|FG000|Overall Study|Lost to Follow-up|11|||
146130105|NCT02910167|526996534|FG000|Overall Study|Adverse Event|1|||
146130106|NCT02910167|526996534|FG000|Overall Study|Lost to Follow-up|18|||
146130107|NCT01418937|526996535|FG000|Overall Study|Lost to Follow-up|5|||
146130108|NCT01418937|526996535|FG000|Overall Study|Protocol Violation|1|||
146130109|NCT01418937|526996535|FG000|Overall Study|Pregnancy|1|||
146130110|NCT01418937|526996535|FG000|Overall Study|Withdrawal by Subject|1|||
146130111|NCT01623596|526996536|FG000|Overall Study|Abnormal laboratory values|2|||
146130112|NCT01623596|526996537|FG001|Overall Study|Abnormal laboratory values|0|||
146130113|NCT01623596|526996536|FG000|Overall Study|Administrative problems|9|||
146130114|NCT01623596|526996537|FG001|Overall Study|Administrative problems|13|||
146130115|NCT01623596|526996536|FG000|Overall Study|Adverse Event|20|||
146130116|NCT01623596|526996537|FG001|Overall Study|Adverse Event|29|||
146130117|NCT01623596|526996536|FG000|Overall Study|Death|0|||
146130118|NCT01623596|526996537|FG001|Overall Study|Death|2|||
146130119|NCT01623596|526996536|FG000|Overall Study|Lost to Follow-up|12|||
146130120|NCT01623596|526996537|FG001|Overall Study|Lost to Follow-up|16|||
146130121|NCT01623596|526996536|FG000|Overall Study|Withdrawal by Subject|13|||
146130122|NCT01623596|526996537|FG001|Overall Study|Withdrawal by Subject|31|||
146130123|NCT01623596|526996536|FG000|Overall Study|Patient no longer requires study drug|1|||
146130124|NCT01623596|526996537|FG001|Overall Study|Patient no longer requires study drug|0|||
146130125|NCT01623596|526996536|FG000|Overall Study|Protocol Violation|0|||
146130126|NCT01623596|526996537|FG001|Overall Study|Protocol Violation|6|||
146130127|NCT01623596|526996536|FG000|Overall Study|Lack of Efficacy|5|||
146130128|NCT01623596|526996537|FG001|Overall Study|Lack of Efficacy|3|||
146130129|NCT04059146|526996538|FG000|Overall Study|Withdrawal by Subject|0|||
146130130|NCT04059146|526996539|FG001|Overall Study|Withdrawal by Subject|1|||
146130131|NCT01324349|526996540|FG000|Overall Study|Death|1|||
146130132|NCT01324349|526996541|FG001|Overall Study|Death|1|||
146130133|NCT01324349|526996540|FG000|Overall Study|Withdrawal by Subject|0|||
146130134|NCT01324349|526996541|FG001|Overall Study|Withdrawal by Subject|1|||
146130135|NCT00748215|526996542|FG000|Overall Study|Withdrawal by Subject|7|||
146130136|NCT00748215|526996543|FG001|Overall Study|Withdrawal by Subject|7|||
146130137|NCT00748215|526996542|FG000|Overall Study|Treatment change|2|||
146130138|NCT00748215|526996543|FG001|Overall Study|Treatment change|1|||
146130139|NCT00748215|526996542|FG000|Overall Study|Change in patient condition|0|||
146130140|NCT00748215|526996543|FG001|Overall Study|Change in patient condition|3|||
146130141|NCT00748215|526996542|FG000|Overall Study|Non-compliant|0|||
146130142|NCT00748215|526996543|FG001|Overall Study|Non-compliant|2|||
146130143|NCT00748215|526996542|FG000|Overall Study|Adverse Event|0|||
146130144|NCT00748215|526996543|FG001|Overall Study|Adverse Event|5|||
146130145|NCT03026257|526998163|FG000|Overall Study|Adverse Event|3|||
146130146|NCT03026257|526998164|FG001|Overall Study|Adverse Event|0|||
146130147|NCT03026257|526998165|FG002|Overall Study|Adverse Event|0|||
146130148|NCT03026257|526998166|FG003|Overall Study|Adverse Event|0|||
146130149|NCT03026257|526998167|FG004|Overall Study|Adverse Event|0|||
146130150|NCT03026257|526998168|FG005|Overall Study|Adverse Event|0|||
146130151|NCT03026257|526998163|FG000|Overall Study|Lost to Follow-up|1|||
146130152|NCT03026257|526998164|FG001|Overall Study|Lost to Follow-up|0|||
146130153|NCT03026257|526998165|FG002|Overall Study|Lost to Follow-up|0|||
146130154|NCT03026257|526998166|FG003|Overall Study|Lost to Follow-up|0|||
146130155|NCT03026257|526998167|FG004|Overall Study|Lost to Follow-up|0|||
146130156|NCT03026257|526998168|FG005|Overall Study|Lost to Follow-up|0|||
146130157|NCT03026257|526998163|FG000|Overall Study|Protocol Violation|1|||
146130158|NCT03026257|526998164|FG001|Overall Study|Protocol Violation|0|||
146130159|NCT03026257|526998165|FG002|Overall Study|Protocol Violation|0|||
146130160|NCT03026257|526998166|FG003|Overall Study|Protocol Violation|1|||
146130161|NCT03026257|526998167|FG004|Overall Study|Protocol Violation|1|||
146130162|NCT03026257|526998168|FG005|Overall Study|Protocol Violation|0|||
146130163|NCT03026257|526998163|FG000|Overall Study|Withdrawal by Subject|1|||
146130164|NCT03026257|526998164|FG001|Overall Study|Withdrawal by Subject|1|||
146130165|NCT03026257|526998165|FG002|Overall Study|Withdrawal by Subject|0|||
146130166|NCT03026257|526998166|FG003|Overall Study|Withdrawal by Subject|0|||
146130167|NCT03026257|526998167|FG004|Overall Study|Withdrawal by Subject|0|||
146130168|NCT03026257|526998168|FG005|Overall Study|Withdrawal by Subject|0|||
146130169|NCT00427635|526998169|FG000|Treatment Phase|Withdrawal by Subject|1|||
146130170|NCT00427635|526998170|FG001|Treatment Phase|Withdrawal by Subject|0|||
146130171|NCT00427635|526998169|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
146130172|NCT00427635|526998170|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
146130173|NCT00838201|526998171|FG000|Overall Study|Investigator decision, or other reasons|2|||
146263250|NCT04962698|527478530|FG001|Rest|Technical difficulty|0|||
146263251|NCT04962698|527478529|FG000|Rest|Exclusion criteria met after enrollment|0|||
146263252|NCT04962698|527478530|FG001|Rest|Exclusion criteria met after enrollment|2|||
146263253|NCT00853229|527478531|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
146263254|NCT00853229|527478532|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
146263255|NCT03470545|527478533|FG000|Overall Study|Death|0|||
146263256|NCT03470545|527478534|FG001|Overall Study|Death|1|||
146130174|NCT00838201|526998172|FG001|Overall Study|Investigator decision, or other reasons|3|||
146130175|NCT00838201|526998171|FG000|Overall Study|Noncompliance|0|||
146130176|NCT00838201|526998172|FG001|Overall Study|Noncompliance|1|||
146263257|NCT03470545|527478533|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
146263258|NCT03470545|527478534|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
146263259|NCT03470545|527478533|FG000|Overall Study|Adverse Event|2|||
146130177|NCT00838201|526998171|FG000|Overall Study|Administrative decision|1|||
146130178|NCT00838201|526998172|FG001|Overall Study|Administrative decision|2|||
146130179|NCT00838201|526998171|FG000|Overall Study|Disease progression|3|||
146263260|NCT03470545|527478534|FG001|Overall Study|Adverse Event|0|||
146263261|NCT03470545|527478533|FG000|Overall Study|Withdrawal by Subject|1|||
146263262|NCT03470545|527478534|FG001|Overall Study|Withdrawal by Subject|1|||
146130180|NCT00838201|526998172|FG001|Overall Study|Disease progression|3|||
146130181|NCT00838201|526998171|FG000|Overall Study|Consent withdrawn|16|||
146130182|NCT00838201|526998172|FG001|Overall Study|Consent withdrawn|19|||
146130183|NCT00838201|526998171|FG000|Overall Study|Lost to Follow-up|4|||
146130184|NCT00838201|526998172|FG001|Overall Study|Lost to Follow-up|3|||
146130185|NCT00838201|526998171|FG000|Overall Study|Adverse Event|5|||
146130186|NCT00838201|526998172|FG001|Overall Study|Adverse Event|9|||
146130187|NCT00838201|526998171|FG000|Overall Study|Death|11|||
146130188|NCT00838201|526998172|FG001|Overall Study|Death|13|||
146130189|NCT02042924|526998176|FG000|Overall Study|Early Death|1|||
146130190|NCT04033003|526998177|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
146130191|NCT04033003|526998178|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
146130192|NCT04033003|526998177|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
146130193|NCT04033003|526998178|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
146130194|NCT04033003|526998177|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
146130195|NCT04033003|526998178|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
146130196|NCT04033003|526998177|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
146130197|NCT04033003|526998178|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
146130198|NCT04033003|526998177|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
146130199|NCT04033003|526998178|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
146130200|NCT04033003|526998177|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
146130201|NCT04033003|526998178|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
146130202|NCT04033003|526998177|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
146130203|NCT04033003|526998178|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
146130204|NCT04033003|526998177|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
146130205|NCT04033003|526998178|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
146130206|NCT04033003|526998177|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
146130207|NCT04033003|526998178|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
146130208|NCT04033003|526998177|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
146130209|NCT04033003|526998178|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
146130210|NCT04033003|526998177|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
146130211|NCT04033003|526998178|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
146130212|NCT04033003|526998177|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
146130213|NCT04033003|526998178|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
146130214|NCT04033003|526998177|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
146130215|NCT04033003|526998178|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
146130216|NCT01714310|526998179|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
146130217|NCT01714310|526998180|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
146130218|NCT01714310|526998181|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
146130219|NCT01714310|526998179|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
146130220|NCT01714310|526998180|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
146130221|NCT01714310|526998181|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
146130222|NCT01714310|526998179|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
146130223|NCT01714310|526998180|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
146130224|NCT01714310|526998181|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
146130225|NCT01714310|526998179|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
146130226|NCT01714310|526998180|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
146130227|NCT01714310|526998181|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
146130228|NCT02487394|526998182|FG000|Phase 1|Withdrawal by Subject|0|||
146130229|NCT02487394|526998183|FG001|Phase 1|Withdrawal by Subject|1|||
146130230|NCT00826267|526998188|FG000|Overall Study|Other Adverse Event|1|||
146130231|NCT00826267|526998189|FG001|Overall Study|Other Adverse Event|0|||
146130232|NCT00826267|526998190|FG002|Overall Study|Other Adverse Event|0|||
146130233|NCT01675882|526998207|FG000|Overall Study|Adverse Event|0|||
146130234|NCT01675882|526998208|FG001|Overall Study|Adverse Event|2|||
146130235|NCT01675882|526998209|FG002|Overall Study|Adverse Event|1|||
146130236|NCT01675882|526998210|FG003|Overall Study|Adverse Event|0|||
146130237|NCT01675882|526998207|FG000|Overall Study|Participant unwilling to continue|2|||
146130238|NCT01675882|526998208|FG001|Overall Study|Participant unwilling to continue|4|||
146130239|NCT01675882|526998209|FG002|Overall Study|Participant unwilling to continue|2|||
146130240|NCT01675882|526998210|FG003|Overall Study|Participant unwilling to continue|1|||
146130241|NCT01675882|526998207|FG000|Overall Study|Lost to Follow-up|0|||
146130242|NCT01675882|526998208|FG001|Overall Study|Lost to Follow-up|1|||
146130243|NCT01675882|526998209|FG002|Overall Study|Lost to Follow-up|0|||
146130244|NCT01675882|526998210|FG003|Overall Study|Lost to Follow-up|0|||
146130245|NCT01675882|526998207|FG000|Overall Study|Non-compliance|0|||
146130246|NCT01675882|526998208|FG001|Overall Study|Non-compliance|0|||
146130247|NCT01675882|526998209|FG002|Overall Study|Non-compliance|0|||
146130248|NCT01675882|526998210|FG003|Overall Study|Non-compliance|1|||
146130249|NCT02711800|526998214|FG000|Overall Study|Lost to Follow-up|1|||
146130250|NCT02711800|526998214|FG000|Overall Study|Withdrawal by Subject|1|||
146130251|NCT00314574|526998227|FG000|Overall Study|Death|3|||
146130252|NCT00314574|526998228|FG001|Overall Study|Death|0|||
146130253|NCT00314574|526998227|FG000|Overall Study|Adverse Event|11|||
146130254|NCT00314574|526998228|FG001|Overall Study|Adverse Event|16|||
146130255|NCT00314574|526998227|FG000|Overall Study|Lost to Follow-up|19|||
146130256|NCT00314574|526998228|FG001|Overall Study|Lost to Follow-up|25|||
146130257|NCT00314574|526998227|FG000|Overall Study|Withdrawal by Subject|33|||
146130258|NCT00314574|526998228|FG001|Overall Study|Withdrawal by Subject|22|||
146130259|NCT00314574|526998227|FG000|Overall Study|Physician Decision|22|||
146130260|NCT00314574|526998228|FG001|Overall Study|Physician Decision|15|||
146130261|NCT00314574|526998227|FG000|Overall Study|Pregnancy|6|||
146130262|NCT00314574|526998228|FG001|Overall Study|Pregnancy|4|||
146130263|NCT00314574|526998227|FG000|Overall Study|Data unknown at database lock|0|||
146130264|NCT00314574|526998228|FG001|Overall Study|Data unknown at database lock|1|||
146130265|NCT00449956|526998229|FG000|Overall Study|Adverse Event|7|||
146130266|NCT00449956|526998230|FG001|Overall Study|Adverse Event|1|||
146130267|NCT00449956|526998231|FG002|Overall Study|Adverse Event|6|||
146130268|NCT00449956|526998229|FG000|Overall Study|Lack of Efficacy|0|||
146130269|NCT00449956|526998230|FG001|Overall Study|Lack of Efficacy|0|||
146130270|NCT00449956|526998231|FG002|Overall Study|Lack of Efficacy|1|||
146130271|NCT00449956|526998229|FG000|Overall Study|Protocol Violation|1|||
146130272|NCT00449956|526998230|FG001|Overall Study|Protocol Violation|1|||
146130273|NCT00449956|526998231|FG002|Overall Study|Protocol Violation|1|||
146130274|NCT00449956|526998229|FG000|Overall Study|Withdrawal by Subject|0|||
146130275|NCT00449956|526998230|FG001|Overall Study|Withdrawal by Subject|1|||
146130276|NCT00449956|526998231|FG002|Overall Study|Withdrawal by Subject|0|||
146130277|NCT00449956|526998229|FG000|Overall Study|Physician Decision|2|||
146130278|NCT00449956|526998230|FG001|Overall Study|Physician Decision|1|||
146130279|NCT00449956|526998231|FG002|Overall Study|Physician Decision|1|||
146130280|NCT01446965|526998236|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
146130281|NCT01446965|526998237|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
146130282|NCT01446965|526998236|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
146130283|NCT01446965|526998237|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
146130284|NCT00004412|526998238|FG000|Randomized Period|Moved to Crossover Period|3|||
146130285|NCT00004412|526998239|FG001|Randomized Period|Moved to Crossover Period|0|||
146130286|NCT00004412|526998240|FG002|Randomized Period|Moved to Crossover Period|0|||
146130287|NCT03144180|526998246|FG000|Overall Study|STAT Delivery|1|||
146130288|NCT03144180|526998247|FG001|Overall Study|STAT Delivery|1|||
146130289|NCT03144180|526998246|FG000|Overall Study|Provider forgot to fill out forms|1|||
146130290|NCT03144180|526998247|FG001|Overall Study|Provider forgot to fill out forms|3|||
146130291|NCT03144180|526998246|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
146130292|NCT03144180|526998247|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
146130293|NCT03144180|526998246|FG000|Overall Study|Scrub tech removed tube cap|0|||
146130294|NCT03144180|526998247|FG001|Overall Study|Scrub tech removed tube cap|1|||
146130295|NCT03387813|526998250|FG000|Overall Study|Death|40|||
146130296|NCT03387813|526998251|FG001|Overall Study|Death|37|||
146130297|NCT03387813|526998252|FG002|Overall Study|Death|190|||
146130298|NCT03387813|526998250|FG000|Overall Study|Withdrawal by Subject|9|||
146130299|NCT03387813|526998251|FG001|Overall Study|Withdrawal by Subject|19|||
146130300|NCT03387813|526998252|FG002|Overall Study|Withdrawal by Subject|32|||
146130301|NCT03387813|526998250|FG000|Overall Study|Lost to Follow-up|3|||
146130302|NCT03387813|526998251|FG001|Overall Study|Lost to Follow-up|9|||
146130303|NCT03387813|526998252|FG002|Overall Study|Lost to Follow-up|15|||
146130304|NCT03387813|526998250|FG000|Overall Study|Non-Compliance|6|||
146130305|NCT03387813|526998251|FG001|Overall Study|Non-Compliance|6|||
146130306|NCT03387813|526998252|FG002|Overall Study|Non-Compliance|31|||
146130307|NCT03387813|526998250|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
146130308|NCT03387813|526998251|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
146130309|NCT03387813|526998252|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
146130310|NCT00743652|526998253|FG000|Overall Study|Parent/Legal Guardian Request|3|||
146130311|NCT00743652|526998254|FG001|Overall Study|Parent/Legal Guardian Request|2|||
146130312|NCT00743652|526998255|FG002|Overall Study|Parent/Legal Guardian Request|2|||
146130313|NCT00743652|526998256|FG003|Overall Study|Parent/Legal Guardian Request|2|||
146130314|NCT00743652|526998257|FG004|Overall Study|Parent/Legal Guardian Request|0|||
146130315|NCT00743652|526998253|FG000|Overall Study|Adverse Event|3|||
146130316|NCT00743652|526998254|FG001|Overall Study|Adverse Event|0|||
146130317|NCT00743652|526998255|FG002|Overall Study|Adverse Event|0|||
146263263|NCT03470545|527478533|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
146263264|NCT03470545|527478534|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
146263265|NCT03672175|527478539|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
146263266|NCT03672175|527478540|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
146263267|NCT03672175|527478541|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
146130318|NCT00743652|526998256|FG003|Overall Study|Adverse Event|0|||
146130319|NCT00743652|526998257|FG004|Overall Study|Adverse Event|0|||
146130320|NCT00743652|526998253|FG000|Overall Study|Death|2|||
146130321|NCT00743652|526998254|FG001|Overall Study|Death|0|||
146130322|NCT00743652|526998255|FG002|Overall Study|Death|0|||
146130323|NCT00743652|526998256|FG003|Overall Study|Death|0|||
146130324|NCT00743652|526998257|FG004|Overall Study|Death|0|||
146130325|NCT00743652|526998253|FG000|Overall Study|Investigator Request|0|||
146130326|NCT00743652|526998254|FG001|Overall Study|Investigator Request|0|||
146263268|NCT03672175|527478539|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
146263269|NCT03672175|527478540|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
146263270|NCT03672175|527478541|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
146263271|NCT03672175|527478539|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
146263272|NCT03672175|527478540|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
146263273|NCT03672175|527478541|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
146263274|NCT03672175|527478539|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
146263275|NCT03672175|527478540|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
146263276|NCT03672175|527478541|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
146263277|NCT03672175|527478539|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
146263278|NCT03672175|527478540|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
146263279|NCT03672175|527478541|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
146263280|NCT03672175|527478539|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
146263281|NCT03672175|527478540|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
146263282|NCT03672175|527478541|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
146263283|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
146263284|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
146263285|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
146263286|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
146263287|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
146263288|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
146263289|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
146263290|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
146263291|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
146263292|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
146263293|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
146263294|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
146263295|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
146263296|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
146263297|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
146263298|NCT03672175|527478539|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
146263299|NCT03672175|527478540|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
146263300|NCT03672175|527478541|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
146263301|NCT02586415|527478543|FG000|Overall Study|Death|13|||
146263302|NCT02586415|527478544|FG001|Overall Study|Death|23|||
146263303|NCT02586415|527478543|FG000|Overall Study|Lost to Follow-up|1|||
146263304|NCT02586415|527478544|FG001|Overall Study|Lost to Follow-up|2|||
146263305|NCT02777242|527478545|FG000|Overall Study|Other|2|||
146263306|NCT02777242|527478545|FG000|Overall Study|Lost to Follow-up|1|||
146263307|NCT02777242|527478545|FG000|Overall Study|Multiple|1|||
146263308|NCT02777242|527478545|FG000|Overall Study|Sponsor's request|1|||
146263309|NCT02777242|527478545|FG000|Overall Study|Withdrawal by Subject|1|||
146263310|NCT00255944|527478546|FG000|Overall Study|Lost to Follow-up|797|||
146263311|NCT00255944|527478547|FG001|Overall Study|Lost to Follow-up|834|||
146263312|NCT05178979|527478548|FG000|Overall Study|Death|0|||
146263313|NCT05178979|527478549|FG001|Overall Study|Death|5|||
146263314|NCT05178979|527478550|FG002|Overall Study|Death|0|||
146263315|NCT05178979|527478551|FG003|Overall Study|Death|3|||
146263316|NCT05178979|527478548|FG000|Overall Study|Adverse Event|0|||
146263317|NCT05178979|527478549|FG001|Overall Study|Adverse Event|1|||
146263318|NCT05178979|527478550|FG002|Overall Study|Adverse Event|0|||
146263319|NCT05178979|527478551|FG003|Overall Study|Adverse Event|0|||
146263320|NCT05178979|527478548|FG000|Overall Study|Lost to Follow-up|1|||
146263321|NCT05178979|527478549|FG001|Overall Study|Lost to Follow-up|8|||
146263322|NCT05178979|527478550|FG002|Overall Study|Lost to Follow-up|3|||
146263323|NCT05178979|527478551|FG003|Overall Study|Lost to Follow-up|8|||
146263324|NCT02299427|527478553|FG000|Overall Study|Withdrawal by Subject|1|||
146263325|NCT02299427|527478554|FG001|Overall Study|Withdrawal by Subject|0|||
146263326|NCT02299427|527478553|FG000|Overall Study|Lost to Follow-up|1|||
146263327|NCT02299427|527478554|FG001|Overall Study|Lost to Follow-up|3|||
146263328|NCT02299427|527478553|FG000|Overall Study|not adherent to dog website use|21|||
146263329|NCT02299427|527478554|FG001|Overall Study|not adherent to dog website use|0|||
146263330|NCT00937521|527478555|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263331|NCT00937521|527478556|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263332|NCT00937521|527478557|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
146263333|NCT00937521|527478558|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263334|NCT00937521|527478559|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263335|NCT00937521|527478560|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263336|NCT00937521|527478561|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
146263337|NCT00937521|527478562|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
146263338|NCT00937521|527478555|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
146263339|NCT00937521|527478556|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146263340|NCT00937521|527478557|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
146263341|NCT00937521|527478558|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
146263342|NCT00937521|527478559|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146263343|NCT00937521|527478560|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
146263344|NCT00937521|527478561|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
146263345|NCT00937521|527478562|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
146263346|NCT00937521|527478555|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263347|NCT00937521|527478556|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263348|NCT00937521|527478557|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
146263349|NCT00937521|527478558|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
146263350|NCT00937521|527478559|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263351|NCT00937521|527478560|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263352|NCT00937521|527478561|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263353|NCT00937521|527478562|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
146263354|NCT00937521|527478555|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146263355|NCT00937521|527478556|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
146263356|NCT00937521|527478557|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146263357|NCT00937521|527478558|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146263358|NCT00937521|527478559|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
146263359|NCT00937521|527478560|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
146263360|NCT00937521|527478561|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
146263361|NCT00937521|527478562|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
146263362|NCT00937521|527478555|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
146263363|NCT00937521|527478556|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263364|NCT00937521|527478557|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263365|NCT00937521|527478558|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263366|NCT00937521|527478559|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263367|NCT00937521|527478560|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263368|NCT00937521|527478561|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
146263369|NCT00937521|527478562|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
146263370|NCT00937521|527478555|FG000|Booster Phase|Adverse Event|0|||
146263371|NCT00937521|527478556|FG001|Booster Phase|Adverse Event|0|||
146263372|NCT00937521|527478557|FG002|Booster Phase|Adverse Event|0|||
146263373|NCT00937521|527478558|FG003|Booster Phase|Adverse Event|0|||
146263374|NCT00937521|527478559|FG004|Booster Phase|Adverse Event|0|||
146263375|NCT00937521|527478560|FG005|Booster Phase|Adverse Event|0|||
146263376|NCT00937521|527478561|FG006|Booster Phase|Adverse Event|1|||
146263377|NCT00937521|527478562|FG007|Booster Phase|Adverse Event|0|||
146263378|NCT00937521|527478555|FG000|Booster Phase|Withdrawal by Subject|1|||
146263379|NCT00937521|527478556|FG001|Booster Phase|Withdrawal by Subject|0|||
146263380|NCT00937521|527478557|FG002|Booster Phase|Withdrawal by Subject|0|||
146263381|NCT00937521|527478558|FG003|Booster Phase|Withdrawal by Subject|1|||
146263382|NCT00937521|527478559|FG004|Booster Phase|Withdrawal by Subject|0|||
146263383|NCT00937521|527478560|FG005|Booster Phase|Withdrawal by Subject|0|||
146263384|NCT00937521|527478561|FG006|Booster Phase|Withdrawal by Subject|0|||
146263385|NCT00937521|527478562|FG007|Booster Phase|Withdrawal by Subject|2|||
146263386|NCT00937521|527478555|FG000|Booster Phase|Lost to Follow-up|2|||
146263387|NCT00937521|527478556|FG001|Booster Phase|Lost to Follow-up|2|||
146263388|NCT00937521|527478557|FG002|Booster Phase|Lost to Follow-up|4|||
146263389|NCT00937521|527478558|FG003|Booster Phase|Lost to Follow-up|2|||
146263390|NCT00937521|527478559|FG004|Booster Phase|Lost to Follow-up|4|||
146263391|NCT00937521|527478560|FG005|Booster Phase|Lost to Follow-up|4|||
146263392|NCT00937521|527478561|FG006|Booster Phase|Lost to Follow-up|3|||
146263393|NCT00937521|527478562|FG007|Booster Phase|Lost to Follow-up|0|||
146303551|NCT01514136|527625841|FG000|Test Period 2; Test A*|Adverse Event|0|||
146303552|NCT01514136|527625842|FG001|Test Period 2; Test A*|Adverse Event|0|||
146303553|NCT01514136|527625843|FG002|Test Period 2; Test A*|Adverse Event|0|||
146303554|NCT01514136|527625844|FG003|Test Period 2; Test A*|Adverse Event|0|||
146303555|NCT01514136|527625845|FG004|Test Period 2; Test A*|Adverse Event|1|||
146303556|NCT01514136|527625846|FG005|Test Period 2; Test A*|Adverse Event|0|||
146303557|NCT01514136|527625847|FG006|Test Period 2; Test A*|Adverse Event|0|||
146263394|NCT00937521|527478555|FG000|Booster Phase|Administrative Reason|0|||
146303558|NCT01514136|527625848|FG007|Test Period 2; Test A*|Adverse Event|0|||
146303559|NCT01514136|527625841|FG000|Test Period 2; Test A*|Holiday|0|||
146303560|NCT01514136|527625842|FG001|Test Period 2; Test A*|Holiday|0|||
146263395|NCT00937521|527478556|FG001|Booster Phase|Administrative Reason|0|||
146263396|NCT00937521|527478557|FG002|Booster Phase|Administrative Reason|1|||
146263397|NCT00937521|527478558|FG003|Booster Phase|Administrative Reason|0|||
146263398|NCT00937521|527478559|FG004|Booster Phase|Administrative Reason|1|||
146263399|NCT00937521|527478560|FG005|Booster Phase|Administrative Reason|1|||
146263400|NCT00937521|527478561|FG006|Booster Phase|Administrative Reason|0|||
146263401|NCT00937521|527478562|FG007|Booster Phase|Administrative Reason|0|||
146263402|NCT00937521|527478555|FG000|Booster Phase|Protocol Deviation|0|||
146263403|NCT00937521|527478556|FG001|Booster Phase|Protocol Deviation|0|||
146263404|NCT00937521|527478557|FG002|Booster Phase|Protocol Deviation|0|||
146263405|NCT00937521|527478558|FG003|Booster Phase|Protocol Deviation|0|||
146263406|NCT00937521|527478559|FG004|Booster Phase|Protocol Deviation|0|||
146263407|NCT00937521|527478560|FG005|Booster Phase|Protocol Deviation|0|||
146263408|NCT00937521|527478561|FG006|Booster Phase|Protocol Deviation|1|||
146263409|NCT00937521|527478562|FG007|Booster Phase|Protocol Deviation|0|||
146263410|NCT03269695|527478565|FG000|Overall Study|Adverse Event|2|||
146263411|NCT03269695|527478566|FG001|Overall Study|Adverse Event|1|||
146263412|NCT03269695|527478565|FG000|Overall Study|Lack of Efficacy|0|||
146263413|NCT03269695|527478566|FG001|Overall Study|Lack of Efficacy|1|||
146263414|NCT03269695|527478565|FG000|Overall Study|Withdrawal by Subject|0|||
146263415|NCT03269695|527478566|FG001|Overall Study|Withdrawal by Subject|1|||
146263416|NCT00104637|527478567|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
146263417|NCT00104637|527478568|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
146263418|NCT01313624|527478569|FG000|Double-Blind Phase|Adverse Event|27|||
146263419|NCT01313624|527478570|FG001|Double-Blind Phase|Adverse Event|4|||
146263420|NCT01313624|527478569|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
146263421|NCT01313624|527478570|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
146263422|NCT01313624|527478569|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146263423|NCT01313624|527478570|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146263424|NCT01313624|527478569|FG000|Double-Blind Phase|Physician Decision|1|||
146263425|NCT01313624|527478570|FG001|Double-Blind Phase|Physician Decision|0|||
146263426|NCT01313624|527478569|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146263427|NCT01313624|527478570|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146263428|NCT01313624|527478569|FG000|Open-Label Phase|Adverse Event|1|||
146263429|NCT01313624|527478570|FG001|Open-Label Phase|Adverse Event|10|||
146263430|NCT01313624|527478569|FG000|Open-Label Phase|Withdrawal by Subject|2|||
146263431|NCT01313624|527478570|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146263432|NCT01313624|527478569|FG000|Open-Label Phase|Lost to Follow-up|1|||
146263433|NCT01313624|527478570|FG001|Open-Label Phase|Lost to Follow-up|1|||
146263434|NCT02447718|527478573|FG000|Overall Study|Lost to Follow-up|8|||
146263435|NCT02447718|527478574|FG001|Overall Study|Lost to Follow-up|0|||
146263436|NCT02447718|527478573|FG000|Overall Study|Withdrawal by Subject|3|||
146263437|NCT02447718|527478574|FG001|Overall Study|Withdrawal by Subject|0|||
146263438|NCT02447718|527478573|FG000|Overall Study|Screen Failure|1|||
146263439|NCT02447718|527478574|FG001|Overall Study|Screen Failure|0|||
146263440|NCT00239681|527478575|FG000|Overall Study|Adverse Event|100|||
146263441|NCT00239681|527478576|FG001|Overall Study|Adverse Event|99|||
146263442|NCT00239681|527478575|FG000|Overall Study|Withdrawal by Subject|458|||
146263443|NCT00239681|527478576|FG001|Overall Study|Withdrawal by Subject|489|||
146263444|NCT00239681|527478575|FG000|Overall Study|Lost to Follow-up|28|||
146263445|NCT00239681|527478576|FG001|Overall Study|Lost to Follow-up|22|||
146263446|NCT00239681|527478575|FG000|Overall Study|Protocol Violation|4|||
146263447|NCT00239681|527478576|FG001|Overall Study|Protocol Violation|4|||
146263448|NCT00239681|527478575|FG000|Overall Study|Physician Decision|13|||
146130327|NCT00743652|526998255|FG002|Overall Study|Investigator Request|0|||
146130328|NCT00743652|526998256|FG003|Overall Study|Investigator Request|2|||
146130329|NCT00743652|526998257|FG004|Overall Study|Investigator Request|0|||
146130330|NCT00743652|526998253|FG000|Overall Study|Other|1|||
146130331|NCT00743652|526998254|FG001|Overall Study|Other|1|||
146130332|NCT00743652|526998255|FG002|Overall Study|Other|0|||
146130333|NCT00743652|526998256|FG003|Overall Study|Other|0|||
146130334|NCT00743652|526998257|FG004|Overall Study|Other|0|||
146130335|NCT00743652|526998253|FG000|Overall Study|Lost to Follow-up|1|||
146130336|NCT00743652|526998254|FG001|Overall Study|Lost to Follow-up|0|||
146130337|NCT00743652|526998255|FG002|Overall Study|Lost to Follow-up|0|||
146130338|NCT00743652|526998256|FG003|Overall Study|Lost to Follow-up|0|||
146263449|NCT00239681|527478576|FG001|Overall Study|Physician Decision|17|||
146263450|NCT00239681|527478575|FG000|Overall Study|No information chacked on CaseReportForm|90|||
146263451|NCT00239681|527478576|FG001|Overall Study|No information chacked on CaseReportForm|84|||
146263452|NCT02654132|527478579|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
146263453|NCT02654132|527478580|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
146263454|NCT02654132|527478579|FG000|Treatment Period|Disease progression|43|||
146263455|NCT02654132|527478580|FG001|Treatment Period|Disease progression|38|||
146130339|NCT00743652|526998257|FG004|Overall Study|Lost to Follow-up|0|||
146130340|NCT02547129|526998258|FG000|Overall Study|Difficulty with ongoing infection|1|||
146263456|NCT02654132|527478579|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
146263457|NCT02654132|527478580|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
146263458|NCT02654132|527478579|FG000|Treatment Period|Other reasons|4|||
146263459|NCT02654132|527478580|FG001|Treatment Period|Other reasons|2|||
146263460|NCT02654132|527478579|FG000|Treatment Period|Study drug toxicity|2|||
146263461|NCT02654132|527478580|FG001|Treatment Period|Study drug toxicity|2|||
146263462|NCT02654132|527478579|FG000|Treatment Period|Withdrawal by Subject|2|||
146263463|NCT02654132|527478580|FG001|Treatment Period|Withdrawal by Subject|1|||
146263464|NCT02654132|527478579|FG000|Treatment Period|Maximum Clinical Benefit|0|||
146263465|NCT02654132|527478580|FG001|Treatment Period|Maximum Clinical Benefit|2|||
146263466|NCT02654132|527478579|FG000|Treatment Period|Participant request to discontinue|2|||
146263467|NCT02654132|527478580|FG001|Treatment Period|Participant request to discontinue|0|||
146263468|NCT02654132|527478579|FG000|Treatment Period|Administrative reasons by sponsor|0|||
146263469|NCT02654132|527478580|FG001|Treatment Period|Administrative reasons by sponsor|1|||
146263470|NCT02654132|527478579|FG000|Treatment Period|Death|1|||
146263471|NCT02654132|527478580|FG001|Treatment Period|Death|0|||
146263472|NCT03713320|527478581|FG000|Randomized Period|Adverse Event|1|||
146263473|NCT03713320|527478582|FG001|Randomized Period|Adverse Event|5|||
146263474|NCT03713320|527478583|FG002|Randomized Period|Adverse Event|0|||
146263475|NCT03713320|527478581|FG000|Randomized Period|Physician Decision|1|||
146263476|NCT03713320|527478582|FG001|Randomized Period|Physician Decision|1|||
146263477|NCT03713320|527478583|FG002|Randomized Period|Physician Decision|0|||
146263478|NCT03713320|527478581|FG000|Randomized Period|Withdrawal by Subject|4|||
146263479|NCT03713320|527478582|FG001|Randomized Period|Withdrawal by Subject|0|||
146263480|NCT03713320|527478583|FG002|Randomized Period|Withdrawal by Subject|0|||
146263481|NCT03713320|527478581|FG000|Randomized Period|Participant decision|3|||
146263482|NCT03713320|527478582|FG001|Randomized Period|Participant decision|1|||
146263483|NCT03713320|527478583|FG002|Randomized Period|Participant decision|0|||
146263484|NCT03713320|527478581|FG000|Randomized Period|Study terminated by sponsor|6|||
146263485|NCT03713320|527478582|FG001|Randomized Period|Study terminated by sponsor|3|||
146263486|NCT03713320|527478583|FG002|Randomized Period|Study terminated by sponsor|0|||
146263487|NCT03713320|527478581|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
146263488|NCT03713320|527478582|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
146263489|NCT03713320|527478583|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
146263490|NCT03713320|527478581|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
146263491|NCT03713320|527478582|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
146263492|NCT03713320|527478583|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
146263493|NCT01880437|527478584|FG000|Overall Study|Death|12|||
146263494|NCT01880437|527478585|FG001|Overall Study|Death|4|||
146263495|NCT01880437|527478586|FG002|Overall Study|Death|17|||
146263496|NCT01880437|527478584|FG000|Overall Study|Study terminated by Sponsor|3|||
146263497|NCT01880437|527478585|FG001|Overall Study|Study terminated by Sponsor|0|||
146263498|NCT01880437|527478586|FG002|Overall Study|Study terminated by Sponsor|2|||
146263499|NCT00909532|527478587|FG000|Overall Study|Adverse Event|4|||
146263500|NCT00909532|527478588|FG001|Overall Study|Adverse Event|1|||
146263501|NCT00909532|527478587|FG000|Overall Study|Pregnancy|0|||
146263502|NCT00909532|527478588|FG001|Overall Study|Pregnancy|1|||
146263503|NCT00909532|527478587|FG000|Overall Study|Prohibited Medication|2|||
146263504|NCT00909532|527478588|FG001|Overall Study|Prohibited Medication|1|||
146263505|NCT00909532|527478587|FG000|Overall Study|Withdrawal of Consent|1|||
146263506|NCT00909532|527478588|FG001|Overall Study|Withdrawal of Consent|1|||
146263507|NCT00909532|527478587|FG000|Overall Study|Noncompliance with Study Requirements|0|||
146263508|NCT00909532|527478588|FG001|Overall Study|Noncompliance with Study Requirements|2|||
146263509|NCT00909532|527478587|FG000|Overall Study|Physician Decision|1|||
146263510|NCT00909532|527478588|FG001|Overall Study|Physician Decision|0|||
146263511|NCT00909532|527478587|FG000|Overall Study|Wrong Genotype|1|||
146263512|NCT00909532|527478588|FG001|Overall Study|Wrong Genotype|0|||
146263513|NCT00909532|527478587|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
146263514|NCT00909532|527478588|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
146263515|NCT01209598|527478589|FG000|Overall Study|Withdrawal by Subject|1|||
146263516|NCT01209598|527478590|FG001|Overall Study|Withdrawal by Subject|0|||
146263517|NCT01174264|527478591|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
146263518|NCT01174264|527478592|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
146263519|NCT01174264|527478593|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
146263520|NCT01174264|527478591|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
146263521|NCT01174264|527478592|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
146263522|NCT01174264|527478593|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
146263523|NCT01174264|527478591|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
146263524|NCT01174264|527478592|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
146263525|NCT01174264|527478593|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
146263526|NCT04469465|527481108|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
146263527|NCT04469465|527481109|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
146263528|NCT04469465|527481108|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
146263529|NCT04469465|527481109|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
146263530|NCT04469465|527481108|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
146263531|NCT04469465|527481109|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
146263532|NCT04469465|527481108|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
146263533|NCT04469465|527481109|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
146263534|NCT04469465|527481108|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
146263535|NCT04469465|527481109|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
146263536|NCT04469465|527481108|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
146263537|NCT04469465|527481109|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
146263538|NCT04469465|527481108|FG000|Long-Term Extension (LTE)|Death|0|||
146263539|NCT04469465|527481109|FG001|Long-Term Extension (LTE)|Death|1|||
146263540|NCT04469465|527481108|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
146263541|NCT04469465|527481109|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
146263542|NCT01150045|527481110|FG000|Overall Study|Protocol Violation|0|||
146263543|NCT01150045|527481111|FG001|Overall Study|Protocol Violation|1|||
146263544|NCT01150045|527481112|FG002|Overall Study|Protocol Violation|0|||
146263545|NCT01150045|527481113|FG003|Overall Study|Protocol Violation|1|||
146263546|NCT04504630|527481117|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
146263547|NCT04504630|527481118|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
146263548|NCT04504630|527481117|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
146263549|NCT04504630|527481118|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
146263550|NCT01288209|527481119|FG000|Overall Study|Withdrawal by Subject|1|||
146263551|NCT01288209|527481120|FG001|Overall Study|Withdrawal by Subject|3|||
146263552|NCT01288209|527481119|FG000|Overall Study|Other|1|||
146263553|NCT01288209|527481120|FG001|Overall Study|Other|0|||
146263554|NCT01496365|527481121|FG000|Overall Study|Adverse Event|2|||
146263555|NCT01496365|527481122|FG001|Overall Study|Adverse Event|3|||
146263556|NCT01496365|527481123|FG002|Overall Study|Adverse Event|3|||
146263557|NCT01496365|527481124|FG003|Overall Study|Adverse Event|2|||
146263558|NCT01496365|527481125|FG004|Overall Study|Adverse Event|5|||
146263559|NCT01496365|527481126|FG005|Overall Study|Adverse Event|6|||
146263560|NCT01496365|527481127|FG006|Overall Study|Adverse Event|4|||
146263561|NCT01496365|527481121|FG000|Overall Study|Withdrawal by Subject|6|||
146263562|NCT01496365|527481122|FG001|Overall Study|Withdrawal by Subject|6|||
146263563|NCT01496365|527481123|FG002|Overall Study|Withdrawal by Subject|0|||
146263564|NCT01496365|527481124|FG003|Overall Study|Withdrawal by Subject|1|||
146263565|NCT01496365|527481125|FG004|Overall Study|Withdrawal by Subject|3|||
146263566|NCT01496365|527481126|FG005|Overall Study|Withdrawal by Subject|2|||
146263567|NCT01496365|527481127|FG006|Overall Study|Withdrawal by Subject|1|||
146263568|NCT01496365|527481121|FG000|Overall Study|Protocol Violation|2|||
146263569|NCT01496365|527481122|FG001|Overall Study|Protocol Violation|1|||
146263570|NCT01496365|527481123|FG002|Overall Study|Protocol Violation|1|||
146263571|NCT01496365|527481124|FG003|Overall Study|Protocol Violation|0|||
146263572|NCT01496365|527481125|FG004|Overall Study|Protocol Violation|0|||
146263573|NCT01496365|527481126|FG005|Overall Study|Protocol Violation|1|||
146263574|NCT01496365|527481127|FG006|Overall Study|Protocol Violation|0|||
146263575|NCT01496365|527481121|FG000|Overall Study|Lack of Efficacy|1|||
146263576|NCT01496365|527481122|FG001|Overall Study|Lack of Efficacy|0|||
146263577|NCT01496365|527481123|FG002|Overall Study|Lack of Efficacy|0|||
146263578|NCT01496365|527481124|FG003|Overall Study|Lack of Efficacy|0|||
146263579|NCT01496365|527481125|FG004|Overall Study|Lack of Efficacy|0|||
146263580|NCT01496365|527481126|FG005|Overall Study|Lack of Efficacy|1|||
146263581|NCT01496365|527481127|FG006|Overall Study|Lack of Efficacy|0|||
146263582|NCT01496365|527481121|FG000|Overall Study|Lost to Follow-up|0|||
146263583|NCT01496365|527481122|FG001|Overall Study|Lost to Follow-up|1|||
146263584|NCT01496365|527481123|FG002|Overall Study|Lost to Follow-up|0|||
146263585|NCT01496365|527481124|FG003|Overall Study|Lost to Follow-up|0|||
146263586|NCT01496365|527481125|FG004|Overall Study|Lost to Follow-up|2|||
146263587|NCT01496365|527481126|FG005|Overall Study|Lost to Follow-up|0|||
146263588|NCT01496365|527481127|FG006|Overall Study|Lost to Follow-up|0|||
146263589|NCT01496365|527481121|FG000|Overall Study|Other|4|||
146263590|NCT01496365|527481122|FG001|Overall Study|Other|4|||
146263591|NCT01496365|527481123|FG002|Overall Study|Other|2|||
146263592|NCT01496365|527481124|FG003|Overall Study|Other|1|||
146263593|NCT01496365|527481125|FG004|Overall Study|Other|3|||
146263594|NCT01496365|527481126|FG005|Overall Study|Other|0|||
146263595|NCT01496365|527481127|FG006|Overall Study|Other|1|||
146263596|NCT01015677|527481128|FG000|Overall Study|Adverse Event|0|||
146263597|NCT01015677|527481129|FG001|Overall Study|Adverse Event|1|||
146130341|NCT02547129|526998259|FG001|Overall Study|Difficulty with ongoing infection|0|||
146263598|NCT01015677|527481130|FG002|Overall Study|Adverse Event|0|||
146263599|NCT01015677|527481128|FG000|Overall Study|Lack of Efficacy|0|||
146130342|NCT00805766|526998260|FG000|Screening Period|Adverse Event|1|||
146130343|NCT00805766|526998260|FG000|Screening Period|Lack of Efficacy|2|||
146263600|NCT01015677|527481129|FG001|Overall Study|Lack of Efficacy|1|||
146263601|NCT01015677|527481130|FG002|Overall Study|Lack of Efficacy|0|||
146263602|NCT01015677|527481128|FG000|Overall Study|Protocol Violation|0|||
146263603|NCT01015677|527481129|FG001|Overall Study|Protocol Violation|1|||
146263604|NCT01015677|527481130|FG002|Overall Study|Protocol Violation|0|||
146263605|NCT01015677|527481128|FG000|Overall Study|Withdrawal by Subject|1|||
146263606|NCT01015677|527481129|FG001|Overall Study|Withdrawal by Subject|1|||
146263607|NCT01015677|527481130|FG002|Overall Study|Withdrawal by Subject|0|||
146263608|NCT02232399|527481131|FG000|Overall Study|Adverse Event|1|||
146263609|NCT02232399|527481132|FG001|Overall Study|Adverse Event|0|||
146263610|NCT02232399|527481131|FG000|Overall Study|Withdrawal by Subject|0|||
146263611|NCT02232399|527481132|FG001|Overall Study|Withdrawal by Subject|1|||
146263612|NCT03491215|527481133|FG000|Overall Study|Death|6|||
146263613|NCT03491215|527481134|FG001|Overall Study|Death|2|||
146263614|NCT03491215|527481135|FG002|Overall Study|Death|1|||
146263615|NCT03491215|527481136|FG003|Overall Study|Death|0|||
146263616|NCT03491215|527481133|FG000|Overall Study|Physician Decision|1|||
146263617|NCT03491215|527481134|FG001|Overall Study|Physician Decision|0|||
146263618|NCT03491215|527481135|FG002|Overall Study|Physician Decision|0|||
146263619|NCT03491215|527481136|FG003|Overall Study|Physician Decision|0|||
146263620|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
146263621|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
146263622|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
146263623|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
146263624|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
146263625|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
146263626|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
146263627|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
146263628|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
146263629|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
146263630|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
146263631|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
146263632|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
146263633|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
146263634|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
146263635|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
146263636|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
146263637|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
146263638|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
146263639|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
146263640|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
146263641|NCT04599855|527481137|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
146263642|NCT04599855|527481138|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
146263643|NCT04599855|527481139|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
146263644|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
146263645|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
146263646|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
146263647|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
146263648|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
146263649|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
146263650|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
146263651|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
146263652|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
146263653|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
146263654|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
146263655|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
146263656|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
146263657|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
146263658|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
146263659|NCT04599855|527481137|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
146263660|NCT04599855|527481138|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
146263661|NCT04599855|527481139|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
146263662|NCT04294667|527481140|FG000|Overall Study|Lack of Efficacy|4|||
146263663|NCT04294667|527481141|FG001|Overall Study|Lack of Efficacy|4|||
146263664|NCT04294667|527481140|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
146263665|NCT04294667|527481141|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
146303561|NCT01514136|527625843|FG002|Test Period 2; Test A*|Holiday|0|||
146303562|NCT01514136|527625844|FG003|Test Period 2; Test A*|Holiday|0|||
146303563|NCT01514136|527625845|FG004|Test Period 2; Test A*|Holiday|1|||
146130344|NCT00805766|526998260|FG000|Screening Period|Pregnancy|1|||
146130345|NCT00805766|526998260|FG000|Screening Period|Responder|2|||
146130346|NCT00805766|526998260|FG000|Increased Dose Period|Adverse Event|4|||
146130347|NCT00805766|526998260|FG000|Increased Dose Period|Lack of Efficacy|7|||
146130348|NCT00805766|526998260|FG000|Increased Dose Period|Pregnancy|1|||
146130349|NCT00805766|526998260|FG000|Increased Dose Period|Withdrawal by Subject|1|||
146130350|NCT03925324|526998261|FG000|Overall Study|Death|1|||
146130351|NCT03925324|526998262|FG001|Overall Study|Death|1|||
146130352|NCT00794196|526998263|FG000|Overall Study|Lost to Follow-up|5|||
146130353|NCT00794196|526998264|FG001|Overall Study|Lost to Follow-up|23|||
146130354|NCT02129803|526998268|FG000|Overall Study|Protocol Violation|4|||
146130355|NCT02129803|526998269|FG001|Overall Study|Protocol Violation|0|||
146263666|NCT04294667|527481140|FG000|Overall Study|Patient has a Renal Flare|1|||
146263667|NCT04294667|527481141|FG001|Overall Study|Patient has a Renal Flare|0|||
146263668|NCT04294667|527481140|FG000|Overall Study|SLE Worsening|0|||
146263669|NCT04294667|527481141|FG001|Overall Study|SLE Worsening|1|||
146130356|NCT02129803|526998268|FG000|Overall Study|Physician Decision|0|||
146130357|NCT02129803|526998269|FG001|Overall Study|Physician Decision|1|||
146130358|NCT02129803|526998268|FG000|Overall Study|Difficulty sleeping|1|||
146130359|NCT02129803|526998269|FG001|Overall Study|Difficulty sleeping|0|||
146130360|NCT02129803|526998268|FG000|Overall Study|Morning headache|0|||
146130361|NCT02129803|526998269|FG001|Overall Study|Morning headache|1|||
146130362|NCT02129803|526998268|FG000|Overall Study|Withdrawal by Subject|1|||
146130363|NCT02129803|526998269|FG001|Overall Study|Withdrawal by Subject|1|||
146130364|NCT00149747|526998276|FG000|Overall Study|Death|1|||
146130365|NCT00149747|526998277|FG001|Overall Study|Death|0|||
146130366|NCT00149747|526998276|FG000|Overall Study|Withdrawal by Subject|3|||
146130367|NCT00149747|526998277|FG001|Overall Study|Withdrawal by Subject|3|||
146130368|NCT03818516|526998278|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
146130369|NCT03742141|526998283|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
146130370|NCT00850395|526998284|FG000|Overall Study|Death|1|||
146130371|NCT00850395|526998284|FG000|Overall Study|Adverse Event|1|||
146130372|NCT00850395|526998284|FG000|Overall Study|Insufficient clinical response|3|||
146130373|NCT00850395|526998284|FG000|Overall Study|Other|5|||
146130374|NCT04371380|526998285|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
146130375|NCT04371380|526998286|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
146130376|NCT04371380|526998287|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
146130377|NCT02739269|526998288|FG000|Overall Study|Protocol Violation|5|||
146130378|NCT02739269|526998289|FG001|Overall Study|Protocol Violation|0|||
146130379|NCT02739269|526998288|FG000|Overall Study|Cycle cancellation|2|||
146130380|NCT02739269|526998289|FG001|Overall Study|Cycle cancellation|2|||
146130381|NCT02739269|526998288|FG000|Overall Study|Withdrawal by Subject|0|||
146130382|NCT02739269|526998289|FG001|Overall Study|Withdrawal by Subject|2|||
146130383|NCT00405548|526998292|FG000|Overall Study|Cognitive Memory problems on study day|1|||
146130384|NCT00405548|526998293|FG001|Overall Study|Cognitive Memory problems on study day|0|||
146130385|NCT00405548|526998292|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
146130386|NCT00405548|526998293|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
146130387|NCT00405548|526998292|FG000|Overall Study|Unable to self-administer shots|1|||
146130388|NCT00405548|526998293|FG001|Overall Study|Unable to self-administer shots|0|||
146130389|NCT00405548|526998292|FG000|Overall Study|Venous access failed during study day|1|||
146130390|NCT00405548|526998293|FG001|Overall Study|Venous access failed during study day|0|||
146130391|NCT00405548|526998292|FG000|Overall Study|Withdrawal by Subject|1|||
146130392|NCT00405548|526998293|FG001|Overall Study|Withdrawal by Subject|0|||
146130393|NCT01709695|526998294|FG000|Overall Study|Withdrawal by Subject|1|||
146130394|NCT01709695|526998295|FG001|Overall Study|Withdrawal by Subject|1|||
146130395|NCT00680901|526998299|FG000|Overall Study|Ongoing: On Study Treatment|1|||
146130396|NCT00680901|526998300|FG001|Overall Study|Ongoing: On Study Treatment|0|||
146130397|NCT00680901|526998299|FG000|Overall Study|Ongoing: In Follow Up|1|||
146130398|NCT00680901|526998300|FG001|Overall Study|Ongoing: In Follow Up|0|||
146130399|NCT00680901|526998299|FG000|Overall Study|Adverse Event|1|||
146130400|NCT00680901|526998300|FG001|Overall Study|Adverse Event|1|||
146130401|NCT00680901|526998299|FG000|Overall Study|Lost to Follow-up|3|||
146130402|NCT00680901|526998300|FG001|Overall Study|Lost to Follow-up|5|||
146130403|NCT00680901|526998299|FG000|Overall Study|Subject decided to withdraw from the study|4|||
146130404|NCT00680901|526998300|FG001|Overall Study|Subject decided to withdraw from the study|15|||
146130405|NCT00680901|526998299|FG000|Overall Study|Sponsor decision|1|||
146130406|NCT00680901|526998300|FG001|Overall Study|Sponsor decision|0|||
146130407|NCT00680901|526998299|FG000|Overall Study|Physician Decision|0|||
146130408|NCT00680901|526998300|FG001|Overall Study|Physician Decision|2|||
146130409|NCT00680901|526998299|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
146130410|NCT00680901|526998300|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
146130411|NCT00680901|526998299|FG000|Overall Study|Other protocol defined stopping criteria|17|||
146130412|NCT00680901|526998300|FG001|Overall Study|Other protocol defined stopping criteria|17|||
146130413|NCT00075582|526998301|FG000|Overall Study|Adverse Event|3|||
146130414|NCT00075582|526998302|FG001|Overall Study|Adverse Event|1|||
146130415|NCT00075582|526998301|FG000|Overall Study|Lack of Efficacy|4|||
146263670|NCT04294667|527481140|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
146263671|NCT04294667|527481141|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
146263672|NCT04294667|527481140|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
146263673|NCT04294667|527481141|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
146263674|NCT04294667|527481140|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
146130416|NCT00075582|526998302|FG001|Overall Study|Lack of Efficacy|8|||
146130417|NCT00075582|526998301|FG000|Overall Study|Physician Decision|5|||
146130418|NCT00075582|526998302|FG001|Overall Study|Physician Decision|8|||
146130419|NCT00075582|526998301|FG000|Overall Study|Withdrawal by Subject|2|||
146130420|NCT00075582|526998302|FG001|Overall Study|Withdrawal by Subject|2|||
146130421|NCT00075582|526998301|FG000|Overall Study|Ineligible for study|36|||
146130422|NCT00075582|526998302|FG001|Overall Study|Ineligible for study|16|||
146130423|NCT01177540|526998303|FG000|Overall Study|Adverse Event|1|||
146263675|NCT04294667|527481141|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
146263676|NCT04294667|527481140|FG000|Overall Study|Subject Moved to Another State|0|||
146263677|NCT04294667|527481141|FG001|Overall Study|Subject Moved to Another State|1|||
146263678|NCT04294667|527481140|FG000|Overall Study|Adverse event, serious fatal|0|||
146263679|NCT04294667|527481141|FG001|Overall Study|Adverse event, serious fatal|1|||
146263680|NCT04294667|527481140|FG000|Overall Study|Adverse event, non-fatal|3|||
146263681|NCT04294667|527481141|FG001|Overall Study|Adverse event, non-fatal|4|||
146263682|NCT02165397|527481142|FG000|Overall Study|Death|7|||
146263683|NCT02165397|527481143|FG001|Overall Study|Death|10|||
146263684|NCT02165397|527481144|FG002|Overall Study|Death|8|||
146263685|NCT02165397|527481142|FG000|Overall Study|Lost to Follow-up|1|||
146263686|NCT02165397|527481143|FG001|Overall Study|Lost to Follow-up|3|||
146263687|NCT02165397|527481144|FG002|Overall Study|Lost to Follow-up|0|||
146263688|NCT02165397|527481142|FG000|Overall Study|Withdrawal by Subject|6|||
146263689|NCT02165397|527481143|FG001|Overall Study|Withdrawal by Subject|6|||
146263690|NCT02165397|527481144|FG002|Overall Study|Withdrawal by Subject|1|||
146263691|NCT02165397|527481142|FG000|Overall Study|Other, Not Specified|0|||
146263692|NCT02165397|527481143|FG001|Overall Study|Other, Not Specified|0|||
146263693|NCT02165397|527481144|FG002|Overall Study|Other, Not Specified|1|||
146263694|NCT03297398|527481145|FG000|Overall Study|Sponsor's decision|6|||
146263695|NCT03297398|527481146|FG001|Overall Study|Sponsor's decision|9|||
146263696|NCT03297398|527481147|FG002|Overall Study|Sponsor's decision|7|||
146263697|NCT03297398|527481145|FG000|Overall Study|Adverse Event|1|||
146263698|NCT03297398|527481146|FG001|Overall Study|Adverse Event|4|||
146263699|NCT03297398|527481147|FG002|Overall Study|Adverse Event|4|||
146263700|NCT03297398|527481145|FG000|Overall Study|Withdrawal by Subject|1|||
146263701|NCT03297398|527481146|FG001|Overall Study|Withdrawal by Subject|2|||
146263702|NCT03297398|527481147|FG002|Overall Study|Withdrawal by Subject|2|||
146263703|NCT03297398|527481145|FG000|Overall Study|Protocol Violation|0|||
146263704|NCT03297398|527481146|FG001|Overall Study|Protocol Violation|2|||
146263705|NCT03297398|527481147|FG002|Overall Study|Protocol Violation|0|||
146263706|NCT03297398|527481145|FG000|Overall Study|Physician Decision|0|||
146263707|NCT03297398|527481146|FG001|Overall Study|Physician Decision|0|||
146263708|NCT03297398|527481147|FG002|Overall Study|Physician Decision|1|||
146263709|NCT03297398|527481145|FG000|Overall Study|Lost to Follow-up|0|||
146263710|NCT03297398|527481146|FG001|Overall Study|Lost to Follow-up|0|||
146263711|NCT03297398|527481147|FG002|Overall Study|Lost to Follow-up|1|||
146263712|NCT03481556|527481152|FG000|Overall Study|Adverse Event|1|||
146263713|NCT03481556|527481153|FG001|Overall Study|Adverse Event|0|||
146263714|NCT03481556|527481154|FG002|Overall Study|Adverse Event|0|||
146263715|NCT03481556|527481155|FG003|Overall Study|Adverse Event|0|||
146263716|NCT03481556|527481152|FG000|Overall Study|Death|4|||
146263717|NCT03481556|527481153|FG001|Overall Study|Death|2|||
146263718|NCT03481556|527481154|FG002|Overall Study|Death|3|||
146263719|NCT03481556|527481155|FG003|Overall Study|Death|16|||
146263720|NCT03481556|527481152|FG000|Overall Study|Study Terminated by Sponsor|10|||
146263721|NCT03481556|527481153|FG001|Overall Study|Study Terminated by Sponsor|5|||
146263722|NCT03481556|527481154|FG002|Overall Study|Study Terminated by Sponsor|2|||
146263723|NCT03481556|527481155|FG003|Overall Study|Study Terminated by Sponsor|9|||
146263724|NCT01316887|527481156|FG000|Overall Study|Adverse Event|13|||
146303564|NCT01514136|527625846|FG005|Test Period 2; Test A*|Holiday|0|||
146303565|NCT01514136|527625847|FG006|Test Period 2; Test A*|Holiday|0|||
146303566|NCT01514136|527625848|FG007|Test Period 2; Test A*|Holiday|0|||
146303567|NCT01514136|527625841|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
146303568|NCT01514136|527625842|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
146130424|NCT01177540|526998304|FG001|Overall Study|Adverse Event|0|||
146130425|NCT01070316|526998305|FG000|Extension Phase|Lack of Efficacy|3|||
146130426|NCT01070316|526998305|FG000|Extension Phase|Withdrawal by Subject|1|||
146130427|NCT01132495|526998308|FG000|Overall Study|Various reasons|40|||
146130428|NCT01132495|526998309|FG001|Overall Study|Various reasons|38|||
146263725|NCT01316887|527481157|FG001|Overall Study|Adverse Event|21|||
146263726|NCT01316887|527481158|FG002|Overall Study|Adverse Event|17|||
146263727|NCT01316887|527481156|FG000|Overall Study|Lack of Efficacy|9|||
146263728|NCT01316887|527481157|FG001|Overall Study|Lack of Efficacy|3|||
146263729|NCT01316887|527481158|FG002|Overall Study|Lack of Efficacy|1|||
146303569|NCT01514136|527625843|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
146303570|NCT01514136|527625844|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
146263730|NCT01316887|527481156|FG000|Overall Study|Protocol Violation|2|||
146263731|NCT01316887|527481157|FG001|Overall Study|Protocol Violation|6|||
146263732|NCT01316887|527481158|FG002|Overall Study|Protocol Violation|6|||
146263733|NCT01316887|527481156|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
146130429|NCT01132495|526998310|FG002|Overall Study|Various reasons|20|||
146130430|NCT01132495|526998311|FG003|Overall Study|Various reasons|12|||
146263734|NCT01316887|527481157|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
146263735|NCT01316887|527481158|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
146263736|NCT01316887|527481156|FG000|Overall Study|Study Closed/Terminated|2|||
146263737|NCT01316887|527481157|FG001|Overall Study|Study Closed/Terminated|4|||
146263738|NCT01316887|527481158|FG002|Overall Study|Study Closed/Terminated|3|||
146263739|NCT01316887|527481156|FG000|Overall Study|Lost to Follow-up|1|||
146263740|NCT01316887|527481157|FG001|Overall Study|Lost to Follow-up|7|||
146263741|NCT01316887|527481158|FG002|Overall Study|Lost to Follow-up|5|||
146263742|NCT01316887|527481156|FG000|Overall Study|Withdrawal by Subject|8|||
146263743|NCT01316887|527481157|FG001|Overall Study|Withdrawal by Subject|16|||
146263744|NCT01316887|527481158|FG002|Overall Study|Withdrawal by Subject|15|||
146263745|NCT02172950|527481159|FG000|Overall Study|Physician Decision|3|||
146263746|NCT02172950|527481160|FG001|Overall Study|Physician Decision|3|||
146263747|NCT02172950|527481159|FG000|Overall Study|Lack of Efficacy|1|||
146263748|NCT02172950|527481160|FG001|Overall Study|Lack of Efficacy|0|||
146263749|NCT02172950|527481159|FG000|Overall Study|Adverse Event|4|||
146263750|NCT02172950|527481160|FG001|Overall Study|Adverse Event|1|||
146263751|NCT02172950|527481159|FG000|Overall Study|Withdrawal by Subject|10|||
146263752|NCT02172950|527481160|FG001|Overall Study|Withdrawal by Subject|0|||
146263753|NCT02172950|527481159|FG000|Overall Study|Protocol Violation|1|||
146263754|NCT02172950|527481160|FG001|Overall Study|Protocol Violation|0|||
146263755|NCT02172950|527481159|FG000|Overall Study|Lost to Follow-up|1|||
146263756|NCT02172950|527481160|FG001|Overall Study|Lost to Follow-up|0|||
146263757|NCT02172950|527481159|FG000|Overall Study|Death|1|||
146263758|NCT02172950|527481160|FG001|Overall Study|Death|0|||
146263759|NCT02172950|527481159|FG000|Overall Study|Patient traveling|1|||
146263760|NCT02172950|527481160|FG001|Overall Study|Patient traveling|0|||
146263761|NCT02172950|527481159|FG000|Overall Study|Patient went to other country|1|||
146263762|NCT02172950|527481160|FG001|Overall Study|Patient went to other country|0|||
146263763|NCT02172950|527481159|FG000|Overall Study|Patient relocated overseas|1|||
146263764|NCT02172950|527481160|FG001|Overall Study|Patient relocated overseas|1|||
146263765|NCT02172950|527481159|FG000|Overall Study|Patient moving|1|||
146263766|NCT02172950|527481160|FG001|Overall Study|Patient moving|0|||
146263767|NCT00611715|527481161|FG000|Overall Study|Disease Progression|24|||
146263768|NCT00611715|527481162|FG001|Overall Study|Disease Progression|4|||
146263769|NCT00611715|527481161|FG000|Overall Study|Withdrawal by Subject|5|||
146263770|NCT00611715|527481162|FG001|Overall Study|Withdrawal by Subject|1|||
146263771|NCT00611715|527481161|FG000|Overall Study|Adverse Event|9|||
146263772|NCT00611715|527481162|FG001|Overall Study|Adverse Event|1|||
146263773|NCT00611715|527481161|FG000|Overall Study|Death|1|||
146263774|NCT00611715|527481162|FG001|Overall Study|Death|0|||
146263775|NCT00611715|527481161|FG000|Overall Study|two patients are still on treatment|2|||
146263776|NCT00611715|527481162|FG001|Overall Study|two patients are still on treatment|0|||
146263777|NCT00107978|527481163|FG000|Overall Study|Adverse Event|1|||
146263778|NCT00107978|527481164|FG001|Overall Study|Adverse Event|5|||
146263779|NCT00107978|527481163|FG000|Overall Study|Death|3|||
146263780|NCT00107978|527481164|FG001|Overall Study|Death|3|||
146263781|NCT00107978|527481163|FG000|Overall Study|Lost to Follow-up|20|||
146263782|NCT00107978|527481164|FG001|Overall Study|Lost to Follow-up|28|||
146263783|NCT00107978|527481163|FG000|Overall Study|Withdrawal by Subject|4|||
146263784|NCT00107978|527481164|FG001|Overall Study|Withdrawal by Subject|9|||
146263785|NCT00107978|527481163|FG000|Overall Study|Protocol Violation|0|||
146263786|NCT00107978|527481164|FG001|Overall Study|Protocol Violation|1|||
146263787|NCT00107978|527481163|FG000|Overall Study|Other|5|||
146263788|NCT00107978|527481164|FG001|Overall Study|Other|4|||
146263789|NCT00350298|527481167|FG000|Overall Study|Death|7|||
146263790|NCT00350298|527481168|FG001|Overall Study|Death|8|||
146263791|NCT00350298|527481167|FG000|Overall Study|Lost to Follow-up|1|||
146263792|NCT00350298|527481168|FG001|Overall Study|Lost to Follow-up|2|||
146263793|NCT00350298|527481167|FG000|Overall Study|Withdrawal by Subject|1|||
146263794|NCT00350298|527481168|FG001|Overall Study|Withdrawal by Subject|3|||
146263795|NCT00233389|527481171|FG000|Overall Study|Adverse Event|5|||
146263796|NCT00233389|527481172|FG001|Overall Study|Adverse Event|5|||
146263797|NCT00233389|527481171|FG000|Overall Study|Lack of Efficacy|11|||
146263798|NCT00233389|527481172|FG001|Overall Study|Lack of Efficacy|8|||
146263799|NCT00233389|527481171|FG000|Overall Study|Lost to Follow-up|1|||
146263800|NCT00233389|527481172|FG001|Overall Study|Lost to Follow-up|1|||
146263801|NCT00233389|527481171|FG000|Overall Study|Physician Decision|1|||
146263802|NCT00233389|527481172|FG001|Overall Study|Physician Decision|0|||
146263803|NCT00233389|527481171|FG000|Overall Study|Protocol Violation|0|||
146263804|NCT00233389|527481172|FG001|Overall Study|Protocol Violation|1|||
146263805|NCT00233389|527481171|FG000|Overall Study|Withdrawal by Subject|0|||
146263806|NCT00233389|527481172|FG001|Overall Study|Withdrawal by Subject|1|||
146263807|NCT02312206|527481181|FG000|Overall Study|Adverse Event|3|||
146263808|NCT02312206|527481182|FG001|Overall Study|Adverse Event|6|||
146263809|NCT02312206|527481181|FG000|Overall Study|Withdrawal by Subject|6|||
146303571|NCT01514136|527625845|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
146263810|NCT02312206|527481182|FG001|Overall Study|Withdrawal by Subject|6|||
146263811|NCT02312206|527481181|FG000|Overall Study|Physician Decision|7|||
146263812|NCT02312206|527481182|FG001|Overall Study|Physician Decision|6|||
146263813|NCT02312206|527481181|FG000|Overall Study|Death|31|||
146263814|NCT02312206|527481182|FG001|Overall Study|Death|36|||
146263815|NCT02312206|527481181|FG000|Overall Study|Study Terminated by Sponsor|81|||
146263816|NCT02312206|527481182|FG001|Overall Study|Study Terminated by Sponsor|74|||
146263817|NCT02312206|527481181|FG000|Overall Study|Patient transferred to hospice|0|||
146263818|NCT02312206|527481182|FG001|Overall Study|Patient transferred to hospice|1|||
146263819|NCT02312206|527481181|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
146263820|NCT02312206|527481182|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
146263821|NCT02312206|527481181|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
146263822|NCT02312206|527481182|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
146263823|NCT02312206|527481181|FG000|Overall Study|Disease Progression|1|||
146263824|NCT02312206|527481182|FG001|Overall Study|Disease Progression|0|||
146263825|NCT00585975|527481183|FG000|Overall Study|Withdrawal by Subject|3|||
146263826|NCT00585975|527481184|FG001|Overall Study|Withdrawal by Subject|3|||
146263827|NCT00585975|527481183|FG000|Overall Study|Lost to Follow-up|2|||
146263828|NCT00585975|527481184|FG001|Overall Study|Lost to Follow-up|1|||
146263829|NCT00585975|527481183|FG000|Overall Study|Enrollment met/over-enrolled|10|||
146263830|NCT00585975|527481184|FG001|Overall Study|Enrollment met/over-enrolled|9|||
146263831|NCT03082612|527481185|FG000|Overall Study|Lost to Follow-up|2|||
146263832|NCT03082612|527481186|FG001|Overall Study|Lost to Follow-up|0|||
146263833|NCT01006616|527481187|FG000|Period 1 (6 Months)|Adverse Event|10|||
146263834|NCT01006616|527481188|FG001|Period 1 (6 Months)|Adverse Event|31|||
146263835|NCT01006616|527481189|FG002|Period 1 (6 Months)|Adverse Event|37|||
146263836|NCT01006616|527481190|FG003|Period 1 (6 Months)|Adverse Event|9|||
146263837|NCT01006616|527481187|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
146263838|NCT01006616|527481188|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
146263839|NCT01006616|527481189|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
146263840|NCT01006616|527481190|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
146263841|NCT01006616|527481187|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
146263842|NCT01006616|527481188|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
146263843|NCT01006616|527481189|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
146263844|NCT01006616|527481190|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
146263845|NCT01006616|527481187|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
146263846|NCT01006616|527481188|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
146263847|NCT01006616|527481189|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
146263848|NCT01006616|527481190|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146263849|NCT01006616|527481187|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
146263850|NCT01006616|527481188|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
146263851|NCT01006616|527481189|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
146263852|NCT01006616|527481190|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
146263853|NCT01006616|527481187|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
146263854|NCT01006616|527481188|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
146263855|NCT01006616|527481189|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
146263856|NCT01006616|527481190|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
146263857|NCT01006616|527481187|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146263858|NCT01006616|527481188|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
146263859|NCT01006616|527481189|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146263860|NCT01006616|527481190|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
146263861|NCT01006616|527481187|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
146263862|NCT01006616|527481188|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
146263863|NCT01006616|527481189|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
146263864|NCT01006616|527481190|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
146263865|NCT01006616|527481187|FG000|Period 1 (6 Months)|Not Treated|0|||
146263866|NCT01006616|527481188|FG001|Period 1 (6 Months)|Not Treated|0|||
146263867|NCT01006616|527481189|FG002|Period 1 (6 Months)|Not Treated|1|||
146263868|NCT01006616|527481190|FG003|Period 1 (6 Months)|Not Treated|1|||
146263869|NCT01006616|527481187|FG000|Period 2 (18 Months)|Adverse Event|6|||
146263870|NCT01006616|527481188|FG001|Period 2 (18 Months)|Adverse Event|6|||
146263871|NCT01006616|527481189|FG002|Period 2 (18 Months)|Adverse Event|6|||
146263872|NCT01006616|527481190|FG003|Period 2 (18 Months)|Adverse Event|4|||
146263873|NCT01006616|527481187|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
146263874|NCT01006616|527481188|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
146263875|NCT01006616|527481189|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
146263876|NCT01006616|527481190|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
146263877|NCT01006616|527481187|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
146263878|NCT01006616|527481188|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
146263879|NCT01006616|527481189|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
146263880|NCT01006616|527481190|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
146263881|NCT01006616|527481187|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146263882|NCT01006616|527481188|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
146263883|NCT01006616|527481189|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
146263884|NCT01006616|527481190|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
146263885|NCT01006616|527481187|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
146263886|NCT01006616|527481188|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
146263887|NCT01006616|527481189|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
146303572|NCT01514136|527625846|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
146263888|NCT01006616|527481190|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
146263889|NCT01006616|527481187|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
146263890|NCT01006616|527481188|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
146263891|NCT01006616|527481189|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
146263892|NCT01006616|527481190|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
146263893|NCT01006616|527481187|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
146263894|NCT01006616|527481188|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
146263895|NCT01006616|527481189|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
146263896|NCT01006616|527481190|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
146263897|NCT01006616|527481187|FG000|Period 2 (18 Months)|Study Terminated|63|||
146263898|NCT01006616|527481188|FG001|Period 2 (18 Months)|Study Terminated|46|||
146263899|NCT01006616|527481189|FG002|Period 2 (18 Months)|Study Terminated|44|||
146263900|NCT01006616|527481190|FG003|Period 2 (18 Months)|Study Terminated|70|||
146263901|NCT00992992|527481197|FG000|Overall Study|Lost to Follow-up|3|||
146263902|NCT00992992|527481197|FG000|Overall Study|Death|16|||
146263903|NCT00992992|527481197|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
146263904|NCT00992992|527481197|FG000|Overall Study|Sponsor Closed the Study|4|||
146263905|NCT00952848|527481198|FG000|Overall Study|Withdrawal by Subject|4|||
146263906|NCT02250534|527481199|FG000|Overall Study|Lost to Follow-up|18|||
146263907|NCT02250534|527481200|FG001|Overall Study|Lost to Follow-up|28|||
146263908|NCT02250534|527481201|FG002|Overall Study|Lost to Follow-up|33|||
146263909|NCT02250534|527481199|FG000|Overall Study|Personal reasons|7|||
146263910|NCT02250534|527481200|FG001|Overall Study|Personal reasons|8|||
146263911|NCT02250534|527481201|FG002|Overall Study|Personal reasons|14|||
146263912|NCT02250534|527481199|FG000|Overall Study|Adverse Event|6|||
146263913|NCT02250534|527481200|FG001|Overall Study|Adverse Event|3|||
146263914|NCT02250534|527481201|FG002|Overall Study|Adverse Event|8|||
146263915|NCT02250534|527481199|FG000|Overall Study|incarcerated|2|||
146263916|NCT02250534|527481200|FG001|Overall Study|incarcerated|1|||
146263917|NCT02250534|527481201|FG002|Overall Study|incarcerated|2|||
146263918|NCT02250534|527481199|FG000|Overall Study|Withdrawal by Subject|0|||
146263919|NCT02250534|527481200|FG001|Overall Study|Withdrawal by Subject|1|||
146263920|NCT02250534|527481201|FG002|Overall Study|Withdrawal by Subject|2|||
146263921|NCT02250534|527481199|FG000|Overall Study|Death|0|||
146263922|NCT02250534|527481200|FG001|Overall Study|Death|1|||
146263923|NCT02250534|527481201|FG002|Overall Study|Death|1|||
146263924|NCT02250534|527481199|FG000|Overall Study|Physician Decision|1|||
146263925|NCT02250534|527481200|FG001|Overall Study|Physician Decision|3|||
146263926|NCT02250534|527481201|FG002|Overall Study|Physician Decision|1|||
146263927|NCT02250534|527481199|FG000|Overall Study|Protocol Violation|1|||
146263928|NCT02250534|527481200|FG001|Overall Study|Protocol Violation|0|||
146263929|NCT02250534|527481201|FG002|Overall Study|Protocol Violation|1|||
146263930|NCT02250534|527481199|FG000|Overall Study|Reason unknown|1|||
146263931|NCT02250534|527481200|FG001|Overall Study|Reason unknown|0|||
146263932|NCT02250534|527481201|FG002|Overall Study|Reason unknown|0|||
146263933|NCT00217022|527481203|FG000|Overall Study|Withdrawal by Subject|1|||
146263934|NCT00217022|527481204|FG001|Overall Study|Withdrawal by Subject|1|||
146263935|NCT00458393|527481205|FG000|Overall Study|Withdrawal by Subject|67|||
146263936|NCT00458393|527481206|FG001|Overall Study|Withdrawal by Subject|80|||
146263937|NCT00458393|527481205|FG000|Overall Study|Physician Decision|31|||
146263938|NCT00458393|527481206|FG001|Overall Study|Physician Decision|22|||
146263939|NCT00458393|527481205|FG000|Overall Study|Relocated|77|||
146263940|NCT00458393|527481206|FG001|Overall Study|Relocated|81|||
146263941|NCT00458393|527481205|FG000|Overall Study|Lost to Follow-up|115|||
146263942|NCT00458393|527481206|FG001|Overall Study|Lost to Follow-up|92|||
146263943|NCT00458393|527481205|FG000|Overall Study|Sites marked other on the form.|19|||
146263944|NCT00458393|527481206|FG001|Overall Study|Sites marked other on the form.|20|||
146263945|NCT01253447|527481208|FG000|Overall Study|Adverse Event|2|||
146263946|NCT02108652|527481209|FG000|Overall Study|Death|253|||
146263947|NCT02108652|527481209|FG000|Overall Study|Lost to Follow-up|2|||
146263948|NCT02108652|527481209|FG000|Overall Study|Withdrawal by Subject|16|||
146263949|NCT02108652|527481209|FG000|Overall Study|Study Terminated By Sponsor|31|||
146263950|NCT02108652|527481209|FG000|Overall Study|Non-Compliance|1|||
146263951|NCT02108652|527481209|FG000|Overall Study|Physician Decision|6|||
146263952|NCT02108652|527481209|FG000|Overall Study|Progression Of Disease|1|||
146263953|NCT00511797|527481217|FG000|Overall Study|Adverse Event|1|||
146263954|NCT00511797|527481218|FG001|Overall Study|Adverse Event|2|||
146263955|NCT00511797|527481219|FG002|Overall Study|Adverse Event|2|||
146263956|NCT00511797|527481220|FG003|Overall Study|Adverse Event|2|||
146263957|NCT00511797|527481217|FG000|Overall Study|Lost to Follow-up|1|||
146263958|NCT00511797|527481218|FG001|Overall Study|Lost to Follow-up|0|||
146263959|NCT00511797|527481219|FG002|Overall Study|Lost to Follow-up|0|||
146263960|NCT00511797|527481220|FG003|Overall Study|Lost to Follow-up|1|||
146263961|NCT00511797|527481217|FG000|Overall Study|Pregnancy|0|||
146263962|NCT00511797|527481218|FG001|Overall Study|Pregnancy|0|||
146263963|NCT00511797|527481219|FG002|Overall Study|Pregnancy|0|||
146263964|NCT00511797|527481220|FG003|Overall Study|Pregnancy|1|||
146263965|NCT00511797|527481217|FG000|Overall Study|Protocol Violation|0|||
146263966|NCT00511797|527481218|FG001|Overall Study|Protocol Violation|2|||
146263967|NCT00511797|527481219|FG002|Overall Study|Protocol Violation|2|||
146263968|NCT00511797|527481220|FG003|Overall Study|Protocol Violation|3|||
146263969|NCT00511797|527481217|FG000|Overall Study|Withdrawal by Subject|3|||
146263970|NCT00511797|527481218|FG001|Overall Study|Withdrawal by Subject|3|||
146263971|NCT00511797|527481219|FG002|Overall Study|Withdrawal by Subject|4|||
146263972|NCT00511797|527481220|FG003|Overall Study|Withdrawal by Subject|2|||
146263973|NCT00511797|527481217|FG000|Overall Study|Never dispensed|1|||
146263974|NCT00511797|527481218|FG001|Overall Study|Never dispensed|0|||
146263975|NCT00511797|527481219|FG002|Overall Study|Never dispensed|1|||
146263976|NCT00511797|527481220|FG003|Overall Study|Never dispensed|3|||
146263977|NCT00511797|527481217|FG000|Overall Study|Study drug not taken|0|||
146263978|NCT00511797|527481218|FG001|Overall Study|Study drug not taken|1|||
146263979|NCT00511797|527481219|FG002|Overall Study|Study drug not taken|0|||
146263980|NCT00511797|527481220|FG003|Overall Study|Study drug not taken|1|||
146263981|NCT00511797|527481217|FG000|Overall Study|Partially missing diary|0|||
146263982|NCT00511797|527481218|FG001|Overall Study|Partially missing diary|0|||
146263983|NCT00511797|527481219|FG002|Overall Study|Partially missing diary|1|||
146263984|NCT00511797|527481220|FG003|Overall Study|Partially missing diary|0|||
146263985|NCT00511797|527481217|FG000|Overall Study|Other (moving etc)|1|||
146263986|NCT00511797|527481218|FG001|Overall Study|Other (moving etc)|0|||
146263987|NCT00511797|527481219|FG002|Overall Study|Other (moving etc)|1|||
146263988|NCT00511797|527481220|FG003|Overall Study|Other (moving etc)|2|||
146263989|NCT01121913|527481221|FG000|First Intervention Period|Adverse Event|0|||
146263990|NCT01121913|527481222|FG001|First Intervention Period|Adverse Event|0|||
146263991|NCT01121913|527481223|FG002|First Intervention Period|Adverse Event|1|||
146263992|NCT01121913|527481224|FG003|First Intervention Period|Adverse Event|0|||
146263993|NCT01121913|527481221|FG000|First Washout Period|Withdrawal by Subject|1|||
146263994|NCT01121913|527481222|FG001|First Washout Period|Withdrawal by Subject|0|||
146263995|NCT01121913|527481223|FG002|First Washout Period|Withdrawal by Subject|0|||
146263996|NCT01121913|527481224|FG003|First Washout Period|Withdrawal by Subject|0|||
146263997|NCT01121913|527481221|FG000|Second Intervention Period|Adverse Event|0|||
146263998|NCT01121913|527481222|FG001|Second Intervention Period|Adverse Event|0|||
146263999|NCT01121913|527481223|FG002|Second Intervention Period|Adverse Event|1|||
146264000|NCT01121913|527481224|FG003|Second Intervention Period|Adverse Event|0|||
146264001|NCT01121913|527481221|FG000|Second Washout Period|Withdrawal by Subject|0|||
146264002|NCT01121913|527481222|FG001|Second Washout Period|Withdrawal by Subject|0|||
146264003|NCT01121913|527481223|FG002|Second Washout Period|Withdrawal by Subject|1|||
146264004|NCT01121913|527481224|FG003|Second Washout Period|Withdrawal by Subject|0|||
146264005|NCT01121913|527481221|FG000|Third Washout Period|Adverse Event|1|||
146264006|NCT01121913|527481222|FG001|Third Washout Period|Adverse Event|0|||
146264007|NCT01121913|527481223|FG002|Third Washout Period|Adverse Event|0|||
146264008|NCT01121913|527481224|FG003|Third Washout Period|Adverse Event|0|||
146264009|NCT03845075|527481225|FG000|Part 1 - DB|Withdrawal by Subject|1|||
146264010|NCT03845075|527481226|FG001|Part 1 - DB|Withdrawal by Subject|1|||
146264011|NCT03845075|527481227|FG002|Part 1 - DB|Withdrawal by Subject|0|||
146264012|NCT03845075|527481228|FG003|Part 1 - DB|Withdrawal by Subject|0|||
146264013|NCT03845075|527481225|FG000|Part 1 - DB|Adverse Event|0|||
146264014|NCT03845075|527481226|FG001|Part 1 - DB|Adverse Event|1|||
146264015|NCT03845075|527481227|FG002|Part 1 - DB|Adverse Event|0|||
146264016|NCT03845075|527481228|FG003|Part 1 - DB|Adverse Event|0|||
146264017|NCT03845075|527481225|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
146264018|NCT03845075|527481226|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146264019|NCT03845075|527481227|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146264020|NCT03845075|527481228|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
146264021|NCT01017263|527481229|FG000|Overall Study|not eligible|12|||
146264022|NCT01560871|527481230|FG000|Overall Study|transportation issues|2|||
146264023|NCT01560871|527481231|FG001|Overall Study|transportation issues|1|||
146264024|NCT01560871|527481230|FG000|Overall Study|relocation|1|||
146264025|NCT01560871|527481231|FG001|Overall Study|relocation|0|||
146264026|NCT01560871|527481230|FG000|Overall Study|readmission to a hospital|2|||
146264027|NCT01560871|527481231|FG001|Overall Study|readmission to a hospital|1|||
146264028|NCT01560871|527481230|FG000|Overall Study|Lost to Follow-up|1|||
146264029|NCT01560871|527481231|FG001|Overall Study|Lost to Follow-up|0|||
146264030|NCT02287233|527481232|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
146264031|NCT02287233|527481233|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
146264032|NCT02287233|527481234|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
146264033|NCT02287233|527481232|FG000|Overall Study|Adverse Event Related to Progression|0|||
146264034|NCT02287233|527481233|FG001|Overall Study|Adverse Event Related to Progression|2|||
146130431|NCT00082433|526998312|FG000|Overall Study|Adverse Event|12|||
146264035|NCT02287233|527481234|FG002|Overall Study|Adverse Event Related to Progression|8|||
146264036|NCT02287233|527481232|FG000|Overall Study|Physician Decision|1|||
146264037|NCT02287233|527481233|FG001|Overall Study|Physician Decision|2|||
146130432|NCT00082433|526998313|FG001|Overall Study|Adverse Event|17|||
146130433|NCT00082433|526998312|FG000|Overall Study|Death|8|||
146130434|NCT00082433|526998313|FG001|Overall Study|Death|18|||
146130435|NCT00082433|526998312|FG000|Overall Study|Disease Progression/Relapse|270|||
146130436|NCT00082433|526998313|FG001|Overall Study|Disease Progression/Relapse|388|||
146130437|NCT00082433|526998312|FG000|Overall Study|Physician Decision|50|||
146130438|NCT00082433|526998313|FG001|Overall Study|Physician Decision|61|||
146130439|NCT00082433|526998312|FG000|Overall Study|Lost to Follow-up|1|||
146130440|NCT00082433|526998313|FG001|Overall Study|Lost to Follow-up|2|||
146130441|NCT00082433|526998312|FG000|Overall Study|Study Drug Toxicity|179|||
146130442|NCT00082433|526998313|FG001|Overall Study|Study Drug Toxicity|66|||
146130443|NCT00082433|526998312|FG000|Overall Study|Withdrawal by Subject|55|||
146130444|NCT00082433|526998313|FG001|Overall Study|Withdrawal by Subject|30|||
146130445|NCT00082433|526998312|FG000|Overall Study|Still On Treatment|2|||
146130446|NCT00082433|526998313|FG001|Overall Study|Still On Treatment|1|||
146130447|NCT00082433|526998312|FG000|Overall Study|Not Treated|12|||
146130448|NCT00082433|526998313|FG001|Overall Study|Not Treated|11|||
146130449|NCT00082433|526998312|FG000|Overall Study|Ineligible|2|||
146130450|NCT00082433|526998313|FG001|Overall Study|Ineligible|1|||
146130451|NCT00082433|526998312|FG000|Overall Study|Noncompliance|2|||
146130452|NCT00082433|526998313|FG001|Overall Study|Noncompliance|1|||
146130453|NCT00082433|526998312|FG000|Overall Study|New primary cancer|1|||
146130454|NCT00082433|526998313|FG001|Overall Study|New primary cancer|0|||
146130455|NCT00082433|526998312|FG000|Overall Study|Impending surgery|0|||
146130456|NCT00082433|526998313|FG001|Overall Study|Impending surgery|1|||
146130457|NCT01796197|526998316|FG000|Overall Study|Lost to Follow-up|1|||
146130458|NCT01796197|526998316|FG000|Overall Study|Lack of Efficacy|1|||
146130459|NCT04097821|526998317|FG000|Overall Study|Subject Decision|0|||
146130460|NCT04097821|526998318|FG001|Overall Study|Subject Decision|0|||
146130461|NCT04097821|526998319|FG002|Overall Study|Subject Decision|0|||
146130462|NCT04097821|526998320|FG003|Overall Study|Subject Decision|1|||
146130463|NCT04097821|526998321|FG004|Overall Study|Subject Decision|2|||
146130464|NCT04097821|526998322|FG005|Overall Study|Subject Decision|2|||
146130465|NCT04097821|526998323|FG006|Overall Study|Subject Decision|0|||
146130466|NCT04097821|526998324|FG007|Overall Study|Subject Decision|1|||
146130467|NCT04097821|526998317|FG000|Overall Study|Death|0|||
146130468|NCT04097821|526998318|FG001|Overall Study|Death|0|||
146130469|NCT04097821|526998319|FG002|Overall Study|Death|3|||
146130470|NCT04097821|526998320|FG003|Overall Study|Death|1|||
146130471|NCT04097821|526998321|FG004|Overall Study|Death|0|||
146130472|NCT04097821|526998322|FG005|Overall Study|Death|0|||
146130473|NCT04097821|526998323|FG006|Overall Study|Death|0|||
146130474|NCT04097821|526998324|FG007|Overall Study|Death|0|||
146130475|NCT04097821|526998317|FG000|Overall Study|Physician Decision|1|||
146130476|NCT04097821|526998318|FG001|Overall Study|Physician Decision|2|||
146130477|NCT04097821|526998319|FG002|Overall Study|Physician Decision|0|||
146130478|NCT04097821|526998320|FG003|Overall Study|Physician Decision|0|||
146130479|NCT04097821|526998321|FG004|Overall Study|Physician Decision|0|||
146130480|NCT04097821|526998322|FG005|Overall Study|Physician Decision|0|||
146130481|NCT04097821|526998323|FG006|Overall Study|Physician Decision|0|||
146130482|NCT04097821|526998324|FG007|Overall Study|Physician Decision|0|||
146130483|NCT04097821|526998317|FG000|Overall Study|Adverse Event|0|||
146130484|NCT04097821|526998318|FG001|Overall Study|Adverse Event|0|||
146130485|NCT04097821|526998319|FG002|Overall Study|Adverse Event|1|||
146130486|NCT04097821|526998320|FG003|Overall Study|Adverse Event|1|||
146130487|NCT04097821|526998321|FG004|Overall Study|Adverse Event|0|||
146130488|NCT04097821|526998322|FG005|Overall Study|Adverse Event|0|||
146130489|NCT04097821|526998323|FG006|Overall Study|Adverse Event|0|||
146130490|NCT04097821|526998324|FG007|Overall Study|Adverse Event|0|||
146130491|NCT04097821|526998317|FG000|Overall Study|New Therapy For Study Indication|0|||
146130492|NCT04097821|526998318|FG001|Overall Study|New Therapy For Study Indication|0|||
146130493|NCT04097821|526998319|FG002|Overall Study|New Therapy For Study Indication|0|||
146130494|NCT04097821|526998320|FG003|Overall Study|New Therapy For Study Indication|0|||
146130495|NCT04097821|526998321|FG004|Overall Study|New Therapy For Study Indication|0|||
146264038|NCT02287233|527481234|FG002|Overall Study|Physician Decision|4|||
146264039|NCT02287233|527481232|FG000|Overall Study|Progressive Disease with Death|0|||
146264040|NCT02287233|527481233|FG001|Overall Study|Progressive Disease with Death|0|||
146130496|NCT04097821|526998322|FG005|Overall Study|New Therapy For Study Indication|0|||
146130497|NCT04097821|526998323|FG006|Overall Study|New Therapy For Study Indication|1|||
146130498|NCT04097821|526998324|FG007|Overall Study|New Therapy For Study Indication|0|||
146264041|NCT02287233|527481234|FG002|Overall Study|Progressive Disease with Death|10|||
146264042|NCT02287233|527481232|FG000|Overall Study|Progressive Disease Without Death|2|||
146264043|NCT02287233|527481233|FG001|Overall Study|Progressive Disease Without Death|3|||
146264044|NCT02287233|527481234|FG002|Overall Study|Progressive Disease Without Death|20|||
146264045|NCT02287233|527481232|FG000|Overall Study|Withdrawal by Subject|1|||
146264046|NCT02287233|527481233|FG001|Overall Study|Withdrawal by Subject|1|||
146264047|NCT02287233|527481234|FG002|Overall Study|Withdrawal by Subject|7|||
146264048|NCT02287233|527481232|FG000|Overall Study|Other|3|||
146264049|NCT02287233|527481233|FG001|Overall Study|Other|0|||
146264050|NCT02287233|527481234|FG002|Overall Study|Other|15|||
146264051|NCT02287233|527481232|FG000|Overall Study|Did Not Receive Treatment|0|||
146264052|NCT02287233|527481233|FG001|Overall Study|Did Not Receive Treatment|0|||
146264053|NCT02287233|527481234|FG002|Overall Study|Did Not Receive Treatment|2|||
146264054|NCT00085566|527481235|FG000|Overall Study|Adverse Event|0|||
146264055|NCT00085566|527481236|FG001|Overall Study|Adverse Event|0|||
146264056|NCT00085566|527481237|FG002|Overall Study|Adverse Event|10|||
146264057|NCT00085566|527481235|FG000|Overall Study|Patient Not treated|0|||
146264058|NCT00085566|527481236|FG001|Overall Study|Patient Not treated|0|||
146264059|NCT00085566|527481237|FG002|Overall Study|Patient Not treated|3|||
146264060|NCT00085566|527481235|FG000|Overall Study|Clinical progression|0|||
146264061|NCT00085566|527481236|FG001|Overall Study|Clinical progression|0|||
146264062|NCT00085566|527481237|FG002|Overall Study|Clinical progression|1|||
146264063|NCT02804399|527481238|FG000|Period 2|Adverse Event|0|||
146303573|NCT01514136|527625847|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
146303574|NCT01514136|527625848|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
146264064|NCT02804399|527481239|FG001|Period 2|Adverse Event|1|||
146264065|NCT01774305|527481240|FG000|Overall Study|Physician Decision|1|||
146264066|NCT01774305|527481241|FG001|Overall Study|Physician Decision|0|||
146303575|NCT01514136|527625841|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
146264067|NCT01157377|527481243|FG000|Overall Study|Lost to Follow-up|0|||
146264068|NCT01157377|527481244|FG001|Overall Study|Lost to Follow-up|0|||
146264069|NCT01157377|527481245|FG002|Overall Study|Lost to Follow-up|1|||
146264070|NCT01157377|527481246|FG003|Overall Study|Lost to Follow-up|0|||
146264071|NCT01157377|527481247|FG004|Overall Study|Lost to Follow-up|1|||
146264072|NCT01157377|527481248|FG005|Overall Study|Lost to Follow-up|1|||
146264073|NCT01157377|527481249|FG006|Overall Study|Lost to Follow-up|0|||
146264074|NCT01157377|527481243|FG000|Overall Study|Personal Reasons|2|||
146264075|NCT01157377|527481244|FG001|Overall Study|Personal Reasons|1|||
146264076|NCT01157377|527481245|FG002|Overall Study|Personal Reasons|0|||
146264077|NCT01157377|527481246|FG003|Overall Study|Personal Reasons|1|||
146264078|NCT01157377|527481247|FG004|Overall Study|Personal Reasons|0|||
146264079|NCT01157377|527481248|FG005|Overall Study|Personal Reasons|0|||
146264080|NCT01157377|527481249|FG006|Overall Study|Personal Reasons|0|||
146264081|NCT01157377|527481243|FG000|Overall Study|Protocol Violation|0|||
146264082|NCT01157377|527481244|FG001|Overall Study|Protocol Violation|0|||
146264083|NCT01157377|527481245|FG002|Overall Study|Protocol Violation|0|||
146264084|NCT01157377|527481246|FG003|Overall Study|Protocol Violation|0|||
146264085|NCT01157377|527481247|FG004|Overall Study|Protocol Violation|0|||
146264086|NCT01157377|527481248|FG005|Overall Study|Protocol Violation|1|||
146264087|NCT01157377|527481249|FG006|Overall Study|Protocol Violation|0|||
146264088|NCT01157377|527481243|FG000|Overall Study|Lack of Efficacy|0|||
146264089|NCT01157377|527481244|FG001|Overall Study|Lack of Efficacy|0|||
146264090|NCT01157377|527481245|FG002|Overall Study|Lack of Efficacy|0|||
146264091|NCT01157377|527481246|FG003|Overall Study|Lack of Efficacy|0|||
146264092|NCT01157377|527481247|FG004|Overall Study|Lack of Efficacy|0|||
146264093|NCT01157377|527481248|FG005|Overall Study|Lack of Efficacy|0|||
146264094|NCT01157377|527481249|FG006|Overall Study|Lack of Efficacy|1|||
146264095|NCT01157377|527481243|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146264096|NCT01157377|527481244|FG001|Overall Study|Other Miscellaneous Reasons|2|||
146264097|NCT01157377|527481245|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146264098|NCT01157377|527481246|FG003|Overall Study|Other Miscellaneous Reasons|0|||
146264099|NCT01157377|527481247|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146264100|NCT01157377|527481248|FG005|Overall Study|Other Miscellaneous Reasons|1|||
146264101|NCT01157377|527481249|FG006|Overall Study|Other Miscellaneous Reasons|1|||
146264102|NCT00087555|527481250|FG000|Overall Study|Adverse Event|3|||
146264103|NCT00087555|527481251|FG001|Overall Study|Adverse Event|6|||
146264104|NCT00087555|527481252|FG002|Overall Study|Adverse Event|14|||
146264105|NCT00087555|527481250|FG000|Overall Study|Lost to Follow-up|0|||
146264106|NCT00087555|527481251|FG001|Overall Study|Lost to Follow-up|1|||
146264107|NCT00087555|527481252|FG002|Overall Study|Lost to Follow-up|1|||
146264108|NCT00087555|527481250|FG000|Overall Study|Non - Compliance|1|||
146264109|NCT00087555|527481251|FG001|Overall Study|Non - Compliance|0|||
146264110|NCT00087555|527481252|FG002|Overall Study|Non - Compliance|0|||
146264111|NCT00087555|527481250|FG000|Overall Study|Protocol Violation|0|||
146264112|NCT00087555|527481251|FG001|Overall Study|Protocol Violation|0|||
146264113|NCT00087555|527481252|FG002|Overall Study|Protocol Violation|2|||
146264114|NCT00087555|527481250|FG000|Overall Study|Screen Failure|1|||
146264115|NCT00087555|527481251|FG001|Overall Study|Screen Failure|1|||
146264116|NCT00087555|527481252|FG002|Overall Study|Screen Failure|0|||
146264117|NCT00087555|527481250|FG000|Overall Study|Pregnancy|0|||
146264118|NCT00087555|527481251|FG001|Overall Study|Pregnancy|1|||
146264119|NCT00087555|527481252|FG002|Overall Study|Pregnancy|1|||
146264120|NCT00087555|527481250|FG000|Overall Study|Withdrawal by Subject|3|||
146264121|NCT00087555|527481251|FG001|Overall Study|Withdrawal by Subject|2|||
146264122|NCT00087555|527481252|FG002|Overall Study|Withdrawal by Subject|1|||
146264123|NCT00087555|527481250|FG000|Overall Study|Lack of Efficacy|2|||
146264124|NCT00087555|527481251|FG001|Overall Study|Lack of Efficacy|0|||
146264125|NCT00087555|527481252|FG002|Overall Study|Lack of Efficacy|1|||
146264126|NCT00087555|527481250|FG000|Overall Study|Non Compliance|0|||
146264127|NCT00087555|527481251|FG001|Overall Study|Non Compliance|0|||
146264128|NCT00087555|527481252|FG002|Overall Study|Non Compliance|1|||
146264129|NCT00087555|527481250|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
146264130|NCT00087555|527481251|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
146264131|NCT00087555|527481252|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
146264132|NCT00087555|527481250|FG000|Overall Study|Patient wanted to go back on Med|1|||
146264133|NCT00087555|527481251|FG001|Overall Study|Patient wanted to go back on Med|0|||
146264134|NCT00087555|527481252|FG002|Overall Study|Patient wanted to go back on Med|0|||
146264135|NCT05523219|527481253|FG000|Overall Study|Wrong inclusion|1|||
146264136|NCT05523219|527481253|FG000|Overall Study|Lost to Follow-up|7|||
146264137|NCT00904722|527481256|FG000|Overall Study|Physician Decision|1|||
146264138|NCT03772613|527481257|FG000|Overall Study|Lost to Follow-up|0|||
146264139|NCT03772613|527481258|FG001|Overall Study|Lost to Follow-up|1|||
146264140|NCT03772613|527481259|FG002|Overall Study|Lost to Follow-up|1|||
146264141|NCT00661713|527481260|FG000|Overall Study|Death|1|||
146264142|NCT00661713|527481261|FG001|Overall Study|Death|0|||
146264143|NCT00661713|527481262|FG002|Overall Study|Death|0|||
146264144|NCT00661713|527481263|FG003|Overall Study|Death|0|||
146264145|NCT00661713|527481264|FG004|Overall Study|Death|1|||
146264146|NCT00661713|527481265|FG005|Overall Study|Death|0|||
146264147|NCT00661713|527481266|FG006|Overall Study|Death|0|||
146264148|NCT00661713|527481267|FG007|Overall Study|Death|0|||
146264149|NCT00661713|527481260|FG000|Overall Study|Unable to Classify|1|||
146264150|NCT00661713|527481261|FG001|Overall Study|Unable to Classify|0|||
146264151|NCT00661713|527481262|FG002|Overall Study|Unable to Classify|0|||
146264152|NCT00661713|527481263|FG003|Overall Study|Unable to Classify|0|||
146264153|NCT00661713|527481264|FG004|Overall Study|Unable to Classify|0|||
146264154|NCT00661713|527481265|FG005|Overall Study|Unable to Classify|0|||
146264155|NCT00661713|527481266|FG006|Overall Study|Unable to Classify|0|||
146264156|NCT00661713|527481267|FG007|Overall Study|Unable to Classify|0|||
146264157|NCT00661713|527481260|FG000|Overall Study|Protocol Violation|1|||
146264158|NCT00661713|527481261|FG001|Overall Study|Protocol Violation|6|||
146264159|NCT00661713|527481262|FG002|Overall Study|Protocol Violation|3|||
146264160|NCT00661713|527481263|FG003|Overall Study|Protocol Violation|3|||
146264161|NCT00661713|527481264|FG004|Overall Study|Protocol Violation|0|||
146264162|NCT00661713|527481265|FG005|Overall Study|Protocol Violation|2|||
146264163|NCT00661713|527481266|FG006|Overall Study|Protocol Violation|2|||
146264164|NCT00661713|527481267|FG007|Overall Study|Protocol Violation|1|||
146264165|NCT00661713|527481260|FG000|Overall Study|Withdrawal by Subject|11|||
146264166|NCT00661713|527481261|FG001|Overall Study|Withdrawal by Subject|25|||
146264167|NCT00661713|527481262|FG002|Overall Study|Withdrawal by Subject|12|||
146264168|NCT00661713|527481263|FG003|Overall Study|Withdrawal by Subject|21|||
146264169|NCT00661713|527481264|FG004|Overall Study|Withdrawal by Subject|12|||
146264170|NCT00661713|527481265|FG005|Overall Study|Withdrawal by Subject|26|||
146264171|NCT00661713|527481266|FG006|Overall Study|Withdrawal by Subject|45|||
146264172|NCT00661713|527481267|FG007|Overall Study|Withdrawal by Subject|9|||
146264173|NCT00661713|527481260|FG000|Overall Study|Lost to Follow-up|2|||
146264174|NCT00661713|527481261|FG001|Overall Study|Lost to Follow-up|7|||
146264175|NCT00661713|527481262|FG002|Overall Study|Lost to Follow-up|2|||
146264176|NCT00661713|527481263|FG003|Overall Study|Lost to Follow-up|2|||
146264177|NCT00661713|527481264|FG004|Overall Study|Lost to Follow-up|5|||
146264178|NCT00661713|527481265|FG005|Overall Study|Lost to Follow-up|7|||
146264179|NCT00661713|527481266|FG006|Overall Study|Lost to Follow-up|14|||
146264180|NCT00661713|527481267|FG007|Overall Study|Lost to Follow-up|1|||
146264181|NCT00661713|527481260|FG000|Overall Study|Administrative Reason|0|||
146264182|NCT00661713|527481261|FG001|Overall Study|Administrative Reason|1|||
146264183|NCT00661713|527481262|FG002|Overall Study|Administrative Reason|0|||
146264184|NCT00661713|527481263|FG003|Overall Study|Administrative Reason|2|||
146264185|NCT00661713|527481264|FG004|Overall Study|Administrative Reason|2|||
146264186|NCT00661713|527481265|FG005|Overall Study|Administrative Reason|2|||
146264187|NCT00661713|527481266|FG006|Overall Study|Administrative Reason|1|||
146264188|NCT00661713|527481267|FG007|Overall Study|Administrative Reason|0|||
146264189|NCT00661713|527481260|FG000|Overall Study|Adverse Event|0|||
146264190|NCT00661713|527481261|FG001|Overall Study|Adverse Event|0|||
146264191|NCT00661713|527481262|FG002|Overall Study|Adverse Event|0|||
146264192|NCT00661713|527481263|FG003|Overall Study|Adverse Event|0|||
146264193|NCT00661713|527481264|FG004|Overall Study|Adverse Event|0|||
146264194|NCT00661713|527481265|FG005|Overall Study|Adverse Event|0|||
146264195|NCT00661713|527481266|FG006|Overall Study|Adverse Event|1|||
146264196|NCT00661713|527481267|FG007|Overall Study|Adverse Event|0|||
146264197|NCT00661713|527481260|FG000|Overall Study|Inappropriate Enrollment|0|||
146264198|NCT00661713|527481261|FG001|Overall Study|Inappropriate Enrollment|0|||
146264199|NCT00661713|527481262|FG002|Overall Study|Inappropriate Enrollment|0|||
146264200|NCT00661713|527481263|FG003|Overall Study|Inappropriate Enrollment|0|||
146264201|NCT00661713|527481264|FG004|Overall Study|Inappropriate Enrollment|0|||
146264202|NCT00661713|527481265|FG005|Overall Study|Inappropriate Enrollment|0|||
146264203|NCT00661713|527481266|FG006|Overall Study|Inappropriate Enrollment|1|||
146264204|NCT00661713|527481267|FG007|Overall Study|Inappropriate Enrollment|0|||
146264205|NCT01801982|527481271|FG000|Overall Study|Lost to Follow-up|1|||
146264206|NCT00727506|527481272|FG000|Overall Study|Adverse Event|0|||
146264207|NCT00727506|527481273|FG001|Overall Study|Adverse Event|0|||
146303576|NCT01514136|527625842|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
146303577|NCT01514136|527625843|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
146264208|NCT00727506|527481274|FG002|Overall Study|Adverse Event|4|||
146264209|NCT00727506|527481275|FG003|Overall Study|Adverse Event|4|||
146264210|NCT00727506|527481276|FG004|Overall Study|Adverse Event|1|||
146264211|NCT00727506|527481277|FG005|Overall Study|Adverse Event|8|||
146264212|NCT00727506|527481272|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146264213|NCT00727506|527481273|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146264214|NCT00727506|527481274|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146264215|NCT00727506|527481275|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146264216|NCT00727506|527481276|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146264217|NCT00727506|527481277|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146264218|NCT00727506|527481272|FG000|Overall Study|Progressive disease|4|||
146264219|NCT00727506|527481273|FG001|Overall Study|Progressive disease|7|||
146264220|NCT00727506|527481274|FG002|Overall Study|Progressive disease|9|||
146264221|NCT00727506|527481275|FG003|Overall Study|Progressive disease|28|||
146264222|NCT00727506|527481276|FG004|Overall Study|Progressive disease|38|||
146264223|NCT00727506|527481277|FG005|Overall Study|Progressive disease|28|||
146264224|NCT00727506|527481272|FG000|Overall Study|Refused to continue medication|0|||
146264225|NCT00727506|527481273|FG001|Overall Study|Refused to continue medication|1|||
146264226|NCT00727506|527481274|FG002|Overall Study|Refused to continue medication|2|||
146264227|NCT00727506|527481275|FG003|Overall Study|Refused to continue medication|3|||
146264228|NCT00727506|527481276|FG004|Overall Study|Refused to continue medication|1|||
146264229|NCT00727506|527481277|FG005|Overall Study|Refused to continue medication|2|||
146264230|NCT00727506|527481272|FG000|Overall Study|Other reason not described above|0|||
146264231|NCT00727506|527481273|FG001|Overall Study|Other reason not described above|0|||
146264232|NCT00727506|527481274|FG002|Overall Study|Other reason not described above|1|||
146264233|NCT00727506|527481275|FG003|Overall Study|Other reason not described above|4|||
146264234|NCT00727506|527481276|FG004|Overall Study|Other reason not described above|1|||
146264235|NCT00727506|527481277|FG005|Overall Study|Other reason not described above|1|||
146264236|NCT01482429|527481278|FG000|Care Usual|Protocol Violation|0|||
146264237|NCT01482429|527481279|FG001|Care Usual|Protocol Violation|172|||
146264238|NCT01482429|527481278|FG000|Care Usual|Lost to Follow-up|0|||
146264239|NCT01482429|527481279|FG001|Care Usual|Lost to Follow-up|1|||
146264240|NCT01482429|527481278|FG000|Protocol|Protocol Violation|275|||
146264241|NCT01482429|527481279|FG001|Protocol|Protocol Violation|0|||
146264242|NCT03561597|527481280|FG000|Overall Study|Lost to Follow-up|20|||
146264243|NCT04887506|527481281|FG000|Overall Study|Death|1|||
146264244|NCT04887506|527481282|FG001|Overall Study|Death|1|||
146264245|NCT04887506|527481281|FG000|Overall Study|Withdrawal by Subject|0|||
146264246|NCT04887506|527481282|FG001|Overall Study|Withdrawal by Subject|3|||
146264247|NCT04887506|527481281|FG000|Overall Study|Adverse Event|4|||
146264248|NCT04887506|527481282|FG001|Overall Study|Adverse Event|3|||
146264249|NCT04887506|527481281|FG000|Overall Study|Other - Not Reported|1|||
146264250|NCT04887506|527481282|FG001|Overall Study|Other - Not Reported|1|||
146264251|NCT02636608|527481283|FG000|Overall Study|Failure to Return|4|||
146264252|NCT02636608|527481283|FG000|Overall Study|Insufficient Virological Response|1|||
146264253|NCT02636608|527481283|FG000|Overall Study|Death|3|||
146264254|NCT02636608|527481283|FG000|Overall Study|Other|2|||
146264255|NCT02636608|527481283|FG000|Overall Study|Did Not Receive Treatment|1|||
146264256|NCT04594733|527481307|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146264257|NCT04594733|527481308|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
146264258|NCT04594733|527481307|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
146264259|NCT04594733|527481308|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
146264260|NCT04594733|527481307|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
146264261|NCT04594733|527481308|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
146264262|NCT01024036|527481311|FG000|Blinded Treatment|Adverse Event|1|||
146264263|NCT01024036|527481312|FG001|Blinded Treatment|Adverse Event|1|||
146264264|NCT01024036|527481311|FG000|Blinded Treatment|Lack of Efficacy|16|||
146264265|NCT01024036|527481312|FG001|Blinded Treatment|Lack of Efficacy|14|||
146264266|NCT01024036|527481311|FG000|Blinded Treatment|Physician Decision|1|||
146264267|NCT01024036|527481312|FG001|Blinded Treatment|Physician Decision|0|||
146264268|NCT01024036|527481311|FG000|Blinded Treatment|Death|0|||
146264269|NCT01024036|527481312|FG001|Blinded Treatment|Death|2|||
146264270|NCT01024036|527481311|FG000|Blinded Treatment|Withdrawal by Subject|4|||
146264271|NCT01024036|527481312|FG001|Blinded Treatment|Withdrawal by Subject|3|||
146264272|NCT01024036|527481311|FG000|Unblinded Treatment|Adverse Event|0|||
146264273|NCT01024036|527481312|FG001|Unblinded Treatment|Adverse Event|1|||
146264274|NCT01024036|527481311|FG000|Unblinded Treatment|Lack of Efficacy|0|||
146264275|NCT01024036|527481312|FG001|Unblinded Treatment|Lack of Efficacy|2|||
146264276|NCT01024036|527481311|FG000|Follow-Up Period|Lost to Follow-up|1|||
146264277|NCT01024036|527481312|FG001|Follow-Up Period|Lost to Follow-up|1|||
146264278|NCT01024036|527481311|FG000|Follow-Up Period|Withdrawal by Subject|0|||
146264279|NCT01024036|527481312|FG001|Follow-Up Period|Withdrawal by Subject|1|||
146264280|NCT01024036|527481311|FG000|Follow-Up Period|Adverse Event|4|||
146264281|NCT01024036|527481312|FG001|Follow-Up Period|Adverse Event|1|||
146264282|NCT01190449|527481317|FG000|Overall Study|Ineligible|0|||
146264283|NCT01190449|527481318|FG001|Overall Study|Ineligible|4|||
146264284|NCT04811339|527481319|FG000|Overall Study|lack of transportation not wanting to return|4|||
146264285|NCT04811339|527481320|FG001|Overall Study|lack of transportation not wanting to return|8|||
146264286|NCT04811339|527481321|FG002|Overall Study|lack of transportation not wanting to return|0|||
146264287|NCT04811339|527481319|FG000|Overall Study|Adverse Event|3|||
146264288|NCT04811339|527481320|FG001|Overall Study|Adverse Event|0|||
146303578|NCT01514136|527625844|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
146303579|NCT01514136|527625845|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
146303580|NCT01514136|527625846|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
146264289|NCT04811339|527481321|FG002|Overall Study|Adverse Event|0|||
146264290|NCT04811339|527481319|FG000|Overall Study|Lost to Follow-up|1|||
146264291|NCT04811339|527481320|FG001|Overall Study|Lost to Follow-up|0|||
146303581|NCT01514136|527625847|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
146264292|NCT04811339|527481321|FG002|Overall Study|Lost to Follow-up|0|||
146303582|NCT01514136|527625848|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
146303583|NCT01514136|527625841|FG000|Test Period 2; Test C*|holiday|0|||
146303584|NCT01514136|527625842|FG001|Test Period 2; Test C*|holiday|0|||
146303585|NCT01514136|527625843|FG002|Test Period 2; Test C*|holiday|0|||
146303586|NCT01514136|527625844|FG003|Test Period 2; Test C*|holiday|0|||
146264293|NCT04811339|527481319|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
146264294|NCT04811339|527481320|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
146264295|NCT04811339|527481321|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
146264296|NCT04811339|527481319|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
146264297|NCT04811339|527481320|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
146264298|NCT04811339|527481321|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
146264299|NCT04811339|527481319|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
146264300|NCT04811339|527481320|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
146264301|NCT04811339|527481321|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
146264302|NCT04811339|527481319|FG000|Overall Study|Withdrawal by Subject|0|||
146264303|NCT04811339|527481320|FG001|Overall Study|Withdrawal by Subject|3|||
146264304|NCT04811339|527481321|FG002|Overall Study|Withdrawal by Subject|0|||
146264305|NCT04811339|527481319|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
146264306|NCT04811339|527481320|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
146264307|NCT04811339|527481321|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
146264308|NCT04811339|527481319|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
146264309|NCT04811339|527481320|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
146264310|NCT04811339|527481321|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
146264311|NCT00903760|527483011|FG000|Overall Study|Disease Progression/Death|8|||
146264312|NCT00903760|527483012|FG001|Overall Study|Disease Progression/Death|6|||
146264313|NCT00903760|527483011|FG000|Overall Study|Stem Cell Transplant|8|||
146264314|NCT00903760|527483012|FG001|Overall Study|Stem Cell Transplant|4|||
146264315|NCT00903760|527483011|FG000|Overall Study|Physician Decision|1|||
146264316|NCT00903760|527483012|FG001|Overall Study|Physician Decision|2|||
146264317|NCT00903760|527483011|FG000|Overall Study|Death|0|||
146264318|NCT00903760|527483012|FG001|Overall Study|Death|1|||
146264319|NCT00903760|527483011|FG000|Overall Study|Lost to Follow-up|1|||
146264320|NCT00903760|527483012|FG001|Overall Study|Lost to Follow-up|0|||
146264321|NCT00903760|527483011|FG000|Overall Study|Withdrawal by Subject|1|||
146264322|NCT00903760|527483012|FG001|Overall Study|Withdrawal by Subject|2|||
146264323|NCT00903760|527483011|FG000|Overall Study|Off treatment for long period|0|||
146264324|NCT00903760|527483012|FG001|Overall Study|Off treatment for long period|1|||
146264325|NCT01256671|527483018|FG000|Overall Study|Adverse Event|29|||
146264326|NCT01256671|527483018|FG000|Overall Study|Lost to Follow-up|16|||
146264327|NCT01256671|527483018|FG000|Overall Study|Withdrawal by Subject|31|||
146264328|NCT01256671|527483018|FG000|Overall Study|Physician Decision|3|||
146264329|NCT01256671|527483018|FG000|Overall Study|Lack of Efficacy|4|||
146264330|NCT01256671|527483018|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
146264331|NCT04411186|527483019|FG000|Overall Study|Withdrawn due to protocol violation|0|||
146264332|NCT04411186|527483020|FG001|Overall Study|Withdrawn due to protocol violation|1|||
146264333|NCT01266018|527483021|FG000|Overall Study|Physician Decision|1|||
146264334|NCT01266018|527483022|FG001|Overall Study|Physician Decision|0|||
146264335|NCT01266018|527483021|FG000|Overall Study|Progressive disease|0|||
146264336|NCT01266018|527483022|FG001|Overall Study|Progressive disease|1|||
146264337|NCT02370251|527483024|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
146264338|NCT02370251|527483024|FG000|Overall Study|Death|4|||
146264339|NCT02053610|527483025|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
146264340|NCT02053610|527483026|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
146264341|NCT02053610|527483025|FG000|Overall Study|Withdrew Consent|2|||
146264342|NCT02053610|527483026|FG001|Overall Study|Withdrew Consent|9|||
146264343|NCT02053610|527483025|FG000|Overall Study|Death|5|||
146264344|NCT02053610|527483026|FG001|Overall Study|Death|5|||
146264345|NCT02053610|527483025|FG000|Overall Study|Administrative/Other|1|||
146264346|NCT02053610|527483026|FG001|Overall Study|Administrative/Other|1|||
146264347|NCT02053610|527483025|FG000|Overall Study|Disease Progression|2|||
146264348|NCT02053610|527483026|FG001|Overall Study|Disease Progression|3|||
146264349|NCT02053610|527483025|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
146264350|NCT02053610|527483026|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
146264351|NCT02053610|527483025|FG000|Overall Study|Did not Receive Treatment|4|||
146264352|NCT02053610|527483026|FG001|Overall Study|Did not Receive Treatment|2|||
146264353|NCT02053610|527483025|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146264354|NCT02053610|527483026|FG001|Overall Study|Insufficient Therapeutic Response|1|||
146264355|NCT02053610|527483025|FG000|Overall Study|Violation of Selection Criteria|1|||
146264356|NCT02053610|527483026|FG001|Overall Study|Violation of Selection Criteria|0|||
146264357|NCT02641587|527483027|FG000|Confinement Period|Adverse Event|1|||
146264358|NCT02641587|527483028|FG001|Confinement Period|Adverse Event|0|||
146264359|NCT02641587|527483027|FG000|Confinement Period|Withdrawal by Subject|2|||
146264360|NCT02641587|527483028|FG001|Confinement Period|Withdrawal by Subject|1|||
146264361|NCT02641587|527483027|FG000|Ambulatory Period|Withdrawal by Subject|1|||
146264362|NCT02641587|527483028|FG001|Ambulatory Period|Withdrawal by Subject|0|||
146264363|NCT01165177|527483029|FG000|Overall Study|Serious Adverse Event|227|||
146264364|NCT01165177|527483030|FG001|Overall Study|Serious Adverse Event|235|||
146264365|NCT01165177|527483029|FG000|Overall Study|Withdrawal by Subject|368|||
146264366|NCT01165177|527483030|FG001|Overall Study|Withdrawal by Subject|354|||
146264367|NCT01165177|527483029|FG000|Overall Study|Protocol Violation|19|||
146264368|NCT01165177|527483030|FG001|Overall Study|Protocol Violation|21|||
146264369|NCT01165177|527483029|FG000|Overall Study|Non-serious adverse event|30|||
146264370|NCT01165177|527483030|FG001|Overall Study|Non-serious adverse event|18|||
146264371|NCT01165177|527483029|FG000|Overall Study|Other unspecified reasons|47|||
146264372|NCT01165177|527483030|FG001|Overall Study|Other unspecified reasons|35|||
146264373|NCT01165177|527483029|FG000|Overall Study|Suspected HZ episode|0|||
146264374|NCT01165177|527483030|FG001|Overall Study|Suspected HZ episode|2|||
146264375|NCT01165177|527483029|FG000|Overall Study|Lost to Follow-up|183|||
146264376|NCT01165177|527483030|FG001|Overall Study|Lost to Follow-up|194|||
146264377|NCT01165177|527483029|FG000|Overall Study|Migrated/ moved from study area|48|||
146264378|NCT01165177|527483030|FG001|Overall Study|Migrated/ moved from study area|43|||
146264379|NCT01660256|527483032|FG000|Overall Study|Adverse Event|4|||
146264380|NCT01660256|527483033|FG001|Overall Study|Adverse Event|0|||
146264381|NCT01660256|527483034|FG002|Overall Study|Adverse Event|2|||
146264382|NCT01660256|527483032|FG000|Overall Study|Withdrawal by Subject|1|||
146264383|NCT01660256|527483033|FG001|Overall Study|Withdrawal by Subject|0|||
146264384|NCT01660256|527483034|FG002|Overall Study|Withdrawal by Subject|2|||
146264385|NCT01646385|527483036|FG000|Overall Study|Death|202|||
146264386|NCT01646385|527483037|FG001|Overall Study|Death|222|||
146264387|NCT01646385|527483036|FG000|Overall Study|Switched to alternate biologic|636|||
146264388|NCT01646385|527483037|FG001|Overall Study|Switched to alternate biologic|649|||
146264389|NCT01777334|527483040|FG000|Overall Study|Adverse Event|18|||
146264390|NCT01777334|527483041|FG001|Overall Study|Adverse Event|14|||
146264391|NCT01777334|527483040|FG000|Overall Study|Lack of Efficacy|15|||
146264392|NCT01777334|527483041|FG001|Overall Study|Lack of Efficacy|29|||
146264393|NCT01777334|527483040|FG000|Overall Study|Protocol Violation|3|||
146264394|NCT01777334|527483041|FG001|Overall Study|Protocol Violation|7|||
146264395|NCT01777334|527483040|FG000|Overall Study|Lost to Follow-up|3|||
146264396|NCT01777334|527483041|FG001|Overall Study|Lost to Follow-up|2|||
146264397|NCT01777334|527483040|FG000|Overall Study|Withdrawal by Subject|14|||
146264398|NCT01777334|527483041|FG001|Overall Study|Withdrawal by Subject|11|||
146264399|NCT01841697|527483045|FG000|Overall Study|Death|0|||
146264400|NCT01841697|527483046|FG001|Overall Study|Death|1|||
146264401|NCT01841697|527483045|FG000|Overall Study|Lost to Follow-up|4|||
146264402|NCT01841697|527483046|FG001|Overall Study|Lost to Follow-up|1|||
146264403|NCT01841697|527483045|FG000|Overall Study|Withdrawal by Subject|16|||
146264404|NCT01841697|527483046|FG001|Overall Study|Withdrawal by Subject|16|||
146264405|NCT00727415|527483047|FG000|Phase I|Dose Limiting Toxicity|2|||
146264406|NCT00756457|527483049|FG000|Overall Study|Lost to Follow-up|1|||
146264407|NCT00756457|527483050|FG001|Overall Study|Lost to Follow-up|2|||
146264408|NCT01777490|527483054|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
146264409|NCT01777490|527483055|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
146264410|NCT01777490|527483056|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
146264411|NCT01777490|527483057|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
146264412|NCT02564718|527483060|FG000|Overall Study|Withdrew from treatment|0|||
146264413|NCT02564718|527483061|FG001|Overall Study|Withdrew from treatment|1|||
146264414|NCT05043883|527483062|FG000|Overall Study|Minimum required measurements could not be taken|4|||
146264415|NCT02980705|527483063|FG000|Overall Study|Adverse Event|0|||
146264416|NCT02980705|527483064|FG001|Overall Study|Adverse Event|1|||
146264417|NCT02980705|527483063|FG000|Overall Study|Withdrawal by Subject|6|||
146264418|NCT02980705|527483064|FG001|Overall Study|Withdrawal by Subject|9|||
146264419|NCT02980705|527483063|FG000|Overall Study|withdrew participation|0|||
146264420|NCT02980705|527483064|FG001|Overall Study|withdrew participation|1|||
146264421|NCT02980705|527483063|FG000|Overall Study|Lost to Follow-up|2|||
146264422|NCT02980705|527483064|FG001|Overall Study|Lost to Follow-up|0|||
146264423|NCT00263575|527483065|FG000|Titration Period|Adverse Event|14|||
146264424|NCT00263575|527483065|FG000|Titration Period|Withdrawal by Subject|10|||
146264425|NCT00263575|527483065|FG000|Titration Period|Protocol Violation|9|||
146264426|NCT00263575|527483065|FG000|Titration Period|Sponsor Decision|2|||
146264427|NCT00263575|527483065|FG000|Titration Period|Other|2|||
146264428|NCT00263575|527483065|FG000|Titration Period|Lack of Efficacy|6|||
146264429|NCT00263575|527483065|FG000|Maintence Period|Adverse Event|23|||
146264430|NCT00263575|527483065|FG000|Maintence Period|Withdrawal by Subject|8|||
146264431|NCT00263575|527483065|FG000|Maintence Period|Protocol Violation|4|||
146264432|NCT00263575|527483065|FG000|Maintence Period|Lack of Efficacy|4|||
146264433|NCT00263575|527483065|FG000|Maintence Period|Physician Decision|6|||
146264434|NCT00263575|527483065|FG000|Maintence Period|Lost to Follow-up|1|||
146264435|NCT00263575|527483065|FG000|Maintence Period|Sponsor Decision|24|||
146264436|NCT00263575|527483065|FG000|Maintence Period|Other|7|||
146264437|NCT00537329|527483066|FG000|Overall Study|Death|10|||
146264438|NCT00537329|527483066|FG000|Overall Study|Adverse Event|3|||
146264439|NCT00537329|527483066|FG000|Overall Study|Lack of Efficacy|2|||
146264440|NCT00537329|527483066|FG000|Overall Study|Lost to Follow-up|6|||
146264441|NCT00537329|527483066|FG000|Overall Study|Withdrawal by Subject|4|||
146264442|NCT00537329|527483066|FG000|Overall Study|Other|1|||
146264443|NCT03599622|527483067|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
146264444|NCT03599622|527483068|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
146264445|NCT03599622|527483069|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
146264446|NCT03599622|527483070|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
146264447|NCT03599622|527483067|FG000|Pre-Treatment Period|Other reasons|1|||
146264448|NCT03599622|527483068|FG001|Pre-Treatment Period|Other reasons|1|||
146264449|NCT03599622|527483069|FG002|Pre-Treatment Period|Other reasons|1|||
146264450|NCT03599622|527483070|FG003|Pre-Treatment Period|Other reasons|0|||
146264451|NCT03599622|527483067|FG000|Treatment Period|Adverse Event|11|||
146264452|NCT03599622|527483068|FG001|Treatment Period|Adverse Event|20|||
146264453|NCT03599622|527483069|FG002|Treatment Period|Adverse Event|18|||
146264454|NCT03599622|527483070|FG003|Treatment Period|Adverse Event|2|||
146264455|NCT03599622|527483067|FG000|Treatment Period|Lack of Efficacy|18|||
146264456|NCT03599622|527483068|FG001|Treatment Period|Lack of Efficacy|12|||
146264457|NCT03599622|527483069|FG002|Treatment Period|Lack of Efficacy|13|||
146264458|NCT03599622|527483070|FG003|Treatment Period|Lack of Efficacy|2|||
146264459|NCT03599622|527483067|FG000|Treatment Period|Withdrawal by Subject|5|||
146264460|NCT03599622|527483068|FG001|Treatment Period|Withdrawal by Subject|11|||
146264461|NCT03599622|527483069|FG002|Treatment Period|Withdrawal by Subject|16|||
146264462|NCT03599622|527483070|FG003|Treatment Period|Withdrawal by Subject|1|||
146264463|NCT03599622|527483067|FG000|Treatment Period|Other reasons|4|||
146264464|NCT03599622|527483068|FG001|Treatment Period|Other reasons|6|||
146264465|NCT03599622|527483069|FG002|Treatment Period|Other reasons|7|||
146264466|NCT03599622|527483070|FG003|Treatment Period|Other reasons|0|||
146264467|NCT03599622|527483067|FG000|Treatment Period|Lost to Follow-up|1|||
146264468|NCT03599622|527483068|FG001|Treatment Period|Lost to Follow-up|0|||
146264469|NCT03599622|527483069|FG002|Treatment Period|Lost to Follow-up|0|||
146264470|NCT03599622|527483070|FG003|Treatment Period|Lost to Follow-up|0|||
146264471|NCT03599622|527483067|FG000|Treatment Period|Study terminated by sponsor|7|||
146264472|NCT03599622|527483068|FG001|Treatment Period|Study terminated by sponsor|20|||
146264473|NCT03599622|527483069|FG002|Treatment Period|Study terminated by sponsor|15|||
146264474|NCT03599622|527483070|FG003|Treatment Period|Study terminated by sponsor|0|||
146264475|NCT03599622|527483067|FG000|Treatment Period|Site terminated by sponsor|0|||
146264476|NCT03599622|527483068|FG001|Treatment Period|Site terminated by sponsor|1|||
146264477|NCT03599622|527483069|FG002|Treatment Period|Site terminated by sponsor|0|||
146264478|NCT03599622|527483070|FG003|Treatment Period|Site terminated by sponsor|0|||
146264479|NCT01278615|527483075|FG000|Overall Study|Withdrawal by Subject|2|||
146264480|NCT00905359|527483076|FG000|Overall Study|Lost to Follow-up|17|||
146264481|NCT00905359|527483077|FG001|Overall Study|Lost to Follow-up|10|||
146264482|NCT00905359|527483076|FG000|Overall Study|Death|2|||
146264483|NCT00905359|527483077|FG001|Overall Study|Death|0|||
146264484|NCT00905359|527483076|FG000|Overall Study|Withdrawal consent|5|||
146264485|NCT00905359|527483077|FG001|Overall Study|Withdrawal consent|6|||
146264486|NCT02138253|527483078|FG000|Overall Study|Adverse Event|3|||
146264487|NCT02138253|527483079|FG001|Overall Study|Adverse Event|3|||
146264488|NCT02138253|527483078|FG000|Overall Study|Lost to Follow-up|2|||
146264489|NCT02138253|527483079|FG001|Overall Study|Lost to Follow-up|1|||
146264490|NCT02138253|527483078|FG000|Overall Study|Physician Decision|2|||
146264491|NCT02138253|527483079|FG001|Overall Study|Physician Decision|0|||
146264492|NCT02138253|527483078|FG000|Overall Study|Non compliance|1|||
146264493|NCT02138253|527483079|FG001|Overall Study|Non compliance|0|||
146264494|NCT02138253|527483078|FG000|Overall Study|Withdrawal by Subject|1|||
146264495|NCT02138253|527483079|FG001|Overall Study|Withdrawal by Subject|0|||
146264496|NCT01918371|527483080|FG000|Overall Study|Missing Data|1|||
146264497|NCT01918371|527483081|FG001|Overall Study|Missing Data|1|||
146264498|NCT01006889|527483082|FG000|Overall Study|Withdrawal by Subject|3|||
146264499|NCT00243022|527483083|FG000|Overall Study|Withdrawal by Subject|1|||
146264500|NCT00243022|527483084|FG001|Overall Study|Withdrawal by Subject|0|||
146264501|NCT00243022|527483083|FG000|Overall Study|Death|1|||
146264502|NCT00243022|527483084|FG001|Overall Study|Death|0|||
146264503|NCT00243022|527483083|FG000|Overall Study|Difficult Travel Distance|0|||
146264504|NCT00243022|527483084|FG001|Overall Study|Difficult Travel Distance|1|||
146264505|NCT01390441|527483089|FG000|Treatment Period|Protocol Violation|0|||
146264506|NCT01390441|527483090|FG001|Treatment Period|Protocol Violation|1|||
146264507|NCT01390441|527483091|FG002|Treatment Period|Protocol Violation|0|||
146264508|NCT01390441|527483092|FG003|Treatment Period|Protocol Violation|0|||
146264509|NCT01390441|527483093|FG004|Treatment Period|Protocol Violation|0|||
146264510|NCT01390441|527483089|FG000|Treatment Period|Physician Decision|0|||
146264511|NCT01390441|527483090|FG001|Treatment Period|Physician Decision|0|||
146264512|NCT01390441|527483091|FG002|Treatment Period|Physician Decision|0|||
146264513|NCT01390441|527483092|FG003|Treatment Period|Physician Decision|1|||
146264514|NCT01390441|527483093|FG004|Treatment Period|Physician Decision|0|||
146264515|NCT01390441|527483089|FG000|Treatment Period|Lack of Efficacy|0|||
146264516|NCT01390441|527483090|FG001|Treatment Period|Lack of Efficacy|0|||
146264517|NCT01390441|527483091|FG002|Treatment Period|Lack of Efficacy|0|||
146264518|NCT01390441|527483092|FG003|Treatment Period|Lack of Efficacy|0|||
146264519|NCT01390441|527483093|FG004|Treatment Period|Lack of Efficacy|1|||
146264520|NCT01390441|527483089|FG000|Treatment Period|Unknown due to early stopping of study|0|||
146264521|NCT01390441|527483090|FG001|Treatment Period|Unknown due to early stopping of study|0|||
146264522|NCT01390441|527483091|FG002|Treatment Period|Unknown due to early stopping of study|8|||
146264523|NCT01390441|527483092|FG003|Treatment Period|Unknown due to early stopping of study|11|||
146264524|NCT01390441|527483093|FG004|Treatment Period|Unknown due to early stopping of study|7|||
146264525|NCT01390441|527483089|FG000|Treatment Period|Adverse Event|0|||
146264526|NCT01390441|527483090|FG001|Treatment Period|Adverse Event|0|||
146264527|NCT01390441|527483091|FG002|Treatment Period|Adverse Event|1|||
146264528|NCT01390441|527483092|FG003|Treatment Period|Adverse Event|1|||
146264529|NCT01390441|527483093|FG004|Treatment Period|Adverse Event|2|||
146264530|NCT01390441|527483089|FG000|Treatment Period|Withdrawal by Subject|0|||
146264531|NCT01390441|527483090|FG001|Treatment Period|Withdrawal by Subject|0|||
146264532|NCT01390441|527483091|FG002|Treatment Period|Withdrawal by Subject|1|||
146264533|NCT01390441|527483092|FG003|Treatment Period|Withdrawal by Subject|0|||
146264534|NCT01390441|527483093|FG004|Treatment Period|Withdrawal by Subject|1|||
146264535|NCT01390441|527483089|FG000|Treatment Period|Lost to Follow-up|1|||
146264536|NCT01390441|527483090|FG001|Treatment Period|Lost to Follow-up|0|||
146264537|NCT01390441|527483091|FG002|Treatment Period|Lost to Follow-up|0|||
146264538|NCT01390441|527483092|FG003|Treatment Period|Lost to Follow-up|0|||
146264539|NCT01390441|527483093|FG004|Treatment Period|Lost to Follow-up|0|||
146264540|NCT01390441|527483089|FG000|Extension Period|Protocol Violation|3|||
146264541|NCT01390441|527483090|FG001|Extension Period|Protocol Violation|1|||
146264542|NCT01390441|527483091|FG002|Extension Period|Protocol Violation|0|||
146264543|NCT01390441|527483092|FG003|Extension Period|Protocol Violation|1|||
146264544|NCT01390441|527483093|FG004|Extension Period|Protocol Violation|0|||
146264545|NCT00621192|527483094|FG000|Overall Study|Withdrawal by Subject|0|||
146264546|NCT00621192|527483095|FG001|Overall Study|Withdrawal by Subject|0|||
146264547|NCT00621192|527483096|FG002|Overall Study|Withdrawal by Subject|2|||
146264548|NCT00621192|527483097|FG003|Overall Study|Withdrawal by Subject|0|||
146264549|NCT00621192|527483094|FG000|Overall Study|Physician Decision|1|||
146264550|NCT00621192|527483095|FG001|Overall Study|Physician Decision|3|||
146264551|NCT00621192|527483096|FG002|Overall Study|Physician Decision|0|||
146264552|NCT00621192|527483097|FG003|Overall Study|Physician Decision|0|||
146264553|NCT00621192|527483094|FG000|Overall Study|Protocol Violation|1|||
146264554|NCT00621192|527483095|FG001|Overall Study|Protocol Violation|0|||
146264555|NCT00621192|527483096|FG002|Overall Study|Protocol Violation|0|||
146264556|NCT00621192|527483097|FG003|Overall Study|Protocol Violation|1|||
146264557|NCT00621192|527483094|FG000|Overall Study|Adverse Event|0|||
146264558|NCT00621192|527483095|FG001|Overall Study|Adverse Event|1|||
146264559|NCT00621192|527483096|FG002|Overall Study|Adverse Event|0|||
146264560|NCT00621192|527483097|FG003|Overall Study|Adverse Event|1|||
146264561|NCT00621192|527483094|FG000|Overall Study|Death|2|||
146264562|NCT00621192|527483095|FG001|Overall Study|Death|5|||
146264563|NCT00621192|527483096|FG002|Overall Study|Death|0|||
146264564|NCT00621192|527483097|FG003|Overall Study|Death|0|||
146264565|NCT00621192|527483094|FG000|Overall Study|Final Assessments not Completed|0|||
146264566|NCT00621192|527483095|FG001|Overall Study|Final Assessments not Completed|0|||
146264567|NCT00621192|527483096|FG002|Overall Study|Final Assessments not Completed|3|||
146264568|NCT00621192|527483097|FG003|Overall Study|Final Assessments not Completed|1|||
146264569|NCT04706793|527483098|FG000|Treatment|Disease worsening|10|||
146264570|NCT04706793|527483099|FG001|Treatment|Disease worsening|10|||
146264571|NCT04706793|527483098|FG000|Follow-up|Lack of Efficacy|1|||
146264572|NCT04706793|527483099|FG001|Follow-up|Lack of Efficacy|0|||
146264573|NCT04706793|527483098|FG000|Follow-up|Disease worsening|8|||
146264574|NCT04706793|527483099|FG001|Follow-up|Disease worsening|10|||
146303587|NCT01514136|527625845|FG004|Test Period 2; Test C*|holiday|0|||
146303588|NCT01514136|527625846|FG005|Test Period 2; Test C*|holiday|0|||
146264575|NCT04706793|527483098|FG000|Follow-up|Adverse Event|1|||
146264576|NCT04706793|527483099|FG001|Follow-up|Adverse Event|0|||
146264577|NCT00823836|527483103|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
146264578|NCT00823836|527483104|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
146264579|NCT00823836|527483103|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
146264580|NCT00823836|527483104|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
146264581|NCT00823836|527483103|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
146264582|NCT00823836|527483104|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
146264583|NCT00823836|527483103|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
146264584|NCT00823836|527483104|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
146303589|NCT01514136|527625847|FG006|Test Period 2; Test C*|holiday|1|||
146303590|NCT01514136|527625848|FG007|Test Period 2; Test C*|holiday|0|||
146264585|NCT00823836|527483103|FG000|Long-term Phase|Adverse Event|3|||
146264586|NCT00823836|527483104|FG001|Long-term Phase|Adverse Event|2|||
146264587|NCT00823836|527483103|FG000|Long-term Phase|Physician Decision|1|||
146264588|NCT00823836|527483104|FG001|Long-term Phase|Physician Decision|2|||
146264589|NCT00823836|527483103|FG000|Long-term Phase|Withdrawal by Subject|1|||
146264590|NCT00823836|527483104|FG001|Long-term Phase|Withdrawal by Subject|1|||
146264591|NCT01099579|527483105|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
146264592|NCT01099579|527483106|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
146264593|NCT01099579|527483107|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
146264594|NCT01099579|527483105|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
146303591|NCT01514136|527625841|FG000|Test Period 2; Test C*|Protocol Violation|0|||
146303592|NCT01514136|527625842|FG001|Test Period 2; Test C*|Protocol Violation|0|||
146264595|NCT01099579|527483106|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
146264596|NCT01099579|527483107|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
146264597|NCT01099579|527483105|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
146264598|NCT01099579|527483106|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
146264599|NCT01099579|527483107|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
146264600|NCT01099579|527483105|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
146264601|NCT01099579|527483106|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
146264602|NCT01099579|527483107|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
146264603|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
146264604|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
146264605|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
146264606|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146264607|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146264608|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
146264609|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
146264610|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
146264611|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
146264612|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146264613|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146264614|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
146264615|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
146264616|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
146264617|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
146264618|NCT01099579|527483105|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
146264619|NCT01099579|527483106|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
146264620|NCT01099579|527483107|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
146264621|NCT01130168|527483112|FG000|Period 1|Withdrawal by Subject|0|||
146264622|NCT01130168|527483113|FG001|Period 1|Withdrawal by Subject|1|||
146264623|NCT01130168|527483114|FG002|Period 1|Withdrawal by Subject|0|||
146264624|NCT01130168|527483115|FG003|Period 1|Withdrawal by Subject|1|||
146264625|NCT01130168|527483116|FG004|Period 1|Withdrawal by Subject|0|||
146264626|NCT01130168|527483117|FG005|Period 1|Withdrawal by Subject|0|||
146264627|NCT01130168|527483112|FG000|Period 1|Discontinued For Other Reason|0|||
146264628|NCT01130168|527483113|FG001|Period 1|Discontinued For Other Reason|0|||
146264629|NCT01130168|527483114|FG002|Period 1|Discontinued For Other Reason|1|||
146264630|NCT01130168|527483115|FG003|Period 1|Discontinued For Other Reason|1|||
146264631|NCT01130168|527483116|FG004|Period 1|Discontinued For Other Reason|0|||
146264632|NCT01130168|527483117|FG005|Period 1|Discontinued For Other Reason|0|||
146264633|NCT01130168|527483112|FG000|Period 1|Adverse Event|0|||
146264634|NCT01130168|527483113|FG001|Period 1|Adverse Event|0|||
146264635|NCT01130168|527483114|FG002|Period 1|Adverse Event|0|||
146264636|NCT01130168|527483115|FG003|Period 1|Adverse Event|1|||
146264637|NCT01130168|527483116|FG004|Period 1|Adverse Event|0|||
146264638|NCT01130168|527483117|FG005|Period 1|Adverse Event|0|||
146264639|NCT02725528|527483118|FG000|Overall Study|Lost to Follow-up|1|||
146264640|NCT02725528|527483119|FG001|Overall Study|Lost to Follow-up|4|||
146264641|NCT02725528|527483118|FG000|Overall Study|Withdrawal by Subject|0|||
146264642|NCT02725528|527483119|FG001|Overall Study|Withdrawal by Subject|1|||
146264643|NCT04354168|527483122|FG000|Overall Study|Lost to Follow-up|22|||
146264644|NCT01781832|527483123|FG000|Overall Study|Withdrawal by Subject|1|||
146264645|NCT03432390|527483126|FG000|Apnea Period|Protocol Violation|2|||
146264646|NCT03432390|527483127|FG001|Apnea Period|Protocol Violation|2|||
146264647|NCT03783689|527483129|FG000|Overall Study|Adverse Event|2|||
146264648|NCT03783689|527483130|FG001|Overall Study|Adverse Event|0|||
146264649|NCT03783689|527483129|FG000|Overall Study|Lost to Follow-up|2|||
146264650|NCT03783689|527483130|FG001|Overall Study|Lost to Follow-up|1|||
146264651|NCT03783689|527483129|FG000|Overall Study|Physician Decision|2|||
146264652|NCT03783689|527483130|FG001|Overall Study|Physician Decision|1|||
146264653|NCT03783689|527483129|FG000|Overall Study|Withdrawal by Subject|3|||
146264654|NCT03783689|527483130|FG001|Overall Study|Withdrawal by Subject|3|||
146264655|NCT04680637|527483135|FG000|Overall Study|Lost to Follow-up|0|||
146264656|NCT04680637|527483136|FG001|Overall Study|Lost to Follow-up|1|||
146264657|NCT04680637|527483137|FG002|Overall Study|Lost to Follow-up|0|||
146264658|NCT04680637|527483138|FG003|Overall Study|Lost to Follow-up|1|||
146264659|NCT04680637|527483135|FG000|Overall Study|Death|1|||
146264660|NCT04680637|527483136|FG001|Overall Study|Death|0|||
146264661|NCT04680637|527483137|FG002|Overall Study|Death|0|||
146264662|NCT04680637|527483138|FG003|Overall Study|Death|0|||
146264663|NCT04680637|527483135|FG000|Overall Study|Withdrawal by Subject|7|||
146264664|NCT04680637|527483136|FG001|Overall Study|Withdrawal by Subject|10|||
146264665|NCT04680637|527483137|FG002|Overall Study|Withdrawal by Subject|17|||
146264666|NCT04680637|527483138|FG003|Overall Study|Withdrawal by Subject|15|||
146264667|NCT04680637|527483135|FG000|Overall Study|Decision by Sponsor|21|||
146264668|NCT04680637|527483136|FG001|Overall Study|Decision by Sponsor|15|||
146264669|NCT04680637|527483137|FG002|Overall Study|Decision by Sponsor|7|||
146264670|NCT04680637|527483138|FG003|Overall Study|Decision by Sponsor|32|||
146264671|NCT00691678|527483139|FG000|Overall Study|Adverse Event|5|||
146264672|NCT00691678|527483139|FG000|Overall Study|life events, pain|11|||
146264673|NCT01251887|527483140|FG000|Overall Study|Scheduling conflict|1|||
146264674|NCT01251887|527483141|FG001|Overall Study|Scheduling conflict|2|||
146264675|NCT01251887|527483142|FG002|Overall Study|Scheduling conflict|2|||
146264676|NCT01251887|527483140|FG000|Overall Study|Physician Decision|0|||
146264677|NCT01251887|527483141|FG001|Overall Study|Physician Decision|1|||
146264678|NCT01251887|527483142|FG002|Overall Study|Physician Decision|0|||
146264679|NCT03167151|527484539|FG000|Overall Study|Withdrawal by Subject|1|||
146264680|NCT03167151|527484540|FG001|Overall Study|Withdrawal by Subject|0|||
146264681|NCT03167151|527484541|FG002|Overall Study|Withdrawal by Subject|0|||
146264682|NCT03167151|527484539|FG000|Overall Study|No evidence of tumour at surgery|0|||
146264683|NCT03167151|527484540|FG001|Overall Study|No evidence of tumour at surgery|1|||
146264684|NCT03167151|527484541|FG002|Overall Study|No evidence of tumour at surgery|1|||
146264685|NCT01458522|527484542|FG000|Overall Study|Withdrawal by Subject|2|||
146264686|NCT01458522|527484543|FG001|Overall Study|Withdrawal by Subject|2|||
146264687|NCT01458522|527484542|FG000|Overall Study|Physician Decision|1|||
146264688|NCT01458522|527484543|FG001|Overall Study|Physician Decision|9|||
146264689|NCT00516139|527484544|FG000|Overall Study|Adverse Event|27|||
146264690|NCT00516139|527484544|FG000|Overall Study|Lost to Follow-up|1|||
146264691|NCT00516139|527484544|FG000|Overall Study|Protocol Violation|1|||
146264692|NCT00516139|527484544|FG000|Overall Study|Withdrawal by Subject|8|||
146264693|NCT00516139|527484544|FG000|Overall Study|Lack of Efficacy|1|||
146264694|NCT00416598|527484545|FG000|Induction & Intensification|Adverse Event|38|||
146264695|NCT00416598|527484545|FG000|Induction & Intensification|Death|32|||
146264696|NCT00416598|527484545|FG000|Induction & Intensification|Withdrawal by Subject|46|||
146264697|NCT00416598|527484545|FG000|Induction & Intensification|Alternative Treatment|135|||
146264698|NCT00416598|527484545|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
146264699|NCT00416598|527484545|FG000|Induction & Intensification|Relapse/progression|29|||
146264700|NCT00416598|527484545|FG000|Induction & Intensification|Failed induction|87|||
146264701|NCT00416598|527484545|FG000|Decitabine Maintenance|Adverse Event|5|||
146264702|NCT00416598|527484545|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
146264703|NCT00416598|527484545|FG000|Decitabine Maintenance|Progression/relapse|38|||
146264704|NCT00416598|527484545|FG000|Decitabine Maintenance|Alternative treatment|2|||
146264705|NCT00416598|527484545|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
146264706|NCT02166476|527484552|FG000|Overall Study|Withdrawal by Subject|5|||
146264707|NCT02166476|527484553|FG001|Overall Study|Withdrawal by Subject|7|||
146264708|NCT02166476|527484552|FG000|Overall Study|Adverse Event|3|||
146264709|NCT02166476|527484553|FG001|Overall Study|Adverse Event|3|||
146264710|NCT02166476|527484552|FG000|Overall Study|Lost to Follow-up|5|||
146264711|NCT02166476|527484553|FG001|Overall Study|Lost to Follow-up|10|||
146264712|NCT02166476|527484552|FG000|Overall Study|Physician Decision|1|||
146264713|NCT02166476|527484553|FG001|Overall Study|Physician Decision|0|||
146264714|NCT02166476|527484552|FG000|Overall Study|Unable to Come for Visit|0|||
146264715|NCT02166476|527484553|FG001|Overall Study|Unable to Come for Visit|3|||
146264716|NCT04367480|527484560|FG000|Overall Study|Adverse Event|1|||
146264717|NCT04367480|527484561|FG001|Overall Study|Adverse Event|1|||
146264718|NCT04367480|527484560|FG000|Overall Study|Death|1|||
146264719|NCT04367480|527484561|FG001|Overall Study|Death|0|||
146264720|NCT04367480|527484560|FG000|Overall Study|Lost to Follow-up|1|||
146264721|NCT04367480|527484561|FG001|Overall Study|Lost to Follow-up|1|||
146264722|NCT04367480|527484560|FG000|Overall Study|Withdrawal by Subject|0|||
146264723|NCT04367480|527484561|FG001|Overall Study|Withdrawal by Subject|3|||
146264724|NCT04367480|527484560|FG000|Overall Study|App glitch during the study|1|||
146264725|NCT04367480|527484561|FG001|Overall Study|App glitch during the study|0|||
146264726|NCT04367480|527484560|FG000|Overall Study|Device Distribution Error|0|||
146264727|NCT04367480|527484561|FG001|Overall Study|Device Distribution Error|2|||
146264728|NCT04367480|527484560|FG000|Overall Study|Ineligible after Randomization|0|||
146264729|NCT04367480|527484561|FG001|Overall Study|Ineligible after Randomization|1|||
146264730|NCT04367480|527484560|FG000|Overall Study|Other Medical Reasons|0|||
146264731|NCT04367480|527484561|FG001|Overall Study|Other Medical Reasons|2|||
146264732|NCT03382561|527484562|FG000|Overall Study|Disease progression|47|||
146264733|NCT03382561|527484563|FG001|Overall Study|Disease progression|6|||
146264734|NCT03382561|527484562|FG000|Overall Study|Adverse Event|10|||
146264735|NCT03382561|527484563|FG001|Overall Study|Adverse Event|2|||
146264736|NCT03382561|527484562|FG000|Overall Study|Death|8|||
146264737|NCT03382561|527484563|FG001|Overall Study|Death|3|||
146264738|NCT03382561|527484562|FG000|Overall Study|Withdrawal by Subject|6|||
146264739|NCT03382561|527484563|FG001|Overall Study|Withdrawal by Subject|5|||
146264740|NCT03382561|527484562|FG000|Overall Study|Alternative therapy|2|||
146264741|NCT03382561|527484563|FG001|Overall Study|Alternative therapy|8|||
146264742|NCT03382561|527484562|FG000|Overall Study|Never started treatment|3|||
146264743|NCT03382561|527484563|FG001|Overall Study|Never started treatment|6|||
146264744|NCT03382561|527484562|FG000|Overall Study|Lack of Efficacy|0|||
146264745|NCT03382561|527484563|FG001|Overall Study|Lack of Efficacy|1|||
146264746|NCT03382561|527484562|FG000|Overall Study|Physician Decision|0|||
146264747|NCT03382561|527484563|FG001|Overall Study|Physician Decision|1|||
146264748|NCT03382561|527484562|FG000|Overall Study|Other complicating disease|0|||
146264749|NCT03382561|527484563|FG001|Overall Study|Other complicating disease|1|||
146264750|NCT01131104|527484564|FG000|Overall Study|Withdrawal by Subject|3|||
146264751|NCT01131104|527484564|FG000|Overall Study|Physician Decision|4|||
146264752|NCT01131104|527484564|FG000|Overall Study|Information Not Available|5|||
146264753|NCT01131104|527484564|FG000|Overall Study|No Information on Index Date of Onset|1|||
146264754|NCT04836559|527484566|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146264755|NCT04836559|527484567|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
146264756|NCT04836559|527484568|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
146264757|NCT04836559|527484569|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
146264758|NCT04836559|527484570|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146264759|NCT04836559|527484571|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146264760|NCT04836559|527484572|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146264761|NCT04836559|527484573|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
146264762|NCT04836559|527484566|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146264763|NCT04836559|527484567|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146264764|NCT04836559|527484568|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
146264765|NCT04836559|527484569|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
146264766|NCT04836559|527484570|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146264767|NCT04836559|527484571|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146264768|NCT04836559|527484572|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146264769|NCT04836559|527484573|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
146264770|NCT04836559|527484566|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
146264771|NCT04836559|527484567|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264772|NCT04836559|527484568|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264773|NCT04836559|527484569|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264774|NCT04836559|527484570|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264775|NCT04836559|527484571|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264776|NCT04836559|527484572|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264777|NCT04836559|527484573|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
146264778|NCT04836559|527484566|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
146264779|NCT04836559|527484567|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264780|NCT04836559|527484568|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264781|NCT04836559|527484569|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264782|NCT04836559|527484570|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264783|NCT04836559|527484571|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264784|NCT04836559|527484572|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264785|NCT04836559|527484573|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
146264786|NCT04836559|527484566|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264787|NCT04836559|527484567|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264788|NCT04836559|527484568|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264789|NCT04836559|527484569|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
146264790|NCT04836559|527484570|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264791|NCT04836559|527484571|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264792|NCT04836559|527484572|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264793|NCT04836559|527484573|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
146264794|NCT04836559|527484566|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146264795|NCT04836559|527484567|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146264796|NCT04836559|527484568|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146264797|NCT04836559|527484569|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
146264798|NCT04836559|527484570|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
146264799|NCT04836559|527484571|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
146264800|NCT04836559|527484572|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
146264801|NCT04836559|527484573|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
146264802|NCT04836559|527484566|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146264803|NCT04836559|527484567|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146264804|NCT04836559|527484568|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146264805|NCT04836559|527484569|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
146264806|NCT04836559|527484570|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
146264807|NCT04836559|527484571|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
146264808|NCT04836559|527484572|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
146264809|NCT04836559|527484573|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
146264810|NCT04836559|527484566|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146264811|NCT04836559|527484567|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146264812|NCT04836559|527484568|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146264813|NCT04836559|527484569|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146264814|NCT04836559|527484570|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
146264815|NCT04836559|527484571|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
146264816|NCT04836559|527484572|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
146264817|NCT04836559|527484573|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
146303593|NCT01514136|527625843|FG002|Test Period 2; Test C*|Protocol Violation|0|||
146303594|NCT01514136|527625844|FG003|Test Period 2; Test C*|Protocol Violation|0|||
146303595|NCT01514136|527625845|FG004|Test Period 2; Test C*|Protocol Violation|0|||
146303596|NCT01514136|527625846|FG005|Test Period 2; Test C*|Protocol Violation|0|||
146303597|NCT01514136|527625847|FG006|Test Period 2; Test C*|Protocol Violation|1|||
146264818|NCT04836559|527484566|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264819|NCT04836559|527484567|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264820|NCT04836559|527484568|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264821|NCT04836559|527484569|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264822|NCT04836559|527484570|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264823|NCT04836559|527484571|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264824|NCT04836559|527484572|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
146264825|NCT04836559|527484573|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
146264826|NCT00730015|527484574|FG000|Overall Study|Adverse Event|11|||
146264827|NCT00730015|527484575|FG001|Overall Study|Adverse Event|10|||
146264828|NCT00730015|527484576|FG002|Overall Study|Adverse Event|8|||
146264829|NCT00730015|527484574|FG000|Overall Study|Protocol Violation|2|||
146264830|NCT00730015|527484575|FG001|Overall Study|Protocol Violation|6|||
146264831|NCT00730015|527484576|FG002|Overall Study|Protocol Violation|4|||
146264832|NCT00730015|527484574|FG000|Overall Study|Withdrawal by Subject|12|||
146264833|NCT00730015|527484575|FG001|Overall Study|Withdrawal by Subject|12|||
146264834|NCT00730015|527484576|FG002|Overall Study|Withdrawal by Subject|8|||
146264835|NCT00730015|527484574|FG000|Overall Study|Lost to Follow-up|4|||
146264836|NCT00730015|527484575|FG001|Overall Study|Lost to Follow-up|10|||
146264837|NCT00730015|527484576|FG002|Overall Study|Lost to Follow-up|3|||
146264838|NCT00730015|527484574|FG000|Overall Study|Lack of Efficacy|1|||
146264839|NCT00730015|527484575|FG001|Overall Study|Lack of Efficacy|2|||
146264840|NCT00730015|527484576|FG002|Overall Study|Lack of Efficacy|8|||
146264841|NCT00730015|527484574|FG000|Overall Study|Other Reason|1|||
146264842|NCT00730015|527484575|FG001|Overall Study|Other Reason|0|||
146264843|NCT00730015|527484576|FG002|Overall Study|Other Reason|1|||
146264844|NCT01432626|527484577|FG000|Overall Study|LV function recovered|2|||
146264845|NCT01432626|527484577|FG000|Overall Study|Withdrawal by Subject|2|||
146264846|NCT01432626|527484577|FG000|Overall Study|Only 1 image competed|2|||
146264847|NCT01432626|527484577|FG000|Overall Study|Imaging agent not available|1|||
146264848|NCT05382039|527484578|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
146264849|NCT05382039|527484579|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
146264850|NCT05382039|527484580|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
146264851|NCT05382039|527484578|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
146264852|NCT05382039|527484579|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
146264853|NCT05382039|527484580|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
146264854|NCT05382039|527484578|FG000|Overall Study|waiting for confirmation|0|||
146264855|NCT05382039|527484579|FG001|Overall Study|waiting for confirmation|0|||
146264856|NCT05382039|527484580|FG002|Overall Study|waiting for confirmation|1|||
146264857|NCT03210519|527484583|FG000|Overall Study|Adverse Event|2|||
146264858|NCT03210519|527484584|FG001|Overall Study|Adverse Event|0|||
146264859|NCT02270671|527484585|FG000|Overall Study|Withdrawal by Subject|1|||
146264860|NCT02270671|527484586|FG001|Overall Study|Withdrawal by Subject|1|||
146264861|NCT02270671|527484585|FG000|Overall Study|Protocol Violation|0|||
146264862|NCT02270671|527484586|FG001|Overall Study|Protocol Violation|1|||
146264863|NCT02270671|527484585|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
146264864|NCT02270671|527484586|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
146264865|NCT02270671|527484585|FG000|Overall Study|Lost to Follow-up|2|||
146264866|NCT02270671|527484586|FG001|Overall Study|Lost to Follow-up|1|||
146264867|NCT01657799|527484590|FG000|Overall Study|Adverse Event Related to progression|6|||
146264868|NCT01657799|527484591|FG001|Overall Study|Adverse Event Related to progression|8|||
146264869|NCT01657799|527484592|FG002|Overall Study|Adverse Event Related to progression|12|||
146264870|NCT01657799|527484590|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
146264871|NCT01657799|527484591|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
146264872|NCT01657799|527484592|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
146264873|NCT01657799|527484590|FG000|Overall Study|Withdrawal by Subject|13|||
146264874|NCT01657799|527484591|FG001|Overall Study|Withdrawal by Subject|10|||
146264875|NCT01657799|527484592|FG002|Overall Study|Withdrawal by Subject|10|||
146264876|NCT01657799|527484590|FG000|Overall Study|Lost to Follow-up|1|||
146264877|NCT01657799|527484591|FG001|Overall Study|Lost to Follow-up|0|||
146264878|NCT01657799|527484592|FG002|Overall Study|Lost to Follow-up|1|||
146264879|NCT01657799|527484590|FG000|Overall Study|Disease Progression|2|||
146264880|NCT01657799|527484591|FG001|Overall Study|Disease Progression|4|||
146264881|NCT01657799|527484592|FG002|Overall Study|Disease Progression|4|||
146264882|NCT01657799|527484590|FG000|Overall Study|Progressive Disease Clinical|7|||
146264883|NCT01657799|527484591|FG001|Overall Study|Progressive Disease Clinical|4|||
146264884|NCT01657799|527484592|FG002|Overall Study|Progressive Disease Clinical|7|||
146264885|NCT01657799|527484590|FG000|Overall Study|Radiographic & Clinical Progression|16|||
146264886|NCT01657799|527484591|FG001|Overall Study|Radiographic & Clinical Progression|11|||
146264887|NCT01657799|527484592|FG002|Overall Study|Radiographic & Clinical Progression|15|||
146264888|NCT01657799|527484590|FG000|Overall Study|Other|52|||
146264889|NCT01657799|527484591|FG001|Overall Study|Other|62|||
146264890|NCT01657799|527484592|FG002|Overall Study|Other|49|||
146303598|NCT01514136|527625848|FG007|Test Period 2; Test C*|Protocol Violation|0|||
146264891|NCT00174447|527484593|FG000|Overall Study|Adverse Event|19|||
146264892|NCT00174447|527484593|FG000|Overall Study|Withdrawal by Subject|15|||
146264893|NCT00174447|527484593|FG000|Overall Study|Protocol Violation|1|||
146264894|NCT00174447|527484593|FG000|Overall Study|Lack of Efficacy|1|||
146264895|NCT00174447|527484593|FG000|Overall Study|Administrative reason/Other|2|||
146264896|NCT00940875|527484602|FG000|Treatment Phase|Adverse Event|9|||
146264897|NCT00940875|527484603|FG001|Treatment Phase|Adverse Event|3|||
146264898|NCT00940875|527484602|FG000|Treatment Phase|Death|3|||
146264899|NCT00940875|527484603|FG001|Treatment Phase|Death|5|||
146264900|NCT00940875|527484602|FG000|Treatment Phase|Lack of Efficacy|1|||
146264901|NCT00940875|527484603|FG001|Treatment Phase|Lack of Efficacy|0|||
146264902|NCT00940875|527484602|FG000|Treatment Phase|Withdrawal by Subject|3|||
146264903|NCT00940875|527484603|FG001|Treatment Phase|Withdrawal by Subject|0|||
146264904|NCT00940875|527484602|FG000|Treatment Phase|Disease progression|9|||
146264905|NCT00940875|527484603|FG001|Treatment Phase|Disease progression|11|||
146264906|NCT00940875|527484602|FG000|Treatment Phase|Physician Decision|1|||
146264907|NCT00940875|527484603|FG001|Treatment Phase|Physician Decision|0|||
146264908|NCT00940875|527484602|FG000|Post-Study Treatment|Death|0|||
146264909|NCT00940875|527484603|FG001|Post-Study Treatment|Death|1|||
146264910|NCT00940875|527484602|FG000|Post-Study Treatment|Disease Progression|0|||
146264911|NCT00940875|527484603|FG001|Post-Study Treatment|Disease Progression|2|||
146264912|NCT03603639|527484608|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146264913|NCT03603639|527484609|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146264914|NCT03603639|527484610|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146264915|NCT03603639|527484611|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
146264916|NCT03603639|527484612|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146264917|NCT03603639|527484613|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
146264918|NCT03603639|527484608|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146264919|NCT03603639|527484609|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146264920|NCT03603639|527484610|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146264921|NCT03603639|527484611|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
146264922|NCT03603639|527484612|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146264923|NCT03603639|527484613|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
146264924|NCT02402322|527484619|FG000|Pretreatment|Withdrawal by Subject|3|||
146264925|NCT02402322|527484620|FG001|Pretreatment|Withdrawal by Subject|1|||
146264926|NCT02402322|527484621|FG002|Pretreatment|Withdrawal by Subject|1|||
146264927|NCT02402322|527484619|FG000|Follow-up|Withdrawal by Subject|6|||
146264928|NCT02402322|527484620|FG001|Follow-up|Withdrawal by Subject|3|||
146264929|NCT02402322|527484621|FG002|Follow-up|Withdrawal by Subject|24|||
146303599|NCT01010633|527625849|FG000|Overall Study|Adverse Event|1|||
146303600|NCT01010633|527625850|FG001|Overall Study|Adverse Event|1|||
146303601|NCT01010633|527625849|FG000|Overall Study|Protocol Violation|1|||
146303602|NCT01010633|527625850|FG001|Overall Study|Protocol Violation|2|||
146303603|NCT01010633|527625849|FG000|Overall Study|Withdrawal by Subject|2|||
146303604|NCT01010633|527625850|FG001|Overall Study|Withdrawal by Subject|1|||
146303605|NCT01010633|527625849|FG000|Overall Study|Investigator decision|0|||
146303606|NCT01010633|527625850|FG001|Overall Study|Investigator decision|1|||
146303607|NCT02941926|527625852|FG000|Core Phase|Progressive disease|1109|||
146303608|NCT02941926|527625852|FG000|Core Phase|Adverse Event|504|||
146303609|NCT02941926|527625852|FG000|Core Phase|Subject/guardian decision|127|||
146303610|NCT02941926|527625852|FG000|Core Phase|Physician Decision|112|||
146303611|NCT02941926|527625852|FG000|Core Phase|Death|46|||
146303612|NCT02941926|527625852|FG000|Core Phase|Protocol deviation|34|||
146303613|NCT02941926|527625852|FG000|Core Phase|Lost to Follow-up|8|||
146303614|NCT02941926|527625852|FG000|Core Phase|Technical problems|5|||
146303615|NCT02941926|527625852|FG000|Extension Phase|Physician Decision|155|||
146303616|NCT02941926|527625852|FG000|Extension Phase|Progressive disease|115|||
146303617|NCT02941926|527625852|FG000|Extension Phase|Adverse Event|13|||
146303618|NCT02941926|527625852|FG000|Extension Phase|Subject/Guardian decision|12|||
146303619|NCT02941926|527625852|FG000|Extension Phase|Death|6|||
146303620|NCT00888381|527625853|FG000|Overall Study|Lost to Follow-up|0|||
146303621|NCT00888381|527625854|FG001|Overall Study|Lost to Follow-up|1|||
146303622|NCT00097773|527625855|FG000|Overall Study|Lost to Follow-up|2|||
146303623|NCT00097773|527625856|FG001|Overall Study|Lost to Follow-up|2|||
146303624|NCT00097773|527625857|FG002|Overall Study|Lost to Follow-up|0|||
146303625|NCT00097773|527625858|FG003|Overall Study|Lost to Follow-up|1|||
146303626|NCT00097773|527625855|FG000|Overall Study|Physician Decision|2|||
146303627|NCT00097773|527625856|FG001|Overall Study|Physician Decision|2|||
146303628|NCT00097773|527625857|FG002|Overall Study|Physician Decision|3|||
146303629|NCT00097773|527625858|FG003|Overall Study|Physician Decision|1|||
146303630|NCT00097773|527625855|FG000|Overall Study|Withdrawal by Subject|3|||
146303631|NCT00097773|527625856|FG001|Overall Study|Withdrawal by Subject|3|||
146303632|NCT00097773|527625857|FG002|Overall Study|Withdrawal by Subject|3|||
146303633|NCT00097773|527625858|FG003|Overall Study|Withdrawal by Subject|1|||
146303634|NCT00097773|527625855|FG000|Overall Study|Adverse Event|0|||
146303635|NCT00097773|527625856|FG001|Overall Study|Adverse Event|1|||
146303636|NCT00097773|527625857|FG002|Overall Study|Adverse Event|0|||
146303637|NCT00097773|527625858|FG003|Overall Study|Adverse Event|0|||
146303638|NCT00097773|527625855|FG000|Overall Study|Other|1|||
146303639|NCT00097773|527625856|FG001|Overall Study|Other|0|||
146303640|NCT00097773|527625857|FG002|Overall Study|Other|2|||
146303641|NCT00097773|527625858|FG003|Overall Study|Other|0|||
146303642|NCT04305275|527625859|FG000|Overall Study|Adverse Event|4|||
146303643|NCT04305275|527625860|FG001|Overall Study|Adverse Event|0|||
146303644|NCT04305275|527625859|FG000|Overall Study|Lost to Follow-up|1|||
146303645|NCT04305275|527625860|FG001|Overall Study|Lost to Follow-up|1|||
146303646|NCT04305275|527625859|FG000|Overall Study|Withdrawal by Participant|8|||
146303647|NCT04305275|527625860|FG001|Overall Study|Withdrawal by Participant|1|||
146303648|NCT02243865|527625863|FG000|Overall Study|Protocol Violation|1|||
146303649|NCT02243865|527625864|FG001|Overall Study|Protocol Violation|3|||
146303650|NCT02243865|527625863|FG000|Overall Study|Lost to Follow-up|1|||
146303651|NCT02243865|527625864|FG001|Overall Study|Lost to Follow-up|1|||
146303652|NCT02243865|527625863|FG000|Overall Study|Withdrawal by Subject|1|||
146303653|NCT02243865|527625864|FG001|Overall Study|Withdrawal by Subject|0|||
146303654|NCT02243865|527625863|FG000|Overall Study|Adverse Event|1|||
146264930|NCT02818998|527484622|FG000|Overall Study|Adverse Event|3|||
146168278|NCT02889133|527128093|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
146168279|NCT02889133|527128094|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
146168280|NCT02889133|527128093|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
146168281|NCT02889133|527128094|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
146168282|NCT02889133|527128093|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
146168283|NCT02889133|527128094|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
146168284|NCT04252742|527128097|FG000|Overall Study|Decision by sponsor|0|||
146168285|NCT04252742|527128098|FG001|Overall Study|Decision by sponsor|2|||
146168286|NCT04252742|527128097|FG000|Overall Study|Withdrawal by Subject|15|||
146168287|NCT04252742|527128098|FG001|Overall Study|Withdrawal by Subject|9|||
146168288|NCT04252742|527128097|FG000|Overall Study|Lost to Follow-up|0|||
146168289|NCT04252742|527128098|FG001|Overall Study|Lost to Follow-up|1|||
146168290|NCT04179032|527128099|FG000|Part B (Up to Week 52)|Adverse Event|1|||
146168291|NCT04179032|527128099|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
146168292|NCT04179032|527128099|FG000|Access Extension Phase|Ongoing|11|||
146168293|NCT02597036|527128103|FG000|Overall Study|Progressive Disease|0|||
146168294|NCT02597036|527128104|FG001|Overall Study|Progressive Disease|0|||
146168295|NCT02597036|527128105|FG002|Overall Study|Progressive Disease|0|||
146168296|NCT02597036|527128106|FG003|Overall Study|Progressive Disease|0|||
146168297|NCT02597036|527128107|FG004|Overall Study|Progressive Disease|1|||
146168298|NCT02597036|527128108|FG005|Overall Study|Progressive Disease|1|||
146168299|NCT02597036|527128109|FG006|Overall Study|Progressive Disease|1|||
146168300|NCT02597036|527128110|FG007|Overall Study|Progressive Disease|0|||
146168301|NCT02597036|527128111|FG008|Overall Study|Progressive Disease|0|||
146168302|NCT02597036|527128112|FG009|Overall Study|Progressive Disease|0|||
146168303|NCT02597036|527128113|FG010|Overall Study|Progressive Disease|0|||
146168304|NCT02597036|527128114|FG011|Overall Study|Progressive Disease|0|||
146168305|NCT02597036|527128103|FG000|Overall Study|Adverse Event|0|||
146168306|NCT02597036|527128104|FG001|Overall Study|Adverse Event|0|||
146168307|NCT02597036|527128105|FG002|Overall Study|Adverse Event|0|||
146168308|NCT02597036|527128106|FG003|Overall Study|Adverse Event|0|||
146168309|NCT02597036|527128107|FG004|Overall Study|Adverse Event|0|||
146168310|NCT02597036|527128108|FG005|Overall Study|Adverse Event|0|||
146168311|NCT02597036|527128109|FG006|Overall Study|Adverse Event|0|||
146168312|NCT02597036|527128110|FG007|Overall Study|Adverse Event|1|||
146168313|NCT02597036|527128111|FG008|Overall Study|Adverse Event|0|||
146168314|NCT02597036|527128112|FG009|Overall Study|Adverse Event|0|||
146168315|NCT02597036|527128113|FG010|Overall Study|Adverse Event|0|||
146168316|NCT02597036|527128114|FG011|Overall Study|Adverse Event|1|||
146168317|NCT02597036|527128103|FG000|Overall Study|Death|0|||
146168318|NCT02597036|527128104|FG001|Overall Study|Death|0|||
146168319|NCT02597036|527128105|FG002|Overall Study|Death|0|||
146168320|NCT02597036|527128106|FG003|Overall Study|Death|0|||
146168321|NCT02597036|527128107|FG004|Overall Study|Death|0|||
146168322|NCT02597036|527128108|FG005|Overall Study|Death|0|||
146168323|NCT02597036|527128109|FG006|Overall Study|Death|0|||
146168324|NCT02597036|527128110|FG007|Overall Study|Death|0|||
146168325|NCT02597036|527128111|FG008|Overall Study|Death|0|||
146168326|NCT02597036|527128112|FG009|Overall Study|Death|1|||
146168327|NCT02597036|527128113|FG010|Overall Study|Death|1|||
146303655|NCT02243865|527625864|FG001|Overall Study|Adverse Event|1|||
146168328|NCT02597036|527128114|FG011|Overall Study|Death|0|||
146168329|NCT02597036|527128103|FG000|Overall Study|Lost to Follow-up|0|||
146168330|NCT02597036|527128104|FG001|Overall Study|Lost to Follow-up|0|||
146168331|NCT02597036|527128105|FG002|Overall Study|Lost to Follow-up|0|||
146168332|NCT02597036|527128106|FG003|Overall Study|Lost to Follow-up|0|||
146303656|NCT02003014|527625875|FG000|Overall Study|Case report forms uncollected|9|||
146131523|NCT00574405|527002240|FG000|Overall Study|Withdrawal by Subject|3|||
146131524|NCT00574405|527002241|FG001|Overall Study|Withdrawal by Subject|2|||
146131525|NCT04380857|527002243|FG000|Overall Study|Lost to Follow-up|3|||
146131526|NCT04380857|527002244|FG001|Overall Study|Lost to Follow-up|3|||
146131527|NCT02558790|527002245|FG000|Overall Study|Lost to Follow-up|2|||
146131528|NCT02558790|527002245|FG000|Overall Study|Physician Decision|1|||
146131529|NCT02558790|527002245|FG000|Overall Study|Withdrawal by Subject|1|||
146131530|NCT02558790|527002245|FG000|Overall Study|Screen Fail|3|||
146131531|NCT01572038|527002247|FG000|Overall Study|Death|648|||
146131532|NCT01572038|527002247|FG000|Overall Study|Withdrawal by Subject|204|||
146131533|NCT01572038|527002247|FG000|Overall Study|Lost to Follow-up|81|||
146131534|NCT01572038|527002247|FG000|Overall Study|Physician Decision|20|||
146131535|NCT01572038|527002247|FG000|Overall Study|Patient Decision|14|||
146131536|NCT01572038|527002247|FG000|Overall Study|Progressive Disease|8|||
146131537|NCT01572038|527002247|FG000|Overall Study|Site Closed Before Completing Form|6|||
146131538|NCT01572038|527002247|FG000|Overall Study|Enrolled into Another Trial|3|||
146131539|NCT01572038|527002247|FG000|Overall Study|Participated in Another Trial|3|||
146131540|NCT01572038|527002247|FG000|Overall Study|Termination by Sponsor|2|||
146131541|NCT01572038|527002247|FG000|Overall Study|Patient Deterioration|1|||
146131542|NCT01572038|527002247|FG000|Overall Study|Sponsor Decision|1|||
146131543|NCT01888497|527002248|FG000|Washout Period 1|Withdrawal by Subject|0|||
146131544|NCT01888497|527002249|FG001|Washout Period 1|Withdrawal by Subject|0|||
146131545|NCT01888497|527002250|FG002|Washout Period 1|Withdrawal by Subject|1|||
146131546|NCT01888497|527002251|FG003|Washout Period 1|Withdrawal by Subject|1|||
146131547|NCT01888497|527002248|FG000|Washout Period 2|Adverse Event|0|||
146131548|NCT01888497|527002249|FG001|Washout Period 2|Adverse Event|0|||
146131549|NCT01888497|527002250|FG002|Washout Period 2|Adverse Event|0|||
146131550|NCT01888497|527002251|FG003|Washout Period 2|Adverse Event|1|||
146131551|NCT01888497|527002248|FG000|Washout Period 2|Withdrawal by Subject|0|||
146131552|NCT01888497|527002249|FG001|Washout Period 2|Withdrawal by Subject|0|||
146131553|NCT01888497|527002250|FG002|Washout Period 2|Withdrawal by Subject|0|||
146131554|NCT01888497|527002251|FG003|Washout Period 2|Withdrawal by Subject|1|||
146131555|NCT04152447|527002252|FG000|Overall Study|Lost to Follow-up|1|||
146131556|NCT04152447|527002253|FG001|Overall Study|Lost to Follow-up|0|||
146131557|NCT04152447|527002252|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
146131558|NCT04152447|527002253|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
146131559|NCT04152447|527002252|FG000|Overall Study|Withdrawal by Subject|0|||
146131560|NCT04152447|527002253|FG001|Overall Study|Withdrawal by Subject|1|||
146131561|NCT04152447|527002252|FG000|Overall Study|Found ineligible after enrolling|1|||
146131562|NCT04152447|527002253|FG001|Overall Study|Found ineligible after enrolling|1|||
146131563|NCT04152447|527002252|FG000|Overall Study|Did not receive VR headset in time.|0|||
146131564|NCT04152447|527002253|FG001|Overall Study|Did not receive VR headset in time.|2|||
146131565|NCT03240133|527002256|FG000|Overall Study|Withdrawal by Subject|0|||
146131566|NCT03240133|527002257|FG001|Overall Study|Withdrawal by Subject|1|||
146131567|NCT03240133|527002258|FG002|Overall Study|Withdrawal by Subject|0|||
146131568|NCT03240133|527002256|FG000|Overall Study|Adverse Event|1|||
146131569|NCT03240133|527002257|FG001|Overall Study|Adverse Event|1|||
146131570|NCT03240133|527002258|FG002|Overall Study|Adverse Event|0|||
146131571|NCT03240133|527002256|FG000|Overall Study|Rash|1|||
146131572|NCT03240133|527002257|FG001|Overall Study|Rash|0|||
146131573|NCT03240133|527002258|FG002|Overall Study|Rash|0|||
146131574|NCT03240133|527002256|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
146131575|NCT03240133|527002257|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
146131576|NCT03240133|527002258|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
146131577|NCT03240133|527002256|FG000|Overall Study|Intercurrent illness.|0|||
146131578|NCT03240133|527002257|FG001|Overall Study|Intercurrent illness.|1|||
146131579|NCT03240133|527002258|FG002|Overall Study|Intercurrent illness.|0|||
146131580|NCT03240133|527002256|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
146131581|NCT03240133|527002257|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
146131582|NCT03240133|527002258|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
146131583|NCT00097721|527002259|FG000|Overall Study|Adverse Event|8|||
146131584|NCT00097721|527002260|FG001|Overall Study|Adverse Event|1|||
146131585|NCT00097721|527002259|FG000|Overall Study|Withdrawal by Subject|6|||
146131586|NCT00097721|527002260|FG001|Overall Study|Withdrawal by Subject|1|||
146131587|NCT00097721|527002259|FG000|Overall Study|Progressive Disease|55|||
146131588|NCT00097721|527002260|FG001|Overall Study|Progressive Disease|27|||
146131589|NCT00097721|527002259|FG000|Overall Study|Physician Decision|1|||
146131590|NCT00097721|527002260|FG001|Overall Study|Physician Decision|3|||
146131591|NCT00097721|527002259|FG000|Overall Study|Reason not given|1|||
146131592|NCT00097721|527002260|FG001|Overall Study|Reason not given|1|||
146131593|NCT04327999|527002267|FG000|Overall Study|Protocol Violation|1|||
146131594|NCT02872116|527002272|FG000|Pre-Treatment|Disease Progression|0|||
146131595|NCT02872116|527002273|FG001|Pre-Treatment|Disease Progression|1|||
146131596|NCT02872116|527002274|FG002|Pre-Treatment|Disease Progression|0|||
146264931|NCT02818998|527484623|FG001|Overall Study|Adverse Event|2|||
146131597|NCT02872116|527002272|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
146131598|NCT02872116|527002273|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
146131599|NCT02872116|527002274|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
146131600|NCT02872116|527002272|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
146131601|NCT02872116|527002273|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
146131602|NCT02872116|527002274|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
146131603|NCT02872116|527002272|FG000|Pre-Treatment|Participant withdrew consent|2|||
146131604|NCT02872116|527002273|FG001|Pre-Treatment|Participant withdrew consent|20|||
146131605|NCT02872116|527002274|FG002|Pre-Treatment|Participant withdrew consent|3|||
146131606|NCT02872116|527002272|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
146131607|NCT02872116|527002273|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
146131608|NCT02872116|527002274|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
146131609|NCT02872116|527002272|FG000|Pre-Treatment|Other reasons|1|||
146131610|NCT02872116|527002273|FG001|Pre-Treatment|Other reasons|2|||
146131611|NCT02872116|527002274|FG002|Pre-Treatment|Other reasons|2|||
146131612|NCT02872116|527002272|FG000|Treatment|Death|121|||
146131613|NCT02872116|527002273|FG001|Treatment|Death|94|||
146131614|NCT02872116|527002274|FG002|Treatment|Death|68|||
146131615|NCT02872116|527002272|FG000|Treatment|Lost to Follow-up|5|||
146131616|NCT02872116|527002273|FG001|Treatment|Lost to Follow-up|7|||
146131617|NCT02872116|527002274|FG002|Treatment|Lost to Follow-up|3|||
146131618|NCT02872116|527002272|FG000|Treatment|Participant withdrew consent|20|||
146131619|NCT02872116|527002273|FG001|Treatment|Participant withdrew consent|40|||
146131620|NCT02872116|527002274|FG002|Treatment|Participant withdrew consent|8|||
146131621|NCT02872116|527002272|FG000|Treatment|Other reasons|13|||
146131622|NCT02872116|527002273|FG001|Treatment|Other reasons|12|||
146131623|NCT02872116|527002274|FG002|Treatment|Other reasons|5|||
146131624|NCT02346136|527002275|FG000|Overall Study|Withdrawal by Subject|7|||
146131625|NCT02346136|527002276|FG001|Overall Study|Withdrawal by Subject|5|||
146131626|NCT02346136|527002275|FG000|Overall Study|Death|1|||
146131627|NCT02346136|527002276|FG001|Overall Study|Death|0|||
146131628|NCT02346136|527002275|FG000|Overall Study|Study termination|14|||
146131629|NCT02346136|527002276|FG001|Overall Study|Study termination|18|||
146131630|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
146131631|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
146131632|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
146131633|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
146131634|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
146131635|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
146131636|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
146131637|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
146131638|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
146131639|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
146131640|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
146131641|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
146131642|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
146131643|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
146131644|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
146131645|NCT03735667|527002277|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
146131646|NCT03735667|527002278|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
146131647|NCT03735667|527002279|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
146131648|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
146131649|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
146131650|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
146131651|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
146131652|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
146131653|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
146131654|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
146131655|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
146131656|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
146131657|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
146131658|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
146131659|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
146131660|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
146131661|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
146131662|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
146131663|NCT03735667|527002277|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
146131664|NCT03735667|527002278|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
146131665|NCT03735667|527002279|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
146131666|NCT02308735|527002280|FG000|Overall Study|Physician Decision|2|||
146131667|NCT02308735|527002281|FG001|Overall Study|Physician Decision|0|||
146131668|NCT02308735|527002282|FG002|Overall Study|Physician Decision|0|||
146131669|NCT02308735|527002283|FG003|Overall Study|Physician Decision|2|||
146131670|NCT00006478|527002291|FG000|Overall Study|Vaccine could not be produced|1|||
146131671|NCT00006478|527002291|FG000|Overall Study|Physician Decision|6|||
146131672|NCT04238728|527002296|FG000|Overall Study|Withdrawal by Subject|1|||
146131673|NCT04238728|527002296|FG000|Overall Study|Lost to Follow-up|2|||
146131674|NCT01907828|527002298|FG000|Overall Study|Exclusion criteria not met|0|||
146131675|NCT01907828|527002299|FG001|Overall Study|Exclusion criteria not met|1|||
146131676|NCT01907828|527002298|FG000|Overall Study|Withdrawal by Subject|3|||
146131677|NCT01907828|527002299|FG001|Overall Study|Withdrawal by Subject|4|||
146131678|NCT01907828|527002298|FG000|Overall Study|Lost to Follow-up|3|||
146131679|NCT01907828|527002299|FG001|Overall Study|Lost to Follow-up|0|||
146131680|NCT01907828|527002298|FG000|Overall Study|Participant refused 24-month follow-up|1|||
146131681|NCT01907828|527002299|FG001|Overall Study|Participant refused 24-month follow-up|0|||
146131682|NCT01907828|527002298|FG000|Overall Study|Participant met exclusion criteria|0|||
146131683|NCT01907828|527002299|FG001|Overall Study|Participant met exclusion criteria|1|||
146131684|NCT04960228|527002304|FG000|Overall Study|Withdrawal by Subject|216|||
146131685|NCT04960228|527002305|FG001|Overall Study|Withdrawal by Subject|35|||
146131686|NCT04960228|527002304|FG000|Overall Study|Failed attention check|69|||
146131687|NCT04960228|527002305|FG001|Overall Study|Failed attention check|148|||
146131688|NCT04960228|527002304|FG000|Overall Study|Flagged for response quality by Dynata|3|||
146131689|NCT04960228|527002305|FG001|Overall Study|Flagged for response quality by Dynata|3|||
146131690|NCT01364428|527002306|FG000|Overall Study|Adverse Event|1|||
146131691|NCT01364428|527002307|FG001|Overall Study|Adverse Event|2|||
146131692|NCT01364428|527002306|FG000|Overall Study|Protocol Violation|2|||
146131693|NCT01364428|527002307|FG001|Overall Study|Protocol Violation|0|||
146131694|NCT01364428|527002306|FG000|Overall Study|Withdrawal Criteria|14|||
146131695|NCT01364428|527002307|FG001|Overall Study|Withdrawal Criteria|10|||
146131696|NCT01364428|527002306|FG000|Overall Study|Other|3|||
146131697|NCT01364428|527002307|FG001|Overall Study|Other|3|||
146131698|NCT01987427|527002308|FG000|Overall Study|Adverse Event|4|||
146131699|NCT01987427|527002309|FG001|Overall Study|Adverse Event|2|||
146131700|NCT01987427|527002310|FG002|Overall Study|Adverse Event|8|||
146131701|NCT01987427|527002308|FG000|Overall Study|Lost to Follow-up|6|||
146131702|NCT01987427|527002309|FG001|Overall Study|Lost to Follow-up|6|||
146131703|NCT01987427|527002310|FG002|Overall Study|Lost to Follow-up|9|||
146131704|NCT01987427|527002308|FG000|Overall Study|Withdrawal by Subject|2|||
146131705|NCT01987427|527002309|FG001|Overall Study|Withdrawal by Subject|1|||
146131706|NCT01987427|527002310|FG002|Overall Study|Withdrawal by Subject|3|||
146131707|NCT01987427|527002308|FG000|Overall Study|Lack of Efficacy|1|||
146131708|NCT01987427|527002309|FG001|Overall Study|Lack of Efficacy|0|||
146131709|NCT01987427|527002310|FG002|Overall Study|Lack of Efficacy|0|||
146131710|NCT01987427|527002308|FG000|Overall Study|Other|1|||
146131711|NCT01987427|527002309|FG001|Overall Study|Other|1|||
146131712|NCT01987427|527002310|FG002|Overall Study|Other|0|||
146131713|NCT01073865|527002311|FG000|Overall Study|Reasons other than below|19|||
146131714|NCT01073865|527002312|FG001|Overall Study|Reasons other than below|31|||
146131715|NCT01073865|527002311|FG000|Overall Study|Lost to Follow-up|1|||
146131716|NCT01073865|527002312|FG001|Overall Study|Lost to Follow-up|1|||
146131717|NCT01073865|527002311|FG000|Overall Study|Death|3|||
146131718|NCT01073865|527002312|FG001|Overall Study|Death|2|||
146131719|NCT01073865|527002311|FG000|Overall Study|Withdrawal by Subject|5|||
146131720|NCT01073865|527002312|FG001|Overall Study|Withdrawal by Subject|5|||
146131721|NCT01256593|527002317|FG000|Overall Study|Protocol Violation|26|||
146131722|NCT01256593|527002317|FG000|Overall Study|No Drug Administration Information|2|||
146131723|NCT01256593|527002317|FG000|Overall Study|No Visit After Treatment|186|||
146131724|NCT04414553|527002318|FG000|Overall Study|Lost to Follow-up|20|||
146131725|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
146131726|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
146131727|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
146131728|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
146131729|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
146131730|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
146131731|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
146131732|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146131733|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146131734|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
146131735|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
146131736|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
146131737|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
146131738|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
146131739|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
146131740|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
146131741|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146131742|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146131743|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146131744|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
146131745|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
146131746|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146131747|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
146131748|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146131749|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
146131750|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146131751|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
146131752|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146131753|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146131754|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
146131755|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
146131756|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
146131757|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
146131758|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
146131759|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
146131760|NCT03373383|527002321|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
146131761|NCT03373383|527002322|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
146131762|NCT03373383|527002323|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
146131763|NCT03373383|527002324|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
146131764|NCT03373383|527002325|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
146131765|NCT03373383|527002321|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
146131766|NCT03373383|527002322|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146131767|NCT03373383|527002323|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146131768|NCT03373383|527002324|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146131769|NCT03373383|527002325|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
146131770|NCT02159521|527002326|FG000|Overall Study|Enrolled but not treated|3|||
146131771|NCT02159521|527002326|FG000|Overall Study|Withdrawal by Subject|7|||
146131772|NCT02159521|527002326|FG000|Overall Study|Lost to Follow-up|6|||
146131773|NCT02159521|527002326|FG000|Overall Study|Death|1|||
146131774|NCT02159521|527002326|FG000|Overall Study|Other than specified|1|||
146131775|NCT00694369|527002327|FG000|Overall Study|Adverse Event|0|||
146131776|NCT00694369|527002328|FG001|Overall Study|Adverse Event|1|||
146131777|NCT00694369|527002329|FG002|Overall Study|Adverse Event|0|||
146131778|NCT00694369|527002330|FG003|Overall Study|Adverse Event|1|||
146131779|NCT00694369|527002331|FG004|Overall Study|Adverse Event|3|||
146131780|NCT00694369|527002327|FG000|Overall Study|Lost to Follow-up|0|||
146131781|NCT00694369|527002328|FG001|Overall Study|Lost to Follow-up|0|||
146131782|NCT00694369|527002329|FG002|Overall Study|Lost to Follow-up|1|||
146131783|NCT00694369|527002330|FG003|Overall Study|Lost to Follow-up|1|||
146131784|NCT00694369|527002331|FG004|Overall Study|Lost to Follow-up|0|||
146131785|NCT00694369|527002327|FG000|Overall Study|Physician Decision|0|||
146131786|NCT00694369|527002328|FG001|Overall Study|Physician Decision|0|||
146131787|NCT00694369|527002329|FG002|Overall Study|Physician Decision|0|||
146131788|NCT00694369|527002330|FG003|Overall Study|Physician Decision|0|||
146131789|NCT00694369|527002331|FG004|Overall Study|Physician Decision|1|||
146131790|NCT00694369|527002327|FG000|Overall Study|Protocol Violation|0|||
146131791|NCT00694369|527002328|FG001|Overall Study|Protocol Violation|1|||
146131792|NCT00694369|527002329|FG002|Overall Study|Protocol Violation|0|||
146131793|NCT00694369|527002330|FG003|Overall Study|Protocol Violation|0|||
146131794|NCT00694369|527002331|FG004|Overall Study|Protocol Violation|0|||
146131795|NCT00694369|527002327|FG000|Overall Study|Withdrawal by Subject|1|||
146131796|NCT00694369|527002328|FG001|Overall Study|Withdrawal by Subject|1|||
146131797|NCT00694369|527002329|FG002|Overall Study|Withdrawal by Subject|1|||
146131798|NCT00694369|527002330|FG003|Overall Study|Withdrawal by Subject|1|||
146131799|NCT00694369|527002331|FG004|Overall Study|Withdrawal by Subject|2|||
146131800|NCT00907374|527002332|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
146131801|NCT00907374|527002333|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
146131802|NCT03131440|527002338|FG000|Overall Study|Withdrawal by Subject|1|||
146131803|NCT03131440|527002339|FG001|Overall Study|Withdrawal by Subject|3|||
146131804|NCT03131440|527002340|FG002|Overall Study|Withdrawal by Subject|0|||
146131805|NCT03131440|527002341|FG003|Overall Study|Withdrawal by Subject|0|||
146131806|NCT03131440|527002342|FG004|Overall Study|Withdrawal by Subject|1|||
146131807|NCT03131440|527002343|FG005|Overall Study|Withdrawal by Subject|0|||
146131808|NCT03131440|527002344|FG006|Overall Study|Withdrawal by Subject|0|||
146131809|NCT03131440|527002345|FG007|Overall Study|Withdrawal by Subject|1|||
146131810|NCT03131440|527002346|FG008|Overall Study|Withdrawal by Subject|1|||
146131811|NCT03131440|527002347|FG009|Overall Study|Withdrawal by Subject|1|||
146131812|NCT03131440|527002348|FG010|Overall Study|Withdrawal by Subject|0|||
146131813|NCT03131440|527002349|FG011|Overall Study|Withdrawal by Subject|1|||
146131814|NCT03131440|527002350|FG012|Overall Study|Withdrawal by Subject|1|||
146131815|NCT03131440|527002351|FG013|Overall Study|Withdrawal by Subject|0|||
146131816|NCT03131440|527002352|FG014|Overall Study|Withdrawal by Subject|1|||
146131817|NCT03131440|527002353|FG015|Overall Study|Withdrawal by Subject|0|||
146131818|NCT03131440|527002354|FG016|Overall Study|Withdrawal by Subject|0|||
146131819|NCT03131440|527002355|FG017|Overall Study|Withdrawal by Subject|0|||
146131820|NCT03131440|527002356|FG018|Overall Study|Withdrawal by Subject|1|||
146131821|NCT03131440|527002357|FG019|Overall Study|Withdrawal by Subject|0|||
146131822|NCT03131440|527002358|FG020|Overall Study|Withdrawal by Subject|1|||
146131823|NCT03131440|527002359|FG021|Overall Study|Withdrawal by Subject|1|||
146131824|NCT03131440|527002360|FG022|Overall Study|Withdrawal by Subject|1|||
146131825|NCT03131440|527002361|FG023|Overall Study|Withdrawal by Subject|0|||
146131826|NCT03131440|527002362|FG024|Overall Study|Withdrawal by Subject|0|||
146131827|NCT03131440|527002363|FG025|Overall Study|Withdrawal by Subject|0|||
146131828|NCT03131440|527002364|FG026|Overall Study|Withdrawal by Subject|0|||
146131829|NCT03131440|527002365|FG027|Overall Study|Withdrawal by Subject|0|||
146131830|NCT03131440|527002366|FG028|Overall Study|Withdrawal by Subject|0|||
146131831|NCT03131440|527002367|FG029|Overall Study|Withdrawal by Subject|0|||
146131832|NCT03131440|527002368|FG030|Overall Study|Withdrawal by Subject|1|||
146131833|NCT03131440|527002369|FG031|Overall Study|Withdrawal by Subject|0|||
146131834|NCT03131440|527002338|FG000|Overall Study|Lost to Follow-up|0|||
146131835|NCT03131440|527002339|FG001|Overall Study|Lost to Follow-up|0|||
146131836|NCT03131440|527002340|FG002|Overall Study|Lost to Follow-up|0|||
146131837|NCT03131440|527002341|FG003|Overall Study|Lost to Follow-up|0|||
146131838|NCT03131440|527002342|FG004|Overall Study|Lost to Follow-up|0|||
146131839|NCT03131440|527002343|FG005|Overall Study|Lost to Follow-up|1|||
146131840|NCT03131440|527002344|FG006|Overall Study|Lost to Follow-up|0|||
146131841|NCT03131440|527002345|FG007|Overall Study|Lost to Follow-up|0|||
146131842|NCT03131440|527002346|FG008|Overall Study|Lost to Follow-up|0|||
146131843|NCT03131440|527002347|FG009|Overall Study|Lost to Follow-up|0|||
146131844|NCT03131440|527002348|FG010|Overall Study|Lost to Follow-up|0|||
146131845|NCT03131440|527002349|FG011|Overall Study|Lost to Follow-up|0|||
146131846|NCT03131440|527002350|FG012|Overall Study|Lost to Follow-up|0|||
146131847|NCT03131440|527002351|FG013|Overall Study|Lost to Follow-up|0|||
146131848|NCT03131440|527002352|FG014|Overall Study|Lost to Follow-up|0|||
146131849|NCT03131440|527002353|FG015|Overall Study|Lost to Follow-up|0|||
146131850|NCT03131440|527002354|FG016|Overall Study|Lost to Follow-up|0|||
146131851|NCT03131440|527002355|FG017|Overall Study|Lost to Follow-up|0|||
146131852|NCT03131440|527002356|FG018|Overall Study|Lost to Follow-up|0|||
146131853|NCT03131440|527002357|FG019|Overall Study|Lost to Follow-up|2|||
146131854|NCT03131440|527002358|FG020|Overall Study|Lost to Follow-up|1|||
146131855|NCT03131440|527002359|FG021|Overall Study|Lost to Follow-up|0|||
146131856|NCT03131440|527002360|FG022|Overall Study|Lost to Follow-up|1|||
146131857|NCT03131440|527002361|FG023|Overall Study|Lost to Follow-up|0|||
146131858|NCT03131440|527002362|FG024|Overall Study|Lost to Follow-up|1|||
146131859|NCT03131440|527002363|FG025|Overall Study|Lost to Follow-up|0|||
146131860|NCT03131440|527002364|FG026|Overall Study|Lost to Follow-up|0|||
146131861|NCT03131440|527002365|FG027|Overall Study|Lost to Follow-up|2|||
146131862|NCT03131440|527002366|FG028|Overall Study|Lost to Follow-up|0|||
146131863|NCT03131440|527002367|FG029|Overall Study|Lost to Follow-up|2|||
146131864|NCT03131440|527002368|FG030|Overall Study|Lost to Follow-up|0|||
146131865|NCT03131440|527002369|FG031|Overall Study|Lost to Follow-up|0|||
146131866|NCT03131440|527002338|FG000|Overall Study|Death|0|||
146131867|NCT03131440|527002339|FG001|Overall Study|Death|0|||
146131868|NCT03131440|527002340|FG002|Overall Study|Death|0|||
146131869|NCT03131440|527002341|FG003|Overall Study|Death|0|||
146131870|NCT03131440|527002342|FG004|Overall Study|Death|0|||
146131871|NCT03131440|527002343|FG005|Overall Study|Death|0|||
146131872|NCT03131440|527002344|FG006|Overall Study|Death|0|||
146131873|NCT03131440|527002345|FG007|Overall Study|Death|0|||
146131874|NCT03131440|527002346|FG008|Overall Study|Death|0|||
146131875|NCT03131440|527002347|FG009|Overall Study|Death|0|||
146131876|NCT03131440|527002348|FG010|Overall Study|Death|0|||
146131877|NCT03131440|527002349|FG011|Overall Study|Death|0|||
146131878|NCT03131440|527002350|FG012|Overall Study|Death|0|||
146131879|NCT03131440|527002351|FG013|Overall Study|Death|0|||
146131880|NCT03131440|527002352|FG014|Overall Study|Death|0|||
146131881|NCT03131440|527002353|FG015|Overall Study|Death|0|||
146131882|NCT03131440|527002354|FG016|Overall Study|Death|0|||
146131883|NCT03131440|527002355|FG017|Overall Study|Death|0|||
146131884|NCT03131440|527002356|FG018|Overall Study|Death|0|||
146131885|NCT03131440|527002357|FG019|Overall Study|Death|0|||
146131886|NCT03131440|527002358|FG020|Overall Study|Death|0|||
146264932|NCT02818998|527484624|FG002|Overall Study|Adverse Event|1|||
146264933|NCT02818998|527484622|FG000|Overall Study|Lost to Follow-up|4|||
146264934|NCT02818998|527484623|FG001|Overall Study|Lost to Follow-up|1|||
146131887|NCT03131440|527002359|FG021|Overall Study|Death|0|||
146131888|NCT03131440|527002360|FG022|Overall Study|Death|0|||
146131889|NCT03131440|527002361|FG023|Overall Study|Death|0|||
146131890|NCT03131440|527002362|FG024|Overall Study|Death|0|||
146131891|NCT03131440|527002363|FG025|Overall Study|Death|1|||
146131892|NCT03131440|527002364|FG026|Overall Study|Death|0|||
146131893|NCT03131440|527002365|FG027|Overall Study|Death|0|||
146131894|NCT03131440|527002366|FG028|Overall Study|Death|0|||
146131895|NCT03131440|527002367|FG029|Overall Study|Death|0|||
146131896|NCT03131440|527002368|FG030|Overall Study|Death|0|||
146131897|NCT03131440|527002369|FG031|Overall Study|Death|0|||
146131898|NCT00746941|527002372|FG000|Overall Study|Death|2|||
146131899|NCT00746941|527002373|FG001|Overall Study|Death|0|||
146131900|NCT00746941|527002374|FG002|Overall Study|Death|0|||
146131901|NCT00746941|527002375|FG003|Overall Study|Death|6|||
146131902|NCT00746941|527002372|FG000|Overall Study|Physician Decision|0|||
146131903|NCT00746941|527002373|FG001|Overall Study|Physician Decision|0|||
146131904|NCT00746941|527002374|FG002|Overall Study|Physician Decision|2|||
146131905|NCT00746941|527002375|FG003|Overall Study|Physician Decision|0|||
146131906|NCT00746941|527002372|FG000|Overall Study|Withdrawal by Subject|3|||
146131907|NCT00746941|527002373|FG001|Overall Study|Withdrawal by Subject|0|||
146131908|NCT00746941|527002374|FG002|Overall Study|Withdrawal by Subject|0|||
146131909|NCT00746941|527002375|FG003|Overall Study|Withdrawal by Subject|2|||
146131910|NCT00746941|527002372|FG000|Overall Study|Other, reason not provided|2|||
146131911|NCT00746941|527002373|FG001|Overall Study|Other, reason not provided|4|||
146131912|NCT00746941|527002374|FG002|Overall Study|Other, reason not provided|0|||
146131913|NCT00746941|527002375|FG003|Overall Study|Other, reason not provided|4|||
146131914|NCT00746941|527002372|FG000|Overall Study|Adverse Event|0|||
146131915|NCT00746941|527002373|FG001|Overall Study|Adverse Event|0|||
146131916|NCT00746941|527002374|FG002|Overall Study|Adverse Event|0|||
146131917|NCT00746941|527002375|FG003|Overall Study|Adverse Event|1|||
146131918|NCT01640366|527002382|FG000|Overall Study|Withdrawal by Subject|1|||
146131919|NCT01640366|527002382|FG000|Overall Study|Protocol Violation|16|||
146131920|NCT01640366|527002382|FG000|Overall Study|Lost to Follow-up|5|||
146131921|NCT02818777|527002386|FG000|Overall Study|Adverse Event|3|||
146131922|NCT00856908|527002409|FG000|Overall Study|Lost to Follow-up|1|||
146131923|NCT00856908|527002410|FG001|Overall Study|Lost to Follow-up|0|||
146131924|NCT01712256|527002417|FG000|Overall Study|Lost to Follow-up|1|||
146131925|NCT00962104|527002418|FG000|Overall Study|Adverse Event|10|||
146131926|NCT00962104|527002419|FG001|Overall Study|Adverse Event|3|||
146131927|NCT00962104|527002418|FG000|Overall Study|Entry Criteria Not Met|1|||
146131928|NCT00962104|527002419|FG001|Overall Study|Entry Criteria Not Met|2|||
146131929|NCT00962104|527002418|FG000|Overall Study|Lack of Efficacy|0|||
146131930|NCT00962104|527002419|FG001|Overall Study|Lack of Efficacy|1|||
146131931|NCT00962104|527002418|FG000|Overall Study|Lost to Follow-up|10|||
146131932|NCT00962104|527002419|FG001|Overall Study|Lost to Follow-up|4|||
146131933|NCT00962104|527002418|FG000|Overall Study|Physician Decision|1|||
146131934|NCT00962104|527002419|FG001|Overall Study|Physician Decision|0|||
146131935|NCT00962104|527002418|FG000|Overall Study|Protocol Violation|6|||
146131936|NCT00962104|527002419|FG001|Overall Study|Protocol Violation|8|||
146131937|NCT00962104|527002418|FG000|Overall Study|Sponsor Decision|0|||
146131938|NCT00962104|527002419|FG001|Overall Study|Sponsor Decision|1|||
146131939|NCT00962104|527002418|FG000|Overall Study|Withdrawal by Subject|10|||
146131940|NCT00962104|527002419|FG001|Overall Study|Withdrawal by Subject|6|||
146131941|NCT00962104|527002418|FG000|Overall Study|Other|2|||
146131942|NCT00962104|527002419|FG001|Overall Study|Other|0|||
146131943|NCT02013167|527002423|FG000|Overall Study|Withdrawal by Subject|15|||
146131944|NCT02013167|527002424|FG001|Overall Study|Withdrawal by Subject|14|||
146131945|NCT02013167|527002423|FG000|Overall Study|Sponsor Decision|1|||
146131946|NCT02013167|527002424|FG001|Overall Study|Sponsor Decision|3|||
146131947|NCT02013167|527002423|FG000|Overall Study|Lost to Follow-up|0|||
146131948|NCT02013167|527002424|FG001|Overall Study|Lost to Follow-up|1|||
146131949|NCT02013167|527002423|FG000|Overall Study|Death|85|||
146131950|NCT02013167|527002424|FG001|Overall Study|Death|160|||
146131951|NCT00842348|527002427|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
146131952|NCT00842348|527002428|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
146131953|NCT00842348|527002427|FG000|Study 729|Disease progression/death|19|||
146131954|NCT00842348|527002428|FG001|Study 729|Disease progression/death|30|||
146131955|NCT00842348|527002427|FG000|Study 729|Adverse Event|1|||
146131956|NCT00842348|527002428|FG001|Study 729|Adverse Event|1|||
146131957|NCT00842348|527002427|FG000|Study 729|Protocol Violation|1|||
146131958|NCT00842348|527002428|FG001|Study 729|Protocol Violation|1|||
146131959|NCT00842348|527002427|FG000|Study 729|Withdrawal by Subject|2|||
146131960|NCT00842348|527002428|FG001|Study 729|Withdrawal by Subject|4|||
146131961|NCT00842348|527002427|FG000|Study 729|Due to Sponsor stopping the study|1|||
146131962|NCT00842348|527002428|FG001|Study 729|Due to Sponsor stopping the study|1|||
146131963|NCT00842348|527002427|FG000|Study 729|Due to non-availability of IP|0|||
146131964|NCT00842348|527002428|FG001|Study 729|Due to non-availability of IP|1|||
146131965|NCT00842348|527002427|FG000|Study 729|Sponsor's decision|1|||
146131966|NCT00842348|527002428|FG001|Study 729|Sponsor's decision|0|||
146131967|NCT00842348|527002427|FG000|Study 729|Surgical resection|1|||
146131968|NCT00842348|527002428|FG001|Study 729|Surgical resection|0|||
146131969|NCT01113879|527002431|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
146131970|NCT01113879|527002432|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
146131971|NCT00026793|527002433|FG000|Overall Study|Death on study due to underlying disease|4|||
146131972|NCT00026793|527002433|FG000|Overall Study|Physician Decision|2|||
146131973|NCT00026793|527002433|FG000|Overall Study|Off study|2|||
146131974|NCT04151290|527002435|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
146131975|NCT02276612|527002438|FG000|Overall Study|Death|1|||
146131976|NCT02276612|527002439|FG001|Overall Study|Death|0|||
146131977|NCT02276612|527002438|FG000|Overall Study|Pregnancy|1|||
146131978|NCT02276612|527002439|FG001|Overall Study|Pregnancy|0|||
146131979|NCT02276612|527002438|FG000|Overall Study|Withdrew Consent|1|||
146131980|NCT02276612|527002439|FG001|Overall Study|Withdrew Consent|0|||
146131981|NCT02276612|527002438|FG000|Overall Study|Lost to Follow-up|1|||
146131982|NCT02276612|527002439|FG001|Overall Study|Lost to Follow-up|0|||
146131983|NCT00244712|527002440|FG000|Overall Study|Adverse Event|20|||
146131984|NCT00244712|527002441|FG001|Overall Study|Adverse Event|21|||
146131985|NCT00244712|527002440|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
146131986|NCT00244712|527002441|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
146131987|NCT00244712|527002440|FG000|Overall Study|Lack of Compliance|10|||
146131988|NCT00244712|527002441|FG001|Overall Study|Lack of Compliance|11|||
146131989|NCT00244712|527002440|FG000|Overall Study|Lost to Follow-up|45|||
146131990|NCT00244712|527002441|FG001|Overall Study|Lost to Follow-up|52|||
146131991|NCT00244712|527002440|FG000|Overall Study|Withdrawal by Subject|13|||
146131992|NCT00244712|527002441|FG001|Overall Study|Withdrawal by Subject|23|||
146131993|NCT00244712|527002440|FG000|Overall Study|Protocol Violation, disease progression|13|||
146131994|NCT00244712|527002441|FG001|Overall Study|Protocol Violation, disease progression|11|||
146131995|NCT01077804|527002442|FG000|Overall Study|Unreachable|102|||
146131996|NCT01077804|527002442|FG000|Overall Study|Refused to continue|79|||
146131997|NCT01077804|527002442|FG000|Overall Study|Other|18|||
146131998|NCT00403273|527004427|FG000|Overall Study|Lost to Follow-up|3|||
146131999|NCT00403273|527004428|FG001|Overall Study|Lost to Follow-up|2|||
146132000|NCT00403273|527004427|FG000|Overall Study|Physician Decision|0|||
146132001|NCT00403273|527004428|FG001|Overall Study|Physician Decision|1|||
146132002|NCT00403273|527004427|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
146132003|NCT00403273|527004428|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
146132004|NCT01336738|527004430|FG000|Overall Study|Adverse Event|0|||
146132005|NCT01336738|527004431|FG001|Overall Study|Adverse Event|3|||
146132006|NCT01336738|527004432|FG002|Overall Study|Adverse Event|2|||
146132007|NCT01336738|527004433|FG003|Overall Study|Adverse Event|1|||
146132008|NCT01336738|527004434|FG004|Overall Study|Adverse Event|3|||
146132009|NCT01336738|527004430|FG000|Overall Study|Lost to Follow-up|2|||
146132010|NCT01336738|527004431|FG001|Overall Study|Lost to Follow-up|1|||
146132011|NCT01336738|527004432|FG002|Overall Study|Lost to Follow-up|2|||
146132012|NCT01336738|527004433|FG003|Overall Study|Lost to Follow-up|2|||
146132013|NCT01336738|527004434|FG004|Overall Study|Lost to Follow-up|2|||
146132014|NCT01336738|527004430|FG000|Overall Study|Did not meet entrance criteria|0|||
146132015|NCT01336738|527004431|FG001|Overall Study|Did not meet entrance criteria|1|||
146132016|NCT01336738|527004432|FG002|Overall Study|Did not meet entrance criteria|0|||
146132017|NCT01336738|527004433|FG003|Overall Study|Did not meet entrance criteria|0|||
146132018|NCT01336738|527004434|FG004|Overall Study|Did not meet entrance criteria|0|||
146132019|NCT01336738|527004430|FG000|Overall Study|Protocol Violation|0|||
146132020|NCT01336738|527004431|FG001|Overall Study|Protocol Violation|1|||
146132021|NCT01336738|527004432|FG002|Overall Study|Protocol Violation|0|||
146132022|NCT01336738|527004433|FG003|Overall Study|Protocol Violation|0|||
146132023|NCT01336738|527004434|FG004|Overall Study|Protocol Violation|0|||
146132024|NCT01336738|527004430|FG000|Overall Study|Withdrawal by Subject|2|||
146132025|NCT01336738|527004431|FG001|Overall Study|Withdrawal by Subject|0|||
146132026|NCT01336738|527004432|FG002|Overall Study|Withdrawal by Subject|2|||
146132027|NCT01336738|527004433|FG003|Overall Study|Withdrawal by Subject|1|||
146132028|NCT01336738|527004434|FG004|Overall Study|Withdrawal by Subject|1|||
146132029|NCT01336738|527004430|FG000|Overall Study|Other|3|||
146132030|NCT01336738|527004431|FG001|Overall Study|Other|3|||
146132031|NCT01336738|527004432|FG002|Overall Study|Other|2|||
146132032|NCT01336738|527004433|FG003|Overall Study|Other|3|||
146132033|NCT01336738|527004434|FG004|Overall Study|Other|4|||
146132034|NCT01083433|527004435|FG000|Overall Study|Lost to Follow-up|2|||
146132035|NCT01083433|527004436|FG001|Overall Study|Lost to Follow-up|1|||
146132036|NCT01083433|527004437|FG002|Overall Study|Lost to Follow-up|1|||
146132037|NCT01083433|527004435|FG000|Overall Study|Withdrawal by Subject|0|||
146132038|NCT01083433|527004436|FG001|Overall Study|Withdrawal by Subject|5|||
146303657|NCT02003014|527625875|FG000|Overall Study|Treatment started after contract period|1|||
146132039|NCT01083433|527004437|FG002|Overall Study|Withdrawal by Subject|3|||
146132040|NCT01083433|527004435|FG000|Overall Study|Pregnancy|0|||
146132041|NCT01083433|527004436|FG001|Overall Study|Pregnancy|0|||
146132042|NCT01083433|527004437|FG002|Overall Study|Pregnancy|1|||
146132043|NCT01332149|527004439|FG000|Overall Study|Adverse Event|11|||
146132044|NCT01332149|527004440|FG001|Overall Study|Adverse Event|9|||
146132045|NCT01332149|527004439|FG000|Overall Study|Other unspecified|5|||
146132046|NCT01332149|527004440|FG001|Overall Study|Other unspecified|7|||
146132047|NCT01332149|527004439|FG000|Overall Study|Protocol Violation|1|||
146132048|NCT01332149|527004440|FG001|Overall Study|Protocol Violation|3|||
146132049|NCT01332149|527004439|FG000|Overall Study|Withdrawal by Subject|4|||
146132050|NCT01332149|527004440|FG001|Overall Study|Withdrawal by Subject|5|||
146132051|NCT01332149|527004439|FG000|Overall Study|Lost to Follow-up|1|||
146132052|NCT01332149|527004440|FG001|Overall Study|Lost to Follow-up|1|||
146132053|NCT01332149|527004439|FG000|Overall Study|Insufficient clinical response|4|||
146132054|NCT01332149|527004440|FG001|Overall Study|Insufficient clinical response|7|||
146132055|NCT01332149|527004439|FG000|Overall Study|Did not meet entrance criteria|3|||
146132056|NCT01332149|527004440|FG001|Overall Study|Did not meet entrance criteria|4|||
146132057|NCT01332149|527004439|FG000|Overall Study|Randomized but not treated|1|||
146132058|NCT01332149|527004440|FG001|Overall Study|Randomized but not treated|2|||
146132059|NCT04615949|527004445|FG000|Overall Study|Withdrawal by Subject|2|||
146132060|NCT04615949|527004446|FG001|Overall Study|Withdrawal by Subject|4|||
146132061|NCT04615949|527004445|FG000|Overall Study|Lost to Follow-up|2|||
146132062|NCT04615949|527004446|FG001|Overall Study|Lost to Follow-up|2|||
146132063|NCT04615949|527004445|FG000|Overall Study|Death|0|||
146132064|NCT04615949|527004446|FG001|Overall Study|Death|2|||
146132065|NCT03036566|527004447|FG000|Overall Study|Lost to Follow-up|3|||
146132066|NCT05458856|527004448|FG000|Overall Study|Withdrawal by Subject|5|||
146132067|NCT05458856|527004448|FG000|Overall Study|Death|4|||
146132068|NCT05458856|527004448|FG000|Overall Study|Protocol Deviation|3|||
146132069|NCT05458856|527004448|FG000|Overall Study|Physician Decision|1|||
146132070|NCT01852292|527004449|FG000|Overall Study|Untreated - did not receive study drug|3|||
146132071|NCT01852292|527004450|FG001|Overall Study|Untreated - did not receive study drug|1|||
146132072|NCT01852292|527004449|FG000|Overall Study|Death|9|||
146132073|NCT01852292|527004450|FG001|Overall Study|Death|8|||
146132074|NCT01852292|527004449|FG000|Overall Study|Patient/guardian decision|8|||
146132075|NCT01852292|527004450|FG001|Overall Study|Patient/guardian decision|4|||
146132076|NCT01852292|527004449|FG000|Overall Study|Adverse Event|8|||
146132077|NCT01852292|527004450|FG001|Overall Study|Adverse Event|11|||
146132078|NCT01852292|527004449|FG000|Overall Study|Physician Decision|6|||
146132079|NCT01852292|527004450|FG001|Overall Study|Physician Decision|2|||
146132080|NCT01852292|527004449|FG000|Overall Study|Protocol Violation|2|||
146132081|NCT01852292|527004450|FG001|Overall Study|Protocol Violation|0|||
146132082|NCT01852292|527004449|FG000|Overall Study|Non-compliance with study treatment|1|||
146132083|NCT01852292|527004450|FG001|Overall Study|Non-compliance with study treatment|0|||
146132084|NCT01852292|527004449|FG000|Overall Study|Study terminated by Sponsor|0|||
146132085|NCT01852292|527004450|FG001|Overall Study|Study terminated by Sponsor|1|||
146132086|NCT01852292|527004449|FG000|Overall Study|Progressive disease|42|||
146132087|NCT01852292|527004450|FG001|Overall Study|Progressive disease|52|||
146132088|NCT04013191|527004453|FG000|Overall Study|Adverse Event|1|||
146132089|NCT04013191|527004454|FG001|Overall Study|Adverse Event|0|||
146132090|NCT03711162|527004461|FG000|Overall Study|Adverse Event|5|||
146132091|NCT03711162|527004462|FG001|Overall Study|Adverse Event|2|||
146132092|NCT03711162|527004463|FG002|Overall Study|Adverse Event|4|||
146132093|NCT03711162|527004461|FG000|Overall Study|Death|11|||
146132094|NCT03711162|527004462|FG001|Overall Study|Death|7|||
146132095|NCT03711162|527004463|FG002|Overall Study|Death|8|||
146132096|NCT03711162|527004461|FG000|Overall Study|Lost to Follow-up|1|||
146132097|NCT03711162|527004462|FG001|Overall Study|Lost to Follow-up|0|||
146132098|NCT03711162|527004463|FG002|Overall Study|Lost to Follow-up|1|||
146132099|NCT03711162|527004461|FG000|Overall Study|Study Terminated by Sponsor|139|||
146132100|NCT03711162|527004462|FG001|Overall Study|Study Terminated by Sponsor|152|||
146132101|NCT03711162|527004463|FG002|Overall Study|Study Terminated by Sponsor|146|||
146132102|NCT03711162|527004461|FG000|Overall Study|Withdrawal by Subject|17|||
146132103|NCT03711162|527004462|FG001|Overall Study|Withdrawal by Subject|10|||
146132104|NCT03711162|527004463|FG002|Overall Study|Withdrawal by Subject|10|||
146132105|NCT03711162|527004461|FG000|Overall Study|Miscellaneous|1|||
146132106|NCT03711162|527004462|FG001|Overall Study|Miscellaneous|2|||
146132107|NCT03711162|527004463|FG002|Overall Study|Miscellaneous|2|||
146132108|NCT03711162|527004461|FG000|Overall Study|Not Treated|1|||
146132109|NCT03711162|527004462|FG001|Overall Study|Not Treated|0|||
146132110|NCT03711162|527004463|FG002|Overall Study|Not Treated|1|||
146132111|NCT03711162|527004461|FG000|Overall Study|Physician Decision|0|||
146132112|NCT03711162|527004462|FG001|Overall Study|Physician Decision|2|||
146132113|NCT03711162|527004463|FG002|Overall Study|Physician Decision|0|||
146132114|NCT03711162|527004461|FG000|Overall Study|Lack of Efficacy|0|||
146132115|NCT03711162|527004462|FG001|Overall Study|Lack of Efficacy|0|||
146132116|NCT03711162|527004463|FG002|Overall Study|Lack of Efficacy|2|||
146132117|NCT03711162|527004461|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
146132118|NCT03711162|527004462|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
146132119|NCT03711162|527004463|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
146132120|NCT03034954|527004464|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
146132121|NCT03034954|527004465|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
146132122|NCT01275066|527004472|FG000|Overall Study|Withdrawal by Subject|0|||
146132123|NCT01275066|527004473|FG001|Overall Study|Withdrawal by Subject|0|||
146132124|NCT01275066|527004474|FG002|Overall Study|Withdrawal by Subject|1|||
146132125|NCT01275066|527004472|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
146132126|NCT01275066|527004473|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
146132127|NCT01275066|527004474|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
146132128|NCT00394212|527004477|FG000|Overall Study|Lost to Follow-up|3|||
146132129|NCT00394212|527004478|FG001|Overall Study|Lost to Follow-up|0|||
146132130|NCT00394212|527004477|FG000|Overall Study|Withdrawal by Subject|4|||
146132131|NCT00394212|527004478|FG001|Overall Study|Withdrawal by Subject|1|||
146132132|NCT00588445|527004479|FG000|Overall Study|Protocol Violation|1|||
146132133|NCT00588445|527004479|FG000|Overall Study|Withdrawal by Subject|3|||
146132134|NCT00588445|527004479|FG000|Overall Study|Disease Progression|1|||
146132135|NCT00588445|527004479|FG000|Overall Study|Not Treated|10|||
146132136|NCT00116831|527004482|FG000|Overall Study|Adverse Event|14|||
146132137|NCT00116831|527004483|FG001|Overall Study|Adverse Event|16|||
146132138|NCT00116831|527004482|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
146132139|NCT00116831|527004483|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
146132140|NCT00116831|527004482|FG000|Overall Study|Lost to Follow-up|8|||
146132141|NCT00116831|527004483|FG001|Overall Study|Lost to Follow-up|6|||
146132142|NCT00116831|527004482|FG000|Overall Study|Protocol Violation|3|||
146132143|NCT00116831|527004483|FG001|Overall Study|Protocol Violation|6|||
146132144|NCT00116831|527004482|FG000|Overall Study|Hypoglycaemic events|1|||
146132145|NCT00116831|527004483|FG001|Overall Study|Hypoglycaemic events|0|||
146132146|NCT00116831|527004482|FG000|Overall Study|Low haemoglobin on screening|1|||
146132147|NCT00116831|527004483|FG001|Overall Study|Low haemoglobin on screening|0|||
146132148|NCT00116831|527004482|FG000|Overall Study|Withdrawn investigational product|1|||
146132149|NCT00116831|527004483|FG001|Overall Study|Withdrawn investigational product|0|||
146132150|NCT00116831|527004482|FG000|Overall Study|Withdrawal by Subject|32|||
146132151|NCT00116831|527004483|FG001|Overall Study|Withdrawal by Subject|32|||
146132152|NCT00116831|527004482|FG000|Overall Study|Insufficient therapeutic effect|0|||
146132153|NCT00116831|527004483|FG001|Overall Study|Insufficient therapeutic effect|1|||
146132154|NCT00116831|527004482|FG000|Overall Study|Missing data for participant|1|||
146132155|NCT00116831|527004483|FG001|Overall Study|Missing data for participant|0|||
146132156|NCT04904185|527004484|FG000|Overall Study|Expansion failure|1|||
146132157|NCT04904185|527004485|FG001|Overall Study|Expansion failure|0|||
146132158|NCT04904185|527004484|FG000|Overall Study|Late response on prior treatment|1|||
146132159|NCT04904185|527004485|FG001|Overall Study|Late response on prior treatment|0|||
146132160|NCT02945410|527004486|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146132161|NCT02945410|527004487|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
146132162|NCT02945410|527004488|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146132163|NCT02945410|527004489|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146132164|NCT02945410|527004490|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146132165|NCT02945410|527004491|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
146132166|NCT02945410|527004486|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
146132167|NCT02945410|527004487|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
146132168|NCT02945410|527004488|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
146132169|NCT02945410|527004489|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
146132170|NCT02945410|527004490|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
146132171|NCT02945410|527004491|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
146132172|NCT02945410|527004486|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146132173|NCT02945410|527004487|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146132174|NCT02945410|527004488|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
146132175|NCT02945410|527004489|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146132176|NCT02945410|527004490|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
146132177|NCT02945410|527004491|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
146132178|NCT00110812|527004494|FG000|Main Study|Death|0|||
146132179|NCT00110812|527004495|FG001|Main Study|Death|0|||
146132180|NCT00110812|527004496|FG002|Main Study|Death|2|||
146132181|NCT00110812|527004494|FG000|Main Study|Withdrawal by Subject|0|||
146132182|NCT00110812|527004495|FG001|Main Study|Withdrawal by Subject|0|||
146132183|NCT00110812|527004496|FG002|Main Study|Withdrawal by Subject|1|||
146132184|NCT00110812|527004494|FG000|Main Study|Lost to Follow-up|8|||
146132185|NCT00110812|527004495|FG001|Main Study|Lost to Follow-up|11|||
146132186|NCT00110812|527004496|FG002|Main Study|Lost to Follow-up|10|||
146132187|NCT00110812|527004494|FG000|Extended Follow-up|Death|1|||
146132188|NCT00110812|527004495|FG001|Extended Follow-up|Death|0|||
146132189|NCT00110812|527004496|FG002|Extended Follow-up|Death|3|||
146132190|NCT00110812|527004494|FG000|Extended Follow-up|Withdrawal by Subject|0|||
146132191|NCT00110812|527004495|FG001|Extended Follow-up|Withdrawal by Subject|1|||
146132192|NCT00110812|527004496|FG002|Extended Follow-up|Withdrawal by Subject|0|||
146132193|NCT00110812|527004494|FG000|Extended Follow-up|Lost to Follow-up|1|||
146132194|NCT00110812|527004495|FG001|Extended Follow-up|Lost to Follow-up|3|||
146132195|NCT00110812|527004496|FG002|Extended Follow-up|Lost to Follow-up|1|||
146132196|NCT00735371|527004499|FG000|Overall Study|Adverse Event|3|||
146132197|NCT00735371|527004500|FG001|Overall Study|Adverse Event|3|||
146132198|NCT00735371|527004501|FG002|Overall Study|Adverse Event|4|||
146132199|NCT00735371|527004502|FG003|Overall Study|Adverse Event|1|||
146132200|NCT00735371|527004499|FG000|Overall Study|Protocol Violation|2|||
146132201|NCT00735371|527004500|FG001|Overall Study|Protocol Violation|2|||
146132202|NCT00735371|527004501|FG002|Overall Study|Protocol Violation|0|||
146132203|NCT00735371|527004502|FG003|Overall Study|Protocol Violation|3|||
146132204|NCT00735371|527004499|FG000|Overall Study|Withdrawal by Subject|0|||
146132205|NCT00735371|527004500|FG001|Overall Study|Withdrawal by Subject|2|||
146132206|NCT00735371|527004501|FG002|Overall Study|Withdrawal by Subject|2|||
146132207|NCT00735371|527004502|FG003|Overall Study|Withdrawal by Subject|0|||
146132208|NCT00735371|527004499|FG000|Overall Study|Lost to Follow-up|1|||
146132209|NCT00735371|527004500|FG001|Overall Study|Lost to Follow-up|1|||
146132210|NCT00735371|527004501|FG002|Overall Study|Lost to Follow-up|3|||
146132211|NCT00735371|527004502|FG003|Overall Study|Lost to Follow-up|1|||
146132212|NCT00735371|527004499|FG000|Overall Study|Lack of Efficacy|4|||
146132213|NCT00735371|527004500|FG001|Overall Study|Lack of Efficacy|2|||
146132214|NCT00735371|527004501|FG002|Overall Study|Lack of Efficacy|0|||
146132215|NCT00735371|527004502|FG003|Overall Study|Lack of Efficacy|4|||
146132216|NCT00735371|527004499|FG000|Overall Study|Sponsor Decision|3|||
146132217|NCT00735371|527004500|FG001|Overall Study|Sponsor Decision|1|||
146132218|NCT00735371|527004501|FG002|Overall Study|Sponsor Decision|0|||
146132219|NCT00735371|527004502|FG003|Overall Study|Sponsor Decision|1|||
146132220|NCT00735371|527004499|FG000|Overall Study|Protocol Violation|0|||
146132221|NCT00735371|527004500|FG001|Overall Study|Protocol Violation|1|||
146132222|NCT00735371|527004501|FG002|Overall Study|Protocol Violation|2|||
146132223|NCT00735371|527004502|FG003|Overall Study|Protocol Violation|0|||
146132224|NCT00735371|527004499|FG000|Overall Study|Prior Vyvanse Exposure|1|||
146132225|NCT00735371|527004500|FG001|Overall Study|Prior Vyvanse Exposure|1|||
146132226|NCT00735371|527004501|FG002|Overall Study|Prior Vyvanse Exposure|0|||
146132227|NCT00735371|527004502|FG003|Overall Study|Prior Vyvanse Exposure|0|||
146132228|NCT00735371|527004499|FG000|Overall Study|Exclusion criteria|1|||
146132229|NCT00735371|527004500|FG001|Overall Study|Exclusion criteria|0|||
146132230|NCT00735371|527004501|FG002|Overall Study|Exclusion criteria|0|||
146132231|NCT00735371|527004502|FG003|Overall Study|Exclusion criteria|0|||
146132232|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
146132233|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
146132234|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
146132235|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
146132236|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
146132237|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
146132238|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
146132239|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
146132240|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
146132241|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
146132242|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
146132243|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
146132244|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
146132245|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
146132246|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
146132247|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Death|5|||
146132248|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Death|0|||
146132249|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Death|2|||
146132250|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Death|0|||
146132251|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Death|4|||
146132252|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
146132253|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
146132254|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
146132255|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
146132256|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
146132257|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
146132258|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
146132259|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
146132260|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
146132261|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
146132262|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
146132263|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146132264|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
146132265|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146132266|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
146132267|NCT01604343|527004503|FG000|Prior to W52 Administration(Through W52)|Other|15|||
146132268|NCT01604343|527004504|FG001|Prior to W52 Administration(Through W52)|Other|0|||
146132269|NCT01604343|527004505|FG002|Prior to W52 Administration(Through W52)|Other|10|||
146132270|NCT01604343|527004506|FG003|Prior to W52 Administration(Through W52)|Other|0|||
146132271|NCT01604343|527004507|FG004|Prior to W52 Administration(Through W52)|Other|6|||
146132272|NCT01604343|527004503|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
146132273|NCT01604343|527004504|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
146132274|NCT01604343|527004505|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
146132275|NCT01604343|527004506|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
146132276|NCT01604343|527004507|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
146132277|NCT01604343|527004503|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
146303658|NCT02003014|527625875|FG000|Overall Study|Patient did not visit the study site|5|||
146132278|NCT01604343|527004504|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
146132279|NCT01604343|527004505|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
146132280|NCT01604343|527004506|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
146132281|NCT01604343|527004507|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
146132282|NCT01604343|527004503|FG000|Week 52 to Week 104|Adverse Event|0|||
146132283|NCT01604343|527004504|FG001|Week 52 to Week 104|Adverse Event|12|||
146132284|NCT01604343|527004505|FG002|Week 52 to Week 104|Adverse Event|26|||
146132285|NCT01604343|527004506|FG003|Week 52 to Week 104|Adverse Event|21|||
146132286|NCT01604343|527004507|FG004|Week 52 to Week 104|Adverse Event|27|||
146132287|NCT01604343|527004503|FG000|Week 52 to Week 104|Death|0|||
146132288|NCT01604343|527004504|FG001|Week 52 to Week 104|Death|4|||
146132289|NCT01604343|527004505|FG002|Week 52 to Week 104|Death|2|||
146132290|NCT01604343|527004506|FG003|Week 52 to Week 104|Death|5|||
146132291|NCT01604343|527004507|FG004|Week 52 to Week 104|Death|0|||
146132292|NCT01604343|527004503|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
146132293|NCT01604343|527004504|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
146132294|NCT01604343|527004505|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
146132295|NCT01604343|527004506|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
146132296|NCT01604343|527004507|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
146132297|NCT01604343|527004503|FG000|Week 52 to Week 104|Physician Decision|0|||
146132298|NCT01604343|527004504|FG001|Week 52 to Week 104|Physician Decision|1|||
146132299|NCT01604343|527004505|FG002|Week 52 to Week 104|Physician Decision|0|||
146132300|NCT01604343|527004506|FG003|Week 52 to Week 104|Physician Decision|0|||
146132301|NCT01604343|527004507|FG004|Week 52 to Week 104|Physician Decision|2|||
146132302|NCT01604343|527004503|FG000|Week 52 to Week 104|Pregnancy|0|||
146132303|NCT01604343|527004504|FG001|Week 52 to Week 104|Pregnancy|0|||
146132304|NCT01604343|527004505|FG002|Week 52 to Week 104|Pregnancy|1|||
146132305|NCT01604343|527004506|FG003|Week 52 to Week 104|Pregnancy|2|||
146132306|NCT01604343|527004507|FG004|Week 52 to Week 104|Pregnancy|1|||
146132307|NCT01604343|527004503|FG000|Week 52 to Week 104|Other|0|||
146132308|NCT01604343|527004504|FG001|Week 52 to Week 104|Other|11|||
146132309|NCT01604343|527004505|FG002|Week 52 to Week 104|Other|11|||
146132310|NCT01604343|527004506|FG003|Week 52 to Week 104|Other|6|||
146132311|NCT01604343|527004507|FG004|Week 52 to Week 104|Other|3|||
146132312|NCT01604343|527004503|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
146132313|NCT01604343|527004504|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146132314|NCT01604343|527004505|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
146132315|NCT01604343|527004506|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146132316|NCT01604343|527004507|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
146132317|NCT01604343|527004503|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
146132318|NCT01604343|527004504|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
146132319|NCT01604343|527004505|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
146132320|NCT01604343|527004506|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
146132321|NCT01604343|527004507|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
146132322|NCT01604343|527004503|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
146132323|NCT01604343|527004504|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
146132324|NCT01604343|527004505|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
146132325|NCT01604343|527004506|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
146132326|NCT01604343|527004507|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
146132327|NCT01828034|527004511|FG000|Overall Study|Withdrawal by Subject|0|||
146132328|NCT01828034|527004512|FG001|Overall Study|Withdrawal by Subject|0|||
146132329|NCT01828034|527004513|FG002|Overall Study|Withdrawal by Subject|0|||
146132330|NCT01828034|527004514|FG003|Overall Study|Withdrawal by Subject|1|||
146132331|NCT02871375|527004515|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
146132332|NCT02871375|527004516|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
146132333|NCT01988571|527004517|FG000|Overall Study|Death|3|||
146132334|NCT01988571|527004518|FG001|Overall Study|Death|1|||
146132335|NCT01988571|527004517|FG000|Overall Study|Physician Decision|2|||
146132336|NCT01988571|527004518|FG001|Overall Study|Physician Decision|1|||
146132337|NCT01988571|527004517|FG000|Overall Study|Lost to Follow-up|3|||
146132338|NCT01988571|527004518|FG001|Overall Study|Lost to Follow-up|0|||
146132339|NCT01988571|527004517|FG000|Overall Study|Withdrawal by Subject|31|||
146132340|NCT01988571|527004518|FG001|Overall Study|Withdrawal by Subject|33|||
146132341|NCT03792672|527004522|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
146132342|NCT03792672|527004523|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146132343|NCT03792672|527004524|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146132344|NCT03792672|527004525|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
146132345|NCT03792672|527004526|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146132346|NCT03792672|527004527|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
146132347|NCT03792672|527004522|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
146132348|NCT03792672|527004523|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
146132349|NCT03792672|527004524|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
146132350|NCT03792672|527004525|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
146132351|NCT03792672|527004526|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
146168333|NCT02597036|527128107|FG004|Overall Study|Lost to Follow-up|0|||
146132352|NCT03792672|527004527|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
146132353|NCT03792672|527004522|FG000|Treatment Period 4 (2 Days)|Other|1|||
146132354|NCT03792672|527004523|FG001|Treatment Period 4 (2 Days)|Other|0|||
146132355|NCT03792672|527004524|FG002|Treatment Period 4 (2 Days)|Other|0|||
146132356|NCT03792672|527004525|FG003|Treatment Period 4 (2 Days)|Other|0|||
146132357|NCT03792672|527004526|FG004|Treatment Period 4 (2 Days)|Other|0|||
146132358|NCT03792672|527004527|FG005|Treatment Period 4 (2 Days)|Other|0|||
146132359|NCT00453999|527004528|FG000|Overall Study|Adverse Event|1|||
146132360|NCT00453999|527004529|FG001|Overall Study|Adverse Event|2|||
146132361|NCT00453999|527004530|FG002|Overall Study|Adverse Event|1|||
146132362|NCT00453999|527004528|FG000|Overall Study|Lost to Follow-up|0|||
146132363|NCT00453999|527004529|FG001|Overall Study|Lost to Follow-up|1|||
146132364|NCT00453999|527004530|FG002|Overall Study|Lost to Follow-up|1|||
146132365|NCT00453999|527004528|FG000|Overall Study|Withdrawal by Subject|2|||
146132366|NCT00453999|527004529|FG001|Overall Study|Withdrawal by Subject|1|||
146132367|NCT00453999|527004530|FG002|Overall Study|Withdrawal by Subject|1|||
146132368|NCT00453999|527004528|FG000|Overall Study|Subject Request|2|||
146132369|NCT00453999|527004529|FG001|Overall Study|Subject Request|1|||
146132370|NCT00453999|527004530|FG002|Overall Study|Subject Request|0|||
146132371|NCT01417481|527004545|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
146132372|NCT01417481|527004546|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
146132373|NCT00829296|527004547|FG000|Overall Study|Adverse Event|5|||
146132374|NCT00829296|527004548|FG001|Overall Study|Adverse Event|4|||
146132375|NCT03029624|527004549|FG000|Overall Study|Adverse Event|1|||
146132376|NCT03029624|527004549|FG000|Overall Study|Withdrawal by Subject|1|||
146132377|NCT03029624|527004549|FG000|Overall Study|Lack of Efficacy|1|||
146132378|NCT03029624|527004549|FG000|Overall Study|MRI need|2|||
146132379|NCT00785486|527004552|FG000|Midazolam Alone|Withdrawal by Subject|1|||
146132380|NCT03316885|527004553|FG000|Overall Study|Adverse Event|1|||
146132381|NCT03316885|527004553|FG000|Overall Study|Death|10|||
146132382|NCT03316885|527004553|FG000|Overall Study|Lost to Follow-up|4|||
146132383|NCT03316885|527004553|FG000|Overall Study|Withdrawal by Subject|9|||
146132384|NCT03316885|527004553|FG000|Overall Study|COVID related|8|||
146132385|NCT00978068|527004554|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
146132386|NCT00978068|527004555|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
146132387|NCT00978068|527004554|FG000|Overall Study|Death|1|||
146132388|NCT00978068|527004555|FG001|Overall Study|Death|2|||
146132389|NCT00978068|527004554|FG000|Overall Study|Lost to Follow-up|1|||
146132390|NCT00978068|527004555|FG001|Overall Study|Lost to Follow-up|2|||
146132391|NCT00978068|527004554|FG000|Overall Study|Physician Decision|0|||
146132392|NCT00978068|527004555|FG001|Overall Study|Physician Decision|1|||
146132393|NCT00978068|527004554|FG000|Overall Study|Unable to Comply with Study|0|||
146132394|NCT00978068|527004555|FG001|Overall Study|Unable to Comply with Study|2|||
146132395|NCT01148511|527004557|FG000|Exposed to Study Drug|Protocol Violation|2|||
146132396|NCT01148511|527004558|FG001|Exposed to Study Drug|Protocol Violation|0|||
146132397|NCT01148511|527004559|FG002|Exposed to Study Drug|Protocol Violation|0|||
146132398|NCT01148511|527004557|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
146132399|NCT01148511|527004558|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
146132400|NCT01148511|527004559|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
146132401|NCT01148511|527004557|FG000|Randomized|Adverse Event|0|||
146132402|NCT01148511|527004558|FG001|Randomized|Adverse Event|1|||
146132403|NCT01148511|527004559|FG002|Randomized|Adverse Event|0|||
146132404|NCT01148511|527004557|FG000|Randomized|Protocol Violation|0|||
146132405|NCT01148511|527004558|FG001|Randomized|Protocol Violation|2|||
146132406|NCT01148511|527004559|FG002|Randomized|Protocol Violation|1|||
146132407|NCT01148511|527004557|FG000|Randomized|Lost to Follow-up|0|||
146132408|NCT01148511|527004558|FG001|Randomized|Lost to Follow-up|1|||
146132409|NCT01148511|527004559|FG002|Randomized|Lost to Follow-up|1|||
146132410|NCT01148511|527004557|FG000|Randomized|Consent withdrawal|0|||
146132411|NCT01148511|527004558|FG001|Randomized|Consent withdrawal|5|||
146132412|NCT01148511|527004559|FG002|Randomized|Consent withdrawal|3|||
146132413|NCT01148511|527004557|FG000|Randomized|Other|0|||
146132414|NCT01148511|527004558|FG001|Randomized|Other|1|||
146132415|NCT01148511|527004559|FG002|Randomized|Other|1|||
146132416|NCT01644175|527004562|FG000|Overall Study|Randomized But Not Treated|0|||
146132417|NCT01644175|527004563|FG001|Overall Study|Randomized But Not Treated|2|||
146303659|NCT02003014|527625875|FG000|Overall Study|Investigator's transfer|4|||
146303660|NCT01660451|527625876|FG000|Overall Study|Protocol Violation|0|||
146132418|NCT01644175|527004562|FG000|Overall Study|Adverse Event|8|||
146132419|NCT01644175|527004563|FG001|Overall Study|Adverse Event|13|||
146132420|NCT01644175|527004562|FG000|Overall Study|Death|1|||
146132421|NCT01644175|527004563|FG001|Overall Study|Death|2|||
146132422|NCT01644175|527004562|FG000|Overall Study|Poor compliance to protocol|9|||
146132423|NCT01644175|527004563|FG001|Overall Study|Poor compliance to protocol|10|||
146132424|NCT01644175|527004562|FG000|Overall Study|Physician Decision|1|||
146132425|NCT01644175|527004563|FG001|Overall Study|Physician Decision|2|||
146132426|NCT01644175|527004562|FG000|Overall Study|Participant Moved|1|||
146132427|NCT01644175|527004563|FG001|Overall Study|Participant Moved|2|||
146132428|NCT01644175|527004562|FG000|Overall Study|Consent withdrawn by participant|3|||
146303661|NCT01660451|527625877|FG001|Overall Study|Protocol Violation|1|||
146132429|NCT01644175|527004563|FG001|Overall Study|Consent withdrawn by participant|4|||
146132430|NCT01644175|527004562|FG000|Overall Study|Related to Autoinjector Administration|2|||
146132431|NCT01644175|527004563|FG001|Overall Study|Related to Autoinjector Administration|1|||
146132432|NCT01644175|527004562|FG000|Overall Study|Last visit outside protocol visit window|4|||
146132433|NCT01644175|527004563|FG001|Overall Study|Last visit outside protocol visit window|11|||
146132434|NCT01644175|527004562|FG000|Overall Study|Selection criteria finally not met|0|||
146132435|NCT01644175|527004563|FG001|Overall Study|Selection criteria finally not met|1|||
146132436|NCT01644175|527004562|FG000|Overall Study|Site closure|2|||
146132437|NCT01644175|527004563|FG001|Overall Study|Site closure|2|||
146132438|NCT01644175|527004562|FG000|Overall Study|Lost to Follow-up|1|||
146132439|NCT01644175|527004563|FG001|Overall Study|Lost to Follow-up|0|||
146132440|NCT01644175|527004562|FG000|Overall Study|Other than specified above|0|||
146132441|NCT01644175|527004563|FG001|Overall Study|Other than specified above|3|||
146132442|NCT04258605|527004565|FG000|Overall Study|Death|1|||
146132443|NCT04258605|527004566|FG001|Overall Study|Death|0|||
146132444|NCT04258605|527004565|FG000|Overall Study|Early study termination|21|||
146132445|NCT04258605|527004566|FG001|Overall Study|Early study termination|2|||
146132446|NCT03913091|527004573|FG000|Overall Study|Lost to Follow-up|18|||
146132447|NCT03913091|527004574|FG001|Overall Study|Lost to Follow-up|11|||
146132448|NCT03913091|527004573|FG000|Overall Study|Required additional meds/surgery|1|||
146132449|NCT03913091|527004574|FG001|Overall Study|Required additional meds/surgery|2|||
146132450|NCT03913091|527004573|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
146132451|NCT03913091|527004574|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
146132452|NCT02196324|527004576|FG000|Overall Study|Withdrawal by Subject|8|||
146132453|NCT02196324|527004577|FG001|Overall Study|Withdrawal by Subject|4|||
146132454|NCT02196324|527004576|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
146132455|NCT02196324|527004577|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
146132456|NCT02196324|527004576|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
146132457|NCT02196324|527004577|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
146132458|NCT02196324|527004576|FG000|Overall Study|Other|1|||
146132459|NCT02196324|527004577|FG001|Overall Study|Other|0|||
146132460|NCT01380184|527004578|FG000|Part 1 (19 Days)|Adverse Event|1|||
146132461|NCT01380184|527004578|FG000|Part 2|Adverse Event|5|||
146132462|NCT01380184|527004578|FG000|Part 2|Disease Progression|8|||
146132463|NCT01380184|527004578|FG000|Part 2|Lost to Follow-up|1|||
146132464|NCT04243538|527004579|FG000|Overall Study|Withdrawal by Subject|0|||
146132465|NCT04243538|527004580|FG001|Overall Study|Withdrawal by Subject|2|||
146132466|NCT04243538|527004579|FG000|Overall Study|Lost to Follow-up|0|||
146132467|NCT04243538|527004580|FG001|Overall Study|Lost to Follow-up|3|||
146132468|NCT00655564|527004581|FG000|Overall Study|Adverse Event|1|||
146132469|NCT00655564|527004581|FG000|Overall Study|Lost to Follow-up|1|||
146132470|NCT00655564|527004581|FG000|Overall Study|Desired Alternate Therapy|1|||
146132471|NCT00344773|527004586|FG000|Overall Study|Adverse Event|2|||
146132472|NCT00344773|527004586|FG000|Overall Study|Objective Disease Progression|16|||
146132473|NCT00344773|527004586|FG000|Overall Study|Withdrawal by Subject|1|||
146132474|NCT00344773|527004586|FG000|Overall Study|Not Eligible for the study|2|||
146132475|NCT00500370|527004593|FG000|Overall Study|Adverse Event|9|||
146132476|NCT00500370|527004594|FG001|Overall Study|Adverse Event|3|||
146132477|NCT00500370|527004593|FG000|Overall Study|Lost to Follow-up|10|||
146132478|NCT00500370|527004594|FG001|Overall Study|Lost to Follow-up|10|||
146132479|NCT00500370|527004593|FG000|Overall Study|Protocol Violation|2|||
146132480|NCT00500370|527004594|FG001|Overall Study|Protocol Violation|4|||
146132481|NCT00500370|527004593|FG000|Overall Study|Sponsor Decision|2|||
146132482|NCT00500370|527004594|FG001|Overall Study|Sponsor Decision|0|||
146264935|NCT02818998|527484624|FG002|Overall Study|Lost to Follow-up|2|||
146264936|NCT02818998|527484622|FG000|Overall Study|Withdrawal by sponsor|0|||
146264937|NCT02818998|527484623|FG001|Overall Study|Withdrawal by sponsor|1|||
146264938|NCT02818998|527484624|FG002|Overall Study|Withdrawal by sponsor|1|||
146264939|NCT02818998|527484622|FG000|Overall Study|Death|3|||
146264940|NCT02818998|527484623|FG001|Overall Study|Death|6|||
146264941|NCT02818998|527484624|FG002|Overall Study|Death|8|||
146264942|NCT02818998|527484622|FG000|Overall Study|Withdrawal by Subject|7|||
146264943|NCT02818998|527484623|FG001|Overall Study|Withdrawal by Subject|6|||
146264944|NCT02818998|527484624|FG002|Overall Study|Withdrawal by Subject|6|||
146264945|NCT02818998|527484622|FG000|Overall Study|Physician Decision|1|||
146264946|NCT02818998|527484623|FG001|Overall Study|Physician Decision|0|||
146264947|NCT02818998|527484624|FG002|Overall Study|Physician Decision|0|||
146264948|NCT03414047|527484625|FG000|Overall Study|Adverse Event|0|||
146264949|NCT03414047|527484626|FG001|Overall Study|Adverse Event|0|||
146264950|NCT03414047|527484627|FG002|Overall Study|Adverse Event|1|||
146264951|NCT03414047|527484628|FG003|Overall Study|Adverse Event|1|||
146264952|NCT03414047|527484625|FG000|Overall Study|Physician Decision|1|||
146132483|NCT00500370|527004593|FG000|Overall Study|Subject Decision|10|||
146132484|NCT00500370|527004594|FG001|Overall Study|Subject Decision|17|||
146264953|NCT03414047|527484626|FG001|Overall Study|Physician Decision|0|||
146264954|NCT03414047|527484627|FG002|Overall Study|Physician Decision|0|||
146264955|NCT03414047|527484628|FG003|Overall Study|Physician Decision|1|||
146132485|NCT04804813|527004595|FG000|Overall Study|Protocol Violation|2|||
146132486|NCT04804813|527004596|FG001|Overall Study|Protocol Violation|0|||
146132487|NCT04804813|527004595|FG000|Overall Study|Withdrawal by Subject|1|||
146132488|NCT04804813|527004596|FG001|Overall Study|Withdrawal by Subject|0|||
146132489|NCT05627518|527004597|FG000|Treatment Period 1|Adverse Event|0|||
146132490|NCT05627518|527004598|FG001|Treatment Period 1|Adverse Event|0|||
146132491|NCT05627518|527004599|FG002|Treatment Period 1|Adverse Event|1|||
146132492|NCT05627518|527004600|FG003|Treatment Period 1|Adverse Event|0|||
146132493|NCT05627518|527004601|FG004|Treatment Period 1|Adverse Event|0|||
146132494|NCT05627518|527004602|FG005|Treatment Period 1|Adverse Event|0|||
146132495|NCT05627518|527004603|FG006|Treatment Period 1|Adverse Event|0|||
146132496|NCT05627518|527004604|FG007|Treatment Period 1|Adverse Event|1|||
146132497|NCT05627518|527004597|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146132498|NCT05627518|527004598|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146132499|NCT05627518|527004599|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146132500|NCT05627518|527004600|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146132501|NCT05627518|527004601|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146132502|NCT05627518|527004602|FG005|Treatment Period 1|Withdrawal by Subject|1|||
146132503|NCT05627518|527004603|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146132504|NCT05627518|527004604|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146132505|NCT05627518|527004597|FG000|Treatment Period 1|Protocol Violation|0|||
146132506|NCT05627518|527004598|FG001|Treatment Period 1|Protocol Violation|0|||
146132507|NCT05627518|527004599|FG002|Treatment Period 1|Protocol Violation|0|||
146132508|NCT05627518|527004600|FG003|Treatment Period 1|Protocol Violation|0|||
146132509|NCT05627518|527004601|FG004|Treatment Period 1|Protocol Violation|0|||
146132510|NCT05627518|527004602|FG005|Treatment Period 1|Protocol Violation|0|||
146132511|NCT05627518|527004603|FG006|Treatment Period 1|Protocol Violation|6|||
146132512|NCT05627518|527004604|FG007|Treatment Period 1|Protocol Violation|6|||
146132513|NCT05627518|527004597|FG000|Treatment Period 2|Adverse Event|1|||
146132514|NCT05627518|527004598|FG001|Treatment Period 2|Adverse Event|0|||
146132515|NCT05627518|527004599|FG002|Treatment Period 2|Adverse Event|0|||
146132516|NCT05627518|527004600|FG003|Treatment Period 2|Adverse Event|0|||
146132517|NCT05627518|527004601|FG004|Treatment Period 2|Adverse Event|0|||
146132518|NCT05627518|527004602|FG005|Treatment Period 2|Adverse Event|0|||
146132519|NCT05627518|527004603|FG006|Treatment Period 2|Adverse Event|0|||
146132520|NCT05627518|527004604|FG007|Treatment Period 2|Adverse Event|0|||
146132521|NCT05627518|527004597|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146132522|NCT05627518|527004598|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146132523|NCT05627518|527004599|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146132524|NCT05627518|527004600|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146132525|NCT05627518|527004601|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146132526|NCT05627518|527004602|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146132527|NCT05627518|527004603|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146132528|NCT05627518|527004604|FG007|Treatment Period 2|Withdrawal by Subject|0|||
146132529|NCT02776917|527004605|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
146132530|NCT02620046|527004606|FG000|Overall Study|Adverse Event|22|||
146132531|NCT02620046|527004607|FG001|Overall Study|Adverse Event|42|||
146132532|NCT02620046|527004606|FG000|Overall Study|Lost to Follow-up|4|||
146132533|NCT02620046|527004607|FG001|Overall Study|Lost to Follow-up|10|||
146132534|NCT02620046|527004606|FG000|Overall Study|Withdrawal by Subject|36|||
146132535|NCT02620046|527004607|FG001|Overall Study|Withdrawal by Subject|66|||
146132536|NCT02620046|527004606|FG000|Overall Study|Site Termination|3|||
146132537|NCT02620046|527004607|FG001|Overall Study|Site Termination|3|||
146132538|NCT02620046|527004606|FG000|Overall Study|Pregnancy|3|||
146132539|NCT02620046|527004607|FG001|Overall Study|Pregnancy|7|||
146132540|NCT02620046|527004606|FG000|Overall Study|Lack of Efficacy|81|||
146132541|NCT02620046|527004607|FG001|Overall Study|Lack of Efficacy|146|||
146132542|NCT02620046|527004606|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
146132543|NCT02620046|527004607|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
146132544|NCT02620046|527004606|FG000|Overall Study|Reason Not Specified|13|||
146132545|NCT02620046|527004607|FG001|Overall Study|Reason Not Specified|21|||
146264956|NCT03414047|527484625|FG000|Overall Study|Withdrawal by Subject|1|||
146264957|NCT03414047|527484626|FG001|Overall Study|Withdrawal by Subject|0|||
146132546|NCT02620046|527004606|FG000|Overall Study|Significant Protocol Deviation|0|||
146132547|NCT02620046|527004607|FG001|Overall Study|Significant Protocol Deviation|1|||
146132548|NCT01581593|527006196|FG000|Overall Study|Withdrawal by Subject|1|||
146132549|NCT04982029|527006197|FG000|Overall Study|Lost to Follow-up|2|||
146132550|NCT04982029|527006198|FG001|Overall Study|Lost to Follow-up|3|||
146132551|NCT03264404|527006199|FG000|Overall Study|Death|2|||
146132552|NCT03264404|527006199|FG000|Overall Study|Physician Decision|1|||
146132553|NCT03264404|527006199|FG000|Overall Study|Disease Progression|28|||
146132554|NCT03264404|527006199|FG000|Overall Study|Adverse Event|1|||
146132555|NCT03264404|527006199|FG000|Overall Study|Off study prior to treatment|2|||
146132556|NCT02586012|527006200|FG000|Overall Study|Withdrawal by Subject|1|||
146132557|NCT02586012|527006201|FG001|Overall Study|Withdrawal by Subject|1|||
146132558|NCT02586012|527006202|FG002|Overall Study|Withdrawal by Subject|0|||
146264958|NCT03414047|527484627|FG002|Overall Study|Withdrawal by Subject|2|||
146132559|NCT02586012|527006203|FG003|Overall Study|Withdrawal by Subject|1|||
146132560|NCT02586012|527006204|FG004|Overall Study|Withdrawal by Subject|0|||
146132561|NCT02586012|527006205|FG005|Overall Study|Withdrawal by Subject|2|||
146132562|NCT02586012|527006200|FG000|Overall Study|Protocol Violation|0|||
146132563|NCT02586012|527006201|FG001|Overall Study|Protocol Violation|0|||
146132564|NCT02586012|527006202|FG002|Overall Study|Protocol Violation|0|||
146132565|NCT02586012|527006203|FG003|Overall Study|Protocol Violation|0|||
146132566|NCT02586012|527006204|FG004|Overall Study|Protocol Violation|0|||
146132567|NCT02586012|527006205|FG005|Overall Study|Protocol Violation|1|||
146132568|NCT02586012|527006200|FG000|Overall Study|study terminated|0|||
146132569|NCT02586012|527006201|FG001|Overall Study|study terminated|2|||
146132570|NCT02586012|527006202|FG002|Overall Study|study terminated|1|||
146132571|NCT02586012|527006203|FG003|Overall Study|study terminated|1|||
146132572|NCT02586012|527006204|FG004|Overall Study|study terminated|1|||
146132573|NCT02586012|527006205|FG005|Overall Study|study terminated|0|||
146132574|NCT02388737|527006207|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
146132575|NCT02388737|527006208|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
146132576|NCT02388737|527006209|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
146132577|NCT02388737|527006207|FG000|Overall Study|Major Protocol Deviation|18|||
146132578|NCT02388737|527006208|FG001|Overall Study|Major Protocol Deviation|25|||
146132579|NCT02388737|527006209|FG002|Overall Study|Major Protocol Deviation|22|||
146132580|NCT02388737|527006207|FG000|Overall Study|Lost to Follow-up|5|||
146132581|NCT02388737|527006208|FG001|Overall Study|Lost to Follow-up|1|||
146132582|NCT02388737|527006209|FG002|Overall Study|Lost to Follow-up|4|||
146132583|NCT02388737|527006207|FG000|Overall Study|Voluntary Withdrawal|10|||
146132584|NCT02388737|527006208|FG001|Overall Study|Voluntary Withdrawal|18|||
146132585|NCT02388737|527006209|FG002|Overall Study|Voluntary Withdrawal|17|||
146303662|NCT01660451|527625878|FG002|Overall Study|Protocol Violation|1|||
146132586|NCT02388737|527006207|FG000|Overall Study|Lack of Efficacy|3|||
146132587|NCT02388737|527006208|FG001|Overall Study|Lack of Efficacy|0|||
146132588|NCT02388737|527006209|FG002|Overall Study|Lack of Efficacy|3|||
146132589|NCT02388737|527006207|FG000|Overall Study|Reason Not Specified|5|||
146132590|NCT02388737|527006208|FG001|Overall Study|Reason Not Specified|5|||
146132591|NCT02388737|527006209|FG002|Overall Study|Reason Not Specified|4|||
146132592|NCT01920932|527006210|FG000|Overall Study|Death|1|||
146132593|NCT01920932|527006210|FG000|Overall Study|Withdrawal of consent|1|||
146132594|NCT03299842|527006211|FG000|Overall Study|Caregiver withdrew consent|2|||
146132595|NCT03299842|527006211|FG000|Overall Study|Child would not keep the watch on|3|||
146132596|NCT00071812|527006212|FG000|24-Week Double-Blind Period|Adverse Event|2|||
146132597|NCT00071812|527006213|FG001|24-Week Double-Blind Period|Adverse Event|3|||
146132598|NCT00071812|527006214|FG002|24-Week Double-Blind Period|Adverse Event|4|||
146132599|NCT00071812|527006215|FG003|24-Week Double-Blind Period|Adverse Event|4|||
146132600|NCT00071812|527006212|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
146132601|NCT00071812|527006213|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
146132602|NCT00071812|527006214|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
146132603|NCT00071812|527006215|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
146132604|NCT00071812|527006212|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
146132605|NCT00071812|527006213|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
146132606|NCT00071812|527006214|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
146132607|NCT00071812|527006215|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
146132608|NCT00071812|527006212|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
146132609|NCT00071812|527006213|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
146132610|NCT00071812|527006214|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
146132611|NCT00071812|527006215|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
146132612|NCT00071812|527006212|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
146132613|NCT00071812|527006213|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
146132614|NCT00071812|527006214|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
146132615|NCT00071812|527006215|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
146132616|NCT00071812|527006212|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
146132617|NCT00071812|527006213|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
146132618|NCT00071812|527006214|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
146132619|NCT00071812|527006215|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
146132620|NCT00071812|527006212|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146132621|NCT00071812|527006213|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146132622|NCT00071812|527006214|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146132623|NCT00071812|527006215|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
146132624|NCT00071812|527006212|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146132625|NCT00071812|527006213|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146132626|NCT00071812|527006214|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146132627|NCT00071812|527006215|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
146132628|NCT00071812|527006212|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146132629|NCT00071812|527006213|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146132630|NCT00071812|527006214|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146132631|NCT00071812|527006215|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
146132632|NCT00071812|527006212|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146132633|NCT00071812|527006213|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146132634|NCT00071812|527006214|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
146132635|NCT00071812|527006215|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
146132636|NCT01816139|527006216|FG000|Overall Study|Adverse Event|6|||
146132637|NCT01816139|527006217|FG001|Overall Study|Adverse Event|8|||
146132638|NCT01816139|527006216|FG000|Overall Study|Lack of Efficacy|1|||
146132639|NCT01816139|527006217|FG001|Overall Study|Lack of Efficacy|2|||
146132640|NCT01816139|527006216|FG000|Overall Study|Lost to Follow-up|5|||
146132641|NCT01816139|527006217|FG001|Overall Study|Lost to Follow-up|3|||
146132642|NCT01816139|527006216|FG000|Overall Study|Withdrew Consent|6|||
146132643|NCT01816139|527006217|FG001|Overall Study|Withdrew Consent|4|||
146132644|NCT01816139|527006216|FG000|Overall Study|Protocol Violation|6|||
146132645|NCT01816139|527006217|FG001|Overall Study|Protocol Violation|3|||
146132646|NCT01816139|527006216|FG000|Overall Study|Reason not Specified|4|||
146132647|NCT01816139|527006217|FG001|Overall Study|Reason not Specified|2|||
146132648|NCT00302003|527006221|FG000|Overall Study|Lack of Efficacy|62|||
146132649|NCT00302003|527006221|FG000|Overall Study|Lost to Follow-up|1|||
146132650|NCT00302003|527006221|FG000|Overall Study|Physician Decision|2|||
146132651|NCT00302003|527006221|FG000|Overall Study|Withdrawal by Subject|5|||
146132652|NCT00302003|527006221|FG000|Overall Study|Ineligible|9|||
146132653|NCT00302003|527006221|FG000|Overall Study|Protocol Violation|1|||
146132654|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
146132655|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
146132656|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
146132657|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
146132658|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146132659|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
146132660|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146132661|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
146132662|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
146132663|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
146132664|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
146132665|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
146132666|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
146132667|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146132668|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146132669|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
146132670|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
146132671|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
146132672|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
146132673|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
146132674|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146132675|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
146132676|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146132677|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
146132678|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146132679|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
146132680|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146132681|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
146132682|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146132683|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
146132684|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146132685|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
146132686|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
146132687|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
146132688|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
146132689|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
146132690|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146303663|NCT01660451|527625876|FG000|Overall Study|AE not associated with clinical disease progression|13|||
146303664|NCT01660451|527625877|FG001|Overall Study|AE not associated with clinical disease progression|10|||
146132691|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
146132692|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146132693|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
146303665|NCT01660451|527625878|FG002|Overall Study|AE not associated with clinical disease progression|40|||
146132694|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
146132695|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
146132696|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
146132697|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
146132698|NCT01218516|527006222|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
146132699|NCT01218516|527006223|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
146132700|NCT01218516|527006224|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
146132701|NCT01218516|527006225|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
146132702|NCT01539226|527006226|FG000|Overall Study|Withdrawal by Subject|24|||
146132703|NCT01539226|527006227|FG001|Overall Study|Withdrawal by Subject|54|||
146132704|NCT01539226|527006226|FG000|Overall Study|Lost to Follow-up|20|||
146132705|NCT01539226|527006227|FG001|Overall Study|Lost to Follow-up|54|||
146132706|NCT01539226|527006226|FG000|Overall Study|Death|1|||
146132707|NCT01539226|527006227|FG001|Overall Study|Death|2|||
146132708|NCT01539226|527006226|FG000|Overall Study|Adverse Event|2|||
146132709|NCT01539226|527006227|FG001|Overall Study|Adverse Event|0|||
146132710|NCT01539226|527006226|FG000|Overall Study|Pregnancy|13|||
146132711|NCT01539226|527006227|FG001|Overall Study|Pregnancy|29|||
146132712|NCT01539226|527006226|FG000|Overall Study|inappropriate enrollment|0|||
146132713|NCT01539226|527006227|FG001|Overall Study|inappropriate enrollment|1|||
146132714|NCT01539226|527006226|FG000|Overall Study|Multiple Reasons|3|||
146132715|NCT01539226|527006227|FG001|Overall Study|Multiple Reasons|1|||
146132716|NCT01539226|527006226|FG000|Overall Study|not HIV seroconversion-related|93|||
146132717|NCT01539226|527006227|FG001|Overall Study|not HIV seroconversion-related|176|||
146132718|NCT01539226|527006226|FG000|Overall Study|HIV seroconversion-related|55|||
146132719|NCT01539226|527006227|FG001|Overall Study|HIV seroconversion-related|80|||
146132720|NCT01539226|527006226|FG000|Overall Study|Non-compliance|6|||
146132721|NCT01539226|527006227|FG001|Overall Study|Non-compliance|8|||
146132722|NCT02919670|527006228|FG000|Overall Study|Only 17 participants met compliance|43|||
146132723|NCT02919670|527006229|FG001|Overall Study|Only 17 participants met compliance|39|||
146132724|NCT00436748|527006234|FG000|Overall Study|Ineligibility Determined|1|||
146132725|NCT00436748|527006235|FG001|Overall Study|Ineligibility Determined|1|||
146132726|NCT00436748|527006234|FG000|Overall Study|Adverse Event|0|||
146132727|NCT00436748|527006235|FG001|Overall Study|Adverse Event|2|||
146132728|NCT00436748|527006234|FG000|Overall Study|Consent Withdrawn|1|||
146132729|NCT00436748|527006235|FG001|Overall Study|Consent Withdrawn|4|||
146132730|NCT00436748|527006234|FG000|Overall Study|Administrative Decision|1|||
146132731|NCT00436748|527006235|FG001|Overall Study|Administrative Decision|0|||
146132732|NCT00436748|527006234|FG000|Overall Study|Lost to Follow-up|0|||
146132733|NCT00436748|527006235|FG001|Overall Study|Lost to Follow-up|1|||
146132734|NCT00436748|527006234|FG000|Overall Study|Protocol-specified Criteria|5|||
146132735|NCT00436748|527006235|FG001|Overall Study|Protocol-specified Criteria|4|||
146132736|NCT00436748|527006234|FG000|Overall Study|Other|3|||
146132737|NCT00436748|527006235|FG001|Overall Study|Other|0|||
146132738|NCT01610791|527006236|FG000|Overall Study|Lost to Follow-up|7|||
146132739|NCT01610791|527006236|FG000|Overall Study|Adverse Event|6|||
146132740|NCT01610791|527006236|FG000|Overall Study|Physician Decision|1|||
146132741|NCT01610791|527006236|FG000|Overall Study|Adverse event and Investigator decision|1|||
146132742|NCT01610791|527006236|FG000|Overall Study|Death|1|||
146132743|NCT01610791|527006236|FG000|Overall Study|Not determined|5|||
146132744|NCT00850200|527006239|FG000|Overall Study|Physician Decision|2|||
146132745|NCT00850200|527006239|FG000|Overall Study|Did not recieve treatment|2|||
146132746|NCT00850200|527006239|FG000|Overall Study|Withdrawal by Subject|1|||
146132747|NCT02086110|527006251|FG000|Overall Study|Withdrawal by Subject|1|||
146132748|NCT02086110|527006252|FG001|Overall Study|Withdrawal by Subject|1|||
146132749|NCT01203072|527006253|FG000|Overall Study|Adverse Event|5|||
146132750|NCT01203072|527006254|FG001|Overall Study|Adverse Event|3|||
146132751|NCT01203072|527006255|FG002|Overall Study|Adverse Event|2|||
146132752|NCT01203072|527006256|FG003|Overall Study|Adverse Event|4|||
146132753|NCT01203072|527006257|FG004|Overall Study|Adverse Event|2|||
146132754|NCT01203072|527006253|FG000|Overall Study|Lack of Efficacy|1|||
146132755|NCT01203072|527006254|FG001|Overall Study|Lack of Efficacy|0|||
146132756|NCT01203072|527006255|FG002|Overall Study|Lack of Efficacy|0|||
146132757|NCT01203072|527006256|FG003|Overall Study|Lack of Efficacy|0|||
146132758|NCT01203072|527006257|FG004|Overall Study|Lack of Efficacy|0|||
146132759|NCT01203072|527006253|FG000|Overall Study|Lost to Follow-up|0|||
146132760|NCT01203072|527006254|FG001|Overall Study|Lost to Follow-up|1|||
146132761|NCT01203072|527006255|FG002|Overall Study|Lost to Follow-up|0|||
146132762|NCT01203072|527006256|FG003|Overall Study|Lost to Follow-up|0|||
146132763|NCT01203072|527006257|FG004|Overall Study|Lost to Follow-up|0|||
146132764|NCT01203072|527006253|FG000|Overall Study|Protocol Violation|2|||
146132765|NCT01203072|527006254|FG001|Overall Study|Protocol Violation|0|||
146132766|NCT01203072|527006255|FG002|Overall Study|Protocol Violation|0|||
146132767|NCT01203072|527006256|FG003|Overall Study|Protocol Violation|0|||
146132768|NCT01203072|527006257|FG004|Overall Study|Protocol Violation|1|||
146132769|NCT01203072|527006253|FG000|Overall Study|Withdrawal by Subject|2|||
146132770|NCT01203072|527006254|FG001|Overall Study|Withdrawal by Subject|2|||
146132771|NCT01203072|527006255|FG002|Overall Study|Withdrawal by Subject|1|||
146132772|NCT01203072|527006256|FG003|Overall Study|Withdrawal by Subject|2|||
146132773|NCT01203072|527006257|FG004|Overall Study|Withdrawal by Subject|3|||
146132774|NCT02272413|527006259|FG000|Randomized Through Treatment Start|Not treated|3|||
146132775|NCT02272413|527006260|FG001|Randomized Through Treatment Start|Not treated|5|||
146132776|NCT02272413|527006259|FG000|Pre-switch Period|Adverse Event|38|||
146132777|NCT02272413|527006260|FG001|Pre-switch Period|Adverse Event|37|||
146132778|NCT02272413|527006259|FG000|Pre-switch Period|Death|26|||
146132779|NCT02272413|527006260|FG001|Pre-switch Period|Death|26|||
146132780|NCT02272413|527006259|FG000|Pre-switch Period|Withdrawal by Subject|27|||
146132781|NCT02272413|527006260|FG001|Pre-switch Period|Withdrawal by Subject|15|||
146132782|NCT02272413|527006259|FG000|Pre-switch Period|Physician Decision|6|||
146132783|NCT02272413|527006260|FG001|Pre-switch Period|Physician Decision|18|||
146132784|NCT02272413|527006259|FG000|Pre-switch Period|Progressive disease|185|||
146132785|NCT02272413|527006260|FG001|Pre-switch Period|Progressive disease|173|||
146132786|NCT02272413|527006259|FG000|Pre-switch Period|Lost to Follow-up|0|||
146132787|NCT02272413|527006260|FG001|Pre-switch Period|Lost to Follow-up|2|||
146132788|NCT02272413|527006259|FG000|Pre-switch Period|Protocol Violation|1|||
146132789|NCT02272413|527006260|FG001|Pre-switch Period|Protocol Violation|0|||
146132790|NCT02272413|527006259|FG000|Pre-switch Period|Other than listed|10|||
146132791|NCT02272413|527006260|FG001|Pre-switch Period|Other than listed|11|||
146132792|NCT02272413|527006259|FG000|Post-switch Period|Adverse Event|4|||
146132793|NCT02272413|527006260|FG001|Post-switch Period|Adverse Event|4|||
146132794|NCT02272413|527006259|FG000|Post-switch Period|Death|3|||
146132795|NCT02272413|527006260|FG001|Post-switch Period|Death|2|||
146132796|NCT02272413|527006259|FG000|Post-switch Period|Withdrawal by Subject|1|||
146132797|NCT02272413|527006260|FG001|Post-switch Period|Withdrawal by Subject|2|||
146132798|NCT02272413|527006259|FG000|Post-switch Period|Physician Decision|1|||
146132799|NCT02272413|527006260|FG001|Post-switch Period|Physician Decision|1|||
146132800|NCT02272413|527006259|FG000|Post-switch Period|Progressive disease|21|||
146132801|NCT02272413|527006260|FG001|Post-switch Period|Progressive disease|21|||
146132802|NCT02272413|527006259|FG000|Post-switch Period|Study terminated by sponsor|8|||
146132803|NCT02272413|527006260|FG001|Post-switch Period|Study terminated by sponsor|11|||
146132804|NCT02272413|527006259|FG000|Post-switch Period|Other than listed|4|||
146132805|NCT02272413|527006260|FG001|Post-switch Period|Other than listed|5|||
146132806|NCT02286193|527006263|FG000|Overall Study|Referred: CRS unable to make contact|62|||
146132807|NCT02286193|527006263|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
146132808|NCT02286193|527006263|FG000|Overall Study|Referred: Declined service|38|||
146132809|NCT00423891|527006264|FG000|Enrolled|Withdrawal by Subject|0|||
146132810|NCT00423891|527006265|FG001|Enrolled|Withdrawal by Subject|0|||
146132811|NCT00423891|527006266|FG002|Enrolled|Withdrawal by Subject|1|||
146132812|NCT00423891|527006264|FG000|Enrolled|Lost to Follow-up|0|||
146132813|NCT00423891|527006265|FG001|Enrolled|Lost to Follow-up|0|||
146132814|NCT00423891|527006266|FG002|Enrolled|Lost to Follow-up|1|||
146132815|NCT00423891|527006264|FG000|Enrolled|No longer met criteria|11|||
146132816|NCT00423891|527006265|FG001|Enrolled|No longer met criteria|2|||
146132817|NCT00423891|527006266|FG002|Enrolled|No longer met criteria|1|||
146132818|NCT00423891|527006264|FG000|Treatment|Withdrawal by Subject|1|||
146132819|NCT00423891|527006265|FG001|Treatment|Withdrawal by Subject|0|||
146132820|NCT00423891|527006266|FG002|Treatment|Withdrawal by Subject|0|||
146132821|NCT00423891|527006264|FG000|Treatment|Lost to Follow-up|1|||
146132822|NCT00423891|527006265|FG001|Treatment|Lost to Follow-up|0|||
146132823|NCT00423891|527006266|FG002|Treatment|Lost to Follow-up|0|||
146132824|NCT00423891|527006264|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
146132825|NCT00423891|527006265|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
146132826|NCT00423891|527006266|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
146132827|NCT00423891|527006264|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
146132828|NCT00423891|527006265|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
146132829|NCT00423891|527006266|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
146132830|NCT02852265|527006267|FG000|3-month Follow-up|Lost to Follow-up|1|||
146132831|NCT02852265|527006268|FG001|3-month Follow-up|Lost to Follow-up|1|||
146132832|NCT01585766|527006269|FG000|Overall Study|Withdrawal by Subject|0|||
146132833|NCT01585766|527006270|FG001|Overall Study|Withdrawal by Subject|1|||
146132834|NCT01585766|527006271|FG002|Overall Study|Withdrawal by Subject|1|||
146132835|NCT01585766|527006272|FG003|Overall Study|Withdrawal by Subject|0|||
146132836|NCT01585766|527006273|FG004|Overall Study|Withdrawal by Subject|0|||
146132837|NCT01585766|527006274|FG005|Overall Study|Withdrawal by Subject|0|||
146132838|NCT01585766|527006269|FG000|Overall Study|Death|0|||
146132839|NCT01585766|527006270|FG001|Overall Study|Death|1|||
146132840|NCT01585766|527006271|FG002|Overall Study|Death|0|||
146132841|NCT01585766|527006272|FG003|Overall Study|Death|0|||
146132842|NCT01585766|527006273|FG004|Overall Study|Death|0|||
146132843|NCT01585766|527006274|FG005|Overall Study|Death|0|||
146132844|NCT01585766|527006269|FG000|Overall Study|Physician Decision|0|||
146132845|NCT01585766|527006270|FG001|Overall Study|Physician Decision|0|||
146132846|NCT01585766|527006271|FG002|Overall Study|Physician Decision|1|||
146132847|NCT01585766|527006272|FG003|Overall Study|Physician Decision|0|||
146132848|NCT01585766|527006273|FG004|Overall Study|Physician Decision|0|||
146132849|NCT01585766|527006274|FG005|Overall Study|Physician Decision|0|||
146132850|NCT04116710|527006275|FG000|Overall Study|Death|4|||
146132851|NCT04116710|527006276|FG001|Overall Study|Death|6|||
146132852|NCT04116710|527006277|FG002|Overall Study|Death|3|||
146132853|NCT04116710|527006278|FG003|Overall Study|Death|1|||
146132854|NCT04116710|527006275|FG000|Overall Study|Withdrawal by Subject|0|||
146132855|NCT04116710|527006276|FG001|Overall Study|Withdrawal by Subject|0|||
146132856|NCT04116710|527006277|FG002|Overall Study|Withdrawal by Subject|0|||
146132857|NCT04116710|527006278|FG003|Overall Study|Withdrawal by Subject|1|||
146132858|NCT00582933|527006279|FG000|Overall Study|Physician Decision|3|||
146132859|NCT02319031|527006280|FG000|Treatment Period|Death|1|||
146132860|NCT02319031|527006281|FG001|Treatment Period|Death|0|||
146132861|NCT02689258|527006285|FG000|Overall Study|Subject Non-Compliance|0|||
146132862|NCT02689258|527006286|FG001|Overall Study|Subject Non-Compliance|1|||
146132863|NCT02689258|527006287|FG002|Overall Study|Subject Non-Compliance|0|||
146132864|NCT02689258|527006288|FG003|Overall Study|Subject Non-Compliance|0|||
146132865|NCT02689258|527006289|FG004|Overall Study|Subject Non-Compliance|0|||
146132866|NCT02689258|527006290|FG005|Overall Study|Subject Non-Compliance|0|||
146132867|NCT02689258|527006291|FG006|Overall Study|Subject Non-Compliance|0|||
146132868|NCT02689258|527006292|FG007|Overall Study|Subject Non-Compliance|0|||
146132869|NCT02689258|527006293|FG008|Overall Study|Subject Non-Compliance|0|||
146132870|NCT02689258|527006294|FG009|Overall Study|Subject Non-Compliance|0|||
146132871|NCT02689258|527006295|FG010|Overall Study|Subject Non-Compliance|0|||
146132872|NCT02689258|527006296|FG011|Overall Study|Subject Non-Compliance|0|||
146132873|NCT02689258|527006285|FG000|Overall Study|Subject Refusal to Continue|0|||
146132874|NCT02689258|527006286|FG001|Overall Study|Subject Refusal to Continue|1|||
146132875|NCT02689258|527006287|FG002|Overall Study|Subject Refusal to Continue|0|||
146132876|NCT02689258|527006288|FG003|Overall Study|Subject Refusal to Continue|0|||
146132877|NCT02689258|527006289|FG004|Overall Study|Subject Refusal to Continue|0|||
146132878|NCT02689258|527006290|FG005|Overall Study|Subject Refusal to Continue|0|||
146132879|NCT02689258|527006291|FG006|Overall Study|Subject Refusal to Continue|0|||
146132880|NCT02689258|527006292|FG007|Overall Study|Subject Refusal to Continue|0|||
146132881|NCT02689258|527006293|FG008|Overall Study|Subject Refusal to Continue|1|||
146132882|NCT02689258|527006294|FG009|Overall Study|Subject Refusal to Continue|0|||
146132883|NCT02689258|527006295|FG010|Overall Study|Subject Refusal to Continue|0|||
146132884|NCT02689258|527006296|FG011|Overall Study|Subject Refusal to Continue|1|||
146132885|NCT02689258|527006285|FG000|Overall Study|Other|0|||
146132886|NCT02689258|527006286|FG001|Overall Study|Other|2|||
146132887|NCT02689258|527006287|FG002|Overall Study|Other|0|||
146132888|NCT02689258|527006288|FG003|Overall Study|Other|0|||
146132889|NCT02689258|527006289|FG004|Overall Study|Other|1|||
146132890|NCT02689258|527006290|FG005|Overall Study|Other|0|||
146132891|NCT02689258|527006291|FG006|Overall Study|Other|0|||
146132892|NCT02689258|527006292|FG007|Overall Study|Other|0|||
146132893|NCT02689258|527006293|FG008|Overall Study|Other|1|||
146132894|NCT02689258|527006294|FG009|Overall Study|Other|0|||
146132895|NCT02689258|527006295|FG010|Overall Study|Other|0|||
146132896|NCT02689258|527006296|FG011|Overall Study|Other|0|||
146132897|NCT04753164|527006298|FG000|Overall Study|Adverse Event|0|||
146132898|NCT04753164|527006299|FG001|Overall Study|Adverse Event|2|||
146132899|NCT04753164|527006298|FG000|Overall Study|Withdrawal by Subject|9|||
146132900|NCT04753164|527006299|FG001|Overall Study|Withdrawal by Subject|7|||
146132901|NCT04753164|527006298|FG000|Overall Study|Lost to Follow-up|6|||
146132902|NCT04753164|527006299|FG001|Overall Study|Lost to Follow-up|6|||
146132903|NCT04753164|527006298|FG000|Overall Study|Other|12|||
146132904|NCT04753164|527006299|FG001|Overall Study|Other|5|||
146132905|NCT00696137|527006301|FG000|Overall Study|Withdrawal by Subject|2|||
146132906|NCT01371656|527006306|FG000|Overall Study|Death|7|||
146132907|NCT01371656|527006307|FG001|Overall Study|Death|4|||
146132908|NCT01371656|527006306|FG000|Overall Study|Physician Decision|46|||
146132909|NCT01371656|527006307|FG001|Overall Study|Physician Decision|7|||
146132910|NCT01371656|527006306|FG000|Overall Study|Withdrawal by Subject|7|||
146132911|NCT01371656|527006307|FG001|Overall Study|Withdrawal by Subject|0|||
146132912|NCT01371656|527006306|FG000|Overall Study|Ineligible|4|||
146132913|NCT01371656|527006307|FG001|Overall Study|Ineligible|3|||
146132914|NCT01465464|527006317|FG000|Overall Study|Adverse Event|96|||
146132915|NCT01465464|527006318|FG001|Overall Study|Adverse Event|49|||
146132916|NCT01465464|527006317|FG000|Overall Study|Lack of Efficacy|139|||
146132917|NCT01465464|527006318|FG001|Overall Study|Lack of Efficacy|190|||
146132918|NCT01465464|527006317|FG000|Overall Study|Physician Decision|13|||
146132919|NCT01465464|527006318|FG001|Overall Study|Physician Decision|5|||
146132920|NCT01465464|527006317|FG000|Overall Study|Protocol Violation|1|||
146132921|NCT01465464|527006318|FG001|Overall Study|Protocol Violation|1|||
146132922|NCT01465464|527006317|FG000|Overall Study|Withdrawal by Subject|46|||
146132923|NCT01465464|527006318|FG001|Overall Study|Withdrawal by Subject|30|||
146132924|NCT01465464|527006317|FG000|Overall Study|Other|9|||
146132925|NCT01465464|527006318|FG001|Overall Study|Other|3|||
146132926|NCT01465464|527006317|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
146132927|NCT01465464|527006318|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
146132928|NCT00775437|527006324|FG000|Overall Study|Loss of efficacy|2|||
146132929|NCT00775437|527006324|FG000|Overall Study|Withdrawal by Subject|3|||
146132930|NCT00775437|527006324|FG000|Overall Study|Lost to Follow-up|1|||
146132931|NCT01183975|527006325|FG000|Overall Study|Lost to Follow-up|73|||
146132932|NCT02376166|527006328|FG000|Overall Study|Adverse Event|1|||
146132933|NCT02376166|527006328|FG000|Overall Study|Discontinued metformin early|2|||
146132934|NCT04180020|527006329|FG000|Overall Study|missed visit|18|||
146132935|NCT04180020|527006330|FG001|Overall Study|missed visit|16|||
146132936|NCT04180020|527006329|FG000|Overall Study|Death|2|||
146132937|NCT04180020|527006330|FG001|Overall Study|Death|3|||
146132938|NCT04180020|527006329|FG000|Overall Study|Withdrawal by Subject|1|||
146132939|NCT04180020|527006330|FG001|Overall Study|Withdrawal by Subject|5|||
146132940|NCT04180020|527006329|FG000|Overall Study|incarcerated|1|||
146132941|NCT04180020|527006330|FG001|Overall Study|incarcerated|1|||
146132942|NCT04180020|527006329|FG000|Overall Study|Physician Decision|0|||
146132943|NCT04180020|527006330|FG001|Overall Study|Physician Decision|2|||
146132944|NCT02244580|527006337|FG000|Overall Study|No cancer tissues available|241|||
146132945|NCT00811577|527006340|FG000|Overall Study|Lost to Follow-up|7|||
146132946|NCT00811577|527006341|FG001|Overall Study|Lost to Follow-up|1|||
146132947|NCT00811577|527006340|FG000|Overall Study|Withdrawal by Subject|3|||
146132948|NCT00811577|527006341|FG001|Overall Study|Withdrawal by Subject|0|||
146132949|NCT04251221|527006342|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
146132950|NCT04251221|527006343|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
146132951|NCT00329407|527006344|FG000|Overall Study|Withdrawal by Subject|1|||
146132952|NCT02357940|527006345|FG000|Overall Study|Adverse Event|0|||
146132953|NCT02357940|527006346|FG001|Overall Study|Adverse Event|1|||
146132954|NCT02357940|527006345|FG000|Overall Study|Investigator's judgement|0|||
146132955|NCT02357940|527006346|FG001|Overall Study|Investigator's judgement|1|||
146132956|NCT02442778|527006347|FG000|Overall Study|Adverse Event|2|||
146132957|NCT02442778|527006348|FG001|Overall Study|Adverse Event|6|||
146132958|NCT02442778|527006349|FG002|Overall Study|Adverse Event|6|||
146132959|NCT02442778|527006347|FG000|Overall Study|Death|0|||
146132960|NCT02442778|527006348|FG001|Overall Study|Death|2|||
146132961|NCT02442778|527006349|FG002|Overall Study|Death|0|||
146132962|NCT02442778|527006347|FG000|Overall Study|Lack of Efficacy|1|||
146132963|NCT02442778|527006348|FG001|Overall Study|Lack of Efficacy|0|||
146132964|NCT02442778|527006349|FG002|Overall Study|Lack of Efficacy|0|||
146132965|NCT02442778|527006347|FG000|Overall Study|Lost to Follow-up|1|||
146132966|NCT02442778|527006348|FG001|Overall Study|Lost to Follow-up|1|||
146132967|NCT02442778|527006349|FG002|Overall Study|Lost to Follow-up|1|||
146132968|NCT02442778|527006347|FG000|Overall Study|Non-compliance with study drug|2|||
146132969|NCT02442778|527006348|FG001|Overall Study|Non-compliance with study drug|0|||
146132970|NCT02442778|527006349|FG002|Overall Study|Non-compliance with study drug|1|||
146132971|NCT02442778|527006347|FG000|Overall Study|Physician Decision|1|||
146132972|NCT02442778|527006348|FG001|Overall Study|Physician Decision|1|||
146132973|NCT02442778|527006349|FG002|Overall Study|Physician Decision|1|||
146132974|NCT02442778|527006347|FG000|Overall Study|Protocol Deviation|3|||
146132975|NCT02442778|527006348|FG001|Overall Study|Protocol Deviation|0|||
146132976|NCT02442778|527006349|FG002|Overall Study|Protocol Deviation|1|||
146132977|NCT02442778|527006347|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
146132978|NCT02442778|527006348|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
146132979|NCT02442778|527006349|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
146132980|NCT02442778|527006347|FG000|Overall Study|Withdrawal by Subject|4|||
146132981|NCT02442778|527006348|FG001|Overall Study|Withdrawal by Subject|4|||
146132982|NCT02442778|527006349|FG002|Overall Study|Withdrawal by Subject|3|||
146132983|NCT02442778|527006347|FG000|Overall Study|Reason not specified|1|||
146132984|NCT02442778|527006348|FG001|Overall Study|Reason not specified|4|||
146132985|NCT02442778|527006349|FG002|Overall Study|Reason not specified|0|||
146132986|NCT04964128|527006352|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
146132987|NCT04964128|527006352|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
146132988|NCT02917031|527006356|FG000|Overall Study|Reason not specified|7|||
146132989|NCT02917031|527006357|FG001|Overall Study|Reason not specified|5|||
146132990|NCT02917031|527006358|FG002|Overall Study|Reason not specified|6|||
146132991|NCT02917031|527006356|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
146132992|NCT02917031|527006357|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
146132993|NCT02917031|527006358|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
146132994|NCT02917031|527006356|FG000|Overall Study|Withdrawal by Subject|3|||
146132995|NCT02917031|527006357|FG001|Overall Study|Withdrawal by Subject|3|||
146132996|NCT02917031|527006358|FG002|Overall Study|Withdrawal by Subject|0|||
146132997|NCT02917031|527006356|FG000|Overall Study|Physician Decision|1|||
146132998|NCT02917031|527006357|FG001|Overall Study|Physician Decision|0|||
146303666|NCT01660451|527625876|FG000|Overall Study|AE associated with clinical disease progression|1|||
146132999|NCT02917031|527006358|FG002|Overall Study|Physician Decision|0|||
146133000|NCT02917031|527006356|FG000|Overall Study|Adverse Event|4|||
146133001|NCT02917031|527006357|FG001|Overall Study|Adverse Event|1|||
146133002|NCT02917031|527006358|FG002|Overall Study|Adverse Event|5|||
146133003|NCT02917031|527006356|FG000|Overall Study|Death|2|||
146133004|NCT02917031|527006357|FG001|Overall Study|Death|3|||
146133005|NCT02917031|527006358|FG002|Overall Study|Death|4|||
146133006|NCT03003520|527008450|FG000|Overall Study|Adverse Event|9|||
146133007|NCT03003520|527008451|FG001|Overall Study|Adverse Event|0|||
146133008|NCT03003520|527008450|FG000|Overall Study|Death|1|||
146133009|NCT03003520|527008451|FG001|Overall Study|Death|0|||
146133010|NCT03003520|527008450|FG000|Overall Study|Other reasons|4|||
146133011|NCT03003520|527008451|FG001|Overall Study|Other reasons|0|||
146133012|NCT03003520|527008450|FG000|Overall Study|Withdrawal by Subject|6|||
146133013|NCT03003520|527008451|FG001|Overall Study|Withdrawal by Subject|0|||
146133014|NCT03003520|527008450|FG000|Overall Study|Progressive disease|9|||
146133015|NCT03003520|527008451|FG001|Overall Study|Progressive disease|1|||
146133016|NCT01914666|527008457|FG000|Treatment Period|Lack of Efficacy|0|||
146133017|NCT01914666|527008458|FG001|Treatment Period|Lack of Efficacy|0|||
146133018|NCT01914666|527008459|FG002|Treatment Period|Lack of Efficacy|2|||
146133019|NCT01914666|527008457|FG000|Treatment Period|Adverse Event|10|||
146133020|NCT01914666|527008458|FG001|Treatment Period|Adverse Event|4|||
146133021|NCT01914666|527008459|FG002|Treatment Period|Adverse Event|2|||
146133022|NCT01914666|527008457|FG000|Treatment Period|Withdrawal by Subject|3|||
146133023|NCT01914666|527008458|FG001|Treatment Period|Withdrawal by Subject|2|||
146133024|NCT01914666|527008459|FG002|Treatment Period|Withdrawal by Subject|2|||
146133025|NCT01914666|527008457|FG000|Treatment Period|Physician Decision|0|||
146133026|NCT01914666|527008458|FG001|Treatment Period|Physician Decision|0|||
146133027|NCT01914666|527008459|FG002|Treatment Period|Physician Decision|2|||
146133028|NCT00358527|527008464|FG000|Overall Study|Adverse Event|4|||
146133029|NCT00358527|527008465|FG001|Overall Study|Adverse Event|0|||
146133030|NCT00358527|527008464|FG000|Overall Study|Withdrawal by Subject|1|||
146133031|NCT00358527|527008465|FG001|Overall Study|Withdrawal by Subject|1|||
146133032|NCT00358527|527008464|FG000|Overall Study|Non-compliance with protocol|6|||
146133033|NCT00358527|527008465|FG001|Overall Study|Non-compliance with protocol|1|||
146133034|NCT00358527|527008464|FG000|Overall Study|Administrative|2|||
146133035|NCT00358527|527008465|FG001|Overall Study|Administrative|1|||
146133036|NCT00749463|527008466|FG000|Overall Study|Adverse Event|0|||
146133037|NCT00749463|527008467|FG001|Overall Study|Adverse Event|4|||
146133038|NCT00749463|527008468|FG002|Overall Study|Adverse Event|1|||
146133039|NCT00749463|527008466|FG000|Overall Study|Withdrawal by Subject|1|||
146133040|NCT00749463|527008467|FG001|Overall Study|Withdrawal by Subject|0|||
146133041|NCT00749463|527008468|FG002|Overall Study|Withdrawal by Subject|0|||
146133042|NCT00913744|527008470|FG000|Overall Study|Adverse Event|2|||
146133043|NCT00913744|527008471|FG001|Overall Study|Adverse Event|0|||
146133044|NCT00913744|527008470|FG000|Overall Study|Withdrawal by Subject|2|||
146133045|NCT00913744|527008471|FG001|Overall Study|Withdrawal by Subject|1|||
146133046|NCT00913744|527008470|FG000|Overall Study|Death|1|||
146133047|NCT00913744|527008471|FG001|Overall Study|Death|0|||
146133048|NCT01344369|527008472|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
146133049|NCT01344369|527008473|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
146133050|NCT01344369|527008472|FG000|Washout of 28 Days|Physician Decision|0|||
146133051|NCT01344369|527008473|FG001|Washout of 28 Days|Physician Decision|1|||
146133052|NCT01344369|527008472|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
146133053|NCT01344369|527008473|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
146133054|NCT01886833|527008476|FG000|Overall Study|IgA not available from both periods|204|||
146133055|NCT01454726|527008477|FG000|Overall Study|Withdrawal by Subject|0|||
146133056|NCT01454726|527008478|FG001|Overall Study|Withdrawal by Subject|1|||
146133057|NCT04200248|527008479|FG000|Overall Study|Personal reasons|0|||
146133058|NCT04200248|527008480|FG001|Overall Study|Personal reasons|0|||
146133059|NCT04200248|527008481|FG002|Overall Study|Personal reasons|1|||
146133060|NCT04200248|527008479|FG000|Overall Study|Discontinued prior to treatment|3|||
146133061|NCT04200248|527008480|FG001|Overall Study|Discontinued prior to treatment|3|||
146133062|NCT04200248|527008481|FG002|Overall Study|Discontinued prior to treatment|2|||
146133063|NCT02342704|527008484|FG000|Overall Study|Physician Decision|0|||
146133064|NCT02342704|527008485|FG001|Overall Study|Physician Decision|3|||
146133065|NCT02342704|527008484|FG000|Overall Study|Sponsor Termination|49|||
146133066|NCT02342704|527008485|FG001|Overall Study|Sponsor Termination|43|||
146133067|NCT02342704|527008484|FG000|Overall Study|Other|0|||
146133068|NCT02342704|527008485|FG001|Overall Study|Other|1|||
146133069|NCT02342704|527008484|FG000|Overall Study|Withdrawal by Subject|1|||
146133070|NCT02342704|527008485|FG001|Overall Study|Withdrawal by Subject|0|||
146133071|NCT02342704|527008484|FG000|Overall Study|Lost to Follow-up|2|||
146133072|NCT02342704|527008485|FG001|Overall Study|Lost to Follow-up|1|||
146133073|NCT02342704|527008484|FG000|Overall Study|Adverse Event|1|||
146133074|NCT02342704|527008485|FG001|Overall Study|Adverse Event|3|||
146133075|NCT00283439|527008487|FG000|Overall Study|Adverse Event|0|||
146133076|NCT00283439|527008488|FG001|Overall Study|Adverse Event|0|||
146133077|NCT00283439|527008489|FG002|Overall Study|Adverse Event|0|||
146133078|NCT00283439|527008490|FG003|Overall Study|Adverse Event|1|||
146133079|NCT00283439|527008487|FG000|Overall Study|Death|0|||
146133080|NCT00283439|527008488|FG001|Overall Study|Death|0|||
146133081|NCT00283439|527008489|FG002|Overall Study|Death|1|||
146133082|NCT00283439|527008490|FG003|Overall Study|Death|0|||
146133083|NCT00283439|527008487|FG000|Overall Study|Disease progression|0|||
146133084|NCT00283439|527008488|FG001|Overall Study|Disease progression|1|||
146133085|NCT00283439|527008489|FG002|Overall Study|Disease progression|0|||
146133086|NCT00283439|527008490|FG003|Overall Study|Disease progression|0|||
146133087|NCT00283439|527008487|FG000|Overall Study|Requirement for alternative therapy|1|||
146133088|NCT00283439|527008488|FG001|Overall Study|Requirement for alternative therapy|2|||
146133089|NCT00283439|527008489|FG002|Overall Study|Requirement for alternative therapy|5|||
146133090|NCT00283439|527008490|FG003|Overall Study|Requirement for alternative therapy|2|||
146133091|NCT00283439|527008487|FG000|Overall Study|Stem cell transplant|6|||
146133092|NCT00283439|527008488|FG001|Overall Study|Stem cell transplant|6|||
146133093|NCT00283439|527008489|FG002|Overall Study|Stem cell transplant|4|||
146133094|NCT00283439|527008490|FG003|Overall Study|Stem cell transplant|3|||
146133095|NCT00283439|527008487|FG000|Overall Study|Treatment discontinued|0|||
146133096|NCT00283439|527008488|FG001|Overall Study|Treatment discontinued|2|||
146133097|NCT00283439|527008489|FG002|Overall Study|Treatment discontinued|1|||
146133098|NCT00283439|527008490|FG003|Overall Study|Treatment discontinued|3|||
146133099|NCT00283439|527008487|FG000|Overall Study|Other|1|||
146133100|NCT00283439|527008488|FG001|Overall Study|Other|0|||
146133101|NCT00283439|527008489|FG002|Overall Study|Other|0|||
146133102|NCT00283439|527008490|FG003|Overall Study|Other|0|||
146133103|NCT00333229|527008491|FG000|Overall Study|Lack of Efficacy|0|||
146133104|NCT00333229|527008492|FG001|Overall Study|Lack of Efficacy|1|||
146133105|NCT01632891|527008495|FG000|Overall Study|Lost to Follow-up|0|||
146133106|NCT01632891|527008496|FG001|Overall Study|Lost to Follow-up|1|||
146133107|NCT01632891|527008495|FG000|Overall Study|Withdrawal by Subject|1|||
146133108|NCT01632891|527008496|FG001|Overall Study|Withdrawal by Subject|0|||
146133109|NCT00240071|527008498|FG000|Overall Study|Withdrawal by Subject|3|||
146133110|NCT02118428|527008509|FG000|Overall Study|Physician Decision|0|||
146133111|NCT02118428|527008510|FG001|Overall Study|Physician Decision|1|||
146133112|NCT02118428|527008511|FG002|Overall Study|Physician Decision|0|||
146133113|NCT02118428|527008509|FG000|Overall Study|Withdrawal by Subject|2|||
146133114|NCT02118428|527008510|FG001|Overall Study|Withdrawal by Subject|2|||
146133115|NCT02118428|527008511|FG002|Overall Study|Withdrawal by Subject|0|||
146133116|NCT02118428|527008509|FG000|Overall Study|Death|7|||
146133117|NCT02118428|527008510|FG001|Overall Study|Death|5|||
146133118|NCT02118428|527008511|FG002|Overall Study|Death|0|||
146133119|NCT02118428|527008509|FG000|Overall Study|Lost to Follow-up|3|||
146133120|NCT02118428|527008510|FG001|Overall Study|Lost to Follow-up|1|||
146133121|NCT02118428|527008511|FG002|Overall Study|Lost to Follow-up|0|||
146133122|NCT02118428|527008509|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
146133123|NCT02118428|527008510|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
146133124|NCT02118428|527008511|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
146133125|NCT00782210|527008525|FG000|Overall Study|Adverse Event|21|||
146133126|NCT00782210|527008526|FG001|Overall Study|Adverse Event|17|||
146133127|NCT00782210|527008527|FG002|Overall Study|Adverse Event|16|||
146133128|NCT00782210|527008525|FG000|Overall Study|Lost to Follow-up|2|||
146133129|NCT00782210|527008526|FG001|Overall Study|Lost to Follow-up|1|||
146133130|NCT00782210|527008527|FG002|Overall Study|Lost to Follow-up|2|||
146133131|NCT00782210|527008525|FG000|Overall Study|Withdrawal by Subject|11|||
146133132|NCT00782210|527008526|FG001|Overall Study|Withdrawal by Subject|8|||
146133133|NCT00782210|527008527|FG002|Overall Study|Withdrawal by Subject|11|||
146133134|NCT00782210|527008525|FG000|Overall Study|Non compliance with protocol|0|||
146133135|NCT00782210|527008526|FG001|Overall Study|Non compliance with protocol|3|||
146133136|NCT00782210|527008527|FG002|Overall Study|Non compliance with protocol|2|||
146133137|NCT00782210|527008525|FG000|Overall Study|Lack of Efficacy|13|||
146133138|NCT00782210|527008526|FG001|Overall Study|Lack of Efficacy|4|||
146133139|NCT00782210|527008527|FG002|Overall Study|Lack of Efficacy|1|||
146133140|NCT00782210|527008525|FG000|Overall Study|Other reason not described above|3|||
146133141|NCT00782210|527008526|FG001|Overall Study|Other reason not described above|2|||
146133142|NCT00782210|527008527|FG002|Overall Study|Other reason not described above|3|||
146133143|NCT01641367|527008528|FG000|Cohorts|Death|18|||
146264959|NCT03414047|527484628|FG003|Overall Study|Withdrawal by Subject|0|||
146264960|NCT04593823|527484629|FG000|Overall Study|Withdrawal by Subject|1|||
146264961|NCT04593823|527484630|FG001|Overall Study|Withdrawal by Subject|1|||
146133144|NCT01641367|527008529|FG001|Cohorts|Death|1|||
146133145|NCT01641367|527008530|FG002|Cohorts|Death|2|||
146133146|NCT01641367|527008531|FG003|Cohorts|Death|0|||
146133147|NCT01641367|527008532|FG004|Cohorts|Death|1|||
146133148|NCT01641367|527008533|FG005|Cohorts|Death|1|||
146133149|NCT01641367|527008534|FG006|Cohorts|Death|0|||
146133150|NCT01641367|527008535|FG007|Cohorts|Death|0|||
146133151|NCT01641367|527008528|FG000|Cohorts|Lost to Follow-up|16|||
146133152|NCT01641367|527008529|FG001|Cohorts|Lost to Follow-up|0|||
146133153|NCT01641367|527008530|FG002|Cohorts|Lost to Follow-up|2|||
146133154|NCT01641367|527008531|FG003|Cohorts|Lost to Follow-up|0|||
146133155|NCT01641367|527008532|FG004|Cohorts|Lost to Follow-up|2|||
146264962|NCT04593823|527484629|FG000|Overall Study|Lost to Follow-up|0|||
146133156|NCT01641367|527008533|FG005|Cohorts|Lost to Follow-up|0|||
146133157|NCT01641367|527008534|FG006|Cohorts|Lost to Follow-up|0|||
146133158|NCT01641367|527008535|FG007|Cohorts|Lost to Follow-up|0|||
146133159|NCT01641367|527008528|FG000|Randomized Adherence Intervention|Death|0|||
146133160|NCT01641367|527008529|FG001|Randomized Adherence Intervention|Death|0|||
146133161|NCT01641367|527008530|FG002|Randomized Adherence Intervention|Death|0|||
146133162|NCT01641367|527008531|FG003|Randomized Adherence Intervention|Death|0|||
146133163|NCT01641367|527008532|FG004|Randomized Adherence Intervention|Death|0|||
146133164|NCT01641367|527008533|FG005|Randomized Adherence Intervention|Death|0|||
146133165|NCT01641367|527008534|FG006|Randomized Adherence Intervention|Death|11|||
146133166|NCT01641367|527008535|FG007|Randomized Adherence Intervention|Death|12|||
146133167|NCT01641367|527008528|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133168|NCT01641367|527008529|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133169|NCT01641367|527008530|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133170|NCT01641367|527008531|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133171|NCT01641367|527008532|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133172|NCT01641367|527008533|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
146133173|NCT01641367|527008534|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
146133174|NCT01641367|527008535|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
146133175|NCT00654381|527008536|FG000|1st Stage|Adverse Event|3|||
146133176|NCT00654381|527008537|FG001|1st Stage|Adverse Event|3|||
146133177|NCT00654381|527008538|FG002|1st Stage|Adverse Event|3|||
146133178|NCT00654381|527008539|FG003|1st Stage|Adverse Event|3|||
146133179|NCT00654381|527008540|FG004|1st Stage|Adverse Event|2|||
146133180|NCT00654381|527008541|FG005|1st Stage|Adverse Event|1|||
146133181|NCT00654381|527008536|FG000|1st Stage|Withdrawal by Subject|0|||
146133182|NCT00654381|527008537|FG001|1st Stage|Withdrawal by Subject|0|||
146133183|NCT00654381|527008538|FG002|1st Stage|Withdrawal by Subject|0|||
146133184|NCT00654381|527008539|FG003|1st Stage|Withdrawal by Subject|1|||
146133185|NCT00654381|527008540|FG004|1st Stage|Withdrawal by Subject|0|||
146133186|NCT00654381|527008541|FG005|1st Stage|Withdrawal by Subject|1|||
146133187|NCT00654381|527008536|FG000|1st Stage|Investigator's decision|0|||
146133188|NCT00654381|527008537|FG001|1st Stage|Investigator's decision|0|||
146133189|NCT00654381|527008538|FG002|1st Stage|Investigator's decision|0|||
146133190|NCT00654381|527008539|FG003|1st Stage|Investigator's decision|1|||
146133191|NCT00654381|527008540|FG004|1st Stage|Investigator's decision|0|||
146133192|NCT00654381|527008541|FG005|1st Stage|Investigator's decision|0|||
146133193|NCT00654381|527008536|FG000|2nd Stage|Adverse Event|2|||
146133194|NCT00654381|527008537|FG001|2nd Stage|Adverse Event|0|||
146133195|NCT00654381|527008538|FG002|2nd Stage|Adverse Event|2|||
146133196|NCT00654381|527008539|FG003|2nd Stage|Adverse Event|3|||
146133197|NCT00654381|527008540|FG004|2nd Stage|Adverse Event|7|||
146133198|NCT00654381|527008541|FG005|2nd Stage|Adverse Event|2|||
146133199|NCT00654381|527008536|FG000|2nd Stage|Withdrawal by Subject|0|||
146133200|NCT00654381|527008537|FG001|2nd Stage|Withdrawal by Subject|0|||
146133201|NCT00654381|527008538|FG002|2nd Stage|Withdrawal by Subject|0|||
146133202|NCT00654381|527008539|FG003|2nd Stage|Withdrawal by Subject|0|||
146133203|NCT00654381|527008540|FG004|2nd Stage|Withdrawal by Subject|1|||
146133204|NCT00654381|527008541|FG005|2nd Stage|Withdrawal by Subject|1|||
146133205|NCT00654381|527008536|FG000|2nd Stage|Investigator's decision|0|||
146133206|NCT00654381|527008537|FG001|2nd Stage|Investigator's decision|0|||
146133207|NCT00654381|527008538|FG002|2nd Stage|Investigator's decision|1|||
146133208|NCT00654381|527008539|FG003|2nd Stage|Investigator's decision|1|||
146133209|NCT00654381|527008540|FG004|2nd Stage|Investigator's decision|0|||
146133210|NCT00654381|527008541|FG005|2nd Stage|Investigator's decision|0|||
146133211|NCT00654381|527008536|FG000|Extension Stage|Adverse Event|1|||
146133212|NCT00654381|527008537|FG001|Extension Stage|Adverse Event|2|||
146133213|NCT00654381|527008538|FG002|Extension Stage|Adverse Event|9|||
146133214|NCT00654381|527008539|FG003|Extension Stage|Adverse Event|7|||
146133215|NCT00654381|527008540|FG004|Extension Stage|Adverse Event|1|||
146133216|NCT00654381|527008541|FG005|Extension Stage|Adverse Event|1|||
146303667|NCT01660451|527625877|FG001|Overall Study|AE associated with clinical disease progression|3|||
146303668|NCT01660451|527625878|FG002|Overall Study|AE associated with clinical disease progression|11|||
146303669|NCT01660451|527625876|FG000|Overall Study|Sponsor Decision|0|||
146133217|NCT00654381|527008536|FG000|Extension Stage|Protocol Violation|0|||
146133218|NCT00654381|527008537|FG001|Extension Stage|Protocol Violation|0|||
146133219|NCT00654381|527008538|FG002|Extension Stage|Protocol Violation|0|||
146133220|NCT00654381|527008539|FG003|Extension Stage|Protocol Violation|1|||
146133221|NCT00654381|527008540|FG004|Extension Stage|Protocol Violation|0|||
146133222|NCT00654381|527008541|FG005|Extension Stage|Protocol Violation|0|||
146133223|NCT00654381|527008536|FG000|Extension Stage|Lack of Efficacy|0|||
146133224|NCT00654381|527008537|FG001|Extension Stage|Lack of Efficacy|0|||
146133225|NCT00654381|527008538|FG002|Extension Stage|Lack of Efficacy|1|||
146133226|NCT00654381|527008539|FG003|Extension Stage|Lack of Efficacy|0|||
146133227|NCT00654381|527008540|FG004|Extension Stage|Lack of Efficacy|0|||
146133228|NCT00654381|527008541|FG005|Extension Stage|Lack of Efficacy|0|||
146133229|NCT00654381|527008536|FG000|Extension Stage|Withdrawal by Subject|0|||
146133230|NCT00654381|527008537|FG001|Extension Stage|Withdrawal by Subject|0|||
146133231|NCT00654381|527008538|FG002|Extension Stage|Withdrawal by Subject|1|||
146133232|NCT00654381|527008539|FG003|Extension Stage|Withdrawal by Subject|1|||
146133233|NCT00654381|527008540|FG004|Extension Stage|Withdrawal by Subject|1|||
146133234|NCT00654381|527008541|FG005|Extension Stage|Withdrawal by Subject|1|||
146133235|NCT00654381|527008536|FG000|Extension Stage|Closure of the trial site|0|||
146133236|NCT00654381|527008537|FG001|Extension Stage|Closure of the trial site|0|||
146133237|NCT00654381|527008538|FG002|Extension Stage|Closure of the trial site|0|||
146133238|NCT00654381|527008539|FG003|Extension Stage|Closure of the trial site|0|||
146133239|NCT00654381|527008540|FG004|Extension Stage|Closure of the trial site|1|||
146133240|NCT00654381|527008541|FG005|Extension Stage|Closure of the trial site|1|||
146133241|NCT03100825|527008542|FG000|Overall Study|Participant/Guardian Decision|7|||
146133242|NCT03100825|527008542|FG000|Overall Study|Physician Decision|1|||
146133243|NCT00994448|527008544|FG000|Overall Study|Adverse Event|1|||
146133244|NCT00994448|527008545|FG001|Overall Study|Adverse Event|0|||
146133245|NCT00994448|527008544|FG000|Overall Study|Lost to Follow-up|5|||
146133246|NCT00994448|527008545|FG001|Overall Study|Lost to Follow-up|1|||
146133247|NCT00994448|527008544|FG000|Overall Study|Withdrawal by Subject|1|||
146133248|NCT00994448|527008545|FG001|Overall Study|Withdrawal by Subject|1|||
146133249|NCT00994448|527008544|FG000|Overall Study|Physician Decision|1|||
146133250|NCT00994448|527008545|FG001|Overall Study|Physician Decision|0|||
146133251|NCT04164901|527008548|FG000|Overall Study|Withdrawal by Subject|4|||
146133252|NCT04164901|527008549|FG001|Overall Study|Withdrawal by Subject|4|||
146133253|NCT05358821|527008552|FG000|Overall Study|Withdrawal by Subject|0|||
146133254|NCT05358821|527008553|FG001|Overall Study|Withdrawal by Subject|1|||
146133255|NCT05358821|527008554|FG002|Overall Study|Withdrawal by Subject|0|||
146133256|NCT05358821|527008552|FG000|Overall Study|Withdrawal of Consent|0|||
146133257|NCT05358821|527008553|FG001|Overall Study|Withdrawal of Consent|0|||
146133258|NCT05358821|527008554|FG002|Overall Study|Withdrawal of Consent|1|||
146133259|NCT00048542|527008556|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146133260|NCT00048542|527008557|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
146133261|NCT00048542|527008558|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
146133262|NCT00048542|527008559|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146133263|NCT00048542|527008560|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146133264|NCT00048542|527008561|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
146133265|NCT00048542|527008562|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
146133266|NCT00048542|527008563|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
146133267|NCT00048542|527008556|FG000|Double-Blind Phase|Protocol Violation|0|||
146133268|NCT00048542|527008557|FG001|Double-Blind Phase|Protocol Violation|0|||
146133269|NCT00048542|527008558|FG002|Double-Blind Phase|Protocol Violation|1|||
146133270|NCT00048542|527008559|FG003|Double-Blind Phase|Protocol Violation|0|||
146133271|NCT00048542|527008560|FG004|Double-Blind Phase|Protocol Violation|0|||
146133272|NCT00048542|527008561|FG005|Double-Blind Phase|Protocol Violation|0|||
146133273|NCT00048542|527008562|FG006|Double-Blind Phase|Protocol Violation|0|||
146133274|NCT00048542|527008563|FG007|Double-Blind Phase|Protocol Violation|0|||
146133275|NCT00048542|527008556|FG000|Double-Blind Phase|Sponsor request or decision|2|||
146133276|NCT00048542|527008557|FG001|Double-Blind Phase|Sponsor request or decision|0|||
146133277|NCT00048542|527008558|FG002|Double-Blind Phase|Sponsor request or decision|0|||
146133278|NCT00048542|527008559|FG003|Double-Blind Phase|Sponsor request or decision|0|||
146133279|NCT00048542|527008560|FG004|Double-Blind Phase|Sponsor request or decision|0|||
146133280|NCT00048542|527008561|FG005|Double-Blind Phase|Sponsor request or decision|0|||
146133281|NCT00048542|527008562|FG006|Double-Blind Phase|Sponsor request or decision|0|||
146133282|NCT00048542|527008563|FG007|Double-Blind Phase|Sponsor request or decision|0|||
146133283|NCT00048542|527008556|FG000|Double-Blind Phase|Randomized in error|1|||
146133284|NCT00048542|527008557|FG001|Double-Blind Phase|Randomized in error|0|||
146133285|NCT00048542|527008558|FG002|Double-Blind Phase|Randomized in error|0|||
146133286|NCT00048542|527008559|FG003|Double-Blind Phase|Randomized in error|0|||
146133287|NCT00048542|527008560|FG004|Double-Blind Phase|Randomized in error|0|||
146133288|NCT00048542|527008561|FG005|Double-Blind Phase|Randomized in error|0|||
146133289|NCT00048542|527008562|FG006|Double-Blind Phase|Randomized in error|0|||
146133290|NCT00048542|527008563|FG007|Double-Blind Phase|Randomized in error|0|||
146133291|NCT00048542|527008556|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133292|NCT00048542|527008557|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133293|NCT00048542|527008558|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133294|NCT00048542|527008559|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133295|NCT00048542|527008560|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
146133296|NCT00048542|527008561|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
146133297|NCT00048542|527008562|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133298|NCT00048542|527008563|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
146133299|NCT00048542|527008556|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133300|NCT00048542|527008557|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133301|NCT00048542|527008558|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133302|NCT00048542|527008559|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133303|NCT00048542|527008560|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133304|NCT00048542|527008561|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
146133305|NCT00048542|527008562|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133306|NCT00048542|527008563|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
146133307|NCT00048542|527008556|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133308|NCT00048542|527008557|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133309|NCT00048542|527008558|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133310|NCT00048542|527008559|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133311|NCT00048542|527008560|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
146133312|NCT00048542|527008561|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
146133313|NCT00048542|527008562|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133314|NCT00048542|527008563|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
146133315|NCT00048542|527008556|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
146133316|NCT00048542|527008557|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
146133317|NCT00048542|527008558|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
146133318|NCT00048542|527008559|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
146133319|NCT00048542|527008560|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
146133320|NCT00048542|527008561|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
146133321|NCT00048542|527008562|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
146133322|NCT00048542|527008563|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
146133323|NCT00048542|527008556|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133324|NCT00048542|527008557|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133325|NCT00048542|527008558|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133326|NCT00048542|527008559|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133327|NCT00048542|527008560|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
146133328|NCT00048542|527008561|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
146133329|NCT00048542|527008562|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133330|NCT00048542|527008563|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
146133331|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133332|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133333|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133334|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133335|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133336|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
146133337|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
146133338|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
146133339|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133340|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133341|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133342|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133343|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133344|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
146133345|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
146133346|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
146133347|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133348|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133349|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133350|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133351|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133352|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
146133353|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
146133354|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
146133355|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133356|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133357|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133358|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133359|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133360|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
146133361|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
146133362|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
146133363|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133364|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133365|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133366|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133367|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133368|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
146133369|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
146133370|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
146133371|NCT00048542|527008556|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133372|NCT00048542|527008557|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133373|NCT00048542|527008558|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133374|NCT00048542|527008559|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133375|NCT00048542|527008560|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133376|NCT00048542|527008561|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
146133377|NCT00048542|527008562|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
146133378|NCT00048542|527008563|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
146133379|NCT04098458|527008567|FG000|Overall Study|Death|1|||
146133380|NCT04098458|527008567|FG000|Overall Study|did not meet study inclusion criteria|3|||
146133381|NCT00006489|527008568|FG000|Overall Study|Adverse Event|3|||
146133382|NCT00006489|527008569|FG001|Overall Study|Adverse Event|2|||
146133383|NCT00006489|527008570|FG002|Overall Study|Adverse Event|4|||
146133384|NCT00006489|527008571|FG003|Overall Study|Adverse Event|3|||
146133385|NCT00006489|527008568|FG000|Overall Study|Withdrawal by Subject|10|||
146133386|NCT00006489|527008569|FG001|Overall Study|Withdrawal by Subject|9|||
146133387|NCT00006489|527008570|FG002|Overall Study|Withdrawal by Subject|9|||
146133388|NCT00006489|527008571|FG003|Overall Study|Withdrawal by Subject|6|||
146133389|NCT00006489|527008568|FG000|Overall Study|Scheduling Conflict|0|||
146133390|NCT00006489|527008569|FG001|Overall Study|Scheduling Conflict|3|||
146133391|NCT00006489|527008570|FG002|Overall Study|Scheduling Conflict|2|||
146133392|NCT00006489|527008571|FG003|Overall Study|Scheduling Conflict|1|||
146133393|NCT00006489|527008568|FG000|Overall Study|Death|0|||
146133394|NCT00006489|527008569|FG001|Overall Study|Death|0|||
146133395|NCT00006489|527008570|FG002|Overall Study|Death|0|||
146133396|NCT00006489|527008571|FG003|Overall Study|Death|1|||
146133397|NCT00578175|527008572|FG000|Overall Study|Adverse Event|0|||
146133398|NCT00578175|527008573|FG001|Overall Study|Adverse Event|1|||
146133399|NCT00578175|527008574|FG002|Overall Study|Adverse Event|1|||
146133400|NCT00578175|527008572|FG000|Overall Study|Other reasons|70|||
146133401|NCT00578175|527008573|FG001|Overall Study|Other reasons|42|||
146133402|NCT00578175|527008574|FG002|Overall Study|Other reasons|23|||
146133403|NCT01869192|527008575|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
146133404|NCT01869192|527008576|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
146133405|NCT01869192|527008575|FG000|Postoperative Chemotherapy|Physician Decision|0|||
146133406|NCT01869192|527008576|FG001|Postoperative Chemotherapy|Physician Decision|2|||
146133407|NCT01479621|527008584|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
146133408|NCT01479621|527008585|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133409|NCT01479621|527008586|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133410|NCT01479621|527008587|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133411|NCT01479621|527008588|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133412|NCT01479621|527008589|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133413|NCT01479621|527008590|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
146133414|NCT01479621|527008584|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
146133415|NCT01479621|527008585|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133416|NCT01479621|527008586|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133417|NCT01479621|527008587|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133418|NCT01479621|527008588|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133419|NCT01479621|527008589|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133420|NCT01479621|527008590|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
146133421|NCT01479621|527008584|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
146133422|NCT01479621|527008585|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133423|NCT01479621|527008586|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133424|NCT01479621|527008587|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133425|NCT01479621|527008588|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133426|NCT01479621|527008589|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133427|NCT01479621|527008590|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
146133428|NCT01479621|527008584|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
146133429|NCT01479621|527008585|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146264963|NCT04593823|527484630|FG001|Overall Study|Lost to Follow-up|1|||
146264964|NCT01704547|527484632|FG000|Overall Study|Physician Decision|4|||
146264965|NCT01704547|527484632|FG000|Overall Study|Withdrawal by Subject|1|||
146264966|NCT02413593|527484635|FG000|Overall Study|Lost to Follow-up|3|||
146264967|NCT02413593|527484635|FG000|Overall Study|Adverse Event|1|||
146264968|NCT02569957|527484636|FG000|Overall Study|Withdrawal by Subject|0|||
146264969|NCT02569957|527484637|FG001|Overall Study|Withdrawal by Subject|1|||
146264970|NCT02635386|527484638|FG000|Overall Study|Pregnancy|2|||
146264971|NCT02635386|527484639|FG001|Overall Study|Pregnancy|0|||
146264972|NCT02635386|527484640|FG002|Overall Study|Pregnancy|0|||
146264973|NCT02635386|527484641|FG003|Overall Study|Pregnancy|0|||
146133430|NCT01479621|527008586|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146133431|NCT01479621|527008587|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146133432|NCT01479621|527008588|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146133433|NCT01479621|527008589|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146133434|NCT01479621|527008590|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
146133435|NCT01479621|527008584|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
146133436|NCT01479621|527008585|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133437|NCT01479621|527008586|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133438|NCT01479621|527008587|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133439|NCT01479621|527008588|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133440|NCT01479621|527008589|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133441|NCT01479621|527008590|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
146133442|NCT01479621|527008584|FG000|Treatment Period|Adverse Event|0|||
146133443|NCT01479621|527008585|FG001|Treatment Period|Adverse Event|0|||
146133444|NCT01479621|527008586|FG002|Treatment Period|Adverse Event|0|||
146133445|NCT01479621|527008587|FG003|Treatment Period|Adverse Event|0|||
146133446|NCT01479621|527008588|FG004|Treatment Period|Adverse Event|1|||
146133447|NCT01479621|527008589|FG005|Treatment Period|Adverse Event|2|||
146133448|NCT01479621|527008590|FG006|Treatment Period|Adverse Event|2|||
146133449|NCT01479621|527008584|FG000|Treatment Period|Withdrawal by Subject|0|||
146133450|NCT01479621|527008585|FG001|Treatment Period|Withdrawal by Subject|4|||
146133451|NCT01479621|527008586|FG002|Treatment Period|Withdrawal by Subject|2|||
146133452|NCT01479621|527008587|FG003|Treatment Period|Withdrawal by Subject|2|||
146133453|NCT01479621|527008588|FG004|Treatment Period|Withdrawal by Subject|5|||
146133454|NCT01479621|527008589|FG005|Treatment Period|Withdrawal by Subject|5|||
146133455|NCT01479621|527008590|FG006|Treatment Period|Withdrawal by Subject|1|||
146133456|NCT01479621|527008584|FG000|Treatment Period|Physician Decision|0|||
146133457|NCT01479621|527008585|FG001|Treatment Period|Physician Decision|0|||
146133458|NCT01479621|527008586|FG002|Treatment Period|Physician Decision|0|||
146133459|NCT01479621|527008587|FG003|Treatment Period|Physician Decision|0|||
146133460|NCT01479621|527008588|FG004|Treatment Period|Physician Decision|1|||
146133461|NCT01479621|527008589|FG005|Treatment Period|Physician Decision|1|||
146133462|NCT01479621|527008590|FG006|Treatment Period|Physician Decision|0|||
146133463|NCT01479621|527008584|FG000|Treatment Period|Non-compliance to study drug|0|||
146133464|NCT01479621|527008585|FG001|Treatment Period|Non-compliance to study drug|1|||
146133465|NCT01479621|527008586|FG002|Treatment Period|Non-compliance to study drug|0|||
146133466|NCT01479621|527008587|FG003|Treatment Period|Non-compliance to study drug|0|||
146133467|NCT01479621|527008588|FG004|Treatment Period|Non-compliance to study drug|0|||
146133468|NCT01479621|527008589|FG005|Treatment Period|Non-compliance to study drug|0|||
146133469|NCT01479621|527008590|FG006|Treatment Period|Non-compliance to study drug|1|||
146133470|NCT01479621|527008584|FG000|Treatment Period|Protocol Violation|0|||
146133471|NCT01479621|527008585|FG001|Treatment Period|Protocol Violation|9|||
146133472|NCT01479621|527008586|FG002|Treatment Period|Protocol Violation|6|||
146133473|NCT01479621|527008587|FG003|Treatment Period|Protocol Violation|5|||
146133474|NCT01479621|527008588|FG004|Treatment Period|Protocol Violation|2|||
146133475|NCT01479621|527008589|FG005|Treatment Period|Protocol Violation|10|||
146133476|NCT01479621|527008590|FG006|Treatment Period|Protocol Violation|6|||
146133477|NCT01479621|527008584|FG000|Treatment Period|Pregnancy|0|||
146133478|NCT01479621|527008585|FG001|Treatment Period|Pregnancy|0|||
146133479|NCT01479621|527008586|FG002|Treatment Period|Pregnancy|2|||
146133480|NCT01479621|527008587|FG003|Treatment Period|Pregnancy|0|||
146133481|NCT01479621|527008588|FG004|Treatment Period|Pregnancy|0|||
146133482|NCT01479621|527008589|FG005|Treatment Period|Pregnancy|0|||
146133483|NCT01479621|527008590|FG006|Treatment Period|Pregnancy|0|||
146133484|NCT01479621|527008584|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
146133485|NCT01479621|527008585|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
146133486|NCT01479621|527008586|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
146133487|NCT01479621|527008587|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
146133488|NCT01479621|527008588|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
146133489|NCT01479621|527008589|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
146133490|NCT01479621|527008590|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
146133491|NCT01479621|527008584|FG000|Treatment Period|Lost to Follow-up|0|||
146133492|NCT01479621|527008585|FG001|Treatment Period|Lost to Follow-up|0|||
146133493|NCT01479621|527008586|FG002|Treatment Period|Lost to Follow-up|1|||
146133494|NCT01479621|527008587|FG003|Treatment Period|Lost to Follow-up|0|||
146133495|NCT01479621|527008588|FG004|Treatment Period|Lost to Follow-up|2|||
146133496|NCT01479621|527008589|FG005|Treatment Period|Lost to Follow-up|2|||
146133497|NCT01479621|527008590|FG006|Treatment Period|Lost to Follow-up|1|||
146133498|NCT01479621|527008584|FG000|Treatment Period|Met stopping criteria|0|||
146133499|NCT01479621|527008585|FG001|Treatment Period|Met stopping criteria|8|||
146133500|NCT01479621|527008586|FG002|Treatment Period|Met stopping criteria|7|||
146133501|NCT01479621|527008587|FG003|Treatment Period|Met stopping criteria|4|||
146133502|NCT01479621|527008588|FG004|Treatment Period|Met stopping criteria|9|||
146133503|NCT01479621|527008589|FG005|Treatment Period|Met stopping criteria|20|||
146133504|NCT01479621|527008590|FG006|Treatment Period|Met stopping criteria|6|||
146133505|NCT04225923|527008595|FG000|Overall Study|Protocol Violation|1|||
146133506|NCT04225923|527008596|FG001|Overall Study|Protocol Violation|0|||
146133507|NCT04225923|527008597|FG002|Overall Study|Protocol Violation|1|||
146133508|NCT04225923|527008595|FG000|Overall Study|Withdrawal by Subject|4|||
146133509|NCT04225923|527008596|FG001|Overall Study|Withdrawal by Subject|1|||
146133510|NCT04225923|527008597|FG002|Overall Study|Withdrawal by Subject|3|||
146133511|NCT04225923|527008595|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
146133512|NCT04225923|527008596|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
146133513|NCT04225923|527008597|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
146133514|NCT00855309|527008598|FG000|Overall Study|patient never recieved drug|1|||
146133515|NCT00855309|527008599|FG001|Overall Study|patient never recieved drug|0|||
146133516|NCT01228747|527008604|FG000|Overall Study|Adverse Event|8|||
146133517|NCT01228747|527008605|FG001|Overall Study|Adverse Event|4|||
146133518|NCT01228747|527008604|FG000|Overall Study|Lack of Efficacy|40|||
146133519|NCT01228747|527008605|FG001|Overall Study|Lack of Efficacy|27|||
146133520|NCT01228747|527008604|FG000|Overall Study|Protocol Violation|6|||
146133521|NCT01228747|527008605|FG001|Overall Study|Protocol Violation|5|||
146133522|NCT01228747|527008604|FG000|Overall Study|Lost to Follow-up|4|||
146133523|NCT01228747|527008605|FG001|Overall Study|Lost to Follow-up|3|||
146133524|NCT01228747|527008604|FG000|Overall Study|Withdrawal by Subject|5|||
146133525|NCT01228747|527008605|FG001|Overall Study|Withdrawal by Subject|1|||
146133526|NCT01228747|527008604|FG000|Overall Study|Other Reason|2|||
146133527|NCT01228747|527008605|FG001|Overall Study|Other Reason|5|||
146133528|NCT02036502|527008606|FG000|Part 1:Dose Determination/Escalation|Death|3|||
146133529|NCT02036502|527008607|FG001|Part 1:Dose Determination/Escalation|Death|2|||
146133530|NCT02036502|527008608|FG002|Part 1:Dose Determination/Escalation|Death|0|||
146133531|NCT02036502|527008609|FG003|Part 1:Dose Determination/Escalation|Death|0|||
146133532|NCT02036502|527008610|FG004|Part 1:Dose Determination/Escalation|Death|0|||
146133533|NCT02036502|527008611|FG005|Part 1:Dose Determination/Escalation|Death|0|||
146133534|NCT02036502|527008612|FG006|Part 1:Dose Determination/Escalation|Death|0|||
146133535|NCT02036502|527008613|FG007|Part 1:Dose Determination/Escalation|Death|0|||
146133536|NCT02036502|527008606|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
146133537|NCT02036502|527008607|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133538|NCT02036502|527008608|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133539|NCT02036502|527008609|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133540|NCT02036502|527008610|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133541|NCT02036502|527008611|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133542|NCT02036502|527008612|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133543|NCT02036502|527008613|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
146133544|NCT02036502|527008606|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133545|NCT02036502|527008607|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
146133546|NCT02036502|527008608|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133547|NCT02036502|527008609|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133548|NCT02036502|527008610|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133549|NCT02036502|527008611|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133550|NCT02036502|527008612|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133551|NCT02036502|527008613|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
146133552|NCT02036502|527008606|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
146133553|NCT02036502|527008607|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
146133554|NCT02036502|527008608|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
146133555|NCT02036502|527008609|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
146133556|NCT02036502|527008610|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
146133557|NCT02036502|527008611|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
146133558|NCT02036502|527008612|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
146133559|NCT02036502|527008613|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
146133560|NCT02036502|527008606|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146133561|NCT02036502|527008607|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146133562|NCT02036502|527008608|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
146133563|NCT02036502|527008609|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
146133564|NCT02036502|527008610|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
146133565|NCT02036502|527008611|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146133566|NCT02036502|527008612|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146133567|NCT02036502|527008613|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
146133568|NCT02036502|527008606|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133569|NCT02036502|527008607|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133570|NCT02036502|527008608|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
146133571|NCT02036502|527008609|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133572|NCT02036502|527008610|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133573|NCT02036502|527008611|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133574|NCT02036502|527008612|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133575|NCT02036502|527008613|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
146133576|NCT02036502|527008606|FG000|Part 2:Dose Confirmation|Death|0|||
146133577|NCT02036502|527008607|FG001|Part 2:Dose Confirmation|Death|0|||
146133578|NCT02036502|527008608|FG002|Part 2:Dose Confirmation|Death|1|||
146133579|NCT02036502|527008609|FG003|Part 2:Dose Confirmation|Death|0|||
146133580|NCT02036502|527008610|FG004|Part 2:Dose Confirmation|Death|0|||
146133581|NCT02036502|527008611|FG005|Part 2:Dose Confirmation|Death|0|||
146133582|NCT02036502|527008612|FG006|Part 2:Dose Confirmation|Death|0|||
146133583|NCT02036502|527008613|FG007|Part 2:Dose Confirmation|Death|0|||
146133584|NCT02036502|527008606|FG000|Part 2:Dose Confirmation|Not treated|0|||
146133585|NCT02036502|527008607|FG001|Part 2:Dose Confirmation|Not treated|0|||
146133586|NCT02036502|527008608|FG002|Part 2:Dose Confirmation|Not treated|0|||
146133587|NCT02036502|527008609|FG003|Part 2:Dose Confirmation|Not treated|1|||
146133588|NCT02036502|527008610|FG004|Part 2:Dose Confirmation|Not treated|0|||
146133589|NCT02036502|527008611|FG005|Part 2:Dose Confirmation|Not treated|0|||
146133590|NCT02036502|527008612|FG006|Part 2:Dose Confirmation|Not treated|0|||
146133591|NCT02036502|527008613|FG007|Part 2:Dose Confirmation|Not treated|0|||
146133592|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Adverse Event|0|||
146133593|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Adverse Event|0|||
146133594|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Adverse Event|0|||
146133595|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Adverse Event|0|||
146133596|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Adverse Event|0|||
146133597|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Adverse Event|4|||
146133598|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Adverse Event|0|||
146133599|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Adverse Event|2|||
146133600|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Death|0|||
146133601|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Death|0|||
146133602|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Death|0|||
146133603|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Death|0|||
146133604|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Death|0|||
146133605|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Death|24|||
146133606|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Death|0|||
146133607|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Death|3|||
146133608|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133609|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133610|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133611|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133612|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133613|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133614|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
146133615|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
146133616|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Physician Decision|0|||
146133617|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Physician Decision|0|||
146133618|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Physician Decision|0|||
146133619|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Physician Decision|0|||
146133620|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Physician Decision|0|||
146133621|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Physician Decision|1|||
146133622|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Physician Decision|0|||
146133623|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Physician Decision|0|||
146133624|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
146133625|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
146133626|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
146133627|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
146133628|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
146133629|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
146133630|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
146133631|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
146133632|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146133633|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146133634|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146133635|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146133636|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146264974|NCT02635386|527484642|FG004|Overall Study|Pregnancy|2|||
146264975|NCT02635386|527484638|FG000|Overall Study|Withdrawal by Subject|1|||
146133637|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
146264976|NCT02635386|527484639|FG001|Overall Study|Withdrawal by Subject|1|||
146133638|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
146133639|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
146133640|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146133641|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146133642|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146133643|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146133644|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
146133645|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
146133646|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
146133647|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
146133648|NCT02036502|527008606|FG000|Part 3:Dose Expansion|Not Treated|0|||
146133649|NCT02036502|527008607|FG001|Part 3:Dose Expansion|Not Treated|0|||
146133650|NCT02036502|527008608|FG002|Part 3:Dose Expansion|Not Treated|0|||
146133651|NCT02036502|527008609|FG003|Part 3:Dose Expansion|Not Treated|0|||
146133652|NCT02036502|527008610|FG004|Part 3:Dose Expansion|Not Treated|0|||
146133653|NCT02036502|527008611|FG005|Part 3:Dose Expansion|Not Treated|2|||
146133654|NCT02036502|527008612|FG006|Part 3:Dose Expansion|Not Treated|0|||
146133655|NCT02036502|527008613|FG007|Part 3:Dose Expansion|Not Treated|0|||
146133656|NCT01068509|527008616|FG000|Overall Study|Death|0|||
146133657|NCT01068509|527008617|FG001|Overall Study|Death|0|||
146133658|NCT01068509|527008618|FG002|Overall Study|Death|1|||
146133659|NCT01068509|527008616|FG000|Overall Study|Disease Progression|5|||
146133660|NCT01068509|527008617|FG001|Overall Study|Disease Progression|20|||
146133661|NCT01068509|527008618|FG002|Overall Study|Disease Progression|18|||
146133662|NCT01068509|527008616|FG000|Overall Study|Lost to Follow-up|1|||
146133663|NCT01068509|527008617|FG001|Overall Study|Lost to Follow-up|0|||
146133664|NCT01068509|527008618|FG002|Overall Study|Lost to Follow-up|0|||
146133665|NCT01068509|527008616|FG000|Overall Study|Withdrew Consent|0|||
146133666|NCT01068509|527008617|FG001|Overall Study|Withdrew Consent|1|||
146133667|NCT01068509|527008618|FG002|Overall Study|Withdrew Consent|2|||
146133668|NCT01068509|527008616|FG000|Overall Study|Reason Not Specified|0|||
146133669|NCT01068509|527008617|FG001|Overall Study|Reason Not Specified|1|||
146133670|NCT01068509|527008618|FG002|Overall Study|Reason Not Specified|0|||
146133671|NCT01165138|527008623|FG000|Overall Study|Adverse Event|0|||
146133672|NCT01165138|527008624|FG001|Overall Study|Adverse Event|1|||
146133673|NCT01165138|527008625|FG002|Overall Study|Adverse Event|0|||
146133674|NCT01165138|527008626|FG003|Overall Study|Adverse Event|2|||
146133675|NCT01165138|527008623|FG000|Overall Study|Lack of Efficacy|0|||
146133676|NCT01165138|527008624|FG001|Overall Study|Lack of Efficacy|32|||
146133677|NCT01165138|527008625|FG002|Overall Study|Lack of Efficacy|6|||
146133678|NCT01165138|527008626|FG003|Overall Study|Lack of Efficacy|7|||
146133679|NCT01165138|527008623|FG000|Overall Study|Protocol Violation|0|||
146133680|NCT01165138|527008624|FG001|Overall Study|Protocol Violation|7|||
146133681|NCT01165138|527008625|FG002|Overall Study|Protocol Violation|0|||
146133682|NCT01165138|527008626|FG003|Overall Study|Protocol Violation|2|||
146133683|NCT01165138|527008623|FG000|Overall Study|Lost to Follow-up|0|||
146133684|NCT01165138|527008624|FG001|Overall Study|Lost to Follow-up|0|||
146133685|NCT01165138|527008625|FG002|Overall Study|Lost to Follow-up|1|||
146133686|NCT01165138|527008626|FG003|Overall Study|Lost to Follow-up|2|||
146133687|NCT01165138|527008623|FG000|Overall Study|Physician Decision|0|||
146133688|NCT01165138|527008624|FG001|Overall Study|Physician Decision|6|||
146133689|NCT01165138|527008625|FG002|Overall Study|Physician Decision|7|||
146133690|NCT01165138|527008626|FG003|Overall Study|Physician Decision|6|||
146133691|NCT01165138|527008623|FG000|Overall Study|Withdrawal by Subject|0|||
146133692|NCT01165138|527008624|FG001|Overall Study|Withdrawal by Subject|6|||
146133693|NCT01165138|527008625|FG002|Overall Study|Withdrawal by Subject|6|||
146133694|NCT01165138|527008626|FG003|Overall Study|Withdrawal by Subject|3|||
146133695|NCT02641379|527008627|FG000|Overall Study|Exclusion criterion during screening|1|||
146133696|NCT02641379|527008628|FG001|Overall Study|Exclusion criterion during screening|0|||
146133697|NCT02641379|527008629|FG002|Overall Study|Exclusion criterion during screening|0|||
146133698|NCT02641379|527008630|FG003|Overall Study|Exclusion criterion during screening|1|||
146133699|NCT02641379|527008631|FG004|Overall Study|Exclusion criterion during screening|2|||
146133700|NCT02641379|527008632|FG005|Overall Study|Exclusion criterion during screening|0|||
146133701|NCT02641379|527008633|FG006|Overall Study|Exclusion criterion during screening|0|||
146133702|NCT02641379|527008634|FG007|Overall Study|Exclusion criterion during screening|0|||
146133703|NCT02641379|527008635|FG008|Overall Study|Exclusion criterion during screening|0|||
146133704|NCT02641379|527008636|FG009|Overall Study|Exclusion criterion during screening|0|||
146133705|NCT02641379|527008637|FG010|Overall Study|Exclusion criterion during screening|0|||
146133706|NCT02641379|527008627|FG000|Overall Study|Withdrawal of informed consent|0|||
146133707|NCT02641379|527008628|FG001|Overall Study|Withdrawal of informed consent|1|||
146133708|NCT02641379|527008629|FG002|Overall Study|Withdrawal of informed consent|0|||
146133709|NCT02641379|527008630|FG003|Overall Study|Withdrawal of informed consent|0|||
146133710|NCT02641379|527008631|FG004|Overall Study|Withdrawal of informed consent|0|||
146133711|NCT02641379|527008632|FG005|Overall Study|Withdrawal of informed consent|0|||
146303670|NCT01660451|527625877|FG001|Overall Study|Sponsor Decision|0|||
146133712|NCT02641379|527008633|FG006|Overall Study|Withdrawal of informed consent|0|||
146133713|NCT02641379|527008634|FG007|Overall Study|Withdrawal of informed consent|1|||
146133714|NCT02641379|527008635|FG008|Overall Study|Withdrawal of informed consent|0|||
146133715|NCT02641379|527008636|FG009|Overall Study|Withdrawal of informed consent|0|||
146133716|NCT02641379|527008637|FG010|Overall Study|Withdrawal of informed consent|0|||
146133717|NCT02641379|527008627|FG000|Overall Study|Adverse Event|7|||
146133718|NCT02641379|527008628|FG001|Overall Study|Adverse Event|8|||
146133719|NCT02641379|527008629|FG002|Overall Study|Adverse Event|2|||
146133720|NCT02641379|527008630|FG003|Overall Study|Adverse Event|2|||
146133721|NCT02641379|527008631|FG004|Overall Study|Adverse Event|5|||
146133722|NCT02641379|527008632|FG005|Overall Study|Adverse Event|1|||
146133723|NCT02641379|527008633|FG006|Overall Study|Adverse Event|5|||
146133724|NCT02641379|527008634|FG007|Overall Study|Adverse Event|0|||
146133725|NCT02641379|527008635|FG008|Overall Study|Adverse Event|1|||
146133726|NCT02641379|527008636|FG009|Overall Study|Adverse Event|1|||
146133727|NCT02641379|527008637|FG010|Overall Study|Adverse Event|5|||
146133728|NCT02641379|527008627|FG000|Overall Study|Lack of Efficacy|0|||
146133729|NCT02641379|527008628|FG001|Overall Study|Lack of Efficacy|0|||
146133730|NCT02641379|527008629|FG002|Overall Study|Lack of Efficacy|2|||
146133731|NCT02641379|527008630|FG003|Overall Study|Lack of Efficacy|0|||
146133732|NCT02641379|527008631|FG004|Overall Study|Lack of Efficacy|0|||
146133733|NCT02641379|527008632|FG005|Overall Study|Lack of Efficacy|2|||
146133734|NCT02641379|527008633|FG006|Overall Study|Lack of Efficacy|0|||
146133735|NCT02641379|527008634|FG007|Overall Study|Lack of Efficacy|5|||
146133736|NCT02641379|527008635|FG008|Overall Study|Lack of Efficacy|0|||
146133737|NCT02641379|527008636|FG009|Overall Study|Lack of Efficacy|0|||
146133738|NCT02641379|527008637|FG010|Overall Study|Lack of Efficacy|0|||
146133739|NCT02641379|527008627|FG000|Overall Study|Participant unable to attend study visit|4|||
146133740|NCT02641379|527008628|FG001|Overall Study|Participant unable to attend study visit|10|||
146133741|NCT02641379|527008629|FG002|Overall Study|Participant unable to attend study visit|1|||
146133742|NCT02641379|527008630|FG003|Overall Study|Participant unable to attend study visit|2|||
146133743|NCT02641379|527008631|FG004|Overall Study|Participant unable to attend study visit|5|||
146133744|NCT02641379|527008632|FG005|Overall Study|Participant unable to attend study visit|1|||
146133745|NCT02641379|527008633|FG006|Overall Study|Participant unable to attend study visit|1|||
146133746|NCT02641379|527008634|FG007|Overall Study|Participant unable to attend study visit|1|||
146133747|NCT02641379|527008635|FG008|Overall Study|Participant unable to attend study visit|0|||
146133748|NCT02641379|527008636|FG009|Overall Study|Participant unable to attend study visit|2|||
146133749|NCT02641379|527008637|FG010|Overall Study|Participant unable to attend study visit|0|||
146133750|NCT02641379|527008627|FG000|Overall Study|Participant's compliance|0|||
146133751|NCT02641379|527008628|FG001|Overall Study|Participant's compliance|1|||
146133752|NCT02641379|527008629|FG002|Overall Study|Participant's compliance|0|||
146133753|NCT02641379|527008630|FG003|Overall Study|Participant's compliance|1|||
146133754|NCT02641379|527008631|FG004|Overall Study|Participant's compliance|0|||
146133755|NCT02641379|527008632|FG005|Overall Study|Participant's compliance|2|||
146133756|NCT02641379|527008633|FG006|Overall Study|Participant's compliance|0|||
146133757|NCT02641379|527008634|FG007|Overall Study|Participant's compliance|0|||
146133758|NCT02641379|527008635|FG008|Overall Study|Participant's compliance|1|||
146133759|NCT02641379|527008636|FG009|Overall Study|Participant's compliance|1|||
146133760|NCT02641379|527008637|FG010|Overall Study|Participant's compliance|1|||
146133761|NCT02641379|527008627|FG000|Overall Study|Participant cannot be reached|4|||
146133762|NCT02641379|527008628|FG001|Overall Study|Participant cannot be reached|4|||
146133763|NCT02641379|527008629|FG002|Overall Study|Participant cannot be reached|0|||
146133764|NCT02641379|527008630|FG003|Overall Study|Participant cannot be reached|8|||
146133765|NCT02641379|527008631|FG004|Overall Study|Participant cannot be reached|2|||
146133766|NCT02641379|527008632|FG005|Overall Study|Participant cannot be reached|1|||
146133767|NCT02641379|527008633|FG006|Overall Study|Participant cannot be reached|0|||
146133768|NCT02641379|527008634|FG007|Overall Study|Participant cannot be reached|1|||
146133769|NCT02641379|527008635|FG008|Overall Study|Participant cannot be reached|0|||
146133770|NCT02641379|527008636|FG009|Overall Study|Participant cannot be reached|2|||
146133771|NCT02641379|527008637|FG010|Overall Study|Participant cannot be reached|1|||
146133772|NCT02641379|527008627|FG000|Overall Study|PCR positive at Week 24|15|||
146133773|NCT02641379|527008628|FG001|Overall Study|PCR positive at Week 24|21|||
146133774|NCT02641379|527008629|FG002|Overall Study|PCR positive at Week 24|62|||
146133775|NCT02641379|527008630|FG003|Overall Study|PCR positive at Week 24|0|||
146133776|NCT02641379|527008631|FG004|Overall Study|PCR positive at Week 24|0|||
146133777|NCT02641379|527008632|FG005|Overall Study|PCR positive at Week 24|6|||
146133778|NCT02641379|527008633|FG006|Overall Study|PCR positive at Week 24|3|||
146133779|NCT02641379|527008634|FG007|Overall Study|PCR positive at Week 24|8|||
146133780|NCT02641379|527008635|FG008|Overall Study|PCR positive at Week 24|0|||
146133781|NCT02641379|527008636|FG009|Overall Study|PCR positive at Week 24|1|||
146133782|NCT02641379|527008637|FG010|Overall Study|PCR positive at Week 24|0|||
146133783|NCT02641379|527008627|FG000|Overall Study|PCR positive at follow up 2|1|||
146133784|NCT02641379|527008628|FG001|Overall Study|PCR positive at follow up 2|0|||
146133785|NCT02641379|527008629|FG002|Overall Study|PCR positive at follow up 2|0|||
146133786|NCT02641379|527008630|FG003|Overall Study|PCR positive at follow up 2|0|||
146133787|NCT02641379|527008631|FG004|Overall Study|PCR positive at follow up 2|0|||
146133788|NCT02641379|527008632|FG005|Overall Study|PCR positive at follow up 2|0|||
146133789|NCT02641379|527008633|FG006|Overall Study|PCR positive at follow up 2|0|||
146133790|NCT02641379|527008634|FG007|Overall Study|PCR positive at follow up 2|0|||
146133791|NCT02641379|527008635|FG008|Overall Study|PCR positive at follow up 2|0|||
146133792|NCT02641379|527008636|FG009|Overall Study|PCR positive at follow up 2|0|||
146133793|NCT02641379|527008637|FG010|Overall Study|PCR positive at follow up 2|0|||
146133794|NCT02641379|527008627|FG000|Overall Study|Participant showed relapse|1|||
146133795|NCT02641379|527008628|FG001|Overall Study|Participant showed relapse|0|||
146133796|NCT02641379|527008629|FG002|Overall Study|Participant showed relapse|0|||
146133797|NCT02641379|527008630|FG003|Overall Study|Participant showed relapse|0|||
146133798|NCT02641379|527008631|FG004|Overall Study|Participant showed relapse|0|||
146133799|NCT02641379|527008632|FG005|Overall Study|Participant showed relapse|0|||
146133800|NCT02641379|527008633|FG006|Overall Study|Participant showed relapse|1|||
146133801|NCT02641379|527008634|FG007|Overall Study|Participant showed relapse|0|||
146133802|NCT02641379|527008635|FG008|Overall Study|Participant showed relapse|0|||
146133803|NCT02641379|527008636|FG009|Overall Study|Participant showed relapse|0|||
146133804|NCT02641379|527008637|FG010|Overall Study|Participant showed relapse|0|||
146133805|NCT02641379|527008627|FG000|Overall Study|Participant stopped study/treatment|1|||
146133806|NCT02641379|527008628|FG001|Overall Study|Participant stopped study/treatment|3|||
146133807|NCT02641379|527008629|FG002|Overall Study|Participant stopped study/treatment|1|||
146133808|NCT02641379|527008630|FG003|Overall Study|Participant stopped study/treatment|0|||
146133809|NCT02641379|527008631|FG004|Overall Study|Participant stopped study/treatment|0|||
146133810|NCT02641379|527008632|FG005|Overall Study|Participant stopped study/treatment|1|||
146133811|NCT02641379|527008633|FG006|Overall Study|Participant stopped study/treatment|2|||
146133812|NCT02641379|527008634|FG007|Overall Study|Participant stopped study/treatment|0|||
146133813|NCT02641379|527008635|FG008|Overall Study|Participant stopped study/treatment|1|||
146133814|NCT02641379|527008636|FG009|Overall Study|Participant stopped study/treatment|0|||
146133815|NCT02641379|527008637|FG010|Overall Study|Participant stopped study/treatment|0|||
146133816|NCT02641379|527008627|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
146133817|NCT02641379|527008628|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
146133818|NCT02641379|527008629|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
146133819|NCT02641379|527008630|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
146133820|NCT02641379|527008631|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
146133821|NCT02641379|527008632|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
146133822|NCT02641379|527008633|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
146133823|NCT02641379|527008634|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
146133824|NCT02641379|527008635|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
146133825|NCT02641379|527008636|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
146133826|NCT02641379|527008637|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
146133827|NCT02641379|527008627|FG000|Overall Study|Financial problems|0|||
146133828|NCT02641379|527008628|FG001|Overall Study|Financial problems|1|||
146133829|NCT02641379|527008629|FG002|Overall Study|Financial problems|0|||
146133830|NCT02641379|527008630|FG003|Overall Study|Financial problems|0|||
146133831|NCT02641379|527008631|FG004|Overall Study|Financial problems|0|||
146133832|NCT02641379|527008632|FG005|Overall Study|Financial problems|0|||
146133833|NCT02641379|527008633|FG006|Overall Study|Financial problems|0|||
146133834|NCT02641379|527008634|FG007|Overall Study|Financial problems|0|||
146133835|NCT02641379|527008635|FG008|Overall Study|Financial problems|0|||
146133836|NCT02641379|527008636|FG009|Overall Study|Financial problems|0|||
146133837|NCT02641379|527008637|FG010|Overall Study|Financial problems|0|||
146133838|NCT02641379|527008627|FG000|Overall Study|PCR positive at Week 68|0|||
146133839|NCT02641379|527008628|FG001|Overall Study|PCR positive at Week 68|1|||
146133840|NCT02641379|527008629|FG002|Overall Study|PCR positive at Week 68|0|||
146133841|NCT02641379|527008630|FG003|Overall Study|PCR positive at Week 68|0|||
146133842|NCT02641379|527008631|FG004|Overall Study|PCR positive at Week 68|0|||
146133843|NCT02641379|527008632|FG005|Overall Study|PCR positive at Week 68|0|||
146133844|NCT02641379|527008633|FG006|Overall Study|PCR positive at Week 68|0|||
146133845|NCT02641379|527008634|FG007|Overall Study|PCR positive at Week 68|0|||
146133846|NCT02641379|527008635|FG008|Overall Study|PCR positive at Week 68|0|||
146133847|NCT02641379|527008636|FG009|Overall Study|PCR positive at Week 68|0|||
146133848|NCT02641379|527008637|FG010|Overall Study|PCR positive at Week 68|0|||
146133849|NCT02641379|527008627|FG000|Overall Study|PCR positive at Week 48|0|||
146133850|NCT02641379|527008628|FG001|Overall Study|PCR positive at Week 48|1|||
146133851|NCT02641379|527008629|FG002|Overall Study|PCR positive at Week 48|0|||
146133852|NCT02641379|527008630|FG003|Overall Study|PCR positive at Week 48|0|||
146133853|NCT02641379|527008631|FG004|Overall Study|PCR positive at Week 48|0|||
146133854|NCT02641379|527008632|FG005|Overall Study|PCR positive at Week 48|0|||
146133855|NCT02641379|527008633|FG006|Overall Study|PCR positive at Week 48|0|||
146133856|NCT02641379|527008634|FG007|Overall Study|PCR positive at Week 48|0|||
146133857|NCT02641379|527008635|FG008|Overall Study|PCR positive at Week 48|0|||
146133858|NCT02641379|527008636|FG009|Overall Study|PCR positive at Week 48|0|||
146133859|NCT02641379|527008637|FG010|Overall Study|PCR positive at Week 48|0|||
146133860|NCT02641379|527008627|FG000|Overall Study|PCR not performed at Week 12|0|||
146133861|NCT02641379|527008628|FG001|Overall Study|PCR not performed at Week 12|0|||
146133862|NCT02641379|527008629|FG002|Overall Study|PCR not performed at Week 12|1|||
146133863|NCT02641379|527008630|FG003|Overall Study|PCR not performed at Week 12|0|||
146133864|NCT02641379|527008631|FG004|Overall Study|PCR not performed at Week 12|0|||
146133865|NCT02641379|527008632|FG005|Overall Study|PCR not performed at Week 12|0|||
146133866|NCT02641379|527008633|FG006|Overall Study|PCR not performed at Week 12|0|||
146133867|NCT02641379|527008634|FG007|Overall Study|PCR not performed at Week 12|0|||
146133868|NCT02641379|527008635|FG008|Overall Study|PCR not performed at Week 12|0|||
146133869|NCT02641379|527008636|FG009|Overall Study|PCR not performed at Week 12|0|||
146133870|NCT02641379|527008637|FG010|Overall Study|PCR not performed at Week 12|0|||
146133871|NCT02641379|527008627|FG000|Overall Study|No PCR at baseline|0|||
146133872|NCT02641379|527008628|FG001|Overall Study|No PCR at baseline|0|||
146133873|NCT02641379|527008629|FG002|Overall Study|No PCR at baseline|1|||
146133874|NCT02641379|527008630|FG003|Overall Study|No PCR at baseline|0|||
146133875|NCT02641379|527008631|FG004|Overall Study|No PCR at baseline|0|||
146133876|NCT02641379|527008632|FG005|Overall Study|No PCR at baseline|0|||
146133877|NCT02641379|527008633|FG006|Overall Study|No PCR at baseline|0|||
146133878|NCT02641379|527008634|FG007|Overall Study|No PCR at baseline|0|||
146133879|NCT02641379|527008635|FG008|Overall Study|No PCR at baseline|0|||
146133880|NCT02641379|527008636|FG009|Overall Study|No PCR at baseline|0|||
146133881|NCT02641379|527008637|FG010|Overall Study|No PCR at baseline|0|||
146133882|NCT02641379|527008627|FG000|Overall Study|PCR positive at Week 28|0|||
146133883|NCT02641379|527008628|FG001|Overall Study|PCR positive at Week 28|0|||
146133884|NCT02641379|527008629|FG002|Overall Study|PCR positive at Week 28|1|||
146133885|NCT02641379|527008630|FG003|Overall Study|PCR positive at Week 28|0|||
146133886|NCT02641379|527008631|FG004|Overall Study|PCR positive at Week 28|0|||
146133887|NCT02641379|527008632|FG005|Overall Study|PCR positive at Week 28|0|||
146133888|NCT02641379|527008633|FG006|Overall Study|PCR positive at Week 28|0|||
146133889|NCT02641379|527008634|FG007|Overall Study|PCR positive at Week 28|0|||
146133890|NCT02641379|527008635|FG008|Overall Study|PCR positive at Week 28|0|||
146133891|NCT02641379|527008636|FG009|Overall Study|PCR positive at Week 28|0|||
146133892|NCT02641379|527008637|FG010|Overall Study|PCR positive at Week 28|0|||
146133893|NCT02641379|527008627|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
146133894|NCT02641379|527008628|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
146133895|NCT02641379|527008629|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
146133896|NCT02641379|527008630|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
146133897|NCT02641379|527008631|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
146133898|NCT02641379|527008632|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
146133899|NCT02641379|527008633|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
146133900|NCT02641379|527008634|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
146133901|NCT02641379|527008635|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
146133902|NCT02641379|527008636|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
146133903|NCT02641379|527008637|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
146133904|NCT02641379|527008627|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
146133905|NCT02641379|527008628|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
146133906|NCT02641379|527008629|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
146133907|NCT02641379|527008630|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
146133908|NCT02641379|527008631|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
146133909|NCT02641379|527008632|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
146133910|NCT02641379|527008633|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
146133911|NCT02641379|527008634|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
146133912|NCT02641379|527008635|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
146133913|NCT02641379|527008636|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
146133914|NCT02641379|527008637|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
146133915|NCT02641379|527008627|FG000|Overall Study|Baseline viral load unavailable|0|||
146133916|NCT02641379|527008628|FG001|Overall Study|Baseline viral load unavailable|0|||
146133917|NCT02641379|527008629|FG002|Overall Study|Baseline viral load unavailable|0|||
146133918|NCT02641379|527008630|FG003|Overall Study|Baseline viral load unavailable|1|||
146133919|NCT02641379|527008631|FG004|Overall Study|Baseline viral load unavailable|0|||
146133920|NCT02641379|527008632|FG005|Overall Study|Baseline viral load unavailable|0|||
146133921|NCT02641379|527008633|FG006|Overall Study|Baseline viral load unavailable|0|||
146133922|NCT02641379|527008634|FG007|Overall Study|Baseline viral load unavailable|0|||
146133923|NCT02641379|527008635|FG008|Overall Study|Baseline viral load unavailable|0|||
146133924|NCT02641379|527008636|FG009|Overall Study|Baseline viral load unavailable|0|||
146133925|NCT02641379|527008637|FG010|Overall Study|Baseline viral load unavailable|0|||
146133926|NCT02641379|527008627|FG000|Overall Study|Blood could not be drawn|0|||
146133927|NCT02641379|527008628|FG001|Overall Study|Blood could not be drawn|0|||
146133928|NCT02641379|527008629|FG002|Overall Study|Blood could not be drawn|0|||
146303671|NCT01660451|527625878|FG002|Overall Study|Sponsor Decision|1|||
146303672|NCT01660451|527625876|FG000|Overall Study|Protocol Deviation|0|||
146303673|NCT01660451|527625877|FG001|Overall Study|Protocol Deviation|0|||
146133929|NCT02641379|527008630|FG003|Overall Study|Blood could not be drawn|0|||
146133930|NCT02641379|527008631|FG004|Overall Study|Blood could not be drawn|1|||
146133931|NCT02641379|527008632|FG005|Overall Study|Blood could not be drawn|0|||
146133932|NCT02641379|527008633|FG006|Overall Study|Blood could not be drawn|0|||
146133933|NCT02641379|527008634|FG007|Overall Study|Blood could not be drawn|0|||
146133934|NCT02641379|527008635|FG008|Overall Study|Blood could not be drawn|0|||
146133935|NCT02641379|527008636|FG009|Overall Study|Blood could not be drawn|0|||
146133936|NCT02641379|527008637|FG010|Overall Study|Blood could not be drawn|0|||
146133937|NCT02641379|527008627|FG000|Overall Study|Protocol Violation|0|||
146133938|NCT02641379|527008628|FG001|Overall Study|Protocol Violation|0|||
146133939|NCT02641379|527008629|FG002|Overall Study|Protocol Violation|0|||
146133940|NCT02641379|527008630|FG003|Overall Study|Protocol Violation|0|||
146133941|NCT02641379|527008631|FG004|Overall Study|Protocol Violation|2|||
146133942|NCT02641379|527008632|FG005|Overall Study|Protocol Violation|0|||
146133943|NCT02641379|527008633|FG006|Overall Study|Protocol Violation|0|||
146133944|NCT02641379|527008634|FG007|Overall Study|Protocol Violation|0|||
146133945|NCT02641379|527008635|FG008|Overall Study|Protocol Violation|1|||
146133946|NCT02641379|527008636|FG009|Overall Study|Protocol Violation|0|||
146133947|NCT02641379|527008637|FG010|Overall Study|Protocol Violation|0|||
146133948|NCT02641379|527008627|FG000|Overall Study|Participation in sili rescue study|0|||
146133949|NCT02641379|527008628|FG001|Overall Study|Participation in sili rescue study|0|||
146133950|NCT02641379|527008629|FG002|Overall Study|Participation in sili rescue study|0|||
146133951|NCT02641379|527008630|FG003|Overall Study|Participation in sili rescue study|0|||
146133952|NCT02641379|527008631|FG004|Overall Study|Participation in sili rescue study|0|||
146133953|NCT02641379|527008632|FG005|Overall Study|Participation in sili rescue study|1|||
146133954|NCT02641379|527008633|FG006|Overall Study|Participation in sili rescue study|0|||
146133955|NCT02641379|527008634|FG007|Overall Study|Participation in sili rescue study|0|||
146133956|NCT02641379|527008635|FG008|Overall Study|Participation in sili rescue study|0|||
146133957|NCT02641379|527008636|FG009|Overall Study|Participation in sili rescue study|0|||
146133958|NCT02641379|527008637|FG010|Overall Study|Participation in sili rescue study|0|||
146133959|NCT02641379|527008627|FG000|Overall Study|Lost to Follow-up|0|||
146133960|NCT02641379|527008628|FG001|Overall Study|Lost to Follow-up|0|||
146133961|NCT02641379|527008629|FG002|Overall Study|Lost to Follow-up|0|||
146133962|NCT02641379|527008630|FG003|Overall Study|Lost to Follow-up|0|||
146133963|NCT02641379|527008631|FG004|Overall Study|Lost to Follow-up|0|||
146133964|NCT02641379|527008632|FG005|Overall Study|Lost to Follow-up|0|||
146133965|NCT02641379|527008633|FG006|Overall Study|Lost to Follow-up|0|||
146133966|NCT02641379|527008634|FG007|Overall Study|Lost to Follow-up|0|||
146133967|NCT02641379|527008635|FG008|Overall Study|Lost to Follow-up|1|||
146133968|NCT02641379|527008636|FG009|Overall Study|Lost to Follow-up|0|||
146133969|NCT02641379|527008637|FG010|Overall Study|Lost to Follow-up|0|||
146133970|NCT02641379|527008627|FG000|Overall Study|Source data not found|0|||
146133971|NCT02641379|527008628|FG001|Overall Study|Source data not found|0|||
146133972|NCT02641379|527008629|FG002|Overall Study|Source data not found|0|||
146133973|NCT02641379|527008630|FG003|Overall Study|Source data not found|0|||
146133974|NCT02641379|527008631|FG004|Overall Study|Source data not found|0|||
146133975|NCT02641379|527008632|FG005|Overall Study|Source data not found|1|||
146133976|NCT02641379|527008633|FG006|Overall Study|Source data not found|0|||
146133977|NCT02641379|527008634|FG007|Overall Study|Source data not found|0|||
146133978|NCT02641379|527008635|FG008|Overall Study|Source data not found|0|||
146133979|NCT02641379|527008636|FG009|Overall Study|Source data not found|0|||
146133980|NCT02641379|527008637|FG010|Overall Study|Source data not found|0|||
146133981|NCT02641379|527008627|FG000|Overall Study|Participant showed weight reduction|0|||
146133982|NCT02641379|527008628|FG001|Overall Study|Participant showed weight reduction|0|||
146133983|NCT02641379|527008629|FG002|Overall Study|Participant showed weight reduction|0|||
146133984|NCT02641379|527008630|FG003|Overall Study|Participant showed weight reduction|0|||
146133985|NCT02641379|527008631|FG004|Overall Study|Participant showed weight reduction|0|||
146133986|NCT02641379|527008632|FG005|Overall Study|Participant showed weight reduction|0|||
146133987|NCT02641379|527008633|FG006|Overall Study|Participant showed weight reduction|0|||
146133988|NCT02641379|527008634|FG007|Overall Study|Participant showed weight reduction|1|||
146133989|NCT02641379|527008635|FG008|Overall Study|Participant showed weight reduction|0|||
146133990|NCT02641379|527008636|FG009|Overall Study|Participant showed weight reduction|0|||
146133991|NCT02641379|527008637|FG010|Overall Study|Participant showed weight reduction|0|||
146133992|NCT02641379|527008627|FG000|Overall Study|Non-response Week 12|0|||
146133993|NCT02641379|527008628|FG001|Overall Study|Non-response Week 12|0|||
146133994|NCT02641379|527008629|FG002|Overall Study|Non-response Week 12|0|||
146133995|NCT02641379|527008630|FG003|Overall Study|Non-response Week 12|0|||
146133996|NCT02641379|527008631|FG004|Overall Study|Non-response Week 12|0|||
146264977|NCT02635386|527484640|FG002|Overall Study|Withdrawal by Subject|0|||
146264978|NCT02635386|527484641|FG003|Overall Study|Withdrawal by Subject|1|||
146264979|NCT02635386|527484642|FG004|Overall Study|Withdrawal by Subject|0|||
146264980|NCT02635386|527484638|FG000|Overall Study|Physician Decision|0|||
146264981|NCT02635386|527484639|FG001|Overall Study|Physician Decision|1|||
146264982|NCT02635386|527484640|FG002|Overall Study|Physician Decision|0|||
146133997|NCT02641379|527008632|FG005|Overall Study|Non-response Week 12|0|||
146133998|NCT02641379|527008633|FG006|Overall Study|Non-response Week 12|0|||
146133999|NCT02641379|527008634|FG007|Overall Study|Non-response Week 12|1|||
146264983|NCT02635386|527484641|FG003|Overall Study|Physician Decision|0|||
146134000|NCT02641379|527008635|FG008|Overall Study|Non-response Week 12|0|||
146134001|NCT02641379|527008636|FG009|Overall Study|Non-response Week 12|0|||
146134002|NCT02641379|527008637|FG010|Overall Study|Non-response Week 12|0|||
146134003|NCT02641379|527008627|FG000|Overall Study|No 2 Log drop at Week 12|0|||
146134004|NCT02641379|527008628|FG001|Overall Study|No 2 Log drop at Week 12|0|||
146134005|NCT02641379|527008629|FG002|Overall Study|No 2 Log drop at Week 12|0|||
146134006|NCT02641379|527008630|FG003|Overall Study|No 2 Log drop at Week 12|0|||
146134007|NCT02641379|527008631|FG004|Overall Study|No 2 Log drop at Week 12|0|||
146134008|NCT02641379|527008632|FG005|Overall Study|No 2 Log drop at Week 12|0|||
146134009|NCT02641379|527008633|FG006|Overall Study|No 2 Log drop at Week 12|0|||
146134010|NCT02641379|527008634|FG007|Overall Study|No 2 Log drop at Week 12|0|||
146134011|NCT02641379|527008635|FG008|Overall Study|No 2 Log drop at Week 12|0|||
146134012|NCT02641379|527008636|FG009|Overall Study|No 2 Log drop at Week 12|0|||
146134013|NCT02641379|527008637|FG010|Overall Study|No 2 Log drop at Week 12|1|||
146134014|NCT02641379|527008627|FG000|Overall Study|Negative PCR result|0|||
146134015|NCT02641379|527008628|FG001|Overall Study|Negative PCR result|0|||
146134016|NCT02641379|527008629|FG002|Overall Study|Negative PCR result|0|||
146134017|NCT02641379|527008630|FG003|Overall Study|Negative PCR result|0|||
146134018|NCT02641379|527008631|FG004|Overall Study|Negative PCR result|0|||
146134019|NCT02641379|527008632|FG005|Overall Study|Negative PCR result|0|||
146134020|NCT02641379|527008633|FG006|Overall Study|Negative PCR result|0|||
146134021|NCT02641379|527008634|FG007|Overall Study|Negative PCR result|0|||
146134022|NCT02641379|527008635|FG008|Overall Study|Negative PCR result|0|||
146134023|NCT02641379|527008636|FG009|Overall Study|Negative PCR result|1|||
146134024|NCT02641379|527008637|FG010|Overall Study|Negative PCR result|0|||
146134025|NCT02641379|527008627|FG000|Overall Study|Participant's PCR high|0|||
146134026|NCT02641379|527008628|FG001|Overall Study|Participant's PCR high|0|||
146134027|NCT02641379|527008629|FG002|Overall Study|Participant's PCR high|0|||
146134028|NCT02641379|527008630|FG003|Overall Study|Participant's PCR high|0|||
146134029|NCT02641379|527008631|FG004|Overall Study|Participant's PCR high|0|||
146134030|NCT02641379|527008632|FG005|Overall Study|Participant's PCR high|0|||
146134031|NCT02641379|527008633|FG006|Overall Study|Participant's PCR high|0|||
146134032|NCT02641379|527008634|FG007|Overall Study|Participant's PCR high|1|||
146134033|NCT02641379|527008635|FG008|Overall Study|Participant's PCR high|0|||
146134034|NCT02641379|527008636|FG009|Overall Study|Participant's PCR high|0|||
146134035|NCT02641379|527008637|FG010|Overall Study|Participant's PCR high|0|||
146134036|NCT02641379|527008627|FG000|Overall Study|Participant treated after Week 24|0|||
146134037|NCT02641379|527008628|FG001|Overall Study|Participant treated after Week 24|0|||
146134038|NCT02641379|527008629|FG002|Overall Study|Participant treated after Week 24|0|||
146134039|NCT02641379|527008630|FG003|Overall Study|Participant treated after Week 24|0|||
146134040|NCT02641379|527008631|FG004|Overall Study|Participant treated after Week 24|0|||
146134041|NCT02641379|527008632|FG005|Overall Study|Participant treated after Week 24|0|||
146134042|NCT02641379|527008633|FG006|Overall Study|Participant treated after Week 24|0|||
146134043|NCT02641379|527008634|FG007|Overall Study|Participant treated after Week 24|0|||
146134044|NCT02641379|527008635|FG008|Overall Study|Participant treated after Week 24|1|||
146134045|NCT02641379|527008636|FG009|Overall Study|Participant treated after Week 24|0|||
146134046|NCT02641379|527008637|FG010|Overall Study|Participant treated after Week 24|0|||
146134047|NCT02641379|527008627|FG000|Overall Study|Missing PCR result at Week 8|0|||
146134048|NCT02641379|527008628|FG001|Overall Study|Missing PCR result at Week 8|0|||
146134049|NCT02641379|527008629|FG002|Overall Study|Missing PCR result at Week 8|0|||
146134050|NCT02641379|527008630|FG003|Overall Study|Missing PCR result at Week 8|0|||
146134051|NCT02641379|527008631|FG004|Overall Study|Missing PCR result at Week 8|0|||
146134052|NCT02641379|527008632|FG005|Overall Study|Missing PCR result at Week 8|0|||
146134053|NCT02641379|527008633|FG006|Overall Study|Missing PCR result at Week 8|0|||
146134054|NCT02641379|527008634|FG007|Overall Study|Missing PCR result at Week 8|0|||
146134055|NCT02641379|527008635|FG008|Overall Study|Missing PCR result at Week 8|0|||
146134056|NCT02641379|527008636|FG009|Overall Study|Missing PCR result at Week 8|1|||
146134057|NCT02641379|527008637|FG010|Overall Study|Missing PCR result at Week 8|0|||
146134058|NCT02641379|527008627|FG000|Overall Study|PCR positive|0|||
146134059|NCT02641379|527008628|FG001|Overall Study|PCR positive|0|||
146134060|NCT02641379|527008629|FG002|Overall Study|PCR positive|0|||
146134061|NCT02641379|527008630|FG003|Overall Study|PCR positive|0|||
146134062|NCT02641379|527008631|FG004|Overall Study|PCR positive|0|||
146264984|NCT02635386|527484642|FG004|Overall Study|Physician Decision|0|||
146264985|NCT02635386|527484638|FG000|Overall Study|Moved Out of State|0|||
146264986|NCT02635386|527484639|FG001|Overall Study|Moved Out of State|1|||
146264987|NCT02635386|527484640|FG002|Overall Study|Moved Out of State|0|||
146264988|NCT02635386|527484641|FG003|Overall Study|Moved Out of State|0|||
146264989|NCT02635386|527484642|FG004|Overall Study|Moved Out of State|0|||
146264990|NCT02635386|527484638|FG000|Overall Study|Noncompliant|0|||
146264991|NCT02635386|527484639|FG001|Overall Study|Noncompliant|2|||
146264992|NCT02635386|527484640|FG002|Overall Study|Noncompliant|1|||
146264993|NCT02635386|527484641|FG003|Overall Study|Noncompliant|1|||
146264994|NCT02635386|527484642|FG004|Overall Study|Noncompliant|1|||
146134063|NCT02641379|527008632|FG005|Overall Study|PCR positive|0|||
146134064|NCT02641379|527008633|FG006|Overall Study|PCR positive|1|||
146134065|NCT02641379|527008634|FG007|Overall Study|PCR positive|0|||
146134066|NCT02641379|527008635|FG008|Overall Study|PCR positive|0|||
146264995|NCT02635386|527484638|FG000|Overall Study|side effects|0|||
146264996|NCT02635386|527484639|FG001|Overall Study|side effects|0|||
146134067|NCT02641379|527008636|FG009|Overall Study|PCR positive|0|||
146134068|NCT02641379|527008637|FG010|Overall Study|PCR positive|0|||
146134069|NCT03323658|527008640|FG000|Overall Study|Adverse Event|0|||
146134070|NCT03323658|527008641|FG001|Overall Study|Adverse Event|1|||
146134071|NCT03323658|527008642|FG002|Overall Study|Adverse Event|0|||
146134072|NCT00615056|527008643|FG000|Overall Study|Death|31|||
146134073|NCT00615056|527008644|FG001|Overall Study|Death|31|||
146134074|NCT00615056|527008645|FG002|Overall Study|Death|21|||
146134075|NCT00615056|527008646|FG003|Overall Study|Death|23|||
146134076|NCT00615056|527008643|FG000|Overall Study|Lost to Follow-up|1|||
146134077|NCT00615056|527008644|FG001|Overall Study|Lost to Follow-up|2|||
146134078|NCT00615056|527008645|FG002|Overall Study|Lost to Follow-up|4|||
146134079|NCT00615056|527008646|FG003|Overall Study|Lost to Follow-up|5|||
146134080|NCT00615056|527008643|FG000|Overall Study|Other|13|||
146134081|NCT00615056|527008644|FG001|Overall Study|Other|15|||
146134082|NCT00615056|527008645|FG002|Overall Study|Other|10|||
146134083|NCT00615056|527008646|FG003|Overall Study|Other|7|||
146134084|NCT00615056|527008643|FG000|Overall Study|Objective progression or relapse|0|||
146134085|NCT00615056|527008644|FG001|Overall Study|Objective progression or relapse|2|||
146134086|NCT00615056|527008645|FG002|Overall Study|Objective progression or relapse|0|||
146134087|NCT00615056|527008646|FG003|Overall Study|Objective progression or relapse|0|||
146134088|NCT00615056|527008643|FG000|Overall Study|Withdrawal by Subject|0|||
146134089|NCT00615056|527008644|FG001|Overall Study|Withdrawal by Subject|1|||
146134090|NCT00615056|527008645|FG002|Overall Study|Withdrawal by Subject|1|||
146134091|NCT00615056|527008646|FG003|Overall Study|Withdrawal by Subject|0|||
146134092|NCT00615056|527008643|FG000|Overall Study|Discontinued by Sponsor|1|||
146134093|NCT00615056|527008644|FG001|Overall Study|Discontinued by Sponsor|0|||
146134094|NCT00615056|527008645|FG002|Overall Study|Discontinued by Sponsor|0|||
146134095|NCT00615056|527008646|FG003|Overall Study|Discontinued by Sponsor|0|||
146134096|NCT00615056|527008643|FG000|Overall Study|Randomized but not treated|3|||
146134097|NCT00615056|527008644|FG001|Overall Study|Randomized but not treated|0|||
146134098|NCT00615056|527008645|FG002|Overall Study|Randomized but not treated|0|||
146134099|NCT00615056|527008646|FG003|Overall Study|Randomized but not treated|0|||
146134100|NCT04536727|527008647|FG000|Overall Study|Lost to Follow-up|1|||
146134101|NCT04536727|527008648|FG001|Overall Study|Lost to Follow-up|1|||
146134102|NCT04536727|527008647|FG000|Overall Study|Death|0|||
146134103|NCT04536727|527008648|FG001|Overall Study|Death|1|||
146134104|NCT00560950|527008651|FG000|Overall Study|Lost to Follow-up|1|||
146134105|NCT00560950|527008652|FG001|Overall Study|Lost to Follow-up|0|||
146134106|NCT02565381|527010380|FG000|Overall Study|Lost to Follow-up|1|||
146134107|NCT02565381|527010381|FG001|Overall Study|Lost to Follow-up|0|||
146134108|NCT02565381|527010382|FG002|Overall Study|Lost to Follow-up|1|||
146134109|NCT05308901|527010385|FG000|Overall Study|Death|6|||
146134110|NCT03252522|527010386|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
146134111|NCT03252522|527010387|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
146134112|NCT03252522|527010388|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
146134113|NCT03252522|527010386|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
146134114|NCT03252522|527010387|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
146303674|NCT01660451|527625878|FG002|Overall Study|Protocol Deviation|1|||
146303675|NCT01660451|527625876|FG000|Overall Study|Physician Decision|1|||
146303676|NCT01660451|527625877|FG001|Overall Study|Physician Decision|2|||
146303677|NCT01660451|527625878|FG002|Overall Study|Physician Decision|5|||
146303678|NCT01660451|527625876|FG000|Overall Study|Withdrawal by Subject|1|||
146303679|NCT01660451|527625877|FG001|Overall Study|Withdrawal by Subject|1|||
146303680|NCT01660451|527625878|FG002|Overall Study|Withdrawal by Subject|20|||
146303681|NCT01660451|527625876|FG000|Overall Study|Trial closure.|0|||
146134115|NCT03252522|527010388|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
146134116|NCT03252522|527010386|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
146134117|NCT03252522|527010387|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
146134118|NCT03252522|527010388|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
146134119|NCT03252522|527010386|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
146134120|NCT03252522|527010387|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
146134121|NCT03252522|527010388|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
146134122|NCT03252522|527010386|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
146134123|NCT03252522|527010387|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
146134124|NCT03252522|527010388|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
146303682|NCT01660451|527625877|FG001|Overall Study|Trial closure.|0|||
146134125|NCT03252522|527010386|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
146134126|NCT03252522|527010387|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
146134127|NCT03252522|527010388|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
146303683|NCT01660451|527625878|FG002|Overall Study|Trial closure.|1|||
146303684|NCT01660451|527625876|FG000|Overall Study|Switching to other therapy|0|||
146134128|NCT03252522|527010386|FG000|Phase 2: Open Label|Adverse Event|0|||
146134129|NCT03252522|527010387|FG001|Phase 2: Open Label|Adverse Event|0|||
146134130|NCT03252522|527010388|FG002|Phase 2: Open Label|Adverse Event|2|||
146134131|NCT03252522|527010386|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
146134132|NCT03252522|527010387|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
146134133|NCT03252522|527010388|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
146134134|NCT01940120|527010392|FG000|Overall Study|Death|40|||
146134135|NCT01940120|527010392|FG000|Overall Study|Withdrawal by Subject|8|||
146134136|NCT03277846|527010393|FG000|Overall Study|Inpatient stay too brief|12|||
146134137|NCT03277846|527010394|FG001|Overall Study|Inpatient stay too brief|11|||
146134138|NCT02554656|527010395|FG000|Overall Study|Protocol Violation|3|||
146134139|NCT03240575|527010396|FG000|Overall Study|Adverse Event|0|||
146134140|NCT03240575|527010397|FG001|Overall Study|Adverse Event|2|||
146134141|NCT03240575|527010398|FG002|Overall Study|Adverse Event|0|||
146134142|NCT03240575|527010399|FG003|Overall Study|Adverse Event|1|||
146134143|NCT03240575|527010396|FG000|Overall Study|Withdrawal by Subject|2|||
146134144|NCT03240575|527010397|FG001|Overall Study|Withdrawal by Subject|11|||
146134145|NCT03240575|527010398|FG002|Overall Study|Withdrawal by Subject|0|||
146134146|NCT03240575|527010399|FG003|Overall Study|Withdrawal by Subject|1|||
146134147|NCT03240575|527010396|FG000|Overall Study|Other|0|||
146134148|NCT03240575|527010397|FG001|Overall Study|Other|1|||
146134149|NCT03240575|527010398|FG002|Overall Study|Other|0|||
146134150|NCT03240575|527010399|FG003|Overall Study|Other|0|||
146134151|NCT03568942|527010402|FG000|Overall Study|Family emergency|1|||
146134152|NCT03568942|527010402|FG000|Overall Study|Lost to Follow-up|1|||
146134153|NCT01945489|527010403|FG000|Cycle 1|Adverse Event|2|||
146134154|NCT01945489|527010404|FG001|Cycle 1|Adverse Event|0|||
146134155|NCT01945489|527010403|FG000|Cycle 1|Lost to Follow-up|4|||
146134156|NCT01945489|527010404|FG001|Cycle 1|Lost to Follow-up|0|||
146134157|NCT01945489|527010403|FG000|Cycle 1|Personal Reasons|4|||
146134158|NCT01945489|527010404|FG001|Cycle 1|Personal Reasons|2|||
146134159|NCT01945489|527010403|FG000|Cycle 1|Protocol Violation|0|||
146134160|NCT01945489|527010404|FG001|Cycle 1|Protocol Violation|1|||
146134161|NCT01945489|527010403|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
146134162|NCT01945489|527010404|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
146134163|NCT01945489|527010403|FG000|Cycle 2|Adverse Event|1|||
146134164|NCT01945489|527010404|FG001|Cycle 2|Adverse Event|0|||
146134165|NCT01945489|527010403|FG000|Cycle 2|Lost to Follow-up|0|||
146134166|NCT01945489|527010404|FG001|Cycle 2|Lost to Follow-up|1|||
146134167|NCT04144166|527010406|FG000|Overall Study|Discharged before study start|1|||
146134168|NCT04144166|527010406|FG000|Overall Study|Pregnancy|1|||
146134169|NCT04144166|527010406|FG000|Overall Study|Nail polish could not be removed from finger|1|||
146134170|NCT02223767|527010413|FG000|Overall Study|Withdrawal by Subject|4|||
146134171|NCT02223767|527010414|FG001|Overall Study|Withdrawal by Subject|4|||
146134172|NCT02433834|527010415|FG000|Overall Study|Protocol-specified criteria|7|||
146134173|NCT02433834|527010415|FG000|Overall Study|Protocol Violation|3|||
146134174|NCT02433834|527010415|FG000|Overall Study|Lost to Follow-up|6|||
146134175|NCT02433834|527010415|FG000|Overall Study|Withdrawal by Subject|14|||
146134176|NCT02433834|527010415|FG000|Overall Study|Adverse Event|6|||
146134177|NCT02433834|527010415|FG000|Overall Study|Physician Decision|1|||
146134178|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
146134179|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
146134180|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
146134181|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
146134182|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
146134183|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
146134184|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
146134185|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
146134186|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
146134187|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
146134188|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
146134189|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
146134190|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
146134191|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
146134192|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
146134193|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
146134194|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
146134195|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
146134196|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
146134197|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
146134198|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
146134199|NCT00934544|527010417|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
146134200|NCT00934544|527010418|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
146134201|NCT00934544|527010419|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
146134202|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
146134203|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
146134204|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
146134205|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
146134206|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
146134207|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
146134208|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
146134209|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
146134210|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
146134211|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
146134212|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
146134213|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
146134214|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
146134215|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
146134216|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
146134217|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
146134218|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
146134219|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
146134220|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
146134221|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
146134222|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
146134223|NCT00934544|527010417|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
146134224|NCT00934544|527010418|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
146134225|NCT00934544|527010419|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
146134226|NCT04476017|527010420|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
146134227|NCT04476017|527010421|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
146134228|NCT02704364|527010422|FG000|Overall Study|Adverse Event|1|||
146134229|NCT02704364|527010423|FG001|Overall Study|Adverse Event|1|||
146134230|NCT02704364|527010424|FG002|Overall Study|Adverse Event|0|||
146134231|NCT02704364|527010422|FG000|Overall Study|Noncompliance with study drug|1|||
146134232|NCT02704364|527010423|FG001|Overall Study|Noncompliance with study drug|1|||
146134233|NCT02704364|527010424|FG002|Overall Study|Noncompliance with study drug|0|||
146134234|NCT02704364|527010422|FG000|Overall Study|Other|0|||
146134235|NCT02704364|527010423|FG001|Overall Study|Other|1|||
146134236|NCT02704364|527010424|FG002|Overall Study|Other|1|||
146134237|NCT00846742|527010425|FG000|Overall Study|Withdrawal by Subject|1|||
146134238|NCT02775344|527010427|FG000|Overall Study|No ovarian cyst identified|3|||
146134239|NCT02775344|527010428|FG001|Overall Study|No ovarian cyst identified|2|||
146134240|NCT04627064|527010429|FG000|Overall Study|Progressive disease|8|||
146134241|NCT04627064|527010430|FG001|Overall Study|Progressive disease|0|||
146134242|NCT04627064|527010429|FG000|Overall Study|Withdrawal by Subject|2|||
146134243|NCT04627064|527010430|FG001|Overall Study|Withdrawal by Subject|0|||
146134244|NCT04627064|527010429|FG000|Overall Study|Physician Decision|1|||
146134245|NCT04627064|527010430|FG001|Overall Study|Physician Decision|0|||
146134246|NCT00235872|527010433|FG000|Overall Study|Adverse Event|34|||
146134247|NCT00235872|527010433|FG000|Overall Study|Death|1|||
146134248|NCT00235872|527010433|FG000|Overall Study|Lost to Follow-up|1|||
146134249|NCT00235872|527010433|FG000|Overall Study|Withdrawal by Subject|50|||
146134250|NCT00235872|527010433|FG000|Overall Study|Administrative reason|61|||
146134251|NCT02126969|527010434|FG000|Overall Study|Withdrawal by Subject|1|||
146134252|NCT02126969|527010435|FG001|Overall Study|Withdrawal by Subject|2|||
146134253|NCT01533246|527010438|FG000|Overall Study|Adverse Event|1|||
146134254|NCT01533246|527010438|FG000|Overall Study|Withdrawal by Subject|1|||
146134255|NCT00354172|527010439|FG000|Overall Study|Did not receive transplant|1|||
146134256|NCT01800916|527010440|FG000|Test Period 1 (1 Week)|Convex product user|0|||
146134257|NCT01800916|527010441|FG001|Test Period 1 (1 Week)|Convex product user|0|||
146134258|NCT01800916|527010442|FG002|Test Period 1 (1 Week)|Convex product user|0|||
146134259|NCT01800916|527010443|FG003|Test Period 1 (1 Week)|Convex product user|1|||
146134260|NCT01800916|527010444|FG004|Test Period 1 (1 Week)|Convex product user|0|||
146303685|NCT01660451|527625877|FG001|Overall Study|Switching to other therapy|1|||
146303686|NCT01660451|527625878|FG002|Overall Study|Switching to other therapy|1|||
146303687|NCT01660451|527625876|FG000|Overall Study|Progressive disease - clinical progression|4|||
146134261|NCT01800916|527010445|FG005|Test Period 1 (1 Week)|Convex product user|0|||
146134262|NCT01800916|527010446|FG006|Test Period 1 (1 Week)|Convex product user|0|||
146134263|NCT01800916|527010447|FG007|Test Period 1 (1 Week)|Convex product user|0|||
146134264|NCT01800916|527010448|FG008|Test Period 1 (1 Week)|Convex product user|0|||
146134265|NCT01800916|527010440|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
146134266|NCT01800916|527010441|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
146134267|NCT01800916|527010442|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
146303688|NCT01660451|527625877|FG001|Overall Study|Progressive disease - clinical progression|10|||
146303689|NCT01660451|527625878|FG002|Overall Study|Progressive disease - clinical progression|9|||
146303690|NCT01660451|527625876|FG000|Overall Study|Progressive disease - radiological progression|12|||
146303691|NCT01660451|527625877|FG001|Overall Study|Progressive disease - radiological progression|23|||
146134268|NCT01800916|527010443|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
146134269|NCT01800916|527010444|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
146134270|NCT01800916|527010445|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
146134271|NCT01800916|527010446|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
146134272|NCT01800916|527010447|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
146134273|NCT01800916|527010448|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
146134274|NCT01232296|527010449|FG000|Overall Study|Adverse Event|24|||
146134275|NCT01232296|527010450|FG001|Overall Study|Adverse Event|12|||
146134276|NCT01232296|527010449|FG000|Overall Study|Physician Decision|1|||
146134277|NCT01232296|527010450|FG001|Overall Study|Physician Decision|1|||
146134278|NCT01232296|527010449|FG000|Overall Study|Progressive disease|43|||
146134279|NCT01232296|527010450|FG001|Overall Study|Progressive disease|61|||
146134280|NCT01232296|527010449|FG000|Overall Study|Study terminated by sponsor|0|||
146134281|NCT01232296|527010450|FG001|Overall Study|Study terminated by sponsor|1|||
146134282|NCT01232296|527010449|FG000|Overall Study|Technical problems|3|||
146134283|NCT01232296|527010450|FG001|Overall Study|Technical problems|0|||
146134284|NCT01232296|527010449|FG000|Overall Study|Subject/guardian decision|10|||
146134285|NCT01232296|527010450|FG001|Overall Study|Subject/guardian decision|2|||
146134286|NCT01232296|527010449|FG000|Overall Study|Death|1|||
146134287|NCT01232296|527010450|FG001|Overall Study|Death|6|||
146134288|NCT00937547|527010457|FG000|Overall Study|misdiagnosis|1|||
146134289|NCT00937547|527010458|FG001|Overall Study|misdiagnosis|6|||
146134290|NCT00937547|527010459|FG002|Overall Study|misdiagnosis|7|||
146134291|NCT01234467|527010460|FG000|Overall Study|Adverse Event|3|||
146134292|NCT01234467|527010460|FG000|Overall Study|Death|2|||
146134293|NCT01234467|527010460|FG000|Overall Study|Withdrawal by Subject|2|||
146134294|NCT01234467|527010460|FG000|Overall Study|Disease Progression|2|||
146134295|NCT01234467|527010460|FG000|Overall Study|Clinical deterioration|1|||
146134296|NCT01234467|527010460|FG000|Overall Study|Physician Decision|1|||
146134297|NCT01234467|527010460|FG000|Overall Study|Other complicating disease (stroke)|1|||
146134298|NCT01461096|527010462|FG000|Overall Study|Death|3|||
146134299|NCT01461096|527010463|FG001|Overall Study|Death|6|||
146134300|NCT01461096|527010462|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146134301|NCT01461096|527010463|FG001|Overall Study|Severe debilitation, unable to continue|1|||
146134302|NCT01461096|527010462|FG000|Overall Study|Subj not able to get to clinic|15|||
146134303|NCT01461096|527010463|FG001|Overall Study|Subj not able to get to clinic|13|||
146134304|NCT01461096|527010462|FG000|Overall Study|Site is closing|27|||
146134305|NCT01461096|527010463|FG001|Overall Study|Site is closing|30|||
146134306|NCT01461096|527010462|FG000|Overall Study|Withdrawal by Subject|5|||
146134307|NCT01461096|527010463|FG001|Overall Study|Withdrawal by Subject|3|||
146134308|NCT01461096|527010462|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
146134309|NCT01461096|527010463|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
146134310|NCT01461096|527010462|FG000|Overall Study|Lost to Follow-up|8|||
146134311|NCT01461096|527010463|FG001|Overall Study|Lost to Follow-up|4|||
146134312|NCT04889625|527010464|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
146134313|NCT04889625|527010465|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
146134314|NCT04889625|527010464|FG000|Period 1|Subject out of window|0|||
146134315|NCT04889625|527010465|FG001|Period 1|Subject out of window|1|||
146134316|NCT04889625|527010464|FG000|Period 1|Wrong add power dispensed|0|||
146134317|NCT04889625|527010465|FG001|Period 1|Wrong add power dispensed|1|||
146134318|NCT04889625|527010464|FG000|Period 1|Discontinued due to fitting guide error|1|||
146134319|NCT04889625|527010465|FG001|Period 1|Discontinued due to fitting guide error|1|||
146134320|NCT04889625|527010464|FG000|Period 2|Test article no longer available|1|||
146134321|NCT04889625|527010465|FG001|Period 2|Test article no longer available|0|||
146134322|NCT04889625|527010464|FG000|Period 2|Incorrect lens dispensed|1|||
146134323|NCT04889625|527010465|FG001|Period 2|Incorrect lens dispensed|0|||
146134324|NCT04889625|527010464|FG000|Period 2|Wrong add power dispensed|0|||
146134325|NCT04889625|527010465|FG001|Period 2|Wrong add power dispensed|1|||
146134326|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
146134327|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
146134328|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
146134329|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
146134330|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
146134331|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
146134332|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
146134333|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
146134334|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
146134335|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
146134336|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
146134337|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
146134338|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
146134339|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
146134340|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
146134341|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
146134342|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
146134343|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
146134344|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Death|0|||
146134345|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Death|0|||
146134346|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Death|1|||
146134347|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Death|0|||
146134348|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Death|0|||
146134349|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Death|0|||
146134350|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Death|0|||
146134351|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Death|0|||
146134352|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Death|0|||
146134353|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
146134354|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
146134355|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
146134356|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134357|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134358|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134359|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134360|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134361|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
146134362|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
146134363|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
146134364|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
146134365|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134366|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134367|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134368|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134369|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134370|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
146134371|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
146134372|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
146134373|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
146134374|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
146134375|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
146134376|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
146134377|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
146134378|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
146134379|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
146134380|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
146134381|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
146134382|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
146134383|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
146134384|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
146134385|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
146134386|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
146134387|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
146134388|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
146134389|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
146134390|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
146134391|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
146134392|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146134393|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146134394|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146134395|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146303692|NCT01660451|527625878|FG002|Overall Study|Progressive disease - radiological progression|50|||
146303693|NCT01660451|527625876|FG000|Overall Study|Death|1|||
146303694|NCT01660451|527625877|FG001|Overall Study|Death|0|||
146134396|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146134397|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
146134398|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134399|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
146134400|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134401|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134402|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134403|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146303695|NCT01660451|527625878|FG002|Overall Study|Death|1|||
146303696|NCT01660451|527625876|FG000|Overall Study|Other|0|||
146303697|NCT01660451|527625877|FG001|Overall Study|Other|0|||
146134404|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146303698|NCT01660451|527625878|FG002|Overall Study|Other|1|||
146303699|NCT05093322|527625879|FG000|Overall Study|Death|6|||
146134405|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134406|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
146134407|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
146134408|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
146134409|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
146134410|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
146134411|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
146134412|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
146134413|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
146134414|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
146134415|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
146134416|NCT00404352|527010475|FG000|Double Blind (up to 24 Month)|Other|0|||
146134417|NCT00404352|527010476|FG001|Double Blind (up to 24 Month)|Other|1|||
146134418|NCT00404352|527010477|FG002|Double Blind (up to 24 Month)|Other|0|||
146134419|NCT00404352|527010478|FG003|Double Blind (up to 24 Month)|Other|0|||
146134420|NCT00404352|527010479|FG004|Double Blind (up to 24 Month)|Other|0|||
146134421|NCT00404352|527010480|FG005|Double Blind (up to 24 Month)|Other|0|||
146134422|NCT00404352|527010481|FG006|Double Blind (up to 24 Month)|Other|0|||
146134423|NCT00404352|527010482|FG007|Double Blind (up to 24 Month)|Other|0|||
146134424|NCT00404352|527010483|FG008|Double Blind (up to 24 Month)|Other|0|||
146134425|NCT00404352|527010475|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
146134426|NCT00404352|527010476|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
146134427|NCT00404352|527010477|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
146134428|NCT00404352|527010478|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
146134429|NCT00404352|527010479|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
146134430|NCT00404352|527010480|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
146134431|NCT00404352|527010481|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
146134432|NCT00404352|527010482|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
146134433|NCT00404352|527010483|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
146134434|NCT00404352|527010475|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
146134435|NCT00404352|527010476|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
146134436|NCT00404352|527010477|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
146134437|NCT00404352|527010478|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
146134438|NCT00404352|527010479|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
146134439|NCT00404352|527010480|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
146134440|NCT00404352|527010481|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
146134441|NCT00404352|527010482|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
146134442|NCT00404352|527010483|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
146134443|NCT00404352|527010475|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134444|NCT00404352|527010476|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134445|NCT00404352|527010477|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134446|NCT00404352|527010478|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134447|NCT00404352|527010479|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
146134448|NCT00404352|527010480|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134449|NCT00404352|527010481|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134450|NCT00404352|527010482|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134451|NCT00404352|527010483|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
146134452|NCT00404352|527010475|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134453|NCT00404352|527010476|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134454|NCT00404352|527010477|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134455|NCT00404352|527010478|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134456|NCT00404352|527010479|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134457|NCT00404352|527010480|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
146134458|NCT00404352|527010481|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134459|NCT00404352|527010482|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134460|NCT00404352|527010483|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
146134461|NCT00404352|527010475|FG000|Open Label (up to 24 Month)|Disease progression|0|||
146134462|NCT00404352|527010476|FG001|Open Label (up to 24 Month)|Disease progression|0|||
146134463|NCT00404352|527010477|FG002|Open Label (up to 24 Month)|Disease progression|0|||
146134464|NCT00404352|527010478|FG003|Open Label (up to 24 Month)|Disease progression|1|||
146134465|NCT00404352|527010479|FG004|Open Label (up to 24 Month)|Disease progression|0|||
146134466|NCT00404352|527010480|FG005|Open Label (up to 24 Month)|Disease progression|0|||
146134467|NCT00404352|527010481|FG006|Open Label (up to 24 Month)|Disease progression|0|||
146134468|NCT00404352|527010482|FG007|Open Label (up to 24 Month)|Disease progression|0|||
146134469|NCT00404352|527010483|FG008|Open Label (up to 24 Month)|Disease progression|0|||
146134470|NCT00404352|527010475|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134471|NCT00404352|527010476|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134472|NCT00404352|527010477|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134473|NCT00404352|527010478|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134474|NCT00404352|527010479|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146168334|NCT02597036|527128108|FG005|Overall Study|Lost to Follow-up|0|||
146168335|NCT02597036|527128109|FG006|Overall Study|Lost to Follow-up|0|||
146134475|NCT00404352|527010480|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134476|NCT00404352|527010481|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
146134477|NCT00404352|527010482|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
146134478|NCT00404352|527010483|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
146134479|NCT00404352|527010475|FG000|Open Label Extension (up to 36 Months)|Other|0|||
146134480|NCT00404352|527010476|FG001|Open Label Extension (up to 36 Months)|Other|0|||
146134481|NCT00404352|527010477|FG002|Open Label Extension (up to 36 Months)|Other|0|||
146134482|NCT00404352|527010478|FG003|Open Label Extension (up to 36 Months)|Other|0|||
146134483|NCT00404352|527010479|FG004|Open Label Extension (up to 36 Months)|Other|0|||
146134484|NCT00404352|527010480|FG005|Open Label Extension (up to 36 Months)|Other|0|||
146134485|NCT00404352|527010481|FG006|Open Label Extension (up to 36 Months)|Other|0|||
146134486|NCT00404352|527010482|FG007|Open Label Extension (up to 36 Months)|Other|0|||
146134487|NCT00404352|527010483|FG008|Open Label Extension (up to 36 Months)|Other|2|||
146134488|NCT04370691|527010486|FG000|Overall Study|Pending visit|48|||
146134489|NCT04370691|527010486|FG000|Overall Study|Have Not Reached Lower Window|15|||
146134490|NCT04370691|527010486|FG000|Overall Study|Termination|14|||
146134491|NCT04370691|527010486|FG000|Overall Study|Missed or Overdue|10|||
146134492|NCT00606892|527010492|FG000|First Intervention|Protocol Violation|1|||
146134493|NCT00606892|527010493|FG001|First Intervention|Protocol Violation|4|||
146134494|NCT03216850|527010498|FG000|Overall Study|Pre-analytical error|6|||
146134495|NCT01116232|527010499|FG000|Overall Study|Progressive diease|4|||
146134496|NCT03554291|527010500|FG000|Overall Study|Death|2|||
146134497|NCT03554291|527010501|FG001|Overall Study|Death|1|||
146134498|NCT03554291|527010500|FG000|Overall Study|Lost to Follow-up|1|||
146134499|NCT03554291|527010501|FG001|Overall Study|Lost to Follow-up|0|||
146134500|NCT03554291|527010500|FG000|Overall Study|Withdrawal by Subject|1|||
146134501|NCT03554291|527010501|FG001|Overall Study|Withdrawal by Subject|0|||
146134502|NCT03554291|527010500|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
146134503|NCT03554291|527010501|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
146134504|NCT03274986|527010507|FG000|Overall Study|Withdrawal by Subject|0|||
146134505|NCT03274986|527010508|FG001|Overall Study|Withdrawal by Subject|1|||
146134506|NCT03274986|527010507|FG000|Overall Study|Lost to Follow-up|0|||
146134507|NCT03274986|527010508|FG001|Overall Study|Lost to Follow-up|1|||
146134508|NCT00603746|527010509|FG000|Overall Study|Adverse Event|2|||
146134509|NCT00603746|527010510|FG001|Overall Study|Adverse Event|3|||
146134510|NCT00603746|527010511|FG002|Overall Study|Adverse Event|0|||
146134511|NCT00603746|527010512|FG003|Overall Study|Adverse Event|1|||
146134512|NCT00603746|527010513|FG004|Overall Study|Adverse Event|0|||
146134513|NCT00603746|527010514|FG005|Overall Study|Adverse Event|4|||
146134514|NCT00603746|527010509|FG000|Overall Study|Lack of Efficacy|34|||
146134515|NCT00603746|527010510|FG001|Overall Study|Lack of Efficacy|11|||
146134516|NCT00603746|527010511|FG002|Overall Study|Lack of Efficacy|6|||
146134517|NCT00603746|527010512|FG003|Overall Study|Lack of Efficacy|11|||
146134518|NCT00603746|527010513|FG004|Overall Study|Lack of Efficacy|12|||
146134519|NCT00603746|527010514|FG005|Overall Study|Lack of Efficacy|8|||
146134520|NCT00603746|527010509|FG000|Overall Study|Protocol Violation|0|||
146134521|NCT00603746|527010510|FG001|Overall Study|Protocol Violation|3|||
146134522|NCT00603746|527010511|FG002|Overall Study|Protocol Violation|1|||
146134523|NCT00603746|527010512|FG003|Overall Study|Protocol Violation|0|||
146134524|NCT00603746|527010513|FG004|Overall Study|Protocol Violation|1|||
146134525|NCT00603746|527010514|FG005|Overall Study|Protocol Violation|0|||
146134526|NCT00603746|527010509|FG000|Overall Study|Lost to Follow-up|0|||
146134527|NCT00603746|527010510|FG001|Overall Study|Lost to Follow-up|1|||
146134528|NCT00603746|527010511|FG002|Overall Study|Lost to Follow-up|1|||
146134529|NCT00603746|527010512|FG003|Overall Study|Lost to Follow-up|0|||
146134530|NCT00603746|527010513|FG004|Overall Study|Lost to Follow-up|0|||
146134531|NCT00603746|527010514|FG005|Overall Study|Lost to Follow-up|0|||
146134532|NCT00603746|527010509|FG000|Overall Study|Physician Decision|1|||
146134533|NCT00603746|527010510|FG001|Overall Study|Physician Decision|0|||
146134534|NCT00603746|527010511|FG002|Overall Study|Physician Decision|0|||
146134535|NCT00603746|527010512|FG003|Overall Study|Physician Decision|0|||
146134536|NCT00603746|527010513|FG004|Overall Study|Physician Decision|1|||
146134537|NCT00603746|527010514|FG005|Overall Study|Physician Decision|0|||
146264997|NCT02635386|527484640|FG002|Overall Study|side effects|1|||
146134538|NCT00603746|527010509|FG000|Overall Study|Withdrawal by Subject|1|||
146134539|NCT00603746|527010510|FG001|Overall Study|Withdrawal by Subject|0|||
146134540|NCT00603746|527010511|FG002|Overall Study|Withdrawal by Subject|0|||
146134541|NCT00603746|527010512|FG003|Overall Study|Withdrawal by Subject|1|||
146134542|NCT00603746|527010513|FG004|Overall Study|Withdrawal by Subject|3|||
146134543|NCT00603746|527010514|FG005|Overall Study|Withdrawal by Subject|1|||
146134544|NCT01524627|527010517|FG000|Overall Study|Physician Decision|0|||
146134545|NCT01524627|527010518|FG001|Overall Study|Physician Decision|1|||
146134546|NCT01524627|527010517|FG000|Overall Study|Lost to Follow-up|1|||
146134547|NCT01524627|527010518|FG001|Overall Study|Lost to Follow-up|1|||
146134548|NCT00717769|527010519|FG000|Overall Study|Adverse Event|9|||
146134549|NCT00717769|527010520|FG001|Overall Study|Adverse Event|6|||
146134550|NCT00717769|527010521|FG002|Overall Study|Adverse Event|1|||
146134551|NCT00717769|527010519|FG000|Overall Study|Lack of compliance|0|||
146134552|NCT00717769|527010520|FG001|Overall Study|Lack of compliance|2|||
146134553|NCT00717769|527010521|FG002|Overall Study|Lack of compliance|0|||
146134554|NCT00717769|527010519|FG000|Overall Study|Lost to Follow-up|3|||
146134555|NCT00717769|527010520|FG001|Overall Study|Lost to Follow-up|4|||
146134556|NCT00717769|527010521|FG002|Overall Study|Lost to Follow-up|0|||
146134557|NCT00717769|527010519|FG000|Overall Study|Lack of Efficacy|1|||
146134558|NCT00717769|527010520|FG001|Overall Study|Lack of Efficacy|2|||
146134559|NCT00717769|527010521|FG002|Overall Study|Lack of Efficacy|0|||
146134560|NCT00717769|527010519|FG000|Overall Study|Protocol Violation|0|||
146134561|NCT00717769|527010520|FG001|Overall Study|Protocol Violation|2|||
146134562|NCT00717769|527010521|FG002|Overall Study|Protocol Violation|0|||
146134563|NCT00717769|527010519|FG000|Overall Study|Sponsor decision|1|||
146134564|NCT00717769|527010520|FG001|Overall Study|Sponsor decision|0|||
146134565|NCT00717769|527010521|FG002|Overall Study|Sponsor decision|10|||
146134566|NCT00717769|527010519|FG000|Overall Study|Withdrew consent|2|||
146134567|NCT00717769|527010520|FG001|Overall Study|Withdrew consent|2|||
146134568|NCT00717769|527010521|FG002|Overall Study|Withdrew consent|0|||
146134569|NCT03350503|527010525|FG000|Overall Study|Adverse Event|5|||
146134570|NCT03350503|527010525|FG000|Overall Study|Withdrawal by Subject|5|||
146134571|NCT03350503|527010525|FG000|Overall Study|Continuation impossible due to move|4|||
146134572|NCT03350503|527010525|FG000|Overall Study|Physician Decision|3|||
146134573|NCT02970968|527012111|FG000|Overall Study|Withdrawal by Subject|3|||
146134574|NCT02970968|527012112|FG001|Overall Study|Withdrawal by Subject|3|||
146134575|NCT02970968|527012111|FG000|Overall Study|Adverse Event|1|||
146134576|NCT02970968|527012112|FG001|Overall Study|Adverse Event|2|||
146134577|NCT02970968|527012111|FG000|Overall Study|Lost to Follow-up|1|||
146134578|NCT02970968|527012112|FG001|Overall Study|Lost to Follow-up|1|||
146134579|NCT02970968|527012111|FG000|Overall Study|Non-Compliance|0|||
146134580|NCT02970968|527012112|FG001|Overall Study|Non-Compliance|1|||
146134581|NCT01904604|527012115|FG000|Overall Study|Withdrew before receiving dosing|0|||
146134582|NCT01904604|527012116|FG001|Overall Study|Withdrew before receiving dosing|1|||
146134583|NCT01904604|527012117|FG002|Overall Study|Withdrew before receiving dosing|0|||
146134584|NCT01904604|527012115|FG000|Overall Study|Non-compliance|1|||
146134585|NCT01904604|527012116|FG001|Overall Study|Non-compliance|0|||
146134586|NCT01904604|527012117|FG002|Overall Study|Non-compliance|0|||
146134587|NCT01904604|527012115|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
146134588|NCT01904604|527012116|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
146134589|NCT01904604|527012117|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
146134590|NCT01904604|527012115|FG000|Overall Study|Patch site reactions|1|||
146134591|NCT01904604|527012116|FG001|Overall Study|Patch site reactions|1|||
146134592|NCT01904604|527012117|FG002|Overall Study|Patch site reactions|0|||
146134593|NCT01904604|527012115|FG000|Overall Study|Increased syncope|0|||
146134594|NCT01904604|527012116|FG001|Overall Study|Increased syncope|1|||
146134595|NCT01904604|527012117|FG002|Overall Study|Increased syncope|0|||
146134596|NCT01904604|527012115|FG000|Overall Study|Unrelated illness|0|||
146134597|NCT01904604|527012116|FG001|Overall Study|Unrelated illness|1|||
146134598|NCT01904604|527012117|FG002|Overall Study|Unrelated illness|0|||
146134599|NCT01904604|527012115|FG000|Overall Study|Passed Week 52 OFC|1|||
146134600|NCT01904604|527012116|FG001|Overall Study|Passed Week 52 OFC|0|||
146134601|NCT01904604|527012117|FG002|Overall Study|Passed Week 52 OFC|0|||
146134602|NCT01904604|527012115|FG000|Overall Study|Withdrawal by Subject|1|||
146134603|NCT01904604|527012116|FG001|Overall Study|Withdrawal by Subject|2|||
146134604|NCT01904604|527012117|FG002|Overall Study|Withdrawal by Subject|0|||
146134605|NCT01904604|527012115|FG000|Overall Study|Participant Relocated|1|||
146134606|NCT01904604|527012116|FG001|Overall Study|Participant Relocated|1|||
146134607|NCT01904604|527012117|FG002|Overall Study|Participant Relocated|1|||
146134608|NCT01904604|527012115|FG000|Overall Study|Lost to Follow-up|0|||
146134609|NCT01904604|527012116|FG001|Overall Study|Lost to Follow-up|0|||
146134610|NCT01904604|527012117|FG002|Overall Study|Lost to Follow-up|1|||
146134611|NCT00697346|527012120|FG000|Overall Study|Adverse Event|4|||
146134612|NCT00697346|527012121|FG001|Overall Study|Adverse Event|5|||
146134613|NCT00697346|527012122|FG002|Overall Study|Adverse Event|0|||
146134614|NCT00697346|527012120|FG000|Overall Study|Progressive Disease|19|||
146134615|NCT00697346|527012121|FG001|Overall Study|Progressive Disease|18|||
146134616|NCT00697346|527012122|FG002|Overall Study|Progressive Disease|0|||
146134617|NCT00697346|527012120|FG000|Overall Study|Symptomatic Deterioration|0|||
146134618|NCT00697346|527012121|FG001|Overall Study|Symptomatic Deterioration|1|||
146134619|NCT00697346|527012122|FG002|Overall Study|Symptomatic Deterioration|0|||
146134620|NCT00697346|527012120|FG000|Overall Study|Withdrawal by Subject|2|||
146134621|NCT00697346|527012121|FG001|Overall Study|Withdrawal by Subject|2|||
146134622|NCT00697346|527012122|FG002|Overall Study|Withdrawal by Subject|0|||
146134623|NCT00697346|527012120|FG000|Overall Study|Reason not Specified|3|||
146134624|NCT00697346|527012121|FG001|Overall Study|Reason not Specified|0|||
146134625|NCT00697346|527012122|FG002|Overall Study|Reason not Specified|1|||
146134626|NCT03643562|527012123|FG000|Overall Study|Adverse Event|1|||
146134627|NCT03643562|527012124|FG001|Overall Study|Adverse Event|0|||
146134628|NCT03643562|527012123|FG000|Overall Study|Lack of Efficacy|0|||
146134629|NCT03643562|527012124|FG001|Overall Study|Lack of Efficacy|1|||
146134630|NCT03643562|527012123|FG000|Overall Study|Physician Decision|0|||
146134631|NCT03643562|527012124|FG001|Overall Study|Physician Decision|1|||
146134632|NCT03643562|527012123|FG000|Overall Study|Study Terminated by Sponsor|2|||
146134633|NCT03643562|527012124|FG001|Overall Study|Study Terminated by Sponsor|10|||
146134634|NCT03643562|527012123|FG000|Overall Study|Withdrawal by Subject|2|||
146134635|NCT03643562|527012124|FG001|Overall Study|Withdrawal by Subject|2|||
146134636|NCT03643562|527012123|FG000|Overall Study|Other than specified|3|||
146134637|NCT03643562|527012124|FG001|Overall Study|Other than specified|2|||
146134638|NCT04145895|527012125|FG000|Overall Study|Physician Decision|2|||
146134639|NCT04145895|527012126|FG001|Overall Study|Physician Decision|0|||
146134640|NCT04145895|527012125|FG000|Overall Study|Withdrawal by Subject|0|||
146134641|NCT04145895|527012126|FG001|Overall Study|Withdrawal by Subject|2|||
146134642|NCT01236755|527012127|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
146134643|NCT01236755|527012127|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
146134644|NCT01236755|527012127|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
146134645|NCT01236755|527012127|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
146134646|NCT01481116|527012128|FG000|Overall Study|Adverse Event|26|||
146134647|NCT01481116|527012129|FG001|Overall Study|Adverse Event|26|||
146134648|NCT01481116|527012130|FG002|Overall Study|Adverse Event|42|||
146134649|NCT01481116|527012128|FG000|Overall Study|Major Protocol Deviation|3|||
146134650|NCT01481116|527012129|FG001|Overall Study|Major Protocol Deviation|7|||
146134651|NCT01481116|527012130|FG002|Overall Study|Major Protocol Deviation|1|||
146134652|NCT01481116|527012128|FG000|Overall Study|Lost to Follow-up|8|||
146134653|NCT01481116|527012129|FG001|Overall Study|Lost to Follow-up|12|||
146134654|NCT01481116|527012130|FG002|Overall Study|Lost to Follow-up|11|||
146134655|NCT01481116|527012128|FG000|Overall Study|Withdrawal by Subject|37|||
146134656|NCT01481116|527012129|FG001|Overall Study|Withdrawal by Subject|33|||
146134657|NCT01481116|527012130|FG002|Overall Study|Withdrawal by Subject|37|||
146134658|NCT01481116|527012128|FG000|Overall Study|Study Termination|730|||
146134659|NCT01481116|527012129|FG001|Overall Study|Study Termination|729|||
146134660|NCT01481116|527012130|FG002|Overall Study|Study Termination|713|||
146134661|NCT01481116|527012128|FG000|Overall Study|Pregnancy|0|||
146134662|NCT01481116|527012129|FG001|Overall Study|Pregnancy|0|||
146134663|NCT01481116|527012130|FG002|Overall Study|Pregnancy|1|||
146134664|NCT01481116|527012128|FG000|Overall Study|Lack of Efficacy|3|||
146134665|NCT01481116|527012129|FG001|Overall Study|Lack of Efficacy|3|||
146134666|NCT01481116|527012130|FG002|Overall Study|Lack of Efficacy|1|||
146134667|NCT01481116|527012128|FG000|Overall Study|Contraindications|1|||
146134668|NCT01481116|527012129|FG001|Overall Study|Contraindications|1|||
146134669|NCT01481116|527012130|FG002|Overall Study|Contraindications|0|||
146134670|NCT01481116|527012128|FG000|Overall Study|Other|1|||
146134671|NCT01481116|527012129|FG001|Overall Study|Other|1|||
146134672|NCT01481116|527012130|FG002|Overall Study|Other|0|||
146134673|NCT01481116|527012128|FG000|Overall Study|Participant Started Taking Glipizide|1|||
146134674|NCT01481116|527012129|FG001|Overall Study|Participant Started Taking Glipizide|0|||
146134675|NCT01481116|527012130|FG002|Overall Study|Participant Started Taking Glipizide|0|||
146134676|NCT01481116|527012128|FG000|Overall Study|Participant Moved Out of Area|2|||
146134677|NCT01481116|527012129|FG001|Overall Study|Participant Moved Out of Area|0|||
146134678|NCT01481116|527012130|FG002|Overall Study|Participant Moved Out of Area|1|||
146134679|NCT01481116|527012128|FG000|Overall Study|Participant Moved Out of Country|1|||
146134680|NCT01481116|527012129|FG001|Overall Study|Participant Moved Out of Country|0|||
146134681|NCT01481116|527012130|FG002|Overall Study|Participant Moved Out of Country|1|||
146134682|NCT01481116|527012128|FG000|Overall Study|Investigator Decision|3|||
146134683|NCT01481116|527012129|FG001|Overall Study|Investigator Decision|2|||
146134684|NCT01481116|527012130|FG002|Overall Study|Investigator Decision|1|||
146134685|NCT01481116|527012128|FG000|Overall Study|Sponsor Decision|0|||
146134686|NCT01481116|527012129|FG001|Overall Study|Sponsor Decision|1|||
146134687|NCT01481116|527012130|FG002|Overall Study|Sponsor Decision|3|||
146134688|NCT01481116|527012128|FG000|Overall Study|Non-Compliant With Study Drug|0|||
146134689|NCT01481116|527012129|FG001|Overall Study|Non-Compliant With Study Drug|1|||
146134690|NCT01481116|527012130|FG002|Overall Study|Non-Compliant With Study Drug|1|||
146134691|NCT01481116|527012128|FG000|Overall Study|Investigator's Discretion|2|||
146134692|NCT01481116|527012129|FG001|Overall Study|Investigator's Discretion|0|||
146134693|NCT01481116|527012130|FG002|Overall Study|Investigator's Discretion|0|||
146134694|NCT01481116|527012128|FG000|Overall Study|Death|2|||
146134695|NCT01481116|527012129|FG001|Overall Study|Death|1|||
146134696|NCT01481116|527012130|FG002|Overall Study|Death|0|||
146134697|NCT01481116|527012128|FG000|Overall Study|Hypoglycemic Event|4|||
146134698|NCT01481116|527012129|FG001|Overall Study|Hypoglycemic Event|0|||
146134699|NCT01481116|527012130|FG002|Overall Study|Hypoglycemic Event|0|||
146134700|NCT00805935|527012131|FG000|Overall Study|Stimulation Failure|1|||
146134701|NCT00805935|527012132|FG001|Overall Study|Stimulation Failure|5|||
146134702|NCT00805935|527012133|FG002|Overall Study|Stimulation Failure|2|||
146134703|NCT00805935|527012134|FG003|Overall Study|Stimulation Failure|2|||
146134704|NCT00805935|527012131|FG000|Overall Study|Cycle cancelled|0|||
146134705|NCT00805935|527012132|FG001|Overall Study|Cycle cancelled|0|||
146134706|NCT00805935|527012133|FG002|Overall Study|Cycle cancelled|2|||
146134707|NCT00805935|527012134|FG003|Overall Study|Cycle cancelled|0|||
146134708|NCT00805935|527012131|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
146134709|NCT00805935|527012132|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
146134710|NCT00805935|527012133|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
146134711|NCT00805935|527012134|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
146134712|NCT00805935|527012131|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146134713|NCT00805935|527012132|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146134714|NCT00805935|527012133|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
146134715|NCT00805935|527012134|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
146134716|NCT00805935|527012131|FG000|Overall Study|Lost to Follow-up|1|||
146134717|NCT00805935|527012132|FG001|Overall Study|Lost to Follow-up|0|||
146134718|NCT00805935|527012133|FG002|Overall Study|Lost to Follow-up|0|||
146134719|NCT00805935|527012134|FG003|Overall Study|Lost to Follow-up|0|||
146134720|NCT00805935|527012131|FG000|Overall Study|No positive serum pregnancy|8|||
146134721|NCT00805935|527012132|FG001|Overall Study|No positive serum pregnancy|7|||
146134722|NCT00805935|527012133|FG002|Overall Study|No positive serum pregnancy|6|||
146134723|NCT00805935|527012134|FG003|Overall Study|No positive serum pregnancy|5|||
146134724|NCT00805935|527012131|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146134725|NCT00805935|527012132|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146134726|NCT00805935|527012133|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146134727|NCT00805935|527012134|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146134728|NCT00805935|527012131|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
146134729|NCT00805935|527012132|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
146134730|NCT00805935|527012133|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
146134731|NCT00805935|527012134|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
146134732|NCT00805935|527012131|FG000|Overall Study|Biochemical pregnancy|0|||
146134733|NCT00805935|527012132|FG001|Overall Study|Biochemical pregnancy|1|||
146134734|NCT00805935|527012133|FG002|Overall Study|Biochemical pregnancy|0|||
146134735|NCT00805935|527012134|FG003|Overall Study|Biochemical pregnancy|0|||
146134736|NCT00805935|527012131|FG000|Overall Study|Chemical pregnancy|0|||
146134737|NCT00805935|527012132|FG001|Overall Study|Chemical pregnancy|5|||
146134738|NCT00805935|527012133|FG002|Overall Study|Chemical pregnancy|3|||
146134739|NCT00805935|527012134|FG003|Overall Study|Chemical pregnancy|2|||
146134740|NCT00805935|527012131|FG000|Overall Study|Ectopic pregnancy|0|||
146134741|NCT00805935|527012132|FG001|Overall Study|Ectopic pregnancy|0|||
146134742|NCT00805935|527012133|FG002|Overall Study|Ectopic pregnancy|1|||
146134743|NCT00805935|527012134|FG003|Overall Study|Ectopic pregnancy|0|||
146134744|NCT00805935|527012131|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146134745|NCT00805935|527012132|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
146134746|NCT00805935|527012133|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146134747|NCT00805935|527012134|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
146134748|NCT02347527|527012135|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
146134749|NCT02347527|527012136|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
146134750|NCT02347527|527012137|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
146134751|NCT02347527|527012138|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
146134752|NCT02347527|527012135|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
146134753|NCT02347527|527012136|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
146134754|NCT02347527|527012137|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
146134755|NCT02347527|527012138|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
146134756|NCT02347527|527012135|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
146134757|NCT02347527|527012136|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
146134758|NCT02347527|527012137|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
146134759|NCT02347527|527012138|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
146134760|NCT02347527|527012135|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
146134761|NCT02347527|527012136|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
146134762|NCT02347527|527012137|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
146134763|NCT02347527|527012138|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
146134764|NCT02347527|527012135|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146134765|NCT02347527|527012136|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
146134766|NCT02347527|527012137|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146134767|NCT02347527|527012138|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
146134768|NCT02643251|527012139|FG000|Overall Study|Adverse Event|3|||
146134769|NCT02643251|527012140|FG001|Overall Study|Adverse Event|1|||
146134770|NCT02643251|527012139|FG000|Overall Study|Withdrawal by Subject|2|||
146134771|NCT02643251|527012140|FG001|Overall Study|Withdrawal by Subject|0|||
146134772|NCT02643251|527012139|FG000|Overall Study|Lost to Follow-up|4|||
146264998|NCT02635386|527484641|FG003|Overall Study|side effects|4|||
146134773|NCT02643251|527012140|FG001|Overall Study|Lost to Follow-up|1|||
146134774|NCT02643251|527012139|FG000|Overall Study|Protocol Violation|1|||
146134775|NCT02643251|527012140|FG001|Overall Study|Protocol Violation|0|||
146134776|NCT02643251|527012139|FG000|Overall Study|PI Decision to terminate patient|1|||
146134777|NCT02643251|527012140|FG001|Overall Study|PI Decision to terminate patient|0|||
146134778|NCT01466270|527012141|FG000|Overall Study|Withdrawal by Subject|4|||
146134779|NCT01466270|527012142|FG001|Overall Study|Withdrawal by Subject|1|||
146134780|NCT01466270|527012141|FG000|Overall Study|Physician Decision|1|||
146134781|NCT01466270|527012142|FG001|Overall Study|Physician Decision|0|||
146134782|NCT01466270|527012141|FG000|Overall Study|Lost to Follow-up|1|||
146134783|NCT01466270|527012142|FG001|Overall Study|Lost to Follow-up|3|||
146134784|NCT01466270|527012141|FG000|Overall Study|Progression|1|||
146134785|NCT01466270|527012142|FG001|Overall Study|Progression|0|||
146134786|NCT01466270|527012141|FG000|Overall Study|Toxicity|4|||
146134787|NCT01466270|527012142|FG001|Overall Study|Toxicity|1|||
146134788|NCT01466270|527012141|FG000|Overall Study|Multiple|1|||
146134789|NCT01466270|527012142|FG001|Overall Study|Multiple|1|||
146134790|NCT02821962|527012143|FG000|Overall Study|Lost to Follow-up|2|||
146134791|NCT02821962|527012144|FG001|Overall Study|Lost to Follow-up|0|||
146134792|NCT04206293|527012149|FG000|Overall Study|Consent withdrawal|1|||
146134793|NCT00706966|527012151|FG000|Overall Study|Adverse Event|1|||
146134794|NCT03752619|527012155|FG000|Overall Study|Lost to Follow-up|2|||
146134795|NCT03752619|527012156|FG001|Overall Study|Lost to Follow-up|1|||
146134796|NCT03752619|527012155|FG000|Overall Study|Withdrawal by Subject|1|||
146134797|NCT03752619|527012156|FG001|Overall Study|Withdrawal by Subject|1|||
146134798|NCT03752619|527012155|FG000|Overall Study|Adverse Event|0|||
146134799|NCT03752619|527012156|FG001|Overall Study|Adverse Event|1|||
146134800|NCT05040152|527012157|FG000|Overall Study|Withdrawal by Subject|5|||
146134801|NCT05040152|527012158|FG001|Overall Study|Withdrawal by Subject|0|||
146134802|NCT05040152|527012157|FG000|Overall Study|Lost to Follow-up|0|||
146134803|NCT05040152|527012158|FG001|Overall Study|Lost to Follow-up|2|||
146134804|NCT03907683|527012159|FG000|Overall Study|Pregnancy|1|||
146134805|NCT03907683|527012159|FG000|Overall Study|Withdrawal by Subject|1|||
146134806|NCT03400332|527012160|FG000|Pre-Treatment|Other reasons|0|||
146134807|NCT03400332|527012161|FG001|Pre-Treatment|Other reasons|0|||
146134808|NCT03400332|527012162|FG002|Pre-Treatment|Other reasons|0|||
146134809|NCT03400332|527012163|FG003|Pre-Treatment|Other reasons|0|||
146134810|NCT03400332|527012164|FG004|Pre-Treatment|Other reasons|0|||
146134811|NCT03400332|527012165|FG005|Pre-Treatment|Other reasons|0|||
146134812|NCT03400332|527012166|FG006|Pre-Treatment|Other reasons|0|||
146134813|NCT03400332|527012167|FG007|Pre-Treatment|Other reasons|0|||
146134814|NCT03400332|527012168|FG008|Pre-Treatment|Other reasons|1|||
146134815|NCT03400332|527012160|FG000|Pre-Treatment|No longer met study criteria|0|||
146134816|NCT03400332|527012161|FG001|Pre-Treatment|No longer met study criteria|0|||
146134817|NCT03400332|527012162|FG002|Pre-Treatment|No longer met study criteria|0|||
146134818|NCT03400332|527012163|FG003|Pre-Treatment|No longer met study criteria|0|||
146134819|NCT03400332|527012164|FG004|Pre-Treatment|No longer met study criteria|0|||
146134820|NCT03400332|527012165|FG005|Pre-Treatment|No longer met study criteria|0|||
146134821|NCT03400332|527012166|FG006|Pre-Treatment|No longer met study criteria|0|||
146134822|NCT03400332|527012167|FG007|Pre-Treatment|No longer met study criteria|0|||
146134823|NCT03400332|527012168|FG008|Pre-Treatment|No longer met study criteria|1|||
146134824|NCT03400332|527012160|FG000|Pre-Treatment|Withdrawal by Subject|0|||
146134825|NCT03400332|527012161|FG001|Pre-Treatment|Withdrawal by Subject|0|||
146134826|NCT03400332|527012162|FG002|Pre-Treatment|Withdrawal by Subject|0|||
146134827|NCT03400332|527012163|FG003|Pre-Treatment|Withdrawal by Subject|0|||
146134828|NCT03400332|527012164|FG004|Pre-Treatment|Withdrawal by Subject|0|||
146134829|NCT03400332|527012165|FG005|Pre-Treatment|Withdrawal by Subject|0|||
146134830|NCT03400332|527012166|FG006|Pre-Treatment|Withdrawal by Subject|0|||
146134831|NCT03400332|527012167|FG007|Pre-Treatment|Withdrawal by Subject|0|||
146134832|NCT03400332|527012168|FG008|Pre-Treatment|Withdrawal by Subject|1|||
146134833|NCT03400332|527012160|FG000|Treatment|Participant withdrew consent|2|||
146134834|NCT03400332|527012161|FG001|Treatment|Participant withdrew consent|2|||
146134835|NCT03400332|527012162|FG002|Treatment|Participant withdrew consent|0|||
146134836|NCT03400332|527012163|FG003|Treatment|Participant withdrew consent|0|||
146134837|NCT03400332|527012164|FG004|Treatment|Participant withdrew consent|3|||
146134838|NCT03400332|527012165|FG005|Treatment|Participant withdrew consent|3|||
146134839|NCT03400332|527012166|FG006|Treatment|Participant withdrew consent|1|||
146134840|NCT03400332|527012167|FG007|Treatment|Participant withdrew consent|1|||
146134841|NCT03400332|527012168|FG008|Treatment|Participant withdrew consent|1|||
146134842|NCT03400332|527012160|FG000|Treatment|Other reasons|0|||
146134843|NCT03400332|527012161|FG001|Treatment|Other reasons|1|||
146134844|NCT03400332|527012162|FG002|Treatment|Other reasons|1|||
146134845|NCT03400332|527012163|FG003|Treatment|Other reasons|0|||
146134846|NCT03400332|527012164|FG004|Treatment|Other reasons|3|||
146134847|NCT03400332|527012165|FG005|Treatment|Other reasons|1|||
146134848|NCT03400332|527012166|FG006|Treatment|Other reasons|2|||
146134849|NCT03400332|527012167|FG007|Treatment|Other reasons|0|||
146134850|NCT03400332|527012168|FG008|Treatment|Other reasons|1|||
146303700|NCT05093322|527625880|FG001|Overall Study|Death|2|||
146134851|NCT03400332|527012160|FG000|Treatment|Lost to Follow-up|0|||
146134852|NCT03400332|527012161|FG001|Treatment|Lost to Follow-up|1|||
146134853|NCT03400332|527012162|FG002|Treatment|Lost to Follow-up|0|||
146134854|NCT03400332|527012163|FG003|Treatment|Lost to Follow-up|0|||
146134855|NCT03400332|527012164|FG004|Treatment|Lost to Follow-up|0|||
146134856|NCT03400332|527012165|FG005|Treatment|Lost to Follow-up|0|||
146134857|NCT03400332|527012166|FG006|Treatment|Lost to Follow-up|0|||
146134858|NCT03400332|527012167|FG007|Treatment|Lost to Follow-up|0|||
146134859|NCT03400332|527012168|FG008|Treatment|Lost to Follow-up|0|||
146134860|NCT03400332|527012160|FG000|Treatment|Death|3|||
146134861|NCT03400332|527012161|FG001|Treatment|Death|1|||
146134862|NCT03400332|527012162|FG002|Treatment|Death|2|||
146134863|NCT03400332|527012163|FG003|Treatment|Death|3|||
146134864|NCT03400332|527012164|FG004|Treatment|Death|6|||
146134865|NCT03400332|527012165|FG005|Treatment|Death|2|||
146134866|NCT03400332|527012166|FG006|Treatment|Death|1|||
146134867|NCT03400332|527012167|FG007|Treatment|Death|3|||
146134868|NCT03400332|527012168|FG008|Treatment|Death|6|||
146134869|NCT02075840|527012171|FG000|Overall Study|Withdrawal by Subject|13|||
146134870|NCT02075840|527012172|FG001|Overall Study|Withdrawal by Subject|22|||
146134871|NCT02075840|527012171|FG000|Overall Study|Reason not specified|1|||
146134872|NCT02075840|527012172|FG001|Overall Study|Reason not specified|0|||
146134873|NCT02075840|527012171|FG000|Overall Study|Adverse Event|0|||
146134874|NCT02075840|527012172|FG001|Overall Study|Adverse Event|2|||
146134875|NCT02075840|527012171|FG000|Overall Study|Death|35|||
146134876|NCT02075840|527012172|FG001|Overall Study|Death|40|||
146134877|NCT02075840|527012171|FG000|Overall Study|Lost to Follow-up|3|||
146134878|NCT02075840|527012172|FG001|Overall Study|Lost to Follow-up|2|||
146134879|NCT02075840|527012171|FG000|Overall Study|Physician Decision|1|||
146134880|NCT02075840|527012172|FG001|Overall Study|Physician Decision|3|||
146134881|NCT02075840|527012171|FG000|Overall Study|Ongoing at CCOD|99|||
146134882|NCT02075840|527012172|FG001|Overall Study|Ongoing at CCOD|82|||
146134883|NCT03909165|527012175|FG000|Overall Study|Physician Decision|0|||
146134884|NCT03909165|527012176|FG001|Overall Study|Physician Decision|1|||
146134885|NCT03909165|527012177|FG002|Overall Study|Physician Decision|0|||
146134886|NCT03909165|527012178|FG003|Overall Study|Physician Decision|0|||
146134887|NCT03909165|527012179|FG004|Overall Study|Physician Decision|0|||
146134888|NCT03909165|527012175|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146134889|NCT03909165|527012176|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146134890|NCT03909165|527012177|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146134891|NCT03909165|527012178|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
146134892|NCT03909165|527012179|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
146134893|NCT03909165|527012175|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146134894|NCT03909165|527012176|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146134895|NCT03909165|527012177|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146134896|NCT03909165|527012178|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
146134897|NCT03909165|527012179|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
146134898|NCT03909165|527012175|FG000|Overall Study|Previous Drug Exposure|0|||
146134899|NCT03909165|527012176|FG001|Overall Study|Previous Drug Exposure|0|||
146134900|NCT03909165|527012177|FG002|Overall Study|Previous Drug Exposure|1|||
146134901|NCT03909165|527012178|FG003|Overall Study|Previous Drug Exposure|0|||
146134902|NCT03909165|527012179|FG004|Overall Study|Previous Drug Exposure|0|||
146134903|NCT03909165|527012175|FG000|Overall Study|Early Discharge|1|||
146264999|NCT02635386|527484642|FG004|Overall Study|side effects|6|||
146265000|NCT02635386|527484638|FG000|Overall Study|needed other major surgery|0|||
146265001|NCT02635386|527484639|FG001|Overall Study|needed other major surgery|1|||
146265002|NCT02635386|527484640|FG002|Overall Study|needed other major surgery|0|||
146265003|NCT02635386|527484641|FG003|Overall Study|needed other major surgery|0|||
146265004|NCT02635386|527484642|FG004|Overall Study|needed other major surgery|0|||
146265005|NCT02635386|527484638|FG000|Overall Study|Other medical problems not drug related|0|||
146265006|NCT02635386|527484639|FG001|Overall Study|Other medical problems not drug related|0|||
146265007|NCT02635386|527484640|FG002|Overall Study|Other medical problems not drug related|0|||
146265008|NCT02635386|527484641|FG003|Overall Study|Other medical problems not drug related|1|||
146265009|NCT02635386|527484642|FG004|Overall Study|Other medical problems not drug related|0|||
146265010|NCT02706847|527484645|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
146265011|NCT02706847|527484646|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
146134904|NCT03909165|527012176|FG001|Overall Study|Early Discharge|0|||
146134905|NCT03909165|527012177|FG002|Overall Study|Early Discharge|0|||
146134906|NCT03909165|527012178|FG003|Overall Study|Early Discharge|0|||
146134907|NCT03909165|527012179|FG004|Overall Study|Early Discharge|0|||
146134908|NCT00414661|527012180|FG000|Overall Study|Death|2|||
146134909|NCT00414661|527012181|FG001|Overall Study|Death|5|||
146134910|NCT00414661|527012182|FG002|Overall Study|Death|0|||
146134911|NCT00414661|527012183|FG003|Overall Study|Death|0|||
146134912|NCT00414661|527012180|FG000|Overall Study|Lost to Follow-up|1|||
146134913|NCT00414661|527012181|FG001|Overall Study|Lost to Follow-up|4|||
146134914|NCT00414661|527012182|FG002|Overall Study|Lost to Follow-up|0|||
146134915|NCT00414661|527012183|FG003|Overall Study|Lost to Follow-up|1|||
146303701|NCT05093322|527625879|FG000|Overall Study|Other|4|||
146303702|NCT05093322|527625880|FG001|Overall Study|Other|1|||
146303703|NCT00074581|527625882|FG000|Overall Study|Death|15|||
146303704|NCT00074581|527625883|FG001|Overall Study|Death|16|||
146303705|NCT00074581|527625882|FG000|Overall Study|Withdrawal by Subject|50|||
146303706|NCT00074581|527625883|FG001|Overall Study|Withdrawal by Subject|49|||
146303707|NCT00074581|527625882|FG000|Overall Study|Unable to adhere to visit schedule|13|||
146303708|NCT00074581|527625883|FG001|Overall Study|Unable to adhere to visit schedule|14|||
146303709|NCT00074581|527625882|FG000|Overall Study|Relocated|14|||
146303710|NCT00074581|527625883|FG001|Overall Study|Relocated|9|||
146303711|NCT00074581|527625882|FG000|Overall Study|Were withdrawn by investigator|5|||
146303712|NCT00074581|527625883|FG001|Overall Study|Were withdrawn by investigator|2|||
146303713|NCT00074581|527625882|FG000|Overall Study|Lost to Follow-up|16|||
146303714|NCT00074581|527625883|FG001|Overall Study|Lost to Follow-up|11|||
146303715|NCT00074581|527625882|FG000|Overall Study|Ended relationship w. index participant|117|||
146303716|NCT00074581|527625883|FG001|Overall Study|Ended relationship w. index participant|106|||
146265012|NCT02706847|527484647|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
146265013|NCT02706847|527484648|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
146265014|NCT02706847|527484645|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
146265015|NCT02706847|527484646|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
146265016|NCT02706847|527484647|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
146265017|NCT02706847|527484648|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
146265018|NCT02706847|527484645|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
146265019|NCT02706847|527484646|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
146265020|NCT02706847|527484647|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
146265021|NCT02706847|527484648|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
146265022|NCT02706847|527484645|FG000|Period 1: Day 1 to Week 12|Other|4|||
146265023|NCT02706847|527484646|FG001|Period 1: Day 1 to Week 12|Other|4|||
146265024|NCT02706847|527484647|FG002|Period 1: Day 1 to Week 12|Other|2|||
146265025|NCT02706847|527484648|FG003|Period 1: Day 1 to Week 12|Other|2|||
146265026|NCT02706847|527484645|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146265027|NCT02706847|527484646|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146265028|NCT02706847|527484647|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
146265029|NCT02706847|527484648|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
146265030|NCT02706847|527484645|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
146265031|NCT02706847|527484646|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
146265032|NCT02706847|527484647|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
146265033|NCT02706847|527484648|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
146265034|NCT02706847|527484645|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
146265035|NCT02706847|527484646|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
146265036|NCT02706847|527484647|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
146265037|NCT02706847|527484648|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
146265038|NCT02706847|527484645|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146265039|NCT02706847|527484646|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146265040|NCT02706847|527484647|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
146265041|NCT02706847|527484648|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
146265042|NCT02706847|527484645|FG000|Period 1: Week 12 to Week 24|Other|1|||
146265043|NCT02706847|527484646|FG001|Period 1: Week 12 to Week 24|Other|0|||
146265044|NCT02706847|527484647|FG002|Period 1: Week 12 to Week 24|Other|1|||
146265045|NCT02706847|527484648|FG003|Period 1: Week 12 to Week 24|Other|4|||
146265046|NCT02706847|527484645|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
146265047|NCT02706847|527484646|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
146265048|NCT02706847|527484647|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
146265049|NCT02706847|527484648|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
146265050|NCT02706847|527484645|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
146265051|NCT02706847|527484646|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
146265052|NCT02706847|527484647|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
146303717|NCT00074581|527625882|FG000|Overall Study|Other|14|||
146265053|NCT02706847|527484648|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
146265054|NCT02706847|527484645|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
146265055|NCT02706847|527484646|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
146265056|NCT02706847|527484647|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
146265057|NCT02706847|527484648|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
146265058|NCT02706847|527484645|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
146265059|NCT02706847|527484646|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
146265060|NCT02706847|527484647|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
146265061|NCT02706847|527484648|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
146265062|NCT02706847|527484645|FG000|Period 2: Week 24 to Week 260|Other|8|||
146303718|NCT00074581|527625883|FG001|Overall Study|Other|19|||
146303719|NCT05293743|527625891|FG000|Overall Study|Withdrawal by Subject|1|||
146303720|NCT05293743|527625892|FG001|Overall Study|Withdrawal by Subject|0|||
146303721|NCT02064920|527625893|FG000|Overall Study|Adverse Event|0|||
146303722|NCT02064920|527625894|FG001|Overall Study|Adverse Event|4|||
146265063|NCT02706847|527484646|FG001|Period 2: Week 24 to Week 260|Other|5|||
146265064|NCT02706847|527484647|FG002|Period 2: Week 24 to Week 260|Other|15|||
146265065|NCT02706847|527484648|FG003|Period 2: Week 24 to Week 260|Other|15|||
146265066|NCT02058836|527484649|FG000|Overall Study|Withdrawal by Subject|1|||
146265067|NCT02058836|527484650|FG001|Overall Study|Withdrawal by Subject|1|||
146265068|NCT01087814|527484652|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
146265069|NCT01087814|527484653|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
146265070|NCT01087814|527484652|FG000|Second Intervention (5 Days)|Physician Decision|1|||
146265071|NCT01087814|527484653|FG001|Second Intervention (5 Days)|Physician Decision|0|||
146265072|NCT01427738|527484654|FG000|Overall Study|Death|12|||
146265073|NCT01427738|527484655|FG001|Overall Study|Death|9|||
146265074|NCT01427738|527484654|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146265075|NCT01427738|527484655|FG001|Overall Study|Severe debilitation, unable to continue|1|||
146265076|NCT01427738|527484654|FG000|Overall Study|Subject unable to get to clinic|5|||
146265077|NCT01427738|527484655|FG001|Overall Study|Subject unable to get to clinic|2|||
146265078|NCT01427738|527484654|FG000|Overall Study|Withdrawal by Subject|0|||
146265079|NCT01427738|527484655|FG001|Overall Study|Withdrawal by Subject|2|||
146265080|NCT01427738|527484654|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
146265081|NCT01427738|527484655|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
146265082|NCT01427738|527484654|FG000|Overall Study|Lost to Follow-up|1|||
146265083|NCT01427738|527484655|FG001|Overall Study|Lost to Follow-up|5|||
146265084|NCT05314374|527484656|FG000|Overall Study|Adverse Event|2|||
146265085|NCT05314374|527484657|FG001|Overall Study|Adverse Event|2|||
146265086|NCT02658175|527484658|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
146265087|NCT02658175|527484659|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
146265088|NCT02658175|527484660|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
146265089|NCT02658175|527484658|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
146265090|NCT02658175|527484659|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
146265091|NCT02658175|527484660|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
146265092|NCT02658175|527484658|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
146265093|NCT02658175|527484659|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
146265094|NCT02658175|527484660|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
146265095|NCT02658175|527484658|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
146265096|NCT02658175|527484659|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
146265097|NCT02658175|527484660|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
146265098|NCT02658175|527484658|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
146265099|NCT02658175|527484659|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
146265100|NCT02658175|527484660|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
146265101|NCT02658175|527484658|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
146265102|NCT02658175|527484659|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
146265103|NCT02658175|527484660|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
146265104|NCT02658175|527484658|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
146265105|NCT02658175|527484659|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
146265106|NCT02658175|527484660|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
146265107|NCT02658175|527484658|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
146265108|NCT02658175|527484659|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
146265109|NCT02658175|527484660|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
146265110|NCT02658175|527484658|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
146265111|NCT02658175|527484659|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
146265112|NCT02658175|527484660|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
146265113|NCT02658175|527484658|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
146265114|NCT02658175|527484659|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
146265115|NCT02658175|527484660|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
146265116|NCT02918292|527484663|FG000|Study Enrollment Prior to Transplant|Death|1|||
146265117|NCT02918292|527484663|FG000|Study Follow up After Transplant|Death|6|||
146265118|NCT02650466|527484664|FG000|Overall Study|Physician Decision|1|||
146265119|NCT02650466|527484664|FG000|Overall Study|Withdrawal by Subject|5|||
146265120|NCT02650466|527484664|FG000|Overall Study|Lost to Follow-up|1|||
146265121|NCT01214421|527484665|FG000|Overall Study|Lost to Follow-up|7|||
146265122|NCT01214421|527484666|FG001|Overall Study|Lost to Follow-up|3|||
146265123|NCT01214421|527484667|FG002|Overall Study|Lost to Follow-up|7|||
146265124|NCT01214421|527484668|FG003|Overall Study|Lost to Follow-up|3|||
146265125|NCT01214421|527484665|FG000|Overall Study|Adverse Event|16|||
146265126|NCT01214421|527484666|FG001|Overall Study|Adverse Event|35|||
146265127|NCT01214421|527484667|FG002|Overall Study|Adverse Event|14|||
146303723|NCT02064920|527625893|FG000|Overall Study|Physician Decision|0|||
146265128|NCT01214421|527484668|FG003|Overall Study|Adverse Event|3|||
146303724|NCT02064920|527625894|FG001|Overall Study|Physician Decision|1|||
146303725|NCT02064920|527625893|FG000|Overall Study|Technical Problems|0|||
146303726|NCT02064920|527625894|FG001|Overall Study|Technical Problems|1|||
146303727|NCT02064920|527625893|FG000|Overall Study|Withdrawal by Subject|1|||
146303728|NCT02064920|527625894|FG001|Overall Study|Withdrawal by Subject|3|||
146303729|NCT00916279|527625895|FG000|Overall Study|Death|2|||
146303730|NCT00916279|527625895|FG000|Overall Study|Lost to Follow-up|2|||
146303731|NCT00382720|527627365|FG000|Overall Study|Adverse Event|21|||
146303732|NCT00382720|527627366|FG001|Overall Study|Adverse Event|23|||
146303733|NCT00382720|527627367|FG002|Overall Study|Adverse Event|15|||
146303734|NCT00382720|527627365|FG000|Overall Study|Protocol Violation|2|||
146303735|NCT00382720|527627366|FG001|Overall Study|Protocol Violation|5|||
146303736|NCT00382720|527627367|FG002|Overall Study|Protocol Violation|1|||
146303737|NCT00382720|527627365|FG000|Overall Study|Death|0|||
146303738|NCT00382720|527627366|FG001|Overall Study|Death|1|||
146303739|NCT00382720|527627367|FG002|Overall Study|Death|2|||
146303740|NCT00382720|527627365|FG000|Overall Study|Progressive disease|37|||
146303741|NCT00382720|527627366|FG001|Overall Study|Progressive disease|28|||
146303742|NCT00382720|527627367|FG002|Overall Study|Progressive disease|38|||
146303743|NCT00382720|527627365|FG000|Overall Study|Withdrew consent|1|||
146303744|NCT00382720|527627366|FG001|Overall Study|Withdrew consent|1|||
146303745|NCT00382720|527627367|FG002|Overall Study|Withdrew consent|2|||
146303746|NCT00382720|527627365|FG000|Overall Study|Withdrawal by Subject|11|||
146303747|NCT00382720|527627366|FG001|Overall Study|Withdrawal by Subject|20|||
146303748|NCT00382720|527627367|FG002|Overall Study|Withdrawal by Subject|12|||
146303749|NCT00382720|527627365|FG000|Overall Study|Surgery|1|||
146303750|NCT00382720|527627366|FG001|Overall Study|Surgery|1|||
146303751|NCT00382720|527627367|FG002|Overall Study|Surgery|4|||
146303752|NCT00382720|527627365|FG000|Overall Study|Patient did not receive study medication|1|||
146303753|NCT00382720|527627366|FG001|Overall Study|Patient did not receive study medication|1|||
146303754|NCT00382720|527627367|FG002|Overall Study|Patient did not receive study medication|4|||
146303755|NCT00382720|527627365|FG000|Overall Study|Clinically progressive disease|0|||
146303756|NCT00382720|527627366|FG001|Overall Study|Clinically progressive disease|1|||
146303757|NCT00382720|527627367|FG002|Overall Study|Clinically progressive disease|0|||
146303758|NCT00382720|527627365|FG000|Overall Study|Good prognosis|0|||
146303759|NCT00382720|527627366|FG001|Overall Study|Good prognosis|1|||
146303760|NCT00382720|527627367|FG002|Overall Study|Good prognosis|0|||
146303761|NCT00382720|527627365|FG000|Overall Study|Investigator/Clinical decision|5|||
146303762|NCT00382720|527627366|FG001|Overall Study|Investigator/Clinical decision|6|||
146303763|NCT00382720|527627367|FG002|Overall Study|Investigator/Clinical decision|6|||
146303764|NCT00382720|527627365|FG000|Overall Study|Discontinued at end of study|0|||
146303765|NCT00382720|527627366|FG001|Overall Study|Discontinued at end of study|1|||
146303766|NCT00382720|527627367|FG002|Overall Study|Discontinued at end of study|2|||
146303767|NCT02737852|527627370|FG000|Overall Study|Withdrawal by Subject|2|||
146303768|NCT01183143|527627371|FG000|Overall Study|Protocol Violation|115|||
146134916|NCT00414661|527012180|FG000|Overall Study|Withdrawal by Subject|5|||
146134917|NCT00414661|527012181|FG001|Overall Study|Withdrawal by Subject|2|||
146134918|NCT00414661|527012182|FG002|Overall Study|Withdrawal by Subject|2|||
146134919|NCT00414661|527012183|FG003|Overall Study|Withdrawal by Subject|2|||
146134920|NCT00414661|527012180|FG000|Overall Study|Other|6|||
146134921|NCT00414661|527012181|FG001|Overall Study|Other|3|||
146134922|NCT00414661|527012182|FG002|Overall Study|Other|0|||
146134923|NCT00414661|527012183|FG003|Overall Study|Other|0|||
146134924|NCT00559962|527012187|FG000|Overall Study|Adverse Event|1|||
146134925|NCT00559962|527012188|FG001|Overall Study|Adverse Event|7|||
146134926|NCT00559962|527012189|FG002|Overall Study|Adverse Event|8|||
146134927|NCT00559962|527012190|FG003|Overall Study|Adverse Event|5|||
146134928|NCT00559962|527012191|FG004|Overall Study|Adverse Event|11|||
146134929|NCT00559962|527012192|FG005|Overall Study|Adverse Event|4|||
146134930|NCT00559962|527012193|FG006|Overall Study|Adverse Event|4|||
146134931|NCT00559962|527012194|FG007|Overall Study|Adverse Event|2|||
146134932|NCT00559962|527012187|FG000|Overall Study|Lost to Follow-up|0|||
146134933|NCT00559962|527012188|FG001|Overall Study|Lost to Follow-up|1|||
146134934|NCT00559962|527012189|FG002|Overall Study|Lost to Follow-up|0|||
146134935|NCT00559962|527012190|FG003|Overall Study|Lost to Follow-up|0|||
146134936|NCT00559962|527012191|FG004|Overall Study|Lost to Follow-up|0|||
146134937|NCT00559962|527012192|FG005|Overall Study|Lost to Follow-up|0|||
146134938|NCT00559962|527012193|FG006|Overall Study|Lost to Follow-up|0|||
146134939|NCT00559962|527012194|FG007|Overall Study|Lost to Follow-up|0|||
146303769|NCT01183143|527627371|FG000|Overall Study|Withdrawal by Subject|19|||
146303770|NCT01183143|527627371|FG000|Overall Study|Subject Questionnaires not returned|5|||
146303771|NCT01183143|527627371|FG000|Overall Study|Subjects enrolled, but not treated|11|||
146303772|NCT04042740|527627373|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
146303773|NCT04042740|527627373|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
146303774|NCT01717287|527627374|FG000|Overall Study|Lost to Follow-up|0|||
146303775|NCT01717287|527627375|FG001|Overall Study|Lost to Follow-up|2|||
146134940|NCT00559962|527012187|FG000|Overall Study|Withdrawal by Subject|1|||
146134941|NCT00559962|527012188|FG001|Overall Study|Withdrawal by Subject|1|||
146134942|NCT00559962|527012189|FG002|Overall Study|Withdrawal by Subject|2|||
146134943|NCT00559962|527012190|FG003|Overall Study|Withdrawal by Subject|0|||
146134944|NCT00559962|527012191|FG004|Overall Study|Withdrawal by Subject|3|||
146134945|NCT00559962|527012192|FG005|Overall Study|Withdrawal by Subject|1|||
146134946|NCT00559962|527012193|FG006|Overall Study|Withdrawal by Subject|0|||
146134947|NCT00559962|527012194|FG007|Overall Study|Withdrawal by Subject|2|||
146134948|NCT00559962|527012187|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
146134949|NCT00559962|527012188|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
146134950|NCT00559962|527012189|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
146134951|NCT00559962|527012190|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
146134952|NCT00559962|527012191|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
146134953|NCT00559962|527012192|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
146134954|NCT00559962|527012193|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
146134955|NCT00559962|527012194|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
146134956|NCT03047135|527012195|FG000|Overall Study|Still being treated|3|||
146134957|NCT00323414|527012196|FG000|Overall Study|Withdrawal by Subject|0|||
146134958|NCT00323414|527012197|FG001|Overall Study|Withdrawal by Subject|1|||
146134959|NCT01077960|527012198|FG000|Overall Study|Adverse Event|6|||
146134960|NCT01077960|527012198|FG000|Overall Study|Protocol Violation|3|||
146134961|NCT01077960|527012198|FG000|Overall Study|Lost to Follow-up|5|||
146134962|NCT01077960|527012198|FG000|Overall Study|Subject decision|1|||
146134963|NCT01077960|527012198|FG000|Overall Study|Reason unspecified|1|||
146134964|NCT05619692|527012199|FG000|Overall Study|Adverse Event|2|||
146134965|NCT05619692|527012200|FG001|Overall Study|Adverse Event|2|||
146134966|NCT05619692|527012199|FG000|Overall Study|Withdrawal by Participant|3|||
146134967|NCT05619692|527012200|FG001|Overall Study|Withdrawal by Participant|4|||
146134968|NCT05619692|527012199|FG000|Overall Study|Lost to Follow-up|2|||
146134969|NCT05619692|527012200|FG001|Overall Study|Lost to Follow-up|1|||
146134970|NCT05619692|527012199|FG000|Overall Study|Randomized but not treated|1|||
146134971|NCT05619692|527012200|FG001|Overall Study|Randomized but not treated|3|||
146134972|NCT02703636|527012210|FG000|Overall Study|Adverse Event|14|||
146134973|NCT02703636|527012210|FG000|Overall Study|Study stopped by sponsor|1|||
146303776|NCT01717287|527627374|FG000|Overall Study|Protocol Violation|0|||
146303777|NCT01717287|527627375|FG001|Overall Study|Protocol Violation|1|||
146303778|NCT04490395|527627376|FG000|Overall Study|Lost to Follow-up|0|||
146303779|NCT04490395|527627377|FG001|Overall Study|Lost to Follow-up|1|||
146303780|NCT00388505|527627378|FG000|Overall Study|Adverse Event or Death|43|||
146303781|NCT00388505|527627379|FG001|Overall Study|Adverse Event or Death|17|||
146303782|NCT00388505|527627378|FG000|Overall Study|Withdrawal by Subject|24|||
146303783|NCT00388505|527627379|FG001|Overall Study|Withdrawal by Subject|9|||
146303784|NCT00388505|527627378|FG000|Overall Study|Lost to Follow-up|5|||
146303785|NCT00388505|527627379|FG001|Overall Study|Lost to Follow-up|3|||
146303786|NCT00388505|527627378|FG000|Overall Study|Inappropriate Enrollment|0|||
146303787|NCT00388505|527627379|FG001|Overall Study|Inappropriate Enrollment|1|||
146303788|NCT00388505|527627378|FG000|Overall Study|Administrative Reason|1|||
146303789|NCT00388505|527627379|FG001|Overall Study|Administrative Reason|0|||
146303790|NCT00388505|527627378|FG000|Overall Study|Protocol Violation|6|||
146303791|NCT00388505|527627379|FG001|Overall Study|Protocol Violation|5|||
146303792|NCT00388505|527627378|FG000|Overall Study|Unable to classify|4|||
146303793|NCT00388505|527627379|FG001|Overall Study|Unable to classify|3|||
146303794|NCT02163187|527627383|FG000|Overall Study|Device removed|1|||
146303795|NCT02163187|527627384|FG001|Overall Study|Device removed|0|||
146303796|NCT02163187|527627383|FG000|Overall Study|Progressive disease|1|||
146303797|NCT02163187|527627384|FG001|Overall Study|Progressive disease|0|||
146303798|NCT03281668|527627385|FG000|Overall Study|Physician Decision|1|||
146303799|NCT03281668|527627385|FG000|Overall Study|scheduling conflict, family circumstance|2|||
146303800|NCT03281668|527627385|FG000|Overall Study|Withdrawal by Subject|4|||
146303801|NCT03281668|527627385|FG000|Overall Study|Lost to Follow-up|1|||
146303802|NCT00762892|527627387|FG000|Overall Study|Lost to Follow-up|2|||
146303803|NCT00762892|527627388|FG001|Overall Study|Lost to Follow-up|5|||
146303804|NCT00762892|527627387|FG000|Overall Study|Withdrawal by Subject|0|||
146303805|NCT00762892|527627388|FG001|Overall Study|Withdrawal by Subject|1|||
146303806|NCT00762892|527627387|FG000|Overall Study|Death|1|||
146303807|NCT00762892|527627388|FG001|Overall Study|Death|0|||
146303808|NCT00762892|527627387|FG000|Overall Study|Pregnancy|1|||
146303809|NCT00762892|527627388|FG001|Overall Study|Pregnancy|0|||
146303810|NCT00762892|527627387|FG000|Overall Study|Incarceration|1|||
146303811|NCT00762892|527627388|FG001|Overall Study|Incarceration|0|||
146303812|NCT03374995|527627392|FG000|Overall Study|Withdrawal by Subject|0|||
146303813|NCT03374995|527627393|FG001|Overall Study|Withdrawal by Subject|1|||
146134974|NCT02703636|527012210|FG000|Overall Study|Withdrawal by Subject|1|||
146134975|NCT04334460|527012214|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
146134976|NCT04334460|527012215|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
146303814|NCT00003895|527627396|FG000|Overall Study|Adverse Event|4|||
146303815|NCT00003895|527627397|FG001|Overall Study|Adverse Event|0|||
146303816|NCT00003895|527627396|FG000|Overall Study|Lack of Efficacy|1|||
146303817|NCT00003895|527627397|FG001|Overall Study|Lack of Efficacy|1|||
146303818|NCT00003895|527627396|FG000|Overall Study|Patient Vacation|2|||
146134977|NCT04334460|527012214|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
146134978|NCT04334460|527012215|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
146134979|NCT03778931|527012218|FG000|Overall Study|Withdrawal by Subject|12|||
146134980|NCT03778931|527012219|FG001|Overall Study|Withdrawal by Subject|25|||
146134981|NCT03778931|527012218|FG000|Overall Study|Physician Decision|1|||
146134982|NCT03778931|527012219|FG001|Overall Study|Physician Decision|3|||
146134983|NCT03778931|527012218|FG000|Overall Study|Participant Noncompliance|1|||
146134984|NCT03778931|527012219|FG001|Overall Study|Participant Noncompliance|1|||
146134985|NCT03778931|527012218|FG000|Overall Study|Lost to Follow-up|4|||
146134986|NCT03778931|527012219|FG001|Overall Study|Lost to Follow-up|1|||
146134987|NCT03778931|527012218|FG000|Overall Study|Death|69|||
146134988|NCT03778931|527012219|FG001|Overall Study|Death|79|||
146134989|NCT02130765|527012224|FG000|Overall Study|Did not receive treatment|4|||
146134990|NCT02130765|527012225|FG001|Overall Study|Did not receive treatment|0|||
146134991|NCT02130765|527012226|FG002|Overall Study|Did not receive treatment|0|||
146134992|NCT02130765|527012227|FG003|Overall Study|Did not receive treatment|0|||
146134993|NCT01398956|527012233|FG000|Overall Study|Withdrawal by Subject|4|||
146134994|NCT01398956|527012233|FG000|Overall Study|AE, non-serious non-fatal|4|||
146134995|NCT01398956|527012233|FG000|Overall Study|Withdrawal Criteria No.3|1|||
146134996|NCT01398956|527012233|FG000|Overall Study|Subject moved a long distance|1|||
146134997|NCT00451035|527012234|FG000|Overall Study|Disease progression|11|||
146134998|NCT00451035|527012234|FG000|Overall Study|Death|3|||
146134999|NCT00451035|527012234|FG000|Overall Study|New anti-neoplastic therapy|3|||
146135000|NCT00969553|527012237|FG000|Overall Study|Progressive disease (PD)|2|||
146135001|NCT00969553|527012238|FG001|Overall Study|Progressive disease (PD)|2|||
146135002|NCT00969553|527012239|FG002|Overall Study|Progressive disease (PD)|6|||
146135003|NCT00969553|527012240|FG003|Overall Study|Progressive disease (PD)|9|||
146135004|NCT00969553|527012241|FG004|Overall Study|Progressive disease (PD)|2|||
146135005|NCT00969553|527012242|FG005|Overall Study|Progressive disease (PD)|4|||
146135006|NCT00969553|527012243|FG006|Overall Study|Progressive disease (PD)|2|||
146135007|NCT00969553|527012244|FG007|Overall Study|Progressive disease (PD)|12|||
146135008|NCT00969553|527012245|FG008|Overall Study|Progressive disease (PD)|3|||
146135009|NCT00969553|527012237|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135010|NCT00969553|527012238|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135011|NCT00969553|527012239|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135012|NCT00969553|527012240|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135013|NCT00969553|527012241|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
146135014|NCT00969553|527012242|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135015|NCT00969553|527012243|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135016|NCT00969553|527012244|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135017|NCT00969553|527012245|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
146135018|NCT00969553|527012237|FG000|Overall Study|Other Adverse Event|0|||
146135019|NCT00969553|527012238|FG001|Overall Study|Other Adverse Event|0|||
146135020|NCT00969553|527012239|FG002|Overall Study|Other Adverse Event|0|||
146135021|NCT00969553|527012240|FG003|Overall Study|Other Adverse Event|1|||
146135022|NCT00969553|527012241|FG004|Overall Study|Other Adverse Event|0|||
146135023|NCT00969553|527012242|FG005|Overall Study|Other Adverse Event|0|||
146135024|NCT00969553|527012243|FG006|Overall Study|Other Adverse Event|1|||
146135025|NCT00969553|527012244|FG007|Overall Study|Other Adverse Event|0|||
146135026|NCT00969553|527012245|FG008|Overall Study|Other Adverse Event|0|||
146135027|NCT00969553|527012237|FG000|Overall Study|Refused cont. medication|1|||
146135028|NCT00969553|527012238|FG001|Overall Study|Refused cont. medication|1|||
146135029|NCT00969553|527012239|FG002|Overall Study|Refused cont. medication|0|||
146135030|NCT00969553|527012240|FG003|Overall Study|Refused cont. medication|2|||
146303819|NCT00003895|527627397|FG001|Overall Study|Patient Vacation|0|||
146135031|NCT00969553|527012241|FG004|Overall Study|Refused cont. medication|0|||
146135032|NCT00969553|527012242|FG005|Overall Study|Refused cont. medication|0|||
146135033|NCT00969553|527012243|FG006|Overall Study|Refused cont. medication|0|||
146135034|NCT00969553|527012244|FG007|Overall Study|Refused cont. medication|1|||
146135035|NCT00969553|527012245|FG008|Overall Study|Refused cont. medication|0|||
146135036|NCT00969553|527012237|FG000|Overall Study|Not specified above|0|||
146135037|NCT00969553|527012238|FG001|Overall Study|Not specified above|0|||
146135038|NCT00969553|527012239|FG002|Overall Study|Not specified above|0|||
146135039|NCT00969553|527012240|FG003|Overall Study|Not specified above|4|||
146135040|NCT00969553|527012241|FG004|Overall Study|Not specified above|0|||
146135041|NCT00969553|527012242|FG005|Overall Study|Not specified above|0|||
146135042|NCT00969553|527012243|FG006|Overall Study|Not specified above|1|||
146135043|NCT00969553|527012244|FG007|Overall Study|Not specified above|1|||
146135044|NCT00969553|527012245|FG008|Overall Study|Not specified above|0|||
146135045|NCT02321462|527012247|FG000|Overall Study|Withdrawal by Subject|5|||
146135046|NCT02321462|527012248|FG001|Overall Study|Withdrawal by Subject|2|||
146135047|NCT02321462|527012247|FG000|Overall Study|Subject withdrawn before any treatment|1|||
146135048|NCT02321462|527012248|FG001|Overall Study|Subject withdrawn before any treatment|1|||
146135049|NCT04248816|527012251|FG000|Overall Study|Ineligible post-randomization|7|||
146135050|NCT04248816|527012252|FG001|Overall Study|Ineligible post-randomization|21|||
146135051|NCT04248816|527012253|FG002|Overall Study|Ineligible post-randomization|25|||
146135052|NCT04327986|527012254|FG000|Overall Study|Physician Decision|2|||
146135053|NCT04327986|527012255|FG001|Overall Study|Physician Decision|0|||
146135054|NCT04327986|527012256|FG002|Overall Study|Physician Decision|0|||
146135055|NCT04327986|527012254|FG000|Overall Study|Death|1|||
146135056|NCT04327986|527012255|FG001|Overall Study|Death|0|||
146135057|NCT04327986|527012256|FG002|Overall Study|Death|0|||
146135058|NCT03829046|527012259|FG000|Overall Study|Withdrawal by Subject|1|||
146135059|NCT03829046|527012260|FG001|Overall Study|Withdrawal by Subject|0|||
146135060|NCT01399593|527012262|FG000|Overall Study|Physician Decision|1|||
146135061|NCT01399593|527012263|FG001|Overall Study|Physician Decision|0|||
146135062|NCT01399593|527012262|FG000|Overall Study|Adverse Event|1|||
146135063|NCT01399593|527012263|FG001|Overall Study|Adverse Event|0|||
146135064|NCT01399593|527012262|FG000|Overall Study|Death|1|||
146135065|NCT01399593|527012263|FG001|Overall Study|Death|1|||
146135066|NCT01399593|527012262|FG000|Overall Study|Transplantectomy|0|||
146135067|NCT01399593|527012263|FG001|Overall Study|Transplantectomy|1|||
146135068|NCT02357147|527012266|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
146135069|NCT02357147|527012267|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
146135070|NCT02357147|527012266|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
146135071|NCT02357147|527012267|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
146135072|NCT02357147|527012266|FG000|Combination Treatment Phase|Investigator Discretion|1|||
146135073|NCT02357147|527012267|FG001|Combination Treatment Phase|Investigator Discretion|1|||
146135074|NCT02357147|527012266|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
146135075|NCT02357147|527012267|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
146135076|NCT02357147|527012266|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
146135077|NCT02357147|527012267|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
146135078|NCT02357147|527012266|FG000|Combination Treatment Phase|Adverse Event|12|||
146135079|NCT02357147|527012267|FG001|Combination Treatment Phase|Adverse Event|4|||
146135080|NCT02357147|527012266|FG000|Combination Treatment Phase|Death|1|||
146135081|NCT02357147|527012267|FG001|Combination Treatment Phase|Death|1|||
146135082|NCT02357147|527012266|FG000|Combination Treatment Phase|Sponsor Decision|0|||
146135083|NCT02357147|527012267|FG001|Combination Treatment Phase|Sponsor Decision|12|||
146135084|NCT02357147|527012266|FG000|Combination Treatment Phase|Other|1|||
146135085|NCT02357147|527012267|FG001|Combination Treatment Phase|Other|0|||
146135086|NCT02357147|527012266|FG000|Combination Treatment Phase|Not treated|0|||
146135087|NCT02357147|527012267|FG001|Combination Treatment Phase|Not treated|2|||
146135088|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
146135089|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
146135090|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
146135091|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
146135092|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
146135093|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
146135094|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146135095|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Adverse Event|3|||
146135096|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
146135097|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
146135098|NCT02357147|527012266|FG000|Maintenance Treatment Phase|Not Treated|1|||
146135099|NCT02357147|527012267|FG001|Maintenance Treatment Phase|Not Treated|0|||
146135100|NCT04477304|527012268|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
146135101|NCT04477304|527012269|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
146135102|NCT03962543|527012270|FG000|Treatment Phase|Death|0|||
146135103|NCT03962543|527012271|FG001|Treatment Phase|Death|1|||
146135104|NCT03962543|527012270|FG000|Treatment Phase|Withdrawal by Subject|3|||
146135105|NCT03962543|527012271|FG001|Treatment Phase|Withdrawal by Subject|0|||
146135106|NCT03962543|527012270|FG000|Treatment Phase|Adverse Event|3|||
146135107|NCT03962543|527012271|FG001|Treatment Phase|Adverse Event|12|||
146135108|NCT03962543|527012270|FG000|Treatment Phase|Lost to Follow-up|1|||
146135109|NCT03962543|527012271|FG001|Treatment Phase|Lost to Follow-up|2|||
146135110|NCT03962543|527012270|FG000|Treatment Phase|Radiographic PD|9|||
146135111|NCT03962543|527012271|FG001|Treatment Phase|Radiographic PD|3|||
146135112|NCT03962543|527012270|FG000|Treatment Phase|Participant Decision|3|||
146135113|NCT03962543|527012271|FG001|Treatment Phase|Participant Decision|8|||
146135114|NCT03962543|527012270|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
146135115|NCT03962543|527012271|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
146135116|NCT03962543|527012270|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
146135117|NCT03962543|527012271|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
146135118|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
146135119|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
146135120|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
146135121|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
146135122|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
146135123|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
146135124|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
146135125|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
146135126|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
146135127|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
146135128|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
146135129|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
146135130|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
146135131|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
146135132|NCT03962543|527012270|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
146135133|NCT03962543|527012271|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
146135134|NCT03569371|527013684|FG000|Overall Study|Lack of Efficacy|1|||
146135135|NCT03569371|527013684|FG000|Overall Study|Lost to Follow-up|1|||
146135136|NCT03569371|527013684|FG000|Overall Study|Adverse Event|1|||
146135137|NCT02789176|527013685|FG000|Overall Study|Death|0|||
146135138|NCT02789176|527013686|FG001|Overall Study|Death|0|||
146135139|NCT02789176|527013687|FG002|Overall Study|Death|3|||
146135140|NCT02789176|527013688|FG003|Overall Study|Death|0|||
146135141|NCT02789176|527013685|FG000|Overall Study|Withdrawal by Subject|0|||
146135142|NCT02789176|527013686|FG001|Overall Study|Withdrawal by Subject|0|||
146135143|NCT02789176|527013687|FG002|Overall Study|Withdrawal by Subject|1|||
146135144|NCT02789176|527013688|FG003|Overall Study|Withdrawal by Subject|0|||
146135145|NCT02789176|527013685|FG000|Overall Study|Lost to Follow-up|8|||
146135146|NCT02789176|527013686|FG001|Overall Study|Lost to Follow-up|2|||
146135147|NCT02789176|527013687|FG002|Overall Study|Lost to Follow-up|6|||
146135148|NCT02789176|527013688|FG003|Overall Study|Lost to Follow-up|1|||
146135149|NCT00596011|527013690|FG000|Overall Study|Withdrawal by Subject|2|||
146135150|NCT00596011|527013691|FG001|Overall Study|Withdrawal by Subject|3|||
146135151|NCT00596011|527013690|FG000|Overall Study|Adverse Event|11|||
146135152|NCT00596011|527013691|FG001|Overall Study|Adverse Event|7|||
146135153|NCT00348556|527013692|FG000|Overall Study|Adverse Event|1|||
146135154|NCT00192075|527013693|FG000|Overall Study|Disease Progression|23|||
146135155|NCT00192075|527013694|FG001|Overall Study|Disease Progression|6|||
146135156|NCT00192075|527013693|FG000|Overall Study|Adverse Event|1|||
146135157|NCT00192075|527013694|FG001|Overall Study|Adverse Event|3|||
146135158|NCT00192075|527013693|FG000|Overall Study|Death|0|||
146135159|NCT00192075|527013694|FG001|Overall Study|Death|1|||
146135160|NCT00192075|527013693|FG000|Overall Study|Lack of Efficacy|0|||
146135161|NCT00192075|527013694|FG001|Overall Study|Lack of Efficacy|0|||
146135162|NCT00192075|527013693|FG000|Overall Study|Physician Decision|3|||
146135163|NCT00192075|527013694|FG001|Overall Study|Physician Decision|0|||
146135164|NCT00192075|527013693|FG000|Overall Study|Withdrawal by Subject|5|||
146135165|NCT00192075|527013694|FG001|Overall Study|Withdrawal by Subject|5|||
146135166|NCT00192075|527013693|FG000|Overall Study|Patient Non-Compliance|0|||
146135167|NCT00192075|527013694|FG001|Overall Study|Patient Non-Compliance|1|||
146135168|NCT00192075|527013693|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
146135169|NCT00192075|527013694|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
146135170|NCT00192075|527013693|FG000|Overall Study|Other|5|||
146135171|NCT00192075|527013694|FG001|Overall Study|Other|2|||
146135172|NCT01944059|527013695|FG000|Overall Study|Lost to Follow-up|1|||
146135173|NCT01944059|527013695|FG000|Overall Study|Physician Decision|3|||
146135174|NCT01944059|527013695|FG000|Overall Study|Withdrawal by Subject|1|||
146135175|NCT01944059|527013695|FG000|Overall Study|Adverse Event|2|||
146135176|NCT00430092|527013703|FG000|Overall Study|Adverse Event|0|||
146135177|NCT00430092|527013704|FG001|Overall Study|Adverse Event|0|||
146135178|NCT00430092|527013705|FG002|Overall Study|Adverse Event|1|||
146135179|NCT00430092|527013703|FG000|Overall Study|Lack of Efficacy|5|||
146135180|NCT00430092|527013704|FG001|Overall Study|Lack of Efficacy|2|||
146135181|NCT00430092|527013705|FG002|Overall Study|Lack of Efficacy|54|||
146135182|NCT00430092|527013703|FG000|Overall Study|Lost to Follow-up|1|||
146135183|NCT00430092|527013704|FG001|Overall Study|Lost to Follow-up|0|||
146303820|NCT00003895|527627396|FG000|Overall Study|Withdrawal by Subject|0|||
146303821|NCT00003895|527627397|FG001|Overall Study|Withdrawal by Subject|3|||
146303822|NCT01735279|527627398|FG000|Overall Study|Lost to Follow-up|11|||
146135184|NCT00430092|527013705|FG002|Overall Study|Lost to Follow-up|0|||
146135185|NCT00430092|527013703|FG000|Overall Study|Protocol Violation|0|||
146135186|NCT00430092|527013704|FG001|Overall Study|Protocol Violation|1|||
146135187|NCT00430092|527013705|FG002|Overall Study|Protocol Violation|1|||
146135188|NCT00430092|527013703|FG000|Overall Study|Withdrawal by Subject|0|||
146135189|NCT00430092|527013704|FG001|Overall Study|Withdrawal by Subject|1|||
146135190|NCT00430092|527013705|FG002|Overall Study|Withdrawal by Subject|1|||
146135191|NCT05923229|527013712|FG000|Overall Study|Withdrawal by Subject|3|||
146303823|NCT01735279|527627399|FG001|Overall Study|Lost to Follow-up|8|||
146135192|NCT05923229|527013713|FG001|Overall Study|Withdrawal by Subject|0|||
146303824|NCT02490475|527627400|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
146303825|NCT02490475|527627401|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
146135193|NCT05923229|527013712|FG000|Overall Study|Health related|2|||
146135194|NCT05923229|527013713|FG001|Overall Study|Health related|1|||
146135195|NCT03064126|527013714|FG000|Overall Study|Death|40|||
146135196|NCT03064126|527013715|FG001|Overall Study|Death|16|||
146135197|NCT03064126|527013716|FG002|Overall Study|Death|4|||
146135198|NCT03064126|527013717|FG003|Overall Study|Death|2|||
146135199|NCT03064126|527013714|FG000|Overall Study|Withdrawal by Subject|17|||
146135200|NCT03064126|527013715|FG001|Overall Study|Withdrawal by Subject|9|||
146135201|NCT03064126|527013716|FG002|Overall Study|Withdrawal by Subject|0|||
146135202|NCT03064126|527013717|FG003|Overall Study|Withdrawal by Subject|2|||
146135203|NCT03064126|527013714|FG000|Overall Study|Lost to Follow-up|7|||
146135204|NCT03064126|527013715|FG001|Overall Study|Lost to Follow-up|3|||
146135205|NCT03064126|527013716|FG002|Overall Study|Lost to Follow-up|0|||
146135206|NCT03064126|527013717|FG003|Overall Study|Lost to Follow-up|0|||
146135207|NCT03064126|527013714|FG000|Overall Study|Adverse Event|2|||
146135208|NCT03064126|527013715|FG001|Overall Study|Adverse Event|0|||
146135209|NCT03064126|527013716|FG002|Overall Study|Adverse Event|0|||
146135210|NCT03064126|527013717|FG003|Overall Study|Adverse Event|0|||
146135211|NCT03064126|527013714|FG000|Overall Study|Physician Decision|3|||
146135212|NCT03064126|527013715|FG001|Overall Study|Physician Decision|0|||
146135213|NCT03064126|527013716|FG002|Overall Study|Physician Decision|0|||
146135214|NCT03064126|527013717|FG003|Overall Study|Physician Decision|0|||
146135215|NCT03064126|527013714|FG000|Overall Study|Other reason for early termination|3|||
146303826|NCT02490475|527627402|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
146303827|NCT02490475|527627403|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
146303828|NCT02490475|527627400|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146303829|NCT02490475|527627401|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
146303830|NCT02490475|527627402|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146303831|NCT02490475|527627403|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
146303832|NCT02490475|527627400|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
146303833|NCT02490475|527627401|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
146303834|NCT02490475|527627402|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
146303835|NCT02490475|527627403|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
146303836|NCT02490475|527627400|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
146303837|NCT02490475|527627401|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
146303838|NCT02490475|527627402|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
146303839|NCT02490475|527627403|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
146303840|NCT02490475|527627400|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
146303841|NCT02490475|527627401|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
146135216|NCT03064126|527013715|FG001|Overall Study|Other reason for early termination|2|||
146135217|NCT03064126|527013716|FG002|Overall Study|Other reason for early termination|0|||
146135218|NCT03064126|527013717|FG003|Overall Study|Other reason for early termination|0|||
146135219|NCT03064126|527013714|FG000|Overall Study|Missed Visit|3|||
146265129|NCT01214421|527484665|FG000|Overall Study|Sponsor Discontinued Site|1|||
146265130|NCT01214421|527484666|FG001|Overall Study|Sponsor Discontinued Site|2|||
146265131|NCT01214421|527484667|FG002|Overall Study|Sponsor Discontinued Site|0|||
146265132|NCT01214421|527484668|FG003|Overall Study|Sponsor Discontinued Site|0|||
146265133|NCT01214421|527484665|FG000|Overall Study|Withdrawal Criteria Met|3|||
146265134|NCT01214421|527484666|FG001|Overall Study|Withdrawal Criteria Met|0|||
146265135|NCT01214421|527484667|FG002|Overall Study|Withdrawal Criteria Met|2|||
146265136|NCT01214421|527484668|FG003|Overall Study|Withdrawal Criteria Met|1|||
146265137|NCT01214421|527484665|FG000|Overall Study|Physician Decision|2|||
146265138|NCT01214421|527484666|FG001|Overall Study|Physician Decision|0|||
146265139|NCT01214421|527484667|FG002|Overall Study|Physician Decision|4|||
146265140|NCT01214421|527484668|FG003|Overall Study|Physician Decision|0|||
146265141|NCT01214421|527484665|FG000|Overall Study|Withdrawal by Subject|21|||
146265142|NCT01214421|527484666|FG001|Overall Study|Withdrawal by Subject|18|||
146303842|NCT02490475|527627402|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
146303843|NCT02490475|527627403|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
146303844|NCT02490475|527627400|FG000|Period 2: Extension Phase|Refused Treatment|0|||
146303845|NCT02490475|527627401|FG001|Period 2: Extension Phase|Refused Treatment|0|||
146303846|NCT02490475|527627402|FG002|Period 2: Extension Phase|Refused Treatment|0|||
146303847|NCT02490475|527627403|FG003|Period 2: Extension Phase|Refused Treatment|1|||
146303848|NCT02490475|527627400|FG000|Period 2: Extension Phase|Adverse Event|0|||
146303849|NCT02490475|527627401|FG001|Period 2: Extension Phase|Adverse Event|0|||
146303850|NCT02490475|527627402|FG002|Period 2: Extension Phase|Adverse Event|1|||
146135220|NCT03064126|527013715|FG001|Overall Study|Missed Visit|1|||
146303851|NCT02490475|527627403|FG003|Period 2: Extension Phase|Adverse Event|0|||
146265143|NCT01214421|527484667|FG002|Overall Study|Withdrawal by Subject|11|||
146303852|NCT01195090|527627405|FG000|Overall Study|Adverse Event|1|||
146135221|NCT03064126|527013716|FG002|Overall Study|Missed Visit|0|||
146265144|NCT01214421|527484668|FG003|Overall Study|Withdrawal by Subject|2|||
146265145|NCT02392104|527484669|FG000|Overall Study|discontinuation of warfarin|3|||
146265146|NCT02392104|527484669|FG000|Overall Study|bleeding event|1|||
146265147|NCT02392104|527484669|FG000|Overall Study|transferred care to another doctor|2|||
146265148|NCT02392104|527484669|FG000|Overall Study|INR goal range changed|1|||
146265149|NCT02392104|527484669|FG000|Overall Study|admitted to skilled nursing facility|3|||
146265150|NCT02392104|527484669|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
146265151|NCT03912532|527484673|FG000|Overall Study|Adverse Event|3|||
146265152|NCT03912532|527484674|FG001|Overall Study|Adverse Event|3|||
146265153|NCT03912532|527484675|FG002|Overall Study|Adverse Event|2|||
146265154|NCT03912532|527484676|FG003|Overall Study|Adverse Event|2|||
146265155|NCT03912532|527484673|FG000|Overall Study|Lost to Follow-up|3|||
146265156|NCT03912532|527484674|FG001|Overall Study|Lost to Follow-up|2|||
146265157|NCT03912532|527484675|FG002|Overall Study|Lost to Follow-up|1|||
146265158|NCT03912532|527484676|FG003|Overall Study|Lost to Follow-up|2|||
146265159|NCT03912532|527484673|FG000|Overall Study|Withdrawal by Subject|1|||
146265160|NCT03912532|527484674|FG001|Overall Study|Withdrawal by Subject|1|||
146265161|NCT03912532|527484675|FG002|Overall Study|Withdrawal by Subject|2|||
146265162|NCT03912532|527484676|FG003|Overall Study|Withdrawal by Subject|0|||
146265163|NCT03912532|527484673|FG000|Overall Study|Physician Decision|1|||
146265164|NCT03912532|527484674|FG001|Overall Study|Physician Decision|0|||
146265165|NCT03912532|527484675|FG002|Overall Study|Physician Decision|0|||
146265166|NCT03912532|527484676|FG003|Overall Study|Physician Decision|3|||
146265167|NCT03912532|527484673|FG000|Overall Study|Other|0|||
146265168|NCT03912532|527484674|FG001|Overall Study|Other|1|||
146265169|NCT03912532|527484675|FG002|Overall Study|Other|1|||
146265170|NCT03912532|527484676|FG003|Overall Study|Other|0|||
146265171|NCT04913948|527484677|FG000|Overall Study|Withdrawal by Subject|2|||
146303853|NCT01195090|527627406|FG001|Overall Study|Adverse Event|2|||
146303854|NCT01195090|527627405|FG000|Overall Study|Lost to Follow-up|2|||
146303855|NCT01195090|527627406|FG001|Overall Study|Lost to Follow-up|2|||
146303856|NCT01195090|527627405|FG000|Overall Study|Protocol Violation|3|||
146303857|NCT01195090|527627406|FG001|Overall Study|Protocol Violation|4|||
146303858|NCT04912245|527627407|FG000|Overall Study|Withdrawal by Subject|21|||
146303859|NCT04912245|527627408|FG001|Overall Study|Withdrawal by Subject|4|||
146303860|NCT04912245|527627407|FG000|Overall Study|Lost to Follow-up|5|||
146303861|NCT04912245|527627408|FG001|Overall Study|Lost to Follow-up|11|||
146303862|NCT01205230|527627409|FG000|Overall Study|Adverse Event|4|||
146303863|NCT01205230|527627410|FG001|Overall Study|Adverse Event|0|||
146303864|NCT01205230|527627409|FG000|Overall Study|Physician Decision|1|||
146303865|NCT01205230|527627410|FG001|Overall Study|Physician Decision|0|||
146303866|NCT04784897|527627411|FG000|Overall Study|Death|4|||
146303867|NCT04784897|527627412|FG001|Overall Study|Death|2|||
146303868|NCT04784897|527627413|FG002|Overall Study|Death|1|||
146303869|NCT04784897|527627411|FG000|Overall Study|Withdrawal by Subject|0|||
146303870|NCT04784897|527627412|FG001|Overall Study|Withdrawal by Subject|0|||
146303871|NCT04784897|527627413|FG002|Overall Study|Withdrawal by Subject|1|||
146303872|NCT02665052|527627414|FG000|Overall Study|Lost to Follow-up|1|||
146303873|NCT02665052|527627415|FG001|Overall Study|Lost to Follow-up|0|||
146303874|NCT02665052|527627416|FG002|Overall Study|Lost to Follow-up|0|||
146303875|NCT02665052|527627417|FG003|Overall Study|Lost to Follow-up|0|||
146303876|NCT02665052|527627414|FG000|Overall Study|Withdrawal by Subject|1|||
146303877|NCT02665052|527627415|FG001|Overall Study|Withdrawal by Subject|1|||
146303878|NCT02665052|527627416|FG002|Overall Study|Withdrawal by Subject|0|||
146303879|NCT02665052|527627417|FG003|Overall Study|Withdrawal by Subject|5|||
146303880|NCT02665052|527627414|FG000|Overall Study|Adverse Event|1|||
146303881|NCT02665052|527627415|FG001|Overall Study|Adverse Event|1|||
146303882|NCT02665052|527627416|FG002|Overall Study|Adverse Event|0|||
146303883|NCT02665052|527627417|FG003|Overall Study|Adverse Event|0|||
146303884|NCT02234284|527627418|FG000|Overall Study|Death|4|||
146303885|NCT02234284|527627419|FG001|Overall Study|Death|2|||
146303886|NCT02234284|527627418|FG000|Overall Study|Withdrawal by Subject|1|||
146303887|NCT02234284|527627419|FG001|Overall Study|Withdrawal by Subject|0|||
146303888|NCT02234284|527627418|FG000|Overall Study|Lost to Follow-up|20|||
146303889|NCT02234284|527627419|FG001|Overall Study|Lost to Follow-up|7|||
146303890|NCT04754802|527627421|FG000|Overall Study|Lost to Follow-up|0|||
146303891|NCT04754802|527627422|FG001|Overall Study|Lost to Follow-up|2|||
146303892|NCT04754802|527627421|FG000|Overall Study|Withdrawal by Subject|2|||
146303893|NCT04754802|527627422|FG001|Overall Study|Withdrawal by Subject|0|||
146303894|NCT04569032|527627423|FG000|Overall Study|Death|10|||
146135222|NCT03064126|527013717|FG003|Overall Study|Missed Visit|0|||
146135223|NCT05288556|527013721|FG000|Overall Study|Protocol Violation|1|||
146265172|NCT04913948|527484677|FG000|Overall Study|Sample processing issues|1|||
146265173|NCT04913948|527484677|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
146265174|NCT03783871|527484680|FG000|Overall Study|Withdrawal by Subject|15|||
146265175|NCT03783871|527484680|FG000|Overall Study|Death|13|||
146265176|NCT03783871|527484680|FG000|Overall Study|Lost to Follow-up|2|||
146265177|NCT00604188|527484681|FG000|Overall Study|Adverse Event|1|||
146265178|NCT00604188|527484682|FG001|Overall Study|Adverse Event|4|||
146303895|NCT04569032|527627424|FG001|Overall Study|Death|13|||
146303896|NCT04569032|527627423|FG000|Overall Study|Withdrawal by Subject|2|||
146303897|NCT04569032|527627424|FG001|Overall Study|Withdrawal by Subject|0|||
146303898|NCT04569032|527627423|FG000|Overall Study|Lost to Follow-up|0|||
146265179|NCT00604188|527484681|FG000|Overall Study|Lost to Follow-up|17|||
146265180|NCT00604188|527484682|FG001|Overall Study|Lost to Follow-up|15|||
146265181|NCT00604188|527484681|FG000|Overall Study|Withdrawal by Subject|5|||
146265182|NCT00604188|527484682|FG001|Overall Study|Withdrawal by Subject|1|||
146265183|NCT00604188|527484681|FG000|Overall Study|Non-compliance with protocol|4|||
146265184|NCT00604188|527484682|FG001|Overall Study|Non-compliance with protocol|4|||
146265185|NCT00604188|527484681|FG000|Overall Study|Did not receive study drug|0|||
146265186|NCT00604188|527484682|FG001|Overall Study|Did not receive study drug|1|||
146265187|NCT03668223|527484684|FG000|Overall Study|Death|10|||
146265188|NCT03668223|527484685|FG001|Overall Study|Death|5|||
146265189|NCT03668223|527484684|FG000|Overall Study|Lost to Follow-up|12|||
146265190|NCT03668223|527484685|FG001|Overall Study|Lost to Follow-up|12|||
146265191|NCT03668223|527484684|FG000|Overall Study|Withdrawal by Subject|8|||
146265192|NCT03668223|527484685|FG001|Overall Study|Withdrawal by Subject|3|||
146265193|NCT00443599|527484689|FG000|Overall Study|Physician Decision|2|||
146265194|NCT00443599|527484690|FG001|Overall Study|Physician Decision|1|||
146265195|NCT00443599|527484689|FG000|Overall Study|Death|1|||
146265196|NCT00443599|527484690|FG001|Overall Study|Death|1|||
146265197|NCT00443599|527484689|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
146265198|NCT00443599|527484690|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
146265199|NCT00575042|527486782|FG000|Overall Study|Adverse Event|2|||
146265200|NCT00575042|527486782|FG000|Overall Study|Lost to Follow-up|1|||
146265201|NCT01638390|527486783|FG000|Overall Study|screening failures|21|||
146265202|NCT01536587|527486790|FG000|Overall Study|Adverse Event|2|||
146265203|NCT02666664|527486791|FG000|Overall Study|Physician Decision|0|||
146265204|NCT02666664|527486792|FG001|Overall Study|Physician Decision|1|||
146265205|NCT02666664|527486791|FG000|Overall Study|Protocol Violation|0|||
146265206|NCT02666664|527486792|FG001|Overall Study|Protocol Violation|2|||
146265207|NCT02666664|527486791|FG000|Overall Study|Other|0|||
146265208|NCT02666664|527486792|FG001|Overall Study|Other|1|||
146265209|NCT02666664|527486791|FG000|Overall Study|Adverse Event|12|||
146265210|NCT02666664|527486792|FG001|Overall Study|Adverse Event|37|||
146265211|NCT02666664|527486791|FG000|Overall Study|Withdrawal by participant|23|||
146265212|NCT02666664|527486792|FG001|Overall Study|Withdrawal by participant|40|||
146265213|NCT02666664|527486791|FG000|Overall Study|Sponsor decision|0|||
146265214|NCT02666664|527486792|FG001|Overall Study|Sponsor decision|1|||
146265215|NCT02666664|527486791|FG000|Overall Study|Lost to Follow-up|1|||
146265216|NCT02666664|527486792|FG001|Overall Study|Lost to Follow-up|2|||
146265217|NCT04596995|527486793|FG000|Overall Study|Lack of Efficacy|8|||
146265218|NCT04596995|527486793|FG000|Overall Study|Lost to Follow-up|3|||
146265219|NCT04596995|527486793|FG000|Overall Study|Withdrawal by Subject|12|||
146265220|NCT04596995|527486793|FG000|Overall Study|Sponsor decision|3|||
146265221|NCT04596995|527486793|FG000|Overall Study|Enrolled in managed access program|3|||
146265222|NCT00129935|527486794|FG000|Overall Study|Adverse Event|18|||
146265223|NCT00129935|527486795|FG001|Overall Study|Adverse Event|56|||
146265224|NCT00129935|527486794|FG000|Overall Study|Death|1|||
146265225|NCT00129935|527486795|FG001|Overall Study|Death|1|||
146265226|NCT00129935|527486794|FG000|Overall Study|Withdrawal by Subject|7|||
146265227|NCT00129935|527486795|FG001|Overall Study|Withdrawal by Subject|20|||
146265228|NCT00129935|527486794|FG000|Overall Study|Protocol Violation|0|||
146265229|NCT00129935|527486795|FG001|Overall Study|Protocol Violation|4|||
146265230|NCT00129935|527486794|FG000|Overall Study|Physician Decision|3|||
146265231|NCT00129935|527486795|FG001|Overall Study|Physician Decision|4|||
146265232|NCT00129935|527486794|FG000|Overall Study|Recurrence|1|||
146265233|NCT00129935|527486795|FG001|Overall Study|Recurrence|3|||
146265234|NCT00129935|527486794|FG000|Overall Study|Second primary|0|||
146265235|NCT00129935|527486795|FG001|Overall Study|Second primary|1|||
146265236|NCT00129935|527486794|FG000|Overall Study|Other|3|||
146265237|NCT00129935|527486795|FG001|Overall Study|Other|2|||
146265238|NCT00129935|527486794|FG000|Overall Study|Crossed to the other arm|2|||
146265239|NCT00129935|527486795|FG001|Overall Study|Crossed to the other arm|1|||
146265240|NCT00129935|527486794|FG000|Overall Study|Incorrect study treatment|1|||
146265241|NCT00129935|527486795|FG001|Overall Study|Incorrect study treatment|0|||
146265242|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
146265243|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
146265244|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
146265245|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Death|4|||
146265246|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Death|2|||
146265247|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Death|3|||
146265248|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146265249|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
146265250|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
146265251|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
145943209|NCT00483704|526300456|FG000|Randomization|Physician Decision|2|||
146265252|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
146265253|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
146265254|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
146265255|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
146265256|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
146265257|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
146265258|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
146265259|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
146265260|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
146265261|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
146265262|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
146265263|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
146265264|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
146265265|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
146265266|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
146265267|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
146265268|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
146265269|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
146265270|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
146265271|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
146265272|NCT02783573|527486797|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
146265273|NCT02783573|527486798|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
146265274|NCT02783573|527486799|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
146265275|NCT02783573|527486797|FG000|Delayed-Start Period|Sponsor Decision|0|||
146265276|NCT02783573|527486798|FG001|Delayed-Start Period|Sponsor Decision|17|||
146265277|NCT02783573|527486799|FG002|Delayed-Start Period|Sponsor Decision|12|||
146265278|NCT03020069|527486800|FG000|Overall Study|Lost to Follow-up|0|||
146265279|NCT03020069|527486801|FG001|Overall Study|Lost to Follow-up|1|||
146265280|NCT00589303|527486802|FG000|Overall Study|Withdrawal by Subject|2|||
146265281|NCT00589303|527486803|FG001|Overall Study|Withdrawal by Subject|1|||
146265282|NCT02056626|527486804|FG000|Overall Study|patient did not follow directions|3|||
146265283|NCT02056626|527486805|FG001|Overall Study|patient did not follow directions|1|||
146265284|NCT02056626|527486806|FG002|Overall Study|patient did not follow directions|0|||
146265285|NCT02056626|527486807|FG003|Overall Study|patient did not follow directions|0|||
146265286|NCT04978350|527486810|FG000|Overall Study|Lost to Follow-up|6|||
146265287|NCT00013611|527486811|FG000|Overall Study|Lost to Follow-up|91|||
146265288|NCT00013611|527486812|FG001|Overall Study|Lost to Follow-up|100|||
146265289|NCT02577003|527486813|FG000|Overall Study|Adverse Event|2|||
146265290|NCT02577003|527486814|FG001|Overall Study|Adverse Event|4|||
146265291|NCT02577003|527486813|FG000|Overall Study|Withdrawal by Subject|0|||
146265292|NCT02577003|527486814|FG001|Overall Study|Withdrawal by Subject|1|||
146265293|NCT02786004|527486815|FG000|Overall Study|Withdrawal by Subject|0|||
146265294|NCT02786004|527486816|FG001|Overall Study|Withdrawal by Subject|1|||
146265295|NCT04486313|527486819|FG000|Overall Study|Lost to Follow-up|7|||
146265296|NCT04486313|527486820|FG001|Overall Study|Lost to Follow-up|9|||
146265297|NCT04486313|527486819|FG000|Overall Study|Withdrawal by Subject|8|||
146265298|NCT04486313|527486820|FG001|Overall Study|Withdrawal by Subject|6|||
146265299|NCT04486313|527486819|FG000|Overall Study|Physician Decision|1|||
146265300|NCT04486313|527486820|FG001|Overall Study|Physician Decision|1|||
146265301|NCT04486313|527486819|FG000|Overall Study|Death|2|||
146265302|NCT04486313|527486820|FG001|Overall Study|Death|0|||
146265303|NCT04486313|527486819|FG000|Overall Study|Protocol Violation|1|||
146265304|NCT04486313|527486820|FG001|Overall Study|Protocol Violation|1|||
146265305|NCT00126659|527486821|FG000|Overall Study|Adverse Event|0|||
146265306|NCT00126659|527486822|FG001|Overall Study|Adverse Event|0|||
146265307|NCT00126659|527486823|FG002|Overall Study|Adverse Event|2|||
146265308|NCT01271504|527486824|FG000|Overall Study|Death|7|||
146265309|NCT01271504|527486825|FG001|Overall Study|Death|6|||
146265310|NCT01271504|527486826|FG002|Overall Study|Death|32|||
146265311|NCT01271504|527486827|FG003|Overall Study|Death|32|||
146265312|NCT01271504|527486824|FG000|Overall Study|Lost to Follow-up|0|||
146265313|NCT01271504|527486825|FG001|Overall Study|Lost to Follow-up|1|||
146265314|NCT01271504|527486826|FG002|Overall Study|Lost to Follow-up|3|||
146265315|NCT01271504|527486827|FG003|Overall Study|Lost to Follow-up|1|||
146265316|NCT01271504|527486824|FG000|Overall Study|Protocol Violation|0|||
146265317|NCT01271504|527486825|FG001|Overall Study|Protocol Violation|0|||
146265318|NCT01271504|527486826|FG002|Overall Study|Protocol Violation|0|||
146265319|NCT01271504|527486827|FG003|Overall Study|Protocol Violation|2|||
146265320|NCT01271504|527486824|FG000|Overall Study|Administrative Reasons|0|||
146265321|NCT01271504|527486825|FG001|Overall Study|Administrative Reasons|0|||
146265322|NCT01271504|527486826|FG002|Overall Study|Administrative Reasons|6|||
146265323|NCT01271504|527486827|FG003|Overall Study|Administrative Reasons|5|||
146265324|NCT01271504|527486824|FG000|Overall Study|Withdrawal by Subject|0|||
146265325|NCT01271504|527486825|FG001|Overall Study|Withdrawal by Subject|0|||
146265326|NCT01271504|527486826|FG002|Overall Study|Withdrawal by Subject|1|||
146265327|NCT01271504|527486827|FG003|Overall Study|Withdrawal by Subject|3|||
146265328|NCT01271504|527486824|FG000|Overall Study|Other|0|||
146265329|NCT01271504|527486825|FG001|Overall Study|Other|1|||
146135224|NCT05288556|527013721|FG000|Overall Study|Withdrawal by Subject|1|||
146135225|NCT02465528|527013722|FG000|Overall Study|Progressive disease|0|||
146135226|NCT02465528|527013723|FG001|Overall Study|Progressive disease|2|||
146135227|NCT02465528|527013724|FG002|Overall Study|Progressive disease|9|||
146135228|NCT02465528|527013725|FG003|Overall Study|Progressive disease|4|||
146135229|NCT02465528|527013722|FG000|Overall Study|Study terminated by sponsor|1|||
146135230|NCT02465528|527013723|FG001|Overall Study|Study terminated by sponsor|2|||
146135231|NCT02465528|527013724|FG002|Overall Study|Study terminated by sponsor|0|||
146135232|NCT02465528|527013725|FG003|Overall Study|Study terminated by sponsor|0|||
146135233|NCT02465528|527013722|FG000|Overall Study|Withdrawal by Subject|0|||
146135234|NCT02465528|527013723|FG001|Overall Study|Withdrawal by Subject|0|||
146135235|NCT02465528|527013724|FG002|Overall Study|Withdrawal by Subject|2|||
146135236|NCT02465528|527013725|FG003|Overall Study|Withdrawal by Subject|0|||
146135237|NCT02465528|527013722|FG000|Overall Study|Adverse Event|0|||
146135238|NCT02465528|527013723|FG001|Overall Study|Adverse Event|0|||
146135239|NCT02465528|527013724|FG002|Overall Study|Adverse Event|0|||
146135240|NCT02465528|527013725|FG003|Overall Study|Adverse Event|1|||
146135241|NCT02465528|527013722|FG000|Overall Study|Physician Decision|0|||
146135242|NCT02465528|527013723|FG001|Overall Study|Physician Decision|0|||
146135243|NCT02465528|527013724|FG002|Overall Study|Physician Decision|1|||
146135244|NCT02465528|527013725|FG003|Overall Study|Physician Decision|0|||
146135245|NCT03795610|527013726|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
146135246|NCT03795610|527013726|FG000|Overall Study|Withdrawal by Subject|1|||
146135247|NCT03795610|527013726|FG000|Overall Study|Screen Failure (Unknown)|1|||
146135248|NCT01428193|527013737|FG000|Overall Study|Physician Decision|1|||
146135249|NCT01428193|527013737|FG000|Overall Study|Elevated screening liver enzymes|1|||
146135250|NCT03762083|527013738|FG000|Overall Study|Withdrawal by Subject|2|||
146135251|NCT03762083|527013738|FG000|Overall Study|Physician Decision|1|||
146135252|NCT02027844|527013739|FG000|Overall Study|Withdrawal by Subject|3|||
146135253|NCT02027844|527013740|FG001|Overall Study|Withdrawal by Subject|2|||
146135254|NCT02027844|527013741|FG002|Overall Study|Withdrawal by Subject|1|||
146135255|NCT02027844|527013739|FG000|Overall Study|Lost to Follow-up|0|||
146135256|NCT02027844|527013740|FG001|Overall Study|Lost to Follow-up|2|||
146135257|NCT02027844|527013741|FG002|Overall Study|Lost to Follow-up|1|||
146135258|NCT02027844|527013739|FG000|Overall Study|Protocol Violation|0|||
146135259|NCT02027844|527013740|FG001|Overall Study|Protocol Violation|2|||
146135260|NCT02027844|527013741|FG002|Overall Study|Protocol Violation|0|||
146135261|NCT02027844|527013739|FG000|Overall Study|Incomlete data|2|||
146135262|NCT02027844|527013740|FG001|Overall Study|Incomlete data|0|||
146135263|NCT02027844|527013741|FG002|Overall Study|Incomlete data|0|||
146135264|NCT02659020|527013742|FG000|Overall Study|Adverse Event|0|||
146135265|NCT02659020|527013743|FG001|Overall Study|Adverse Event|0|||
146135266|NCT02659020|527013744|FG002|Overall Study|Adverse Event|0|||
146135267|NCT02659020|527013745|FG003|Overall Study|Adverse Event|2|||
146135268|NCT02659020|527013746|FG004|Overall Study|Adverse Event|0|||
146135269|NCT02659020|527013747|FG005|Overall Study|Adverse Event|0|||
146135270|NCT02659020|527013748|FG006|Overall Study|Adverse Event|2|||
146135271|NCT02659020|527013742|FG000|Overall Study|Lost to Follow-up|1|||
146135272|NCT02659020|527013743|FG001|Overall Study|Lost to Follow-up|2|||
146135273|NCT02659020|527013744|FG002|Overall Study|Lost to Follow-up|1|||
146135274|NCT02659020|527013745|FG003|Overall Study|Lost to Follow-up|6|||
146135275|NCT02659020|527013746|FG004|Overall Study|Lost to Follow-up|1|||
146135276|NCT02659020|527013747|FG005|Overall Study|Lost to Follow-up|5|||
146135277|NCT02659020|527013748|FG006|Overall Study|Lost to Follow-up|0|||
146135278|NCT02659020|527013742|FG000|Overall Study|Physician Decision|0|||
146135279|NCT02659020|527013743|FG001|Overall Study|Physician Decision|0|||
146135280|NCT02659020|527013744|FG002|Overall Study|Physician Decision|0|||
146135281|NCT02659020|527013745|FG003|Overall Study|Physician Decision|1|||
146135282|NCT02659020|527013746|FG004|Overall Study|Physician Decision|1|||
146135283|NCT02659020|527013747|FG005|Overall Study|Physician Decision|0|||
146135284|NCT02659020|527013748|FG006|Overall Study|Physician Decision|1|||
146265330|NCT01271504|527486826|FG002|Overall Study|Other|2|||
146265331|NCT01271504|527486827|FG003|Overall Study|Other|0|||
146135285|NCT02659020|527013742|FG000|Overall Study|Withdrawal by Subject|2|||
146135286|NCT02659020|527013743|FG001|Overall Study|Withdrawal by Subject|1|||
146135287|NCT02659020|527013744|FG002|Overall Study|Withdrawal by Subject|0|||
146135288|NCT02659020|527013745|FG003|Overall Study|Withdrawal by Subject|3|||
146135289|NCT02659020|527013746|FG004|Overall Study|Withdrawal by Subject|3|||
146265332|NCT03865953|527486838|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
146265333|NCT03865953|527486839|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
146135290|NCT02659020|527013747|FG005|Overall Study|Withdrawal by Subject|6|||
146135291|NCT02659020|527013748|FG006|Overall Study|Withdrawal by Subject|3|||
146135292|NCT02659020|527013742|FG000|Overall Study|Progressive Disease|0|||
146135293|NCT02659020|527013743|FG001|Overall Study|Progressive Disease|0|||
146135294|NCT02659020|527013744|FG002|Overall Study|Progressive Disease|0|||
146135295|NCT02659020|527013745|FG003|Overall Study|Progressive Disease|4|||
146135296|NCT02659020|527013746|FG004|Overall Study|Progressive Disease|1|||
146135297|NCT02659020|527013747|FG005|Overall Study|Progressive Disease|0|||
146135298|NCT02659020|527013748|FG006|Overall Study|Progressive Disease|2|||
146265334|NCT03865953|527486838|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
146265335|NCT03865953|527486839|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
146265336|NCT03865953|527486838|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
146265337|NCT03865953|527486839|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
146265338|NCT00882115|527486840|FG000|Overall Study|Withdrawal by Subject|3|||
146265339|NCT00882115|527486840|FG000|Overall Study|did not respond to DEP challe|6|||
146265340|NCT02229578|527486845|FG000|Overall Study|Withdrawal by Subject|1|||
146265341|NCT02229578|527486846|FG001|Overall Study|Withdrawal by Subject|3|||
146265342|NCT02229578|527486845|FG000|Overall Study|Protocol Violation|2|||
146265343|NCT02229578|527486846|FG001|Overall Study|Protocol Violation|0|||
146265344|NCT00943787|527486847|FG000|Overall Study|Physician Decision|4|||
146265345|NCT00943787|527486847|FG000|Overall Study|Withdrawal by Subject|3|||
146265346|NCT00490945|527486848|FG000|Overall Study|Adverse Event|0|||
146265347|NCT00490945|527486849|FG001|Overall Study|Adverse Event|1|||
146265348|NCT00490945|527486850|FG002|Overall Study|Adverse Event|0|||
146265349|NCT00490945|527486851|FG003|Overall Study|Adverse Event|0|||
146265350|NCT00490945|527486852|FG004|Overall Study|Adverse Event|0|||
146265351|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
146265352|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
146265353|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
146265354|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
146265355|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
146265356|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
146265357|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
146265358|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
146265359|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
146265360|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
146265361|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
146265362|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
146265363|NCT01216072|527486855|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
146265364|NCT01216072|527486856|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
146265365|NCT01216072|527486855|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
146265366|NCT01216072|527486856|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
146265367|NCT01216072|527486855|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
146265368|NCT01216072|527486856|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
146265369|NCT01216072|527486855|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
146265370|NCT01216072|527486856|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
146265371|NCT02947100|527486857|FG000|Overall Study|study terminated early|3|||
146265372|NCT02947100|527486857|FG000|Overall Study|did not meet inclusion criteria|1|||
146265373|NCT00822770|527486858|FG000|Overall Study|Not treated|1|||
146265374|NCT00822770|527486859|FG001|Overall Study|Not treated|0|||
146265375|NCT00822770|527486858|FG000|Overall Study|Complication/Incomplete treatment|1|||
146265376|NCT00822770|527486859|FG001|Overall Study|Complication/Incomplete treatment|0|||
146265377|NCT00822770|527486858|FG000|Overall Study|Death|1|||
146265378|NCT00822770|527486859|FG001|Overall Study|Death|1|||
146265379|NCT02472145|527486863|FG000|Overall Study|Death|10|||
146265380|NCT02472145|527486864|FG001|Overall Study|Death|101|||
146265381|NCT02472145|527486865|FG002|Overall Study|Death|99|||
146265382|NCT02472145|527486863|FG000|Overall Study|Lost to Follow-up|0|||
146265383|NCT02472145|527486864|FG001|Overall Study|Lost to Follow-up|1|||
146265384|NCT02472145|527486865|FG002|Overall Study|Lost to Follow-up|0|||
146265385|NCT02472145|527486863|FG000|Overall Study|Withdrawal by Subject|0|||
146265386|NCT02472145|527486864|FG001|Overall Study|Withdrawal by Subject|9|||
146265387|NCT02472145|527486865|FG002|Overall Study|Withdrawal by Subject|13|||
146265388|NCT02472145|527486863|FG000|Overall Study|Sponsor decision|0|||
146265389|NCT02472145|527486864|FG001|Overall Study|Sponsor decision|3|||
146265390|NCT02472145|527486865|FG002|Overall Study|Sponsor decision|2|||
146265391|NCT02472145|527486863|FG000|Overall Study|Other|0|||
146265392|NCT02472145|527486864|FG001|Overall Study|Other|45|||
146265393|NCT02472145|527486865|FG002|Overall Study|Other|43|||
146265394|NCT01080326|527486866|FG000|Overall Study|Patient deterioration prior to procedure|3|||
146265395|NCT01080326|527486866|FG000|Overall Study|Surgeon decision|1|||
146265396|NCT01296555|527486867|FG000|Overall Study|Adverse Event|0|||
146265397|NCT01296555|527486868|FG001|Overall Study|Adverse Event|0|||
146265398|NCT01296555|527486869|FG002|Overall Study|Adverse Event|1|||
146265399|NCT01296555|527486870|FG003|Overall Study|Adverse Event|1|||
146265400|NCT01296555|527486871|FG004|Overall Study|Adverse Event|2|||
146265401|NCT01296555|527486872|FG005|Overall Study|Adverse Event|4|||
146265402|NCT01296555|527486873|FG006|Overall Study|Adverse Event|1|||
146265403|NCT01296555|527486874|FG007|Overall Study|Adverse Event|4|||
146265404|NCT01296555|527486875|FG008|Overall Study|Adverse Event|3|||
146265405|NCT01296555|527486876|FG009|Overall Study|Adverse Event|1|||
146265406|NCT01296555|527486877|FG010|Overall Study|Adverse Event|0|||
145943210|NCT00483704|526300457|FG001|Randomization|Physician Decision|4|||
146135299|NCT04049760|527013750|FG000|Overall Study|Withdrawal by Subject|1|||
146135300|NCT02457598|527013751|FG000|Overall Study|Progressive Disease|2|||
146135301|NCT02457598|527013752|FG001|Overall Study|Progressive Disease|2|||
146135302|NCT02457598|527013753|FG002|Overall Study|Progressive Disease|1|||
146135303|NCT02457598|527013754|FG003|Overall Study|Progressive Disease|11|||
146135304|NCT02457598|527013755|FG004|Overall Study|Progressive Disease|7|||
146135305|NCT02457598|527013756|FG005|Overall Study|Progressive Disease|3|||
146135306|NCT02457598|527013757|FG006|Overall Study|Progressive Disease|2|||
146135307|NCT02457598|527013758|FG007|Overall Study|Progressive Disease|1|||
146135308|NCT02457598|527013759|FG008|Overall Study|Progressive Disease|1|||
146135309|NCT02457598|527013760|FG009|Overall Study|Progressive Disease|2|||
146135310|NCT02457598|527013761|FG010|Overall Study|Progressive Disease|45|||
146135311|NCT02457598|527013762|FG011|Overall Study|Progressive Disease|6|||
146135312|NCT02457598|527013763|FG012|Overall Study|Progressive Disease|2|||
146135313|NCT02457598|527013764|FG013|Overall Study|Progressive Disease|2|||
146135314|NCT02457598|527013765|FG014|Overall Study|Progressive Disease|10|||
146135315|NCT02457598|527013766|FG015|Overall Study|Progressive Disease|1|||
146135316|NCT02457598|527013767|FG016|Overall Study|Progressive Disease|1|||
146135317|NCT02457598|527013751|FG000|Overall Study|Investigator's Discretion|0|||
146135318|NCT02457598|527013752|FG001|Overall Study|Investigator's Discretion|2|||
146135319|NCT02457598|527013753|FG002|Overall Study|Investigator's Discretion|2|||
146135320|NCT02457598|527013754|FG003|Overall Study|Investigator's Discretion|2|||
146135321|NCT02457598|527013755|FG004|Overall Study|Investigator's Discretion|0|||
146135322|NCT02457598|527013756|FG005|Overall Study|Investigator's Discretion|0|||
146135323|NCT02457598|527013757|FG006|Overall Study|Investigator's Discretion|0|||
146135324|NCT02457598|527013758|FG007|Overall Study|Investigator's Discretion|1|||
146135325|NCT02457598|527013759|FG008|Overall Study|Investigator's Discretion|2|||
146135326|NCT02457598|527013760|FG009|Overall Study|Investigator's Discretion|0|||
146135327|NCT02457598|527013761|FG010|Overall Study|Investigator's Discretion|10|||
146135328|NCT02457598|527013762|FG011|Overall Study|Investigator's Discretion|2|||
146135329|NCT02457598|527013763|FG012|Overall Study|Investigator's Discretion|2|||
146135330|NCT02457598|527013764|FG013|Overall Study|Investigator's Discretion|1|||
146135331|NCT02457598|527013765|FG014|Overall Study|Investigator's Discretion|5|||
146135332|NCT02457598|527013766|FG015|Overall Study|Investigator's Discretion|0|||
146135333|NCT02457598|527013767|FG016|Overall Study|Investigator's Discretion|0|||
146135334|NCT02457598|527013751|FG000|Overall Study|Study Terminated by Sponsor|0|||
146135335|NCT02457598|527013752|FG001|Overall Study|Study Terminated by Sponsor|1|||
146135336|NCT02457598|527013753|FG002|Overall Study|Study Terminated by Sponsor|0|||
146135337|NCT02457598|527013754|FG003|Overall Study|Study Terminated by Sponsor|4|||
146135338|NCT02457598|527013755|FG004|Overall Study|Study Terminated by Sponsor|1|||
146135339|NCT02457598|527013756|FG005|Overall Study|Study Terminated by Sponsor|0|||
146135340|NCT02457598|527013757|FG006|Overall Study|Study Terminated by Sponsor|1|||
146135341|NCT02457598|527013758|FG007|Overall Study|Study Terminated by Sponsor|0|||
146135342|NCT02457598|527013759|FG008|Overall Study|Study Terminated by Sponsor|0|||
146135343|NCT02457598|527013760|FG009|Overall Study|Study Terminated by Sponsor|0|||
146135344|NCT02457598|527013761|FG010|Overall Study|Study Terminated by Sponsor|4|||
146135345|NCT02457598|527013762|FG011|Overall Study|Study Terminated by Sponsor|0|||
146135346|NCT02457598|527013763|FG012|Overall Study|Study Terminated by Sponsor|1|||
146135347|NCT02457598|527013764|FG013|Overall Study|Study Terminated by Sponsor|0|||
146135348|NCT02457598|527013765|FG014|Overall Study|Study Terminated by Sponsor|8|||
146135349|NCT02457598|527013766|FG015|Overall Study|Study Terminated by Sponsor|1|||
146135350|NCT02457598|527013767|FG016|Overall Study|Study Terminated by Sponsor|0|||
146135351|NCT02457598|527013751|FG000|Overall Study|Adverse Event|0|||
146135352|NCT02457598|527013752|FG001|Overall Study|Adverse Event|1|||
146135353|NCT02457598|527013753|FG002|Overall Study|Adverse Event|1|||
146135354|NCT02457598|527013754|FG003|Overall Study|Adverse Event|4|||
146135355|NCT02457598|527013755|FG004|Overall Study|Adverse Event|1|||
146135356|NCT02457598|527013756|FG005|Overall Study|Adverse Event|0|||
146135357|NCT02457598|527013757|FG006|Overall Study|Adverse Event|0|||
146135358|NCT02457598|527013758|FG007|Overall Study|Adverse Event|1|||
146135359|NCT02457598|527013759|FG008|Overall Study|Adverse Event|0|||
146135360|NCT02457598|527013760|FG009|Overall Study|Adverse Event|1|||
146135361|NCT02457598|527013761|FG010|Overall Study|Adverse Event|6|||
146135362|NCT02457598|527013762|FG011|Overall Study|Adverse Event|0|||
146135363|NCT02457598|527013763|FG012|Overall Study|Adverse Event|0|||
146135364|NCT02457598|527013764|FG013|Overall Study|Adverse Event|1|||
146135365|NCT02457598|527013765|FG014|Overall Study|Adverse Event|2|||
146135366|NCT02457598|527013766|FG015|Overall Study|Adverse Event|0|||
146135367|NCT02457598|527013767|FG016|Overall Study|Adverse Event|0|||
146135368|NCT02457598|527013751|FG000|Overall Study|Death|0|||
146135369|NCT02457598|527013752|FG001|Overall Study|Death|0|||
146265407|NCT01296555|527486878|FG011|Overall Study|Adverse Event|4|||
146265408|NCT01296555|527486879|FG012|Overall Study|Adverse Event|1|||
146265409|NCT01296555|527486880|FG013|Overall Study|Adverse Event|4|||
146135370|NCT02457598|527013753|FG002|Overall Study|Death|0|||
146135371|NCT02457598|527013754|FG003|Overall Study|Death|3|||
146135372|NCT02457598|527013755|FG004|Overall Study|Death|0|||
146265410|NCT01296555|527486881|FG014|Overall Study|Adverse Event|0|||
146265411|NCT01296555|527486882|FG015|Overall Study|Adverse Event|0|||
146303899|NCT04569032|527627424|FG001|Overall Study|Lost to Follow-up|1|||
146303900|NCT04569032|527627423|FG000|Overall Study|In long term follow up|22|||
146303901|NCT04569032|527627424|FG001|Overall Study|In long term follow up|34|||
146303902|NCT00496730|527627427|FG000|Overall Study|Lost to Follow-up|4|||
146303903|NCT00496730|527627428|FG001|Overall Study|Lost to Follow-up|3|||
146303904|NCT00496730|527627427|FG000|Overall Study|Withdrawal by Subject|2|||
146303905|NCT00496730|527627428|FG001|Overall Study|Withdrawal by Subject|2|||
146303906|NCT03716050|527627434|FG000|Overall Study|Lost to Follow-up|0|||
146303907|NCT03716050|527627435|FG001|Overall Study|Lost to Follow-up|0|||
146303908|NCT03716050|527627436|FG002|Overall Study|Lost to Follow-up|1|||
146303909|NCT03716050|527627437|FG003|Overall Study|Lost to Follow-up|0|||
146303910|NCT03716050|527627438|FG004|Overall Study|Lost to Follow-up|0|||
146303911|NCT03716050|527627439|FG005|Overall Study|Lost to Follow-up|0|||
146303912|NCT03716050|527627440|FG006|Overall Study|Lost to Follow-up|0|||
146303913|NCT03716050|527627441|FG007|Overall Study|Lost to Follow-up|0|||
146303914|NCT03716050|527627434|FG000|Overall Study|Physician Decision|0|||
146303915|NCT03716050|527627435|FG001|Overall Study|Physician Decision|0|||
146303916|NCT03716050|527627436|FG002|Overall Study|Physician Decision|0|||
146303917|NCT03716050|527627437|FG003|Overall Study|Physician Decision|1|||
146303918|NCT03716050|527627438|FG004|Overall Study|Physician Decision|0|||
146303919|NCT03716050|527627439|FG005|Overall Study|Physician Decision|0|||
146303920|NCT03716050|527627440|FG006|Overall Study|Physician Decision|0|||
146135373|NCT02457598|527013756|FG005|Overall Study|Death|1|||
146135374|NCT02457598|527013757|FG006|Overall Study|Death|0|||
146135375|NCT02457598|527013758|FG007|Overall Study|Death|0|||
146135376|NCT02457598|527013759|FG008|Overall Study|Death|0|||
146265412|NCT01296555|527486883|FG016|Overall Study|Adverse Event|0|||
146265413|NCT01296555|527486884|FG017|Overall Study|Adverse Event|0|||
146265414|NCT01296555|527486885|FG018|Overall Study|Adverse Event|0|||
146265415|NCT01296555|527486886|FG019|Overall Study|Adverse Event|1|||
146265416|NCT01296555|527486887|FG020|Overall Study|Adverse Event|0|||
146265417|NCT01296555|527486888|FG021|Overall Study|Adverse Event|0|||
146265418|NCT01296555|527486889|FG022|Overall Study|Adverse Event|0|||
146265419|NCT01296555|527486890|FG023|Overall Study|Adverse Event|0|||
146265420|NCT01296555|527486891|FG024|Overall Study|Adverse Event|0|||
146265421|NCT01296555|527486892|FG025|Overall Study|Adverse Event|0|||
146265422|NCT01296555|527486893|FG026|Overall Study|Adverse Event|0|||
146265423|NCT01296555|527486894|FG027|Overall Study|Adverse Event|0|||
146265424|NCT01296555|527486895|FG028|Overall Study|Adverse Event|0|||
146265425|NCT01296555|527486867|FG000|Overall Study|Reason Not Specified|0|||
146135377|NCT02457598|527013760|FG009|Overall Study|Death|0|||
146135378|NCT02457598|527013761|FG010|Overall Study|Death|3|||
146135379|NCT02457598|527013762|FG011|Overall Study|Death|0|||
146135380|NCT02457598|527013763|FG012|Overall Study|Death|0|||
146135381|NCT02457598|527013764|FG013|Overall Study|Death|1|||
146135382|NCT02457598|527013765|FG014|Overall Study|Death|2|||
146135383|NCT02457598|527013766|FG015|Overall Study|Death|0|||
146135384|NCT02457598|527013767|FG016|Overall Study|Death|1|||
146135385|NCT02457598|527013751|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135386|NCT02457598|527013752|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
146135387|NCT02457598|527013753|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135388|NCT02457598|527013754|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
146135389|NCT02457598|527013755|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135390|NCT02457598|527013756|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135391|NCT02457598|527013757|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135392|NCT02457598|527013758|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
146135393|NCT02457598|527013759|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135394|NCT02457598|527013760|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135395|NCT02457598|527013761|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
146135396|NCT02457598|527013762|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135397|NCT02457598|527013763|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135398|NCT02457598|527013764|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
146135399|NCT02457598|527013765|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
146135400|NCT02457598|527013766|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
146135401|NCT02457598|527013767|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
146265426|NCT01296555|527486868|FG001|Overall Study|Reason Not Specified|0|||
146265427|NCT01296555|527486869|FG002|Overall Study|Reason Not Specified|0|||
146265428|NCT01296555|527486870|FG003|Overall Study|Reason Not Specified|0|||
146265429|NCT01296555|527486871|FG004|Overall Study|Reason Not Specified|0|||
146265430|NCT01296555|527486872|FG005|Overall Study|Reason Not Specified|0|||
146265431|NCT01296555|527486873|FG006|Overall Study|Reason Not Specified|0|||
146265432|NCT01296555|527486874|FG007|Overall Study|Reason Not Specified|0|||
146303921|NCT03716050|527627441|FG007|Overall Study|Physician Decision|0|||
146303922|NCT03716050|527627434|FG000|Overall Study|Protocol Violation|0|||
145943211|NCT00483704|526300458|FG002|Randomization|Physician Decision|0|||
146303923|NCT03716050|527627435|FG001|Overall Study|Protocol Violation|0|||
146303924|NCT03716050|527627436|FG002|Overall Study|Protocol Violation|0|||
146265433|NCT01296555|527486875|FG008|Overall Study|Reason Not Specified|0|||
146265434|NCT01296555|527486876|FG009|Overall Study|Reason Not Specified|0|||
146265435|NCT01296555|527486877|FG010|Overall Study|Reason Not Specified|0|||
146265436|NCT01296555|527486878|FG011|Overall Study|Reason Not Specified|0|||
146265437|NCT01296555|527486879|FG012|Overall Study|Reason Not Specified|0|||
146265438|NCT01296555|527486880|FG013|Overall Study|Reason Not Specified|1|||
146265439|NCT01296555|527486881|FG014|Overall Study|Reason Not Specified|2|||
146265440|NCT01296555|527486882|FG015|Overall Study|Reason Not Specified|3|||
146265441|NCT01296555|527486883|FG016|Overall Study|Reason Not Specified|7|||
146265442|NCT01296555|527486884|FG017|Overall Study|Reason Not Specified|4|||
146265443|NCT01296555|527486885|FG018|Overall Study|Reason Not Specified|3|||
146265444|NCT01296555|527486886|FG019|Overall Study|Reason Not Specified|7|||
146265445|NCT01296555|527486887|FG020|Overall Study|Reason Not Specified|11|||
146265446|NCT01296555|527486888|FG021|Overall Study|Reason Not Specified|5|||
146265447|NCT01296555|527486889|FG022|Overall Study|Reason Not Specified|5|||
146265448|NCT01296555|527486890|FG023|Overall Study|Reason Not Specified|7|||
146265449|NCT01296555|527486891|FG024|Overall Study|Reason Not Specified|2|||
146265450|NCT01296555|527486892|FG025|Overall Study|Reason Not Specified|2|||
146265451|NCT01296555|527486893|FG026|Overall Study|Reason Not Specified|19|||
146265452|NCT01296555|527486894|FG027|Overall Study|Reason Not Specified|11|||
146265453|NCT01296555|527486895|FG028|Overall Study|Reason Not Specified|9|||
146265454|NCT01296555|527486867|FG000|Overall Study|Physician Decision|0|||
146265455|NCT01296555|527486868|FG001|Overall Study|Physician Decision|0|||
146265456|NCT01296555|527486869|FG002|Overall Study|Physician Decision|0|||
146265457|NCT01296555|527486870|FG003|Overall Study|Physician Decision|0|||
146265458|NCT01296555|527486871|FG004|Overall Study|Physician Decision|1|||
146265459|NCT01296555|527486872|FG005|Overall Study|Physician Decision|0|||
146265460|NCT01296555|527486873|FG006|Overall Study|Physician Decision|0|||
146265461|NCT01296555|527486874|FG007|Overall Study|Physician Decision|0|||
146265462|NCT01296555|527486875|FG008|Overall Study|Physician Decision|0|||
146265463|NCT01296555|527486876|FG009|Overall Study|Physician Decision|0|||
146265464|NCT01296555|527486877|FG010|Overall Study|Physician Decision|0|||
146265465|NCT01296555|527486878|FG011|Overall Study|Physician Decision|0|||
146265466|NCT01296555|527486879|FG012|Overall Study|Physician Decision|0|||
146265467|NCT01296555|527486880|FG013|Overall Study|Physician Decision|1|||
146265468|NCT01296555|527486881|FG014|Overall Study|Physician Decision|0|||
146265469|NCT01296555|527486882|FG015|Overall Study|Physician Decision|0|||
146265470|NCT01296555|527486883|FG016|Overall Study|Physician Decision|0|||
146265471|NCT01296555|527486884|FG017|Overall Study|Physician Decision|0|||
146265472|NCT01296555|527486885|FG018|Overall Study|Physician Decision|0|||
146265473|NCT01296555|527486886|FG019|Overall Study|Physician Decision|1|||
146265474|NCT01296555|527486887|FG020|Overall Study|Physician Decision|0|||
146265475|NCT01296555|527486888|FG021|Overall Study|Physician Decision|0|||
146265476|NCT01296555|527486889|FG022|Overall Study|Physician Decision|0|||
146265477|NCT01296555|527486890|FG023|Overall Study|Physician Decision|0|||
146265478|NCT01296555|527486891|FG024|Overall Study|Physician Decision|0|||
146265479|NCT01296555|527486892|FG025|Overall Study|Physician Decision|0|||
146265480|NCT01296555|527486893|FG026|Overall Study|Physician Decision|0|||
146265481|NCT01296555|527486894|FG027|Overall Study|Physician Decision|0|||
146265482|NCT01296555|527486895|FG028|Overall Study|Physician Decision|0|||
146265483|NCT01296555|527486867|FG000|Overall Study|Progressive Disease|6|||
146265484|NCT01296555|527486868|FG001|Overall Study|Progressive Disease|3|||
146265485|NCT01296555|527486869|FG002|Overall Study|Progressive Disease|3|||
146265486|NCT01296555|527486870|FG003|Overall Study|Progressive Disease|7|||
146265487|NCT01296555|527486871|FG004|Overall Study|Progressive Disease|6|||
146265488|NCT01296555|527486872|FG005|Overall Study|Progressive Disease|16|||
146265489|NCT01296555|527486873|FG006|Overall Study|Progressive Disease|16|||
146265490|NCT01296555|527486874|FG007|Overall Study|Progressive Disease|8|||
146265491|NCT01296555|527486875|FG008|Overall Study|Progressive Disease|7|||
146265492|NCT01296555|527486876|FG009|Overall Study|Progressive Disease|18|||
146135402|NCT02457598|527013751|FG000|Overall Study|Withdrew Consent|0|||
146135403|NCT02457598|527013752|FG001|Overall Study|Withdrew Consent|0|||
146135404|NCT02457598|527013753|FG002|Overall Study|Withdrew Consent|0|||
146135405|NCT02457598|527013754|FG003|Overall Study|Withdrew Consent|0|||
146135406|NCT02457598|527013755|FG004|Overall Study|Withdrew Consent|0|||
146265493|NCT01296555|527486877|FG010|Overall Study|Progressive Disease|7|||
146265494|NCT01296555|527486878|FG011|Overall Study|Progressive Disease|14|||
146265495|NCT01296555|527486879|FG012|Overall Study|Progressive Disease|5|||
146265496|NCT01296555|527486880|FG013|Overall Study|Progressive Disease|12|||
146265497|NCT01296555|527486881|FG014|Overall Study|Progressive Disease|1|||
146265498|NCT01296555|527486882|FG015|Overall Study|Progressive Disease|1|||
146265499|NCT01296555|527486883|FG016|Overall Study|Progressive Disease|0|||
146265500|NCT01296555|527486884|FG017|Overall Study|Progressive Disease|0|||
146135407|NCT02457598|527013756|FG005|Overall Study|Withdrew Consent|0|||
146265501|NCT01296555|527486885|FG018|Overall Study|Progressive Disease|0|||
146265502|NCT01296555|527486886|FG019|Overall Study|Progressive Disease|1|||
146265503|NCT01296555|527486887|FG020|Overall Study|Progressive Disease|0|||
146265504|NCT01296555|527486888|FG021|Overall Study|Progressive Disease|0|||
146265505|NCT01296555|527486889|FG022|Overall Study|Progressive Disease|0|||
146265506|NCT01296555|527486890|FG023|Overall Study|Progressive Disease|0|||
146265507|NCT01296555|527486891|FG024|Overall Study|Progressive Disease|1|||
146265508|NCT01296555|527486892|FG025|Overall Study|Progressive Disease|0|||
146265509|NCT01296555|527486893|FG026|Overall Study|Progressive Disease|5|||
146265510|NCT01296555|527486894|FG027|Overall Study|Progressive Disease|1|||
146265511|NCT01296555|527486895|FG028|Overall Study|Progressive Disease|0|||
146265512|NCT01296555|527486867|FG000|Overall Study|Protocol Violation|0|||
146265513|NCT01296555|527486868|FG001|Overall Study|Protocol Violation|0|||
146265514|NCT01296555|527486869|FG002|Overall Study|Protocol Violation|0|||
146265515|NCT01296555|527486870|FG003|Overall Study|Protocol Violation|0|||
146265516|NCT01296555|527486871|FG004|Overall Study|Protocol Violation|0|||
146265517|NCT01296555|527486872|FG005|Overall Study|Protocol Violation|0|||
146265518|NCT01296555|527486873|FG006|Overall Study|Protocol Violation|0|||
146265519|NCT01296555|527486874|FG007|Overall Study|Protocol Violation|0|||
146265520|NCT01296555|527486875|FG008|Overall Study|Protocol Violation|0|||
146265521|NCT01296555|527486876|FG009|Overall Study|Protocol Violation|0|||
146265522|NCT01296555|527486877|FG010|Overall Study|Protocol Violation|0|||
146265523|NCT01296555|527486878|FG011|Overall Study|Protocol Violation|0|||
146265524|NCT01296555|527486879|FG012|Overall Study|Protocol Violation|0|||
146265525|NCT01296555|527486880|FG013|Overall Study|Protocol Violation|1|||
146265526|NCT01296555|527486881|FG014|Overall Study|Protocol Violation|0|||
146265527|NCT01296555|527486882|FG015|Overall Study|Protocol Violation|0|||
146265528|NCT01296555|527486883|FG016|Overall Study|Protocol Violation|0|||
146265529|NCT01296555|527486884|FG017|Overall Study|Protocol Violation|0|||
146265530|NCT01296555|527486885|FG018|Overall Study|Protocol Violation|0|||
146265531|NCT01296555|527486886|FG019|Overall Study|Protocol Violation|0|||
146265532|NCT01296555|527486887|FG020|Overall Study|Protocol Violation|0|||
146265533|NCT01296555|527486888|FG021|Overall Study|Protocol Violation|0|||
146265534|NCT01296555|527486889|FG022|Overall Study|Protocol Violation|0|||
146265535|NCT01296555|527486890|FG023|Overall Study|Protocol Violation|0|||
146265536|NCT01296555|527486891|FG024|Overall Study|Protocol Violation|0|||
146265537|NCT01296555|527486892|FG025|Overall Study|Protocol Violation|0|||
146265538|NCT01296555|527486893|FG026|Overall Study|Protocol Violation|0|||
146265539|NCT01296555|527486894|FG027|Overall Study|Protocol Violation|0|||
146265540|NCT01296555|527486895|FG028|Overall Study|Protocol Violation|0|||
146265541|NCT01296555|527486867|FG000|Overall Study|Study Terminated By Sponsor|0|||
146265542|NCT01296555|527486868|FG001|Overall Study|Study Terminated By Sponsor|0|||
146265543|NCT01296555|527486869|FG002|Overall Study|Study Terminated By Sponsor|0|||
146265544|NCT01296555|527486870|FG003|Overall Study|Study Terminated By Sponsor|0|||
146265545|NCT01296555|527486871|FG004|Overall Study|Study Terminated By Sponsor|0|||
146265546|NCT01296555|527486872|FG005|Overall Study|Study Terminated By Sponsor|0|||
146265547|NCT01296555|527486873|FG006|Overall Study|Study Terminated By Sponsor|0|||
146265548|NCT01296555|527486874|FG007|Overall Study|Study Terminated By Sponsor|0|||
146265549|NCT01296555|527486875|FG008|Overall Study|Study Terminated By Sponsor|0|||
146265550|NCT01296555|527486876|FG009|Overall Study|Study Terminated By Sponsor|0|||
146265551|NCT01296555|527486877|FG010|Overall Study|Study Terminated By Sponsor|0|||
146265552|NCT01296555|527486878|FG011|Overall Study|Study Terminated By Sponsor|0|||
146265553|NCT01296555|527486879|FG012|Overall Study|Study Terminated By Sponsor|0|||
146265554|NCT01296555|527486880|FG013|Overall Study|Study Terminated By Sponsor|0|||
146265555|NCT01296555|527486881|FG014|Overall Study|Study Terminated By Sponsor|0|||
146265556|NCT01296555|527486882|FG015|Overall Study|Study Terminated By Sponsor|0|||
146265557|NCT01296555|527486883|FG016|Overall Study|Study Terminated By Sponsor|0|||
146265558|NCT01296555|527486884|FG017|Overall Study|Study Terminated By Sponsor|0|||
146265559|NCT01296555|527486885|FG018|Overall Study|Study Terminated By Sponsor|0|||
146265560|NCT01296555|527486886|FG019|Overall Study|Study Terminated By Sponsor|0|||
146265561|NCT01296555|527486887|FG020|Overall Study|Study Terminated By Sponsor|0|||
146265562|NCT01296555|527486888|FG021|Overall Study|Study Terminated By Sponsor|0|||
146265563|NCT01296555|527486889|FG022|Overall Study|Study Terminated By Sponsor|0|||
146265564|NCT01296555|527486890|FG023|Overall Study|Study Terminated By Sponsor|0|||
146265565|NCT01296555|527486891|FG024|Overall Study|Study Terminated By Sponsor|0|||
146265566|NCT01296555|527486892|FG025|Overall Study|Study Terminated By Sponsor|1|||
146265567|NCT01296555|527486893|FG026|Overall Study|Study Terminated By Sponsor|0|||
146265568|NCT01296555|527486894|FG027|Overall Study|Study Terminated By Sponsor|0|||
146265569|NCT01296555|527486895|FG028|Overall Study|Study Terminated By Sponsor|0|||
146265570|NCT01296555|527486867|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265571|NCT01296555|527486868|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265572|NCT01296555|527486869|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265573|NCT01296555|527486870|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265574|NCT01296555|527486871|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265575|NCT01296555|527486872|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265576|NCT01296555|527486873|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265577|NCT01296555|527486874|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265578|NCT01296555|527486875|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265579|NCT01296555|527486876|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265580|NCT01296555|527486877|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265581|NCT01296555|527486878|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265582|NCT01296555|527486879|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265583|NCT01296555|527486880|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265584|NCT01296555|527486881|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265585|NCT01296555|527486882|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265586|NCT01296555|527486883|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265587|NCT01296555|527486884|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265588|NCT01296555|527486885|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265589|NCT01296555|527486886|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
146265590|NCT01296555|527486887|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265591|NCT01296555|527486888|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265592|NCT01296555|527486889|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265593|NCT01296555|527486890|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265594|NCT01296555|527486891|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265595|NCT01296555|527486892|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265596|NCT01296555|527486893|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265597|NCT01296555|527486894|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265598|NCT01296555|527486895|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
146265599|NCT01296555|527486867|FG000|Overall Study|Death|0|||
146265600|NCT01296555|527486868|FG001|Overall Study|Death|0|||
146265601|NCT01296555|527486869|FG002|Overall Study|Death|0|||
146265602|NCT01296555|527486870|FG003|Overall Study|Death|2|||
146265603|NCT01296555|527486871|FG004|Overall Study|Death|1|||
146265604|NCT01296555|527486872|FG005|Overall Study|Death|0|||
146265605|NCT01296555|527486873|FG006|Overall Study|Death|2|||
146265606|NCT01296555|527486874|FG007|Overall Study|Death|0|||
146265607|NCT01296555|527486875|FG008|Overall Study|Death|0|||
146265608|NCT01296555|527486876|FG009|Overall Study|Death|1|||
146265609|NCT01296555|527486877|FG010|Overall Study|Death|0|||
146265610|NCT01296555|527486878|FG011|Overall Study|Death|1|||
146265611|NCT01296555|527486879|FG012|Overall Study|Death|0|||
146265612|NCT01296555|527486880|FG013|Overall Study|Death|2|||
146265613|NCT01296555|527486881|FG014|Overall Study|Death|27|||
146265614|NCT01296555|527486882|FG015|Overall Study|Death|15|||
146265615|NCT01296555|527486883|FG016|Overall Study|Death|11|||
146265616|NCT01296555|527486884|FG017|Overall Study|Death|11|||
146135408|NCT02457598|527013757|FG006|Overall Study|Withdrew Consent|0|||
146135409|NCT02457598|527013758|FG007|Overall Study|Withdrew Consent|2|||
146135410|NCT02457598|527013759|FG008|Overall Study|Withdrew Consent|0|||
146135411|NCT02457598|527013760|FG009|Overall Study|Withdrew Consent|0|||
146135412|NCT02457598|527013761|FG010|Overall Study|Withdrew Consent|3|||
146135413|NCT02457598|527013762|FG011|Overall Study|Withdrew Consent|0|||
146135414|NCT02457598|527013763|FG012|Overall Study|Withdrew Consent|0|||
146135415|NCT02457598|527013764|FG013|Overall Study|Withdrew Consent|1|||
146135416|NCT02457598|527013765|FG014|Overall Study|Withdrew Consent|0|||
146135417|NCT02457598|527013766|FG015|Overall Study|Withdrew Consent|0|||
146135418|NCT02457598|527013767|FG016|Overall Study|Withdrew Consent|0|||
146135419|NCT02457598|527013751|FG000|Overall Study|Unacceptable Toxicity|0|||
146135420|NCT02457598|527013752|FG001|Overall Study|Unacceptable Toxicity|0|||
146135421|NCT02457598|527013753|FG002|Overall Study|Unacceptable Toxicity|0|||
146135422|NCT02457598|527013754|FG003|Overall Study|Unacceptable Toxicity|0|||
146135423|NCT02457598|527013755|FG004|Overall Study|Unacceptable Toxicity|0|||
146135424|NCT02457598|527013756|FG005|Overall Study|Unacceptable Toxicity|0|||
146135425|NCT02457598|527013757|FG006|Overall Study|Unacceptable Toxicity|0|||
146135426|NCT02457598|527013758|FG007|Overall Study|Unacceptable Toxicity|0|||
146135427|NCT02457598|527013759|FG008|Overall Study|Unacceptable Toxicity|0|||
146135428|NCT02457598|527013760|FG009|Overall Study|Unacceptable Toxicity|0|||
146135429|NCT02457598|527013761|FG010|Overall Study|Unacceptable Toxicity|1|||
146135430|NCT02457598|527013762|FG011|Overall Study|Unacceptable Toxicity|0|||
146135431|NCT02457598|527013763|FG012|Overall Study|Unacceptable Toxicity|1|||
146135432|NCT02457598|527013764|FG013|Overall Study|Unacceptable Toxicity|1|||
146135433|NCT02457598|527013765|FG014|Overall Study|Unacceptable Toxicity|1|||
146265617|NCT01296555|527486885|FG018|Overall Study|Death|17|||
146265618|NCT01296555|527486886|FG019|Overall Study|Death|12|||
146135434|NCT02457598|527013766|FG015|Overall Study|Unacceptable Toxicity|0|||
146135435|NCT02457598|527013767|FG016|Overall Study|Unacceptable Toxicity|0|||
146265619|NCT01296555|527486887|FG020|Overall Study|Death|13|||
146265620|NCT01296555|527486888|FG021|Overall Study|Death|12|||
146265621|NCT01296555|527486889|FG022|Overall Study|Death|12|||
146265622|NCT01296555|527486890|FG023|Overall Study|Death|13|||
146265623|NCT01296555|527486891|FG024|Overall Study|Death|7|||
146265624|NCT01296555|527486892|FG025|Overall Study|Death|7|||
146135436|NCT02457598|527013751|FG000|Overall Study|Intercurrent Illness|0|||
146265625|NCT01296555|527486893|FG026|Overall Study|Death|35|||
146265626|NCT01296555|527486894|FG027|Overall Study|Death|92|||
146265627|NCT01296555|527486895|FG028|Overall Study|Death|44|||
146265628|NCT01296555|527486867|FG000|Overall Study|Lost to Follow-up|0|||
146265629|NCT01296555|527486868|FG001|Overall Study|Lost to Follow-up|0|||
146265630|NCT01296555|527486869|FG002|Overall Study|Lost to Follow-up|0|||
146265631|NCT01296555|527486870|FG003|Overall Study|Lost to Follow-up|0|||
146265632|NCT01296555|527486871|FG004|Overall Study|Lost to Follow-up|0|||
146265633|NCT01296555|527486872|FG005|Overall Study|Lost to Follow-up|0|||
146265634|NCT01296555|527486873|FG006|Overall Study|Lost to Follow-up|0|||
146135437|NCT02457598|527013752|FG001|Overall Study|Intercurrent Illness|0|||
146135438|NCT02457598|527013753|FG002|Overall Study|Intercurrent Illness|0|||
146135439|NCT02457598|527013754|FG003|Overall Study|Intercurrent Illness|0|||
146135440|NCT02457598|527013755|FG004|Overall Study|Intercurrent Illness|0|||
146135441|NCT02457598|527013756|FG005|Overall Study|Intercurrent Illness|0|||
146135442|NCT02457598|527013757|FG006|Overall Study|Intercurrent Illness|0|||
146135443|NCT02457598|527013758|FG007|Overall Study|Intercurrent Illness|0|||
146135444|NCT02457598|527013759|FG008|Overall Study|Intercurrent Illness|0|||
146135445|NCT02457598|527013760|FG009|Overall Study|Intercurrent Illness|0|||
146135446|NCT02457598|527013761|FG010|Overall Study|Intercurrent Illness|1|||
146135447|NCT02457598|527013762|FG011|Overall Study|Intercurrent Illness|0|||
146135448|NCT02457598|527013763|FG012|Overall Study|Intercurrent Illness|0|||
146135449|NCT02457598|527013764|FG013|Overall Study|Intercurrent Illness|0|||
146135450|NCT02457598|527013765|FG014|Overall Study|Intercurrent Illness|0|||
146135451|NCT02457598|527013766|FG015|Overall Study|Intercurrent Illness|0|||
146135452|NCT02457598|527013767|FG016|Overall Study|Intercurrent Illness|0|||
146135453|NCT02457598|527013751|FG000|Overall Study|Protocol Violation|0|||
146135454|NCT02457598|527013752|FG001|Overall Study|Protocol Violation|0|||
146135455|NCT02457598|527013753|FG002|Overall Study|Protocol Violation|0|||
146135456|NCT02457598|527013754|FG003|Overall Study|Protocol Violation|0|||
146135457|NCT02457598|527013755|FG004|Overall Study|Protocol Violation|0|||
146135458|NCT02457598|527013756|FG005|Overall Study|Protocol Violation|0|||
146135459|NCT02457598|527013757|FG006|Overall Study|Protocol Violation|0|||
146135460|NCT02457598|527013758|FG007|Overall Study|Protocol Violation|0|||
146135461|NCT02457598|527013759|FG008|Overall Study|Protocol Violation|0|||
146135462|NCT02457598|527013760|FG009|Overall Study|Protocol Violation|0|||
146135463|NCT02457598|527013761|FG010|Overall Study|Protocol Violation|1|||
146135464|NCT02457598|527013762|FG011|Overall Study|Protocol Violation|0|||
146135465|NCT02457598|527013763|FG012|Overall Study|Protocol Violation|0|||
146135466|NCT02457598|527013764|FG013|Overall Study|Protocol Violation|0|||
146135467|NCT02457598|527013765|FG014|Overall Study|Protocol Violation|0|||
146135468|NCT02457598|527013766|FG015|Overall Study|Protocol Violation|0|||
146135469|NCT02457598|527013767|FG016|Overall Study|Protocol Violation|0|||
146135470|NCT03837899|527013768|FG000|Overall Study|Death|6|||
146135471|NCT03837899|527013769|FG001|Overall Study|Death|8|||
146135472|NCT03837899|527013770|FG002|Overall Study|Death|3|||
146135473|NCT03837899|527013771|FG003|Overall Study|Death|7|||
146135474|NCT03837899|527013772|FG004|Overall Study|Death|8|||
146135475|NCT03837899|527013773|FG005|Overall Study|Death|7|||
146135476|NCT03837899|527013768|FG000|Overall Study|Moved to post-trial access program|0|||
146135477|NCT03837899|527013769|FG001|Overall Study|Moved to post-trial access program|1|||
146135478|NCT03837899|527013770|FG002|Overall Study|Moved to post-trial access program|0|||
146135479|NCT03837899|527013771|FG003|Overall Study|Moved to post-trial access program|0|||
146135480|NCT03837899|527013772|FG004|Overall Study|Moved to post-trial access program|0|||
146135481|NCT03837899|527013773|FG005|Overall Study|Moved to post-trial access program|0|||
146135482|NCT03837899|527013768|FG000|Overall Study|Other|0|||
146135483|NCT03837899|527013769|FG001|Overall Study|Other|0|||
146135484|NCT03837899|527013770|FG002|Overall Study|Other|0|||
146135485|NCT03837899|527013771|FG003|Overall Study|Other|0|||
146135486|NCT03837899|527013772|FG004|Overall Study|Other|0|||
146135487|NCT03837899|527013773|FG005|Overall Study|Other|2|||
146135488|NCT03837899|527013768|FG000|Overall Study|Lost to Follow-up|0|||
146135489|NCT03837899|527013769|FG001|Overall Study|Lost to Follow-up|1|||
146135490|NCT03837899|527013770|FG002|Overall Study|Lost to Follow-up|0|||
146135491|NCT03837899|527013771|FG003|Overall Study|Lost to Follow-up|0|||
146135492|NCT03837899|527013772|FG004|Overall Study|Lost to Follow-up|0|||
146135493|NCT03837899|527013773|FG005|Overall Study|Lost to Follow-up|0|||
146135494|NCT03837899|527013768|FG000|Overall Study|Withdrawal by Subject|0|||
146135495|NCT03837899|527013769|FG001|Overall Study|Withdrawal by Subject|0|||
146135496|NCT03837899|527013770|FG002|Overall Study|Withdrawal by Subject|0|||
146135497|NCT03837899|527013771|FG003|Overall Study|Withdrawal by Subject|1|||
146135498|NCT03837899|527013772|FG004|Overall Study|Withdrawal by Subject|0|||
146135499|NCT03837899|527013773|FG005|Overall Study|Withdrawal by Subject|0|||
146135500|NCT03837899|527013768|FG000|Overall Study|Study specific discontinuation criteria|0|||
146135501|NCT03837899|527013769|FG001|Overall Study|Study specific discontinuation criteria|1|||
146135502|NCT03837899|527013770|FG002|Overall Study|Study specific discontinuation criteria|0|||
146135503|NCT03837899|527013771|FG003|Overall Study|Study specific discontinuation criteria|0|||
146135504|NCT03837899|527013772|FG004|Overall Study|Study specific discontinuation criteria|3|||
146135505|NCT03837899|527013773|FG005|Overall Study|Study specific discontinuation criteria|1|||
146135506|NCT01537783|527013782|FG000|Overall Study|Lost to Follow-up|11|||
146135507|NCT01537783|527013783|FG001|Overall Study|Lost to Follow-up|2|||
146135508|NCT01554618|527013784|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
146135509|NCT01554618|527013785|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
146135510|NCT01554618|527013784|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
146135511|NCT01554618|527013785|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
146135512|NCT01554618|527013784|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
146265635|NCT01296555|527486874|FG007|Overall Study|Lost to Follow-up|0|||
146135513|NCT01554618|527013785|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
146135514|NCT01554618|527013784|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
146135515|NCT01554618|527013785|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
146135516|NCT01554618|527013784|FG000|Open-Label Extension Period|Physician Decision|0|||
146135517|NCT01554618|527013785|FG001|Open-Label Extension Period|Physician Decision|1|||
146135518|NCT01554618|527013784|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
146135519|NCT01554618|527013785|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
146135520|NCT00477672|527013786|FG000|Overall Study|Adverse Event|3|||
146135521|NCT00477672|527013787|FG001|Overall Study|Adverse Event|5|||
146135522|NCT00477672|527013788|FG002|Overall Study|Adverse Event|6|||
146135523|NCT00477672|527013786|FG000|Overall Study|Death|0|||
146135524|NCT00477672|527013787|FG001|Overall Study|Death|1|||
146135525|NCT00477672|527013788|FG002|Overall Study|Death|0|||
146135526|NCT00477672|527013786|FG000|Overall Study|Disease progression|0|||
146135527|NCT00477672|527013787|FG001|Overall Study|Disease progression|1|||
146135528|NCT00477672|527013788|FG002|Overall Study|Disease progression|0|||
146135529|NCT00477672|527013786|FG000|Overall Study|Physician Decision|1|||
146135530|NCT00477672|527013787|FG001|Overall Study|Physician Decision|0|||
146135531|NCT00477672|527013788|FG002|Overall Study|Physician Decision|0|||
146135532|NCT00477672|527013786|FG000|Overall Study|Protocol noncompliance|0|||
146135533|NCT00477672|527013787|FG001|Overall Study|Protocol noncompliance|2|||
146135534|NCT00477672|527013788|FG002|Overall Study|Protocol noncompliance|0|||
146135535|NCT00477672|527013786|FG000|Overall Study|Consent withdrawn|2|||
146135536|NCT00477672|527013787|FG001|Overall Study|Consent withdrawn|5|||
146135537|NCT00477672|527013788|FG002|Overall Study|Consent withdrawn|10|||
146135538|NCT00477672|527013786|FG000|Overall Study|Discretion of Sponsor|1|||
146135539|NCT00477672|527013787|FG001|Overall Study|Discretion of Sponsor|2|||
146135540|NCT00477672|527013788|FG002|Overall Study|Discretion of Sponsor|0|||
146135541|NCT02722928|527013791|FG000|Overall Study|Standard CT was not as required per prot|5|||
146135542|NCT02722928|527013792|FG001|Overall Study|Standard CT was not as required per prot|13|||
146135543|NCT02722928|527013791|FG000|Overall Study|Required Intraoperative MRI|5|||
146135544|NCT02722928|527013792|FG001|Overall Study|Required Intraoperative MRI|7|||
146135545|NCT04011410|527013793|FG000|Overall Study|Withdrawal by Subject|1|||
146135546|NCT01557400|527013794|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
146135547|NCT01557400|527013794|FG000|Overall Study|Adverse Event|3|||
146135548|NCT01557400|527013794|FG000|Overall Study|Lost to Follow-up|5|||
146135549|NCT01557400|527013794|FG000|Overall Study|Withdrawal by Subject|9|||
146135550|NCT01393405|527013797|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
146135551|NCT01393405|527013798|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
146135552|NCT01393405|527013799|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
146135553|NCT01393405|527013797|FG000|Induction Period (week1-16)|Adverse Event|16|||
146135554|NCT01393405|527013798|FG001|Induction Period (week1-16)|Adverse Event|0|||
146135555|NCT01393405|527013799|FG002|Induction Period (week1-16)|Adverse Event|0|||
146135556|NCT01393405|527013797|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
146135557|NCT01393405|527013798|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
146135558|NCT01393405|527013799|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
146135559|NCT01393405|527013797|FG000|Maintenance Period Week|Lack of Efficacy|0|||
146135560|NCT01393405|527013798|FG001|Maintenance Period Week|Lack of Efficacy|22|||
146135561|NCT01393405|527013799|FG002|Maintenance Period Week|Lack of Efficacy|22|||
146135562|NCT01393405|527013797|FG000|Maintenance Period Week|Adverse Event|0|||
146265636|NCT01296555|527486875|FG008|Overall Study|Lost to Follow-up|0|||
146265637|NCT01296555|527486876|FG009|Overall Study|Lost to Follow-up|0|||
146265638|NCT01296555|527486877|FG010|Overall Study|Lost to Follow-up|0|||
146265639|NCT01296555|527486878|FG011|Overall Study|Lost to Follow-up|0|||
146265640|NCT01296555|527486879|FG012|Overall Study|Lost to Follow-up|0|||
146265641|NCT01296555|527486880|FG013|Overall Study|Lost to Follow-up|0|||
146265642|NCT01296555|527486881|FG014|Overall Study|Lost to Follow-up|2|||
146265643|NCT01296555|527486882|FG015|Overall Study|Lost to Follow-up|1|||
146135563|NCT01393405|527013798|FG001|Maintenance Period Week|Adverse Event|5|||
146135564|NCT01393405|527013799|FG002|Maintenance Period Week|Adverse Event|2|||
146135565|NCT01393405|527013797|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
146135566|NCT01393405|527013798|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
146135567|NCT01393405|527013799|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
146135568|NCT01393405|527013797|FG000|Maintenance Period Week|Lost to Follow-up|0|||
146135569|NCT01393405|527013798|FG001|Maintenance Period Week|Lost to Follow-up|1|||
146135570|NCT01393405|527013799|FG002|Maintenance Period Week|Lost to Follow-up|0|||
146265644|NCT01296555|527486883|FG016|Overall Study|Lost to Follow-up|0|||
146135571|NCT04365699|527013800|FG000|Overall Study|Death|2|||
146135572|NCT04365699|527013801|FG001|Overall Study|Death|5|||
146135573|NCT04365699|527013802|FG002|Overall Study|Death|15|||
146135574|NCT00692770|527013815|FG000|Overall Study|Protocol Violation|2|||
146135575|NCT00692770|527013816|FG001|Overall Study|Protocol Violation|7|||
146135576|NCT00692770|527013815|FG000|Overall Study|Withdrawal by Subject|97|||
146135577|NCT00692770|527013816|FG001|Overall Study|Withdrawal by Subject|36|||
146135578|NCT00692770|527013815|FG000|Overall Study|Adverse Event|136|||
146265645|NCT01296555|527486884|FG017|Overall Study|Lost to Follow-up|2|||
146135579|NCT00692770|527013816|FG001|Overall Study|Adverse Event|41|||
146135580|NCT00692770|527013815|FG000|Overall Study|Death|10|||
146135581|NCT00692770|527013816|FG001|Overall Study|Death|5|||
146135582|NCT00692770|527013815|FG000|Overall Study|Lost to Follow-up|7|||
146135583|NCT00692770|527013816|FG001|Overall Study|Lost to Follow-up|3|||
146135584|NCT00692770|527013815|FG000|Overall Study|Non-compliant with study medication|11|||
146135585|NCT00692770|527013816|FG001|Overall Study|Non-compliant with study medication|5|||
146135586|NCT00692770|527013815|FG000|Overall Study|Progression by clinical judgment|2|||
146135587|NCT00692770|527013816|FG001|Overall Study|Progression by clinical judgment|3|||
146135588|NCT00692770|527013815|FG000|Overall Study|Physician decision not protocol driven|10|||
146135589|NCT00692770|527013816|FG001|Overall Study|Physician decision not protocol driven|14|||
146135590|NCT00692770|527013815|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
146135591|NCT00692770|527013816|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
146135592|NCT00692770|527013815|FG000|Overall Study|Protocol driven decision point|3|||
146135593|NCT00692770|527013816|FG001|Overall Study|Protocol driven decision point|7|||
146135594|NCT00692770|527013815|FG000|Overall Study|Completed all planned assessments|79|||
146135595|NCT00692770|527013816|FG001|Overall Study|Completed all planned assessments|101|||
146135596|NCT00692770|527013815|FG000|Overall Study|Radiological and clinical progression|8|||
146135597|NCT00692770|527013816|FG001|Overall Study|Radiological and clinical progression|8|||
146135598|NCT00692770|527013815|FG000|Overall Study|Clinical endpoint reached|16|||
146135599|NCT00692770|527013816|FG001|Overall Study|Clinical endpoint reached|43|||
146135600|NCT00692770|527013815|FG000|Overall Study|Study terminated by sponsor|2|||
146135601|NCT00692770|527013816|FG001|Overall Study|Study terminated by sponsor|2|||
146135602|NCT00692770|527013815|FG000|Overall Study|Randomized but not treated|3|||
146135603|NCT00692770|527013816|FG001|Overall Study|Randomized but not treated|4|||
146135604|NCT00834912|527013817|FG000|Treatment Period 1|Adverse Event|0|||
146135605|NCT00834912|527013818|FG001|Treatment Period 1|Adverse Event|1|||
146135606|NCT00834912|527013819|FG002|Treatment Period 1|Adverse Event|0|||
146135607|NCT00834912|527013820|FG003|Treatment Period 1|Adverse Event|1|||
146135608|NCT00834912|527013821|FG004|Treatment Period 1|Adverse Event|0|||
146135609|NCT00834912|527013822|FG005|Treatment Period 1|Adverse Event|0|||
146135610|NCT00834912|527013817|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146135611|NCT00834912|527013818|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146135612|NCT00834912|527013819|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146135613|NCT00834912|527013820|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146135614|NCT00834912|527013821|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146135615|NCT00834912|527013822|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146135616|NCT03044197|527013823|FG000|Overall Study|Withdrawal by Subject|3|||
146135617|NCT03044197|527013824|FG001|Overall Study|Withdrawal by Subject|1|||
146135618|NCT00262067|527013830|FG000|Overall Study|Death|190|||
146135619|NCT00262067|527013831|FG001|Overall Study|Death|89|||
146135620|NCT00262067|527013832|FG002|Overall Study|Death|186|||
146135621|NCT00262067|527013833|FG003|Overall Study|Death|99|||
146135622|NCT00262067|527013830|FG000|Overall Study|Lost to Follow-up|5|||
146135623|NCT00262067|527013831|FG001|Overall Study|Lost to Follow-up|4|||
146135624|NCT00262067|527013832|FG002|Overall Study|Lost to Follow-up|7|||
146135625|NCT00262067|527013833|FG003|Overall Study|Lost to Follow-up|5|||
146135626|NCT00262067|527013830|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
146135627|NCT00262067|527013831|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
146135628|NCT00262067|527013832|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
146135629|NCT00262067|527013833|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
146135630|NCT00262067|527013830|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
146135631|NCT00262067|527013831|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
146135632|NCT00262067|527013832|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
146135633|NCT00262067|527013833|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
146135634|NCT02849548|527013836|FG000|Overall Study|Lost to Follow-up|1|||
146135635|NCT02849548|527013837|FG001|Overall Study|Lost to Follow-up|2|||
146135636|NCT02849548|527013836|FG000|Overall Study|Protocol Violation|1|||
146135637|NCT02849548|527013837|FG001|Overall Study|Protocol Violation|0|||
146135638|NCT00714259|527013838|FG000|Overall Study|Death|2|||
146135639|NCT00256698|527013841|FG000|Overall Study|Withdrawal by Subject|7|||
146135640|NCT00256698|527013842|FG001|Overall Study|Withdrawal by Subject|7|||
146135641|NCT00256698|527013841|FG000|Overall Study|Adverse Event|13|||
146135642|NCT00256698|527013842|FG001|Overall Study|Adverse Event|6|||
146135643|NCT00256698|527013841|FG000|Overall Study|Protocol Violation|6|||
146135644|NCT00256698|527013842|FG001|Overall Study|Protocol Violation|5|||
146135645|NCT00256698|527013841|FG000|Overall Study|Lost to Follow-up|1|||
146135646|NCT00256698|527013842|FG001|Overall Study|Lost to Follow-up|3|||
146135647|NCT00256698|527013841|FG000|Overall Study|disease progression|97|||
146135648|NCT00256698|527013842|FG001|Overall Study|disease progression|105|||
146135649|NCT00256698|527013841|FG000|Overall Study|still ongoing at data cut-off|41|||
146135650|NCT00256698|527013842|FG001|Overall Study|still ongoing at data cut-off|46|||
146135651|NCT00256698|527013841|FG000|Overall Study|withdrawn due to osteoporosis|1|||
146135652|NCT00256698|527013842|FG001|Overall Study|withdrawn due to osteoporosis|0|||
146135653|NCT00256698|527013841|FG000|Overall Study|Prematurely Discontinued|1|||
146135654|NCT00256698|527013842|FG001|Overall Study|Prematurely Discontinued|0|||
146135655|NCT05168475|527015507|FG000|Period 1|Protocol Violation|1|||
146135656|NCT05168475|527015507|FG000|Period 1|IMP shortage|2|||
146135657|NCT05168475|527015507|FG000|Period 1|Not randomised|2|||
146135658|NCT05168475|527015507|FG000|Period 2|IMP shortage|1|||
146135659|NCT01589822|527015508|FG000|Overall Study|Withdrawal by Subject|1|||
146135660|NCT01589822|527015509|FG001|Overall Study|Withdrawal by Subject|2|||
146265646|NCT01296555|527486885|FG018|Overall Study|Lost to Follow-up|0|||
146265647|NCT01296555|527486886|FG019|Overall Study|Lost to Follow-up|2|||
146265648|NCT01296555|527486887|FG020|Overall Study|Lost to Follow-up|3|||
146265649|NCT01296555|527486888|FG021|Overall Study|Lost to Follow-up|2|||
146265650|NCT01296555|527486889|FG022|Overall Study|Lost to Follow-up|0|||
146265651|NCT01296555|527486890|FG023|Overall Study|Lost to Follow-up|0|||
146265652|NCT01296555|527486891|FG024|Overall Study|Lost to Follow-up|0|||
146265653|NCT01296555|527486892|FG025|Overall Study|Lost to Follow-up|0|||
146265654|NCT01296555|527486893|FG026|Overall Study|Lost to Follow-up|3|||
146265655|NCT01296555|527486894|FG027|Overall Study|Lost to Follow-up|13|||
146265656|NCT01296555|527486895|FG028|Overall Study|Lost to Follow-up|5|||
146265657|NCT01296555|527486867|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146265658|NCT01296555|527486868|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146265659|NCT01296555|527486869|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146265660|NCT01296555|527486870|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146265661|NCT01296555|527486871|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146265662|NCT01296555|527486872|FG005|Overall Study|Non-Compliance With Study Drug|0|||
146265663|NCT01296555|527486873|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146265664|NCT01296555|527486874|FG007|Overall Study|Non-Compliance With Study Drug|1|||
146265665|NCT01296555|527486875|FG008|Overall Study|Non-Compliance With Study Drug|0|||
146265666|NCT01296555|527486876|FG009|Overall Study|Non-Compliance With Study Drug|0|||
146265667|NCT01296555|527486877|FG010|Overall Study|Non-Compliance With Study Drug|0|||
146265668|NCT01296555|527486878|FG011|Overall Study|Non-Compliance With Study Drug|0|||
146265669|NCT01296555|527486879|FG012|Overall Study|Non-Compliance With Study Drug|0|||
146265670|NCT01296555|527486880|FG013|Overall Study|Non-Compliance With Study Drug|0|||
146265671|NCT01296555|527486881|FG014|Overall Study|Non-Compliance With Study Drug|0|||
146265672|NCT01296555|527486882|FG015|Overall Study|Non-Compliance With Study Drug|0|||
146265673|NCT01296555|527486883|FG016|Overall Study|Non-Compliance With Study Drug|0|||
146265674|NCT01296555|527486884|FG017|Overall Study|Non-Compliance With Study Drug|0|||
146265675|NCT01296555|527486885|FG018|Overall Study|Non-Compliance With Study Drug|0|||
146265676|NCT01296555|527486886|FG019|Overall Study|Non-Compliance With Study Drug|0|||
146265677|NCT01296555|527486887|FG020|Overall Study|Non-Compliance With Study Drug|0|||
146265678|NCT01296555|527486888|FG021|Overall Study|Non-Compliance With Study Drug|0|||
146265679|NCT01296555|527486889|FG022|Overall Study|Non-Compliance With Study Drug|0|||
146265680|NCT01296555|527486890|FG023|Overall Study|Non-Compliance With Study Drug|0|||
146265681|NCT01296555|527486891|FG024|Overall Study|Non-Compliance With Study Drug|0|||
146265682|NCT01296555|527486892|FG025|Overall Study|Non-Compliance With Study Drug|0|||
146265683|NCT01296555|527486893|FG026|Overall Study|Non-Compliance With Study Drug|0|||
146265684|NCT01296555|527486894|FG027|Overall Study|Non-Compliance With Study Drug|0|||
146265685|NCT01296555|527486895|FG028|Overall Study|Non-Compliance With Study Drug|0|||
146265686|NCT01296555|527486867|FG000|Overall Study|Withdrawal by Subject|0|||
146265687|NCT01296555|527486868|FG001|Overall Study|Withdrawal by Subject|0|||
146265688|NCT01296555|527486869|FG002|Overall Study|Withdrawal by Subject|0|||
146265689|NCT01296555|527486870|FG003|Overall Study|Withdrawal by Subject|0|||
146265690|NCT01296555|527486871|FG004|Overall Study|Withdrawal by Subject|1|||
146265691|NCT01296555|527486872|FG005|Overall Study|Withdrawal by Subject|0|||
146265692|NCT01296555|527486873|FG006|Overall Study|Withdrawal by Subject|1|||
146265693|NCT01296555|527486874|FG007|Overall Study|Withdrawal by Subject|0|||
146265694|NCT01296555|527486875|FG008|Overall Study|Withdrawal by Subject|0|||
146135661|NCT01589822|527015510|FG002|Overall Study|Withdrawal by Subject|0|||
146135662|NCT01589822|527015508|FG000|Overall Study|Death|1|||
146135663|NCT01589822|527015509|FG001|Overall Study|Death|0|||
146135664|NCT01589822|527015510|FG002|Overall Study|Death|0|||
146135665|NCT01589822|527015508|FG000|Overall Study|Missed 90 day visit|2|||
146135666|NCT01589822|527015509|FG001|Overall Study|Missed 90 day visit|1|||
146135667|NCT01589822|527015510|FG002|Overall Study|Missed 90 day visit|1|||
146135668|NCT01140477|527015511|FG000|Overall Study|Lost to Follow-up|4|||
146135669|NCT01140477|527015512|FG001|Overall Study|Lost to Follow-up|0|||
146135670|NCT01140477|527015511|FG000|Overall Study|Withdrawal by Subject|1|||
146265695|NCT01296555|527486876|FG009|Overall Study|Withdrawal by Subject|0|||
146265696|NCT01296555|527486877|FG010|Overall Study|Withdrawal by Subject|1|||
146265697|NCT01296555|527486878|FG011|Overall Study|Withdrawal by Subject|1|||
146265698|NCT01296555|527486879|FG012|Overall Study|Withdrawal by Subject|0|||
146265699|NCT01296555|527486880|FG013|Overall Study|Withdrawal by Subject|0|||
146265700|NCT01296555|527486881|FG014|Overall Study|Withdrawal by Subject|3|||
146265701|NCT01296555|527486882|FG015|Overall Study|Withdrawal by Subject|0|||
146265702|NCT01296555|527486883|FG016|Overall Study|Withdrawal by Subject|2|||
146265703|NCT01296555|527486884|FG017|Overall Study|Withdrawal by Subject|1|||
146135671|NCT01140477|527015512|FG001|Overall Study|Withdrawal by Subject|4|||
146135672|NCT01140477|527015511|FG000|Overall Study|Surgical complication preventing implant|2|||
146168336|NCT02597036|527128110|FG007|Overall Study|Lost to Follow-up|0|||
146168337|NCT02597036|527128111|FG008|Overall Study|Lost to Follow-up|0|||
146168338|NCT02597036|527128112|FG009|Overall Study|Lost to Follow-up|0|||
146168339|NCT02597036|527128113|FG010|Overall Study|Lost to Follow-up|1|||
146168340|NCT02597036|527128114|FG011|Overall Study|Lost to Follow-up|0|||
146168341|NCT02597036|527128103|FG000|Overall Study|Withdrawal by Subject|0|||
146168342|NCT02597036|527128104|FG001|Overall Study|Withdrawal by Subject|0|||
146168343|NCT02597036|527128105|FG002|Overall Study|Withdrawal by Subject|0|||
146168344|NCT02597036|527128106|FG003|Overall Study|Withdrawal by Subject|0|||
146168345|NCT02597036|527128107|FG004|Overall Study|Withdrawal by Subject|0|||
146168346|NCT02597036|527128108|FG005|Overall Study|Withdrawal by Subject|0|||
146168347|NCT02597036|527128109|FG006|Overall Study|Withdrawal by Subject|0|||
146168348|NCT02597036|527128110|FG007|Overall Study|Withdrawal by Subject|0|||
146168349|NCT02597036|527128111|FG008|Overall Study|Withdrawal by Subject|0|||
146168350|NCT02597036|527128112|FG009|Overall Study|Withdrawal by Subject|0|||
146168351|NCT02597036|527128113|FG010|Overall Study|Withdrawal by Subject|0|||
146168352|NCT02597036|527128114|FG011|Overall Study|Withdrawal by Subject|1|||
146168353|NCT06351371|527128115|FG000|Overall Study|Mutation Status Not Confirmed|9|||
146168354|NCT06351371|527128115|FG000|Overall Study|Ineligible|1|||
146168355|NCT06351371|527128115|FG000|Overall Study|Adverse Event|4|||
146168356|NCT06351371|527128115|FG000|Overall Study|Death|1|||
146168357|NCT06351371|527128115|FG000|Overall Study|Disease progression|14|||
146168358|NCT06351371|527128115|FG000|Overall Study|Withdrawal by Subject|3|||
146168359|NCT06351371|527128115|FG000|Overall Study|Physician Decision|3|||
146168360|NCT04359784|527128117|FG000|Overall Study|Death|2|||
146168361|NCT03217747|527128125|FG000|Overall Study|Adverse Event|0|||
146168362|NCT03217747|527128126|FG001|Overall Study|Adverse Event|1|||
146168363|NCT03217747|527128127|FG002|Overall Study|Adverse Event|0|||
146168364|NCT03217747|527128128|FG003|Overall Study|Adverse Event|0|||
146168365|NCT03217747|527128129|FG004|Overall Study|Adverse Event|0|||
146168366|NCT03217747|527128130|FG005|Overall Study|Adverse Event|0|||
146168367|NCT03217747|527128131|FG006|Overall Study|Adverse Event|0|||
146168368|NCT03217747|527128132|FG007|Overall Study|Adverse Event|0|||
146168369|NCT03217747|527128133|FG008|Overall Study|Adverse Event|0|||
146168370|NCT03217747|527128134|FG009|Overall Study|Adverse Event|0|||
146168371|NCT03217747|527128135|FG010|Overall Study|Adverse Event|0|||
146168372|NCT03217747|527128136|FG011|Overall Study|Adverse Event|0|||
146168373|NCT03217747|527128137|FG012|Overall Study|Adverse Event|1|||
146168374|NCT03217747|527128138|FG013|Overall Study|Adverse Event|1|||
146168375|NCT03217747|527128125|FG000|Overall Study|Death|0|||
146168376|NCT03217747|527128126|FG001|Overall Study|Death|0|||
146168377|NCT03217747|527128127|FG002|Overall Study|Death|0|||
146168378|NCT03217747|527128128|FG003|Overall Study|Death|0|||
146168379|NCT03217747|527128129|FG004|Overall Study|Death|0|||
146168380|NCT03217747|527128130|FG005|Overall Study|Death|0|||
146168381|NCT03217747|527128131|FG006|Overall Study|Death|0|||
146168382|NCT03217747|527128132|FG007|Overall Study|Death|0|||
146168383|NCT03217747|527128133|FG008|Overall Study|Death|1|||
146168384|NCT03217747|527128134|FG009|Overall Study|Death|0|||
146168385|NCT03217747|527128135|FG010|Overall Study|Death|0|||
146168386|NCT03217747|527128136|FG011|Overall Study|Death|0|||
146168387|NCT03217747|527128137|FG012|Overall Study|Death|0|||
146168388|NCT03217747|527128138|FG013|Overall Study|Death|0|||
146168389|NCT03217747|527128125|FG000|Overall Study|Lack of Efficacy|12|||
146168390|NCT03217747|527128126|FG001|Overall Study|Lack of Efficacy|6|||
146168391|NCT03217747|527128127|FG002|Overall Study|Lack of Efficacy|15|||
146168392|NCT03217747|527128128|FG003|Overall Study|Lack of Efficacy|11|||
146168393|NCT03217747|527128129|FG004|Overall Study|Lack of Efficacy|3|||
146168394|NCT03217747|527128130|FG005|Overall Study|Lack of Efficacy|14|||
146168395|NCT03217747|527128131|FG006|Overall Study|Lack of Efficacy|10|||
146168396|NCT03217747|527128132|FG007|Overall Study|Lack of Efficacy|4|||
146168397|NCT03217747|527128133|FG008|Overall Study|Lack of Efficacy|2|||
146168398|NCT03217747|527128134|FG009|Overall Study|Lack of Efficacy|7|||
146168399|NCT03217747|527128135|FG010|Overall Study|Lack of Efficacy|3|||
146168400|NCT03217747|527128136|FG011|Overall Study|Lack of Efficacy|1|||
146168401|NCT03217747|527128137|FG012|Overall Study|Lack of Efficacy|3|||
146168402|NCT03217747|527128138|FG013|Overall Study|Lack of Efficacy|1|||
146168403|NCT03217747|527128125|FG000|Overall Study|Withdrawal by Subject|2|||
146168404|NCT03217747|527128126|FG001|Overall Study|Withdrawal by Subject|1|||
146168405|NCT03217747|527128127|FG002|Overall Study|Withdrawal by Subject|1|||
146168406|NCT03217747|527128128|FG003|Overall Study|Withdrawal by Subject|1|||
146168407|NCT03217747|527128129|FG004|Overall Study|Withdrawal by Subject|1|||
146168408|NCT03217747|527128130|FG005|Overall Study|Withdrawal by Subject|2|||
146168409|NCT03217747|527128131|FG006|Overall Study|Withdrawal by Subject|1|||
146168410|NCT03217747|527128132|FG007|Overall Study|Withdrawal by Subject|0|||
146168411|NCT03217747|527128133|FG008|Overall Study|Withdrawal by Subject|0|||
146265704|NCT01296555|527486885|FG018|Overall Study|Withdrawal by Subject|0|||
146265705|NCT01296555|527486886|FG019|Overall Study|Withdrawal by Subject|1|||
146265706|NCT01296555|527486887|FG020|Overall Study|Withdrawal by Subject|1|||
146265707|NCT01296555|527486888|FG021|Overall Study|Withdrawal by Subject|1|||
146265708|NCT01296555|527486889|FG022|Overall Study|Withdrawal by Subject|3|||
146265709|NCT01296555|527486890|FG023|Overall Study|Withdrawal by Subject|0|||
146265710|NCT01296555|527486891|FG024|Overall Study|Withdrawal by Subject|0|||
146265711|NCT01296555|527486892|FG025|Overall Study|Withdrawal by Subject|0|||
146265712|NCT01296555|527486893|FG026|Overall Study|Withdrawal by Subject|8|||
146265713|NCT01296555|527486894|FG027|Overall Study|Withdrawal by Subject|4|||
146265714|NCT01296555|527486895|FG028|Overall Study|Withdrawal by Subject|2|||
146265715|NCT01628692|527486898|FG000|Overall Study|Lack of Efficacy|4|||
146265716|NCT01628692|527486899|FG001|Overall Study|Lack of Efficacy|4|||
146265717|NCT01628692|527486900|FG002|Overall Study|Lack of Efficacy|5|||
146265718|NCT01628692|527486901|FG003|Overall Study|Lack of Efficacy|1|||
146265719|NCT01628692|527486902|FG004|Overall Study|Lack of Efficacy|4|||
146265720|NCT01628692|527486903|FG005|Overall Study|Lack of Efficacy|7|||
146265721|NCT01628692|527486898|FG000|Overall Study|Adverse Event|2|||
146265722|NCT01628692|527486899|FG001|Overall Study|Adverse Event|0|||
146265723|NCT01628692|527486900|FG002|Overall Study|Adverse Event|2|||
146265724|NCT01628692|527486901|FG003|Overall Study|Adverse Event|0|||
146265725|NCT01628692|527486902|FG004|Overall Study|Adverse Event|0|||
146265726|NCT01628692|527486903|FG005|Overall Study|Adverse Event|0|||
146265727|NCT01628692|527486898|FG000|Overall Study|Withdrawal by Subject|0|||
146265728|NCT01628692|527486899|FG001|Overall Study|Withdrawal by Subject|1|||
146265729|NCT01628692|527486900|FG002|Overall Study|Withdrawal by Subject|1|||
146265730|NCT01628692|527486901|FG003|Overall Study|Withdrawal by Subject|0|||
146265731|NCT01628692|527486902|FG004|Overall Study|Withdrawal by Subject|0|||
146265732|NCT01628692|527486903|FG005|Overall Study|Withdrawal by Subject|0|||
146265733|NCT01628692|527486898|FG000|Overall Study|Death|0|||
146265734|NCT01628692|527486899|FG001|Overall Study|Death|1|||
146303925|NCT03716050|527627437|FG003|Overall Study|Protocol Violation|1|||
146303926|NCT03716050|527627438|FG004|Overall Study|Protocol Violation|0|||
146303927|NCT03716050|527627439|FG005|Overall Study|Protocol Violation|0|||
146303928|NCT03716050|527627440|FG006|Overall Study|Protocol Violation|0|||
146303929|NCT03716050|527627441|FG007|Overall Study|Protocol Violation|2|||
146303930|NCT03123250|527627442|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
146303931|NCT04340557|527627443|FG000|Overall Study|Transferred to ICU and/or death|1|||
146303932|NCT04340557|527627444|FG001|Overall Study|Transferred to ICU and/or death|2|||
146303933|NCT01221727|527627445|FG000|Overall Study|Physician Decision|2|||
146303934|NCT01221727|527627446|FG001|Overall Study|Physician Decision|0|||
146303935|NCT01221727|527627445|FG000|Overall Study|Withdrawal by Subject|1|||
146303936|NCT01221727|527627446|FG001|Overall Study|Withdrawal by Subject|1|||
146303937|NCT00529451|527627447|FG000|Overall Study|Subject withdrew consent|16|||
146303938|NCT00529451|527627448|FG001|Overall Study|Subject withdrew consent|21|||
146303939|NCT00529451|527627449|FG002|Overall Study|Subject withdrew consent|13|||
146303940|NCT00529451|527627450|FG003|Overall Study|Subject withdrew consent|12|||
146303941|NCT00529451|527627447|FG000|Overall Study|Adverse Event|9|||
146303942|NCT00529451|527627448|FG001|Overall Study|Adverse Event|16|||
146303943|NCT00529451|527627449|FG002|Overall Study|Adverse Event|14|||
146303944|NCT00529451|527627450|FG003|Overall Study|Adverse Event|8|||
146303945|NCT00529451|527627447|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
146303946|NCT00529451|527627448|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
146303947|NCT00529451|527627449|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
146303948|NCT00529451|527627450|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
146303949|NCT00529451|527627447|FG000|Overall Study|Lost to Follow-up|4|||
146303950|NCT00529451|527627448|FG001|Overall Study|Lost to Follow-up|7|||
146303951|NCT00529451|527627449|FG002|Overall Study|Lost to Follow-up|4|||
146303952|NCT00529451|527627450|FG003|Overall Study|Lost to Follow-up|4|||
146303953|NCT00529451|527627447|FG000|Overall Study|Protocol deviation|1|||
146303954|NCT00529451|527627448|FG001|Overall Study|Protocol deviation|1|||
146303955|NCT00529451|527627449|FG002|Overall Study|Protocol deviation|4|||
146303956|NCT00529451|527627450|FG003|Overall Study|Protocol deviation|1|||
146303957|NCT00529451|527627447|FG000|Overall Study|Administrative problems|1|||
146265735|NCT01628692|527486900|FG002|Overall Study|Death|0|||
146265736|NCT01628692|527486901|FG003|Overall Study|Death|0|||
146265737|NCT01628692|527486902|FG004|Overall Study|Death|0|||
146303958|NCT00529451|527627448|FG001|Overall Study|Administrative problems|1|||
146265738|NCT01628692|527486903|FG005|Overall Study|Death|0|||
146265739|NCT01628692|527486898|FG000|Overall Study|Poor compliance/noncompliance|1|||
146265740|NCT01628692|527486899|FG001|Overall Study|Poor compliance/noncompliance|0|||
146303959|NCT00529451|527627449|FG002|Overall Study|Administrative problems|0|||
146303960|NCT00529451|527627450|FG003|Overall Study|Administrative problems|2|||
146303961|NCT00773136|527627451|FG000|Overall Study|Physician Decision|2|||
146265741|NCT01628692|527486900|FG002|Overall Study|Poor compliance/noncompliance|0|||
146303962|NCT02463071|527627454|FG000|Overall Study|Adverse Event|3|||
146303963|NCT02463071|527627455|FG001|Overall Study|Adverse Event|5|||
146303964|NCT02463071|527627456|FG002|Overall Study|Adverse Event|1|||
146265742|NCT01628692|527486901|FG003|Overall Study|Poor compliance/noncompliance|0|||
146265743|NCT01628692|527486902|FG004|Overall Study|Poor compliance/noncompliance|0|||
146265744|NCT01628692|527486903|FG005|Overall Study|Poor compliance/noncompliance|0|||
146265745|NCT01628692|527486898|FG000|Overall Study|Administrative reason by sponsor|0|||
146265746|NCT01628692|527486899|FG001|Overall Study|Administrative reason by sponsor|0|||
146265747|NCT01628692|527486900|FG002|Overall Study|Administrative reason by sponsor|0|||
146265748|NCT01628692|527486901|FG003|Overall Study|Administrative reason by sponsor|0|||
146265749|NCT01628692|527486902|FG004|Overall Study|Administrative reason by sponsor|0|||
146265750|NCT01628692|527486903|FG005|Overall Study|Administrative reason by sponsor|1|||
146265751|NCT01628692|527486898|FG000|Overall Study|Completed 12 Week only|0|||
146265752|NCT01628692|527486899|FG001|Overall Study|Completed 12 Week only|0|||
146265753|NCT01628692|527486900|FG002|Overall Study|Completed 12 Week only|0|||
146265754|NCT01628692|527486901|FG003|Overall Study|Completed 12 Week only|0|||
146265755|NCT01628692|527486902|FG004|Overall Study|Completed 12 Week only|0|||
146265756|NCT01628692|527486903|FG005|Overall Study|Completed 12 Week only|1|||
146265757|NCT01182181|527486904|FG000|First Intervention|Adverse Event|1|||
146265758|NCT01182181|527486905|FG001|First Intervention|Adverse Event|0|||
146265759|NCT01182181|527486904|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
146265760|NCT01182181|527486905|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
146265761|NCT01101061|527486906|FG000|Overall Study|Adverse Event|0|||
146265762|NCT01101061|527486907|FG001|Overall Study|Adverse Event|0|||
146265763|NCT01101061|527486908|FG002|Overall Study|Adverse Event|1|||
146265764|NCT01101061|527486909|FG003|Overall Study|Adverse Event|0|||
146265765|NCT01101061|527486910|FG004|Overall Study|Adverse Event|0|||
146265766|NCT01101061|527486911|FG005|Overall Study|Adverse Event|0|||
146265767|NCT00857233|527486912|FG000|Overall Study|Adverse Event|24|||
146265768|NCT00857233|527486912|FG000|Overall Study|Lack of Efficacy|1|||
146265769|NCT00857233|527486912|FG000|Overall Study|Non-compliance|1|||
146265770|NCT00857233|527486912|FG000|Overall Study|Withdrawal of Consent|9|||
146265771|NCT00857233|527486912|FG000|Overall Study|Lost to Follow-up|4|||
146265772|NCT00857233|527486912|FG000|Overall Study|Nursing Home Placement|14|||
146265773|NCT00857233|527486912|FG000|Overall Study|Other Reasons|2|||
146265774|NCT01587118|527486913|FG000|Overall Study|Adverse Event|3|||
146265775|NCT01587118|527486913|FG000|Overall Study|Lost to Follow-up|2|||
146265776|NCT01587118|527486913|FG000|Overall Study|Relocation|1|||
146265777|NCT01587118|527486913|FG000|Overall Study|nonresponse|1|||
146265778|NCT00409409|527486914|FG000|Overall Study|Adverse Event|7|||
146265779|NCT00409409|527486915|FG001|Overall Study|Adverse Event|2|||
146265780|NCT00409409|527486914|FG000|Overall Study|Withdrawal by Subject|1|||
146265781|NCT00409409|527486915|FG001|Overall Study|Withdrawal by Subject|1|||
146265782|NCT00409409|527486914|FG000|Overall Study|Any other reason not above-mentioned|0|||
146265783|NCT00409409|527486915|FG001|Overall Study|Any other reason not above-mentioned|1|||
146265784|NCT00267098|527486916|FG000|Overall Study|Death|0|||
146265785|NCT00267098|527486917|FG001|Overall Study|Death|0|||
146265786|NCT00267098|527486918|FG002|Overall Study|Death|57|||
146135673|NCT01140477|527015512|FG001|Overall Study|Surgical complication preventing implant|0|||
146135674|NCT01140477|527015511|FG000|Overall Study|Death|1|||
146135675|NCT01140477|527015512|FG001|Overall Study|Death|1|||
146135676|NCT01140477|527015511|FG000|Overall Study|Subject explanted|0|||
146135677|NCT01140477|527015512|FG001|Overall Study|Subject explanted|1|||
146135678|NCT04482179|527015513|FG000|Overall Study|Death|1|||
146135679|NCT04482179|527015514|FG001|Overall Study|Death|0|||
146135680|NCT04482179|527015513|FG000|Overall Study|Withdrawal by Subject|1|||
146135681|NCT04482179|527015514|FG001|Overall Study|Withdrawal by Subject|0|||
146135682|NCT01302964|527015515|FG000|Overall Study|Adverse Event|1|||
146135683|NCT01302964|527015516|FG001|Overall Study|Adverse Event|0|||
146135684|NCT05723770|527015517|FG000|Overall Study|Lost to Follow-up|4|||
146135685|NCT05723770|527015517|FG000|Overall Study|Withdrawal by Subject|2|||
146135686|NCT04127786|527015518|FG000|Primary Series|Adverse Event|1|||
146135687|NCT04127786|527015519|FG001|Primary Series|Adverse Event|0|||
146135688|NCT04127786|527015520|FG002|Primary Series|Adverse Event|0|||
146135689|NCT04127786|527015521|FG003|Primary Series|Adverse Event|1|||
146265787|NCT00267098|527486919|FG003|Overall Study|Death|66|||
146265788|NCT00267098|527486920|FG004|Overall Study|Death|14|||
146265789|NCT00267098|527486921|FG005|Overall Study|Death|23|||
146303965|NCT02463071|527627454|FG000|Overall Study|Death|1|||
146135690|NCT04127786|527015522|FG004|Primary Series|Adverse Event|0|||
146135691|NCT04127786|527015523|FG005|Primary Series|Adverse Event|1|||
146135692|NCT04127786|527015518|FG000|Primary Series|Protocol Violation|5|||
146135693|NCT04127786|527015519|FG001|Primary Series|Protocol Violation|3|||
146265790|NCT00267098|527486922|FG006|Overall Study|Death|28|||
146265791|NCT00267098|527486923|FG007|Overall Study|Death|9|||
146265792|NCT00267098|527486916|FG000|Overall Study|Lost to Follow-up|0|||
146265793|NCT00267098|527486917|FG001|Overall Study|Lost to Follow-up|0|||
146265794|NCT00267098|527486918|FG002|Overall Study|Lost to Follow-up|6|||
146265795|NCT00267098|527486919|FG003|Overall Study|Lost to Follow-up|5|||
146265796|NCT00267098|527486920|FG004|Overall Study|Lost to Follow-up|2|||
146265797|NCT00267098|527486921|FG005|Overall Study|Lost to Follow-up|3|||
146135694|NCT04127786|527015520|FG002|Primary Series|Protocol Violation|4|||
146265798|NCT00267098|527486922|FG006|Overall Study|Lost to Follow-up|1|||
146265799|NCT00267098|527486923|FG007|Overall Study|Lost to Follow-up|1|||
146265800|NCT00267098|527486916|FG000|Overall Study|Withdrawal by Subject|8|||
146265801|NCT00267098|527486917|FG001|Overall Study|Withdrawal by Subject|0|||
146265802|NCT00267098|527486918|FG002|Overall Study|Withdrawal by Subject|24|||
146265803|NCT00267098|527486919|FG003|Overall Study|Withdrawal by Subject|21|||
146265804|NCT00267098|527486920|FG004|Overall Study|Withdrawal by Subject|12|||
146265805|NCT00267098|527486921|FG005|Overall Study|Withdrawal by Subject|9|||
146265806|NCT00267098|527486922|FG006|Overall Study|Withdrawal by Subject|12|||
146265807|NCT00267098|527486923|FG007|Overall Study|Withdrawal by Subject|5|||
146265808|NCT00267098|527486916|FG000|Overall Study|Physician Decision|5|||
146265809|NCT00267098|527486917|FG001|Overall Study|Physician Decision|0|||
146265810|NCT00267098|527486918|FG002|Overall Study|Physician Decision|7|||
146265811|NCT00267098|527486919|FG003|Overall Study|Physician Decision|11|||
146265812|NCT00267098|527486920|FG004|Overall Study|Physician Decision|5|||
146265813|NCT00267098|527486921|FG005|Overall Study|Physician Decision|4|||
146265814|NCT00267098|527486922|FG006|Overall Study|Physician Decision|3|||
146265815|NCT00267098|527486923|FG007|Overall Study|Physician Decision|0|||
146265816|NCT00267098|527486916|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
146265817|NCT00267098|527486917|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265818|NCT00267098|527486918|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265819|NCT00267098|527486919|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265820|NCT00267098|527486920|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146265821|NCT00267098|527486921|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265822|NCT00267098|527486922|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265823|NCT00267098|527486923|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146265824|NCT00267098|527486916|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265825|NCT00267098|527486917|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
146265826|NCT00267098|527486918|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265827|NCT00267098|527486919|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265828|NCT00267098|527486920|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265829|NCT00267098|527486921|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265830|NCT00267098|527486922|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265831|NCT00267098|527486923|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
146265832|NCT00267098|527486916|FG000|Overall Study|Site closure|0|||
146265833|NCT00267098|527486917|FG001|Overall Study|Site closure|0|||
146265834|NCT00267098|527486918|FG002|Overall Study|Site closure|0|||
146265835|NCT00267098|527486919|FG003|Overall Study|Site closure|1|||
146265836|NCT00267098|527486920|FG004|Overall Study|Site closure|0|||
146265837|NCT00267098|527486921|FG005|Overall Study|Site closure|1|||
146265838|NCT00267098|527486922|FG006|Overall Study|Site closure|1|||
146265839|NCT00267098|527486923|FG007|Overall Study|Site closure|0|||
146265840|NCT00267098|527486916|FG000|Overall Study|Explanted Medtronic device|0|||
146265841|NCT00267098|527486917|FG001|Overall Study|Explanted Medtronic device|0|||
146265842|NCT00267098|527486918|FG002|Overall Study|Explanted Medtronic device|0|||
146265843|NCT00267098|527486919|FG003|Overall Study|Explanted Medtronic device|1|||
146265844|NCT00267098|527486920|FG004|Overall Study|Explanted Medtronic device|0|||
146265845|NCT00267098|527486921|FG005|Overall Study|Explanted Medtronic device|0|||
146265846|NCT00267098|527486922|FG006|Overall Study|Explanted Medtronic device|0|||
146265847|NCT00267098|527486923|FG007|Overall Study|Explanted Medtronic device|0|||
146265848|NCT00267098|527486916|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265849|NCT00267098|527486917|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265850|NCT00267098|527486918|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265851|NCT00267098|527486919|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265852|NCT00267098|527486920|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
146265853|NCT00267098|527486921|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265854|NCT00267098|527486922|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265855|NCT00267098|527486923|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
146265856|NCT00267098|527486916|FG000|Overall Study|Subject listed for heart transplant|0|||
146265857|NCT00267098|527486917|FG001|Overall Study|Subject listed for heart transplant|0|||
146303966|NCT02463071|527627455|FG001|Overall Study|Death|0|||
146303967|NCT02463071|527627456|FG002|Overall Study|Death|0|||
146265858|NCT00267098|527486918|FG002|Overall Study|Subject listed for heart transplant|0|||
146265859|NCT00267098|527486919|FG003|Overall Study|Subject listed for heart transplant|0|||
146265860|NCT00267098|527486920|FG004|Overall Study|Subject listed for heart transplant|0|||
146265861|NCT00267098|527486921|FG005|Overall Study|Subject listed for heart transplant|0|||
146265862|NCT00267098|527486922|FG006|Overall Study|Subject listed for heart transplant|1|||
146265863|NCT00267098|527486923|FG007|Overall Study|Subject listed for heart transplant|0|||
146265864|NCT00267098|527486916|FG000|Overall Study|Sponsor withdrew subject|0|||
146265865|NCT00267098|527486917|FG001|Overall Study|Sponsor withdrew subject|0|||
146265866|NCT00267098|527486918|FG002|Overall Study|Sponsor withdrew subject|0|||
146303968|NCT02463071|527627454|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
146265867|NCT00267098|527486919|FG003|Overall Study|Sponsor withdrew subject|1|||
146265868|NCT00267098|527486920|FG004|Overall Study|Sponsor withdrew subject|0|||
146265869|NCT00267098|527486921|FG005|Overall Study|Sponsor withdrew subject|0|||
146265870|NCT00267098|527486922|FG006|Overall Study|Sponsor withdrew subject|0|||
146265871|NCT00267098|527486923|FG007|Overall Study|Sponsor withdrew subject|0|||
146265872|NCT00798304|527486926|FG000|Overall Study|Adverse Event|0|||
146265873|NCT00798304|527486927|FG001|Overall Study|Adverse Event|1|||
146265874|NCT00798304|527486928|FG002|Overall Study|Adverse Event|1|||
146265875|NCT00798304|527486926|FG000|Overall Study|Discontinuation by Sponsor|14|||
146265876|NCT00798304|527486927|FG001|Overall Study|Discontinuation by Sponsor|21|||
146265877|NCT00798304|527486928|FG002|Overall Study|Discontinuation by Sponsor|9|||
146265878|NCT04211389|527486929|FG000|Overall Study|Adverse Event|1|||
146265879|NCT04211389|527486930|FG001|Overall Study|Adverse Event|2|||
146265880|NCT04211389|527486929|FG000|Overall Study|Lost to Follow-up|15|||
146265881|NCT04211389|527486930|FG001|Overall Study|Lost to Follow-up|7|||
146265882|NCT04211389|527486929|FG000|Overall Study|Protocol Violation|0|||
146265883|NCT04211389|527486930|FG001|Overall Study|Protocol Violation|1|||
146265884|NCT04211389|527486929|FG000|Overall Study|Withdrawal by Subject|10|||
146265885|NCT04211389|527486930|FG001|Overall Study|Withdrawal by Subject|11|||
146265886|NCT00547534|527486933|FG000|Overall Study|Adverse Event|7|||
146265887|NCT00547534|527486933|FG000|Overall Study|Disease Progression|4|||
146265888|NCT02688530|527486942|FG000|Overall Study|Withdrawal by Subject|0|||
146265889|NCT02688530|527486943|FG001|Overall Study|Withdrawal by Subject|1|||
146265890|NCT02688530|527486944|FG002|Overall Study|Withdrawal by Subject|0|||
146265891|NCT02688530|527486945|FG003|Overall Study|Withdrawal by Subject|0|||
146265892|NCT02688530|527486942|FG000|Overall Study|Lost to Follow-up|0|||
146265893|NCT02688530|527486943|FG001|Overall Study|Lost to Follow-up|0|||
146265894|NCT02688530|527486944|FG002|Overall Study|Lost to Follow-up|2|||
146265895|NCT02688530|527486945|FG003|Overall Study|Lost to Follow-up|0|||
146265896|NCT01658020|527486946|FG000|Overall Study|Adverse Event|3|||
146265897|NCT01658020|527486947|FG001|Overall Study|Adverse Event|3|||
146265898|NCT01658020|527486946|FG000|Overall Study|Lost to Follow-up|1|||
146265899|NCT01658020|527486947|FG001|Overall Study|Lost to Follow-up|0|||
146265900|NCT01658020|527486946|FG000|Overall Study|Withdrawal by Subject|4|||
146265901|NCT01658020|527486947|FG001|Overall Study|Withdrawal by Subject|5|||
146265902|NCT01658020|527486946|FG000|Overall Study|Protocol Violation|0|||
146265903|NCT01658020|527486947|FG001|Overall Study|Protocol Violation|1|||
146265904|NCT04206085|527486948|FG000|Overall Study|Lost to Follow-up|0|||
146265905|NCT04206085|527486949|FG001|Overall Study|Lost to Follow-up|1|||
146265906|NCT04206085|527486950|FG002|Overall Study|Lost to Follow-up|0|||
146265907|NCT04206085|527486948|FG000|Overall Study|Lost to Follow-up|0|||
146265908|NCT04206085|527486949|FG001|Overall Study|Lost to Follow-up|0|||
146265909|NCT04206085|527486950|FG002|Overall Study|Lost to Follow-up|1|||
146265910|NCT00763451|527486951|FG000|Overall Study|Adverse Event|4|||
146265911|NCT00763451|527486952|FG001|Overall Study|Adverse Event|6|||
146265912|NCT00763451|527486953|FG002|Overall Study|Adverse Event|19|||
146265913|NCT00763451|527486954|FG003|Overall Study|Adverse Event|14|||
146265914|NCT00763451|527486951|FG000|Overall Study|Lack of Efficacy|1|||
146265915|NCT00763451|527486952|FG001|Overall Study|Lack of Efficacy|4|||
146265916|NCT00763451|527486953|FG002|Overall Study|Lack of Efficacy|3|||
146265917|NCT00763451|527486954|FG003|Overall Study|Lack of Efficacy|2|||
146265918|NCT00763451|527486951|FG000|Overall Study|Withdrawal by Subject|1|||
146303969|NCT02463071|527627455|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146303970|NCT02463071|527627456|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146303971|NCT02463071|527627454|FG000|Overall Study|Reason not specified|7|||
146265919|NCT00763451|527486952|FG001|Overall Study|Withdrawal by Subject|6|||
146265920|NCT00763451|527486953|FG002|Overall Study|Withdrawal by Subject|9|||
146265921|NCT00763451|527486954|FG003|Overall Study|Withdrawal by Subject|7|||
146265922|NCT00763451|527486951|FG000|Overall Study|Protocol Violation|0|||
146265923|NCT00763451|527486952|FG001|Overall Study|Protocol Violation|0|||
146265924|NCT00763451|527486953|FG002|Overall Study|Protocol Violation|1|||
146265925|NCT00763451|527486954|FG003|Overall Study|Protocol Violation|0|||
146265926|NCT00763451|527486951|FG000|Overall Study|Poor Compliance to Protocol|1|||
146265927|NCT00763451|527486952|FG001|Overall Study|Poor Compliance to Protocol|1|||
146265928|NCT00763451|527486953|FG002|Overall Study|Poor Compliance to Protocol|2|||
146265929|NCT00763451|527486954|FG003|Overall Study|Poor Compliance to Protocol|2|||
146303972|NCT02463071|527627455|FG001|Overall Study|Reason not specified|9|||
146265930|NCT00763451|527486951|FG000|Overall Study|Familial and Personal Reasons|5|||
146265931|NCT00763451|527486952|FG001|Overall Study|Familial and Personal Reasons|3|||
146265932|NCT00763451|527486953|FG002|Overall Study|Familial and Personal Reasons|5|||
146265933|NCT00763451|527486954|FG003|Overall Study|Familial and Personal Reasons|4|||
146265934|NCT00763451|527486951|FG000|Overall Study|Randomized but not Treated|1|||
146265935|NCT00763451|527486952|FG001|Overall Study|Randomized but not Treated|1|||
146265936|NCT00763451|527486953|FG002|Overall Study|Randomized but not Treated|0|||
146265937|NCT00763451|527486954|FG003|Overall Study|Randomized but not Treated|0|||
146265938|NCT00763451|527486951|FG000|Overall Study|Study Site Reason|0|||
146265939|NCT00763451|527486952|FG001|Overall Study|Study Site Reason|1|||
146265940|NCT00763451|527486953|FG002|Overall Study|Study Site Reason|1|||
146265941|NCT00763451|527486954|FG003|Overall Study|Study Site Reason|1|||
146265942|NCT00725543|527486958|FG000|Overall Study|Adverse Event|10|||
146265943|NCT00725543|527486958|FG000|Overall Study|Lack of Efficacy|3|||
146265944|NCT00725543|527486958|FG000|Overall Study|Withdrawal by Subject|10|||
146265945|NCT00725543|527486958|FG000|Overall Study|Physician Decision|5|||
146265946|NCT00725543|527486958|FG000|Overall Study|Lost to Follow-up|4|||
146265947|NCT00725543|527486958|FG000|Overall Study|Non-compliance|2|||
146265948|NCT00725543|527486958|FG000|Overall Study|Other|119|||
146265949|NCT05594589|527486961|FG000|Overall Study|Other|0|||
146265950|NCT05594589|527486962|FG001|Overall Study|Other|1|||
146265951|NCT05594589|527486963|FG002|Overall Study|Other|0|||
146265952|NCT02168478|527486971|FG000|Overall Study|Withdrawal by Subject|1|||
146265953|NCT02168478|527486971|FG000|Overall Study|Did Not Consent to Participation|2|||
146265954|NCT02168478|527486971|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
146265955|NCT01062971|527486972|FG000|Overall Study|Protocol Violation|1|||
146265956|NCT01062971|527486973|FG001|Overall Study|Protocol Violation|3|||
146265957|NCT01062971|527486972|FG000|Overall Study|Lost to Follow-up|3|||
146265958|NCT01062971|527486973|FG001|Overall Study|Lost to Follow-up|4|||
146265959|NCT01530087|527486974|FG000|Overall Study|Physician Decision|2|||
146265960|NCT02760485|527486983|FG000|Phase 1|Death|3|||
146265961|NCT02760485|527486984|FG001|Phase 1|Death|6|||
146265962|NCT02760485|527486985|FG002|Phase 1|Death|0|||
146265963|NCT02760485|527486983|FG000|Phase 1|Withdrawal by Subject|2|||
146265964|NCT02760485|527486984|FG001|Phase 1|Withdrawal by Subject|0|||
146265965|NCT02760485|527486985|FG002|Phase 1|Withdrawal by Subject|0|||
146265966|NCT02760485|527486983|FG000|Phase 1|Progressive Disease|1|||
146265967|NCT02760485|527486984|FG001|Phase 1|Progressive Disease|0|||
146265968|NCT02760485|527486985|FG002|Phase 1|Progressive Disease|0|||
146265969|NCT02760485|527486983|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
146265970|NCT02760485|527486984|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
146265971|NCT02760485|527486985|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
146265972|NCT02760485|527486983|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
146265973|NCT02760485|527486984|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
146265974|NCT02760485|527486985|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
146265975|NCT02760485|527486983|FG000|Phase 2|Death|0|||
146265976|NCT02760485|527486984|FG001|Phase 2|Death|0|||
146265977|NCT02760485|527486985|FG002|Phase 2|Death|12|||
146265978|NCT02760485|527486983|FG000|Phase 2|Withdrawal by Subject|0|||
146265979|NCT02760485|527486984|FG001|Phase 2|Withdrawal by Subject|0|||
146265980|NCT02760485|527486985|FG002|Phase 2|Withdrawal by Subject|3|||
146265981|NCT02760485|527486983|FG000|Phase 2|Progressive Disease|0|||
146265982|NCT02760485|527486984|FG001|Phase 2|Progressive Disease|0|||
146265983|NCT02760485|527486985|FG002|Phase 2|Progressive Disease|1|||
146265984|NCT02760485|527486983|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
146265985|NCT02760485|527486984|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
146265986|NCT02760485|527486985|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
146265987|NCT01182207|527486986|FG000|First Intervention|Positive Hepatitis Results|0|||
146265988|NCT01182207|527486987|FG001|First Intervention|Positive Hepatitis Results|1|||
146265989|NCT01182207|527486986|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
146265990|NCT01182207|527486987|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
146265991|NCT02581059|527486994|FG000|Study Treatment|Disease Progression|1|||
146265992|NCT02581059|527486995|FG001|Study Treatment|Disease Progression|1|||
146265993|NCT02581059|527486994|FG000|Study Treatment|Adverse Event|2|||
146265994|NCT02581059|527486995|FG001|Study Treatment|Adverse Event|1|||
146265995|NCT02581059|527486994|FG000|Study Treatment|Death|1|||
146265996|NCT02581059|527486995|FG001|Study Treatment|Death|1|||
146265997|NCT02581059|527486994|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146265998|NCT02581059|527486995|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
146265999|NCT02581059|527486994|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
146266000|NCT02581059|527486995|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
146266001|NCT02581059|527486994|FG000|Follow up|Death|1|||
146266002|NCT02581059|527486995|FG001|Follow up|Death|3|||
146266003|NCT02581059|527486994|FG000|Follow up|study terminated|1|||
146266004|NCT02581059|527486995|FG001|Follow up|study terminated|1|||
146266005|NCT02581059|527486994|FG000|Follow up|screen failure|0|||
146266006|NCT02581059|527486995|FG001|Follow up|screen failure|1|||
146266007|NCT02581059|527486994|FG000|Follow up|Patient started new clinical trial|1|||
146266008|NCT02581059|527486995|FG001|Follow up|Patient started new clinical trial|0|||
146266009|NCT03569891|527486997|FG000|Lead-in|Ineligible during lead-in|8|||
146266010|NCT03569891|527486997|FG000|Lead-in|Withdrawal by Subject|3|||
146266011|NCT03569891|527486997|FG000|Lead-in|Risks related to COVID-19|2|||
146266012|NCT03569891|527486997|FG000|AMT-061|Adverse Event|1|||
146266013|NCT05990387|527486998|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
146266014|NCT05990387|527486999|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
146266015|NCT00815919|527487000|FG000|Overall Study|Unrelated Fungal Infection|1|||
146266016|NCT00815919|527487000|FG000|Overall Study|AML Relapse|1|||
146266017|NCT00815919|527487000|FG000|Overall Study|Lack of Efficacy|2|||
146266018|NCT03522389|527487001|FG000|Overall Study|Lost to Follow-up|1|||
146266019|NCT03522389|527487002|FG001|Overall Study|Lost to Follow-up|1|||
146266020|NCT03522389|527487003|FG002|Overall Study|Lost to Follow-up|2|||
146266021|NCT03522389|527487001|FG000|Overall Study|had herniated nucleus pulposus|0|||
146266022|NCT03522389|527487002|FG001|Overall Study|had herniated nucleus pulposus|1|||
146266023|NCT03522389|527487003|FG002|Overall Study|had herniated nucleus pulposus|0|||
146266024|NCT03522389|527487001|FG000|Overall Study|go to work in other province|1|||
146266025|NCT03522389|527487002|FG001|Overall Study|go to work in other province|0|||
146266026|NCT03522389|527487003|FG002|Overall Study|go to work in other province|0|||
146266027|NCT04750577|527487004|FG000|Overall Study|Adverse Event|2|||
146266028|NCT04750577|527487005|FG001|Overall Study|Adverse Event|10|||
146266029|NCT04750577|527487006|FG002|Overall Study|Adverse Event|8|||
146266030|NCT04750577|527487007|FG003|Overall Study|Adverse Event|1|||
146266031|NCT04750577|527487004|FG000|Overall Study|Change of residence|0|||
146266032|NCT04750577|527487005|FG001|Overall Study|Change of residence|0|||
146266033|NCT04750577|527487006|FG002|Overall Study|Change of residence|1|||
146266034|NCT04750577|527487007|FG003|Overall Study|Change of residence|0|||
146266035|NCT04750577|527487004|FG000|Overall Study|Burden of study procedures|0|||
146266036|NCT04750577|527487005|FG001|Overall Study|Burden of study procedures|2|||
146266037|NCT04750577|527487006|FG002|Overall Study|Burden of study procedures|2|||
146266038|NCT04750577|527487007|FG003|Overall Study|Burden of study procedures|0|||
146266039|NCT04750577|527487004|FG000|Overall Study|Prematurely discontinued|0|||
146266040|NCT04750577|527487005|FG001|Overall Study|Prematurely discontinued|0|||
146266041|NCT04750577|527487006|FG002|Overall Study|Prematurely discontinued|0|||
146266042|NCT04750577|527487007|FG003|Overall Study|Prematurely discontinued|2|||
146266043|NCT04750577|527487004|FG000|Overall Study|Protocol deviation|1|||
146266044|NCT04750577|527487005|FG001|Overall Study|Protocol deviation|1|||
146266045|NCT04750577|527487006|FG002|Overall Study|Protocol deviation|1|||
146266046|NCT04750577|527487007|FG003|Overall Study|Protocol deviation|1|||
146266047|NCT04750577|527487004|FG000|Overall Study|Other than listed|3|||
146266048|NCT04750577|527487005|FG001|Overall Study|Other than listed|2|||
146266049|NCT04750577|527487006|FG002|Overall Study|Other than listed|2|||
146266050|NCT04750577|527487007|FG003|Overall Study|Other than listed|1|||
146266051|NCT04750577|527487004|FG000|Overall Study|Not treated|0|||
146266052|NCT04750577|527487005|FG001|Overall Study|Not treated|0|||
146266053|NCT04750577|527487006|FG002|Overall Study|Not treated|0|||
146266054|NCT04750577|527487007|FG003|Overall Study|Not treated|2|||
146266055|NCT02647645|527487012|FG000|Overall Study|Lost to Follow-up|2|||
146266056|NCT02647645|527487013|FG001|Overall Study|Lost to Follow-up|1|||
146266057|NCT02037256|527487014|FG000|Overall Study|Protocol Violation|0|||
146266058|NCT02037256|527487015|FG001|Overall Study|Protocol Violation|1|||
146266059|NCT02037256|527487014|FG000|Overall Study|Withdrawn prior to Velcade|0|||
146266060|NCT02037256|527487015|FG001|Overall Study|Withdrawn prior to Velcade|2|||
146266061|NCT04599907|527487018|FG000|Overall Study|Withdrawal by Subject|1|||
146266062|NCT04599907|527487019|FG001|Overall Study|Withdrawal by Subject|7|||
146266063|NCT04599907|527487020|FG002|Overall Study|Withdrawal by Subject|6|||
146266064|NCT04599907|527487018|FG000|Overall Study|Lost to Follow-up|0|||
146266065|NCT04599907|527487019|FG001|Overall Study|Lost to Follow-up|1|||
146266066|NCT04599907|527487020|FG002|Overall Study|Lost to Follow-up|0|||
146266067|NCT01466790|527487023|FG000|Overall Study|Adverse Event|1|||
146266068|NCT01466790|527487024|FG001|Overall Study|Adverse Event|0|||
146266069|NCT01466790|527487025|FG002|Overall Study|Adverse Event|0|||
146266070|NCT01466790|527487026|FG003|Overall Study|Adverse Event|0|||
146266071|NCT01466790|527487027|FG004|Overall Study|Adverse Event|2|||
146266072|NCT01466790|527487028|FG005|Overall Study|Adverse Event|0|||
146266073|NCT01466790|527487029|FG006|Overall Study|Adverse Event|0|||
146266074|NCT01466790|527487030|FG007|Overall Study|Adverse Event|0|||
146266075|NCT01466790|527487023|FG000|Overall Study|Lost to Follow-up|2|||
146266076|NCT01466790|527487024|FG001|Overall Study|Lost to Follow-up|0|||
146266077|NCT01466790|527487025|FG002|Overall Study|Lost to Follow-up|0|||
146266078|NCT01466790|527487026|FG003|Overall Study|Lost to Follow-up|0|||
146266079|NCT01466790|527487027|FG004|Overall Study|Lost to Follow-up|0|||
146266080|NCT01466790|527487028|FG005|Overall Study|Lost to Follow-up|0|||
146266081|NCT01466790|527487029|FG006|Overall Study|Lost to Follow-up|0|||
146266082|NCT01466790|527487030|FG007|Overall Study|Lost to Follow-up|0|||
146266083|NCT01466790|527487023|FG000|Overall Study|Withdrawal by Subject|1|||
146266084|NCT01466790|527487024|FG001|Overall Study|Withdrawal by Subject|1|||
146266085|NCT01466790|527487025|FG002|Overall Study|Withdrawal by Subject|0|||
146266086|NCT01466790|527487026|FG003|Overall Study|Withdrawal by Subject|0|||
146266087|NCT01466790|527487027|FG004|Overall Study|Withdrawal by Subject|1|||
146266088|NCT01466790|527487028|FG005|Overall Study|Withdrawal by Subject|0|||
146135695|NCT04127786|527015521|FG003|Primary Series|Protocol Violation|3|||
146266089|NCT01466790|527487029|FG006|Overall Study|Withdrawal by Subject|1|||
146266090|NCT01466790|527487030|FG007|Overall Study|Withdrawal by Subject|1|||
146266091|NCT00826228|527488670|FG000|Overall Study|Withdrawal by Subject|1|||
146266092|NCT00966264|527488671|FG000|Overall Study|Lost to Follow-up|4|||
146266093|NCT00966264|527488672|FG001|Overall Study|Lost to Follow-up|3|||
146266094|NCT00487825|527488674|FG000|Overall Study|Adverse Event|2|||
146266095|NCT00487825|527488675|FG001|Overall Study|Adverse Event|2|||
146266096|NCT00487825|527488674|FG000|Overall Study|Lack of Efficacy|1|||
146266097|NCT00487825|527488675|FG001|Overall Study|Lack of Efficacy|1|||
146266098|NCT00487825|527488674|FG000|Overall Study|Other|3|||
146266099|NCT00487825|527488675|FG001|Overall Study|Other|2|||
146266100|NCT00321685|527488678|FG000|Overall Study|Adverse Event|18|||
146266101|NCT00321685|527488678|FG000|Overall Study|Death|2|||
146266102|NCT00321685|527488678|FG000|Overall Study|Withdrawal by Subject|8|||
146266103|NCT00321685|527488678|FG000|Overall Study|Alternative therapy|1|||
146266104|NCT00321685|527488678|FG000|Overall Study|Complicating disese|1|||
146266105|NCT00321685|527488678|FG000|Overall Study|Other|5|||
146266106|NCT00321685|527488678|FG000|Overall Study|Not start protocol therapy|2|||
146266107|NCT00321685|527488678|FG000|Overall Study|Ineligible|2|||
146266108|NCT01986114|527488682|FG000|Overall Study|Adverse Event|59|||
146266109|NCT01986114|527488682|FG000|Overall Study|Lack of Efficacy|23|||
146266110|NCT01986114|527488682|FG000|Overall Study|Withdrawal by Subject|58|||
146266111|NCT01986114|527488682|FG000|Overall Study|Noncompliance|3|||
146266112|NCT01986114|527488682|FG000|Overall Study|Protocol Violation|1|||
146266113|NCT01986114|527488682|FG000|Overall Study|Lost to Follow-up|5|||
146266114|NCT01986114|527488682|FG000|Overall Study|Other reason|7|||
146266115|NCT01190644|527488683|FG000|Overall Study|Death|2|||
146266116|NCT01190644|527488683|FG000|Overall Study|Disease progression|1|||
146266117|NCT02366143|527488684|FG000|Overall Study|Death|307|||
146266118|NCT02366143|527488685|FG001|Overall Study|Death|278|||
146266119|NCT02366143|527488686|FG002|Overall Study|Death|280|||
146266120|NCT02366143|527488684|FG000|Overall Study|Lost to Follow-up|2|||
146266121|NCT02366143|527488685|FG001|Overall Study|Lost to Follow-up|4|||
146266122|NCT02366143|527488686|FG002|Overall Study|Lost to Follow-up|2|||
146266123|NCT02366143|527488684|FG000|Overall Study|Physician Decision|1|||
146266124|NCT02366143|527488685|FG001|Overall Study|Physician Decision|2|||
146266125|NCT02366143|527488686|FG002|Overall Study|Physician Decision|1|||
146266126|NCT02366143|527488684|FG000|Overall Study|Protocol Violation|0|||
146266127|NCT02366143|527488685|FG001|Overall Study|Protocol Violation|0|||
146266128|NCT02366143|527488686|FG002|Overall Study|Protocol Violation|2|||
146266129|NCT02366143|527488684|FG000|Overall Study|Withdrawal by Subject|16|||
146266130|NCT02366143|527488685|FG001|Overall Study|Withdrawal by Subject|17|||
146266131|NCT02366143|527488686|FG002|Overall Study|Withdrawal by Subject|22|||
146266132|NCT02366143|527488684|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
146266133|NCT02366143|527488685|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
146266134|NCT02366143|527488686|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
146266135|NCT02366143|527488684|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
146266136|NCT02366143|527488685|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
146266137|NCT02366143|527488686|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
146266138|NCT02366143|527488684|FG000|Overall Study|Randomization Error|1|||
146266139|NCT02366143|527488685|FG001|Overall Study|Randomization Error|0|||
146266140|NCT02366143|527488686|FG002|Overall Study|Randomization Error|0|||
146266141|NCT02366143|527488684|FG000|Overall Study|PI Move and Site Closure|1|||
146266142|NCT02366143|527488685|FG001|Overall Study|PI Move and Site Closure|0|||
146266143|NCT02366143|527488686|FG002|Overall Study|PI Move and Site Closure|1|||
146266144|NCT02366143|527488684|FG000|Overall Study|Study Terminated By Sponsor|0|||
146266145|NCT02366143|527488685|FG001|Overall Study|Study Terminated By Sponsor|0|||
146266146|NCT02366143|527488686|FG002|Overall Study|Study Terminated By Sponsor|2|||
146266147|NCT02366143|527488684|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
146266148|NCT02366143|527488685|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
146266149|NCT02366143|527488686|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
146266150|NCT02366143|527488684|FG000|Overall Study|Patient moved to roll-over study|1|||
146266151|NCT02366143|527488685|FG001|Overall Study|Patient moved to roll-over study|19|||
146266152|NCT02366143|527488686|FG002|Overall Study|Patient moved to roll-over study|28|||
146266153|NCT02366143|527488684|FG000|Overall Study|Patient moved to commercial stock|0|||
146266154|NCT02366143|527488685|FG001|Overall Study|Patient moved to commercial stock|0|||
146266155|NCT02366143|527488686|FG002|Overall Study|Patient moved to commercial stock|1|||
146266156|NCT02366143|527488684|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
146266157|NCT02366143|527488685|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
146266158|NCT02366143|527488686|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
146135696|NCT04127786|527015522|FG004|Primary Series|Protocol Violation|2|||
146135697|NCT04127786|527015523|FG005|Primary Series|Protocol Violation|0|||
146135698|NCT04127786|527015518|FG000|Primary Series|Withdrawal by Subject|0|||
146135699|NCT04127786|527015519|FG001|Primary Series|Withdrawal by Subject|0|||
146135700|NCT04127786|527015520|FG002|Primary Series|Withdrawal by Subject|0|||
146266159|NCT02366143|527488684|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
146266160|NCT02366143|527488685|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
146266161|NCT02366143|527488686|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
146266162|NCT02366143|527488684|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
146282352|NCT01879722|527546477|FG008|Overall Study|Voluntary Withdrawal|1|||
146135701|NCT04127786|527015521|FG003|Primary Series|Withdrawal by Subject|1|||
146266163|NCT02366143|527488685|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
146266164|NCT02366143|527488686|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
146266165|NCT02366143|527488684|FG000|Overall Study|Requester's instructions|1|||
146266166|NCT02366143|527488685|FG001|Overall Study|Requester's instructions|1|||
146266167|NCT02366143|527488686|FG002|Overall Study|Requester's instructions|1|||
146266168|NCT02366143|527488684|FG000|Overall Study|Uneligible|0|||
146266169|NCT02366143|527488685|FG001|Overall Study|Uneligible|1|||
146266170|NCT02366143|527488686|FG002|Overall Study|Uneligible|0|||
146266171|NCT02366143|527488684|FG000|Overall Study|Post Trial Migration|0|||
146266172|NCT02366143|527488685|FG001|Overall Study|Post Trial Migration|1|||
146266173|NCT02366143|527488686|FG002|Overall Study|Post Trial Migration|0|||
146266174|NCT02366143|527488684|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
146266175|NCT02366143|527488685|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
146266176|NCT02366143|527488686|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
146266177|NCT02366143|527488684|FG000|Overall Study|Patient switched to PTAP|0|||
146266178|NCT02366143|527488685|FG001|Overall Study|Patient switched to PTAP|1|||
146266179|NCT02366143|527488686|FG002|Overall Study|Patient switched to PTAP|0|||
146266180|NCT02366143|527488684|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
146266181|NCT02366143|527488685|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
146266182|NCT02366143|527488686|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
146266183|NCT02172911|527488687|FG000|Overall Study|Serious Adverse Event|0|||
146266184|NCT02172911|527488688|FG001|Overall Study|Serious Adverse Event|1|||
146266185|NCT02172911|527488687|FG000|Overall Study|Progression of Disease|0|||
146266186|NCT02172911|527488688|FG001|Overall Study|Progression of Disease|1|||
146266187|NCT02172911|527488687|FG000|Overall Study|Loss of insurance coverage|1|||
146266188|NCT02172911|527488688|FG001|Overall Study|Loss of insurance coverage|0|||
146266189|NCT04795336|527488693|FG000|Overall Study|Withdrawal by Subject|3|||
146266190|NCT04795336|527488694|FG001|Overall Study|Withdrawal by Subject|4|||
146266191|NCT04795336|527488695|FG002|Overall Study|Withdrawal by Subject|3|||
146266192|NCT04795336|527488696|FG003|Overall Study|Withdrawal by Subject|12|||
146266193|NCT04795336|527488693|FG000|Overall Study|Lost study logs|0|||
146266194|NCT04795336|527488694|FG001|Overall Study|Lost study logs|1|||
146266195|NCT04795336|527488695|FG002|Overall Study|Lost study logs|0|||
146266196|NCT04795336|527488696|FG003|Overall Study|Lost study logs|2|||
146266197|NCT04795336|527488693|FG000|Overall Study|Did not take study medication|2|||
146266198|NCT04795336|527488694|FG001|Overall Study|Did not take study medication|0|||
146266199|NCT04795336|527488695|FG002|Overall Study|Did not take study medication|0|||
146266200|NCT04795336|527488696|FG003|Overall Study|Did not take study medication|0|||
146266201|NCT01234883|527488697|FG000|Overall Study|Early treatment release|8|||
146266202|NCT01234883|527488698|FG001|Overall Study|Early treatment release|10|||
146266203|NCT01234883|527488697|FG000|Overall Study|Parent/guardian withdrew consent|1|||
146266204|NCT01234883|527488698|FG001|Overall Study|Parent/guardian withdrew consent|2|||
146266205|NCT01234883|527488697|FG000|Overall Study|Technical difficulties with IV infusion|0|||
146266206|NCT01234883|527488698|FG001|Overall Study|Technical difficulties with IV infusion|1|||
146266207|NCT01234883|527488697|FG000|Overall Study|Inclusion/exclusion failure|1|||
146266208|NCT01234883|527488698|FG001|Overall Study|Inclusion/exclusion failure|0|||
146303973|NCT02463071|527627456|FG002|Overall Study|Reason not specified|4|||
146303974|NCT02463071|527627454|FG000|Overall Study|Protocol Violation|0|||
146135702|NCT04127786|527015522|FG004|Primary Series|Withdrawal by Subject|0|||
146135703|NCT04127786|527015523|FG005|Primary Series|Withdrawal by Subject|0|||
146135704|NCT04127786|527015518|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
146135705|NCT04127786|527015519|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
146266209|NCT04351269|527488699|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
146266210|NCT04351269|527488700|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
146266211|NCT04351269|527488701|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
146266212|NCT04351269|527488699|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
146266213|NCT04351269|527488700|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
146266214|NCT04351269|527488701|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
146266215|NCT04351269|527488699|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
146266216|NCT04351269|527488700|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
146266217|NCT04351269|527488701|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
146266218|NCT04351269|527488699|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
146266219|NCT04351269|527488700|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
146303975|NCT02463071|527627455|FG001|Overall Study|Protocol Violation|2|||
146266220|NCT04351269|527488701|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
146266221|NCT04351269|527488699|FG000|Overall Study|Lost to Follow-up|1|||
146266222|NCT04351269|527488700|FG001|Overall Study|Lost to Follow-up|3|||
146303976|NCT02463071|527627456|FG002|Overall Study|Protocol Violation|0|||
146135706|NCT04127786|527015520|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
146135707|NCT04127786|527015521|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
146135708|NCT04127786|527015522|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
146135709|NCT04127786|527015523|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
146135710|NCT04127786|527015518|FG000|Booster Phase|Withdrawal by Subject|2|||
146135711|NCT04127786|527015519|FG001|Booster Phase|Withdrawal by Subject|0|||
146303977|NCT02463071|527627454|FG000|Overall Study|Lost to Follow-up|0|||
146135712|NCT04127786|527015520|FG002|Booster Phase|Withdrawal by Subject|0|||
146135713|NCT04127786|527015521|FG003|Booster Phase|Withdrawal by Subject|0|||
146135714|NCT04127786|527015522|FG004|Booster Phase|Withdrawal by Subject|0|||
146135715|NCT04127786|527015523|FG005|Booster Phase|Withdrawal by Subject|0|||
146135716|NCT01982253|527015533|FG000|Overall Study|Withdrawal by Subject|1|||
146135717|NCT01982253|527015534|FG001|Overall Study|Withdrawal by Subject|0|||
146135718|NCT01982253|527015535|FG002|Overall Study|Withdrawal by Subject|0|||
146135719|NCT01982253|527015533|FG000|Overall Study|Study terminated by sponsor|1|||
146135720|NCT01982253|527015534|FG001|Overall Study|Study terminated by sponsor|4|||
146135721|NCT01982253|527015535|FG002|Overall Study|Study terminated by sponsor|4|||
146135722|NCT03848845|527015536|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146135723|NCT03848845|527015537|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
146135724|NCT03848845|527015538|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146135725|NCT03848845|527015539|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
146135726|NCT03848845|527015536|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146135727|NCT03848845|527015537|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146135728|NCT03848845|527015538|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
146135729|NCT03848845|527015539|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
146135730|NCT03848845|527015536|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
146135731|NCT03848845|527015537|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
146135732|NCT03848845|527015538|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
146135733|NCT03848845|527015539|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
146135734|NCT03848845|527015536|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146135735|NCT03848845|527015537|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146135736|NCT03848845|527015538|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
146135737|NCT03848845|527015539|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
146135738|NCT02365636|527015540|FG000|Overall Study|Adverse Event|3|||
146135739|NCT02365636|527015541|FG001|Overall Study|Adverse Event|3|||
146135740|NCT02365636|527015542|FG002|Overall Study|Adverse Event|2|||
146135741|NCT02365636|527015540|FG000|Overall Study|Protocol Violation|1|||
146135742|NCT02365636|527015541|FG001|Overall Study|Protocol Violation|4|||
146135743|NCT02365636|527015542|FG002|Overall Study|Protocol Violation|0|||
146135744|NCT02365636|527015540|FG000|Overall Study|Lost to Follow-up|0|||
146135745|NCT02365636|527015541|FG001|Overall Study|Lost to Follow-up|0|||
146135746|NCT02365636|527015542|FG002|Overall Study|Lost to Follow-up|1|||
146135747|NCT02365636|527015540|FG000|Overall Study|Other|2|||
146135748|NCT02365636|527015541|FG001|Overall Study|Other|0|||
146135749|NCT02365636|527015542|FG002|Overall Study|Other|0|||
146135750|NCT00355238|527015543|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146135751|NCT00355238|527015544|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146135752|NCT00355238|527015545|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146135753|NCT00355238|527015546|FG003|Overall Study|Adverse event unrelated to study drug|1|||
146135754|NCT00355238|527015543|FG000|Overall Study|Death|1|||
146135755|NCT00355238|527015544|FG001|Overall Study|Death|0|||
146135756|NCT00355238|527015545|FG002|Overall Study|Death|0|||
146135757|NCT00355238|527015546|FG003|Overall Study|Death|0|||
146135758|NCT00355238|527015543|FG000|Overall Study|Disease progression|37|||
146135759|NCT00355238|527015544|FG001|Overall Study|Disease progression|36|||
146135760|NCT00355238|527015545|FG002|Overall Study|Disease progression|16|||
146135761|NCT00355238|527015546|FG003|Overall Study|Disease progression|11|||
146135762|NCT00355238|527015543|FG000|Overall Study|Study drug toxicity|11|||
146135763|NCT00355238|527015544|FG001|Overall Study|Study drug toxicity|7|||
146135764|NCT00355238|527015545|FG002|Overall Study|Study drug toxicity|5|||
146135765|NCT00355238|527015546|FG003|Overall Study|Study drug toxicity|2|||
146135766|NCT00355238|527015543|FG000|Overall Study|Participant withdrew consent|3|||
146135767|NCT00355238|527015544|FG001|Overall Study|Participant withdrew consent|1|||
146135768|NCT00355238|527015545|FG002|Overall Study|Participant withdrew consent|0|||
146135769|NCT00355238|527015546|FG003|Overall Study|Participant withdrew consent|0|||
146135770|NCT00355238|527015543|FG000|Overall Study|Participant request to discontinue study treatment|1|||
146135771|NCT00355238|527015544|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146135772|NCT00355238|527015545|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146135773|NCT00355238|527015546|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146135774|NCT01454934|527015547|FG000|Overall Study|Clinical progression|28|||
146135775|NCT01454934|527015548|FG001|Overall Study|Clinical progression|25|||
146135776|NCT01454934|527015547|FG000|Overall Study|Other|6|||
146135777|NCT01454934|527015548|FG001|Overall Study|Other|17|||
146135778|NCT01454934|527015547|FG000|Overall Study|Adverse Event|28|||
146135779|NCT01454934|527015548|FG001|Overall Study|Adverse Event|24|||
146135780|NCT01454934|527015547|FG000|Overall Study|Withdrawn consent|2|||
146135781|NCT01454934|527015548|FG001|Overall Study|Withdrawn consent|5|||
146135782|NCT01454934|527015547|FG000|Overall Study|Withdrawal by Subject|11|||
146135783|NCT01454934|527015548|FG001|Overall Study|Withdrawal by Subject|15|||
146135784|NCT01454934|527015547|FG000|Overall Study|Disease progression|194|||
146135785|NCT01454934|527015548|FG001|Overall Study|Disease progression|181|||
146135786|NCT01454934|527015547|FG000|Overall Study|Lost to Follow-up|0|||
146135787|NCT01454934|527015548|FG001|Overall Study|Lost to Follow-up|1|||
146135788|NCT01454934|527015547|FG000|Overall Study|Not treated|1|||
146135789|NCT01454934|527015548|FG001|Overall Study|Not treated|2|||
146135790|NCT02884089|527015555|FG000|Period 1|Dosing error|2|||
146135791|NCT02884089|527015556|FG001|Period 1|Dosing error|2|||
146135792|NCT02884089|527015557|FG002|Period 1|Dosing error|0|||
146135793|NCT02884089|527015558|FG003|Period 1|Dosing error|0|||
146135794|NCT02884089|527015555|FG000|Washout Period 1|Lost to Follow-up|0|||
146135795|NCT02884089|527015556|FG001|Washout Period 1|Lost to Follow-up|1|||
146135796|NCT02884089|527015557|FG002|Washout Period 1|Lost to Follow-up|0|||
146135797|NCT02884089|527015558|FG003|Washout Period 1|Lost to Follow-up|1|||
146135798|NCT02884089|527015555|FG000|Washout Period 1|Withdrawal by Subject|0|||
146135799|NCT02884089|527015556|FG001|Washout Period 1|Withdrawal by Subject|1|||
146135800|NCT02884089|527015557|FG002|Washout Period 1|Withdrawal by Subject|0|||
146135801|NCT02884089|527015558|FG003|Washout Period 1|Withdrawal by Subject|0|||
146135802|NCT02884089|527015555|FG000|Period 2|Adverse Event|1|||
146135803|NCT02884089|527015556|FG001|Period 2|Adverse Event|0|||
146135804|NCT02884089|527015557|FG002|Period 2|Adverse Event|0|||
146135805|NCT02884089|527015558|FG003|Period 2|Adverse Event|0|||
146135806|NCT02884089|527015555|FG000|Period 3|Withdrawal by Subject|0|||
146135807|NCT02884089|527015556|FG001|Period 3|Withdrawal by Subject|0|||
146135808|NCT02884089|527015557|FG002|Period 3|Withdrawal by Subject|1|||
146135809|NCT02884089|527015558|FG003|Period 3|Withdrawal by Subject|0|||
146135810|NCT02884089|527015555|FG000|Washout Period 3|Withdrawal by Subject|0|||
146135811|NCT02884089|527015556|FG001|Washout Period 3|Withdrawal by Subject|0|||
146135812|NCT02884089|527015557|FG002|Washout Period 3|Withdrawal by Subject|1|||
146135813|NCT02884089|527015558|FG003|Washout Period 3|Withdrawal by Subject|0|||
146135814|NCT02884089|527015555|FG000|Washout Period 3|Lost to Follow-up|0|||
146135815|NCT02884089|527015556|FG001|Washout Period 3|Lost to Follow-up|0|||
146135816|NCT02884089|527015557|FG002|Washout Period 3|Lost to Follow-up|0|||
146135817|NCT02884089|527015558|FG003|Washout Period 3|Lost to Follow-up|1|||
146135818|NCT02884089|527015555|FG000|Period 4|Withdrawal by Subject|0|||
146135819|NCT02884089|527015556|FG001|Period 4|Withdrawal by Subject|1|||
146135820|NCT02884089|527015557|FG002|Period 4|Withdrawal by Subject|0|||
146135821|NCT02884089|527015558|FG003|Period 4|Withdrawal by Subject|0|||
146135822|NCT02884089|527015555|FG000|Period 4|Lost to Follow-up|1|||
146135823|NCT02884089|527015556|FG001|Period 4|Lost to Follow-up|0|||
146135824|NCT02884089|527015557|FG002|Period 4|Lost to Follow-up|0|||
146135825|NCT02884089|527015558|FG003|Period 4|Lost to Follow-up|0|||
146135826|NCT02884089|527015555|FG000|Follow-up Visit|Withdrawal by Subject|1|||
146135827|NCT02884089|527015556|FG001|Follow-up Visit|Withdrawal by Subject|0|||
146135828|NCT02884089|527015557|FG002|Follow-up Visit|Withdrawal by Subject|0|||
146135829|NCT02884089|527015558|FG003|Follow-up Visit|Withdrawal by Subject|1|||
146135830|NCT01631474|527015559|FG000|Overall Study|Lost to Follow-up|8|||
146135831|NCT01631474|527015560|FG001|Overall Study|Lost to Follow-up|5|||
146135832|NCT01631474|527015561|FG002|Overall Study|Lost to Follow-up|7|||
146135833|NCT01631474|527015562|FG003|Overall Study|Lost to Follow-up|5|||
146135834|NCT01631474|527015563|FG004|Overall Study|Lost to Follow-up|5|||
146135835|NCT01631474|527015559|FG000|Overall Study|Withdrawal by Subject|4|||
146135836|NCT01631474|527015560|FG001|Overall Study|Withdrawal by Subject|4|||
146135837|NCT01631474|527015561|FG002|Overall Study|Withdrawal by Subject|2|||
146135838|NCT01631474|527015562|FG003|Overall Study|Withdrawal by Subject|6|||
146135839|NCT01631474|527015563|FG004|Overall Study|Withdrawal by Subject|5|||
146135840|NCT01631474|527015559|FG000|Overall Study|Lack of Efficacy|2|||
146135841|NCT01631474|527015560|FG001|Overall Study|Lack of Efficacy|2|||
146135842|NCT01631474|527015561|FG002|Overall Study|Lack of Efficacy|0|||
146135843|NCT01631474|527015562|FG003|Overall Study|Lack of Efficacy|0|||
146135844|NCT01631474|527015563|FG004|Overall Study|Lack of Efficacy|2|||
146135845|NCT01631474|527015559|FG000|Overall Study|Noncompliance with Study Drug|0|||
146135846|NCT01631474|527015560|FG001|Overall Study|Noncompliance with Study Drug|0|||
146135847|NCT01631474|527015561|FG002|Overall Study|Noncompliance with Study Drug|0|||
146266223|NCT04351269|527488701|FG002|Overall Study|Lost to Follow-up|0|||
146135848|NCT01631474|527015562|FG003|Overall Study|Noncompliance with Study Drug|0|||
146135849|NCT01631474|527015563|FG004|Overall Study|Noncompliance with Study Drug|1|||
146135850|NCT01631474|527015559|FG000|Overall Study|Adverse Event|0|||
146135851|NCT01631474|527015560|FG001|Overall Study|Adverse Event|1|||
146135852|NCT01631474|527015561|FG002|Overall Study|Adverse Event|0|||
146135853|NCT01631474|527015562|FG003|Overall Study|Adverse Event|0|||
146135854|NCT01631474|527015563|FG004|Overall Study|Adverse Event|0|||
146135855|NCT01467076|527015564|FG000|Overall Study|Lost to Follow-up|1|||
146135856|NCT01467076|527015565|FG001|Overall Study|Lost to Follow-up|0|||
146266224|NCT01013961|527488702|FG000|Overall Study|Adverse Event|2|||
146266225|NCT01013961|527488703|FG001|Overall Study|Adverse Event|2|||
146266226|NCT01013961|527488702|FG000|Overall Study|Withdrawal by Subject|1|||
146266227|NCT01013961|527488703|FG001|Overall Study|Withdrawal by Subject|0|||
146266228|NCT01013961|527488702|FG000|Overall Study|Physician Decision|0|||
146266229|NCT01013961|527488703|FG001|Overall Study|Physician Decision|1|||
146266230|NCT04071301|527488709|FG000|Overall Study|Withdrawal by Subject|6|||
146266231|NCT04071301|527488709|FG000|Overall Study|Death|1|||
146266232|NCT01850589|527488715|FG000|Overall Study|Withdrawal by Subject|8|||
146266233|NCT01850589|527488716|FG001|Overall Study|Withdrawal by Subject|0|||
146266234|NCT03721705|527488720|FG000|Overall Study|Adverse Event|2|||
146266235|NCT03721705|527488721|FG001|Overall Study|Adverse Event|0|||
146266236|NCT03721705|527488720|FG000|Overall Study|Withdrawal by Subject|4|||
146266237|NCT03721705|527488721|FG001|Overall Study|Withdrawal by Subject|10|||
146266238|NCT03721705|527488720|FG000|Overall Study|No Suitable Study Partner|1|||
146266239|NCT03721705|527488721|FG001|Overall Study|No Suitable Study Partner|0|||
146266240|NCT03721705|527488720|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
146266241|NCT03721705|527488721|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
146266242|NCT03721705|527488720|FG000|Overall Study|Death|0|||
146266243|NCT03721705|527488721|FG001|Overall Study|Death|1|||
146266244|NCT01843777|527488722|FG000|Overall Study|Withdrawal by Subject|1|||
146266245|NCT01843777|527488723|FG001|Overall Study|Withdrawal by Subject|0|||
146266246|NCT03721172|527488725|FG000|Placebo-controlled Phase|Adverse Event|7|||
146266247|NCT03721172|527488726|FG001|Placebo-controlled Phase|Adverse Event|7|||
146266248|NCT03721172|527488727|FG002|Placebo-controlled Phase|Adverse Event|0|||
146266249|NCT03721172|527488725|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
146266250|NCT03721172|527488726|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
146266251|NCT03721172|527488727|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
146266252|NCT03721172|527488725|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
146266253|NCT03721172|527488726|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
146266254|NCT03721172|527488727|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
146266255|NCT03721172|527488725|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
146266256|NCT03721172|527488726|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
146266257|NCT03721172|527488727|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
146266258|NCT03721172|527488725|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
146266259|NCT03721172|527488726|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
146266260|NCT03721172|527488727|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
146266261|NCT03721172|527488725|FG000|Placebo-controlled Phase|Other|3|||
146266262|NCT03721172|527488726|FG001|Placebo-controlled Phase|Other|0|||
146266263|NCT03721172|527488727|FG002|Placebo-controlled Phase|Other|0|||
146266264|NCT03721172|527488725|FG000|Apremilast Extension Phase|Adverse Event|0|||
146266265|NCT03721172|527488726|FG001|Apremilast Extension Phase|Adverse Event|0|||
146266266|NCT03721172|527488727|FG002|Apremilast Extension Phase|Adverse Event|10|||
146266267|NCT03721172|527488725|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
146266268|NCT03721172|527488726|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
146135857|NCT01467076|527015566|FG002|Overall Study|Lost to Follow-up|0|||
146135858|NCT03354429|527015567|FG000|Overall Study|Withdrawal by Subject|8|||
146135859|NCT03354429|527015568|FG001|Overall Study|Withdrawal by Subject|7|||
146135860|NCT03354429|527015567|FG000|Overall Study|Lost to Follow-up|1|||
146135861|NCT03354429|527015568|FG001|Overall Study|Lost to Follow-up|0|||
146135862|NCT02624284|527015569|FG000|Overall Study|Withdrawal by Subject|3|||
146135863|NCT02624284|527015570|FG001|Overall Study|Withdrawal by Subject|6|||
146135864|NCT02624284|527015571|FG002|Overall Study|Withdrawal by Subject|3|||
146135865|NCT02624284|527015569|FG000|Overall Study|Protocol Violation|9|||
146135866|NCT02624284|527015570|FG001|Overall Study|Protocol Violation|10|||
146135867|NCT02624284|527015571|FG002|Overall Study|Protocol Violation|7|||
146135868|NCT02624284|527015569|FG000|Overall Study|Revealed exclusionary condition|2|||
146266269|NCT03721172|527488727|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
146266270|NCT03721172|527488725|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
146266271|NCT03721172|527488726|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
146266272|NCT03721172|527488727|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
146266273|NCT03721172|527488725|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
146266274|NCT03721172|527488726|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
146266275|NCT03721172|527488727|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
146135869|NCT02624284|527015570|FG001|Overall Study|Revealed exclusionary condition|2|||
146135870|NCT02624284|527015571|FG002|Overall Study|Revealed exclusionary condition|0|||
146266276|NCT03721172|527488725|FG000|Apremilast Extension Phase|Protocol Violation|0|||
146266277|NCT03721172|527488726|FG001|Apremilast Extension Phase|Protocol Violation|0|||
146266278|NCT03721172|527488727|FG002|Apremilast Extension Phase|Protocol Violation|1|||
146266279|NCT03721172|527488725|FG000|Apremilast Extension Phase|Physician Decision|0|||
146266280|NCT03721172|527488726|FG001|Apremilast Extension Phase|Physician Decision|0|||
146266281|NCT03721172|527488727|FG002|Apremilast Extension Phase|Physician Decision|1|||
146303978|NCT02463071|527627455|FG001|Overall Study|Lost to Follow-up|0|||
146135871|NCT02624284|527015569|FG000|Overall Study|Adverse Event|0|||
146135872|NCT02624284|527015570|FG001|Overall Study|Adverse Event|0|||
146135873|NCT02624284|527015571|FG002|Overall Study|Adverse Event|1|||
146135874|NCT02018458|527015574|FG000|Overall Study|Death|4|||
146135875|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
146135876|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
146135877|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Graft loss|1|||
146135878|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Graft loss|2|||
146135879|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Death|5|||
146135880|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Death|3|||
146135881|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
146135882|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
146135883|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
146135884|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
146135885|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
146135886|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
146135887|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
146135888|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
146135889|NCT00378014|527015575|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
146135890|NCT00378014|527015576|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
146135891|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
146266282|NCT03721172|527488725|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
146266283|NCT03721172|527488726|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
146266284|NCT03721172|527488727|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
146266285|NCT03721172|527488725|FG000|Apremilast Extension Phase|Other|0|||
146266286|NCT03721172|527488726|FG001|Apremilast Extension Phase|Other|0|||
146266287|NCT03721172|527488727|FG002|Apremilast Extension Phase|Other|3|||
146266288|NCT03721172|527488725|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
146266289|NCT03721172|527488726|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
146266290|NCT03721172|527488727|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
146266291|NCT01162135|527488729|FG000|Overall Study|Withdrawal by Subject|1|||
146266292|NCT01162135|527488729|FG000|Overall Study|Severe back pain|1|||
146266293|NCT01162135|527488729|FG000|Overall Study|Ineligible|1|||
146266294|NCT00632021|527488733|FG000|Overall Study|Withdrawal/death|4|||
146266295|NCT00632021|527488734|FG001|Overall Study|Withdrawal/death|7|||
146266296|NCT02049515|527488735|FG000|Overall Study|Adverse Event|46|||
146266297|NCT02049515|527488736|FG001|Overall Study|Adverse Event|2|||
146266298|NCT02049515|527488735|FG000|Overall Study|Protocol-specified Disease Progression|23|||
146266299|NCT02049515|527488736|FG001|Overall Study|Protocol-specified Disease Progression|2|||
146266300|NCT02049515|527488735|FG000|Overall Study|Death|6|||
146266301|NCT02049515|527488736|FG001|Overall Study|Death|0|||
146266302|NCT02049515|527488735|FG000|Overall Study|Physician Decision|5|||
146266303|NCT02049515|527488736|FG001|Overall Study|Physician Decision|1|||
146266304|NCT02049515|527488735|FG000|Overall Study|Withdrawal by Subject|3|||
146266305|NCT02049515|527488736|FG001|Overall Study|Withdrawal by Subject|0|||
146266306|NCT02049515|527488735|FG000|Overall Study|Termination of the Study by Sponsor|2|||
146266307|NCT02049515|527488736|FG001|Overall Study|Termination of the Study by Sponsor|0|||
146266308|NCT02049515|527488735|FG000|Overall Study|Protocol Violation|1|||
146266309|NCT02049515|527488736|FG001|Overall Study|Protocol Violation|1|||
146266310|NCT02049515|527488735|FG000|Overall Study|Clinical Deterioration|1|||
146266311|NCT02049515|527488736|FG001|Overall Study|Clinical Deterioration|0|||
146266312|NCT02049515|527488735|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
146266313|NCT02049515|527488736|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
146266314|NCT02049515|527488735|FG000|Overall Study|Treatment Interruption >42 Days|1|||
146266315|NCT02049515|527488736|FG001|Overall Study|Treatment Interruption >42 Days|0|||
146266316|NCT02049515|527488735|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
146266317|NCT02049515|527488736|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
146266318|NCT00224029|527488743|FG000|Overall Study|Lost to Follow-up|1|||
146266319|NCT00224029|527488743|FG000|Overall Study|Withdrawal by Subject|4|||
146266320|NCT00224029|527488743|FG000|Overall Study|Other|1|||
146266321|NCT02872012|527488744|FG000|Overall Study|Withdrawal by Subject|1|||
146135892|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
146135893|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Death|1|||
146135894|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Death|2|||
146135895|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
146135896|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
146266322|NCT02872012|527488745|FG001|Overall Study|Withdrawal by Subject|0|||
146303979|NCT02463071|527627456|FG002|Overall Study|Lost to Follow-up|1|||
146135897|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
146266323|NCT02872012|527488746|FG002|Overall Study|Withdrawal by Subject|0|||
146266324|NCT02872012|527488747|FG003|Overall Study|Withdrawal by Subject|0|||
146266325|NCT02872012|527488748|FG004|Overall Study|Withdrawal by Subject|0|||
146266326|NCT01728623|527488749|FG000|Overall Study|Disease progression|26|||
146266327|NCT01728623|527488749|FG000|Overall Study|Adverse Event|1|||
146266328|NCT01728623|527488749|FG000|Overall Study|Withdrawal by Subject|1|||
146266329|NCT03000348|527488750|FG000|Overall Study|Adverse Event|1|||
146266330|NCT03000348|527488751|FG001|Overall Study|Adverse Event|1|||
146266331|NCT03000348|527488752|FG002|Overall Study|Adverse Event|1|||
146266332|NCT03000348|527488753|FG003|Overall Study|Adverse Event|1|||
146266333|NCT03000348|527488754|FG004|Overall Study|Adverse Event|1|||
146266334|NCT03000348|527488755|FG005|Overall Study|Adverse Event|1|||
146266335|NCT03000348|527488750|FG000|Overall Study|Lost to Follow-up|0|||
146266336|NCT03000348|527488751|FG001|Overall Study|Lost to Follow-up|0|||
146266337|NCT03000348|527488752|FG002|Overall Study|Lost to Follow-up|1|||
146266338|NCT03000348|527488753|FG003|Overall Study|Lost to Follow-up|0|||
146266339|NCT03000348|527488754|FG004|Overall Study|Lost to Follow-up|0|||
146266340|NCT03000348|527488755|FG005|Overall Study|Lost to Follow-up|0|||
146266341|NCT03000348|527488750|FG000|Overall Study|Withdrawal by Subject|0|||
146266342|NCT03000348|527488751|FG001|Overall Study|Withdrawal by Subject|1|||
146266343|NCT03000348|527488752|FG002|Overall Study|Withdrawal by Subject|0|||
146266344|NCT03000348|527488753|FG003|Overall Study|Withdrawal by Subject|0|||
146266345|NCT03000348|527488754|FG004|Overall Study|Withdrawal by Subject|0|||
146135898|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
146135899|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
146135900|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
146135901|NCT00378014|527015575|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
146135902|NCT00378014|527015576|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
146135903|NCT00357370|527015577|FG000|Cohort 2|Lack of Efficacy|0|||
146135904|NCT00357370|527015578|FG001|Cohort 2|Lack of Efficacy|2|||
146135905|NCT00357370|527015579|FG002|Cohort 2|Lack of Efficacy|1|||
146135906|NCT00357370|527015577|FG000|Cohort 2|Adverse Event|1|||
146135907|NCT00357370|527015578|FG001|Cohort 2|Adverse Event|1|||
146135908|NCT00357370|527015579|FG002|Cohort 2|Adverse Event|1|||
146135909|NCT00357370|527015577|FG000|Cohort 2|Lost to Follow-up|0|||
146135910|NCT00357370|527015578|FG001|Cohort 2|Lost to Follow-up|1|||
146135911|NCT00357370|527015579|FG002|Cohort 2|Lost to Follow-up|0|||
146135912|NCT00357370|527015577|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
146135913|NCT00357370|527015578|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
146135914|NCT00357370|527015579|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
146135915|NCT00357370|527015577|FG000|Cohort 2|Withdrawal by Subject|0|||
146135916|NCT00357370|527015578|FG001|Cohort 2|Withdrawal by Subject|2|||
146135917|NCT00357370|527015579|FG002|Cohort 2|Withdrawal by Subject|0|||
146135918|NCT02644967|527015591|FG000|Overall Study|Death|26|||
146135919|NCT02644967|527015591|FG000|Overall Study|Physician Decision|1|||
146135920|NCT02644967|527015591|FG000|Overall Study|Withdrawal by Subject|2|||
146135921|NCT02644967|527015591|FG000|Overall Study|Protocol Violation|1|||
146135922|NCT02644967|527015591|FG000|Overall Study|Progressive Disease|1|||
146135923|NCT02644967|527015591|FG000|Overall Study|Study Terminated by Sponsor|4|||
146135924|NCT02287896|527015592|FG000|Second Injection Visit|Withdrawal by Subject|0|||
146135925|NCT02287896|527015593|FG001|Second Injection Visit|Withdrawal by Subject|1|||
146135926|NCT03746522|527015594|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
146135927|NCT03746522|527015595|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
146135928|NCT03746522|527015596|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
146135929|NCT03746522|527015594|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
146135930|NCT03746522|527015595|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
146135931|NCT03746522|527015596|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
146135932|NCT03746522|527015594|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
146135933|NCT03746522|527015595|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
146135934|NCT03746522|527015596|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
146135935|NCT03746522|527015594|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
146135936|NCT03746522|527015595|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
146135937|NCT03746522|527015596|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
146135938|NCT03746522|527015594|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
146135939|NCT03746522|527015595|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
146135940|NCT03746522|527015596|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
146135941|NCT01639040|527015597|FG000|Overall Study|Adverse Event|1|||
146303980|NCT01009034|527627457|FG000|Overall Study|Lost to Follow-up|2|||
146135942|NCT01639040|527015598|FG001|Overall Study|Adverse Event|0|||
146135943|NCT00486265|527015602|FG000|Overall Study|Adverse Event|1|||
146135944|NCT00486265|527015602|FG000|Overall Study|Lack of Efficacy|8|||
146135945|NCT01452412|527015603|FG000|Overall Study|Withdrawal by Subject|15|||
146266346|NCT03000348|527488755|FG005|Overall Study|Withdrawal by Subject|0|||
146303981|NCT01009034|527627457|FG000|Overall Study|Withdrawal by Subject|2|||
146135946|NCT01452412|527015604|FG001|Overall Study|Withdrawal by Subject|11|||
146135947|NCT01452412|527015603|FG000|Overall Study|Adverse Event|4|||
146135948|NCT01452412|527015604|FG001|Overall Study|Adverse Event|3|||
146266347|NCT03000348|527488750|FG000|Overall Study|Consent|0|||
146266348|NCT03000348|527488751|FG001|Overall Study|Consent|0|||
146266349|NCT03000348|527488752|FG002|Overall Study|Consent|0|||
146266350|NCT03000348|527488753|FG003|Overall Study|Consent|0|||
146266351|NCT03000348|527488754|FG004|Overall Study|Consent|1|||
146266352|NCT03000348|527488755|FG005|Overall Study|Consent|0|||
146266353|NCT03000348|527488750|FG000|Overall Study|Failure to expectorate sputum|1|||
146266354|NCT03000348|527488751|FG001|Overall Study|Failure to expectorate sputum|0|||
146266355|NCT03000348|527488752|FG002|Overall Study|Failure to expectorate sputum|1|||
146266356|NCT03000348|527488753|FG003|Overall Study|Failure to expectorate sputum|0|||
146266357|NCT03000348|527488754|FG004|Overall Study|Failure to expectorate sputum|1|||
146266358|NCT03000348|527488755|FG005|Overall Study|Failure to expectorate sputum|0|||
146266359|NCT03000348|527488750|FG000|Overall Study|No gram negative|1|||
146266360|NCT03000348|527488751|FG001|Overall Study|No gram negative|2|||
146266361|NCT03000348|527488752|FG002|Overall Study|No gram negative|1|||
146266362|NCT03000348|527488753|FG003|Overall Study|No gram negative|1|||
146266363|NCT03000348|527488754|FG004|Overall Study|No gram negative|1|||
146266364|NCT03000348|527488755|FG005|Overall Study|No gram negative|1|||
146266365|NCT03000348|527488750|FG000|Overall Study|Patient had no transport|0|||
146266366|NCT03000348|527488751|FG001|Overall Study|Patient had no transport|0|||
146266367|NCT03000348|527488752|FG002|Overall Study|Patient had no transport|0|||
146266368|NCT03000348|527488753|FG003|Overall Study|Patient had no transport|1|||
146266369|NCT03000348|527488754|FG004|Overall Study|Patient had no transport|0|||
146266370|NCT03000348|527488755|FG005|Overall Study|Patient had no transport|0|||
146266371|NCT03000348|527488750|FG000|Overall Study|Dosing|0|||
146266372|NCT03000348|527488751|FG001|Overall Study|Dosing|0|||
146266373|NCT03000348|527488752|FG002|Overall Study|Dosing|0|||
146266374|NCT03000348|527488753|FG003|Overall Study|Dosing|0|||
146266375|NCT03000348|527488754|FG004|Overall Study|Dosing|1|||
146266376|NCT03000348|527488755|FG005|Overall Study|Dosing|0|||
146266377|NCT01807182|527488757|FG000|Overall Study|Death|1|||
146266378|NCT01807182|527488757|FG000|Overall Study|New therapy|1|||
146266379|NCT01807182|527488757|FG000|Overall Study|Moved to hospice care|1|||
146266380|NCT03513068|527488758|FG000|Overall Study|Death|1|||
146266381|NCT03513068|527488759|FG001|Overall Study|Death|0|||
146266382|NCT03513068|527488758|FG000|Overall Study|Withdrawal by Subject|4|||
146266383|NCT03513068|527488759|FG001|Overall Study|Withdrawal by Subject|6|||
146266384|NCT00745498|527488760|FG000|Overall Study|Lost to Follow-up|1|||
146266385|NCT00745498|527488761|FG001|Overall Study|Lost to Follow-up|1|||
146266386|NCT00745498|527488762|FG002|Overall Study|Lost to Follow-up|3|||
146266387|NCT00745498|527488760|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
146266388|NCT00745498|527488761|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
146266389|NCT00745498|527488762|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
146266390|NCT00745498|527488760|FG000|Overall Study|Non-PDR related VH|0|||
146266391|NCT00745498|527488761|FG001|Overall Study|Non-PDR related VH|1|||
146266392|NCT00745498|527488762|FG002|Overall Study|Non-PDR related VH|1|||
146266393|NCT00745498|527488760|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
146266394|NCT00745498|527488761|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
146266395|NCT00745498|527488762|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
146266396|NCT03174782|527488763|FG000|Overall Study|Protocol Violation|1|||
146266397|NCT03174782|527488764|FG001|Overall Study|Protocol Violation|0|||
146266398|NCT03174782|527488763|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
146266399|NCT03174782|527488764|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
146266400|NCT01791413|527488765|FG000|Overall Study|Lost to Follow-up|5|||
146266401|NCT01791413|527488766|FG001|Overall Study|Lost to Follow-up|1|||
146266402|NCT00778921|527488767|FG000|Overall Study|Adverse Event|9|||
146266403|NCT00778921|527488768|FG001|Overall Study|Adverse Event|10|||
146266404|NCT00778921|527488769|FG002|Overall Study|Adverse Event|14|||
146266405|NCT00778921|527488767|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
146266406|NCT00778921|527488768|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
146266407|NCT00778921|527488769|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146266408|NCT00778921|527488767|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
146266409|NCT00778921|527488768|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
146266410|NCT00778921|527488769|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
146266411|NCT00778921|527488767|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146266412|NCT00778921|527488768|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
146266413|NCT00778921|527488769|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
146266414|NCT00778921|527488767|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
146135949|NCT01452412|527015603|FG000|Overall Study|Lost to Follow-up|5|||
146135950|NCT01452412|527015604|FG001|Overall Study|Lost to Follow-up|3|||
146266415|NCT00778921|527488768|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
146266416|NCT00778921|527488769|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
146266417|NCT00778921|527488767|FG000|Overall Study|Patient withdrew request|3|||
146266418|NCT00778921|527488768|FG001|Overall Study|Patient withdrew request|1|||
146266419|NCT00778921|527488769|FG002|Overall Study|Patient withdrew request|6|||
146266420|NCT00778921|527488767|FG000|Overall Study|Lost to Follow-up|0|||
146266421|NCT00778921|527488768|FG001|Overall Study|Lost to Follow-up|2|||
146266422|NCT00778921|527488769|FG002|Overall Study|Lost to Follow-up|1|||
146266423|NCT00778921|527488767|FG000|Overall Study|Administrative Problems|1|||
146266424|NCT00778921|527488768|FG001|Overall Study|Administrative Problems|2|||
146266425|NCT00778921|527488769|FG002|Overall Study|Administrative Problems|0|||
146266426|NCT00778921|527488767|FG000|Overall Study|Protocol Violation|3|||
146266427|NCT00778921|527488768|FG001|Overall Study|Protocol Violation|0|||
146266428|NCT00778921|527488769|FG002|Overall Study|Protocol Violation|2|||
146266429|NCT00778921|527488767|FG000|Overall Study|Not treated|0|||
146266430|NCT00778921|527488768|FG001|Overall Study|Not treated|2|||
146266431|NCT00778921|527488769|FG002|Overall Study|Not treated|2|||
146266432|NCT03178045|527488770|FG000|Overall Study|Withdrawal by Subject|5|||
146266433|NCT03178045|527488771|FG001|Overall Study|Withdrawal by Subject|7|||
146266434|NCT03178045|527488770|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
146266435|NCT03178045|527488771|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
146266436|NCT03178045|527488770|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
146266437|NCT03178045|527488771|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
146266438|NCT03636373|527488773|FG000|Overall Study|Study closure due to Covid-19|1|||
146266439|NCT03636373|527488774|FG001|Overall Study|Study closure due to Covid-19|0|||
146266440|NCT00572533|527488784|FG000|Overall Study|Death|4|||
146266441|NCT00572533|527488785|FG001|Overall Study|Death|1|||
146266442|NCT00572533|527488784|FG000|Overall Study|Received Kidney Transplant|2|||
146266443|NCT00572533|527488785|FG001|Overall Study|Received Kidney Transplant|1|||
146266444|NCT00572533|527488784|FG000|Overall Study|Social Issues|1|||
146266445|NCT00572533|527488785|FG001|Overall Study|Social Issues|0|||
146266446|NCT00572533|527488784|FG000|Overall Study|Transfer out of Facility|0|||
146266447|NCT00572533|527488785|FG001|Overall Study|Transfer out of Facility|1|||
146266448|NCT01078922|527488786|FG000|Overall Study|Adverse Event|1|||
146266449|NCT01236352|527488789|FG000|Overall Study|Death|0|||
146266450|NCT01236352|527488790|FG001|Overall Study|Death|0|||
146266451|NCT01236352|527488791|FG002|Overall Study|Death|0|||
146266452|NCT01236352|527488792|FG003|Overall Study|Death|0|||
146266453|NCT01236352|527488793|FG004|Overall Study|Death|0|||
146266454|NCT01236352|527488794|FG005|Overall Study|Death|0|||
146266455|NCT01236352|527488795|FG006|Overall Study|Death|0|||
146266456|NCT01236352|527488796|FG007|Overall Study|Death|1|||
146266457|NCT01236352|527488797|FG008|Overall Study|Death|0|||
146266458|NCT01236352|527488798|FG009|Overall Study|Death|0|||
146266459|NCT01236352|527488799|FG010|Overall Study|Death|0|||
146266460|NCT01236352|527488789|FG000|Overall Study|Withdrawal by Subject|0|||
146266461|NCT01236352|527488790|FG001|Overall Study|Withdrawal by Subject|0|||
146266462|NCT01236352|527488791|FG002|Overall Study|Withdrawal by Subject|0|||
146266463|NCT01236352|527488792|FG003|Overall Study|Withdrawal by Subject|0|||
146266464|NCT01236352|527488793|FG004|Overall Study|Withdrawal by Subject|0|||
146266465|NCT01236352|527488794|FG005|Overall Study|Withdrawal by Subject|0|||
146266466|NCT01236352|527488795|FG006|Overall Study|Withdrawal by Subject|0|||
146266467|NCT01236352|527488796|FG007|Overall Study|Withdrawal by Subject|0|||
146266468|NCT01236352|527488797|FG008|Overall Study|Withdrawal by Subject|0|||
146266469|NCT01236352|527488798|FG009|Overall Study|Withdrawal by Subject|2|||
146266470|NCT01236352|527488799|FG010|Overall Study|Withdrawal by Subject|1|||
146266471|NCT01236352|527488789|FG000|Overall Study|Adverse Event|0|||
146266472|NCT01236352|527488790|FG001|Overall Study|Adverse Event|0|||
146266473|NCT01236352|527488791|FG002|Overall Study|Adverse Event|0|||
146266474|NCT01236352|527488792|FG003|Overall Study|Adverse Event|0|||
146266475|NCT01236352|527488793|FG004|Overall Study|Adverse Event|0|||
146266476|NCT01236352|527488794|FG005|Overall Study|Adverse Event|0|||
146266477|NCT01236352|527488795|FG006|Overall Study|Adverse Event|2|||
146266478|NCT01236352|527488796|FG007|Overall Study|Adverse Event|0|||
146266479|NCT01236352|527488797|FG008|Overall Study|Adverse Event|0|||
146266480|NCT01236352|527488798|FG009|Overall Study|Adverse Event|4|||
146266481|NCT01236352|527488799|FG010|Overall Study|Adverse Event|1|||
146266482|NCT01236352|527488789|FG000|Overall Study|Study drug toxicity|0|||
146266483|NCT01236352|527488790|FG001|Overall Study|Study drug toxicity|0|||
146266484|NCT01236352|527488791|FG002|Overall Study|Study drug toxicity|0|||
146266485|NCT01236352|527488792|FG003|Overall Study|Study drug toxicity|0|||
146266486|NCT01236352|527488793|FG004|Overall Study|Study drug toxicity|0|||
146266487|NCT01236352|527488794|FG005|Overall Study|Study drug toxicity|1|||
146266488|NCT01236352|527488795|FG006|Overall Study|Study drug toxicity|1|||
146266489|NCT01236352|527488796|FG007|Overall Study|Study drug toxicity|0|||
146266490|NCT01236352|527488797|FG008|Overall Study|Study drug toxicity|0|||
146266491|NCT01236352|527488798|FG009|Overall Study|Study drug toxicity|2|||
146266492|NCT01236352|527488799|FG010|Overall Study|Study drug toxicity|2|||
146266493|NCT01236352|527488789|FG000|Overall Study|Disease progression|1|||
146266494|NCT01236352|527488790|FG001|Overall Study|Disease progression|2|||
146266495|NCT01236352|527488791|FG002|Overall Study|Disease progression|1|||
145943212|NCT00483704|526300456|FG000|Randomization|Progressive disease|0|||
146266496|NCT01236352|527488792|FG003|Overall Study|Disease progression|2|||
146266497|NCT01236352|527488793|FG004|Overall Study|Disease progression|2|||
146266498|NCT01236352|527488794|FG005|Overall Study|Disease progression|2|||
146266499|NCT01236352|527488795|FG006|Overall Study|Disease progression|1|||
146266500|NCT01236352|527488796|FG007|Overall Study|Disease progression|3|||
146266501|NCT01236352|527488797|FG008|Overall Study|Disease progression|2|||
146266502|NCT01236352|527488798|FG009|Overall Study|Disease progression|2|||
146266503|NCT01236352|527488799|FG010|Overall Study|Disease progression|2|||
146266504|NCT01236352|527488789|FG000|Overall Study|Poor/Non-compliance|1|||
146266505|NCT01236352|527488790|FG001|Overall Study|Poor/Non-compliance|0|||
146266506|NCT01236352|527488791|FG002|Overall Study|Poor/Non-compliance|0|||
146266507|NCT01236352|527488792|FG003|Overall Study|Poor/Non-compliance|0|||
146266508|NCT01236352|527488793|FG004|Overall Study|Poor/Non-compliance|0|||
146135951|NCT01452412|527015603|FG000|Overall Study|Death|1|||
146135952|NCT01452412|527015604|FG001|Overall Study|Death|0|||
146135953|NCT01452412|527015603|FG000|Overall Study|Initiated dialysis|1|||
146135954|NCT01452412|527015604|FG001|Overall Study|Initiated dialysis|0|||
146135955|NCT01452412|527015603|FG000|Overall Study|Other|2|||
146135956|NCT01452412|527015604|FG001|Overall Study|Other|0|||
146135957|NCT05132127|527015605|FG000|Overall Study|Adverse Event|1|||
146135958|NCT03013543|527015606|FG000|Overall Study|Withdrawal by Subject|0|||
146135959|NCT03013543|527015607|FG001|Overall Study|Withdrawal by Subject|2|||
146135960|NCT03013543|527015608|FG002|Overall Study|Withdrawal by Subject|0|||
146135961|NCT03013543|527015609|FG003|Overall Study|Withdrawal by Subject|5|||
146135962|NCT03013543|527015610|FG004|Overall Study|Withdrawal by Subject|6|||
146135963|NCT03013543|527015611|FG005|Overall Study|Withdrawal by Subject|2|||
146135964|NCT03013543|527015612|FG006|Overall Study|Withdrawal by Subject|3|||
146135965|NCT03013543|527015613|FG007|Overall Study|Withdrawal by Subject|1|||
146135966|NCT03013543|527015614|FG008|Overall Study|Withdrawal by Subject|0|||
146135967|NCT03013543|527015615|FG009|Overall Study|Withdrawal by Subject|4|||
146135968|NCT03013543|527015606|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146135969|NCT03013543|527015607|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
146135970|NCT03013543|527015608|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
146135971|NCT03013543|527015609|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
146135972|NCT03013543|527015610|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
146135973|NCT03013543|527015611|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
146135974|NCT03013543|527015612|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
146135975|NCT03013543|527015613|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
146135976|NCT03013543|527015614|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
146135977|NCT03013543|527015615|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
146135978|NCT03013543|527015606|FG000|Overall Study|Other|0|||
146135979|NCT03013543|527015607|FG001|Overall Study|Other|0|||
146135980|NCT03013543|527015608|FG002|Overall Study|Other|2|||
146135981|NCT03013543|527015609|FG003|Overall Study|Other|0|||
146135982|NCT03013543|527015610|FG004|Overall Study|Other|2|||
146135983|NCT03013543|527015611|FG005|Overall Study|Other|0|||
146135984|NCT03013543|527015612|FG006|Overall Study|Other|0|||
146135985|NCT03013543|527015613|FG007|Overall Study|Other|0|||
146135986|NCT03013543|527015614|FG008|Overall Study|Other|1|||
146135987|NCT03013543|527015615|FG009|Overall Study|Other|0|||
146135988|NCT03013543|527015606|FG000|Overall Study|Adverse Event|0|||
146135989|NCT03013543|527015607|FG001|Overall Study|Adverse Event|0|||
146135990|NCT03013543|527015608|FG002|Overall Study|Adverse Event|0|||
146135991|NCT03013543|527015609|FG003|Overall Study|Adverse Event|3|||
146135992|NCT03013543|527015610|FG004|Overall Study|Adverse Event|2|||
146135993|NCT03013543|527015611|FG005|Overall Study|Adverse Event|1|||
146135994|NCT03013543|527015612|FG006|Overall Study|Adverse Event|3|||
146135995|NCT03013543|527015613|FG007|Overall Study|Adverse Event|8|||
146135996|NCT03013543|527015614|FG008|Overall Study|Adverse Event|0|||
146135997|NCT03013543|527015615|FG009|Overall Study|Adverse Event|2|||
146135998|NCT03013543|527015606|FG000|Overall Study|Death|0|||
146135999|NCT03013543|527015607|FG001|Overall Study|Death|0|||
146136000|NCT03013543|527015608|FG002|Overall Study|Death|0|||
146136001|NCT03013543|527015609|FG003|Overall Study|Death|1|||
146136002|NCT03013543|527015610|FG004|Overall Study|Death|0|||
146136003|NCT03013543|527015611|FG005|Overall Study|Death|0|||
146136004|NCT03013543|527015612|FG006|Overall Study|Death|0|||
146136005|NCT03013543|527015613|FG007|Overall Study|Death|0|||
146136006|NCT03013543|527015614|FG008|Overall Study|Death|0|||
146136007|NCT03013543|527015615|FG009|Overall Study|Death|0|||
146136008|NCT03013543|527015606|FG000|Overall Study|Lack of Efficacy|0|||
146136009|NCT03013543|527015607|FG001|Overall Study|Lack of Efficacy|0|||
146136010|NCT03013543|527015608|FG002|Overall Study|Lack of Efficacy|0|||
146266509|NCT01236352|527488794|FG005|Overall Study|Poor/Non-compliance|0|||
146136011|NCT03013543|527015609|FG003|Overall Study|Lack of Efficacy|1|||
146136012|NCT03013543|527015610|FG004|Overall Study|Lack of Efficacy|0|||
146136013|NCT03013543|527015611|FG005|Overall Study|Lack of Efficacy|0|||
146266510|NCT01236352|527488795|FG006|Overall Study|Poor/Non-compliance|0|||
146136014|NCT03013543|527015612|FG006|Overall Study|Lack of Efficacy|0|||
146136015|NCT03013543|527015613|FG007|Overall Study|Lack of Efficacy|0|||
146136016|NCT03013543|527015614|FG008|Overall Study|Lack of Efficacy|0|||
146136017|NCT03013543|527015615|FG009|Overall Study|Lack of Efficacy|0|||
146136018|NCT03013543|527015606|FG000|Overall Study|Lost to Follow-up|0|||
146136019|NCT03013543|527015607|FG001|Overall Study|Lost to Follow-up|0|||
146136020|NCT03013543|527015608|FG002|Overall Study|Lost to Follow-up|0|||
146136021|NCT03013543|527015609|FG003|Overall Study|Lost to Follow-up|1|||
146136022|NCT03013543|527015610|FG004|Overall Study|Lost to Follow-up|0|||
146266511|NCT01236352|527488796|FG007|Overall Study|Poor/Non-compliance|0|||
146266512|NCT01236352|527488797|FG008|Overall Study|Poor/Non-compliance|0|||
146266513|NCT01236352|527488798|FG009|Overall Study|Poor/Non-compliance|0|||
146266514|NCT01236352|527488799|FG010|Overall Study|Poor/Non-compliance|0|||
146266515|NCT01236352|527488789|FG000|Overall Study|Maximum clinical benefit|1|||
146266516|NCT01236352|527488790|FG001|Overall Study|Maximum clinical benefit|1|||
146266517|NCT01236352|527488791|FG002|Overall Study|Maximum clinical benefit|1|||
146266518|NCT01236352|527488792|FG003|Overall Study|Maximum clinical benefit|0|||
146266519|NCT01236352|527488793|FG004|Overall Study|Maximum clinical benefit|2|||
146266520|NCT01236352|527488794|FG005|Overall Study|Maximum clinical benefit|0|||
146266521|NCT01236352|527488795|FG006|Overall Study|Maximum clinical benefit|3|||
146266522|NCT01236352|527488796|FG007|Overall Study|Maximum clinical benefit|1|||
146266523|NCT01236352|527488797|FG008|Overall Study|Maximum clinical benefit|1|||
146266524|NCT01236352|527488798|FG009|Overall Study|Maximum clinical benefit|4|||
146266525|NCT01236352|527488799|FG010|Overall Study|Maximum clinical benefit|2|||
146266526|NCT01236352|527488789|FG000|Overall Study|Subject request to discontinue treatment|0|||
146266527|NCT01236352|527488790|FG001|Overall Study|Subject request to discontinue treatment|0|||
146266528|NCT01236352|527488791|FG002|Overall Study|Subject request to discontinue treatment|1|||
146266529|NCT01236352|527488792|FG003|Overall Study|Subject request to discontinue treatment|1|||
146266530|NCT01236352|527488793|FG004|Overall Study|Subject request to discontinue treatment|0|||
146266531|NCT01236352|527488794|FG005|Overall Study|Subject request to discontinue treatment|1|||
146266532|NCT01236352|527488795|FG006|Overall Study|Subject request to discontinue treatment|0|||
146266533|NCT01236352|527488796|FG007|Overall Study|Subject request to discontinue treatment|0|||
146266534|NCT01236352|527488797|FG008|Overall Study|Subject request to discontinue treatment|0|||
146266535|NCT01236352|527488798|FG009|Overall Study|Subject request to discontinue treatment|1|||
146266536|NCT01236352|527488799|FG010|Overall Study|Subject request to discontinue treatment|4|||
146266537|NCT01236352|527488789|FG000|Overall Study|Subject to receive drug via EAP|1|||
146266538|NCT01236352|527488790|FG001|Overall Study|Subject to receive drug via EAP|1|||
146266539|NCT01236352|527488791|FG002|Overall Study|Subject to receive drug via EAP|1|||
146266540|NCT01236352|527488792|FG003|Overall Study|Subject to receive drug via EAP|0|||
146266541|NCT01236352|527488793|FG004|Overall Study|Subject to receive drug via EAP|0|||
146266542|NCT01236352|527488794|FG005|Overall Study|Subject to receive drug via EAP|0|||
146266543|NCT01236352|527488795|FG006|Overall Study|Subject to receive drug via EAP|0|||
146266544|NCT01236352|527488796|FG007|Overall Study|Subject to receive drug via EAP|2|||
146266545|NCT01236352|527488797|FG008|Overall Study|Subject to receive drug via EAP|0|||
146266546|NCT01236352|527488798|FG009|Overall Study|Subject to receive drug via EAP|4|||
146266547|NCT01236352|527488799|FG010|Overall Study|Subject to receive drug via EAP|0|||
146266548|NCT01236352|527488789|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
146266549|NCT01236352|527488790|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
146266550|NCT01236352|527488791|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
146266551|NCT01236352|527488792|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
146266552|NCT01236352|527488793|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
146266553|NCT01236352|527488794|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
146266554|NCT01236352|527488795|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
146266555|NCT01236352|527488796|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
146266556|NCT01236352|527488797|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
146266557|NCT01236352|527488798|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
146266558|NCT01236352|527488799|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
146266559|NCT01236352|527488789|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266560|NCT01236352|527488790|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266561|NCT01236352|527488791|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266562|NCT01236352|527488792|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266563|NCT01236352|527488793|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266564|NCT01236352|527488794|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266565|NCT01236352|527488795|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266566|NCT01236352|527488796|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266567|NCT01236352|527488797|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266568|NCT01236352|527488798|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
146266569|NCT01236352|527488799|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
146266570|NCT01236352|527488789|FG000|Overall Study|Lack of response to drug|0|||
146266571|NCT01236352|527488790|FG001|Overall Study|Lack of response to drug|0|||
146266572|NCT01236352|527488791|FG002|Overall Study|Lack of response to drug|0|||
146266573|NCT01236352|527488792|FG003|Overall Study|Lack of response to drug|0|||
146303982|NCT01494350|527627458|FG000|Overall Study|Worsening of lesion|1|||
145943213|NCT00483704|526300457|FG001|Randomization|Progressive disease|0|||
146266574|NCT01236352|527488793|FG004|Overall Study|Lack of response to drug|0|||
146266575|NCT01236352|527488794|FG005|Overall Study|Lack of response to drug|0|||
146266576|NCT01236352|527488795|FG006|Overall Study|Lack of response to drug|0|||
146266577|NCT01236352|527488796|FG007|Overall Study|Lack of response to drug|0|||
146266578|NCT01236352|527488797|FG008|Overall Study|Lack of response to drug|0|||
146266579|NCT01236352|527488798|FG009|Overall Study|Lack of response to drug|1|||
146266580|NCT01236352|527488799|FG010|Overall Study|Lack of response to drug|1|||
146266581|NCT01236352|527488789|FG000|Overall Study|Patient transferred to IST|0|||
146266582|NCT01236352|527488790|FG001|Overall Study|Patient transferred to IST|0|||
146266583|NCT01236352|527488791|FG002|Overall Study|Patient transferred to IST|0|||
146266584|NCT01236352|527488792|FG003|Overall Study|Patient transferred to IST|0|||
146266585|NCT01236352|527488793|FG004|Overall Study|Patient transferred to IST|0|||
146266586|NCT01236352|527488794|FG005|Overall Study|Patient transferred to IST|0|||
146266587|NCT01236352|527488795|FG006|Overall Study|Patient transferred to IST|0|||
146266588|NCT01236352|527488796|FG007|Overall Study|Patient transferred to IST|0|||
146266589|NCT01236352|527488797|FG008|Overall Study|Patient transferred to IST|0|||
146266590|NCT01236352|527488798|FG009|Overall Study|Patient transferred to IST|2|||
146266591|NCT01236352|527488799|FG010|Overall Study|Patient transferred to IST|6|||
146266592|NCT01575873|527488800|FG000|Overall Study|Withdrawal by Subject|15|||
146266593|NCT01575873|527488801|FG001|Overall Study|Withdrawal by Subject|20|||
146266594|NCT01575873|527488802|FG002|Overall Study|Withdrawal by Subject|34|||
146266595|NCT01575873|527488803|FG003|Overall Study|Withdrawal by Subject|34|||
146266596|NCT01575873|527488800|FG000|Overall Study|Adverse Event|7|||
146266597|NCT01575873|527488801|FG001|Overall Study|Adverse Event|7|||
146266598|NCT01575873|527488802|FG002|Overall Study|Adverse Event|9|||
146266599|NCT01575873|527488803|FG003|Overall Study|Adverse Event|12|||
146266600|NCT01575873|527488800|FG000|Overall Study|Lost to Follow-up|1|||
146266601|NCT01575873|527488801|FG001|Overall Study|Lost to Follow-up|3|||
146266602|NCT01575873|527488802|FG002|Overall Study|Lost to Follow-up|13|||
146266603|NCT01575873|527488803|FG003|Overall Study|Lost to Follow-up|5|||
146266604|NCT01575873|527488800|FG000|Overall Study|Death|3|||
146266605|NCT01575873|527488801|FG001|Overall Study|Death|2|||
146266606|NCT01575873|527488802|FG002|Overall Study|Death|8|||
146266607|NCT01575873|527488803|FG003|Overall Study|Death|9|||
146266608|NCT01575873|527488800|FG000|Overall Study|Noncompliance|1|||
146266609|NCT01575873|527488801|FG001|Overall Study|Noncompliance|2|||
146266610|NCT01575873|527488802|FG002|Overall Study|Noncompliance|4|||
146266611|NCT01575873|527488803|FG003|Overall Study|Noncompliance|3|||
146266612|NCT01575873|527488800|FG000|Overall Study|Administrative decision|1|||
146266613|NCT01575873|527488801|FG001|Overall Study|Administrative decision|1|||
146266614|NCT01575873|527488802|FG002|Overall Study|Administrative decision|1|||
146266615|NCT01575873|527488803|FG003|Overall Study|Administrative decision|0|||
146266616|NCT01575873|527488800|FG000|Overall Study|Protocol deviation|0|||
146266617|NCT01575873|527488801|FG001|Overall Study|Protocol deviation|1|||
146266618|NCT01575873|527488802|FG002|Overall Study|Protocol deviation|0|||
146266619|NCT01575873|527488803|FG003|Overall Study|Protocol deviation|1|||
146266620|NCT01575873|527488800|FG000|Overall Study|Requirement for Alternative Therapy|0|||
146266621|NCT01575873|527488801|FG001|Overall Study|Requirement for Alternative Therapy|0|||
146266622|NCT01575873|527488802|FG002|Overall Study|Requirement for Alternative Therapy|1|||
146266623|NCT01575873|527488803|FG003|Overall Study|Requirement for Alternative Therapy|1|||
146266624|NCT01575873|527488800|FG000|Overall Study|Other|0|||
146266625|NCT01575873|527488801|FG001|Overall Study|Other|0|||
146266626|NCT01575873|527488802|FG002|Overall Study|Other|4|||
146266627|NCT01575873|527488803|FG003|Overall Study|Other|2|||
146266628|NCT02031536|527488804|FG000|Overall Study|ineligible|1|||
146266629|NCT02031536|527488805|FG001|Overall Study|ineligible|0|||
146266630|NCT01850030|527488806|FG000|Overall Study|Adverse Event|64|||
146266631|NCT01850030|527488807|FG001|Overall Study|Adverse Event|82|||
146266632|NCT01850030|527488806|FG000|Overall Study|Lack of Efficacy|3|||
146266633|NCT01850030|527488807|FG001|Overall Study|Lack of Efficacy|1|||
146266634|NCT01850030|527488806|FG000|Overall Study|Lost to Follow-up|5|||
146266635|NCT01850030|527488807|FG001|Overall Study|Lost to Follow-up|5|||
146266636|NCT01850030|527488806|FG000|Overall Study|Withdrawal by Subject|3|||
146266637|NCT01850030|527488807|FG001|Overall Study|Withdrawal by Subject|4|||
146266638|NCT01850030|527488806|FG000|Overall Study|Protocol Violation|24|||
146266639|NCT01850030|527488807|FG001|Overall Study|Protocol Violation|28|||
146266640|NCT01850030|527488806|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
146266641|NCT01850030|527488807|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
146266642|NCT03845023|527488809|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
146266643|NCT03845023|527488810|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
146266644|NCT03845023|527488811|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
146266645|NCT03845023|527488812|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
146266646|NCT03845023|527488809|FG000|Follow-Up (14 Days)|Adverse Event|0|||
146266647|NCT03845023|527488810|FG001|Follow-Up (14 Days)|Adverse Event|0|||
146266648|NCT03845023|527488811|FG002|Follow-Up (14 Days)|Adverse Event|1|||
146266649|NCT03845023|527488812|FG003|Follow-Up (14 Days)|Adverse Event|1|||
146266650|NCT00356811|527488813|FG000|Overall Study|Death|35|||
146266651|NCT00356811|527488813|FG000|Overall Study|Lost to Follow-up|2|||
146266652|NCT00356811|527488813|FG000|Overall Study|Withdrawal by Subject|6|||
146266653|NCT00356811|527488813|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
146266654|NCT00356811|527488813|FG000|Overall Study|Study Is Terminating|3|||
146266655|NCT00356811|527488813|FG000|Overall Study|Site Closed during Follow-up|2|||
146266656|NCT02386839|527488814|FG000|Overall Study|Death|1|||
146266657|NCT02386839|527488815|FG001|Overall Study|Death|0|||
146266658|NCT02386839|527488814|FG000|Overall Study|Withdrawal by Subject|9|||
146266659|NCT02386839|527488815|FG001|Overall Study|Withdrawal by Subject|10|||
146266660|NCT02386839|527488814|FG000|Overall Study|Lost to Follow-up|4|||
146266661|NCT02386839|527488815|FG001|Overall Study|Lost to Follow-up|4|||
146266662|NCT02386839|527488814|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
146266663|NCT02386839|527488815|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
146266664|NCT02386839|527488814|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
146266665|NCT02386839|527488815|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
146266666|NCT02386839|527488814|FG000|Overall Study|Other (unspecified)|1|||
146266667|NCT02386839|527488815|FG001|Overall Study|Other (unspecified)|0|||
146266668|NCT02242643|527488818|FG000|Overall Study|Protocol Violation|1|||
146266669|NCT02242643|527488819|FG001|Overall Study|Protocol Violation|2|||
146266670|NCT02242643|527488818|FG000|Overall Study|Withdrawal by Subject|15|||
146266671|NCT02242643|527488819|FG001|Overall Study|Withdrawal by Subject|10|||
146266672|NCT02242643|527488818|FG000|Overall Study|Migrated/moved from study area|1|||
146266673|NCT02242643|527488819|FG001|Overall Study|Migrated/moved from study area|3|||
146266674|NCT02242643|527488818|FG000|Overall Study|Lost to Follow-up|54|||
146266675|NCT02242643|527488819|FG001|Overall Study|Lost to Follow-up|61|||
146266676|NCT02242643|527488818|FG000|Overall Study|Child placed in foster care by family|0|||
146266677|NCT02242643|527488819|FG001|Overall Study|Child placed in foster care by family|1|||
146266678|NCT02242643|527488818|FG000|Overall Study|Non-compliance|1|||
146266679|NCT02242643|527488819|FG001|Overall Study|Non-compliance|0|||
146266680|NCT02242643|527488818|FG000|Overall Study|Consent withdrawal by parent|1|||
146266681|NCT02242643|527488819|FG001|Overall Study|Consent withdrawal by parent|0|||
146266682|NCT02242643|527488818|FG000|Overall Study|Protocol requirements not followed|1|||
146266683|NCT02242643|527488819|FG001|Overall Study|Protocol requirements not followed|0|||
146266684|NCT02242643|527488818|FG000|Overall Study|Language barrier|1|||
146266685|NCT02242643|527488819|FG001|Overall Study|Language barrier|0|||
146266686|NCT02242643|527488818|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
146266687|NCT02242643|527488819|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
146266688|NCT02101983|527488823|FG000|Overall Study|Physician Decision|1|||
146266689|NCT02101983|527488824|FG001|Overall Study|Physician Decision|0|||
146266690|NCT01103232|527488826|FG000|Overall Study|Withdrawal by Subject|1|||
146266691|NCT01103232|527488827|FG001|Overall Study|Withdrawal by Subject|1|||
146266692|NCT01103232|527488826|FG000|Overall Study|Protocol Violation|0|||
146266693|NCT01103232|527488827|FG001|Overall Study|Protocol Violation|1|||
146266694|NCT05093504|527488828|FG000|Overall Study|Death|0|||
146266695|NCT05093504|527488829|FG001|Overall Study|Death|1|||
146266696|NCT05347485|527488834|FG000|Overall Study|Death|14|||
146266697|NCT05347485|527488834|FG000|Overall Study|Lost to Follow-up|2|||
146266698|NCT05347485|527488834|FG000|Overall Study|Withdrawal by Subject|13|||
146266699|NCT05347485|527488834|FG000|Overall Study|Progressive Disease|1|||
146266700|NCT05347485|527488834|FG000|Overall Study|Study Terminated by Sponsor|49|||
146266701|NCT05347485|527488834|FG000|Overall Study|Other|1|||
146266702|NCT05347485|527488834|FG000|Overall Study|Enrolled (consented) but not treated|4|||
146266703|NCT05347485|527488834|FG000|Overall Study|Disease Relapse|2|||
146266704|NCT04886518|527488835|FG000|Overall Study|Noncompliance with study drug|1|||
146266705|NCT04886518|527488836|FG001|Overall Study|Noncompliance with study drug|0|||
146266706|NCT04886518|527488837|FG002|Overall Study|Noncompliance with study drug|0|||
146266707|NCT04886518|527488835|FG000|Overall Study|Adverse Event|0|||
146266708|NCT04886518|527488836|FG001|Overall Study|Adverse Event|1|||
146266709|NCT04886518|527488837|FG002|Overall Study|Adverse Event|0|||
146266710|NCT04886518|527488835|FG000|Overall Study|Withdrawal by Subject|1|||
146266711|NCT04886518|527488836|FG001|Overall Study|Withdrawal by Subject|0|||
146266712|NCT04886518|527488837|FG002|Overall Study|Withdrawal by Subject|0|||
146266713|NCT03733899|527488838|FG000|Period 1|Protocol Violation|0|||
146266714|NCT03733899|527488839|FG001|Period 1|Protocol Violation|0|||
146266715|NCT03733899|527488840|FG002|Period 1|Protocol Violation|0|||
146266716|NCT03733899|527488841|FG003|Period 1|Protocol Violation|0|||
146266717|NCT03733899|527488842|FG004|Period 1|Protocol Violation|0|||
146266718|NCT03733899|527488843|FG005|Period 1|Protocol Violation|1|||
146266719|NCT03733899|527488838|FG000|Period 2|Unscuccessful Treatment|0|||
146266720|NCT03733899|527488839|FG001|Period 2|Unscuccessful Treatment|1|||
146266721|NCT03733899|527488840|FG002|Period 2|Unscuccessful Treatment|0|||
146266722|NCT03733899|527488841|FG003|Period 2|Unscuccessful Treatment|0|||
146136023|NCT03013543|527015611|FG005|Overall Study|Lost to Follow-up|0|||
146136024|NCT03013543|527015612|FG006|Overall Study|Lost to Follow-up|1|||
146266723|NCT03733899|527488842|FG004|Period 2|Unscuccessful Treatment|0|||
146266724|NCT03733899|527488843|FG005|Period 2|Unscuccessful Treatment|0|||
146266725|NCT03733899|527488838|FG000|Period 3|Withdrawal by Subject|1|||
146266726|NCT03733899|527488839|FG001|Period 3|Withdrawal by Subject|0|||
146266727|NCT03733899|527488840|FG002|Period 3|Withdrawal by Subject|0|||
146266728|NCT03733899|527488841|FG003|Period 3|Withdrawal by Subject|0|||
146136025|NCT03013543|527015613|FG007|Overall Study|Lost to Follow-up|0|||
146266729|NCT03733899|527488842|FG004|Period 3|Withdrawal by Subject|0|||
146266730|NCT03733899|527488843|FG005|Period 3|Withdrawal by Subject|0|||
146266731|NCT02035696|527490860|FG000|Overall Study|Lost to Follow-up|0|||
146266732|NCT02035696|527490861|FG001|Overall Study|Lost to Follow-up|3|||
146266733|NCT02035696|527490862|FG002|Overall Study|Lost to Follow-up|1|||
146266734|NCT02035696|527490863|FG003|Overall Study|Lost to Follow-up|2|||
146136026|NCT03013543|527015614|FG008|Overall Study|Lost to Follow-up|0|||
146136027|NCT03013543|527015615|FG009|Overall Study|Lost to Follow-up|2|||
146266735|NCT02035696|527490860|FG000|Overall Study|Withdrawal by Subject|3|||
146266736|NCT02035696|527490861|FG001|Overall Study|Withdrawal by Subject|0|||
146266737|NCT02035696|527490862|FG002|Overall Study|Withdrawal by Subject|2|||
146266738|NCT02035696|527490863|FG003|Overall Study|Withdrawal by Subject|1|||
146266739|NCT01246999|527490865|FG000|Overall Study|Lost to Follow-up|0|||
146266740|NCT01246999|527490866|FG001|Overall Study|Lost to Follow-up|1|||
146266741|NCT01246999|527490867|FG002|Overall Study|Lost to Follow-up|0|||
146266742|NCT01246999|527490868|FG003|Overall Study|Lost to Follow-up|0|||
146266743|NCT01246999|527490865|FG000|Overall Study|Withdrawal by Subject|0|||
146266744|NCT01246999|527490866|FG001|Overall Study|Withdrawal by Subject|0|||
146266745|NCT01246999|527490867|FG002|Overall Study|Withdrawal by Subject|0|||
146266746|NCT01246999|527490868|FG003|Overall Study|Withdrawal by Subject|2|||
146266747|NCT01867047|527490869|FG000|Overall Study|Lost to Follow-up|3|||
146266748|NCT01867047|527490870|FG001|Overall Study|Lost to Follow-up|3|||
146266749|NCT01867047|527490869|FG000|Overall Study|Withdrawal by Subject|2|||
146266750|NCT01867047|527490870|FG001|Overall Study|Withdrawal by Subject|0|||
146266751|NCT01867047|527490869|FG000|Overall Study|Physician Decision|2|||
146266752|NCT01867047|527490870|FG001|Overall Study|Physician Decision|0|||
146266753|NCT01867047|527490869|FG000|Overall Study|surgery not indicated in protocol|1|||
146266754|NCT01867047|527490870|FG001|Overall Study|surgery not indicated in protocol|2|||
146266755|NCT04650698|527490871|FG000|Overall Study|Protocol Violation|2|||
146266756|NCT04650698|527490872|FG001|Overall Study|Protocol Violation|1|||
146266757|NCT04650698|527490871|FG000|Overall Study|Withdrawal by Subject|0|||
146266758|NCT04650698|527490872|FG001|Overall Study|Withdrawal by Subject|1|||
146266759|NCT01090011|527490873|FG000|Overall Study|Progressive disease|128|||
146266760|NCT01090011|527490873|FG000|Overall Study|Adverse Event|32|||
146266761|NCT01090011|527490873|FG000|Overall Study|Protocol Violation|1|||
146266762|NCT01090011|527490873|FG000|Overall Study|Refusal to start/continue medication|5|||
146266763|NCT01090011|527490873|FG000|Overall Study|Other reason not defined above|5|||
146266764|NCT00307047|527490874|FG000|Overall Study|Lost to Follow-up|35|||
146266765|NCT00307047|527490875|FG001|Overall Study|Lost to Follow-up|24|||
146266766|NCT00307047|527490874|FG000|Overall Study|Withdrawal by Subject|6|||
146136028|NCT03013543|527015606|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146136029|NCT03013543|527015607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146266767|NCT00307047|527490875|FG001|Overall Study|Withdrawal by Subject|6|||
146266768|NCT00307047|527490874|FG000|Overall Study|Physician Decision|1|||
146266769|NCT00307047|527490875|FG001|Overall Study|Physician Decision|2|||
146266770|NCT00307047|527490874|FG000|Overall Study|Lost to follow-up for other reasons|0|||
146266771|NCT00307047|527490875|FG001|Overall Study|Lost to follow-up for other reasons|1|||
146266772|NCT00307047|527490874|FG000|Overall Study|All death, all MI, all Revascularization|27|||
146266773|NCT00307047|527490875|FG001|Overall Study|All death, all MI, all Revascularization|16|||
146266774|NCT00379769|527490876|FG000|Main Study|Death|57|||
146266775|NCT00379769|527490877|FG001|Main Study|Death|67|||
146266776|NCT00379769|527490878|FG002|Main Study|Death|54|||
146266777|NCT00379769|527490879|FG003|Main Study|Death|72|||
146266778|NCT00379769|527490880|FG004|Main Study|Death|0|||
146266779|NCT00379769|527490881|FG005|Main Study|Death|0|||
146266780|NCT00379769|527490876|FG000|Main Study|Adverse Event|5|||
146266781|NCT00379769|527490877|FG001|Main Study|Adverse Event|8|||
146266782|NCT00379769|527490878|FG002|Main Study|Adverse Event|10|||
146266783|NCT00379769|527490879|FG003|Main Study|Adverse Event|11|||
146266784|NCT00379769|527490880|FG004|Main Study|Adverse Event|0|||
146266785|NCT00379769|527490881|FG005|Main Study|Adverse Event|0|||
146266786|NCT00379769|527490876|FG000|Main Study|Lost to Follow-up|29|||
146266787|NCT00379769|527490877|FG001|Main Study|Lost to Follow-up|29|||
146136030|NCT03013543|527015608|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146136031|NCT03013543|527015609|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146136032|NCT03013543|527015610|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146136033|NCT03013543|527015611|FG005|Overall Study|Non-Compliance With Study Drug|0|||
146136034|NCT03013543|527015612|FG006|Overall Study|Non-Compliance With Study Drug|0|||
146266788|NCT00379769|527490878|FG002|Main Study|Lost to Follow-up|25|||
146266789|NCT00379769|527490879|FG003|Main Study|Lost to Follow-up|26|||
146266790|NCT00379769|527490880|FG004|Main Study|Lost to Follow-up|0|||
146266791|NCT00379769|527490881|FG005|Main Study|Lost to Follow-up|0|||
146266792|NCT00379769|527490876|FG000|Main Study|Withdrawal by Subject|46|||
146266793|NCT00379769|527490877|FG001|Main Study|Withdrawal by Subject|56|||
146266794|NCT00379769|527490878|FG002|Main Study|Withdrawal by Subject|72|||
146266795|NCT00379769|527490879|FG003|Main Study|Withdrawal by Subject|70|||
146266796|NCT00379769|527490880|FG004|Main Study|Withdrawal by Subject|0|||
146266797|NCT00379769|527490881|FG005|Main Study|Withdrawal by Subject|0|||
146266798|NCT00379769|527490876|FG000|Main Study|Moved to survival status follow-up only|27|||
146266799|NCT00379769|527490877|FG001|Main Study|Moved to survival status follow-up only|25|||
146266800|NCT00379769|527490878|FG002|Main Study|Moved to survival status follow-up only|32|||
146266801|NCT00379769|527490879|FG003|Main Study|Moved to survival status follow-up only|36|||
146303983|NCT00199836|527627460|FG000|Overall Study|Progressive Disease|5|||
146266802|NCT00379769|527490880|FG004|Main Study|Moved to survival status follow-up only|0|||
146266803|NCT00379769|527490881|FG005|Main Study|Moved to survival status follow-up only|0|||
146266804|NCT00379769|527490876|FG000|Main Study|Participant moved|3|||
146266805|NCT00379769|527490877|FG001|Main Study|Participant moved|2|||
146266806|NCT00379769|527490878|FG002|Main Study|Participant moved|3|||
146266807|NCT00379769|527490879|FG003|Main Study|Participant moved|3|||
146266808|NCT00379769|527490880|FG004|Main Study|Participant moved|0|||
146266809|NCT00379769|527490881|FG005|Main Study|Participant moved|0|||
146266810|NCT00379769|527490876|FG000|Main Study|Poor compliance|3|||
146266811|NCT00379769|527490877|FG001|Main Study|Poor compliance|2|||
146266812|NCT00379769|527490878|FG002|Main Study|Poor compliance|2|||
146266813|NCT00379769|527490879|FG003|Main Study|Poor compliance|1|||
146266814|NCT00379769|527490880|FG004|Main Study|Poor compliance|0|||
146266815|NCT00379769|527490881|FG005|Main Study|Poor compliance|0|||
146266816|NCT00379769|527490876|FG000|Main Study|Prohibited glucose lowering medication|0|||
146266817|NCT00379769|527490877|FG001|Main Study|Prohibited glucose lowering medication|3|||
146266818|NCT00379769|527490878|FG002|Main Study|Prohibited glucose lowering medication|0|||
146266819|NCT00379769|527490879|FG003|Main Study|Prohibited glucose lowering medication|1|||
146266820|NCT00379769|527490880|FG004|Main Study|Prohibited glucose lowering medication|0|||
146266821|NCT00379769|527490881|FG005|Main Study|Prohibited glucose lowering medication|0|||
146266822|NCT00379769|527490876|FG000|Main Study|Site closed|4|||
146266823|NCT00379769|527490877|FG001|Main Study|Site closed|4|||
146266824|NCT00379769|527490878|FG002|Main Study|Site closed|4|||
146266825|NCT00379769|527490879|FG003|Main Study|Site closed|8|||
146266826|NCT00379769|527490880|FG004|Main Study|Site closed|0|||
146266827|NCT00379769|527490881|FG005|Main Study|Site closed|0|||
146266828|NCT00379769|527490876|FG000|Main Study|Entry criteria violation|0|||
146266829|NCT00379769|527490877|FG001|Main Study|Entry criteria violation|0|||
146266830|NCT00379769|527490878|FG002|Main Study|Entry criteria violation|1|||
146266831|NCT00379769|527490879|FG003|Main Study|Entry criteria violation|1|||
146266832|NCT00379769|527490880|FG004|Main Study|Entry criteria violation|0|||
146266833|NCT00379769|527490881|FG005|Main Study|Entry criteria violation|0|||
146266834|NCT00379769|527490876|FG000|Main Study|Participant did not take study drug|0|||
146266835|NCT00379769|527490877|FG001|Main Study|Participant did not take study drug|0|||
146266836|NCT00379769|527490878|FG002|Main Study|Participant did not take study drug|1|||
146266837|NCT00379769|527490879|FG003|Main Study|Participant did not take study drug|0|||
146266838|NCT00379769|527490880|FG004|Main Study|Participant did not take study drug|0|||
146266839|NCT00379769|527490881|FG005|Main Study|Participant did not take study drug|0|||
146266840|NCT00379769|527490876|FG000|Main Study|Physician Decision|2|||
146266841|NCT00379769|527490877|FG001|Main Study|Physician Decision|2|||
146266842|NCT00379769|527490878|FG002|Main Study|Physician Decision|1|||
146266843|NCT00379769|527490879|FG003|Main Study|Physician Decision|1|||
146266844|NCT00379769|527490880|FG004|Main Study|Physician Decision|0|||
146266845|NCT00379769|527490881|FG005|Main Study|Physician Decision|0|||
146266846|NCT00379769|527490876|FG000|Main Study|Participant completed study at visit 27|1|||
146266847|NCT00379769|527490877|FG001|Main Study|Participant completed study at visit 27|0|||
146266848|NCT00379769|527490878|FG002|Main Study|Participant completed study at visit 27|0|||
146266849|NCT00379769|527490879|FG003|Main Study|Participant completed study at visit 27|0|||
146266850|NCT00379769|527490880|FG004|Main Study|Participant completed study at visit 27|0|||
146266851|NCT00379769|527490881|FG005|Main Study|Participant completed study at visit 27|0|||
146266852|NCT00379769|527490876|FG000|Main Study|Personal reasons|1|||
146266853|NCT00379769|527490877|FG001|Main Study|Personal reasons|0|||
146266854|NCT00379769|527490878|FG002|Main Study|Personal reasons|0|||
146266855|NCT00379769|527490879|FG003|Main Study|Personal reasons|0|||
146266856|NCT00379769|527490880|FG004|Main Study|Personal reasons|0|||
146266857|NCT00379769|527490881|FG005|Main Study|Personal reasons|0|||
146266858|NCT00379769|527490876|FG000|Main Study|Risk of heart failure|0|||
146266859|NCT00379769|527490877|FG001|Main Study|Risk of heart failure|1|||
146266860|NCT00379769|527490878|FG002|Main Study|Risk of heart failure|0|||
146266861|NCT00379769|527490879|FG003|Main Study|Risk of heart failure|0|||
146266862|NCT00379769|527490880|FG004|Main Study|Risk of heart failure|0|||
146266863|NCT00379769|527490881|FG005|Main Study|Risk of heart failure|0|||
146266864|NCT00379769|527490876|FG000|Main Study|Investigator refused to log temperature|0|||
146266865|NCT00379769|527490877|FG001|Main Study|Investigator refused to log temperature|0|||
146303984|NCT00199836|527627460|FG000|Overall Study|Death|1|||
146266866|NCT00379769|527490878|FG002|Main Study|Investigator refused to log temperature|1|||
146266867|NCT00379769|527490879|FG003|Main Study|Investigator refused to log temperature|0|||
146266868|NCT00379769|527490880|FG004|Main Study|Investigator refused to log temperature|0|||
146266869|NCT00379769|527490881|FG005|Main Study|Investigator refused to log temperature|0|||
146266870|NCT00379769|527490876|FG000|Main Study|Reason unspecified|0|||
146266871|NCT00379769|527490877|FG001|Main Study|Reason unspecified|0|||
146266872|NCT00379769|527490878|FG002|Main Study|Reason unspecified|1|||
146266873|NCT00379769|527490879|FG003|Main Study|Reason unspecified|0|||
146266874|NCT00379769|527490880|FG004|Main Study|Reason unspecified|0|||
146266875|NCT00379769|527490881|FG005|Main Study|Reason unspecified|0|||
146266876|NCT00379769|527490876|FG000|Observational Follow-up|Death|0|||
146266877|NCT00379769|527490877|FG001|Observational Follow-up|Death|0|||
146266878|NCT00379769|527490878|FG002|Observational Follow-up|Death|0|||
146266879|NCT00379769|527490879|FG003|Observational Follow-up|Death|0|||
146266880|NCT00379769|527490880|FG004|Observational Follow-up|Death|78|||
146266881|NCT00379769|527490881|FG005|Observational Follow-up|Death|70|||
146266882|NCT00379769|527490876|FG000|Observational Follow-up|Adverse Event|0|||
146266883|NCT00379769|527490877|FG001|Observational Follow-up|Adverse Event|0|||
146266884|NCT00379769|527490878|FG002|Observational Follow-up|Adverse Event|0|||
146266885|NCT00379769|527490879|FG003|Observational Follow-up|Adverse Event|0|||
146266886|NCT00379769|527490880|FG004|Observational Follow-up|Adverse Event|1|||
146266887|NCT00379769|527490881|FG005|Observational Follow-up|Adverse Event|0|||
146266888|NCT00379769|527490876|FG000|Observational Follow-up|Lost to Follow-up|0|||
146266889|NCT00379769|527490877|FG001|Observational Follow-up|Lost to Follow-up|0|||
146266890|NCT00379769|527490878|FG002|Observational Follow-up|Lost to Follow-up|0|||
146266891|NCT00379769|527490879|FG003|Observational Follow-up|Lost to Follow-up|0|||
146266892|NCT00379769|527490880|FG004|Observational Follow-up|Lost to Follow-up|25|||
146266893|NCT00379769|527490881|FG005|Observational Follow-up|Lost to Follow-up|27|||
146266894|NCT00379769|527490876|FG000|Observational Follow-up|Withdrawal by Subject|0|||
146266895|NCT00379769|527490877|FG001|Observational Follow-up|Withdrawal by Subject|0|||
146266896|NCT00379769|527490878|FG002|Observational Follow-up|Withdrawal by Subject|0|||
146266897|NCT00379769|527490879|FG003|Observational Follow-up|Withdrawal by Subject|0|||
146266898|NCT00379769|527490880|FG004|Observational Follow-up|Withdrawal by Subject|12|||
146266899|NCT00379769|527490881|FG005|Observational Follow-up|Withdrawal by Subject|12|||
146266900|NCT00379769|527490876|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
146266901|NCT00379769|527490877|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
146266902|NCT00379769|527490878|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
146266903|NCT00379769|527490879|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
146266904|NCT00379769|527490880|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
146266905|NCT00379769|527490881|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
146266906|NCT00379769|527490876|FG000|Observational Follow-up|Physician Decision|0|||
146266907|NCT00379769|527490877|FG001|Observational Follow-up|Physician Decision|0|||
146266908|NCT00379769|527490878|FG002|Observational Follow-up|Physician Decision|0|||
146266909|NCT00379769|527490879|FG003|Observational Follow-up|Physician Decision|0|||
146266910|NCT00379769|527490880|FG004|Observational Follow-up|Physician Decision|8|||
146266911|NCT00379769|527490881|FG005|Observational Follow-up|Physician Decision|8|||
146266912|NCT00379769|527490876|FG000|Observational Follow-up|Site Closed Early|0|||
146266913|NCT00379769|527490877|FG001|Observational Follow-up|Site Closed Early|0|||
146266914|NCT00379769|527490878|FG002|Observational Follow-up|Site Closed Early|0|||
146266915|NCT00379769|527490879|FG003|Observational Follow-up|Site Closed Early|0|||
146266916|NCT00379769|527490880|FG004|Observational Follow-up|Site Closed Early|6|||
146266917|NCT00379769|527490881|FG005|Observational Follow-up|Site Closed Early|7|||
146266918|NCT00379769|527490876|FG000|Observational Follow-up|Participant Moved|0|||
146266919|NCT00379769|527490877|FG001|Observational Follow-up|Participant Moved|0|||
146266920|NCT00379769|527490878|FG002|Observational Follow-up|Participant Moved|0|||
146266921|NCT00379769|527490879|FG003|Observational Follow-up|Participant Moved|0|||
146266922|NCT00379769|527490880|FG004|Observational Follow-up|Participant Moved|0|||
146266923|NCT00379769|527490881|FG005|Observational Follow-up|Participant Moved|1|||
146266924|NCT00379769|527490876|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
146266925|NCT00379769|527490877|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
146266926|NCT00379769|527490878|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
146266927|NCT00379769|527490879|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
146266928|NCT00379769|527490880|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
146266929|NCT00379769|527490881|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
146266930|NCT03778294|527490882|FG000|Overall Study|Death|1|||
146266931|NCT03778294|527490882|FG000|Overall Study|Issues with insurance|1|||
146266932|NCT03778294|527490882|FG000|Overall Study|disease progression before treatment|2|||
146266933|NCT02825251|527490885|FG000|Overall Study|Adverse Event|0|||
146266934|NCT02825251|527490886|FG001|Overall Study|Adverse Event|1|||
146266935|NCT02825251|527490885|FG000|Overall Study|Lost to Follow-up|0|||
146266936|NCT02825251|527490886|FG001|Overall Study|Lost to Follow-up|1|||
146266937|NCT02825251|527490885|FG000|Overall Study|Withdrawal by Subject|1|||
146266938|NCT02825251|527490886|FG001|Overall Study|Withdrawal by Subject|4|||
146266939|NCT02825251|527490885|FG000|Overall Study|Unclassified|2|||
146266940|NCT02825251|527490886|FG001|Overall Study|Unclassified|0|||
146266941|NCT01689363|527490893|FG000|Overall Study|Protocol Violation|0|||
146266942|NCT01689363|527490894|FG001|Overall Study|Protocol Violation|1|||
146266943|NCT01689363|527490895|FG002|Overall Study|Protocol Violation|0|||
146266944|NCT01689363|527490896|FG003|Overall Study|Protocol Violation|0|||
146266945|NCT01689363|527490897|FG004|Overall Study|Protocol Violation|0|||
146266946|NCT01689363|527490898|FG005|Overall Study|Protocol Violation|0|||
146266947|NCT01689363|527490899|FG006|Overall Study|Protocol Violation|0|||
146266948|NCT01689363|527490900|FG007|Overall Study|Protocol Violation|0|||
146266949|NCT02104505|527490901|FG000|First Intervention (14 Days)|Adverse Event|2|||
146266950|NCT02104505|527490902|FG001|First Intervention (14 Days)|Adverse Event|0|||
146266951|NCT02104505|527490901|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
146266952|NCT02104505|527490902|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
146266953|NCT02104505|527490901|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
146266954|NCT02104505|527490902|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
146266955|NCT02104505|527490901|FG000|First Intervention (14 Days)|exclusionary condition|0|||
146266956|NCT02104505|527490902|FG001|First Intervention (14 Days)|exclusionary condition|1|||
146266957|NCT02104505|527490901|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146266958|NCT02104505|527490902|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146266959|NCT02104505|527490901|FG000|Second Intervention (14 Days)|Adverse Event|2|||
146266960|NCT02104505|527490902|FG001|Second Intervention (14 Days)|Adverse Event|0|||
146266961|NCT01845805|527490903|FG000|Overall Study|Withdrawal by Subject|1|||
146266962|NCT01845805|527490904|FG001|Overall Study|Withdrawal by Subject|2|||
146266963|NCT01845805|527490903|FG000|Overall Study|Disease Progression|13|||
146266964|NCT01845805|527490904|FG001|Overall Study|Disease Progression|14|||
146266965|NCT01845805|527490903|FG000|Overall Study|Drug-related Toxicity|4|||
146266966|NCT01845805|527490904|FG001|Overall Study|Drug-related Toxicity|0|||
146266967|NCT02859064|527490905|FG000|Overall Study|Progressive Disease|3|||
146266968|NCT02859064|527490905|FG000|Overall Study|Physician Decision|1|||
146266969|NCT02859064|527490905|FG000|Overall Study|Withdrawal by Subject|1|||
146266970|NCT02859064|527490905|FG000|Overall Study|Death|1|||
146266971|NCT00127842|527490906|FG000|Overall Study|Adverse Event|15|||
146266972|NCT00127842|527490906|FG000|Overall Study|Withdrawal by Subject|3|||
146266973|NCT00127842|527490906|FG000|Overall Study|Lost to Follow-up|1|||
146266974|NCT00127842|527490906|FG000|Overall Study|Lack of Efficacy|12|||
146266975|NCT00127842|527490906|FG000|Overall Study|Noncompliance|2|||
146266976|NCT00127842|527490906|FG000|Overall Study|Protocol Violation|1|||
146266977|NCT00127842|527490906|FG000|Overall Study|Other|5|||
146266978|NCT01730950|527490907|FG000|Overall Study|Protocol Violation|6|||
146266979|NCT01730950|527490908|FG001|Overall Study|Protocol Violation|6|||
146266980|NCT03023722|527490909|FG000|Overall Study|No follow-up assessment|4|||
146266981|NCT00667459|527490910|FG000|Overall Study|Death|0|||
146266982|NCT00667459|527490911|FG001|Overall Study|Death|2|||
146266983|NCT00667459|527490910|FG000|Overall Study|Lost to Follow-up|8|||
146266984|NCT00667459|527490911|FG001|Overall Study|Lost to Follow-up|43|||
146266985|NCT03616964|527490912|FG000|Overall Study|Adverse Event|15|||
146266986|NCT03616964|527490913|FG001|Overall Study|Adverse Event|10|||
146266987|NCT03616964|527490914|FG002|Overall Study|Adverse Event|16|||
146266988|NCT03616964|527490912|FG000|Overall Study|Death|3|||
146266989|NCT03616964|527490913|FG001|Overall Study|Death|0|||
146266990|NCT03616964|527490914|FG002|Overall Study|Death|4|||
146266991|NCT03616964|527490912|FG000|Overall Study|Lack of Efficacy|4|||
146266992|NCT03616964|527490913|FG001|Overall Study|Lack of Efficacy|8|||
146266993|NCT03616964|527490914|FG002|Overall Study|Lack of Efficacy|8|||
146266994|NCT03616964|527490912|FG000|Overall Study|Lost to Follow-up|2|||
146266995|NCT03616964|527490913|FG001|Overall Study|Lost to Follow-up|1|||
146266996|NCT03616964|527490914|FG002|Overall Study|Lost to Follow-up|3|||
146266997|NCT03616964|527490912|FG000|Overall Study|Withdrawal by Subject|18|||
146266998|NCT03616964|527490913|FG001|Overall Study|Withdrawal by Subject|14|||
146266999|NCT03616964|527490914|FG002|Overall Study|Withdrawal by Subject|21|||
146267000|NCT03616964|527490912|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146267001|NCT03616964|527490913|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146267002|NCT03616964|527490914|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
146267003|NCT03616964|527490912|FG000|Overall Study|Sponsor's Decision|1|||
146267004|NCT03616964|527490913|FG001|Overall Study|Sponsor's Decision|0|||
146267005|NCT03616964|527490914|FG002|Overall Study|Sponsor's Decision|0|||
146267006|NCT03616964|527490912|FG000|Overall Study|Physician Decision|0|||
146267007|NCT03616964|527490913|FG001|Overall Study|Physician Decision|2|||
146267008|NCT03616964|527490914|FG002|Overall Study|Physician Decision|0|||
146267009|NCT03616964|527490912|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
146267010|NCT03616964|527490913|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
146303985|NCT03098836|527627466|FG000|Overall Study|Adverse Event|1|||
146303986|NCT03098836|527627467|FG001|Overall Study|Adverse Event|3|||
146267011|NCT03616964|527490914|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
146267012|NCT03616964|527490912|FG000|Overall Study|Protocol Violation|0|||
146267013|NCT03616964|527490913|FG001|Overall Study|Protocol Violation|1|||
146303987|NCT03098836|527627466|FG000|Overall Study|Lack of Efficacy|30|||
146303988|NCT03098836|527627467|FG001|Overall Study|Lack of Efficacy|15|||
146267014|NCT03616964|527490914|FG002|Overall Study|Protocol Violation|0|||
146267015|NCT03616964|527490912|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
146267016|NCT03616964|527490913|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
146267017|NCT03616964|527490914|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
146267018|NCT03616964|527490912|FG000|Overall Study|Randomized but Never Treated|1|||
146267019|NCT03616964|527490913|FG001|Overall Study|Randomized but Never Treated|1|||
146267020|NCT03616964|527490914|FG002|Overall Study|Randomized but Never Treated|1|||
146267021|NCT02568397|527490915|FG000|Period 2|Withdrawal by Subject|0|||
146267022|NCT02568397|527490916|FG001|Period 2|Withdrawal by Subject|1|||
146267023|NCT02568397|527490915|FG000|Period 2|Physician Decision|0|||
146267024|NCT02568397|527490916|FG001|Period 2|Physician Decision|1|||
146267025|NCT01385748|527490917|FG000|Overall Study|Withdrawal by Subject|7|||
146267026|NCT01385748|527490918|FG001|Overall Study|Withdrawal by Subject|4|||
146267027|NCT01385748|527490919|FG002|Overall Study|Withdrawal by Subject|5|||
146267028|NCT01385748|527490917|FG000|Overall Study|Noncompliance|3|||
146267029|NCT01385748|527490918|FG001|Overall Study|Noncompliance|1|||
146267030|NCT01385748|527490919|FG002|Overall Study|Noncompliance|6|||
146267031|NCT01385748|527490917|FG000|Overall Study|Other|1|||
146267032|NCT01385748|527490918|FG001|Overall Study|Other|7|||
146267033|NCT01385748|527490919|FG002|Overall Study|Other|1|||
146267034|NCT01385748|527490917|FG000|Overall Study|Adverse Event|4|||
146267035|NCT01385748|527490918|FG001|Overall Study|Adverse Event|2|||
146267036|NCT01385748|527490919|FG002|Overall Study|Adverse Event|1|||
146267037|NCT02354651|527490920|FG000|Overall Study|Withdrawal by Subject|2|||
146267038|NCT02354651|527490920|FG000|Overall Study|Physician Decision|1|||
146267039|NCT00581893|527490921|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
146267040|NCT00581893|527490922|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
146267041|NCT00590564|527490923|FG000|Overall Study|Withdrawal by Subject|4|||
146267042|NCT00590564|527490923|FG000|Overall Study|Lost to Follow-up|6|||
146267043|NCT00590564|527490923|FG000|Overall Study|Protocol Violation|1|||
146267044|NCT00590564|527490923|FG000|Overall Study|Patient Found to be Ineligible|1|||
146267045|NCT00590564|527490923|FG000|Overall Study|Patient Non-compliance|6|||
146267046|NCT01377389|527490926|FG000|Overall Study|Withdrawal by Subject|1|||
146267047|NCT01377389|527490926|FG000|Overall Study|Screen failure|2|||
146267048|NCT01434680|527490933|FG000|Overall Study|Withdrawal by Subject|1|||
146267049|NCT01434680|527490934|FG001|Overall Study|Withdrawal by Subject|0|||
146267050|NCT01434680|527490935|FG002|Overall Study|Withdrawal by Subject|2|||
146267051|NCT01434680|527490936|FG003|Overall Study|Withdrawal by Subject|0|||
146267052|NCT01434680|527490933|FG000|Overall Study|Lost to Follow-up|1|||
146267053|NCT01434680|527490934|FG001|Overall Study|Lost to Follow-up|1|||
146267054|NCT01434680|527490935|FG002|Overall Study|Lost to Follow-up|0|||
146267055|NCT01434680|527490936|FG003|Overall Study|Lost to Follow-up|0|||
146267056|NCT01434680|527490933|FG000|Overall Study|Protocol Violation|1|||
146267057|NCT01434680|527490934|FG001|Overall Study|Protocol Violation|1|||
146267058|NCT01434680|527490935|FG002|Overall Study|Protocol Violation|0|||
146267059|NCT01434680|527490936|FG003|Overall Study|Protocol Violation|0|||
146267060|NCT00725712|527490938|FG000|Overall Study|Withdrawal by Subject|2|||
146267061|NCT00725712|527490939|FG001|Overall Study|Withdrawal by Subject|1|||
146267062|NCT00725712|527490938|FG000|Overall Study|Protocol Violation|1|||
146267063|NCT00725712|527490939|FG001|Overall Study|Protocol Violation|0|||
146267064|NCT00725712|527490938|FG000|Overall Study|Progressive disease|37|||
146267065|NCT00725712|527490939|FG001|Overall Study|Progressive disease|16|||
146267066|NCT00725712|527490938|FG000|Overall Study|Clinical progression not based on RECIST|0|||
146267067|NCT00725712|527490939|FG001|Overall Study|Clinical progression not based on RECIST|3|||
146267068|NCT00725712|527490938|FG000|Overall Study|Adverse Event|5|||
146267069|NCT00725712|527490939|FG001|Overall Study|Adverse Event|5|||
146267070|NCT00725712|527490938|FG000|Overall Study|Death|2|||
146267071|NCT00725712|527490939|FG001|Overall Study|Death|0|||
146267072|NCT00725712|527490938|FG000|Overall Study|Other: Death|1|||
146267073|NCT00725712|527490939|FG001|Overall Study|Other: Death|0|||
146267074|NCT00725712|527490938|FG000|Overall Study|Hospitalized, unable to continue|0|||
146267075|NCT00725712|527490939|FG001|Overall Study|Hospitalized, unable to continue|1|||
146267076|NCT02684123|527490943|FG000|Phase 1|Lack of Efficacy|5|||
146267077|NCT02684123|527490944|FG001|Phase 1|Lack of Efficacy|0|||
146267078|NCT02684123|527490943|FG000|Phase 1|Adverse Event|3|||
146267079|NCT02684123|527490944|FG001|Phase 1|Adverse Event|0|||
146267080|NCT02684123|527490943|FG000|Phase 1|Lost to Follow-up|0|||
146136035|NCT03013543|527015613|FG007|Overall Study|Non-Compliance With Study Drug|0|||
146136036|NCT03013543|527015614|FG008|Overall Study|Non-Compliance With Study Drug|1|||
146267081|NCT02684123|527490944|FG001|Phase 1|Lost to Follow-up|1|||
146267082|NCT02684123|527490943|FG000|Phase 2|Lack of Efficacy|1|||
146267083|NCT02684123|527490944|FG001|Phase 2|Lack of Efficacy|8|||
146267084|NCT02037477|527490950|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146267085|NCT02037477|527490951|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146267086|NCT02037477|527490952|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
146267087|NCT02037477|527490953|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
146267088|NCT00983749|527490954|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
146267089|NCT00983749|527490955|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
146267090|NCT05765435|527490956|FG000|Overall Study|Lost to Follow-up|0|||
146267091|NCT05765435|527490957|FG001|Overall Study|Lost to Follow-up|1|||
146267092|NCT05765435|527490958|FG002|Overall Study|Lost to Follow-up|0|||
146267093|NCT05765435|527490956|FG000|Overall Study|Withdrawal by Subject|0|||
146267094|NCT05765435|527490957|FG001|Overall Study|Withdrawal by Subject|0|||
146267095|NCT05765435|527490958|FG002|Overall Study|Withdrawal by Subject|1|||
146267096|NCT01952847|527490959|FG000|Overall Study|Ineligible|1|||
146267097|NCT01952847|527490960|FG001|Overall Study|Ineligible|0|||
146267098|NCT01952847|527490961|FG002|Overall Study|Ineligible|0|||
146303989|NCT03098836|527627466|FG000|Overall Study|Physician Decision|2|||
146303990|NCT03098836|527627467|FG001|Overall Study|Physician Decision|1|||
146303991|NCT03098836|527627466|FG000|Overall Study|Withdrawal by Subject|3|||
146303992|NCT03098836|527627467|FG001|Overall Study|Withdrawal by Subject|2|||
146303993|NCT03986866|527627468|FG000|Overall Study|Withdrawal by Subject|0|||
146303994|NCT03986866|527627469|FG001|Overall Study|Withdrawal by Subject|3|||
146303995|NCT03986866|527627468|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
146303996|NCT03986866|527627469|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
146303997|NCT00898443|527627470|FG000|Overall Study|Withdrawal by Subject|1|||
146303998|NCT00898443|527627471|FG001|Overall Study|Withdrawal by Subject|0|||
146303999|NCT00617604|527627473|FG000|Overall Study|Death|2|||
146304000|NCT00617604|527627474|FG001|Overall Study|Death|1|||
146304001|NCT00617604|527627473|FG000|Overall Study|Lost to Follow-up|1|||
146304002|NCT00617604|527627474|FG001|Overall Study|Lost to Follow-up|0|||
146304003|NCT00617604|527627473|FG000|Overall Study|Miscellaneous Reasons|8|||
146304004|NCT00617604|527627474|FG001|Overall Study|Miscellaneous Reasons|10|||
146136037|NCT03013543|527015615|FG009|Overall Study|Non-Compliance With Study Drug|0|||
146136038|NCT03013543|527015606|FG000|Overall Study|Physician Decision|0|||
146136039|NCT03013543|527015607|FG001|Overall Study|Physician Decision|0|||
146136040|NCT03013543|527015608|FG002|Overall Study|Physician Decision|0|||
146136041|NCT03013543|527015609|FG003|Overall Study|Physician Decision|0|||
146136042|NCT03013543|527015610|FG004|Overall Study|Physician Decision|1|||
146136043|NCT03013543|527015611|FG005|Overall Study|Physician Decision|0|||
146136044|NCT03013543|527015612|FG006|Overall Study|Physician Decision|0|||
146136045|NCT03013543|527015613|FG007|Overall Study|Physician Decision|0|||
146136046|NCT03013543|527015614|FG008|Overall Study|Physician Decision|0|||
146136047|NCT03013543|527015615|FG009|Overall Study|Physician Decision|0|||
146136048|NCT03013543|527015606|FG000|Overall Study|Protocol Violation|0|||
146136049|NCT03013543|527015607|FG001|Overall Study|Protocol Violation|0|||
146136050|NCT03013543|527015608|FG002|Overall Study|Protocol Violation|0|||
146136051|NCT03013543|527015609|FG003|Overall Study|Protocol Violation|0|||
146136052|NCT03013543|527015610|FG004|Overall Study|Protocol Violation|0|||
146136053|NCT03013543|527015611|FG005|Overall Study|Protocol Violation|0|||
146136054|NCT03013543|527015612|FG006|Overall Study|Protocol Violation|0|||
146136055|NCT03013543|527015613|FG007|Overall Study|Protocol Violation|0|||
146136056|NCT03013543|527015614|FG008|Overall Study|Protocol Violation|0|||
146136057|NCT03013543|527015615|FG009|Overall Study|Protocol Violation|1|||
146136058|NCT02552316|527015617|FG000|Overall Study|Withdrawal by Subject|1|||
146136059|NCT02552316|527015617|FG000|Overall Study|Withdrawal due to non-compliance|1|||
146136060|NCT04382911|527015618|FG000|Overall Study|unable to be imaged prior to surgery|2|||
146136061|NCT01120210|527015624|FG000|MAIN INFUSION|Adverse Event|1|||
146136062|NCT01120210|527015625|FG001|MAIN INFUSION|Adverse Event|0|||
146136063|NCT01120210|527015624|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
146136064|NCT01120210|527015625|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
146136065|NCT04697628|527015636|FG000|Overall Study|Withdrawal by Subject|17|||
146136066|NCT04697628|527015637|FG001|Overall Study|Withdrawal by Subject|23|||
146136067|NCT04697628|527015636|FG000|Overall Study|Lost to Follow-up|0|||
146136068|NCT04697628|527015637|FG001|Overall Study|Lost to Follow-up|4|||
146136069|NCT04697628|527015636|FG000|Overall Study|On-going in study|122|||
146136070|NCT04697628|527015637|FG001|Overall Study|On-going in study|91|||
146136071|NCT00974571|527015638|FG000|Overall Study|Adverse Event|31|||
146136072|NCT00974571|527015639|FG001|Overall Study|Adverse Event|4|||
146136073|NCT00974571|527015640|FG002|Overall Study|Adverse Event|27|||
146136074|NCT00974571|527015638|FG000|Overall Study|Lack of Efficacy|3|||
146136075|NCT00974571|527015639|FG001|Overall Study|Lack of Efficacy|2|||
146136076|NCT00974571|527015640|FG002|Overall Study|Lack of Efficacy|9|||
146136077|NCT00974571|527015638|FG000|Overall Study|Lost to Follow-up|2|||
146136078|NCT00974571|527015639|FG001|Overall Study|Lost to Follow-up|1|||
146136079|NCT00974571|527015640|FG002|Overall Study|Lost to Follow-up|2|||
146136080|NCT00974571|527015638|FG000|Overall Study|Protocol Violation|13|||
146136081|NCT00974571|527015639|FG001|Overall Study|Protocol Violation|4|||
146136082|NCT00974571|527015640|FG002|Overall Study|Protocol Violation|18|||
146136083|NCT00974571|527015638|FG000|Overall Study|Withdrawal by Subject|14|||
146136084|NCT00974571|527015639|FG001|Overall Study|Withdrawal by Subject|5|||
146136085|NCT00974571|527015640|FG002|Overall Study|Withdrawal by Subject|16|||
146136086|NCT00974571|527015638|FG000|Overall Study|Patient Moved|1|||
146136087|NCT00974571|527015639|FG001|Overall Study|Patient Moved|0|||
146136088|NCT00974571|527015640|FG002|Overall Study|Patient Moved|1|||
146136089|NCT00974571|527015638|FG000|Overall Study|Other|4|||
146136090|NCT00974571|527015639|FG001|Overall Study|Other|0|||
146136091|NCT00974571|527015640|FG002|Overall Study|Other|10|||
146136092|NCT00393939|527015641|FG000|Overall Study|Protocol Violation|1|||
146136093|NCT00393939|527015642|FG001|Overall Study|Protocol Violation|1|||
146304005|NCT00617604|527627473|FG000|Overall Study|Withdrawal by Subject|4|||
146136094|NCT00393939|527015641|FG000|Overall Study|Lost to Follow-up|2|||
146136095|NCT00393939|527015642|FG001|Overall Study|Lost to Follow-up|4|||
146136096|NCT00393939|527015641|FG000|Overall Study|Death|10|||
146136097|NCT00393939|527015642|FG001|Overall Study|Death|4|||
146267099|NCT01952847|527490962|FG003|Overall Study|Ineligible|0|||
146267100|NCT01952847|527490959|FG000|Overall Study|Lack of Insurance Coverage|0|||
146267101|NCT01952847|527490960|FG001|Overall Study|Lack of Insurance Coverage|1|||
146267102|NCT01952847|527490961|FG002|Overall Study|Lack of Insurance Coverage|0|||
146267103|NCT01952847|527490962|FG003|Overall Study|Lack of Insurance Coverage|0|||
146267104|NCT01952847|527490959|FG000|Overall Study|Withdrawal by Subject|1|||
146267105|NCT01952847|527490960|FG001|Overall Study|Withdrawal by Subject|1|||
146267106|NCT01952847|527490961|FG002|Overall Study|Withdrawal by Subject|0|||
146267107|NCT01952847|527490962|FG003|Overall Study|Withdrawal by Subject|1|||
146267108|NCT02367352|527490970|FG000|Overall Study|Progressive disease|7|||
146267109|NCT02367352|527490971|FG001|Overall Study|Progressive disease|0|||
146267110|NCT02367352|527490972|FG002|Overall Study|Progressive disease|0|||
146267111|NCT02367352|527490970|FG000|Overall Study|Participant Received Alternative Therapy|1|||
146267112|NCT02367352|527490971|FG001|Overall Study|Participant Received Alternative Therapy|0|||
146267113|NCT02367352|527490972|FG002|Overall Study|Participant Received Alternative Therapy|0|||
146267114|NCT02367352|527490970|FG000|Overall Study|Adverse Event|1|||
146267115|NCT02367352|527490971|FG001|Overall Study|Adverse Event|0|||
146267116|NCT02367352|527490972|FG002|Overall Study|Adverse Event|0|||
146267117|NCT01437423|527490973|FG000|Overall Study|Lost to Follow-up|12|||
146267118|NCT01437423|527490973|FG000|Overall Study|Off label usage|3|||
146267119|NCT05878873|527490974|FG000|Overall Study|Lost to Follow-up|2|||
146267120|NCT05878873|527490975|FG001|Overall Study|Lost to Follow-up|0|||
146267121|NCT02980523|527490976|FG000|Overall Study|Lost to Follow-up|1|||
146267122|NCT02980523|527490977|FG001|Overall Study|Lost to Follow-up|4|||
146267123|NCT02980523|527490978|FG002|Overall Study|Lost to Follow-up|1|||
146267124|NCT02980523|527490979|FG003|Overall Study|Lost to Follow-up|2|||
146267125|NCT02980523|527490980|FG004|Overall Study|Lost to Follow-up|1|||
146267126|NCT02980523|527490976|FG000|Overall Study|Excluded from analysis|1|||
146267127|NCT02980523|527490977|FG001|Overall Study|Excluded from analysis|3|||
146267128|NCT02980523|527490978|FG002|Overall Study|Excluded from analysis|1|||
146267129|NCT02980523|527490979|FG003|Overall Study|Excluded from analysis|1|||
146267130|NCT02980523|527490980|FG004|Overall Study|Excluded from analysis|1|||
146267131|NCT02980523|527490976|FG000|Overall Study|Lack of Efficacy|1|||
146267132|NCT02980523|527490977|FG001|Overall Study|Lack of Efficacy|4|||
146267133|NCT02980523|527490978|FG002|Overall Study|Lack of Efficacy|4|||
146267134|NCT02980523|527490979|FG003|Overall Study|Lack of Efficacy|5|||
146267135|NCT02980523|527490980|FG004|Overall Study|Lack of Efficacy|8|||
146267136|NCT02980523|527490976|FG000|Overall Study|Did not receive intervention|0|||
146267137|NCT02980523|527490977|FG001|Overall Study|Did not receive intervention|0|||
146267138|NCT02980523|527490978|FG002|Overall Study|Did not receive intervention|0|||
146267139|NCT02980523|527490979|FG003|Overall Study|Did not receive intervention|1|||
146267140|NCT02980523|527490980|FG004|Overall Study|Did not receive intervention|0|||
146267141|NCT00633945|527490981|FG000|Overall Study|Physician Decision|2|||
146267142|NCT02552147|527490982|FG000|First Intervention (7 Days)|Protocol Violation|1|||
146267143|NCT02552147|527490983|FG001|First Intervention (7 Days)|Protocol Violation|0|||
146267144|NCT02552147|527490982|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
146267145|NCT02552147|527490983|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
146267146|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
146267147|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
146267148|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
146267149|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
146267150|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
146267151|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
146267152|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
146267153|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
146267154|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
146267155|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
146136098|NCT00393939|527015641|FG000|Overall Study|Sponsor|5|||
146136099|NCT00393939|527015642|FG001|Overall Study|Sponsor|13|||
146136100|NCT00393939|527015641|FG000|Overall Study|Objective progression or relapse|239|||
146136101|NCT00393939|527015642|FG001|Overall Study|Objective progression or relapse|223|||
146136102|NCT00393939|527015641|FG000|Overall Study|Withdrawal by Subject|2|||
146136103|NCT00393939|527015642|FG001|Overall Study|Withdrawal by Subject|7|||
146267156|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
146267157|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
146267158|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
146267159|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
146267160|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
146267161|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
146267162|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
146267163|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
146267164|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Missing|2|||
146267165|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Missing|1|||
146267166|NCT00443209|527490987|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
146136104|NCT00393939|527015641|FG000|Overall Study|Other|37|||
146136105|NCT00393939|527015642|FG001|Overall Study|Other|45|||
146136106|NCT02385799|527015643|FG000|Overall Study|Lost to Follow-up|1|||
146136107|NCT02385799|527015644|FG001|Overall Study|Lost to Follow-up|2|||
146136108|NCT02385799|527015643|FG000|Overall Study|Adverse Event|4|||
146136109|NCT02385799|527015644|FG001|Overall Study|Adverse Event|2|||
146136110|NCT02385799|527015643|FG000|Overall Study|Withdrawal by Subject|0|||
146136111|NCT02385799|527015644|FG001|Overall Study|Withdrawal by Subject|4|||
146136112|NCT00547703|527015645|FG000|Overall Study|Lost to Follow-up|1|||
146136113|NCT00547703|527015646|FG001|Overall Study|Lost to Follow-up|0|||
146136114|NCT02275481|527015647|FG000|Overall Study|Death|2|||
146136115|NCT02275481|527015648|FG001|Overall Study|Death|1|||
146136116|NCT02275481|527015647|FG000|Overall Study|Lost to Follow-up|2|||
146136117|NCT02275481|527015648|FG001|Overall Study|Lost to Follow-up|0|||
146136118|NCT02275481|527015647|FG000|Overall Study|Withdrawal by Subject|3|||
146136119|NCT02275481|527015648|FG001|Overall Study|Withdrawal by Subject|0|||
146136120|NCT02275481|527015647|FG000|Overall Study|all other reasons combined|2|||
146136121|NCT02275481|527015648|FG001|Overall Study|all other reasons combined|1|||
146136122|NCT02275481|527015647|FG000|Overall Study|Physician Decision|0|||
146136123|NCT02275481|527015648|FG001|Overall Study|Physician Decision|1|||
146136124|NCT01838642|527015650|FG000|Overall Study|Died on study|1|||
146136125|NCT01215227|527015654|FG000|Overall Study|Adverse Event|11|||
146136126|NCT01215227|527015655|FG001|Overall Study|Adverse Event|11|||
146136127|NCT01215227|527015656|FG002|Overall Study|Adverse Event|4|||
146136128|NCT01215227|527015657|FG003|Overall Study|Adverse Event|8|||
146136129|NCT01215227|527015658|FG004|Overall Study|Adverse Event|7|||
146136130|NCT01215227|527015659|FG005|Overall Study|Adverse Event|6|||
146136131|NCT01215227|527015654|FG000|Overall Study|Treatment Failure|8|||
146136132|NCT01215227|527015655|FG001|Overall Study|Treatment Failure|4|||
146136133|NCT01215227|527015656|FG002|Overall Study|Treatment Failure|1|||
146136134|NCT01215227|527015657|FG003|Overall Study|Treatment Failure|5|||
146136135|NCT01215227|527015658|FG004|Overall Study|Treatment Failure|1|||
146136136|NCT01215227|527015659|FG005|Overall Study|Treatment Failure|1|||
146136137|NCT01215227|527015654|FG000|Overall Study|Lost to Follow-up|1|||
146136138|NCT01215227|527015655|FG001|Overall Study|Lost to Follow-up|4|||
146136139|NCT01215227|527015656|FG002|Overall Study|Lost to Follow-up|1|||
146136140|NCT01215227|527015657|FG003|Overall Study|Lost to Follow-up|1|||
146136141|NCT01215227|527015658|FG004|Overall Study|Lost to Follow-up|1|||
146136142|NCT01215227|527015659|FG005|Overall Study|Lost to Follow-up|2|||
146136143|NCT01215227|527015654|FG000|Overall Study|Subject Withdrew Consent|16|||
146136144|NCT01215227|527015655|FG001|Overall Study|Subject Withdrew Consent|20|||
146136145|NCT01215227|527015656|FG002|Overall Study|Subject Withdrew Consent|7|||
146136146|NCT01215227|527015657|FG003|Overall Study|Subject Withdrew Consent|10|||
146136147|NCT01215227|527015658|FG004|Overall Study|Subject Withdrew Consent|11|||
146136148|NCT01215227|527015659|FG005|Overall Study|Subject Withdrew Consent|8|||
146304006|NCT00617604|527627474|FG001|Overall Study|Withdrawal by Subject|6|||
146304007|NCT00617604|527627473|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
146304008|NCT00617604|527627474|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
146304009|NCT03250832|527627475|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
146304010|NCT03250832|527627476|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
146304011|NCT03250832|527627477|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
146304012|NCT03250832|527627478|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
146304013|NCT03250832|527627479|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
146136149|NCT01215227|527015654|FG000|Overall Study|Non-Compliance With Protocol|2|||
146136150|NCT01215227|527015655|FG001|Overall Study|Non-Compliance With Protocol|6|||
146136151|NCT01215227|527015656|FG002|Overall Study|Non-Compliance With Protocol|1|||
146136152|NCT01215227|527015657|FG003|Overall Study|Non-Compliance With Protocol|0|||
146136153|NCT01215227|527015658|FG004|Overall Study|Non-Compliance With Protocol|0|||
146136154|NCT01215227|527015659|FG005|Overall Study|Non-Compliance With Protocol|0|||
146136155|NCT01215227|527015654|FG000|Overall Study|Administrative|83|||
146136156|NCT01215227|527015655|FG001|Overall Study|Administrative|73|||
146136157|NCT01215227|527015656|FG002|Overall Study|Administrative|42|||
146136158|NCT01215227|527015657|FG003|Overall Study|Administrative|24|||
146136159|NCT01215227|527015658|FG004|Overall Study|Administrative|28|||
146136160|NCT01215227|527015659|FG005|Overall Study|Administrative|40|||
146136161|NCT01215227|527015654|FG000|Overall Study|Missing Status|0|||
146136162|NCT01215227|527015655|FG001|Overall Study|Missing Status|1|||
146304014|NCT03250832|527627480|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
146304015|NCT03250832|527627481|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
146136163|NCT01215227|527015656|FG002|Overall Study|Missing Status|0|||
146136164|NCT01215227|527015657|FG003|Overall Study|Missing Status|0|||
146136165|NCT01215227|527015658|FG004|Overall Study|Missing Status|0|||
145943214|NCT00483704|526300458|FG002|Randomization|Progressive disease|1|||
146136166|NCT01215227|527015659|FG005|Overall Study|Missing Status|0|||
146136167|NCT01215227|527015654|FG000|Overall Study|Randomized but not treated|0|||
146136168|NCT01215227|527015655|FG001|Overall Study|Randomized but not treated|0|||
146136169|NCT01215227|527015656|FG002|Overall Study|Randomized but not treated|1|||
146136170|NCT01215227|527015657|FG003|Overall Study|Randomized but not treated|1|||
146267167|NCT00443209|527490988|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
146267168|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
146267169|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
146267170|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
146267171|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
146267172|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
146267173|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
146267174|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
146267175|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
146267176|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
146267177|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
146267178|NCT00443209|527490987|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
146267179|NCT00443209|527490988|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
146267180|NCT01318876|527490989|FG000|Day 8 Survey|email address invalid|96|||
146267181|NCT01318876|527490989|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
146267182|NCT01318876|527490989|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
146267183|NCT00825305|527490993|FG000|Overall Study|Adverse Event|1|||
146267184|NCT00825305|527490994|FG001|Overall Study|Adverse Event|1|||
146267185|NCT00825305|527490993|FG000|Overall Study|Withdrawal by Subject|6|||
146267186|NCT00825305|527490994|FG001|Overall Study|Withdrawal by Subject|12|||
146267187|NCT00825305|527490993|FG000|Overall Study|Inappropriate inclusion|1|||
146267188|NCT00825305|527490994|FG001|Overall Study|Inappropriate inclusion|0|||
146136171|NCT01215227|527015658|FG004|Overall Study|Randomized but not treated|0|||
146136172|NCT01215227|527015659|FG005|Overall Study|Randomized but not treated|1|||
146136173|NCT00291668|527015660|FG000|Overall Study|Lack of Efficacy|1|||
146136174|NCT00291668|527015661|FG001|Overall Study|Lack of Efficacy|0|||
146136175|NCT00291668|527015662|FG002|Overall Study|Lack of Efficacy|0|||
146136176|NCT00291668|527015660|FG000|Overall Study|SAE, non-fatal|1|||
146136177|NCT00291668|527015661|FG001|Overall Study|SAE, non-fatal|1|||
146136178|NCT00291668|527015662|FG002|Overall Study|SAE, non-fatal|1|||
146136179|NCT00291668|527015660|FG000|Overall Study|AE, non-serious non-fatal|1|||
146136180|NCT00291668|527015661|FG001|Overall Study|AE, non-serious non-fatal|0|||
146136181|NCT00291668|527015662|FG002|Overall Study|AE, non-serious non-fatal|0|||
146136182|NCT00291668|527015660|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
146136183|NCT00291668|527015661|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146136184|NCT00291668|527015662|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
146136185|NCT00313612|527015665|FG000|Overall Study|Patient never received treatment|0|||
146136186|NCT00313612|527015666|FG001|Overall Study|Patient never received treatment|1|||
146136187|NCT03925727|527015668|FG000|Overall Study|Adverse Event|4|||
146136188|NCT03925727|527015669|FG001|Overall Study|Adverse Event|0|||
146267189|NCT00825305|527490993|FG000|Overall Study|Protocol Violation|9|||
146267190|NCT00825305|527490994|FG001|Overall Study|Protocol Violation|9|||
146267191|NCT00825305|527490993|FG000|Overall Study|Can not be classified|0|||
146267192|NCT00825305|527490994|FG001|Overall Study|Can not be classified|1|||
146267193|NCT04016272|527490995|FG000|Overall Study|Withdrawal by Subject|1|||
146267194|NCT04016272|527490996|FG001|Overall Study|Withdrawal by Subject|2|||
146267195|NCT02353468|527490999|FG000|Overall Study|Study terminated|3|||
146267196|NCT00003477|527491000|FG000|Overall Study|Not evalauable|4|||
146267197|NCT00246090|527491003|FG000|Overall Study|Adverse Event|25|||
146267198|NCT00246090|527491003|FG000|Overall Study|Withdrawal by Subject|7|||
146267199|NCT00246090|527491003|FG000|Overall Study|Progressive Disease|212|||
146267200|NCT00246090|527491003|FG000|Overall Study|Clinical Progression|30|||
146267201|NCT00246090|527491003|FG000|Overall Study|Physician Decision|11|||
146267202|NCT00246090|527491003|FG000|Overall Study|Not Otherwise Specified|10|||
146267203|NCT01827046|527491009|FG000|Overall Study|Lost to Follow-up|1|||
146267204|NCT01827046|527491010|FG001|Overall Study|Lost to Follow-up|5|||
146267205|NCT01827046|527491009|FG000|Overall Study|Withdrawal by Subject|0|||
146267206|NCT01827046|527491010|FG001|Overall Study|Withdrawal by Subject|4|||
146267207|NCT02353871|527491012|FG000|Overall Study|Protocol deviation|0|||
146267208|NCT02353871|527491013|FG001|Overall Study|Protocol deviation|1|||
146267209|NCT02353871|527491012|FG000|Overall Study|Consent withdrawn|1|||
146267210|NCT02353871|527491013|FG001|Overall Study|Consent withdrawn|8|||
146267211|NCT02353871|527491012|FG000|Overall Study|Lost to Follow-up|2|||
146267212|NCT02353871|527491013|FG001|Overall Study|Lost to Follow-up|0|||
146267213|NCT00115336|527491014|FG000|Overall Study|Hospital discharge before study drug|0|||
146136189|NCT03925727|527015670|FG002|Overall Study|Adverse Event|3|||
146136190|NCT03925727|527015668|FG000|Overall Study|Protocol Violation|1|||
146136191|NCT03925727|527015669|FG001|Overall Study|Protocol Violation|2|||
146136192|NCT03925727|527015670|FG002|Overall Study|Protocol Violation|2|||
146267214|NCT00115336|527491015|FG001|Overall Study|Hospital discharge before study drug|1|||
146267215|NCT02554383|527491016|FG000|Overall Study|Ineligible|3|||
146267216|NCT02554383|527491017|FG001|Overall Study|Ineligible|2|||
146267217|NCT02554383|527491016|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
146267218|NCT02554383|527491017|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
146136193|NCT03925727|527015668|FG000|Overall Study|Withdrawal by Subject|3|||
146136194|NCT03925727|527015669|FG001|Overall Study|Withdrawal by Subject|2|||
146136195|NCT03925727|527015670|FG002|Overall Study|Withdrawal by Subject|4|||
146136196|NCT03925727|527015668|FG000|Overall Study|Administrative Reasons|3|||
146136197|NCT03925727|527015669|FG001|Overall Study|Administrative Reasons|1|||
146136198|NCT03925727|527015670|FG002|Overall Study|Administrative Reasons|2|||
146136199|NCT03925727|527015668|FG000|Overall Study|Randomized in error or Disqualified|8|||
146136200|NCT03925727|527015669|FG001|Overall Study|Randomized in error or Disqualified|1|||
146304016|NCT03250832|527627482|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
146304017|NCT03250832|527627483|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
146304018|NCT03250832|527627484|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
146304019|NCT03250832|527627485|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
146304020|NCT03250832|527627486|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
146304021|NCT03250832|527627475|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
146304022|NCT03250832|527627476|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
146136201|NCT03925727|527015670|FG002|Overall Study|Randomized in error or Disqualified|7|||
146136202|NCT01574352|527015671|FG000|Overall Study|Withdrawal by Subject|6|||
146136203|NCT01574352|527015672|FG001|Overall Study|Withdrawal by Subject|13|||
146136204|NCT01574352|527015671|FG000|Overall Study|Injury in non-camp related sport|1|||
146136205|NCT01574352|527015672|FG001|Overall Study|Injury in non-camp related sport|0|||
146136206|NCT02777125|527015673|FG000|Overall Study|Consent form violation|14|||
146136207|NCT02777125|527015674|FG001|Overall Study|Consent form violation|12|||
146136208|NCT02777125|527015673|FG000|Overall Study|Assent form violation|21|||
146136209|NCT02777125|527015674|FG001|Overall Study|Assent form violation|23|||
146136210|NCT02777125|527015673|FG000|Overall Study|Protocol Violation|8|||
146136211|NCT02777125|527015674|FG001|Overall Study|Protocol Violation|12|||
146136212|NCT02283788|527015677|FG000|Overall Study|Adverse Event|1|||
146136213|NCT02283788|527015678|FG001|Overall Study|Adverse Event|3|||
146136214|NCT02283788|527015679|FG002|Overall Study|Adverse Event|5|||
146136215|NCT02283788|527015680|FG003|Overall Study|Adverse Event|1|||
146136216|NCT02283788|527015677|FG000|Overall Study|Withdrawal by Subject|0|||
146136217|NCT02283788|527015678|FG001|Overall Study|Withdrawal by Subject|1|||
146136218|NCT02283788|527015679|FG002|Overall Study|Withdrawal by Subject|0|||
146136219|NCT02283788|527015680|FG003|Overall Study|Withdrawal by Subject|1|||
146136220|NCT00653224|527018225|FG000|Overall Study|Adverse Event|2|||
146136221|NCT00653224|527018226|FG001|Overall Study|Adverse Event|1|||
146136222|NCT00653224|527018225|FG000|Overall Study|Lack of Efficacy|1|||
146136223|NCT00653224|527018226|FG001|Overall Study|Lack of Efficacy|2|||
146136224|NCT00653224|527018225|FG000|Overall Study|Loss of efficacy|1|||
146136225|NCT00653224|527018226|FG001|Overall Study|Loss of efficacy|0|||
146136226|NCT00653224|527018225|FG000|Overall Study|Lost to Follow-up|1|||
146136227|NCT00653224|527018226|FG001|Overall Study|Lost to Follow-up|0|||
146136228|NCT00653224|527018225|FG000|Overall Study|Other|2|||
146136229|NCT00653224|527018226|FG001|Overall Study|Other|4|||
146304023|NCT03250832|527627477|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
146304024|NCT03250832|527627478|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
146304025|NCT03250832|527627479|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
146304026|NCT03250832|527627480|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
146136230|NCT00773175|527018227|FG000|Overall Study|Adverse Event|2|||
146136231|NCT00773175|527018228|FG001|Overall Study|Adverse Event|0|||
146136232|NCT00773175|527018227|FG000|Overall Study|Consent Withdrawn|0|||
146136233|NCT00773175|527018228|FG001|Overall Study|Consent Withdrawn|2|||
146136234|NCT00503841|527018229|FG000|Overall Study|All screen failures|44|||
146136235|NCT00326612|527018234|FG000|Overall Study|They did not have a seizure requiring tx|129|||
146136236|NCT00326612|527018235|FG001|Overall Study|They did not have a seizure requiring tx|137|||
146136237|NCT00419562|527018236|FG000|Overall Study|Lost to Follow-up|12|||
146136238|NCT00419562|527018237|FG001|Overall Study|Lost to Follow-up|13|||
146136239|NCT00419562|527018236|FG000|Overall Study|Withdrawal by Subject|20|||
146136240|NCT00419562|527018237|FG001|Overall Study|Withdrawal by Subject|18|||
146136241|NCT00419562|527018236|FG000|Overall Study|Participant Institutionalized|1|||
146136242|NCT00419562|527018237|FG001|Overall Study|Participant Institutionalized|0|||
146136243|NCT00640510|527018238|FG000|Overall Study|Lack of Efficacy|0|||
146136244|NCT00640510|527018239|FG001|Overall Study|Lack of Efficacy|1|||
146136245|NCT00640510|527018238|FG000|Overall Study|Protocol Violation|1|||
146136246|NCT00640510|527018239|FG001|Overall Study|Protocol Violation|0|||
146136247|NCT00640510|527018238|FG000|Overall Study|Physician Decision|0|||
146136248|NCT00640510|527018239|FG001|Overall Study|Physician Decision|1|||
146136249|NCT00779675|527018240|FG000|Treatment Period|Adverse Event|87|||
146136250|NCT00779675|527018240|FG000|Treatment Period|Treatment Failure|80|||
146136251|NCT00779675|527018240|FG000|Treatment Period|Transferred to Another Study|38|||
146136252|NCT00779675|527018240|FG000|Treatment Period|Lost to Follow-up|23|||
146136253|NCT00779675|527018240|FG000|Treatment Period|Withdrawal by Subject|46|||
146136254|NCT00779675|527018240|FG000|Treatment Period|Protocol Violation|54|||
146136255|NCT00779675|527018240|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
146267219|NCT02554383|527491016|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
146267220|NCT02554383|527491017|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
146267221|NCT02554383|527491016|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
146267222|NCT02554383|527491017|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
146267223|NCT00715117|527491026|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
146267224|NCT00715117|527491027|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
146267225|NCT02394665|527491031|FG000|Overall Study|Physician Decision|1|||
146267226|NCT02394665|527491032|FG001|Overall Study|Physician Decision|0|||
146267227|NCT02394665|527491033|FG002|Overall Study|Physician Decision|0|||
146267228|NCT01191008|527491034|FG000|Overall Study|Protocol Violation|7|||
146267229|NCT01191008|527491034|FG000|Overall Study|Lost to Follow-up|8|||
146267230|NCT00978562|527491035|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
146267231|NCT03371823|527491040|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
146267232|NCT03371823|527491041|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
146267233|NCT02282059|527491042|FG000|Overall Study|Other|15|||
146267234|NCT02282059|527491043|FG001|Overall Study|Other|3|||
146267235|NCT02282059|527491042|FG000|Overall Study|Participant refused further follow-up|8|||
146267236|NCT02282059|527491043|FG001|Overall Study|Participant refused further follow-up|4|||
146267237|NCT02282059|527491042|FG000|Overall Study|Lost to Follow-up|19|||
146267238|NCT02282059|527491043|FG001|Overall Study|Lost to Follow-up|3|||
146267239|NCT02282059|527491042|FG000|Overall Study|Death|40|||
146267240|NCT02282059|527491043|FG001|Overall Study|Death|8|||
146267241|NCT01245140|527492426|FG000|Overall Study|Adverse Event|1|||
146267242|NCT01245140|527492427|FG001|Overall Study|Adverse Event|3|||
146267243|NCT01245140|527492426|FG000|Overall Study|Lack of Efficacy|2|||
146267244|NCT01245140|527492427|FG001|Overall Study|Lack of Efficacy|4|||
146267245|NCT01245140|527492426|FG000|Overall Study|Protocol Violation|0|||
146267246|NCT01245140|527492427|FG001|Overall Study|Protocol Violation|1|||
146267247|NCT01245140|527492426|FG000|Overall Study|Withdrawal by Subject|0|||
146267248|NCT01245140|527492427|FG001|Overall Study|Withdrawal by Subject|1|||
146267249|NCT01245140|527492426|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
146267250|NCT01245140|527492427|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
146267251|NCT02635360|527492428|FG000|Overall Study|Adverse Event|0|||
146267252|NCT02635360|527492429|FG001|Overall Study|Adverse Event|3|||
146267253|NCT02635360|527492428|FG000|Overall Study|Withdrawal by Subject|2|||
146267254|NCT02635360|527492429|FG001|Overall Study|Withdrawal by Subject|0|||
146267255|NCT02635360|527492428|FG000|Overall Study|Non-Compliance|3|||
146267256|NCT02635360|527492429|FG001|Overall Study|Non-Compliance|1|||
146267257|NCT02635360|527492428|FG000|Overall Study|Disease Progression|0|||
146267258|NCT02635360|527492429|FG001|Overall Study|Disease Progression|2|||
146267259|NCT02635360|527492428|FG000|Overall Study|Lost to Follow-up|1|||
146267260|NCT02635360|527492429|FG001|Overall Study|Lost to Follow-up|1|||
146267261|NCT00334542|527492430|FG000|Overall Study|Adverse Event|3|||
146267262|NCT00334542|527492430|FG000|Overall Study|Withdrawal by Subject|1|||
146267263|NCT00334542|527492430|FG000|Overall Study|New cancer diagnosis|1|||
146267264|NCT01454739|527492435|FG000|Overall Study|Protocol Violation|2|||
146267265|NCT01454739|527492436|FG001|Overall Study|Protocol Violation|3|||
146267266|NCT01454739|527492435|FG000|Overall Study|Withdrawal by Subject|2|||
146267267|NCT01454739|527492436|FG001|Overall Study|Withdrawal by Subject|6|||
146267268|NCT01454739|527492435|FG000|Overall Study|Other|3|||
146267269|NCT01454739|527492436|FG001|Overall Study|Other|5|||
146267270|NCT01454739|527492435|FG000|Overall Study|Physician Decision|0|||
146267271|NCT01454739|527492436|FG001|Overall Study|Physician Decision|5|||
146267272|NCT01454739|527492435|FG000|Overall Study|Lost to Follow-up|0|||
146267273|NCT01454739|527492436|FG001|Overall Study|Lost to Follow-up|1|||
146267274|NCT01454739|527492435|FG000|Overall Study|Adverse Event|0|||
146267275|NCT01454739|527492436|FG001|Overall Study|Adverse Event|1|||
146267276|NCT01375751|527492437|FG000|Overall Study|Other|0|||
146267277|NCT01375751|527492438|FG001|Overall Study|Other|1|||
146267278|NCT01375751|527492439|FG002|Overall Study|Other|0|||
146267279|NCT02375347|527492441|FG000|Overall Study|Protocol Violation|1|||
146267280|NCT00193479|527492442|FG000|Induction Chemotherapy|Adverse Event|2|||
146267281|NCT00193479|527492442|FG000|Induction Chemotherapy|Disease Progression|1|||
146267282|NCT00193479|527492442|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
146267283|NCT00193479|527492442|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
146136256|NCT00779675|527018240|FG000|Treatment Period|Administrative|3|||
146267284|NCT00559377|527492444|FG000|Overall Study|Withdrawal by Subject|9|||
146267285|NCT02229227|527492450|FG000|Overall Study|Adverse Event|14|||
146267286|NCT02229227|527492451|FG001|Overall Study|Adverse Event|9|||
146136257|NCT00779675|527018240|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
146267287|NCT02229227|527492450|FG000|Overall Study|Lack of Efficacy|3|||
146267288|NCT02229227|527492451|FG001|Overall Study|Lack of Efficacy|3|||
146267289|NCT02229227|527492450|FG000|Overall Study|Protocol Violation|6|||
146267290|NCT02229227|527492451|FG001|Overall Study|Protocol Violation|8|||
146267291|NCT02229227|527492450|FG000|Overall Study|Protocol defined stopping criteria|1|||
146136258|NCT00779675|527018240|FG000|Extended Treatment Period|Protocol Violation|13|||
146136259|NCT00779675|527018240|FG000|Extended Treatment Period|Adverse Event|6|||
146136260|NCT00779675|527018240|FG000|Extended Treatment Period|Treatment Failure|11|||
146136261|NCT00779675|527018240|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
146136262|NCT00779675|527018240|FG000|Extended Treatment Period|Lost to Follow-up|6|||
146136263|NCT01440322|527018241|FG000|Overall Study|Discomfort|2|||
146136264|NCT01440322|527018242|FG001|Overall Study|Discomfort|0|||
146136265|NCT01440322|527018241|FG000|Overall Study|Biomicroscopy|1|||
146136266|NCT01440322|527018242|FG001|Overall Study|Biomicroscopy|0|||
146136267|NCT01440322|527018241|FG000|Overall Study|Symptoms and Problems|1|||
146136268|NCT01440322|527018242|FG001|Overall Study|Symptoms and Problems|0|||
146136269|NCT01440322|527018241|FG000|Overall Study|Unacceptable Subjective Vision|1|||
146136270|NCT01440322|527018242|FG001|Overall Study|Unacceptable Subjective Vision|0|||
146136271|NCT01440322|527018241|FG000|Overall Study|Other Product Related|1|||
146136272|NCT01440322|527018242|FG001|Overall Study|Other Product Related|0|||
146136273|NCT01440322|527018241|FG000|Overall Study|Unrelated Medical Problem|0|||
146136274|NCT01440322|527018242|FG001|Overall Study|Unrelated Medical Problem|1|||
146136275|NCT01440322|527018241|FG000|Overall Study|Other Non-Product Related|1|||
146136276|NCT01440322|527018242|FG001|Overall Study|Other Non-Product Related|0|||
146136277|NCT01956110|527018252|FG000|Overall Study|Protocol Violation|25|||
146136278|NCT01956110|527018253|FG001|Overall Study|Protocol Violation|11|||
146136279|NCT01956110|527018252|FG000|Overall Study|Adverse Event|9|||
146136280|NCT01956110|527018253|FG001|Overall Study|Adverse Event|10|||
146136281|NCT01956110|527018252|FG000|Overall Study|Personal reasons|1|||
146136282|NCT01956110|527018253|FG001|Overall Study|Personal reasons|1|||
146136283|NCT03325166|527018256|FG000|Overall Study|Adverse Event|1|||
146136284|NCT01633944|527018257|FG000|Open-label Titration Phase|Adverse Event|109|||
146136285|NCT01633944|527018258|FG001|Open-label Titration Phase|Adverse Event|0|||
146136286|NCT01633944|527018259|FG002|Open-label Titration Phase|Adverse Event|0|||
146136287|NCT01633944|527018257|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
146136288|NCT01633944|527018258|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
146136289|NCT01633944|527018259|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
146136290|NCT01633944|527018257|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
146136291|NCT01633944|527018258|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
146136292|NCT01633944|527018259|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
146136293|NCT01633944|527018257|FG000|Open-label Titration Phase|Protocol Violation|24|||
146136294|NCT01633944|527018258|FG001|Open-label Titration Phase|Protocol Violation|0|||
146136295|NCT01633944|527018259|FG002|Open-label Titration Phase|Protocol Violation|0|||
146136296|NCT01633944|527018257|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
146136297|NCT01633944|527018258|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
146136298|NCT01633944|527018259|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
146136299|NCT01633944|527018257|FG000|Open-label Titration Phase|Other|68|||
146136300|NCT01633944|527018258|FG001|Open-label Titration Phase|Other|0|||
146136301|NCT01633944|527018259|FG002|Open-label Titration Phase|Other|0|||
146136302|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Adverse Event|0|||
146136303|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Adverse Event|13|||
146136304|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Adverse Event|7|||
146136305|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
146136306|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
146136307|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
146136308|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
146136309|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
146136310|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
146267292|NCT02229227|527492451|FG001|Overall Study|Protocol defined stopping criteria|3|||
146267293|NCT02229227|527492450|FG000|Overall Study|Lost to Follow-up|3|||
146267294|NCT02229227|527492451|FG001|Overall Study|Lost to Follow-up|3|||
146267295|NCT02229227|527492450|FG000|Overall Study|Study terminated by sponsor|11|||
146267296|NCT02229227|527492451|FG001|Overall Study|Study terminated by sponsor|11|||
146267297|NCT02229227|527492450|FG000|Overall Study|Withdrawal by Subject|8|||
146267298|NCT02229227|527492451|FG001|Overall Study|Withdrawal by Subject|12|||
146267299|NCT02229227|527492450|FG000|Overall Study|Other|0|||
146267300|NCT02229227|527492451|FG001|Overall Study|Other|1|||
146267301|NCT02229227|527492450|FG000|Overall Study|Physician Decision|5|||
146267302|NCT02229227|527492451|FG001|Overall Study|Physician Decision|12|||
146136311|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
146136312|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
146136313|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
146136314|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146136315|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
146136316|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
146267303|NCT00872001|527492452|FG000|Overall Study|Adverse Event|34|||
146267304|NCT00872001|527492453|FG001|Overall Study|Adverse Event|23|||
146267305|NCT00872001|527492452|FG000|Overall Study|Protocol Defined Clinical Event|5|||
146267306|NCT00872001|527492453|FG001|Overall Study|Protocol Defined Clinical Event|7|||
146267307|NCT00872001|527492452|FG000|Overall Study|Lost to Follow-up|13|||
146267308|NCT00872001|527492453|FG001|Overall Study|Lost to Follow-up|12|||
146267309|NCT00872001|527492452|FG000|Overall Study|Withdrawal by Subject|18|||
146267310|NCT00872001|527492453|FG001|Overall Study|Withdrawal by Subject|30|||
146267311|NCT00872001|527492452|FG000|Overall Study|Protocol Violation|5|||
146267312|NCT00872001|527492453|FG001|Overall Study|Protocol Violation|8|||
146267313|NCT00872001|527492452|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
146267314|NCT00872001|527492453|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
146267315|NCT00872001|527492452|FG000|Overall Study|Administrative|23|||
146267316|NCT00872001|527492453|FG001|Overall Study|Administrative|15|||
146267317|NCT01453023|527492456|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
146267318|NCT01453023|527492457|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
146267319|NCT01453023|527492456|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
146267320|NCT01453023|527492457|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
146267321|NCT01453023|527492456|FG000|Treatment Period 2|Protocol Violation|0|||
146267322|NCT01453023|527492457|FG001|Treatment Period 2|Protocol Violation|1|||
146267323|NCT04468230|527492460|FG000|Overall Study|Adverse Event|2|||
146267324|NCT01790295|527492462|FG000|Overall Study|Adverse Event|1|||
146267325|NCT01790295|527492462|FG000|Overall Study|Death|4|||
146267326|NCT01790295|527492462|FG000|Overall Study|Lack of Efficacy|2|||
146267327|NCT01790295|527492462|FG000|Overall Study|Study closure|4|||
146267328|NCT00420784|527492465|FG000|Overall Study|Adverse Event|11|||
146267329|NCT00420784|527492466|FG001|Overall Study|Adverse Event|29|||
146267330|NCT00420784|527492467|FG002|Overall Study|Adverse Event|10|||
146267331|NCT00420784|527492468|FG003|Overall Study|Adverse Event|5|||
146267332|NCT00420784|527492465|FG000|Overall Study|Withdrawal by Subject|0|||
146267333|NCT00420784|527492466|FG001|Overall Study|Withdrawal by Subject|1|||
146267334|NCT00420784|527492467|FG002|Overall Study|Withdrawal by Subject|0|||
146267335|NCT00420784|527492468|FG003|Overall Study|Withdrawal by Subject|0|||
146267336|NCT00420784|527492465|FG000|Overall Study|Lost to Follow-up|0|||
146267337|NCT00420784|527492466|FG001|Overall Study|Lost to Follow-up|0|||
146267338|NCT00420784|527492467|FG002|Overall Study|Lost to Follow-up|2|||
146267339|NCT00420784|527492468|FG003|Overall Study|Lost to Follow-up|1|||
146267340|NCT00420784|527492465|FG000|Overall Study|Virologic Stopping Rule|17|||
146267341|NCT00420784|527492466|FG001|Overall Study|Virologic Stopping Rule|26|||
146267342|NCT00420784|527492467|FG002|Overall Study|Virologic Stopping Rule|41|||
146267343|NCT00420784|527492468|FG003|Overall Study|Virologic Stopping Rule|67|||
146267344|NCT00420784|527492465|FG000|Overall Study|Other|1|||
146267345|NCT00420784|527492466|FG001|Overall Study|Other|2|||
146267346|NCT00420784|527492467|FG002|Overall Study|Other|0|||
146267347|NCT00420784|527492468|FG003|Overall Study|Other|5|||
146267348|NCT02417441|527492471|FG000|Overall Study|Inconclusive due to missing data|52|||
146267349|NCT02417441|527492472|FG001|Overall Study|Inconclusive due to missing data|19|||
146267350|NCT00983853|527492473|FG000|Overall Study|Lost to Follow-up|1|||
146267351|NCT00983853|527492474|FG001|Overall Study|Lost to Follow-up|1|||
146267352|NCT00983853|527492475|FG002|Overall Study|Lost to Follow-up|2|||
146267353|NCT00983853|527492476|FG003|Overall Study|Lost to Follow-up|2|||
146267354|NCT00983853|527492477|FG004|Overall Study|Lost to Follow-up|2|||
146267355|NCT00983853|527492478|FG005|Overall Study|Lost to Follow-up|1|||
146267356|NCT00983853|527492473|FG000|Overall Study|Withdrawal by Subject|0|||
146267357|NCT00983853|527492474|FG001|Overall Study|Withdrawal by Subject|0|||
146267358|NCT00983853|527492475|FG002|Overall Study|Withdrawal by Subject|1|||
146267359|NCT00983853|527492476|FG003|Overall Study|Withdrawal by Subject|0|||
146267360|NCT00983853|527492477|FG004|Overall Study|Withdrawal by Subject|1|||
146267361|NCT00983853|527492478|FG005|Overall Study|Withdrawal by Subject|0|||
146267362|NCT00983853|527492473|FG000|Overall Study|Unable to come to study follow-up visits|0|||
146267363|NCT00983853|527492474|FG001|Overall Study|Unable to come to study follow-up visits|1|||
146267364|NCT00983853|527492475|FG002|Overall Study|Unable to come to study follow-up visits|0|||
146267365|NCT00983853|527492476|FG003|Overall Study|Unable to come to study follow-up visits|0|||
146267366|NCT00983853|527492477|FG004|Overall Study|Unable to come to study follow-up visits|0|||
146267367|NCT00983853|527492478|FG005|Overall Study|Unable to come to study follow-up visits|0|||
146267368|NCT03016598|527492483|FG000|Overall Study|Lost to Follow-up|0|||
146267369|NCT03016598|527492484|FG001|Overall Study|Lost to Follow-up|2|||
146267370|NCT01667549|527492489|FG000|Overall Study|Withdrawal by Subject|3|||
146267371|NCT01667549|527492490|FG001|Overall Study|Withdrawal by Subject|5|||
146267372|NCT01667549|527492491|FG002|Overall Study|Withdrawal by Subject|7|||
146267373|NCT01667549|527492492|FG003|Overall Study|Withdrawal by Subject|6|||
146267374|NCT01667549|527492493|FG004|Overall Study|Withdrawal by Subject|1|||
146267375|NCT01407276|527492494|FG000|Overall Study|Withdrawal by Subject|0|||
146267376|NCT01407276|527492495|FG001|Overall Study|Withdrawal by Subject|0|||
146267377|NCT01407276|527492496|FG002|Overall Study|Withdrawal by Subject|0|||
146267378|NCT01407276|527492497|FG003|Overall Study|Withdrawal by Subject|0|||
146267379|NCT01407276|527492498|FG004|Overall Study|Withdrawal by Subject|0|||
146267380|NCT01407276|527492499|FG005|Overall Study|Withdrawal by Subject|0|||
146267381|NCT01407276|527492500|FG006|Overall Study|Withdrawal by Subject|0|||
146267382|NCT01407276|527492501|FG007|Overall Study|Withdrawal by Subject|1|||
146136317|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
146136318|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
146136319|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
146136320|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
146136321|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
146136322|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
146136323|NCT01633944|527018257|FG000|Double-blind Treatment Phase|Other|0|||
146136324|NCT01633944|527018258|FG001|Double-blind Treatment Phase|Other|7|||
146136325|NCT01633944|527018259|FG002|Double-blind Treatment Phase|Other|0|||
146136326|NCT00463060|527018263|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
146136327|NCT00463060|527018263|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
146136328|NCT01400841|527018264|FG000|Initial Study Phase (6 Months)|Death|1|||
146136329|NCT01400841|527018264|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
146136330|NCT00701129|527018265|FG000|Overall Study|Death|2|||
146136331|NCT00910715|527018268|FG000|Overall Study|Lost to Follow-up|22|||
146136332|NCT00910715|527018269|FG001|Overall Study|Lost to Follow-up|26|||
146136333|NCT00910715|527018270|FG002|Overall Study|Lost to Follow-up|0|||
146136334|NCT02412631|527018271|FG000|Overall Study|Adverse Event|1|||
146136335|NCT02412631|527018272|FG001|Overall Study|Adverse Event|2|||
146136336|NCT02412631|527018271|FG000|Overall Study|Lost to Follow-up|5|||
146136337|NCT02412631|527018272|FG001|Overall Study|Lost to Follow-up|9|||
146136338|NCT02412631|527018271|FG000|Overall Study|Withdrawal by Subject|9|||
146136339|NCT02412631|527018272|FG001|Overall Study|Withdrawal by Subject|3|||
146136340|NCT02412631|527018271|FG000|Overall Study|Early stop by FDA|5|||
146136341|NCT02412631|527018272|FG001|Overall Study|Early stop by FDA|2|||
146136342|NCT02412631|527018271|FG000|Overall Study|Unspecified reason|6|||
146136343|NCT02412631|527018272|FG001|Overall Study|Unspecified reason|8|||
146136344|NCT00770120|527018273|FG000|Overall Study|Progression|31|||
146136345|NCT00770120|527018273|FG000|Overall Study|Adverse Event|11|||
146136346|NCT00770120|527018273|FG000|Overall Study|Not Protocol Specified|11|||
146136347|NCT00770120|527018273|FG000|Overall Study|Death|3|||
146136348|NCT00770120|527018273|FG000|Overall Study|Withdrawal by Subject|2|||
146136349|NCT00770120|527018273|FG000|Overall Study|Ineligible|1|||
146136350|NCT00770120|527018273|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
146136351|NCT00770120|527018273|FG000|Overall Study|Reason under Review|1|||
146136352|NCT01782313|527018281|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
146136353|NCT01782313|527018281|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
146136354|NCT01782313|527018281|FG000|Treated Cycle 3|Progressive Disease|21|||
146136355|NCT01782313|527018281|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
146136356|NCT01782313|527018281|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
146136357|NCT01782313|527018281|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
146136358|NCT01782313|527018281|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
146136359|NCT01782313|527018281|FG000|Survival Follow up|Lost to Follow-up|1|||
146136360|NCT00958776|527018282|FG000|Overall Study|Adverse Event|0|||
146136361|NCT00958776|527018283|FG001|Overall Study|Adverse Event|1|||
146136362|NCT00958776|527018282|FG000|Overall Study|Physician Decision|1|||
146136363|NCT00958776|527018283|FG001|Overall Study|Physician Decision|0|||
146136364|NCT00958776|527018282|FG000|Overall Study|Lost to Follow-up|2|||
146136365|NCT00958776|527018283|FG001|Overall Study|Lost to Follow-up|6|||
146136366|NCT00958776|527018282|FG000|Overall Study|Withdrawal by Subject|7|||
146136367|NCT00958776|527018283|FG001|Overall Study|Withdrawal by Subject|16|||
146136368|NCT00958776|527018282|FG000|Overall Study|Protocol Violation|1|||
146136369|NCT00958776|527018283|FG001|Overall Study|Protocol Violation|1|||
146136370|NCT00958776|527018282|FG000|Overall Study|Death|2|||
146136371|NCT00958776|527018283|FG001|Overall Study|Death|1|||
146136372|NCT00958776|527018282|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
146136373|NCT00958776|527018283|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
146136374|NCT00958776|527018282|FG000|Overall Study|Missing|1|||
146136375|NCT00958776|527018283|FG001|Overall Study|Missing|1|||
146136376|NCT00480636|527018284|FG000|Overall Study|Death|12|||
146136377|NCT00480636|527018284|FG000|Overall Study|Lost to Follow-up|4|||
146136378|NCT00480636|527018284|FG000|Overall Study|Other|2|||
146136379|NCT00480636|527018284|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
146136380|NCT02583256|527018285|FG000|Overall Study|Withdrawal by Subject|0|||
146136381|NCT02583256|527018286|FG001|Overall Study|Withdrawal by Subject|1|||
146267383|NCT02165826|527492506|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
146267384|NCT02165826|527492507|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
146267385|NCT02165826|527492508|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
146267386|NCT02165826|527492506|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
146267387|NCT02165826|527492507|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
146136382|NCT02583256|527018287|FG002|Overall Study|Withdrawal by Subject|1|||
146136383|NCT02583256|527018288|FG003|Overall Study|Withdrawal by Subject|0|||
146136384|NCT02583256|527018285|FG000|Overall Study|Lost to Follow-up|1|||
146136385|NCT02583256|527018286|FG001|Overall Study|Lost to Follow-up|1|||
146267388|NCT02165826|527492508|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
146267389|NCT02165826|527492506|FG000|Main Treatment Period|Lost to Follow-up|4|||
146267390|NCT02165826|527492507|FG001|Main Treatment Period|Lost to Follow-up|2|||
146267391|NCT02165826|527492508|FG002|Main Treatment Period|Lost to Follow-up|1|||
146267392|NCT02165826|527492506|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
146267393|NCT02165826|527492507|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
146267394|NCT02165826|527492508|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
146267395|NCT02165826|527492506|FG000|Main Treatment Period|Lack of Efficacy|2|||
146267396|NCT02165826|527492507|FG001|Main Treatment Period|Lack of Efficacy|0|||
146267397|NCT02165826|527492508|FG002|Main Treatment Period|Lack of Efficacy|0|||
146267398|NCT02165826|527492506|FG000|Main Treatment Period|Reason Not Specified|8|||
146267399|NCT02165826|527492507|FG001|Main Treatment Period|Reason Not Specified|5|||
146267400|NCT02165826|527492508|FG002|Main Treatment Period|Reason Not Specified|16|||
146267401|NCT02165826|527492506|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
146267402|NCT02165826|527492507|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
146267403|NCT02165826|527492508|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
146267404|NCT02165826|527492506|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
146267405|NCT02165826|527492507|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
146267406|NCT02165826|527492508|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
146267407|NCT02165826|527492506|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
146267408|NCT02165826|527492507|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
146267409|NCT02165826|527492508|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
146267410|NCT02165826|527492506|FG000|Down-Titration Period|Reason Not Specified|1|||
146267411|NCT02165826|527492507|FG001|Down-Titration Period|Reason Not Specified|0|||
146267412|NCT02165826|527492508|FG002|Down-Titration Period|Reason Not Specified|2|||
146267413|NCT00250432|527492511|FG000|Overall Study|Adverse Event|25|||
146267414|NCT00250432|527492512|FG001|Overall Study|Adverse Event|29|||
146267415|NCT00250432|527492511|FG000|Overall Study|Lack of Efficacy|2|||
146267416|NCT00250432|527492512|FG001|Overall Study|Lack of Efficacy|1|||
146267417|NCT00250432|527492511|FG000|Overall Study|Lost to Follow-up|6|||
146267418|NCT00250432|527492512|FG001|Overall Study|Lost to Follow-up|5|||
146267419|NCT00250432|527492511|FG000|Overall Study|Patient Moved|0|||
146267420|NCT00250432|527492512|FG001|Overall Study|Patient Moved|1|||
146267421|NCT00250432|527492511|FG000|Overall Study|Protocol Violation|0|||
146267422|NCT00250432|527492512|FG001|Overall Study|Protocol Violation|3|||
146267423|NCT00250432|527492511|FG000|Overall Study|Withdrawal by Subject|6|||
146267424|NCT00250432|527492512|FG001|Overall Study|Withdrawal by Subject|2|||
146267425|NCT00250432|527492511|FG000|Overall Study|Pt died out of posttherapy report period|6|||
146267426|NCT00250432|527492512|FG001|Overall Study|Pt died out of posttherapy report period|5|||
146267427|NCT00250432|527492511|FG000|Overall Study|Pt was considered untreatable|0|||
146267428|NCT00250432|527492512|FG001|Overall Study|Pt was considered untreatable|1|||
146267429|NCT01056263|527492513|FG000|Overall Study|Adverse Event|12|||
146267430|NCT01056263|527492513|FG000|Overall Study|Death|1|||
146267431|NCT01056263|527492513|FG000|Overall Study|Withdrawal by Subject|1|||
146267432|NCT01056263|527492513|FG000|Overall Study|Lack of Efficacy|29|||
146267433|NCT01056263|527492513|FG000|Overall Study|Progressive disease|2|||
146267434|NCT01056263|527492513|FG000|Overall Study|Neoplasm progression|1|||
146267435|NCT01056263|527492513|FG000|Overall Study|Objective progression or relapse|1|||
146267436|NCT01056263|527492513|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
146267437|NCT00658606|527492516|FG000|Overall Study|Adverse Event|2|||
146267438|NCT00658606|527492517|FG001|Overall Study|Adverse Event|1|||
146267439|NCT00658606|527492516|FG000|Overall Study|Lack of Efficacy|6|||
146267440|NCT00658606|527492517|FG001|Overall Study|Lack of Efficacy|3|||
146267441|NCT00658606|527492516|FG000|Overall Study|Lost to Follow-up|1|||
146267442|NCT00658606|527492517|FG001|Overall Study|Lost to Follow-up|0|||
146267443|NCT00658606|527492516|FG000|Overall Study|Withdrawal by Subject|7|||
146267444|NCT00658606|527492517|FG001|Overall Study|Withdrawal by Subject|16|||
146267445|NCT00658606|527492516|FG000|Overall Study|Lack of Compliance|0|||
146267446|NCT00658606|527492517|FG001|Overall Study|Lack of Compliance|3|||
146267447|NCT01068210|527492522|FG000|Overall Study|Lost to Follow-up|1|||
146267448|NCT01068210|527492523|FG001|Overall Study|Lost to Follow-up|2|||
146267449|NCT01068210|527492524|FG002|Overall Study|Lost to Follow-up|2|||
146267450|NCT01068210|527492525|FG003|Overall Study|Lost to Follow-up|1|||
146267451|NCT01068210|527492522|FG000|Overall Study|Second cancer|0|||
146267452|NCT01068210|527492523|FG001|Overall Study|Second cancer|1|||
146267453|NCT01068210|527492524|FG002|Overall Study|Second cancer|0|||
146267454|NCT01068210|527492525|FG003|Overall Study|Second cancer|0|||
146267455|NCT01068210|527492522|FG000|Overall Study|Disease progression|0|||
146267456|NCT01068210|527492523|FG001|Overall Study|Disease progression|0|||
146267457|NCT01068210|527492524|FG002|Overall Study|Disease progression|0|||
146267458|NCT01068210|527492525|FG003|Overall Study|Disease progression|2|||
146267459|NCT00699842|527492526|FG000|Overall Study|Death|0|||
146267460|NCT00699842|527492527|FG001|Overall Study|Death|1|||
146267461|NCT00699842|527492528|FG002|Overall Study|Death|0|||
146267462|NCT01806389|527492531|FG000|Overall Study|Withdrawal by Subject|4|||
146267463|NCT01310699|527492532|FG000|Overall Study|Patients did not complete tandem.|4|||
146136386|NCT02583256|527018287|FG002|Overall Study|Lost to Follow-up|0|||
146136387|NCT02583256|527018288|FG003|Overall Study|Lost to Follow-up|1|||
146136388|NCT02583256|527018285|FG000|Overall Study|Administrative/Other|2|||
146136389|NCT02583256|527018286|FG001|Overall Study|Administrative/Other|0|||
146136390|NCT02583256|527018287|FG002|Overall Study|Administrative/Other|1|||
146136391|NCT02583256|527018288|FG003|Overall Study|Administrative/Other|2|||
146136392|NCT00116558|527018295|FG000|Overall Study|Death|11|||
146136393|NCT00116558|527018296|FG001|Overall Study|Death|5|||
146136394|NCT00116558|527018297|FG002|Overall Study|Death|3|||
146136395|NCT00116558|527018295|FG000|Overall Study|Withdrawal by Subject|17|||
146136396|NCT00116558|527018296|FG001|Overall Study|Withdrawal by Subject|3|||
146136397|NCT00116558|527018297|FG002|Overall Study|Withdrawal by Subject|12|||
146136398|NCT00116558|527018295|FG000|Overall Study|disease progression|3|||
146136399|NCT00116558|527018296|FG001|Overall Study|disease progression|7|||
146136400|NCT00116558|527018297|FG002|Overall Study|disease progression|18|||
146136401|NCT01143090|527018298|FG000|Overall Study|Lack of Efficacy|2|||
146136402|NCT01143090|527018298|FG000|Overall Study|Adverse Event|17|||
146136403|NCT01143090|527018298|FG000|Overall Study|Lost to Follow-up|9|||
146136404|NCT01143090|527018298|FG000|Overall Study|Protocol Violation|2|||
146136405|NCT01143090|527018298|FG000|Overall Study|Withdrawal by Subject|18|||
146136406|NCT01143090|527018298|FG000|Overall Study|Non-compliance with study drug|1|||
146136407|NCT01143090|527018298|FG000|Overall Study|Failure to meet eligibility criteria|1|||
146136408|NCT01143090|527018298|FG000|Overall Study|Administrative|1|||
146136409|NCT03491150|527018299|FG000|Overall Study|Adverse Event|1|||
146136410|NCT03491150|527018300|FG001|Overall Study|Adverse Event|0|||
146136411|NCT03491150|527018299|FG000|Overall Study|Study Terminated by Sponsor|74|||
146136412|NCT03491150|527018300|FG001|Overall Study|Study Terminated by Sponsor|70|||
146136413|NCT03491150|527018299|FG000|Overall Study|Other|0|||
146136414|NCT03491150|527018300|FG001|Overall Study|Other|1|||
146136415|NCT03491150|527018299|FG000|Overall Study|Withdrawal by Subject|1|||
146136416|NCT03491150|527018300|FG001|Overall Study|Withdrawal by Subject|2|||
146136417|NCT00727714|527018304|FG000|Overall Study|Lost to Follow-up|2|||
146136418|NCT00325234|527018307|FG000|Overall Study|Adverse Event|10|||
146136419|NCT00325234|527018308|FG001|Overall Study|Adverse Event|7|||
146136420|NCT00325234|527018307|FG000|Overall Study|Death due to Study Disease|1|||
146136421|NCT00325234|527018308|FG001|Overall Study|Death due to Study Disease|0|||
146136422|NCT00325234|527018307|FG000|Overall Study|Entry Criteria Not Met|1|||
146136423|NCT00325234|527018308|FG001|Overall Study|Entry Criteria Not Met|2|||
146136424|NCT00325234|527018307|FG000|Overall Study|Subject Decision|6|||
146136425|NCT00325234|527018308|FG001|Overall Study|Subject Decision|8|||
146136426|NCT00325234|527018307|FG000|Overall Study|Physician Decision|17|||
146136427|NCT00325234|527018308|FG001|Overall Study|Physician Decision|12|||
146136428|NCT00325234|527018307|FG000|Overall Study|Progressive Disease|34|||
146136429|NCT00325234|527018308|FG001|Overall Study|Progressive Disease|37|||
146136430|NCT02043015|527018309|FG000|Overall Study|Lost to Follow-up|4|||
146136431|NCT02043015|527018309|FG000|Overall Study|Withdrawal by Subject|4|||
146136432|NCT02043015|527018309|FG000|Overall Study|Removed once target enrollment reached|15|||
146136433|NCT02043015|527018309|FG000|Overall Study|Participant moved away from study city|4|||
146136434|NCT02043015|527018309|FG000|Overall Study|Incarceration|1|||
146136435|NCT01403974|527018310|FG000|Overall Study|Progressive disease according to RECIST|3|||
146136436|NCT01403974|527018311|FG001|Overall Study|Progressive disease according to RECIST|3|||
146136437|NCT01403974|527018312|FG002|Overall Study|Progressive disease according to RECIST|2|||
146136438|NCT01403974|527018313|FG003|Overall Study|Progressive disease according to RECIST|3|||
146136439|NCT01403974|527018314|FG004|Overall Study|Progressive disease according to RECIST|3|||
146136440|NCT01403974|527018315|FG005|Overall Study|Progressive disease according to RECIST|2|||
146136441|NCT01403974|527018316|FG006|Overall Study|Progressive disease according to RECIST|3|||
146136442|NCT01403974|527018317|FG007|Overall Study|Progressive disease according to RECIST|2|||
146136443|NCT01403974|527018318|FG008|Overall Study|Progressive disease according to RECIST|6|||
146136444|NCT01403974|527018319|FG009|Overall Study|Progressive disease according to RECIST|2|||
146136445|NCT01403974|527018320|FG010|Overall Study|Progressive disease according to RECIST|3|||
146136446|NCT01403974|527018321|FG011|Overall Study|Progressive disease according to RECIST|2|||
146267464|NCT01310699|527492533|FG001|Overall Study|Patients did not complete tandem.|6|||
146267465|NCT00926575|527492534|FG000|Overall Study|Adverse Event|1|||
146267466|NCT00926575|527492535|FG001|Overall Study|Adverse Event|1|||
146267467|NCT00926575|527492534|FG000|Overall Study|Death|4|||
146267468|NCT00926575|527492535|FG001|Overall Study|Death|4|||
146136447|NCT01403974|527018322|FG012|Overall Study|Progressive disease according to RECIST|2|||
146136448|NCT01403974|527018323|FG013|Overall Study|Progressive disease according to RECIST|3|||
146136449|NCT01403974|527018324|FG014|Overall Study|Progressive disease according to RECIST|1|||
146136450|NCT01403974|527018325|FG015|Overall Study|Progressive disease according to RECIST|8|||
146136451|NCT01403974|527018310|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
146136452|NCT01403974|527018311|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
146136453|NCT01403974|527018312|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
146136454|NCT01403974|527018313|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
146136455|NCT01403974|527018314|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
146267469|NCT00926575|527492534|FG000|Overall Study|Lost to Follow-up|1|||
146267470|NCT00926575|527492535|FG001|Overall Study|Lost to Follow-up|1|||
146267471|NCT00926575|527492534|FG000|Overall Study|Physician Decision|1|||
146267472|NCT00926575|527492535|FG001|Overall Study|Physician Decision|2|||
146267473|NCT00926575|527492534|FG000|Overall Study|Protocol Violation|1|||
146267474|NCT00926575|527492535|FG001|Overall Study|Protocol Violation|0|||
146267475|NCT00926575|527492534|FG000|Overall Study|Withdrawal by Subject|8|||
146267476|NCT00926575|527492535|FG001|Overall Study|Withdrawal by Subject|9|||
146267477|NCT02201901|527492536|FG000|Overall Study|Randomized but never treated|0|||
146267478|NCT02201901|527492537|FG001|Overall Study|Randomized but never treated|1|||
146267479|NCT02201901|527492538|FG002|Overall Study|Randomized but never treated|0|||
146267480|NCT02201901|527492536|FG000|Overall Study|Lack of Efficacy|7|||
146267481|NCT02201901|527492537|FG001|Overall Study|Lack of Efficacy|1|||
146267482|NCT02201901|527492538|FG002|Overall Study|Lack of Efficacy|6|||
146267483|NCT02201901|527492536|FG000|Overall Study|Death|3|||
146267484|NCT02201901|527492537|FG001|Overall Study|Death|3|||
146267485|NCT02201901|527492538|FG002|Overall Study|Death|3|||
146267486|NCT02201901|527492536|FG000|Overall Study|Lost to Follow-up|2|||
146267487|NCT02201901|527492537|FG001|Overall Study|Lost to Follow-up|3|||
146267488|NCT02201901|527492538|FG002|Overall Study|Lost to Follow-up|2|||
146267489|NCT02201901|527492536|FG000|Overall Study|Withdrew Consent|2|||
146267490|NCT02201901|527492537|FG001|Overall Study|Withdrew Consent|0|||
146267491|NCT02201901|527492538|FG002|Overall Study|Withdrew Consent|2|||
146267492|NCT02201901|527492536|FG000|Overall Study|Adverse Event|1|||
146267493|NCT02201901|527492537|FG001|Overall Study|Adverse Event|1|||
146267494|NCT02201901|527492538|FG002|Overall Study|Adverse Event|0|||
146267495|NCT00490698|527492539|FG000|Overall Study|Withdrawal by Subject|1|||
146267496|NCT00490698|527492539|FG000|Overall Study|Disease Progression|7|||
146267497|NCT00490698|527492539|FG000|Overall Study|Physician Decision|2|||
146267498|NCT00738283|527492545|FG000|Overall Study|Death|1|||
146267499|NCT00738283|527492545|FG000|Overall Study|Transfer to another facility|2|||
146267500|NCT00738283|527492545|FG000|Overall Study|Discharge home prior to end of study|1|||
146267501|NCT02559310|527492548|FG000|Overall Study|Death|4|||
146267502|NCT02559310|527492549|FG001|Overall Study|Death|3|||
146267503|NCT02559310|527492548|FG000|Overall Study|Lost to Follow-up|5|||
146267504|NCT02559310|527492549|FG001|Overall Study|Lost to Follow-up|3|||
146267505|NCT02559310|527492548|FG000|Overall Study|Physician Decision|2|||
146267506|NCT02559310|527492549|FG001|Overall Study|Physician Decision|1|||
146267507|NCT02559310|527492548|FG000|Overall Study|Withdrawal by Subject|13|||
146267508|NCT02559310|527492549|FG001|Overall Study|Withdrawal by Subject|9|||
146267509|NCT02559310|527492548|FG000|Overall Study|Sponsor Decision|0|||
146267510|NCT02559310|527492549|FG001|Overall Study|Sponsor Decision|1|||
146267511|NCT02559310|527492548|FG000|Overall Study|Randomized but not treated|3|||
146267512|NCT02559310|527492549|FG001|Overall Study|Randomized but not treated|2|||
146267513|NCT02633397|527492550|FG000|Overall Study|Adverse Event|8|||
146267514|NCT02633397|527492551|FG001|Overall Study|Adverse Event|8|||
146267515|NCT02633397|527492550|FG000|Overall Study|Study Burden|4|||
146267516|NCT02633397|527492551|FG001|Overall Study|Study Burden|1|||
146267517|NCT02633397|527492550|FG000|Overall Study|Treatment interruption|2|||
146267518|NCT02633397|527492551|FG001|Overall Study|Treatment interruption|5|||
146267519|NCT02633397|527492550|FG000|Overall Study|Death|2|||
146267520|NCT02633397|527492551|FG001|Overall Study|Death|2|||
146267521|NCT02633397|527492550|FG000|Overall Study|Physician Decision|0|||
146267522|NCT02633397|527492551|FG001|Overall Study|Physician Decision|1|||
146267523|NCT03595878|527492552|FG000|Overall Study|Death|2|||
146267524|NCT03595878|527492553|FG001|Overall Study|Death|1|||
146267525|NCT03595878|527492554|FG002|Overall Study|Death|0|||
146267526|NCT03595878|527492552|FG000|Overall Study|Disease progression|2|||
146267527|NCT03595878|527492553|FG001|Overall Study|Disease progression|1|||
146267528|NCT03595878|527492554|FG002|Overall Study|Disease progression|2|||
146267529|NCT00469859|527492555|FG000|Overall Study|Inevaluable|0|||
146267530|NCT00469859|527492556|FG001|Overall Study|Inevaluable|2|||
146267531|NCT03494985|527492557|FG000|Overall Study|Adverse Event|3|||
146267532|NCT03494985|527492558|FG001|Overall Study|Adverse Event|2|||
146267533|NCT03494985|527492559|FG002|Overall Study|Adverse Event|3|||
146267534|NCT03494985|527492560|FG003|Overall Study|Adverse Event|0|||
146267535|NCT03494985|527492557|FG000|Overall Study|Other (Withdrawal of consent)|2|||
146267536|NCT03494985|527492558|FG001|Overall Study|Other (Withdrawal of consent)|3|||
146267537|NCT03494985|527492559|FG002|Overall Study|Other (Withdrawal of consent)|2|||
146267538|NCT03494985|527492560|FG003|Overall Study|Other (Withdrawal of consent)|5|||
146267539|NCT03494985|527492557|FG000|Overall Study|Other (Not specified)|0|||
146267540|NCT03494985|527492558|FG001|Overall Study|Other (Not specified)|1|||
146267541|NCT03494985|527492559|FG002|Overall Study|Other (Not specified)|1|||
146267542|NCT03494985|527492560|FG003|Overall Study|Other (Not specified)|0|||
146267543|NCT04124471|527492561|FG000|Overall Study|screen failure|1|||
146267544|NCT03036124|527492562|FG000|Overall Study|Lost to Follow-up|0|||
146267545|NCT03036124|527492563|FG001|Overall Study|Lost to Follow-up|2|||
146267546|NCT03036124|527492562|FG000|Overall Study|Withdrawal by Subject|5|||
146267547|NCT03036124|527492563|FG001|Overall Study|Withdrawal by Subject|4|||
146267548|NCT02394925|527492564|FG000|Overall Study|Adverse Event|1|||
146136456|NCT01403974|527018315|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
146136457|NCT01403974|527018316|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
146136458|NCT01403974|527018317|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
146267549|NCT02394925|527492564|FG000|Overall Study|Lens Discomfort|3|||
146267550|NCT02394925|527492564|FG000|Overall Study|Lens handling difficulities|5|||
146267551|NCT02394925|527492564|FG000|Overall Study|Lost to Follow-up|9|||
146267552|NCT02394925|527492564|FG000|Overall Study|Protocol Violation|5|||
146267553|NCT02394925|527492564|FG000|Overall Study|No longer meet eligibility criteria|1|||
146267554|NCT02394925|527492564|FG000|Overall Study|Unsatisfactory Visual Response|5|||
146267555|NCT02737826|527494833|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
146267556|NCT02737826|527494834|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
146267557|NCT02737826|527494835|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
146267558|NCT00078377|527494836|FG000|Overall Study|Adverse Event|2|||
146267559|NCT00078377|527494837|FG001|Overall Study|Adverse Event|5|||
146267560|NCT00078377|527494838|FG002|Overall Study|Adverse Event|1|||
146267561|NCT00078377|527494836|FG000|Overall Study|Lack of Efficacy|2|||
146267562|NCT00078377|527494837|FG001|Overall Study|Lack of Efficacy|0|||
146267563|NCT00078377|527494838|FG002|Overall Study|Lack of Efficacy|2|||
146267564|NCT00078377|527494836|FG000|Overall Study|Lost to Follow-up|0|||
146267565|NCT00078377|527494837|FG001|Overall Study|Lost to Follow-up|1|||
146267566|NCT00078377|527494838|FG002|Overall Study|Lost to Follow-up|1|||
146267567|NCT00078377|527494836|FG000|Overall Study|Physician Decision|2|||
146267568|NCT00078377|527494837|FG001|Overall Study|Physician Decision|0|||
146267569|NCT00078377|527494838|FG002|Overall Study|Physician Decision|0|||
146267570|NCT00078377|527494836|FG000|Overall Study|Withdrawal by Subject|3|||
146267571|NCT00078377|527494837|FG001|Overall Study|Withdrawal by Subject|4|||
146267572|NCT00078377|527494838|FG002|Overall Study|Withdrawal by Subject|4|||
146267573|NCT00078377|527494836|FG000|Overall Study|Miscellaneous|2|||
146267574|NCT00078377|527494837|FG001|Overall Study|Miscellaneous|6|||
146267575|NCT00078377|527494838|FG002|Overall Study|Miscellaneous|1|||
146267576|NCT04546217|527494839|FG000|Overall Study|Withdrawal by Subject|2|||
146267577|NCT04546217|527494840|FG001|Overall Study|Withdrawal by Subject|0|||
146267578|NCT04546217|527494839|FG000|Overall Study|Uncontrolled hypertension|1|||
146267579|NCT04546217|527494840|FG001|Overall Study|Uncontrolled hypertension|0|||
146267580|NCT00863512|527494841|FG000|Overall Study|Adverse Event|2|||
146267581|NCT00863512|527494842|FG001|Overall Study|Adverse Event|0|||
146267582|NCT00863512|527494841|FG000|Overall Study|Withdrawal by Subject|11|||
146267583|NCT00863512|527494842|FG001|Overall Study|Withdrawal by Subject|0|||
146267584|NCT00863512|527494841|FG000|Overall Study|Physician Decision|1|||
146267585|NCT00863512|527494842|FG001|Overall Study|Physician Decision|0|||
146267586|NCT04292470|527494847|FG000|Overall Study|Withdrawal by Subject|0|||
146267587|NCT04292470|527494848|FG001|Overall Study|Withdrawal by Subject|1|||
146267588|NCT04829747|527494867|FG000|Overall Study|Protocol Violation|1|||
146267589|NCT00079339|527494873|FG000|Overall Study|Adverse Event|1|||
146267590|NCT00079339|527494874|FG001|Overall Study|Adverse Event|7|||
146267591|NCT00079339|527494875|FG002|Overall Study|Adverse Event|2|||
146267592|NCT00079339|527494873|FG000|Overall Study|Death|1|||
146267593|NCT00079339|527494874|FG001|Overall Study|Death|0|||
146267594|NCT00079339|527494875|FG002|Overall Study|Death|0|||
146267595|NCT00079339|527494873|FG000|Overall Study|Non-compliance|0|||
146267596|NCT00079339|527494874|FG001|Overall Study|Non-compliance|0|||
146267597|NCT00079339|527494875|FG002|Overall Study|Non-compliance|1|||
146267598|NCT00079339|527494873|FG000|Overall Study|Withdrawal by Subject|0|||
146267599|NCT00079339|527494874|FG001|Overall Study|Withdrawal by Subject|4|||
146267600|NCT00079339|527494875|FG002|Overall Study|Withdrawal by Subject|1|||
146267601|NCT00079339|527494873|FG000|Overall Study|Disease progression|3|||
146136459|NCT01403974|527018318|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
146267602|NCT00079339|527494874|FG001|Overall Study|Disease progression|28|||
146267603|NCT00079339|527494875|FG002|Overall Study|Disease progression|2|||
146267604|NCT01547598|527494876|FG000|Overall Study|Withdrew consent|1|||
146267605|NCT01547598|527494877|FG001|Overall Study|Withdrew consent|1|||
146267606|NCT01547598|527494876|FG000|Overall Study|Lost to Follow-up|1|||
146267607|NCT01547598|527494877|FG001|Overall Study|Lost to Follow-up|1|||
146267608|NCT01547598|527494876|FG000|Overall Study|Adverse Event|1|||
146267609|NCT01547598|527494877|FG001|Overall Study|Adverse Event|1|||
146267610|NCT01547598|527494876|FG000|Overall Study|Protocol Violation|1|||
146136460|NCT01403974|527018319|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
146267611|NCT01547598|527494877|FG001|Overall Study|Protocol Violation|1|||
146267612|NCT01547598|527494876|FG000|Overall Study|Other Miscellaneous Reasons|2|||
146267613|NCT01547598|527494877|FG001|Overall Study|Other Miscellaneous Reasons|1|||
146267614|NCT00340704|527494881|FG000|PK Study|Adverse Event|0|||
146267615|NCT00340704|527494882|FG001|PK Study|Adverse Event|1|||
146267616|NCT00340704|527494883|FG002|PK Study|Adverse Event|0|||
146267617|NCT00340704|527494884|FG003|PK Study|Adverse Event|0|||
146267618|NCT00340704|527494885|FG004|PK Study|Adverse Event|0|||
146136461|NCT01403974|527018320|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
146267619|NCT00340704|527494886|FG005|PK Study|Adverse Event|0|||
146267620|NCT00340704|527494887|FG006|PK Study|Adverse Event|0|||
146267621|NCT00340704|527494888|FG007|PK Study|Adverse Event|0|||
146136462|NCT01403974|527018321|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
146136463|NCT01403974|527018322|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
146136464|NCT01403974|527018323|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
146136465|NCT01403974|527018324|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
146136466|NCT01403974|527018325|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
146136467|NCT01403974|527018310|FG000|Overall Study|Refused to continue study medication|0|||
146136468|NCT01403974|527018311|FG001|Overall Study|Refused to continue study medication|0|||
146136469|NCT01403974|527018312|FG002|Overall Study|Refused to continue study medication|0|||
146136470|NCT01403974|527018313|FG003|Overall Study|Refused to continue study medication|0|||
146136471|NCT01403974|527018314|FG004|Overall Study|Refused to continue study medication|0|||
146136472|NCT01403974|527018315|FG005|Overall Study|Refused to continue study medication|1|||
146136473|NCT01403974|527018316|FG006|Overall Study|Refused to continue study medication|0|||
146136474|NCT01403974|527018317|FG007|Overall Study|Refused to continue study medication|0|||
146136475|NCT01403974|527018318|FG008|Overall Study|Refused to continue study medication|1|||
146136476|NCT01403974|527018319|FG009|Overall Study|Refused to continue study medication|0|||
146136477|NCT01403974|527018320|FG010|Overall Study|Refused to continue study medication|1|||
146136478|NCT01403974|527018321|FG011|Overall Study|Refused to continue study medication|0|||
146136479|NCT01403974|527018322|FG012|Overall Study|Refused to continue study medication|0|||
146136480|NCT01403974|527018323|FG013|Overall Study|Refused to continue study medication|0|||
146136481|NCT01403974|527018324|FG014|Overall Study|Refused to continue study medication|0|||
146136482|NCT01403974|527018325|FG015|Overall Study|Refused to continue study medication|4|||
146136483|NCT01403974|527018310|FG000|Overall Study|Adverse Event|0|||
146136484|NCT01403974|527018311|FG001|Overall Study|Adverse Event|0|||
146136485|NCT01403974|527018312|FG002|Overall Study|Adverse Event|1|||
146136486|NCT01403974|527018313|FG003|Overall Study|Adverse Event|0|||
146136487|NCT01403974|527018314|FG004|Overall Study|Adverse Event|0|||
146136488|NCT01403974|527018315|FG005|Overall Study|Adverse Event|0|||
146136489|NCT01403974|527018316|FG006|Overall Study|Adverse Event|0|||
146136490|NCT01403974|527018317|FG007|Overall Study|Adverse Event|1|||
146136491|NCT01403974|527018318|FG008|Overall Study|Adverse Event|0|||
146136492|NCT01403974|527018319|FG009|Overall Study|Adverse Event|0|||
146136493|NCT01403974|527018320|FG010|Overall Study|Adverse Event|0|||
146136494|NCT01403974|527018321|FG011|Overall Study|Adverse Event|0|||
146136495|NCT01403974|527018322|FG012|Overall Study|Adverse Event|1|||
146136496|NCT01403974|527018323|FG013|Overall Study|Adverse Event|0|||
146136497|NCT01403974|527018324|FG014|Overall Study|Adverse Event|0|||
146136498|NCT01403974|527018325|FG015|Overall Study|Adverse Event|0|||
146136499|NCT01403974|527018310|FG000|Overall Study|Other than specified|0|||
146136500|NCT01403974|527018311|FG001|Overall Study|Other than specified|0|||
146136501|NCT01403974|527018312|FG002|Overall Study|Other than specified|0|||
146136502|NCT01403974|527018313|FG003|Overall Study|Other than specified|0|||
146136503|NCT01403974|527018314|FG004|Overall Study|Other than specified|0|||
146136504|NCT01403974|527018315|FG005|Overall Study|Other than specified|0|||
146136505|NCT01403974|527018316|FG006|Overall Study|Other than specified|0|||
146136506|NCT01403974|527018317|FG007|Overall Study|Other than specified|0|||
146136507|NCT01403974|527018318|FG008|Overall Study|Other than specified|0|||
146136508|NCT01403974|527018319|FG009|Overall Study|Other than specified|1|||
146136509|NCT01403974|527018320|FG010|Overall Study|Other than specified|0|||
146136510|NCT01403974|527018321|FG011|Overall Study|Other than specified|1|||
146136511|NCT01403974|527018322|FG012|Overall Study|Other than specified|0|||
146136512|NCT01403974|527018323|FG013|Overall Study|Other than specified|0|||
146136513|NCT01403974|527018324|FG014|Overall Study|Other than specified|0|||
146136514|NCT01403974|527018325|FG015|Overall Study|Other than specified|0|||
146136515|NCT01494610|527018328|FG000|Period 1|Withdrawal by Subject|1|||
146136516|NCT01494610|527018329|FG001|Period 1|Withdrawal by Subject|1|||
146136517|NCT01494610|527018328|FG000|Period 3|Adverse Event|1|||
146136518|NCT01494610|527018329|FG001|Period 3|Adverse Event|0|||
146136519|NCT01494610|527018328|FG000|Period 3|Withdrawal by Subject|1|||
146136520|NCT01494610|527018329|FG001|Period 3|Withdrawal by Subject|0|||
146136521|NCT01494610|527018328|FG000|Period 4|Protocol Violation|1|||
146136522|NCT01494610|527018329|FG001|Period 4|Protocol Violation|0|||
146136523|NCT03995953|527018332|FG000|Overall Study|Death|3|||
146136524|NCT03995953|527018333|FG001|Overall Study|Death|0|||
146136525|NCT03995953|527018334|FG002|Overall Study|Death|3|||
146267622|NCT00340704|527494889|FG008|PK Study|Adverse Event|0|||
146267623|NCT00340704|527494881|FG000|PK Study|Not treated|0|||
146267624|NCT00340704|527494882|FG001|PK Study|Not treated|0|||
146267625|NCT00340704|527494883|FG002|PK Study|Not treated|1|||
146267626|NCT00340704|527494884|FG003|PK Study|Not treated|0|||
146267627|NCT00340704|527494885|FG004|PK Study|Not treated|0|||
146267628|NCT00340704|527494886|FG005|PK Study|Not treated|0|||
146267629|NCT00340704|527494887|FG006|PK Study|Not treated|0|||
146267630|NCT00340704|527494888|FG007|PK Study|Not treated|0|||
146267631|NCT00340704|527494889|FG008|PK Study|Not treated|0|||
146267632|NCT00340704|527494881|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146267633|NCT00340704|527494882|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146136526|NCT03995953|527018335|FG003|Overall Study|Death|0|||
146136527|NCT03995953|527018336|FG004|Overall Study|Death|3|||
146136528|NCT03995953|527018337|FG005|Overall Study|Death|0|||
146136529|NCT03995953|527018338|FG006|Overall Study|Death|0|||
146136530|NCT03995953|527018339|FG007|Overall Study|Death|0|||
146136531|NCT03995953|527018340|FG008|Overall Study|Death|1|||
146136532|NCT03995953|527018341|FG009|Overall Study|Death|0|||
146136533|NCT03995953|527018342|FG010|Overall Study|Death|0|||
146136534|NCT03995953|527018343|FG011|Overall Study|Death|0|||
146136535|NCT03995953|527018332|FG000|Overall Study|Lost to Follow-up|6|||
146136536|NCT03995953|527018333|FG001|Overall Study|Lost to Follow-up|54|||
146136537|NCT03995953|527018334|FG002|Overall Study|Lost to Follow-up|3|||
146136538|NCT03995953|527018335|FG003|Overall Study|Lost to Follow-up|32|||
146136539|NCT03995953|527018336|FG004|Overall Study|Lost to Follow-up|5|||
146136540|NCT03995953|527018337|FG005|Overall Study|Lost to Follow-up|44|||
146136541|NCT03995953|527018338|FG006|Overall Study|Lost to Follow-up|0|||
146136542|NCT03995953|527018339|FG007|Overall Study|Lost to Follow-up|31|||
146136543|NCT03995953|527018340|FG008|Overall Study|Lost to Follow-up|8|||
146136544|NCT03995953|527018341|FG009|Overall Study|Lost to Follow-up|36|||
146136545|NCT03995953|527018342|FG010|Overall Study|Lost to Follow-up|5|||
146136546|NCT03995953|527018343|FG011|Overall Study|Lost to Follow-up|41|||
146136547|NCT03995953|527018332|FG000|Overall Study|Withdrawal by Subject|4|||
146136548|NCT03995953|527018333|FG001|Overall Study|Withdrawal by Subject|0|||
146136549|NCT03995953|527018334|FG002|Overall Study|Withdrawal by Subject|1|||
146136550|NCT03995953|527018335|FG003|Overall Study|Withdrawal by Subject|0|||
146136551|NCT03995953|527018336|FG004|Overall Study|Withdrawal by Subject|1|||
146136552|NCT03995953|527018337|FG005|Overall Study|Withdrawal by Subject|0|||
146136553|NCT03995953|527018338|FG006|Overall Study|Withdrawal by Subject|1|||
146136554|NCT03995953|527018339|FG007|Overall Study|Withdrawal by Subject|0|||
146136555|NCT03995953|527018340|FG008|Overall Study|Withdrawal by Subject|3|||
146136556|NCT03995953|527018341|FG009|Overall Study|Withdrawal by Subject|0|||
146136557|NCT03995953|527018342|FG010|Overall Study|Withdrawal by Subject|3|||
146136558|NCT03995953|527018343|FG011|Overall Study|Withdrawal by Subject|0|||
146136559|NCT03995953|527018332|FG000|Overall Study|Health Issues|0|||
146136560|NCT03995953|527018333|FG001|Overall Study|Health Issues|0|||
146136561|NCT03995953|527018334|FG002|Overall Study|Health Issues|0|||
146136562|NCT03995953|527018335|FG003|Overall Study|Health Issues|0|||
146136563|NCT03995953|527018336|FG004|Overall Study|Health Issues|1|||
146136564|NCT03995953|527018337|FG005|Overall Study|Health Issues|0|||
146136565|NCT03995953|527018338|FG006|Overall Study|Health Issues|0|||
146136566|NCT03995953|527018339|FG007|Overall Study|Health Issues|0|||
146136567|NCT03995953|527018340|FG008|Overall Study|Health Issues|4|||
146136568|NCT03995953|527018341|FG009|Overall Study|Health Issues|0|||
146136569|NCT03995953|527018342|FG010|Overall Study|Health Issues|0|||
146136570|NCT03995953|527018343|FG011|Overall Study|Health Issues|0|||
146136571|NCT03995953|527018332|FG000|Overall Study|Relocated|11|||
146136572|NCT03995953|527018333|FG001|Overall Study|Relocated|0|||
146136573|NCT03995953|527018334|FG002|Overall Study|Relocated|16|||
146136574|NCT03995953|527018335|FG003|Overall Study|Relocated|0|||
146136575|NCT03995953|527018336|FG004|Overall Study|Relocated|14|||
146136576|NCT03995953|527018337|FG005|Overall Study|Relocated|0|||
146136577|NCT03995953|527018338|FG006|Overall Study|Relocated|16|||
146136578|NCT03995953|527018339|FG007|Overall Study|Relocated|0|||
146136579|NCT03995953|527018340|FG008|Overall Study|Relocated|14|||
146136580|NCT03995953|527018341|FG009|Overall Study|Relocated|0|||
146136581|NCT03995953|527018342|FG010|Overall Study|Relocated|15|||
146136582|NCT03995953|527018343|FG011|Overall Study|Relocated|0|||
146136583|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
146136584|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
146136585|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
146267634|NCT00340704|527494883|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146267635|NCT00340704|527494884|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
146267636|NCT00340704|527494885|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
146267637|NCT00340704|527494886|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146267638|NCT00340704|527494887|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
146136586|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
146136587|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
146136588|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
146136589|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
146136590|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
146136591|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
146136592|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
146136593|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
146136594|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
146136595|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
146136596|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
146136597|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
146136598|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
146267639|NCT00340704|527494888|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
146267640|NCT00340704|527494889|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
146267641|NCT00340704|527494881|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267642|NCT00340704|527494882|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267643|NCT00340704|527494883|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267644|NCT00340704|527494884|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267645|NCT00340704|527494885|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267646|NCT00340704|527494886|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
146267647|NCT00340704|527494887|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267648|NCT00340704|527494888|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267649|NCT00340704|527494889|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
146267650|NCT00340704|527494881|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267651|NCT00340704|527494882|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267652|NCT00340704|527494883|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267653|NCT00340704|527494884|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267654|NCT00340704|527494885|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
146267655|NCT00340704|527494886|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
146267656|NCT00340704|527494887|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267657|NCT00340704|527494888|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267658|NCT00340704|527494889|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
146267659|NCT00340704|527494881|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146267660|NCT00340704|527494882|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146267661|NCT00340704|527494883|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146267662|NCT00340704|527494884|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146267663|NCT00340704|527494885|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
146267664|NCT00340704|527494886|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
146267665|NCT00340704|527494887|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
146267666|NCT00340704|527494888|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
146267667|NCT00340704|527494889|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
146267668|NCT00121667|527494890|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
146267669|NCT00121667|527494891|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
146267670|NCT00121667|527494892|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
146267671|NCT00121667|527494893|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
146267672|NCT00121667|527494890|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
146267673|NCT00121667|527494891|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
146267674|NCT00121667|527494892|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
146267675|NCT00121667|527494893|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
146267676|NCT00121667|527494890|FG000|Short Term (ST) Period|Adverse Event|5|||
146267677|NCT00121667|527494891|FG001|Short Term (ST) Period|Adverse Event|6|||
146267678|NCT00121667|527494892|FG002|Short Term (ST) Period|Adverse Event|5|||
146267679|NCT00121667|527494893|FG003|Short Term (ST) Period|Adverse Event|3|||
146267680|NCT00121667|527494890|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
146267681|NCT00121667|527494891|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
146267682|NCT00121667|527494892|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
146267683|NCT00121667|527494893|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
146267684|NCT00121667|527494890|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
146267685|NCT00121667|527494891|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
146267686|NCT00121667|527494892|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
146267687|NCT00121667|527494893|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
146267688|NCT00121667|527494890|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
146267689|NCT00121667|527494891|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
146267690|NCT00121667|527494892|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
146267691|NCT00121667|527494893|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
146267692|NCT00121667|527494890|FG000|Short Term (ST) Period|Other Reason|3|||
146267693|NCT00121667|527494891|FG001|Short Term (ST) Period|Other Reason|0|||
146267694|NCT00121667|527494892|FG002|Short Term (ST) Period|Other Reason|0|||
146267695|NCT00121667|527494893|FG003|Short Term (ST) Period|Other Reason|0|||
146267696|NCT00121667|527494890|FG000|Short Term (ST) Period|Death|0|||
146267697|NCT00121667|527494891|FG001|Short Term (ST) Period|Death|0|||
146267698|NCT00121667|527494892|FG002|Short Term (ST) Period|Death|0|||
146267699|NCT00121667|527494893|FG003|Short Term (ST) Period|Death|1|||
146267700|NCT00121667|527494890|FG000|Short Term (ST) Period|Pregnancy|0|||
146304027|NCT03250832|527627481|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
146304028|NCT03250832|527627482|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146267701|NCT00121667|527494891|FG001|Short Term (ST) Period|Pregnancy|0|||
146267702|NCT00121667|527494892|FG002|Short Term (ST) Period|Pregnancy|0|||
146267703|NCT00121667|527494893|FG003|Short Term (ST) Period|Pregnancy|1|||
146136599|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
146136600|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
146136601|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
146136602|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
146136603|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
146136604|NCT02161718|527018346|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
146136605|NCT02161718|527018347|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
146136606|NCT02161718|527018348|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
146136607|NCT02161718|527018346|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
146136608|NCT02161718|527018347|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
146136609|NCT02161718|527018348|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
146136610|NCT02161718|527018346|FG000|Post- Randomization Period|Lost to Follow-up|0|||
146136611|NCT02161718|527018347|FG001|Post- Randomization Period|Lost to Follow-up|9|||
146136612|NCT02161718|527018348|FG002|Post- Randomization Period|Lost to Follow-up|15|||
146136613|NCT02161718|527018346|FG000|Post- Randomization Period|Adverse Event|0|||
146136614|NCT02161718|527018347|FG001|Post- Randomization Period|Adverse Event|9|||
146136615|NCT02161718|527018348|FG002|Post- Randomization Period|Adverse Event|10|||
146136616|NCT02161718|527018346|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
146136617|NCT02161718|527018347|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
146136618|NCT02161718|527018348|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
146136619|NCT02161718|527018346|FG000|Post- Randomization Period|Physician Decision|0|||
146136620|NCT02161718|527018347|FG001|Post- Randomization Period|Physician Decision|2|||
146136621|NCT02161718|527018348|FG002|Post- Randomization Period|Physician Decision|4|||
146136622|NCT02161718|527018346|FG000|Post- Randomization Period|Protocol Violation|0|||
146136623|NCT02161718|527018347|FG001|Post- Randomization Period|Protocol Violation|2|||
146136624|NCT02161718|527018348|FG002|Post- Randomization Period|Protocol Violation|3|||
146136625|NCT02161718|527018346|FG000|Post- Randomization Period|Lack of Efficacy|0|||
146136626|NCT02161718|527018347|FG001|Post- Randomization Period|Lack of Efficacy|0|||
146136627|NCT02161718|527018348|FG002|Post- Randomization Period|Lack of Efficacy|1|||
146136628|NCT02161718|527018346|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
146136629|NCT02161718|527018347|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
146136630|NCT02161718|527018348|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
146136631|NCT02161718|527018346|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
146136632|NCT02161718|527018347|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
146136633|NCT02161718|527018348|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
146136634|NCT02161718|527018346|FG000|Post- Randomization Period|Relocation|0|||
146136635|NCT02161718|527018347|FG001|Post- Randomization Period|Relocation|3|||
146136636|NCT02161718|527018348|FG002|Post- Randomization Period|Relocation|0|||
146136637|NCT02350309|527018353|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
146136638|NCT02350309|527018354|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
146136639|NCT02350309|527018355|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
146136640|NCT02350309|527018356|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
146136641|NCT02350309|527018357|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
146136642|NCT02350309|527018358|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
146136643|NCT02350309|527018353|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
146136644|NCT02350309|527018354|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
146136645|NCT02350309|527018355|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
146136646|NCT02350309|527018356|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
146136647|NCT02350309|527018357|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
146136648|NCT02350309|527018358|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
146136649|NCT01256710|527018359|FG000|Overall Study|Death|449|||
146136650|NCT01256710|527018359|FG000|Overall Study|System Explant|67|||
146267704|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
146267705|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
146267706|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
146267707|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
146267708|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
146267709|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
146267710|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
146267711|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
146267712|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
146267713|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
146267714|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
146267715|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
146267716|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
146267717|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
146267718|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
146267719|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
146267720|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
146267721|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
146267722|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
146267723|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
146267724|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
146267725|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
146267726|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
146267727|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
146267728|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
146267729|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
146267730|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
146267731|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
146267732|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146267733|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146267734|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
146267735|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
146267736|NCT00121667|527494890|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
146267737|NCT00121667|527494891|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
146267738|NCT00121667|527494892|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
146267739|NCT00121667|527494893|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
146267740|NCT02879383|527494894|FG000|First 24 Weeks|Physician Decision|0|||
146267741|NCT02879383|527494895|FG001|First 24 Weeks|Physician Decision|1|||
146267742|NCT02879383|527494896|FG002|First 24 Weeks|Physician Decision|0|||
146267743|NCT02879383|527494897|FG003|First 24 Weeks|Physician Decision|0|||
146267744|NCT05186311|527494898|FG000|Part A: Serum|Withdrawal by Subject|1|||
146267745|NCT02125279|527494899|FG000|Overall Study|Lack of Efficacy|2|||
146267746|NCT02125279|527494899|FG000|Overall Study|Withdrawal by Subject|6|||
146267747|NCT02125279|527494899|FG000|Overall Study|Protocol Violation|1|||
146267748|NCT02125279|527494899|FG000|Overall Study|Lost to Follow-up|4|||
146267749|NCT01607879|527494904|FG000|Overall Study|Death|1|||
146267750|NCT01607879|527494905|FG001|Overall Study|Death|0|||
146267751|NCT03845140|527494909|FG000|Overall Study|Participant travelled outside study area|0|||
146267752|NCT03845140|527494910|FG001|Overall Study|Participant travelled outside study area|1|||
146136651|NCT01256710|527018359|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
146136652|NCT01256710|527018359|FG000|Overall Study|Lost to Follow-up|67|||
146136653|NCT01256710|527018359|FG000|Overall Study|Withdrawal by Subject|29|||
146136654|NCT01256710|527018359|FG000|Overall Study|Physician Decision|9|||
146136655|NCT01256710|527018359|FG000|Overall Study|Subject Noncompliance|2|||
146136656|NCT01256710|527018359|FG000|Overall Study|Study Terminated by Sponsor|273|||
146136657|NCT01205165|527018361|FG000|Overall Study|Lost to Follow-up|2|||
146136658|NCT02681302|527018364|FG000|Overall Study|Withdrawal by Subject|1|||
146136659|NCT02681302|527018365|FG001|Overall Study|Withdrawal by Subject|1|||
146136660|NCT02681302|527018366|FG002|Overall Study|Withdrawal by Subject|0|||
146136661|NCT02681302|527018367|FG003|Overall Study|Withdrawal by Subject|0|||
146136662|NCT02681302|527018368|FG004|Overall Study|Withdrawal by Subject|1|||
146136663|NCT02681302|527018369|FG005|Overall Study|Withdrawal by Subject|0|||
146136664|NCT02681302|527018364|FG000|Overall Study|Screen Failure|2|||
146136665|NCT02681302|527018365|FG001|Overall Study|Screen Failure|4|||
146136666|NCT02681302|527018366|FG002|Overall Study|Screen Failure|2|||
146136667|NCT02681302|527018367|FG003|Overall Study|Screen Failure|0|||
146136668|NCT02681302|527018368|FG004|Overall Study|Screen Failure|1|||
146136669|NCT02681302|527018369|FG005|Overall Study|Screen Failure|1|||
146136670|NCT02681302|527018364|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146136671|NCT02681302|527018365|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146136672|NCT02681302|527018366|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146136673|NCT02681302|527018367|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146136674|NCT02681302|527018368|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
146136675|NCT02681302|527018369|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
146136676|NCT02942017|527018370|FG000|Overall Study|Adverse Event|0|||
146136677|NCT02942017|527018371|FG001|Overall Study|Adverse Event|1|||
146136678|NCT02942017|527018370|FG000|Overall Study|Withdrawal by Subject|0|||
146267753|NCT03845140|527494911|FG002|Overall Study|Participant travelled outside study area|0|||
146136679|NCT02942017|527018371|FG001|Overall Study|Withdrawal by Subject|1|||
146136680|NCT02942017|527018370|FG000|Overall Study|Lost to Follow-up|1|||
146136681|NCT02942017|527018371|FG001|Overall Study|Lost to Follow-up|1|||
146136682|NCT02942017|527018370|FG000|Overall Study|Randomized but not dosed|1|||
146136683|NCT02942017|527018371|FG001|Overall Study|Randomized but not dosed|3|||
146267754|NCT03845140|527494912|FG003|Overall Study|Participant travelled outside study area|0|||
146267755|NCT03845140|527494913|FG004|Overall Study|Participant travelled outside study area|0|||
146267756|NCT03845140|527494914|FG005|Overall Study|Participant travelled outside study area|0|||
146267757|NCT01592045|527494922|FG000|Overall Study|Disease Progression|1|||
146136684|NCT04399161|527018372|FG000|Overall Study|Withdrawal by Subject|1|||
146136685|NCT04399161|527018373|FG001|Overall Study|Withdrawal by Subject|0|||
146136686|NCT04399161|527018374|FG002|Overall Study|Withdrawal by Subject|2|||
146136687|NCT04399161|527018372|FG000|Overall Study|Protocol Violation|1|||
146136688|NCT04399161|527018373|FG001|Overall Study|Protocol Violation|2|||
146136689|NCT04399161|527018374|FG002|Overall Study|Protocol Violation|0|||
146136690|NCT03417141|527018375|FG000|Overall Study|Withdrawal by Subject|1|||
146136691|NCT03417141|527018375|FG000|Overall Study|Protocol Violation|3|||
146136692|NCT01736696|527018376|FG000|Overall Study|Withdrawal by Subject|0|||
146136693|NCT01736696|527018377|FG001|Overall Study|Withdrawal by Subject|0|||
146136694|NCT01736696|527018378|FG002|Overall Study|Withdrawal by Subject|1|||
146136695|NCT01736696|527018379|FG003|Overall Study|Withdrawal by Subject|0|||
146136696|NCT01736696|527018380|FG004|Overall Study|Withdrawal by Subject|0|||
146136697|NCT01736696|527018381|FG005|Overall Study|Withdrawal by Subject|0|||
146136698|NCT01736696|527018382|FG006|Overall Study|Withdrawal by Subject|0|||
146136699|NCT00838565|527018383|FG000|Overall Study|Withdrawal by Subject|0|||
146267758|NCT01592045|527494923|FG001|Overall Study|Disease Progression|1|||
146267759|NCT01592045|527494922|FG000|Overall Study|Adverse Event|1|||
146267760|NCT01592045|527494923|FG001|Overall Study|Adverse Event|1|||
146267761|NCT01592045|527494922|FG000|Overall Study|Withdrawal by Subject|1|||
146267762|NCT01592045|527494923|FG001|Overall Study|Withdrawal by Subject|0|||
146267763|NCT01592045|527494922|FG000|Overall Study|Moved out of country|2|||
146267764|NCT01592045|527494923|FG001|Overall Study|Moved out of country|0|||
146267765|NCT02599688|527494938|FG000|Overall Study|Lack of Efficacy|1|||
146267766|NCT02599688|527494938|FG000|Overall Study|Withdrawal by Subject|1|||
146267767|NCT02599688|527494938|FG000|Overall Study|Termination by Sponsor|2|||
146267768|NCT00742326|527494939|FG000|Overall Study|Physician Decision|0|||
146267769|NCT00742326|527494940|FG001|Overall Study|Physician Decision|1|||
146267770|NCT03635086|527494949|FG000|Overall Study|Withdrawal of consent|0|||
146267771|NCT03635086|527494950|FG001|Overall Study|Withdrawal of consent|0|||
146267772|NCT03635086|527494951|FG002|Overall Study|Withdrawal of consent|1|||
146267773|NCT03635086|527494952|FG003|Overall Study|Withdrawal of consent|0|||
146267774|NCT03635086|527494953|FG004|Overall Study|Withdrawal of consent|0|||
146267775|NCT03635086|527494949|FG000|Overall Study|Adverse Event|0|||
146267776|NCT03635086|527494950|FG001|Overall Study|Adverse Event|1|||
146267777|NCT03635086|527494951|FG002|Overall Study|Adverse Event|0|||
146267778|NCT03635086|527494952|FG003|Overall Study|Adverse Event|0|||
146267779|NCT03635086|527494953|FG004|Overall Study|Adverse Event|0|||
146267780|NCT03635086|527494949|FG000|Overall Study|Lost to Follow-up|1|||
146267781|NCT03635086|527494950|FG001|Overall Study|Lost to Follow-up|0|||
146267782|NCT03635086|527494951|FG002|Overall Study|Lost to Follow-up|0|||
146267783|NCT03635086|527494952|FG003|Overall Study|Lost to Follow-up|0|||
146136700|NCT00838565|527018384|FG001|Overall Study|Withdrawal by Subject|0|||
146136701|NCT00838565|527018385|FG002|Overall Study|Withdrawal by Subject|1|||
146136702|NCT00838565|527018386|FG003|Overall Study|Withdrawal by Subject|0|||
146136703|NCT00838565|527018387|FG004|Overall Study|Withdrawal by Subject|0|||
146136704|NCT00838565|527018388|FG005|Overall Study|Withdrawal by Subject|2|||
146136705|NCT00838565|527018383|FG000|Overall Study|Other|0|||
146136706|NCT00838565|527018384|FG001|Overall Study|Other|2|||
146136707|NCT00838565|527018385|FG002|Overall Study|Other|0|||
146136708|NCT00838565|527018386|FG003|Overall Study|Other|0|||
146136709|NCT00838565|527018387|FG004|Overall Study|Other|0|||
146136710|NCT00838565|527018388|FG005|Overall Study|Other|0|||
146136711|NCT00838565|527018383|FG000|Overall Study|Randomized but not Treated|0|||
146136712|NCT00838565|527018384|FG001|Overall Study|Randomized but not Treated|1|||
146136713|NCT00838565|527018385|FG002|Overall Study|Randomized but not Treated|0|||
146136714|NCT00838565|527018386|FG003|Overall Study|Randomized but not Treated|0|||
146136715|NCT00838565|527018387|FG004|Overall Study|Randomized but not Treated|0|||
146136716|NCT00838565|527018388|FG005|Overall Study|Randomized but not Treated|0|||
146136717|NCT00458484|527018389|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
146304029|NCT03250832|527627483|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146304030|NCT03250832|527627484|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146136718|NCT00458484|527018390|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
146267784|NCT03635086|527494953|FG004|Overall Study|Lost to Follow-up|0|||
146267785|NCT00723125|527494954|FG000|Overall Study|Met Dx|1|||
146136719|NCT00458484|527018391|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
146136720|NCT00458484|527018392|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
146136721|NCT00458484|527018393|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
146136722|NCT00458484|527018394|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
146136723|NCT00458484|527018395|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
146136724|NCT03571516|527018396|FG000|Overall Study|Severe diarrhea|1|||
146267786|NCT00723125|527494955|FG001|Overall Study|Met Dx|0|||
146267787|NCT00723125|527494954|FG000|Overall Study|Withdrawal by Subject|15|||
146267788|NCT00723125|527494955|FG001|Overall Study|Withdrawal by Subject|6|||
146267789|NCT00723125|527494954|FG000|Overall Study|Adverse Event|2|||
146267790|NCT00723125|527494955|FG001|Overall Study|Adverse Event|0|||
146267791|NCT02196077|527494956|FG000|Overall Study|Adverse Event|4|||
146267792|NCT02196077|527494956|FG000|Overall Study|Lack of Efficacy|1|||
146267793|NCT02196077|527494956|FG000|Overall Study|Withdrawal by Subject|14|||
146267794|NCT02196077|527494956|FG000|Overall Study|Physician Decision|1|||
146267795|NCT02196077|527494956|FG000|Overall Study|Lost to Follow-up|3|||
146267796|NCT02196077|527494956|FG000|Overall Study|Protocol Violation|24|||
146267797|NCT04042077|527494959|FG000|Overall Study|Adverse Event|0|||
146267798|NCT04042077|527494960|FG001|Overall Study|Adverse Event|1|||
146267799|NCT04042077|527494959|FG000|Overall Study|Death|2|||
146267800|NCT04042077|527494960|FG001|Overall Study|Death|1|||
146267801|NCT04042077|527494959|FG000|Overall Study|Physician Decision|2|||
146267802|NCT04042077|527494960|FG001|Overall Study|Physician Decision|0|||
146267803|NCT04042077|527494959|FG000|Overall Study|Withdrawal by Subject|3|||
146267804|NCT04042077|527494960|FG001|Overall Study|Withdrawal by Subject|2|||
146267805|NCT04042077|527494959|FG000|Overall Study|Lack of Efficacy|0|||
146267806|NCT04042077|527494960|FG001|Overall Study|Lack of Efficacy|1|||
146267807|NCT03482752|527494963|FG000|Overall Study|Withdrawal by Subject|2|||
146267808|NCT03482752|527494963|FG000|Overall Study|Lost to Follow-up|1|||
146267809|NCT03482752|527494963|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
146267810|NCT01080300|527494964|FG000|Overall Study|Adverse Event|49|||
146267811|NCT01080300|527494965|FG001|Overall Study|Adverse Event|35|||
146267812|NCT01080300|527494964|FG000|Overall Study|Lack of Efficacy|12|||
146267813|NCT01080300|527494965|FG001|Overall Study|Lack of Efficacy|15|||
146267814|NCT01080300|527494964|FG000|Overall Study|Protocol Violation|7|||
146267815|NCT01080300|527494965|FG001|Overall Study|Protocol Violation|13|||
146267816|NCT01080300|527494964|FG000|Overall Study|Lost to Follow-up|10|||
146267817|NCT01080300|527494965|FG001|Overall Study|Lost to Follow-up|6|||
146267818|NCT01080300|527494964|FG000|Overall Study|Death|0|||
146267819|NCT01080300|527494965|FG001|Overall Study|Death|1|||
146267820|NCT01080300|527494964|FG000|Overall Study|Withdrawal by Subject|12|||
146267821|NCT01080300|527494965|FG001|Overall Study|Withdrawal by Subject|28|||
146267822|NCT01080300|527494964|FG000|Overall Study|Reasons not specified|4|||
146267823|NCT01080300|527494965|FG001|Overall Study|Reasons not specified|6|||
146267824|NCT02844777|527494966|FG000|Overall Study|Withdrawal by Subject|2|||
146267825|NCT02844777|527494967|FG001|Overall Study|Withdrawal by Subject|0|||
146267826|NCT02844777|527494968|FG002|Overall Study|Withdrawal by Subject|0|||
146267827|NCT01776008|527494969|FG000|Overall Study|ineligible|2|||
146267828|NCT00150618|527494970|FG000|Overall Study|Adverse Event|2|||
146267829|NCT00150618|527494971|FG001|Overall Study|Adverse Event|2|||
146267830|NCT00150618|527494972|FG002|Overall Study|Adverse Event|6|||
146267831|NCT00150618|527494973|FG003|Overall Study|Adverse Event|9|||
146267832|NCT00150618|527494974|FG004|Overall Study|Adverse Event|5|||
146267833|NCT00150618|527494970|FG000|Overall Study|Withdrawal by Subject|6|||
146267834|NCT00150618|527494971|FG001|Overall Study|Withdrawal by Subject|8|||
146267835|NCT00150618|527494972|FG002|Overall Study|Withdrawal by Subject|8|||
146267836|NCT00150618|527494973|FG003|Overall Study|Withdrawal by Subject|4|||
146267837|NCT00150618|527494974|FG004|Overall Study|Withdrawal by Subject|5|||
146267838|NCT00150618|527494970|FG000|Overall Study|Lost to Follow-up|4|||
146267839|NCT00150618|527494971|FG001|Overall Study|Lost to Follow-up|1|||
146267840|NCT00150618|527494972|FG002|Overall Study|Lost to Follow-up|5|||
146267841|NCT00150618|527494973|FG003|Overall Study|Lost to Follow-up|8|||
146267842|NCT00150618|527494974|FG004|Overall Study|Lost to Follow-up|4|||
146267843|NCT00150618|527494970|FG000|Overall Study|Protocol Violation|1|||
146267844|NCT00150618|527494971|FG001|Overall Study|Protocol Violation|0|||
146267845|NCT00150618|527494972|FG002|Overall Study|Protocol Violation|0|||
146267846|NCT00150618|527494973|FG003|Overall Study|Protocol Violation|0|||
146267847|NCT00150618|527494974|FG004|Overall Study|Protocol Violation|1|||
146267848|NCT00150618|527494970|FG000|Overall Study|Lack of Efficacy|1|||
146267849|NCT00150618|527494971|FG001|Overall Study|Lack of Efficacy|4|||
146267850|NCT00150618|527494972|FG002|Overall Study|Lack of Efficacy|7|||
146267851|NCT00150618|527494973|FG003|Overall Study|Lack of Efficacy|4|||
146267852|NCT00150618|527494974|FG004|Overall Study|Lack of Efficacy|6|||
146267853|NCT00150618|527494970|FG000|Overall Study|No study meds|0|||
146267854|NCT00150618|527494971|FG001|Overall Study|No study meds|0|||
146267855|NCT00150618|527494972|FG002|Overall Study|No study meds|0|||
146267856|NCT00150618|527494973|FG003|Overall Study|No study meds|0|||
146304031|NCT03250832|527627485|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146304032|NCT03250832|527627486|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
146304033|NCT03250832|527627475|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304034|NCT03250832|527627476|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304035|NCT03250832|527627477|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
146304036|NCT03250832|527627478|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146267857|NCT00150618|527494974|FG004|Overall Study|No study meds|2|||
146267858|NCT00150618|527494970|FG000|Overall Study|Physician Decision|0|||
146267859|NCT00150618|527494971|FG001|Overall Study|Physician Decision|2|||
146267860|NCT00150618|527494972|FG002|Overall Study|Physician Decision|0|||
146267861|NCT00150618|527494973|FG003|Overall Study|Physician Decision|0|||
146267862|NCT00150618|527494974|FG004|Overall Study|Physician Decision|1|||
146267863|NCT00150618|527494970|FG000|Overall Study|Lack of compliance|2|||
146267864|NCT00150618|527494971|FG001|Overall Study|Lack of compliance|1|||
146267865|NCT00150618|527494972|FG002|Overall Study|Lack of compliance|1|||
146267866|NCT00150618|527494973|FG003|Overall Study|Lack of compliance|0|||
146267867|NCT00150618|527494974|FG004|Overall Study|Lack of compliance|1|||
146267868|NCT00150618|527494970|FG000|Overall Study|Abnormal ECG|1|||
146267869|NCT00150618|527494971|FG001|Overall Study|Abnormal ECG|0|||
146267870|NCT00150618|527494972|FG002|Overall Study|Abnormal ECG|0|||
146267871|NCT00150618|527494973|FG003|Overall Study|Abnormal ECG|0|||
146267872|NCT00150618|527494974|FG004|Overall Study|Abnormal ECG|0|||
146267873|NCT00150618|527494970|FG000|Overall Study|Sponsor's decision|0|||
146267874|NCT00150618|527494971|FG001|Overall Study|Sponsor's decision|0|||
146267875|NCT00150618|527494972|FG002|Overall Study|Sponsor's decision|0|||
146267876|NCT00150618|527494973|FG003|Overall Study|Sponsor's decision|1|||
146267877|NCT00150618|527494974|FG004|Overall Study|Sponsor's decision|0|||
146267878|NCT00478205|527494976|FG000|Overall Study|Adverse Event|182|||
146267879|NCT00478205|527494977|FG001|Overall Study|Adverse Event|39|||
146267880|NCT00478205|527494976|FG000|Overall Study|Medication Non-compliance|9|||
146267881|NCT00478205|527494977|FG001|Overall Study|Medication Non-compliance|4|||
146267882|NCT00478205|527494976|FG000|Overall Study|Protocol Violation|15|||
146267883|NCT00478205|527494977|FG001|Overall Study|Protocol Violation|5|||
146267884|NCT00478205|527494976|FG000|Overall Study|Request of Investigator or Sponsor|4|||
146267885|NCT00478205|527494977|FG001|Overall Study|Request of Investigator or Sponsor|5|||
146267886|NCT00478205|527494976|FG000|Overall Study|Withdrawal by Subject|61|||
146267887|NCT00478205|527494977|FG001|Overall Study|Withdrawal by Subject|22|||
146267888|NCT00478205|527494976|FG000|Overall Study|Lack of Efficacy|1|||
146267889|NCT00478205|527494977|FG001|Overall Study|Lack of Efficacy|0|||
146267890|NCT00478205|527494976|FG000|Overall Study|Other|24|||
146267891|NCT00478205|527494977|FG001|Overall Study|Other|12|||
146267892|NCT04092452|527494979|FG000|Overall Study|Adverse Event|1|||
146267893|NCT04092452|527494980|FG001|Overall Study|Adverse Event|3|||
146267894|NCT04092452|527494981|FG002|Overall Study|Adverse Event|3|||
146267895|NCT04092452|527494982|FG003|Overall Study|Adverse Event|7|||
146267896|NCT04092452|527494979|FG000|Overall Study|Lack of Efficacy|1|||
146267897|NCT04092452|527494980|FG001|Overall Study|Lack of Efficacy|1|||
146267898|NCT04092452|527494981|FG002|Overall Study|Lack of Efficacy|1|||
146267899|NCT04092452|527494982|FG003|Overall Study|Lack of Efficacy|0|||
146267900|NCT04092452|527494979|FG000|Overall Study|Lost to Follow-up|4|||
146267901|NCT04092452|527494980|FG001|Overall Study|Lost to Follow-up|3|||
146267902|NCT04092452|527494981|FG002|Overall Study|Lost to Follow-up|5|||
146267903|NCT04092452|527494982|FG003|Overall Study|Lost to Follow-up|1|||
146267904|NCT04092452|527494979|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146267905|NCT04092452|527494980|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146267906|NCT04092452|527494981|FG002|Overall Study|Non-Compliance With Study Drug|1|||
146267907|NCT04092452|527494982|FG003|Overall Study|Non-Compliance With Study Drug|1|||
146267908|NCT04092452|527494979|FG000|Overall Study|Physician Decision|1|||
146267909|NCT04092452|527494980|FG001|Overall Study|Physician Decision|0|||
146267910|NCT04092452|527494981|FG002|Overall Study|Physician Decision|1|||
146267911|NCT04092452|527494982|FG003|Overall Study|Physician Decision|0|||
146267912|NCT04092452|527494979|FG000|Overall Study|Pregnancy|2|||
146267913|NCT04092452|527494980|FG001|Overall Study|Pregnancy|0|||
146267914|NCT04092452|527494981|FG002|Overall Study|Pregnancy|0|||
146267915|NCT04092452|527494982|FG003|Overall Study|Pregnancy|0|||
146267916|NCT04092452|527494979|FG000|Overall Study|Protocol Deviation|1|||
146267917|NCT04092452|527494980|FG001|Overall Study|Protocol Deviation|0|||
146267918|NCT04092452|527494981|FG002|Overall Study|Protocol Deviation|0|||
146267919|NCT04092452|527494982|FG003|Overall Study|Protocol Deviation|0|||
146267920|NCT04092452|527494979|FG000|Overall Study|Withdrawal by Subject|3|||
146267921|NCT04092452|527494980|FG001|Overall Study|Withdrawal by Subject|10|||
146267922|NCT04092452|527494981|FG002|Overall Study|Withdrawal by Subject|3|||
146267923|NCT04092452|527494982|FG003|Overall Study|Withdrawal by Subject|5|||
146267924|NCT04092452|527494979|FG000|Overall Study|Other|0|||
146267925|NCT04092452|527494980|FG001|Overall Study|Other|0|||
146304037|NCT03250832|527627479|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304038|NCT03250832|527627480|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146267926|NCT04092452|527494981|FG002|Overall Study|Other|1|||
146267927|NCT04092452|527494982|FG003|Overall Study|Other|2|||
146267928|NCT01012947|527494990|FG000|Overall Study|Lost to Follow-up|131|||
146267929|NCT01012947|527494991|FG001|Overall Study|Lost to Follow-up|135|||
146267930|NCT01012947|527494992|FG002|Overall Study|Lost to Follow-up|130|||
146267931|NCT01012947|527494993|FG003|Overall Study|Lost to Follow-up|118|||
146267932|NCT01012947|527494994|FG004|Overall Study|Lost to Follow-up|142|||
146267933|NCT02127125|527494995|FG000|Overall Study|Lost to Follow-up|0|||
146267934|NCT02127125|527494996|FG001|Overall Study|Lost to Follow-up|0|||
146267935|NCT02127125|527494997|FG002|Overall Study|Lost to Follow-up|0|||
146267936|NCT02127125|527494998|FG003|Overall Study|Lost to Follow-up|0|||
146267937|NCT02127125|527494999|FG004|Overall Study|Lost to Follow-up|2|||
146267938|NCT02127125|527495000|FG005|Overall Study|Lost to Follow-up|1|||
146267939|NCT02127125|527495001|FG006|Overall Study|Lost to Follow-up|0|||
146267940|NCT02127125|527495002|FG007|Overall Study|Lost to Follow-up|0|||
146267941|NCT02127125|527495003|FG008|Overall Study|Lost to Follow-up|0|||
146267942|NCT02127125|527494995|FG000|Overall Study|Withdrawal by Subject|0|||
146267943|NCT02127125|527494996|FG001|Overall Study|Withdrawal by Subject|0|||
146267944|NCT02127125|527494997|FG002|Overall Study|Withdrawal by Subject|0|||
146267945|NCT02127125|527494998|FG003|Overall Study|Withdrawal by Subject|1|||
146267946|NCT02127125|527494999|FG004|Overall Study|Withdrawal by Subject|0|||
146267947|NCT02127125|527495000|FG005|Overall Study|Withdrawal by Subject|0|||
146267948|NCT02127125|527495001|FG006|Overall Study|Withdrawal by Subject|0|||
146267949|NCT02127125|527495002|FG007|Overall Study|Withdrawal by Subject|0|||
146267950|NCT02127125|527495003|FG008|Overall Study|Withdrawal by Subject|0|||
146267951|NCT02127125|527494995|FG000|Overall Study|Physician Decision|0|||
146267952|NCT02127125|527494996|FG001|Overall Study|Physician Decision|0|||
146267953|NCT02127125|527494997|FG002|Overall Study|Physician Decision|1|||
146267954|NCT02127125|527494998|FG003|Overall Study|Physician Decision|0|||
146267955|NCT02127125|527494999|FG004|Overall Study|Physician Decision|1|||
146267956|NCT02127125|527495000|FG005|Overall Study|Physician Decision|2|||
146267957|NCT02127125|527495001|FG006|Overall Study|Physician Decision|0|||
146267958|NCT02127125|527495002|FG007|Overall Study|Physician Decision|0|||
146267959|NCT02127125|527495003|FG008|Overall Study|Physician Decision|0|||
146267960|NCT02493946|527495007|FG000|DB Period|Withdrawal by Subject|8|||
146267961|NCT02493946|527495008|FG001|DB Period|Withdrawal by Subject|5|||
146267962|NCT02493946|527495009|FG002|DB Period|Withdrawal by Subject|0|||
146267963|NCT02493946|527495007|FG000|Open Label Period|Withdrawal by Subject|0|||
146267964|NCT02493946|527495008|FG001|Open Label Period|Withdrawal by Subject|0|||
146267965|NCT02493946|527495009|FG002|Open Label Period|Withdrawal by Subject|74|||
146267966|NCT02493946|527495007|FG000|Open Label Period|Adverse Event|0|||
146267967|NCT02493946|527495008|FG001|Open Label Period|Adverse Event|0|||
146267968|NCT02493946|527495009|FG002|Open Label Period|Adverse Event|4|||
146267969|NCT02493946|527495007|FG000|Open Label Period|Lost to Follow-up|0|||
146267970|NCT02493946|527495008|FG001|Open Label Period|Lost to Follow-up|0|||
146267971|NCT02493946|527495009|FG002|Open Label Period|Lost to Follow-up|1|||
146267972|NCT02493946|527495007|FG000|Open Label Period|Investigator decision, non-compliance|0|||
146267973|NCT02493946|527495008|FG001|Open Label Period|Investigator decision, non-compliance|0|||
146267974|NCT02493946|527495009|FG002|Open Label Period|Investigator decision, non-compliance|2|||
146267975|NCT02493946|527495007|FG000|Open Label Period|Investigator decision, non-availability|0|||
146267976|NCT02493946|527495008|FG001|Open Label Period|Investigator decision, non-availability|0|||
146136725|NCT03571516|527018397|FG001|Overall Study|Severe diarrhea|0|||
146136726|NCT03571516|527018396|FG000|Overall Study|Withdrawal by Subject|0|||
146136727|NCT03571516|527018397|FG001|Overall Study|Withdrawal by Subject|1|||
146136728|NCT02253810|527018398|FG000|Overall Study|Withdrawal by Subject|2|||
146136729|NCT02253810|527018399|FG001|Overall Study|Withdrawal by Subject|1|||
146136730|NCT02253810|527018398|FG000|Overall Study|Unknown concomitant procedure|3|||
146136731|NCT02253810|527018399|FG001|Overall Study|Unknown concomitant procedure|2|||
146136732|NCT01434290|527018407|FG000|Overall Study|Protocol Violation|6|||
146136733|NCT01434290|527018408|FG001|Overall Study|Protocol Violation|3|||
146136734|NCT01434290|527018407|FG000|Overall Study|No protocol treatment|2|||
146136735|NCT01434290|527018408|FG001|Overall Study|No protocol treatment|4|||
146136736|NCT02281552|527018409|FG000|Overall Study|Medication error|1|||
146136737|NCT02281552|527018410|FG001|Overall Study|Medication error|0|||
146136738|NCT02281552|527018409|FG000|Overall Study|Insufficient clinical response|0|||
146136739|NCT02281552|527018410|FG001|Overall Study|Insufficient clinical response|1|||
146136740|NCT02281552|527018409|FG000|Overall Study|Adverse Event|3|||
146136741|NCT02281552|527018410|FG001|Overall Study|Adverse Event|9|||
146136742|NCT01224639|527018411|FG000|Overall Study|Withdrawal by Subject|0|||
146136743|NCT01224639|527018412|FG001|Overall Study|Withdrawal by Subject|0|||
146267977|NCT02493946|527495009|FG002|Open Label Period|Investigator decision, non-availability|1|||
146267978|NCT02493946|527495007|FG000|Open Label Period|Pregnancy|0|||
146267979|NCT02493946|527495008|FG001|Open Label Period|Pregnancy|0|||
146267980|NCT02493946|527495009|FG002|Open Label Period|Pregnancy|3|||
146136744|NCT01224639|527018413|FG002|Overall Study|Withdrawal by Subject|0|||
146136745|NCT01224639|527018414|FG003|Overall Study|Withdrawal by Subject|0|||
146136746|NCT01224639|527018415|FG004|Overall Study|Withdrawal by Subject|2|||
146136747|NCT01224639|527018416|FG005|Overall Study|Withdrawal by Subject|0|||
146136748|NCT01224639|527018417|FG006|Overall Study|Withdrawal by Subject|1|||
146136749|NCT01224639|527018418|FG007|Overall Study|Withdrawal by Subject|1|||
146136750|NCT01224639|527018411|FG000|Overall Study|Adverse Event|0|||
146136751|NCT01224639|527018412|FG001|Overall Study|Adverse Event|0|||
146267981|NCT02493946|527495007|FG000|Open Label Period|Site error|0|||
146136752|NCT01224639|527018413|FG002|Overall Study|Adverse Event|0|||
146267982|NCT02493946|527495008|FG001|Open Label Period|Site error|0|||
146267983|NCT02493946|527495009|FG002|Open Label Period|Site error|1|||
146136753|NCT01224639|527018414|FG003|Overall Study|Adverse Event|0|||
146136754|NCT01224639|527018415|FG004|Overall Study|Adverse Event|0|||
146136755|NCT01224639|527018416|FG005|Overall Study|Adverse Event|0|||
146267984|NCT01162486|527495016|FG000|Overall Study|low ANC|1|||
146136756|NCT01224639|527018417|FG006|Overall Study|Adverse Event|0|||
146136757|NCT01224639|527018418|FG007|Overall Study|Adverse Event|1|||
146136758|NCT03465878|527018421|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146267985|NCT01162486|527495017|FG001|Overall Study|low ANC|0|||
146267986|NCT01162486|527495018|FG002|Overall Study|low ANC|0|||
146267987|NCT01162486|527495019|FG003|Overall Study|low ANC|0|||
146267988|NCT01162486|527495020|FG004|Overall Study|low ANC|0|||
146267989|NCT01162486|527495016|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
146267990|NCT01162486|527495017|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146267991|NCT01162486|527495018|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146267992|NCT01162486|527495019|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146267993|NCT01162486|527495020|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
146267994|NCT01162486|527495016|FG000|Overall Study|elevated LFTs|0|||
146267995|NCT01162486|527495017|FG001|Overall Study|elevated LFTs|0|||
146267996|NCT01162486|527495018|FG002|Overall Study|elevated LFTs|1|||
146267997|NCT01162486|527495019|FG003|Overall Study|elevated LFTs|0|||
146267998|NCT01162486|527495020|FG004|Overall Study|elevated LFTs|0|||
146267999|NCT01162486|527495016|FG000|Overall Study|Pregnancy|0|||
146268000|NCT01162486|527495017|FG001|Overall Study|Pregnancy|0|||
146268001|NCT01162486|527495018|FG002|Overall Study|Pregnancy|0|||
146268002|NCT01162486|527495019|FG003|Overall Study|Pregnancy|1|||
146268003|NCT01162486|527495020|FG004|Overall Study|Pregnancy|0|||
146268004|NCT00953615|527495021|FG000|Overall Study|Adverse Event|1|||
146268005|NCT03332784|527495022|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268006|NCT03332784|527495023|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
146268007|NCT03332784|527495024|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268008|NCT03332784|527495025|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268009|NCT03332784|527495026|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268010|NCT03332784|527495027|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268011|NCT03332784|527495028|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268012|NCT03332784|527495029|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268013|NCT03332784|527495030|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268014|NCT03332784|527495031|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268015|NCT03332784|527495032|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268016|NCT03332784|527495033|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268017|NCT03332784|527495034|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268018|NCT03332784|527495035|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268019|NCT03332784|527495036|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
146268020|NCT03332784|527495037|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268021|NCT03332784|527495038|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268022|NCT03332784|527495039|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268023|NCT03332784|527495040|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268024|NCT03332784|527495041|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
146268025|NCT00585078|527495053|FG000|Overall Study|Withdrawal by Subject|4|||
146268026|NCT00585078|527495053|FG000|Overall Study|Poor performance status|1|||
146268027|NCT00585078|527495053|FG000|Overall Study|Disease Progression|24|||
146268028|NCT00585078|527495053|FG000|Overall Study|Adverse Event|10|||
146268029|NCT00585078|527495053|FG000|Overall Study|Death|1|||
146268030|NCT01536171|527495054|FG000|Overall Study|Withdrawal by Subject|1|||
146268031|NCT01018732|527495055|FG000|Overall Study|Lost to Follow-up|0|||
146268032|NCT01018732|527495056|FG001|Overall Study|Lost to Follow-up|0|||
146268033|NCT01018732|527495057|FG002|Overall Study|Lost to Follow-up|3|||
146268034|NCT01018732|527495055|FG000|Overall Study|Protocol Violation|1|||
146268035|NCT01018732|527495056|FG001|Overall Study|Protocol Violation|1|||
146268036|NCT01018732|527495057|FG002|Overall Study|Protocol Violation|0|||
146268037|NCT01018732|527495055|FG000|Overall Study|Inappropriate Enrollment|0|||
146268038|NCT01018732|527495056|FG001|Overall Study|Inappropriate Enrollment|1|||
146268039|NCT01018732|527495057|FG002|Overall Study|Inappropriate Enrollment|0|||
146268040|NCT01018732|527495055|FG000|Overall Study|Unable to Classify|0|||
146268041|NCT01018732|527495056|FG001|Overall Study|Unable to Classify|0|||
146268042|NCT01018732|527495057|FG002|Overall Study|Unable to Classify|1|||
146268043|NCT02781311|527495060|FG000|Overall Study|Adverse Event|2|||
146268044|NCT02781311|527495061|FG001|Overall Study|Adverse Event|6|||
146268045|NCT02781311|527495062|FG002|Overall Study|Adverse Event|1|||
146268046|NCT02781311|527495060|FG000|Overall Study|Withdrawal of Consent|11|||
146136759|NCT03465878|527018422|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
146136760|NCT03465878|527018423|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146136761|NCT03465878|527018424|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
146136762|NCT03465878|527018421|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146268047|NCT02781311|527495061|FG001|Overall Study|Withdrawal of Consent|12|||
146268048|NCT02781311|527495062|FG002|Overall Study|Withdrawal of Consent|2|||
146268049|NCT02781311|527495060|FG000|Overall Study|Lost to Follow-up|11|||
146268050|NCT02781311|527495061|FG001|Overall Study|Lost to Follow-up|8|||
146268051|NCT02781311|527495062|FG002|Overall Study|Lost to Follow-up|1|||
146268052|NCT02781311|527495060|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146268053|NCT02781311|527495061|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146268054|NCT02781311|527495062|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146304039|NCT03250832|527627481|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304040|NCT03250832|527627482|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304041|NCT03250832|527627483|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304042|NCT03250832|527627484|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304043|NCT03250832|527627485|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304044|NCT03250832|527627486|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
146304045|NCT03250832|527627475|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304046|NCT03250832|527627476|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304047|NCT03250832|527627477|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304048|NCT03250832|527627478|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304049|NCT03250832|527627479|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304050|NCT03250832|527627480|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304051|NCT03250832|527627481|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304052|NCT03250832|527627482|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
146304053|NCT03250832|527627483|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304054|NCT03250832|527627484|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304055|NCT03250832|527627485|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304056|NCT03250832|527627486|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
146304057|NCT03250832|527627475|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304058|NCT03250832|527627476|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304059|NCT03250832|527627477|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146136763|NCT03465878|527018422|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146136764|NCT03465878|527018423|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
146136765|NCT03465878|527018424|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
146136766|NCT03465878|527018421|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146136767|NCT03465878|527018422|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146136768|NCT03465878|527018423|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
146136769|NCT03465878|527018424|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
146268055|NCT04905849|527495063|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
146268056|NCT04905849|527495064|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
146268057|NCT00838929|527495069|FG000|Overall Study|Protocol Violation|0|||
146268058|NCT00838929|527495070|FG001|Overall Study|Protocol Violation|1|||
146268059|NCT00838929|527495071|FG002|Overall Study|Protocol Violation|0|||
146268060|NCT00838929|527495069|FG000|Overall Study|Disease progression|0|||
146268061|NCT00838929|527495070|FG001|Overall Study|Disease progression|2|||
146268062|NCT00838929|527495071|FG002|Overall Study|Disease progression|1|||
146268063|NCT01240551|527497137|FG000|Overall Study|Refused further treatment|3|||
146268064|NCT01240551|527497138|FG001|Overall Study|Refused further treatment|2|||
146268065|NCT01240551|527497137|FG000|Overall Study|Lost to Follow-up|1|||
146268066|NCT01240551|527497138|FG001|Overall Study|Lost to Follow-up|1|||
146268067|NCT02906020|527497141|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
146268068|NCT02906020|527497142|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
146268069|NCT02906020|527497143|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
146268070|NCT02906020|527497144|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
146268071|NCT02906020|527497145|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
146268072|NCT02906020|527497146|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
146268073|NCT02906020|527497147|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
146268074|NCT02906020|527497148|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
146268075|NCT02906020|527497149|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
146268076|NCT02906020|527497150|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
146268077|NCT02906020|527497151|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
146268078|NCT02906020|527497152|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
146268079|NCT02906020|527497153|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
146268080|NCT02906020|527497154|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
146268081|NCT02906020|527497155|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
146268082|NCT02906020|527497156|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
146268083|NCT02906020|527497141|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268084|NCT02906020|527497142|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268085|NCT02906020|527497143|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268086|NCT02906020|527497144|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268087|NCT02906020|527497145|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268088|NCT02906020|527497146|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146304060|NCT03250832|527627478|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304061|NCT03250832|527627479|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304062|NCT03250832|527627480|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304063|NCT03250832|527627481|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146304064|NCT03250832|527627482|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
146304065|NCT03250832|527627483|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146268089|NCT02906020|527497147|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268090|NCT02906020|527497148|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268091|NCT02906020|527497149|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
146268092|NCT02906020|527497150|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
146268093|NCT02906020|527497151|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268094|NCT02906020|527497152|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268095|NCT02906020|527497153|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268096|NCT02906020|527497154|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268097|NCT02906020|527497155|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268098|NCT02906020|527497156|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
146268099|NCT02906020|527497141|FG000|Part 2: Double-blind Treatment Period|Other|0|||
146268100|NCT02906020|527497142|FG001|Part 2: Double-blind Treatment Period|Other|0|||
146268101|NCT02906020|527497143|FG002|Part 2: Double-blind Treatment Period|Other|0|||
146268102|NCT02906020|527497144|FG003|Part 2: Double-blind Treatment Period|Other|0|||
146268103|NCT02906020|527497145|FG004|Part 2: Double-blind Treatment Period|Other|0|||
146268104|NCT02906020|527497146|FG005|Part 2: Double-blind Treatment Period|Other|0|||
146268105|NCT02906020|527497147|FG006|Part 2: Double-blind Treatment Period|Other|0|||
146268106|NCT02906020|527497148|FG007|Part 2: Double-blind Treatment Period|Other|0|||
146268107|NCT02906020|527497149|FG008|Part 2: Double-blind Treatment Period|Other|6|||
146268108|NCT02906020|527497150|FG009|Part 2: Double-blind Treatment Period|Other|10|||
146268109|NCT02906020|527497151|FG010|Part 2: Double-blind Treatment Period|Other|0|||
146268110|NCT02906020|527497152|FG011|Part 2: Double-blind Treatment Period|Other|0|||
146268111|NCT02906020|527497153|FG012|Part 2: Double-blind Treatment Period|Other|0|||
146268112|NCT02906020|527497154|FG013|Part 2: Double-blind Treatment Period|Other|0|||
146268113|NCT02906020|527497155|FG014|Part 2: Double-blind Treatment Period|Other|0|||
146268114|NCT02906020|527497156|FG015|Part 2: Double-blind Treatment Period|Other|0|||
146268115|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268116|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268117|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268118|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268119|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268120|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268121|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268122|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268123|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268124|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268125|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268126|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268127|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
146268128|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
146268129|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268130|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
146268131|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268132|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268133|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268134|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268135|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268136|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268137|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268138|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268139|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268140|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268141|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268142|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268143|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
146268144|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
146268145|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
146268146|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
146268147|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268148|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268149|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268150|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268151|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268152|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268153|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268154|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146304066|NCT03250832|527627484|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146268155|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268156|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268157|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268158|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268159|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
146268160|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
146136770|NCT04656132|527018425|FG000|Overall Study|Lost to Follow-up|4|||
146136771|NCT04656132|527018425|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
146268161|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268162|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
146268163|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268164|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268165|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268166|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268167|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268168|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268169|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268170|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268171|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268172|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268173|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268174|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268175|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
146268176|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
146268177|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268178|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
146268179|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268180|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268181|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268182|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268183|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268184|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268185|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268186|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268187|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268188|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268189|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268190|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
146268191|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
146268192|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
146268193|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
146268194|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
146268195|NCT02906020|527497141|FG000|Part 2: Long-term Follow-up Period|Other|0|||
146268196|NCT02906020|527497142|FG001|Part 2: Long-term Follow-up Period|Other|0|||
146268197|NCT02906020|527497143|FG002|Part 2: Long-term Follow-up Period|Other|0|||
146268198|NCT02906020|527497144|FG003|Part 2: Long-term Follow-up Period|Other|0|||
146268199|NCT02906020|527497145|FG004|Part 2: Long-term Follow-up Period|Other|0|||
146268200|NCT02906020|527497146|FG005|Part 2: Long-term Follow-up Period|Other|0|||
146268201|NCT02906020|527497147|FG006|Part 2: Long-term Follow-up Period|Other|0|||
146268202|NCT02906020|527497148|FG007|Part 2: Long-term Follow-up Period|Other|0|||
146268203|NCT02906020|527497149|FG008|Part 2: Long-term Follow-up Period|Other|0|||
146136772|NCT04019041|527018426|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
146136773|NCT04019041|527018427|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
146136774|NCT04019041|527018428|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146136775|NCT04019041|527018429|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146136776|NCT04019041|527018430|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146136777|NCT04019041|527018431|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146136778|NCT04019041|527018426|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146136779|NCT04019041|527018427|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146136780|NCT04019041|527018428|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
146136781|NCT04019041|527018429|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146136782|NCT04019041|527018430|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146268204|NCT02906020|527497150|FG009|Part 2: Long-term Follow-up Period|Other|0|||
146304067|NCT03250832|527627485|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146268205|NCT02906020|527497151|FG010|Part 2: Long-term Follow-up Period|Other|0|||
146268206|NCT02906020|527497152|FG011|Part 2: Long-term Follow-up Period|Other|0|||
146268207|NCT02906020|527497153|FG012|Part 2: Long-term Follow-up Period|Other|13|||
146268208|NCT02906020|527497154|FG013|Part 2: Long-term Follow-up Period|Other|8|||
146268209|NCT02906020|527497155|FG014|Part 2: Long-term Follow-up Period|Other|3|||
146268210|NCT02906020|527497156|FG015|Part 2: Long-term Follow-up Period|Other|2|||
146268211|NCT04698915|527497157|FG000|Overall Study|Adverse Event|2|||
146268212|NCT04698915|527497158|FG001|Overall Study|Adverse Event|0|||
146268213|NCT04698915|527497157|FG000|Overall Study|Death|23|||
146268214|NCT04698915|527497158|FG001|Overall Study|Death|20|||
146268215|NCT04698915|527497157|FG000|Overall Study|Physician Decision|1|||
146268216|NCT04698915|527497158|FG001|Overall Study|Physician Decision|1|||
146268217|NCT04698915|527497157|FG000|Overall Study|Lost to Follow-up|1|||
146268218|NCT04698915|527497158|FG001|Overall Study|Lost to Follow-up|0|||
146268219|NCT04698915|527497157|FG000|Overall Study|Study Terminated by Sponsor|55|||
146268220|NCT04698915|527497158|FG001|Overall Study|Study Terminated by Sponsor|60|||
146268221|NCT04698915|527497157|FG000|Overall Study|Withdrawal by Subject|2|||
146268222|NCT04698915|527497158|FG001|Overall Study|Withdrawal by Subject|3|||
146268223|NCT00979953|527497159|FG000|Overall Study|Adverse Event|5|||
146268224|NCT00979953|527497160|FG001|Overall Study|Adverse Event|2|||
146268225|NCT00979953|527497161|FG002|Overall Study|Adverse Event|17|||
146268226|NCT00979953|527497162|FG003|Overall Study|Adverse Event|4|||
146268227|NCT00979953|527497159|FG000|Overall Study|Lack of Efficacy|1|||
146268228|NCT00979953|527497160|FG001|Overall Study|Lack of Efficacy|2|||
146268229|NCT00979953|527497161|FG002|Overall Study|Lack of Efficacy|0|||
146268230|NCT00979953|527497162|FG003|Overall Study|Lack of Efficacy|0|||
146268231|NCT00979953|527497159|FG000|Overall Study|Lost to Follow-up|1|||
146268232|NCT00979953|527497160|FG001|Overall Study|Lost to Follow-up|1|||
146268233|NCT00979953|527497161|FG002|Overall Study|Lost to Follow-up|1|||
146268234|NCT00979953|527497162|FG003|Overall Study|Lost to Follow-up|0|||
146268235|NCT00979953|527497159|FG000|Overall Study|Withdrawal by Subject|0|||
146268236|NCT00979953|527497160|FG001|Overall Study|Withdrawal by Subject|0|||
146268237|NCT00979953|527497161|FG002|Overall Study|Withdrawal by Subject|2|||
146268238|NCT00979953|527497162|FG003|Overall Study|Withdrawal by Subject|1|||
146268239|NCT00979953|527497159|FG000|Overall Study|Protocol Violation|1|||
146268240|NCT00979953|527497160|FG001|Overall Study|Protocol Violation|0|||
146268241|NCT00979953|527497161|FG002|Overall Study|Protocol Violation|2|||
146268242|NCT00979953|527497162|FG003|Overall Study|Protocol Violation|2|||
146268243|NCT01124097|527497163|FG000|Overall Study|Withdrawal by Subject|4|||
146268244|NCT01124097|527497164|FG001|Overall Study|Withdrawal by Subject|3|||
146268245|NCT01124097|527497165|FG002|Overall Study|Withdrawal by Subject|2|||
146268246|NCT01124097|527497166|FG003|Overall Study|Withdrawal by Subject|3|||
146268247|NCT01124097|527497163|FG000|Overall Study|Lack of Efficacy|2|||
146268248|NCT01124097|527497164|FG001|Overall Study|Lack of Efficacy|3|||
146268249|NCT01124097|527497165|FG002|Overall Study|Lack of Efficacy|1|||
146268250|NCT01124097|527497166|FG003|Overall Study|Lack of Efficacy|3|||
146268251|NCT01124097|527497163|FG000|Overall Study|Adverse Event|24|||
146268252|NCT01124097|527497164|FG001|Overall Study|Adverse Event|15|||
146268253|NCT01124097|527497165|FG002|Overall Study|Adverse Event|15|||
146268254|NCT01124097|527497166|FG003|Overall Study|Adverse Event|7|||
146268255|NCT01124097|527497163|FG000|Overall Study|Protocol Violation|2|||
146268256|NCT01124097|527497164|FG001|Overall Study|Protocol Violation|0|||
146268257|NCT01124097|527497165|FG002|Overall Study|Protocol Violation|2|||
146268258|NCT01124097|527497166|FG003|Overall Study|Protocol Violation|1|||
146268259|NCT01124097|527497163|FG000|Overall Study|Physician Decision|2|||
146268260|NCT01124097|527497164|FG001|Overall Study|Physician Decision|1|||
146268261|NCT01124097|527497165|FG002|Overall Study|Physician Decision|0|||
146268262|NCT01124097|527497166|FG003|Overall Study|Physician Decision|0|||
146268263|NCT00425607|527497171|FG000|Overall Study|Death|1|||
146268264|NCT00425607|527497171|FG000|Overall Study|Withdrawal by Subject|1|||
146268265|NCT02563548|527497172|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
146268266|NCT02563548|527497173|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146268267|NCT02563548|527497174|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146268268|NCT02563548|527497175|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
146268269|NCT02563548|527497176|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146136783|NCT04019041|527018431|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
146136784|NCT04019041|527018426|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
146136785|NCT04019041|527018427|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
146136786|NCT04019041|527018428|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
146268270|NCT02563548|527497177|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
146268271|NCT02563548|527497172|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
146268272|NCT02563548|527497173|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
146268273|NCT02563548|527497174|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
146268274|NCT02563548|527497175|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146268275|NCT02563548|527497176|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146268276|NCT02563548|527497177|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
146268277|NCT02563548|527497172|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146268278|NCT02563548|527497173|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146268279|NCT02563548|527497174|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
146268280|NCT02563548|527497175|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146268281|NCT02563548|527497176|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146268282|NCT02563548|527497177|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
146268283|NCT02563548|527497172|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146268284|NCT02563548|527497173|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146268285|NCT02563548|527497174|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
146268286|NCT02563548|527497175|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
146268287|NCT02563548|527497176|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146268288|NCT02563548|527497177|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
146268289|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146268290|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146268291|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146268292|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
146268293|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
146268294|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
146268295|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146268296|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146268297|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146268298|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
146268299|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
146268300|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
146268301|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146268302|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146268303|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146268304|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146268305|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
146268306|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
146268307|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146268308|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146268309|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146268310|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
146268311|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
146268312|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
146268313|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146268314|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146268315|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146268316|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146268317|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
146268318|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
146268319|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146268320|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146268321|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146268322|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146268323|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
146268324|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
146268325|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146268326|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146268327|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146268328|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146268329|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
146268330|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
146268331|NCT02563548|527497172|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146268332|NCT02563548|527497173|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146268333|NCT02563548|527497174|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146268334|NCT02563548|527497175|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146268335|NCT02563548|527497176|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
146268336|NCT02563548|527497177|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
146268337|NCT00203047|527497178|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
146268338|NCT00203047|527497179|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
146304068|NCT03250832|527627486|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
146136787|NCT04019041|527018429|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146136788|NCT04019041|527018430|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146136789|NCT04019041|527018431|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146268339|NCT00203047|527497178|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
146268340|NCT00203047|527497179|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
146268341|NCT00203047|527497178|FG000|Overall Study|Withdrawal by Subject|13|||
146268342|NCT00203047|527497179|FG001|Overall Study|Withdrawal by Subject|47|||
146268343|NCT00203047|527497178|FG000|Overall Study|Teva requested participant withdrawal|1|||
146268344|NCT00203047|527497179|FG001|Overall Study|Teva requested participant withdrawal|1|||
146268345|NCT00203047|527497178|FG000|Overall Study|Physician Decision|8|||
146268346|NCT00203047|527497179|FG001|Overall Study|Physician Decision|7|||
146268347|NCT00203047|527497178|FG000|Overall Study|Non-compliance|4|||
146268348|NCT00203047|527497179|FG001|Overall Study|Non-compliance|8|||
146268349|NCT00203047|527497178|FG000|Overall Study|Protocol Violation|1|||
146268350|NCT00203047|527497179|FG001|Overall Study|Protocol Violation|0|||
146268351|NCT00203047|527497178|FG000|Overall Study|Lost to Follow-up|11|||
146268352|NCT00203047|527497179|FG001|Overall Study|Lost to Follow-up|5|||
146268353|NCT00203047|527497178|FG000|Overall Study|Adverse Event|8|||
146268354|NCT00203047|527497179|FG001|Overall Study|Adverse Event|18|||
146268355|NCT00203047|527497178|FG000|Overall Study|Death|1|||
146268356|NCT00203047|527497179|FG001|Overall Study|Death|2|||
146268357|NCT00203047|527497178|FG000|Overall Study|Pregnancy|3|||
146268358|NCT00203047|527497179|FG001|Overall Study|Pregnancy|0|||
146268359|NCT00203047|527497178|FG000|Overall Study|Other|5|||
146268360|NCT00203047|527497179|FG001|Overall Study|Other|5|||
146268361|NCT01163474|527497183|FG000|Overall Study|Withdrawal by Subject|1|||
146268362|NCT01163474|527497183|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
146268363|NCT01163474|527497183|FG000|Overall Study|Lost to Follow-up|3|||
146268364|NCT00762476|527497185|FG000|Overall Study|Adverse Event|7|||
146268365|NCT00762476|527497186|FG001|Overall Study|Adverse Event|1|||
146268366|NCT00762476|527497185|FG000|Overall Study|Lost to Follow-up|2|||
146268367|NCT00762476|527497186|FG001|Overall Study|Lost to Follow-up|0|||
146268368|NCT00762476|527497185|FG000|Overall Study|Protocol Violation|5|||
146268369|NCT00762476|527497186|FG001|Overall Study|Protocol Violation|6|||
146268370|NCT00762476|527497185|FG000|Overall Study|Physician Decision|2|||
146268371|NCT00762476|527497186|FG001|Overall Study|Physician Decision|14|||
146268372|NCT00762476|527497185|FG000|Overall Study|Withdrawal by Subject|6|||
146268373|NCT00762476|527497186|FG001|Overall Study|Withdrawal by Subject|12|||
146268374|NCT00762476|527497185|FG000|Overall Study|antibiotic use|0|||
146268375|NCT00762476|527497186|FG001|Overall Study|antibiotic use|1|||
146268376|NCT00762476|527497185|FG000|Overall Study|non-compliance with study visits|0|||
146268377|NCT00762476|527497186|FG001|Overall Study|non-compliance with study visits|2|||
146268378|NCT00762476|527497185|FG000|Overall Study|Seasonal allergies|1|||
146268379|NCT00762476|527497186|FG001|Overall Study|Seasonal allergies|0|||
146268380|NCT00965497|527497188|FG000|Overall Study|Physician Decision|1|||
146268381|NCT02878603|527497189|FG000|Overall Study|Lost to Follow-up|4|||
146268382|NCT02878603|527497190|FG001|Overall Study|Lost to Follow-up|1|||
146268383|NCT02878603|527497189|FG000|Overall Study|Withdrawal by Subject|1|||
146268384|NCT02878603|527497190|FG001|Overall Study|Withdrawal by Subject|1|||
146268385|NCT02878603|527497189|FG000|Overall Study|Death|1|||
146268386|NCT02878603|527497190|FG001|Overall Study|Death|0|||
146268387|NCT02878603|527497189|FG000|Overall Study|Physician Decision|0|||
146268388|NCT02878603|527497190|FG001|Overall Study|Physician Decision|3|||
146268389|NCT02689453|527497191|FG000|Overall Study|Progressive disease|0|||
146268390|NCT02689453|527497192|FG001|Overall Study|Progressive disease|1|||
146268391|NCT02689453|527497193|FG002|Overall Study|Progressive disease|1|||
146268392|NCT02638103|527497194|FG000|Overall Study|Adverse Event|13|||
146268393|NCT02638103|527497195|FG001|Overall Study|Adverse Event|12|||
146268394|NCT02638103|527497196|FG002|Overall Study|Adverse Event|19|||
146268395|NCT02638103|527497197|FG003|Overall Study|Adverse Event|12|||
146268396|NCT02638103|527497194|FG000|Overall Study|Withdrawal by Subject|43|||
146268397|NCT02638103|527497195|FG001|Overall Study|Withdrawal by Subject|53|||
146268398|NCT02638103|527497196|FG002|Overall Study|Withdrawal by Subject|30|||
146268399|NCT02638103|527497197|FG003|Overall Study|Withdrawal by Subject|61|||
146268400|NCT02638103|527497194|FG000|Overall Study|Protocol Violation|1|||
146268401|NCT02638103|527497195|FG001|Overall Study|Protocol Violation|2|||
146268402|NCT02638103|527497196|FG002|Overall Study|Protocol Violation|1|||
146268403|NCT02638103|527497197|FG003|Overall Study|Protocol Violation|4|||
146268404|NCT02638103|527497194|FG000|Overall Study|Pregnancy|2|||
146268405|NCT02638103|527497195|FG001|Overall Study|Pregnancy|3|||
146268406|NCT02638103|527497196|FG002|Overall Study|Pregnancy|0|||
146268407|NCT02638103|527497197|FG003|Overall Study|Pregnancy|1|||
146268408|NCT02638103|527497194|FG000|Overall Study|Non-compliance to Study Procedures|2|||
146268409|NCT02638103|527497195|FG001|Overall Study|Non-compliance to Study Procedures|1|||
146268410|NCT02638103|527497196|FG002|Overall Study|Non-compliance to Study Procedures|1|||
146304069|NCT03250832|527627475|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146268411|NCT02638103|527497197|FG003|Overall Study|Non-compliance to Study Procedures|1|||
146268412|NCT02638103|527497194|FG000|Overall Study|Lost to Follow-up|26|||
146268413|NCT02638103|527497195|FG001|Overall Study|Lost to Follow-up|33|||
146268414|NCT02638103|527497196|FG002|Overall Study|Lost to Follow-up|20|||
146268415|NCT02638103|527497197|FG003|Overall Study|Lost to Follow-up|37|||
146268416|NCT02638103|527497194|FG000|Overall Study|Lack of Efficacy|14|||
146268417|NCT02638103|527497195|FG001|Overall Study|Lack of Efficacy|10|||
146268418|NCT02638103|527497196|FG002|Overall Study|Lack of Efficacy|12|||
146268419|NCT02638103|527497197|FG003|Overall Study|Lack of Efficacy|22|||
146268420|NCT02638103|527497194|FG000|Overall Study|Other than specified|5|||
146268421|NCT02638103|527497195|FG001|Overall Study|Other than specified|4|||
146268422|NCT02638103|527497196|FG002|Overall Study|Other than specified|2|||
146268423|NCT02638103|527497197|FG003|Overall Study|Other than specified|4|||
146268424|NCT01358331|527497199|FG000|Overall Study|Lost to Follow-up|0|||
146268425|NCT01358331|527497200|FG001|Overall Study|Lost to Follow-up|0|||
146268426|NCT01358331|527497201|FG002|Overall Study|Lost to Follow-up|0|||
146268427|NCT01358331|527497202|FG003|Overall Study|Lost to Follow-up|1|||
146268428|NCT01358331|527497203|FG004|Overall Study|Lost to Follow-up|0|||
146268429|NCT01358331|527497204|FG005|Overall Study|Lost to Follow-up|0|||
146268430|NCT01358331|527497199|FG000|Overall Study|Withdrawal by Subject|0|||
146268431|NCT01358331|527497200|FG001|Overall Study|Withdrawal by Subject|0|||
146268432|NCT01358331|527497201|FG002|Overall Study|Withdrawal by Subject|0|||
146268433|NCT01358331|527497202|FG003|Overall Study|Withdrawal by Subject|1|||
146268434|NCT01358331|527497203|FG004|Overall Study|Withdrawal by Subject|1|||
146268435|NCT01358331|527497204|FG005|Overall Study|Withdrawal by Subject|1|||
146268436|NCT01358331|527497199|FG000|Overall Study|Adverse Events|1|||
146268437|NCT01358331|527497200|FG001|Overall Study|Adverse Events|1|||
146268438|NCT01358331|527497201|FG002|Overall Study|Adverse Events|1|||
146268439|NCT01358331|527497202|FG003|Overall Study|Adverse Events|0|||
146304070|NCT03250832|527627476|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146304071|NCT03250832|527627477|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146136790|NCT04019041|527018426|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146136791|NCT04019041|527018427|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146136792|NCT04019041|527018428|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
146136793|NCT04019041|527018429|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146136794|NCT04019041|527018430|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146136795|NCT04019041|527018431|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
146136796|NCT04019041|527018426|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146136797|NCT04019041|527018427|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146136798|NCT04019041|527018428|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146136799|NCT04019041|527018429|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
146136800|NCT04019041|527018430|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
146136801|NCT04019041|527018431|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
146136802|NCT04019041|527018426|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146136803|NCT04019041|527018427|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146136804|NCT04019041|527018428|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146136805|NCT04019041|527018429|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
146136806|NCT04019041|527018430|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146136807|NCT04019041|527018431|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
146136808|NCT04019041|527018426|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146136809|NCT04019041|527018427|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146136810|NCT04019041|527018428|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146136811|NCT04019041|527018429|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146136812|NCT04019041|527018430|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
146136813|NCT04019041|527018431|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
146136814|NCT04019041|527018426|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146136815|NCT04019041|527018427|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146136816|NCT04019041|527018428|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146136817|NCT04019041|527018429|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
146136818|NCT04019041|527018430|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
146136819|NCT04019041|527018431|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146136820|NCT04019041|527018426|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146136821|NCT04019041|527018427|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146136822|NCT04019041|527018428|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146136823|NCT04019041|527018429|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146136824|NCT04019041|527018430|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
146136825|NCT04019041|527018431|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
146136826|NCT02540954|527018432|FG000|Overall Study|Physician Decision|3|||
146268440|NCT01358331|527497203|FG004|Overall Study|Adverse Events|1|||
146268441|NCT01358331|527497204|FG005|Overall Study|Adverse Events|5|||
146268442|NCT01358331|527497199|FG000|Overall Study|Symptomatic Deterioration|0|||
146268443|NCT01358331|527497200|FG001|Overall Study|Symptomatic Deterioration|0|||
146268444|NCT01358331|527497201|FG002|Overall Study|Symptomatic Deterioration|0|||
146268445|NCT01358331|527497202|FG003|Overall Study|Symptomatic Deterioration|0|||
146268446|NCT01358331|527497203|FG004|Overall Study|Symptomatic Deterioration|1|||
146268447|NCT01358331|527497204|FG005|Overall Study|Symptomatic Deterioration|0|||
146268448|NCT01358331|527497199|FG000|Overall Study|Participants did not wish to continue|0|||
146268449|NCT01358331|527497200|FG001|Overall Study|Participants did not wish to continue|0|||
146268450|NCT01358331|527497201|FG002|Overall Study|Participants did not wish to continue|0|||
146268451|NCT01358331|527497202|FG003|Overall Study|Participants did not wish to continue|0|||
146268452|NCT01358331|527497203|FG004|Overall Study|Participants did not wish to continue|1|||
146268453|NCT01358331|527497204|FG005|Overall Study|Participants did not wish to continue|0|||
146268454|NCT01358331|527497199|FG000|Overall Study|Progress of disease under investigation|1|||
146268455|NCT01358331|527497200|FG001|Overall Study|Progress of disease under investigation|2|||
146268456|NCT01358331|527497201|FG002|Overall Study|Progress of disease under investigation|3|||
146268457|NCT01358331|527497202|FG003|Overall Study|Progress of disease under investigation|1|||
146268458|NCT01358331|527497203|FG004|Overall Study|Progress of disease under investigation|3|||
146268459|NCT01358331|527497204|FG005|Overall Study|Progress of disease under investigation|0|||
146268460|NCT04674189|527497205|FG000|Overall Study|Adverse Event|0|||
146268461|NCT04674189|527497206|FG001|Overall Study|Adverse Event|0|||
146268462|NCT04674189|527497207|FG002|Overall Study|Adverse Event|1|||
146268463|NCT04674189|527497205|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
146268464|NCT04674189|527497206|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
146268465|NCT04674189|527497207|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
146268466|NCT04674189|527497205|FG000|Overall Study|Physician Decision|1|||
146268467|NCT04674189|527497206|FG001|Overall Study|Physician Decision|0|||
146268468|NCT04674189|527497207|FG002|Overall Study|Physician Decision|0|||
146268469|NCT04674189|527497205|FG000|Overall Study|Withdrawal by Participant|83|||
146268470|NCT04674189|527497206|FG001|Overall Study|Withdrawal by Participant|71|||
146268471|NCT04674189|527497207|FG002|Overall Study|Withdrawal by Participant|142|||
146268472|NCT04674189|527497205|FG000|Overall Study|Lost to Follow-up|55|||
146268473|NCT04674189|527497206|FG001|Overall Study|Lost to Follow-up|53|||
146268474|NCT04674189|527497207|FG002|Overall Study|Lost to Follow-up|44|||
146268475|NCT04674189|527497205|FG000|Overall Study|Miscellaneous|27|||
146268476|NCT04674189|527497206|FG001|Overall Study|Miscellaneous|23|||
146268477|NCT04674189|527497207|FG002|Overall Study|Miscellaneous|207|||
146268478|NCT04674189|527497205|FG000|Overall Study|Did Not Receive Treatment|3|||
146268479|NCT04674189|527497206|FG001|Overall Study|Did Not Receive Treatment|1|||
146268480|NCT04674189|527497207|FG002|Overall Study|Did Not Receive Treatment|2|||
146268481|NCT02838134|527497208|FG000|Overall Study|Lost to Follow-up|1|||
146268482|NCT02838134|527497209|FG001|Overall Study|Lost to Follow-up|2|||
146268483|NCT02838134|527497208|FG000|Overall Study|logistic problems|1|||
146268484|NCT02838134|527497209|FG001|Overall Study|logistic problems|1|||
146268485|NCT01637077|527497210|FG000|Overall Study|Cancel|1|||
146268486|NCT01637077|527497211|FG001|Overall Study|Cancel|1|||
146268487|NCT01637077|527497210|FG000|Overall Study|Withdrawal by Subject|1|||
146268488|NCT01637077|527497211|FG001|Overall Study|Withdrawal by Subject|0|||
146268489|NCT01637077|527497210|FG000|Overall Study|No cycle 1 questionnaire data|2|||
146268490|NCT01637077|527497211|FG001|Overall Study|No cycle 1 questionnaire data|0|||
146268491|NCT00794924|527497212|FG000|Overall Study|Lost to Follow-up|6|||
146268492|NCT00794924|527497213|FG001|Overall Study|Lost to Follow-up|8|||
146268493|NCT00794924|527497212|FG000|Overall Study|Withdrawal by Subject|48|||
146268494|NCT00794924|527497213|FG001|Overall Study|Withdrawal by Subject|60|||
146268495|NCT00794924|527497212|FG000|Overall Study|Adverse Event|6|||
146268496|NCT00794924|527497213|FG001|Overall Study|Adverse Event|2|||
146268497|NCT03274895|527497214|FG000|Overall Study|Lack of Efficacy|1|||
146268498|NCT03274895|527497215|FG001|Overall Study|Lack of Efficacy|0|||
146268499|NCT03274895|527497214|FG000|Overall Study|Adverse Event|8|||
146268500|NCT03274895|527497215|FG001|Overall Study|Adverse Event|7|||
146268501|NCT03274895|527497214|FG000|Overall Study|Lost to Follow-up|1|||
146268502|NCT03274895|527497215|FG001|Overall Study|Lost to Follow-up|0|||
146268503|NCT03274895|527497214|FG000|Overall Study|Diagnosis not confirmed|3|||
146268504|NCT03274895|527497215|FG001|Overall Study|Diagnosis not confirmed|4|||
146268505|NCT01294436|527497216|FG000|Overall Study|Adverse Event|10|||
146268506|NCT01294436|527497217|FG001|Overall Study|Adverse Event|17|||
146268507|NCT01294436|527497216|FG000|Overall Study|Withdrawal by Subject|11|||
146268508|NCT01294436|527497217|FG001|Overall Study|Withdrawal by Subject|28|||
146268509|NCT01294436|527497216|FG000|Overall Study|subject no longer meets study criteria|5|||
146268510|NCT01294436|527497217|FG001|Overall Study|subject no longer meets study criteria|20|||
146268511|NCT01294436|527497216|FG000|Overall Study|poor/non-compliance|2|||
146268512|NCT01294436|527497217|FG001|Overall Study|poor/non-compliance|5|||
146268513|NCT02389764|527497218|FG000|Overall Study|Lack of Efficacy|9|||
146268514|NCT02498236|527497224|FG000|Overall Study|Did not show for testing|1|||
146268515|NCT02498236|527497225|FG001|Overall Study|Did not show for testing|0|||
146268516|NCT02498236|527497226|FG002|Overall Study|Did not show for testing|0|||
146268517|NCT02498236|527497227|FG003|Overall Study|Did not show for testing|0|||
146136827|NCT02540954|527018433|FG001|Overall Study|Physician Decision|1|||
146268518|NCT02498236|527497228|FG004|Overall Study|Did not show for testing|0|||
146268519|NCT02498236|527497229|FG005|Overall Study|Did not show for testing|0|||
146268520|NCT02498236|527497230|FG006|Overall Study|Did not show for testing|0|||
146268521|NCT02498236|527497231|FG007|Overall Study|Did not show for testing|1|||
146268522|NCT02498236|527497224|FG000|Overall Study|Equipment failure|0|||
146268523|NCT02498236|527497225|FG001|Overall Study|Equipment failure|0|||
146268524|NCT02498236|527497226|FG002|Overall Study|Equipment failure|0|||
146268525|NCT02498236|527497227|FG003|Overall Study|Equipment failure|0|||
146268526|NCT02498236|527497228|FG004|Overall Study|Equipment failure|0|||
146268527|NCT02498236|527497229|FG005|Overall Study|Equipment failure|0|||
146268528|NCT02498236|527497230|FG006|Overall Study|Equipment failure|1|||
146268529|NCT02498236|527497231|FG007|Overall Study|Equipment failure|0|||
146268530|NCT02498236|527497224|FG000|Overall Study|Withdrawal by Subject|0|||
146268531|NCT02498236|527497225|FG001|Overall Study|Withdrawal by Subject|0|||
146268532|NCT02498236|527497226|FG002|Overall Study|Withdrawal by Subject|0|||
146268533|NCT02498236|527497227|FG003|Overall Study|Withdrawal by Subject|0|||
146268534|NCT02498236|527497228|FG004|Overall Study|Withdrawal by Subject|1|||
146268535|NCT02498236|527497229|FG005|Overall Study|Withdrawal by Subject|0|||
146268536|NCT02498236|527497230|FG006|Overall Study|Withdrawal by Subject|0|||
146268537|NCT02498236|527497231|FG007|Overall Study|Withdrawal by Subject|0|||
146268538|NCT02296892|527497232|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
146268539|NCT02296892|527497233|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
146268540|NCT02296892|527497234|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
146268541|NCT02296892|527497232|FG000|Overall Study|Lost to Follow-up|5|||
146268542|NCT02296892|527497233|FG001|Overall Study|Lost to Follow-up|0|||
146268543|NCT02296892|527497234|FG002|Overall Study|Lost to Follow-up|1|||
146268544|NCT01814072|527497237|FG000|Overall Study|Lost to Follow-up|2|||
146268545|NCT01814072|527497238|FG001|Overall Study|Lost to Follow-up|2|||
146268546|NCT01814072|527497239|FG002|Overall Study|Lost to Follow-up|2|||
146268547|NCT01814072|527497240|FG003|Overall Study|Lost to Follow-up|0|||
146268548|NCT01814072|527497241|FG004|Overall Study|Lost to Follow-up|2|||
146268549|NCT01814072|527497242|FG005|Overall Study|Lost to Follow-up|3|||
146268550|NCT01814072|527497243|FG006|Overall Study|Lost to Follow-up|3|||
146268551|NCT01814072|527497244|FG007|Overall Study|Lost to Follow-up|1|||
146268552|NCT01814072|527497245|FG008|Overall Study|Lost to Follow-up|2|||
146268553|NCT01814072|527497246|FG009|Overall Study|Lost to Follow-up|3|||
146268554|NCT01814072|527497247|FG010|Overall Study|Lost to Follow-up|1|||
146268555|NCT01814072|527497248|FG011|Overall Study|Lost to Follow-up|2|||
146268556|NCT01814072|527497249|FG012|Overall Study|Lost to Follow-up|2|||
146268557|NCT01814072|527497250|FG013|Overall Study|Lost to Follow-up|1|||
146268558|NCT01814072|527497251|FG014|Overall Study|Lost to Follow-up|2|||
146268559|NCT01814072|527497252|FG015|Overall Study|Lost to Follow-up|1|||
146268560|NCT01814072|527497253|FG016|Overall Study|Lost to Follow-up|3|||
146268561|NCT01814072|527497254|FG017|Overall Study|Lost to Follow-up|1|||
146268562|NCT01814072|527497255|FG018|Overall Study|Lost to Follow-up|3|||
146268563|NCT01814072|527497256|FG019|Overall Study|Lost to Follow-up|3|||
146268564|NCT01814072|527497257|FG020|Overall Study|Lost to Follow-up|2|||
146268565|NCT01814072|527497258|FG021|Overall Study|Lost to Follow-up|1|||
146268566|NCT01814072|527497259|FG022|Overall Study|Lost to Follow-up|3|||
146268567|NCT01814072|527497260|FG023|Overall Study|Lost to Follow-up|1|||
146268568|NCT01814072|527497261|FG024|Overall Study|Lost to Follow-up|4|||
146268569|NCT01814072|527497262|FG025|Overall Study|Lost to Follow-up|1|||
146268570|NCT01814072|527497263|FG026|Overall Study|Lost to Follow-up|1|||
146268571|NCT01814072|527497264|FG027|Overall Study|Lost to Follow-up|2|||
146268572|NCT01814072|527497265|FG028|Overall Study|Lost to Follow-up|3|||
146268573|NCT01814072|527497266|FG029|Overall Study|Lost to Follow-up|3|||
146268574|NCT01814072|527497267|FG030|Overall Study|Lost to Follow-up|2|||
146268575|NCT01814072|527497268|FG031|Overall Study|Lost to Follow-up|0|||
146268576|NCT01814072|527497237|FG000|Overall Study|Withdrawal by Subject|2|||
146268577|NCT01814072|527497238|FG001|Overall Study|Withdrawal by Subject|0|||
146268578|NCT01814072|527497239|FG002|Overall Study|Withdrawal by Subject|1|||
146268579|NCT01814072|527497240|FG003|Overall Study|Withdrawal by Subject|0|||
146268580|NCT01814072|527497241|FG004|Overall Study|Withdrawal by Subject|2|||
146268581|NCT01814072|527497242|FG005|Overall Study|Withdrawal by Subject|3|||
146268582|NCT01814072|527497243|FG006|Overall Study|Withdrawal by Subject|1|||
146268583|NCT01814072|527497244|FG007|Overall Study|Withdrawal by Subject|0|||
146268584|NCT01814072|527497245|FG008|Overall Study|Withdrawal by Subject|1|||
146268585|NCT01814072|527497246|FG009|Overall Study|Withdrawal by Subject|2|||
146268586|NCT01814072|527497247|FG010|Overall Study|Withdrawal by Subject|0|||
146268587|NCT01814072|527497248|FG011|Overall Study|Withdrawal by Subject|0|||
146268588|NCT01814072|527497249|FG012|Overall Study|Withdrawal by Subject|1|||
146268589|NCT01814072|527497250|FG013|Overall Study|Withdrawal by Subject|1|||
146268590|NCT01814072|527497251|FG014|Overall Study|Withdrawal by Subject|1|||
146268591|NCT01814072|527497252|FG015|Overall Study|Withdrawal by Subject|1|||
146268592|NCT01814072|527497253|FG016|Overall Study|Withdrawal by Subject|0|||
146268593|NCT01814072|527497254|FG017|Overall Study|Withdrawal by Subject|0|||
146268594|NCT01814072|527497255|FG018|Overall Study|Withdrawal by Subject|0|||
146268595|NCT01814072|527497256|FG019|Overall Study|Withdrawal by Subject|2|||
146268596|NCT01814072|527497257|FG020|Overall Study|Withdrawal by Subject|0|||
146268597|NCT01814072|527497258|FG021|Overall Study|Withdrawal by Subject|0|||
146268598|NCT01814072|527497259|FG022|Overall Study|Withdrawal by Subject|1|||
146136828|NCT02540954|527018432|FG000|Overall Study|Withdrawal by Subject|6|||
146136829|NCT02540954|527018433|FG001|Overall Study|Withdrawal by Subject|5|||
146136830|NCT02540954|527018432|FG000|Overall Study|Lost to Follow-up|1|||
146136831|NCT02540954|527018433|FG001|Overall Study|Lost to Follow-up|1|||
146136832|NCT02540954|527018432|FG000|Overall Study|Adverse Event|4|||
146136833|NCT02540954|527018433|FG001|Overall Study|Adverse Event|2|||
146136834|NCT02540954|527018432|FG000|Overall Study|Death|0|||
146136835|NCT02540954|527018433|FG001|Overall Study|Death|3|||
146136836|NCT02540954|527018432|FG000|Overall Study|Treatment failure|1|||
146136837|NCT02540954|527018433|FG001|Overall Study|Treatment failure|0|||
146136838|NCT02540954|527018432|FG000|Overall Study|Other reason|4|||
146136839|NCT02540954|527018433|FG001|Overall Study|Other reason|2|||
146136840|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
146136841|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
146136842|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
146136843|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
146136844|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
146136845|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
146136846|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
146136847|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
146136848|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
146136849|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
146136850|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
146136851|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
146136852|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
146136853|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
146136854|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
146136855|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
146136856|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
146136857|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
146136858|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
146136859|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
146136860|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Other|3|||
146136861|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Other|0|||
146136862|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Other|2|||
146136863|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Other|2|||
146136864|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Other|7|||
146136865|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136866|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136867|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136868|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
146136869|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136870|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136871|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136872|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136873|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136874|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
146136875|NCT00213148|527018434|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
146136876|NCT00213148|527018435|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
146136877|NCT00213148|527018436|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
146136878|NCT00213148|527018437|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
146136879|NCT00213148|527018438|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
146136880|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
146136881|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
146136882|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
146136883|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
146136884|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
146136885|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
146136886|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
146136887|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
146136888|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
146268599|NCT01814072|527497260|FG023|Overall Study|Withdrawal by Subject|0|||
146268600|NCT01814072|527497261|FG024|Overall Study|Withdrawal by Subject|2|||
146268601|NCT01814072|527497262|FG025|Overall Study|Withdrawal by Subject|1|||
146136889|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
146268602|NCT01814072|527497263|FG026|Overall Study|Withdrawal by Subject|1|||
146268603|NCT01814072|527497264|FG027|Overall Study|Withdrawal by Subject|2|||
146136890|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Other|2|||
146136891|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Other|1|||
146136892|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Other|2|||
146136893|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Other|8|||
146136894|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Other|7|||
146136895|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136896|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
146136897|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136898|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146268604|NCT01814072|527497265|FG028|Overall Study|Withdrawal by Subject|1|||
146268605|NCT01814072|527497266|FG029|Overall Study|Withdrawal by Subject|0|||
146268606|NCT01814072|527497267|FG030|Overall Study|Withdrawal by Subject|0|||
146268607|NCT01814072|527497268|FG031|Overall Study|Withdrawal by Subject|0|||
146268608|NCT00383123|527497269|FG000|Overall Study|Adverse Event|1|||
146268609|NCT00383123|527497270|FG001|Overall Study|Adverse Event|0|||
146268610|NCT00383123|527497269|FG000|Overall Study|Lost to Follow-up|68|||
146268611|NCT00383123|527497270|FG001|Overall Study|Lost to Follow-up|61|||
146268612|NCT00383123|527497269|FG000|Overall Study|Protocol Violation|5|||
146268613|NCT00383123|527497270|FG001|Overall Study|Protocol Violation|1|||
146268614|NCT00383123|527497269|FG000|Overall Study|Withdrawal by Subject|27|||
146268615|NCT00383123|527497270|FG001|Overall Study|Withdrawal by Subject|18|||
146268616|NCT00383123|527497269|FG000|Overall Study|Other reason|10|||
146268617|NCT00383123|527497270|FG001|Overall Study|Other reason|6|||
146268618|NCT03566979|527497272|FG000|Overall Study|Withdrawal by Subject|2|||
146268619|NCT03566979|527497273|FG001|Overall Study|Withdrawal by Subject|0|||
146268620|NCT03566979|527497274|FG002|Overall Study|Withdrawal by Subject|1|||
146268621|NCT03566979|527497275|FG003|Overall Study|Withdrawal by Subject|1|||
146268622|NCT03566979|527497272|FG000|Overall Study|Lost to Follow-up|2|||
146268623|NCT03566979|527497273|FG001|Overall Study|Lost to Follow-up|7|||
146268624|NCT03566979|527497274|FG002|Overall Study|Lost to Follow-up|9|||
146268625|NCT03566979|527497275|FG003|Overall Study|Lost to Follow-up|5|||
146268626|NCT03566979|527497272|FG000|Overall Study|Adverse Event|1|||
146268627|NCT03566979|527497273|FG001|Overall Study|Adverse Event|0|||
146268628|NCT03566979|527497274|FG002|Overall Study|Adverse Event|0|||
146268629|NCT03566979|527497275|FG003|Overall Study|Adverse Event|0|||
146268630|NCT04547023|527497282|FG000|Overall Study|Did Not Receive Intervention|3|||
146268631|NCT04547023|527497283|FG001|Overall Study|Did Not Receive Intervention|2|||
146268632|NCT04547023|527497282|FG000|Overall Study|Lost to Follow-up|1|||
146268633|NCT04547023|527497283|FG001|Overall Study|Lost to Follow-up|1|||
146268634|NCT01011868|527497284|FG000|After Week 18 Follow-up|Adverse Event|8|||
146268635|NCT01011868|527497285|FG001|After Week 18 Follow-up|Adverse Event|6|||
146268636|NCT01011868|527497286|FG002|After Week 18 Follow-up|Adverse Event|13|||
146268637|NCT01011868|527497284|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
146268638|NCT01011868|527497285|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
146268639|NCT01011868|527497286|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
146268640|NCT01011868|527497284|FG000|After Week 18 Follow-up|Protocol Violation|1|||
146268641|NCT01011868|527497285|FG001|After Week 18 Follow-up|Protocol Violation|1|||
146268642|NCT01011868|527497286|FG002|After Week 18 Follow-up|Protocol Violation|1|||
146268643|NCT01011868|527497284|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
146268644|NCT01011868|527497285|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
146268645|NCT01011868|527497286|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
146268646|NCT01011868|527497284|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
146268647|NCT01011868|527497285|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
146268648|NCT01011868|527497286|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
146268649|NCT01011868|527497284|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
146268650|NCT01011868|527497285|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
146268651|NCT01011868|527497286|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
146268652|NCT01011868|527497284|FG000|After Week 78 Follow-up|Adverse Event|14|||
146268653|NCT01011868|527497285|FG001|After Week 78 Follow-up|Adverse Event|18|||
146268654|NCT01011868|527497286|FG002|After Week 78 Follow-up|Adverse Event|21|||
146268655|NCT01011868|527497284|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
146268656|NCT01011868|527497285|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
146268657|NCT01011868|527497286|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
146268658|NCT01011868|527497284|FG000|After Week 78 Follow-up|Protocol Violation|9|||
146268659|NCT01011868|527497285|FG001|After Week 78 Follow-up|Protocol Violation|1|||
146268660|NCT01011868|527497286|FG002|After Week 78 Follow-up|Protocol Violation|2|||
146268661|NCT01011868|527497284|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
146268662|NCT01011868|527497285|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
146268663|NCT01011868|527497286|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
146268664|NCT01011868|527497284|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
146268665|NCT01011868|527497285|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
146268666|NCT01011868|527497286|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
146268667|NCT01011868|527497284|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
146268668|NCT01011868|527497285|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
146268669|NCT01011868|527497286|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
146304072|NCT03250832|527627478|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146268670|NCT01262092|527497287|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
146268671|NCT01262092|527497288|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
146268672|NCT01262092|527497287|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
146268673|NCT01262092|527497288|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
146268674|NCT01262092|527497287|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
146268675|NCT01262092|527497288|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
146136899|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
146136900|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
146136901|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136902|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136903|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136904|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
146136905|NCT00213148|527018434|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
146136906|NCT00213148|527018435|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
146136907|NCT00213148|527018436|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
146136908|NCT00213148|527018437|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
146136909|NCT00213148|527018438|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
146136910|NCT00213148|527018434|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146136911|NCT00213148|527018435|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
146136912|NCT00213148|527018436|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146136913|NCT00213148|527018437|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
146136914|NCT00213148|527018438|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
146136915|NCT00213148|527018434|FG000|Cycle 3 (1 Month)|Other|0|||
146136916|NCT00213148|527018435|FG001|Cycle 3 (1 Month)|Other|0|||
146136917|NCT00213148|527018436|FG002|Cycle 3 (1 Month)|Other|1|||
146136918|NCT00213148|527018437|FG003|Cycle 3 (1 Month)|Other|1|||
146136919|NCT00213148|527018438|FG004|Cycle 3 (1 Month)|Other|0|||
146136920|NCT00245765|527018440|FG000|Overall Study|Adverse Event|1|||
146136921|NCT00245765|527018441|FG001|Overall Study|Adverse Event|1|||
146136922|NCT00245765|527018442|FG002|Overall Study|Adverse Event|0|||
146136923|NCT00245765|527018440|FG000|Overall Study|Lack of Efficacy|14|||
146136924|NCT00245765|527018441|FG001|Overall Study|Lack of Efficacy|7|||
146136925|NCT00245765|527018442|FG002|Overall Study|Lack of Efficacy|0|||
146136926|NCT00245765|527018440|FG000|Overall Study|Lost to Follow-up|1|||
146136927|NCT00245765|527018441|FG001|Overall Study|Lost to Follow-up|2|||
146136928|NCT00245765|527018442|FG002|Overall Study|Lost to Follow-up|0|||
146136929|NCT00245765|527018440|FG000|Overall Study|Withdrawal by Subject|1|||
146136930|NCT00245765|527018441|FG001|Overall Study|Withdrawal by Subject|0|||
146136931|NCT00245765|527018442|FG002|Overall Study|Withdrawal by Subject|3|||
146136932|NCT00245765|527018440|FG000|Overall Study|Other reason|2|||
146136933|NCT00245765|527018441|FG001|Overall Study|Other reason|0|||
146136934|NCT00245765|527018442|FG002|Overall Study|Other reason|1|||
146136935|NCT00245765|527018440|FG000|Overall Study|Other|13|||
146136936|NCT00245765|527018441|FG001|Overall Study|Other|4|||
146136937|NCT00245765|527018442|FG002|Overall Study|Other|4|||
146136938|NCT03080961|527018443|FG000|Overall Study|Withdrawal by Subject|3|||
146136939|NCT02741115|527018444|FG000|Overall Study|Adverse Event|1|||
146136940|NCT02741115|527018445|FG001|Overall Study|Adverse Event|0|||
146136941|NCT02741115|527018444|FG000|Overall Study|Lost to Follow-up|7|||
146136942|NCT02741115|527018445|FG001|Overall Study|Lost to Follow-up|4|||
146136943|NCT02741115|527018444|FG000|Overall Study|Withdrawal by Subject|4|||
146136944|NCT02741115|527018445|FG001|Overall Study|Withdrawal by Subject|2|||
146136945|NCT04602624|527018446|FG000|Overall Study|Protocol Deviation|1|||
146136946|NCT04602624|527018446|FG000|Overall Study|Withdrawal by Participant|1|||
146136947|NCT06425458|527018447|FG000|Overall Study|Removed by study team|2|||
146136948|NCT06425458|527018447|FG000|Overall Study|Lost to Follow-up|5|||
146136949|NCT03945981|527018450|FG000|Overall Study|Lost to Follow-up|12|||
146136950|NCT03945981|527018450|FG000|Overall Study|Physician Decision|4|||
146136951|NCT03945981|527018450|FG000|Overall Study|Withdrawal by Subject|6|||
146136952|NCT03945981|527018450|FG000|Overall Study|Protocol Violation|1|||
146136953|NCT02177266|527019510|FG000|Overall Study|Adverse Event|0|||
146136954|NCT02177266|527019511|FG001|Overall Study|Adverse Event|1|||
146136955|NCT02177266|527019510|FG000|Overall Study|Withdrawal by Subject|1|||
146136956|NCT02177266|527019511|FG001|Overall Study|Withdrawal by Subject|0|||
146136957|NCT03364049|527019513|FG000|Overall Study|Death|6|||
146136958|NCT03364049|527019514|FG001|Overall Study|Death|4|||
146268676|NCT01262092|527497287|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
146136959|NCT03364049|527019515|FG002|Overall Study|Death|5|||
146136960|NCT03364049|527019516|FG003|Overall Study|Death|14|||
146136961|NCT03364049|527019513|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146136962|NCT03364049|527019514|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
146136963|NCT03364049|527019515|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146136964|NCT03364049|527019516|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
146136965|NCT03364049|527019513|FG000|Overall Study|Withdrawal by Subject|0|||
146136966|NCT03364049|527019514|FG001|Overall Study|Withdrawal by Subject|1|||
146136967|NCT03364049|527019515|FG002|Overall Study|Withdrawal by Subject|1|||
146268677|NCT01262092|527497288|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
146268678|NCT03784820|527497289|FG000|Overall Study|Lost to Follow-up|5|||
146136968|NCT03364049|527019516|FG003|Overall Study|Withdrawal by Subject|1|||
146136969|NCT00546715|527019517|FG000|Overall Study|Withdrawal by Subject|0|||
146136970|NCT00546715|527019518|FG001|Overall Study|Withdrawal by Subject|1|||
146268679|NCT03784820|527497290|FG001|Overall Study|Lost to Follow-up|5|||
146268680|NCT03784820|527497291|FG002|Overall Study|Lost to Follow-up|3|||
146268681|NCT03784820|527497292|FG003|Overall Study|Lost to Follow-up|3|||
146268682|NCT01255761|527497293|FG000|Overall Study|Adverse Event|29|||
146268683|NCT01255761|527497294|FG001|Overall Study|Adverse Event|43|||
146268684|NCT01255761|527497293|FG000|Overall Study|Lack of Efficacy|86|||
146268685|NCT01255761|527497294|FG001|Overall Study|Lack of Efficacy|74|||
146268686|NCT01255761|527497293|FG000|Overall Study|Protocol Violation|9|||
146268687|NCT01255761|527497294|FG001|Overall Study|Protocol Violation|5|||
146268688|NCT01255761|527497293|FG000|Overall Study|Lost to Follow-up|10|||
146268689|NCT01255761|527497294|FG001|Overall Study|Lost to Follow-up|8|||
146268690|NCT01255761|527497293|FG000|Overall Study|Withdrawal by Subject|11|||
146268691|NCT01255761|527497294|FG001|Overall Study|Withdrawal by Subject|27|||
146268692|NCT01255761|527497293|FG000|Overall Study|Other Reasons|37|||
146268693|NCT01255761|527497294|FG001|Overall Study|Other Reasons|18|||
146268694|NCT04147858|527497296|FG000|Overall Study|Adverse Event|6|||
146268695|NCT04147858|527497297|FG001|Overall Study|Adverse Event|6|||
146268696|NCT04147858|527497298|FG002|Overall Study|Adverse Event|6|||
146268697|NCT04147858|527497296|FG000|Overall Study|Lack of Efficacy|3|||
146268698|NCT04147858|527497297|FG001|Overall Study|Lack of Efficacy|3|||
146268699|NCT04147858|527497298|FG002|Overall Study|Lack of Efficacy|1|||
146268700|NCT04147858|527497296|FG000|Overall Study|Lost to Follow-up|1|||
146268701|NCT04147858|527497297|FG001|Overall Study|Lost to Follow-up|6|||
146268702|NCT04147858|527497298|FG002|Overall Study|Lost to Follow-up|2|||
146268703|NCT04147858|527497296|FG000|Overall Study|Withdrawal by Subject|3|||
146268704|NCT04147858|527497297|FG001|Overall Study|Withdrawal by Subject|4|||
146268705|NCT04147858|527497298|FG002|Overall Study|Withdrawal by Subject|10|||
146268706|NCT04147858|527497296|FG000|Overall Study|Subject Noncompliance, Other|4|||
146268707|NCT04147858|527497297|FG001|Overall Study|Subject Noncompliance, Other|3|||
146268708|NCT04147858|527497298|FG002|Overall Study|Subject Noncompliance, Other|1|||
146268709|NCT02336425|527497299|FG000|Overall Study|Study terminated.|2|||
146268710|NCT02336425|527497300|FG001|Overall Study|Study terminated.|2|||
146268711|NCT02336425|527497301|FG002|Overall Study|Study terminated.|3|||
146268712|NCT02336425|527497302|FG003|Overall Study|Study terminated.|3|||
146268713|NCT04946942|527497309|FG000|Overall Study|Lost to Follow-up|6|||
146268714|NCT04946942|527497310|FG001|Overall Study|Lost to Follow-up|2|||
146268715|NCT04946942|527497311|FG002|Overall Study|Lost to Follow-up|0|||
146268716|NCT04907357|527497312|FG000|Overall Study|Death|0|||
146268717|NCT04907357|527497313|FG001|Overall Study|Death|1|||
146268718|NCT04907357|527497312|FG000|Overall Study|Lost to Follow-up|9|||
146268719|NCT04907357|527497313|FG001|Overall Study|Lost to Follow-up|18|||
146268720|NCT04907357|527497312|FG000|Overall Study|Physician Decision|1|||
146268721|NCT04907357|527497313|FG001|Overall Study|Physician Decision|0|||
146268722|NCT04907357|527497312|FG000|Overall Study|Withdrawal by Subject|0|||
146268723|NCT04907357|527497313|FG001|Overall Study|Withdrawal by Subject|1|||
146268724|NCT04907357|527497312|FG000|Overall Study|Unable to attend visits|1|||
146268725|NCT04907357|527497313|FG001|Overall Study|Unable to attend visits|0|||
146268726|NCT04907357|527497312|FG000|Overall Study|Incarcerated|1|||
146268727|NCT04907357|527497313|FG001|Overall Study|Incarcerated|1|||
146268728|NCT00365547|527497314|FG000|Overall Study|Insurance did not cover Avastin|1|||
146268729|NCT00365547|527497314|FG000|Overall Study|Screen failure|1|||
146268730|NCT00365547|527497314|FG000|Overall Study|Withdrawal by Subject|1|||
146268731|NCT03170518|527497315|FG000|Overall Study|Lost to Follow-up|4|||
146268732|NCT03170518|527497316|FG001|Overall Study|Lost to Follow-up|1|||
146268733|NCT03170518|527497317|FG002|Overall Study|Lost to Follow-up|0|||
146268734|NCT03170518|527497315|FG000|Overall Study|Physician Decision|1|||
146268735|NCT03170518|527497316|FG001|Overall Study|Physician Decision|0|||
146268736|NCT03170518|527497317|FG002|Overall Study|Physician Decision|0|||
146268737|NCT03170518|527497315|FG000|Overall Study|Withdrawal by Subject|4|||
146268738|NCT03170518|527497316|FG001|Overall Study|Withdrawal by Subject|5|||
146268739|NCT03170518|527497317|FG002|Overall Study|Withdrawal by Subject|2|||
146268740|NCT03170518|527497315|FG000|Overall Study|Site terminated by sponsor|0|||
146268741|NCT03170518|527497316|FG001|Overall Study|Site terminated by sponsor|1|||
146268742|NCT03170518|527497317|FG002|Overall Study|Site terminated by sponsor|0|||
146268743|NCT03170518|527497315|FG000|Overall Study|Non-compliance with study drug|1|||
146268744|NCT03170518|527497316|FG001|Overall Study|Non-compliance with study drug|0|||
146268745|NCT03170518|527497317|FG002|Overall Study|Non-compliance with study drug|1|||
146268746|NCT03170518|527497315|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146268747|NCT03170518|527497316|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146268748|NCT03170518|527497317|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146268749|NCT00546078|527497318|FG000|Overall Study|Lost to Follow-up|1|||
146268750|NCT00546078|527497319|FG001|Overall Study|Lost to Follow-up|3|||
146268751|NCT00546078|527497318|FG000|Overall Study|Withdrawal by Subject|2|||
146268752|NCT00546078|527497319|FG001|Overall Study|Withdrawal by Subject|3|||
146268753|NCT00546078|527497318|FG000|Overall Study|Other reason|1|||
146268754|NCT00546078|527497319|FG001|Overall Study|Other reason|1|||
146268755|NCT02257918|527497320|FG000|Overall Study|Lost to Follow-up|4|||
146268756|NCT02257918|527497321|FG001|Overall Study|Lost to Follow-up|1|||
146268757|NCT02257918|527497322|FG002|Overall Study|Lost to Follow-up|0|||
146268758|NCT02257918|527497320|FG000|Overall Study|Withdrawal by Subject|0|||
146268759|NCT02257918|527497321|FG001|Overall Study|Withdrawal by Subject|0|||
146268760|NCT02257918|527497322|FG002|Overall Study|Withdrawal by Subject|1|||
146268761|NCT02257918|527497320|FG000|Overall Study|Pregnancy|0|||
146268762|NCT02257918|527497321|FG001|Overall Study|Pregnancy|0|||
146268763|NCT02257918|527497322|FG002|Overall Study|Pregnancy|1|||
146268764|NCT03023423|527497323|FG000|Overall Study|Death|5|||
146268765|NCT03023423|527497324|FG001|Overall Study|Death|12|||
146268766|NCT03023423|527497325|FG002|Overall Study|Death|20|||
146268767|NCT03023423|527497323|FG000|Overall Study|Other|0|||
146268768|NCT03023423|527497324|FG001|Overall Study|Other|2|||
146268769|NCT03023423|527497325|FG002|Overall Study|Other|2|||
146268770|NCT03023423|527497323|FG000|Overall Study|Ongoing|2|||
146268771|NCT03023423|527497324|FG001|Overall Study|Ongoing|32|||
146136971|NCT00546715|527019519|FG002|Overall Study|Withdrawal by Subject|0|||
146136972|NCT00546715|527019520|FG003|Overall Study|Withdrawal by Subject|0|||
146136973|NCT00418691|527019521|FG000|Overall Study|Lost to Follow-up|1|||
146136974|NCT00418691|527019522|FG001|Overall Study|Lost to Follow-up|2|||
146136975|NCT00418691|527019523|FG002|Overall Study|Lost to Follow-up|3|||
146136976|NCT00418691|527019521|FG000|Overall Study|Started new medication voiding entry|0|||
146136977|NCT00418691|527019522|FG001|Overall Study|Started new medication voiding entry|0|||
146136978|NCT00418691|527019523|FG002|Overall Study|Started new medication voiding entry|1|||
146136979|NCT00418691|527019521|FG000|Overall Study|Progressive Disease|1|||
146136980|NCT00418691|527019522|FG001|Overall Study|Progressive Disease|0|||
146136981|NCT00418691|527019523|FG002|Overall Study|Progressive Disease|1|||
146136982|NCT01802775|527019524|FG000|Overall Study|Death|0|||
146136983|NCT01802775|527019525|FG001|Overall Study|Death|3|||
146136984|NCT01802775|527019524|FG000|Overall Study|Reason not provided|0|||
146136985|NCT01802775|527019525|FG001|Overall Study|Reason not provided|1|||
146136986|NCT01802775|527019524|FG000|Overall Study|Physician Decision|1|||
146136987|NCT01802775|527019525|FG001|Overall Study|Physician Decision|0|||
146136988|NCT01802775|527019524|FG000|Overall Study|Adverse Event|1|||
146136989|NCT01802775|527019525|FG001|Overall Study|Adverse Event|1|||
146136990|NCT01802775|527019524|FG000|Overall Study|Withdrawal by Subject|3|||
146136991|NCT01802775|527019525|FG001|Overall Study|Withdrawal by Subject|5|||
146136992|NCT01802775|527019524|FG000|Overall Study|Lost to Follow-up|1|||
146136993|NCT01802775|527019525|FG001|Overall Study|Lost to Follow-up|2|||
146136994|NCT01096784|527019526|FG000|Overall Study|Withdrawal by Subject|2|||
146136995|NCT01096784|527019527|FG001|Overall Study|Withdrawal by Subject|1|||
146136996|NCT01096784|527019526|FG000|Overall Study|Adverse Event|11|||
146136997|NCT01096784|527019527|FG001|Overall Study|Adverse Event|9|||
146136998|NCT01096784|527019526|FG000|Overall Study|Protocol Deviation|2|||
146136999|NCT01096784|527019527|FG001|Overall Study|Protocol Deviation|2|||
146137000|NCT01096784|527019526|FG000|Overall Study|Administrative Decision|0|||
146137001|NCT01096784|527019527|FG001|Overall Study|Administrative Decision|1|||
146137002|NCT01096784|527019526|FG000|Overall Study|Other Unspecified|0|||
146137003|NCT01096784|527019527|FG001|Overall Study|Other Unspecified|1|||
146137004|NCT03761628|527019528|FG000|Overall Study|Withdrawal by Subject|3|||
146137005|NCT03761628|527019528|FG000|Overall Study|Physician Decision|1|||
146137006|NCT03761628|527019528|FG000|Overall Study|Pregnancy|1|||
146137007|NCT03761628|527019528|FG000|Overall Study|Lost to Follow-up|1|||
146137008|NCT04649151|527019531|FG000|Overall Study|Pregnancy|0|||
146137009|NCT04649151|527019532|FG001|Overall Study|Pregnancy|0|||
146137010|NCT04649151|527019533|FG002|Overall Study|Pregnancy|0|||
146137011|NCT04649151|527019534|FG003|Overall Study|Pregnancy|0|||
146137012|NCT04649151|527019535|FG004|Overall Study|Pregnancy|3|||
146268772|NCT03023423|527497325|FG002|Overall Study|Ongoing|24|||
146268773|NCT03512197|527497326|FG000|Overall Study|Guardian decision|1|||
146268774|NCT03512197|527497327|FG001|Overall Study|Guardian decision|1|||
146137013|NCT04649151|527019531|FG000|Overall Study|Physician Decision|10|||
146137014|NCT04649151|527019532|FG001|Overall Study|Physician Decision|0|||
146137015|NCT04649151|527019533|FG002|Overall Study|Physician Decision|0|||
146137016|NCT04649151|527019534|FG003|Overall Study|Physician Decision|1|||
146137017|NCT04649151|527019535|FG004|Overall Study|Physician Decision|1|||
146137018|NCT04649151|527019531|FG000|Overall Study|Protocol Deviation|25|||
146137019|NCT04649151|527019532|FG001|Overall Study|Protocol Deviation|3|||
146137020|NCT04649151|527019533|FG002|Overall Study|Protocol Deviation|0|||
146137021|NCT04649151|527019534|FG003|Overall Study|Protocol Deviation|0|||
146268775|NCT03512197|527497326|FG000|Overall Study|Lack of Efficacy|19|||
146268776|NCT03512197|527497327|FG001|Overall Study|Lack of Efficacy|11|||
146268777|NCT03512197|527497326|FG000|Overall Study|New Therapy for Study Indication|16|||
146137022|NCT04649151|527019535|FG004|Overall Study|Protocol Deviation|0|||
146137023|NCT04649151|527019531|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
146137024|NCT04649151|527019532|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
146137025|NCT04649151|527019533|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146137026|NCT04649151|527019534|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146137027|NCT04649151|527019535|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
146268778|NCT03512197|527497327|FG001|Overall Study|New Therapy for Study Indication|16|||
146268779|NCT03512197|527497326|FG000|Overall Study|Physician Decision|60|||
146268780|NCT03512197|527497327|FG001|Overall Study|Physician Decision|60|||
146268781|NCT03512197|527497326|FG000|Overall Study|Protocol Violation|0|||
146268782|NCT03512197|527497327|FG001|Overall Study|Protocol Violation|2|||
146268783|NCT03512197|527497326|FG000|Overall Study|Terminated by Sponsored|46|||
146268784|NCT03512197|527497327|FG001|Overall Study|Terminated by Sponsored|50|||
146268785|NCT03512197|527497326|FG000|Overall Study|Subject Decision|15|||
146268786|NCT03512197|527497327|FG001|Overall Study|Subject Decision|12|||
146268787|NCT03512197|527497326|FG000|Overall Study|Withdrawal of informed consent|20|||
146268788|NCT03512197|527497327|FG001|Overall Study|Withdrawal of informed consent|14|||
146268789|NCT03512197|527497326|FG000|Overall Study|Adverse Event|30|||
146268790|NCT03512197|527497327|FG001|Overall Study|Adverse Event|34|||
146268791|NCT03512197|527497326|FG000|Overall Study|Death|14|||
146268792|NCT03512197|527497327|FG001|Overall Study|Death|9|||
146268793|NCT03512197|527497326|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
146268794|NCT03512197|527497327|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
146268795|NCT03512197|527497326|FG000|Overall Study|Missing|3|||
146268796|NCT03512197|527497327|FG001|Overall Study|Missing|13|||
146268797|NCT03842436|527497328|FG000|Overall Study|Lost to Follow-up|1|||
146268798|NCT01263054|527497332|FG000|Overall Study|Death|1|||
146268799|NCT01263054|527497333|FG001|Overall Study|Death|0|||
146268800|NCT01263054|527497332|FG000|Overall Study|Lost to Follow-up|2|||
146268801|NCT01263054|527497333|FG001|Overall Study|Lost to Follow-up|2|||
146268802|NCT01263054|527497332|FG000|Overall Study|Withdrawal by Subject|1|||
146268803|NCT01263054|527497333|FG001|Overall Study|Withdrawal by Subject|3|||
146268804|NCT01263054|527497332|FG000|Overall Study|Qualification Violation|1|||
146268805|NCT01263054|527497333|FG001|Overall Study|Qualification Violation|0|||
146268806|NCT01263054|527497332|FG000|Overall Study|Other|0|||
146268807|NCT01263054|527497333|FG001|Overall Study|Other|1|||
146268808|NCT00936598|527497334|FG000|Overall Study|Withdrawal by Subject|1|||
146268809|NCT00936598|527497335|FG001|Overall Study|Withdrawal by Subject|0|||
146268810|NCT00936598|527497334|FG000|Overall Study|Ineligible after consent|1|||
146268811|NCT00936598|527497335|FG001|Overall Study|Ineligible after consent|0|||
146268812|NCT03358238|527497337|FG000|Overall Study|Withdrawal by Subject|0|||
146268813|NCT03358238|527497338|FG001|Overall Study|Withdrawal by Subject|1|||
146268814|NCT04277507|527497341|FG000|Overall Study|Lost to Follow-up|17|||
146268815|NCT04277507|527497341|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
146268816|NCT04277507|527497341|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
146268817|NCT04277507|527497341|FG000|Overall Study|Withdrawal by Subject|3|||
146268818|NCT04277507|527497341|FG000|Overall Study|Death due to COVID-19|1|||
146268819|NCT04277507|527497341|FG000|Overall Study|Data missing for full evaluation|5|||
146268820|NCT01431950|527497342|FG000|Overall Study|Study Site Closed/Terminated|7|||
146268821|NCT01431950|527497343|FG001|Overall Study|Study Site Closed/Terminated|3|||
146268822|NCT01431950|527497342|FG000|Overall Study|Withdrawal by Subject|4|||
146268823|NCT01431950|527497343|FG001|Overall Study|Withdrawal by Subject|3|||
146268824|NCT01431950|527497342|FG000|Overall Study|Protocol Violation|2|||
146268825|NCT01431950|527497343|FG001|Overall Study|Protocol Violation|3|||
146268826|NCT01431950|527497342|FG000|Overall Study|Adverse Event|2|||
146268827|NCT01431950|527497343|FG001|Overall Study|Adverse Event|2|||
146268828|NCT01431950|527497342|FG000|Overall Study|Physician Decision|2|||
146268829|NCT01431950|527497343|FG001|Overall Study|Physician Decision|1|||
146268830|NCT01431950|527497342|FG000|Overall Study|Lack of Efficacy|2|||
146268831|NCT01431950|527497343|FG001|Overall Study|Lack of Efficacy|1|||
146268832|NCT01431950|527497342|FG000|Overall Study|Lost to Follow-up|0|||
146268833|NCT01431950|527497343|FG001|Overall Study|Lost to Follow-up|1|||
146268834|NCT01431950|527497342|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146268835|NCT01431950|527497343|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146268836|NCT04577573|527497344|FG000|Overall Study|Technical - invalid protocol|0|||
146268837|NCT04577573|527497345|FG001|Overall Study|Technical - invalid protocol|2|||
146268838|NCT04577573|527497346|FG002|Overall Study|Technical - invalid protocol|0|||
146268839|NCT04297618|527497347|FG000|Overall Study|Adverse Event|1|||
146268840|NCT04297618|527497347|FG000|Overall Study|Withdrawal by Subject|1|||
146268841|NCT04949802|527499412|FG000|Overall Study|Lost to Follow-up|3|||
146268842|NCT02358668|527499418|FG000|Overall Study|Adverse Event|2|||
146268843|NCT02358668|527499419|FG001|Overall Study|Adverse Event|0|||
146268844|NCT02358668|527499420|FG002|Overall Study|Adverse Event|0|||
146268845|NCT02358668|527499418|FG000|Overall Study|Withdrawal by Subject|0|||
146268846|NCT02358668|527499419|FG001|Overall Study|Withdrawal by Subject|1|||
146268847|NCT02358668|527499420|FG002|Overall Study|Withdrawal by Subject|0|||
146268848|NCT02419417|527499423|FG000|Overall Study|Disease progression|5|||
146268849|NCT02419417|527499424|FG001|Overall Study|Disease progression|4|||
146268850|NCT02419417|527499425|FG002|Overall Study|Disease progression|13|||
146268851|NCT02419417|527499426|FG003|Overall Study|Disease progression|10|||
146268852|NCT02419417|527499427|FG004|Overall Study|Disease progression|10|||
146268853|NCT02419417|527499428|FG005|Overall Study|Disease progression|3|||
146268854|NCT02419417|527499429|FG006|Overall Study|Disease progression|4|||
146268855|NCT02419417|527499430|FG007|Overall Study|Disease progression|5|||
146268856|NCT02419417|527499431|FG008|Overall Study|Disease progression|13|||
146268857|NCT02419417|527499432|FG009|Overall Study|Disease progression|9|||
146268858|NCT02419417|527499433|FG010|Overall Study|Disease progression|0|||
146268859|NCT02419417|527499423|FG000|Overall Study|Study drug toxicity|0|||
146268860|NCT02419417|527499424|FG001|Overall Study|Study drug toxicity|0|||
146268861|NCT02419417|527499425|FG002|Overall Study|Study drug toxicity|0|||
146268862|NCT02419417|527499426|FG003|Overall Study|Study drug toxicity|0|||
146268863|NCT02419417|527499427|FG004|Overall Study|Study drug toxicity|1|||
146268864|NCT02419417|527499428|FG005|Overall Study|Study drug toxicity|0|||
146268865|NCT02419417|527499429|FG006|Overall Study|Study drug toxicity|0|||
146268866|NCT02419417|527499430|FG007|Overall Study|Study drug toxicity|0|||
146268867|NCT02419417|527499431|FG008|Overall Study|Study drug toxicity|0|||
146268868|NCT02419417|527499432|FG009|Overall Study|Study drug toxicity|0|||
146268869|NCT02419417|527499433|FG010|Overall Study|Study drug toxicity|0|||
146268870|NCT02419417|527499423|FG000|Overall Study|Adverse event unrelated to study drug|0|||
146268871|NCT02419417|527499424|FG001|Overall Study|Adverse event unrelated to study drug|0|||
146268872|NCT02419417|527499425|FG002|Overall Study|Adverse event unrelated to study drug|0|||
146268873|NCT02419417|527499426|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146268874|NCT02419417|527499427|FG004|Overall Study|Adverse event unrelated to study drug|2|||
146268875|NCT02419417|527499428|FG005|Overall Study|Adverse event unrelated to study drug|1|||
146268876|NCT02419417|527499429|FG006|Overall Study|Adverse event unrelated to study drug|0|||
146268877|NCT02419417|527499430|FG007|Overall Study|Adverse event unrelated to study drug|1|||
146268878|NCT02419417|527499431|FG008|Overall Study|Adverse event unrelated to study drug|0|||
146268879|NCT02419417|527499432|FG009|Overall Study|Adverse event unrelated to study drug|0|||
146268880|NCT02419417|527499433|FG010|Overall Study|Adverse event unrelated to study drug|0|||
146268881|NCT02419417|527499423|FG000|Overall Study|Participant request to discontinue|0|||
146268882|NCT02419417|527499424|FG001|Overall Study|Participant request to discontinue|0|||
146268883|NCT02419417|527499425|FG002|Overall Study|Participant request to discontinue|0|||
146268884|NCT02419417|527499426|FG003|Overall Study|Participant request to discontinue|0|||
146268885|NCT02419417|527499427|FG004|Overall Study|Participant request to discontinue|0|||
146268886|NCT02419417|527499428|FG005|Overall Study|Participant request to discontinue|0|||
146268887|NCT02419417|527499429|FG006|Overall Study|Participant request to discontinue|0|||
146268888|NCT02419417|527499430|FG007|Overall Study|Participant request to discontinue|0|||
146268889|NCT02419417|527499431|FG008|Overall Study|Participant request to discontinue|0|||
146268890|NCT02419417|527499432|FG009|Overall Study|Participant request to discontinue|1|||
146268891|NCT02419417|527499433|FG010|Overall Study|Participant request to discontinue|0|||
146268892|NCT02419417|527499423|FG000|Overall Study|Withdrawal by Subject|0|||
146268893|NCT02419417|527499424|FG001|Overall Study|Withdrawal by Subject|0|||
146268894|NCT02419417|527499425|FG002|Overall Study|Withdrawal by Subject|0|||
146268895|NCT02419417|527499426|FG003|Overall Study|Withdrawal by Subject|0|||
146268896|NCT02419417|527499427|FG004|Overall Study|Withdrawal by Subject|0|||
146268897|NCT02419417|527499428|FG005|Overall Study|Withdrawal by Subject|0|||
146268898|NCT02419417|527499429|FG006|Overall Study|Withdrawal by Subject|0|||
146268899|NCT02419417|527499430|FG007|Overall Study|Withdrawal by Subject|0|||
146268900|NCT02419417|527499431|FG008|Overall Study|Withdrawal by Subject|0|||
146268901|NCT02419417|527499432|FG009|Overall Study|Withdrawal by Subject|0|||
146268902|NCT02419417|527499433|FG010|Overall Study|Withdrawal by Subject|1|||
146268903|NCT01317875|527499437|FG000|Overall Study|Other|0|||
146268904|NCT01317875|527499438|FG001|Overall Study|Other|0|||
146268905|NCT01317875|527499439|FG002|Overall Study|Other|1|||
146268906|NCT01317875|527499440|FG003|Overall Study|Other|0|||
146268907|NCT01317875|527499441|FG004|Overall Study|Other|0|||
146268908|NCT01317875|527499442|FG005|Overall Study|Other|0|||
146268909|NCT01317875|527499443|FG006|Overall Study|Other|0|||
146268910|NCT01317875|527499444|FG007|Overall Study|Other|0|||
146268911|NCT01317875|527499445|FG008|Overall Study|Other|0|||
146268912|NCT01317875|527499446|FG009|Overall Study|Other|0|||
146268913|NCT01317875|527499437|FG000|Overall Study|Noncompliance with study drug|0|||
146268914|NCT01317875|527499438|FG001|Overall Study|Noncompliance with study drug|0|||
146268915|NCT01317875|527499439|FG002|Overall Study|Noncompliance with study drug|1|||
146268916|NCT01317875|527499440|FG003|Overall Study|Noncompliance with study drug|0|||
146268917|NCT01317875|527499441|FG004|Overall Study|Noncompliance with study drug|0|||
146268918|NCT01317875|527499442|FG005|Overall Study|Noncompliance with study drug|0|||
146268919|NCT01317875|527499443|FG006|Overall Study|Noncompliance with study drug|0|||
146268920|NCT01317875|527499444|FG007|Overall Study|Noncompliance with study drug|0|||
146268921|NCT01317875|527499445|FG008|Overall Study|Noncompliance with study drug|0|||
146268922|NCT01317875|527499446|FG009|Overall Study|Noncompliance with study drug|0|||
146268923|NCT01317875|527499437|FG000|Overall Study|Progressive Disease|1|||
146268924|NCT01317875|527499438|FG001|Overall Study|Progressive Disease|0|||
146268925|NCT01317875|527499439|FG002|Overall Study|Progressive Disease|2|||
146268926|NCT01317875|527499440|FG003|Overall Study|Progressive Disease|0|||
146268927|NCT01317875|527499441|FG004|Overall Study|Progressive Disease|1|||
146268928|NCT01317875|527499442|FG005|Overall Study|Progressive Disease|0|||
146268929|NCT01317875|527499443|FG006|Overall Study|Progressive Disease|0|||
146268930|NCT01317875|527499444|FG007|Overall Study|Progressive Disease|1|||
146268931|NCT01317875|527499445|FG008|Overall Study|Progressive Disease|0|||
146268932|NCT01317875|527499446|FG009|Overall Study|Progressive Disease|0|||
146268933|NCT01317875|527499437|FG000|Overall Study|Withdrawal by Subject|0|||
146268934|NCT01317875|527499438|FG001|Overall Study|Withdrawal by Subject|0|||
146268935|NCT01317875|527499439|FG002|Overall Study|Withdrawal by Subject|0|||
146268936|NCT01317875|527499440|FG003|Overall Study|Withdrawal by Subject|0|||
146268937|NCT01317875|527499441|FG004|Overall Study|Withdrawal by Subject|1|||
146268938|NCT01317875|527499442|FG005|Overall Study|Withdrawal by Subject|0|||
146268939|NCT01317875|527499443|FG006|Overall Study|Withdrawal by Subject|0|||
146268940|NCT01317875|527499444|FG007|Overall Study|Withdrawal by Subject|3|||
146268941|NCT01317875|527499445|FG008|Overall Study|Withdrawal by Subject|0|||
146268942|NCT01317875|527499446|FG009|Overall Study|Withdrawal by Subject|0|||
146268943|NCT01317875|527499437|FG000|Overall Study|Physician Decision|0|||
146268944|NCT01317875|527499438|FG001|Overall Study|Physician Decision|1|||
146268945|NCT01317875|527499439|FG002|Overall Study|Physician Decision|1|||
146268946|NCT01317875|527499440|FG003|Overall Study|Physician Decision|0|||
146268947|NCT01317875|527499441|FG004|Overall Study|Physician Decision|2|||
146268948|NCT01317875|527499442|FG005|Overall Study|Physician Decision|0|||
146268949|NCT01317875|527499443|FG006|Overall Study|Physician Decision|0|||
146268950|NCT01317875|527499444|FG007|Overall Study|Physician Decision|2|||
146268951|NCT01317875|527499445|FG008|Overall Study|Physician Decision|0|||
146268952|NCT01317875|527499446|FG009|Overall Study|Physician Decision|0|||
146268953|NCT01317875|527499437|FG000|Overall Study|Death|0|||
146268954|NCT01317875|527499438|FG001|Overall Study|Death|0|||
146268955|NCT01317875|527499439|FG002|Overall Study|Death|2|||
146268956|NCT01317875|527499440|FG003|Overall Study|Death|1|||
146268957|NCT01317875|527499441|FG004|Overall Study|Death|0|||
146268958|NCT01317875|527499442|FG005|Overall Study|Death|1|||
146268959|NCT01317875|527499443|FG006|Overall Study|Death|0|||
146268960|NCT01317875|527499444|FG007|Overall Study|Death|4|||
146268961|NCT01317875|527499445|FG008|Overall Study|Death|0|||
146268962|NCT01317875|527499446|FG009|Overall Study|Death|0|||
146268963|NCT01317875|527499437|FG000|Overall Study|Adverse Event|2|||
146268964|NCT01317875|527499438|FG001|Overall Study|Adverse Event|1|||
146268965|NCT01317875|527499439|FG002|Overall Study|Adverse Event|2|||
146268966|NCT01317875|527499440|FG003|Overall Study|Adverse Event|1|||
146268967|NCT01317875|527499441|FG004|Overall Study|Adverse Event|5|||
146268968|NCT01317875|527499442|FG005|Overall Study|Adverse Event|1|||
146268969|NCT01317875|527499443|FG006|Overall Study|Adverse Event|2|||
146268970|NCT01317875|527499444|FG007|Overall Study|Adverse Event|5|||
146268971|NCT01317875|527499445|FG008|Overall Study|Adverse Event|0|||
146268972|NCT01317875|527499446|FG009|Overall Study|Adverse Event|0|||
146268973|NCT00233480|527499447|FG000|Overall Study|Underwent status II heart transplant|0|||
146268974|NCT00233480|527499448|FG001|Overall Study|Underwent status II heart transplant|1|||
146268975|NCT01381575|527499449|FG000|Overall Study|Serious Adverse Event|1|||
146268976|NCT01381575|527499450|FG001|Overall Study|Serious Adverse Event|0|||
146268977|NCT01381575|527499451|FG002|Overall Study|Serious Adverse Event|0|||
146268978|NCT01381575|527499449|FG000|Overall Study|Non-Serious Adverse Event|0|||
146268979|NCT01381575|527499450|FG001|Overall Study|Non-Serious Adverse Event|0|||
146268980|NCT01381575|527499451|FG002|Overall Study|Non-Serious Adverse Event|1|||
146268981|NCT01381575|527499449|FG000|Overall Study|Protocol Violation|0|||
146268982|NCT01381575|527499450|FG001|Overall Study|Protocol Violation|1|||
146268983|NCT01381575|527499451|FG002|Overall Study|Protocol Violation|1|||
146268984|NCT01381575|527499449|FG000|Overall Study|Withdrawal by Subject|15|||
146268985|NCT01381575|527499450|FG001|Overall Study|Withdrawal by Subject|9|||
146268986|NCT01381575|527499451|FG002|Overall Study|Withdrawal by Subject|7|||
146268987|NCT01381575|527499449|FG000|Overall Study|Migrated/moved from study area|2|||
146268988|NCT01381575|527499450|FG001|Overall Study|Migrated/moved from study area|12|||
146268989|NCT01381575|527499451|FG002|Overall Study|Migrated/moved from study area|2|||
146268990|NCT01381575|527499449|FG000|Overall Study|Lost to Follow-up|8|||
146268991|NCT01381575|527499450|FG001|Overall Study|Lost to Follow-up|17|||
146268992|NCT01381575|527499451|FG002|Overall Study|Lost to Follow-up|9|||
146268993|NCT01443403|527499452|FG000|Overall Study|Adverse Event|1|||
146268994|NCT01443403|527499453|FG001|Overall Study|Adverse Event|1|||
146268995|NCT01443403|527499454|FG002|Overall Study|Adverse Event|4|||
146268996|NCT01443403|527499455|FG003|Overall Study|Adverse Event|5|||
146268997|NCT01443403|527499452|FG000|Overall Study|Withdrawal by Subject|0|||
146268998|NCT01443403|527499453|FG001|Overall Study|Withdrawal by Subject|1|||
146268999|NCT01443403|527499454|FG002|Overall Study|Withdrawal by Subject|2|||
146269000|NCT01443403|527499455|FG003|Overall Study|Withdrawal by Subject|1|||
146269001|NCT01443403|527499452|FG000|Overall Study|Lost to Follow-up|0|||
146269002|NCT01443403|527499453|FG001|Overall Study|Lost to Follow-up|0|||
146269003|NCT01443403|527499454|FG002|Overall Study|Lost to Follow-up|0|||
146269004|NCT01443403|527499455|FG003|Overall Study|Lost to Follow-up|1|||
146269005|NCT01443403|527499452|FG000|Overall Study|Protocol Violation|2|||
146269006|NCT01443403|527499453|FG001|Overall Study|Protocol Violation|1|||
146269007|NCT01443403|527499454|FG002|Overall Study|Protocol Violation|1|||
146269008|NCT01443403|527499455|FG003|Overall Study|Protocol Violation|1|||
146269009|NCT01443403|527499452|FG000|Overall Study|Use of Prohibited Treatment|2|||
146269010|NCT01443403|527499453|FG001|Overall Study|Use of Prohibited Treatment|3|||
146137028|NCT04649151|527019531|FG000|Overall Study|Withdrawal by Subject|370|||
146137029|NCT04649151|527019532|FG001|Overall Study|Withdrawal by Subject|113|||
146137030|NCT04649151|527019533|FG002|Overall Study|Withdrawal by Subject|2|||
146137031|NCT04649151|527019534|FG003|Overall Study|Withdrawal by Subject|7|||
146137032|NCT04649151|527019535|FG004|Overall Study|Withdrawal by Subject|15|||
146137033|NCT04649151|527019531|FG000|Overall Study|Adverse Event|1|||
146137034|NCT04649151|527019532|FG001|Overall Study|Adverse Event|0|||
146137035|NCT04649151|527019533|FG002|Overall Study|Adverse Event|0|||
146137036|NCT04649151|527019534|FG003|Overall Study|Adverse Event|0|||
146137037|NCT04649151|527019535|FG004|Overall Study|Adverse Event|0|||
146137038|NCT04649151|527019531|FG000|Overall Study|Lost to Follow-up|256|||
146137039|NCT04649151|527019532|FG001|Overall Study|Lost to Follow-up|29|||
146137040|NCT04649151|527019533|FG002|Overall Study|Lost to Follow-up|10|||
146137041|NCT04649151|527019534|FG003|Overall Study|Lost to Follow-up|3|||
146137042|NCT04649151|527019535|FG004|Overall Study|Lost to Follow-up|6|||
146137043|NCT04649151|527019531|FG000|Overall Study|Other than specified|59|||
146137044|NCT04649151|527019532|FG001|Overall Study|Other than specified|294|||
146137045|NCT04649151|527019533|FG002|Overall Study|Other than specified|0|||
146137046|NCT04649151|527019534|FG003|Overall Study|Other than specified|0|||
146137047|NCT04649151|527019535|FG004|Overall Study|Other than specified|4|||
146137048|NCT04649151|527019531|FG000|Overall Study|Death|0|||
146137049|NCT04649151|527019532|FG001|Overall Study|Death|0|||
146137050|NCT04649151|527019533|FG002|Overall Study|Death|0|||
146137051|NCT04649151|527019534|FG003|Overall Study|Death|0|||
146137052|NCT04649151|527019535|FG004|Overall Study|Death|1|||
146137053|NCT02975934|527019536|FG000|Treatment Phase|Never initiated study drug|0|||
146137054|NCT02975934|527019537|FG001|Treatment Phase|Never initiated study drug|5|||
146137055|NCT02975934|527019538|FG002|Treatment Phase|Never initiated study drug|0|||
146137056|NCT03362502|527019539|FG000|Overall Study|Death|0|||
146137057|NCT03362502|527019540|FG001|Overall Study|Death|0|||
146137058|NCT03362502|527019541|FG002|Overall Study|Death|1|||
146137059|NCT00433654|527019544|FG000|Overall Study|Death|4|||
146137060|NCT00433654|527019545|FG001|Overall Study|Death|0|||
146137061|NCT00433654|527019544|FG000|Overall Study|Missed visit|6|||
146137062|NCT00433654|527019545|FG001|Overall Study|Missed visit|3|||
146137063|NCT00433654|527019544|FG000|Overall Study|Subject not yet due for visit|4|||
146137064|NCT00433654|527019545|FG001|Overall Study|Subject not yet due for visit|0|||
146137065|NCT00433654|527019544|FG000|Overall Study|Withdrawal by Subject|1|||
146137066|NCT00433654|527019545|FG001|Overall Study|Withdrawal by Subject|2|||
146137067|NCT06034496|527019546|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
146137068|NCT06034496|527019547|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
146137069|NCT06034496|527019546|FG000|Overall Study|Withdrawal by Subject|5|||
146137070|NCT06034496|527019547|FG001|Overall Study|Withdrawal by Subject|4|||
146137071|NCT05179421|527019548|FG000|First Infusion Day|Adverse Event|1|||
146137072|NCT05179421|527019549|FG001|First Infusion Day|Adverse Event|0|||
146137073|NCT00207142|527019553|FG000|Induction Phase|Adverse Event|9|||
146137074|NCT00207142|527019554|FG001|Induction Phase|Adverse Event|0|||
146137075|NCT00207142|527019555|FG002|Induction Phase|Adverse Event|0|||
146137076|NCT00207142|527019556|FG003|Induction Phase|Adverse Event|0|||
146137077|NCT00207142|527019553|FG000|Induction Phase|Death|1|||
146137078|NCT00207142|527019554|FG001|Induction Phase|Death|0|||
146137079|NCT00207142|527019555|FG002|Induction Phase|Death|0|||
146137080|NCT00207142|527019556|FG003|Induction Phase|Death|0|||
146137081|NCT00207142|527019553|FG000|Induction Phase|Lack of Efficacy|1|||
146137082|NCT00207142|527019554|FG001|Induction Phase|Lack of Efficacy|0|||
146137083|NCT00207142|527019555|FG002|Induction Phase|Lack of Efficacy|0|||
146137084|NCT00207142|527019556|FG003|Induction Phase|Lack of Efficacy|0|||
146137085|NCT00207142|527019553|FG000|Induction Phase|Lost to Follow-up|5|||
146269011|NCT01443403|527499454|FG002|Overall Study|Use of Prohibited Treatment|0|||
146137086|NCT00207142|527019554|FG001|Induction Phase|Lost to Follow-up|0|||
146137087|NCT00207142|527019555|FG002|Induction Phase|Lost to Follow-up|0|||
146137088|NCT00207142|527019556|FG003|Induction Phase|Lost to Follow-up|0|||
146137089|NCT00207142|527019553|FG000|Induction Phase|Physician Decision|2|||
146137090|NCT00207142|527019554|FG001|Induction Phase|Physician Decision|0|||
146137091|NCT00207142|527019555|FG002|Induction Phase|Physician Decision|0|||
146137092|NCT00207142|527019556|FG003|Induction Phase|Physician Decision|0|||
146137093|NCT00207142|527019553|FG000|Induction Phase|Poor/noncompliance|2|||
146137094|NCT00207142|527019554|FG001|Induction Phase|Poor/noncompliance|0|||
146137095|NCT00207142|527019555|FG002|Induction Phase|Poor/noncompliance|0|||
146137096|NCT00207142|527019556|FG003|Induction Phase|Poor/noncompliance|0|||
146137097|NCT00207142|527019553|FG000|Induction Phase|Pregnancy|1|||
146137098|NCT00207142|527019554|FG001|Induction Phase|Pregnancy|0|||
146137099|NCT00207142|527019555|FG002|Induction Phase|Pregnancy|0|||
146137100|NCT00207142|527019556|FG003|Induction Phase|Pregnancy|0|||
146137101|NCT00207142|527019553|FG000|Induction Phase|Subject no longer meets study criteria|3|||
146137102|NCT00207142|527019554|FG001|Induction Phase|Subject no longer meets study criteria|0|||
146137103|NCT00207142|527019555|FG002|Induction Phase|Subject no longer meets study criteria|0|||
146137104|NCT00207142|527019556|FG003|Induction Phase|Subject no longer meets study criteria|0|||
146137105|NCT00207142|527019553|FG000|Induction Phase|Withdrawal by Subject|4|||
146137106|NCT00207142|527019554|FG001|Induction Phase|Withdrawal by Subject|0|||
146137107|NCT00207142|527019555|FG002|Induction Phase|Withdrawal by Subject|0|||
146137108|NCT00207142|527019556|FG003|Induction Phase|Withdrawal by Subject|0|||
146137109|NCT00207142|527019553|FG000|Induction Phase|Incarceration|1|||
146137110|NCT00207142|527019554|FG001|Induction Phase|Incarceration|0|||
146137111|NCT00207142|527019555|FG002|Induction Phase|Incarceration|0|||
146137112|NCT00207142|527019556|FG003|Induction Phase|Incarceration|0|||
146137113|NCT00207142|527019553|FG000|Induction Phase|Missing lab data|1|||
146137114|NCT00207142|527019554|FG001|Induction Phase|Missing lab data|0|||
146137115|NCT00207142|527019555|FG002|Induction Phase|Missing lab data|0|||
146137116|NCT00207142|527019556|FG003|Induction Phase|Missing lab data|0|||
146137117|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
146137118|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
146137119|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
146137120|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
146137121|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
146137122|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
146137123|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
146137124|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
146137125|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146137126|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146137127|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
146137128|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
146137129|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
146137130|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
146137131|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
146137132|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
146137133|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
146137134|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
146137135|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
146137136|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
146137137|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146137138|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146137139|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
146137140|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
146137141|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
146137142|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
146137143|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
146137144|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
146137145|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Death|0|||
146137146|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Death|0|||
146137147|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Death|0|||
146137148|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Death|1|||
146137149|NCT00207142|527019553|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146137150|NCT00207142|527019554|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146137151|NCT00207142|527019555|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
146137152|NCT00207142|527019556|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
146137153|NCT01822132|527019562|FG000|Overall Study|Lost to Follow-up|4|||
146137154|NCT01822132|527019563|FG001|Overall Study|Lost to Follow-up|2|||
146137155|NCT01393743|527019564|FG000|Core Study|Adverse Event|5|||
146137156|NCT01393743|527019565|FG001|Core Study|Adverse Event|9|||
146137157|NCT01393743|527019566|FG002|Core Study|Adverse Event|0|||
146137158|NCT01393743|527019564|FG000|Core Study|Lost to Follow-up|1|||
146137159|NCT01393743|527019565|FG001|Core Study|Lost to Follow-up|1|||
146137160|NCT01393743|527019566|FG002|Core Study|Lost to Follow-up|0|||
146137161|NCT01393743|527019564|FG000|Core Study|Participant's Choice|2|||
146137162|NCT01393743|527019565|FG001|Core Study|Participant's Choice|3|||
146137163|NCT01393743|527019566|FG002|Core Study|Participant's Choice|0|||
146137164|NCT01393743|527019564|FG000|Core Study|Inadequate therapeutic effect|2|||
146137165|NCT01393743|527019565|FG001|Core Study|Inadequate therapeutic effect|0|||
146137166|NCT01393743|527019566|FG002|Core Study|Inadequate therapeutic effect|0|||
146137167|NCT01393743|527019564|FG000|Extension Phase|Adverse Event|0|||
146137168|NCT01393743|527019565|FG001|Extension Phase|Adverse Event|0|||
146137169|NCT01393743|527019566|FG002|Extension Phase|Adverse Event|12|||
146137170|NCT01393743|527019564|FG000|Extension Phase|Lost to Follow-up|0|||
146137171|NCT01393743|527019565|FG001|Extension Phase|Lost to Follow-up|0|||
146137172|NCT01393743|527019566|FG002|Extension Phase|Lost to Follow-up|2|||
146137173|NCT01393743|527019564|FG000|Extension Phase|Participant choice|0|||
146137174|NCT01393743|527019565|FG001|Extension Phase|Participant choice|0|||
146137175|NCT01393743|527019566|FG002|Extension Phase|Participant choice|16|||
146137176|NCT01393743|527019564|FG000|Extension Phase|Inadequate therapeutic effect|0|||
146137177|NCT01393743|527019565|FG001|Extension Phase|Inadequate therapeutic effect|0|||
146269012|NCT01443403|527499455|FG003|Overall Study|Use of Prohibited Treatment|0|||
146269013|NCT01443403|527499452|FG000|Overall Study|Other - Miscellaneous|1|||
146269014|NCT01443403|527499453|FG001|Overall Study|Other - Miscellaneous|0|||
146269015|NCT01443403|527499454|FG002|Overall Study|Other - Miscellaneous|0|||
146269016|NCT01443403|527499455|FG003|Overall Study|Other - Miscellaneous|1|||
146269017|NCT01200342|527499456|FG000|Overall Study|Disease Progression|1|||
146269018|NCT02550938|527499459|FG000|Overall Study|Lost to Follow-up|8|||
146269019|NCT02550938|527499460|FG001|Overall Study|Lost to Follow-up|7|||
146269020|NCT02550938|527499461|FG002|Overall Study|Lost to Follow-up|12|||
146269021|NCT02550938|527499462|FG003|Overall Study|Lost to Follow-up|11|||
146269022|NCT01367847|527499463|FG000|Overall Study|Withdrawal by Subject|2|||
146269023|NCT01367847|527499464|FG001|Overall Study|Withdrawal by Subject|2|||
146269024|NCT01439867|527499465|FG000|Overall Study|Non-compliance|0|||
146269025|NCT01439867|527499466|FG001|Overall Study|Non-compliance|1|||
146269026|NCT01439867|527499465|FG000|Overall Study|Withdrawal by Subject|1|||
146269027|NCT01439867|527499466|FG001|Overall Study|Withdrawal by Subject|2|||
146269028|NCT01439867|527499465|FG000|Overall Study|Administrative Decision|4|||
146269029|NCT01439867|527499466|FG001|Overall Study|Administrative Decision|5|||
146269030|NCT01439867|527499465|FG000|Overall Study|Protocol-specified Criteria|1|||
146269031|NCT01439867|527499466|FG001|Overall Study|Protocol-specified Criteria|0|||
146269032|NCT02763215|527499467|FG000|Overall Study|Participants withdrew from study|3|||
146269033|NCT02763215|527499467|FG000|Overall Study|Missed visit|1|||
146269034|NCT02763215|527499467|FG000|Overall Study|Visit outside visit-window|1|||
146269035|NCT02763215|527499467|FG000|Overall Study|Death|1|||
146269036|NCT02763215|527499467|FG000|Overall Study|Lost to Follow-up|1|||
146269037|NCT03258723|527499468|FG000|Overall Study|COVID Interruption of study|54|||
146269038|NCT03258723|527499468|FG000|Overall Study|Lost to Follow-up|8|||
146269039|NCT01107899|527499469|FG000|Overall Study|Physician Decision|5|||
146269040|NCT01107899|527499470|FG001|Overall Study|Physician Decision|0|||
146269041|NCT01107899|527499471|FG002|Overall Study|Physician Decision|3|||
146269042|NCT01107899|527499469|FG000|Overall Study|Withdrawal by Subject|0|||
146269043|NCT01107899|527499470|FG001|Overall Study|Withdrawal by Subject|0|||
146269044|NCT01107899|527499471|FG002|Overall Study|Withdrawal by Subject|1|||
146269045|NCT00953771|527499472|FG000|Overall Study|Death|1|||
146269046|NCT00953771|527499473|FG001|Overall Study|Death|0|||
146269047|NCT00974259|527499474|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
146269048|NCT00974259|527499475|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
146269049|NCT00592293|527499477|FG000|Overall Study|Withdrawal by Subject|1|||
146269050|NCT01606319|527499478|FG000|Overall Study|Lost to Follow-up|17|||
146269051|NCT01606319|527499479|FG001|Overall Study|Lost to Follow-up|14|||
146269052|NCT01606319|527499478|FG000|Overall Study|Withdrawal by Subject|9|||
146269053|NCT01606319|527499479|FG001|Overall Study|Withdrawal by Subject|12|||
146269054|NCT01606319|527499478|FG000|Overall Study|Physician Decision|1|||
146269055|NCT01606319|527499479|FG001|Overall Study|Physician Decision|2|||
146269056|NCT01606319|527499478|FG000|Overall Study|Lack of Efficacy|6|||
146269057|NCT01606319|527499479|FG001|Overall Study|Lack of Efficacy|8|||
146269058|NCT01606319|527499478|FG000|Overall Study|Adverse Event|1|||
146269059|NCT01606319|527499479|FG001|Overall Study|Adverse Event|4|||
146269060|NCT01375673|527499489|FG000|Overall Study|Withdrawal by Subject|0|||
146269061|NCT01375673|527499490|FG001|Overall Study|Withdrawal by Subject|1|||
146269062|NCT01784523|527499493|FG000|Overall Study|Study closed early|7|||
146269063|NCT01784523|527499494|FG001|Overall Study|Study closed early|4|||
146269064|NCT02179177|527499497|FG000|Overall Study|Lost to Follow-up|1|||
146269065|NCT02179177|527499498|FG001|Overall Study|Lost to Follow-up|1|||
146269066|NCT02179177|527499497|FG000|Overall Study|Withdrawal by Subject|1|||
146269067|NCT02179177|527499498|FG001|Overall Study|Withdrawal by Subject|1|||
146269068|NCT00022659|527499499|FG000|Overall Study|Ineligible: wrong primary|1|||
146269069|NCT00022659|527499499|FG000|Overall Study|Never treated|1|||
146269070|NCT04340947|527499500|FG000|7-day Washout Period|Lost to Follow-up|5|||
146269071|NCT04340947|527499501|FG001|7-day Washout Period|Lost to Follow-up|4|||
146269072|NCT01907906|527499504|FG000|Overall Study|Withdrawal by Subject|1|||
146269073|NCT01907906|527499505|FG001|Overall Study|Withdrawal by Subject|0|||
146269074|NCT01907906|527499504|FG000|Overall Study|Physician Decision|3|||
146269075|NCT01907906|527499505|FG001|Overall Study|Physician Decision|1|||
146269076|NCT00884650|527499506|FG000|Overall Study|Did not return complete pain diaries|7|||
146269077|NCT00884650|527499507|FG001|Overall Study|Did not return complete pain diaries|7|||
146269078|NCT00884650|527499506|FG000|Overall Study|Admitted Post-Op|1|||
146269079|NCT00884650|527499507|FG001|Overall Study|Admitted Post-Op|0|||
146269080|NCT00884650|527499506|FG000|Overall Study|Femoral Stress Fracture|1|||
146269081|NCT00884650|527499507|FG001|Overall Study|Femoral Stress Fracture|0|||
146269082|NCT00884650|527499506|FG000|Overall Study|Pain Pump Complication|0|||
146269083|NCT00884650|527499507|FG001|Overall Study|Pain Pump Complication|1|||
146269084|NCT04052425|527499516|FG000|24-Week Double-blind Period|Adverse Event|0|||
146269085|NCT04052425|527499517|FG001|24-Week Double-blind Period|Adverse Event|1|||
146269086|NCT04052425|527499518|FG002|24-Week Double-blind Period|Adverse Event|0|||
146269087|NCT04052425|527499519|FG003|24-Week Double-blind Period|Adverse Event|0|||
146269088|NCT04052425|527499516|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
146137178|NCT01393743|527019566|FG002|Extension Phase|Inadequate therapeutic effect|7|||
146137179|NCT01393743|527019564|FG000|Extension Phase|Withdrawal by Subject|0|||
146137180|NCT01393743|527019565|FG001|Extension Phase|Withdrawal by Subject|0|||
146137181|NCT01393743|527019566|FG002|Extension Phase|Withdrawal by Subject|8|||
146137182|NCT01393743|527019564|FG000|Extension Phase|Pregnancy|0|||
146137183|NCT01393743|527019565|FG001|Extension Phase|Pregnancy|0|||
146137184|NCT01393743|527019566|FG002|Extension Phase|Pregnancy|1|||
146137185|NCT01393743|527019564|FG000|Extension Phase|Other|0|||
146137186|NCT01393743|527019565|FG001|Extension Phase|Other|0|||
146137187|NCT01393743|527019566|FG002|Extension Phase|Other|14|||
146137188|NCT01723228|527019568|FG000|Overall Study|Adverse Event|2|||
146137189|NCT01723228|527019569|FG001|Overall Study|Adverse Event|6|||
146137190|NCT01723228|527019568|FG000|Overall Study|Withdrawal by Subject|2|||
146137191|NCT01723228|527019569|FG001|Overall Study|Withdrawal by Subject|1|||
146137192|NCT01723228|527019568|FG000|Overall Study|Protocol Violation|0|||
146137193|NCT01723228|527019569|FG001|Overall Study|Protocol Violation|2|||
146137194|NCT01723228|527019568|FG000|Overall Study|Lost to Follow-up|2|||
146137195|NCT01723228|527019569|FG001|Overall Study|Lost to Follow-up|1|||
146137196|NCT01723228|527019568|FG000|Overall Study|Other|2|||
146137197|NCT01723228|527019569|FG001|Overall Study|Other|1|||
146137198|NCT01806896|527019570|FG000|Overall Study|Adverse Event|2|||
146137199|NCT01806896|527019571|FG001|Overall Study|Adverse Event|0|||
146269089|NCT04052425|527499517|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
146304073|NCT03250832|527627479|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146304074|NCT03250832|527627480|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146304075|NCT03250832|527627481|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146304076|NCT03250832|527627482|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
146304077|NCT03250832|527627483|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146269090|NCT04052425|527499518|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
146269091|NCT04052425|527499519|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
146269092|NCT04052425|527499516|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
146269093|NCT04052425|527499517|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
146269094|NCT04052425|527499518|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
146269095|NCT04052425|527499519|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
146269096|NCT04052425|527499516|FG000|24-Week Double-blind Period|Physician Decision|1|||
146269097|NCT04052425|527499517|FG001|24-Week Double-blind Period|Physician Decision|0|||
146269098|NCT04052425|527499518|FG002|24-Week Double-blind Period|Physician Decision|0|||
146269099|NCT04052425|527499519|FG003|24-Week Double-blind Period|Physician Decision|0|||
146269100|NCT04052425|527499516|FG000|24-Week Double-blind Period|Protocol Violation|1|||
146269101|NCT04052425|527499517|FG001|24-Week Double-blind Period|Protocol Violation|0|||
146269102|NCT04052425|527499518|FG002|24-Week Double-blind Period|Protocol Violation|0|||
146269103|NCT04052425|527499519|FG003|24-Week Double-blind Period|Protocol Violation|0|||
146269104|NCT04052425|527499516|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
146269105|NCT04052425|527499517|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
146269106|NCT04052425|527499518|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
146269107|NCT04052425|527499519|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
146269108|NCT04052425|527499516|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
146269109|NCT04052425|527499517|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146269110|NCT04052425|527499518|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146269111|NCT04052425|527499519|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
146269112|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
146269113|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
146137200|NCT01806896|527019570|FG000|Overall Study|Other|1|||
146269114|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
146269115|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
146269116|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146269117|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146269118|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
146269119|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
146137201|NCT01806896|527019571|FG001|Overall Study|Other|0|||
146137202|NCT02434770|527019572|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
146137203|NCT02434770|527019573|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
146269120|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146269121|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
146269122|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
146137204|NCT02434770|527019574|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
146137205|NCT02434770|527019572|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
146137206|NCT02434770|527019573|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
146137207|NCT02434770|527019574|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
146137208|NCT02434770|527019572|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
146137209|NCT02434770|527019573|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
146269123|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
146269124|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
146269125|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
146269126|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
146269127|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
146269128|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146269129|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
146269130|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
146269131|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
146137210|NCT02434770|527019574|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
146137211|NCT02434770|527019572|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
146269132|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146269133|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146269134|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
146269135|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
146269136|NCT04052425|527499516|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
146269137|NCT04052425|527499517|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
146269138|NCT04052425|527499518|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
146269139|NCT04052425|527499519|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
146269140|NCT04334278|527499520|FG000|Overall Study|Lost to Follow-up|0|||
146269141|NCT04334278|527499521|FG001|Overall Study|Lost to Follow-up|3|||
146137212|NCT02434770|527019573|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
146137213|NCT02434770|527019574|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
146137214|NCT02434770|527019572|FG000|Week 1 to Week 18|Death|1|||
146137215|NCT02434770|527019573|FG001|Week 1 to Week 18|Death|0|||
146137216|NCT02434770|527019574|FG002|Week 1 to Week 18|Death|0|||
146137217|NCT02434770|527019572|FG000|Week 18 to Week|Lost to Follow-up|2|||
146137218|NCT02434770|527019573|FG001|Week 18 to Week|Lost to Follow-up|2|||
146137219|NCT02434770|527019574|FG002|Week 18 to Week|Lost to Follow-up|1|||
146137220|NCT02434770|527019572|FG000|Week 18 to Week|Withdrawal by Subject|0|||
146137221|NCT02434770|527019573|FG001|Week 18 to Week|Withdrawal by Subject|0|||
146137222|NCT02434770|527019574|FG002|Week 18 to Week|Withdrawal by Subject|2|||
146137223|NCT02434770|527019572|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
146137224|NCT02434770|527019573|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
146137225|NCT02434770|527019574|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
146137226|NCT00660348|527019575|FG000|Overall Study|Withdrawal by Subject|1|||
146137227|NCT00660348|527019576|FG001|Overall Study|Withdrawal by Subject|0|||
146137228|NCT01282424|527019582|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
146137229|NCT01282424|527019582|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
146137230|NCT01282424|527019582|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
146137231|NCT01282424|527019582|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
146137232|NCT01282424|527019582|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
146137233|NCT01282424|527019582|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
146137234|NCT01282424|527019582|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
146137235|NCT01282424|527019582|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
146137236|NCT00528528|527019583|FG000|Overall Study|Lost to Follow-up|0|||
146137237|NCT00528528|527019584|FG001|Overall Study|Lost to Follow-up|0|||
146137238|NCT00528528|527019585|FG002|Overall Study|Lost to Follow-up|1|||
146137239|NCT00528528|527019586|FG003|Overall Study|Lost to Follow-up|1|||
146137240|NCT00528528|527019583|FG000|Overall Study|Ineligible to continue the trial|0|||
146137241|NCT00528528|527019584|FG001|Overall Study|Ineligible to continue the trial|0|||
146137242|NCT00528528|527019585|FG002|Overall Study|Ineligible to continue the trial|0|||
146137243|NCT00528528|527019586|FG003|Overall Study|Ineligible to continue the trial|1|||
146269142|NCT04334278|527499520|FG000|Overall Study|Withdrawal by Subject|4|||
146269143|NCT04334278|527499521|FG001|Overall Study|Withdrawal by Subject|2|||
146269144|NCT01821937|527499522|FG000|Overall Study|Adverse Event|0|||
146269145|NCT01821937|527499523|FG001|Overall Study|Adverse Event|3|||
146269146|NCT01677299|527499524|FG000|Overall Study|Adverse Event|0|||
146269147|NCT01677299|527499525|FG001|Overall Study|Adverse Event|2|||
146269148|NCT01677299|527499526|FG002|Overall Study|Adverse Event|1|||
146269149|NCT01677299|527499527|FG003|Overall Study|Adverse Event|0|||
146269150|NCT01677299|527499524|FG000|Overall Study|Withdrawal by Subject|0|||
146269151|NCT01677299|527499525|FG001|Overall Study|Withdrawal by Subject|1|||
146137244|NCT00528528|527019583|FG000|Overall Study|Other|0|||
146137245|NCT00528528|527019584|FG001|Overall Study|Other|1|||
146137246|NCT00528528|527019585|FG002|Overall Study|Other|0|||
146137247|NCT00528528|527019586|FG003|Overall Study|Other|0|||
146137248|NCT00528528|527019583|FG000|Overall Study|Withdrawal by Subject|3|||
146137249|NCT00528528|527019584|FG001|Overall Study|Withdrawal by Subject|2|||
146137250|NCT00528528|527019585|FG002|Overall Study|Withdrawal by Subject|1|||
146137251|NCT00528528|527019586|FG003|Overall Study|Withdrawal by Subject|1|||
146137252|NCT00528528|527019583|FG000|Overall Study|Ongoing participant|0|||
146269152|NCT01677299|527499526|FG002|Overall Study|Withdrawal by Subject|0|||
146269153|NCT01677299|527499527|FG003|Overall Study|Withdrawal by Subject|1|||
146269154|NCT02153905|527499528|FG000|Overall Study|Death|1|||
146269155|NCT02153905|527499529|FG001|Overall Study|Death|0|||
146269156|NCT00351377|527499530|FG000|Overall Study|Adverse Event|5|||
146269157|NCT00351377|527499530|FG000|Overall Study|Death|1|||
146269158|NCT00351377|527499530|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146269159|NCT01969851|527499531|FG000|Overall Study|Adverse Event|0|||
146269160|NCT01969851|527499532|FG001|Overall Study|Adverse Event|0|||
146269161|NCT01969851|527499533|FG002|Overall Study|Adverse Event|3|||
146269162|NCT01969851|527499531|FG000|Overall Study|Lack of Efficacy|0|||
146269163|NCT01969851|527499532|FG001|Overall Study|Lack of Efficacy|3|||
146269164|NCT01969851|527499533|FG002|Overall Study|Lack of Efficacy|1|||
146269165|NCT01969851|527499531|FG000|Overall Study|Withdrawal by Subject|1|||
146269166|NCT01969851|527499532|FG001|Overall Study|Withdrawal by Subject|0|||
146269167|NCT01969851|527499533|FG002|Overall Study|Withdrawal by Subject|1|||
146269168|NCT01969851|527499531|FG000|Overall Study|No effective dose in Titration period|0|||
146269169|NCT01969851|527499532|FG001|Overall Study|No effective dose in Titration period|0|||
146269170|NCT01969851|527499533|FG002|Overall Study|No effective dose in Titration period|1|||
146269171|NCT01969851|527499531|FG000|Overall Study|Sponsor decision|0|||
146269172|NCT01969851|527499532|FG001|Overall Study|Sponsor decision|0|||
146269173|NCT01969851|527499533|FG002|Overall Study|Sponsor decision|1|||
146269174|NCT00583947|527499534|FG000|Cross-over Period|Adverse Event|2|||
146269175|NCT00583947|527499535|FG001|Cross-over Period|Adverse Event|0|||
146269176|NCT00583947|527499534|FG000|Cross-over Period|Withdrawal by Subject|2|||
146269177|NCT00583947|527499535|FG001|Cross-over Period|Withdrawal by Subject|0|||
146269178|NCT00583947|527499534|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
146269179|NCT00583947|527499535|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
146269180|NCT00583947|527499534|FG000|Cross-over Period|Other|1|||
146269181|NCT00583947|527499535|FG001|Cross-over Period|Other|1|||
146269182|NCT00486252|527499537|FG000|Overall Study|Adverse Event|7|||
146269183|NCT00486252|527499537|FG000|Overall Study|Lack of Efficacy|9|||
146269184|NCT00486252|527499537|FG000|Overall Study|Lost to Follow-up|24|||
146269185|NCT00486252|527499537|FG000|Overall Study|Other|18|||
146269186|NCT01210651|527499538|FG000|Overall Study|Lost to Follow-up|1|||
146269187|NCT01210651|527499539|FG001|Overall Study|Lost to Follow-up|1|||
146269188|NCT01210651|527499538|FG000|Overall Study|schedule conflicts|1|||
146269189|NCT01210651|527499539|FG001|Overall Study|schedule conflicts|5|||
146269190|NCT01210651|527499538|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
146269191|NCT01210651|527499539|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
146269192|NCT01210651|527499538|FG000|Overall Study|Withdrawal by Subject|1|||
146269193|NCT01210651|527499539|FG001|Overall Study|Withdrawal by Subject|1|||
146269194|NCT01210651|527499538|FG000|Overall Study|Injury outside study|2|||
146269195|NCT01210651|527499539|FG001|Overall Study|Injury outside study|0|||
146269196|NCT01261247|527499540|FG000|Overall Study|Ineligible|2|||
146269197|NCT01740154|527499541|FG000|Overall Study|Adverse Event|1|||
146269198|NCT05226130|527499542|FG000|Overall Study|Lost to Follow-up|0|||
146269199|NCT05226130|527499543|FG001|Overall Study|Lost to Follow-up|1|||
146269200|NCT05226130|527499542|FG000|Overall Study|Not treatment adherent|0|||
146269201|NCT05226130|527499543|FG001|Overall Study|Not treatment adherent|2|||
146269202|NCT04013971|527499544|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
146269203|NCT04013971|527499545|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
146269204|NCT04013971|527499544|FG000|Overall Study|Missing biomechanical data|0|||
146269205|NCT04013971|527499545|FG001|Overall Study|Missing biomechanical data|1|||
146269206|NCT01340014|527499548|FG000|Period 1, First 7 Days|Adverse Event|1|||
146269207|NCT01340014|527499549|FG001|Period 1, First 7 Days|Adverse Event|0|||
146269208|NCT01340014|527499548|FG000|Period 1, First 7 Days|Personal Reasons|1|||
146269209|NCT01340014|527499549|FG001|Period 1, First 7 Days|Personal Reasons|0|||
146269210|NCT01340014|527499548|FG000|Period 2, Second 7 Days|Adverse Event|0|||
146269211|NCT01340014|527499549|FG001|Period 2, Second 7 Days|Adverse Event|1|||
146269212|NCT02520310|527499550|FG000|At 6 Months Clinical Follow-up|Death|1|||
146269213|NCT02520310|527499550|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
146269214|NCT02520310|527499550|FG000|AT 3 Year Clinical Follow-up|Death|2|||
146269215|NCT02520310|527499550|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
146269216|NCT02520310|527499550|FG000|AT 4 Year Clinical Follow-up|Death|1|||
146269217|NCT02520310|527499550|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
146269218|NCT05101993|527499553|FG000|Overall Study|Withdrawal by Subject|1|||
146269219|NCT01124838|527499554|FG000|Overall Study|Miscellaneous|4|||
146269220|NCT01124838|527499555|FG001|Overall Study|Miscellaneous|2|||
146269221|NCT01124838|527499554|FG000|Overall Study|Adverse Event|7|||
146269222|NCT01124838|527499555|FG001|Overall Study|Adverse Event|11|||
146269223|NCT01124838|527499554|FG000|Overall Study|Lack of Efficacy|2|||
146269224|NCT01124838|527499555|FG001|Overall Study|Lack of Efficacy|0|||
146269225|NCT01124838|527499554|FG000|Overall Study|Withdrawal by Subject|3|||
146269226|NCT01124838|527499555|FG001|Overall Study|Withdrawal by Subject|2|||
146269227|NCT01124838|527499554|FG000|Overall Study|Lost to Follow-up|2|||
146269228|NCT01124838|527499555|FG001|Overall Study|Lost to Follow-up|0|||
146269229|NCT02065882|527499556|FG000|Part I: PK/PD|Screening failure|5|||
146269230|NCT02065882|527499556|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
146269231|NCT02065882|527499556|FG000|Part I: PK/PD|Adverse Event|1|||
146269232|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|Screening failure|7|||
146269233|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
146269234|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
146269235|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
146269236|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
146269237|NCT02065882|527499556|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
146269238|NCT03816761|527501360|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146269239|NCT03816761|527501361|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146269240|NCT03816761|527501362|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146269241|NCT03816761|527501363|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146269242|NCT03816761|527501364|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
146269243|NCT03816761|527501365|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
146269244|NCT03816761|527501360|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
146269245|NCT03816761|527501361|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
146269246|NCT03816761|527501362|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
146269247|NCT03816761|527501363|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
146269248|NCT03816761|527501364|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
146269249|NCT03816761|527501365|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
146137253|NCT00528528|527019584|FG001|Overall Study|Ongoing participant|0|||
146137254|NCT00528528|527019585|FG002|Overall Study|Ongoing participant|1|||
146137255|NCT00528528|527019586|FG003|Overall Study|Ongoing participant|0|||
146137256|NCT03508219|527019589|FG000|Overall Study|Death|2|||
146137257|NCT03508219|527019589|FG000|Overall Study|Withdrawal by Subject|1|||
146137258|NCT03508219|527019589|FG000|Overall Study|Lost to Follow-up|4|||
146137259|NCT03508219|527019589|FG000|Overall Study|Missed visit|2|||
146137260|NCT04466891|527019590|FG000|Overall Study|Death|60|||
146137261|NCT04466891|527019591|FG001|Overall Study|Death|6|||
146137262|NCT04466891|527019590|FG000|Overall Study|Withdrawal by Subject|8|||
146137263|NCT04466891|527019591|FG001|Overall Study|Withdrawal by Subject|1|||
146137264|NCT04466891|527019590|FG000|Overall Study|Study terminated by sponsor|5|||
146137265|NCT04466891|527019591|FG001|Overall Study|Study terminated by sponsor|0|||
146137266|NCT04466891|527019590|FG000|Overall Study|Lost to Follow-up|2|||
146137267|NCT04466891|527019591|FG001|Overall Study|Lost to Follow-up|0|||
146137268|NCT04466891|527019590|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
146137269|NCT04466891|527019591|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
146137270|NCT00445328|527019592|FG000|Overall Study|Death|0|||
146137271|NCT00445328|527019593|FG001|Overall Study|Death|1|||
146137272|NCT00445328|527019592|FG000|Overall Study|Adverse Event|0|||
146137273|NCT00445328|527019593|FG001|Overall Study|Adverse Event|3|||
146137274|NCT00445328|527019592|FG000|Overall Study|Other|0|||
146137275|NCT00445328|527019593|FG001|Overall Study|Other|2|||
146137276|NCT00445328|527019592|FG000|Overall Study|Withdrawal by Subject|2|||
146137277|NCT00445328|527019593|FG001|Overall Study|Withdrawal by Subject|0|||
146137278|NCT00445328|527019592|FG000|Overall Study|Protocol Violation|1|||
146137279|NCT00445328|527019593|FG001|Overall Study|Protocol Violation|0|||
146137280|NCT00316199|527019594|FG000|Overall Study|Adverse Event|2|||
146137281|NCT00316199|527019594|FG000|Overall Study|Death|8|||
146137282|NCT00316199|527019594|FG000|Overall Study|Lost to Follow-up|2|||
146137283|NCT00590954|527019595|FG000|Overall Study|Inevaluable|2|||
146137284|NCT02782949|527019597|FG000|Overall Study|Protocol Violation|1|||
146137285|NCT02782949|527019598|FG001|Overall Study|Protocol Violation|0|||
146137286|NCT02782949|527019597|FG000|Overall Study|Withdrawal by Subject|0|||
146137287|NCT02782949|527019598|FG001|Overall Study|Withdrawal by Subject|1|||
146137288|NCT03316872|527019599|FG000|Overall Study|Death|1|||
146137289|NCT06023394|527019602|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
146137290|NCT06023394|527019603|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
146269250|NCT00474526|527501366|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
146137291|NCT06023394|527019602|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
146137292|NCT06023394|527019603|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
146137293|NCT06023394|527019602|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
146137294|NCT06023394|527019603|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
146137295|NCT06023394|527019602|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
146137296|NCT06023394|527019603|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
146137297|NCT01101841|527021160|FG000|Overall Study|Adverse Event|15|||
146137298|NCT01101841|527021161|FG001|Overall Study|Adverse Event|15|||
146137299|NCT01101841|527021160|FG000|Overall Study|Lost to Follow-up|9|||
146269251|NCT00474526|527501367|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
146269252|NCT00474526|527501368|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
146269253|NCT00474526|527501369|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
146269254|NCT00474526|527501370|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
146269255|NCT00474526|527501371|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
146269256|NCT00474526|527501372|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
146269257|NCT00474526|527501373|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
146269258|NCT00474526|527501374|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
146269259|NCT00474526|527501375|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
146269260|NCT00474526|527501376|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
146269261|NCT00474526|527501377|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
146269262|NCT00474526|527501378|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
146269263|NCT00474526|527501379|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
146269264|NCT00474526|527501380|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
146269265|NCT00474526|527501381|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
146269266|NCT00474526|527501382|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
146269267|NCT00474526|527501366|FG000|Overall Study|Adverse Event|2|||
146269268|NCT00474526|527501367|FG001|Overall Study|Adverse Event|0|||
146269269|NCT00474526|527501368|FG002|Overall Study|Adverse Event|2|||
146269270|NCT00474526|527501369|FG003|Overall Study|Adverse Event|4|||
146269271|NCT00474526|527501370|FG004|Overall Study|Adverse Event|2|||
146269272|NCT00474526|527501371|FG005|Overall Study|Adverse Event|1|||
146269273|NCT00474526|527501372|FG006|Overall Study|Adverse Event|1|||
146269274|NCT00474526|527501373|FG007|Overall Study|Adverse Event|0|||
146269275|NCT00474526|527501374|FG008|Overall Study|Adverse Event|0|||
146269276|NCT00474526|527501375|FG009|Overall Study|Adverse Event|0|||
146269277|NCT00474526|527501376|FG010|Overall Study|Adverse Event|0|||
146269278|NCT00474526|527501377|FG011|Overall Study|Adverse Event|0|||
146269279|NCT00474526|527501378|FG012|Overall Study|Adverse Event|0|||
146269280|NCT00474526|527501379|FG013|Overall Study|Adverse Event|0|||
146269281|NCT00474526|527501380|FG014|Overall Study|Adverse Event|1|||
146269282|NCT00474526|527501381|FG015|Overall Study|Adverse Event|1|||
146269283|NCT00474526|527501382|FG016|Overall Study|Adverse Event|0|||
146269284|NCT00474526|527501366|FG000|Overall Study|Death|0|||
146269285|NCT00474526|527501367|FG001|Overall Study|Death|0|||
146269286|NCT00474526|527501368|FG002|Overall Study|Death|0|||
146269287|NCT00474526|527501369|FG003|Overall Study|Death|0|||
146269288|NCT00474526|527501370|FG004|Overall Study|Death|0|||
146269289|NCT00474526|527501371|FG005|Overall Study|Death|0|||
146269290|NCT00474526|527501372|FG006|Overall Study|Death|0|||
146269291|NCT00474526|527501373|FG007|Overall Study|Death|0|||
146269292|NCT00474526|527501374|FG008|Overall Study|Death|0|||
146269293|NCT00474526|527501375|FG009|Overall Study|Death|0|||
146269294|NCT00474526|527501376|FG010|Overall Study|Death|0|||
146269295|NCT00474526|527501377|FG011|Overall Study|Death|0|||
146269296|NCT00474526|527501378|FG012|Overall Study|Death|0|||
146269297|NCT00474526|527501379|FG013|Overall Study|Death|3|||
146269298|NCT00474526|527501380|FG014|Overall Study|Death|0|||
146269299|NCT00474526|527501381|FG015|Overall Study|Death|0|||
146269300|NCT00474526|527501382|FG016|Overall Study|Death|0|||
146269301|NCT00474526|527501366|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269302|NCT00474526|527501367|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
146269303|NCT00474526|527501368|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269304|NCT00474526|527501369|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
146269305|NCT00474526|527501370|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146269306|NCT00474526|527501371|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146304078|NCT03250832|527627484|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146269307|NCT00474526|527501372|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269308|NCT00474526|527501373|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269309|NCT00474526|527501374|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269310|NCT00474526|527501375|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269311|NCT00474526|527501376|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146304079|NCT03250832|527627485|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146304080|NCT03250832|527627486|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
146269312|NCT00474526|527501377|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269313|NCT00474526|527501378|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269314|NCT00474526|527501379|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146304081|NCT03250832|527627475|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146269315|NCT00474526|527501380|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
146269316|NCT00474526|527501381|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269317|NCT00474526|527501382|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
146269318|NCT00474526|527501366|FG000|Overall Study|Lost to Follow-up|8|||
146269319|NCT00474526|527501367|FG001|Overall Study|Lost to Follow-up|6|||
146269320|NCT00474526|527501368|FG002|Overall Study|Lost to Follow-up|13|||
146269321|NCT00474526|527501369|FG003|Overall Study|Lost to Follow-up|29|||
146269322|NCT00474526|527501370|FG004|Overall Study|Lost to Follow-up|11|||
146269323|NCT00474526|527501371|FG005|Overall Study|Lost to Follow-up|5|||
146269324|NCT00474526|527501372|FG006|Overall Study|Lost to Follow-up|8|||
146269325|NCT00474526|527501373|FG007|Overall Study|Lost to Follow-up|1|||
146269326|NCT00474526|527501374|FG008|Overall Study|Lost to Follow-up|0|||
146304082|NCT03250832|527627476|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146269327|NCT00474526|527501375|FG009|Overall Study|Lost to Follow-up|6|||
146269328|NCT00474526|527501376|FG010|Overall Study|Lost to Follow-up|2|||
146269329|NCT00474526|527501377|FG011|Overall Study|Lost to Follow-up|4|||
146269330|NCT00474526|527501378|FG012|Overall Study|Lost to Follow-up|6|||
146269331|NCT00474526|527501379|FG013|Overall Study|Lost to Follow-up|74|||
146269332|NCT00474526|527501380|FG014|Overall Study|Lost to Follow-up|29|||
146269333|NCT00474526|527501381|FG015|Overall Study|Lost to Follow-up|4|||
146269334|NCT00474526|527501382|FG016|Overall Study|Lost to Follow-up|5|||
146269335|NCT00474526|527501366|FG000|Overall Study|Protocol Violation|2|||
146269336|NCT00474526|527501367|FG001|Overall Study|Protocol Violation|6|||
146269337|NCT00474526|527501368|FG002|Overall Study|Protocol Violation|4|||
146269338|NCT00474526|527501369|FG003|Overall Study|Protocol Violation|12|||
146269339|NCT00474526|527501370|FG004|Overall Study|Protocol Violation|3|||
146269340|NCT00474526|527501371|FG005|Overall Study|Protocol Violation|1|||
146269341|NCT00474526|527501372|FG006|Overall Study|Protocol Violation|3|||
146269342|NCT00474526|527501373|FG007|Overall Study|Protocol Violation|0|||
146269343|NCT00474526|527501374|FG008|Overall Study|Protocol Violation|0|||
146269344|NCT00474526|527501375|FG009|Overall Study|Protocol Violation|4|||
146269345|NCT00474526|527501376|FG010|Overall Study|Protocol Violation|2|||
146269346|NCT00474526|527501377|FG011|Overall Study|Protocol Violation|2|||
146269347|NCT00474526|527501378|FG012|Overall Study|Protocol Violation|4|||
146269348|NCT00474526|527501379|FG013|Overall Study|Protocol Violation|19|||
146269349|NCT00474526|527501380|FG014|Overall Study|Protocol Violation|9|||
146269350|NCT00474526|527501381|FG015|Overall Study|Protocol Violation|6|||
146269351|NCT00474526|527501382|FG016|Overall Study|Protocol Violation|2|||
146269352|NCT00474526|527501366|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
146269353|NCT00474526|527501367|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
146269354|NCT00474526|527501368|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
146269355|NCT00474526|527501369|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
146269356|NCT00474526|527501370|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
146269357|NCT00474526|527501371|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
146269358|NCT00474526|527501372|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
146269359|NCT00474526|527501373|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
146269360|NCT00474526|527501374|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
146269361|NCT00474526|527501375|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
146269362|NCT00474526|527501376|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
146269363|NCT00474526|527501377|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
146269364|NCT00474526|527501378|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
146269365|NCT00474526|527501379|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
146269366|NCT00474526|527501380|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
146269367|NCT00474526|527501381|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
146269368|NCT00474526|527501382|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
146269369|NCT00474526|527501366|FG000|Overall Study|Withdrawal by Subject|9|||
146269370|NCT00474526|527501367|FG001|Overall Study|Withdrawal by Subject|24|||
146269371|NCT00474526|527501368|FG002|Overall Study|Withdrawal by Subject|21|||
146269372|NCT00474526|527501369|FG003|Overall Study|Withdrawal by Subject|52|||
146269373|NCT00474526|527501370|FG004|Overall Study|Withdrawal by Subject|38|||
146269374|NCT00474526|527501371|FG005|Overall Study|Withdrawal by Subject|6|||
146269375|NCT00474526|527501372|FG006|Overall Study|Withdrawal by Subject|12|||
146269376|NCT00474526|527501373|FG007|Overall Study|Withdrawal by Subject|4|||
146269377|NCT00474526|527501374|FG008|Overall Study|Withdrawal by Subject|4|||
146269378|NCT00474526|527501375|FG009|Overall Study|Withdrawal by Subject|13|||
146269379|NCT00474526|527501376|FG010|Overall Study|Withdrawal by Subject|5|||
146269380|NCT00474526|527501377|FG011|Overall Study|Withdrawal by Subject|4|||
146269381|NCT00474526|527501378|FG012|Overall Study|Withdrawal by Subject|4|||
146269382|NCT00474526|527501379|FG013|Overall Study|Withdrawal by Subject|37|||
146269383|NCT00474526|527501380|FG014|Overall Study|Withdrawal by Subject|22|||
146269384|NCT00474526|527501381|FG015|Overall Study|Withdrawal by Subject|1|||
146269385|NCT00474526|527501382|FG016|Overall Study|Withdrawal by Subject|1|||
146269386|NCT02797522|527501383|FG000|Overall Study|Study Terminated by Sponsor|0|||
146269387|NCT02797522|527501384|FG001|Overall Study|Study Terminated by Sponsor|0|||
146137300|NCT01101841|527021161|FG001|Overall Study|Lost to Follow-up|3|||
146137301|NCT01101841|527021160|FG000|Overall Study|Withdrawal by Subject|21|||
146269388|NCT02797522|527501385|FG002|Overall Study|Study Terminated by Sponsor|0|||
146269389|NCT02797522|527501386|FG003|Overall Study|Study Terminated by Sponsor|0|||
146137302|NCT01101841|527021161|FG001|Overall Study|Withdrawal by Subject|40|||
146269390|NCT02797522|527501387|FG004|Overall Study|Study Terminated by Sponsor|0|||
146269391|NCT02797522|527501388|FG005|Overall Study|Study Terminated by Sponsor|0|||
146269392|NCT02797522|527501389|FG006|Overall Study|Study Terminated by Sponsor|0|||
146137303|NCT01101841|527021160|FG000|Overall Study|Protocol Violation|1|||
146137304|NCT01101841|527021161|FG001|Overall Study|Protocol Violation|1|||
146269393|NCT02797522|527501390|FG007|Overall Study|Study Terminated by Sponsor|4|||
146269394|NCT02797522|527501391|FG008|Overall Study|Study Terminated by Sponsor|2|||
146269395|NCT02797522|527501392|FG009|Overall Study|Study Terminated by Sponsor|4|||
146269396|NCT02797522|527501393|FG010|Overall Study|Study Terminated by Sponsor|1|||
146269397|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
146269398|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
146269399|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
146269400|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
146137305|NCT01101841|527021160|FG000|Overall Study|Physician Decision|0|||
146137306|NCT01101841|527021161|FG001|Overall Study|Physician Decision|2|||
146137307|NCT01101841|527021160|FG000|Overall Study|Lack of Efficacy|0|||
146137308|NCT01101841|527021161|FG001|Overall Study|Lack of Efficacy|2|||
146137309|NCT01101841|527021160|FG000|Overall Study|Other|0|||
146137310|NCT01101841|527021161|FG001|Overall Study|Other|1|||
146137311|NCT01101841|527021160|FG000|Overall Study|Suicidality Tracking Scale|3|||
146137312|NCT01101841|527021161|FG001|Overall Study|Suicidality Tracking Scale|1|||
146137313|NCT01101841|527021160|FG000|Overall Study|Eligibility Criteria|1|||
146137314|NCT01101841|527021161|FG001|Overall Study|Eligibility Criteria|2|||
146137315|NCT02896400|527021165|FG000|1 Month Follow-up|Lost to Follow-up|7|||
146137316|NCT02896400|527021166|FG001|1 Month Follow-up|Lost to Follow-up|7|||
146137317|NCT02896400|527021167|FG002|1 Month Follow-up|Lost to Follow-up|5|||
146137318|NCT02896400|527021168|FG003|1 Month Follow-up|Lost to Follow-up|8|||
146137319|NCT02896400|527021169|FG004|1 Month Follow-up|Lost to Follow-up|9|||
146137320|NCT02896400|527021170|FG005|1 Month Follow-up|Lost to Follow-up|6|||
146137321|NCT02896400|527021171|FG006|1 Month Follow-up|Lost to Follow-up|5|||
146137322|NCT02896400|527021172|FG007|1 Month Follow-up|Lost to Follow-up|6|||
146137323|NCT02896400|527021173|FG008|1 Month Follow-up|Lost to Follow-up|4|||
146137324|NCT02896400|527021174|FG009|1 Month Follow-up|Lost to Follow-up|7|||
146137325|NCT02896400|527021175|FG010|1 Month Follow-up|Lost to Follow-up|5|||
146137326|NCT02896400|527021176|FG011|1 Month Follow-up|Lost to Follow-up|5|||
146137327|NCT02896400|527021177|FG012|1 Month Follow-up|Lost to Follow-up|3|||
146137328|NCT02896400|527021178|FG013|1 Month Follow-up|Lost to Follow-up|4|||
146137329|NCT02896400|527021179|FG014|1 Month Follow-up|Lost to Follow-up|1|||
146137330|NCT02896400|527021180|FG015|1 Month Follow-up|Lost to Follow-up|2|||
146137331|NCT02896400|527021165|FG000|1 Month Follow-up|Death|0|||
146137332|NCT02896400|527021166|FG001|1 Month Follow-up|Death|0|||
146137333|NCT02896400|527021167|FG002|1 Month Follow-up|Death|0|||
146137334|NCT02896400|527021168|FG003|1 Month Follow-up|Death|0|||
146137335|NCT02896400|527021169|FG004|1 Month Follow-up|Death|0|||
146137336|NCT02896400|527021170|FG005|1 Month Follow-up|Death|0|||
146137337|NCT02896400|527021171|FG006|1 Month Follow-up|Death|0|||
146137338|NCT02896400|527021172|FG007|1 Month Follow-up|Death|0|||
146137339|NCT02896400|527021173|FG008|1 Month Follow-up|Death|0|||
146137340|NCT02896400|527021174|FG009|1 Month Follow-up|Death|0|||
146137341|NCT02896400|527021175|FG010|1 Month Follow-up|Death|0|||
146137342|NCT02896400|527021176|FG011|1 Month Follow-up|Death|0|||
146137343|NCT02896400|527021177|FG012|1 Month Follow-up|Death|0|||
146137344|NCT02896400|527021178|FG013|1 Month Follow-up|Death|0|||
146137345|NCT02896400|527021179|FG014|1 Month Follow-up|Death|0|||
146137346|NCT02896400|527021180|FG015|1 Month Follow-up|Death|1|||
146137347|NCT02896400|527021165|FG000|3 Month Follow-up|Lost to Follow-up|6|||
146137348|NCT02896400|527021166|FG001|3 Month Follow-up|Lost to Follow-up|3|||
146137349|NCT02896400|527021167|FG002|3 Month Follow-up|Lost to Follow-up|6|||
146137350|NCT02896400|527021168|FG003|3 Month Follow-up|Lost to Follow-up|11|||
146137351|NCT02896400|527021169|FG004|3 Month Follow-up|Lost to Follow-up|12|||
146137352|NCT02896400|527021170|FG005|3 Month Follow-up|Lost to Follow-up|6|||
146137353|NCT02896400|527021171|FG006|3 Month Follow-up|Lost to Follow-up|4|||
146137354|NCT02896400|527021172|FG007|3 Month Follow-up|Lost to Follow-up|3|||
146137355|NCT02896400|527021173|FG008|3 Month Follow-up|Lost to Follow-up|6|||
146137356|NCT02896400|527021174|FG009|3 Month Follow-up|Lost to Follow-up|5|||
146137357|NCT02896400|527021175|FG010|3 Month Follow-up|Lost to Follow-up|6|||
146137358|NCT02896400|527021176|FG011|3 Month Follow-up|Lost to Follow-up|6|||
146137359|NCT02896400|527021177|FG012|3 Month Follow-up|Lost to Follow-up|3|||
146137360|NCT02896400|527021178|FG013|3 Month Follow-up|Lost to Follow-up|5|||
146137361|NCT02896400|527021179|FG014|3 Month Follow-up|Lost to Follow-up|3|||
146137362|NCT02896400|527021180|FG015|3 Month Follow-up|Lost to Follow-up|2|||
146137363|NCT02896400|527021165|FG000|3 Month Follow-up|Death|0|||
146137364|NCT02896400|527021166|FG001|3 Month Follow-up|Death|0|||
146137365|NCT02896400|527021167|FG002|3 Month Follow-up|Death|0|||
146137366|NCT02896400|527021168|FG003|3 Month Follow-up|Death|0|||
146137367|NCT02896400|527021169|FG004|3 Month Follow-up|Death|0|||
146137368|NCT02896400|527021170|FG005|3 Month Follow-up|Death|0|||
146137369|NCT02896400|527021171|FG006|3 Month Follow-up|Death|0|||
146137370|NCT02896400|527021172|FG007|3 Month Follow-up|Death|0|||
146137371|NCT02896400|527021173|FG008|3 Month Follow-up|Death|0|||
146137372|NCT02896400|527021174|FG009|3 Month Follow-up|Death|0|||
146137373|NCT02896400|527021175|FG010|3 Month Follow-up|Death|0|||
146137374|NCT02896400|527021176|FG011|3 Month Follow-up|Death|0|||
146137375|NCT02896400|527021177|FG012|3 Month Follow-up|Death|0|||
146137376|NCT02896400|527021178|FG013|3 Month Follow-up|Death|1|||
146137377|NCT02896400|527021179|FG014|3 Month Follow-up|Death|1|||
146137378|NCT02896400|527021180|FG015|3 Month Follow-up|Death|0|||
146137379|NCT02896400|527021165|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137380|NCT02896400|527021166|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146137381|NCT02896400|527021167|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137382|NCT02896400|527021168|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137383|NCT02896400|527021169|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146137384|NCT02896400|527021170|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146269401|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
146269402|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
146269403|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
146269404|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
146269405|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
146269406|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
146269407|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
146269408|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
146269409|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
146269410|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
146269411|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
146269412|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
146269413|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
146269414|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
146269415|NCT00132678|527501398|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
146269416|NCT00132678|527501399|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
146269417|NCT00132678|527501400|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
146269418|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Death|2|||
146269419|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Death|0|||
146269420|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Death|0|||
146269421|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
146269422|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
146269423|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
146269424|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
146269425|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
146269426|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
146269427|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
146269428|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
146269429|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
146269430|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
146269431|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
146269432|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
146269433|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
146269434|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
146269435|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
146269436|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
146269437|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
146269438|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
146269439|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
146269440|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
146269441|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
146269442|NCT00132678|527501398|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
146269443|NCT00132678|527501399|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
146269444|NCT00132678|527501400|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
146269445|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
146269446|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
146269447|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
146269448|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
146269449|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
146269450|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
146269451|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
146269452|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
146269453|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
146269454|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
146269455|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
146269456|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
146269457|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
146269458|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
146269459|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
146269460|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
146269461|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
146269462|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
146269463|NCT00132678|527501398|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
146269464|NCT00132678|527501399|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
146137385|NCT02896400|527021171|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
146137386|NCT02896400|527021172|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
146137387|NCT02896400|527021173|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137388|NCT02896400|527021174|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137389|NCT02896400|527021175|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146137390|NCT02896400|527021176|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146137391|NCT02896400|527021177|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137392|NCT02896400|527021178|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
146137393|NCT02896400|527021179|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
146137394|NCT02896400|527021180|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
146137395|NCT02896400|527021165|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
146137396|NCT02896400|527021166|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146137397|NCT02896400|527021167|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
146137398|NCT02896400|527021168|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
146137399|NCT02896400|527021169|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
146137400|NCT02896400|527021170|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146137401|NCT02896400|527021171|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146137402|NCT02896400|527021172|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
146137403|NCT02896400|527021173|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
146137404|NCT02896400|527021174|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146137405|NCT02896400|527021175|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
146137406|NCT02896400|527021176|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
146137407|NCT02896400|527021177|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146137408|NCT02896400|527021178|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
146137409|NCT02896400|527021179|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
146137410|NCT02896400|527021180|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
146137411|NCT00634647|527021181|FG000|Overall Study|death on study|3|||
146137412|NCT00634647|527021181|FG000|Overall Study|refused further treatment|3|||
146137413|NCT00634647|527021181|FG000|Overall Study|declined to participate before treatment|1|||
146137414|NCT02984020|527021182|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
146137415|NCT02984020|527021182|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
146137416|NCT02984020|527021182|FG000|Overall Study|Other significant protocol violation|2|||
146137417|NCT01896895|527021183|FG000|Double-blind MP|Physician Decision|0|||
146137418|NCT01896895|527021184|FG001|Double-blind MP|Physician Decision|0|||
146137419|NCT01896895|527021185|FG002|Double-blind MP|Physician Decision|1|||
146137420|NCT01896895|527021186|FG003|Double-blind MP|Physician Decision|0|||
146137421|NCT01896895|527021183|FG000|Double-blind MP|Withdrawal by Subject|0|||
146137422|NCT01896895|527021184|FG001|Double-blind MP|Withdrawal by Subject|2|||
146137423|NCT01896895|527021185|FG002|Double-blind MP|Withdrawal by Subject|1|||
146137424|NCT01896895|527021186|FG003|Double-blind MP|Withdrawal by Subject|0|||
146137425|NCT01896895|527021183|FG000|Double-blind MP|Lost to Follow-up|1|||
146137426|NCT01896895|527021184|FG001|Double-blind MP|Lost to Follow-up|0|||
146137427|NCT01896895|527021185|FG002|Double-blind MP|Lost to Follow-up|1|||
146137428|NCT01896895|527021186|FG003|Double-blind MP|Lost to Follow-up|0|||
146137429|NCT00667342|527021187|FG000|Overall Study|Protocol Violation|1|||
146137430|NCT00667342|527021188|FG001|Overall Study|Protocol Violation|0|||
146137431|NCT00667342|527021189|FG002|Overall Study|Protocol Violation|0|||
146137432|NCT00667342|527021187|FG000|Overall Study|Withdrawal by Subject|1|||
146137433|NCT00667342|527021188|FG001|Overall Study|Withdrawal by Subject|0|||
146137434|NCT00667342|527021189|FG002|Overall Study|Withdrawal by Subject|0|||
146137435|NCT00667342|527021187|FG000|Overall Study|Physician Decision|3|||
146137436|NCT00667342|527021188|FG001|Overall Study|Physician Decision|0|||
146137437|NCT00667342|527021189|FG002|Overall Study|Physician Decision|0|||
146137438|NCT00667342|527021187|FG000|Overall Study|Relapse or tumor progression|9|||
146137439|NCT00667342|527021188|FG001|Overall Study|Relapse or tumor progression|0|||
146137440|NCT00667342|527021189|FG002|Overall Study|Relapse or tumor progression|7|||
146137441|NCT00667342|527021187|FG000|Overall Study|Adverse Event|0|||
146137442|NCT00667342|527021188|FG001|Overall Study|Adverse Event|0|||
146137443|NCT00667342|527021189|FG002|Overall Study|Adverse Event|1|||
146137444|NCT00667342|527021187|FG000|Overall Study|Ineligible|0|||
146137445|NCT00667342|527021188|FG001|Overall Study|Ineligible|0|||
146269465|NCT00132678|527501400|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
146269466|NCT00953147|527501401|FG000|Overall Study|Adverse Event|8|||
146269467|NCT00953147|527501402|FG001|Overall Study|Adverse Event|16|||
146137446|NCT00667342|527021189|FG002|Overall Study|Ineligible|1|||
146137447|NCT01207778|527021190|FG000|Overall Study|Lost to Follow-up|0|||
146269468|NCT00953147|527501403|FG002|Overall Study|Adverse Event|6|||
146269469|NCT00953147|527501401|FG000|Overall Study|Protocol Violation|2|||
146269470|NCT00953147|527501402|FG001|Overall Study|Protocol Violation|8|||
146137448|NCT01207778|527021191|FG001|Overall Study|Lost to Follow-up|3|||
146137449|NCT01207778|527021192|FG002|Overall Study|Lost to Follow-up|3|||
146137450|NCT03107988|527021193|FG000|Overall Study|Adverse Event|0|||
146137451|NCT03107988|527021194|FG001|Overall Study|Adverse Event|0|||
146137452|NCT03107988|527021195|FG002|Overall Study|Adverse Event|0|||
146137453|NCT03107988|527021196|FG003|Overall Study|Adverse Event|1|||
146137454|NCT03107988|527021197|FG004|Overall Study|Adverse Event|0|||
146137455|NCT03107988|527021198|FG005|Overall Study|Adverse Event|1|||
146137456|NCT03107988|527021199|FG006|Overall Study|Adverse Event|0|||
146137457|NCT03107988|527021200|FG007|Overall Study|Adverse Event|1|||
146137458|NCT03107988|527021201|FG008|Overall Study|Adverse Event|0|||
146137459|NCT03107988|527021202|FG009|Overall Study|Adverse Event|0|||
146137460|NCT03107988|527021203|FG010|Overall Study|Adverse Event|0|||
146137461|NCT03107988|527021204|FG011|Overall Study|Adverse Event|0|||
146137462|NCT03107988|527021205|FG012|Overall Study|Adverse Event|0|||
146137463|NCT03107988|527021193|FG000|Overall Study|Disease Progression or Relapse|1|||
146137464|NCT03107988|527021194|FG001|Overall Study|Disease Progression or Relapse|2|||
146137465|NCT03107988|527021195|FG002|Overall Study|Disease Progression or Relapse|2|||
146137466|NCT03107988|527021196|FG003|Overall Study|Disease Progression or Relapse|5|||
146137467|NCT03107988|527021197|FG004|Overall Study|Disease Progression or Relapse|1|||
146137468|NCT03107988|527021198|FG005|Overall Study|Disease Progression or Relapse|1|||
146137469|NCT03107988|527021199|FG006|Overall Study|Disease Progression or Relapse|0|||
146137470|NCT03107988|527021200|FG007|Overall Study|Disease Progression or Relapse|0|||
146137471|NCT03107988|527021201|FG008|Overall Study|Disease Progression or Relapse|0|||
146137472|NCT03107988|527021202|FG009|Overall Study|Disease Progression or Relapse|1|||
146137473|NCT03107988|527021203|FG010|Overall Study|Disease Progression or Relapse|4|||
146137474|NCT03107988|527021204|FG011|Overall Study|Disease Progression or Relapse|0|||
146137475|NCT03107988|527021205|FG012|Overall Study|Disease Progression or Relapse|0|||
146137476|NCT03107988|527021193|FG000|Overall Study|Ineligible|0|||
146137477|NCT03107988|527021194|FG001|Overall Study|Ineligible|0|||
146137478|NCT03107988|527021195|FG002|Overall Study|Ineligible|0|||
146137479|NCT03107988|527021196|FG003|Overall Study|Ineligible|0|||
146137480|NCT03107988|527021197|FG004|Overall Study|Ineligible|0|||
146137481|NCT03107988|527021198|FG005|Overall Study|Ineligible|0|||
146137482|NCT03107988|527021199|FG006|Overall Study|Ineligible|0|||
146137483|NCT03107988|527021200|FG007|Overall Study|Ineligible|0|||
146137484|NCT03107988|527021201|FG008|Overall Study|Ineligible|1|||
146137485|NCT03107988|527021202|FG009|Overall Study|Ineligible|0|||
146137486|NCT03107988|527021203|FG010|Overall Study|Ineligible|0|||
146137487|NCT03107988|527021204|FG011|Overall Study|Ineligible|0|||
146137488|NCT03107988|527021205|FG012|Overall Study|Ineligible|0|||
146137489|NCT04709237|527021206|FG000|Overall Study|Lost to Follow-up|1|||
146137490|NCT04709237|527021207|FG001|Overall Study|Lost to Follow-up|0|||
146137491|NCT04709237|527021208|FG002|Overall Study|Lost to Follow-up|0|||
146137492|NCT00145509|527021209|FG000|Overall Study|Adverse Event|10|||
146137493|NCT00145509|527021210|FG001|Overall Study|Adverse Event|3|||
146137494|NCT00145509|527021209|FG000|Overall Study|Lack of Efficacy|3|||
146137495|NCT00145509|527021210|FG001|Overall Study|Lack of Efficacy|1|||
146137496|NCT00145509|527021209|FG000|Overall Study|Lost to Follow-up|5|||
146137497|NCT00145509|527021210|FG001|Overall Study|Lost to Follow-up|9|||
146137498|NCT00145509|527021209|FG000|Overall Study|Withdrew Consent|2|||
146137499|NCT00145509|527021210|FG001|Overall Study|Withdrew Consent|7|||
146137500|NCT00145509|527021209|FG000|Overall Study|Reason not provided|2|||
146137501|NCT00145509|527021210|FG001|Overall Study|Reason not provided|1|||
146137502|NCT01359592|527021211|FG000|Initial Registration|Adverse Event|1|||
146137503|NCT01359592|527021212|FG001|Initial Registration|Adverse Event|0|||
146137504|NCT01359592|527021213|FG002|Initial Registration|Adverse Event|0|||
146137505|NCT01359592|527021214|FG003|Initial Registration|Adverse Event|0|||
146137506|NCT01359592|527021211|FG000|Initial Registration|Death|1|||
146137507|NCT01359592|527021212|FG001|Initial Registration|Death|0|||
146137508|NCT01359592|527021213|FG002|Initial Registration|Death|0|||
146137509|NCT01359592|527021214|FG003|Initial Registration|Death|0|||
146137510|NCT01359592|527021211|FG000|Initial Registration|Other reason not protocol specified|1|||
146137511|NCT01359592|527021212|FG001|Initial Registration|Other reason not protocol specified|0|||
146137512|NCT01359592|527021213|FG002|Initial Registration|Other reason not protocol specified|0|||
146137513|NCT01359592|527021214|FG003|Initial Registration|Other reason not protocol specified|0|||
146137514|NCT01359592|527021211|FG000|Initial Registration|Ineligible|26|||
146137515|NCT01359592|527021212|FG001|Initial Registration|Ineligible|0|||
146137516|NCT01359592|527021213|FG002|Initial Registration|Ineligible|0|||
146137517|NCT01359592|527021214|FG003|Initial Registration|Ineligible|0|||
146137518|NCT01359592|527021211|FG000|PET-Directed Therapy|Adverse Event|0|||
146137519|NCT01359592|527021212|FG001|PET-Directed Therapy|Adverse Event|0|||
146137520|NCT01359592|527021213|FG002|PET-Directed Therapy|Adverse Event|1|||
146137521|NCT01359592|527021214|FG003|PET-Directed Therapy|Adverse Event|0|||
146137522|NCT01359592|527021211|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146137523|NCT01359592|527021212|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146137524|NCT01359592|527021213|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
146137525|NCT01359592|527021214|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
146269471|NCT00953147|527501403|FG002|Overall Study|Protocol Violation|4|||
146269472|NCT00953147|527501401|FG000|Overall Study|Withdrawal by Subject|13|||
146269473|NCT00953147|527501402|FG001|Overall Study|Withdrawal by Subject|15|||
146269474|NCT00953147|527501403|FG002|Overall Study|Withdrawal by Subject|12|||
146269475|NCT00953147|527501401|FG000|Overall Study|Lost to Follow-up|8|||
146269476|NCT00953147|527501402|FG001|Overall Study|Lost to Follow-up|9|||
146269477|NCT00953147|527501403|FG002|Overall Study|Lost to Follow-up|4|||
146269478|NCT00953147|527501401|FG000|Overall Study|Physician Decision|2|||
146269479|NCT00953147|527501402|FG001|Overall Study|Physician Decision|7|||
146269480|NCT00953147|527501403|FG002|Overall Study|Physician Decision|3|||
146269481|NCT00953147|527501401|FG000|Overall Study|Other|4|||
146269482|NCT00953147|527501402|FG001|Overall Study|Other|11|||
146269483|NCT00953147|527501403|FG002|Overall Study|Other|13|||
146269484|NCT01484431|527501404|FG000|Period 1: High Dose|Physician Decision|0|||
146269485|NCT01484431|527501405|FG001|Period 1: High Dose|Physician Decision|1|||
146269486|NCT01484431|527501406|FG002|Period 1: High Dose|Physician Decision|0|||
146269487|NCT01484431|527501404|FG000|Period 2|Death|0|||
146269488|NCT01484431|527501405|FG001|Period 2|Death|1|||
146269489|NCT01484431|527501406|FG002|Period 2|Death|1|||
146269490|NCT01484431|527501404|FG000|Period 2|Physician Decision|0|||
146269491|NCT01484431|527501405|FG001|Period 2|Physician Decision|0|||
146269492|NCT01484431|527501406|FG002|Period 2|Physician Decision|1|||
146269493|NCT01484431|527501404|FG000|Period 2|Non-Compliance with Study Drug|1|||
146269494|NCT01484431|527501405|FG001|Period 2|Non-Compliance with Study Drug|0|||
146269495|NCT01484431|527501406|FG002|Period 2|Non-Compliance with Study Drug|0|||
146269496|NCT01251770|527501407|FG000|Overall Study|Protocol Violation|13|||
146269497|NCT01251770|527501408|FG001|Overall Study|Protocol Violation|7|||
146269498|NCT02514239|527501409|FG000|Overall Study|Refused to continue trial medication|0|||
146269499|NCT02514239|527501410|FG001|Overall Study|Refused to continue trial medication|0|||
146269500|NCT02514239|527501411|FG002|Overall Study|Refused to continue trial medication|0|||
146269501|NCT02514239|527501412|FG003|Overall Study|Refused to continue trial medication|0|||
146269502|NCT02514239|527501413|FG004|Overall Study|Refused to continue trial medication|0|||
146269503|NCT02514239|527501414|FG005|Overall Study|Refused to continue trial medication|0|||
146269504|NCT02514239|527501415|FG006|Overall Study|Refused to continue trial medication|0|||
146269505|NCT02514239|527501416|FG007|Overall Study|Refused to continue trial medication|0|||
146269506|NCT02514239|527501417|FG008|Overall Study|Refused to continue trial medication|0|||
146269507|NCT02514239|527501418|FG009|Overall Study|Refused to continue trial medication|1|||
146269508|NCT02514239|527501409|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269509|NCT02514239|527501410|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269510|NCT02514239|527501411|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269511|NCT02514239|527501412|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269512|NCT02514239|527501413|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269513|NCT02514239|527501414|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269514|NCT02514239|527501415|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269515|NCT02514239|527501416|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
146269516|NCT02514239|527501417|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
146269517|NCT02514239|527501418|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
146269518|NCT02514239|527501409|FG000|Overall Study|Not treated|0|||
146269519|NCT02514239|527501410|FG001|Overall Study|Not treated|1|||
146269520|NCT02514239|527501411|FG002|Overall Study|Not treated|0|||
146269521|NCT02514239|527501412|FG003|Overall Study|Not treated|0|||
146269522|NCT02514239|527501413|FG004|Overall Study|Not treated|0|||
146269523|NCT02514239|527501414|FG005|Overall Study|Not treated|0|||
146269524|NCT02514239|527501415|FG006|Overall Study|Not treated|0|||
146269525|NCT02514239|527501416|FG007|Overall Study|Not treated|0|||
146269526|NCT02514239|527501417|FG008|Overall Study|Not treated|0|||
146269527|NCT02514239|527501418|FG009|Overall Study|Not treated|0|||
146269528|NCT02514239|527501409|FG000|Overall Study|Other Adverse Events|2|||
146269529|NCT02514239|527501410|FG001|Overall Study|Other Adverse Events|0|||
146269530|NCT02514239|527501411|FG002|Overall Study|Other Adverse Events|0|||
146269531|NCT02514239|527501412|FG003|Overall Study|Other Adverse Events|1|||
146269532|NCT02514239|527501413|FG004|Overall Study|Other Adverse Events|0|||
146269533|NCT02514239|527501414|FG005|Overall Study|Other Adverse Events|1|||
146137526|NCT01359592|527021211|FG000|PET-Directed Therapy|Ineligible|0|||
146269534|NCT02514239|527501415|FG006|Overall Study|Other Adverse Events|0|||
146137527|NCT01359592|527021212|FG001|PET-Directed Therapy|Ineligible|0|||
146137528|NCT01359592|527021213|FG002|PET-Directed Therapy|Ineligible|24|||
146137529|NCT01359592|527021214|FG003|PET-Directed Therapy|Ineligible|0|||
146269535|NCT02514239|527501416|FG007|Overall Study|Other Adverse Events|1|||
146269536|NCT02514239|527501417|FG008|Overall Study|Other Adverse Events|2|||
146269537|NCT02514239|527501418|FG009|Overall Study|Other Adverse Events|0|||
146269538|NCT02514239|527501409|FG000|Overall Study|Progressive disease|3|||
146269539|NCT02514239|527501410|FG001|Overall Study|Progressive disease|3|||
146304083|NCT03250832|527627477|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146269540|NCT02514239|527501411|FG002|Overall Study|Progressive disease|2|||
146269541|NCT02514239|527501412|FG003|Overall Study|Progressive disease|2|||
146269542|NCT02514239|527501413|FG004|Overall Study|Progressive disease|3|||
146137530|NCT00749775|527021221|FG000|Overall Study|Protocol Violation|24|||
146137531|NCT00749775|527021221|FG000|Overall Study|Lost to Follow-up|36|||
146137532|NCT00749775|527021221|FG000|Overall Study|No visit after first day of treatment|44|||
146137533|NCT00749775|527021221|FG000|Overall Study|No drug administration|3|||
146137534|NCT02506816|527021226|FG000|Overall Study|Adverse Event|3|||
146137535|NCT03019627|527021227|FG000|Overall Study|Adverse Event|8|||
146137536|NCT03019627|527021228|FG001|Overall Study|Adverse Event|0|||
146137537|NCT03019627|527021227|FG000|Overall Study|Unrelated to adverse event|1|||
146137538|NCT03019627|527021228|FG001|Overall Study|Unrelated to adverse event|3|||
146137539|NCT03019627|527021227|FG000|Overall Study|Lost to Follow-up|2|||
146137540|NCT03019627|527021228|FG001|Overall Study|Lost to Follow-up|1|||
146137541|NCT03019627|527021227|FG000|Overall Study|not compliance|2|||
146137542|NCT03019627|527021228|FG001|Overall Study|not compliance|2|||
146137543|NCT03019627|527021227|FG000|Overall Study|Other|2|||
146137544|NCT03019627|527021228|FG001|Overall Study|Other|2|||
146137545|NCT02103478|527021231|FG000|Overall Study|Adverse Event|0|||
146137546|NCT02103478|527021232|FG001|Overall Study|Adverse Event|0|||
146137547|NCT02103478|527021233|FG002|Overall Study|Adverse Event|1|||
146137548|NCT02103478|527021234|FG003|Overall Study|Adverse Event|1|||
146137549|NCT02103478|527021235|FG004|Overall Study|Adverse Event|2|||
146137550|NCT02103478|527021236|FG005|Overall Study|Adverse Event|1|||
146137551|NCT02103478|527021237|FG006|Overall Study|Adverse Event|0|||
146137552|NCT02103478|527021238|FG007|Overall Study|Adverse Event|0|||
146137553|NCT02103478|527021239|FG008|Overall Study|Adverse Event|0|||
146137554|NCT02103478|527021231|FG000|Overall Study|Death|2|||
146137555|NCT02103478|527021232|FG001|Overall Study|Death|2|||
146137556|NCT02103478|527021233|FG002|Overall Study|Death|1|||
146137557|NCT02103478|527021234|FG003|Overall Study|Death|1|||
146137558|NCT02103478|527021235|FG004|Overall Study|Death|5|||
146137559|NCT02103478|527021236|FG005|Overall Study|Death|15|||
146137560|NCT02103478|527021237|FG006|Overall Study|Death|14|||
146137561|NCT02103478|527021238|FG007|Overall Study|Death|10|||
146137562|NCT02103478|527021239|FG008|Overall Study|Death|11|||
146137563|NCT02103478|527021231|FG000|Overall Study|Progressive Disease|2|||
146137564|NCT02103478|527021232|FG001|Overall Study|Progressive Disease|1|||
146137565|NCT02103478|527021233|FG002|Overall Study|Progressive Disease|2|||
146137566|NCT02103478|527021234|FG003|Overall Study|Progressive Disease|0|||
146137567|NCT02103478|527021235|FG004|Overall Study|Progressive Disease|9|||
146137568|NCT02103478|527021236|FG005|Overall Study|Progressive Disease|1|||
146137569|NCT02103478|527021237|FG006|Overall Study|Progressive Disease|2|||
146137570|NCT02103478|527021238|FG007|Overall Study|Progressive Disease|0|||
146137571|NCT02103478|527021239|FG008|Overall Study|Progressive Disease|1|||
146137572|NCT02103478|527021231|FG000|Overall Study|Withdrawal by Subject|2|||
146137573|NCT02103478|527021232|FG001|Overall Study|Withdrawal by Subject|0|||
146137574|NCT02103478|527021233|FG002|Overall Study|Withdrawal by Subject|0|||
146137575|NCT02103478|527021234|FG003|Overall Study|Withdrawal by Subject|4|||
146137576|NCT02103478|527021235|FG004|Overall Study|Withdrawal by Subject|0|||
146137577|NCT02103478|527021236|FG005|Overall Study|Withdrawal by Subject|0|||
146137578|NCT02103478|527021237|FG006|Overall Study|Withdrawal by Subject|1|||
146137579|NCT02103478|527021238|FG007|Overall Study|Withdrawal by Subject|1|||
146137580|NCT02103478|527021239|FG008|Overall Study|Withdrawal by Subject|0|||
146137581|NCT02103478|527021231|FG000|Overall Study|Lost to Follow-up|0|||
146137582|NCT02103478|527021232|FG001|Overall Study|Lost to Follow-up|0|||
146137583|NCT02103478|527021233|FG002|Overall Study|Lost to Follow-up|0|||
146137584|NCT02103478|527021234|FG003|Overall Study|Lost to Follow-up|0|||
146137585|NCT02103478|527021235|FG004|Overall Study|Lost to Follow-up|0|||
146137586|NCT02103478|527021236|FG005|Overall Study|Lost to Follow-up|0|||
146137587|NCT02103478|527021237|FG006|Overall Study|Lost to Follow-up|0|||
146137588|NCT02103478|527021238|FG007|Overall Study|Lost to Follow-up|1|||
146137589|NCT02103478|527021239|FG008|Overall Study|Lost to Follow-up|0|||
146137590|NCT02103478|527021231|FG000|Overall Study|Other|1|||
146137591|NCT02103478|527021232|FG001|Overall Study|Other|3|||
146304084|NCT03250832|527627478|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146137592|NCT02103478|527021233|FG002|Overall Study|Other|2|||
146137593|NCT02103478|527021234|FG003|Overall Study|Other|0|||
146137594|NCT02103478|527021235|FG004|Overall Study|Other|3|||
146137595|NCT02103478|527021236|FG005|Overall Study|Other|8|||
146137596|NCT02103478|527021237|FG006|Overall Study|Other|8|||
146137597|NCT02103478|527021238|FG007|Overall Study|Other|4|||
146137598|NCT02103478|527021239|FG008|Overall Study|Other|2|||
146137599|NCT00723606|527021240|FG000|Overall Study|Adverse Event|2|||
146137600|NCT00723606|527021241|FG001|Overall Study|Adverse Event|5|||
146137601|NCT00723606|527021240|FG000|Overall Study|Other|2|||
146137602|NCT00723606|527021241|FG001|Overall Study|Other|0|||
146137603|NCT00723606|527021240|FG000|Overall Study|Withdrawal by Subject|0|||
146137604|NCT00723606|527021241|FG001|Overall Study|Withdrawal by Subject|2|||
146137605|NCT00976898|527021242|FG000|Overall Study|Protocol Violation|1|||
146137606|NCT00976898|527021242|FG000|Overall Study|Adverse Event|1|||
146137607|NCT00976898|527021242|FG000|Overall Study|Physician Decision|1|||
146137608|NCT00976898|527021242|FG000|Overall Study|Liver Transplant|1|||
146137609|NCT00976898|527021242|FG000|Overall Study|Progressive Disease|1|||
146269543|NCT02514239|527501414|FG005|Overall Study|Progressive disease|3|||
146269544|NCT02514239|527501415|FG006|Overall Study|Progressive disease|4|||
146269545|NCT02514239|527501416|FG007|Overall Study|Progressive disease|2|||
146269546|NCT02514239|527501417|FG008|Overall Study|Progressive disease|5|||
146269547|NCT02514239|527501418|FG009|Overall Study|Progressive disease|0|||
146269548|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146269549|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146269550|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146269551|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
146269552|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146269553|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
146269554|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
146269555|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
146269556|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
146269557|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
146269558|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
146269559|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
146269560|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
146269561|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
146269562|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269563|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269564|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269565|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269566|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269567|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
146269568|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
146269569|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146269570|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146269571|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
146269572|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146269573|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146269574|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146269575|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146269576|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269577|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269578|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269579|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269580|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
146269581|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269582|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146269583|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269584|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
146269585|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269586|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269587|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269588|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269589|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
146269590|NCT01888874|527501419|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146269591|NCT01888874|527501420|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
146269592|NCT01888874|527501421|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146269593|NCT01888874|527501422|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146269594|NCT01888874|527501423|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146269595|NCT01888874|527501424|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
146269596|NCT01888874|527501425|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
146269597|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146269598|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146269599|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
146269600|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146269601|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
146137610|NCT04033159|527021269|FG000|Washout Period|Physician Decision|0|||
146137611|NCT04033159|527021270|FG001|Washout Period|Physician Decision|1|||
146137612|NCT04033159|527021271|FG002|Washout Period|Physician Decision|0|||
146137613|NCT04033159|527021269|FG000|Washout Period|Study terminated by Sponsor|0|||
146137614|NCT04033159|527021270|FG001|Washout Period|Study terminated by Sponsor|7|||
146137615|NCT04033159|527021271|FG002|Washout Period|Study terminated by Sponsor|0|||
146137616|NCT04033159|527021269|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
146269602|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146269603|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146269604|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269605|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269606|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269607|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269608|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
146269609|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269610|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
146269611|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146269612|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146269613|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
146269614|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146269615|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146269616|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
146269617|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
146269618|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269619|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269620|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
146269621|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269622|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269623|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269624|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
146269625|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146269626|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
146269627|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146269628|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146269629|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146269630|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146269631|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146269632|NCT01888874|527501419|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146269633|NCT01888874|527501420|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
146269634|NCT01888874|527501421|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146269635|NCT01888874|527501422|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146269636|NCT01888874|527501423|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146269637|NCT01888874|527501424|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
146269638|NCT01888874|527501425|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
146269639|NCT01411241|527501426|FG000|Overall Study|Protocol Violation|0|||
146269640|NCT01411241|527501427|FG001|Overall Study|Protocol Violation|5|||
146269641|NCT01411241|527501426|FG000|Overall Study|Withdrawal by Subject|9|||
146269642|NCT01411241|527501427|FG001|Overall Study|Withdrawal by Subject|10|||
146137617|NCT04033159|527021270|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
146137618|NCT04033159|527021271|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
146137619|NCT03277261|527021278|FG000|Overall Study|Adverse Event|17|||
146137620|NCT03277261|527021279|FG001|Overall Study|Adverse Event|1|||
146137621|NCT03277261|527021278|FG000|Overall Study|Participant Withdrawal of Consent|6|||
146137622|NCT03277261|527021279|FG001|Overall Study|Participant Withdrawal of Consent|15|||
146137623|NCT03277261|527021278|FG000|Overall Study|Investigator / Sponsor Decision|4|||
146137624|NCT03277261|527021279|FG001|Overall Study|Investigator / Sponsor Decision|2|||
146137625|NCT03277261|527021278|FG000|Overall Study|Pregnancy|2|||
146137626|NCT03277261|527021279|FG001|Overall Study|Pregnancy|0|||
146137627|NCT03277261|527021278|FG000|Overall Study|Lost to Follow-up|2|||
146137628|NCT03277261|527021279|FG001|Overall Study|Lost to Follow-up|2|||
146137629|NCT03277261|527021278|FG000|Overall Study|Lack of Efficacy|2|||
146137630|NCT03277261|527021279|FG001|Overall Study|Lack of Efficacy|2|||
146137631|NCT03277261|527021278|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
146137632|NCT03277261|527021279|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
146137633|NCT00499603|527021280|FG000|Overall Study|Adverse Event|0|||
146137634|NCT00499603|527021281|FG001|Overall Study|Adverse Event|1|||
146137635|NCT03323099|527021282|FG000|Overall Study|Withdrawal by Subject|6|||
146137636|NCT03323099|527021283|FG001|Overall Study|Withdrawal by Subject|12|||
146137637|NCT03323099|527021282|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
146137638|NCT03323099|527021283|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
146137639|NCT01502644|527021284|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
146137640|NCT01502644|527021285|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146137641|NCT01502644|527021286|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146137642|NCT01502644|527021287|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
146137643|NCT01502644|527021284|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
146137644|NCT01502644|527021285|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146137645|NCT01502644|527021286|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146137646|NCT01502644|527021287|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
146137647|NCT01502644|527021284|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
146137648|NCT01502644|527021285|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146137649|NCT01502644|527021286|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146137650|NCT01502644|527021287|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
146137651|NCT01502644|527021284|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
146137652|NCT01502644|527021285|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
146137653|NCT01502644|527021286|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
146137654|NCT01502644|527021287|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
146137655|NCT01502644|527021284|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
146137656|NCT01502644|527021285|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
146137657|NCT01502644|527021286|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
146137658|NCT01502644|527021287|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
146137659|NCT01526889|527021288|FG000|Treatment Period|Adverse Event|2|||
146137660|NCT01526889|527021289|FG001|Treatment Period|Adverse Event|0|||
146137661|NCT01526889|527021288|FG000|Treatment Extension Period|Administrative problems|1|||
146137662|NCT01526889|527021289|FG001|Treatment Extension Period|Administrative problems|0|||
146137663|NCT02388997|527021290|FG000|Overall Study|Adverse Event|1|||
146137664|NCT02388997|527021291|FG001|Overall Study|Adverse Event|2|||
146137665|NCT02388997|527021290|FG000|Overall Study|Withdrawal by Subject|2|||
146137666|NCT02388997|527021291|FG001|Overall Study|Withdrawal by Subject|1|||
146137667|NCT02388997|527021290|FG000|Overall Study|Lung function exclusion criteria|0|||
146137668|NCT02388997|527021291|FG001|Overall Study|Lung function exclusion criteria|2|||
146137669|NCT02388997|527021290|FG000|Overall Study|Tested positive for virus during run-in|0|||
146137670|NCT02388997|527021291|FG001|Overall Study|Tested positive for virus during run-in|1|||
146137671|NCT00006184|527021292|FG000|Overall Study|Death|1|||
146137672|NCT00006184|527021293|FG001|Overall Study|Death|0|||
146137673|NCT01110915|527021298|FG000|Overall Study|Death|2|||
146137674|NCT01110915|527021299|FG001|Overall Study|Death|1|||
146137675|NCT01110915|527021298|FG000|Overall Study|Lost to Follow-up|1|||
146137676|NCT01110915|527021299|FG001|Overall Study|Lost to Follow-up|0|||
146137677|NCT01110915|527021298|FG000|Overall Study|Withdrawal by Subject|7|||
146137678|NCT01110915|527021299|FG001|Overall Study|Withdrawal by Subject|1|||
146137679|NCT02948842|527021304|FG000|Overall Study|Withdrawal by Subject|4|||
146137680|NCT01857063|527021307|FG000|Period 1 (7 Days)|Adverse Event|0|||
146137681|NCT01857063|527021308|FG001|Period 1 (7 Days)|Adverse Event|1|||
146137682|NCT01857063|527021307|FG000|Period 1 (7 Days)|Physician Decision|1|||
146137683|NCT01857063|527021308|FG001|Period 1 (7 Days)|Physician Decision|0|||
146137684|NCT01857063|527021307|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
146137685|NCT01857063|527021308|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
146137686|NCT01857063|527021307|FG000|Period 2 (7 Days)|Adverse Event|2|||
146137687|NCT01857063|527021308|FG001|Period 2 (7 Days)|Adverse Event|1|||
146137688|NCT01857063|527021307|FG000|Period 2 (7 Days)|Physician Decision|1|||
146137689|NCT01857063|527021308|FG001|Period 2 (7 Days)|Physician Decision|1|||
146137690|NCT01857063|527021307|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
146137691|NCT01857063|527021308|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
146137692|NCT04958109|527021309|FG000|Overall Study|Withdrawal by Subject|0|||
146137693|NCT04958109|527021310|FG001|Overall Study|Withdrawal by Subject|1|||
146137694|NCT04958109|527021309|FG000|Overall Study|Lost to Follow-up|0|||
146137695|NCT04958109|527021310|FG001|Overall Study|Lost to Follow-up|1|||
146137696|NCT00715793|527021311|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
146137697|NCT00715793|527021312|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
146137698|NCT00715793|527021311|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
146137699|NCT00715793|527021312|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
146137700|NCT00058825|527021313|FG000|Overall Study|Relapse|9|||
146137701|NCT00058825|527021313|FG000|Overall Study|Progressive Disease|5|||
146137702|NCT00058825|527021313|FG000|Overall Study|Graft Failure|5|||
146137703|NCT00058825|527021313|FG000|Overall Study|Death|3|||
146137704|NCT04115358|527021314|FG000|Overall Study|exfoliation|0|||
146137705|NCT04115358|527021315|FG001|Overall Study|exfoliation|0|||
146137706|NCT04115358|527021316|FG002|Overall Study|exfoliation|1|||
146137707|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137708|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
146137709|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
146137710|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
146137711|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137712|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137713|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146269643|NCT01411241|527501426|FG000|Overall Study|Serious Adverse Event|0|||
146269644|NCT01411241|527501427|FG001|Overall Study|Serious Adverse Event|3|||
146269645|NCT01411241|527501426|FG000|Overall Study|Lost to Follow-up|2|||
146269646|NCT01411241|527501427|FG001|Overall Study|Lost to Follow-up|4|||
146269647|NCT02980042|527501430|FG000|Overall Study|Lost to Follow-up|5|||
146269648|NCT02980042|527501431|FG001|Overall Study|Lost to Follow-up|0|||
146269649|NCT02980042|527501430|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
146269650|NCT02980042|527501431|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
146269651|NCT00520845|527501437|FG000|Overall Study|Death|3|||
146269652|NCT00520845|527501437|FG000|Overall Study|Adverse Event|4|||
146269653|NCT00520845|527501437|FG000|Overall Study|Disease Progression, relapse|13|||
146269654|NCT00520845|527501437|FG000|Overall Study|Withdrawal by Subject|1|||
146269655|NCT00520845|527501437|FG000|Overall Study|Alternative Therapy|1|||
146269656|NCT01732549|527501440|FG000|Overall Study|Adverse Event|13|||
146269657|NCT01732549|527501441|FG001|Overall Study|Adverse Event|3|||
146269658|NCT01732549|527501440|FG000|Overall Study|Consent withdrawn|13|||
146269659|NCT01732549|527501441|FG001|Overall Study|Consent withdrawn|6|||
146269660|NCT01732549|527501440|FG000|Overall Study|Disease progression|37|||
146269661|NCT01732549|527501441|FG001|Overall Study|Disease progression|50|||
146269662|NCT01732549|527501440|FG000|Overall Study|Other|8|||
146269663|NCT01732549|527501441|FG001|Overall Study|Other|14|||
146269664|NCT01516749|527501442|FG000|Active Therapy|Lost to Follow-up|1|||
146269665|NCT01516749|527501442|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
146269666|NCT02030002|527501443|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
146269667|NCT02030002|527501443|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
146269668|NCT02030002|527501443|FG000|Follow-up|Lost to Follow-up|2|||
146269669|NCT03994731|527501445|FG000|Pegloticase + IMM Period|Death|2|||
146269670|NCT03994731|527501446|FG001|Pegloticase + IMM Period|Death|0|||
146269671|NCT03994731|527501445|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
146269672|NCT03994731|527501446|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
146269673|NCT03994731|527501445|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
146269674|NCT03994731|527501446|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
146269675|NCT01681992|527501451|FG000|Overall Study|Adverse Event|3|||
146269676|NCT01681992|527501452|FG001|Overall Study|Adverse Event|2|||
146269677|NCT01681992|527501453|FG002|Overall Study|Adverse Event|3|||
146269678|NCT01681992|527501451|FG000|Overall Study|Lost to Follow-up|36|||
146269679|NCT01681992|527501452|FG001|Overall Study|Lost to Follow-up|38|||
146269680|NCT01681992|527501453|FG002|Overall Study|Lost to Follow-up|53|||
146269681|NCT01681992|527501451|FG000|Overall Study|As Per Sponsor Decision|0|||
146269682|NCT01681992|527501452|FG001|Overall Study|As Per Sponsor Decision|0|||
146269683|NCT01681992|527501453|FG002|Overall Study|As Per Sponsor Decision|1|||
146269684|NCT01681992|527501451|FG000|Overall Study|Protocol Violation|0|||
146269685|NCT01681992|527501452|FG001|Overall Study|Protocol Violation|0|||
146269686|NCT01681992|527501453|FG002|Overall Study|Protocol Violation|1|||
146269687|NCT01681992|527501451|FG000|Overall Study|Withdrawal by Subject|27|||
146269688|NCT01681992|527501452|FG001|Overall Study|Withdrawal by Subject|30|||
146269689|NCT01681992|527501453|FG002|Overall Study|Withdrawal by Subject|25|||
146269690|NCT02406248|527501456|FG000|Overall Study|Death|7|||
146269691|NCT02406248|527501456|FG000|Overall Study|Withdrawal by Subject|2|||
146269692|NCT00732992|527501461|FG000|Overall Study|Adverse Event|1|||
146269693|NCT00732992|527501462|FG001|Overall Study|Adverse Event|1|||
146269694|NCT00732992|527501461|FG000|Overall Study|Objective Progression or Relapse|3|||
146269695|NCT00732992|527501462|FG001|Overall Study|Objective Progression or Relapse|5|||
146269696|NCT00732992|527501461|FG000|Overall Study|Global Deterioration of Health Status|1|||
146269697|NCT00732992|527501462|FG001|Overall Study|Global Deterioration of Health Status|0|||
146269698|NCT00732992|527501461|FG000|Overall Study|Withdrawal by Subject|1|||
146269699|NCT00732992|527501462|FG001|Overall Study|Withdrawal by Subject|0|||
146269700|NCT04805073|527501467|FG000|Overall Study|study personnel not available|2|||
146269701|NCT04805073|527501468|FG001|Overall Study|study personnel not available|0|||
146269702|NCT04805073|527501467|FG000|Overall Study|spinal anesthesia failure|0|||
146269703|NCT04805073|527501468|FG001|Overall Study|spinal anesthesia failure|1|||
146269704|NCT04805073|527501467|FG000|Overall Study|Lost to Follow-up|0|||
146269705|NCT04805073|527501468|FG001|Overall Study|Lost to Follow-up|2|||
146269706|NCT03017742|527501471|FG000|Overall Study|Protocol Violation|36|||
146269707|NCT03017742|527501471|FG000|Overall Study|Withdrawal by Subject|37|||
146269708|NCT02975102|527501472|FG000|Overall Study|Adverse Event|2|||
146269709|NCT02975102|527501473|FG001|Overall Study|Adverse Event|1|||
146269710|NCT01825577|527501477|FG000|Overall Study|Physician Decision|2|||
146269711|NCT01825577|527501477|FG000|Overall Study|Withdrawal by Subject|1|||
146269712|NCT01825577|527501477|FG000|Overall Study|Withdrawn by family members|2|||
146269713|NCT01825577|527501477|FG000|Overall Study|Lack of Efficacy|3|||
146269714|NCT01245374|527501484|FG000|Overall Study|Protocol Violation|1|||
146269715|NCT01245374|527501484|FG000|Overall Study|Withdrawal by Subject|3|||
146269716|NCT01782690|527501486|FG000|Overall Study|Not reported|7|||
146269717|NCT01782690|527501486|FG000|Overall Study|Toxicity of gemcitabine|1|||
146269718|NCT01782690|527501486|FG000|Overall Study|Toxicity of erlotinib|1|||
146269719|NCT01782690|527501486|FG000|Overall Study|Lost to Follow-up|31|||
146269720|NCT01782690|527501486|FG000|Overall Study|Withdrawal of informed consent|2|||
146269721|NCT01782690|527501486|FG000|Overall Study|Absent rash|9|||
146269722|NCT01782690|527501486|FG000|Overall Study|Physician Decision|13|||
146269723|NCT01782690|527501486|FG000|Overall Study|Patient's wish|21|||
146269724|NCT01782690|527501486|FG000|Overall Study|Tumor progression|74|||
146269725|NCT01782690|527501486|FG000|Overall Study|Death|133|||
146269726|NCT01782690|527501486|FG000|Overall Study|Study completion unknown|7|||
146269727|NCT04199052|527501489|FG000|Overall Study|Lost to Follow-up|11|||
146269728|NCT04199052|527501490|FG001|Overall Study|Lost to Follow-up|18|||
146269729|NCT01948076|527501491|FG000|Overall Study|Withdrawal by Subject|0|||
146304085|NCT03250832|527627479|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146304086|NCT03250832|527627480|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146304087|NCT03250832|527627481|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146304088|NCT03250832|527627482|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
146304089|NCT03250832|527627483|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146304090|NCT03250832|527627484|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146137714|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137715|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137716|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137717|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137718|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137719|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137720|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137721|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137722|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137723|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137724|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137725|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137726|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137727|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137728|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137729|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137730|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
146137731|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137732|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
146137733|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137734|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137735|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137736|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137737|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137738|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137739|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137740|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137741|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137742|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137743|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137744|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137745|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137746|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137747|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137748|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137749|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137750|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137751|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146269730|NCT01948076|527501492|FG001|Overall Study|Withdrawal by Subject|1|||
146304091|NCT03250832|527627485|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146137752|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137753|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137754|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
146137755|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137756|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
146137757|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137758|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137759|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146269731|NCT01151423|527501493|FG000|Overall Study|Study terminated by Sponsor|9|||
146269732|NCT01151423|527501494|FG001|Overall Study|Study terminated by Sponsor|10|||
146304092|NCT03250832|527627486|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
146269733|NCT01151423|527501493|FG000|Overall Study|Protocol Violation|0|||
146269734|NCT01151423|527501494|FG001|Overall Study|Protocol Violation|1|||
146269735|NCT01151423|527501493|FG000|Overall Study|Physician Decision|1|||
146269736|NCT01151423|527501494|FG001|Overall Study|Physician Decision|1|||
146269737|NCT01151423|527501493|FG000|Overall Study|Pregnancy|0|||
146269738|NCT01151423|527501494|FG001|Overall Study|Pregnancy|1|||
146269739|NCT01151423|527501493|FG000|Overall Study|Death|0|||
146269740|NCT01151423|527501494|FG001|Overall Study|Death|1|||
146269741|NCT01151423|527501493|FG000|Overall Study|Adverse Event|3|||
146269742|NCT01151423|527501494|FG001|Overall Study|Adverse Event|0|||
146269743|NCT01151423|527501493|FG000|Overall Study|Withdrawal by Subject|1|||
146269744|NCT01151423|527501494|FG001|Overall Study|Withdrawal by Subject|3|||
146269745|NCT01151423|527501493|FG000|Overall Study|Lost to Follow-up|1|||
146269746|NCT01151423|527501494|FG001|Overall Study|Lost to Follow-up|0|||
146269747|NCT01151423|527501493|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
146269748|NCT01151423|527501494|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
146269749|NCT01151423|527501493|FG000|Overall Study|Participated in other clinical trial|1|||
146269750|NCT01151423|527501494|FG001|Overall Study|Participated in other clinical trial|0|||
146269751|NCT00681668|527501495|FG000|Overall Study|Protocol Violation|1|||
146269752|NCT00681668|527501495|FG000|Overall Study|Withdrawal by Subject|1|||
146269753|NCT06719986|527501507|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
146269754|NCT06719986|527501508|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
146269755|NCT06719986|527501509|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
146269756|NCT06719986|527501507|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
146269757|NCT06719986|527501508|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
146269758|NCT06719986|527501509|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
146269759|NCT02600897|527501510|FG000|Overall Study|Death|1|||
146269760|NCT02600897|527501511|FG001|Overall Study|Death|2|||
146269761|NCT02600897|527501512|FG002|Overall Study|Death|1|||
146269762|NCT02600897|527501513|FG003|Overall Study|Death|2|||
146269763|NCT02600897|527501514|FG004|Overall Study|Death|3|||
146269764|NCT02600897|527501515|FG005|Overall Study|Death|2|||
146269765|NCT02600897|527501516|FG006|Overall Study|Death|10|||
146269766|NCT02600897|527501517|FG007|Overall Study|Death|7|||
146137760|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137761|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137762|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137763|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137764|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137765|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137766|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137767|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137768|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137769|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137770|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137771|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137772|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137773|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137774|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137775|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146269767|NCT02600897|527501518|FG008|Overall Study|Death|20|||
146269768|NCT02600897|527501510|FG000|Overall Study|Lost to Follow-up|1|||
146269769|NCT02600897|527501511|FG001|Overall Study|Lost to Follow-up|0|||
146269770|NCT02600897|527501512|FG002|Overall Study|Lost to Follow-up|0|||
146269771|NCT02600897|527501513|FG003|Overall Study|Lost to Follow-up|0|||
146269772|NCT02600897|527501514|FG004|Overall Study|Lost to Follow-up|0|||
146269773|NCT02600897|527501515|FG005|Overall Study|Lost to Follow-up|0|||
146269774|NCT02600897|527501516|FG006|Overall Study|Lost to Follow-up|0|||
146269775|NCT02600897|527501517|FG007|Overall Study|Lost to Follow-up|1|||
146269776|NCT02600897|527501518|FG008|Overall Study|Lost to Follow-up|0|||
146269777|NCT02600897|527501510|FG000|Overall Study|Withdrawal by Subject|0|||
146269778|NCT02600897|527501511|FG001|Overall Study|Withdrawal by Subject|0|||
146269779|NCT02600897|527501512|FG002|Overall Study|Withdrawal by Subject|0|||
146269780|NCT02600897|527501513|FG003|Overall Study|Withdrawal by Subject|0|||
146269781|NCT02600897|527501514|FG004|Overall Study|Withdrawal by Subject|0|||
146269782|NCT02600897|527501515|FG005|Overall Study|Withdrawal by Subject|0|||
146269783|NCT02600897|527501516|FG006|Overall Study|Withdrawal by Subject|0|||
146137776|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146269784|NCT02600897|527501517|FG007|Overall Study|Withdrawal by Subject|4|||
146269785|NCT02600897|527501518|FG008|Overall Study|Withdrawal by Subject|2|||
146269786|NCT02600897|527501510|FG000|Overall Study|Reason Not Specified|0|||
146137777|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146269787|NCT02600897|527501511|FG001|Overall Study|Reason Not Specified|0|||
146269788|NCT02600897|527501512|FG002|Overall Study|Reason Not Specified|0|||
146269789|NCT02600897|527501513|FG003|Overall Study|Reason Not Specified|0|||
146269790|NCT02600897|527501514|FG004|Overall Study|Reason Not Specified|0|||
146269791|NCT02600897|527501515|FG005|Overall Study|Reason Not Specified|0|||
146269792|NCT02600897|527501516|FG006|Overall Study|Reason Not Specified|0|||
146269793|NCT02600897|527501517|FG007|Overall Study|Reason Not Specified|0|||
146269794|NCT02600897|527501518|FG008|Overall Study|Reason Not Specified|1|||
146269795|NCT05992922|527501519|FG000|Overall Study|Adverse Event|6|||
146269796|NCT05992922|527501520|FG001|Overall Study|Adverse Event|0|||
146269797|NCT05992922|527501519|FG000|Overall Study|Sponsor Termination of Study|14|||
146269798|NCT05992922|527501520|FG001|Overall Study|Sponsor Termination of Study|20|||
146269799|NCT04991753|527502913|FG000|Overall Study|Withdrawal by Subject|0|||
146269800|NCT04991753|527502914|FG001|Overall Study|Withdrawal by Subject|1|||
146269801|NCT00475644|527502918|FG000|Overall Study|Protocol Violation|13|||
146269802|NCT01020877|527502920|FG000|Second Intervention|Withdrawal by Subject|1|||
146269803|NCT01020877|527502921|FG001|Second Intervention|Withdrawal by Subject|0|||
146269804|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
146269805|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
146269806|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
146269807|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
146269808|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
146269809|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
146269810|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
146269811|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
146269812|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
146269813|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
146269814|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
146269815|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
146269816|NCT00790400|527502922|FG000|Double-blind Period (Core Phase)|Death|1|||
146269817|NCT00790400|527502923|FG001|Double-blind Period (Core Phase)|Death|0|||
146269818|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
146269819|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
146269820|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
146269821|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
146269822|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
146269823|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
146269824|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
146137778|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
146137779|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
146137780|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
146137781|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
146137782|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
146137783|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137784|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137785|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146269825|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
146269826|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
146269827|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
146269828|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Death|1|||
146269829|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Death|0|||
146269830|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
146269831|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
146269832|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
146269833|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
146269834|NCT00790400|527502922|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
146269835|NCT00790400|527502923|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
146269836|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
146269837|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
146137786|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146269838|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
146269839|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
146269840|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Death|13|||
146269841|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Death|12|||
146269842|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Progression|257|||
146269843|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Progression|218|||
146269844|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
146137787|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137788|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137789|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137790|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137791|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137792|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137793|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137794|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137795|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137796|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137797|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137798|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137799|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137800|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137801|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137802|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
146137803|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
146137804|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
146137805|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
146137806|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
146137807|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137808|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137809|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137810|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137811|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137812|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137813|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137814|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137815|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137816|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137817|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137818|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137819|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137820|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137821|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137822|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137823|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137824|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137825|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137826|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
146137827|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137828|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
146137829|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137830|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
146137831|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137832|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137833|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137834|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137835|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137836|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137837|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137838|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137839|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137840|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137841|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137842|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137843|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137844|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137845|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137846|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137847|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137848|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137849|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137850|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
146137851|NCT02346240|527021317|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137852|NCT02346240|527021318|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137853|NCT02346240|527021319|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
146137854|NCT02346240|527021320|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137855|NCT02346240|527021321|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146269845|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
146269846|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
146269847|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
146269848|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
146269849|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
146269850|NCT01006980|527502925|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
146269851|NCT01006980|527502926|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
146269852|NCT01006980|527502925|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
146269853|NCT01006980|527502926|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
146269854|NCT01006980|527502925|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
146269855|NCT01006980|527502926|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
146269856|NCT01006980|527502925|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
146269857|NCT01006980|527502926|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
146269858|NCT01006980|527502925|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
146269859|NCT01006980|527502926|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
146269860|NCT01006980|527502925|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
146269861|NCT01006980|527502926|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
146269862|NCT00078338|527502927|FG000|Overall Study|Adverse Event|31|||
146269863|NCT00078338|527502928|FG001|Overall Study|Adverse Event|24|||
146269864|NCT00078338|527502927|FG000|Overall Study|Lost to Follow-up|17|||
146269865|NCT00078338|527502928|FG001|Overall Study|Lost to Follow-up|2|||
146269866|NCT00078338|527502927|FG000|Overall Study|Protocol Violation|2|||
146269867|NCT00078338|527502928|FG001|Overall Study|Protocol Violation|2|||
146269868|NCT00078338|527502927|FG000|Overall Study|Disease Progression|4|||
146269869|NCT00078338|527502928|FG001|Overall Study|Disease Progression|7|||
146269870|NCT00078338|527502927|FG000|Overall Study|Other|28|||
146269871|NCT00078338|527502928|FG001|Overall Study|Other|16|||
146269872|NCT00078338|527502927|FG000|Overall Study|Subjects randomized, but not treated|3|||
146269873|NCT00078338|527502928|FG001|Overall Study|Subjects randomized, but not treated|3|||
146269874|NCT01483144|527502929|FG000|Overall Study|Adverse Event|9|||
146269875|NCT01483144|527502930|FG001|Overall Study|Adverse Event|4|||
146269876|NCT01483144|527502931|FG002|Overall Study|Adverse Event|6|||
146269877|NCT01483144|527502929|FG000|Overall Study|Withdrawal by Subject|0|||
146269878|NCT01483144|527502930|FG001|Overall Study|Withdrawal by Subject|2|||
146269879|NCT01483144|527502931|FG002|Overall Study|Withdrawal by Subject|5|||
146269880|NCT01483144|527502929|FG000|Overall Study|Physician Decision|1|||
146269881|NCT01483144|527502930|FG001|Overall Study|Physician Decision|0|||
146269882|NCT01483144|527502931|FG002|Overall Study|Physician Decision|0|||
146269883|NCT01483144|527502929|FG000|Overall Study|Lost to Follow-up|2|||
146269884|NCT01483144|527502930|FG001|Overall Study|Lost to Follow-up|4|||
146269885|NCT01483144|527502931|FG002|Overall Study|Lost to Follow-up|1|||
146269886|NCT01483144|527502929|FG000|Overall Study|Protocol Violation|3|||
146269887|NCT01483144|527502930|FG001|Overall Study|Protocol Violation|3|||
146269888|NCT01483144|527502931|FG002|Overall Study|Protocol Violation|3|||
146269889|NCT02460575|527502932|FG000|Overall Study|Lost to Follow-up|1|||
146269890|NCT02460575|527502933|FG001|Overall Study|Lost to Follow-up|0|||
146269891|NCT04307940|527502934|FG000|Overall Study|Adverse Event|1|||
146269892|NCT04307940|527502935|FG001|Overall Study|Adverse Event|0|||
146269893|NCT04307940|527502936|FG002|Overall Study|Adverse Event|0|||
146269894|NCT04307940|527502934|FG000|Overall Study|Withdrawal by Subject|2|||
146269895|NCT04307940|527502935|FG001|Overall Study|Withdrawal by Subject|3|||
146269896|NCT04307940|527502936|FG002|Overall Study|Withdrawal by Subject|1|||
146269897|NCT04307940|527502934|FG000|Overall Study|Lost to Follow-up|2|||
146269898|NCT04307940|527502935|FG001|Overall Study|Lost to Follow-up|0|||
146269899|NCT04307940|527502936|FG002|Overall Study|Lost to Follow-up|1|||
146269900|NCT02521363|527502937|FG000|Overall Study|Withdrawal by Subject|1|||
146269901|NCT02521363|527502938|FG001|Overall Study|Withdrawal by Subject|2|||
146269902|NCT05543174|527502939|FG000|Overall Study|Ongoing|7|||
146269903|NCT03104075|527502940|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
146269904|NCT03104075|527502941|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
146269905|NCT00944229|527502942|FG000|Overall Study|Withdrawal by Subject|11|||
146269906|NCT00944229|527502942|FG000|Overall Study|Physician Decision|14|||
146269907|NCT01810939|527502943|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
146137856|NCT02346240|527021322|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146269908|NCT01810939|527502944|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
146269909|NCT01810939|527502945|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
146137857|NCT02346240|527021323|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146304093|NCT03250832|527627475|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
146269910|NCT01810939|527502943|FG000|Part A Treatment Period|Protocol Violation|2|||
146269911|NCT01810939|527502944|FG001|Part A Treatment Period|Protocol Violation|0|||
146269912|NCT01810939|527502945|FG002|Part A Treatment Period|Protocol Violation|0|||
146269913|NCT01810939|527502943|FG000|Part A Treatment Period|Adverse Event|10|||
146137858|NCT02346240|527021324|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137859|NCT02346240|527021325|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137860|NCT02346240|527021326|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137861|NCT02346240|527021327|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137862|NCT02346240|527021328|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137863|NCT02346240|527021329|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137864|NCT02346240|527021330|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137865|NCT02346240|527021331|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137866|NCT02346240|527021332|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137867|NCT02346240|527021333|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137868|NCT02346240|527021334|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137869|NCT02346240|527021335|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137870|NCT02346240|527021336|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137871|NCT02346240|527021337|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137872|NCT02346240|527021338|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137873|NCT02346240|527021339|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137874|NCT02346240|527021340|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
146137875|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137876|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137877|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137878|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137879|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137880|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137881|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137882|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146137883|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146137884|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137885|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137886|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137887|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137888|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146137889|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
146137890|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146137891|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
146137892|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137893|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137894|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137895|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137896|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137897|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137898|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146137899|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137900|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137901|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137902|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137903|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137904|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137905|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137906|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137907|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137908|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137909|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137910|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137911|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146304094|NCT03250832|527627476|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
146137912|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
146137913|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137914|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
146137915|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137916|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137917|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137918|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137919|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137920|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146269914|NCT01810939|527502944|FG001|Part A Treatment Period|Adverse Event|0|||
146269915|NCT01810939|527502945|FG002|Part A Treatment Period|Adverse Event|0|||
146269916|NCT01810939|527502943|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
146269917|NCT01810939|527502944|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
146269918|NCT01810939|527502945|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
146269919|NCT01810939|527502943|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
146269920|NCT01810939|527502944|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
146269921|NCT01810939|527502945|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
146269922|NCT01810939|527502943|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
146269923|NCT01810939|527502944|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
146269924|NCT01810939|527502945|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
146269925|NCT01810939|527502943|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
146137921|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137922|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
146137923|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137924|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137925|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137926|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137927|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137928|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137929|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137930|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137931|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137932|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137933|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137934|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137935|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137936|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137937|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
146137938|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137939|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137940|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137941|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137942|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137943|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137944|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137945|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137946|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146137947|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137948|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137949|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146269926|NCT01810939|527502944|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
146269927|NCT01810939|527502945|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
146269928|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
146269929|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
146269930|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
146269931|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
146269932|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
146137950|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137951|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137952|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137953|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137954|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137955|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137956|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137957|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137958|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146137959|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137960|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146137961|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
146269933|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
146269934|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
146269935|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
146269936|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
146269937|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
146269938|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
146269939|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
146269940|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
146269941|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
146269942|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
146269943|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
146269944|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
146269945|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
146269946|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
146269947|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
146269948|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
146269949|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
146269950|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
146269951|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
146269952|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
146269953|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
146269954|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
146269955|NCT01810939|527502943|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
146269956|NCT01810939|527502944|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
146269957|NCT01810939|527502945|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
146269958|NCT02963090|527502946|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
146269959|NCT02963090|527502947|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
146269960|NCT00709228|527502948|FG000|Overall Study|Not treated|14|||
146269961|NCT00709228|527502948|FG000|Overall Study|Eligibility criteria not met|281|||
146269962|NCT00709228|527502948|FG000|Overall Study|Adverse events|2|||
146269963|NCT00709228|527502948|FG000|Overall Study|Discontinued treatment|14|||
146269964|NCT00709228|527502948|FG000|Overall Study|Did not enter follow-up|4|||
146269965|NCT00709228|527502948|FG000|Overall Study|Discontinued follow-up|5|||
146269966|NCT00709228|527502948|FG000|Overall Study|Disease progression|1|||
146269967|NCT00709228|527502948|FG000|Overall Study|Lost to Follow-up|6|||
146269968|NCT00709228|527502948|FG000|Overall Study|Non-compliance|5|||
146269969|NCT04400487|527502949|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146269970|NCT04400487|527502949|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
146269971|NCT04400487|527502949|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
146269972|NCT01594827|527502951|FG000|Overall Study|Adverse Event|1|||
146269973|NCT01594827|527502952|FG001|Overall Study|Adverse Event|0|||
146269974|NCT01594827|527502951|FG000|Overall Study|Physician Decision|3|||
146269975|NCT01594827|527502952|FG001|Overall Study|Physician Decision|0|||
146269976|NCT03334253|527502954|FG000|Overall Study|Withdrawal by Subject|1|||
146269977|NCT03334253|527502955|FG001|Overall Study|Withdrawal by Subject|0|||
146269978|NCT03334253|527502954|FG000|Overall Study|Lost to Follow-up|4|||
146269979|NCT03334253|527502955|FG001|Overall Study|Lost to Follow-up|3|||
146269980|NCT03334253|527502954|FG000|Overall Study|Moved residence|2|||
146269981|NCT03334253|527502955|FG001|Overall Study|Moved residence|2|||
146269982|NCT00945672|527502957|FG000|Overall Study|Withdrawal by Subject|0|||
146269983|NCT00945672|527502958|FG001|Overall Study|Withdrawal by Subject|0|||
146269984|NCT00945672|527502959|FG002|Overall Study|Withdrawal by Subject|0|||
146269985|NCT00945672|527502960|FG003|Overall Study|Withdrawal by Subject|1|||
146269986|NCT03054337|527502962|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146269987|NCT03054337|527502963|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
146269988|NCT03054337|527502964|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146269989|NCT03054337|527502965|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
146269990|NCT03054337|527502966|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
146269991|NCT03054337|527502967|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
146269992|NCT00447590|527502970|FG000|Overall Study|Withdrawal by Subject|26|||
146269993|NCT00447590|527502970|FG000|Overall Study|Lost to Follow-up|24|||
146269994|NCT00447590|527502970|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
146269995|NCT00609947|527502974|FG000|Overall Study|Death|1|||
146269996|NCT05569421|527502975|FG000|Overall Study|Withdrawal by Subject|1|||
146269997|NCT05569421|527502976|FG001|Overall Study|Withdrawal by Subject|0|||
146269998|NCT05569421|527502977|FG002|Overall Study|Withdrawal by Subject|0|||
146269999|NCT00504075|527502978|FG000|Overall Study|Adverse Event|1|||
146270000|NCT00504075|527502978|FG000|Overall Study|Lost to Follow-up|5|||
146270001|NCT00504075|527502978|FG000|Overall Study|Withdrawal by Subject|1|||
146270002|NCT00504075|527502978|FG000|Overall Study|Required other therapeutic intervention|1|||
146270003|NCT03812029|527502981|FG000|Overall Study|Protocol Violation|1|||
146270004|NCT03812029|527502982|FG001|Overall Study|Protocol Violation|0|||
146270005|NCT03812029|527502983|FG002|Overall Study|Protocol Violation|0|||
146270006|NCT03812029|527502984|FG003|Overall Study|Protocol Violation|1|||
146270007|NCT03812029|527502985|FG004|Overall Study|Protocol Violation|0|||
146270008|NCT03812029|527502981|FG000|Overall Study|Withdrawal by Subject|1|||
146270009|NCT03812029|527502982|FG001|Overall Study|Withdrawal by Subject|0|||
146270010|NCT03812029|527502983|FG002|Overall Study|Withdrawal by Subject|0|||
146270011|NCT03812029|527502984|FG003|Overall Study|Withdrawal by Subject|2|||
146270012|NCT03812029|527502985|FG004|Overall Study|Withdrawal by Subject|2|||
146270013|NCT03812029|527502981|FG000|Overall Study|Stopping rules|0|||
146270014|NCT03812029|527502982|FG001|Overall Study|Stopping rules|1|||
146270015|NCT03812029|527502983|FG002|Overall Study|Stopping rules|0|||
146270016|NCT03812029|527502984|FG003|Overall Study|Stopping rules|0|||
146270017|NCT03812029|527502985|FG004|Overall Study|Stopping rules|0|||
146270018|NCT03812029|527502981|FG000|Overall Study|Adverse Event|0|||
146270019|NCT03812029|527502982|FG001|Overall Study|Adverse Event|9|||
146270020|NCT03812029|527502983|FG002|Overall Study|Adverse Event|0|||
146270021|NCT03812029|527502984|FG003|Overall Study|Adverse Event|3|||
146270022|NCT03812029|527502985|FG004|Overall Study|Adverse Event|5|||
146270023|NCT03812029|527502981|FG000|Overall Study|Lost to Follow-up|0|||
146270024|NCT03812029|527502982|FG001|Overall Study|Lost to Follow-up|0|||
146270025|NCT03812029|527502983|FG002|Overall Study|Lost to Follow-up|0|||
146270026|NCT03812029|527502984|FG003|Overall Study|Lost to Follow-up|0|||
146270027|NCT03812029|527502985|FG004|Overall Study|Lost to Follow-up|3|||
146270028|NCT00581477|527502986|FG000|Overall Study|Physician Decision|2|||
146270029|NCT03106753|527502987|FG000|Overall Study|Withdrawal by Subject|0|||
146270030|NCT03106753|527502988|FG001|Overall Study|Withdrawal by Subject|1|||
146270031|NCT01643044|527502989|FG000|Overall Study|Lost to Follow-up|1|||
146270032|NCT01643044|527502990|FG001|Overall Study|Lost to Follow-up|1|||
146270033|NCT01643044|527502989|FG000|Overall Study|Miscarried baby|2|||
146270034|NCT01643044|527502990|FG001|Overall Study|Miscarried baby|2|||
146270035|NCT01643044|527502989|FG000|Overall Study|Delivered outside of hospital|1|||
146270036|NCT01643044|527502990|FG001|Overall Study|Delivered outside of hospital|2|||
146270037|NCT03149042|527502991|FG000|Overall Study|Invasive FFR not performed|21|||
146270038|NCT03149042|527502991|FG000|Overall Study|Poor CT Image Quality|1|||
146270039|NCT03149042|527502991|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
146270040|NCT00790205|527502992|FG000|Overall Study|Lost to Follow-up|61|||
146270041|NCT00790205|527502993|FG001|Overall Study|Lost to Follow-up|71|||
146270042|NCT00790205|527502992|FG000|Overall Study|Withdrawal by Subject|299|||
146270043|NCT00790205|527502993|FG001|Overall Study|Withdrawal by Subject|363|||
146270044|NCT02643628|527502994|FG000|Overall Study|Lost to Follow-up|1|||
146270045|NCT02643628|527502995|FG001|Overall Study|Lost to Follow-up|4|||
146270046|NCT02643628|527502994|FG000|Overall Study|Withdrawal by Subject|0|||
146270047|NCT02643628|527502995|FG001|Overall Study|Withdrawal by Subject|1|||
146270048|NCT02643628|527502994|FG000|Overall Study|Relocated out of state|0|||
146270049|NCT02643628|527502995|FG001|Overall Study|Relocated out of state|1|||
146270050|NCT01441635|527503001|FG000|Overall Study|Adverse Event|4|||
146270051|NCT01441635|527503002|FG001|Overall Study|Adverse Event|3|||
146270052|NCT01441635|527503003|FG002|Overall Study|Adverse Event|1|||
146270053|NCT01441635|527503004|FG003|Overall Study|Adverse Event|5|||
146270054|NCT01441635|527503005|FG004|Overall Study|Adverse Event|1|||
146270055|NCT01441635|527503006|FG005|Overall Study|Adverse Event|2|||
146270056|NCT01441635|527503007|FG006|Overall Study|Adverse Event|2|||
146270057|NCT01441635|527503008|FG007|Overall Study|Adverse Event|2|||
146270058|NCT01441635|527503009|FG008|Overall Study|Adverse Event|1|||
146270059|NCT01441635|527503010|FG009|Overall Study|Adverse Event|0|||
146270060|NCT01441635|527503001|FG000|Overall Study|Withdrawal by Subject|1|||
146270061|NCT01441635|527503002|FG001|Overall Study|Withdrawal by Subject|1|||
146270062|NCT01441635|527503003|FG002|Overall Study|Withdrawal by Subject|0|||
146270063|NCT01441635|527503004|FG003|Overall Study|Withdrawal by Subject|1|||
146270064|NCT01441635|527503005|FG004|Overall Study|Withdrawal by Subject|0|||
146270065|NCT01441635|527503006|FG005|Overall Study|Withdrawal by Subject|0|||
146270066|NCT01441635|527503007|FG006|Overall Study|Withdrawal by Subject|2|||
146270067|NCT01441635|527503008|FG007|Overall Study|Withdrawal by Subject|0|||
146270068|NCT01441635|527503009|FG008|Overall Study|Withdrawal by Subject|1|||
146270069|NCT01441635|527503010|FG009|Overall Study|Withdrawal by Subject|1|||
146270070|NCT01441635|527503001|FG000|Overall Study|Lost to Follow-up|0|||
146270071|NCT01441635|527503002|FG001|Overall Study|Lost to Follow-up|1|||
146270072|NCT01441635|527503003|FG002|Overall Study|Lost to Follow-up|1|||
146270073|NCT01441635|527503004|FG003|Overall Study|Lost to Follow-up|1|||
146270074|NCT01441635|527503005|FG004|Overall Study|Lost to Follow-up|1|||
146270075|NCT01441635|527503006|FG005|Overall Study|Lost to Follow-up|3|||
146270076|NCT01441635|527503007|FG006|Overall Study|Lost to Follow-up|1|||
146270077|NCT01441635|527503008|FG007|Overall Study|Lost to Follow-up|1|||
146270078|NCT01441635|527503009|FG008|Overall Study|Lost to Follow-up|0|||
146270079|NCT01441635|527503010|FG009|Overall Study|Lost to Follow-up|1|||
146270080|NCT01441635|527503001|FG000|Overall Study|Noncompliance|0|||
146270081|NCT01441635|527503002|FG001|Overall Study|Noncompliance|1|||
146270082|NCT01441635|527503003|FG002|Overall Study|Noncompliance|0|||
146270083|NCT01441635|527503004|FG003|Overall Study|Noncompliance|0|||
146270084|NCT01441635|527503005|FG004|Overall Study|Noncompliance|0|||
146270085|NCT01441635|527503006|FG005|Overall Study|Noncompliance|0|||
146270086|NCT01441635|527503007|FG006|Overall Study|Noncompliance|1|||
146137962|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
146137963|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
146137964|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137965|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137966|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137967|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137968|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137969|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137970|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146137971|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137972|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137973|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137974|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137975|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137976|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137977|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137978|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137979|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137980|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137981|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137982|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137983|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137984|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
146137985|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
146137986|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
146137987|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
146137988|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137989|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137990|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137991|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137992|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137993|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137994|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
146137995|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146137996|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146137997|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146137998|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146137999|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138000|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138001|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
146138002|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138003|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138004|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138005|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138006|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138007|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138008|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138009|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138010|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138011|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138012|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138013|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138014|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138015|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138016|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138017|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138018|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
146138019|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138020|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138021|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270087|NCT01441635|527503008|FG007|Overall Study|Noncompliance|0|||
146270088|NCT01441635|527503009|FG008|Overall Study|Noncompliance|0|||
146138022|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138023|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138024|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270089|NCT01441635|527503010|FG009|Overall Study|Noncompliance|0|||
146270090|NCT01441635|527503001|FG000|Overall Study|Surgery or Invasive Intervention|0|||
146270091|NCT01441635|527503002|FG001|Overall Study|Surgery or Invasive Intervention|0|||
146270092|NCT01441635|527503003|FG002|Overall Study|Surgery or Invasive Intervention|1|||
146270093|NCT01441635|527503004|FG003|Overall Study|Surgery or Invasive Intervention|0|||
146270094|NCT01441635|527503005|FG004|Overall Study|Surgery or Invasive Intervention|0|||
146270095|NCT01441635|527503006|FG005|Overall Study|Surgery or Invasive Intervention|0|||
146270096|NCT01441635|527503007|FG006|Overall Study|Surgery or Invasive Intervention|0|||
146270097|NCT01441635|527503008|FG007|Overall Study|Surgery or Invasive Intervention|0|||
146270098|NCT01441635|527503009|FG008|Overall Study|Surgery or Invasive Intervention|0|||
146270099|NCT01441635|527503010|FG009|Overall Study|Surgery or Invasive Intervention|0|||
146270100|NCT01441635|527503001|FG000|Overall Study|Received Exclusionary Medication|1|||
146270101|NCT01441635|527503002|FG001|Overall Study|Received Exclusionary Medication|0|||
146270102|NCT01441635|527503003|FG002|Overall Study|Received Exclusionary Medication|0|||
146270103|NCT01441635|527503004|FG003|Overall Study|Received Exclusionary Medication|0|||
146270104|NCT01441635|527503005|FG004|Overall Study|Received Exclusionary Medication|0|||
146270105|NCT01441635|527503006|FG005|Overall Study|Received Exclusionary Medication|0|||
146270106|NCT01441635|527503007|FG006|Overall Study|Received Exclusionary Medication|0|||
146270107|NCT01441635|527503008|FG007|Overall Study|Received Exclusionary Medication|0|||
146270108|NCT01441635|527503009|FG008|Overall Study|Received Exclusionary Medication|0|||
146270109|NCT01441635|527503010|FG009|Overall Study|Received Exclusionary Medication|0|||
146270110|NCT01441635|527503001|FG000|Overall Study|Other|0|||
146270111|NCT01441635|527503002|FG001|Overall Study|Other|0|||
146270112|NCT01441635|527503003|FG002|Overall Study|Other|0|||
146270113|NCT01441635|527503004|FG003|Overall Study|Other|0|||
146270114|NCT01441635|527503005|FG004|Overall Study|Other|0|||
146270115|NCT01441635|527503006|FG005|Overall Study|Other|0|||
146270116|NCT01441635|527503007|FG006|Overall Study|Other|0|||
146270117|NCT01441635|527503008|FG007|Overall Study|Other|1|||
146270118|NCT01441635|527503009|FG008|Overall Study|Other|0|||
146270119|NCT01441635|527503010|FG009|Overall Study|Other|0|||
146270120|NCT02637323|527503011|FG000|Overall Study|Lost to Follow-up|2|||
146270121|NCT02637323|527503012|FG001|Overall Study|Lost to Follow-up|0|||
146270122|NCT02637323|527503011|FG000|Overall Study|Protocol Violation|0|||
146270123|NCT02637323|527503012|FG001|Overall Study|Protocol Violation|1|||
146270124|NCT00358644|527503013|FG000|Overall Study|Progressive Disease|21|||
146270125|NCT00358644|527503013|FG000|Overall Study|Adverse Event|7|||
146270126|NCT00358644|527503013|FG000|Overall Study|Death|11|||
146270127|NCT00358644|527503013|FG000|Overall Study|Withdrawal by Subject|4|||
146270128|NCT00358644|527503013|FG000|Overall Study|Physician Decision|6|||
146270129|NCT00358644|527503013|FG000|Overall Study|Patient not eligible for study|1|||
146270130|NCT00513708|527503014|FG000|Overall Study|Lost to Follow-up|4|||
146270131|NCT00513708|527503015|FG001|Overall Study|Lost to Follow-up|4|||
146270132|NCT00513708|527503016|FG002|Overall Study|Lost to Follow-up|4|||
146270133|NCT00368875|527503017|FG000|Overall Study|Adverse Event|0|||
146270134|NCT00368875|527503018|FG001|Overall Study|Adverse Event|12|||
146270135|NCT00368875|527503017|FG000|Overall Study|Progressive disease|3|||
146270136|NCT00368875|527503018|FG001|Overall Study|Progressive disease|27|||
146270137|NCT00368875|527503017|FG000|Overall Study|Withdrawal by Subject|2|||
146270138|NCT00368875|527503018|FG001|Overall Study|Withdrawal by Subject|6|||
146270139|NCT00368875|527503017|FG000|Overall Study|Other Reason|0|||
146270140|NCT00368875|527503018|FG001|Overall Study|Other Reason|2|||
146270141|NCT00368875|527503017|FG000|Overall Study|Alternative Therapy|1|||
146270142|NCT00368875|527503018|FG001|Overall Study|Alternative Therapy|1|||
146270143|NCT03327831|527503019|FG000|Overall Study|Lost to Follow-up|2|||
146270144|NCT01564277|527503020|FG000|Overall Study|Protocol Violation|0|||
146270145|NCT01564277|527503021|FG001|Overall Study|Protocol Violation|1|||
146270146|NCT01564277|527503020|FG000|Overall Study|Physician Decision|1|||
146270147|NCT01564277|527503021|FG001|Overall Study|Physician Decision|0|||
146270148|NCT02595372|527503022|FG000|Overall Study|Adverse Event|6|||
146270149|NCT02595372|527503022|FG000|Overall Study|Physician Decision|2|||
146270150|NCT02595372|527503022|FG000|Overall Study|Disease Progression|1|||
146270151|NCT00401258|527503025|FG000|Overall Study|Adverse Event|7|||
146270152|NCT01305239|527503027|FG000|Overall Study|Adverse Event|22|||
146138025|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270153|NCT01305239|527503027|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
146270154|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Adverse Event|10|||
146270155|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Adverse Event|9|||
146270156|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Adverse Event|7|||
146270157|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
146270158|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
146270159|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
146270160|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
146270161|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
146270162|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
146270163|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Physician Decision|7|||
146270164|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Physician Decision|3|||
146270165|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Physician Decision|2|||
146270166|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Pregnancy|2|||
146270167|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Pregnancy|1|||
146270168|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Pregnancy|3|||
146270169|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
146270170|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
146270171|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
146270172|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
146270173|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
146270174|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
146270175|NCT02614183|527503033|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
146270176|NCT02614183|527503034|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
146270177|NCT02614183|527503035|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
146270178|NCT02614183|527503033|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
146270179|NCT02614183|527503034|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
146270180|NCT02614183|527503035|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
146270181|NCT02614183|527503033|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
146270182|NCT02614183|527503034|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
146270183|NCT02614183|527503035|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
146270184|NCT02614183|527503033|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
146270185|NCT02614183|527503034|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
146270186|NCT02614183|527503035|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
146270187|NCT02614183|527503033|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
146270188|NCT02614183|527503034|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
146270189|NCT02614183|527503035|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
146270190|NCT02726945|527503036|FG000|Overall Study|Withdrawal by Subject|0|||
146270191|NCT02726945|527503037|FG001|Overall Study|Withdrawal by Subject|0|||
146270192|NCT02726945|527503038|FG002|Overall Study|Withdrawal by Subject|1|||
146270193|NCT02726945|527503036|FG000|Overall Study|Elected to have total knee replacement|0|||
146270194|NCT02726945|527503037|FG001|Overall Study|Elected to have total knee replacement|1|||
146270195|NCT02726945|527503038|FG002|Overall Study|Elected to have total knee replacement|0|||
146270196|NCT02473965|527505701|FG000|Overall Study|Adverse Event|6|||
146270197|NCT02473965|527505702|FG001|Overall Study|Adverse Event|4|||
146270198|NCT02473965|527505701|FG000|Overall Study|MG worsening|4|||
146270199|NCT02473965|527505702|FG001|Overall Study|MG worsening|1|||
146270200|NCT02473965|527505701|FG000|Overall Study|Withdrawal by Subject|2|||
146270201|NCT02473965|527505702|FG001|Overall Study|Withdrawal by Subject|3|||
146270202|NCT02473965|527505701|FG000|Overall Study|Physician Decision|0|||
146270203|NCT02473965|527505702|FG001|Overall Study|Physician Decision|2|||
146270204|NCT01183390|527505703|FG000|First Intervention|Adverse Event|0|||
146270205|NCT01183390|527505704|FG001|First Intervention|Adverse Event|1|||
146270206|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Adverse Event|2|||
146270207|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Adverse Event|0|||
146270208|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Adverse Event|0|||
146270209|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Adverse Event|0|||
146270210|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
146270211|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
146270212|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
146270213|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
146270214|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
146270215|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
146270216|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
146270217|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
146138026|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270218|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Physician Decision|1|||
146270219|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Physician Decision|0|||
146138027|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146138028|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270220|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Physician Decision|0|||
146138029|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146270221|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Physician Decision|0|||
146270222|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Pregnancy|1|||
146270223|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Pregnancy|0|||
146270224|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Pregnancy|0|||
146270225|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Pregnancy|0|||
146138030|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146138031|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138032|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146138033|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
146138034|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138035|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138036|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138037|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138038|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138039|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138040|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138041|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138042|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
146138043|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138044|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138045|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138046|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138047|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138048|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138049|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138050|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138051|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138052|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
146138053|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138054|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138055|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138056|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138057|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138058|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138059|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138060|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138061|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138062|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138063|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138064|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138065|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138066|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
146138067|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138068|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138069|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138070|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138071|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138072|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138073|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138074|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138075|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138076|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138077|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
146138078|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138079|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138080|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138081|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138082|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138083|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146270226|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
146270227|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
146270228|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146270229|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
146270230|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
146270231|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
146270232|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
146270233|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
146270234|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
146270235|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146270236|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146270237|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
146270238|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146270239|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
146270240|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146270241|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
146270242|NCT04057573|527505705|FG000|24-Week Double-Blind Period|Not Treated|1|||
146270243|NCT04057573|527505706|FG001|24-Week Double-Blind Period|Not Treated|0|||
146270244|NCT04057573|527505707|FG002|24-Week Double-Blind Period|Not Treated|0|||
146270245|NCT04057573|527505708|FG003|24-Week Double-Blind Period|Not Treated|0|||
146270246|NCT04057573|527505705|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
146270247|NCT04057573|527505706|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
146270248|NCT04057573|527505707|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
146270249|NCT04057573|527505708|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
146270250|NCT04057573|527505705|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146270251|NCT04057573|527505706|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146270252|NCT04057573|527505707|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
146270253|NCT04057573|527505708|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
146270254|NCT04057573|527505705|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
146270255|NCT04057573|527505706|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
146270256|NCT04057573|527505707|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
146270257|NCT04057573|527505708|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
146270258|NCT04057573|527505705|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
146270259|NCT04057573|527505706|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
146270260|NCT04057573|527505707|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
146270261|NCT04057573|527505708|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
146270262|NCT04057573|527505705|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146270263|NCT04057573|527505706|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146270264|NCT04057573|527505707|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
146270265|NCT04057573|527505708|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
146270266|NCT02113124|527505712|FG000|Overall Study|Unable to retrieve blood sample|1|||
146270267|NCT02113124|527505713|FG001|Overall Study|Unable to retrieve blood sample|1|||
146270268|NCT03299049|527505714|FG000|Overall Study|On-going|486|||
146270269|NCT03299049|527505715|FG001|Overall Study|On-going|481|||
146270270|NCT03299049|527505714|FG000|Overall Study|Withdrawal by Subject|6|||
146270271|NCT03299049|527505715|FG001|Overall Study|Withdrawal by Subject|21|||
146270272|NCT03299049|527505714|FG000|Overall Study|Physician Decision|5|||
146270273|NCT03299049|527505715|FG001|Overall Study|Physician Decision|1|||
146270274|NCT03299049|527505714|FG000|Overall Study|Lost to Follow-up|2|||
146270275|NCT03299049|527505715|FG001|Overall Study|Lost to Follow-up|0|||
146270276|NCT03299049|527505714|FG000|Overall Study|Pregnancy|1|||
146270277|NCT03299049|527505715|FG001|Overall Study|Pregnancy|3|||
146270278|NCT03299049|527505714|FG000|Overall Study|Protocol Violation|1|||
146270279|NCT03299049|527505715|FG001|Overall Study|Protocol Violation|1|||
146270280|NCT03299049|527505714|FG000|Overall Study|Lack of Efficacy|9|||
146270281|NCT03299049|527505715|FG001|Overall Study|Lack of Efficacy|3|||
146270282|NCT03299049|527505714|FG000|Overall Study|Adverse Event|12|||
146270283|NCT03299049|527505715|FG001|Overall Study|Adverse Event|13|||
146270284|NCT01901419|527505716|FG000|Overall Study|Protocol Violation|2|||
146270285|NCT01901419|527505717|FG001|Overall Study|Protocol Violation|6|||
146270286|NCT01901419|527505716|FG000|Overall Study|unavailable researchers|6|||
146270287|NCT01901419|527505717|FG001|Overall Study|unavailable researchers|3|||
146270288|NCT04024462|527505727|FG000|Overall Study|Withdrawal by Subject|6|||
146270289|NCT04024462|527505728|FG001|Overall Study|Withdrawal by Subject|7|||
146270290|NCT04024462|527505727|FG000|Overall Study|Progressive Disease|0|||
146270291|NCT04024462|527505728|FG001|Overall Study|Progressive Disease|1|||
146270292|NCT04024462|527505727|FG000|Overall Study|Adverse Event|0|||
146270293|NCT04024462|527505728|FG001|Overall Study|Adverse Event|1|||
146270294|NCT04024462|527505727|FG000|Overall Study|Death|0|||
146270295|NCT04024462|527505728|FG001|Overall Study|Death|1|||
146270296|NCT04024462|527505727|FG000|Overall Study|Lost to Follow-up|1|||
146270297|NCT04024462|527505728|FG001|Overall Study|Lost to Follow-up|0|||
146270298|NCT04024462|527505727|FG000|Overall Study|Ongoing in the Study|94|||
146270299|NCT04024462|527505728|FG001|Overall Study|Ongoing in the Study|89|||
146270300|NCT04896008|527505729|FG000|Overall Study|Ongoing|70|||
146270301|NCT04896008|527505730|FG001|Overall Study|Ongoing|38|||
146270302|NCT04896008|527505729|FG000|Overall Study|Adverse Event|0|||
146270303|NCT04896008|527505730|FG001|Overall Study|Adverse Event|2|||
146270304|NCT04896008|527505729|FG000|Overall Study|Death|5|||
146270305|NCT04896008|527505730|FG001|Overall Study|Death|10|||
146270306|NCT04896008|527505729|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
146270307|NCT04896008|527505730|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
146270308|NCT04896008|527505729|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
146270309|NCT04896008|527505730|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
146270310|NCT04896008|527505729|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
146270311|NCT04896008|527505730|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
146270312|NCT04896008|527505729|FG000|Overall Study|Withdrawal by Subject|1|||
146270313|NCT04896008|527505730|FG001|Overall Study|Withdrawal by Subject|4|||
146270314|NCT04896008|527505729|FG000|Overall Study|Investigator Decision|2|||
146270315|NCT04896008|527505730|FG001|Overall Study|Investigator Decision|0|||
146270316|NCT04896008|527505729|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
146270317|NCT04896008|527505730|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
146270318|NCT01270828|527505735|FG000|Pregabalin CR SB|Reason Unspecified|0|||
146270319|NCT01270828|527505736|FG001|Pregabalin CR SB|Reason Unspecified|0|||
146270320|NCT01270828|527505737|FG002|Pregabalin CR SB|Reason Unspecified|8|||
146270321|NCT01270828|527505735|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
146270322|NCT01270828|527505736|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
146270323|NCT01270828|527505737|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
146270324|NCT01270828|527505735|FG000|Pregabalin CR SB|Related adverse event|0|||
146270325|NCT01270828|527505736|FG001|Pregabalin CR SB|Related adverse event|0|||
146270326|NCT01270828|527505737|FG002|Pregabalin CR SB|Related adverse event|46|||
146270327|NCT01270828|527505735|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
146270328|NCT01270828|527505736|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
146270329|NCT01270828|527505737|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
146270330|NCT01270828|527505735|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
146270331|NCT01270828|527505736|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
146270332|NCT01270828|527505737|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
146270333|NCT01270828|527505735|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
146270334|NCT01270828|527505736|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
146270335|NCT01270828|527505737|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
146270336|NCT01270828|527505735|FG000|Pregabalin CR SB|Unrelated AE|0|||
146270337|NCT01270828|527505736|FG001|Pregabalin CR SB|Unrelated AE|0|||
146270338|NCT01270828|527505737|FG002|Pregabalin CR SB|Unrelated AE|8|||
146270339|NCT01270828|527505735|FG000|Pregabalin CR SB|Protocol Violation|0|||
146270340|NCT01270828|527505736|FG001|Pregabalin CR SB|Protocol Violation|0|||
146270341|NCT01270828|527505737|FG002|Pregabalin CR SB|Protocol Violation|8|||
146270342|NCT01270828|527505735|FG000|Double Blind Phase|Death|0|||
146270343|NCT01270828|527505736|FG001|Double Blind Phase|Death|1|||
146270344|NCT01270828|527505737|FG002|Double Blind Phase|Death|0|||
146270345|NCT01270828|527505735|FG000|Double Blind Phase|Protocol Violation|0|||
146270346|NCT01270828|527505736|FG001|Double Blind Phase|Protocol Violation|1|||
146270347|NCT01270828|527505737|FG002|Double Blind Phase|Protocol Violation|0|||
146270348|NCT01270828|527505735|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
146270349|NCT01270828|527505736|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
146270350|NCT01270828|527505737|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
146270351|NCT01270828|527505735|FG000|Double Blind Phase|Reason Unspecified|7|||
146270352|NCT01270828|527505736|FG001|Double Blind Phase|Reason Unspecified|4|||
146270353|NCT01270828|527505737|FG002|Double Blind Phase|Reason Unspecified|0|||
146270354|NCT01270828|527505735|FG000|Double Blind Phase|Withdrawal by Subject|6|||
146270355|NCT01270828|527505736|FG001|Double Blind Phase|Withdrawal by Subject|15|||
146270356|NCT01270828|527505737|FG002|Double Blind Phase|Withdrawal by Subject|0|||
146270357|NCT01270828|527505735|FG000|Double Blind Phase|Lost to Follow-up|1|||
146270358|NCT01270828|527505736|FG001|Double Blind Phase|Lost to Follow-up|2|||
146270359|NCT01270828|527505737|FG002|Double Blind Phase|Lost to Follow-up|0|||
146270360|NCT01270828|527505735|FG000|Double Blind Phase|Lack of Efficacy|2|||
146270361|NCT01270828|527505736|FG001|Double Blind Phase|Lack of Efficacy|11|||
146270362|NCT01270828|527505737|FG002|Double Blind Phase|Lack of Efficacy|0|||
146270363|NCT01270828|527505735|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
146138084|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146270364|NCT01270828|527505736|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
146138085|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146270365|NCT01270828|527505737|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
146270366|NCT01270828|527505735|FG000|Double Blind Phase|Adverse event related to study drug|5|||
146270367|NCT01270828|527505736|FG001|Double Blind Phase|Adverse event related to study drug|7|||
146270368|NCT01270828|527505737|FG002|Double Blind Phase|Adverse event related to study drug|0|||
146270369|NCT02870972|527505743|FG000|Overall Study|Adverse Event|1|||
146270370|NCT02870972|527505744|FG001|Overall Study|Adverse Event|0|||
146270371|NCT02870972|527505745|FG002|Overall Study|Adverse Event|0|||
146270372|NCT02870972|527505746|FG003|Overall Study|Adverse Event|0|||
146270373|NCT02870972|527505747|FG004|Overall Study|Adverse Event|0|||
146270374|NCT01736540|527505750|FG000|Overall Study|Did not complete scan within 45 days|2|||
146270375|NCT01736540|527505750|FG000|Overall Study|Death|1|||
146270376|NCT01736540|527505750|FG000|Overall Study|Abnormal test procedure|1|||
146270377|NCT01736540|527505750|FG000|Overall Study|Withdrawal by Subject|5|||
146270378|NCT01736540|527505750|FG000|Overall Study|Protocol Violation|1|||
146270379|NCT01736540|527505750|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
146270380|NCT01736540|527505750|FG000|Overall Study|No show for MRI appointment|1|||
146270381|NCT01736540|527505750|FG000|Overall Study|Unable to make MRI appointment|3|||
146270382|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
146270383|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
146270384|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
146270385|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
146270386|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
146270387|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146270388|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146270389|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
146270390|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
146270391|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
146270392|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
146270393|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
146270394|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
146270395|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
146270396|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
146270397|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
146270398|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
146270399|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
146270400|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
146270401|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
146270402|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
146270403|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
146270404|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
146270405|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
146270406|NCT00479882|527505751|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
146270407|NCT00479882|527505752|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
146270408|NCT00479882|527505753|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
146270409|NCT00479882|527505754|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
146270410|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
146270411|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
146270412|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
146270413|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
146270414|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
146270415|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
146270416|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
146270417|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
146270418|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146270419|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
146270420|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146270421|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
146270422|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
146270423|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
146138086|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138087|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138088|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138089|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138090|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
146138091|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138092|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138093|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138094|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146270424|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
146270425|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
146138095|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138096|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138097|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138098|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138099|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138100|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138101|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138102|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138103|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138104|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138105|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
146138106|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138107|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138108|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138109|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138110|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138111|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138112|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138113|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138114|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
146138115|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138116|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138117|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138118|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138119|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138120|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138121|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138122|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138123|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138124|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138125|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138126|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138127|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138128|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138129|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
146138130|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138131|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138132|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138133|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138134|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138135|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138136|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138137|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138138|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
146138139|NCT02346240|527021317|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138140|NCT02346240|527021318|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138141|NCT02346240|527021319|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138142|NCT02346240|527021320|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138143|NCT02346240|527021321|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138144|NCT02346240|527021322|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138145|NCT02346240|527021323|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138146|NCT02346240|527021324|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138147|NCT02346240|527021325|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138148|NCT02346240|527021326|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138149|NCT02346240|527021327|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138150|NCT02346240|527021328|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146304095|NCT03250832|527627477|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
146304096|NCT03250832|527627478|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
146138151|NCT02346240|527021329|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138152|NCT02346240|527021330|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138153|NCT02346240|527021331|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
146138154|NCT02346240|527021332|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138155|NCT02346240|527021333|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138156|NCT02346240|527021334|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138157|NCT02346240|527021335|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138158|NCT02346240|527021336|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138159|NCT02346240|527021337|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138160|NCT02346240|527021338|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138161|NCT02346240|527021339|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138162|NCT02346240|527021340|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
146138163|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138164|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138165|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138166|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138167|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138168|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138169|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138170|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138171|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138172|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138173|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138174|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138175|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138176|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138177|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138178|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138179|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
146138180|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
146138181|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
146138182|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
146138183|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146138184|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
146138185|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146138186|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
146138187|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138188|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138189|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138190|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138191|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138192|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138193|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138194|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138195|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138196|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138197|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138198|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138199|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138200|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138201|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138202|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138203|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138204|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138205|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
146138206|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
146138207|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138208|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
146138209|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138210|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
146138211|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138212|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138213|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138214|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138215|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146270426|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
146270427|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
146270428|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
146270429|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
146270430|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146270431|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146270432|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
146270433|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
146270434|NCT00479882|527505751|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146270435|NCT00479882|527505752|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146270436|NCT00479882|527505753|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
146270437|NCT00479882|527505754|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
146270438|NCT03004404|527505769|FG000|Period 2|Adverse Event|0|||
146270439|NCT03004404|527505770|FG001|Period 2|Adverse Event|0|||
146270440|NCT03004404|527505771|FG002|Period 2|Adverse Event|0|||
146270441|NCT03004404|527505772|FG003|Period 2|Adverse Event|0|||
146270442|NCT03004404|527505773|FG004|Period 2|Adverse Event|0|||
146270443|NCT03004404|527505774|FG005|Period 2|Adverse Event|0|||
146270444|NCT03004404|527505775|FG006|Period 2|Adverse Event|0|||
146270445|NCT03004404|527505776|FG007|Period 2|Adverse Event|0|||
146270446|NCT03004404|527505777|FG008|Period 2|Adverse Event|1|||
146270447|NCT03004404|527505778|FG009|Period 2|Adverse Event|0|||
146270448|NCT03004404|527505779|FG010|Period 2|Adverse Event|0|||
146270449|NCT03004404|527505780|FG011|Period 2|Adverse Event|0|||
146270450|NCT03004404|527505781|FG012|Period 2|Adverse Event|0|||
146270451|NCT03004404|527505782|FG013|Period 2|Adverse Event|0|||
146270452|NCT03004404|527505783|FG014|Period 2|Adverse Event|0|||
146270453|NCT03004404|527505784|FG015|Period 2|Adverse Event|1|||
146270454|NCT03933462|527505787|FG000|Overall Study|Adverse Event|2|||
146270455|NCT03933462|527505788|FG001|Overall Study|Adverse Event|0|||
146270456|NCT02522728|527505793|FG000|Overall Study|Withdrawal by Subject|6|||
146270457|NCT02522728|527505794|FG001|Overall Study|Withdrawal by Subject|6|||
146270458|NCT02522728|527505793|FG000|Overall Study|Death|4|||
146270459|NCT02522728|527505794|FG001|Overall Study|Death|3|||
146270460|NCT02522728|527505793|FG000|Overall Study|Adverse Event|2|||
146270461|NCT02522728|527505794|FG001|Overall Study|Adverse Event|1|||
146270462|NCT02522728|527505793|FG000|Overall Study|Did not receive randomized study device|0|||
146270463|NCT02522728|527505794|FG001|Overall Study|Did not receive randomized study device|1|||
146270464|NCT01266161|527505801|FG000|Overall Study|Ineligible|1|||
146270465|NCT01266161|527505802|FG001|Overall Study|Ineligible|0|||
146270466|NCT01266161|527505801|FG000|Overall Study|Lack of Efficacy|0|||
146270467|NCT01266161|527505802|FG001|Overall Study|Lack of Efficacy|1|||
146270468|NCT01266161|527505801|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
146270469|NCT01266161|527505802|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
146270470|NCT02990468|527505803|FG000|Phase 2: MTD|Change in treatment|0|||
146270471|NCT02990468|527505804|FG001|Phase 2: MTD|Change in treatment|0|||
146270472|NCT02990468|527505805|FG002|Phase 2: MTD|Change in treatment|1|||
146270473|NCT01436305|527505807|FG000|Overall Study|Death|1|||
146270474|NCT01436305|527505808|FG001|Overall Study|Death|0|||
146270475|NCT01436305|527505809|FG002|Overall Study|Death|0|||
146270476|NCT01436305|527505807|FG000|Overall Study|Lost to Follow-up|0|||
146270477|NCT01436305|527505808|FG001|Overall Study|Lost to Follow-up|1|||
146270478|NCT01436305|527505809|FG002|Overall Study|Lost to Follow-up|0|||
146270479|NCT01436305|527505807|FG000|Overall Study|Withdrawal by Subject|1|||
146138216|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146270480|NCT01436305|527505808|FG001|Overall Study|Withdrawal by Subject|3|||
146270481|NCT01436305|527505809|FG002|Overall Study|Withdrawal by Subject|0|||
146270482|NCT04148651|527505817|FG000|Overall Study|Lost to Follow-up|2|||
146270483|NCT03690427|527505820|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
146270484|NCT03690427|527505821|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
146270485|NCT03519204|527505827|FG000|Overall Study|Lost to Follow-up|3|||
146270486|NCT03519204|527505828|FG001|Overall Study|Lost to Follow-up|8|||
146270487|NCT03519204|527505827|FG000|Overall Study|Withdrawal by Subject|9|||
146270488|NCT03519204|527505828|FG001|Overall Study|Withdrawal by Subject|7|||
146270489|NCT03519204|527505827|FG000|Overall Study|Other Miscellaneous Reasons|1|||
146270490|NCT03519204|527505828|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146270491|NCT01721954|527505830|FG000|Overall Study|Death|58|||
146270492|NCT01721954|527505831|FG001|Overall Study|Death|64|||
146270493|NCT01721954|527505830|FG000|Overall Study|Withdrawal by Subject|8|||
146270494|NCT01721954|527505831|FG001|Overall Study|Withdrawal by Subject|4|||
146270495|NCT01721954|527505830|FG000|Overall Study|Adverse Event|2|||
146270496|NCT01721954|527505831|FG001|Overall Study|Adverse Event|0|||
146270497|NCT01721954|527505830|FG000|Overall Study|Lost to Follow-up|2|||
146270498|NCT01721954|527505831|FG001|Overall Study|Lost to Follow-up|1|||
146270499|NCT02609672|527505832|FG000|Overall Study|Lost to Follow-up|3|||
146270500|NCT02609672|527505833|FG001|Overall Study|Lost to Follow-up|1|||
146270501|NCT03392168|527505834|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
146270502|NCT03392168|527505835|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
146270503|NCT03392168|527505836|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
146270504|NCT03392168|527505837|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
146270505|NCT03392168|527505834|FG000|Period 2: Cohort 2|Other|0|||
146270506|NCT03392168|527505835|FG001|Period 2: Cohort 2|Other|1|||
146270507|NCT03392168|527505836|FG002|Period 2: Cohort 2|Other|0|||
146270508|NCT03392168|527505837|FG003|Period 2: Cohort 2|Other|0|||
146270509|NCT02956837|527505838|FG000|Overall Study|Serious Adverse Events|0|||
146270510|NCT02956837|527505839|FG001|Overall Study|Serious Adverse Events|1|||
146270511|NCT02956837|527505840|FG002|Overall Study|Serious Adverse Events|0|||
146270512|NCT02956837|527505841|FG003|Overall Study|Serious Adverse Events|0|||
146270513|NCT02956837|527505838|FG000|Overall Study|Withdrawal by Subject|0|||
146270514|NCT02956837|527505839|FG001|Overall Study|Withdrawal by Subject|1|||
146270515|NCT02956837|527505840|FG002|Overall Study|Withdrawal by Subject|0|||
146270516|NCT02956837|527505841|FG003|Overall Study|Withdrawal by Subject|3|||
146270517|NCT02956837|527505838|FG000|Overall Study|Lost to Follow-up|0|||
146270518|NCT02956837|527505839|FG001|Overall Study|Lost to Follow-up|1|||
146270519|NCT02956837|527505840|FG002|Overall Study|Lost to Follow-up|2|||
146270520|NCT02956837|527505841|FG003|Overall Study|Lost to Follow-up|0|||
146270521|NCT02597712|527505846|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
146270522|NCT02597712|527505847|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
146270523|NCT02597712|527505846|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
146270524|NCT02597712|527505847|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
146270525|NCT02597712|527505846|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
146270526|NCT02597712|527505847|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
146270527|NCT01727505|527505848|FG000|First 24 Hours|Adverse Event|0|||
146270528|NCT01727505|527505849|FG001|First 24 Hours|Adverse Event|1|||
146270529|NCT01727505|527505848|FG000|Second 24 Hours|Missing data|0|||
146270530|NCT01727505|527505849|FG001|Second 24 Hours|Missing data|1|||
146270531|NCT01594970|527505850|FG000|Overall Study|Non-Adverse Event Related|4|||
146270532|NCT01594970|527505851|FG001|Overall Study|Non-Adverse Event Related|5|||
146270533|NCT01594970|527505852|FG002|Overall Study|Non-Adverse Event Related|6|||
146270534|NCT01594970|527505850|FG000|Overall Study|Adverse Event|17|||
146270535|NCT01594970|527505851|FG001|Overall Study|Adverse Event|23|||
146270536|NCT01594970|527505852|FG002|Overall Study|Adverse Event|23|||
146270537|NCT01594970|527505850|FG000|Overall Study|Lost to Follow-up|54|||
146270538|NCT01594970|527505851|FG001|Overall Study|Lost to Follow-up|54|||
146270539|NCT01594970|527505852|FG002|Overall Study|Lost to Follow-up|37|||
146270540|NCT01427725|527505853|FG000|Overall Study|Lost to Follow-up|17|||
146270541|NCT01427725|527505853|FG000|Overall Study|Protocol Violation|1|||
146270542|NCT01427725|527505853|FG000|Overall Study|Drug not administered|1|||
146270543|NCT01427725|527505853|FG000|Overall Study|Failure to visit|7|||
146270544|NCT01427725|527505853|FG000|Overall Study|Adverse Event|46|||
146270545|NCT01427725|527505853|FG000|Overall Study|Failure to visit after administration|40|||
146138217|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138218|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138219|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138220|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138221|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138222|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138223|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138224|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138225|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138226|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138227|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138228|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138229|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146138230|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138231|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138232|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
146138233|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138234|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146138235|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138236|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138237|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138238|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138239|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146270546|NCT01427725|527505853|FG000|Overall Study|Patient's rejection|27|||
146270547|NCT01427725|527505853|FG000|Overall Study|Transfer to a different hospital|17|||
146270548|NCT01427725|527505853|FG000|Overall Study|Lack of Efficacy|8|||
146270549|NCT01427725|527505853|FG000|Overall Study|Death|7|||
146270550|NCT01427725|527505853|FG000|Overall Study|Symptom improvement|6|||
146138240|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138241|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138242|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138243|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138244|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138245|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138246|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138247|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138248|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138249|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138250|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138251|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138252|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138253|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138254|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146304097|NCT03250832|527627479|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
146304098|NCT03250832|527627480|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
146138255|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138256|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
146138257|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138258|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
146138259|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138260|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138261|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138262|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138263|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138264|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138265|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138266|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138267|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138268|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138269|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138270|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138271|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138272|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138273|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138274|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138275|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138276|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
146138277|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
146138278|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
146138279|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
146138280|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146138281|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146138282|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
146138283|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138284|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138285|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138286|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138287|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138288|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138289|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138290|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138291|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138292|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138293|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138294|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138295|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138296|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138297|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138298|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138299|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146304099|NCT03250832|527627481|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
146138300|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138301|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
146138302|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146138303|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146138304|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
146138305|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146138306|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146138307|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138308|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138309|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138310|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138311|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138312|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138313|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138314|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138315|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138316|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138317|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138318|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138319|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138320|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138321|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138322|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138323|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138324|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138325|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
146138326|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138327|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
146138328|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
146138329|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
146138330|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
146138331|NCT02346240|527021317|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138332|NCT02346240|527021318|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138333|NCT02346240|527021319|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138334|NCT02346240|527021320|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138335|NCT02346240|527021321|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138336|NCT02346240|527021322|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138337|NCT02346240|527021323|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138338|NCT02346240|527021324|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138339|NCT02346240|527021325|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138340|NCT02346240|527021326|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138341|NCT02346240|527021327|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138342|NCT02346240|527021328|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138343|NCT02346240|527021329|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138344|NCT02346240|527021330|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138345|NCT02346240|527021331|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138346|NCT02346240|527021332|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138347|NCT02346240|527021333|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138348|NCT02346240|527021334|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138349|NCT02346240|527021335|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
146138350|NCT02346240|527021336|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138351|NCT02346240|527021337|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138352|NCT02346240|527021338|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138353|NCT02346240|527021339|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138354|NCT02346240|527021340|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
146138355|NCT01455012|527021341|FG000|Overall Study|Adverse Event|0|||
146138356|NCT01455012|527021342|FG001|Overall Study|Adverse Event|2|||
146138357|NCT01455012|527021341|FG000|Overall Study|Lack of Efficacy|6|||
146138358|NCT01455012|527021342|FG001|Overall Study|Lack of Efficacy|1|||
146138359|NCT01455012|527021341|FG000|Overall Study|Withdrawal by Subject|3|||
146270551|NCT01427725|527505853|FG000|Overall Study|AE and Patient's rejection|5|||
146270552|NCT01427725|527505853|FG000|Overall Study|Physician Decision|5|||
146138360|NCT01455012|527021342|FG001|Overall Study|Withdrawal by Subject|1|||
146138361|NCT01455012|527021341|FG000|Overall Study|Unknown reason|2|||
146138362|NCT01455012|527021342|FG001|Overall Study|Unknown reason|0|||
146138363|NCT04552587|527021343|FG000|Overall Study|Lost to Follow-up|4|||
146138364|NCT00613509|527021344|FG000|Cycle 1|Adverse Event|2|||
146138365|NCT00613509|527021345|FG001|Cycle 1|Adverse Event|1|||
146138366|NCT00613509|527021344|FG000|Cycle 1|Disease Progression|2|||
146138367|NCT00613509|527021345|FG001|Cycle 1|Disease Progression|6|||
146138368|NCT00613509|527021344|FG000|Cycle 1|Unacceptable Toxicity|1|||
146138369|NCT00613509|527021345|FG001|Cycle 1|Unacceptable Toxicity|0|||
146138370|NCT00613509|527021344|FG000|Cycle 1|Other administrative reason|0|||
146138371|NCT00613509|527021345|FG001|Cycle 1|Other administrative reason|1|||
146270553|NCT01427725|527505853|FG000|Overall Study|Exacerbation of underlying disease|5|||
146270554|NCT01427725|527505853|FG000|Overall Study|Oral feeding difficulty|5|||
146270555|NCT01427725|527505853|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
146270556|NCT01427725|527505853|FG000|Overall Study|Forgetting prescription|1|||
146270557|NCT01427725|527505853|FG000|Overall Study|Other|2|||
146270558|NCT01299480|527505854|FG000|Overall Study|No longer willing to participate|19|||
146270559|NCT01299480|527505855|FG001|Overall Study|No longer willing to participate|17|||
146270560|NCT01299480|527505856|FG002|Overall Study|No longer willing to participate|14|||
146270561|NCT01299480|527505857|FG003|Overall Study|No longer willing to participate|13|||
146270562|NCT01299480|527505858|FG004|Overall Study|No longer willing to participate|10|||
146270563|NCT01299480|527505854|FG000|Overall Study|Protocol Violation|7|||
146270564|NCT01299480|527505855|FG001|Overall Study|Protocol Violation|5|||
146270565|NCT01299480|527505856|FG002|Overall Study|Protocol Violation|8|||
146270566|NCT01299480|527505857|FG003|Overall Study|Protocol Violation|1|||
146270567|NCT01299480|527505858|FG004|Overall Study|Protocol Violation|1|||
146270568|NCT01299480|527505854|FG000|Overall Study|Withdrawal by Subject|3|||
146270569|NCT01299480|527505855|FG001|Overall Study|Withdrawal by Subject|4|||
146270570|NCT01299480|527505856|FG002|Overall Study|Withdrawal by Subject|7|||
146270571|NCT01299480|527505857|FG003|Overall Study|Withdrawal by Subject|3|||
146270572|NCT01299480|527505858|FG004|Overall Study|Withdrawal by Subject|4|||
146270573|NCT01299480|527505854|FG000|Overall Study|Adverse Event|6|||
146270574|NCT01299480|527505855|FG001|Overall Study|Adverse Event|4|||
146270575|NCT01299480|527505856|FG002|Overall Study|Adverse Event|5|||
146270576|NCT01299480|527505857|FG003|Overall Study|Adverse Event|4|||
146270577|NCT01299480|527505858|FG004|Overall Study|Adverse Event|0|||
146270578|NCT01299480|527505854|FG000|Overall Study|Withdrawal due to pregnancy|0|||
146270579|NCT01299480|527505855|FG001|Overall Study|Withdrawal due to pregnancy|1|||
146270580|NCT01299480|527505856|FG002|Overall Study|Withdrawal due to pregnancy|1|||
146270581|NCT01299480|527505857|FG003|Overall Study|Withdrawal due to pregnancy|0|||
146270582|NCT01299480|527505858|FG004|Overall Study|Withdrawal due to pregnancy|0|||
146270583|NCT01299480|527505854|FG000|Overall Study|Physician Decision|1|||
146270584|NCT01299480|527505855|FG001|Overall Study|Physician Decision|1|||
146270585|NCT01299480|527505856|FG002|Overall Study|Physician Decision|0|||
146270586|NCT01299480|527505857|FG003|Overall Study|Physician Decision|2|||
146270587|NCT01299480|527505858|FG004|Overall Study|Physician Decision|0|||
146270588|NCT01299480|527505854|FG000|Overall Study|Lost to Follow-up|3|||
146270589|NCT01299480|527505855|FG001|Overall Study|Lost to Follow-up|1|||
146270590|NCT01299480|527505856|FG002|Overall Study|Lost to Follow-up|2|||
146270591|NCT01299480|527505857|FG003|Overall Study|Lost to Follow-up|1|||
146270592|NCT01299480|527505858|FG004|Overall Study|Lost to Follow-up|2|||
146270593|NCT01299480|527505854|FG000|Overall Study|Other|3|||
146270594|NCT01299480|527505855|FG001|Overall Study|Other|2|||
146270595|NCT01299480|527505856|FG002|Overall Study|Other|3|||
146270596|NCT01299480|527505857|FG003|Overall Study|Other|0|||
146270597|NCT01299480|527505858|FG004|Overall Study|Other|3|||
146270598|NCT01299480|527505854|FG000|Overall Study|Started, but not vaccinated|0|||
146270599|NCT01299480|527505855|FG001|Overall Study|Started, but not vaccinated|0|||
146270600|NCT01299480|527505856|FG002|Overall Study|Started, but not vaccinated|1|||
146270601|NCT01299480|527505857|FG003|Overall Study|Started, but not vaccinated|1|||
146270602|NCT01299480|527505858|FG004|Overall Study|Started, but not vaccinated|0|||
146138372|NCT00314366|527021346|FG000|Overall Study|not treated due to patient medical condi|1|||
146138373|NCT00314366|527021347|FG001|Overall Study|not treated due to patient medical condi|0|||
146270603|NCT01430468|527505865|FG000|Overall Study|Physician Decision|2|||
146270604|NCT01430468|527505866|FG001|Overall Study|Physician Decision|1|||
146270605|NCT01430468|527505865|FG000|Overall Study|Withdrawal by Subject|5|||
146138374|NCT03400033|527021348|FG000|Overall Study|Withdrawal by Subject|1|||
146138375|NCT03400033|527021349|FG001|Overall Study|Withdrawal by Subject|2|||
146138376|NCT02469610|527021359|FG000|Overall Study|Death|1|||
146270606|NCT01430468|527505866|FG001|Overall Study|Withdrawal by Subject|5|||
146270607|NCT01281839|527505867|FG000|Overall Study|Lost to Follow-up|6|||
146270608|NCT01281839|527505868|FG001|Overall Study|Lost to Follow-up|3|||
146270609|NCT01281839|527505867|FG000|Overall Study|Withdrawal by Subject|4|||
146270610|NCT01281839|527505868|FG001|Overall Study|Withdrawal by Subject|10|||
146270611|NCT01281839|527505867|FG000|Overall Study|Reason not specified|0|||
146270612|NCT01281839|527505868|FG001|Overall Study|Reason not specified|1|||
146138377|NCT02469610|527021360|FG001|Overall Study|Death|0|||
146304100|NCT03250832|527627482|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
146304101|NCT03250832|527627483|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
146304102|NCT03250832|527627484|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
146304103|NCT03250832|527627485|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
146138378|NCT02469610|527021359|FG000|Overall Study|Lost to Follow-up|1|||
146138379|NCT02469610|527021360|FG001|Overall Study|Lost to Follow-up|0|||
146138380|NCT02469610|527021359|FG000|Overall Study|exclusion criteria|2|||
146138381|NCT02469610|527021360|FG001|Overall Study|exclusion criteria|1|||
146138382|NCT01387607|527021363|FG000|Overall Study|Adverse Event|23|||
146138383|NCT01387607|527021364|FG001|Overall Study|Adverse Event|11|||
146138384|NCT01387607|527021363|FG000|Overall Study|Lack of Efficacy|8|||
146138385|NCT01387607|527021364|FG001|Overall Study|Lack of Efficacy|6|||
146138386|NCT01387607|527021363|FG000|Overall Study|Lost to Follow-up|2|||
146138387|NCT01387607|527021364|FG001|Overall Study|Lost to Follow-up|1|||
146138388|NCT01387607|527021363|FG000|Overall Study|No longer meets eligibility criteria|0|||
146138389|NCT01387607|527021364|FG001|Overall Study|No longer meets eligibility criteria|1|||
146138390|NCT01387607|527021363|FG000|Overall Study|Protocol Violation|1|||
146138391|NCT01387607|527021364|FG001|Overall Study|Protocol Violation|5|||
146138392|NCT01387607|527021363|FG000|Overall Study|Withdrawal by Subject|13|||
146138393|NCT01387607|527021364|FG001|Overall Study|Withdrawal by Subject|14|||
146138394|NCT01387607|527021363|FG000|Overall Study|Other|1|||
146138395|NCT01387607|527021364|FG001|Overall Study|Other|1|||
146138396|NCT01387607|527021363|FG000|Overall Study|Randomized, not treated|3|||
146138397|NCT01387607|527021364|FG001|Overall Study|Randomized, not treated|6|||
146138398|NCT04074317|527021370|FG000|Third Period|Withdrawal by Subject|0|||
146138399|NCT04074317|527021371|FG001|Third Period|Withdrawal by Subject|0|||
146138400|NCT04074317|527021372|FG002|Third Period|Withdrawal by Subject|0|||
146138401|NCT04074317|527021373|FG003|Third Period|Withdrawal by Subject|1|||
146138402|NCT04074317|527021374|FG004|Third Period|Withdrawal by Subject|0|||
146138403|NCT04074317|527021375|FG005|Third Period|Withdrawal by Subject|0|||
146138404|NCT03756558|527023043|FG000|Overall Study|Death|1|||
146138405|NCT03756558|527023043|FG000|Overall Study|Lost to Follow-up|2|||
146138406|NCT03756558|527023043|FG000|Overall Study|Withdrawal by Subject|2|||
146138407|NCT01700179|527023046|FG000|Overall Study|Physician Decision|2|||
146138408|NCT01433263|527023049|FG000|Overall Study|Adverse Event|3|||
146138409|NCT01433263|527023050|FG001|Overall Study|Adverse Event|1|||
146138410|NCT01433263|527023049|FG000|Overall Study|Death|5|||
146138411|NCT01433263|527023050|FG001|Overall Study|Death|3|||
146138412|NCT01433263|527023049|FG000|Overall Study|Lost to Follow-up|0|||
146138413|NCT01433263|527023050|FG001|Overall Study|Lost to Follow-up|1|||
146138414|NCT01433263|527023049|FG000|Overall Study|Protocol Deviation|1|||
146138415|NCT01433263|527023050|FG001|Overall Study|Protocol Deviation|0|||
146138416|NCT01433263|527023049|FG000|Overall Study|Withdrawal by Subject|10|||
146138417|NCT01433263|527023050|FG001|Overall Study|Withdrawal by Subject|7|||
146138418|NCT00646204|527023051|FG000|Overall Study|Adverse Event|3|||
146138419|NCT00646204|527023052|FG001|Overall Study|Adverse Event|0|||
146138420|NCT00646204|527023051|FG000|Overall Study|Withdrawal by Subject|1|||
146138421|NCT00646204|527023052|FG001|Overall Study|Withdrawal by Subject|0|||
146138422|NCT00293384|527023058|FG000|Overall Study|Non-compliance|2|||
146138423|NCT00293384|527023058|FG000|Overall Study|Missed dosage/study drug|1|||
146138424|NCT00293384|527023058|FG000|Overall Study|Ineligible|2|||
146138425|NCT02610192|527023060|FG000|Overall Study|Received other treatment|8|||
146138426|NCT02610192|527023060|FG000|Overall Study|Physician Decision|1|||
146138427|NCT01344057|527023062|FG000|Overall Study|Premature Withdrawal|1|||
146138428|NCT04300296|527023068|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
146138429|NCT04300296|527023069|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146138430|NCT04300296|527023070|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146138431|NCT04300296|527023071|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146138432|NCT04300296|527023072|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146304104|NCT03250832|527627486|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
146138433|NCT04300296|527023073|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
146138434|NCT04300296|527023068|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146138435|NCT04300296|527023069|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146138436|NCT04300296|527023070|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146138437|NCT04300296|527023071|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146138438|NCT04300296|527023072|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
146138439|NCT04300296|527023073|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
146138440|NCT04300296|527023068|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
146138441|NCT04300296|527023069|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
146138442|NCT04300296|527023070|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146138443|NCT04300296|527023071|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146138444|NCT04300296|527023072|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
146304105|NCT03250832|527627475|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
146270613|NCT00617929|527505870|FG000|Overall Study|Physician Decision|1|||
146270614|NCT03229486|527505871|FG000|Overall Study|Protocol Violation|0|||
146270615|NCT03229486|527505872|FG001|Overall Study|Protocol Violation|1|||
146270616|NCT04855734|527505880|FG000|Overall Study|Lost to Follow-up|2|||
146270617|NCT04855734|527505881|FG001|Overall Study|Lost to Follow-up|2|||
146270618|NCT04535544|527505882|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146270619|NCT04535544|527505883|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146270620|NCT04535544|527505884|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
146270621|NCT04535544|527505885|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
146270622|NCT04535544|527505882|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
146270623|NCT04535544|527505883|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
146270624|NCT04535544|527505884|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
146270625|NCT04535544|527505885|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
146270626|NCT04535544|527505882|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
146270627|NCT04535544|527505883|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
146270628|NCT04535544|527505884|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
146270629|NCT04535544|527505885|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
146270630|NCT04535544|527505882|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
146270631|NCT04535544|527505883|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
146270632|NCT04535544|527505884|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
146270633|NCT04535544|527505885|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
146270634|NCT04535544|527505882|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
146270635|NCT04535544|527505883|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
146270636|NCT04535544|527505884|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
146270637|NCT04535544|527505885|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
146270638|NCT04535544|527505882|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
146270639|NCT04535544|527505883|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
146270640|NCT04535544|527505884|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
146270641|NCT04535544|527505885|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
146270642|NCT04535544|527505882|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
146270643|NCT04535544|527505883|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146270644|NCT04535544|527505884|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146270645|NCT04535544|527505885|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
146270646|NCT04535544|527505882|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
146270647|NCT04535544|527505883|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
146270648|NCT04535544|527505884|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
146270649|NCT04535544|527505885|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
146270650|NCT00344032|527505886|FG000|Overall Study|Adverse Event|0|||
146270651|NCT00344032|527505887|FG001|Overall Study|Adverse Event|1|||
146270652|NCT00344032|527505886|FG000|Overall Study|Withdrawal by Subject|6|||
146270653|NCT00344032|527505887|FG001|Overall Study|Withdrawal by Subject|2|||
146270654|NCT00344032|527505886|FG000|Overall Study|Lost to Follow-up|4|||
146270655|NCT00344032|527505887|FG001|Overall Study|Lost to Follow-up|6|||
146270656|NCT00344032|527505886|FG000|Overall Study|Physician Decision|4|||
146270657|NCT00344032|527505887|FG001|Overall Study|Physician Decision|1|||
146270658|NCT05131477|527505894|FG000|PART 1|Withdrawal by Subject|2|||
146270659|NCT05131477|527505895|FG001|PART 1|Withdrawal by Subject|9|||
146270660|NCT05131477|527505896|FG002|PART 1|Withdrawal by Subject|6|||
146270661|NCT05131477|527505897|FG003|PART 1|Withdrawal by Subject|2|||
146270662|NCT05131477|527505898|FG004|PART 1|Withdrawal by Subject|8|||
146270663|NCT05131477|527505899|FG005|PART 1|Withdrawal by Subject|0|||
146270664|NCT05131477|527505900|FG006|PART 1|Withdrawal by Subject|0|||
146270665|NCT05131477|527505901|FG007|PART 1|Withdrawal by Subject|0|||
146270666|NCT05131477|527505902|FG008|PART 1|Withdrawal by Subject|0|||
146270667|NCT05131477|527505903|FG009|PART 1|Withdrawal by Subject|0|||
146270668|NCT05131477|527505904|FG010|PART 1|Withdrawal by Subject|0|||
146270669|NCT05131477|527505905|FG011|PART 1|Withdrawal by Subject|0|||
146270670|NCT05131477|527505906|FG012|PART 1|Withdrawal by Subject|0|||
146270671|NCT05131477|527505907|FG013|PART 1|Withdrawal by Subject|0|||
146270672|NCT05131477|527505894|FG000|PART 1|Physician Decision|1|||
146270673|NCT05131477|527505895|FG001|PART 1|Physician Decision|0|||
146270674|NCT05131477|527505896|FG002|PART 1|Physician Decision|0|||
146270675|NCT05131477|527505897|FG003|PART 1|Physician Decision|0|||
146270676|NCT05131477|527505898|FG004|PART 1|Physician Decision|0|||
146304106|NCT03250832|527627476|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
146304107|NCT03250832|527627477|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
146270677|NCT05131477|527505899|FG005|PART 1|Physician Decision|0|||
146270678|NCT05131477|527505900|FG006|PART 1|Physician Decision|0|||
146270679|NCT05131477|527505901|FG007|PART 1|Physician Decision|0|||
146270680|NCT05131477|527505902|FG008|PART 1|Physician Decision|0|||
146270681|NCT05131477|527505903|FG009|PART 1|Physician Decision|0|||
146270682|NCT05131477|527505904|FG010|PART 1|Physician Decision|0|||
146270683|NCT05131477|527505905|FG011|PART 1|Physician Decision|0|||
146270684|NCT05131477|527505906|FG012|PART 1|Physician Decision|0|||
146270685|NCT05131477|527505907|FG013|PART 1|Physician Decision|0|||
146270686|NCT05131477|527505894|FG000|PART 1|Adverse Event|3|||
146270687|NCT05131477|527505895|FG001|PART 1|Adverse Event|5|||
146270688|NCT05131477|527505896|FG002|PART 1|Adverse Event|1|||
146270689|NCT05131477|527505897|FG003|PART 1|Adverse Event|6|||
146270690|NCT05131477|527505898|FG004|PART 1|Adverse Event|4|||
146270691|NCT05131477|527505899|FG005|PART 1|Adverse Event|0|||
146270692|NCT05131477|527505900|FG006|PART 1|Adverse Event|0|||
146270693|NCT05131477|527505901|FG007|PART 1|Adverse Event|0|||
146270694|NCT05131477|527505902|FG008|PART 1|Adverse Event|0|||
146270695|NCT05131477|527505903|FG009|PART 1|Adverse Event|0|||
146270696|NCT05131477|527505904|FG010|PART 1|Adverse Event|0|||
146270697|NCT05131477|527505905|FG011|PART 1|Adverse Event|0|||
146270698|NCT05131477|527505906|FG012|PART 1|Adverse Event|0|||
146270699|NCT05131477|527505907|FG013|PART 1|Adverse Event|0|||
146270700|NCT05131477|527505894|FG000|PART 1|unclassified|1|||
146270701|NCT05131477|527505895|FG001|PART 1|unclassified|1|||
146270702|NCT05131477|527505896|FG002|PART 1|unclassified|0|||
146270703|NCT05131477|527505897|FG003|PART 1|unclassified|0|||
146270704|NCT05131477|527505898|FG004|PART 1|unclassified|4|||
146270705|NCT05131477|527505899|FG005|PART 1|unclassified|0|||
146270706|NCT05131477|527505900|FG006|PART 1|unclassified|0|||
146270707|NCT05131477|527505901|FG007|PART 1|unclassified|0|||
146270708|NCT05131477|527505902|FG008|PART 1|unclassified|0|||
146270709|NCT05131477|527505903|FG009|PART 1|unclassified|0|||
146270710|NCT05131477|527505904|FG010|PART 1|unclassified|0|||
146270711|NCT05131477|527505905|FG011|PART 1|unclassified|0|||
146270712|NCT05131477|527505906|FG012|PART 1|unclassified|0|||
146270713|NCT05131477|527505907|FG013|PART 1|unclassified|0|||
146270714|NCT05131477|527505894|FG000|PART 1|Randomized and not treated|0|||
146270715|NCT05131477|527505895|FG001|PART 1|Randomized and not treated|0|||
146270716|NCT05131477|527505896|FG002|PART 1|Randomized and not treated|0|||
146270717|NCT05131477|527505897|FG003|PART 1|Randomized and not treated|1|||
146270718|NCT05131477|527505898|FG004|PART 1|Randomized and not treated|1|||
146270719|NCT05131477|527505899|FG005|PART 1|Randomized and not treated|0|||
146270720|NCT05131477|527505900|FG006|PART 1|Randomized and not treated|0|||
146270721|NCT05131477|527505901|FG007|PART 1|Randomized and not treated|0|||
146270722|NCT05131477|527505902|FG008|PART 1|Randomized and not treated|0|||
146270723|NCT05131477|527505903|FG009|PART 1|Randomized and not treated|0|||
146270724|NCT05131477|527505904|FG010|PART 1|Randomized and not treated|0|||
146270725|NCT05131477|527505905|FG011|PART 1|Randomized and not treated|0|||
146270726|NCT05131477|527505906|FG012|PART 1|Randomized and not treated|0|||
146270727|NCT05131477|527505907|FG013|PART 1|Randomized and not treated|0|||
146270728|NCT05131477|527505894|FG000|PART 1|Protocol Violation|2|||
146270729|NCT05131477|527505895|FG001|PART 1|Protocol Violation|0|||
146270730|NCT05131477|527505896|FG002|PART 1|Protocol Violation|0|||
146270731|NCT05131477|527505897|FG003|PART 1|Protocol Violation|1|||
146270732|NCT05131477|527505898|FG004|PART 1|Protocol Violation|0|||
146270733|NCT05131477|527505899|FG005|PART 1|Protocol Violation|0|||
146270734|NCT05131477|527505900|FG006|PART 1|Protocol Violation|0|||
146270735|NCT05131477|527505901|FG007|PART 1|Protocol Violation|0|||
146270736|NCT05131477|527505902|FG008|PART 1|Protocol Violation|0|||
146270737|NCT05131477|527505903|FG009|PART 1|Protocol Violation|0|||
146270738|NCT05131477|527505904|FG010|PART 1|Protocol Violation|0|||
146270739|NCT05131477|527505905|FG011|PART 1|Protocol Violation|0|||
146270740|NCT05131477|527505906|FG012|PART 1|Protocol Violation|0|||
146270741|NCT05131477|527505907|FG013|PART 1|Protocol Violation|0|||
146270742|NCT05131477|527505894|FG000|PART 1|Lack of Efficacy|0|||
146270743|NCT05131477|527505895|FG001|PART 1|Lack of Efficacy|1|||
146270744|NCT05131477|527505896|FG002|PART 1|Lack of Efficacy|1|||
146270745|NCT05131477|527505897|FG003|PART 1|Lack of Efficacy|2|||
146270746|NCT05131477|527505898|FG004|PART 1|Lack of Efficacy|5|||
146270747|NCT05131477|527505899|FG005|PART 1|Lack of Efficacy|0|||
146270748|NCT05131477|527505900|FG006|PART 1|Lack of Efficacy|0|||
146270749|NCT05131477|527505901|FG007|PART 1|Lack of Efficacy|0|||
146270750|NCT05131477|527505902|FG008|PART 1|Lack of Efficacy|0|||
146270751|NCT05131477|527505903|FG009|PART 1|Lack of Efficacy|0|||
146270752|NCT05131477|527505904|FG010|PART 1|Lack of Efficacy|0|||
146270753|NCT05131477|527505905|FG011|PART 1|Lack of Efficacy|0|||
146270754|NCT05131477|527505906|FG012|PART 1|Lack of Efficacy|0|||
146270755|NCT05131477|527505907|FG013|PART 1|Lack of Efficacy|0|||
146270756|NCT05131477|527505894|FG000|PART 2|Withdrawal by Subject|0|||
146270757|NCT05131477|527505895|FG001|PART 2|Withdrawal by Subject|0|||
146270758|NCT05131477|527505896|FG002|PART 2|Withdrawal by Subject|0|||
146270759|NCT05131477|527505897|FG003|PART 2|Withdrawal by Subject|0|||
146270760|NCT05131477|527505898|FG004|PART 2|Withdrawal by Subject|0|||
146270761|NCT05131477|527505899|FG005|PART 2|Withdrawal by Subject|0|||
146270762|NCT05131477|527505900|FG006|PART 2|Withdrawal by Subject|2|||
146270763|NCT05131477|527505901|FG007|PART 2|Withdrawal by Subject|0|||
146270764|NCT05131477|527505902|FG008|PART 2|Withdrawal by Subject|0|||
146270765|NCT05131477|527505903|FG009|PART 2|Withdrawal by Subject|0|||
146270766|NCT05131477|527505904|FG010|PART 2|Withdrawal by Subject|2|||
146270767|NCT05131477|527505905|FG011|PART 2|Withdrawal by Subject|0|||
146270768|NCT05131477|527505906|FG012|PART 2|Withdrawal by Subject|2|||
146270769|NCT05131477|527505907|FG013|PART 2|Withdrawal by Subject|2|||
146270770|NCT05131477|527505894|FG000|PART 2|Other|0|||
146270771|NCT05131477|527505895|FG001|PART 2|Other|0|||
146270772|NCT05131477|527505896|FG002|PART 2|Other|0|||
146270773|NCT05131477|527505897|FG003|PART 2|Other|0|||
146270774|NCT05131477|527505898|FG004|PART 2|Other|0|||
146270775|NCT05131477|527505899|FG005|PART 2|Other|0|||
146270776|NCT05131477|527505900|FG006|PART 2|Other|0|||
146270777|NCT05131477|527505901|FG007|PART 2|Other|0|||
146270778|NCT05131477|527505902|FG008|PART 2|Other|1|||
146270779|NCT05131477|527505903|FG009|PART 2|Other|1|||
146270780|NCT05131477|527505904|FG010|PART 2|Other|0|||
146270781|NCT05131477|527505905|FG011|PART 2|Other|0|||
146270782|NCT05131477|527505906|FG012|PART 2|Other|1|||
146270783|NCT05131477|527505907|FG013|PART 2|Other|0|||
146270784|NCT05131477|527505894|FG000|PART 2|Lack of Efficacy|0|||
146270785|NCT05131477|527505895|FG001|PART 2|Lack of Efficacy|0|||
146270786|NCT05131477|527505896|FG002|PART 2|Lack of Efficacy|0|||
146270787|NCT05131477|527505897|FG003|PART 2|Lack of Efficacy|0|||
146270788|NCT05131477|527505898|FG004|PART 2|Lack of Efficacy|0|||
146270789|NCT05131477|527505899|FG005|PART 2|Lack of Efficacy|1|||
146270790|NCT05131477|527505900|FG006|PART 2|Lack of Efficacy|1|||
146270791|NCT05131477|527505901|FG007|PART 2|Lack of Efficacy|0|||
146270792|NCT05131477|527505902|FG008|PART 2|Lack of Efficacy|3|||
146270793|NCT05131477|527505903|FG009|PART 2|Lack of Efficacy|0|||
146270794|NCT05131477|527505904|FG010|PART 2|Lack of Efficacy|1|||
146270795|NCT05131477|527505905|FG011|PART 2|Lack of Efficacy|0|||
146270796|NCT05131477|527505906|FG012|PART 2|Lack of Efficacy|2|||
146270797|NCT05131477|527505907|FG013|PART 2|Lack of Efficacy|0|||
146270798|NCT05131477|527505894|FG000|PART 2|Unclassified|0|||
146270799|NCT05131477|527505895|FG001|PART 2|Unclassified|0|||
146270800|NCT05131477|527505896|FG002|PART 2|Unclassified|0|||
146270801|NCT05131477|527505897|FG003|PART 2|Unclassified|0|||
146270802|NCT05131477|527505898|FG004|PART 2|Unclassified|0|||
146270803|NCT05131477|527505899|FG005|PART 2|Unclassified|0|||
146270804|NCT05131477|527505900|FG006|PART 2|Unclassified|0|||
146270805|NCT05131477|527505901|FG007|PART 2|Unclassified|0|||
146270806|NCT05131477|527505902|FG008|PART 2|Unclassified|0|||
146270807|NCT05131477|527505903|FG009|PART 2|Unclassified|0|||
146270808|NCT05131477|527505904|FG010|PART 2|Unclassified|1|||
146270809|NCT05131477|527505905|FG011|PART 2|Unclassified|0|||
146270810|NCT05131477|527505906|FG012|PART 2|Unclassified|0|||
146270811|NCT05131477|527505907|FG013|PART 2|Unclassified|0|||
146270812|NCT05131477|527505894|FG000|PART 2|Re-randomized and not treated|0|||
146270813|NCT05131477|527505895|FG001|PART 2|Re-randomized and not treated|0|||
146270814|NCT05131477|527505896|FG002|PART 2|Re-randomized and not treated|0|||
146270815|NCT05131477|527505897|FG003|PART 2|Re-randomized and not treated|0|||
146270816|NCT05131477|527505898|FG004|PART 2|Re-randomized and not treated|0|||
146270817|NCT05131477|527505899|FG005|PART 2|Re-randomized and not treated|0|||
146270818|NCT05131477|527505900|FG006|PART 2|Re-randomized and not treated|0|||
146270819|NCT05131477|527505901|FG007|PART 2|Re-randomized and not treated|1|||
146270820|NCT05131477|527505902|FG008|PART 2|Re-randomized and not treated|0|||
146270821|NCT05131477|527505903|FG009|PART 2|Re-randomized and not treated|0|||
146270822|NCT05131477|527505904|FG010|PART 2|Re-randomized and not treated|1|||
146270823|NCT05131477|527505905|FG011|PART 2|Re-randomized and not treated|0|||
146270824|NCT05131477|527505906|FG012|PART 2|Re-randomized and not treated|1|||
146270825|NCT05131477|527505907|FG013|PART 2|Re-randomized and not treated|1|||
146270826|NCT02194829|527505908|FG000|Overall Study|Adverse Event|2|||
146270827|NCT02194829|527505909|FG001|Overall Study|Adverse Event|2|||
146270828|NCT02194829|527505908|FG000|Overall Study|Death|0|||
146270829|NCT02194829|527505909|FG001|Overall Study|Death|1|||
146270830|NCT02194829|527505908|FG000|Overall Study|Disease progression|0|||
146270831|NCT02194829|527505909|FG001|Overall Study|Disease progression|1|||
146270832|NCT02194829|527505908|FG000|Overall Study|Withdrawal by Subject|0|||
146270833|NCT02194829|527505909|FG001|Overall Study|Withdrawal by Subject|1|||
146270834|NCT02194829|527505908|FG000|Overall Study|Never started protocol therapy|0|||
146270835|NCT02194829|527505909|FG001|Overall Study|Never started protocol therapy|1|||
146270836|NCT06840769|527505911|FG000|Overall Study|Withdrawal by Subject|1|||
146270837|NCT06840769|527505912|FG001|Overall Study|Withdrawal by Subject|0|||
146270838|NCT06840769|527505913|FG002|Overall Study|Withdrawal by Subject|0|||
146270839|NCT06840769|527505914|FG003|Overall Study|Withdrawal by Subject|0|||
146270840|NCT06840769|527505915|FG004|Overall Study|Withdrawal by Subject|0|||
146270841|NCT00699153|527507844|FG000|Overall Study|Lost to Follow-up|1|||
146270842|NCT00699153|527507845|FG001|Overall Study|Lost to Follow-up|0|||
146270843|NCT00699153|527507844|FG000|Overall Study|Adverse Event|0|||
146304108|NCT03250832|527627478|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
146270844|NCT00699153|527507845|FG001|Overall Study|Adverse Event|2|||
146270845|NCT00699153|527507844|FG000|Overall Study|Protocol Violation|1|||
146270846|NCT00699153|527507845|FG001|Overall Study|Protocol Violation|0|||
146270847|NCT00699153|527507844|FG000|Overall Study|Travel Problem|1|||
146270848|NCT00699153|527507845|FG001|Overall Study|Travel Problem|0|||
146270849|NCT04201288|527507855|FG000|Overall Study|Death|1|||
146270850|NCT04201288|527507856|FG001|Overall Study|Death|1|||
146270851|NCT04201288|527507855|FG000|Overall Study|Lost to Follow-up|5|||
146270852|NCT04201288|527507856|FG001|Overall Study|Lost to Follow-up|3|||
146270853|NCT04201288|527507855|FG000|Overall Study|Withdrawal by Subject|1|||
146270854|NCT04201288|527507856|FG001|Overall Study|Withdrawal by Subject|0|||
146270855|NCT04497389|527507859|FG000|Overall Study|Withdrawal by Subject|1|||
146270856|NCT04497389|527507860|FG001|Overall Study|Withdrawal by Subject|0|||
146270857|NCT00789360|527507863|FG000|Overall Study|Protocol Violation|3|||
146270858|NCT00789360|527507864|FG001|Overall Study|Protocol Violation|1|||
146270859|NCT03559062|527507865|FG000|Overall Study|Other|0|||
146270860|NCT03559062|527507866|FG001|Overall Study|Other|1|||
146270861|NCT03559062|527507867|FG002|Overall Study|Other|0|||
146270862|NCT03322540|527507872|FG000|Overall Study|Death|21|||
146270863|NCT03322540|527507873|FG001|Overall Study|Death|28|||
146270864|NCT03322540|527507872|FG000|Overall Study|Lost to Follow-up|0|||
146270865|NCT03322540|527507873|FG001|Overall Study|Lost to Follow-up|1|||
146270866|NCT03322540|527507872|FG000|Overall Study|Physician Decision|7|||
146270867|NCT03322540|527507873|FG001|Overall Study|Physician Decision|6|||
146270868|NCT03322540|527507872|FG000|Overall Study|Withdrawal by Subject|3|||
146270869|NCT03322540|527507873|FG001|Overall Study|Withdrawal by Subject|1|||
146270870|NCT03322540|527507872|FG000|Overall Study|Study terminated by sponsor|0|||
146270871|NCT03322540|527507873|FG001|Overall Study|Study terminated by sponsor|1|||
146270872|NCT03445533|527507874|FG000|Overall Study|Progressive Disease|48|||
146270873|NCT03445533|527507875|FG001|Overall Study|Progressive Disease|81|||
146270874|NCT03445533|527507874|FG000|Overall Study|Adverse Event|60|||
146270875|NCT03445533|527507875|FG001|Overall Study|Adverse Event|64|||
146270876|NCT03445533|527507874|FG000|Overall Study|Death|9|||
146270877|NCT03445533|527507875|FG001|Overall Study|Death|19|||
146270878|NCT03445533|527507874|FG000|Overall Study|Miscellaneous|0|||
146270879|NCT03445533|527507875|FG001|Overall Study|Miscellaneous|16|||
146270880|NCT03445533|527507874|FG000|Overall Study|Withdrawal by Subject|3|||
146270881|NCT03445533|527507875|FG001|Overall Study|Withdrawal by Subject|4|||
146270882|NCT03445533|527507874|FG000|Overall Study|Physician Decision|1|||
146270883|NCT03445533|527507875|FG001|Overall Study|Physician Decision|3|||
146138445|NCT04300296|527023073|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
146138446|NCT04300296|527023068|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
146138447|NCT04300296|527023069|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146138448|NCT04300296|527023070|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
146138449|NCT04300296|527023071|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146138450|NCT04300296|527023072|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
146138451|NCT04300296|527023073|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
146138452|NCT04300296|527023068|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
146138453|NCT04300296|527023069|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146138454|NCT04300296|527023070|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
146138455|NCT04300296|527023071|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146138456|NCT04300296|527023072|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
146138457|NCT04300296|527023073|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
146138458|NCT04300296|527023068|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146138459|NCT04300296|527023069|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
146138460|NCT04300296|527023070|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146138461|NCT04300296|527023071|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146138462|NCT04300296|527023072|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146138463|NCT04300296|527023073|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
146138464|NCT04300296|527023068|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
146138465|NCT04300296|527023069|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
146138466|NCT04300296|527023070|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
146138467|NCT04300296|527023071|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
146138468|NCT04300296|527023072|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
146138469|NCT04300296|527023073|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
146138470|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Adverse Event|9|||
146138471|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Adverse Event|2|||
146138472|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
146138473|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
146138474|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
146138475|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
146138476|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Physician Decision|1|||
146138477|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Physician Decision|1|||
146270884|NCT03445533|527507874|FG000|Overall Study|Sponsor Decision|0|||
146270885|NCT03445533|527507875|FG001|Overall Study|Sponsor Decision|1|||
146138478|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Pregnancy|2|||
146270886|NCT03445533|527507874|FG000|Overall Study|Lost to Follow-up|0|||
146270887|NCT03445533|527507875|FG001|Overall Study|Lost to Follow-up|1|||
146270888|NCT03445533|527507874|FG000|Overall Study|Never Received any Study Treatment|7|||
146270889|NCT03445533|527507875|FG001|Overall Study|Never Received any Study Treatment|4|||
146270890|NCT02615509|527507876|FG000|Overall Study|Lost to Follow-up|134|||
146270891|NCT02615509|527507876|FG000|Overall Study|Death|4|||
146270892|NCT02615509|527507876|FG000|Overall Study|Withdrawal by Subject|8|||
146138479|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Pregnancy|0|||
146138480|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
146138481|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
146138482|NCT02896127|527023074|FG000|COMPLETED WEEK 52|Technical problems|1|||
146138483|NCT02896127|527023075|FG001|COMPLETED WEEK 52|Technical problems|0|||
146138484|NCT02896127|527023074|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
146138485|NCT02896127|527023075|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
146138486|NCT02896127|527023074|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
146138487|NCT02896127|527023075|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
146138488|NCT02896127|527023074|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
146138489|NCT02896127|527023075|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
146138490|NCT02896127|527023074|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
146138491|NCT02896127|527023075|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
146138492|NCT02896127|527023074|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
146138493|NCT02896127|527023075|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
146138494|NCT03912233|527023076|FG000|Overall Study|Adverse Event|1|||
146138495|NCT03912233|527023077|FG001|Overall Study|Adverse Event|0|||
146138496|NCT03912233|527023078|FG002|Overall Study|Adverse Event|0|||
146138497|NCT03912233|527023079|FG003|Overall Study|Adverse Event|0|||
146138498|NCT03912233|527023080|FG004|Overall Study|Adverse Event|0|||
146138499|NCT03912233|527023081|FG005|Overall Study|Adverse Event|0|||
146138500|NCT03912233|527023076|FG000|Overall Study|Physician Decision|1|||
146138501|NCT03912233|527023077|FG001|Overall Study|Physician Decision|0|||
146138502|NCT03912233|527023078|FG002|Overall Study|Physician Decision|0|||
146138503|NCT03912233|527023079|FG003|Overall Study|Physician Decision|0|||
146138504|NCT03912233|527023080|FG004|Overall Study|Physician Decision|0|||
146138505|NCT03912233|527023081|FG005|Overall Study|Physician Decision|0|||
146138506|NCT03912233|527023076|FG000|Overall Study|Other|0|||
146138507|NCT03912233|527023077|FG001|Overall Study|Other|0|||
146138508|NCT03912233|527023078|FG002|Overall Study|Other|0|||
146138509|NCT03912233|527023079|FG003|Overall Study|Other|0|||
146138510|NCT03912233|527023080|FG004|Overall Study|Other|7|||
146138511|NCT03912233|527023081|FG005|Overall Study|Other|12|||
146138512|NCT00326911|527023082|FG000|Overall Study|Hospitalization prior to treatment|0|||
146138513|NCT00326911|527023083|FG001|Overall Study|Hospitalization prior to treatment|1|||
146138514|NCT00326911|527023082|FG000|Overall Study|Physician decision prior to treatment|1|||
146138515|NCT00326911|527023083|FG001|Overall Study|Physician decision prior to treatment|0|||
146138516|NCT00326911|527023082|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
146138517|NCT00326911|527023083|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
146138518|NCT04537806|527023092|FG000|Overall Study|Randomized but not treated|1|||
146138519|NCT04537806|527023093|FG001|Overall Study|Randomized but not treated|0|||
146138520|NCT04537806|527023092|FG000|Overall Study|Adverse Event|1|||
146138521|NCT04537806|527023093|FG001|Overall Study|Adverse Event|1|||
146138522|NCT02477020|527023096|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
146138523|NCT02477020|527023097|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146138524|NCT02477020|527023096|FG000|Overall Study|Voluntary Withdrawal|7|||
146138525|NCT02477020|527023097|FG001|Overall Study|Voluntary Withdrawal|16|||
146138526|NCT02477020|527023096|FG000|Overall Study|Reason not Specified|3|||
146138527|NCT02477020|527023097|FG001|Overall Study|Reason not Specified|1|||
146138528|NCT02477020|527023096|FG000|Overall Study|Lack of Efficacy|14|||
146138529|NCT02477020|527023097|FG001|Overall Study|Lack of Efficacy|5|||
146138530|NCT00501540|527023101|FG000|Overall Study|Death|5|||
146138531|NCT00519649|527023102|FG000|Overall Study|Withdrawal by Subject|1|||
146138532|NCT01465802|527023103|FG000|Overall Study|Study terminated by sponsor|1|||
146138533|NCT01465802|527023104|FG001|Overall Study|Study terminated by sponsor|0|||
146138534|NCT01465802|527023105|FG002|Overall Study|Study terminated by sponsor|0|||
146138535|NCT01465802|527023106|FG003|Overall Study|Study terminated by sponsor|1|||
146138536|NCT01465802|527023107|FG004|Overall Study|Study terminated by sponsor|7|||
146138537|NCT01465802|527023103|FG000|Overall Study|Withdrawal by Subject|7|||
146138538|NCT01465802|527023104|FG001|Overall Study|Withdrawal by Subject|7|||
146138539|NCT01465802|527023105|FG002|Overall Study|Withdrawal by Subject|0|||
146138540|NCT01465802|527023106|FG003|Overall Study|Withdrawal by Subject|8|||
146138541|NCT01465802|527023107|FG004|Overall Study|Withdrawal by Subject|1|||
146138542|NCT01465802|527023103|FG000|Overall Study|Lost to Follow-up|1|||
146138543|NCT01465802|527023104|FG001|Overall Study|Lost to Follow-up|1|||
146138544|NCT01465802|527023105|FG002|Overall Study|Lost to Follow-up|0|||
146138545|NCT01465802|527023106|FG003|Overall Study|Lost to Follow-up|0|||
146138546|NCT01465802|527023107|FG004|Overall Study|Lost to Follow-up|0|||
146138547|NCT01465802|527023103|FG000|Overall Study|Reason not specified|9|||
146138548|NCT01465802|527023104|FG001|Overall Study|Reason not specified|4|||
146138549|NCT01465802|527023105|FG002|Overall Study|Reason not specified|0|||
146138550|NCT01465802|527023106|FG003|Overall Study|Reason not specified|10|||
146138551|NCT01465802|527023107|FG004|Overall Study|Reason not specified|2|||
146138552|NCT01465802|527023103|FG000|Overall Study|Death|15|||
146138553|NCT01465802|527023104|FG001|Overall Study|Death|12|||
146138554|NCT01465802|527023105|FG002|Overall Study|Death|0|||
146270893|NCT03274453|527507877|FG000|Overall Study|Lost to Follow-up|2|||
146270894|NCT03274453|527507878|FG001|Overall Study|Lost to Follow-up|5|||
146270895|NCT03274453|527507879|FG002|Overall Study|Lost to Follow-up|4|||
146270896|NCT03274453|527507880|FG003|Overall Study|Lost to Follow-up|1|||
146270897|NCT03274453|527507877|FG000|Overall Study|Physician Decision|2|||
146270898|NCT03274453|527507878|FG001|Overall Study|Physician Decision|0|||
146270899|NCT03274453|527507879|FG002|Overall Study|Physician Decision|0|||
146270900|NCT03274453|527507880|FG003|Overall Study|Physician Decision|3|||
146270901|NCT03274453|527507877|FG000|Overall Study|Surgery Cancelled|0|||
146270902|NCT03274453|527507878|FG001|Overall Study|Surgery Cancelled|1|||
146270903|NCT03274453|527507879|FG002|Overall Study|Surgery Cancelled|0|||
146270904|NCT03274453|527507880|FG003|Overall Study|Surgery Cancelled|0|||
146270905|NCT00968526|527507882|FG000|Overall Study|Adverse Event|2|||
146270906|NCT00968526|527507883|FG001|Overall Study|Adverse Event|0|||
146270907|NCT00968526|527507882|FG000|Overall Study|Migrated/moved from study area|1|||
146270908|NCT00968526|527507883|FG001|Overall Study|Migrated/moved from study area|0|||
146270909|NCT03926195|527507886|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
146270910|NCT03926195|527507887|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
146270911|NCT03926195|527507886|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
146270912|NCT03926195|527507887|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
146270913|NCT03926195|527507886|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
146270914|NCT03926195|527507887|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
146270915|NCT03926195|527507886|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
146270916|NCT03926195|527507887|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
146270917|NCT03926195|527507886|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
146270918|NCT03926195|527507887|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
146270919|NCT03926195|527507886|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
146270920|NCT03926195|527507887|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
146270921|NCT01967069|527507889|FG000|Overall Study|Adverse Event|2|||
146270922|NCT01967069|527507890|FG001|Overall Study|Adverse Event|2|||
146270923|NCT01967069|527507889|FG000|Overall Study|Lost to Follow-up|5|||
146270924|NCT01967069|527507890|FG001|Overall Study|Lost to Follow-up|2|||
146270925|NCT01967069|527507889|FG000|Overall Study|Withdrawal by Subject|1|||
146270926|NCT01967069|527507890|FG001|Overall Study|Withdrawal by Subject|3|||
146270927|NCT01967069|527507889|FG000|Overall Study|Lack of Efficacy|0|||
146270928|NCT01967069|527507890|FG001|Overall Study|Lack of Efficacy|1|||
146270929|NCT01689857|527507892|FG000|Overall Study|Lost to Follow-up|5|||
146270930|NCT01689857|527507893|FG001|Overall Study|Lost to Follow-up|2|||
146270931|NCT01730378|527507895|FG000|Overall Study|Lost to Follow-up|1|||
146270932|NCT01730378|527507896|FG001|Overall Study|Lost to Follow-up|0|||
146270933|NCT00874731|527507897|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
146270934|NCT00874731|527507898|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
146270935|NCT00874731|527507899|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
146270936|NCT00874731|527507897|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
146270937|NCT00874731|527507898|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
146270938|NCT00874731|527507899|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
146270939|NCT00874731|527507897|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
146270940|NCT00874731|527507898|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
146270941|NCT00874731|527507899|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
146270942|NCT05105087|527507901|FG000|Overall Study|Withdrawal by Subject|2|||
146270943|NCT05105087|527507901|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
146270944|NCT01016262|527507902|FG000|Double-blind Phase|Adverse Event|0|||
146270945|NCT01016262|527507903|FG001|Double-blind Phase|Adverse Event|0|||
146270946|NCT01016262|527507904|FG002|Double-blind Phase|Adverse Event|1|||
146270947|NCT01016262|527507905|FG003|Double-blind Phase|Adverse Event|0|||
146270948|NCT01016262|527507906|FG004|Double-blind Phase|Adverse Event|0|||
146270949|NCT01016262|527507907|FG005|Double-blind Phase|Adverse Event|0|||
146270950|NCT01016262|527507902|FG000|Double-blind Phase|Lack of Efficacy|1|||
146138555|NCT01465802|527023106|FG003|Overall Study|Death|10|||
146138556|NCT01465802|527023107|FG004|Overall Study|Death|2|||
146138557|NCT01340976|527023108|FG000|Overall Study|Physician Decision|2|||
146138558|NCT01340976|527023109|FG001|Overall Study|Physician Decision|0|||
146138559|NCT01340976|527023110|FG002|Overall Study|Physician Decision|1|||
146270951|NCT01016262|527507903|FG001|Double-blind Phase|Lack of Efficacy|0|||
146270952|NCT01016262|527507904|FG002|Double-blind Phase|Lack of Efficacy|5|||
146270953|NCT01016262|527507905|FG003|Double-blind Phase|Lack of Efficacy|0|||
146270954|NCT01016262|527507906|FG004|Double-blind Phase|Lack of Efficacy|0|||
146270955|NCT01016262|527507907|FG005|Double-blind Phase|Lack of Efficacy|0|||
146270956|NCT01016262|527507902|FG000|Double-blind Phase|Disease Progression|0|||
146270957|NCT01016262|527507903|FG001|Double-blind Phase|Disease Progression|1|||
146270958|NCT01016262|527507904|FG002|Double-blind Phase|Disease Progression|2|||
146270959|NCT01016262|527507905|FG003|Double-blind Phase|Disease Progression|0|||
146138560|NCT01340976|527023111|FG003|Overall Study|Physician Decision|1|||
146138561|NCT01340976|527023112|FG004|Overall Study|Physician Decision|1|||
146138562|NCT01340976|527023113|FG005|Overall Study|Physician Decision|0|||
146138563|NCT01340976|527023108|FG000|Overall Study|Death|0|||
146138564|NCT01340976|527023109|FG001|Overall Study|Death|1|||
146138565|NCT01340976|527023110|FG002|Overall Study|Death|0|||
146138566|NCT01340976|527023111|FG003|Overall Study|Death|0|||
146138567|NCT01340976|527023112|FG004|Overall Study|Death|0|||
146138568|NCT01340976|527023113|FG005|Overall Study|Death|0|||
146138569|NCT01340976|527023108|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
146138570|NCT01340976|527023109|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146138571|NCT01340976|527023110|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146138572|NCT01340976|527023111|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146138573|NCT01340976|527023112|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146138574|NCT01340976|527023113|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
146138575|NCT01340976|527023108|FG000|Overall Study|Withdrawal by Subject|0|||
146138576|NCT01340976|527023109|FG001|Overall Study|Withdrawal by Subject|0|||
146138577|NCT01340976|527023110|FG002|Overall Study|Withdrawal by Subject|0|||
146138578|NCT01340976|527023111|FG003|Overall Study|Withdrawal by Subject|1|||
146138579|NCT01340976|527023112|FG004|Overall Study|Withdrawal by Subject|1|||
146138580|NCT01340976|527023113|FG005|Overall Study|Withdrawal by Subject|0|||
146138581|NCT01340976|527023108|FG000|Overall Study|Other anemia treatment|1|||
146138582|NCT01340976|527023109|FG001|Overall Study|Other anemia treatment|0|||
146138583|NCT01340976|527023110|FG002|Overall Study|Other anemia treatment|2|||
146138584|NCT01340976|527023111|FG003|Overall Study|Other anemia treatment|1|||
146138585|NCT01340976|527023112|FG004|Overall Study|Other anemia treatment|0|||
146138586|NCT01340976|527023113|FG005|Overall Study|Other anemia treatment|1|||
146138587|NCT01340976|527023108|FG000|Overall Study|Adverse Event|0|||
146138588|NCT01340976|527023109|FG001|Overall Study|Adverse Event|1|||
146138589|NCT01340976|527023110|FG002|Overall Study|Adverse Event|0|||
146138590|NCT01340976|527023111|FG003|Overall Study|Adverse Event|0|||
146138591|NCT01340976|527023112|FG004|Overall Study|Adverse Event|0|||
146138592|NCT01340976|527023113|FG005|Overall Study|Adverse Event|0|||
146138593|NCT02953821|527023114|FG000|Overall Study|Adverse Event|0|||
146138594|NCT02953821|527023115|FG001|Overall Study|Adverse Event|4|||
146138595|NCT02953821|527023114|FG000|Overall Study|Death|1|||
146138596|NCT02953821|527023115|FG001|Overall Study|Death|0|||
146138597|NCT02953821|527023114|FG000|Overall Study|Progressive Disease|5|||
146138598|NCT02953821|527023115|FG001|Overall Study|Progressive Disease|1|||
146138599|NCT02953821|527023114|FG000|Overall Study|Lost to Follow-up|2|||
146138600|NCT02953821|527023115|FG001|Overall Study|Lost to Follow-up|0|||
146138601|NCT02953821|527023114|FG000|Overall Study|Physician Decision|1|||
146138602|NCT02953821|527023115|FG001|Overall Study|Physician Decision|1|||
146138603|NCT02953821|527023114|FG000|Overall Study|Withdrawal by Subject|3|||
146138604|NCT02953821|527023115|FG001|Overall Study|Withdrawal by Subject|3|||
146138605|NCT02953821|527023114|FG000|Overall Study|Change of address|0|||
146138606|NCT02953821|527023115|FG001|Overall Study|Change of address|1|||
146138607|NCT02953821|527023114|FG000|Overall Study|Lack of Efficacy|1|||
146138608|NCT02953821|527023115|FG001|Overall Study|Lack of Efficacy|0|||
146138609|NCT02953821|527023114|FG000|Overall Study|Out of state for indeterminate time|0|||
146138610|NCT02953821|527023115|FG001|Overall Study|Out of state for indeterminate time|1|||
146138611|NCT02953821|527023114|FG000|Overall Study|No improvement|0|||
146138612|NCT02953821|527023115|FG001|Overall Study|No improvement|1|||
146138613|NCT02953821|527023114|FG000|Overall Study|Refused follow-up visit|2|||
146138614|NCT02953821|527023115|FG001|Overall Study|Refused follow-up visit|1|||
146138615|NCT01067352|527023116|FG000|Overall Study|Withdrawal by Subject|1|||
146138616|NCT01067352|527023117|FG001|Overall Study|Withdrawal by Subject|2|||
146138617|NCT01067352|527023118|FG002|Overall Study|Withdrawal by Subject|1|||
146138618|NCT01067352|527023116|FG000|Overall Study|Physician Decision|0|||
146138619|NCT01067352|527023117|FG001|Overall Study|Physician Decision|1|||
146138620|NCT01067352|527023118|FG002|Overall Study|Physician Decision|0|||
146138621|NCT03219333|527023119|FG000|Overall Study|Withdrawal by Subject|9|||
146138622|NCT03219333|527023120|FG001|Overall Study|Withdrawal by Subject|4|||
146138623|NCT03219333|527023119|FG000|Overall Study|Lost to Follow-up|1|||
146138624|NCT03219333|527023120|FG001|Overall Study|Lost to Follow-up|1|||
146138625|NCT03219333|527023119|FG000|Overall Study|Death|104|||
146138626|NCT03219333|527023120|FG001|Overall Study|Death|72|||
146138627|NCT03219333|527023119|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
146138628|NCT03219333|527023120|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
146138629|NCT03219333|527023119|FG000|Overall Study|Other|2|||
146138630|NCT03219333|527023120|FG001|Overall Study|Other|2|||
146138631|NCT02566759|527023121|FG000|All Parts|Withdrawal by Subject|0|||
146138632|NCT02566759|527023122|FG001|All Parts|Withdrawal by Subject|1|||
146138633|NCT02566759|527023123|FG002|All Parts|Withdrawal by Subject|0|||
146138634|NCT02566759|527023124|FG003|All Parts|Withdrawal by Subject|0|||
146138635|NCT02566759|527023125|FG004|All Parts|Withdrawal by Subject|0|||
146138636|NCT02566759|527023126|FG005|All Parts|Withdrawal by Subject|0|||
146138637|NCT02566759|527023127|FG006|All Parts|Withdrawal by Subject|0|||
146138638|NCT02566759|527023128|FG007|All Parts|Withdrawal by Subject|0|||
146138639|NCT02566759|527023129|FG008|All Parts|Withdrawal by Subject|0|||
146138640|NCT02566759|527023130|FG009|All Parts|Withdrawal by Subject|0|||
146138641|NCT02566759|527023131|FG010|All Parts|Withdrawal by Subject|0|||
146138642|NCT02566759|527023132|FG011|All Parts|Withdrawal by Subject|0|||
146138643|NCT02566759|527023133|FG012|All Parts|Withdrawal by Subject|0|||
146138644|NCT02566759|527023134|FG013|All Parts|Withdrawal by Subject|0|||
146138645|NCT02566759|527023135|FG014|All Parts|Withdrawal by Subject|0|||
146138646|NCT02566759|527023136|FG015|All Parts|Withdrawal by Subject|0|||
146270960|NCT01016262|527507906|FG004|Double-blind Phase|Disease Progression|0|||
146270961|NCT01016262|527507907|FG005|Double-blind Phase|Disease Progression|0|||
146270962|NCT01016262|527507902|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
146270963|NCT01016262|527507903|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
146270964|NCT01016262|527507904|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
146270965|NCT01016262|527507905|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
146270966|NCT01016262|527507906|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
146270967|NCT01016262|527507907|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
146270968|NCT01016262|527507902|FG000|Open-Label Phase|Adverse Event|0|||
146270969|NCT01016262|527507903|FG001|Open-Label Phase|Adverse Event|0|||
146270970|NCT01016262|527507904|FG002|Open-Label Phase|Adverse Event|0|||
146270971|NCT01016262|527507905|FG003|Open-Label Phase|Adverse Event|1|||
146270972|NCT01016262|527507906|FG004|Open-Label Phase|Adverse Event|0|||
146270973|NCT01016262|527507907|FG005|Open-Label Phase|Adverse Event|0|||
146270974|NCT01016262|527507902|FG000|Open-Label Phase|Lost to Follow-up|0|||
146270975|NCT01016262|527507903|FG001|Open-Label Phase|Lost to Follow-up|0|||
146270976|NCT01016262|527507904|FG002|Open-Label Phase|Lost to Follow-up|0|||
146270977|NCT01016262|527507905|FG003|Open-Label Phase|Lost to Follow-up|0|||
146270978|NCT01016262|527507906|FG004|Open-Label Phase|Lost to Follow-up|1|||
146270979|NCT01016262|527507907|FG005|Open-Label Phase|Lost to Follow-up|0|||
146270980|NCT01016262|527507902|FG000|Open-Label Phase|Lack of Efficacy|0|||
146270981|NCT01016262|527507903|FG001|Open-Label Phase|Lack of Efficacy|0|||
146270982|NCT01016262|527507904|FG002|Open-Label Phase|Lack of Efficacy|0|||
146270983|NCT01016262|527507905|FG003|Open-Label Phase|Lack of Efficacy|1|||
146270984|NCT01016262|527507906|FG004|Open-Label Phase|Lack of Efficacy|0|||
146270985|NCT01016262|527507907|FG005|Open-Label Phase|Lack of Efficacy|0|||
146270986|NCT01016262|527507902|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
146270987|NCT01016262|527507903|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
146270988|NCT01016262|527507904|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
146270989|NCT01016262|527507905|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
146270990|NCT01016262|527507906|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
146304109|NCT03250832|527627479|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
146304110|NCT03250832|527627480|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
146138647|NCT02566759|527023137|FG016|All Parts|Withdrawal by Subject|0|||
146138648|NCT02566759|527023121|FG000|All Parts|Adverse Event|0|||
146138649|NCT02566759|527023122|FG001|All Parts|Adverse Event|0|||
146138650|NCT02566759|527023123|FG002|All Parts|Adverse Event|0|||
146138651|NCT02566759|527023124|FG003|All Parts|Adverse Event|0|||
146138652|NCT02566759|527023125|FG004|All Parts|Adverse Event|0|||
146138653|NCT02566759|527023126|FG005|All Parts|Adverse Event|0|||
146138654|NCT02566759|527023127|FG006|All Parts|Adverse Event|0|||
146138655|NCT02566759|527023128|FG007|All Parts|Adverse Event|0|||
146138656|NCT02566759|527023129|FG008|All Parts|Adverse Event|0|||
146138657|NCT02566759|527023130|FG009|All Parts|Adverse Event|0|||
146138658|NCT02566759|527023131|FG010|All Parts|Adverse Event|0|||
146138659|NCT02566759|527023132|FG011|All Parts|Adverse Event|0|||
146138660|NCT02566759|527023133|FG012|All Parts|Adverse Event|1|||
146138661|NCT02566759|527023134|FG013|All Parts|Adverse Event|3|||
146138662|NCT02566759|527023135|FG014|All Parts|Adverse Event|0|||
146138663|NCT02566759|527023136|FG015|All Parts|Adverse Event|0|||
146138664|NCT02566759|527023137|FG016|All Parts|Adverse Event|0|||
146138665|NCT02566759|527023121|FG000|All Parts|Other|0|||
146138666|NCT02566759|527023122|FG001|All Parts|Other|0|||
146138667|NCT02566759|527023123|FG002|All Parts|Other|0|||
146138668|NCT02566759|527023124|FG003|All Parts|Other|0|||
146270991|NCT01016262|527507907|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
146270992|NCT03199469|527507908|FG000|Overall Study|Randomized, not treated|0|||
146270993|NCT03199469|527507909|FG001|Overall Study|Randomized, not treated|3|||
146138669|NCT02566759|527023125|FG004|All Parts|Other|0|||
146138670|NCT02566759|527023126|FG005|All Parts|Other|0|||
146138671|NCT02566759|527023127|FG006|All Parts|Other|0|||
146138672|NCT02566759|527023128|FG007|All Parts|Other|0|||
146138673|NCT02566759|527023129|FG008|All Parts|Other|0|||
146270994|NCT03199469|527507908|FG000|Overall Study|Withdrawal by Subject|1|||
146270995|NCT03199469|527507909|FG001|Overall Study|Withdrawal by Subject|0|||
146270996|NCT03199469|527507908|FG000|Overall Study|Death|1|||
146138674|NCT02566759|527023130|FG009|All Parts|Other|0|||
146138675|NCT02566759|527023131|FG010|All Parts|Other|0|||
146138676|NCT02566759|527023132|FG011|All Parts|Other|0|||
146138677|NCT02566759|527023133|FG012|All Parts|Other|0|||
146138678|NCT02566759|527023134|FG013|All Parts|Other|2|||
146138679|NCT02566759|527023135|FG014|All Parts|Other|0|||
146138680|NCT02566759|527023136|FG015|All Parts|Other|0|||
146138681|NCT02566759|527023137|FG016|All Parts|Other|0|||
146138682|NCT02566759|527023121|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146270997|NCT03199469|527507909|FG001|Overall Study|Death|3|||
146270998|NCT03199469|527507908|FG000|Overall Study|Ongoing|5|||
146270999|NCT03199469|527507909|FG001|Overall Study|Ongoing|14|||
146271000|NCT01023958|527507914|FG000|Overall Study|Progressive disease|48|||
146271001|NCT01023958|527507914|FG000|Overall Study|Other adverse event|1|||
146271002|NCT01023958|527507914|FG000|Overall Study|Refused to continue medication|1|||
146271003|NCT01031628|527507915|FG000|Overall Study|Study terminated early|0|||
146271004|NCT01031628|527507916|FG001|Overall Study|Study terminated early|1|||
146271005|NCT01031628|527507917|FG002|Overall Study|Study terminated early|3|||
146271006|NCT01031628|527507918|FG003|Overall Study|Study terminated early|0|||
146271007|NCT03080493|527507919|FG000|Overall Study|Did not provide NRS pain results|1|||
146271008|NCT03080493|527507920|FG001|Overall Study|Did not provide NRS pain results|0|||
146271009|NCT03080493|527507919|FG000|Overall Study|Adverse Event|0|||
146271010|NCT03080493|527507920|FG001|Overall Study|Adverse Event|1|||
146271011|NCT03080493|527507919|FG000|Overall Study|Randomization error (parity group)|0|||
146271012|NCT03080493|527507920|FG001|Overall Study|Randomization error (parity group)|1|||
146271013|NCT00755417|527507922|FG000|Overall Study|Adverse Event|28|||
146271014|NCT00755417|527507923|FG001|Overall Study|Adverse Event|20|||
146271015|NCT00755417|527507924|FG002|Overall Study|Adverse Event|7|||
146271016|NCT00755417|527507922|FG000|Overall Study|Lack of Efficacy|8|||
146271017|NCT00755417|527507923|FG001|Overall Study|Lack of Efficacy|4|||
146271018|NCT00755417|527507924|FG002|Overall Study|Lack of Efficacy|9|||
146271019|NCT00755417|527507922|FG000|Overall Study|Protocol Violation|2|||
146271020|NCT00755417|527507923|FG001|Overall Study|Protocol Violation|1|||
146271021|NCT00755417|527507924|FG002|Overall Study|Protocol Violation|1|||
146271022|NCT00755417|527507922|FG000|Overall Study|Lost to Follow-up|3|||
146271023|NCT00755417|527507923|FG001|Overall Study|Lost to Follow-up|0|||
146271024|NCT00755417|527507924|FG002|Overall Study|Lost to Follow-up|1|||
146271025|NCT00755417|527507922|FG000|Overall Study|Withdrawal by Subject|12|||
146271026|NCT00755417|527507923|FG001|Overall Study|Withdrawal by Subject|12|||
146271027|NCT00755417|527507924|FG002|Overall Study|Withdrawal by Subject|12|||
146271028|NCT00755417|527507922|FG000|Overall Study|Not specified or missing data|9|||
146271029|NCT00755417|527507923|FG001|Overall Study|Not specified or missing data|18|||
146271030|NCT00755417|527507924|FG002|Overall Study|Not specified or missing data|12|||
146271031|NCT02362503|527507926|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
146271032|NCT02362503|527507927|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
146271033|NCT02362503|527507928|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
146271034|NCT02362503|527507926|FG000|Double-blind Period-Up to 8 Days|Death|1|||
146271035|NCT02362503|527507927|FG001|Double-blind Period-Up to 8 Days|Death|0|||
146271036|NCT02362503|527507928|FG002|Double-blind Period-Up to 8 Days|Death|0|||
146271037|NCT02362503|527507926|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
146271038|NCT02362503|527507927|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
146271039|NCT02362503|527507928|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
146271040|NCT02362503|527507926|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
146271041|NCT02362503|527507927|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
146271042|NCT02362503|527507928|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
146271043|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
146271044|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
146271045|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
146271046|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
146271047|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
146271048|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
146271049|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
146271050|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
146271051|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
146271052|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
146271053|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
146271054|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
146271055|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
146271056|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
146304111|NCT03250832|527627481|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
146304112|NCT03250832|527627482|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
146304113|NCT03250832|527627483|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
146271057|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
146304114|NCT03250832|527627484|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
146138683|NCT02566759|527023122|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146271058|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
146271059|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
146271060|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
146271061|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
146271062|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
146271063|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
146271064|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
146271065|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
146271066|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
146271067|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
146271068|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
146271069|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
146271070|NCT02362503|527507926|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
146271071|NCT02362503|527507927|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
146271072|NCT02362503|527507928|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
146271073|NCT02803593|527507929|FG000|Overall Study|Lost to Follow-up|17|||
146271074|NCT02803593|527507930|FG001|Overall Study|Lost to Follow-up|35|||
146271075|NCT05143138|527507931|FG000|Overall Study|Death|5|||
146271076|NCT05143138|527507932|FG001|Overall Study|Death|35|||
146271077|NCT05143138|527507933|FG002|Overall Study|Death|1|||
146271078|NCT05143138|527507931|FG000|Overall Study|Lost to Follow-up|2|||
146271079|NCT05143138|527507932|FG001|Overall Study|Lost to Follow-up|4|||
146271080|NCT05143138|527507933|FG002|Overall Study|Lost to Follow-up|0|||
146271081|NCT05143138|527507931|FG000|Overall Study|withdrawal|1|||
146271082|NCT05143138|527507932|FG001|Overall Study|withdrawal|1|||
146271083|NCT05143138|527507933|FG002|Overall Study|withdrawal|0|||
146271084|NCT04245345|527507944|FG000|Overall Study|Death|1|||
146271085|NCT04245345|527507944|FG000|Overall Study|Exited prior to implant|5|||
146271086|NCT04245345|527507944|FG000|Overall Study|Exited prior to 1-month|9|||
146271087|NCT04245345|527507944|FG000|Overall Study|Missed 1-month visit|3|||
146271088|NCT04245345|527507944|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
146271089|NCT04245345|527507944|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
146271090|NCT01834586|527507945|FG000|Overall Study|Adverse Event|1|||
146271091|NCT03443414|527507946|FG000|Overall Study|Adverse Event|6|||
146271092|NCT03443414|527507947|FG001|Overall Study|Adverse Event|0|||
146271093|NCT03443414|527507948|FG002|Overall Study|Adverse Event|4|||
146271094|NCT03443414|527507949|FG003|Overall Study|Adverse Event|2|||
146271095|NCT03443414|527507950|FG004|Overall Study|Adverse Event|3|||
146271096|NCT03443414|527507946|FG000|Overall Study|Withdrawal by Subject|3|||
146271097|NCT03443414|527507947|FG001|Overall Study|Withdrawal by Subject|2|||
146271098|NCT03443414|527507948|FG002|Overall Study|Withdrawal by Subject|2|||
146271099|NCT03443414|527507949|FG003|Overall Study|Withdrawal by Subject|2|||
146271100|NCT03443414|527507950|FG004|Overall Study|Withdrawal by Subject|1|||
146271101|NCT03443414|527507946|FG000|Overall Study|Death|0|||
146271102|NCT03443414|527507947|FG001|Overall Study|Death|1|||
146271103|NCT03443414|527507948|FG002|Overall Study|Death|0|||
146271104|NCT03443414|527507949|FG003|Overall Study|Death|1|||
146271105|NCT03443414|527507950|FG004|Overall Study|Death|0|||
146271106|NCT03443414|527507946|FG000|Overall Study|Reason not specified|2|||
146271107|NCT03443414|527507947|FG001|Overall Study|Reason not specified|0|||
146271108|NCT03443414|527507948|FG002|Overall Study|Reason not specified|0|||
146271109|NCT03443414|527507949|FG003|Overall Study|Reason not specified|0|||
146271110|NCT03443414|527507950|FG004|Overall Study|Reason not specified|1|||
146271111|NCT03325777|527507951|FG000|Overall Study|Lost to Follow-up|9|||
146271112|NCT03325777|527507952|FG001|Overall Study|Lost to Follow-up|12|||
146271113|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
146271114|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
146271115|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
146271116|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
146271117|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
146271118|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
146271119|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
146271120|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
146271121|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
146271122|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
146271123|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
146271124|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
146271125|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
146271126|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
146271127|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
146271128|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
146271129|NCT04210843|527507954|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
146271130|NCT04210843|527507955|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
146271131|NCT04210843|527507954|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
146271132|NCT04210843|527507955|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
146304115|NCT03250832|527627485|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
146271133|NCT04210843|527507954|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
146271134|NCT04210843|527507955|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
146271135|NCT04210843|527507954|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
146271136|NCT04210843|527507955|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
146271137|NCT04210843|527507954|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
146271138|NCT04210843|527507955|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
146271139|NCT04210843|527507954|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
146271140|NCT04210843|527507955|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
146271141|NCT04210843|527507954|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
146271142|NCT04210843|527507955|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
146271143|NCT04210843|527507954|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
146271144|NCT04210843|527507955|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
146271145|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
146271146|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
146271147|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
146271148|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
146271149|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
146271150|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
146271151|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
146271152|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
146271153|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
146271154|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
146271155|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
146271156|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
146271157|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
146271158|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
146271159|NCT04210843|527507954|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
146271160|NCT04210843|527507955|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
146271161|NCT01099917|527507956|FG000|Overall Study|Adverse Event|3|||
146271162|NCT01099917|527507956|FG000|Overall Study|Not Treated|24|||
146271163|NCT01485120|527507959|FG000|Overall Study|Withdrawal by Subject|2|||
146271164|NCT00422734|527507960|FG000|Overall Study|Physician Decision|1|||
146271165|NCT00422734|527507961|FG001|Overall Study|Physician Decision|1|||
146271166|NCT00422734|527507960|FG000|Overall Study|Protocol Violation|1|||
146271167|NCT00422734|527507961|FG001|Overall Study|Protocol Violation|6|||
146271168|NCT00422734|527507960|FG000|Overall Study|Withdrawal by Subject|12|||
146271169|NCT00422734|527507961|FG001|Overall Study|Withdrawal by Subject|8|||
146271170|NCT00422734|527507960|FG000|Overall Study|Adverse Event|0|||
146271171|NCT00422734|527507961|FG001|Overall Study|Adverse Event|3|||
146271172|NCT00422734|527507960|FG000|Overall Study|Partner Decision|0|||
146271173|NCT00422734|527507961|FG001|Overall Study|Partner Decision|3|||
146271174|NCT02344342|527507962|FG000|Overall Study|Industry partner dropped out|11|||
146271175|NCT02344342|527507963|FG001|Overall Study|Industry partner dropped out|9|||
146271176|NCT02344342|527507964|FG002|Overall Study|Industry partner dropped out|14|||
146271177|NCT02344342|527507965|FG003|Overall Study|Industry partner dropped out|10|||
146271178|NCT00848484|527507966|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
146271179|NCT00848484|527507967|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
146271180|NCT00848484|527507966|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
146271181|NCT00848484|527507967|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
146271182|NCT00848484|527507966|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
146271183|NCT00848484|527507967|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
146271184|NCT00848484|527507966|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
146271185|NCT00848484|527507967|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
146271186|NCT00848484|527507966|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
146271187|NCT00848484|527507967|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
146271188|NCT01081886|527507971|FG000|Overall Study|Study termination|11|||
146271189|NCT01081886|527507972|FG001|Overall Study|Study termination|13|||
146271190|NCT03355209|527507973|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
146138684|NCT02566759|527023123|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138685|NCT02566759|527023124|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146304116|NCT03250832|527627486|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
146138686|NCT02566759|527023125|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146271191|NCT03355209|527507974|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
146271192|NCT03355209|527507975|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
146271193|NCT03355209|527507976|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
146271194|NCT03355209|527507977|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
146271195|NCT03355209|527507978|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
146271196|NCT03355209|527507973|FG000|Part 1: Double-Blind Period|Death|0|||
146271197|NCT03355209|527507974|FG001|Part 1: Double-Blind Period|Death|0|||
146271198|NCT03355209|527507975|FG002|Part 1: Double-Blind Period|Death|1|||
146271199|NCT03355209|527507976|FG003|Part 1: Double-Blind Period|Death|0|||
146304117|NCT03250832|527627475|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146271200|NCT03355209|527507977|FG004|Part 1: Double-Blind Period|Death|0|||
146271201|NCT03355209|527507978|FG005|Part 1: Double-Blind Period|Death|0|||
146271202|NCT03355209|527507973|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
146271203|NCT03355209|527507974|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
146271204|NCT03355209|527507975|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
146271205|NCT03355209|527507976|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
146271206|NCT03355209|527507977|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
146271207|NCT03355209|527507978|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
146271208|NCT03355209|527507973|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146271209|NCT03355209|527507974|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146271210|NCT03355209|527507975|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
146271211|NCT03355209|527507976|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146271212|NCT03355209|527507977|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146271213|NCT03355209|527507978|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
146271214|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
146271215|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
146271216|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
146271217|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
146271218|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
146271219|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
146271220|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146271221|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
146271222|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146271223|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146271224|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146271225|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
146271226|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
146271227|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
146271228|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
146271229|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
146271230|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
146271231|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
146271232|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146271233|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146271234|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
146271235|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
146271236|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
146271237|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
146271238|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
146271239|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
146271240|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
146271241|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146271242|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146271243|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146271244|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146271245|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146271246|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146271247|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
146271248|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
146271249|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
146271250|NCT03355209|527507973|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
146271251|NCT03355209|527507974|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146271252|NCT03355209|527507975|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
146271253|NCT03355209|527507976|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146271254|NCT03355209|527507977|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146271255|NCT03355209|527507978|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
146271256|NCT02567708|527507979|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
146271257|NCT02567708|527507980|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
146271258|NCT02567708|527507979|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
146271259|NCT02567708|527507980|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
146271260|NCT02567708|527507979|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
146271261|NCT02567708|527507980|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
146271262|NCT02567708|527507979|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
146271263|NCT02567708|527507980|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
146271264|NCT00706654|527507981|FG000|Conversion Phase|Lost to Follow-up|4|||
146304118|NCT03250832|527627476|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146138687|NCT02566759|527023126|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138688|NCT02566759|527023127|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138689|NCT02566759|527023128|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138690|NCT02566759|527023129|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138691|NCT02566759|527023130|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138692|NCT02566759|527023131|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138693|NCT02566759|527023132|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138694|NCT02566759|527023133|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138695|NCT02566759|527023134|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138696|NCT02566759|527023135|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138697|NCT02566759|527023136|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
146138698|NCT02566759|527023137|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
146138699|NCT05107128|527023138|FG000|Overall Study|Adverse Event|2|||
146138700|NCT05107128|527023139|FG001|Overall Study|Adverse Event|0|||
146138701|NCT05107128|527023138|FG000|Overall Study|Withdrawal by Subject|3|||
146138702|NCT05107128|527023139|FG001|Overall Study|Withdrawal by Subject|3|||
146138703|NCT05107128|527023138|FG000|Overall Study|Withdrawal of Consent|0|||
146138704|NCT05107128|527023139|FG001|Overall Study|Withdrawal of Consent|1|||
146138705|NCT05107128|527023138|FG000|Overall Study|Reason Not Specified|2|||
146138706|NCT05107128|527023139|FG001|Overall Study|Reason Not Specified|0|||
146138707|NCT05459129|527023142|FG000|Overall Study|Death|1|||
146138708|NCT05459129|527023143|FG001|Overall Study|Death|0|||
146138709|NCT05459129|527023142|FG000|Overall Study|Study Terminated By Sponsor|5|||
146138710|NCT05459129|527023143|FG001|Overall Study|Study Terminated By Sponsor|6|||
146138711|NCT04304001|527023146|FG000|Overall Study|Lost to Follow-up|13|||
146138712|NCT04304001|527023147|FG001|Overall Study|Lost to Follow-up|9|||
146138713|NCT05220397|527023148|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146138714|NCT05220397|527023149|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146138715|NCT05220397|527023150|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
146138716|NCT05220397|527023151|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146138717|NCT05220397|527023152|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
146138718|NCT02052739|527023155|FG000|Overall Study|Withdrew due to Adverse Event|3|||
146138719|NCT02052739|527023156|FG001|Overall Study|Withdrew due to Adverse Event|0|||
146138720|NCT02052739|527023155|FG000|Overall Study|Participant Died|2|||
146138721|NCT02052739|527023156|FG001|Overall Study|Participant Died|1|||
146138722|NCT01573624|527023157|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146138723|NCT01573624|527023158|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146138724|NCT01573624|527023159|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
146138725|NCT01573624|527023160|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146138726|NCT01573624|527023161|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146138727|NCT01573624|527023162|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
146138728|NCT01573624|527023163|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
146138729|NCT01573624|527023157|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
146138730|NCT01573624|527023158|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
146138731|NCT01573624|527023159|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
146138732|NCT01573624|527023160|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146138733|NCT01573624|527023161|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
146138734|NCT01573624|527023162|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
146138735|NCT01573624|527023163|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
146138736|NCT01573624|527023157|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
146138737|NCT01573624|527023158|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138738|NCT01573624|527023159|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138739|NCT01573624|527023160|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138740|NCT01573624|527023161|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138741|NCT01573624|527023162|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138742|NCT01573624|527023163|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
146138743|NCT01573624|527023157|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146138744|NCT01573624|527023158|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146138745|NCT01573624|527023159|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
146138746|NCT01573624|527023160|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146138747|NCT01573624|527023161|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146138748|NCT01573624|527023162|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
146138749|NCT01573624|527023163|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
146138750|NCT01573624|527023157|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146138751|NCT01573624|527023158|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146271265|NCT00706654|527507982|FG001|Conversion Phase|Lost to Follow-up|0|||
146271266|NCT00706654|527507983|FG002|Conversion Phase|Lost to Follow-up|0|||
146271267|NCT00706654|527507984|FG003|Conversion Phase|Lost to Follow-up|0|||
146271268|NCT00706654|527507981|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
146271269|NCT00706654|527507982|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
146271270|NCT00706654|527507983|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
146271271|NCT00706654|527507984|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
146271272|NCT00706654|527507981|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
146271273|NCT00706654|527507982|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
146271274|NCT00706654|527507983|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
146271275|NCT00706654|527507984|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
146271276|NCT00706654|527507981|FG000|Conversion Phase|Withdrawn by Investigator|14|||
146271277|NCT00706654|527507982|FG001|Conversion Phase|Withdrawn by Investigator|0|||
146271278|NCT00706654|527507983|FG002|Conversion Phase|Withdrawn by Investigator|0|||
146271279|NCT00706654|527507984|FG003|Conversion Phase|Withdrawn by Investigator|0|||
146271280|NCT00706654|527507981|FG000|Conversion Phase|Withdrew Consent|38|||
146138752|NCT01573624|527023159|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146138753|NCT01573624|527023160|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146138754|NCT01573624|527023161|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
146138755|NCT01573624|527023162|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146138756|NCT01573624|527023163|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
146138757|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138758|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138759|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138760|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138761|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138762|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
146138763|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
146138764|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146138765|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146138766|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146138767|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146138768|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146138769|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
146138770|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
146138771|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146138772|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146138773|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
146138774|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
146138775|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146138776|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146138777|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
146138778|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138779|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138780|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138781|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138782|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138783|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
146138784|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
146138785|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146138786|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146138787|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146138788|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
146138789|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146138790|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
146138791|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
146138792|NCT01573624|527023157|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138793|NCT01573624|527023158|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146271281|NCT00706654|527507982|FG001|Conversion Phase|Withdrew Consent|0|||
146271282|NCT00706654|527507983|FG002|Conversion Phase|Withdrew Consent|0|||
146271283|NCT00706654|527507984|FG003|Conversion Phase|Withdrew Consent|0|||
146271284|NCT00706654|527507981|FG000|Conversion Phase|Adverse Event|18|||
146271285|NCT00706654|527507982|FG001|Conversion Phase|Adverse Event|0|||
146271286|NCT00706654|527507983|FG002|Conversion Phase|Adverse Event|0|||
146271287|NCT00706654|527507984|FG003|Conversion Phase|Adverse Event|0|||
146271288|NCT00706654|527507981|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
146271289|NCT00706654|527507982|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146271290|NCT00706654|527507983|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146271291|NCT00706654|527507984|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146271292|NCT00706654|527507981|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
146271293|NCT00706654|527507982|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146271294|NCT00706654|527507983|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146271295|NCT00706654|527507984|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146271296|NCT00706654|527507981|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
146271297|NCT00706654|527507982|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
146271298|NCT00706654|527507983|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
146271299|NCT00706654|527507984|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
146271300|NCT00706654|527507981|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
146271301|NCT00706654|527507982|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146271302|NCT00706654|527507983|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146271303|NCT00706654|527507984|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
146271304|NCT00706654|527507981|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
146271305|NCT00706654|527507982|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146271306|NCT00706654|527507983|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146271307|NCT00706654|527507984|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146271308|NCT00706654|527507981|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
146271309|NCT00706654|527507982|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146271310|NCT00706654|527507983|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146271311|NCT00706654|527507984|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146271312|NCT00706654|527507981|FG000|Oral Stabilization Phase|Withdrew consent|55|||
146271313|NCT00706654|527507982|FG001|Oral Stabilization Phase|Withdrew consent|0|||
146271314|NCT00706654|527507983|FG002|Oral Stabilization Phase|Withdrew consent|0|||
146271315|NCT00706654|527507984|FG003|Oral Stabilization Phase|Withdrew consent|0|||
146271316|NCT00706654|527507981|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
146271317|NCT00706654|527507982|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
146271318|NCT00706654|527507983|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
146271319|NCT00706654|527507984|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
146271320|NCT00706654|527507981|FG000|Oral Stabilization Phase|Adverse Event|21|||
146271321|NCT00706654|527507982|FG001|Oral Stabilization Phase|Adverse Event|0|||
146271322|NCT00706654|527507983|FG002|Oral Stabilization Phase|Adverse Event|0|||
146271323|NCT00706654|527507984|FG003|Oral Stabilization Phase|Adverse Event|0|||
146271324|NCT00706654|527507981|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
146271325|NCT00706654|527507982|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146271326|NCT00706654|527507983|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146271327|NCT00706654|527507984|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146271328|NCT00706654|527507981|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
146271329|NCT00706654|527507982|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146271330|NCT00706654|527507983|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146271331|NCT00706654|527507984|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146271332|NCT00706654|527507981|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
146271333|NCT00706654|527507982|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
146271334|NCT00706654|527507983|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
146271335|NCT00706654|527507984|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
146271336|NCT00706654|527507981|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
146271337|NCT00706654|527507982|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
146271338|NCT00706654|527507983|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
146271339|NCT00706654|527507984|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
146271340|NCT00706654|527507981|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
146271341|NCT00706654|527507982|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146271342|NCT00706654|527507983|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
146271343|NCT00706654|527507984|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146271344|NCT00706654|527507981|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
146271345|NCT00706654|527507982|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
146271346|NCT00706654|527507983|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
146271347|NCT00706654|527507984|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
146271348|NCT00706654|527507981|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
146271349|NCT00706654|527507982|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
146271350|NCT00706654|527507983|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
146271351|NCT00706654|527507984|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
146271352|NCT00706654|527507981|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
146271353|NCT00706654|527507982|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
146271354|NCT00706654|527507983|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
146271355|NCT00706654|527507984|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
146271356|NCT00706654|527507981|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
146271357|NCT00706654|527507982|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
146271358|NCT00706654|527507983|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
146271359|NCT00706654|527507984|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
146271360|NCT00706654|527507981|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
146138794|NCT01573624|527023159|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138795|NCT01573624|527023160|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138796|NCT01573624|527023161|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138797|NCT01573624|527023162|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138798|NCT01573624|527023163|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138799|NCT01573624|527023157|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
146138800|NCT01573624|527023158|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
146138801|NCT01573624|527023159|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
146138802|NCT01573624|527023160|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
146138803|NCT01573624|527023161|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
146138804|NCT01573624|527023162|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
146138805|NCT01573624|527023163|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
146138806|NCT01573624|527023157|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146138807|NCT01573624|527023158|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
146138808|NCT01573624|527023159|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146138809|NCT01573624|527023160|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146138810|NCT01573624|527023161|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146138811|NCT01573624|527023162|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
146138812|NCT01573624|527023163|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
146138813|NCT01573624|527023157|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
146138814|NCT01573624|527023158|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138815|NCT01573624|527023159|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138816|NCT01573624|527023160|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138817|NCT01573624|527023161|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138818|NCT01573624|527023162|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138819|NCT01573624|527023163|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
146138820|NCT01573624|527023157|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146138821|NCT01573624|527023158|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146138822|NCT01573624|527023159|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146138823|NCT01573624|527023160|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146138824|NCT01573624|527023161|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146138825|NCT01573624|527023162|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146138826|NCT01573624|527023163|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146138827|NCT01573624|527023157|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
146138828|NCT01573624|527023158|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138829|NCT01573624|527023159|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138830|NCT01573624|527023160|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138831|NCT01573624|527023161|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138832|NCT01573624|527023162|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138833|NCT01573624|527023163|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
146138834|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
146138835|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146138836|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146138837|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146138838|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146138839|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
146138840|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
146138841|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
146138842|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146138843|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146138844|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146138845|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146138846|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
146271361|NCT00706654|527507982|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
146271362|NCT00706654|527507983|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
146271363|NCT00706654|527507984|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
146271364|NCT05262751|527507986|FG000|Washout Period 2|Adverse Event|1|||
146271365|NCT05262751|527507987|FG001|Washout Period 2|Adverse Event|0|||
146138847|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
146138848|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138849|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
146138850|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138851|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138852|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138853|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138854|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
146138855|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138856|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
146138857|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138858|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138859|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138860|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138861|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
146138862|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146138863|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146138864|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146138865|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146138866|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
146138867|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146138868|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
146138869|NCT01573624|527023157|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138870|NCT01573624|527023158|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138871|NCT01573624|527023159|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138872|NCT01573624|527023160|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138873|NCT01573624|527023161|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138874|NCT01573624|527023162|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
146138875|NCT01573624|527023163|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
146138876|NCT01573624|527023157|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
146138877|NCT01573624|527023158|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146138878|NCT01573624|527023159|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146138879|NCT01573624|527023160|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
146138880|NCT01573624|527023161|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146138881|NCT01573624|527023162|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
146138882|NCT01573624|527023163|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
146138883|NCT01573624|527023157|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146138884|NCT01573624|527023158|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
146138885|NCT01573624|527023159|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146138886|NCT01573624|527023160|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146138887|NCT01573624|527023161|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146138888|NCT01573624|527023162|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
146138889|NCT01573624|527023163|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
146138890|NCT01573624|527023157|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
146138891|NCT01573624|527023158|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138892|NCT01573624|527023159|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138893|NCT01573624|527023160|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138894|NCT01573624|527023161|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138895|NCT01573624|527023162|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138896|NCT01573624|527023163|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
146138897|NCT01573624|527023157|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146138898|NCT01573624|527023158|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146138899|NCT01573624|527023159|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146138900|NCT01573624|527023160|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146138901|NCT01573624|527023161|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
146138902|NCT01573624|527023162|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
146138903|NCT01573624|527023163|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
146138904|NCT01573624|527023157|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
146138905|NCT01573624|527023158|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138906|NCT01573624|527023159|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138907|NCT01573624|527023160|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138908|NCT01573624|527023161|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138909|NCT01573624|527023162|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138910|NCT01573624|527023163|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
146138911|NCT05059600|527023164|FG000|Overall Study|Enrolled but not Treated|10|||
146138912|NCT04907032|527023166|FG000|Overall Study|Withdrawal by Subject|7|||
146138913|NCT04907032|527023167|FG001|Overall Study|Withdrawal by Subject|1|||
146138914|NCT02519712|527023169|FG000|Overall Study|Disease Relapse|1|||
146138915|NCT02519712|527023169|FG000|Overall Study|Disease Progression|1|||
146138916|NCT02519712|527023169|FG000|Overall Study|Accruals are donors|2|||
146138917|NCT04847674|527023178|FG000|Overall Study|Withdrawal by Subject|0|||
146138918|NCT04847674|527023179|FG001|Overall Study|Withdrawal by Subject|1|||
146138919|NCT04847674|527023180|FG002|Overall Study|Withdrawal by Subject|0|||
146138920|NCT04847674|527023178|FG000|Overall Study|Lost to Follow-up|0|||
146138921|NCT04847674|527023179|FG001|Overall Study|Lost to Follow-up|0|||
146138922|NCT04847674|527023180|FG002|Overall Study|Lost to Follow-up|2|||
146138923|NCT04847674|527023178|FG000|Overall Study|Other than specified|21|||
146138924|NCT04847674|527023179|FG001|Overall Study|Other than specified|20|||
146138925|NCT04847674|527023180|FG002|Overall Study|Other than specified|20|||
146138926|NCT02705820|527023181|FG000|Overall Study|Death|2|||
146138927|NCT02705820|527023181|FG000|Overall Study|Disease Progression|34|||
146138928|NCT02705820|527023181|FG000|Overall Study|Clinical Deterioration|3|||
146138929|NCT00677807|527023184|FG000|Overall Study|Adverse Event|4|||
146138930|NCT00677807|527023185|FG001|Overall Study|Adverse Event|1|||
146138931|NCT00677807|527023186|FG002|Overall Study|Adverse Event|6|||
146138932|NCT00677807|527023184|FG000|Overall Study|Lack of Efficacy|0|||
146138933|NCT00677807|527023185|FG001|Overall Study|Lack of Efficacy|0|||
146138934|NCT00677807|527023186|FG002|Overall Study|Lack of Efficacy|2|||
146138935|NCT00677807|527023184|FG000|Overall Study|Participant no longer needs study drug|0|||
146138936|NCT00677807|527023185|FG001|Overall Study|Participant no longer needs study drug|0|||
146138937|NCT00677807|527023186|FG002|Overall Study|Participant no longer needs study drug|1|||
146138938|NCT00677807|527023184|FG000|Overall Study|Withdrawal by Subject|10|||
146138939|NCT00677807|527023185|FG001|Overall Study|Withdrawal by Subject|3|||
146138940|NCT00677807|527023186|FG002|Overall Study|Withdrawal by Subject|6|||
146138941|NCT00677807|527023184|FG000|Overall Study|Lost to Follow-up|2|||
146138942|NCT00677807|527023185|FG001|Overall Study|Lost to Follow-up|2|||
146138943|NCT00677807|527023186|FG002|Overall Study|Lost to Follow-up|2|||
146138944|NCT00677807|527023184|FG000|Overall Study|Administrative problems|1|||
146138945|NCT00677807|527023185|FG001|Overall Study|Administrative problems|1|||
146138946|NCT00677807|527023186|FG002|Overall Study|Administrative problems|2|||
146138947|NCT00677807|527023184|FG000|Overall Study|Death|0|||
146138948|NCT00677807|527023185|FG001|Overall Study|Death|1|||
146138949|NCT00677807|527023186|FG002|Overall Study|Death|1|||
146138950|NCT00677807|527023184|FG000|Overall Study|Protocol Deviation|1|||
146138951|NCT00677807|527023185|FG001|Overall Study|Protocol Deviation|3|||
146138952|NCT00677807|527023186|FG002|Overall Study|Protocol Deviation|0|||
146138953|NCT01524770|527023191|FG000|First Intervention|Withdrawal by Subject|1|||
146138954|NCT01524770|527023192|FG001|First Intervention|Withdrawal by Subject|0|||
146138955|NCT01524770|527023191|FG000|First Intervention|Adverse Event|1|||
146138956|NCT01524770|527023192|FG001|First Intervention|Adverse Event|1|||
146138957|NCT01524770|527023191|FG000|First Intervention|Protocol Violation|1|||
146138958|NCT01524770|527023192|FG001|First Intervention|Protocol Violation|0|||
146138959|NCT00989833|527023194|FG000|Overall Study|Lost to Follow-up|0|||
146138960|NCT00989833|527023195|FG001|Overall Study|Lost to Follow-up|1|||
146138961|NCT00989833|527023196|FG002|Overall Study|Lost to Follow-up|0|||
146138962|NCT00989833|527023194|FG000|Overall Study|Protocol Violation|1|||
146138963|NCT00989833|527023195|FG001|Overall Study|Protocol Violation|2|||
146138964|NCT00989833|527023196|FG002|Overall Study|Protocol Violation|1|||
146138965|NCT00989833|527023194|FG000|Overall Study|Withdrawal by Subject|0|||
146138966|NCT00989833|527023195|FG001|Overall Study|Withdrawal by Subject|0|||
146138967|NCT00989833|527023196|FG002|Overall Study|Withdrawal by Subject|1|||
146138968|NCT00989833|527023194|FG000|Overall Study|Incorrectly randomized|1|||
146138969|NCT00989833|527023195|FG001|Overall Study|Incorrectly randomized|0|||
146138970|NCT00989833|527023196|FG002|Overall Study|Incorrectly randomized|0|||
146138971|NCT02167256|527023197|FG000|Overall Study|Adverse Event|13|||
146138972|NCT02167256|527023198|FG001|Overall Study|Adverse Event|6|||
146138973|NCT02167256|527023197|FG000|Overall Study|Withdrawal by Subject|4|||
146138974|NCT02167256|527023198|FG001|Overall Study|Withdrawal by Subject|4|||
146138975|NCT02167256|527023197|FG000|Overall Study|non-compliance|3|||
146138976|NCT02167256|527023198|FG001|Overall Study|non-compliance|0|||
146138977|NCT02167256|527023197|FG000|Overall Study|Study partner unable to participate|1|||
146271366|NCT05262751|527507988|FG002|Washout Period 2|Adverse Event|0|||
146138978|NCT02167256|527023198|FG001|Overall Study|Study partner unable to participate|0|||
146138979|NCT00414388|527023199|FG000|Overall Study|Adverse Event|1|||
146138980|NCT03467425|527023200|FG000|Overall Study|Adverse Event|9|||
146138981|NCT03467425|527023201|FG001|Overall Study|Adverse Event|9|||
146138982|NCT03467425|527023200|FG000|Overall Study|Lack of Efficacy|3|||
146138983|NCT03467425|527023201|FG001|Overall Study|Lack of Efficacy|1|||
146138984|NCT03467425|527023200|FG000|Overall Study|Protocol Violation|0|||
146138985|NCT03467425|527023201|FG001|Overall Study|Protocol Violation|1|||
146138986|NCT03467425|527023200|FG000|Overall Study|Lost to Follow-up|18|||
146138987|NCT03467425|527023201|FG001|Overall Study|Lost to Follow-up|25|||
146138988|NCT03467425|527023200|FG000|Overall Study|Physician Decision|2|||
146138989|NCT03467425|527023201|FG001|Overall Study|Physician Decision|1|||
146138990|NCT03467425|527023200|FG000|Overall Study|Withdrawal by Subject|15|||
146138991|NCT03467425|527023201|FG001|Overall Study|Withdrawal by Subject|17|||
146138992|NCT01864291|527023202|FG000|Overall Study|need for revision surgery|2|||
146138993|NCT03091192|527023209|FG000|Overall Study|Study terminated by sponsor|21|||
146138994|NCT03091192|527023210|FG001|Overall Study|Study terminated by sponsor|14|||
146138995|NCT03091192|527023209|FG000|Overall Study|Death|9|||
146138996|NCT03091192|527023210|FG001|Overall Study|Death|13|||
146138997|NCT03091192|527023209|FG000|Overall Study|Withdrawal by Subject|2|||
146138998|NCT03091192|527023210|FG001|Overall Study|Withdrawal by Subject|0|||
146138999|NCT03091192|527023209|FG000|Overall Study|Lost to Follow-up|1|||
146139000|NCT03091192|527023210|FG001|Overall Study|Lost to Follow-up|0|||
146139001|NCT03548584|527024503|FG000|Overall Study|Lost to Follow-up|0|||
146139002|NCT03548584|527024504|FG001|Overall Study|Lost to Follow-up|0|||
146139003|NCT03548584|527024505|FG002|Overall Study|Lost to Follow-up|1|||
146139004|NCT03548584|527024503|FG000|Overall Study|Adverse Event|1|||
146139005|NCT03548584|527024504|FG001|Overall Study|Adverse Event|11|||
146139006|NCT03548584|527024505|FG002|Overall Study|Adverse Event|5|||
146139007|NCT03548584|527024503|FG000|Overall Study|Site Terminated by Sponsor|1|||
146139008|NCT03548584|527024504|FG001|Overall Study|Site Terminated by Sponsor|3|||
146139009|NCT03548584|527024505|FG002|Overall Study|Site Terminated by Sponsor|2|||
146139010|NCT03548584|527024503|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
146139011|NCT03548584|527024504|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
146139012|NCT03548584|527024505|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
146139013|NCT03548584|527024503|FG000|Overall Study|Lack of Efficacy|0|||
146139014|NCT03548584|527024504|FG001|Overall Study|Lack of Efficacy|1|||
146139015|NCT03548584|527024505|FG002|Overall Study|Lack of Efficacy|0|||
146139016|NCT03548584|527024503|FG000|Overall Study|Non-compliance with Study Drug|0|||
146139017|NCT03548584|527024504|FG001|Overall Study|Non-compliance with Study Drug|1|||
146139018|NCT03548584|527024505|FG002|Overall Study|Non-compliance with Study Drug|0|||
146139019|NCT03548584|527024503|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
146139020|NCT03548584|527024504|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
146139021|NCT03548584|527024505|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
146139022|NCT00533949|527024506|FG000|Overall Study|Protocol Violation|12|||
146139023|NCT00533949|527024507|FG001|Overall Study|Protocol Violation|12|||
146139024|NCT00533949|527024508|FG002|Overall Study|Protocol Violation|9|||
146139025|NCT00533949|527024509|FG003|Overall Study|Protocol Violation|9|||
146139026|NCT00533949|527024506|FG000|Overall Study|Withdrawal by Subject|3|||
146139027|NCT00533949|527024507|FG001|Overall Study|Withdrawal by Subject|2|||
146139028|NCT00533949|527024508|FG002|Overall Study|Withdrawal by Subject|1|||
146139029|NCT00533949|527024509|FG003|Overall Study|Withdrawal by Subject|1|||
146139030|NCT00727194|527024510|FG000|Screening Period|Low QMG scores|0|||
146139031|NCT00727194|527024511|FG001|Screening Period|Low QMG scores|0|||
146139032|NCT00727194|527024512|FG002|Screening Period|Low QMG scores|6|||
146139033|NCT00727194|527024510|FG000|Screening Period|Lacked AChR antibodies|0|||
146139034|NCT00727194|527024511|FG001|Screening Period|Lacked AChR antibodies|0|||
146139035|NCT00727194|527024512|FG002|Screening Period|Lacked AChR antibodies|5|||
146139036|NCT00727194|527024510|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
146139037|NCT00727194|527024511|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
146139038|NCT00727194|527024512|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
146139039|NCT00727194|527024510|FG000|Screening Period|Severe infections|0|||
146139040|NCT00727194|527024511|FG001|Screening Period|Severe infections|0|||
146139041|NCT00727194|527024512|FG002|Screening Period|Severe infections|2|||
146271367|NCT05262751|527507989|FG003|Washout Period 2|Adverse Event|0|||
146271368|NCT05262751|527507990|FG004|Washout Period 2|Adverse Event|0|||
146271369|NCT05262751|527507991|FG005|Washout Period 2|Adverse Event|0|||
146271370|NCT05262751|527507986|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
146271371|NCT05262751|527507987|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
146271372|NCT05262751|527507988|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
146271373|NCT05262751|527507989|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
146139042|NCT00727194|527024510|FG000|Screening Period|History of thymoma|0|||
146139043|NCT00727194|527024511|FG001|Screening Period|History of thymoma|0|||
146139044|NCT00727194|527024512|FG002|Screening Period|History of thymoma|1|||
146139045|NCT00727194|527024510|FG000|Treatment Period 2|Lack of Efficacy|0|||
146139046|NCT00727194|527024511|FG001|Treatment Period 2|Lack of Efficacy|1|||
146139047|NCT00727194|527024512|FG002|Treatment Period 2|Lack of Efficacy|0|||
146139048|NCT04269161|527024513|FG000|Overall Study|Change of modality and no longer eligible|3|||
146139049|NCT04269161|527024514|FG001|Overall Study|Change of modality and no longer eligible|3|||
146139050|NCT04269161|527024513|FG000|Overall Study|Required procedure outside of NICU|1|||
146139051|NCT04269161|527024514|FG001|Overall Study|Required procedure outside of NICU|0|||
146139052|NCT04269161|527024513|FG000|Overall Study|Equipment issue|1|||
146139053|NCT04269161|527024514|FG001|Overall Study|Equipment issue|1|||
146139054|NCT01677195|527024515|FG000|Overall Study|Lost to Follow-up|14|||
146139055|NCT01677195|527024516|FG001|Overall Study|Lost to Follow-up|22|||
146139056|NCT01677195|527024517|FG002|Overall Study|Lost to Follow-up|22|||
146139057|NCT01677195|527024515|FG000|Overall Study|Withdrawal by Subject|1|||
146139058|NCT01677195|527024516|FG001|Overall Study|Withdrawal by Subject|0|||
146139059|NCT01677195|527024517|FG002|Overall Study|Withdrawal by Subject|1|||
146139060|NCT01677195|527024515|FG000|Overall Study|Adverse Event|6|||
146139061|NCT01677195|527024516|FG001|Overall Study|Adverse Event|4|||
146139062|NCT01677195|527024517|FG002|Overall Study|Adverse Event|1|||
146139063|NCT01677195|527024515|FG000|Overall Study|Physician Decision|1|||
146139064|NCT01677195|527024516|FG001|Overall Study|Physician Decision|2|||
146139065|NCT01677195|527024517|FG002|Overall Study|Physician Decision|2|||
146139066|NCT01677195|527024515|FG000|Overall Study|Pregnancy|0|||
146139067|NCT01677195|527024516|FG001|Overall Study|Pregnancy|1|||
146139068|NCT01677195|527024517|FG002|Overall Study|Pregnancy|0|||
146139069|NCT01677195|527024515|FG000|Overall Study|Protocol Violation|7|||
146139070|NCT01677195|527024516|FG001|Overall Study|Protocol Violation|3|||
146139071|NCT01677195|527024517|FG002|Overall Study|Protocol Violation|4|||
146139072|NCT04368429|527024518|FG000|Overall Study|Adverse Event|1|||
146139073|NCT04368429|527024519|FG001|Overall Study|Adverse Event|0|||
146139074|NCT03633396|527024522|FG000|Overall Study|Withdrawal by Subject|4|||
146139075|NCT03633396|527024523|FG001|Overall Study|Withdrawal by Subject|4|||
146139076|NCT03633396|527024522|FG000|Overall Study|Adverse Event|1|||
146139077|NCT03633396|527024523|FG001|Overall Study|Adverse Event|1|||
146139078|NCT03633396|527024522|FG000|Overall Study|Lack of Efficacy|1|||
146139079|NCT03633396|527024523|FG001|Overall Study|Lack of Efficacy|0|||
146139080|NCT03633396|527024522|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
146139081|NCT03633396|527024523|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
146139082|NCT01012817|527024524|FG000|Overall Study|Withdrawal by Subject|0|||
146139083|NCT01012817|527024525|FG001|Overall Study|Withdrawal by Subject|0|||
146139084|NCT01012817|527024526|FG002|Overall Study|Withdrawal by Subject|0|||
146139085|NCT01012817|527024527|FG003|Overall Study|Withdrawal by Subject|1|||
146139086|NCT01012817|527024528|FG004|Overall Study|Withdrawal by Subject|0|||
146139087|NCT01012817|527024529|FG005|Overall Study|Withdrawal by Subject|0|||
146139088|NCT01012817|527024530|FG006|Overall Study|Withdrawal by Subject|0|||
146139089|NCT01012817|527024531|FG007|Overall Study|Withdrawal by Subject|1|||
146139090|NCT01012817|527024532|FG008|Overall Study|Withdrawal by Subject|0|||
146139091|NCT01012817|527024533|FG009|Overall Study|Withdrawal by Subject|0|||
146139092|NCT01012817|527024534|FG010|Overall Study|Withdrawal by Subject|1|||
146139093|NCT01012817|527024535|FG011|Overall Study|Withdrawal by Subject|1|||
146139094|NCT01012817|527024536|FG012|Overall Study|Withdrawal by Subject|0|||
146139095|NCT01012817|527024537|FG013|Overall Study|Withdrawal by Subject|1|||
146139096|NCT01012817|527024524|FG000|Overall Study|Adverse Event|0|||
146139097|NCT01012817|527024525|FG001|Overall Study|Adverse Event|0|||
146139098|NCT01012817|527024526|FG002|Overall Study|Adverse Event|0|||
146139099|NCT01012817|527024527|FG003|Overall Study|Adverse Event|0|||
146139100|NCT01012817|527024528|FG004|Overall Study|Adverse Event|0|||
146139101|NCT01012817|527024529|FG005|Overall Study|Adverse Event|1|||
146139102|NCT01012817|527024530|FG006|Overall Study|Adverse Event|0|||
146139103|NCT01012817|527024531|FG007|Overall Study|Adverse Event|0|||
146139104|NCT01012817|527024532|FG008|Overall Study|Adverse Event|0|||
146139105|NCT01012817|527024533|FG009|Overall Study|Adverse Event|0|||
146139106|NCT01012817|527024534|FG010|Overall Study|Adverse Event|1|||
146139107|NCT01012817|527024535|FG011|Overall Study|Adverse Event|0|||
146139108|NCT01012817|527024536|FG012|Overall Study|Adverse Event|0|||
146139109|NCT01012817|527024537|FG013|Overall Study|Adverse Event|1|||
146139110|NCT02472756|527024538|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
146139111|NCT02472756|527024538|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
146139112|NCT02472756|527024538|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
146139113|NCT02472756|527024538|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
146139114|NCT02472756|527024538|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
146139115|NCT02143414|527024539|FG000|Induction|Adverse Event|1|||
146139116|NCT02143414|527024540|FG001|Induction|Adverse Event|2|||
146139117|NCT02143414|527024539|FG000|Induction|Death|1|||
146139118|NCT02143414|527024540|FG001|Induction|Death|2|||
146139119|NCT02143414|527024539|FG000|Induction|Patient refusal|1|||
146139120|NCT02143414|527024540|FG001|Induction|Patient refusal|1|||
146139121|NCT02143414|527024539|FG000|Induction|Refractory|1|||
146139122|NCT02143414|527024540|FG001|Induction|Refractory|0|||
146139123|NCT02143414|527024539|FG000|Induction|Began alternative treatment|1|||
146139124|NCT02143414|527024540|FG001|Induction|Began alternative treatment|0|||
146139125|NCT02143414|527024539|FG000|Induction|Ineligible for postremission|5|||
146139126|NCT02143414|527024540|FG001|Induction|Ineligible for postremission|1|||
146271374|NCT05262751|527507990|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
146139127|NCT02143414|527024539|FG000|Post-remission|Adverse Event|0|||
146139128|NCT02143414|527024540|FG001|Post-remission|Adverse Event|2|||
146139129|NCT02143414|527024539|FG000|Post-remission|Disease progression/relapse|5|||
146139130|NCT02143414|527024540|FG001|Post-remission|Disease progression/relapse|0|||
146139131|NCT02143414|527024539|FG000|Maintenance|Adverse Event|4|||
146139132|NCT02143414|527024540|FG001|Maintenance|Adverse Event|6|||
146139133|NCT02143414|527024539|FG000|Maintenance|Disease progression/relapse|3|||
146139134|NCT02143414|527024540|FG001|Maintenance|Disease progression/relapse|2|||
146139135|NCT02143414|527024539|FG000|Maintenance|Patient refusal|2|||
146139136|NCT02143414|527024540|FG001|Maintenance|Patient refusal|1|||
146139137|NCT02143414|527024539|FG000|Maintenance|Physician Decision|1|||
146139138|NCT02143414|527024540|FG001|Maintenance|Physician Decision|0|||
146139139|NCT02143414|527024539|FG000|Maintenance|Death|0|||
146139140|NCT02143414|527024540|FG001|Maintenance|Death|1|||
146139141|NCT02143414|527024539|FG000|Maintenance|On protocol treatment|0|||
146139142|NCT02143414|527024540|FG001|Maintenance|On protocol treatment|6|||
146139143|NCT00110266|527024544|FG000|Overall Study|Adverse Event|27|||
146139144|NCT00110266|527024544|FG000|Overall Study|Abnormal laboratory value|15|||
146139145|NCT00110266|527024544|FG000|Overall Study|Withdrawal by Subject|16|||
146139146|NCT00110266|527024544|FG000|Overall Study|Death|17|||
146139147|NCT00110266|527024544|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146139148|NCT00110266|527024544|FG000|Overall Study|Participant condition no longer requires study drug|1|||
146139149|NCT00978731|527024545|FG000|Overall Study|Death|4|||
146139150|NCT00978731|527024546|FG001|Overall Study|Death|1|||
146139151|NCT00978731|527024547|FG002|Overall Study|Death|1|||
146139152|NCT00978731|527024548|FG003|Overall Study|Death|0|||
146139153|NCT00978731|527024545|FG000|Overall Study|Lost to Follow-up|0|||
146139154|NCT00978731|527024546|FG001|Overall Study|Lost to Follow-up|0|||
146139155|NCT00978731|527024547|FG002|Overall Study|Lost to Follow-up|0|||
146139156|NCT00978731|527024548|FG003|Overall Study|Lost to Follow-up|1|||
146139157|NCT00978731|527024545|FG000|Overall Study|Adverse Event|5|||
146139158|NCT00978731|527024546|FG001|Overall Study|Adverse Event|2|||
146139159|NCT00978731|527024547|FG002|Overall Study|Adverse Event|0|||
146139160|NCT00978731|527024548|FG003|Overall Study|Adverse Event|0|||
146139161|NCT00978731|527024545|FG000|Overall Study|Participant's request|1|||
146139162|NCT00978731|527024546|FG001|Overall Study|Participant's request|0|||
146139163|NCT00978731|527024547|FG002|Overall Study|Participant's request|0|||
146139164|NCT00978731|527024548|FG003|Overall Study|Participant's request|0|||
146139165|NCT00978731|527024545|FG000|Overall Study|Administrative reason|3|||
146139166|NCT00978731|527024546|FG001|Overall Study|Administrative reason|3|||
146139167|NCT00978731|527024547|FG002|Overall Study|Administrative reason|1|||
146139168|NCT00978731|527024548|FG003|Overall Study|Administrative reason|0|||
146139169|NCT00978731|527024545|FG000|Overall Study|Deterioration without progression|0|||
146139170|NCT00978731|527024546|FG001|Overall Study|Deterioration without progression|1|||
146139171|NCT00978731|527024547|FG002|Overall Study|Deterioration without progression|0|||
146139172|NCT00978731|527024548|FG003|Overall Study|Deterioration without progression|0|||
146139173|NCT00978731|527024545|FG000|Overall Study|Disease progression/relapse|5|||
146139174|NCT00978731|527024546|FG001|Overall Study|Disease progression/relapse|4|||
146139175|NCT00978731|527024547|FG002|Overall Study|Disease progression/relapse|2|||
146139176|NCT00978731|527024548|FG003|Overall Study|Disease progression/relapse|2|||
146139177|NCT00978731|527024545|FG000|Overall Study|Study closure|3|||
146139178|NCT00978731|527024546|FG001|Overall Study|Study closure|4|||
146139179|NCT00978731|527024547|FG002|Overall Study|Study closure|1|||
146139180|NCT00978731|527024548|FG003|Overall Study|Study closure|1|||
146139181|NCT00978731|527024545|FG000|Overall Study|No response|1|||
146139182|NCT00978731|527024546|FG001|Overall Study|No response|0|||
146139183|NCT00978731|527024547|FG002|Overall Study|No response|0|||
146139184|NCT00978731|527024548|FG003|Overall Study|No response|0|||
146139185|NCT03285646|527024563|FG000|Overall Study|Adverse Event|1|||
146139186|NCT03285646|527024564|FG001|Overall Study|Adverse Event|0|||
146139187|NCT03285646|527024563|FG000|Overall Study|Withdrawal by Subject|10|||
146139188|NCT03285646|527024564|FG001|Overall Study|Withdrawal by Subject|2|||
146139189|NCT03285646|527024563|FG000|Overall Study|Lost to Follow-up|2|||
146139190|NCT03285646|527024564|FG001|Overall Study|Lost to Follow-up|1|||
146139191|NCT03285646|527024563|FG000|Overall Study|Investigator/Sponsor Decision|0|||
146139192|NCT03285646|527024564|FG001|Overall Study|Investigator/Sponsor Decision|1|||
146139193|NCT00548808|527024565|FG000|Overall Study|Lost to Follow-up|9|||
146139194|NCT00548808|527024566|FG001|Overall Study|Lost to Follow-up|3|||
146139195|NCT00548808|527024565|FG000|Overall Study|Protocol Violation|8|||
146139196|NCT00548808|527024566|FG001|Overall Study|Protocol Violation|8|||
146139197|NCT00548808|527024565|FG000|Overall Study|Withdrawal by Subject|8|||
146139198|NCT00548808|527024566|FG001|Overall Study|Withdrawal by Subject|4|||
146139199|NCT00548808|527024565|FG000|Overall Study|Physician Decision|6|||
146139200|NCT00548808|527024566|FG001|Overall Study|Physician Decision|3|||
146139201|NCT00548808|527024565|FG000|Overall Study|Adverse Event|4|||
146139202|NCT00548808|527024566|FG001|Overall Study|Adverse Event|5|||
146139203|NCT00548808|527024565|FG000|Overall Study|Death|2|||
146139204|NCT00548808|527024566|FG001|Overall Study|Death|0|||
146139205|NCT00548808|527024565|FG000|Overall Study|Entry Criteria Not Met|2|||
146139206|NCT00548808|527024566|FG001|Overall Study|Entry Criteria Not Met|2|||
146139207|NCT00548808|527024565|FG000|Overall Study|Lack of Efficacy|2|||
146139208|NCT00548808|527024566|FG001|Overall Study|Lack of Efficacy|0|||
146139209|NCT00548808|527024565|FG000|Overall Study|Sponsor Decision|1|||
146139210|NCT00548808|527024566|FG001|Overall Study|Sponsor Decision|1|||
146139211|NCT05044234|527024568|FG000|Overall Study|Lost to Follow-up|2|||
146139212|NCT05044234|527024569|FG001|Overall Study|Lost to Follow-up|1|||
146139213|NCT05044234|527024570|FG002|Overall Study|Lost to Follow-up|1|||
146139214|NCT05044234|527024571|FG003|Overall Study|Lost to Follow-up|2|||
146139215|NCT05044234|527024568|FG000|Overall Study|Withdrawal by Subject|6|||
146139216|NCT05044234|527024569|FG001|Overall Study|Withdrawal by Subject|4|||
146139217|NCT05044234|527024570|FG002|Overall Study|Withdrawal by Subject|5|||
146139218|NCT05044234|527024571|FG003|Overall Study|Withdrawal by Subject|8|||
146139219|NCT05044234|527024568|FG000|Overall Study|Study terminated by Sponsor|21|||
146139220|NCT05044234|527024569|FG001|Overall Study|Study terminated by Sponsor|21|||
146139221|NCT05044234|527024570|FG002|Overall Study|Study terminated by Sponsor|20|||
146139222|NCT05044234|527024571|FG003|Overall Study|Study terminated by Sponsor|14|||
146139223|NCT05044234|527024568|FG000|Overall Study|Other, not specified|0|||
146139224|NCT05044234|527024569|FG001|Overall Study|Other, not specified|0|||
146139225|NCT05044234|527024570|FG002|Overall Study|Other, not specified|1|||
146139226|NCT05044234|527024571|FG003|Overall Study|Other, not specified|2|||
146139227|NCT05044234|527024568|FG000|Overall Study|Delayed data entry|0|||
146139228|NCT05044234|527024569|FG001|Overall Study|Delayed data entry|0|||
146139229|NCT05044234|527024570|FG002|Overall Study|Delayed data entry|0|||
146139230|NCT05044234|527024571|FG003|Overall Study|Delayed data entry|1|||
146139231|NCT00279708|527024572|FG000|Overall Study|Withdrawal by Subject|2|||
146139232|NCT00279708|527024573|FG001|Overall Study|Withdrawal by Subject|3|||
146139233|NCT00279708|527024572|FG000|Overall Study|Adverse Event|1|||
146139234|NCT00279708|527024573|FG001|Overall Study|Adverse Event|1|||
146139235|NCT02940691|527024574|FG000|Overall Study|Lost to Follow-up|5|||
146139236|NCT02940691|527024574|FG000|Overall Study|Incarceration|1|||
146139237|NCT01023659|527024575|FG000|Overall Study|Lost to Follow-up|73|||
146139238|NCT01023659|527024576|FG001|Overall Study|Lost to Follow-up|228|||
146139239|NCT01023659|527024577|FG002|Overall Study|Lost to Follow-up|99|||
146139240|NCT04879745|527024578|FG000|Overall Study|Lost to Follow-up|4|||
146271375|NCT05262751|527507991|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
146271376|NCT01754753|527507994|FG000|Overall Study|Study close|43|||
146271377|NCT01754753|527507995|FG001|Overall Study|Study close|44|||
146271378|NCT01754753|527507994|FG000|Overall Study|Lost to Follow-up|9|||
146271379|NCT01754753|527507995|FG001|Overall Study|Lost to Follow-up|5|||
146271380|NCT00760747|527507998|FG000|Study Period II|Adverse Event|3|||
146271381|NCT00760747|527507999|FG001|Study Period II|Adverse Event|4|||
146271382|NCT00760747|527507998|FG000|Study Period II|Lack of Efficacy|0|||
146271383|NCT00760747|527507999|FG001|Study Period II|Lack of Efficacy|6|||
146271384|NCT00760747|527507998|FG000|Study Period II|Parent/Caregiver Decision|3|||
146271385|NCT00760747|527507999|FG001|Study Period II|Parent/Caregiver Decision|0|||
146271386|NCT00760747|527507998|FG000|Study Period II|Protocol Violation|6|||
146271387|NCT00760747|527507999|FG001|Study Period II|Protocol Violation|3|||
146271388|NCT00760747|527507998|FG000|Study Period II|Withdrawal by Subject|1|||
146271389|NCT00760747|527507999|FG001|Study Period II|Withdrawal by Subject|0|||
146271390|NCT00760747|527507998|FG000|Study Period II|No drug administered|0|||
146271391|NCT00760747|527507999|FG001|Study Period II|No drug administered|1|||
146271392|NCT00760747|527507998|FG000|Study Period III|Adverse Event|1|||
146271393|NCT00760747|527507999|FG001|Study Period III|Adverse Event|0|||
146271394|NCT00760747|527507998|FG000|Study Period III|Lack of Efficacy|1|||
146271395|NCT00760747|527507999|FG001|Study Period III|Lack of Efficacy|0|||
146271396|NCT00760747|527507998|FG000|Study Period III|Parent/Caregiver Decision|0|||
146271397|NCT00760747|527507999|FG001|Study Period III|Parent/Caregiver Decision|1|||
146304119|NCT03250832|527627477|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146304120|NCT03250832|527627478|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146139241|NCT04879745|527024579|FG001|Overall Study|Lost to Follow-up|1|||
146139242|NCT01126541|527024581|FG000|Overall Study|Adverse Event|0|||
146139243|NCT01126541|527024582|FG001|Overall Study|Adverse Event|2|||
146139244|NCT01126541|527024583|FG002|Overall Study|Adverse Event|4|||
146139245|NCT01126541|527024581|FG000|Overall Study|Death|0|||
146139246|NCT01126541|527024582|FG001|Overall Study|Death|1|||
146271398|NCT00760747|527507998|FG000|Study Period III|Protocol Violation|1|||
146271399|NCT00760747|527507999|FG001|Study Period III|Protocol Violation|1|||
146271400|NCT00760747|527507998|FG000|Study Period III|Physician Decision|0|||
146271401|NCT00760747|527507999|FG001|Study Period III|Physician Decision|1|||
146271402|NCT00844597|527508000|FG000|Overall Study|Adverse Event|0|||
146271403|NCT00844597|527508001|FG001|Overall Study|Adverse Event|0|||
146139247|NCT01126541|527024583|FG002|Overall Study|Death|0|||
146139248|NCT01126541|527024581|FG000|Overall Study|Lack of Efficacy|6|||
146139249|NCT01126541|527024582|FG001|Overall Study|Lack of Efficacy|1|||
146139250|NCT01126541|527024583|FG002|Overall Study|Lack of Efficacy|11|||
146139251|NCT01126541|527024581|FG000|Overall Study|Lost to Follow-up|1|||
146139252|NCT01126541|527024582|FG001|Overall Study|Lost to Follow-up|2|||
146139253|NCT01126541|527024583|FG002|Overall Study|Lost to Follow-up|2|||
146139254|NCT01126541|527024581|FG000|Overall Study|Withdrawal by Subject|2|||
146271404|NCT00844597|527508002|FG002|Overall Study|Adverse Event|0|||
146139255|NCT01126541|527024582|FG001|Overall Study|Withdrawal by Subject|5|||
146139256|NCT01126541|527024583|FG002|Overall Study|Withdrawal by Subject|6|||
146139257|NCT01126541|527024581|FG000|Overall Study|Protocol Violation|0|||
146139258|NCT01126541|527024582|FG001|Overall Study|Protocol Violation|0|||
146139259|NCT01126541|527024583|FG002|Overall Study|Protocol Violation|1|||
146139260|NCT01126541|527024581|FG000|Overall Study|Administrative reason or other|1|||
146139261|NCT01126541|527024582|FG001|Overall Study|Administrative reason or other|1|||
146304121|NCT03250832|527627479|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146139262|NCT01126541|527024583|FG002|Overall Study|Administrative reason or other|2|||
146139263|NCT03670810|527024584|FG000|Main Study|Adverse Event|37|||
146139264|NCT03670810|527024585|FG001|Main Study|Adverse Event|38|||
146139265|NCT03670810|527024586|FG002|Main Study|Adverse Event|3|||
146139266|NCT03670810|527024587|FG003|Main Study|Adverse Event|4|||
146139267|NCT03670810|527024588|FG004|Main Study|Adverse Event|4|||
146139268|NCT03670810|527024589|FG005|Main Study|Adverse Event|5|||
146139269|NCT03670810|527024590|FG006|Main Study|Adverse Event|0|||
146139270|NCT03670810|527024591|FG007|Main Study|Adverse Event|0|||
146139271|NCT03670810|527024592|FG008|Main Study|Adverse Event|0|||
146139272|NCT03670810|527024584|FG000|Main Study|Lack of Efficacy|8|||
146139273|NCT03670810|527024585|FG001|Main Study|Lack of Efficacy|9|||
146139274|NCT03670810|527024586|FG002|Main Study|Lack of Efficacy|3|||
146139275|NCT03670810|527024587|FG003|Main Study|Lack of Efficacy|4|||
146139276|NCT03670810|527024588|FG004|Main Study|Lack of Efficacy|0|||
146139277|NCT03670810|527024589|FG005|Main Study|Lack of Efficacy|0|||
146139278|NCT03670810|527024590|FG006|Main Study|Lack of Efficacy|0|||
146139279|NCT03670810|527024591|FG007|Main Study|Lack of Efficacy|0|||
146139280|NCT03670810|527024592|FG008|Main Study|Lack of Efficacy|0|||
146139281|NCT03670810|527024584|FG000|Main Study|Lost to Follow-up|9|||
146139282|NCT03670810|527024585|FG001|Main Study|Lost to Follow-up|7|||
146139283|NCT03670810|527024586|FG002|Main Study|Lost to Follow-up|4|||
146139284|NCT03670810|527024587|FG003|Main Study|Lost to Follow-up|6|||
146139285|NCT03670810|527024588|FG004|Main Study|Lost to Follow-up|1|||
146139286|NCT03670810|527024589|FG005|Main Study|Lost to Follow-up|0|||
146139287|NCT03670810|527024590|FG006|Main Study|Lost to Follow-up|0|||
146139288|NCT03670810|527024591|FG007|Main Study|Lost to Follow-up|0|||
146304122|NCT03250832|527627480|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146304123|NCT03250832|527627481|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146304124|NCT03250832|527627482|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146304125|NCT03250832|527627483|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
146304126|NCT03250832|527627484|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
146304127|NCT03250832|527627485|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146139289|NCT03670810|527024592|FG008|Main Study|Lost to Follow-up|0|||
146139290|NCT03670810|527024584|FG000|Main Study|Non-compliance with Study Drug|0|||
146139291|NCT03670810|527024585|FG001|Main Study|Non-compliance with Study Drug|2|||
146139292|NCT03670810|527024586|FG002|Main Study|Non-compliance with Study Drug|3|||
146139293|NCT03670810|527024587|FG003|Main Study|Non-compliance with Study Drug|0|||
146139294|NCT03670810|527024588|FG004|Main Study|Non-compliance with Study Drug|0|||
146139295|NCT03670810|527024589|FG005|Main Study|Non-compliance with Study Drug|0|||
146139296|NCT03670810|527024590|FG006|Main Study|Non-compliance with Study Drug|0|||
146271405|NCT00844597|527508003|FG003|Overall Study|Adverse Event|1|||
146271406|NCT00844597|527508004|FG004|Overall Study|Adverse Event|0|||
146271407|NCT00844597|527508005|FG005|Overall Study|Adverse Event|0|||
146271408|NCT00455741|527508007|FG000|Overall Study|Physician Decision|0|||
146271409|NCT00455741|527508008|FG001|Overall Study|Physician Decision|1|||
146271410|NCT00475228|527508010|FG000|Overall Study|Lost to Follow-up|17|||
146271411|NCT00475228|527508011|FG001|Overall Study|Lost to Follow-up|17|||
146139297|NCT03670810|527024591|FG007|Main Study|Non-compliance with Study Drug|1|||
146139298|NCT03670810|527024592|FG008|Main Study|Non-compliance with Study Drug|0|||
146139299|NCT03670810|527024584|FG000|Main Study|Physician Decision|3|||
146139300|NCT03670810|527024585|FG001|Main Study|Physician Decision|0|||
146139301|NCT03670810|527024586|FG002|Main Study|Physician Decision|1|||
146139302|NCT03670810|527024587|FG003|Main Study|Physician Decision|0|||
146139303|NCT03670810|527024588|FG004|Main Study|Physician Decision|0|||
146139304|NCT03670810|527024589|FG005|Main Study|Physician Decision|0|||
146139305|NCT03670810|527024590|FG006|Main Study|Physician Decision|1|||
146139306|NCT03670810|527024591|FG007|Main Study|Physician Decision|1|||
146139307|NCT03670810|527024592|FG008|Main Study|Physician Decision|0|||
146139308|NCT03670810|527024584|FG000|Main Study|Pregnancy|1|||
146139309|NCT03670810|527024585|FG001|Main Study|Pregnancy|2|||
146139310|NCT03670810|527024586|FG002|Main Study|Pregnancy|0|||
146139311|NCT03670810|527024587|FG003|Main Study|Pregnancy|0|||
146271412|NCT02209181|527508012|FG000|Overall Study|Adverse Event|1|||
146271413|NCT02209181|527508013|FG001|Overall Study|Adverse Event|0|||
146271414|NCT02209181|527508014|FG002|Overall Study|Adverse Event|1|||
146271415|NCT02209181|527508015|FG003|Overall Study|Adverse Event|0|||
146271416|NCT02209181|527508012|FG000|Overall Study|Withdrawal by Subject|0|||
146139312|NCT03670810|527024588|FG004|Main Study|Pregnancy|0|||
146139313|NCT03670810|527024589|FG005|Main Study|Pregnancy|0|||
146271417|NCT02209181|527508013|FG001|Overall Study|Withdrawal by Subject|1|||
146139314|NCT03670810|527024590|FG006|Main Study|Pregnancy|0|||
146139315|NCT03670810|527024591|FG007|Main Study|Pregnancy|0|||
146139316|NCT03670810|527024592|FG008|Main Study|Pregnancy|0|||
146139317|NCT03670810|527024584|FG000|Main Study|Protocol Deviation|2|||
146139318|NCT03670810|527024585|FG001|Main Study|Protocol Deviation|12|||
146139319|NCT03670810|527024586|FG002|Main Study|Protocol Deviation|8|||
146139320|NCT03670810|527024587|FG003|Main Study|Protocol Deviation|4|||
146139321|NCT03670810|527024588|FG004|Main Study|Protocol Deviation|0|||
146139322|NCT03670810|527024589|FG005|Main Study|Protocol Deviation|0|||
146139323|NCT03670810|527024590|FG006|Main Study|Protocol Deviation|0|||
146139324|NCT03670810|527024591|FG007|Main Study|Protocol Deviation|0|||
146139325|NCT03670810|527024592|FG008|Main Study|Protocol Deviation|0|||
146139326|NCT03670810|527024584|FG000|Main Study|Withdrawal by Subject|21|||
146139327|NCT03670810|527024585|FG001|Main Study|Withdrawal by Subject|21|||
146139328|NCT03670810|527024586|FG002|Main Study|Withdrawal by Subject|8|||
146139329|NCT03670810|527024587|FG003|Main Study|Withdrawal by Subject|9|||
146139330|NCT03670810|527024588|FG004|Main Study|Withdrawal by Subject|5|||
146139331|NCT03670810|527024589|FG005|Main Study|Withdrawal by Subject|2|||
146139332|NCT03670810|527024590|FG006|Main Study|Withdrawal by Subject|1|||
146139333|NCT03670810|527024591|FG007|Main Study|Withdrawal by Subject|1|||
146139334|NCT03670810|527024592|FG008|Main Study|Withdrawal by Subject|0|||
146139335|NCT03670810|527024584|FG000|Main Study|Participant did not want to take the three other treatments|1|||
146139336|NCT03670810|527024585|FG001|Main Study|Participant did not want to take the three other treatments|0|||
146139337|NCT03670810|527024586|FG002|Main Study|Participant did not want to take the three other treatments|0|||
146139338|NCT03670810|527024587|FG003|Main Study|Participant did not want to take the three other treatments|0|||
146139339|NCT03670810|527024588|FG004|Main Study|Participant did not want to take the three other treatments|0|||
146139340|NCT03670810|527024589|FG005|Main Study|Participant did not want to take the three other treatments|0|||
146139341|NCT03670810|527024590|FG006|Main Study|Participant did not want to take the three other treatments|0|||
146139342|NCT03670810|527024591|FG007|Main Study|Participant did not want to take the three other treatments|0|||
146139343|NCT03670810|527024592|FG008|Main Study|Participant did not want to take the three other treatments|0|||
146139344|NCT03670810|527024584|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139345|NCT03670810|527024585|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
146139346|NCT03670810|527024586|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139347|NCT03670810|527024587|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139348|NCT03670810|527024588|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139349|NCT03670810|527024589|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139350|NCT03670810|527024590|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139351|NCT03670810|527024591|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139352|NCT03670810|527024592|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
146139353|NCT03670810|527024584|FG000|Main Study|Travel and Coronavirus issues|0|||
146139354|NCT03670810|527024585|FG001|Main Study|Travel and Coronavirus issues|0|||
146139355|NCT03670810|527024586|FG002|Main Study|Travel and Coronavirus issues|0|||
146139356|NCT03670810|527024587|FG003|Main Study|Travel and Coronavirus issues|1|||
146139357|NCT03670810|527024588|FG004|Main Study|Travel and Coronavirus issues|0|||
146139358|NCT03670810|527024589|FG005|Main Study|Travel and Coronavirus issues|0|||
146139359|NCT03670810|527024590|FG006|Main Study|Travel and Coronavirus issues|0|||
146139360|NCT03670810|527024591|FG007|Main Study|Travel and Coronavirus issues|0|||
146139361|NCT03670810|527024592|FG008|Main Study|Travel and Coronavirus issues|0|||
146139362|NCT03670810|527024584|FG000|Open Label Extension|Protocol Deviation|0|||
146139363|NCT03670810|527024585|FG001|Open Label Extension|Protocol Deviation|0|||
146139364|NCT03670810|527024586|FG002|Open Label Extension|Protocol Deviation|0|||
146139365|NCT03670810|527024587|FG003|Open Label Extension|Protocol Deviation|0|||
146139366|NCT03670810|527024588|FG004|Open Label Extension|Protocol Deviation|0|||
146139367|NCT03670810|527024589|FG005|Open Label Extension|Protocol Deviation|0|||
146139368|NCT03670810|527024590|FG006|Open Label Extension|Protocol Deviation|0|||
146139369|NCT03670810|527024591|FG007|Open Label Extension|Protocol Deviation|0|||
146139370|NCT03670810|527024592|FG008|Open Label Extension|Protocol Deviation|5|||
146139371|NCT03670810|527024584|FG000|Open Label Extension|Death|0|||
146139372|NCT03670810|527024585|FG001|Open Label Extension|Death|0|||
146139373|NCT03670810|527024586|FG002|Open Label Extension|Death|0|||
146139374|NCT03670810|527024587|FG003|Open Label Extension|Death|0|||
146139375|NCT03670810|527024588|FG004|Open Label Extension|Death|0|||
146139376|NCT03670810|527024589|FG005|Open Label Extension|Death|0|||
146139377|NCT03670810|527024590|FG006|Open Label Extension|Death|0|||
146139378|NCT03670810|527024591|FG007|Open Label Extension|Death|0|||
146139379|NCT03670810|527024592|FG008|Open Label Extension|Death|1|||
146139380|NCT03670810|527024584|FG000|Open Label Extension|COVID-19|0|||
146139381|NCT03670810|527024585|FG001|Open Label Extension|COVID-19|0|||
146139382|NCT03670810|527024586|FG002|Open Label Extension|COVID-19|0|||
146139383|NCT03670810|527024587|FG003|Open Label Extension|COVID-19|0|||
146139384|NCT03670810|527024588|FG004|Open Label Extension|COVID-19|0|||
146139385|NCT03670810|527024589|FG005|Open Label Extension|COVID-19|0|||
146139386|NCT03670810|527024590|FG006|Open Label Extension|COVID-19|0|||
146139387|NCT03670810|527024591|FG007|Open Label Extension|COVID-19|0|||
146139388|NCT03670810|527024592|FG008|Open Label Extension|COVID-19|1|||
146139389|NCT03670810|527024584|FG000|Open Label Extension|Lack of Efficacy|0|||
146139390|NCT03670810|527024585|FG001|Open Label Extension|Lack of Efficacy|0|||
146139391|NCT03670810|527024586|FG002|Open Label Extension|Lack of Efficacy|0|||
146139392|NCT03670810|527024587|FG003|Open Label Extension|Lack of Efficacy|0|||
146139393|NCT03670810|527024588|FG004|Open Label Extension|Lack of Efficacy|0|||
146139394|NCT03670810|527024589|FG005|Open Label Extension|Lack of Efficacy|0|||
146139395|NCT03670810|527024590|FG006|Open Label Extension|Lack of Efficacy|0|||
146139396|NCT03670810|527024591|FG007|Open Label Extension|Lack of Efficacy|0|||
146139397|NCT03670810|527024592|FG008|Open Label Extension|Lack of Efficacy|39|||
146139398|NCT03670810|527024584|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
146139399|NCT03670810|527024585|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
146139400|NCT03670810|527024586|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
146139401|NCT03670810|527024587|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
146139402|NCT03670810|527024588|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
146139403|NCT03670810|527024589|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
146139404|NCT03670810|527024590|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
146139405|NCT03670810|527024591|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
146139406|NCT03670810|527024592|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
146139407|NCT03670810|527024584|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139408|NCT03670810|527024585|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139409|NCT03670810|527024586|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139410|NCT03670810|527024587|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139411|NCT03670810|527024588|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139412|NCT03670810|527024589|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139413|NCT03670810|527024590|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139414|NCT03670810|527024591|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
146139415|NCT03670810|527024592|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
146139416|NCT03670810|527024584|FG000|Open Label Extension|Withdrawal by Subject|0|||
146139417|NCT03670810|527024585|FG001|Open Label Extension|Withdrawal by Subject|0|||
146139418|NCT03670810|527024586|FG002|Open Label Extension|Withdrawal by Subject|0|||
146139419|NCT03670810|527024587|FG003|Open Label Extension|Withdrawal by Subject|0|||
146139420|NCT03670810|527024588|FG004|Open Label Extension|Withdrawal by Subject|0|||
146139421|NCT03670810|527024589|FG005|Open Label Extension|Withdrawal by Subject|0|||
146139422|NCT03670810|527024590|FG006|Open Label Extension|Withdrawal by Subject|0|||
146139423|NCT03670810|527024591|FG007|Open Label Extension|Withdrawal by Subject|0|||
146139424|NCT03670810|527024592|FG008|Open Label Extension|Withdrawal by Subject|46|||
146139425|NCT03670810|527024584|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139426|NCT03670810|527024585|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139427|NCT03670810|527024586|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139428|NCT03670810|527024587|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139429|NCT03670810|527024588|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139430|NCT03670810|527024589|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139431|NCT03670810|527024590|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139432|NCT03670810|527024591|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
146139433|NCT03670810|527024592|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
146139434|NCT03670810|527024584|FG000|Open Label Extension|Physician Decision|0|||
146139435|NCT03670810|527024585|FG001|Open Label Extension|Physician Decision|0|||
146139436|NCT03670810|527024586|FG002|Open Label Extension|Physician Decision|0|||
146139437|NCT03670810|527024587|FG003|Open Label Extension|Physician Decision|0|||
146139438|NCT03670810|527024588|FG004|Open Label Extension|Physician Decision|0|||
146139439|NCT03670810|527024589|FG005|Open Label Extension|Physician Decision|0|||
146139440|NCT03670810|527024590|FG006|Open Label Extension|Physician Decision|0|||
146139441|NCT03670810|527024591|FG007|Open Label Extension|Physician Decision|0|||
146139442|NCT03670810|527024592|FG008|Open Label Extension|Physician Decision|2|||
146139443|NCT03670810|527024584|FG000|Open Label Extension|Non-compliance with study drug|0|||
146139444|NCT03670810|527024585|FG001|Open Label Extension|Non-compliance with study drug|0|||
146139445|NCT03670810|527024586|FG002|Open Label Extension|Non-compliance with study drug|0|||
146139446|NCT03670810|527024587|FG003|Open Label Extension|Non-compliance with study drug|0|||
146139447|NCT03670810|527024588|FG004|Open Label Extension|Non-compliance with study drug|0|||
146139448|NCT03670810|527024589|FG005|Open Label Extension|Non-compliance with study drug|0|||
146139449|NCT03670810|527024590|FG006|Open Label Extension|Non-compliance with study drug|0|||
146139450|NCT03670810|527024591|FG007|Open Label Extension|Non-compliance with study drug|0|||
146139451|NCT03670810|527024592|FG008|Open Label Extension|Non-compliance with study drug|5|||
146139452|NCT03670810|527024584|FG000|Open Label Extension|Pregnancy|0|||
146139453|NCT03670810|527024585|FG001|Open Label Extension|Pregnancy|0|||
146139454|NCT03670810|527024586|FG002|Open Label Extension|Pregnancy|0|||
146139455|NCT03670810|527024587|FG003|Open Label Extension|Pregnancy|0|||
146139456|NCT03670810|527024588|FG004|Open Label Extension|Pregnancy|0|||
146139457|NCT03670810|527024589|FG005|Open Label Extension|Pregnancy|0|||
146139458|NCT03670810|527024590|FG006|Open Label Extension|Pregnancy|0|||
146139459|NCT03670810|527024591|FG007|Open Label Extension|Pregnancy|0|||
146139460|NCT03670810|527024592|FG008|Open Label Extension|Pregnancy|3|||
146139461|NCT03670810|527024584|FG000|Open Label Extension|Adverse Event|0|||
146139462|NCT03670810|527024585|FG001|Open Label Extension|Adverse Event|0|||
146139463|NCT03670810|527024586|FG002|Open Label Extension|Adverse Event|0|||
146139464|NCT03670810|527024587|FG003|Open Label Extension|Adverse Event|0|||
146139465|NCT03670810|527024588|FG004|Open Label Extension|Adverse Event|0|||
146139466|NCT03670810|527024589|FG005|Open Label Extension|Adverse Event|0|||
146139467|NCT03670810|527024590|FG006|Open Label Extension|Adverse Event|0|||
146139468|NCT03670810|527024591|FG007|Open Label Extension|Adverse Event|0|||
146139469|NCT03670810|527024592|FG008|Open Label Extension|Adverse Event|24|||
146139470|NCT03670810|527024584|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
146139471|NCT03670810|527024585|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
146139472|NCT03670810|527024586|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
146139473|NCT03670810|527024587|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
146139474|NCT03670810|527024588|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
146139475|NCT03670810|527024589|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
146139476|NCT03670810|527024590|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
146139477|NCT03670810|527024591|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
146139478|NCT03670810|527024592|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
146139479|NCT03670810|527024584|FG000|Open Label Extension|Lost to Follow-up|0|||
146139480|NCT03670810|527024585|FG001|Open Label Extension|Lost to Follow-up|0|||
146139481|NCT03670810|527024586|FG002|Open Label Extension|Lost to Follow-up|0|||
146139482|NCT03670810|527024587|FG003|Open Label Extension|Lost to Follow-up|0|||
146139483|NCT03670810|527024588|FG004|Open Label Extension|Lost to Follow-up|0|||
146139484|NCT03670810|527024589|FG005|Open Label Extension|Lost to Follow-up|0|||
146139485|NCT03670810|527024590|FG006|Open Label Extension|Lost to Follow-up|0|||
146139486|NCT03670810|527024591|FG007|Open Label Extension|Lost to Follow-up|0|||
146139487|NCT03670810|527024592|FG008|Open Label Extension|Lost to Follow-up|23|||
146139488|NCT01470469|527024593|FG000|Overall Study|Withdrawal by Subject|4|||
146139489|NCT01470469|527024594|FG001|Overall Study|Withdrawal by Subject|6|||
146139490|NCT01470469|527024593|FG000|Overall Study|Lack of Efficacy|1|||
146139491|NCT01470469|527024594|FG001|Overall Study|Lack of Efficacy|7|||
146139492|NCT01470469|527024593|FG000|Overall Study|Adverse Event|0|||
146139493|NCT01470469|527024594|FG001|Overall Study|Adverse Event|7|||
146139494|NCT01470469|527024593|FG000|Overall Study|Lost to Follow-up|2|||
146139495|NCT01470469|527024594|FG001|Overall Study|Lost to Follow-up|2|||
146139496|NCT01470469|527024593|FG000|Overall Study|Protocol Violation|1|||
146139497|NCT01470469|527024594|FG001|Overall Study|Protocol Violation|1|||
146139498|NCT01470469|527024593|FG000|Overall Study|Other|2|||
146139499|NCT01470469|527024594|FG001|Overall Study|Other|1|||
146139500|NCT04182100|527024595|FG000|Overall Study|Adverse Event|1|||
146139501|NCT04182100|527024595|FG000|Overall Study|Withdrawal by Subject|1|||
146139502|NCT02504372|527024597|FG000|Overall Study|Death|136|||
146139503|NCT02504372|527024598|FG001|Overall Study|Death|154|||
146139504|NCT02504372|527024597|FG000|Overall Study|Lost to Follow-up|0|||
146139505|NCT02504372|527024598|FG001|Overall Study|Lost to Follow-up|2|||
146139506|NCT02504372|527024597|FG000|Overall Study|Withdrawal of consent|25|||
146139507|NCT02504372|527024598|FG001|Overall Study|Withdrawal of consent|16|||
146139508|NCT02504372|527024597|FG000|Overall Study|Participants ongoing|429|||
146139509|NCT02504372|527024598|FG001|Overall Study|Participants ongoing|415|||
146139518|NCT00376168|527024606|FG000|Overall Study|Adverse Event|1|||
146139519|NCT00376168|527024607|FG001|Overall Study|Adverse Event|1|||
146139520|NCT00376168|527024606|FG000|Overall Study|Pregnancy|1|||
146139521|NCT00376168|527024607|FG001|Overall Study|Pregnancy|0|||
146139522|NCT02214121|527024608|FG000|Part A|Patient decision|2|||
146139523|NCT02214121|527024609|FG001|Part A|Patient decision|0|||
146139524|NCT02214121|527024610|FG002|Part A|Patient decision|0|||
146139525|NCT02214121|527024608|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
146139526|NCT02214121|527024609|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
146139527|NCT02214121|527024610|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
146139528|NCT02214121|527024608|FG000|Part A|Other|1|||
146139529|NCT02214121|527024609|FG001|Part A|Other|0|||
146139530|NCT02214121|527024610|FG002|Part A|Other|0|||
146139531|NCT02214121|527024608|FG000|Part B|Patient decision|0|||
146139532|NCT02214121|527024609|FG001|Part B|Patient decision|1|||
146139533|NCT02214121|527024610|FG002|Part B|Patient decision|0|||
146139534|NCT02214121|527024608|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
146271418|NCT02209181|527508014|FG002|Overall Study|Withdrawal by Subject|0|||
146271419|NCT02209181|527508015|FG003|Overall Study|Withdrawal by Subject|0|||
146271420|NCT02579772|527508016|FG000|Overall Study|Withdrawal by Subject|0|||
146271421|NCT02579772|527508017|FG001|Overall Study|Withdrawal by Subject|1|||
146271422|NCT02579772|527508016|FG000|Overall Study|Usage of additional antioxidants|1|||
146271423|NCT02579772|527508017|FG001|Overall Study|Usage of additional antioxidants|0|||
146271424|NCT02579772|527508016|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
146271425|NCT02579772|527508017|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
146271426|NCT00862836|527508019|FG000|Overall Study|Withdrawal by Subject|1|||
146271427|NCT04463680|527508022|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
146271428|NCT04463680|527508022|FG000|Overall Study|Not eligible due to implant duration of use|1|||
146271429|NCT04463680|527508022|FG000|Overall Study|Withdrawal by Subject|3|||
146271430|NCT02592707|527508023|FG000|Overall Study|Consent Withdrawn|0|||
146271431|NCT02592707|527508024|FG001|Overall Study|Consent Withdrawn|1|||
146271432|NCT02592707|527508025|FG002|Overall Study|Consent Withdrawn|2|||
146271433|NCT02592707|527508026|FG003|Overall Study|Consent Withdrawn|0|||
146271434|NCT02592707|527508023|FG000|Overall Study|Death|1|||
146271435|NCT02592707|527508024|FG001|Overall Study|Death|0|||
146271436|NCT02592707|527508025|FG002|Overall Study|Death|0|||
146139535|NCT02214121|527024609|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
146139536|NCT02214121|527024610|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
146139537|NCT02214121|527024608|FG000|Part B|Lost to Follow-up|0|||
146139538|NCT02214121|527024609|FG001|Part B|Lost to Follow-up|0|||
146139539|NCT02214121|527024610|FG002|Part B|Lost to Follow-up|1|||
146139540|NCT02114879|527024615|FG000|Overall Study|Withdrawal by Subject|9|||
146139541|NCT02114879|527024616|FG001|Overall Study|Withdrawal by Subject|5|||
146139542|NCT02114879|527024615|FG000|Overall Study|Death|6|||
146139543|NCT02114879|527024616|FG001|Overall Study|Death|11|||
146139544|NCT02114879|527024615|FG000|Overall Study|Lost to Follow-up|4|||
146139545|NCT02114879|527024616|FG001|Overall Study|Lost to Follow-up|6|||
146139546|NCT02114879|527024615|FG000|Overall Study|Physician Decision|0|||
146139547|NCT02114879|527024616|FG001|Overall Study|Physician Decision|2|||
146139548|NCT02152995|527024617|FG000|Overall Study|Withdrawal by Subject|1|||
146139549|NCT02152995|527024618|FG001|Overall Study|Withdrawal by Subject|0|||
146139550|NCT01365273|527024619|FG000|Overall Study|Lost to Follow-up|1|||
146139551|NCT01365273|527024620|FG001|Overall Study|Lost to Follow-up|0|||
146139552|NCT01365273|527024619|FG000|Overall Study|Protocol Violation|0|||
146139553|NCT01365273|527024620|FG001|Overall Study|Protocol Violation|1|||
146139554|NCT01365273|527024619|FG000|Overall Study|Physician Decision|1|||
146139555|NCT01365273|527024620|FG001|Overall Study|Physician Decision|0|||
146139556|NCT00308711|527024622|FG000|Overall Study|Withdrawal by Subject|1|||
146139557|NCT00308711|527024623|FG001|Overall Study|Withdrawal by Subject|0|||
146139558|NCT00308711|527024624|FG002|Overall Study|Withdrawal by Subject|1|||
146139559|NCT00308711|527024622|FG000|Overall Study|Protocol Violation|0|||
146139560|NCT00308711|527024623|FG001|Overall Study|Protocol Violation|1|||
146139561|NCT00308711|527024624|FG002|Overall Study|Protocol Violation|1|||
146139562|NCT00308711|527024622|FG000|Overall Study|Lost to Follow-up|0|||
146139563|NCT00308711|527024623|FG001|Overall Study|Lost to Follow-up|1|||
146139564|NCT00308711|527024624|FG002|Overall Study|Lost to Follow-up|0|||
146139565|NCT00308711|527024622|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
146139566|NCT00308711|527024623|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
146271437|NCT02592707|527508026|FG003|Overall Study|Death|0|||
146271438|NCT02592707|527508023|FG000|Overall Study|Progressive Disease|4|||
146271439|NCT02592707|527508024|FG001|Overall Study|Progressive Disease|4|||
146271440|NCT02592707|527508025|FG002|Overall Study|Progressive Disease|3|||
146271441|NCT02592707|527508026|FG003|Overall Study|Progressive Disease|3|||
146139567|NCT00308711|527024624|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
146271442|NCT02592707|527508023|FG000|Overall Study|Other|0|||
146271443|NCT02592707|527508024|FG001|Overall Study|Other|0|||
146271444|NCT02592707|527508025|FG002|Overall Study|Other|1|||
146271445|NCT02592707|527508026|FG003|Overall Study|Other|2|||
146271446|NCT02592707|527508023|FG000|Overall Study|Never entered LTFU period|1|||
146139568|NCT00308711|527024622|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
146139569|NCT00308711|527024623|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
146139570|NCT00308711|527024624|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
146139571|NCT02318693|527024626|FG000|Overall Study|Protocol Violation|0|||
146139572|NCT02318693|527024627|FG001|Overall Study|Protocol Violation|1|||
146139573|NCT00689481|527024628|FG000|Overall Study|Adverse Event|7|||
146271447|NCT02592707|527508024|FG001|Overall Study|Never entered LTFU period|0|||
146271448|NCT02592707|527508025|FG002|Overall Study|Never entered LTFU period|0|||
146139574|NCT00689481|527024629|FG001|Overall Study|Adverse Event|1|||
146139575|NCT00689481|527024628|FG000|Overall Study|Lost to Follow-up|4|||
146139576|NCT00689481|527024629|FG001|Overall Study|Lost to Follow-up|3|||
146139577|NCT00689481|527024628|FG000|Overall Study|Lack of Efficacy|4|||
146139578|NCT00689481|527024629|FG001|Overall Study|Lack of Efficacy|3|||
146139579|NCT00689481|527024628|FG000|Overall Study|Non-compliance with study treatment|1|||
146139580|NCT00689481|527024629|FG001|Overall Study|Non-compliance with study treatment|1|||
146139581|NCT00689481|527024628|FG000|Overall Study|Withdrawal by Subject|8|||
146139582|NCT00689481|527024629|FG001|Overall Study|Withdrawal by Subject|4|||
146139583|NCT00689481|527024628|FG000|Overall Study|Excluded medication started during study|0|||
146139584|NCT00689481|527024629|FG001|Overall Study|Excluded medication started during study|1|||
146139585|NCT00689481|527024628|FG000|Overall Study|Subject early term, left on vacation|0|||
146139586|NCT00689481|527024629|FG001|Overall Study|Subject early term, left on vacation|1|||
146139587|NCT05645432|527024634|FG000|Overall Study|Withdrawal by Subject|1|||
146139588|NCT03195478|527024635|FG000|Overall Study|Disease Progression|5|||
146139589|NCT03195478|527024636|FG001|Overall Study|Disease Progression|4|||
146139590|NCT03195478|527024637|FG002|Overall Study|Disease Progression|6|||
146139591|NCT03195478|527024638|FG003|Overall Study|Disease Progression|1|||
146139592|NCT03195478|527024635|FG000|Overall Study|Study Drug Toxicity|2|||
146139593|NCT03195478|527024636|FG001|Overall Study|Study Drug Toxicity|0|||
146139594|NCT03195478|527024637|FG002|Overall Study|Study Drug Toxicity|0|||
146139595|NCT03195478|527024638|FG003|Overall Study|Study Drug Toxicity|1|||
146139596|NCT03195478|527024635|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
146139597|NCT03195478|527024636|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
146139598|NCT03195478|527024637|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
146139599|NCT03195478|527024638|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
146139600|NCT03195478|527024635|FG000|Overall Study|Participant Withdrew Consent|1|||
146139601|NCT03195478|527024636|FG001|Overall Study|Participant Withdrew Consent|0|||
146139602|NCT03195478|527024637|FG002|Overall Study|Participant Withdrew Consent|0|||
146139603|NCT03195478|527024638|FG003|Overall Study|Participant Withdrew Consent|0|||
146139604|NCT03195478|527024635|FG000|Overall Study|Maximum Clinical benefit|0|||
146139605|NCT03195478|527024636|FG001|Overall Study|Maximum Clinical benefit|0|||
146139606|NCT03195478|527024637|FG002|Overall Study|Maximum Clinical benefit|1|||
146139607|NCT03195478|527024638|FG003|Overall Study|Maximum Clinical benefit|0|||
146139608|NCT03195478|527024635|FG000|Overall Study|Other Reasons|0|||
146139609|NCT03195478|527024636|FG001|Overall Study|Other Reasons|0|||
146139610|NCT03195478|527024637|FG002|Overall Study|Other Reasons|1|||
146139611|NCT03195478|527024638|FG003|Overall Study|Other Reasons|0|||
146139612|NCT02742103|527026470|FG000|Overall Study|Protocol Violation|1|||
146139613|NCT02742103|527026471|FG001|Overall Study|Protocol Violation|0|||
146139614|NCT02742103|527026470|FG000|Overall Study|Death|2|||
146139615|NCT02742103|527026471|FG001|Overall Study|Death|2|||
146139616|NCT02742103|527026470|FG000|Overall Study|Adverse Event|1|||
146139617|NCT02742103|527026471|FG001|Overall Study|Adverse Event|0|||
146139618|NCT02742103|527026470|FG000|Overall Study|Moved to another town|0|||
146139619|NCT02742103|527026471|FG001|Overall Study|Moved to another town|1|||
146139620|NCT02742103|527026470|FG000|Overall Study|Withdrawal by Subject|5|||
146139621|NCT02742103|527026471|FG001|Overall Study|Withdrawal by Subject|2|||
146139622|NCT04346615|527026474|FG000|Overall Study|Lost to Follow-up|0|||
146139623|NCT04346615|527026475|FG001|Overall Study|Lost to Follow-up|2|||
146139624|NCT04346615|527026474|FG000|Overall Study|Withdrawal by Subject|1|||
146139625|NCT04346615|527026475|FG001|Overall Study|Withdrawal by Subject|0|||
146139626|NCT04346615|527026474|FG000|Overall Study|Death|5|||
146139627|NCT04346615|527026475|FG001|Overall Study|Death|1|||
146139628|NCT04346615|527026474|FG000|Overall Study|Other|0|||
146139629|NCT04346615|527026475|FG001|Overall Study|Other|2|||
146139630|NCT04346615|527026474|FG000|Overall Study|Randomized not treated|1|||
146139631|NCT04346615|527026475|FG001|Overall Study|Randomized not treated|0|||
146139632|NCT02349711|527026489|FG000|Overall Study|Withdrawal by Subject|2|||
146139633|NCT02349711|527026490|FG001|Overall Study|Withdrawal by Subject|1|||
146139634|NCT02349711|527026489|FG000|Overall Study|Lost to Follow-up|1|||
146139635|NCT02349711|527026490|FG001|Overall Study|Lost to Follow-up|1|||
146139636|NCT01105533|527026496|FG000|Overall Study|Death|0|||
146139637|NCT01105533|527026497|FG001|Overall Study|Death|0|||
146139638|NCT01105533|527026498|FG002|Overall Study|Death|0|||
146139639|NCT01105533|527026499|FG003|Overall Study|Death|0|||
146139640|NCT01105533|527026500|FG004|Overall Study|Death|1|||
146139641|NCT01105533|527026501|FG005|Overall Study|Death|0|||
146139642|NCT01105533|527026502|FG006|Overall Study|Death|0|||
146139643|NCT01105533|527026503|FG007|Overall Study|Death|0|||
146139644|NCT01105533|527026504|FG008|Overall Study|Death|0|||
146139645|NCT01105533|527026496|FG000|Overall Study|Lack of Efficacy|1|||
146139646|NCT01105533|527026497|FG001|Overall Study|Lack of Efficacy|1|||
146139647|NCT01105533|527026498|FG002|Overall Study|Lack of Efficacy|3|||
146139648|NCT01105533|527026499|FG003|Overall Study|Lack of Efficacy|3|||
146139649|NCT01105533|527026500|FG004|Overall Study|Lack of Efficacy|4|||
146139650|NCT01105533|527026501|FG005|Overall Study|Lack of Efficacy|5|||
146139651|NCT01105533|527026502|FG006|Overall Study|Lack of Efficacy|3|||
146139652|NCT01105533|527026503|FG007|Overall Study|Lack of Efficacy|2|||
146139653|NCT01105533|527026504|FG008|Overall Study|Lack of Efficacy|9|||
146139654|NCT01105533|527026496|FG000|Overall Study|Adverse Event|0|||
146139655|NCT01105533|527026497|FG001|Overall Study|Adverse Event|0|||
146139656|NCT01105533|527026498|FG002|Overall Study|Adverse Event|0|||
146139657|NCT01105533|527026499|FG003|Overall Study|Adverse Event|0|||
146139658|NCT01105533|527026500|FG004|Overall Study|Adverse Event|1|||
146139659|NCT01105533|527026501|FG005|Overall Study|Adverse Event|2|||
146139660|NCT01105533|527026502|FG006|Overall Study|Adverse Event|2|||
146139661|NCT01105533|527026503|FG007|Overall Study|Adverse Event|0|||
146139662|NCT01105533|527026504|FG008|Overall Study|Adverse Event|1|||
146139663|NCT01105533|527026496|FG000|Overall Study|Other|0|||
146139664|NCT01105533|527026497|FG001|Overall Study|Other|0|||
146139665|NCT01105533|527026498|FG002|Overall Study|Other|0|||
146139666|NCT01105533|527026499|FG003|Overall Study|Other|0|||
146139667|NCT01105533|527026500|FG004|Overall Study|Other|1|||
146139668|NCT01105533|527026501|FG005|Overall Study|Other|0|||
146139669|NCT01105533|527026502|FG006|Overall Study|Other|3|||
146139670|NCT01105533|527026503|FG007|Overall Study|Other|1|||
146139671|NCT01105533|527026504|FG008|Overall Study|Other|2|||
146139672|NCT01105533|527026496|FG000|Overall Study|Physician Decision|0|||
146139673|NCT01105533|527026497|FG001|Overall Study|Physician Decision|0|||
146139674|NCT01105533|527026498|FG002|Overall Study|Physician Decision|0|||
146139675|NCT01105533|527026499|FG003|Overall Study|Physician Decision|0|||
146139676|NCT01105533|527026500|FG004|Overall Study|Physician Decision|0|||
146139677|NCT01105533|527026501|FG005|Overall Study|Physician Decision|0|||
146139678|NCT01105533|527026502|FG006|Overall Study|Physician Decision|0|||
146139679|NCT01105533|527026503|FG007|Overall Study|Physician Decision|1|||
146139680|NCT01105533|527026504|FG008|Overall Study|Physician Decision|0|||
146139681|NCT02096835|527026505|FG000|Overall Study|Withdrawal by Subject|1|||
146139682|NCT02096835|527026506|FG001|Overall Study|Withdrawal by Subject|0|||
146139683|NCT02096835|527026507|FG002|Overall Study|Withdrawal by Subject|0|||
146139684|NCT02096835|527026505|FG000|Overall Study|converted to open procedures|1|||
146139685|NCT02096835|527026506|FG001|Overall Study|converted to open procedures|0|||
146139686|NCT02096835|527026507|FG002|Overall Study|converted to open procedures|0|||
146139687|NCT02096835|527026505|FG000|Overall Study|Lost to Follow-up|1|||
146139688|NCT02096835|527026506|FG001|Overall Study|Lost to Follow-up|0|||
146139689|NCT02096835|527026507|FG002|Overall Study|Lost to Follow-up|1|||
146139690|NCT00023673|527026509|FG000|Overall Study|Ineligible / no protocol treatment|0|||
146139691|NCT00023673|527026510|FG001|Overall Study|Ineligible / no protocol treatment|0|||
146139692|NCT00023673|527026511|FG002|Overall Study|Ineligible / no protocol treatment|0|||
146139693|NCT00023673|527026512|FG003|Overall Study|Ineligible / no protocol treatment|1|||
146139694|NCT00023673|527026509|FG000|Overall Study|Patient withdrew consent|0|||
146139695|NCT00023673|527026510|FG001|Overall Study|Patient withdrew consent|0|||
146139696|NCT00023673|527026511|FG002|Overall Study|Patient withdrew consent|0|||
146139697|NCT00023673|527026512|FG003|Overall Study|Patient withdrew consent|1|||
146139698|NCT02453594|527026513|FG000|Overall Study|Protocol Violation|0|||
146139699|NCT02453594|527026514|FG001|Overall Study|Protocol Violation|0|||
146139700|NCT02453594|527026515|FG002|Overall Study|Protocol Violation|1|||
146139701|NCT02453594|527026513|FG000|Overall Study|Cohort Was Closed|17|||
146139702|NCT02453594|527026514|FG001|Overall Study|Cohort Was Closed|21|||
146139703|NCT02453594|527026515|FG002|Overall Study|Cohort Was Closed|14|||
146139704|NCT02453594|527026513|FG000|Overall Study|Death|20|||
146139705|NCT02453594|527026514|FG001|Overall Study|Death|24|||
146139706|NCT02453594|527026515|FG002|Overall Study|Death|16|||
146139707|NCT02453594|527026513|FG000|Overall Study|Lost to Follow-up|6|||
146139708|NCT02453594|527026514|FG001|Overall Study|Lost to Follow-up|14|||
146139709|NCT02453594|527026515|FG002|Overall Study|Lost to Follow-up|2|||
146139710|NCT02453594|527026513|FG000|Overall Study|Physician Decision|2|||
146139711|NCT02453594|527026514|FG001|Overall Study|Physician Decision|4|||
146139712|NCT02453594|527026515|FG002|Overall Study|Physician Decision|0|||
146139713|NCT02453594|527026513|FG000|Overall Study|Site Terminated by Sponsor|1|||
146139714|NCT02453594|527026514|FG001|Overall Study|Site Terminated by Sponsor|0|||
146139715|NCT02453594|527026515|FG002|Overall Study|Site Terminated by Sponsor|1|||
146139716|NCT02453594|527026513|FG000|Overall Study|Transitioned to Extension Study|16|||
146139717|NCT02453594|527026514|FG001|Overall Study|Transitioned to Extension Study|9|||
146139718|NCT02453594|527026515|FG002|Overall Study|Transitioned to Extension Study|16|||
146139719|NCT02453594|527026513|FG000|Overall Study|Withdrawal by Subject|7|||
146139720|NCT02453594|527026514|FG001|Overall Study|Withdrawal by Subject|9|||
146139721|NCT02453594|527026515|FG002|Overall Study|Withdrawal by Subject|11|||
146139722|NCT02097134|527026516|FG000|Overall Study|Physician Decision|4|||
146139723|NCT02097134|527026516|FG000|Overall Study|Non-Protocol Therapy|1|||
146139724|NCT02097134|527026516|FG000|Overall Study|Progressive Disease|3|||
146139725|NCT02097134|527026516|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
146139726|NCT00306592|527026521|FG000|Overall Study|Adverse Event|8|||
146139727|NCT00306592|527026522|FG001|Overall Study|Adverse Event|15|||
146139728|NCT00306592|527026521|FG000|Overall Study|Lost to Follow-up|1|||
146139729|NCT00306592|527026522|FG001|Overall Study|Lost to Follow-up|0|||
146139730|NCT00306592|527026521|FG000|Overall Study|Noncompliance|0|||
146139731|NCT00306592|527026522|FG001|Overall Study|Noncompliance|2|||
146139732|NCT00306592|527026521|FG000|Overall Study|Persistent Antibodies|6|||
146139733|NCT00306592|527026522|FG001|Overall Study|Persistent Antibodies|3|||
146139734|NCT00306592|527026521|FG000|Overall Study|Voluntary|10|||
146139735|NCT00306592|527026522|FG001|Overall Study|Voluntary|6|||
146139736|NCT00306592|527026521|FG000|Overall Study|Other|5|||
146139737|NCT00306592|527026522|FG001|Overall Study|Other|10|||
146139738|NCT00306592|527026521|FG000|Overall Study|Other|1|||
146139739|NCT00306592|527026522|FG001|Overall Study|Other|2|||
146139740|NCT00306592|527026521|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
146139741|NCT00306592|527026522|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
146139742|NCT04101526|527026524|FG000|Overall Study|Did not complete all sleep diary entries|0|||
146139743|NCT04101526|527026525|FG001|Overall Study|Did not complete all sleep diary entries|1|||
146139744|NCT01434823|527026528|FG000|Overall Study|Incomplete data in medical record|4|||
146139745|NCT01434823|527026529|FG001|Overall Study|Incomplete data in medical record|7|||
146139746|NCT02331446|527026530|FG000|Overall Study|Lost to Follow-up|2|||
146139747|NCT02331446|527026531|FG001|Overall Study|Lost to Follow-up|1|||
146139748|NCT02331446|527026532|FG002|Overall Study|Lost to Follow-up|0|||
146139749|NCT02331446|527026533|FG003|Overall Study|Lost to Follow-up|1|||
146139750|NCT02331446|527026530|FG000|Overall Study|Personal Problem|2|||
146139751|NCT02331446|527026531|FG001|Overall Study|Personal Problem|0|||
146139752|NCT02331446|527026532|FG002|Overall Study|Personal Problem|0|||
146139753|NCT02331446|527026533|FG003|Overall Study|Personal Problem|0|||
146139754|NCT02331446|527026530|FG000|Overall Study|Disease|0|||
146139755|NCT02331446|527026531|FG001|Overall Study|Disease|2|||
146139756|NCT02331446|527026532|FG002|Overall Study|Disease|2|||
146139757|NCT02331446|527026533|FG003|Overall Study|Disease|1|||
146139758|NCT02331446|527026530|FG000|Overall Study|Physician Decision|0|||
146139759|NCT02331446|527026531|FG001|Overall Study|Physician Decision|1|||
146139760|NCT02331446|527026532|FG002|Overall Study|Physician Decision|0|||
146139761|NCT02331446|527026533|FG003|Overall Study|Physician Decision|1|||
146139762|NCT02331446|527026530|FG000|Overall Study|Lost before baseline analysis|0|||
146139763|NCT02331446|527026531|FG001|Overall Study|Lost before baseline analysis|1|||
146139764|NCT02331446|527026532|FG002|Overall Study|Lost before baseline analysis|1|||
146139765|NCT02331446|527026533|FG003|Overall Study|Lost before baseline analysis|0|||
146139766|NCT00120042|527026534|FG000|Overall Study|all completed protocl|0|||
146139767|NCT00120042|527026535|FG001|Overall Study|all completed protocl|0|||
146139768|NCT00120042|527026536|FG002|Overall Study|all completed protocl|0|||
146139769|NCT03852316|527026537|FG000|Overall Study|Protocol Violation|1|||
146139770|NCT03852316|527026537|FG000|Overall Study|Withdrawal by Subject|2|||
146139771|NCT03852316|527026537|FG000|Overall Study|Enrolled but Device not Utilized|1|||
146139772|NCT04532112|527026538|FG000|Overall Study|Adverse Event|3|||
146139773|NCT04532112|527026539|FG001|Overall Study|Adverse Event|0|||
146139774|NCT03592641|527026540|FG000|Overall Study|Withdrawal by Subject|1|||
146139775|NCT01049919|527026542|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
146139776|NCT01049919|527026543|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
146139777|NCT01049919|527026542|FG000|Overall Study|Withdrawal by Subject|5|||
146139778|NCT01049919|527026543|FG001|Overall Study|Withdrawal by Subject|0|||
146139779|NCT01049919|527026542|FG000|Overall Study|Lost to Follow-up|6|||
146139780|NCT01049919|527026543|FG001|Overall Study|Lost to Follow-up|1|||
146139781|NCT01049919|527026542|FG000|Overall Study|Physician Decision|2|||
146139782|NCT01049919|527026543|FG001|Overall Study|Physician Decision|0|||
146139783|NCT01049919|527026542|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
146139784|NCT01049919|527026543|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
146139785|NCT01049919|527026542|FG000|Overall Study|Early study termination by sponsor.|2|||
146139786|NCT01049919|527026543|FG001|Overall Study|Early study termination by sponsor.|0|||
146139787|NCT02984995|527026544|FG000|Overall Study|Required stem cell transplant|13|||
146139788|NCT02984995|527026545|FG001|Overall Study|Required stem cell transplant|2|||
146139789|NCT02984995|527026544|FG000|Overall Study|Progressive disease|11|||
146139790|NCT02984995|527026545|FG001|Overall Study|Progressive disease|1|||
146139791|NCT02984995|527026544|FG000|Overall Study|Adverse Event|1|||
146139792|NCT02984995|527026545|FG001|Overall Study|Adverse Event|0|||
146139793|NCT01401530|527026546|FG000|Overall Study|Disease Progression|1|||
146139794|NCT01401530|527026547|FG001|Overall Study|Disease Progression|2|||
146139795|NCT01401530|527026548|FG002|Overall Study|Disease Progression|1|||
146139796|NCT01401530|527026546|FG000|Overall Study|Adverse Event|1|||
146139797|NCT01401530|527026547|FG001|Overall Study|Adverse Event|1|||
146139798|NCT01401530|527026548|FG002|Overall Study|Adverse Event|1|||
146139799|NCT01401530|527026546|FG000|Overall Study|Participant Choice|1|||
146139800|NCT01401530|527026547|FG001|Overall Study|Participant Choice|2|||
146139801|NCT01401530|527026548|FG002|Overall Study|Participant Choice|1|||
146139802|NCT01401530|527026546|FG000|Overall Study|Physician Decision|0|||
146139803|NCT01401530|527026547|FG001|Overall Study|Physician Decision|1|||
146139804|NCT01401530|527026548|FG002|Overall Study|Physician Decision|0|||
146139805|NCT00813124|527026554|FG000|Overall Study|Death|2|||
146139806|NCT00813124|527026554|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
146139807|NCT00813124|527026554|FG000|Overall Study|Withdrawal by Subject|1|||
146139808|NCT00079274|527026557|FG000|Overall Study|Withdrawal by Subject|111|||
146139809|NCT00079274|527026558|FG001|Overall Study|Withdrawal by Subject|10|||
146139810|NCT00079274|527026559|FG002|Overall Study|Withdrawal by Subject|12|||
146139811|NCT00079274|527026560|FG003|Overall Study|Withdrawal by Subject|163|||
146139812|NCT00079274|527026561|FG004|Overall Study|Withdrawal by Subject|7|||
146139813|NCT00079274|527026562|FG005|Overall Study|Withdrawal by Subject|8|||
146139814|NCT00079274|527026563|FG006|Overall Study|Withdrawal by Subject|0|||
146139815|NCT00079274|527026557|FG000|Overall Study|Adverse Event|130|||
146139816|NCT00079274|527026558|FG001|Overall Study|Adverse Event|8|||
146139817|NCT00079274|527026559|FG002|Overall Study|Adverse Event|8|||
146139818|NCT00079274|527026560|FG003|Overall Study|Adverse Event|184|||
146139819|NCT00079274|527026561|FG004|Overall Study|Adverse Event|7|||
146139820|NCT00079274|527026562|FG005|Overall Study|Adverse Event|8|||
146139821|NCT00079274|527026563|FG006|Overall Study|Adverse Event|0|||
146139822|NCT00079274|527026557|FG000|Overall Study|Recurrence|21|||
146139823|NCT00079274|527026558|FG001|Overall Study|Recurrence|0|||
146139824|NCT00079274|527026559|FG002|Overall Study|Recurrence|1|||
146139825|NCT00079274|527026560|FG003|Overall Study|Recurrence|15|||
146139826|NCT00079274|527026561|FG004|Overall Study|Recurrence|0|||
146139827|NCT00079274|527026562|FG005|Overall Study|Recurrence|2|||
146139828|NCT00079274|527026563|FG006|Overall Study|Recurrence|0|||
146139829|NCT00079274|527026557|FG000|Overall Study|Alternate Treatment|6|||
146139830|NCT00079274|527026558|FG001|Overall Study|Alternate Treatment|1|||
146139831|NCT00079274|527026559|FG002|Overall Study|Alternate Treatment|0|||
146139832|NCT00079274|527026560|FG003|Overall Study|Alternate Treatment|3|||
146139833|NCT00079274|527026561|FG004|Overall Study|Alternate Treatment|0|||
146139834|NCT00079274|527026562|FG005|Overall Study|Alternate Treatment|0|||
146139835|NCT00079274|527026563|FG006|Overall Study|Alternate Treatment|0|||
146139836|NCT00079274|527026557|FG000|Overall Study|Other Medical Problems|6|||
146139837|NCT00079274|527026558|FG001|Overall Study|Other Medical Problems|1|||
146139838|NCT00079274|527026559|FG002|Overall Study|Other Medical Problems|0|||
146139839|NCT00079274|527026560|FG003|Overall Study|Other Medical Problems|7|||
146139840|NCT00079274|527026561|FG004|Overall Study|Other Medical Problems|0|||
146139841|NCT00079274|527026562|FG005|Overall Study|Other Medical Problems|0|||
146139842|NCT00079274|527026563|FG006|Overall Study|Other Medical Problems|0|||
146139843|NCT00079274|527026557|FG000|Overall Study|Death|4|||
146139844|NCT00079274|527026558|FG001|Overall Study|Death|0|||
146139845|NCT00079274|527026559|FG002|Overall Study|Death|1|||
146139846|NCT00079274|527026560|FG003|Overall Study|Death|15|||
146139847|NCT00079274|527026561|FG004|Overall Study|Death|0|||
146139848|NCT00079274|527026562|FG005|Overall Study|Death|0|||
146139849|NCT00079274|527026563|FG006|Overall Study|Death|0|||
146139850|NCT00079274|527026557|FG000|Overall Study|Cytogenetic resistance|0|||
146139851|NCT00079274|527026558|FG001|Overall Study|Cytogenetic resistance|0|||
146139852|NCT00079274|527026559|FG002|Overall Study|Cytogenetic resistance|0|||
146139853|NCT00079274|527026560|FG003|Overall Study|Cytogenetic resistance|2|||
146139854|NCT00079274|527026561|FG004|Overall Study|Cytogenetic resistance|0|||
146139855|NCT00079274|527026562|FG005|Overall Study|Cytogenetic resistance|0|||
146139856|NCT00079274|527026563|FG006|Overall Study|Cytogenetic resistance|0|||
146139857|NCT00079274|527026557|FG000|Overall Study|Other|43|||
146139858|NCT00079274|527026558|FG001|Overall Study|Other|7|||
146139859|NCT00079274|527026559|FG002|Overall Study|Other|5|||
146139860|NCT00079274|527026560|FG003|Overall Study|Other|55|||
146139861|NCT00079274|527026561|FG004|Overall Study|Other|1|||
146139862|NCT00079274|527026562|FG005|Overall Study|Other|2|||
146139863|NCT00079274|527026563|FG006|Overall Study|Other|0|||
146139864|NCT00767676|527026564|FG000|Overall Study|Investigator error|54|||
146139865|NCT00617240|527026567|FG000|Overall Study|Lack of Efficacy|1|||
146139866|NCT00617240|527026568|FG001|Overall Study|Lack of Efficacy|0|||
146139867|NCT01611259|527026569|FG000|Overall Study|Physician Decision|1|||
146139868|NCT01611259|527026569|FG000|Overall Study|Lack of Efficacy|2|||
146139869|NCT01611259|527026569|FG000|Overall Study|Adverse Event|4|||
146139870|NCT01611259|527026569|FG000|Overall Study|Withdrawal by Subject|7|||
146139871|NCT03969212|527026570|FG000|Overall Study|Adverse Event|1|||
146139872|NCT03969212|527026571|FG001|Overall Study|Adverse Event|0|||
146139873|NCT03969212|527026572|FG002|Overall Study|Adverse Event|0|||
146139874|NCT03969212|527026573|FG003|Overall Study|Adverse Event|0|||
146139875|NCT03969212|527026570|FG000|Overall Study|Lost to Follow-up|2|||
146139876|NCT03969212|527026571|FG001|Overall Study|Lost to Follow-up|2|||
146139877|NCT03969212|527026572|FG002|Overall Study|Lost to Follow-up|2|||
146139878|NCT03969212|527026573|FG003|Overall Study|Lost to Follow-up|2|||
146139879|NCT03969212|527026570|FG000|Overall Study|Protocol Violation|0|||
146139880|NCT03969212|527026571|FG001|Overall Study|Protocol Violation|0|||
146139881|NCT03969212|527026572|FG002|Overall Study|Protocol Violation|0|||
146139882|NCT03969212|527026573|FG003|Overall Study|Protocol Violation|1|||
146139883|NCT03969212|527026570|FG000|Overall Study|Withdrawal by Subject|7|||
146139884|NCT03969212|527026571|FG001|Overall Study|Withdrawal by Subject|13|||
146139885|NCT03969212|527026572|FG002|Overall Study|Withdrawal by Subject|5|||
146139886|NCT03969212|527026573|FG003|Overall Study|Withdrawal by Subject|11|||
146139887|NCT03969212|527026570|FG000|Overall Study|Physician Decision|0|||
146139888|NCT03969212|527026571|FG001|Overall Study|Physician Decision|0|||
146139889|NCT03969212|527026572|FG002|Overall Study|Physician Decision|1|||
146139890|NCT03969212|527026573|FG003|Overall Study|Physician Decision|0|||
146139891|NCT03969212|527026570|FG000|Overall Study|Reason not Specified|22|||
146139892|NCT03969212|527026571|FG001|Overall Study|Reason not Specified|23|||
146139893|NCT03969212|527026572|FG002|Overall Study|Reason not Specified|28|||
146139894|NCT03969212|527026573|FG003|Overall Study|Reason not Specified|26|||
146139895|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
146139896|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
146139897|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
146139898|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
146139899|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
146139900|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
146139901|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
146139902|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
146139903|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
146139904|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
146139905|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
146139906|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
146139907|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
146139908|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
146139909|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
146139910|NCT00280566|527026577|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
146139911|NCT00280566|527026578|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
146139912|NCT00280566|527026579|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
146139913|NCT00280566|527026577|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
146139914|NCT00280566|527026578|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
146139915|NCT00280566|527026579|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
146139916|NCT00280566|527026577|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
146139917|NCT00280566|527026578|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
146139918|NCT00280566|527026579|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
146139919|NCT00280566|527026577|FG000|Period 2 Double Blind|Adverse Event|0|||
146139920|NCT00280566|527026578|FG001|Period 2 Double Blind|Adverse Event|11|||
146271449|NCT02592707|527508026|FG003|Overall Study|Never entered LTFU period|2|||
146271450|NCT03358472|527508027|FG000|Overall Study|Death|6|||
146271451|NCT03358472|527508028|FG001|Overall Study|Death|3|||
146271452|NCT03358472|527508029|FG002|Overall Study|Death|10|||
146271453|NCT03358472|527508027|FG000|Overall Study|Physician Decision|0|||
146271454|NCT03358472|527508028|FG001|Overall Study|Physician Decision|1|||
146271455|NCT03358472|527508029|FG002|Overall Study|Physician Decision|0|||
146271456|NCT03358472|527508027|FG000|Overall Study|Withdrawal by Subject|0|||
146271457|NCT03358472|527508028|FG001|Overall Study|Withdrawal by Subject|0|||
146271458|NCT03358472|527508029|FG002|Overall Study|Withdrawal by Subject|1|||
146271459|NCT03358472|527508027|FG000|Overall Study|On-going at clinical cut off date|9|||
146139921|NCT00280566|527026579|FG002|Period 2 Double Blind|Adverse Event|15|||
146139922|NCT00280566|527026577|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
146139923|NCT00280566|527026578|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
146139924|NCT00280566|527026579|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
146139925|NCT00280566|527026577|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
146139926|NCT00280566|527026578|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
146139927|NCT00280566|527026579|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
146139928|NCT00280566|527026577|FG000|Period 2 Double Blind|miscellaneous|0|||
146139929|NCT00280566|527026578|FG001|Period 2 Double Blind|miscellaneous|10|||
146139930|NCT00280566|527026579|FG002|Period 2 Double Blind|miscellaneous|5|||
146139931|NCT01147653|527026580|FG000|Year 2|Withdrawal by Subject|2|||
146139932|NCT01147653|527026581|FG001|Year 2|Withdrawal by Subject|3|||
146139933|NCT00353366|527026582|FG000|Overall Study|Adverse Event|8|||
146139934|NCT00353366|527026582|FG000|Overall Study|Protocol Violation|12|||
146139935|NCT00353366|527026582|FG000|Overall Study|Withdrawal by Subject|12|||
146139936|NCT00353366|527026582|FG000|Overall Study|Lost to Follow-up|92|||
146139937|NCT00353366|527026582|FG000|Overall Study|Other|19|||
146139938|NCT01302392|527026583|FG000|Overall Study|Lost to Follow-up|1|||
146139939|NCT01302392|527026584|FG001|Overall Study|Lost to Follow-up|0|||
146139940|NCT01302392|527026583|FG000|Overall Study|Withdrawal by Subject|6|||
146139941|NCT01302392|527026584|FG001|Overall Study|Withdrawal by Subject|1|||
146139942|NCT00259857|527026585|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
146139943|NCT00259857|527026586|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
146139944|NCT00259857|527026585|FG000|24 Months Treatment|Lost to Follow-up|0|||
146139945|NCT00259857|527026586|FG001|24 Months Treatment|Lost to Follow-up|3|||
146139946|NCT00670228|527026587|FG000|Overall Study|Adverse Event|1|||
146271460|NCT03358472|527508028|FG001|Overall Study|On-going at clinical cut off date|6|||
146271461|NCT03358472|527508029|FG002|Overall Study|On-going at clinical cut off date|5|||
146271462|NCT02412735|527509749|FG000|Overall Study|Adverse Event|0|||
146139947|NCT00670228|527026588|FG001|Overall Study|Adverse Event|0|||
146139948|NCT00670228|527026587|FG000|Overall Study|Death or MACE|0|||
146139949|NCT00670228|527026588|FG001|Overall Study|Death or MACE|1|||
146139950|NCT00670228|527026587|FG000|Overall Study|Not treated|2|||
146139951|NCT00670228|527026588|FG001|Overall Study|Not treated|2|||
146139952|NCT00670228|527026587|FG000|Overall Study|Not meeting the selection criteria|2|||
146139953|NCT00670228|527026588|FG001|Overall Study|Not meeting the selection criteria|0|||
146139954|NCT05267054|527026589|FG000|Overall Study|Death|13|||
146139955|NCT05267054|527026590|FG001|Overall Study|Death|14|||
146139956|NCT05267054|527026589|FG000|Overall Study|Study Ended by Sponsor|9|||
146139957|NCT05267054|527026590|FG001|Overall Study|Study Ended by Sponsor|13|||
146139958|NCT05267054|527026589|FG000|Overall Study|Lost to Follow-up|1|||
146139959|NCT05267054|527026590|FG001|Overall Study|Lost to Follow-up|1|||
146139960|NCT05267054|527026589|FG000|Overall Study|Withdrawal by Subject|1|||
146139961|NCT05267054|527026590|FG001|Overall Study|Withdrawal by Subject|1|||
146139962|NCT01552226|527026594|FG000|Overall Study|Withdrawal by Subject|4|||
146139963|NCT01552226|527026595|FG001|Overall Study|Withdrawal by Subject|4|||
146139964|NCT03604692|527026596|FG000|Overall Study|Investigator's Decision|0|||
146139965|NCT03604692|527026597|FG001|Overall Study|Investigator's Decision|0|||
146139966|NCT03604692|527026598|FG002|Overall Study|Investigator's Decision|0|||
146139967|NCT03604692|527026599|FG003|Overall Study|Investigator's Decision|1|||
146139968|NCT03604692|527026600|FG004|Overall Study|Investigator's Decision|0|||
146139969|NCT03604692|527026601|FG005|Overall Study|Investigator's Decision|7|||
146139970|NCT03604692|527026596|FG000|Overall Study|Withdrawal by Subject|0|||
146139971|NCT03604692|527026597|FG001|Overall Study|Withdrawal by Subject|0|||
146139972|NCT03604692|527026598|FG002|Overall Study|Withdrawal by Subject|0|||
146139973|NCT03604692|527026599|FG003|Overall Study|Withdrawal by Subject|0|||
146139974|NCT03604692|527026600|FG004|Overall Study|Withdrawal by Subject|0|||
146139975|NCT03604692|527026601|FG005|Overall Study|Withdrawal by Subject|2|||
146139976|NCT03604692|527026596|FG000|Overall Study|Progressive Disease|1|||
146139977|NCT03604692|527026597|FG001|Overall Study|Progressive Disease|0|||
146139978|NCT03604692|527026598|FG002|Overall Study|Progressive Disease|1|||
146139979|NCT03604692|527026599|FG003|Overall Study|Progressive Disease|0|||
146139980|NCT03604692|527026600|FG004|Overall Study|Progressive Disease|3|||
146139981|NCT03604692|527026601|FG005|Overall Study|Progressive Disease|4|||
146139982|NCT03604692|527026596|FG000|Overall Study|Difficulty Coming into Site|0|||
146139983|NCT03604692|527026597|FG001|Overall Study|Difficulty Coming into Site|0|||
146139984|NCT03604692|527026598|FG002|Overall Study|Difficulty Coming into Site|0|||
146139985|NCT03604692|527026599|FG003|Overall Study|Difficulty Coming into Site|0|||
146139986|NCT03604692|527026600|FG004|Overall Study|Difficulty Coming into Site|0|||
146139987|NCT03604692|527026601|FG005|Overall Study|Difficulty Coming into Site|1|||
146139988|NCT03604692|527026596|FG000|Overall Study|Death|0|||
146139989|NCT03604692|527026597|FG001|Overall Study|Death|0|||
146139990|NCT03604692|527026598|FG002|Overall Study|Death|1|||
146139991|NCT03604692|527026599|FG003|Overall Study|Death|0|||
146139992|NCT03604692|527026600|FG004|Overall Study|Death|0|||
146139993|NCT03604692|527026601|FG005|Overall Study|Death|0|||
146139994|NCT03604692|527026596|FG000|Overall Study|Drug Intolerance|0|||
146139995|NCT03604692|527026597|FG001|Overall Study|Drug Intolerance|0|||
146139996|NCT03604692|527026598|FG002|Overall Study|Drug Intolerance|0|||
146139997|NCT03604692|527026599|FG003|Overall Study|Drug Intolerance|1|||
146139998|NCT03604692|527026600|FG004|Overall Study|Drug Intolerance|0|||
146139999|NCT03604692|527026601|FG005|Overall Study|Drug Intolerance|0|||
146140000|NCT03604692|527026596|FG000|Overall Study|Noncompliance with follow-up visit|0|||
146140001|NCT03604692|527026597|FG001|Overall Study|Noncompliance with follow-up visit|0|||
146140002|NCT03604692|527026598|FG002|Overall Study|Noncompliance with follow-up visit|0|||
146140003|NCT03604692|527026599|FG003|Overall Study|Noncompliance with follow-up visit|1|||
146140004|NCT03604692|527026600|FG004|Overall Study|Noncompliance with follow-up visit|0|||
146140005|NCT03604692|527026601|FG005|Overall Study|Noncompliance with follow-up visit|0|||
146140006|NCT03604692|527026596|FG000|Overall Study|Not Treated|0|||
146140007|NCT03604692|527026597|FG001|Overall Study|Not Treated|0|||
146140008|NCT03604692|527026598|FG002|Overall Study|Not Treated|0|||
146140009|NCT03604692|527026599|FG003|Overall Study|Not Treated|0|||
146140010|NCT03604692|527026600|FG004|Overall Study|Not Treated|1|||
146140011|NCT03604692|527026601|FG005|Overall Study|Not Treated|0|||
146140012|NCT00637195|527026605|FG000|Overall Study|Lost to Follow-up|1|||
146140013|NCT00637195|527026606|FG001|Overall Study|Lost to Follow-up|0|||
146140014|NCT00637195|527026605|FG000|Overall Study|Other|2|||
146140015|NCT00637195|527026606|FG001|Overall Study|Other|0|||
146140016|NCT00637195|527026605|FG000|Overall Study|Withdrawal by Subject|0|||
146140017|NCT00637195|527026606|FG001|Overall Study|Withdrawal by Subject|1|||
146140018|NCT01469065|527026607|FG000|Overall Study|Lack of Efficacy|0|||
146140019|NCT01469065|527026608|FG001|Overall Study|Lack of Efficacy|0|||
146140020|NCT01469065|527026609|FG002|Overall Study|Lack of Efficacy|0|||
146140021|NCT01469065|527026610|FG003|Overall Study|Lack of Efficacy|0|||
146140022|NCT01469065|527026611|FG004|Overall Study|Lack of Efficacy|1|||
146140023|NCT01469065|527026607|FG000|Overall Study|Other|0|||
146140024|NCT01469065|527026608|FG001|Overall Study|Other|1|||
146140025|NCT01469065|527026609|FG002|Overall Study|Other|0|||
146140026|NCT01469065|527026610|FG003|Overall Study|Other|0|||
146140027|NCT01469065|527026611|FG004|Overall Study|Other|0|||
146140028|NCT01020019|527026617|FG000|Overall Study|Lost to Follow-up|21|||
146140029|NCT01020019|527026618|FG001|Overall Study|Lost to Follow-up|18|||
146140030|NCT01020019|527026617|FG000|Overall Study|Adverse Event|1|||
146140031|NCT01020019|527026618|FG001|Overall Study|Adverse Event|5|||
146140032|NCT01020019|527026617|FG000|Overall Study|not interested in treatment|4|||
146140033|NCT01020019|527026618|FG001|Overall Study|not interested in treatment|4|||
146140034|NCT01020019|527026617|FG000|Overall Study|moving|0|||
146140035|NCT01020019|527026618|FG001|Overall Study|moving|2|||
146140036|NCT05091528|527026619|FG000|Overall Study|Study Termination by Sponsor|0|||
146140037|NCT05091528|527026620|FG001|Overall Study|Study Termination by Sponsor|1|||
146140038|NCT05091528|527026621|FG002|Overall Study|Study Termination by Sponsor|0|||
146140039|NCT05091528|527026622|FG003|Overall Study|Study Termination by Sponsor|1|||
146140040|NCT02375672|527026623|FG000|Overall Study|remain on follow up|20|||
146140041|NCT00094653|527026626|FG000|Overall Study|Death|306|||
146140042|NCT00094653|527026627|FG001|Overall Study|Death|100|||
146140043|NCT00094653|527026628|FG002|Overall Study|Death|119|||
146140044|NCT00094653|527026626|FG000|Overall Study|Subject Withdrew Consent|10|||
146140045|NCT00094653|527026627|FG001|Overall Study|Subject Withdrew Consent|2|||
146140046|NCT00094653|527026628|FG002|Overall Study|Subject Withdrew Consent|3|||
146140047|NCT00094653|527026626|FG000|Overall Study|Other|2|||
146140048|NCT00094653|527026627|FG001|Overall Study|Other|2|||
146140049|NCT00094653|527026628|FG002|Overall Study|Other|2|||
146140050|NCT00094653|527026626|FG000|Overall Study|Lost to Follow-up|3|||
146140051|NCT00094653|527026627|FG001|Overall Study|Lost to Follow-up|2|||
146140052|NCT00094653|527026628|FG002|Overall Study|Lost to Follow-up|1|||
146140053|NCT00094653|527026626|FG000|Overall Study|Protocol Violation|0|||
146140054|NCT00094653|527026627|FG001|Overall Study|Protocol Violation|0|||
146140055|NCT00094653|527026628|FG002|Overall Study|Protocol Violation|1|||
146140056|NCT03921411|527026629|FG000|Overall Study|Withdrawal by Subject|1|||
146140057|NCT03921411|527026629|FG000|Overall Study|Protocol Deviation|2|||
146140058|NCT03921411|527026629|FG000|Overall Study|Enrolled, but never treated|2|||
146140059|NCT00006916|527026630|FG000|Overall Study|Device not inserted|4|||
146140060|NCT00006916|527026630|FG000|Overall Study|Complication of device insertion|1|||
146140061|NCT00558103|527026631|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
146140062|NCT00558103|527026632|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
146140063|NCT00558103|527026633|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
146140064|NCT00558103|527026634|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
146140065|NCT00558103|527026635|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
146140066|NCT00558103|527026636|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
146140067|NCT00558103|527026631|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
146140068|NCT00558103|527026632|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
146140069|NCT00558103|527026633|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
146140070|NCT00558103|527026634|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
146140071|NCT00558103|527026635|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
146140072|NCT00558103|527026636|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
146140073|NCT00558103|527026631|FG000|Randomized Treatment Phase|Disease Progression|1|||
146140074|NCT00558103|527026632|FG001|Randomized Treatment Phase|Disease Progression|0|||
146140075|NCT00558103|527026633|FG002|Randomized Treatment Phase|Disease Progression|1|||
146140076|NCT00558103|527026634|FG003|Randomized Treatment Phase|Disease Progression|0|||
146140077|NCT00558103|527026635|FG004|Randomized Treatment Phase|Disease Progression|0|||
146140078|NCT00558103|527026636|FG005|Randomized Treatment Phase|Disease Progression|0|||
146140079|NCT00558103|527026631|FG000|Randomized Treatment Phase|Adverse Event|0|||
146140080|NCT00558103|527026632|FG001|Randomized Treatment Phase|Adverse Event|0|||
146140081|NCT00558103|527026633|FG002|Randomized Treatment Phase|Adverse Event|0|||
146140082|NCT00558103|527026634|FG003|Randomized Treatment Phase|Adverse Event|1|||
146140083|NCT00558103|527026635|FG004|Randomized Treatment Phase|Adverse Event|1|||
146140084|NCT00558103|527026636|FG005|Randomized Treatment Phase|Adverse Event|0|||
146140085|NCT00558103|527026631|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
146140086|NCT00558103|527026632|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
146140087|NCT00558103|527026633|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
146140088|NCT00558103|527026634|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
146140089|NCT00558103|527026635|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
146140090|NCT00558103|527026636|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
146140091|NCT00558103|527026631|FG000|Monotherapy Extension Phase|Disease Progression|0|||
146140092|NCT00558103|527026632|FG001|Monotherapy Extension Phase|Disease Progression|0|||
146140093|NCT00558103|527026633|FG002|Monotherapy Extension Phase|Disease Progression|0|||
146140094|NCT00558103|527026634|FG003|Monotherapy Extension Phase|Disease Progression|0|||
146140095|NCT00558103|527026635|FG004|Monotherapy Extension Phase|Disease Progression|0|||
146140096|NCT00558103|527026636|FG005|Monotherapy Extension Phase|Disease Progression|8|||
146140097|NCT01420081|527026638|FG000|Overall Study|Death|1|||
146140098|NCT01420081|527026639|FG001|Overall Study|Death|0|||
146140099|NCT01420081|527026640|FG002|Overall Study|Death|8|||
146140100|NCT01420081|527026641|FG003|Overall Study|Death|0|||
146140101|NCT01420081|527026642|FG004|Overall Study|Death|7|||
146140102|NCT01420081|527026643|FG005|Overall Study|Death|12|||
146140103|NCT01420081|527026644|FG006|Overall Study|Death|0|||
146140104|NCT01420081|527026645|FG007|Overall Study|Death|1|||
146140105|NCT01420081|527026646|FG008|Overall Study|Death|1|||
146140106|NCT01420081|527026638|FG000|Overall Study|Lost to Follow-up|0|||
146140107|NCT01420081|527026639|FG001|Overall Study|Lost to Follow-up|0|||
146140108|NCT01420081|527026640|FG002|Overall Study|Lost to Follow-up|0|||
146140109|NCT01420081|527026641|FG003|Overall Study|Lost to Follow-up|0|||
146140110|NCT01420081|527026642|FG004|Overall Study|Lost to Follow-up|1|||
146140111|NCT01420081|527026643|FG005|Overall Study|Lost to Follow-up|1|||
146140112|NCT01420081|527026644|FG006|Overall Study|Lost to Follow-up|0|||
146140113|NCT01420081|527026645|FG007|Overall Study|Lost to Follow-up|0|||
146140114|NCT01420081|527026646|FG008|Overall Study|Lost to Follow-up|0|||
146140115|NCT01420081|527026638|FG000|Overall Study|Study Terminated by Sponsor|2|||
146140116|NCT01420081|527026639|FG001|Overall Study|Study Terminated by Sponsor|1|||
146140117|NCT01420081|527026640|FG002|Overall Study|Study Terminated by Sponsor|1|||
146140118|NCT01420081|527026641|FG003|Overall Study|Study Terminated by Sponsor|3|||
146140119|NCT01420081|527026642|FG004|Overall Study|Study Terminated by Sponsor|11|||
146140120|NCT01420081|527026643|FG005|Overall Study|Study Terminated by Sponsor|7|||
146140121|NCT01420081|527026644|FG006|Overall Study|Study Terminated by Sponsor|3|||
146140122|NCT01420081|527026645|FG007|Overall Study|Study Terminated by Sponsor|2|||
146140123|NCT01420081|527026646|FG008|Overall Study|Study Terminated by Sponsor|2|||
146140124|NCT01420081|527026638|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
146140125|NCT01420081|527026639|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
146140126|NCT01420081|527026640|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
146140127|NCT01420081|527026641|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
146140128|NCT01420081|527026642|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
146140129|NCT01420081|527026643|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
146140130|NCT01420081|527026644|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
146140131|NCT01420081|527026645|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
146140132|NCT01420081|527026646|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
146140133|NCT01420081|527026638|FG000|Overall Study|Other Reasons|0|||
146140134|NCT01420081|527026639|FG001|Overall Study|Other Reasons|0|||
146140135|NCT01420081|527026640|FG002|Overall Study|Other Reasons|1|||
146140136|NCT01420081|527026641|FG003|Overall Study|Other Reasons|0|||
146140137|NCT01420081|527026642|FG004|Overall Study|Other Reasons|0|||
146140138|NCT01420081|527026643|FG005|Overall Study|Other Reasons|0|||
146140139|NCT01420081|527026644|FG006|Overall Study|Other Reasons|0|||
146140140|NCT01420081|527026645|FG007|Overall Study|Other Reasons|0|||
146140141|NCT01420081|527026646|FG008|Overall Study|Other Reasons|0|||
146140142|NCT00218543|527026647|FG000|Overall Study|Lost to Follow-up|8|||
146140143|NCT00218543|527026647|FG000|Overall Study|relocated|1|||
146140144|NCT00218543|527026647|FG000|Overall Study|Withdrawal by Subject|1|||
146140145|NCT00218543|527026647|FG000|Overall Study|Physician Decision|3|||
146140146|NCT00218543|527026647|FG000|Overall Study|Adverse Event|2|||
146140147|NCT02448875|527026648|FG000|Overall Study|Adverse Event|2|||
146140148|NCT02448875|527026649|FG001|Overall Study|Adverse Event|1|||
146140149|NCT02448875|527026650|FG002|Overall Study|Adverse Event|0|||
146140150|NCT02448875|527026648|FG000|Overall Study|Lost to Follow-up|1|||
146140151|NCT02448875|527026649|FG001|Overall Study|Lost to Follow-up|0|||
146140152|NCT02448875|527026650|FG002|Overall Study|Lost to Follow-up|0|||
146140153|NCT02448875|527026648|FG000|Overall Study|Investigator Decision|3|||
146140154|NCT02448875|527026649|FG001|Overall Study|Investigator Decision|0|||
146140155|NCT02448875|527026650|FG002|Overall Study|Investigator Decision|1|||
146140156|NCT02448875|527026648|FG000|Overall Study|Withdrawal by Subject|1|||
146140157|NCT02448875|527026649|FG001|Overall Study|Withdrawal by Subject|0|||
146140158|NCT02448875|527026650|FG002|Overall Study|Withdrawal by Subject|0|||
146140159|NCT03337724|527026653|FG000|Overall Study|Reason not Specified|12|||
146140160|NCT03337724|527026654|FG001|Overall Study|Reason not Specified|21|||
146140161|NCT03337724|527026655|FG002|Overall Study|Reason not Specified|9|||
146140162|NCT03337724|527026656|FG003|Overall Study|Reason not Specified|9|||
146140163|NCT03337724|527026657|FG004|Overall Study|Reason not Specified|29|||
146140164|NCT03337724|527026653|FG000|Overall Study|Withdrawal by Subject|13|||
146140165|NCT03337724|527026654|FG001|Overall Study|Withdrawal by Subject|15|||
146140166|NCT03337724|527026655|FG002|Overall Study|Withdrawal by Subject|4|||
146140167|NCT03337724|527026656|FG003|Overall Study|Withdrawal by Subject|15|||
146140168|NCT03337724|527026657|FG004|Overall Study|Withdrawal by Subject|6|||
146140169|NCT03337724|527026653|FG000|Overall Study|Protocol Deviation|0|||
146140170|NCT03337724|527026654|FG001|Overall Study|Protocol Deviation|1|||
146140171|NCT03337724|527026655|FG002|Overall Study|Protocol Deviation|1|||
146140172|NCT03337724|527026656|FG003|Overall Study|Protocol Deviation|1|||
146140173|NCT03337724|527026657|FG004|Overall Study|Protocol Deviation|0|||
146140174|NCT03337724|527026653|FG000|Overall Study|Adverse Event|1|||
146140175|NCT03337724|527026654|FG001|Overall Study|Adverse Event|1|||
146140176|NCT03337724|527026655|FG002|Overall Study|Adverse Event|0|||
146140177|NCT03337724|527026656|FG003|Overall Study|Adverse Event|1|||
146140178|NCT03337724|527026657|FG004|Overall Study|Adverse Event|0|||
146140179|NCT03337724|527026653|FG000|Overall Study|Death|40|||
146140180|NCT03337724|527026654|FG001|Overall Study|Death|89|||
146140181|NCT03337724|527026655|FG002|Overall Study|Death|43|||
146140182|NCT03337724|527026656|FG003|Overall Study|Death|76|||
146140183|NCT03337724|527026657|FG004|Overall Study|Death|50|||
146140184|NCT03337724|527026653|FG000|Overall Study|Lost to Follow-up|5|||
146140185|NCT03337724|527026654|FG001|Overall Study|Lost to Follow-up|5|||
146140186|NCT03337724|527026655|FG002|Overall Study|Lost to Follow-up|4|||
146140187|NCT03337724|527026656|FG003|Overall Study|Lost to Follow-up|7|||
146140188|NCT03337724|527026657|FG004|Overall Study|Lost to Follow-up|4|||
146140189|NCT03337724|527026653|FG000|Overall Study|Physician Decision|16|||
146140190|NCT03337724|527026654|FG001|Overall Study|Physician Decision|34|||
146140191|NCT03337724|527026655|FG002|Overall Study|Physician Decision|14|||
146140192|NCT03337724|527026656|FG003|Overall Study|Physician Decision|34|||
146140193|NCT03337724|527026657|FG004|Overall Study|Physician Decision|13|||
146140194|NCT03337724|527026653|FG000|Overall Study|Progressive Disease|0|||
146140195|NCT03337724|527026654|FG001|Overall Study|Progressive Disease|2|||
146140196|NCT03337724|527026655|FG002|Overall Study|Progressive Disease|1|||
146140197|NCT03337724|527026656|FG003|Overall Study|Progressive Disease|2|||
146140198|NCT03337724|527026657|FG004|Overall Study|Progressive Disease|0|||
146140199|NCT03337724|527026653|FG000|Overall Study|Symptomatic Deterioration|0|||
146140200|NCT03337724|527026654|FG001|Overall Study|Symptomatic Deterioration|0|||
146140201|NCT03337724|527026655|FG002|Overall Study|Symptomatic Deterioration|0|||
146140202|NCT03337724|527026656|FG003|Overall Study|Symptomatic Deterioration|1|||
146140203|NCT03337724|527026657|FG004|Overall Study|Symptomatic Deterioration|0|||
146140204|NCT00773097|527026658|FG000|Overall Study|Withdrawal by Subject|1|||
146140205|NCT00773097|527026658|FG000|Overall Study|Physician Decision|6|||
146140206|NCT01038778|527026659|FG000|Overall Study|Withdrawal by Subject|0|||
146140207|NCT01038778|527026660|FG001|Overall Study|Withdrawal by Subject|2|||
146140208|NCT01038778|527026661|FG002|Overall Study|Withdrawal by Subject|3|||
146140209|NCT02488629|527028133|FG000|Overall Study|Lack of Efficacy|3|||
146140210|NCT02488629|527028134|FG001|Overall Study|Lack of Efficacy|1|||
146140211|NCT02488629|527028135|FG002|Overall Study|Lack of Efficacy|0|||
146140212|NCT02488629|527028136|FG003|Overall Study|Lack of Efficacy|0|||
146140213|NCT02488629|527028133|FG000|Overall Study|Withdrawal by Subject|0|||
146140214|NCT02488629|527028134|FG001|Overall Study|Withdrawal by Subject|1|||
146140215|NCT02488629|527028135|FG002|Overall Study|Withdrawal by Subject|0|||
146140216|NCT02488629|527028136|FG003|Overall Study|Withdrawal by Subject|0|||
146140217|NCT00796861|527028137|FG000|Overall Study|Withdrawal by Subject|2|||
146140218|NCT00796861|527028137|FG000|Overall Study|Death|2|||
146140219|NCT00529386|527028146|FG000|Overall Study|Lost to Follow-up|1|||
146140220|NCT02039427|527028150|FG000|Overall Study|Duration of surgery > 3h|1|||
146140221|NCT02039427|527028151|FG001|Overall Study|Duration of surgery > 3h|1|||
146140222|NCT02039427|527028152|FG002|Overall Study|Duration of surgery > 3h|0|||
146140223|NCT02039427|527028153|FG003|Overall Study|Duration of surgery > 3h|0|||
146140224|NCT02039427|527028150|FG000|Overall Study|Withdrawal on concent|0|||
146140225|NCT02039427|527028151|FG001|Overall Study|Withdrawal on concent|0|||
146140226|NCT02039427|527028152|FG002|Overall Study|Withdrawal on concent|0|||
146140227|NCT02039427|527028153|FG003|Overall Study|Withdrawal on concent|1|||
146140228|NCT02039427|527028150|FG000|Overall Study|Cancellation of surgery|0|||
146140229|NCT02039427|527028151|FG001|Overall Study|Cancellation of surgery|0|||
146140230|NCT02039427|527028152|FG002|Overall Study|Cancellation of surgery|1|||
146140231|NCT02039427|527028153|FG003|Overall Study|Cancellation of surgery|0|||
146140232|NCT02039427|527028150|FG000|Overall Study|Loss of follow - up|1|||
146140233|NCT02039427|527028151|FG001|Overall Study|Loss of follow - up|0|||
146140234|NCT02039427|527028152|FG002|Overall Study|Loss of follow - up|2|||
146140235|NCT02039427|527028153|FG003|Overall Study|Loss of follow - up|4|||
146140236|NCT02039427|527028150|FG000|Overall Study|Steroid Use|1|||
146140237|NCT02039427|527028151|FG001|Overall Study|Steroid Use|0|||
146271463|NCT02412735|527509750|FG001|Overall Study|Adverse Event|1|||
146140238|NCT02039427|527028152|FG002|Overall Study|Steroid Use|0|||
146140239|NCT02039427|527028153|FG003|Overall Study|Steroid Use|0|||
146140240|NCT00844545|527028154|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
146140241|NCT00844545|527028154|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
146140242|NCT00844545|527028154|FG000|Extension Treatment Period|Adverse Event|2|||
146140243|NCT00844545|527028154|FG000|Post Treatment Period|Withdrawal by Subject|1|||
146140244|NCT01532687|527028161|FG000|Overall Study|Death|2|||
146140245|NCT01532687|527028162|FG001|Overall Study|Death|0|||
146140246|NCT01532687|527028161|FG000|Overall Study|Adverse Event|6|||
146140247|NCT01532687|527028162|FG001|Overall Study|Adverse Event|1|||
146140248|NCT01532687|527028161|FG000|Overall Study|Withdrawal by Subject|1|||
146140249|NCT01532687|527028162|FG001|Overall Study|Withdrawal by Subject|0|||
146140250|NCT01532687|527028161|FG000|Overall Study|Physician Decision|2|||
146140251|NCT01532687|527028162|FG001|Overall Study|Physician Decision|1|||
146140252|NCT01532687|527028161|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
146140253|NCT01532687|527028162|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
146140254|NCT04354831|527028163|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
146140255|NCT04354831|527028164|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
146140256|NCT02939404|527028165|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
146140257|NCT02939404|527028166|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
146140258|NCT02939404|527028165|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
146140259|NCT02939404|527028166|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
146140260|NCT06640829|527028168|FG000|Overall Study|Withdrawal by Subject|1|||
146140261|NCT06640829|527028168|FG000|Overall Study|Lost to Follow-up|1|||
146140262|NCT01350128|527028169|FG000|Overall Study|Withdrawal by Subject|3|||
146140263|NCT01350128|527028169|FG000|Overall Study|Protocol discontinuation criteria|8|||
146140264|NCT01350128|527028169|FG000|Overall Study|Physician Decision|1|||
146140265|NCT01350128|527028169|FG000|Overall Study|Lost to Follow-up|2|||
146140266|NCT01252290|527028172|FG000|Overall Study|Withdrawal by Subject|1|||
146140267|NCT02075437|527028173|FG000|Overall Study|Withdrawal by Subject|5|||
146140268|NCT02075437|527028173|FG000|Overall Study|Lost to Follow-up|1|||
146140269|NCT04439240|527028174|FG000|Overall Study|Ineligible|2|||
146140270|NCT04439240|527028174|FG000|Overall Study|Never started treatment|2|||
146140271|NCT04439240|527028174|FG000|Overall Study|Adverse Event|12|||
146140272|NCT04439240|527028174|FG000|Overall Study|Death|2|||
146140273|NCT04439240|527028174|FG000|Overall Study|Disease progression|25|||
146140274|NCT04439240|527028174|FG000|Overall Study|Other diseases|2|||
146140275|NCT04439240|527028174|FG000|Overall Study|Withdrawal by Subject|3|||
146140276|NCT04439240|527028174|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
146140277|NCT04439240|527028174|FG000|Overall Study|Symptomatic decline|1|||
146140278|NCT04439240|527028174|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
146140279|NCT04439240|527028174|FG000|Overall Study|Clinical progression|1|||
146140280|NCT03120013|527028178|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
146140281|NCT03120013|527028179|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146140282|NCT02098109|527028180|FG000|Overall Study|Protocol Violation|3|||
146140283|NCT02098109|527028181|FG001|Overall Study|Protocol Violation|0|||
146140284|NCT01541826|527028182|FG000|Overall Study|Lost to Follow-up|2|||
146140285|NCT01541826|527028183|FG001|Overall Study|Lost to Follow-up|3|||
146140286|NCT01541826|527028184|FG002|Overall Study|Lost to Follow-up|0|||
146140287|NCT01541826|527028182|FG000|Overall Study|Withdrawal by Subject|2|||
146140288|NCT01541826|527028183|FG001|Overall Study|Withdrawal by Subject|0|||
146140289|NCT01541826|527028184|FG002|Overall Study|Withdrawal by Subject|0|||
146140290|NCT01565291|527028185|FG000|Overall Study|Withdrawal by Subject|1|||
146140291|NCT01565291|527028186|FG001|Overall Study|Withdrawal by Subject|0|||
146140292|NCT02143843|527028187|FG000|Overall Study|Adverse Event|8|||
146140293|NCT02143843|527028187|FG000|Overall Study|Lack of Efficacy|2|||
146140294|NCT02143843|527028187|FG000|Overall Study|Withdrawal by Subject|2|||
146140295|NCT02702401|527028192|FG000|Overall Study|Death|242|||
146140296|NCT02702401|527028193|FG001|Overall Study|Death|125|||
146140297|NCT02702401|527028192|FG000|Overall Study|Withdrawal by Subject|15|||
146140298|NCT02702401|527028193|FG001|Overall Study|Withdrawal by Subject|5|||
146140299|NCT02702401|527028192|FG000|Overall Study|Sponsor Decision|19|||
146140300|NCT02702401|527028193|FG001|Overall Study|Sponsor Decision|3|||
146140301|NCT02702401|527028192|FG000|Overall Study|Physician Decision|1|||
146140302|NCT02702401|527028193|FG001|Overall Study|Physician Decision|2|||
146140303|NCT02702401|527028192|FG000|Overall Study|Lost to Follow-up|1|||
146140304|NCT02702401|527028193|FG001|Overall Study|Lost to Follow-up|0|||
146140305|NCT01462357|527028198|FG000|Overall Study|Death|0|||
146140306|NCT01462357|527028199|FG001|Overall Study|Death|0|||
146140307|NCT01462357|527028200|FG002|Overall Study|Death|1|||
146140308|NCT01462357|527028198|FG000|Overall Study|Withdrawal by Subject|3|||
146140309|NCT01462357|527028199|FG001|Overall Study|Withdrawal by Subject|11|||
146140310|NCT01462357|527028200|FG002|Overall Study|Withdrawal by Subject|3|||
146140311|NCT01462357|527028198|FG000|Overall Study|Migrated/moved from study area|2|||
146140312|NCT01462357|527028199|FG001|Overall Study|Migrated/moved from study area|3|||
146140313|NCT01462357|527028200|FG002|Overall Study|Migrated/moved from study area|1|||
146140314|NCT01462357|527028198|FG000|Overall Study|Lost to Follow-up|3|||
146140315|NCT01462357|527028199|FG001|Overall Study|Lost to Follow-up|5|||
146140316|NCT01462357|527028200|FG002|Overall Study|Lost to Follow-up|7|||
146140317|NCT04292730|527028202|FG000|Overall Study|Lost to Follow-up|8|||
146140318|NCT04292730|527028203|FG001|Overall Study|Lost to Follow-up|12|||
146140319|NCT04292730|527028204|FG002|Overall Study|Lost to Follow-up|12|||
146140320|NCT04292730|527028205|FG003|Overall Study|Lost to Follow-up|48|||
146140321|NCT04292730|527028202|FG000|Overall Study|Death|2|||
146140322|NCT04292730|527028203|FG001|Overall Study|Death|2|||
146140323|NCT04292730|527028204|FG002|Overall Study|Death|4|||
146140324|NCT04292730|527028205|FG003|Overall Study|Death|12|||
146140325|NCT04292730|527028202|FG000|Overall Study|Withdrew Consent|2|||
146140326|NCT04292730|527028203|FG001|Overall Study|Withdrew Consent|2|||
146140327|NCT04292730|527028204|FG002|Overall Study|Withdrew Consent|5|||
146140328|NCT04292730|527028205|FG003|Overall Study|Withdrew Consent|6|||
146140329|NCT04292730|527028202|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146140330|NCT04292730|527028203|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146140331|NCT04292730|527028204|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146140332|NCT04292730|527028205|FG003|Overall Study|Non-Compliance with Study Drug|0|||
146140333|NCT04292730|527028202|FG000|Overall Study|Protocol Violation|0|||
146140334|NCT04292730|527028203|FG001|Overall Study|Protocol Violation|0|||
146140335|NCT04292730|527028204|FG002|Overall Study|Protocol Violation|1|||
146140336|NCT04292730|527028205|FG003|Overall Study|Protocol Violation|0|||
146140337|NCT04292730|527028202|FG000|Overall Study|Randomized but not Treated|8|||
146140338|NCT04292730|527028203|FG001|Overall Study|Randomized but not Treated|4|||
146140339|NCT04292730|527028204|FG002|Overall Study|Randomized but not Treated|0|||
146140340|NCT04292730|527028205|FG003|Overall Study|Randomized but not Treated|14|||
146140341|NCT01527292|527028206|FG000|Overall Study|Physician Decision|0|||
146140342|NCT01527292|527028207|FG001|Overall Study|Physician Decision|3|||
146140343|NCT01482767|527028210|FG000|Overall Study|Death|1|||
146140344|NCT01482767|527028211|FG001|Overall Study|Death|1|||
146140345|NCT01482767|527028210|FG000|Overall Study|Withdrawal by Subject|7|||
146140346|NCT01482767|527028211|FG001|Overall Study|Withdrawal by Subject|5|||
146140347|NCT01482767|527028210|FG000|Overall Study|Lost to Follow-up|12|||
146140348|NCT01482767|527028211|FG001|Overall Study|Lost to Follow-up|6|||
146140349|NCT01482767|527028210|FG000|Overall Study|Adverse Event|0|||
146140350|NCT01482767|527028211|FG001|Overall Study|Adverse Event|3|||
146140351|NCT01482767|527028210|FG000|Overall Study|Site closure|22|||
146140352|NCT01482767|527028211|FG001|Overall Study|Site closure|14|||
146140353|NCT01482767|527028210|FG000|Overall Study|Non-adherence to study requirements|4|||
146140354|NCT01482767|527028211|FG001|Overall Study|Non-adherence to study requirements|7|||
146140355|NCT01482767|527028210|FG000|Overall Study|Alternate HCV treatment|7|||
146140356|NCT01482767|527028211|FG001|Overall Study|Alternate HCV treatment|8|||
146140357|NCT01482767|527028210|FG000|Overall Study|Ineligible|0|||
146140358|NCT01482767|527028211|FG001|Overall Study|Ineligible|5|||
146140359|NCT01482767|527028210|FG000|Overall Study|Nurse error|1|||
146140360|NCT01482767|527028211|FG001|Overall Study|Nurse error|0|||
146140361|NCT01247090|527028214|FG000|Overall Study|Physician Decision|1|||
146140362|NCT01247090|527028215|FG001|Overall Study|Physician Decision|0|||
146140363|NCT01247090|527028216|FG002|Overall Study|Physician Decision|0|||
146140364|NCT01247090|527028214|FG000|Overall Study|Withdrawal by Subject|0|||
146140365|NCT01247090|527028215|FG001|Overall Study|Withdrawal by Subject|1|||
146140366|NCT01247090|527028216|FG002|Overall Study|Withdrawal by Subject|0|||
146140367|NCT02457325|527028220|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
146140368|NCT02457325|527028221|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
146140369|NCT03385239|527028224|FG000|Overall Study|Voluntary Withdrawal|2|||
146140370|NCT03385239|527028225|FG001|Overall Study|Voluntary Withdrawal|3|||
146140371|NCT03385239|527028226|FG002|Overall Study|Voluntary Withdrawal|2|||
146140372|NCT03385239|527028227|FG003|Overall Study|Voluntary Withdrawal|3|||
146140373|NCT03385239|527028228|FG004|Overall Study|Voluntary Withdrawal|0|||
146140374|NCT03385239|527028224|FG000|Overall Study|Adverse Event|0|||
146140375|NCT03385239|527028225|FG001|Overall Study|Adverse Event|0|||
146140376|NCT03385239|527028226|FG002|Overall Study|Adverse Event|1|||
146140377|NCT03385239|527028227|FG003|Overall Study|Adverse Event|0|||
146140378|NCT03385239|527028228|FG004|Overall Study|Adverse Event|0|||
146140379|NCT03385239|527028224|FG000|Overall Study|Other|0|||
146140380|NCT03385239|527028225|FG001|Overall Study|Other|0|||
146140381|NCT03385239|527028226|FG002|Overall Study|Other|0|||
146140382|NCT03385239|527028227|FG003|Overall Study|Other|1|||
146140383|NCT03385239|527028228|FG004|Overall Study|Other|0|||
146140384|NCT01574703|527028229|FG000|Overall Study|Adverse Event|0|||
146140385|NCT01574703|527028230|FG001|Overall Study|Adverse Event|2|||
146140386|NCT01574703|527028231|FG002|Overall Study|Adverse Event|1|||
146140387|NCT01574703|527028232|FG003|Overall Study|Adverse Event|1|||
146140388|NCT01574703|527028229|FG000|Overall Study|Protocol Violation|0|||
146140389|NCT01574703|527028230|FG001|Overall Study|Protocol Violation|0|||
146140390|NCT01574703|527028231|FG002|Overall Study|Protocol Violation|0|||
146140391|NCT01574703|527028232|FG003|Overall Study|Protocol Violation|1|||
146140392|NCT01574703|527028229|FG000|Overall Study|Unspecified Reason|27|||
146140393|NCT01574703|527028230|FG001|Overall Study|Unspecified Reason|15|||
146140394|NCT01574703|527028231|FG002|Overall Study|Unspecified Reason|20|||
146140395|NCT01574703|527028232|FG003|Overall Study|Unspecified Reason|16|||
146140396|NCT01574703|527028229|FG000|Overall Study|Withdrawal by Subject|53|||
146140397|NCT01574703|527028230|FG001|Overall Study|Withdrawal by Subject|52|||
146140398|NCT01574703|527028231|FG002|Overall Study|Withdrawal by Subject|36|||
146140399|NCT01574703|527028232|FG003|Overall Study|Withdrawal by Subject|61|||
146140400|NCT01574703|527028229|FG000|Overall Study|Met Withdrawal Criteria|0|||
146140401|NCT01574703|527028230|FG001|Overall Study|Met Withdrawal Criteria|1|||
146140402|NCT01574703|527028231|FG002|Overall Study|Met Withdrawal Criteria|1|||
146140403|NCT01574703|527028232|FG003|Overall Study|Met Withdrawal Criteria|0|||
146140404|NCT01574703|527028229|FG000|Overall Study|Lost to Follow-up|43|||
146140405|NCT01574703|527028230|FG001|Overall Study|Lost to Follow-up|41|||
146140406|NCT01574703|527028231|FG002|Overall Study|Lost to Follow-up|46|||
146140407|NCT01574703|527028232|FG003|Overall Study|Lost to Follow-up|35|||
146140408|NCT01574703|527028229|FG000|Overall Study|Death|2|||
146140409|NCT01574703|527028230|FG001|Overall Study|Death|1|||
146140410|NCT01574703|527028231|FG002|Overall Study|Death|1|||
146140411|NCT01574703|527028232|FG003|Overall Study|Death|0|||
146140412|NCT02751983|527028233|FG000|Treatment|Stopped ACT, but Remained in study|2|||
146140413|NCT02751983|527028234|FG001|Treatment|Stopped ACT, but Remained in study|0|||
146140414|NCT02751983|527028233|FG000|Treatment|Discharged prior to beginning ACT|2|||
146140415|NCT02751983|527028234|FG001|Treatment|Discharged prior to beginning ACT|0|||
146140416|NCT02751983|527028233|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
146140417|NCT02751983|527028234|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
146140418|NCT02751983|527028233|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
146140419|NCT02751983|527028234|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
146140420|NCT02751983|527028233|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
146140421|NCT02751983|527028234|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
146140422|NCT03139916|527028237|FG000|Overall Study|Withdrawal by Subject|2|||
146140423|NCT03139916|527028237|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
146140424|NCT00025883|527028238|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
146140425|NCT00025883|527028238|FG000|Overall Study|no baseline data|1|||
146140426|NCT00025883|527028238|FG000|Overall Study|Death|1|||
146140427|NCT00025883|527028238|FG000|Overall Study|Adverse Event|1|||
146140428|NCT00025883|527028238|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
146140429|NCT03591575|527028239|FG000|Overall Study|Adverse Event|2|||
146140430|NCT03591575|527028240|FG001|Overall Study|Adverse Event|0|||
146140431|NCT03591575|527028239|FG000|Overall Study|Withdrawal by Subject|4|||
146140432|NCT03591575|527028240|FG001|Overall Study|Withdrawal by Subject|1|||
146140433|NCT01282216|527028241|FG000|Overall Study|Graft failure|0|||
146140434|NCT01282216|527028242|FG001|Overall Study|Graft failure|0|||
146140435|NCT01282216|527028243|FG002|Overall Study|Graft failure|3|||
146140436|NCT01282216|527028244|FG003|Overall Study|Graft failure|2|||
146140437|NCT01282216|527028241|FG000|Overall Study|Physician Decision|0|||
146140438|NCT01282216|527028242|FG001|Overall Study|Physician Decision|0|||
146140439|NCT01282216|527028243|FG002|Overall Study|Physician Decision|11|||
146140440|NCT01282216|527028244|FG003|Overall Study|Physician Decision|0|||
146140441|NCT01282216|527028241|FG000|Overall Study|Relapse|0|||
146140442|NCT01282216|527028242|FG001|Overall Study|Relapse|0|||
146140443|NCT01282216|527028243|FG002|Overall Study|Relapse|17|||
146140444|NCT01282216|527028244|FG003|Overall Study|Relapse|6|||
146140445|NCT01282216|527028241|FG000|Overall Study|Death|0|||
146140446|NCT01282216|527028242|FG001|Overall Study|Death|0|||
146140447|NCT01282216|527028243|FG002|Overall Study|Death|2|||
146140448|NCT01282216|527028244|FG003|Overall Study|Death|0|||
146140449|NCT02908529|527028247|FG000|Overall Study|Lost to Follow-up|0|||
146140450|NCT02908529|527028248|FG001|Overall Study|Lost to Follow-up|2|||
146140451|NCT04084769|527028255|FG000|Overall Study|Protocol Violation|1|||
146140452|NCT04084769|527028256|FG001|Overall Study|Protocol Violation|3|||
146140453|NCT04084769|527028257|FG002|Overall Study|Protocol Violation|0|||
146140454|NCT04084769|527028258|FG003|Overall Study|Protocol Violation|1|||
146140455|NCT04084769|527028255|FG000|Overall Study|Withdrawal by Subject|0|||
146140456|NCT04084769|527028256|FG001|Overall Study|Withdrawal by Subject|1|||
146140457|NCT04084769|527028257|FG002|Overall Study|Withdrawal by Subject|0|||
146140458|NCT04084769|527028258|FG003|Overall Study|Withdrawal by Subject|0|||
146140459|NCT04084769|527028255|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146140460|NCT04084769|527028256|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146140461|NCT04084769|527028257|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146140462|NCT04084769|527028258|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146140463|NCT04084769|527028255|FG000|Overall Study|Lost to Follow-up|2|||
146140464|NCT04084769|527028256|FG001|Overall Study|Lost to Follow-up|0|||
146140465|NCT04084769|527028257|FG002|Overall Study|Lost to Follow-up|0|||
146140466|NCT04084769|527028258|FG003|Overall Study|Lost to Follow-up|0|||
146140467|NCT01660412|527028259|FG000|Overall Study|Protocol Violation|0|||
146140468|NCT01660412|527028260|FG001|Overall Study|Protocol Violation|3|||
146140469|NCT03013491|527028261|FG000|Main Study|Death|2|||
146140470|NCT03013491|527028262|FG001|Main Study|Death|2|||
146140471|NCT03013491|527028263|FG002|Main Study|Death|5|||
146140472|NCT03013491|527028264|FG003|Main Study|Death|3|||
146140473|NCT03013491|527028265|FG004|Main Study|Death|9|||
146140474|NCT03013491|527028266|FG005|Main Study|Death|12|||
146140475|NCT03013491|527028267|FG006|Main Study|Death|3|||
146140476|NCT03013491|527028268|FG007|Main Study|Death|5|||
146140477|NCT03013491|527028269|FG008|Main Study|Death|1|||
146140478|NCT03013491|527028270|FG009|Main Study|Death|2|||
146140479|NCT03013491|527028271|FG010|Main Study|Death|4|||
146140480|NCT03013491|527028272|FG011|Main Study|Death|1|||
146140481|NCT03013491|527028273|FG012|Main Study|Death|1|||
146140482|NCT03013491|527028274|FG013|Main Study|Death|4|||
146140483|NCT03013491|527028275|FG014|Main Study|Death|0|||
146140484|NCT03013491|527028276|FG015|Main Study|Death|3|||
146140485|NCT03013491|527028277|FG016|Main Study|Death|5|||
146140486|NCT03013491|527028278|FG017|Main Study|Death|1|||
146140487|NCT03013491|527028279|FG018|Main Study|Death|47|||
146140488|NCT03013491|527028261|FG000|Main Study|Lost to Follow-up|0|||
146140489|NCT03013491|527028262|FG001|Main Study|Lost to Follow-up|0|||
146140490|NCT03013491|527028263|FG002|Main Study|Lost to Follow-up|1|||
146140491|NCT03013491|527028264|FG003|Main Study|Lost to Follow-up|0|||
146140492|NCT03013491|527028265|FG004|Main Study|Lost to Follow-up|1|||
146140493|NCT03013491|527028266|FG005|Main Study|Lost to Follow-up|0|||
146140494|NCT03013491|527028267|FG006|Main Study|Lost to Follow-up|0|||
146140495|NCT03013491|527028268|FG007|Main Study|Lost to Follow-up|0|||
146140496|NCT03013491|527028269|FG008|Main Study|Lost to Follow-up|0|||
146140497|NCT03013491|527028270|FG009|Main Study|Lost to Follow-up|0|||
146140498|NCT03013491|527028271|FG010|Main Study|Lost to Follow-up|0|||
146140499|NCT03013491|527028272|FG011|Main Study|Lost to Follow-up|0|||
146140500|NCT03013491|527028273|FG012|Main Study|Lost to Follow-up|0|||
146140501|NCT03013491|527028274|FG013|Main Study|Lost to Follow-up|0|||
146140502|NCT03013491|527028275|FG014|Main Study|Lost to Follow-up|0|||
146140503|NCT03013491|527028276|FG015|Main Study|Lost to Follow-up|0|||
146140504|NCT03013491|527028277|FG016|Main Study|Lost to Follow-up|0|||
146140505|NCT03013491|527028278|FG017|Main Study|Lost to Follow-up|0|||
146140506|NCT03013491|527028279|FG018|Main Study|Lost to Follow-up|3|||
146140507|NCT03013491|527028261|FG000|Main Study|Termination of the study by Sponsor|0|||
146140508|NCT03013491|527028262|FG001|Main Study|Termination of the study by Sponsor|0|||
146140509|NCT03013491|527028263|FG002|Main Study|Termination of the study by Sponsor|2|||
146140510|NCT03013491|527028264|FG003|Main Study|Termination of the study by Sponsor|0|||
146140511|NCT03013491|527028265|FG004|Main Study|Termination of the study by Sponsor|1|||
146140512|NCT03013491|527028266|FG005|Main Study|Termination of the study by Sponsor|2|||
146140513|NCT03013491|527028267|FG006|Main Study|Termination of the study by Sponsor|0|||
146140514|NCT03013491|527028268|FG007|Main Study|Termination of the study by Sponsor|0|||
146140515|NCT03013491|527028269|FG008|Main Study|Termination of the study by Sponsor|1|||
146140516|NCT03013491|527028270|FG009|Main Study|Termination of the study by Sponsor|1|||
146140517|NCT03013491|527028271|FG010|Main Study|Termination of the study by Sponsor|1|||
146140518|NCT03013491|527028272|FG011|Main Study|Termination of the study by Sponsor|2|||
146140519|NCT03013491|527028273|FG012|Main Study|Termination of the study by Sponsor|0|||
146140520|NCT03013491|527028274|FG013|Main Study|Termination of the study by Sponsor|0|||
146140521|NCT03013491|527028275|FG014|Main Study|Termination of the study by Sponsor|0|||
146140522|NCT03013491|527028276|FG015|Main Study|Termination of the study by Sponsor|0|||
146140523|NCT03013491|527028277|FG016|Main Study|Termination of the study by Sponsor|0|||
146140524|NCT03013491|527028278|FG017|Main Study|Termination of the study by Sponsor|1|||
146140525|NCT03013491|527028279|FG018|Main Study|Termination of the study by Sponsor|13|||
146140526|NCT03013491|527028261|FG000|Main Study|Withdrawal by Subject|0|||
146140527|NCT03013491|527028262|FG001|Main Study|Withdrawal by Subject|0|||
146140528|NCT03013491|527028263|FG002|Main Study|Withdrawal by Subject|0|||
146140529|NCT03013491|527028264|FG003|Main Study|Withdrawal by Subject|4|||
146140530|NCT03013491|527028265|FG004|Main Study|Withdrawal by Subject|2|||
146140531|NCT03013491|527028266|FG005|Main Study|Withdrawal by Subject|1|||
146140532|NCT03013491|527028267|FG006|Main Study|Withdrawal by Subject|0|||
146140533|NCT03013491|527028268|FG007|Main Study|Withdrawal by Subject|0|||
146140534|NCT03013491|527028269|FG008|Main Study|Withdrawal by Subject|0|||
146140535|NCT03013491|527028270|FG009|Main Study|Withdrawal by Subject|0|||
146140536|NCT03013491|527028271|FG010|Main Study|Withdrawal by Subject|1|||
146140537|NCT03013491|527028272|FG011|Main Study|Withdrawal by Subject|2|||
146140538|NCT03013491|527028273|FG012|Main Study|Withdrawal by Subject|0|||
146140539|NCT03013491|527028274|FG013|Main Study|Withdrawal by Subject|2|||
146140540|NCT03013491|527028275|FG014|Main Study|Withdrawal by Subject|0|||
146140541|NCT03013491|527028276|FG015|Main Study|Withdrawal by Subject|0|||
146140542|NCT03013491|527028277|FG016|Main Study|Withdrawal by Subject|0|||
146140543|NCT03013491|527028278|FG017|Main Study|Withdrawal by Subject|0|||
146140544|NCT03013491|527028279|FG018|Main Study|Withdrawal by Subject|18|||
146140545|NCT03013491|527028261|FG000|Main Study|Disease progression|0|||
146140546|NCT03013491|527028262|FG001|Main Study|Disease progression|0|||
146140547|NCT03013491|527028263|FG002|Main Study|Disease progression|0|||
146140548|NCT03013491|527028264|FG003|Main Study|Disease progression|1|||
146140549|NCT03013491|527028265|FG004|Main Study|Disease progression|0|||
146140550|NCT03013491|527028266|FG005|Main Study|Disease progression|0|||
146140551|NCT03013491|527028267|FG006|Main Study|Disease progression|0|||
146140552|NCT03013491|527028268|FG007|Main Study|Disease progression|0|||
146140553|NCT03013491|527028269|FG008|Main Study|Disease progression|1|||
146140554|NCT03013491|527028270|FG009|Main Study|Disease progression|0|||
146140555|NCT03013491|527028271|FG010|Main Study|Disease progression|1|||
146140556|NCT03013491|527028272|FG011|Main Study|Disease progression|0|||
146140557|NCT03013491|527028273|FG012|Main Study|Disease progression|0|||
146140558|NCT03013491|527028274|FG013|Main Study|Disease progression|0|||
146140559|NCT03013491|527028275|FG014|Main Study|Disease progression|0|||
146271464|NCT02412735|527509751|FG002|Overall Study|Adverse Event|2|||
146271465|NCT02412735|527509749|FG000|Overall Study|Withdrawal by Subject|23|||
146271466|NCT02412735|527509750|FG001|Overall Study|Withdrawal by Subject|27|||
146140560|NCT03013491|527028276|FG015|Main Study|Disease progression|0|||
146140561|NCT03013491|527028277|FG016|Main Study|Disease progression|0|||
146140562|NCT03013491|527028278|FG017|Main Study|Disease progression|0|||
146140563|NCT03013491|527028279|FG018|Main Study|Disease progression|4|||
146140564|NCT03013491|527028261|FG000|Main Study|Symptomatic deterioration|0|||
146140565|NCT03013491|527028262|FG001|Main Study|Symptomatic deterioration|0|||
146140566|NCT03013491|527028263|FG002|Main Study|Symptomatic deterioration|0|||
146140567|NCT03013491|527028264|FG003|Main Study|Symptomatic deterioration|0|||
146140568|NCT03013491|527028265|FG004|Main Study|Symptomatic deterioration|0|||
146140569|NCT03013491|527028266|FG005|Main Study|Symptomatic deterioration|1|||
146140570|NCT03013491|527028267|FG006|Main Study|Symptomatic deterioration|0|||
146304128|NCT03250832|527627486|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
146304129|NCT03250832|527627475|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304130|NCT03250832|527627476|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304131|NCT03250832|527627477|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304132|NCT03250832|527627478|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304133|NCT03250832|527627479|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304134|NCT03250832|527627480|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304135|NCT03250832|527627481|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304136|NCT03250832|527627482|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304137|NCT03250832|527627483|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
146304138|NCT03250832|527627484|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
146304139|NCT03250832|527627485|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146140571|NCT03013491|527028268|FG007|Main Study|Symptomatic deterioration|0|||
146140572|NCT03013491|527028269|FG008|Main Study|Symptomatic deterioration|0|||
146140573|NCT03013491|527028270|FG009|Main Study|Symptomatic deterioration|0|||
146140574|NCT03013491|527028271|FG010|Main Study|Symptomatic deterioration|0|||
146140575|NCT03013491|527028272|FG011|Main Study|Symptomatic deterioration|0|||
146140576|NCT03013491|527028273|FG012|Main Study|Symptomatic deterioration|0|||
146140577|NCT03013491|527028274|FG013|Main Study|Symptomatic deterioration|0|||
146140578|NCT03013491|527028275|FG014|Main Study|Symptomatic deterioration|0|||
146140579|NCT03013491|527028276|FG015|Main Study|Symptomatic deterioration|0|||
146140580|NCT03013491|527028277|FG016|Main Study|Symptomatic deterioration|0|||
146140581|NCT03013491|527028278|FG017|Main Study|Symptomatic deterioration|0|||
146140582|NCT03013491|527028279|FG018|Main Study|Symptomatic deterioration|0|||
146140583|NCT03013491|527028261|FG000|Main Study|Protocol version 8.0 approval|0|||
146140584|NCT03013491|527028262|FG001|Main Study|Protocol version 8.0 approval|0|||
146140585|NCT03013491|527028263|FG002|Main Study|Protocol version 8.0 approval|0|||
146140586|NCT03013491|527028264|FG003|Main Study|Protocol version 8.0 approval|0|||
146140587|NCT03013491|527028265|FG004|Main Study|Protocol version 8.0 approval|0|||
146140588|NCT03013491|527028266|FG005|Main Study|Protocol version 8.0 approval|0|||
146140589|NCT03013491|527028267|FG006|Main Study|Protocol version 8.0 approval|0|||
146140590|NCT03013491|527028268|FG007|Main Study|Protocol version 8.0 approval|0|||
146140591|NCT03013491|527028269|FG008|Main Study|Protocol version 8.0 approval|0|||
146140592|NCT03013491|527028270|FG009|Main Study|Protocol version 8.0 approval|0|||
146140593|NCT03013491|527028271|FG010|Main Study|Protocol version 8.0 approval|1|||
146140594|NCT03013491|527028272|FG011|Main Study|Protocol version 8.0 approval|0|||
146140595|NCT03013491|527028273|FG012|Main Study|Protocol version 8.0 approval|0|||
146271467|NCT02412735|527509751|FG002|Overall Study|Withdrawal by Subject|22|||
146271468|NCT02412735|527509749|FG000|Overall Study|Investigator Decision|3|||
146271469|NCT02412735|527509750|FG001|Overall Study|Investigator Decision|3|||
146271470|NCT02412735|527509751|FG002|Overall Study|Investigator Decision|2|||
146271471|NCT02412735|527509749|FG000|Overall Study|Lost to Follow-up|17|||
146271472|NCT02412735|527509750|FG001|Overall Study|Lost to Follow-up|11|||
146271473|NCT02412735|527509751|FG002|Overall Study|Lost to Follow-up|18|||
146271474|NCT02412735|527509749|FG000|Overall Study|Reason not Specified|3|||
146271475|NCT02412735|527509750|FG001|Overall Study|Reason not Specified|2|||
146271476|NCT02412735|527509751|FG002|Overall Study|Reason not Specified|2|||
146271477|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
146271478|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
146271479|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146271480|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
146271481|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146271482|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146271483|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
146271484|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
146271485|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146271486|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146271487|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
146271488|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146271489|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
146271490|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
146271491|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146271492|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
146271493|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
146140596|NCT03013491|527028274|FG013|Main Study|Protocol version 8.0 approval|0|||
146140597|NCT03013491|527028275|FG014|Main Study|Protocol version 8.0 approval|0|||
146140598|NCT03013491|527028276|FG015|Main Study|Protocol version 8.0 approval|0|||
146140599|NCT03013491|527028277|FG016|Main Study|Protocol version 8.0 approval|0|||
146271494|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
146271495|NCT00603525|527509752|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
146271496|NCT00603525|527509753|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
146140600|NCT03013491|527028278|FG017|Main Study|Protocol version 8.0 approval|0|||
146140601|NCT03013491|527028279|FG018|Main Study|Protocol version 8.0 approval|0|||
146140602|NCT03013491|527028261|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
146140603|NCT03013491|527028262|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
146140604|NCT03013491|527028263|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
146140605|NCT03013491|527028264|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
146140606|NCT03013491|527028265|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
146140607|NCT03013491|527028266|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
146140608|NCT03013491|527028267|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
146140609|NCT03013491|527028268|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
146140610|NCT03013491|527028269|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
146140611|NCT03013491|527028270|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
146140612|NCT03013491|527028271|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
146140613|NCT03013491|527028272|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
146140614|NCT03013491|527028273|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
146140615|NCT03013491|527028274|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
146140616|NCT03013491|527028275|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
146140617|NCT03013491|527028276|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
146140618|NCT03013491|527028277|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
146140619|NCT03013491|527028278|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
146140620|NCT03013491|527028279|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
146140621|NCT03013491|527028261|FG000|Main Study|Start of new anticancer therapy|0|||
146140622|NCT03013491|527028262|FG001|Main Study|Start of new anticancer therapy|0|||
146140623|NCT03013491|527028263|FG002|Main Study|Start of new anticancer therapy|0|||
146140624|NCT03013491|527028264|FG003|Main Study|Start of new anticancer therapy|0|||
146140625|NCT03013491|527028265|FG004|Main Study|Start of new anticancer therapy|0|||
146140626|NCT03013491|527028266|FG005|Main Study|Start of new anticancer therapy|0|||
146140627|NCT03013491|527028267|FG006|Main Study|Start of new anticancer therapy|0|||
146140628|NCT03013491|527028268|FG007|Main Study|Start of new anticancer therapy|0|||
146140629|NCT03013491|527028269|FG008|Main Study|Start of new anticancer therapy|0|||
146140630|NCT03013491|527028270|FG009|Main Study|Start of new anticancer therapy|0|||
146140631|NCT03013491|527028271|FG010|Main Study|Start of new anticancer therapy|0|||
146140632|NCT03013491|527028272|FG011|Main Study|Start of new anticancer therapy|0|||
146140633|NCT03013491|527028273|FG012|Main Study|Start of new anticancer therapy|0|||
146140634|NCT03013491|527028274|FG013|Main Study|Start of new anticancer therapy|0|||
146140635|NCT03013491|527028275|FG014|Main Study|Start of new anticancer therapy|0|||
146140636|NCT03013491|527028276|FG015|Main Study|Start of new anticancer therapy|0|||
146140637|NCT03013491|527028277|FG016|Main Study|Start of new anticancer therapy|0|||
146140638|NCT03013491|527028278|FG017|Main Study|Start of new anticancer therapy|0|||
146140639|NCT03013491|527028279|FG018|Main Study|Start of new anticancer therapy|2|||
146140640|NCT03013491|527028261|FG000|Long-term Extension|Disease progression|0|||
146140641|NCT03013491|527028262|FG001|Long-term Extension|Disease progression|0|||
146140642|NCT03013491|527028263|FG002|Long-term Extension|Disease progression|0|||
146140643|NCT03013491|527028264|FG003|Long-term Extension|Disease progression|1|||
146140644|NCT03013491|527028265|FG004|Long-term Extension|Disease progression|0|||
146140645|NCT03013491|527028266|FG005|Long-term Extension|Disease progression|0|||
146140646|NCT03013491|527028267|FG006|Long-term Extension|Disease progression|0|||
146140647|NCT03013491|527028268|FG007|Long-term Extension|Disease progression|0|||
146140648|NCT03013491|527028269|FG008|Long-term Extension|Disease progression|0|||
146140649|NCT03013491|527028270|FG009|Long-term Extension|Disease progression|0|||
146140650|NCT03013491|527028271|FG010|Long-term Extension|Disease progression|0|||
146140651|NCT03013491|527028272|FG011|Long-term Extension|Disease progression|0|||
146140652|NCT03013491|527028273|FG012|Long-term Extension|Disease progression|0|||
146140653|NCT03013491|527028274|FG013|Long-term Extension|Disease progression|0|||
146140654|NCT03013491|527028275|FG014|Long-term Extension|Disease progression|0|||
146140655|NCT03013491|527028276|FG015|Long-term Extension|Disease progression|0|||
146140656|NCT03013491|527028277|FG016|Long-term Extension|Disease progression|0|||
146140657|NCT03013491|527028278|FG017|Long-term Extension|Disease progression|0|||
146140658|NCT03013491|527028279|FG018|Long-term Extension|Disease progression|1|||
146140659|NCT03013491|527028261|FG000|Long-term Extension|Withdrawal by Subject|0|||
146140660|NCT03013491|527028262|FG001|Long-term Extension|Withdrawal by Subject|0|||
146140661|NCT03013491|527028263|FG002|Long-term Extension|Withdrawal by Subject|0|||
146140662|NCT03013491|527028264|FG003|Long-term Extension|Withdrawal by Subject|0|||
146140663|NCT03013491|527028265|FG004|Long-term Extension|Withdrawal by Subject|0|||
146140664|NCT03013491|527028266|FG005|Long-term Extension|Withdrawal by Subject|0|||
146140665|NCT03013491|527028267|FG006|Long-term Extension|Withdrawal by Subject|0|||
146140666|NCT03013491|527028268|FG007|Long-term Extension|Withdrawal by Subject|1|||
146140667|NCT03013491|527028269|FG008|Long-term Extension|Withdrawal by Subject|0|||
146140668|NCT03013491|527028270|FG009|Long-term Extension|Withdrawal by Subject|0|||
146140669|NCT03013491|527028271|FG010|Long-term Extension|Withdrawal by Subject|0|||
146140670|NCT03013491|527028272|FG011|Long-term Extension|Withdrawal by Subject|0|||
146140671|NCT03013491|527028273|FG012|Long-term Extension|Withdrawal by Subject|0|||
146140672|NCT03013491|527028274|FG013|Long-term Extension|Withdrawal by Subject|0|||
146140673|NCT03013491|527028275|FG014|Long-term Extension|Withdrawal by Subject|0|||
146140674|NCT03013491|527028276|FG015|Long-term Extension|Withdrawal by Subject|0|||
146140675|NCT03013491|527028277|FG016|Long-term Extension|Withdrawal by Subject|0|||
146140676|NCT03013491|527028278|FG017|Long-term Extension|Withdrawal by Subject|0|||
146140677|NCT03013491|527028279|FG018|Long-term Extension|Withdrawal by Subject|0|||
146140678|NCT03013491|527028261|FG000|Long-term Extension|Adverse Event|0|||
146140679|NCT03013491|527028262|FG001|Long-term Extension|Adverse Event|0|||
146140680|NCT03013491|527028263|FG002|Long-term Extension|Adverse Event|0|||
146140681|NCT03013491|527028264|FG003|Long-term Extension|Adverse Event|0|||
146140682|NCT03013491|527028265|FG004|Long-term Extension|Adverse Event|0|||
146140683|NCT03013491|527028266|FG005|Long-term Extension|Adverse Event|0|||
146140684|NCT03013491|527028267|FG006|Long-term Extension|Adverse Event|0|||
146140685|NCT03013491|527028268|FG007|Long-term Extension|Adverse Event|0|||
146140686|NCT03013491|527028269|FG008|Long-term Extension|Adverse Event|0|||
146140687|NCT03013491|527028270|FG009|Long-term Extension|Adverse Event|0|||
146140688|NCT03013491|527028271|FG010|Long-term Extension|Adverse Event|0|||
146140689|NCT03013491|527028272|FG011|Long-term Extension|Adverse Event|0|||
146140690|NCT03013491|527028273|FG012|Long-term Extension|Adverse Event|0|||
146140691|NCT03013491|527028274|FG013|Long-term Extension|Adverse Event|0|||
146140692|NCT03013491|527028275|FG014|Long-term Extension|Adverse Event|0|||
146140693|NCT03013491|527028276|FG015|Long-term Extension|Adverse Event|0|||
146140694|NCT03013491|527028277|FG016|Long-term Extension|Adverse Event|0|||
146140695|NCT03013491|527028278|FG017|Long-term Extension|Adverse Event|0|||
146140696|NCT03013491|527028279|FG018|Long-term Extension|Adverse Event|1|||
146140697|NCT03013491|527028261|FG000|Long-term Extension|Death|0|||
146140698|NCT03013491|527028262|FG001|Long-term Extension|Death|0|||
146140699|NCT03013491|527028263|FG002|Long-term Extension|Death|0|||
146140700|NCT03013491|527028264|FG003|Long-term Extension|Death|0|||
146140701|NCT03013491|527028265|FG004|Long-term Extension|Death|0|||
146140702|NCT03013491|527028266|FG005|Long-term Extension|Death|0|||
146140703|NCT03013491|527028267|FG006|Long-term Extension|Death|0|||
146140704|NCT03013491|527028268|FG007|Long-term Extension|Death|0|||
146140705|NCT03013491|527028269|FG008|Long-term Extension|Death|0|||
146140706|NCT03013491|527028270|FG009|Long-term Extension|Death|0|||
146140707|NCT03013491|527028271|FG010|Long-term Extension|Death|0|||
146140708|NCT03013491|527028272|FG011|Long-term Extension|Death|0|||
146140709|NCT03013491|527028273|FG012|Long-term Extension|Death|0|||
146140710|NCT03013491|527028274|FG013|Long-term Extension|Death|0|||
146140711|NCT03013491|527028275|FG014|Long-term Extension|Death|0|||
146140712|NCT03013491|527028276|FG015|Long-term Extension|Death|0|||
146140713|NCT03013491|527028277|FG016|Long-term Extension|Death|0|||
146140714|NCT03013491|527028278|FG017|Long-term Extension|Death|0|||
146140715|NCT03013491|527028279|FG018|Long-term Extension|Death|1|||
146140716|NCT03238911|527028282|FG000|Overall Study|Withdrawal by Subject|1|||
146140717|NCT03238911|527028283|FG001|Overall Study|Withdrawal by Subject|2|||
146140718|NCT03238911|527028282|FG000|Overall Study|Lost to Follow-up|2|||
146140719|NCT03238911|527028283|FG001|Overall Study|Lost to Follow-up|1|||
146140720|NCT02239536|527028284|FG000|Overall Study|Non-neoplastic polyp|23|||
146140721|NCT02239536|527028285|FG001|Overall Study|Non-neoplastic polyp|17|||
146140722|NCT04740034|527028291|FG000|Overall Study|Death|0|||
146140723|NCT04740034|527028292|FG001|Overall Study|Death|1|||
146140724|NCT04740034|527028293|FG002|Overall Study|Death|2|||
146140725|NCT04740034|527028294|FG003|Overall Study|Death|3|||
146271497|NCT00603525|527509754|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
146271498|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146271499|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
146140726|NCT04740034|527028295|FG004|Overall Study|Death|4|||
146140727|NCT04740034|527028296|FG005|Overall Study|Death|4|||
146140728|NCT04740034|527028297|FG006|Overall Study|Death|2|||
146140729|NCT04740034|527028298|FG007|Overall Study|Death|2|||
146140730|NCT04740034|527028299|FG008|Overall Study|Death|2|||
146140731|NCT04740034|527028300|FG009|Overall Study|Death|4|||
146140732|NCT04740034|527028301|FG010|Overall Study|Death|0|||
146140733|NCT04740034|527028291|FG000|Overall Study|Lost to Follow-up|0|||
146140734|NCT04740034|527028292|FG001|Overall Study|Lost to Follow-up|0|||
146140735|NCT04740034|527028293|FG002|Overall Study|Lost to Follow-up|0|||
146140736|NCT04740034|527028294|FG003|Overall Study|Lost to Follow-up|1|||
146140737|NCT04740034|527028295|FG004|Overall Study|Lost to Follow-up|2|||
146140738|NCT04740034|527028296|FG005|Overall Study|Lost to Follow-up|2|||
146140739|NCT04740034|527028297|FG006|Overall Study|Lost to Follow-up|0|||
146140740|NCT04740034|527028298|FG007|Overall Study|Lost to Follow-up|0|||
146140741|NCT04740034|527028299|FG008|Overall Study|Lost to Follow-up|0|||
146140742|NCT04740034|527028300|FG009|Overall Study|Lost to Follow-up|1|||
146140743|NCT04740034|527028301|FG010|Overall Study|Lost to Follow-up|0|||
146140744|NCT04740034|527028291|FG000|Overall Study|Withdrawal by Subject|1|||
146140745|NCT04740034|527028292|FG001|Overall Study|Withdrawal by Subject|0|||
146140746|NCT04740034|527028293|FG002|Overall Study|Withdrawal by Subject|0|||
146140747|NCT04740034|527028294|FG003|Overall Study|Withdrawal by Subject|0|||
146140748|NCT04740034|527028295|FG004|Overall Study|Withdrawal by Subject|0|||
146140749|NCT04740034|527028296|FG005|Overall Study|Withdrawal by Subject|0|||
146140750|NCT04740034|527028297|FG006|Overall Study|Withdrawal by Subject|0|||
146140751|NCT04740034|527028298|FG007|Overall Study|Withdrawal by Subject|1|||
146140752|NCT04740034|527028299|FG008|Overall Study|Withdrawal by Subject|0|||
146140753|NCT04740034|527028300|FG009|Overall Study|Withdrawal by Subject|1|||
146140754|NCT04740034|527028301|FG010|Overall Study|Withdrawal by Subject|0|||
146140755|NCT04740034|527028291|FG000|Overall Study|Decision by sponsor|0|||
146140756|NCT04740034|527028292|FG001|Overall Study|Decision by sponsor|0|||
146140757|NCT04740034|527028293|FG002|Overall Study|Decision by sponsor|1|||
146140758|NCT04740034|527028294|FG003|Overall Study|Decision by sponsor|0|||
146140759|NCT04740034|527028295|FG004|Overall Study|Decision by sponsor|0|||
146140760|NCT04740034|527028296|FG005|Overall Study|Decision by sponsor|0|||
146140761|NCT04740034|527028297|FG006|Overall Study|Decision by sponsor|1|||
146140762|NCT04740034|527028298|FG007|Overall Study|Decision by sponsor|2|||
146140763|NCT04740034|527028299|FG008|Overall Study|Decision by sponsor|1|||
146140764|NCT04740034|527028300|FG009|Overall Study|Decision by sponsor|1|||
146140765|NCT04740034|527028301|FG010|Overall Study|Decision by sponsor|2|||
146140766|NCT00991302|527030444|FG000|Overall Study|Death|0|||
146140767|NCT00991302|527030445|FG001|Overall Study|Death|1|||
146140768|NCT00991302|527030444|FG000|Overall Study|Lost to Follow-up|14|||
146140769|NCT00991302|527030445|FG001|Overall Study|Lost to Follow-up|12|||
146140770|NCT01709318|527030446|FG000|Overall Study|Adverse Event|3|||
146140771|NCT01709318|527030447|FG001|Overall Study|Adverse Event|4|||
146271500|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146271501|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146271502|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
146271503|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146271504|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146271505|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
146271506|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146271507|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146271508|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
146271509|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146271510|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146271511|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
146271512|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146271513|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146271514|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
146271515|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146271516|NCT00603525|527509752|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146271517|NCT00603525|527509753|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
146271518|NCT00603525|527509754|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146271519|NCT00603525|527509752|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
146271520|NCT00603525|527509753|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
146271521|NCT00603525|527509754|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
146271522|NCT04043143|527509755|FG000|Overall Study|Lost to Follow-up|5|||
146271523|NCT04043143|527509756|FG001|Overall Study|Lost to Follow-up|5|||
146271524|NCT04043143|527509755|FG000|Overall Study|screen failure|1|||
146271525|NCT04043143|527509756|FG001|Overall Study|screen failure|0|||
146271526|NCT03374488|527509762|FG000|Overall Study|Death|13|||
146271527|NCT03374488|527509763|FG001|Overall Study|Death|13|||
146271528|NCT03374488|527509762|FG000|Overall Study|Withdrawal by Subject|3|||
146271529|NCT03374488|527509763|FG001|Overall Study|Withdrawal by Subject|1|||
146271530|NCT03374488|527509762|FG000|Overall Study|Physician Decision|3|||
146271531|NCT03374488|527509763|FG001|Overall Study|Physician Decision|0|||
146271532|NCT04703192|527509767|FG000|Overall Study|Withdrawal by Subject|2|||
146271533|NCT04703192|527509768|FG001|Overall Study|Withdrawal by Subject|0|||
146271534|NCT04703192|527509767|FG000|Overall Study|Death|3|||
146271535|NCT04703192|527509768|FG001|Overall Study|Death|1|||
146271536|NCT04703192|527509767|FG000|Overall Study|Adverse Event|13|||
146271537|NCT04703192|527509768|FG001|Overall Study|Adverse Event|2|||
146271538|NCT04703192|527509767|FG000|Overall Study|Progressive or Relapsed Disease|46|||
146271539|NCT04703192|527509768|FG001|Overall Study|Progressive or Relapsed Disease|7|||
146140772|NCT01709318|527030448|FG002|Overall Study|Adverse Event|2|||
146140773|NCT01709318|527030449|FG003|Overall Study|Adverse Event|2|||
146140774|NCT01709318|527030450|FG004|Overall Study|Adverse Event|0|||
146140775|NCT01709318|527030451|FG005|Overall Study|Adverse Event|1|||
146140776|NCT01709318|527030452|FG006|Overall Study|Adverse Event|2|||
146271540|NCT04703192|527509767|FG000|Overall Study|Clinical Progression|19|||
146271541|NCT04703192|527509768|FG001|Overall Study|Clinical Progression|8|||
146271542|NCT04703192|527509767|FG000|Overall Study|Lost to Follow-up|1|||
146140777|NCT01709318|527030446|FG000|Overall Study|Lost to Follow-up|2|||
146140778|NCT01709318|527030447|FG001|Overall Study|Lost to Follow-up|0|||
146304140|NCT03250832|527627486|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
146304141|NCT03250832|527627475|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304142|NCT03250832|527627476|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304143|NCT03250832|527627477|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146140779|NCT01709318|527030448|FG002|Overall Study|Lost to Follow-up|0|||
146140780|NCT01709318|527030449|FG003|Overall Study|Lost to Follow-up|0|||
146140781|NCT01709318|527030450|FG004|Overall Study|Lost to Follow-up|1|||
146140782|NCT01709318|527030451|FG005|Overall Study|Lost to Follow-up|1|||
146140783|NCT01709318|527030452|FG006|Overall Study|Lost to Follow-up|1|||
146140784|NCT01709318|527030446|FG000|Overall Study|Non-compliance with Study Drug|0|||
146140785|NCT01709318|527030447|FG001|Overall Study|Non-compliance with Study Drug|2|||
146140786|NCT01709318|527030448|FG002|Overall Study|Non-compliance with Study Drug|1|||
146140787|NCT01709318|527030449|FG003|Overall Study|Non-compliance with Study Drug|1|||
146140788|NCT01709318|527030450|FG004|Overall Study|Non-compliance with Study Drug|0|||
146140789|NCT01709318|527030451|FG005|Overall Study|Non-compliance with Study Drug|0|||
146140790|NCT01709318|527030452|FG006|Overall Study|Non-compliance with Study Drug|2|||
146140791|NCT01709318|527030446|FG000|Overall Study|Physician Decision|0|||
146140792|NCT01709318|527030447|FG001|Overall Study|Physician Decision|0|||
146140793|NCT01709318|527030448|FG002|Overall Study|Physician Decision|0|||
146140794|NCT01709318|527030449|FG003|Overall Study|Physician Decision|0|||
146140795|NCT01709318|527030450|FG004|Overall Study|Physician Decision|0|||
146140796|NCT01709318|527030451|FG005|Overall Study|Physician Decision|0|||
146140797|NCT01709318|527030452|FG006|Overall Study|Physician Decision|1|||
146140798|NCT01709318|527030446|FG000|Overall Study|Pregnancy|0|||
146140799|NCT01709318|527030447|FG001|Overall Study|Pregnancy|0|||
146140800|NCT01709318|527030448|FG002|Overall Study|Pregnancy|0|||
146140801|NCT01709318|527030449|FG003|Overall Study|Pregnancy|0|||
146140802|NCT01709318|527030450|FG004|Overall Study|Pregnancy|1|||
146140803|NCT01709318|527030451|FG005|Overall Study|Pregnancy|0|||
146140804|NCT01709318|527030452|FG006|Overall Study|Pregnancy|0|||
146140805|NCT01709318|527030446|FG000|Overall Study|Protocol Violation|0|||
146140806|NCT01709318|527030447|FG001|Overall Study|Protocol Violation|0|||
146140807|NCT01709318|527030448|FG002|Overall Study|Protocol Violation|0|||
146140808|NCT01709318|527030449|FG003|Overall Study|Protocol Violation|0|||
146140809|NCT01709318|527030450|FG004|Overall Study|Protocol Violation|2|||
146140810|NCT01709318|527030451|FG005|Overall Study|Protocol Violation|0|||
146140811|NCT01709318|527030452|FG006|Overall Study|Protocol Violation|1|||
146140812|NCT01709318|527030446|FG000|Overall Study|Technical Problems|1|||
146140813|NCT01709318|527030447|FG001|Overall Study|Technical Problems|0|||
146140814|NCT01709318|527030448|FG002|Overall Study|Technical Problems|0|||
146140815|NCT01709318|527030449|FG003|Overall Study|Technical Problems|0|||
146140816|NCT01709318|527030450|FG004|Overall Study|Technical Problems|0|||
146140817|NCT01709318|527030451|FG005|Overall Study|Technical Problems|0|||
146140818|NCT01709318|527030452|FG006|Overall Study|Technical Problems|0|||
146140819|NCT01709318|527030446|FG000|Overall Study|Withdrawal by Subject|3|||
146140820|NCT01709318|527030447|FG001|Overall Study|Withdrawal by Subject|0|||
146140821|NCT01709318|527030448|FG002|Overall Study|Withdrawal by Subject|3|||
146140822|NCT01709318|527030449|FG003|Overall Study|Withdrawal by Subject|3|||
146140823|NCT01709318|527030450|FG004|Overall Study|Withdrawal by Subject|0|||
146140824|NCT01709318|527030451|FG005|Overall Study|Withdrawal by Subject|2|||
146304144|NCT03250832|527627478|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146140825|NCT01709318|527030452|FG006|Overall Study|Withdrawal by Subject|4|||
146140826|NCT01709318|527030446|FG000|Overall Study|Other Protocol Specified Criteria|0|||
146140827|NCT01709318|527030447|FG001|Overall Study|Other Protocol Specified Criteria|1|||
146140828|NCT01709318|527030448|FG002|Overall Study|Other Protocol Specified Criteria|0|||
146140829|NCT01709318|527030449|FG003|Overall Study|Other Protocol Specified Criteria|0|||
146140830|NCT01709318|527030450|FG004|Overall Study|Other Protocol Specified Criteria|0|||
146140831|NCT01709318|527030451|FG005|Overall Study|Other Protocol Specified Criteria|0|||
146140832|NCT01709318|527030452|FG006|Overall Study|Other Protocol Specified Criteria|0|||
146140833|NCT03370341|527030453|FG000|Overall Study|Lost to Follow-up|0|||
146140834|NCT03370341|527030454|FG001|Overall Study|Lost to Follow-up|1|||
146140835|NCT01707004|527030455|FG000|Overall Study|Physician Decision|3|||
146140836|NCT03085927|527030459|FG000|Overall Study|Withdrawal by Subject|1|||
146140837|NCT03085927|527030460|FG001|Overall Study|Withdrawal by Subject|4|||
146140838|NCT03085927|527030459|FG000|Overall Study|Lost to Follow-up|3|||
146140839|NCT03085927|527030460|FG001|Overall Study|Lost to Follow-up|1|||
146140840|NCT03085927|527030459|FG000|Overall Study|Death|1|||
146140841|NCT03085927|527030460|FG001|Overall Study|Death|0|||
146140842|NCT03085927|527030459|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
146140843|NCT03085927|527030460|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
146140844|NCT03085927|527030459|FG000|Overall Study|Dyad Became Ineligible|0|||
146140845|NCT03085927|527030460|FG001|Overall Study|Dyad Became Ineligible|1|||
146140846|NCT02573324|527030461|FG000|Overall Study|Withdrawal by Subject|26|||
146140847|NCT02573324|527030462|FG001|Overall Study|Withdrawal by Subject|23|||
146140848|NCT02573324|527030463|FG002|Overall Study|Withdrawal by Subject|3|||
146140849|NCT02573324|527030461|FG000|Overall Study|Lost to Follow-up|4|||
146140850|NCT02573324|527030462|FG001|Overall Study|Lost to Follow-up|5|||
146140851|NCT02573324|527030463|FG002|Overall Study|Lost to Follow-up|0|||
146140852|NCT02573324|527030461|FG000|Overall Study|Study Terminated by Sponsor|107|||
146140853|NCT02573324|527030462|FG001|Overall Study|Study Terminated by Sponsor|89|||
146140854|NCT02573324|527030463|FG002|Overall Study|Study Terminated by Sponsor|2|||
146140855|NCT02573324|527030461|FG000|Overall Study|Death|182|||
146140856|NCT02573324|527030462|FG001|Overall Study|Death|200|||
146140857|NCT02573324|527030463|FG002|Overall Study|Death|1|||
146140858|NCT02573324|527030461|FG000|Overall Study|Other, Not Specified|20|||
146140859|NCT02573324|527030462|FG001|Overall Study|Other, Not Specified|27|||
146140860|NCT02573324|527030463|FG002|Overall Study|Other, Not Specified|0|||
146140861|NCT02573324|527030461|FG000|Overall Study|Unknown Reason|2|||
146140862|NCT02573324|527030462|FG001|Overall Study|Unknown Reason|0|||
146140863|NCT02573324|527030463|FG002|Overall Study|Unknown Reason|0|||
146140864|NCT00600821|527030464|FG000|Overall Study|Death|45|||
146140865|NCT00600821|527030465|FG001|Overall Study|Death|46|||
146140866|NCT00600821|527030464|FG000|Overall Study|Lost to Follow-up|2|||
146140867|NCT00600821|527030465|FG001|Overall Study|Lost to Follow-up|2|||
146140868|NCT00600821|527030464|FG000|Overall Study|Withdrawal by Subject|1|||
146140869|NCT00600821|527030465|FG001|Overall Study|Withdrawal by Subject|1|||
146140870|NCT00600821|527030464|FG000|Overall Study|Terminated by sponsor|8|||
146140871|NCT00600821|527030465|FG001|Overall Study|Terminated by sponsor|6|||
146140872|NCT00600821|527030464|FG000|Overall Study|Objective progression or relapse|0|||
146140873|NCT00600821|527030465|FG001|Overall Study|Objective progression or relapse|1|||
146140874|NCT00600821|527030464|FG000|Overall Study|Randomized but not treated|0|||
146140875|NCT00600821|527030465|FG001|Overall Study|Randomized but not treated|1|||
146140876|NCT00600821|527030464|FG000|Overall Study|Other|2|||
146140877|NCT00600821|527030465|FG001|Overall Study|Other|3|||
146140878|NCT01607905|527030466|FG000|Overall Study|Withdrawal by participant|7|||
146140879|NCT01607905|527030467|FG001|Overall Study|Withdrawal by participant|2|||
146140880|NCT01607905|527030468|FG002|Overall Study|Withdrawal by participant|4|||
146140881|NCT01607905|527030469|FG003|Overall Study|Withdrawal by participant|6|||
146140882|NCT01607905|527030470|FG004|Overall Study|Withdrawal by participant|0|||
146140883|NCT01607905|527030471|FG005|Overall Study|Withdrawal by participant|4|||
146140884|NCT01607905|527030472|FG006|Overall Study|Withdrawal by participant|12|||
146140885|NCT01607905|527030466|FG000|Overall Study|Incidence or severity of AEs|5|||
146140886|NCT01607905|527030467|FG001|Overall Study|Incidence or severity of AEs|1|||
146140887|NCT01607905|527030468|FG002|Overall Study|Incidence or severity of AEs|1|||
146140888|NCT01607905|527030469|FG003|Overall Study|Incidence or severity of AEs|3|||
146140889|NCT01607905|527030470|FG004|Overall Study|Incidence or severity of AEs|0|||
146140890|NCT01607905|527030471|FG005|Overall Study|Incidence or severity of AEs|2|||
146140891|NCT01607905|527030472|FG006|Overall Study|Incidence or severity of AEs|8|||
146140892|NCT01607905|527030466|FG000|Overall Study|Disease progression|44|||
146140893|NCT01607905|527030467|FG001|Overall Study|Disease progression|16|||
146140894|NCT01607905|527030468|FG002|Overall Study|Disease progression|15|||
146140895|NCT01607905|527030469|FG003|Overall Study|Disease progression|11|||
146140896|NCT01607905|527030470|FG004|Overall Study|Disease progression|6|||
146140897|NCT01607905|527030471|FG005|Overall Study|Disease progression|7|||
146271543|NCT04703192|527509768|FG001|Overall Study|Lost to Follow-up|0|||
146271544|NCT04703192|527509767|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
146271545|NCT04703192|527509768|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
146271546|NCT04703192|527509767|FG000|Overall Study|Other|5|||
146271547|NCT04703192|527509768|FG001|Overall Study|Other|1|||
146140898|NCT01607905|527030472|FG006|Overall Study|Disease progression|21|||
146140899|NCT01607905|527030466|FG000|Overall Study|Non-compliance with study procedures|0|||
146140900|NCT01607905|527030467|FG001|Overall Study|Non-compliance with study procedures|0|||
146140901|NCT01607905|527030468|FG002|Overall Study|Non-compliance with study procedures|0|||
146140902|NCT01607905|527030469|FG003|Overall Study|Non-compliance with study procedures|0|||
146140903|NCT01607905|527030470|FG004|Overall Study|Non-compliance with study procedures|0|||
146140904|NCT01607905|527030471|FG005|Overall Study|Non-compliance with study procedures|0|||
146140905|NCT01607905|527030472|FG006|Overall Study|Non-compliance with study procedures|1|||
146140906|NCT01607905|527030466|FG000|Overall Study|Death|1|||
146140907|NCT01607905|527030467|FG001|Overall Study|Death|1|||
146140908|NCT01607905|527030468|FG002|Overall Study|Death|1|||
146140909|NCT01607905|527030469|FG003|Overall Study|Death|1|||
146140910|NCT01607905|527030470|FG004|Overall Study|Death|0|||
146140911|NCT01607905|527030471|FG005|Overall Study|Death|0|||
146140912|NCT01607905|527030472|FG006|Overall Study|Death|3|||
146271548|NCT02493062|527509769|FG000|Overall Study|Physician Decision|12|||
146271549|NCT01327612|527509770|FG000|Overall Study|Withdrawal by Subject|0|||
146271550|NCT01327612|527509771|FG001|Overall Study|Withdrawal by Subject|0|||
146271551|NCT01327612|527509772|FG002|Overall Study|Withdrawal by Subject|0|||
146140913|NCT01607905|527030466|FG000|Overall Study|Other treatments become available|1|||
146140914|NCT01607905|527030467|FG001|Overall Study|Other treatments become available|0|||
146140915|NCT01607905|527030468|FG002|Overall Study|Other treatments become available|0|||
146140916|NCT01607905|527030469|FG003|Overall Study|Other treatments become available|0|||
146271552|NCT01327612|527509773|FG003|Overall Study|Withdrawal by Subject|0|||
146140917|NCT01607905|527030470|FG004|Overall Study|Other treatments become available|0|||
146140918|NCT01607905|527030471|FG005|Overall Study|Other treatments become available|0|||
146140919|NCT01607905|527030472|FG006|Overall Study|Other treatments become available|1|||
146140920|NCT01607905|527030466|FG000|Overall Study|Investigator discretion|0|||
146304145|NCT03250832|527627479|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304146|NCT03250832|527627480|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304147|NCT03250832|527627481|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304148|NCT03250832|527627482|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304149|NCT03250832|527627483|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304150|NCT03250832|527627484|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304151|NCT03250832|527627485|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
146304152|NCT03250832|527627486|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
146304153|NCT02303704|527627487|FG000|Overall Study|Protocol Violation|5|||
146304154|NCT02303704|527627488|FG001|Overall Study|Protocol Violation|9|||
146140921|NCT01607905|527030467|FG001|Overall Study|Investigator discretion|0|||
146140922|NCT01607905|527030468|FG002|Overall Study|Investigator discretion|0|||
146140923|NCT01607905|527030469|FG003|Overall Study|Investigator discretion|0|||
146140924|NCT01607905|527030470|FG004|Overall Study|Investigator discretion|0|||
146140925|NCT01607905|527030471|FG005|Overall Study|Investigator discretion|1|||
146140926|NCT01607905|527030472|FG006|Overall Study|Investigator discretion|0|||
146140927|NCT01607905|527030466|FG000|Overall Study|Other|1|||
146140928|NCT01607905|527030467|FG001|Overall Study|Other|0|||
146140929|NCT01607905|527030468|FG002|Overall Study|Other|0|||
146140930|NCT01607905|527030469|FG003|Overall Study|Other|0|||
146140931|NCT01607905|527030470|FG004|Overall Study|Other|0|||
146140932|NCT01607905|527030471|FG005|Overall Study|Other|0|||
146140933|NCT01607905|527030472|FG006|Overall Study|Other|1|||
146140934|NCT01607905|527030466|FG000|Overall Study|Randomized but not treated|1|||
146140935|NCT01607905|527030467|FG001|Overall Study|Randomized but not treated|0|||
146140936|NCT01607905|527030468|FG002|Overall Study|Randomized but not treated|0|||
146140937|NCT01607905|527030469|FG003|Overall Study|Randomized but not treated|0|||
146140938|NCT01607905|527030470|FG004|Overall Study|Randomized but not treated|1|||
146140939|NCT01607905|527030471|FG005|Overall Study|Randomized but not treated|1|||
146140940|NCT01607905|527030472|FG006|Overall Study|Randomized but not treated|0|||
146140941|NCT03892889|527030473|FG000|Overall Study|Adverse Event|17|||
146140942|NCT03892889|527030473|FG000|Overall Study|Lack of Efficacy|1|||
146140943|NCT03892889|527030473|FG000|Overall Study|Lost to Follow-up|46|||
146140944|NCT03892889|527030473|FG000|Overall Study|Non-compliance with study drug|22|||
146140945|NCT03892889|527030473|FG000|Overall Study|Pregnancy|1|||
146140946|NCT03892889|527030473|FG000|Overall Study|Protocol Deviation|3|||
146140947|NCT03892889|527030473|FG000|Overall Study|Withdrawal by Subject|50|||
146140948|NCT03892889|527030473|FG000|Overall Study|Withdrawal by Caregiver|1|||
146140949|NCT03892889|527030473|FG000|Overall Study|Study Terminated by Sponsor|50|||
146140950|NCT03892889|527030473|FG000|Overall Study|Physician Decision|8|||
146140951|NCT03892889|527030473|FG000|Overall Study|Reason not Specified|5|||
146140952|NCT01610700|527030474|FG000|Overall Study|Adverse Event|3|||
146140953|NCT01610700|527030475|FG001|Overall Study|Adverse Event|1|||
146140954|NCT01610700|527030474|FG000|Overall Study|Withdrawal by Subject|0|||
146140955|NCT01610700|527030475|FG001|Overall Study|Withdrawal by Subject|1|||
146140956|NCT01610700|527030474|FG000|Overall Study|subject took one dose of street cannabis|0|||
146140957|NCT01610700|527030475|FG001|Overall Study|subject took one dose of street cannabis|1|||
146271553|NCT01327612|527509774|FG004|Overall Study|Withdrawal by Subject|0|||
146271554|NCT01327612|527509775|FG005|Overall Study|Withdrawal by Subject|1|||
146271555|NCT01327612|527509776|FG006|Overall Study|Withdrawal by Subject|0|||
146271556|NCT01327612|527509770|FG000|Overall Study|Disease Progression|1|||
146271557|NCT01327612|527509771|FG001|Overall Study|Disease Progression|1|||
146271558|NCT01327612|527509772|FG002|Overall Study|Disease Progression|1|||
146271559|NCT01327612|527509773|FG003|Overall Study|Disease Progression|0|||
146271560|NCT01327612|527509774|FG004|Overall Study|Disease Progression|1|||
146271561|NCT01327612|527509775|FG005|Overall Study|Disease Progression|2|||
146271562|NCT01327612|527509776|FG006|Overall Study|Disease Progression|2|||
146271563|NCT01327612|527509770|FG000|Overall Study|Administrative Decision|0|||
146271564|NCT01327612|527509771|FG001|Overall Study|Administrative Decision|0|||
146271565|NCT01327612|527509772|FG002|Overall Study|Administrative Decision|0|||
146271566|NCT01327612|527509773|FG003|Overall Study|Administrative Decision|1|||
146271567|NCT01327612|527509774|FG004|Overall Study|Administrative Decision|0|||
146271568|NCT01327612|527509775|FG005|Overall Study|Administrative Decision|0|||
146140958|NCT00679341|527030477|FG000|Overall Study|Disease progression|42|||
146271569|NCT01327612|527509776|FG006|Overall Study|Administrative Decision|0|||
146271570|NCT01327612|527509770|FG000|Overall Study|Death|0|||
146140959|NCT00679341|527030478|FG001|Overall Study|Disease progression|36|||
146271571|NCT01327612|527509771|FG001|Overall Study|Death|0|||
146140960|NCT00679341|527030477|FG000|Overall Study|Adverse Event|5|||
146140961|NCT00679341|527030478|FG001|Overall Study|Adverse Event|6|||
146140962|NCT00679341|527030477|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
146271572|NCT01327612|527509772|FG002|Overall Study|Death|0|||
146140963|NCT00679341|527030478|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
146140964|NCT00679341|527030477|FG000|Overall Study|Death|1|||
146140965|NCT00679341|527030478|FG001|Overall Study|Death|1|||
146140966|NCT00679341|527030477|FG000|Overall Study|Other|1|||
146140967|NCT00679341|527030478|FG001|Overall Study|Other|0|||
146140968|NCT00679341|527030477|FG000|Overall Study|Physician Decision|1|||
146140969|NCT00679341|527030478|FG001|Overall Study|Physician Decision|0|||
146140970|NCT00679341|527030477|FG000|Overall Study|Not treated|0|||
146140971|NCT00679341|527030478|FG001|Overall Study|Not treated|2|||
146140972|NCT00679341|527030477|FG000|Overall Study|Physician/patient decision to withdraw|0|||
146140973|NCT00679341|527030478|FG001|Overall Study|Physician/patient decision to withdraw|6|||
146140974|NCT02652624|527030481|FG000|Randomized Phase|Pregnancy|3|||
146140975|NCT02652624|527030482|FG001|Randomized Phase|Pregnancy|1|||
146140976|NCT02652624|527030481|FG000|Randomized Phase|Investigator's Discretion|0|||
146140977|NCT02652624|527030482|FG001|Randomized Phase|Investigator's Discretion|2|||
146140978|NCT02652624|527030481|FG000|Randomized Phase|Death|0|||
146140979|NCT02652624|527030482|FG001|Randomized Phase|Death|1|||
146140980|NCT02652624|527030481|FG000|Randomized Phase|Lost to Follow-up|0|||
146140981|NCT02652624|527030482|FG001|Randomized Phase|Lost to Follow-up|1|||
146140982|NCT02652624|527030481|FG000|Extension Phase|Lost to Follow-up|3|||
146140983|NCT02652624|527030482|FG001|Extension Phase|Lost to Follow-up|1|||
146140984|NCT02652624|527030481|FG000|Extension Phase|Pregnancy|1|||
146140985|NCT02652624|527030482|FG001|Extension Phase|Pregnancy|1|||
146140986|NCT02652624|527030481|FG000|Extension Phase|Adverse Event|0|||
146140987|NCT02652624|527030482|FG001|Extension Phase|Adverse Event|1|||
146140988|NCT02652624|527030481|FG000|Extension Phase|Withdrew Consent|0|||
146140989|NCT02652624|527030482|FG001|Extension Phase|Withdrew Consent|1|||
146140990|NCT00654628|527030483|FG000|6-week Active Treatment Period|Adverse Event|9|||
146140991|NCT00654628|527030483|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
146140992|NCT00654628|527030483|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
146140993|NCT00654628|527030483|FG000|6-week Active Treatment Period|Out of window period|1|||
146140994|NCT00654628|527030483|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
146140995|NCT00654628|527030483|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
146140996|NCT00912405|527030486|FG000|Overall Study|Lost to Follow-up|5|||
146140997|NCT00953329|527030487|FG000|Overall Study|Lack of Efficacy|1|||
146140998|NCT01797536|527030488|FG000|Overall Study|Adverse Event|0|||
146140999|NCT01797536|527030489|FG001|Overall Study|Adverse Event|1|||
146141000|NCT01797536|527030490|FG002|Overall Study|Adverse Event|0|||
146141001|NCT01797536|527030491|FG003|Overall Study|Adverse Event|0|||
146141002|NCT00403455|527030492|FG000|Overall Study|Withdrawal by Subject|1|||
146141003|NCT03160703|527030493|FG000|Overall Study|Withdrawal by Subject|0|||
146141004|NCT03160703|527030494|FG001|Overall Study|Withdrawal by Subject|0|||
146141005|NCT03160703|527030495|FG002|Overall Study|Withdrawal by Subject|0|||
146141006|NCT03160703|527030496|FG003|Overall Study|Withdrawal by Subject|1|||
146141007|NCT00226941|527030503|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
146141008|NCT00226941|527030504|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
146141009|NCT00226941|527030505|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
146141010|NCT00226941|527030506|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
146141011|NCT00226941|527030503|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146141012|NCT00226941|527030504|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146141013|NCT00226941|527030505|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
146141014|NCT00226941|527030506|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
146141015|NCT01513291|527030507|FG000|Treatment Period|Adverse Event|8|||
146141016|NCT01513291|527030508|FG001|Treatment Period|Adverse Event|4|||
146141017|NCT01513291|527030509|FG002|Treatment Period|Adverse Event|0|||
146141018|NCT01513291|527030510|FG003|Treatment Period|Adverse Event|0|||
146141019|NCT01513291|527030511|FG004|Treatment Period|Adverse Event|0|||
146141020|NCT01513291|527030507|FG000|Treatment Period|Lack of Efficacy|3|||
146141021|NCT01513291|527030508|FG001|Treatment Period|Lack of Efficacy|0|||
146141022|NCT01513291|527030509|FG002|Treatment Period|Lack of Efficacy|0|||
146141023|NCT01513291|527030510|FG003|Treatment Period|Lack of Efficacy|0|||
146141024|NCT01513291|527030511|FG004|Treatment Period|Lack of Efficacy|0|||
146141025|NCT01513291|527030507|FG000|Treatment Period|Lost to Follow-up|2|||
146141026|NCT01513291|527030508|FG001|Treatment Period|Lost to Follow-up|3|||
146141027|NCT01513291|527030509|FG002|Treatment Period|Lost to Follow-up|0|||
146141028|NCT01513291|527030510|FG003|Treatment Period|Lost to Follow-up|0|||
146141029|NCT01513291|527030511|FG004|Treatment Period|Lost to Follow-up|0|||
146141030|NCT01513291|527030507|FG000|Treatment Period|Physician Decision|1|||
146141031|NCT01513291|527030508|FG001|Treatment Period|Physician Decision|0|||
146141032|NCT01513291|527030509|FG002|Treatment Period|Physician Decision|0|||
146141033|NCT01513291|527030510|FG003|Treatment Period|Physician Decision|0|||
146141034|NCT01513291|527030511|FG004|Treatment Period|Physician Decision|0|||
146141035|NCT01513291|527030507|FG000|Treatment Period|Protocol Violation|1|||
146141036|NCT01513291|527030508|FG001|Treatment Period|Protocol Violation|2|||
146141037|NCT01513291|527030509|FG002|Treatment Period|Protocol Violation|0|||
146141038|NCT01513291|527030510|FG003|Treatment Period|Protocol Violation|0|||
146141039|NCT01513291|527030511|FG004|Treatment Period|Protocol Violation|0|||
146141040|NCT01513291|527030507|FG000|Treatment Period|Withdrawal by Subject|8|||
146141041|NCT01513291|527030508|FG001|Treatment Period|Withdrawal by Subject|5|||
146141042|NCT01513291|527030509|FG002|Treatment Period|Withdrawal by Subject|0|||
146141043|NCT01513291|527030510|FG003|Treatment Period|Withdrawal by Subject|0|||
146141044|NCT01513291|527030511|FG004|Treatment Period|Withdrawal by Subject|0|||
146141045|NCT01513291|527030507|FG000|Treatment Period|Randomized not treated|0|||
146141046|NCT01513291|527030508|FG001|Treatment Period|Randomized not treated|2|||
146141047|NCT01513291|527030509|FG002|Treatment Period|Randomized not treated|0|||
146141048|NCT01513291|527030510|FG003|Treatment Period|Randomized not treated|0|||
146141049|NCT01513291|527030511|FG004|Treatment Period|Randomized not treated|0|||
146141050|NCT01513291|527030507|FG000|Run-out Period|Lost to Follow-up|0|||
146141051|NCT01513291|527030508|FG001|Run-out Period|Lost to Follow-up|0|||
146141052|NCT01513291|527030509|FG002|Run-out Period|Lost to Follow-up|0|||
146141053|NCT01513291|527030510|FG003|Run-out Period|Lost to Follow-up|1|||
146141054|NCT01513291|527030511|FG004|Run-out Period|Lost to Follow-up|0|||
146141055|NCT01513291|527030507|FG000|Run-out Period|Withdrawal by Subject|0|||
146141056|NCT01513291|527030508|FG001|Run-out Period|Withdrawal by Subject|0|||
146141057|NCT01513291|527030509|FG002|Run-out Period|Withdrawal by Subject|0|||
146141058|NCT01513291|527030510|FG003|Run-out Period|Withdrawal by Subject|1|||
146141059|NCT01513291|527030511|FG004|Run-out Period|Withdrawal by Subject|0|||
146141060|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
146141061|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
146141062|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
146141063|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
146141064|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
146141065|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
146141066|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
146141067|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
146141068|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
146141069|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
146141070|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
146141071|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
146141072|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
146141073|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
146141074|NCT03732638|527030512|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
146141075|NCT03732638|527030513|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
146141076|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
146141077|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
146141078|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
146141079|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
146141080|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
146141081|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
146141082|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
146141083|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
146141084|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
146141085|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
146141086|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
146141087|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
146141088|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
146141089|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
146141090|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
146141091|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
146141092|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
146141093|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
146141094|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
146141095|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
146141096|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
146141097|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
146141098|NCT03732638|527030512|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
146141099|NCT03732638|527030513|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
146141100|NCT03732638|527030512|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
146271573|NCT01327612|527509773|FG003|Overall Study|Death|0|||
146271574|NCT01327612|527509774|FG004|Overall Study|Death|1|||
146141101|NCT03732638|527030513|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
146141102|NCT03732638|527030512|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
146141103|NCT03732638|527030513|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
146141104|NCT03732638|527030512|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
146141105|NCT03732638|527030513|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
146141106|NCT03732638|527030512|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
146271575|NCT01327612|527509775|FG005|Overall Study|Death|0|||
146271576|NCT01327612|527509776|FG006|Overall Study|Death|0|||
146141107|NCT03732638|527030513|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
146141108|NCT01358981|527030514|FG000|Period 1|Withdrawal by Subject|0|||
146141109|NCT01358981|527030515|FG001|Period 1|Withdrawal by Subject|0|||
146141110|NCT01358981|527030516|FG002|Period 1|Withdrawal by Subject|0|||
146141111|NCT01358981|527030517|FG003|Period 1|Withdrawal by Subject|1|||
146141112|NCT01358981|527030518|FG004|Period 1|Withdrawal by Subject|0|||
146141113|NCT01358981|527030519|FG005|Period 1|Withdrawal by Subject|0|||
146141114|NCT01358981|527030520|FG006|Period 1|Withdrawal by Subject|0|||
146141115|NCT03728582|527030521|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
146141116|NCT03728582|527030522|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
146141117|NCT03728582|527030521|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
146141118|NCT03728582|527030522|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
146141119|NCT02732847|527030523|FG000|Overall Study|some filled early|42|||
146141120|NCT02732847|527030524|FG001|Overall Study|some filled early|42|||
146141121|NCT01018264|527030525|FG000|Overall Study|Withdrawal by Subject|1|||
146141122|NCT01018264|527030526|FG001|Overall Study|Withdrawal by Subject|0|||
146141123|NCT01018264|527030525|FG000|Overall Study|Lost to Follow-up|0|||
146141124|NCT01018264|527030526|FG001|Overall Study|Lost to Follow-up|1|||
146141125|NCT03217136|527030532|FG000|Overall Study|Lost to Follow-up|2|||
146141126|NCT03217136|527030533|FG001|Overall Study|Lost to Follow-up|1|||
146141127|NCT03217136|527030532|FG000|Overall Study|Site Randomized Participant in Error|0|||
146141128|NCT03217136|527030533|FG001|Overall Study|Site Randomized Participant in Error|1|||
146141129|NCT03217136|527030532|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
146141130|NCT03217136|527030533|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
146141131|NCT03217136|527030532|FG000|Overall Study|Dispensing Error|1|||
146141132|NCT03217136|527030533|FG001|Overall Study|Dispensing Error|0|||
146141133|NCT03217136|527030532|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146141134|NCT03217136|527030533|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146141135|NCT00678691|527030534|FG000|Overall Study|Adverse Event|6|||
146141136|NCT00678691|527030535|FG001|Overall Study|Adverse Event|4|||
146141137|NCT01859715|527030538|FG000|Overall Study|No 2nd VAS|16|||
146141138|NCT01859715|527030539|FG001|Overall Study|No 2nd VAS|8|||
146141139|NCT01859715|527030540|FG002|Overall Study|No 2nd VAS|23|||
146141140|NCT04936685|527030541|FG000|Overall Study|Protocol Violation|1|||
146141141|NCT04936685|527030542|FG001|Overall Study|Protocol Violation|0|||
146141142|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
146141143|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
146141144|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
146141145|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
146141146|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
146141147|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
146141148|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
146141149|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
146141150|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
146141151|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
146141152|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
146141153|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
146141154|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
146141155|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
146141156|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
146141157|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
146141158|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
146141159|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
146141160|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
146141161|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
146141162|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
146141163|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
146141164|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
146141165|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
146141166|NCT04542070|527030545|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
146141167|NCT04542070|527030546|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
146141168|NCT04542070|527030547|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
146141169|NCT04542070|527030548|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
146141170|NCT04542070|527030545|FG000|Maintenance + Extension Period|Adverse Event|10|||
146141171|NCT04542070|527030546|FG001|Maintenance + Extension Period|Adverse Event|2|||
146141172|NCT04542070|527030547|FG002|Maintenance + Extension Period|Adverse Event|0|||
146141173|NCT04542070|527030548|FG003|Maintenance + Extension Period|Adverse Event|0|||
146141174|NCT04542070|527030545|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
146141175|NCT04542070|527030546|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
146141176|NCT04542070|527030547|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
146141177|NCT04542070|527030548|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
146141178|NCT04542070|527030545|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
146141179|NCT04542070|527030546|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
146141180|NCT04542070|527030547|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
146141181|NCT04542070|527030548|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
146141182|NCT04542070|527030545|FG000|Maintenance + Extension Period|Physician Decision|1|||
146141183|NCT04542070|527030546|FG001|Maintenance + Extension Period|Physician Decision|1|||
146141184|NCT04542070|527030547|FG002|Maintenance + Extension Period|Physician Decision|0|||
146141185|NCT04542070|527030548|FG003|Maintenance + Extension Period|Physician Decision|0|||
146141186|NCT04542070|527030545|FG000|Maintenance + Extension Period|Protocol Violation|2|||
146141187|NCT04542070|527030546|FG001|Maintenance + Extension Period|Protocol Violation|5|||
146141188|NCT04542070|527030547|FG002|Maintenance + Extension Period|Protocol Violation|0|||
146141189|NCT04542070|527030548|FG003|Maintenance + Extension Period|Protocol Violation|0|||
146141190|NCT04542070|527030545|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
146141191|NCT04542070|527030546|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
146141192|NCT04542070|527030547|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
146141193|NCT04542070|527030548|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
146141194|NCT04542070|527030545|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
146141195|NCT04542070|527030546|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
146141196|NCT04542070|527030547|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
146141197|NCT04542070|527030548|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
146141198|NCT04542070|527030545|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146141199|NCT04542070|527030546|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146141200|NCT04542070|527030547|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
146141201|NCT04542070|527030548|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
146141202|NCT04542070|527030545|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146141203|NCT04542070|527030546|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146141204|NCT04542070|527030547|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
146141205|NCT04542070|527030548|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
146141206|NCT04542070|527030545|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146141207|NCT04542070|527030546|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146141208|NCT04542070|527030547|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
146141209|NCT04542070|527030548|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
146141210|NCT04542070|527030545|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146141211|NCT04542070|527030546|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146141212|NCT04542070|527030547|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
146141213|NCT04542070|527030548|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
146141214|NCT04542070|527030545|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146141215|NCT04542070|527030546|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146141216|NCT04542070|527030547|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
146141217|NCT04542070|527030548|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
146141218|NCT03049813|527030551|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146141219|NCT03049813|527030552|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
146141220|NCT03049813|527030553|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146141221|NCT03049813|527030554|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
146141222|NCT03049813|527030551|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
146141223|NCT03049813|527030552|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
146141224|NCT03049813|527030553|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
146141225|NCT03049813|527030554|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
146141226|NCT03049813|527030551|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146141227|NCT03049813|527030552|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
146141228|NCT03049813|527030553|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146141229|NCT03049813|527030554|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
146141230|NCT03049813|527030551|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
146141231|NCT03049813|527030552|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
146141232|NCT03049813|527030553|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
146141233|NCT03049813|527030554|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
146271577|NCT01294397|527509777|FG000|Overall Study|Withdrawal by Subject|1|||
146271578|NCT01294397|527509777|FG000|Overall Study|Administrative Decision|1|||
146271579|NCT01661205|527509778|FG000|Overall Study|Physician Decision|2|||
146271580|NCT00426127|527509779|FG000|Overall Study|Adverse Event|1|||
146271581|NCT00426127|527509779|FG000|Overall Study|Removed due to disease progression|1|||
146271582|NCT03111095|527509783|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
146271583|NCT03111095|527509784|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
146271584|NCT03111095|527509783|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
146271585|NCT03111095|527509784|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
146141234|NCT01813019|527030555|FG000|Overall Study|Adverse Event|0|||
146141235|NCT01813019|527030556|FG001|Overall Study|Adverse Event|3|||
146141236|NCT01813019|527030555|FG000|Overall Study|Withdrawal by Subject|3|||
146141237|NCT01813019|527030556|FG001|Overall Study|Withdrawal by Subject|2|||
146141238|NCT01813019|527030555|FG000|Overall Study|administrative problems|2|||
146141239|NCT01813019|527030556|FG001|Overall Study|administrative problems|0|||
146141240|NCT01813019|527030555|FG000|Overall Study|Protocol Deviation|2|||
146141241|NCT01813019|527030556|FG001|Overall Study|Protocol Deviation|1|||
146141242|NCT01193556|527030562|FG000|Overall Study|Study termination|26|||
146141243|NCT01193556|527030563|FG001|Overall Study|Study termination|25|||
146141244|NCT01696032|527030565|FG000|Overall Study|Withdrawal by Subject|0|||
146141245|NCT01696032|527030566|FG001|Overall Study|Withdrawal by Subject|0|||
146141246|NCT01696032|527030567|FG002|Overall Study|Withdrawal by Subject|1|||
146141247|NCT01696032|527030568|FG003|Overall Study|Withdrawal by Subject|2|||
146141248|NCT01696032|527030565|FG000|Overall Study|Death|14|||
146141249|NCT01696032|527030566|FG001|Overall Study|Death|4|||
146141250|NCT01696032|527030567|FG002|Overall Study|Death|43|||
146141251|NCT01696032|527030568|FG003|Overall Study|Death|18|||
146141252|NCT01696032|527030565|FG000|Overall Study|Lost to Follow-up|0|||
146141253|NCT01696032|527030566|FG001|Overall Study|Lost to Follow-up|1|||
146141254|NCT01696032|527030567|FG002|Overall Study|Lost to Follow-up|0|||
146141255|NCT01696032|527030568|FG003|Overall Study|Lost to Follow-up|0|||
146141256|NCT01696032|527030565|FG000|Overall Study|Database lock|0|||
146141257|NCT01696032|527030566|FG001|Overall Study|Database lock|1|||
146141258|NCT01696032|527030567|FG002|Overall Study|Database lock|7|||
146141259|NCT01696032|527030568|FG003|Overall Study|Database lock|2|||
146141260|NCT03025828|527030571|FG000|Overall Study|Lost to Follow-up|1|||
146141261|NCT02203591|527030572|FG000|Overall Study|Did not meet treatment day baseline|147|||
146141262|NCT02203591|527030573|FG001|Overall Study|Did not meet treatment day baseline|141|||
146141263|NCT02203591|527030574|FG002|Overall Study|Did not meet treatment day baseline|150|||
146141264|NCT02203591|527030575|FG003|Overall Study|Did not meet treatment day baseline|45|||
146141265|NCT02203591|527030576|FG004|Overall Study|Did not meet treatment day baseline|33|||
146141266|NCT02203591|527030577|FG005|Overall Study|Did not meet treatment day baseline|35|||
146141267|NCT02203591|527030578|FG006|Overall Study|Did not meet treatment day baseline|29|||
146141268|NCT02203591|527030579|FG007|Overall Study|Did not meet treatment day baseline|12|||
146141269|NCT02203591|527030572|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
146141270|NCT02203591|527030573|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
146141271|NCT02203591|527030574|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
146141272|NCT02203591|527030575|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
146141273|NCT02203591|527030576|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
146141274|NCT02203591|527030577|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
146141275|NCT02203591|527030578|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
146141276|NCT02203591|527030579|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
146141277|NCT03306264|527030582|FG000|Overall Study|Death|33|||
146141278|NCT03306264|527030583|FG001|Overall Study|Death|25|||
146141279|NCT03306264|527030584|FG002|Overall Study|Death|34|||
146141280|NCT03306264|527030585|FG003|Overall Study|Death|34|||
146141281|NCT03306264|527030582|FG000|Overall Study|Complete Consent Withdrawal|4|||
146141282|NCT03306264|527030583|FG001|Overall Study|Complete Consent Withdrawal|4|||
146141283|NCT03306264|527030584|FG002|Overall Study|Complete Consent Withdrawal|1|||
146141284|NCT03306264|527030585|FG003|Overall Study|Complete Consent Withdrawal|8|||
146141285|NCT03306264|527030582|FG000|Overall Study|Lost to Follow-up|1|||
146141286|NCT03306264|527030583|FG001|Overall Study|Lost to Follow-up|0|||
146141287|NCT03306264|527030584|FG002|Overall Study|Lost to Follow-up|1|||
146141288|NCT03306264|527030585|FG003|Overall Study|Lost to Follow-up|0|||
146141289|NCT03306264|527030582|FG000|Overall Study|Rollover to ASTX727-06|10|||
146141290|NCT03306264|527030583|FG001|Overall Study|Rollover to ASTX727-06|18|||
146141291|NCT03306264|527030584|FG002|Overall Study|Rollover to ASTX727-06|4|||
146141292|NCT03306264|527030585|FG003|Overall Study|Rollover to ASTX727-06|2|||
146141293|NCT03306264|527030582|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
146141294|NCT03306264|527030583|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
146141295|NCT03306264|527030584|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
146141296|NCT03306264|527030585|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
146141297|NCT00806546|527030602|FG000|Overall Study|Enrolled, not treated|35|||
146141298|NCT00806546|527030602|FG000|Overall Study|Lost to Follow-up|32|||
146141299|NCT00806546|527030602|FG000|Overall Study|Adverse Event|74|||
146141300|NCT00806546|527030602|FG000|Overall Study|Withdrawal by Subject|75|||
146141301|NCT00806546|527030602|FG000|Overall Study|Protocol Violation|49|||
146141302|NCT00806546|527030602|FG000|Overall Study|Various|42|||
146141303|NCT01466192|527030607|FG000|Overall Study|Physician Decision|1|||
146141304|NCT01466192|527030607|FG000|Overall Study|Withdrawal by Subject|3|||
146141305|NCT00700011|527030609|FG000|Overall Study|Death|0|||
146141306|NCT00700011|527030610|FG001|Overall Study|Death|1|||
146141307|NCT00678561|527030611|FG000|Overall Study|Adverse Event|0|||
146141308|NCT00678561|527030612|FG001|Overall Study|Adverse Event|1|||
146141309|NCT00678561|527030613|FG002|Overall Study|Adverse Event|1|||
146141310|NCT00678561|527030614|FG003|Overall Study|Adverse Event|0|||
146141311|NCT00678561|527030615|FG004|Overall Study|Adverse Event|1|||
146141312|NCT00678561|527030616|FG005|Overall Study|Adverse Event|0|||
146141313|NCT00678561|527030617|FG006|Overall Study|Adverse Event|0|||
146141314|NCT00678561|527030618|FG007|Overall Study|Adverse Event|0|||
146141315|NCT00678561|527030611|FG000|Overall Study|Protocol Violation|0|||
146141316|NCT00678561|527030612|FG001|Overall Study|Protocol Violation|0|||
146141317|NCT00678561|527030613|FG002|Overall Study|Protocol Violation|0|||
146141318|NCT00678561|527030614|FG003|Overall Study|Protocol Violation|0|||
146141319|NCT00678561|527030615|FG004|Overall Study|Protocol Violation|1|||
146141320|NCT00678561|527030616|FG005|Overall Study|Protocol Violation|1|||
146141321|NCT00678561|527030617|FG006|Overall Study|Protocol Violation|0|||
146141322|NCT00678561|527030618|FG007|Overall Study|Protocol Violation|0|||
146141323|NCT00678561|527030611|FG000|Overall Study|Withdrawal by Subject|0|||
146141324|NCT00678561|527030612|FG001|Overall Study|Withdrawal by Subject|0|||
146141325|NCT00678561|527030613|FG002|Overall Study|Withdrawal by Subject|0|||
146141326|NCT00678561|527030614|FG003|Overall Study|Withdrawal by Subject|0|||
146141327|NCT00678561|527030615|FG004|Overall Study|Withdrawal by Subject|0|||
146141328|NCT00678561|527030616|FG005|Overall Study|Withdrawal by Subject|0|||
146141329|NCT00678561|527030617|FG006|Overall Study|Withdrawal by Subject|0|||
146141330|NCT00678561|527030618|FG007|Overall Study|Withdrawal by Subject|1|||
146141331|NCT00004031|527030619|FG000|Overall Study|Adverse Event|5|||
146141332|NCT00004031|527030620|FG001|Overall Study|Adverse Event|0|||
146141333|NCT00004031|527030619|FG000|Overall Study|Refusal unrelated to adverse events|2|||
146141334|NCT00004031|527030620|FG001|Overall Study|Refusal unrelated to adverse events|11|||
146141335|NCT00004031|527030619|FG000|Overall Study|Progression/relapse|9|||
146141336|NCT00004031|527030620|FG001|Overall Study|Progression/relapse|4|||
146141337|NCT00004031|527030619|FG000|Overall Study|Death|3|||
146141338|NCT00004031|527030620|FG001|Overall Study|Death|1|||
146141339|NCT00004031|527030619|FG000|Overall Study|Other- not protocol specified|3|||
146141340|NCT00004031|527030620|FG001|Overall Study|Other- not protocol specified|3|||
146141341|NCT00004031|527030619|FG000|Overall Study|Reason under review|3|||
146141342|NCT00004031|527030620|FG001|Overall Study|Reason under review|2|||
146141343|NCT01451424|527030621|FG000|Overall Study|Withdrawal by Subject|1|||
146141344|NCT01451424|527030622|FG001|Overall Study|Withdrawal by Subject|1|||
146141345|NCT01451424|527030623|FG002|Overall Study|Withdrawal by Subject|0|||
146141346|NCT01451424|527030624|FG003|Overall Study|Withdrawal by Subject|2|||
146141347|NCT01451424|527030621|FG000|Overall Study|Lost to Follow-up|0|||
146141348|NCT01451424|527030622|FG001|Overall Study|Lost to Follow-up|1|||
146141349|NCT01451424|527030623|FG002|Overall Study|Lost to Follow-up|0|||
146141350|NCT01451424|527030624|FG003|Overall Study|Lost to Follow-up|1|||
146141351|NCT01451424|527030621|FG000|Overall Study|Physician Decision|0|||
146141352|NCT01451424|527030622|FG001|Overall Study|Physician Decision|0|||
146141353|NCT01451424|527030623|FG002|Overall Study|Physician Decision|1|||
146141354|NCT01451424|527030624|FG003|Overall Study|Physician Decision|1|||
146141355|NCT01451424|527030621|FG000|Overall Study|Adverse Event|0|||
146141356|NCT01451424|527030622|FG001|Overall Study|Adverse Event|0|||
146141357|NCT01451424|527030623|FG002|Overall Study|Adverse Event|0|||
146141358|NCT01451424|527030624|FG003|Overall Study|Adverse Event|1|||
146141359|NCT02920983|527030625|FG000|Dispense 1|Unacceptable Lens Fit|0|||
146141360|NCT02920983|527030626|FG001|Dispense 1|Unacceptable Lens Fit|0|||
146141361|NCT02920983|527030627|FG002|Dispense 1|Unacceptable Lens Fit|0|||
146141362|NCT02920983|527030628|FG003|Dispense 1|Unacceptable Lens Fit|0|||
146141363|NCT02920983|527030629|FG004|Dispense 1|Unacceptable Lens Fit|1|||
146141364|NCT02920983|527030630|FG005|Dispense 1|Unacceptable Lens Fit|0|||
146141365|NCT02920983|527030625|FG000|Dispense 2|Unscceptable lens fit|1|||
146141366|NCT02920983|527030626|FG001|Dispense 2|Unscceptable lens fit|0|||
146141367|NCT02920983|527030627|FG002|Dispense 2|Unscceptable lens fit|0|||
146141368|NCT02920983|527030628|FG003|Dispense 2|Unscceptable lens fit|0|||
146141369|NCT02920983|527030629|FG004|Dispense 2|Unscceptable lens fit|1|||
146141370|NCT02920983|527030630|FG005|Dispense 2|Unscceptable lens fit|0|||
146141371|NCT02920983|527030625|FG000|Dispense 3|Unacceptable Lens Fit|1|||
146141372|NCT02920983|527030626|FG001|Dispense 3|Unacceptable Lens Fit|1|||
146141373|NCT02920983|527030627|FG002|Dispense 3|Unacceptable Lens Fit|0|||
146141374|NCT02920983|527030628|FG003|Dispense 3|Unacceptable Lens Fit|0|||
146141375|NCT02920983|527030629|FG004|Dispense 3|Unacceptable Lens Fit|1|||
146141376|NCT02920983|527030630|FG005|Dispense 3|Unacceptable Lens Fit|0|||
146141377|NCT02553421|527030633|FG000|Overall Study|Lost to Follow-up|21|||
146141378|NCT02553421|527030634|FG001|Overall Study|Lost to Follow-up|1|||
146141379|NCT02553421|527030633|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
146141380|NCT02553421|527030634|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
146141381|NCT02553421|527030633|FG000|Overall Study|Improper Device Placement|3|||
146141382|NCT02553421|527030634|FG001|Overall Study|Improper Device Placement|0|||
146141383|NCT03551210|527030637|FG000|Overall Study|Adverse Event|5|||
146141384|NCT03551210|527030638|FG001|Overall Study|Adverse Event|6|||
146141385|NCT03551210|527030637|FG000|Overall Study|Withdrawal by Subject|1|||
146141386|NCT03551210|527030638|FG001|Overall Study|Withdrawal by Subject|7|||
146141387|NCT03551210|527030637|FG000|Overall Study|Needed in other antibiotic treatment|2|||
146271586|NCT00955708|527509785|FG000|Overall Study|Death|269|||
146141388|NCT03551210|527030638|FG001|Overall Study|Needed in other antibiotic treatment|5|||
146141389|NCT03551210|527030637|FG000|Overall Study|Lost to Follow-up|1|||
146141390|NCT03551210|527030638|FG001|Overall Study|Lost to Follow-up|1|||
146141391|NCT03551210|527030637|FG000|Overall Study|Absence of visit 4 and 5|1|||
146141392|NCT03551210|527030638|FG001|Overall Study|Absence of visit 4 and 5|0|||
146141393|NCT03551210|527030637|FG000|Overall Study|No drug for dispensing|0|||
146141394|NCT03551210|527030638|FG001|Overall Study|No drug for dispensing|1|||
146141395|NCT03265119|527030639|FG000|Overall Study|Adverse Event|2|||
146141396|NCT03265119|527030640|FG001|Overall Study|Adverse Event|1|||
146141397|NCT03265119|527030639|FG000|Overall Study|Lack of Efficacy|3|||
146141398|NCT03265119|527030640|FG001|Overall Study|Lack of Efficacy|0|||
146141399|NCT03265119|527030639|FG000|Overall Study|Protocol Violation|1|||
146141400|NCT03265119|527030640|FG001|Overall Study|Protocol Violation|2|||
146141401|NCT03265119|527030639|FG000|Overall Study|Withdrawal by Subject|2|||
146141402|NCT03265119|527030640|FG001|Overall Study|Withdrawal by Subject|4|||
146141403|NCT03265119|527030639|FG000|Overall Study|Lost to Follow-up|1|||
146141404|NCT03265119|527030640|FG001|Overall Study|Lost to Follow-up|0|||
146141405|NCT03265119|527030639|FG000|Overall Study|Lack of Compliance|1|||
146141406|NCT03265119|527030640|FG001|Overall Study|Lack of Compliance|0|||
146141407|NCT04579679|527030641|FG000|Overall Study|New Antitumor Therapy|6|||
146141408|NCT04579679|527030642|FG001|Overall Study|New Antitumor Therapy|4|||
146141409|NCT04579679|527030643|FG002|Overall Study|New Antitumor Therapy|7|||
146141410|NCT04579679|527030644|FG003|Overall Study|New Antitumor Therapy|0|||
146141411|NCT04579679|527030641|FG000|Overall Study|Withdrawal of Consent|1|||
146141412|NCT04579679|527030642|FG001|Overall Study|Withdrawal of Consent|1|||
146141413|NCT04579679|527030643|FG002|Overall Study|Withdrawal of Consent|2|||
146141414|NCT04579679|527030644|FG003|Overall Study|Withdrawal of Consent|4|||
146141415|NCT04579679|527030641|FG000|Overall Study|Death|2|||
146141416|NCT04579679|527030642|FG001|Overall Study|Death|2|||
146141417|NCT04579679|527030643|FG002|Overall Study|Death|2|||
146141418|NCT04579679|527030644|FG003|Overall Study|Death|0|||
146141419|NCT04579679|527030641|FG000|Overall Study|Adverse Event|0|||
146141420|NCT04579679|527030642|FG001|Overall Study|Adverse Event|4|||
146141421|NCT04579679|527030643|FG002|Overall Study|Adverse Event|0|||
146141422|NCT04579679|527030644|FG003|Overall Study|Adverse Event|0|||
146141423|NCT04579679|527030641|FG000|Overall Study|Disease Progression|9|||
146141424|NCT04579679|527030642|FG001|Overall Study|Disease Progression|13|||
146141425|NCT04579679|527030643|FG002|Overall Study|Disease Progression|7|||
146141426|NCT04579679|527030644|FG003|Overall Study|Disease Progression|0|||
146141427|NCT04579679|527030641|FG000|Overall Study|Physician Decision|0|||
146141428|NCT04579679|527030642|FG001|Overall Study|Physician Decision|0|||
146141429|NCT04579679|527030643|FG002|Overall Study|Physician Decision|1|||
146141430|NCT04579679|527030644|FG003|Overall Study|Physician Decision|0|||
146141431|NCT04579679|527030641|FG000|Overall Study|Study Terminated by Sponsor|2|||
146141432|NCT04579679|527030642|FG001|Overall Study|Study Terminated by Sponsor|7|||
146141433|NCT04579679|527030643|FG002|Overall Study|Study Terminated by Sponsor|1|||
146141434|NCT04579679|527030644|FG003|Overall Study|Study Terminated by Sponsor|0|||
146141435|NCT04524403|527032203|FG000|Overall Study|Withdrawal by Subject|10|||
146141436|NCT04524403|527032204|FG001|Overall Study|Withdrawal by Subject|3|||
146141437|NCT04524403|527032205|FG002|Overall Study|Withdrawal by Subject|8|||
146141438|NCT04524403|527032203|FG000|Overall Study|Lost to Follow-up|3|||
146141439|NCT04524403|527032204|FG001|Overall Study|Lost to Follow-up|4|||
146141440|NCT04524403|527032205|FG002|Overall Study|Lost to Follow-up|3|||
146141441|NCT04524403|527032203|FG000|Overall Study|Adverse Event|3|||
146141442|NCT04524403|527032204|FG001|Overall Study|Adverse Event|1|||
146141443|NCT04524403|527032205|FG002|Overall Study|Adverse Event|4|||
146141444|NCT04524403|527032203|FG000|Overall Study|Non-compliant with study drug|1|||
146141445|NCT04524403|527032204|FG001|Overall Study|Non-compliant with study drug|2|||
146141446|NCT04524403|527032205|FG002|Overall Study|Non-compliant with study drug|3|||
146141447|NCT04524403|527032203|FG000|Overall Study|Moved|0|||
146141448|NCT04524403|527032204|FG001|Overall Study|Moved|1|||
146141449|NCT04524403|527032205|FG002|Overall Study|Moved|0|||
146141450|NCT02383758|527032206|FG000|Overall Study|Withdrawal by Subject|0|||
146141451|NCT02383758|527032207|FG001|Overall Study|Withdrawal by Subject|2|||
146141452|NCT00194012|527032210|FG000|Randomized Phase|Lack of Efficacy|8|||
146141453|NCT00194012|527032211|FG001|Randomized Phase|Lack of Efficacy|18|||
146141454|NCT00194012|527032210|FG000|Randomized Phase|Study nonadherence|2|||
146141455|NCT00194012|527032211|FG001|Randomized Phase|Study nonadherence|1|||
146141456|NCT00194012|527032210|FG000|Randomized Phase|Withdrawal by Subject|3|||
146141457|NCT00194012|527032211|FG001|Randomized Phase|Withdrawal by Subject|3|||
146141458|NCT00194012|527032210|FG000|Randomized Phase|Adverse Event|2|||
146141459|NCT00194012|527032211|FG001|Randomized Phase|Adverse Event|1|||
146141460|NCT00194012|527032210|FG000|Randomized Phase|Participant reported having a rash|1|||
146141461|NCT00194012|527032211|FG001|Randomized Phase|Participant reported having a rash|0|||
146141462|NCT00194012|527032210|FG000|Randomized Phase|Emesis and enuresis|0|||
146141463|NCT00194012|527032211|FG001|Randomized Phase|Emesis and enuresis|1|||
146141464|NCT00194012|527032210|FG000|Randomized Phase|Oral/nasal twitching|0|||
146141465|NCT00194012|527032211|FG001|Randomized Phase|Oral/nasal twitching|1|||
146304155|NCT01034540|527627491|FG000|Overall Study|Adverse Event|0|||
146304156|NCT01034540|527627492|FG001|Overall Study|Adverse Event|1|||
146141466|NCT00194012|527032210|FG000|Open Label Extension (OLE)|Weight Gain|1|||
146141467|NCT00194012|527032211|FG001|Open Label Extension (OLE)|Weight Gain|0|||
146141468|NCT00194012|527032210|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
146304157|NCT00932425|527627493|FG000|Overall Study|Lost to Follow-up|0|||
146304158|NCT00932425|527627494|FG001|Overall Study|Lost to Follow-up|1|||
146304159|NCT00932425|527627493|FG000|Overall Study|Withdrawal by Subject|0|||
146304160|NCT00932425|527627494|FG001|Overall Study|Withdrawal by Subject|1|||
146304161|NCT01721876|527627498|FG000|Overall Study|Not treated|1|||
146304162|NCT01721876|527627499|FG001|Overall Study|Not treated|4|||
146304163|NCT01721876|527627498|FG000|Overall Study|Disease progression / relapse|123|||
146141469|NCT00194012|527032211|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
146141470|NCT00194012|527032210|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
146141471|NCT00194012|527032211|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
146141472|NCT00194012|527032210|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
146141473|NCT00194012|527032211|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
146141474|NCT02649972|527032212|FG000|Overall Study|Not treated|1|||
146141475|NCT00436280|527032213|FG000|Period 1: Induction|Adverse Event|8|||
146141476|NCT00436280|527032213|FG000|Period 1: Induction|Progressive Disease|12|||
146141477|NCT00436280|527032213|FG000|Period 1: Induction|Stable Disease|6|||
146141478|NCT00436280|527032213|FG000|Period 1: Induction|Withdrawal by Subject|1|||
146141479|NCT00436280|527032213|FG000|Period 1: Induction|Death|1|||
146141480|NCT00436280|527032213|FG000|Period 2: Consolidation|Adverse Event|1|||
146141481|NCT00436280|527032213|FG000|Period 2: Consolidation|Progressive Disease|10|||
146141482|NCT00436280|527032213|FG000|Period 2: Consolidation|Stable Disease|1|||
146141483|NCT00436280|527032213|FG000|Period 2: Consolidation|Physician Decision|2|||
146141484|NCT00436280|527032213|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
146141485|NCT00436280|527032213|FG000|Period 2: Consolidation|Death|1|||
146141486|NCT00436280|527032213|FG000|Period 3: Maintenance|Adverse Event|6|||
146141487|NCT00436280|527032213|FG000|Period 3: Maintenance|Progressive Disease|12|||
146141488|NCT02738775|527032214|FG000|Overall Study|Withdrawal by Subject|0|||
146141489|NCT02738775|527032215|FG001|Overall Study|Withdrawal by Subject|1|||
146141490|NCT02738775|527032216|FG002|Overall Study|Withdrawal by Subject|0|||
146141491|NCT02738775|527032217|FG003|Overall Study|Withdrawal by Subject|0|||
146141492|NCT02738775|527032218|FG004|Overall Study|Withdrawal by Subject|0|||
146141493|NCT02738775|527032219|FG005|Overall Study|Withdrawal by Subject|0|||
146141494|NCT02738775|527032214|FG000|Overall Study|Adverse Event|0|||
146141495|NCT02738775|527032215|FG001|Overall Study|Adverse Event|0|||
146141496|NCT02738775|527032216|FG002|Overall Study|Adverse Event|0|||
146141497|NCT02738775|527032217|FG003|Overall Study|Adverse Event|1|||
146141498|NCT02738775|527032218|FG004|Overall Study|Adverse Event|0|||
146141499|NCT02738775|527032219|FG005|Overall Study|Adverse Event|0|||
146141500|NCT02738775|527032214|FG000|Overall Study|Pregnancy|0|||
146141501|NCT02738775|527032215|FG001|Overall Study|Pregnancy|1|||
146141502|NCT02738775|527032216|FG002|Overall Study|Pregnancy|0|||
146141503|NCT02738775|527032217|FG003|Overall Study|Pregnancy|0|||
146141504|NCT02738775|527032218|FG004|Overall Study|Pregnancy|0|||
146141505|NCT02738775|527032219|FG005|Overall Study|Pregnancy|0|||
146271587|NCT00955708|527509785|FG000|Overall Study|Lost to Follow-up|72|||
146271588|NCT00955708|527509785|FG000|Overall Study|Physician Decision|36|||
146271589|NCT00955708|527509785|FG000|Overall Study|Protocol Violation|134|||
146271590|NCT00955708|527509785|FG000|Overall Study|Registry Conclusion|186|||
146271591|NCT00955708|527509785|FG000|Overall Study|Product removed from service|94|||
146271592|NCT00955708|527509785|FG000|Overall Study|Patient Refused to participate further|116|||
146271593|NCT00955708|527509785|FG000|Overall Study|Closure of study location|60|||
146271594|NCT00955708|527509785|FG000|Overall Study|Patient changed care provider/moved|91|||
146271595|NCT03738475|527509786|FG000|Overall Study|Participant Non-Compliance|1|||
146271596|NCT03738475|527509787|FG001|Overall Study|Participant Non-Compliance|0|||
146271597|NCT00737477|527509788|FG000|Overall Study|Adverse Event|9|||
146271598|NCT00737477|527509788|FG000|Overall Study|Death|9|||
146304164|NCT01721876|527627499|FG001|Overall Study|Disease progression / relapse|156|||
146304165|NCT01721876|527627498|FG000|Overall Study|Death|6|||
146141506|NCT02738775|527032214|FG000|Overall Study|Missing|0|||
146141507|NCT02738775|527032215|FG001|Overall Study|Missing|0|||
146271599|NCT00737477|527509788|FG000|Overall Study|Treatment Refusal|1|||
146271600|NCT00737477|527509788|FG000|Overall Study|Withdrawal by Subject|1|||
146141508|NCT02738775|527032216|FG002|Overall Study|Missing|0|||
146271601|NCT00737477|527509788|FG000|Overall Study|Renal Transplantation|10|||
146304166|NCT01721876|527627499|FG001|Overall Study|Death|13|||
146141509|NCT02738775|527032217|FG003|Overall Study|Missing|0|||
146304167|NCT01721876|527627498|FG000|Overall Study|Adverse Event|41|||
146141510|NCT02738775|527032218|FG004|Overall Study|Missing|0|||
146141511|NCT02738775|527032219|FG005|Overall Study|Missing|1|||
146141512|NCT01785524|527032220|FG000|Overall Study|Withdrawal by Subject|2|||
146141513|NCT01785524|527032221|FG001|Overall Study|Withdrawal by Subject|2|||
146141514|NCT01060384|527032222|FG000|Overall Study|Withdrawal by Subject|0|||
146141515|NCT01060384|527032223|FG001|Overall Study|Withdrawal by Subject|1|||
146141516|NCT01060384|527032224|FG002|Overall Study|Withdrawal by Subject|0|||
146141517|NCT01060384|527032225|FG003|Overall Study|Withdrawal by Subject|0|||
146141518|NCT01060384|527032226|FG004|Overall Study|Withdrawal by Subject|0|||
146141519|NCT01060384|527032222|FG000|Overall Study|Death|0|||
146141520|NCT01060384|527032223|FG001|Overall Study|Death|0|||
146141521|NCT01060384|527032224|FG002|Overall Study|Death|0|||
146141522|NCT01060384|527032225|FG003|Overall Study|Death|0|||
146141523|NCT01060384|527032226|FG004|Overall Study|Death|1|||
146141524|NCT01060384|527032222|FG000|Overall Study|Intercurrent illness|0|||
146141525|NCT01060384|527032223|FG001|Overall Study|Intercurrent illness|0|||
146141526|NCT01060384|527032224|FG002|Overall Study|Intercurrent illness|0|||
146141527|NCT01060384|527032225|FG003|Overall Study|Intercurrent illness|0|||
146141528|NCT01060384|527032226|FG004|Overall Study|Intercurrent illness|1|||
146141529|NCT00812929|527032229|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
146141530|NCT00812929|527032230|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
146141531|NCT00812929|527032231|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
146141532|NCT00812929|527032232|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
146141533|NCT00812929|527032233|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
146141534|NCT00812929|527032234|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
146141535|NCT00812929|527032235|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
146141536|NCT00812929|527032236|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
146141537|NCT00812929|527032237|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
146141538|NCT00812929|527032238|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
146141539|NCT00812929|527032229|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
146141540|NCT00812929|527032230|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
146141541|NCT00812929|527032231|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
146141542|NCT00812929|527032232|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
146141543|NCT00812929|527032233|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
146141544|NCT00812929|527032234|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
146141545|NCT00812929|527032235|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
146141546|NCT00812929|527032236|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
146141547|NCT00812929|527032237|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
146141548|NCT00812929|527032238|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
146141549|NCT00812929|527032229|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
146141550|NCT00812929|527032230|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
146141551|NCT00812929|527032231|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
146141552|NCT00812929|527032232|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
146141553|NCT00812929|527032233|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
146141554|NCT00812929|527032234|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
146141555|NCT00812929|527032235|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
146141556|NCT00812929|527032236|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
146141557|NCT00812929|527032237|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
146141558|NCT00812929|527032238|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
146141559|NCT03296696|527032258|FG000|Overall Study|Started Other Antitumor Therapy|1|||
146141560|NCT03296696|527032259|FG001|Overall Study|Started Other Antitumor Therapy|2|||
146141561|NCT03296696|527032260|FG002|Overall Study|Started Other Antitumor Therapy|1|||
146141562|NCT03296696|527032261|FG003|Overall Study|Started Other Antitumor Therapy|2|||
146141563|NCT03296696|527032262|FG004|Overall Study|Started Other Antitumor Therapy|1|||
146141564|NCT03296696|527032263|FG005|Overall Study|Started Other Antitumor Therapy|1|||
146141565|NCT03296696|527032264|FG006|Overall Study|Started Other Antitumor Therapy|2|||
146141566|NCT03296696|527032265|FG007|Overall Study|Started Other Antitumor Therapy|3|||
146141567|NCT03296696|527032266|FG008|Overall Study|Started Other Antitumor Therapy|1|||
146141568|NCT03296696|527032267|FG009|Overall Study|Started Other Antitumor Therapy|0|||
146141569|NCT03296696|527032258|FG000|Overall Study|Death|0|||
146141570|NCT03296696|527032259|FG001|Overall Study|Death|1|||
146141571|NCT03296696|527032260|FG002|Overall Study|Death|1|||
146141572|NCT03296696|527032261|FG003|Overall Study|Death|2|||
146141573|NCT03296696|527032262|FG004|Overall Study|Death|2|||
146141574|NCT03296696|527032263|FG005|Overall Study|Death|3|||
146141575|NCT03296696|527032264|FG006|Overall Study|Death|1|||
146141576|NCT03296696|527032265|FG007|Overall Study|Death|2|||
146141577|NCT03296696|527032266|FG008|Overall Study|Death|0|||
146141578|NCT03296696|527032267|FG009|Overall Study|Death|0|||
146141579|NCT03296696|527032258|FG000|Overall Study|Withdrawal by Subject|0|||
146141580|NCT03296696|527032259|FG001|Overall Study|Withdrawal by Subject|0|||
146141581|NCT03296696|527032260|FG002|Overall Study|Withdrawal by Subject|1|||
146141582|NCT03296696|527032261|FG003|Overall Study|Withdrawal by Subject|0|||
146141583|NCT03296696|527032262|FG004|Overall Study|Withdrawal by Subject|1|||
146141584|NCT03296696|527032263|FG005|Overall Study|Withdrawal by Subject|0|||
146141585|NCT03296696|527032264|FG006|Overall Study|Withdrawal by Subject|0|||
146141586|NCT03296696|527032265|FG007|Overall Study|Withdrawal by Subject|0|||
146141587|NCT03296696|527032266|FG008|Overall Study|Withdrawal by Subject|0|||
146141588|NCT03296696|527032267|FG009|Overall Study|Withdrawal by Subject|1|||
146141589|NCT04694131|527032270|FG000|Overall Study|Withdrawal by Subject|7|||
146141590|NCT04694131|527032270|FG000|Overall Study|Screen Failure|1|||
146141591|NCT04694131|527032270|FG000|Overall Study|High stimulation threshold|3|||
146141592|NCT04456699|527032271|FG000|Overall Study|Death|48|||
146141593|NCT04456699|527032272|FG001|Overall Study|Death|50|||
146141594|NCT04456699|527032273|FG002|Overall Study|Death|52|||
146141595|NCT04456699|527032271|FG000|Overall Study|Physician Decision|0|||
146141596|NCT04456699|527032272|FG001|Overall Study|Physician Decision|0|||
146141597|NCT04456699|527032273|FG002|Overall Study|Physician Decision|2|||
146141598|NCT04456699|527032271|FG000|Overall Study|Sponsor Decision|55|||
146141599|NCT04456699|527032272|FG001|Overall Study|Sponsor Decision|61|||
146141600|NCT04456699|527032273|FG002|Overall Study|Sponsor Decision|50|||
146141601|NCT04456699|527032271|FG000|Overall Study|Withdrawal by Subject|8|||
146141602|NCT04456699|527032272|FG001|Overall Study|Withdrawal by Subject|4|||
146141603|NCT04456699|527032273|FG002|Overall Study|Withdrawal by Subject|5|||
146141604|NCT00261716|527032279|FG000|Overall Study|Withdrawal by Subject|6|||
146141605|NCT00261716|527032280|FG001|Overall Study|Withdrawal by Subject|8|||
146141606|NCT00261716|527032279|FG000|Overall Study|Lost to Follow-up|0|||
146141607|NCT00261716|527032280|FG001|Overall Study|Lost to Follow-up|2|||
146141608|NCT02047110|527032283|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
146141609|NCT02047110|527032284|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
146141610|NCT02047110|527032285|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
146141611|NCT02047110|527032286|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
146141612|NCT02047110|527032283|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
146141613|NCT02047110|527032284|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146141614|NCT02047110|527032285|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146141615|NCT02047110|527032286|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
146141616|NCT02047110|527032283|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
146141617|NCT02047110|527032284|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
146141618|NCT02047110|527032285|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
146141619|NCT02047110|527032286|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
146141620|NCT02047110|527032283|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
146141621|NCT02047110|527032284|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
146141622|NCT02047110|527032285|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
146141623|NCT02047110|527032286|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
146141624|NCT02047110|527032283|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
146141625|NCT02047110|527032284|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
146141626|NCT02047110|527032285|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
146141627|NCT02047110|527032286|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
146141628|NCT02047110|527032283|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146141629|NCT02047110|527032284|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
146141630|NCT02047110|527032285|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146141631|NCT02047110|527032286|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
146141632|NCT02047110|527032283|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
146141633|NCT02047110|527032284|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
146141634|NCT02047110|527032285|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
146141635|NCT02047110|527032286|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
146141636|NCT02047110|527032283|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
146141637|NCT02047110|527032284|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
146141638|NCT02047110|527032285|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
146141639|NCT02047110|527032286|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
146141640|NCT02047110|527032283|FG000|Escape Treatment Period|Adverse Event|1|||
146141641|NCT02047110|527032284|FG001|Escape Treatment Period|Adverse Event|2|||
146141642|NCT02047110|527032285|FG002|Escape Treatment Period|Adverse Event|2|||
146141643|NCT02047110|527032286|FG003|Escape Treatment Period|Adverse Event|0|||
146141644|NCT02047110|527032283|FG000|Escape Treatment Period|Other than specified|1|||
146141645|NCT02047110|527032284|FG001|Escape Treatment Period|Other than specified|2|||
146141646|NCT02047110|527032285|FG002|Escape Treatment Period|Other than specified|0|||
146141647|NCT02047110|527032286|FG003|Escape Treatment Period|Other than specified|1|||
146271602|NCT00737477|527509788|FG000|Overall Study|Other|4|||
146141648|NCT02047110|527032283|FG000|OLE Treatment Period|Other than specified|0|||
146141649|NCT02047110|527032284|FG001|OLE Treatment Period|Other than specified|0|||
146141650|NCT02047110|527032285|FG002|OLE Treatment Period|Other than specified|1|||
146141651|NCT02047110|527032286|FG003|OLE Treatment Period|Other than specified|0|||
146141652|NCT01632800|527032289|FG000|Overall Study|Subject did not fit in apparatus|1|||
146141653|NCT01000051|527032290|FG000|Overall Study|Withdrawal by Subject|1|||
146141654|NCT01000051|527032291|FG001|Overall Study|Withdrawal by Subject|1|||
146141655|NCT01000051|527032290|FG000|Overall Study|Disease Progression|1|||
146141656|NCT01000051|527032291|FG001|Overall Study|Disease Progression|0|||
146141657|NCT01000051|527032290|FG000|Overall Study|Serious noncompliance|1|||
146141658|NCT01000051|527032291|FG001|Overall Study|Serious noncompliance|0|||
146141659|NCT02247349|527032292|FG000|Overall Study|Disease Progression|7|||
146141660|NCT02247349|527032293|FG001|Overall Study|Disease Progression|4|||
146271603|NCT01132820|527509789|FG000|Overall Study|Ineligible: wrong cell type|1|||
146271604|NCT01132820|527509789|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
146141661|NCT02247349|527032294|FG002|Overall Study|Disease Progression|26|||
146141662|NCT02247349|527032295|FG003|Overall Study|Disease Progression|31|||
146141663|NCT02247349|527032296|FG004|Overall Study|Disease Progression|16|||
146141664|NCT02247349|527032297|FG005|Overall Study|Disease Progression|6|||
146141665|NCT02247349|527032292|FG000|Overall Study|Study drug toxicity|0|||
146141666|NCT02247349|527032293|FG001|Overall Study|Study drug toxicity|1|||
146141667|NCT02247349|527032294|FG002|Overall Study|Study drug toxicity|1|||
146141668|NCT02247349|527032295|FG003|Overall Study|Study drug toxicity|1|||
146141669|NCT02247349|527032296|FG004|Overall Study|Study drug toxicity|2|||
146141670|NCT02247349|527032297|FG005|Overall Study|Study drug toxicity|2|||
146141671|NCT02247349|527032292|FG000|Overall Study|Death|0|||
146141672|NCT02247349|527032293|FG001|Overall Study|Death|0|||
146141673|NCT02247349|527032294|FG002|Overall Study|Death|0|||
146141674|NCT02247349|527032295|FG003|Overall Study|Death|1|||
146141675|NCT02247349|527032296|FG004|Overall Study|Death|0|||
146141676|NCT02247349|527032297|FG005|Overall Study|Death|0|||
146141677|NCT02247349|527032292|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146141678|NCT02247349|527032293|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146141679|NCT02247349|527032294|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146141680|NCT02247349|527032295|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
146141681|NCT02247349|527032296|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
146141682|NCT02247349|527032297|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
146141683|NCT02247349|527032292|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146141684|NCT02247349|527032293|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146141685|NCT02247349|527032294|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146141686|NCT02247349|527032295|FG003|Overall Study|Participant request to discontinue study treatment|2|||
146141687|NCT02247349|527032296|FG004|Overall Study|Participant request to discontinue study treatment|1|||
146141688|NCT02247349|527032297|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146141689|NCT02247349|527032292|FG000|Overall Study|Withdrawal by Subject|0|||
146141690|NCT02247349|527032293|FG001|Overall Study|Withdrawal by Subject|1|||
146141691|NCT02247349|527032294|FG002|Overall Study|Withdrawal by Subject|0|||
146141692|NCT02247349|527032295|FG003|Overall Study|Withdrawal by Subject|0|||
146141693|NCT02247349|527032296|FG004|Overall Study|Withdrawal by Subject|0|||
146141694|NCT02247349|527032297|FG005|Overall Study|Withdrawal by Subject|0|||
146141695|NCT02247349|527032292|FG000|Overall Study|Administrative reason by sponsor|0|||
146141696|NCT02247349|527032293|FG001|Overall Study|Administrative reason by sponsor|0|||
146141697|NCT02247349|527032294|FG002|Overall Study|Administrative reason by sponsor|0|||
146141698|NCT02247349|527032295|FG003|Overall Study|Administrative reason by sponsor|0|||
146141699|NCT02247349|527032296|FG004|Overall Study|Administrative reason by sponsor|1|||
146141700|NCT02247349|527032297|FG005|Overall Study|Administrative reason by sponsor|0|||
146141701|NCT02247349|527032292|FG000|Overall Study|Other reasons|0|||
146141702|NCT02247349|527032293|FG001|Overall Study|Other reasons|0|||
146141703|NCT02247349|527032294|FG002|Overall Study|Other reasons|1|||
146141704|NCT02247349|527032295|FG003|Overall Study|Other reasons|0|||
146141705|NCT02247349|527032296|FG004|Overall Study|Other reasons|0|||
146141706|NCT02247349|527032297|FG005|Overall Study|Other reasons|0|||
146141707|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Adverse Event|41|||
146141708|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Adverse Event|24|||
146141709|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
146141710|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
146141711|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
146141712|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
146141713|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Physician Decision|0|||
146141714|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Physician Decision|6|||
146141715|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
146141716|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
146141717|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
146141718|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
146141719|NCT00673452|527032298|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
146141720|NCT00673452|527032299|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
146141721|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
146141722|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
146141723|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
146141724|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
146141725|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
146141726|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
146141727|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
146304168|NCT01721876|527627499|FG001|Overall Study|Adverse Event|165|||
146141728|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
146141729|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
146141730|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
146141731|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
146141732|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
146304169|NCT01721876|527627498|FG000|Overall Study|Protocol Violation|2|||
146304170|NCT01721876|527627499|FG001|Overall Study|Protocol Violation|1|||
146304171|NCT01721876|527627498|FG000|Overall Study|Withdrawal by Subject|15|||
146304172|NCT01721876|527627499|FG001|Overall Study|Withdrawal by Subject|38|||
146304173|NCT01721876|527627498|FG000|Overall Study|Reason not listed|34|||
146304174|NCT01721876|527627499|FG001|Overall Study|Reason not listed|63|||
146304175|NCT01721876|527627498|FG000|Overall Study|Sponsor terminated trial|0|||
146304176|NCT01721876|527627499|FG001|Overall Study|Sponsor terminated trial|4|||
146304177|NCT00310804|527627500|FG000|Overall Study|Lost to Follow-up|2|||
146304178|NCT00310804|527627501|FG001|Overall Study|Lost to Follow-up|0|||
146304179|NCT00310804|527627500|FG000|Overall Study|Withdrawal by Subject|3|||
146304180|NCT00310804|527627501|FG001|Overall Study|Withdrawal by Subject|0|||
146304181|NCT02109562|527627502|FG000|Overall Study|Insufficient clinical response|2|||
146304182|NCT02109562|527627503|FG001|Overall Study|Insufficient clinical response|0|||
146304183|NCT02109562|527627504|FG002|Overall Study|Insufficient clinical response|4|||
146304184|NCT02109562|527627502|FG000|Overall Study|Adverse Event|0|||
146304185|NCT02109562|527627503|FG001|Overall Study|Adverse Event|2|||
146304186|NCT02109562|527627504|FG002|Overall Study|Adverse Event|3|||
146304187|NCT02109562|527627502|FG000|Overall Study|Lost to Follow-up|1|||
146304188|NCT02109562|527627503|FG001|Overall Study|Lost to Follow-up|0|||
146304189|NCT02109562|527627504|FG002|Overall Study|Lost to Follow-up|1|||
146304190|NCT02109562|527627502|FG000|Overall Study|Protocol Violation|0|||
146304191|NCT02109562|527627503|FG001|Overall Study|Protocol Violation|3|||
146304192|NCT02109562|527627504|FG002|Overall Study|Protocol Violation|1|||
146304193|NCT02109562|527627502|FG000|Overall Study|Withdrawal by Subject|20|||
146304194|NCT02109562|527627503|FG001|Overall Study|Withdrawal by Subject|25|||
146304195|NCT02109562|527627504|FG002|Overall Study|Withdrawal by Subject|21|||
146304196|NCT02109562|527627502|FG000|Overall Study|Physician Decision|3|||
146304197|NCT02109562|527627503|FG001|Overall Study|Physician Decision|4|||
146304198|NCT02109562|527627504|FG002|Overall Study|Physician Decision|5|||
146304199|NCT00688155|527627505|FG000|Overall Study|Withdrawal by Subject|2|||
146304200|NCT00688155|527627506|FG001|Overall Study|Withdrawal by Subject|2|||
146304201|NCT00688155|527627507|FG002|Overall Study|Withdrawal by Subject|1|||
146304202|NCT00688155|527627508|FG003|Overall Study|Withdrawal by Subject|1|||
146304203|NCT03734016|527627513|FG000|Overall Study|Sponsor Ended Study|225|||
146304204|NCT03734016|527627514|FG001|Overall Study|Sponsor Ended Study|200|||
146304205|NCT03734016|527627513|FG000|Overall Study|Death|69|||
146304206|NCT03734016|527627514|FG001|Overall Study|Death|83|||
146304207|NCT03734016|527627513|FG000|Overall Study|Withdrawal by Subject|21|||
146304208|NCT03734016|527627514|FG001|Overall Study|Withdrawal by Subject|27|||
146304209|NCT03734016|527627513|FG000|Overall Study|Physician Decision|1|||
146304210|NCT03734016|527627514|FG001|Overall Study|Physician Decision|12|||
146304211|NCT03734016|527627513|FG000|Overall Study|Lost to Follow-up|6|||
146304212|NCT03734016|527627514|FG001|Overall Study|Lost to Follow-up|2|||
146304213|NCT03734016|527627513|FG000|Overall Study|Miscellaneous|5|||
146304214|NCT03734016|527627514|FG001|Overall Study|Miscellaneous|1|||
146304215|NCT01979835|527627515|FG000|Primary Outcome SA Measurment|failed insertion|18|||
146304216|NCT01979835|527627515|FG000|Follow-up|Lost to Follow-up|32|||
146304217|NCT01428661|527627518|FG000|Double-Masked Phase|Protocol Violation|9|||
146304218|NCT01428661|527627519|FG001|Double-Masked Phase|Protocol Violation|4|||
146304219|NCT01428661|527627520|FG002|Double-Masked Phase|Protocol Violation|0|||
146304220|NCT01428661|527627518|FG000|Double-Masked Phase|Adverse Event|13|||
146304221|NCT01428661|527627519|FG001|Double-Masked Phase|Adverse Event|4|||
146304222|NCT01428661|527627520|FG002|Double-Masked Phase|Adverse Event|0|||
146304223|NCT01428661|527627518|FG000|Double-Masked Phase|Lost to Follow-up|14|||
146304224|NCT01428661|527627519|FG001|Double-Masked Phase|Lost to Follow-up|14|||
146304225|NCT01428661|527627520|FG002|Double-Masked Phase|Lost to Follow-up|0|||
146304226|NCT01428661|527627518|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
146304227|NCT01428661|527627519|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
146304228|NCT01428661|527627520|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
146304229|NCT01428661|527627518|FG000|Double-Masked Phase|Lack of Efficacy|2|||
146304230|NCT01428661|527627519|FG001|Double-Masked Phase|Lack of Efficacy|1|||
146304231|NCT01428661|527627520|FG002|Double-Masked Phase|Lack of Efficacy|0|||
146304232|NCT01428661|527627518|FG000|Double-Masked Phase|*Various|1|||
146304233|NCT01428661|527627519|FG001|Double-Masked Phase|*Various|6|||
146141733|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
146141734|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
146304234|NCT01428661|527627520|FG002|Double-Masked Phase|*Various|0|||
146304235|NCT01428661|527627518|FG000|Open Label Extension|Protocol Violation|0|||
146304236|NCT01428661|527627519|FG001|Open Label Extension|Protocol Violation|0|||
146304237|NCT01428661|527627520|FG002|Open Label Extension|Protocol Violation|9|||
146304238|NCT01428661|527627518|FG000|Open Label Extension|Adverse Event|0|||
146304239|NCT01428661|527627519|FG001|Open Label Extension|Adverse Event|0|||
146304240|NCT01428661|527627520|FG002|Open Label Extension|Adverse Event|15|||
146304241|NCT01428661|527627518|FG000|Open Label Extension|Lost to Follow-up|0|||
146304242|NCT01428661|527627519|FG001|Open Label Extension|Lost to Follow-up|0|||
146304243|NCT01428661|527627520|FG002|Open Label Extension|Lost to Follow-up|38|||
146141735|NCT00673452|527032298|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
146141736|NCT00673452|527032299|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
146141737|NCT03495908|527032302|FG000|Overall Study|Withdrawal by Subject|3|||
146141738|NCT03495908|527032303|FG001|Overall Study|Withdrawal by Subject|1|||
146141739|NCT03495908|527032302|FG000|Overall Study|Lost to Follow-up|1|||
146141740|NCT03495908|527032303|FG001|Overall Study|Lost to Follow-up|4|||
146141741|NCT03495908|527032302|FG000|Overall Study|Adverse Event|0|||
146141742|NCT03495908|527032303|FG001|Overall Study|Adverse Event|2|||
146141743|NCT03495908|527032302|FG000|Overall Study|Death|1|||
146141744|NCT03495908|527032303|FG001|Overall Study|Death|0|||
146141745|NCT03495908|527032302|FG000|Overall Study|Physician Decision|5|||
146141746|NCT03495908|527032303|FG001|Overall Study|Physician Decision|4|||
146141747|NCT03495908|527032302|FG000|Overall Study|No documented reason|0|||
146141748|NCT03495908|527032303|FG001|Overall Study|No documented reason|2|||
146141749|NCT02410811|527032308|FG000|Overall Study|Withdrawal by Subject|0|||
146141750|NCT02410811|527032309|FG001|Overall Study|Withdrawal by Subject|0|||
146141751|NCT02410811|527032310|FG002|Overall Study|Withdrawal by Subject|1|||
146141752|NCT02410811|527032311|FG003|Overall Study|Withdrawal by Subject|0|||
146141753|NCT00480779|527032317|FG000|Overall Study|Other|2|||
146141754|NCT00480779|527032318|FG001|Overall Study|Other|0|||
146141755|NCT00480779|527032317|FG000|Overall Study|Job and Health-related|0|||
146141756|NCT00480779|527032318|FG001|Overall Study|Job and Health-related|3|||
146141757|NCT00854581|527032323|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
146141758|NCT00854581|527032323|FG000|Induction (Up to Day 21)|Death|1|||
146141759|NCT00854581|527032323|FG000|Induction (Up to Day 21)|Physician Decision|1|||
146141760|NCT00854581|527032323|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
146141761|NCT01339390|527032324|FG000|Overall Study|Death|32|||
146141762|NCT01339390|527032325|FG001|Overall Study|Death|29|||
146141763|NCT01339390|527032324|FG000|Overall Study|Lost to Follow-up|125|||
146141764|NCT01339390|527032325|FG001|Overall Study|Lost to Follow-up|127|||
146271605|NCT01132820|527509789|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
146271606|NCT01132820|527509789|FG000|Overall Study|Never treated|1|||
146271607|NCT01132820|527509789|FG000|Overall Study|Inadequate data|1|||
146271608|NCT01370655|527509790|FG000|Period 1|Adverse Event|2|||
146271609|NCT01370655|527509791|FG001|Period 1|Adverse Event|0|||
146271610|NCT01370655|527509792|FG002|Period 1|Adverse Event|0|||
146271611|NCT01370655|527509793|FG003|Period 1|Adverse Event|0|||
146271612|NCT01370655|527509794|FG004|Period 1|Adverse Event|0|||
146271613|NCT01370655|527509795|FG005|Period 1|Adverse Event|0|||
146271614|NCT01370655|527509796|FG006|Period 1|Adverse Event|1|||
146271615|NCT01370655|527509797|FG007|Period 1|Adverse Event|0|||
146271616|NCT01370655|527509798|FG008|Period 1|Adverse Event|0|||
146271617|NCT01370655|527509799|FG009|Period 1|Adverse Event|0|||
146271618|NCT01370655|527509800|FG010|Period 1|Adverse Event|0|||
146271619|NCT01370655|527509801|FG011|Period 1|Adverse Event|0|||
146271620|NCT01370655|527509790|FG000|Period 2|Adverse Event|0|||
146271621|NCT01370655|527509791|FG001|Period 2|Adverse Event|0|||
146271622|NCT01370655|527509792|FG002|Period 2|Adverse Event|1|||
146271623|NCT01370655|527509793|FG003|Period 2|Adverse Event|0|||
146271624|NCT01370655|527509794|FG004|Period 2|Adverse Event|1|||
146271625|NCT01370655|527509795|FG005|Period 2|Adverse Event|0|||
146271626|NCT01370655|527509796|FG006|Period 2|Adverse Event|0|||
146271627|NCT01370655|527509797|FG007|Period 2|Adverse Event|1|||
146271628|NCT01370655|527509798|FG008|Period 2|Adverse Event|0|||
146271629|NCT01370655|527509799|FG009|Period 2|Adverse Event|0|||
146271630|NCT01370655|527509800|FG010|Period 2|Adverse Event|0|||
146271631|NCT01370655|527509801|FG011|Period 2|Adverse Event|0|||
146271632|NCT01370655|527509790|FG000|Period 2|met protocol specified stopping criteria|0|||
146271633|NCT01370655|527509791|FG001|Period 2|met protocol specified stopping criteria|0|||
146271634|NCT01370655|527509792|FG002|Period 2|met protocol specified stopping criteria|1|||
146271635|NCT01370655|527509793|FG003|Period 2|met protocol specified stopping criteria|0|||
146271636|NCT01370655|527509794|FG004|Period 2|met protocol specified stopping criteria|0|||
146271637|NCT01370655|527509795|FG005|Period 2|met protocol specified stopping criteria|0|||
146271638|NCT01370655|527509796|FG006|Period 2|met protocol specified stopping criteria|1|||
146304244|NCT01428661|527627518|FG000|Open Label Extension|Withdrawal by Subject|0|||
146141765|NCT00378703|527032328|FG000|Overall Study|Disease progression|59|||
146141766|NCT00378703|527032329|FG001|Overall Study|Disease progression|43|||
146141767|NCT00378703|527032330|FG002|Overall Study|Disease progression|48|||
146271639|NCT01370655|527509797|FG007|Period 2|met protocol specified stopping criteria|0|||
146271640|NCT01370655|527509798|FG008|Period 2|met protocol specified stopping criteria|1|||
146271641|NCT01370655|527509799|FG009|Period 2|met protocol specified stopping criteria|0|||
146271642|NCT01370655|527509800|FG010|Period 2|met protocol specified stopping criteria|1|||
146271643|NCT01370655|527509801|FG011|Period 2|met protocol specified stopping criteria|0|||
146271644|NCT01370655|527509790|FG000|Period 2|Withdrawal by Subject|0|||
146271645|NCT01370655|527509791|FG001|Period 2|Withdrawal by Subject|0|||
146271646|NCT01370655|527509792|FG002|Period 2|Withdrawal by Subject|0|||
146271647|NCT01370655|527509793|FG003|Period 2|Withdrawal by Subject|0|||
146271648|NCT01370655|527509794|FG004|Period 2|Withdrawal by Subject|0|||
146271649|NCT01370655|527509795|FG005|Period 2|Withdrawal by Subject|0|||
146141768|NCT00378703|527032331|FG003|Overall Study|Disease progression|49|||
146141769|NCT00378703|527032328|FG000|Overall Study|Adverse Event|11|||
146141770|NCT00378703|527032329|FG001|Overall Study|Adverse Event|17|||
146141771|NCT00378703|527032330|FG002|Overall Study|Adverse Event|20|||
146141772|NCT00378703|527032331|FG003|Overall Study|Adverse Event|18|||
146141773|NCT00378703|527032328|FG000|Overall Study|Death|2|||
146141774|NCT00378703|527032329|FG001|Overall Study|Death|2|||
146141775|NCT00378703|527032330|FG002|Overall Study|Death|4|||
146141776|NCT00378703|527032331|FG003|Overall Study|Death|3|||
146141777|NCT00378703|527032328|FG000|Overall Study|Withdrawal by Subject|4|||
146141778|NCT00378703|527032329|FG001|Overall Study|Withdrawal by Subject|8|||
146141779|NCT00378703|527032330|FG002|Overall Study|Withdrawal by Subject|5|||
146141780|NCT00378703|527032331|FG003|Overall Study|Withdrawal by Subject|7|||
146141781|NCT00378703|527032328|FG000|Overall Study|Physician Decision|1|||
146141782|NCT00378703|527032329|FG001|Overall Study|Physician Decision|4|||
146141783|NCT00378703|527032330|FG002|Overall Study|Physician Decision|1|||
146141784|NCT00378703|527032331|FG003|Overall Study|Physician Decision|0|||
146141785|NCT00378703|527032328|FG000|Overall Study|Alternative therapy|4|||
146141786|NCT00378703|527032329|FG001|Overall Study|Alternative therapy|2|||
146141787|NCT00378703|527032330|FG002|Overall Study|Alternative therapy|0|||
146141788|NCT00378703|527032331|FG003|Overall Study|Alternative therapy|0|||
146141789|NCT00378703|527032328|FG000|Overall Study|Other complicated disease|0|||
146141790|NCT00378703|527032329|FG001|Overall Study|Other complicated disease|2|||
146141791|NCT00378703|527032330|FG002|Overall Study|Other complicated disease|2|||
146141792|NCT00378703|527032331|FG003|Overall Study|Other complicated disease|0|||
146141793|NCT00378703|527032328|FG000|Overall Study|Symptomatic deterioration|0|||
146141794|NCT00378703|527032329|FG001|Overall Study|Symptomatic deterioration|1|||
146141795|NCT00378703|527032330|FG002|Overall Study|Symptomatic deterioration|0|||
146141796|NCT00378703|527032331|FG003|Overall Study|Symptomatic deterioration|2|||
146141797|NCT00378703|527032328|FG000|Overall Study|Surgery|1|||
146141798|NCT00378703|527032329|FG001|Overall Study|Surgery|0|||
146141799|NCT00378703|527032330|FG002|Overall Study|Surgery|0|||
146141800|NCT00378703|527032331|FG003|Overall Study|Surgery|1|||
146141801|NCT00378703|527032328|FG000|Overall Study|Joint decision of physician and patient|1|||
146141802|NCT00378703|527032329|FG001|Overall Study|Joint decision of physician and patient|0|||
146141803|NCT00378703|527032330|FG002|Overall Study|Joint decision of physician and patient|0|||
146141804|NCT00378703|527032331|FG003|Overall Study|Joint decision of physician and patient|0|||
146141805|NCT00378703|527032328|FG000|Overall Study|Adverse events and progressive disease|0|||
146141806|NCT00378703|527032329|FG001|Overall Study|Adverse events and progressive disease|0|||
146141807|NCT00378703|527032330|FG002|Overall Study|Adverse events and progressive disease|0|||
146141808|NCT00378703|527032331|FG003|Overall Study|Adverse events and progressive disease|1|||
146141809|NCT00378703|527032328|FG000|Overall Study|Relocation|0|||
146141810|NCT00378703|527032329|FG001|Overall Study|Relocation|0|||
146141811|NCT00378703|527032330|FG002|Overall Study|Relocation|1|||
146141812|NCT00378703|527032331|FG003|Overall Study|Relocation|0|||
146141813|NCT00378703|527032328|FG000|Overall Study|Ineligible|4|||
146141814|NCT00378703|527032329|FG001|Overall Study|Ineligible|7|||
146141815|NCT00378703|527032330|FG002|Overall Study|Ineligible|7|||
146141816|NCT00378703|527032331|FG003|Overall Study|Ineligible|7|||
146141817|NCT00378703|527032328|FG000|Overall Study|Never started treatment|1|||
146141818|NCT00378703|527032329|FG001|Overall Study|Never started treatment|4|||
146141819|NCT00378703|527032330|FG002|Overall Study|Never started treatment|0|||
146271650|NCT01370655|527509796|FG006|Period 2|Withdrawal by Subject|0|||
146271651|NCT01370655|527509797|FG007|Period 2|Withdrawal by Subject|0|||
146271652|NCT01370655|527509798|FG008|Period 2|Withdrawal by Subject|1|||
146271653|NCT01370655|527509799|FG009|Period 2|Withdrawal by Subject|0|||
146271654|NCT01370655|527509800|FG010|Period 2|Withdrawal by Subject|0|||
146271655|NCT01370655|527509801|FG011|Period 2|Withdrawal by Subject|0|||
146271656|NCT01735175|527509804|FG000|Overall Study|Withdrawal by Subject|9|||
146271657|NCT01735175|527509805|FG001|Overall Study|Withdrawal by Subject|2|||
146271658|NCT01735175|527509804|FG000|Overall Study|Lost to Follow-up|4|||
146271659|NCT01735175|527509805|FG001|Overall Study|Lost to Follow-up|2|||
146271660|NCT01735175|527509804|FG000|Overall Study|Death|3|||
146271661|NCT01735175|527509805|FG001|Overall Study|Death|2|||
146271662|NCT01735175|527509804|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
146271663|NCT01735175|527509805|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
146271664|NCT01853475|527509806|FG000|Overall Study|Withdrawal by Subject|0|||
146271665|NCT01853475|527509807|FG001|Overall Study|Withdrawal by Subject|1|||
146271666|NCT01853475|527509808|FG002|Overall Study|Withdrawal by Subject|0|||
146271667|NCT00659880|527509809|FG000|Overall Study|Lost to Follow-up|5|||
146271668|NCT02159040|527509810|FG000|Overall Study|Death|1|||
146271669|NCT01304498|527509811|FG000|Overall Study|Adverse Event|1|||
146141820|NCT00378703|527032331|FG003|Overall Study|Never started treatment|0|||
146141821|NCT00378703|527032328|FG000|Overall Study|Other|1|||
146271670|NCT01304498|527509812|FG001|Overall Study|Adverse Event|1|||
146271671|NCT01304498|527509811|FG000|Overall Study|Withdrawal by Subject|2|||
146271672|NCT01304498|527509812|FG001|Overall Study|Withdrawal by Subject|3|||
146141822|NCT00378703|527032329|FG001|Overall Study|Other|1|||
146141823|NCT00378703|527032330|FG002|Overall Study|Other|2|||
146141824|NCT00378703|527032331|FG003|Overall Study|Other|3|||
146141825|NCT01541930|527032339|FG000|Overall Study|Withdrawal by Subject|1|||
146141826|NCT01957475|527032340|FG000|Test Period 1|Withdrawal by Subject|1|||
146141827|NCT01957475|527032341|FG001|Test Period 1|Withdrawal by Subject|0|||
146141828|NCT01957475|527032340|FG000|Test Period 1|Other|1|||
146141829|NCT01957475|527032341|FG001|Test Period 1|Other|0|||
146141830|NCT01957475|527032340|FG000|Test Period 1|Lack of Efficacy|0|||
146141831|NCT01957475|527032341|FG001|Test Period 1|Lack of Efficacy|1|||
146141832|NCT01957475|527032340|FG000|Test Period 2|Adverse Event|1|||
146141833|NCT01957475|527032341|FG001|Test Period 2|Adverse Event|0|||
146141834|NCT00813358|527032344|FG000|Overall Study|Death|32|||
146141835|NCT00813358|527032344|FG000|Overall Study|Lost to Follow-up|12|||
146141836|NCT00813358|527032344|FG000|Overall Study|other endpoints|5|||
146141837|NCT00813358|527032344|FG000|Overall Study|Withdrawal by Subject|20|||
146141838|NCT04497987|527032345|FG000|Overall Study|Adverse Event|1|||
146141839|NCT04497987|527032346|FG001|Overall Study|Adverse Event|0|||
146141840|NCT04497987|527032345|FG000|Overall Study|Death|21|||
146141841|NCT04497987|527032346|FG001|Overall Study|Death|13|||
146141842|NCT04497987|527032345|FG000|Overall Study|Lost to Follow-up|19|||
146141843|NCT04497987|527032346|FG001|Overall Study|Lost to Follow-up|17|||
146271673|NCT01304498|527509811|FG000|Overall Study|Protocol Violation|1|||
146271674|NCT01304498|527509812|FG001|Overall Study|Protocol Violation|0|||
146271675|NCT01304498|527509811|FG000|Overall Study|Lost to Follow-up|2|||
146271676|NCT01304498|527509812|FG001|Overall Study|Lost to Follow-up|1|||
146271677|NCT01151215|527509813|FG000|Overall Study|Worsening of condition under study|1|||
146271678|NCT01151215|527509814|FG001|Overall Study|Worsening of condition under study|1|||
146271679|NCT01151215|527509815|FG002|Overall Study|Worsening of condition under study|1|||
146271680|NCT01151215|527509813|FG000|Overall Study|Death|16|||
146271681|NCT01151215|527509814|FG001|Overall Study|Death|20|||
146271682|NCT01151215|527509815|FG002|Overall Study|Death|11|||
146271683|NCT01151215|527509813|FG000|Overall Study|Lost to Follow-up|0|||
146271684|NCT01151215|527509814|FG001|Overall Study|Lost to Follow-up|0|||
146271685|NCT01151215|527509815|FG002|Overall Study|Lost to Follow-up|3|||
146271686|NCT01151215|527509813|FG000|Overall Study|Withdrawal by Subject|3|||
146271687|NCT01151215|527509814|FG001|Overall Study|Withdrawal by Subject|1|||
146271688|NCT01151215|527509815|FG002|Overall Study|Withdrawal by Subject|2|||
146271689|NCT01151215|527509813|FG000|Overall Study|Disease progression|0|||
146271690|NCT01151215|527509814|FG001|Overall Study|Disease progression|1|||
146271691|NCT01151215|527509815|FG002|Overall Study|Disease progression|1|||
146271692|NCT01151215|527509813|FG000|Overall Study|Safety as judged by the investigator|0|||
146271693|NCT01151215|527509814|FG001|Overall Study|Safety as judged by the investigator|0|||
146271694|NCT01151215|527509815|FG002|Overall Study|Safety as judged by the investigator|1|||
146271695|NCT01154140|527509817|FG000|Overall Study|Death|71|||
146271696|NCT01154140|527509818|FG001|Overall Study|Death|81|||
146271697|NCT01154140|527509817|FG000|Overall Study|Lost to Follow-up|4|||
146271698|NCT01154140|527509818|FG001|Overall Study|Lost to Follow-up|5|||
146271699|NCT01154140|527509817|FG000|Overall Study|Withdrawal by Subject|12|||
146271700|NCT01154140|527509818|FG001|Overall Study|Withdrawal by Subject|13|||
146271701|NCT01154140|527509817|FG000|Overall Study|Other|3|||
146271702|NCT01154140|527509818|FG001|Overall Study|Other|1|||
146271703|NCT01154140|527509817|FG000|Overall Study|Randomized but not treated|1|||
146271704|NCT01154140|527509818|FG001|Overall Study|Randomized but not treated|2|||
146271705|NCT04276051|527509819|FG000|Overall Study|Lost to Follow-up|0|||
146271706|NCT04276051|527509820|FG001|Overall Study|Lost to Follow-up|1|||
146271707|NCT04276051|527509819|FG000|Overall Study|Physician Decision|0|||
146271708|NCT04276051|527509820|FG001|Overall Study|Physician Decision|1|||
146271709|NCT04276051|527509819|FG000|Overall Study|Withdrawal by Subject|1|||
146271710|NCT04276051|527509820|FG001|Overall Study|Withdrawal by Subject|1|||
146271711|NCT01912404|527509821|FG000|Overall Study|Due to personal reasons|1|||
146271712|NCT01912404|527509822|FG001|Overall Study|Due to personal reasons|0|||
146271713|NCT00856245|527509828|FG000|Overall Study|Was not transplanted|5|||
146271714|NCT01443923|527509829|FG000|Overall Study|Adverse Event|1|||
146141844|NCT04497987|527032345|FG000|Overall Study|Other - as reported by the investigator|22|||
146141845|NCT04497987|527032346|FG001|Overall Study|Other - as reported by the investigator|16|||
146141846|NCT04497987|527032345|FG000|Overall Study|Physician Decision|1|||
146141847|NCT04497987|527032346|FG001|Overall Study|Physician Decision|0|||
146141848|NCT04497987|527032345|FG000|Overall Study|Withdrawal by Subject|35|||
146271715|NCT01443923|527509830|FG001|Overall Study|Adverse Event|0|||
146271716|NCT04160988|527509833|FG000|Overall Study|poor image quality|28|||
146271717|NCT01250509|527509834|FG000|Overall Study|Lost to Follow-up|5|||
146271718|NCT01250509|527509835|FG001|Overall Study|Lost to Follow-up|2|||
146271719|NCT02670122|527509836|FG000|Overall Study|Lost to Follow-up|4|||
146271720|NCT02762903|527509842|FG000|Overall Study|Lost to Follow-up|0|||
146271721|NCT02762903|527509843|FG001|Overall Study|Lost to Follow-up|1|||
146271722|NCT01889069|527509844|FG000|Overall Study|Death|18|||
146271723|NCT01889069|527509844|FG000|Overall Study|Progression of Disease|14|||
146271724|NCT01889069|527509844|FG000|Overall Study|Lost to Follow-up|6|||
146271725|NCT01889069|527509844|FG000|Overall Study|Other|4|||
146271726|NCT01889069|527509844|FG000|Overall Study|Consent Withdrawal|3|||
146141849|NCT04497987|527032346|FG001|Overall Study|Withdrawal by Subject|21|||
146141850|NCT03665038|527032347|FG000|Overall Study|Lost to Follow-up|0|||
146141851|NCT03665038|527032348|FG001|Overall Study|Lost to Follow-up|0|||
146271727|NCT01228175|527509845|FG000|Overall Study|Lost to Follow-up|64|||
146271728|NCT01228175|527509846|FG001|Overall Study|Lost to Follow-up|50|||
146271729|NCT01228175|527509845|FG000|Overall Study|Withdrawal by Subject|1|||
146271730|NCT01228175|527509846|FG001|Overall Study|Withdrawal by Subject|2|||
146141852|NCT03665038|527032349|FG002|Overall Study|Lost to Follow-up|1|||
146141853|NCT03890367|527032355|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146141854|NCT03890367|527032356|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146141855|NCT03890367|527032357|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146141856|NCT03890367|527032355|FG000|Overall Study|Protocol deviation|2|||
146141857|NCT03890367|527032356|FG001|Overall Study|Protocol deviation|2|||
146141858|NCT03890367|527032357|FG002|Overall Study|Protocol deviation|1|||
146141859|NCT03890367|527032355|FG000|Overall Study|Lost to Follow-up|1|||
146141860|NCT03890367|527032356|FG001|Overall Study|Lost to Follow-up|1|||
146141861|NCT03890367|527032357|FG002|Overall Study|Lost to Follow-up|0|||
146141862|NCT00646958|527033858|FG000|Overall Study|Lack of Efficacy|1|||
146141863|NCT00646958|527033859|FG001|Overall Study|Lack of Efficacy|0|||
146141864|NCT00646958|527033860|FG002|Overall Study|Lack of Efficacy|0|||
146141865|NCT00646958|527033858|FG000|Overall Study|Adverse Event|4|||
146141866|NCT00646958|527033859|FG001|Overall Study|Adverse Event|0|||
146141867|NCT00646958|527033860|FG002|Overall Study|Adverse Event|0|||
146141868|NCT00646958|527033858|FG000|Overall Study|Lost to Follow-up|1|||
146141869|NCT00646958|527033859|FG001|Overall Study|Lost to Follow-up|5|||
146141870|NCT00646958|527033860|FG002|Overall Study|Lost to Follow-up|7|||
146141871|NCT00646958|527033858|FG000|Overall Study|Protocol Violation|1|||
146141872|NCT00646958|527033859|FG001|Overall Study|Protocol Violation|1|||
146141873|NCT00646958|527033860|FG002|Overall Study|Protocol Violation|0|||
146141874|NCT00646958|527033858|FG000|Overall Study|Abnormal screening lab tests|1|||
146141875|NCT00646958|527033859|FG001|Overall Study|Abnormal screening lab tests|1|||
146141876|NCT00646958|527033860|FG002|Overall Study|Abnormal screening lab tests|0|||
146141877|NCT00646958|527033858|FG000|Overall Study|Withdrawal by Subject|1|||
146141878|NCT00646958|527033859|FG001|Overall Study|Withdrawal by Subject|2|||
146141879|NCT00646958|527033860|FG002|Overall Study|Withdrawal by Subject|0|||
146141880|NCT00646958|527033858|FG000|Overall Study|Did not receive study drug|2|||
146141881|NCT00646958|527033859|FG001|Overall Study|Did not receive study drug|0|||
146141882|NCT00646958|527033860|FG002|Overall Study|Did not receive study drug|2|||
146141883|NCT02602288|527033864|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
146141884|NCT02602288|527033865|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
146141885|NCT02602288|527033864|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
146141886|NCT02602288|527033865|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
146141887|NCT02602288|527033864|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
146141888|NCT02602288|527033865|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
146141889|NCT02602288|527033864|FG000|12 Month Follow-up|Lost to Follow-up|0|||
146141890|NCT02602288|527033865|FG001|12 Month Follow-up|Lost to Follow-up|4|||
146141891|NCT02602288|527033864|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
146141892|NCT02602288|527033865|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
146141893|NCT02066298|527033871|FG000|Overall Study|Lost to Follow-up|3|||
146141894|NCT02066298|527033872|FG001|Overall Study|Lost to Follow-up|2|||
146141895|NCT02066298|527033873|FG002|Overall Study|Lost to Follow-up|3|||
146141896|NCT02066298|527033874|FG003|Overall Study|Lost to Follow-up|2|||
146141897|NCT02066298|527033875|FG004|Overall Study|Lost to Follow-up|3|||
146141898|NCT02066298|527033876|FG005|Overall Study|Lost to Follow-up|4|||
146141899|NCT02066298|527033871|FG000|Overall Study|Withdrawal by Subject|6|||
146141900|NCT02066298|527033872|FG001|Overall Study|Withdrawal by Subject|6|||
146141901|NCT02066298|527033873|FG002|Overall Study|Withdrawal by Subject|6|||
146141902|NCT02066298|527033874|FG003|Overall Study|Withdrawal by Subject|4|||
146271731|NCT01228175|527509845|FG000|Overall Study|Physician Decision|1|||
146271732|NCT01228175|527509846|FG001|Overall Study|Physician Decision|1|||
146271733|NCT00108745|527509847|FG000|Overall Study|Withdrawal by Subject|19|||
146141903|NCT02066298|527033875|FG004|Overall Study|Withdrawal by Subject|5|||
146141904|NCT02066298|527033876|FG005|Overall Study|Withdrawal by Subject|8|||
146141905|NCT02066298|527033871|FG000|Overall Study|Physician Decision|0|||
146141906|NCT02066298|527033872|FG001|Overall Study|Physician Decision|0|||
146271734|NCT00108745|527509848|FG001|Overall Study|Withdrawal by Subject|12|||
146141907|NCT02066298|527033873|FG002|Overall Study|Physician Decision|1|||
146141908|NCT02066298|527033874|FG003|Overall Study|Physician Decision|0|||
146271735|NCT00108745|527509849|FG002|Overall Study|Withdrawal by Subject|12|||
146271736|NCT00108745|527509847|FG000|Overall Study|Never Treated|8|||
146141909|NCT02066298|527033875|FG004|Overall Study|Physician Decision|1|||
146141910|NCT02066298|527033876|FG005|Overall Study|Physician Decision|0|||
146141911|NCT04260191|527033877|FG000|Overall Study|Decision by Sponsor|0|||
146141912|NCT04260191|527033878|FG001|Overall Study|Decision by Sponsor|1|||
146141913|NCT04260191|527033879|FG002|Overall Study|Decision by Sponsor|0|||
146141914|NCT04260191|527033877|FG000|Overall Study|Withdrawal by Subject|1|||
146141915|NCT04260191|527033878|FG001|Overall Study|Withdrawal by Subject|0|||
146141916|NCT04260191|527033879|FG002|Overall Study|Withdrawal by Subject|3|||
146141917|NCT04260191|527033877|FG000|Overall Study|Death|4|||
146141918|NCT04260191|527033878|FG001|Overall Study|Death|3|||
146141919|NCT04260191|527033879|FG002|Overall Study|Death|2|||
146141920|NCT00630877|527033882|FG000|Overall Study|Adverse Event|11|||
146141921|NCT00630877|527033883|FG001|Overall Study|Adverse Event|8|||
146141922|NCT00630877|527033884|FG002|Overall Study|Adverse Event|7|||
146141923|NCT00630877|527033882|FG000|Overall Study|Withdrawal by Subject|3|||
146141924|NCT00630877|527033883|FG001|Overall Study|Withdrawal by Subject|4|||
146141925|NCT00630877|527033884|FG002|Overall Study|Withdrawal by Subject|0|||
146141926|NCT00630877|527033882|FG000|Overall Study|Lost to Follow-up|2|||
146141927|NCT00630877|527033883|FG001|Overall Study|Lost to Follow-up|0|||
146141928|NCT00630877|527033884|FG002|Overall Study|Lost to Follow-up|0|||
146141929|NCT00630877|527033882|FG000|Overall Study|Noncompliance|2|||
146141930|NCT00630877|527033883|FG001|Overall Study|Noncompliance|3|||
146141931|NCT00630877|527033884|FG002|Overall Study|Noncompliance|1|||
146141932|NCT00630877|527033882|FG000|Overall Study|Protocol violation|1|||
146141933|NCT00630877|527033883|FG001|Overall Study|Protocol violation|0|||
146141934|NCT00630877|527033884|FG002|Overall Study|Protocol violation|1|||
146141935|NCT00630877|527033882|FG000|Overall Study|Personal reasons|0|||
146141936|NCT00630877|527033883|FG001|Overall Study|Personal reasons|0|||
146141937|NCT00630877|527033884|FG002|Overall Study|Personal reasons|1|||
146141938|NCT01643473|527033885|FG000|Overall Study|Lost to Follow-up|1|||
146141939|NCT01643473|527033886|FG001|Overall Study|Lost to Follow-up|0|||
146141940|NCT01519518|527033887|FG000|Overall Study|Consent not available|7|||
146141941|NCT01519518|527033888|FG001|Overall Study|Consent not available|10|||
146141942|NCT02033889|527033889|FG000|Overall Study|Adverse Event|3|||
146141943|NCT02033889|527033890|FG001|Overall Study|Adverse Event|1|||
146141944|NCT02033889|527033891|FG002|Overall Study|Adverse Event|3|||
146141945|NCT02033889|527033889|FG000|Overall Study|Death|3|||
146141946|NCT02033889|527033890|FG001|Overall Study|Death|1|||
146141947|NCT02033889|527033891|FG002|Overall Study|Death|2|||
146141948|NCT02033889|527033889|FG000|Overall Study|Excluded Medication|1|||
146141949|NCT02033889|527033890|FG001|Overall Study|Excluded Medication|1|||
146141950|NCT02033889|527033891|FG002|Overall Study|Excluded Medication|0|||
146141951|NCT02033889|527033889|FG000|Overall Study|Lost to Follow-up|8|||
146141952|NCT02033889|527033890|FG001|Overall Study|Lost to Follow-up|5|||
146141953|NCT02033889|527033891|FG002|Overall Study|Lost to Follow-up|6|||
146141954|NCT02033889|527033889|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146141955|NCT02033889|527033890|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146141956|NCT02033889|527033891|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146141957|NCT02033889|527033889|FG000|Overall Study|Physician Decision|0|||
146141958|NCT02033889|527033890|FG001|Overall Study|Physician Decision|1|||
146141959|NCT02033889|527033891|FG002|Overall Study|Physician Decision|1|||
146141960|NCT02033889|527033889|FG000|Overall Study|Participant moved|0|||
146141961|NCT02033889|527033890|FG001|Overall Study|Participant moved|1|||
146141962|NCT02033889|527033891|FG002|Overall Study|Participant moved|0|||
146141963|NCT02033889|527033889|FG000|Overall Study|Withdrawal by Subject|18|||
146141964|NCT02033889|527033890|FG001|Overall Study|Withdrawal by Subject|10|||
146141965|NCT02033889|527033891|FG002|Overall Study|Withdrawal by Subject|13|||
146141966|NCT02343458|527033895|FG000|Overall Study|Adverse Event|15|||
146141967|NCT02343458|527033896|FG001|Overall Study|Adverse Event|14|||
146141968|NCT02343458|527033897|FG002|Overall Study|Adverse Event|15|||
146141969|NCT02343458|527033898|FG003|Overall Study|Adverse Event|3|||
146141970|NCT02343458|527033895|FG000|Overall Study|Lack of Efficacy|3|||
146141971|NCT02343458|527033896|FG001|Overall Study|Lack of Efficacy|8|||
146141972|NCT02343458|527033897|FG002|Overall Study|Lack of Efficacy|4|||
146141973|NCT02343458|527033898|FG003|Overall Study|Lack of Efficacy|8|||
146141974|NCT02343458|527033895|FG000|Overall Study|Withdrawal by Subject|18|||
146141975|NCT02343458|527033896|FG001|Overall Study|Withdrawal by Subject|17|||
146141976|NCT02343458|527033897|FG002|Overall Study|Withdrawal by Subject|23|||
146141977|NCT02343458|527033898|FG003|Overall Study|Withdrawal by Subject|14|||
146141978|NCT02343458|527033895|FG000|Overall Study|Physician Decision|1|||
146141979|NCT02343458|527033896|FG001|Overall Study|Physician Decision|4|||
146141980|NCT02343458|527033897|FG002|Overall Study|Physician Decision|2|||
146141981|NCT02343458|527033898|FG003|Overall Study|Physician Decision|2|||
146141982|NCT02343458|527033895|FG000|Overall Study|Lost to Follow-up|5|||
146141983|NCT02343458|527033896|FG001|Overall Study|Lost to Follow-up|5|||
146141984|NCT02343458|527033897|FG002|Overall Study|Lost to Follow-up|3|||
146141985|NCT02343458|527033898|FG003|Overall Study|Lost to Follow-up|1|||
146141986|NCT02343458|527033895|FG000|Overall Study|Protocol Violation|2|||
146141987|NCT02343458|527033896|FG001|Overall Study|Protocol Violation|5|||
146141988|NCT02343458|527033897|FG002|Overall Study|Protocol Violation|2|||
146141989|NCT02343458|527033898|FG003|Overall Study|Protocol Violation|2|||
146141990|NCT02343458|527033895|FG000|Overall Study|Protocol Specified Criteria|17|||
146141991|NCT02343458|527033896|FG001|Overall Study|Protocol Specified Criteria|13|||
146141992|NCT02343458|527033897|FG002|Overall Study|Protocol Specified Criteria|14|||
146141993|NCT02343458|527033898|FG003|Overall Study|Protocol Specified Criteria|8|||
146141994|NCT01312909|527033899|FG000|Overall Study|Randomized but not treated|1|||
146141995|NCT01312909|527033900|FG001|Overall Study|Randomized but not treated|3|||
146141996|NCT01312909|527033901|FG002|Overall Study|Randomized but not treated|1|||
146141997|NCT01312909|527033899|FG000|Overall Study|Adverse Event|1|||
146141998|NCT01312909|527033900|FG001|Overall Study|Adverse Event|0|||
146141999|NCT01312909|527033901|FG002|Overall Study|Adverse Event|3|||
146142000|NCT01312909|527033899|FG000|Overall Study|Protocol Violation|2|||
146142001|NCT01312909|527033900|FG001|Overall Study|Protocol Violation|0|||
146142002|NCT01312909|527033901|FG002|Overall Study|Protocol Violation|2|||
146142003|NCT01312909|527033899|FG000|Overall Study|Other|9|||
146142004|NCT01312909|527033900|FG001|Overall Study|Other|6|||
146142005|NCT01312909|527033901|FG002|Overall Study|Other|11|||
146142006|NCT01312909|527033899|FG000|Overall Study|Withdrawal by Subject|8|||
146142007|NCT01312909|527033900|FG001|Overall Study|Withdrawal by Subject|10|||
146142008|NCT01312909|527033901|FG002|Overall Study|Withdrawal by Subject|7|||
146142009|NCT01312909|527033899|FG000|Overall Study|Lost to Follow-up|21|||
146142010|NCT01312909|527033900|FG001|Overall Study|Lost to Follow-up|17|||
146142011|NCT01312909|527033901|FG002|Overall Study|Lost to Follow-up|20|||
146142012|NCT01312909|527033899|FG000|Overall Study|Insufficient clinical response|0|||
146142013|NCT01312909|527033900|FG001|Overall Study|Insufficient clinical response|0|||
146142014|NCT01312909|527033901|FG002|Overall Study|Insufficient clinical response|1|||
146142015|NCT01312909|527033899|FG000|Overall Study|Entrance criteria not met|0|||
146142016|NCT01312909|527033900|FG001|Overall Study|Entrance criteria not met|0|||
146142017|NCT01312909|527033901|FG002|Overall Study|Entrance criteria not met|2|||
146142018|NCT01913041|527033902|FG000|Overall Study|Protocol Violation|35|||
146142019|NCT01913041|527033902|FG000|Overall Study|Withdrawal by Subject|3|||
146142020|NCT01913041|527033902|FG000|Overall Study|Physician Decision|1|||
146142021|NCT01513317|527033903|FG000|Overall Study|Withdrawal by Subject|15|||
146142022|NCT01513317|527033904|FG001|Overall Study|Withdrawal by Subject|4|||
146142023|NCT01513317|527033903|FG000|Overall Study|Death|1|||
146142024|NCT01513317|527033904|FG001|Overall Study|Death|1|||
146142025|NCT01513317|527033903|FG000|Overall Study|Study terminated by sponsor|18|||
146142026|NCT01513317|527033904|FG001|Overall Study|Study terminated by sponsor|18|||
146142027|NCT01513317|527033903|FG000|Overall Study|Other|0|||
146142028|NCT01513317|527033904|FG001|Overall Study|Other|1|||
146142029|NCT02564198|527033906|FG000|Overall Study|Withdrawal by Subject|2|||
146142030|NCT02564198|527033907|FG001|Overall Study|Withdrawal by Subject|4|||
146142031|NCT02564198|527033908|FG002|Overall Study|Withdrawal by Subject|0|||
146142032|NCT02564198|527033906|FG000|Overall Study|Adverse Event|0|||
146142033|NCT02564198|527033907|FG001|Overall Study|Adverse Event|1|||
146142034|NCT02564198|527033908|FG002|Overall Study|Adverse Event|0|||
146142035|NCT01639001|527033916|FG000|Overall Study|Refused further follow-up|9|||
146142036|NCT01639001|527033917|FG001|Overall Study|Refused further follow-up|12|||
146142037|NCT01639001|527033916|FG000|Overall Study|Lost to Follow-up|3|||
146142038|NCT01639001|527033917|FG001|Overall Study|Lost to Follow-up|0|||
146142039|NCT01639001|527033916|FG000|Overall Study|Death|62|||
146142040|NCT01639001|527033917|FG001|Overall Study|Death|61|||
146142041|NCT01639001|527033916|FG000|Overall Study|Randomized but not treated|0|||
146142042|NCT01639001|527033917|FG001|Overall Study|Randomized but not treated|2|||
146142043|NCT01639001|527033916|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
146142044|NCT01639001|527033917|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
146142045|NCT00424372|527033918|FG000|Overall Study|Death|1|||
146142046|NCT00424372|527033918|FG000|Overall Study|Adverse Event|18|||
146142047|NCT00424372|527033918|FG000|Overall Study|Lack of Efficacy|6|||
146142048|NCT00424372|527033918|FG000|Overall Study|Withdrawal by Subject|4|||
146142049|NCT00424372|527033918|FG000|Overall Study|Protocol Violation|1|||
146142050|NCT00424372|527033918|FG000|Overall Study|Health deterioration|1|||
146142051|NCT00098839|527033919|FG000|Overall Study|Adverse Event|5|||
146142052|NCT00098839|527033920|FG001|Overall Study|Adverse Event|2|||
146142053|NCT00098839|527033919|FG000|Overall Study|Death|1|||
146142054|NCT00098839|527033920|FG001|Overall Study|Death|2|||
146142055|NCT00098839|527033919|FG000|Overall Study|Physician Decision|4|||
146142056|NCT00098839|527033920|FG001|Overall Study|Physician Decision|14|||
146142057|NCT00098839|527033919|FG000|Overall Study|Withdrawal by Subject|1|||
146142058|NCT00098839|527033920|FG001|Overall Study|Withdrawal by Subject|0|||
146142059|NCT00098839|527033919|FG000|Overall Study|Refusal of further protocol therapy|3|||
146142060|NCT00098839|527033920|FG001|Overall Study|Refusal of further protocol therapy|1|||
146142061|NCT00098839|527033919|FG000|Overall Study|Relapse|6|||
146142062|NCT00098839|527033920|FG001|Overall Study|Relapse|3|||
146142063|NCT00098839|527033919|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
146142064|NCT00098839|527033920|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
146142065|NCT00098839|527033919|FG000|Overall Study|Ineligible|2|||
146142066|NCT00098839|527033920|FG001|Overall Study|Ineligible|0|||
146142067|NCT02167035|527033922|FG000|Overall Study|Adverse Event|2|||
146142068|NCT02167035|527033923|FG001|Overall Study|Adverse Event|2|||
146142069|NCT02167035|527033922|FG000|Overall Study|Lost to Follow-up|3|||
146142070|NCT02167035|527033923|FG001|Overall Study|Lost to Follow-up|3|||
146142071|NCT02167035|527033922|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
146142072|NCT02167035|527033923|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
146142073|NCT02148003|527033924|FG000|Overall Study|Failed inclusion criteria|1|||
146142074|NCT02148003|527033925|FG001|Overall Study|Failed inclusion criteria|0|||
146142075|NCT02148003|527033924|FG000|Overall Study|Met exclusion criteria|0|||
146142076|NCT02148003|527033925|FG001|Overall Study|Met exclusion criteria|1|||
146142077|NCT02148003|527033924|FG000|Overall Study|Withdrawal by Subject|0|||
146142078|NCT02148003|527033925|FG001|Overall Study|Withdrawal by Subject|1|||
146142079|NCT03348904|527033928|FG000|Overall Study|Administrative reason by the sponsor|0|||
146142080|NCT03348904|527033929|FG001|Overall Study|Administrative reason by the sponsor|1|||
146142081|NCT03348904|527033930|FG002|Overall Study|Administrative reason by the sponsor|0|||
146142082|NCT01743092|527033932|FG000|Overall Study|Lost to Follow-up|14|||
146142083|NCT01743092|527033933|FG001|Overall Study|Lost to Follow-up|15|||
146142084|NCT03586869|527033934|FG000|Overall Study|Progressive Disease|3|||
146142085|NCT00087568|527033935|FG000|Overall Study|Adverse Event|4|||
146142086|NCT00087568|527033936|FG001|Overall Study|Adverse Event|0|||
146142087|NCT00087568|527033935|FG000|Overall Study|Withdrawal by Subject|1|||
146142088|NCT00087568|527033936|FG001|Overall Study|Withdrawal by Subject|1|||
146142089|NCT00087568|527033935|FG000|Overall Study|Lost to Follow-up|1|||
146142090|NCT00087568|527033936|FG001|Overall Study|Lost to Follow-up|0|||
146142091|NCT00087568|527033935|FG000|Overall Study|Lack of Efficacy|24|||
146142092|NCT00087568|527033936|FG001|Overall Study|Lack of Efficacy|1|||
146142093|NCT02992899|527033941|FG000|Overall Study|Withdrawal by Subject|1|||
146142094|NCT02992899|527033942|FG001|Overall Study|Withdrawal by Subject|0|||
146142095|NCT02992899|527033941|FG000|Overall Study|Lost to Follow-up|1|||
146142096|NCT02992899|527033942|FG001|Overall Study|Lost to Follow-up|3|||
146142097|NCT02370888|527033943|FG000|Overall Study|disease progression|2|||
146142098|NCT02370888|527033943|FG000|Overall Study|did not meet chimerism criteria|6|||
146142099|NCT01034397|527033944|FG000|Overall Study|Lack of compliance|0|||
146142100|NCT01034397|527033945|FG001|Overall Study|Lack of compliance|1|||
146142101|NCT01034397|527033944|FG000|Overall Study|Lack of Efficacy|3|||
146142102|NCT01034397|527033945|FG001|Overall Study|Lack of Efficacy|0|||
146142103|NCT01034397|527033944|FG000|Overall Study|Adverse Event|4|||
146142104|NCT01034397|527033945|FG001|Overall Study|Adverse Event|0|||
146142105|NCT01034397|527033944|FG000|Overall Study|Other|0|||
146142106|NCT01034397|527033945|FG001|Overall Study|Other|1|||
146142107|NCT04027686|527033946|FG000|Overall Study|Lost to Follow-up|2|||
146142108|NCT04027686|527033947|FG001|Overall Study|Lost to Follow-up|0|||
146142109|NCT04027686|527033946|FG000|Overall Study|Withdrawal by Subject|0|||
146142110|NCT04027686|527033947|FG001|Overall Study|Withdrawal by Subject|1|||
146142111|NCT01263873|527033948|FG000|Overall Study|One provider unable to complete numbers|1|||
146142112|NCT01263873|527033949|FG001|Overall Study|One provider unable to complete numbers|1|||
146142113|NCT03192150|527033952|FG000|Overall Study|Adverse Event|14|||
146142114|NCT03192150|527033953|FG001|Overall Study|Adverse Event|12|||
146142115|NCT03192150|527033952|FG000|Overall Study|Lack of Efficacy|23|||
146142116|NCT03192150|527033953|FG001|Overall Study|Lack of Efficacy|30|||
146142117|NCT03192150|527033952|FG000|Overall Study|Lost to Follow-up|1|||
146142118|NCT03192150|527033953|FG001|Overall Study|Lost to Follow-up|1|||
146142119|NCT03192150|527033952|FG000|Overall Study|Withdrawal by Subject|4|||
146142120|NCT03192150|527033953|FG001|Overall Study|Withdrawal by Subject|2|||
146142121|NCT03192150|527033952|FG000|Overall Study|Protocol Violation|5|||
146142122|NCT03192150|527033953|FG001|Overall Study|Protocol Violation|2|||
146142123|NCT03192150|527033952|FG000|Overall Study|Surgery Canceled|6|||
146304245|NCT01428661|527627519|FG001|Open Label Extension|Withdrawal by Subject|0|||
146142124|NCT03192150|527033953|FG001|Overall Study|Surgery Canceled|2|||
146142125|NCT03192150|527033952|FG000|Overall Study|Other-Various Administrative Reasons|2|||
146142126|NCT03192150|527033953|FG001|Overall Study|Other-Various Administrative Reasons|5|||
146142127|NCT02579616|527033954|FG000|Overall Study|Participants did not receive treatment|3|||
146142128|NCT01448850|527033955|FG000|Overall Study|Death|3|||
146142129|NCT01448850|527033956|FG001|Overall Study|Death|6|||
146271737|NCT00108745|527509848|FG001|Overall Study|Never Treated|10|||
146271738|NCT00108745|527509849|FG002|Overall Study|Never Treated|12|||
146271739|NCT00108745|527509847|FG000|Overall Study|Ineligible|7|||
146271740|NCT00108745|527509848|FG001|Overall Study|Ineligible|13|||
146271741|NCT00108745|527509849|FG002|Overall Study|Ineligible|13|||
146271742|NCT01426347|527509853|FG000|Overall Study|Lost to Follow-up|0|||
146142130|NCT01448850|527033955|FG000|Overall Study|Withdrawal by Subject|13|||
146142131|NCT01448850|527033956|FG001|Overall Study|Withdrawal by Subject|21|||
146142132|NCT01448850|527033955|FG000|Overall Study|Lost to Follow-up|3|||
146142133|NCT01448850|527033956|FG001|Overall Study|Lost to Follow-up|1|||
146142134|NCT01448850|527033955|FG000|Overall Study|Other|15|||
146142135|NCT01448850|527033956|FG001|Overall Study|Other|12|||
146142136|NCT00482391|527033957|FG000|Overall Study|Withdrawal by Subject|1|||
146271743|NCT01426347|527509854|FG001|Overall Study|Lost to Follow-up|3|||
146271744|NCT01426347|527509853|FG000|Overall Study|Protocol Violation|2|||
146271745|NCT01426347|527509854|FG001|Overall Study|Protocol Violation|0|||
146271746|NCT01426347|527509853|FG000|Overall Study|Withdrawal by Subject|5|||
146271747|NCT01426347|527509854|FG001|Overall Study|Withdrawal by Subject|0|||
146271748|NCT00243074|527509855|FG000|Overall Study|Ineligible|6|||
146271749|NCT00243074|527509855|FG000|Overall Study|Adverse Event|6|||
146271750|NCT00243074|527509855|FG000|Overall Study|Withdrawal by Subject|2|||
146142137|NCT00482391|527033957|FG000|Overall Study|Adverse Event|1|||
146142138|NCT00482391|527033957|FG000|Overall Study|Death|1|||
146142139|NCT02664038|527033960|FG000|13 Week|Lost to Follow-up|7|||
146142140|NCT02664038|527033961|FG001|13 Week|Lost to Follow-up|14|||
146142141|NCT02664038|527033960|FG000|13 Week|Withdrawal by Subject|1|||
146142142|NCT02664038|527033961|FG001|13 Week|Withdrawal by Subject|0|||
146142143|NCT02664038|527033960|FG000|26 Week|Lost to Follow-up|5|||
146142144|NCT02664038|527033961|FG001|26 Week|Lost to Follow-up|4|||
146142145|NCT02606136|527033964|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
146142146|NCT02606136|527033964|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
146142147|NCT02606136|527033964|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
146142148|NCT02606136|527033964|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
146142149|NCT00086580|527033968|FG000|Treatment Period|Disease progression|9|||
146142150|NCT00086580|527033969|FG001|Treatment Period|Disease progression|8|||
146142151|NCT00086580|527033968|FG000|Treatment Period|Unable to comply with protocol|3|||
146142152|NCT00086580|527033969|FG001|Treatment Period|Unable to comply with protocol|1|||
146142153|NCT00086580|527033968|FG000|Treatment Period|Withdrawal by Subject|7|||
146142154|NCT00086580|527033969|FG001|Treatment Period|Withdrawal by Subject|8|||
146142155|NCT00086580|527033968|FG000|Treatment Period|Physician Decision|13|||
146142156|NCT00086580|527033969|FG001|Treatment Period|Physician Decision|7|||
146142157|NCT00086580|527033968|FG000|Treatment Period|AE - not treatment related|7|||
146142158|NCT00086580|527033969|FG001|Treatment Period|AE - not treatment related|7|||
146142159|NCT00086580|527033968|FG000|Treatment Period|Toxicity - treatment related|15|||
146142160|NCT00086580|527033969|FG001|Treatment Period|Toxicity - treatment related|15|||
146142161|NCT00086580|527033968|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
146142162|NCT00086580|527033969|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
146142163|NCT00086580|527033968|FG000|Treatment Period|Death|5|||
146142164|NCT00086580|527033969|FG001|Treatment Period|Death|7|||
146142165|NCT00086580|527033968|FG000|Treatment Period|Other|5|||
146142166|NCT00086580|527033969|FG001|Treatment Period|Other|3|||
146142167|NCT00086580|527033968|FG000|Follow-up Period|Disease progression|72|||
146142168|NCT00086580|527033969|FG001|Follow-up Period|Disease progression|99|||
146142169|NCT00086580|527033968|FG000|Follow-up Period|Unable to comply with protocol|5|||
146142170|NCT00086580|527033969|FG001|Follow-up Period|Unable to comply with protocol|0|||
146142171|NCT00086580|527033968|FG000|Follow-up Period|Withdrawal by Subject|6|||
146142172|NCT00086580|527033969|FG001|Follow-up Period|Withdrawal by Subject|6|||
146142173|NCT00086580|527033968|FG000|Follow-up Period|Physician Decision|0|||
146142174|NCT00086580|527033969|FG001|Follow-up Period|Physician Decision|1|||
146142175|NCT00086580|527033968|FG000|Follow-up Period|AE - not related|1|||
146142176|NCT00086580|527033969|FG001|Follow-up Period|AE - not related|0|||
146142177|NCT00086580|527033968|FG000|Follow-up Period|Death|13|||
146142178|NCT00086580|527033969|FG001|Follow-up Period|Death|7|||
146142179|NCT00086580|527033968|FG000|Follow-up Period|Other|7|||
146142180|NCT00086580|527033969|FG001|Follow-up Period|Other|6|||
146142181|NCT00086580|527033968|FG000|Observation Period|Unable to comply with protocol|1|||
146142182|NCT00086580|527033969|FG001|Observation Period|Unable to comply with protocol|1|||
146142183|NCT00086580|527033968|FG000|Observation Period|Withdrawal by Subject|4|||
146142184|NCT00086580|527033969|FG001|Observation Period|Withdrawal by Subject|2|||
146142185|NCT00086580|527033968|FG000|Observation Period|Death|33|||
146142186|NCT00086580|527033969|FG001|Observation Period|Death|55|||
146142187|NCT00086580|527033968|FG000|Observation Period|Other|8|||
146142188|NCT00086580|527033969|FG001|Observation Period|Other|7|||
146142189|NCT03235024|527033970|FG000|Overall Study|Adverse Event|2|||
146142190|NCT03235024|527033971|FG001|Overall Study|Adverse Event|2|||
146142191|NCT03235024|527033970|FG000|Overall Study|Death|1|||
146142192|NCT03235024|527033971|FG001|Overall Study|Death|0|||
146142193|NCT03235024|527033970|FG000|Overall Study|Lost to Follow-up|2|||
146142194|NCT03235024|527033971|FG001|Overall Study|Lost to Follow-up|5|||
146142195|NCT03235024|527033970|FG000|Overall Study|Protocol Violation|1|||
146142196|NCT03235024|527033971|FG001|Overall Study|Protocol Violation|0|||
146142197|NCT03235024|527033970|FG000|Overall Study|Withdrawal by Subject|0|||
146142198|NCT03235024|527033971|FG001|Overall Study|Withdrawal by Subject|3|||
146142199|NCT02357576|527033972|FG000|Treatment Period|Withdrawal by Subject|0|||
146142200|NCT02357576|527033973|FG001|Treatment Period|Withdrawal by Subject|1|||
146142201|NCT02357576|527033972|FG000|Treatment Period|Physician Decision|0|||
146142202|NCT02357576|527033973|FG001|Treatment Period|Physician Decision|1|||
146142203|NCT02357576|527033972|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
146142204|NCT02357576|527033973|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
146142205|NCT02357576|527033972|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
146142206|NCT02357576|527033973|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
146142207|NCT02357576|527033972|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
146142208|NCT02357576|527033973|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
146142209|NCT02357576|527033972|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
146142210|NCT02357576|527033973|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
146142211|NCT00699699|527033974|FG000|Overall Study|Adverse Event|36|||
146304246|NCT01428661|527627520|FG002|Open Label Extension|Withdrawal by Subject|49|||
146142212|NCT00699699|527033974|FG000|Overall Study|Individual different reasons|21|||
146142213|NCT00705575|527033975|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146142214|NCT00705575|527033976|FG001|Overall Study|Abnormal laboratory value(s)|3|||
146142215|NCT00705575|527033975|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146142216|NCT00705575|527033976|FG001|Overall Study|Abnormal test procedure result(s)|12|||
146142217|NCT00705575|527033975|FG000|Overall Study|Adverse Event|11|||
146142218|NCT00705575|527033976|FG001|Overall Study|Adverse Event|15|||
146142219|NCT00705575|527033975|FG000|Overall Study|Lost to Follow-up|3|||
146142220|NCT00705575|527033976|FG001|Overall Study|Lost to Follow-up|4|||
146142221|NCT00705575|527033975|FG000|Overall Study|Protocol Violation|2|||
146142222|NCT00705575|527033976|FG001|Overall Study|Protocol Violation|2|||
146142223|NCT00705575|527033975|FG000|Overall Study|Withdrawal by Subject|5|||
146142224|NCT00705575|527033976|FG001|Overall Study|Withdrawal by Subject|10|||
146142225|NCT01959581|527033980|FG000|Overall Study|Lost to Follow-up|5|||
146142226|NCT02075320|527033984|FG000|Overall Study|Withdrawal by Subject|2|||
146142227|NCT03773757|527033985|FG000|Overall Study|Withdrawal by Subject|2|||
146142228|NCT03773757|527033986|FG001|Overall Study|Withdrawal by Subject|4|||
146142229|NCT02985736|527033989|FG000|Overall Study|Lost to Follow-up|3|||
146142230|NCT00382733|527033990|FG000|Overall Study|Withdrawal by Subject|0|||
146142231|NCT00382733|527033991|FG001|Overall Study|Withdrawal by Subject|1|||
146142232|NCT00382733|527033992|FG002|Overall Study|Withdrawal by Subject|0|||
146142233|NCT00382733|527033993|FG003|Overall Study|Withdrawal by Subject|0|||
146142234|NCT00382733|527033994|FG004|Overall Study|Withdrawal by Subject|0|||
146142235|NCT00550836|527033995|FG000|Overall Study|Withdrawal by Subject|3|||
146142236|NCT00550836|527033996|FG001|Overall Study|Withdrawal by Subject|9|||
146142237|NCT01458171|527033999|FG000|Overall Study|Adverse Event|1|||
146142238|NCT00578565|527034000|FG000|Overall Study|Adverse Event|3|||
146142239|NCT01559311|527034001|FG000|Overall Study|Protocol Violation|0|||
146142240|NCT01559311|527034002|FG001|Overall Study|Protocol Violation|0|||
146142241|NCT01559311|527034003|FG002|Overall Study|Protocol Violation|2|||
146142242|NCT01559311|527034001|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
146142243|NCT01559311|527034002|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
146142244|NCT01559311|527034003|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
146142245|NCT01559311|527034001|FG000|Overall Study|Withdrawal by Subject|2|||
146142246|NCT01559311|527034002|FG001|Overall Study|Withdrawal by Subject|1|||
146142247|NCT01559311|527034003|FG002|Overall Study|Withdrawal by Subject|0|||
146142248|NCT01559311|527034001|FG000|Overall Study|Death|0|||
146142249|NCT01559311|527034002|FG001|Overall Study|Death|2|||
146142250|NCT01559311|527034003|FG002|Overall Study|Death|3|||
146142251|NCT01559311|527034001|FG000|Overall Study|Lost to Follow-up|0|||
146142252|NCT01559311|527034002|FG001|Overall Study|Lost to Follow-up|3|||
146142253|NCT01559311|527034003|FG002|Overall Study|Lost to Follow-up|2|||
146142254|NCT01559311|527034001|FG000|Overall Study|Adverse Event|0|||
146142255|NCT01559311|527034002|FG001|Overall Study|Adverse Event|0|||
146142256|NCT01559311|527034003|FG002|Overall Study|Adverse Event|1|||
146142257|NCT05013905|527034004|FG000|Overall Study|Adverse Event|1|||
146142258|NCT05013905|527034004|FG000|Overall Study|Lack of Efficacy|1|||
146142259|NCT01849588|527034005|FG000|Overall Study|Lack of Efficacy|3|||
146142260|NCT00515827|527034006|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
146142261|NCT00515827|527034007|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
146142262|NCT00515827|527034006|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
146142263|NCT00515827|527034007|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
146142264|NCT02200042|527035957|FG000|Overall Study|Withdrawal by Subject|0|||
146142265|NCT02200042|527035958|FG001|Overall Study|Withdrawal by Subject|1|||
146142266|NCT01969838|527035959|FG000|Double-blind Phase|Adverse Event|10|||
146142267|NCT01969838|527035960|FG001|Double-blind Phase|Adverse Event|4|||
146142268|NCT01969838|527035961|FG002|Double-blind Phase|Adverse Event|0|||
146142269|NCT01969838|527035962|FG003|Double-blind Phase|Adverse Event|0|||
146142270|NCT01969838|527035959|FG000|Double-blind Phase|Death|5|||
146142271|NCT01969838|527035960|FG001|Double-blind Phase|Death|2|||
146142272|NCT01969838|527035961|FG002|Double-blind Phase|Death|0|||
146142273|NCT01969838|527035962|FG003|Double-blind Phase|Death|0|||
146142274|NCT01969838|527035959|FG000|Double-blind Phase|Physician Decision|5|||
146142275|NCT01969838|527035960|FG001|Double-blind Phase|Physician Decision|1|||
146142276|NCT01969838|527035961|FG002|Double-blind Phase|Physician Decision|0|||
146271751|NCT00243074|527509855|FG000|Overall Study|Lack of Efficacy|36|||
146142277|NCT01969838|527035962|FG003|Double-blind Phase|Physician Decision|0|||
146142278|NCT01969838|527035959|FG000|Double-blind Phase|Subject Decision|4|||
146142279|NCT01969838|527035960|FG001|Double-blind Phase|Subject Decision|2|||
146142280|NCT01969838|527035961|FG002|Double-blind Phase|Subject Decision|0|||
146142281|NCT01969838|527035962|FG003|Double-blind Phase|Subject Decision|0|||
146142282|NCT01969838|527035959|FG000|Double-blind Phase|Disease Progression|2|||
146142283|NCT01969838|527035960|FG001|Double-blind Phase|Disease Progression|0|||
146142284|NCT01969838|527035961|FG002|Double-blind Phase|Disease Progression|0|||
146142285|NCT01969838|527035962|FG003|Double-blind Phase|Disease Progression|0|||
146142286|NCT01969838|527035959|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
146271752|NCT00243074|527509855|FG000|Overall Study|Death|2|||
146142287|NCT01969838|527035960|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
146142288|NCT01969838|527035961|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
146142289|NCT01969838|527035962|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
146142290|NCT01969838|527035959|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
146142291|NCT01969838|527035960|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
146142292|NCT01969838|527035961|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
146142293|NCT01969838|527035962|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
146142294|NCT01969838|527035959|FG000|Open-label Phase|Adverse Event|0|||
146142295|NCT01969838|527035960|FG001|Open-label Phase|Adverse Event|0|||
146142296|NCT01969838|527035961|FG002|Open-label Phase|Adverse Event|37|||
146142297|NCT01969838|527035962|FG003|Open-label Phase|Adverse Event|49|||
146142298|NCT01969838|527035959|FG000|Open-label Phase|Disease Progression|0|||
146142299|NCT01969838|527035960|FG001|Open-label Phase|Disease Progression|0|||
146142300|NCT01969838|527035961|FG002|Open-label Phase|Disease Progression|26|||
146142301|NCT01969838|527035962|FG003|Open-label Phase|Disease Progression|27|||
146142302|NCT01969838|527035959|FG000|Open-label Phase|Lack of Efficacy|0|||
146142303|NCT01969838|527035960|FG001|Open-label Phase|Lack of Efficacy|0|||
146142304|NCT01969838|527035961|FG002|Open-label Phase|Lack of Efficacy|17|||
146142305|NCT01969838|527035962|FG003|Open-label Phase|Lack of Efficacy|19|||
146142306|NCT01969838|527035959|FG000|Open-label Phase|Subject Decision|0|||
146142307|NCT01969838|527035960|FG001|Open-label Phase|Subject Decision|0|||
146142308|NCT01969838|527035961|FG002|Open-label Phase|Subject Decision|14|||
146142309|NCT01969838|527035962|FG003|Open-label Phase|Subject Decision|15|||
146142310|NCT01969838|527035959|FG000|Open-label Phase|Death|0|||
146142311|NCT01969838|527035960|FG001|Open-label Phase|Death|0|||
146142312|NCT01969838|527035961|FG002|Open-label Phase|Death|13|||
146142313|NCT01969838|527035962|FG003|Open-label Phase|Death|11|||
146142314|NCT01969838|527035959|FG000|Open-label Phase|Physician Decision|0|||
146142315|NCT01969838|527035960|FG001|Open-label Phase|Physician Decision|0|||
146142316|NCT01969838|527035961|FG002|Open-label Phase|Physician Decision|9|||
146142317|NCT01969838|527035962|FG003|Open-label Phase|Physician Decision|14|||
146142318|NCT01969838|527035959|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
146142319|NCT01969838|527035960|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
146142320|NCT01969838|527035961|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
146142321|NCT01969838|527035962|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
146142322|NCT00408993|527035963|FG000|Overall Study|Adverse Event|15|||
146142323|NCT00408993|527035964|FG001|Overall Study|Adverse Event|4|||
146142324|NCT00408993|527035963|FG000|Overall Study|Protocol Violation|1|||
146142325|NCT00408993|527035964|FG001|Overall Study|Protocol Violation|6|||
146142326|NCT00408993|527035963|FG000|Overall Study|Lack of Efficacy|1|||
146142327|NCT00408993|527035964|FG001|Overall Study|Lack of Efficacy|4|||
146142328|NCT00408993|527035963|FG000|Overall Study|Withdrawal by Subject|2|||
146142329|NCT00408993|527035964|FG001|Overall Study|Withdrawal by Subject|3|||
146142330|NCT00298896|527035965|FG000|Overall Study|Death|3|||
146142331|NCT00298896|527035965|FG000|Overall Study|Physician Decision|2|||
146142332|NCT00298896|527035965|FG000|Overall Study|Intercurrent Illness|1|||
146142333|NCT00298896|527035965|FG000|Overall Study|Disease Progression|41|||
146142334|NCT00298896|527035965|FG000|Overall Study|Withdrawal by Subject|2|||
146142335|NCT00298896|527035965|FG000|Overall Study|Assigned to treatment in error|1|||
146142336|NCT02880371|527035966|FG000|Phase 1b|Lost to Follow-up|1|||
146142337|NCT02880371|527035967|FG001|Phase 1b|Lost to Follow-up|0|||
146142338|NCT02880371|527035968|FG002|Phase 1b|Lost to Follow-up|0|||
146142339|NCT02880371|527035969|FG003|Phase 1b|Lost to Follow-up|0|||
146142340|NCT02880371|527035970|FG004|Phase 1b|Lost to Follow-up|0|||
146142341|NCT02880371|527035971|FG005|Phase 1b|Lost to Follow-up|0|||
146142342|NCT02880371|527035972|FG006|Phase 1b|Lost to Follow-up|0|||
146142343|NCT02880371|527035973|FG007|Phase 1b|Lost to Follow-up|0|||
146142344|NCT02880371|527035966|FG000|Phase 1b|Participants terminated by Sponsor|1|||
146142345|NCT02880371|527035967|FG001|Phase 1b|Participants terminated by Sponsor|0|||
146142346|NCT02880371|527035968|FG002|Phase 1b|Participants terminated by Sponsor|0|||
146142347|NCT02880371|527035969|FG003|Phase 1b|Participants terminated by Sponsor|0|||
146142348|NCT02880371|527035970|FG004|Phase 1b|Participants terminated by Sponsor|0|||
146142349|NCT02880371|527035971|FG005|Phase 1b|Participants terminated by Sponsor|0|||
146142350|NCT02880371|527035972|FG006|Phase 1b|Participants terminated by Sponsor|0|||
146304247|NCT01428661|527627518|FG000|Open Label Extension|Lack of Efficacy|0|||
146142351|NCT02880371|527035973|FG007|Phase 1b|Participants terminated by Sponsor|0|||
146304248|NCT01428661|527627519|FG001|Open Label Extension|Lack of Efficacy|0|||
146142352|NCT02880371|527035966|FG000|Phase 1b|Withdrawal by Subject|0|||
146142353|NCT02880371|527035967|FG001|Phase 1b|Withdrawal by Subject|0|||
146142354|NCT02880371|527035968|FG002|Phase 1b|Withdrawal by Subject|1|||
146304249|NCT01428661|527627520|FG002|Open Label Extension|Lack of Efficacy|24|||
146142355|NCT02880371|527035969|FG003|Phase 1b|Withdrawal by Subject|0|||
146142356|NCT02880371|527035970|FG004|Phase 1b|Withdrawal by Subject|0|||
146142357|NCT02880371|527035971|FG005|Phase 1b|Withdrawal by Subject|0|||
146304250|NCT01428661|527627518|FG000|Open Label Extension|**Various|0|||
146142358|NCT02880371|527035972|FG006|Phase 1b|Withdrawal by Subject|0|||
146142359|NCT02880371|527035973|FG007|Phase 1b|Withdrawal by Subject|0|||
146142360|NCT02880371|527035966|FG000|Phase 1b|Death|4|||
146142361|NCT02880371|527035967|FG001|Phase 1b|Death|6|||
146142362|NCT02880371|527035968|FG002|Phase 1b|Death|5|||
146142363|NCT02880371|527035969|FG003|Phase 1b|Death|1|||
146142364|NCT02880371|527035970|FG004|Phase 1b|Death|0|||
146142365|NCT02880371|527035971|FG005|Phase 1b|Death|0|||
146142366|NCT02880371|527035972|FG006|Phase 1b|Death|0|||
146142367|NCT02880371|527035973|FG007|Phase 1b|Death|0|||
146142368|NCT02880371|527035966|FG000|Phase 1b|Enrolled but not Treated|0|||
146142369|NCT02880371|527035967|FG001|Phase 1b|Enrolled but not Treated|1|||
146142370|NCT02880371|527035968|FG002|Phase 1b|Enrolled but not Treated|0|||
146142371|NCT02880371|527035969|FG003|Phase 1b|Enrolled but not Treated|0|||
146142372|NCT02880371|527035970|FG004|Phase 1b|Enrolled but not Treated|0|||
146142373|NCT02880371|527035971|FG005|Phase 1b|Enrolled but not Treated|0|||
146142374|NCT02880371|527035972|FG006|Phase 1b|Enrolled but not Treated|0|||
146142375|NCT02880371|527035973|FG007|Phase 1b|Enrolled but not Treated|0|||
146142376|NCT02880371|527035966|FG000|Phase 2|Enrolled but not Treated|0|||
146142377|NCT02880371|527035967|FG001|Phase 2|Enrolled but not Treated|0|||
146142378|NCT02880371|527035968|FG002|Phase 2|Enrolled but not Treated|0|||
146142379|NCT02880371|527035969|FG003|Phase 2|Enrolled but not Treated|0|||
146142380|NCT02880371|527035970|FG004|Phase 2|Enrolled but not Treated|0|||
146142381|NCT02880371|527035971|FG005|Phase 2|Enrolled but not Treated|1|||
146142382|NCT02880371|527035972|FG006|Phase 2|Enrolled but not Treated|1|||
146142383|NCT02880371|527035973|FG007|Phase 2|Enrolled but not Treated|0|||
146142384|NCT02880371|527035966|FG000|Phase 2|Other|0|||
146142385|NCT02880371|527035967|FG001|Phase 2|Other|0|||
146142386|NCT02880371|527035968|FG002|Phase 2|Other|0|||
146142387|NCT02880371|527035969|FG003|Phase 2|Other|0|||
146142388|NCT02880371|527035970|FG004|Phase 2|Other|0|||
146142389|NCT02880371|527035971|FG005|Phase 2|Other|1|||
146142390|NCT02880371|527035972|FG006|Phase 2|Other|2|||
146142391|NCT02880371|527035973|FG007|Phase 2|Other|1|||
146142392|NCT02880371|527035966|FG000|Phase 2|Participants terminated by Sponsor|0|||
146142393|NCT02880371|527035967|FG001|Phase 2|Participants terminated by Sponsor|0|||
146142394|NCT02880371|527035968|FG002|Phase 2|Participants terminated by Sponsor|0|||
146142395|NCT02880371|527035969|FG003|Phase 2|Participants terminated by Sponsor|0|||
146142396|NCT02880371|527035970|FG004|Phase 2|Participants terminated by Sponsor|1|||
146142397|NCT02880371|527035971|FG005|Phase 2|Participants terminated by Sponsor|6|||
146142398|NCT02880371|527035972|FG006|Phase 2|Participants terminated by Sponsor|1|||
146142399|NCT02880371|527035973|FG007|Phase 2|Participants terminated by Sponsor|5|||
146142400|NCT02880371|527035966|FG000|Phase 2|Death|0|||
146142401|NCT02880371|527035967|FG001|Phase 2|Death|0|||
146142402|NCT02880371|527035968|FG002|Phase 2|Death|0|||
146142403|NCT02880371|527035969|FG003|Phase 2|Death|0|||
146142404|NCT02880371|527035970|FG004|Phase 2|Death|1|||
146142405|NCT02880371|527035971|FG005|Phase 2|Death|10|||
146142406|NCT02880371|527035972|FG006|Phase 2|Death|20|||
146142407|NCT02880371|527035973|FG007|Phase 2|Death|5|||
146142408|NCT02880371|527035966|FG000|Phase 2|Lost to Follow-up|0|||
146142409|NCT02880371|527035967|FG001|Phase 2|Lost to Follow-up|0|||
146142410|NCT02880371|527035968|FG002|Phase 2|Lost to Follow-up|0|||
146142411|NCT02880371|527035969|FG003|Phase 2|Lost to Follow-up|0|||
146142412|NCT02880371|527035970|FG004|Phase 2|Lost to Follow-up|0|||
146142413|NCT02880371|527035971|FG005|Phase 2|Lost to Follow-up|0|||
146142414|NCT02880371|527035972|FG006|Phase 2|Lost to Follow-up|3|||
146142415|NCT02880371|527035973|FG007|Phase 2|Lost to Follow-up|0|||
146142416|NCT02880371|527035966|FG000|Phase 2|Withdrawal by Subject|0|||
146142417|NCT02880371|527035967|FG001|Phase 2|Withdrawal by Subject|0|||
146142418|NCT02880371|527035968|FG002|Phase 2|Withdrawal by Subject|0|||
146142419|NCT02880371|527035969|FG003|Phase 2|Withdrawal by Subject|0|||
146142420|NCT02880371|527035970|FG004|Phase 2|Withdrawal by Subject|0|||
146142421|NCT02880371|527035971|FG005|Phase 2|Withdrawal by Subject|1|||
146142422|NCT02880371|527035972|FG006|Phase 2|Withdrawal by Subject|1|||
146304251|NCT01428661|527627519|FG001|Open Label Extension|**Various|0|||
146142423|NCT02880371|527035973|FG007|Phase 2|Withdrawal by Subject|0|||
146142424|NCT02880371|527035966|FG000|Phase 2|End of Study page not completed by error|0|||
146142425|NCT02880371|527035967|FG001|Phase 2|End of Study page not completed by error|0|||
146142426|NCT02880371|527035968|FG002|Phase 2|End of Study page not completed by error|0|||
146142427|NCT02880371|527035969|FG003|Phase 2|End of Study page not completed by error|0|||
146142428|NCT02880371|527035970|FG004|Phase 2|End of Study page not completed by error|0|||
146142429|NCT02880371|527035971|FG005|Phase 2|End of Study page not completed by error|1|||
146142430|NCT02880371|527035972|FG006|Phase 2|End of Study page not completed by error|0|||
146142431|NCT02880371|527035973|FG007|Phase 2|End of Study page not completed by error|0|||
146304252|NCT01428661|527627520|FG002|Open Label Extension|**Various|185|||
146142432|NCT02660359|527035974|FG000|Overall Study|Protocol Deviation|0|||
146142433|NCT02660359|527035975|FG001|Overall Study|Protocol Deviation|0|||
146142434|NCT02660359|527035976|FG002|Overall Study|Protocol Deviation|1|||
146142435|NCT02660359|527035974|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
146142436|NCT02660359|527035975|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
146142437|NCT02660359|527035976|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
146142438|NCT02660359|527035974|FG000|Overall Study|Lack of Efficacy|1|||
146142439|NCT02660359|527035975|FG001|Overall Study|Lack of Efficacy|1|||
146304253|NCT02248259|527629139|FG000|Treatment Period 1|Adverse Event|0|||
146142440|NCT02660359|527035976|FG002|Overall Study|Lack of Efficacy|1|||
146142441|NCT02660359|527035974|FG000|Overall Study|Adverse Event|0|||
146142442|NCT02660359|527035975|FG001|Overall Study|Adverse Event|1|||
146142443|NCT02660359|527035976|FG002|Overall Study|Adverse Event|0|||
146142444|NCT02660359|527035974|FG000|Overall Study|Other|2|||
146142445|NCT02660359|527035975|FG001|Overall Study|Other|1|||
146142446|NCT02660359|527035976|FG002|Overall Study|Other|3|||
146142447|NCT02660359|527035974|FG000|Overall Study|Withdrawal by Subject|7|||
146142448|NCT02660359|527035975|FG001|Overall Study|Withdrawal by Subject|5|||
146142449|NCT02660359|527035976|FG002|Overall Study|Withdrawal by Subject|8|||
146142450|NCT02660359|527035974|FG000|Overall Study|Lost to Follow-up|3|||
146142451|NCT02660359|527035975|FG001|Overall Study|Lost to Follow-up|3|||
146142452|NCT02660359|527035976|FG002|Overall Study|Lost to Follow-up|0|||
146142453|NCT03394391|527035980|FG000|Overall Study|Lost to Follow-up|1|||
146142454|NCT03394391|527035981|FG001|Overall Study|Lost to Follow-up|2|||
146142455|NCT04622254|527035982|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146142456|NCT04622254|527035983|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
146142457|NCT04622254|527035984|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146142458|NCT04622254|527035985|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146142459|NCT04622254|527035986|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146142460|NCT04622254|527035987|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
146142461|NCT04622254|527035982|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146142462|NCT04622254|527035983|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
146142463|NCT04622254|527035984|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146142464|NCT04622254|527035985|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146142465|NCT04622254|527035986|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146142466|NCT04622254|527035987|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146142467|NCT04622254|527035982|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
146142468|NCT04622254|527035983|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146142469|NCT04622254|527035984|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146142470|NCT04622254|527035985|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146142471|NCT04622254|527035986|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146142472|NCT04622254|527035987|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
146142473|NCT04622254|527035982|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146142474|NCT04622254|527035983|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
146142475|NCT04622254|527035984|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146142476|NCT04622254|527035985|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146142477|NCT04622254|527035986|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146142478|NCT04622254|527035987|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146142479|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146142480|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146142481|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146142482|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
146142483|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146142484|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146142485|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146142486|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146142487|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146142488|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
146142489|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146142490|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
146142491|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146142492|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146142493|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146142494|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
146142495|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146142496|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146271753|NCT00243074|527509855|FG000|Overall Study|not protocol specified|1|||
146271754|NCT00243074|527509855|FG000|Overall Study|Did not receive any treatment|1|||
146271755|NCT00664534|527509856|FG000|Overall Study|Adverse Event|2|||
146271756|NCT00664534|527509857|FG001|Overall Study|Adverse Event|3|||
146271757|NCT00664534|527509856|FG000|Overall Study|Lost to Follow-up|6|||
146271758|NCT00664534|527509857|FG001|Overall Study|Lost to Follow-up|10|||
146142497|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146142498|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146142499|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146271759|NCT00664534|527509856|FG000|Overall Study|Protocol Violation|10|||
146271760|NCT00664534|527509857|FG001|Overall Study|Protocol Violation|8|||
146271761|NCT00664534|527509856|FG000|Overall Study|Withdrawal by Subject|7|||
146271762|NCT00664534|527509857|FG001|Overall Study|Withdrawal by Subject|6|||
146271763|NCT00664534|527509856|FG000|Overall Study|Physician Decision|8|||
146271764|NCT00664534|527509857|FG001|Overall Study|Physician Decision|0|||
146271765|NCT00664534|527509856|FG000|Overall Study|Sponsor decision|8|||
146142500|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
146142501|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146142502|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146142503|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146142504|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146142505|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146142506|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
146142507|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
146142508|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
146142509|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146142510|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146142511|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146142512|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
146142513|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
146142514|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
146142515|NCT04622254|527035982|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
146142516|NCT04622254|527035983|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
146142517|NCT04622254|527035984|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
146142518|NCT04622254|527035985|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
146142519|NCT04622254|527035986|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
146142520|NCT04622254|527035987|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
146142521|NCT00451282|527035990|FG000|Overall Study|Lost to Follow-up|6|||
146142522|NCT00451282|527035991|FG001|Overall Study|Lost to Follow-up|5|||
146142523|NCT03228680|527035992|FG000|Overall Study|Adverse Event|13|||
146142524|NCT03228680|527035993|FG001|Overall Study|Adverse Event|18|||
146142525|NCT03228680|527035992|FG000|Overall Study|Randomization failure|0|||
146142526|NCT03228680|527035993|FG001|Overall Study|Randomization failure|1|||
146142527|NCT03228680|527035992|FG000|Overall Study|Withdrawal by Subject|1|||
146142528|NCT03228680|527035993|FG001|Overall Study|Withdrawal by Subject|0|||
146142529|NCT03228680|527035992|FG000|Overall Study|Other|9|||
146142530|NCT03228680|527035993|FG001|Overall Study|Other|16|||
146142531|NCT02489981|527035994|FG000|Overall Study|Adverse Event|21|||
146142532|NCT02489981|527035994|FG000|Overall Study|Insufficient effectiveness|16|||
146142533|NCT02489981|527035994|FG000|Overall Study|Improved|31|||
146142534|NCT02489981|527035994|FG000|Overall Study|Lost to Follow-up|31|||
146142535|NCT02489981|527035994|FG000|Overall Study|Other than listed|28|||
146142536|NCT01332305|527035995|FG000|Overall Study|Adverse Event|1|||
146142537|NCT01332305|527035996|FG001|Overall Study|Adverse Event|4|||
146142538|NCT01332305|527035997|FG002|Overall Study|Adverse Event|6|||
146142539|NCT01332305|527035998|FG003|Overall Study|Adverse Event|3|||
146142540|NCT01332305|527035999|FG004|Overall Study|Adverse Event|5|||
146142541|NCT01332305|527035995|FG000|Overall Study|Withdrawal by Subject|6|||
146142542|NCT01332305|527035996|FG001|Overall Study|Withdrawal by Subject|5|||
146142543|NCT01332305|527035997|FG002|Overall Study|Withdrawal by Subject|4|||
146142544|NCT01332305|527035998|FG003|Overall Study|Withdrawal by Subject|1|||
146142545|NCT01332305|527035999|FG004|Overall Study|Withdrawal by Subject|0|||
146142546|NCT01332305|527035995|FG000|Overall Study|Lost to Follow-up|0|||
146142547|NCT01332305|527035996|FG001|Overall Study|Lost to Follow-up|2|||
146142548|NCT01332305|527035997|FG002|Overall Study|Lost to Follow-up|3|||
146142549|NCT01332305|527035998|FG003|Overall Study|Lost to Follow-up|2|||
146142550|NCT01332305|527035999|FG004|Overall Study|Lost to Follow-up|3|||
146142551|NCT01332305|527035995|FG000|Overall Study|Protocol Violation|1|||
146142552|NCT01332305|527035996|FG001|Overall Study|Protocol Violation|2|||
146142553|NCT01332305|527035997|FG002|Overall Study|Protocol Violation|1|||
146142554|NCT01332305|527035998|FG003|Overall Study|Protocol Violation|0|||
146142555|NCT01332305|527035999|FG004|Overall Study|Protocol Violation|3|||
146142556|NCT01332305|527035995|FG000|Overall Study|Withdrawal by Sponsor|1|||
146142557|NCT01332305|527035996|FG001|Overall Study|Withdrawal by Sponsor|0|||
146142558|NCT01332305|527035997|FG002|Overall Study|Withdrawal by Sponsor|0|||
146142559|NCT01332305|527035998|FG003|Overall Study|Withdrawal by Sponsor|1|||
146142560|NCT01332305|527035999|FG004|Overall Study|Withdrawal by Sponsor|1|||
146142561|NCT01332305|527035995|FG000|Overall Study|Treatment Failure|1|||
146142562|NCT01332305|527035996|FG001|Overall Study|Treatment Failure|1|||
146142563|NCT01332305|527035997|FG002|Overall Study|Treatment Failure|0|||
146142564|NCT01332305|527035998|FG003|Overall Study|Treatment Failure|0|||
146142565|NCT01332305|527035999|FG004|Overall Study|Treatment Failure|0|||
146142566|NCT01332305|527035995|FG000|Overall Study|Physician Decision|0|||
146142567|NCT01332305|527035996|FG001|Overall Study|Physician Decision|0|||
146142568|NCT01332305|527035997|FG002|Overall Study|Physician Decision|0|||
146142569|NCT01332305|527035998|FG003|Overall Study|Physician Decision|1|||
146142570|NCT01332305|527035999|FG004|Overall Study|Physician Decision|0|||
146142571|NCT00642304|527036000|FG000|Overall Study|Adverse Event|1|||
146142572|NCT00642304|527036000|FG000|Overall Study|Death|1|||
146142573|NCT00642304|527036000|FG000|Overall Study|Blood transfusion|2|||
146142574|NCT00642304|527036000|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
146142575|NCT00642304|527036000|FG000|Overall Study|Transplantation|1|||
146142576|NCT02178475|527036004|FG000|Overall Study|Withdrawal by Subject|7|||
146142577|NCT02178475|527036004|FG000|Overall Study|Lost to Follow-up|10|||
146142578|NCT02178475|527036004|FG000|Overall Study|Death|13|||
146142579|NCT02178475|527036004|FG000|Overall Study|Protocol-specified Criteria|99|||
146142580|NCT01430585|527036005|FG000|Overall Study|Death|1|||
146142581|NCT01430585|527036005|FG000|Overall Study|Objective Progression or Relapse|3|||
146142582|NCT01430585|527036005|FG000|Overall Study|Study Terminated by Sponsor|3|||
146142583|NCT01430585|527036005|FG000|Overall Study|Other|7|||
146142584|NCT00779766|527036006|FG000|Month 24|Serious Adverse Event|2|||
146142585|NCT00779766|527036007|FG001|Month 24|Serious Adverse Event|3|||
146142586|NCT00779766|527036006|FG000|Month 24|Adverse Event|3|||
146142587|NCT00779766|527036007|FG001|Month 24|Adverse Event|3|||
146142588|NCT00779766|527036006|FG000|Month 24|Protocol Violation|3|||
146142589|NCT00779766|527036007|FG001|Month 24|Protocol Violation|1|||
146142590|NCT00779766|527036006|FG000|Month 24|Withdrawal by Subject|159|||
146142591|NCT00779766|527036007|FG001|Month 24|Withdrawal by Subject|127|||
146142592|NCT00779766|527036006|FG000|Month 24|Migrated/moved from study area|138|||
146142593|NCT00779766|527036007|FG001|Month 24|Migrated/moved from study area|162|||
146142594|NCT00779766|527036006|FG000|Month 24|Lost to Follow-up|9|||
146142595|NCT00779766|527036007|FG001|Month 24|Lost to Follow-up|9|||
146142596|NCT00779766|527036006|FG000|Month 24|Other|18|||
146142597|NCT00779766|527036007|FG001|Month 24|Other|27|||
146142598|NCT00779766|527036006|FG000|Month 48|Withdrawal by Subject|68|||
146142599|NCT00779766|527036007|FG001|Month 48|Withdrawal by Subject|63|||
146142600|NCT00779766|527036006|FG000|Month 48|Migrated/moved from study area|76|||
146142601|NCT00779766|527036007|FG001|Month 48|Migrated/moved from study area|75|||
146142602|NCT00779766|527036006|FG000|Month 48|Lost to Follow-up|29|||
146142603|NCT00779766|527036007|FG001|Month 48|Lost to Follow-up|30|||
146142604|NCT00779766|527036006|FG000|Month 48|Other|1|||
146142605|NCT00779766|527036007|FG001|Month 48|Other|0|||
146142606|NCT00779766|527036006|FG000|Month 72|Withdrawal by Subject|55|||
146142607|NCT00779766|527036007|FG001|Month 72|Withdrawal by Subject|71|||
146142608|NCT00779766|527036006|FG000|Month 72|Migrated/moved from study area|124|||
146142609|NCT00779766|527036007|FG001|Month 72|Migrated/moved from study area|109|||
146142610|NCT00779766|527036006|FG000|Month 72|Lost to Follow-up|6|||
146142611|NCT00779766|527036007|FG001|Month 72|Lost to Follow-up|8|||
146142612|NCT00779766|527036006|FG000|Month 72|Other|0|||
146142613|NCT00779766|527036007|FG001|Month 72|Other|1|||
146142614|NCT01412424|527036014|FG000|Core Treatment Period|Treatment Failure|24|||
146142615|NCT01412424|527036014|FG000|Core Treatment Period|Adverse Event|21|||
146142616|NCT01412424|527036014|FG000|Core Treatment Period|Patient Request|5|||
146142617|NCT01412424|527036014|FG000|Core Treatment Period|Lost to Follow-up|2|||
146142618|NCT01412424|527036014|FG000|Core Treatment Period|Sponsor Request|1|||
146142619|NCT01412424|527036014|FG000|Extension Treatment Period|Adverse Event|2|||
146142620|NCT01412424|527036014|FG000|Extension Treatment Period|Treatment Failure|2|||
146142621|NCT01412424|527036014|FG000|Extension Treatment Period|Patient Request|2|||
146142622|NCT01274637|527036015|FG000|Overall Study|Withdrawal by Subject|0|||
146142623|NCT01274637|527036016|FG001|Overall Study|Withdrawal by Subject|1|||
146142624|NCT01274637|527036015|FG000|Overall Study|Lost to Follow-up|0|||
146142625|NCT01274637|527036016|FG001|Overall Study|Lost to Follow-up|1|||
146142626|NCT02170727|527036029|FG000|Overall Study|Lost to Follow-up|1|||
146142627|NCT02170727|527036030|FG001|Overall Study|Lost to Follow-up|0|||
146142628|NCT02170727|527036029|FG000|Overall Study|Withdrawal by Subject|2|||
146142629|NCT02170727|527036030|FG001|Overall Study|Withdrawal by Subject|0|||
146142630|NCT00414050|527036031|FG000|Overall Study|Adverse Event|1|||
146142631|NCT00414050|527036032|FG001|Overall Study|Adverse Event|1|||
146142632|NCT00414050|527036033|FG002|Overall Study|Adverse Event|1|||
146142633|NCT00414050|527036034|FG003|Overall Study|Adverse Event|1|||
146142634|NCT00414050|527036031|FG000|Overall Study|Lost to Follow-up|2|||
146142635|NCT00414050|527036032|FG001|Overall Study|Lost to Follow-up|2|||
146142636|NCT00414050|527036033|FG002|Overall Study|Lost to Follow-up|1|||
146142637|NCT00414050|527036034|FG003|Overall Study|Lost to Follow-up|1|||
146142638|NCT00414050|527036031|FG000|Overall Study|Withdrawal by Subject|5|||
146142639|NCT00414050|527036032|FG001|Overall Study|Withdrawal by Subject|3|||
146142640|NCT00414050|527036033|FG002|Overall Study|Withdrawal by Subject|2|||
146142641|NCT00414050|527036034|FG003|Overall Study|Withdrawal by Subject|4|||
146142642|NCT00414050|527036031|FG000|Overall Study|Subject discontinued for other reason|1|||
146142643|NCT00414050|527036032|FG001|Overall Study|Subject discontinued for other reason|2|||
146142644|NCT00414050|527036033|FG002|Overall Study|Subject discontinued for other reason|2|||
146304254|NCT02248259|527629140|FG001|Treatment Period 1|Adverse Event|0|||
146142645|NCT00414050|527036034|FG003|Overall Study|Subject discontinued for other reason|1|||
146142646|NCT00414050|527036031|FG000|Overall Study|Subject Moved|0|||
146142647|NCT00414050|527036032|FG001|Overall Study|Subject Moved|0|||
146142648|NCT00414050|527036033|FG002|Overall Study|Subject Moved|0|||
146142649|NCT00414050|527036034|FG003|Overall Study|Subject Moved|1|||
146142650|NCT00057746|527036036|FG000|Overall Study|Withdrawal by Subject|0|||
146142651|NCT00057746|527036037|FG001|Overall Study|Withdrawal by Subject|0|||
146142652|NCT00057746|527036038|FG002|Overall Study|Withdrawal by Subject|1|||
146142653|NCT01109316|527036039|FG000|Study Period 1|Adverse Event|0|||
146142654|NCT01109316|527036040|FG001|Study Period 1|Adverse Event|0|||
146142655|NCT01109316|527036041|FG002|Study Period 1|Adverse Event|1|||
146142656|NCT01109316|527036042|FG003|Study Period 1|Adverse Event|0|||
146142657|NCT01109316|527036043|FG004|Study Period 1|Adverse Event|0|||
146142658|NCT01109316|527036044|FG005|Study Period 1|Adverse Event|0|||
146142659|NCT01109316|527036039|FG000|Study Period 1|Lost to Follow-up|0|||
146142660|NCT01109316|527036040|FG001|Study Period 1|Lost to Follow-up|0|||
146142661|NCT01109316|527036041|FG002|Study Period 1|Lost to Follow-up|1|||
146142662|NCT01109316|527036042|FG003|Study Period 1|Lost to Follow-up|1|||
146142663|NCT01109316|527036043|FG004|Study Period 1|Lost to Follow-up|0|||
146142664|NCT01109316|527036044|FG005|Study Period 1|Lost to Follow-up|0|||
146142665|NCT01109316|527036039|FG000|Study Period 1|Withdrawal by Subject|0|||
146142666|NCT01109316|527036040|FG001|Study Period 1|Withdrawal by Subject|0|||
146142667|NCT01109316|527036041|FG002|Study Period 1|Withdrawal by Subject|1|||
146142668|NCT01109316|527036042|FG003|Study Period 1|Withdrawal by Subject|0|||
146142669|NCT01109316|527036043|FG004|Study Period 1|Withdrawal by Subject|2|||
146142670|NCT01109316|527036044|FG005|Study Period 1|Withdrawal by Subject|0|||
146142671|NCT01109316|527036039|FG000|Study Period 1|Sponsor Decision|0|||
146142672|NCT01109316|527036040|FG001|Study Period 1|Sponsor Decision|0|||
146142673|NCT01109316|527036041|FG002|Study Period 1|Sponsor Decision|0|||
146142674|NCT01109316|527036042|FG003|Study Period 1|Sponsor Decision|0|||
146142675|NCT01109316|527036043|FG004|Study Period 1|Sponsor Decision|0|||
146142676|NCT01109316|527036044|FG005|Study Period 1|Sponsor Decision|2|||
146142677|NCT01109316|527036039|FG000|Study Period 2|Entry Criteria Not Met|0|||
146142678|NCT01109316|527036040|FG001|Study Period 2|Entry Criteria Not Met|1|||
146142679|NCT01109316|527036041|FG002|Study Period 2|Entry Criteria Not Met|0|||
146142680|NCT01109316|527036042|FG003|Study Period 2|Entry Criteria Not Met|0|||
146142681|NCT01109316|527036043|FG004|Study Period 2|Entry Criteria Not Met|0|||
146142682|NCT01109316|527036044|FG005|Study Period 2|Entry Criteria Not Met|0|||
146142683|NCT01109316|527036039|FG000|Study Period 2|Physician Decision|0|||
146142684|NCT01109316|527036040|FG001|Study Period 2|Physician Decision|0|||
146142685|NCT01109316|527036041|FG002|Study Period 2|Physician Decision|0|||
146142686|NCT01109316|527036042|FG003|Study Period 2|Physician Decision|1|||
146142687|NCT01109316|527036043|FG004|Study Period 2|Physician Decision|0|||
146142688|NCT01109316|527036044|FG005|Study Period 2|Physician Decision|0|||
146142689|NCT01109316|527036039|FG000|Study Period 2|Protocol Violation|1|||
146142690|NCT01109316|527036040|FG001|Study Period 2|Protocol Violation|0|||
146142691|NCT01109316|527036041|FG002|Study Period 2|Protocol Violation|0|||
146142692|NCT01109316|527036042|FG003|Study Period 2|Protocol Violation|0|||
146142693|NCT01109316|527036043|FG004|Study Period 2|Protocol Violation|0|||
146142694|NCT01109316|527036044|FG005|Study Period 2|Protocol Violation|0|||
146142695|NCT01109316|527036039|FG000|Study Period 2|Withdrawal by Subject|0|||
146142696|NCT01109316|527036040|FG001|Study Period 2|Withdrawal by Subject|0|||
146142697|NCT01109316|527036041|FG002|Study Period 2|Withdrawal by Subject|1|||
146142698|NCT01109316|527036042|FG003|Study Period 2|Withdrawal by Subject|0|||
146142699|NCT01109316|527036043|FG004|Study Period 2|Withdrawal by Subject|0|||
146142700|NCT01109316|527036044|FG005|Study Period 2|Withdrawal by Subject|1|||
146142701|NCT01109316|527036039|FG000|Study Period 3|Lost to Follow-up|0|||
146142702|NCT01109316|527036040|FG001|Study Period 3|Lost to Follow-up|0|||
146142703|NCT01109316|527036041|FG002|Study Period 3|Lost to Follow-up|0|||
146142704|NCT01109316|527036042|FG003|Study Period 3|Lost to Follow-up|0|||
146142705|NCT01109316|527036043|FG004|Study Period 3|Lost to Follow-up|1|||
146142706|NCT01109316|527036044|FG005|Study Period 3|Lost to Follow-up|0|||
146142707|NCT01109316|527036039|FG000|Study Period 3|Withdrawal by Subject|1|||
146142708|NCT01109316|527036040|FG001|Study Period 3|Withdrawal by Subject|0|||
146142709|NCT01109316|527036041|FG002|Study Period 3|Withdrawal by Subject|0|||
146142710|NCT01109316|527036042|FG003|Study Period 3|Withdrawal by Subject|0|||
146142711|NCT01109316|527036043|FG004|Study Period 3|Withdrawal by Subject|1|||
146142712|NCT01109316|527036044|FG005|Study Period 3|Withdrawal by Subject|0|||
146142713|NCT03511560|527036052|FG000|Overall Study|Death|0|||
146142714|NCT03511560|527036053|FG001|Overall Study|Death|1|||
146142715|NCT03511560|527036052|FG000|Overall Study|Adverse Event|0|||
146142716|NCT03511560|527036053|FG001|Overall Study|Adverse Event|2|||
146142717|NCT03511560|527036052|FG000|Overall Study|Transplant cancelled|0|||
146271766|NCT00664534|527509857|FG001|Overall Study|Sponsor decision|6|||
146142718|NCT03511560|527036053|FG001|Overall Study|Transplant cancelled|1|||
146271767|NCT03041792|527509858|FG000|Overall Study|Adverse Event|4|||
146271768|NCT03041792|527509859|FG001|Overall Study|Adverse Event|0|||
146142719|NCT03511560|527036052|FG000|Overall Study|Patient switched to another drug|1|||
146271769|NCT03041792|527509858|FG000|Overall Study|Death in the family|0|||
146142720|NCT03511560|527036053|FG001|Overall Study|Patient switched to another drug|0|||
146142721|NCT00179413|527036058|FG000|Overall Study|Adverse Event|38|||
146142722|NCT00179413|527036059|FG001|Overall Study|Adverse Event|20|||
146142723|NCT00179413|527036058|FG000|Overall Study|Withdrawal by Subject|87|||
146142724|NCT00179413|527036059|FG001|Overall Study|Withdrawal by Subject|95|||
146271770|NCT03041792|527509859|FG001|Overall Study|Death in the family|2|||
146142725|NCT00439140|527036060|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
146142726|NCT00439140|527036061|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
146142727|NCT00439140|527036062|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
146142728|NCT00439140|527036060|FG000|Treatment Cycle 1|Personal reasons|0|||
146142729|NCT00439140|527036061|FG001|Treatment Cycle 1|Personal reasons|2|||
146142730|NCT00439140|527036062|FG002|Treatment Cycle 1|Personal reasons|0|||
146142731|NCT00439140|527036060|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
146142732|NCT00439140|527036061|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
146142733|NCT00439140|527036062|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
146142734|NCT00439140|527036060|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
146142735|NCT00439140|527036061|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
146142736|NCT00439140|527036062|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
146142737|NCT00439140|527036060|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
146142738|NCT00439140|527036061|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
146142739|NCT00439140|527036062|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
146142740|NCT01192152|527036066|FG000|Period 1|left prematurely (while on treatment B)|0|||
146142741|NCT01192152|527036067|FG001|Period 1|left prematurely (while on treatment B)|1|||
146142742|NCT01192152|527036066|FG000|Period 3|family emergency|1|||
146142743|NCT01192152|527036067|FG001|Period 3|family emergency|0|||
146142744|NCT03181542|527036070|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
146142745|NCT03181542|527036071|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
146142746|NCT01009099|527036072|FG000|Overall Study|Lost to Follow-up|1|||
146142747|NCT01009099|527036073|FG001|Overall Study|Lost to Follow-up|0|||
146142748|NCT01009099|527036072|FG000|Overall Study|Physician Decision|3|||
146142749|NCT01009099|527036073|FG001|Overall Study|Physician Decision|2|||
146142750|NCT01009099|527036072|FG000|Overall Study|Withdrawal by Subject|1|||
146142751|NCT01009099|527036073|FG001|Overall Study|Withdrawal by Subject|1|||
146142752|NCT01009099|527036072|FG000|Overall Study|Death|0|||
146142753|NCT01009099|527036073|FG001|Overall Study|Death|1|||
146142754|NCT01856543|527036074|FG000|Overall Study|Treatment discontinued|6|||
146142755|NCT01856543|527036075|FG001|Overall Study|Treatment discontinued|3|||
146142756|NCT01856543|527036074|FG000|Overall Study|Withdrawn before start|7|||
146142757|NCT01856543|527036075|FG001|Overall Study|Withdrawn before start|3|||
146142758|NCT01848990|527036076|FG000|Overall Study|Adverse Event|6|||
146142759|NCT01848990|527036077|FG001|Overall Study|Adverse Event|2|||
146142760|NCT01848990|527036078|FG002|Overall Study|Adverse Event|0|||
146142761|NCT01848990|527036076|FG000|Overall Study|Lost to Follow-up|6|||
146142762|NCT01848990|527036077|FG001|Overall Study|Lost to Follow-up|2|||
146142763|NCT01848990|527036078|FG002|Overall Study|Lost to Follow-up|2|||
146142764|NCT01848990|527036076|FG000|Overall Study|Protocol Violation|1|||
146142765|NCT01848990|527036077|FG001|Overall Study|Protocol Violation|1|||
146142766|NCT01848990|527036078|FG002|Overall Study|Protocol Violation|0|||
146142767|NCT01848990|527036076|FG000|Overall Study|Withdrawal by Subject|29|||
146142768|NCT01848990|527036077|FG001|Overall Study|Withdrawal by Subject|10|||
146142769|NCT01848990|527036078|FG002|Overall Study|Withdrawal by Subject|11|||
146142770|NCT01848990|527036076|FG000|Overall Study|Physician Decision|1|||
146142771|NCT01848990|527036077|FG001|Overall Study|Physician Decision|1|||
146142772|NCT01848990|527036078|FG002|Overall Study|Physician Decision|0|||
146142773|NCT01848990|527036076|FG000|Overall Study|Non Compliance|1|||
146142774|NCT01848990|527036077|FG001|Overall Study|Non Compliance|0|||
146142775|NCT01848990|527036078|FG002|Overall Study|Non Compliance|0|||
146142776|NCT01848990|527036076|FG000|Overall Study|Death|1|||
146142777|NCT01848990|527036077|FG001|Overall Study|Death|0|||
146142778|NCT01848990|527036078|FG002|Overall Study|Death|1|||
146142779|NCT01848990|527036076|FG000|Overall Study|Other|1|||
146142780|NCT01848990|527036077|FG001|Overall Study|Other|4|||
146142781|NCT01848990|527036078|FG002|Overall Study|Other|2|||
146142782|NCT01712984|527036079|FG000|Overall Study|Adverse Event|0|||
146142783|NCT01712984|527036080|FG001|Overall Study|Adverse Event|0|||
146142784|NCT01712984|527036081|FG002|Overall Study|Adverse Event|1|||
146142785|NCT01712984|527036079|FG000|Overall Study|Protocol Violation|2|||
146142786|NCT01712984|527036080|FG001|Overall Study|Protocol Violation|0|||
146142787|NCT01712984|527036081|FG002|Overall Study|Protocol Violation|1|||
146142788|NCT01712984|527036079|FG000|Overall Study|Lost to Follow-up|8|||
146142789|NCT01712984|527036080|FG001|Overall Study|Lost to Follow-up|10|||
146304255|NCT02248259|527629141|FG002|Treatment Period 1|Adverse Event|1|||
146304256|NCT02248259|527629142|FG003|Treatment Period 1|Adverse Event|0|||
146304257|NCT02369848|527629147|FG000|Overall Study|Death|1|||
146304258|NCT02369848|527629147|FG000|Overall Study|Withdrawal by Subject|2|||
146304259|NCT02369848|527629147|FG000|Overall Study|Lost to Follow-up|1|||
146142790|NCT01712984|527036081|FG002|Overall Study|Lost to Follow-up|1|||
146142791|NCT01712984|527036079|FG000|Overall Study|Withdrawal by Subject|6|||
146142792|NCT01712984|527036080|FG001|Overall Study|Withdrawal by Subject|6|||
146142793|NCT01712984|527036081|FG002|Overall Study|Withdrawal by Subject|7|||
146142794|NCT00096044|527036082|FG000|Overall Study|Withdrawal by Subject|9|||
146142795|NCT00096044|527036082|FG000|Overall Study|Adverse Event|21|||
146142796|NCT00096044|527036082|FG000|Overall Study|Disease Progression|4|||
146142797|NCT01552772|527036083|FG000|Overall Study|Lost to Follow-up|2|||
146142798|NCT01552772|527036083|FG000|Overall Study|Adverse Event|1|||
146142799|NCT01552772|527036083|FG000|Overall Study|Protocol Deviation|1|||
146304260|NCT02573870|527629150|FG000|Overall Study|Adverse Event|0|||
146304261|NCT02573870|527629151|FG001|Overall Study|Adverse Event|2|||
146304262|NCT02573870|527629150|FG000|Overall Study|Lack of Efficacy|0|||
146304263|NCT02573870|527629151|FG001|Overall Study|Lack of Efficacy|1|||
146304264|NCT02573870|527629150|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
146304265|NCT02573870|527629151|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
146304266|NCT02573870|527629150|FG000|Overall Study|Lost to Follow-up|0|||
146304267|NCT02573870|527629151|FG001|Overall Study|Lost to Follow-up|1|||
146304268|NCT02573870|527629150|FG000|Overall Study|Other: Fail to Meet Visit|0|||
146304269|NCT02573870|527629151|FG001|Overall Study|Other: Fail to Meet Visit|2|||
146304270|NCT03785925|527629152|FG000|Overall Study|Withdrawal by Subject|15|||
146304271|NCT03785925|527629152|FG000|Overall Study|Lost to Follow-up|1|||
146304272|NCT00957528|527629154|FG000|Overall Study|Protocol Violation|0|||
146304273|NCT00957528|527629155|FG001|Overall Study|Protocol Violation|1|||
146304274|NCT00957528|527629156|FG002|Overall Study|Protocol Violation|0|||
146304275|NCT00957528|527629154|FG000|Overall Study|Withdrawal by Subject|0|||
146304276|NCT00957528|527629155|FG001|Overall Study|Withdrawal by Subject|0|||
146304277|NCT00957528|527629156|FG002|Overall Study|Withdrawal by Subject|1|||
146304278|NCT01848288|527629158|FG000|Overall Study|Death|1|||
146304279|NCT01848288|527629158|FG000|Overall Study|Protocol Violation|1|||
146304280|NCT01848288|527629158|FG000|Overall Study|Withdrawal by Subject|1|||
146304281|NCT01841749|527629159|FG000|Overall Study|Protocol Violation|1|||
146304282|NCT02285920|527629160|FG000|Overall Study|Kidney transplantation|2|||
146304283|NCT02285920|527629161|FG001|Overall Study|Kidney transplantation|2|||
146304284|NCT02285920|527629162|FG002|Overall Study|Kidney transplantation|2|||
146304285|NCT02285920|527629163|FG003|Overall Study|Kidney transplantation|0|||
146142800|NCT03851016|527036086|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146142801|NCT03851016|527036087|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
146271771|NCT03041792|527509858|FG000|Overall Study|Randomized but not treated|0|||
146271772|NCT03041792|527509859|FG001|Overall Study|Randomized but not treated|1|||
146271773|NCT04978090|527509862|FG000|Overall Study|unable to adequately fit device|2|||
146271774|NCT00935532|527509865|FG000|Overall Study|Adverse Event|11|||
146271775|NCT00935532|527509866|FG001|Overall Study|Adverse Event|6|||
146271776|NCT00935532|527509865|FG000|Overall Study|Death|1|||
146271777|NCT00935532|527509866|FG001|Overall Study|Death|0|||
146271778|NCT00935532|527509865|FG000|Overall Study|Lost to Follow-up|1|||
146271779|NCT00935532|527509866|FG001|Overall Study|Lost to Follow-up|0|||
146271780|NCT00935532|527509865|FG000|Overall Study|Physician Decision|1|||
146271781|NCT00935532|527509866|FG001|Overall Study|Physician Decision|2|||
146271782|NCT00935532|527509865|FG000|Overall Study|Protocol Violation|2|||
146271783|NCT00935532|527509866|FG001|Overall Study|Protocol Violation|1|||
146271784|NCT00935532|527509865|FG000|Overall Study|Subject Decision|2|||
146271785|NCT00935532|527509866|FG001|Overall Study|Subject Decision|1|||
146271786|NCT00935532|527509865|FG000|Overall Study|Sponsor Decision|0|||
146271787|NCT00935532|527509866|FG001|Overall Study|Sponsor Decision|1|||
146271788|NCT00935532|527509865|FG000|Overall Study|Loss Glucose Control|4|||
146271789|NCT00935532|527509866|FG001|Overall Study|Loss Glucose Control|0|||
146271790|NCT02227992|527509869|FG000|Overall Study|Lost to Follow-up|1|||
146271791|NCT02227992|527509870|FG001|Overall Study|Lost to Follow-up|1|||
146271792|NCT01371708|527509875|FG000|Overall Study|Insufficient clinical response|3|||
146271793|NCT01371708|527509876|FG001|Overall Study|Insufficient clinical response|2|||
146271794|NCT01371708|527509877|FG002|Overall Study|Insufficient clinical response|0|||
146271795|NCT01371708|527509875|FG000|Overall Study|Lost to Follow-up|5|||
146271796|NCT01371708|527509876|FG001|Overall Study|Lost to Follow-up|9|||
146271797|NCT01371708|527509877|FG002|Overall Study|Lost to Follow-up|7|||
146271798|NCT01371708|527509875|FG000|Overall Study|Protocol Violation|2|||
146271799|NCT01371708|527509876|FG001|Overall Study|Protocol Violation|1|||
146271800|NCT01371708|527509877|FG002|Overall Study|Protocol Violation|2|||
146271801|NCT01371708|527509875|FG000|Overall Study|No longer willing to participate|7|||
146271802|NCT01371708|527509876|FG001|Overall Study|No longer willing to participate|7|||
146271803|NCT01371708|527509877|FG002|Overall Study|No longer willing to participate|13|||
146271804|NCT01371708|527509875|FG000|Overall Study|Medication error/not related to AE|0|||
146304286|NCT02285920|527629160|FG000|Overall Study|Change to peritoneal dialysis|0|||
146304287|NCT02285920|527629161|FG001|Overall Study|Change to peritoneal dialysis|0|||
146304288|NCT02285920|527629162|FG002|Overall Study|Change to peritoneal dialysis|1|||
146304289|NCT02285920|527629163|FG003|Overall Study|Change to peritoneal dialysis|0|||
146271805|NCT01371708|527509876|FG001|Overall Study|Medication error/not related to AE|1|||
146304290|NCT02285920|527629160|FG000|Overall Study|Transfer to non-participating unit|0|||
146271806|NCT01371708|527509877|FG002|Overall Study|Medication error/not related to AE|0|||
146271807|NCT01371708|527509875|FG000|Overall Study|Other|3|||
146271808|NCT01371708|527509876|FG001|Overall Study|Other|2|||
146271809|NCT01371708|527509877|FG002|Overall Study|Other|4|||
146271810|NCT01371708|527509875|FG000|Overall Study|Adverse Event|5|||
146271811|NCT01371708|527509876|FG001|Overall Study|Adverse Event|8|||
146271812|NCT01371708|527509877|FG002|Overall Study|Adverse Event|12|||
146304291|NCT02285920|527629161|FG001|Overall Study|Transfer to non-participating unit|1|||
146271813|NCT01371708|527509875|FG000|Overall Study|Started but did not receive treatment|1|||
146304292|NCT02285920|527629162|FG002|Overall Study|Transfer to non-participating unit|0|||
146304293|NCT02285920|527629163|FG003|Overall Study|Transfer to non-participating unit|0|||
146304294|NCT02285920|527629160|FG000|Overall Study|Dialysis discontinuation|0|||
146304295|NCT02285920|527629161|FG001|Overall Study|Dialysis discontinuation|1|||
146142802|NCT03878134|527036088|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
146142803|NCT00853658|527036089|FG000|Overall Study|Death|713|||
146142804|NCT00853658|527036090|FG001|Overall Study|Death|768|||
146142805|NCT00853658|527036091|FG002|Overall Study|Death|753|||
146142806|NCT00853658|527036089|FG000|Overall Study|Lost to Follow-up|11|||
146142807|NCT00853658|527036090|FG001|Overall Study|Lost to Follow-up|6|||
146142808|NCT00853658|527036091|FG002|Overall Study|Lost to Follow-up|11|||
146142809|NCT00853658|527036089|FG000|Overall Study|H.A. Request|26|||
146142810|NCT00853658|527036090|FG001|Overall Study|H.A. Request|23|||
146142811|NCT00853658|527036091|FG002|Overall Study|H.A. Request|19|||
146142812|NCT00853658|527036089|FG000|Overall Study|IRB request|0|||
146142813|NCT00853658|527036090|FG001|Overall Study|IRB request|0|||
146142814|NCT00853658|527036091|FG002|Overall Study|IRB request|2|||
146142815|NCT00853658|527036089|FG000|Overall Study|Vital Status known (alive) at study end|2|||
146142816|NCT00853658|527036090|FG001|Overall Study|Vital Status known (alive) at study end|3|||
146142817|NCT00853658|527036091|FG002|Overall Study|Vital Status known (alive) at study end|3|||
146142818|NCT00853658|527036089|FG000|Overall Study|Vital Status unknown at study end|1|||
146142819|NCT00853658|527036090|FG001|Overall Study|Vital Status unknown at study end|1|||
146142820|NCT00853658|527036091|FG002|Overall Study|Vital Status unknown at study end|0|||
146142821|NCT00853658|527036089|FG000|Overall Study|Vital Status at study end N/A|8|||
146142822|NCT00853658|527036090|FG001|Overall Study|Vital Status at study end N/A|10|||
146142823|NCT00853658|527036091|FG002|Overall Study|Vital Status at study end N/A|10|||
146142824|NCT00853658|527036089|FG000|Overall Study|Patient's request|21|||
146142825|NCT00853658|527036090|FG001|Overall Study|Patient's request|17|||
146142826|NCT00853658|527036091|FG002|Overall Study|Patient's request|11|||
146142827|NCT00853658|527036089|FG000|Overall Study|Missing study completion information|5|||
146142828|NCT00853658|527036090|FG001|Overall Study|Missing study completion information|4|||
146142829|NCT00853658|527036091|FG002|Overall Study|Missing study completion information|6|||
146142830|NCT00586469|527036092|FG000|Overall Study|Adverse Event|0|||
146142831|NCT00586469|527036093|FG001|Overall Study|Adverse Event|1|||
146142832|NCT01227512|527036095|FG000|Overall Study|Physician Decision|6|||
146142833|NCT01227512|527036096|FG001|Overall Study|Physician Decision|6|||
146142834|NCT01227512|527036095|FG000|Overall Study|Adverse Event|4|||
146142835|NCT01227512|527036096|FG001|Overall Study|Adverse Event|3|||
146142836|NCT01227512|527036095|FG000|Overall Study|Withdrawal by Subject|3|||
146142837|NCT01227512|527036096|FG001|Overall Study|Withdrawal by Subject|0|||
146142838|NCT01227512|527036095|FG000|Overall Study|Participant met withdrawal criteria|0|||
146142839|NCT01227512|527036096|FG001|Overall Study|Participant met withdrawal criteria|1|||
146142840|NCT04055116|527036103|FG000|First Intervention|Physician Decision|2|||
146142841|NCT04055116|527036104|FG001|First Intervention|Physician Decision|7|||
146142842|NCT02774681|527036105|FG000|Treatment on Study|Progressive Disease|7|||
146142843|NCT02774681|527036105|FG000|Follow-Up for 3 Years|Death|11|||
146142844|NCT02774681|527036105|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
146142845|NCT00512096|527036110|FG000|Overall Study|Adverse Event|2|||
146142846|NCT00512096|527036110|FG000|Overall Study|Withdrawal by Subject|2|||
146142847|NCT00512096|527036110|FG000|Overall Study|Lack of Efficacy|3|||
146142848|NCT01069289|527036114|FG000|Overall Study|Withdrawal by Subject|15|||
146142849|NCT01069289|527036115|FG001|Overall Study|Withdrawal by Subject|26|||
146142850|NCT01069289|527036114|FG000|Overall Study|Adverse Event|21|||
146142851|NCT01069289|527036115|FG001|Overall Study|Adverse Event|28|||
146142852|NCT01069289|527036114|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146142853|NCT01069289|527036115|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146142854|NCT01069289|527036114|FG000|Overall Study|Severe non-compliance to protocol|3|||
146142855|NCT01069289|527036115|FG001|Overall Study|Severe non-compliance to protocol|2|||
146142856|NCT01069289|527036114|FG000|Overall Study|Due to deteriorating health condition|1|||
146142857|NCT01069289|527036115|FG001|Overall Study|Due to deteriorating health condition|0|||
146142858|NCT01310413|527037625|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
146142859|NCT01310413|527037626|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
146142860|NCT01310413|527037627|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
146142861|NCT01310413|527037628|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
146142862|NCT01310413|527037629|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
146142863|NCT01310413|527037630|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
146142864|NCT01310413|527037631|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
146142865|NCT01310413|527037625|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
146142866|NCT01310413|527037626|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
146142867|NCT01310413|527037627|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
146142868|NCT01310413|527037628|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
146142869|NCT01310413|527037629|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
146142870|NCT01310413|527037630|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
146142871|NCT01310413|527037631|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
146304296|NCT02285920|527629162|FG002|Overall Study|Dialysis discontinuation|0|||
146271814|NCT01371708|527509876|FG001|Overall Study|Started but did not receive treatment|0|||
146271815|NCT01371708|527509877|FG002|Overall Study|Started but did not receive treatment|1|||
146271816|NCT00402051|527509878|FG000|Overall Study|Progressive Disease|13|||
146271817|NCT00402051|527509879|FG001|Overall Study|Progressive Disease|20|||
146271818|NCT00402051|527509878|FG000|Overall Study|Adverse Event|11|||
146271819|NCT00402051|527509879|FG001|Overall Study|Adverse Event|4|||
146271820|NCT00402051|527509878|FG000|Overall Study|Physician Decision|7|||
146271821|NCT00402051|527509879|FG001|Overall Study|Physician Decision|3|||
146271822|NCT00402051|527509878|FG000|Overall Study|Withdrawal by Subject|3|||
146271823|NCT00402051|527509879|FG001|Overall Study|Withdrawal by Subject|3|||
146271824|NCT00402051|527509878|FG000|Overall Study|Death - Related to Study Drug|1|||
146271825|NCT00402051|527509879|FG001|Overall Study|Death - Related to Study Drug|2|||
146271826|NCT00402051|527509878|FG000|Overall Study|Death Due to Study Disease|2|||
146271827|NCT00402051|527509879|FG001|Overall Study|Death Due to Study Disease|1|||
146271828|NCT00402051|527509878|FG000|Overall Study|Death Due to Adverse Event|0|||
146271829|NCT00402051|527509879|FG001|Overall Study|Death Due to Adverse Event|2|||
146142872|NCT01310413|527037625|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
146142873|NCT01310413|527037626|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
146142874|NCT01310413|527037627|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
146142875|NCT01310413|527037628|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
146142876|NCT01310413|527037629|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
146142877|NCT01310413|527037630|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
146142878|NCT01310413|527037631|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
146142879|NCT01310413|527037625|FG000|Day 0 to Day 385|Other|1|||
146142880|NCT01310413|527037626|FG001|Day 0 to Day 385|Other|0|||
146142881|NCT01310413|527037627|FG002|Day 0 to Day 385|Other|3|||
146142882|NCT01310413|527037628|FG003|Day 0 to Day 385|Other|0|||
146142883|NCT01310413|527037629|FG004|Day 0 to Day 385|Other|0|||
146142884|NCT01310413|527037630|FG005|Day 0 to Day 385|Other|0|||
146142885|NCT01310413|527037631|FG006|Day 0 to Day 385|Other|0|||
146142886|NCT01310413|527037625|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142887|NCT01310413|527037626|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142888|NCT01310413|527037627|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142889|NCT01310413|527037628|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142890|NCT01310413|527037629|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142891|NCT01310413|527037630|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
146142892|NCT01310413|527037631|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
146142893|NCT01310413|527037625|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
146142894|NCT01310413|527037626|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
146142895|NCT01310413|527037627|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
146142896|NCT01310413|527037628|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
146142897|NCT01310413|527037629|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
146142898|NCT01310413|527037630|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
146142899|NCT01310413|527037631|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
146142900|NCT02564471|527037632|FG000|Overall Study|Adverse Event|1|||
146142901|NCT02564471|527037633|FG001|Overall Study|Adverse Event|0|||
146142902|NCT02564471|527037634|FG002|Overall Study|Adverse Event|0|||
146142903|NCT02564471|527037635|FG003|Overall Study|Adverse Event|0|||
146142904|NCT02564471|527037632|FG000|Overall Study|Withdrawal by Subject|2|||
146142905|NCT02564471|527037633|FG001|Overall Study|Withdrawal by Subject|1|||
146142906|NCT02564471|527037634|FG002|Overall Study|Withdrawal by Subject|3|||
146142907|NCT02564471|527037635|FG003|Overall Study|Withdrawal by Subject|0|||
146142908|NCT02564471|527037632|FG000|Overall Study|Lost to Follow-up|0|||
146142909|NCT02564471|527037633|FG001|Overall Study|Lost to Follow-up|2|||
146142910|NCT02564471|527037634|FG002|Overall Study|Lost to Follow-up|0|||
146142911|NCT02564471|527037635|FG003|Overall Study|Lost to Follow-up|0|||
146142912|NCT00941733|527037636|FG000|Overall Study|Death|24|||
146142913|NCT00941733|527037637|FG001|Overall Study|Death|10|||
146142914|NCT00941733|527037636|FG000|Overall Study|Withdrawal by Subject|14|||
146142915|NCT00941733|527037637|FG001|Overall Study|Withdrawal by Subject|6|||
146271830|NCT00402051|527509878|FG000|Overall Study|Lost to Follow-up|1|||
146142916|NCT00941733|527037636|FG000|Overall Study|Adverse Event|20|||
146271831|NCT00402051|527509879|FG001|Overall Study|Lost to Follow-up|0|||
146271832|NCT00281320|527509892|FG000|Overall Study|Adverse Event|12|||
146271833|NCT00281320|527509893|FG001|Overall Study|Adverse Event|9|||
146271834|NCT00281320|527509892|FG000|Overall Study|Lack of Efficacy|4|||
146142917|NCT00941733|527037637|FG001|Overall Study|Adverse Event|4|||
146142918|NCT00941733|527037636|FG000|Overall Study|Lost to Follow-up|1|||
146142919|NCT00941733|527037637|FG001|Overall Study|Lost to Follow-up|2|||
146142920|NCT00941733|527037636|FG000|Overall Study|Protocol Violation|15|||
146142921|NCT00941733|527037637|FG001|Overall Study|Protocol Violation|6|||
146142922|NCT03019536|527037640|FG000|Overall Study|Withdrawal by Subject|1|||
146142923|NCT03019536|527037641|FG001|Overall Study|Withdrawal by Subject|1|||
146142924|NCT03019536|527037642|FG002|Overall Study|Withdrawal by Subject|0|||
146142925|NCT03019536|527037640|FG000|Overall Study|Adverse Event|0|||
146142926|NCT03019536|527037641|FG001|Overall Study|Adverse Event|0|||
146271835|NCT00281320|527509893|FG001|Overall Study|Lack of Efficacy|3|||
146142927|NCT03019536|527037642|FG002|Overall Study|Adverse Event|2|||
146142928|NCT00182689|527037648|FG000|Overall Study|Adverse Event|8|||
146142929|NCT00182689|527037649|FG001|Overall Study|Adverse Event|11|||
146142930|NCT00182689|527037648|FG000|Overall Study|Withdrawal by Subject|2|||
146142931|NCT00182689|527037649|FG001|Overall Study|Withdrawal by Subject|2|||
146142932|NCT00182689|527037648|FG000|Overall Study|Progression|27|||
146142933|NCT00182689|527037649|FG001|Overall Study|Progression|29|||
146142934|NCT00182689|527037648|FG000|Overall Study|Death|1|||
146142935|NCT00182689|527037649|FG001|Overall Study|Death|0|||
146142936|NCT00182689|527037648|FG000|Overall Study|not protocol specified|0|||
146142937|NCT00182689|527037649|FG001|Overall Study|not protocol specified|3|||
146142938|NCT00182689|527037648|FG000|Overall Study|Ineligible|1|||
146142939|NCT00182689|527037649|FG001|Overall Study|Ineligible|4|||
146142940|NCT00182689|527037648|FG000|Overall Study|Never received treatment|1|||
146142941|NCT00182689|527037649|FG001|Overall Study|Never received treatment|0|||
146142942|NCT00659646|527037650|FG000|Overall Study|Protocol Violation|12|||
146142943|NCT00659646|527037651|FG001|Overall Study|Protocol Violation|8|||
146142944|NCT00659646|527037650|FG000|Overall Study|Adverse Event|1|||
146142945|NCT00659646|527037651|FG001|Overall Study|Adverse Event|0|||
146142946|NCT00659646|527037650|FG000|Overall Study|Lost to Follow-up|1|||
146142947|NCT00659646|527037651|FG001|Overall Study|Lost to Follow-up|0|||
146142948|NCT00659646|527037650|FG000|Overall Study|protocol noncompliance after randomized|1|||
146142949|NCT00659646|527037651|FG001|Overall Study|protocol noncompliance after randomized|0|||
146142950|NCT01640301|527037652|FG000|Overall Study|Death|0|||
146142951|NCT01640301|527037653|FG001|Overall Study|Death|8|||
146142952|NCT02391948|527037654|FG000|6-month Assessment|Death|0|||
146142953|NCT02391948|527037655|FG001|6-month Assessment|Death|0|||
146142954|NCT02391948|527037656|FG002|6-month Assessment|Death|0|||
146142955|NCT02391948|527037657|FG003|6-month Assessment|Death|0|||
146142956|NCT02391948|527037658|FG004|6-month Assessment|Death|1|||
146142957|NCT02391948|527037654|FG000|6-month Assessment|Withdrawal by Subject|0|||
146142958|NCT02391948|527037655|FG001|6-month Assessment|Withdrawal by Subject|0|||
146142959|NCT02391948|527037656|FG002|6-month Assessment|Withdrawal by Subject|1|||
146142960|NCT02391948|527037657|FG003|6-month Assessment|Withdrawal by Subject|2|||
146142961|NCT02391948|527037658|FG004|6-month Assessment|Withdrawal by Subject|0|||
146142962|NCT02391948|527037654|FG000|6-month Assessment|Lost to Follow-up|4|||
146142963|NCT02391948|527037655|FG001|6-month Assessment|Lost to Follow-up|5|||
146142964|NCT02391948|527037656|FG002|6-month Assessment|Lost to Follow-up|2|||
146142965|NCT02391948|527037657|FG003|6-month Assessment|Lost to Follow-up|3|||
146142966|NCT02391948|527037658|FG004|6-month Assessment|Lost to Follow-up|1|||
146142967|NCT02391948|527037654|FG000|6-month Assessment|Medical issue/illness|1|||
146142968|NCT02391948|527037655|FG001|6-month Assessment|Medical issue/illness|1|||
146142969|NCT02391948|527037656|FG002|6-month Assessment|Medical issue/illness|0|||
146142970|NCT02391948|527037657|FG003|6-month Assessment|Medical issue/illness|0|||
146142971|NCT02391948|527037658|FG004|6-month Assessment|Medical issue/illness|0|||
146142972|NCT02391948|527037654|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
146142973|NCT02391948|527037655|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
146142974|NCT02391948|527037656|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
146142975|NCT02391948|527037657|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
146142976|NCT02391948|527037658|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
146142977|NCT02391948|527037654|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
146142978|NCT02391948|527037655|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
146142979|NCT02391948|527037656|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
146142980|NCT02391948|527037657|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
146142981|NCT02391948|527037658|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
146142982|NCT02391948|527037654|FG000|12-month Assessment|Death|0|||
146142983|NCT02391948|527037655|FG001|12-month Assessment|Death|0|||
146142984|NCT02391948|527037656|FG002|12-month Assessment|Death|0|||
146142985|NCT02391948|527037657|FG003|12-month Assessment|Death|1|||
146142986|NCT02391948|527037658|FG004|12-month Assessment|Death|0|||
146142987|NCT02391948|527037654|FG000|12-month Assessment|Withdrawal by Subject|1|||
146142988|NCT02391948|527037655|FG001|12-month Assessment|Withdrawal by Subject|0|||
146142989|NCT02391948|527037656|FG002|12-month Assessment|Withdrawal by Subject|0|||
146142990|NCT02391948|527037657|FG003|12-month Assessment|Withdrawal by Subject|1|||
146142991|NCT02391948|527037658|FG004|12-month Assessment|Withdrawal by Subject|0|||
146142992|NCT02391948|527037654|FG000|12-month Assessment|Lost to Follow-up|5|||
146142993|NCT02391948|527037655|FG001|12-month Assessment|Lost to Follow-up|4|||
146142994|NCT02391948|527037656|FG002|12-month Assessment|Lost to Follow-up|4|||
146142995|NCT02391948|527037657|FG003|12-month Assessment|Lost to Follow-up|4|||
146142996|NCT02391948|527037658|FG004|12-month Assessment|Lost to Follow-up|5|||
146142997|NCT02391948|527037654|FG000|12-month Assessment|Medical issue/illness|0|||
146142998|NCT02391948|527037655|FG001|12-month Assessment|Medical issue/illness|1|||
146142999|NCT02391948|527037656|FG002|12-month Assessment|Medical issue/illness|0|||
146143000|NCT02391948|527037657|FG003|12-month Assessment|Medical issue/illness|1|||
146143001|NCT02391948|527037658|FG004|12-month Assessment|Medical issue/illness|0|||
146143002|NCT02391948|527037654|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
146271836|NCT00281320|527509892|FG000|Overall Study|Withdrawal by Subject|5|||
146271837|NCT00281320|527509893|FG001|Overall Study|Withdrawal by Subject|6|||
146271838|NCT00281320|527509892|FG000|Overall Study|Lost to Follow-up|1|||
146271839|NCT00281320|527509893|FG001|Overall Study|Lost to Follow-up|2|||
146271840|NCT00281320|527509892|FG000|Overall Study|Other|3|||
146271841|NCT00281320|527509893|FG001|Overall Study|Other|1|||
146271842|NCT00975676|527509897|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
146271843|NCT00975676|527509898|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
146271844|NCT02548078|527509899|FG000|Overall Study|Serious adverse event/Adverse event|1|||
146271845|NCT02548078|527509900|FG001|Overall Study|Serious adverse event/Adverse event|0|||
146271846|NCT02548078|527509899|FG000|Overall Study|Moved from study area|3|||
146271847|NCT02548078|527509900|FG001|Overall Study|Moved from study area|3|||
146271848|NCT02548078|527509899|FG000|Overall Study|Lost to Follow-up|1|||
146271849|NCT02548078|527509900|FG001|Overall Study|Lost to Follow-up|3|||
146271850|NCT03128671|527509901|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
146271851|NCT03128671|527509902|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
146271852|NCT03128671|527509901|FG000|Allocation|Death|1|||
146271853|NCT03128671|527509902|FG001|Allocation|Death|0|||
146271854|NCT03128671|527509901|FG000|Allocation|Withdrawal by Subject|4|||
146271855|NCT03128671|527509902|FG001|Allocation|Withdrawal by Subject|0|||
146271856|NCT03128671|527509901|FG000|Intervention|Withdrawal by Subject|11|||
146271857|NCT03128671|527509902|FG001|Intervention|Withdrawal by Subject|10|||
146271858|NCT03128671|527509901|FG000|Intervention|Palliative/hospice care initiated|9|||
146271859|NCT03128671|527509902|FG001|Intervention|Palliative/hospice care initiated|10|||
146271860|NCT03128671|527509901|FG000|Intervention|Death|13|||
146271861|NCT03128671|527509902|FG001|Intervention|Death|11|||
146271862|NCT03128671|527509901|FG000|Intervention|Interrupted by hurricane|1|||
146271863|NCT03128671|527509902|FG001|Intervention|Interrupted by hurricane|0|||
146271864|NCT03128671|527509901|FG000|Intervention|Physician Decision|2|||
146271865|NCT03128671|527509902|FG001|Intervention|Physician Decision|3|||
146271866|NCT04641962|527509904|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
146271867|NCT04641962|527509905|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
146271868|NCT04641962|527509906|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
146271869|NCT04641962|527509907|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
146271870|NCT04641962|527509908|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
146271871|NCT04641962|527509904|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146271872|NCT04641962|527509905|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146271873|NCT04641962|527509906|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146271874|NCT04641962|527509907|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
146271875|NCT04641962|527509908|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
146271876|NCT04641962|527509904|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
146271877|NCT04641962|527509905|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146271878|NCT04641962|527509906|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146271879|NCT04641962|527509907|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
146271880|NCT04641962|527509908|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
146271881|NCT04641962|527509904|FG000|DBT Period: Up to 52 Weeks|Death|1|||
146271882|NCT04641962|527509905|FG001|DBT Period: Up to 52 Weeks|Death|0|||
146271883|NCT04641962|527509906|FG002|DBT Period: Up to 52 Weeks|Death|0|||
146271884|NCT04641962|527509907|FG003|DBT Period: Up to 52 Weeks|Death|0|||
146271885|NCT04641962|527509908|FG004|DBT Period: Up to 52 Weeks|Death|0|||
146271886|NCT04641962|527509904|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146271887|NCT04641962|527509905|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
146271888|NCT04641962|527509906|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146271889|NCT04641962|527509907|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
146271890|NCT04641962|527509908|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
146271891|NCT04641962|527509904|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146271892|NCT04641962|527509905|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146271893|NCT04641962|527509906|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
146271894|NCT04641962|527509907|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
146271895|NCT04641962|527509908|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
146271896|NCT04641962|527509904|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146271897|NCT04641962|527509905|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146271898|NCT04641962|527509906|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
146271899|NCT04641962|527509907|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146271900|NCT04641962|527509908|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
146271901|NCT03832595|527509913|FG000|Overall Study|Death|142|||
146271902|NCT03832595|527509914|FG001|Overall Study|Death|130|||
146271903|NCT03832595|527509913|FG000|Overall Study|Medical management without dialysis|37|||
146271904|NCT03832595|527509914|FG001|Overall Study|Medical management without dialysis|1|||
146271905|NCT03277352|527509915|FG000|Overall Study|Study Terminated By Sponsor|2|||
146271906|NCT03277352|527509915|FG000|Overall Study|Withdrawal by Subject|4|||
146271907|NCT03277352|527509915|FG000|Overall Study|Death|4|||
146271908|NCT04147195|527509916|FG000|Overall Study|Adverse Event|0|||
146271909|NCT04147195|527509917|FG001|Overall Study|Adverse Event|3|||
146271910|NCT04147195|527509916|FG000|Overall Study|Study Terminated by Sponsor|4|||
146271911|NCT04147195|527509917|FG001|Overall Study|Study Terminated by Sponsor|2|||
146271912|NCT04147195|527509916|FG000|Overall Study|Withdrawal by Subject|0|||
146271913|NCT04147195|527509917|FG001|Overall Study|Withdrawal by Subject|1|||
146271914|NCT03939689|527512362|FG000|Overall Study|Radiographic progression|14|||
146271915|NCT03939689|527512363|FG001|Overall Study|Radiographic progression|17|||
146271916|NCT03939689|527512362|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
146271917|NCT03939689|527512363|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
146271918|NCT03939689|527512362|FG000|Overall Study|Adverse Event|1|||
146271919|NCT03939689|527512363|FG001|Overall Study|Adverse Event|8|||
146271920|NCT03939689|527512362|FG000|Overall Study|Unequivocal clinical progression|2|||
146271921|NCT03939689|527512363|FG001|Overall Study|Unequivocal clinical progression|5|||
146271922|NCT03939689|527512362|FG000|Overall Study|Other|1|||
146271923|NCT03939689|527512363|FG001|Overall Study|Other|4|||
146271924|NCT03939689|527512362|FG000|Overall Study|Death|0|||
146271925|NCT03939689|527512363|FG001|Overall Study|Death|3|||
146271926|NCT03939689|527512362|FG000|Overall Study|Participant decision|0|||
146271927|NCT03939689|527512363|FG001|Overall Study|Participant decision|3|||
146271928|NCT03939689|527512362|FG000|Overall Study|Withdrawal of consent|2|||
146271929|NCT03939689|527512363|FG001|Overall Study|Withdrawal of consent|1|||
146143003|NCT02391948|527037655|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
146143004|NCT02391948|527037656|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
146143005|NCT02391948|527037657|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
146143006|NCT02391948|527037658|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
146143007|NCT02391948|527037654|FG000|18-month Assessment|Death|0|||
146143008|NCT02391948|527037655|FG001|18-month Assessment|Death|0|||
146143009|NCT02391948|527037656|FG002|18-month Assessment|Death|0|||
146143010|NCT02391948|527037657|FG003|18-month Assessment|Death|1|||
146143011|NCT02391948|527037658|FG004|18-month Assessment|Death|1|||
146143012|NCT02391948|527037654|FG000|18-month Assessment|Withdrawal by Subject|1|||
146143013|NCT02391948|527037655|FG001|18-month Assessment|Withdrawal by Subject|0|||
146143014|NCT02391948|527037656|FG002|18-month Assessment|Withdrawal by Subject|0|||
146143015|NCT02391948|527037657|FG003|18-month Assessment|Withdrawal by Subject|1|||
146143016|NCT02391948|527037658|FG004|18-month Assessment|Withdrawal by Subject|0|||
146143017|NCT02391948|527037654|FG000|18-month Assessment|Lost to Follow-up|2|||
146143018|NCT02391948|527037655|FG001|18-month Assessment|Lost to Follow-up|6|||
146143019|NCT02391948|527037656|FG002|18-month Assessment|Lost to Follow-up|2|||
146143020|NCT02391948|527037657|FG003|18-month Assessment|Lost to Follow-up|2|||
146143021|NCT02391948|527037658|FG004|18-month Assessment|Lost to Follow-up|3|||
146143022|NCT02391948|527037654|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
146143023|NCT02391948|527037655|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
146143024|NCT02391948|527037656|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
146143025|NCT02391948|527037657|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
146143026|NCT02391948|527037658|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
146143027|NCT02391948|527037654|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
146143028|NCT02391948|527037655|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
146143029|NCT02391948|527037656|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
146143030|NCT02391948|527037657|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
146143031|NCT02391948|527037658|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
146143032|NCT02391948|527037654|FG000|24-month Assessment|Death|0|||
146143033|NCT02391948|527037655|FG001|24-month Assessment|Death|0|||
146271930|NCT03939689|527512362|FG000|Overall Study|Investigator decision|1|||
146271931|NCT03939689|527512363|FG001|Overall Study|Investigator decision|0|||
146271932|NCT04427280|527512364|FG000|Overall Study|Withdrawal by Subject|0|||
146271933|NCT04427280|527512365|FG001|Overall Study|Withdrawal by Subject|2|||
146271934|NCT01667926|527512376|FG000|Overall Study|Withdrawal by Subject|1|||
146271935|NCT01667926|527512377|FG001|Overall Study|Withdrawal by Subject|2|||
146271936|NCT01667926|527512378|FG002|Overall Study|Withdrawal by Subject|2|||
146271937|NCT01667926|527512376|FG000|Overall Study|Physician Decision|0|||
146271938|NCT01667926|527512377|FG001|Overall Study|Physician Decision|0|||
146271939|NCT01667926|527512378|FG002|Overall Study|Physician Decision|1|||
146271940|NCT01667926|527512376|FG000|Overall Study|Time committment|0|||
146271941|NCT01667926|527512377|FG001|Overall Study|Time committment|0|||
146271942|NCT01667926|527512378|FG002|Overall Study|Time committment|2|||
146271943|NCT01667926|527512376|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
146271944|NCT01667926|527512377|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146271945|NCT01667926|527512378|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
146271946|NCT01667926|527512376|FG000|Overall Study|Lost to Follow-up|1|||
146143034|NCT02391948|527037656|FG002|24-month Assessment|Death|0|||
146271947|NCT01667926|527512377|FG001|Overall Study|Lost to Follow-up|2|||
146271948|NCT01667926|527512378|FG002|Overall Study|Lost to Follow-up|1|||
146271949|NCT01667926|527512376|FG000|Overall Study|Side effects|3|||
146271950|NCT01667926|527512377|FG001|Overall Study|Side effects|0|||
146271951|NCT01667926|527512378|FG002|Overall Study|Side effects|0|||
146143035|NCT02391948|527037657|FG003|24-month Assessment|Death|0|||
146143036|NCT02391948|527037658|FG004|24-month Assessment|Death|1|||
146143037|NCT02391948|527037654|FG000|24-month Assessment|Withdrawal by Subject|1|||
146143038|NCT02391948|527037655|FG001|24-month Assessment|Withdrawal by Subject|1|||
146143039|NCT02391948|527037656|FG002|24-month Assessment|Withdrawal by Subject|0|||
146143040|NCT02391948|527037657|FG003|24-month Assessment|Withdrawal by Subject|0|||
146143041|NCT02391948|527037658|FG004|24-month Assessment|Withdrawal by Subject|1|||
146143042|NCT02391948|527037654|FG000|24-month Assessment|Lost to Follow-up|5|||
146143043|NCT02391948|527037655|FG001|24-month Assessment|Lost to Follow-up|4|||
146143044|NCT02391948|527037656|FG002|24-month Assessment|Lost to Follow-up|0|||
146143045|NCT02391948|527037657|FG003|24-month Assessment|Lost to Follow-up|0|||
146143046|NCT02391948|527037658|FG004|24-month Assessment|Lost to Follow-up|0|||
146143047|NCT02391948|527037654|FG000|24-month Assessment|Medical issue/illness|0|||
146143048|NCT02391948|527037655|FG001|24-month Assessment|Medical issue/illness|0|||
146143049|NCT02391948|527037656|FG002|24-month Assessment|Medical issue/illness|1|||
146143050|NCT02391948|527037657|FG003|24-month Assessment|Medical issue/illness|0|||
146143051|NCT02391948|527037658|FG004|24-month Assessment|Medical issue/illness|0|||
146143052|NCT02391948|527037654|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
146143053|NCT02391948|527037655|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
146143054|NCT02391948|527037656|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
146143055|NCT02391948|527037657|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
146143056|NCT02391948|527037658|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
146143057|NCT02348489|527037661|FG000|Overall Study|Death|336|||
146143058|NCT02348489|527037662|FG001|Overall Study|Death|335|||
146143059|NCT02348489|527037661|FG000|Overall Study|Withdrawal by Subject|14|||
146143060|NCT02348489|527037662|FG001|Overall Study|Withdrawal by Subject|27|||
146143061|NCT02348489|527037661|FG000|Overall Study|Lost to Follow-up|3|||
146143062|NCT02348489|527037662|FG001|Overall Study|Lost to Follow-up|5|||
146143063|NCT02866682|527037663|FG000|Overall Study|Death|0|||
146143064|NCT02866682|527037664|FG001|Overall Study|Death|1|||
146143065|NCT02866682|527037663|FG000|Overall Study|Lost to Follow-up|0|||
146143066|NCT02866682|527037664|FG001|Overall Study|Lost to Follow-up|4|||
146143067|NCT02866682|527037663|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
146143068|NCT02866682|527037664|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
146143069|NCT02866682|527037663|FG000|Overall Study|Other|0|||
146143070|NCT02866682|527037664|FG001|Overall Study|Other|1|||
146143071|NCT00201006|527037665|FG000|Overall Study|Withdrawal by Subject|7|||
146143072|NCT00201006|527037666|FG001|Overall Study|Withdrawal by Subject|2|||
146143073|NCT00201006|527037667|FG002|Overall Study|Withdrawal by Subject|3|||
146143074|NCT00201006|527037665|FG000|Overall Study|Adverse Event|1|||
146143075|NCT00201006|527037666|FG001|Overall Study|Adverse Event|0|||
146143076|NCT00201006|527037667|FG002|Overall Study|Adverse Event|1|||
146143077|NCT00938431|527037671|FG000|Overall Study|Adverse Event|5|||
146143078|NCT00938431|527037672|FG001|Overall Study|Adverse Event|8|||
146143079|NCT00938431|527037673|FG002|Overall Study|Adverse Event|6|||
146143080|NCT00938431|527037671|FG000|Overall Study|Lack of Efficacy|0|||
146143081|NCT00938431|527037672|FG001|Overall Study|Lack of Efficacy|1|||
146143082|NCT00938431|527037673|FG002|Overall Study|Lack of Efficacy|0|||
146143083|NCT00938431|527037671|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
146143084|NCT00938431|527037672|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
146143085|NCT00938431|527037673|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
146143086|NCT00938431|527037671|FG000|Overall Study|Dosing compliance issue|0|||
146143087|NCT00938431|527037672|FG001|Overall Study|Dosing compliance issue|0|||
146143088|NCT00938431|527037673|FG002|Overall Study|Dosing compliance issue|1|||
146143089|NCT00938431|527037671|FG000|Overall Study|Reached maximum dose early|0|||
146143090|NCT00938431|527037672|FG001|Overall Study|Reached maximum dose early|0|||
146143091|NCT00938431|527037673|FG002|Overall Study|Reached maximum dose early|1|||
146143092|NCT02086591|527037674|FG000|Overall Study|Adverse Event|1|||
146143093|NCT02086591|527037674|FG000|Overall Study|Withdrawal by Subject|1|||
146143094|NCT02086591|527037674|FG000|Overall Study|protocol terminated|3|||
146143095|NCT03738865|527037677|FG000|Overall Study|Withdrawal by Subject|3|||
146143096|NCT03738865|527037678|FG001|Overall Study|Withdrawal by Subject|3|||
146143097|NCT03738865|527037677|FG000|Overall Study|Adverse Event|2|||
146143098|NCT03738865|527037678|FG001|Overall Study|Adverse Event|0|||
146143099|NCT03738865|527037677|FG000|Overall Study|Physician Decision|0|||
146143100|NCT03738865|527037678|FG001|Overall Study|Physician Decision|1|||
146143101|NCT00723801|527037680|FG000|Overall Study|Lost to Follow-up|1|||
146143102|NCT00723801|527037681|FG001|Overall Study|Lost to Follow-up|2|||
146143103|NCT00723801|527037680|FG000|Overall Study|Protocol Violation|2|||
146143104|NCT00723801|527037681|FG001|Overall Study|Protocol Violation|1|||
146143105|NCT01565993|527037682|FG000|Overall Study|Physician Decision|0|||
146143106|NCT01565993|527037683|FG001|Overall Study|Physician Decision|3|||
146143107|NCT01824303|527037684|FG000|Randomized Study|Withdrawal by Subject|1|||
146271952|NCT02271984|527512381|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146143108|NCT01824303|527037685|FG001|Randomized Study|Withdrawal by Subject|1|||
146143109|NCT01824303|527037684|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
146143110|NCT01824303|527037685|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
146143111|NCT04086472|527037686|FG000|Overall Study|Lost to Follow-up|1|||
146143112|NCT04086472|527037687|FG001|Overall Study|Lost to Follow-up|0|||
146143113|NCT04086472|527037688|FG002|Overall Study|Lost to Follow-up|0|||
146143114|NCT04086472|527037689|FG003|Overall Study|Lost to Follow-up|0|||
146143115|NCT04086472|527037690|FG004|Overall Study|Lost to Follow-up|1|||
146143116|NCT04086472|527037686|FG000|Overall Study|Physician Decision|0|||
146143117|NCT04086472|527037687|FG001|Overall Study|Physician Decision|1|||
146143118|NCT04086472|527037688|FG002|Overall Study|Physician Decision|1|||
146143119|NCT04086472|527037689|FG003|Overall Study|Physician Decision|0|||
146143120|NCT04086472|527037690|FG004|Overall Study|Physician Decision|0|||
146143121|NCT04086472|527037686|FG000|Overall Study|Withdrawal by Subject|1|||
146143122|NCT04086472|527037687|FG001|Overall Study|Withdrawal by Subject|1|||
146143123|NCT04086472|527037688|FG002|Overall Study|Withdrawal by Subject|1|||
146143124|NCT04086472|527037689|FG003|Overall Study|Withdrawal by Subject|0|||
146143125|NCT04086472|527037690|FG004|Overall Study|Withdrawal by Subject|0|||
146143126|NCT04086472|527037686|FG000|Overall Study|Various reasons|2|||
146143127|NCT04086472|527037687|FG001|Overall Study|Various reasons|0|||
146143128|NCT04086472|527037688|FG002|Overall Study|Various reasons|0|||
146143129|NCT04086472|527037689|FG003|Overall Study|Various reasons|3|||
146143130|NCT04086472|527037690|FG004|Overall Study|Various reasons|1|||
146143131|NCT02252081|527037696|FG000|Overall Study|Withdrawal by Subject|2|||
146143132|NCT02252081|527037697|FG001|Overall Study|Withdrawal by Subject|1|||
146143133|NCT02252081|527037696|FG000|Overall Study|Adverse Event|4|||
146143134|NCT02252081|527037697|FG001|Overall Study|Adverse Event|1|||
146143135|NCT02252081|527037696|FG000|Overall Study|non compliance & others|0|||
146143136|NCT02252081|527037697|FG001|Overall Study|non compliance & others|2|||
146143137|NCT00048724|527037698|FG000|Overall Study|Adverse Event|53|||
146143138|NCT00048724|527037699|FG001|Overall Study|Adverse Event|12|||
146143139|NCT00048724|527037698|FG000|Overall Study|Withdrawal by Subject|34|||
146143140|NCT00048724|527037699|FG001|Overall Study|Withdrawal by Subject|54|||
146143141|NCT00048724|527037698|FG000|Overall Study|Lost to Follow-up|5|||
146143142|NCT00048724|527037699|FG001|Overall Study|Lost to Follow-up|5|||
146143143|NCT00048724|527037698|FG000|Overall Study|Protocol-defined Clinical Event|17|||
146143144|NCT00048724|527037699|FG001|Overall Study|Protocol-defined Clinical Event|32|||
146143145|NCT00048724|527037698|FG000|Overall Study|Noncompliance With Protocol|4|||
146143146|NCT00048724|527037699|FG001|Overall Study|Noncompliance With Protocol|12|||
146143147|NCT00048724|527037698|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
146143148|NCT00048724|527037699|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
146143149|NCT00048724|527037698|FG000|Overall Study|Administrative|1|||
146143150|NCT00048724|527037699|FG001|Overall Study|Administrative|1|||
146143151|NCT04116229|527037700|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
146143152|NCT04116229|527037701|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
146143153|NCT04116229|527037700|FG000|Overall Study|Scheduling not possible.|0|||
146143154|NCT04116229|527037701|FG001|Overall Study|Scheduling not possible.|1|||
146143155|NCT04574362|527037704|FG000|Overall Study|Other|0|||
146143156|NCT04574362|527037705|FG001|Overall Study|Other|5|||
146143157|NCT04574362|527037704|FG000|Overall Study|COVID-19|0|||
146143158|NCT04574362|527037705|FG001|Overall Study|COVID-19|1|||
146143159|NCT04574362|527037704|FG000|Overall Study|Adverse Event|1|||
146143160|NCT04574362|527037705|FG001|Overall Study|Adverse Event|1|||
146143161|NCT04574362|527037704|FG000|Overall Study|Withdrawal by Subject|2|||
146143162|NCT04574362|527037705|FG001|Overall Study|Withdrawal by Subject|4|||
146143163|NCT04574362|527037704|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
146143164|NCT04574362|527037705|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
146143165|NCT04574362|527037704|FG000|Overall Study|Participant refused to come to the hospital|1|||
146143166|NCT04574362|527037705|FG001|Overall Study|Participant refused to come to the hospital|0|||
146143167|NCT04574362|527037704|FG000|Overall Study|Participant refused the visit|1|||
146143168|NCT04574362|527037705|FG001|Overall Study|Participant refused the visit|0|||
146143169|NCT04574362|527037704|FG000|Overall Study|Participant quit early because of business trip|1|||
146143170|NCT04574362|527037705|FG001|Overall Study|Participant quit early because of business trip|0|||
146143171|NCT01600040|527037707|FG000|Overall Study|Withdrawal by Subject|1|||
146271953|NCT02271984|527512382|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146143172|NCT00047463|527037708|FG000|Overall Study|Withdrawal by Subject|0|||
146143173|NCT00047463|527037709|FG001|Overall Study|Withdrawal by Subject|3|||
146271954|NCT02271984|527512383|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146143174|NCT00113516|527037710|FG000|Part 1|Adverse Event|6|||
146143175|NCT00113516|527037711|FG001|Part 1|Adverse Event|0|||
146143176|NCT00113516|527037710|FG000|Part 1|Death|3|||
146143177|NCT00113516|527037711|FG001|Part 1|Death|0|||
146143178|NCT00113516|527037710|FG000|Part 1|Other|3|||
146143179|NCT00113516|527037711|FG001|Part 1|Other|0|||
146271955|NCT02271984|527512384|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146143180|NCT00113516|527037710|FG000|Part 1|Withdrawal by Subject|2|||
146143181|NCT00113516|527037711|FG001|Part 1|Withdrawal by Subject|0|||
146143182|NCT00113516|527037710|FG000|Part 1|Lack of Efficacy|2|||
146271956|NCT02271984|527512385|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271957|NCT02271984|527512386|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
146271958|NCT02271984|527512387|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271959|NCT02271984|527512388|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
146271960|NCT02271984|527512389|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271961|NCT02271984|527512390|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271962|NCT02271984|527512391|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271963|NCT02271984|527512392|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
146271964|NCT01088984|527512393|FG000|Phase 1|Death|2|||
146271965|NCT01088984|527512394|FG001|Phase 1|Death|1|||
146271966|NCT01088984|527512393|FG000|Phase 1|Disease Progression|2|||
146271967|NCT01088984|527512394|FG001|Phase 1|Disease Progression|4|||
146271968|NCT01088984|527512393|FG000|Phase 1|Other|1|||
146271969|NCT01088984|527512394|FG001|Phase 1|Other|1|||
146271970|NCT01088984|527512393|FG000|Phase 2|Death|0|||
146271971|NCT01088984|527512394|FG001|Phase 2|Death|5|||
146271972|NCT01088984|527512393|FG000|Phase 2|Withdrawal by Subject|0|||
146271973|NCT01088984|527512394|FG001|Phase 2|Withdrawal by Subject|1|||
146271974|NCT01088984|527512393|FG000|Phase 2|DIsease Progression|0|||
146271975|NCT01088984|527512394|FG001|Phase 2|DIsease Progression|25|||
146271976|NCT01088984|527512393|FG000|Phase 2|Other|0|||
146271977|NCT01088984|527512394|FG001|Phase 2|Other|1|||
146271978|NCT01228318|527512399|FG000|Overall Study|Clinic no show to receive intervention|1|||
146271979|NCT01228318|527512400|FG001|Overall Study|Clinic no show to receive intervention|0|||
146271980|NCT01228318|527512399|FG000|Overall Study|Unable to contact|2|||
146271981|NCT01228318|527512400|FG001|Overall Study|Unable to contact|5|||
146271982|NCT01228318|527512399|FG000|Overall Study|Moved|0|||
146271983|NCT01228318|527512400|FG001|Overall Study|Moved|2|||
146271984|NCT01228318|527512399|FG000|Overall Study|Incarcerated|1|||
146271985|NCT01228318|527512400|FG001|Overall Study|Incarcerated|0|||
146271986|NCT00770029|527512405|FG000|Overall Study|Lost to Follow-up|2|||
146271987|NCT00770029|527512406|FG001|Overall Study|Lost to Follow-up|0|||
146271988|NCT00770029|527512405|FG000|Overall Study|Withdrawal by Subject|3|||
146271989|NCT00770029|527512406|FG001|Overall Study|Withdrawal by Subject|3|||
146271990|NCT00770029|527512405|FG000|Overall Study|Adverse Event|1|||
146271991|NCT00770029|527512406|FG001|Overall Study|Adverse Event|0|||
146271992|NCT02124811|527512407|FG000|Overall Study|Early termination|2|||
146271993|NCT02124811|527512408|FG001|Overall Study|Early termination|2|||
146271994|NCT02124811|527512407|FG000|Overall Study|Withdrawal by Subject|1|||
146271995|NCT02124811|527512408|FG001|Overall Study|Withdrawal by Subject|0|||
146271996|NCT03480932|527512409|FG000|Overall Study|Death|1|||
146271997|NCT03480932|527512410|FG001|Overall Study|Death|1|||
146271998|NCT03480932|527512411|FG002|Overall Study|Death|0|||
146271999|NCT03480932|527512409|FG000|Overall Study|Lost to Follow-up|0|||
146272000|NCT03480932|527512410|FG001|Overall Study|Lost to Follow-up|2|||
146272001|NCT03480932|527512411|FG002|Overall Study|Lost to Follow-up|3|||
146272002|NCT03480932|527512409|FG000|Overall Study|Incarcerated|2|||
146272003|NCT03480932|527512410|FG001|Overall Study|Incarcerated|2|||
146272004|NCT03480932|527512411|FG002|Overall Study|Incarcerated|2|||
146272005|NCT04624243|527512412|FG000|Overall Study|Death|0|||
146272006|NCT04624243|527512413|FG001|Overall Study|Death|1|||
146272007|NCT04624243|527512414|FG002|Overall Study|Death|0|||
146272008|NCT04624243|527512415|FG003|Overall Study|Death|0|||
146272009|NCT04624243|527512416|FG004|Overall Study|Death|0|||
146272010|NCT04624243|527512412|FG000|Overall Study|Lost to Follow-up|2|||
146272011|NCT04624243|527512413|FG001|Overall Study|Lost to Follow-up|3|||
146272012|NCT04624243|527512414|FG002|Overall Study|Lost to Follow-up|7|||
146272013|NCT04624243|527512415|FG003|Overall Study|Lost to Follow-up|1|||
146272014|NCT04624243|527512416|FG004|Overall Study|Lost to Follow-up|3|||
146272015|NCT04624243|527512412|FG000|Overall Study|Physician Decision|3|||
146272016|NCT04624243|527512413|FG001|Overall Study|Physician Decision|8|||
146272017|NCT04624243|527512414|FG002|Overall Study|Physician Decision|15|||
146272018|NCT04624243|527512415|FG003|Overall Study|Physician Decision|2|||
146272019|NCT04624243|527512416|FG004|Overall Study|Physician Decision|11|||
146272020|NCT04624243|527512412|FG000|Overall Study|Withdrawal by Subject|19|||
146272021|NCT04624243|527512413|FG001|Overall Study|Withdrawal by Subject|44|||
146272022|NCT04624243|527512414|FG002|Overall Study|Withdrawal by Subject|40|||
146272023|NCT04624243|527512415|FG003|Overall Study|Withdrawal by Subject|21|||
146272024|NCT04624243|527512416|FG004|Overall Study|Withdrawal by Subject|39|||
146272025|NCT04624243|527512412|FG000|Overall Study|Miscellaneous|3|||
146272026|NCT04624243|527512413|FG001|Overall Study|Miscellaneous|12|||
146272027|NCT04624243|527512414|FG002|Overall Study|Miscellaneous|9|||
146272028|NCT04624243|527512415|FG003|Overall Study|Miscellaneous|4|||
146272029|NCT04624243|527512416|FG004|Overall Study|Miscellaneous|6|||
146272030|NCT04996004|527512417|FG000|Phase I|Death|1|||
146272031|NCT04996004|527512418|FG001|Phase I|Death|2|||
146272032|NCT04996004|527512419|FG002|Phase I|Death|1|||
146272033|NCT04996004|527512420|FG003|Phase I|Death|0|||
146272034|NCT04996004|527512421|FG004|Phase I|Death|0|||
146272035|NCT04996004|527512422|FG005|Phase I|Death|0|||
146272036|NCT04996004|527512417|FG000|Phase I|Study terminated by sponsor|2|||
146272037|NCT04996004|527512418|FG001|Phase I|Study terminated by sponsor|1|||
146304297|NCT02285920|527629163|FG003|Overall Study|Dialysis discontinuation|0|||
146304298|NCT02285920|527629160|FG000|Overall Study|Death|2|||
146304299|NCT02285920|527629161|FG001|Overall Study|Death|0|||
146304300|NCT02285920|527629162|FG002|Overall Study|Death|2|||
146304301|NCT02285920|527629163|FG003|Overall Study|Death|1|||
146143183|NCT00113516|527037711|FG001|Part 1|Lack of Efficacy|0|||
146143184|NCT00113516|527037710|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
146143185|NCT00113516|527037711|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
146143186|NCT00113516|527037710|FG000|Part 1|Laboratory Abnormality|1|||
146143187|NCT00113516|527037711|FG001|Part 1|Laboratory Abnormality|0|||
146143188|NCT00113516|527037710|FG000|Part 1|Ongoing|1|||
146143189|NCT00113516|527037711|FG001|Part 1|Ongoing|0|||
146143190|NCT00113516|527037710|FG000|Part 1|Missing|65|||
146143191|NCT00113516|527037711|FG001|Part 1|Missing|0|||
146143192|NCT00113516|527037710|FG000|Part 2|Adverse Event|0|||
146143193|NCT00113516|527037711|FG001|Part 2|Adverse Event|16|||
146143194|NCT00113516|527037710|FG000|Part 2|Death|0|||
146143195|NCT00113516|527037711|FG001|Part 2|Death|5|||
146143196|NCT00113516|527037710|FG000|Part 2|Lack of Efficacy|0|||
146143197|NCT00113516|527037711|FG001|Part 2|Lack of Efficacy|37|||
146143198|NCT00113516|527037710|FG000|Part 2|Withdrawal by Subject|0|||
146143199|NCT00113516|527037711|FG001|Part 2|Withdrawal by Subject|3|||
146143200|NCT00113516|527037710|FG000|Part 2|Other|0|||
146143201|NCT00113516|527037711|FG001|Part 2|Other|3|||
146143202|NCT00113516|527037710|FG000|Part 2|Laboratory Abnormality|0|||
146143203|NCT00113516|527037711|FG001|Part 2|Laboratory Abnormality|1|||
146143204|NCT00113516|527037710|FG000|Part 2|Ongoing|0|||
146143205|NCT00113516|527037711|FG001|Part 2|Ongoing|1|||
146143206|NCT02802345|527037722|FG000|Overall Study|Not Treated|0|||
146143207|NCT02802345|527037723|FG001|Overall Study|Not Treated|1|||
146143208|NCT02802345|527037722|FG000|Overall Study|Adverse Event|28|||
146143209|NCT02802345|527037723|FG001|Overall Study|Adverse Event|20|||
146143210|NCT02802345|527037722|FG000|Overall Study|Withdrawal by Subject|3|||
146143211|NCT02802345|527037723|FG001|Overall Study|Withdrawal by Subject|3|||
146143212|NCT02802345|527037722|FG000|Overall Study|Protocol Violation|0|||
146143213|NCT02802345|527037723|FG001|Overall Study|Protocol Violation|1|||
146143214|NCT02802345|527037722|FG000|Overall Study|Other than listed|1|||
146143215|NCT02802345|527037723|FG001|Overall Study|Other than listed|5|||
146143216|NCT01706250|527037724|FG000|Overall Study|Lost to Follow-up|2|||
146143217|NCT03286140|527037725|FG000|Overall Study|Withdrawal by Subject|10|||
146143218|NCT03286140|527037726|FG001|Overall Study|Withdrawal by Subject|5|||
146143219|NCT03286140|527037725|FG000|Overall Study|Lost to Follow-up|5|||
146143220|NCT03286140|527037726|FG001|Overall Study|Lost to Follow-up|10|||
146143221|NCT03286140|527037725|FG000|Overall Study|Failure to comply|0|||
146143222|NCT03286140|527037726|FG001|Overall Study|Failure to comply|1|||
146143223|NCT01826825|527037727|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
146143224|NCT01826825|527037728|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
146143225|NCT02563028|527037729|FG000|Overall Study|Lack of equipment|1|||
146143226|NCT02563028|527037729|FG000|Overall Study|Unable to elicit VEP post induction|1|||
146143227|NCT03254134|527037730|FG000|Overall Study|Not eligible patients|599|||
146143228|NCT03254134|527037731|FG001|Overall Study|Not eligible patients|3630|||
146143229|NCT00799617|527037736|FG000|Main Testosterone Trial|Randomized in error|1|||
146143230|NCT00799617|527037737|FG001|Main Testosterone Trial|Randomized in error|1|||
146143231|NCT00799617|527037736|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
146143232|NCT00799617|527037737|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
146143233|NCT00799617|527037736|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
146143234|NCT00799617|527037737|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
146143235|NCT00799617|527037736|FG000|Sexual Funtion Trial|No Baseline Data|4|||
146143236|NCT00799617|527037737|FG001|Sexual Funtion Trial|No Baseline Data|7|||
146143237|NCT00799617|527037736|FG000|Physical Function Trial|Lost to Follow-up|6|||
146143238|NCT00799617|527037737|FG001|Physical Function Trial|Lost to Follow-up|11|||
146143239|NCT00799617|527037736|FG000|Vitality Trial|Lost to Follow-up|7|||
146143240|NCT00799617|527037737|FG001|Vitality Trial|Lost to Follow-up|22|||
146143241|NCT00799617|527037736|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
146143242|NCT00799617|527037737|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
146143243|NCT00799617|527037736|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
146143244|NCT00799617|527037737|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
146143245|NCT00799617|527037736|FG000|Bone Trial|Month 12 scan not available|6|||
146143246|NCT00799617|527037737|FG001|Bone Trial|Month 12 scan not available|16|||
146143247|NCT00799617|527037736|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
146143248|NCT00799617|527037737|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
146143249|NCT00799617|527037736|FG000|Anemia Trial|Withdrawal by Subject|3|||
146143250|NCT00799617|527037737|FG001|Anemia Trial|Withdrawal by Subject|3|||
146143251|NCT04545515|527037738|FG000|Overall Study|Adverse Event|1|||
146143252|NCT04545515|527037738|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
146143253|NCT04545515|527037738|FG000|Overall Study|Commercial drug is available for participant|7|||
146143254|NCT02501096|527037739|FG000|Overall Study|Lost to Follow-up|0|||
146143255|NCT02501096|527037740|FG001|Overall Study|Lost to Follow-up|0|||
146304302|NCT00677820|527629164|FG000|Overall Study|Lost to Follow-up|1|||
146143256|NCT02501096|527037741|FG002|Overall Study|Lost to Follow-up|0|||
146143257|NCT02501096|527037742|FG003|Overall Study|Lost to Follow-up|0|||
146143258|NCT02501096|527037743|FG004|Overall Study|Lost to Follow-up|1|||
146143259|NCT02501096|527037744|FG005|Overall Study|Lost to Follow-up|1|||
146143260|NCT02501096|527037745|FG006|Overall Study|Lost to Follow-up|3|||
146143261|NCT02501096|527037746|FG007|Overall Study|Lost to Follow-up|0|||
146143262|NCT02501096|527037747|FG008|Overall Study|Lost to Follow-up|0|||
146143263|NCT02501096|527037739|FG000|Overall Study|Withdrawal by Subject|1|||
146143264|NCT02501096|527037740|FG001|Overall Study|Withdrawal by Subject|0|||
146143265|NCT02501096|527037741|FG002|Overall Study|Withdrawal by Subject|7|||
146143266|NCT02501096|527037742|FG003|Overall Study|Withdrawal by Subject|13|||
146143267|NCT02501096|527037743|FG004|Overall Study|Withdrawal by Subject|2|||
146143268|NCT02501096|527037744|FG005|Overall Study|Withdrawal by Subject|2|||
146143269|NCT02501096|527037745|FG006|Overall Study|Withdrawal by Subject|2|||
146143270|NCT02501096|527037746|FG007|Overall Study|Withdrawal by Subject|3|||
146143271|NCT02501096|527037747|FG008|Overall Study|Withdrawal by Subject|0|||
146143272|NCT02501096|527037739|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
146143273|NCT02501096|527037740|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
146143274|NCT02501096|527037741|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
146143275|NCT02501096|527037742|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
146143276|NCT02501096|527037743|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
146143277|NCT02501096|527037744|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
146143278|NCT02501096|527037745|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
146143279|NCT02501096|527037746|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
146143280|NCT02501096|527037747|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
146143281|NCT02501096|527037739|FG000|Overall Study|Death|1|||
146143282|NCT02501096|527037740|FG001|Overall Study|Death|1|||
146143283|NCT02501096|527037741|FG002|Overall Study|Death|88|||
146143284|NCT02501096|527037742|FG003|Overall Study|Death|74|||
146143285|NCT02501096|527037743|FG004|Overall Study|Death|15|||
146143286|NCT02501096|527037744|FG005|Overall Study|Death|16|||
146143287|NCT02501096|527037745|FG006|Overall Study|Death|15|||
146143288|NCT02501096|527037746|FG007|Overall Study|Death|16|||
146143289|NCT02501096|527037747|FG008|Overall Study|Death|1|||
146143290|NCT02442830|527037750|FG000|Overall Study|Technical Failure|0|||
146143291|NCT02442830|527037751|FG001|Overall Study|Technical Failure|1|||
146143292|NCT04587193|527037752|FG000|Overall Study|Screen failure after consent|3|||
146143293|NCT04587193|527037753|FG001|Overall Study|Screen failure after consent|0|||
146143294|NCT04587193|527037752|FG000|Overall Study|Device broke during study|3|||
146143295|NCT04587193|527037753|FG001|Overall Study|Device broke during study|2|||
146143296|NCT00298038|527037756|FG000|Overall Study|Lost to Follow-up|0|||
146143297|NCT00298038|527037757|FG001|Overall Study|Lost to Follow-up|1|||
146143298|NCT00298038|527037756|FG000|Overall Study|Liver Transplant|0|||
146143299|NCT00298038|527037757|FG001|Overall Study|Liver Transplant|1|||
146143300|NCT00298038|527037756|FG000|Overall Study|Protocol Violation|1|||
146143301|NCT00298038|527037757|FG001|Overall Study|Protocol Violation|3|||
146143302|NCT00298038|527037756|FG000|Overall Study|Death|6|||
146143303|NCT00298038|527037757|FG001|Overall Study|Death|3|||
146143304|NCT00298038|527037756|FG000|Overall Study|Withdrawal by Subject|6|||
146143305|NCT00298038|527037757|FG001|Overall Study|Withdrawal by Subject|9|||
146143306|NCT00298038|527037756|FG000|Overall Study|Adverse Event|8|||
146143307|NCT00298038|527037757|FG001|Overall Study|Adverse Event|7|||
146143308|NCT00298038|527037756|FG000|Overall Study|Breakthrough overt HE episode|28|||
146143309|NCT00298038|527037757|FG001|Overall Study|Breakthrough overt HE episode|69|||
146143310|NCT00298038|527037756|FG000|Overall Study|Noncompliance|1|||
146143311|NCT00298038|527037757|FG001|Overall Study|Noncompliance|0|||
146143312|NCT00298038|527037756|FG000|Overall Study|Cocaine Abuse|1|||
146143313|NCT00298038|527037757|FG001|Overall Study|Cocaine Abuse|0|||
146143314|NCT00298038|527037756|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
146143315|NCT00298038|527037757|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
146143316|NCT02696096|527037758|FG000|Overall Study|ruled out at screening|1|||
146143317|NCT02696096|527037758|FG000|Overall Study|did not attend second fMRI|1|||
146143318|NCT02707640|527037759|FG000|Overall Study|Adverse Event|4|||
146143319|NCT02707640|527037760|FG001|Overall Study|Adverse Event|2|||
146143320|NCT02707640|527037759|FG000|Overall Study|Death|1|||
146143321|NCT02707640|527037760|FG001|Overall Study|Death|2|||
146143322|NCT02707640|527037759|FG000|Overall Study|Physician Decision|2|||
146143323|NCT02707640|527037760|FG001|Overall Study|Physician Decision|0|||
146143324|NCT02707640|527037759|FG000|Overall Study|Withdrawal by Subject|0|||
146143325|NCT02707640|527037760|FG001|Overall Study|Withdrawal by Subject|1|||
146143326|NCT02707640|527037759|FG000|Overall Study|Participant's Personal Decision|1|||
146143327|NCT02707640|527037760|FG001|Overall Study|Participant's Personal Decision|2|||
146143328|NCT02707640|527037759|FG000|Overall Study|Sponsor Discretion|1|||
146143329|NCT02707640|527037760|FG001|Overall Study|Sponsor Discretion|0|||
146168412|NCT03217747|527128134|FG009|Overall Study|Withdrawal by Subject|0|||
146168413|NCT03217747|527128135|FG010|Overall Study|Withdrawal by Subject|0|||
146168414|NCT03217747|527128136|FG011|Overall Study|Withdrawal by Subject|1|||
146272038|NCT04996004|527512419|FG002|Phase I|Study terminated by sponsor|2|||
146272039|NCT04996004|527512420|FG003|Phase I|Study terminated by sponsor|0|||
146272040|NCT04996004|527512421|FG004|Phase I|Study terminated by sponsor|0|||
146272041|NCT04996004|527512422|FG005|Phase I|Study terminated by sponsor|0|||
146272042|NCT04996004|527512417|FG000|Phase II|Study terminated by sponsor|0|||
146272043|NCT04996004|527512418|FG001|Phase II|Study terminated by sponsor|0|||
146272044|NCT04996004|527512419|FG002|Phase II|Study terminated by sponsor|0|||
146272045|NCT04996004|527512420|FG003|Phase II|Study terminated by sponsor|20|||
146272046|NCT04996004|527512421|FG004|Phase II|Study terminated by sponsor|10|||
146272047|NCT04996004|527512422|FG005|Phase II|Study terminated by sponsor|10|||
146272048|NCT04996004|527512417|FG000|Phase II|Withdrawal by Subject|0|||
146272049|NCT04996004|527512418|FG001|Phase II|Withdrawal by Subject|0|||
146272050|NCT04996004|527512419|FG002|Phase II|Withdrawal by Subject|0|||
146272051|NCT04996004|527512420|FG003|Phase II|Withdrawal by Subject|0|||
146272052|NCT04996004|527512421|FG004|Phase II|Withdrawal by Subject|1|||
146272053|NCT04996004|527512422|FG005|Phase II|Withdrawal by Subject|2|||
146272054|NCT04996004|527512417|FG000|Phase II|Death|0|||
146272055|NCT04996004|527512418|FG001|Phase II|Death|0|||
146272056|NCT04996004|527512419|FG002|Phase II|Death|0|||
146272057|NCT04996004|527512420|FG003|Phase II|Death|12|||
146272058|NCT04996004|527512421|FG004|Phase II|Death|2|||
146272059|NCT04996004|527512422|FG005|Phase II|Death|9|||
146272060|NCT04996004|527512417|FG000|Phase II|Other|0|||
146272061|NCT04996004|527512418|FG001|Phase II|Other|0|||
146272062|NCT04996004|527512419|FG002|Phase II|Other|0|||
146272063|NCT04996004|527512420|FG003|Phase II|Other|0|||
146272064|NCT04996004|527512421|FG004|Phase II|Other|0|||
146272065|NCT04996004|527512422|FG005|Phase II|Other|1|||
146272066|NCT04079868|527512423|FG000|Overall Study|Lost to Follow-up|100|||
146272067|NCT04079868|527512424|FG001|Overall Study|Lost to Follow-up|200|||
146272068|NCT04079868|527512423|FG000|Overall Study|Physician Decision|100|||
146272069|NCT04079868|527512424|FG001|Overall Study|Physician Decision|0|||
146272070|NCT05000216|527512430|FG000|Stage 1|Lost to Follow-up|0|||
146272071|NCT05000216|527512431|FG001|Stage 1|Lost to Follow-up|0|||
146272072|NCT05000216|527512432|FG002|Stage 1|Lost to Follow-up|0|||
146272073|NCT05000216|527512433|FG003|Stage 1|Lost to Follow-up|0|||
146272074|NCT05000216|527512434|FG004|Stage 1|Lost to Follow-up|0|||
146272075|NCT05000216|527512435|FG005|Stage 1|Lost to Follow-up|0|||
146272076|NCT05000216|527512436|FG006|Stage 1|Lost to Follow-up|1|||
146272077|NCT05000216|527512437|FG007|Stage 1|Lost to Follow-up|1|||
146272078|NCT05000216|527512438|FG008|Stage 1|Lost to Follow-up|0|||
146272079|NCT05000216|527512439|FG009|Stage 1|Lost to Follow-up|2|||
146272080|NCT05000216|527512440|FG010|Stage 1|Lost to Follow-up|3|||
146272081|NCT05000216|527512441|FG011|Stage 1|Lost to Follow-up|0|||
146272082|NCT05000216|527512442|FG012|Stage 1|Lost to Follow-up|0|||
146272083|NCT05000216|527512443|FG013|Stage 1|Lost to Follow-up|0|||
146272084|NCT05000216|527512444|FG014|Stage 1|Lost to Follow-up|0|||
146272085|NCT05000216|527512445|FG015|Stage 1|Lost to Follow-up|0|||
146272086|NCT05000216|527512446|FG016|Stage 1|Lost to Follow-up|0|||
146272087|NCT05000216|527512447|FG017|Stage 1|Lost to Follow-up|0|||
146272088|NCT05000216|527512448|FG018|Stage 1|Lost to Follow-up|0|||
146272089|NCT05000216|527512449|FG019|Stage 1|Lost to Follow-up|0|||
146272090|NCT05000216|527512450|FG020|Stage 1|Lost to Follow-up|0|||
146272091|NCT05000216|527512451|FG021|Stage 1|Lost to Follow-up|0|||
146272092|NCT05000216|527512430|FG000|Stage 1|Physician Decision|0|||
146272093|NCT05000216|527512431|FG001|Stage 1|Physician Decision|0|||
146272094|NCT05000216|527512432|FG002|Stage 1|Physician Decision|0|||
146272095|NCT05000216|527512433|FG003|Stage 1|Physician Decision|0|||
146272096|NCT05000216|527512434|FG004|Stage 1|Physician Decision|0|||
146272097|NCT05000216|527512435|FG005|Stage 1|Physician Decision|0|||
146272098|NCT05000216|527512436|FG006|Stage 1|Physician Decision|0|||
146272099|NCT05000216|527512437|FG007|Stage 1|Physician Decision|1|||
146272100|NCT05000216|527512438|FG008|Stage 1|Physician Decision|1|||
146143330|NCT02556710|527039418|FG000|Overall Study|Surgical treatment|3|||
146143331|NCT02556710|527039419|FG001|Overall Study|Surgical treatment|0|||
146272101|NCT05000216|527512439|FG009|Stage 1|Physician Decision|0|||
146272102|NCT05000216|527512440|FG010|Stage 1|Physician Decision|0|||
146272103|NCT05000216|527512441|FG011|Stage 1|Physician Decision|0|||
146272104|NCT05000216|527512442|FG012|Stage 1|Physician Decision|0|||
146272105|NCT05000216|527512443|FG013|Stage 1|Physician Decision|0|||
146272106|NCT05000216|527512444|FG014|Stage 1|Physician Decision|0|||
146272107|NCT05000216|527512445|FG015|Stage 1|Physician Decision|0|||
146272108|NCT05000216|527512446|FG016|Stage 1|Physician Decision|0|||
146143332|NCT02556710|527039418|FG000|Overall Study|Required proscribed pain medication|2|||
146272109|NCT05000216|527512447|FG017|Stage 1|Physician Decision|0|||
146272110|NCT05000216|527512448|FG018|Stage 1|Physician Decision|0|||
146272111|NCT05000216|527512449|FG019|Stage 1|Physician Decision|0|||
146272112|NCT05000216|527512450|FG020|Stage 1|Physician Decision|0|||
146272113|NCT05000216|527512451|FG021|Stage 1|Physician Decision|0|||
146272114|NCT05000216|527512430|FG000|Stage 1|Withdrawal by Subject|0|||
146272115|NCT05000216|527512431|FG001|Stage 1|Withdrawal by Subject|1|||
146272116|NCT05000216|527512432|FG002|Stage 1|Withdrawal by Subject|0|||
146272117|NCT05000216|527512433|FG003|Stage 1|Withdrawal by Subject|0|||
146272118|NCT05000216|527512434|FG004|Stage 1|Withdrawal by Subject|0|||
146272119|NCT05000216|527512435|FG005|Stage 1|Withdrawal by Subject|0|||
146272120|NCT05000216|527512436|FG006|Stage 1|Withdrawal by Subject|0|||
146272121|NCT05000216|527512437|FG007|Stage 1|Withdrawal by Subject|0|||
146272122|NCT05000216|527512438|FG008|Stage 1|Withdrawal by Subject|0|||
146272123|NCT05000216|527512439|FG009|Stage 1|Withdrawal by Subject|3|||
146272124|NCT05000216|527512440|FG010|Stage 1|Withdrawal by Subject|10|||
146272125|NCT05000216|527512441|FG011|Stage 1|Withdrawal by Subject|0|||
146272126|NCT05000216|527512442|FG012|Stage 1|Withdrawal by Subject|0|||
146272127|NCT05000216|527512443|FG013|Stage 1|Withdrawal by Subject|0|||
146272128|NCT05000216|527512444|FG014|Stage 1|Withdrawal by Subject|0|||
146272129|NCT05000216|527512445|FG015|Stage 1|Withdrawal by Subject|0|||
146272130|NCT05000216|527512446|FG016|Stage 1|Withdrawal by Subject|0|||
146272131|NCT05000216|527512447|FG017|Stage 1|Withdrawal by Subject|0|||
146272132|NCT05000216|527512448|FG018|Stage 1|Withdrawal by Subject|0|||
146272133|NCT05000216|527512449|FG019|Stage 1|Withdrawal by Subject|0|||
146272134|NCT05000216|527512450|FG020|Stage 1|Withdrawal by Subject|0|||
146272135|NCT05000216|527512451|FG021|Stage 1|Withdrawal by Subject|0|||
146272136|NCT05000216|527512430|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
146272137|NCT05000216|527512431|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
146272138|NCT05000216|527512432|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
146272139|NCT05000216|527512433|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
146272140|NCT05000216|527512434|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
146272141|NCT05000216|527512435|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
146272142|NCT05000216|527512436|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
146272143|NCT05000216|527512437|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
146272144|NCT05000216|527512438|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
146272145|NCT05000216|527512439|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
146272146|NCT05000216|527512440|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
146272147|NCT05000216|527512441|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
146272148|NCT05000216|527512442|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
146272149|NCT05000216|527512443|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
146272150|NCT05000216|527512444|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
146272151|NCT05000216|527512445|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
146272152|NCT05000216|527512446|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
146272153|NCT05000216|527512447|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
146272154|NCT05000216|527512448|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
146272155|NCT05000216|527512449|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
146272156|NCT05000216|527512450|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
146272157|NCT05000216|527512451|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
146272158|NCT05000216|527512430|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272159|NCT05000216|527512431|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272160|NCT05000216|527512432|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272161|NCT05000216|527512433|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272162|NCT05000216|527512434|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272163|NCT05000216|527512435|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272164|NCT05000216|527512436|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272165|NCT05000216|527512437|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272166|NCT05000216|527512438|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
146272167|NCT05000216|527512439|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272168|NCT05000216|527512440|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272169|NCT05000216|527512441|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272170|NCT05000216|527512442|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272171|NCT05000216|527512443|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272172|NCT05000216|527512444|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272173|NCT05000216|527512445|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146143333|NCT02556710|527039419|FG001|Overall Study|Required proscribed pain medication|1|||
146143334|NCT02556710|527039418|FG000|Overall Study|Lack of Efficacy|1|||
146143335|NCT02556710|527039419|FG001|Overall Study|Lack of Efficacy|0|||
146143336|NCT02556710|527039418|FG000|Overall Study|Worsening osteoarthritis|1|||
146143337|NCT02556710|527039419|FG001|Overall Study|Worsening osteoarthritis|0|||
146143338|NCT02556710|527039418|FG000|Overall Study|Moved out of state|1|||
146143339|NCT02556710|527039419|FG001|Overall Study|Moved out of state|0|||
146143340|NCT02556710|527039418|FG000|Overall Study|Missing reason|3|||
146143341|NCT02556710|527039419|FG001|Overall Study|Missing reason|1|||
146272174|NCT05000216|527512446|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272175|NCT05000216|527512447|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272176|NCT05000216|527512448|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272177|NCT05000216|527512449|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272178|NCT05000216|527512450|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272179|NCT05000216|527512451|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
146272180|NCT05000216|527512430|FG000|Stage 1|Other|0|||
146272181|NCT05000216|527512431|FG001|Stage 1|Other|0|||
146143342|NCT02556710|527039418|FG000|Overall Study|Pain as lack of efficacy|0|||
146272182|NCT05000216|527512432|FG002|Stage 1|Other|0|||
146143343|NCT02556710|527039419|FG001|Overall Study|Pain as lack of efficacy|4|||
146143344|NCT00827372|527039420|FG000|Overall Study|Adverse Event|5|||
146272183|NCT05000216|527512433|FG003|Stage 1|Other|0|||
146272184|NCT05000216|527512434|FG004|Stage 1|Other|1|||
146272185|NCT05000216|527512435|FG005|Stage 1|Other|0|||
146272186|NCT05000216|527512436|FG006|Stage 1|Other|0|||
146272187|NCT05000216|527512437|FG007|Stage 1|Other|2|||
146272188|NCT05000216|527512438|FG008|Stage 1|Other|0|||
146272189|NCT05000216|527512439|FG009|Stage 1|Other|0|||
146272190|NCT05000216|527512440|FG010|Stage 1|Other|1|||
146272191|NCT05000216|527512441|FG011|Stage 1|Other|1|||
146272192|NCT05000216|527512442|FG012|Stage 1|Other|0|||
146272193|NCT05000216|527512443|FG013|Stage 1|Other|0|||
146272194|NCT05000216|527512444|FG014|Stage 1|Other|0|||
146272195|NCT05000216|527512445|FG015|Stage 1|Other|0|||
146272196|NCT05000216|527512446|FG016|Stage 1|Other|0|||
146272197|NCT05000216|527512447|FG017|Stage 1|Other|0|||
146272198|NCT05000216|527512448|FG018|Stage 1|Other|0|||
146272199|NCT05000216|527512449|FG019|Stage 1|Other|0|||
146272200|NCT05000216|527512450|FG020|Stage 1|Other|0|||
146272201|NCT05000216|527512451|FG021|Stage 1|Other|0|||
146272202|NCT05000216|527512430|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
146272203|NCT05000216|527512431|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
146272204|NCT05000216|527512432|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
146272205|NCT05000216|527512433|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
146272206|NCT05000216|527512434|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
146272207|NCT05000216|527512435|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
146272208|NCT05000216|527512436|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
146272209|NCT05000216|527512437|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
146272210|NCT05000216|527512438|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
146272211|NCT05000216|527512439|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
146272212|NCT05000216|527512440|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
146272213|NCT05000216|527512441|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
146272214|NCT05000216|527512442|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
146272215|NCT05000216|527512443|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
146272216|NCT05000216|527512444|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
146272217|NCT05000216|527512445|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
146272218|NCT05000216|527512446|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
146272219|NCT05000216|527512447|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
146272220|NCT05000216|527512448|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
146272221|NCT05000216|527512449|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
146272222|NCT05000216|527512450|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
146272223|NCT05000216|527512451|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
146272224|NCT05000216|527512430|FG000|Stage 2|Lost to Follow-up|0|||
146272225|NCT05000216|527512431|FG001|Stage 2|Lost to Follow-up|0|||
146272226|NCT05000216|527512432|FG002|Stage 2|Lost to Follow-up|0|||
146272227|NCT05000216|527512433|FG003|Stage 2|Lost to Follow-up|0|||
146272228|NCT05000216|527512434|FG004|Stage 2|Lost to Follow-up|0|||
146272229|NCT05000216|527512435|FG005|Stage 2|Lost to Follow-up|0|||
146272230|NCT05000216|527512436|FG006|Stage 2|Lost to Follow-up|0|||
146272231|NCT05000216|527512437|FG007|Stage 2|Lost to Follow-up|0|||
146272232|NCT05000216|527512438|FG008|Stage 2|Lost to Follow-up|0|||
146272233|NCT05000216|527512439|FG009|Stage 2|Lost to Follow-up|0|||
146272234|NCT05000216|527512440|FG010|Stage 2|Lost to Follow-up|0|||
146272235|NCT05000216|527512441|FG011|Stage 2|Lost to Follow-up|0|||
146272236|NCT05000216|527512442|FG012|Stage 2|Lost to Follow-up|0|||
146272237|NCT05000216|527512443|FG013|Stage 2|Lost to Follow-up|0|||
146272238|NCT05000216|527512444|FG014|Stage 2|Lost to Follow-up|0|||
146272239|NCT05000216|527512445|FG015|Stage 2|Lost to Follow-up|0|||
146272240|NCT05000216|527512446|FG016|Stage 2|Lost to Follow-up|4|||
146272241|NCT05000216|527512447|FG017|Stage 2|Lost to Follow-up|0|||
146272242|NCT05000216|527512448|FG018|Stage 2|Lost to Follow-up|0|||
146272243|NCT05000216|527512449|FG019|Stage 2|Lost to Follow-up|0|||
146143345|NCT00827372|527039420|FG000|Overall Study|Lack of Efficacy|3|||
146143346|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
146272244|NCT05000216|527512450|FG020|Stage 2|Lost to Follow-up|0|||
146272245|NCT05000216|527512451|FG021|Stage 2|Lost to Follow-up|0|||
146272246|NCT05000216|527512430|FG000|Stage 2|Physician Decision|0|||
146272247|NCT05000216|527512431|FG001|Stage 2|Physician Decision|0|||
146272248|NCT05000216|527512432|FG002|Stage 2|Physician Decision|0|||
146272249|NCT05000216|527512433|FG003|Stage 2|Physician Decision|0|||
146272250|NCT05000216|527512434|FG004|Stage 2|Physician Decision|0|||
146272251|NCT05000216|527512435|FG005|Stage 2|Physician Decision|0|||
146272252|NCT05000216|527512436|FG006|Stage 2|Physician Decision|0|||
146272253|NCT05000216|527512437|FG007|Stage 2|Physician Decision|0|||
146272254|NCT05000216|527512438|FG008|Stage 2|Physician Decision|0|||
146272255|NCT05000216|527512439|FG009|Stage 2|Physician Decision|0|||
146272256|NCT05000216|527512440|FG010|Stage 2|Physician Decision|0|||
146272257|NCT05000216|527512441|FG011|Stage 2|Physician Decision|0|||
146272258|NCT05000216|527512442|FG012|Stage 2|Physician Decision|1|||
146272259|NCT05000216|527512443|FG013|Stage 2|Physician Decision|0|||
146272260|NCT05000216|527512444|FG014|Stage 2|Physician Decision|0|||
146272261|NCT05000216|527512445|FG015|Stage 2|Physician Decision|0|||
146272262|NCT05000216|527512446|FG016|Stage 2|Physician Decision|0|||
146272263|NCT05000216|527512447|FG017|Stage 2|Physician Decision|0|||
146272264|NCT05000216|527512448|FG018|Stage 2|Physician Decision|0|||
146272265|NCT05000216|527512449|FG019|Stage 2|Physician Decision|0|||
146272266|NCT05000216|527512450|FG020|Stage 2|Physician Decision|0|||
146272267|NCT05000216|527512451|FG021|Stage 2|Physician Decision|0|||
146272268|NCT05000216|527512430|FG000|Stage 2|Withdrawal by Subject|0|||
146272269|NCT05000216|527512431|FG001|Stage 2|Withdrawal by Subject|0|||
146272270|NCT05000216|527512432|FG002|Stage 2|Withdrawal by Subject|0|||
146272271|NCT05000216|527512433|FG003|Stage 2|Withdrawal by Subject|0|||
146272272|NCT05000216|527512434|FG004|Stage 2|Withdrawal by Subject|0|||
146272273|NCT05000216|527512435|FG005|Stage 2|Withdrawal by Subject|0|||
146272274|NCT05000216|527512436|FG006|Stage 2|Withdrawal by Subject|0|||
146272275|NCT05000216|527512437|FG007|Stage 2|Withdrawal by Subject|0|||
146272276|NCT05000216|527512438|FG008|Stage 2|Withdrawal by Subject|0|||
146272277|NCT05000216|527512439|FG009|Stage 2|Withdrawal by Subject|0|||
146272278|NCT05000216|527512440|FG010|Stage 2|Withdrawal by Subject|0|||
146272279|NCT05000216|527512441|FG011|Stage 2|Withdrawal by Subject|0|||
146272280|NCT05000216|527512442|FG012|Stage 2|Withdrawal by Subject|0|||
146272281|NCT05000216|527512443|FG013|Stage 2|Withdrawal by Subject|0|||
146272282|NCT05000216|527512444|FG014|Stage 2|Withdrawal by Subject|2|||
146272283|NCT05000216|527512445|FG015|Stage 2|Withdrawal by Subject|0|||
146272284|NCT05000216|527512446|FG016|Stage 2|Withdrawal by Subject|9|||
146272285|NCT05000216|527512447|FG017|Stage 2|Withdrawal by Subject|0|||
146272286|NCT05000216|527512448|FG018|Stage 2|Withdrawal by Subject|0|||
146272287|NCT05000216|527512449|FG019|Stage 2|Withdrawal by Subject|0|||
146272288|NCT05000216|527512450|FG020|Stage 2|Withdrawal by Subject|0|||
146272289|NCT05000216|527512451|FG021|Stage 2|Withdrawal by Subject|0|||
146272290|NCT05000216|527512430|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
146272291|NCT05000216|527512431|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
146272292|NCT05000216|527512432|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
146272293|NCT05000216|527512433|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
146272294|NCT05000216|527512434|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
146272295|NCT05000216|527512435|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
146272296|NCT05000216|527512436|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
146272297|NCT05000216|527512437|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
146272298|NCT05000216|527512438|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
146272299|NCT05000216|527512439|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
146272300|NCT05000216|527512440|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
146272301|NCT05000216|527512441|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
146272302|NCT05000216|527512442|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
146272303|NCT05000216|527512443|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
146272304|NCT05000216|527512444|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
146272305|NCT05000216|527512445|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
146272306|NCT05000216|527512446|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
146272307|NCT05000216|527512447|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
146272308|NCT05000216|527512448|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
146272309|NCT05000216|527512449|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
146272310|NCT05000216|527512450|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
146272311|NCT05000216|527512451|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
146272312|NCT05000216|527512430|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272313|NCT05000216|527512431|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272314|NCT05000216|527512432|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272315|NCT05000216|527512433|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272316|NCT05000216|527512434|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272317|NCT05000216|527512435|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272318|NCT05000216|527512436|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272319|NCT05000216|527512437|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272320|NCT05000216|527512438|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272321|NCT05000216|527512439|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272322|NCT05000216|527512440|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272323|NCT05000216|527512441|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272324|NCT05000216|527512442|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272325|NCT05000216|527512443|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272326|NCT05000216|527512444|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
146272327|NCT05000216|527512445|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272328|NCT05000216|527512446|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
146272329|NCT05000216|527512447|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272330|NCT05000216|527512448|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272331|NCT05000216|527512449|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272332|NCT05000216|527512450|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272333|NCT05000216|527512451|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
146272334|NCT05000216|527512430|FG000|Stage 2|Other reason|0|||
146272335|NCT05000216|527512431|FG001|Stage 2|Other reason|0|||
146272336|NCT05000216|527512432|FG002|Stage 2|Other reason|0|||
146272337|NCT05000216|527512433|FG003|Stage 2|Other reason|0|||
146272338|NCT05000216|527512434|FG004|Stage 2|Other reason|0|||
146143347|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146143348|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146143349|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146143350|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146143351|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146143352|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
146143353|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146143354|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146143355|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146143356|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146143357|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146143358|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
146143359|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146143360|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146143361|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146143362|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146143363|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146143364|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
146143365|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146143366|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146143367|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146143368|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146143369|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146143370|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
146143371|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146143372|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146143373|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146143374|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146143375|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146143376|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
146143377|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146143378|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146143379|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146143380|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146143381|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146143382|NCT02139644|527039421|FG000|Run-In Period (Pre-assignment)|Other|6|||
146143383|NCT02139644|527039422|FG001|Run-In Period (Pre-assignment)|Other|0|||
146143384|NCT02139644|527039423|FG002|Run-In Period (Pre-assignment)|Other|0|||
146143385|NCT02139644|527039424|FG003|Run-In Period (Pre-assignment)|Other|0|||
146143386|NCT02139644|527039425|FG004|Run-In Period (Pre-assignment)|Other|0|||
146143387|NCT02139644|527039426|FG005|Run-In Period (Pre-assignment)|Other|0|||
146143388|NCT02139644|527039421|FG000|Treatment Period|Adverse Event|0|||
146143389|NCT02139644|527039422|FG001|Treatment Period|Adverse Event|0|||
146143390|NCT02139644|527039423|FG002|Treatment Period|Adverse Event|3|||
146143391|NCT02139644|527039424|FG003|Treatment Period|Adverse Event|2|||
146143392|NCT02139644|527039425|FG004|Treatment Period|Adverse Event|1|||
146143393|NCT02139644|527039426|FG005|Treatment Period|Adverse Event|6|||
146143394|NCT02139644|527039421|FG000|Treatment Period|Withdrawal by Subject|0|||
146143395|NCT02139644|527039422|FG001|Treatment Period|Withdrawal by Subject|0|||
146143396|NCT02139644|527039423|FG002|Treatment Period|Withdrawal by Subject|2|||
146143397|NCT02139644|527039424|FG003|Treatment Period|Withdrawal by Subject|2|||
146143398|NCT02139644|527039425|FG004|Treatment Period|Withdrawal by Subject|3|||
146143399|NCT02139644|527039426|FG005|Treatment Period|Withdrawal by Subject|2|||
146143400|NCT02139644|527039421|FG000|Treatment Period|Non-compliance|0|||
146143401|NCT02139644|527039422|FG001|Treatment Period|Non-compliance|0|||
146143402|NCT02139644|527039423|FG002|Treatment Period|Non-compliance|0|||
146143403|NCT02139644|527039424|FG003|Treatment Period|Non-compliance|1|||
146143404|NCT02139644|527039425|FG004|Treatment Period|Non-compliance|0|||
146143405|NCT02139644|527039426|FG005|Treatment Period|Non-compliance|0|||
146143406|NCT02139644|527039421|FG000|Treatment Period|Protocol Violation|0|||
146143407|NCT02139644|527039422|FG001|Treatment Period|Protocol Violation|0|||
146143408|NCT02139644|527039423|FG002|Treatment Period|Protocol Violation|0|||
146143409|NCT02139644|527039424|FG003|Treatment Period|Protocol Violation|1|||
146143410|NCT02139644|527039425|FG004|Treatment Period|Protocol Violation|1|||
146143411|NCT02139644|527039426|FG005|Treatment Period|Protocol Violation|1|||
146143412|NCT02139644|527039421|FG000|Treatment Period|Disease progression|0|||
146143413|NCT02139644|527039422|FG001|Treatment Period|Disease progression|0|||
146143414|NCT02139644|527039423|FG002|Treatment Period|Disease progression|0|||
146143415|NCT02139644|527039424|FG003|Treatment Period|Disease progression|1|||
146143416|NCT02139644|527039425|FG004|Treatment Period|Disease progression|1|||
146143417|NCT02139644|527039426|FG005|Treatment Period|Disease progression|2|||
146272339|NCT05000216|527512435|FG005|Stage 2|Other reason|0|||
146272340|NCT05000216|527512436|FG006|Stage 2|Other reason|0|||
146272341|NCT05000216|527512437|FG007|Stage 2|Other reason|0|||
146272342|NCT05000216|527512438|FG008|Stage 2|Other reason|0|||
146272343|NCT05000216|527512439|FG009|Stage 2|Other reason|0|||
146272344|NCT05000216|527512440|FG010|Stage 2|Other reason|0|||
146272345|NCT05000216|527512441|FG011|Stage 2|Other reason|0|||
146272346|NCT05000216|527512442|FG012|Stage 2|Other reason|0|||
146272347|NCT05000216|527512443|FG013|Stage 2|Other reason|0|||
146272348|NCT05000216|527512444|FG014|Stage 2|Other reason|0|||
146272349|NCT05000216|527512445|FG015|Stage 2|Other reason|0|||
146272350|NCT05000216|527512446|FG016|Stage 2|Other reason|1|||
146272351|NCT05000216|527512447|FG017|Stage 2|Other reason|0|||
146272352|NCT05000216|527512448|FG018|Stage 2|Other reason|0|||
146272353|NCT05000216|527512449|FG019|Stage 2|Other reason|0|||
146272354|NCT05000216|527512450|FG020|Stage 2|Other reason|0|||
146272355|NCT05000216|527512451|FG021|Stage 2|Other reason|0|||
146272356|NCT05000216|527512430|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
146272357|NCT05000216|527512431|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
146272358|NCT05000216|527512432|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
146272359|NCT05000216|527512433|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
146272360|NCT05000216|527512434|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
146272361|NCT05000216|527512435|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
146272362|NCT05000216|527512436|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
146272363|NCT05000216|527512437|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
146272364|NCT05000216|527512438|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
146272365|NCT05000216|527512439|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
146272366|NCT05000216|527512440|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
146272367|NCT05000216|527512441|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
146272368|NCT05000216|527512442|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
146272369|NCT05000216|527512443|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
146272370|NCT05000216|527512444|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
146272371|NCT05000216|527512445|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
146272372|NCT05000216|527512446|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
146272373|NCT05000216|527512447|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
146272374|NCT05000216|527512448|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
146272375|NCT05000216|527512449|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
146272376|NCT05000216|527512450|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
146272377|NCT05000216|527512451|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
146272378|NCT05000216|527512430|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272379|NCT05000216|527512431|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272380|NCT05000216|527512432|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272381|NCT05000216|527512433|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272382|NCT05000216|527512434|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272383|NCT05000216|527512435|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272384|NCT05000216|527512436|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272385|NCT05000216|527512437|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272386|NCT05000216|527512438|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272387|NCT05000216|527512439|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272388|NCT05000216|527512440|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272389|NCT05000216|527512441|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272390|NCT05000216|527512442|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272391|NCT05000216|527512443|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272392|NCT05000216|527512444|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272393|NCT05000216|527512445|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
146272394|NCT05000216|527512446|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272395|NCT05000216|527512447|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272396|NCT05000216|527512448|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272397|NCT05000216|527512449|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272398|NCT05000216|527512450|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
146272399|NCT05000216|527512451|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
146143418|NCT02139644|527039421|FG000|Treatment Period|Lost to Follow-up|0|||
146143419|NCT02139644|527039422|FG001|Treatment Period|Lost to Follow-up|0|||
146143420|NCT02139644|527039423|FG002|Treatment Period|Lost to Follow-up|1|||
146272400|NCT05000216|527512430|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272401|NCT05000216|527512431|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272402|NCT05000216|527512432|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272403|NCT05000216|527512433|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272404|NCT05000216|527512434|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146143421|NCT02139644|527039424|FG003|Treatment Period|Lost to Follow-up|1|||
146143422|NCT02139644|527039425|FG004|Treatment Period|Lost to Follow-up|1|||
146272405|NCT05000216|527512435|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272406|NCT05000216|527512436|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272407|NCT05000216|527512437|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272408|NCT05000216|527512438|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272409|NCT05000216|527512439|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272410|NCT05000216|527512440|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272411|NCT05000216|527512441|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146143423|NCT02139644|527039426|FG005|Treatment Period|Lost to Follow-up|1|||
146143424|NCT02139644|527039421|FG000|Treatment Period|Lack of Efficacy|0|||
146143425|NCT02139644|527039422|FG001|Treatment Period|Lack of Efficacy|0|||
146143426|NCT02139644|527039423|FG002|Treatment Period|Lack of Efficacy|1|||
146143427|NCT02139644|527039424|FG003|Treatment Period|Lack of Efficacy|0|||
146143428|NCT02139644|527039425|FG004|Treatment Period|Lack of Efficacy|1|||
146143429|NCT02139644|527039426|FG005|Treatment Period|Lack of Efficacy|4|||
146143430|NCT02139644|527039421|FG000|Treatment Period|Other|0|||
146143431|NCT02139644|527039422|FG001|Treatment Period|Other|3|||
146143432|NCT02139644|527039423|FG002|Treatment Period|Other|1|||
146143433|NCT02139644|527039424|FG003|Treatment Period|Other|1|||
146143434|NCT02139644|527039425|FG004|Treatment Period|Other|0|||
146143435|NCT02139644|527039426|FG005|Treatment Period|Other|1|||
146143436|NCT01076400|527039428|FG000|Overall Study|Adverse Event|2|||
146143437|NCT01076400|527039429|FG001|Overall Study|Adverse Event|0|||
146143438|NCT01076400|527039430|FG002|Overall Study|Adverse Event|0|||
146143439|NCT01076400|527039428|FG000|Overall Study|Progressive Disease|5|||
146143440|NCT01076400|527039429|FG001|Overall Study|Progressive Disease|0|||
146143441|NCT01076400|527039430|FG002|Overall Study|Progressive Disease|0|||
146143442|NCT01265953|527039436|FG000|Overall Study|Non compliance|5|||
146143443|NCT01265953|527039437|FG001|Overall Study|Non compliance|3|||
146143444|NCT01750268|527039443|FG000|Overall Study|Lost to Follow-up|0|||
146143445|NCT01750268|527039444|FG001|Overall Study|Lost to Follow-up|2|||
146143446|NCT01750268|527039443|FG000|Overall Study|Physician Decision|0|||
146143447|NCT01750268|527039444|FG001|Overall Study|Physician Decision|3|||
146143448|NCT01750268|527039443|FG000|Overall Study|Withdrawal by Subject|2|||
146143449|NCT01750268|527039444|FG001|Overall Study|Withdrawal by Subject|0|||
146143450|NCT01529645|527039449|FG000|Overall Study|Lost to Follow-up|0|||
146143451|NCT01529645|527039450|FG001|Overall Study|Lost to Follow-up|1|||
146143452|NCT01529645|527039451|FG002|Overall Study|Lost to Follow-up|1|||
146143453|NCT01529645|527039452|FG003|Overall Study|Lost to Follow-up|1|||
146143454|NCT01529645|527039453|FG004|Overall Study|Lost to Follow-up|1|||
146143455|NCT01529645|527039454|FG005|Overall Study|Lost to Follow-up|0|||
146143456|NCT01529645|527039455|FG006|Overall Study|Lost to Follow-up|2|||
146143457|NCT01529645|527039456|FG007|Overall Study|Lost to Follow-up|0|||
146143458|NCT01529645|527039457|FG008|Overall Study|Lost to Follow-up|1|||
146143459|NCT01529645|527039458|FG009|Overall Study|Lost to Follow-up|0|||
146143460|NCT01529645|527039449|FG000|Overall Study|SAE - Premature contractions|0|||
146143461|NCT01529645|527039450|FG001|Overall Study|SAE - Premature contractions|0|||
146143462|NCT01529645|527039451|FG002|Overall Study|SAE - Premature contractions|1|||
146143463|NCT01529645|527039452|FG003|Overall Study|SAE - Premature contractions|0|||
146143464|NCT01529645|527039453|FG004|Overall Study|SAE - Premature contractions|0|||
146143465|NCT01529645|527039454|FG005|Overall Study|SAE - Premature contractions|0|||
146143466|NCT01529645|527039455|FG006|Overall Study|SAE - Premature contractions|0|||
146143467|NCT01529645|527039456|FG007|Overall Study|SAE - Premature contractions|0|||
146143468|NCT01529645|527039457|FG008|Overall Study|SAE - Premature contractions|0|||
146143469|NCT01529645|527039458|FG009|Overall Study|SAE - Premature contractions|0|||
146143470|NCT01529645|527039449|FG000|Overall Study|Withdrawal by Subject|2|||
146143471|NCT01529645|527039450|FG001|Overall Study|Withdrawal by Subject|0|||
146143472|NCT01529645|527039451|FG002|Overall Study|Withdrawal by Subject|0|||
146143473|NCT01529645|527039452|FG003|Overall Study|Withdrawal by Subject|1|||
146143474|NCT01529645|527039453|FG004|Overall Study|Withdrawal by Subject|1|||
146143475|NCT01529645|527039454|FG005|Overall Study|Withdrawal by Subject|1|||
146143476|NCT01529645|527039455|FG006|Overall Study|Withdrawal by Subject|0|||
146143477|NCT01529645|527039456|FG007|Overall Study|Withdrawal by Subject|0|||
146143478|NCT01529645|527039457|FG008|Overall Study|Withdrawal by Subject|0|||
146143479|NCT01529645|527039458|FG009|Overall Study|Withdrawal by Subject|0|||
146143480|NCT00274716|527039459|FG000|Phase A|Other non-reported reason|4|||
146143481|NCT00274716|527039460|FG001|Phase A|Other non-reported reason|2|||
146143482|NCT00274716|527039461|FG002|Phase A|Other non-reported reason|1|||
146143483|NCT00274716|527039462|FG003|Phase A|Other non-reported reason|2|||
146272412|NCT05000216|527512442|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146304303|NCT00677820|527629165|FG001|Overall Study|Lost to Follow-up|0|||
146143484|NCT00274716|527039463|FG004|Phase A|Other non-reported reason|0|||
146143485|NCT00274716|527039464|FG005|Phase A|Other non-reported reason|1|||
146143486|NCT00274716|527039459|FG000|Phase A|Participant moved|0|||
146143487|NCT00274716|527039460|FG001|Phase A|Participant moved|0|||
146143488|NCT00274716|527039461|FG002|Phase A|Participant moved|1|||
146143489|NCT00274716|527039462|FG003|Phase A|Participant moved|0|||
146143490|NCT00274716|527039463|FG004|Phase A|Participant moved|0|||
146143491|NCT00274716|527039464|FG005|Phase A|Participant moved|1|||
146143492|NCT00274716|527039459|FG000|Phase A|Site Terminated|0|||
146143493|NCT00274716|527039460|FG001|Phase A|Site Terminated|0|||
146143494|NCT00274716|527039461|FG002|Phase A|Site Terminated|0|||
146143495|NCT00274716|527039462|FG003|Phase A|Site Terminated|1|||
146143496|NCT00274716|527039463|FG004|Phase A|Site Terminated|0|||
146143497|NCT00274716|527039464|FG005|Phase A|Site Terminated|0|||
146143498|NCT00274716|527039459|FG000|Phase A|Protocol Violation|1|||
146143499|NCT00274716|527039460|FG001|Phase A|Protocol Violation|0|||
146143500|NCT00274716|527039461|FG002|Phase A|Protocol Violation|0|||
146143501|NCT00274716|527039462|FG003|Phase A|Protocol Violation|1|||
146143502|NCT00274716|527039463|FG004|Phase A|Protocol Violation|0|||
146143503|NCT00274716|527039464|FG005|Phase A|Protocol Violation|0|||
146143504|NCT00274716|527039459|FG000|Phase A|Met criteria for discontinuation|1|||
146143505|NCT00274716|527039460|FG001|Phase A|Met criteria for discontinuation|1|||
146143506|NCT00274716|527039461|FG002|Phase A|Met criteria for discontinuation|0|||
146143507|NCT00274716|527039462|FG003|Phase A|Met criteria for discontinuation|0|||
146143508|NCT00274716|527039463|FG004|Phase A|Met criteria for discontinuation|0|||
146143509|NCT00274716|527039464|FG005|Phase A|Met criteria for discontinuation|0|||
146143510|NCT00274716|527039459|FG000|Phase A|Withdrawal by Subject|2|||
146143511|NCT00274716|527039460|FG001|Phase A|Withdrawal by Subject|2|||
146143512|NCT00274716|527039461|FG002|Phase A|Withdrawal by Subject|1|||
146143513|NCT00274716|527039462|FG003|Phase A|Withdrawal by Subject|3|||
146143514|NCT00274716|527039463|FG004|Phase A|Withdrawal by Subject|0|||
146143515|NCT00274716|527039464|FG005|Phase A|Withdrawal by Subject|1|||
146143516|NCT00274716|527039459|FG000|Phase A|Adverse Event|2|||
146143517|NCT00274716|527039460|FG001|Phase A|Adverse Event|3|||
146143518|NCT00274716|527039461|FG002|Phase A|Adverse Event|3|||
146143519|NCT00274716|527039462|FG003|Phase A|Adverse Event|0|||
146143520|NCT00274716|527039463|FG004|Phase A|Adverse Event|2|||
146143521|NCT00274716|527039464|FG005|Phase A|Adverse Event|0|||
146143522|NCT00274716|527039459|FG000|Phase A|Completed but did not enter Phase B|1|||
146143523|NCT00274716|527039460|FG001|Phase A|Completed but did not enter Phase B|2|||
146143524|NCT00274716|527039461|FG002|Phase A|Completed but did not enter Phase B|2|||
146143525|NCT00274716|527039462|FG003|Phase A|Completed but did not enter Phase B|2|||
146143526|NCT00274716|527039463|FG004|Phase A|Completed but did not enter Phase B|1|||
146143527|NCT00274716|527039464|FG005|Phase A|Completed but did not enter Phase B|1|||
146143528|NCT00274716|527039459|FG000|Phase B|Adverse Event|0|||
146143529|NCT00274716|527039460|FG001|Phase B|Adverse Event|0|||
146143530|NCT00274716|527039461|FG002|Phase B|Adverse Event|2|||
146143531|NCT00274716|527039462|FG003|Phase B|Adverse Event|0|||
146143532|NCT00274716|527039463|FG004|Phase B|Adverse Event|0|||
146143533|NCT00274716|527039464|FG005|Phase B|Adverse Event|1|||
146143534|NCT00274716|527039459|FG000|Phase B|Protocol Violation|0|||
146143535|NCT00274716|527039460|FG001|Phase B|Protocol Violation|2|||
146143536|NCT00274716|527039461|FG002|Phase B|Protocol Violation|0|||
146143537|NCT00274716|527039462|FG003|Phase B|Protocol Violation|0|||
146143538|NCT00274716|527039463|FG004|Phase B|Protocol Violation|0|||
146143539|NCT00274716|527039464|FG005|Phase B|Protocol Violation|0|||
146143540|NCT00274716|527039459|FG000|Phase B|Withdrawal by Subject|0|||
146143541|NCT00274716|527039460|FG001|Phase B|Withdrawal by Subject|1|||
146143542|NCT00274716|527039461|FG002|Phase B|Withdrawal by Subject|0|||
146143543|NCT00274716|527039462|FG003|Phase B|Withdrawal by Subject|0|||
146143544|NCT00274716|527039463|FG004|Phase B|Withdrawal by Subject|0|||
146143545|NCT00274716|527039464|FG005|Phase B|Withdrawal by Subject|0|||
146143546|NCT00274716|527039459|FG000|Phase B|Participant moved|1|||
146143547|NCT00274716|527039460|FG001|Phase B|Participant moved|0|||
146143548|NCT00274716|527039461|FG002|Phase B|Participant moved|0|||
146143549|NCT00274716|527039462|FG003|Phase B|Participant moved|0|||
146143550|NCT00274716|527039463|FG004|Phase B|Participant moved|0|||
146143551|NCT00274716|527039464|FG005|Phase B|Participant moved|0|||
146143552|NCT00274716|527039459|FG000|Phase B|Other non-reported reason|0|||
146143553|NCT00274716|527039460|FG001|Phase B|Other non-reported reason|0|||
146143554|NCT00274716|527039461|FG002|Phase B|Other non-reported reason|1|||
146143555|NCT00274716|527039462|FG003|Phase B|Other non-reported reason|1|||
146143556|NCT00274716|527039463|FG004|Phase B|Other non-reported reason|0|||
146143557|NCT00274716|527039464|FG005|Phase B|Other non-reported reason|0|||
146143558|NCT00274716|527039459|FG000|Phase B|Lost to Follow-up|0|||
146143559|NCT00274716|527039460|FG001|Phase B|Lost to Follow-up|1|||
146143560|NCT00274716|527039461|FG002|Phase B|Lost to Follow-up|0|||
146143561|NCT00274716|527039462|FG003|Phase B|Lost to Follow-up|0|||
146143562|NCT00274716|527039463|FG004|Phase B|Lost to Follow-up|0|||
146143563|NCT00274716|527039464|FG005|Phase B|Lost to Follow-up|0|||
146143564|NCT04193202|527039465|FG000|Overall Study|Adverse Event|2|||
146272413|NCT05000216|527512443|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
146272414|NCT05000216|527512444|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146143565|NCT04193202|527039466|FG001|Overall Study|Adverse Event|1|||
146143566|NCT04193202|527039465|FG000|Overall Study|Death|0|||
146143567|NCT04193202|527039466|FG001|Overall Study|Death|1|||
146143568|NCT04193202|527039465|FG000|Overall Study|Physician Decision|1|||
146143569|NCT04193202|527039466|FG001|Overall Study|Physician Decision|1|||
146143570|NCT04193202|527039465|FG000|Overall Study|Protocol Violation|2|||
146143571|NCT04193202|527039466|FG001|Overall Study|Protocol Violation|2|||
146143572|NCT04193202|527039465|FG000|Overall Study|Withdrawal by Subject|11|||
146143573|NCT04193202|527039466|FG001|Overall Study|Withdrawal by Subject|5|||
146143574|NCT02212730|527039467|FG000|Overall Study|Tumor not of the required cell histology|1|||
146143575|NCT02212730|527039468|FG001|Overall Study|Tumor not of the required cell histology|0|||
146143576|NCT02212730|527039467|FG000|Overall Study|Withdrawal by Subject|1|||
146143577|NCT02212730|527039468|FG001|Overall Study|Withdrawal by Subject|0|||
146143578|NCT02212730|527039467|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
146272415|NCT05000216|527512445|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
146272416|NCT05000216|527512446|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272417|NCT05000216|527512447|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272418|NCT05000216|527512448|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
146272419|NCT05000216|527512449|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272420|NCT05000216|527512450|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272421|NCT05000216|527512451|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
146272422|NCT02057575|527512453|FG000|Overall Study|Adverse Event|0|||
146272423|NCT02057575|527512454|FG001|Overall Study|Adverse Event|2|||
146272424|NCT02057575|527512455|FG002|Overall Study|Adverse Event|0|||
146272425|NCT02057575|527512456|FG003|Overall Study|Adverse Event|1|||
146272426|NCT02057575|527512453|FG000|Overall Study|Withdrawal by Subject|1|||
146272427|NCT02057575|527512454|FG001|Overall Study|Withdrawal by Subject|0|||
146272428|NCT02057575|527512455|FG002|Overall Study|Withdrawal by Subject|0|||
146272429|NCT02057575|527512456|FG003|Overall Study|Withdrawal by Subject|0|||
146272430|NCT02057575|527512453|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
146272431|NCT02057575|527512454|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
146272432|NCT02057575|527512455|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
146272433|NCT02057575|527512456|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
146272434|NCT02057575|527512453|FG000|Overall Study|Protocol Violation|0|||
146272435|NCT02057575|527512454|FG001|Overall Study|Protocol Violation|1|||
146272436|NCT02057575|527512455|FG002|Overall Study|Protocol Violation|0|||
146272437|NCT02057575|527512456|FG003|Overall Study|Protocol Violation|0|||
146272438|NCT00332462|527512457|FG000|Overall Study|Adverse Event|5|||
146272439|NCT00332462|527512457|FG000|Overall Study|Abnormal Lab Value|1|||
146272440|NCT00332462|527512457|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146272441|NCT00332462|527512457|FG000|Overall Study|no longer requires study drug|1|||
146272442|NCT00332462|527512457|FG000|Overall Study|Death|3|||
146272443|NCT00332462|527512457|FG000|Overall Study|Graft Loss|2|||
146272444|NCT02922023|527512458|FG000|Overall Study|Lost to Follow-up|2|||
146272445|NCT02922023|527512459|FG001|Overall Study|Lost to Follow-up|0|||
146272446|NCT00863681|527512460|FG000|Overall Study|Other|2|||
146272447|NCT00863681|527512461|FG001|Overall Study|Other|0|||
146272448|NCT00863681|527512462|FG002|Overall Study|Other|0|||
146272449|NCT00863681|527512460|FG000|Overall Study|Missing|1|||
146272450|NCT00863681|527512461|FG001|Overall Study|Missing|0|||
146272451|NCT00863681|527512462|FG002|Overall Study|Missing|0|||
146272452|NCT00863681|527512460|FG000|Overall Study|Death|40|||
146272453|NCT00863681|527512461|FG001|Overall Study|Death|23|||
146272454|NCT00863681|527512462|FG002|Overall Study|Death|6|||
146272455|NCT00863681|527512460|FG000|Overall Study|Withdrawal by Subject|12|||
146272456|NCT00863681|527512461|FG001|Overall Study|Withdrawal by Subject|5|||
146272457|NCT00863681|527512462|FG002|Overall Study|Withdrawal by Subject|2|||
146272458|NCT00863681|527512460|FG000|Overall Study|Protocol Violation|2|||
146272459|NCT00863681|527512461|FG001|Overall Study|Protocol Violation|0|||
146272460|NCT00863681|527512462|FG002|Overall Study|Protocol Violation|0|||
146272461|NCT00863681|527512460|FG000|Overall Study|Lost to Follow-up|3|||
146272462|NCT00863681|527512461|FG001|Overall Study|Lost to Follow-up|0|||
146272463|NCT00863681|527512462|FG002|Overall Study|Lost to Follow-up|3|||
146272464|NCT00863681|527512460|FG000|Overall Study|Adverse Event|28|||
146272465|NCT00863681|527512461|FG001|Overall Study|Adverse Event|10|||
146272466|NCT00863681|527512462|FG002|Overall Study|Adverse Event|6|||
146272467|NCT00863681|527512460|FG000|Overall Study|Lack of Efficacy|2|||
146272468|NCT00863681|527512461|FG001|Overall Study|Lack of Efficacy|2|||
146272469|NCT00863681|527512462|FG002|Overall Study|Lack of Efficacy|1|||
146272470|NCT00863681|527512460|FG000|Overall Study|Non-compliance with study drug|1|||
146272471|NCT00863681|527512461|FG001|Overall Study|Non-compliance with study drug|3|||
146272472|NCT00863681|527512462|FG002|Overall Study|Non-compliance with study drug|0|||
146272473|NCT03842228|527512463|FG000|Overall Study|Adverse Event|1|||
146272474|NCT03842228|527512464|FG001|Overall Study|Adverse Event|1|||
146272475|NCT03842228|527512465|FG002|Overall Study|Adverse Event|1|||
146272476|NCT03842228|527512466|FG003|Overall Study|Adverse Event|0|||
146272477|NCT03842228|527512467|FG004|Overall Study|Adverse Event|0|||
146272478|NCT03842228|527512468|FG005|Overall Study|Adverse Event|0|||
146272479|NCT03842228|527512469|FG006|Overall Study|Adverse Event|0|||
146272480|NCT03842228|527512463|FG000|Overall Study|Death|0|||
146272481|NCT03842228|527512464|FG001|Overall Study|Death|1|||
146272482|NCT03842228|527512465|FG002|Overall Study|Death|0|||
146272483|NCT03842228|527512466|FG003|Overall Study|Death|0|||
146272484|NCT03842228|527512467|FG004|Overall Study|Death|0|||
146272485|NCT03842228|527512468|FG005|Overall Study|Death|0|||
146272486|NCT03842228|527512469|FG006|Overall Study|Death|0|||
146304304|NCT01480284|527629171|FG000|Overall Study|Withdrawal by Subject|2|||
146272487|NCT03842228|527512463|FG000|Overall Study|Withdrawal by Subject|0|||
146272488|NCT03842228|527512464|FG001|Overall Study|Withdrawal by Subject|0|||
146272489|NCT03842228|527512465|FG002|Overall Study|Withdrawal by Subject|2|||
146272490|NCT03842228|527512466|FG003|Overall Study|Withdrawal by Subject|1|||
146272491|NCT03842228|527512467|FG004|Overall Study|Withdrawal by Subject|0|||
146272492|NCT03842228|527512468|FG005|Overall Study|Withdrawal by Subject|0|||
146272493|NCT03842228|527512469|FG006|Overall Study|Withdrawal by Subject|2|||
146272494|NCT03842228|527512463|FG000|Overall Study|Progression|8|||
146272495|NCT03842228|527512464|FG001|Overall Study|Progression|1|||
146272496|NCT03842228|527512465|FG002|Overall Study|Progression|7|||
146272497|NCT03842228|527512466|FG003|Overall Study|Progression|5|||
146272498|NCT03842228|527512467|FG004|Overall Study|Progression|4|||
146272499|NCT03842228|527512468|FG005|Overall Study|Progression|2|||
146272500|NCT03842228|527512469|FG006|Overall Study|Progression|3|||
146272501|NCT01263509|527512470|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
146272502|NCT01263509|527512471|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
146272503|NCT01263509|527512472|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
146272504|NCT01263509|527512473|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
146272505|NCT01263509|527512470|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146272506|NCT01263509|527512471|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
146272507|NCT01263509|527512472|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
146272508|NCT01263509|527512473|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146272509|NCT01263509|527512470|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146272510|NCT01263509|527512471|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146272511|NCT01263509|527512472|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146272512|NCT01263509|527512473|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146272513|NCT01263509|527512470|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146272514|NCT01263509|527512471|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
146272515|NCT01263509|527512472|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146272516|NCT01263509|527512473|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
146272517|NCT01263509|527512470|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146272518|NCT01263509|527512471|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146272519|NCT01263509|527512472|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
146272520|NCT01263509|527512473|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
146272521|NCT01374568|527512478|FG000|Overall Study|Lab unable to analyze BTM|0|||
146272522|NCT01374568|527512479|FG001|Overall Study|Lab unable to analyze BTM|2|||
146272523|NCT02269423|527512483|FG000|Overall Study|Discontinued due to change in residence|0|||
146272524|NCT02269423|527512484|FG001|Overall Study|Discontinued due to change in residence|1|||
146272525|NCT02269423|527512485|FG002|Overall Study|Discontinued due to change in residence|0|||
146272526|NCT02269423|527512486|FG003|Overall Study|Discontinued due to change in residence|1|||
146272527|NCT04916730|527512489|FG000|Overall Study|Withdrawal by Subject|4|||
146272528|NCT04916730|527512490|FG001|Overall Study|Withdrawal by Subject|2|||
146272529|NCT04916730|527512489|FG000|Overall Study|Lost to Follow-up|0|||
146272530|NCT04916730|527512490|FG001|Overall Study|Lost to Follow-up|2|||
146272531|NCT04916730|527512489|FG000|Overall Study|Physician Decision|1|||
146272532|NCT04916730|527512490|FG001|Overall Study|Physician Decision|0|||
146272533|NCT02514551|527512493|FG000|Overall Study|Lost to Follow-up|0|||
146272534|NCT02514551|527512494|FG001|Overall Study|Lost to Follow-up|1|||
146272535|NCT02514551|527512493|FG000|Overall Study|Participant Never Treated|0|||
146272536|NCT02514551|527512494|FG001|Overall Study|Participant Never Treated|2|||
146272537|NCT00996606|527512495|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
146272538|NCT00996606|527512495|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146272539|NCT00996606|527512495|FG000|Overall Study|Protocol Violation|1|||
146272540|NCT00996606|527512495|FG000|Overall Study|Withdrawal by Subject|3|||
146272541|NCT00632502|527512500|FG000|Overall Study|Adverse Event|0|||
146272542|NCT00632502|527512501|FG001|Overall Study|Adverse Event|1|||
146272543|NCT00632502|527512500|FG000|Overall Study|Randomized not treated|3|||
146272544|NCT00632502|527512501|FG001|Overall Study|Randomized not treated|0|||
146272545|NCT04954326|527512502|FG000|Overall Study|Protocol Violation|0|||
146272546|NCT04954326|527512503|FG001|Overall Study|Protocol Violation|1|||
146272547|NCT04954326|527512502|FG000|Overall Study|Death|0|||
146272548|NCT04954326|527512503|FG001|Overall Study|Death|2|||
146272549|NCT04954326|527512502|FG000|Overall Study|Physician Decision|0|||
146272550|NCT04954326|527512503|FG001|Overall Study|Physician Decision|1|||
146272551|NCT00277095|527512504|FG000|Overall Study|Death|2|||
146272552|NCT00277095|527512504|FG000|Overall Study|Explanted|7|||
146304305|NCT01480284|527629172|FG001|Overall Study|Withdrawal by Subject|0|||
146304306|NCT01480284|527629171|FG000|Overall Study|Adverse Event|1|||
146304307|NCT01480284|527629172|FG001|Overall Study|Adverse Event|0|||
146304308|NCT01480284|527629171|FG000|Overall Study|Study closed/terminated|3|||
146272553|NCT00277095|527512504|FG000|Overall Study|Lost to Follow-up|2|||
146272554|NCT00277095|527512504|FG000|Overall Study|Missed Follow-up|9|||
146272555|NCT00277095|527512504|FG000|Overall Study|Physician Decision|1|||
146272556|NCT01213524|527512505|FG000|Baseline|Withdrawal by Subject|5|||
146272557|NCT01213524|527512505|FG000|Baseline|high breath alcohol levels|1|||
146272558|NCT01213524|527512505|FG000|Baseline|Physician Decision|1|||
146272559|NCT01213524|527512505|FG000|Session 2|Withdrawal by Subject|5|||
146272560|NCT01213524|527512505|FG000|Session 3|Withdrawal by Subject|4|||
146304309|NCT01480284|527629172|FG001|Overall Study|Study closed/terminated|0|||
146272561|NCT01213524|527512505|FG000|Session 4|Physician Decision|1|||
146272562|NCT01213524|527512505|FG000|Session 4|Withdrawal by Subject|2|||
146272563|NCT02519348|527512511|FG000|Overall Study|Death|31|||
146272564|NCT02519348|527512512|FG001|Overall Study|Death|74|||
146272565|NCT02519348|527512513|FG002|Overall Study|Death|47|||
146272566|NCT02519348|527512514|FG003|Overall Study|Death|54|||
146272567|NCT02519348|527512515|FG004|Overall Study|Death|63|||
146272568|NCT02519348|527512516|FG005|Overall Study|Death|18|||
146272569|NCT02519348|527512517|FG006|Overall Study|Death|2|||
146272570|NCT02519348|527512518|FG007|Overall Study|Death|5|||
146272571|NCT02519348|527512519|FG008|Overall Study|Death|5|||
146272572|NCT02519348|527512511|FG000|Overall Study|Withdrawal by Subject|4|||
146272573|NCT02519348|527512512|FG001|Overall Study|Withdrawal by Subject|7|||
146272574|NCT02519348|527512513|FG002|Overall Study|Withdrawal by Subject|4|||
146272575|NCT02519348|527512514|FG003|Overall Study|Withdrawal by Subject|3|||
146272576|NCT02519348|527512515|FG004|Overall Study|Withdrawal by Subject|3|||
146272577|NCT02519348|527512516|FG005|Overall Study|Withdrawal by Subject|2|||
146272578|NCT02519348|527512517|FG006|Overall Study|Withdrawal by Subject|0|||
146272579|NCT02519348|527512518|FG007|Overall Study|Withdrawal by Subject|0|||
146272580|NCT02519348|527512519|FG008|Overall Study|Withdrawal by Subject|1|||
146272581|NCT02519348|527512511|FG000|Overall Study|Lost to Follow-up|0|||
146272582|NCT02519348|527512512|FG001|Overall Study|Lost to Follow-up|0|||
146272583|NCT02519348|527512513|FG002|Overall Study|Lost to Follow-up|1|||
146272584|NCT02519348|527512514|FG003|Overall Study|Lost to Follow-up|0|||
146272585|NCT02519348|527512515|FG004|Overall Study|Lost to Follow-up|2|||
146272586|NCT02519348|527512516|FG005|Overall Study|Lost to Follow-up|1|||
146272587|NCT02519348|527512517|FG006|Overall Study|Lost to Follow-up|1|||
146272588|NCT02519348|527512518|FG007|Overall Study|Lost to Follow-up|0|||
146272589|NCT02519348|527512519|FG008|Overall Study|Lost to Follow-up|0|||
146272590|NCT02519348|527512511|FG000|Overall Study|Other|0|||
146272591|NCT02519348|527512512|FG001|Overall Study|Other|3|||
146272592|NCT02519348|527512513|FG002|Overall Study|Other|0|||
146272593|NCT02519348|527512514|FG003|Overall Study|Other|0|||
146272594|NCT02519348|527512515|FG004|Overall Study|Other|1|||
146272595|NCT02519348|527512516|FG005|Overall Study|Other|0|||
146272596|NCT02519348|527512517|FG006|Overall Study|Other|0|||
146272597|NCT02519348|527512518|FG007|Overall Study|Other|0|||
146272598|NCT02519348|527512519|FG008|Overall Study|Other|0|||
146272599|NCT02519348|527512511|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
146272600|NCT02519348|527512512|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
146272601|NCT02519348|527512513|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
146272602|NCT02519348|527512514|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
146272603|NCT02519348|527512515|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
146272604|NCT02519348|527512516|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
146272605|NCT02519348|527512517|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
146272606|NCT02519348|527512518|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
146272607|NCT02519348|527512519|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
146272608|NCT05415748|527512523|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
146272609|NCT05415748|527512524|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
146272610|NCT05415748|527512525|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
146272611|NCT05415748|527512526|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
146272612|NCT05415748|527512523|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
146272613|NCT05415748|527512524|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146272614|NCT05415748|527512525|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146272615|NCT05415748|527512526|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
146272616|NCT03075527|527512527|FG000|Overall Study|Death|1|||
146272617|NCT03075527|527512527|FG000|Overall Study|Withdrawal by Subject|1|||
146272618|NCT03075527|527512527|FG000|Overall Study|Physician Decision|3|||
146272619|NCT03075527|527512527|FG000|Overall Study|Progression/Relapse|14|||
146272620|NCT05239598|527512531|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
146272621|NCT05239598|527512532|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
146272622|NCT05239598|527512531|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
146272623|NCT05239598|527512532|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
146272624|NCT02998476|527512533|FG000|Overall Study|Lost to Follow-up|1|||
146143579|NCT02212730|527039468|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
146143580|NCT01777997|527039471|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
146143581|NCT01777997|527039471|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
146272625|NCT02998476|527512534|FG001|Overall Study|Lost to Follow-up|0|||
146143582|NCT01777997|527039471|FG000|Weeks 48 to 72/96 on ART|Death|1|||
146272626|NCT02998476|527512533|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
146143583|NCT01777997|527039471|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
146272627|NCT02998476|527512534|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
146272628|NCT02998476|527512533|FG000|Overall Study|Withdrawal by Subject|1|||
146272629|NCT02998476|527512534|FG001|Overall Study|Withdrawal by Subject|2|||
146272630|NCT02998476|527512533|FG000|Overall Study|Death|45|||
146143584|NCT01694706|527039472|FG000|Overall Study|Adverse Event|0|||
146272631|NCT02998476|527512534|FG001|Overall Study|Death|2|||
146272632|NCT02998476|527512533|FG000|Overall Study|Other|6|||
146272633|NCT02998476|527512534|FG001|Overall Study|Other|1|||
146272634|NCT05855967|527512535|FG000|Overall Study|Withdrawal by Subject|7|||
146272635|NCT05855967|527512536|FG001|Overall Study|Withdrawal by Subject|5|||
146272636|NCT05855967|527512535|FG000|Overall Study|Lost to Follow-up|2|||
146272637|NCT05855967|527512536|FG001|Overall Study|Lost to Follow-up|1|||
146272638|NCT01435772|527512537|FG000|Overall Study|Adverse Event|1|||
146272639|NCT01435772|527512538|FG001|Overall Study|Adverse Event|0|||
146272640|NCT01435772|527512539|FG002|Overall Study|Adverse Event|2|||
146272641|NCT01435772|527512537|FG000|Overall Study|Withdrawal by Subject|0|||
146272642|NCT01435772|527512538|FG001|Overall Study|Withdrawal by Subject|1|||
146272643|NCT01435772|527512539|FG002|Overall Study|Withdrawal by Subject|3|||
146272644|NCT01435772|527512537|FG000|Overall Study|Other - study termination|2|||
146272645|NCT01435772|527512538|FG001|Overall Study|Other - study termination|2|||
146272646|NCT01435772|527512539|FG002|Overall Study|Other - study termination|10|||
146272647|NCT03238963|527512540|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
146272648|NCT03238963|527512541|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
146272649|NCT03238963|527512540|FG000|Overall Study|Withdrawal by Subject|1|||
146272650|NCT03238963|527512541|FG001|Overall Study|Withdrawal by Subject|1|||
146143585|NCT01694706|527039473|FG001|Overall Study|Adverse Event|1|||
146143586|NCT01694706|527039474|FG002|Overall Study|Adverse Event|0|||
146143587|NCT01694706|527039472|FG000|Overall Study|other reason not defined above|1|||
146143588|NCT01694706|527039473|FG001|Overall Study|other reason not defined above|0|||
146143589|NCT01694706|527039474|FG002|Overall Study|other reason not defined above|0|||
146143590|NCT00975975|527039475|FG000|Overall Study|Death|6|||
146143591|NCT01923181|527039476|FG000|Overall Study|Protocol Violation|2|||
146143592|NCT01923181|527039477|FG001|Overall Study|Protocol Violation|2|||
146143593|NCT01923181|527039478|FG002|Overall Study|Protocol Violation|0|||
146143594|NCT01923181|527039479|FG003|Overall Study|Protocol Violation|2|||
146143595|NCT01923181|527039480|FG004|Overall Study|Protocol Violation|2|||
146143596|NCT01923181|527039481|FG005|Overall Study|Protocol Violation|1|||
146143597|NCT01923181|527039482|FG006|Overall Study|Protocol Violation|1|||
146143598|NCT01923181|527039483|FG007|Overall Study|Protocol Violation|2|||
146143599|NCT01923181|527039484|FG008|Overall Study|Protocol Violation|1|||
146143600|NCT01923181|527039476|FG000|Overall Study|Withdrawal by Subject|0|||
146143601|NCT01923181|527039477|FG001|Overall Study|Withdrawal by Subject|1|||
146143602|NCT01923181|527039478|FG002|Overall Study|Withdrawal by Subject|0|||
146143603|NCT01923181|527039479|FG003|Overall Study|Withdrawal by Subject|1|||
146143604|NCT01923181|527039480|FG004|Overall Study|Withdrawal by Subject|4|||
146143605|NCT01923181|527039481|FG005|Overall Study|Withdrawal by Subject|2|||
146143606|NCT01923181|527039482|FG006|Overall Study|Withdrawal by Subject|4|||
146143607|NCT01923181|527039483|FG007|Overall Study|Withdrawal by Subject|3|||
146143608|NCT01923181|527039484|FG008|Overall Study|Withdrawal by Subject|1|||
146143609|NCT01923181|527039476|FG000|Overall Study|Other|1|||
146143610|NCT01923181|527039477|FG001|Overall Study|Other|0|||
146143611|NCT01923181|527039478|FG002|Overall Study|Other|0|||
146143612|NCT01923181|527039479|FG003|Overall Study|Other|1|||
146143613|NCT01923181|527039480|FG004|Overall Study|Other|0|||
146143614|NCT01923181|527039481|FG005|Overall Study|Other|0|||
146143615|NCT01923181|527039482|FG006|Overall Study|Other|0|||
146143616|NCT01923181|527039483|FG007|Overall Study|Other|0|||
146143617|NCT01923181|527039484|FG008|Overall Study|Other|0|||
146143618|NCT01923181|527039476|FG000|Overall Study|Lost to Follow-up|0|||
146143619|NCT01923181|527039477|FG001|Overall Study|Lost to Follow-up|3|||
146143620|NCT01923181|527039478|FG002|Overall Study|Lost to Follow-up|2|||
146143621|NCT01923181|527039479|FG003|Overall Study|Lost to Follow-up|1|||
146143622|NCT01923181|527039480|FG004|Overall Study|Lost to Follow-up|2|||
146143623|NCT01923181|527039481|FG005|Overall Study|Lost to Follow-up|1|||
146143624|NCT01923181|527039482|FG006|Overall Study|Lost to Follow-up|3|||
146272651|NCT03238963|527512540|FG000|Overall Study|Lost to Follow-up|1|||
146272652|NCT03238963|527512541|FG001|Overall Study|Lost to Follow-up|0|||
146272653|NCT03238963|527512540|FG000|Overall Study|Protocol Violation|1|||
146272654|NCT03238963|527512541|FG001|Overall Study|Protocol Violation|1|||
146272655|NCT03238963|527512540|FG000|Overall Study|Adverse Event|1|||
146272656|NCT03238963|527512541|FG001|Overall Study|Adverse Event|0|||
146143625|NCT01923181|527039483|FG007|Overall Study|Lost to Follow-up|3|||
146143626|NCT01923181|527039484|FG008|Overall Study|Lost to Follow-up|1|||
146143627|NCT02944578|527039485|FG000|Overall Study|Physician Decision|1|||
146143628|NCT02944578|527039486|FG001|Overall Study|Physician Decision|0|||
146143629|NCT02932891|527039488|FG000|Overall Study|Lost to Follow-up|2|||
146143630|NCT02932891|527039488|FG000|Overall Study|HPA Suppress|2|||
146143631|NCT00577122|527039491|FG000|Overall Study|Adverse Event|0|||
146143632|NCT00577122|527039492|FG001|Overall Study|Adverse Event|2|||
146143633|NCT00577122|527039491|FG000|Overall Study|Progression, relapse during active trt|6|||
146143634|NCT00577122|527039492|FG001|Overall Study|Progression, relapse during active trt|8|||
146272657|NCT06926673|527512542|FG000|Overall Study|Lost to Follow-up|0|||
146272658|NCT06926673|527512543|FG001|Overall Study|Lost to Follow-up|0|||
146272659|NCT06926673|527512544|FG002|Overall Study|Lost to Follow-up|0|||
146143635|NCT00577122|527039491|FG000|Overall Study|Prog, refract disease during active trt|8|||
146143636|NCT00577122|527039492|FG001|Overall Study|Prog, refract disease during active trt|5|||
146143637|NCT00577122|527039491|FG000|Overall Study|Alternative Therapy|0|||
146143638|NCT00577122|527039492|FG001|Overall Study|Alternative Therapy|1|||
146143639|NCT00440271|527039494|FG000|Overall Study|Protocol Violation|1|||
146143640|NCT00440271|527039495|FG001|Overall Study|Protocol Violation|1|||
146143641|NCT00440271|527039494|FG000|Overall Study|Adverse Event|0|||
146143642|NCT00440271|527039495|FG001|Overall Study|Adverse Event|1|||
146143643|NCT00440271|527039494|FG000|Overall Study|Lost to Follow-up|1|||
146143644|NCT00440271|527039495|FG001|Overall Study|Lost to Follow-up|0|||
146143645|NCT00440271|527039494|FG000|Overall Study|Withdrawal by Subject|0|||
146143646|NCT00440271|527039495|FG001|Overall Study|Withdrawal by Subject|2|||
146143647|NCT00440271|527039494|FG000|Overall Study|Lack of Efficacy|0|||
146143648|NCT00440271|527039495|FG001|Overall Study|Lack of Efficacy|1|||
146143649|NCT00440271|527039494|FG000|Overall Study|Due to closure of trial|8|||
146143650|NCT00440271|527039495|FG001|Overall Study|Due to closure of trial|10|||
146143651|NCT00440271|527039494|FG000|Overall Study|Other|2|||
146143652|NCT00440271|527039495|FG001|Overall Study|Other|0|||
146143653|NCT00456092|527039496|FG000|Extension Phase|Grade 2 or Greater AE|2|||
146143654|NCT00456092|527039497|FG001|Extension Phase|Grade 2 or Greater AE|2|||
146143655|NCT00456092|527039498|FG002|Extension Phase|Grade 2 or Greater AE|0|||
146143656|NCT00456092|527039499|FG003|Extension Phase|Grade 2 or Greater AE|0|||
146143657|NCT00456092|527039500|FG004|Extension Phase|Grade 2 or Greater AE|2|||
146143658|NCT00456092|527039496|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
146143659|NCT00456092|527039497|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
146143660|NCT00456092|527039498|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
146143661|NCT00456092|527039499|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
146143662|NCT00456092|527039500|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
146143663|NCT00456092|527039496|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
146143664|NCT00456092|527039497|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
146143665|NCT00456092|527039498|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
146143666|NCT00456092|527039499|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
146143667|NCT00456092|527039500|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
146143668|NCT00456092|527039496|FG000|Extension Phase|Withdrew Consent|2|||
146143669|NCT00456092|527039497|FG001|Extension Phase|Withdrew Consent|0|||
146143670|NCT00456092|527039498|FG002|Extension Phase|Withdrew Consent|0|||
146143671|NCT00456092|527039499|FG003|Extension Phase|Withdrew Consent|0|||
146143672|NCT00456092|527039500|FG004|Extension Phase|Withdrew Consent|0|||
146143673|NCT00456092|527039496|FG000|Extension Phase|Lost to Follow-up|1|||
146143674|NCT00456092|527039497|FG001|Extension Phase|Lost to Follow-up|1|||
146143675|NCT00456092|527039498|FG002|Extension Phase|Lost to Follow-up|0|||
146143676|NCT00456092|527039499|FG003|Extension Phase|Lost to Follow-up|0|||
146143677|NCT00456092|527039500|FG004|Extension Phase|Lost to Follow-up|1|||
146143678|NCT00456092|527039496|FG000|Extension Phase|Other|2|||
146143679|NCT00456092|527039497|FG001|Extension Phase|Other|0|||
146143680|NCT00456092|527039498|FG002|Extension Phase|Other|0|||
146143681|NCT00456092|527039499|FG003|Extension Phase|Other|1|||
146143682|NCT00456092|527039500|FG004|Extension Phase|Other|1|||
146143683|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
146143684|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
146143685|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
146143686|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
146143687|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
146143688|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
146143689|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
146143690|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146143691|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146143692|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
146143693|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
146143694|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146143695|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146143696|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146143697|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
146143698|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146143699|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
146143700|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
146143701|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146143702|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
146143703|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146143704|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
146143705|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
146143706|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146272660|NCT06926673|527512545|FG003|Overall Study|Lost to Follow-up|1|||
146272661|NCT06926673|527512546|FG004|Overall Study|Lost to Follow-up|0|||
146272662|NCT06926673|527512547|FG005|Overall Study|Lost to Follow-up|0|||
146272663|NCT06926673|527512548|FG006|Overall Study|Lost to Follow-up|0|||
146272664|NCT06926673|527512542|FG000|Overall Study|Physician Decision|0|||
146272665|NCT06926673|527512543|FG001|Overall Study|Physician Decision|0|||
146272666|NCT06926673|527512544|FG002|Overall Study|Physician Decision|0|||
146272667|NCT06926673|527512545|FG003|Overall Study|Physician Decision|0|||
146272668|NCT06926673|527512546|FG004|Overall Study|Physician Decision|0|||
146272669|NCT06926673|527512547|FG005|Overall Study|Physician Decision|0|||
146272670|NCT06926673|527512548|FG006|Overall Study|Physician Decision|1|||
146272671|NCT06926673|527512542|FG000|Overall Study|Withdrawal by Subject|0|||
146272672|NCT06926673|527512543|FG001|Overall Study|Withdrawal by Subject|3|||
146272673|NCT06926673|527512544|FG002|Overall Study|Withdrawal by Subject|2|||
146272674|NCT06926673|527512545|FG003|Overall Study|Withdrawal by Subject|1|||
146272675|NCT06926673|527512546|FG004|Overall Study|Withdrawal by Subject|0|||
146272676|NCT06926673|527512547|FG005|Overall Study|Withdrawal by Subject|2|||
146272677|NCT06926673|527512548|FG006|Overall Study|Withdrawal by Subject|0|||
146272678|NCT01424813|527512549|FG000|Overall Study|Withdrawal by Subject|3|||
146272679|NCT01424813|527512550|FG001|Overall Study|Withdrawal by Subject|0|||
146272680|NCT01424813|527512549|FG000|Overall Study|Protocol Violation|1|||
146272681|NCT01424813|527512550|FG001|Overall Study|Protocol Violation|0|||
146272682|NCT01424813|527512549|FG000|Overall Study|Other|1|||
146272683|NCT01424813|527512550|FG001|Overall Study|Other|2|||
146272684|NCT01920477|527513998|FG000|Overall Study|Adverse Event|0|||
146272685|NCT01920477|527513999|FG001|Overall Study|Adverse Event|1|||
146272686|NCT01920477|527513998|FG000|Overall Study|Lack of Efficacy|1|||
146272687|NCT01920477|527513999|FG001|Overall Study|Lack of Efficacy|0|||
146272688|NCT01920477|527513998|FG000|Overall Study|Study closed/terminated|14|||
146272689|NCT01920477|527513999|FG001|Overall Study|Study closed/terminated|15|||
146272690|NCT01920477|527513998|FG000|Overall Study|Withdrawal by Subject|0|||
146272691|NCT01920477|527513999|FG001|Overall Study|Withdrawal by Subject|1|||
146272692|NCT01681277|527514000|FG000|Overall Study|Adverse Event|1|||
146272693|NCT01681277|527514001|FG001|Overall Study|Adverse Event|0|||
146143707|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
146143708|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146143709|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
146143710|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
146143711|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146143712|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
146143713|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146143714|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
146143715|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
146143716|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146143717|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
146143718|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146143719|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146143720|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
146143721|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146143722|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
146143723|NCT00456092|527039496|FG000|Treatment Phase (12 Weeks)|Other|1|||
146143724|NCT00456092|527039497|FG001|Treatment Phase (12 Weeks)|Other|0|||
146143725|NCT00456092|527039498|FG002|Treatment Phase (12 Weeks)|Other|1|||
146143726|NCT00456092|527039499|FG003|Treatment Phase (12 Weeks)|Other|0|||
146143727|NCT00456092|527039500|FG004|Treatment Phase (12 Weeks)|Other|0|||
146143728|NCT00563797|527039515|FG000|Overall Study|Lost to Follow-up|7|||
146143729|NCT00563797|527039516|FG001|Overall Study|Lost to Follow-up|2|||
146143730|NCT02809976|527039517|FG000|Overall Study|Lost to Follow-up|1|||
146143731|NCT02809976|527039517|FG000|Overall Study|Withdrawal by Subject|1|||
146143732|NCT00211081|527039518|FG000|Overall Study|Withdrawal by Subject|2|||
146143733|NCT03755765|527039523|FG000|Overall Study|Withdrawal by Subject|2|||
146143734|NCT03755765|527039524|FG001|Overall Study|Withdrawal by Subject|4|||
146143735|NCT03755765|527039525|FG002|Overall Study|Withdrawal by Subject|4|||
146143736|NCT02104557|527039526|FG000|Overall Study|Adverse Event|24|||
146272694|NCT01681277|527514002|FG002|Overall Study|Adverse Event|0|||
146272695|NCT01681277|527514003|FG003|Overall Study|Adverse Event|0|||
146272696|NCT01681277|527514004|FG004|Overall Study|Adverse Event|0|||
146304310|NCT01480284|527629171|FG000|Overall Study|Lost to Follow-up|1|||
146304311|NCT01480284|527629172|FG001|Overall Study|Lost to Follow-up|0|||
146143737|NCT02104557|527039526|FG000|Overall Study|Lost to Follow-up|34|||
146272697|NCT03838731|527514005|FG000|Overall Study|Pregnancy|0|||
146272698|NCT03838731|527514006|FG001|Overall Study|Pregnancy|1|||
146272699|NCT03838731|527514005|FG000|Overall Study|Withdrawal of consent|1|||
146272700|NCT03838731|527514006|FG001|Overall Study|Withdrawal of consent|0|||
146272701|NCT04707664|527514007|FG000|Overall Study|Adverse Event|2|||
146272702|NCT04707664|527514008|FG001|Overall Study|Adverse Event|0|||
146143738|NCT02104557|527039526|FG000|Overall Study|Violated the usage and dosage|14|||
146143739|NCT02104557|527039526|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
146143740|NCT02104557|527039526|FG000|Overall Study|Administered Sayana prior to the contract|1|||
146143741|NCT02104557|527039526|FG000|Overall Study|Other|17|||
146143742|NCT02104557|527039526|FG000|Overall Study|Change to other contraception methods|5|||
146143743|NCT02104557|527039526|FG000|Overall Study|Discontinuation due to no pain|1|||
146143744|NCT02104557|527039526|FG000|Overall Study|Withdrawal consent|2|||
146143745|NCT02104557|527039526|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
146143746|NCT02104557|527039526|FG000|Overall Study|Discontinuation of contraception|9|||
146143747|NCT01490060|527039532|FG000|Cycle 1|Change of Treatment|0|||
146143748|NCT01490060|527039533|FG001|Cycle 1|Change of Treatment|1|||
146143749|NCT01490060|527039534|FG002|Cycle 1|Change of Treatment|1|||
146143750|NCT01490060|527039535|FG003|Cycle 1|Change of Treatment|1|||
146143751|NCT01490060|527039532|FG000|Cycle 1|Insurance Denied|0|||
146143752|NCT01490060|527039533|FG001|Cycle 1|Insurance Denied|0|||
146143753|NCT01490060|527039534|FG002|Cycle 1|Insurance Denied|2|||
146143754|NCT01490060|527039535|FG003|Cycle 1|Insurance Denied|0|||
146143755|NCT01490060|527039532|FG000|Cycle 1|Withdrawal by Subject|0|||
146143756|NCT01490060|527039533|FG001|Cycle 1|Withdrawal by Subject|0|||
146143757|NCT01490060|527039534|FG002|Cycle 1|Withdrawal by Subject|0|||
146143758|NCT01490060|527039535|FG003|Cycle 1|Withdrawal by Subject|1|||
146143759|NCT01490060|527039532|FG000|Cycle 1|Treatment at Another Facility|0|||
146143760|NCT01490060|527039533|FG001|Cycle 1|Treatment at Another Facility|0|||
146143761|NCT01490060|527039534|FG002|Cycle 1|Treatment at Another Facility|0|||
146143762|NCT01490060|527039535|FG003|Cycle 1|Treatment at Another Facility|1|||
146143763|NCT01490060|527039532|FG000|Cycle 2|Change of Treatment|1|||
146143764|NCT01490060|527039533|FG001|Cycle 2|Change of Treatment|1|||
146143765|NCT01490060|527039534|FG002|Cycle 2|Change of Treatment|0|||
146143766|NCT01490060|527039535|FG003|Cycle 2|Change of Treatment|0|||
146143767|NCT01490060|527039532|FG000|Cycle 2|Non-Compliance|0|||
146143768|NCT01490060|527039533|FG001|Cycle 2|Non-Compliance|0|||
146143769|NCT01490060|527039534|FG002|Cycle 2|Non-Compliance|1|||
146143770|NCT01490060|527039535|FG003|Cycle 2|Non-Compliance|0|||
146143771|NCT01490060|527039532|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
146143772|NCT01490060|527039533|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146143773|NCT01490060|527039534|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146143774|NCT01490060|527039535|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
146143775|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
146143776|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
146143777|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
146143778|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
146143779|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
146143780|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
146143781|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
146143782|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
146143783|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
146143784|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
146143785|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
146143786|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
146143787|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
146143788|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
146143789|NCT02464969|527039538|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
146143790|NCT02464969|527039539|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
146143791|NCT02464969|527039538|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
146143792|NCT02464969|527039539|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
146143793|NCT02464969|527039538|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
146143794|NCT02464969|527039539|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
146143795|NCT02464969|527039538|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
146143796|NCT02464969|527039539|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
146143797|NCT02863354|527039540|FG000|Year 1|Lost to Follow-up|1|||
146143798|NCT02863354|527039541|FG001|Year 1|Lost to Follow-up|1|||
146143799|NCT02863354|527039540|FG000|Year 1|Withdrawal by Subject|3|||
146272703|NCT04707664|527514007|FG000|Overall Study|Death|1|||
146272704|NCT04707664|527514008|FG001|Overall Study|Death|2|||
146272705|NCT04707664|527514007|FG000|Overall Study|Withdrawal by Subject|13|||
146272706|NCT04707664|527514008|FG001|Overall Study|Withdrawal by Subject|21|||
146143800|NCT02863354|527039541|FG001|Year 1|Withdrawal by Subject|0|||
146143801|NCT02863354|527039540|FG000|Year 1|Death|0|||
146143802|NCT02863354|527039541|FG001|Year 1|Death|1|||
146143803|NCT02863354|527039540|FG000|Year 2|Lost to Follow-up|2|||
146143804|NCT02863354|527039541|FG001|Year 2|Lost to Follow-up|2|||
146143805|NCT03698773|527039542|FG000|Overall Study|Lost to Follow-up|2|||
146143806|NCT03698773|527039543|FG001|Overall Study|Lost to Follow-up|1|||
146143807|NCT02399085|527039544|FG000|Overall Study|Adverse Event|16|||
146143808|NCT02399085|527039544|FG000|Overall Study|Death|2|||
146272707|NCT04707664|527514007|FG000|Overall Study|Lost to Follow-up|11|||
146272708|NCT04707664|527514008|FG001|Overall Study|Lost to Follow-up|13|||
146272709|NCT04707664|527514007|FG000|Overall Study|Not treated|2|||
146272710|NCT04707664|527514008|FG001|Overall Study|Not treated|0|||
146272711|NCT01182441|527514009|FG000|Overall Study|Patient Still in Follow-up|152|||
146272712|NCT01182441|527514010|FG001|Overall Study|Patient Still in Follow-up|72|||
146272713|NCT01182441|527514009|FG000|Overall Study|Death|37|||
146272714|NCT01182441|527514010|FG001|Overall Study|Death|25|||
146272715|NCT01182441|527514009|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
146272716|NCT01182441|527514010|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
146272717|NCT01182441|527514009|FG000|Overall Study|Lost to Follow-up|5|||
146272718|NCT01182441|527514010|FG001|Overall Study|Lost to Follow-up|8|||
146272719|NCT01182441|527514009|FG000|Overall Study|Withdrawal by Subject|6|||
146272720|NCT01182441|527514010|FG001|Overall Study|Withdrawal by Subject|13|||
146272721|NCT01182441|527514009|FG000|Overall Study|Implant Not Attempted|4|||
146272722|NCT01182441|527514010|FG001|Overall Study|Implant Not Attempted|0|||
146272723|NCT01182441|527514009|FG000|Overall Study|Adverse Event|2|||
146272724|NCT01182441|527514010|FG001|Overall Study|Adverse Event|0|||
146272725|NCT01182441|527514009|FG000|Overall Study|Physician Decision|1|||
146272726|NCT01182441|527514010|FG001|Overall Study|Physician Decision|1|||
146272727|NCT05620108|527514011|FG000|Overall Study|Physician Decision|1|||
146272728|NCT05620108|527514012|FG001|Overall Study|Physician Decision|2|||
146272729|NCT02038842|527514013|FG000|Overall Study|Withdrawal by Subject|2|||
146272730|NCT02038842|527514014|FG001|Overall Study|Withdrawal by Subject|2|||
146272731|NCT02038842|527514015|FG002|Overall Study|Withdrawal by Subject|0|||
146272732|NCT02038842|527514016|FG003|Overall Study|Withdrawal by Subject|0|||
146272733|NCT02038842|527514013|FG000|Overall Study|Participant decision|0|||
146272734|NCT02038842|527514014|FG001|Overall Study|Participant decision|0|||
146272735|NCT02038842|527514015|FG002|Overall Study|Participant decision|2|||
146272736|NCT02038842|527514016|FG003|Overall Study|Participant decision|1|||
146272737|NCT02038842|527514013|FG000|Overall Study|Adverse Event|0|||
146272738|NCT02038842|527514014|FG001|Overall Study|Adverse Event|0|||
146272739|NCT02038842|527514015|FG002|Overall Study|Adverse Event|3|||
146272740|NCT02038842|527514016|FG003|Overall Study|Adverse Event|1|||
146272741|NCT02038842|527514013|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
146272742|NCT02038842|527514014|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
146272743|NCT02038842|527514015|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
146272744|NCT02038842|527514016|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
146272745|NCT01757197|527514019|FG000|Overall Study|Death|2|||
146272746|NCT05332912|527514020|FG000|Overall Study|Withdrawal by Subject|0|||
146272747|NCT05332912|527514021|FG001|Overall Study|Withdrawal by Subject|1|||
146272748|NCT05332912|527514022|FG002|Overall Study|Withdrawal by Subject|2|||
146272749|NCT05332912|527514023|FG003|Overall Study|Withdrawal by Subject|0|||
146272750|NCT05332912|527514020|FG000|Overall Study|Lost to Follow-up|0|||
146272751|NCT05332912|527514021|FG001|Overall Study|Lost to Follow-up|0|||
146272752|NCT05332912|527514022|FG002|Overall Study|Lost to Follow-up|1|||
146272753|NCT05332912|527514023|FG003|Overall Study|Lost to Follow-up|0|||
146272754|NCT02088957|527514024|FG000|Overall Study|Lack of Efficacy|1|||
146272755|NCT02088957|527514025|FG001|Overall Study|Lack of Efficacy|0|||
146272756|NCT01923662|527514026|FG000|Overall Study|Withdrawal by Subject|1|||
146272757|NCT00677534|527514031|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
146272758|NCT00677534|527514031|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
146272759|NCT00677534|527514031|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
146272760|NCT00667394|527514032|FG000|Overall Study|Adverse Event|3|||
146272761|NCT00667394|527514033|FG001|Overall Study|Adverse Event|0|||
146272762|NCT00667394|527514032|FG000|Overall Study|Progressive disease|1|||
146272763|NCT00667394|527514033|FG001|Overall Study|Progressive disease|0|||
146272764|NCT04638660|527514035|FG000|Overall Study|Withdrawal by Subject|2|||
146272765|NCT04638660|527514036|FG001|Overall Study|Withdrawal by Subject|0|||
146272766|NCT04638660|527514035|FG000|Overall Study|Lost to Follow-up|1|||
146272767|NCT04638660|527514036|FG001|Overall Study|Lost to Follow-up|0|||
146272768|NCT04481373|527514037|FG000|Overall Study|Protocol Violation|1|||
146272769|NCT04481373|527514038|FG001|Overall Study|Protocol Violation|0|||
146272770|NCT04481373|527514037|FG000|Overall Study|Viral load in hospital not over 1000|2|||
146272771|NCT04481373|527514038|FG001|Overall Study|Viral load in hospital not over 1000|1|||
146272772|NCT04481373|527514037|FG000|Overall Study|Death before hospital discharge|1|||
146272773|NCT04481373|527514038|FG001|Overall Study|Death before hospital discharge|0|||
146272774|NCT02224703|527514040|FG000|Overall Study|Adverse Event|0|||
146272775|NCT02224703|527514041|FG001|Overall Study|Adverse Event|5|||
146272776|NCT02224703|527514042|FG002|Overall Study|Adverse Event|0|||
146272777|NCT02224703|527514040|FG000|Overall Study|Withdrawn by investigator|1|||
146272778|NCT02224703|527514041|FG001|Overall Study|Withdrawn by investigator|0|||
146272779|NCT02224703|527514042|FG002|Overall Study|Withdrawn by investigator|0|||
146272780|NCT02224703|527514040|FG000|Overall Study|Advised by medical monitor|1|||
146272781|NCT02224703|527514041|FG001|Overall Study|Advised by medical monitor|0|||
146272782|NCT02224703|527514042|FG002|Overall Study|Advised by medical monitor|0|||
146272783|NCT02224703|527514040|FG000|Overall Study|Withdrawn by parent/guardian|0|||
146272784|NCT02224703|527514041|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146143809|NCT02399085|527039544|FG000|Overall Study|Withdrawal by Subject|8|||
146143810|NCT02399085|527039544|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
146143811|NCT02399085|527039544|FG000|Overall Study|Physician Decision|5|||
146143812|NCT00724451|527039548|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
146143813|NCT00724451|527039548|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
146143814|NCT00724451|527039548|FG000|Overall Study|Not Eligible for Treatment|431|||
146143815|NCT00724451|527039548|FG000|Overall Study|Participant Refused Treatment|89|||
146143816|NCT00724451|527039548|FG000|Overall Study|Never Started Treatment|89|||
146143817|NCT00724451|527039548|FG000|Overall Study|Unknown; No Data Sources Available|9|||
146143818|NCT00724451|527039548|FG000|Overall Study|Physician Decision|116|||
146143819|NCT00724451|527039548|FG000|Overall Study|Withdrawal by Subject|45|||
146143820|NCT00724451|527039548|FG000|Overall Study|Investigator + Participant Decision|13|||
146143821|NCT01599650|527039549|FG000|Overall Study|Administrative issue|1|||
146143822|NCT01599650|527039550|FG001|Overall Study|Administrative issue|0|||
146143823|NCT01599650|527039551|FG002|Overall Study|Administrative issue|1|||
146143824|NCT01599650|527039549|FG000|Overall Study|Physician Decision|2|||
146143825|NCT01599650|527039550|FG001|Overall Study|Physician Decision|0|||
146143826|NCT01599650|527039551|FG002|Overall Study|Physician Decision|7|||
146143827|NCT01599650|527039549|FG000|Overall Study|Protocol Violation|0|||
146143828|NCT01599650|527039550|FG001|Overall Study|Protocol Violation|3|||
146143829|NCT01599650|527039551|FG002|Overall Study|Protocol Violation|0|||
146143830|NCT01599650|527039549|FG000|Overall Study|Death|2|||
146143831|NCT01599650|527039550|FG001|Overall Study|Death|1|||
146143832|NCT01599650|527039551|FG002|Overall Study|Death|2|||
146143833|NCT01599650|527039549|FG000|Overall Study|Lost to Follow-up|3|||
146143834|NCT01599650|527039550|FG001|Overall Study|Lost to Follow-up|3|||
146143835|NCT01599650|527039551|FG002|Overall Study|Lost to Follow-up|3|||
146143836|NCT01599650|527039549|FG000|Overall Study|Withdrawal by Subject|11|||
146143837|NCT01599650|527039550|FG001|Overall Study|Withdrawal by Subject|11|||
146143838|NCT01599650|527039551|FG002|Overall Study|Withdrawal by Subject|10|||
146143839|NCT01599650|527039549|FG000|Overall Study|Adverse Event|3|||
146143840|NCT01599650|527039550|FG001|Overall Study|Adverse Event|8|||
146143841|NCT01599650|527039551|FG002|Overall Study|Adverse Event|4|||
146143842|NCT00720876|527039552|FG000|Overall Study|found to be ineligible after starting tx|2|||
146143843|NCT03304379|527039554|FG000|Overall Study|Protocol Violation|8|||
146143844|NCT03304379|527039555|FG001|Overall Study|Protocol Violation|10|||
146143845|NCT03304379|527039556|FG002|Overall Study|Protocol Violation|5|||
146143846|NCT03304379|527039557|FG003|Overall Study|Protocol Violation|0|||
146143847|NCT03304379|527039558|FG004|Overall Study|Protocol Violation|2|||
146143848|NCT03304379|527039554|FG000|Overall Study|Adverse Event|4|||
146143849|NCT03304379|527039555|FG001|Overall Study|Adverse Event|20|||
146143850|NCT03304379|527039556|FG002|Overall Study|Adverse Event|17|||
146143851|NCT03304379|527039557|FG003|Overall Study|Adverse Event|1|||
146143852|NCT03304379|527039558|FG004|Overall Study|Adverse Event|0|||
146143853|NCT03304379|527039554|FG000|Overall Study|Lack of Efficacy|17|||
146143854|NCT03304379|527039555|FG001|Overall Study|Lack of Efficacy|16|||
146143855|NCT03304379|527039556|FG002|Overall Study|Lack of Efficacy|20|||
146143856|NCT03304379|527039557|FG003|Overall Study|Lack of Efficacy|0|||
146143857|NCT03304379|527039558|FG004|Overall Study|Lack of Efficacy|0|||
146143858|NCT03304379|527039554|FG000|Overall Study|Physician Decision|6|||
146143859|NCT03304379|527039555|FG001|Overall Study|Physician Decision|10|||
146143860|NCT03304379|527039556|FG002|Overall Study|Physician Decision|6|||
146143861|NCT03304379|527039557|FG003|Overall Study|Physician Decision|9|||
146143862|NCT03304379|527039558|FG004|Overall Study|Physician Decision|10|||
146143863|NCT03304379|527039554|FG000|Overall Study|Withdrawal by Subject|26|||
146143864|NCT03304379|527039555|FG001|Overall Study|Withdrawal by Subject|58|||
146143865|NCT03304379|527039556|FG002|Overall Study|Withdrawal by Subject|66|||
146143866|NCT03304379|527039557|FG003|Overall Study|Withdrawal by Subject|3|||
146143867|NCT03304379|527039558|FG004|Overall Study|Withdrawal by Subject|5|||
146143868|NCT03304379|527039554|FG000|Overall Study|Lost to Follow-up|8|||
146143869|NCT03304379|527039555|FG001|Overall Study|Lost to Follow-up|24|||
146143870|NCT03304379|527039556|FG002|Overall Study|Lost to Follow-up|35|||
146143871|NCT03304379|527039557|FG003|Overall Study|Lost to Follow-up|4|||
146143872|NCT03304379|527039558|FG004|Overall Study|Lost to Follow-up|0|||
146143873|NCT03304379|527039554|FG000|Overall Study|Death|1|||
146143874|NCT03304379|527039555|FG001|Overall Study|Death|2|||
146143875|NCT03304379|527039556|FG002|Overall Study|Death|0|||
146143876|NCT03304379|527039557|FG003|Overall Study|Death|0|||
146143877|NCT03304379|527039558|FG004|Overall Study|Death|0|||
146143878|NCT03304379|527039554|FG000|Overall Study|Other|0|||
146143879|NCT03304379|527039555|FG001|Overall Study|Other|1|||
146143880|NCT03304379|527039556|FG002|Overall Study|Other|0|||
146143881|NCT03304379|527039557|FG003|Overall Study|Other|0|||
146143882|NCT03304379|527039558|FG004|Overall Study|Other|0|||
146143883|NCT03075644|527039568|FG000|Overall Study|Withdrawal by Subject|1|||
146143884|NCT03075644|527039569|FG001|Overall Study|Withdrawal by Subject|1|||
146143885|NCT02486406|527039578|FG000|Overall Study|Withdrew consent|1|||
146143886|NCT02486406|527039579|FG001|Overall Study|Withdrew consent|0|||
146143887|NCT02486406|527039580|FG002|Overall Study|Withdrew consent|0|||
146272785|NCT02224703|527514042|FG002|Overall Study|Withdrawn by parent/guardian|0|||
146272786|NCT02224703|527514040|FG000|Overall Study|Lack of Efficacy|1|||
146272787|NCT02224703|527514041|FG001|Overall Study|Lack of Efficacy|0|||
146272788|NCT02224703|527514042|FG002|Overall Study|Lack of Efficacy|0|||
146272789|NCT01886287|527514051|FG000|Overall Study|Radiographic disease progression|1|||
146272790|NCT01886287|527514051|FG000|Overall Study|Clinical progression due to disease|1|||
146272791|NCT03596762|527514052|FG000|Overall Study|Protocol Violation|0|||
146272792|NCT03596762|527514053|FG001|Overall Study|Protocol Violation|0|||
146272793|NCT03596762|527514054|FG002|Overall Study|Protocol Violation|0|||
146272794|NCT03596762|527514055|FG003|Overall Study|Protocol Violation|0|||
146272795|NCT03596762|527514056|FG004|Overall Study|Protocol Violation|1|||
146272796|NCT03596762|527514052|FG000|Overall Study|Adverse Event|2|||
146272797|NCT03596762|527514053|FG001|Overall Study|Adverse Event|0|||
146272798|NCT03596762|527514054|FG002|Overall Study|Adverse Event|1|||
146272799|NCT03596762|527514055|FG003|Overall Study|Adverse Event|0|||
146272800|NCT03596762|527514056|FG004|Overall Study|Adverse Event|5|||
146272801|NCT03596762|527514052|FG000|Overall Study|Withdrawal by Subject|2|||
146272802|NCT03596762|527514053|FG001|Overall Study|Withdrawal by Subject|1|||
146272803|NCT03596762|527514054|FG002|Overall Study|Withdrawal by Subject|0|||
146272804|NCT03596762|527514055|FG003|Overall Study|Withdrawal by Subject|1|||
146272805|NCT03596762|527514056|FG004|Overall Study|Withdrawal by Subject|1|||
146272806|NCT02195479|527514057|FG000|Overall Study|Lost to Follow-up|18|||
146272807|NCT02195479|527514058|FG001|Overall Study|Lost to Follow-up|15|||
146272808|NCT02195479|527514057|FG000|Overall Study|Death|217|||
146272809|NCT02195479|527514058|FG001|Overall Study|Death|171|||
146272810|NCT02195479|527514057|FG000|Overall Study|Physician Decision|1|||
146272811|NCT02195479|527514058|FG001|Overall Study|Physician Decision|0|||
146272812|NCT02195479|527514057|FG000|Overall Study|Withdrawal by Subject|30|||
146272813|NCT02195479|527514058|FG001|Overall Study|Withdrawal by Subject|30|||
146272814|NCT02195479|527514057|FG000|Overall Study|Other|3|||
146272815|NCT02195479|527514058|FG001|Overall Study|Other|4|||
146272816|NCT02195479|527514057|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
146272817|NCT02195479|527514058|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
146272818|NCT02593123|527514059|FG000|Overall Study|Physician Decision|2|||
146272819|NCT02593123|527514060|FG001|Overall Study|Physician Decision|1|||
146272820|NCT02593123|527514059|FG000|Overall Study|Relapse|1|||
146272821|NCT02593123|527514060|FG001|Overall Study|Relapse|1|||
146272822|NCT01602510|527514068|FG000|Open Label Phase|Adverse Event|46|||
146272823|NCT01602510|527514069|FG001|Open Label Phase|Adverse Event|0|||
146272824|NCT01602510|527514070|FG002|Open Label Phase|Adverse Event|0|||
146272825|NCT01602510|527514068|FG000|Open Label Phase|Lack of Efficacy|22|||
146272826|NCT01602510|527514069|FG001|Open Label Phase|Lack of Efficacy|0|||
146272827|NCT01602510|527514070|FG002|Open Label Phase|Lack of Efficacy|0|||
146143888|NCT02486406|527039581|FG003|Overall Study|Withdrew consent|1|||
146143889|NCT02486406|527039578|FG000|Overall Study|Lost to Follow-up|1|||
146143890|NCT02486406|527039579|FG001|Overall Study|Lost to Follow-up|3|||
146143891|NCT02486406|527039580|FG002|Overall Study|Lost to Follow-up|1|||
146143892|NCT02486406|527039581|FG003|Overall Study|Lost to Follow-up|3|||
146143893|NCT02486406|527039578|FG000|Overall Study|Other, not specified|0|||
146143894|NCT02486406|527039579|FG001|Overall Study|Other, not specified|0|||
146143895|NCT02486406|527039580|FG002|Overall Study|Other, not specified|1|||
146143896|NCT02486406|527039581|FG003|Overall Study|Other, not specified|0|||
146143897|NCT01858194|527039582|FG000|Overall Study|Total Artificial Heart Implant|0|||
146143898|NCT01858194|527039583|FG001|Overall Study|Total Artificial Heart Implant|1|||
146143899|NCT01858194|527039582|FG000|Overall Study|Lost to Follow-up|0|||
146143900|NCT01858194|527039583|FG001|Overall Study|Lost to Follow-up|1|||
146143901|NCT03509948|527039587|FG000|Overall Study|Protocol Violation|0|||
146143902|NCT03509948|527039588|FG001|Overall Study|Protocol Violation|1|||
146143903|NCT03221257|527039589|FG000|Overall Study|Lost to Follow-up|0|||
146143904|NCT03221257|527039590|FG001|Overall Study|Lost to Follow-up|1|||
146143905|NCT03221257|527039589|FG000|Overall Study|Withdrawal by Subject|1|||
146143906|NCT03221257|527039590|FG001|Overall Study|Withdrawal by Subject|1|||
146143907|NCT03149237|527039592|FG000|Overall Study|Withdrawal by Subject|4|||
146272828|NCT01602510|527514068|FG000|Open Label Phase|Protocol Violation|15|||
146272829|NCT01602510|527514069|FG001|Open Label Phase|Protocol Violation|0|||
146272830|NCT01602510|527514070|FG002|Open Label Phase|Protocol Violation|0|||
146272831|NCT01602510|527514068|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
146143908|NCT03149237|527039593|FG001|Overall Study|Withdrawal by Subject|5|||
146272832|NCT01602510|527514069|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
146143909|NCT00437034|527039594|FG000|Overall Study|Adverse Event|1|||
146272833|NCT01602510|527514070|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
146272834|NCT01602510|527514068|FG000|Open Label Phase|Lost to Follow-up|22|||
146272835|NCT01602510|527514069|FG001|Open Label Phase|Lost to Follow-up|0|||
146143910|NCT00437034|527039594|FG000|Overall Study|Disease progression during treatment|5|||
146143911|NCT01976845|527039597|FG000|Overall Study|Physician Decision|8|||
146143912|NCT01976845|527039598|FG001|Overall Study|Physician Decision|8|||
146272836|NCT01602510|527514070|FG002|Open Label Phase|Lost to Follow-up|0|||
146272837|NCT01602510|527514068|FG000|Open Label Phase|Physician Decision|19|||
146272838|NCT01602510|527514069|FG001|Open Label Phase|Physician Decision|0|||
146272839|NCT01602510|527514070|FG002|Open Label Phase|Physician Decision|0|||
146272840|NCT01602510|527514068|FG000|Open Label Phase|Withdrawal by Subject|57|||
146272841|NCT01602510|527514069|FG001|Open Label Phase|Withdrawal by Subject|0|||
146272842|NCT01602510|527514070|FG002|Open Label Phase|Withdrawal by Subject|0|||
146272843|NCT01602510|527514068|FG000|Randomized Phase|Adverse Event|0|||
146272844|NCT01602510|527514069|FG001|Randomized Phase|Adverse Event|2|||
146272845|NCT01602510|527514070|FG002|Randomized Phase|Adverse Event|6|||
146272846|NCT01602510|527514068|FG000|Randomized Phase|Lack of Efficacy|0|||
146272847|NCT01602510|527514069|FG001|Randomized Phase|Lack of Efficacy|4|||
146272848|NCT01602510|527514070|FG002|Randomized Phase|Lack of Efficacy|4|||
146272849|NCT01602510|527514068|FG000|Randomized Phase|Protocol Violation|0|||
146272850|NCT01602510|527514069|FG001|Randomized Phase|Protocol Violation|3|||
146272851|NCT01602510|527514070|FG002|Randomized Phase|Protocol Violation|3|||
146272852|NCT01602510|527514068|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
146272853|NCT01602510|527514069|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
146272854|NCT01602510|527514070|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
146272855|NCT01602510|527514068|FG000|Randomized Phase|Lost to Follow-up|0|||
146272856|NCT01602510|527514069|FG001|Randomized Phase|Lost to Follow-up|1|||
146272857|NCT01602510|527514070|FG002|Randomized Phase|Lost to Follow-up|3|||
146272858|NCT01602510|527514068|FG000|Randomized Phase|Physician Decision|0|||
146272859|NCT01602510|527514069|FG001|Randomized Phase|Physician Decision|0|||
146272860|NCT01602510|527514070|FG002|Randomized Phase|Physician Decision|2|||
146272861|NCT01602510|527514068|FG000|Randomized Phase|Withdrawal by Subject|0|||
146272862|NCT01602510|527514069|FG001|Randomized Phase|Withdrawal by Subject|6|||
146272863|NCT01602510|527514070|FG002|Randomized Phase|Withdrawal by Subject|7|||
146272864|NCT01001390|527514071|FG000|Overall Study|Failure to wear AFO device|2|||
146272865|NCT01001390|527514072|FG001|Overall Study|Failure to wear AFO device|0|||
146272866|NCT01261000|527514073|FG000|Overall Study|Screen failure|1|||
146272867|NCT03019640|527514074|FG000|Overall Study|Screen Failures|4|||
146272868|NCT03019640|527514074|FG000|Overall Study|Adverse Event|3|||
146272869|NCT03019640|527514074|FG000|Overall Study|Participant Relapsed|1|||
146272870|NCT00504777|527514075|FG000|Overall Study|Adverse Event|1|||
146272871|NCT01195623|527514079|FG000|Overall Study|Lost to Follow-up|35|||
146272872|NCT01195623|527514080|FG001|Overall Study|Lost to Follow-up|37|||
146272873|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
146272874|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
146272875|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
146272876|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
146272877|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
146272878|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
146272879|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
146272880|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
146143913|NCT01976845|527039599|FG002|Overall Study|Physician Decision|3|||
146143914|NCT02293005|527041895|FG000|Overall Study|Adverse Event|2|||
146143915|NCT02293005|527041895|FG000|Overall Study|Death|4|||
146143916|NCT02293005|527041895|FG000|Overall Study|Lost to Follow-up|1|||
146143917|NCT02293005|527041895|FG000|Overall Study|Withdrawal by Subject|2|||
146143918|NCT02293005|527041895|FG000|Overall Study|Progression|17|||
146143919|NCT03328897|527041896|FG000|Randomized-treatment Epoch|Adverse Event|4|||
146143920|NCT03328897|527041897|FG001|Randomized-treatment Epoch|Adverse Event|1|||
146143921|NCT03328897|527041898|FG002|Randomized-treatment Epoch|Adverse Event|1|||
146143922|NCT03328897|527041896|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
146143923|NCT03328897|527041897|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
146143924|NCT03328897|527041898|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
146272881|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
146272882|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
146272883|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272884|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272885|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
146272886|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
146143925|NCT03328897|527041896|FG000|Randomized-treatment Epoch|Pregnancy|3|||
146272887|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272888|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272889|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272890|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
146272891|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
146272892|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272893|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272894|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272895|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
146272896|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
146143926|NCT03328897|527041897|FG001|Randomized-treatment Epoch|Pregnancy|0|||
146143927|NCT03328897|527041898|FG002|Randomized-treatment Epoch|Pregnancy|0|||
146143928|NCT03328897|527041896|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
146143929|NCT03328897|527041897|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
146143930|NCT03328897|527041898|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
146143931|NCT03328897|527041896|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
146143932|NCT03328897|527041897|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
146143933|NCT03328897|527041898|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
146143934|NCT03328897|527041896|FG000|Follow-up Epoch|Adverse Event|4|||
146143935|NCT03328897|527041897|FG001|Follow-up Epoch|Adverse Event|0|||
146143936|NCT03328897|527041898|FG002|Follow-up Epoch|Adverse Event|1|||
146143937|NCT03328897|527041896|FG000|Follow-up Epoch|Lack of Efficacy|1|||
146143938|NCT03328897|527041897|FG001|Follow-up Epoch|Lack of Efficacy|1|||
146143939|NCT03328897|527041898|FG002|Follow-up Epoch|Lack of Efficacy|1|||
146143940|NCT03328897|527041896|FG000|Follow-up Epoch|Lost to Follow-up|0|||
146143941|NCT03328897|527041897|FG001|Follow-up Epoch|Lost to Follow-up|1|||
146143942|NCT03328897|527041898|FG002|Follow-up Epoch|Lost to Follow-up|0|||
146143943|NCT03328897|527041896|FG000|Follow-up Epoch|Pregnancy|1|||
146143944|NCT03328897|527041897|FG001|Follow-up Epoch|Pregnancy|0|||
146143945|NCT03328897|527041898|FG002|Follow-up Epoch|Pregnancy|0|||
146143946|NCT03328897|527041896|FG000|Follow-up Epoch|Patient/guardian decision|2|||
146143947|NCT03328897|527041897|FG001|Follow-up Epoch|Patient/guardian decision|1|||
146143948|NCT03328897|527041898|FG002|Follow-up Epoch|Patient/guardian decision|0|||
146143949|NCT00608829|527041899|FG000|Overall Study|Death|6|||
146143950|NCT00608829|527041899|FG000|Overall Study|Withdrawal by Subject|4|||
146143951|NCT00608829|527041899|FG000|Overall Study|Subject refuses to follow up or return.|5|||
146143952|NCT02766608|527041900|FG000|Overall Study|Adverse Event|27|||
146143953|NCT02766608|527041901|FG001|Overall Study|Adverse Event|22|||
146143954|NCT02766608|527041902|FG002|Overall Study|Adverse Event|17|||
146143955|NCT02766608|527041903|FG003|Overall Study|Adverse Event|13|||
146143956|NCT02766608|527041904|FG004|Overall Study|Adverse Event|12|||
146143957|NCT02766608|527041900|FG000|Overall Study|Withdrawal by Subject|21|||
146143958|NCT02766608|527041901|FG001|Overall Study|Withdrawal by Subject|20|||
146143959|NCT02766608|527041902|FG002|Overall Study|Withdrawal by Subject|24|||
146143960|NCT02766608|527041903|FG003|Overall Study|Withdrawal by Subject|13|||
146143961|NCT02766608|527041904|FG004|Overall Study|Withdrawal by Subject|10|||
146143962|NCT02766608|527041900|FG000|Overall Study|Lack of Efficacy|16|||
146143963|NCT02766608|527041901|FG001|Overall Study|Lack of Efficacy|15|||
146143964|NCT02766608|527041902|FG002|Overall Study|Lack of Efficacy|32|||
146143965|NCT02766608|527041903|FG003|Overall Study|Lack of Efficacy|8|||
146143966|NCT02766608|527041904|FG004|Overall Study|Lack of Efficacy|2|||
146143967|NCT02766608|527041900|FG000|Overall Study|Lost to Follow-up|6|||
146143968|NCT02766608|527041901|FG001|Overall Study|Lost to Follow-up|3|||
146143969|NCT02766608|527041902|FG002|Overall Study|Lost to Follow-up|5|||
146143970|NCT02766608|527041903|FG003|Overall Study|Lost to Follow-up|2|||
146143971|NCT02766608|527041904|FG004|Overall Study|Lost to Follow-up|2|||
146143972|NCT02766608|527041900|FG000|Overall Study|Physician Decision|3|||
146143973|NCT02766608|527041901|FG001|Overall Study|Physician Decision|2|||
146143974|NCT02766608|527041902|FG002|Overall Study|Physician Decision|3|||
146143975|NCT02766608|527041903|FG003|Overall Study|Physician Decision|1|||
146143976|NCT02766608|527041904|FG004|Overall Study|Physician Decision|2|||
146143977|NCT02766608|527041900|FG000|Overall Study|Protocol disc criteria|3|||
146143978|NCT02766608|527041901|FG001|Overall Study|Protocol disc criteria|3|||
146143979|NCT02766608|527041902|FG002|Overall Study|Protocol disc criteria|4|||
146143980|NCT02766608|527041903|FG003|Overall Study|Protocol disc criteria|0|||
146143981|NCT02766608|527041904|FG004|Overall Study|Protocol disc criteria|0|||
146143982|NCT02766608|527041900|FG000|Overall Study|Protocol Violation|0|||
146143983|NCT02766608|527041901|FG001|Overall Study|Protocol Violation|4|||
146143984|NCT02766608|527041902|FG002|Overall Study|Protocol Violation|4|||
146143985|NCT02766608|527041903|FG003|Overall Study|Protocol Violation|0|||
146143986|NCT02766608|527041904|FG004|Overall Study|Protocol Violation|1|||
146143987|NCT02766608|527041900|FG000|Overall Study|Administrative Reasons|3|||
146143988|NCT02766608|527041901|FG001|Overall Study|Administrative Reasons|1|||
146143989|NCT02766608|527041902|FG002|Overall Study|Administrative Reasons|1|||
146143990|NCT02766608|527041903|FG003|Overall Study|Administrative Reasons|0|||
146143991|NCT02766608|527041904|FG004|Overall Study|Administrative Reasons|0|||
146143992|NCT00612066|527041905|FG000|Overall Study|Adverse Event|1|||
146143993|NCT02080091|527041906|FG000|Overall Study|Study Terminated|22|||
146143994|NCT02080091|527041906|FG000|Overall Study|Death|1|||
146143995|NCT02080091|527041906|FG000|Overall Study|Withdrawal by Subject|1|||
146143996|NCT02080091|527041906|FG000|Overall Study|Other|1|||
146143997|NCT02648698|527041907|FG000|Overall Study|Protocol Violation|1|||
146143998|NCT02648698|527041908|FG001|Overall Study|Protocol Violation|5|||
146143999|NCT03143829|527041909|FG000|Overall Study|Withdrawal by Subject|2|||
146144000|NCT03143829|527041910|FG001|Overall Study|Withdrawal by Subject|5|||
146144001|NCT03143829|527041909|FG000|Overall Study|Lost to Follow-up|0|||
146144002|NCT03143829|527041910|FG001|Overall Study|Lost to Follow-up|2|||
146144003|NCT03143829|527041909|FG000|Overall Study|Death|1|||
146144004|NCT03143829|527041910|FG001|Overall Study|Death|1|||
146144005|NCT03143829|527041909|FG000|Overall Study|changed treatment, no longer eligible|2|||
146272897|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272898|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272899|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
146272900|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
146272901|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
146272902|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
146272903|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
146272904|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
146272905|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146272906|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146272907|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146272908|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
146272909|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
146272910|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
146272911|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
146272912|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
146272913|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
146272914|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146272915|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146272916|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146272917|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
146272918|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
146272919|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
146272920|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
146272921|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
146272922|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
146272923|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
146272924|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
146272925|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
146272926|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
146272927|NCT00477490|527514085|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
146272928|NCT00477490|527514086|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
146272929|NCT00477490|527514087|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
146272930|NCT00477490|527514088|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
146272931|NCT00477490|527514089|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
146272932|NCT00477490|527514090|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
146272933|NCT00477490|527514091|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
146272934|NCT00477490|527514092|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
146272935|NCT00477490|527514093|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
146272936|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
146272937|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
146272938|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
146272939|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
146272940|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
146272941|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
146272942|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
146272943|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
146272944|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
146272945|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
146272946|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
146272947|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
146272948|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146272949|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146272950|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146272951|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146272952|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
146272953|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
146272954|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146272955|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
146272956|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
146272957|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146272958|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
146272959|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146272960|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
146272961|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146272962|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
146272963|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146272964|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146304312|NCT01480284|527629171|FG000|Overall Study|Physician Decision|1|||
146272965|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146272966|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146272967|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146272968|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146272969|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
146272970|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146272971|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
146272972|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272973|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
146272974|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272975|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272976|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272977|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272978|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272979|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272980|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
146272981|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
146272982|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
146272983|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
146272984|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
146272985|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
146272986|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146272987|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146272988|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
146272989|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
146272990|NCT00477490|527514085|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272991|NCT00477490|527514086|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
146272992|NCT00477490|527514087|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
146272993|NCT00477490|527514088|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272994|NCT00477490|527514089|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
146272995|NCT00477490|527514090|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272996|NCT00477490|527514091|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272997|NCT00477490|527514092|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272998|NCT00477490|527514093|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
146272999|NCT01110408|527514096|FG000|Overall Study|Protocol Violation|1|||
146273000|NCT01110408|527514097|FG001|Overall Study|Protocol Violation|0|||
146273001|NCT00669877|527514098|FG000|Overall Study|Disease Progression/Death|4|||
146273002|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
146273003|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
146273004|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
146273005|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
146273006|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273007|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273008|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273009|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273010|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273011|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273012|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273013|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
146273014|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
146273015|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
146273016|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
146273017|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
146273018|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273019|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273020|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273021|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273022|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273023|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273024|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273025|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
146273026|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
146273027|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
146273028|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
146304313|NCT01480284|527629172|FG001|Overall Study|Physician Decision|0|||
146144006|NCT03143829|527041910|FG001|Overall Study|changed treatment, no longer eligible|2|||
146144007|NCT00966940|527041912|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
146144008|NCT00966940|527041913|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
146144009|NCT00966940|527041912|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
146144010|NCT00966940|527041913|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
146144011|NCT01774903|527041918|FG000|Overall Study|Adverse Event|7|||
146144012|NCT01774903|527041918|FG000|Overall Study|Withdrawal by Subject|2|||
146144013|NCT01774903|527041918|FG000|Overall Study|Lack of Efficacy|1|||
146144014|NCT01774903|527041918|FG000|Overall Study|Ineligible to continue the trial|1|||
146144015|NCT00924950|527041919|FG000|Overall Study|Lost to Follow-up|2|||
146144016|NCT01602315|527041920|FG000|Overall Study|Protocol Violation|0|||
146144017|NCT01602315|527041921|FG001|Overall Study|Protocol Violation|0|||
146144018|NCT01602315|527041922|FG002|Overall Study|Protocol Violation|0|||
146144019|NCT01602315|527041923|FG003|Overall Study|Protocol Violation|0|||
146144020|NCT01602315|527041924|FG004|Overall Study|Protocol Violation|0|||
146144021|NCT01602315|527041925|FG005|Overall Study|Protocol Violation|1|||
146144022|NCT01602315|527041926|FG006|Overall Study|Protocol Violation|0|||
146144023|NCT01602315|527041920|FG000|Overall Study|Physician Decision|2|||
146144024|NCT01602315|527041921|FG001|Overall Study|Physician Decision|0|||
146144025|NCT01602315|527041922|FG002|Overall Study|Physician Decision|0|||
146144026|NCT01602315|527041923|FG003|Overall Study|Physician Decision|0|||
146144027|NCT01602315|527041924|FG004|Overall Study|Physician Decision|2|||
146144028|NCT01602315|527041925|FG005|Overall Study|Physician Decision|1|||
146144029|NCT01602315|527041926|FG006|Overall Study|Physician Decision|1|||
146144030|NCT01602315|527041920|FG000|Overall Study|Disease progression|6|||
146144031|NCT01602315|527041921|FG001|Overall Study|Disease progression|3|||
146144032|NCT01602315|527041922|FG002|Overall Study|Disease progression|10|||
146144033|NCT01602315|527041923|FG003|Overall Study|Disease progression|1|||
146144034|NCT01602315|527041924|FG004|Overall Study|Disease progression|41|||
146144035|NCT01602315|527041925|FG005|Overall Study|Disease progression|12|||
146144036|NCT01602315|527041926|FG006|Overall Study|Disease progression|15|||
146144037|NCT01602315|527041920|FG000|Overall Study|Death|1|||
146144038|NCT01602315|527041921|FG001|Overall Study|Death|1|||
146144039|NCT01602315|527041922|FG002|Overall Study|Death|1|||
146144040|NCT01602315|527041923|FG003|Overall Study|Death|1|||
146144041|NCT01602315|527041924|FG004|Overall Study|Death|7|||
146144042|NCT01602315|527041925|FG005|Overall Study|Death|2|||
146144043|NCT01602315|527041926|FG006|Overall Study|Death|2|||
146144044|NCT01602315|527041920|FG000|Overall Study|Withdrawal by Subject|2|||
146144045|NCT01602315|527041921|FG001|Overall Study|Withdrawal by Subject|0|||
146144046|NCT01602315|527041922|FG002|Overall Study|Withdrawal by Subject|2|||
146144047|NCT01602315|527041923|FG003|Overall Study|Withdrawal by Subject|0|||
146144048|NCT01602315|527041924|FG004|Overall Study|Withdrawal by Subject|6|||
146144049|NCT01602315|527041925|FG005|Overall Study|Withdrawal by Subject|0|||
146144050|NCT01602315|527041926|FG006|Overall Study|Withdrawal by Subject|1|||
146144051|NCT01602315|527041920|FG000|Overall Study|Adverse Event|5|||
146144052|NCT01602315|527041921|FG001|Overall Study|Adverse Event|1|||
146144053|NCT01602315|527041922|FG002|Overall Study|Adverse Event|5|||
146144054|NCT01602315|527041923|FG003|Overall Study|Adverse Event|4|||
146144055|NCT01602315|527041924|FG004|Overall Study|Adverse Event|15|||
146144056|NCT01602315|527041925|FG005|Overall Study|Adverse Event|3|||
146144057|NCT01602315|527041926|FG006|Overall Study|Adverse Event|9|||
146144058|NCT01602315|527041920|FG000|Overall Study|Subject/guardian decision|0|||
146144059|NCT01602315|527041921|FG001|Overall Study|Subject/guardian decision|0|||
146144060|NCT01602315|527041922|FG002|Overall Study|Subject/guardian decision|0|||
146144061|NCT01602315|527041923|FG003|Overall Study|Subject/guardian decision|0|||
146144062|NCT01602315|527041924|FG004|Overall Study|Subject/guardian decision|0|||
146144063|NCT01602315|527041925|FG005|Overall Study|Subject/guardian decision|0|||
146144064|NCT01602315|527041926|FG006|Overall Study|Subject/guardian decision|1|||
146144065|NCT01602315|527041920|FG000|Overall Study|Cross-over patients to combo treatment|0|||
146144066|NCT01602315|527041921|FG001|Overall Study|Cross-over patients to combo treatment|0|||
146144067|NCT01602315|527041922|FG002|Overall Study|Cross-over patients to combo treatment|0|||
146144068|NCT01602315|527041923|FG003|Overall Study|Cross-over patients to combo treatment|0|||
146144069|NCT01602315|527041924|FG004|Overall Study|Cross-over patients to combo treatment|0|||
146144070|NCT01602315|527041925|FG005|Overall Study|Cross-over patients to combo treatment|16|||
146144071|NCT01602315|527041926|FG006|Overall Study|Cross-over patients to combo treatment|0|||
146144072|NCT00961259|527041933|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
146144073|NCT00961259|527041934|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
146144074|NCT00961259|527041935|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
146273029|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
146144075|NCT01252251|527041936|FG000|Overall Study|Withdrawal by Subject|1|||
146144076|NCT01324024|527041937|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
146144077|NCT01324024|527041938|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146144078|NCT02691455|527041939|FG000|Overall Study|Withdrawal by Subject|1|||
146144079|NCT02691455|527041940|FG001|Overall Study|Withdrawal by Subject|2|||
146144080|NCT02691455|527041939|FG000|Overall Study|Lost to Follow-up|15|||
146273030|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273031|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273032|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273033|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273034|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273035|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273036|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273037|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
146273038|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
146273039|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
146273040|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
146273041|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
146273042|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273043|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273044|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273045|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273046|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273047|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273048|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273049|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
146273050|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273051|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273052|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
146273053|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
146273054|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273055|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273056|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273057|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273058|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273059|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273060|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273061|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
146273062|NCT01646177|527514099|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
146273063|NCT01646177|527514100|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
146273064|NCT01646177|527514101|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
146273065|NCT01646177|527514102|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273066|NCT01646177|527514103|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273067|NCT01646177|527514104|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273068|NCT01646177|527514105|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273069|NCT01646177|527514106|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273070|NCT01646177|527514107|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273071|NCT01646177|527514108|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273072|NCT01646177|527514109|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273073|NCT01646177|527514110|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
146273074|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273075|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273076|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273077|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273078|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
146273079|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
146273080|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
146273081|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
146273082|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273083|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273084|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273085|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
146273086|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273087|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273088|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273089|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273090|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
146273091|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
146273092|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
146273093|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
146273094|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273095|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273096|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273097|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
146273098|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273099|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273100|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273101|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273102|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
146273103|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
146273104|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
146273105|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
146273106|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273107|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273108|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273109|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
146273110|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273111|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273112|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273113|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273114|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
146273115|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
146273116|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
146273117|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
146273118|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273119|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273120|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273121|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
146273122|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273123|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273124|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273125|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273126|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
146273127|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146273128|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146273129|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
146273130|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273131|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273132|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273133|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
146273134|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273135|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273136|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273137|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273138|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
146273139|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
146273140|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146304314|NCT00066742|527629173|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
146144081|NCT02691455|527041940|FG001|Overall Study|Lost to Follow-up|15|||
146144082|NCT02057757|527041941|FG000|Overall Study|Withdrawal by Subject|3|||
146144083|NCT02057757|527041942|FG001|Overall Study|Withdrawal by Subject|5|||
146144084|NCT02057757|527041941|FG000|Overall Study|Death|2|||
146144085|NCT02057757|527041942|FG001|Overall Study|Death|0|||
146144086|NCT02057757|527041941|FG000|Overall Study|Lost to Follow-up|8|||
146144087|NCT02057757|527041942|FG001|Overall Study|Lost to Follow-up|3|||
146144088|NCT02057757|527041941|FG000|Overall Study|Non-compliance|1|||
146144089|NCT02057757|527041942|FG001|Overall Study|Non-compliance|0|||
146144090|NCT00530023|527041943|FG000|Overall Study|Withdrawal by Subject|0|||
146144091|NCT00530023|527041944|FG001|Overall Study|Withdrawal by Subject|1|||
146144092|NCT01158222|527041945|FG000|Overall Study|Not eligible for intermediate phase|17|||
146144093|NCT00111228|527041946|FG000|Overall Study|Withdrawal by Subject|5|||
146144094|NCT00111228|527041947|FG001|Overall Study|Withdrawal by Subject|1|||
146144095|NCT00111228|527041948|FG002|Overall Study|Withdrawal by Subject|0|||
146144096|NCT02480621|527041951|FG000|Randomization|Withdrawal by Subject|1|||
146144097|NCT02480621|527041952|FG001|Randomization|Withdrawal by Subject|0|||
146144098|NCT02480621|527041951|FG000|Randomization|Surgeon did not give intervention|0|||
146144099|NCT02480621|527041952|FG001|Randomization|Surgeon did not give intervention|1|||
146273141|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
146273142|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273143|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273144|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273145|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
146273146|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273147|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273148|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273149|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273150|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
146273151|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146273152|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146273153|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
146273154|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273155|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273156|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273157|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
146273158|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
146273159|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
146273160|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
146273161|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
146273162|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
146273163|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
146273164|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
146273165|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
146273166|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
146273167|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
146273168|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
146273169|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
146273170|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273171|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273172|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273173|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273174|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146273175|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146273176|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
146273177|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
146273178|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273179|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273180|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273181|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
146273182|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273183|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273184|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273185|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273186|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273187|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273188|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273189|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
146273190|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273191|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273192|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273193|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
146273194|NCT01646177|527514099|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273195|NCT01646177|527514100|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273196|NCT01646177|527514101|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273197|NCT01646177|527514102|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273198|NCT01646177|527514103|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273199|NCT01646177|527514104|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
146273200|NCT01646177|527514105|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
146273201|NCT01646177|527514106|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
146144100|NCT02480621|527041951|FG000|Follow Up|Lost to Follow-up|4|||
146144101|NCT02480621|527041952|FG001|Follow Up|Lost to Follow-up|2|||
146144102|NCT04632940|527041955|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
146144103|NCT04632940|527041956|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
146144104|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
146144105|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
146144106|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
146144107|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
146144108|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
146144109|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
146144110|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
146144111|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
146144112|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
146144113|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
146144114|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Other than specified|0|||
146144115|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Other than specified|1|||
146144116|NCT04632940|527041955|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
146144117|NCT04632940|527041956|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
146144118|NCT00684424|527041957|FG000|Overall Study|Adverse Event|1|||
146144119|NCT00684424|527041957|FG000|Overall Study|Lost to Follow-up|2|||
146144120|NCT00684424|527041957|FG000|Overall Study|Other|2|||
146144121|NCT02520531|527041960|FG000|Overall Study|Revision of study device components|2|||
146144122|NCT02520531|527041961|FG001|Overall Study|Revision of study device components|2|||
146144123|NCT02520531|527041960|FG000|Overall Study|Death|1|||
146144124|NCT02520531|527041961|FG001|Overall Study|Death|2|||
146144125|NCT02520531|527041960|FG000|Overall Study|Lost to Follow-up|1|||
146144126|NCT02520531|527041961|FG001|Overall Study|Lost to Follow-up|1|||
146144127|NCT02520531|527041960|FG000|Overall Study|Meet exclusion criterion|0|||
146144128|NCT02520531|527041961|FG001|Overall Study|Meet exclusion criterion|1|||
146144129|NCT02520531|527041960|FG000|Overall Study|Withdrawal by Subject|1|||
146144130|NCT02520531|527041961|FG001|Overall Study|Withdrawal by Subject|0|||
146144131|NCT02520531|527041960|FG000|Overall Study|Not study device|1|||
146144132|NCT02520531|527041961|FG001|Overall Study|Not study device|0|||
146144133|NCT01752933|527041964|FG000|Treatment|Disease Progression|3|||
146144134|NCT01752933|527041965|FG001|Treatment|Disease Progression|29|||
146144135|NCT01752933|527041964|FG000|Treatment|Withdrawal by Subject|0|||
146144136|NCT01752933|527041965|FG001|Treatment|Withdrawal by Subject|5|||
146144137|NCT01752933|527041964|FG000|Treatment|Adverse Event|1|||
146144138|NCT01752933|527041965|FG001|Treatment|Adverse Event|4|||
146144139|NCT01752933|527041964|FG000|Treatment|Physician Decision|0|||
146144140|NCT01752933|527041965|FG001|Treatment|Physician Decision|3|||
146144141|NCT01752933|527041964|FG000|Treatment|Death|0|||
146144142|NCT01752933|527041965|FG001|Treatment|Death|2|||
146144143|NCT01752933|527041964|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
146144144|NCT01752933|527041965|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
146144145|NCT01752933|527041964|FG000|Treatment|Patient noncompliant|0|||
146144146|NCT01752933|527041965|FG001|Treatment|Patient noncompliant|1|||
146144147|NCT01752933|527041964|FG000|Treatment|Patient unable to travel to appointments|0|||
146144148|NCT01752933|527041965|FG001|Treatment|Patient unable to travel to appointments|1|||
146144149|NCT01752933|527041964|FG000|Overall Study and Follow-up|Death|4|||
146144150|NCT01752933|527041965|FG001|Overall Study and Follow-up|Death|34|||
146144151|NCT01752933|527041964|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
146144152|NCT01752933|527041965|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
146144153|NCT01752933|527041964|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
146144154|NCT01752933|527041965|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
146144155|NCT01752933|527041964|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
146144156|NCT01752933|527041965|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
146144157|NCT00179647|527041970|FG000|Overall Study|Adverse Event|294|||
146144158|NCT00179647|527041970|FG000|Overall Study|Lack of Efficacy|478|||
146144159|NCT00179647|527041970|FG000|Overall Study|Withdrawal by Subject|83|||
146144160|NCT00179647|527041970|FG000|Overall Study|Lost to Follow-up|4|||
146144161|NCT00179647|527041970|FG000|Overall Study|Death|94|||
146144162|NCT00179647|527041970|FG000|Overall Study|Other|960|||
146144163|NCT00622635|527041971|FG000|Treatment Period 1|Adverse Event|0|||
146144164|NCT00622635|527041972|FG001|Treatment Period 1|Adverse Event|0|||
146144165|NCT00622635|527041973|FG002|Treatment Period 1|Adverse Event|1|||
146144166|NCT00622635|527041974|FG003|Treatment Period 1|Adverse Event|0|||
146144167|NCT00622635|527041975|FG004|Treatment Period 1|Adverse Event|0|||
146144168|NCT00622635|527041976|FG005|Treatment Period 1|Adverse Event|0|||
146144169|NCT00622635|527041971|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146144170|NCT00622635|527041972|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146144171|NCT00622635|527041973|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146144172|NCT00622635|527041974|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146144173|NCT00622635|527041975|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146144174|NCT00622635|527041976|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146144175|NCT00622635|527041971|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
146273202|NCT01646177|527514107|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273203|NCT01646177|527514108|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273204|NCT01646177|527514109|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273205|NCT01646177|527514110|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
146273206|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273207|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273208|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273209|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273210|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273211|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273212|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273213|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
146273214|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
146273215|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
146273216|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
146273217|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
146273218|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273219|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273220|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273221|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273222|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273223|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273224|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273225|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
146273226|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
146273227|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
146273228|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
146273229|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
146273230|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273231|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273232|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273233|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273234|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273235|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273236|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273237|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
146273238|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
146273239|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
146273240|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
146273241|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
146273242|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273243|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273244|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273245|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273246|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273247|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273248|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273249|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
146273250|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
146273251|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
146273252|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
146273253|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
146273254|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273255|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146144176|NCT00622635|527041972|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
146273256|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273257|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273258|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273259|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273260|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273261|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
146273262|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
146144177|NCT00622635|527041973|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
146144178|NCT00622635|527041974|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
146273263|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
146273264|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
146273265|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
146273266|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273267|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273268|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273269|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273270|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273271|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273272|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273273|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
146273274|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
146273275|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
146273276|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
146273277|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
146273278|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273279|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273280|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273281|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273282|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273283|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273284|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273285|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273286|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
146273287|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
146273288|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
146273289|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
146273290|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273291|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273292|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273293|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273294|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273295|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273296|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273297|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273298|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
146273299|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146273300|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146273301|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
146273302|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273303|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273304|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273305|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273306|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273307|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273308|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273309|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273310|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146273311|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
146273312|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146273313|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
146273314|NCT01646177|527514099|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273315|NCT01646177|527514100|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273316|NCT01646177|527514101|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273317|NCT01646177|527514102|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273318|NCT01646177|527514103|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273319|NCT01646177|527514104|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273320|NCT01646177|527514105|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273321|NCT01646177|527514106|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273322|NCT01646177|527514107|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273323|NCT01646177|527514108|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
146273324|NCT01646177|527514109|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
146273325|NCT01646177|527514110|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
146273326|NCT02920970|527514111|FG000|First Intervention|Protocol Violation|0|||
146144179|NCT00622635|527041975|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
146273327|NCT02920970|527514112|FG001|First Intervention|Protocol Violation|1|||
146273328|NCT02920970|527514111|FG000|First Intervention|Adverse Event|0|||
146273329|NCT02920970|527514112|FG001|First Intervention|Adverse Event|1|||
146273330|NCT02920970|527514111|FG000|Second Intervention|Poor Lens Fit|1|||
146273331|NCT02920970|527514112|FG001|Second Intervention|Poor Lens Fit|0|||
146273332|NCT01711853|527514115|FG000|Overall Study|Not treated|3|||
146144180|NCT00622635|527041976|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
146144181|NCT00622635|527041971|FG000|Treatment Period 2|Adverse Event|1|||
146144182|NCT00622635|527041972|FG001|Treatment Period 2|Adverse Event|0|||
146144183|NCT00622635|527041973|FG002|Treatment Period 2|Adverse Event|0|||
146144184|NCT00622635|527041974|FG003|Treatment Period 2|Adverse Event|0|||
146144185|NCT00622635|527041975|FG004|Treatment Period 2|Adverse Event|0|||
146144186|NCT00622635|527041976|FG005|Treatment Period 2|Adverse Event|0|||
146144187|NCT00622635|527041971|FG000|Treatment Period 3|Adverse Event|0|||
146144188|NCT00622635|527041972|FG001|Treatment Period 3|Adverse Event|0|||
146144189|NCT00622635|527041973|FG002|Treatment Period 3|Adverse Event|0|||
146144190|NCT00622635|527041974|FG003|Treatment Period 3|Adverse Event|2|||
146144191|NCT00622635|527041975|FG004|Treatment Period 3|Adverse Event|0|||
146144192|NCT00622635|527041976|FG005|Treatment Period 3|Adverse Event|0|||
146144193|NCT00622635|527041971|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146144194|NCT00622635|527041972|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146144195|NCT00622635|527041973|FG002|Treatment Period 3|Withdrawal by Subject|0|||
146144196|NCT00622635|527041974|FG003|Treatment Period 3|Withdrawal by Subject|1|||
146144197|NCT00622635|527041975|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146144198|NCT00622635|527041976|FG005|Treatment Period 3|Withdrawal by Subject|0|||
146144199|NCT00835406|527041977|FG000|Period: First Intervention|Adverse Event|0|||
146144200|NCT00835406|527041978|FG001|Period: First Intervention|Adverse Event|1|||
146144201|NCT00835406|527041977|FG000|Period: First Intervention|Withdrawal by Subject|2|||
146144202|NCT00835406|527041978|FG001|Period: First Intervention|Withdrawal by Subject|0|||
146144203|NCT00835406|527041977|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
146144204|NCT00835406|527041978|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
146144205|NCT00281840|527041979|FG000|Overall Study|Adverse Event|12|||
146144206|NCT00281840|527041979|FG000|Overall Study|Physician Decision|6|||
146144207|NCT00281840|527041979|FG000|Overall Study|Withdrawal by Subject|3|||
146144208|NCT00281840|527041979|FG000|Overall Study|Disease Progression|2|||
146144209|NCT00281840|527041979|FG000|Overall Study|exceed maximum delay in treatment|1|||
146144210|NCT00281840|527041979|FG000|Overall Study|Complicating Disease|1|||
146144211|NCT02185768|527041982|FG000|Overall Study|Patients were not treated|2|||
146144212|NCT02550652|527041986|FG000|Overall Study|Death|1|||
146144213|NCT02550652|527041987|FG001|Overall Study|Death|4|||
146144214|NCT02550652|527041986|FG000|Overall Study|Lack of Efficacy|1|||
146144215|NCT02550652|527041987|FG001|Overall Study|Lack of Efficacy|0|||
146144216|NCT02550652|527041986|FG000|Overall Study|Withdrawal by Subject|4|||
146144217|NCT02550652|527041987|FG001|Overall Study|Withdrawal by Subject|7|||
146144218|NCT02550652|527041986|FG000|Overall Study|Post Trial Access|1|||
146144219|NCT02550652|527041987|FG001|Overall Study|Post Trial Access|0|||
146144220|NCT02550652|527041986|FG000|Overall Study|Lost to Follow-up|1|||
146144221|NCT02550652|527041987|FG001|Overall Study|Lost to Follow-up|3|||
146144222|NCT02550652|527041986|FG000|Overall Study|Physician Decision|0|||
146144223|NCT02550652|527041987|FG001|Overall Study|Physician Decision|2|||
146144224|NCT02550652|527041986|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
146144225|NCT02550652|527041987|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
146144226|NCT03027466|527041988|FG000|Overall Study|Opting out of the app|1869|||
146144227|NCT03027466|527041989|FG001|Overall Study|Opting out of the app|1819|||
146144228|NCT03027466|527041990|FG002|Overall Study|Opting out of the app|1743|||
146144229|NCT03027466|527041991|FG003|Overall Study|Opting out of the app|1821|||
146144230|NCT02158039|527041992|FG000|Overall Study|Withdrawal by Subject|1|||
146144231|NCT02158039|527041992|FG000|Overall Study|Screen Failure|9|||
146144232|NCT03062891|527042004|FG000|Overall Study|Withdrawal by Subject|2|||
146144233|NCT03062891|527042005|FG001|Overall Study|Withdrawal by Subject|0|||
146144234|NCT03062891|527042004|FG000|Overall Study|Lost to Follow-up|50|||
146144235|NCT03062891|527042005|FG001|Overall Study|Lost to Follow-up|38|||
146144236|NCT01079234|527042008|FG000|Main: Week 0 to 26|Adverse Event|5|||
146144237|NCT01079234|527042009|FG001|Main: Week 0 to 26|Adverse Event|4|||
146144238|NCT01079234|527042010|FG002|Main: Week 0 to 26|Adverse Event|1|||
146144239|NCT01079234|527042011|FG003|Main: Week 0 to 26|Adverse Event|0|||
146144240|NCT01079234|527042008|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
146144241|NCT01079234|527042009|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
146144242|NCT01079234|527042010|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
146144243|NCT01079234|527042011|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
146144244|NCT01079234|527042008|FG000|Main: Week 0 to 26|Protocol Violation|6|||
146144245|NCT01079234|527042009|FG001|Main: Week 0 to 26|Protocol Violation|2|||
146144246|NCT01079234|527042010|FG002|Main: Week 0 to 26|Protocol Violation|4|||
146144247|NCT01079234|527042011|FG003|Main: Week 0 to 26|Protocol Violation|0|||
146273333|NCT01277887|527514116|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
146273334|NCT01277887|527514117|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
146273335|NCT01277887|527514116|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
146273336|NCT01277887|527514117|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
146273337|NCT01277887|527514116|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
146273338|NCT01277887|527514117|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
146273339|NCT03651700|527514118|FG000|Overall Study|Withdrawal by Subject|1|||
146273340|NCT03651700|527514119|FG001|Overall Study|Withdrawal by Subject|0|||
146273341|NCT05479734|527514122|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
146273342|NCT05479734|527514123|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146273343|NCT05479734|527514122|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146273344|NCT05479734|527514123|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
146273345|NCT05479734|527514122|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
146273346|NCT05479734|527514123|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
146273347|NCT05479734|527514122|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
146273348|NCT05479734|527514123|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
146273349|NCT00600613|527514124|FG000|Overall Study|Protocol Deviation|1|||
146273350|NCT01509547|527514127|FG000|Overall Study|Lost to Follow-up|24|||
146273351|NCT01509547|527514128|FG001|Overall Study|Lost to Follow-up|14|||
146273352|NCT01509547|527514127|FG000|Overall Study|Withdrawal by Subject|11|||
146273353|NCT01509547|527514128|FG001|Overall Study|Withdrawal by Subject|24|||
146273354|NCT01509547|527514127|FG000|Overall Study|Physician Decision|0|||
146273355|NCT01509547|527514128|FG001|Overall Study|Physician Decision|1|||
146273356|NCT00570908|527514129|FG000|Overall Study|Adverse Event|5|||
146273357|NCT00570908|527514129|FG000|Overall Study|Withdrawal by Subject|2|||
146273358|NCT01447576|527514130|FG000|Overall Study|Lost to Follow-up|52|||
146273359|NCT01447576|527514130|FG000|Overall Study|Adverse Event|127|||
146273360|NCT01447576|527514130|FG000|Overall Study|Participant met withdrawal criteria|40|||
146273361|NCT01447576|527514130|FG000|Overall Study|Withdrawal by Subject|100|||
146273362|NCT01447576|527514130|FG000|Overall Study|Protocol deviation|83|||
146273363|NCT01447576|527514130|FG000|Overall Study|Lack of Efficacy|68|||
146273364|NCT01447576|527514130|FG000|Overall Study|Physician Decision|6|||
146273365|NCT04942366|527516127|FG000|Overall Study|Withdrawal by Subject|5|||
146273366|NCT04942366|527516128|FG001|Overall Study|Withdrawal by Subject|5|||
146273367|NCT02706405|527516134|FG000|Overall Study|Death|3|||
146273368|NCT02706405|527516135|FG001|Overall Study|Death|2|||
146273369|NCT02706405|527516136|FG002|Overall Study|Death|0|||
146273370|NCT02706405|527516137|FG003|Overall Study|Death|1|||
146273371|NCT02706405|527516138|FG004|Overall Study|Death|0|||
146273372|NCT02706405|527516139|FG005|Overall Study|Death|0|||
146273373|NCT02706405|527516140|FG006|Overall Study|Death|3|||
146273374|NCT02706405|527516141|FG007|Overall Study|Death|4|||
146273375|NCT02706405|527516134|FG000|Overall Study|Disease progression|0|||
146273376|NCT02706405|527516135|FG001|Overall Study|Disease progression|0|||
146273377|NCT02706405|527516136|FG002|Overall Study|Disease progression|0|||
146273378|NCT02706405|527516137|FG003|Overall Study|Disease progression|0|||
146273379|NCT02706405|527516138|FG004|Overall Study|Disease progression|0|||
146273380|NCT02706405|527516139|FG005|Overall Study|Disease progression|0|||
146273381|NCT02706405|527516140|FG006|Overall Study|Disease progression|0|||
146273382|NCT02706405|527516141|FG007|Overall Study|Disease progression|1|||
146273383|NCT02706405|527516134|FG000|Overall Study|Pt moved to new therapy|0|||
146273384|NCT02706405|527516135|FG001|Overall Study|Pt moved to new therapy|0|||
146273385|NCT02706405|527516136|FG002|Overall Study|Pt moved to new therapy|0|||
146273386|NCT02706405|527516137|FG003|Overall Study|Pt moved to new therapy|0|||
146273387|NCT02706405|527516138|FG004|Overall Study|Pt moved to new therapy|0|||
146273388|NCT02706405|527516139|FG005|Overall Study|Pt moved to new therapy|1|||
146273389|NCT02706405|527516140|FG006|Overall Study|Pt moved to new therapy|0|||
146273390|NCT02706405|527516141|FG007|Overall Study|Pt moved to new therapy|1|||
146273391|NCT02706405|527516134|FG000|Overall Study|Physician Decision|1|||
146273392|NCT02706405|527516135|FG001|Overall Study|Physician Decision|0|||
146273393|NCT02706405|527516136|FG002|Overall Study|Physician Decision|0|||
146273394|NCT02706405|527516137|FG003|Overall Study|Physician Decision|0|||
146273395|NCT02706405|527516138|FG004|Overall Study|Physician Decision|0|||
146273396|NCT02706405|527516139|FG005|Overall Study|Physician Decision|0|||
146273397|NCT02706405|527516140|FG006|Overall Study|Physician Decision|0|||
146273398|NCT02706405|527516141|FG007|Overall Study|Physician Decision|0|||
146273399|NCT02304705|527516142|FG000|Overall Study|Withdrawal by Subject|2|||
146144248|NCT01079234|527042008|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
146273400|NCT02304705|527516143|FG001|Overall Study|Withdrawal by Subject|0|||
146273401|NCT02304705|527516142|FG000|Overall Study|Physician Decision|2|||
146273402|NCT02304705|527516143|FG001|Overall Study|Physician Decision|4|||
146273403|NCT02304705|527516142|FG000|Overall Study|Death|0|||
146273404|NCT02304705|527516143|FG001|Overall Study|Death|1|||
146273405|NCT02304705|527516142|FG000|Overall Study|Lost to Follow-up|0|||
146273406|NCT02304705|527516143|FG001|Overall Study|Lost to Follow-up|2|||
146273407|NCT01195948|527516144|FG000|Overall Study|Lost to Follow-up|0|||
146273408|NCT01195948|527516145|FG001|Overall Study|Lost to Follow-up|1|||
146273409|NCT01195948|527516146|FG002|Overall Study|Lost to Follow-up|2|||
146273410|NCT03140280|527516147|FG000|Overall Study|Physician Decision|5|||
146144249|NCT01079234|527042009|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
146144250|NCT01079234|527042010|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
146144251|NCT01079234|527042011|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
146144252|NCT01079234|527042008|FG000|Main: Week 0 to 26|Unclassified|7|||
146144253|NCT01079234|527042009|FG001|Main: Week 0 to 26|Unclassified|13|||
146144254|NCT01079234|527042010|FG002|Main: Week 0 to 26|Unclassified|4|||
146144255|NCT01079234|527042011|FG003|Main: Week 0 to 26|Unclassified|0|||
146144256|NCT01079234|527042008|FG000|Extension: Week 27 to 52|Adverse Event|0|||
146144257|NCT01079234|527042009|FG001|Extension: Week 27 to 52|Adverse Event|0|||
146144258|NCT01079234|527042010|FG002|Extension: Week 27 to 52|Adverse Event|1|||
146144259|NCT01079234|527042011|FG003|Extension: Week 27 to 52|Adverse Event|0|||
146144260|NCT01079234|527042008|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
146144261|NCT01079234|527042009|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
146144262|NCT01079234|527042010|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
146144263|NCT01079234|527042011|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
146144264|NCT01079234|527042008|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
146144265|NCT01079234|527042009|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
146144266|NCT01079234|527042010|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
146144267|NCT01079234|527042011|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
146144268|NCT01079234|527042008|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
146144269|NCT01079234|527042009|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
146144270|NCT01079234|527042010|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
146144271|NCT01079234|527042011|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
146144272|NCT01079234|527042008|FG000|Extension: Week 27 to 52|Unclassified|0|||
146144273|NCT01079234|527042009|FG001|Extension: Week 27 to 52|Unclassified|0|||
146144274|NCT01079234|527042010|FG002|Extension: Week 27 to 52|Unclassified|4|||
146144275|NCT01079234|527042011|FG003|Extension: Week 27 to 52|Unclassified|7|||
146144276|NCT05402995|527042022|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
146144277|NCT05402995|527042023|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146144278|NCT05402995|527042024|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146144279|NCT05402995|527042025|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
146144280|NCT00205712|527042026|FG000|Overall Study|Lost to Follow-up|0|||
146144281|NCT00205712|527042027|FG001|Overall Study|Lost to Follow-up|1|||
146144282|NCT01071512|527042028|FG000|Overall Study|Adverse Event|1|||
146144283|NCT01071512|527042028|FG000|Overall Study|Development of antibodies to drug|2|||
146144284|NCT01071512|527042028|FG000|Overall Study|positive anti-JC virus antibody test|2|||
146144285|NCT02188485|527042029|FG000|Overall Study|Withdrawal by Subject|2|||
146144286|NCT02188485|527042030|FG001|Overall Study|Withdrawal by Subject|1|||
146144287|NCT02188485|527042029|FG000|Overall Study|PI withdrew, lack of capacity|0|||
146144288|NCT02188485|527042030|FG001|Overall Study|PI withdrew, lack of capacity|2|||
146144289|NCT02316717|527042033|FG000|Overall Study|Adverse Event|2|||
146144290|NCT02316717|527042034|FG001|Overall Study|Adverse Event|2|||
146144291|NCT02316717|527042035|FG002|Overall Study|Adverse Event|0|||
146144292|NCT02316717|527042033|FG000|Overall Study|Lost to Follow-up|1|||
146144293|NCT02316717|527042034|FG001|Overall Study|Lost to Follow-up|2|||
146144294|NCT02316717|527042035|FG002|Overall Study|Lost to Follow-up|1|||
146144295|NCT02316717|527042033|FG000|Overall Study|Non compliance|3|||
146144296|NCT02316717|527042034|FG001|Overall Study|Non compliance|1|||
146144297|NCT02316717|527042035|FG002|Overall Study|Non compliance|0|||
146144298|NCT02316717|527042033|FG000|Overall Study|Protocol Violation|2|||
146144299|NCT02316717|527042034|FG001|Overall Study|Protocol Violation|0|||
146144300|NCT02316717|527042035|FG002|Overall Study|Protocol Violation|0|||
146144301|NCT02316717|527042033|FG000|Overall Study|Withdrawal by Subject|2|||
146144302|NCT02316717|527042034|FG001|Overall Study|Withdrawal by Subject|1|||
146144303|NCT02316717|527042035|FG002|Overall Study|Withdrawal by Subject|1|||
146144304|NCT02316717|527042033|FG000|Overall Study|Death|0|||
146144305|NCT02316717|527042034|FG001|Overall Study|Death|0|||
146144306|NCT02316717|527042035|FG002|Overall Study|Death|1|||
146144307|NCT02316717|527042033|FG000|Overall Study|Physician Decision|0|||
146144308|NCT02316717|527042034|FG001|Overall Study|Physician Decision|1|||
146144309|NCT02316717|527042035|FG002|Overall Study|Physician Decision|0|||
146144310|NCT02316717|527042033|FG000|Overall Study|TBC|1|||
146144311|NCT02316717|527042034|FG001|Overall Study|TBC|0|||
146144312|NCT02316717|527042035|FG002|Overall Study|TBC|0|||
146144313|NCT02296112|527042036|FG000|Overall Study|Disease progression|7|||
146144314|NCT02296112|527042036|FG000|Overall Study|Toxicity|1|||
146144315|NCT02296112|527042036|FG000|Overall Study|Began an alternate therapy|1|||
146144316|NCT01720069|527042037|FG000|Overall Study|Could not use e-diary correctly|0|||
146144317|NCT01720069|527042038|FG001|Overall Study|Could not use e-diary correctly|1|||
146144318|NCT01720069|527042039|FG002|Overall Study|Could not use e-diary correctly|1|||
146304315|NCT00066742|527629173|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
146304316|NCT00066742|527629173|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
146144319|NCT01720069|527042037|FG000|Overall Study|Randomised without baseline values|0|||
146144320|NCT01720069|527042038|FG001|Overall Study|Randomised without baseline values|0|||
146144321|NCT01720069|527042039|FG002|Overall Study|Randomised without baseline values|1|||
146273411|NCT05577715|527516156|FG000|Overall Study|Withdrawal by Subject|1|||
146273412|NCT05577715|527516156|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
146273413|NCT05577715|527516156|FG000|Overall Study|Lost to Follow-up|1|||
146273414|NCT05577715|527516156|FG000|Overall Study|Death|6|||
146273415|NCT03412773|527516157|FG000|Overall Study|Lost to Follow-up|0|||
146273416|NCT03412773|527516158|FG001|Overall Study|Lost to Follow-up|7|||
146273417|NCT03412773|527516159|FG002|Overall Study|Lost to Follow-up|6|||
146273418|NCT03412773|527516157|FG000|Overall Study|Withdrawal by Subject|0|||
146273419|NCT03412773|527516158|FG001|Overall Study|Withdrawal by Subject|15|||
146273420|NCT03412773|527516159|FG002|Overall Study|Withdrawal by Subject|19|||
146273421|NCT03412773|527516157|FG000|Overall Study|Study Closed By Sponsor|3|||
146273422|NCT03412773|527516158|FG001|Overall Study|Study Closed By Sponsor|46|||
146273423|NCT03412773|527516159|FG002|Overall Study|Study Closed By Sponsor|33|||
146273424|NCT03412773|527516157|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
146273425|NCT03412773|527516158|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
146273426|NCT03412773|527516159|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
146273427|NCT03412773|527516157|FG000|Overall Study|Death|7|||
146273428|NCT03412773|527516158|FG001|Overall Study|Death|259|||
146273429|NCT03412773|527516159|FG002|Overall Study|Death|273|||
146273430|NCT03412773|527516157|FG000|Overall Study|Physician Decision|0|||
146273431|NCT03412773|527516158|FG001|Overall Study|Physician Decision|0|||
146273432|NCT03412773|527516159|FG002|Overall Study|Physician Decision|1|||
146273433|NCT01174446|527516164|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146273434|NCT01174446|527516165|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146273435|NCT01174446|527516166|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
146273436|NCT01174446|527516167|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
146273437|NCT01174446|527516164|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146273438|NCT01174446|527516165|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146273439|NCT01174446|527516166|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
146273440|NCT01174446|527516167|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
146273441|NCT01174446|527516164|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
146273442|NCT01174446|527516165|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146273443|NCT01174446|527516166|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146273444|NCT01174446|527516167|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
146273445|NCT01174446|527516164|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146273446|NCT01174446|527516165|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
146273447|NCT01174446|527516166|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146273448|NCT01174446|527516167|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
146273449|NCT03057847|527516170|FG000|Overall Study|Lost to Follow-up|16|||
146273450|NCT01706705|527516174|FG000|Overall Study|Death|1|||
146273451|NCT01706705|527516174|FG000|Overall Study|Lack of Efficacy|13|||
146273452|NCT01706705|527516174|FG000|Overall Study|Non-clinical|6|||
146273453|NCT03510455|527516175|FG000|Overall Study|Physician Decision|1|||
146273454|NCT00384189|527516176|FG000|Overall Study|Reason Not Specified|50|||
146273455|NCT00384189|527516177|FG001|Overall Study|Reason Not Specified|57|||
146273456|NCT00384189|527516178|FG002|Overall Study|Reason Not Specified|58|||
146273457|NCT00384189|527516179|FG003|Overall Study|Reason Not Specified|40|||
146273458|NCT04958642|527516180|FG000|Overall Study|Transferred to OLEX program|3|||
146273459|NCT04958642|527516181|FG001|Overall Study|Transferred to OLEX program|0|||
146273460|NCT04958642|527516182|FG002|Overall Study|Transferred to OLEX program|5|||
146273461|NCT04958642|527516180|FG000|Overall Study|Death|0|||
146273462|NCT04958642|527516181|FG001|Overall Study|Death|0|||
146273463|NCT04958642|527516182|FG002|Overall Study|Death|1|||
146273464|NCT04958642|527516180|FG000|Overall Study|Withdrawal by Subject|4|||
146273465|NCT04958642|527516181|FG001|Overall Study|Withdrawal by Subject|9|||
146273466|NCT04958642|527516182|FG002|Overall Study|Withdrawal by Subject|13|||
146273467|NCT04958642|527516180|FG000|Overall Study|Investigator's Decision|0|||
146273468|NCT04958642|527516181|FG001|Overall Study|Investigator's Decision|0|||
146273469|NCT04958642|527516182|FG002|Overall Study|Investigator's Decision|1|||
146273470|NCT04958642|527516180|FG000|Overall Study|Adverse Event|1|||
146273471|NCT04958642|527516181|FG001|Overall Study|Adverse Event|0|||
146273472|NCT04958642|527516182|FG002|Overall Study|Adverse Event|1|||
146273473|NCT04958642|527516180|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
146273474|NCT04958642|527516181|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
146273475|NCT04958642|527516182|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
146273476|NCT04958642|527516180|FG000|Overall Study|Lost to Follow-up|1|||
146273477|NCT04958642|527516181|FG001|Overall Study|Lost to Follow-up|0|||
146273478|NCT04958642|527516182|FG002|Overall Study|Lost to Follow-up|0|||
146273479|NCT04958642|527516180|FG000|Overall Study|Transferred to EAP following study termination|0|||
146273480|NCT04958642|527516181|FG001|Overall Study|Transferred to EAP following study termination|0|||
146304317|NCT00066742|527629173|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
146304318|NCT00066742|527629173|FG000|Induction Chemoradiotherapy|Ineligible|3|||
146273481|NCT04958642|527516182|FG002|Overall Study|Transferred to EAP following study termination|1|||
146273482|NCT04958642|527516180|FG000|Overall Study|Transferred to Expanded Access Program|1|||
146273483|NCT04958642|527516181|FG001|Overall Study|Transferred to Expanded Access Program|0|||
146273484|NCT04958642|527516182|FG002|Overall Study|Transferred to Expanded Access Program|0|||
146273485|NCT02942004|527516183|FG000|Overall Study|Withdrawal by Subject|0|||
146273486|NCT02942004|527516184|FG001|Overall Study|Withdrawal by Subject|2|||
146273487|NCT02942004|527516185|FG002|Overall Study|Withdrawal by Subject|3|||
146273488|NCT02942004|527516183|FG000|Overall Study|Lost to Follow-up|1|||
146273489|NCT02942004|527516184|FG001|Overall Study|Lost to Follow-up|1|||
146273490|NCT02942004|527516185|FG002|Overall Study|Lost to Follow-up|2|||
146273491|NCT02942004|527516183|FG000|Overall Study|Randomized but not dosed|3|||
146273492|NCT02942004|527516184|FG001|Overall Study|Randomized but not dosed|9|||
146273493|NCT02942004|527516185|FG002|Overall Study|Randomized but not dosed|4|||
146273494|NCT05627258|527516186|FG000|Overall Study|Lost to Follow-up|1|||
146273495|NCT05627258|527516187|FG001|Overall Study|Lost to Follow-up|0|||
146273496|NCT05627258|527516188|FG002|Overall Study|Lost to Follow-up|0|||
146273497|NCT05627258|527516189|FG003|Overall Study|Lost to Follow-up|0|||
146273498|NCT05627258|527516190|FG004|Overall Study|Lost to Follow-up|0|||
146273499|NCT05627258|527516191|FG005|Overall Study|Lost to Follow-up|0|||
146273500|NCT05627258|527516186|FG000|Overall Study|Withdrawal by Subject|0|||
146273501|NCT05627258|527516187|FG001|Overall Study|Withdrawal by Subject|0|||
146273502|NCT05627258|527516188|FG002|Overall Study|Withdrawal by Subject|0|||
146273503|NCT05627258|527516189|FG003|Overall Study|Withdrawal by Subject|0|||
146273504|NCT05627258|527516190|FG004|Overall Study|Withdrawal by Subject|2|||
146273505|NCT05627258|527516191|FG005|Overall Study|Withdrawal by Subject|0|||
146273506|NCT05627258|527516186|FG000|Overall Study|Enrolled, but product not administered|1|||
146273507|NCT05627258|527516187|FG001|Overall Study|Enrolled, but product not administered|0|||
146273508|NCT05627258|527516188|FG002|Overall Study|Enrolled, but product not administered|0|||
146273509|NCT05627258|527516189|FG003|Overall Study|Enrolled, but product not administered|0|||
146273510|NCT05627258|527516190|FG004|Overall Study|Enrolled, but product not administered|0|||
146273511|NCT05627258|527516191|FG005|Overall Study|Enrolled, but product not administered|0|||
146273512|NCT05627258|527516186|FG000|Overall Study|Other subject illness/injury|1|||
146273513|NCT05627258|527516187|FG001|Overall Study|Other subject illness/injury|0|||
146273514|NCT05627258|527516188|FG002|Overall Study|Other subject illness/injury|0|||
146273515|NCT05627258|527516189|FG003|Overall Study|Other subject illness/injury|0|||
146273516|NCT05627258|527516190|FG004|Overall Study|Other subject illness/injury|0|||
146273517|NCT05627258|527516191|FG005|Overall Study|Other subject illness/injury|0|||
146273518|NCT05627258|527516186|FG000|Overall Study|Subject moved from area|0|||
146273519|NCT05627258|527516187|FG001|Overall Study|Subject moved from area|0|||
146273520|NCT05627258|527516188|FG002|Overall Study|Subject moved from area|1|||
146273521|NCT05627258|527516189|FG003|Overall Study|Subject moved from area|0|||
146273522|NCT05627258|527516190|FG004|Overall Study|Subject moved from area|0|||
146273523|NCT05627258|527516191|FG005|Overall Study|Subject moved from area|0|||
146273524|NCT04517669|527516192|FG000|Overall Study|Lost to Follow-up|2|||
146273525|NCT04517669|527516192|FG000|Overall Study|Withdrawal by Subject|3|||
146273526|NCT04517669|527516192|FG000|Overall Study|Drug withdrawn|44|||
146273527|NCT04517669|527516192|FG000|Overall Study|Other|1|||
146273528|NCT04517669|527516192|FG000|Overall Study|Eligibility criteria not met|4|||
146273529|NCT04517669|527516192|FG000|Overall Study|Did not receive treatment|3|||
146273530|NCT02138786|527516193|FG000|Overall Study|Adverse Event|0|||
146273531|NCT02138786|527516194|FG001|Overall Study|Adverse Event|2|||
146273532|NCT02138786|527516195|FG002|Overall Study|Adverse Event|1|||
146273533|NCT02138786|527516193|FG000|Overall Study|Death|1|||
146273534|NCT02138786|527516194|FG001|Overall Study|Death|7|||
146273535|NCT02138786|527516195|FG002|Overall Study|Death|2|||
146273536|NCT02138786|527516193|FG000|Overall Study|Disease Progression|1|||
146273537|NCT02138786|527516194|FG001|Overall Study|Disease Progression|1|||
146273538|NCT02138786|527516195|FG002|Overall Study|Disease Progression|3|||
146273539|NCT02138786|527516193|FG000|Overall Study|Withdrawal by Subject|1|||
146273540|NCT02138786|527516194|FG001|Overall Study|Withdrawal by Subject|2|||
146273541|NCT02138786|527516195|FG002|Overall Study|Withdrawal by Subject|0|||
146273542|NCT02138786|527516193|FG000|Overall Study|Patient's Wish|0|||
146273543|NCT02138786|527516194|FG001|Overall Study|Patient's Wish|2|||
146273544|NCT02138786|527516195|FG002|Overall Study|Patient's Wish|0|||
146273545|NCT02138786|527516193|FG000|Overall Study|Sponsor Terminated Study|0|||
146273546|NCT02138786|527516194|FG001|Overall Study|Sponsor Terminated Study|1|||
146273547|NCT02138786|527516195|FG002|Overall Study|Sponsor Terminated Study|1|||
146273548|NCT02138786|527516193|FG000|Overall Study|Non-Compliance|0|||
146273549|NCT02138786|527516194|FG001|Overall Study|Non-Compliance|0|||
146273550|NCT02138786|527516195|FG002|Overall Study|Non-Compliance|1|||
146273551|NCT01199068|527516199|FG000|Overall Study|Unacceptable toxicity|0|||
146273552|NCT01199068|527516200|FG001|Overall Study|Unacceptable toxicity|0|||
146273553|NCT01199068|527516201|FG002|Overall Study|Unacceptable toxicity|2|||
146273554|NCT01199068|527516199|FG000|Overall Study|Progressive disease|3|||
146144322|NCT01720069|527042037|FG000|Overall Study|Adverse Event|0|||
146273555|NCT01199068|527516200|FG001|Overall Study|Progressive disease|3|||
146273556|NCT01199068|527516201|FG002|Overall Study|Progressive disease|6|||
146273557|NCT01199068|527516199|FG000|Overall Study|Withdrawal by Subject|0|||
146273558|NCT01199068|527516200|FG001|Overall Study|Withdrawal by Subject|0|||
146273559|NCT01199068|527516201|FG002|Overall Study|Withdrawal by Subject|1|||
146273560|NCT01250925|527516202|FG000|Overall Study|Lost to Follow-up|1|||
146273561|NCT01250925|527516203|FG001|Overall Study|Lost to Follow-up|1|||
146273562|NCT01250925|527516204|FG002|Overall Study|Lost to Follow-up|0|||
146273563|NCT01250925|527516202|FG000|Overall Study|Withdrawal by Subject|2|||
146273564|NCT01250925|527516203|FG001|Overall Study|Withdrawal by Subject|0|||
146273565|NCT01250925|527516204|FG002|Overall Study|Withdrawal by Subject|0|||
146273566|NCT01250925|527516202|FG000|Overall Study|Protocol Violation|2|||
146273567|NCT01250925|527516203|FG001|Overall Study|Protocol Violation|0|||
146273568|NCT01250925|527516204|FG002|Overall Study|Protocol Violation|0|||
146273569|NCT01250925|527516202|FG000|Overall Study|Physician Decision|0|||
146273570|NCT01250925|527516203|FG001|Overall Study|Physician Decision|2|||
146273571|NCT01250925|527516204|FG002|Overall Study|Physician Decision|1|||
146273572|NCT01250925|527516202|FG000|Overall Study|Adverse Event|0|||
146273573|NCT01250925|527516203|FG001|Overall Study|Adverse Event|0|||
146273574|NCT01250925|527516204|FG002|Overall Study|Adverse Event|1|||
146273575|NCT00678301|527516205|FG000|Overall Study|Non-compliance with study procedures|0|||
146273576|NCT00678301|527516206|FG001|Overall Study|Non-compliance with study procedures|1|||
146273577|NCT00678301|527516205|FG000|Overall Study|Adverse Event|1|||
146273578|NCT00678301|527516206|FG001|Overall Study|Adverse Event|0|||
146273579|NCT00678301|527516205|FG000|Overall Study|Withdrawal by Subject|4|||
146273580|NCT00678301|527516206|FG001|Overall Study|Withdrawal by Subject|0|||
146273581|NCT00678301|527516205|FG000|Overall Study|Lost to Follow-up|3|||
146273582|NCT00678301|527516206|FG001|Overall Study|Lost to Follow-up|1|||
146273583|NCT03338296|527516207|FG000|Overall Study|Adverse Event|0|||
146273584|NCT03338296|527516208|FG001|Overall Study|Adverse Event|1|||
146273585|NCT03338296|527516207|FG000|Overall Study|Withdrawal by Subject|14|||
146273586|NCT03338296|527516208|FG001|Overall Study|Withdrawal by Subject|13|||
146273587|NCT03338296|527516207|FG000|Overall Study|Lost to Follow-up|10|||
146273588|NCT03338296|527516208|FG001|Overall Study|Lost to Follow-up|10|||
146273589|NCT03338296|527516207|FG000|Overall Study|Study Terminated by Sponsor|77|||
146273590|NCT03338296|527516208|FG001|Overall Study|Study Terminated by Sponsor|76|||
146273591|NCT03338296|527516207|FG000|Overall Study|Other|2|||
146273592|NCT03338296|527516208|FG001|Overall Study|Other|7|||
146273593|NCT03338296|527516207|FG000|Overall Study|Missing|0|||
146273594|NCT03338296|527516208|FG001|Overall Study|Missing|1|||
146273595|NCT01939353|527516209|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
146273596|NCT01939353|527516209|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
146273597|NCT01939353|527516209|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
146273598|NCT01939353|527516209|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146273599|NCT01939353|527516209|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
146273600|NCT04421950|527516215|FG000|Overall Study|Dropped or lost to follow up|4|||
146273601|NCT04421950|527516216|FG001|Overall Study|Dropped or lost to follow up|2|||
146273602|NCT05048238|527516217|FG000|Overall Study|Withdrawal by Subject|1|||
146273603|NCT00335140|527516220|FG000|Overall Study|Ineligible|1|||
146273604|NCT04546425|527516221|FG000|Overall Study|Protocol Violation|1|||
146273605|NCT04546425|527516222|FG001|Overall Study|Protocol Violation|1|||
146273606|NCT04546425|527516223|FG002|Overall Study|Protocol Violation|0|||
146273607|NCT04546425|527516224|FG003|Overall Study|Protocol Violation|0|||
146273608|NCT04546425|527516221|FG000|Overall Study|Adverse Event|3|||
146273609|NCT04546425|527516222|FG001|Overall Study|Adverse Event|0|||
146273610|NCT04546425|527516223|FG002|Overall Study|Adverse Event|0|||
146273611|NCT04546425|527516224|FG003|Overall Study|Adverse Event|0|||
146273612|NCT04546425|527516221|FG000|Overall Study|Lost to Follow-up|5|||
146273613|NCT04546425|527516222|FG001|Overall Study|Lost to Follow-up|4|||
146273614|NCT04546425|527516223|FG002|Overall Study|Lost to Follow-up|0|||
146273615|NCT04546425|527516224|FG003|Overall Study|Lost to Follow-up|0|||
146273616|NCT04546425|527516221|FG000|Overall Study|No Longer met eligibility criteria|3|||
146273617|NCT04546425|527516222|FG001|Overall Study|No Longer met eligibility criteria|3|||
146273618|NCT04546425|527516223|FG002|Overall Study|No Longer met eligibility criteria|1|||
146273619|NCT04546425|527516224|FG003|Overall Study|No Longer met eligibility criteria|1|||
146273620|NCT04546425|527516221|FG000|Overall Study|Withdrawal by parent/guardian|6|||
146273621|NCT04546425|527516222|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146273622|NCT04546425|527516223|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146273623|NCT04546425|527516224|FG003|Overall Study|Withdrawal by parent/guardian|1|||
146273624|NCT02687035|527516225|FG000|Overall Study|Withdrawal by Subject|1|||
146273625|NCT02687035|527516225|FG000|Overall Study|Death|87|||
146273626|NCT02687035|527516225|FG000|Overall Study|Lost to Follow-up|1|||
146273627|NCT02687035|527516225|FG000|Overall Study|Missed Visit|87|||
146273628|NCT02687035|527516225|FG000|Overall Study|Did not receive Study Device|8|||
146273629|NCT04076943|527516235|FG000|Overall Study|Withdrawal by Subject|12|||
146273630|NCT04076943|527516235|FG000|Overall Study|Adverse Event|1|||
146273631|NCT04076943|527516235|FG000|Overall Study|Progressive Disease|2|||
146273632|NCT04076943|527516235|FG000|Overall Study|Death|13|||
146273633|NCT04076943|527516235|FG000|Overall Study|Other than specified|6|||
146273634|NCT02766777|527516242|FG000|Overall Study|Adverse Event|12|||
146273635|NCT02766777|527516242|FG000|Overall Study|Lost to Follow-up|16|||
146273636|NCT02766777|527516242|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146273637|NCT02766777|527516242|FG000|Overall Study|Protocol Violation|1|||
146273638|NCT02766777|527516242|FG000|Overall Study|Withdrawal by Subject|4|||
146144323|NCT01720069|527042038|FG001|Overall Study|Adverse Event|0|||
146144324|NCT01720069|527042039|FG002|Overall Study|Adverse Event|1|||
146144325|NCT01720069|527042037|FG000|Overall Study|Lack of Efficacy|0|||
146144326|NCT01720069|527042038|FG001|Overall Study|Lack of Efficacy|4|||
146144327|NCT01720069|527042039|FG002|Overall Study|Lack of Efficacy|0|||
146144328|NCT01720069|527042037|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
146144329|NCT01720069|527042038|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
146144330|NCT01720069|527042039|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
146144331|NCT01720069|527042037|FG000|Overall Study|Withdrawal by Subject|0|||
146144332|NCT01720069|527042038|FG001|Overall Study|Withdrawal by Subject|2|||
146144333|NCT01720069|527042039|FG002|Overall Study|Withdrawal by Subject|1|||
146144334|NCT01720069|527042037|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
146144335|NCT01720069|527042038|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
146144336|NCT01720069|527042039|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
146144337|NCT01720069|527042037|FG000|Overall Study|Non-compliance on using e-diary|0|||
146144338|NCT01720069|527042038|FG001|Overall Study|Non-compliance on using e-diary|0|||
146144339|NCT01720069|527042039|FG002|Overall Study|Non-compliance on using e-diary|1|||
146144340|NCT01720069|527042037|FG000|Overall Study|Lost to Follow-up|0|||
146144341|NCT01720069|527042038|FG001|Overall Study|Lost to Follow-up|0|||
146144342|NCT01720069|527042039|FG002|Overall Study|Lost to Follow-up|1|||
146144343|NCT00508742|527042040|FG000|Period 1: Infant Series|Adverse Event|5|||
146144344|NCT00508742|527042041|FG001|Period 1: Infant Series|Adverse Event|4|||
146144345|NCT00508742|527042040|FG000|Period 1: Infant Series|Protocol Violation|1|||
146144346|NCT00508742|527042041|FG001|Period 1: Infant Series|Protocol Violation|0|||
146144347|NCT00508742|527042040|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
146144348|NCT00508742|527042041|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
146144349|NCT00508742|527042040|FG000|Period 1: Infant Series|Physician Decision|1|||
146144350|NCT00508742|527042041|FG001|Period 1: Infant Series|Physician Decision|0|||
146144351|NCT00508742|527042040|FG000|Period 1: Infant Series|Other|4|||
146144352|NCT00508742|527042041|FG001|Period 1: Infant Series|Other|1|||
146144353|NCT00508742|527042040|FG000|Period 2: After Infant Series|Adverse Event|2|||
146144354|NCT00508742|527042041|FG001|Period 2: After Infant Series|Adverse Event|6|||
146144355|NCT00508742|527042040|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
146144356|NCT00508742|527042041|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
146144357|NCT00508742|527042040|FG000|Period 2: After Infant Series|Protocol Violation|1|||
146144358|NCT00508742|527042041|FG001|Period 2: After Infant Series|Protocol Violation|0|||
146144359|NCT00508742|527042040|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
146144360|NCT00508742|527042041|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
146144361|NCT00508742|527042040|FG000|Period 2: After Infant Series|Failed to Return|1|||
146144362|NCT00508742|527042041|FG001|Period 2: After Infant Series|Failed to Return|0|||
146144363|NCT00508742|527042040|FG000|Period 2: After Infant Series|Other|2|||
146144364|NCT00508742|527042041|FG001|Period 2: After Infant Series|Other|1|||
146144365|NCT00508742|527042040|FG000|Period 3: Toddler Dose|Adverse Event|1|||
146144366|NCT00508742|527042041|FG001|Period 3: Toddler Dose|Adverse Event|0|||
146144367|NCT00508742|527042040|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
146144368|NCT00508742|527042041|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
146144369|NCT00508742|527042040|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
146144370|NCT00508742|527042041|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
146144371|NCT00508742|527042040|FG000|Period 3: Toddler Dose|Other|5|||
146144372|NCT00508742|527042041|FG001|Period 3: Toddler Dose|Other|4|||
146144373|NCT02460224|527042048|FG000|Overall Study|Adverse Event|0|||
146144374|NCT02460224|527042049|FG001|Overall Study|Adverse Event|0|||
146144375|NCT02460224|527042050|FG002|Overall Study|Adverse Event|0|||
146144376|NCT02460224|527042051|FG003|Overall Study|Adverse Event|0|||
146144377|NCT02460224|527042052|FG004|Overall Study|Adverse Event|0|||
146144378|NCT02460224|527042053|FG005|Overall Study|Adverse Event|0|||
146273639|NCT05071053|527516243|FG000|Overall Study|Progressive disease|30|||
146273640|NCT05071053|527516243|FG000|Overall Study|Adverse Event|5|||
146273641|NCT00895895|527516244|FG000|Period 1|Adverse Event|7|||
146273642|NCT00895895|527516245|FG001|Period 1|Adverse Event|6|||
146144379|NCT02460224|527042054|FG006|Overall Study|Adverse Event|1|||
146144380|NCT02460224|527042055|FG007|Overall Study|Adverse Event|0|||
146144381|NCT02460224|527042056|FG008|Overall Study|Adverse Event|0|||
146144382|NCT02460224|527042057|FG009|Overall Study|Adverse Event|0|||
146144383|NCT02460224|527042058|FG010|Overall Study|Adverse Event|0|||
146144384|NCT02460224|527042059|FG011|Overall Study|Adverse Event|0|||
146273643|NCT00895895|527516246|FG002|Period 1|Adverse Event|4|||
146273644|NCT00895895|527516247|FG003|Period 1|Adverse Event|6|||
146273645|NCT00895895|527516248|FG004|Period 1|Adverse Event|7|||
146273646|NCT00895895|527516244|FG000|Period 1|Death|0|||
146273647|NCT00895895|527516245|FG001|Period 1|Death|0|||
146273648|NCT00895895|527516246|FG002|Period 1|Death|0|||
146273649|NCT00895895|527516247|FG003|Period 1|Death|0|||
146273650|NCT00895895|527516248|FG004|Period 1|Death|1|||
146273651|NCT00895895|527516244|FG000|Period 1|discontinued by sponsor|2|||
146273652|NCT00895895|527516245|FG001|Period 1|discontinued by sponsor|1|||
146273653|NCT00895895|527516246|FG002|Period 1|discontinued by sponsor|2|||
146273654|NCT00895895|527516247|FG003|Period 1|discontinued by sponsor|1|||
146273655|NCT00895895|527516248|FG004|Period 1|discontinued by sponsor|1|||
146273656|NCT00895895|527516244|FG000|Period 1|failed to return|0|||
146273657|NCT00895895|527516245|FG001|Period 1|failed to return|0|||
146273658|NCT00895895|527516246|FG002|Period 1|failed to return|1|||
146273659|NCT00895895|527516247|FG003|Period 1|failed to return|0|||
146273660|NCT00895895|527516248|FG004|Period 1|failed to return|1|||
146273661|NCT00895895|527516244|FG000|Period 1|investigator request|0|||
146273662|NCT00895895|527516245|FG001|Period 1|investigator request|1|||
146273663|NCT00895895|527516246|FG002|Period 1|investigator request|0|||
146273664|NCT00895895|527516247|FG003|Period 1|investigator request|0|||
146273665|NCT00895895|527516248|FG004|Period 1|investigator request|0|||
146273666|NCT00895895|527516244|FG000|Period 1|Lost to Follow-up|2|||
146273667|NCT00895895|527516245|FG001|Period 1|Lost to Follow-up|1|||
146273668|NCT00895895|527516246|FG002|Period 1|Lost to Follow-up|3|||
146273669|NCT00895895|527516247|FG003|Period 1|Lost to Follow-up|2|||
146273670|NCT00895895|527516248|FG004|Period 1|Lost to Follow-up|3|||
146273671|NCT00895895|527516244|FG000|Period 1|Other|1|||
146273672|NCT00895895|527516245|FG001|Period 1|Other|2|||
146273673|NCT00895895|527516246|FG002|Period 1|Other|1|||
146273674|NCT00895895|527516247|FG003|Period 1|Other|1|||
146273675|NCT00895895|527516248|FG004|Period 1|Other|1|||
146273676|NCT00895895|527516244|FG000|Period 1|Protocol Violation|0|||
146273677|NCT00895895|527516245|FG001|Period 1|Protocol Violation|1|||
146273678|NCT00895895|527516246|FG002|Period 1|Protocol Violation|0|||
146273679|NCT00895895|527516247|FG003|Period 1|Protocol Violation|0|||
146273680|NCT00895895|527516248|FG004|Period 1|Protocol Violation|0|||
146273681|NCT00895895|527516244|FG000|Period 1|Withdrawal by Subject|6|||
146273682|NCT00895895|527516245|FG001|Period 1|Withdrawal by Subject|6|||
146273683|NCT00895895|527516246|FG002|Period 1|Withdrawal by Subject|8|||
146273684|NCT00895895|527516247|FG003|Period 1|Withdrawal by Subject|2|||
146273685|NCT00895895|527516248|FG004|Period 1|Withdrawal by Subject|4|||
146273686|NCT00895895|527516244|FG000|Period 1|unsatisfactory response-efficacy|2|||
146273687|NCT00895895|527516245|FG001|Period 1|unsatisfactory response-efficacy|0|||
146273688|NCT00895895|527516246|FG002|Period 1|unsatisfactory response-efficacy|0|||
146273689|NCT00895895|527516247|FG003|Period 1|unsatisfactory response-efficacy|0|||
146273690|NCT00895895|527516248|FG004|Period 1|unsatisfactory response-efficacy|0|||
146273691|NCT00895895|527516244|FG000|Period 1|randomized and not treated|1|||
146273692|NCT00895895|527516245|FG001|Period 1|randomized and not treated|3|||
146273693|NCT00895895|527516246|FG002|Period 1|randomized and not treated|1|||
146273694|NCT00895895|527516247|FG003|Period 1|randomized and not treated|1|||
146273695|NCT00895895|527516248|FG004|Period 1|randomized and not treated|2|||
146273696|NCT00895895|527516244|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
146273697|NCT00895895|527516245|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
146273698|NCT00895895|527516246|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
146273699|NCT00895895|527516247|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
146273700|NCT00895895|527516248|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
146273701|NCT00895895|527516244|FG000|After Period 1, Prior to Period 2|Other|0|||
146273702|NCT00895895|527516245|FG001|After Period 1, Prior to Period 2|Other|0|||
146273703|NCT00895895|527516246|FG002|After Period 1, Prior to Period 2|Other|1|||
146273704|NCT00895895|527516247|FG003|After Period 1, Prior to Period 2|Other|0|||
146144385|NCT02460224|527042060|FG012|Overall Study|Adverse Event|1|||
146144386|NCT02460224|527042061|FG013|Overall Study|Adverse Event|0|||
146144387|NCT02460224|527042062|FG014|Overall Study|Adverse Event|0|||
146144388|NCT02460224|527042063|FG015|Overall Study|Adverse Event|0|||
146144389|NCT02460224|527042064|FG016|Overall Study|Adverse Event|1|||
146144390|NCT02460224|527042065|FG017|Overall Study|Adverse Event|0|||
146144391|NCT02460224|527042066|FG018|Overall Study|Adverse Event|1|||
146273705|NCT00895895|527516248|FG004|After Period 1, Prior to Period 2|Other|0|||
146273706|NCT00895895|527516244|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
146273707|NCT00895895|527516245|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
146273708|NCT00895895|527516246|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
146273709|NCT00895895|527516247|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
146273710|NCT00895895|527516248|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
146273711|NCT00895895|527516244|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146273712|NCT00895895|527516245|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146273713|NCT00895895|527516246|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146273714|NCT00895895|527516247|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
146273715|NCT00895895|527516248|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
146273716|NCT00895895|527516244|FG000|Period 2|Adverse Event|3|||
146273717|NCT00895895|527516245|FG001|Period 2|Adverse Event|3|||
146144392|NCT02460224|527042067|FG019|Overall Study|Adverse Event|0|||
146144393|NCT02460224|527042068|FG020|Overall Study|Adverse Event|1|||
146144394|NCT02460224|527042069|FG021|Overall Study|Adverse Event|1|||
146144395|NCT02460224|527042070|FG022|Overall Study|Adverse Event|1|||
146144396|NCT02460224|527042071|FG023|Overall Study|Adverse Event|0|||
146144397|NCT02460224|527042072|FG024|Overall Study|Adverse Event|0|||
146144398|NCT02460224|527042073|FG025|Overall Study|Adverse Event|0|||
146144399|NCT02460224|527042074|FG026|Overall Study|Adverse Event|11|||
146144400|NCT02460224|527042075|FG027|Overall Study|Adverse Event|1|||
146144401|NCT02460224|527042076|FG028|Overall Study|Adverse Event|6|||
146144402|NCT02460224|527042048|FG000|Overall Study|Death|0|||
146144403|NCT02460224|527042049|FG001|Overall Study|Death|0|||
146144404|NCT02460224|527042050|FG002|Overall Study|Death|0|||
146144405|NCT02460224|527042051|FG003|Overall Study|Death|0|||
146144406|NCT02460224|527042052|FG004|Overall Study|Death|0|||
146144407|NCT02460224|527042053|FG005|Overall Study|Death|2|||
146144408|NCT02460224|527042054|FG006|Overall Study|Death|1|||
146144409|NCT02460224|527042055|FG007|Overall Study|Death|0|||
146144410|NCT02460224|527042056|FG008|Overall Study|Death|0|||
146144411|NCT02460224|527042057|FG009|Overall Study|Death|1|||
146144412|NCT02460224|527042058|FG010|Overall Study|Death|0|||
146144413|NCT02460224|527042059|FG011|Overall Study|Death|0|||
146144414|NCT02460224|527042060|FG012|Overall Study|Death|0|||
146144415|NCT02460224|527042061|FG013|Overall Study|Death|1|||
146144416|NCT02460224|527042062|FG014|Overall Study|Death|0|||
146144417|NCT02460224|527042063|FG015|Overall Study|Death|0|||
146144418|NCT02460224|527042064|FG016|Overall Study|Death|2|||
146144419|NCT02460224|527042065|FG017|Overall Study|Death|1|||
146144420|NCT02460224|527042066|FG018|Overall Study|Death|0|||
146144421|NCT02460224|527042067|FG019|Overall Study|Death|2|||
146144422|NCT02460224|527042068|FG020|Overall Study|Death|0|||
146144423|NCT02460224|527042069|FG021|Overall Study|Death|0|||
146144424|NCT02460224|527042070|FG022|Overall Study|Death|0|||
146144425|NCT02460224|527042071|FG023|Overall Study|Death|0|||
146144426|NCT02460224|527042072|FG024|Overall Study|Death|1|||
146144427|NCT02460224|527042073|FG025|Overall Study|Death|1|||
146144428|NCT02460224|527042074|FG026|Overall Study|Death|5|||
146144429|NCT02460224|527042075|FG027|Overall Study|Death|0|||
146144430|NCT02460224|527042076|FG028|Overall Study|Death|1|||
146144431|NCT02460224|527042048|FG000|Overall Study|Lost to Follow-up|0|||
146144432|NCT02460224|527042049|FG001|Overall Study|Lost to Follow-up|0|||
146144433|NCT02460224|527042050|FG002|Overall Study|Lost to Follow-up|0|||
146144434|NCT02460224|527042051|FG003|Overall Study|Lost to Follow-up|0|||
146144435|NCT02460224|527042052|FG004|Overall Study|Lost to Follow-up|0|||
146144436|NCT02460224|527042053|FG005|Overall Study|Lost to Follow-up|0|||
146144437|NCT02460224|527042054|FG006|Overall Study|Lost to Follow-up|0|||
146144438|NCT02460224|527042055|FG007|Overall Study|Lost to Follow-up|0|||
146144439|NCT02460224|527042056|FG008|Overall Study|Lost to Follow-up|0|||
146144440|NCT02460224|527042057|FG009|Overall Study|Lost to Follow-up|0|||
146144441|NCT02460224|527042058|FG010|Overall Study|Lost to Follow-up|0|||
146144442|NCT02460224|527042059|FG011|Overall Study|Lost to Follow-up|0|||
146144443|NCT02460224|527042060|FG012|Overall Study|Lost to Follow-up|0|||
146144444|NCT02460224|527042061|FG013|Overall Study|Lost to Follow-up|0|||
146144445|NCT02460224|527042062|FG014|Overall Study|Lost to Follow-up|0|||
146144446|NCT02460224|527042063|FG015|Overall Study|Lost to Follow-up|0|||
146144447|NCT02460224|527042064|FG016|Overall Study|Lost to Follow-up|0|||
146144448|NCT02460224|527042065|FG017|Overall Study|Lost to Follow-up|0|||
146144449|NCT02460224|527042066|FG018|Overall Study|Lost to Follow-up|0|||
146144450|NCT02460224|527042067|FG019|Overall Study|Lost to Follow-up|0|||
146144451|NCT02460224|527042068|FG020|Overall Study|Lost to Follow-up|0|||
146144452|NCT02460224|527042069|FG021|Overall Study|Lost to Follow-up|0|||
146144453|NCT02460224|527042070|FG022|Overall Study|Lost to Follow-up|1|||
146144454|NCT02460224|527042071|FG023|Overall Study|Lost to Follow-up|0|||
146144455|NCT02460224|527042072|FG024|Overall Study|Lost to Follow-up|0|||
146144456|NCT02460224|527042073|FG025|Overall Study|Lost to Follow-up|0|||
146144457|NCT02460224|527042074|FG026|Overall Study|Lost to Follow-up|0|||
146144458|NCT02460224|527042075|FG027|Overall Study|Lost to Follow-up|0|||
146144459|NCT02460224|527042076|FG028|Overall Study|Lost to Follow-up|0|||
146144460|NCT02460224|527042048|FG000|Overall Study|Physician Decision|0|||
146144461|NCT02460224|527042049|FG001|Overall Study|Physician Decision|1|||
146144462|NCT02460224|527042050|FG002|Overall Study|Physician Decision|0|||
146144463|NCT02460224|527042051|FG003|Overall Study|Physician Decision|0|||
146144464|NCT02460224|527042052|FG004|Overall Study|Physician Decision|1|||
146144465|NCT02460224|527042053|FG005|Overall Study|Physician Decision|0|||
146144466|NCT02460224|527042054|FG006|Overall Study|Physician Decision|0|||
146144467|NCT02460224|527042055|FG007|Overall Study|Physician Decision|1|||
146144468|NCT02460224|527042056|FG008|Overall Study|Physician Decision|0|||
146144469|NCT02460224|527042057|FG009|Overall Study|Physician Decision|0|||
146144470|NCT02460224|527042058|FG010|Overall Study|Physician Decision|0|||
146144471|NCT02460224|527042059|FG011|Overall Study|Physician Decision|1|||
146144472|NCT02460224|527042060|FG012|Overall Study|Physician Decision|0|||
146144473|NCT02460224|527042061|FG013|Overall Study|Physician Decision|1|||
146144474|NCT02460224|527042062|FG014|Overall Study|Physician Decision|0|||
146144475|NCT02460224|527042063|FG015|Overall Study|Physician Decision|0|||
146273718|NCT00895895|527516246|FG002|Period 2|Adverse Event|5|||
146273719|NCT00895895|527516247|FG003|Period 2|Adverse Event|2|||
146273720|NCT00895895|527516248|FG004|Period 2|Adverse Event|5|||
146273721|NCT00895895|527516244|FG000|Period 2|Death|0|||
146273722|NCT00895895|527516245|FG001|Period 2|Death|0|||
146273723|NCT00895895|527516246|FG002|Period 2|Death|1|||
146273724|NCT00895895|527516247|FG003|Period 2|Death|0|||
146273725|NCT00895895|527516248|FG004|Period 2|Death|0|||
146273726|NCT00895895|527516244|FG000|Period 2|discontinued by sponsor|44|||
146273727|NCT00895895|527516245|FG001|Period 2|discontinued by sponsor|44|||
146273728|NCT00895895|527516246|FG002|Period 2|discontinued by sponsor|38|||
146273729|NCT00895895|527516247|FG003|Period 2|discontinued by sponsor|46|||
146273730|NCT00895895|527516248|FG004|Period 2|discontinued by sponsor|37|||
146273731|NCT00895895|527516244|FG000|Period 2|failed to return|2|||
146273732|NCT00895895|527516245|FG001|Period 2|failed to return|0|||
146273733|NCT00895895|527516246|FG002|Period 2|failed to return|0|||
146273734|NCT00895895|527516247|FG003|Period 2|failed to return|0|||
146273735|NCT00895895|527516248|FG004|Period 2|failed to return|0|||
146273736|NCT00895895|527516244|FG000|Period 2|investigator request|2|||
146273737|NCT00895895|527516245|FG001|Period 2|investigator request|0|||
146273738|NCT00895895|527516246|FG002|Period 2|investigator request|0|||
146273739|NCT00895895|527516247|FG003|Period 2|investigator request|0|||
146273740|NCT00895895|527516248|FG004|Period 2|investigator request|0|||
146273741|NCT00895895|527516244|FG000|Period 2|Lost to Follow-up|1|||
146273742|NCT00895895|527516245|FG001|Period 2|Lost to Follow-up|2|||
146273743|NCT00895895|527516246|FG002|Period 2|Lost to Follow-up|1|||
146273744|NCT00895895|527516247|FG003|Period 2|Lost to Follow-up|1|||
146273745|NCT00895895|527516248|FG004|Period 2|Lost to Follow-up|0|||
146273746|NCT00895895|527516244|FG000|Period 2|Other|1|||
146273747|NCT00895895|527516245|FG001|Period 2|Other|1|||
146273748|NCT00895895|527516246|FG002|Period 2|Other|3|||
146273749|NCT00895895|527516247|FG003|Period 2|Other|1|||
146273750|NCT00895895|527516248|FG004|Period 2|Other|1|||
146273751|NCT00895895|527516244|FG000|Period 2|Protocol Violation|1|||
146273752|NCT00895895|527516245|FG001|Period 2|Protocol Violation|0|||
146273753|NCT00895895|527516246|FG002|Period 2|Protocol Violation|1|||
146273754|NCT00895895|527516247|FG003|Period 2|Protocol Violation|1|||
146273755|NCT00895895|527516248|FG004|Period 2|Protocol Violation|1|||
146273756|NCT00895895|527516244|FG000|Period 2|Withdrawal by Subject|0|||
146273757|NCT00895895|527516245|FG001|Period 2|Withdrawal by Subject|2|||
146273758|NCT00895895|527516246|FG002|Period 2|Withdrawal by Subject|0|||
146273759|NCT00895895|527516247|FG003|Period 2|Withdrawal by Subject|3|||
146273760|NCT00895895|527516248|FG004|Period 2|Withdrawal by Subject|5|||
146273761|NCT00895895|527516244|FG000|Period 2|unsatisfactory response-efficacy|2|||
146273762|NCT00895895|527516245|FG001|Period 2|unsatisfactory response-efficacy|1|||
146273763|NCT00895895|527516246|FG002|Period 2|unsatisfactory response-efficacy|0|||
146273764|NCT00895895|527516247|FG003|Period 2|unsatisfactory response-efficacy|0|||
146273765|NCT00895895|527516248|FG004|Period 2|unsatisfactory response-efficacy|0|||
146273766|NCT01572740|527516249|FG000|Overall Study|Adverse Event|1|||
146273767|NCT01572740|527516250|FG001|Overall Study|Adverse Event|1|||
146273768|NCT01572740|527516249|FG000|Overall Study|Withdrawal by Subject|1|||
146273769|NCT01572740|527516250|FG001|Overall Study|Withdrawal by Subject|1|||
146273770|NCT01572740|527516249|FG000|Overall Study|unclassified|4|||
146273771|NCT01572740|527516250|FG001|Overall Study|unclassified|3|||
146273772|NCT00214019|527516251|FG000|Overall Study|Lost to Follow-up|11|||
146273773|NCT00214019|527516251|FG000|Overall Study|Withdrawal by Subject|2|||
146273774|NCT00214019|527516251|FG000|Overall Study|Screen Failed prior to randomization|17|||
146273775|NCT04230122|527516252|FG000|Overall Study|Lost to Follow-up|1|||
146273776|NCT04230122|527516253|FG001|Overall Study|Lost to Follow-up|0|||
146273777|NCT03945825|527516254|FG000|Overall Study|Enrolled but treatment not administered|0|||
146273778|NCT03945825|527516255|FG001|Overall Study|Enrolled but treatment not administered|0|||
146273779|NCT03945825|527516256|FG002|Overall Study|Enrolled but treatment not administered|0|||
146273780|NCT03945825|527516257|FG003|Overall Study|Enrolled but treatment not administered|0|||
146273781|NCT03945825|527516258|FG004|Overall Study|Enrolled but treatment not administered|1|||
146273782|NCT03945825|527516259|FG005|Overall Study|Enrolled but treatment not administered|0|||
146273783|NCT03945825|527516254|FG000|Overall Study|Lost to Follow-up|1|||
146273784|NCT03945825|527516255|FG001|Overall Study|Lost to Follow-up|5|||
146273785|NCT03945825|527516256|FG002|Overall Study|Lost to Follow-up|0|||
146273786|NCT03945825|527516257|FG003|Overall Study|Lost to Follow-up|1|||
146273787|NCT03945825|527516258|FG004|Overall Study|Lost to Follow-up|2|||
146273788|NCT03945825|527516259|FG005|Overall Study|Lost to Follow-up|2|||
146273789|NCT03945825|527516254|FG000|Overall Study|Withdrawal by Subject|1|||
146273790|NCT03945825|527516255|FG001|Overall Study|Withdrawal by Subject|0|||
146273791|NCT03945825|527516256|FG002|Overall Study|Withdrawal by Subject|1|||
146273792|NCT03945825|527516257|FG003|Overall Study|Withdrawal by Subject|1|||
146273793|NCT03945825|527516258|FG004|Overall Study|Withdrawal by Subject|0|||
146273794|NCT03945825|527516259|FG005|Overall Study|Withdrawal by Subject|1|||
146273795|NCT01461005|527516260|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
146273796|NCT01399918|527516261|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
146273797|NCT04844879|527516264|FG000|Overall Study|Death|1|||
146273798|NCT04844879|527516264|FG000|Overall Study|Withdrawal by Subject|1|||
146144476|NCT02460224|527042064|FG016|Overall Study|Physician Decision|2|||
146144477|NCT02460224|527042065|FG017|Overall Study|Physician Decision|1|||
146144478|NCT02460224|527042066|FG018|Overall Study|Physician Decision|1|||
146144479|NCT02460224|527042067|FG019|Overall Study|Physician Decision|2|||
146144480|NCT02460224|527042068|FG020|Overall Study|Physician Decision|1|||
146144481|NCT02460224|527042069|FG021|Overall Study|Physician Decision|1|||
146144482|NCT02460224|527042070|FG022|Overall Study|Physician Decision|0|||
146144483|NCT02460224|527042071|FG023|Overall Study|Physician Decision|0|||
146144484|NCT02460224|527042072|FG024|Overall Study|Physician Decision|1|||
146144485|NCT02460224|527042073|FG025|Overall Study|Physician Decision|0|||
146144486|NCT02460224|527042074|FG026|Overall Study|Physician Decision|14|||
146144487|NCT02460224|527042075|FG027|Overall Study|Physician Decision|1|||
146144488|NCT02460224|527042076|FG028|Overall Study|Physician Decision|6|||
146144489|NCT02460224|527042048|FG000|Overall Study|Progressive disease|15|||
146144490|NCT02460224|527042049|FG001|Overall Study|Progressive disease|11|||
146144491|NCT02460224|527042050|FG002|Overall Study|Progressive disease|5|||
146144492|NCT02460224|527042051|FG003|Overall Study|Progressive disease|6|||
146144493|NCT02460224|527042052|FG004|Overall Study|Progressive disease|3|||
146144494|NCT02460224|527042053|FG005|Overall Study|Progressive disease|26|||
146144495|NCT02460224|527042054|FG006|Overall Study|Progressive disease|28|||
146144496|NCT02460224|527042055|FG007|Overall Study|Progressive disease|4|||
146144497|NCT02460224|527042056|FG008|Overall Study|Progressive disease|5|||
146144498|NCT02460224|527042057|FG009|Overall Study|Progressive disease|9|||
146144499|NCT02460224|527042058|FG010|Overall Study|Progressive disease|5|||
146144500|NCT02460224|527042059|FG011|Overall Study|Progressive disease|4|||
146144501|NCT02460224|527042060|FG012|Overall Study|Progressive disease|5|||
146144502|NCT02460224|527042061|FG013|Overall Study|Progressive disease|4|||
146144503|NCT02460224|527042062|FG014|Overall Study|Progressive disease|5|||
146144504|NCT02460224|527042063|FG015|Overall Study|Progressive disease|5|||
146144505|NCT02460224|527042064|FG016|Overall Study|Progressive disease|15|||
146144506|NCT02460224|527042065|FG017|Overall Study|Progressive disease|3|||
146144507|NCT02460224|527042066|FG018|Overall Study|Progressive disease|8|||
146144508|NCT02460224|527042067|FG019|Overall Study|Progressive disease|3|||
146144509|NCT02460224|527042068|FG020|Overall Study|Progressive disease|4|||
146144510|NCT02460224|527042069|FG021|Overall Study|Progressive disease|9|||
146144511|NCT02460224|527042070|FG022|Overall Study|Progressive disease|4|||
146144512|NCT02460224|527042071|FG023|Overall Study|Progressive disease|11|||
146144513|NCT02460224|527042072|FG024|Overall Study|Progressive disease|4|||
146144514|NCT02460224|527042073|FG025|Overall Study|Progressive disease|5|||
146144515|NCT02460224|527042074|FG026|Overall Study|Progressive disease|85|||
146144516|NCT02460224|527042075|FG027|Overall Study|Progressive disease|17|||
146144517|NCT02460224|527042076|FG028|Overall Study|Progressive disease|77|||
146144518|NCT02460224|527042048|FG000|Overall Study|Subject/guardian decision|2|||
146144519|NCT02460224|527042049|FG001|Overall Study|Subject/guardian decision|0|||
146144520|NCT02460224|527042050|FG002|Overall Study|Subject/guardian decision|1|||
146144521|NCT02460224|527042051|FG003|Overall Study|Subject/guardian decision|0|||
146144522|NCT02460224|527042052|FG004|Overall Study|Subject/guardian decision|2|||
146144523|NCT02460224|527042053|FG005|Overall Study|Subject/guardian decision|2|||
146144524|NCT02460224|527042054|FG006|Overall Study|Subject/guardian decision|0|||
146144525|NCT02460224|527042055|FG007|Overall Study|Subject/guardian decision|0|||
146144526|NCT02460224|527042056|FG008|Overall Study|Subject/guardian decision|1|||
146144527|NCT02460224|527042057|FG009|Overall Study|Subject/guardian decision|1|||
146144528|NCT02460224|527042058|FG010|Overall Study|Subject/guardian decision|0|||
146144529|NCT02460224|527042059|FG011|Overall Study|Subject/guardian decision|1|||
146144530|NCT02460224|527042060|FG012|Overall Study|Subject/guardian decision|0|||
146144531|NCT02460224|527042061|FG013|Overall Study|Subject/guardian decision|0|||
146144532|NCT02460224|527042062|FG014|Overall Study|Subject/guardian decision|0|||
146144533|NCT02460224|527042063|FG015|Overall Study|Subject/guardian decision|1|||
146144534|NCT02460224|527042064|FG016|Overall Study|Subject/guardian decision|0|||
146144535|NCT02460224|527042065|FG017|Overall Study|Subject/guardian decision|1|||
146144536|NCT02460224|527042066|FG018|Overall Study|Subject/guardian decision|2|||
146144537|NCT02460224|527042067|FG019|Overall Study|Subject/guardian decision|0|||
146144538|NCT02460224|527042068|FG020|Overall Study|Subject/guardian decision|0|||
146144539|NCT02460224|527042069|FG021|Overall Study|Subject/guardian decision|1|||
146144540|NCT02460224|527042070|FG022|Overall Study|Subject/guardian decision|0|||
146144541|NCT02460224|527042071|FG023|Overall Study|Subject/guardian decision|0|||
146144542|NCT02460224|527042072|FG024|Overall Study|Subject/guardian decision|0|||
146144543|NCT02460224|527042073|FG025|Overall Study|Subject/guardian decision|0|||
146144544|NCT02460224|527042074|FG026|Overall Study|Subject/guardian decision|6|||
146144545|NCT02460224|527042075|FG027|Overall Study|Subject/guardian decision|2|||
146273799|NCT04844879|527516264|FG000|Overall Study|Adverse Event|1|||
146144546|NCT02460224|527042076|FG028|Overall Study|Subject/guardian decision|3|||
146144547|NCT03146650|527042077|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
146144548|NCT03146650|527042077|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
146144549|NCT03146650|527042077|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
146144550|NCT03146650|527042077|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
146273800|NCT04520659|527516265|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
146273801|NCT04520659|527516266|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
146273802|NCT04520659|527516267|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
146273803|NCT04520659|527516268|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
146273804|NCT04103892|527516269|FG000|Overall Study|Adverse Event|0|||
146273805|NCT04103892|527516270|FG001|Overall Study|Adverse Event|0|||
146273806|NCT04103892|527516271|FG002|Overall Study|Adverse Event|0|||
146273807|NCT04103892|527516272|FG003|Overall Study|Adverse Event|3|||
146273808|NCT04103892|527516269|FG000|Overall Study|Lost to Follow-up|0|||
146273809|NCT04103892|527516270|FG001|Overall Study|Lost to Follow-up|0|||
146273810|NCT04103892|527516271|FG002|Overall Study|Lost to Follow-up|2|||
146273811|NCT04103892|527516272|FG003|Overall Study|Lost to Follow-up|0|||
146273812|NCT04103892|527516269|FG000|Overall Study|Protocol Violation|0|||
146273813|NCT04103892|527516270|FG001|Overall Study|Protocol Violation|0|||
146273814|NCT04103892|527516271|FG002|Overall Study|Protocol Violation|1|||
146273815|NCT04103892|527516272|FG003|Overall Study|Protocol Violation|1|||
146273816|NCT04103892|527516269|FG000|Overall Study|Withdrawal by Subject|1|||
146273817|NCT04103892|527516270|FG001|Overall Study|Withdrawal by Subject|0|||
146273818|NCT04103892|527516271|FG002|Overall Study|Withdrawal by Subject|2|||
146273819|NCT04103892|527516272|FG003|Overall Study|Withdrawal by Subject|5|||
146273820|NCT04103892|527516269|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
146273821|NCT04103892|527516270|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
146273822|NCT04103892|527516271|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
146273823|NCT04103892|527516272|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
146273824|NCT03008005|527516276|FG000|Overall Study|Physician Decision|1|||
146273825|NCT03008005|527516277|FG001|Overall Study|Physician Decision|0|||
146273826|NCT03008005|527516278|FG002|Overall Study|Physician Decision|0|||
146273827|NCT03008005|527516276|FG000|Overall Study|Withdrawal by Subject|1|||
146273828|NCT03008005|527516277|FG001|Overall Study|Withdrawal by Subject|0|||
146273829|NCT03008005|527516278|FG002|Overall Study|Withdrawal by Subject|0|||
146273830|NCT03008005|527516276|FG000|Overall Study|Ineligible|0|||
146273831|NCT03008005|527516277|FG001|Overall Study|Ineligible|1|||
146273832|NCT03008005|527516278|FG002|Overall Study|Ineligible|0|||
146273833|NCT07149155|527516282|FG000|Overall Study|Lost to Follow-up|10|||
146273834|NCT03345576|527516283|FG000|Overall Study|Withdrawal by Subject|2|||
146273835|NCT03345576|527516284|FG001|Overall Study|Withdrawal by Subject|2|||
146273836|NCT03345576|527516283|FG000|Overall Study|Adverse Event|1|||
146273837|NCT03345576|527516284|FG001|Overall Study|Adverse Event|0|||
146273838|NCT03829501|527518135|FG000|Overall Study|Withdrawal of Consent|2|||
146273839|NCT03829501|527518136|FG001|Overall Study|Withdrawal of Consent|0|||
146273840|NCT03829501|527518137|FG002|Overall Study|Withdrawal of Consent|3|||
146273841|NCT03829501|527518138|FG003|Overall Study|Withdrawal of Consent|0|||
146273842|NCT03829501|527518139|FG004|Overall Study|Withdrawal of Consent|1|||
146273843|NCT03829501|527518140|FG005|Overall Study|Withdrawal of Consent|1|||
146273844|NCT03829501|527518141|FG006|Overall Study|Withdrawal of Consent|0|||
146273845|NCT03829501|527518142|FG007|Overall Study|Withdrawal of Consent|10|||
146273846|NCT03829501|527518143|FG008|Overall Study|Withdrawal of Consent|10|||
146273847|NCT03829501|527518144|FG009|Overall Study|Withdrawal of Consent|3|||
146273848|NCT03829501|527518145|FG010|Overall Study|Withdrawal of Consent|4|||
146273849|NCT03829501|527518146|FG011|Overall Study|Withdrawal of Consent|4|||
146273850|NCT03829501|527518147|FG012|Overall Study|Withdrawal of Consent|4|||
146273851|NCT03829501|527518148|FG013|Overall Study|Withdrawal of Consent|0|||
146273852|NCT03829501|527518149|FG014|Overall Study|Withdrawal of Consent|3|||
146273853|NCT03829501|527518150|FG015|Overall Study|Withdrawal of Consent|0|||
146273854|NCT03829501|527518151|FG016|Overall Study|Withdrawal of Consent|1|||
146273855|NCT03829501|527518152|FG017|Overall Study|Withdrawal of Consent|1|||
146273856|NCT03829501|527518153|FG018|Overall Study|Withdrawal of Consent|0|||
146273857|NCT03829501|527518154|FG019|Overall Study|Withdrawal of Consent|0|||
146273858|NCT03829501|527518155|FG020|Overall Study|Withdrawal of Consent|3|||
146273859|NCT03829501|527518156|FG021|Overall Study|Withdrawal of Consent|0|||
146273860|NCT03829501|527518157|FG022|Overall Study|Withdrawal of Consent|1|||
146273861|NCT03829501|527518135|FG000|Overall Study|PD|0|||
146273862|NCT03829501|527518136|FG001|Overall Study|PD|0|||
146273863|NCT03829501|527518137|FG002|Overall Study|PD|0|||
146273864|NCT03829501|527518138|FG003|Overall Study|PD|2|||
146273865|NCT03829501|527518139|FG004|Overall Study|PD|0|||
146273866|NCT03829501|527518140|FG005|Overall Study|PD|0|||
146273867|NCT03829501|527518141|FG006|Overall Study|PD|0|||
146144551|NCT03146650|527042077|FG000|2 Year Follow-up|Death|11|||
146273868|NCT03829501|527518142|FG007|Overall Study|PD|0|||
146273869|NCT03829501|527518143|FG008|Overall Study|PD|0|||
146273870|NCT03829501|527518144|FG009|Overall Study|PD|0|||
146273871|NCT03829501|527518145|FG010|Overall Study|PD|0|||
146273872|NCT03829501|527518146|FG011|Overall Study|PD|0|||
146273873|NCT03829501|527518147|FG012|Overall Study|PD|0|||
146273874|NCT03829501|527518148|FG013|Overall Study|PD|0|||
146273875|NCT03829501|527518149|FG014|Overall Study|PD|0|||
146273876|NCT03829501|527518150|FG015|Overall Study|PD|1|||
146273877|NCT03829501|527518151|FG016|Overall Study|PD|0|||
146273878|NCT03829501|527518152|FG017|Overall Study|PD|0|||
146273879|NCT03829501|527518153|FG018|Overall Study|PD|0|||
146273880|NCT03829501|527518154|FG019|Overall Study|PD|0|||
146273881|NCT03829501|527518155|FG020|Overall Study|PD|1|||
146273882|NCT03829501|527518156|FG021|Overall Study|PD|0|||
146273883|NCT03829501|527518157|FG022|Overall Study|PD|0|||
146273884|NCT03829501|527518135|FG000|Overall Study|Study Terminated by Sponsor|0|||
146273885|NCT03829501|527518136|FG001|Overall Study|Study Terminated by Sponsor|0|||
146273886|NCT03829501|527518137|FG002|Overall Study|Study Terminated by Sponsor|0|||
146273887|NCT03829501|527518138|FG003|Overall Study|Study Terminated by Sponsor|0|||
146273888|NCT03829501|527518139|FG004|Overall Study|Study Terminated by Sponsor|0|||
146273889|NCT03829501|527518140|FG005|Overall Study|Study Terminated by Sponsor|0|||
146273890|NCT03829501|527518141|FG006|Overall Study|Study Terminated by Sponsor|0|||
146273891|NCT03829501|527518142|FG007|Overall Study|Study Terminated by Sponsor|3|||
146273892|NCT03829501|527518143|FG008|Overall Study|Study Terminated by Sponsor|1|||
146273893|NCT03829501|527518144|FG009|Overall Study|Study Terminated by Sponsor|0|||
146273894|NCT03829501|527518145|FG010|Overall Study|Study Terminated by Sponsor|0|||
146273895|NCT03829501|527518146|FG011|Overall Study|Study Terminated by Sponsor|0|||
146273896|NCT03829501|527518147|FG012|Overall Study|Study Terminated by Sponsor|0|||
146273897|NCT03829501|527518148|FG013|Overall Study|Study Terminated by Sponsor|0|||
146273898|NCT03829501|527518149|FG014|Overall Study|Study Terminated by Sponsor|3|||
146273899|NCT03829501|527518150|FG015|Overall Study|Study Terminated by Sponsor|2|||
146273900|NCT03829501|527518151|FG016|Overall Study|Study Terminated by Sponsor|2|||
146273901|NCT03829501|527518152|FG017|Overall Study|Study Terminated by Sponsor|0|||
146273902|NCT03829501|527518153|FG018|Overall Study|Study Terminated by Sponsor|0|||
146273903|NCT03829501|527518154|FG019|Overall Study|Study Terminated by Sponsor|0|||
146273904|NCT03829501|527518155|FG020|Overall Study|Study Terminated by Sponsor|1|||
146273905|NCT03829501|527518156|FG021|Overall Study|Study Terminated by Sponsor|0|||
146273906|NCT03829501|527518157|FG022|Overall Study|Study Terminated by Sponsor|3|||
146273907|NCT03829501|527518135|FG000|Overall Study|Lost to Follow Up|0|||
146273908|NCT03829501|527518136|FG001|Overall Study|Lost to Follow Up|0|||
146273909|NCT03829501|527518137|FG002|Overall Study|Lost to Follow Up|0|||
146273910|NCT03829501|527518138|FG003|Overall Study|Lost to Follow Up|0|||
146273911|NCT03829501|527518139|FG004|Overall Study|Lost to Follow Up|1|||
146273912|NCT03829501|527518140|FG005|Overall Study|Lost to Follow Up|0|||
146273913|NCT03829501|527518141|FG006|Overall Study|Lost to Follow Up|0|||
146273914|NCT03829501|527518142|FG007|Overall Study|Lost to Follow Up|2|||
146273915|NCT03829501|527518143|FG008|Overall Study|Lost to Follow Up|2|||
146273916|NCT03829501|527518144|FG009|Overall Study|Lost to Follow Up|0|||
146273917|NCT03829501|527518145|FG010|Overall Study|Lost to Follow Up|2|||
146273918|NCT03829501|527518146|FG011|Overall Study|Lost to Follow Up|1|||
146273919|NCT03829501|527518147|FG012|Overall Study|Lost to Follow Up|0|||
146273920|NCT03829501|527518148|FG013|Overall Study|Lost to Follow Up|1|||
146273921|NCT03829501|527518149|FG014|Overall Study|Lost to Follow Up|1|||
146273922|NCT03829501|527518150|FG015|Overall Study|Lost to Follow Up|0|||
146273923|NCT03829501|527518151|FG016|Overall Study|Lost to Follow Up|0|||
146273924|NCT03829501|527518152|FG017|Overall Study|Lost to Follow Up|0|||
146273925|NCT03829501|527518153|FG018|Overall Study|Lost to Follow Up|0|||
146273926|NCT03829501|527518154|FG019|Overall Study|Lost to Follow Up|0|||
146273927|NCT03829501|527518155|FG020|Overall Study|Lost to Follow Up|0|||
146273928|NCT03829501|527518156|FG021|Overall Study|Lost to Follow Up|0|||
146273929|NCT03829501|527518157|FG022|Overall Study|Lost to Follow Up|1|||
146273930|NCT03829501|527518135|FG000|Overall Study|Death|2|||
146273931|NCT03829501|527518136|FG001|Overall Study|Death|4|||
146273932|NCT03829501|527518137|FG002|Overall Study|Death|5|||
146273933|NCT03829501|527518138|FG003|Overall Study|Death|6|||
146273934|NCT03829501|527518139|FG004|Overall Study|Death|5|||
146273935|NCT03829501|527518140|FG005|Overall Study|Death|4|||
146273936|NCT03829501|527518141|FG006|Overall Study|Death|5|||
146273937|NCT03829501|527518142|FG007|Overall Study|Death|24|||
146273938|NCT03829501|527518143|FG008|Overall Study|Death|22|||
146273939|NCT03829501|527518144|FG009|Overall Study|Death|6|||
146273940|NCT03829501|527518145|FG010|Overall Study|Death|3|||
146273941|NCT03829501|527518146|FG011|Overall Study|Death|10|||
146144552|NCT03146650|527042077|FG000|2 Year Follow-up|Still in follow-up|7|||
146144553|NCT03146650|527042077|FG000|2 Year Follow-up|Lost to Follow-up|1|||
146144554|NCT02517905|527042078|FG000|Overall Study|Lost to Follow-up|4|||
146273942|NCT03829501|527518147|FG012|Overall Study|Death|10|||
146273943|NCT03829501|527518148|FG013|Overall Study|Death|5|||
146273944|NCT03829501|527518149|FG014|Overall Study|Death|7|||
146273945|NCT03829501|527518150|FG015|Overall Study|Death|2|||
146273946|NCT03829501|527518151|FG016|Overall Study|Death|2|||
146273947|NCT03829501|527518152|FG017|Overall Study|Death|1|||
146273948|NCT03829501|527518153|FG018|Overall Study|Death|1|||
146273949|NCT03829501|527518154|FG019|Overall Study|Death|1|||
146273950|NCT03829501|527518155|FG020|Overall Study|Death|1|||
146273951|NCT03829501|527518156|FG021|Overall Study|Death|2|||
146273952|NCT03829501|527518157|FG022|Overall Study|Death|3|||
146273953|NCT03829501|527518135|FG000|Overall Study|Miscellaneous|0|||
146273954|NCT03829501|527518136|FG001|Overall Study|Miscellaneous|0|||
146273955|NCT03829501|527518137|FG002|Overall Study|Miscellaneous|1|||
146273956|NCT03829501|527518138|FG003|Overall Study|Miscellaneous|0|||
146273957|NCT03829501|527518139|FG004|Overall Study|Miscellaneous|0|||
146273958|NCT03829501|527518140|FG005|Overall Study|Miscellaneous|0|||
146273959|NCT03829501|527518141|FG006|Overall Study|Miscellaneous|0|||
146273960|NCT03829501|527518142|FG007|Overall Study|Miscellaneous|1|||
146273961|NCT03829501|527518143|FG008|Overall Study|Miscellaneous|0|||
146273962|NCT03829501|527518144|FG009|Overall Study|Miscellaneous|0|||
146273963|NCT03829501|527518145|FG010|Overall Study|Miscellaneous|0|||
146273964|NCT03829501|527518146|FG011|Overall Study|Miscellaneous|0|||
146273965|NCT03829501|527518147|FG012|Overall Study|Miscellaneous|0|||
146273966|NCT03829501|527518148|FG013|Overall Study|Miscellaneous|0|||
146273967|NCT03829501|527518149|FG014|Overall Study|Miscellaneous|0|||
146273968|NCT03829501|527518150|FG015|Overall Study|Miscellaneous|0|||
146273969|NCT03829501|527518151|FG016|Overall Study|Miscellaneous|0|||
146273970|NCT03829501|527518152|FG017|Overall Study|Miscellaneous|0|||
146273971|NCT03829501|527518153|FG018|Overall Study|Miscellaneous|0|||
146273972|NCT03829501|527518154|FG019|Overall Study|Miscellaneous|0|||
146273973|NCT03829501|527518155|FG020|Overall Study|Miscellaneous|0|||
146273974|NCT03829501|527518156|FG021|Overall Study|Miscellaneous|0|||
146273975|NCT03829501|527518157|FG022|Overall Study|Miscellaneous|1|||
146273976|NCT03301155|527518167|FG000|Overall Study|Сompliance with exclusion criteria|8|||
146273977|NCT03301155|527518168|FG001|Overall Study|Сompliance with exclusion criteria|7|||
146273978|NCT01685229|527518175|FG000|Overall Study|Subjects missing Study Exit form|3|||
146273979|NCT01685229|527518176|FG001|Overall Study|Subjects missing Study Exit form|1|||
146273980|NCT01685229|527518175|FG000|Overall Study|Lost to Follow-up|16|||
146273981|NCT01685229|527518176|FG001|Overall Study|Lost to Follow-up|10|||
146273982|NCT01685229|527518175|FG000|Overall Study|Withdrawal by Subject|6|||
146273983|NCT01685229|527518176|FG001|Overall Study|Withdrawal by Subject|5|||
146273984|NCT01685229|527518175|FG000|Overall Study|Death|1|||
146273985|NCT01685229|527518176|FG001|Overall Study|Death|0|||
146273986|NCT02964325|527518182|FG000|Overall Study|Lost to Follow-up|3|||
146273987|NCT02964325|527518183|FG001|Overall Study|Lost to Follow-up|3|||
146273988|NCT02964325|527518182|FG000|Overall Study|Physician Decision|5|||
146273989|NCT02964325|527518183|FG001|Overall Study|Physician Decision|4|||
146273990|NCT02964325|527518182|FG000|Overall Study|Death|1|||
146273991|NCT02964325|527518183|FG001|Overall Study|Death|3|||
146273992|NCT02964325|527518182|FG000|Overall Study|Withdrawal by Subject|2|||
146273993|NCT02964325|527518183|FG001|Overall Study|Withdrawal by Subject|1|||
146273994|NCT02964325|527518182|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
146273995|NCT02964325|527518183|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
146273996|NCT01371825|527518188|FG000|Overall Study|Death|4|||
146273997|NCT00534495|527518189|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
146273998|NCT00534495|527518190|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
146273999|NCT00534495|527518191|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
146274000|NCT00534495|527518189|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
146274001|NCT00534495|527518190|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
146274002|NCT00534495|527518191|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
146274003|NCT00534495|527518189|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
146274004|NCT00534495|527518190|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
146274005|NCT00534495|527518191|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
146274006|NCT00534495|527518189|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
146274007|NCT00534495|527518190|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
146274008|NCT00534495|527518191|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
146274009|NCT00534495|527518189|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
146274010|NCT00534495|527518190|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
146274011|NCT00534495|527518191|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
146274012|NCT00534495|527518189|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
146274013|NCT00534495|527518190|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
146274014|NCT00534495|527518191|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
146274015|NCT00534495|527518189|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
146274016|NCT00534495|527518190|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
146274017|NCT00534495|527518191|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
146274018|NCT00534495|527518189|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
146274019|NCT00534495|527518190|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
146274020|NCT00534495|527518191|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
146274021|NCT00534495|527518189|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
146274022|NCT00534495|527518190|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
146274023|NCT00534495|527518191|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
146274024|NCT04868539|527518192|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
146274025|NCT04868539|527518193|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
146274026|NCT03635099|527518196|FG000|Period 1|Adverse Event|1|||
146274027|NCT03635099|527518197|FG001|Period 1|Adverse Event|0|||
146274028|NCT03635099|527518198|FG002|Period 1|Adverse Event|0|||
146274029|NCT03635099|527518199|FG003|Period 1|Adverse Event|1|||
146274030|NCT03635099|527518200|FG004|Period 1|Adverse Event|0|||
146274031|NCT03635099|527518201|FG005|Period 1|Adverse Event|0|||
146274032|NCT03635099|527518202|FG006|Period 1|Adverse Event|0|||
146274033|NCT03635099|527518203|FG007|Period 1|Adverse Event|0|||
146274034|NCT03635099|527518196|FG000|Period 1|Protocol Violation|0|||
146274035|NCT03635099|527518197|FG001|Period 1|Protocol Violation|0|||
146274036|NCT03635099|527518198|FG002|Period 1|Protocol Violation|1|||
146274037|NCT03635099|527518199|FG003|Period 1|Protocol Violation|0|||
146274038|NCT03635099|527518200|FG004|Period 1|Protocol Violation|0|||
146274039|NCT03635099|527518201|FG005|Period 1|Protocol Violation|0|||
146274040|NCT03635099|527518202|FG006|Period 1|Protocol Violation|0|||
146274041|NCT03635099|527518203|FG007|Period 1|Protocol Violation|0|||
146274042|NCT03635099|527518196|FG000|Period 1|Lost to Follow-up|0|||
146274043|NCT03635099|527518197|FG001|Period 1|Lost to Follow-up|0|||
146274044|NCT03635099|527518198|FG002|Period 1|Lost to Follow-up|1|||
146274045|NCT03635099|527518199|FG003|Period 1|Lost to Follow-up|2|||
146274046|NCT03635099|527518200|FG004|Period 1|Lost to Follow-up|1|||
146274047|NCT03635099|527518201|FG005|Period 1|Lost to Follow-up|0|||
146274048|NCT03635099|527518202|FG006|Period 1|Lost to Follow-up|1|||
146274049|NCT03635099|527518203|FG007|Period 1|Lost to Follow-up|2|||
146274050|NCT03635099|527518196|FG000|Period 1|Withdrawal by Subject|3|||
146274051|NCT03635099|527518197|FG001|Period 1|Withdrawal by Subject|3|||
146274052|NCT03635099|527518198|FG002|Period 1|Withdrawal by Subject|5|||
146274053|NCT03635099|527518199|FG003|Period 1|Withdrawal by Subject|2|||
146274054|NCT03635099|527518200|FG004|Period 1|Withdrawal by Subject|2|||
146274055|NCT03635099|527518201|FG005|Period 1|Withdrawal by Subject|0|||
146274056|NCT03635099|527518202|FG006|Period 1|Withdrawal by Subject|3|||
146274057|NCT03635099|527518203|FG007|Period 1|Withdrawal by Subject|0|||
146274058|NCT03635099|527518196|FG000|Period 1|History of suicidal ideation|0|||
146274059|NCT03635099|527518197|FG001|Period 1|History of suicidal ideation|0|||
146274060|NCT03635099|527518198|FG002|Period 1|History of suicidal ideation|1|||
146274061|NCT03635099|527518199|FG003|Period 1|History of suicidal ideation|0|||
146274062|NCT03635099|527518200|FG004|Period 1|History of suicidal ideation|0|||
146274063|NCT03635099|527518201|FG005|Period 1|History of suicidal ideation|0|||
146274064|NCT03635099|527518202|FG006|Period 1|History of suicidal ideation|0|||
146274065|NCT03635099|527518203|FG007|Period 1|History of suicidal ideation|0|||
146274066|NCT03635099|527518196|FG000|Period 1|pursue other treatment options|0|||
146274067|NCT03635099|527518197|FG001|Period 1|pursue other treatment options|0|||
146274068|NCT03635099|527518198|FG002|Period 1|pursue other treatment options|0|||
146274069|NCT03635099|527518199|FG003|Period 1|pursue other treatment options|0|||
146274070|NCT03635099|527518200|FG004|Period 1|pursue other treatment options|0|||
146274071|NCT03635099|527518201|FG005|Period 1|pursue other treatment options|1|||
146274072|NCT03635099|527518202|FG006|Period 1|pursue other treatment options|0|||
146274073|NCT03635099|527518203|FG007|Period 1|pursue other treatment options|0|||
146274074|NCT03635099|527518196|FG000|Not Eligible for Period 2|Pregnancy|0|||
146274075|NCT03635099|527518197|FG001|Not Eligible for Period 2|Pregnancy|0|||
146274076|NCT03635099|527518198|FG002|Not Eligible for Period 2|Pregnancy|0|||
146274077|NCT03635099|527518199|FG003|Not Eligible for Period 2|Pregnancy|1|||
146274078|NCT03635099|527518200|FG004|Not Eligible for Period 2|Pregnancy|0|||
146274079|NCT03635099|527518201|FG005|Not Eligible for Period 2|Pregnancy|0|||
146274080|NCT03635099|527518202|FG006|Not Eligible for Period 2|Pregnancy|0|||
146274081|NCT03635099|527518203|FG007|Not Eligible for Period 2|Pregnancy|0|||
146274082|NCT03635099|527518196|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
146274083|NCT03635099|527518197|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274084|NCT03635099|527518198|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274085|NCT03635099|527518199|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274086|NCT03635099|527518200|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274087|NCT03635099|527518201|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274088|NCT03635099|527518202|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274089|NCT03635099|527518203|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
146274090|NCT03635099|527518196|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146274091|NCT03635099|527518197|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146274092|NCT03635099|527518198|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146274093|NCT03635099|527518199|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146274094|NCT03635099|527518200|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
146274095|NCT03635099|527518201|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
146274096|NCT03635099|527518202|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
146274097|NCT03635099|527518203|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
146274098|NCT03635099|527518196|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
146274099|NCT03635099|527518197|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
146274100|NCT03635099|527518198|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
146274101|NCT03635099|527518199|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
146274102|NCT03635099|527518200|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146274103|NCT03635099|527518201|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146274104|NCT03635099|527518202|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146274105|NCT03635099|527518203|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
146274106|NCT03635099|527518196|FG000|Period 2|Adverse Event|0|||
146274107|NCT03635099|527518197|FG001|Period 2|Adverse Event|0|||
146274108|NCT03635099|527518198|FG002|Period 2|Adverse Event|1|||
146274109|NCT03635099|527518199|FG003|Period 2|Adverse Event|0|||
146274110|NCT03635099|527518200|FG004|Period 2|Adverse Event|1|||
146274111|NCT03635099|527518201|FG005|Period 2|Adverse Event|0|||
146274112|NCT03635099|527518202|FG006|Period 2|Adverse Event|0|||
146274113|NCT03635099|527518203|FG007|Period 2|Adverse Event|0|||
146274114|NCT03635099|527518196|FG000|Period 2|Lost to Follow-up|0|||
146274115|NCT03635099|527518197|FG001|Period 2|Lost to Follow-up|0|||
146274116|NCT03635099|527518198|FG002|Period 2|Lost to Follow-up|1|||
146274117|NCT03635099|527518199|FG003|Period 2|Lost to Follow-up|0|||
146274118|NCT03635099|527518200|FG004|Period 2|Lost to Follow-up|4|||
146274119|NCT03635099|527518201|FG005|Period 2|Lost to Follow-up|0|||
146274120|NCT03635099|527518202|FG006|Period 2|Lost to Follow-up|0|||
146274121|NCT03635099|527518203|FG007|Period 2|Lost to Follow-up|0|||
146274122|NCT03635099|527518196|FG000|Period 2|Withdrawal by Subject|0|||
146274123|NCT03635099|527518197|FG001|Period 2|Withdrawal by Subject|0|||
146274124|NCT03635099|527518198|FG002|Period 2|Withdrawal by Subject|7|||
146274125|NCT03635099|527518199|FG003|Period 2|Withdrawal by Subject|4|||
146274126|NCT03635099|527518200|FG004|Period 2|Withdrawal by Subject|7|||
146274127|NCT03635099|527518201|FG005|Period 2|Withdrawal by Subject|0|||
146274128|NCT03635099|527518202|FG006|Period 2|Withdrawal by Subject|0|||
146274129|NCT03635099|527518203|FG007|Period 2|Withdrawal by Subject|0|||
146274130|NCT01465763|527518204|FG000|Overall Study|Withdrawal by Subject|4|||
146274131|NCT01465763|527518205|FG001|Overall Study|Withdrawal by Subject|0|||
146274132|NCT01465763|527518206|FG002|Overall Study|Withdrawal by Subject|1|||
146274133|NCT01465763|527518204|FG000|Overall Study|Insufficient Clinical Response|11|||
146274134|NCT01465763|527518205|FG001|Overall Study|Insufficient Clinical Response|0|||
146274135|NCT01465763|527518206|FG002|Overall Study|Insufficient Clinical Response|1|||
146274136|NCT01465763|527518204|FG000|Overall Study|Adverse Event|9|||
146274137|NCT01465763|527518205|FG001|Overall Study|Adverse Event|0|||
146304319|NCT00066742|527629173|FG000|Consolidation Chemotherapy|not protocol specified|1|||
146304320|NCT00066742|527629173|FG000|Consolidation Chemotherapy|Ineligible|2|||
146304321|NCT01380730|527629180|FG000|Overall Study|Death|0|||
146144555|NCT02517905|527042079|FG001|Overall Study|Lost to Follow-up|0|||
146144556|NCT02517905|527042078|FG000|Overall Study|Withdrawal by Subject|4|||
146144557|NCT02517905|527042079|FG001|Overall Study|Withdrawal by Subject|0|||
146144558|NCT02517905|527042078|FG000|Overall Study|Screen failure|2|||
146144559|NCT02517905|527042079|FG001|Overall Study|Screen failure|2|||
146144560|NCT01755416|527042082|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
146144561|NCT01755416|527042083|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
146144562|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
146144563|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
146144564|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
146144565|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Death|1|||
146144566|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Death|0|||
146144567|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Death|0|||
146144568|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
146144569|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
146144570|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
146144571|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
146144572|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
146144573|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
146144574|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
146144575|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
146144576|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
146144577|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
146144578|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
146144579|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
146144580|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
146274138|NCT01465763|527518206|FG002|Overall Study|Adverse Event|1|||
146274139|NCT01465763|527518204|FG000|Overall Study|Other|2|||
146274140|NCT01465763|527518205|FG001|Overall Study|Other|0|||
146274141|NCT01465763|527518206|FG002|Overall Study|Other|0|||
146274142|NCT01465763|527518204|FG000|Overall Study|Protocol Violation|4|||
146144581|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
146144582|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
146274143|NCT01465763|527518205|FG001|Overall Study|Protocol Violation|1|||
146274144|NCT01465763|527518206|FG002|Overall Study|Protocol Violation|1|||
146274145|NCT01465763|527518204|FG000|Overall Study|Death|1|||
146274146|NCT01465763|527518205|FG001|Overall Study|Death|0|||
146274147|NCT01465763|527518206|FG002|Overall Study|Death|0|||
146274148|NCT02807272|527518209|FG000|Overall Study|Death|9|||
146274149|NCT02807272|527518210|FG001|Overall Study|Death|5|||
146274150|NCT02807272|527518211|FG002|Overall Study|Death|2|||
146274151|NCT02807272|527518212|FG003|Overall Study|Death|0|||
146274152|NCT02807272|527518213|FG004|Overall Study|Death|1|||
146274153|NCT02807272|527518209|FG000|Overall Study|Lost to Follow-up|1|||
146274154|NCT02807272|527518210|FG001|Overall Study|Lost to Follow-up|0|||
146274155|NCT02807272|527518211|FG002|Overall Study|Lost to Follow-up|0|||
146274156|NCT02807272|527518212|FG003|Overall Study|Lost to Follow-up|0|||
146274157|NCT02807272|527518213|FG004|Overall Study|Lost to Follow-up|0|||
146274158|NCT02807272|527518209|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
146274159|NCT02807272|527518210|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
146274160|NCT02807272|527518211|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
146274161|NCT02807272|527518212|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
146274162|NCT02807272|527518213|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
146274163|NCT02807272|527518209|FG000|Overall Study|Protocol-defined Disease Progression|0|||
146274164|NCT02807272|527518210|FG001|Overall Study|Protocol-defined Disease Progression|1|||
146274165|NCT02807272|527518211|FG002|Overall Study|Protocol-defined Disease Progression|0|||
146274166|NCT02807272|527518212|FG003|Overall Study|Protocol-defined Disease Progression|0|||
146274167|NCT02807272|527518213|FG004|Overall Study|Protocol-defined Disease Progression|1|||
146274168|NCT02807272|527518209|FG000|Overall Study|Study Terminated by Sponsor|1|||
146274169|NCT02807272|527518210|FG001|Overall Study|Study Terminated by Sponsor|0|||
146274170|NCT02807272|527518211|FG002|Overall Study|Study Terminated by Sponsor|0|||
146274171|NCT02807272|527518212|FG003|Overall Study|Study Terminated by Sponsor|1|||
146144583|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
146144584|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
146144585|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
146144586|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
146144587|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
146274172|NCT02807272|527518213|FG004|Overall Study|Study Terminated by Sponsor|0|||
146274173|NCT02807272|527518209|FG000|Overall Study|Other|1|||
146274174|NCT02807272|527518210|FG001|Overall Study|Other|0|||
146274175|NCT02807272|527518211|FG002|Overall Study|Other|0|||
146274176|NCT02807272|527518212|FG003|Overall Study|Other|0|||
146274177|NCT02807272|527518213|FG004|Overall Study|Other|1|||
146274178|NCT04191616|527518214|FG000|Pre-assignment Period|Did not receive study treatment|2|||
146274179|NCT04191616|527518214|FG000|Treatment Period|Death|37|||
146274180|NCT04191616|527518214|FG000|Treatment Period|Sponsor decision|11|||
146274181|NCT04191616|527518214|FG000|Treatment Period|Withdrawal by Subject|4|||
146274182|NCT01038427|527518215|FG000|Overall Study|Lost to follow up|1|||
146274183|NCT01038427|527518216|FG001|Overall Study|Lost to follow up|1|||
146144588|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
146144589|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
146144590|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
146144591|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
146144592|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
146144593|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
146144594|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
146274184|NCT01038427|527518217|FG002|Overall Study|Lost to follow up|0|||
146274185|NCT01038427|527518215|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146274186|NCT01038427|527518216|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146274187|NCT01038427|527518217|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
146274188|NCT01038427|527518215|FG000|Overall Study|Withdrew consent|0|||
146274189|NCT01038427|527518216|FG001|Overall Study|Withdrew consent|0|||
146274190|NCT01038427|527518217|FG002|Overall Study|Withdrew consent|1|||
146274191|NCT01038427|527518215|FG000|Overall Study|Adverse Event|2|||
146274192|NCT01038427|527518216|FG001|Overall Study|Adverse Event|2|||
146274193|NCT01038427|527518217|FG002|Overall Study|Adverse Event|1|||
146274194|NCT01038427|527518215|FG000|Overall Study|Enrolled in error|0|||
146274195|NCT01038427|527518216|FG001|Overall Study|Enrolled in error|1|||
146274196|NCT01038427|527518217|FG002|Overall Study|Enrolled in error|1|||
146274197|NCT01038427|527518215|FG000|Overall Study|Other|0|||
146304322|NCT01380730|527629181|FG001|Overall Study|Death|0|||
146304323|NCT01380730|527629182|FG002|Overall Study|Death|0|||
146274198|NCT01038427|527518216|FG001|Overall Study|Other|2|||
146274199|NCT01038427|527518217|FG002|Overall Study|Other|0|||
146274200|NCT00604708|527518221|FG000|Overall Study|Withdrawal by Subject|9|||
146274201|NCT00604708|527518222|FG001|Overall Study|Withdrawal by Subject|10|||
146274202|NCT00604708|527518221|FG000|Overall Study|Protocol Violation|2|||
146274203|NCT00604708|527518222|FG001|Overall Study|Protocol Violation|8|||
146274204|NCT00604708|527518221|FG000|Overall Study|Lost to Follow-up|5|||
146274205|NCT00604708|527518222|FG001|Overall Study|Lost to Follow-up|5|||
146304324|NCT01380730|527629183|FG003|Overall Study|Death|0|||
146144595|NCT03655236|527042084|FG000|Subject Disposition in Part 1 Period|Other|0|||
146144596|NCT03655236|527042085|FG001|Subject Disposition in Part 1 Period|Other|2|||
146144597|NCT03655236|527042086|FG002|Subject Disposition in Part 1 Period|Other|2|||
146144598|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
146144599|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
146144600|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
146144601|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
146144602|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
146144603|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
146144604|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
146144605|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
146144606|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
146144607|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
146144608|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
146144609|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
146144610|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
146144611|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
146144612|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
146144613|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
146144614|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
146144615|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
146144616|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
146144617|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
146144618|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
146144619|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
146144620|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
146144621|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
146144622|NCT03655236|527042084|FG000|Subject Disposition in Part 2 Period|Other|1|||
146144623|NCT03655236|527042085|FG001|Subject Disposition in Part 2 Period|Other|0|||
146144624|NCT03655236|527042086|FG002|Subject Disposition in Part 2 Period|Other|0|||
146144625|NCT04258839|527043409|FG000|Overall Study|Adverse Event|2|||
146144626|NCT04258839|527043410|FG001|Overall Study|Adverse Event|4|||
146144627|NCT04258839|527043409|FG000|Overall Study|Lack of Efficacy|0|||
146144628|NCT04258839|527043410|FG001|Overall Study|Lack of Efficacy|2|||
146144629|NCT04258839|527043409|FG000|Overall Study|Lost to Follow-up|2|||
146144630|NCT04258839|527043410|FG001|Overall Study|Lost to Follow-up|0|||
146144631|NCT04258839|527043409|FG000|Overall Study|Withdrawal by Subject|1|||
146144632|NCT04258839|527043410|FG001|Overall Study|Withdrawal by Subject|2|||
146144633|NCT04258839|527043409|FG000|Overall Study|Withdrawal by Caregiver|5|||
146144634|NCT04258839|527043410|FG001|Overall Study|Withdrawal by Caregiver|6|||
146144635|NCT04258839|527043409|FG000|Overall Study|Reason not Specified|0|||
146144636|NCT04258839|527043410|FG001|Overall Study|Reason not Specified|1|||
146144637|NCT00672477|527043415|FG000|Overall Study|Adverse Event|10|||
146144638|NCT00672477|527043416|FG001|Overall Study|Adverse Event|7|||
146144639|NCT00672477|527043415|FG000|Overall Study|Death|7|||
146144640|NCT00672477|527043416|FG001|Overall Study|Death|11|||
146144641|NCT00672477|527043415|FG000|Overall Study|Physician Decision|2|||
146144642|NCT00672477|527043416|FG001|Overall Study|Physician Decision|0|||
146144643|NCT00672477|527043415|FG000|Overall Study|Protocol Violation|1|||
146144644|NCT00672477|527043416|FG001|Overall Study|Protocol Violation|1|||
146144645|NCT00672477|527043415|FG000|Overall Study|Withdrawal by Subject|5|||
146144646|NCT00672477|527043416|FG001|Overall Study|Withdrawal by Subject|3|||
146144647|NCT00672477|527043415|FG000|Overall Study|Lack of Efficacy|1|||
146144648|NCT00672477|527043416|FG001|Overall Study|Lack of Efficacy|1|||
146144649|NCT00672477|527043415|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
146144650|NCT00672477|527043416|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
146144651|NCT02886572|527043417|FG000|Overall Study|Death|8|||
146144652|NCT01933334|527043420|FG000|Overall Study|Adverse Event|5|||
146144653|NCT01933334|527043421|FG001|Overall Study|Adverse Event|1|||
146144654|NCT01933334|527043420|FG000|Overall Study|Withdrawal by Subject|0|||
146144655|NCT01933334|527043421|FG001|Overall Study|Withdrawal by Subject|1|||
146144656|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
146144657|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
146144658|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
146144659|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
146144660|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
146144661|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
146144662|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146144663|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
146144664|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
146274206|NCT00604708|527518221|FG000|Overall Study|administrative reasons|9|||
146274207|NCT00604708|527518222|FG001|Overall Study|administrative reasons|11|||
146274208|NCT00604708|527518221|FG000|Overall Study|Adverse Event|6|||
146274209|NCT00604708|527518222|FG001|Overall Study|Adverse Event|6|||
146274210|NCT03995316|527518223|FG000|Overall Study|Lost to Follow-up|10|||
146274211|NCT03995316|527518224|FG001|Overall Study|Lost to Follow-up|3|||
146274212|NCT02180243|527518225|FG000|Overall Study|Withdrawal by Subject|12|||
146274213|NCT02180243|527518226|FG001|Overall Study|Withdrawal by Subject|12|||
146144665|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146274214|NCT02180243|527518225|FG000|Overall Study|Lost to Follow-up|12|||
146274215|NCT02180243|527518226|FG001|Overall Study|Lost to Follow-up|2|||
146274216|NCT02202785|527518227|FG000|Overall Study|Study Terminated by Sponsor|1|||
146274217|NCT02202785|527518228|FG001|Overall Study|Study Terminated by Sponsor|6|||
146274218|NCT02202785|527518229|FG002|Overall Study|Study Terminated by Sponsor|4|||
146274219|NCT02202785|527518227|FG000|Overall Study|Withdrawal by Subject|0|||
146274220|NCT02202785|527518228|FG001|Overall Study|Withdrawal by Subject|1|||
146274221|NCT02202785|527518229|FG002|Overall Study|Withdrawal by Subject|0|||
146274222|NCT02202785|527518227|FG000|Overall Study|Lost to Follow-up|0|||
146274223|NCT02202785|527518228|FG001|Overall Study|Lost to Follow-up|1|||
146274224|NCT02202785|527518229|FG002|Overall Study|Lost to Follow-up|0|||
146274225|NCT02202785|527518227|FG000|Overall Study|Reason not Specified|10|||
146274226|NCT02202785|527518228|FG001|Overall Study|Reason not Specified|7|||
146274227|NCT02202785|527518229|FG002|Overall Study|Reason not Specified|13|||
146274228|NCT01137578|527518230|FG000|Overall Study|Participant requested to Discontinue|3|||
146274229|NCT01137578|527518231|FG001|Overall Study|Participant requested to Discontinue|0|||
146274230|NCT01137578|527518232|FG002|Overall Study|Participant requested to Discontinue|0|||
146274231|NCT01137578|527518230|FG000|Overall Study|Withdrawal by Subject|1|||
146274232|NCT01137578|527518231|FG001|Overall Study|Withdrawal by Subject|0|||
146274233|NCT01137578|527518232|FG002|Overall Study|Withdrawal by Subject|0|||
146274234|NCT01137578|527518230|FG000|Overall Study|Other|12|||
146274235|NCT01137578|527518231|FG001|Overall Study|Other|2|||
146274236|NCT01137578|527518232|FG002|Overall Study|Other|6|||
146274237|NCT00415051|527518234|FG000|Overall Study|Protocol Violation|1|||
146274238|NCT03197766|527518235|FG000|Overall Study|Withdrawal by Subject|2|||
146274239|NCT03197766|527518236|FG001|Overall Study|Withdrawal by Subject|0|||
146274240|NCT01436253|527518237|FG000|Overall Study|Lost to Follow-up|182|||
146274241|NCT01436253|527518237|FG000|Overall Study|Not meeting all eligibility criteria|117|||
146274242|NCT04879849|527518243|FG000|Overall Study|Lost to Follow-up|0|||
146274243|NCT04879849|527518244|FG001|Overall Study|Lost to Follow-up|0|||
146274244|NCT04879849|527518245|FG002|Overall Study|Lost to Follow-up|0|||
146274245|NCT04879849|527518246|FG003|Overall Study|Lost to Follow-up|1|||
146274246|NCT04879849|527518247|FG004|Overall Study|Lost to Follow-up|0|||
146274247|NCT04879849|527518248|FG005|Overall Study|Lost to Follow-up|0|||
146274248|NCT04879849|527518249|FG006|Overall Study|Lost to Follow-up|0|||
146274249|NCT04879849|527518250|FG007|Overall Study|Lost to Follow-up|0|||
146274250|NCT04879849|527518243|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
146274251|NCT04879849|527518244|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
146274252|NCT04879849|527518245|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
146274253|NCT04879849|527518246|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
146274254|NCT04879849|527518247|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
146274255|NCT04879849|527518248|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
146274256|NCT04879849|527518249|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
146274257|NCT04879849|527518250|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
146144666|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
146274258|NCT04879849|527518243|FG000|Overall Study|Withdrawal by Subject|0|||
146274259|NCT04879849|527518244|FG001|Overall Study|Withdrawal by Subject|0|||
146274260|NCT04879849|527518245|FG002|Overall Study|Withdrawal by Subject|0|||
146274261|NCT04879849|527518246|FG003|Overall Study|Withdrawal by Subject|0|||
146274262|NCT04879849|527518247|FG004|Overall Study|Withdrawal by Subject|2|||
146274263|NCT04879849|527518248|FG005|Overall Study|Withdrawal by Subject|0|||
146274264|NCT04879849|527518249|FG006|Overall Study|Withdrawal by Subject|1|||
146274265|NCT04879849|527518250|FG007|Overall Study|Withdrawal by Subject|0|||
146274266|NCT04879849|527518243|FG000|Overall Study|Progressive Disease|0|||
146274267|NCT04879849|527518244|FG001|Overall Study|Progressive Disease|0|||
146274268|NCT04879849|527518245|FG002|Overall Study|Progressive Disease|1|||
146274269|NCT04879849|527518246|FG003|Overall Study|Progressive Disease|0|||
146274270|NCT04879849|527518247|FG004|Overall Study|Progressive Disease|0|||
146274271|NCT04879849|527518248|FG005|Overall Study|Progressive Disease|0|||
146274272|NCT04879849|527518249|FG006|Overall Study|Progressive Disease|0|||
146274273|NCT04879849|527518250|FG007|Overall Study|Progressive Disease|0|||
146274274|NCT04879849|527518243|FG000|Overall Study|Death|0|||
146274275|NCT04879849|527518244|FG001|Overall Study|Death|0|||
146274276|NCT04879849|527518245|FG002|Overall Study|Death|1|||
146274277|NCT04879849|527518246|FG003|Overall Study|Death|1|||
146274278|NCT04879849|527518247|FG004|Overall Study|Death|1|||
146274279|NCT04879849|527518248|FG005|Overall Study|Death|2|||
146144667|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
146144668|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
146144669|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
146144670|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
146144671|NCT01257204|527043426|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
146144672|NCT01257204|527043427|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
146144673|NCT01257204|527043428|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
146144674|NCT01257204|527043426|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
146144675|NCT01257204|527043427|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
146144676|NCT01257204|527043428|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
146144677|NCT01257204|527043426|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
146144678|NCT01257204|527043427|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
146144679|NCT01257204|527043428|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
146144680|NCT01257204|527043426|FG000|Follow-up Period (up to Week 48)|Other|0|||
146144681|NCT01257204|527043427|FG001|Follow-up Period (up to Week 48)|Other|0|||
146144682|NCT01257204|527043428|FG002|Follow-up Period (up to Week 48)|Other|5|||
146144683|NCT02082522|527043431|FG000|Overall Study|Sponsor termination|5|||
146144684|NCT02082522|527043432|FG001|Overall Study|Sponsor termination|3|||
146144685|NCT02082522|527043431|FG000|Overall Study|Withdrawal by Subject|2|||
146144686|NCT02082522|527043432|FG001|Overall Study|Withdrawal by Subject|4|||
146144687|NCT02082522|527043431|FG000|Overall Study|Death|1|||
146144688|NCT02082522|527043432|FG001|Overall Study|Death|0|||
146144689|NCT02082522|527043431|FG000|Overall Study|Lost to Follow-up|1|||
146144690|NCT02082522|527043432|FG001|Overall Study|Lost to Follow-up|0|||
146144691|NCT02082522|527043431|FG000|Overall Study|Physician Decision|3|||
146144692|NCT02082522|527043432|FG001|Overall Study|Physician Decision|1|||
146144693|NCT02082522|527043431|FG000|Overall Study|Disease progression|2|||
146144694|NCT02082522|527043432|FG001|Overall Study|Disease progression|2|||
146144695|NCT02082522|527043431|FG000|Overall Study|Chemotherapy change|1|||
146144696|NCT02082522|527043432|FG001|Overall Study|Chemotherapy change|3|||
146144697|NCT01863446|527043433|FG000|Overall Study|Withdrawal by Subject|1|||
146144698|NCT01863446|527043434|FG001|Overall Study|Withdrawal by Subject|0|||
146144699|NCT01863446|527043435|FG002|Overall Study|Withdrawal by Subject|1|||
146144700|NCT01863446|527043436|FG003|Overall Study|Withdrawal by Subject|2|||
146144701|NCT01863446|527043433|FG000|Overall Study|Physician Decision|0|||
146144702|NCT01863446|527043434|FG001|Overall Study|Physician Decision|0|||
146144703|NCT01863446|527043435|FG002|Overall Study|Physician Decision|1|||
146144704|NCT01863446|527043436|FG003|Overall Study|Physician Decision|0|||
146144705|NCT03603964|527043439|FG000|Overall Study|Death|9|||
146144706|NCT03603964|527043439|FG000|Overall Study|Withdrawal by participant|7|||
146144707|NCT03603964|527043439|FG000|Overall Study|Study terminated by Sponsor|19|||
146144708|NCT03095417|527043442|FG000|Overall Study|missed|1|||
146144709|NCT03095417|527043443|FG001|Overall Study|missed|2|||
146144710|NCT03095417|527043444|FG002|Overall Study|missed|0|||
146144711|NCT03095417|527043445|FG003|Overall Study|missed|1|||
146144712|NCT03095417|527043442|FG000|Overall Study|Lost to Follow-up|2|||
146144713|NCT03095417|527043443|FG001|Overall Study|Lost to Follow-up|2|||
146144714|NCT03095417|527043444|FG002|Overall Study|Lost to Follow-up|1|||
146144715|NCT03095417|527043445|FG003|Overall Study|Lost to Follow-up|0|||
146144716|NCT03095417|527043442|FG000|Overall Study|refusal|0|||
146144717|NCT03095417|527043443|FG001|Overall Study|refusal|1|||
146144718|NCT03095417|527043444|FG002|Overall Study|refusal|0|||
146144719|NCT03095417|527043445|FG003|Overall Study|refusal|1|||
146144720|NCT03095417|527043442|FG000|Overall Study|Withdrawal by Subject|8|||
146144721|NCT03095417|527043443|FG001|Overall Study|Withdrawal by Subject|2|||
146144722|NCT03095417|527043444|FG002|Overall Study|Withdrawal by Subject|5|||
146144723|NCT03095417|527043445|FG003|Overall Study|Withdrawal by Subject|4|||
146144724|NCT03095417|527043442|FG000|Overall Study|Physician Decision|1|||
146144725|NCT03095417|527043443|FG001|Overall Study|Physician Decision|2|||
146144726|NCT03095417|527043444|FG002|Overall Study|Physician Decision|2|||
146144727|NCT03095417|527043445|FG003|Overall Study|Physician Decision|2|||
146144728|NCT03095417|527043442|FG000|Overall Study|Death|1|||
146144729|NCT03095417|527043443|FG001|Overall Study|Death|2|||
146144730|NCT03095417|527043444|FG002|Overall Study|Death|1|||
146144731|NCT03095417|527043445|FG003|Overall Study|Death|3|||
146144732|NCT02571452|527043446|FG000|Overall Study Treatment|Protocol Violation|0|||
146144733|NCT02571452|527043447|FG001|Overall Study Treatment|Protocol Violation|1|||
146144734|NCT02571452|527043446|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
146144735|NCT02571452|527043447|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
146144736|NCT02571452|527043446|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
146144737|NCT02571452|527043447|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
146144738|NCT03795922|527043451|FG000|Overall Study|Adverse Event|2|||
146144739|NCT03795922|527043452|FG001|Overall Study|Adverse Event|1|||
146144740|NCT03795922|527043451|FG000|Overall Study|Withdrawal by Subject|5|||
146144741|NCT03795922|527043452|FG001|Overall Study|Withdrawal by Subject|13|||
146144742|NCT03795922|527043451|FG000|Overall Study|Lost to Follow-up|2|||
146274280|NCT04879849|527518249|FG006|Overall Study|Death|1|||
146274281|NCT04879849|527518250|FG007|Overall Study|Death|2|||
146274282|NCT04879849|527518243|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
146274283|NCT04879849|527518244|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
146274284|NCT04879849|527518245|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
146274285|NCT04879849|527518246|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
146274286|NCT04879849|527518247|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
146274287|NCT04879849|527518248|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
146274288|NCT04879849|527518249|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
146274289|NCT04879849|527518250|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
146274290|NCT04879849|527518243|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274291|NCT04879849|527518244|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274292|NCT04879849|527518245|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274293|NCT04879849|527518246|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274294|NCT04879849|527518247|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274295|NCT04879849|527518248|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274296|NCT04879849|527518249|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
146274297|NCT04879849|527518250|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
146274298|NCT04879849|527518243|FG000|Overall Study|Reason Not Specified|1|||
146274299|NCT04879849|527518244|FG001|Overall Study|Reason Not Specified|0|||
146274300|NCT04879849|527518245|FG002|Overall Study|Reason Not Specified|0|||
146274301|NCT04879849|527518246|FG003|Overall Study|Reason Not Specified|0|||
146274302|NCT04879849|527518247|FG004|Overall Study|Reason Not Specified|0|||
146274303|NCT04879849|527518248|FG005|Overall Study|Reason Not Specified|0|||
146274304|NCT04879849|527518249|FG006|Overall Study|Reason Not Specified|0|||
146274305|NCT04879849|527518250|FG007|Overall Study|Reason Not Specified|0|||
146274306|NCT03361865|527518251|FG000|Overall Study|Death|17|||
146274307|NCT03361865|527518252|FG001|Overall Study|Death|18|||
146274308|NCT03361865|527518251|FG000|Overall Study|Physician Decision|1|||
146274309|NCT03361865|527518252|FG001|Overall Study|Physician Decision|9|||
146274310|NCT03361865|527518251|FG000|Overall Study|Withdrawal by Subject|1|||
146274311|NCT03361865|527518252|FG001|Overall Study|Withdrawal by Subject|0|||
146274312|NCT04201262|527518254|FG000|Primary Treatment Period|Adverse Event|1|||
146274313|NCT04201262|527518255|FG001|Primary Treatment Period|Adverse Event|2|||
146274314|NCT04201262|527518254|FG000|Primary Treatment Period|Physician Decision|1|||
146274315|NCT04201262|527518255|FG001|Primary Treatment Period|Physician Decision|1|||
146274316|NCT04201262|527518254|FG000|Long-term Extension Period|Death|1|||
146274317|NCT04201262|527518255|FG001|Long-term Extension Period|Death|0|||
146274318|NCT02819024|527518257|FG000|Overall Study|Withdrawal by Subject|1|||
146274319|NCT05576662|527518258|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
146274320|NCT05576662|527518259|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
146274321|NCT05576662|527518258|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
146274322|NCT05576662|527518259|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
146274323|NCT05576662|527518258|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
146274324|NCT05576662|527518259|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
146274325|NCT05576662|527518258|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
146274326|NCT05576662|527518259|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
146274327|NCT05217641|527518264|FG000|Overall Study|Lost to Follow-up|1|||
146274328|NCT05217641|527518265|FG001|Overall Study|Lost to Follow-up|1|||
146274329|NCT05217641|527518266|FG002|Overall Study|Lost to Follow-up|0|||
146274330|NCT05217641|527518267|FG003|Overall Study|Lost to Follow-up|1|||
146274331|NCT05217641|527518268|FG004|Overall Study|Lost to Follow-up|1|||
146274332|NCT05217641|527518269|FG005|Overall Study|Lost to Follow-up|0|||
146274333|NCT05217641|527518264|FG000|Overall Study|Withdrawal by Subject|0|||
146274334|NCT05217641|527518265|FG001|Overall Study|Withdrawal by Subject|0|||
146274335|NCT05217641|527518266|FG002|Overall Study|Withdrawal by Subject|0|||
146274336|NCT05217641|527518267|FG003|Overall Study|Withdrawal by Subject|3|||
146274337|NCT05217641|527518268|FG004|Overall Study|Withdrawal by Subject|1|||
146274338|NCT05217641|527518269|FG005|Overall Study|Withdrawal by Subject|0|||
146274339|NCT05217641|527518264|FG000|Overall Study|Other: participant did not specify reason|0|||
146274340|NCT05217641|527518265|FG001|Overall Study|Other: participant did not specify reason|0|||
146274341|NCT05217641|527518266|FG002|Overall Study|Other: participant did not specify reason|0|||
146274342|NCT05217641|527518267|FG003|Overall Study|Other: participant did not specify reason|0|||
146274343|NCT05217641|527518268|FG004|Overall Study|Other: participant did not specify reason|1|||
146274344|NCT05217641|527518269|FG005|Overall Study|Other: participant did not specify reason|0|||
146144743|NCT03795922|527043452|FG001|Overall Study|Lost to Follow-up|3|||
146304325|NCT01380730|527629184|FG004|Overall Study|Death|1|||
146304326|NCT01380730|527629185|FG005|Overall Study|Death|0|||
146304327|NCT01380730|527629186|FG006|Overall Study|Death|0|||
146304328|NCT01380730|527629187|FG007|Overall Study|Death|0|||
146304329|NCT00922480|527629191|FG000|Main Study|Protocol Violation|3|||
146304330|NCT00922480|527629192|FG001|Main Study|Protocol Violation|6|||
146304331|NCT00922480|527629191|FG000|Main Study|Adverse Event|6|||
146304332|NCT00922480|527629192|FG001|Main Study|Adverse Event|7|||
146304333|NCT00922480|527629191|FG000|Main Study|Lack of Efficacy|3|||
146304334|NCT00922480|527629192|FG001|Main Study|Lack of Efficacy|0|||
146304335|NCT00922480|527629191|FG000|Main Study|Withdrawal by Subject|20|||
146304336|NCT00922480|527629192|FG001|Main Study|Withdrawal by Subject|15|||
146304337|NCT00922480|527629191|FG000|Main Study|Lost to Follow-up|5|||
146304338|NCT00922480|527629192|FG001|Main Study|Lost to Follow-up|0|||
146304339|NCT00922480|527629191|FG000|Main Study|Physician Decision|0|||
146304340|NCT00922480|527629192|FG001|Main Study|Physician Decision|1|||
146304341|NCT00922480|527629191|FG000|Extension Study|Protocol Violation|3|||
146304342|NCT00922480|527629192|FG001|Extension Study|Protocol Violation|0|||
146304343|NCT00922480|527629191|FG000|Extension Study|Adverse Event|1|||
146304344|NCT00922480|527629192|FG001|Extension Study|Adverse Event|1|||
146304345|NCT00922480|527629191|FG000|Extension Study|Withdrawal by Subject|1|||
146304346|NCT00922480|527629192|FG001|Extension Study|Withdrawal by Subject|1|||
146304347|NCT00922480|527629191|FG000|Extension Study|Others|0|||
146304348|NCT00922480|527629192|FG001|Extension Study|Others|1|||
146304349|NCT00873366|527629193|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
146304350|NCT00873366|527629193|FG000|Overall Study|Off tamoxifen due to side effects|2|||
146304351|NCT00873366|527629193|FG000|Overall Study|Refused to continue DM-BT testing|3|||
146304352|NCT01970488|527629194|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
146304353|NCT01970488|527629195|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
146304354|NCT01970488|527629196|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146304355|NCT01970488|527629197|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146304356|NCT01970488|527629198|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
146304357|NCT01970488|527629194|FG000|Part 1: Through Week 16|Protocol Violation|1|||
146304358|NCT01970488|527629195|FG001|Part 1: Through Week 16|Protocol Violation|2|||
146304359|NCT01970488|527629196|FG002|Part 1: Through Week 16|Protocol Violation|0|||
146304360|NCT01970488|527629197|FG003|Part 1: Through Week 16|Protocol Violation|0|||
146304361|NCT01970488|527629198|FG004|Part 1: Through Week 16|Protocol Violation|0|||
146304362|NCT01970488|527629194|FG000|Part 1: Through Week 16|Adverse Event|6|||
146304363|NCT01970488|527629195|FG001|Part 1: Through Week 16|Adverse Event|5|||
146304364|NCT01970488|527629196|FG002|Part 1: Through Week 16|Adverse Event|0|||
146304365|NCT01970488|527629197|FG003|Part 1: Through Week 16|Adverse Event|0|||
146304366|NCT01970488|527629198|FG004|Part 1: Through Week 16|Adverse Event|0|||
146304367|NCT01970488|527629194|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
146304368|NCT01970488|527629195|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
146304369|NCT01970488|527629196|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
146304370|NCT01970488|527629197|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
146304371|NCT01970488|527629198|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
146304372|NCT01970488|527629194|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
146304373|NCT01970488|527629195|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
146304374|NCT01970488|527629196|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
146304375|NCT01970488|527629197|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
146274345|NCT05217641|527518264|FG000|Overall Study|Extended Follow up|1|||
146274346|NCT05217641|527518265|FG001|Overall Study|Extended Follow up|1|||
146274347|NCT05217641|527518266|FG002|Overall Study|Extended Follow up|0|||
146274348|NCT05217641|527518267|FG003|Overall Study|Extended Follow up|0|||
146274349|NCT05217641|527518268|FG004|Overall Study|Extended Follow up|1|||
146274350|NCT05217641|527518269|FG005|Overall Study|Extended Follow up|0|||
146274351|NCT05292586|527518270|FG000|Overall Study|Withdrawal by Subject|3|||
146274352|NCT05292586|527518271|FG001|Overall Study|Withdrawal by Subject|10|||
146274353|NCT05292586|527518270|FG000|Overall Study|Randomization error|3|||
146274354|NCT05292586|527518271|FG001|Overall Study|Randomization error|7|||
146274355|NCT05292586|527518270|FG000|Overall Study|Adverse Event|3|||
146304376|NCT01970488|527629198|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
146304377|NCT01970488|527629194|FG000|Part 2: Post Week 16|Physician Decision|0|||
146304378|NCT01970488|527629195|FG001|Part 2: Post Week 16|Physician Decision|0|||
146304379|NCT01970488|527629196|FG002|Part 2: Post Week 16|Physician Decision|0|||
146274356|NCT05292586|527518271|FG001|Overall Study|Adverse Event|0|||
146304380|NCT01970488|527629197|FG003|Part 2: Post Week 16|Physician Decision|0|||
146304381|NCT01970488|527629198|FG004|Part 2: Post Week 16|Physician Decision|1|||
146274357|NCT05292586|527518270|FG000|Overall Study|Lost to Follow-up|0|||
146274358|NCT05292586|527518271|FG001|Overall Study|Lost to Follow-up|1|||
146304382|NCT01970488|527629194|FG000|Part 2: Post Week 16|Non-compliance|0|||
146304383|NCT01970488|527629195|FG001|Part 2: Post Week 16|Non-compliance|0|||
146304384|NCT01970488|527629196|FG002|Part 2: Post Week 16|Non-compliance|1|||
146304385|NCT01970488|527629197|FG003|Part 2: Post Week 16|Non-compliance|0|||
146304386|NCT01970488|527629198|FG004|Part 2: Post Week 16|Non-compliance|0|||
146274359|NCT05292586|527518270|FG000|Overall Study|Patient refused treatment|1|||
146274360|NCT05292586|527518271|FG001|Overall Study|Patient refused treatment|0|||
146274361|NCT05292586|527518270|FG000|Overall Study|Patient could not travel to the study site|1|||
146274362|NCT05292586|527518271|FG001|Overall Study|Patient could not travel to the study site|0|||
146274363|NCT05292586|527518270|FG000|Overall Study|Technical issues with the masterscope|0|||
146274364|NCT05292586|527518271|FG001|Overall Study|Technical issues with the masterscope|3|||
146274365|NCT05292586|527518270|FG000|Overall Study|Patient moved to a different state|0|||
146274366|NCT05292586|527518271|FG001|Overall Study|Patient moved to a different state|1|||
146274367|NCT03633799|527518288|FG000|Overall Study|Adverse Event|349|||
146274368|NCT03633799|527518288|FG000|Overall Study|Withdrawal by Subject|288|||
146274369|NCT03633799|527518288|FG000|Overall Study|Lost to Follow-up|97|||
146274370|NCT03633799|527518288|FG000|Overall Study|Physician Decision|9|||
146274371|NCT03633799|527518288|FG000|Overall Study|Protocol Violation|4|||
146274372|NCT03633799|527518288|FG000|Overall Study|Pregnancy|20|||
146274373|NCT03633799|527518288|FG000|Overall Study|other|39|||
146274374|NCT03633799|527518288|FG000|Overall Study|ongoing within third year of study|106|||
146274375|NCT03633799|527518288|FG000|Overall Study|unsuccessful study drug placement|19|||
146274376|NCT02477618|527518291|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
146274377|NCT02477618|527518292|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
146274378|NCT02477618|527518291|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
146274379|NCT02477618|527518292|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
146274380|NCT02477618|527518291|FG000|Overall Study|Adverse Event|1|||
146274381|NCT02477618|527518292|FG001|Overall Study|Adverse Event|1|||
146274382|NCT02477618|527518291|FG000|Overall Study|Transferred Away from Study Site|1|||
146274383|NCT02477618|527518292|FG001|Overall Study|Transferred Away from Study Site|0|||
146274384|NCT02477618|527518291|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
146274385|NCT02477618|527518292|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
146274386|NCT02446821|527518293|FG000|Overall Study|Adverse Event|28|||
146274387|NCT02446821|527518293|FG000|Overall Study|Withdrawal by Subject|6|||
146274388|NCT02446821|527518293|FG000|Overall Study|Lost to Follow-up|22|||
146274389|NCT02446821|527518293|FG000|Overall Study|other|9|||
146274390|NCT02446821|527518293|FG000|Overall Study|insertion failure|3|||
146274391|NCT03007420|527518294|FG000|Overall Study|Withdrawal by Subject|0|||
146274392|NCT03007420|527518295|FG001|Overall Study|Withdrawal by Subject|2|||
146274393|NCT03007420|527518294|FG000|Overall Study|Physician Decision|0|||
146274394|NCT03007420|527518295|FG001|Overall Study|Physician Decision|1|||
146274395|NCT02284009|527518296|FG000|Overall Study|Adverse Event|3|||
146274396|NCT02284009|527518297|FG001|Overall Study|Adverse Event|0|||
146274397|NCT02284009|527518296|FG000|Overall Study|Lost to Follow-up|1|||
146274398|NCT02284009|527518297|FG001|Overall Study|Lost to Follow-up|3|||
146274399|NCT02284009|527518296|FG000|Overall Study|Physician Decision|0|||
146274400|NCT02284009|527518297|FG001|Overall Study|Physician Decision|2|||
146274401|NCT02284009|527518296|FG000|Overall Study|Withdrawal by Subject|2|||
146274402|NCT02284009|527518297|FG001|Overall Study|Withdrawal by Subject|5|||
146274403|NCT02397447|527518298|FG000|Overall Study|Lost to Follow-up|2|||
146274404|NCT02397447|527518299|FG001|Overall Study|Lost to Follow-up|2|||
146274405|NCT05823012|527518300|FG000|Titration Period|Adverse Event|1|||
146274406|NCT05823012|527518300|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
146274407|NCT05823012|527518300|FG000|Maintenance Period|Adverse Event|1|||
146274408|NCT05823012|527518300|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
146274409|NCT05823012|527518300|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
146274410|NCT00747227|527519800|FG000|Overall Study|Death|3|||
146274411|NCT00747227|527519801|FG001|Overall Study|Death|1|||
146274412|NCT00747227|527519800|FG000|Overall Study|Withdrawal by Subject|1|||
146274413|NCT00747227|527519801|FG001|Overall Study|Withdrawal by Subject|0|||
146274414|NCT00747227|527519800|FG000|Overall Study|Lost to Follow-up|1|||
146274415|NCT00747227|527519801|FG001|Overall Study|Lost to Follow-up|2|||
146274416|NCT00747227|527519800|FG000|Overall Study|Illness|1|||
146304387|NCT01970488|527629194|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
146304388|NCT01970488|527629195|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
146304389|NCT01970488|527629196|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
146304390|NCT01970488|527629197|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
146304391|NCT01970488|527629198|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
146304392|NCT01970488|527629194|FG000|Part 2: Post Week 16|Adverse Event|0|||
146304393|NCT01970488|527629195|FG001|Part 2: Post Week 16|Adverse Event|0|||
146274417|NCT00747227|527519801|FG001|Overall Study|Illness|1|||
146274418|NCT03554629|527519802|FG000|Overall Study|Inadequate data|6|||
146274419|NCT00663702|527519807|FG000|Overall Study|Adverse Event|8|||
146274420|NCT00663702|527519808|FG001|Overall Study|Adverse Event|4|||
146274421|NCT00663702|527519807|FG000|Overall Study|Withdrawal by Subject|3|||
146144744|NCT03795922|527043451|FG000|Overall Study|Pregnancy|0|||
146274422|NCT00663702|527519808|FG001|Overall Study|Withdrawal by Subject|1|||
146274423|NCT00663702|527519807|FG000|Overall Study|Pregnancy|0|||
146274424|NCT00663702|527519808|FG001|Overall Study|Pregnancy|1|||
146274425|NCT00663702|527519807|FG000|Overall Study|Lost to Follow-up|3|||
146274426|NCT00663702|527519808|FG001|Overall Study|Lost to Follow-up|0|||
146274427|NCT00663702|527519807|FG000|Overall Study|Death|1|||
146274428|NCT00663702|527519808|FG001|Overall Study|Death|1|||
146274429|NCT00663702|527519807|FG000|Overall Study|Lack of Efficacy|3|||
146274430|NCT00663702|527519808|FG001|Overall Study|Lack of Efficacy|3|||
146274431|NCT03056300|527519809|FG000|Overall Study|Surgical reason per study protocol|3|||
146274432|NCT00461981|527519814|FG000|Overall Study|Lost to Follow-up|9|||
146274433|NCT00461981|527519815|FG001|Overall Study|Lost to Follow-up|6|||
146274434|NCT00461981|527519814|FG000|Overall Study|Withdrawal by Subject|2|||
146274435|NCT00461981|527519815|FG001|Overall Study|Withdrawal by Subject|3|||
146274436|NCT01077128|527519816|FG000|Overall Study|Adverse Event|8|||
146274437|NCT01077128|527519816|FG000|Overall Study|Lack of Efficacy|1|||
146274438|NCT01077128|527519816|FG000|Overall Study|Disease exacerbation|1|||
146274439|NCT01077128|527519816|FG000|Overall Study|Adverse event and consent withdrawal|1|||
146274440|NCT01077128|527519816|FG000|Overall Study|Adverse event and disease exacerbation|1|||
146274441|NCT01077128|527519816|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
146274442|NCT01077128|527519816|FG000|Overall Study|Other|54|||
146274443|NCT00847626|527519817|FG000|Overall Study|Adverse Event|10|||
146274444|NCT00847626|527519818|FG001|Overall Study|Adverse Event|10|||
146274445|NCT00847626|527519819|FG002|Overall Study|Adverse Event|6|||
146274446|NCT00847626|527519820|FG003|Overall Study|Adverse Event|19|||
146274447|NCT00847626|527519821|FG004|Overall Study|Adverse Event|11|||
146274448|NCT00847626|527519822|FG005|Overall Study|Adverse Event|22|||
146274449|NCT00847626|527519823|FG006|Overall Study|Adverse Event|4|||
146274450|NCT00847626|527519824|FG007|Overall Study|Adverse Event|6|||
146274451|NCT00847626|527519825|FG008|Overall Study|Adverse Event|3|||
146274452|NCT00847626|527519826|FG009|Overall Study|Adverse Event|6|||
146274453|NCT00847626|527519827|FG010|Overall Study|Adverse Event|6|||
146274454|NCT00847626|527519817|FG000|Overall Study|Protocol Violation|2|||
146274455|NCT00847626|527519818|FG001|Overall Study|Protocol Violation|1|||
146274456|NCT00847626|527519819|FG002|Overall Study|Protocol Violation|2|||
146274457|NCT00847626|527519820|FG003|Overall Study|Protocol Violation|1|||
146274458|NCT00847626|527519821|FG004|Overall Study|Protocol Violation|1|||
146274459|NCT00847626|527519822|FG005|Overall Study|Protocol Violation|1|||
146274460|NCT00847626|527519823|FG006|Overall Study|Protocol Violation|1|||
146274461|NCT00847626|527519824|FG007|Overall Study|Protocol Violation|1|||
146274462|NCT00847626|527519825|FG008|Overall Study|Protocol Violation|0|||
146274463|NCT00847626|527519826|FG009|Overall Study|Protocol Violation|1|||
146274464|NCT00847626|527519827|FG010|Overall Study|Protocol Violation|1|||
146274465|NCT00847626|527519817|FG000|Overall Study|Lost to Follow-up|0|||
146274466|NCT00847626|527519818|FG001|Overall Study|Lost to Follow-up|1|||
146274467|NCT00847626|527519819|FG002|Overall Study|Lost to Follow-up|1|||
146274468|NCT00847626|527519820|FG003|Overall Study|Lost to Follow-up|1|||
146274469|NCT00847626|527519821|FG004|Overall Study|Lost to Follow-up|0|||
146274470|NCT00847626|527519822|FG005|Overall Study|Lost to Follow-up|3|||
146274471|NCT00847626|527519823|FG006|Overall Study|Lost to Follow-up|1|||
146274472|NCT00847626|527519824|FG007|Overall Study|Lost to Follow-up|3|||
146274473|NCT00847626|527519825|FG008|Overall Study|Lost to Follow-up|1|||
146274474|NCT00847626|527519826|FG009|Overall Study|Lost to Follow-up|0|||
146274475|NCT00847626|527519827|FG010|Overall Study|Lost to Follow-up|1|||
146304394|NCT01970488|527629196|FG002|Part 2: Post Week 16|Adverse Event|5|||
146304395|NCT01970488|527629197|FG003|Part 2: Post Week 16|Adverse Event|1|||
146144745|NCT03795922|527043452|FG001|Overall Study|Pregnancy|1|||
146144746|NCT03795922|527043451|FG000|Overall Study|Physician Decision|1|||
146144747|NCT03795922|527043452|FG001|Overall Study|Physician Decision|2|||
146144748|NCT03795922|527043451|FG000|Overall Study|Protocol Violation|0|||
146144749|NCT03795922|527043452|FG001|Overall Study|Protocol Violation|1|||
146144750|NCT03795922|527043451|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
146144751|NCT03795922|527043452|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
146144752|NCT01416805|527043465|FG000|Overall Study|Lost to Follow-up|4|||
146144753|NCT01416805|527043466|FG001|Overall Study|Lost to Follow-up|4|||
146144754|NCT01723904|527043468|FG000|Overall Study|Noncompliant|3|||
146144755|NCT01723904|527043468|FG000|Overall Study|Adverse Event|5|||
146144756|NCT01723904|527043468|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
146144757|NCT00887341|527043479|FG000|Overall Study|Refused treatment|1|||
146274476|NCT00847626|527519817|FG000|Overall Study|Withdrawal by Subject|5|||
146274477|NCT00847626|527519818|FG001|Overall Study|Withdrawal by Subject|5|||
146274478|NCT00847626|527519819|FG002|Overall Study|Withdrawal by Subject|3|||
146274479|NCT00847626|527519820|FG003|Overall Study|Withdrawal by Subject|8|||
146274480|NCT00847626|527519821|FG004|Overall Study|Withdrawal by Subject|12|||
146274481|NCT00847626|527519822|FG005|Overall Study|Withdrawal by Subject|9|||
146274482|NCT00847626|527519823|FG006|Overall Study|Withdrawal by Subject|8|||
146274483|NCT00847626|527519824|FG007|Overall Study|Withdrawal by Subject|4|||
146274484|NCT00847626|527519825|FG008|Overall Study|Withdrawal by Subject|4|||
146304396|NCT01970488|527629198|FG004|Part 2: Post Week 16|Adverse Event|1|||
146144758|NCT00887341|527043480|FG001|Overall Study|Refused treatment|0|||
146274485|NCT00847626|527519826|FG009|Overall Study|Withdrawal by Subject|5|||
146274486|NCT00847626|527519827|FG010|Overall Study|Withdrawal by Subject|2|||
146274487|NCT00847626|527519817|FG000|Overall Study|Lack of Efficacy|3|||
146144759|NCT00887341|527043479|FG000|Overall Study|Withdrawal by Subject|1|||
146144760|NCT00887341|527043480|FG001|Overall Study|Withdrawal by Subject|1|||
146144761|NCT00887341|527043479|FG000|Overall Study|Adverse Event|0|||
146274488|NCT00847626|527519818|FG001|Overall Study|Lack of Efficacy|1|||
146274489|NCT00847626|527519819|FG002|Overall Study|Lack of Efficacy|0|||
146274490|NCT00847626|527519820|FG003|Overall Study|Lack of Efficacy|1|||
146274491|NCT00847626|527519821|FG004|Overall Study|Lack of Efficacy|2|||
146274492|NCT00847626|527519822|FG005|Overall Study|Lack of Efficacy|0|||
146274493|NCT00847626|527519823|FG006|Overall Study|Lack of Efficacy|6|||
146274494|NCT00847626|527519824|FG007|Overall Study|Lack of Efficacy|2|||
146274495|NCT00847626|527519825|FG008|Overall Study|Lack of Efficacy|5|||
146274496|NCT00847626|527519826|FG009|Overall Study|Lack of Efficacy|1|||
146274497|NCT00847626|527519827|FG010|Overall Study|Lack of Efficacy|7|||
146274498|NCT00847626|527519817|FG000|Overall Study|Other|1|||
146274499|NCT00847626|527519818|FG001|Overall Study|Other|5|||
146274500|NCT00847626|527519819|FG002|Overall Study|Other|4|||
146274501|NCT00847626|527519820|FG003|Overall Study|Other|1|||
146274502|NCT00847626|527519821|FG004|Overall Study|Other|2|||
146274503|NCT00847626|527519822|FG005|Overall Study|Other|2|||
146274504|NCT00847626|527519823|FG006|Overall Study|Other|2|||
146274505|NCT00847626|527519824|FG007|Overall Study|Other|3|||
146274506|NCT00847626|527519825|FG008|Overall Study|Other|1|||
146274507|NCT00847626|527519826|FG009|Overall Study|Other|1|||
146274508|NCT00847626|527519827|FG010|Overall Study|Other|3|||
146274509|NCT03031496|527519830|FG000|Period 1|Adverse Event|2|||
146274510|NCT03031496|527519831|FG001|Period 1|Adverse Event|0|||
146274511|NCT03031496|527519830|FG000|Period 1|Withdrawal by Subject|0|||
146274512|NCT03031496|527519831|FG001|Period 1|Withdrawal by Subject|2|||
146274513|NCT02979249|527519833|FG000|Overall Study|Lost to Follow-up|2|||
146274514|NCT02979249|527519833|FG000|Overall Study|Withdrawal by Subject|4|||
146274515|NCT01125046|527519834|FG000|First 6 Months of Treatment|Death|1|||
146274516|NCT01125046|527519834|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
146274517|NCT01125046|527519834|FG000|First 6 Months of Treatment|Non-compliance|1|||
146274518|NCT01125046|527519834|FG000|First 6 Months of Treatment|Surgery|1|||
146274519|NCT01125046|527519834|FG000|First 6 Months of Treatment|Progressive Disease|7|||
146274520|NCT01125046|527519834|FG000|First 6 Months of Treatment|Adverse Event|2|||
146274521|NCT01125046|527519834|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
146274522|NCT01125046|527519834|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
146274523|NCT01125046|527519834|FG000|Follow-up/Data Cut Off Point|Death|29|||
146274524|NCT01125046|527519834|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
146274525|NCT03868787|527519835|FG000|Overall Study|Withdrawal by Subject|2|||
146274526|NCT03868787|527519836|FG001|Overall Study|Withdrawal by Subject|1|||
146274527|NCT02510040|527519837|FG000|Overall Study|Deemed no longer eligible|18|||
146274528|NCT02510040|527519838|FG001|Overall Study|Deemed no longer eligible|3|||
146274529|NCT02510040|527519839|FG002|Overall Study|Deemed no longer eligible|1|||
146274530|NCT00967005|527519840|FG000|Overall Study|Lost to Follow-up|7|||
146274531|NCT00967005|527519841|FG001|Overall Study|Lost to Follow-up|10|||
146274532|NCT01401153|527519846|FG000|First Test Day|Learning disabilities; illness|1|||
146144762|NCT00887341|527043480|FG001|Overall Study|Adverse Event|1|||
146144763|NCT00887341|527043479|FG000|Overall Study|Lost to Follow-up|0|||
146144764|NCT00887341|527043480|FG001|Overall Study|Lost to Follow-up|1|||
146144765|NCT01591681|527043483|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
146144766|NCT01591681|527043483|FG000|Overall Study|Failed to use system during run-in|1|||
146144767|NCT01649856|527043484|FG000|Overall Study|Withdrawal by Subject|14|||
146144768|NCT01649856|527043485|FG001|Overall Study|Withdrawal by Subject|14|||
146144769|NCT01649856|527043484|FG000|Overall Study|Protocol Violation|4|||
146144770|NCT01649856|527043485|FG001|Overall Study|Protocol Violation|4|||
146144771|NCT01649856|527043484|FG000|Overall Study|Treatment Failure|1|||
146144772|NCT01649856|527043485|FG001|Overall Study|Treatment Failure|1|||
146144773|NCT01649856|527043484|FG000|Overall Study|Death|69|||
146144774|NCT01649856|527043485|FG001|Overall Study|Death|34|||
146144775|NCT01649856|527043484|FG000|Overall Study|Stable or Progressed Disease|5|||
146144776|NCT01649856|527043485|FG001|Overall Study|Stable or Progressed Disease|3|||
146144777|NCT01649856|527043484|FG000|Overall Study|Lost to Follow-up|20|||
146144778|NCT01649856|527043485|FG001|Overall Study|Lost to Follow-up|16|||
146144779|NCT01649856|527043484|FG000|Overall Study|Lack of Compliance|6|||
146144780|NCT01649856|527043485|FG001|Overall Study|Lack of Compliance|1|||
146144781|NCT01649856|527043484|FG000|Overall Study|Other|20|||
146274533|NCT01401153|527519847|FG001|First Test Day|Learning disabilities; illness|10|||
146304397|NCT01970488|527629194|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
146274534|NCT01401153|527519846|FG000|Second Test Day|illness|0|||
146144782|NCT01649856|527043485|FG001|Overall Study|Other|5|||
146144783|NCT02138214|527043486|FG000|Overall Study|Withdrawal by Subject|0|||
146274535|NCT01401153|527519847|FG001|Second Test Day|illness|5|||
146274536|NCT01818531|527519850|FG000|Overall Study|Withdrawn for case delay after block|1|||
146274537|NCT01818531|527519851|FG001|Overall Study|Withdrawn for case delay after block|0|||
146274538|NCT01818531|527519850|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
146274539|NCT01818531|527519851|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
146144784|NCT02138214|527043487|FG001|Overall Study|Withdrawal by Subject|1|||
146144785|NCT02138214|527043488|FG002|Overall Study|Withdrawal by Subject|0|||
146144786|NCT02138214|527043486|FG000|Overall Study|Lost to Follow-up|0|||
146144787|NCT02138214|527043487|FG001|Overall Study|Lost to Follow-up|2|||
146144788|NCT02138214|527043488|FG002|Overall Study|Lost to Follow-up|4|||
146144789|NCT02138214|527043486|FG000|Overall Study|Screen Failure|0|||
146144790|NCT02138214|527043487|FG001|Overall Study|Screen Failure|1|||
146144791|NCT02138214|527043488|FG002|Overall Study|Screen Failure|0|||
146144792|NCT00235989|527043494|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
146144793|NCT00235989|527043495|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
146144794|NCT00235989|527043496|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
146144795|NCT00235989|527043497|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
146144796|NCT00235989|527043498|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
146144797|NCT00235989|527043499|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
146144798|NCT00235989|527043494|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
146144799|NCT00235989|527043495|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
146144800|NCT00235989|527043496|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
146144801|NCT00235989|527043497|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
146144802|NCT00235989|527043498|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
146144803|NCT00235989|527043499|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
146144804|NCT00235989|527043494|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
146144805|NCT00235989|527043495|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146144806|NCT00235989|527043496|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
146144807|NCT00235989|527043497|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146144808|NCT00235989|527043498|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146144809|NCT00235989|527043499|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
146144810|NCT00235989|527043494|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146144811|NCT00235989|527043495|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146144812|NCT00235989|527043496|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
146144813|NCT00235989|527043497|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
146144814|NCT00235989|527043498|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
146144815|NCT00235989|527043499|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
146144816|NCT00235989|527043494|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
146144817|NCT00235989|527043495|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
146144818|NCT00235989|527043496|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
146144819|NCT00235989|527043497|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
146144820|NCT00235989|527043498|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
146144821|NCT00235989|527043499|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
146144822|NCT01334866|527043511|FG000|Overall Study|Withdrawal by Subject|10|||
146144823|NCT01334866|527043511|FG000|Overall Study|Lost to Follow-up|3|||
146144824|NCT01334866|527043511|FG000|Overall Study|Physician Decision|3|||
146144825|NCT01334866|527043511|FG000|Overall Study|medically necessary prior to procedure|2|||
146144826|NCT01334866|527043511|FG000|Overall Study|medically necessary post-procedure|1|||
146304398|NCT01970488|527629195|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
146304399|NCT01970488|527629196|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
146304400|NCT01970488|527629197|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
146304401|NCT01970488|527629198|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
146304402|NCT01970488|527629194|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
146304403|NCT01970488|527629195|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
146304404|NCT01970488|527629196|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
146304405|NCT01970488|527629197|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
146304406|NCT01970488|527629198|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
146304407|NCT01490814|527629202|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
146304408|NCT01490814|527629203|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
146304409|NCT01490814|527629202|FG000|Overall Study|Physician Decision|1|||
146304410|NCT01490814|527629203|FG001|Overall Study|Physician Decision|0|||
146304411|NCT01490814|527629202|FG000|Overall Study|Withdrawal by Subject|0|||
146304412|NCT01490814|527629203|FG001|Overall Study|Withdrawal by Subject|5|||
146304413|NCT01537198|527629204|FG000|Overall Study|RSV infection|2|||
146304414|NCT01537198|527629204|FG000|Overall Study|Adverse Event|4|||
146304415|NCT01537198|527629204|FG000|Overall Study|No Further Visits to the Clinic|37|||
146304416|NCT01537198|527629204|FG000|Overall Study|Other|111|||
146304417|NCT00574288|527629207|FG000|Overall Study|Adverse Event|2|||
146304418|NCT00574288|527629208|FG001|Overall Study|Adverse Event|0|||
146144827|NCT00958880|527043525|FG000|Overall Study|Lost to Follow-up|2|||
146144828|NCT00958880|527043526|FG001|Overall Study|Lost to Follow-up|2|||
146144829|NCT01971346|527043527|FG000|Overall Study|Protocol Violation|3|||
146144830|NCT01971346|527043527|FG000|Overall Study|Lost to Follow-up|2|||
146144831|NCT01971346|527043527|FG000|Overall Study|Withdrawal by Subject|2|||
146304419|NCT00574288|527629209|FG002|Overall Study|Adverse Event|0|||
146304420|NCT00574288|527629210|FG003|Overall Study|Adverse Event|0|||
146304421|NCT00574288|527629211|FG004|Overall Study|Adverse Event|1|||
146144832|NCT01971346|527043527|FG000|Overall Study|Physician Decision|1|||
146144833|NCT01687166|527043530|FG000|Overall Study|Attempt subject|2|||
146144834|NCT01687166|527043531|FG001|Overall Study|Attempt subject|3|||
146144835|NCT01687166|527043532|FG002|Overall Study|Attempt subject|2|||
146144836|NCT01687166|527043533|FG003|Overall Study|Attempt subject|0|||
146144837|NCT01687166|527043530|FG000|Overall Study|Did not meet eligibility criteria|4|||
146144838|NCT01687166|527043531|FG001|Overall Study|Did not meet eligibility criteria|6|||
146144839|NCT01687166|527043532|FG002|Overall Study|Did not meet eligibility criteria|1|||
146144840|NCT01687166|527043533|FG003|Overall Study|Did not meet eligibility criteria|1|||
146144841|NCT01687166|527043530|FG000|Overall Study|Adverse Event|2|||
146144842|NCT01687166|527043531|FG001|Overall Study|Adverse Event|1|||
146144843|NCT01687166|527043532|FG002|Overall Study|Adverse Event|0|||
146144844|NCT01687166|527043533|FG003|Overall Study|Adverse Event|0|||
146144845|NCT01687166|527043530|FG000|Overall Study|Physician Decision|3|||
146144846|NCT01687166|527043531|FG001|Overall Study|Physician Decision|2|||
146144847|NCT01687166|527043532|FG002|Overall Study|Physician Decision|1|||
146144848|NCT01687166|527043533|FG003|Overall Study|Physician Decision|0|||
146144849|NCT01687166|527043530|FG000|Overall Study|Withdrawal by Subject|11|||
146144850|NCT01687166|527043531|FG001|Overall Study|Withdrawal by Subject|4|||
146144851|NCT01687166|527043532|FG002|Overall Study|Withdrawal by Subject|3|||
146144852|NCT01687166|527043533|FG003|Overall Study|Withdrawal by Subject|0|||
146144853|NCT01687166|527043530|FG000|Overall Study|Lost to Follow-up|2|||
146144854|NCT01687166|527043531|FG001|Overall Study|Lost to Follow-up|5|||
146144855|NCT01687166|527043532|FG002|Overall Study|Lost to Follow-up|1|||
146144856|NCT01687166|527043533|FG003|Overall Study|Lost to Follow-up|0|||
146144857|NCT01687166|527043530|FG000|Overall Study|Equipment/Device Availability|0|||
146144858|NCT01687166|527043531|FG001|Overall Study|Equipment/Device Availability|1|||
146144859|NCT01687166|527043532|FG002|Overall Study|Equipment/Device Availability|0|||
146144860|NCT01687166|527043533|FG003|Overall Study|Equipment/Device Availability|0|||
146144861|NCT01687166|527043530|FG000|Overall Study|Death|1|||
146144862|NCT01687166|527043531|FG001|Overall Study|Death|1|||
146144863|NCT01687166|527043532|FG002|Overall Study|Death|0|||
146144864|NCT01687166|527043533|FG003|Overall Study|Death|0|||
146144865|NCT01687166|527043530|FG000|Overall Study|Protocol Violation|1|||
146144866|NCT01687166|527043531|FG001|Overall Study|Protocol Violation|1|||
146144867|NCT01687166|527043532|FG002|Overall Study|Protocol Violation|1|||
146144868|NCT01687166|527043533|FG003|Overall Study|Protocol Violation|0|||
146144869|NCT01687166|527043530|FG000|Overall Study|Subject moved out of state|0|||
146144870|NCT01687166|527043531|FG001|Overall Study|Subject moved out of state|1|||
146144871|NCT01687166|527043532|FG002|Overall Study|Subject moved out of state|0|||
146144872|NCT01687166|527043533|FG003|Overall Study|Subject moved out of state|0|||
146144873|NCT01687166|527043530|FG000|Overall Study|Patient unable to be compliant|1|||
146144874|NCT01687166|527043531|FG001|Overall Study|Patient unable to be compliant|0|||
146144875|NCT01687166|527043532|FG002|Overall Study|Patient unable to be compliant|0|||
146144876|NCT01687166|527043533|FG003|Overall Study|Patient unable to be compliant|0|||
146144877|NCT01687166|527043530|FG000|Overall Study|Physician choice to use different device|1|||
146144878|NCT01687166|527043531|FG001|Overall Study|Physician choice to use different device|2|||
146144879|NCT01687166|527043532|FG002|Overall Study|Physician choice to use different device|4|||
146144880|NCT01687166|527043533|FG003|Overall Study|Physician choice to use different device|0|||
146144881|NCT01687166|527043530|FG000|Overall Study|Insurance|0|||
146144882|NCT01687166|527043531|FG001|Overall Study|Insurance|0|||
146144883|NCT01687166|527043532|FG002|Overall Study|Insurance|1|||
146144884|NCT01687166|527043533|FG003|Overall Study|Insurance|1|||
146144885|NCT02755831|527043534|FG000|Overall Study|Lost to Follow-up|3|||
146144886|NCT02755831|527043535|FG001|Overall Study|Lost to Follow-up|3|||
146144887|NCT00298831|527043536|FG000|Overall Study|Adverse Event|1|||
146144888|NCT00298831|527043536|FG000|Overall Study|Lost to Follow-up|3|||
146144889|NCT00298831|527043536|FG000|Overall Study|Withdrawal by Subject|1|||
146144890|NCT00298831|527043536|FG000|Overall Study|Participants did not receive treatment|27|||
146274540|NCT01818531|527519850|FG000|Overall Study|Withdrawn for failure to place block|0|||
146274541|NCT01818531|527519851|FG001|Overall Study|Withdrawn for failure to place block|1|||
146274542|NCT01068665|527519852|FG000|Overall Study|Adverse Event|5|||
146274543|NCT01068665|527519853|FG001|Overall Study|Adverse Event|4|||
146274544|NCT01068665|527519852|FG000|Overall Study|Lack of Efficacy|0|||
146274545|NCT01068665|527519853|FG001|Overall Study|Lack of Efficacy|2|||
146274546|NCT01068665|527519852|FG000|Overall Study|Protocol Violation|5|||
146274547|NCT01068665|527519853|FG001|Overall Study|Protocol Violation|2|||
146274548|NCT01068665|527519852|FG000|Overall Study|Withdrawal Criteria|3|||
146274549|NCT01068665|527519853|FG001|Overall Study|Withdrawal Criteria|9|||
146274550|NCT01068665|527519852|FG000|Overall Study|Other|17|||
146304422|NCT00574288|527629212|FG005|Overall Study|Adverse Event|0|||
146144891|NCT01516879|527043537|FG000|Overall Study|Withdrawal by Subject|9|||
146144892|NCT01516879|527043538|FG001|Overall Study|Withdrawal by Subject|11|||
146144893|NCT01516879|527043537|FG000|Overall Study|Death|0|||
146144894|NCT01516879|527043538|FG001|Overall Study|Death|2|||
146144895|NCT01516879|527043537|FG000|Overall Study|Lost to Follow-up|2|||
146144896|NCT01516879|527043538|FG001|Overall Study|Lost to Follow-up|11|||
146274551|NCT01068665|527519853|FG001|Overall Study|Other|12|||
146274552|NCT01162863|527519856|FG000|Overall Study|Lack of Efficacy|1|||
146144897|NCT01516879|527043537|FG000|Overall Study|Other|5|||
146144898|NCT01516879|527043538|FG001|Overall Study|Other|10|||
146274553|NCT01162863|527519857|FG001|Overall Study|Lack of Efficacy|0|||
146274554|NCT01162863|527519858|FG002|Overall Study|Lack of Efficacy|0|||
146274555|NCT01162863|527519856|FG000|Overall Study|Adverse Event|0|||
146274556|NCT01162863|527519857|FG001|Overall Study|Adverse Event|1|||
146274557|NCT01162863|527519858|FG002|Overall Study|Adverse Event|0|||
146274558|NCT02992691|527519859|FG000|Overall Study|Adverse Event|2|||
146274559|NCT02992691|527519859|FG000|Overall Study|Withdrawal by Subject|1|||
146274560|NCT00588692|527519860|FG000|Overall Study|Withdrawal by Subject|4|||
146274561|NCT00588692|527519861|FG001|Overall Study|Withdrawal by Subject|2|||
146274562|NCT00588692|527519860|FG000|Overall Study|Hip Surgery|0|||
146274563|NCT00588692|527519861|FG001|Overall Study|Hip Surgery|1|||
146274564|NCT00588692|527519860|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
146274565|NCT00588692|527519861|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
146274566|NCT00588692|527519860|FG000|Overall Study|Cancer|1|||
146274567|NCT00588692|527519861|FG001|Overall Study|Cancer|0|||
146274568|NCT00588692|527519860|FG000|Overall Study|Death|1|||
146274569|NCT00588692|527519861|FG001|Overall Study|Death|0|||
146274570|NCT00392925|527519863|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
146274571|NCT00392925|527519864|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146274572|NCT00392925|527519865|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146274573|NCT00392925|527519866|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
146274574|NCT00392925|527519863|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
146274575|NCT00392925|527519864|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146274576|NCT00392925|527519865|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146274577|NCT00392925|527519866|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
146274578|NCT00392925|527519863|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
146274579|NCT00392925|527519864|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146274580|NCT00392925|527519865|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146274581|NCT00392925|527519866|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
146274582|NCT00392925|527519863|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
146274583|NCT00392925|527519864|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146274584|NCT00392925|527519865|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146274585|NCT00392925|527519866|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
146274586|NCT00392925|527519863|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
146274587|NCT00392925|527519864|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146274588|NCT00392925|527519865|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146274589|NCT00392925|527519866|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
146274590|NCT00392925|527519863|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
146274591|NCT00392925|527519864|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
146274592|NCT00392925|527519865|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
146274593|NCT00392925|527519866|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
146274594|NCT00392925|527519863|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
146274595|NCT00392925|527519864|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
146274596|NCT00392925|527519865|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
146274597|NCT00392925|527519866|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
146274598|NCT00392925|527519863|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
146274599|NCT00392925|527519864|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
146274600|NCT00392925|527519865|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
146274601|NCT00392925|527519866|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
146274602|NCT00392925|527519863|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
146274603|NCT00392925|527519864|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
146274604|NCT00392925|527519865|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
146274605|NCT00392925|527519866|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
146274606|NCT00820170|527519867|FG000|Overall Study|Adverse Event|0|||
146274607|NCT00820170|527519868|FG001|Overall Study|Adverse Event|0|||
146274608|NCT00820170|527519869|FG002|Overall Study|Adverse Event|0|||
146274609|NCT00820170|527519870|FG003|Overall Study|Adverse Event|0|||
146274610|NCT00820170|527519871|FG004|Overall Study|Adverse Event|2|||
146274611|NCT00820170|527519867|FG000|Overall Study|Progressive Disease|0|||
146144899|NCT02052466|527043539|FG000|Overall Study|Withdrawal by Subject|1|||
146144900|NCT02052466|527043539|FG000|Overall Study|Acromial fracture|1|||
146274612|NCT00820170|527519868|FG001|Overall Study|Progressive Disease|0|||
146274613|NCT00820170|527519869|FG002|Overall Study|Progressive Disease|0|||
146274614|NCT00820170|527519870|FG003|Overall Study|Progressive Disease|0|||
146274615|NCT00820170|527519871|FG004|Overall Study|Progressive Disease|2|||
146144901|NCT04568122|527043540|FG000|Overall Study|Lost to Follow-up|48|||
146274616|NCT03552523|527519872|FG000|Overall Study|Withdrawal by Subject|1|||
146144902|NCT04568122|527043541|FG001|Overall Study|Lost to Follow-up|44|||
146144903|NCT04568122|527043542|FG002|Overall Study|Lost to Follow-up|4|||
146144904|NCT04568122|527043543|FG003|Overall Study|Lost to Follow-up|0|||
146144905|NCT04568122|527043544|FG004|Overall Study|Lost to Follow-up|0|||
146144906|NCT02047604|527043552|FG000|Overall Study|Withdrawal by Subject|0|||
146144907|NCT02047604|527043553|FG001|Overall Study|Withdrawal by Subject|0|||
146144908|NCT02047604|527043554|FG002|Overall Study|Withdrawal by Subject|0|||
146144909|NCT02047604|527043555|FG003|Overall Study|Withdrawal by Subject|0|||
146144910|NCT02047604|527043556|FG004|Overall Study|Withdrawal by Subject|1|||
146144911|NCT02047604|527043557|FG005|Overall Study|Withdrawal by Subject|1|||
146144912|NCT00983814|527043559|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
146144913|NCT00983814|527043560|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
146144914|NCT00983814|527043561|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
146144915|NCT00983814|527043559|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
146144916|NCT00983814|527043560|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
146144917|NCT00983814|527043561|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
146144918|NCT00983814|527043559|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
146144919|NCT00983814|527043560|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
146144920|NCT00983814|527043561|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
146144921|NCT00983814|527043559|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
146144922|NCT00983814|527043560|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
146144923|NCT00983814|527043561|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
146144924|NCT00983814|527043559|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
146144925|NCT00983814|527043560|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
146144926|NCT00983814|527043561|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
146144927|NCT01994395|527043567|FG000|Overall Study|Withdrawal by Subject|1|||
146144928|NCT01994395|527043568|FG001|Overall Study|Withdrawal by Subject|2|||
146144929|NCT00459134|527043569|FG000|Overall Study|Physician Decision|1|||
146144930|NCT00459134|527043570|FG001|Overall Study|Physician Decision|1|||
146144931|NCT00459134|527043569|FG000|Overall Study|Withdrawal by Subject|8|||
146144932|NCT00459134|527043570|FG001|Overall Study|Withdrawal by Subject|7|||
146144933|NCT00459134|527043569|FG000|Overall Study|Lost to Follow-up|6|||
146144934|NCT00459134|527043570|FG001|Overall Study|Lost to Follow-up|7|||
146144935|NCT00459134|527043569|FG000|Overall Study|Surgery|1|||
146144936|NCT00459134|527043570|FG001|Overall Study|Surgery|2|||
146144937|NCT00459134|527043569|FG000|Overall Study|Toxicity|4|||
146144938|NCT00459134|527043570|FG001|Overall Study|Toxicity|5|||
146144939|NCT00459134|527043569|FG000|Overall Study|Progression|1|||
146144940|NCT00459134|527043570|FG001|Overall Study|Progression|0|||
146144941|NCT00459134|527043569|FG000|Overall Study|Multiple Reasons|2|||
146144942|NCT00459134|527043570|FG001|Overall Study|Multiple Reasons|3|||
146144943|NCT00829621|527043571|FG000|Overall Study|Death|1|||
146144944|NCT00829621|527043572|FG001|Overall Study|Death|0|||
146144945|NCT00829621|527043571|FG000|Overall Study|Lost to Follow-up|3|||
146144946|NCT00829621|527043572|FG001|Overall Study|Lost to Follow-up|4|||
146144947|NCT00441337|527043573|FG000|Overall Study|Disease Progression|6|||
146144948|NCT00441337|527043574|FG001|Overall Study|Disease Progression|6|||
146144949|NCT00441337|527043575|FG002|Overall Study|Disease Progression|4|||
146144950|NCT00441337|527043576|FG003|Overall Study|Disease Progression|18|||
146144951|NCT00441337|527043573|FG000|Overall Study|Lost to Follow-up|0|||
146144952|NCT00441337|527043574|FG001|Overall Study|Lost to Follow-up|0|||
146144953|NCT00441337|527043575|FG002|Overall Study|Lost to Follow-up|0|||
146144954|NCT00441337|527043576|FG003|Overall Study|Lost to Follow-up|1|||
146144955|NCT00441337|527043573|FG000|Overall Study|Sponsor Decision|0|||
146144956|NCT00441337|527043574|FG001|Overall Study|Sponsor Decision|0|||
146144957|NCT00441337|527043575|FG002|Overall Study|Sponsor Decision|1|||
146144958|NCT00441337|527043576|FG003|Overall Study|Sponsor Decision|2|||
146144959|NCT00441337|527043573|FG000|Overall Study|Did not meet inclusion criteria|0|||
146144960|NCT00441337|527043574|FG001|Overall Study|Did not meet inclusion criteria|0|||
146144961|NCT00441337|527043575|FG002|Overall Study|Did not meet inclusion criteria|1|||
146304423|NCT00574288|527629213|FG006|Overall Study|Adverse Event|0|||
146304424|NCT00574288|527629207|FG000|Overall Study|Death|0|||
146304425|NCT00574288|527629208|FG001|Overall Study|Death|0|||
146144962|NCT00441337|527043576|FG003|Overall Study|Did not meet inclusion criteria|0|||
146144963|NCT01818336|527045020|FG000|Overall Study|Declined retest visit|0|||
146144964|NCT01818336|527045021|FG001|Overall Study|Declined retest visit|11|||
146144965|NCT01818336|527045020|FG000|Overall Study|Lost to Follow-up|0|||
146144966|NCT01818336|527045021|FG001|Overall Study|Lost to Follow-up|1|||
146144967|NCT03042312|527045024|FG000|Overall Study|Administrative Reason|1|||
146144968|NCT03042312|527045025|FG001|Overall Study|Administrative Reason|1|||
146144969|NCT03042312|527045024|FG000|Overall Study|Adverse Event|0|||
146144970|NCT03042312|527045025|FG001|Overall Study|Adverse Event|1|||
146144971|NCT03042312|527045024|FG000|Overall Study|Lost to Follow-up|1|||
146144972|NCT03042312|527045025|FG001|Overall Study|Lost to Follow-up|3|||
146144973|NCT03042312|527045024|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
146144974|NCT03042312|527045025|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
146144975|NCT03042312|527045024|FG000|Overall Study|Withdrawal by Subject|4|||
146144976|NCT03042312|527045025|FG001|Overall Study|Withdrawal by Subject|5|||
146274617|NCT03552523|527519873|FG001|Overall Study|Withdrawal by Subject|1|||
146274618|NCT03538938|527519874|FG000|Overall Study|Death|0|||
146274619|NCT03538938|527519875|FG001|Overall Study|Death|0|||
146274620|NCT03538938|527519876|FG002|Overall Study|Death|2|||
146274621|NCT03538938|527519877|FG003|Overall Study|Death|0|||
146274622|NCT03538938|527519878|FG004|Overall Study|Death|0|||
146274623|NCT03538938|527519879|FG005|Overall Study|Death|1|||
146274624|NCT03538938|527519880|FG006|Overall Study|Death|0|||
146274625|NCT03538938|527519881|FG007|Overall Study|Death|1|||
146274626|NCT03538938|527519882|FG008|Overall Study|Death|1|||
146274627|NCT03538938|527519883|FG009|Overall Study|Death|1|||
146274628|NCT03538938|527519884|FG010|Overall Study|Death|0|||
146274629|NCT03538938|527519885|FG011|Overall Study|Death|0|||
146274630|NCT03538938|527519886|FG012|Overall Study|Death|1|||
146274631|NCT03538938|527519887|FG013|Overall Study|Death|1|||
146274632|NCT03538938|527519888|FG014|Overall Study|Death|0|||
146274633|NCT03538938|527519889|FG015|Overall Study|Death|1|||
146274634|NCT03538938|527519874|FG000|Overall Study|Withdrawal by Subject|4|||
146274635|NCT03538938|527519875|FG001|Overall Study|Withdrawal by Subject|6|||
146274636|NCT03538938|527519876|FG002|Overall Study|Withdrawal by Subject|5|||
146274637|NCT03538938|527519877|FG003|Overall Study|Withdrawal by Subject|3|||
146274638|NCT03538938|527519878|FG004|Overall Study|Withdrawal by Subject|0|||
146274639|NCT03538938|527519879|FG005|Overall Study|Withdrawal by Subject|0|||
146274640|NCT03538938|527519880|FG006|Overall Study|Withdrawal by Subject|3|||
146274641|NCT03538938|527519881|FG007|Overall Study|Withdrawal by Subject|1|||
146274642|NCT03538938|527519882|FG008|Overall Study|Withdrawal by Subject|5|||
146274643|NCT03538938|527519883|FG009|Overall Study|Withdrawal by Subject|1|||
146274644|NCT03538938|527519884|FG010|Overall Study|Withdrawal by Subject|2|||
146274645|NCT03538938|527519885|FG011|Overall Study|Withdrawal by Subject|1|||
146274646|NCT03538938|527519886|FG012|Overall Study|Withdrawal by Subject|3|||
146274647|NCT03538938|527519887|FG013|Overall Study|Withdrawal by Subject|0|||
146274648|NCT03538938|527519888|FG014|Overall Study|Withdrawal by Subject|2|||
146274649|NCT03538938|527519889|FG015|Overall Study|Withdrawal by Subject|4|||
146274650|NCT03538938|527519874|FG000|Overall Study|Incarcerated|0|||
146274651|NCT03538938|527519875|FG001|Overall Study|Incarcerated|0|||
146274652|NCT03538938|527519876|FG002|Overall Study|Incarcerated|0|||
146274653|NCT03538938|527519877|FG003|Overall Study|Incarcerated|0|||
146274654|NCT03538938|527519878|FG004|Overall Study|Incarcerated|0|||
146274655|NCT03538938|527519879|FG005|Overall Study|Incarcerated|0|||
146274656|NCT03538938|527519880|FG006|Overall Study|Incarcerated|0|||
146274657|NCT03538938|527519881|FG007|Overall Study|Incarcerated|0|||
146274658|NCT03538938|527519882|FG008|Overall Study|Incarcerated|0|||
146274659|NCT03538938|527519883|FG009|Overall Study|Incarcerated|0|||
146274660|NCT03538938|527519884|FG010|Overall Study|Incarcerated|0|||
146274661|NCT03538938|527519885|FG011|Overall Study|Incarcerated|1|||
146274662|NCT03538938|527519886|FG012|Overall Study|Incarcerated|0|||
146274663|NCT03538938|527519887|FG013|Overall Study|Incarcerated|0|||
146274664|NCT03538938|527519888|FG014|Overall Study|Incarcerated|0|||
146274665|NCT03538938|527519889|FG015|Overall Study|Incarcerated|0|||
146274666|NCT01361594|527519891|FG000|Overall Study|Withdrawal by Subject|1|||
146274667|NCT01361594|527519892|FG001|Overall Study|Withdrawal by Subject|2|||
146274668|NCT01518153|527519895|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
146274669|NCT01518153|527519896|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
146274670|NCT01518153|527519897|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
146274671|NCT01518153|527519895|FG000|Stem Cell Transplant|Death|2|||
146274672|NCT01518153|527519896|FG001|Stem Cell Transplant|Death|0|||
146274673|NCT01518153|527519897|FG002|Stem Cell Transplant|Death|0|||
146274674|NCT01518153|527519895|FG000|Stem Cell Transplant|Secondary graft failure|1|||
146144977|NCT02805257|527045030|FG000|Overall Study|Lost to Follow-up|7|||
146274675|NCT01518153|527519896|FG001|Stem Cell Transplant|Secondary graft failure|0|||
146274676|NCT01518153|527519897|FG002|Stem Cell Transplant|Secondary graft failure|0|||
146274677|NCT01518153|527519895|FG000|Stem Cell Transplant|Adverse Event|1|||
146274678|NCT01518153|527519896|FG001|Stem Cell Transplant|Adverse Event|0|||
146274679|NCT01518153|527519897|FG002|Stem Cell Transplant|Adverse Event|0|||
146274680|NCT01518153|527519895|FG000|Donor Lymphocyte Infusion|Death|0|||
146274681|NCT01518153|527519896|FG001|Donor Lymphocyte Infusion|Death|2|||
146274682|NCT01518153|527519897|FG002|Donor Lymphocyte Infusion|Death|1|||
146274683|NCT03083665|527519898|FG000|Double-Blind Period|Adverse Event|5|||
146274684|NCT03083665|527519899|FG001|Double-Blind Period|Adverse Event|4|||
146274685|NCT03083665|527519900|FG002|Double-Blind Period|Adverse Event|5|||
146274686|NCT03083665|527519901|FG003|Double-Blind Period|Adverse Event|0|||
146274687|NCT03083665|527519902|FG004|Double-Blind Period|Adverse Event|0|||
146274688|NCT03083665|527519903|FG005|Double-Blind Period|Adverse Event|0|||
146274689|NCT03083665|527519898|FG000|Double-Blind Period|Lack of Efficacy|0|||
146274690|NCT03083665|527519899|FG001|Double-Blind Period|Lack of Efficacy|0|||
146274691|NCT03083665|527519900|FG002|Double-Blind Period|Lack of Efficacy|1|||
146274692|NCT03083665|527519901|FG003|Double-Blind Period|Lack of Efficacy|0|||
146274693|NCT03083665|527519902|FG004|Double-Blind Period|Lack of Efficacy|0|||
146274694|NCT03083665|527519903|FG005|Double-Blind Period|Lack of Efficacy|0|||
146144978|NCT02805257|527045031|FG001|Overall Study|Lost to Follow-up|6|||
146144979|NCT02805257|527045030|FG000|Overall Study|Death|0|||
146144980|NCT02805257|527045031|FG001|Overall Study|Death|1|||
146144981|NCT01043874|527045033|FG000|Overall Study|Adverse Event|3|||
146144982|NCT01043874|527045033|FG000|Overall Study|Withdrawal by Subject|1|||
146144983|NCT01043874|527045033|FG000|Overall Study|Lack of Efficacy|1|||
146144984|NCT01043874|527045033|FG000|Overall Study|Administrative Problems|1|||
146144985|NCT01627249|527045039|FG000|Overall Study|Death|3|||
146144986|NCT01627249|527045040|FG001|Overall Study|Death|5|||
146144987|NCT01627249|527045041|FG002|Overall Study|Death|3|||
146144988|NCT01627249|527045039|FG000|Overall Study|Withdrawal by Subject|12|||
146144989|NCT01627249|527045040|FG001|Overall Study|Withdrawal by Subject|6|||
146144990|NCT01627249|527045041|FG002|Overall Study|Withdrawal by Subject|9|||
146144991|NCT01627249|527045039|FG000|Overall Study|Missed Visit|1|||
146144992|NCT01627249|527045040|FG001|Overall Study|Missed Visit|1|||
146144993|NCT01627249|527045041|FG002|Overall Study|Missed Visit|0|||
146274695|NCT03083665|527519898|FG000|Double-Blind Period|Protocol Violation|1|||
146274696|NCT03083665|527519899|FG001|Double-Blind Period|Protocol Violation|0|||
146274697|NCT03083665|527519900|FG002|Double-Blind Period|Protocol Violation|1|||
146274698|NCT03083665|527519901|FG003|Double-Blind Period|Protocol Violation|0|||
146274699|NCT03083665|527519902|FG004|Double-Blind Period|Protocol Violation|0|||
146274700|NCT03083665|527519903|FG005|Double-Blind Period|Protocol Violation|0|||
146274701|NCT03083665|527519898|FG000|Double-Blind Period|Lost to Follow-up|1|||
146274702|NCT03083665|527519899|FG001|Double-Blind Period|Lost to Follow-up|0|||
146274703|NCT03083665|527519900|FG002|Double-Blind Period|Lost to Follow-up|1|||
146274704|NCT03083665|527519901|FG003|Double-Blind Period|Lost to Follow-up|0|||
146274705|NCT03083665|527519902|FG004|Double-Blind Period|Lost to Follow-up|0|||
146274706|NCT03083665|527519903|FG005|Double-Blind Period|Lost to Follow-up|0|||
146274707|NCT03083665|527519898|FG000|Double-Blind Period|Withdrawal by Subject|3|||
146274708|NCT03083665|527519899|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146274709|NCT03083665|527519900|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146274710|NCT03083665|527519901|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146274711|NCT03083665|527519902|FG004|Double-Blind Period|Withdrawal by Subject|0|||
146274712|NCT03083665|527519903|FG005|Double-Blind Period|Withdrawal by Subject|0|||
146274713|NCT03083665|527519898|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
146274714|NCT03083665|527519899|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146274715|NCT03083665|527519900|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146274716|NCT03083665|527519901|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146274717|NCT03083665|527519902|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146274718|NCT03083665|527519903|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
146274719|NCT03083665|527519898|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
146274720|NCT03083665|527519899|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
146274721|NCT03083665|527519900|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
146274722|NCT03083665|527519901|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
146274723|NCT03083665|527519902|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
146274724|NCT03083665|527519903|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
146274725|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146274726|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146274727|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146274728|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
146274729|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146274730|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
146274731|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146274732|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146274733|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146274734|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146274735|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
146274736|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
146274737|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146274738|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146274739|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
146274740|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146274741|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146274742|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
146274743|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146274744|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146274745|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146144994|NCT03266588|527045042|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
146144995|NCT03266588|527045043|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
146144996|NCT03266588|527045044|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
146144997|NCT03266588|527045042|FG000|Observational Period|Withdrawal by Subject|44|||
146144998|NCT03266588|527045043|FG001|Observational Period|Withdrawal by Subject|22|||
146144999|NCT03266588|527045044|FG002|Observational Period|Withdrawal by Subject|13|||
146145000|NCT03266588|527045042|FG000|Observational Period|Non-compliance|18|||
146145001|NCT03266588|527045043|FG001|Observational Period|Non-compliance|12|||
146145002|NCT03266588|527045044|FG002|Observational Period|Non-compliance|10|||
146145003|NCT03266588|527045042|FG000|Observational Period|Lost to Follow-up|8|||
146145004|NCT03266588|527045043|FG001|Observational Period|Lost to Follow-up|12|||
146145005|NCT03266588|527045044|FG002|Observational Period|Lost to Follow-up|4|||
146145006|NCT03266588|527045042|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
146145007|NCT03266588|527045043|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
146145008|NCT03266588|527045044|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
146145009|NCT03266588|527045042|FG000|Observational Period|Protocol Deviation|1|||
146145010|NCT03266588|527045043|FG001|Observational Period|Protocol Deviation|0|||
146145011|NCT03266588|527045044|FG002|Observational Period|Protocol Deviation|0|||
146145012|NCT03266588|527045042|FG000|Observational Period|Other Reasons|3|||
146145013|NCT03266588|527045043|FG001|Observational Period|Other Reasons|0|||
146145014|NCT03266588|527045044|FG002|Observational Period|Other Reasons|1|||
146145015|NCT03266588|527045042|FG000|Long-term Treatment Period|Adverse Event|33|||
146145016|NCT03266588|527045043|FG001|Long-term Treatment Period|Adverse Event|17|||
146145017|NCT03266588|527045044|FG002|Long-term Treatment Period|Adverse Event|8|||
146145018|NCT03266588|527045042|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
146145019|NCT03266588|527045043|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
146145020|NCT03266588|527045044|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
146145021|NCT03266588|527045042|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
146145022|NCT03266588|527045043|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
146145023|NCT03266588|527045044|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
146145024|NCT03266588|527045042|FG000|Long-term Treatment Period|Non-Compliance|126|||
146145025|NCT03266588|527045043|FG001|Long-term Treatment Period|Non-Compliance|57|||
146145026|NCT03266588|527045044|FG002|Long-term Treatment Period|Non-Compliance|7|||
146145027|NCT03266588|527045042|FG000|Long-term Treatment Period|Pregnancy|11|||
146145028|NCT03266588|527045043|FG001|Long-term Treatment Period|Pregnancy|5|||
146145029|NCT03266588|527045044|FG002|Long-term Treatment Period|Pregnancy|0|||
146145030|NCT03266588|527045042|FG000|Long-term Treatment Period|Protocol Deviation|17|||
146145031|NCT03266588|527045043|FG001|Long-term Treatment Period|Protocol Deviation|10|||
146145032|NCT03266588|527045044|FG002|Long-term Treatment Period|Protocol Deviation|4|||
146145033|NCT03266588|527045042|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
146145034|NCT03266588|527045043|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
146145035|NCT03266588|527045044|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
146145036|NCT03266588|527045042|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
146145037|NCT03266588|527045043|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
146145038|NCT03266588|527045044|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
146145039|NCT03266588|527045042|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
146145040|NCT03266588|527045043|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
146145041|NCT03266588|527045044|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
146145042|NCT03266588|527045042|FG000|Long-term Treatment Period|Other Reasons|5|||
146145043|NCT03266588|527045043|FG001|Long-term Treatment Period|Other Reasons|0|||
146145044|NCT03266588|527045044|FG002|Long-term Treatment Period|Other Reasons|0|||
146145045|NCT03266588|527045042|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
146145046|NCT03266588|527045043|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
146145047|NCT03266588|527045044|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
146145048|NCT03087591|527045045|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
146145049|NCT03087591|527045045|FG000|Overall Study|Withdrawal by Subject|1|||
146145050|NCT00982319|527045054|FG000|Overall Study|Surgery date change|1|||
146145051|NCT00982319|527045055|FG001|Overall Study|Surgery date change|0|||
146145052|NCT00982319|527045054|FG000|Overall Study|Preop values out of acceptable range|1|||
146145053|NCT00982319|527045055|FG001|Overall Study|Preop values out of acceptable range|1|||
146145054|NCT00982319|527045054|FG000|Overall Study|Pregnancy|0|||
146145055|NCT00982319|527045055|FG001|Overall Study|Pregnancy|1|||
146145056|NCT03614793|527045057|FG000|Overall Study|Lost to Follow-up|1|||
146145057|NCT03614793|527045058|FG001|Overall Study|Lost to Follow-up|2|||
146145058|NCT03614793|527045057|FG000|Overall Study|Lack of Efficacy|0|||
146145059|NCT03614793|527045058|FG001|Overall Study|Lack of Efficacy|5|||
146145060|NCT03614793|527045057|FG000|Overall Study|Withdrawal by Subject|0|||
146145061|NCT03614793|527045058|FG001|Overall Study|Withdrawal by Subject|1|||
146145062|NCT03614793|527045057|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
146145063|NCT03614793|527045058|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
146145064|NCT02496884|527045059|FG000|Overall Study|Counted twice as enrolled|2|||
146145065|NCT02496884|527045060|FG001|Overall Study|Counted twice as enrolled|0|||
146145066|NCT02496884|527045061|FG002|Overall Study|Counted twice as enrolled|0|||
146145067|NCT02496884|527045062|FG003|Overall Study|Counted twice as enrolled|0|||
146274746|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146274747|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
146274748|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
146274749|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146274750|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146274751|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146274752|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
146274753|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146274754|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
146274755|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146274756|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146274757|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146274758|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146274759|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
146274760|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
146274761|NCT03083665|527519898|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146274762|NCT03083665|527519899|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146274763|NCT03083665|527519900|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146274764|NCT03083665|527519901|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146274765|NCT03083665|527519902|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
146274766|NCT03083665|527519903|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
146274767|NCT06285240|527519904|FG000|Overall Study|Withdrawal by Subject|2|||
146274768|NCT06285240|527519905|FG001|Overall Study|Withdrawal by Subject|0|||
146274769|NCT06285240|527519906|FG002|Overall Study|Withdrawal by Subject|0|||
146274770|NCT06285240|527519907|FG003|Overall Study|Withdrawal by Subject|0|||
146274771|NCT06285240|527519904|FG000|Overall Study|Serious Adverse Event|0|||
146274772|NCT06285240|527519905|FG001|Overall Study|Serious Adverse Event|0|||
146274773|NCT06285240|527519906|FG002|Overall Study|Serious Adverse Event|1|||
146274774|NCT06285240|527519907|FG003|Overall Study|Serious Adverse Event|0|||
146274775|NCT05140915|527519908|FG000|Overall Study|Lost to Follow-up|2|||
146274776|NCT05140915|527519909|FG001|Overall Study|Lost to Follow-up|1|||
146274777|NCT04485611|527519910|FG000|Prehabilitation|Physician Decision|1|||
146274778|NCT01647542|527519911|FG000|Overall Study|Major Protocol Deviation|1|||
146274779|NCT01647542|527519912|FG001|Overall Study|Major Protocol Deviation|0|||
146274780|NCT01647542|527519913|FG002|Overall Study|Major Protocol Deviation|0|||
146274781|NCT01647542|527519911|FG000|Overall Study|Adverse Event|4|||
146274782|NCT01647542|527519912|FG001|Overall Study|Adverse Event|5|||
146274783|NCT01647542|527519913|FG002|Overall Study|Adverse Event|4|||
146274784|NCT01647542|527519911|FG000|Overall Study|Lost to Follow-up|0|||
146274785|NCT01647542|527519912|FG001|Overall Study|Lost to Follow-up|2|||
146274786|NCT01647542|527519913|FG002|Overall Study|Lost to Follow-up|2|||
146274787|NCT01647542|527519911|FG000|Overall Study|Withdrawal by Subject|6|||
146274788|NCT01647542|527519912|FG001|Overall Study|Withdrawal by Subject|4|||
146274789|NCT01647542|527519913|FG002|Overall Study|Withdrawal by Subject|0|||
146274790|NCT01647542|527519911|FG000|Overall Study|Study Termination|64|||
146274791|NCT01647542|527519912|FG001|Overall Study|Study Termination|61|||
146274792|NCT01647542|527519913|FG002|Overall Study|Study Termination|65|||
146274793|NCT01647542|527519911|FG000|Overall Study|Lack of Efficacy|1|||
146274794|NCT01647542|527519912|FG001|Overall Study|Lack of Efficacy|1|||
146274795|NCT01647542|527519913|FG002|Overall Study|Lack of Efficacy|0|||
146274796|NCT01647542|527519911|FG000|Overall Study|Death|0|||
146274797|NCT01647542|527519912|FG001|Overall Study|Death|0|||
146274798|NCT01647542|527519913|FG002|Overall Study|Death|1|||
146274799|NCT01040169|527519914|FG000|Overall Study|Lost to Follow-up|3|||
146274800|NCT01040169|527519915|FG001|Overall Study|Lost to Follow-up|8|||
146274801|NCT00350727|527519916|FG000|Phase I: Dose Escalation|Adverse Event|4|||
146274802|NCT00350727|527519917|FG001|Phase I: Dose Escalation|Adverse Event|0|||
146274803|NCT00350727|527519918|FG002|Phase I: Dose Escalation|Adverse Event|0|||
146274804|NCT00350727|527519916|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
146274805|NCT00350727|527519917|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
146274806|NCT00350727|527519918|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
146274807|NCT00350727|527519916|FG000|Phase I: Dose Escalation|Death|1|||
146274808|NCT00350727|527519917|FG001|Phase I: Dose Escalation|Death|0|||
146274809|NCT00350727|527519918|FG002|Phase I: Dose Escalation|Death|0|||
146274810|NCT00350727|527519916|FG000|Phase I: Dose Escalation|Physician Decision|1|||
146274811|NCT00350727|527519917|FG001|Phase I: Dose Escalation|Physician Decision|0|||
146274812|NCT00350727|527519918|FG002|Phase I: Dose Escalation|Physician Decision|0|||
146274813|NCT00350727|527519916|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
146274814|NCT00350727|527519917|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
146274815|NCT00350727|527519918|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
146274816|NCT00350727|527519916|FG000|Phase II|Disease Progression|0|||
146274817|NCT00350727|527519917|FG001|Phase II|Disease Progression|15|||
146274818|NCT00350727|527519918|FG002|Phase II|Disease Progression|16|||
146274819|NCT00350727|527519916|FG000|Phase II|Clinical Deterioration|0|||
146274820|NCT00350727|527519917|FG001|Phase II|Clinical Deterioration|1|||
146274821|NCT00350727|527519918|FG002|Phase II|Clinical Deterioration|0|||
146274822|NCT00350727|527519916|FG000|Phase II|Withdrawal by Subject|0|||
146274823|NCT00350727|527519917|FG001|Phase II|Withdrawal by Subject|2|||
146274824|NCT00350727|527519918|FG002|Phase II|Withdrawal by Subject|1|||
146274825|NCT00350727|527519916|FG000|Phase II|Adverse Event|0|||
146274826|NCT00350727|527519917|FG001|Phase II|Adverse Event|1|||
146274827|NCT00350727|527519918|FG002|Phase II|Adverse Event|1|||
146274828|NCT00350727|527519916|FG000|Phase II|Death|0|||
146274829|NCT00350727|527519917|FG001|Phase II|Death|0|||
146274830|NCT00350727|527519918|FG002|Phase II|Death|2|||
146274831|NCT00350727|527519916|FG000|Phase II|Sponsor Terminated Study|0|||
146274832|NCT00350727|527519917|FG001|Phase II|Sponsor Terminated Study|0|||
146274833|NCT00350727|527519918|FG002|Phase II|Sponsor Terminated Study|1|||
146274834|NCT00350727|527519916|FG000|Phase II|Enrolled in Rollover Study|0|||
146274835|NCT00350727|527519917|FG001|Phase II|Enrolled in Rollover Study|0|||
146274836|NCT00350727|527519918|FG002|Phase II|Enrolled in Rollover Study|1|||
146274837|NCT03551691|527519923|FG000|Overall Study|Withdrawal by Subject|3|||
146274838|NCT03551691|527519924|FG001|Overall Study|Withdrawal by Subject|3|||
146274839|NCT02367040|527519925|FG000|Overall Study|Lost to Follow-up|1|||
146274840|NCT02367040|527519926|FG001|Overall Study|Lost to Follow-up|1|||
146274841|NCT02367040|527519925|FG000|Overall Study|Lack of Efficacy|1|||
146274842|NCT02367040|527519926|FG001|Overall Study|Lack of Efficacy|0|||
146274843|NCT02367040|527519925|FG000|Overall Study|Additional primary malignancy|1|||
146274844|NCT02367040|527519926|FG001|Overall Study|Additional primary malignancy|1|||
146274845|NCT02367040|527519925|FG000|Overall Study|AE not associated with clinical disease progression|117|||
146274846|NCT02367040|527519926|FG001|Overall Study|AE not associated with clinical disease progression|12|||
146274847|NCT02367040|527519925|FG000|Overall Study|AE associated with clinical disease progression|1|||
146274848|NCT02367040|527519926|FG001|Overall Study|AE associated with clinical disease progression|4|||
146274849|NCT02367040|527519925|FG000|Overall Study|Physician Decision|2|||
146274850|NCT02367040|527519926|FG001|Overall Study|Physician Decision|8|||
146274851|NCT02367040|527519925|FG000|Overall Study|Non-compliance to study drug|1|||
146274852|NCT02367040|527519926|FG001|Overall Study|Non-compliance to study drug|0|||
146274853|NCT02367040|527519925|FG000|Overall Study|Failure to meet continuation criteria|1|||
146274854|NCT02367040|527519926|FG001|Overall Study|Failure to meet continuation criteria|0|||
146274855|NCT02367040|527519925|FG000|Overall Study|Switching to other therapy|2|||
146274856|NCT02367040|527519926|FG001|Overall Study|Switching to other therapy|0|||
146274857|NCT02367040|527519925|FG000|Overall Study|Withdrawal by Subject|51|||
146274858|NCT02367040|527519926|FG001|Overall Study|Withdrawal by Subject|16|||
146274859|NCT02367040|527519925|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
146274860|NCT02367040|527519926|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146274861|NCT02367040|527519925|FG000|Overall Study|Patient decision|40|||
146274862|NCT02367040|527519926|FG001|Overall Study|Patient decision|14|||
146274863|NCT02367040|527519925|FG000|Overall Study|Required procedure failed|1|||
146274864|NCT02367040|527519926|FG001|Overall Study|Required procedure failed|0|||
146274865|NCT02367040|527519925|FG000|Overall Study|Randomized by mistake with study treatment|1|||
146274866|NCT02367040|527519926|FG001|Overall Study|Randomized by mistake with study treatment|0|||
146274867|NCT02367040|527519925|FG000|Overall Study|Protocol Violation|1|||
146274868|NCT02367040|527519926|FG001|Overall Study|Protocol Violation|0|||
146274869|NCT02367040|527519925|FG000|Overall Study|Progressive disease - radiological progression|54|||
146274870|NCT02367040|527519926|FG001|Overall Study|Progressive disease - radiological progression|80|||
146274871|NCT02367040|527519925|FG000|Overall Study|Progressive disease - clinical progression|6|||
146274872|NCT02367040|527519926|FG001|Overall Study|Progressive disease - clinical progression|6|||
146274873|NCT02367040|527519925|FG000|Overall Study|Drug not administered|3|||
146274874|NCT02367040|527519926|FG001|Overall Study|Drug not administered|2|||
146274875|NCT02367040|527519925|FG000|Overall Study|Progressive disease|0|||
146274876|NCT02367040|527519926|FG001|Overall Study|Progressive disease|1|||
146274877|NCT02367040|527519925|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
146274878|NCT02367040|527519926|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
146274879|NCT02367040|527519925|FG000|Overall Study|Death|2|||
146274880|NCT02367040|527519926|FG001|Overall Study|Death|0|||
146274881|NCT02367040|527519925|FG000|Overall Study|Study terminated by sponsor|19|||
146274882|NCT02367040|527519926|FG001|Overall Study|Study terminated by sponsor|2|||
146274883|NCT02994069|527519930|FG000|Overall Study|Death|7|||
146274884|NCT02994069|527519931|FG001|Overall Study|Death|13|||
146274885|NCT02994069|527519930|FG000|Overall Study|Adverse Event|1|||
146274886|NCT02994069|527519931|FG001|Overall Study|Adverse Event|0|||
146274887|NCT02994069|527519930|FG000|Overall Study|Other|2|||
146274888|NCT02994069|527519931|FG001|Overall Study|Other|0|||
146274889|NCT02994069|527519930|FG000|Overall Study|still on follow up/treatment|5|||
146274890|NCT02994069|527519931|FG001|Overall Study|still on follow up/treatment|6|||
146274891|NCT01876082|527521346|FG000|Overall Study|Withdrawal by Subject|0|||
146274892|NCT01876082|527521347|FG001|Overall Study|Withdrawal by Subject|2|||
146274893|NCT01876082|527521346|FG000|Overall Study|Protocol Violation|1|||
146274894|NCT01876082|527521347|FG001|Overall Study|Protocol Violation|0|||
146274895|NCT01876082|527521346|FG000|Overall Study|Adverse Event|1|||
146274896|NCT01876082|527521347|FG001|Overall Study|Adverse Event|1|||
146274897|NCT01876082|527521346|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
146274898|NCT01876082|527521347|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
146274899|NCT02964013|527521348|FG000|Overall Study|Death|58|||
146274900|NCT02964013|527521349|FG001|Overall Study|Death|239|||
146274901|NCT02964013|527521350|FG002|Overall Study|Death|38|||
146274902|NCT02964013|527521351|FG003|Overall Study|Death|10|||
146274903|NCT02964013|527521352|FG004|Overall Study|Death|33|||
146274904|NCT02964013|527521348|FG000|Overall Study|Lost to Follow-up|1|||
146274905|NCT02964013|527521349|FG001|Overall Study|Lost to Follow-up|4|||
146274906|NCT02964013|527521350|FG002|Overall Study|Lost to Follow-up|2|||
146274907|NCT02964013|527521351|FG003|Overall Study|Lost to Follow-up|0|||
146274908|NCT02964013|527521352|FG004|Overall Study|Lost to Follow-up|0|||
146274909|NCT02964013|527521348|FG000|Overall Study|Physician Decision|0|||
146274910|NCT02964013|527521349|FG001|Overall Study|Physician Decision|1|||
146274911|NCT02964013|527521350|FG002|Overall Study|Physician Decision|0|||
146274912|NCT02964013|527521351|FG003|Overall Study|Physician Decision|0|||
146274913|NCT02964013|527521352|FG004|Overall Study|Physician Decision|0|||
146274914|NCT02964013|527521348|FG000|Overall Study|Sponsor Decision|3|||
146274915|NCT02964013|527521349|FG001|Overall Study|Sponsor Decision|22|||
146274916|NCT02964013|527521350|FG002|Overall Study|Sponsor Decision|11|||
146274917|NCT02964013|527521351|FG003|Overall Study|Sponsor Decision|0|||
146274918|NCT02964013|527521352|FG004|Overall Study|Sponsor Decision|7|||
146274919|NCT02964013|527521348|FG000|Overall Study|Withdrawal by Subject|6|||
146145068|NCT02496884|527045059|FG000|Overall Study|Withdrawal by Subject|0|||
146145069|NCT02496884|527045060|FG001|Overall Study|Withdrawal by Subject|3|||
146145070|NCT02496884|527045061|FG002|Overall Study|Withdrawal by Subject|0|||
146145071|NCT02496884|527045062|FG003|Overall Study|Withdrawal by Subject|0|||
146145072|NCT00097591|527045063|FG000|Overall Study|Withdrawal of consent|342|||
146145073|NCT00097591|527045064|FG001|Overall Study|Withdrawal of consent|323|||
146145074|NCT00097591|527045063|FG000|Overall Study|Less than 6 months on study drug|9|||
146145075|NCT00097591|527045064|FG001|Overall Study|Less than 6 months on study drug|7|||
146145076|NCT00097591|527045063|FG000|Overall Study|Unable to attend termination visit|53|||
146145077|NCT00097591|527045064|FG001|Overall Study|Unable to attend termination visit|51|||
146145078|NCT00097591|527045063|FG000|Overall Study|Lost to follow up|6|||
146145079|NCT00097591|527045064|FG001|Overall Study|Lost to follow up|10|||
146145080|NCT00097591|527045063|FG000|Overall Study|Other|0|||
146145081|NCT00097591|527045064|FG001|Overall Study|Other|3|||
146145082|NCT01168999|527045069|FG000|Overall Study|Lost to Follow-up|2|||
146145083|NCT01168999|527045070|FG001|Overall Study|Lost to Follow-up|1|||
146145084|NCT01168999|527045071|FG002|Overall Study|Lost to Follow-up|0|||
146145085|NCT01168999|527045072|FG003|Overall Study|Lost to Follow-up|0|||
146145086|NCT04317586|527045073|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
146145087|NCT04317586|527045073|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
146145088|NCT01276327|527045074|FG000|Overall Study|Adverse Event|1|||
146145089|NCT01276327|527045075|FG001|Overall Study|Adverse Event|3|||
146145090|NCT01276327|527045074|FG000|Overall Study|Withdrawal by Subject|1|||
146145091|NCT01276327|527045075|FG001|Overall Study|Withdrawal by Subject|0|||
146145092|NCT00807092|527045076|FG000|Overall Study|Adverse Event|0|||
146145093|NCT00807092|527045077|FG001|Overall Study|Adverse Event|1|||
146145094|NCT00807092|527045076|FG000|Overall Study|Protocol Violation|0|||
146145095|NCT00807092|527045077|FG001|Overall Study|Protocol Violation|2|||
146145096|NCT00807092|527045076|FG000|Overall Study|Withdrawal by Subject|1|||
146145097|NCT00807092|527045077|FG001|Overall Study|Withdrawal by Subject|0|||
146145098|NCT00807092|527045076|FG000|Overall Study|CGMS data collection failed|0|||
146145099|NCT00807092|527045077|FG001|Overall Study|CGMS data collection failed|1|||
146145100|NCT01794949|527045078|FG000|Overall Study|Lost to Follow-up|1|||
146274920|NCT02964013|527521349|FG001|Overall Study|Withdrawal by Subject|27|||
146274921|NCT02964013|527521350|FG002|Overall Study|Withdrawal by Subject|9|||
146145101|NCT01794949|527045079|FG001|Overall Study|Lost to Follow-up|0|||
146145102|NCT03003676|527045080|FG000|Overall Study|Lack of Efficacy|5|||
146145103|NCT03003676|527045081|FG001|Overall Study|Lack of Efficacy|7|||
146274922|NCT02964013|527521351|FG003|Overall Study|Withdrawal by Subject|0|||
146274923|NCT02964013|527521352|FG004|Overall Study|Withdrawal by Subject|0|||
146274924|NCT02964013|527521348|FG000|Overall Study|Not Treated|0|||
146274925|NCT02964013|527521349|FG001|Overall Study|Not Treated|2|||
146274926|NCT02964013|527521350|FG002|Overall Study|Not Treated|0|||
146145104|NCT03003676|527045080|FG000|Overall Study|Withdrawal by Subject|0|||
146145105|NCT03003676|527045081|FG001|Overall Study|Withdrawal by Subject|1|||
146145106|NCT03003676|527045080|FG000|Overall Study|Hepatitis B infection|1|||
146274927|NCT02964013|527521351|FG003|Overall Study|Not Treated|1|||
146145107|NCT03003676|527045081|FG001|Overall Study|Hepatitis B infection|0|||
146274928|NCT02964013|527521352|FG004|Overall Study|Not Treated|0|||
146145108|NCT03766646|527045082|FG000|Overall Study|Withdrawal by Subject|1|||
146145109|NCT03766646|527045083|FG001|Overall Study|Withdrawal by Subject|0|||
146145110|NCT03766646|527045082|FG000|Overall Study|Protocol Violation|0|||
146145111|NCT03766646|527045083|FG001|Overall Study|Protocol Violation|3|||
146145112|NCT01931839|527045093|FG000|Overall Study|Death|0|||
146145113|NCT01931839|527045094|FG001|Overall Study|Death|1|||
146145114|NCT01931839|527045095|FG002|Overall Study|Death|2|||
146145115|NCT01931839|527045096|FG003|Overall Study|Death|0|||
146145116|NCT01931839|527045097|FG004|Overall Study|Death|0|||
146145117|NCT01931839|527045098|FG005|Overall Study|Death|0|||
146145118|NCT01931839|527045099|FG006|Overall Study|Death|0|||
146145119|NCT01931839|527045093|FG000|Overall Study|Physician Decision|1|||
146145120|NCT01931839|527045094|FG001|Overall Study|Physician Decision|0|||
146145121|NCT01931839|527045095|FG002|Overall Study|Physician Decision|1|||
146145122|NCT01931839|527045096|FG003|Overall Study|Physician Decision|0|||
146145123|NCT01931839|527045097|FG004|Overall Study|Physician Decision|0|||
146145124|NCT01931839|527045098|FG005|Overall Study|Physician Decision|0|||
146145125|NCT01931839|527045099|FG006|Overall Study|Physician Decision|1|||
146145126|NCT01931839|527045093|FG000|Overall Study|Withdrawal of consent|0|||
146145127|NCT01931839|527045094|FG001|Overall Study|Withdrawal of consent|0|||
146145128|NCT01931839|527045095|FG002|Overall Study|Withdrawal of consent|0|||
146145129|NCT01931839|527045096|FG003|Overall Study|Withdrawal of consent|0|||
146145130|NCT01931839|527045097|FG004|Overall Study|Withdrawal of consent|1|||
146145131|NCT01931839|527045098|FG005|Overall Study|Withdrawal of consent|0|||
146145132|NCT01931839|527045099|FG006|Overall Study|Withdrawal of consent|0|||
146145133|NCT01931839|527045093|FG000|Overall Study|Adverse Event|9|||
146145134|NCT01931839|527045094|FG001|Overall Study|Adverse Event|4|||
146145135|NCT01931839|527045095|FG002|Overall Study|Adverse Event|1|||
146145136|NCT01931839|527045096|FG003|Overall Study|Adverse Event|3|||
146145137|NCT01931839|527045097|FG004|Overall Study|Adverse Event|0|||
146145138|NCT01931839|527045098|FG005|Overall Study|Adverse Event|0|||
146145139|NCT01931839|527045099|FG006|Overall Study|Adverse Event|1|||
146145140|NCT01931839|527045093|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
146145141|NCT01931839|527045094|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
146145142|NCT01931839|527045095|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
146145143|NCT01931839|527045096|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
146145144|NCT01931839|527045097|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
146145145|NCT01931839|527045098|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
146145146|NCT01931839|527045099|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
146145147|NCT01931839|527045093|FG000|Overall Study|Other non-compliance|15|||
146145148|NCT01931839|527045094|FG001|Overall Study|Other non-compliance|9|||
146145149|NCT01931839|527045095|FG002|Overall Study|Other non-compliance|12|||
146145150|NCT01931839|527045096|FG003|Overall Study|Other non-compliance|3|||
146145151|NCT01931839|527045097|FG004|Overall Study|Other non-compliance|0|||
146145152|NCT01931839|527045098|FG005|Overall Study|Other non-compliance|3|||
146145153|NCT01931839|527045099|FG006|Overall Study|Other non-compliance|0|||
146145154|NCT01931839|527045093|FG000|Overall Study|Lost to Follow-up|1|||
146145155|NCT01931839|527045094|FG001|Overall Study|Lost to Follow-up|2|||
146145156|NCT01931839|527045095|FG002|Overall Study|Lost to Follow-up|4|||
146145157|NCT01931839|527045096|FG003|Overall Study|Lost to Follow-up|5|||
146145158|NCT01931839|527045097|FG004|Overall Study|Lost to Follow-up|0|||
146145159|NCT01931839|527045098|FG005|Overall Study|Lost to Follow-up|0|||
146145160|NCT01931839|527045099|FG006|Overall Study|Lost to Follow-up|0|||
146145161|NCT01931839|527045093|FG000|Overall Study|Other|4|||
146145162|NCT01931839|527045094|FG001|Overall Study|Other|2|||
146145163|NCT01931839|527045095|FG002|Overall Study|Other|6|||
146145164|NCT01931839|527045096|FG003|Overall Study|Other|0|||
146145165|NCT01931839|527045097|FG004|Overall Study|Other|0|||
146145166|NCT01931839|527045098|FG005|Overall Study|Other|0|||
146145167|NCT01931839|527045099|FG006|Overall Study|Other|0|||
146145168|NCT03224468|527045105|FG000|Overall Study|Did not obtain MM card|53|||
146145169|NCT03224468|527045106|FG001|Overall Study|Did not obtain MM card|0|||
146145170|NCT03224468|527045105|FG000|Overall Study|Lost to Follow-up|4|||
146145171|NCT03224468|527045106|FG001|Overall Study|Lost to Follow-up|11|||
146145172|NCT03224468|527045105|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
146145173|NCT03224468|527045106|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
146145174|NCT01978119|527045107|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
146145175|NCT01978119|527045108|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
146145176|NCT01978119|527045107|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
146145177|NCT01978119|527045108|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146145178|NCT01978119|527045107|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146145179|NCT01978119|527045108|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
146145180|NCT00812812|527045109|FG000|Overall Study|Adverse Event|2|||
146145181|NCT00812812|527045110|FG001|Overall Study|Adverse Event|1|||
146145182|NCT00812812|527045109|FG000|Overall Study|Lack of Efficacy|1|||
146145183|NCT00812812|527045110|FG001|Overall Study|Lack of Efficacy|0|||
146145184|NCT00812812|527045109|FG000|Overall Study|Lost to Follow-up|0|||
146145185|NCT00812812|527045110|FG001|Overall Study|Lost to Follow-up|1|||
146145186|NCT00812812|527045109|FG000|Overall Study|Withdrawal by Subject|0|||
146145187|NCT00812812|527045110|FG001|Overall Study|Withdrawal by Subject|2|||
146145188|NCT01877421|527045111|FG000|Phase 2|Lost to Follow-up|0|||
146145189|NCT01877421|527045112|FG001|Phase 2|Lost to Follow-up|0|||
146145190|NCT01877421|527045113|FG002|Phase 2|Lost to Follow-up|0|||
146145191|NCT01877421|527045114|FG003|Phase 2|Lost to Follow-up|0|||
146274929|NCT03284229|527521353|FG000|Overall Study|Lost to Follow-up|3|||
146274930|NCT01498887|527521354|FG000|Overall Study|Administrative problems|1|||
146274931|NCT01498887|527521355|FG001|Overall Study|Administrative problems|0|||
146274932|NCT01498887|527521354|FG000|Overall Study|Lost to Follow-up|1|||
146274933|NCT01498887|527521355|FG001|Overall Study|Lost to Follow-up|1|||
146274934|NCT01498887|527521354|FG000|Overall Study|Withdrawal by Subject|1|||
146274935|NCT01498887|527521355|FG001|Overall Study|Withdrawal by Subject|0|||
146274936|NCT01498887|527521354|FG000|Overall Study|Protocol Violation|1|||
146274937|NCT01498887|527521355|FG001|Overall Study|Protocol Violation|3|||
146274938|NCT01498887|527521354|FG000|Overall Study|Lack of Efficacy|5|||
146274939|NCT01498887|527521355|FG001|Overall Study|Lack of Efficacy|3|||
146274940|NCT01498887|527521354|FG000|Overall Study|Abnormal result from test procedure|1|||
146274941|NCT01498887|527521355|FG001|Overall Study|Abnormal result from test procedure|1|||
146274942|NCT01498887|527521354|FG000|Overall Study|Abnormal laboratory value|2|||
146274943|NCT01498887|527521355|FG001|Overall Study|Abnormal laboratory value|2|||
146274944|NCT01498887|527521354|FG000|Overall Study|Adverse Event|4|||
146274945|NCT01498887|527521355|FG001|Overall Study|Adverse Event|1|||
146274946|NCT00667225|527521358|FG000|Overall Study|Subject had no more lesions to treat.|1|||
146274947|NCT00667225|527521359|FG001|Overall Study|Subject had no more lesions to treat.|0|||
146274948|NCT00667225|527521358|FG000|Overall Study|Lost to Follow-up|0|||
146274949|NCT00667225|527521359|FG001|Overall Study|Lost to Follow-up|1|||
146274950|NCT02993406|527521366|FG000|Overall Study|Withdrawal by Subject|170|||
146274951|NCT02993406|527521367|FG001|Overall Study|Withdrawal by Subject|196|||
146274952|NCT02993406|527521366|FG000|Overall Study|Physician Decision|3|||
146274953|NCT02993406|527521367|FG001|Overall Study|Physician Decision|5|||
146274954|NCT02993406|527521366|FG000|Overall Study|Lost to Follow-up|12|||
146274955|NCT02993406|527521367|FG001|Overall Study|Lost to Follow-up|13|||
146274956|NCT02993406|527521366|FG000|Overall Study|Unclassifiable Response|105|||
146274957|NCT02993406|527521367|FG001|Overall Study|Unclassifiable Response|139|||
146274958|NCT02993406|527521366|FG000|Overall Study|Administrative decision|1|||
146274959|NCT02993406|527521367|FG001|Overall Study|Administrative decision|0|||
146274960|NCT02993406|527521366|FG000|Overall Study|Sponsor decision|4|||
146274961|NCT02993406|527521367|FG001|Overall Study|Sponsor decision|5|||
146274962|NCT03563157|527521368|FG000|Overall Study|Progressive Disease|2|||
146274963|NCT02248818|527521369|FG000|Screening|Protocol Violation|0|||
146274964|NCT02248818|527521370|FG001|Screening|Protocol Violation|0|||
146274965|NCT02248818|527521371|FG002|Screening|Protocol Violation|0|||
146274966|NCT02248818|527521372|FG003|Screening|Protocol Violation|0|||
146274967|NCT02248818|527521373|FG004|Screening|Protocol Violation|0|||
146274968|NCT02248818|527521374|FG005|Screening|Protocol Violation|0|||
146274969|NCT02248818|527521375|FG006|Screening|Protocol Violation|0|||
146274970|NCT02248818|527521376|FG007|Screening|Protocol Violation|0|||
146274971|NCT02248818|527521377|FG008|Screening|Protocol Violation|7|||
146274972|NCT02248818|527521369|FG000|Screening|Study fully enrolled|0|||
146274973|NCT02248818|527521370|FG001|Screening|Study fully enrolled|0|||
146274974|NCT02248818|527521371|FG002|Screening|Study fully enrolled|0|||
146274975|NCT02248818|527521372|FG003|Screening|Study fully enrolled|0|||
146274976|NCT02248818|527521373|FG004|Screening|Study fully enrolled|0|||
146274977|NCT02248818|527521374|FG005|Screening|Study fully enrolled|0|||
146274978|NCT02248818|527521375|FG006|Screening|Study fully enrolled|0|||
146274979|NCT02248818|527521376|FG007|Screening|Study fully enrolled|0|||
146274980|NCT02248818|527521377|FG008|Screening|Study fully enrolled|14|||
146274981|NCT02248818|527521369|FG000|Screening|Physician Decision|0|||
146274982|NCT02248818|527521370|FG001|Screening|Physician Decision|0|||
146274983|NCT02248818|527521371|FG002|Screening|Physician Decision|0|||
146274984|NCT02248818|527521372|FG003|Screening|Physician Decision|0|||
146274985|NCT02248818|527521373|FG004|Screening|Physician Decision|0|||
146274986|NCT02248818|527521374|FG005|Screening|Physician Decision|0|||
146274987|NCT02248818|527521375|FG006|Screening|Physician Decision|0|||
146274988|NCT02248818|527521376|FG007|Screening|Physician Decision|0|||
146274989|NCT02248818|527521377|FG008|Screening|Physician Decision|73|||
146274990|NCT02248818|527521369|FG000|Screening|Withdrawal by Subject|0|||
146274991|NCT02248818|527521370|FG001|Screening|Withdrawal by Subject|0|||
146274992|NCT02248818|527521371|FG002|Screening|Withdrawal by Subject|0|||
146274993|NCT02248818|527521372|FG003|Screening|Withdrawal by Subject|0|||
146145192|NCT01877421|527045115|FG004|Phase 2|Lost to Follow-up|0|||
146274994|NCT02248818|527521373|FG004|Screening|Withdrawal by Subject|0|||
146274995|NCT02248818|527521374|FG005|Screening|Withdrawal by Subject|0|||
146274996|NCT02248818|527521375|FG006|Screening|Withdrawal by Subject|0|||
146145193|NCT01877421|527045116|FG005|Phase 2|Lost to Follow-up|0|||
146274997|NCT02248818|527521376|FG007|Screening|Withdrawal by Subject|0|||
146274998|NCT02248818|527521377|FG008|Screening|Withdrawal by Subject|6|||
146274999|NCT02248818|527521369|FG000|Screening|Lost to Follow-up|0|||
146275000|NCT02248818|527521370|FG001|Screening|Lost to Follow-up|0|||
146275001|NCT02248818|527521371|FG002|Screening|Lost to Follow-up|0|||
146275002|NCT02248818|527521372|FG003|Screening|Lost to Follow-up|0|||
146275003|NCT02248818|527521373|FG004|Screening|Lost to Follow-up|0|||
146275004|NCT02248818|527521374|FG005|Screening|Lost to Follow-up|0|||
146275005|NCT02248818|527521375|FG006|Screening|Lost to Follow-up|0|||
146275006|NCT02248818|527521376|FG007|Screening|Lost to Follow-up|0|||
146275007|NCT02248818|527521377|FG008|Screening|Lost to Follow-up|7|||
146275008|NCT02248818|527521369|FG000|Randomised Study|Administrative - randomization error|0|||
146275009|NCT02248818|527521370|FG001|Randomised Study|Administrative - randomization error|0|||
146275010|NCT02248818|527521371|FG002|Randomised Study|Administrative - randomization error|0|||
146275011|NCT02248818|527521372|FG003|Randomised Study|Administrative - randomization error|0|||
146275012|NCT02248818|527521373|FG004|Randomised Study|Administrative - randomization error|0|||
146275013|NCT02248818|527521374|FG005|Randomised Study|Administrative - randomization error|8|||
146275014|NCT02248818|527521375|FG006|Randomised Study|Administrative - randomization error|0|||
146275015|NCT02248818|527521376|FG007|Randomised Study|Administrative - randomization error|0|||
146275016|NCT02248818|527521377|FG008|Randomised Study|Administrative - randomization error|0|||
146275017|NCT01283152|527521378|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
146275018|NCT01283152|527521379|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
146275019|NCT01283152|527521378|FG000|Overall Study|Refused HESA|1|||
146275020|NCT01283152|527521379|FG001|Overall Study|Refused HESA|0|||
146275021|NCT00626197|527521380|FG000|Overall Study|Did not cooperate|2|||
146275022|NCT00626197|527521381|FG001|Overall Study|Did not cooperate|6|||
146275023|NCT00626197|527521382|FG002|Overall Study|Did not cooperate|1|||
146275024|NCT00626197|527521380|FG000|Overall Study|Failure to return|6|||
146275025|NCT00626197|527521381|FG001|Overall Study|Failure to return|5|||
146275026|NCT00626197|527521382|FG002|Overall Study|Failure to return|6|||
146275027|NCT00626197|527521380|FG000|Overall Study|Adverse event, serious fatal|3|||
146275028|NCT00626197|527521381|FG001|Overall Study|Adverse event, serious fatal|6|||
146275029|NCT00626197|527521382|FG002|Overall Study|Adverse event, serious fatal|6|||
146275030|NCT00626197|527521380|FG000|Overall Study|Adverse Event|1|||
146275031|NCT00626197|527521381|FG001|Overall Study|Adverse Event|1|||
146275032|NCT00626197|527521382|FG002|Overall Study|Adverse Event|2|||
146275033|NCT00626197|527521380|FG000|Overall Study|Withdrawal by Subject|17|||
146275034|NCT00626197|527521381|FG001|Overall Study|Withdrawal by Subject|17|||
146275035|NCT00626197|527521382|FG002|Overall Study|Withdrawal by Subject|7|||
146275036|NCT00626197|527521380|FG000|Overall Study|Administrative reasons|15|||
146275037|NCT00626197|527521381|FG001|Overall Study|Administrative reasons|19|||
146275038|NCT00626197|527521382|FG002|Overall Study|Administrative reasons|55|||
146275039|NCT03809039|527521392|FG000|Part 1|Withdrawal by Subject|1|||
146275040|NCT03809039|527521393|FG001|Part 1|Withdrawal by Subject|0|||
146275041|NCT03809039|527521394|FG002|Part 1|Withdrawal by Subject|0|||
146275042|NCT03809039|527521395|FG003|Part 1|Withdrawal by Subject|1|||
146275043|NCT03809039|527521396|FG004|Part 1|Withdrawal by Subject|0|||
146275044|NCT03809039|527521397|FG005|Part 1|Withdrawal by Subject|0|||
146275045|NCT03809039|527521398|FG006|Part 1|Withdrawal by Subject|0|||
146275046|NCT03809039|527521399|FG007|Part 1|Withdrawal by Subject|0|||
146275047|NCT03809039|527521400|FG008|Part 1|Withdrawal by Subject|0|||
146275048|NCT03809039|527521392|FG000|Part 3|Withdrawn by study termination|0|||
146275049|NCT03809039|527521393|FG001|Part 3|Withdrawn by study termination|0|||
146275050|NCT03809039|527521394|FG002|Part 3|Withdrawn by study termination|0|||
146275051|NCT03809039|527521395|FG003|Part 3|Withdrawn by study termination|0|||
146275052|NCT03809039|527521396|FG004|Part 3|Withdrawn by study termination|0|||
146275053|NCT03809039|527521397|FG005|Part 3|Withdrawn by study termination|0|||
146275054|NCT03809039|527521398|FG006|Part 3|Withdrawn by study termination|0|||
146275055|NCT03809039|527521399|FG007|Part 3|Withdrawn by study termination|2|||
146275056|NCT03809039|527521400|FG008|Part 3|Withdrawn by study termination|6|||
146275057|NCT02476175|527521403|FG000|Overall Study|Adverse Event|2|||
146275058|NCT01399697|527521404|FG000|Overall Study|Adverse Event|13|||
146275059|NCT01399697|527521405|FG001|Overall Study|Adverse Event|3|||
146275060|NCT01399697|527521406|FG002|Overall Study|Adverse Event|1|||
146275061|NCT01399697|527521404|FG000|Overall Study|Lost to Follow-up|2|||
146275062|NCT01399697|527521405|FG001|Overall Study|Lost to Follow-up|0|||
146275063|NCT01399697|527521406|FG002|Overall Study|Lost to Follow-up|0|||
146275064|NCT01399697|527521404|FG000|Overall Study|Withdrawal by Subject|8|||
146275065|NCT01399697|527521405|FG001|Overall Study|Withdrawal by Subject|0|||
146275066|NCT01399697|527521406|FG002|Overall Study|Withdrawal by Subject|0|||
146275067|NCT01399697|527521404|FG000|Overall Study|Investigator Decisión|1|||
146275068|NCT01399697|527521405|FG001|Overall Study|Investigator Decisión|0|||
146275069|NCT01399697|527521406|FG002|Overall Study|Investigator Decisión|2|||
146275070|NCT01399697|527521404|FG000|Overall Study|Lack of Efficacy|9|||
146275071|NCT01399697|527521405|FG001|Overall Study|Lack of Efficacy|0|||
146275072|NCT01399697|527521406|FG002|Overall Study|Lack of Efficacy|1|||
146275073|NCT01399697|527521404|FG000|Overall Study|Protocol Violation|2|||
146275074|NCT01399697|527521405|FG001|Overall Study|Protocol Violation|0|||
146275075|NCT01399697|527521406|FG002|Overall Study|Protocol Violation|0|||
146275076|NCT01399697|527521404|FG000|Overall Study|Non-Compliant|1|||
146275077|NCT01399697|527521405|FG001|Overall Study|Non-Compliant|0|||
146275078|NCT01399697|527521406|FG002|Overall Study|Non-Compliant|0|||
146275079|NCT01399697|527521404|FG000|Overall Study|Inclusion Error|2|||
146275080|NCT01399697|527521405|FG001|Overall Study|Inclusion Error|0|||
146275081|NCT01399697|527521406|FG002|Overall Study|Inclusion Error|0|||
146275082|NCT01399697|527521404|FG000|Overall Study|Positive result for hepatitis B|1|||
146275083|NCT01399697|527521405|FG001|Overall Study|Positive result for hepatitis B|0|||
146275084|NCT01399697|527521406|FG002|Overall Study|Positive result for hepatitis B|0|||
146275085|NCT01399697|527521404|FG000|Overall Study|Clinical RA remission|1|||
146275086|NCT01399697|527521405|FG001|Overall Study|Clinical RA remission|0|||
146275087|NCT01399697|527521406|FG002|Overall Study|Clinical RA remission|0|||
146275088|NCT01399697|527521404|FG000|Overall Study|Sponsor Decision|1|||
146275089|NCT01399697|527521405|FG001|Overall Study|Sponsor Decision|0|||
146275090|NCT01399697|527521406|FG002|Overall Study|Sponsor Decision|0|||
146275091|NCT01289210|527521410|FG000|Overall Study|Adverse Event|1|||
146275092|NCT01677767|527521411|FG000|Overall Study|Adverse Event|1|||
146275093|NCT01677767|527521411|FG000|Overall Study|Death|4|||
146275094|NCT01677767|527521411|FG000|Overall Study|Protocol Violation|4|||
146275095|NCT01677767|527521411|FG000|Overall Study|Withdrawal by Subject|10|||
146275096|NCT01677767|527521411|FG000|Overall Study|Non-compliance by the participants|3|||
146275097|NCT00755105|527521412|FG000|Overall Study|Withdrawal by Subject|9|||
146275098|NCT00755105|527521413|FG001|Overall Study|Withdrawal by Subject|11|||
146275099|NCT00755105|527521414|FG002|Overall Study|Withdrawal by Subject|4|||
146275100|NCT00818779|527521417|FG000|Overall Study|Protocol Violation|1|||
146275101|NCT00818779|527521418|FG001|Overall Study|Protocol Violation|0|||
146275102|NCT00818779|527521417|FG000|Overall Study|Lost to Follow-up|1|||
146275103|NCT00818779|527521418|FG001|Overall Study|Lost to Follow-up|0|||
146275104|NCT00818779|527521417|FG000|Overall Study|Adverse Event|4|||
146275105|NCT00818779|527521418|FG001|Overall Study|Adverse Event|1|||
146275106|NCT01840410|527521422|FG000|Overall Study|Physician Decision|1|||
146275107|NCT01840410|527521423|FG001|Overall Study|Physician Decision|2|||
146275108|NCT01840410|527521422|FG000|Overall Study|Pregnancy|1|||
146275109|NCT01840410|527521423|FG001|Overall Study|Pregnancy|0|||
146275110|NCT01840410|527521422|FG000|Overall Study|Protocol deviation|1|||
146275111|NCT01840410|527521423|FG001|Overall Study|Protocol deviation|0|||
146275112|NCT01840410|527521422|FG000|Overall Study|Lost to Follow-up|1|||
146275113|NCT01840410|527521423|FG001|Overall Study|Lost to Follow-up|0|||
146275114|NCT01840410|527521422|FG000|Overall Study|Withdrawal by Subject|2|||
146275115|NCT01840410|527521423|FG001|Overall Study|Withdrawal by Subject|1|||
146275116|NCT01840410|527521422|FG000|Overall Study|Adverse Event|1|||
146275117|NCT01840410|527521423|FG001|Overall Study|Adverse Event|1|||
146275118|NCT00839956|527521424|FG000|Overall Study|Adverse Event|2|||
146275119|NCT00839956|527521424|FG000|Overall Study|Lack of Efficacy|6|||
146275120|NCT00839956|527521424|FG000|Overall Study|Physician Decision|1|||
146275121|NCT00839956|527521424|FG000|Overall Study|Withdrawal by Subject|3|||
146275122|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
146275123|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
146275124|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
146275125|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
146275126|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
146275127|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
146275128|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
146275129|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
146275130|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
146275131|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
146275132|NCT00245960|527521426|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
146275133|NCT00245960|527521427|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
146275134|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
146275135|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
146304426|NCT00574288|527629209|FG002|Overall Study|Death|0|||
146304427|NCT00574288|527629210|FG003|Overall Study|Death|0|||
146304428|NCT00574288|527629211|FG004|Overall Study|Death|0|||
146145194|NCT01877421|527045117|FG006|Phase 2|Lost to Follow-up|1|||
146275136|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
146275137|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
146275138|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
146275139|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
146275140|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
146275141|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
146275142|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
146275143|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
146275144|NCT00245960|527521426|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
146304429|NCT00574288|527629212|FG005|Overall Study|Death|25|||
146304430|NCT00574288|527629213|FG006|Overall Study|Death|21|||
146145195|NCT01877421|527045118|FG007|Phase 2|Lost to Follow-up|0|||
146145196|NCT01877421|527045119|FG008|Phase 2|Lost to Follow-up|0|||
146145197|NCT01877421|527045120|FG009|Phase 2|Lost to Follow-up|0|||
146145198|NCT01877421|527045121|FG010|Phase 2|Lost to Follow-up|0|||
146145199|NCT01877421|527045122|FG011|Phase 2|Lost to Follow-up|0|||
146145200|NCT01877421|527045123|FG012|Phase 2|Lost to Follow-up|0|||
146145201|NCT01877421|527045124|FG013|Phase 2|Lost to Follow-up|0|||
146145202|NCT01877421|527045125|FG014|Phase 2|Lost to Follow-up|0|||
146145203|NCT01877421|527045126|FG015|Phase 2|Lost to Follow-up|0|||
146145204|NCT01877421|527045127|FG016|Phase 2|Lost to Follow-up|0|||
146145205|NCT01877421|527045128|FG017|Phase 2|Lost to Follow-up|0|||
146145206|NCT01877421|527045111|FG000|Phase 2|Withdrawal by Subject|0|||
146145207|NCT01877421|527045112|FG001|Phase 2|Withdrawal by Subject|0|||
146145208|NCT01877421|527045113|FG002|Phase 2|Withdrawal by Subject|0|||
146145209|NCT01877421|527045114|FG003|Phase 2|Withdrawal by Subject|0|||
146145210|NCT01877421|527045115|FG004|Phase 2|Withdrawal by Subject|0|||
146145211|NCT01877421|527045116|FG005|Phase 2|Withdrawal by Subject|0|||
146145212|NCT01877421|527045117|FG006|Phase 2|Withdrawal by Subject|0|||
146145213|NCT01877421|527045118|FG007|Phase 2|Withdrawal by Subject|0|||
146145214|NCT01877421|527045119|FG008|Phase 2|Withdrawal by Subject|1|||
146145215|NCT01877421|527045120|FG009|Phase 2|Withdrawal by Subject|0|||
146145216|NCT01877421|527045121|FG010|Phase 2|Withdrawal by Subject|1|||
146145217|NCT01877421|527045122|FG011|Phase 2|Withdrawal by Subject|0|||
146145218|NCT01877421|527045123|FG012|Phase 2|Withdrawal by Subject|1|||
146145219|NCT01877421|527045124|FG013|Phase 2|Withdrawal by Subject|0|||
146145220|NCT01877421|527045125|FG014|Phase 2|Withdrawal by Subject|0|||
146145221|NCT01877421|527045126|FG015|Phase 2|Withdrawal by Subject|1|||
146145222|NCT01877421|527045127|FG016|Phase 2|Withdrawal by Subject|0|||
146145223|NCT01877421|527045128|FG017|Phase 2|Withdrawal by Subject|0|||
146145224|NCT01877421|527045111|FG000|Phase 2|Protocol Violation|0|||
146145225|NCT01877421|527045112|FG001|Phase 2|Protocol Violation|0|||
146145226|NCT01877421|527045113|FG002|Phase 2|Protocol Violation|0|||
146145227|NCT01877421|527045114|FG003|Phase 2|Protocol Violation|0|||
146145228|NCT01877421|527045115|FG004|Phase 2|Protocol Violation|0|||
146145229|NCT01877421|527045116|FG005|Phase 2|Protocol Violation|0|||
146145230|NCT01877421|527045117|FG006|Phase 2|Protocol Violation|0|||
146145231|NCT01877421|527045118|FG007|Phase 2|Protocol Violation|0|||
146145232|NCT01877421|527045119|FG008|Phase 2|Protocol Violation|0|||
146145233|NCT01877421|527045120|FG009|Phase 2|Protocol Violation|0|||
146145234|NCT01877421|527045121|FG010|Phase 2|Protocol Violation|1|||
146145235|NCT01877421|527045122|FG011|Phase 2|Protocol Violation|0|||
146145236|NCT01877421|527045123|FG012|Phase 2|Protocol Violation|0|||
146145237|NCT01877421|527045124|FG013|Phase 2|Protocol Violation|0|||
146145238|NCT01877421|527045125|FG014|Phase 2|Protocol Violation|0|||
146145239|NCT01877421|527045126|FG015|Phase 2|Protocol Violation|0|||
146145240|NCT01877421|527045127|FG016|Phase 2|Protocol Violation|0|||
146145241|NCT01877421|527045128|FG017|Phase 2|Protocol Violation|0|||
146145242|NCT00908960|527045129|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
146145243|NCT00908960|527045130|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
146145244|NCT00908960|527045131|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
146145245|NCT01158924|527045132|FG000|Overall Study|Withdrawal by Subject|1|||
146145246|NCT01158924|527045133|FG001|Overall Study|Withdrawal by Subject|2|||
146145247|NCT01158924|527045132|FG000|Overall Study|Lost to Follow-up|0|||
146145248|NCT01158924|527045133|FG001|Overall Study|Lost to Follow-up|1|||
146145249|NCT03056690|527045136|FG000|Overall Study|Adverse Event|3|||
146145250|NCT03056690|527045137|FG001|Overall Study|Adverse Event|2|||
146145251|NCT03056690|527045136|FG000|Overall Study|Lack of Efficacy|1|||
146145252|NCT03056690|527045137|FG001|Overall Study|Lack of Efficacy|2|||
146145253|NCT03056690|527045136|FG000|Overall Study|Lost to Follow-up|3|||
146145254|NCT03056690|527045137|FG001|Overall Study|Lost to Follow-up|2|||
146145255|NCT03056690|527045136|FG000|Overall Study|Protocol Violation|2|||
146145256|NCT03056690|527045137|FG001|Overall Study|Protocol Violation|2|||
146145257|NCT03056690|527045136|FG000|Overall Study|Withdrawal by Subject|3|||
146145258|NCT03056690|527045137|FG001|Overall Study|Withdrawal by Subject|6|||
146145259|NCT03056690|527045136|FG000|Overall Study|Non-compliance with Study Drug|1|||
146145260|NCT03056690|527045137|FG001|Overall Study|Non-compliance with Study Drug|0|||
146145261|NCT03056690|527045136|FG000|Overall Study|Miscellaneous|1|||
146145262|NCT03056690|527045137|FG001|Overall Study|Miscellaneous|2|||
146145263|NCT02127307|527045141|FG000|Overall Study|Protocol Violation|36|||
146145264|NCT02127307|527045141|FG000|Overall Study|Lost to Follow-up|2|||
146145265|NCT02127307|527045141|FG000|Overall Study|Death|101|||
146145266|NCT02127307|527045141|FG000|Overall Study|Other than specified above|169|||
146145267|NCT04187196|527045143|FG000|Overall Study|Screen Failure|2|||
146145268|NCT04187196|527045144|FG001|Overall Study|Screen Failure|0|||
146145269|NCT00183872|527045145|FG000|Overall Study|Death|3|||
146145270|NCT00183872|527045145|FG000|Overall Study|Adverse Event|9|||
146145271|NCT00183872|527045145|FG000|Overall Study|Withdrawal by Subject|2|||
146145272|NCT00183872|527045145|FG000|Overall Study|Drug delayed more than 28 days|2|||
146145273|NCT00595582|527045146|FG000|Overall Study|Pilot study that PI terminated|2|||
146145274|NCT00595582|527045146|FG000|Overall Study|Lost to Follow-up|1|||
146145275|NCT00595582|527045146|FG000|Overall Study|Adverse Event|2|||
146275145|NCT00245960|527521427|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
146275146|NCT01077518|527521429|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
146275147|NCT01077518|527521430|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
146275148|NCT01077518|527521431|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
146275149|NCT01077518|527521429|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
146275150|NCT01077518|527521430|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
146275151|NCT01077518|527521431|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
146275152|NCT01077518|527521429|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
146275153|NCT01077518|527521430|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
146275154|NCT01077518|527521431|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
146275155|NCT01077518|527521429|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
146275156|NCT01077518|527521430|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
146275157|NCT01077518|527521431|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
146275158|NCT01077518|527521429|FG000|Optional Ofa Phase|Physician Decision|0|||
146275159|NCT01077518|527521430|FG001|Optional Ofa Phase|Physician Decision|0|||
146275160|NCT01077518|527521431|FG002|Optional Ofa Phase|Physician Decision|1|||
146275161|NCT01077518|527521429|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
146275162|NCT01077518|527521430|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
146275163|NCT01077518|527521431|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
146275164|NCT01077518|527521429|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
146275165|NCT01077518|527521430|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
146275166|NCT01077518|527521431|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
146275167|NCT01495598|527521432|FG000|Overall Study|Death during follow up period|2|||
146275168|NCT01495598|527521432|FG000|Overall Study|Death on study|1|||
146275169|NCT01495598|527521432|FG000|Overall Study|Lost to Follow-up|3|||
146275170|NCT01495598|527521432|FG000|Overall Study|Physician Decision|8|||
146275171|NCT03852719|527521433|FG000|Overall Study|Withdrawal of consent|8|||
146275172|NCT03852719|527521434|FG001|Overall Study|Withdrawal of consent|8|||
146275173|NCT03852719|527521435|FG002|Overall Study|Withdrawal of consent|9|||
146275174|NCT03852719|527521433|FG000|Overall Study|Physician Decision|5|||
146275175|NCT03852719|527521434|FG001|Overall Study|Physician Decision|4|||
146275176|NCT03852719|527521435|FG002|Overall Study|Physician Decision|1|||
146275177|NCT03852719|527521433|FG000|Overall Study|Pregnancy|2|||
146275178|NCT03852719|527521434|FG001|Overall Study|Pregnancy|1|||
146275179|NCT03852719|527521435|FG002|Overall Study|Pregnancy|0|||
146275180|NCT03852719|527521433|FG000|Overall Study|Death|1|||
146275181|NCT03852719|527521434|FG001|Overall Study|Death|0|||
146275182|NCT03852719|527521435|FG002|Overall Study|Death|0|||
146275183|NCT03852719|527521433|FG000|Overall Study|Reason not Specified|3|||
146275184|NCT03852719|527521434|FG001|Overall Study|Reason not Specified|3|||
146275185|NCT03852719|527521435|FG002|Overall Study|Reason not Specified|5|||
146275186|NCT03852719|527521433|FG000|Overall Study|Adverse Event|2|||
146275187|NCT03852719|527521434|FG001|Overall Study|Adverse Event|1|||
146275188|NCT03852719|527521435|FG002|Overall Study|Adverse Event|4|||
146275189|NCT03852719|527521433|FG000|Overall Study|Progressive disease|1|||
146275190|NCT03852719|527521434|FG001|Overall Study|Progressive disease|4|||
146275191|NCT03852719|527521435|FG002|Overall Study|Progressive disease|1|||
146275192|NCT03852719|527521433|FG000|Overall Study|Lost to Follow-up|1|||
146275193|NCT03852719|527521434|FG001|Overall Study|Lost to Follow-up|0|||
146275194|NCT03852719|527521435|FG002|Overall Study|Lost to Follow-up|0|||
146275195|NCT03086655|527521436|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
146275196|NCT03086655|527521437|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
146275197|NCT03086655|527521436|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
146275198|NCT03086655|527521437|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
146275199|NCT03086655|527521436|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
146275200|NCT03086655|527521437|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
146275201|NCT03086655|527521436|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
146275202|NCT03086655|527521437|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
146275203|NCT03086655|527521436|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
146275204|NCT03086655|527521437|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
146275205|NCT03086655|527521436|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
146275206|NCT03086655|527521437|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
146275207|NCT03086655|527521436|FG000|12 Month Follow-up = Final Assessment|Death|0|||
146275208|NCT03086655|527521437|FG001|12 Month Follow-up = Final Assessment|Death|1|||
146275209|NCT03841526|527521439|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
146275210|NCT03841526|527521440|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146275211|NCT03841526|527521441|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146275212|NCT03841526|527521442|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
146275213|NCT03841526|527521443|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146275214|NCT03841526|527521444|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
146275215|NCT03841526|527521439|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
146275216|NCT03841526|527521440|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
146275217|NCT03841526|527521441|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
146275218|NCT03841526|527521442|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
146275219|NCT03841526|527521443|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
146275220|NCT03841526|527521444|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
146275221|NCT03841526|527521439|FG000|Outpatient Phase Treatment|Physician Decision|0|||
146275222|NCT03841526|527521440|FG001|Outpatient Phase Treatment|Physician Decision|1|||
146275223|NCT03841526|527521441|FG002|Outpatient Phase Treatment|Physician Decision|0|||
146275224|NCT03841526|527521442|FG003|Outpatient Phase Treatment|Physician Decision|0|||
146275225|NCT03841526|527521443|FG004|Outpatient Phase Treatment|Physician Decision|0|||
146275226|NCT03841526|527521444|FG005|Outpatient Phase Treatment|Physician Decision|0|||
146275227|NCT03841526|527521439|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146275228|NCT03841526|527521440|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146275229|NCT03841526|527521441|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
146275230|NCT03841526|527521442|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146275231|NCT03841526|527521443|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
146275232|NCT03841526|527521444|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
146275233|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
146275234|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
146275235|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
146275236|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146275237|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146275238|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
146275239|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
146275240|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
146275241|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
146275242|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146275243|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146275244|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
146145276|NCT00595582|527045146|FG000|Overall Study|Physician Decision|5|||
146145277|NCT02797262|527045147|FG000|Overall Study|Withdrawal by Subject|5|||
146145278|NCT02797262|527045148|FG001|Overall Study|Withdrawal by Subject|1|||
146145279|NCT02797262|527045147|FG000|Overall Study|Lost to Follow-up|10|||
146145280|NCT02797262|527045148|FG001|Overall Study|Lost to Follow-up|7|||
146145281|NCT02797262|527045147|FG000|Overall Study|Death|1|||
146145282|NCT02797262|527045148|FG001|Overall Study|Death|2|||
146145283|NCT02797262|527045147|FG000|Overall Study|Adverse Event|1|||
146145284|NCT02797262|527045148|FG001|Overall Study|Adverse Event|0|||
146145285|NCT02797262|527045147|FG000|Overall Study|COVID-19|2|||
146145286|NCT02797262|527045148|FG001|Overall Study|COVID-19|1|||
146275245|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146275246|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
146275247|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146275248|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146275249|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146275250|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
146275251|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146275252|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
146275253|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146275254|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146275255|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146275256|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
146275257|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146275258|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146275259|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
146275260|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146275261|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146275262|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
146275263|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146275264|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
146275265|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
146275266|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146275267|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146275268|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
146275269|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
146275270|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
146275271|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
146304431|NCT00574288|527629207|FG000|Overall Study|Lost to Follow-up|0|||
146145287|NCT02797262|527045147|FG000|Overall Study|Out-of-country|1|||
146145288|NCT02797262|527045148|FG001|Overall Study|Out-of-country|0|||
146145289|NCT01600586|527045149|FG000|Overall Study|Physician Decision|3|||
146145290|NCT01600586|527045150|FG001|Overall Study|Physician Decision|3|||
146275272|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146275273|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146275274|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
146275275|NCT03524092|527521449|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
146275276|NCT03524092|527521450|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
146275277|NCT03524092|527521451|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
146275278|NCT03524092|527521452|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146275279|NCT03524092|527521453|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146275280|NCT03524092|527521454|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
146275281|NCT03524092|527521449|FG000|Loss of Response Rescue Period|Adverse Event|0|||
146275282|NCT03524092|527521450|FG001|Loss of Response Rescue Period|Adverse Event|0|||
146275283|NCT03524092|527521451|FG002|Loss of Response Rescue Period|Adverse Event|0|||
146275284|NCT03524092|527521452|FG003|Loss of Response Rescue Period|Adverse Event|2|||
146275285|NCT03524092|527521453|FG004|Loss of Response Rescue Period|Adverse Event|0|||
146275286|NCT03524092|527521454|FG005|Loss of Response Rescue Period|Adverse Event|0|||
146275287|NCT03524092|527521449|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
146275288|NCT03524092|527521450|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
146275289|NCT03524092|527521451|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
146275290|NCT03524092|527521452|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
146275291|NCT03524092|527521453|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
146275292|NCT03524092|527521454|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
146275293|NCT03524092|527521449|FG000|Loss of Response Rescue Period|Pregnancy|0|||
146275294|NCT03524092|527521450|FG001|Loss of Response Rescue Period|Pregnancy|0|||
146275295|NCT03524092|527521451|FG002|Loss of Response Rescue Period|Pregnancy|0|||
146275296|NCT03524092|527521452|FG003|Loss of Response Rescue Period|Pregnancy|1|||
146275297|NCT03524092|527521453|FG004|Loss of Response Rescue Period|Pregnancy|0|||
146275298|NCT03524092|527521454|FG005|Loss of Response Rescue Period|Pregnancy|0|||
146275299|NCT03524092|527521449|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146275300|NCT03524092|527521450|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146275301|NCT03524092|527521451|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146275302|NCT03524092|527521452|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
146275303|NCT03524092|527521453|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146275304|NCT03524092|527521454|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
146275305|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146275306|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146275307|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146275308|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146275309|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
146275310|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
146275311|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146275312|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146275313|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146275314|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146275315|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
146275316|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
146275317|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146275318|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146275319|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146275320|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146275321|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
146275322|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
146275323|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146275324|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146275325|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146275326|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146275327|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
146275328|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
146275329|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146275330|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146275331|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146275332|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146275333|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
146275334|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
146275335|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146304432|NCT00574288|527629208|FG001|Overall Study|Lost to Follow-up|0|||
146275336|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146275337|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146275338|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146275339|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
146275340|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
146275341|NCT03524092|527521449|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146275342|NCT03524092|527521450|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146275343|NCT03524092|527521451|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146275344|NCT03524092|527521452|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146275345|NCT03524092|527521453|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
146275346|NCT03524092|527521454|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
146275347|NCT03524092|527521449|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146275348|NCT03524092|527521450|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146275349|NCT03524092|527521451|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146275350|NCT03524092|527521452|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146275351|NCT03524092|527521453|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
146275352|NCT03524092|527521454|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
146275353|NCT03524092|527521449|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146275354|NCT03524092|527521450|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146275355|NCT03524092|527521451|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146275356|NCT03524092|527521452|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146275357|NCT03524092|527521453|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
146275358|NCT03524092|527521454|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
146275359|NCT03524092|527521449|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146275360|NCT03524092|527521450|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146275361|NCT03524092|527521451|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146275362|NCT03524092|527521452|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146275363|NCT03524092|527521453|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
146275364|NCT03524092|527521454|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
146275365|NCT03524092|527521449|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146275366|NCT03524092|527521450|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146275367|NCT03524092|527521451|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146275368|NCT03524092|527521452|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146275369|NCT03524092|527521453|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
146275370|NCT03524092|527521454|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
146275371|NCT04303780|527521455|FG000|Overall Study|Death|104|||
146275372|NCT04303780|527521456|FG001|Overall Study|Death|85|||
146275373|NCT04303780|527521455|FG000|Overall Study|Lost to Follow-up|5|||
146275374|NCT04303780|527521456|FG001|Overall Study|Lost to Follow-up|2|||
146275375|NCT04303780|527521455|FG000|Overall Study|Withdrawal by Subject|12|||
146275376|NCT04303780|527521456|FG001|Overall Study|Withdrawal by Subject|39|||
146275377|NCT04303780|527521455|FG000|Overall Study|Ongoing in study|50|||
146275378|NCT04303780|527521456|FG001|Overall Study|Ongoing in study|45|||
146275379|NCT04893460|527521457|FG000|Overall Study|Lost to Follow-up|18|||
146275380|NCT01123070|527522914|FG000|Part B Double Blind Period|Protocol Violation|0|||
146275381|NCT01123070|527522915|FG001|Part B Double Blind Period|Protocol Violation|0|||
146275382|NCT01123070|527522916|FG002|Part B Double Blind Period|Protocol Violation|0|||
146275383|NCT01123070|527522917|FG003|Part B Double Blind Period|Protocol Violation|1|||
146275384|NCT01123070|527522914|FG000|Part B Double Blind Period|Adverse Event|0|||
146275385|NCT01123070|527522915|FG001|Part B Double Blind Period|Adverse Event|0|||
146275386|NCT01123070|527522916|FG002|Part B Double Blind Period|Adverse Event|2|||
146275387|NCT01123070|527522917|FG003|Part B Double Blind Period|Adverse Event|0|||
146275388|NCT01123070|527522914|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
146275389|NCT01123070|527522915|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
146275390|NCT01123070|527522916|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
146275391|NCT01123070|527522917|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
146275392|NCT01977677|527522918|FG000|Overall Study|Unrelated Adverse Event|0|||
146275393|NCT01977677|527522919|FG001|Overall Study|Unrelated Adverse Event|0|||
146304433|NCT00574288|527629209|FG002|Overall Study|Lost to Follow-up|0|||
146304434|NCT00574288|527629210|FG003|Overall Study|Lost to Follow-up|0|||
146304435|NCT00574288|527629211|FG004|Overall Study|Lost to Follow-up|0|||
146304436|NCT00574288|527629212|FG005|Overall Study|Lost to Follow-up|1|||
146275394|NCT01977677|527522920|FG002|Overall Study|Unrelated Adverse Event|1|||
146304437|NCT00574288|527629213|FG006|Overall Study|Lost to Follow-up|2|||
146304438|NCT00574288|527629207|FG000|Overall Study|Study Terminated By Sponsor|0|||
146304439|NCT00574288|527629208|FG001|Overall Study|Study Terminated By Sponsor|0|||
146145291|NCT01978184|527045152|FG000|Overall Study|Progressive disease|5|||
146304440|NCT00574288|527629209|FG002|Overall Study|Study Terminated By Sponsor|0|||
146304441|NCT00574288|527629210|FG003|Overall Study|Study Terminated By Sponsor|0|||
146304442|NCT00574288|527629211|FG004|Overall Study|Study Terminated By Sponsor|0|||
146304443|NCT00574288|527629212|FG005|Overall Study|Study Terminated By Sponsor|0|||
146304444|NCT00574288|527629213|FG006|Overall Study|Study Terminated By Sponsor|5|||
146304445|NCT00574288|527629207|FG000|Overall Study|Progressive Disease|17|||
146304446|NCT00574288|527629208|FG001|Overall Study|Progressive Disease|2|||
146304447|NCT00574288|527629209|FG002|Overall Study|Progressive Disease|3|||
146304448|NCT00574288|527629210|FG003|Overall Study|Progressive Disease|2|||
146304449|NCT00574288|527629211|FG004|Overall Study|Progressive Disease|1|||
146304450|NCT00574288|527629212|FG005|Overall Study|Progressive Disease|0|||
146304451|NCT00574288|527629213|FG006|Overall Study|Progressive Disease|0|||
146304452|NCT00574288|527629207|FG000|Overall Study|Other|1|||
146304453|NCT00574288|527629208|FG001|Overall Study|Other|1|||
146304454|NCT00574288|527629209|FG002|Overall Study|Other|0|||
146304455|NCT00574288|527629210|FG003|Overall Study|Other|0|||
146304456|NCT00574288|527629211|FG004|Overall Study|Other|0|||
146304457|NCT00574288|527629212|FG005|Overall Study|Other|0|||
146304458|NCT00574288|527629213|FG006|Overall Study|Other|0|||
146304459|NCT02247960|527629214|FG000|Patient Consent and Randomization|Physician Decision|2|||
146304460|NCT02247960|527629215|FG001|Patient Consent and Randomization|Physician Decision|2|||
146304461|NCT02247960|527629214|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
146304462|NCT02247960|527629215|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
146304463|NCT02247960|527629214|FG000|Catheter Removed|Lost to Follow-up|7|||
146304464|NCT02247960|527629215|FG001|Catheter Removed|Lost to Follow-up|10|||
146304465|NCT02361944|527629218|FG000|Overall Study|surgery cancellation|0|||
146304466|NCT02361944|527629219|FG001|Overall Study|surgery cancellation|1|||
146304467|NCT03086057|527629221|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
146304468|NCT03086057|527629222|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
146304469|NCT03086057|527629223|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
146304470|NCT03086057|527629224|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
146304471|NCT03086057|527629221|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
146304472|NCT03086057|527629222|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
146304473|NCT03086057|527629223|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
146304474|NCT03086057|527629224|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
146304475|NCT03086057|527629221|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
146304476|NCT03086057|527629222|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
146304477|NCT03086057|527629223|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
146304478|NCT03086057|527629224|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
146304479|NCT03086057|527629221|FG000|Stage 1: PrEP Uptake|Death|1|||
146304480|NCT03086057|527629222|FG001|Stage 1: PrEP Uptake|Death|0|||
146304481|NCT03086057|527629223|FG002|Stage 1: PrEP Uptake|Death|0|||
146304482|NCT03086057|527629224|FG003|Stage 1: PrEP Uptake|Death|0|||
146304483|NCT03086057|527629221|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
146304484|NCT03086057|527629222|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
146304485|NCT03086057|527629223|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
146304486|NCT03086057|527629224|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
146304487|NCT03086057|527629221|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146304488|NCT03086057|527629222|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146304489|NCT03086057|527629223|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
146304490|NCT03086057|527629224|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
146304491|NCT03086057|527629221|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
146304492|NCT03086057|527629222|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
146304493|NCT03086057|527629223|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
146304494|NCT03086057|527629224|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
146304495|NCT01786603|527629225|FG000|Overall Study|Death|5|||
146304496|NCT01786603|527629226|FG001|Overall Study|Death|1|||
146304497|NCT01786603|527629225|FG000|Overall Study|Adverse Event|6|||
146304498|NCT01786603|527629226|FG001|Overall Study|Adverse Event|2|||
146145292|NCT01978184|527045153|FG001|Overall Study|Progressive disease|5|||
146275395|NCT05262517|527522923|FG000|Overall Study|Randomized but not treated|5|||
146275396|NCT05262517|527522924|FG001|Overall Study|Randomized but not treated|11|||
146275397|NCT02942277|527522925|FG000|Year 1|Withdrawal by Subject|0|||
146275398|NCT02942277|527522926|FG001|Year 1|Withdrawal by Subject|0|||
146275399|NCT02942277|527522927|FG002|Year 1|Withdrawal by Subject|0|||
146275400|NCT02942277|527522928|FG003|Year 1|Withdrawal by Subject|0|||
146275401|NCT02942277|527522929|FG004|Year 1|Withdrawal by Subject|1|||
146275402|NCT02942277|527522930|FG005|Year 1|Withdrawal by Subject|3|||
146275403|NCT02942277|527522931|FG006|Year 1|Withdrawal by Subject|0|||
146275404|NCT02942277|527522932|FG007|Year 1|Withdrawal by Subject|1|||
146275405|NCT02942277|527522933|FG008|Year 1|Withdrawal by Subject|0|||
146304499|NCT01786603|527629225|FG000|Overall Study|Physician decision to withdraw|6|||
146304500|NCT01786603|527629226|FG001|Overall Study|Physician decision to withdraw|7|||
146304501|NCT01786603|527629225|FG000|Overall Study|Lost to Follow-up|1|||
146145293|NCT01978184|527045152|FG000|Overall Study|Other than PDA|2|||
146275406|NCT02942277|527522934|FG009|Year 1|Withdrawal by Subject|0|||
146304502|NCT01786603|527629226|FG001|Overall Study|Lost to Follow-up|2|||
146304503|NCT03700320|527629227|FG000|Overall Study|Adverse Event|5|||
146275407|NCT02942277|527522935|FG010|Year 1|Withdrawal by Subject|3|||
146275408|NCT02942277|527522925|FG000|Year 1|Travel|0|||
146275409|NCT02942277|527522926|FG001|Year 1|Travel|1|||
146275410|NCT02942277|527522927|FG002|Year 1|Travel|0|||
146275411|NCT02942277|527522928|FG003|Year 1|Travel|0|||
146275412|NCT02942277|527522929|FG004|Year 1|Travel|4|||
146275413|NCT02942277|527522930|FG005|Year 1|Travel|5|||
146275414|NCT02942277|527522931|FG006|Year 1|Travel|0|||
146275415|NCT02942277|527522932|FG007|Year 1|Travel|0|||
146275416|NCT02942277|527522933|FG008|Year 1|Travel|0|||
146275417|NCT02942277|527522934|FG009|Year 1|Travel|0|||
146275418|NCT02942277|527522935|FG010|Year 1|Travel|8|||
146275419|NCT02942277|527522925|FG000|Year 1|Joined Army|0|||
146275420|NCT02942277|527522926|FG001|Year 1|Joined Army|1|||
146275421|NCT02942277|527522927|FG002|Year 1|Joined Army|0|||
146275422|NCT02942277|527522928|FG003|Year 1|Joined Army|0|||
146275423|NCT02942277|527522929|FG004|Year 1|Joined Army|0|||
146275424|NCT02942277|527522930|FG005|Year 1|Joined Army|0|||
146275425|NCT02942277|527522931|FG006|Year 1|Joined Army|0|||
146275426|NCT02942277|527522932|FG007|Year 1|Joined Army|0|||
146275427|NCT02942277|527522933|FG008|Year 1|Joined Army|0|||
146275428|NCT02942277|527522934|FG009|Year 1|Joined Army|0|||
146275429|NCT02942277|527522935|FG010|Year 1|Joined Army|0|||
146275430|NCT02942277|527522925|FG000|Year 1|Subject met withdrawal criteria|0|||
146275431|NCT02942277|527522926|FG001|Year 1|Subject met withdrawal criteria|0|||
146275432|NCT02942277|527522927|FG002|Year 1|Subject met withdrawal criteria|0|||
146275433|NCT02942277|527522928|FG003|Year 1|Subject met withdrawal criteria|1|||
146275434|NCT02942277|527522929|FG004|Year 1|Subject met withdrawal criteria|0|||
146275435|NCT02942277|527522930|FG005|Year 1|Subject met withdrawal criteria|0|||
146275436|NCT02942277|527522931|FG006|Year 1|Subject met withdrawal criteria|0|||
146275437|NCT02942277|527522932|FG007|Year 1|Subject met withdrawal criteria|0|||
146275438|NCT02942277|527522933|FG008|Year 1|Subject met withdrawal criteria|0|||
146275439|NCT02942277|527522934|FG009|Year 1|Subject met withdrawal criteria|0|||
146275440|NCT02942277|527522935|FG010|Year 1|Subject met withdrawal criteria|0|||
146275441|NCT02942277|527522925|FG000|Year 1|Lost to Follow-up|0|||
146275442|NCT02942277|527522926|FG001|Year 1|Lost to Follow-up|0|||
146275443|NCT02942277|527522927|FG002|Year 1|Lost to Follow-up|0|||
146275444|NCT02942277|527522928|FG003|Year 1|Lost to Follow-up|0|||
146275445|NCT02942277|527522929|FG004|Year 1|Lost to Follow-up|1|||
146275446|NCT02942277|527522930|FG005|Year 1|Lost to Follow-up|0|||
146275447|NCT02942277|527522931|FG006|Year 1|Lost to Follow-up|0|||
146275448|NCT02942277|527522932|FG007|Year 1|Lost to Follow-up|0|||
146275449|NCT02942277|527522933|FG008|Year 1|Lost to Follow-up|0|||
146275450|NCT02942277|527522934|FG009|Year 1|Lost to Follow-up|0|||
146275451|NCT02942277|527522935|FG010|Year 1|Lost to Follow-up|2|||
146275452|NCT02942277|527522925|FG000|Year 1|Protocol Violation|0|||
146275453|NCT02942277|527522926|FG001|Year 1|Protocol Violation|0|||
146275454|NCT02942277|527522927|FG002|Year 1|Protocol Violation|0|||
146275455|NCT02942277|527522928|FG003|Year 1|Protocol Violation|0|||
146275456|NCT02942277|527522929|FG004|Year 1|Protocol Violation|1|||
146275457|NCT02942277|527522930|FG005|Year 1|Protocol Violation|1|||
146275458|NCT02942277|527522931|FG006|Year 1|Protocol Violation|0|||
146275459|NCT02942277|527522932|FG007|Year 1|Protocol Violation|0|||
146275460|NCT02942277|527522933|FG008|Year 1|Protocol Violation|0|||
146275461|NCT02942277|527522934|FG009|Year 1|Protocol Violation|0|||
146275462|NCT02942277|527522935|FG010|Year 1|Protocol Violation|2|||
146275463|NCT02942277|527522925|FG000|Year 1|Pregnancy|0|||
146275464|NCT02942277|527522926|FG001|Year 1|Pregnancy|0|||
146275465|NCT02942277|527522927|FG002|Year 1|Pregnancy|0|||
146275466|NCT02942277|527522928|FG003|Year 1|Pregnancy|0|||
146275467|NCT02942277|527522929|FG004|Year 1|Pregnancy|0|||
146275468|NCT02942277|527522930|FG005|Year 1|Pregnancy|1|||
146275469|NCT02942277|527522931|FG006|Year 1|Pregnancy|0|||
146275470|NCT02942277|527522932|FG007|Year 1|Pregnancy|0|||
146275471|NCT02942277|527522933|FG008|Year 1|Pregnancy|0|||
146275472|NCT02942277|527522934|FG009|Year 1|Pregnancy|0|||
146275473|NCT02942277|527522935|FG010|Year 1|Pregnancy|0|||
146275474|NCT02942277|527522925|FG000|Year 2|Lost to Follow-up|0|||
146275475|NCT02942277|527522926|FG001|Year 2|Lost to Follow-up|0|||
146275476|NCT02942277|527522927|FG002|Year 2|Lost to Follow-up|0|||
146275477|NCT02942277|527522928|FG003|Year 2|Lost to Follow-up|0|||
146275478|NCT02942277|527522929|FG004|Year 2|Lost to Follow-up|2|||
146275479|NCT02942277|527522930|FG005|Year 2|Lost to Follow-up|1|||
146275480|NCT02942277|527522931|FG006|Year 2|Lost to Follow-up|0|||
146275481|NCT02942277|527522932|FG007|Year 2|Lost to Follow-up|0|||
146275482|NCT02942277|527522933|FG008|Year 2|Lost to Follow-up|0|||
146275483|NCT02942277|527522934|FG009|Year 2|Lost to Follow-up|0|||
146275484|NCT02942277|527522935|FG010|Year 2|Lost to Follow-up|0|||
146275485|NCT02942277|527522925|FG000|Year 2|Did not rescreen|0|||
146275486|NCT02942277|527522926|FG001|Year 2|Did not rescreen|0|||
146275487|NCT02942277|527522927|FG002|Year 2|Did not rescreen|1|||
146275488|NCT02942277|527522928|FG003|Year 2|Did not rescreen|1|||
146275489|NCT02942277|527522929|FG004|Year 2|Did not rescreen|9|||
146275490|NCT02942277|527522930|FG005|Year 2|Did not rescreen|6|||
146275491|NCT02942277|527522931|FG006|Year 2|Did not rescreen|0|||
146275492|NCT02942277|527522932|FG007|Year 2|Did not rescreen|1|||
146275493|NCT02942277|527522933|FG008|Year 2|Did not rescreen|0|||
146275494|NCT02942277|527522934|FG009|Year 2|Did not rescreen|0|||
146275495|NCT02942277|527522935|FG010|Year 2|Did not rescreen|21|||
146275496|NCT02942277|527522925|FG000|Year 2|Met withdrawal criteria|0|||
146275497|NCT02942277|527522926|FG001|Year 2|Met withdrawal criteria|0|||
146275498|NCT02942277|527522927|FG002|Year 2|Met withdrawal criteria|0|||
146275499|NCT02942277|527522928|FG003|Year 2|Met withdrawal criteria|0|||
146275500|NCT02942277|527522929|FG004|Year 2|Met withdrawal criteria|1|||
146275501|NCT02942277|527522930|FG005|Year 2|Met withdrawal criteria|2|||
146275502|NCT02942277|527522931|FG006|Year 2|Met withdrawal criteria|0|||
146275503|NCT02942277|527522932|FG007|Year 2|Met withdrawal criteria|0|||
146275504|NCT02942277|527522933|FG008|Year 2|Met withdrawal criteria|0|||
146275505|NCT02942277|527522934|FG009|Year 2|Met withdrawal criteria|0|||
146275506|NCT02942277|527522935|FG010|Year 2|Met withdrawal criteria|1|||
146275507|NCT02942277|527522925|FG000|Year 2|Travel|0|||
146275508|NCT02942277|527522926|FG001|Year 2|Travel|1|||
146275509|NCT02942277|527522927|FG002|Year 2|Travel|0|||
146275510|NCT02942277|527522928|FG003|Year 2|Travel|0|||
146275511|NCT02942277|527522929|FG004|Year 2|Travel|0|||
146275512|NCT02942277|527522930|FG005|Year 2|Travel|1|||
146275513|NCT02942277|527522931|FG006|Year 2|Travel|0|||
146275514|NCT02942277|527522932|FG007|Year 2|Travel|0|||
146275515|NCT02942277|527522933|FG008|Year 2|Travel|0|||
146275516|NCT02942277|527522934|FG009|Year 2|Travel|1|||
146275517|NCT02942277|527522935|FG010|Year 2|Travel|3|||
146275518|NCT02942277|527522925|FG000|Year 2|Non-compliant|0|||
146275519|NCT02942277|527522926|FG001|Year 2|Non-compliant|0|||
146275520|NCT02942277|527522927|FG002|Year 2|Non-compliant|0|||
146275521|NCT02942277|527522928|FG003|Year 2|Non-compliant|0|||
146275522|NCT02942277|527522929|FG004|Year 2|Non-compliant|1|||
146275523|NCT02942277|527522930|FG005|Year 2|Non-compliant|1|||
146275524|NCT02942277|527522931|FG006|Year 2|Non-compliant|0|||
146275525|NCT02942277|527522932|FG007|Year 2|Non-compliant|0|||
146275526|NCT02942277|527522933|FG008|Year 2|Non-compliant|0|||
146275527|NCT02942277|527522934|FG009|Year 2|Non-compliant|0|||
146275528|NCT02942277|527522935|FG010|Year 2|Non-compliant|0|||
146275529|NCT02942277|527522925|FG000|Year 2|Withdrawal by Subject|0|||
146275530|NCT02942277|527522926|FG001|Year 2|Withdrawal by Subject|0|||
146275531|NCT02942277|527522927|FG002|Year 2|Withdrawal by Subject|0|||
146275532|NCT02942277|527522928|FG003|Year 2|Withdrawal by Subject|0|||
146275533|NCT02942277|527522929|FG004|Year 2|Withdrawal by Subject|0|||
146275534|NCT02942277|527522930|FG005|Year 2|Withdrawal by Subject|0|||
146275535|NCT02942277|527522931|FG006|Year 2|Withdrawal by Subject|1|||
146275536|NCT02942277|527522932|FG007|Year 2|Withdrawal by Subject|0|||
146275537|NCT02942277|527522933|FG008|Year 2|Withdrawal by Subject|0|||
146275538|NCT02942277|527522934|FG009|Year 2|Withdrawal by Subject|0|||
146275539|NCT02942277|527522935|FG010|Year 2|Withdrawal by Subject|0|||
146275540|NCT05602727|527522936|FG000|Overall Study|Physician Decision|0|||
146275541|NCT05602727|527522937|FG001|Overall Study|Physician Decision|1|||
146275542|NCT05602727|527522938|FG002|Overall Study|Physician Decision|0|||
146275543|NCT05602727|527522936|FG000|Overall Study|Randomized by mistake without study medication|1|||
146275544|NCT05602727|527522937|FG001|Overall Study|Randomized by mistake without study medication|0|||
146275545|NCT05602727|527522938|FG002|Overall Study|Randomized by mistake without study medication|0|||
146275546|NCT05602727|527522936|FG000|Overall Study|Study termination by Sponsor|18|||
146275547|NCT05602727|527522937|FG001|Overall Study|Study termination by Sponsor|15|||
146275548|NCT05602727|527522938|FG002|Overall Study|Study termination by Sponsor|19|||
146275549|NCT05602727|527522936|FG000|Overall Study|Withdrawal by Subject|2|||
146275550|NCT05602727|527522937|FG001|Overall Study|Withdrawal by Subject|1|||
146275551|NCT05602727|527522938|FG002|Overall Study|Withdrawal by Subject|1|||
146275552|NCT05602727|527522936|FG000|Overall Study|Various reasons|1|||
146275553|NCT05602727|527522937|FG001|Overall Study|Various reasons|6|||
146275554|NCT05602727|527522938|FG002|Overall Study|Various reasons|1|||
146275555|NCT02187159|527522939|FG000|Overall Study|Protocol Violation|4|||
146275556|NCT02187159|527522940|FG001|Overall Study|Protocol Violation|6|||
146275557|NCT02187159|527522941|FG002|Overall Study|Protocol Violation|3|||
146275558|NCT02187159|527522942|FG003|Overall Study|Protocol Violation|4|||
146275559|NCT02187159|527522939|FG000|Overall Study|Lack of Efficacy|10|||
146275560|NCT02187159|527522940|FG001|Overall Study|Lack of Efficacy|5|||
146275561|NCT02187159|527522941|FG002|Overall Study|Lack of Efficacy|4|||
146145294|NCT01978184|527045153|FG001|Overall Study|Other than PDA|2|||
146275562|NCT02187159|527522942|FG003|Overall Study|Lack of Efficacy|7|||
146275563|NCT02187159|527522939|FG000|Overall Study|Adverse Event|28|||
146145295|NCT01978184|527045152|FG000|Overall Study|Physician Decision|0|||
146145296|NCT01978184|527045153|FG001|Overall Study|Physician Decision|3|||
146145297|NCT01978184|527045152|FG000|Overall Study|Noncompliance|1|||
146275564|NCT02187159|527522940|FG001|Overall Study|Adverse Event|33|||
146275565|NCT02187159|527522941|FG002|Overall Study|Adverse Event|42|||
146275566|NCT02187159|527522942|FG003|Overall Study|Adverse Event|50|||
146145298|NCT01978184|527045153|FG001|Overall Study|Noncompliance|2|||
146275567|NCT02187159|527522939|FG000|Overall Study|Withdrawal by Subject|24|||
146275568|NCT02187159|527522940|FG001|Overall Study|Withdrawal by Subject|28|||
146275569|NCT02187159|527522941|FG002|Overall Study|Withdrawal by Subject|25|||
146275570|NCT02187159|527522942|FG003|Overall Study|Withdrawal by Subject|26|||
146275571|NCT02187159|527522939|FG000|Overall Study|Other|3|||
146275572|NCT02187159|527522940|FG001|Overall Study|Other|7|||
146275573|NCT02187159|527522941|FG002|Overall Study|Other|3|||
146275574|NCT02187159|527522942|FG003|Overall Study|Other|9|||
146275575|NCT04325282|527522943|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
146275576|NCT04325282|527522944|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
146275577|NCT04325282|527522943|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
146275578|NCT04325282|527522944|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
146275579|NCT04020185|527522950|FG000|Overall Study|Death|0|||
146275580|NCT04020185|527522951|FG001|Overall Study|Death|0|||
146275581|NCT04020185|527522952|FG002|Overall Study|Death|1|||
146275582|NCT04020185|527522953|FG003|Overall Study|Death|2|||
146275583|NCT04020185|527522954|FG004|Overall Study|Death|1|||
146275584|NCT04020185|527522955|FG005|Overall Study|Death|0|||
146275585|NCT04020185|527522956|FG006|Overall Study|Death|1|||
146275586|NCT04020185|527522957|FG007|Overall Study|Death|0|||
146275587|NCT04020185|527522950|FG000|Overall Study|Consent withdrawn|1|||
146275588|NCT04020185|527522951|FG001|Overall Study|Consent withdrawn|0|||
146275589|NCT04020185|527522952|FG002|Overall Study|Consent withdrawn|0|||
146275590|NCT04020185|527522953|FG003|Overall Study|Consent withdrawn|0|||
146275591|NCT04020185|527522954|FG004|Overall Study|Consent withdrawn|2|||
146275592|NCT04020185|527522955|FG005|Overall Study|Consent withdrawn|0|||
146275593|NCT04020185|527522956|FG006|Overall Study|Consent withdrawn|1|||
146275594|NCT04020185|527522957|FG007|Overall Study|Consent withdrawn|1|||
146275595|NCT04020185|527522950|FG000|Overall Study|Patient in hospice|0|||
146275596|NCT04020185|527522951|FG001|Overall Study|Patient in hospice|1|||
146275597|NCT04020185|527522952|FG002|Overall Study|Patient in hospice|0|||
146275598|NCT04020185|527522953|FG003|Overall Study|Patient in hospice|0|||
146275599|NCT04020185|527522954|FG004|Overall Study|Patient in hospice|0|||
146275600|NCT04020185|527522955|FG005|Overall Study|Patient in hospice|0|||
146275601|NCT04020185|527522956|FG006|Overall Study|Patient in hospice|0|||
146275602|NCT04020185|527522957|FG007|Overall Study|Patient in hospice|0|||
146275603|NCT04020185|527522950|FG000|Overall Study|Continuing on expanded access|0|||
146275604|NCT04020185|527522951|FG001|Overall Study|Continuing on expanded access|0|||
146275605|NCT04020185|527522952|FG002|Overall Study|Continuing on expanded access|0|||
146275606|NCT04020185|527522953|FG003|Overall Study|Continuing on expanded access|0|||
146275607|NCT04020185|527522954|FG004|Overall Study|Continuing on expanded access|0|||
146275608|NCT04020185|527522955|FG005|Overall Study|Continuing on expanded access|0|||
146275609|NCT04020185|527522956|FG006|Overall Study|Continuing on expanded access|1|||
146275610|NCT04020185|527522957|FG007|Overall Study|Continuing on expanded access|1|||
146275611|NCT00527787|527522960|FG000|Overall Study|Adverse Event|14|||
146275612|NCT00527787|527522961|FG001|Overall Study|Adverse Event|24|||
146275613|NCT00527787|527522960|FG000|Overall Study|Withdrawal by Subject|13|||
146275614|NCT00527787|527522961|FG001|Overall Study|Withdrawal by Subject|25|||
146275615|NCT00527787|527522960|FG000|Overall Study|Lost to Follow-up|5|||
146275616|NCT00527787|527522961|FG001|Overall Study|Lost to Follow-up|2|||
146275617|NCT00527787|527522960|FG000|Overall Study|Duodenal Ulcer|1|||
146275618|NCT00527787|527522961|FG001|Overall Study|Duodenal Ulcer|10|||
146275619|NCT00527787|527522960|FG000|Overall Study|misc|5|||
146275620|NCT00527787|527522961|FG001|Overall Study|misc|2|||
146275621|NCT02643303|527522962|FG000|Overall Study|Progressive Disease|4|||
146275622|NCT02643303|527522963|FG001|Overall Study|Progressive Disease|4|||
146275623|NCT02643303|527522964|FG002|Overall Study|Progressive Disease|1|||
146275624|NCT02643303|527522965|FG003|Overall Study|Progressive Disease|12|||
146275625|NCT02643303|527522966|FG004|Overall Study|Progressive Disease|6|||
146275626|NCT02643303|527522967|FG005|Overall Study|Progressive Disease|4|||
146275627|NCT02643303|527522968|FG006|Overall Study|Progressive Disease|8|||
146275628|NCT02643303|527522969|FG007|Overall Study|Progressive Disease|2|||
146275629|NCT02643303|527522970|FG008|Overall Study|Progressive Disease|6|||
146275630|NCT02643303|527522962|FG000|Overall Study|Adverse Event|0|||
146275631|NCT02643303|527522963|FG001|Overall Study|Adverse Event|1|||
146275632|NCT02643303|527522964|FG002|Overall Study|Adverse Event|0|||
146275633|NCT02643303|527522965|FG003|Overall Study|Adverse Event|0|||
146275634|NCT02643303|527522966|FG004|Overall Study|Adverse Event|1|||
146275635|NCT02643303|527522967|FG005|Overall Study|Adverse Event|0|||
146275636|NCT02643303|527522968|FG006|Overall Study|Adverse Event|0|||
146275637|NCT02643303|527522969|FG007|Overall Study|Adverse Event|0|||
146275638|NCT02643303|527522970|FG008|Overall Study|Adverse Event|0|||
146275639|NCT02643303|527522962|FG000|Overall Study|Withdrawal by Subject|0|||
146275640|NCT02643303|527522963|FG001|Overall Study|Withdrawal by Subject|0|||
146275641|NCT02643303|527522964|FG002|Overall Study|Withdrawal by Subject|0|||
146275642|NCT02643303|527522965|FG003|Overall Study|Withdrawal by Subject|1|||
146275643|NCT02643303|527522966|FG004|Overall Study|Withdrawal by Subject|0|||
146275644|NCT02643303|527522967|FG005|Overall Study|Withdrawal by Subject|0|||
146275645|NCT02643303|527522968|FG006|Overall Study|Withdrawal by Subject|1|||
146275646|NCT02643303|527522969|FG007|Overall Study|Withdrawal by Subject|1|||
146275647|NCT02643303|527522970|FG008|Overall Study|Withdrawal by Subject|1|||
146275648|NCT04833127|527522975|FG000|Overall Study|Lost to Follow-up|1|||
146275649|NCT04833127|527522976|FG001|Overall Study|Lost to Follow-up|1|||
146275650|NCT04335591|527522977|FG000|Overall Study|Adverse Event|5|||
146145299|NCT01978184|527045152|FG000|Overall Study|Death|1|||
146145300|NCT01978184|527045153|FG001|Overall Study|Death|0|||
146145301|NCT01978184|527045152|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
146145302|NCT01978184|527045153|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
146145303|NCT00965848|527045159|FG000|Overall Study|Protocol Violation|3|||
146145304|NCT00965848|527045160|FG001|Overall Study|Protocol Violation|0|||
146145305|NCT00965848|527045161|FG002|Overall Study|Protocol Violation|1|||
146145306|NCT00965848|527045159|FG000|Overall Study|Death|11|||
146145307|NCT00965848|527045160|FG001|Overall Study|Death|1|||
146145308|NCT00965848|527045161|FG002|Overall Study|Death|5|||
146145309|NCT00965848|527045159|FG000|Overall Study|Lost to Follow-up|0|||
146145310|NCT00965848|527045160|FG001|Overall Study|Lost to Follow-up|0|||
146145311|NCT00965848|527045161|FG002|Overall Study|Lost to Follow-up|1|||
146145312|NCT00965848|527045159|FG000|Overall Study|Withdrawal by Subject|1|||
146145313|NCT00965848|527045160|FG001|Overall Study|Withdrawal by Subject|0|||
146145314|NCT00965848|527045161|FG002|Overall Study|Withdrawal by Subject|0|||
146145315|NCT00965848|527045159|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
146145316|NCT00965848|527045160|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
146145317|NCT00965848|527045161|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
146145318|NCT00965848|527045159|FG000|Overall Study|Not Clinically Evaluable|7|||
146145319|NCT00965848|527045160|FG001|Overall Study|Not Clinically Evaluable|1|||
146145320|NCT00965848|527045161|FG002|Overall Study|Not Clinically Evaluable|1|||
146145321|NCT00965848|527045159|FG000|Overall Study|Other|5|||
146145322|NCT00965848|527045160|FG001|Overall Study|Other|0|||
146145323|NCT00965848|527045161|FG002|Overall Study|Other|1|||
146145324|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
146145325|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146145326|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146145327|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
146145328|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
146145329|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
146145330|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
146145331|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
146145332|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146145333|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146145334|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
146145335|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
146145336|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146145337|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146145338|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
146145339|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
146145340|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146145341|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146145342|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
146145343|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
146145344|NCT00813761|527045162|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146145345|NCT00813761|527045163|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
146145346|NCT00813761|527045164|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146145347|NCT00813761|527045165|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
146145348|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
146145349|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
146145350|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
146145351|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
146145352|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
146145353|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
146145354|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
146145355|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
146145356|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
146145357|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
146145358|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
146145359|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
146145360|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146145361|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146145362|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
146145363|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
146145364|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
146145365|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
146145366|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
146145367|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
146145368|NCT00813761|527045162|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
146145369|NCT00813761|527045163|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
146145370|NCT00813761|527045164|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
146145371|NCT00813761|527045165|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
146145372|NCT05789875|527045166|FG000|Overall Study|Lost to Follow-up|6|||
146145373|NCT02447991|527045169|FG000|Overall Study|Withdrawn by subject - no data|0|||
146145374|NCT02447991|527045170|FG001|Overall Study|Withdrawn by subject - no data|2|||
146145375|NCT02447991|527045169|FG000|Overall Study|Withdrawn by Subject - with data|4|||
146275651|NCT04335591|527522978|FG001|Overall Study|Adverse Event|2|||
146275652|NCT04335591|527522979|FG002|Overall Study|Adverse Event|3|||
146275653|NCT04335591|527522980|FG003|Overall Study|Adverse Event|2|||
146275654|NCT04335591|527522977|FG000|Overall Study|Protocol Violation|1|||
146275655|NCT04335591|527522978|FG001|Overall Study|Protocol Violation|0|||
146275656|NCT04335591|527522979|FG002|Overall Study|Protocol Violation|0|||
146275657|NCT04335591|527522980|FG003|Overall Study|Protocol Violation|0|||
146275658|NCT04335591|527522977|FG000|Overall Study|Withdrawal by Subject|8|||
146275659|NCT04335591|527522978|FG001|Overall Study|Withdrawal by Subject|4|||
146275660|NCT04335591|527522979|FG002|Overall Study|Withdrawal by Subject|4|||
146275661|NCT04335591|527522980|FG003|Overall Study|Withdrawal by Subject|5|||
146275662|NCT04335591|527522977|FG000|Overall Study|Subject planning pregnancy|0|||
146275663|NCT04335591|527522978|FG001|Overall Study|Subject planning pregnancy|1|||
146275664|NCT04335591|527522979|FG002|Overall Study|Subject planning pregnancy|0|||
146275665|NCT04335591|527522980|FG003|Overall Study|Subject planning pregnancy|0|||
146275666|NCT04335591|527522977|FG000|Overall Study|Ukrainian Russian war conflict|4|||
146275667|NCT04335591|527522978|FG001|Overall Study|Ukrainian Russian war conflict|5|||
146275668|NCT04335591|527522979|FG002|Overall Study|Ukrainian Russian war conflict|2|||
146275669|NCT04335591|527522980|FG003|Overall Study|Ukrainian Russian war conflict|0|||
146275670|NCT05282121|527522981|FG000|Overall Study|Adverse Event|1|||
146275671|NCT05282121|527522982|FG001|Overall Study|Adverse Event|1|||
146275672|NCT05282121|527522983|FG002|Overall Study|Adverse Event|4|||
146275673|NCT05282121|527522984|FG003|Overall Study|Adverse Event|1|||
146275674|NCT05282121|527522981|FG000|Overall Study|Study Terminated by Sponsor|1|||
146275675|NCT05282121|527522982|FG001|Overall Study|Study Terminated by Sponsor|2|||
146275676|NCT05282121|527522983|FG002|Overall Study|Study Terminated by Sponsor|2|||
146275677|NCT05282121|527522984|FG003|Overall Study|Study Terminated by Sponsor|2|||
146275678|NCT05282121|527522981|FG000|Overall Study|Other than listed|0|||
146275679|NCT05282121|527522982|FG001|Overall Study|Other than listed|0|||
146275680|NCT05282121|527522983|FG002|Overall Study|Other than listed|1|||
146275681|NCT05282121|527522984|FG003|Overall Study|Other than listed|0|||
146275682|NCT05282121|527522981|FG000|Overall Study|No reason available|0|||
146275683|NCT05282121|527522982|FG001|Overall Study|No reason available|0|||
146275684|NCT05282121|527522983|FG002|Overall Study|No reason available|1|||
146275685|NCT05282121|527522984|FG003|Overall Study|No reason available|0|||
146275686|NCT01736189|527522987|FG000|Overall Study|Violation of registration criteria|41|||
146275687|NCT01736189|527522987|FG000|Overall Study|Protocol Violation|4|||
146275688|NCT01736189|527522987|FG000|Overall Study|Criteria and protocol violations|1|||
146275689|NCT01499303|527522990|FG000|Overall Study|Ongoing|2|||
146275690|NCT01499303|527522991|FG001|Overall Study|Ongoing|1|||
146275691|NCT01499303|527522990|FG000|Overall Study|Withdrawal by Subject|0|||
146275692|NCT01499303|527522991|FG001|Overall Study|Withdrawal by Subject|1|||
146275693|NCT01499303|527522990|FG000|Overall Study|Adverse Event|1|||
146275694|NCT01499303|527522991|FG001|Overall Study|Adverse Event|4|||
146275695|NCT01499303|527522990|FG000|Overall Study|Other|0|||
146275696|NCT01499303|527522991|FG001|Overall Study|Other|1|||
146275697|NCT00608868|527522992|FG000|Overall Study|Withdrawal by Subject|7|||
146275698|NCT00608868|527522992|FG000|Overall Study|Protocol Violation|3|||
146275699|NCT00608868|527522992|FG000|Overall Study|Lost to Follow-up|2|||
146275700|NCT00608868|527522992|FG000|Overall Study|Adverse Event|1|||
146275701|NCT00608868|527522992|FG000|Overall Study|Physician Decision|2|||
146275702|NCT03853551|527522996|FG000|Overall Study|Death|2|||
146275703|NCT03853551|527522996|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
146275704|NCT01252355|527522997|FG000|Overall Study|Adverse Event|9|||
146275705|NCT01252355|527522998|FG001|Overall Study|Adverse Event|17|||
146145376|NCT02447991|527045170|FG001|Overall Study|Withdrawn by Subject - with data|4|||
146145377|NCT02447991|527045169|FG000|Overall Study|Lost to Follow-up - no data|3|||
146275706|NCT01252355|527522999|FG002|Overall Study|Adverse Event|22|||
146275707|NCT01252355|527522997|FG000|Overall Study|Lack of Efficacy|6|||
146275708|NCT01252355|527522998|FG001|Overall Study|Lack of Efficacy|4|||
146275709|NCT01252355|527522999|FG002|Overall Study|Lack of Efficacy|2|||
146275710|NCT01252355|527522997|FG000|Overall Study|Lost to Follow-up|0|||
146145378|NCT02447991|527045170|FG001|Overall Study|Lost to Follow-up - no data|6|||
146145379|NCT02447991|527045169|FG000|Overall Study|Lost to follow-up - with data|0|||
146145380|NCT02447991|527045170|FG001|Overall Study|Lost to follow-up - with data|3|||
146145381|NCT02447991|527045169|FG000|Overall Study|End of study - no treatment results|3|||
146275711|NCT01252355|527522998|FG001|Overall Study|Lost to Follow-up|0|||
146275712|NCT01252355|527522999|FG002|Overall Study|Lost to Follow-up|1|||
146275713|NCT01252355|527522997|FG000|Overall Study|Poor Compliance to Protocol|1|||
146275714|NCT01252355|527522998|FG001|Overall Study|Poor Compliance to Protocol|1|||
146275715|NCT01252355|527522999|FG002|Overall Study|Poor Compliance to Protocol|1|||
146275716|NCT01252355|527522997|FG000|Overall Study|Progressive Disease|2|||
146275717|NCT01252355|527522998|FG001|Overall Study|Progressive Disease|0|||
146275718|NCT01252355|527522999|FG002|Overall Study|Progressive Disease|0|||
146275719|NCT01252355|527522997|FG000|Overall Study|Sponsor Early Termination of Study|149|||
146275720|NCT01252355|527522998|FG001|Overall Study|Sponsor Early Termination of Study|149|||
146275721|NCT01252355|527522999|FG002|Overall Study|Sponsor Early Termination of Study|146|||
146275722|NCT01252355|527522997|FG000|Overall Study|Randomized but not Treated|2|||
146275723|NCT01252355|527522998|FG001|Overall Study|Randomized but not Treated|0|||
146275724|NCT01252355|527522999|FG002|Overall Study|Randomized but not Treated|0|||
146275725|NCT01252355|527522997|FG000|Overall Study|Other Than Above|8|||
146275726|NCT01252355|527522998|FG001|Overall Study|Other Than Above|7|||
146275727|NCT01252355|527522999|FG002|Overall Study|Other Than Above|7|||
146275728|NCT01876901|527523000|FG000|Overall Study|Protocol Violation|10|||
146275729|NCT01876901|527523001|FG001|Overall Study|Protocol Violation|2|||
146275730|NCT01876901|527523000|FG000|Overall Study|No or other surgical intervention|7|||
146275731|NCT01876901|527523001|FG001|Overall Study|No or other surgical intervention|5|||
146275732|NCT02242097|527523002|FG000|Ibrutinib Treatment|Adverse Event|16|||
146275733|NCT02242097|527523002|FG000|Ibrutinib Treatment|Physician Decision|1|||
146275734|NCT02242097|527523002|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
146275735|NCT02242097|527523002|FG000|Ibrutinib Treatment|Death|1|||
146275736|NCT02242097|527523002|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
146275737|NCT02242097|527523002|FG000|Post Therapy Follow Up|Death|3|||
146275738|NCT02242097|527523002|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
146275739|NCT03435692|527523005|FG000|Overall Study|Lack of Efficacy|2|||
146275740|NCT03435692|527523006|FG001|Overall Study|Lack of Efficacy|2|||
146275741|NCT03435692|527523007|FG002|Overall Study|Lack of Efficacy|0|||
146275742|NCT04313608|527523008|FG000|Overall Study|Death|12|||
146275743|NCT04313608|527523009|FG001|Overall Study|Death|3|||
146275744|NCT01145898|527523010|FG000|3-year Treatment|medication change by treating physician|3|||
146275745|NCT01145898|527523011|FG001|3-year Treatment|medication change by treating physician|16|||
146275746|NCT01712061|527523012|FG000|Overall Study|Adverse Event|4|||
146275747|NCT01712061|527523013|FG001|Overall Study|Adverse Event|9|||
146275748|NCT01712061|527523014|FG002|Overall Study|Adverse Event|5|||
146275749|NCT01712061|527523012|FG000|Overall Study|Death|0|||
146275750|NCT01712061|527523013|FG001|Overall Study|Death|0|||
146275751|NCT01712061|527523014|FG002|Overall Study|Death|1|||
146275752|NCT01712061|527523012|FG000|Overall Study|Lost to Follow-up|1|||
146275753|NCT01712061|527523013|FG001|Overall Study|Lost to Follow-up|0|||
146275754|NCT01712061|527523014|FG002|Overall Study|Lost to Follow-up|1|||
146275755|NCT01712061|527523012|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
146275756|NCT01712061|527523013|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
146275757|NCT01712061|527523014|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
146275758|NCT01712061|527523012|FG000|Overall Study|Medication Error Without Associated AE|0|||
146275759|NCT01712061|527523013|FG001|Overall Study|Medication Error Without Associated AE|1|||
146275760|NCT01712061|527523014|FG002|Overall Study|Medication Error Without Associated AE|0|||
146275761|NCT01712061|527523012|FG000|Overall Study|Withdrawal by Subject|1|||
146275762|NCT01712061|527523013|FG001|Overall Study|Withdrawal by Subject|7|||
146275763|NCT01712061|527523014|FG002|Overall Study|Withdrawal by Subject|1|||
146275764|NCT01712061|527523012|FG000|Overall Study|Other|0|||
146275765|NCT01712061|527523013|FG001|Overall Study|Other|3|||
146275766|NCT01712061|527523014|FG002|Overall Study|Other|0|||
146275767|NCT00879775|527523017|FG000|Overall Study|Lost to Follow-up|2|||
146275768|NCT00879775|527523018|FG001|Overall Study|Lost to Follow-up|1|||
146275769|NCT02440425|527523019|FG000|Overall Study|Death likely due to disease progression|1|||
146275770|NCT02440425|527523019|FG000|Overall Study|Withdrawal by Subject|2|||
146275771|NCT02440425|527523019|FG000|Overall Study|Adverse Event|1|||
146275772|NCT02440425|527523019|FG000|Overall Study|Adverse Event/Ineligible|1|||
146275773|NCT00842244|527523020|FG000|Overall Study|Death|3|||
146275774|NCT00842244|527523020|FG000|Overall Study|Withdrawal by Subject|1|||
146275775|NCT00842244|527523020|FG000|Overall Study|Other|17|||
146275776|NCT04145700|527523021|FG000|Overall Study|Withdrawal by Subject|8|||
146275777|NCT04145700|527523022|FG001|Overall Study|Withdrawal by Subject|3|||
146275778|NCT00780559|527523023|FG000|Overall Study|Lost to Follow-up|2|||
146275779|NCT00780559|527523024|FG001|Overall Study|Lost to Follow-up|7|||
146275780|NCT00780559|527523023|FG000|Overall Study|Death|1|||
146275781|NCT00780559|527523024|FG001|Overall Study|Death|0|||
146275782|NCT01327846|527523026|FG000|Core Phase|Subject decision (vital status: missing)|1|||
146275783|NCT01327846|527523027|FG001|Core Phase|Subject decision (vital status: missing)|2|||
146275784|NCT01327846|527523028|FG002|Core Phase|Subject decision (vital status: missing)|2|||
146275785|NCT01327846|527523029|FG003|Core Phase|Subject decision (vital status: missing)|1|||
146275786|NCT01327846|527523026|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
146275787|NCT01327846|527523027|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
146275788|NCT01327846|527523028|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
146275789|NCT01327846|527523029|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
146275790|NCT01327846|527523026|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
146275791|NCT01327846|527523027|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
146275792|NCT01327846|527523028|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
146275793|NCT01327846|527523029|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
146275794|NCT01327846|527523026|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
146275795|NCT01327846|527523027|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
146275796|NCT01327846|527523028|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
146275797|NCT01327846|527523029|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
146275798|NCT01327846|527523026|FG000|Core Phase|Lost to Follow-up|3|||
146275799|NCT01327846|527523027|FG001|Core Phase|Lost to Follow-up|3|||
146275800|NCT01327846|527523028|FG002|Core Phase|Lost to Follow-up|4|||
146275801|NCT01327846|527523029|FG003|Core Phase|Lost to Follow-up|5|||
146275802|NCT01327846|527523026|FG000|Extension Phase|Study terminated by sponsor|1073|||
146275803|NCT01327846|527523027|FG001|Extension Phase|Study terminated by sponsor|1124|||
146275804|NCT01327846|527523028|FG002|Extension Phase|Study terminated by sponsor|1067|||
146275805|NCT01327846|527523029|FG003|Extension Phase|Study terminated by sponsor|1660|||
146275806|NCT01327846|527523026|FG000|Extension Phase|Withdrawal by Subject|20|||
146275807|NCT01327846|527523027|FG001|Extension Phase|Withdrawal by Subject|13|||
146275808|NCT01327846|527523028|FG002|Extension Phase|Withdrawal by Subject|19|||
146275809|NCT01327846|527523029|FG003|Extension Phase|Withdrawal by Subject|37|||
146275810|NCT01327846|527523026|FG000|Extension Phase|Lost to Follow-up|4|||
146275811|NCT01327846|527523027|FG001|Extension Phase|Lost to Follow-up|3|||
146275812|NCT01327846|527523028|FG002|Extension Phase|Lost to Follow-up|4|||
146275813|NCT01327846|527523029|FG003|Extension Phase|Lost to Follow-up|7|||
146275814|NCT01327846|527523026|FG000|Extension Phase|Technical Problems|2|||
146275815|NCT01327846|527523027|FG001|Extension Phase|Technical Problems|4|||
146275816|NCT01327846|527523028|FG002|Extension Phase|Technical Problems|2|||
146275817|NCT01327846|527523029|FG003|Extension Phase|Technical Problems|2|||
146275818|NCT00203268|527523035|FG000|Early Treatment|only treated one headache|2|||
146275819|NCT00203268|527523035|FG000|Early Treatment|Lost to Follow-up|1|||
146275820|NCT00203268|527523035|FG000|Early Treatment|Withdrawal by Subject|1|||
146275821|NCT04343976|527523036|FG000|Overall Study|Withdrawal by Subject|0|||
146275822|NCT04343976|527523037|FG001|Overall Study|Withdrawal by Subject|1|||
146275823|NCT02807883|527523038|FG000|Overall Study|Withdrawal by Subject|2|||
146275824|NCT00594880|527523039|FG000|Overall Study|Withdrawal by Subject|1|||
146275825|NCT00594880|527523040|FG001|Overall Study|Withdrawal by Subject|1|||
146275826|NCT00594880|527523039|FG000|Overall Study|Lost to Follow-up|1|||
146275827|NCT00594880|527523040|FG001|Overall Study|Lost to Follow-up|0|||
146275828|NCT00694109|527523041|FG000|Overall Study|Physician Decision|3|||
146275829|NCT00694109|527523041|FG000|Overall Study|Adverse Event|74|||
146275830|NCT00694109|527523041|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
146275831|NCT00694109|527523041|FG000|Overall Study|Lack of Efficacy|2|||
146275832|NCT00694109|527523041|FG000|Overall Study|Withdrawal by Subject|13|||
146275833|NCT00694109|527523041|FG000|Overall Study|Pregnancy|1|||
146275834|NCT00694109|527523041|FG000|Overall Study|Enrolled but not treated|1|||
146275835|NCT00694109|527523041|FG000|Overall Study|Other|2|||
146275836|NCT00694109|527523041|FG000|Overall Study|Consented but no additional treatment|3|||
146275837|NCT01254747|527523044|FG000|Overall Study|Unacceptable subjective vision|0|||
146275838|NCT01254747|527523045|FG001|Overall Study|Unacceptable subjective vision|0|||
146275839|NCT01254747|527523046|FG002|Overall Study|Unacceptable subjective vision|0|||
146275840|NCT01254747|527523047|FG003|Overall Study|Unacceptable subjective vision|2|||
146275841|NCT01254747|527523044|FG000|Overall Study|Difficult removal handling|0|||
146275842|NCT01254747|527523045|FG001|Overall Study|Difficult removal handling|0|||
146275843|NCT01254747|527523046|FG002|Overall Study|Difficult removal handling|1|||
146275844|NCT01254747|527523047|FG003|Overall Study|Difficult removal handling|0|||
146275845|NCT01254747|527523044|FG000|Overall Study|Symptoms and problems|0|||
146275846|NCT01254747|527523045|FG001|Overall Study|Symptoms and problems|2|||
146275847|NCT01254747|527523046|FG002|Overall Study|Symptoms and problems|1|||
146275848|NCT01254747|527523047|FG003|Overall Study|Symptoms and problems|0|||
146275849|NCT01254747|527523044|FG000|Overall Study|Lost to Follow-up|0|||
146275850|NCT01254747|527523045|FG001|Overall Study|Lost to Follow-up|0|||
146275851|NCT01254747|527523046|FG002|Overall Study|Lost to Follow-up|1|||
146275852|NCT01254747|527523047|FG003|Overall Study|Lost to Follow-up|0|||
146275853|NCT01254747|527523044|FG000|Overall Study|Biomicroscopy|0|||
146275854|NCT01254747|527523045|FG001|Overall Study|Biomicroscopy|0|||
146275855|NCT01254747|527523046|FG002|Overall Study|Biomicroscopy|1|||
146275856|NCT01254747|527523047|FG003|Overall Study|Biomicroscopy|0|||
146275857|NCT01254747|527523044|FG000|Overall Study|Discomfort|0|||
146275858|NCT01254747|527523045|FG001|Overall Study|Discomfort|4|||
146275859|NCT01254747|527523046|FG002|Overall Study|Discomfort|0|||
146275860|NCT01254747|527523047|FG003|Overall Study|Discomfort|0|||
146275861|NCT00846807|527523048|FG000|Overall Study|Adverse Event|270|||
146275862|NCT00846807|527523048|FG000|Overall Study|Lost to Follow-up|94|||
146275863|NCT00846807|527523048|FG000|Overall Study|Withdrawal by Subject|56|||
146275864|NCT00846807|527523048|FG000|Overall Study|Non compliant with European label|7|||
146275865|NCT00846807|527523048|FG000|Overall Study|Switch to other anticoagulants|89|||
146275866|NCT00846807|527523048|FG000|Overall Study|No prescription after hospital discharge|56|||
146275867|NCT00846807|527523048|FG000|Overall Study|Other|60|||
146275868|NCT00737698|527523049|FG000|Overall Study|Withdrawal by Subject|6|||
146275869|NCT00737698|527523050|FG001|Overall Study|Withdrawal by Subject|5|||
146304504|NCT03700320|527629228|FG001|Overall Study|Adverse Event|31|||
146145382|NCT02447991|527045170|FG001|Overall Study|End of study - no treatment results|6|||
146145383|NCT02447991|527045169|FG000|Overall Study|End of study - partial treatment results|0|||
146145384|NCT02447991|527045170|FG001|Overall Study|End of study - partial treatment results|9|||
146145385|NCT02770391|527045173|FG000|Overall Study|Lost to Follow-up|2|||
146145386|NCT02770391|527045173|FG000|Overall Study|Withdrawal by Subject|1|||
146145387|NCT02770391|527045173|FG000|Overall Study|Surgery delayed unevaluable|2|||
146145388|NCT02770391|527045173|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
146145389|NCT03333486|527045176|FG000|Overall Study|Withdrawal by Subject|1|||
146145390|NCT03333486|527045176|FG000|Overall Study|Lost to Follow-up|1|||
146145391|NCT03246529|527045185|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
146145392|NCT03246529|527045186|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
146145393|NCT03246529|527045187|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
146145394|NCT03246529|527045185|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
146145395|NCT03246529|527045186|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
146145396|NCT03246529|527045187|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
146145397|NCT03246529|527045185|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
146145398|NCT03246529|527045186|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
146145399|NCT03246529|527045187|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
146145400|NCT03246529|527045185|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
146145401|NCT03246529|527045186|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
146145402|NCT03246529|527045187|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
146145403|NCT03246529|527045185|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
146145404|NCT03246529|527045186|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
146145405|NCT03246529|527045187|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
146145406|NCT03246529|527045185|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
146145407|NCT03246529|527045186|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
146145408|NCT03246529|527045187|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
146145409|NCT03246529|527045185|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
146145410|NCT03246529|527045186|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
146145411|NCT03246529|527045187|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
146145412|NCT03246529|527045185|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
146145413|NCT03246529|527045186|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
146145414|NCT03246529|527045187|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
146145415|NCT03246529|527045185|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
146145416|NCT03246529|527045186|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
146145417|NCT03246529|527045187|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
146145418|NCT03136068|527047229|FG000|Overall Study|Lost to Follow-up|1|||
146145419|NCT03136068|527047230|FG001|Overall Study|Lost to Follow-up|1|||
146145420|NCT03136068|527047229|FG000|Overall Study|Protocol Violation|1|||
146145421|NCT03136068|527047230|FG001|Overall Study|Protocol Violation|0|||
146145422|NCT01337089|527047231|FG000|Overall Study|Adverse Event|237|||
146145423|NCT01337089|527047231|FG000|Overall Study|Withdrawal by Subject|129|||
146145424|NCT01337089|527047231|FG000|Overall Study|Withdrawal by Investigator|33|||
146145425|NCT01337089|527047231|FG000|Overall Study|Met Withdrawal Criteria|3|||
146145426|NCT01337089|527047231|FG000|Overall Study|Lost to Follow-up|2|||
146145427|NCT01040871|527047232|FG000|Overall Study|Adverse Event|6|||
146145428|NCT01040871|527047233|FG001|Overall Study|Adverse Event|2|||
146145429|NCT01040871|527047232|FG000|Overall Study|Withdrawal by Subject|2|||
146145430|NCT01040871|527047233|FG001|Overall Study|Withdrawal by Subject|0|||
146145431|NCT01040871|527047232|FG000|Overall Study|Death|1|||
146145432|NCT01040871|527047233|FG001|Overall Study|Death|3|||
146145433|NCT01040871|527047232|FG000|Overall Study|Lack of Efficacy|1|||
146145434|NCT01040871|527047233|FG001|Overall Study|Lack of Efficacy|1|||
146145435|NCT01040871|527047232|FG000|Overall Study|drug supply issue|1|||
146145436|NCT01040871|527047233|FG001|Overall Study|drug supply issue|0|||
146145437|NCT01040871|527047232|FG000|Overall Study|Randomized and Not Treated|2|||
146145438|NCT01040871|527047233|FG001|Overall Study|Randomized and Not Treated|1|||
146145439|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
146145440|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
146145441|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
146145442|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
146145443|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Death|235|||
146145444|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Death|167|||
146145445|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Death|1|||
146145446|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Death|0|||
146145447|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
146145448|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
146145449|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
146145450|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
146304505|NCT03700320|527629227|FG000|Overall Study|Lack of Efficacy|2|||
146275870|NCT00737698|527523051|FG002|Overall Study|Withdrawal by Subject|3|||
146275871|NCT00737698|527523049|FG000|Overall Study|Death|0|||
146275872|NCT00737698|527523050|FG001|Overall Study|Death|0|||
146275873|NCT00737698|527523051|FG002|Overall Study|Death|1|||
146275874|NCT01067846|527523052|FG000|Overall Study|Lost to Follow-up|17|||
146275875|NCT01067846|527523053|FG001|Overall Study|Lost to Follow-up|19|||
146275876|NCT01067846|527523052|FG000|Overall Study|Withdrawal by Subject|1|||
146275877|NCT01067846|527523053|FG001|Overall Study|Withdrawal by Subject|0|||
146275878|NCT01067846|527523052|FG000|Overall Study|participation in other tx study|1|||
146275879|NCT01067846|527523053|FG001|Overall Study|participation in other tx study|0|||
146275880|NCT02817906|527523054|FG000|Overall Study|Adverse Event|3|||
146275881|NCT02817906|527523055|FG001|Overall Study|Adverse Event|0|||
146275882|NCT02817906|527523054|FG000|Overall Study|Lack of Efficacy|1|||
146275883|NCT02817906|527523055|FG001|Overall Study|Lack of Efficacy|0|||
146275884|NCT02817906|527523054|FG000|Overall Study|Protocol Violation|1|||
146275885|NCT02817906|527523055|FG001|Overall Study|Protocol Violation|1|||
146275886|NCT02817906|527523054|FG000|Overall Study|Study Terminated by Sponsor|2|||
146275887|NCT02817906|527523055|FG001|Overall Study|Study Terminated by Sponsor|2|||
146275888|NCT02817906|527523054|FG000|Overall Study|Withdrawal by Subject|7|||
146275889|NCT02817906|527523055|FG001|Overall Study|Withdrawal by Subject|0|||
146275890|NCT02817906|527523054|FG000|Overall Study|Other|2|||
146275891|NCT02817906|527523055|FG001|Overall Study|Other|2|||
146275892|NCT03686423|527523063|FG000|Overall Study|Withdrawal by Subject|9|||
146275893|NCT03686423|527523063|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
146275894|NCT04608773|527523064|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
146275895|NCT04608773|527523065|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
146275896|NCT04608773|527523064|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
146275897|NCT04608773|527523065|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146275898|NCT04608773|527523064|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
146275899|NCT04608773|527523065|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
146275900|NCT04608773|527523064|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
146275901|NCT04608773|527523065|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
146275902|NCT04608773|527523064|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
146275903|NCT04608773|527523065|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
146275904|NCT02833077|527523066|FG000|Overall Study|Adverse Event|1|||
146275905|NCT02833077|527523067|FG001|Overall Study|Adverse Event|2|||
146275906|NCT02833077|527523066|FG000|Overall Study|Lost to Follow-up|10|||
146275907|NCT02833077|527523067|FG001|Overall Study|Lost to Follow-up|1|||
146275908|NCT02833077|527523066|FG000|Overall Study|Personal Reasons|6|||
146275909|NCT02833077|527523067|FG001|Overall Study|Personal Reasons|4|||
146275910|NCT02833077|527523066|FG000|Overall Study|Protocol Deviation|0|||
146275911|NCT02833077|527523067|FG001|Overall Study|Protocol Deviation|1|||
146275912|NCT00972322|527523070|FG000|Overall Study|Adverse Event|2|||
146275913|NCT00972322|527523071|FG001|Overall Study|Adverse Event|1|||
146275914|NCT00972322|527523070|FG000|Overall Study|Positive drug screen|0|||
146275915|NCT00972322|527523071|FG001|Overall Study|Positive drug screen|1|||
146275916|NCT00972322|527523070|FG000|Overall Study|Lost to Follow-up|0|||
146275917|NCT00972322|527523071|FG001|Overall Study|Lost to Follow-up|1|||
146275918|NCT00972322|527523070|FG000|Overall Study|Consistently high glucose values|1|||
146275919|NCT00972322|527523071|FG001|Overall Study|Consistently high glucose values|0|||
146275920|NCT04958200|527523072|FG000|Overall Study|Withdrawal by Subject|0|||
146275921|NCT04958200|527523073|FG001|Overall Study|Withdrawal by Subject|2|||
146275922|NCT04958200|527523072|FG000|Overall Study|Lost to Follow-up|3|||
146275923|NCT04958200|527523073|FG001|Overall Study|Lost to Follow-up|2|||
146275924|NCT02387970|527523074|FG000|Overall Study|Did not complete 1-year follow up|1|||
146275925|NCT02387970|527523075|FG001|Overall Study|Did not complete 1-year follow up|2|||
146275926|NCT00316017|527523082|FG000|Overall Study|Protocol Violation|11|||
146275927|NCT00316017|527523083|FG001|Overall Study|Protocol Violation|13|||
146275928|NCT00316017|527523084|FG002|Overall Study|Protocol Violation|19|||
146275929|NCT05511038|527523096|FG000|Overall|Withdrawal by Subject|5|||
146275930|NCT05511038|527523097|FG001|Overall|Withdrawal by Subject|3|||
146275931|NCT05511038|527523096|FG000|Overall|Screen Failure|20|||
146275932|NCT05511038|527523097|FG001|Overall|Screen Failure|1|||
146275933|NCT05511038|527523096|FG000|Overall|Physician Decision|3|||
146275934|NCT05511038|527523097|FG001|Overall|Physician Decision|0|||
146275935|NCT05511038|527523096|FG000|Overall|Lost to Follow-up|3|||
146275936|NCT05511038|527523097|FG001|Overall|Lost to Follow-up|0|||
146275937|NCT05511038|527523096|FG000|Overall|Death|1|||
146275938|NCT05511038|527523097|FG001|Overall|Death|0|||
146275939|NCT05511038|527523096|FG000|Screening|Withdrawal by Subject|1|||
146275940|NCT05511038|527523097|FG001|Screening|Withdrawal by Subject|0|||
146275941|NCT05511038|527523096|FG000|Screening|Lost to Follow Up (1 participant)|1|||
146275942|NCT05511038|527523097|FG001|Screening|Lost to Follow Up (1 participant)|0|||
146275943|NCT05511038|527523096|FG000|Screening|Screen Failure|3|||
146275944|NCT05511038|527523097|FG001|Screening|Screen Failure|0|||
146275945|NCT05511038|527523096|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
146275946|NCT05511038|527523097|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
146145451|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
146145452|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
146145453|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
146145454|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
146145455|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Other|1|||
146145456|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Other|2|||
146145457|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Other|0|||
146145458|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Other|0|||
146145459|NCT00673049|527047235|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
146145460|NCT00673049|527047236|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
146145461|NCT00673049|527047237|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
146145462|NCT00673049|527047238|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
146145463|NCT00673049|527047235|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
146145464|NCT00673049|527047236|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
146145465|NCT00673049|527047237|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
146304506|NCT03700320|527629228|FG001|Overall Study|Lack of Efficacy|5|||
146304507|NCT03700320|527629227|FG000|Overall Study|Withdrawal by Subject|29|||
146304508|NCT03700320|527629228|FG001|Overall Study|Withdrawal by Subject|75|||
146304509|NCT03700320|527629227|FG000|Overall Study|Lost to Follow-up|16|||
146304510|NCT03700320|527629228|FG001|Overall Study|Lost to Follow-up|23|||
146304511|NCT03700320|527629227|FG000|Overall Study|Pregnancy|2|||
146304512|NCT03700320|527629228|FG001|Overall Study|Pregnancy|4|||
146304513|NCT03700320|527629227|FG000|Overall Study|Protocol Deviation|7|||
146304514|NCT03700320|527629228|FG001|Overall Study|Protocol Deviation|31|||
146304515|NCT03700320|527629227|FG000|Overall Study|Non-compliance with Study Drug|1|||
146304516|NCT03700320|527629228|FG001|Overall Study|Non-compliance with Study Drug|3|||
146304517|NCT03700320|527629227|FG000|Overall Study|Reason not Specified|0|||
146304518|NCT03700320|527629228|FG001|Overall Study|Reason not Specified|1|||
146304519|NCT01770912|527629233|FG000|Overall Study|Lost to Follow-up|2|||
146304520|NCT01770912|527629234|FG001|Overall Study|Lost to Follow-up|0|||
146304521|NCT00430482|527629236|FG000|Completed Treatment|Insufficient Treatment|7|||
146304522|NCT00430482|527629237|FG001|Completed Treatment|Insufficient Treatment|11|||
146145466|NCT00673049|527047238|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
146275947|NCT05511038|527523096|FG000|Treatment|Withdrawal by Subject|5|||
146275948|NCT05511038|527523097|FG001|Treatment|Withdrawal by Subject|3|||
146275949|NCT05511038|527523096|FG000|Treatment|Physician Decision|4|||
146275950|NCT05511038|527523097|FG001|Treatment|Physician Decision|0|||
146275951|NCT05511038|527523096|FG000|Treatment|Lost to Follow-up|2|||
146275952|NCT05511038|527523097|FG001|Treatment|Lost to Follow-up|0|||
146275953|NCT05511038|527523096|FG000|Treatment|Death|1|||
146275954|NCT05511038|527523097|FG001|Treatment|Death|0|||
146275955|NCT05511038|527523096|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
146275956|NCT05511038|527523097|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
146275957|NCT05511038|527523096|FG000|Treatment|Refuse by subject|1|||
146275958|NCT05511038|527523097|FG001|Treatment|Refuse by subject|0|||
146275959|NCT05511038|527523096|FG000|Treatment|Subject did not go to the site for visit|1|||
146275960|NCT05511038|527523097|FG001|Treatment|Subject did not go to the site for visit|0|||
146275961|NCT05543187|527523100|FG000|Overall Study|Ongoing|3|||
146275962|NCT05543187|527523101|FG001|Overall Study|Ongoing|2|||
146275963|NCT04777864|527523102|FG000|Overall Study|Lost to Follow-up|8|||
146275964|NCT04777864|527523103|FG001|Overall Study|Lost to Follow-up|19|||
146275965|NCT05718466|527524971|FG000|Overall Study|Withdrawal by Subject|1|||
146275966|NCT05718466|527524972|FG001|Overall Study|Withdrawal by Subject|2|||
146275967|NCT05718466|527524971|FG000|Overall Study|Death|0|||
146275968|NCT05718466|527524972|FG001|Overall Study|Death|1|||
146275969|NCT00387426|527524973|FG000|Overall Study|Lack of Response|7|||
146275970|NCT00387426|527524973|FG000|Overall Study|Toxicities|4|||
146275971|NCT00387426|527524973|FG000|Overall Study|Disease Progression|3|||
146275972|NCT01253135|527524974|FG000|Original Protocol|Protocol Amendment|15|||
146275973|NCT01253135|527524974|FG000|Amended Protocol|Non-compliance|1|||
146275974|NCT01901432|527524975|FG000|Overall Study|Adverse Event|0|||
146275975|NCT01901432|527524976|FG001|Overall Study|Adverse Event|1|||
146275976|NCT01901432|527524977|FG002|Overall Study|Adverse Event|1|||
146275977|NCT01901432|527524978|FG003|Overall Study|Adverse Event|0|||
146145467|NCT00673049|527047235|FG000|After Progression on Erlotinib|Death|0|||
146275978|NCT01901432|527524979|FG004|Overall Study|Adverse Event|1|||
146275979|NCT01901432|527524975|FG000|Overall Study|Withdrawal by Subject|0|||
146275980|NCT01901432|527524976|FG001|Overall Study|Withdrawal by Subject|0|||
146275981|NCT01901432|527524977|FG002|Overall Study|Withdrawal by Subject|1|||
146304523|NCT00555477|527629238|FG000|Overall Study|Adverse Event|0|||
146304524|NCT00555477|527629239|FG001|Overall Study|Adverse Event|9|||
146145468|NCT00673049|527047236|FG001|After Progression on Erlotinib|Death|0|||
146275982|NCT01901432|527524978|FG003|Overall Study|Withdrawal by Subject|0|||
146304525|NCT00555477|527629238|FG000|Overall Study|Withdrawal by Subject|1|||
146304526|NCT00555477|527629239|FG001|Overall Study|Withdrawal by Subject|2|||
146275983|NCT01901432|527524979|FG004|Overall Study|Withdrawal by Subject|5|||
146275984|NCT01901432|527524975|FG000|Overall Study|Physician Decision|0|||
146275985|NCT01901432|527524976|FG001|Overall Study|Physician Decision|0|||
146275986|NCT01901432|527524977|FG002|Overall Study|Physician Decision|0|||
146275987|NCT01901432|527524978|FG003|Overall Study|Physician Decision|0|||
146275988|NCT01901432|527524979|FG004|Overall Study|Physician Decision|2|||
146275989|NCT01901432|527524975|FG000|Overall Study|Patient decision to stop study drug|0|||
146275990|NCT01901432|527524976|FG001|Overall Study|Patient decision to stop study drug|0|||
146275991|NCT01901432|527524977|FG002|Overall Study|Patient decision to stop study drug|0|||
146275992|NCT01901432|527524978|FG003|Overall Study|Patient decision to stop study drug|0|||
146275993|NCT01901432|527524979|FG004|Overall Study|Patient decision to stop study drug|1|||
146275994|NCT00379288|527524980|FG000|Overall Study|Adverse Event|5|||
146275995|NCT00379288|527524981|FG001|Overall Study|Adverse Event|6|||
146275996|NCT00379288|527524982|FG002|Overall Study|Adverse Event|2|||
146275997|NCT00379288|527524983|FG003|Overall Study|Adverse Event|0|||
146275998|NCT00379288|527524980|FG000|Overall Study|Treatment Failure|0|||
146275999|NCT00379288|527524981|FG001|Overall Study|Treatment Failure|1|||
146276000|NCT00379288|527524982|FG002|Overall Study|Treatment Failure|0|||
146276001|NCT00379288|527524983|FG003|Overall Study|Treatment Failure|1|||
146276002|NCT00379288|527524980|FG000|Overall Study|Lost to Follow-up|3|||
146276003|NCT00379288|527524981|FG001|Overall Study|Lost to Follow-up|3|||
146276004|NCT00379288|527524982|FG002|Overall Study|Lost to Follow-up|2|||
146276005|NCT00379288|527524983|FG003|Overall Study|Lost to Follow-up|0|||
146276006|NCT00379288|527524980|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
146276007|NCT00379288|527524981|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
146276008|NCT00379288|527524982|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
146276009|NCT00379288|527524983|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
146276010|NCT00379288|527524980|FG000|Overall Study|Subject withdrew-related to study drug|1|||
146276011|NCT00379288|527524981|FG001|Overall Study|Subject withdrew-related to study drug|0|||
146276012|NCT00379288|527524982|FG002|Overall Study|Subject withdrew-related to study drug|0|||
146276013|NCT00379288|527524983|FG003|Overall Study|Subject withdrew-related to study drug|1|||
146276014|NCT00379288|527524980|FG000|Overall Study|Noncompliance with protocol|8|||
146276015|NCT00379288|527524981|FG001|Overall Study|Noncompliance with protocol|6|||
146276016|NCT00379288|527524982|FG002|Overall Study|Noncompliance with protocol|2|||
146276017|NCT00379288|527524983|FG003|Overall Study|Noncompliance with protocol|1|||
146276018|NCT00379288|527524980|FG000|Overall Study|Did not meet protocol eligibility|0|||
146276019|NCT00379288|527524981|FG001|Overall Study|Did not meet protocol eligibility|1|||
146276020|NCT00379288|527524982|FG002|Overall Study|Did not meet protocol eligibility|0|||
146276021|NCT00379288|527524983|FG003|Overall Study|Did not meet protocol eligibility|2|||
146276022|NCT00379288|527524980|FG000|Overall Study|Administrative|2|||
146276023|NCT00379288|527524981|FG001|Overall Study|Administrative|2|||
146276024|NCT00379288|527524982|FG002|Overall Study|Administrative|0|||
146276025|NCT00379288|527524983|FG003|Overall Study|Administrative|1|||
146276026|NCT00918879|527524984|FG000|Overall Study|Withdrawal by Subject|4|||
146276027|NCT00918879|527524985|FG001|Overall Study|Withdrawal by Subject|4|||
146276028|NCT00918879|527524984|FG000|Overall Study|Lost to Follow-up|1|||
146276029|NCT00918879|527524985|FG001|Overall Study|Lost to Follow-up|1|||
146276030|NCT00918879|527524984|FG000|Overall Study|Severe non-compliance to protocol|1|||
146276031|NCT00918879|527524985|FG001|Overall Study|Severe non-compliance to protocol|1|||
146276032|NCT00357110|527524988|FG000|Overall Study|Early study termination|5|||
146276033|NCT00357110|527524989|FG001|Overall Study|Early study termination|5|||
146276034|NCT01255631|527524992|FG000|Overall Study|poor enrollment, no data analyzed|9|||
146276035|NCT01255631|527524993|FG001|Overall Study|poor enrollment, no data analyzed|6|||
146276036|NCT03339245|527524996|FG000|Overall Study|Adverse Event|1|||
146276037|NCT03339245|527524997|FG001|Overall Study|Adverse Event|1|||
146276038|NCT03339245|527524996|FG000|Overall Study|Withdrawal by Subject|1|||
146276039|NCT03339245|527524997|FG001|Overall Study|Withdrawal by Subject|0|||
146276040|NCT00515671|527524998|FG000|Overall Study|Lost to Follow-up|13|||
146276041|NCT00515671|527524999|FG001|Overall Study|Lost to Follow-up|10|||
146276042|NCT00515671|527524998|FG000|Overall Study|Withdrawal by Subject|3|||
146276043|NCT00515671|527524999|FG001|Overall Study|Withdrawal by Subject|5|||
146276044|NCT00515671|527524998|FG000|Overall Study|incarcerated|1|||
146276045|NCT00515671|527524999|FG001|Overall Study|incarcerated|2|||
146276046|NCT00288639|527525011|FG000|Overall Study|Adverse Event|5|||
146276047|NCT00288639|527525011|FG000|Overall Study|Lack of Efficacy|4|||
146276048|NCT00288639|527525011|FG000|Overall Study|Withdrawal by Subject|2|||
146276049|NCT00288639|527525011|FG000|Overall Study|Other|1|||
146276050|NCT02815579|527525017|FG000|Overall Study|Non-payment of loan down-payment|16|||
146276051|NCT02815579|527525018|FG001|Overall Study|Non-payment of loan down-payment|0|||
146276052|NCT02815579|527525017|FG000|Overall Study|Withdrawal by Subject|7|||
146276053|NCT02815579|527525018|FG001|Overall Study|Withdrawal by Subject|1|||
146276054|NCT02815579|527525017|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
146276055|NCT02815579|527525018|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
146276056|NCT02815579|527525017|FG000|Overall Study|Lost to Follow-up|7|||
146276057|NCT02815579|527525018|FG001|Overall Study|Lost to Follow-up|4|||
146276058|NCT02815579|527525017|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
146276059|NCT02815579|527525018|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
146276060|NCT02815579|527525017|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
146276061|NCT02815579|527525018|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
146276062|NCT02815579|527525017|FG000|Overall Study|Death|5|||
146276063|NCT02815579|527525018|FG001|Overall Study|Death|4|||
146276064|NCT02815579|527525017|FG000|Overall Study|Imprisoned|0|||
146276065|NCT02815579|527525018|FG001|Overall Study|Imprisoned|2|||
146276066|NCT02815579|527525017|FG000|Overall Study|Did not meet enrollment criteria|0|||
146276067|NCT02815579|527525018|FG001|Overall Study|Did not meet enrollment criteria|1|||
146276068|NCT02311673|527525022|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146276069|NCT02311673|527525023|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146276070|NCT02311673|527525024|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
146276071|NCT02311673|527525025|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
146276072|NCT01014208|527525026|FG000|Overall Study|Lost to Follow-up|2|||
146276073|NCT01014208|527525027|FG001|Overall Study|Lost to Follow-up|5|||
146276074|NCT01014208|527525026|FG000|Overall Study|Participant Withdrew Consent|12|||
146276075|NCT01014208|527525027|FG001|Overall Study|Participant Withdrew Consent|12|||
146276076|NCT01014208|527525026|FG000|Overall Study|Did Not Receive Study Drug|2|||
146276077|NCT01014208|527525027|FG001|Overall Study|Did Not Receive Study Drug|0|||
146276078|NCT01014208|527525026|FG000|Overall Study|Study Closed/terminated|78|||
146276079|NCT01014208|527525027|FG001|Overall Study|Study Closed/terminated|83|||
146276080|NCT00414908|527525030|FG000|Overall Study|Protocol Violation|1|||
146276081|NCT00414908|527525031|FG001|Overall Study|Protocol Violation|1|||
146276082|NCT01076153|527525032|FG000|Overall Study|Symptoms improved/resolved|10|||
146276083|NCT01076153|527525032|FG000|Overall Study|Adverse Event|1|||
146276084|NCT03330405|527525033|FG000|Overall Study|Other|1|||
146276085|NCT03330405|527525034|FG001|Overall Study|Other|3|||
146276086|NCT03330405|527525035|FG002|Overall Study|Other|1|||
146276087|NCT03330405|527525036|FG003|Overall Study|Other|0|||
146276088|NCT03330405|527525037|FG004|Overall Study|Other|2|||
146276089|NCT03330405|527525038|FG005|Overall Study|Other|0|||
146276090|NCT03330405|527525039|FG006|Overall Study|Other|1|||
146276091|NCT03330405|527525040|FG007|Overall Study|Other|0|||
146276092|NCT03330405|527525041|FG008|Overall Study|Other|0|||
146276093|NCT03330405|527525042|FG009|Overall Study|Other|0|||
146276094|NCT03330405|527525043|FG010|Overall Study|Other|0|||
146276095|NCT03330405|527525033|FG000|Overall Study|Progressive disease|8|||
146276096|NCT03330405|527525034|FG001|Overall Study|Progressive disease|27|||
146276097|NCT03330405|527525035|FG002|Overall Study|Progressive disease|4|||
146276098|NCT03330405|527525036|FG003|Overall Study|Progressive disease|18|||
146276099|NCT03330405|527525037|FG004|Overall Study|Progressive disease|16|||
146276100|NCT03330405|527525038|FG005|Overall Study|Progressive disease|14|||
146276101|NCT03330405|527525039|FG006|Overall Study|Progressive disease|7|||
146276102|NCT03330405|527525040|FG007|Overall Study|Progressive disease|29|||
146276103|NCT03330405|527525041|FG008|Overall Study|Progressive disease|9|||
146276104|NCT03330405|527525042|FG009|Overall Study|Progressive disease|11|||
146276105|NCT03330405|527525043|FG010|Overall Study|Progressive disease|5|||
146276106|NCT03330405|527525033|FG000|Overall Study|Withdrawal by Subject|1|||
146276107|NCT03330405|527525034|FG001|Overall Study|Withdrawal by Subject|4|||
146276108|NCT03330405|527525035|FG002|Overall Study|Withdrawal by Subject|0|||
146276109|NCT03330405|527525036|FG003|Overall Study|Withdrawal by Subject|1|||
146276110|NCT03330405|527525037|FG004|Overall Study|Withdrawal by Subject|1|||
146276111|NCT03330405|527525038|FG005|Overall Study|Withdrawal by Subject|1|||
146276112|NCT03330405|527525039|FG006|Overall Study|Withdrawal by Subject|0|||
146276113|NCT03330405|527525040|FG007|Overall Study|Withdrawal by Subject|2|||
146276114|NCT03330405|527525041|FG008|Overall Study|Withdrawal by Subject|2|||
146276115|NCT03330405|527525042|FG009|Overall Study|Withdrawal by Subject|1|||
146276116|NCT03330405|527525043|FG010|Overall Study|Withdrawal by Subject|1|||
146276117|NCT03330405|527525033|FG000|Overall Study|Global deterioration of health status|2|||
146276118|NCT03330405|527525034|FG001|Overall Study|Global deterioration of health status|3|||
146276119|NCT03330405|527525035|FG002|Overall Study|Global deterioration of health status|0|||
146276120|NCT03330405|527525036|FG003|Overall Study|Global deterioration of health status|2|||
146276121|NCT03330405|527525037|FG004|Overall Study|Global deterioration of health status|3|||
146276122|NCT03330405|527525038|FG005|Overall Study|Global deterioration of health status|3|||
146276123|NCT03330405|527525039|FG006|Overall Study|Global deterioration of health status|0|||
146276124|NCT03330405|527525040|FG007|Overall Study|Global deterioration of health status|2|||
146276125|NCT03330405|527525041|FG008|Overall Study|Global deterioration of health status|8|||
146276126|NCT03330405|527525042|FG009|Overall Study|Global deterioration of health status|4|||
146276127|NCT03330405|527525043|FG010|Overall Study|Global deterioration of health status|1|||
146276128|NCT03330405|527525033|FG000|Overall Study|Adverse Event|0|||
146276129|NCT03330405|527525034|FG001|Overall Study|Adverse Event|1|||
146276130|NCT03330405|527525035|FG002|Overall Study|Adverse Event|0|||
146276131|NCT03330405|527525036|FG003|Overall Study|Adverse Event|1|||
146145469|NCT00673049|527047237|FG002|After Progression on Erlotinib|Death|0|||
146145470|NCT00673049|527047238|FG003|After Progression on Erlotinib|Death|71|||
146145471|NCT00673049|527047235|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
146145472|NCT00673049|527047236|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
146145473|NCT00673049|527047237|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
146145474|NCT00673049|527047238|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
146145475|NCT00673049|527047235|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
146145476|NCT00673049|527047236|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
146145477|NCT00673049|527047237|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
146145478|NCT00673049|527047238|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
146145479|NCT00673049|527047235|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
146145480|NCT00673049|527047236|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
146145481|NCT00673049|527047237|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
146145482|NCT00673049|527047238|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
146145483|NCT02044510|527047239|FG000|Overall Study|Adverse Event|1|||
146145484|NCT02044510|527047240|FG001|Overall Study|Adverse Event|2|||
146145485|NCT01175824|527047241|FG000|Overall Study|Adverse Event|2|||
146145486|NCT01175824|527047242|FG001|Overall Study|Adverse Event|1|||
146145487|NCT01175824|527047241|FG000|Overall Study|Lack of Efficacy|2|||
146145488|NCT01175824|527047242|FG001|Overall Study|Lack of Efficacy|0|||
146145489|NCT01175824|527047241|FG000|Overall Study|Lost to Follow-up|0|||
146145490|NCT01175824|527047242|FG001|Overall Study|Lost to Follow-up|1|||
146145491|NCT01175824|527047241|FG000|Overall Study|Physician Decision|0|||
146145492|NCT01175824|527047242|FG001|Overall Study|Physician Decision|4|||
146145493|NCT01175824|527047241|FG000|Overall Study|Protocol Violation|2|||
146145494|NCT01175824|527047242|FG001|Overall Study|Protocol Violation|5|||
146145495|NCT01175824|527047241|FG000|Overall Study|Withdrawal by Subject|3|||
146145496|NCT01175824|527047242|FG001|Overall Study|Withdrawal by Subject|7|||
146145497|NCT01175824|527047241|FG000|Overall Study|Sponsor Decision|1|||
146145498|NCT01175824|527047242|FG001|Overall Study|Sponsor Decision|0|||
146145499|NCT01175824|527047241|FG000|Overall Study|Entry Criteria Not Met|6|||
146145500|NCT01175824|527047242|FG001|Overall Study|Entry Criteria Not Met|4|||
146145501|NCT03455855|527047243|FG000|Overall Study|Lost to Follow-up|4|||
146145502|NCT03455855|527047244|FG001|Overall Study|Lost to Follow-up|2|||
146145503|NCT02979535|527047245|FG000|Overall Study|Non compliance with the protocol|78|||
146145504|NCT02979535|527047246|FG001|Overall Study|Non compliance with the protocol|82|||
146145505|NCT02979535|527047245|FG000|Overall Study|Consent withdrawn by participant|11|||
146145506|NCT02979535|527047246|FG001|Overall Study|Consent withdrawn by participant|18|||
146145507|NCT02979535|527047245|FG000|Overall Study|Lost to Follow-up|6|||
146145508|NCT02979535|527047246|FG001|Overall Study|Lost to Follow-up|1|||
146145509|NCT04820673|527047247|FG000|Overall Study|Adverse Event|6|||
146145510|NCT04820673|527047247|FG000|Overall Study|Due to Lack of Effectiveness|1|||
146145511|NCT04820673|527047247|FG000|Overall Study|Pregnancy|1|||
146145512|NCT04820673|527047247|FG000|Overall Study|Voluntary Withdrawal|20|||
146145513|NCT04820673|527047247|FG000|Overall Study|Lost to Follow-up|10|||
146145514|NCT00587587|527047248|FG000|Overall Study|Lost to Follow-up|6|||
146145515|NCT00587587|527047249|FG001|Overall Study|Lost to Follow-up|1|||
146145516|NCT00767000|527047255|FG000|54-week Study|Adverse Event|4|||
146145517|NCT00767000|527047256|FG001|54-week Study|Adverse Event|6|||
146145518|NCT00767000|527047257|FG002|54-week Study|Adverse Event|6|||
146145519|NCT00767000|527047258|FG003|54-week Study|Adverse Event|8|||
146145520|NCT00767000|527047259|FG004|54-week Study|Adverse Event|4|||
146145521|NCT00767000|527047255|FG000|54-week Study|Creaninine/creatinine clearance|2|||
146145522|NCT00767000|527047256|FG001|54-week Study|Creaninine/creatinine clearance|1|||
146145523|NCT00767000|527047257|FG002|54-week Study|Creaninine/creatinine clearance|2|||
146145524|NCT00767000|527047258|FG003|54-week Study|Creaninine/creatinine clearance|2|||
146145525|NCT00767000|527047259|FG004|54-week Study|Creaninine/creatinine clearance|4|||
146145526|NCT00767000|527047255|FG000|54-week Study|Hyperglycemia|0|||
146145527|NCT00767000|527047256|FG001|54-week Study|Hyperglycemia|0|||
146276132|NCT03330405|527525037|FG004|Overall Study|Adverse Event|1|||
146276133|NCT03330405|527525038|FG005|Overall Study|Adverse Event|1|||
146276134|NCT03330405|527525039|FG006|Overall Study|Adverse Event|3|||
146276135|NCT03330405|527525040|FG007|Overall Study|Adverse Event|4|||
146276136|NCT03330405|527525041|FG008|Overall Study|Adverse Event|2|||
146145528|NCT00767000|527047257|FG002|54-week Study|Hyperglycemia|1|||
146145529|NCT00767000|527047258|FG003|54-week Study|Hyperglycemia|0|||
146145530|NCT00767000|527047259|FG004|54-week Study|Hyperglycemia|1|||
146145531|NCT00767000|527047255|FG000|54-week Study|Hypoglycemia|0|||
146145532|NCT00767000|527047256|FG001|54-week Study|Hypoglycemia|1|||
146145533|NCT00767000|527047257|FG002|54-week Study|Hypoglycemia|0|||
146145534|NCT00767000|527047258|FG003|54-week Study|Hypoglycemia|0|||
146145535|NCT00767000|527047259|FG004|54-week Study|Hypoglycemia|0|||
146145536|NCT00767000|527047255|FG000|54-week Study|Interruption of study medication|0|||
146145537|NCT00767000|527047256|FG001|54-week Study|Interruption of study medication|0|||
146145538|NCT00767000|527047257|FG002|54-week Study|Interruption of study medication|1|||
146276137|NCT03330405|527525042|FG009|Overall Study|Adverse Event|2|||
146145539|NCT00767000|527047258|FG003|54-week Study|Interruption of study medication|0|||
146145540|NCT00767000|527047259|FG004|54-week Study|Interruption of study medication|0|||
146145541|NCT00767000|527047255|FG000|54-week Study|Lack of Efficacy|2|||
146145542|NCT00767000|527047256|FG001|54-week Study|Lack of Efficacy|0|||
146145543|NCT00767000|527047257|FG002|54-week Study|Lack of Efficacy|1|||
146145544|NCT00767000|527047258|FG003|54-week Study|Lack of Efficacy|0|||
146145545|NCT00767000|527047259|FG004|54-week Study|Lack of Efficacy|5|||
146145546|NCT00767000|527047255|FG000|54-week Study|Lost to Follow-up|4|||
146145547|NCT00767000|527047256|FG001|54-week Study|Lost to Follow-up|0|||
146145548|NCT00767000|527047257|FG002|54-week Study|Lost to Follow-up|1|||
146145549|NCT00767000|527047258|FG003|54-week Study|Lost to Follow-up|4|||
146145550|NCT00767000|527047259|FG004|54-week Study|Lost to Follow-up|2|||
146145551|NCT00767000|527047255|FG000|54-week Study|Physician Decision|4|||
146145552|NCT00767000|527047256|FG001|54-week Study|Physician Decision|0|||
146145553|NCT00767000|527047257|FG002|54-week Study|Physician Decision|1|||
146145554|NCT00767000|527047258|FG003|54-week Study|Physician Decision|1|||
146145555|NCT00767000|527047259|FG004|54-week Study|Physician Decision|1|||
146145556|NCT00767000|527047255|FG000|54-week Study|Progressive disease|0|||
146145557|NCT00767000|527047256|FG001|54-week Study|Progressive disease|0|||
146145558|NCT00767000|527047257|FG002|54-week Study|Progressive disease|1|||
146145559|NCT00767000|527047258|FG003|54-week Study|Progressive disease|0|||
146145560|NCT00767000|527047259|FG004|54-week Study|Progressive disease|0|||
146145561|NCT00767000|527047255|FG000|54-week Study|Protocol Violation|0|||
146145562|NCT00767000|527047256|FG001|54-week Study|Protocol Violation|0|||
146145563|NCT00767000|527047257|FG002|54-week Study|Protocol Violation|1|||
146145564|NCT00767000|527047258|FG003|54-week Study|Protocol Violation|2|||
146145565|NCT00767000|527047259|FG004|54-week Study|Protocol Violation|0|||
146145566|NCT00767000|527047255|FG000|54-week Study|Withdrawal by Subject|2|||
146145567|NCT00767000|527047256|FG001|54-week Study|Withdrawal by Subject|3|||
146145568|NCT00767000|527047257|FG002|54-week Study|Withdrawal by Subject|5|||
146145569|NCT00767000|527047258|FG003|54-week Study|Withdrawal by Subject|11|||
146145570|NCT00767000|527047259|FG004|54-week Study|Withdrawal by Subject|13|||
146145571|NCT00767000|527047255|FG000|54-week Study|Study terminated by sponsor|90|||
146145572|NCT00767000|527047256|FG001|54-week Study|Study terminated by sponsor|102|||
146145573|NCT00767000|527047257|FG002|54-week Study|Study terminated by sponsor|89|||
146145574|NCT00767000|527047258|FG003|54-week Study|Study terminated by sponsor|196|||
146145575|NCT00767000|527047259|FG004|54-week Study|Study terminated by sponsor|194|||
146145576|NCT00767000|527047255|FG000|54-week Study|Reason not reported|0|||
146145577|NCT00767000|527047256|FG001|54-week Study|Reason not reported|0|||
146145578|NCT00767000|527047257|FG002|54-week Study|Reason not reported|0|||
146145579|NCT00767000|527047258|FG003|54-week Study|Reason not reported|1|||
146145580|NCT00767000|527047259|FG004|54-week Study|Reason not reported|0|||
146145581|NCT00767000|527047255|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
146145582|NCT00767000|527047256|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
146145583|NCT00767000|527047257|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
146145584|NCT00767000|527047258|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
146145585|NCT00767000|527047259|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
146145586|NCT02039505|527047261|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
146145587|NCT02039505|527047262|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
146145588|NCT02039505|527047263|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
146145589|NCT02039505|527047264|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146145590|NCT02039505|527047265|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146145591|NCT02039505|527047266|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146145592|NCT02039505|527047267|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
146145593|NCT02039505|527047261|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
146145594|NCT02039505|527047262|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
146145595|NCT02039505|527047263|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
146145596|NCT02039505|527047264|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146145597|NCT02039505|527047265|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146145598|NCT02039505|527047266|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146276138|NCT03330405|527525043|FG010|Overall Study|Adverse Event|2|||
146276139|NCT03330405|527525033|FG000|Overall Study|Death|0|||
146276140|NCT03330405|527525034|FG001|Overall Study|Death|4|||
146145599|NCT02039505|527047267|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
146145600|NCT02039505|527047261|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
146145601|NCT02039505|527047262|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146276141|NCT03330405|527525035|FG002|Overall Study|Death|0|||
146276142|NCT03330405|527525036|FG003|Overall Study|Death|0|||
146276143|NCT03330405|527525037|FG004|Overall Study|Death|0|||
146145602|NCT02039505|527047263|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146276144|NCT03330405|527525038|FG005|Overall Study|Death|1|||
146276145|NCT03330405|527525039|FG006|Overall Study|Death|0|||
146276146|NCT03330405|527525040|FG007|Overall Study|Death|2|||
146276147|NCT03330405|527525041|FG008|Overall Study|Death|0|||
146276148|NCT03330405|527525042|FG009|Overall Study|Death|0|||
146276149|NCT03330405|527525043|FG010|Overall Study|Death|0|||
146276150|NCT03330405|527525033|FG000|Overall Study|Physician Decision|0|||
146276151|NCT03330405|527525034|FG001|Overall Study|Physician Decision|0|||
146276152|NCT03330405|527525035|FG002|Overall Study|Physician Decision|0|||
146276153|NCT03330405|527525036|FG003|Overall Study|Physician Decision|0|||
146276154|NCT03330405|527525037|FG004|Overall Study|Physician Decision|0|||
146276155|NCT03330405|527525038|FG005|Overall Study|Physician Decision|0|||
146276156|NCT03330405|527525039|FG006|Overall Study|Physician Decision|0|||
146276157|NCT03330405|527525040|FG007|Overall Study|Physician Decision|1|||
146276158|NCT03330405|527525041|FG008|Overall Study|Physician Decision|0|||
146276159|NCT03330405|527525042|FG009|Overall Study|Physician Decision|0|||
146276160|NCT03330405|527525043|FG010|Overall Study|Physician Decision|0|||
146276161|NCT04187326|527525050|FG000|Overall Study|Lost to Follow-up|2|||
146276162|NCT04187326|527525051|FG001|Overall Study|Lost to Follow-up|1|||
146276163|NCT04187326|527525050|FG000|Overall Study|Computer error- task was only partially completed.|0|||
146276164|NCT04187326|527525051|FG001|Overall Study|Computer error- task was only partially completed.|1|||
146276165|NCT05235269|527525060|FG000|Overall Study|Adverse Event|1|||
146276166|NCT05235269|527525060|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
146276167|NCT05235269|527525060|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
146276168|NCT03810235|527525061|FG000|Overall Study|Withdrawal by Subject|2|||
146276169|NCT03810235|527525062|FG001|Overall Study|Withdrawal by Subject|0|||
146276170|NCT00798434|527525063|FG000|Double-Blind|Adverse Event|22|||
146276171|NCT00798434|527525064|FG001|Double-Blind|Adverse Event|46|||
146276172|NCT00798434|527525063|FG000|Double-Blind|Death|0|||
146276173|NCT00798434|527525064|FG001|Double-Blind|Death|1|||
146276174|NCT00798434|527525063|FG000|Double-Blind|Lost to Follow-up|1|||
146276175|NCT00798434|527525064|FG001|Double-Blind|Lost to Follow-up|0|||
146276176|NCT00798434|527525063|FG000|Double-Blind|Lack of Efficacy|8|||
146276177|NCT00798434|527525064|FG001|Double-Blind|Lack of Efficacy|12|||
146276178|NCT00798434|527525063|FG000|Double-Blind|Withdrawal by Subject|17|||
146276179|NCT00798434|527525064|FG001|Double-Blind|Withdrawal by Subject|14|||
146276180|NCT00798434|527525063|FG000|Double-Blind|Protocol Violation|1|||
146276181|NCT00798434|527525064|FG001|Double-Blind|Protocol Violation|4|||
146276182|NCT00798434|527525063|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
146276183|NCT00798434|527525064|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
146276184|NCT00798434|527525063|FG000|Double-Blind|Other|1|||
146276185|NCT00798434|527525064|FG001|Double-Blind|Other|0|||
146276186|NCT00798434|527525063|FG000|Double-Blind|Not Treated|3|||
146276187|NCT00798434|527525064|FG001|Double-Blind|Not Treated|6|||
146276188|NCT00798434|527525063|FG000|Open-Label|Adverse Event|33|||
146276189|NCT00798434|527525064|FG001|Open-Label|Adverse Event|11|||
146276190|NCT00798434|527525063|FG000|Open-Label|Lack of Efficacy|5|||
146276191|NCT00798434|527525064|FG001|Open-Label|Lack of Efficacy|11|||
146276192|NCT00798434|527525063|FG000|Open-Label|Withdrawal by Subject|2|||
146276193|NCT00798434|527525064|FG001|Open-Label|Withdrawal by Subject|7|||
146276194|NCT00798434|527525063|FG000|Open-Label|Protocol Violation|1|||
146276195|NCT00798434|527525064|FG001|Open-Label|Protocol Violation|0|||
146276196|NCT00798434|527525063|FG000|Open-Label|Other|1|||
146276197|NCT00798434|527525064|FG001|Open-Label|Other|2|||
146276198|NCT00798434|527525063|FG000|Open-Label|Not Treated|0|||
146276199|NCT00798434|527525064|FG001|Open-Label|Not Treated|1|||
146276200|NCT03682185|527525070|FG000|Overall Study|Lost to Follow-up|4|||
146276201|NCT03682185|527525071|FG001|Overall Study|Lost to Follow-up|7|||
146276202|NCT03682185|527525072|FG002|Overall Study|Lost to Follow-up|4|||
146276203|NCT03682185|527525073|FG003|Overall Study|Lost to Follow-up|7|||
146276204|NCT03682185|527525074|FG004|Overall Study|Lost to Follow-up|1|||
146276205|NCT03682185|527525070|FG000|Overall Study|Withdrawal by Subject|7|||
146276206|NCT03682185|527525071|FG001|Overall Study|Withdrawal by Subject|3|||
146276207|NCT03682185|527525072|FG002|Overall Study|Withdrawal by Subject|7|||
146276208|NCT03682185|527525073|FG003|Overall Study|Withdrawal by Subject|3|||
146276209|NCT03682185|527525074|FG004|Overall Study|Withdrawal by Subject|0|||
146276210|NCT04908631|527525075|FG000|Overall Study|Lost to Follow-up|1|||
146276211|NCT04908631|527525075|FG000|Overall Study|Physician Decision|1|||
146276212|NCT04908631|527525075|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
146276213|NCT02336451|527525079|FG000|Overall Study|Adverse Event|1|||
146276214|NCT02336451|527525080|FG001|Overall Study|Adverse Event|2|||
146276215|NCT02336451|527525081|FG002|Overall Study|Adverse Event|0|||
146276216|NCT02336451|527525082|FG003|Overall Study|Adverse Event|6|||
146276217|NCT02336451|527525083|FG004|Overall Study|Adverse Event|4|||
146276218|NCT02336451|527525079|FG000|Overall Study|Death|6|||
146276219|NCT02336451|527525080|FG001|Overall Study|Death|2|||
146276220|NCT02336451|527525081|FG002|Overall Study|Death|3|||
146276221|NCT02336451|527525082|FG003|Overall Study|Death|6|||
146276222|NCT02336451|527525083|FG004|Overall Study|Death|6|||
146276223|NCT02336451|527525079|FG000|Overall Study|Physician Decision|9|||
146276224|NCT02336451|527525080|FG001|Overall Study|Physician Decision|6|||
146276225|NCT02336451|527525081|FG002|Overall Study|Physician Decision|7|||
146276226|NCT02336451|527525082|FG003|Overall Study|Physician Decision|16|||
146276227|NCT02336451|527525083|FG004|Overall Study|Physician Decision|3|||
146276228|NCT02336451|527525079|FG000|Overall Study|Progressive disease|23|||
146276229|NCT02336451|527525080|FG001|Overall Study|Progressive disease|26|||
146276230|NCT02336451|527525081|FG002|Overall Study|Progressive disease|2|||
146276231|NCT02336451|527525082|FG003|Overall Study|Progressive disease|14|||
146276232|NCT02336451|527525083|FG004|Overall Study|Progressive disease|4|||
146276233|NCT02336451|527525079|FG000|Overall Study|Protocol Violation|1|||
146276234|NCT02336451|527525080|FG001|Overall Study|Protocol Violation|0|||
146276235|NCT02336451|527525081|FG002|Overall Study|Protocol Violation|0|||
146276236|NCT02336451|527525082|FG003|Overall Study|Protocol Violation|0|||
146276237|NCT02336451|527525083|FG004|Overall Study|Protocol Violation|0|||
146276238|NCT02336451|527525079|FG000|Overall Study|Patient/guardian decision|2|||
146276239|NCT02336451|527525080|FG001|Overall Study|Patient/guardian decision|4|||
146276240|NCT02336451|527525081|FG002|Overall Study|Patient/guardian decision|0|||
146276241|NCT02336451|527525082|FG003|Overall Study|Patient/guardian decision|2|||
146276242|NCT02336451|527525083|FG004|Overall Study|Patient/guardian decision|1|||
146276243|NCT03520712|527525085|FG000|Overall Study|Early termination of the study by Sponsor|2|||
146276244|NCT02344290|527525092|FG000|Overall Study|Withdrawal by Subject|315|||
146276245|NCT02344290|527525093|FG001|Overall Study|Withdrawal by Subject|324|||
146276246|NCT02344290|527525092|FG000|Overall Study|Lost to Follow-up|258|||
146276247|NCT02344290|527525093|FG001|Overall Study|Lost to Follow-up|249|||
146276248|NCT02344290|527525092|FG000|Overall Study|Unable to get to clinic|69|||
146276249|NCT02344290|527525093|FG001|Overall Study|Unable to get to clinic|60|||
146276250|NCT02344290|527525092|FG000|Overall Study|Physician Decision|25|||
146276251|NCT02344290|527525093|FG001|Overall Study|Physician Decision|25|||
146276252|NCT02344290|527525092|FG000|Overall Study|Site Closure|15|||
146276253|NCT02344290|527525093|FG001|Overall Study|Site Closure|19|||
146276254|NCT02344290|527525092|FG000|Overall Study|Other|5|||
146276255|NCT02344290|527525093|FG001|Overall Study|Other|3|||
146276256|NCT04998812|527525094|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
146276257|NCT04998812|527525095|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
146276258|NCT04998812|527525094|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
146276259|NCT04998812|527525095|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
146276260|NCT04998812|527525094|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
146276261|NCT04998812|527525095|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
146276262|NCT04998812|527525094|FG000|Vaccination Period|Ongoing in study|23|||
146276263|NCT04998812|527525095|FG001|Vaccination Period|Ongoing in study|23|||
146276264|NCT04047862|527525104|FG000|Overall Study|Death|0|||
146276265|NCT04047862|527525105|FG001|Overall Study|Death|0|||
146276266|NCT04047862|527525106|FG002|Overall Study|Death|4|||
146276267|NCT04047862|527525107|FG003|Overall Study|Death|7|||
146276268|NCT04047862|527525108|FG004|Overall Study|Death|2|||
146276269|NCT04047862|527525109|FG005|Overall Study|Death|4|||
146276270|NCT04047862|527525110|FG006|Overall Study|Death|3|||
146276271|NCT04047862|527525111|FG007|Overall Study|Death|24|||
146276272|NCT04047862|527525112|FG008|Overall Study|Death|24|||
146276273|NCT04047862|527525113|FG009|Overall Study|Death|22|||
146276274|NCT04047862|527525114|FG010|Overall Study|Death|35|||
146276275|NCT04047862|527525115|FG011|Overall Study|Death|18|||
146276276|NCT04047862|527525116|FG012|Overall Study|Death|14|||
146276277|NCT04047862|527525117|FG013|Overall Study|Death|6|||
146276278|NCT04047862|527525118|FG014|Overall Study|Death|19|||
146276279|NCT04047862|527525119|FG015|Overall Study|Death|42|||
146276280|NCT04047862|527525120|FG016|Overall Study|Death|9|||
146276281|NCT04047862|527525121|FG017|Overall Study|Death|8|||
146276282|NCT04047862|527525122|FG018|Overall Study|Death|10|||
146304527|NCT00555477|527629238|FG000|Overall Study|Physician Decision|1|||
146145603|NCT02039505|527047264|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146145604|NCT02039505|527047265|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146276283|NCT04047862|527525104|FG000|Overall Study|Withdrawal by Subject|0|||
146276284|NCT04047862|527525105|FG001|Overall Study|Withdrawal by Subject|0|||
146276285|NCT04047862|527525106|FG002|Overall Study|Withdrawal by Subject|0|||
146276286|NCT04047862|527525107|FG003|Overall Study|Withdrawal by Subject|5|||
146276287|NCT04047862|527525108|FG004|Overall Study|Withdrawal by Subject|2|||
146276288|NCT04047862|527525109|FG005|Overall Study|Withdrawal by Subject|0|||
146276289|NCT04047862|527525110|FG006|Overall Study|Withdrawal by Subject|1|||
146276290|NCT04047862|527525111|FG007|Overall Study|Withdrawal by Subject|0|||
146276291|NCT04047862|527525112|FG008|Overall Study|Withdrawal by Subject|4|||
146276292|NCT04047862|527525113|FG009|Overall Study|Withdrawal by Subject|4|||
146276293|NCT04047862|527525114|FG010|Overall Study|Withdrawal by Subject|4|||
146145605|NCT02039505|527047266|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146276294|NCT04047862|527525115|FG011|Overall Study|Withdrawal by Subject|2|||
146276295|NCT04047862|527525116|FG012|Overall Study|Withdrawal by Subject|3|||
146276296|NCT04047862|527525117|FG013|Overall Study|Withdrawal by Subject|0|||
146276297|NCT04047862|527525118|FG014|Overall Study|Withdrawal by Subject|9|||
146276298|NCT04047862|527525119|FG015|Overall Study|Withdrawal by Subject|5|||
146276299|NCT04047862|527525120|FG016|Overall Study|Withdrawal by Subject|1|||
146276300|NCT04047862|527525121|FG017|Overall Study|Withdrawal by Subject|3|||
146145606|NCT02039505|527047267|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
146145607|NCT02039505|527047261|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146145608|NCT02039505|527047262|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146145609|NCT02039505|527047263|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146145610|NCT02039505|527047264|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
146145611|NCT02039505|527047265|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
146145612|NCT02039505|527047266|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
146145613|NCT02039505|527047267|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
146145614|NCT02039505|527047261|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146145615|NCT02039505|527047262|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146145616|NCT02039505|527047263|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146145617|NCT02039505|527047264|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
146145618|NCT02039505|527047265|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
146145619|NCT02039505|527047266|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
146145620|NCT02039505|527047267|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
146145621|NCT02039505|527047261|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146145622|NCT02039505|527047262|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146145623|NCT02039505|527047263|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146145624|NCT02039505|527047264|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
146145625|NCT02039505|527047265|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
146145626|NCT02039505|527047266|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
146145627|NCT02039505|527047267|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
146145628|NCT02039505|527047261|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145629|NCT02039505|527047262|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145630|NCT02039505|527047263|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145631|NCT02039505|527047264|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
146145632|NCT02039505|527047265|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145633|NCT02039505|527047266|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145634|NCT02039505|527047267|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
146145635|NCT02039505|527047261|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145636|NCT02039505|527047262|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145637|NCT02039505|527047263|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145638|NCT02039505|527047264|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145639|NCT02039505|527047265|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145640|NCT02039505|527047266|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
146145641|NCT02039505|527047267|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
146145642|NCT02039505|527047261|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145643|NCT02039505|527047262|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145644|NCT02039505|527047263|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145645|NCT02039505|527047264|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145646|NCT02039505|527047265|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145647|NCT02039505|527047266|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
146145648|NCT02039505|527047267|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
146145649|NCT02039505|527047261|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145650|NCT02039505|527047262|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145651|NCT02039505|527047263|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145652|NCT02039505|527047264|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145653|NCT02039505|527047265|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145654|NCT02039505|527047266|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
146145655|NCT02039505|527047267|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
146145656|NCT02039505|527047261|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145657|NCT02039505|527047262|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145658|NCT02039505|527047263|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145659|NCT02039505|527047264|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145660|NCT02039505|527047265|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145661|NCT02039505|527047266|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
146145662|NCT02039505|527047267|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
146276301|NCT04047862|527525122|FG018|Overall Study|Withdrawal by Subject|1|||
146276302|NCT04047862|527525104|FG000|Overall Study|Lost to Follow-up|0|||
146276303|NCT04047862|527525105|FG001|Overall Study|Lost to Follow-up|0|||
146276304|NCT04047862|527525106|FG002|Overall Study|Lost to Follow-up|1|||
146276305|NCT04047862|527525107|FG003|Overall Study|Lost to Follow-up|0|||
146276306|NCT04047862|527525108|FG004|Overall Study|Lost to Follow-up|0|||
146276307|NCT04047862|527525109|FG005|Overall Study|Lost to Follow-up|0|||
146276308|NCT04047862|527525110|FG006|Overall Study|Lost to Follow-up|0|||
146145663|NCT00633984|527047268|FG000|Overall Study|Lost to Follow-up|0|||
146145664|NCT00633984|527047269|FG001|Overall Study|Lost to Follow-up|6|||
146145665|NCT00633984|527047268|FG000|Overall Study|Withdrawal by Subject|8|||
146145666|NCT00633984|527047269|FG001|Overall Study|Withdrawal by Subject|7|||
146145667|NCT00633984|527047268|FG000|Overall Study|Hospitalized|1|||
146145668|NCT00633984|527047269|FG001|Overall Study|Hospitalized|0|||
146145669|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
146145670|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
146145671|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
146145672|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145673|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145674|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145675|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145676|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145677|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146145678|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
146145679|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
146145680|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
146145681|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145682|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145683|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145684|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145685|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145686|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146145687|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145688|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146145689|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
146145690|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145691|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145692|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145693|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145694|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145695|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146145696|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
146145697|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
146145698|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
146145699|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145700|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145701|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145702|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145703|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145704|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146145705|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145706|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
146145707|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145708|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145709|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145710|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145711|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145712|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145713|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
146145714|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
146145715|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145716|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145717|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145718|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145719|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145720|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145721|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146276309|NCT04047862|527525111|FG007|Overall Study|Lost to Follow-up|1|||
146276310|NCT04047862|527525112|FG008|Overall Study|Lost to Follow-up|0|||
146276311|NCT04047862|527525113|FG009|Overall Study|Lost to Follow-up|1|||
146276312|NCT04047862|527525114|FG010|Overall Study|Lost to Follow-up|0|||
146145722|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146145723|NCT01172938|527047271|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
146276313|NCT04047862|527525115|FG011|Overall Study|Lost to Follow-up|3|||
146276314|NCT04047862|527525116|FG012|Overall Study|Lost to Follow-up|0|||
146276315|NCT04047862|527525117|FG013|Overall Study|Lost to Follow-up|0|||
146145724|NCT01172938|527047272|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
146145725|NCT01172938|527047273|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
146145726|NCT01172938|527047274|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145727|NCT01172938|527047275|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145728|NCT01172938|527047276|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145729|NCT01172938|527047277|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145730|NCT01172938|527047278|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145731|NCT01172938|527047279|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
146145732|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146145733|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
146145734|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
146145735|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
146145736|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
146145737|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
146145738|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146145739|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146145740|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
146145741|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146145742|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
146145743|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
146145744|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
146145745|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
146145746|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
146145747|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146145748|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146145749|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
146145750|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145751|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145752|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
146145753|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145754|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145755|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145756|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145757|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145758|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
146145759|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146145760|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
146145761|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
146145762|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
146145763|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
146145764|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
146145765|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
146145766|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146145767|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
146145768|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145769|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146145770|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146145771|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
146145772|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145773|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145774|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145775|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145776|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
146145777|NCT01172938|527047271|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145778|NCT01172938|527047272|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145779|NCT01172938|527047273|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145780|NCT01172938|527047274|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145781|NCT01172938|527047275|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
146276316|NCT04047862|527525118|FG014|Overall Study|Lost to Follow-up|2|||
146276317|NCT04047862|527525119|FG015|Overall Study|Lost to Follow-up|2|||
146276318|NCT04047862|527525120|FG016|Overall Study|Lost to Follow-up|1|||
146276319|NCT04047862|527525121|FG017|Overall Study|Lost to Follow-up|0|||
146276320|NCT04047862|527525122|FG018|Overall Study|Lost to Follow-up|0|||
146276321|NCT04047862|527525104|FG000|Overall Study|Physician Decision|0|||
146145782|NCT01172938|527047276|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
146145783|NCT01172938|527047277|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
146145784|NCT01172938|527047278|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145785|NCT01172938|527047279|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
146145786|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146145787|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
146145788|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
146145789|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146145790|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146145791|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146145792|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
146145793|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
146145794|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
146145795|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145796|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
146145797|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
146145798|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145799|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145800|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145801|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145802|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
146145803|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
146145804|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145805|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145806|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
146145807|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145808|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145809|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145810|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145811|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145812|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
146145813|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146276322|NCT04047862|527525105|FG001|Overall Study|Physician Decision|0|||
146276323|NCT04047862|527525106|FG002|Overall Study|Physician Decision|0|||
146276324|NCT04047862|527525107|FG003|Overall Study|Physician Decision|1|||
146276325|NCT04047862|527525108|FG004|Overall Study|Physician Decision|0|||
146276326|NCT04047862|527525109|FG005|Overall Study|Physician Decision|0|||
146276327|NCT04047862|527525110|FG006|Overall Study|Physician Decision|0|||
146276328|NCT04047862|527525111|FG007|Overall Study|Physician Decision|0|||
146276329|NCT04047862|527525112|FG008|Overall Study|Physician Decision|0|||
146276330|NCT04047862|527525113|FG009|Overall Study|Physician Decision|0|||
146276331|NCT04047862|527525114|FG010|Overall Study|Physician Decision|0|||
146276332|NCT04047862|527525115|FG011|Overall Study|Physician Decision|0|||
146276333|NCT04047862|527525116|FG012|Overall Study|Physician Decision|0|||
146276334|NCT04047862|527525117|FG013|Overall Study|Physician Decision|0|||
146276335|NCT04047862|527525118|FG014|Overall Study|Physician Decision|1|||
146276336|NCT04047862|527525119|FG015|Overall Study|Physician Decision|0|||
146276337|NCT04047862|527525120|FG016|Overall Study|Physician Decision|1|||
146276338|NCT04047862|527525121|FG017|Overall Study|Physician Decision|0|||
146276339|NCT04047862|527525122|FG018|Overall Study|Physician Decision|0|||
146276340|NCT04047862|527525104|FG000|Overall Study|Completed all Assessments|1|||
146276341|NCT04047862|527525105|FG001|Overall Study|Completed all Assessments|3|||
146276342|NCT04047862|527525106|FG002|Overall Study|Completed all Assessments|1|||
146276343|NCT04047862|527525107|FG003|Overall Study|Completed all Assessments|3|||
146276344|NCT04047862|527525108|FG004|Overall Study|Completed all Assessments|2|||
146276345|NCT04047862|527525109|FG005|Overall Study|Completed all Assessments|5|||
146276346|NCT04047862|527525110|FG006|Overall Study|Completed all Assessments|7|||
146276347|NCT04047862|527525111|FG007|Overall Study|Completed all Assessments|0|||
146276348|NCT04047862|527525112|FG008|Overall Study|Completed all Assessments|0|||
146276349|NCT04047862|527525113|FG009|Overall Study|Completed all Assessments|0|||
146276350|NCT04047862|527525114|FG010|Overall Study|Completed all Assessments|0|||
146276351|NCT04047862|527525115|FG011|Overall Study|Completed all Assessments|0|||
146276352|NCT04047862|527525116|FG012|Overall Study|Completed all Assessments|0|||
146276353|NCT04047862|527525117|FG013|Overall Study|Completed all Assessments|0|||
146276354|NCT04047862|527525118|FG014|Overall Study|Completed all Assessments|0|||
146276355|NCT04047862|527525119|FG015|Overall Study|Completed all Assessments|0|||
146276356|NCT04047862|527525120|FG016|Overall Study|Completed all Assessments|0|||
146276357|NCT04047862|527525121|FG017|Overall Study|Completed all Assessments|0|||
146276358|NCT04047862|527525122|FG018|Overall Study|Completed all Assessments|0|||
146276359|NCT04047862|527525104|FG000|Overall Study|Sponsor Decision|0|||
146276360|NCT04047862|527525105|FG001|Overall Study|Sponsor Decision|0|||
146276361|NCT04047862|527525106|FG002|Overall Study|Sponsor Decision|0|||
146276362|NCT04047862|527525107|FG003|Overall Study|Sponsor Decision|0|||
146276363|NCT04047862|527525108|FG004|Overall Study|Sponsor Decision|0|||
146276364|NCT04047862|527525109|FG005|Overall Study|Sponsor Decision|0|||
146276365|NCT04047862|527525110|FG006|Overall Study|Sponsor Decision|0|||
146276366|NCT04047862|527525111|FG007|Overall Study|Sponsor Decision|13|||
146276367|NCT04047862|527525112|FG008|Overall Study|Sponsor Decision|10|||
146276368|NCT04047862|527525113|FG009|Overall Study|Sponsor Decision|18|||
146276369|NCT04047862|527525114|FG010|Overall Study|Sponsor Decision|3|||
146276370|NCT04047862|527525115|FG011|Overall Study|Sponsor Decision|3|||
146276371|NCT04047862|527525116|FG012|Overall Study|Sponsor Decision|4|||
146276372|NCT04047862|527525117|FG013|Overall Study|Sponsor Decision|0|||
146276373|NCT04047862|527525118|FG014|Overall Study|Sponsor Decision|7|||
146276374|NCT04047862|527525119|FG015|Overall Study|Sponsor Decision|8|||
146276375|NCT04047862|527525120|FG016|Overall Study|Sponsor Decision|9|||
146276376|NCT04047862|527525121|FG017|Overall Study|Sponsor Decision|7|||
146276377|NCT04047862|527525122|FG018|Overall Study|Sponsor Decision|8|||
146276378|NCT04047862|527525104|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276379|NCT04047862|527525105|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276380|NCT04047862|527525106|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276381|NCT04047862|527525107|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276382|NCT04047862|527525108|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276383|NCT04047862|527525109|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276384|NCT04047862|527525110|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276385|NCT04047862|527525111|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
146276386|NCT04047862|527525112|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
146276387|NCT04047862|527525113|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276388|NCT04047862|527525114|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146276389|NCT04047862|527525115|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276390|NCT04047862|527525116|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276391|NCT04047862|527525117|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
146276392|NCT04047862|527525118|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146276393|NCT04047862|527525119|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
146276394|NCT04047862|527525120|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146276395|NCT04047862|527525121|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146276396|NCT04047862|527525122|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
146276397|NCT04047862|527525104|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276398|NCT04047862|527525105|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276399|NCT04047862|527525106|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276400|NCT04047862|527525107|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276401|NCT04047862|527525108|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276402|NCT04047862|527525109|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276403|NCT04047862|527525110|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276404|NCT04047862|527525111|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276405|NCT04047862|527525112|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276406|NCT04047862|527525113|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276407|NCT04047862|527525114|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276408|NCT04047862|527525115|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276409|NCT04047862|527525116|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276410|NCT04047862|527525117|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276411|NCT04047862|527525118|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276412|NCT04047862|527525119|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
146276413|NCT04047862|527525120|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276414|NCT04047862|527525121|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
146276415|NCT04047862|527525122|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
146276416|NCT04047862|527525104|FG000|Overall Study|Other|0|||
146276417|NCT04047862|527525105|FG001|Overall Study|Other|0|||
146276418|NCT04047862|527525106|FG002|Overall Study|Other|0|||
146276419|NCT04047862|527525107|FG003|Overall Study|Other|0|||
146276420|NCT04047862|527525108|FG004|Overall Study|Other|0|||
146276421|NCT04047862|527525109|FG005|Overall Study|Other|0|||
146276422|NCT04047862|527525110|FG006|Overall Study|Other|0|||
146276423|NCT04047862|527525111|FG007|Overall Study|Other|0|||
146276424|NCT04047862|527525112|FG008|Overall Study|Other|0|||
146276425|NCT04047862|527525113|FG009|Overall Study|Other|0|||
146276426|NCT04047862|527525114|FG010|Overall Study|Other|0|||
146276427|NCT04047862|527525115|FG011|Overall Study|Other|0|||
146276428|NCT04047862|527525116|FG012|Overall Study|Other|0|||
146276429|NCT04047862|527525117|FG013|Overall Study|Other|0|||
146276430|NCT04047862|527525118|FG014|Overall Study|Other|2|||
146276431|NCT04047862|527525119|FG015|Overall Study|Other|1|||
146276432|NCT04047862|527525120|FG016|Overall Study|Other|1|||
146276433|NCT04047862|527525121|FG017|Overall Study|Other|1|||
146276434|NCT04047862|527525122|FG018|Overall Study|Other|0|||
146276435|NCT01015560|527526283|FG000|Overall Study|Adverse Event|1|||
146276436|NCT01015560|527526283|FG000|Overall Study|Not protocol specified|1|||
146276437|NCT01015560|527526283|FG000|Overall Study|Withdrawal by Subject|1|||
146276438|NCT04165031|527526288|FG000|Overall Study|Adverse Event|1|||
146276439|NCT04165031|527526289|FG001|Overall Study|Adverse Event|1|||
146276440|NCT04165031|527526290|FG002|Overall Study|Adverse Event|0|||
146276441|NCT04165031|527526291|FG003|Overall Study|Adverse Event|0|||
146276442|NCT04165031|527526292|FG004|Overall Study|Adverse Event|0|||
146276443|NCT04165031|527526293|FG005|Overall Study|Adverse Event|0|||
146276444|NCT04165031|527526288|FG000|Overall Study|Withdrawal by Subject|0|||
146276445|NCT04165031|527526289|FG001|Overall Study|Withdrawal by Subject|0|||
146276446|NCT04165031|527526290|FG002|Overall Study|Withdrawal by Subject|1|||
146276447|NCT04165031|527526291|FG003|Overall Study|Withdrawal by Subject|0|||
146276448|NCT04165031|527526292|FG004|Overall Study|Withdrawal by Subject|0|||
146276449|NCT04165031|527526293|FG005|Overall Study|Withdrawal by Subject|0|||
146276450|NCT01332630|527526294|FG000|Overall Study|Withdrawal by Subject|3|||
146276451|NCT02787044|527526302|FG000|Overall Study|Lost to Follow-up|15|||
146276452|NCT02787044|527526303|FG001|Overall Study|Lost to Follow-up|19|||
146276453|NCT00567567|527526304|FG000|Overall Study|Adverse Event|0|||
146276454|NCT00567567|527526305|FG001|Overall Study|Adverse Event|2|||
146276455|NCT00567567|527526306|FG002|Overall Study|Adverse Event|5|||
146276456|NCT00567567|527526304|FG000|Overall Study|Death|8|||
146276457|NCT00567567|527526305|FG001|Overall Study|Death|1|||
146276458|NCT00567567|527526306|FG002|Overall Study|Death|5|||
146276459|NCT00567567|527526304|FG000|Overall Study|Lack of Efficacy|16|||
146276460|NCT00567567|527526305|FG001|Overall Study|Lack of Efficacy|17|||
146276461|NCT00567567|527526306|FG002|Overall Study|Lack of Efficacy|48|||
146276462|NCT00567567|527526304|FG000|Overall Study|Lost to Follow-up|0|||
146276463|NCT00567567|527526305|FG001|Overall Study|Lost to Follow-up|0|||
146276464|NCT00567567|527526306|FG002|Overall Study|Lost to Follow-up|1|||
146276465|NCT00567567|527526304|FG000|Overall Study|Physician Decision|16|||
146276466|NCT00567567|527526305|FG001|Overall Study|Physician Decision|18|||
146276467|NCT00567567|527526306|FG002|Overall Study|Physician Decision|84|||
146276468|NCT00567567|527526304|FG000|Overall Study|Withdrawal by Subject|0|||
146276469|NCT00567567|527526305|FG001|Overall Study|Withdrawal by Subject|0|||
146276470|NCT00567567|527526306|FG002|Overall Study|Withdrawal by Subject|2|||
146276471|NCT00567567|527526304|FG000|Overall Study|Ineligible|4|||
146276472|NCT00567567|527526305|FG001|Overall Study|Ineligible|0|||
146276473|NCT00567567|527526306|FG002|Overall Study|Ineligible|9|||
146276474|NCT00567567|527526304|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
146276475|NCT00567567|527526305|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
146276476|NCT00567567|527526306|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
146276477|NCT00567567|527526304|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
146276478|NCT00567567|527526305|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
146276479|NCT00567567|527526306|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
146276480|NCT00567567|527526304|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
146276481|NCT00567567|527526305|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
146276482|NCT00567567|527526306|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
146276483|NCT03433677|527526307|FG000|Period 1|Protocol Violation|1|||
146276484|NCT03433677|527526308|FG001|Period 1|Protocol Violation|0|||
146276485|NCT03433677|527526307|FG000|Period 2|Withdrawal by Subject|1|||
146276486|NCT03433677|527526308|FG001|Period 2|Withdrawal by Subject|1|||
146276487|NCT03889704|527526310|FG000|Overall Study|Study terminated due to pandemic|1|||
146276488|NCT04552899|527526311|FG000|Overall Study|Adverse Event|4|||
146276489|NCT04552899|527526312|FG001|Overall Study|Adverse Event|3|||
146276490|NCT04552899|527526311|FG000|Overall Study|Death|4|||
146276491|NCT04552899|527526312|FG001|Overall Study|Death|4|||
146276492|NCT04552899|527526311|FG000|Overall Study|Lost to Follow-up|8|||
146276493|NCT04552899|527526312|FG001|Overall Study|Lost to Follow-up|13|||
146276494|NCT04552899|527526311|FG000|Overall Study|Lung Transplant|4|||
146276495|NCT04552899|527526312|FG001|Overall Study|Lung Transplant|3|||
146276496|NCT04552899|527526311|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
146276497|NCT04552899|527526312|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
146276498|NCT04552899|527526311|FG000|Overall Study|Physician Decision|3|||
146276499|NCT04552899|527526312|FG001|Overall Study|Physician Decision|4|||
146276500|NCT04552899|527526311|FG000|Overall Study|Study Terminated By Sponsor|237|||
146276501|NCT04552899|527526312|FG001|Overall Study|Study Terminated By Sponsor|239|||
146276502|NCT04552899|527526311|FG000|Overall Study|Withdrawal by Subject|15|||
146276503|NCT04552899|527526312|FG001|Overall Study|Withdrawal by Subject|17|||
146276504|NCT00731133|527526315|FG000|Overall Study|Withdrawal by Subject|10|||
146276505|NCT01725126|527526316|FG000|Overall Study|Protocol Violation|0|||
146276506|NCT01725126|527526317|FG001|Overall Study|Protocol Violation|1|||
146276507|NCT01725126|527526318|FG002|Overall Study|Protocol Violation|0|||
146276508|NCT01725126|527526319|FG003|Overall Study|Protocol Violation|0|||
146276509|NCT01725126|527526320|FG004|Overall Study|Protocol Violation|0|||
146276510|NCT01725126|527526321|FG005|Overall Study|Protocol Violation|0|||
146276511|NCT01725126|527526316|FG000|Overall Study|Withdrawal by Subject|0|||
146276512|NCT01725126|527526317|FG001|Overall Study|Withdrawal by Subject|0|||
146276513|NCT01725126|527526318|FG002|Overall Study|Withdrawal by Subject|0|||
146276514|NCT01725126|527526319|FG003|Overall Study|Withdrawal by Subject|1|||
146276515|NCT01725126|527526320|FG004|Overall Study|Withdrawal by Subject|0|||
146276516|NCT01725126|527526321|FG005|Overall Study|Withdrawal by Subject|0|||
146276517|NCT01240915|527526326|FG000|Overall Study|Adverse Event|0|||
146276518|NCT01240915|527526327|FG001|Overall Study|Adverse Event|0|||
146276519|NCT01240915|527526328|FG002|Overall Study|Adverse Event|0|||
146276520|NCT01240915|527526329|FG003|Overall Study|Adverse Event|1|||
146276521|NCT01240915|527526330|FG004|Overall Study|Adverse Event|0|||
146276522|NCT01240915|527526331|FG005|Overall Study|Adverse Event|2|||
146276523|NCT01240915|527526332|FG006|Overall Study|Adverse Event|0|||
146276524|NCT01240915|527526333|FG007|Overall Study|Adverse Event|0|||
146276525|NCT01240915|527526334|FG008|Overall Study|Adverse Event|1|||
146276526|NCT01240915|527526326|FG000|Overall Study|Lost to Follow-up|0|||
146276527|NCT01240915|527526327|FG001|Overall Study|Lost to Follow-up|0|||
146276528|NCT01240915|527526328|FG002|Overall Study|Lost to Follow-up|0|||
146276529|NCT01240915|527526329|FG003|Overall Study|Lost to Follow-up|0|||
146276530|NCT01240915|527526330|FG004|Overall Study|Lost to Follow-up|1|||
146276531|NCT01240915|527526331|FG005|Overall Study|Lost to Follow-up|1|||
146276532|NCT01240915|527526332|FG006|Overall Study|Lost to Follow-up|0|||
146276533|NCT01240915|527526333|FG007|Overall Study|Lost to Follow-up|1|||
146276534|NCT01240915|527526334|FG008|Overall Study|Lost to Follow-up|1|||
146276535|NCT01240915|527526326|FG000|Overall Study|Withdrawal by Subject|2|||
146276536|NCT01240915|527526327|FG001|Overall Study|Withdrawal by Subject|1|||
146276537|NCT01240915|527526328|FG002|Overall Study|Withdrawal by Subject|0|||
146276538|NCT01240915|527526329|FG003|Overall Study|Withdrawal by Subject|2|||
146276539|NCT01240915|527526330|FG004|Overall Study|Withdrawal by Subject|0|||
146276540|NCT01240915|527526331|FG005|Overall Study|Withdrawal by Subject|4|||
146276541|NCT01240915|527526332|FG006|Overall Study|Withdrawal by Subject|2|||
146276542|NCT01240915|527526333|FG007|Overall Study|Withdrawal by Subject|3|||
146276543|NCT01240915|527526334|FG008|Overall Study|Withdrawal by Subject|3|||
146276544|NCT01240915|527526326|FG000|Overall Study|Other|0|||
146276545|NCT01240915|527526327|FG001|Overall Study|Other|0|||
146276546|NCT01240915|527526328|FG002|Overall Study|Other|0|||
146276547|NCT01240915|527526329|FG003|Overall Study|Other|0|||
146276548|NCT01240915|527526330|FG004|Overall Study|Other|2|||
146276549|NCT01240915|527526331|FG005|Overall Study|Other|0|||
146276550|NCT01240915|527526332|FG006|Overall Study|Other|0|||
146276551|NCT01240915|527526333|FG007|Overall Study|Other|0|||
146276552|NCT01240915|527526334|FG008|Overall Study|Other|0|||
146276553|NCT01240915|527526326|FG000|Overall Study|Insufficient Clinical Response|0|||
146276554|NCT01240915|527526327|FG001|Overall Study|Insufficient Clinical Response|0|||
146276555|NCT01240915|527526328|FG002|Overall Study|Insufficient Clinical Response|0|||
146276556|NCT01240915|527526329|FG003|Overall Study|Insufficient Clinical Response|0|||
146276557|NCT01240915|527526330|FG004|Overall Study|Insufficient Clinical Response|1|||
146276558|NCT01240915|527526331|FG005|Overall Study|Insufficient Clinical Response|3|||
146276559|NCT01240915|527526332|FG006|Overall Study|Insufficient Clinical Response|6|||
146276560|NCT01240915|527526333|FG007|Overall Study|Insufficient Clinical Response|0|||
146276561|NCT01240915|527526334|FG008|Overall Study|Insufficient Clinical Response|3|||
146276562|NCT01598662|527526336|FG000|Overall Study|Lost to Follow-up|10|||
146276563|NCT01598662|527526337|FG001|Overall Study|Lost to Follow-up|17|||
146276564|NCT01598662|527526336|FG000|Overall Study|Physician Decision|1|||
146276565|NCT01598662|527526337|FG001|Overall Study|Physician Decision|2|||
146276566|NCT01598662|527526336|FG000|Overall Study|IUD expelled before month 6|0|||
146276567|NCT01598662|527526337|FG001|Overall Study|IUD expelled before month 6|2|||
146276568|NCT02574845|527526338|FG000|Overall Study|Consent withdrawn further participation|0|||
146276569|NCT02574845|527526339|FG001|Overall Study|Consent withdrawn further participation|0|||
146276570|NCT02574845|527526340|FG002|Overall Study|Consent withdrawn further participation|0|||
146276571|NCT02574845|527526341|FG003|Overall Study|Consent withdrawn further participation|0|||
146276572|NCT02574845|527526342|FG004|Overall Study|Consent withdrawn further participation|1|||
146276573|NCT02574845|527526343|FG005|Overall Study|Consent withdrawn further participation|0|||
146276574|NCT02574845|527526338|FG000|Overall Study|Adverse Event|0|||
146276575|NCT02574845|527526339|FG001|Overall Study|Adverse Event|1|||
146276576|NCT02574845|527526340|FG002|Overall Study|Adverse Event|0|||
146276577|NCT02574845|527526341|FG003|Overall Study|Adverse Event|0|||
146276578|NCT02574845|527526342|FG004|Overall Study|Adverse Event|0|||
146276579|NCT02574845|527526343|FG005|Overall Study|Adverse Event|1|||
146276580|NCT02781090|527526347|FG000|3-Month Follow-Up|Missed Visit|20|||
146276581|NCT02781090|527526348|FG001|3-Month Follow-Up|Missed Visit|20|||
146276582|NCT02781090|527526347|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
146276583|NCT02781090|527526348|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
146276584|NCT02781090|527526347|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
146276585|NCT02781090|527526348|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
146145814|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
146145815|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
146145816|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146145817|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146145818|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146145819|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
146145820|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
146145821|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
146145822|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145823|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146276586|NCT02781090|527526347|FG000|3-Month Follow-Up|Death|1|||
146276587|NCT02781090|527526348|FG001|3-Month Follow-Up|Death|0|||
146276588|NCT02781090|527526347|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
146276589|NCT02781090|527526348|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
146145824|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
146145825|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145826|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145827|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145828|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145829|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145830|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
146145831|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145832|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
146145833|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
146145834|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145835|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145836|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145837|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145838|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
146145839|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
146145840|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145841|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
146145842|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145843|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145844|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145845|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145846|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145847|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
146145848|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
146145849|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145850|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
146145851|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145852|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145853|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145854|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145855|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145856|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145857|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
146145858|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145859|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145860|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145861|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145862|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145863|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145864|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145865|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
146145866|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
146145867|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146145868|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
146145869|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146145870|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146145871|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146145872|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146145873|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
146276590|NCT02781090|527526347|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
146276591|NCT02781090|527526348|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
146276592|NCT02781090|527526347|FG000|6-Month Follow-Up|Death|0|||
146276593|NCT02781090|527526348|FG001|6-Month Follow-Up|Death|1|||
146276594|NCT01867333|527526349|FG000|Overall Study|Withdrawal by Subject|1|||
146276595|NCT01867333|527526350|FG001|Overall Study|Withdrawal by Subject|0|||
146276596|NCT01867333|527526349|FG000|Overall Study|Adverse Event|1|||
146276597|NCT01867333|527526350|FG001|Overall Study|Adverse Event|0|||
146276598|NCT01867333|527526349|FG000|Overall Study|Participant choice|1|||
146276599|NCT01867333|527526350|FG001|Overall Study|Participant choice|2|||
146276600|NCT01867333|527526349|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
146276601|NCT01867333|527526350|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
146276602|NCT01867333|527526349|FG000|Overall Study|Death|0|||
146276603|NCT01867333|527526350|FG001|Overall Study|Death|1|||
146276604|NCT01867333|527526349|FG000|Overall Study|Physician Decision|3|||
146276605|NCT01867333|527526350|FG001|Overall Study|Physician Decision|2|||
146276606|NCT01867333|527526349|FG000|Overall Study|Switched to alternative treatment|1|||
146276607|NCT01867333|527526350|FG001|Overall Study|Switched to alternative treatment|0|||
146276608|NCT02683785|527526353|FG000|Overall Study|Withdrawal by Subject|1|||
146276609|NCT02683785|527526354|FG001|Overall Study|Withdrawal by Subject|1|||
146276610|NCT02683785|527526353|FG000|Overall Study|Lost to Follow-up|0|||
146276611|NCT02683785|527526354|FG001|Overall Study|Lost to Follow-up|1|||
146276612|NCT02683785|527526353|FG000|Overall Study|Adverse Event|0|||
146276613|NCT02683785|527526354|FG001|Overall Study|Adverse Event|2|||
146276614|NCT00368927|527526357|FG000|Overall Study|Lost to Follow-up|2|||
146276615|NCT00368927|527526358|FG001|Overall Study|Lost to Follow-up|0|||
146276616|NCT00368927|527526357|FG000|Overall Study|Adverse Event|1|||
146276617|NCT00368927|527526358|FG001|Overall Study|Adverse Event|1|||
146276618|NCT00368927|527526357|FG000|Overall Study|Withdrawal by Subject|1|||
146276619|NCT00368927|527526358|FG001|Overall Study|Withdrawal by Subject|2|||
146276620|NCT00368927|527526357|FG000|Overall Study|Physician Decision|1|||
146276621|NCT00368927|527526358|FG001|Overall Study|Physician Decision|0|||
146276622|NCT04462289|527526359|FG000|Overall Study|Lost to Follow-up|4|||
146276623|NCT04462289|527526360|FG001|Overall Study|Lost to Follow-up|5|||
146276624|NCT04462289|527526359|FG000|Overall Study|Death|0|||
146276625|NCT04462289|527526360|FG001|Overall Study|Death|3|||
146276626|NCT04462289|527526359|FG000|Overall Study|Withdrawal by Subject|1|||
146276627|NCT04462289|527526360|FG001|Overall Study|Withdrawal by Subject|3|||
146276628|NCT03309813|527526361|FG000|Main Randomized Study|Withdrawal by Subject|1|||
146276629|NCT03309813|527526362|FG001|Main Randomized Study|Withdrawal by Subject|0|||
146276630|NCT04978493|527526363|FG000|Overall Study|No reason available|0|||
146276631|NCT04978493|527526364|FG001|Overall Study|No reason available|1|||
146276632|NCT04978493|527526363|FG000|Overall Study|Adverse Event|1|||
146276633|NCT04978493|527526364|FG001|Overall Study|Adverse Event|0|||
146276634|NCT01128114|527526365|FG000|Overall Study|Treatment Withdrawn|6|||
146276635|NCT01128114|527526365|FG000|Overall Study|Screening Failed|2|||
146276636|NCT02206061|527526366|FG000|Overall Study|Withdrawal by Subject|4|||
146276637|NCT02206061|527526367|FG001|Overall Study|Withdrawal by Subject|7|||
146276638|NCT02206061|527526368|FG002|Overall Study|Withdrawal by Subject|1|||
146276639|NCT02206061|527526366|FG000|Overall Study|Lost to Follow-up|14|||
146276640|NCT02206061|527526367|FG001|Overall Study|Lost to Follow-up|7|||
146276641|NCT02206061|527526368|FG002|Overall Study|Lost to Follow-up|20|||
146276642|NCT02738853|527526371|FG000|Enrollment|Inclusion/Exclusion not met|21|||
146276643|NCT02738853|527526371|FG000|Enrollment|Withdrawal by Subject|3|||
146276644|NCT02738853|527526371|FG000|Enrollment|Subject treated with commercially available device|6|||
146276645|NCT02738853|527526371|FG000|Enrollment|Study Enrollment Closed|3|||
146276646|NCT02738853|527526371|FG000|Procedure|Death|1|||
146276647|NCT02738853|527526371|FG000|1 Month|Death|2|||
146276648|NCT02738853|527526371|FG000|6 Month|Death|4|||
146276649|NCT02738853|527526371|FG000|6 Month|Withdrawal by Subject|2|||
146276650|NCT02738853|527526371|FG000|1 Year|Death|6|||
146276651|NCT02738853|527526371|FG000|1 Year|Withdrawal by Subject|1|||
146276652|NCT02738853|527526371|FG000|2 Year|Death|2|||
146276653|NCT02738853|527526371|FG000|2 Year|Lost to Follow-up|1|||
146276654|NCT02738853|527526371|FG000|3 Year|Death|2|||
146276655|NCT02738853|527526371|FG000|3 Year|Withdrawal by Subject|1|||
146276656|NCT02738853|527526371|FG000|4 Year|Death|9|||
146276657|NCT02738853|527526371|FG000|5 Year|Lost to Follow-up|4|||
146276658|NCT04157400|527526373|FG000|Overall Study|Withdrawal by Subject|1|||
146276659|NCT04157400|527526373|FG000|Overall Study|Lost to Follow-up|3|||
146276660|NCT01803282|527526375|FG000|Overall Study|Progressive Disease|4|||
146276661|NCT01803282|527526376|FG001|Overall Study|Progressive Disease|3|||
146276662|NCT01803282|527526377|FG002|Overall Study|Progressive Disease|6|||
146276663|NCT01803282|527526378|FG003|Overall Study|Progressive Disease|22|||
146276664|NCT01803282|527526379|FG004|Overall Study|Progressive Disease|5|||
146276665|NCT01803282|527526380|FG005|Overall Study|Progressive Disease|8|||
146276666|NCT01803282|527526381|FG006|Overall Study|Progressive Disease|23|||
146276667|NCT01803282|527526382|FG007|Overall Study|Progressive Disease|24|||
146276668|NCT01803282|527526383|FG008|Overall Study|Progressive Disease|3|||
146276669|NCT01803282|527526384|FG009|Overall Study|Progressive Disease|29|||
146276670|NCT01803282|527526385|FG010|Overall Study|Progressive Disease|6|||
146276671|NCT01803282|527526386|FG011|Overall Study|Progressive Disease|11|||
146276672|NCT01803282|527526375|FG000|Overall Study|Death|0|||
146276673|NCT01803282|527526376|FG001|Overall Study|Death|0|||
146276674|NCT01803282|527526377|FG002|Overall Study|Death|0|||
146276675|NCT01803282|527526378|FG003|Overall Study|Death|0|||
146276676|NCT01803282|527526379|FG004|Overall Study|Death|2|||
146276677|NCT01803282|527526380|FG005|Overall Study|Death|1|||
146276678|NCT01803282|527526381|FG006|Overall Study|Death|1|||
146276679|NCT01803282|527526382|FG007|Overall Study|Death|5|||
146276680|NCT01803282|527526383|FG008|Overall Study|Death|1|||
146276681|NCT01803282|527526384|FG009|Overall Study|Death|1|||
146276682|NCT01803282|527526385|FG010|Overall Study|Death|0|||
146276683|NCT01803282|527526386|FG011|Overall Study|Death|0|||
146276684|NCT01803282|527526375|FG000|Overall Study|Withdrew Consent|0|||
146276685|NCT01803282|527526376|FG001|Overall Study|Withdrew Consent|0|||
146276686|NCT01803282|527526377|FG002|Overall Study|Withdrew Consent|0|||
146276687|NCT01803282|527526378|FG003|Overall Study|Withdrew Consent|6|||
146276688|NCT01803282|527526379|FG004|Overall Study|Withdrew Consent|1|||
146276689|NCT01803282|527526380|FG005|Overall Study|Withdrew Consent|0|||
146276690|NCT01803282|527526381|FG006|Overall Study|Withdrew Consent|8|||
146276691|NCT01803282|527526382|FG007|Overall Study|Withdrew Consent|3|||
146276692|NCT01803282|527526383|FG008|Overall Study|Withdrew Consent|1|||
146276693|NCT01803282|527526384|FG009|Overall Study|Withdrew Consent|5|||
146276694|NCT01803282|527526385|FG010|Overall Study|Withdrew Consent|0|||
146276695|NCT01803282|527526386|FG011|Overall Study|Withdrew Consent|1|||
146276696|NCT01803282|527526375|FG000|Overall Study|Investigator's Discretion|0|||
146276697|NCT01803282|527526376|FG001|Overall Study|Investigator's Discretion|0|||
146276698|NCT01803282|527526377|FG002|Overall Study|Investigator's Discretion|0|||
146276699|NCT01803282|527526378|FG003|Overall Study|Investigator's Discretion|7|||
146276700|NCT01803282|527526379|FG004|Overall Study|Investigator's Discretion|2|||
146276701|NCT01803282|527526380|FG005|Overall Study|Investigator's Discretion|1|||
146276702|NCT01803282|527526381|FG006|Overall Study|Investigator's Discretion|7|||
146276703|NCT01803282|527526382|FG007|Overall Study|Investigator's Discretion|10|||
146276704|NCT01803282|527526383|FG008|Overall Study|Investigator's Discretion|6|||
146276705|NCT01803282|527526384|FG009|Overall Study|Investigator's Discretion|7|||
146276706|NCT01803282|527526385|FG010|Overall Study|Investigator's Discretion|1|||
146276707|NCT01803282|527526386|FG011|Overall Study|Investigator's Discretion|0|||
146276708|NCT01803282|527526375|FG000|Overall Study|Adverse Event|0|||
146276709|NCT01803282|527526376|FG001|Overall Study|Adverse Event|0|||
146276710|NCT01803282|527526377|FG002|Overall Study|Adverse Event|0|||
146276711|NCT01803282|527526378|FG003|Overall Study|Adverse Event|0|||
146276712|NCT01803282|527526379|FG004|Overall Study|Adverse Event|0|||
146276713|NCT01803282|527526380|FG005|Overall Study|Adverse Event|0|||
146276714|NCT01803282|527526381|FG006|Overall Study|Adverse Event|1|||
146276715|NCT01803282|527526382|FG007|Overall Study|Adverse Event|2|||
146276716|NCT01803282|527526383|FG008|Overall Study|Adverse Event|0|||
146276717|NCT01803282|527526384|FG009|Overall Study|Adverse Event|1|||
146276718|NCT01803282|527526385|FG010|Overall Study|Adverse Event|0|||
146276719|NCT01803282|527526386|FG011|Overall Study|Adverse Event|3|||
146276720|NCT01803282|527526375|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146276721|NCT01803282|527526376|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146276722|NCT01803282|527526377|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146276723|NCT01803282|527526378|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146276724|NCT01803282|527526379|FG004|Overall Study|Non-Compliance with Study Drug|0|||
146276725|NCT01803282|527526380|FG005|Overall Study|Non-Compliance with Study Drug|0|||
146276726|NCT01803282|527526381|FG006|Overall Study|Non-Compliance with Study Drug|0|||
146276727|NCT01803282|527526382|FG007|Overall Study|Non-Compliance with Study Drug|0|||
146276728|NCT01803282|527526383|FG008|Overall Study|Non-Compliance with Study Drug|0|||
146276729|NCT01803282|527526384|FG009|Overall Study|Non-Compliance with Study Drug|0|||
146276730|NCT01803282|527526385|FG010|Overall Study|Non-Compliance with Study Drug|0|||
146276731|NCT01803282|527526386|FG011|Overall Study|Non-Compliance with Study Drug|0|||
146276732|NCT01803282|527526375|FG000|Overall Study|Unknown Reason|0|||
146276733|NCT01803282|527526376|FG001|Overall Study|Unknown Reason|0|||
146276734|NCT01803282|527526377|FG002|Overall Study|Unknown Reason|0|||
146276735|NCT01803282|527526378|FG003|Overall Study|Unknown Reason|0|||
146276736|NCT01803282|527526379|FG004|Overall Study|Unknown Reason|0|||
146276737|NCT01803282|527526380|FG005|Overall Study|Unknown Reason|0|||
146276738|NCT01803282|527526381|FG006|Overall Study|Unknown Reason|0|||
146276739|NCT01803282|527526382|FG007|Overall Study|Unknown Reason|1|||
146276740|NCT01803282|527526383|FG008|Overall Study|Unknown Reason|0|||
146276741|NCT01803282|527526384|FG009|Overall Study|Unknown Reason|0|||
146276742|NCT01803282|527526385|FG010|Overall Study|Unknown Reason|0|||
146276743|NCT01803282|527526386|FG011|Overall Study|Unknown Reason|0|||
146276744|NCT01803282|527526375|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
146276745|NCT01803282|527526376|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
146276746|NCT01803282|527526377|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
146276747|NCT01803282|527526378|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
146276748|NCT01803282|527526379|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
146276749|NCT01803282|527526380|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
146276750|NCT01803282|527526381|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
146276751|NCT01803282|527526382|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
146276752|NCT01803282|527526383|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
146276753|NCT01803282|527526384|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
146276754|NCT01803282|527526385|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
146276755|NCT01803282|527526386|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
146276756|NCT01803282|527526375|FG000|Overall Study|Enrolled but Never Treated|0|||
146276757|NCT01803282|527526376|FG001|Overall Study|Enrolled but Never Treated|0|||
146276758|NCT01803282|527526377|FG002|Overall Study|Enrolled but Never Treated|0|||
146276759|NCT01803282|527526378|FG003|Overall Study|Enrolled but Never Treated|0|||
146276760|NCT01803282|527526379|FG004|Overall Study|Enrolled but Never Treated|1|||
146276761|NCT01803282|527526380|FG005|Overall Study|Enrolled but Never Treated|0|||
146276762|NCT01803282|527526381|FG006|Overall Study|Enrolled but Never Treated|1|||
146276763|NCT01803282|527526382|FG007|Overall Study|Enrolled but Never Treated|1|||
146276764|NCT01803282|527526383|FG008|Overall Study|Enrolled but Never Treated|0|||
146276765|NCT01803282|527526384|FG009|Overall Study|Enrolled but Never Treated|1|||
146276766|NCT01803282|527526385|FG010|Overall Study|Enrolled but Never Treated|0|||
146276767|NCT01803282|527526386|FG011|Overall Study|Enrolled but Never Treated|0|||
146276768|NCT02671500|527526387|FG000|Overall Study|Lack of Efficacy|12|||
146276769|NCT02671500|527526387|FG000|Overall Study|Lost to Follow-up|2|||
146276770|NCT01217437|527526388|FG000|Overall Study|Adverse Event|0|||
146276771|NCT01217437|527526389|FG001|Overall Study|Adverse Event|8|||
146276772|NCT01217437|527526388|FG000|Overall Study|Death|5|||
146276773|NCT01217437|527526389|FG001|Overall Study|Death|0|||
146276774|NCT01217437|527526388|FG000|Overall Study|Lack of Efficacy|29|||
146276775|NCT01217437|527526389|FG001|Overall Study|Lack of Efficacy|25|||
146276776|NCT01217437|527526388|FG000|Overall Study|Physician Decision|8|||
146276777|NCT01217437|527526389|FG001|Overall Study|Physician Decision|5|||
146276778|NCT01217437|527526388|FG000|Overall Study|Withdrawal by Subject|0|||
146276779|NCT01217437|527526389|FG001|Overall Study|Withdrawal by Subject|2|||
146276780|NCT01217437|527526388|FG000|Overall Study|Ineligible|1|||
146276781|NCT01217437|527526389|FG001|Overall Study|Ineligible|1|||
146276782|NCT06655558|527526392|FG000|Overall Study|Protocol Violation|1|||
146276783|NCT06748729|527526394|FG000|Overall Study|Withdrawal by Subject|1|||
146276784|NCT03578887|527526395|FG000|Overall Study|Withdrawal by Subject|7|||
146276785|NCT03578887|527526396|FG001|Overall Study|Withdrawal by Subject|2|||
146276786|NCT03578887|527526397|FG002|Overall Study|Withdrawal by Subject|1|||
146276787|NCT03578887|527526395|FG000|Overall Study|Lost to Follow-up|13|||
146276788|NCT03578887|527526396|FG001|Overall Study|Lost to Follow-up|1|||
146276789|NCT03578887|527526397|FG002|Overall Study|Lost to Follow-up|4|||
146276790|NCT03578887|527526395|FG000|Overall Study|Physician Decision|0|||
146276791|NCT03578887|527526396|FG001|Overall Study|Physician Decision|1|||
146276792|NCT03578887|527526397|FG002|Overall Study|Physician Decision|1|||
146276793|NCT00890695|527528390|FG000|Overall Study|Protocol Violation|1|||
146276794|NCT00890695|527528391|FG001|Overall Study|Protocol Violation|0|||
146276795|NCT00833261|527528400|FG000|Overall Study|Withdrawal by Subject|4|||
146276796|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
146276797|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
146276798|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
146276799|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
146276800|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
146276801|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
146276802|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
146276803|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146276804|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146276805|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146276806|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146276807|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
146276808|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Death|1|||
146276809|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Death|2|||
146276810|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Death|2|||
146276811|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Death|0|||
146276812|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Death|0|||
146276813|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Death|0|||
146276814|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146276815|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
146276816|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
146276817|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146276818|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146276819|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
146276820|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
146276821|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146276822|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146276823|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146145874|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146145875|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
146145876|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146145877|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
146145878|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
146145879|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146145880|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146145881|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146145882|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
146145883|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
146145884|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
146145885|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145886|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145887|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145888|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145889|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145890|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145891|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145892|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
146145893|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
146145894|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145895|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
146145896|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145897|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145898|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145899|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145900|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145901|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145902|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
146145903|NCT01172938|527047271|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145904|NCT01172938|527047272|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145905|NCT01172938|527047273|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
146145906|NCT01172938|527047274|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145907|NCT01172938|527047275|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145908|NCT01172938|527047276|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145909|NCT01172938|527047277|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145910|NCT01172938|527047278|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145911|NCT01172938|527047279|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
146145912|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145913|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
146145914|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
146145915|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145916|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145917|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145918|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145919|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
146145920|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
146145921|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146145922|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
146145923|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
146145924|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146145925|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146145926|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146145927|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
146145928|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
146145929|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
146145930|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146145931|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
146145932|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
146145933|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146145934|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146145935|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146276824|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146276825|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
146276826|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
146276827|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146276828|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146276829|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146276830|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146276831|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
146276832|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
146276833|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146276834|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146276835|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146276836|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146276837|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
146276838|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146276839|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
146276840|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146276841|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146276842|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146276843|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
146276844|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
146276845|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
146276846|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
146276847|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
146276848|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
146276849|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
146276850|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146276851|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146276852|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
146276853|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146276854|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146276855|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
146276856|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Site closure|0|||
146276857|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Site closure|0|||
146276858|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Site closure|1|||
146276859|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Site closure|0|||
146276860|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Site closure|0|||
146276861|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Site closure|0|||
146276862|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
146276863|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
146304528|NCT00555477|527629239|FG001|Overall Study|Physician Decision|2|||
146304529|NCT00545402|527629240|FG000|Overall Study|Discontinuation of treatment|17|||
146304530|NCT00545402|527629241|FG001|Overall Study|Discontinuation of treatment|9|||
146304531|NCT00545402|527629240|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
146304532|NCT00545402|527629241|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
146304533|NCT00545402|527629240|FG000|Overall Study|Death|5|||
146304534|NCT00545402|527629241|FG001|Overall Study|Death|7|||
146276864|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
146276865|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
146276866|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
146276867|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
146276868|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
146276869|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
146276870|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
146276871|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
146276872|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
146304535|NCT00545402|527629240|FG000|Overall Study|Graft loss|2|||
146304536|NCT00545402|527629241|FG001|Overall Study|Graft loss|4|||
146304537|NCT00545402|527629240|FG000|Overall Study|Withdrawal by Subject|0|||
146304538|NCT00545402|527629241|FG001|Overall Study|Withdrawal by Subject|1|||
146304539|NCT00545402|527629240|FG000|Overall Study|Protocol Violation|1|||
146145936|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
146145937|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
146145938|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
146276873|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
146276874|NCT03439254|527528401|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
146276875|NCT03439254|527528402|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
146276876|NCT03439254|527528403|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
146276877|NCT03439254|527528404|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146276878|NCT03439254|527528405|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146276879|NCT03439254|527528406|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
146276880|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146276881|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146276882|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
146276883|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
146276884|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
146276885|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
146276886|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146276887|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146276888|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146276889|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
146276890|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
146276891|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
146276892|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146276893|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146276894|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146276895|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146276896|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
146276897|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
146276898|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146276899|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146276900|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146276901|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146276902|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
146276903|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
146276904|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146276905|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146276906|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146276907|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146276908|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
146276909|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
146276910|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146276911|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146276912|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146276913|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146276914|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
146276915|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
146276916|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146276917|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146276918|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146276919|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
146276920|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146276921|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
146276922|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146276923|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146276924|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146276925|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
146276926|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
146276927|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
146276928|NCT03439254|527528401|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146276929|NCT03439254|527528402|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146276930|NCT03439254|527528403|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
146276931|NCT03439254|527528404|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
146276932|NCT03439254|527528405|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
146276933|NCT03439254|527528406|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
146276934|NCT01531673|527528407|FG000|Overall Study|Non-Compliance|0|||
146304540|NCT00545402|527629241|FG001|Overall Study|Protocol Violation|0|||
146304541|NCT00545402|527629240|FG000|Overall Study|Reason not specified|1|||
146276935|NCT01531673|527528408|FG001|Overall Study|Non-Compliance|0|||
146276936|NCT01531673|527528409|FG002|Overall Study|Non-Compliance|0|||
146276937|NCT01531673|527528410|FG003|Overall Study|Non-Compliance|0|||
146276938|NCT01531673|527528411|FG004|Overall Study|Non-Compliance|0|||
146276939|NCT01531673|527528412|FG005|Overall Study|Non-Compliance|1|||
146276940|NCT01531673|527528413|FG006|Overall Study|Non-Compliance|0|||
146276941|NCT01531673|527528414|FG007|Overall Study|Non-Compliance|0|||
146276942|NCT01531673|527528415|FG008|Overall Study|Non-Compliance|0|||
146304542|NCT00545402|527629241|FG001|Overall Study|Reason not specified|1|||
146276943|NCT01531673|527528416|FG009|Overall Study|Non-Compliance|0|||
146276944|NCT01531673|527528417|FG010|Overall Study|Non-Compliance|0|||
146276945|NCT01531673|527528418|FG011|Overall Study|Non-Compliance|0|||
146276946|NCT01531673|527528419|FG012|Overall Study|Non-Compliance|0|||
146276947|NCT01531673|527528407|FG000|Overall Study|Adverse Event|0|||
146276948|NCT01531673|527528408|FG001|Overall Study|Adverse Event|1|||
146276949|NCT01531673|527528409|FG002|Overall Study|Adverse Event|0|||
146276950|NCT01531673|527528410|FG003|Overall Study|Adverse Event|0|||
146276951|NCT01531673|527528411|FG004|Overall Study|Adverse Event|0|||
146276952|NCT01531673|527528412|FG005|Overall Study|Adverse Event|0|||
146276953|NCT01531673|527528413|FG006|Overall Study|Adverse Event|0|||
146276954|NCT01531673|527528414|FG007|Overall Study|Adverse Event|0|||
146276955|NCT01531673|527528415|FG008|Overall Study|Adverse Event|0|||
146276956|NCT01531673|527528416|FG009|Overall Study|Adverse Event|0|||
146276957|NCT01531673|527528417|FG010|Overall Study|Adverse Event|0|||
146276958|NCT01531673|527528418|FG011|Overall Study|Adverse Event|0|||
146276959|NCT01531673|527528419|FG012|Overall Study|Adverse Event|0|||
146276960|NCT01531673|527528407|FG000|Overall Study|Lost to Follow-up|0|||
146276961|NCT01531673|527528408|FG001|Overall Study|Lost to Follow-up|0|||
146276962|NCT01531673|527528409|FG002|Overall Study|Lost to Follow-up|0|||
146276963|NCT01531673|527528410|FG003|Overall Study|Lost to Follow-up|0|||
146276964|NCT01531673|527528411|FG004|Overall Study|Lost to Follow-up|1|||
146276965|NCT01531673|527528412|FG005|Overall Study|Lost to Follow-up|0|||
146276966|NCT01531673|527528413|FG006|Overall Study|Lost to Follow-up|0|||
146276967|NCT01531673|527528414|FG007|Overall Study|Lost to Follow-up|0|||
146276968|NCT01531673|527528415|FG008|Overall Study|Lost to Follow-up|0|||
146276969|NCT01531673|527528416|FG009|Overall Study|Lost to Follow-up|0|||
146276970|NCT01531673|527528417|FG010|Overall Study|Lost to Follow-up|0|||
146276971|NCT01531673|527528418|FG011|Overall Study|Lost to Follow-up|0|||
146276972|NCT01531673|527528419|FG012|Overall Study|Lost to Follow-up|0|||
146276973|NCT01531673|527528407|FG000|Overall Study|Other|0|||
146276974|NCT01531673|527528408|FG001|Overall Study|Other|0|||
146276975|NCT01531673|527528409|FG002|Overall Study|Other|0|||
146276976|NCT01531673|527528410|FG003|Overall Study|Other|1|||
146276977|NCT01531673|527528411|FG004|Overall Study|Other|0|||
146276978|NCT01531673|527528412|FG005|Overall Study|Other|0|||
146276979|NCT01531673|527528413|FG006|Overall Study|Other|0|||
146276980|NCT01531673|527528414|FG007|Overall Study|Other|0|||
146276981|NCT01531673|527528415|FG008|Overall Study|Other|0|||
146276982|NCT01531673|527528416|FG009|Overall Study|Other|1|||
146276983|NCT01531673|527528417|FG010|Overall Study|Other|0|||
146276984|NCT01531673|527528418|FG011|Overall Study|Other|0|||
146276985|NCT01531673|527528419|FG012|Overall Study|Other|0|||
146276986|NCT00568178|527528420|FG000|Double Blind Base Study|Adverse Event|0|||
146276987|NCT00568178|527528421|FG001|Double Blind Base Study|Adverse Event|2|||
146276988|NCT00568178|527528422|FG002|Double Blind Base Study|Adverse Event|1|||
146276989|NCT00568178|527528423|FG003|Double Blind Base Study|Adverse Event|2|||
146276990|NCT00568178|527528424|FG004|Double Blind Base Study|Adverse Event|0|||
146276991|NCT00568178|527528425|FG005|Double Blind Base Study|Adverse Event|0|||
146276992|NCT00568178|527528420|FG000|Double Blind Base Study|Lost to Follow-up|1|||
146276993|NCT00568178|527528421|FG001|Double Blind Base Study|Lost to Follow-up|0|||
146276994|NCT00568178|527528422|FG002|Double Blind Base Study|Lost to Follow-up|0|||
146276995|NCT00568178|527528423|FG003|Double Blind Base Study|Lost to Follow-up|1|||
146276996|NCT00568178|527528424|FG004|Double Blind Base Study|Lost to Follow-up|0|||
146276997|NCT00568178|527528425|FG005|Double Blind Base Study|Lost to Follow-up|0|||
146304543|NCT00397033|527629242|FG000|Overall Study|Adverse Event|7|||
146304544|NCT00397033|527629243|FG001|Overall Study|Adverse Event|10|||
146276998|NCT00568178|527528420|FG000|Double Blind Base Study|Physician Decision|1|||
146276999|NCT00568178|527528421|FG001|Double Blind Base Study|Physician Decision|1|||
146277000|NCT00568178|527528422|FG002|Double Blind Base Study|Physician Decision|0|||
146277001|NCT00568178|527528423|FG003|Double Blind Base Study|Physician Decision|1|||
146277002|NCT00568178|527528424|FG004|Double Blind Base Study|Physician Decision|0|||
146277003|NCT00568178|527528425|FG005|Double Blind Base Study|Physician Decision|0|||
146277004|NCT00568178|527528420|FG000|Double Blind Base Study|Protocol Violation|3|||
146277005|NCT00568178|527528421|FG001|Double Blind Base Study|Protocol Violation|2|||
146277006|NCT00568178|527528422|FG002|Double Blind Base Study|Protocol Violation|0|||
146277007|NCT00568178|527528423|FG003|Double Blind Base Study|Protocol Violation|0|||
146277008|NCT00568178|527528424|FG004|Double Blind Base Study|Protocol Violation|0|||
146277009|NCT00568178|527528425|FG005|Double Blind Base Study|Protocol Violation|0|||
146277010|NCT00568178|527528420|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
146277011|NCT00568178|527528421|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
146277012|NCT00568178|527528422|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
146277013|NCT00568178|527528423|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
146277014|NCT00568178|527528424|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
146277015|NCT00568178|527528425|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
146277016|NCT00568178|527528420|FG000|Double Blind Base Study|Progressive Disease|0|||
146277017|NCT00568178|527528421|FG001|Double Blind Base Study|Progressive Disease|0|||
146277018|NCT00568178|527528422|FG002|Double Blind Base Study|Progressive Disease|0|||
146277019|NCT00568178|527528423|FG003|Double Blind Base Study|Progressive Disease|1|||
146277020|NCT00568178|527528424|FG004|Double Blind Base Study|Progressive Disease|0|||
146277021|NCT00568178|527528425|FG005|Double Blind Base Study|Progressive Disease|0|||
146277022|NCT00568178|527528420|FG000|Open Label Extension|Adverse Event|0|||
146277023|NCT00568178|527528421|FG001|Open Label Extension|Adverse Event|0|||
146277024|NCT00568178|527528422|FG002|Open Label Extension|Adverse Event|0|||
146277025|NCT00568178|527528423|FG003|Open Label Extension|Adverse Event|0|||
146277026|NCT00568178|527528424|FG004|Open Label Extension|Adverse Event|11|||
146277027|NCT00568178|527528425|FG005|Open Label Extension|Adverse Event|8|||
146277028|NCT00568178|527528420|FG000|Open Label Extension|Protocol Violation|0|||
146277029|NCT00568178|527528421|FG001|Open Label Extension|Protocol Violation|0|||
146277030|NCT00568178|527528422|FG002|Open Label Extension|Protocol Violation|0|||
146277031|NCT00568178|527528423|FG003|Open Label Extension|Protocol Violation|0|||
146277032|NCT00568178|527528424|FG004|Open Label Extension|Protocol Violation|1|||
146277033|NCT00568178|527528425|FG005|Open Label Extension|Protocol Violation|0|||
146277034|NCT00568178|527528420|FG000|Open Label Extension|Lost to Follow-up|0|||
146277035|NCT00568178|527528421|FG001|Open Label Extension|Lost to Follow-up|0|||
146277036|NCT00568178|527528422|FG002|Open Label Extension|Lost to Follow-up|0|||
146277037|NCT00568178|527528423|FG003|Open Label Extension|Lost to Follow-up|0|||
146277038|NCT00568178|527528424|FG004|Open Label Extension|Lost to Follow-up|6|||
146277039|NCT00568178|527528425|FG005|Open Label Extension|Lost to Follow-up|11|||
146277040|NCT00568178|527528420|FG000|Open Label Extension|Physician Decision|0|||
146277041|NCT00568178|527528421|FG001|Open Label Extension|Physician Decision|0|||
146277042|NCT00568178|527528422|FG002|Open Label Extension|Physician Decision|0|||
146277043|NCT00568178|527528423|FG003|Open Label Extension|Physician Decision|0|||
146277044|NCT00568178|527528424|FG004|Open Label Extension|Physician Decision|9|||
146277045|NCT00568178|527528425|FG005|Open Label Extension|Physician Decision|8|||
146277046|NCT00568178|527528420|FG000|Open Label Extension|Pregnancy|0|||
146277047|NCT00568178|527528421|FG001|Open Label Extension|Pregnancy|0|||
146277048|NCT00568178|527528422|FG002|Open Label Extension|Pregnancy|0|||
146277049|NCT00568178|527528423|FG003|Open Label Extension|Pregnancy|0|||
146277050|NCT00568178|527528424|FG004|Open Label Extension|Pregnancy|0|||
146277051|NCT00568178|527528425|FG005|Open Label Extension|Pregnancy|1|||
146277052|NCT00568178|527528420|FG000|Open Label Extension|Progressive Disease|0|||
146277053|NCT00568178|527528421|FG001|Open Label Extension|Progressive Disease|0|||
146277054|NCT00568178|527528422|FG002|Open Label Extension|Progressive Disease|0|||
146277055|NCT00568178|527528423|FG003|Open Label Extension|Progressive Disease|0|||
146277056|NCT00568178|527528424|FG004|Open Label Extension|Progressive Disease|3|||
146277057|NCT00568178|527528425|FG005|Open Label Extension|Progressive Disease|1|||
146277058|NCT00568178|527528420|FG000|Open Label Extension|Termination of Trial|0|||
146277059|NCT00568178|527528421|FG001|Open Label Extension|Termination of Trial|0|||
146277060|NCT00568178|527528422|FG002|Open Label Extension|Termination of Trial|0|||
146277061|NCT00568178|527528423|FG003|Open Label Extension|Termination of Trial|0|||
146277062|NCT00568178|527528424|FG004|Open Label Extension|Termination of Trial|45|||
146277063|NCT00568178|527528425|FG005|Open Label Extension|Termination of Trial|47|||
146277064|NCT00568178|527528420|FG000|Open Label Extension|Withdrawal by Subject|0|||
146277065|NCT00568178|527528421|FG001|Open Label Extension|Withdrawal by Subject|0|||
146277066|NCT00568178|527528422|FG002|Open Label Extension|Withdrawal by Subject|0|||
146277067|NCT00568178|527528423|FG003|Open Label Extension|Withdrawal by Subject|0|||
146277068|NCT00568178|527528424|FG004|Open Label Extension|Withdrawal by Subject|4|||
146277069|NCT00568178|527528425|FG005|Open Label Extension|Withdrawal by Subject|4|||
146277070|NCT00264303|527528426|FG000|Overall Study|Adverse Event|4|||
146277071|NCT00264303|527528427|FG001|Overall Study|Adverse Event|3|||
146277072|NCT00264303|527528426|FG000|Overall Study|Lack of Efficacy|10|||
146277073|NCT00264303|527528427|FG001|Overall Study|Lack of Efficacy|13|||
146277074|NCT00264303|527528426|FG000|Overall Study|Lost to Follow-up|3|||
146277075|NCT00264303|527528427|FG001|Overall Study|Lost to Follow-up|3|||
146277076|NCT00264303|527528426|FG000|Overall Study|Withdrawal by Subject|2|||
146277077|NCT00264303|527528427|FG001|Overall Study|Withdrawal by Subject|3|||
146277078|NCT00264303|527528426|FG000|Overall Study|Various reasons listed in study report|6|||
146277079|NCT00264303|527528427|FG001|Overall Study|Various reasons listed in study report|7|||
146277080|NCT02389452|527528428|FG000|Overall Study|Lost to Follow-up|13|||
146277081|NCT02389452|527528428|FG000|Overall Study|Adverse Event|1|||
146277082|NCT02389452|527528428|FG000|Overall Study|Withdrawal by Subject|5|||
146277083|NCT02389452|527528428|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
146277084|NCT00837694|527528431|FG000|Overall Study|Lost to Follow-up|2|||
146277085|NCT00837694|527528432|FG001|Overall Study|Lost to Follow-up|0|||
146277086|NCT00837694|527528433|FG002|Overall Study|Lost to Follow-up|2|||
146277087|NCT00837694|527528434|FG003|Overall Study|Lost to Follow-up|1|||
146277088|NCT00837694|527528435|FG004|Overall Study|Lost to Follow-up|1|||
146277089|NCT00837694|527528436|FG005|Overall Study|Lost to Follow-up|1|||
146277090|NCT00818168|527528442|FG000|Overall Study|Lack of Efficacy|18|||
146277091|NCT00818168|527528442|FG000|Overall Study|Pregnancy|2|||
146277092|NCT00818168|527528442|FG000|Overall Study|Withdrawal by Subject|16|||
146277093|NCT00818168|527528442|FG000|Overall Study|Lost to Follow-up|7|||
146277094|NCT00818168|527528442|FG000|Overall Study|Adverse Event|19|||
146277095|NCT00818168|527528442|FG000|Overall Study|Reason for Non-completion Not reported|6|||
146277096|NCT00818168|527528442|FG000|Overall Study|Participant Moved|2|||
146277097|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Physician Decision|2|||
146277098|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Physician Decision|0|||
146277099|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Physician Decision|0|||
146277100|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Adverse Event|33|||
146277101|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Adverse Event|0|||
146277102|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Adverse Event|0|||
146277103|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
146277104|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146277105|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
146277106|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
146277107|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
146277108|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
146277109|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
146277110|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146277111|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
146277112|NCT01008553|527528443|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
146277113|NCT01008553|527528444|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
146277114|NCT01008553|527528445|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
146277115|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
146277116|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
146277117|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
146277118|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
146277119|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
146277120|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
146277121|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
146277122|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146277123|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
146277124|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
146277125|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
146277126|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
146277127|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
146277128|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
146277129|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
146277130|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
146277131|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
146277132|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
146277133|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146277134|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
146277135|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
146277136|NCT01008553|527528443|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
146277137|NCT01008553|527528444|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
146277138|NCT01008553|527528445|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
146277139|NCT01008410|527528446|FG000|Overall Study|Adverse Event|13|||
146277140|NCT01008410|527528447|FG001|Overall Study|Adverse Event|7|||
146277141|NCT01008410|527528446|FG000|Overall Study|Withdrawal by Subject|6|||
146277142|NCT01008410|527528447|FG001|Overall Study|Withdrawal by Subject|2|||
146277143|NCT01008410|527528446|FG000|Overall Study|Lost to Follow-up|1|||
146277144|NCT01008410|527528447|FG001|Overall Study|Lost to Follow-up|0|||
146277145|NCT01008410|527528446|FG000|Overall Study|Noncompliance|1|||
146277146|NCT01008410|527528447|FG001|Overall Study|Noncompliance|0|||
146277147|NCT01008410|527528446|FG000|Overall Study|Low Cortisol|2|||
146277148|NCT01008410|527528447|FG001|Overall Study|Low Cortisol|0|||
146277149|NCT01008410|527528446|FG000|Overall Study|Lack of Efficacy|2|||
146277150|NCT01008410|527528447|FG001|Overall Study|Lack of Efficacy|6|||
146277151|NCT01008410|527528446|FG000|Overall Study|Met Exclusion Criterion|0|||
146277152|NCT01008410|527528447|FG001|Overall Study|Met Exclusion Criterion|1|||
146277153|NCT03482466|527528452|FG000|Overall Study|Protocol Violation|2|||
146277154|NCT03268603|527528453|FG000|Overall Study|Withdrawal by Subject|6|||
146145939|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145940|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145941|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
146145942|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145943|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145944|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145945|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145946|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
146145947|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
146145948|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145949|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145950|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145951|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145952|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145953|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145954|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145955|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
146145956|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
146145957|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145958|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145959|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146145960|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145961|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145962|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145963|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
146145964|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146145965|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
146145966|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145967|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145968|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
146145969|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145970|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145971|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145972|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145973|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145974|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
146145975|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145976|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
146145977|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145978|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145979|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145980|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145981|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145982|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
146145983|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
146145984|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145985|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
146145986|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
146145987|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145988|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145989|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145990|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145991|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
146145992|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
146145993|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146145994|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146145995|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
146145996|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146145997|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146145998|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146145999|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146146000|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146146001|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
146146002|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146277155|NCT03268603|527528453|FG000|Overall Study|Physician Decision|1|||
146277156|NCT03268603|527528453|FG000|Overall Study|Withdrawn due to disease progression|2|||
146277157|NCT02591953|527528454|FG000|Overall Study|Lost to Follow-up|6|||
146277158|NCT02591953|527528455|FG001|Overall Study|Lost to Follow-up|6|||
146277159|NCT02060370|527528456|FG000|Overall Study|Physician Decision|1|||
146277160|NCT04939701|527528457|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
146277161|NCT04939701|527528458|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
146277162|NCT04939701|527528459|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
146277163|NCT04939701|527528457|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
146277164|NCT04939701|527528458|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
146277165|NCT04939701|527528459|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
146277166|NCT04939701|527528457|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
146277167|NCT04939701|527528458|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
146277168|NCT04939701|527528459|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
146277169|NCT04939701|527528457|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
146277170|NCT04939701|527528458|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
146277171|NCT04939701|527528459|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
146277172|NCT04939701|527528457|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
146277173|NCT04939701|527528458|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
146277174|NCT04939701|527528459|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
146277175|NCT04939701|527528457|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
146277176|NCT04939701|527528458|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
146277177|NCT04939701|527528459|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
146277178|NCT04939701|527528457|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
146277179|NCT04939701|527528458|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
146277180|NCT04939701|527528459|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
146277181|NCT02383940|527528464|FG000|Overall Study|Adverse Event|1|||
146277182|NCT02383940|527528465|FG001|Overall Study|Adverse Event|0|||
146277183|NCT02383940|527528464|FG000|Overall Study|Lost to Follow-up|2|||
146277184|NCT02383940|527528465|FG001|Overall Study|Lost to Follow-up|2|||
146277185|NCT02383940|527528464|FG000|Overall Study|Physician Decision|2|||
146277186|NCT02383940|527528465|FG001|Overall Study|Physician Decision|0|||
146277187|NCT02383940|527528464|FG000|Overall Study|Withdrawal by Subject|1|||
146277188|NCT02383940|527528465|FG001|Overall Study|Withdrawal by Subject|1|||
146277189|NCT02383940|527528464|FG000|Overall Study|Randomized but not treated|2|||
146277190|NCT02383940|527528465|FG001|Overall Study|Randomized but not treated|0|||
146277191|NCT02383940|527528464|FG000|Overall Study|Other than specified above|1|||
146277192|NCT02383940|527528465|FG001|Overall Study|Other than specified above|0|||
146277193|NCT01517295|527528466|FG000|Overall Study|Physician Decision|1|||
146277194|NCT01517295|527528467|FG001|Overall Study|Physician Decision|0|||
146277195|NCT02672852|527528469|FG000|Part A1|Disease Worsening|1|||
146277196|NCT02672852|527528470|FG001|Part A1|Disease Worsening|0|||
146277197|NCT02672852|527528471|FG002|Part A1|Disease Worsening|0|||
146277198|NCT02672852|527528472|FG003|Part A1|Disease Worsening|0|||
146277199|NCT02672852|527528473|FG004|Part A1|Disease Worsening|0|||
146277200|NCT02672852|527528474|FG005|Part A1|Disease Worsening|0|||
146277201|NCT02672852|527528475|FG006|Part A1|Disease Worsening|0|||
146277202|NCT02672852|527528469|FG000|Part A1|Adverse Event|0|||
146277203|NCT02672852|527528470|FG001|Part A1|Adverse Event|1|||
146277204|NCT02672852|527528471|FG002|Part A1|Adverse Event|0|||
146277205|NCT02672852|527528472|FG003|Part A1|Adverse Event|0|||
146277206|NCT02672852|527528473|FG004|Part A1|Adverse Event|0|||
146277207|NCT02672852|527528474|FG005|Part A1|Adverse Event|0|||
146277208|NCT02672852|527528475|FG006|Part A1|Adverse Event|0|||
146277209|NCT02672852|527528469|FG000|Part A1|Lost to Follow-up|1|||
146277210|NCT02672852|527528470|FG001|Part A1|Lost to Follow-up|2|||
146277211|NCT02672852|527528471|FG002|Part A1|Lost to Follow-up|0|||
146277212|NCT02672852|527528472|FG003|Part A1|Lost to Follow-up|0|||
146277213|NCT02672852|527528473|FG004|Part A1|Lost to Follow-up|0|||
146277214|NCT02672852|527528474|FG005|Part A1|Lost to Follow-up|0|||
146277215|NCT02672852|527528475|FG006|Part A1|Lost to Follow-up|0|||
146277216|NCT02672852|527528469|FG000|Part A1|Withdrawal by Subject|1|||
146277217|NCT02672852|527528470|FG001|Part A1|Withdrawal by Subject|1|||
146277218|NCT02672852|527528471|FG002|Part A1|Withdrawal by Subject|0|||
146277219|NCT02672852|527528472|FG003|Part A1|Withdrawal by Subject|0|||
146277220|NCT02672852|527528473|FG004|Part A1|Withdrawal by Subject|0|||
146277221|NCT02672852|527528474|FG005|Part A1|Withdrawal by Subject|0|||
146277222|NCT02672852|527528475|FG006|Part A1|Withdrawal by Subject|0|||
146277223|NCT02672852|527528469|FG000|Part A2|Disease worsening|0|||
146277224|NCT02672852|527528470|FG001|Part A2|Disease worsening|0|||
146277225|NCT02672852|527528471|FG002|Part A2|Disease worsening|1|||
146277226|NCT02672852|527528472|FG003|Part A2|Disease worsening|0|||
146277227|NCT02672852|527528473|FG004|Part A2|Disease worsening|0|||
146277228|NCT02672852|527528474|FG005|Part A2|Disease worsening|0|||
146277229|NCT02672852|527528475|FG006|Part A2|Disease worsening|0|||
146277230|NCT02672852|527528469|FG000|Part A2|Adverse Event|0|||
146304545|NCT00397033|527629244|FG002|Overall Study|Adverse Event|4|||
146304546|NCT00397033|527629242|FG000|Overall Study|Lack of Efficacy|22|||
146304547|NCT00397033|527629243|FG001|Overall Study|Lack of Efficacy|12|||
146304548|NCT00397033|527629244|FG002|Overall Study|Lack of Efficacy|9|||
146304549|NCT00397033|527629242|FG000|Overall Study|Lost to Follow-up|3|||
146304550|NCT00397033|527629243|FG001|Overall Study|Lost to Follow-up|3|||
146304551|NCT00397033|527629244|FG002|Overall Study|Lost to Follow-up|3|||
146304552|NCT00397033|527629242|FG000|Overall Study|Withdrawal by Subject|12|||
146304553|NCT00397033|527629243|FG001|Overall Study|Withdrawal by Subject|7|||
146304554|NCT00397033|527629244|FG002|Overall Study|Withdrawal by Subject|5|||
146304555|NCT00397033|527629242|FG000|Overall Study|Other|0|||
146304556|NCT00397033|527629243|FG001|Overall Study|Other|5|||
146304557|NCT00397033|527629244|FG002|Overall Study|Other|2|||
146304558|NCT03519867|527629245|FG000|Overall Study|Adverse Event|1|||
146304559|NCT03519867|527629246|FG001|Overall Study|Adverse Event|1|||
146304560|NCT03519867|527629247|FG002|Overall Study|Adverse Event|0|||
146304561|NCT03519867|527629248|FG003|Overall Study|Adverse Event|0|||
146304562|NCT03519867|527629249|FG004|Overall Study|Adverse Event|0|||
146304563|NCT03519867|527629250|FG005|Overall Study|Adverse Event|0|||
146304564|NCT03519867|527629251|FG006|Overall Study|Adverse Event|0|||
146304565|NCT03519867|527629252|FG007|Overall Study|Adverse Event|0|||
146304566|NCT03519867|527629253|FG008|Overall Study|Adverse Event|0|||
146304567|NCT03519867|527629254|FG009|Overall Study|Adverse Event|0|||
146304568|NCT03519867|527629245|FG000|Overall Study|Protocol Violation|0|||
146304569|NCT03519867|527629246|FG001|Overall Study|Protocol Violation|0|||
146304570|NCT03519867|527629247|FG002|Overall Study|Protocol Violation|0|||
146304571|NCT03519867|527629248|FG003|Overall Study|Protocol Violation|0|||
146304572|NCT03519867|527629249|FG004|Overall Study|Protocol Violation|0|||
146304573|NCT03519867|527629250|FG005|Overall Study|Protocol Violation|1|||
146304574|NCT03519867|527629251|FG006|Overall Study|Protocol Violation|0|||
146304575|NCT03519867|527629252|FG007|Overall Study|Protocol Violation|0|||
146304576|NCT03519867|527629253|FG008|Overall Study|Protocol Violation|0|||
146304577|NCT03519867|527629254|FG009|Overall Study|Protocol Violation|0|||
146304578|NCT03519867|527629245|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304579|NCT03519867|527629246|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304580|NCT03519867|527629247|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304581|NCT03519867|527629248|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304582|NCT03519867|527629249|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304583|NCT03519867|527629250|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304584|NCT03519867|527629251|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
146304585|NCT03519867|527629252|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304586|NCT03519867|527629253|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304587|NCT03519867|527629254|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
146304588|NCT03519867|527629245|FG000|Overall Study|Admin. of other reversal agent|1|||
146304589|NCT03519867|527629246|FG001|Overall Study|Admin. of other reversal agent|1|||
146304590|NCT03519867|527629247|FG002|Overall Study|Admin. of other reversal agent|0|||
146304591|NCT03519867|527629248|FG003|Overall Study|Admin. of other reversal agent|0|||
146304592|NCT03519867|527629249|FG004|Overall Study|Admin. of other reversal agent|0|||
146304593|NCT03519867|527629250|FG005|Overall Study|Admin. of other reversal agent|1|||
146304594|NCT03519867|527629251|FG006|Overall Study|Admin. of other reversal agent|0|||
146304595|NCT03519867|527629252|FG007|Overall Study|Admin. of other reversal agent|0|||
146304596|NCT03519867|527629253|FG008|Overall Study|Admin. of other reversal agent|0|||
146304597|NCT03519867|527629254|FG009|Overall Study|Admin. of other reversal agent|0|||
146304598|NCT03519867|527629245|FG000|Overall Study|Reason not provided|1|||
146146003|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146304599|NCT03519867|527629246|FG001|Overall Study|Reason not provided|1|||
146304600|NCT03519867|527629247|FG002|Overall Study|Reason not provided|1|||
146304601|NCT03519867|527629248|FG003|Overall Study|Reason not provided|1|||
146304602|NCT03519867|527629249|FG004|Overall Study|Reason not provided|0|||
146304603|NCT03519867|527629250|FG005|Overall Study|Reason not provided|1|||
146304604|NCT03519867|527629251|FG006|Overall Study|Reason not provided|0|||
146146004|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
146146005|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146146006|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146304605|NCT03519867|527629252|FG007|Overall Study|Reason not provided|1|||
146304606|NCT03519867|527629253|FG008|Overall Study|Reason not provided|1|||
146304607|NCT03519867|527629254|FG009|Overall Study|Reason not provided|0|||
146304608|NCT01721057|527629255|FG000|Treatment Period|Withdrawal by Subject|11|||
146304609|NCT01721057|527629256|FG001|Treatment Period|Withdrawal by Subject|5|||
146304610|NCT01721057|527629257|FG002|Treatment Period|Withdrawal by Subject|8|||
146304611|NCT01721057|527629258|FG003|Treatment Period|Withdrawal by Subject|0|||
146304612|NCT01721057|527629259|FG004|Treatment Period|Withdrawal by Subject|0|||
146146007|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146304613|NCT01721057|527629260|FG005|Treatment Period|Withdrawal by Subject|0|||
146304614|NCT01721057|527629261|FG006|Treatment Period|Withdrawal by Subject|0|||
146146008|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146146009|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146146010|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
146146011|NCT01172938|527047271|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146012|NCT01172938|527047272|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146013|NCT01172938|527047273|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146014|NCT01172938|527047274|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146015|NCT01172938|527047275|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146016|NCT01172938|527047276|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146017|NCT01172938|527047277|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146018|NCT01172938|527047278|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
146146019|NCT01172938|527047279|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
146146020|NCT00003498|527047280|FG000|Overall Study|Not evaluable.|4|||
146146021|NCT02956629|527047281|FG000|Overall Study|Adverse Event|0|||
146146022|NCT02956629|527047282|FG001|Overall Study|Adverse Event|0|||
146146023|NCT02956629|527047283|FG002|Overall Study|Adverse Event|1|||
146146024|NCT02956629|527047284|FG003|Overall Study|Adverse Event|0|||
146146025|NCT02956629|527047285|FG004|Overall Study|Adverse Event|0|||
146146026|NCT02956629|527047286|FG005|Overall Study|Adverse Event|0|||
146146027|NCT02956629|527047281|FG000|Overall Study|Lost to Follow-up|2|||
146146028|NCT02956629|527047282|FG001|Overall Study|Lost to Follow-up|5|||
146146029|NCT02956629|527047283|FG002|Overall Study|Lost to Follow-up|3|||
146146030|NCT02956629|527047284|FG003|Overall Study|Lost to Follow-up|1|||
146146031|NCT02956629|527047285|FG004|Overall Study|Lost to Follow-up|0|||
146146032|NCT02956629|527047286|FG005|Overall Study|Lost to Follow-up|1|||
146146033|NCT02956629|527047281|FG000|Overall Study|Withdrawal by Subject|3|||
146146034|NCT02956629|527047282|FG001|Overall Study|Withdrawal by Subject|1|||
146146035|NCT02956629|527047283|FG002|Overall Study|Withdrawal by Subject|0|||
146146036|NCT02956629|527047284|FG003|Overall Study|Withdrawal by Subject|0|||
146146037|NCT02956629|527047285|FG004|Overall Study|Withdrawal by Subject|0|||
146146038|NCT02956629|527047286|FG005|Overall Study|Withdrawal by Subject|0|||
146146039|NCT05282004|527047294|FG000|Overall Study|Adverse Event|2|||
146146040|NCT04808609|527047295|FG000|Overall Study|Lost to Follow-up|0|||
146146041|NCT04808609|527047296|FG001|Overall Study|Lost to Follow-up|2|||
146146042|NCT04808609|527047295|FG000|Overall Study|Administrative Withdrawal|0|||
146146043|NCT04808609|527047296|FG001|Overall Study|Administrative Withdrawal|1|||
146146044|NCT01993719|527047297|FG000|First Drug Administration|Not treated|1|||
146146045|NCT01993719|527047298|FG001|First Drug Administration|Not treated|0|||
146146046|NCT01993719|527047299|FG002|First Drug Administration|Not treated|0|||
146146047|NCT01993719|527047300|FG003|First Drug Administration|Not treated|0|||
146146048|NCT01993719|527047301|FG004|First Drug Administration|Not treated|0|||
146146049|NCT04067141|527047308|FG000|First Intervention|Withdrawal by Subject|0|||
146146050|NCT04067141|527047309|FG001|First Intervention|Withdrawal by Subject|1|||
146146051|NCT04067141|527047308|FG000|Second Intervention|Adverse Event|0|||
146146052|NCT04067141|527047309|FG001|Second Intervention|Adverse Event|2|||
146146053|NCT03295201|527047310|FG000|Overall Study|Lost to Follow-up|1|||
146146054|NCT03295201|527047311|FG001|Overall Study|Lost to Follow-up|1|||
146146055|NCT03295201|527047310|FG000|Overall Study|Hospital admission|0|||
146146056|NCT03295201|527047311|FG001|Overall Study|Hospital admission|1|||
146146057|NCT00572572|527047312|FG000|Overall Study|Withdrawal by Subject|3|||
146146058|NCT00572572|527047313|FG001|Overall Study|Withdrawal by Subject|6|||
146146059|NCT00889421|527047314|FG000|Overall Study|Lack of Efficacy|3|||
146146060|NCT01958918|527047315|FG000|Overall Study|Death|1|||
146277231|NCT02672852|527528470|FG001|Part A2|Adverse Event|0|||
146277232|NCT02672852|527528471|FG002|Part A2|Adverse Event|3|||
146277233|NCT02672852|527528472|FG003|Part A2|Adverse Event|0|||
146277234|NCT02672852|527528473|FG004|Part A2|Adverse Event|0|||
146277235|NCT02672852|527528474|FG005|Part A2|Adverse Event|0|||
146277236|NCT02672852|527528475|FG006|Part A2|Adverse Event|0|||
146277237|NCT02672852|527528469|FG000|Part A2|Lost to Follow-up|0|||
146277238|NCT02672852|527528470|FG001|Part A2|Lost to Follow-up|0|||
146277239|NCT02672852|527528471|FG002|Part A2|Lost to Follow-up|2|||
146277240|NCT02672852|527528472|FG003|Part A2|Lost to Follow-up|0|||
146277241|NCT02672852|527528473|FG004|Part A2|Lost to Follow-up|0|||
146277242|NCT02672852|527528474|FG005|Part A2|Lost to Follow-up|0|||
146277243|NCT02672852|527528475|FG006|Part A2|Lost to Follow-up|0|||
146277244|NCT02672852|527528469|FG000|Part A2|Withdrawal by Subject|0|||
146277245|NCT02672852|527528470|FG001|Part A2|Withdrawal by Subject|0|||
146277246|NCT02672852|527528471|FG002|Part A2|Withdrawal by Subject|1|||
146304615|NCT01721057|527629255|FG000|Treatment Period|Adverse Event|7|||
146146061|NCT01958918|527047316|FG001|Overall Study|Death|3|||
146146062|NCT01958918|527047315|FG000|Overall Study|Lost to Follow-up|4|||
146146063|NCT01958918|527047316|FG001|Overall Study|Lost to Follow-up|7|||
146146064|NCT01958918|527047315|FG000|Overall Study|Withdrawal by Subject|13|||
146146065|NCT01958918|527047316|FG001|Overall Study|Withdrawal by Subject|8|||
146146066|NCT01958918|527047315|FG000|Overall Study|Lack of Efficacy|13|||
146277247|NCT02672852|527528472|FG003|Part A2|Withdrawal by Subject|0|||
146277248|NCT02672852|527528473|FG004|Part A2|Withdrawal by Subject|0|||
146304616|NCT01721057|527629256|FG001|Treatment Period|Adverse Event|10|||
146304617|NCT01721057|527629257|FG002|Treatment Period|Adverse Event|12|||
146304618|NCT01721057|527629258|FG003|Treatment Period|Adverse Event|0|||
146304619|NCT01721057|527629259|FG004|Treatment Period|Adverse Event|0|||
146304620|NCT01721057|527629260|FG005|Treatment Period|Adverse Event|0|||
146304621|NCT01721057|527629261|FG006|Treatment Period|Adverse Event|0|||
146304622|NCT01721057|527629255|FG000|Treatment Period|Lack of Efficacy|7|||
146304623|NCT01721057|527629256|FG001|Treatment Period|Lack of Efficacy|3|||
146304624|NCT01721057|527629257|FG002|Treatment Period|Lack of Efficacy|0|||
146304625|NCT01721057|527629258|FG003|Treatment Period|Lack of Efficacy|0|||
146304626|NCT01721057|527629259|FG004|Treatment Period|Lack of Efficacy|0|||
146304627|NCT01721057|527629260|FG005|Treatment Period|Lack of Efficacy|0|||
146304628|NCT01721057|527629261|FG006|Treatment Period|Lack of Efficacy|0|||
146304629|NCT01721057|527629255|FG000|Treatment Period|Lost to Follow-up|1|||
146304630|NCT01721057|527629256|FG001|Treatment Period|Lost to Follow-up|0|||
146304631|NCT01721057|527629257|FG002|Treatment Period|Lost to Follow-up|0|||
146304632|NCT01721057|527629258|FG003|Treatment Period|Lost to Follow-up|0|||
146304633|NCT01721057|527629259|FG004|Treatment Period|Lost to Follow-up|0|||
146304634|NCT01721057|527629260|FG005|Treatment Period|Lost to Follow-up|0|||
146304635|NCT01721057|527629261|FG006|Treatment Period|Lost to Follow-up|0|||
146304636|NCT01721057|527629255|FG000|Treatment Period|Physician Decision|0|||
146304637|NCT01721057|527629256|FG001|Treatment Period|Physician Decision|1|||
146304638|NCT01721057|527629257|FG002|Treatment Period|Physician Decision|3|||
146304639|NCT01721057|527629258|FG003|Treatment Period|Physician Decision|0|||
146304640|NCT01721057|527629259|FG004|Treatment Period|Physician Decision|0|||
146304641|NCT01721057|527629260|FG005|Treatment Period|Physician Decision|0|||
146304642|NCT01721057|527629261|FG006|Treatment Period|Physician Decision|0|||
146304643|NCT01721057|527629255|FG000|Treatment Period|Death|2|||
146304644|NCT01721057|527629256|FG001|Treatment Period|Death|0|||
146304645|NCT01721057|527629257|FG002|Treatment Period|Death|0|||
146304646|NCT01721057|527629258|FG003|Treatment Period|Death|0|||
146304647|NCT01721057|527629259|FG004|Treatment Period|Death|0|||
146304648|NCT01721057|527629260|FG005|Treatment Period|Death|0|||
146304649|NCT01721057|527629261|FG006|Treatment Period|Death|0|||
146304650|NCT01721057|527629255|FG000|Rescue Period|Adverse Event|0|||
146304651|NCT01721057|527629256|FG001|Rescue Period|Adverse Event|0|||
146304652|NCT01721057|527629257|FG002|Rescue Period|Adverse Event|0|||
146304653|NCT01721057|527629258|FG003|Rescue Period|Adverse Event|1|||
146304654|NCT01721057|527629259|FG004|Rescue Period|Adverse Event|0|||
146304655|NCT01721057|527629260|FG005|Rescue Period|Adverse Event|0|||
146304656|NCT01721057|527629261|FG006|Rescue Period|Adverse Event|0|||
146304657|NCT01721057|527629255|FG000|Rescue Period|Lack of Efficacy|0|||
146304658|NCT01721057|527629256|FG001|Rescue Period|Lack of Efficacy|0|||
146304659|NCT01721057|527629257|FG002|Rescue Period|Lack of Efficacy|0|||
146304660|NCT01721057|527629258|FG003|Rescue Period|Lack of Efficacy|2|||
146304661|NCT01721057|527629259|FG004|Rescue Period|Lack of Efficacy|0|||
146304662|NCT01721057|527629260|FG005|Rescue Period|Lack of Efficacy|0|||
146304663|NCT01721057|527629261|FG006|Rescue Period|Lack of Efficacy|0|||
146304664|NCT01202279|527629264|FG000|Overall Study|Adverse Event|8|||
146304665|NCT01202279|527629265|FG001|Overall Study|Adverse Event|6|||
146304666|NCT01202279|527629264|FG000|Overall Study|Withdrawal by Subject|13|||
146304667|NCT01202279|527629265|FG001|Overall Study|Withdrawal by Subject|10|||
146304668|NCT01202279|527629264|FG000|Overall Study|Physician Decision|0|||
146304669|NCT01202279|527629265|FG001|Overall Study|Physician Decision|1|||
146304670|NCT01202279|527629264|FG000|Overall Study|Lost to Follow-up|10|||
146304671|NCT01202279|527629265|FG001|Overall Study|Lost to Follow-up|7|||
146304672|NCT01202279|527629264|FG000|Overall Study|Protocol Violation|1|||
146304673|NCT01202279|527629265|FG001|Overall Study|Protocol Violation|1|||
146304674|NCT01202279|527629264|FG000|Overall Study|study compliance|5|||
146304675|NCT01202279|527629265|FG001|Overall Study|study compliance|2|||
146304676|NCT03805750|527629266|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
146304677|NCT03805750|527629267|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
146304678|NCT01984164|527629268|FG000|Overall Study|Withdrawal by Subject|4|||
146304679|NCT01984164|527629269|FG001|Overall Study|Withdrawal by Subject|3|||
146304680|NCT01984164|527629268|FG000|Overall Study|Adverse Event|5|||
146304681|NCT01984164|527629269|FG001|Overall Study|Adverse Event|19|||
146304682|NCT01984164|527629268|FG000|Overall Study|Lost to Follow-up|1|||
146304683|NCT01984164|527629269|FG001|Overall Study|Lost to Follow-up|3|||
146304684|NCT02811549|527629270|FG000|Overall Study|Lost to Follow-up|1|||
146304685|NCT02811549|527629270|FG000|Overall Study|Withdrawal by Subject|3|||
146304686|NCT02811549|527629270|FG000|Overall Study|Subject screen failed|4|||
146304687|NCT02811549|527629270|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
146304688|NCT03472924|527629271|FG000|Overall Study|Adverse Event|1|||
146304689|NCT03472924|527629272|FG001|Overall Study|Adverse Event|0|||
146304690|NCT02546765|527629276|FG000|Overall Study|Withdrawal by Subject|0|||
146304691|NCT02546765|527629277|FG001|Overall Study|Withdrawal by Subject|1|||
146304692|NCT02546765|527629278|FG002|Overall Study|Withdrawal by Subject|0|||
146304693|NCT02546765|527629279|FG003|Overall Study|Withdrawal by Subject|0|||
146304694|NCT00475722|527629280|FG000|Overall Study|Withdrawal by Subject|12|||
146304695|NCT00475722|527629281|FG001|Overall Study|Withdrawal by Subject|12|||
146304696|NCT00475722|527629280|FG000|Overall Study|Protocol Violation|3|||
146304697|NCT00475722|527629281|FG001|Overall Study|Protocol Violation|0|||
146304698|NCT01889238|527629283|FG000|Overall Study|Death|1|||
146304699|NCT01889238|527629283|FG000|Overall Study|Withdrawal by Subject|1|||
146304700|NCT01889238|527629283|FG000|Overall Study|Adverse Event|6|||
146304701|NCT01889238|527629283|FG000|Overall Study|Disease Progression|104|||
146304702|NCT01889238|527629283|FG000|Overall Study|Other|6|||
146304703|NCT04136184|527629284|FG000|Overall Study|Lost to Follow-up|0|||
146304704|NCT04136184|527629285|FG001|Overall Study|Lost to Follow-up|3|||
146304705|NCT04136184|527629284|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
146304706|NCT04136184|527629285|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
146304707|NCT03318978|527629289|FG000|Overall Study|Withdrawal by Subject|1|||
146304708|NCT02844816|527629290|FG000|Overall Study|No protocol treatment received|5|||
146304709|NCT02844816|527629291|FG001|Overall Study|No protocol treatment received|1|||
146304710|NCT02844816|527629290|FG000|Overall Study|Ineligible|22|||
146304711|NCT02844816|527629291|FG001|Overall Study|Ineligible|15|||
146304712|NCT02844816|527629290|FG000|Overall Study|Participant refusal|5|||
146304713|NCT02844816|527629291|FG001|Overall Study|Participant refusal|5|||
146304714|NCT02844816|527629290|FG000|Overall Study|Adverse Event|5|||
146304715|NCT02844816|527629291|FG001|Overall Study|Adverse Event|4|||
146304716|NCT02844816|527629290|FG000|Overall Study|Death|0|||
146304717|NCT02844816|527629291|FG001|Overall Study|Death|1|||
146304718|NCT02844816|527629290|FG000|Overall Study|Disease progression/recurrence|50|||
146304719|NCT02844816|527629291|FG001|Overall Study|Disease progression/recurrence|24|||
146304720|NCT02844816|527629290|FG000|Overall Study|Physician Decision|1|||
146304721|NCT02844816|527629291|FG001|Overall Study|Physician Decision|1|||
146304722|NCT01200238|527629295|FG000|Overall Study|Adverse Event|2|||
146304723|NCT01200238|527629296|FG001|Overall Study|Adverse Event|1|||
146304724|NCT01200238|527629295|FG000|Overall Study|Progressive Disease|5|||
146304725|NCT01200238|527629296|FG001|Overall Study|Progressive Disease|8|||
146304726|NCT01200238|527629295|FG000|Overall Study|Withdrawal by Subject|0|||
146304727|NCT01200238|527629296|FG001|Overall Study|Withdrawal by Subject|1|||
146304728|NCT02717754|527629297|FG000|Overall Study|Incorrect Infusion Duration|0|||
146304729|NCT02717754|527629298|FG001|Overall Study|Incorrect Infusion Duration|0|||
146304730|NCT02717754|527629299|FG002|Overall Study|Incorrect Infusion Duration|0|||
146304731|NCT02717754|527629300|FG003|Overall Study|Incorrect Infusion Duration|10|||
146146067|NCT01958918|527047316|FG001|Overall Study|Lack of Efficacy|10|||
146146068|NCT01958918|527047315|FG000|Overall Study|Adverse Event|12|||
146146069|NCT01958918|527047316|FG001|Overall Study|Adverse Event|12|||
146146070|NCT01958918|527047315|FG000|Overall Study|administrative problems|0|||
146146071|NCT01958918|527047316|FG001|Overall Study|administrative problems|2|||
146146072|NCT02114892|527047320|FG000|Overall Study|Lost to Follow-up|1|||
146146073|NCT02114892|527047321|FG001|Overall Study|Lost to Follow-up|2|||
146146074|NCT00659269|527047325|FG000|Overall Study|Physician Decision|1|||
146146075|NCT00659269|527047326|FG001|Overall Study|Physician Decision|1|||
146146076|NCT00718042|527047328|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146146077|NCT00718042|527047329|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146146078|NCT00718042|527047330|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146146079|NCT00718042|527047331|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146146080|NCT00718042|527047332|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
146146081|NCT00718042|527047333|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
146146082|NCT00718042|527047328|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
146146083|NCT00718042|527047329|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146146084|NCT00718042|527047330|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146146085|NCT00718042|527047331|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146146086|NCT00718042|527047332|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
146146087|NCT00718042|527047333|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
146146088|NCT00718042|527047328|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146146089|NCT00718042|527047329|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
146146090|NCT00718042|527047330|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
146146091|NCT00718042|527047331|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146146092|NCT00718042|527047332|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146304732|NCT02717754|527629301|FG004|Overall Study|Incorrect Infusion Duration|20|||
146304733|NCT02717754|527629302|FG005|Overall Study|Incorrect Infusion Duration|20|||
146304734|NCT00482703|527629303|FG000|Overall Study|Poor compliance|1|||
146304735|NCT00482703|527629304|FG001|Overall Study|Poor compliance|0|||
146304736|NCT00667823|527629306|FG000|Overall Study|Lost to Follow-up|5|||
146304737|NCT00667823|527629306|FG000|Overall Study|Adverse Event|7|||
146304738|NCT00667823|527629306|FG000|Overall Study|Death|182|||
146304739|NCT00667823|527629306|FG000|Overall Study|Withdrawal by Subject|12|||
146146093|NCT00718042|527047333|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
146146094|NCT00718042|527047328|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146146095|NCT00718042|527047329|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
146146096|NCT00718042|527047330|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146304740|NCT00667823|527629306|FG000|Overall Study|Other|8|||
146146097|NCT00718042|527047331|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146277249|NCT02672852|527528474|FG005|Part A2|Withdrawal by Subject|0|||
146277250|NCT02672852|527528475|FG006|Part A2|Withdrawal by Subject|0|||
146277251|NCT02672852|527528469|FG000|Part A2|Other|0|||
146277252|NCT02672852|527528470|FG001|Part A2|Other|0|||
146277253|NCT02672852|527528471|FG002|Part A2|Other|3|||
146277254|NCT02672852|527528472|FG003|Part A2|Other|0|||
146277255|NCT02672852|527528473|FG004|Part A2|Other|0|||
146277256|NCT02672852|527528474|FG005|Part A2|Other|0|||
146277257|NCT02672852|527528475|FG006|Part A2|Other|0|||
146277258|NCT02672852|527528469|FG000|Part A2|Not entered in Part B|0|||
146277259|NCT02672852|527528470|FG001|Part A2|Not entered in Part B|0|||
146277260|NCT02672852|527528471|FG002|Part A2|Not entered in Part B|0|||
146277261|NCT02672852|527528472|FG003|Part A2|Not entered in Part B|4|||
146277262|NCT02672852|527528473|FG004|Part A2|Not entered in Part B|0|||
146277263|NCT02672852|527528474|FG005|Part A2|Not entered in Part B|0|||
146277264|NCT02672852|527528475|FG006|Part A2|Not entered in Part B|0|||
146277265|NCT02672852|527528469|FG000|Part B|Disease worsening|0|||
146277266|NCT02672852|527528470|FG001|Part B|Disease worsening|0|||
146277267|NCT02672852|527528471|FG002|Part B|Disease worsening|0|||
146277268|NCT02672852|527528472|FG003|Part B|Disease worsening|0|||
146277269|NCT02672852|527528473|FG004|Part B|Disease worsening|1|||
146277270|NCT02672852|527528474|FG005|Part B|Disease worsening|0|||
146277271|NCT02672852|527528475|FG006|Part B|Disease worsening|1|||
146277272|NCT02672852|527528469|FG000|Part B|Worsening pre-existing condition|0|||
146277273|NCT02672852|527528470|FG001|Part B|Worsening pre-existing condition|0|||
146277274|NCT02672852|527528471|FG002|Part B|Worsening pre-existing condition|0|||
146277275|NCT02672852|527528472|FG003|Part B|Worsening pre-existing condition|0|||
146277276|NCT02672852|527528473|FG004|Part B|Worsening pre-existing condition|0|||
146277277|NCT02672852|527528474|FG005|Part B|Worsening pre-existing condition|1|||
146277278|NCT02672852|527528475|FG006|Part B|Worsening pre-existing condition|0|||
146277279|NCT02672852|527528469|FG000|Part B|Other adverse event|0|||
146277280|NCT02672852|527528470|FG001|Part B|Other adverse event|0|||
146277281|NCT02672852|527528471|FG002|Part B|Other adverse event|0|||
146277282|NCT02672852|527528472|FG003|Part B|Other adverse event|0|||
146277283|NCT02672852|527528473|FG004|Part B|Other adverse event|3|||
146277284|NCT02672852|527528474|FG005|Part B|Other adverse event|5|||
146277285|NCT02672852|527528475|FG006|Part B|Other adverse event|1|||
146277286|NCT02672852|527528469|FG000|Part B|Lost to Follow-up|0|||
146277287|NCT02672852|527528470|FG001|Part B|Lost to Follow-up|0|||
146277288|NCT02672852|527528471|FG002|Part B|Lost to Follow-up|0|||
146277289|NCT02672852|527528472|FG003|Part B|Lost to Follow-up|0|||
146277290|NCT02672852|527528473|FG004|Part B|Lost to Follow-up|3|||
146277291|NCT02672852|527528474|FG005|Part B|Lost to Follow-up|4|||
146277292|NCT02672852|527528475|FG006|Part B|Lost to Follow-up|1|||
146277293|NCT02672852|527528469|FG000|Part B|Withdrawal by Subject|0|||
146277294|NCT02672852|527528470|FG001|Part B|Withdrawal by Subject|0|||
146277295|NCT02672852|527528471|FG002|Part B|Withdrawal by Subject|0|||
146277296|NCT02672852|527528472|FG003|Part B|Withdrawal by Subject|0|||
146277297|NCT02672852|527528473|FG004|Part B|Withdrawal by Subject|5|||
146277298|NCT02672852|527528474|FG005|Part B|Withdrawal by Subject|0|||
146277299|NCT02672852|527528475|FG006|Part B|Withdrawal by Subject|7|||
146277300|NCT02672852|527528469|FG000|Part B|Other|0|||
146277301|NCT02672852|527528470|FG001|Part B|Other|0|||
146277302|NCT02672852|527528471|FG002|Part B|Other|0|||
146277303|NCT02672852|527528472|FG003|Part B|Other|0|||
146277304|NCT02672852|527528473|FG004|Part B|Other|4|||
146277305|NCT02672852|527528474|FG005|Part B|Other|1|||
146277306|NCT02672852|527528475|FG006|Part B|Other|2|||
146277307|NCT03248882|527528476|FG000|Overall Study|Adverse Event|3|||
146277308|NCT03248882|527528477|FG001|Overall Study|Adverse Event|3|||
146277309|NCT03248882|527528478|FG002|Overall Study|Adverse Event|2|||
146277310|NCT03248882|527528479|FG003|Overall Study|Adverse Event|6|||
146277311|NCT03248882|527528480|FG004|Overall Study|Adverse Event|9|||
146277312|NCT03248882|527528476|FG000|Overall Study|Lost to Follow-up|0|||
146277313|NCT03248882|527528477|FG001|Overall Study|Lost to Follow-up|0|||
146277314|NCT03248882|527528478|FG002|Overall Study|Lost to Follow-up|0|||
146277315|NCT03248882|527528479|FG003|Overall Study|Lost to Follow-up|0|||
146277316|NCT03248882|527528480|FG004|Overall Study|Lost to Follow-up|1|||
146277317|NCT03248882|527528476|FG000|Overall Study|Protocol Violation|2|||
146277318|NCT03248882|527528477|FG001|Overall Study|Protocol Violation|0|||
146277319|NCT03248882|527528478|FG002|Overall Study|Protocol Violation|2|||
146277320|NCT03248882|527528479|FG003|Overall Study|Protocol Violation|0|||
146277321|NCT03248882|527528480|FG004|Overall Study|Protocol Violation|1|||
146277322|NCT03248882|527528476|FG000|Overall Study|Withdrawal by Subject|2|||
146277323|NCT03248882|527528477|FG001|Overall Study|Withdrawal by Subject|2|||
146277324|NCT03248882|527528478|FG002|Overall Study|Withdrawal by Subject|3|||
146277325|NCT03248882|527528479|FG003|Overall Study|Withdrawal by Subject|4|||
146277326|NCT03248882|527528480|FG004|Overall Study|Withdrawal by Subject|2|||
146277327|NCT04308590|527528481|FG000|Overall Study|Adverse Event|12|||
146304741|NCT00667823|527629306|FG000|Overall Study|Missing (completion page missing)|2|||
146304742|NCT02592018|527629307|FG000|Overall Study|Adverse Event|1|||
146304743|NCT02592018|527629307|FG000|Overall Study|Lost to Follow-up|1|||
146304744|NCT03697720|527630877|FG000|Overall Study|Lost to Follow-up|7|||
146304745|NCT04096274|527630878|FG000|Phase I|Lost to Follow-up|5|||
146304746|NCT04096274|527630879|FG001|Phase I|Lost to Follow-up|5|||
146304747|NCT04096274|527630878|FG000|Phase II|Lost to Follow-up|11|||
146304748|NCT04096274|527630879|FG001|Phase II|Lost to Follow-up|11|||
146304749|NCT05092919|527630881|FG000|Overall Study|Lost to Follow-up|7|||
146304750|NCT05092919|527630881|FG000|Overall Study|Withdrawal by Subject|2|||
146304751|NCT01942148|527630882|FG000|Overall Study|Adverse Event|4|||
146304752|NCT01942148|527630882|FG000|Overall Study|Lack of Efficacy|2|||
146304753|NCT01942148|527630882|FG000|Overall Study|Physician Decision|11|||
146304754|NCT01942148|527630882|FG000|Overall Study|Protocol Violation|1|||
146304755|NCT01942148|527630882|FG000|Overall Study|Withdrawal by Subject|8|||
146304756|NCT01942148|527630882|FG000|Overall Study|Use of the prohibition medicine|1|||
146304757|NCT02807480|527630883|FG000|Overall Study|Withdrawal by Subject|14|||
146304758|NCT02807480|527630884|FG001|Overall Study|Withdrawal by Subject|10|||
146304759|NCT00096785|527630888|FG000|Overall Study|Lost to Follow-up|1|||
146304760|NCT00096785|527630889|FG001|Overall Study|Lost to Follow-up|0|||
146304761|NCT00096785|527630888|FG000|Overall Study|Withdrawal by Subject|0|||
146304762|NCT00096785|527630889|FG001|Overall Study|Withdrawal by Subject|1|||
146304763|NCT00096785|527630888|FG000|Overall Study|Relocated|1|||
146304764|NCT00096785|527630889|FG001|Overall Study|Relocated|0|||
146304765|NCT00257725|527630890|FG000|Overall Study|Adverse Event|3|||
146304766|NCT01858532|527630891|FG000|Overall Study|Adverse Event|58|||
146304767|NCT01858532|527630892|FG001|Overall Study|Adverse Event|50|||
146304768|NCT01858532|527630893|FG002|Overall Study|Adverse Event|23|||
146304769|NCT01858532|527630894|FG003|Overall Study|Adverse Event|28|||
146304770|NCT01858532|527630891|FG000|Overall Study|Withdrew consent|71|||
146304771|NCT01858532|527630892|FG001|Overall Study|Withdrew consent|93|||
146304772|NCT01858532|527630893|FG002|Overall Study|Withdrew consent|46|||
146304773|NCT01858532|527630894|FG003|Overall Study|Withdrew consent|27|||
146304774|NCT01858532|527630891|FG000|Overall Study|Lost to Follow-up|17|||
146304775|NCT01858532|527630892|FG001|Overall Study|Lost to Follow-up|26|||
146304776|NCT01858532|527630893|FG002|Overall Study|Lost to Follow-up|11|||
146304777|NCT01858532|527630894|FG003|Overall Study|Lost to Follow-up|14|||
146304778|NCT01858532|527630891|FG000|Overall Study|Deterioration of medical status|3|||
146304779|NCT01858532|527630892|FG001|Overall Study|Deterioration of medical status|4|||
146304780|NCT01858532|527630893|FG002|Overall Study|Deterioration of medical status|3|||
146304781|NCT01858532|527630894|FG003|Overall Study|Deterioration of medical status|7|||
146304782|NCT01858532|527630891|FG000|Overall Study|Investigator request|3|||
146304783|NCT01858532|527630892|FG001|Overall Study|Investigator request|4|||
146304784|NCT01858532|527630893|FG002|Overall Study|Investigator request|2|||
146304785|NCT01858532|527630894|FG003|Overall Study|Investigator request|6|||
146304786|NCT01858532|527630891|FG000|Overall Study|Other, not specified|29|||
146304787|NCT01858532|527630892|FG001|Overall Study|Other, not specified|15|||
146304788|NCT01858532|527630893|FG002|Overall Study|Other, not specified|13|||
146304789|NCT01858532|527630894|FG003|Overall Study|Other, not specified|11|||
146304790|NCT00514514|527630895|FG000|Pre-phase|Death|10|||
146304791|NCT00514514|527630896|FG001|Pre-phase|Death|0|||
146304792|NCT00514514|527630897|FG002|Pre-phase|Death|0|||
146304793|NCT00514514|527630895|FG000|Pre-phase|administrative problems|2|||
146304794|NCT00514514|527630896|FG001|Pre-phase|administrative problems|0|||
146304795|NCT00514514|527630897|FG002|Pre-phase|administrative problems|0|||
146304796|NCT00514514|527630895|FG000|Pre-phase|Protocol Violation|6|||
146304797|NCT00514514|527630896|FG001|Pre-phase|Protocol Violation|0|||
146304798|NCT00514514|527630897|FG002|Pre-phase|Protocol Violation|0|||
146304799|NCT00514514|527630895|FG000|Pre-phase|condition no longer requires study drug|7|||
146146098|NCT00718042|527047332|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146146099|NCT00718042|527047333|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
146304800|NCT00514514|527630896|FG001|Pre-phase|condition no longer requires study drug|0|||
146304801|NCT00514514|527630897|FG002|Pre-phase|condition no longer requires study drug|0|||
146304802|NCT00514514|527630895|FG000|Pre-phase|abnormal test procedure results|15|||
146304803|NCT00514514|527630896|FG001|Pre-phase|abnormal test procedure results|0|||
146304804|NCT00514514|527630897|FG002|Pre-phase|abnormal test procedure results|0|||
146304805|NCT00514514|527630895|FG000|Pre-phase|Lost to Follow-up|2|||
146304806|NCT00514514|527630896|FG001|Pre-phase|Lost to Follow-up|0|||
146304807|NCT00514514|527630897|FG002|Pre-phase|Lost to Follow-up|0|||
146304808|NCT00514514|527630895|FG000|Pre-phase|abnormal lab values|23|||
146304809|NCT00514514|527630896|FG001|Pre-phase|abnormal lab values|0|||
146304810|NCT00514514|527630897|FG002|Pre-phase|abnormal lab values|0|||
146304811|NCT00514514|527630895|FG000|Pre-phase|Lack of Efficacy|35|||
146304812|NCT00514514|527630896|FG001|Pre-phase|Lack of Efficacy|0|||
146304813|NCT00514514|527630897|FG002|Pre-phase|Lack of Efficacy|0|||
146304814|NCT00514514|527630895|FG000|Pre-phase|Adverse Event|137|||
146304815|NCT00514514|527630896|FG001|Pre-phase|Adverse Event|0|||
146304816|NCT00514514|527630897|FG002|Pre-phase|Adverse Event|0|||
146304817|NCT00514514|527630895|FG000|Pre-phase|Withdrawal by Subject|66|||
146277328|NCT04308590|527528482|FG001|Overall Study|Adverse Event|2|||
146277329|NCT04308590|527528481|FG000|Overall Study|Withdrawal by Subject|10|||
146277330|NCT04308590|527528482|FG001|Overall Study|Withdrawal by Subject|4|||
146277331|NCT04308590|527528481|FG000|Overall Study|Death|1|||
146277332|NCT04308590|527528482|FG001|Overall Study|Death|0|||
146277333|NCT04308590|527528481|FG000|Overall Study|Lost to Follow-up|1|||
146277334|NCT04308590|527528482|FG001|Overall Study|Lost to Follow-up|1|||
146277335|NCT04308590|527528481|FG000|Overall Study|Physician Decision|1|||
146277336|NCT04308590|527528482|FG001|Overall Study|Physician Decision|0|||
146277337|NCT04308590|527528481|FG000|Overall Study|Subject does not want to continue with Pi|0|||
146277338|NCT04308590|527528482|FG001|Overall Study|Subject does not want to continue with Pi|1|||
146277339|NCT00356408|527528483|FG000|Overall Study|Adverse Event|9|||
146277340|NCT00356408|527528483|FG000|Overall Study|Lack of Efficacy|36|||
146277341|NCT00356408|527528483|FG000|Overall Study|Lost to Follow-up|2|||
146277342|NCT00356408|527528483|FG000|Overall Study|Withdrawal by Subject|6|||
146277343|NCT00356408|527528483|FG000|Overall Study|Other: Principal investigator discretion|3|||
146277344|NCT00356408|527528483|FG000|Overall Study|Other: Sponsor request|1|||
146277345|NCT00356408|527528483|FG000|Overall Study|Other: Azathioprine stopped|1|||
146277346|NCT00356408|527528483|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
146277347|NCT00356408|527528483|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
146277348|NCT01156376|527528485|FG000|Overall Study|Adverse Event|1|||
146277349|NCT01156376|527528486|FG001|Overall Study|Adverse Event|0|||
146277350|NCT01156376|527528487|FG002|Overall Study|Adverse Event|1|||
146277351|NCT01156376|527528485|FG000|Overall Study|Withdrawal by Subject|0|||
146277352|NCT01156376|527528486|FG001|Overall Study|Withdrawal by Subject|0|||
146277353|NCT01156376|527528487|FG002|Overall Study|Withdrawal by Subject|3|||
146277354|NCT05487586|527528488|FG000|Overall Study|Death|22|||
146277355|NCT05487586|527528488|FG000|Overall Study|Physician Decision|1|||
146277356|NCT05487586|527528488|FG000|Overall Study|Transfer to another hospital|4|||
146277357|NCT05487586|527528488|FG000|Overall Study|Other|1|||
146277358|NCT01493427|527528489|FG000|Overall Study|Adverse Event|10|||
146277359|NCT01493427|527528489|FG000|Overall Study|Personal Reasons|4|||
146277360|NCT01493427|527528489|FG000|Overall Study|Lost to Follow-up|2|||
146277361|NCT01493427|527528489|FG000|Overall Study|Inability to Follow Instructions|2|||
146277362|NCT01493427|527528489|FG000|Overall Study|Other|2|||
146277363|NCT00565773|527528490|FG000|Overall Study|Withdrawal by Subject|1|||
146277364|NCT00565773|527528490|FG000|Overall Study|Physician Decision|1|||
146277365|NCT05775991|527528491|FG000|Overall Study|Withdrawal by Subject|0|||
146277366|NCT05775991|527528492|FG001|Overall Study|Withdrawal by Subject|0|||
146277367|NCT05775991|527528493|FG002|Overall Study|Withdrawal by Subject|2|||
146277368|NCT00702962|527528494|FG000|Overall Study|Progressive disease|0|||
146277369|NCT00702962|527528495|FG001|Overall Study|Progressive disease|1|||
146277370|NCT00702962|527528494|FG000|Overall Study|Hospitalized for other health disorder|1|||
146277371|NCT00702962|527528495|FG001|Overall Study|Hospitalized for other health disorder|0|||
146277372|NCT02175641|527528497|FG000|Overall Study|Death|3|||
146277373|NCT02175641|527528498|FG001|Overall Study|Death|4|||
146277374|NCT02175641|527528497|FG000|Overall Study|Lost to Follow-up|4|||
146277375|NCT02175641|527528498|FG001|Overall Study|Lost to Follow-up|4|||
146277376|NCT02175641|527528497|FG000|Overall Study|Withdrawal by Subject|7|||
146277377|NCT02175641|527528498|FG001|Overall Study|Withdrawal by Subject|4|||
146277378|NCT02175641|527528497|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
146277379|NCT02175641|527528498|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
146277380|NCT02175641|527528497|FG000|Overall Study|Developed Contraindicated Condition|8|||
146277381|NCT02175641|527528498|FG001|Overall Study|Developed Contraindicated Condition|0|||
146277382|NCT01923467|527528501|FG000|Overall Study|Lost to Follow-up|62|||
146277383|NCT01923467|527528501|FG000|Overall Study|Subject non-interest|479|||
146277384|NCT01075958|527528502|FG000|Overall Study|Blood sample could not be obtained|44|||
146277385|NCT00643617|527528503|FG000|Overall Study|Death|6|||
146277386|NCT00643617|527528504|FG001|Overall Study|Death|9|||
146277387|NCT00643617|527528503|FG000|Overall Study|Lost to Follow-up|42|||
146277388|NCT00643617|527528504|FG001|Overall Study|Lost to Follow-up|51|||
146277389|NCT02075073|527528505|FG000|Overall Study|Withdrawal by Subject|0|||
146277390|NCT02075073|527528506|FG001|Overall Study|Withdrawal by Subject|1|||
146277391|NCT02075073|527528507|FG002|Overall Study|Withdrawal by Subject|0|||
146277392|NCT02233803|527528508|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
146277393|NCT02233803|527528509|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
146277394|NCT02233803|527528508|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
146277395|NCT02233803|527528509|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
146277396|NCT02233803|527528508|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
146277397|NCT02233803|527528509|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
146277398|NCT02233803|527528508|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
146277399|NCT02233803|527528509|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
146304818|NCT00514514|527630896|FG001|Pre-phase|Withdrawal by Subject|0|||
146277400|NCT02233803|527528508|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
146277401|NCT02233803|527528509|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
146277402|NCT02233803|527528508|FG000|Washout Period (4-Wks)|Physician Decision|1|||
146277403|NCT02233803|527528509|FG001|Washout Period (4-Wks)|Physician Decision|0|||
146277404|NCT02233803|527528508|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
146277405|NCT02233803|527528509|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
146277406|NCT02233803|527528508|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
146277407|NCT02233803|527528509|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
146277408|NCT02233803|527528508|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
146277409|NCT02233803|527528509|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
146277410|NCT01559129|527528514|FG000|Treatment Phase|Adverse Event|0|||
146277411|NCT01559129|527528515|FG001|Treatment Phase|Adverse Event|2|||
146277412|NCT01559129|527528514|FG000|Treatment Phase|Progressive Disease|1|||
146277413|NCT01559129|527528515|FG001|Treatment Phase|Progressive Disease|1|||
146277414|NCT01559129|527528514|FG000|Treatment Phase|Lack of Efficacy|0|||
146277415|NCT01559129|527528515|FG001|Treatment Phase|Lack of Efficacy|1|||
146277416|NCT01559129|527528514|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
146277417|NCT01559129|527528515|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
146277418|NCT01559129|527528514|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
146277419|NCT01559129|527528515|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
146277420|NCT01559129|527528514|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
146277421|NCT01559129|527528515|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
146277422|NCT01559129|527528514|FG000|Open-label Extension Period|Adverse Event|1|||
146277423|NCT01559129|527528515|FG001|Open-label Extension Period|Adverse Event|0|||
146277424|NCT01559129|527528514|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
146277425|NCT01559129|527528515|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
146277426|NCT03525392|527528516|FG000|Overall Study|Adverse Event|1|||
146277427|NCT03525392|527528517|FG001|Overall Study|Adverse Event|0|||
146277428|NCT03525392|527528518|FG002|Overall Study|Adverse Event|2|||
146277429|NCT03525392|527528519|FG003|Overall Study|Adverse Event|0|||
146277430|NCT03525392|527528520|FG004|Overall Study|Adverse Event|0|||
146277431|NCT03525392|527528516|FG000|Overall Study|Progressive disease|0|||
146277432|NCT03525392|527528517|FG001|Overall Study|Progressive disease|1|||
146277433|NCT03525392|527528518|FG002|Overall Study|Progressive disease|1|||
146277434|NCT03525392|527528519|FG003|Overall Study|Progressive disease|3|||
146277435|NCT03525392|527528520|FG004|Overall Study|Progressive disease|1|||
146277436|NCT03284203|527528521|FG000|Overall Study|Lost to Follow-up|3|||
146277437|NCT00208325|527528522|FG000|Overall Study|Death|18|||
146277438|NCT00208325|527528523|FG001|Overall Study|Death|19|||
146277439|NCT00208325|527528524|FG002|Overall Study|Death|7|||
146277440|NCT00208325|527528525|FG003|Overall Study|Death|5|||
146277441|NCT00208325|527528522|FG000|Overall Study|Withdrawal by Subject|0|||
146277442|NCT00208325|527528523|FG001|Overall Study|Withdrawal by Subject|1|||
146277443|NCT00208325|527528524|FG002|Overall Study|Withdrawal by Subject|0|||
146277444|NCT00208325|527528525|FG003|Overall Study|Withdrawal by Subject|0|||
146277445|NCT00208325|527528522|FG000|Overall Study|Revision|4|||
146277446|NCT00208325|527528523|FG001|Overall Study|Revision|1|||
146277447|NCT00208325|527528524|FG002|Overall Study|Revision|0|||
146277448|NCT00208325|527528525|FG003|Overall Study|Revision|4|||
146277449|NCT00208325|527528522|FG000|Overall Study|Lost to Follow-up|1|||
146277450|NCT00208325|527528523|FG001|Overall Study|Lost to Follow-up|0|||
146277451|NCT00208325|527528524|FG002|Overall Study|Lost to Follow-up|2|||
146277452|NCT00208325|527528525|FG003|Overall Study|Lost to Follow-up|0|||
146277453|NCT00208325|527528522|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
146277454|NCT00208325|527528523|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
146277455|NCT00208325|527528524|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
146277456|NCT00208325|527528525|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
146277457|NCT00208325|527528522|FG000|Overall Study|Does not wish to Continue in Study|5|||
146277458|NCT00208325|527528523|FG001|Overall Study|Does not wish to Continue in Study|8|||
146277459|NCT00208325|527528524|FG002|Overall Study|Does not wish to Continue in Study|3|||
146277460|NCT00208325|527528525|FG003|Overall Study|Does not wish to Continue in Study|2|||
146277461|NCT00208325|527528522|FG000|Overall Study|Other|2|||
146277462|NCT00208325|527528523|FG001|Overall Study|Other|1|||
146277463|NCT00208325|527528524|FG002|Overall Study|Other|1|||
146277464|NCT00208325|527528525|FG003|Overall Study|Other|0|||
146277465|NCT00208325|527528522|FG000|Overall Study|Mis-Randomized|17|||
146277466|NCT00208325|527528523|FG001|Overall Study|Mis-Randomized|20|||
146277467|NCT00208325|527528524|FG002|Overall Study|Mis-Randomized|0|||
146277468|NCT00208325|527528525|FG003|Overall Study|Mis-Randomized|0|||
146277469|NCT00586612|527528526|FG000|Primary Phase|Protocol Violation|1|||
146277470|NCT00586612|527528527|FG001|Primary Phase|Protocol Violation|0|||
146277471|NCT00586612|527528526|FG000|Primary Phase|Lost to Follow-up|0|||
146277472|NCT00586612|527528527|FG001|Primary Phase|Lost to Follow-up|1|||
146277473|NCT00586612|527528526|FG000|Primary Phase|Withdrawal by Subject|0|||
146277474|NCT00586612|527528527|FG001|Primary Phase|Withdrawal by Subject|2|||
146277475|NCT00586612|527528526|FG000|Booster Phase|Lost to Follow-up|3|||
146277476|NCT00586612|527528527|FG001|Booster Phase|Lost to Follow-up|1|||
146277477|NCT00623805|527528528|FG000|Overall Study|Adverse Event|9|||
146277478|NCT00623805|527528529|FG001|Overall Study|Adverse Event|6|||
146277479|NCT00623805|527528528|FG000|Overall Study|Death|2|||
146277480|NCT00623805|527528529|FG001|Overall Study|Death|0|||
146146100|NCT00718042|527047328|FG000|Donor Follow-up|Lost to Follow-up|13|||
146146101|NCT00718042|527047329|FG001|Donor Follow-up|Lost to Follow-up|0|||
146146102|NCT00718042|527047330|FG002|Donor Follow-up|Lost to Follow-up|0|||
146146103|NCT00718042|527047331|FG003|Donor Follow-up|Lost to Follow-up|0|||
146146104|NCT00718042|527047332|FG004|Donor Follow-up|Lost to Follow-up|19|||
146146105|NCT00718042|527047333|FG005|Donor Follow-up|Lost to Follow-up|0|||
146146106|NCT04327934|527047334|FG000|Overall Study|Did not qualify|7|||
146146107|NCT04327934|527047335|FG001|Overall Study|Did not qualify|4|||
146146108|NCT04327934|527047334|FG000|Overall Study|Physician Decision|0|||
146146109|NCT04327934|527047335|FG001|Overall Study|Physician Decision|1|||
146146110|NCT02822794|527047337|FG000|Overall Study|Withdrew Consent|1|||
146146111|NCT02822794|527047338|FG001|Overall Study|Withdrew Consent|0|||
146146112|NCT03732248|527047339|FG000|Overall Study|Withdrawal by Subject|1|||
146146113|NCT03732248|527047340|FG001|Overall Study|Withdrawal by Subject|0|||
146146114|NCT02266381|527047341|FG000|Overall Study|Physician Decision|3|||
146146115|NCT02266381|527047342|FG001|Overall Study|Physician Decision|5|||
146146116|NCT02266381|527047343|FG002|Overall Study|Physician Decision|4|||
146146117|NCT03653429|527047351|FG000|Overall Study|Physician Decision|4|||
146146118|NCT03653429|527047352|FG001|Overall Study|Physician Decision|10|||
146146119|NCT00403546|527047353|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
146146120|NCT00403546|527047354|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
146146121|NCT00403546|527047355|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
146146122|NCT00403546|527047353|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
146146123|NCT00403546|527047354|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
146146124|NCT00403546|527047355|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
146146125|NCT00403546|527047353|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
146146126|NCT00403546|527047354|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
146146127|NCT00403546|527047355|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
146146128|NCT00403546|527047353|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
146146129|NCT00403546|527047354|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
146146130|NCT00403546|527047355|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
146146131|NCT00403546|527047353|FG000|Screening Phase|Screening Failure|22|||
146146132|NCT00403546|527047354|FG001|Screening Phase|Screening Failure|0|||
146146133|NCT00403546|527047355|FG002|Screening Phase|Screening Failure|0|||
146146134|NCT00403546|527047353|FG000|Screening Phase|Adverse Event|1|||
146146135|NCT00403546|527047354|FG001|Screening Phase|Adverse Event|0|||
146146136|NCT00403546|527047355|FG002|Screening Phase|Adverse Event|0|||
146146137|NCT00403546|527047353|FG000|Screening Phase|Terminated Prior to Randomization|5|||
146146138|NCT00403546|527047354|FG001|Screening Phase|Terminated Prior to Randomization|0|||
146146139|NCT00403546|527047355|FG002|Screening Phase|Terminated Prior to Randomization|0|||
146146140|NCT00403546|527047353|FG000|Randomized Trial|Early Terminations|0|||
146146141|NCT00403546|527047354|FG001|Randomized Trial|Early Terminations|17|||
146146142|NCT00403546|527047355|FG002|Randomized Trial|Early Terminations|16|||
146146143|NCT02604589|527047356|FG000|Overall Study|catheter dislodgement|0|||
146146144|NCT02604589|527047357|FG001|Overall Study|catheter dislodgement|0|||
146146145|NCT02604589|527047358|FG002|Overall Study|catheter dislodgement|1|||
146146146|NCT00793910|527047361|FG000|Overall Study|discarded study pills|0|||
146146147|NCT00793910|527047362|FG001|Overall Study|discarded study pills|1|||
146146148|NCT00793910|527047361|FG000|Overall Study|did not pick up medications|1|||
146146149|NCT00793910|527047362|FG001|Overall Study|did not pick up medications|1|||
146146150|NCT00793910|527047361|FG000|Overall Study|ineligible based on entry criteria|2|||
146146151|NCT00793910|527047362|FG001|Overall Study|ineligible based on entry criteria|3|||
146146152|NCT00793910|527047361|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
146146153|NCT00793910|527047362|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
146146154|NCT00793910|527047361|FG000|Overall Study|Withdrawal by Subject|0|||
146146155|NCT00793910|527047362|FG001|Overall Study|Withdrawal by Subject|1|||
146146156|NCT01700946|527047363|FG000|Overall Study|Lost to Follow-up|1|||
146146157|NCT01700946|527047364|FG001|Overall Study|Lost to Follow-up|0|||
146146158|NCT01700946|527047363|FG000|Overall Study|Physician Decision|7|||
146146159|NCT01700946|527047364|FG001|Overall Study|Physician Decision|12|||
146146160|NCT01700946|527047363|FG000|Overall Study|Withdrawal by Subject|0|||
146146161|NCT01700946|527047364|FG001|Overall Study|Withdrawal by Subject|2|||
146146162|NCT01700946|527047363|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
146277481|NCT00623805|527528528|FG000|Overall Study|Lack of Efficacy|3|||
146277482|NCT00623805|527528529|FG001|Overall Study|Lack of Efficacy|7|||
146277483|NCT00623805|527528528|FG000|Overall Study|Lost to Follow-up|2|||
146277484|NCT00623805|527528529|FG001|Overall Study|Lost to Follow-up|2|||
146277485|NCT00623805|527528528|FG000|Overall Study|Protocol Violation|1|||
146146163|NCT01700946|527047364|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
146146164|NCT01700946|527047363|FG000|Overall Study|Relapse|2|||
146146165|NCT01700946|527047364|FG001|Overall Study|Relapse|1|||
146146166|NCT01700946|527047363|FG000|Overall Study|Unacceptable toxicity|1|||
146146167|NCT01700946|527047364|FG001|Overall Study|Unacceptable toxicity|0|||
146146168|NCT02610140|527047369|FG000|Randomization and Treatment Period|Radiological progression|23|||
146277486|NCT00623805|527528529|FG001|Overall Study|Protocol Violation|1|||
146277487|NCT00623805|527528528|FG000|Overall Study|Reason not Specified|3|||
146277488|NCT00623805|527528529|FG001|Overall Study|Reason not Specified|6|||
146277489|NCT03548220|527528534|FG000|Overall Study|Lost to Follow-up|1|||
146277490|NCT03548220|527528535|FG001|Overall Study|Lost to Follow-up|0|||
146277491|NCT03548220|527528536|FG002|Overall Study|Lost to Follow-up|0|||
146277492|NCT03548220|527528537|FG003|Overall Study|Lost to Follow-up|0|||
146277493|NCT02906007|527528538|FG000|Overall Study|Physician Decision|0|||
146277494|NCT02906007|527528539|FG001|Overall Study|Physician Decision|0|||
146277495|NCT02906007|527528540|FG002|Overall Study|Physician Decision|1|||
146277496|NCT02906007|527528538|FG000|Overall Study|Died|1|||
146277497|NCT02906007|527528539|FG001|Overall Study|Died|0|||
146277498|NCT02906007|527528540|FG002|Overall Study|Died|0|||
146277499|NCT04531982|527528541|FG000|Overall Study|Withdrawal by Subject|10|||
146277500|NCT04531982|527528542|FG001|Overall Study|Withdrawal by Subject|11|||
146277501|NCT04531982|527528541|FG000|Overall Study|Adverse Event|6|||
146277502|NCT04531982|527528542|FG001|Overall Study|Adverse Event|14|||
146277503|NCT04531982|527528541|FG000|Overall Study|Protocol Violation|6|||
146277504|NCT04531982|527528542|FG001|Overall Study|Protocol Violation|9|||
146277505|NCT04531982|527528541|FG000|Overall Study|Non-compliance with study drug|3|||
146277506|NCT04531982|527528542|FG001|Overall Study|Non-compliance with study drug|2|||
146277507|NCT04531982|527528541|FG000|Overall Study|Use of prohibited medication|2|||
146277508|NCT04531982|527528542|FG001|Overall Study|Use of prohibited medication|0|||
146277509|NCT04531982|527528541|FG000|Overall Study|Lost to Follow-up|0|||
146277510|NCT04531982|527528542|FG001|Overall Study|Lost to Follow-up|1|||
146277511|NCT04531982|527528541|FG000|Overall Study|Geopolitical conflict|2|||
146277512|NCT04531982|527528542|FG001|Overall Study|Geopolitical conflict|0|||
146277513|NCT04531982|527528541|FG000|Overall Study|Lack of Efficacy|3|||
146277514|NCT04531982|527528542|FG001|Overall Study|Lack of Efficacy|1|||
146277515|NCT03820947|527528549|FG000|Overall Study|Physician Decision|0|||
146277516|NCT03820947|527528550|FG001|Overall Study|Physician Decision|1|||
146277517|NCT03820947|527528551|FG002|Overall Study|Physician Decision|1|||
146277518|NCT03820947|527528552|FG003|Overall Study|Physician Decision|0|||
146277519|NCT03820947|527528553|FG004|Overall Study|Physician Decision|3|||
146277520|NCT03820947|527528549|FG000|Overall Study|Withdrawal by Subject|6|||
146277521|NCT03820947|527528550|FG001|Overall Study|Withdrawal by Subject|10|||
146277522|NCT03820947|527528551|FG002|Overall Study|Withdrawal by Subject|3|||
146277523|NCT03820947|527528552|FG003|Overall Study|Withdrawal by Subject|8|||
146277524|NCT03820947|527528553|FG004|Overall Study|Withdrawal by Subject|5|||
146277525|NCT03820947|527528549|FG000|Overall Study|Procedure Not Attempted|0|||
146277526|NCT03820947|527528550|FG001|Overall Study|Procedure Not Attempted|2|||
146277527|NCT03820947|527528551|FG002|Overall Study|Procedure Not Attempted|1|||
146277528|NCT03820947|527528552|FG003|Overall Study|Procedure Not Attempted|0|||
146277529|NCT03820947|527528553|FG004|Overall Study|Procedure Not Attempted|0|||
146277530|NCT03820947|527528549|FG000|Overall Study|Other Exit|1|||
146277531|NCT03820947|527528550|FG001|Overall Study|Other Exit|3|||
146277532|NCT03820947|527528551|FG002|Overall Study|Other Exit|3|||
146277533|NCT03820947|527528552|FG003|Overall Study|Other Exit|3|||
146277534|NCT03820947|527528553|FG004|Overall Study|Other Exit|0|||
146277535|NCT03820947|527528549|FG000|Overall Study|Follow-up Not Done|10|||
146277536|NCT03820947|527528550|FG001|Overall Study|Follow-up Not Done|13|||
146277537|NCT03820947|527528551|FG002|Overall Study|Follow-up Not Done|2|||
146277538|NCT03820947|527528552|FG003|Overall Study|Follow-up Not Done|3|||
146277539|NCT03820947|527528553|FG004|Overall Study|Follow-up Not Done|12|||
146277540|NCT03820947|527528549|FG000|Overall Study|Death|0|||
146277541|NCT03820947|527528550|FG001|Overall Study|Death|0|||
146277542|NCT03820947|527528551|FG002|Overall Study|Death|0|||
146277543|NCT03820947|527528552|FG003|Overall Study|Death|0|||
146277544|NCT03820947|527528553|FG004|Overall Study|Death|9|||
146277545|NCT03820947|527528549|FG000|Overall Study|Lost to Follow-up|4|||
146277546|NCT03820947|527528550|FG001|Overall Study|Lost to Follow-up|6|||
146277547|NCT03820947|527528551|FG002|Overall Study|Lost to Follow-up|0|||
146277548|NCT03820947|527528552|FG003|Overall Study|Lost to Follow-up|0|||
146277549|NCT03820947|527528553|FG004|Overall Study|Lost to Follow-up|9|||
146277550|NCT01967147|527530226|FG000|Overall Study|Adverse Event|5|||
146277551|NCT01967147|527530227|FG001|Overall Study|Adverse Event|2|||
146277552|NCT01967147|527530226|FG000|Overall Study|Lack of Efficacy|1|||
146277553|NCT01967147|527530227|FG001|Overall Study|Lack of Efficacy|4|||
146277554|NCT01967147|527530226|FG000|Overall Study|Lost to Follow-up|1|||
146277555|NCT01967147|527530227|FG001|Overall Study|Lost to Follow-up|2|||
146277556|NCT01967147|527530226|FG000|Overall Study|Withdrawal by Subject|2|||
146277557|NCT01967147|527530227|FG001|Overall Study|Withdrawal by Subject|4|||
146277558|NCT01967147|527530226|FG000|Overall Study|Non-compliance with Study Drug|0|||
146277559|NCT01967147|527530227|FG001|Overall Study|Non-compliance with Study Drug|3|||
146277560|NCT01967147|527530226|FG000|Overall Study|Other|4|||
146277561|NCT01967147|527530227|FG001|Overall Study|Other|5|||
146277562|NCT03986944|527530230|FG000|Overall Study|Adverse Event|1|||
146277563|NCT03986944|527530231|FG001|Overall Study|Adverse Event|2|||
146277564|NCT03986944|527530232|FG002|Overall Study|Adverse Event|3|||
146277565|NCT03986944|527530230|FG000|Overall Study|Protocol Violation|0|||
146304819|NCT00514514|527630897|FG002|Pre-phase|Withdrawal by Subject|0|||
146304820|NCT00514514|527630895|FG000|Randomized - 9 Month|Death|3|||
146304821|NCT00514514|527630896|FG001|Randomized - 9 Month|Death|2|||
146304822|NCT00514514|527630897|FG002|Randomized - 9 Month|Death|2|||
146304823|NCT00514514|527630895|FG000|Randomized - 9 Month|Administrative problems|1|||
146304824|NCT00514514|527630896|FG001|Randomized - 9 Month|Administrative problems|1|||
146304825|NCT00514514|527630897|FG002|Randomized - 9 Month|Administrative problems|2|||
146304826|NCT00514514|527630895|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
146304827|NCT00514514|527630896|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
146304828|NCT00514514|527630897|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
146304829|NCT00514514|527630895|FG000|Randomized - 9 Month|Protocol Violation|1|||
146304830|NCT00514514|527630896|FG001|Randomized - 9 Month|Protocol Violation|1|||
146304831|NCT00514514|527630897|FG002|Randomized - 9 Month|Protocol Violation|0|||
146304832|NCT00514514|527630895|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
146304833|NCT00514514|527630896|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
146304834|NCT00514514|527630897|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
146304835|NCT00514514|527630895|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
146304836|NCT00514514|527630896|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
146304837|NCT00514514|527630897|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
146304838|NCT00514514|527630895|FG000|Randomized - 9 Month|Adverse Event|25|||
146304839|NCT00514514|527630896|FG001|Randomized - 9 Month|Adverse Event|44|||
146304840|NCT00514514|527630897|FG002|Randomized - 9 Month|Adverse Event|27|||
146304841|NCT00514514|527630895|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
146304842|NCT00514514|527630896|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
146304843|NCT00514514|527630897|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
146304844|NCT00514514|527630895|FG000|Extension - 4 Years|Lost to Follow-up|12|||
146304845|NCT00514514|527630896|FG001|Extension - 4 Years|Lost to Follow-up|10|||
146304846|NCT00514514|527630897|FG002|Extension - 4 Years|Lost to Follow-up|9|||
146304847|NCT00514514|527630895|FG000|Extension - 4 Years|Administrative problems|3|||
146304848|NCT00514514|527630896|FG001|Extension - 4 Years|Administrative problems|1|||
146304849|NCT00514514|527630897|FG002|Extension - 4 Years|Administrative problems|1|||
146304850|NCT00514514|527630895|FG000|Extension - 4 Years|Death|8|||
146304851|NCT00514514|527630896|FG001|Extension - 4 Years|Death|3|||
146304852|NCT00514514|527630897|FG002|Extension - 4 Years|Death|6|||
146304853|NCT00514514|527630895|FG000|Extension - 4 Years|Adverse Event|9|||
146304854|NCT00514514|527630896|FG001|Extension - 4 Years|Adverse Event|6|||
146304855|NCT00514514|527630897|FG002|Extension - 4 Years|Adverse Event|3|||
146304856|NCT02081534|527630904|FG000|Overall Study|Adverse Event|5|||
146304857|NCT02081534|527630905|FG001|Overall Study|Adverse Event|4|||
146304858|NCT02081534|527630906|FG002|Overall Study|Adverse Event|3|||
146304859|NCT02081534|527630907|FG003|Overall Study|Adverse Event|10|||
146304860|NCT02081534|527630908|FG004|Overall Study|Adverse Event|2|||
146304861|NCT02081534|527630909|FG005|Overall Study|Adverse Event|8|||
146304862|NCT02081534|527630910|FG006|Overall Study|Adverse Event|2|||
146304863|NCT02081534|527630904|FG000|Overall Study|Withdrawal by Subject|0|||
146304864|NCT02081534|527630905|FG001|Overall Study|Withdrawal by Subject|1|||
146304865|NCT02081534|527630906|FG002|Overall Study|Withdrawal by Subject|1|||
146304866|NCT02081534|527630907|FG003|Overall Study|Withdrawal by Subject|1|||
146304867|NCT02081534|527630908|FG004|Overall Study|Withdrawal by Subject|1|||
146304868|NCT02081534|527630909|FG005|Overall Study|Withdrawal by Subject|0|||
146304869|NCT02081534|527630910|FG006|Overall Study|Withdrawal by Subject|1|||
146304870|NCT02081534|527630904|FG000|Overall Study|Protocol Violation|0|||
146304871|NCT02081534|527630905|FG001|Overall Study|Protocol Violation|3|||
146304872|NCT02081534|527630906|FG002|Overall Study|Protocol Violation|0|||
146304873|NCT02081534|527630907|FG003|Overall Study|Protocol Violation|0|||
146304874|NCT02081534|527630908|FG004|Overall Study|Protocol Violation|0|||
146304875|NCT02081534|527630909|FG005|Overall Study|Protocol Violation|0|||
146304876|NCT02081534|527630910|FG006|Overall Study|Protocol Violation|1|||
146304877|NCT02081534|527630904|FG000|Overall Study|Lost to Follow-up|0|||
146146169|NCT02610140|527047370|FG001|Randomization and Treatment Period|Radiological progression|15|||
146146170|NCT02610140|527047369|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
146146171|NCT02610140|527047370|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
146146172|NCT02610140|527047369|FG000|Randomization and Treatment Period|Protocol Violation|1|||
146146173|NCT02610140|527047370|FG001|Randomization and Treatment Period|Protocol Violation|0|||
146146174|NCT02610140|527047369|FG000|Randomization and Treatment Period|Physician Decision|0|||
146304878|NCT02081534|527630905|FG001|Overall Study|Lost to Follow-up|0|||
146304879|NCT02081534|527630906|FG002|Overall Study|Lost to Follow-up|0|||
146304880|NCT02081534|527630907|FG003|Overall Study|Lost to Follow-up|2|||
146304881|NCT02081534|527630908|FG004|Overall Study|Lost to Follow-up|1|||
146304882|NCT02081534|527630909|FG005|Overall Study|Lost to Follow-up|1|||
146304883|NCT02081534|527630910|FG006|Overall Study|Lost to Follow-up|0|||
146304884|NCT02234479|527630911|FG000|Overall Study|Withdrawal by Subject|1|||
146304885|NCT02234479|527630912|FG001|Overall Study|Withdrawal by Subject|3|||
146304886|NCT01007032|527630914|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
146304887|NCT01007032|527630915|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
146277566|NCT03986944|527530231|FG001|Overall Study|Protocol Violation|1|||
146277567|NCT03986944|527530232|FG002|Overall Study|Protocol Violation|1|||
146277568|NCT03986944|527530230|FG000|Overall Study|Withdrawal by Subject|3|||
146277569|NCT03986944|527530231|FG001|Overall Study|Withdrawal by Subject|5|||
146277570|NCT03986944|527530232|FG002|Overall Study|Withdrawal by Subject|5|||
146277571|NCT03986944|527530230|FG000|Overall Study|Study termination|10|||
146277572|NCT03986944|527530231|FG001|Overall Study|Study termination|10|||
146277573|NCT03986944|527530232|FG002|Overall Study|Study termination|10|||
146277574|NCT03986944|527530230|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
146277575|NCT03986944|527530231|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
146277576|NCT03986944|527530232|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
146277577|NCT03986944|527530230|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
146277578|NCT03986944|527530231|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
146277579|NCT03986944|527530232|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
146277580|NCT01302080|527530240|FG000|Overall Study|Withdrew Consent|92|||
146277581|NCT01302080|527530241|FG001|Overall Study|Withdrew Consent|39|||
146277582|NCT01302080|527530240|FG000|Overall Study|Patient/Family Moved|28|||
146277583|NCT01302080|527530241|FG001|Overall Study|Patient/Family Moved|3|||
146277584|NCT01302080|527530240|FG000|Overall Study|Lost to Follow-up|192|||
146277585|NCT01302080|527530241|FG001|Overall Study|Lost to Follow-up|93|||
146277586|NCT01302080|527530240|FG000|Overall Study|Death|1|||
146277587|NCT01302080|527530241|FG001|Overall Study|Death|0|||
146277588|NCT01302080|527530240|FG000|Overall Study|Other|52|||
146277589|NCT01302080|527530241|FG001|Overall Study|Other|8|||
146277590|NCT01302080|527530240|FG000|Overall Study|Reason Missing For Discontinuation|1|||
146277591|NCT01302080|527530241|FG001|Overall Study|Reason Missing For Discontinuation|0|||
146277592|NCT00416195|527530264|FG000|Overall Study|Adverse Event|1|||
146277593|NCT00416195|527530265|FG001|Overall Study|Adverse Event|2|||
146277594|NCT00416195|527530264|FG000|Overall Study|Protocol Violation|1|||
146277595|NCT00416195|527530265|FG001|Overall Study|Protocol Violation|1|||
146277596|NCT00416195|527530264|FG000|Overall Study|Other|0|||
146277597|NCT00416195|527530265|FG001|Overall Study|Other|1|||
146277598|NCT03361605|527530270|FG000|Overall Study|Analyzable data not available|3|||
146277599|NCT01305408|527530271|FG000|Overall Study|Adverse Event|10|||
146277600|NCT01305408|527530272|FG001|Overall Study|Adverse Event|7|||
146277601|NCT01305408|527530271|FG000|Overall Study|Lack of Efficacy|3|||
146277602|NCT01305408|527530272|FG001|Overall Study|Lack of Efficacy|4|||
146277603|NCT01305408|527530271|FG000|Overall Study|Withdrawal by Subject|9|||
146277604|NCT01305408|527530272|FG001|Overall Study|Withdrawal by Subject|9|||
146277605|NCT01305408|527530271|FG000|Overall Study|Protocol Violation|4|||
146277606|NCT01305408|527530272|FG001|Overall Study|Protocol Violation|6|||
146277607|NCT01305408|527530271|FG000|Overall Study|Lost to Follow-up|5|||
146277608|NCT01305408|527530272|FG001|Overall Study|Lost to Follow-up|3|||
146277609|NCT01305408|527530271|FG000|Overall Study|Noncompliance with study medication|0|||
146277610|NCT01305408|527530272|FG001|Overall Study|Noncompliance with study medication|1|||
146277611|NCT01305408|527530271|FG000|Overall Study|Noncompliance with study procedures|0|||
146277612|NCT01305408|527530272|FG001|Overall Study|Noncompliance with study procedures|1|||
146277613|NCT01305408|527530271|FG000|Overall Study|Other|1|||
146277614|NCT01305408|527530272|FG001|Overall Study|Other|0|||
146277615|NCT03101462|527530273|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
146277616|NCT03101462|527530274|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
146277617|NCT02530970|527530275|FG000|Overall Study|Adverse Event|8|||
146277618|NCT02530970|527530275|FG000|Overall Study|Lost to Follow-up|88|||
146277619|NCT02530970|527530275|FG000|Overall Study|Physician Decision|5|||
146277620|NCT02530970|527530275|FG000|Overall Study|Withdrawal by Subject|14|||
146277621|NCT02530970|527530275|FG000|Overall Study|Death|6|||
146277622|NCT02530970|527530275|FG000|Overall Study|Hospitalization|1|||
146277623|NCT02530970|527530275|FG000|Overall Study|Insurance|2|||
146277624|NCT02530970|527530275|FG000|Overall Study|Explant|2|||
146277625|NCT02530970|527530275|FG000|Overall Study|Change in Provider|5|||
146277626|NCT02530970|527530275|FG000|Overall Study|Relocation|3|||
146277627|NCT02770612|527530278|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
146277628|NCT03846453|527530279|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
146277629|NCT03846453|527530280|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
146277630|NCT03846453|527530281|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
146277631|NCT03846453|527530279|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
146277632|NCT03846453|527530280|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
146277633|NCT03846453|527530281|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
146277634|NCT03846453|527530279|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
146304888|NCT01007032|527630916|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
146277635|NCT03846453|527530280|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
146277636|NCT03846453|527530281|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
146277637|NCT03846453|527530279|FG000|Placebo Run-in (14 Days)|Other|2|||
146277638|NCT03846453|527530280|FG001|Placebo Run-in (14 Days)|Other|0|||
146277639|NCT03846453|527530281|FG002|Placebo Run-in (14 Days)|Other|0|||
146277640|NCT03846453|527530279|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
146277641|NCT03846453|527530280|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
146277642|NCT03846453|527530281|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
146277643|NCT03846453|527530279|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
146277644|NCT03846453|527530280|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
146277645|NCT03846453|527530281|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
146277646|NCT03846453|527530279|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
146277647|NCT03846453|527530280|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
146277648|NCT03846453|527530281|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
146277649|NCT03846453|527530279|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
146277650|NCT03846453|527530280|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
146277651|NCT03846453|527530281|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
146277652|NCT03846453|527530279|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
146277653|NCT03846453|527530280|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
146277654|NCT03846453|527530281|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
146277655|NCT00468143|527530282|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
146277656|NCT00468143|527530283|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
146277657|NCT00468143|527530282|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
146277658|NCT00468143|527530283|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
146277659|NCT01606670|527530284|FG000|Overall Study|Adverse Event|6|||
146277660|NCT01606670|527530284|FG000|Overall Study|Lack of Efficacy|2|||
146277661|NCT01606670|527530284|FG000|Overall Study|Lost to Follow-up|3|||
146277662|NCT01606670|527530284|FG000|Overall Study|Withdrawal by Subject|3|||
146277663|NCT01606670|527530284|FG000|Overall Study|Other Reason|2|||
146277664|NCT02636725|527530285|FG000|Overall Study|Adverse Event|1|||
146277665|NCT03653208|527530288|FG000|Overall Study|Withdrawal by Subject|0|||
146277666|NCT03653208|527530289|FG001|Overall Study|Withdrawal by Subject|0|||
146277667|NCT03653208|527530290|FG002|Overall Study|Withdrawal by Subject|0|||
146277668|NCT03653208|527530291|FG003|Overall Study|Withdrawal by Subject|0|||
146277669|NCT03653208|527530292|FG004|Overall Study|Withdrawal by Subject|1|||
146277670|NCT03653208|527530293|FG005|Overall Study|Withdrawal by Subject|0|||
146277671|NCT03653208|527530294|FG006|Overall Study|Withdrawal by Subject|0|||
146277672|NCT03653208|527530295|FG007|Overall Study|Withdrawal by Subject|1|||
146277673|NCT03653208|527530296|FG008|Overall Study|Withdrawal by Subject|1|||
146277674|NCT01696045|527530298|FG000|Overall Study|Study drug toxicity|1|||
146277675|NCT01696045|527530299|FG001|Overall Study|Study drug toxicity|5|||
146277676|NCT01696045|527530298|FG000|Overall Study|Disease progression|2|||
146277677|NCT01696045|527530299|FG001|Overall Study|Disease progression|2|||
146277678|NCT01152814|527530301|FG000|Overall Study|Lost to Follow-up|2|||
146277679|NCT00831129|527530304|FG000|Overall Study|Adverse Event|0|||
146277680|NCT00831129|527530305|FG001|Overall Study|Adverse Event|1|||
146277681|NCT00831129|527530304|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
146277682|NCT00831129|527530305|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
146277683|NCT01877239|527530306|FG000|Overall Study|Adverse Event|4|||
146277684|NCT01877239|527530306|FG000|Overall Study|Disease Remission|1|||
146277685|NCT01877239|527530306|FG000|Overall Study|Withdrawal by Subject|4|||
146277686|NCT01877239|527530306|FG000|Overall Study|Other|2|||
146277687|NCT01877239|527530306|FG000|Overall Study|Lack of Efficacy|4|||
146277688|NCT01877239|527530306|FG000|Overall Study|Data not available|35|||
146277689|NCT01283516|527530310|FG000|Overall Study|Adverse Event|0|||
146277690|NCT01283516|527530311|FG001|Overall Study|Adverse Event|0|||
146277691|NCT01283516|527530312|FG002|Overall Study|Adverse Event|0|||
146277692|NCT01283516|527530313|FG003|Overall Study|Adverse Event|0|||
146277693|NCT01283516|527530314|FG004|Overall Study|Adverse Event|0|||
146277694|NCT01283516|527530315|FG005|Overall Study|Adverse Event|0|||
146277695|NCT01283516|527530316|FG006|Overall Study|Adverse Event|2|||
146277696|NCT01283516|527530317|FG007|Overall Study|Adverse Event|0|||
146277697|NCT01283516|527530318|FG008|Overall Study|Adverse Event|28|||
146277698|NCT01283516|527530310|FG000|Overall Study|Death|0|||
146277699|NCT01283516|527530311|FG001|Overall Study|Death|0|||
146277700|NCT01283516|527530312|FG002|Overall Study|Death|0|||
146277701|NCT01283516|527530313|FG003|Overall Study|Death|0|||
146277702|NCT01283516|527530314|FG004|Overall Study|Death|0|||
146277703|NCT01283516|527530315|FG005|Overall Study|Death|1|||
146277704|NCT01283516|527530316|FG006|Overall Study|Death|0|||
146277705|NCT01283516|527530317|FG007|Overall Study|Death|1|||
146277706|NCT01283516|527530318|FG008|Overall Study|Death|12|||
146277707|NCT01283516|527530310|FG000|Overall Study|Disease Progression|2|||
146277708|NCT01283516|527530311|FG001|Overall Study|Disease Progression|2|||
146277709|NCT01283516|527530312|FG002|Overall Study|Disease Progression|3|||
146277710|NCT01283516|527530313|FG003|Overall Study|Disease Progression|3|||
146277711|NCT01283516|527530314|FG004|Overall Study|Disease Progression|13|||
146277712|NCT01283516|527530315|FG005|Overall Study|Disease Progression|8|||
146277713|NCT01283516|527530316|FG006|Overall Study|Disease Progression|6|||
146277714|NCT01283516|527530317|FG007|Overall Study|Disease Progression|3|||
146277715|NCT01283516|527530318|FG008|Overall Study|Disease Progression|139|||
146277716|NCT01283516|527530310|FG000|Overall Study|Withdrawal by Subject|0|||
146277717|NCT01283516|527530311|FG001|Overall Study|Withdrawal by Subject|0|||
146277718|NCT01283516|527530312|FG002|Overall Study|Withdrawal by Subject|0|||
146277719|NCT01283516|527530313|FG003|Overall Study|Withdrawal by Subject|0|||
146277720|NCT01283516|527530314|FG004|Overall Study|Withdrawal by Subject|1|||
146277721|NCT01283516|527530315|FG005|Overall Study|Withdrawal by Subject|0|||
146277722|NCT01283516|527530316|FG006|Overall Study|Withdrawal by Subject|1|||
146277723|NCT01283516|527530317|FG007|Overall Study|Withdrawal by Subject|0|||
146277724|NCT01283516|527530318|FG008|Overall Study|Withdrawal by Subject|36|||
146277725|NCT01283516|527530310|FG000|Overall Study|Administrative problems|0|||
146277726|NCT01283516|527530311|FG001|Overall Study|Administrative problems|0|||
146277727|NCT01283516|527530312|FG002|Overall Study|Administrative problems|0|||
146277728|NCT01283516|527530313|FG003|Overall Study|Administrative problems|0|||
146277729|NCT01283516|527530314|FG004|Overall Study|Administrative problems|0|||
146277730|NCT01283516|527530315|FG005|Overall Study|Administrative problems|1|||
146277731|NCT01283516|527530316|FG006|Overall Study|Administrative problems|1|||
146277732|NCT01283516|527530317|FG007|Overall Study|Administrative problems|1|||
146277733|NCT01283516|527530318|FG008|Overall Study|Administrative problems|39|||
146277734|NCT01283516|527530310|FG000|Overall Study|Lost to Follow-up|0|||
146277735|NCT01283516|527530311|FG001|Overall Study|Lost to Follow-up|0|||
146277736|NCT01283516|527530312|FG002|Overall Study|Lost to Follow-up|0|||
146277737|NCT01283516|527530313|FG003|Overall Study|Lost to Follow-up|0|||
146277738|NCT01283516|527530314|FG004|Overall Study|Lost to Follow-up|0|||
146277739|NCT01283516|527530315|FG005|Overall Study|Lost to Follow-up|0|||
146277740|NCT01283516|527530316|FG006|Overall Study|Lost to Follow-up|0|||
146277741|NCT01283516|527530317|FG007|Overall Study|Lost to Follow-up|0|||
146277742|NCT01283516|527530318|FG008|Overall Study|Lost to Follow-up|1|||
146277743|NCT00132873|527530321|FG000|Overall Study|Adverse Event|3|||
146277744|NCT00132873|527530321|FG000|Overall Study|Lost to Follow-up|1|||
146277745|NCT00132873|527530321|FG000|Overall Study|Lack of Efficacy|1|||
146277746|NCT00132873|527530321|FG000|Overall Study|Withdrawal by Subject|3|||
146277747|NCT00132873|527530321|FG000|Overall Study|Planned Pregnancy|1|||
146277748|NCT01204710|527530325|FG000|Randomization Treatment|Lost to Follow-up|1|||
146277749|NCT01204710|527530326|FG001|Randomization Treatment|Lost to Follow-up|0|||
146277750|NCT01204710|527530325|FG000|Randomization Treatment|Withdrawal by Subject|6|||
146277751|NCT01204710|527530326|FG001|Randomization Treatment|Withdrawal by Subject|5|||
146277752|NCT01204710|527530325|FG000|Randomization Treatment|Physician Decision|3|||
146277753|NCT01204710|527530326|FG001|Randomization Treatment|Physician Decision|2|||
146277754|NCT01204710|527530325|FG000|Randomization Treatment|Entry criteria not met|0|||
146277755|NCT01204710|527530326|FG001|Randomization Treatment|Entry criteria not met|1|||
146277756|NCT01204710|527530325|FG000|Randomization Treatment|Adverse Event|4|||
146277757|NCT01204710|527530326|FG001|Randomization Treatment|Adverse Event|2|||
146277758|NCT01204710|527530325|FG000|Randomization Treatment|Sponsor Decision|0|||
146277759|NCT01204710|527530326|FG001|Randomization Treatment|Sponsor Decision|1|||
146277760|NCT01204710|527530325|FG000|Randomization Treatment|Worsening of General condition|0|||
146277761|NCT01204710|527530326|FG001|Randomization Treatment|Worsening of General condition|1|||
146277762|NCT01204710|527530325|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
146277763|NCT01204710|527530326|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
146277764|NCT01204710|527530325|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
146277765|NCT01204710|527530326|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
146277766|NCT01204710|527530325|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
146277767|NCT01204710|527530326|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
146277768|NCT01204710|527530325|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
146277769|NCT01204710|527530326|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
146277770|NCT00743431|527530327|FG000|Overall Study|Toxicity|6|||
146277771|NCT00743431|527530327|FG000|Overall Study|Tumor progression|56|||
146277772|NCT00743431|527530327|FG000|Overall Study|Withdrawal by Subject|13|||
146277773|NCT00743431|527530327|FG000|Overall Study|Death|9|||
146277774|NCT00743431|527530327|FG000|Overall Study|Reason for discontinuation not specified|29|||
146277775|NCT00743431|527530327|FG000|Overall Study|No documentation available|13|||
146277776|NCT03291288|527530328|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
146277777|NCT03291288|527530329|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
146277778|NCT03291288|527530328|FG000|Drug-drug Interaction Phase|Disease progression|1|||
146277779|NCT03291288|527530329|FG001|Drug-drug Interaction Phase|Disease progression|0|||
146277780|NCT03291288|527530328|FG000|Drug-drug Interaction Phase|Other|3|||
146277781|NCT03291288|527530329|FG001|Drug-drug Interaction Phase|Other|0|||
146277782|NCT03291288|527530328|FG000|Pexidartinib Only|Ongoing|0|||
146277783|NCT03291288|527530329|FG001|Pexidartinib Only|Ongoing|2|||
146277784|NCT04276415|527530330|FG000|Overall Study|Adverse Event|0|||
146277785|NCT04276415|527530331|FG001|Overall Study|Adverse Event|0|||
146277786|NCT04276415|527530332|FG002|Overall Study|Adverse Event|0|||
146277787|NCT04276415|527530333|FG003|Overall Study|Adverse Event|3|||
146277788|NCT04276415|527530334|FG004|Overall Study|Adverse Event|0|||
146277789|NCT04276415|527530335|FG005|Overall Study|Adverse Event|0|||
146146175|NCT02610140|527047370|FG001|Randomization and Treatment Period|Physician Decision|1|||
146146176|NCT02610140|527047369|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
146277790|NCT04276415|527530330|FG000|Overall Study|Clinical progression|1|||
146277791|NCT04276415|527530331|FG001|Overall Study|Clinical progression|1|||
146277792|NCT04276415|527530332|FG002|Overall Study|Clinical progression|0|||
146277793|NCT04276415|527530333|FG003|Overall Study|Clinical progression|0|||
146277794|NCT04276415|527530334|FG004|Overall Study|Clinical progression|1|||
146277795|NCT04276415|527530335|FG005|Overall Study|Clinical progression|0|||
146277796|NCT04276415|527530330|FG000|Overall Study|Other|0|||
146277797|NCT04276415|527530331|FG001|Overall Study|Other|0|||
146277798|NCT04276415|527530332|FG002|Overall Study|Other|0|||
146277799|NCT04276415|527530333|FG003|Overall Study|Other|1|||
146277800|NCT04276415|527530334|FG004|Overall Study|Other|0|||
146277801|NCT04276415|527530335|FG005|Overall Study|Other|0|||
146277802|NCT04276415|527530330|FG000|Overall Study|Physician Decision|0|||
146277803|NCT04276415|527530331|FG001|Overall Study|Physician Decision|0|||
146277804|NCT04276415|527530332|FG002|Overall Study|Physician Decision|1|||
146277805|NCT04276415|527530333|FG003|Overall Study|Physician Decision|3|||
146277806|NCT04276415|527530334|FG004|Overall Study|Physician Decision|2|||
146277807|NCT04276415|527530335|FG005|Overall Study|Physician Decision|0|||
146277808|NCT04276415|527530330|FG000|Overall Study|Progressive disease|3|||
146277809|NCT04276415|527530331|FG001|Overall Study|Progressive disease|3|||
146277810|NCT04276415|527530332|FG002|Overall Study|Progressive disease|4|||
146277811|NCT04276415|527530333|FG003|Overall Study|Progressive disease|5|||
146277812|NCT04276415|527530334|FG004|Overall Study|Progressive disease|1|||
146277813|NCT04276415|527530335|FG005|Overall Study|Progressive disease|2|||
146277814|NCT04276415|527530330|FG000|Overall Study|Withdrawal by patient|0|||
146277815|NCT04276415|527530331|FG001|Overall Study|Withdrawal by patient|0|||
146277816|NCT04276415|527530332|FG002|Overall Study|Withdrawal by patient|0|||
146277817|NCT04276415|527530333|FG003|Overall Study|Withdrawal by patient|1|||
146277818|NCT04276415|527530334|FG004|Overall Study|Withdrawal by patient|2|||
146277819|NCT04276415|527530335|FG005|Overall Study|Withdrawal by patient|0|||
146277820|NCT01896726|527530336|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
146277821|NCT01896726|527530336|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
146277822|NCT02406677|527530337|FG000|Overall Study|Death|16|||
146277823|NCT02406677|527530338|FG001|Overall Study|Death|8|||
146277824|NCT02406677|527530337|FG000|Overall Study|Discharged without P2Y12|1|||
146277825|NCT02406677|527530338|FG001|Overall Study|Discharged without P2Y12|3|||
146277826|NCT02406677|527530337|FG000|Overall Study|Discharged on prasugrel|283|||
146277827|NCT02406677|527530338|FG001|Overall Study|Discharged on prasugrel|587|||
146277828|NCT02406677|527530337|FG000|Overall Study|Withdrawal by Subject|1|||
146277829|NCT02406677|527530338|FG001|Overall Study|Withdrawal by Subject|0|||
146277830|NCT01114880|527530339|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
146277831|NCT01114880|527530340|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
146277832|NCT01114880|527530339|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
146277833|NCT01114880|527530340|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
146277834|NCT01114880|527530339|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
146277835|NCT01114880|527530340|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
146277836|NCT01114880|527530339|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
146277837|NCT01114880|527530340|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
146277838|NCT01114880|527530339|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
146277839|NCT01114880|527530340|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
146277840|NCT01114880|527530339|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
146277841|NCT01114880|527530340|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
146277842|NCT04531904|527530344|FG000|Overall Study|Lost to Follow-up|1|||
146277843|NCT04531904|527530344|FG000|Overall Study|Death|14|||
146277844|NCT04531098|527530345|FG000|Stage I|Adverse Event|0|||
146277845|NCT04531098|527530346|FG001|Stage I|Adverse Event|0|||
146277846|NCT04531098|527530347|FG002|Stage I|Adverse Event|3|||
146277847|NCT04531098|527530345|FG000|Stage I|Protocol Violation|0|||
146277848|NCT04531098|527530346|FG001|Stage I|Protocol Violation|0|||
146277849|NCT04531098|527530347|FG002|Stage I|Protocol Violation|5|||
146277850|NCT04531098|527530345|FG000|Stage I|Withdrawal by Subject|0|||
146277851|NCT04531098|527530346|FG001|Stage I|Withdrawal by Subject|5|||
146277852|NCT04531098|527530347|FG002|Stage I|Withdrawal by Subject|10|||
146277853|NCT04531098|527530345|FG000|Stage II|Adverse Event|1|||
146277854|NCT04531098|527530346|FG001|Stage II|Adverse Event|2|||
146277855|NCT04531098|527530347|FG002|Stage II|Adverse Event|0|||
146277856|NCT04531098|527530345|FG000|Stage II|Protocol Violation|1|||
146277857|NCT04531098|527530346|FG001|Stage II|Protocol Violation|2|||
146277858|NCT04531098|527530347|FG002|Stage II|Protocol Violation|0|||
146277859|NCT04531098|527530345|FG000|Stage II|Withdrawal by Subject|3|||
146277860|NCT04531098|527530346|FG001|Stage II|Withdrawal by Subject|1|||
146277861|NCT04531098|527530347|FG002|Stage II|Withdrawal by Subject|0|||
146277862|NCT04531098|527530345|FG000|Stage II|Moved from study area|8|||
146277863|NCT04531098|527530346|FG001|Stage II|Moved from study area|5|||
146277864|NCT04531098|527530347|FG002|Stage II|Moved from study area|0|||
146277865|NCT00283244|527530348|FG000|Overall Study|Adverse Event|0|||
146277866|NCT00283244|527530349|FG001|Overall Study|Adverse Event|8|||
146277867|NCT00283244|527530350|FG002|Overall Study|Adverse Event|11|||
146277868|NCT00283244|527530348|FG000|Overall Study|Death|4|||
146277869|NCT00283244|527530349|FG001|Overall Study|Death|3|||
146277870|NCT00283244|527530350|FG002|Overall Study|Death|2|||
146277871|NCT00283244|527530348|FG000|Overall Study|Lack of Efficacy|8|||
146277872|NCT00283244|527530349|FG001|Overall Study|Lack of Efficacy|32|||
146277873|NCT00283244|527530350|FG002|Overall Study|Lack of Efficacy|26|||
146277874|NCT00283244|527530348|FG000|Overall Study|Withdrawal by Subject|1|||
146277875|NCT00283244|527530349|FG001|Overall Study|Withdrawal by Subject|2|||
146277876|NCT00283244|527530350|FG002|Overall Study|Withdrawal by Subject|2|||
146277877|NCT00283244|527530348|FG000|Overall Study|Physician Decision|0|||
146277878|NCT00283244|527530349|FG001|Overall Study|Physician Decision|0|||
146277879|NCT00283244|527530350|FG002|Overall Study|Physician Decision|1|||
146277880|NCT00283244|527530348|FG000|Overall Study|Medical illness (other complicating dz)|4|||
146277881|NCT00283244|527530349|FG001|Overall Study|Medical illness (other complicating dz)|3|||
146277882|NCT00283244|527530350|FG002|Overall Study|Medical illness (other complicating dz)|6|||
146277883|NCT00283244|527530348|FG000|Overall Study|Clinical deterioration|1|||
146277884|NCT00283244|527530349|FG001|Overall Study|Clinical deterioration|3|||
146277885|NCT00283244|527530350|FG002|Overall Study|Clinical deterioration|3|||
146277886|NCT02628028|527530351|FG000|Dosing Period|Withdrawal by Subject|0|||
146277887|NCT02628028|527530352|FG001|Dosing Period|Withdrawal by Subject|0|||
146277888|NCT02628028|527530353|FG002|Dosing Period|Withdrawal by Subject|1|||
146277889|NCT02628028|527530354|FG003|Dosing Period|Withdrawal by Subject|0|||
146277890|NCT02628028|527530355|FG004|Dosing Period|Withdrawal by Subject|2|||
146277891|NCT02628028|527530356|FG005|Dosing Period|Withdrawal by Subject|4|||
146277892|NCT02628028|527530357|FG006|Dosing Period|Withdrawal by Subject|1|||
146277893|NCT02628028|527530358|FG007|Dosing Period|Withdrawal by Subject|1|||
146277894|NCT02628028|527530351|FG000|Dosing Period|Adverse Event|0|||
146277895|NCT02628028|527530352|FG001|Dosing Period|Adverse Event|0|||
146277896|NCT02628028|527530353|FG002|Dosing Period|Adverse Event|0|||
146277897|NCT02628028|527530354|FG003|Dosing Period|Adverse Event|0|||
146277898|NCT02628028|527530355|FG004|Dosing Period|Adverse Event|2|||
146277899|NCT02628028|527530356|FG005|Dosing Period|Adverse Event|1|||
146277900|NCT02628028|527530357|FG006|Dosing Period|Adverse Event|3|||
146277901|NCT02628028|527530358|FG007|Dosing Period|Adverse Event|2|||
146277902|NCT02628028|527530351|FG000|Dosing Period|Death|0|||
146277903|NCT02628028|527530352|FG001|Dosing Period|Death|0|||
146277904|NCT02628028|527530353|FG002|Dosing Period|Death|0|||
146277905|NCT02628028|527530354|FG003|Dosing Period|Death|0|||
146277906|NCT02628028|527530355|FG004|Dosing Period|Death|0|||
146277907|NCT02628028|527530356|FG005|Dosing Period|Death|0|||
146277908|NCT02628028|527530357|FG006|Dosing Period|Death|0|||
146277909|NCT02628028|527530358|FG007|Dosing Period|Death|1|||
146277910|NCT02628028|527530351|FG000|Dosing Period|Lack of Efficacy|0|||
146277911|NCT02628028|527530352|FG001|Dosing Period|Lack of Efficacy|0|||
146277912|NCT02628028|527530353|FG002|Dosing Period|Lack of Efficacy|0|||
146277913|NCT02628028|527530354|FG003|Dosing Period|Lack of Efficacy|0|||
146277914|NCT02628028|527530355|FG004|Dosing Period|Lack of Efficacy|3|||
146277915|NCT02628028|527530356|FG005|Dosing Period|Lack of Efficacy|0|||
146277916|NCT02628028|527530357|FG006|Dosing Period|Lack of Efficacy|1|||
146277917|NCT02628028|527530358|FG007|Dosing Period|Lack of Efficacy|0|||
146277918|NCT02628028|527530351|FG000|Dosing Period|Study Terminated by Sponsor|0|||
146277919|NCT02628028|527530352|FG001|Dosing Period|Study Terminated by Sponsor|0|||
146277920|NCT02628028|527530353|FG002|Dosing Period|Study Terminated by Sponsor|0|||
146277921|NCT02628028|527530354|FG003|Dosing Period|Study Terminated by Sponsor|0|||
146277922|NCT02628028|527530355|FG004|Dosing Period|Study Terminated by Sponsor|7|||
146277923|NCT02628028|527530356|FG005|Dosing Period|Study Terminated by Sponsor|6|||
146277924|NCT02628028|527530357|FG006|Dosing Period|Study Terminated by Sponsor|7|||
146277925|NCT02628028|527530358|FG007|Dosing Period|Study Terminated by Sponsor|7|||
146277926|NCT02628028|527530351|FG000|Dosing Period|Physician Decision|0|||
146277927|NCT02628028|527530352|FG001|Dosing Period|Physician Decision|0|||
146277928|NCT02628028|527530353|FG002|Dosing Period|Physician Decision|0|||
146277929|NCT02628028|527530354|FG003|Dosing Period|Physician Decision|0|||
146277930|NCT02628028|527530355|FG004|Dosing Period|Physician Decision|0|||
146277931|NCT02628028|527530356|FG005|Dosing Period|Physician Decision|1|||
146304889|NCT01007032|527630917|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
146277932|NCT02628028|527530357|FG006|Dosing Period|Physician Decision|0|||
146277933|NCT02628028|527530358|FG007|Dosing Period|Physician Decision|0|||
146277934|NCT02628028|527530351|FG000|Dosing Period|Site Terminated by Sponsor|0|||
146277935|NCT02628028|527530352|FG001|Dosing Period|Site Terminated by Sponsor|0|||
146277936|NCT02628028|527530353|FG002|Dosing Period|Site Terminated by Sponsor|0|||
146277937|NCT02628028|527530354|FG003|Dosing Period|Site Terminated by Sponsor|0|||
146277938|NCT02628028|527530355|FG004|Dosing Period|Site Terminated by Sponsor|0|||
146277939|NCT02628028|527530356|FG005|Dosing Period|Site Terminated by Sponsor|1|||
146277940|NCT02628028|527530357|FG006|Dosing Period|Site Terminated by Sponsor|1|||
146277941|NCT02628028|527530358|FG007|Dosing Period|Site Terminated by Sponsor|0|||
146277942|NCT02628028|527530351|FG000|Dosing Period|Lost to Follow-up|0|||
146277943|NCT02628028|527530352|FG001|Dosing Period|Lost to Follow-up|0|||
146304890|NCT01007032|527630914|FG000|Overall Study|Withdrawal by Subject|0|||
146304891|NCT01007032|527630915|FG001|Overall Study|Withdrawal by Subject|0|||
146304892|NCT01007032|527630916|FG002|Overall Study|Withdrawal by Subject|0|||
146304893|NCT01007032|527630917|FG003|Overall Study|Withdrawal by Subject|1|||
146304894|NCT01101438|527630918|FG000|Overall Study|Withdrawal by Subject|8|||
146304895|NCT01101438|527630919|FG001|Overall Study|Withdrawal by Subject|9|||
146304896|NCT03677596|527630924|FG000|Overall Study|Adverse Event|0|||
146304897|NCT03677596|527630925|FG001|Overall Study|Adverse Event|1|||
146304898|NCT03677596|527630924|FG000|Overall Study|Death|10|||
146304899|NCT03677596|527630925|FG001|Overall Study|Death|6|||
146304900|NCT03677596|527630924|FG000|Overall Study|Lost to Follow-up|0|||
146304901|NCT03677596|527630925|FG001|Overall Study|Lost to Follow-up|1|||
146304902|NCT03677596|527630924|FG000|Overall Study|Progressive Disease|8|||
146304903|NCT03677596|527630925|FG001|Overall Study|Progressive Disease|8|||
146304904|NCT03677596|527630924|FG000|Overall Study|Withdrawal by Subject|3|||
146304905|NCT03677596|527630925|FG001|Overall Study|Withdrawal by Subject|0|||
146304906|NCT03677596|527630924|FG000|Overall Study|Disease Relapse|2|||
146304907|NCT03677596|527630925|FG001|Overall Study|Disease Relapse|2|||
146304908|NCT03677596|527630924|FG000|Overall Study|Other|0|||
146304909|NCT03677596|527630925|FG001|Overall Study|Other|1|||
146304910|NCT03794583|527630926|FG000|Overall Study|Death|8|||
146304911|NCT03794583|527630926|FG000|Overall Study|Study Terminated by Sponsor|24|||
146304912|NCT03794583|527630926|FG000|Overall Study|Withdrawal by Subject|9|||
146304913|NCT00806195|527630927|FG000|Overall Study|Death|6|||
146304914|NCT00806195|527630928|FG001|Overall Study|Death|0|||
146277944|NCT02628028|527530353|FG002|Dosing Period|Lost to Follow-up|0|||
146277945|NCT02628028|527530354|FG003|Dosing Period|Lost to Follow-up|0|||
146277946|NCT02628028|527530355|FG004|Dosing Period|Lost to Follow-up|0|||
146277947|NCT02628028|527530356|FG005|Dosing Period|Lost to Follow-up|0|||
146277948|NCT02628028|527530357|FG006|Dosing Period|Lost to Follow-up|1|||
146277949|NCT02628028|527530358|FG007|Dosing Period|Lost to Follow-up|0|||
146277950|NCT02628028|527530351|FG000|Dosing Period|Other|0|||
146277951|NCT02628028|527530352|FG001|Dosing Period|Other|0|||
146277952|NCT02628028|527530353|FG002|Dosing Period|Other|0|||
146277953|NCT02628028|527530354|FG003|Dosing Period|Other|0|||
146277954|NCT02628028|527530355|FG004|Dosing Period|Other|2|||
146277955|NCT02628028|527530356|FG005|Dosing Period|Other|1|||
146277956|NCT02628028|527530357|FG006|Dosing Period|Other|2|||
146277957|NCT02628028|527530358|FG007|Dosing Period|Other|4|||
146277958|NCT02628028|527530351|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
146277959|NCT02628028|527530352|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
146277960|NCT02628028|527530353|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
146277961|NCT02628028|527530354|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
146277962|NCT02628028|527530355|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
146277963|NCT02628028|527530356|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
146277964|NCT02628028|527530357|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
146277965|NCT02628028|527530358|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
146277966|NCT02628028|527530351|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277967|NCT02628028|527530352|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277968|NCT02628028|527530353|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277969|NCT02628028|527530354|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277970|NCT02628028|527530355|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277971|NCT02628028|527530356|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
146277972|NCT02628028|527530357|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
146277973|NCT02628028|527530358|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
146277974|NCT02628028|527530351|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146277975|NCT02628028|527530352|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146304915|NCT00806195|527630929|FG002|Overall Study|Death|1|||
146304916|NCT00806195|527630930|FG003|Overall Study|Death|0|||
146304917|NCT00806195|527630927|FG000|Overall Study|Adverse Event|25|||
146277976|NCT02628028|527530353|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146277977|NCT02628028|527530354|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146277978|NCT02628028|527530355|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
146304918|NCT00806195|527630928|FG001|Overall Study|Adverse Event|5|||
146304919|NCT00806195|527630929|FG002|Overall Study|Adverse Event|11|||
146304920|NCT00806195|527630930|FG003|Overall Study|Adverse Event|2|||
146304921|NCT00806195|527630927|FG000|Overall Study|Withdrawal by Subject|119|||
146304922|NCT00806195|527630928|FG001|Overall Study|Withdrawal by Subject|31|||
146304923|NCT00806195|527630929|FG002|Overall Study|Withdrawal by Subject|76|||
146304924|NCT00806195|527630930|FG003|Overall Study|Withdrawal by Subject|35|||
146304925|NCT00806195|527630927|FG000|Overall Study|Lost to Follow-up|217|||
146277979|NCT02628028|527530356|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
146277980|NCT02628028|527530357|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
146277981|NCT02628028|527530358|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
146304926|NCT00806195|527630928|FG001|Overall Study|Lost to Follow-up|66|||
146304927|NCT00806195|527630929|FG002|Overall Study|Lost to Follow-up|90|||
146277982|NCT02628028|527530351|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146277983|NCT02628028|527530352|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146277984|NCT02628028|527530353|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146277985|NCT02628028|527530354|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146277986|NCT02628028|527530355|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
146277987|NCT02628028|527530356|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
146277988|NCT02628028|527530357|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
146277989|NCT02628028|527530358|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
146277990|NCT02628028|527530351|FG000|Long-term Extension (LTE) Period|Other|0|||
146277991|NCT02628028|527530352|FG001|Long-term Extension (LTE) Period|Other|0|||
146277992|NCT02628028|527530353|FG002|Long-term Extension (LTE) Period|Other|0|||
146277993|NCT02628028|527530354|FG003|Long-term Extension (LTE) Period|Other|0|||
146277994|NCT02628028|527530355|FG004|Long-term Extension (LTE) Period|Other|0|||
146277995|NCT02628028|527530356|FG005|Long-term Extension (LTE) Period|Other|3|||
146277996|NCT02628028|527530357|FG006|Long-term Extension (LTE) Period|Other|4|||
146277997|NCT02628028|527530358|FG007|Long-term Extension (LTE) Period|Other|3|||
146277998|NCT02145468|527530359|FG000|Overall Study|Withdrawal by Subject|5|||
146277999|NCT02145468|527530360|FG001|Overall Study|Withdrawal by Subject|8|||
146278000|NCT04372121|527530367|FG000|Overall Study|Lost to Follow-up|0|||
146278001|NCT04372121|527530368|FG001|Overall Study|Lost to Follow-up|0|||
146278002|NCT04372121|527530369|FG002|Overall Study|Lost to Follow-up|0|||
146278003|NCT04372121|527530370|FG003|Overall Study|Lost to Follow-up|1|||
146278004|NCT04372121|527530367|FG000|Overall Study|Protocol Violation|0|||
146278005|NCT04372121|527530368|FG001|Overall Study|Protocol Violation|0|||
146278006|NCT04372121|527530369|FG002|Overall Study|Protocol Violation|1|||
146278007|NCT04372121|527530370|FG003|Overall Study|Protocol Violation|0|||
146278008|NCT04372121|527530367|FG000|Overall Study|Withdrawal by Subject|3|||
146278009|NCT04372121|527530368|FG001|Overall Study|Withdrawal by Subject|1|||
146278010|NCT04372121|527530369|FG002|Overall Study|Withdrawal by Subject|0|||
146278011|NCT04372121|527530370|FG003|Overall Study|Withdrawal by Subject|0|||
146278012|NCT04372121|527530367|FG000|Overall Study|Study termination|6|||
146278013|NCT04372121|527530368|FG001|Overall Study|Study termination|5|||
146278014|NCT04372121|527530369|FG002|Overall Study|Study termination|1|||
146278015|NCT04372121|527530370|FG003|Overall Study|Study termination|1|||
146278016|NCT04372121|527530367|FG000|Overall Study|Hysterectomy planned|1|||
146278017|NCT04372121|527530368|FG001|Overall Study|Hysterectomy planned|0|||
146278018|NCT04372121|527530369|FG002|Overall Study|Hysterectomy planned|0|||
146278019|NCT04372121|527530370|FG003|Overall Study|Hysterectomy planned|0|||
146278020|NCT04500769|527531856|FG000|Overall Study|Withdrawal by Subject|5|||
146278021|NCT03843554|527531857|FG000|Overall Study|Physician Decision|0|||
146278022|NCT03843554|527531858|FG001|Overall Study|Physician Decision|2|||
146278023|NCT01099215|527531859|FG000|Overall Study|Withdrawal by Subject|1|||
146278024|NCT01099215|527531860|FG001|Overall Study|Withdrawal by Subject|0|||
146278025|NCT01099215|527531859|FG000|Overall Study|Adverse Event|0|||
146278026|NCT01099215|527531860|FG001|Overall Study|Adverse Event|1|||
146278027|NCT04396366|527531863|FG000|Overall Study|Adverse Event|1|||
146278028|NCT04396366|527531864|FG001|Overall Study|Adverse Event|0|||
146278029|NCT00166712|527531865|FG000|Overall Study|Death|0|||
146278030|NCT00166712|527531866|FG001|Overall Study|Death|1|||
146278031|NCT00166712|527531865|FG000|Overall Study|Adverse Event|1|||
146278032|NCT00166712|527531866|FG001|Overall Study|Adverse Event|0|||
146278033|NCT00166712|527531865|FG000|Overall Study|Withdrawal by Subject|1|||
146278034|NCT00166712|527531866|FG001|Overall Study|Withdrawal by Subject|2|||
146278035|NCT00166712|527531865|FG000|Overall Study|Physician Decision|0|||
146278036|NCT00166712|527531866|FG001|Overall Study|Physician Decision|2|||
146278037|NCT04684394|527531867|FG000|Overall Study|Death|1|||
146278038|NCT04684394|527531868|FG001|Overall Study|Death|2|||
146278039|NCT04684394|527531867|FG000|Overall Study|Lost to Follow-up|1|||
146278040|NCT04684394|527531868|FG001|Overall Study|Lost to Follow-up|0|||
146278041|NCT04684394|527531867|FG000|Overall Study|Withdrawal by Subject|2|||
146278042|NCT04684394|527531868|FG001|Overall Study|Withdrawal by Subject|0|||
146278043|NCT04684394|527531867|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
146278044|NCT04684394|527531868|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
146278045|NCT03002220|527531869|FG000|Overall Study|Lack of Efficacy|2|||
146278046|NCT03002220|527531869|FG000|Overall Study|Withdrawal by Subject|3|||
146278047|NCT03002220|527531869|FG000|Overall Study|Adverse Event|2|||
146278048|NCT03002220|527531869|FG000|Overall Study|Disease progression|13|||
146278049|NCT03002220|527531869|FG000|Overall Study|Physician Decision|1|||
146278050|NCT01183260|527531870|FG000|Overall Study|Intraop screen failure|2|||
146278051|NCT01183260|527531871|FG001|Overall Study|Intraop screen failure|0|||
146278052|NCT01183260|527531870|FG000|Overall Study|Withdrawal by Subject|1|||
146278053|NCT01183260|527531871|FG001|Overall Study|Withdrawal by Subject|1|||
146304928|NCT00806195|527630930|FG003|Overall Study|Lost to Follow-up|34|||
146278054|NCT01183260|527531870|FG000|Overall Study|Revised within 30 days|0|||
146278055|NCT01183260|527531871|FG001|Overall Study|Revised within 30 days|1|||
146278056|NCT01183260|527531870|FG000|Overall Study|Death|1|||
146278057|NCT01183260|527531871|FG001|Overall Study|Death|0|||
146146177|NCT02610140|527047370|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
146146178|NCT02610140|527047369|FG000|Randomization and Treatment Period|Death|7|||
146146179|NCT02610140|527047370|FG001|Randomization and Treatment Period|Death|1|||
146146180|NCT02610140|527047369|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
146146181|NCT02610140|527047370|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
146146182|NCT02610140|527047369|FG000|Randomization and Treatment Period|Adverse Event|44|||
146146183|NCT02610140|527047370|FG001|Randomization and Treatment Period|Adverse Event|13|||
146146184|NCT02610140|527047369|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
146146185|NCT02610140|527047370|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
146278058|NCT01202903|527531872|FG000|Overall Study|Administrative Probelms|1|||
146278059|NCT01202903|527531873|FG001|Overall Study|Administrative Probelms|4|||
146278060|NCT01202903|527531872|FG000|Overall Study|Protocol Violation|0|||
146278061|NCT01202903|527531873|FG001|Overall Study|Protocol Violation|1|||
146278062|NCT01202903|527531872|FG000|Overall Study|Death|1|||
146278063|NCT01202903|527531873|FG001|Overall Study|Death|0|||
146278064|NCT01202903|527531872|FG000|Overall Study|Lost to Follow-up|1|||
146278065|NCT01202903|527531873|FG001|Overall Study|Lost to Follow-up|1|||
146278066|NCT01202903|527531872|FG000|Overall Study|Lack of Efficacy|1|||
146278067|NCT01202903|527531873|FG001|Overall Study|Lack of Efficacy|3|||
146278068|NCT01202903|527531872|FG000|Overall Study|Adverse Event|3|||
146278069|NCT01202903|527531873|FG001|Overall Study|Adverse Event|3|||
146278070|NCT01202903|527531872|FG000|Overall Study|Withdrawal by Subject|4|||
146278071|NCT01202903|527531873|FG001|Overall Study|Withdrawal by Subject|4|||
146278072|NCT01896557|527531878|FG000|Clopidogrel Alone|Adverse Event|1|||
146278073|NCT01896557|527531879|FG001|Clopidogrel Alone|Adverse Event|0|||
146278074|NCT01896557|527531878|FG000|Clopidogrel + GI Protector|low adherence|1|||
146278075|NCT01896557|527531879|FG001|Clopidogrel + GI Protector|low adherence|1|||
146278076|NCT01896557|527531878|FG000|Clopidogrel + GI Protector|Reading error|1|||
146278077|NCT01896557|527531879|FG001|Clopidogrel + GI Protector|Reading error|3|||
146278078|NCT02182947|527531880|FG000|Overall Study|Withdrawal by Subject|7|||
146278079|NCT02182947|527531880|FG000|Overall Study|Lost to Follow-up|3|||
146278080|NCT02182947|527531880|FG000|Overall Study|Failed screening activities|8|||
146278081|NCT01072630|527531885|FG000|Overall Study|Adverse Event|11|||
146278082|NCT01072630|527531886|FG001|Overall Study|Adverse Event|19|||
146278083|NCT01072630|527531887|FG002|Overall Study|Adverse Event|2|||
146278084|NCT01072630|527531885|FG000|Overall Study|Lack of Efficacy|10|||
146278085|NCT01072630|527531886|FG001|Overall Study|Lack of Efficacy|10|||
146278086|NCT01072630|527531887|FG002|Overall Study|Lack of Efficacy|1|||
146278087|NCT01072630|527531885|FG000|Overall Study|Withdrawal by Subject|8|||
146278088|NCT01072630|527531886|FG001|Overall Study|Withdrawal by Subject|7|||
146278089|NCT01072630|527531887|FG002|Overall Study|Withdrawal by Subject|2|||
146278090|NCT01072630|527531885|FG000|Overall Study|Protocol Violation|10|||
146278091|NCT01072630|527531886|FG001|Overall Study|Protocol Violation|8|||
146278092|NCT01072630|527531887|FG002|Overall Study|Protocol Violation|4|||
146278093|NCT01072630|527531885|FG000|Overall Study|Lost to Follow-up|11|||
146278094|NCT01072630|527531886|FG001|Overall Study|Lost to Follow-up|11|||
146278095|NCT01072630|527531887|FG002|Overall Study|Lost to Follow-up|1|||
146278096|NCT01072630|527531885|FG000|Overall Study|Noncompliance with study medication|1|||
146278097|NCT01072630|527531886|FG001|Overall Study|Noncompliance with study medication|1|||
146278098|NCT01072630|527531887|FG002|Overall Study|Noncompliance with study medication|1|||
146278099|NCT01072630|527531885|FG000|Overall Study|Noncompliance with study procedures|1|||
146278100|NCT01072630|527531886|FG001|Overall Study|Noncompliance with study procedures|2|||
146278101|NCT01072630|527531887|FG002|Overall Study|Noncompliance with study procedures|1|||
146278102|NCT01072630|527531885|FG000|Overall Study|Other|3|||
146278103|NCT01072630|527531886|FG001|Overall Study|Other|2|||
146278104|NCT01072630|527531887|FG002|Overall Study|Other|1|||
146278105|NCT04488770|527531894|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278106|NCT04488770|527531895|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278107|NCT04488770|527531896|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278108|NCT04488770|527531897|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
146278109|NCT04488770|527531898|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278110|NCT04488770|527531899|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278111|NCT04488770|527531900|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278112|NCT04488770|527531901|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278113|NCT04488770|527531902|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278114|NCT04488770|527531903|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278115|NCT04488770|527531904|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278116|NCT04488770|527531905|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278117|NCT04488770|527531906|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
146278118|NCT04488770|527531894|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
146278119|NCT04488770|527531895|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278120|NCT04488770|527531896|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146304929|NCT00806195|527630927|FG000|Overall Study|Inappropriate Enrollment|0|||
146304930|NCT00806195|527630928|FG001|Overall Study|Inappropriate Enrollment|1|||
146278121|NCT04488770|527531897|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278122|NCT04488770|527531898|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278123|NCT04488770|527531899|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278124|NCT04488770|527531900|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278125|NCT04488770|527531901|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278126|NCT04488770|527531902|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278127|NCT04488770|527531903|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278128|NCT04488770|527531904|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278129|NCT04488770|527531905|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278130|NCT04488770|527531906|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
146278131|NCT04488770|527531894|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278132|NCT04488770|527531895|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278133|NCT04488770|527531896|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278134|NCT04488770|527531897|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278135|NCT04488770|527531898|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278136|NCT04488770|527531899|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146278137|NCT04488770|527531900|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
146278138|NCT04488770|527531901|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278139|NCT04488770|527531902|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278140|NCT04488770|527531903|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278141|NCT04488770|527531904|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278142|NCT04488770|527531905|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278143|NCT04488770|527531906|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
146278144|NCT04488770|527531894|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278145|NCT04488770|527531895|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278146|NCT04488770|527531896|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278147|NCT04488770|527531897|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278148|NCT04488770|527531898|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
146278149|NCT04488770|527531899|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278150|NCT04488770|527531900|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278151|NCT04488770|527531901|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278152|NCT04488770|527531902|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278153|NCT04488770|527531903|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278154|NCT04488770|527531904|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278155|NCT04488770|527531905|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278156|NCT04488770|527531906|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
146278157|NCT01208103|527531907|FG000|Overall Study|Adverse Event|1|||
146278158|NCT01208103|527531907|FG000|Overall Study|Withdrawal by Subject|1|||
146278159|NCT00886795|527531908|FG000|Overall Study|Lack of Efficacy|1|||
146278160|NCT01669577|527531914|FG000|Overall Study|Death|22|||
146278161|NCT01669577|527531914|FG000|Overall Study|Lost to Follow-up|78|||
146278162|NCT01669577|527531914|FG000|Overall Study|Physician Decision|34|||
146278163|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
146278164|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
146278165|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
146278166|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
146278167|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
146278168|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
146278169|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
146278170|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
146278171|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
146278172|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
146278173|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Adverse Event|0|||
146278174|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Adverse Event|0|||
146278175|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Adverse Event|3|||
146278176|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Adverse Event|2|||
146278177|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Adverse Event|13|||
146278178|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146278179|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146278180|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
146278181|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
146278182|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
146278183|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Patient's wish|0|||
146278184|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Patient's wish|0|||
146278185|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Patient's wish|19|||
146278186|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Patient's wish|9|||
146278187|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Patient's wish|20|||
146278188|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
146278189|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
146278190|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
146278191|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
146278192|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
146278193|NCT00444275|527531918|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
146278194|NCT00444275|527531919|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
146278195|NCT00444275|527531920|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
146278196|NCT00444275|527531921|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
146278197|NCT00444275|527531922|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
146278198|NCT04662931|527531925|FG000|Overall Study|Withdrawal by Subject|17|||
146278199|NCT04662931|527531925|FG000|Overall Study|Death|3|||
146278200|NCT04662931|527531925|FG000|Overall Study|Lost to Follow-up|3|||
146278201|NCT04662931|527531925|FG000|Overall Study|Guardian Decision|1|||
146278202|NCT01989169|527531926|FG000|Period 2|Adverse Event|0|||
146278203|NCT01989169|527531927|FG001|Period 2|Adverse Event|1|||
146278204|NCT01585155|527531928|FG000|Overall Study|Adverse Event|1|||
146278205|NCT01585155|527531928|FG000|Overall Study|Lack of Efficacy|2|||
146278206|NCT01585155|527531928|FG000|Overall Study|Worsening ulcerative colitis|2|||
146278207|NCT02235311|527531933|FG000|Overall Study|Lost to Follow-up|0|||
146278208|NCT02235311|527531934|FG001|Overall Study|Lost to Follow-up|1|||
146278209|NCT02235311|527531933|FG000|Overall Study|Protocol Violation|0|||
146278210|NCT02235311|527531934|FG001|Overall Study|Protocol Violation|1|||
146278211|NCT04655027|527531935|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
146278212|NCT04655027|527531936|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
146278213|NCT00658788|527531937|FG000|Overall Study|Adverse Event|11|||
146278214|NCT00658788|527531937|FG000|Overall Study|Withdrawal by Subject|13|||
146278215|NCT00658788|527531937|FG000|Overall Study|Lost to Follow-up|18|||
146278216|NCT00658788|527531937|FG000|Overall Study|Treatment Discontinuation|32|||
146278217|NCT00653523|527531938|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
146278218|NCT00653523|527531938|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
146278219|NCT00653523|527531938|FG000|Overall Study|Adverse Event|7|||
146278220|NCT00653523|527531938|FG000|Overall Study|Withdrawal by Subject|6|||
146278221|NCT00653523|527531938|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
146278222|NCT00653523|527531938|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
146278223|NCT03519997|527531941|FG000|Overall Study|Adverse Event|4|||
146278224|NCT03519997|527531941|FG000|Overall Study|Withdrawal by Subject|2|||
146278225|NCT03519997|527531941|FG000|Overall Study|Protocol Violation|1|||
146278226|NCT05543707|527531942|FG000|Overall Study|Study drug non-compliance/|5|||
146278227|NCT05543707|527531943|FG001|Overall Study|Study drug non-compliance/|0|||
146278228|NCT05543707|527531942|FG000|Overall Study|Withdrawal by Subject|1|||
146278229|NCT05543707|527531943|FG001|Overall Study|Withdrawal by Subject|1|||
146278230|NCT05543707|527531942|FG000|Overall Study|Adverse Event|1|||
146278231|NCT05543707|527531943|FG001|Overall Study|Adverse Event|0|||
146278232|NCT05543707|527531942|FG000|Overall Study|concurrent illness|0|||
146278233|NCT05543707|527531943|FG001|Overall Study|concurrent illness|1|||
146278234|NCT05543707|527531942|FG000|Overall Study|Pregnancy|1|||
146278235|NCT05543707|527531943|FG001|Overall Study|Pregnancy|1|||
146278236|NCT00186888|527531944|FG000|Overall Study|Toxicity|0|||
146278237|NCT00186888|527531945|FG001|Overall Study|Toxicity|1|||
146278238|NCT00186888|527531946|FG002|Overall Study|Toxicity|0|||
146278239|NCT00186888|527531944|FG000|Overall Study|Relapse or progression of disease|4|||
146278240|NCT00186888|527531945|FG001|Overall Study|Relapse or progression of disease|2|||
146278241|NCT00186888|527531946|FG002|Overall Study|Relapse or progression of disease|0|||
146278242|NCT03006848|527531947|FG000|Overall Study|Adverse Event|1|||
146278243|NCT03006848|527531947|FG000|Overall Study|Physician Decision|1|||
146278244|NCT03006848|527531947|FG000|Overall Study|Lack of Efficacy|16|||
146278245|NCT03898167|527531948|FG000|Overall Study|Terminated phone call early|7|||
146278246|NCT03898167|527531949|FG001|Overall Study|Terminated phone call early|0|||
146278247|NCT03898167|527531950|FG002|Overall Study|Terminated phone call early|0|||
146278248|NCT03898167|527531948|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
146278249|NCT03898167|527531949|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
146278250|NCT03898167|527531950|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
146278251|NCT00384397|527531952|FG000|Overall Study|Adverse Event|0|||
146278252|NCT00384397|527531953|FG001|Overall Study|Adverse Event|1|||
146278253|NCT00384397|527531954|FG002|Overall Study|Adverse Event|2|||
146278254|NCT00384397|527531952|FG000|Overall Study|Protocol Violation|7|||
146278255|NCT00384397|527531953|FG001|Overall Study|Protocol Violation|15|||
146278256|NCT00384397|527531954|FG002|Overall Study|Protocol Violation|13|||
146278257|NCT00384397|527531952|FG000|Overall Study|Lost to Follow-up|11|||
146278258|NCT00384397|527531953|FG001|Overall Study|Lost to Follow-up|13|||
146278259|NCT00384397|527531954|FG002|Overall Study|Lost to Follow-up|3|||
146304931|NCT00806195|527630929|FG002|Overall Study|Inappropriate Enrollment|0|||
146146186|NCT02610140|527047369|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
146146187|NCT02610140|527047370|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
146146188|NCT02610140|527047369|FG000|Randomization and Treatment Period|Not treated|3|||
146146189|NCT02610140|527047370|FG001|Randomization and Treatment Period|Not treated|10|||
146146190|NCT02610140|527047369|FG000|Safety Follow-up|Other|0|||
146146191|NCT02610140|527047370|FG001|Safety Follow-up|Other|2|||
146146192|NCT02610140|527047369|FG000|Safety Follow-up|Lost to Follow-up|1|||
146146193|NCT02610140|527047370|FG001|Safety Follow-up|Lost to Follow-up|0|||
146146194|NCT02610140|527047369|FG000|Safety Follow-up|No follow-up|5|||
146146195|NCT02610140|527047370|FG001|Safety Follow-up|No follow-up|3|||
146146196|NCT02610140|527047369|FG000|Safety Follow-up|Death|12|||
146146197|NCT02610140|527047370|FG001|Safety Follow-up|Death|2|||
146146198|NCT02610140|527047369|FG000|Safety Follow-up|Deterioration of general conditions|15|||
146146199|NCT02610140|527047370|FG001|Safety Follow-up|Deterioration of general conditions|5|||
146146200|NCT02610140|527047369|FG000|Safety Follow-up|Withdrawal by Subject|12|||
146146201|NCT02610140|527047370|FG001|Safety Follow-up|Withdrawal by Subject|12|||
146146202|NCT02610140|527047369|FG000|Active Follow-up|Progressive disease - radiological|30|||
146146203|NCT02610140|527047370|FG001|Active Follow-up|Progressive disease - radiological|22|||
146146204|NCT02610140|527047369|FG000|Active Follow-up|Death|8|||
146146205|NCT02610140|527047370|FG001|Active Follow-up|Death|1|||
146146206|NCT02610140|527047369|FG000|Active Follow-up|Withdrawal by Subject|4|||
146146207|NCT02610140|527047370|FG001|Active Follow-up|Withdrawal by Subject|0|||
146146208|NCT02610140|527047369|FG000|Active Follow-up|Progressive disease - clinical|1|||
146146209|NCT02610140|527047370|FG001|Active Follow-up|Progressive disease - clinical|2|||
146146210|NCT02610140|527047369|FG000|Active Follow-up|Deterioration of general conditions|1|||
146146211|NCT02610140|527047370|FG001|Active Follow-up|Deterioration of general conditions|0|||
146146212|NCT02610140|527047369|FG000|Active Follow-up|Ongoing but not completed|4|||
146146213|NCT02610140|527047370|FG001|Active Follow-up|Ongoing but not completed|1|||
146146214|NCT02610140|527047369|FG000|Long-term Follow-up|Death|86|||
146146215|NCT02610140|527047370|FG001|Long-term Follow-up|Death|44|||
146146216|NCT02610140|527047369|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
146146217|NCT02610140|527047370|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
146146218|NCT02610140|527047369|FG000|Long-term Follow-up|Lost to Follow-up|1|||
146146219|NCT02610140|527047370|FG001|Long-term Follow-up|Lost to Follow-up|2|||
146146220|NCT02610140|527047369|FG000|Long-term Follow-up|Ongoing but not completed|30|||
146146221|NCT02610140|527047370|FG001|Long-term Follow-up|Ongoing but not completed|17|||
146146222|NCT02617589|527047371|FG000|Randomization|Request to Discontinue Study Treatment|1|||
146146223|NCT02617589|527047372|FG001|Randomization|Request to Discontinue Study Treatment|3|||
146146224|NCT02617589|527047371|FG000|Randomization|Participant Withdrew Consent|1|||
146146225|NCT02617589|527047372|FG001|Randomization|Participant Withdrew Consent|2|||
146146226|NCT02617589|527047371|FG000|Treatment|Other Reasons|3|||
146146227|NCT02617589|527047372|FG001|Treatment|Other Reasons|3|||
146146228|NCT02617589|527047371|FG000|Treatment|Poor/Non Compliance|1|||
146146229|NCT02617589|527047372|FG001|Treatment|Poor/Non Compliance|1|||
146146230|NCT02617589|527047371|FG000|Treatment|Maximum Clinical Benefit|0|||
146146231|NCT02617589|527047372|FG001|Treatment|Maximum Clinical Benefit|2|||
146146232|NCT02617589|527047371|FG000|Treatment|Participant Withdrew Consent|2|||
146146233|NCT02617589|527047372|FG001|Treatment|Participant Withdrew Consent|6|||
146146234|NCT02617589|527047371|FG000|Treatment|Participant Request to Discontinue|12|||
146146235|NCT02617589|527047372|FG001|Treatment|Participant Request to Discontinue|21|||
146146236|NCT02617589|527047371|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
146146237|NCT02617589|527047372|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
146146238|NCT02617589|527047371|FG000|Treatment|Death|1|||
146146239|NCT02617589|527047372|FG001|Treatment|Death|1|||
146146240|NCT02617589|527047371|FG000|Treatment|Study Drug Toxicity|27|||
146146241|NCT02617589|527047372|FG001|Treatment|Study Drug Toxicity|20|||
146146242|NCT02617589|527047371|FG000|Treatment|Disease Progression|216|||
146146243|NCT02617589|527047372|FG001|Treatment|Disease Progression|136|||
146146244|NCT01975389|527047373|FG000|Overall Study|Adverse Event|10|||
146146245|NCT01975389|527047374|FG001|Overall Study|Adverse Event|6|||
146146246|NCT01975389|527047373|FG000|Overall Study|Death|61|||
146146247|NCT01975389|527047374|FG001|Overall Study|Death|54|||
146146248|NCT01975389|527047373|FG000|Overall Study|Lost to Follow-up|81|||
146146249|NCT01975389|527047374|FG001|Overall Study|Lost to Follow-up|86|||
146146250|NCT01975389|527047373|FG000|Overall Study|Withdrawal by Subject|90|||
146146251|NCT01975389|527047374|FG001|Overall Study|Withdrawal by Subject|76|||
146146252|NCT01975389|527047373|FG000|Overall Study|Other|6|||
146146253|NCT01975389|527047374|FG001|Overall Study|Other|9|||
146146254|NCT01975389|527047373|FG000|Overall Study|Randomized, not treated|4|||
146146255|NCT01975389|527047374|FG001|Overall Study|Randomized, not treated|5|||
146146256|NCT01312961|527047375|FG000|Overall Study|Adverse Event|3|||
146146257|NCT01312961|527047376|FG001|Overall Study|Adverse Event|3|||
146146258|NCT01312961|527047375|FG000|Overall Study|Lack of Efficacy|11|||
146304932|NCT00806195|527630930|FG003|Overall Study|Inappropriate Enrollment|0|||
146146259|NCT01312961|527047376|FG001|Overall Study|Lack of Efficacy|1|||
146146260|NCT01312961|527047375|FG000|Overall Study|Poor compliance to protocol|1|||
146146261|NCT01312961|527047376|FG001|Overall Study|Poor compliance to protocol|0|||
146146262|NCT01312961|527047375|FG000|Overall Study|Other than specified above|2|||
146146263|NCT01312961|527047376|FG001|Overall Study|Other than specified above|3|||
146146264|NCT02460198|527047378|FG000|Overall Study|Adverse Event|1|||
146146265|NCT02460198|527047379|FG001|Overall Study|Adverse Event|3|||
146146266|NCT02460198|527047378|FG000|Overall Study|Death|36|||
146146267|NCT02460198|527047379|FG001|Overall Study|Death|28|||
146146268|NCT02460198|527047378|FG000|Overall Study|Lost to Follow-up|1|||
146146269|NCT02460198|527047379|FG001|Overall Study|Lost to Follow-up|1|||
146146270|NCT02460198|527047378|FG000|Overall Study|Transferred to Extension Study|15|||
146146271|NCT02460198|527047379|FG001|Overall Study|Transferred to Extension Study|15|||
146146272|NCT02460198|527047378|FG000|Overall Study|Withdrawal by Subject|2|||
146146273|NCT02460198|527047379|FG001|Overall Study|Withdrawal by Subject|4|||
146278260|NCT00384397|527531952|FG000|Overall Study|Withdrawal by Subject|14|||
146278261|NCT00384397|527531953|FG001|Overall Study|Withdrawal by Subject|17|||
146278262|NCT00384397|527531954|FG002|Overall Study|Withdrawal by Subject|15|||
146278263|NCT01525238|527531955|FG000|Overall Study|Withdrawal by Subject|1|||
146278264|NCT01525238|527531956|FG001|Overall Study|Withdrawal by Subject|0|||
146278265|NCT01525238|527531957|FG002|Overall Study|Withdrawal by Subject|0|||
146278266|NCT01214642|527531958|FG000|Overall Study|Progressive Disease|3|||
146278267|NCT01214642|527531959|FG001|Overall Study|Progressive Disease|2|||
146278268|NCT01214642|527531960|FG002|Overall Study|Progressive Disease|3|||
146278269|NCT01214642|527531961|FG003|Overall Study|Progressive Disease|5|||
146278270|NCT01214642|527531962|FG004|Overall Study|Progressive Disease|5|||
146278271|NCT01214642|527531963|FG005|Overall Study|Progressive Disease|3|||
146278272|NCT01214642|527531964|FG006|Overall Study|Progressive Disease|5|||
146278273|NCT01214642|527531965|FG007|Overall Study|Progressive Disease|3|||
146278274|NCT01214642|527531966|FG008|Overall Study|Progressive Disease|10|||
146278275|NCT01214642|527531967|FG009|Overall Study|Progressive Disease|2|||
146278276|NCT01214642|527531968|FG010|Overall Study|Progressive Disease|1|||
146278277|NCT01214642|527531969|FG011|Overall Study|Progressive Disease|4|||
146278278|NCT01214642|527531958|FG000|Overall Study|Adverse Event|0|||
146278279|NCT01214642|527531959|FG001|Overall Study|Adverse Event|1|||
146278280|NCT01214642|527531960|FG002|Overall Study|Adverse Event|0|||
146278281|NCT01214642|527531961|FG003|Overall Study|Adverse Event|0|||
146278282|NCT01214642|527531962|FG004|Overall Study|Adverse Event|0|||
146278283|NCT01214642|527531963|FG005|Overall Study|Adverse Event|0|||
146278284|NCT01214642|527531964|FG006|Overall Study|Adverse Event|1|||
146278285|NCT01214642|527531965|FG007|Overall Study|Adverse Event|0|||
146278286|NCT01214642|527531966|FG008|Overall Study|Adverse Event|0|||
146278287|NCT01214642|527531967|FG009|Overall Study|Adverse Event|1|||
146278288|NCT01214642|527531968|FG010|Overall Study|Adverse Event|1|||
146278289|NCT01214642|527531969|FG011|Overall Study|Adverse Event|0|||
146278290|NCT01214642|527531958|FG000|Overall Study|Death|0|||
146278291|NCT01214642|527531959|FG001|Overall Study|Death|0|||
146278292|NCT01214642|527531960|FG002|Overall Study|Death|1|||
146278293|NCT01214642|527531961|FG003|Overall Study|Death|0|||
146278294|NCT01214642|527531962|FG004|Overall Study|Death|0|||
146278295|NCT01214642|527531963|FG005|Overall Study|Death|0|||
146278296|NCT01214642|527531964|FG006|Overall Study|Death|0|||
146278297|NCT01214642|527531965|FG007|Overall Study|Death|0|||
146278298|NCT01214642|527531966|FG008|Overall Study|Death|0|||
146278299|NCT01214642|527531967|FG009|Overall Study|Death|0|||
146278300|NCT01214642|527531968|FG010|Overall Study|Death|1|||
146278301|NCT01214642|527531969|FG011|Overall Study|Death|0|||
146278302|NCT01214642|527531958|FG000|Overall Study|Withdrawal by Subject|0|||
146278303|NCT01214642|527531959|FG001|Overall Study|Withdrawal by Subject|0|||
146278304|NCT01214642|527531960|FG002|Overall Study|Withdrawal by Subject|1|||
146278305|NCT01214642|527531961|FG003|Overall Study|Withdrawal by Subject|0|||
146278306|NCT01214642|527531962|FG004|Overall Study|Withdrawal by Subject|0|||
146278307|NCT01214642|527531963|FG005|Overall Study|Withdrawal by Subject|0|||
146278308|NCT01214642|527531964|FG006|Overall Study|Withdrawal by Subject|0|||
146278309|NCT01214642|527531965|FG007|Overall Study|Withdrawal by Subject|0|||
146278310|NCT01214642|527531966|FG008|Overall Study|Withdrawal by Subject|3|||
146278311|NCT01214642|527531967|FG009|Overall Study|Withdrawal by Subject|1|||
146278312|NCT01214642|527531968|FG010|Overall Study|Withdrawal by Subject|1|||
146278313|NCT01214642|527531969|FG011|Overall Study|Withdrawal by Subject|0|||
146278314|NCT01214642|527531958|FG000|Overall Study|Physician Decision|0|||
146278315|NCT01214642|527531959|FG001|Overall Study|Physician Decision|0|||
146146274|NCT02460198|527047378|FG000|Overall Study|Site Terminated By Sponsor|0|||
146146275|NCT02460198|527047379|FG001|Overall Study|Site Terminated By Sponsor|1|||
146146276|NCT02460198|527047378|FG000|Overall Study|Did Not Continue on Extension Study|6|||
146278316|NCT01214642|527531960|FG002|Overall Study|Physician Decision|1|||
146278317|NCT01214642|527531961|FG003|Overall Study|Physician Decision|1|||
146278318|NCT01214642|527531962|FG004|Overall Study|Physician Decision|1|||
146278319|NCT01214642|527531963|FG005|Overall Study|Physician Decision|0|||
146278320|NCT01214642|527531964|FG006|Overall Study|Physician Decision|0|||
146278321|NCT01214642|527531965|FG007|Overall Study|Physician Decision|0|||
146278322|NCT01214642|527531966|FG008|Overall Study|Physician Decision|0|||
146278323|NCT01214642|527531967|FG009|Overall Study|Physician Decision|0|||
146304933|NCT00806195|527630927|FG000|Overall Study|Administrative Reason|113|||
146304934|NCT00806195|527630928|FG001|Overall Study|Administrative Reason|35|||
146304935|NCT00806195|527630929|FG002|Overall Study|Administrative Reason|66|||
146304936|NCT00806195|527630930|FG003|Overall Study|Administrative Reason|26|||
146304937|NCT00806195|527630927|FG000|Overall Study|Protocol Violation|34|||
146304938|NCT00806195|527630928|FG001|Overall Study|Protocol Violation|24|||
146304939|NCT00806195|527630929|FG002|Overall Study|Protocol Violation|26|||
146304940|NCT00806195|527630930|FG003|Overall Study|Protocol Violation|9|||
146304941|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
146304942|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146304943|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146304944|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
146304945|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
146304946|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146304947|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146304948|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
146304949|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
146304950|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146304951|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146304952|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
146304953|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
146304954|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146304955|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146304956|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
146304957|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
146304958|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
146304959|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
146304960|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
146304961|NCT02752035|527630933|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
146304962|NCT02752035|527630934|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146304963|NCT02752035|527630935|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146304964|NCT02752035|527630936|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
146304965|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
146304966|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
146304967|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
146304968|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
146304969|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
146304970|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
146304971|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
146304972|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
146304973|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
146304974|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
146304975|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
146304976|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
146304977|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
146304978|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
146304979|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
146304980|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
146304981|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
146304982|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
146304983|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
146304984|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
146304985|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Death|0|||
146304986|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Death|25|||
146304987|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Death|13|||
146304988|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Death|4|||
146304989|NCT02752035|527630933|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
146304990|NCT02752035|527630934|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
146304991|NCT02752035|527630935|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
146304992|NCT02752035|527630936|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
146304993|NCT02752035|527630933|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
146304994|NCT02752035|527630934|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
146304995|NCT02752035|527630935|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
146304996|NCT02752035|527630936|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
146304997|NCT02752035|527630933|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
146304998|NCT02752035|527630934|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
146304999|NCT02752035|527630935|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
146305000|NCT02752035|527630936|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
146305001|NCT02752035|527630933|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
146305002|NCT02752035|527630934|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
146305003|NCT02752035|527630935|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
146305004|NCT02752035|527630936|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
146305005|NCT02752035|527630933|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146305006|NCT02752035|527630934|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
146305007|NCT02752035|527630935|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146305008|NCT02752035|527630936|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
146305009|NCT01519934|527630937|FG000|Overall Study|Lost to Follow-up|3|||
146305010|NCT01161043|527630938|FG000|Overall Study|Withdrawal by Subject|3|||
146305011|NCT02161575|527630940|FG000|Overall Study|Protocol Violation|8|||
146305012|NCT02161575|527630940|FG000|Overall Study|Lack of Efficacy|1|||
146305013|NCT02161575|527630940|FG000|Overall Study|Adverse Event|2|||
146305014|NCT01231659|527630950|FG000|Overall Study|Adverse Event|9|||
146305015|NCT01231659|527630950|FG000|Overall Study|Disease Progression|48|||
146305016|NCT01231659|527630950|FG000|Overall Study|Death|2|||
146305017|NCT01231659|527630950|FG000|Overall Study|Patient refused to complete study visit|1|||
146305018|NCT01231659|527630950|FG000|Overall Study|Other protocol defined criteria|12|||
146305019|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
146305020|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
146305021|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
146305022|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
146305023|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
146305024|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
146305025|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
146305026|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
146305027|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
146305028|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
146305029|NCT01299376|527630951|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
146305030|NCT01299376|527630952|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
146305031|NCT01299376|527630951|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
146305032|NCT01299376|527630952|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
146305033|NCT01299376|527630951|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
146305034|NCT01299376|527630952|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
146305035|NCT01299376|527630951|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
146305036|NCT01299376|527630952|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
146305037|NCT01299376|527630951|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
146305038|NCT01299376|527630952|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
146305039|NCT01299376|527630951|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
146305040|NCT01299376|527630952|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
146305041|NCT03680911|527630953|FG000|At Home Treatment|Study Termination|3|||
146305042|NCT03680911|527630954|FG001|At Home Treatment|Study Termination|0|||
146305043|NCT03680911|527630953|FG000|At Home Treatment|Lost to Follow-up|0|||
146305044|NCT03680911|527630954|FG001|At Home Treatment|Lost to Follow-up|1|||
146305045|NCT03680911|527630953|FG000|At Home Treatment|Withdrawal by Subject|0|||
146305046|NCT03680911|527630954|FG001|At Home Treatment|Withdrawal by Subject|2|||
146305047|NCT03680911|527630953|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
146305048|NCT03680911|527630954|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
146305049|NCT03962738|527630955|FG000|Overall Study|Protocol Deviation|3|||
146305050|NCT03962738|527630956|FG001|Overall Study|Protocol Deviation|0|||
146305051|NCT03962738|527630957|FG002|Overall Study|Protocol Deviation|1|||
146305052|NCT03962738|527630958|FG003|Overall Study|Protocol Deviation|1|||
146305053|NCT03962738|527630955|FG000|Overall Study|Withdrawal by Subject|4|||
146305054|NCT03962738|527630956|FG001|Overall Study|Withdrawal by Subject|0|||
146305055|NCT03962738|527630957|FG002|Overall Study|Withdrawal by Subject|0|||
146305056|NCT03962738|527630958|FG003|Overall Study|Withdrawal by Subject|0|||
146305057|NCT03962738|527630955|FG000|Overall Study|Lost to Follow-up|0|||
146305058|NCT03962738|527630956|FG001|Overall Study|Lost to Follow-up|0|||
146305059|NCT03962738|527630957|FG002|Overall Study|Lost to Follow-up|1|||
146305060|NCT03962738|527630958|FG003|Overall Study|Lost to Follow-up|0|||
146305061|NCT00702325|527630970|FG000|Overall Study|Adverse Event|1|||
146305062|NCT00702325|527630971|FG001|Overall Study|Adverse Event|0|||
146305063|NCT00702325|527630970|FG000|Overall Study|Withdrawal by Subject|7|||
146305064|NCT00702325|527630971|FG001|Overall Study|Withdrawal by Subject|7|||
146305065|NCT00702325|527630970|FG000|Overall Study|Lost to Follow-up|3|||
146305066|NCT00702325|527630971|FG001|Overall Study|Lost to Follow-up|4|||
146305067|NCT00702325|527630970|FG000|Overall Study|Incorrect enrollment|5|||
146305068|NCT00702325|527630971|FG001|Overall Study|Incorrect enrollment|7|||
146305069|NCT00702325|527630970|FG000|Overall Study|Developed study discontinuation criteria|18|||
146305070|NCT00702325|527630971|FG001|Overall Study|Developed study discontinuation criteria|28|||
146305071|NCT00702325|527630970|FG000|Overall Study|Severe noncompliance to protocol|3|||
146305072|NCT00702325|527630971|FG001|Overall Study|Severe noncompliance to protocol|3|||
146305073|NCT00702325|527630970|FG000|Overall Study|Termination due to lab results|1|||
146305074|NCT00702325|527630971|FG001|Overall Study|Termination due to lab results|0|||
146305075|NCT00702325|527630970|FG000|Overall Study|Didn't follow study medication dosage|0|||
146305076|NCT00702325|527630971|FG001|Overall Study|Didn't follow study medication dosage|2|||
146305077|NCT00702325|527630970|FG000|Overall Study|Withdrew consent|0|||
146305078|NCT00702325|527630971|FG001|Overall Study|Withdrew consent|1|||
146305079|NCT00702325|527630970|FG000|Overall Study|Incorrectly Discontinued|0|||
146305080|NCT00702325|527630971|FG001|Overall Study|Incorrectly Discontinued|1|||
146305081|NCT04556136|527630975|FG000|Overall Study|Lost to Follow-up|6|||
146305082|NCT04556136|527630976|FG001|Overall Study|Lost to Follow-up|6|||
146305083|NCT04556136|527630975|FG000|Overall Study|Physician Decision|2|||
146305084|NCT04556136|527630976|FG001|Overall Study|Physician Decision|1|||
146305085|NCT04556136|527630975|FG000|Overall Study|Withdrawal by Subject|2|||
146305086|NCT04556136|527630976|FG001|Overall Study|Withdrawal by Subject|1|||
146305087|NCT01022502|527630979|FG000|Overall Study|Adverse Event|1|||
146305088|NCT01022502|527630979|FG000|Overall Study|employment related reasons|1|||
146305089|NCT01022502|527630979|FG000|Overall Study|Withdrawal by Subject|1|||
146305090|NCT02566577|527630980|FG000|Overall Study|Withdrawal by Subject|1|||
146305091|NCT02566577|527630981|FG001|Overall Study|Withdrawal by Subject|1|||
146305092|NCT02566577|527630980|FG000|Overall Study|Equipment failure|1|||
146305093|NCT02566577|527630981|FG001|Overall Study|Equipment failure|1|||
146305094|NCT02566577|527630980|FG000|Overall Study|Physical limitation|1|||
146305095|NCT02566577|527630981|FG001|Overall Study|Physical limitation|0|||
146305096|NCT00073528|527630991|FG000|Overall Study|Death|488|||
146305097|NCT00073528|527630992|FG001|Overall Study|Death|473|||
146305098|NCT00073528|527630991|FG000|Overall Study|Lost to Follow-up|52|||
146305099|NCT00073528|527630992|FG001|Overall Study|Lost to Follow-up|45|||
146146277|NCT02460198|527047379|FG001|Overall Study|Did Not Continue on Extension Study|11|||
146146278|NCT00931307|527047380|FG000|Overall Study|Lack of Efficacy|12|||
146278324|NCT01214642|527531968|FG010|Overall Study|Physician Decision|0|||
146278325|NCT01214642|527531969|FG011|Overall Study|Physician Decision|2|||
146278326|NCT04696653|527531972|FG000|Overall Study|left organization|18|||
146278327|NCT04696653|527531972|FG000|Overall Study|Lost to Follow-up|3|||
146278328|NCT01946529|527531973|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
146278329|NCT01946529|527531974|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
146278330|NCT01946529|527531975|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
146278331|NCT01946529|527531973|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
146278332|NCT01946529|527531974|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
146278333|NCT01946529|527531975|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
146278334|NCT03826030|527531985|FG000|Overall Study|Withdrawal by Subject|2|||
146278335|NCT03826030|527531986|FG001|Overall Study|Withdrawal by Subject|0|||
146278336|NCT03826030|527531987|FG002|Overall Study|Withdrawal by Subject|1|||
146278337|NCT03826030|527531985|FG000|Overall Study|Lost to Follow-up|1|||
146278338|NCT03826030|527531986|FG001|Overall Study|Lost to Follow-up|1|||
146278339|NCT03826030|527531987|FG002|Overall Study|Lost to Follow-up|1|||
146278340|NCT03826030|527531985|FG000|Overall Study|Too busy to return for visits|1|||
146278341|NCT03826030|527531986|FG001|Overall Study|Too busy to return for visits|0|||
146278342|NCT03826030|527531987|FG002|Overall Study|Too busy to return for visits|0|||
146278343|NCT02218606|527534269|FG000|Overall Study|Adverse Event|1|||
146278344|NCT02218606|527534270|FG001|Overall Study|Adverse Event|1|||
146278345|NCT02218606|527534269|FG000|Overall Study|Death|15|||
146278346|NCT02218606|527534270|FG001|Overall Study|Death|28|||
146278347|NCT02218606|527534269|FG000|Overall Study|Physician Decision|0|||
146278348|NCT02218606|527534270|FG001|Overall Study|Physician Decision|1|||
146278349|NCT02218606|527534269|FG000|Overall Study|Withdrawal by Subject|4|||
146278350|NCT02218606|527534270|FG001|Overall Study|Withdrawal by Subject|0|||
146278351|NCT02218606|527534269|FG000|Overall Study|Noncompliance|1|||
146278352|NCT02218606|527534270|FG001|Overall Study|Noncompliance|0|||
146278353|NCT02218606|527534269|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
146278354|NCT02218606|527534270|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
146278355|NCT02218606|527534269|FG000|Overall Study|Other|2|||
146278356|NCT02218606|527534270|FG001|Overall Study|Other|1|||
146278357|NCT02218606|527534269|FG000|Overall Study|Never started treatment|0|||
146278358|NCT02218606|527534270|FG001|Overall Study|Never started treatment|1|||
146278359|NCT03203473|527534271|FG000|Induction Phase|Never started primary treatment|2|||
146278360|NCT03203473|527534272|FG001|Induction Phase|Never started primary treatment|0|||
146278361|NCT03203473|527534273|FG002|Induction Phase|Never started primary treatment|0|||
146278362|NCT03203473|527534271|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
146305100|NCT00073528|527630991|FG000|Overall Study|Withdrawal by Subject|50|||
146305101|NCT00073528|527630992|FG001|Overall Study|Withdrawal by Subject|45|||
146305102|NCT00073528|527630991|FG000|Overall Study|Study terminated by Sponsor|10|||
146305103|NCT00073528|527630992|FG001|Overall Study|Study terminated by Sponsor|29|||
146305104|NCT00073528|527630991|FG000|Overall Study|Other|18|||
146305105|NCT00073528|527630992|FG001|Overall Study|Other|19|||
146305106|NCT00073528|527630991|FG000|Overall Study|Other|9|||
146146279|NCT00931307|527047380|FG000|Overall Study|Biomicroscopy|1|||
146146280|NCT00691210|527047381|FG000|Overall Study|Progression of Disease|0|||
146146281|NCT00691210|527047382|FG001|Overall Study|Progression of Disease|0|||
146146282|NCT00691210|527047383|FG002|Overall Study|Progression of Disease|0|||
146146283|NCT00691210|527047384|FG003|Overall Study|Progression of Disease|2|||
146146284|NCT00691210|527047385|FG004|Overall Study|Progression of Disease|0|||
146146285|NCT00691210|527047386|FG005|Overall Study|Progression of Disease|0|||
146146286|NCT00691210|527047387|FG006|Overall Study|Progression of Disease|0|||
146146287|NCT00691210|527047388|FG007|Overall Study|Progression of Disease|0|||
146146288|NCT00691210|527047381|FG000|Overall Study|Lack of Efficacy|0|||
146146289|NCT00691210|527047382|FG001|Overall Study|Lack of Efficacy|0|||
146146290|NCT00691210|527047383|FG002|Overall Study|Lack of Efficacy|0|||
146146291|NCT00691210|527047384|FG003|Overall Study|Lack of Efficacy|1|||
146146292|NCT00691210|527047385|FG004|Overall Study|Lack of Efficacy|0|||
146146293|NCT00691210|527047386|FG005|Overall Study|Lack of Efficacy|1|||
146146294|NCT00691210|527047387|FG006|Overall Study|Lack of Efficacy|0|||
146278363|NCT03203473|527534272|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
146278364|NCT03203473|527534273|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
146278365|NCT03203473|527534271|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
146278366|NCT03203473|527534272|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
146278367|NCT03203473|527534273|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
146278368|NCT03203473|527534271|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
146278369|NCT03203473|527534272|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
146278370|NCT03203473|527534273|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
146278371|NCT03203473|527534271|FG000|Arm Allocation Phase|started salvage therapy|0|||
146278372|NCT03203473|527534272|FG001|Arm Allocation Phase|started salvage therapy|5|||
146278373|NCT03203473|527534273|FG002|Arm Allocation Phase|started salvage therapy|0|||
146278374|NCT03203473|527534271|FG000|Arm Allocation Phase|Disease progression|0|||
146278375|NCT03203473|527534272|FG001|Arm Allocation Phase|Disease progression|0|||
146278376|NCT03203473|527534273|FG002|Arm Allocation Phase|Disease progression|37|||
146278377|NCT03203473|527534271|FG000|Arm Allocation Phase|Adverse Event|0|||
146278378|NCT03203473|527534272|FG001|Arm Allocation Phase|Adverse Event|0|||
146278379|NCT03203473|527534273|FG002|Arm Allocation Phase|Adverse Event|11|||
146278380|NCT03203473|527534271|FG000|Arm Allocation Phase|Physician Decision|0|||
146278381|NCT03203473|527534272|FG001|Arm Allocation Phase|Physician Decision|0|||
146278382|NCT03203473|527534273|FG002|Arm Allocation Phase|Physician Decision|3|||
146278383|NCT03203473|527534271|FG000|Arm Allocation Phase|Death|0|||
146278384|NCT03203473|527534272|FG001|Arm Allocation Phase|Death|0|||
146278385|NCT03203473|527534273|FG002|Arm Allocation Phase|Death|1|||
146278386|NCT03203473|527534271|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
146278387|NCT03203473|527534272|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
146278388|NCT03203473|527534273|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
146278389|NCT03203473|527534271|FG000|Arm Allocation Phase|Intercurrent illness|0|||
146278390|NCT03203473|527534272|FG001|Arm Allocation Phase|Intercurrent illness|0|||
146278391|NCT03203473|527534273|FG002|Arm Allocation Phase|Intercurrent illness|1|||
146278392|NCT03203473|527534271|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
146278393|NCT03203473|527534272|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
146278394|NCT03203473|527534273|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
146278395|NCT02314780|527534278|FG000|Overall Study|organizational reasons|0|||
146278396|NCT02314780|527534279|FG001|Overall Study|organizational reasons|2|||
146278397|NCT02314780|527534280|FG002|Overall Study|organizational reasons|0|||
146278398|NCT02314780|527534278|FG000|Overall Study|Adverse Event|0|||
146278399|NCT02314780|527534279|FG001|Overall Study|Adverse Event|1|||
146278400|NCT02314780|527534280|FG002|Overall Study|Adverse Event|0|||
146278401|NCT01077271|527534284|FG000|Overall Study|Parental desire|8|||
146278402|NCT01077271|527534284|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
146278403|NCT01077271|527534284|FG000|Overall Study|Noncompliance|2|||
146278404|NCT01077271|527534284|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
146278405|NCT01077271|527534284|FG000|Overall Study|Changed doctors|2|||
146278406|NCT01077271|527534284|FG000|Overall Study|Parents thought too many injections|2|||
146278407|NCT01077271|527534284|FG000|Overall Study|End of RSV season nearly reached|1|||
146278408|NCT01077271|527534284|FG000|Overall Study|Mother unconvinced of the necessity|1|||
146278409|NCT00215137|527534285|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
146278410|NCT00215137|527534286|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
146278411|NCT00215137|527534287|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
146278412|NCT00215137|527534285|FG000|Randomization Period|Lost to Follow-up|0|||
146278413|NCT00215137|527534286|FG001|Randomization Period|Lost to Follow-up|1|||
146278414|NCT00215137|527534287|FG002|Randomization Period|Lost to Follow-up|0|||
146278415|NCT00215137|527534285|FG000|Randomization Period|Withdrawal by Subject|0|||
146278416|NCT00215137|527534286|FG001|Randomization Period|Withdrawal by Subject|1|||
146278417|NCT00215137|527534287|FG002|Randomization Period|Withdrawal by Subject|0|||
146278418|NCT03333876|527534288|FG000|Screening Period|Screen Failure|4|||
146278419|NCT03333876|527534288|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
146146295|NCT00691210|527047388|FG007|Overall Study|Lack of Efficacy|0|||
146305107|NCT00073528|527630992|FG001|Overall Study|Other|12|||
146305108|NCT00073528|527630991|FG000|Overall Study|Protocol Violation|3|||
146305109|NCT00073528|527630992|FG001|Overall Study|Protocol Violation|5|||
146305110|NCT00003702|527630995|FG000|Overall Study|Ineligible cell types|2|||
146305111|NCT00003702|527630996|FG001|Overall Study|Ineligible cell types|2|||
146305112|NCT00003702|527630995|FG000|Overall Study|Did not meet criteria for persistence|8|||
146305113|NCT00003702|527630996|FG001|Overall Study|Did not meet criteria for persistence|5|||
146305114|NCT00003702|527630995|FG000|Overall Study|WHO score > 6|2|||
146305115|NCT00003702|527630996|FG001|Overall Study|WHO score > 6|1|||
146305116|NCT00003702|527630995|FG000|Overall Study|Inadequate documentation of disease|1|||
146305117|NCT00003702|527630996|FG001|Overall Study|Inadequate documentation of disease|3|||
146305118|NCT02790138|527630999|FG000|Overall Study|Adverse Event|5|||
146305119|NCT02790138|527631000|FG001|Overall Study|Adverse Event|2|||
146305120|NCT02790138|527630999|FG000|Overall Study|Significant Protocol Deviation|0|||
146305121|NCT02790138|527631000|FG001|Overall Study|Significant Protocol Deviation|1|||
146305122|NCT02790138|527630999|FG000|Overall Study|Lost to Follow-up|1|||
146305123|NCT02790138|527631000|FG001|Overall Study|Lost to Follow-up|0|||
146305124|NCT02790138|527630999|FG000|Overall Study|Voluntary Withdrawal|8|||
146305125|NCT02790138|527631000|FG001|Overall Study|Voluntary Withdrawal|9|||
146305126|NCT02790138|527630999|FG000|Overall Study|Lack of Efficacy|6|||
146305127|NCT02790138|527631000|FG001|Overall Study|Lack of Efficacy|7|||
146305128|NCT02790138|527630999|FG000|Overall Study|Reason not Specified|1|||
146305129|NCT02790138|527631000|FG001|Overall Study|Reason not Specified|0|||
146305130|NCT03199040|527631001|FG000|Overall Study|Lack of Efficacy|2|||
146305131|NCT03199040|527631002|FG001|Overall Study|Lack of Efficacy|0|||
146305132|NCT03199040|527631001|FG000|Overall Study|Withdrawal by Subject|2|||
146305133|NCT03199040|527631002|FG001|Overall Study|Withdrawal by Subject|0|||
146305134|NCT03199040|527631001|FG000|Overall Study|Adverse Event|0|||
146305135|NCT03199040|527631002|FG001|Overall Study|Adverse Event|1|||
146305136|NCT03199040|527631001|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
146305137|NCT03199040|527631002|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
146305138|NCT01226459|527631003|FG000|Overall Study|Adverse Event|2|||
146305139|NCT01226459|527631004|FG001|Overall Study|Adverse Event|8|||
146305140|NCT01226459|527631003|FG000|Overall Study|Protocol Violation|4|||
146305141|NCT01226459|527631004|FG001|Overall Study|Protocol Violation|3|||
146305142|NCT01226459|527631003|FG000|Overall Study|Withdrawal by Subject|10|||
146305143|NCT01226459|527631004|FG001|Overall Study|Withdrawal by Subject|13|||
146305144|NCT01226459|527631003|FG000|Overall Study|Lost to Follow-up|4|||
146305145|NCT01226459|527631004|FG001|Overall Study|Lost to Follow-up|8|||
146305146|NCT01226459|527631003|FG000|Overall Study|Pregnancy|1|||
146305147|NCT01226459|527631004|FG001|Overall Study|Pregnancy|0|||
146305148|NCT00474708|527631005|FG000|Overall Study|Lack of Efficacy|11|||
146305149|NCT00474708|527631006|FG001|Overall Study|Lack of Efficacy|5|||
146305150|NCT00474708|527631005|FG000|Overall Study|Suicide ideation/behavior|0|||
146305151|NCT00474708|527631006|FG001|Overall Study|Suicide ideation/behavior|1|||
146305152|NCT00474708|527631005|FG000|Overall Study|Withdrawal by Subject|7|||
146305153|NCT00474708|527631006|FG001|Overall Study|Withdrawal by Subject|0|||
146305154|NCT00474708|527631005|FG000|Overall Study|Lack of compliance|12|||
146305155|NCT00474708|527631006|FG001|Overall Study|Lack of compliance|4|||
146305156|NCT00474708|527631005|FG000|Overall Study|Lost to Follow-up|18|||
146305157|NCT00474708|527631006|FG001|Overall Study|Lost to Follow-up|9|||
146305158|NCT00474708|527631005|FG000|Overall Study|Physician Decision|9|||
146305159|NCT00474708|527631006|FG001|Overall Study|Physician Decision|6|||
146305160|NCT01092143|527631007|FG000|Overall Study|Adverse Event|10|||
146305161|NCT01092143|527631008|FG001|Overall Study|Adverse Event|5|||
146305162|NCT01092143|527631009|FG002|Overall Study|Adverse Event|1|||
146305163|NCT01092143|527631010|FG003|Overall Study|Adverse Event|4|||
146305164|NCT01092143|527631011|FG004|Overall Study|Adverse Event|3|||
146305165|NCT01092143|527631007|FG000|Overall Study|Lost to Follow-up|1|||
146305166|NCT01092143|527631008|FG001|Overall Study|Lost to Follow-up|0|||
146305167|NCT01092143|527631009|FG002|Overall Study|Lost to Follow-up|1|||
146305168|NCT01092143|527631010|FG003|Overall Study|Lost to Follow-up|0|||
146305169|NCT01092143|527631011|FG004|Overall Study|Lost to Follow-up|0|||
146305170|NCT01092143|527631007|FG000|Overall Study|Consent withdrawn|2|||
146305171|NCT01092143|527631008|FG001|Overall Study|Consent withdrawn|1|||
146305172|NCT01092143|527631009|FG002|Overall Study|Consent withdrawn|0|||
146305173|NCT01092143|527631010|FG003|Overall Study|Consent withdrawn|1|||
146305174|NCT01092143|527631011|FG004|Overall Study|Consent withdrawn|3|||
146305175|NCT01092143|527631007|FG000|Overall Study|Not treated|0|||
146305176|NCT01092143|527631008|FG001|Overall Study|Not treated|0|||
146305177|NCT01092143|527631009|FG002|Overall Study|Not treated|1|||
146305178|NCT01092143|527631010|FG003|Overall Study|Not treated|0|||
146305179|NCT01092143|527631011|FG004|Overall Study|Not treated|0|||
146305180|NCT01092143|527631007|FG000|Overall Study|did not reversibility criteria|0|||
146305181|NCT01092143|527631008|FG001|Overall Study|did not reversibility criteria|0|||
146305182|NCT01092143|527631009|FG002|Overall Study|did not reversibility criteria|1|||
146305183|NCT01092143|527631010|FG003|Overall Study|did not reversibility criteria|0|||
146305184|NCT01092143|527631011|FG004|Overall Study|did not reversibility criteria|0|||
146146296|NCT01208233|527047389|FG000|Overall Study|Adverse Event|0|||
146146297|NCT01208233|527047390|FG001|Overall Study|Adverse Event|1|||
146146298|NCT01208233|527047391|FG002|Overall Study|Adverse Event|2|||
146146299|NCT01208233|527047392|FG003|Overall Study|Adverse Event|0|||
146146300|NCT01208233|527047393|FG004|Overall Study|Adverse Event|3|||
146146301|NCT01208233|527047394|FG005|Overall Study|Adverse Event|5|||
146146302|NCT01208233|527047389|FG000|Overall Study|Death|0|||
146146303|NCT01208233|527047390|FG001|Overall Study|Death|0|||
146146304|NCT01208233|527047391|FG002|Overall Study|Death|0|||
146146305|NCT01208233|527047392|FG003|Overall Study|Death|0|||
146146306|NCT01208233|527047393|FG004|Overall Study|Death|3|||
146146307|NCT01208233|527047394|FG005|Overall Study|Death|5|||
146146308|NCT01208233|527047389|FG000|Overall Study|Did not meet entrance criteria|2|||
146146309|NCT01208233|527047390|FG001|Overall Study|Did not meet entrance criteria|1|||
146146310|NCT01208233|527047391|FG002|Overall Study|Did not meet entrance criteria|1|||
146146311|NCT01208233|527047392|FG003|Overall Study|Did not meet entrance criteria|0|||
146146312|NCT01208233|527047393|FG004|Overall Study|Did not meet entrance criteria|1|||
146146313|NCT01208233|527047394|FG005|Overall Study|Did not meet entrance criteria|0|||
146146314|NCT01208233|527047389|FG000|Overall Study|Medication error without adverse event|0|||
146146315|NCT01208233|527047390|FG001|Overall Study|Medication error without adverse event|0|||
146146316|NCT01208233|527047391|FG002|Overall Study|Medication error without adverse event|0|||
146146317|NCT01208233|527047392|FG003|Overall Study|Medication error without adverse event|0|||
146146318|NCT01208233|527047393|FG004|Overall Study|Medication error without adverse event|0|||
146146319|NCT01208233|527047394|FG005|Overall Study|Medication error without adverse event|1|||
146146320|NCT01208233|527047389|FG000|Overall Study|Study terminated by sponsor|0|||
146146321|NCT01208233|527047390|FG001|Overall Study|Study terminated by sponsor|0|||
146146322|NCT01208233|527047391|FG002|Overall Study|Study terminated by sponsor|0|||
146146323|NCT01208233|527047392|FG003|Overall Study|Study terminated by sponsor|0|||
146146324|NCT01208233|527047393|FG004|Overall Study|Study terminated by sponsor|10|||
146146325|NCT01208233|527047394|FG005|Overall Study|Study terminated by sponsor|7|||
146146326|NCT01208233|527047389|FG000|Overall Study|Protocol Violation|0|||
146146327|NCT01208233|527047390|FG001|Overall Study|Protocol Violation|0|||
146146328|NCT01208233|527047391|FG002|Overall Study|Protocol Violation|0|||
146146329|NCT01208233|527047392|FG003|Overall Study|Protocol Violation|0|||
146146330|NCT01208233|527047393|FG004|Overall Study|Protocol Violation|3|||
146146331|NCT01208233|527047394|FG005|Overall Study|Protocol Violation|0|||
146146332|NCT01208233|527047389|FG000|Overall Study|Other|2|||
146146333|NCT01208233|527047390|FG001|Overall Study|Other|1|||
146146334|NCT01208233|527047391|FG002|Overall Study|Other|0|||
146146335|NCT01208233|527047392|FG003|Overall Study|Other|0|||
146146336|NCT01208233|527047393|FG004|Overall Study|Other|0|||
146146337|NCT01208233|527047394|FG005|Overall Study|Other|1|||
146146338|NCT01208233|527047389|FG000|Overall Study|Withdrawal by Subject|1|||
146146339|NCT01208233|527047390|FG001|Overall Study|Withdrawal by Subject|0|||
146146340|NCT01208233|527047391|FG002|Overall Study|Withdrawal by Subject|1|||
146146341|NCT01208233|527047392|FG003|Overall Study|Withdrawal by Subject|1|||
146146342|NCT01208233|527047393|FG004|Overall Study|Withdrawal by Subject|4|||
146146343|NCT01208233|527047394|FG005|Overall Study|Withdrawal by Subject|2|||
146146344|NCT01181895|527047395|FG000|Overall Study|Adverse Event|3|||
146146345|NCT01181895|527047396|FG001|Overall Study|Adverse Event|1|||
146146346|NCT01181895|527047397|FG002|Overall Study|Adverse Event|1|||
146146347|NCT01181895|527047395|FG000|Overall Study|Lack of Efficacy|8|||
146146348|NCT01181895|527047396|FG001|Overall Study|Lack of Efficacy|9|||
146146349|NCT01181895|527047397|FG002|Overall Study|Lack of Efficacy|9|||
146146350|NCT01181895|527047395|FG000|Overall Study|Protocol Violation|2|||
146146351|NCT01181895|527047396|FG001|Overall Study|Protocol Violation|1|||
146305185|NCT01092143|527631007|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
146305186|NCT01092143|527631008|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
146305187|NCT01092143|527631009|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
146305188|NCT01092143|527631010|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
146305189|NCT01092143|527631011|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
146146352|NCT01181895|527047397|FG002|Overall Study|Protocol Violation|0|||
146146353|NCT01181895|527047395|FG000|Overall Study|Lost to Follow-up|0|||
146146354|NCT01181895|527047396|FG001|Overall Study|Lost to Follow-up|1|||
146146355|NCT01181895|527047397|FG002|Overall Study|Lost to Follow-up|2|||
146146356|NCT01181895|527047395|FG000|Overall Study|Investigator Discretion|1|||
146305190|NCT01092143|527631007|FG000|Overall Study|Ineligible patient|1|||
146146357|NCT01181895|527047396|FG001|Overall Study|Investigator Discretion|2|||
146146358|NCT01181895|527047397|FG002|Overall Study|Investigator Discretion|1|||
146305191|NCT01092143|527631008|FG001|Overall Study|Ineligible patient|0|||
146146359|NCT01181895|527047395|FG000|Overall Study|Withdrawal by Subject|3|||
146146360|NCT01181895|527047396|FG001|Overall Study|Withdrawal by Subject|0|||
146146361|NCT01181895|527047397|FG002|Overall Study|Withdrawal by Subject|5|||
146146362|NCT00555438|527047400|FG000|10 Days Post-operative|Death|4|||
146146363|NCT00555438|527047400|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
146146364|NCT02758236|527047403|FG000|Overall Study|Investigator discretion|43|||
146146365|NCT00023452|527047404|FG000|Overall Study|Ineligible for Study|163|||
146146366|NCT00023452|527047405|FG001|Overall Study|Ineligible for Study|159|||
146146367|NCT00023452|527047404|FG000|Overall Study|Out of Window|129|||
146146368|NCT00023452|527047405|FG001|Overall Study|Out of Window|69|||
146146369|NCT00023452|527047404|FG000|Overall Study|Death|2|||
146146370|NCT00023452|527047405|FG001|Overall Study|Death|0|||
146146371|NCT00023452|527047404|FG000|Overall Study|Withdrawal by Subject|66|||
146146372|NCT00023452|527047405|FG001|Overall Study|Withdrawal by Subject|54|||
146146373|NCT00023452|527047404|FG000|Overall Study|Adverse Event|139|||
146146374|NCT00023452|527047405|FG001|Overall Study|Adverse Event|196|||
146146375|NCT00023452|527047404|FG000|Overall Study|Lost to Follow-up|293|||
146146376|NCT00023452|527047405|FG001|Overall Study|Lost to Follow-up|60|||
146146377|NCT00023452|527047404|FG000|Overall Study|Physician Decision|49|||
146146378|NCT00023452|527047405|FG001|Overall Study|Physician Decision|21|||
146146379|NCT00023452|527047404|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
146146380|NCT00023452|527047405|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
146146381|NCT00023452|527047404|FG000|Overall Study|Pregnant|53|||
146146382|NCT00023452|527047405|FG001|Overall Study|Pregnant|20|||
146146383|NCT00023452|527047404|FG000|Overall Study|Other|204|||
146146384|NCT00023452|527047405|FG001|Overall Study|Other|69|||
146146385|NCT01940705|527047407|FG000|Overall Study|Lost to Follow-up|1|||
146146386|NCT01940705|527047408|FG001|Overall Study|Lost to Follow-up|3|||
146146387|NCT01940705|527047409|FG002|Overall Study|Lost to Follow-up|2|||
146146388|NCT01940705|527047410|FG003|Overall Study|Lost to Follow-up|2|||
146146389|NCT01940705|527047407|FG000|Overall Study|Withdrawal by Subject|2|||
146146390|NCT01940705|527047408|FG001|Overall Study|Withdrawal by Subject|2|||
146146391|NCT01940705|527047409|FG002|Overall Study|Withdrawal by Subject|3|||
146146392|NCT01940705|527047410|FG003|Overall Study|Withdrawal by Subject|2|||
146146393|NCT01940705|527047407|FG000|Overall Study|Intervention not given|0|||
146146394|NCT01940705|527047408|FG001|Overall Study|Intervention not given|3|||
146146395|NCT01940705|527047409|FG002|Overall Study|Intervention not given|3|||
146146396|NCT01940705|527047410|FG003|Overall Study|Intervention not given|0|||
146146397|NCT01940705|527047407|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
146146398|NCT01940705|527047408|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
146146399|NCT01940705|527047409|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
146146400|NCT01940705|527047410|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
146146401|NCT06748040|527047417|FG000|Overall Study|Death|3|||
146146402|NCT06748040|527047418|FG001|Overall Study|Death|4|||
146146403|NCT06748040|527047417|FG000|Overall Study|Lost to Follow-up|134|||
146146404|NCT06748040|527047418|FG001|Overall Study|Lost to Follow-up|132|||
146146405|NCT06748040|527047417|FG000|Overall Study|Withdrawal by Subject|3|||
146146406|NCT06748040|527047418|FG001|Overall Study|Withdrawal by Subject|5|||
146146407|NCT04419493|527048938|FG000|Wash-out After Period 1|Adverse Event|1|||
146146408|NCT04419493|527048939|FG001|Wash-out After Period 1|Adverse Event|2|||
146146409|NCT04419493|527048940|FG002|Wash-out After Period 1|Adverse Event|1|||
146146410|NCT04419493|527048941|FG003|Wash-out After Period 1|Adverse Event|0|||
146146411|NCT00524134|527048942|FG000|Overall Study|Withdrawal by Subject|1|||
146146412|NCT00524134|527048942|FG000|Overall Study|Physician Decision|1|||
146146413|NCT01782131|527048943|FG000|Overall Study|Death|93|||
146146414|NCT01782131|527048944|FG001|Overall Study|Death|96|||
146146415|NCT01782131|527048943|FG000|Overall Study|Lost to Follow-up|1|||
146146416|NCT01782131|527048944|FG001|Overall Study|Lost to Follow-up|3|||
146146417|NCT01782131|527048943|FG000|Overall Study|Withdrawal by Subject|10|||
146146418|NCT01782131|527048944|FG001|Overall Study|Withdrawal by Subject|10|||
146146419|NCT01782131|527048943|FG000|Overall Study|Randomized but not treated|5|||
146146420|NCT01782131|527048944|FG001|Overall Study|Randomized but not treated|5|||
146146421|NCT01782131|527048943|FG000|Overall Study|Reason not provided|0|||
146146422|NCT01782131|527048944|FG001|Overall Study|Reason not provided|1|||
146146423|NCT00796718|527048945|FG000|Overall Study|Adverse Event|2|||
146146424|NCT00796718|527048945|FG000|Overall Study|Exclusion Criteria|1|||
146146425|NCT00796718|527048945|FG000|Overall Study|Lost to Follow-up|5|||
146146426|NCT00796718|527048945|FG000|Overall Study|Withdrawal by Informed Consent|1|||
146146427|NCT02627677|527048947|FG000|Overall Study|Adverse event (not progressive disease)|1|||
146146428|NCT02627677|527048948|FG001|Overall Study|Adverse event (not progressive disease)|4|||
146146429|NCT02627677|527048949|FG002|Overall Study|Adverse event (not progressive disease)|1|||
146146430|NCT02627677|527048947|FG000|Overall Study|Progressive disease|1|||
146146431|NCT02627677|527048948|FG001|Overall Study|Progressive disease|3|||
146146432|NCT02627677|527048949|FG002|Overall Study|Progressive disease|0|||
146146433|NCT02627677|527048947|FG000|Overall Study|Lack of Efficacy|1|||
146146434|NCT02627677|527048948|FG001|Overall Study|Lack of Efficacy|2|||
146146435|NCT02627677|527048949|FG002|Overall Study|Lack of Efficacy|0|||
146146436|NCT02627677|527048947|FG000|Overall Study|Lost to Follow-up|0|||
146146437|NCT02627677|527048948|FG001|Overall Study|Lost to Follow-up|0|||
146146438|NCT02627677|527048949|FG002|Overall Study|Lost to Follow-up|1|||
146146439|NCT02627677|527048947|FG000|Overall Study|Pregnancy|0|||
146146440|NCT02627677|527048948|FG001|Overall Study|Pregnancy|1|||
146146441|NCT02627677|527048949|FG002|Overall Study|Pregnancy|0|||
146146442|NCT02627677|527048947|FG000|Overall Study|Study Terminated by Sponsor|5|||
146146443|NCT02627677|527048948|FG001|Overall Study|Study Terminated by Sponsor|10|||
146146444|NCT02627677|527048949|FG002|Overall Study|Study Terminated by Sponsor|6|||
146146445|NCT02627677|527048947|FG000|Overall Study|Physician Decision|0|||
146146446|NCT02627677|527048948|FG001|Overall Study|Physician Decision|0|||
146146447|NCT02627677|527048949|FG002|Overall Study|Physician Decision|2|||
146146448|NCT02627677|527048947|FG000|Overall Study|Withdrawal by Subject|2|||
146146449|NCT02627677|527048948|FG001|Overall Study|Withdrawal by Subject|1|||
146146450|NCT02627677|527048949|FG002|Overall Study|Withdrawal by Subject|1|||
146146451|NCT02627677|527048947|FG000|Overall Study|Reason not Specified|0|||
146146452|NCT02627677|527048948|FG001|Overall Study|Reason not Specified|0|||
146146453|NCT02627677|527048949|FG002|Overall Study|Reason not Specified|1|||
146146454|NCT02627677|527048947|FG000|Overall Study|Randomized but not Treated|1|||
146146455|NCT02627677|527048948|FG001|Overall Study|Randomized but not Treated|0|||
146146456|NCT02627677|527048949|FG002|Overall Study|Randomized but not Treated|0|||
146146457|NCT00317772|527048950|FG000|Overall Study|Adverse Event|0|||
146146458|NCT00317772|527048951|FG001|Overall Study|Adverse Event|0|||
146146459|NCT00317772|527048952|FG002|Overall Study|Adverse Event|0|||
146146460|NCT00317772|527048953|FG003|Overall Study|Adverse Event|2|||
146146461|NCT00317772|527048950|FG000|Overall Study|Disease Progression|2|||
146146462|NCT00317772|527048951|FG001|Overall Study|Disease Progression|2|||
146146463|NCT00317772|527048952|FG002|Overall Study|Disease Progression|1|||
146146464|NCT00317772|527048953|FG003|Overall Study|Disease Progression|7|||
146146465|NCT01073618|527048954|FG000|Overall Study|Death|208|||
146146466|NCT01073618|527048954|FG000|Overall Study|Adverse Event|19|||
146146467|NCT01073618|527048954|FG000|Overall Study|Other|80|||
146146468|NCT02696850|527048955|FG000|Overall Study|Withdrawal by Subject|3|||
146146469|NCT02696850|527048956|FG001|Overall Study|Withdrawal by Subject|3|||
146146470|NCT02696850|527048955|FG000|Overall Study|Lost to Follow-up|8|||
146146471|NCT02696850|527048956|FG001|Overall Study|Lost to Follow-up|5|||
146305192|NCT01092143|527631009|FG002|Overall Study|Ineligible patient|0|||
146305193|NCT01092143|527631010|FG003|Overall Study|Ineligible patient|0|||
146305194|NCT01092143|527631011|FG004|Overall Study|Ineligible patient|0|||
146305195|NCT01092143|527631007|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
146305196|NCT01092143|527631008|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
146305197|NCT01092143|527631009|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
146305198|NCT01092143|527631010|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
146305199|NCT01092143|527631011|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
146305200|NCT01092143|527631007|FG000|Overall Study|Patient travel|0|||
146305201|NCT01092143|527631008|FG001|Overall Study|Patient travel|0|||
146305202|NCT01092143|527631009|FG002|Overall Study|Patient travel|0|||
146305203|NCT01092143|527631010|FG003|Overall Study|Patient travel|0|||
146305204|NCT01092143|527631011|FG004|Overall Study|Patient travel|1|||
146305205|NCT01092143|527631007|FG000|Overall Study|Non compliance with study medication|0|||
146305206|NCT01092143|527631008|FG001|Overall Study|Non compliance with study medication|0|||
146305207|NCT01092143|527631009|FG002|Overall Study|Non compliance with study medication|0|||
146305208|NCT01092143|527631010|FG003|Overall Study|Non compliance with study medication|0|||
146305209|NCT01092143|527631011|FG004|Overall Study|Non compliance with study medication|1|||
146305210|NCT01092143|527631007|FG000|Overall Study|Randomized by mistake|0|||
146305211|NCT01092143|527631008|FG001|Overall Study|Randomized by mistake|0|||
146305212|NCT01092143|527631009|FG002|Overall Study|Randomized by mistake|0|||
146305213|NCT01092143|527631010|FG003|Overall Study|Randomized by mistake|1|||
146305214|NCT01092143|527631011|FG004|Overall Study|Randomized by mistake|0|||
146305215|NCT01092143|527631007|FG000|Overall Study|Pregnancy|0|||
146305216|NCT01092143|527631008|FG001|Overall Study|Pregnancy|0|||
146305217|NCT01092143|527631009|FG002|Overall Study|Pregnancy|0|||
146305218|NCT01092143|527631010|FG003|Overall Study|Pregnancy|1|||
146305219|NCT01092143|527631011|FG004|Overall Study|Pregnancy|0|||
146305220|NCT00117598|527631017|FG000|Prior to Treatment Cross Over|Death|40|||
146305221|NCT00117598|527631018|FG001|Prior to Treatment Cross Over|Death|41|||
146305222|NCT00117598|527631019|FG002|Prior to Treatment Cross Over|Death|37|||
146305223|NCT00117598|527631020|FG003|Prior to Treatment Cross Over|Death|0|||
146305224|NCT00117598|527631021|FG004|Prior to Treatment Cross Over|Death|0|||
146305225|NCT00117598|527631017|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146305226|NCT00117598|527631018|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
146146472|NCT02621606|527048959|FG000|Overall Study|Withdrawal by Subject|0|||
146146473|NCT02621606|527048960|FG001|Overall Study|Withdrawal by Subject|1|||
146146474|NCT02621606|527048961|FG002|Overall Study|Withdrawal by Subject|0|||
146146475|NCT01343082|527048964|FG000|The run-in Period|Not meeting criteria|3|||
146305227|NCT00117598|527631019|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
146305228|NCT00117598|527631020|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146305229|NCT00117598|527631021|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
146305230|NCT00117598|527631017|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
146305231|NCT00117598|527631018|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
146305232|NCT00117598|527631019|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
146146476|NCT01343082|527048965|FG001|The run-in Period|Not meeting criteria|4|||
146146477|NCT01343082|527048966|FG002|The run-in Period|Not meeting criteria|5|||
146146478|NCT01343082|527048964|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
146146479|NCT01343082|527048965|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
146146480|NCT01343082|527048966|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
146146481|NCT01343082|527048964|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
146146482|NCT01343082|527048965|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
146146483|NCT01343082|527048966|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
146146484|NCT01343082|527048964|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
146146485|NCT01343082|527048965|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
146146486|NCT01343082|527048966|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
146146487|NCT01343082|527048964|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
146146488|NCT01343082|527048965|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
146146489|NCT01343082|527048966|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
146146490|NCT02554773|527048967|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
146146491|NCT02554773|527048968|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
146146492|NCT02554773|527048967|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
146146493|NCT02554773|527048968|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
146146494|NCT02554773|527048967|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
146146495|NCT02554773|527048968|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
146146496|NCT02554773|527048967|FG000|Original Dose Regimen (SAS 1)|Death|1|||
146146497|NCT02554773|527048968|FG001|Original Dose Regimen (SAS 1)|Death|0|||
146146498|NCT02554773|527048967|FG000|Original Dose Regimen (SAS 1)|Other|4|||
146146499|NCT02554773|527048968|FG001|Original Dose Regimen (SAS 1)|Other|0|||
146146500|NCT02554773|527048967|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
146146501|NCT02554773|527048968|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
146146502|NCT02554773|527048967|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
146146503|NCT02554773|527048968|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
146146504|NCT02554773|527048967|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
146146505|NCT02554773|527048968|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
146146506|NCT02554773|527048967|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
146146507|NCT02554773|527048968|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
146146508|NCT00009737|527048972|FG000|Overall Study|Adverse Event|112|||
146146509|NCT00009737|527048973|FG001|Overall Study|Adverse Event|75|||
146146510|NCT00009737|527048972|FG000|Overall Study|Death|4|||
146146511|NCT00009737|527048973|FG001|Overall Study|Death|6|||
146146512|NCT00009737|527048972|FG000|Overall Study|Lack of Efficacy|17|||
146146513|NCT00009737|527048973|FG001|Overall Study|Lack of Efficacy|15|||
146146514|NCT00009737|527048972|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
146146515|NCT00009737|527048973|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
146146516|NCT00009737|527048972|FG000|Overall Study|Other Protocol Violation|1|||
146146517|NCT00009737|527048973|FG001|Overall Study|Other Protocol Violation|0|||
146146518|NCT00009737|527048972|FG000|Overall Study|Refused Treatment|15|||
146146519|NCT00009737|527048973|FG001|Overall Study|Refused Treatment|16|||
146146520|NCT00009737|527048972|FG000|Overall Study|Lost to Follow-up|1|||
146146521|NCT00009737|527048973|FG001|Overall Study|Lost to Follow-up|1|||
146146522|NCT00009737|527048972|FG000|Overall Study|Administrative/Other Reasons|7|||
146146523|NCT00009737|527048973|FG001|Overall Study|Administrative/Other Reasons|1|||
146146524|NCT01163682|527048974|FG000|Overall Study|Lost to Follow-up|6|||
146146525|NCT01163682|527048975|FG001|Overall Study|Lost to Follow-up|9|||
146146526|NCT02461589|527048976|FG000|Overall Study|Withdrawal by Subject|5|||
146146527|NCT02461589|527048977|FG001|Overall Study|Withdrawal by Subject|1|||
146146528|NCT02461589|527048978|FG002|Overall Study|Withdrawal by Subject|3|||
146146529|NCT02461589|527048979|FG003|Overall Study|Withdrawal by Subject|2|||
146146530|NCT02461589|527048980|FG004|Overall Study|Withdrawal by Subject|1|||
146146531|NCT02461589|527048981|FG005|Overall Study|Withdrawal by Subject|2|||
146146532|NCT02461589|527048982|FG006|Overall Study|Withdrawal by Subject|1|||
146146533|NCT02461589|527048983|FG007|Overall Study|Withdrawal by Subject|3|||
146146534|NCT02461589|527048984|FG008|Overall Study|Withdrawal by Subject|3|||
146146535|NCT02461589|527048985|FG009|Overall Study|Withdrawal by Subject|1|||
146146536|NCT02461589|527048976|FG000|Overall Study|Lost to Follow-up|0|||
146146537|NCT02461589|527048977|FG001|Overall Study|Lost to Follow-up|0|||
146146538|NCT02461589|527048978|FG002|Overall Study|Lost to Follow-up|2|||
146146539|NCT02461589|527048979|FG003|Overall Study|Lost to Follow-up|3|||
146146540|NCT02461589|527048980|FG004|Overall Study|Lost to Follow-up|1|||
146146541|NCT02461589|527048981|FG005|Overall Study|Lost to Follow-up|1|||
146146542|NCT02461589|527048982|FG006|Overall Study|Lost to Follow-up|3|||
146146543|NCT02461589|527048983|FG007|Overall Study|Lost to Follow-up|1|||
146146544|NCT02461589|527048984|FG008|Overall Study|Lost to Follow-up|3|||
146146545|NCT02461589|527048985|FG009|Overall Study|Lost to Follow-up|1|||
146146546|NCT02461589|527048976|FG000|Overall Study|Death|0|||
146146547|NCT02461589|527048977|FG001|Overall Study|Death|0|||
146278420|NCT03333876|527534288|FG000|Mandibular Advancement|Adverse Event|2|||
146278421|NCT03333876|527534288|FG000|Mandibular Advancement|Product Damage|2|||
146278422|NCT00095498|527534292|FG000|Overall Study|Physician Decision|9|||
146146548|NCT02461589|527048978|FG002|Overall Study|Death|0|||
146278423|NCT00095498|527534293|FG001|Overall Study|Physician Decision|10|||
146146549|NCT02461589|527048979|FG003|Overall Study|Death|0|||
146146550|NCT02461589|527048980|FG004|Overall Study|Death|0|||
146305233|NCT00117598|527631020|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
146305234|NCT00117598|527631021|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
146305235|NCT00117598|527631017|FG000|Prior to Treatment Cross Over|Other|15|||
146305236|NCT00117598|527631018|FG001|Prior to Treatment Cross Over|Other|9|||
146305237|NCT00117598|527631019|FG002|Prior to Treatment Cross Over|Other|9|||
146305238|NCT00117598|527631020|FG003|Prior to Treatment Cross Over|Other|0|||
146305239|NCT00117598|527631021|FG004|Prior to Treatment Cross Over|Other|0|||
146305240|NCT00117598|527631017|FG000|After Treament Cross Over|Death|0|||
146305241|NCT00117598|527631018|FG001|After Treament Cross Over|Death|0|||
146305242|NCT00117598|527631019|FG002|After Treament Cross Over|Death|0|||
146305243|NCT00117598|527631020|FG003|After Treament Cross Over|Death|1|||
146305244|NCT00117598|527631021|FG004|After Treament Cross Over|Death|2|||
146305245|NCT00117598|527631017|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
146305246|NCT00117598|527631018|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
146305247|NCT00117598|527631019|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
146305248|NCT00117598|527631020|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
146305249|NCT00117598|527631021|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
146305250|NCT00117598|527631017|FG000|After Treament Cross Over|Other|0|||
146305251|NCT00117598|527631018|FG001|After Treament Cross Over|Other|0|||
146146551|NCT02461589|527048981|FG005|Overall Study|Death|0|||
146146552|NCT02461589|527048982|FG006|Overall Study|Death|0|||
146146553|NCT02461589|527048983|FG007|Overall Study|Death|1|||
146146554|NCT02461589|527048984|FG008|Overall Study|Death|0|||
146146555|NCT02461589|527048985|FG009|Overall Study|Death|0|||
146146556|NCT02461589|527048976|FG000|Overall Study|Unclassified|0|||
146146557|NCT02461589|527048977|FG001|Overall Study|Unclassified|0|||
146146558|NCT02461589|527048978|FG002|Overall Study|Unclassified|0|||
146146559|NCT02461589|527048979|FG003|Overall Study|Unclassified|0|||
146146560|NCT02461589|527048980|FG004|Overall Study|Unclassified|0|||
146146561|NCT02461589|527048981|FG005|Overall Study|Unclassified|0|||
146146562|NCT02461589|527048982|FG006|Overall Study|Unclassified|1|||
146146563|NCT02461589|527048983|FG007|Overall Study|Unclassified|0|||
146146564|NCT02461589|527048984|FG008|Overall Study|Unclassified|0|||
146146565|NCT02461589|527048985|FG009|Overall Study|Unclassified|2|||
146146566|NCT02461589|527048976|FG000|Overall Study|Missing follow-up information|1|||
146146567|NCT02461589|527048977|FG001|Overall Study|Missing follow-up information|1|||
146146568|NCT02461589|527048978|FG002|Overall Study|Missing follow-up information|0|||
146146569|NCT02461589|527048979|FG003|Overall Study|Missing follow-up information|0|||
146146570|NCT02461589|527048980|FG004|Overall Study|Missing follow-up information|0|||
146146571|NCT02461589|527048981|FG005|Overall Study|Missing follow-up information|0|||
146146572|NCT02461589|527048982|FG006|Overall Study|Missing follow-up information|1|||
146146573|NCT02461589|527048983|FG007|Overall Study|Missing follow-up information|0|||
146146574|NCT02461589|527048984|FG008|Overall Study|Missing follow-up information|0|||
146146575|NCT02461589|527048985|FG009|Overall Study|Missing follow-up information|0|||
146146576|NCT02461589|527048976|FG000|Overall Study|Withdrawal from trial before exposure|0|||
146146577|NCT02461589|527048977|FG001|Overall Study|Withdrawal from trial before exposure|0|||
146146578|NCT02461589|527048978|FG002|Overall Study|Withdrawal from trial before exposure|0|||
146146579|NCT02461589|527048979|FG003|Overall Study|Withdrawal from trial before exposure|0|||
146146580|NCT02461589|527048980|FG004|Overall Study|Withdrawal from trial before exposure|0|||
146146581|NCT02461589|527048981|FG005|Overall Study|Withdrawal from trial before exposure|0|||
146305252|NCT00117598|527631019|FG002|After Treament Cross Over|Other|0|||
146305253|NCT00117598|527631020|FG003|After Treament Cross Over|Other|1|||
146305254|NCT00117598|527631021|FG004|After Treament Cross Over|Other|2|||
146305255|NCT02054325|527631022|FG000|Overall Study|Lost to Follow-up|8|||
146305256|NCT02054325|527631023|FG001|Overall Study|Lost to Follow-up|5|||
146305257|NCT01708291|527631024|FG000|Overall Study|fighting|2|||
146305258|NCT01708291|527631025|FG001|Overall Study|fighting|1|||
146305259|NCT01536951|527631026|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305260|NCT01536951|527631027|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305261|NCT01536951|527631028|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
146305262|NCT01536951|527631029|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305263|NCT01536951|527631030|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146146582|NCT02461589|527048982|FG006|Overall Study|Withdrawal from trial before exposure|0|||
146146583|NCT02461589|527048983|FG007|Overall Study|Withdrawal from trial before exposure|0|||
146146584|NCT02461589|527048984|FG008|Overall Study|Withdrawal from trial before exposure|0|||
146146585|NCT02461589|527048985|FG009|Overall Study|Withdrawal from trial before exposure|1|||
146146586|NCT04713748|527048986|FG000|Overall Study|Not enough kits allocated|35|||
146305264|NCT01536951|527631031|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305265|NCT01536951|527631032|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305266|NCT01536951|527631033|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146305267|NCT01536951|527631034|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
146146587|NCT01557946|527048987|FG000|Overall Study|Adverse Event|3|||
146146588|NCT01557946|527048988|FG001|Overall Study|Adverse Event|0|||
146146589|NCT00406029|527048989|FG000|Overall Study|Adverse Event|12|||
146146590|NCT00406029|527048990|FG001|Overall Study|Adverse Event|2|||
146146591|NCT00406029|527048991|FG002|Overall Study|Adverse Event|5|||
146146592|NCT00406029|527048992|FG003|Overall Study|Adverse Event|10|||
146146593|NCT00406029|527048993|FG004|Overall Study|Adverse Event|7|||
146146594|NCT00406029|527048989|FG000|Overall Study|Withdrawal by Subject|3|||
146146595|NCT00406029|527048990|FG001|Overall Study|Withdrawal by Subject|4|||
146146596|NCT00406029|527048991|FG002|Overall Study|Withdrawal by Subject|2|||
146146597|NCT00406029|527048992|FG003|Overall Study|Withdrawal by Subject|2|||
146146598|NCT00406029|527048993|FG004|Overall Study|Withdrawal by Subject|0|||
146146599|NCT00406029|527048989|FG000|Overall Study|Protocol Violation|1|||
146146600|NCT00406029|527048990|FG001|Overall Study|Protocol Violation|2|||
146146601|NCT00406029|527048991|FG002|Overall Study|Protocol Violation|0|||
146146602|NCT00406029|527048992|FG003|Overall Study|Protocol Violation|2|||
146146603|NCT00406029|527048993|FG004|Overall Study|Protocol Violation|0|||
146146604|NCT00406029|527048989|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146146605|NCT00406029|527048990|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
146146606|NCT00406029|527048991|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
146146607|NCT00406029|527048992|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
146146608|NCT00406029|527048993|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
146146609|NCT00406029|527048989|FG000|Overall Study|Randomized in Error|0|||
146146610|NCT00406029|527048990|FG001|Overall Study|Randomized in Error|0|||
146146611|NCT00406029|527048991|FG002|Overall Study|Randomized in Error|2|||
146146612|NCT00406029|527048992|FG003|Overall Study|Randomized in Error|3|||
146146613|NCT00406029|527048993|FG004|Overall Study|Randomized in Error|1|||
146146614|NCT01038921|527048994|FG000|Overall Study|Withdrawal by Subject|1|||
146146615|NCT01038921|527048995|FG001|Overall Study|Withdrawal by Subject|0|||
146146616|NCT01038921|527048994|FG000|Overall Study|Physician Decision|1|||
146146617|NCT01038921|527048995|FG001|Overall Study|Physician Decision|0|||
146146618|NCT01831089|527048999|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
146146619|NCT01831089|527049000|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
146146620|NCT01831089|527049001|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
146146621|NCT01831089|527049002|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
146146622|NCT01831089|527049003|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
146146623|NCT01831089|527049004|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
146146624|NCT01831089|527048999|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
146146625|NCT01831089|527049000|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
146146626|NCT01831089|527049001|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
146146627|NCT01831089|527049002|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
146146628|NCT01831089|527049003|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
146146629|NCT01831089|527049004|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
146146630|NCT01831089|527048999|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146146631|NCT01831089|527049000|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
146146632|NCT01831089|527049001|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146146633|NCT01831089|527049002|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146146634|NCT01831089|527049003|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146146635|NCT01831089|527049004|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
146146636|NCT01831089|527048999|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
146146637|NCT01831089|527049000|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
146146638|NCT01831089|527049001|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
146146639|NCT01831089|527049002|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
146146640|NCT01831089|527049003|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
146146641|NCT01831089|527049004|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
146146642|NCT01831089|527048999|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146146643|NCT01831089|527049000|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146146644|NCT01831089|527049001|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
146146645|NCT01831089|527049002|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146146646|NCT01831089|527049003|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146146647|NCT01831089|527049004|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
146146648|NCT01831089|527048999|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
146146649|NCT01831089|527049000|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
146146650|NCT01831089|527049001|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
146146651|NCT01831089|527049002|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
146146652|NCT01831089|527049003|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
146146653|NCT01831089|527049004|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
146146654|NCT01831089|527048999|FG000|Cohort III: Dose Level 3|Global end of study|0|||
146146655|NCT01831089|527049000|FG001|Cohort III: Dose Level 3|Global end of study|0|||
146146656|NCT01831089|527049001|FG002|Cohort III: Dose Level 3|Global end of study|1|||
146146657|NCT01831089|527049002|FG003|Cohort III: Dose Level 3|Global end of study|0|||
146146658|NCT01831089|527049003|FG004|Cohort III: Dose Level 3|Global end of study|0|||
146146659|NCT01831089|527049004|FG005|Cohort III: Dose Level 3|Global end of study|0|||
146305268|NCT01536951|527631026|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
146305269|NCT01536951|527631027|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
146305270|NCT01536951|527631028|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
146305271|NCT01536951|527631029|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
146146660|NCT01831089|527048999|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
146146661|NCT01831089|527049000|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
146146662|NCT01831089|527049001|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
146146663|NCT01831089|527049002|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
146146664|NCT01831089|527049003|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
146146665|NCT01831089|527049004|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
146146666|NCT01831089|527048999|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
146146667|NCT01831089|527049000|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
146146668|NCT01831089|527049001|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
146146669|NCT01831089|527049002|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
146146670|NCT01831089|527049003|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
146146671|NCT01831089|527049004|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
146146672|NCT01831089|527048999|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146146673|NCT01831089|527049000|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146146674|NCT01831089|527049001|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146146675|NCT01831089|527049002|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146146676|NCT01831089|527049003|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
146146677|NCT01831089|527049004|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
146146678|NCT01831089|527048999|FG000|Cohort V: Dose Level 5|Death|0|||
146146679|NCT01831089|527049000|FG001|Cohort V: Dose Level 5|Death|0|||
146146680|NCT01831089|527049001|FG002|Cohort V: Dose Level 5|Death|0|||
146146681|NCT01831089|527049002|FG003|Cohort V: Dose Level 5|Death|0|||
146146682|NCT01831089|527049003|FG004|Cohort V: Dose Level 5|Death|1|||
146146683|NCT01831089|527049004|FG005|Cohort V: Dose Level 5|Death|0|||
146146684|NCT01831089|527048999|FG000|Cohort V: Dose Level 5|Global end of study|0|||
146146685|NCT01831089|527049000|FG001|Cohort V: Dose Level 5|Global end of study|0|||
146146686|NCT01831089|527049001|FG002|Cohort V: Dose Level 5|Global end of study|0|||
146146687|NCT01831089|527049002|FG003|Cohort V: Dose Level 5|Global end of study|0|||
146146688|NCT01831089|527049003|FG004|Cohort V: Dose Level 5|Global end of study|2|||
146146689|NCT01831089|527049004|FG005|Cohort V: Dose Level 5|Global end of study|0|||
146146690|NCT01831089|527048999|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146146691|NCT01831089|527049000|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146146692|NCT01831089|527049001|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146146693|NCT01831089|527049002|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146146694|NCT01831089|527049003|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
146146695|NCT01831089|527049004|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
146146696|NCT01831089|527048999|FG000|Cohort B: Arm B|Progressive disease|0|||
146146697|NCT01831089|527049000|FG001|Cohort B: Arm B|Progressive disease|0|||
146146698|NCT01831089|527049001|FG002|Cohort B: Arm B|Progressive disease|0|||
146146699|NCT01831089|527049002|FG003|Cohort B: Arm B|Progressive disease|0|||
146146700|NCT01831089|527049003|FG004|Cohort B: Arm B|Progressive disease|0|||
146146701|NCT01831089|527049004|FG005|Cohort B: Arm B|Progressive disease|8|||
146146702|NCT01831089|527048999|FG000|Cohort B: Arm B|Physician Decision|0|||
146146703|NCT01831089|527049000|FG001|Cohort B: Arm B|Physician Decision|0|||
146146704|NCT01831089|527049001|FG002|Cohort B: Arm B|Physician Decision|0|||
146146705|NCT01831089|527049002|FG003|Cohort B: Arm B|Physician Decision|0|||
146146706|NCT01831089|527049003|FG004|Cohort B: Arm B|Physician Decision|0|||
146146707|NCT01831089|527049004|FG005|Cohort B: Arm B|Physician Decision|2|||
146146708|NCT01831089|527048999|FG000|Cohort B: Arm B|Never treated|0|||
146146709|NCT01831089|527049000|FG001|Cohort B: Arm B|Never treated|0|||
146146710|NCT01831089|527049001|FG002|Cohort B: Arm B|Never treated|0|||
146146711|NCT01831089|527049002|FG003|Cohort B: Arm B|Never treated|0|||
146146712|NCT01831089|527049003|FG004|Cohort B: Arm B|Never treated|0|||
146146713|NCT01831089|527049004|FG005|Cohort B: Arm B|Never treated|2|||
146146714|NCT01831089|527048999|FG000|Cohort B: Arm B|Adverse Event|0|||
146146715|NCT01831089|527049000|FG001|Cohort B: Arm B|Adverse Event|0|||
146146716|NCT01831089|527049001|FG002|Cohort B: Arm B|Adverse Event|0|||
146146717|NCT01831089|527049002|FG003|Cohort B: Arm B|Adverse Event|0|||
146146718|NCT01831089|527049003|FG004|Cohort B: Arm B|Adverse Event|0|||
146146719|NCT01831089|527049004|FG005|Cohort B: Arm B|Adverse Event|1|||
146146720|NCT01831089|527048999|FG000|Cohort B: Arm B|Global end of study|0|||
146146721|NCT01831089|527049000|FG001|Cohort B: Arm B|Global end of study|0|||
146146722|NCT01831089|527049001|FG002|Cohort B: Arm B|Global end of study|0|||
146146723|NCT01831089|527049002|FG003|Cohort B: Arm B|Global end of study|0|||
146146724|NCT01831089|527049003|FG004|Cohort B: Arm B|Global end of study|0|||
146305272|NCT01536951|527631030|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
146146725|NCT01831089|527049004|FG005|Cohort B: Arm B|Global end of study|1|||
146146726|NCT02013765|527049005|FG000|Overall Study|Trial was terminated by sponsor|1|||
146146727|NCT04479618|527049006|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
146146728|NCT04479618|527049007|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
146146729|NCT04479618|527049008|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
146146730|NCT04479618|527049006|FG000|Overall Study|Lack of Efficacy|1|||
146146731|NCT04479618|527049007|FG001|Overall Study|Lack of Efficacy|0|||
146146732|NCT04479618|527049008|FG002|Overall Study|Lack of Efficacy|0|||
146146733|NCT04479618|527049006|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
146146734|NCT04479618|527049007|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
146146735|NCT04479618|527049008|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
146146736|NCT04479618|527049006|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
146146737|NCT04479618|527049007|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
146146738|NCT04479618|527049008|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
146146739|NCT04479618|527049006|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
146146740|NCT04479618|527049007|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
146146741|NCT04479618|527049008|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
146146742|NCT04479618|527049006|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
146146743|NCT04479618|527049007|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
146146744|NCT04479618|527049008|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
146146745|NCT02443298|527049015|FG000|Overall Study|Adverse Event|3|||
146146746|NCT02443298|527049016|FG001|Overall Study|Adverse Event|3|||
146146747|NCT02443298|527049015|FG000|Overall Study|Withdrawal by Subject|1|||
146146748|NCT02443298|527049016|FG001|Overall Study|Withdrawal by Subject|2|||
146146749|NCT01047683|527049017|FG000|Overall Study|Adverse Event|3|||
146146750|NCT01047683|527049018|FG001|Overall Study|Adverse Event|1|||
146146751|NCT01047683|527049019|FG002|Overall Study|Adverse Event|0|||
146146752|NCT01047683|527049017|FG000|Overall Study|Withdrew Consent|1|||
146146753|NCT01047683|527049018|FG001|Overall Study|Withdrew Consent|4|||
146146754|NCT01047683|527049019|FG002|Overall Study|Withdrew Consent|2|||
146146755|NCT01047683|527049017|FG000|Overall Study|Lost to Follow-up|0|||
146146756|NCT01047683|527049018|FG001|Overall Study|Lost to Follow-up|1|||
146146757|NCT01047683|527049019|FG002|Overall Study|Lost to Follow-up|0|||
146146758|NCT01047683|527049017|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
146146759|NCT01047683|527049018|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
146146760|NCT01047683|527049019|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
146146761|NCT05101252|527049036|FG000|Overall Study|Unsatisfactory Test Article|1|||
146146762|NCT05101252|527049037|FG001|Overall Study|Unsatisfactory Test Article|0|||
146146763|NCT05101252|527049036|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146146764|NCT05101252|527049037|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146146765|NCT05101252|527049036|FG000|Overall Study|Withdrew Consent during study|0|||
146146766|NCT05101252|527049037|FG001|Overall Study|Withdrew Consent during study|1|||
146146767|NCT05101252|527049036|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
146146768|NCT05101252|527049037|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
146146769|NCT00733824|527049038|FG000|Phase I|Withdrawal by Subject|1|||
146146770|NCT00733824|527049039|FG001|Phase I|Withdrawal by Subject|0|||
146146771|NCT00733824|527049040|FG002|Phase I|Withdrawal by Subject|0|||
146146772|NCT00733824|527049041|FG003|Phase I|Withdrawal by Subject|0|||
146146773|NCT00733824|527049042|FG004|Phase I|Withdrawal by Subject|0|||
146146774|NCT01243944|527049043|FG000|Overall Study|Adverse Event|15|||
146146775|NCT01243944|527049044|FG001|Overall Study|Adverse Event|13|||
146146776|NCT01243944|527049043|FG000|Overall Study|Lost to Follow-up|2|||
146146777|NCT01243944|527049044|FG001|Overall Study|Lost to Follow-up|1|||
146146778|NCT01243944|527049043|FG000|Overall Study|Physician Decision|2|||
146146779|NCT01243944|527049044|FG001|Overall Study|Physician Decision|7|||
146146780|NCT01243944|527049043|FG000|Overall Study|Disease progression|12|||
146146781|NCT01243944|527049044|FG001|Overall Study|Disease progression|11|||
146146782|NCT01243944|527049043|FG000|Overall Study|Protocol deviation|1|||
146146783|NCT01243944|527049044|FG001|Overall Study|Protocol deviation|1|||
146146784|NCT01243944|527049043|FG000|Overall Study|Participant decision|10|||
146146785|NCT01243944|527049044|FG001|Overall Study|Participant decision|15|||
146146786|NCT01243944|527049043|FG000|Overall Study|Death|2|||
146146787|NCT01243944|527049044|FG001|Overall Study|Death|3|||
146278424|NCT00095498|527534294|FG002|Overall Study|Physician Decision|8|||
146278425|NCT00095498|527534292|FG000|Overall Study|Adverse Event|1|||
146278426|NCT00095498|527534293|FG001|Overall Study|Adverse Event|0|||
146146788|NCT01243944|527049043|FG000|Overall Study|Non-compliance with study treatment|1|||
146146789|NCT01243944|527049044|FG001|Overall Study|Non-compliance with study treatment|0|||
146146790|NCT01731171|527049055|FG000|Overall Study|Withdrawal by Subject|4|||
146278427|NCT00095498|527534294|FG002|Overall Study|Adverse Event|1|||
146146791|NCT01731171|527049056|FG001|Overall Study|Withdrawal by Subject|1|||
146146792|NCT01731171|527049055|FG000|Overall Study|Lost to Follow-up|3|||
146146793|NCT01731171|527049056|FG001|Overall Study|Lost to Follow-up|2|||
146146794|NCT01731171|527049055|FG000|Overall Study|Moved out of Area|0|||
146146795|NCT01731171|527049056|FG001|Overall Study|Moved out of Area|2|||
146146796|NCT01731171|527049055|FG000|Overall Study|Terminated for Lack of Adherence|0|||
146146797|NCT01731171|527049056|FG001|Overall Study|Terminated for Lack of Adherence|1|||
146146798|NCT01731171|527049055|FG000|Overall Study|Terminated for Safety Reasons|0|||
146146799|NCT01731171|527049056|FG001|Overall Study|Terminated for Safety Reasons|1|||
146146800|NCT01410110|527049057|FG000|Overall Study|Withdrawal by Subject|4|||
146146801|NCT01410110|527049058|FG001|Overall Study|Withdrawal by Subject|2|||
146146802|NCT02799082|527049065|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
146146803|NCT02799082|527049066|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
146146804|NCT02799082|527049065|FG000|Overall Study|Protocol Violation|0|||
146146805|NCT02799082|527049066|FG001|Overall Study|Protocol Violation|1|||
146146806|NCT04496258|527049067|FG000|Overall Study|Withdrawal by Subject|2|||
146146807|NCT04496258|527049068|FG001|Overall Study|Withdrawal by Subject|1|||
146146808|NCT00861341|527049071|FG000|Overall Study|Withdrawal by Subject|2|||
146146809|NCT04382612|527049080|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
146146810|NCT03149328|527049081|FG000|Overall Study|Withdrawal by Subject|30|||
146146811|NCT03149328|527049082|FG001|Overall Study|Withdrawal by Subject|26|||
146146812|NCT03149328|527049081|FG000|Overall Study|Changed Dialysis Modality|18|||
146146813|NCT03149328|527049082|FG001|Overall Study|Changed Dialysis Modality|1|||
146146814|NCT03149328|527049081|FG000|Overall Study|Transplant|9|||
146146815|NCT03149328|527049082|FG001|Overall Study|Transplant|1|||
146146816|NCT03149328|527049081|FG000|Overall Study|Lost to Follow-up|25|||
146146817|NCT03149328|527049082|FG001|Overall Study|Lost to Follow-up|16|||
146146818|NCT03149328|527049081|FG000|Overall Study|Left Study Site|1|||
146146819|NCT03149328|527049082|FG001|Overall Study|Left Study Site|2|||
146146820|NCT03149328|527049081|FG000|Overall Study|Language Barrier|1|||
146146821|NCT03149328|527049082|FG001|Overall Study|Language Barrier|0|||
146146822|NCT01328002|527049083|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
146146823|NCT01328002|527049084|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
146146824|NCT01328002|527049083|FG000|Open-Label Period|Adverse Event|8|||
146146825|NCT01328002|527049084|FG001|Open-Label Period|Adverse Event|0|||
146146826|NCT01328002|527049083|FG000|Open-Label Period|Lack of Efficacy|3|||
146146827|NCT01328002|527049084|FG001|Open-Label Period|Lack of Efficacy|0|||
146146828|NCT01328002|527049083|FG000|Open-Label Period|Protocol Violation|2|||
146146829|NCT01328002|527049084|FG001|Open-Label Period|Protocol Violation|0|||
146146830|NCT01328002|527049083|FG000|Open-Label Period|Withdrawal by Subject|9|||
146146831|NCT01328002|527049084|FG001|Open-Label Period|Withdrawal by Subject|0|||
146146832|NCT01328002|527049083|FG000|Open-Label Period|Lost to Follow-up|6|||
146146833|NCT01328002|527049084|FG001|Open-Label Period|Lost to Follow-up|0|||
146146834|NCT01328002|527049083|FG000|Open-Label Period|Other Reason|2|||
146146835|NCT01328002|527049084|FG001|Open-Label Period|Other Reason|0|||
146146836|NCT01328002|527049083|FG000|Double-Blind Period|Adverse Event|1|||
146146837|NCT01328002|527049084|FG001|Double-Blind Period|Adverse Event|0|||
146146838|NCT01328002|527049083|FG000|Double-Blind Period|Lack of Efficacy|1|||
146146839|NCT01328002|527049084|FG001|Double-Blind Period|Lack of Efficacy|0|||
146146840|NCT01306617|527049088|FG000|Overall Study|Adverse Event|1|||
146146841|NCT01306617|527049089|FG001|Overall Study|Adverse Event|0|||
146146842|NCT01306617|527049090|FG002|Overall Study|Adverse Event|0|||
146146843|NCT01306617|527049088|FG000|Overall Study|Virologic Failure|0|||
146146844|NCT01306617|527049089|FG001|Overall Study|Virologic Failure|0|||
146146845|NCT01306617|527049090|FG002|Overall Study|Virologic Failure|5|||
146146846|NCT01306617|527049088|FG000|Overall Study|Non-compliance|0|||
146146847|NCT01306617|527049089|FG001|Overall Study|Non-compliance|1|||
146146848|NCT01306617|527049090|FG002|Overall Study|Non-compliance|0|||
146146849|NCT00766415|527049097|FG000|Overall Study|Withdrawal by Subject|0|||
146146850|NCT00766415|527049098|FG001|Overall Study|Withdrawal by Subject|1|||
146146851|NCT01114516|527049099|FG000|Overall Study|Lost to Follow-up|2|||
146146852|NCT01114516|527049100|FG001|Overall Study|Lost to Follow-up|1|||
146278428|NCT00095498|527534292|FG000|Overall Study|Withdrawal by Subject|15|||
146278429|NCT00095498|527534293|FG001|Overall Study|Withdrawal by Subject|16|||
146278430|NCT00095498|527534294|FG002|Overall Study|Withdrawal by Subject|15|||
146146853|NCT00061048|527049101|FG000|Overall Study|Adverse Event|2|||
146146854|NCT00061048|527049101|FG000|Overall Study|disease progression|20|||
146146855|NCT03779841|527049103|FG000|Randomized Population|Did Not Receive Treatment|3|||
146146856|NCT03779841|527049104|FG001|Randomized Population|Did Not Receive Treatment|1|||
146146857|NCT03779841|527049105|FG002|Randomized Population|Did Not Receive Treatment|0|||
146146858|NCT03779841|527049103|FG000|Treated (Safety) Population|Adverse Event|1|||
146146859|NCT03779841|527049104|FG001|Treated (Safety) Population|Adverse Event|1|||
146278431|NCT00095498|527534292|FG000|Overall Study|Disease progression|0|||
146278432|NCT00095498|527534293|FG001|Overall Study|Disease progression|1|||
146146860|NCT03779841|527049105|FG002|Treated (Safety) Population|Adverse Event|0|||
146146861|NCT03779841|527049103|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
146146862|NCT03779841|527049104|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
146146863|NCT03779841|527049105|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
146146864|NCT03779841|527049103|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
146146865|NCT03779841|527049104|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
146146866|NCT03779841|527049105|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
146146867|NCT03779841|527049103|FG000|Treated (Safety) Population|Death|1|||
146146868|NCT03779841|527049104|FG001|Treated (Safety) Population|Death|0|||
146146869|NCT03779841|527049105|FG002|Treated (Safety) Population|Death|2|||
146146870|NCT01632579|527049106|FG000|Washout Period|Adverse Event|1|||
146146871|NCT01632579|527049107|FG001|Washout Period|Adverse Event|0|||
146146872|NCT01632579|527049108|FG002|Washout Period|Adverse Event|0|||
146146873|NCT01632579|527049109|FG003|Washout Period|Adverse Event|0|||
146146874|NCT01632579|527049110|FG004|Washout Period|Adverse Event|0|||
146146875|NCT01632579|527049111|FG005|Washout Period|Adverse Event|0|||
146146876|NCT01632579|527049112|FG006|Washout Period|Adverse Event|0|||
146146877|NCT01632579|527049113|FG007|Washout Period|Adverse Event|0|||
146146878|NCT01632579|527049114|FG008|Washout Period|Adverse Event|0|||
146146879|NCT01632579|527049106|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
146146880|NCT01632579|527049107|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
146146881|NCT01632579|527049108|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
146146882|NCT01632579|527049109|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
146146883|NCT01632579|527049110|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
146146884|NCT01632579|527049111|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
146305273|NCT01536951|527631031|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
146305274|NCT01536951|527631032|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
146305275|NCT01536951|527631033|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
146305276|NCT01536951|527631034|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
146305277|NCT01252810|527631041|FG000|Overall Study|Withdrawal by Subject|4|||
146305278|NCT01252810|527631042|FG001|Overall Study|Withdrawal by Subject|1|||
146305279|NCT01252810|527631041|FG000|Overall Study|Lost to Follow-up|0|||
146305280|NCT01252810|527631042|FG001|Overall Study|Lost to Follow-up|1|||
146305281|NCT01252810|527631041|FG000|Overall Study|Physician Decision|2|||
146305282|NCT01252810|527631042|FG001|Overall Study|Physician Decision|1|||
146305283|NCT01252810|527631041|FG000|Overall Study|Various reasons|8|||
146305284|NCT01252810|527631042|FG001|Overall Study|Various reasons|0|||
146305285|NCT00698997|527631043|FG000|Overall Study|Lost to Follow-up|3|||
146305286|NCT00698997|527631044|FG001|Overall Study|Lost to Follow-up|0|||
146305287|NCT00698997|527631043|FG000|Overall Study|Withdrawal by Subject|7|||
146305288|NCT00698997|527631044|FG001|Overall Study|Withdrawal by Subject|27|||
146305289|NCT00493220|527631045|FG000|Third Intervention|Withdrawal by Subject|1|||
146305290|NCT00493220|527631046|FG001|Third Intervention|Withdrawal by Subject|0|||
146305291|NCT00493220|527631047|FG002|Third Intervention|Withdrawal by Subject|0|||
146305292|NCT00493220|527631048|FG003|Third Intervention|Withdrawal by Subject|0|||
146305293|NCT00493220|527631049|FG004|Third Intervention|Withdrawal by Subject|0|||
146305294|NCT00493220|527631050|FG005|Third Intervention|Withdrawal by Subject|0|||
146305295|NCT06156215|527631055|FG000|Overall Study|Withdrawal by Subject|2|||
146305296|NCT06156215|527631056|FG001|Overall Study|Withdrawal by Subject|4|||
146305297|NCT06156215|527631057|FG002|Overall Study|Withdrawal by Subject|4|||
146305298|NCT06156215|527631058|FG003|Overall Study|Withdrawal by Subject|0|||
146305299|NCT06156215|527631059|FG004|Overall Study|Withdrawal by Subject|2|||
146305300|NCT06156215|527631060|FG005|Overall Study|Withdrawal by Subject|2|||
146305301|NCT06156215|527631055|FG000|Overall Study|Left ED without completing study|9|||
146305302|NCT06156215|527631056|FG001|Overall Study|Left ED without completing study|3|||
146305303|NCT06156215|527631057|FG002|Overall Study|Left ED without completing study|9|||
146305304|NCT06156215|527631058|FG003|Overall Study|Left ED without completing study|0|||
146305305|NCT06156215|527631059|FG004|Overall Study|Left ED without completing study|8|||
146305306|NCT06156215|527631060|FG005|Overall Study|Left ED without completing study|16|||
146305307|NCT06156215|527631055|FG000|Overall Study|Physician Decision|1|||
146305308|NCT06156215|527631056|FG001|Overall Study|Physician Decision|0|||
146305309|NCT06156215|527631057|FG002|Overall Study|Physician Decision|0|||
146305310|NCT06156215|527631058|FG003|Overall Study|Physician Decision|0|||
146305311|NCT06156215|527631059|FG004|Overall Study|Physician Decision|0|||
146305312|NCT06156215|527631060|FG005|Overall Study|Physician Decision|0|||
146305313|NCT06156215|527631055|FG000|Overall Study|Became or found ineligible|2|||
146305314|NCT06156215|527631056|FG001|Overall Study|Became or found ineligible|0|||
146305315|NCT06156215|527631057|FG002|Overall Study|Became or found ineligible|2|||
146305316|NCT06156215|527631058|FG003|Overall Study|Became or found ineligible|0|||
146305317|NCT06156215|527631059|FG004|Overall Study|Became or found ineligible|1|||
146146885|NCT01632579|527049112|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
146305318|NCT06156215|527631060|FG005|Overall Study|Became or found ineligible|2|||
146305319|NCT05050318|527632516|FG000|Overall Study|Protocol Deviation|1|||
146305320|NCT05050318|527632517|FG001|Overall Study|Protocol Deviation|0|||
146305321|NCT05050318|527632518|FG002|Overall Study|Protocol Deviation|0|||
146146886|NCT01632579|527049113|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
146146887|NCT01632579|527049114|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
146146888|NCT00898677|527049115|FG000|Overall Study|Adverse Event|0|||
146305322|NCT00574145|527632524|FG000|Overall Study|Withdrawal by Subject|2|||
146305323|NCT00574145|527632525|FG001|Overall Study|Withdrawal by Subject|1|||
146305324|NCT03227471|527632526|FG000|Overall Study|Withdrawal by Subject|0|||
146146889|NCT00898677|527049116|FG001|Overall Study|Adverse Event|0|||
146146890|NCT00898677|527049117|FG002|Overall Study|Adverse Event|1|||
146146891|NCT00898677|527049118|FG003|Overall Study|Adverse Event|0|||
146146892|NCT00898677|527049115|FG000|Overall Study|Lost to Follow-up|0|||
146146893|NCT00898677|527049116|FG001|Overall Study|Lost to Follow-up|0|||
146146894|NCT00898677|527049117|FG002|Overall Study|Lost to Follow-up|2|||
146146895|NCT00898677|527049118|FG003|Overall Study|Lost to Follow-up|0|||
146146896|NCT00898677|527049115|FG000|Overall Study|Protocol Violation|1|||
146146897|NCT00898677|527049116|FG001|Overall Study|Protocol Violation|1|||
146146898|NCT00898677|527049117|FG002|Overall Study|Protocol Violation|2|||
146146899|NCT00898677|527049118|FG003|Overall Study|Protocol Violation|0|||
146146900|NCT00898677|527049115|FG000|Overall Study|Withdrawal by Subject|0|||
146146901|NCT00898677|527049116|FG001|Overall Study|Withdrawal by Subject|0|||
146146902|NCT00898677|527049117|FG002|Overall Study|Withdrawal by Subject|0|||
146146903|NCT00898677|527049118|FG003|Overall Study|Withdrawal by Subject|1|||
146146904|NCT00898677|527049115|FG000|Overall Study|Not Treated: Adverse Event|0|||
146146905|NCT00898677|527049116|FG001|Overall Study|Not Treated: Adverse Event|2|||
146146906|NCT00898677|527049117|FG002|Overall Study|Not Treated: Adverse Event|1|||
146146907|NCT00898677|527049118|FG003|Overall Study|Not Treated: Adverse Event|0|||
146146908|NCT00898677|527049115|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
146146909|NCT00898677|527049116|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
146146910|NCT00898677|527049117|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
146146911|NCT00898677|527049118|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
146146912|NCT00898677|527049115|FG000|Overall Study|Not Treated: Pregnancy|0|||
146146913|NCT00898677|527049116|FG001|Overall Study|Not Treated: Pregnancy|0|||
146146914|NCT00898677|527049117|FG002|Overall Study|Not Treated: Pregnancy|1|||
146146915|NCT00898677|527049118|FG003|Overall Study|Not Treated: Pregnancy|0|||
146146916|NCT00898677|527049115|FG000|Overall Study|Not Treated: Protocol Violation|2|||
146146917|NCT00898677|527049116|FG001|Overall Study|Not Treated: Protocol Violation|0|||
146146918|NCT00898677|527049117|FG002|Overall Study|Not Treated: Protocol Violation|2|||
146146919|NCT00898677|527049118|FG003|Overall Study|Not Treated: Protocol Violation|0|||
146146920|NCT00898677|527049115|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
146146921|NCT00898677|527049116|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
146146922|NCT00898677|527049117|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
146146923|NCT00898677|527049118|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
146146924|NCT00898677|527049115|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
146146925|NCT00898677|527049116|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
146146926|NCT00898677|527049117|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
146146927|NCT00898677|527049118|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
146146928|NCT00898677|527049115|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146146929|NCT00898677|527049116|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146146930|NCT00898677|527049117|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
146146931|NCT00898677|527049118|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
146146932|NCT00898677|527049115|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
146146933|NCT00898677|527049116|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146146934|NCT00898677|527049117|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146146935|NCT00898677|527049118|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
146146936|NCT00898677|527049115|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
146146937|NCT00898677|527049116|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
146146938|NCT00898677|527049117|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
146146939|NCT00898677|527049118|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
146146940|NCT00898677|527049115|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
146146941|NCT00898677|527049116|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
146146942|NCT00898677|527049117|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
146146943|NCT00898677|527049118|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
146146944|NCT00898677|527049115|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
146146945|NCT00898677|527049116|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
146146946|NCT00898677|527049117|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
146146947|NCT00898677|527049118|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
146146948|NCT00836875|527049121|FG000|Overall Study|Death|3|||
146146949|NCT00836875|527049122|FG001|Overall Study|Death|2|||
146146950|NCT00836875|527049121|FG000|Overall Study|Withdrawal by Subject|0|||
146146951|NCT00836875|527049122|FG001|Overall Study|Withdrawal by Subject|1|||
146146952|NCT00432380|527051327|FG000|Overall Study|Migrated/moved from study area|3|||
146146953|NCT00432380|527051328|FG001|Overall Study|Migrated/moved from study area|4|||
146146954|NCT00432380|527051329|FG002|Overall Study|Migrated/moved from study area|1|||
146146955|NCT00432380|527051327|FG000|Overall Study|Adverse Event|1|||
146146956|NCT00432380|527051328|FG001|Overall Study|Adverse Event|0|||
146146957|NCT00432380|527051329|FG002|Overall Study|Adverse Event|0|||
146146958|NCT01071395|527051330|FG000|Overall Study|Withdrawal by Subject|2|||
146146959|NCT01071395|527051331|FG001|Overall Study|Withdrawal by Subject|1|||
146146960|NCT01071395|527051330|FG000|Overall Study|Adverse Event|3|||
146146961|NCT01071395|527051331|FG001|Overall Study|Adverse Event|1|||
146146962|NCT03422003|527051335|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
146146963|NCT03422003|527051336|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
146146964|NCT03422003|527051335|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
146146965|NCT03422003|527051336|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
146146966|NCT01404312|527051337|FG000|Overall Study|Death|21|||
146146967|NCT01404312|527051338|FG001|Overall Study|Death|27|||
146146968|NCT01404312|527051337|FG000|Overall Study|Withdrawal by Subject|15|||
146146969|NCT01404312|527051338|FG001|Overall Study|Withdrawal by Subject|18|||
146146970|NCT01404312|527051337|FG000|Overall Study|Participant Unable to get to clinic|93|||
146146971|NCT01404312|527051338|FG001|Overall Study|Participant Unable to get to clinic|103|||
146146972|NCT01404312|527051337|FG000|Overall Study|Lost to Follow-up|115|||
146146973|NCT01404312|527051338|FG001|Overall Study|Lost to Follow-up|111|||
146146974|NCT01404312|527051337|FG000|Overall Study|Site closed|22|||
146146975|NCT01404312|527051338|FG001|Overall Study|Site closed|21|||
146146976|NCT01404312|527051337|FG000|Overall Study|Participant not willing to adhere to req|31|||
146146977|NCT01404312|527051338|FG001|Overall Study|Participant not willing to adhere to req|29|||
146146978|NCT01404312|527051337|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146146979|NCT01404312|527051338|FG001|Overall Study|Severe debilitation, unable to continue|2|||
146146980|NCT00116805|527051339|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
146146981|NCT00116805|527051340|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
146146982|NCT00116805|527051339|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
146146983|NCT00116805|527051340|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
146146984|NCT00116805|527051339|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
146146985|NCT00116805|527051340|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
146146986|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
146146987|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
146146988|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
146146989|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
146146990|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
146278433|NCT00095498|527534294|FG002|Overall Study|Disease progression|1|||
146278434|NCT00095498|527534292|FG000|Overall Study|Ineligibility determined|3|||
146278435|NCT00095498|527534293|FG001|Overall Study|Ineligibility determined|0|||
146278436|NCT00095498|527534294|FG002|Overall Study|Ineligibility determined|2|||
146278437|NCT00095498|527534292|FG000|Overall Study|Lost to Follow-up|1|||
146278438|NCT00095498|527534293|FG001|Overall Study|Lost to Follow-up|1|||
146278439|NCT00095498|527534294|FG002|Overall Study|Lost to Follow-up|2|||
146278440|NCT00095498|527534292|FG000|Overall Study|Noncompliance|1|||
146278441|NCT00095498|527534293|FG001|Overall Study|Noncompliance|0|||
146278442|NCT00095498|527534294|FG002|Overall Study|Noncompliance|1|||
146278443|NCT00095498|527534292|FG000|Overall Study|Other|6|||
146278444|NCT00095498|527534293|FG001|Overall Study|Other|7|||
146278445|NCT00095498|527534294|FG002|Overall Study|Other|6|||
146278446|NCT00095498|527534292|FG000|Overall Study|Protocol Violation|0|||
146278447|NCT00095498|527534293|FG001|Overall Study|Protocol Violation|0|||
146278448|NCT00095498|527534294|FG002|Overall Study|Protocol Violation|1|||
146278449|NCT00095498|527534292|FG000|Overall Study|Requirement for alternative therapy|1|||
146278450|NCT00095498|527534293|FG001|Overall Study|Requirement for alternative therapy|0|||
146278451|NCT00095498|527534294|FG002|Overall Study|Requirement for alternative therapy|2|||
146278452|NCT05020327|527534296|FG000|Overall Study|Physician Decision|3|||
146278453|NCT05020327|527534297|FG001|Overall Study|Physician Decision|0|||
146278454|NCT05020327|527534298|FG002|Overall Study|Physician Decision|0|||
146278455|NCT05020327|527534296|FG000|Overall Study|Withdrawal by Subject|1|||
146278456|NCT05020327|527534297|FG001|Overall Study|Withdrawal by Subject|1|||
146278457|NCT05020327|527534298|FG002|Overall Study|Withdrawal by Subject|0|||
146278458|NCT05020327|527534296|FG000|Overall Study|personal/cultural, ineligible|12|||
146278459|NCT05020327|527534297|FG001|Overall Study|personal/cultural, ineligible|0|||
146278460|NCT05020327|527534298|FG002|Overall Study|personal/cultural, ineligible|0|||
146278461|NCT00640133|527534299|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
146278462|NCT00640133|527534300|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
146278463|NCT00640133|527534299|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
146278464|NCT00640133|527534300|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
146278465|NCT00640133|527534299|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
146278466|NCT00640133|527534300|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
146278467|NCT00128102|527534301|FG000|Overall Study|Site Discontinued|3|||
146278468|NCT00128102|527534302|FG001|Overall Study|Site Discontinued|6|||
146278469|NCT00128102|527534301|FG000|Overall Study|Other|0|||
146278470|NCT00128102|527534302|FG001|Overall Study|Other|1|||
146278471|NCT00128102|527534301|FG000|Overall Study|Progressive Disease|255|||
146278472|NCT00128102|527534302|FG001|Overall Study|Progressive Disease|285|||
146278473|NCT00128102|527534301|FG000|Overall Study|Adverse Event|34|||
146278474|NCT00128102|527534302|FG001|Overall Study|Adverse Event|11|||
146278475|NCT00128102|527534301|FG000|Overall Study|Death|12|||
146146991|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
146146992|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
146146993|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
146146994|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
146146995|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
146146996|NCT00116805|527051339|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
146146997|NCT00116805|527051340|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
146146998|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
146146999|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
146147000|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
146147001|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
146147002|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
146147003|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
146147004|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
146147005|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
146147006|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
146147007|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
146147008|NCT00116805|527051339|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
146147009|NCT00116805|527051340|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
146147010|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
146147011|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
146147012|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
146147013|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
146147014|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
146147015|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
146147016|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
146147017|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
146147018|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
146147019|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
146147020|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
146147021|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
146147022|NCT00116805|527051339|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
146147023|NCT00116805|527051340|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
146147024|NCT00116805|527051339|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
146147025|NCT00116805|527051340|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
146147026|NCT00116805|527051339|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
146147027|NCT00116805|527051340|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
146147028|NCT00116805|527051339|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
146147029|NCT00116805|527051340|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
146147030|NCT00116805|527051339|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146147031|NCT00116805|527051340|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146147032|NCT00116805|527051339|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
146147033|NCT00116805|527051340|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
146147034|NCT00116805|527051339|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
146147035|NCT00116805|527051340|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
146147036|NCT00116805|527051339|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
146147037|NCT00116805|527051340|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
146147038|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
146147039|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
146147040|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
146147041|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
146147042|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
146147043|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
146147044|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
146147045|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
146147046|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
146147047|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
146147048|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
146147049|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
146147050|NCT00116805|527051339|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
146147051|NCT00116805|527051340|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
146147052|NCT00116805|527051339|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
146147053|NCT00116805|527051340|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
146147054|NCT00116805|527051339|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
146147055|NCT00116805|527051340|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
146147056|NCT00116805|527051339|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
146147057|NCT00116805|527051340|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
146147058|NCT00116805|527051339|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
146147059|NCT00116805|527051340|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
146147060|NCT00116805|527051339|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
146147061|NCT00116805|527051340|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
146147062|NCT00116805|527051339|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
146147063|NCT00116805|527051340|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
146147064|NCT00116805|527051339|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
146147065|NCT00116805|527051340|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
146147066|NCT00116805|527051339|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
146147067|NCT00116805|527051340|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
146147068|NCT00116805|527051339|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
146278476|NCT00128102|527534302|FG001|Overall Study|Death|13|||
146278477|NCT00128102|527534301|FG000|Overall Study|Physician Decision|3|||
146278478|NCT00128102|527534302|FG001|Overall Study|Physician Decision|3|||
146278479|NCT00128102|527534301|FG000|Overall Study|Withdrawal by Subject|19|||
146278480|NCT00128102|527534302|FG001|Overall Study|Withdrawal by Subject|11|||
146278481|NCT00128102|527534301|FG000|Overall Study|Protocol Violation|2|||
146278482|NCT00128102|527534302|FG001|Overall Study|Protocol Violation|2|||
146278483|NCT00306670|527534306|FG000|Overall Study|patients recruited; Genentech, the st|0|||
146278484|NCT00306670|527534307|FG001|Overall Study|patients recruited; Genentech, the st|2|||
146278485|NCT00503139|527534309|FG000|Overall Study|Case Report Forms were not collected|4|||
146278486|NCT00503139|527534309|FG000|Overall Study|Protocol Violation|4|||
146278487|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146278488|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146278489|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
146278490|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
146278491|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146278492|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
146278493|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
146278494|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
146278495|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
146278496|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
146278497|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278498|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278499|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
146278500|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146278501|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
146278502|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
146278503|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146278504|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
146278505|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
146278506|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
146278507|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
146278508|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
146278509|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
146278510|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
146278511|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
146278512|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278513|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
146278514|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278515|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278516|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278517|NCT00833833|527534313|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
146278518|NCT00833833|527534314|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
146278519|NCT00833833|527534315|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
146278520|NCT00833833|527534316|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
146278521|NCT00833833|527534317|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
146278522|NCT00833833|527534318|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
146278523|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146278524|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146278525|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146147069|NCT00116805|527051340|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
146147070|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
146278526|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
146278527|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
146147071|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
146305325|NCT03227471|527632527|FG001|Overall Study|Withdrawal by Subject|0|||
146305326|NCT03227471|527632528|FG002|Overall Study|Withdrawal by Subject|0|||
146147072|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
146147073|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
146147074|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Adverse Event|5|||
146147075|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Adverse Event|3|||
146147076|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Adverse Event|4|||
146147077|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Adverse Event|10|||
146147078|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
146147079|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
146147080|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
146147081|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
146147082|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146147083|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146147084|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
146147085|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
146147086|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Pregnancy|5|||
146147087|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Pregnancy|0|||
146147088|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Pregnancy|3|||
146147089|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Pregnancy|2|||
146147090|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Non-compliance|1|||
146147091|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Non-compliance|4|||
146147092|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Non-compliance|0|||
146147093|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Non-compliance|3|||
146147094|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Other|0|||
146147095|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Other|3|||
146147096|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Other|3|||
146147097|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Other|1|||
146147098|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
146147099|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
146147100|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
146147101|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
146147102|NCT01760954|527051341|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
146147103|NCT01760954|527051342|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
146147104|NCT01760954|527051343|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
146147105|NCT01760954|527051344|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
146147106|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146147107|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
146147108|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
146147109|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
146147110|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
146147111|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
146147112|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
146147113|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
146305327|NCT03227471|527632529|FG003|Overall Study|Withdrawal by Subject|0|||
146305328|NCT03227471|527632530|FG004|Overall Study|Withdrawal by Subject|1|||
146305329|NCT03227471|527632531|FG005|Overall Study|Withdrawal by Subject|0|||
146305330|NCT03227471|527632532|FG006|Overall Study|Withdrawal by Subject|0|||
146305331|NCT03227471|527632533|FG007|Overall Study|Withdrawal by Subject|0|||
146305332|NCT03227471|527632534|FG008|Overall Study|Withdrawal by Subject|0|||
146305333|NCT03227471|527632535|FG009|Overall Study|Withdrawal by Subject|0|||
146305334|NCT03227471|527632536|FG010|Overall Study|Withdrawal by Subject|0|||
146305335|NCT03227471|527632537|FG011|Overall Study|Withdrawal by Subject|0|||
146305336|NCT03227471|527632538|FG012|Overall Study|Withdrawal by Subject|1|||
146305337|NCT03227471|527632539|FG013|Overall Study|Withdrawal by Subject|0|||
146147114|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
146147115|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
146147116|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
146147117|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
146147118|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
146305338|NCT03227471|527632540|FG014|Overall Study|Withdrawal by Subject|0|||
146305339|NCT03227471|527632526|FG000|Overall Study|Randomized, Never Dosed|0|||
146305340|NCT03227471|527632527|FG001|Overall Study|Randomized, Never Dosed|0|||
146305341|NCT03227471|527632528|FG002|Overall Study|Randomized, Never Dosed|0|||
146305342|NCT03227471|527632529|FG003|Overall Study|Randomized, Never Dosed|0|||
146305343|NCT03227471|527632530|FG004|Overall Study|Randomized, Never Dosed|0|||
146305344|NCT03227471|527632531|FG005|Overall Study|Randomized, Never Dosed|0|||
146305345|NCT03227471|527632532|FG006|Overall Study|Randomized, Never Dosed|0|||
146147119|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
146147120|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
146147121|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
146147122|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146147123|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146147124|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
146147125|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
146147126|NCT01760954|527051341|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
146147127|NCT01760954|527051342|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
146147128|NCT01760954|527051343|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
146147129|NCT01760954|527051344|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
146147130|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Adverse Event|5|||
146147131|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Adverse Event|8|||
146147132|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Adverse Event|4|||
146147133|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Adverse Event|8|||
146147134|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
146147135|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
146147136|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
146147137|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
146147138|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146147139|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
146147140|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146147141|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
146147142|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Physician Decision|1|||
146147143|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Physician Decision|0|||
146147144|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Physician Decision|0|||
146147145|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Physician Decision|0|||
146147146|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
146147147|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
146147148|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
146147149|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
146147150|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Pregnancy|0|||
146147151|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Pregnancy|1|||
146147152|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Pregnancy|0|||
146147153|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Pregnancy|0|||
146147154|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
146147155|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
146147156|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
146147157|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
146147158|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Death|0|||
146147159|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Death|1|||
146147160|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Death|0|||
146147161|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Death|0|||
146147162|NCT00071487|527051350|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
146147163|NCT00071487|527051351|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
146147164|NCT00071487|527051352|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
146147165|NCT00071487|527051353|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
146147166|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
146147167|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
146147168|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
146147169|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
146147170|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146147171|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146147172|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
146147173|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
146147174|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146147175|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146147176|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
146147177|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
146147178|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
146147179|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
146147180|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
146147181|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
146147182|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146278528|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
146278529|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146278530|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146278531|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146278532|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
146147183|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146147184|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
146147185|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
146147186|NCT00071487|527051350|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146147187|NCT00071487|527051351|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146147188|NCT00071487|527051352|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
146147189|NCT00071487|527051353|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
146147190|NCT02318329|527051356|FG000|Overall Study|Progressive Disease|2|||
146147191|NCT02318329|527051357|FG001|Overall Study|Progressive Disease|3|||
146147192|NCT02318329|527051358|FG002|Overall Study|Progressive Disease|2|||
146147193|NCT02318329|527051359|FG003|Overall Study|Progressive Disease|3|||
146147194|NCT02318329|527051360|FG004|Overall Study|Progressive Disease|3|||
146147195|NCT02318329|527051361|FG005|Overall Study|Progressive Disease|3|||
146147196|NCT02318329|527051362|FG006|Overall Study|Progressive Disease|1|||
146147197|NCT02318329|527051363|FG007|Overall Study|Progressive Disease|1|||
146147198|NCT02318329|527051364|FG008|Overall Study|Progressive Disease|5|||
146147199|NCT02318329|527051365|FG009|Overall Study|Progressive Disease|39|||
146147200|NCT02318329|527051356|FG000|Overall Study|Death|0|||
146147201|NCT02318329|527051357|FG001|Overall Study|Death|0|||
146147202|NCT02318329|527051358|FG002|Overall Study|Death|0|||
146147203|NCT02318329|527051359|FG003|Overall Study|Death|0|||
146147204|NCT02318329|527051360|FG004|Overall Study|Death|0|||
146147205|NCT02318329|527051361|FG005|Overall Study|Death|0|||
146147206|NCT02318329|527051362|FG006|Overall Study|Death|0|||
146147207|NCT02318329|527051363|FG007|Overall Study|Death|0|||
146147208|NCT02318329|527051364|FG008|Overall Study|Death|0|||
146147209|NCT02318329|527051365|FG009|Overall Study|Death|5|||
146147210|NCT02318329|527051356|FG000|Overall Study|Lost to Follow-up|0|||
146147211|NCT02318329|527051357|FG001|Overall Study|Lost to Follow-up|0|||
146147212|NCT02318329|527051358|FG002|Overall Study|Lost to Follow-up|0|||
146147213|NCT02318329|527051359|FG003|Overall Study|Lost to Follow-up|0|||
146147214|NCT02318329|527051360|FG004|Overall Study|Lost to Follow-up|0|||
146147215|NCT02318329|527051361|FG005|Overall Study|Lost to Follow-up|0|||
146147216|NCT02318329|527051362|FG006|Overall Study|Lost to Follow-up|0|||
146147217|NCT02318329|527051363|FG007|Overall Study|Lost to Follow-up|0|||
146147218|NCT02318329|527051364|FG008|Overall Study|Lost to Follow-up|0|||
146147219|NCT02318329|527051365|FG009|Overall Study|Lost to Follow-up|1|||
146147220|NCT02318329|527051356|FG000|Overall Study|Withdrawal by Subject|0|||
146147221|NCT02318329|527051357|FG001|Overall Study|Withdrawal by Subject|0|||
146147222|NCT02318329|527051358|FG002|Overall Study|Withdrawal by Subject|0|||
146147223|NCT02318329|527051359|FG003|Overall Study|Withdrawal by Subject|0|||
146147224|NCT02318329|527051360|FG004|Overall Study|Withdrawal by Subject|0|||
146147225|NCT02318329|527051361|FG005|Overall Study|Withdrawal by Subject|0|||
146147226|NCT02318329|527051362|FG006|Overall Study|Withdrawal by Subject|0|||
146147227|NCT02318329|527051363|FG007|Overall Study|Withdrawal by Subject|0|||
146147228|NCT02318329|527051364|FG008|Overall Study|Withdrawal by Subject|0|||
146147229|NCT02318329|527051365|FG009|Overall Study|Withdrawal by Subject|6|||
146147230|NCT02318329|527051356|FG000|Overall Study|Other|1|||
146147231|NCT02318329|527051357|FG001|Overall Study|Other|1|||
146147232|NCT02318329|527051358|FG002|Overall Study|Other|1|||
146147233|NCT02318329|527051359|FG003|Overall Study|Other|0|||
146147234|NCT02318329|527051360|FG004|Overall Study|Other|0|||
146147235|NCT02318329|527051361|FG005|Overall Study|Other|0|||
146147236|NCT02318329|527051362|FG006|Overall Study|Other|0|||
146147237|NCT02318329|527051363|FG007|Overall Study|Other|0|||
146147238|NCT02318329|527051364|FG008|Overall Study|Other|1|||
146147239|NCT02318329|527051365|FG009|Overall Study|Other|1|||
146147240|NCT02032901|527051368|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
146147241|NCT02032901|527051369|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
146147242|NCT02032901|527051368|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
146147243|NCT02032901|527051369|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
146147244|NCT01722331|527051370|FG000|Part 1|Adverse Event|5|||
146147245|NCT01722331|527051371|FG001|Part 1|Adverse Event|0|||
146147246|NCT01722331|527051372|FG002|Part 1|Adverse Event|0|||
146147247|NCT01722331|527051373|FG003|Part 1|Adverse Event|0|||
146147248|NCT01722331|527051374|FG004|Part 1|Adverse Event|0|||
146147249|NCT01722331|527051375|FG005|Part 1|Adverse Event|0|||
146147250|NCT01722331|527051376|FG006|Part 1|Adverse Event|0|||
146147251|NCT01722331|527051370|FG000|Part 1|Lack of Efficacy|0|||
146147252|NCT01722331|527051371|FG001|Part 1|Lack of Efficacy|0|||
146147253|NCT01722331|527051372|FG002|Part 1|Lack of Efficacy|1|||
146147254|NCT01722331|527051373|FG003|Part 1|Lack of Efficacy|0|||
146147255|NCT01722331|527051374|FG004|Part 1|Lack of Efficacy|2|||
146147256|NCT01722331|527051375|FG005|Part 1|Lack of Efficacy|0|||
146147257|NCT01722331|527051376|FG006|Part 1|Lack of Efficacy|0|||
146147258|NCT01722331|527051370|FG000|Part 1|Lost to Follow-up|1|||
146147259|NCT01722331|527051371|FG001|Part 1|Lost to Follow-up|0|||
146147260|NCT01722331|527051372|FG002|Part 1|Lost to Follow-up|2|||
146147261|NCT01722331|527051373|FG003|Part 1|Lost to Follow-up|0|||
146147262|NCT01722331|527051374|FG004|Part 1|Lost to Follow-up|1|||
146147263|NCT01722331|527051375|FG005|Part 1|Lost to Follow-up|0|||
146147264|NCT01722331|527051376|FG006|Part 1|Lost to Follow-up|0|||
146147265|NCT01722331|527051370|FG000|Part 1|Physician Decision|0|||
146147266|NCT01722331|527051371|FG001|Part 1|Physician Decision|0|||
146147267|NCT01722331|527051372|FG002|Part 1|Physician Decision|3|||
146147268|NCT01722331|527051373|FG003|Part 1|Physician Decision|0|||
146147269|NCT01722331|527051374|FG004|Part 1|Physician Decision|1|||
146147270|NCT01722331|527051375|FG005|Part 1|Physician Decision|0|||
146147271|NCT01722331|527051376|FG006|Part 1|Physician Decision|0|||
146147272|NCT01722331|527051370|FG000|Part 1|Pregnancy|1|||
146147273|NCT01722331|527051371|FG001|Part 1|Pregnancy|0|||
146147274|NCT01722331|527051372|FG002|Part 1|Pregnancy|0|||
146147275|NCT01722331|527051373|FG003|Part 1|Pregnancy|0|||
146147276|NCT01722331|527051374|FG004|Part 1|Pregnancy|0|||
146147277|NCT01722331|527051375|FG005|Part 1|Pregnancy|0|||
146147278|NCT01722331|527051376|FG006|Part 1|Pregnancy|0|||
146147279|NCT01722331|527051370|FG000|Part 1|Progressive Disease|0|||
146147280|NCT01722331|527051371|FG001|Part 1|Progressive Disease|0|||
146147281|NCT01722331|527051372|FG002|Part 1|Progressive Disease|0|||
146147282|NCT01722331|527051373|FG003|Part 1|Progressive Disease|0|||
146147283|NCT01722331|527051374|FG004|Part 1|Progressive Disease|1|||
146147284|NCT01722331|527051375|FG005|Part 1|Progressive Disease|0|||
146147285|NCT01722331|527051376|FG006|Part 1|Progressive Disease|0|||
146147286|NCT01722331|527051370|FG000|Part 1|Protocol Violation|1|||
146147287|NCT01722331|527051371|FG001|Part 1|Protocol Violation|0|||
146147288|NCT01722331|527051372|FG002|Part 1|Protocol Violation|0|||
146147289|NCT01722331|527051373|FG003|Part 1|Protocol Violation|0|||
146147290|NCT01722331|527051374|FG004|Part 1|Protocol Violation|1|||
146147291|NCT01722331|527051375|FG005|Part 1|Protocol Violation|0|||
146147292|NCT01722331|527051376|FG006|Part 1|Protocol Violation|0|||
146147293|NCT01722331|527051370|FG000|Part 1|Withdrawal by Subject|2|||
146147294|NCT01722331|527051371|FG001|Part 1|Withdrawal by Subject|0|||
146147295|NCT01722331|527051372|FG002|Part 1|Withdrawal by Subject|3|||
146147296|NCT01722331|527051373|FG003|Part 1|Withdrawal by Subject|0|||
146147297|NCT01722331|527051374|FG004|Part 1|Withdrawal by Subject|3|||
146147298|NCT01722331|527051375|FG005|Part 1|Withdrawal by Subject|0|||
146147299|NCT01722331|527051376|FG006|Part 1|Withdrawal by Subject|0|||
146147300|NCT01722331|527051370|FG000|Part 2|Adverse Event|3|||
146147301|NCT01722331|527051371|FG001|Part 2|Adverse Event|0|||
146147302|NCT01722331|527051372|FG002|Part 2|Adverse Event|0|||
146147303|NCT01722331|527051373|FG003|Part 2|Adverse Event|0|||
146147304|NCT01722331|527051374|FG004|Part 2|Adverse Event|0|||
146147305|NCT01722331|527051375|FG005|Part 2|Adverse Event|1|||
146147306|NCT01722331|527051376|FG006|Part 2|Adverse Event|0|||
146147307|NCT01722331|527051370|FG000|Part 2|Lack of Efficacy|3|||
146147308|NCT01722331|527051371|FG001|Part 2|Lack of Efficacy|0|||
146147309|NCT01722331|527051372|FG002|Part 2|Lack of Efficacy|11|||
146147310|NCT01722331|527051373|FG003|Part 2|Lack of Efficacy|0|||
146147311|NCT01722331|527051374|FG004|Part 2|Lack of Efficacy|0|||
146147312|NCT01722331|527051375|FG005|Part 2|Lack of Efficacy|3|||
146147313|NCT01722331|527051376|FG006|Part 2|Lack of Efficacy|3|||
146147314|NCT01722331|527051370|FG000|Part 2|Lost to Follow-up|0|||
146147315|NCT01722331|527051371|FG001|Part 2|Lost to Follow-up|0|||
146147316|NCT01722331|527051372|FG002|Part 2|Lost to Follow-up|3|||
146147317|NCT01722331|527051373|FG003|Part 2|Lost to Follow-up|0|||
146147318|NCT01722331|527051374|FG004|Part 2|Lost to Follow-up|0|||
146278533|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
146278534|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
146278535|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
146278536|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
146278537|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
146278538|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
146278539|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
146278540|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
146278541|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278542|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278543|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278544|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
146278545|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
146278546|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
146278547|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278548|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278549|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278550|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
146278551|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
146278552|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
146278553|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
146147319|NCT01722331|527051375|FG005|Part 2|Lost to Follow-up|1|||
146147320|NCT01722331|527051376|FG006|Part 2|Lost to Follow-up|1|||
146147321|NCT01722331|527051370|FG000|Part 2|Non-Compliance with Study Drug|1|||
146147322|NCT01722331|527051371|FG001|Part 2|Non-Compliance with Study Drug|0|||
146147323|NCT01722331|527051372|FG002|Part 2|Non-Compliance with Study Drug|1|||
146147324|NCT01722331|527051373|FG003|Part 2|Non-Compliance with Study Drug|0|||
146147325|NCT01722331|527051374|FG004|Part 2|Non-Compliance with Study Drug|0|||
146147326|NCT01722331|527051375|FG005|Part 2|Non-Compliance with Study Drug|0|||
146147327|NCT01722331|527051376|FG006|Part 2|Non-Compliance with Study Drug|0|||
146147328|NCT01722331|527051370|FG000|Part 2|Physician Decision|0|||
146147329|NCT01722331|527051371|FG001|Part 2|Physician Decision|0|||
146147330|NCT01722331|527051372|FG002|Part 2|Physician Decision|2|||
146147331|NCT01722331|527051373|FG003|Part 2|Physician Decision|0|||
146147332|NCT01722331|527051374|FG004|Part 2|Physician Decision|0|||
146147333|NCT01722331|527051375|FG005|Part 2|Physician Decision|0|||
146147334|NCT01722331|527051376|FG006|Part 2|Physician Decision|0|||
146147335|NCT01722331|527051370|FG000|Part 2|Pregnancy|0|||
146147336|NCT01722331|527051371|FG001|Part 2|Pregnancy|0|||
146147337|NCT01722331|527051372|FG002|Part 2|Pregnancy|0|||
146147338|NCT01722331|527051373|FG003|Part 2|Pregnancy|0|||
146147339|NCT01722331|527051374|FG004|Part 2|Pregnancy|0|||
146147340|NCT01722331|527051375|FG005|Part 2|Pregnancy|1|||
146147341|NCT01722331|527051376|FG006|Part 2|Pregnancy|0|||
146147342|NCT01722331|527051370|FG000|Part 2|Progressive Disease|0|||
146147343|NCT01722331|527051371|FG001|Part 2|Progressive Disease|0|||
146147344|NCT01722331|527051372|FG002|Part 2|Progressive Disease|1|||
146147345|NCT01722331|527051373|FG003|Part 2|Progressive Disease|0|||
146147346|NCT01722331|527051374|FG004|Part 2|Progressive Disease|0|||
146147347|NCT01722331|527051375|FG005|Part 2|Progressive Disease|0|||
146147348|NCT01722331|527051376|FG006|Part 2|Progressive Disease|0|||
146147349|NCT01722331|527051370|FG000|Part 2|Protocol Violation|1|||
146147350|NCT01722331|527051371|FG001|Part 2|Protocol Violation|0|||
146147351|NCT01722331|527051372|FG002|Part 2|Protocol Violation|0|||
146147352|NCT01722331|527051373|FG003|Part 2|Protocol Violation|0|||
146147353|NCT01722331|527051374|FG004|Part 2|Protocol Violation|0|||
146147354|NCT01722331|527051375|FG005|Part 2|Protocol Violation|0|||
146147355|NCT01722331|527051376|FG006|Part 2|Protocol Violation|0|||
146147356|NCT01722331|527051370|FG000|Part 2|Withdrawal by Subject|5|||
146147357|NCT01722331|527051371|FG001|Part 2|Withdrawal by Subject|0|||
146147358|NCT01722331|527051372|FG002|Part 2|Withdrawal by Subject|3|||
146147359|NCT01722331|527051373|FG003|Part 2|Withdrawal by Subject|0|||
146147360|NCT01722331|527051374|FG004|Part 2|Withdrawal by Subject|0|||
146147361|NCT01722331|527051375|FG005|Part 2|Withdrawal by Subject|2|||
146147362|NCT01722331|527051376|FG006|Part 2|Withdrawal by Subject|2|||
146147363|NCT01722331|527051370|FG000|Part 2|Other Protocol Specified Criteria|6|||
146147364|NCT01722331|527051371|FG001|Part 2|Other Protocol Specified Criteria|0|||
146147365|NCT01722331|527051372|FG002|Part 2|Other Protocol Specified Criteria|10|||
146147366|NCT01722331|527051373|FG003|Part 2|Other Protocol Specified Criteria|0|||
146147367|NCT01722331|527051374|FG004|Part 2|Other Protocol Specified Criteria|0|||
146147368|NCT01722331|527051375|FG005|Part 2|Other Protocol Specified Criteria|2|||
146147369|NCT01722331|527051376|FG006|Part 2|Other Protocol Specified Criteria|1|||
146147370|NCT01722331|527051370|FG000|Part 3|Adverse Event|2|||
146147371|NCT01722331|527051371|FG001|Part 3|Adverse Event|2|||
146147372|NCT01722331|527051372|FG002|Part 3|Adverse Event|0|||
146147373|NCT01722331|527051373|FG003|Part 3|Adverse Event|1|||
146147374|NCT01722331|527051374|FG004|Part 3|Adverse Event|0|||
146147375|NCT01722331|527051375|FG005|Part 3|Adverse Event|0|||
146147376|NCT01722331|527051376|FG006|Part 3|Adverse Event|0|||
146147377|NCT01722331|527051370|FG000|Part 3|Death|1|||
146147378|NCT01722331|527051371|FG001|Part 3|Death|0|||
146147379|NCT01722331|527051372|FG002|Part 3|Death|0|||
146147380|NCT01722331|527051373|FG003|Part 3|Death|0|||
146147381|NCT01722331|527051374|FG004|Part 3|Death|0|||
146147382|NCT01722331|527051375|FG005|Part 3|Death|0|||
146147383|NCT01722331|527051376|FG006|Part 3|Death|0|||
146147384|NCT01722331|527051370|FG000|Part 3|Lack of Efficacy|1|||
146147385|NCT01722331|527051371|FG001|Part 3|Lack of Efficacy|0|||
146147386|NCT01722331|527051372|FG002|Part 3|Lack of Efficacy|0|||
146147387|NCT01722331|527051373|FG003|Part 3|Lack of Efficacy|0|||
146305346|NCT03227471|527632533|FG007|Overall Study|Randomized, Never Dosed|0|||
146147388|NCT01722331|527051374|FG004|Part 3|Lack of Efficacy|0|||
146147389|NCT01722331|527051375|FG005|Part 3|Lack of Efficacy|0|||
146147390|NCT01722331|527051376|FG006|Part 3|Lack of Efficacy|0|||
146147391|NCT01722331|527051370|FG000|Part 3|Lost to Follow-up|3|||
146147392|NCT01722331|527051371|FG001|Part 3|Lost to Follow-up|4|||
146147393|NCT01722331|527051372|FG002|Part 3|Lost to Follow-up|0|||
146147394|NCT01722331|527051373|FG003|Part 3|Lost to Follow-up|0|||
146147395|NCT01722331|527051374|FG004|Part 3|Lost to Follow-up|0|||
146147396|NCT01722331|527051375|FG005|Part 3|Lost to Follow-up|1|||
146147397|NCT01722331|527051376|FG006|Part 3|Lost to Follow-up|0|||
146147398|NCT01722331|527051370|FG000|Part 3|Non-Compliance with Study Drug|0|||
146147399|NCT01722331|527051371|FG001|Part 3|Non-Compliance with Study Drug|1|||
146147400|NCT01722331|527051372|FG002|Part 3|Non-Compliance with Study Drug|0|||
146147401|NCT01722331|527051373|FG003|Part 3|Non-Compliance with Study Drug|0|||
146147402|NCT01722331|527051374|FG004|Part 3|Non-Compliance with Study Drug|0|||
146147403|NCT01722331|527051375|FG005|Part 3|Non-Compliance with Study Drug|0|||
146147404|NCT01722331|527051376|FG006|Part 3|Non-Compliance with Study Drug|0|||
146147405|NCT01722331|527051370|FG000|Part 3|Physician Decision|1|||
146147406|NCT01722331|527051371|FG001|Part 3|Physician Decision|1|||
146147407|NCT01722331|527051372|FG002|Part 3|Physician Decision|0|||
146147408|NCT01722331|527051373|FG003|Part 3|Physician Decision|0|||
146147409|NCT01722331|527051374|FG004|Part 3|Physician Decision|0|||
146147410|NCT01722331|527051375|FG005|Part 3|Physician Decision|0|||
146147411|NCT01722331|527051376|FG006|Part 3|Physician Decision|1|||
146147412|NCT01722331|527051370|FG000|Part 3|Protocol Violation|2|||
146147413|NCT01722331|527051371|FG001|Part 3|Protocol Violation|1|||
146147414|NCT01722331|527051372|FG002|Part 3|Protocol Violation|0|||
146147415|NCT01722331|527051373|FG003|Part 3|Protocol Violation|0|||
146147416|NCT01722331|527051374|FG004|Part 3|Protocol Violation|0|||
146147417|NCT01722331|527051375|FG005|Part 3|Protocol Violation|0|||
146147418|NCT01722331|527051376|FG006|Part 3|Protocol Violation|0|||
146147419|NCT01722331|527051370|FG000|Part 3|Withdrawal by Subject|4|||
146147420|NCT01722331|527051371|FG001|Part 3|Withdrawal by Subject|7|||
146147421|NCT01722331|527051372|FG002|Part 3|Withdrawal by Subject|0|||
146147422|NCT01722331|527051373|FG003|Part 3|Withdrawal by Subject|0|||
146147423|NCT01722331|527051374|FG004|Part 3|Withdrawal by Subject|0|||
146147424|NCT01722331|527051375|FG005|Part 3|Withdrawal by Subject|2|||
146147425|NCT01722331|527051376|FG006|Part 3|Withdrawal by Subject|1|||
146147426|NCT01722331|527051370|FG000|Part 3|Other Protocol Specified Criteria|1|||
146147427|NCT01722331|527051371|FG001|Part 3|Other Protocol Specified Criteria|1|||
146147428|NCT01722331|527051372|FG002|Part 3|Other Protocol Specified Criteria|0|||
146147429|NCT01722331|527051373|FG003|Part 3|Other Protocol Specified Criteria|0|||
146147430|NCT01722331|527051374|FG004|Part 3|Other Protocol Specified Criteria|0|||
146147431|NCT01722331|527051375|FG005|Part 3|Other Protocol Specified Criteria|0|||
146147432|NCT01722331|527051376|FG006|Part 3|Other Protocol Specified Criteria|0|||
146147433|NCT01154166|527051377|FG000|Overall Study|Adverse Event|14|||
146147434|NCT01154166|527051378|FG001|Overall Study|Adverse Event|9|||
146147435|NCT01154166|527051377|FG000|Overall Study|Lost to Follow-up|1|||
146147436|NCT01154166|527051378|FG001|Overall Study|Lost to Follow-up|1|||
146147437|NCT01154166|527051377|FG000|Overall Study|Protocol Violation|4|||
146147438|NCT01154166|527051378|FG001|Overall Study|Protocol Violation|1|||
146147439|NCT01154166|527051377|FG000|Overall Study|Withdrawal by Subject|10|||
146147440|NCT01154166|527051378|FG001|Overall Study|Withdrawal by Subject|1|||
146147441|NCT01154166|527051377|FG000|Overall Study|Lack of Efficacy|3|||
146147442|NCT01154166|527051378|FG001|Overall Study|Lack of Efficacy|0|||
146147443|NCT01154166|527051377|FG000|Overall Study|Disease Progression|1|||
146147444|NCT01154166|527051378|FG001|Overall Study|Disease Progression|0|||
146147445|NCT01154166|527051377|FG000|Overall Study|Poor Compliance|1|||
146147446|NCT01154166|527051378|FG001|Overall Study|Poor Compliance|0|||
146147447|NCT04265755|527051379|FG000|Overall Study|Withdrawal by Subject|39|||
146147448|NCT04265755|527051379|FG000|Overall Study|Decision by sponsor|2|||
146147449|NCT04265755|527051379|FG000|Overall Study|Lost to Follow-up|11|||
146147450|NCT04265755|527051379|FG000|Overall Study|Death|1|||
146147451|NCT01375049|527051380|FG000|Overall Study|Adverse Event|2|||
146147452|NCT01375049|527051380|FG000|Overall Study|Lost to Follow-up|1|||
146147453|NCT01375049|527051380|FG000|Overall Study|Withdrawal by Subject|2|||
146147454|NCT01375049|527051380|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
146147455|NCT01575561|527051381|FG000|Overall Study|Adverse Event|9|||
146147456|NCT01575561|527051381|FG000|Overall Study|Lack of Efficacy|8|||
146147457|NCT01575561|527051381|FG000|Overall Study|Lost to Follow-up|6|||
146147458|NCT01575561|527051381|FG000|Overall Study|Protocol Violation|4|||
146147459|NCT01575561|527051381|FG000|Overall Study|Withdrawal by Subject|11|||
146147460|NCT01575561|527051381|FG000|Overall Study|administration|1|||
146147461|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
146147462|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
146147463|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
146147464|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Death|1|||
146147465|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
146147466|NCT02840877|527051382|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
146147467|NCT02840877|527051382|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
146147468|NCT02840877|527051382|FG000|12 Weeks to 6 Months|Treatment failure|1|||
146147469|NCT02840877|527051382|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
146147470|NCT02840877|527051382|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
146147471|NCT02840877|527051382|FG000|12 Weeks to 6 Months|Death|1|||
146147472|NCT02840877|527051382|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
146147473|NCT02840877|527051382|FG000|6 Months to 18 Months|Treatment failure|7|||
146147474|NCT02840877|527051382|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
146147475|NCT02840877|527051382|FG000|6 Months to 18 Months|Moved/transferred out|6|||
146147476|NCT02840877|527051382|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
146147477|NCT02840877|527051382|FG000|6 Months to 18 Months|Death|4|||
146278554|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
146278555|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
146147478|NCT02840877|527051382|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
146147479|NCT02840877|527051382|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
146147480|NCT02840877|527051382|FG000|6 Months to 18 Months|Still in study.|14|||
146147481|NCT02530619|527051392|FG000|Registered for Study|Withdrawal by Subject|2|||
146147482|NCT02530619|527051392|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
146147483|NCT02530619|527051392|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
146147484|NCT02530619|527051392|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
146147485|NCT02530619|527051392|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
146147486|NCT02530619|527051392|FG000|Follow-up Period (6 Months)|Death|4|||
146147487|NCT02530619|527051392|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
146147488|NCT02530619|527051392|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
146147489|NCT01854554|527051403|FG000|Overall Study|Denial of Insurance Coverage|12|||
146147490|NCT01854554|527051404|FG001|Overall Study|Denial of Insurance Coverage|0|||
146147491|NCT01854554|527051403|FG000|Overall Study|Decided to get treatment locally|1|||
146147492|NCT01854554|527051404|FG001|Overall Study|Decided to get treatment locally|5|||
146147493|NCT01854554|527051403|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
146147494|NCT01854554|527051404|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
146147495|NCT01854554|527051403|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146147496|NCT01854554|527051404|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
146147497|NCT01854554|527051403|FG000|Overall Study|Progression|0|||
146147498|NCT01854554|527051404|FG001|Overall Study|Progression|1|||
146147499|NCT01854554|527051403|FG000|Overall Study|Lost to Follow-up|0|||
146147500|NCT01854554|527051404|FG001|Overall Study|Lost to Follow-up|1|||
146147501|NCT00359762|527051407|FG000|Period II|Adverse Event|17|||
146147502|NCT00359762|527051408|FG001|Period II|Adverse Event|0|||
146147503|NCT00359762|527051409|FG002|Period II|Adverse Event|0|||
146147504|NCT00359762|527051410|FG003|Period II|Adverse Event|0|||
146147505|NCT00359762|527051411|FG004|Period II|Adverse Event|49|||
146147506|NCT00359762|527051407|FG000|Period II|Protocol Violation|18|||
146147507|NCT00359762|527051408|FG001|Period II|Protocol Violation|0|||
146147508|NCT00359762|527051409|FG002|Period II|Protocol Violation|0|||
146147509|NCT00359762|527051410|FG003|Period II|Protocol Violation|0|||
146147510|NCT00359762|527051411|FG004|Period II|Protocol Violation|11|||
146147511|NCT00359762|527051407|FG000|Period II|Physician Decision|17|||
146147512|NCT00359762|527051408|FG001|Period II|Physician Decision|0|||
146147513|NCT00359762|527051409|FG002|Period II|Physician Decision|0|||
146147514|NCT00359762|527051410|FG003|Period II|Physician Decision|0|||
146147515|NCT00359762|527051411|FG004|Period II|Physician Decision|23|||
146147516|NCT00359762|527051407|FG000|Period II|Death|2|||
146147517|NCT00359762|527051408|FG001|Period II|Death|0|||
146147518|NCT00359762|527051409|FG002|Period II|Death|0|||
146147519|NCT00359762|527051410|FG003|Period II|Death|0|||
146147520|NCT00359762|527051411|FG004|Period II|Death|4|||
146147521|NCT00359762|527051407|FG000|Period II|Lack of Efficacy|11|||
146147522|NCT00359762|527051408|FG001|Period II|Lack of Efficacy|0|||
146147523|NCT00359762|527051409|FG002|Period II|Lack of Efficacy|0|||
146147524|NCT00359762|527051410|FG003|Period II|Lack of Efficacy|0|||
146147525|NCT00359762|527051411|FG004|Period II|Lack of Efficacy|8|||
146147526|NCT00359762|527051407|FG000|Period II|Lost to follow up|5|||
146147527|NCT00359762|527051408|FG001|Period II|Lost to follow up|0|||
146147528|NCT00359762|527051409|FG002|Period II|Lost to follow up|0|||
146147529|NCT00359762|527051410|FG003|Period II|Lost to follow up|0|||
146147530|NCT00359762|527051411|FG004|Period II|Lost to follow up|5|||
146147531|NCT00359762|527051407|FG000|Period II|Entry Criteria Not Met|8|||
146147532|NCT00359762|527051408|FG001|Period II|Entry Criteria Not Met|0|||
146147533|NCT00359762|527051409|FG002|Period II|Entry Criteria Not Met|0|||
146147534|NCT00359762|527051410|FG003|Period II|Entry Criteria Not Met|0|||
146147535|NCT00359762|527051411|FG004|Period II|Entry Criteria Not Met|4|||
146147536|NCT00359762|527051407|FG000|Period II|Subject Decision|50|||
146147537|NCT00359762|527051408|FG001|Period II|Subject Decision|0|||
146147538|NCT00359762|527051409|FG002|Period II|Subject Decision|0|||
146147539|NCT00359762|527051410|FG003|Period II|Subject Decision|0|||
146147540|NCT00359762|527051411|FG004|Period II|Subject Decision|70|||
146147541|NCT00359762|527051407|FG000|Period III|Protocol Violation|0|||
146147542|NCT00359762|527051408|FG001|Period III|Protocol Violation|5|||
146147543|NCT00359762|527051409|FG002|Period III|Protocol Violation|3|||
146147544|NCT00359762|527051410|FG003|Period III|Protocol Violation|8|||
146147545|NCT00359762|527051411|FG004|Period III|Protocol Violation|0|||
146147546|NCT00359762|527051407|FG000|Period III|Adverse Event|0|||
146147547|NCT00359762|527051408|FG001|Period III|Adverse Event|3|||
146147548|NCT00359762|527051409|FG002|Period III|Adverse Event|4|||
146147549|NCT00359762|527051410|FG003|Period III|Adverse Event|10|||
146147550|NCT00359762|527051411|FG004|Period III|Adverse Event|0|||
146147551|NCT00359762|527051407|FG000|Period III|Physician Decision|0|||
146147552|NCT00359762|527051408|FG001|Period III|Physician Decision|5|||
146147553|NCT00359762|527051409|FG002|Period III|Physician Decision|9|||
146147554|NCT00359762|527051410|FG003|Period III|Physician Decision|15|||
146147555|NCT00359762|527051411|FG004|Period III|Physician Decision|0|||
146147556|NCT00359762|527051407|FG000|Period III|Lack of Efficacy|0|||
146147557|NCT00359762|527051408|FG001|Period III|Lack of Efficacy|7|||
146147558|NCT00359762|527051409|FG002|Period III|Lack of Efficacy|5|||
146147559|NCT00359762|527051410|FG003|Period III|Lack of Efficacy|9|||
146147560|NCT00359762|527051411|FG004|Period III|Lack of Efficacy|0|||
146147561|NCT00359762|527051407|FG000|Period III|Lost to follow up|0|||
146147562|NCT00359762|527051408|FG001|Period III|Lost to follow up|1|||
146147563|NCT00359762|527051409|FG002|Period III|Lost to follow up|1|||
146147564|NCT00359762|527051410|FG003|Period III|Lost to follow up|2|||
146147565|NCT00359762|527051411|FG004|Period III|Lost to follow up|0|||
146147566|NCT00359762|527051407|FG000|Period III|Entry Criteria Not Met|0|||
146147567|NCT00359762|527051408|FG001|Period III|Entry Criteria Not Met|1|||
146147568|NCT00359762|527051409|FG002|Period III|Entry Criteria Not Met|0|||
146147569|NCT00359762|527051410|FG003|Period III|Entry Criteria Not Met|1|||
146147570|NCT00359762|527051411|FG004|Period III|Entry Criteria Not Met|0|||
146147571|NCT00359762|527051407|FG000|Period III|Subject Decision|0|||
146147572|NCT00359762|527051408|FG001|Period III|Subject Decision|7|||
146147573|NCT00359762|527051409|FG002|Period III|Subject Decision|8|||
146147574|NCT00359762|527051410|FG003|Period III|Subject Decision|20|||
146147575|NCT00359762|527051411|FG004|Period III|Subject Decision|0|||
146147576|NCT02819726|527051412|FG000|Part A (All Participants)|Lost to Follow-up|0|||
146147577|NCT02819726|527051413|FG001|Part A (All Participants)|Lost to Follow-up|1|||
146147578|NCT02819726|527051414|FG002|Part A (All Participants)|Lost to Follow-up|0|||
146147579|NCT02819726|527051415|FG003|Part A (All Participants)|Lost to Follow-up|0|||
146147580|NCT02819726|527051412|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
146147581|NCT02819726|527051413|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
146147582|NCT02819726|527051414|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
146147583|NCT02819726|527051415|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
146147584|NCT02819726|527051412|FG000|Part A (All Participants)|Protocol non-compliance|3|||
146147585|NCT02819726|527051413|FG001|Part A (All Participants)|Protocol non-compliance|4|||
146147586|NCT02819726|527051414|FG002|Part A (All Participants)|Protocol non-compliance|5|||
146147587|NCT02819726|527051415|FG003|Part A (All Participants)|Protocol non-compliance|0|||
146147588|NCT02819726|527051412|FG000|Part B (All Participants)|Lost to Follow-up|1|||
146147589|NCT02819726|527051413|FG001|Part B (All Participants)|Lost to Follow-up|1|||
146147590|NCT02819726|527051414|FG002|Part B (All Participants)|Lost to Follow-up|2|||
146147591|NCT02819726|527051415|FG003|Part B (All Participants)|Lost to Follow-up|2|||
146147592|NCT02819726|527051412|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
146147593|NCT02819726|527051413|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
146147594|NCT02819726|527051414|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
146147595|NCT02819726|527051415|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
146147596|NCT02819726|527051412|FG000|Part B (All Participants)|Protocol non-compliance|0|||
146147597|NCT02819726|527051413|FG001|Part B (All Participants)|Protocol non-compliance|0|||
146147598|NCT02819726|527051414|FG002|Part B (All Participants)|Protocol non-compliance|1|||
146147599|NCT02819726|527051415|FG003|Part B (All Participants)|Protocol non-compliance|0|||
146147600|NCT01033747|527051419|FG000|Overall Study|Adverse Event|9|||
146147601|NCT01033747|527051420|FG001|Overall Study|Adverse Event|4|||
146147602|NCT01033747|527051419|FG000|Overall Study|Abnormal Laboratory Value|1|||
146147603|NCT01033747|527051420|FG001|Overall Study|Abnormal Laboratory Value|0|||
146147604|NCT01033747|527051419|FG000|Overall Study|Abnormal test procedure|0|||
146147605|NCT01033747|527051420|FG001|Overall Study|Abnormal test procedure|1|||
146147606|NCT01033747|527051419|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
146147607|NCT01033747|527051420|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
146147608|NCT01033747|527051419|FG000|Overall Study|Protocol Violation|1|||
146147609|NCT01033747|527051420|FG001|Overall Study|Protocol Violation|0|||
146147610|NCT01033747|527051419|FG000|Overall Study|Withdrawal by Subject|9|||
146147611|NCT01033747|527051420|FG001|Overall Study|Withdrawal by Subject|6|||
146147612|NCT01033747|527051419|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
146147613|NCT01033747|527051420|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
146147614|NCT01033747|527051419|FG000|Overall Study|Stopped at end of Extension 1|2|||
146147615|NCT01033747|527051420|FG001|Overall Study|Stopped at end of Extension 1|0|||
146147616|NCT02613481|527051421|FG000|Overall Study|Lost to Follow-up|7|||
146147617|NCT02613481|527051421|FG000|Overall Study|Withdrawal by Subject|2|||
146147618|NCT00803023|527051422|FG000|Overall Study|Adverse Event|5|||
146147619|NCT00803023|527051423|FG001|Overall Study|Adverse Event|4|||
146147620|NCT00803023|527051424|FG002|Overall Study|Adverse Event|8|||
146147621|NCT00803023|527051425|FG003|Overall Study|Adverse Event|6|||
146147622|NCT00803023|527051422|FG000|Overall Study|Withdrawal by Subject|0|||
146147623|NCT00803023|527051423|FG001|Overall Study|Withdrawal by Subject|2|||
146278556|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
146278557|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
146278558|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
146278559|NCT00833833|527534313|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146147624|NCT00803023|527051424|FG002|Overall Study|Withdrawal by Subject|0|||
146147625|NCT00803023|527051425|FG003|Overall Study|Withdrawal by Subject|0|||
146278560|NCT00833833|527534314|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146147626|NCT00803023|527051422|FG000|Overall Study|Lost to Follow-up|0|||
146147627|NCT00803023|527051423|FG001|Overall Study|Lost to Follow-up|1|||
146147628|NCT00803023|527051424|FG002|Overall Study|Lost to Follow-up|2|||
146147629|NCT00803023|527051425|FG003|Overall Study|Lost to Follow-up|1|||
146147630|NCT00803023|527051422|FG000|Overall Study|Lack of Efficacy|0|||
146147631|NCT00803023|527051423|FG001|Overall Study|Lack of Efficacy|1|||
146147632|NCT00803023|527051424|FG002|Overall Study|Lack of Efficacy|1|||
146147633|NCT00803023|527051425|FG003|Overall Study|Lack of Efficacy|1|||
146147634|NCT02647658|527051426|FG000|Overall Study|Consent refusal|15|||
146147635|NCT02647658|527051427|FG001|Overall Study|Consent refusal|24|||
146147636|NCT01542528|527051428|FG000|Overall Study|Lost to Follow-up|2|||
146147637|NCT01542528|527051429|FG001|Overall Study|Lost to Follow-up|1|||
146147638|NCT01542528|527051428|FG000|Overall Study|Physician Decision|1|||
146147639|NCT01542528|527051429|FG001|Overall Study|Physician Decision|0|||
146147640|NCT01542528|527051428|FG000|Overall Study|Withdrawal by Subject|9|||
146147641|NCT01542528|527051429|FG001|Overall Study|Withdrawal by Subject|6|||
146147642|NCT04382326|527051436|FG000|Overall Study|Adverse Event, not serious|1|||
146147643|NCT04382326|527051437|FG001|Overall Study|Adverse Event, not serious|2|||
146147644|NCT04382326|527051436|FG000|Overall Study|Other|1|||
146147645|NCT04382326|527051437|FG001|Overall Study|Other|0|||
146147646|NCT04382326|527051436|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
146147647|NCT04382326|527051437|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
146147648|NCT04382326|527051436|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
146147649|NCT04382326|527051437|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
146147650|NCT04382326|527051436|FG000|Overall Study|Protocol Violation|29|||
146147651|NCT04382326|527051437|FG001|Overall Study|Protocol Violation|23|||
146147652|NCT04382326|527051436|FG000|Overall Study|Physician Decision|0|||
146147653|NCT04382326|527051437|FG001|Overall Study|Physician Decision|1|||
146147654|NCT04382326|527051436|FG000|Overall Study|Lost to Follow-up|48|||
146147655|NCT04382326|527051437|FG001|Overall Study|Lost to Follow-up|63|||
146147656|NCT04382326|527051436|FG000|Overall Study|Adverse Event, non-fatal|1|||
146147657|NCT04382326|527051437|FG001|Overall Study|Adverse Event, non-fatal|1|||
146147658|NCT01762761|527051438|FG000|Overall Study|Adverse Event|15|||
146147659|NCT01762761|527051439|FG001|Overall Study|Adverse Event|17|||
146147660|NCT01762761|527051438|FG000|Overall Study|Lack of Efficacy|9|||
146147661|NCT01762761|527051439|FG001|Overall Study|Lack of Efficacy|25|||
146147662|NCT01762761|527051438|FG000|Overall Study|Protocol Violation|1|||
146147663|NCT01762761|527051439|FG001|Overall Study|Protocol Violation|1|||
146147664|NCT01762761|527051438|FG000|Overall Study|Study closed/terminated|0|||
146147665|NCT01762761|527051439|FG001|Overall Study|Study closed/terminated|2|||
146147666|NCT01762761|527051438|FG000|Overall Study|Lost to Follow-up|3|||
146147667|NCT01762761|527051439|FG001|Overall Study|Lost to Follow-up|6|||
146147668|NCT01762761|527051438|FG000|Overall Study|Physician Decision|4|||
146147669|NCT01762761|527051439|FG001|Overall Study|Physician Decision|6|||
146147670|NCT01762761|527051438|FG000|Overall Study|Withdrawal by Subject|7|||
146147671|NCT01762761|527051439|FG001|Overall Study|Withdrawal by Subject|8|||
146147672|NCT01709227|527051445|FG000|Overall Study|Physician Decision|1|||
146147673|NCT01709227|527051446|FG001|Overall Study|Physician Decision|0|||
146147674|NCT01709227|527051445|FG000|Overall Study|Pleural Peritoneal communication|0|||
146147675|NCT01709227|527051446|FG001|Overall Study|Pleural Peritoneal communication|9|||
146147676|NCT00833924|527051447|FG000|Overall Study|Death|21|||
146147677|NCT00833924|527051447|FG000|Overall Study|Conversion|2|||
146147678|NCT00833924|527051447|FG000|Overall Study|Lost to Follow-up|2|||
146147679|NCT00833924|527051447|FG000|Overall Study|Withdrawal by Subject|13|||
146147680|NCT00833924|527051447|FG000|Overall Study|In study follow-up|71|||
146147681|NCT01485861|527051448|FG000|Phase Ib|Death|1|||
146147682|NCT01485861|527051449|FG001|Phase Ib|Death|0|||
146147683|NCT01485861|527051450|FG002|Phase Ib|Death|0|||
146147684|NCT01485861|527051451|FG003|Phase Ib|Death|0|||
146147685|NCT01485861|527051452|FG004|Phase Ib|Death|0|||
146147686|NCT01485861|527051453|FG005|Phase Ib|Death|0|||
146147687|NCT01485861|527051448|FG000|Phase Ib|Physician Decision|1|||
146147688|NCT01485861|527051449|FG001|Phase Ib|Physician Decision|1|||
146147689|NCT01485861|527051450|FG002|Phase Ib|Physician Decision|0|||
146147690|NCT01485861|527051451|FG003|Phase Ib|Physician Decision|0|||
146147691|NCT01485861|527051452|FG004|Phase Ib|Physician Decision|0|||
146147692|NCT01485861|527051453|FG005|Phase Ib|Physician Decision|0|||
146147693|NCT01485861|527051448|FG000|Phase Ib|Adverse Event|0|||
146147694|NCT01485861|527051449|FG001|Phase Ib|Adverse Event|4|||
146147695|NCT01485861|527051450|FG002|Phase Ib|Adverse Event|0|||
146147696|NCT01485861|527051451|FG003|Phase Ib|Adverse Event|0|||
146147697|NCT01485861|527051452|FG004|Phase Ib|Adverse Event|0|||
146147698|NCT01485861|527051453|FG005|Phase Ib|Adverse Event|0|||
146147699|NCT01485861|527051448|FG000|Phase Ib|Progression of disease|5|||
146147700|NCT01485861|527051449|FG001|Phase Ib|Progression of disease|0|||
146147701|NCT01485861|527051450|FG002|Phase Ib|Progression of disease|0|||
146147702|NCT01485861|527051451|FG003|Phase Ib|Progression of disease|0|||
146147703|NCT01485861|527051452|FG004|Phase Ib|Progression of disease|0|||
146147704|NCT01485861|527051453|FG005|Phase Ib|Progression of disease|0|||
146147705|NCT01485861|527051448|FG000|Phase Ib|Other|3|||
146147706|NCT01485861|527051449|FG001|Phase Ib|Other|0|||
146147707|NCT01485861|527051450|FG002|Phase Ib|Other|0|||
146147708|NCT01485861|527051451|FG003|Phase Ib|Other|0|||
146147709|NCT01485861|527051452|FG004|Phase Ib|Other|0|||
146147710|NCT01485861|527051453|FG005|Phase Ib|Other|0|||
146147711|NCT01485861|527051448|FG000|Phase Ib|Withdrawal by Subject|4|||
146147712|NCT01485861|527051449|FG001|Phase Ib|Withdrawal by Subject|1|||
146147713|NCT01485861|527051450|FG002|Phase Ib|Withdrawal by Subject|0|||
146147714|NCT01485861|527051451|FG003|Phase Ib|Withdrawal by Subject|0|||
146147715|NCT01485861|527051452|FG004|Phase Ib|Withdrawal by Subject|0|||
146147716|NCT01485861|527051453|FG005|Phase Ib|Withdrawal by Subject|0|||
146147717|NCT01485861|527051448|FG000|Phase II|Death|0|||
146147718|NCT01485861|527051449|FG001|Phase II|Death|0|||
146147719|NCT01485861|527051450|FG002|Phase II|Death|67|||
146147720|NCT01485861|527051451|FG003|Phase II|Death|71|||
146147721|NCT01485861|527051452|FG004|Phase II|Death|68|||
146147722|NCT01485861|527051453|FG005|Phase II|Death|0|||
146147723|NCT01485861|527051448|FG000|Phase II|Progression of Disease|0|||
146147724|NCT01485861|527051449|FG001|Phase II|Progression of Disease|0|||
146147725|NCT01485861|527051450|FG002|Phase II|Progression of Disease|1|||
146147726|NCT01485861|527051451|FG003|Phase II|Progression of Disease|0|||
146147727|NCT01485861|527051452|FG004|Phase II|Progression of Disease|0|||
146147728|NCT01485861|527051453|FG005|Phase II|Progression of Disease|0|||
146147729|NCT01485861|527051448|FG000|Phase II|Other|0|||
146147730|NCT01485861|527051449|FG001|Phase II|Other|0|||
146147731|NCT01485861|527051450|FG002|Phase II|Other|0|||
146147732|NCT01485861|527051451|FG003|Phase II|Other|1|||
146147733|NCT01485861|527051452|FG004|Phase II|Other|0|||
146147734|NCT01485861|527051453|FG005|Phase II|Other|0|||
146147735|NCT01485861|527051448|FG000|Phase II|Withdrawal by Subject|0|||
146147736|NCT01485861|527051449|FG001|Phase II|Withdrawal by Subject|0|||
146147737|NCT01485861|527051450|FG002|Phase II|Withdrawal by Subject|6|||
146147738|NCT01485861|527051451|FG003|Phase II|Withdrawal by Subject|3|||
146147739|NCT01485861|527051452|FG004|Phase II|Withdrawal by Subject|4|||
146147740|NCT01485861|527051453|FG005|Phase II|Withdrawal by Subject|0|||
146147741|NCT01485861|527051448|FG000|Phase II|Lost to Follow-up|0|||
146147742|NCT01485861|527051449|FG001|Phase II|Lost to Follow-up|0|||
146147743|NCT01485861|527051450|FG002|Phase II|Lost to Follow-up|2|||
146147744|NCT01485861|527051451|FG003|Phase II|Lost to Follow-up|3|||
146147745|NCT01485861|527051452|FG004|Phase II|Lost to Follow-up|5|||
146147746|NCT01485861|527051453|FG005|Phase II|Lost to Follow-up|0|||
146147747|NCT01485861|527051448|FG000|Phase II|Study Ended|0|||
146147748|NCT01485861|527051449|FG001|Phase II|Study Ended|0|||
146147749|NCT01485861|527051450|FG002|Phase II|Study Ended|7|||
146147750|NCT01485861|527051451|FG003|Phase II|Study Ended|8|||
146147751|NCT01485861|527051452|FG004|Phase II|Study Ended|6|||
146147752|NCT01485861|527051453|FG005|Phase II|Study Ended|0|||
146147753|NCT01485861|527051448|FG000|Safety Phase|Death|0|||
146147754|NCT01485861|527051449|FG001|Safety Phase|Death|0|||
146147755|NCT01485861|527051450|FG002|Safety Phase|Death|0|||
146147756|NCT01485861|527051451|FG003|Safety Phase|Death|0|||
146147757|NCT01485861|527051452|FG004|Safety Phase|Death|0|||
146147758|NCT01485861|527051453|FG005|Safety Phase|Death|2|||
146147759|NCT01485861|527051448|FG000|Safety Phase|Adverse Event|0|||
146278561|NCT00833833|527534315|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146278562|NCT00833833|527534316|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146278563|NCT00833833|527534317|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
146278564|NCT00833833|527534318|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
146278565|NCT02040259|527534319|FG000|Overall Study|Death|280|||
146278566|NCT02040259|527534319|FG000|Overall Study|Lost to Follow-up|76|||
146278567|NCT02040259|527534319|FG000|Overall Study|Assessment not completed|3|||
146278568|NCT02040259|527534319|FG000|Overall Study|Withdrawal by Subject|4|||
146278569|NCT04476251|527534320|FG000|Overall Study|Not treated|1|||
146278570|NCT00297427|527534335|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
146278571|NCT00297427|527534336|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
146278572|NCT00297427|527534335|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
146278573|NCT00297427|527534336|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
146278574|NCT00297427|527534335|FG000|Phase 1: Initial Intervention|Death|0|||
146278575|NCT00297427|527534336|FG001|Phase 1: Initial Intervention|Death|1|||
146278576|NCT00297427|527534335|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
146278577|NCT00297427|527534336|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
146278578|NCT00297427|527534335|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
146278579|NCT00297427|527534336|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
146278580|NCT00297427|527534335|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
146278581|NCT00297427|527534336|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
146278582|NCT00297427|527534335|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
146278583|NCT00297427|527534336|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
146147760|NCT01485861|527051449|FG001|Safety Phase|Adverse Event|0|||
146147761|NCT01485861|527051450|FG002|Safety Phase|Adverse Event|0|||
146147762|NCT01485861|527051451|FG003|Safety Phase|Adverse Event|0|||
146147763|NCT01485861|527051452|FG004|Safety Phase|Adverse Event|0|||
146147764|NCT01485861|527051453|FG005|Safety Phase|Adverse Event|1|||
146147765|NCT01485861|527051448|FG000|Safety Phase|Other|0|||
146147766|NCT01485861|527051449|FG001|Safety Phase|Other|0|||
146147767|NCT01485861|527051450|FG002|Safety Phase|Other|0|||
146147768|NCT01485861|527051451|FG003|Safety Phase|Other|0|||
146147769|NCT01485861|527051452|FG004|Safety Phase|Other|0|||
146147770|NCT01485861|527051453|FG005|Safety Phase|Other|5|||
146147771|NCT01485861|527051448|FG000|Safety Phase|Progression of Disease|0|||
146147772|NCT01485861|527051449|FG001|Safety Phase|Progression of Disease|0|||
146147773|NCT01485861|527051450|FG002|Safety Phase|Progression of Disease|0|||
146147774|NCT01485861|527051451|FG003|Safety Phase|Progression of Disease|0|||
146147775|NCT01485861|527051452|FG004|Safety Phase|Progression of Disease|0|||
146147776|NCT01485861|527051453|FG005|Safety Phase|Progression of Disease|9|||
146147777|NCT01485861|527051448|FG000|Safety Phase|Withdrawal by Subject|0|||
146147778|NCT01485861|527051449|FG001|Safety Phase|Withdrawal by Subject|0|||
146147779|NCT01485861|527051450|FG002|Safety Phase|Withdrawal by Subject|0|||
146147780|NCT01485861|527051451|FG003|Safety Phase|Withdrawal by Subject|0|||
146147781|NCT01485861|527051452|FG004|Safety Phase|Withdrawal by Subject|0|||
146147782|NCT01485861|527051453|FG005|Safety Phase|Withdrawal by Subject|6|||
146147783|NCT01485861|527051448|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
146147784|NCT01485861|527051449|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
146147785|NCT01485861|527051450|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
146147786|NCT01485861|527051451|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
146147787|NCT01485861|527051452|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
146147788|NCT01485861|527051453|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
146147789|NCT01260922|527051454|FG000|First Intervention|Withdrawal by Subject|0|||
146147790|NCT01260922|527051455|FG001|First Intervention|Withdrawal by Subject|1|||
146147791|NCT01260922|527051454|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
146147792|NCT01260922|527051455|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
146147793|NCT01260922|527051454|FG000|Second Intervention|Emesis|0|||
146147794|NCT01260922|527051455|FG001|Second Intervention|Emesis|2|||
146147795|NCT05061446|527051458|FG000|Overall Study|Adverse Event|2|||
146147796|NCT05061446|527051459|FG001|Overall Study|Adverse Event|0|||
146147797|NCT05061446|527051460|FG002|Overall Study|Adverse Event|0|||
146147798|NCT05061446|527051458|FG000|Overall Study|Participant no longer available due to personal reason|0|||
146147799|NCT05061446|527051459|FG001|Overall Study|Participant no longer available due to personal reason|1|||
146147800|NCT05061446|527051460|FG002|Overall Study|Participant no longer available due to personal reason|0|||
146147801|NCT05857527|527051463|FG000|Overall Study|Withdrawal by Subject|0|||
146147802|NCT05857527|527051464|FG001|Overall Study|Withdrawal by Subject|1|||
146147803|NCT02543346|527051465|FG000|Second Priming Visit|Withdrawal by Subject|0|||
146147804|NCT02543346|527051466|FG001|Second Priming Visit|Withdrawal by Subject|2|||
146147805|NCT02543346|527051467|FG002|Second Priming Visit|Withdrawal by Subject|2|||
146147806|NCT02543346|527051468|FG003|Second Priming Visit|Withdrawal by Subject|2|||
146147807|NCT02543346|527051465|FG000|Second Priming Visit|Adverse Event|1|||
146147808|NCT02543346|527051466|FG001|Second Priming Visit|Adverse Event|0|||
146147809|NCT02543346|527051467|FG002|Second Priming Visit|Adverse Event|0|||
146147810|NCT02543346|527051468|FG003|Second Priming Visit|Adverse Event|0|||
146147811|NCT01748994|527051469|FG000|Overall Study|Lost to Follow-up|8|||
146147812|NCT01748994|527051470|FG001|Overall Study|Lost to Follow-up|6|||
146147813|NCT02141516|527051471|FG000|Overall Study|Adverse Event|0|||
146147814|NCT02141516|527051472|FG001|Overall Study|Adverse Event|1|||
146147815|NCT02141516|527051473|FG002|Overall Study|Adverse Event|0|||
146147816|NCT02141516|527051471|FG000|Overall Study|Lost to Follow-up|0|||
146147817|NCT02141516|527051472|FG001|Overall Study|Lost to Follow-up|1|||
146147818|NCT02141516|527051473|FG002|Overall Study|Lost to Follow-up|0|||
146147819|NCT02141516|527051471|FG000|Overall Study|Other|0|||
146147820|NCT02141516|527051472|FG001|Overall Study|Other|3|||
146147821|NCT02141516|527051473|FG002|Overall Study|Other|0|||
146147822|NCT03251924|527051474|FG000|Overall Study|Disease Progression|6|||
146147823|NCT03251924|527051475|FG001|Overall Study|Disease Progression|6|||
146147824|NCT03251924|527051476|FG002|Overall Study|Disease Progression|7|||
146147825|NCT03251924|527051477|FG003|Overall Study|Disease Progression|8|||
146147826|NCT03251924|527051478|FG004|Overall Study|Disease Progression|8|||
146147827|NCT03251924|527051479|FG005|Overall Study|Disease Progression|7|||
146147828|NCT03251924|527051480|FG006|Overall Study|Disease Progression|6|||
146147829|NCT03251924|527051481|FG007|Overall Study|Disease Progression|10|||
146147830|NCT03251924|527051482|FG008|Overall Study|Disease Progression|6|||
146147831|NCT03251924|527051474|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
146147832|NCT03251924|527051475|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
146147833|NCT03251924|527051476|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
146147834|NCT03251924|527051477|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
146147835|NCT03251924|527051478|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
146147836|NCT03251924|527051479|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
146147837|NCT03251924|527051480|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
146147838|NCT03251924|527051481|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
146147839|NCT03251924|527051482|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
146147840|NCT03251924|527051474|FG000|Overall Study|Death|0|||
146147841|NCT03251924|527051475|FG001|Overall Study|Death|1|||
146147842|NCT03251924|527051476|FG002|Overall Study|Death|0|||
146147843|NCT03251924|527051477|FG003|Overall Study|Death|1|||
146147844|NCT03251924|527051478|FG004|Overall Study|Death|1|||
146147845|NCT03251924|527051479|FG005|Overall Study|Death|1|||
146147846|NCT03251924|527051480|FG006|Overall Study|Death|0|||
146147847|NCT03251924|527051481|FG007|Overall Study|Death|0|||
146147848|NCT03251924|527051482|FG008|Overall Study|Death|0|||
146147849|NCT03251924|527051474|FG000|Overall Study|Study Drug Toxicity|0|||
146147850|NCT03251924|527051475|FG001|Overall Study|Study Drug Toxicity|0|||
146147851|NCT03251924|527051476|FG002|Overall Study|Study Drug Toxicity|0|||
146147852|NCT03251924|527051477|FG003|Overall Study|Study Drug Toxicity|1|||
146147853|NCT03251924|527051478|FG004|Overall Study|Study Drug Toxicity|0|||
146147854|NCT03251924|527051479|FG005|Overall Study|Study Drug Toxicity|0|||
146147855|NCT03251924|527051480|FG006|Overall Study|Study Drug Toxicity|0|||
146147856|NCT03251924|527051481|FG007|Overall Study|Study Drug Toxicity|0|||
146147857|NCT03251924|527051482|FG008|Overall Study|Study Drug Toxicity|1|||
146147858|NCT03251924|527051474|FG000|Overall Study|Other Reasons|0|||
146147859|NCT03251924|527051475|FG001|Overall Study|Other Reasons|0|||
146147860|NCT03251924|527051476|FG002|Overall Study|Other Reasons|0|||
146147861|NCT03251924|527051477|FG003|Overall Study|Other Reasons|0|||
146147862|NCT03251924|527051478|FG004|Overall Study|Other Reasons|0|||
146147863|NCT03251924|527051479|FG005|Overall Study|Other Reasons|0|||
146147864|NCT03251924|527051480|FG006|Overall Study|Other Reasons|0|||
146147865|NCT03251924|527051481|FG007|Overall Study|Other Reasons|0|||
146147866|NCT03251924|527051482|FG008|Overall Study|Other Reasons|1|||
146147867|NCT03251924|527051474|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146147868|NCT03251924|527051475|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146147869|NCT03251924|527051476|FG002|Overall Study|Participant request to discontinue study treatment|0|||
146147870|NCT03251924|527051477|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146147871|NCT03251924|527051478|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146147872|NCT03251924|527051479|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146147873|NCT03251924|527051480|FG006|Overall Study|Participant request to discontinue study treatment|0|||
146147874|NCT03251924|527051481|FG007|Overall Study|Participant request to discontinue study treatment|1|||
146147875|NCT03251924|527051482|FG008|Overall Study|Participant request to discontinue study treatment|0|||
146147876|NCT00153101|527051483|FG000|Overall Study|Lost to Follow-up|14|||
146147877|NCT00153101|527051484|FG001|Overall Study|Lost to Follow-up|14|||
146147878|NCT00153101|527051485|FG002|Overall Study|Lost to Follow-up|12|||
146147879|NCT00153101|527051486|FG003|Overall Study|Lost to Follow-up|5|||
146147880|NCT00153101|527051487|FG004|Overall Study|Lost to Follow-up|5|||
146147881|NCT00153101|527051483|FG000|Overall Study|Withdrawal by Subject|3|||
146147882|NCT00153101|527051484|FG001|Overall Study|Withdrawal by Subject|4|||
146147883|NCT00153101|527051485|FG002|Overall Study|Withdrawal by Subject|3|||
146147884|NCT00153101|527051486|FG003|Overall Study|Withdrawal by Subject|3|||
146147885|NCT00153101|527051487|FG004|Overall Study|Withdrawal by Subject|5|||
146147886|NCT03169153|527051488|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146147887|NCT03169153|527051489|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
146147888|NCT03169153|527051488|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
146147889|NCT03169153|527051489|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
146147890|NCT03169153|527051488|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
146147891|NCT03169153|527051489|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
146147892|NCT03169153|527051488|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
146147893|NCT03169153|527051489|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
146147894|NCT03299192|527051490|FG000|Overall Study|Fell before classes started|1|||
146147895|NCT03299192|527051491|FG001|Overall Study|Fell before classes started|0|||
146147896|NCT03299192|527051492|FG002|Overall Study|Fell before classes started|0|||
146147897|NCT03299192|527051490|FG000|Overall Study|Other|0|||
146147898|NCT03299192|527051491|FG001|Overall Study|Other|2|||
146147899|NCT03299192|527051492|FG002|Overall Study|Other|1|||
146147900|NCT00983580|527051494|FG000|Overall Study|Cancel Prior to treatment|1|||
146147901|NCT00983580|527051495|FG001|Overall Study|Cancel Prior to treatment|3|||
146147902|NCT00983580|527051494|FG000|Overall Study|Protocol Violation|1|||
146278584|NCT00297427|527534335|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
146278585|NCT00297427|527534336|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
146278586|NCT01127893|527534337|FG000|Overall Study|Study Termination by the Sponsor|1|||
146278587|NCT01262677|527534338|FG000|Overall Study|Does not meet entrance criteria|0|||
146278588|NCT01262677|527534339|FG001|Overall Study|Does not meet entrance criteria|2|||
146278589|NCT01262677|527534340|FG002|Overall Study|Does not meet entrance criteria|0|||
146147903|NCT00983580|527051495|FG001|Overall Study|Protocol Violation|1|||
146147904|NCT00983580|527051494|FG000|Overall Study|Ineligible|3|||
146147905|NCT00983580|527051495|FG001|Overall Study|Ineligible|0|||
146147906|NCT01652716|527051496|FG000|Overall Study|Loss of glucose control|1|||
146147907|NCT01652716|527051497|FG001|Overall Study|Loss of glucose control|0|||
146147908|NCT01652716|527051496|FG000|Overall Study|Administrative|0|||
146147909|NCT01652716|527051497|FG001|Overall Study|Administrative|2|||
146147910|NCT01652716|527051496|FG000|Overall Study|Investigator decision|1|||
146147911|NCT01652716|527051497|FG001|Overall Study|Investigator decision|4|||
146147912|NCT01652716|527051496|FG000|Overall Study|Lost to Follow-up|12|||
146147913|NCT01652716|527051497|FG001|Overall Study|Lost to Follow-up|11|||
146147914|NCT01652716|527051496|FG000|Overall Study|Protocol Violation|2|||
146147915|NCT01652716|527051497|FG001|Overall Study|Protocol Violation|1|||
146147916|NCT01652716|527051496|FG000|Overall Study|Adverse Event|7|||
146147917|NCT01652716|527051497|FG001|Overall Study|Adverse Event|10|||
146147918|NCT01652716|527051496|FG000|Overall Study|Withdrawal by Subject|33|||
146147919|NCT01652716|527051497|FG001|Overall Study|Withdrawal by Subject|18|||
146147920|NCT01337297|527051499|FG000|Overall Study|They entered to single anodal tDCS|4|||
146147921|NCT01337297|527051500|FG001|Overall Study|They entered to single anodal tDCS|3|||
146147922|NCT01337297|527051499|FG000|Overall Study|Lost to Follow-up|1|||
146147923|NCT01337297|527051500|FG001|Overall Study|Lost to Follow-up|3|||
146147924|NCT02778204|527051501|FG000|Overall Study|Adverse Event|1|||
146147925|NCT02778204|527051502|FG001|Overall Study|Adverse Event|0|||
146147926|NCT02778204|527051503|FG002|Overall Study|Adverse Event|0|||
146147927|NCT02778204|527051504|FG003|Overall Study|Adverse Event|0|||
146147928|NCT02778204|527051501|FG000|Overall Study|Withdrawal by Subject|0|||
146147929|NCT02778204|527051502|FG001|Overall Study|Withdrawal by Subject|0|||
146147930|NCT02778204|527051503|FG002|Overall Study|Withdrawal by Subject|1|||
146147931|NCT02778204|527051504|FG003|Overall Study|Withdrawal by Subject|2|||
146147932|NCT02778204|527051501|FG000|Overall Study|Lost to Follow-up|1|||
146147933|NCT02778204|527051502|FG001|Overall Study|Lost to Follow-up|0|||
146147934|NCT02778204|527051503|FG002|Overall Study|Lost to Follow-up|2|||
146147935|NCT02778204|527051504|FG003|Overall Study|Lost to Follow-up|1|||
146147936|NCT02778204|527051501|FG000|Overall Study|Protocol Violation|0|||
146147937|NCT02778204|527051502|FG001|Overall Study|Protocol Violation|0|||
146147938|NCT02778204|527051503|FG002|Overall Study|Protocol Violation|1|||
146147939|NCT02778204|527051504|FG003|Overall Study|Protocol Violation|0|||
146147940|NCT02778204|527051501|FG000|Overall Study|Eligibility Violation|0|||
146147941|NCT02778204|527051502|FG001|Overall Study|Eligibility Violation|0|||
146147942|NCT02778204|527051503|FG002|Overall Study|Eligibility Violation|0|||
146147943|NCT02778204|527051504|FG003|Overall Study|Eligibility Violation|1|||
146147944|NCT01916304|527051505|FG000|Overall Study|Screening failure|17|||
146147945|NCT04666441|527051506|FG000|Overall Study|Lost to Follow-up|1|||
146147946|NCT04666441|527051507|FG001|Overall Study|Lost to Follow-up|4|||
146147947|NCT04666441|527051508|FG002|Overall Study|Lost to Follow-up|1|||
146147948|NCT04666441|527051509|FG003|Overall Study|Lost to Follow-up|3|||
146147949|NCT04666441|527051510|FG004|Overall Study|Lost to Follow-up|0|||
146147950|NCT04666441|527051511|FG005|Overall Study|Lost to Follow-up|2|||
146147951|NCT04666441|527051512|FG006|Overall Study|Lost to Follow-up|2|||
146147952|NCT04666441|527051513|FG007|Overall Study|Lost to Follow-up|2|||
146147953|NCT04666441|527051506|FG000|Overall Study|Subject Decision|1|||
146147954|NCT04666441|527051507|FG001|Overall Study|Subject Decision|1|||
146147955|NCT04666441|527051508|FG002|Overall Study|Subject Decision|3|||
146147956|NCT04666441|527051509|FG003|Overall Study|Subject Decision|1|||
146147957|NCT04666441|527051510|FG004|Overall Study|Subject Decision|0|||
146147958|NCT04666441|527051511|FG005|Overall Study|Subject Decision|1|||
146147959|NCT04666441|527051512|FG006|Overall Study|Subject Decision|3|||
146147960|NCT04666441|527051513|FG007|Overall Study|Subject Decision|2|||
146278590|NCT01262677|527534338|FG000|Overall Study|Insufficient clinical response|0|||
146278591|NCT01262677|527534339|FG001|Overall Study|Insufficient clinical response|0|||
146278592|NCT01262677|527534340|FG002|Overall Study|Insufficient clinical response|1|||
146278593|NCT01262677|527534338|FG000|Overall Study|Lost to Follow-up|1|||
146278594|NCT01262677|527534339|FG001|Overall Study|Lost to Follow-up|0|||
146278595|NCT01262677|527534340|FG002|Overall Study|Lost to Follow-up|2|||
146278596|NCT01262677|527534338|FG000|Overall Study|No longer willing to participate|3|||
146278597|NCT01262677|527534339|FG001|Overall Study|No longer willing to participate|3|||
146278598|NCT01262677|527534340|FG002|Overall Study|No longer willing to participate|2|||
146278599|NCT01262677|527534338|FG000|Overall Study|Reason not provided|2|||
146278600|NCT01262677|527534339|FG001|Overall Study|Reason not provided|1|||
146278601|NCT01262677|527534340|FG002|Overall Study|Reason not provided|3|||
146278602|NCT01262677|527534338|FG000|Overall Study|Protocol Violation|0|||
146278603|NCT01262677|527534339|FG001|Overall Study|Protocol Violation|1|||
146278604|NCT01262677|527534340|FG002|Overall Study|Protocol Violation|1|||
146278605|NCT01262677|527534338|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
146278606|NCT01262677|527534339|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
146278607|NCT01262677|527534340|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
146278608|NCT05816330|527534348|FG000|Overall Study|Withdrawal by Subject|4|||
146278609|NCT05816330|527534349|FG001|Overall Study|Withdrawal by Subject|1|||
146278610|NCT00996476|527534352|FG000|Overall Study|Withdrawal by Subject|1|||
146278611|NCT00996476|527534353|FG001|Overall Study|Withdrawal by Subject|2|||
146147961|NCT00818441|527051515|FG000|Overall Study|Death|69|||
146147962|NCT00818441|527051516|FG001|Overall Study|Death|26|||
146147963|NCT00818441|527051515|FG000|Overall Study|Other|5|||
146147964|NCT00818441|527051516|FG001|Overall Study|Other|0|||
146147965|NCT00818441|527051515|FG000|Overall Study|Lost to Follow-up|2|||
146278612|NCT00996476|527534354|FG002|Overall Study|Withdrawal by Subject|1|||
146278613|NCT00996476|527534355|FG003|Overall Study|Withdrawal by Subject|0|||
146147966|NCT00818441|527051516|FG001|Overall Study|Lost to Follow-up|1|||
146147967|NCT00818441|527051515|FG000|Overall Study|Withdrawal by Subject|2|||
146147968|NCT00818441|527051516|FG001|Overall Study|Withdrawal by Subject|0|||
146147969|NCT00818441|527051515|FG000|Overall Study|Adverse Event|0|||
146147970|NCT00818441|527051516|FG001|Overall Study|Adverse Event|1|||
146147971|NCT00818441|527051515|FG000|Overall Study|Study terminated by sponsor|11|||
146147972|NCT00818441|527051516|FG001|Overall Study|Study terminated by sponsor|2|||
146147973|NCT03964454|527051520|FG000|Overall Study|Lost to Follow-up|13|||
146147974|NCT03964454|527051521|FG001|Overall Study|Lost to Follow-up|7|||
146147975|NCT03964454|527051520|FG000|Overall Study|Withdrawal by Subject|4|||
146147976|NCT03964454|527051521|FG001|Overall Study|Withdrawal by Subject|11|||
146147977|NCT03794089|527052974|FG000|Overall Study|Lost to Follow-up|4|||
146147978|NCT03794089|527052975|FG001|Overall Study|Lost to Follow-up|1|||
146147979|NCT03794089|527052974|FG000|Overall Study|Withdrawal by Subject|2|||
146147980|NCT03794089|527052975|FG001|Overall Study|Withdrawal by Subject|0|||
146147981|NCT03985423|527052976|FG000|Overall Study|Adverse Event|1|||
146147982|NCT03985423|527052976|FG000|Overall Study|Death|2|||
146147983|NCT03985423|527052976|FG000|Overall Study|Physician Decision|1|||
146147984|NCT03985423|527052976|FG000|Overall Study|Withdrawal by Subject|2|||
146147985|NCT03985423|527052976|FG000|Overall Study|Lack of insurance and citizenship|1|||
146147986|NCT01045447|527052987|FG000|Overall Study|Adverse Event|0|||
146147987|NCT01045447|527052988|FG001|Overall Study|Adverse Event|1|||
146147988|NCT01045447|527052987|FG000|Overall Study|Lack of Efficacy|3|||
146147989|NCT01045447|527052988|FG001|Overall Study|Lack of Efficacy|1|||
146147990|NCT01045447|527052987|FG000|Overall Study|Protocol Violation|6|||
146147991|NCT01045447|527052988|FG001|Overall Study|Protocol Violation|3|||
146147992|NCT01045447|527052987|FG000|Overall Study|Withdrawal Criteria|10|||
146147993|NCT01045447|527052988|FG001|Overall Study|Withdrawal Criteria|10|||
146147994|NCT01045447|527052987|FG000|Overall Study|Unclassified|17|||
146147995|NCT01045447|527052988|FG001|Overall Study|Unclassified|13|||
146147996|NCT00129987|527052989|FG000|1st Educational Session|Withdrawal by Subject|141|||
146147997|NCT00129987|527052990|FG001|1st Educational Session|Withdrawal by Subject|109|||
146147998|NCT00129987|527052989|FG000|1 Year|Withdrawal by Subject|32|||
146147999|NCT00129987|527052990|FG001|1 Year|Withdrawal by Subject|21|||
146148000|NCT01159938|527052991|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146148001|NCT01159938|527052992|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146148002|NCT01159938|527052993|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
146148003|NCT01159938|527052994|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146148004|NCT01159938|527052995|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
146148005|NCT00581945|527052996|FG000|Overall Study|Adverse Event|4|||
146148006|NCT00581945|527052997|FG001|Overall Study|Adverse Event|4|||
146148007|NCT00581945|527052996|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146148008|NCT00581945|527052997|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146148009|NCT00581945|527052996|FG000|Overall Study|Withdrawal by Subject|2|||
146148010|NCT00581945|527052997|FG001|Overall Study|Withdrawal by Subject|6|||
146148011|NCT00581945|527052996|FG000|Overall Study|Death|1|||
146148012|NCT00581945|527052997|FG001|Overall Study|Death|0|||
146148013|NCT01075321|527053004|FG000|Overall Study|Withdrawal by Subject|0|||
146148014|NCT01075321|527053005|FG001|Overall Study|Withdrawal by Subject|0|||
146148015|NCT01075321|527053006|FG002|Overall Study|Withdrawal by Subject|1|||
146148016|NCT01075321|527053007|FG003|Overall Study|Withdrawal by Subject|1|||
146148017|NCT01075321|527053004|FG000|Overall Study|Protocol Violation|0|||
146148018|NCT01075321|527053005|FG001|Overall Study|Protocol Violation|0|||
146148019|NCT01075321|527053006|FG002|Overall Study|Protocol Violation|1|||
146148020|NCT01075321|527053007|FG003|Overall Study|Protocol Violation|0|||
146148021|NCT01075321|527053004|FG000|Overall Study|Treatment Incomplete due to progression|1|||
146148022|NCT01075321|527053005|FG001|Overall Study|Treatment Incomplete due to progression|0|||
146148023|NCT01075321|527053006|FG002|Overall Study|Treatment Incomplete due to progression|0|||
146148024|NCT01075321|527053007|FG003|Overall Study|Treatment Incomplete due to progression|0|||
146148025|NCT01075321|527053004|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
146148026|NCT01075321|527053005|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
146148027|NCT01075321|527053006|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
146148028|NCT01075321|527053007|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
146148029|NCT00982020|527053008|FG000|Overall Study|Adverse Event|19|||
146148030|NCT00982020|527053009|FG001|Overall Study|Adverse Event|15|||
146148031|NCT00982020|527053008|FG000|Overall Study|Withdrawal by Subject|11|||
146305347|NCT03227471|527632534|FG008|Overall Study|Randomized, Never Dosed|0|||
146305348|NCT03227471|527632535|FG009|Overall Study|Randomized, Never Dosed|0|||
146148032|NCT00982020|527053009|FG001|Overall Study|Withdrawal by Subject|14|||
146148033|NCT00982020|527053008|FG000|Overall Study|Lost to Follow-up|5|||
146148034|NCT00982020|527053009|FG001|Overall Study|Lost to Follow-up|11|||
146148035|NCT00982020|527053008|FG000|Overall Study|Lack of Efficacy|10|||
146148036|NCT00982020|527053009|FG001|Overall Study|Lack of Efficacy|4|||
146148037|NCT00982020|527053008|FG000|Overall Study|Parent/Caregiver Decision|5|||
146148038|NCT00982020|527053009|FG001|Overall Study|Parent/Caregiver Decision|5|||
146148039|NCT00982020|527053008|FG000|Overall Study|Treatment Non-compliance|3|||
146148040|NCT00982020|527053009|FG001|Overall Study|Treatment Non-compliance|6|||
146148041|NCT00982020|527053008|FG000|Overall Study|Physician Decision|2|||
146148042|NCT00982020|527053009|FG001|Overall Study|Physician Decision|5|||
146148043|NCT00982020|527053008|FG000|Overall Study|Entry Criteria Not Met|2|||
146148044|NCT00982020|527053009|FG001|Overall Study|Entry Criteria Not Met|1|||
146148045|NCT00982020|527053008|FG000|Overall Study|Protocol Violation|0|||
146148046|NCT00982020|527053009|FG001|Overall Study|Protocol Violation|2|||
146148047|NCT00982020|527053008|FG000|Overall Study|Clinical Relapse|0|||
146148048|NCT00982020|527053009|FG001|Overall Study|Clinical Relapse|1|||
146148049|NCT00003457|527053012|FG000|Overall Study|Not evaluable|9|||
146148050|NCT00466193|527053013|FG000|Overall Study|Adverse Event|0|||
146148051|NCT00466193|527053014|FG001|Overall Study|Adverse Event|1|||
146148052|NCT00466193|527053013|FG000|Overall Study|Lost to Follow-up|2|||
146148053|NCT00466193|527053014|FG001|Overall Study|Lost to Follow-up|4|||
146148054|NCT00466193|527053013|FG000|Overall Study|Physician Decision|1|||
146148055|NCT00466193|527053014|FG001|Overall Study|Physician Decision|0|||
146148056|NCT00466193|527053013|FG000|Overall Study|Protocol Violation|1|||
146148057|NCT00466193|527053014|FG001|Overall Study|Protocol Violation|1|||
146148058|NCT00466193|527053013|FG000|Overall Study|Withdrawal by Subject|7|||
146148059|NCT00466193|527053014|FG001|Overall Study|Withdrawal by Subject|2|||
146148060|NCT00466193|527053013|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
146148061|NCT00466193|527053014|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
146148062|NCT02246998|527053015|FG000|Overall Study|Adverse Event|0|||
146148063|NCT02246998|527053016|FG001|Overall Study|Adverse Event|1|||
146148064|NCT02246998|527053017|FG002|Overall Study|Adverse Event|1|||
146148065|NCT02246998|527053018|FG003|Overall Study|Adverse Event|0|||
146148066|NCT02246998|527053015|FG000|Overall Study|Lost to Follow-up|1|||
146148067|NCT02246998|527053016|FG001|Overall Study|Lost to Follow-up|0|||
146148068|NCT02246998|527053017|FG002|Overall Study|Lost to Follow-up|0|||
146148069|NCT02246998|527053018|FG003|Overall Study|Lost to Follow-up|1|||
146148070|NCT02246998|527053015|FG000|Overall Study|Randomized but Never Dosed|1|||
146148071|NCT02246998|527053016|FG001|Overall Study|Randomized but Never Dosed|2|||
146148072|NCT02246998|527053017|FG002|Overall Study|Randomized but Never Dosed|2|||
146148073|NCT02246998|527053018|FG003|Overall Study|Randomized but Never Dosed|1|||
146148074|NCT00353704|527053031|FG000|Overall Study|Protocol Violation|3|||
146148075|NCT00353704|527053032|FG001|Overall Study|Protocol Violation|1|||
146148076|NCT02473614|527053033|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
146148077|NCT02473614|527053034|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
146148078|NCT02525133|527053035|FG000|Overall Study|Adverse Event|0|||
146148079|NCT02525133|527053036|FG001|Overall Study|Adverse Event|1|||
146148080|NCT02525133|527053035|FG000|Overall Study|Death|0|||
146148081|NCT02525133|527053036|FG001|Overall Study|Death|1|||
146148082|NCT02525133|527053035|FG000|Overall Study|did not meet randomization criteria|1|||
146148083|NCT02525133|527053036|FG001|Overall Study|did not meet randomization criteria|0|||
146148084|NCT02525133|527053035|FG000|Overall Study|Lost to Follow-up|5|||
146148085|NCT02525133|527053036|FG001|Overall Study|Lost to Follow-up|1|||
146148086|NCT02525133|527053035|FG000|Overall Study|randomized not enrolled|3|||
146148087|NCT02525133|527053036|FG001|Overall Study|randomized not enrolled|0|||
146148088|NCT02525133|527053035|FG000|Overall Study|Withdrawal by Subject|1|||
146148089|NCT02525133|527053036|FG001|Overall Study|Withdrawal by Subject|0|||
146148090|NCT01075074|527053037|FG000|Overall Study|Surgeon changed to open incisional case|1|||
146148091|NCT01075074|527053038|FG001|Overall Study|Surgeon changed to open incisional case|2|||
146148092|NCT01075074|527053039|FG002|Overall Study|Surgeon changed to open incisional case|2|||
146148093|NCT01181921|527053041|FG000|Overall Study|Lost to Follow-up|1|||
146148094|NCT03669081|527053042|FG000|Overall Study|Data could not be validated|1|||
146148095|NCT03669081|527053043|FG001|Overall Study|Data could not be validated|1|||
146148096|NCT00389324|527053044|FG000|Run-In Phase|Adverse Event|1|||
146148097|NCT00389324|527053044|FG000|Run-In Phase|Lost to Follow-up|1|||
146148098|NCT00389324|527053044|FG000|Run-In Phase|Withdrawal by Subject|1|||
146148099|NCT00389324|527053044|FG000|Subcutaneous Phase|Adverse Event|2|||
146148100|NCT00389324|527053044|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
146148101|NCT00389324|527053044|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
146148102|NCT00389324|527053044|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
146148103|NCT02519504|527053045|FG000|Overall Study|Protocol Violation|6|||
146148104|NCT02519504|527053046|FG001|Overall Study|Protocol Violation|5|||
146148105|NCT02519504|527053045|FG000|Overall Study|Ineligible for direct testing|12|||
146148106|NCT02519504|527053046|FG001|Overall Study|Ineligible for direct testing|12|||
146148107|NCT02519504|527053045|FG000|Overall Study|Did not participate in direct testing|95|||
146148108|NCT02519504|527053046|FG001|Overall Study|Did not participate in direct testing|86|||
146148109|NCT02317575|527053047|FG000|Period 1|Difficulty with venous cannulation|0|||
146148110|NCT02317575|527053048|FG001|Period 1|Difficulty with venous cannulation|1|||
146148111|NCT02317575|527053049|FG002|Period 1|Difficulty with venous cannulation|0|||
146148112|NCT02317575|527053050|FG003|Period 1|Difficulty with venous cannulation|0|||
146148113|NCT02317575|527053051|FG004|Period 1|Difficulty with venous cannulation|0|||
146148114|NCT02317575|527053047|FG000|Period 1|Withdrawal by Subject|1|||
146148115|NCT02317575|527053048|FG001|Period 1|Withdrawal by Subject|0|||
146148116|NCT02317575|527053049|FG002|Period 1|Withdrawal by Subject|0|||
146148117|NCT02317575|527053050|FG003|Period 1|Withdrawal by Subject|0|||
146148118|NCT02317575|527053051|FG004|Period 1|Withdrawal by Subject|0|||
146148119|NCT01925183|527053056|FG000|Overall Study|Adverse Event|1|||
146148120|NCT01925183|527053057|FG001|Overall Study|Adverse Event|0|||
146148121|NCT02159482|527053058|FG000|Overall Study|Withdrawal by Subject|2|||
146148122|NCT02159482|527053058|FG000|Overall Study|Physician Decision|3|||
146148123|NCT00534352|527053061|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
146148124|NCT00534352|527053061|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
146148125|NCT00534352|527053061|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
146148126|NCT00534352|527053061|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
146148127|NCT00534352|527053061|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
146148128|NCT00534352|527053061|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
146148129|NCT04788147|527053062|FG000|Overall Study|Screen Failure|3|||
146148130|NCT04788147|527053063|FG001|Overall Study|Screen Failure|10|||
146148131|NCT04788147|527053062|FG000|Overall Study|Incomplete RMRS image session|2|||
146148132|NCT04788147|527053063|FG001|Overall Study|Incomplete RMRS image session|0|||
146148133|NCT00781326|527053066|FG000|Phase I|Adverse Event|1|||
146148134|NCT00781326|527053066|FG000|Phase I|Withdrawal by Subject|1|||
146148135|NCT00781326|527053066|FG000|Phase I|Physician Decision|2|||
146148136|NCT04796610|527053069|FG000|Overall Study|Withdrawal by Subject|1|||
146148137|NCT04796610|527053070|FG001|Overall Study|Withdrawal by Subject|0|||
146148138|NCT04796610|527053071|FG002|Overall Study|Withdrawal by Subject|0|||
146148139|NCT04796610|527053072|FG003|Overall Study|Withdrawal by Subject|0|||
146148140|NCT04796610|527053069|FG000|Overall Study|Lost to Follow-up|2|||
146148141|NCT04796610|527053070|FG001|Overall Study|Lost to Follow-up|0|||
146148142|NCT04796610|527053071|FG002|Overall Study|Lost to Follow-up|1|||
146148143|NCT04796610|527053072|FG003|Overall Study|Lost to Follow-up|1|||
146148144|NCT02401672|527053073|FG000|Overall Study|Withdrawal by Subject|1|||
146148145|NCT02401672|527053074|FG001|Overall Study|Withdrawal by Subject|3|||
146148146|NCT01459796|527053075|FG000|Overall Study|Non compliance with protocol|2|||
146148147|NCT01459796|527053076|FG001|Overall Study|Non compliance with protocol|4|||
146148148|NCT01459796|527053075|FG000|Overall Study|Adverse Event|5|||
146148149|NCT01459796|527053076|FG001|Overall Study|Adverse Event|5|||
146148150|NCT01459796|527053075|FG000|Overall Study|Withdrawal by Subject|6|||
146148151|NCT01459796|527053076|FG001|Overall Study|Withdrawal by Subject|3|||
146148152|NCT01459796|527053075|FG000|Overall Study|Lost to Follow-up|5|||
146148153|NCT01459796|527053076|FG001|Overall Study|Lost to Follow-up|4|||
146148154|NCT01459796|527053075|FG000|Overall Study|Reason unspecified|1|||
146148155|NCT01459796|527053076|FG001|Overall Study|Reason unspecified|2|||
146148156|NCT01459796|527053075|FG000|Overall Study|Decision by the sponsor|75|||
146148157|NCT01459796|527053076|FG001|Overall Study|Decision by the sponsor|108|||
146148158|NCT00701051|527053077|FG000|Screening|Failed Screening|40|||
146148159|NCT00701051|527053078|FG001|Screening|Failed Screening|0|||
146148160|NCT00701051|527053079|FG002|Screening|Failed Screening|0|||
146148161|NCT00701051|527053077|FG000|Screening|Time conflicts|19|||
146148162|NCT00701051|527053078|FG001|Screening|Time conflicts|0|||
146148163|NCT00701051|527053079|FG002|Screening|Time conflicts|0|||
146148164|NCT00701051|527053077|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
146148165|NCT00701051|527053078|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
146148166|NCT00701051|527053079|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
146148167|NCT01440946|527053080|FG000|Overall Study|Lost to Follow-up|1|||
146148168|NCT01440946|527053081|FG001|Overall Study|Lost to Follow-up|1|||
146148169|NCT01440946|527053080|FG000|Overall Study|Physician Decision|1|||
146148170|NCT01440946|527053081|FG001|Overall Study|Physician Decision|0|||
146148171|NCT01603875|527053085|FG000|Overall Study|Preexisting rabies antibody|3|||
146148172|NCT01603875|527053086|FG001|Overall Study|Preexisting rabies antibody|4|||
146148173|NCT01603875|527053087|FG002|Overall Study|Preexisting rabies antibody|3|||
146148174|NCT01603875|527053085|FG000|Overall Study|Lost to Follow-up|4|||
146148175|NCT01603875|527053086|FG001|Overall Study|Lost to Follow-up|3|||
146148176|NCT01603875|527053087|FG002|Overall Study|Lost to Follow-up|6|||
146148177|NCT01603875|527053085|FG000|Overall Study|Protocol Violation|0|||
146148178|NCT01603875|527053086|FG001|Overall Study|Protocol Violation|1|||
146148179|NCT01603875|527053087|FG002|Overall Study|Protocol Violation|0|||
146148180|NCT04122443|527053092|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
146148181|NCT04122443|527053093|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
146148182|NCT04122443|527053094|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
146148183|NCT04122443|527053092|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
146148184|NCT04122443|527053093|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
146148185|NCT04122443|527053094|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
146148186|NCT01072201|527053095|FG000|Overall Study|Lost to Follow-up|0|||
146148187|NCT01072201|527053096|FG001|Overall Study|Lost to Follow-up|1|||
146148188|NCT00360334|527053097|FG000|Overall Study|Adverse Event|7|||
146278614|NCT00996476|527534356|FG004|Overall Study|Withdrawal by Subject|1|||
146278615|NCT00996476|527534352|FG000|Overall Study|Adverse Event|0|||
146278616|NCT00996476|527534353|FG001|Overall Study|Adverse Event|1|||
146278617|NCT00996476|527534354|FG002|Overall Study|Adverse Event|0|||
146278618|NCT00996476|527534355|FG003|Overall Study|Adverse Event|0|||
146148189|NCT00360334|527053098|FG001|Overall Study|Adverse Event|4|||
146148190|NCT00360334|527053097|FG000|Overall Study|Protocol Violation|1|||
146148191|NCT00360334|527053098|FG001|Overall Study|Protocol Violation|1|||
146148192|NCT00360334|527053097|FG000|Overall Study|Physician Decision|2|||
146148193|NCT00360334|527053098|FG001|Overall Study|Physician Decision|3|||
146148194|NCT00360334|527053097|FG000|Overall Study|Lack of Efficacy|0|||
146148195|NCT00360334|527053098|FG001|Overall Study|Lack of Efficacy|1|||
146148196|NCT00360334|527053097|FG000|Overall Study|Entry criterion not met|1|||
146148197|NCT00360334|527053098|FG001|Overall Study|Entry criterion not met|2|||
146148198|NCT00360334|527053097|FG000|Overall Study|Subject decision|8|||
146148199|NCT00360334|527053098|FG001|Overall Study|Subject decision|2|||
146148200|NCT01898793|527053099|FG000|Overall Study|Death|2|||
146148201|NCT01898793|527053100|FG001|Overall Study|Death|1|||
146148202|NCT01898793|527053101|FG002|Overall Study|Death|4|||
146148203|NCT01898793|527053102|FG003|Overall Study|Death|0|||
146148204|NCT01898793|527053103|FG004|Overall Study|Death|0|||
146148205|NCT01898793|527053104|FG005|Overall Study|Death|0|||
146148206|NCT01898793|527053105|FG006|Overall Study|Death|0|||
146148207|NCT01578551|527053107|FG000|Overall Study|Adverse Event|1|||
146148208|NCT01578551|527053108|FG001|Overall Study|Adverse Event|0|||
146148209|NCT04028388|527053109|FG000|Overall Study|Evaluations missing|3|||
146148210|NCT04028388|527053110|FG001|Overall Study|Evaluations missing|6|||
146148211|NCT04028388|527053109|FG000|Overall Study|Not started|2|||
146148212|NCT04028388|527053110|FG001|Overall Study|Not started|0|||
146148213|NCT02199691|527053111|FG000|Overall Study|Protocol Violation|3|||
146148214|NCT02199691|527053112|FG001|Overall Study|Protocol Violation|3|||
146148215|NCT02199691|527053113|FG002|Overall Study|Protocol Violation|6|||
146148216|NCT02199691|527053114|FG003|Overall Study|Protocol Violation|7|||
146148217|NCT02199691|527053111|FG000|Overall Study|Withdrawal by Subject|5|||
146148218|NCT02199691|527053112|FG001|Overall Study|Withdrawal by Subject|3|||
146148219|NCT02199691|527053113|FG002|Overall Study|Withdrawal by Subject|12|||
146148220|NCT02199691|527053114|FG003|Overall Study|Withdrawal by Subject|13|||
146148221|NCT02199691|527053111|FG000|Overall Study|Lost to Follow-up|2|||
146148222|NCT02199691|527053112|FG001|Overall Study|Lost to Follow-up|1|||
146148223|NCT02199691|527053113|FG002|Overall Study|Lost to Follow-up|9|||
146148224|NCT02199691|527053114|FG003|Overall Study|Lost to Follow-up|10|||
146148225|NCT00774995|527053115|FG000|Overall Study|Protocol Violation|0|||
146148226|NCT00774995|527053116|FG001|Overall Study|Protocol Violation|0|||
146148227|NCT00774995|527053117|FG002|Overall Study|Protocol Violation|1|||
146148228|NCT00774995|527053118|FG003|Overall Study|Protocol Violation|0|||
146148229|NCT01209624|527053124|FG000|Overall Study|Death|2|||
146148230|NCT01209624|527053124|FG000|Overall Study|Adverse Event|13|||
146148231|NCT01209624|527053124|FG000|Overall Study|Lack of Efficacy|17|||
146148232|NCT01209624|527053124|FG000|Overall Study|Lost to Follow-up|290|||
146148233|NCT01209624|527053124|FG000|Overall Study|Other|4|||
146148234|NCT03403634|527053129|FG000|Overall Study|Disease progression|3|||
146148235|NCT03403634|527053129|FG000|Overall Study|Did not meet eligibility criteria|4|||
146148236|NCT00428610|527053130|FG000|Overall Study|Death Due to Adverse Event|3|||
146148237|NCT00428610|527053131|FG001|Overall Study|Death Due to Adverse Event|0|||
146148238|NCT00428610|527053132|FG002|Overall Study|Death Due to Adverse Event|5|||
146148239|NCT00428610|527053130|FG000|Overall Study|Death Due to Progressive Disease|0|||
146148240|NCT00428610|527053131|FG001|Overall Study|Death Due to Progressive Disease|0|||
146148241|NCT00428610|527053132|FG002|Overall Study|Death Due to Progressive Disease|2|||
146148242|NCT00428610|527053130|FG000|Overall Study|Adverse Event|2|||
146148243|NCT00428610|527053131|FG001|Overall Study|Adverse Event|3|||
146148244|NCT00428610|527053132|FG002|Overall Study|Adverse Event|2|||
146148245|NCT00428610|527053130|FG000|Overall Study|Investigator Decision|2|||
146148246|NCT00428610|527053131|FG001|Overall Study|Investigator Decision|1|||
146148247|NCT00428610|527053132|FG002|Overall Study|Investigator Decision|1|||
146148248|NCT00428610|527053130|FG000|Overall Study|Progressive Disease|42|||
146148249|NCT00428610|527053131|FG001|Overall Study|Progressive Disease|14|||
146148250|NCT00428610|527053132|FG002|Overall Study|Progressive Disease|22|||
146148251|NCT00428610|527053130|FG000|Overall Study|Withdrawal by Subject|4|||
146148252|NCT00428610|527053131|FG001|Overall Study|Withdrawal by Subject|0|||
146148253|NCT00428610|527053132|FG002|Overall Study|Withdrawal by Subject|0|||
146148254|NCT01539291|527055524|FG000|Study GS-US-312-0116|Adverse Event|9|||
146148255|NCT01539291|527055525|FG001|Study GS-US-312-0116|Adverse Event|0|||
146148256|NCT01539291|527055526|FG002|Study GS-US-312-0116|Adverse Event|0|||
146148257|NCT01539291|527055527|FG003|Study GS-US-312-0116|Adverse Event|0|||
146148258|NCT01539291|527055524|FG000|Study GS-US-312-0116|Physician Decision|1|||
146148259|NCT01539291|527055525|FG001|Study GS-US-312-0116|Physician Decision|0|||
146148260|NCT01539291|527055526|FG002|Study GS-US-312-0116|Physician Decision|0|||
146148261|NCT01539291|527055527|FG003|Study GS-US-312-0116|Physician Decision|0|||
146148262|NCT01539291|527055524|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
146148263|NCT01539291|527055525|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
146148264|NCT01539291|527055526|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
146148265|NCT01539291|527055527|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
146148266|NCT01539291|527055524|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
146148267|NCT01539291|527055525|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146148268|NCT01539291|527055526|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146148269|NCT01539291|527055527|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
146148270|NCT01539291|527055524|FG000|Study GS-US-312-0116|Other|1|||
146148271|NCT01539291|527055525|FG001|Study GS-US-312-0116|Other|0|||
146148272|NCT01539291|527055526|FG002|Study GS-US-312-0116|Other|0|||
146148273|NCT01539291|527055527|FG003|Study GS-US-312-0116|Other|0|||
146148274|NCT01539291|527055524|FG000|Study GS-US-312-0117|Adverse Event|22|||
146148275|NCT01539291|527055525|FG001|Study GS-US-312-0117|Adverse Event|1|||
146148276|NCT01539291|527055526|FG002|Study GS-US-312-0117|Adverse Event|9|||
146148277|NCT01539291|527055527|FG003|Study GS-US-312-0117|Adverse Event|12|||
146148278|NCT01539291|527055524|FG000|Study GS-US-312-0117|Physician Decision|9|||
146148279|NCT01539291|527055525|FG001|Study GS-US-312-0117|Physician Decision|0|||
146148280|NCT01539291|527055526|FG002|Study GS-US-312-0117|Physician Decision|6|||
146148281|NCT01539291|527055527|FG003|Study GS-US-312-0117|Physician Decision|4|||
146148282|NCT01539291|527055524|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
146148283|NCT01539291|527055525|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
146148284|NCT01539291|527055526|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
146148285|NCT01539291|527055527|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
146148286|NCT01539291|527055524|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
146148287|NCT01539291|527055525|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
146148288|NCT01539291|527055526|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
146148289|NCT01539291|527055527|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
146148290|NCT01539291|527055524|FG000|Study GS-US-312-0117|Other|2|||
146148291|NCT01539291|527055525|FG001|Study GS-US-312-0117|Other|1|||
146148292|NCT01539291|527055526|FG002|Study GS-US-312-0117|Other|1|||
146148293|NCT01539291|527055527|FG003|Study GS-US-312-0117|Other|1|||
146148294|NCT04450264|527055528|FG000|Overall Study|Incomplete survey|13|||
146148295|NCT04450264|527055529|FG001|Overall Study|Incomplete survey|19|||
146148296|NCT03320070|527055532|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
146148297|NCT03320070|527055533|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
146148298|NCT03320070|527055532|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
146148299|NCT03320070|527055533|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
146148300|NCT03320070|527055532|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
146148301|NCT03320070|527055533|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
146148302|NCT03320070|527055532|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
146148303|NCT03320070|527055533|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
146148304|NCT03320070|527055532|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
146148305|NCT03320070|527055533|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
146148306|NCT03320070|527055532|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
146148307|NCT03320070|527055533|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
146148308|NCT02416791|527055536|FG000|6 Months|Lost to Follow-up|0|||
146148309|NCT02416791|527055537|FG001|6 Months|Lost to Follow-up|0|||
146148310|NCT02416791|527055538|FG002|6 Months|Lost to Follow-up|1|||
146148311|NCT01054729|527055539|FG000|Overall Study|Randomized but Not Treated|0|||
146148312|NCT01054729|527055540|FG001|Overall Study|Randomized but Not Treated|1|||
146148313|NCT01054729|527055541|FG002|Overall Study|Randomized but Not Treated|0|||
146148314|NCT01054729|527055542|FG003|Overall Study|Randomized but Not Treated|0|||
146148315|NCT01054729|527055539|FG000|Overall Study|Adverse Event|1|||
146148316|NCT01054729|527055540|FG001|Overall Study|Adverse Event|1|||
146148317|NCT01054729|527055541|FG002|Overall Study|Adverse Event|2|||
146148318|NCT01054729|527055542|FG003|Overall Study|Adverse Event|1|||
146148319|NCT01054729|527055539|FG000|Overall Study|Withdrawal by Subject|1|||
146148320|NCT01054729|527055540|FG001|Overall Study|Withdrawal by Subject|0|||
146148321|NCT01054729|527055541|FG002|Overall Study|Withdrawal by Subject|1|||
146148322|NCT01054729|527055542|FG003|Overall Study|Withdrawal by Subject|0|||
146148323|NCT01054729|527055539|FG000|Overall Study|Lost to Follow-up|0|||
146148324|NCT01054729|527055540|FG001|Overall Study|Lost to Follow-up|1|||
146148325|NCT01054729|527055541|FG002|Overall Study|Lost to Follow-up|0|||
146148326|NCT01054729|527055542|FG003|Overall Study|Lost to Follow-up|0|||
146148327|NCT01054729|527055539|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146148328|NCT01054729|527055540|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
146148329|NCT01054729|527055541|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146148330|NCT01054729|527055542|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
146148331|NCT01054729|527055539|FG000|Overall Study|Non-responder|1|||
146148332|NCT01054729|527055540|FG001|Overall Study|Non-responder|0|||
146148333|NCT01054729|527055541|FG002|Overall Study|Non-responder|1|||
146148334|NCT01054729|527055542|FG003|Overall Study|Non-responder|1|||
146148335|NCT01054729|527055539|FG000|Overall Study|PEG/RBV Non-responder|1|||
146148336|NCT01054729|527055540|FG001|Overall Study|PEG/RBV Non-responder|0|||
146148337|NCT01054729|527055541|FG002|Overall Study|PEG/RBV Non-responder|1|||
146148338|NCT01054729|527055542|FG003|Overall Study|PEG/RBV Non-responder|0|||
146148339|NCT01054729|527055539|FG000|Overall Study|Personal/Obligations|0|||
146148340|NCT01054729|527055540|FG001|Overall Study|Personal/Obligations|1|||
146148341|NCT01054729|527055541|FG002|Overall Study|Personal/Obligations|0|||
146148342|NCT01054729|527055542|FG003|Overall Study|Personal/Obligations|0|||
146148343|NCT01054729|527055539|FG000|Overall Study|Subject moved|0|||
146148344|NCT01054729|527055540|FG001|Overall Study|Subject moved|0|||
146148345|NCT01054729|527055541|FG002|Overall Study|Subject moved|1|||
146148346|NCT01054729|527055542|FG003|Overall Study|Subject moved|0|||
146148347|NCT01054729|527055539|FG000|Overall Study|Lack of Efficacy|0|||
146148348|NCT01054729|527055540|FG001|Overall Study|Lack of Efficacy|0|||
146148349|NCT01054729|527055541|FG002|Overall Study|Lack of Efficacy|0|||
146148350|NCT01054729|527055542|FG003|Overall Study|Lack of Efficacy|1|||
146148351|NCT00562159|527055543|FG000|Overall Study|Adverse Event|11|||
146148352|NCT00562159|527055544|FG001|Overall Study|Adverse Event|8|||
146148353|NCT00562159|527055543|FG000|Overall Study|Lost to Follow-up|5|||
146148354|NCT00562159|527055544|FG001|Overall Study|Lost to Follow-up|4|||
146148355|NCT00562159|527055543|FG000|Overall Study|Withdrawal by Subject|9|||
146148356|NCT00562159|527055544|FG001|Overall Study|Withdrawal by Subject|8|||
146148357|NCT00562159|527055543|FG000|Overall Study|Protocol Violation|12|||
146148358|NCT00562159|527055544|FG001|Overall Study|Protocol Violation|12|||
146148359|NCT00562159|527055543|FG000|Overall Study|Did not meet protocol eligibility|1|||
146148360|NCT00562159|527055544|FG001|Overall Study|Did not meet protocol eligibility|1|||
146148361|NCT01992536|527055548|FG000|Overall Study|Administrative Reason|0|||
146148362|NCT01992536|527055549|FG001|Overall Study|Administrative Reason|0|||
146148363|NCT01992536|527055550|FG002|Overall Study|Administrative Reason|0|||
146148364|NCT01992536|527055551|FG003|Overall Study|Administrative Reason|0|||
146148365|NCT01992536|527055552|FG004|Overall Study|Administrative Reason|0|||
146148366|NCT01992536|527055553|FG005|Overall Study|Administrative Reason|0|||
146148367|NCT01992536|527055554|FG006|Overall Study|Administrative Reason|7|||
146148368|NCT01992536|527055555|FG007|Overall Study|Administrative Reason|0|||
146148369|NCT01992536|527055556|FG008|Overall Study|Administrative Reason|0|||
146148370|NCT01992536|527055557|FG009|Overall Study|Administrative Reason|0|||
146148371|NCT01992536|527055548|FG000|Overall Study|Lost to Follow-up|4|||
146148372|NCT01992536|527055549|FG001|Overall Study|Lost to Follow-up|2|||
146148373|NCT01992536|527055550|FG002|Overall Study|Lost to Follow-up|1|||
146148374|NCT01992536|527055551|FG003|Overall Study|Lost to Follow-up|0|||
146148375|NCT01992536|527055552|FG004|Overall Study|Lost to Follow-up|0|||
146148376|NCT01992536|527055553|FG005|Overall Study|Lost to Follow-up|1|||
146148377|NCT01992536|527055554|FG006|Overall Study|Lost to Follow-up|0|||
146148378|NCT01992536|527055555|FG007|Overall Study|Lost to Follow-up|0|||
146148379|NCT01992536|527055556|FG008|Overall Study|Lost to Follow-up|1|||
146148380|NCT01992536|527055557|FG009|Overall Study|Lost to Follow-up|1|||
146148381|NCT01992536|527055548|FG000|Overall Study|Withdrawal by Subject|0|||
146148382|NCT01992536|527055549|FG001|Overall Study|Withdrawal by Subject|1|||
146148383|NCT01992536|527055550|FG002|Overall Study|Withdrawal by Subject|0|||
146148384|NCT01992536|527055551|FG003|Overall Study|Withdrawal by Subject|2|||
146148385|NCT01992536|527055552|FG004|Overall Study|Withdrawal by Subject|0|||
146148386|NCT01992536|527055553|FG005|Overall Study|Withdrawal by Subject|0|||
146148387|NCT01992536|527055554|FG006|Overall Study|Withdrawal by Subject|0|||
146148388|NCT01992536|527055555|FG007|Overall Study|Withdrawal by Subject|0|||
146148389|NCT01992536|527055556|FG008|Overall Study|Withdrawal by Subject|0|||
146148390|NCT01992536|527055557|FG009|Overall Study|Withdrawal by Subject|0|||
146148391|NCT01465334|527055558|FG000|Overall Study|Disease Progression|1|||
146148392|NCT01465334|527055559|FG001|Overall Study|Disease Progression|0|||
146148393|NCT01465334|527055558|FG000|Overall Study|Adverse Event|1|||
146148394|NCT01465334|527055559|FG001|Overall Study|Adverse Event|0|||
146148395|NCT01465334|527055558|FG000|Overall Study|Richter's transformation|0|||
146148396|NCT01465334|527055559|FG001|Overall Study|Richter's transformation|3|||
146148397|NCT01465334|527055558|FG000|Overall Study|Refractory Disease|0|||
146148398|NCT01465334|527055559|FG001|Overall Study|Refractory Disease|3|||
146148399|NCT02548962|527055560|FG000|Overall Study|Withdrawal by Subject|1|||
146148400|NCT02548962|527055561|FG001|Overall Study|Withdrawal by Subject|0|||
146148401|NCT04831736|527055562|FG000|Overall Study|Withdrawal by Subject|0|||
146148402|NCT04831736|527055563|FG001|Overall Study|Withdrawal by Subject|1|||
146278619|NCT00996476|527534356|FG004|Overall Study|Adverse Event|1|||
146278620|NCT01470001|527534357|FG000|Overall Study|Lost to Follow-up|1|||
146278621|NCT01470001|527534358|FG001|Overall Study|Lost to Follow-up|1|||
146278622|NCT01470001|527534357|FG000|Overall Study|Physician Decision|2|||
146278623|NCT01470001|527534358|FG001|Overall Study|Physician Decision|0|||
146148403|NCT03551938|527055567|FG000|3-Month Follow Up|Lost to Follow-up|39|||
146148404|NCT03551938|527055568|FG001|3-Month Follow Up|Lost to Follow-up|38|||
146148405|NCT03551938|527055567|FG000|6-Month Follow Up|Lost to Follow-up|46|||
146148406|NCT03551938|527055568|FG001|6-Month Follow Up|Lost to Follow-up|42|||
146148407|NCT03551938|527055567|FG000|9-Month Follow Up|Lost to Follow-up|44|||
146148408|NCT03551938|527055568|FG001|9-Month Follow Up|Lost to Follow-up|43|||
146148409|NCT01114646|527055569|FG000|Overall Study|Withdrawal by Subject|3|||
146148410|NCT01114646|527055570|FG001|Overall Study|Withdrawal by Subject|2|||
146148411|NCT01046110|527055571|FG000|Overall Study|Adverse Event|9|||
146148412|NCT01046110|527055572|FG001|Overall Study|Adverse Event|2|||
146148413|NCT01046110|527055571|FG000|Overall Study|Lack of Efficacy|0|||
146148414|NCT01046110|527055572|FG001|Overall Study|Lack of Efficacy|1|||
146305349|NCT03227471|527632536|FG010|Overall Study|Randomized, Never Dosed|0|||
146305350|NCT03227471|527632537|FG011|Overall Study|Randomized, Never Dosed|0|||
146305351|NCT03227471|527632538|FG012|Overall Study|Randomized, Never Dosed|0|||
146305352|NCT03227471|527632539|FG013|Overall Study|Randomized, Never Dosed|0|||
146305353|NCT03227471|527632540|FG014|Overall Study|Randomized, Never Dosed|1|||
146305354|NCT02322125|527632541|FG000|Overall Study|Withdrawal by Subject|2|||
146305355|NCT00766038|527632547|FG000|Overall Study|Lost to Follow-up|15|||
146305356|NCT00766038|527632548|FG001|Overall Study|Lost to Follow-up|14|||
146305357|NCT00449670|527632549|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
146305358|NCT00449670|527632550|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
146305359|NCT00449670|527632549|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
146305360|NCT00449670|527632550|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
146305361|NCT00449670|527632549|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
146305362|NCT00449670|527632550|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
146305363|NCT00449670|527632549|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
146305364|NCT00449670|527632550|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
146305365|NCT00449670|527632549|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
146305366|NCT00449670|527632550|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
146305367|NCT00449670|527632549|FG000|Booster Phase (Study no.109873)|Other|0|||
146305368|NCT00449670|527632550|FG001|Booster Phase (Study no.109873)|Other|2|||
146305369|NCT04183790|527632551|FG000|Overall Study|Participants did not rollover to Part B|12|||
146305370|NCT04183790|527632552|FG001|Overall Study|Participants did not rollover to Part B|0|||
146305371|NCT04183790|527632551|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
146305372|NCT04183790|527632552|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
146305373|NCT04183790|527632551|FG000|Overall Study|Commercial drug is available for participant|6|||
146305374|NCT04183790|527632552|FG001|Overall Study|Commercial drug is available for participant|0|||
146305375|NCT04183790|527632551|FG000|Overall Study|Adverse Event|1|||
146305376|NCT04183790|527632552|FG001|Overall Study|Adverse Event|0|||
146305377|NCT04183790|527632551|FG000|Overall Study|Not enrolled in 107 study|0|||
146305378|NCT04183790|527632552|FG001|Overall Study|Not enrolled in 107 study|2|||
146305379|NCT01251653|527632553|FG000|Overall Study|Progressive Disease|1|||
146305380|NCT01251653|527632554|FG001|Overall Study|Progressive Disease|7|||
146305381|NCT01251653|527632555|FG002|Overall Study|Progressive Disease|16|||
146305382|NCT01251653|527632556|FG003|Overall Study|Progressive Disease|4|||
146305383|NCT01251653|527632557|FG004|Overall Study|Progressive Disease|0|||
146305384|NCT01251653|527632558|FG005|Overall Study|Progressive Disease|17|||
146305385|NCT01251653|527632559|FG006|Overall Study|Progressive Disease|14|||
146305386|NCT01251653|527632560|FG007|Overall Study|Progressive Disease|7|||
146305387|NCT01251653|527632561|FG008|Overall Study|Progressive Disease|5|||
146305388|NCT01251653|527632553|FG000|Overall Study|Dose-limiting toxicity|0|||
146305389|NCT01251653|527632554|FG001|Overall Study|Dose-limiting toxicity|1|||
146305390|NCT01251653|527632555|FG002|Overall Study|Dose-limiting toxicity|1|||
146305391|NCT01251653|527632556|FG003|Overall Study|Dose-limiting toxicity|1|||
146305392|NCT01251653|527632557|FG004|Overall Study|Dose-limiting toxicity|0|||
146305393|NCT01251653|527632558|FG005|Overall Study|Dose-limiting toxicity|0|||
146305394|NCT01251653|527632559|FG006|Overall Study|Dose-limiting toxicity|2|||
146305395|NCT01251653|527632560|FG007|Overall Study|Dose-limiting toxicity|0|||
146305396|NCT01251653|527632561|FG008|Overall Study|Dose-limiting toxicity|0|||
146305397|NCT01251653|527632553|FG000|Overall Study|Adverse Event|1|||
146305398|NCT01251653|527632554|FG001|Overall Study|Adverse Event|0|||
146305399|NCT01251653|527632555|FG002|Overall Study|Adverse Event|2|||
146305400|NCT01251653|527632556|FG003|Overall Study|Adverse Event|1|||
146305401|NCT01251653|527632557|FG004|Overall Study|Adverse Event|1|||
146305402|NCT01251653|527632558|FG005|Overall Study|Adverse Event|0|||
146305403|NCT01251653|527632559|FG006|Overall Study|Adverse Event|2|||
146305404|NCT01251653|527632560|FG007|Overall Study|Adverse Event|2|||
146305405|NCT01251653|527632561|FG008|Overall Study|Adverse Event|1|||
146305406|NCT01251653|527632553|FG000|Overall Study|Withdrawal by Subject|1|||
146305407|NCT01251653|527632554|FG001|Overall Study|Withdrawal by Subject|0|||
146305408|NCT01251653|527632555|FG002|Overall Study|Withdrawal by Subject|1|||
146305409|NCT01251653|527632556|FG003|Overall Study|Withdrawal by Subject|0|||
146305410|NCT01251653|527632557|FG004|Overall Study|Withdrawal by Subject|1|||
146305411|NCT01251653|527632558|FG005|Overall Study|Withdrawal by Subject|1|||
146305412|NCT01251653|527632559|FG006|Overall Study|Withdrawal by Subject|0|||
146305413|NCT01251653|527632560|FG007|Overall Study|Withdrawal by Subject|1|||
146305414|NCT01251653|527632561|FG008|Overall Study|Withdrawal by Subject|0|||
146305415|NCT01251653|527632553|FG000|Overall Study|Other reason not mentioned above|0|||
146305416|NCT01251653|527632554|FG001|Overall Study|Other reason not mentioned above|0|||
146305417|NCT01251653|527632555|FG002|Overall Study|Other reason not mentioned above|0|||
146305418|NCT01251653|527632556|FG003|Overall Study|Other reason not mentioned above|0|||
146305419|NCT01251653|527632557|FG004|Overall Study|Other reason not mentioned above|0|||
146148415|NCT01046110|527055571|FG000|Overall Study|Protocol Violation|7|||
146305420|NCT01251653|527632558|FG005|Overall Study|Other reason not mentioned above|0|||
146305421|NCT01251653|527632559|FG006|Overall Study|Other reason not mentioned above|0|||
146148416|NCT01046110|527055572|FG001|Overall Study|Protocol Violation|12|||
146148417|NCT01046110|527055571|FG000|Overall Study|Withdrawal Criteria|3|||
146148418|NCT01046110|527055572|FG001|Overall Study|Withdrawal Criteria|5|||
146148419|NCT01046110|527055571|FG000|Overall Study|Unclassified|36|||
146148420|NCT01046110|527055572|FG001|Overall Study|Unclassified|35|||
146148421|NCT01233817|527055573|FG000|Overall Study|Lost to Follow-up|1|||
146148422|NCT01233817|527055573|FG000|Overall Study|Withdrawal by Subject|2|||
146148423|NCT01202773|527055576|FG000|Overall Study|Adverse Event|4|||
146148424|NCT01202773|527055577|FG001|Overall Study|Adverse Event|5|||
146148425|NCT01202773|527055578|FG002|Overall Study|Adverse Event|5|||
146148426|NCT01202773|527055576|FG000|Overall Study|Lack of Efficacy|5|||
146148427|NCT01202773|527055577|FG001|Overall Study|Lack of Efficacy|4|||
146148428|NCT01202773|527055578|FG002|Overall Study|Lack of Efficacy|9|||
146148429|NCT01202773|527055576|FG000|Overall Study|Entry Criteria Not Met|2|||
146148430|NCT01202773|527055577|FG001|Overall Study|Entry Criteria Not Met|0|||
146148431|NCT01202773|527055578|FG002|Overall Study|Entry Criteria Not Met|1|||
146148432|NCT01202773|527055576|FG000|Overall Study|Lost to Follow-up|1|||
146148433|NCT01202773|527055577|FG001|Overall Study|Lost to Follow-up|2|||
146148434|NCT01202773|527055578|FG002|Overall Study|Lost to Follow-up|2|||
146148435|NCT01202773|527055576|FG000|Overall Study|Withdrawal by Subject|13|||
146148436|NCT01202773|527055577|FG001|Overall Study|Withdrawal by Subject|6|||
146148437|NCT01202773|527055578|FG002|Overall Study|Withdrawal by Subject|5|||
146148438|NCT01202773|527055576|FG000|Overall Study|Physician Decision|2|||
146148439|NCT01202773|527055577|FG001|Overall Study|Physician Decision|0|||
146148440|NCT01202773|527055578|FG002|Overall Study|Physician Decision|0|||
146148441|NCT01202773|527055576|FG000|Overall Study|Protocol Violation|11|||
146148442|NCT01202773|527055577|FG001|Overall Study|Protocol Violation|6|||
146148443|NCT01202773|527055578|FG002|Overall Study|Protocol Violation|10|||
146148444|NCT01202773|527055576|FG000|Overall Study|Sponsor Decision|19|||
146148445|NCT01202773|527055577|FG001|Overall Study|Sponsor Decision|20|||
146148446|NCT01202773|527055578|FG002|Overall Study|Sponsor Decision|23|||
146148447|NCT01430130|527055583|FG000|Overall Study|Lost to Follow-up|1|||
146148448|NCT01430130|527055583|FG000|Overall Study|Infection on Control Side of Incision|1|||
146148449|NCT03525834|527055584|FG000|Overall Study|Progressive disease|1|||
146148450|NCT02828111|527055588|FG000|Overall Study|Withdrawal by Subject|0|||
146148451|NCT02828111|527055589|FG001|Overall Study|Withdrawal by Subject|0|||
146148452|NCT02828111|527055590|FG002|Overall Study|Withdrawal by Subject|2|||
146148453|NCT02828111|527055591|FG003|Overall Study|Withdrawal by Subject|0|||
146148454|NCT02828111|527055592|FG004|Overall Study|Withdrawal by Subject|0|||
146148455|NCT02828111|527055588|FG000|Overall Study|Lost to Follow-up|0|||
146148456|NCT02828111|527055589|FG001|Overall Study|Lost to Follow-up|0|||
146148457|NCT02828111|527055590|FG002|Overall Study|Lost to Follow-up|0|||
146148458|NCT02828111|527055591|FG003|Overall Study|Lost to Follow-up|1|||
146148459|NCT02828111|527055592|FG004|Overall Study|Lost to Follow-up|1|||
146148460|NCT00614939|527055595|FG000|Overall Study|Withdrawal by Subject|10|||
146148461|NCT00614939|527055596|FG001|Overall Study|Withdrawal by Subject|17|||
146148462|NCT00614939|527055595|FG000|Overall Study|Study specific discontinuation criteris|13|||
146148463|NCT00614939|527055596|FG001|Overall Study|Study specific discontinuation criteris|16|||
146148464|NCT00614939|527055595|FG000|Overall Study|Adverse Event|2|||
146148465|NCT00614939|527055596|FG001|Overall Study|Adverse Event|5|||
146148466|NCT00614939|527055595|FG000|Overall Study|Incorrect enrollment|1|||
146148467|NCT00614939|527055596|FG001|Overall Study|Incorrect enrollment|2|||
146148468|NCT00614939|527055595|FG000|Overall Study|Death|4|||
146148469|NCT00614939|527055596|FG001|Overall Study|Death|3|||
146148470|NCT00614939|527055595|FG000|Overall Study|Poor/non-compliance|4|||
146148471|NCT00614939|527055596|FG001|Overall Study|Poor/non-compliance|0|||
146148472|NCT00614939|527055595|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
146148473|NCT00614939|527055596|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
146148474|NCT00840970|527055597|FG000|Overall Study|Adverse Event|0|||
146148475|NCT00840970|527055598|FG001|Overall Study|Adverse Event|0|||
146148476|NCT00840970|527055599|FG002|Overall Study|Adverse Event|1|||
146148477|NCT00504829|527055600|FG000|Overall Study|Protocol Violation|6|||
146148478|NCT00504829|527055601|FG001|Overall Study|Protocol Violation|4|||
146148479|NCT00504829|527055602|FG002|Overall Study|Protocol Violation|10|||
146148480|NCT03465540|527055603|FG000|Overall Study|Withdrawal by Subject|0|||
146148481|NCT03465540|527055604|FG001|Overall Study|Withdrawal by Subject|0|||
146148482|NCT03465540|527055605|FG002|Overall Study|Withdrawal by Subject|1|||
146148483|NCT03465540|527055606|FG003|Overall Study|Withdrawal by Subject|1|||
146148484|NCT03465540|527055607|FG004|Overall Study|Withdrawal by Subject|1|||
146148485|NCT03465540|527055608|FG005|Overall Study|Withdrawal by Subject|0|||
146148486|NCT03465540|527055603|FG000|Overall Study|Lost to Follow-up|0|||
146148487|NCT03465540|527055604|FG001|Overall Study|Lost to Follow-up|1|||
146148488|NCT03465540|527055605|FG002|Overall Study|Lost to Follow-up|0|||
146148489|NCT03465540|527055606|FG003|Overall Study|Lost to Follow-up|0|||
146148490|NCT03465540|527055607|FG004|Overall Study|Lost to Follow-up|1|||
146148491|NCT03465540|527055608|FG005|Overall Study|Lost to Follow-up|0|||
146148492|NCT03465540|527055603|FG000|Overall Study|Death|1|||
146148493|NCT03465540|527055604|FG001|Overall Study|Death|1|||
146148494|NCT03465540|527055605|FG002|Overall Study|Death|0|||
146305422|NCT01251653|527632560|FG007|Overall Study|Other reason not mentioned above|2|||
146305423|NCT01251653|527632561|FG008|Overall Study|Other reason not mentioned above|0|||
146305424|NCT01524198|527632563|FG000|Overall Study|Protocol Violation|8|||
146305425|NCT01524198|527632564|FG001|Overall Study|Protocol Violation|6|||
146305426|NCT01524198|527632563|FG000|Overall Study|Withdrawal by Subject|15|||
146305427|NCT01524198|527632564|FG001|Overall Study|Withdrawal by Subject|10|||
146305428|NCT02232802|527632565|FG000|Period 1|Sponsor request|1|||
146305429|NCT02232802|527632566|FG001|Period 1|Sponsor request|0|||
146305430|NCT02232802|527632565|FG000|Period 1|Adverse Event|1|||
146305431|NCT02232802|527632566|FG001|Period 1|Adverse Event|1|||
146305432|NCT00885703|527632568|FG000|Overall Study|Death|9|||
146305433|NCT00885703|527632569|FG001|Overall Study|Death|7|||
146305434|NCT00885703|527632570|FG002|Overall Study|Death|8|||
146305435|NCT00885703|527632571|FG003|Overall Study|Death|7|||
146305436|NCT00885703|527632572|FG004|Overall Study|Death|7|||
146305437|NCT00885703|527632573|FG005|Overall Study|Death|8|||
146305438|NCT00885703|527632574|FG006|Overall Study|Death|4|||
146305439|NCT00885703|527632568|FG000|Overall Study|Lost to Follow-up|0|||
146305440|NCT00885703|527632569|FG001|Overall Study|Lost to Follow-up|0|||
146305441|NCT00885703|527632570|FG002|Overall Study|Lost to Follow-up|1|||
146305442|NCT00885703|527632571|FG003|Overall Study|Lost to Follow-up|0|||
146305443|NCT00885703|527632572|FG004|Overall Study|Lost to Follow-up|0|||
146305444|NCT00885703|527632573|FG005|Overall Study|Lost to Follow-up|1|||
146305445|NCT00885703|527632574|FG006|Overall Study|Lost to Follow-up|0|||
146305446|NCT00885703|527632568|FG000|Overall Study|Withdrawal by Subject|0|||
146305447|NCT00885703|527632569|FG001|Overall Study|Withdrawal by Subject|0|||
146305448|NCT00885703|527632570|FG002|Overall Study|Withdrawal by Subject|0|||
146305449|NCT00885703|527632571|FG003|Overall Study|Withdrawal by Subject|1|||
146305450|NCT00885703|527632572|FG004|Overall Study|Withdrawal by Subject|3|||
146305451|NCT00885703|527632573|FG005|Overall Study|Withdrawal by Subject|1|||
146305452|NCT00885703|527632574|FG006|Overall Study|Withdrawal by Subject|1|||
146305453|NCT00885703|527632568|FG000|Overall Study|Ineligible (no CM)|1|||
146305454|NCT00885703|527632569|FG001|Overall Study|Ineligible (no CM)|3|||
146305455|NCT00885703|527632570|FG002|Overall Study|Ineligible (no CM)|2|||
146305456|NCT00885703|527632571|FG003|Overall Study|Ineligible (no CM)|1|||
146305457|NCT00885703|527632572|FG004|Overall Study|Ineligible (no CM)|2|||
146305458|NCT00885703|527632573|FG005|Overall Study|Ineligible (no CM)|3|||
146148495|NCT03465540|527055606|FG003|Overall Study|Death|2|||
146148496|NCT03465540|527055607|FG004|Overall Study|Death|0|||
146148497|NCT03465540|527055608|FG005|Overall Study|Death|2|||
146148498|NCT03465540|527055603|FG000|Overall Study|Protocol specified criteria|0|||
146148499|NCT03465540|527055604|FG001|Overall Study|Protocol specified criteria|2|||
146148500|NCT03465540|527055605|FG002|Overall Study|Protocol specified criteria|2|||
146148501|NCT03465540|527055606|FG003|Overall Study|Protocol specified criteria|0|||
146148502|NCT03465540|527055607|FG004|Overall Study|Protocol specified criteria|2|||
146148503|NCT03465540|527055608|FG005|Overall Study|Protocol specified criteria|0|||
146148504|NCT04443218|527055609|FG000|Overall Study|Exited study for other reasons|9|||
146148505|NCT04443218|527055609|FG000|Overall Study|Withdrawal by Subject|1|||
146148506|NCT04443218|527055609|FG000|Overall Study|Lost to Follow-up|4|||
146148507|NCT04443218|527055609|FG000|Overall Study|Death|19|||
146148508|NCT02660944|527055618|FG000|Overall Study|Adverse Event|3|||
146148509|NCT02660944|527055619|FG001|Overall Study|Adverse Event|4|||
146148510|NCT02660944|527055618|FG000|Overall Study|Physician Decision|3|||
146148511|NCT02660944|527055619|FG001|Overall Study|Physician Decision|1|||
146148512|NCT02660944|527055618|FG000|Overall Study|Withdrawal by Subject|5|||
146148513|NCT02660944|527055619|FG001|Overall Study|Withdrawal by Subject|3|||
146148514|NCT02660944|527055618|FG000|Overall Study|Lost to Follow-up|4|||
146148515|NCT02660944|527055619|FG001|Overall Study|Lost to Follow-up|1|||
146148516|NCT02660944|527055618|FG000|Overall Study|Subject schedule|0|||
146148517|NCT02660944|527055619|FG001|Overall Study|Subject schedule|1|||
146148518|NCT02660944|527055618|FG000|Overall Study|Exclusion criteria met|2|||
146148519|NCT02660944|527055619|FG001|Overall Study|Exclusion criteria met|0|||
146148520|NCT02843568|527055620|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
146148521|NCT02843568|527055621|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
146305459|NCT00885703|527632574|FG006|Overall Study|Ineligible (no CM)|1|||
146148522|NCT02843568|527055620|FG000|Overall Study|Death|3|||
146148523|NCT02843568|527055621|FG001|Overall Study|Death|3|||
146148524|NCT02843568|527055620|FG000|Overall Study|Withdrawal by Subject|1|||
146148525|NCT02843568|527055621|FG001|Overall Study|Withdrawal by Subject|1|||
146148526|NCT02843568|527055620|FG000|Overall Study|Lost to Follow-up|2|||
146148527|NCT02843568|527055621|FG001|Overall Study|Lost to Follow-up|0|||
146148528|NCT03586999|527055622|FG000|Overall Study|Lack of Efficacy|2|||
146305460|NCT01490450|527632578|FG000|Period 1|Lack of Efficacy|2|||
146305461|NCT01490450|527632579|FG001|Period 1|Lack of Efficacy|0|||
146305462|NCT01490450|527632580|FG002|Period 1|Lack of Efficacy|3|||
146305463|NCT01490450|527632581|FG003|Period 1|Lack of Efficacy|0|||
146305464|NCT01490450|527632578|FG000|Period 1|Adverse Event|0|||
146305465|NCT01490450|527632579|FG001|Period 1|Adverse Event|0|||
146305466|NCT01490450|527632580|FG002|Period 1|Adverse Event|0|||
146305467|NCT01490450|527632581|FG003|Period 1|Adverse Event|5|||
146148529|NCT04096560|527055623|FG000|Overall Study|Reason not Specified|1|||
146148530|NCT04096560|527055624|FG001|Overall Study|Reason not Specified|0|||
146148531|NCT04096560|527055625|FG002|Overall Study|Reason not Specified|0|||
146148532|NCT04096560|527055626|FG003|Overall Study|Reason not Specified|0|||
146148533|NCT04096560|527055627|FG004|Overall Study|Reason not Specified|1|||
146148534|NCT04096560|527055628|FG005|Overall Study|Reason not Specified|1|||
146148535|NCT04096560|527055629|FG006|Overall Study|Reason not Specified|1|||
146148536|NCT04096560|527055630|FG007|Overall Study|Reason not Specified|0|||
146148537|NCT04096560|527055623|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148538|NCT04096560|527055624|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148539|NCT04096560|527055625|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148540|NCT04096560|527055626|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148541|NCT04096560|527055627|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148542|NCT04096560|527055628|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
146148543|NCT04096560|527055629|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
146148544|NCT04096560|527055630|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
146148545|NCT04096560|527055623|FG000|Overall Study|Study Terminated by Sponsor|0|||
146148546|NCT04096560|527055624|FG001|Overall Study|Study Terminated by Sponsor|0|||
146148547|NCT04096560|527055625|FG002|Overall Study|Study Terminated by Sponsor|0|||
146148548|NCT04096560|527055626|FG003|Overall Study|Study Terminated by Sponsor|5|||
146148549|NCT04096560|527055627|FG004|Overall Study|Study Terminated by Sponsor|6|||
146148550|NCT04096560|527055628|FG005|Overall Study|Study Terminated by Sponsor|4|||
146148551|NCT04096560|527055629|FG006|Overall Study|Study Terminated by Sponsor|6|||
146148552|NCT04096560|527055630|FG007|Overall Study|Study Terminated by Sponsor|1|||
146148553|NCT04096560|527055623|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148554|NCT04096560|527055624|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148555|NCT04096560|527055625|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148556|NCT04096560|527055626|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148557|NCT04096560|527055627|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148558|NCT04096560|527055628|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148559|NCT04096560|527055629|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
146148560|NCT04096560|527055630|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
146148561|NCT01343407|527055634|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
146148562|NCT01343407|527055635|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
146148563|NCT01343407|527055636|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
146148564|NCT01343407|527055637|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
146148565|NCT01343407|527055638|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
146148566|NCT01343407|527055639|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
146148567|NCT01343407|527055634|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
146148568|NCT01343407|527055635|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
146148569|NCT01343407|527055636|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
146148570|NCT01343407|527055637|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
146148571|NCT01343407|527055638|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
146148572|NCT01343407|527055639|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
146148573|NCT04079933|527055647|FG000|Overall Study|Withdrawal by Subject|3|||
146148574|NCT04079933|527055648|FG001|Overall Study|Withdrawal by Subject|4|||
146148575|NCT04079933|527055647|FG000|Overall Study|Lost to Follow-up|0|||
146148576|NCT04079933|527055648|FG001|Overall Study|Lost to Follow-up|1|||
146148577|NCT01986829|527055653|FG000|Overall Study|Death|1|||
146148578|NCT02059148|527055654|FG000|Treatment 1|Protocol Violation|0|||
146148579|NCT02059148|527055655|FG001|Treatment 1|Protocol Violation|0|||
146278624|NCT01470001|527534357|FG000|Overall Study|Withdrawal by Subject|2|||
146278625|NCT01470001|527534358|FG001|Overall Study|Withdrawal by Subject|1|||
146278626|NCT01895101|527534359|FG000|Overall Study|OPCAB procedure|1|||
146278627|NCT01895101|527534360|FG001|Overall Study|OPCAB procedure|1|||
146278628|NCT01895101|527534361|FG002|Overall Study|OPCAB procedure|3|||
146148580|NCT02059148|527055656|FG002|Treatment 1|Protocol Violation|0|||
146148581|NCT02059148|527055657|FG003|Treatment 1|Protocol Violation|0|||
146148582|NCT02059148|527055658|FG004|Treatment 1|Protocol Violation|0|||
146148583|NCT02059148|527055659|FG005|Treatment 1|Protocol Violation|1|||
146148584|NCT03231371|527055660|FG000|Overall Study|Withdrawal by Subject|1|||
146148585|NCT03231371|527055660|FG000|Overall Study|chose or were ineligible to have MRI|12|||
146148586|NCT03634579|527055664|FG000|Overall Study|study termination|9|||
146148587|NCT01525082|527055665|FG000|Overall Study|Death|1|||
146148588|NCT03321981|527055666|FG000|Overall Study|Progressive Disease (PD)|15|||
146148589|NCT03321981|527055667|FG001|Overall Study|Progressive Disease (PD)|30|||
146148590|NCT03321981|527055668|FG002|Overall Study|Progressive Disease (PD)|47|||
146148591|NCT03321981|527055666|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
146148592|NCT03321981|527055667|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
146148593|NCT03321981|527055668|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
146148594|NCT03321981|527055666|FG000|Overall Study|Adverse Event|0|||
146148595|NCT03321981|527055667|FG001|Overall Study|Adverse Event|0|||
146148596|NCT03321981|527055668|FG002|Overall Study|Adverse Event|2|||
146148597|NCT03321981|527055666|FG000|Overall Study|symptomatic deterioration|0|||
146148598|NCT03321981|527055667|FG001|Overall Study|symptomatic deterioration|1|||
146148599|NCT03321981|527055668|FG002|Overall Study|symptomatic deterioration|1|||
146148600|NCT03321981|527055666|FG000|Overall Study|Lack of compliance|0|||
146148601|NCT03321981|527055667|FG001|Overall Study|Lack of compliance|1|||
146148602|NCT03321981|527055668|FG002|Overall Study|Lack of compliance|0|||
146148603|NCT03321981|527055666|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
146148604|NCT03321981|527055667|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
146148605|NCT03321981|527055668|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
146148606|NCT03321981|527055666|FG000|Overall Study|Death|0|||
146148607|NCT03321981|527055667|FG001|Overall Study|Death|1|||
146148608|NCT03321981|527055668|FG002|Overall Study|Death|0|||
146148609|NCT03321981|527055666|FG000|Overall Study|Subject withdrawal of investigational product|0|||
146148610|NCT03321981|527055667|FG001|Overall Study|Subject withdrawal of investigational product|1|||
146148611|NCT03321981|527055668|FG002|Overall Study|Subject withdrawal of investigational product|0|||
146148612|NCT03321981|527055666|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
146148613|NCT03321981|527055667|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
146148614|NCT03321981|527055668|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
146148615|NCT03321981|527055666|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
146148616|NCT03321981|527055667|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
146148617|NCT03321981|527055668|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
146148618|NCT04111497|527055671|FG000|Overall Study|relapse of primary disease|1|||
146148619|NCT04111497|527055671|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
146148620|NCT03880578|527055672|FG000|Overall Study|Withdrawal by Subject|0|||
146148621|NCT03880578|527055673|FG001|Overall Study|Withdrawal by Subject|3|||
146148622|NCT03880578|527055674|FG002|Overall Study|Withdrawal by Subject|1|||
146148623|NCT03880578|527055672|FG000|Overall Study|Death|0|||
146148624|NCT03880578|527055673|FG001|Overall Study|Death|1|||
146148625|NCT03880578|527055674|FG002|Overall Study|Death|0|||
146148626|NCT03105362|527055675|FG000|Overall Study|Withdrawal by Subject|1|||
146148627|NCT03105362|527055675|FG000|Overall Study|Lost to Follow-up|1|||
146148628|NCT05204134|527055676|FG000|Overall Study|Withdrawal by Subject|3|||
146148629|NCT05204134|527055676|FG000|Overall Study|Physician Decision|1|||
146148630|NCT01312467|527055683|FG000|Overall Study|Adverse Event|4|||
146148631|NCT01312467|527055683|FG000|Overall Study|Lost to Follow-up|1|||
146148632|NCT01312467|527055683|FG000|Overall Study|Withdrawal by Subject|2|||
146148633|NCT01312467|527055683|FG000|Overall Study|Deported to country of origin|1|||
146148634|NCT01312467|527055683|FG000|Overall Study|Another medical condition|1|||
146148635|NCT01312467|527055683|FG000|Overall Study|Ineligible|4|||
146148636|NCT02752048|527055684|FG000|Overall Study|Withdrawal by Subject|0|||
146148637|NCT02752048|527055685|FG001|Overall Study|Withdrawal by Subject|0|||
146148638|NCT02752048|527055686|FG002|Overall Study|Withdrawal by Subject|3|||
146148639|NCT01431508|527055689|FG000|Overall Study|Lack of Efficacy|1|||
146148640|NCT01431508|527055689|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
146148641|NCT00132769|527055690|FG000|Overall Study|Withdrawal by Subject|1|||
146148642|NCT00132769|527055691|FG001|Overall Study|Withdrawal by Subject|3|||
146148643|NCT00132769|527055690|FG000|Overall Study|Lack of Efficacy|7|||
146148644|NCT00132769|527055691|FG001|Overall Study|Lack of Efficacy|6|||
146148645|NCT00132769|527055690|FG000|Overall Study|Adverse Event|2|||
146148646|NCT00132769|527055691|FG001|Overall Study|Adverse Event|1|||
146148647|NCT00132769|527055690|FG000|Overall Study|Protocol Violation|1|||
146148648|NCT00132769|527055691|FG001|Overall Study|Protocol Violation|1|||
146148649|NCT00129259|527055692|FG000|Overall Study|Lost to Follow-up|1|||
146148650|NCT00129259|527055693|FG001|Overall Study|Lost to Follow-up|1|||
146148651|NCT00129259|527055692|FG000|Overall Study|Withdrawal by Subject|2|||
146148652|NCT00129259|527055693|FG001|Overall Study|Withdrawal by Subject|1|||
146148653|NCT00129259|527055692|FG000|Overall Study|Only available minimal phone assessments|0|||
146148654|NCT00129259|527055693|FG001|Overall Study|Only available minimal phone assessments|1|||
146305468|NCT01490450|527632578|FG000|Period 1|Request to discontinue treatment|1|||
146148655|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148656|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148657|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148658|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148659|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146148660|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148661|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148662|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146148663|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146148664|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148665|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146148666|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
146148667|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148668|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148669|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148670|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
146148671|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146148672|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146148673|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146148674|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
146148675|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
146148676|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
146148677|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
146148678|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
146148679|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146148680|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146148681|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
146148682|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
146148683|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146148684|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146148685|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146148686|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
146148687|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148688|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148689|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148690|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148691|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148692|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146148693|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146148694|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148695|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148696|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
146148697|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
146148698|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
146148699|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148700|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148701|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148702|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
146148703|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148704|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148705|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148706|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148707|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148708|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
146148709|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148710|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148711|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148712|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148713|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148714|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
146148715|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148716|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148717|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148718|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
146148719|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148720|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148721|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148722|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148723|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148724|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
146148725|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148726|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148727|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148728|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148729|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148730|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148731|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148732|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148733|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148734|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
146148735|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148736|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148737|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148738|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148739|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148740|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148741|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148742|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148743|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
146148744|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148745|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148746|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148747|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148748|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148749|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148750|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
146148751|NCT01609556|527055697|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
146148752|NCT01609556|527055698|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148753|NCT01609556|527055699|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148754|NCT01609556|527055700|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148755|NCT01609556|527055701|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148756|NCT01609556|527055702|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
146148757|NCT01609556|527055703|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148758|NCT01609556|527055704|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148759|NCT01609556|527055705|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148760|NCT01609556|527055706|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148761|NCT01609556|527055707|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
146148762|NCT01609556|527055708|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148763|NCT01609556|527055709|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148764|NCT01609556|527055710|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148765|NCT01609556|527055711|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148766|NCT01609556|527055712|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
146148767|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148768|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148769|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148770|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148771|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148772|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148773|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148774|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148775|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148776|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148777|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148778|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
146148779|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
146148780|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146148781|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146148782|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
146148783|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148784|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148785|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148786|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148787|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148788|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148789|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148790|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148791|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146305469|NCT01490450|527632579|FG001|Period 1|Request to discontinue treatment|0|||
146148792|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148793|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148794|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
146148795|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
146148796|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
146148797|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
146148798|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
146148799|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148800|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148801|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148802|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148803|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148804|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148805|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148806|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148807|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148808|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148809|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148810|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
146148811|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146148812|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146148813|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
146148814|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
146148815|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148816|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148817|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148818|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148819|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148820|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148821|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148822|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148823|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148824|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148825|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148826|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148827|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
146148828|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148829|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148830|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
146148831|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148832|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148833|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148834|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148835|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148836|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148837|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148838|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148839|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148840|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148841|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148842|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
146148843|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
146148844|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
146148845|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
146148846|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
146148847|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148848|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148849|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148850|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148851|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146305470|NCT01490450|527632580|FG002|Period 1|Request to discontinue treatment|0|||
146305471|NCT01490450|527632581|FG003|Period 1|Request to discontinue treatment|0|||
146305472|NCT01490450|527632578|FG000|Period 1|Withdrawal by Subject|0|||
146305473|NCT01490450|527632579|FG001|Period 1|Withdrawal by Subject|0|||
146305474|NCT01490450|527632580|FG002|Period 1|Withdrawal by Subject|0|||
146148852|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148853|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148854|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148855|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148856|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148857|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148858|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148859|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148860|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148861|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
146148862|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
146148863|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148864|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148865|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148866|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148867|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148868|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148869|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148870|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148871|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148872|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148873|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148874|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148875|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
146148876|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
146148877|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
146148878|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
146148879|NCT01609556|527055697|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148880|NCT01609556|527055698|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148881|NCT01609556|527055699|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148882|NCT01609556|527055700|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148883|NCT01609556|527055701|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148884|NCT01609556|527055702|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148885|NCT01609556|527055703|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148886|NCT01609556|527055704|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148887|NCT01609556|527055705|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148888|NCT01609556|527055706|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148889|NCT01609556|527055707|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148890|NCT01609556|527055708|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148891|NCT01609556|527055709|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
146148892|NCT01609556|527055710|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148893|NCT01609556|527055711|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148894|NCT01609556|527055712|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
146148895|NCT04452344|527055713|FG000|Overall Study|Withdrawal by Subject|3|||
146148896|NCT04452344|527055714|FG001|Overall Study|Withdrawal by Subject|6|||
146148897|NCT04452344|527055713|FG000|Overall Study|Adverse Event|1|||
146148898|NCT04452344|527055714|FG001|Overall Study|Adverse Event|2|||
146148899|NCT04452344|527055713|FG000|Overall Study|Lost to Follow-up|2|||
146148900|NCT04452344|527055714|FG001|Overall Study|Lost to Follow-up|2|||
146148901|NCT04452344|527055713|FG000|Overall Study|No Post-Op Visit|6|||
146148902|NCT04452344|527055714|FG001|Overall Study|No Post-Op Visit|7|||
146148903|NCT00162136|527055718|FG000|Overall Study|Adverse Event|1|||
146148904|NCT00162136|527055718|FG000|Overall Study|Death|1|||
146148905|NCT00162136|527055718|FG000|Overall Study|Disease Progression/Relapse|23|||
146148906|NCT00162136|527055718|FG000|Overall Study|Investigator Request|5|||
146148907|NCT00162136|527055718|FG000|Overall Study|Study Drug Toxicity|4|||
146148908|NCT00162136|527055718|FG000|Overall Study|Withdrawal by Subject|1|||
146148909|NCT02788175|527055719|FG000|Overall Study|Protocol Violation|3|||
146148910|NCT02788175|527055719|FG000|Overall Study|Withdrawal by Subject|4|||
146278629|NCT01895101|527534359|FG000|Overall Study|Withdrawal by Subject|0|||
146278630|NCT01895101|527534360|FG001|Overall Study|Withdrawal by Subject|1|||
146278631|NCT01895101|527534361|FG002|Overall Study|Withdrawal by Subject|2|||
146278632|NCT01895101|527534359|FG000|Overall Study|another study, enrolled in other study|0|||
146278633|NCT01895101|527534360|FG001|Overall Study|another study, enrolled in other study|1|||
146148911|NCT02788175|527055719|FG000|Overall Study|Ineligible prior to study agent|6|||
146148912|NCT01968434|527055724|FG000|Overall Study|Lost to Follow-up|3|||
146148913|NCT01968434|527055725|FG001|Overall Study|Lost to Follow-up|6|||
146148914|NCT00262834|527057704|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
146148915|NCT00262834|527057705|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
146148916|NCT00844194|527057706|FG000|Overall Study|Adverse Event|17|||
146148917|NCT00844194|527057707|FG001|Overall Study|Adverse Event|5|||
146305475|NCT01490450|527632581|FG003|Period 1|Withdrawal by Subject|3|||
146148918|NCT00844194|527057706|FG000|Overall Study|Protocol Violation|1|||
146148919|NCT00844194|527057707|FG001|Overall Study|Protocol Violation|1|||
146148920|NCT00844194|527057706|FG000|Overall Study|Lost to Follow-up|1|||
146148921|NCT00844194|527057707|FG001|Overall Study|Lost to Follow-up|1|||
146148922|NCT00844194|527057706|FG000|Overall Study|Withdrawal by Subject|2|||
146148923|NCT00844194|527057707|FG001|Overall Study|Withdrawal by Subject|1|||
146148924|NCT00844194|527057706|FG000|Overall Study|Lack of Efficacy|3|||
146148925|NCT00844194|527057707|FG001|Overall Study|Lack of Efficacy|0|||
146148926|NCT00844194|527057706|FG000|Overall Study|Other reason (not specified)|1|||
146148927|NCT00844194|527057707|FG001|Overall Study|Other reason (not specified)|0|||
146148928|NCT02352493|527057714|FG000|Overall Study|Pregnancy|0|||
146148929|NCT02352493|527057715|FG001|Overall Study|Pregnancy|0|||
146148930|NCT02352493|527057716|FG002|Overall Study|Pregnancy|0|||
146148931|NCT02352493|527057717|FG003|Overall Study|Pregnancy|0|||
146148932|NCT02352493|527057718|FG004|Overall Study|Pregnancy|0|||
146148933|NCT02352493|527057719|FG005|Overall Study|Pregnancy|0|||
146148934|NCT02352493|527057720|FG006|Overall Study|Pregnancy|1|||
146148935|NCT02352493|527057721|FG007|Overall Study|Pregnancy|0|||
146148936|NCT02352493|527057722|FG008|Overall Study|Pregnancy|1|||
146148937|NCT02352493|527057723|FG009|Overall Study|Pregnancy|0|||
146148938|NCT02352493|527057724|FG010|Overall Study|Pregnancy|0|||
146148939|NCT02352493|527057725|FG011|Overall Study|Pregnancy|0|||
146148940|NCT02352493|527057726|FG012|Overall Study|Pregnancy|0|||
146148941|NCT02352493|527057727|FG013|Overall Study|Pregnancy|0|||
146148942|NCT02352493|527057728|FG014|Overall Study|Pregnancy|0|||
146148943|NCT02352493|527057729|FG015|Overall Study|Pregnancy|0|||
146148944|NCT02352493|527057730|FG016|Overall Study|Pregnancy|0|||
146148945|NCT02352493|527057731|FG017|Overall Study|Pregnancy|0|||
146148946|NCT02352493|527057714|FG000|Overall Study|Withdrawal by Subject|0|||
146148947|NCT02352493|527057715|FG001|Overall Study|Withdrawal by Subject|0|||
146148948|NCT02352493|527057716|FG002|Overall Study|Withdrawal by Subject|0|||
146148949|NCT02352493|527057717|FG003|Overall Study|Withdrawal by Subject|0|||
146148950|NCT02352493|527057718|FG004|Overall Study|Withdrawal by Subject|0|||
146148951|NCT02352493|527057719|FG005|Overall Study|Withdrawal by Subject|0|||
146148952|NCT02352493|527057720|FG006|Overall Study|Withdrawal by Subject|0|||
146148953|NCT02352493|527057721|FG007|Overall Study|Withdrawal by Subject|0|||
146148954|NCT02352493|527057722|FG008|Overall Study|Withdrawal by Subject|1|||
146148955|NCT02352493|527057723|FG009|Overall Study|Withdrawal by Subject|0|||
146148956|NCT02352493|527057724|FG010|Overall Study|Withdrawal by Subject|0|||
146148957|NCT02352493|527057725|FG011|Overall Study|Withdrawal by Subject|0|||
146148958|NCT02352493|527057726|FG012|Overall Study|Withdrawal by Subject|0|||
146148959|NCT02352493|527057727|FG013|Overall Study|Withdrawal by Subject|0|||
146148960|NCT02352493|527057728|FG014|Overall Study|Withdrawal by Subject|1|||
146148961|NCT02352493|527057729|FG015|Overall Study|Withdrawal by Subject|0|||
146148962|NCT02352493|527057730|FG016|Overall Study|Withdrawal by Subject|0|||
146148963|NCT02352493|527057731|FG017|Overall Study|Withdrawal by Subject|0|||
146148964|NCT02352493|527057714|FG000|Overall Study|Lost to Follow-up|0|||
146148965|NCT02352493|527057715|FG001|Overall Study|Lost to Follow-up|0|||
146148966|NCT02352493|527057716|FG002|Overall Study|Lost to Follow-up|0|||
146148967|NCT02352493|527057717|FG003|Overall Study|Lost to Follow-up|0|||
146148968|NCT02352493|527057718|FG004|Overall Study|Lost to Follow-up|0|||
146148969|NCT02352493|527057719|FG005|Overall Study|Lost to Follow-up|0|||
146148970|NCT02352493|527057720|FG006|Overall Study|Lost to Follow-up|0|||
146148971|NCT02352493|527057721|FG007|Overall Study|Lost to Follow-up|0|||
146148972|NCT02352493|527057722|FG008|Overall Study|Lost to Follow-up|0|||
146148973|NCT02352493|527057723|FG009|Overall Study|Lost to Follow-up|1|||
146148974|NCT02352493|527057724|FG010|Overall Study|Lost to Follow-up|0|||
146148975|NCT02352493|527057725|FG011|Overall Study|Lost to Follow-up|0|||
146148976|NCT02352493|527057726|FG012|Overall Study|Lost to Follow-up|1|||
146148977|NCT02352493|527057727|FG013|Overall Study|Lost to Follow-up|2|||
146148978|NCT02352493|527057728|FG014|Overall Study|Lost to Follow-up|0|||
146148979|NCT02352493|527057729|FG015|Overall Study|Lost to Follow-up|0|||
146148980|NCT02352493|527057730|FG016|Overall Study|Lost to Follow-up|0|||
146148981|NCT02352493|527057731|FG017|Overall Study|Lost to Follow-up|0|||
146148982|NCT02162810|527057732|FG000|Overall Study|Protocol Violation|1|||
146148983|NCT02162810|527057733|FG001|Overall Study|Protocol Violation|0|||
146148984|NCT02162810|527057732|FG000|Overall Study|patients did not report compliance|4|||
146148985|NCT02162810|527057733|FG001|Overall Study|patients did not report compliance|1|||
146148986|NCT02546544|527057738|FG000|Overall Study|Disease Progression|14|||
146148987|NCT02546544|527057738|FG000|Overall Study|Adverse Event|1|||
146148988|NCT02546544|527057738|FG000|Overall Study|Withdrawal by Subject|1|||
146148989|NCT01921348|527057739|FG000|Overall Study|Withdrawal by Subject|1|||
146148990|NCT01921348|527057740|FG001|Overall Study|Withdrawal by Subject|0|||
146148991|NCT01921348|527057739|FG000|Overall Study|Lost to Follow-up|0|||
146148992|NCT01921348|527057740|FG001|Overall Study|Lost to Follow-up|2|||
146148993|NCT02223390|527057741|FG000|Overall Study|Lost to Follow-up|9|||
146278634|NCT01895101|527534361|FG002|Overall Study|another study, enrolled in other study|0|||
146148994|NCT02223390|527057742|FG001|Overall Study|Lost to Follow-up|4|||
146148995|NCT00795600|527057744|FG000|Overall Study|Adverse Event|1|||
146148996|NCT00795600|527057745|FG001|Overall Study|Adverse Event|1|||
146148997|NCT00795600|527057744|FG000|Overall Study|Protocol Violation|1|||
146148998|NCT00795600|527057745|FG001|Overall Study|Protocol Violation|2|||
146148999|NCT00795600|527057744|FG000|Overall Study|Withdrawal by Subject|1|||
146149000|NCT00795600|527057745|FG001|Overall Study|Withdrawal by Subject|0|||
146149001|NCT00795600|527057744|FG000|Overall Study|Unclassified|1|||
146149002|NCT00795600|527057745|FG001|Overall Study|Unclassified|1|||
146149003|NCT03936244|527057749|FG000|Overall Study|Lost to Follow-up|5|||
146149004|NCT03936244|527057750|FG001|Overall Study|Lost to Follow-up|1|||
146149005|NCT03936244|527057749|FG000|Overall Study|Physician Decision|7|||
146149006|NCT03936244|527057750|FG001|Overall Study|Physician Decision|3|||
146149007|NCT01248884|527057755|FG000|Overall Study|Withdrawal by Subject|1|||
146149008|NCT01248884|527057756|FG001|Overall Study|Withdrawal by Subject|3|||
146149009|NCT01248884|527057757|FG002|Overall Study|Withdrawal by Subject|1|||
146149010|NCT01248884|527057755|FG000|Overall Study|Adverse Event|1|||
146149011|NCT01248884|527057756|FG001|Overall Study|Adverse Event|0|||
146149012|NCT01248884|527057757|FG002|Overall Study|Adverse Event|0|||
146149013|NCT00575588|527057758|FG000|Overall Study|Adverse Event|11|||
146149014|NCT00575588|527057759|FG001|Overall Study|Adverse Event|13|||
146149015|NCT00575588|527057758|FG000|Overall Study|Withdrawal by Subject|27|||
146149016|NCT00575588|527057759|FG001|Overall Study|Withdrawal by Subject|31|||
146149017|NCT00575588|527057758|FG000|Overall Study|Lost to Follow-up|1|||
146149018|NCT00575588|527057759|FG001|Overall Study|Lost to Follow-up|3|||
146149019|NCT00575588|527057758|FG000|Overall Study|Death|4|||
146149020|NCT00575588|527057759|FG001|Overall Study|Death|2|||
146149021|NCT00575588|527057758|FG000|Overall Study|Incorrect enrollment|8|||
146149022|NCT00575588|527057759|FG001|Overall Study|Incorrect enrollment|4|||
146149023|NCT00575588|527057758|FG000|Overall Study|Study specific discontinuation criteria|203|||
146149024|NCT00575588|527057759|FG001|Overall Study|Study specific discontinuation criteria|218|||
146149025|NCT00575588|527057758|FG000|Overall Study|Severe non-compliance to protocol|5|||
146149026|NCT00575588|527057759|FG001|Overall Study|Severe non-compliance to protocol|7|||
146149027|NCT00575588|527057758|FG000|Overall Study|Safety reasons|2|||
146149028|NCT00575588|527057759|FG001|Overall Study|Safety reasons|1|||
146149029|NCT00575588|527057758|FG000|Overall Study|Elevated triglyceride|1|||
146149030|NCT00575588|527057759|FG001|Overall Study|Elevated triglyceride|0|||
146149031|NCT00575588|527057758|FG000|Overall Study|Patient moved|1|||
146149032|NCT00575588|527057759|FG001|Overall Study|Patient moved|3|||
146149033|NCT00575588|527057758|FG000|Overall Study|Impossible to determine HbA1c|0|||
146149034|NCT00575588|527057759|FG001|Overall Study|Impossible to determine HbA1c|1|||
146149035|NCT01854827|527057760|FG000|Overall Study|Death|1|||
146149036|NCT00736996|527057761|FG000|Overall Study|Lost to Follow-up|1|||
146149037|NCT00736996|527057762|FG001|Overall Study|Lost to Follow-up|9|||
146149038|NCT00736996|527057763|FG002|Overall Study|Lost to Follow-up|2|||
146149039|NCT02667912|527057764|FG000|Overall Study|Death|3|||
146149040|NCT02667912|527057765|FG001|Overall Study|Death|1|||
146149041|NCT02667912|527057764|FG000|Overall Study|Withdrawal by Subject|1|||
146149042|NCT02667912|527057765|FG001|Overall Study|Withdrawal by Subject|2|||
146149043|NCT02667912|527057764|FG000|Overall Study|Withdrawal by Subject|1|||
146149044|NCT02667912|527057765|FG001|Overall Study|Withdrawal by Subject|0|||
146149045|NCT01751568|527057770|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
146149046|NCT01751568|527057771|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
146149047|NCT01751568|527057772|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
146149048|NCT00797667|527057773|FG000|Overall Study|Lack of Efficacy|0|||
146149049|NCT00797667|527057774|FG001|Overall Study|Lack of Efficacy|1|||
146278635|NCT01895101|527534359|FG000|Overall Study|Death|0|||
146278636|NCT01895101|527534360|FG001|Overall Study|Death|1|||
146278637|NCT01895101|527534361|FG002|Overall Study|Death|0|||
146278638|NCT01895101|527534359|FG000|Overall Study|coagulation disorder|0|||
146278639|NCT01895101|527534360|FG001|Overall Study|coagulation disorder|1|||
146278640|NCT01895101|527534361|FG002|Overall Study|coagulation disorder|0|||
146149050|NCT00797667|527057775|FG002|Overall Study|Lack of Efficacy|0|||
146149051|NCT00797667|527057773|FG000|Overall Study|Lost to Follow-up|8|||
146149052|NCT00797667|527057774|FG001|Overall Study|Lost to Follow-up|12|||
146149053|NCT00797667|527057775|FG002|Overall Study|Lost to Follow-up|2|||
146149054|NCT00797667|527057773|FG000|Overall Study|Physician Decision|3|||
146149055|NCT00797667|527057774|FG001|Overall Study|Physician Decision|1|||
146149056|NCT00797667|527057775|FG002|Overall Study|Physician Decision|0|||
146278641|NCT03339583|527534362|FG000|First Intervention (14 Days)|Adverse Event|1|||
146149057|NCT00797667|527057773|FG000|Overall Study|Pregnancy|2|||
146149058|NCT00797667|527057774|FG001|Overall Study|Pregnancy|0|||
146149059|NCT00797667|527057775|FG002|Overall Study|Pregnancy|0|||
146149060|NCT00797667|527057773|FG000|Overall Study|Protocol Violation|2|||
146149061|NCT00797667|527057774|FG001|Overall Study|Protocol Violation|7|||
146149062|NCT00797667|527057775|FG002|Overall Study|Protocol Violation|0|||
146149063|NCT00797667|527057773|FG000|Overall Study|Study Terminated by Sponsor|217|||
146149064|NCT00797667|527057774|FG001|Overall Study|Study Terminated by Sponsor|216|||
146149065|NCT00797667|527057775|FG002|Overall Study|Study Terminated by Sponsor|115|||
146149066|NCT00797667|527057773|FG000|Overall Study|Withdrawal by Subject|9|||
146149067|NCT00797667|527057774|FG001|Overall Study|Withdrawal by Subject|14|||
146149068|NCT00797667|527057775|FG002|Overall Study|Withdrawal by Subject|2|||
146149069|NCT00797667|527057773|FG000|Overall Study|Adverse Event|19|||
146149070|NCT00797667|527057774|FG001|Overall Study|Adverse Event|8|||
146149071|NCT00797667|527057775|FG002|Overall Study|Adverse Event|8|||
146149072|NCT02504866|527057776|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
146149073|NCT02504866|527057777|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
146149074|NCT02504866|527057778|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
146149075|NCT01229436|527057779|FG000|Overall Study|Withdrawal by Subject|2|||
146149076|NCT01229436|527057779|FG000|Overall Study|Lost to Follow-up|3|||
146149077|NCT00096941|527057780|FG000|Overall Study|disease progression|3|||
146149078|NCT01775137|527057781|FG000|Overall Study|Death|1|||
146149079|NCT01775137|527057781|FG000|Overall Study|Protocol deviation|2|||
146149080|NCT01775137|527057781|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146149081|NCT01775137|527057781|FG000|Overall Study|Adverse Event|1|||
146149082|NCT01775137|527057781|FG000|Overall Study|Withdrawal by participants|5|||
146149083|NCT02673697|527057784|FG000|Overall Study|Adverse Event|2|||
146149084|NCT02673697|527057785|FG001|Overall Study|Adverse Event|0|||
146149085|NCT02673697|527057784|FG000|Overall Study|Death|32|||
146149086|NCT02673697|527057785|FG001|Overall Study|Death|24|||
146149087|NCT02673697|527057784|FG000|Overall Study|Lost to Follow-up|5|||
146149088|NCT02673697|527057785|FG001|Overall Study|Lost to Follow-up|2|||
146149089|NCT02673697|527057784|FG000|Overall Study|Physician Decision|2|||
146149090|NCT02673697|527057785|FG001|Overall Study|Physician Decision|1|||
146149091|NCT02673697|527057784|FG000|Overall Study|Withdrawal by Subject|10|||
146149092|NCT02673697|527057785|FG001|Overall Study|Withdrawal by Subject|7|||
146149093|NCT02673697|527057784|FG000|Overall Study|Change subj medical status|1|||
146149094|NCT02673697|527057785|FG001|Overall Study|Change subj medical status|2|||
146149095|NCT02673697|527057784|FG000|Overall Study|Explant|10|||
146149096|NCT02673697|527057785|FG001|Overall Study|Explant|5|||
146149097|NCT02673697|527057784|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
146149098|NCT02673697|527057785|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
146149099|NCT00437489|527057786|FG000|Overall Study|Study terminated by sponsor|23|||
146149100|NCT00437489|527057787|FG001|Overall Study|Study terminated by sponsor|21|||
146149101|NCT00437489|527057786|FG000|Overall Study|Lost to Follow-up|0|||
146149102|NCT00437489|527057787|FG001|Overall Study|Lost to Follow-up|1|||
146149103|NCT00022516|527057795|FG000|Overall Study|Adverse Event|0|||
146149104|NCT00022516|527057796|FG001|Overall Study|Adverse Event|59|||
146149105|NCT00022516|527057795|FG000|Overall Study|Lack of Efficacy|0|||
146149106|NCT00022516|527057796|FG001|Overall Study|Lack of Efficacy|27|||
146149107|NCT00022516|527057795|FG000|Overall Study|Physician Decision|0|||
146149108|NCT00022516|527057796|FG001|Overall Study|Physician Decision|1|||
146149109|NCT00022516|527057795|FG000|Overall Study|Protocol Violation|1|||
146149110|NCT00022516|527057796|FG001|Overall Study|Protocol Violation|3|||
146149111|NCT00022516|527057795|FG000|Overall Study|Withdrawal by Subject|2|||
146149112|NCT00022516|527057796|FG001|Overall Study|Withdrawal by Subject|113|||
146149113|NCT00022516|527057795|FG000|Overall Study|Incomplete documentation|0|||
146149114|NCT00022516|527057796|FG001|Overall Study|Incomplete documentation|27|||
146149115|NCT03321019|527057798|FG000|Overall Study|Withdrawal by Subject|0|||
146149116|NCT03321019|527057799|FG001|Overall Study|Withdrawal by Subject|6|||
146149117|NCT03321019|527057798|FG000|Overall Study|Lost to Follow-up|0|||
146149118|NCT03321019|527057799|FG001|Overall Study|Lost to Follow-up|22|||
146149119|NCT04934670|527057800|FG000|Overall Study|Death|4|||
146149120|NCT04934670|527057801|FG001|Overall Study|Death|0|||
146149121|NCT04934670|527057800|FG000|Overall Study|Lost to Follow-up|1|||
146149122|NCT04934670|527057801|FG001|Overall Study|Lost to Follow-up|4|||
146149123|NCT03067441|527057804|FG000|Overall Study|Withdrawal by Subject|16|||
146149124|NCT03067441|527057805|FG001|Overall Study|Withdrawal by Subject|34|||
146149125|NCT03067441|527057804|FG000|Overall Study|Lost to Follow-up|7|||
146149126|NCT03067441|527057805|FG001|Overall Study|Lost to Follow-up|5|||
146305476|NCT01490450|527632578|FG000|Period 1|No longer met study criteria|0|||
146305477|NCT01490450|527632579|FG001|Period 1|No longer met study criteria|1|||
146305478|NCT01490450|527632580|FG002|Period 1|No longer met study criteria|1|||
146149127|NCT03067441|527057804|FG000|Overall Study|Adverse Event|7|||
146149128|NCT03067441|527057805|FG001|Overall Study|Adverse Event|14|||
146149129|NCT03067441|527057804|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
146149130|NCT03067441|527057805|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
146149131|NCT03067441|527057804|FG000|Overall Study|Physician Decision|1|||
146149132|NCT03067441|527057805|FG001|Overall Study|Physician Decision|3|||
146149133|NCT03067441|527057804|FG000|Overall Study|Other|1|||
146149134|NCT03067441|527057805|FG001|Overall Study|Other|1|||
146149135|NCT01592708|527057806|FG000|Overall Study|Protocol Violation|3|||
146305479|NCT01490450|527632581|FG003|Period 1|No longer met study criteria|0|||
146149136|NCT01592708|527057807|FG001|Overall Study|Protocol Violation|0|||
146149137|NCT02328326|527057812|FG000|Overall Study|Withdrawal by Subject|10|||
146149138|NCT02328326|527057813|FG001|Overall Study|Withdrawal by Subject|3|||
146149139|NCT02328326|527057812|FG000|Overall Study|Death|2|||
146149140|NCT02328326|527057813|FG001|Overall Study|Death|1|||
146149141|NCT02328326|527057812|FG000|Overall Study|Lost to Follow-up|10|||
146149142|NCT02328326|527057813|FG001|Overall Study|Lost to Follow-up|4|||
146149143|NCT02056301|527057814|FG000|Overall Study|Protocol Violation|1|||
146149144|NCT02056301|527057815|FG001|Overall Study|Protocol Violation|2|||
146149145|NCT02056301|527057814|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
146149146|NCT02056301|527057815|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
146149147|NCT02056301|527057814|FG000|Overall Study|Withdrawal by Subject|0|||
146149148|NCT02056301|527057815|FG001|Overall Study|Withdrawal by Subject|1|||
146149149|NCT02056301|527057814|FG000|Overall Study|Issues with epidural|0|||
146149150|NCT02056301|527057815|FG001|Overall Study|Issues with epidural|3|||
146149151|NCT02209324|527057820|FG000|Overall Study|Adverse Event|2|||
146149152|NCT02209324|527057820|FG000|Overall Study|Lack of Efficacy|1|||
146149153|NCT02209324|527057820|FG000|Overall Study|Lost to Follow-up|1|||
146149154|NCT02209324|527057820|FG000|Overall Study|Physician Decision|3|||
146149155|NCT02209324|527057820|FG000|Overall Study|Protocol Violation|14|||
146149156|NCT02209324|527057820|FG000|Overall Study|Withdrawal by Subject|8|||
146149157|NCT02209324|527057820|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
146149158|NCT02209324|527057820|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
146149159|NCT02209324|527057820|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
146149160|NCT03433456|527057821|FG000|Overall Study|Death|1|||
146149161|NCT03433456|527057822|FG001|Overall Study|Death|1|||
146149162|NCT03433456|527057821|FG000|Overall Study|Lost to Follow-up|14|||
146149163|NCT03433456|527057822|FG001|Overall Study|Lost to Follow-up|11|||
146149164|NCT03433456|527057821|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
146149165|NCT03433456|527057822|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
146149166|NCT01198600|527057830|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
146149167|NCT01198600|527057831|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146149168|NCT01198600|527057832|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146149169|NCT01198600|527057833|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
146149170|NCT01198600|527057830|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
146149171|NCT01198600|527057831|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146149172|NCT01198600|527057832|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146149173|NCT01198600|527057833|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
146149174|NCT01198600|527057830|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146149175|NCT01198600|527057831|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
146149176|NCT01198600|527057832|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146149177|NCT01198600|527057833|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
146149178|NCT01198600|527057830|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146149179|NCT01198600|527057831|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
146149180|NCT01198600|527057832|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146149181|NCT01198600|527057833|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
146149182|NCT01198600|527057830|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
146149183|NCT01198600|527057831|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
146149184|NCT01198600|527057832|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
146149185|NCT01198600|527057833|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
146149186|NCT01198600|527057830|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
146149187|NCT01198600|527057831|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
146149188|NCT01198600|527057832|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
146149189|NCT01198600|527057833|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
146149190|NCT01198600|527057830|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146149191|NCT01198600|527057831|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146149192|NCT01198600|527057832|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
146149193|NCT01198600|527057833|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
146149194|NCT01785602|527057834|FG000|Overall Study|Withdrawal by Subject|2|||
146149195|NCT01785602|527057835|FG001|Overall Study|Withdrawal by Subject|0|||
146149196|NCT01785602|527057834|FG000|Overall Study|Lost to Follow-up|1|||
146305480|NCT01490450|527632578|FG000|Period 2|Lack of Efficacy|0|||
146305481|NCT01490450|527632579|FG001|Period 2|Lack of Efficacy|0|||
146305482|NCT01490450|527632580|FG002|Period 2|Lack of Efficacy|0|||
146305483|NCT01490450|527632581|FG003|Period 2|Lack of Efficacy|1|||
146305484|NCT01490450|527632578|FG000|Period 2|Adverse Event|1|||
146149197|NCT01785602|527057835|FG001|Overall Study|Lost to Follow-up|1|||
146305485|NCT01490450|527632579|FG001|Period 2|Adverse Event|1|||
146149198|NCT01785602|527057834|FG000|Overall Study|Adverse Event|3|||
146149199|NCT01785602|527057835|FG001|Overall Study|Adverse Event|5|||
146149200|NCT01785602|527057834|FG000|Overall Study|Administrative problems|7|||
146149201|NCT01785602|527057835|FG001|Overall Study|Administrative problems|3|||
146149202|NCT04177108|527057837|FG000|Overall Study|Withdrawal by Subject|4|||
146149203|NCT04177108|527057838|FG001|Overall Study|Withdrawal by Subject|8|||
146149204|NCT04177108|527057839|FG002|Overall Study|Withdrawal by Subject|9|||
146149205|NCT04177108|527057840|FG003|Overall Study|Withdrawal by Subject|11|||
146305486|NCT01490450|527632580|FG002|Period 2|Adverse Event|0|||
146305487|NCT01490450|527632581|FG003|Period 2|Adverse Event|1|||
146149206|NCT04177108|527057841|FG004|Overall Study|Withdrawal by Subject|13|||
146149207|NCT04177108|527057837|FG000|Overall Study|Physician Decision|23|||
146149208|NCT04177108|527057838|FG001|Overall Study|Physician Decision|15|||
146149209|NCT04177108|527057839|FG002|Overall Study|Physician Decision|18|||
146149210|NCT04177108|527057840|FG003|Overall Study|Physician Decision|29|||
146149211|NCT04177108|527057841|FG004|Overall Study|Physician Decision|23|||
146149212|NCT04177108|527057837|FG000|Overall Study|Reason Not Specified|0|||
146149213|NCT04177108|527057838|FG001|Overall Study|Reason Not Specified|1|||
146149214|NCT04177108|527057839|FG002|Overall Study|Reason Not Specified|0|||
146149215|NCT04177108|527057840|FG003|Overall Study|Reason Not Specified|0|||
146149216|NCT04177108|527057841|FG004|Overall Study|Reason Not Specified|2|||
146149217|NCT04177108|527057837|FG000|Overall Study|Lost to Follow-up|0|||
146149218|NCT04177108|527057838|FG001|Overall Study|Lost to Follow-up|0|||
146149219|NCT04177108|527057839|FG002|Overall Study|Lost to Follow-up|1|||
146149220|NCT04177108|527057840|FG003|Overall Study|Lost to Follow-up|1|||
146149221|NCT04177108|527057841|FG004|Overall Study|Lost to Follow-up|1|||
146149222|NCT04177108|527057837|FG000|Overall Study|Death|16|||
146149223|NCT04177108|527057838|FG001|Overall Study|Death|19|||
146149224|NCT04177108|527057839|FG002|Overall Study|Death|13|||
146149225|NCT04177108|527057840|FG003|Overall Study|Death|17|||
146149226|NCT04177108|527057841|FG004|Overall Study|Death|18|||
146149227|NCT02041429|527057844|FG000|Overall Study|Progressive Disease|2|||
146149228|NCT02041429|527057845|FG001|Overall Study|Progressive Disease|2|||
146149229|NCT02041429|527057846|FG002|Overall Study|Progressive Disease|3|||
146149230|NCT02041429|527057847|FG003|Overall Study|Progressive Disease|2|||
146149231|NCT02041429|527057844|FG000|Overall Study|Toxicity|0|||
146149232|NCT02041429|527057845|FG001|Overall Study|Toxicity|1|||
146149233|NCT02041429|527057846|FG002|Overall Study|Toxicity|4|||
146149234|NCT02041429|527057847|FG003|Overall Study|Toxicity|2|||
146149235|NCT02041429|527057844|FG000|Overall Study|Withdrawal by Subject|0|||
146149236|NCT02041429|527057845|FG001|Overall Study|Withdrawal by Subject|1|||
146149237|NCT02041429|527057846|FG002|Overall Study|Withdrawal by Subject|0|||
146149238|NCT02041429|527057847|FG003|Overall Study|Withdrawal by Subject|0|||
146149239|NCT02041429|527057844|FG000|Overall Study|On Maintenance Therapy|1|||
146149240|NCT02041429|527057845|FG001|Overall Study|On Maintenance Therapy|0|||
146149241|NCT02041429|527057846|FG002|Overall Study|On Maintenance Therapy|0|||
146149242|NCT02041429|527057847|FG003|Overall Study|On Maintenance Therapy|2|||
146149243|NCT01427712|527057848|FG000|Overall Study|Transfer to a different hospital|2|||
146149244|NCT01427712|527057848|FG000|Overall Study|Lost to Follow-up|1|||
146149245|NCT01427712|527057848|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
146149246|NCT01427712|527057848|FG000|Overall Study|Failure to visit|1|||
146149247|NCT00784043|527057849|FG000|Overall Study|Withdrawal by Subject|8|||
146149248|NCT00784043|527057850|FG001|Overall Study|Withdrawal by Subject|5|||
146149249|NCT00784043|527057849|FG000|Overall Study|Protocol Terminated|23|||
146149250|NCT00784043|527057850|FG001|Overall Study|Protocol Terminated|1|||
146149251|NCT01143259|527057851|FG000|Overall Study|Withdrawal by Subject|3|||
146149252|NCT01143259|527057852|FG001|Overall Study|Withdrawal by Subject|2|||
146149253|NCT01143259|527057851|FG000|Overall Study|Protocol Violation|13|||
146149254|NCT01143259|527057852|FG001|Overall Study|Protocol Violation|9|||
146149255|NCT01143259|527057851|FG000|Overall Study|Screen Failure|7|||
146149256|NCT01143259|527057852|FG001|Overall Study|Screen Failure|9|||
146149257|NCT00099983|527057853|FG000|Overall Study|Lost to Follow-up|2|||
146149258|NCT00099983|527057854|FG001|Overall Study|Lost to Follow-up|3|||
146305488|NCT01490450|527632578|FG000|Period 2|Withdrawal by Subject|1|||
146149259|NCT00099983|527057853|FG000|Overall Study|Missing Source Documents|14|||
146149260|NCT00099983|527057854|FG001|Overall Study|Missing Source Documents|15|||
146149261|NCT00099983|527057853|FG000|Overall Study|Withdrawal by Subject|3|||
146149262|NCT00099983|527057854|FG001|Overall Study|Withdrawal by Subject|2|||
146149263|NCT00099983|527057853|FG000|Overall Study|Adverse Event|1|||
146149264|NCT00099983|527057854|FG001|Overall Study|Adverse Event|1|||
146149265|NCT00099983|527057853|FG000|Overall Study|Lack of Efficacy|0|||
146149266|NCT00099983|527057854|FG001|Overall Study|Lack of Efficacy|1|||
146149267|NCT00099983|527057853|FG000|Overall Study|Unable to return for appointments|1|||
146149268|NCT00099983|527057854|FG001|Overall Study|Unable to return for appointments|1|||
146149269|NCT00099983|527057853|FG000|Overall Study|Moved|1|||
146149270|NCT00099983|527057854|FG001|Overall Study|Moved|0|||
146149271|NCT00099983|527057853|FG000|Overall Study|Other psychiatric problem|1|||
146149272|NCT00099983|527057854|FG001|Overall Study|Other psychiatric problem|0|||
146305489|NCT01490450|527632579|FG001|Period 2|Withdrawal by Subject|0|||
146149273|NCT00099983|527057853|FG000|Overall Study|Incarcerated|0|||
146149274|NCT00099983|527057854|FG001|Overall Study|Incarcerated|1|||
146149275|NCT00099983|527057853|FG000|Overall Study|Intolerant of burden of visits|0|||
146149276|NCT00099983|527057854|FG001|Overall Study|Intolerant of burden of visits|1|||
146149277|NCT00099983|527057853|FG000|Overall Study|Other issue|1|||
146149278|NCT00099983|527057854|FG001|Overall Study|Other issue|0|||
146149279|NCT02641080|527057855|FG000|Overall Study|Physician Decision|2|||
146149280|NCT02641080|527057856|FG001|Overall Study|Physician Decision|0|||
146149281|NCT02641080|527057855|FG000|Overall Study|Withdrawal by Subject|0|||
146149282|NCT02641080|527057856|FG001|Overall Study|Withdrawal by Subject|1|||
146149283|NCT02641080|527057855|FG000|Overall Study|Rehab Center denied use of pumps|0|||
146149284|NCT02641080|527057856|FG001|Overall Study|Rehab Center denied use of pumps|3|||
146149285|NCT02641080|527057855|FG000|Overall Study|Lost to Follow-up|0|||
146149286|NCT02641080|527057856|FG001|Overall Study|Lost to Follow-up|3|||
146149287|NCT00803634|527057857|FG000|Overall Study|Withdrew Consent|1|||
146149288|NCT00803634|527057858|FG001|Overall Study|Withdrew Consent|0|||
146149289|NCT00803634|527057857|FG000|Overall Study|Lost to Follow-up|2|||
146149290|NCT00803634|527057858|FG001|Overall Study|Lost to Follow-up|3|||
146149291|NCT00803634|527057857|FG000|Overall Study|Death|3|||
146149292|NCT00803634|527057858|FG001|Overall Study|Death|2|||
146149293|NCT04307186|527057861|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
146149294|NCT04307186|527057861|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
146149295|NCT04307186|527057861|FG000|Washout 3-14 Days|Progressive disease|1|||
146149296|NCT04307186|527057861|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
146149297|NCT04307186|527057861|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
146149298|NCT03835533|527057865|FG000|Overall Study|Death|5|||
146149299|NCT03835533|527057866|FG001|Overall Study|Death|10|||
146149300|NCT03835533|527057867|FG002|Overall Study|Death|9|||
146149301|NCT03835533|527057865|FG000|Overall Study|Withdrawal by Subject|2|||
146149302|NCT03835533|527057866|FG001|Overall Study|Withdrawal by Subject|2|||
146149303|NCT03835533|527057867|FG002|Overall Study|Withdrawal by Subject|2|||
146149304|NCT03835533|527057865|FG000|Overall Study|Lost to Follow-up|1|||
146149305|NCT03835533|527057866|FG001|Overall Study|Lost to Follow-up|0|||
146149306|NCT03835533|527057867|FG002|Overall Study|Lost to Follow-up|0|||
146149307|NCT03930745|527057868|FG000|Overall Study|Lost to Follow-up|10|||
146149308|NCT03930745|527057869|FG001|Overall Study|Lost to Follow-up|5|||
146149309|NCT03930745|527057868|FG000|Overall Study|Withdrawal by Subject|1|||
146149310|NCT03930745|527057869|FG001|Overall Study|Withdrawal by Subject|2|||
146149311|NCT03930745|527057868|FG000|Overall Study|Protocol Violation|2|||
146149312|NCT03930745|527057869|FG001|Overall Study|Protocol Violation|2|||
146149313|NCT03930745|527057868|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
146149314|NCT03930745|527057869|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
146149315|NCT03930745|527057868|FG000|Overall Study|Adverse Event|0|||
146149316|NCT03930745|527057869|FG001|Overall Study|Adverse Event|1|||
146149317|NCT03930745|527057868|FG000|Overall Study|Pregnancy|0|||
146149318|NCT03930745|527057869|FG001|Overall Study|Pregnancy|1|||
146149319|NCT04095858|527057872|FG000|Overall Study|Death|1|||
146149320|NCT04095858|527057873|FG001|Overall Study|Death|0|||
146149321|NCT04095858|527057872|FG000|Overall Study|Study terminated by Sponsor|2|||
146149322|NCT04095858|527057873|FG001|Overall Study|Study terminated by Sponsor|4|||
146149323|NCT01344460|527057874|FG000|Overall Study|Withdrawal by Subject|1|||
146149324|NCT01344460|527057874|FG000|Overall Study|Lost to Follow-up|2|||
146149325|NCT03285477|527057875|FG000|Treatment and Response Assessment Period|Death|1|||
146149326|NCT03285477|527057876|FG001|Treatment and Response Assessment Period|Death|0|||
146305490|NCT01490450|527632580|FG002|Period 2|Withdrawal by Subject|0|||
146305491|NCT01490450|527632581|FG003|Period 2|Withdrawal by Subject|0|||
146305492|NCT01490450|527632578|FG000|Period 2|Lost to Follow-up|0|||
146305493|NCT01490450|527632579|FG001|Period 2|Lost to Follow-up|0|||
146305494|NCT01490450|527632580|FG002|Period 2|Lost to Follow-up|0|||
146305495|NCT01490450|527632581|FG003|Period 2|Lost to Follow-up|2|||
146305496|NCT03197493|527632582|FG000|Overall Study|Withdrawal by Subject|5|||
146305497|NCT00938717|527632583|FG000|Overall Study|Adverse Event|10|||
146305498|NCT00938717|527632584|FG001|Overall Study|Adverse Event|41|||
146305499|NCT00938717|527632583|FG000|Overall Study|Protocol Violation|11|||
146305500|NCT00938717|527632584|FG001|Overall Study|Protocol Violation|8|||
146305501|NCT00938717|527632583|FG000|Overall Study|Withdrawal by Subject|26|||
146305502|NCT00938717|527632584|FG001|Overall Study|Withdrawal by Subject|24|||
146305503|NCT00938717|527632583|FG000|Overall Study|Lost to Follow-up|13|||
146305504|NCT00938717|527632584|FG001|Overall Study|Lost to Follow-up|18|||
146305505|NCT00938717|527632583|FG000|Overall Study|Lack of Efficacy|33|||
146305506|NCT00938717|527632584|FG001|Overall Study|Lack of Efficacy|15|||
146305507|NCT00938717|527632583|FG000|Overall Study|Other reason|5|||
146305508|NCT00938717|527632584|FG001|Overall Study|Other reason|2|||
146149327|NCT03285477|527057875|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
146149328|NCT03285477|527057876|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
146149329|NCT03285477|527057875|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
146149330|NCT03285477|527057876|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
146149331|NCT03285477|527057875|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
146149332|NCT03285477|527057876|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
146305509|NCT01462435|527632586|FG000|Overall Study|Lack of Efficacy|1|||
146149333|NCT03285477|527057875|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
146149334|NCT03285477|527057876|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
146149335|NCT03483623|527057877|FG000|Overall Study|43 complete sets achieved|1|||
146149336|NCT00852397|527057880|FG000|Overall Study|Adverse Event|4|||
146305510|NCT01462435|527632587|FG001|Overall Study|Lack of Efficacy|0|||
146305511|NCT01462435|527632588|FG002|Overall Study|Lack of Efficacy|0|||
146305512|NCT01462435|527632589|FG003|Overall Study|Lack of Efficacy|3|||
146149337|NCT00852397|527057881|FG001|Overall Study|Adverse Event|6|||
146149338|NCT00852397|527057882|FG002|Overall Study|Adverse Event|4|||
146149339|NCT00852397|527057880|FG000|Overall Study|Death|0|||
146149340|NCT00852397|527057881|FG001|Overall Study|Death|0|||
146149341|NCT00852397|527057882|FG002|Overall Study|Death|1|||
146149342|NCT00852397|527057880|FG000|Overall Study|Withdrawal by Subject|4|||
146149343|NCT00852397|527057881|FG001|Overall Study|Withdrawal by Subject|1|||
146149344|NCT00852397|527057882|FG002|Overall Study|Withdrawal by Subject|2|||
146149345|NCT00852397|527057880|FG000|Overall Study|Study terminated by sponsor|2|||
146149346|NCT00852397|527057881|FG001|Overall Study|Study terminated by sponsor|1|||
146149347|NCT00852397|527057882|FG002|Overall Study|Study terminated by sponsor|6|||
146149348|NCT00852397|527057880|FG000|Overall Study|Difficulty in study site visit|1|||
146149349|NCT00852397|527057881|FG001|Overall Study|Difficulty in study site visit|0|||
146149350|NCT00852397|527057882|FG002|Overall Study|Difficulty in study site visit|0|||
146149351|NCT00852397|527057880|FG000|Overall Study|Protocol Violation|0|||
146149352|NCT00852397|527057881|FG001|Overall Study|Protocol Violation|0|||
146149353|NCT00852397|527057882|FG002|Overall Study|Protocol Violation|1|||
146149354|NCT02239510|527059761|FG000|Overall Study|Lost to Follow-up|2|||
146149355|NCT02239510|527059762|FG001|Overall Study|Lost to Follow-up|1|||
146149356|NCT00074282|527059765|FG000|Step 1|Adverse Event|32|||
146149357|NCT00074282|527059766|FG001|Step 1|Adverse Event|0|||
146149358|NCT00074282|527059767|FG002|Step 1|Adverse Event|0|||
146149359|NCT00074282|527059765|FG000|Step 1|Death|6|||
146149360|NCT00074282|527059766|FG001|Step 1|Death|0|||
146149361|NCT00074282|527059767|FG002|Step 1|Death|0|||
146149362|NCT00074282|527059765|FG000|Step 1|Withdrawal by Subject|7|||
146149363|NCT00074282|527059766|FG001|Step 1|Withdrawal by Subject|0|||
146149364|NCT00074282|527059767|FG002|Step 1|Withdrawal by Subject|0|||
146149365|NCT00074282|527059765|FG000|Step 1|Disease progression|2|||
146149366|NCT00074282|527059766|FG001|Step 1|Disease progression|0|||
146149367|NCT00074282|527059767|FG002|Step 1|Disease progression|0|||
146149368|NCT00074282|527059765|FG000|Step 1|Alternative therapy|2|||
146149369|NCT00074282|527059766|FG001|Step 1|Alternative therapy|0|||
146149370|NCT00074282|527059767|FG002|Step 1|Alternative therapy|0|||
146149371|NCT00074282|527059765|FG000|Step 1|Other complicating disease|2|||
146149372|NCT00074282|527059766|FG001|Step 1|Other complicating disease|0|||
146149373|NCT00074282|527059767|FG002|Step 1|Other complicating disease|0|||
146149374|NCT00074282|527059765|FG000|Step 1|Physician Decision|1|||
146149375|NCT00074282|527059766|FG001|Step 1|Physician Decision|0|||
146149376|NCT00074282|527059767|FG002|Step 1|Physician Decision|0|||
146149377|NCT00074282|527059765|FG000|Step 1|Ineligible|4|||
146149378|NCT00074282|527059766|FG001|Step 1|Ineligible|0|||
146149379|NCT00074282|527059767|FG002|Step 1|Ineligible|0|||
146149380|NCT00074282|527059765|FG000|Step 1|Never started treatment|2|||
146149381|NCT00074282|527059766|FG001|Step 1|Never started treatment|0|||
146149382|NCT00074282|527059767|FG002|Step 1|Never started treatment|0|||
146149383|NCT00074282|527059765|FG000|Step 2|Adverse Event|0|||
146149384|NCT00074282|527059766|FG001|Step 2|Adverse Event|2|||
146149385|NCT00074282|527059767|FG002|Step 2|Adverse Event|12|||
146149386|NCT00074282|527059765|FG000|Step 2|Disease progression|0|||
146149387|NCT00074282|527059766|FG001|Step 2|Disease progression|0|||
146149388|NCT00074282|527059767|FG002|Step 2|Disease progression|5|||
146149389|NCT00074282|527059765|FG000|Step 2|Death|0|||
146149390|NCT00074282|527059766|FG001|Step 2|Death|0|||
146149391|NCT00074282|527059767|FG002|Step 2|Death|3|||
146149392|NCT00074282|527059765|FG000|Step 2|Withdrawal by Subject|0|||
146149393|NCT00074282|527059766|FG001|Step 2|Withdrawal by Subject|0|||
146149394|NCT00074282|527059767|FG002|Step 2|Withdrawal by Subject|2|||
146149395|NCT00074282|527059765|FG000|Step 2|Physician Decision|0|||
146149396|NCT00074282|527059766|FG001|Step 2|Physician Decision|0|||
146149397|NCT00074282|527059767|FG002|Step 2|Physician Decision|1|||
146278642|NCT03339583|527534363|FG001|First Intervention (14 Days)|Adverse Event|0|||
146149398|NCT00074282|527059765|FG000|Step 2|Ineligible|0|||
146149399|NCT00074282|527059766|FG001|Step 2|Ineligible|0|||
146149400|NCT00074282|527059767|FG002|Step 2|Ineligible|1|||
146149401|NCT00464542|527059768|FG000|Pre-treatment|Withdrawal by Subject|2|||
146149402|NCT03859323|527059770|FG000|Overall Study|Lost to Follow-up|0|||
146149403|NCT03859323|527059771|FG001|Overall Study|Lost to Follow-up|0|||
146149404|NCT03859323|527059772|FG002|Overall Study|Lost to Follow-up|0|||
146278643|NCT03339583|527534362|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
146149405|NCT03859323|527059773|FG003|Overall Study|Lost to Follow-up|0|||
146149406|NCT03859323|527059774|FG004|Overall Study|Lost to Follow-up|0|||
146149407|NCT03859323|527059775|FG005|Overall Study|Lost to Follow-up|0|||
146149408|NCT03859323|527059776|FG006|Overall Study|Lost to Follow-up|1|||
146149409|NCT03859323|527059777|FG007|Overall Study|Lost to Follow-up|0|||
146149410|NCT03859323|527059778|FG008|Overall Study|Lost to Follow-up|0|||
146149411|NCT03859323|527059779|FG009|Overall Study|Lost to Follow-up|0|||
146149412|NCT03859323|527059780|FG010|Overall Study|Lost to Follow-up|0|||
146149413|NCT03859323|527059781|FG011|Overall Study|Lost to Follow-up|0|||
146149414|NCT03859323|527059782|FG012|Overall Study|Lost to Follow-up|0|||
146149415|NCT03859323|527059770|FG000|Overall Study|Withdrawal by Subject|0|||
146149416|NCT03859323|527059771|FG001|Overall Study|Withdrawal by Subject|0|||
146149417|NCT03859323|527059772|FG002|Overall Study|Withdrawal by Subject|1|||
146149418|NCT03859323|527059773|FG003|Overall Study|Withdrawal by Subject|0|||
146149419|NCT03859323|527059774|FG004|Overall Study|Withdrawal by Subject|0|||
146149420|NCT03859323|527059775|FG005|Overall Study|Withdrawal by Subject|1|||
146149421|NCT03859323|527059776|FG006|Overall Study|Withdrawal by Subject|0|||
146149422|NCT03859323|527059777|FG007|Overall Study|Withdrawal by Subject|0|||
146149423|NCT03859323|527059778|FG008|Overall Study|Withdrawal by Subject|0|||
146149424|NCT03859323|527059779|FG009|Overall Study|Withdrawal by Subject|1|||
146149425|NCT03859323|527059780|FG010|Overall Study|Withdrawal by Subject|1|||
146149426|NCT03859323|527059781|FG011|Overall Study|Withdrawal by Subject|2|||
146149427|NCT03859323|527059782|FG012|Overall Study|Withdrawal by Subject|1|||
146149428|NCT03859323|527059770|FG000|Overall Study|Pregnancy|0|||
146149429|NCT03859323|527059771|FG001|Overall Study|Pregnancy|0|||
146149430|NCT03859323|527059772|FG002|Overall Study|Pregnancy|0|||
146149431|NCT03859323|527059773|FG003|Overall Study|Pregnancy|0|||
146149432|NCT03859323|527059774|FG004|Overall Study|Pregnancy|0|||
146149433|NCT03859323|527059775|FG005|Overall Study|Pregnancy|0|||
146149434|NCT03859323|527059776|FG006|Overall Study|Pregnancy|0|||
146149435|NCT03859323|527059777|FG007|Overall Study|Pregnancy|0|||
146149436|NCT03859323|527059778|FG008|Overall Study|Pregnancy|0|||
146149437|NCT03859323|527059779|FG009|Overall Study|Pregnancy|1|||
146149438|NCT03859323|527059780|FG010|Overall Study|Pregnancy|0|||
146149439|NCT03859323|527059781|FG011|Overall Study|Pregnancy|0|||
146149440|NCT03859323|527059782|FG012|Overall Study|Pregnancy|0|||
146149441|NCT01682460|527059783|FG000|Overall Study|Withdrawal by Subject|2|||
146149442|NCT01682460|527059783|FG000|Overall Study|Did not meet inclusion criteria|2|||
146149443|NCT02055352|527059787|FG000|Overall Study|Adverse Event|0|||
146149444|NCT02055352|527059788|FG001|Overall Study|Adverse Event|1|||
146149445|NCT02055352|527059787|FG000|Overall Study|Non-eligible|0|||
146149446|NCT02055352|527059788|FG001|Overall Study|Non-eligible|1|||
146149447|NCT02055352|527059787|FG000|Overall Study|Poor compliance|1|||
146149448|NCT02055352|527059788|FG001|Overall Study|Poor compliance|1|||
146149449|NCT02055352|527059787|FG000|Overall Study|Death|1|||
146149450|NCT02055352|527059788|FG001|Overall Study|Death|2|||
146149451|NCT02055352|527059787|FG000|Overall Study|Patient decision|1|||
146149452|NCT02055352|527059788|FG001|Overall Study|Patient decision|1|||
146149453|NCT02055352|527059787|FG000|Overall Study|Use of prohibited treatment|0|||
146149454|NCT02055352|527059788|FG001|Overall Study|Use of prohibited treatment|3|||
146149455|NCT02055352|527059787|FG000|Overall Study|AE, study drug would be detrimental|1|||
146149456|NCT02055352|527059788|FG001|Overall Study|AE, study drug would be detrimental|3|||
146149457|NCT02055352|527059787|FG000|Overall Study|Withdrawal of informed consent|1|||
146149458|NCT02055352|527059788|FG001|Overall Study|Withdrawal of informed consent|0|||
146149459|NCT02055352|527059787|FG000|Overall Study|Reason unknown|1|||
146149460|NCT02055352|527059788|FG001|Overall Study|Reason unknown|5|||
146149461|NCT05349617|527059791|FG000|Overall Study|Death|1|||
146149462|NCT05349617|527059792|FG001|Overall Study|Death|1|||
146149463|NCT05349617|527059791|FG000|Overall Study|Lost to Follow-up|3|||
146149464|NCT05349617|527059792|FG001|Overall Study|Lost to Follow-up|8|||
146149465|NCT05349617|527059791|FG000|Overall Study|Withdrawal by Subject|2|||
146149466|NCT05349617|527059792|FG001|Overall Study|Withdrawal by Subject|10|||
146149467|NCT03811912|527059795|FG000|Overall Study|Withdrew Consent|4|||
146149468|NCT03811912|527059796|FG001|Overall Study|Withdrew Consent|2|||
146149469|NCT04401579|527059797|FG000|Overall Study|Death|23|||
146149470|NCT04401579|527059798|FG001|Overall Study|Death|36|||
146149471|NCT04401579|527059797|FG000|Overall Study|Lost to Follow-up|40|||
146149472|NCT04401579|527059798|FG001|Overall Study|Lost to Follow-up|41|||
146149473|NCT04401579|527059797|FG000|Overall Study|Withdrawal by Subject|8|||
146149474|NCT04401579|527059798|FG001|Overall Study|Withdrawal by Subject|16|||
146149475|NCT04401579|527059797|FG000|Overall Study|Physician Decision|1|||
146149476|NCT04401579|527059798|FG001|Overall Study|Physician Decision|2|||
146149477|NCT04401579|527059797|FG000|Overall Study|Became ineligible after enrollment|1|||
146149478|NCT04401579|527059798|FG001|Overall Study|Became ineligible after enrollment|1|||
146149479|NCT04401579|527059797|FG000|Overall Study|Enrolled but treatment not administered|7|||
146149480|NCT04401579|527059798|FG001|Overall Study|Enrolled but treatment not administered|9|||
146149481|NCT04401579|527059797|FG000|Overall Study|Adverse Event|2|||
146149482|NCT04401579|527059798|FG001|Overall Study|Adverse Event|1|||
146149483|NCT04401579|527059797|FG000|Overall Study|Scheduling error|1|||
146149484|NCT04401579|527059798|FG001|Overall Study|Scheduling error|2|||
146149485|NCT04401579|527059797|FG000|Overall Study|Transferred to another hospital|1|||
146149486|NCT04401579|527059798|FG001|Overall Study|Transferred to another hospital|2|||
146149487|NCT00489970|527059799|FG000|Persistence Year 9|Lost to Follow-up|2|||
146149488|NCT00489970|527059800|FG001|Persistence Year 9|Lost to Follow-up|2|||
146149489|NCT00489970|527059801|FG002|Persistence Year 9|Lost to Follow-up|3|||
146149490|NCT00489970|527059799|FG000|Persistence Year 9|Other|1|||
146149491|NCT00489970|527059800|FG001|Persistence Year 9|Other|0|||
146149492|NCT00489970|527059801|FG002|Persistence Year 9|Other|2|||
146149493|NCT01438411|527059802|FG000|Overall Study|Adverse Event|8|||
146149494|NCT01438411|527059802|FG000|Overall Study|Lost to Follow-up|1|||
146149495|NCT01438411|527059802|FG000|Overall Study|Lack of Efficacy|1|||
146149496|NCT01438411|527059802|FG000|Overall Study|Withdrawal by Subject|3|||
146149497|NCT01863680|527059803|FG000|Overall Study|Adverse Event|17|||
146149498|NCT01863680|527059803|FG000|Overall Study|Risk of OHSS|17|||
146149499|NCT01863680|527059803|FG000|Overall Study|Spontaneous pregnancy|2|||
146149500|NCT01863680|527059803|FG000|Overall Study|Withdrawal by Subject|1|||
146149501|NCT01863680|527059803|FG000|Overall Study|Did not undergo IVF/ET|14|||
146149502|NCT01863680|527059803|FG000|Overall Study|Other|6|||
146149503|NCT00618514|527059804|FG000|Overall Study|Lost to Follow-up|11|||
146149504|NCT00618514|527059805|FG001|Overall Study|Lost to Follow-up|12|||
146149505|NCT00618514|527059806|FG002|Overall Study|Lost to Follow-up|4|||
146149506|NCT00566228|527059811|FG000|Overall Study|Withdrawal by Subject|1|||
146149507|NCT00566228|527059812|FG001|Overall Study|Withdrawal by Subject|0|||
146149508|NCT00566228|527059811|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
146149509|NCT00566228|527059812|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
146149510|NCT00566228|527059811|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
146149511|NCT00566228|527059812|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
146149512|NCT00566228|527059811|FG000|Overall Study|progressed before infusion could occur|0|||
146149513|NCT00566228|527059812|FG001|Overall Study|progressed before infusion could occur|1|||
146149514|NCT02707055|527059815|FG000|Phase 1|Withdrawal by Subject|1|||
146149515|NCT02707055|527059816|FG001|Phase 1|Withdrawal by Subject|2|||
146149516|NCT02707055|527059815|FG000|Phase 1|Physician Decision|0|||
146149517|NCT02707055|527059816|FG001|Phase 1|Physician Decision|1|||
146149518|NCT02707055|527059815|FG000|Phase 2|Adverse Event|1|||
146149519|NCT02707055|527059816|FG001|Phase 2|Adverse Event|2|||
146149520|NCT00902304|527059817|FG000|Overall Study|Adverse Event|4|||
146149521|NCT00902304|527059818|FG001|Overall Study|Adverse Event|10|||
146149522|NCT00902304|527059819|FG002|Overall Study|Adverse Event|25|||
146149523|NCT00902304|527059817|FG000|Overall Study|Investigator discretion|3|||
146149524|NCT00902304|527059818|FG001|Overall Study|Investigator discretion|5|||
146149525|NCT00902304|527059819|FG002|Overall Study|Investigator discretion|13|||
146149526|NCT00902304|527059817|FG000|Overall Study|Lost to Follow-up|7|||
146149527|NCT00902304|527059818|FG001|Overall Study|Lost to Follow-up|7|||
146149528|NCT00902304|527059819|FG002|Overall Study|Lost to Follow-up|7|||
146149529|NCT00902304|527059817|FG000|Overall Study|Protocol Violation|9|||
146149530|NCT00902304|527059818|FG001|Overall Study|Protocol Violation|18|||
146149531|NCT00902304|527059819|FG002|Overall Study|Protocol Violation|20|||
146149532|NCT00902304|527059817|FG000|Overall Study|Withdrawal by Subject|32|||
146149533|NCT00902304|527059818|FG001|Overall Study|Withdrawal by Subject|22|||
146149534|NCT00902304|527059819|FG002|Overall Study|Withdrawal by Subject|43|||
146149535|NCT00902304|527059817|FG000|Overall Study|includes pregnancy|3|||
146149536|NCT00902304|527059818|FG001|Overall Study|includes pregnancy|9|||
146149537|NCT00902304|527059819|FG002|Overall Study|includes pregnancy|2|||
146149538|NCT05706506|527059820|FG000|Overall Study|Adverse Event|1|||
146149539|NCT05706506|527059820|FG000|Overall Study|Withdrawal by Subject|4|||
146149540|NCT05706506|527059820|FG000|Overall Study|Lost to Follow-up|2|||
146149541|NCT05706506|527059820|FG000|Overall Study|Inadvertent Enrolment|12|||
146149542|NCT05706506|527059820|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
146149543|NCT05706506|527059820|FG000|Overall Study|Participant Moved Out of State|1|||
146149544|NCT02646423|527059821|FG000|Overall Study|Adverse Event|5|||
146149545|NCT02646423|527059822|FG001|Overall Study|Adverse Event|7|||
146149546|NCT02646423|527059821|FG000|Overall Study|Ineligible|2|||
146149547|NCT02646423|527059822|FG001|Overall Study|Ineligible|1|||
146149548|NCT02511431|527059829|FG000|Treatment|Lost to Follow-up|0|||
146149549|NCT02511431|527059830|FG001|Treatment|Lost to Follow-up|0|||
146149550|NCT02511431|527059831|FG002|Treatment|Lost to Follow-up|1|||
146149551|NCT02511431|527059832|FG003|Treatment|Lost to Follow-up|0|||
146305513|NCT01462435|527632586|FG000|Overall Study|Physician Decision|0|||
146305514|NCT01462435|527632587|FG001|Overall Study|Physician Decision|0|||
146305515|NCT01462435|527632588|FG002|Overall Study|Physician Decision|1|||
146149552|NCT02511431|527059833|FG004|Treatment|Lost to Follow-up|0|||
146149553|NCT02511431|527059834|FG005|Treatment|Lost to Follow-up|1|||
146149554|NCT00462384|527059835|FG000|Overall Study|Adverse Event|2|||
146149555|NCT00462384|527059835|FG000|Overall Study|Death|2|||
146149556|NCT00462384|527059835|FG000|Overall Study|Withdrawal by Subject|1|||
146149557|NCT00462384|527059835|FG000|Overall Study|Other|4|||
146149558|NCT00817089|527059843|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
146149559|NCT00817089|527059844|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
146149560|NCT00817089|527059845|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
146149561|NCT00817089|527059846|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
146149562|NCT00817089|527059843|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
146149563|NCT00817089|527059844|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
146149564|NCT00817089|527059845|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
146149565|NCT00817089|527059846|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
146149566|NCT03783923|527059847|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
146149567|NCT03783923|527059848|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
146149568|NCT03783923|527059847|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
146149569|NCT03783923|527059848|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
146305516|NCT01462435|527632589|FG003|Overall Study|Physician Decision|0|||
146149570|NCT03783923|527059847|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146149571|NCT03783923|527059848|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
146149572|NCT03783923|527059847|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
146149573|NCT03783923|527059848|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
146149574|NCT03783923|527059847|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
146149575|NCT03783923|527059848|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
146149576|NCT01767116|527059857|FG000|Overall Study|Lost to Follow-up|2|||
146149577|NCT01767116|527059858|FG001|Overall Study|Lost to Follow-up|2|||
146149578|NCT03694548|527059863|FG000|Part A Survey|Protocol Violation|3|||
146149579|NCT03694548|527059864|FG001|Part A Survey|Protocol Violation|3|||
146149580|NCT03694548|527059865|FG002|Part A Survey|Protocol Violation|0|||
146149581|NCT03694548|527059863|FG000|Part B Yoga Program|Protocol Violation|0|||
146149582|NCT03694548|527059864|FG001|Part B Yoga Program|Protocol Violation|0|||
146149583|NCT03694548|527059865|FG002|Part B Yoga Program|Protocol Violation|3|||
146149584|NCT03694548|527059863|FG000|Part B Yoga Program|Did not attend intervention|0|||
146149585|NCT03694548|527059864|FG001|Part B Yoga Program|Did not attend intervention|0|||
146149586|NCT03694548|527059865|FG002|Part B Yoga Program|Did not attend intervention|8|||
146149587|NCT00305058|527059866|FG000|Overall Study|Participant too young|1|||
146149588|NCT00305058|527059867|FG001|Overall Study|Participant too young|0|||
146149589|NCT00305058|527059866|FG000|Overall Study|Missing data collection instrument|3|||
146149590|NCT00305058|527059867|FG001|Overall Study|Missing data collection instrument|2|||
146149591|NCT00305058|527059866|FG000|Overall Study|Missing outcome data|3|||
146149592|NCT00305058|527059867|FG001|Overall Study|Missing outcome data|2|||
146149593|NCT00439777|527059868|FG000|Treatment Period|Death|29|||
146149594|NCT00439777|527059869|FG001|Treatment Period|Death|21|||
146149595|NCT00439777|527059868|FG000|Treatment Period|Study terminated by sponsor|125|||
146149596|NCT00439777|527059869|FG001|Treatment Period|Study terminated by sponsor|132|||
146149597|NCT00439777|527059868|FG000|Treatment Period|Site closed by investigator|0|||
146305517|NCT01462435|527632586|FG000|Overall Study|Withdrawal by Subject|0|||
146305518|NCT01462435|527632587|FG001|Overall Study|Withdrawal by Subject|0|||
146305519|NCT01462435|527632588|FG002|Overall Study|Withdrawal by Subject|0|||
146305520|NCT01462435|527632589|FG003|Overall Study|Withdrawal by Subject|1|||
146305521|NCT01462435|527632586|FG000|Overall Study|Lost to Follow-up|0|||
146305522|NCT01462435|527632587|FG001|Overall Study|Lost to Follow-up|0|||
146305523|NCT01462435|527632588|FG002|Overall Study|Lost to Follow-up|0|||
146305524|NCT01462435|527632589|FG003|Overall Study|Lost to Follow-up|1|||
146305525|NCT01543152|527632596|FG000|Overall Study|Withdrawal by Subject|0|||
146305526|NCT01543152|527632597|FG001|Overall Study|Withdrawal by Subject|2|||
146305527|NCT01543152|527632598|FG002|Overall Study|Withdrawal by Subject|0|||
146305528|NCT01543152|527632599|FG003|Overall Study|Withdrawal by Subject|0|||
146305529|NCT01543152|527632600|FG004|Overall Study|Withdrawal by Subject|0|||
146305530|NCT02053168|527632601|FG000|Overall Study|Withdrawal by Subject|1|||
146305531|NCT02053168|527632601|FG000|Overall Study|Physician Decision|1|||
146305532|NCT02053168|527632601|FG000|Overall Study|Lost to Follow-up|1|||
146305533|NCT00636675|527632602|FG000|Overall Study|Lost to Follow-up|121|||
146305534|NCT00636675|527632603|FG001|Overall Study|Lost to Follow-up|31|||
146305535|NCT00636675|527632602|FG000|Overall Study|Withdrawal by Subject|19|||
146305536|NCT00636675|527632603|FG001|Overall Study|Withdrawal by Subject|10|||
146305537|NCT02687542|527632604|FG000|Overall Study|Medication error without associated AEs|0|||
146305538|NCT02687542|527632605|FG001|Overall Study|Medication error without associated AEs|0|||
146305539|NCT02687542|527632606|FG002|Overall Study|Medication error without associated AEs|0|||
146305540|NCT02687542|527632607|FG003|Overall Study|Medication error without associated AEs|0|||
146305541|NCT02687542|527632608|FG004|Overall Study|Medication error without associated AEs|1|||
146305542|NCT02687542|527632604|FG000|Overall Study|Lost to Follow-up|0|||
146305543|NCT02687542|527632605|FG001|Overall Study|Lost to Follow-up|0|||
146305544|NCT02687542|527632606|FG002|Overall Study|Lost to Follow-up|0|||
146305545|NCT02687542|527632607|FG003|Overall Study|Lost to Follow-up|0|||
146305546|NCT02687542|527632608|FG004|Overall Study|Lost to Follow-up|1|||
146305547|NCT02687542|527632604|FG000|Overall Study|Protocol Violation|0|||
146305548|NCT02687542|527632605|FG001|Overall Study|Protocol Violation|1|||
146305549|NCT02687542|527632606|FG002|Overall Study|Protocol Violation|0|||
146305550|NCT02687542|527632607|FG003|Overall Study|Protocol Violation|0|||
146305551|NCT02687542|527632608|FG004|Overall Study|Protocol Violation|0|||
146305552|NCT02687542|527632604|FG000|Overall Study|Other|5|||
146305553|NCT02687542|527632605|FG001|Overall Study|Other|9|||
146305554|NCT02687542|527632606|FG002|Overall Study|Other|10|||
146149598|NCT00439777|527059869|FG001|Treatment Period|Site closed by investigator|1|||
146149599|NCT00439777|527059868|FG000|Treatment Period|Did not take study treatment|7|||
146149600|NCT00439777|527059869|FG001|Treatment Period|Did not take study treatment|8|||
146305555|NCT02687542|527632607|FG003|Overall Study|Other|6|||
146149601|NCT00439777|527059868|FG000|Treatment Period|Adverse Event|111|||
146149602|NCT00439777|527059869|FG001|Treatment Period|Adverse Event|92|||
146305556|NCT02687542|527632608|FG004|Overall Study|Other|5|||
146305557|NCT02687542|527632604|FG000|Overall Study|Adverse Event|3|||
146305558|NCT02687542|527632605|FG001|Overall Study|Adverse Event|1|||
146305559|NCT02687542|527632606|FG002|Overall Study|Adverse Event|3|||
146149603|NCT00439777|527059868|FG000|Treatment Period|Protocol Violation|23|||
146149604|NCT00439777|527059869|FG001|Treatment Period|Protocol Violation|30|||
146149605|NCT00439777|527059868|FG000|Treatment Period|Withdrawal by Subject|66|||
146149606|NCT00439777|527059869|FG001|Treatment Period|Withdrawal by Subject|118|||
146149607|NCT00439777|527059868|FG000|Treatment Period|Lack of Efficacy|1|||
146149608|NCT00439777|527059869|FG001|Treatment Period|Lack of Efficacy|4|||
146149609|NCT00439777|527059868|FG000|Treatment Period|Lost to Follow-up|8|||
146149610|NCT00439777|527059869|FG001|Treatment Period|Lost to Follow-up|10|||
146149611|NCT00439777|527059868|FG000|Treatment Period|Protocol driven decision point|1|||
146149612|NCT00439777|527059869|FG001|Treatment Period|Protocol driven decision point|3|||
146149613|NCT00439777|527059868|FG000|Treatment Period|Physician Decision|7|||
146149614|NCT00439777|527059869|FG001|Treatment Period|Physician Decision|18|||
146149615|NCT00439777|527059868|FG000|Treatment Period|Clinical endpoint reached|26|||
146149616|NCT00439777|527059869|FG001|Treatment Period|Clinical endpoint reached|13|||
146149617|NCT00439777|527059868|FG000|Treatment Period|Technical problems|3|||
146149618|NCT00439777|527059869|FG001|Treatment Period|Technical problems|1|||
146149619|NCT00439777|527059868|FG000|Treatment Period|Participant convenience|12|||
146149620|NCT00439777|527059869|FG001|Treatment Period|Participant convenience|8|||
146149621|NCT00439777|527059868|FG000|Observational Period|Protocol Violation|0|||
146149622|NCT00439777|527059869|FG001|Observational Period|Protocol Violation|2|||
146149623|NCT00439777|527059868|FG000|Observational Period|Withdrawal by Subject|9|||
146149624|NCT00439777|527059869|FG001|Observational Period|Withdrawal by Subject|5|||
146149625|NCT00439777|527059868|FG000|Observational Period|Lost to Follow-up|1|||
146149626|NCT00439777|527059869|FG001|Observational Period|Lost to Follow-up|11|||
146149627|NCT00439777|527059868|FG000|Observational Period|Death|27|||
146149628|NCT00439777|527059869|FG001|Observational Period|Death|20|||
146149629|NCT00439777|527059868|FG000|Observational Period|Study terminated by sponsor|3|||
146149630|NCT00439777|527059869|FG001|Observational Period|Study terminated by sponsor|1|||
146149631|NCT00439777|527059868|FG000|Observational Period|Protocol driven decision point|0|||
146149632|NCT00439777|527059869|FG001|Observational Period|Protocol driven decision point|1|||
146149633|NCT00439777|527059868|FG000|Observational Period|Lack of Efficacy|1|||
146149634|NCT00439777|527059869|FG001|Observational Period|Lack of Efficacy|0|||
146149635|NCT00439777|527059868|FG000|Observational Period|Technical problems|0|||
146149636|NCT00439777|527059869|FG001|Observational Period|Technical problems|1|||
146149637|NCT00661492|527059870|FG000|Overall Study|Adverse Event|16|||
146149638|NCT00661492|527059871|FG001|Overall Study|Adverse Event|13|||
146149639|NCT00661492|527059870|FG000|Overall Study|Disease Progression|44|||
146149640|NCT00661492|527059871|FG001|Overall Study|Disease Progression|14|||
146149641|NCT00661492|527059870|FG000|Overall Study|Patient Request|6|||
146149642|NCT00661492|527059871|FG001|Overall Study|Patient Request|1|||
146149643|NCT00661492|527059870|FG000|Overall Study|Investigator Request|1|||
146149644|NCT00661492|527059871|FG001|Overall Study|Investigator Request|0|||
146149645|NCT00661492|527059870|FG000|Overall Study|Lost to Follow-up|0|||
146149646|NCT00661492|527059871|FG001|Overall Study|Lost to Follow-up|1|||
146149647|NCT00661492|527059870|FG000|Overall Study|Other|1|||
146149648|NCT00661492|527059871|FG001|Overall Study|Other|0|||
146149649|NCT01024387|527059872|FG000|Overall Study|Radiographic Progression|29|||
146149650|NCT01024387|527059872|FG000|Overall Study|Symptomatic Progression|10|||
146149651|NCT01024387|527059872|FG000|Overall Study|Physician Decision|5|||
146149652|NCT01024387|527059872|FG000|Overall Study|Withdrawal by Subject|5|||
146149653|NCT01024387|527059872|FG000|Overall Study|Death|2|||
146149654|NCT01024387|527059872|FG000|Overall Study|Prolonged Treatment Delay|1|||
146149655|NCT01024387|527059872|FG000|Overall Study|Adverse Event|3|||
146149656|NCT01024387|527059872|FG000|Overall Study|Other|5|||
146149657|NCT03855189|527059873|FG000|Overall Study|Adverse Event|5|||
146149658|NCT03855189|527059874|FG001|Overall Study|Adverse Event|2|||
146149659|NCT03855189|527059875|FG002|Overall Study|Adverse Event|4|||
146149660|NCT03855189|527059873|FG000|Overall Study|Treatment Failure|1|||
146149661|NCT03855189|527059874|FG001|Overall Study|Treatment Failure|1|||
146149662|NCT03855189|527059875|FG002|Overall Study|Treatment Failure|2|||
146149663|NCT03855189|527059873|FG000|Overall Study|Noncompliance with Protocol|0|||
146149664|NCT03855189|527059874|FG001|Overall Study|Noncompliance with Protocol|1|||
146149665|NCT03855189|527059875|FG002|Overall Study|Noncompliance with Protocol|0|||
146149666|NCT03855189|527059873|FG000|Overall Study|Did Not Return|4|||
146149667|NCT03855189|527059874|FG001|Overall Study|Did Not Return|3|||
146149668|NCT03855189|527059875|FG002|Overall Study|Did Not Return|0|||
146278644|NCT03339583|527534363|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
146278645|NCT03339583|527534362|FG000|Second Intervention (14 Days)|Adverse Event|0|||
146278646|NCT03339583|527534363|FG001|Second Intervention (14 Days)|Adverse Event|1|||
146278647|NCT03339583|527534362|FG000|Follow-up (14 Days)|Physician Decision|6|||
146278648|NCT03339583|527534363|FG001|Follow-up (14 Days)|Physician Decision|3|||
146278649|NCT00734591|527534364|FG000|Screening for Prospective Period|Site did not participate|1604|||
146278650|NCT00734591|527534365|FG001|Screening for Prospective Period|Site did not participate|1488|||
146278651|NCT00734591|527534364|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
146278652|NCT00734591|527534365|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
146149669|NCT00586105|527059876|FG000|Overall Study|Adverse Event|4|||
146149670|NCT00586105|527059876|FG000|Overall Study|Death|2|||
146149671|NCT00586105|527059876|FG000|Overall Study|Protocol Violation|1|||
146149672|NCT00586105|527059876|FG000|Overall Study|Withdrawal by Subject|3|||
146149673|NCT00586105|527059876|FG000|Overall Study|Disease progression|19|||
146149674|NCT00586105|527059876|FG000|Overall Study|Switched to commercial drug|9|||
146149675|NCT00586105|527059876|FG000|Overall Study|Reason not reported|1|||
146149676|NCT03238001|527059879|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
146149677|NCT03238001|527059879|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
146149678|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
146149679|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
146149680|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
146149681|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
146149682|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
146149683|NCT03238001|527059879|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
146149684|NCT03791398|527059883|FG000|Overall Study|Progression of Disease Under Study|2|||
146149685|NCT03791398|527059884|FG001|Overall Study|Progression of Disease Under Study|0|||
146149686|NCT03791398|527059885|FG002|Overall Study|Progression of Disease Under Study|0|||
146149687|NCT00766376|527059888|FG000|Overall Study|Withdrawal by Subject|27|||
146149688|NCT02207829|527059889|FG000|Overall Study|Adverse Event|10|||
146149689|NCT02207829|527059890|FG001|Overall Study|Adverse Event|9|||
146149690|NCT02207829|527059889|FG000|Overall Study|Lack of Efficacy|7|||
146149691|NCT02207829|527059890|FG001|Overall Study|Lack of Efficacy|5|||
146149692|NCT02207829|527059889|FG000|Overall Study|Lost to Follow-up|2|||
146149693|NCT02207829|527059890|FG001|Overall Study|Lost to Follow-up|2|||
146149694|NCT02207829|527059889|FG000|Overall Study|Protocol deviation|5|||
146149695|NCT02207829|527059890|FG001|Overall Study|Protocol deviation|4|||
146149696|NCT02207829|527059889|FG000|Overall Study|Withdrew consent|18|||
146149697|NCT02207829|527059890|FG001|Overall Study|Withdrew consent|14|||
146149698|NCT01418209|527059891|FG000|Overall Study|Withdrawal by Subject|1|||
146149699|NCT01418209|527059892|FG001|Overall Study|Withdrawal by Subject|0|||
146149700|NCT01418209|527059893|FG002|Overall Study|Withdrawal by Subject|1|||
146149701|NCT01418209|527059891|FG000|Overall Study|Did not provide hot flash diary data|1|||
146149702|NCT01418209|527059892|FG001|Overall Study|Did not provide hot flash diary data|3|||
146149703|NCT01418209|527059893|FG002|Overall Study|Did not provide hot flash diary data|3|||
146149704|NCT00101101|527059894|FG000|Overall Study|never received vaccine|20|||
146149705|NCT01800903|527059895|FG000|Second Test Period|unable to catheterise|1|||
146149706|NCT01800903|527059896|FG001|Second Test Period|unable to catheterise|0|||
146149707|NCT01800903|527059897|FG002|Second Test Period|unable to catheterise|0|||
146149708|NCT01800903|527059898|FG003|Second Test Period|unable to catheterise|0|||
146149709|NCT01800903|527059899|FG004|Second Test Period|unable to catheterise|0|||
146149710|NCT01800903|527059900|FG005|Second Test Period|unable to catheterise|0|||
146149711|NCT01110239|527059903|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
146149712|NCT01110239|527059904|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
146149713|NCT01110239|527059905|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
146149714|NCT01110239|527059906|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
146149715|NCT01110239|527059903|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
146149716|NCT01110239|527059904|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
146149717|NCT01110239|527059905|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
146149718|NCT01110239|527059906|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
146149719|NCT00080223|527059907|FG000|Overall Study|Adverse Event|23|||
146149720|NCT00080223|527059907|FG000|Overall Study|Death|21|||
146149721|NCT00080223|527059907|FG000|Overall Study|Withdrawal by Subject|13|||
146149722|NCT00080223|527059907|FG000|Overall Study|Lung Transplantation|9|||
146149723|NCT00080223|527059907|FG000|Overall Study|Non-compliance With Study Treatment|7|||
146278653|NCT00734591|527534364|FG000|Prospective Period|Withdrawal by Subject|11|||
146149724|NCT00080223|527059907|FG000|Overall Study|Participant unwilling to continue|2|||
146149725|NCT00080223|527059907|FG000|Overall Study|Physician Decision|1|||
146149726|NCT03099382|527059914|FG000|Overall Study|Protocol Violation|2|||
146149727|NCT03099382|527059915|FG001|Overall Study|Protocol Violation|3|||
146149728|NCT01802411|527059916|FG000|Overall Study|Death|2|||
146149729|NCT01802411|527059917|FG001|Overall Study|Death|1|||
146149730|NCT01802411|527059916|FG000|Overall Study|Adverse Event|2|||
146149731|NCT01802411|527059917|FG001|Overall Study|Adverse Event|7|||
146149732|NCT01802411|527059916|FG000|Overall Study|Lack of Efficacy|8|||
146149733|NCT01802411|527059917|FG001|Overall Study|Lack of Efficacy|10|||
146149734|NCT01802411|527059916|FG000|Overall Study|Withdrawal by Subject|0|||
146149735|NCT01802411|527059917|FG001|Overall Study|Withdrawal by Subject|2|||
146149736|NCT01802411|527059916|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
146149737|NCT01802411|527059917|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
146149738|NCT01802411|527059916|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
146149739|NCT01802411|527059917|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
146149740|NCT01802411|527059916|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
146149741|NCT01802411|527059917|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
146149742|NCT01337245|527059918|FG000|Overall Study|Lost to Follow-up|1|||
146149743|NCT00560833|527059931|FG000|Overall Study|Adverse Event|16|||
146149744|NCT00560833|527059932|FG001|Overall Study|Adverse Event|10|||
146149745|NCT00560833|527059933|FG002|Overall Study|Adverse Event|25|||
146149746|NCT00560833|527059934|FG003|Overall Study|Adverse Event|23|||
146149747|NCT00560833|527059935|FG004|Overall Study|Adverse Event|35|||
146149748|NCT00560833|527059931|FG000|Overall Study|Lost to Follow-up|0|||
146149749|NCT00560833|527059932|FG001|Overall Study|Lost to Follow-up|0|||
146149750|NCT00560833|527059933|FG002|Overall Study|Lost to Follow-up|1|||
146149751|NCT00560833|527059934|FG003|Overall Study|Lost to Follow-up|0|||
146149752|NCT00560833|527059935|FG004|Overall Study|Lost to Follow-up|0|||
146149753|NCT00560833|527059931|FG000|Overall Study|Lack of Efficacy|22|||
146149754|NCT00560833|527059932|FG001|Overall Study|Lack of Efficacy|9|||
146149755|NCT00560833|527059933|FG002|Overall Study|Lack of Efficacy|6|||
146149756|NCT00560833|527059934|FG003|Overall Study|Lack of Efficacy|4|||
146149757|NCT00560833|527059935|FG004|Overall Study|Lack of Efficacy|4|||
146149758|NCT00560833|527059931|FG000|Overall Study|Participant uncooperative|5|||
146149759|NCT00560833|527059932|FG001|Overall Study|Participant uncooperative|5|||
146149760|NCT00560833|527059933|FG002|Overall Study|Participant uncooperative|4|||
146149761|NCT00560833|527059934|FG003|Overall Study|Participant uncooperative|4|||
146149762|NCT00560833|527059935|FG004|Overall Study|Participant uncooperative|2|||
146149763|NCT00560833|527059931|FG000|Overall Study|Other|1|||
146149764|NCT00560833|527059932|FG001|Overall Study|Other|1|||
146149765|NCT00560833|527059933|FG002|Overall Study|Other|3|||
146149766|NCT00560833|527059934|FG003|Overall Study|Other|0|||
146149767|NCT00560833|527059935|FG004|Overall Study|Other|0|||
146149768|NCT00560833|527059931|FG000|Overall Study|Never received drug|0|||
146149769|NCT00560833|527059932|FG001|Overall Study|Never received drug|1|||
146149770|NCT00560833|527059933|FG002|Overall Study|Never received drug|0|||
146149771|NCT00560833|527059934|FG003|Overall Study|Never received drug|0|||
146149772|NCT00560833|527059935|FG004|Overall Study|Never received drug|1|||
146149773|NCT01059617|527059936|FG000|Overall Study|Other|7|||
146149774|NCT01059617|527059937|FG001|Overall Study|Other|1|||
146149775|NCT01059617|527059938|FG002|Overall Study|Other|8|||
146149776|NCT01059617|527059939|FG003|Overall Study|Other|6|||
146149777|NCT03864614|527059943|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
146149778|NCT03864614|527059944|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
146149779|NCT03864614|527059945|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
146149780|NCT03864614|527059946|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
146278654|NCT00734591|527534365|FG001|Prospective Period|Withdrawal by Subject|9|||
146278655|NCT00734591|527534364|FG000|Prospective Period|Lost to Follow-up|37|||
146278656|NCT00734591|527534365|FG001|Prospective Period|Lost to Follow-up|33|||
146278657|NCT00734591|527534364|FG000|Prospective Period|Study Terminated|1|||
146278658|NCT00734591|527534365|FG001|Prospective Period|Study Terminated|0|||
146278659|NCT00734591|527534364|FG000|Prospective Period|Other|2|||
146278660|NCT00734591|527534365|FG001|Prospective Period|Other|2|||
146278661|NCT01656200|527534366|FG000|Overall Study|Withdrawal by Subject|1|||
146278662|NCT02236988|527534367|FG000|Overall Study|Lost to Follow-up|0|||
146278663|NCT02236988|527534368|FG001|Overall Study|Lost to Follow-up|0|||
146278664|NCT02236988|527534369|FG002|Overall Study|Lost to Follow-up|0|||
146278665|NCT02236988|527534370|FG003|Overall Study|Lost to Follow-up|1|||
146278666|NCT02236988|527534367|FG000|Overall Study|Unable to Comply with Study Visits|0|||
146278667|NCT02236988|527534368|FG001|Overall Study|Unable to Comply with Study Visits|0|||
146278668|NCT02236988|527534369|FG002|Overall Study|Unable to Comply with Study Visits|0|||
146278669|NCT02236988|527534370|FG003|Overall Study|Unable to Comply with Study Visits|2|||
146278670|NCT00730275|527534371|FG000|Overall Study|Withdrawal by Subject|0|||
146278671|NCT00730275|527534372|FG001|Overall Study|Withdrawal by Subject|0|||
146278672|NCT00730275|527534373|FG002|Overall Study|Withdrawal by Subject|0|||
146278673|NCT00730275|527534374|FG003|Overall Study|Withdrawal by Subject|1|||
146278674|NCT03921723|527534380|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
146278675|NCT03921723|527534380|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
146278676|NCT01461811|527534381|FG000|Overall Study|Adverse Event|2|||
146278677|NCT01461811|527534382|FG001|Overall Study|Adverse Event|1|||
146278678|NCT01461811|527534381|FG000|Overall Study|Subject decision unrelated to an AE|1|||
146278679|NCT01461811|527534382|FG001|Overall Study|Subject decision unrelated to an AE|1|||
146278680|NCT01461811|527534381|FG000|Overall Study|Noncompliance|1|||
146305560|NCT02687542|527632607|FG003|Overall Study|Adverse Event|2|||
146278681|NCT01461811|527534382|FG001|Overall Study|Noncompliance|1|||
146149781|NCT03864614|527059943|FG000|Overall Study|Withdrawal by Subject|72|||
146149782|NCT03864614|527059944|FG001|Overall Study|Withdrawal by Subject|100|||
146149783|NCT03864614|527059945|FG002|Overall Study|Withdrawal by Subject|1|||
146149784|NCT03864614|527059946|FG003|Overall Study|Withdrawal by Subject|21|||
146149785|NCT03864614|527059943|FG000|Overall Study|Lost to Follow-up|45|||
146149786|NCT03864614|527059944|FG001|Overall Study|Lost to Follow-up|54|||
146149787|NCT03864614|527059945|FG002|Overall Study|Lost to Follow-up|0|||
146149788|NCT03864614|527059946|FG003|Overall Study|Lost to Follow-up|9|||
146149789|NCT03864614|527059943|FG000|Overall Study|Adverse Event|42|||
146149790|NCT03864614|527059944|FG001|Overall Study|Adverse Event|30|||
146149791|NCT03864614|527059945|FG002|Overall Study|Adverse Event|1|||
146149792|NCT03864614|527059946|FG003|Overall Study|Adverse Event|9|||
146149793|NCT03864614|527059943|FG000|Overall Study|Protocol Deviation|6|||
146305561|NCT02687542|527632608|FG004|Overall Study|Adverse Event|9|||
146305562|NCT02687542|527632604|FG000|Overall Study|Withdrawal by Subject|0|||
146305563|NCT02687542|527632605|FG001|Overall Study|Withdrawal by Subject|1|||
146305564|NCT02687542|527632606|FG002|Overall Study|Withdrawal by Subject|1|||
146305565|NCT02687542|527632607|FG003|Overall Study|Withdrawal by Subject|2|||
146305566|NCT02687542|527632608|FG004|Overall Study|Withdrawal by Subject|4|||
146305567|NCT01838616|527632610|FG000|Titration Period|Adverse Event|18|||
146305568|NCT01838616|527632611|FG001|Titration Period|Adverse Event|48|||
146305569|NCT01838616|527632610|FG000|Titration Period|Lack of Efficacy|5|||
146305570|NCT01838616|527632611|FG001|Titration Period|Lack of Efficacy|12|||
146305571|NCT01838616|527632610|FG000|Titration Period|Withdrawal by Subject|5|||
146305572|NCT01838616|527632611|FG001|Titration Period|Withdrawal by Subject|5|||
146305573|NCT01838616|527632610|FG000|Titration Period|Technical problems|1|||
146305574|NCT01838616|527632611|FG001|Titration Period|Technical problems|0|||
146305575|NCT01838616|527632610|FG000|Titration Period|Other|1|||
146305576|NCT01838616|527632611|FG001|Titration Period|Other|0|||
146305577|NCT01838616|527632610|FG000|Titration Period|Protocol Violation|0|||
146305578|NCT01838616|527632611|FG001|Titration Period|Protocol Violation|1|||
146305579|NCT01838616|527632610|FG000|Continuation Period|Lack of Efficacy|3|||
146305580|NCT01838616|527632611|FG001|Continuation Period|Lack of Efficacy|5|||
146305581|NCT01838616|527632610|FG000|Continuation Period|Adverse Event|8|||
146305582|NCT01838616|527632611|FG001|Continuation Period|Adverse Event|4|||
146305583|NCT01838616|527632610|FG000|Continuation Period|Protocol Violation|2|||
146305584|NCT01838616|527632611|FG001|Continuation Period|Protocol Violation|0|||
146305585|NCT01838616|527632610|FG000|Continuation Period|Lost to Follow-up|1|||
146305586|NCT01838616|527632611|FG001|Continuation Period|Lost to Follow-up|0|||
146305587|NCT01838616|527632610|FG000|Continuation Period|Withdrawal by Subject|0|||
146305588|NCT01838616|527632611|FG001|Continuation Period|Withdrawal by Subject|4|||
146305589|NCT01838616|527632610|FG000|Continuation Period|Technical problems|0|||
146305590|NCT01838616|527632611|FG001|Continuation Period|Technical problems|1|||
146305591|NCT01838616|527632610|FG000|Pick-up Arm|Lack of Efficacy|4|||
146305592|NCT01838616|527632611|FG001|Pick-up Arm|Lack of Efficacy|0|||
146305593|NCT01838616|527632610|FG000|Pick-up Arm|Adverse Event|9|||
146305594|NCT01838616|527632611|FG001|Pick-up Arm|Adverse Event|0|||
146305595|NCT01838616|527632610|FG000|Pick-up Arm|Withdrawal by Subject|1|||
146305596|NCT01838616|527632611|FG001|Pick-up Arm|Withdrawal by Subject|0|||
146305597|NCT01838616|527632610|FG000|Pick-up Arm|Technical problems|1|||
146305598|NCT01838616|527632611|FG001|Pick-up Arm|Technical problems|0|||
146305599|NCT00139776|527632612|FG000|Period I|Did not enter Period II|575|||
146305600|NCT00139776|527632613|FG001|Period I|Did not enter Period II|0|||
146305601|NCT00139776|527632614|FG002|Period I|Did not enter Period II|0|||
146305602|NCT00139776|527632615|FG003|Period I|Did not enter Period II|0|||
146305603|NCT00139776|527632612|FG000|Period II|Not Randomized into Period III|0|||
146305604|NCT00139776|527632613|FG001|Period II|Not Randomized into Period III|322|||
146305605|NCT00139776|527632614|FG002|Period II|Not Randomized into Period III|0|||
146305606|NCT00139776|527632615|FG003|Period II|Not Randomized into Period III|0|||
146305607|NCT00139776|527632612|FG000|Period III|Adverse Event|0|||
146305608|NCT00139776|527632613|FG001|Period III|Adverse Event|0|||
146305609|NCT00139776|527632614|FG002|Period III|Adverse Event|22|||
146305610|NCT00139776|527632615|FG003|Period III|Adverse Event|23|||
146305611|NCT00139776|527632612|FG000|Period III|Other|0|||
146305612|NCT00139776|527632613|FG001|Period III|Other|0|||
146305613|NCT00139776|527632614|FG002|Period III|Other|23|||
146305614|NCT00139776|527632615|FG003|Period III|Other|34|||
146305615|NCT00139776|527632612|FG000|Period III|Lack of Efficacy|0|||
146305616|NCT00139776|527632613|FG001|Period III|Lack of Efficacy|0|||
146305617|NCT00139776|527632614|FG002|Period III|Lack of Efficacy|10|||
146305618|NCT00139776|527632615|FG003|Period III|Lack of Efficacy|24|||
146305619|NCT00139776|527632612|FG000|Period III|Lost to Follow-up|0|||
146305620|NCT00139776|527632613|FG001|Period III|Lost to Follow-up|0|||
146305621|NCT00139776|527632614|FG002|Period III|Lost to Follow-up|5|||
146305622|NCT00139776|527632615|FG003|Period III|Lost to Follow-up|4|||
146305623|NCT00139776|527632612|FG000|Period III|Withdrawal by Subject|0|||
146305624|NCT00139776|527632613|FG001|Period III|Withdrawal by Subject|0|||
146305625|NCT00139776|527632614|FG002|Period III|Withdrawal by Subject|16|||
146305626|NCT00139776|527632615|FG003|Period III|Withdrawal by Subject|21|||
146305627|NCT02164929|527632632|FG000|Overall Study|Converted to open procedure|1|||
146305628|NCT02164929|527632633|FG001|Overall Study|Converted to open procedure|0|||
146305629|NCT02164929|527632634|FG002|Overall Study|Converted to open procedure|0|||
146305630|NCT02164929|527632635|FG003|Overall Study|Converted to open procedure|2|||
146305631|NCT02164929|527632632|FG000|Overall Study|Failed regional block|0|||
146305632|NCT02164929|527632633|FG001|Overall Study|Failed regional block|0|||
146305633|NCT02164929|527632634|FG002|Overall Study|Failed regional block|1|||
146305634|NCT02164929|527632635|FG003|Overall Study|Failed regional block|0|||
146305635|NCT00701090|527632638|FG000|Overall Study|Adverse Event|11|||
146305636|NCT00701090|527632639|FG001|Overall Study|Adverse Event|2|||
146149794|NCT03864614|527059944|FG001|Overall Study|Protocol Deviation|26|||
146149795|NCT03864614|527059945|FG002|Overall Study|Protocol Deviation|0|||
146149796|NCT03864614|527059946|FG003|Overall Study|Protocol Deviation|1|||
146149797|NCT03864614|527059943|FG000|Overall Study|Physician Decision|7|||
146149798|NCT03864614|527059944|FG001|Overall Study|Physician Decision|10|||
146149799|NCT03864614|527059945|FG002|Overall Study|Physician Decision|1|||
146149800|NCT03864614|527059946|FG003|Overall Study|Physician Decision|5|||
146149801|NCT03864614|527059943|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
146149802|NCT03864614|527059944|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
146149803|NCT03864614|527059945|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
146149804|NCT03864614|527059946|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
146149805|NCT03864614|527059943|FG000|Overall Study|Sponsor Decision|1|||
146149806|NCT03864614|527059944|FG001|Overall Study|Sponsor Decision|2|||
146149807|NCT03864614|527059945|FG002|Overall Study|Sponsor Decision|0|||
146149808|NCT03864614|527059946|FG003|Overall Study|Sponsor Decision|0|||
146149809|NCT03864614|527059943|FG000|Overall Study|Pregnancy|0|||
146149810|NCT03864614|527059944|FG001|Overall Study|Pregnancy|1|||
146149811|NCT03864614|527059945|FG002|Overall Study|Pregnancy|0|||
146149812|NCT03864614|527059946|FG003|Overall Study|Pregnancy|0|||
146149813|NCT03864614|527059943|FG000|Overall Study|Other|7|||
146149814|NCT03864614|527059944|FG001|Overall Study|Other|9|||
146149815|NCT03864614|527059945|FG002|Overall Study|Other|1|||
146149816|NCT03864614|527059946|FG003|Overall Study|Other|4|||
146149817|NCT03864614|527059943|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
146149818|NCT03864614|527059944|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
146149819|NCT03864614|527059945|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
146149820|NCT03864614|527059946|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
146149821|NCT00136955|527061512|FG000|Overall Study|Adverse Event|8|||
146149822|NCT00136955|527061512|FG000|Overall Study|Lost to Follow-up|1|||
146149823|NCT00136955|527061512|FG000|Overall Study|Withdrawal by Subject|2|||
146149824|NCT00136955|527061512|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
146149825|NCT02280044|527061515|FG000|Overall Study|Planned alternate|0|||
146149826|NCT02280044|527061516|FG001|Overall Study|Planned alternate|2|||
146149827|NCT02105116|527061519|FG000|Overall Study|not eligible for step 2 of trial|5|||
146149828|NCT02105116|527061519|FG000|Overall Study|Death|1|||
146149829|NCT02492100|527061520|FG000|Overall Study|Death|1|||
146149830|NCT03832010|527061521|FG000|Overall Study|Withdrawal by Subject|2|||
146149831|NCT03832010|527061522|FG001|Overall Study|Withdrawal by Subject|1|||
146149832|NCT03832010|527061523|FG002|Overall Study|Withdrawal by Subject|0|||
146149833|NCT03832010|527061521|FG000|Overall Study|Lost to Follow-up|2|||
146149834|NCT03832010|527061522|FG001|Overall Study|Lost to Follow-up|1|||
146149835|NCT03832010|527061523|FG002|Overall Study|Lost to Follow-up|1|||
146149836|NCT04837482|527061524|FG000|Period 2|Withdrawal by Subject|0|||
146149837|NCT04837482|527061525|FG001|Period 2|Withdrawal by Subject|1|||
146149838|NCT00987467|527061529|FG000|Overall Study|Lost to Follow-up|2|||
146149839|NCT00086346|527061530|FG000|Randomization|Did not receive test article|4|||
146149840|NCT00086346|527061531|FG001|Randomization|Did not receive test article|4|||
146149841|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Adverse Event|94|||
146149842|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Adverse Event|11|||
146149843|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
146149844|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
146149845|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
146149846|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
146149847|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
146149848|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
146149849|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
146149850|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
146149851|NCT00086346|527061530|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
146149852|NCT00086346|527061531|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
146149853|NCT02807948|527061532|FG000|Overall Study|Physician Decision|1|||
146149854|NCT02807948|527061533|FG001|Overall Study|Physician Decision|0|||
146149855|NCT03727750|527061534|FG000|Overall Study|Death|45|||
146149856|NCT03727750|527061534|FG000|Overall Study|Withdrawal by Subject|2|||
146149857|NCT03727750|527061534|FG000|Overall Study|Lost to Follow-up|1|||
146149858|NCT03727750|527061534|FG000|Overall Study|Other|1|||
146149859|NCT01303627|527061538|FG000|Overall Study|the failure while performing URS|0|||
146149860|NCT01303627|527061539|FG001|Overall Study|the failure while performing URS|1|||
146149861|NCT01054820|527061541|FG000|Overall Study|Withdrawal by Subject|2|||
146149862|NCT00321919|527061543|FG000|Overall Study|Adverse Event|17|||
146149863|NCT00321919|527061544|FG001|Overall Study|Adverse Event|10|||
146149864|NCT00321919|527061543|FG000|Overall Study|Death|21|||
146149865|NCT00321919|527061544|FG001|Overall Study|Death|17|||
146149866|NCT00321919|527061543|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146149867|NCT00321919|527061544|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146149868|NCT00321919|527061543|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146149869|NCT00321919|527061544|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146149870|NCT00321919|527061543|FG000|Overall Study|Refused Treatment|23|||
146149871|NCT00321919|527061544|FG001|Overall Study|Refused Treatment|14|||
146149872|NCT00321919|527061543|FG000|Overall Study|Other Protocol Violation|2|||
146149873|NCT00321919|527061544|FG001|Overall Study|Other Protocol Violation|3|||
146149874|NCT00321919|527061543|FG000|Overall Study|Failure to Return|3|||
146149875|NCT00321919|527061544|FG001|Overall Study|Failure to Return|1|||
146149876|NCT00321919|527061543|FG000|Overall Study|Other withdrawal reason|7|||
146149877|NCT00321919|527061544|FG001|Overall Study|Other withdrawal reason|6|||
146149878|NCT02624804|527061545|FG000|Overall Study|Screen Failure|5|||
146149879|NCT01227889|527061546|FG000|Randomized Phase (RP)|Adverse Event|13|||
146149880|NCT01227889|527061547|FG001|Randomized Phase (RP)|Adverse Event|0|||
146149881|NCT01227889|527061546|FG000|Randomized Phase (RP)|Physician Decision|13|||
146149882|NCT01227889|527061547|FG001|Randomized Phase (RP)|Physician Decision|5|||
146149883|NCT01227889|527061546|FG000|Randomized Phase (RP)|Progressive Disease|135|||
146149884|NCT01227889|527061547|FG001|Randomized Phase (RP)|Progressive Disease|52|||
146149885|NCT01227889|527061546|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
146149886|NCT01227889|527061547|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
146149887|NCT01227889|527061546|FG000|Randomized Phase (RP)|Missing|1|||
146149888|NCT01227889|527061547|FG001|Randomized Phase (RP)|Missing|3|||
146149889|NCT01227889|527061546|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
146149890|NCT01227889|527061547|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
146149891|NCT01227889|527061546|FG000|Crossover Phase|Adverse Event|0|||
146149892|NCT01227889|527061547|FG001|Crossover Phase|Adverse Event|1|||
146149893|NCT01227889|527061546|FG000|Crossover Phase|Physician Decision|0|||
146149894|NCT01227889|527061547|FG001|Crossover Phase|Physician Decision|3|||
146149895|NCT01227889|527061546|FG000|Crossover Phase|Progressive Disease|0|||
146149896|NCT01227889|527061547|FG001|Crossover Phase|Progressive Disease|31|||
146149897|NCT01227889|527061546|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
146149898|NCT01227889|527061547|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
146149899|NCT01227889|527061546|FG000|Crossover Phase|Withdrawal by Subject|0|||
146149900|NCT01227889|527061547|FG001|Crossover Phase|Withdrawal by Subject|1|||
146149901|NCT04121962|527061550|FG000|Overall Study|Lost to Follow-up|42|||
146149902|NCT04121962|527061551|FG001|Overall Study|Lost to Follow-up|39|||
146149903|NCT01175382|527061552|FG000|Overall Study|Lost to Follow-up|4|||
146149904|NCT01175382|527061553|FG001|Overall Study|Lost to Follow-up|3|||
146149905|NCT01175382|527061554|FG002|Overall Study|Lost to Follow-up|1|||
146149906|NCT01175382|527061552|FG000|Overall Study|Physician Decision|0|||
146149907|NCT01175382|527061553|FG001|Overall Study|Physician Decision|1|||
146149908|NCT01175382|527061554|FG002|Overall Study|Physician Decision|0|||
146149909|NCT01175382|527061552|FG000|Overall Study|Withdrawal by Subject|0|||
146149910|NCT01175382|527061553|FG001|Overall Study|Withdrawal by Subject|0|||
146149911|NCT01175382|527061554|FG002|Overall Study|Withdrawal by Subject|1|||
146149912|NCT01175382|527061552|FG000|Overall Study|No longer having problem|1|||
146149913|NCT01175382|527061553|FG001|Overall Study|No longer having problem|0|||
146149914|NCT01175382|527061554|FG002|Overall Study|No longer having problem|1|||
146149915|NCT01175382|527061552|FG000|Overall Study|Unable/unwilling to attend visits|3|||
146149916|NCT01175382|527061553|FG001|Overall Study|Unable/unwilling to attend visits|1|||
146149917|NCT01175382|527061554|FG002|Overall Study|Unable/unwilling to attend visits|2|||
146149918|NCT01175382|527061552|FG000|Overall Study|Unwilling to follow protocol|0|||
146149919|NCT01175382|527061553|FG001|Overall Study|Unwilling to follow protocol|1|||
146149920|NCT01175382|527061554|FG002|Overall Study|Unwilling to follow protocol|0|||
146149921|NCT01175382|527061552|FG000|Overall Study|Unable to tolerate study meds|0|||
146149922|NCT01175382|527061553|FG001|Overall Study|Unable to tolerate study meds|1|||
146305637|NCT00701090|527632638|FG000|Overall Study|Death|0|||
146305638|NCT00701090|527632639|FG001|Overall Study|Death|1|||
146305639|NCT00701090|527632638|FG000|Overall Study|Lack of Efficacy|5|||
146305640|NCT00701090|527632639|FG001|Overall Study|Lack of Efficacy|4|||
146305641|NCT00701090|527632638|FG000|Overall Study|Lost to Follow-up|9|||
146149923|NCT01175382|527061554|FG002|Overall Study|Unable to tolerate study meds|1|||
146149924|NCT00774787|527061555|FG000|Overall Study|Lost to Follow-up|1|||
146149925|NCT02019719|527061556|FG000|Overall Study|Adverse Event|1|||
146149926|NCT02019719|527061557|FG001|Overall Study|Adverse Event|0|||
146149927|NCT02019719|527061558|FG002|Overall Study|Adverse Event|0|||
146149928|NCT02019719|527061559|FG003|Overall Study|Adverse Event|1|||
146305642|NCT00701090|527632639|FG001|Overall Study|Lost to Follow-up|9|||
146305643|NCT00701090|527632638|FG000|Overall Study|Physician Decision|3|||
146149929|NCT02019719|527061560|FG004|Overall Study|Adverse Event|1|||
146149930|NCT02019719|527061556|FG000|Overall Study|Protocol Violation|1|||
146149931|NCT02019719|527061557|FG001|Overall Study|Protocol Violation|1|||
146149932|NCT02019719|527061558|FG002|Overall Study|Protocol Violation|0|||
146149933|NCT02019719|527061559|FG003|Overall Study|Protocol Violation|0|||
146305644|NCT00701090|527632639|FG001|Overall Study|Physician Decision|4|||
146149934|NCT02019719|527061560|FG004|Overall Study|Protocol Violation|0|||
146149935|NCT02019719|527061556|FG000|Overall Study|Protocol defined stopping criteria|2|||
146149936|NCT02019719|527061557|FG001|Overall Study|Protocol defined stopping criteria|0|||
146149937|NCT02019719|527061558|FG002|Overall Study|Protocol defined stopping criteria|0|||
146305645|NCT00701090|527632638|FG000|Overall Study|Protocol Violation|2|||
146305646|NCT00701090|527632639|FG001|Overall Study|Protocol Violation|3|||
146149938|NCT02019719|527061559|FG003|Overall Study|Protocol defined stopping criteria|1|||
146149939|NCT02019719|527061560|FG004|Overall Study|Protocol defined stopping criteria|1|||
146149940|NCT02019719|527061556|FG000|Overall Study|Physician Decision|2|||
146149941|NCT02019719|527061557|FG001|Overall Study|Physician Decision|0|||
146149942|NCT02019719|527061558|FG002|Overall Study|Physician Decision|0|||
146149943|NCT02019719|527061559|FG003|Overall Study|Physician Decision|0|||
146149944|NCT02019719|527061560|FG004|Overall Study|Physician Decision|0|||
146149945|NCT01055639|527061564|FG000|Overall Study|Adverse Event|0|||
146149946|NCT01055639|527061565|FG001|Overall Study|Adverse Event|1|||
146149947|NCT01055639|527061564|FG000|Overall Study|Lack of Efficacy|0|||
146149948|NCT01055639|527061565|FG001|Overall Study|Lack of Efficacy|1|||
146149949|NCT01055639|527061564|FG000|Overall Study|Lost to Follow-up|8|||
146149950|NCT01055639|527061565|FG001|Overall Study|Lost to Follow-up|11|||
146149951|NCT01055639|527061564|FG000|Overall Study|Protocol Violation|5|||
146149952|NCT01055639|527061565|FG001|Overall Study|Protocol Violation|5|||
146149953|NCT01055639|527061564|FG000|Overall Study|Withdrawal by Subject|8|||
146149954|NCT01055639|527061565|FG001|Overall Study|Withdrawal by Subject|11|||
146149955|NCT00765245|527061566|FG000|Overall Study|disease progression|3|||
146149956|NCT00765245|527061567|FG001|Overall Study|disease progression|2|||
146149957|NCT00765245|527061566|FG000|Overall Study|Withdrawal by Subject|3|||
146149958|NCT00765245|527061567|FG001|Overall Study|Withdrawal by Subject|0|||
146149959|NCT00765245|527061566|FG000|Overall Study|Adverse Event|5|||
146149960|NCT00765245|527061567|FG001|Overall Study|Adverse Event|0|||
146149961|NCT00765245|527061566|FG000|Overall Study|Physician Decision|1|||
146149962|NCT00765245|527061567|FG001|Overall Study|Physician Decision|0|||
146149963|NCT00765245|527061566|FG000|Overall Study|Death|1|||
146149964|NCT00765245|527061567|FG001|Overall Study|Death|0|||
146149965|NCT01197950|527061568|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
146149966|NCT01197950|527061569|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
146149967|NCT01197950|527061570|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
146149968|NCT01659021|527061571|FG000|Main Study|Adverse Event|2|||
146149969|NCT01659021|527061572|FG001|Main Study|Adverse Event|3|||
146149970|NCT01659021|527061571|FG000|Main Study|Lost to Follow-up|1|||
146149971|NCT01659021|527061572|FG001|Main Study|Lost to Follow-up|0|||
146149972|NCT01659021|527061571|FG000|Main Study|Unknown Reasons|2|||
146149973|NCT01659021|527061572|FG001|Main Study|Unknown Reasons|1|||
146149974|NCT01659021|527061571|FG000|Main Study|Physician Decision|34|||
146149975|NCT01659021|527061572|FG001|Main Study|Physician Decision|16|||
146149976|NCT01659021|527061571|FG000|Main Study|Withdrawal by Subject|19|||
146149977|NCT01659021|527061572|FG001|Main Study|Withdrawal by Subject|16|||
146149978|NCT01659021|527061571|FG000|Main Study|Study Terminated by Sponsor|16|||
146149979|NCT01659021|527061572|FG001|Main Study|Study Terminated by Sponsor|1|||
146149980|NCT01659021|527061571|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
146149981|NCT01659021|527061572|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
146149982|NCT01659021|527061571|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
146149983|NCT01659021|527061572|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
146149984|NCT02079805|527061573|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146149985|NCT02079805|527061574|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146149986|NCT02079805|527061573|FG000|Overall Study|Voluntary Withdrawal|0|||
146149987|NCT02079805|527061574|FG001|Overall Study|Voluntary Withdrawal|1|||
146149988|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
146149989|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
146149990|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
146149991|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
146149992|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
146149993|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146149994|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
146149995|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146149996|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
146149997|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
146149998|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
146149999|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
146150000|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146150001|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146150002|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146150003|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
146150004|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
146150005|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
146150006|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
146150007|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
146150008|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
146278682|NCT03015129|527534383|FG000|Overall Study|Death|2|||
146150009|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146150010|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
146150011|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146150012|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
146150013|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
146150014|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146150015|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
146150016|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146150017|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
146150018|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
146150019|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
146150020|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
146150021|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146150022|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
146150023|NCT00383435|527061575|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
146150024|NCT00383435|527061576|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
146278683|NCT03015129|527534384|FG001|Overall Study|Death|2|||
146278684|NCT03015129|527534383|FG000|Overall Study|Lost to Follow-up|0|||
146278685|NCT03015129|527534384|FG001|Overall Study|Lost to Follow-up|1|||
146278686|NCT03015129|527534383|FG000|Overall Study|Progression of disease|38|||
146278687|NCT03015129|527534384|FG001|Overall Study|Progression of disease|33|||
146278688|NCT03015129|527534383|FG000|Overall Study|Adverse Event|0|||
146278689|NCT03015129|527534384|FG001|Overall Study|Adverse Event|4|||
146278690|NCT00338962|527534386|FG000|Overall Study|Lost to Follow-up|3|||
146278691|NCT00338962|527534387|FG001|Overall Study|Lost to Follow-up|3|||
146278692|NCT00338962|527534388|FG002|Overall Study|Lost to Follow-up|2|||
146278693|NCT00338962|527534389|FG003|Overall Study|Lost to Follow-up|3|||
146278694|NCT00338962|527534386|FG000|Overall Study|Withdrawal by Subject|1|||
146278695|NCT00338962|527534387|FG001|Overall Study|Withdrawal by Subject|0|||
146278696|NCT00338962|527534388|FG002|Overall Study|Withdrawal by Subject|0|||
146278697|NCT00338962|527534389|FG003|Overall Study|Withdrawal by Subject|0|||
146278698|NCT00338962|527534386|FG000|Overall Study|No Transportation|2|||
146278699|NCT00338962|527534387|FG001|Overall Study|No Transportation|0|||
146278700|NCT00338962|527534388|FG002|Overall Study|No Transportation|0|||
146278701|NCT00338962|527534389|FG003|Overall Study|No Transportation|0|||
146278702|NCT00338962|527534386|FG000|Overall Study|Time Constraint|2|||
146278703|NCT00338962|527534387|FG001|Overall Study|Time Constraint|0|||
146278704|NCT00338962|527534388|FG002|Overall Study|Time Constraint|0|||
146278705|NCT00338962|527534389|FG003|Overall Study|Time Constraint|0|||
146278706|NCT00338962|527534386|FG000|Overall Study|Moved|0|||
146278707|NCT00338962|527534387|FG001|Overall Study|Moved|1|||
146278708|NCT00338962|527534388|FG002|Overall Study|Moved|0|||
146278709|NCT00338962|527534389|FG003|Overall Study|Moved|0|||
146278710|NCT00338962|527534386|FG000|Overall Study|Adverse Event|0|||
146278711|NCT00338962|527534387|FG001|Overall Study|Adverse Event|0|||
146278712|NCT00338962|527534388|FG002|Overall Study|Adverse Event|2|||
146278713|NCT00338962|527534389|FG003|Overall Study|Adverse Event|0|||
146278714|NCT00338962|527534386|FG000|Overall Study|Poor Compliance|0|||
146278715|NCT00338962|527534387|FG001|Overall Study|Poor Compliance|0|||
146278716|NCT00338962|527534388|FG002|Overall Study|Poor Compliance|2|||
146278717|NCT00338962|527534389|FG003|Overall Study|Poor Compliance|0|||
146278718|NCT03733314|527534390|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
146278719|NCT03733314|527534391|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
146278720|NCT03733314|527534390|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
146278721|NCT03733314|527534391|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
146278722|NCT03733314|527534390|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
146278723|NCT03733314|527534391|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
146278724|NCT03733314|527534390|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
146278725|NCT03733314|527534391|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
146278726|NCT03733314|527534390|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
146278727|NCT03733314|527534391|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
146278728|NCT03733314|527534390|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
146278729|NCT03733314|527534391|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
146278730|NCT03046121|527534392|FG000|Overall Study|Death|32|||
146278731|NCT03046121|527534393|FG001|Overall Study|Death|60|||
146278732|NCT03046121|527534392|FG000|Overall Study|Withdrawal by Subject|14|||
146278733|NCT03046121|527534393|FG001|Overall Study|Withdrawal by Subject|12|||
146278734|NCT03214640|527534394|FG000|Overall Study|Protocol Violation|1|||
146278735|NCT03214640|527534395|FG001|Overall Study|Protocol Violation|2|||
146278736|NCT03214640|527534396|FG002|Overall Study|Protocol Violation|1|||
146278737|NCT03214640|527534397|FG003|Overall Study|Protocol Violation|4|||
146278738|NCT04155047|527534398|FG000|Overall Study|Adverse Event|1|||
146305647|NCT00701090|527632638|FG000|Overall Study|Withdrawal by Subject|11|||
146305648|NCT00701090|527632639|FG001|Overall Study|Withdrawal by Subject|16|||
146305649|NCT00701090|527632638|FG000|Overall Study|Other|7|||
146305650|NCT00701090|527632639|FG001|Overall Study|Other|12|||
146305651|NCT05525689|527632640|FG000|Overall Study|Lost to Follow-up|1|||
146305652|NCT05525689|527632641|FG001|Overall Study|Lost to Follow-up|0|||
146305653|NCT00509067|527632647|FG000|Overall Study|Lost to Follow-up|1|||
146305654|NCT00509067|527632648|FG001|Overall Study|Lost to Follow-up|1|||
146305655|NCT00509067|527632647|FG000|Overall Study|Adverse Event|3|||
146305656|NCT00509067|527632648|FG001|Overall Study|Adverse Event|1|||
146305657|NCT00509067|527632647|FG000|Overall Study|Protocol Violation|0|||
146305658|NCT00509067|527632648|FG001|Overall Study|Protocol Violation|3|||
146305659|NCT03654976|527632649|FG000|Overall Study|Withdrawal by Subject|12|||
146305660|NCT03654976|527632650|FG001|Overall Study|Withdrawal by Subject|11|||
146305661|NCT03654976|527632649|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
146305662|NCT03654976|527632650|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
146305663|NCT03654976|527632649|FG000|Overall Study|Adverse Event|5|||
146305664|NCT03654976|527632650|FG001|Overall Study|Adverse Event|0|||
146305665|NCT03654976|527632649|FG000|Overall Study|Lost to Follow-up|2|||
146305666|NCT03654976|527632650|FG001|Overall Study|Lost to Follow-up|0|||
146305667|NCT03654976|527632649|FG000|Overall Study|Lack of Efficacy|0|||
146305668|NCT03654976|527632650|FG001|Overall Study|Lack of Efficacy|1|||
146305669|NCT01817751|527632651|FG000|Overall Study|Physician Decision|1|||
146305670|NCT00382018|527632652|FG000|Overall Study|Progression|0|||
146305671|NCT00382018|527632653|FG001|Overall Study|Progression|136|||
146305672|NCT00382018|527632654|FG002|Overall Study|Progression|51|||
146305673|NCT00382018|527632655|FG003|Overall Study|Progression|43|||
146150025|NCT00383435|527061577|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
146150026|NCT00383435|527061578|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
146150027|NCT00383435|527061579|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
146150028|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
146150029|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
146150030|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
146150031|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
146150032|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
146150033|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146150034|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146150035|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146150036|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146150037|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146150038|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146150039|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
146150040|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146150041|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146150042|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146150043|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146150044|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146150045|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146150046|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146150047|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
146150048|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146150049|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146150050|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
146150051|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146150052|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146150053|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
146150054|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146150055|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146150056|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146305674|NCT00382018|527632652|FG000|Overall Study|Death|0|||
146150057|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
146305675|NCT00382018|527632653|FG001|Overall Study|Death|9|||
146305676|NCT00382018|527632654|FG002|Overall Study|Death|7|||
146150058|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146305677|NCT00382018|527632655|FG003|Overall Study|Death|11|||
146305678|NCT00382018|527632652|FG000|Overall Study|Withdrawal by Subject|0|||
146305679|NCT00382018|527632653|FG001|Overall Study|Withdrawal by Subject|4|||
146305680|NCT00382018|527632654|FG002|Overall Study|Withdrawal by Subject|3|||
146305681|NCT00382018|527632655|FG003|Overall Study|Withdrawal by Subject|4|||
146305682|NCT00382018|527632652|FG000|Overall Study|Other, not protocol specified|0|||
146305683|NCT00382018|527632653|FG001|Overall Study|Other, not protocol specified|16|||
146150059|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146150060|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146150061|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146150062|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146150063|NCT00383435|527061575|FG000|26-Week Treatment Safety Extension|Administrative|1|||
146150064|NCT00383435|527061576|FG001|26-Week Treatment Safety Extension|Administrative|1|||
146150065|NCT00383435|527061577|FG002|26-Week Treatment Safety Extension|Administrative|0|||
146150066|NCT00383435|527061578|FG003|26-Week Treatment Safety Extension|Administrative|1|||
146150067|NCT00383435|527061579|FG004|26-Week Treatment Safety Extension|Administrative|0|||
146150068|NCT02347761|527061580|FG000|All Collected|Death|1|||
146150069|NCT02347761|527061581|FG001|All Collected|Death|0|||
146150070|NCT02347761|527061582|FG002|All Collected|Death|0|||
146150071|NCT02347761|527061580|FG000|All Collected|Lost to Follow-up|3|||
146150072|NCT02347761|527061581|FG001|All Collected|Lost to Follow-up|2|||
146150073|NCT02347761|527061582|FG002|All Collected|Lost to Follow-up|3|||
146150074|NCT02347761|527061580|FG000|All Collected|Withdrawal by Subject|11|||
146150075|NCT02347761|527061581|FG001|All Collected|Withdrawal by Subject|11|||
146150076|NCT02347761|527061582|FG002|All Collected|Withdrawal by Subject|22|||
146150077|NCT02347761|527061580|FG000|All Collected|invetigator disretion|2|||
146150078|NCT02347761|527061581|FG001|All Collected|invetigator disretion|0|||
146150079|NCT02347761|527061582|FG002|All Collected|invetigator disretion|0|||
146150080|NCT02347761|527061580|FG000|All Collected|instillation site pain|0|||
146150081|NCT02347761|527061581|FG001|All Collected|instillation site pain|0|||
146150082|NCT02347761|527061582|FG002|All Collected|instillation site pain|1|||
146150083|NCT02347761|527061580|FG000|All Collected|exacerbation of COPD|0|||
146150084|NCT02347761|527061581|FG001|All Collected|exacerbation of COPD|0|||
146150085|NCT02347761|527061582|FG002|All Collected|exacerbation of COPD|1|||
146150086|NCT02347761|527061580|FG000|All Collected|moved/travel|0|||
146150087|NCT02347761|527061581|FG001|All Collected|moved/travel|1|||
146150088|NCT02347761|527061582|FG002|All Collected|moved/travel|0|||
146150089|NCT02347761|527061580|FG000|On Study Treatment|Lack of Efficacy|2|||
146150090|NCT02347761|527061581|FG001|On Study Treatment|Lack of Efficacy|3|||
146150091|NCT02347761|527061582|FG002|On Study Treatment|Lack of Efficacy|4|||
146150092|NCT02347761|527061580|FG000|On Study Treatment|non-compliance with study medication|0|||
146150093|NCT02347761|527061581|FG001|On Study Treatment|non-compliance with study medication|0|||
146150094|NCT02347761|527061582|FG002|On Study Treatment|non-compliance with study medication|2|||
146150095|NCT02347761|527061580|FG000|On Study Treatment|Withdrawal by Subject|7|||
146150096|NCT02347761|527061581|FG001|On Study Treatment|Withdrawal by Subject|3|||
146150097|NCT02347761|527061582|FG002|On Study Treatment|Withdrawal by Subject|5|||
146150098|NCT02347761|527061580|FG000|On Study Treatment|move/travel|2|||
146150099|NCT02347761|527061581|FG001|On Study Treatment|move/travel|6|||
146150100|NCT02347761|527061582|FG002|On Study Treatment|move/travel|5|||
146150101|NCT02347761|527061580|FG000|On Study Treatment|dissastisfaction with device|2|||
146150102|NCT02347761|527061581|FG001|On Study Treatment|dissastisfaction with device|1|||
146150103|NCT02347761|527061582|FG002|On Study Treatment|dissastisfaction with device|4|||
146150104|NCT02347761|527061580|FG000|On Study Treatment|Lost to Follow-up|2|||
146150105|NCT02347761|527061581|FG001|On Study Treatment|Lost to Follow-up|1|||
146150106|NCT02347761|527061582|FG002|On Study Treatment|Lost to Follow-up|1|||
146150107|NCT02347761|527061580|FG000|On Study Treatment|investigator discretion|2|||
146150108|NCT02347761|527061581|FG001|On Study Treatment|investigator discretion|0|||
146150109|NCT02347761|527061582|FG002|On Study Treatment|investigator discretion|0|||
146150110|NCT02347761|527061580|FG000|On Study Treatment|durg not working|0|||
146150111|NCT02347761|527061581|FG001|On Study Treatment|durg not working|1|||
146150112|NCT02347761|527061582|FG002|On Study Treatment|durg not working|1|||
146150113|NCT02347761|527061580|FG000|On Study Treatment|Adverse Event|10|||
146150114|NCT02347761|527061581|FG001|On Study Treatment|Adverse Event|8|||
146150115|NCT02347761|527061582|FG002|On Study Treatment|Adverse Event|20|||
146150116|NCT02682264|527061583|FG000|Overall Study|Withdrawal by Subject|56|||
146150117|NCT02682264|527061584|FG001|Overall Study|Withdrawal by Subject|45|||
146150118|NCT02682264|527061583|FG000|Overall Study|Lost to Follow-up|49|||
146150119|NCT02682264|527061584|FG001|Overall Study|Lost to Follow-up|41|||
146150120|NCT02682264|527061583|FG000|Overall Study|Lack of Efficacy|14|||
146150121|NCT02682264|527061584|FG001|Overall Study|Lack of Efficacy|16|||
146150122|NCT02682264|527061583|FG000|Overall Study|Withdrawal by Parent|6|||
146150123|NCT02682264|527061584|FG001|Overall Study|Withdrawal by Parent|7|||
146150124|NCT02682264|527061583|FG000|Overall Study|Adverse Event|9|||
146150125|NCT02682264|527061584|FG001|Overall Study|Adverse Event|0|||
146150126|NCT02682264|527061583|FG000|Overall Study|Noncompliance with study drug|1|||
146278739|NCT04155047|527534399|FG001|Overall Study|Adverse Event|0|||
146278740|NCT04155047|527534398|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
146150127|NCT02682264|527061584|FG001|Overall Study|Noncompliance with study drug|4|||
146150128|NCT02682264|527061583|FG000|Overall Study|Pregnancy|1|||
146150129|NCT02682264|527061584|FG001|Overall Study|Pregnancy|2|||
146150130|NCT02682264|527061583|FG000|Overall Study|Recovery|1|||
146150131|NCT02682264|527061584|FG001|Overall Study|Recovery|2|||
146150132|NCT02682264|527061583|FG000|Overall Study|Progressive Disease|1|||
146150133|NCT02682264|527061584|FG001|Overall Study|Progressive Disease|0|||
146150134|NCT02682264|527061583|FG000|Overall Study|Technical Problems|0|||
146150135|NCT02682264|527061584|FG001|Overall Study|Technical Problems|1|||
146150136|NCT02682264|527061583|FG000|Overall Study|Moved abroad and unable to continue|0|||
146150137|NCT02682264|527061584|FG001|Overall Study|Moved abroad and unable to continue|3|||
146150138|NCT02682264|527061583|FG000|Overall Study|Stopped test article application|0|||
146150139|NCT02682264|527061584|FG001|Overall Study|Stopped test article application|1|||
146150140|NCT01131312|527061585|FG000|Overall Study|Lost to Follow-up|425|||
146150141|NCT01131312|527061586|FG001|Overall Study|Lost to Follow-up|229|||
146150142|NCT01131312|527061587|FG002|Overall Study|Lost to Follow-up|351|||
146150143|NCT03447769|527061589|FG000|Overall Study|Progressive disease|138|||
146150144|NCT03447769|527061590|FG001|Overall Study|Progressive disease|148|||
146150145|NCT03447769|527061589|FG000|Overall Study|Study terminated by Sponsor|60|||
146150146|NCT03447769|527061590|FG001|Overall Study|Study terminated by Sponsor|44|||
146150147|NCT03447769|527061589|FG000|Overall Study|Adverse Event|34|||
146150148|NCT03447769|527061590|FG001|Overall Study|Adverse Event|31|||
146150149|NCT03447769|527061589|FG000|Overall Study|Patient decision|27|||
146150150|NCT03447769|527061590|FG001|Overall Study|Patient decision|27|||
146150151|NCT03447769|527061589|FG000|Overall Study|Protocol deviation|4|||
146150152|NCT03447769|527061590|FG001|Overall Study|Protocol deviation|6|||
146150153|NCT03447769|527061589|FG000|Overall Study|Death|2|||
146150154|NCT03447769|527061590|FG001|Overall Study|Death|7|||
146150155|NCT03447769|527061589|FG000|Overall Study|Technical problems|1|||
146150156|NCT03447769|527061590|FG001|Overall Study|Technical problems|0|||
146150157|NCT03447769|527061589|FG000|Overall Study|Lost to Follow-up|0|||
146150158|NCT03447769|527061590|FG001|Overall Study|Lost to Follow-up|1|||
146150159|NCT03447769|527061589|FG000|Overall Study|Physician Decision|13|||
146150160|NCT03447769|527061590|FG001|Overall Study|Physician Decision|5|||
146150161|NCT03879798|527061592|FG000|Overall Study|Adverse Event|0|||
146150162|NCT03879798|527061593|FG001|Overall Study|Adverse Event|0|||
146150163|NCT03879798|527061594|FG002|Overall Study|Adverse Event|0|||
146150164|NCT03879798|527061595|FG003|Overall Study|Adverse Event|0|||
146150165|NCT03879798|527061596|FG004|Overall Study|Adverse Event|0|||
146150166|NCT03879798|527061597|FG005|Overall Study|Adverse Event|1|||
146150167|NCT03879798|527061592|FG000|Overall Study|Lack of Efficacy|0|||
146150168|NCT03879798|527061593|FG001|Overall Study|Lack of Efficacy|0|||
146150169|NCT03879798|527061594|FG002|Overall Study|Lack of Efficacy|0|||
146150170|NCT03879798|527061595|FG003|Overall Study|Lack of Efficacy|0|||
146150171|NCT03879798|527061596|FG004|Overall Study|Lack of Efficacy|0|||
146150172|NCT03879798|527061597|FG005|Overall Study|Lack of Efficacy|1|||
146150173|NCT03879798|527061592|FG000|Overall Study|Withdrawal by Subject|0|||
146150174|NCT03879798|527061593|FG001|Overall Study|Withdrawal by Subject|0|||
146150175|NCT03879798|527061594|FG002|Overall Study|Withdrawal by Subject|0|||
146150176|NCT03879798|527061595|FG003|Overall Study|Withdrawal by Subject|0|||
146150177|NCT03879798|527061596|FG004|Overall Study|Withdrawal by Subject|0|||
146150178|NCT03879798|527061597|FG005|Overall Study|Withdrawal by Subject|1|||
146150179|NCT01255358|527061598|FG000|Overall Study|Adverse Event|2|||
146150180|NCT01255358|527061598|FG000|Overall Study|Protocol Violation|2|||
146150181|NCT03950739|527061599|FG000|Treatment Phase|Adverse Event|2|||
146150182|NCT03950739|527061599|FG000|Optional Extension Phase|Death|1|||
146150183|NCT03950739|527061599|FG000|Optional Extension Phase|Progressive Disease|5|||
146150184|NCT03950739|527061599|FG000|Optional Extension Phase|Adverse Event|7|||
146150185|NCT03950739|527061599|FG000|Optional Extension Phase|Lost to Follow-up|2|||
146150186|NCT03950739|527061599|FG000|Optional Extension Phase|Site Closure|2|||
146150187|NCT03950739|527061599|FG000|Optional Extension Phase|Pregnancy|1|||
146150188|NCT00856583|527061605|FG000|Overall Study|Lack of Efficacy|389|||
146150189|NCT00856583|527061606|FG001|Overall Study|Lack of Efficacy|377|||
146150190|NCT00856583|527061605|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
146150191|NCT00856583|527061606|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
146150192|NCT00856583|527061605|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
146150193|NCT00856583|527061606|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
146150194|NCT00856583|527061605|FG000|Overall Study|Non-compliance|305|||
146150195|NCT00856583|527061606|FG001|Overall Study|Non-compliance|262|||
146150196|NCT00856583|527061605|FG000|Overall Study|Withdrawal by Subject|1092|||
146150197|NCT00856583|527061606|FG001|Overall Study|Withdrawal by Subject|919|||
146150198|NCT00856583|527061605|FG000|Overall Study|Physician Decision|59|||
146150199|NCT00856583|527061606|FG001|Overall Study|Physician Decision|82|||
146150200|NCT00856583|527061605|FG000|Overall Study|Pregnancy|14|||
146150201|NCT00856583|527061606|FG001|Overall Study|Pregnancy|5|||
146150202|NCT00856583|527061605|FG000|Overall Study|Other|92|||
146150203|NCT00856583|527061606|FG001|Overall Study|Other|104|||
146150204|NCT00856583|527061605|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
146150205|NCT00856583|527061606|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
146150206|NCT01944046|527061607|FG000|Randomized to DB|Adverse Event|5|||
146150207|NCT01944046|527061608|FG001|Randomized to DB|Adverse Event|2|||
146150208|NCT01944046|527061607|FG000|Randomized to DB|Clinical Worsening|3|||
146150209|NCT01944046|527061608|FG001|Randomized to DB|Clinical Worsening|2|||
146150210|NCT01944046|527061607|FG000|Randomized to DB|Lost to Follow-up|3|||
146150211|NCT01944046|527061608|FG001|Randomized to DB|Lost to Follow-up|3|||
146150212|NCT01944046|527061607|FG000|Randomized to DB|Withdrawal by Subject|2|||
146150213|NCT01944046|527061608|FG001|Randomized to DB|Withdrawal by Subject|4|||
146150214|NCT01944046|527061607|FG000|Randomized to DB|Physician Decision|1|||
146150215|NCT01944046|527061608|FG001|Randomized to DB|Physician Decision|2|||
146150216|NCT01944046|527061607|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
146150217|NCT01944046|527061608|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
146150218|NCT01944046|527061607|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
146150219|NCT01944046|527061608|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
146150220|NCT01944046|527061607|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
146150221|NCT01944046|527061608|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
146150222|NCT01944046|527061607|FG000|Open Label Eligible and Consented|Adverse Event|6|||
146150223|NCT01944046|527061608|FG001|Open Label Eligible and Consented|Adverse Event|1|||
146150224|NCT01944046|527061607|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
146150225|NCT01944046|527061608|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
146150226|NCT01944046|527061607|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
146150227|NCT01944046|527061608|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
146150228|NCT01985126|527061612|FG000|Overall Study|Death|15|||
146150229|NCT01985126|527061613|FG001|Overall Study|Death|69|||
146150230|NCT01985126|527061612|FG000|Overall Study|Lost to Follow-up|0|||
146150231|NCT01985126|527061613|FG001|Overall Study|Lost to Follow-up|8|||
146150232|NCT01985126|527061612|FG000|Overall Study|Study Terminated By Sponsor|1|||
146150233|NCT01985126|527061613|FG001|Overall Study|Study Terminated By Sponsor|22|||
146150234|NCT01985126|527061612|FG000|Overall Study|Withdrawal by Subject|2|||
146150235|NCT01985126|527061613|FG001|Overall Study|Withdrawal by Subject|7|||
146150236|NCT05799495|527061616|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
146150237|NCT05799495|527061617|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
146150238|NCT05799495|527061618|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
146150239|NCT05799495|527061619|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
146150240|NCT05799495|527061616|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146150241|NCT05799495|527061617|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146150242|NCT05799495|527061618|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
146150243|NCT05799495|527061619|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
146150244|NCT05799495|527061616|FG000|Treatment (Up to 5 Days)|Other|0|||
146150245|NCT05799495|527061617|FG001|Treatment (Up to 5 Days)|Other|1|||
146150246|NCT05799495|527061618|FG002|Treatment (Up to 5 Days)|Other|0|||
146150247|NCT05799495|527061619|FG003|Treatment (Up to 5 Days)|Other|0|||
146150248|NCT05799495|527061616|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146150249|NCT05799495|527061617|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146150250|NCT05799495|527061618|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
146150251|NCT05799495|527061619|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
146150252|NCT05799495|527061616|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
146150253|NCT05799495|527061617|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
146150254|NCT05799495|527061618|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
146150255|NCT05799495|527061619|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
146150256|NCT05799495|527061616|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146150257|NCT05799495|527061617|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146150258|NCT05799495|527061618|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
146150259|NCT05799495|527061619|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
146150260|NCT04102501|527061620|FG000|Overall Study|Withdrawal by Subject|7|||
146150261|NCT04102501|527061621|FG001|Overall Study|Withdrawal by Subject|9|||
146150262|NCT04102501|527061620|FG000|Overall Study|Adverse Event|1|||
146150263|NCT04102501|527061621|FG001|Overall Study|Adverse Event|3|||
146150264|NCT02338362|527061622|FG000|Overall Study|Withdrawal by Subject|1|||
146150265|NCT02338362|527061623|FG001|Overall Study|Withdrawal by Subject|1|||
146150266|NCT01669343|527061624|FG000|Part A: All Patients|Withdrawal by Subject|7|||
146150267|NCT01669343|527061624|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
146150268|NCT01669343|527061624|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
146150269|NCT01669343|527061624|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
146150270|NCT01669343|527061624|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
146305684|NCT00382018|527632654|FG002|Overall Study|Other, not protocol specified|3|||
146305685|NCT00382018|527632655|FG003|Overall Study|Other, not protocol specified|1|||
146150271|NCT02371369|527061625|FG000|Part 1|Physician Decision|0|||
146150272|NCT02371369|527061626|FG001|Part 1|Physician Decision|3|||
146150273|NCT02371369|527061625|FG000|Part 1|Adverse Event|8|||
146150274|NCT02371369|527061626|FG001|Part 1|Adverse Event|0|||
146150275|NCT02371369|527061625|FG000|Part 1|Withdrawal by Subject|1|||
146150276|NCT02371369|527061626|FG001|Part 1|Withdrawal by Subject|6|||
146150277|NCT02371369|527061625|FG000|Part 1|Disease progression|0|||
146150278|NCT02371369|527061626|FG001|Part 1|Disease progression|1|||
146150279|NCT02371369|527061625|FG000|Part 1|Protocol Violation|0|||
146150280|NCT02371369|527061626|FG001|Part 1|Protocol Violation|1|||
146150281|NCT02371369|527061625|FG000|Part 2|Adverse Event|6|||
146150282|NCT02371369|527061626|FG001|Part 2|Adverse Event|5|||
146150283|NCT02371369|527061625|FG000|Part 2|Withdrawal by Subject|16|||
146150284|NCT02371369|527061626|FG001|Part 2|Withdrawal by Subject|6|||
146150285|NCT02371369|527061625|FG000|Part 2|Investigator decision|1|||
146150286|NCT02371369|527061626|FG001|Part 2|Investigator decision|2|||
146150287|NCT02371369|527061625|FG000|Part 2|Death|0|||
146150288|NCT02371369|527061626|FG001|Part 2|Death|1|||
146150289|NCT02371369|527061625|FG000|Part 2|Disease progression|1|||
146150290|NCT02371369|527061626|FG001|Part 2|Disease progression|0|||
146150291|NCT02371369|527061625|FG000|Part 2|Subject Noncompliance|1|||
146150292|NCT02371369|527061626|FG001|Part 2|Subject Noncompliance|0|||
146150293|NCT02371369|527061625|FG000|Part 2|Lost to Follow-up|1|||
146150294|NCT02371369|527061626|FG001|Part 2|Lost to Follow-up|1|||
146150295|NCT02371369|527061625|FG000|Part 2|Subject transitioned to commercial supply|6|||
146150296|NCT02371369|527061626|FG001|Part 2|Subject transitioned to commercial supply|4|||
146150297|NCT02371369|527061625|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
146150298|NCT02371369|527061626|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
146150299|NCT02371369|527061625|FG000|Part 2|Surgical resection of tumor|1|||
146150300|NCT02371369|527061626|FG001|Part 2|Surgical resection of tumor|1|||
146150301|NCT02371369|527061625|FG000|Part 2|Other|0|||
146150302|NCT02371369|527061626|FG001|Part 2|Other|1|||
146150303|NCT06281548|527061629|FG000|Overall Study|Lost to Follow-up|3|||
146150304|NCT01587651|527061630|FG000|Overall Study|Adverse Event|0|||
146150305|NCT01587651|527061631|FG001|Overall Study|Adverse Event|1|||
146150306|NCT01587651|527061632|FG002|Overall Study|Adverse Event|0|||
146150307|NCT01587651|527061630|FG000|Overall Study|Protocol Violation|0|||
146150308|NCT01587651|527061631|FG001|Overall Study|Protocol Violation|1|||
146150309|NCT01587651|527061632|FG002|Overall Study|Protocol Violation|1|||
146150310|NCT01587651|527061630|FG000|Overall Study|Withdrawal by Subject|0|||
146150311|NCT01587651|527061631|FG001|Overall Study|Withdrawal by Subject|1|||
146150312|NCT01587651|527061632|FG002|Overall Study|Withdrawal by Subject|0|||
146150313|NCT03864900|527061639|FG000|Overall Study|Withdrawal by Subject|1|||
146150314|NCT03864900|527061640|FG001|Overall Study|Withdrawal by Subject|1|||
146150315|NCT03864900|527061639|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
146150316|NCT03864900|527061640|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
146150317|NCT01866709|527061641|FG000|Overall Study|Adverse Event|1|||
146150318|NCT01866709|527061642|FG001|Overall Study|Adverse Event|0|||
146150319|NCT03191903|527061643|FG000|Overall Study|Withdrawal by Subject|6|||
146150320|NCT03191903|527061644|FG001|Overall Study|Withdrawal by Subject|5|||
146150321|NCT03191903|527061645|FG002|Overall Study|Withdrawal by Subject|4|||
146150322|NCT03191903|527061643|FG000|Overall Study|Adverse Event|1|||
146150323|NCT03191903|527061644|FG001|Overall Study|Adverse Event|0|||
146150324|NCT03191903|527061645|FG002|Overall Study|Adverse Event|0|||
146150325|NCT00503685|527061649|FG000|Overall Study|Adverse Event|0|||
146150326|NCT00503685|527061650|FG001|Overall Study|Adverse Event|0|||
146150327|NCT00503685|527061651|FG002|Overall Study|Adverse Event|2|||
146150328|NCT00503685|527061649|FG000|Overall Study|Withdrawal by Subject|0|||
146150329|NCT00503685|527061650|FG001|Overall Study|Withdrawal by Subject|1|||
146150330|NCT00503685|527061651|FG002|Overall Study|Withdrawal by Subject|0|||
146150331|NCT00503685|527061649|FG000|Overall Study|Protocol Violation|0|||
146150332|NCT00503685|527061650|FG001|Overall Study|Protocol Violation|1|||
146150333|NCT00503685|527061651|FG002|Overall Study|Protocol Violation|0|||
146150334|NCT00503685|527061649|FG000|Overall Study|Eligibility Criteria Not Met|0|||
146150335|NCT00503685|527061650|FG001|Overall Study|Eligibility Criteria Not Met|1|||
146150336|NCT00503685|527061651|FG002|Overall Study|Eligibility Criteria Not Met|0|||
146150337|NCT01898195|527061658|FG000|Smoking Abstinence|Did not have good measurements|35|||
146150338|NCT01898195|527061659|FG001|Smoking Abstinence|Did not have good measurements|38|||
146150339|NCT01898195|527061660|FG002|Smoking Abstinence|Did not have good measurements|36|||
146150340|NCT03283670|527061661|FG000|Placebo Gas|Withdrawal by Subject|2|||
146150341|NCT03283670|527061661|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
146278741|NCT04155047|527534399|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
146278742|NCT04514510|527534400|FG000|Overall Study|Lost to Follow-up|0|||
146278743|NCT04514510|527534401|FG001|Overall Study|Lost to Follow-up|1|||
146150342|NCT03283670|527061661|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
146150343|NCT00612313|527061662|FG000|Overall Study|Withdrawal by Subject|6|||
146150344|NCT00612313|527061663|FG001|Overall Study|Withdrawal by Subject|9|||
146150345|NCT00612313|527061662|FG000|Overall Study|Lost to Follow-up|11|||
146150346|NCT00612313|527061663|FG001|Overall Study|Lost to Follow-up|4|||
146150347|NCT03823651|527061664|FG000|Overall Study|Death|5|||
146150348|NCT03823651|527061665|FG001|Overall Study|Death|0|||
146150349|NCT03823651|527061664|FG000|Overall Study|Physician Decision|1|||
146150350|NCT03823651|527061665|FG001|Overall Study|Physician Decision|0|||
146150351|NCT03823651|527061664|FG000|Overall Study|Caregiver to patient who died|0|||
146150352|NCT03823651|527061665|FG001|Overall Study|Caregiver to patient who died|5|||
146150353|NCT03823651|527061664|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
146150354|NCT03823651|527061665|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
146150355|NCT01850004|527061666|FG000|Overall Study|Poor/Non-compliance|1|||
146150356|NCT01850004|527061666|FG000|Overall Study|Participant Withdrew Consent|9|||
146150357|NCT01850004|527061666|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
146150358|NCT01850004|527061666|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
146150359|NCT01850004|527061666|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
146150360|NCT01850004|527061666|FG000|Overall Study|Other Reasons|2|||
146150361|NCT01850004|527061666|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
146150362|NCT01850004|527061666|FG000|Overall Study|Maximum Clinical Benefit|4|||
146150363|NCT05350449|527061667|FG000|Overall Study|Withdrawal by Subject|4|||
146150364|NCT05350449|527061668|FG001|Overall Study|Withdrawal by Subject|8|||
146150365|NCT01773226|527063601|FG000|Overall Study|Withdrawal by Subject|1|||
146150366|NCT00993447|527063606|FG000|Overall Study|Withdrawal by Subject|23|||
146150367|NCT00993447|527063607|FG001|Overall Study|Withdrawal by Subject|8|||
146150368|NCT00993447|527063606|FG000|Overall Study|Protocol Violation|12|||
146150369|NCT00993447|527063607|FG001|Overall Study|Protocol Violation|8|||
146150370|NCT00993447|527063606|FG000|Overall Study|Lost to Follow-up|1|||
146150371|NCT00993447|527063607|FG001|Overall Study|Lost to Follow-up|3|||
146150372|NCT00993447|527063606|FG000|Overall Study|Adverse Event|1|||
146150373|NCT00993447|527063607|FG001|Overall Study|Adverse Event|0|||
146150374|NCT00970502|527063608|FG000|Overall Study|Withdrawal by Subject|1|||
146150375|NCT02041195|527063609|FG000|Overall Study|Adverse Event|1|||
146150376|NCT02041195|527063610|FG001|Overall Study|Adverse Event|2|||
146150377|NCT02041195|527063611|FG002|Overall Study|Adverse Event|0|||
146150378|NCT02041195|527063612|FG003|Overall Study|Adverse Event|0|||
146150379|NCT02041195|527063613|FG004|Overall Study|Adverse Event|0|||
146150380|NCT02041195|527063614|FG005|Overall Study|Adverse Event|0|||
146150381|NCT02041195|527063615|FG006|Overall Study|Adverse Event|3|||
146150382|NCT02041195|527063616|FG007|Overall Study|Adverse Event|0|||
146150383|NCT02041195|527063609|FG000|Overall Study|Withdrawal by Subject|1|||
146150384|NCT02041195|527063610|FG001|Overall Study|Withdrawal by Subject|0|||
146150385|NCT02041195|527063611|FG002|Overall Study|Withdrawal by Subject|0|||
146150386|NCT02041195|527063612|FG003|Overall Study|Withdrawal by Subject|0|||
146150387|NCT02041195|527063613|FG004|Overall Study|Withdrawal by Subject|0|||
146150388|NCT02041195|527063614|FG005|Overall Study|Withdrawal by Subject|0|||
146150389|NCT02041195|527063615|FG006|Overall Study|Withdrawal by Subject|4|||
146150390|NCT02041195|527063616|FG007|Overall Study|Withdrawal by Subject|3|||
146150391|NCT02041195|527063609|FG000|Overall Study|Unable to comply with study visits|0|||
146150392|NCT02041195|527063610|FG001|Overall Study|Unable to comply with study visits|1|||
146150393|NCT02041195|527063611|FG002|Overall Study|Unable to comply with study visits|0|||
146150394|NCT02041195|527063612|FG003|Overall Study|Unable to comply with study visits|0|||
146150395|NCT02041195|527063613|FG004|Overall Study|Unable to comply with study visits|1|||
146150396|NCT02041195|527063614|FG005|Overall Study|Unable to comply with study visits|0|||
146150397|NCT02041195|527063615|FG006|Overall Study|Unable to comply with study visits|0|||
146150398|NCT02041195|527063616|FG007|Overall Study|Unable to comply with study visits|0|||
146150399|NCT03564496|527063617|FG000|Overall Study|Withdrawal by Subject|1|||
146150400|NCT03564496|527063618|FG001|Overall Study|Withdrawal by Subject|1|||
146150401|NCT03564496|527063619|FG002|Overall Study|Withdrawal by Subject|0|||
146150402|NCT03564496|527063617|FG000|Overall Study|Screen failure|0|||
146150403|NCT03564496|527063618|FG001|Overall Study|Screen failure|3|||
146150404|NCT03564496|527063619|FG002|Overall Study|Screen failure|0|||
146150405|NCT00674986|527063620|FG000|Overall Study|Adverse Event|2|||
146150406|NCT00674986|527063621|FG001|Overall Study|Adverse Event|1|||
146150407|NCT00674986|527063620|FG000|Overall Study|Subject withdrew consent|12|||
146150408|NCT00674986|527063621|FG001|Overall Study|Subject withdrew consent|19|||
146150409|NCT00674986|527063620|FG000|Overall Study|Lost to Follow-up|25|||
146150410|NCT00674986|527063621|FG001|Overall Study|Lost to Follow-up|53|||
146150411|NCT00674986|527063620|FG000|Overall Study|Other reasons|4|||
146150412|NCT00674986|527063621|FG001|Overall Study|Other reasons|8|||
146150413|NCT01880424|527063622|FG000|Overall Study|Adverse Event|7|||
146150414|NCT01880424|527063623|FG001|Overall Study|Adverse Event|6|||
146150415|NCT01880424|527063622|FG000|Overall Study|Lack of Efficacy|1|||
146150416|NCT01880424|527063623|FG001|Overall Study|Lack of Efficacy|4|||
146150417|NCT01880424|527063622|FG000|Overall Study|Lost to Follow-up|3|||
146150418|NCT01880424|527063623|FG001|Overall Study|Lost to Follow-up|2|||
146278744|NCT04514510|527534400|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
146150419|NCT01880424|527063622|FG000|Overall Study|Protocol Violation|11|||
146150420|NCT01880424|527063623|FG001|Overall Study|Protocol Violation|13|||
146150421|NCT01880424|527063622|FG000|Overall Study|Withdrawal by Subject|10|||
146150422|NCT01880424|527063623|FG001|Overall Study|Withdrawal by Subject|30|||
146150423|NCT01880424|527063622|FG000|Overall Study|Other|1|||
146150424|NCT01880424|527063623|FG001|Overall Study|Other|0|||
146150425|NCT02590354|527063626|FG000|Phase 1|Active hepatitis B or C infection|1|||
146150426|NCT02590354|527063626|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
146150427|NCT02590354|527063626|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
146150428|NCT02590354|527063626|FG000|Phase 1|Subject does not want to participate|20|||
146150429|NCT02590354|527063626|FG000|Phase 1|Lost to Follow-up|1|||
146150430|NCT02590354|527063626|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
146150431|NCT00996996|527063627|FG000|Overall Study|Progressive Disease|10|||
146150432|NCT00996996|527063627|FG000|Overall Study|Non-compliance|8|||
146150433|NCT00996996|527063627|FG000|Overall Study|Lost to Follow-up|9|||
146150434|NCT00996996|527063627|FG000|Overall Study|Death|5|||
146150435|NCT00996996|527063627|FG000|Overall Study|Did Not Receive Study Medications|1|||
146150436|NCT00760929|527063628|FG000|Overall Study|Adverse Event|2|||
146150437|NCT00760929|527063629|FG001|Overall Study|Adverse Event|0|||
146150438|NCT00760929|527063630|FG002|Overall Study|Adverse Event|6|||
146150439|NCT00760929|527063631|FG003|Overall Study|Adverse Event|10|||
146150440|NCT00760929|527063628|FG000|Overall Study|Lack of Efficacy|0|||
146150441|NCT00760929|527063629|FG001|Overall Study|Lack of Efficacy|2|||
146150442|NCT00760929|527063630|FG002|Overall Study|Lack of Efficacy|1|||
146150443|NCT00760929|527063631|FG003|Overall Study|Lack of Efficacy|0|||
146150444|NCT00760929|527063628|FG000|Overall Study|Withdrawal by Subject|1|||
146150445|NCT00760929|527063629|FG001|Overall Study|Withdrawal by Subject|0|||
146150446|NCT00760929|527063630|FG002|Overall Study|Withdrawal by Subject|9|||
146150447|NCT00760929|527063631|FG003|Overall Study|Withdrawal by Subject|1|||
146150448|NCT00760929|527063628|FG000|Overall Study|Lost to Follow-up|0|||
146150449|NCT00760929|527063629|FG001|Overall Study|Lost to Follow-up|0|||
146150450|NCT00760929|527063630|FG002|Overall Study|Lost to Follow-up|1|||
146150451|NCT00760929|527063631|FG003|Overall Study|Lost to Follow-up|0|||
146150452|NCT00760929|527063628|FG000|Overall Study|Progression of Disease|21|||
146150453|NCT00760929|527063629|FG001|Overall Study|Progression of Disease|26|||
146150454|NCT00760929|527063630|FG002|Overall Study|Progression of Disease|38|||
146150455|NCT00760929|527063631|FG003|Overall Study|Progression of Disease|42|||
146150456|NCT00760929|527063628|FG000|Overall Study|Other|2|||
146150457|NCT00760929|527063629|FG001|Overall Study|Other|0|||
146150458|NCT00760929|527063630|FG002|Overall Study|Other|2|||
146150459|NCT00760929|527063631|FG003|Overall Study|Other|1|||
146150460|NCT00760929|527063628|FG000|Overall Study|Death|0|||
146150461|NCT00760929|527063629|FG001|Overall Study|Death|0|||
146150462|NCT00760929|527063630|FG002|Overall Study|Death|1|||
146150463|NCT00760929|527063631|FG003|Overall Study|Death|0|||
146150464|NCT00760929|527063628|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146150465|NCT00760929|527063629|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146150466|NCT00760929|527063630|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146150467|NCT00760929|527063631|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
146150468|NCT02099838|527063632|FG000|Overall Study|Death|1|||
146150469|NCT02099838|527063633|FG001|Overall Study|Death|0|||
146150470|NCT02099838|527063632|FG000|Overall Study|Lost to Follow-up|3|||
146150471|NCT02099838|527063633|FG001|Overall Study|Lost to Follow-up|1|||
146150472|NCT02099838|527063632|FG000|Overall Study|Withdrawal by Subject|0|||
146150473|NCT02099838|527063633|FG001|Overall Study|Withdrawal by Subject|1|||
146150474|NCT02731131|527063634|FG000|Overall Study|Psychiatric Disorder|0|||
146150475|NCT02731131|527063635|FG001|Overall Study|Psychiatric Disorder|1|||
146150476|NCT02731131|527063634|FG000|Overall Study|Refused Therapy|0|||
146150477|NCT02731131|527063635|FG001|Overall Study|Refused Therapy|1|||
146150478|NCT02348216|527063640|FG000|Overall Study|Death|5|||
146150479|NCT02348216|527063641|FG001|Overall Study|Death|53|||
146150480|NCT02348216|527063642|FG002|Overall Study|Death|11|||
146150481|NCT02348216|527063643|FG003|Overall Study|Death|20|||
146150482|NCT02348216|527063644|FG004|Overall Study|Death|16|||
146150483|NCT02348216|527063645|FG005|Overall Study|Death|32|||
146150484|NCT02348216|527063646|FG006|Overall Study|Death|17|||
146150485|NCT02348216|527063640|FG000|Overall Study|Full consent withdrawal|0|||
146150486|NCT02348216|527063641|FG001|Overall Study|Full consent withdrawal|0|||
146150487|NCT02348216|527063642|FG002|Overall Study|Full consent withdrawal|0|||
146150488|NCT02348216|527063643|FG003|Overall Study|Full consent withdrawal|1|||
146150489|NCT02348216|527063644|FG004|Overall Study|Full consent withdrawal|3|||
146150490|NCT02348216|527063645|FG005|Overall Study|Full consent withdrawal|0|||
146150491|NCT02348216|527063646|FG006|Overall Study|Full consent withdrawal|3|||
146150492|NCT02348216|527063640|FG000|Overall Study|Lost to Follow-up|0|||
146150493|NCT02348216|527063641|FG001|Overall Study|Lost to Follow-up|5|||
146278745|NCT04514510|527534401|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
146278746|NCT00821587|527534402|FG000|Overall Study|Physician Decision|0|||
146150494|NCT02348216|527063642|FG002|Overall Study|Lost to Follow-up|2|||
146150495|NCT02348216|527063643|FG003|Overall Study|Lost to Follow-up|0|||
146150496|NCT02348216|527063644|FG004|Overall Study|Lost to Follow-up|1|||
146150497|NCT02348216|527063645|FG005|Overall Study|Lost to Follow-up|1|||
146150498|NCT02348216|527063646|FG006|Overall Study|Lost to Follow-up|1|||
146150499|NCT02348216|527063640|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
146150500|NCT02348216|527063641|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
146150501|NCT02348216|527063642|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
146150502|NCT02348216|527063643|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
146150503|NCT02348216|527063644|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
146278747|NCT00821587|527534403|FG001|Overall Study|Physician Decision|1|||
146150504|NCT02348216|527063645|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
146150505|NCT02348216|527063646|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
146150506|NCT02348216|527063640|FG000|Overall Study|Reason not specified|2|||
146150507|NCT02348216|527063641|FG001|Overall Study|Reason not specified|19|||
146150508|NCT02348216|527063642|FG002|Overall Study|Reason not specified|11|||
146150509|NCT02348216|527063643|FG003|Overall Study|Reason not specified|17|||
146150510|NCT02348216|527063644|FG004|Overall Study|Reason not specified|21|||
146150511|NCT02348216|527063645|FG005|Overall Study|Reason not specified|17|||
146150512|NCT02348216|527063646|FG006|Overall Study|Reason not specified|19|||
146150513|NCT01666002|527063648|FG000|Overall Study|Lost to Follow-up|5|||
146150514|NCT01666002|527063649|FG001|Overall Study|Lost to Follow-up|0|||
146150515|NCT02265705|527063662|FG000|Treatment Period Week 0-24|Adverse Event|3|||
146150516|NCT02265705|527063663|FG001|Treatment Period Week 0-24|Adverse Event|2|||
146150517|NCT02265705|527063664|FG002|Treatment Period Week 0-24|Adverse Event|0|||
146150518|NCT02265705|527063665|FG003|Treatment Period Week 0-24|Adverse Event|0|||
146150519|NCT02265705|527063666|FG004|Treatment Period Week 0-24|Adverse Event|0|||
146150520|NCT02265705|527063667|FG005|Treatment Period Week 0-24|Adverse Event|0|||
146150521|NCT02265705|527063668|FG006|Treatment Period Week 0-24|Adverse Event|0|||
146150522|NCT02265705|527063662|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
146150523|NCT02265705|527063663|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
146150524|NCT02265705|527063664|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146150525|NCT02265705|527063665|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146150526|NCT02265705|527063666|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146150527|NCT02265705|527063667|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146150528|NCT02265705|527063668|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
146150529|NCT02265705|527063662|FG000|Treatment Period Week 0-24|Physician Decision|1|||
146150530|NCT02265705|527063663|FG001|Treatment Period Week 0-24|Physician Decision|0|||
146150531|NCT02265705|527063664|FG002|Treatment Period Week 0-24|Physician Decision|0|||
146150532|NCT02265705|527063665|FG003|Treatment Period Week 0-24|Physician Decision|0|||
146150533|NCT02265705|527063666|FG004|Treatment Period Week 0-24|Physician Decision|0|||
146150534|NCT02265705|527063667|FG005|Treatment Period Week 0-24|Physician Decision|0|||
146150535|NCT02265705|527063668|FG006|Treatment Period Week 0-24|Physician Decision|0|||
146150536|NCT02265705|527063662|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
146150537|NCT02265705|527063663|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
146150538|NCT02265705|527063664|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146150539|NCT02265705|527063665|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146150540|NCT02265705|527063666|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146150541|NCT02265705|527063667|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146150542|NCT02265705|527063668|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
146150543|NCT02265705|527063662|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150544|NCT02265705|527063663|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
146150545|NCT02265705|527063664|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150546|NCT02265705|527063665|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150547|NCT02265705|527063666|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150548|NCT02265705|527063667|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150549|NCT02265705|527063668|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
146150550|NCT02265705|527063662|FG000|Rescue Period|Withdrawal by Subject|0|||
146150551|NCT02265705|527063663|FG001|Rescue Period|Withdrawal by Subject|0|||
146150552|NCT02265705|527063664|FG002|Rescue Period|Withdrawal by Subject|1|||
146150553|NCT02265705|527063665|FG003|Rescue Period|Withdrawal by Subject|0|||
146150554|NCT02265705|527063666|FG004|Rescue Period|Withdrawal by Subject|0|||
146150555|NCT02265705|527063667|FG005|Rescue Period|Withdrawal by Subject|0|||
146150556|NCT02265705|527063668|FG006|Rescue Period|Withdrawal by Subject|0|||
146150557|NCT02265705|527063662|FG000|Rescue Period|Death|0|||
146150558|NCT02265705|527063663|FG001|Rescue Period|Death|0|||
146150559|NCT02265705|527063664|FG002|Rescue Period|Death|1|||
146150560|NCT02265705|527063665|FG003|Rescue Period|Death|0|||
146150561|NCT02265705|527063666|FG004|Rescue Period|Death|0|||
146150562|NCT02265705|527063667|FG005|Rescue Period|Death|0|||
146150563|NCT02265705|527063668|FG006|Rescue Period|Death|0|||
146150564|NCT02265705|527063662|FG000|Rescue Period|Lack of Efficacy|0|||
146150565|NCT02265705|527063663|FG001|Rescue Period|Lack of Efficacy|0|||
146150566|NCT02265705|527063664|FG002|Rescue Period|Lack of Efficacy|1|||
146150567|NCT02265705|527063665|FG003|Rescue Period|Lack of Efficacy|0|||
146150568|NCT02265705|527063666|FG004|Rescue Period|Lack of Efficacy|0|||
146150569|NCT02265705|527063667|FG005|Rescue Period|Lack of Efficacy|0|||
146150570|NCT02265705|527063668|FG006|Rescue Period|Lack of Efficacy|0|||
146150571|NCT02265705|527063662|FG000|Open Label Period|Adverse Event|0|||
146150572|NCT02265705|527063663|FG001|Open Label Period|Adverse Event|0|||
146150573|NCT02265705|527063664|FG002|Open Label Period|Adverse Event|0|||
146150574|NCT02265705|527063665|FG003|Open Label Period|Adverse Event|2|||
146150575|NCT02265705|527063666|FG004|Open Label Period|Adverse Event|2|||
146150576|NCT02265705|527063667|FG005|Open Label Period|Adverse Event|0|||
146150577|NCT02265705|527063668|FG006|Open Label Period|Adverse Event|0|||
146150578|NCT02265705|527063662|FG000|Open Label Period|Physician Decision|0|||
146150579|NCT02265705|527063663|FG001|Open Label Period|Physician Decision|0|||
146150580|NCT02265705|527063664|FG002|Open Label Period|Physician Decision|0|||
146150581|NCT02265705|527063665|FG003|Open Label Period|Physician Decision|0|||
146150582|NCT02265705|527063666|FG004|Open Label Period|Physician Decision|1|||
146150583|NCT02265705|527063667|FG005|Open Label Period|Physician Decision|0|||
146150584|NCT02265705|527063668|FG006|Open Label Period|Physician Decision|0|||
146150585|NCT02265705|527063662|FG000|Open Label Period|Withdrawal by Subject|0|||
146150586|NCT02265705|527063663|FG001|Open Label Period|Withdrawal by Subject|0|||
146150587|NCT02265705|527063664|FG002|Open Label Period|Withdrawal by Subject|0|||
146150588|NCT02265705|527063665|FG003|Open Label Period|Withdrawal by Subject|0|||
146150589|NCT02265705|527063666|FG004|Open Label Period|Withdrawal by Subject|2|||
146150590|NCT02265705|527063667|FG005|Open Label Period|Withdrawal by Subject|0|||
146150591|NCT02265705|527063668|FG006|Open Label Period|Withdrawal by Subject|0|||
146150592|NCT02265705|527063662|FG000|Follow-up Period|Sponsor Decision|0|||
146150593|NCT02265705|527063663|FG001|Follow-up Period|Sponsor Decision|0|||
146150594|NCT02265705|527063664|FG002|Follow-up Period|Sponsor Decision|0|||
146150595|NCT02265705|527063665|FG003|Follow-up Period|Sponsor Decision|0|||
146150596|NCT02265705|527063666|FG004|Follow-up Period|Sponsor Decision|0|||
146150597|NCT02265705|527063667|FG005|Follow-up Period|Sponsor Decision|1|||
146150598|NCT02265705|527063668|FG006|Follow-up Period|Sponsor Decision|6|||
146150599|NCT02265705|527063662|FG000|Follow-up Period|Adverse Event|0|||
146150600|NCT02265705|527063663|FG001|Follow-up Period|Adverse Event|0|||
146150601|NCT02265705|527063664|FG002|Follow-up Period|Adverse Event|0|||
146150602|NCT02265705|527063665|FG003|Follow-up Period|Adverse Event|0|||
146150603|NCT02265705|527063666|FG004|Follow-up Period|Adverse Event|0|||
146150604|NCT02265705|527063667|FG005|Follow-up Period|Adverse Event|0|||
146150605|NCT02265705|527063668|FG006|Follow-up Period|Adverse Event|3|||
146150606|NCT02265705|527063662|FG000|Follow-up Period|Physician Decision|0|||
146150607|NCT02265705|527063663|FG001|Follow-up Period|Physician Decision|0|||
146150608|NCT02265705|527063664|FG002|Follow-up Period|Physician Decision|0|||
146150609|NCT02265705|527063665|FG003|Follow-up Period|Physician Decision|0|||
146150610|NCT02265705|527063666|FG004|Follow-up Period|Physician Decision|0|||
146150611|NCT02265705|527063667|FG005|Follow-up Period|Physician Decision|0|||
146150612|NCT02265705|527063668|FG006|Follow-up Period|Physician Decision|1|||
146150613|NCT02265705|527063662|FG000|Follow-up Period|Withdrawal by Subject|0|||
146150614|NCT02265705|527063663|FG001|Follow-up Period|Withdrawal by Subject|0|||
146150615|NCT02265705|527063664|FG002|Follow-up Period|Withdrawal by Subject|0|||
146150616|NCT02265705|527063665|FG003|Follow-up Period|Withdrawal by Subject|0|||
146150617|NCT02265705|527063666|FG004|Follow-up Period|Withdrawal by Subject|0|||
146150618|NCT02265705|527063667|FG005|Follow-up Period|Withdrawal by Subject|0|||
146150619|NCT02265705|527063668|FG006|Follow-up Period|Withdrawal by Subject|1|||
146150620|NCT00346034|527063670|FG000|Overall Study|Adverse Event|34|||
146150621|NCT00346034|527063670|FG000|Overall Study|Lack of Efficacy|8|||
146150622|NCT00346034|527063670|FG000|Overall Study|Withdrawal by Subject|13|||
146150623|NCT00346034|527063670|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
146150624|NCT00346034|527063670|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
146150625|NCT04000165|527063671|FG000|Overall Study|Physician Decision|1|||
146150626|NCT04000165|527063671|FG000|Overall Study|Withdrawal by Subject|1|||
146150627|NCT00941603|527063675|FG000|Overall Study|Adverse Event|10|||
146150628|NCT00941603|527063676|FG001|Overall Study|Adverse Event|15|||
146150629|NCT00941603|527063677|FG002|Overall Study|Adverse Event|5|||
146150630|NCT00941603|527063678|FG003|Overall Study|Adverse Event|1|||
146150631|NCT00941603|527063679|FG004|Overall Study|Adverse Event|4|||
146150632|NCT00941603|527063680|FG005|Overall Study|Adverse Event|0|||
146150633|NCT00941603|527063675|FG000|Overall Study|Lost to Follow-up|0|||
146150634|NCT00941603|527063676|FG001|Overall Study|Lost to Follow-up|0|||
146150635|NCT00941603|527063677|FG002|Overall Study|Lost to Follow-up|0|||
146150636|NCT00941603|527063678|FG003|Overall Study|Lost to Follow-up|1|||
146150637|NCT00941603|527063679|FG004|Overall Study|Lost to Follow-up|0|||
146150638|NCT00941603|527063680|FG005|Overall Study|Lost to Follow-up|2|||
146150639|NCT00941603|527063675|FG000|Overall Study|Withdrawal by Subject|0|||
146150640|NCT00941603|527063676|FG001|Overall Study|Withdrawal by Subject|0|||
146150641|NCT00941603|527063677|FG002|Overall Study|Withdrawal by Subject|0|||
146150642|NCT00941603|527063678|FG003|Overall Study|Withdrawal by Subject|2|||
146150643|NCT00941603|527063679|FG004|Overall Study|Withdrawal by Subject|0|||
146150644|NCT00941603|527063680|FG005|Overall Study|Withdrawal by Subject|1|||
146150645|NCT00941603|527063675|FG000|Overall Study|Protocol Violation|0|||
146150646|NCT00941603|527063676|FG001|Overall Study|Protocol Violation|1|||
146150647|NCT00941603|527063677|FG002|Overall Study|Protocol Violation|0|||
146150648|NCT00941603|527063678|FG003|Overall Study|Protocol Violation|0|||
146150649|NCT00941603|527063679|FG004|Overall Study|Protocol Violation|0|||
146150650|NCT00941603|527063680|FG005|Overall Study|Protocol Violation|0|||
146150651|NCT00941603|527063675|FG000|Overall Study|Did not meet protocol eligibility|1|||
146278748|NCT03466073|527534404|FG000|Overall Study|Death|1|||
146278749|NCT03466073|527534405|FG001|Overall Study|Death|0|||
146278750|NCT03466073|527534406|FG002|Overall Study|Death|0|||
146278751|NCT03466073|527534407|FG003|Overall Study|Death|0|||
146278752|NCT03466073|527534408|FG004|Overall Study|Death|0|||
146150652|NCT00941603|527063676|FG001|Overall Study|Did not meet protocol eligibility|0|||
146150653|NCT00941603|527063677|FG002|Overall Study|Did not meet protocol eligibility|0|||
146150654|NCT00941603|527063678|FG003|Overall Study|Did not meet protocol eligibility|0|||
146150655|NCT00941603|527063679|FG004|Overall Study|Did not meet protocol eligibility|0|||
146150656|NCT00941603|527063680|FG005|Overall Study|Did not meet protocol eligibility|0|||
146150657|NCT01753193|527063681|FG000|Overall Study|Withdrawal by Subject|23|||
146150658|NCT01753193|527063681|FG000|Overall Study|Lost to Follow-up|6|||
146150659|NCT01753193|527063681|FG000|Overall Study|Death|1|||
146150660|NCT01753193|527063681|FG000|Overall Study|Other|16|||
146150661|NCT00583557|527063682|FG000|Overall Study|Withdrawal by Subject|18|||
146150662|NCT00583557|527063682|FG000|Overall Study|Adverse Event|9|||
146150663|NCT00583557|527063682|FG000|Overall Study|Lack of Efficacy|31|||
146150664|NCT00583557|527063682|FG000|Overall Study|Lack of Compliance|5|||
146150665|NCT00583557|527063682|FG000|Overall Study|Other|5|||
146150666|NCT00583557|527063682|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
146150667|NCT03625570|527063683|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
146150668|NCT03625570|527063684|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
146150669|NCT03625570|527063683|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
146150670|NCT03625570|527063684|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
146150671|NCT03625570|527063683|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
146150672|NCT03625570|527063684|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
146150673|NCT03264989|527063685|FG000|Overall Study|Lost to Follow-up|1|||
146150674|NCT03264989|527063686|FG001|Overall Study|Lost to Follow-up|0|||
146150675|NCT03264989|527063685|FG000|Overall Study|New Therapy for study Indication|1|||
146150676|NCT03264989|527063686|FG001|Overall Study|New Therapy for study Indication|0|||
146150677|NCT03264989|527063685|FG000|Overall Study|Protocol Violation|0|||
146150678|NCT03264989|527063686|FG001|Overall Study|Protocol Violation|1|||
146150679|NCT03264989|527063685|FG000|Overall Study|Patient decision|13|||
146150680|NCT03264989|527063686|FG001|Overall Study|Patient decision|0|||
146150681|NCT03264989|527063685|FG000|Overall Study|Physician Decision|6|||
146150682|NCT03264989|527063686|FG001|Overall Study|Physician Decision|4|||
146150683|NCT03264989|527063685|FG000|Overall Study|Adverse Event|2|||
146278753|NCT03466073|527534409|FG005|Overall Study|Death|1|||
146278754|NCT02045875|527534410|FG000|Overall Study|Lost to Follow-up|3|||
146278755|NCT02045875|527534411|FG001|Overall Study|Lost to Follow-up|0|||
146278756|NCT02045875|527534410|FG000|Overall Study|Withdrawal by Subject|4|||
146278757|NCT02045875|527534411|FG001|Overall Study|Withdrawal by Subject|3|||
146278758|NCT01276379|527534412|FG000|Overall Study|Screening failure|40|||
146278759|NCT00864253|527534413|FG000|Overall Study|Adverse Event|56|||
146278760|NCT00864253|527534414|FG001|Overall Study|Adverse Event|11|||
146278761|NCT00864253|527534413|FG000|Overall Study|Unrelated Adverse Event|3|||
146278762|NCT00864253|527534414|FG001|Overall Study|Unrelated Adverse Event|1|||
146278763|NCT00864253|527534413|FG000|Overall Study|Physician Decision|11|||
146278764|NCT00864253|527534414|FG001|Overall Study|Physician Decision|15|||
146278765|NCT00864253|527534413|FG000|Overall Study|Protocol Violation|0|||
146278766|NCT00864253|527534414|FG001|Overall Study|Protocol Violation|2|||
146278767|NCT00864253|527534413|FG000|Overall Study|Lost to Follow-up|1|||
146278768|NCT00864253|527534414|FG001|Overall Study|Lost to Follow-up|1|||
146278769|NCT00864253|527534413|FG000|Overall Study|Withdrawal by Subject|18|||
146278770|NCT00864253|527534414|FG001|Overall Study|Withdrawal by Subject|18|||
146278771|NCT00864253|527534413|FG000|Overall Study|Death|1|||
146278772|NCT00864253|527534414|FG001|Overall Study|Death|0|||
146278773|NCT00864253|527534413|FG000|Overall Study|Ongoing|2|||
146278774|NCT00864253|527534414|FG001|Overall Study|Ongoing|3|||
146278775|NCT00864253|527534413|FG000|Overall Study|Untreated|7|||
146278776|NCT00864253|527534414|FG001|Overall Study|Untreated|7|||
146278777|NCT01111240|527534415|FG000|Overall Study|Adverse Event|190|||
146278778|NCT01111240|527534415|FG000|Overall Study|Lack of Efficacy|545|||
146278779|NCT01111240|527534415|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
146278780|NCT01111240|527534415|FG000|Overall Study|Other|312|||
146278781|NCT01743989|527534416|FG000|Treatment Phase|Unstable MR4.0|0|||
146278782|NCT01743989|527534417|FG001|Treatment Phase|Unstable MR4.0|6|||
146278783|NCT01743989|527534418|FG002|Treatment Phase|Unstable MR4.0|263|||
146278784|NCT01743989|527534416|FG000|Treatment Phase|Adverse Event|0|||
146278785|NCT01743989|527534417|FG001|Treatment Phase|Adverse Event|4|||
146278786|NCT01743989|527534418|FG002|Treatment Phase|Adverse Event|67|||
146278787|NCT01743989|527534416|FG000|Treatment Phase|Withdrawal by Subject|1|||
146278788|NCT01743989|527534417|FG001|Treatment Phase|Withdrawal by Subject|3|||
146150684|NCT03264989|527063686|FG001|Overall Study|Adverse Event|1|||
146150685|NCT03264989|527063685|FG000|Overall Study|Death|1|||
146150686|NCT03264989|527063686|FG001|Overall Study|Death|1|||
146150687|NCT03264989|527063685|FG000|Overall Study|Pregnancy|2|||
146150688|NCT03264989|527063686|FG001|Overall Study|Pregnancy|0|||
146150689|NCT03264989|527063685|FG000|Overall Study|End of Study|19|||
146150690|NCT03264989|527063686|FG001|Overall Study|End of Study|5|||
146278789|NCT01743989|527534418|FG002|Treatment Phase|Withdrawal by Subject|28|||
146278790|NCT01743989|527534416|FG000|Treatment Phase|Death|0|||
146278791|NCT01743989|527534417|FG001|Treatment Phase|Death|1|||
146150691|NCT01343056|527063689|FG000|Overall Study|Lost to Follow-up|7|||
146150692|NCT01343056|527063690|FG001|Overall Study|Lost to Follow-up|5|||
146150693|NCT01343056|527063691|FG002|Overall Study|Lost to Follow-up|3|||
146150694|NCT01343056|527063692|FG003|Overall Study|Lost to Follow-up|9|||
146150695|NCT00345579|527063693|FG000|Overall Study|Adverse Event|9|||
146150696|NCT00345579|527063694|FG001|Overall Study|Adverse Event|6|||
146150697|NCT00345579|527063693|FG000|Overall Study|Protocol Violation|14|||
146150698|NCT00345579|527063694|FG001|Overall Study|Protocol Violation|5|||
146150699|NCT00345579|527063693|FG000|Overall Study|Withdrawal by Subject|50|||
146150700|NCT00345579|527063694|FG001|Overall Study|Withdrawal by Subject|17|||
146150701|NCT00345579|527063693|FG000|Overall Study|Lost to Follow-up|82|||
146150702|NCT00345579|527063694|FG001|Overall Study|Lost to Follow-up|36|||
146150703|NCT00345579|527063693|FG000|Overall Study|Other|9|||
146150704|NCT00345579|527063694|FG001|Overall Study|Other|1|||
146150705|NCT03029208|527063695|FG000|Overall Study|Withdrawal by Subject|2|||
146150706|NCT03029208|527063696|FG001|Overall Study|Withdrawal by Subject|3|||
146150707|NCT03029208|527063695|FG000|Overall Study|Lost to Follow-up|0|||
146150708|NCT03029208|527063696|FG001|Overall Study|Lost to Follow-up|1|||
146150709|NCT01732835|527063699|FG000|6-month Primary Endpoint|Did not receive device|19|||
146150710|NCT01732835|527063699|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
146150711|NCT01732835|527063699|FG000|6-month Primary Endpoint|Adverse Event|3|||
146150712|NCT01732835|527063699|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
146150713|NCT01732835|527063699|FG000|2-year Extended Follow-up|Adverse Event|3|||
146150714|NCT01732835|527063699|FG000|2-year Extended Follow-up|Death|1|||
146150715|NCT03207750|527063700|FG000|Overall Study|Adverse Event|3|||
146278792|NCT01743989|527534418|FG002|Treatment Phase|Death|3|||
146278793|NCT01743989|527534416|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
146278794|NCT01743989|527534417|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
146278795|NCT01743989|527534418|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
146278796|NCT01743989|527534416|FG000|Treatment Phase|Protocol deviation|0|||
146278797|NCT01743989|527534417|FG001|Treatment Phase|Protocol deviation|0|||
146278798|NCT01743989|527534418|FG002|Treatment Phase|Protocol deviation|3|||
146278799|NCT01743989|527534416|FG000|Treatment Phase|Pregnancy|0|||
146278800|NCT01743989|527534417|FG001|Treatment Phase|Pregnancy|0|||
146278801|NCT01743989|527534418|FG002|Treatment Phase|Pregnancy|2|||
146278802|NCT01743989|527534416|FG000|Treatment Phase|Lost to Follow-up|0|||
146278803|NCT01743989|527534417|FG001|Treatment Phase|Lost to Follow-up|0|||
146278804|NCT01743989|527534418|FG002|Treatment Phase|Lost to Follow-up|2|||
146278805|NCT01743989|527534416|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
146278806|NCT01743989|527534417|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
146278807|NCT01743989|527534418|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
146278808|NCT01743989|527534416|FG000|Treatment Phase|Administrative problems|0|||
146278809|NCT01743989|527534417|FG001|Treatment Phase|Administrative problems|0|||
146278810|NCT01743989|527534418|FG002|Treatment Phase|Administrative problems|1|||
146278811|NCT01743989|527534416|FG000|Treatment Phase|New cancer (CML) therapy|0|||
146278812|NCT01743989|527534417|FG001|Treatment Phase|New cancer (CML) therapy|1|||
146278813|NCT01743989|527534418|FG002|Treatment Phase|New cancer (CML) therapy|0|||
146278814|NCT01743989|527534416|FG000|Treatment Phase|Physician Decision|0|||
146278815|NCT01743989|527534417|FG001|Treatment Phase|Physician Decision|0|||
146278816|NCT01743989|527534418|FG002|Treatment Phase|Physician Decision|3|||
146278817|NCT01743989|527534416|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
146278818|NCT01743989|527534417|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
146278819|NCT01743989|527534418|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
146278820|NCT01743989|527534416|FG000|Treatment Phase|Not randomized by mistake|0|||
146278821|NCT01743989|527534417|FG001|Treatment Phase|Not randomized by mistake|0|||
146278822|NCT01743989|527534418|FG002|Treatment Phase|Not randomized by mistake|1|||
146278823|NCT01743989|527534416|FG000|Treatment Phase|Included by mistake|0|||
146278824|NCT01743989|527534417|FG001|Treatment Phase|Included by mistake|0|||
146278825|NCT01743989|527534418|FG002|Treatment Phase|Included by mistake|1|||
146278826|NCT01743989|527534416|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
146278827|NCT01743989|527534417|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
146278828|NCT01743989|527534418|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
146278829|NCT01743989|527534416|FG000|TFR Phase|Adverse Event|0|||
146278830|NCT01743989|527534417|FG001|TFR Phase|Adverse Event|1|||
146278831|NCT01743989|527534418|FG002|TFR Phase|Adverse Event|0|||
146278832|NCT01743989|527534416|FG000|TFR Phase|Lost to Follow-up|0|||
146278833|NCT01743989|527534417|FG001|TFR Phase|Lost to Follow-up|2|||
146278834|NCT01743989|527534418|FG002|TFR Phase|Lost to Follow-up|0|||
146278835|NCT01743989|527534416|FG000|TFR Phase|Physician Decision|0|||
146150716|NCT03207750|527063701|FG001|Overall Study|Adverse Event|2|||
146150717|NCT03207750|527063700|FG000|Overall Study|Lost to Follow-up|21|||
146150718|NCT03207750|527063701|FG001|Overall Study|Lost to Follow-up|29|||
146150719|NCT03207750|527063700|FG000|Overall Study|Protocol Violation|0|||
146278836|NCT01743989|527534417|FG001|TFR Phase|Physician Decision|1|||
146305686|NCT00427349|527632658|FG000|Overall Study|Lack of Efficacy|23|||
146150720|NCT03207750|527063701|FG001|Overall Study|Protocol Violation|1|||
146278837|NCT01743989|527534418|FG002|TFR Phase|Physician Decision|0|||
146150721|NCT03207750|527063700|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
146150722|NCT03207750|527063701|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
146150723|NCT03207750|527063700|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
146150724|NCT03207750|527063701|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
146150725|NCT03207750|527063700|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
146150726|NCT03207750|527063701|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
146150727|NCT03207750|527063700|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
146150728|NCT03207750|527063701|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
146150729|NCT03207750|527063700|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
146150730|NCT03207750|527063701|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
146150731|NCT02334748|527063702|FG000|Overall Study|Adverse Event|1|||
146150732|NCT02334748|527063702|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
146150733|NCT02334748|527063702|FG000|Overall Study|Patient no longer required study drug|2|||
146150734|NCT02334748|527063702|FG000|Overall Study|Lack of Efficacy|4|||
146150735|NCT02493361|527063703|FG000|Overall Study|Withdrawal by Subject|3|||
146150736|NCT01046643|527063704|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146150737|NCT01046643|527063705|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
146150738|NCT01046643|527063706|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146150739|NCT01046643|527063707|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
146150740|NCT03893448|527063714|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
146150741|NCT03893448|527063715|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
146150742|NCT03893448|527063714|FG000|Overall Study|Physician Decision|8|||
146150743|NCT03893448|527063715|FG001|Overall Study|Physician Decision|14|||
146150744|NCT03893448|527063714|FG000|Overall Study|Lost to Follow-up|34|||
146150745|NCT03893448|527063715|FG001|Overall Study|Lost to Follow-up|27|||
146150746|NCT03893448|527063714|FG000|Overall Study|Death|1|||
146150747|NCT03893448|527063715|FG001|Overall Study|Death|0|||
146150748|NCT04798586|527063720|FG000|Overall Study|Death|2|||
146150749|NCT04433767|527063722|FG000|Overall Study|Adverse Event|1|||
146150750|NCT01618838|527063727|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
146150751|NCT01764945|527063732|FG000|Overall Study|Adverse Event|0|||
146150752|NCT01764945|527063733|FG001|Overall Study|Adverse Event|1|||
146150753|NCT01764945|527063734|FG002|Overall Study|Adverse Event|0|||
146150754|NCT01764945|527063735|FG003|Overall Study|Adverse Event|0|||
146150755|NCT01764945|527063736|FG004|Overall Study|Adverse Event|0|||
146150756|NCT01764945|527063737|FG005|Overall Study|Adverse Event|0|||
146150757|NCT01764945|527063738|FG006|Overall Study|Adverse Event|1|||
146150758|NCT01764945|527063739|FG007|Overall Study|Adverse Event|0|||
146150759|NCT05077267|527063741|FG000|Treatment Period|Lost to Follow-up|0|||
146150760|NCT05077267|527063742|FG001|Treatment Period|Lost to Follow-up|1|||
146150761|NCT05077267|527063743|FG002|Treatment Period|Lost to Follow-up|0|||
146150762|NCT05077267|527063741|FG000|Treatment Period|Withdrawal by Subject|0|||
146150763|NCT05077267|527063742|FG001|Treatment Period|Withdrawal by Subject|1|||
146150764|NCT05077267|527063743|FG002|Treatment Period|Withdrawal by Subject|0|||
146150765|NCT05077267|527063741|FG000|Follow-up Period|Lost to Follow-up|0|||
146150766|NCT05077267|527063742|FG001|Follow-up Period|Lost to Follow-up|5|||
146150767|NCT05077267|527063743|FG002|Follow-up Period|Lost to Follow-up|7|||
146150768|NCT05077267|527063741|FG000|Follow-up Period|Withdrawal by Subject|0|||
146150769|NCT05077267|527063742|FG001|Follow-up Period|Withdrawal by Subject|2|||
146150770|NCT05077267|527063743|FG002|Follow-up Period|Withdrawal by Subject|5|||
146150771|NCT05077267|527063741|FG000|Follow-up Period|Study terminated by sponsor|0|||
146150772|NCT05077267|527063742|FG001|Follow-up Period|Study terminated by sponsor|27|||
146150773|NCT05077267|527063743|FG002|Follow-up Period|Study terminated by sponsor|23|||
146150774|NCT05077267|527063741|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
146150775|NCT05077267|527063742|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
146150776|NCT05077267|527063743|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
146150777|NCT05077267|527063741|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
146150778|NCT05077267|527063742|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
146150779|NCT05077267|527063743|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
146150780|NCT01136291|527063747|FG000|Overall Study|Lost to Follow-up|1|||
146150781|NCT01136291|527063748|FG001|Overall Study|Lost to Follow-up|1|||
146150782|NCT02308033|527063752|FG000|Overall Study|Normal Gram stain at Baseline|13|||
146150783|NCT02308033|527063753|FG001|Overall Study|Normal Gram stain at Baseline|10|||
146150784|NCT02308033|527063752|FG000|Overall Study|Positive for STD at Baseline|7|||
146150785|NCT02308033|527063753|FG001|Overall Study|Positive for STD at Baseline|4|||
146150786|NCT02308033|527063752|FG000|Overall Study|Lost to Follow-up|6|||
146150787|NCT02308033|527063753|FG001|Overall Study|Lost to Follow-up|5|||
146150788|NCT03165045|527063754|FG000|Visit 1|No registration after visit 1|9|||
146150789|NCT03165045|527063754|FG000|Visit 1|No treatment documented|10|||
146150790|NCT03165045|527063754|FG000|Visit 1|No visit 1|10|||
146278838|NCT01743989|527534416|FG000|TFR Phase|Logistical problems|0|||
146278839|NCT01743989|527534417|FG001|TFR Phase|Logistical problems|2|||
146278840|NCT01743989|527534418|FG002|TFR Phase|Logistical problems|0|||
146150791|NCT03165045|527063754|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
146150792|NCT03165045|527063754|FG000|Visit 2|No available total CCQ score at all|29|||
146150793|NCT03165045|527063754|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
146150794|NCT00499889|527063758|FG000|Overall Study|Infection prior to treatment|1|||
146150795|NCT01870843|527063762|FG000|Overall Study|Adverse Event|10|||
146150796|NCT01870843|527063762|FG000|Overall Study|Lost to Follow-up|24|||
146150797|NCT01870843|527063762|FG000|Overall Study|Death|1|||
146150798|NCT01870843|527063762|FG000|Overall Study|Withdrawal by Subject|18|||
146150799|NCT00345397|527063763|FG000|Overall Study|Death|1|||
146150800|NCT03325712|527063764|FG000|Overall Study|Protocol Violation|0|||
146150801|NCT03325712|527063765|FG001|Overall Study|Protocol Violation|0|||
146150802|NCT03325712|527063766|FG002|Overall Study|Protocol Violation|0|||
146150803|NCT03325712|527063767|FG003|Overall Study|Protocol Violation|0|||
146150804|NCT03325712|527063768|FG004|Overall Study|Protocol Violation|1|||
146150805|NCT03325712|527063769|FG005|Overall Study|Protocol Violation|0|||
146150806|NCT03325712|527063770|FG006|Overall Study|Protocol Violation|0|||
146150807|NCT03325712|527063771|FG007|Overall Study|Protocol Violation|0|||
146150808|NCT03325712|527063764|FG000|Overall Study|Adverse Event|0|||
146150809|NCT03325712|527063765|FG001|Overall Study|Adverse Event|0|||
146150810|NCT03325712|527063766|FG002|Overall Study|Adverse Event|0|||
146150811|NCT03325712|527063767|FG003|Overall Study|Adverse Event|0|||
146150812|NCT03325712|527063768|FG004|Overall Study|Adverse Event|1|||
146150813|NCT03325712|527063769|FG005|Overall Study|Adverse Event|0|||
146150814|NCT03325712|527063770|FG006|Overall Study|Adverse Event|0|||
146150815|NCT03325712|527063771|FG007|Overall Study|Adverse Event|0|||
146150816|NCT01297062|527063773|FG000|Overall Study|Adverse Event|2|||
146150817|NCT01297062|527063774|FG001|Overall Study|Adverse Event|0|||
146150818|NCT01297062|527063775|FG002|Overall Study|Adverse Event|1|||
146150819|NCT01297062|527063776|FG003|Overall Study|Adverse Event|0|||
146150820|NCT01297062|527063777|FG004|Overall Study|Adverse Event|0|||
146150821|NCT01297062|527063778|FG005|Overall Study|Adverse Event|0|||
146150822|NCT01297062|527063779|FG006|Overall Study|Adverse Event|0|||
146150823|NCT01297062|527063773|FG000|Overall Study|Physician Decision|1|||
146150824|NCT01297062|527063774|FG001|Overall Study|Physician Decision|0|||
146150825|NCT01297062|527063775|FG002|Overall Study|Physician Decision|1|||
146150826|NCT01297062|527063776|FG003|Overall Study|Physician Decision|0|||
146150827|NCT01297062|527063777|FG004|Overall Study|Physician Decision|0|||
146150828|NCT01297062|527063778|FG005|Overall Study|Physician Decision|0|||
146150829|NCT01297062|527063779|FG006|Overall Study|Physician Decision|6|||
146150830|NCT01297062|527063773|FG000|Overall Study|Protocol Violation|0|||
146150831|NCT01297062|527063774|FG001|Overall Study|Protocol Violation|0|||
146150832|NCT01297062|527063775|FG002|Overall Study|Protocol Violation|0|||
146150833|NCT01297062|527063776|FG003|Overall Study|Protocol Violation|0|||
146150834|NCT01297062|527063777|FG004|Overall Study|Protocol Violation|1|||
146150835|NCT01297062|527063778|FG005|Overall Study|Protocol Violation|0|||
146150836|NCT01297062|527063779|FG006|Overall Study|Protocol Violation|0|||
146150837|NCT01297062|527063773|FG000|Overall Study|Subject Decision|1|||
146150838|NCT01297062|527063774|FG001|Overall Study|Subject Decision|1|||
146150839|NCT01297062|527063775|FG002|Overall Study|Subject Decision|0|||
146150840|NCT01297062|527063776|FG003|Overall Study|Subject Decision|1|||
146150841|NCT01297062|527063777|FG004|Overall Study|Subject Decision|1|||
146150842|NCT01297062|527063778|FG005|Overall Study|Subject Decision|1|||
146150843|NCT01297062|527063779|FG006|Overall Study|Subject Decision|2|||
146150844|NCT04782323|527063780|FG000|Overall Study|Death|1|||
146150845|NCT04782323|527063781|FG001|Overall Study|Death|0|||
146150846|NCT04782323|527063782|FG002|Overall Study|Death|0|||
146150847|NCT04782323|527063783|FG003|Overall Study|Death|0|||
146150848|NCT04782323|527063784|FG004|Overall Study|Death|1|||
146150849|NCT04782323|527063785|FG005|Overall Study|Death|1|||
146150850|NCT04782323|527063786|FG006|Overall Study|Death|1|||
146150851|NCT04782323|527063787|FG007|Overall Study|Death|0|||
146150852|NCT04782323|527063780|FG000|Overall Study|Withdrawal by Subject|0|||
146150853|NCT04782323|527063781|FG001|Overall Study|Withdrawal by Subject|0|||
146150854|NCT04782323|527063782|FG002|Overall Study|Withdrawal by Subject|1|||
146150855|NCT04782323|527063783|FG003|Overall Study|Withdrawal by Subject|0|||
146150856|NCT04782323|527063784|FG004|Overall Study|Withdrawal by Subject|0|||
146150857|NCT04782323|527063785|FG005|Overall Study|Withdrawal by Subject|1|||
146150858|NCT04782323|527063786|FG006|Overall Study|Withdrawal by Subject|0|||
146150859|NCT04782323|527063787|FG007|Overall Study|Withdrawal by Subject|1|||
146150860|NCT04782323|527063780|FG000|Overall Study|Lost to Follow-up|0|||
146150861|NCT04782323|527063781|FG001|Overall Study|Lost to Follow-up|1|||
146150862|NCT04782323|527063782|FG002|Overall Study|Lost to Follow-up|1|||
146278841|NCT01743989|527534416|FG000|TFR Phase|Protocol deviation|0|||
146150863|NCT04782323|527063783|FG003|Overall Study|Lost to Follow-up|0|||
146150864|NCT04782323|527063784|FG004|Overall Study|Lost to Follow-up|0|||
146150865|NCT04782323|527063785|FG005|Overall Study|Lost to Follow-up|1|||
146150866|NCT04782323|527063786|FG006|Overall Study|Lost to Follow-up|1|||
146150867|NCT04782323|527063787|FG007|Overall Study|Lost to Follow-up|2|||
146150868|NCT04782323|527063780|FG000|Overall Study|randomization in error|1|||
146278842|NCT01743989|527534417|FG001|TFR Phase|Protocol deviation|1|||
146278843|NCT01743989|527534418|FG002|TFR Phase|Protocol deviation|0|||
146150869|NCT04782323|527063781|FG001|Overall Study|randomization in error|0|||
146150870|NCT04782323|527063782|FG002|Overall Study|randomization in error|0|||
146150871|NCT04782323|527063783|FG003|Overall Study|randomization in error|0|||
146150872|NCT04782323|527063784|FG004|Overall Study|randomization in error|0|||
146150873|NCT04782323|527063785|FG005|Overall Study|randomization in error|0|||
146150874|NCT04782323|527063786|FG006|Overall Study|randomization in error|0|||
146150875|NCT04782323|527063787|FG007|Overall Study|randomization in error|0|||
146150876|NCT00927927|527063790|FG000|Overall Study|Withdrawal by Subject|0|||
146150877|NCT00927927|527063791|FG001|Overall Study|Withdrawal by Subject|0|||
146150878|NCT00927927|527063792|FG002|Overall Study|Withdrawal by Subject|0|||
146150879|NCT00927927|527063793|FG003|Overall Study|Withdrawal by Subject|0|||
146150880|NCT00927927|527063794|FG004|Overall Study|Withdrawal by Subject|0|||
146150881|NCT00927927|527063795|FG005|Overall Study|Withdrawal by Subject|0|||
146150882|NCT00927927|527063796|FG006|Overall Study|Withdrawal by Subject|0|||
146150883|NCT00927927|527063797|FG007|Overall Study|Withdrawal by Subject|2|||
146150884|NCT00927927|527063798|FG008|Overall Study|Withdrawal by Subject|0|||
146150885|NCT00927927|527063799|FG009|Overall Study|Withdrawal by Subject|0|||
146150886|NCT00927927|527063800|FG010|Overall Study|Withdrawal by Subject|0|||
146150887|NCT00927927|527063801|FG011|Overall Study|Withdrawal by Subject|2|||
146150888|NCT00927927|527063802|FG012|Overall Study|Withdrawal by Subject|0|||
146150889|NCT00927927|527063803|FG013|Overall Study|Withdrawal by Subject|0|||
146150890|NCT00927927|527063804|FG014|Overall Study|Withdrawal by Subject|0|||
146150891|NCT04369469|527063807|FG000|Overall Study|Lost to Follow-up|2|||
146150892|NCT04369469|527063808|FG001|Overall Study|Lost to Follow-up|4|||
146150893|NCT04369469|527063807|FG000|Overall Study|Physician Decision|2|||
146150894|NCT04369469|527063808|FG001|Overall Study|Physician Decision|1|||
146150895|NCT04369469|527063807|FG000|Overall Study|Withdrawal by Subject|2|||
146150896|NCT04369469|527063808|FG001|Overall Study|Withdrawal by Subject|3|||
146150897|NCT04369469|527063807|FG000|Overall Study|Adverse Event|1|||
146150898|NCT04369469|527063808|FG001|Overall Study|Adverse Event|0|||
146150899|NCT04369469|527063807|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
146150900|NCT04369469|527063808|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
146150901|NCT04369469|527063807|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
146150902|NCT04369469|527063808|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
146150903|NCT04369469|527063807|FG000|Overall Study|Unable to Provide Consent|0|||
146150904|NCT04369469|527063808|FG001|Overall Study|Unable to Provide Consent|1|||
146150905|NCT03135522|527063809|FG000|Overall Study|Adverse Event|1|||
146150906|NCT03135522|527063810|FG001|Overall Study|Adverse Event|0|||
146150907|NCT00499369|527063811|FG000|Overall Study|Adverse Event|2|||
146150908|NCT00499369|527063812|FG001|Overall Study|Adverse Event|2|||
146150909|NCT00499369|527063813|FG002|Overall Study|Adverse Event|3|||
146150910|NCT00499369|527063814|FG003|Overall Study|Adverse Event|1|||
146150911|NCT00499369|527063815|FG004|Overall Study|Adverse Event|2|||
146150912|NCT00499369|527063811|FG000|Overall Study|Withdrawal by Subject|0|||
146150913|NCT00499369|527063812|FG001|Overall Study|Withdrawal by Subject|1|||
146150914|NCT00499369|527063813|FG002|Overall Study|Withdrawal by Subject|1|||
146150915|NCT00499369|527063814|FG003|Overall Study|Withdrawal by Subject|0|||
146150916|NCT00499369|527063815|FG004|Overall Study|Withdrawal by Subject|0|||
146305687|NCT00427349|527632658|FG000|Overall Study|Adverse Event|14|||
146305688|NCT00427349|527632658|FG000|Overall Study|Death|1|||
146305689|NCT00427349|527632658|FG000|Overall Study|Withdrawal by Subject|3|||
146305690|NCT00427349|527632658|FG000|Overall Study|Alternative therapy|1|||
146305691|NCT00427349|527632658|FG000|Overall Study|Other|2|||
146305692|NCT00427349|527632658|FG000|Overall Study|Ineligible|1|||
146305693|NCT00427349|527632658|FG000|Overall Study|Never started therapy|1|||
146305694|NCT05082376|527632659|FG000|Overall Study|Lost to Follow-up|2|||
146150917|NCT00499369|527063811|FG000|Overall Study|Progression|10|||
146150918|NCT00499369|527063812|FG001|Overall Study|Progression|12|||
146150919|NCT00499369|527063813|FG002|Overall Study|Progression|9|||
146150920|NCT00499369|527063814|FG003|Overall Study|Progression|6|||
146150921|NCT00499369|527063815|FG004|Overall Study|Progression|10|||
146150922|NCT00499369|527063811|FG000|Overall Study|Death|0|||
146150923|NCT00499369|527063812|FG001|Overall Study|Death|1|||
146150924|NCT00499369|527063813|FG002|Overall Study|Death|0|||
146150925|NCT00499369|527063814|FG003|Overall Study|Death|0|||
146150926|NCT00499369|527063815|FG004|Overall Study|Death|0|||
146150927|NCT00499369|527063811|FG000|Overall Study|Not protocol specified|2|||
146150928|NCT00499369|527063812|FG001|Overall Study|Not protocol specified|0|||
146150929|NCT00499369|527063813|FG002|Overall Study|Not protocol specified|3|||
146150930|NCT00499369|527063814|FG003|Overall Study|Not protocol specified|1|||
146305695|NCT00445224|527632660|FG000|Specific Exercises|Withdrawal by Subject|3|||
146305696|NCT00445224|527632661|FG001|Specific Exercises|Withdrawal by Subject|3|||
146305697|NCT00445224|527632660|FG000|Specific Exercises|Withdrawal by Subject|1|||
146150931|NCT00499369|527063815|FG004|Overall Study|Not protocol specified|0|||
146150932|NCT00499369|527063811|FG000|Overall Study|Ineligible|2|||
146150933|NCT00499369|527063812|FG001|Overall Study|Ineligible|2|||
146150934|NCT00499369|527063813|FG002|Overall Study|Ineligible|1|||
146150935|NCT00499369|527063814|FG003|Overall Study|Ineligible|1|||
146150936|NCT00499369|527063815|FG004|Overall Study|Ineligible|0|||
146150937|NCT01660906|527063817|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
146150938|NCT04745169|527065567|FG000|Overall Study|Kidney transplantation|1|||
146150939|NCT04745169|527065567|FG000|Overall Study|Participant health problems|3|||
146150940|NCT04745169|527065567|FG000|Overall Study|Physician Decision|2|||
146150941|NCT02053350|527065570|FG000|Overall Study|Withdrawal by Subject|1|||
146150942|NCT02053350|527065570|FG000|Overall Study|Adverse Event|4|||
146150943|NCT03521635|527065571|FG000|Overall Study|Adverse Event|1|||
146150944|NCT03521635|527065572|FG001|Overall Study|Adverse Event|1|||
146150945|NCT03521635|527065571|FG000|Overall Study|Refused to complete study visit|1|||
146150946|NCT03521635|527065572|FG001|Overall Study|Refused to complete study visit|0|||
146150947|NCT03521635|527065571|FG000|Overall Study|Refused to continue trial medication|2|||
146150948|NCT03521635|527065572|FG001|Overall Study|Refused to continue trial medication|2|||
146150949|NCT03521635|527065571|FG000|Overall Study|Lost to Follow-up|0|||
146150950|NCT03521635|527065572|FG001|Overall Study|Lost to Follow-up|1|||
146150951|NCT03521635|527065571|FG000|Overall Study|Meet exclusion criteria|0|||
146150952|NCT03521635|527065572|FG001|Overall Study|Meet exclusion criteria|1|||
146278844|NCT01743989|527534416|FG000|TFR Phase|Withdrawal by Subject|0|||
146278845|NCT01743989|527534417|FG001|TFR Phase|Withdrawal by Subject|2|||
146278846|NCT01743989|527534418|FG002|TFR Phase|Withdrawal by Subject|0|||
146278847|NCT01743989|527534416|FG000|Re-treatment Phase|Adverse Event|8|||
146278848|NCT01743989|527534417|FG001|Re-treatment Phase|Adverse Event|4|||
146278849|NCT01743989|527534418|FG002|Re-treatment Phase|Adverse Event|0|||
146278850|NCT01743989|527534416|FG000|Re-treatment Phase|Death|1|||
146278851|NCT01743989|527534417|FG001|Re-treatment Phase|Death|1|||
146278852|NCT01743989|527534418|FG002|Re-treatment Phase|Death|0|||
146278853|NCT01743989|527534416|FG000|Re-treatment Phase|Administrative problems|1|||
146278854|NCT01743989|527534417|FG001|Re-treatment Phase|Administrative problems|1|||
146278855|NCT01743989|527534418|FG002|Re-treatment Phase|Administrative problems|0|||
146278856|NCT01743989|527534416|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
146278857|NCT01743989|527534417|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
146278858|NCT01743989|527534418|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
146278859|NCT01743989|527534416|FG000|Re-treatment Phase|Unstable MR|1|||
146278860|NCT01743989|527534417|FG001|Re-treatment Phase|Unstable MR|0|||
146278861|NCT01743989|527534418|FG002|Re-treatment Phase|Unstable MR|0|||
146278862|NCT01743989|527534416|FG000|Re-treatment Phase|Physician Decision|0|||
146278863|NCT01743989|527534417|FG001|Re-treatment Phase|Physician Decision|1|||
146278864|NCT01743989|527534418|FG002|Re-treatment Phase|Physician Decision|0|||
146278865|NCT01743989|527534416|FG000|Re-treatment Phase|Lost to Follow-up|0|||
146278866|NCT01743989|527534417|FG001|Re-treatment Phase|Lost to Follow-up|1|||
146278867|NCT01743989|527534418|FG002|Re-treatment Phase|Lost to Follow-up|0|||
146278868|NCT02108964|527534421|FG000|Overall Study|Progressive disease|15|||
146278869|NCT02108964|527534422|FG001|Overall Study|Progressive disease|31|||
146278870|NCT02108964|527534423|FG002|Overall Study|Progressive disease|54|||
146278871|NCT02108964|527534424|FG003|Overall Study|Progressive disease|7|||
146278872|NCT02108964|527534425|FG004|Overall Study|Progressive disease|20|||
146278873|NCT02108964|527534426|FG005|Overall Study|Progressive disease|4|||
146278874|NCT02108964|527534427|FG006|Overall Study|Progressive disease|6|||
146278875|NCT02108964|527534428|FG007|Overall Study|Progressive disease|33|||
146278876|NCT02108964|527534421|FG000|Overall Study|Physician Decision|1|||
146278877|NCT02108964|527534422|FG001|Overall Study|Physician Decision|5|||
146278878|NCT02108964|527534423|FG002|Overall Study|Physician Decision|7|||
146278879|NCT02108964|527534424|FG003|Overall Study|Physician Decision|1|||
146278880|NCT02108964|527534425|FG004|Overall Study|Physician Decision|2|||
146278881|NCT02108964|527534426|FG005|Overall Study|Physician Decision|1|||
146278882|NCT02108964|527534427|FG006|Overall Study|Physician Decision|1|||
146278883|NCT02108964|527534428|FG007|Overall Study|Physician Decision|3|||
146278884|NCT02108964|527534421|FG000|Overall Study|Adverse Event|0|||
146278885|NCT02108964|527534422|FG001|Overall Study|Adverse Event|0|||
146278886|NCT02108964|527534423|FG002|Overall Study|Adverse Event|4|||
146278887|NCT02108964|527534424|FG003|Overall Study|Adverse Event|0|||
146278888|NCT02108964|527534425|FG004|Overall Study|Adverse Event|1|||
146278889|NCT02108964|527534426|FG005|Overall Study|Adverse Event|0|||
146278890|NCT02108964|527534427|FG006|Overall Study|Adverse Event|3|||
146278891|NCT02108964|527534428|FG007|Overall Study|Adverse Event|2|||
146278892|NCT02108964|527534421|FG000|Overall Study|Death|1|||
146278893|NCT02108964|527534422|FG001|Overall Study|Death|1|||
146150953|NCT03521635|527065571|FG000|Overall Study|Patient not taken study medicine|0|||
146150954|NCT03521635|527065572|FG001|Overall Study|Patient not taken study medicine|1|||
146150955|NCT01747772|527065573|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
146150956|NCT02367911|527065574|FG000|Overall Study|Withdrawal by Subject|3|||
146150957|NCT02367911|527065575|FG001|Overall Study|Withdrawal by Subject|2|||
146278894|NCT02108964|527534423|FG002|Overall Study|Death|4|||
146278895|NCT02108964|527534424|FG003|Overall Study|Death|0|||
146278896|NCT02108964|527534425|FG004|Overall Study|Death|3|||
146278897|NCT02108964|527534426|FG005|Overall Study|Death|0|||
146278898|NCT02108964|527534427|FG006|Overall Study|Death|0|||
146278899|NCT02108964|527534428|FG007|Overall Study|Death|2|||
146278900|NCT02108964|527534421|FG000|Overall Study|Subject/Guardian decision|0|||
146150958|NCT02367911|527065574|FG000|Overall Study|Lost to Follow-up|2|||
146150959|NCT02367911|527065575|FG001|Overall Study|Lost to Follow-up|2|||
146150960|NCT00512135|527065576|FG000|Overall Study|Not Treated|5|||
146150961|NCT00512135|527065576|FG000|Overall Study|Lack of Efficacy|2|||
146150962|NCT00512135|527065576|FG000|Overall Study|Adverse Event|6|||
146150963|NCT00512135|527065576|FG000|Overall Study|Withdrawal by Subject|22|||
146150964|NCT00512135|527065576|FG000|Overall Study|Lost to Follow-up|27|||
146150965|NCT00512135|527065576|FG000|Overall Study|Other|22|||
146150966|NCT04495374|527065577|FG000|Overall Study|Protocol Violation|2|||
146150967|NCT04495374|527065578|FG001|Overall Study|Protocol Violation|1|||
146150968|NCT04535037|527065582|FG000|Overall Study|Protocol Violation|1|||
146150969|NCT04535037|527065583|FG001|Overall Study|Protocol Violation|0|||
146150970|NCT04535037|527065582|FG000|Overall Study|Withdrawal by Subject|8|||
146150971|NCT04535037|527065583|FG001|Overall Study|Withdrawal by Subject|9|||
146150972|NCT04535037|527065582|FG000|Overall Study|Migrated / moved from the study area|1|||
146150973|NCT04535037|527065583|FG001|Overall Study|Migrated / moved from the study area|4|||
146150974|NCT04535037|527065582|FG000|Overall Study|Other|2|||
146150975|NCT04535037|527065583|FG001|Overall Study|Other|5|||
146150976|NCT01148810|527065584|FG000|Overall Study|Adverse Event|0|||
146150977|NCT01148810|527065585|FG001|Overall Study|Adverse Event|2|||
146150978|NCT01148810|527065584|FG000|Overall Study|Lack of Efficacy|0|||
146150979|NCT01148810|527065585|FG001|Overall Study|Lack of Efficacy|1|||
146150980|NCT01148810|527065584|FG000|Overall Study|Withdrawal by Subject|0|||
146150981|NCT01148810|527065585|FG001|Overall Study|Withdrawal by Subject|2|||
146150982|NCT01148810|527065584|FG000|Overall Study|Protocol Violation|1|||
146150983|NCT01148810|527065585|FG001|Overall Study|Protocol Violation|0|||
146150984|NCT02417246|527065591|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
146150985|NCT02417246|527065592|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
146150986|NCT02417246|527065591|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
146150987|NCT02417246|527065592|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
146150988|NCT02417246|527065591|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
146150989|NCT02417246|527065592|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
146150990|NCT02417246|527065591|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
146150991|NCT02417246|527065592|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
146150992|NCT04408469|527065595|FG000|Overall Study|Lost to Follow-up|6|||
146150993|NCT04408469|527065596|FG001|Overall Study|Lost to Follow-up|9|||
146150994|NCT04408469|527065595|FG000|Overall Study|Withdrawal by Subject|6|||
146150995|NCT04408469|527065596|FG001|Overall Study|Withdrawal by Subject|1|||
146150996|NCT04408469|527065595|FG000|Overall Study|Dismissal due to ineligibility|0|||
146150997|NCT04408469|527065596|FG001|Overall Study|Dismissal due to ineligibility|1|||
146150998|NCT04321460|527065597|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
146150999|NCT04321460|527065598|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
146151000|NCT01308749|527065599|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
146151001|NCT01308749|527065600|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
146151002|NCT01308749|527065599|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
146151003|NCT01308749|527065600|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
146151004|NCT01308749|527065599|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
146151005|NCT01308749|527065600|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
146151006|NCT02553330|527065605|FG000|Overall Study|Study Terminated by Sponsor|2|||
146151007|NCT02553330|527065606|FG001|Overall Study|Study Terminated by Sponsor|13|||
146151008|NCT02553330|527065607|FG002|Overall Study|Study Terminated by Sponsor|12|||
146151009|NCT02553330|527065605|FG000|Overall Study|Withdrawal by Subject|3|||
146151010|NCT02553330|527065606|FG001|Overall Study|Withdrawal by Subject|19|||
146151011|NCT02553330|527065607|FG002|Overall Study|Withdrawal by Subject|21|||
146151012|NCT02553330|527065605|FG000|Overall Study|Other|0|||
146151013|NCT02553330|527065606|FG001|Overall Study|Other|1|||
146151014|NCT02553330|527065607|FG002|Overall Study|Other|0|||
146151015|NCT02553330|527065605|FG000|Overall Study|Non compliance to study treatment|0|||
146151016|NCT02553330|527065606|FG001|Overall Study|Non compliance to study treatment|1|||
146151017|NCT02553330|527065607|FG002|Overall Study|Non compliance to study treatment|0|||
146151018|NCT02553330|527065605|FG000|Overall Study|Adverse Event|0|||
146151019|NCT02553330|527065606|FG001|Overall Study|Adverse Event|1|||
146151020|NCT02553330|527065607|FG002|Overall Study|Adverse Event|0|||
146278901|NCT02108964|527534422|FG001|Overall Study|Subject/Guardian decision|1|||
146278902|NCT02108964|527534423|FG002|Overall Study|Subject/Guardian decision|4|||
146151021|NCT02553330|527065605|FG000|Overall Study|Lost to Follow-up|0|||
146151022|NCT02553330|527065606|FG001|Overall Study|Lost to Follow-up|4|||
146151023|NCT02553330|527065607|FG002|Overall Study|Lost to Follow-up|4|||
146151024|NCT02896855|527065608|FG000|Overall Study|Death|50|||
146151025|NCT02896855|527065609|FG001|Overall Study|Death|40|||
146151026|NCT02896855|527065608|FG000|Overall Study|Lost to Follow-up|15|||
146151027|NCT02896855|527065609|FG001|Overall Study|Lost to Follow-up|9|||
146151028|NCT02896855|527065608|FG000|Overall Study|Withdrawal by Subject|7|||
146151029|NCT02896855|527065609|FG001|Overall Study|Withdrawal by Subject|4|||
146151030|NCT01205685|527065610|FG000|Overall Study|Disease Progression|10|||
146151031|NCT01205685|527065610|FG000|Overall Study|Withdrawal by Subject|1|||
146151032|NCT02169674|527065611|FG000|Overall Study|Withdrawal by Subject|2|||
146151033|NCT02169674|527065612|FG001|Overall Study|Withdrawal by Subject|1|||
146151034|NCT02169674|527065611|FG000|Overall Study|Seroprotected|30|||
146151035|NCT02169674|527065612|FG001|Overall Study|Seroprotected|76|||
146151036|NCT02169674|527065611|FG000|Overall Study|Lost to Follow-up|0|||
146151037|NCT02169674|527065612|FG001|Overall Study|Lost to Follow-up|1|||
146151038|NCT03058679|527065622|FG000|Baseline to Week 6|Lost to Follow-up|3|||
146151039|NCT03058679|527065623|FG001|Baseline to Week 6|Lost to Follow-up|2|||
146151040|NCT03058679|527065622|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
146151041|NCT03058679|527065623|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
146151042|NCT03058679|527065622|FG000|Baseline to Week 6|Adverse Event|6|||
146151043|NCT03058679|527065623|FG001|Baseline to Week 6|Adverse Event|6|||
146151044|NCT03058679|527065622|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
146151045|NCT03058679|527065623|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
146151046|NCT03058679|527065622|FG000|Baseline to Week 6|Difficulty following the diet|0|||
146151047|NCT03058679|527065623|FG001|Baseline to Week 6|Difficulty following the diet|2|||
146151048|NCT03058679|527065622|FG000|Baseline to Week 6|Physician Decision|1|||
146151049|NCT03058679|527065623|FG001|Baseline to Week 6|Physician Decision|0|||
146151050|NCT03058679|527065622|FG000|Week 6 to Week 12|Change in medication|5|||
146151051|NCT03058679|527065623|FG001|Week 6 to Week 12|Change in medication|7|||
146151052|NCT03058679|527065622|FG000|Week 6 to Week 12|Adverse Event|4|||
146151053|NCT03058679|527065623|FG001|Week 6 to Week 12|Adverse Event|3|||
146151054|NCT03058679|527065622|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
146151055|NCT03058679|527065623|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
146151056|NCT03058679|527065622|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
146151057|NCT03058679|527065623|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
146151058|NCT00599326|527065628|FG000|Overall Study|Lost to Follow-up|1|||
146151059|NCT00599326|527065628|FG000|Overall Study|Noncompliant|1|||
146151060|NCT00784810|527065629|FG000|Overall Study|Adverse Event|32|||
146151061|NCT00784810|527065630|FG001|Overall Study|Adverse Event|20|||
146151062|NCT00784810|527065629|FG000|Overall Study|Lack of Efficacy|14|||
146151063|NCT00784810|527065630|FG001|Overall Study|Lack of Efficacy|11|||
146151064|NCT00784810|527065629|FG000|Overall Study|Withdrawal by Subject|11|||
146151065|NCT00784810|527065630|FG001|Overall Study|Withdrawal by Subject|9|||
146151066|NCT00784810|527065629|FG000|Overall Study|Administrative|5|||
146151067|NCT00784810|527065630|FG001|Overall Study|Administrative|8|||
146151068|NCT00784810|527065629|FG000|Overall Study|Lost to Follow-up|1|||
146151069|NCT00784810|527065630|FG001|Overall Study|Lost to Follow-up|1|||
146151070|NCT04137380|527065631|FG000|Overall Study|Physician Decision|0|||
146151071|NCT04137380|527065632|FG001|Overall Study|Physician Decision|0|||
146151072|NCT04137380|527065633|FG002|Overall Study|Physician Decision|0|||
146151073|NCT04137380|527065634|FG003|Overall Study|Physician Decision|1|||
146151074|NCT04137380|527065635|FG004|Overall Study|Physician Decision|0|||
146151075|NCT04137380|527065636|FG005|Overall Study|Physician Decision|0|||
146151076|NCT04137380|527065637|FG006|Overall Study|Physician Decision|0|||
146151077|NCT00779246|527065638|FG000|Overall Study|Missing sufficient data for analysis|33|||
146151078|NCT00779246|527065639|FG001|Overall Study|Missing sufficient data for analysis|53|||
146151079|NCT03579459|527065640|FG000|Overall Study|Adverse Event|7|||
146151080|NCT03579459|527065641|FG001|Overall Study|Adverse Event|6|||
146151081|NCT03579459|527065642|FG002|Overall Study|Adverse Event|2|||
146151082|NCT03579459|527065643|FG003|Overall Study|Adverse Event|6|||
146151083|NCT03579459|527065640|FG000|Overall Study|Death|1|||
146151084|NCT03579459|527065641|FG001|Overall Study|Death|0|||
146151085|NCT03579459|527065642|FG002|Overall Study|Death|1|||
146151086|NCT03579459|527065643|FG003|Overall Study|Death|2|||
146151087|NCT03579459|527065640|FG000|Overall Study|Lost to Follow-up|6|||
146151088|NCT03579459|527065641|FG001|Overall Study|Lost to Follow-up|2|||
146151089|NCT03579459|527065642|FG002|Overall Study|Lost to Follow-up|4|||
146151090|NCT03579459|527065643|FG003|Overall Study|Lost to Follow-up|1|||
146151091|NCT03579459|527065640|FG000|Overall Study|Physician Decision|0|||
146151092|NCT03579459|527065641|FG001|Overall Study|Physician Decision|1|||
146151093|NCT03579459|527065642|FG002|Overall Study|Physician Decision|0|||
146151094|NCT03579459|527065643|FG003|Overall Study|Physician Decision|1|||
146151095|NCT03579459|527065640|FG000|Overall Study|Protocol Violation|1|||
146151096|NCT03579459|527065641|FG001|Overall Study|Protocol Violation|2|||
146151097|NCT03579459|527065642|FG002|Overall Study|Protocol Violation|3|||
146151098|NCT03579459|527065643|FG003|Overall Study|Protocol Violation|5|||
146151099|NCT03579459|527065640|FG000|Overall Study|Withdrawal by Subject|12|||
146278903|NCT02108964|527534424|FG003|Overall Study|Subject/Guardian decision|0|||
146278904|NCT02108964|527534425|FG004|Overall Study|Subject/Guardian decision|2|||
146151100|NCT03579459|527065641|FG001|Overall Study|Withdrawal by Subject|8|||
146151101|NCT03579459|527065642|FG002|Overall Study|Withdrawal by Subject|11|||
146151102|NCT03579459|527065643|FG003|Overall Study|Withdrawal by Subject|8|||
146151103|NCT03579459|527065640|FG000|Overall Study|Medication error without associated adverse event|2|||
146151104|NCT03579459|527065641|FG001|Overall Study|Medication error without associated adverse event|1|||
146151105|NCT03579459|527065642|FG002|Overall Study|Medication error without associated adverse event|1|||
146305698|NCT00445224|527632661|FG001|Specific Exercises|Withdrawal by Subject|0|||
146305699|NCT03496012|527634084|FG000|Overall Study|Withdrawal by Subject|2|||
146305700|NCT03496012|527634085|FG001|Overall Study|Withdrawal by Subject|0|||
146305701|NCT03496012|527634086|FG002|Overall Study|Withdrawal by Subject|2|||
146305702|NCT03496012|527634084|FG000|Overall Study|Adverse Event|0|||
146305703|NCT03496012|527634085|FG001|Overall Study|Adverse Event|0|||
146305704|NCT03496012|527634086|FG002|Overall Study|Adverse Event|1|||
146305705|NCT03496012|527634084|FG000|Overall Study|Reason Not Specified|2|||
146305706|NCT03496012|527634085|FG001|Overall Study|Reason Not Specified|0|||
146305707|NCT03496012|527634086|FG002|Overall Study|Reason Not Specified|1|||
146305708|NCT00176605|527634087|FG000|Overall Study|Withdrawal by Subject|2|||
146305709|NCT00833053|527634088|FG000|Overall Study|Adverse Event|4|||
146305710|NCT00833053|527634089|FG001|Overall Study|Adverse Event|0|||
146305711|NCT00833053|527634088|FG000|Overall Study|Treatment Failure|3|||
146305712|NCT00833053|527634089|FG001|Overall Study|Treatment Failure|1|||
146305713|NCT00833053|527634088|FG000|Overall Study|Withdrawal by Subject|0|||
146305714|NCT00833053|527634089|FG001|Overall Study|Withdrawal by Subject|1|||
146305715|NCT00833053|527634088|FG000|Overall Study|Protocol Violation|2|||
146305716|NCT00833053|527634089|FG001|Overall Study|Protocol Violation|1|||
146305717|NCT02187471|527634090|FG000|Overall Study|Protocol Violation|4|||
146305718|NCT02187471|527634091|FG001|Overall Study|Protocol Violation|5|||
146305719|NCT02187471|527634092|FG002|Overall Study|Protocol Violation|4|||
146305720|NCT02187471|527634093|FG003|Overall Study|Protocol Violation|4|||
146305721|NCT02187471|527634090|FG000|Overall Study|Missing|0|||
146305722|NCT02187471|527634091|FG001|Overall Study|Missing|0|||
146305723|NCT02187471|527634092|FG002|Overall Study|Missing|0|||
146305724|NCT02187471|527634093|FG003|Overall Study|Missing|1|||
146305725|NCT02187471|527634090|FG000|Overall Study|Lack of Efficacy|18|||
146305726|NCT02187471|527634091|FG001|Overall Study|Lack of Efficacy|9|||
146305727|NCT02187471|527634092|FG002|Overall Study|Lack of Efficacy|13|||
146305728|NCT02187471|527634093|FG003|Overall Study|Lack of Efficacy|11|||
146305729|NCT02187471|527634090|FG000|Overall Study|Adverse Event|24|||
146305730|NCT02187471|527634091|FG001|Overall Study|Adverse Event|34|||
146305731|NCT02187471|527634092|FG002|Overall Study|Adverse Event|44|||
146305732|NCT02187471|527634093|FG003|Overall Study|Adverse Event|36|||
146305733|NCT02187471|527634090|FG000|Overall Study|Withdrawal by Subject|23|||
146305734|NCT02187471|527634091|FG001|Overall Study|Withdrawal by Subject|29|||
146305735|NCT02187471|527634092|FG002|Overall Study|Withdrawal by Subject|22|||
146305736|NCT02187471|527634093|FG003|Overall Study|Withdrawal by Subject|24|||
146305737|NCT02187471|527634090|FG000|Overall Study|Other|7|||
146305738|NCT02187471|527634091|FG001|Overall Study|Other|5|||
146305739|NCT02187471|527634092|FG002|Overall Study|Other|3|||
146305740|NCT02187471|527634093|FG003|Overall Study|Other|4|||
146305741|NCT02236520|527634094|FG000|Overall Study|Physician Decision|0|||
146305742|NCT02236520|527634095|FG001|Overall Study|Physician Decision|5|||
146305743|NCT02236520|527634096|FG002|Overall Study|Physician Decision|0|||
146305744|NCT02236520|527634097|FG003|Overall Study|Physician Decision|0|||
146305745|NCT02236520|527634094|FG000|Overall Study|Withdrawal by Subject|1|||
146305746|NCT02236520|527634095|FG001|Overall Study|Withdrawal by Subject|0|||
146305747|NCT02236520|527634096|FG002|Overall Study|Withdrawal by Subject|0|||
146305748|NCT02236520|527634097|FG003|Overall Study|Withdrawal by Subject|1|||
146305749|NCT02236520|527634094|FG000|Overall Study|Pregnancy|1|||
146305750|NCT02236520|527634095|FG001|Overall Study|Pregnancy|0|||
146305751|NCT02236520|527634096|FG002|Overall Study|Pregnancy|0|||
146305752|NCT02236520|527634097|FG003|Overall Study|Pregnancy|0|||
146305753|NCT01785160|527634098|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
146305754|NCT01785160|527634098|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
146305755|NCT02318667|527634099|FG000|Overall Study|Adverse Event|1|||
146305756|NCT02318667|527634099|FG000|Overall Study|Lack of Efficacy|6|||
146305757|NCT02318667|527634099|FG000|Overall Study|Protocol Violation|2|||
146305758|NCT01033734|527634100|FG000|Overall Study|Withdrawal by Subject|1|||
146305759|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
146305760|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
146305761|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146305762|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146305763|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
146305764|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
146305765|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
146305766|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146305767|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
146305768|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146305769|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
146305770|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
146305771|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
146305772|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
146305773|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
146305774|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
146151106|NCT03579459|527065643|FG003|Overall Study|Medication error without associated adverse event|0|||
146151107|NCT03579459|527065640|FG000|Overall Study|Other|0|||
146151108|NCT03579459|527065641|FG001|Overall Study|Other|1|||
146151109|NCT03579459|527065642|FG002|Overall Study|Other|1|||
146151110|NCT03579459|527065643|FG003|Overall Study|Other|0|||
146151111|NCT03579459|527065640|FG000|Overall Study|Randomized not vaccinated|0|||
146151112|NCT03579459|527065641|FG001|Overall Study|Randomized not vaccinated|2|||
146151113|NCT03579459|527065642|FG002|Overall Study|Randomized not vaccinated|0|||
146151114|NCT03579459|527065643|FG003|Overall Study|Randomized not vaccinated|1|||
146151115|NCT02844946|527065645|FG000|Overall Study|Lost to Follow-up|7|||
146151116|NCT02844946|527065646|FG001|Overall Study|Lost to Follow-up|0|||
146151117|NCT02806986|527065647|FG000|Treatment Stage 1|Adverse Event|1|||
146151118|NCT02806986|527065647|FG000|Treatment Stage 2|Adverse Event|3|||
146151119|NCT02806986|527065647|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
146151120|NCT00407537|527065648|FG000|Overall Study|Death|5|||
146151121|NCT00407537|527065649|FG001|Overall Study|Death|2|||
146151122|NCT00407537|527065648|FG000|Overall Study|Adverse Event|36|||
146151123|NCT00407537|527065649|FG001|Overall Study|Adverse Event|0|||
146151124|NCT00407537|527065648|FG000|Overall Study|Lost to Follow-up|12|||
146151125|NCT00407537|527065649|FG001|Overall Study|Lost to Follow-up|19|||
146151126|NCT00407537|527065648|FG000|Overall Study|Other|6|||
146151127|NCT00407537|527065649|FG001|Overall Study|Other|7|||
146151128|NCT00407537|527065648|FG000|Overall Study|Withdrawal by Subject|34|||
146151129|NCT00407537|527065649|FG001|Overall Study|Withdrawal by Subject|16|||
146151130|NCT00413413|527065653|FG000|Single-Blind|Adverse Event|0|||
146151131|NCT00413413|527065654|FG001|Single-Blind|Adverse Event|9|||
146151132|NCT00413413|527065655|FG002|Single-Blind|Adverse Event|0|||
146151133|NCT00413413|527065653|FG000|Single-Blind|Lack of Efficacy|0|||
146151134|NCT00413413|527065654|FG001|Single-Blind|Lack of Efficacy|5|||
146151135|NCT00413413|527065655|FG002|Single-Blind|Lack of Efficacy|0|||
146151136|NCT00413413|527065653|FG000|Single-Blind|Subject no longer requires study drug|0|||
146151137|NCT00413413|527065654|FG001|Single-Blind|Subject no longer requires study drug|151|||
146151138|NCT00413413|527065655|FG002|Single-Blind|Subject no longer requires study drug|0|||
146151139|NCT00413413|527065653|FG000|Single-Blind|Protocol Violation|0|||
146151140|NCT00413413|527065654|FG001|Single-Blind|Protocol Violation|16|||
146151141|NCT00413413|527065655|FG002|Single-Blind|Protocol Violation|0|||
146151142|NCT00413413|527065653|FG000|Single-Blind|Withdrawal by Subject|0|||
146151143|NCT00413413|527065654|FG001|Single-Blind|Withdrawal by Subject|27|||
146151144|NCT00413413|527065655|FG002|Single-Blind|Withdrawal by Subject|0|||
146151145|NCT00413413|527065653|FG000|Single-Blind|Lost to Follow-up|0|||
146151146|NCT00413413|527065654|FG001|Single-Blind|Lost to Follow-up|8|||
146151147|NCT00413413|527065655|FG002|Single-Blind|Lost to Follow-up|0|||
146151148|NCT00413413|527065653|FG000|Double-Blind|Adverse Event|6|||
146151149|NCT00413413|527065654|FG001|Double-Blind|Adverse Event|0|||
146151150|NCT00413413|527065655|FG002|Double-Blind|Adverse Event|5|||
146151151|NCT00413413|527065653|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
146151152|NCT00413413|527065654|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
146151153|NCT00413413|527065655|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
146151154|NCT00413413|527065653|FG000|Double-Blind|Protocol deviation|1|||
146151155|NCT00413413|527065654|FG001|Double-Blind|Protocol deviation|2|||
146151156|NCT00413413|527065655|FG002|Double-Blind|Protocol deviation|1|||
146151157|NCT00413413|527065653|FG000|Double-Blind|Subject withdrew consent|4|||
146151158|NCT00413413|527065654|FG001|Double-Blind|Subject withdrew consent|6|||
146151159|NCT00413413|527065655|FG002|Double-Blind|Subject withdrew consent|9|||
146151160|NCT00413413|527065653|FG000|Double-Blind|Lost to Follow-up|3|||
146151161|NCT00413413|527065654|FG001|Double-Blind|Lost to Follow-up|4|||
146151162|NCT00413413|527065655|FG002|Double-Blind|Lost to Follow-up|2|||
146151163|NCT01040130|527065656|FG000|Overall Study|Adverse Event|1|||
146151164|NCT01040130|527065657|FG001|Overall Study|Adverse Event|1|||
146151165|NCT01040130|527065658|FG002|Overall Study|Adverse Event|0|||
146151166|NCT01040130|527065659|FG003|Overall Study|Adverse Event|5|||
146151167|NCT01040130|527065660|FG004|Overall Study|Adverse Event|0|||
146151168|NCT01040130|527065661|FG005|Overall Study|Adverse Event|3|||
146151169|NCT01040130|527065656|FG000|Overall Study|Protocol Violation|0|||
146151170|NCT01040130|527065657|FG001|Overall Study|Protocol Violation|0|||
146151171|NCT01040130|527065658|FG002|Overall Study|Protocol Violation|2|||
146151172|NCT01040130|527065659|FG003|Overall Study|Protocol Violation|0|||
146151173|NCT01040130|527065660|FG004|Overall Study|Protocol Violation|0|||
146151174|NCT01040130|527065661|FG005|Overall Study|Protocol Violation|0|||
146151175|NCT01040130|527065656|FG000|Overall Study|Withdrawal by Subject|0|||
146151176|NCT01040130|527065657|FG001|Overall Study|Withdrawal by Subject|2|||
146151177|NCT01040130|527065658|FG002|Overall Study|Withdrawal by Subject|0|||
146278905|NCT02108964|527534426|FG005|Overall Study|Subject/Guardian decision|0|||
146278906|NCT02108964|527534427|FG006|Overall Study|Subject/Guardian decision|1|||
146278907|NCT02108964|527534428|FG007|Overall Study|Subject/Guardian decision|2|||
146278908|NCT02108964|527534421|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146151178|NCT01040130|527065659|FG003|Overall Study|Withdrawal by Subject|0|||
146151179|NCT01040130|527065660|FG004|Overall Study|Withdrawal by Subject|0|||
146151180|NCT01040130|527065661|FG005|Overall Study|Withdrawal by Subject|1|||
146151181|NCT01040130|527065656|FG000|Overall Study|Other reasons not listed above|2|||
146151182|NCT01040130|527065657|FG001|Overall Study|Other reasons not listed above|0|||
146151183|NCT01040130|527065658|FG002|Overall Study|Other reasons not listed above|0|||
146151184|NCT01040130|527065659|FG003|Overall Study|Other reasons not listed above|0|||
146151185|NCT01040130|527065660|FG004|Overall Study|Other reasons not listed above|0|||
146151186|NCT01040130|527065661|FG005|Overall Study|Other reasons not listed above|0|||
146151187|NCT01175668|527065662|FG000|Overall Study|Withdrawal by Subject|2|||
146151188|NCT01175668|527065663|FG001|Overall Study|Withdrawal by Subject|0|||
146305775|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
146305776|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
146305777|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
146305778|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
146305779|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
146305780|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
146305781|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
146305782|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
146305783|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
146305784|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146305785|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146305786|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
146305787|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146305788|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
146305789|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305790|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146305791|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146305792|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146305793|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305794|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146305795|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146305796|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146305797|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146305798|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
146305799|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146305800|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
146305801|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
146305802|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
146305803|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146305804|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146305805|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146305806|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
146305807|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
146305808|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146305809|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146305810|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146305811|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146305812|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
146305813|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146305814|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
146305815|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146305816|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146305817|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146305818|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
146305819|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146305820|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
146305821|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146305822|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146305823|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146305824|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
146305825|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146305826|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
146305827|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146151189|NCT00096135|527065664|FG000|Overall Study|Physician Decision|20|||
146151190|NCT00096135|527065665|FG001|Overall Study|Physician Decision|4|||
146151191|NCT00096135|527065664|FG000|Overall Study|Refusal of further protocol therapy|4|||
146151192|NCT00096135|527065665|FG001|Overall Study|Refusal of further protocol therapy|1|||
146151193|NCT00096135|527065664|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
146151194|NCT00096135|527065665|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
146151195|NCT00096135|527065664|FG000|Overall Study|Other, specify|15|||
146151196|NCT00096135|527065665|FG001|Overall Study|Other, specify|3|||
146151197|NCT00096135|527065664|FG000|Overall Study|Ineligible|2|||
146151198|NCT00096135|527065665|FG001|Overall Study|Ineligible|0|||
146151199|NCT01568047|527065666|FG000|Overall Study|Ineligibility|1|||
146151200|NCT01568047|527065667|FG001|Overall Study|Ineligibility|0|||
146151201|NCT01568047|527065668|FG002|Overall Study|Ineligibility|0|||
146151202|NCT01568047|527065669|FG003|Overall Study|Ineligibility|0|||
146151203|NCT01568047|527065666|FG000|Overall Study|Withdrawal by Subject|0|||
146151204|NCT01568047|527065667|FG001|Overall Study|Withdrawal by Subject|1|||
146151205|NCT01568047|527065668|FG002|Overall Study|Withdrawal by Subject|0|||
146151206|NCT01568047|527065669|FG003|Overall Study|Withdrawal by Subject|0|||
146151207|NCT01568047|527065666|FG000|Overall Study|Adverse Event|0|||
146151208|NCT01568047|527065667|FG001|Overall Study|Adverse Event|0|||
146151209|NCT01568047|527065668|FG002|Overall Study|Adverse Event|1|||
146151210|NCT01568047|527065669|FG003|Overall Study|Adverse Event|1|||
146151211|NCT00874029|527065670|FG000|Overall Study|Withdrawal by Subject|10|||
146151212|NCT00874029|527065670|FG000|Overall Study|Pregnancy|4|||
146151213|NCT00874029|527065670|FG000|Overall Study|Physician Decision|1|||
146151214|NCT00874029|527065670|FG000|Overall Study|Adverse Event|1|||
146151215|NCT00874029|527065670|FG000|Overall Study|Lost to Follow-up|5|||
146151216|NCT02937545|527065677|FG000|Overall Study|Withdrawal by Subject|1|||
146151217|NCT02937545|527065678|FG001|Overall Study|Withdrawal by Subject|2|||
146151218|NCT02937545|527065679|FG002|Overall Study|Withdrawal by Subject|6|||
146151219|NCT02937545|527065680|FG003|Overall Study|Withdrawal by Subject|7|||
146151220|NCT02937545|527065677|FG000|Overall Study|Lost to Follow-up|1|||
146151221|NCT02937545|527065678|FG001|Overall Study|Lost to Follow-up|0|||
146151222|NCT02937545|527065679|FG002|Overall Study|Lost to Follow-up|0|||
146151223|NCT02937545|527065680|FG003|Overall Study|Lost to Follow-up|0|||
146151224|NCT02007577|527065683|FG000|Overall Study|Adverse Event|1|||
146151225|NCT02007577|527065684|FG001|Overall Study|Adverse Event|0|||
146151226|NCT02007577|527065683|FG000|Overall Study|Withdrawal by Subject|0|||
146151227|NCT02007577|527065684|FG001|Overall Study|Withdrawal by Subject|1|||
146151228|NCT00968669|527065685|FG000|Overall Study|Lost to Follow-up|5|||
146151229|NCT00968669|527065686|FG001|Overall Study|Lost to Follow-up|2|||
146151230|NCT00968669|527065687|FG002|Overall Study|Lost to Follow-up|1|||
146151231|NCT00968669|527065688|FG003|Overall Study|Lost to Follow-up|4|||
146151232|NCT00968669|527065685|FG000|Overall Study|Withdrawal by Subject|9|||
146151233|NCT00968669|527065686|FG001|Overall Study|Withdrawal by Subject|7|||
146151234|NCT00968669|527065687|FG002|Overall Study|Withdrawal by Subject|5|||
146151235|NCT00968669|527065688|FG003|Overall Study|Withdrawal by Subject|3|||
146151236|NCT00968669|527065685|FG000|Overall Study|Pregnancy|0|||
146151237|NCT00968669|527065686|FG001|Overall Study|Pregnancy|0|||
146151238|NCT00968669|527065687|FG002|Overall Study|Pregnancy|2|||
146151239|NCT00968669|527065688|FG003|Overall Study|Pregnancy|0|||
146151240|NCT00968669|527065685|FG000|Overall Study|AE|1|||
146151241|NCT00968669|527065686|FG001|Overall Study|AE|0|||
146151242|NCT00968669|527065687|FG002|Overall Study|AE|0|||
146151243|NCT00968669|527065688|FG003|Overall Study|AE|0|||
146151244|NCT00968669|527065685|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146151245|NCT00968669|527065686|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146151246|NCT00968669|527065687|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
146151247|NCT00968669|527065688|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
146151248|NCT00968669|527065685|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
146151249|NCT00968669|527065686|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146151250|NCT00968669|527065687|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146151251|NCT00968669|527065688|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
146151252|NCT00968669|527065685|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
146151253|NCT00968669|527065686|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146151254|NCT00968669|527065687|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146305828|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146305829|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146305830|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
146305831|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146305832|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
146305833|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146151255|NCT00968669|527065688|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
146151256|NCT00968669|527065685|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146151257|NCT00968669|527065686|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146151258|NCT00968669|527065687|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
146151259|NCT00968669|527065688|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
146151260|NCT00968669|527065685|FG000|Overall Study|EARLY WITHDRAWAL|0|||
146151261|NCT00968669|527065686|FG001|Overall Study|EARLY WITHDRAWAL|1|||
146151262|NCT00968669|527065687|FG002|Overall Study|EARLY WITHDRAWAL|0|||
146151263|NCT00968669|527065688|FG003|Overall Study|EARLY WITHDRAWAL|0|||
146151264|NCT00968669|527065685|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146151265|NCT00968669|527065686|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146151266|NCT00968669|527065687|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
146151267|NCT00968669|527065688|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
146151268|NCT00968669|527065685|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
146151269|NCT00968669|527065686|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146151270|NCT00968669|527065687|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146151271|NCT00968669|527065688|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
146151272|NCT00968669|527065685|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146151273|NCT00968669|527065686|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
146151274|NCT00968669|527065687|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146151275|NCT00968669|527065688|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
146151276|NCT00968669|527065685|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146151277|NCT00968669|527065686|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
146151278|NCT00968669|527065687|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146151279|NCT00968669|527065688|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
146151280|NCT00968669|527065685|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146151281|NCT00968669|527065686|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
146151282|NCT00968669|527065687|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146151283|NCT00968669|527065688|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
146151284|NCT00968669|527065685|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146151285|NCT00968669|527065686|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
146151286|NCT00968669|527065687|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146151287|NCT00968669|527065688|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
146151288|NCT00968669|527065685|FG000|Overall Study|SPONSOR DECISION|0|||
146151289|NCT00968669|527065686|FG001|Overall Study|SPONSOR DECISION|1|||
146151290|NCT00968669|527065687|FG002|Overall Study|SPONSOR DECISION|0|||
146151291|NCT00968669|527065688|FG003|Overall Study|SPONSOR DECISION|0|||
146151292|NCT00968669|527065685|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146151293|NCT00968669|527065686|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146151294|NCT00968669|527065687|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
146151295|NCT00968669|527065688|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
146151296|NCT00968669|527065685|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146151297|NCT00968669|527065686|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
146151298|NCT00968669|527065687|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146151299|NCT00968669|527065688|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
146278909|NCT02108964|527534422|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278910|NCT02108964|527534423|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278911|NCT02108964|527534424|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278912|NCT02108964|527534425|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278913|NCT02108964|527534426|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278914|NCT02108964|527534427|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
146278915|NCT02108964|527534428|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
146278916|NCT05384938|527534429|FG000|Overall Study|Withdrawal by Subject|8|||
146278917|NCT05384938|527534429|FG000|Overall Study|Lost to Follow-up|6|||
146278918|NCT05384938|527534429|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
146278919|NCT01732822|527536799|FG000|Overall Study|Withdrawal by Subject|123|||
146278920|NCT01732822|527536800|FG001|Overall Study|Withdrawal by Subject|113|||
146278921|NCT00591370|527536801|FG000|Overall Study|Not Treated|2|||
146278922|NCT00316602|527536802|FG000|Overall Study|Withdrawal by Subject|3|||
146278923|NCT00316602|527536803|FG001|Overall Study|Withdrawal by Subject|2|||
146278924|NCT00316602|527536802|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
146278925|NCT00316602|527536803|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
146278926|NCT00316602|527536802|FG000|Overall Study|Adverse Event|1|||
146278927|NCT00316602|527536803|FG001|Overall Study|Adverse Event|0|||
146278928|NCT00316602|527536802|FG000|Overall Study|Other|3|||
146278929|NCT00316602|527536803|FG001|Overall Study|Other|6|||
146278930|NCT01142232|527536804|FG000|Overall Study|Adverse Event|1|||
146278931|NCT01142232|527536805|FG001|Overall Study|Adverse Event|2|||
146278932|NCT01142232|527536806|FG002|Overall Study|Adverse Event|1|||
146278933|NCT01142232|527536807|FG003|Overall Study|Adverse Event|0|||
146151300|NCT00968669|527065685|FG000|Overall Study|SUBJECT INCARCERATED|0|||
146151301|NCT00968669|527065686|FG001|Overall Study|SUBJECT INCARCERATED|1|||
146151302|NCT00968669|527065687|FG002|Overall Study|SUBJECT INCARCERATED|0|||
146151303|NCT00968669|527065688|FG003|Overall Study|SUBJECT INCARCERATED|0|||
146151304|NCT00968669|527065685|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146151305|NCT00968669|527065686|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
146151306|NCT00968669|527065687|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146151307|NCT00968669|527065688|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
146151308|NCT00968669|527065685|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146151309|NCT00968669|527065686|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146151310|NCT00968669|527065687|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
146151311|NCT00968669|527065688|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
146151312|NCT00968617|527065692|FG000|Overall Study|Study terminated by sponsor|6|||
146151313|NCT00288587|527065696|FG000|Overall Study|Death|4|||
146151314|NCT00288587|527065697|FG001|Overall Study|Death|4|||
146151315|NCT00288587|527065696|FG000|Overall Study|Transplant|0|||
146151316|NCT00288587|527065697|FG001|Overall Study|Transplant|3|||
146151317|NCT00288587|527065696|FG000|Overall Study|Adverse Event|0|||
146151318|NCT00288587|527065697|FG001|Overall Study|Adverse Event|1|||
146151319|NCT00288587|527065696|FG000|Overall Study|Physician Decision|0|||
146151320|NCT00288587|527065697|FG001|Overall Study|Physician Decision|2|||
146151321|NCT00288587|527065696|FG000|Overall Study|Severe Aortic Stenosis|1|||
146151322|NCT00288587|527065697|FG001|Overall Study|Severe Aortic Stenosis|0|||
146151323|NCT01434602|527065698|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146151324|NCT01434602|527065699|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
146151325|NCT01434602|527065700|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146151326|NCT01434602|527065701|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146151327|NCT01434602|527065702|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
146151328|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146151329|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146151330|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146151331|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
146151332|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
146151333|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146151334|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146151335|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146151336|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
146151337|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
146151338|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146151339|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146151340|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146151341|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
146151342|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
146151343|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146151344|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146151345|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146151346|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
146151347|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
146151348|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146151349|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146151350|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146151351|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
146151352|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
146151353|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146151354|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146151355|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146151356|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
146151357|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
146151358|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146151359|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146151360|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
146151361|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
146278934|NCT01142232|527536808|FG004|Overall Study|Adverse Event|4|||
146278935|NCT01142232|527536804|FG000|Overall Study|Death|0|||
146151362|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
146151363|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146151364|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146151365|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146151366|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
146151367|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
146151368|NCT01434602|527065698|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146151369|NCT01434602|527065699|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146151370|NCT01434602|527065700|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146151371|NCT01434602|527065701|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
146151372|NCT01434602|527065702|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
146151373|NCT01827904|527065705|FG000|Main Study|Withdrawal by Subject|1|||
146151374|NCT01827904|527065706|FG001|Main Study|Withdrawal by Subject|0|||
146151375|NCT01827904|527065707|FG002|Main Study|Withdrawal by Subject|0|||
146151376|NCT01827904|527065705|FG000|Main Study|Adverse Event|1|||
146151377|NCT01827904|527065706|FG001|Main Study|Adverse Event|0|||
146151378|NCT01827904|527065707|FG002|Main Study|Adverse Event|0|||
146151379|NCT01827904|527065705|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
146151380|NCT01827904|527065706|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
146151381|NCT01827904|527065707|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
146151382|NCT01827904|527065705|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
146151383|NCT01827904|527065706|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
146151384|NCT01827904|527065707|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
146151385|NCT01827904|527065705|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
146151386|NCT01827904|527065706|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
146151387|NCT01827904|527065707|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
146151388|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
146151389|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
146151390|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
146151391|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
146151392|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
146151393|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
146151394|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
146151395|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
146151396|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
146151397|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
146151398|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
146151399|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
146151400|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Physician Decision|1|||
146151401|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Physician Decision|0|||
146151402|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Physician Decision|0|||
146151403|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
146151404|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
146151405|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
146151406|NCT01827904|527065705|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
146151407|NCT01827904|527065706|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
146151408|NCT01827904|527065707|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
146151409|NCT00142909|527065713|FG000|Randomization|Various Reasons|7|||
146151410|NCT00142909|527065714|FG001|Randomization|Various Reasons|10|||
146151411|NCT00142909|527065713|FG000|Medications Begin|Protocol Violation|2|||
146151412|NCT00142909|527065714|FG001|Medications Begin|Protocol Violation|0|||
146151413|NCT00142909|527065713|FG000|Medications Begin|Withdrawal by Subject|5|||
146151414|NCT00142909|527065714|FG001|Medications Begin|Withdrawal by Subject|3|||
146151415|NCT00142909|527065713|FG000|Medications Begin|Withdrawal by Subject|2|||
146151416|NCT00142909|527065714|FG001|Medications Begin|Withdrawal by Subject|0|||
146151417|NCT01165281|527065715|FG000|Overall Study|Adverse Event|12|||
146151418|NCT01165281|527065716|FG001|Overall Study|Adverse Event|14|||
146151419|NCT01165281|527065715|FG000|Overall Study|Death|3|||
146151420|NCT01165281|527065716|FG001|Overall Study|Death|4|||
146151421|NCT01165281|527065715|FG000|Overall Study|Lack of Efficacy|4|||
146151422|NCT01165281|527065716|FG001|Overall Study|Lack of Efficacy|1|||
146151423|NCT01165281|527065715|FG000|Overall Study|Lost to Follow-up|0|||
146151424|NCT01165281|527065716|FG001|Overall Study|Lost to Follow-up|1|||
146151425|NCT01165281|527065715|FG000|Overall Study|Physician Decision|8|||
146151426|NCT01165281|527065716|FG001|Overall Study|Physician Decision|1|||
146151427|NCT01165281|527065715|FG000|Overall Study|Protocol Violation|6|||
146151428|NCT01165281|527065716|FG001|Overall Study|Protocol Violation|5|||
146151429|NCT01165281|527065715|FG000|Overall Study|Withdrawal by Subject|8|||
146151430|NCT01165281|527065716|FG001|Overall Study|Withdrawal by Subject|7|||
146151431|NCT01165281|527065715|FG000|Overall Study|Noncompliance with Study Drug|1|||
146151432|NCT01165281|527065716|FG001|Overall Study|Noncompliance with Study Drug|4|||
146151433|NCT01165281|527065715|FG000|Overall Study|Progressive Disease|10|||
146151434|NCT01165281|527065716|FG001|Overall Study|Progressive Disease|14|||
146151435|NCT01165281|527065715|FG000|Overall Study|Other|6|||
146151436|NCT01165281|527065716|FG001|Overall Study|Other|0|||
146151437|NCT02863991|527065717|FG000|Overall Study|Death|0|||
146151438|NCT02863991|527065718|FG001|Overall Study|Death|3|||
146151439|NCT02863991|527065717|FG000|Overall Study|Lack of Efficacy|0|||
146151440|NCT02863991|527065718|FG001|Overall Study|Lack of Efficacy|1|||
146151441|NCT02863991|527065717|FG000|Overall Study|Study Terminated|2|||
146151442|NCT02863991|527065718|FG001|Overall Study|Study Terminated|8|||
146151443|NCT00364858|527065723|FG000|Overall Study|Adverse Event|1|||
146151444|NCT00364858|527065724|FG001|Overall Study|Adverse Event|5|||
146151445|NCT00364858|527065723|FG000|Overall Study|Withdrawal by Subject|1|||
146151446|NCT00364858|527065724|FG001|Overall Study|Withdrawal by Subject|1|||
146151447|NCT00364858|527065723|FG000|Overall Study|Pregnancy|1|||
146151448|NCT00364858|527065724|FG001|Overall Study|Pregnancy|1|||
146151449|NCT00364858|527065723|FG000|Overall Study|Clinical failure|2|||
146151450|NCT00364858|527065724|FG001|Overall Study|Clinical failure|13|||
146151451|NCT00364858|527065723|FG000|Overall Study|Discontinuation at baseline|1|||
146151452|NCT00364858|527065724|FG001|Overall Study|Discontinuation at baseline|0|||
146151453|NCT00364858|527065723|FG000|Overall Study|Non-compliant|1|||
146151454|NCT00364858|527065724|FG001|Overall Study|Non-compliant|0|||
146151455|NCT00364858|527065723|FG000|Overall Study|Return to Q2 regimen|0|||
146151456|NCT00364858|527065724|FG001|Overall Study|Return to Q2 regimen|1|||
146151457|NCT00364858|527065723|FG000|Overall Study|Clinical baseline issue|0|||
146151458|NCT00364858|527065724|FG001|Overall Study|Clinical baseline issue|1|||
146151459|NCT01307501|527065725|FG000|Overall Study|Treatment Failure|1|||
146151460|NCT01307501|527065725|FG000|Overall Study|Death|20|||
146151461|NCT01307501|527065725|FG000|Overall Study|Lost to Follow-up|1|||
146151462|NCT01307501|527065725|FG000|Overall Study|Starting Hospice|1|||
146151463|NCT00363766|527065726|FG000|Overall Study|Progressive Disease|15|||
146151464|NCT00363766|527065727|FG001|Overall Study|Progressive Disease|9|||
146151465|NCT00363766|527065726|FG000|Overall Study|Adverse Event|10|||
146151466|NCT00363766|527065727|FG001|Overall Study|Adverse Event|2|||
146151467|NCT00363766|527065726|FG000|Overall Study|Disease Related Death|1|||
146151468|NCT00363766|527065727|FG001|Overall Study|Disease Related Death|3|||
146151469|NCT00363766|527065726|FG000|Overall Study|Not Disease Related Death|3|||
146151470|NCT00363766|527065727|FG001|Overall Study|Not Disease Related Death|4|||
146151471|NCT00363766|527065726|FG000|Overall Study|Withdrawal by Subject|2|||
146151472|NCT00363766|527065727|FG001|Overall Study|Withdrawal by Subject|0|||
146151473|NCT00363766|527065726|FG000|Overall Study|Physician Decision|1|||
146151474|NCT00363766|527065727|FG001|Overall Study|Physician Decision|2|||
146151475|NCT00558285|527065728|FG000|Overall Study|Adverse Event|1|||
146151476|NCT00558285|527065729|FG001|Overall Study|Adverse Event|1|||
146151477|NCT00558285|527065730|FG002|Overall Study|Adverse Event|4|||
146151478|NCT00558285|527065731|FG003|Overall Study|Adverse Event|1|||
146151479|NCT00558285|527065732|FG004|Overall Study|Adverse Event|2|||
146151480|NCT00558285|527065728|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146151481|NCT00558285|527065729|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146151482|NCT00558285|527065730|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146151483|NCT00558285|527065731|FG003|Overall Study|Abnormal test procedure result(s)|0|||
146151484|NCT00558285|527065732|FG004|Overall Study|Abnormal test procedure result(s)|0|||
146151485|NCT00558285|527065728|FG000|Overall Study|Subject withdrew consent|2|||
146151486|NCT00558285|527065729|FG001|Overall Study|Subject withdrew consent|0|||
146151487|NCT00558285|527065730|FG002|Overall Study|Subject withdrew consent|1|||
146151488|NCT00558285|527065731|FG003|Overall Study|Subject withdrew consent|1|||
146151489|NCT00558285|527065732|FG004|Overall Study|Subject withdrew consent|1|||
146151490|NCT00558285|527065728|FG000|Overall Study|Lost to Follow-up|1|||
146278936|NCT01142232|527536805|FG001|Overall Study|Death|0|||
146278937|NCT01142232|527536806|FG002|Overall Study|Death|0|||
146278938|NCT01142232|527536807|FG003|Overall Study|Death|0|||
146278939|NCT01142232|527536808|FG004|Overall Study|Death|1|||
146278940|NCT01142232|527536804|FG000|Overall Study|Disease Progression|2|||
146278941|NCT01142232|527536805|FG001|Overall Study|Disease Progression|0|||
146278942|NCT01142232|527536806|FG002|Overall Study|Disease Progression|1|||
146278943|NCT01142232|527536807|FG003|Overall Study|Disease Progression|2|||
146278944|NCT01142232|527536808|FG004|Overall Study|Disease Progression|12|||
146151491|NCT00558285|527065729|FG001|Overall Study|Lost to Follow-up|1|||
146151492|NCT00558285|527065730|FG002|Overall Study|Lost to Follow-up|0|||
146151493|NCT00558285|527065731|FG003|Overall Study|Lost to Follow-up|0|||
146151494|NCT00558285|527065732|FG004|Overall Study|Lost to Follow-up|0|||
146151495|NCT00558285|527065728|FG000|Overall Study|Administrative problems|0|||
146151496|NCT00558285|527065729|FG001|Overall Study|Administrative problems|0|||
146151497|NCT00558285|527065730|FG002|Overall Study|Administrative problems|0|||
146151498|NCT00558285|527065731|FG003|Overall Study|Administrative problems|1|||
146151499|NCT00558285|527065732|FG004|Overall Study|Administrative problems|1|||
146151500|NCT00558285|527065728|FG000|Overall Study|Protocol deviation|1|||
146151501|NCT00558285|527065729|FG001|Overall Study|Protocol deviation|1|||
146151502|NCT00558285|527065730|FG002|Overall Study|Protocol deviation|0|||
146151503|NCT00558285|527065731|FG003|Overall Study|Protocol deviation|1|||
146151504|NCT00558285|527065732|FG004|Overall Study|Protocol deviation|0|||
146151505|NCT02345512|527065739|FG000|Overall Study|Adverse Event|1|||
146151506|NCT02345512|527065739|FG000|Overall Study|Withdrawal by Subject|1|||
146151507|NCT03478891|527065742|FG000|Overall Study|Enrolled, but product never administered|0|||
146151508|NCT03478891|527065743|FG001|Overall Study|Enrolled, but product never administered|0|||
146151509|NCT03478891|527065744|FG002|Overall Study|Enrolled, but product never administered|1|||
146151510|NCT03478891|527065742|FG000|Overall Study|Moved from area|0|||
146151511|NCT03478891|527065743|FG001|Overall Study|Moved from area|0|||
146151512|NCT03478891|527065744|FG002|Overall Study|Moved from area|1|||
146151513|NCT03478891|527065742|FG000|Overall Study|Lost to Follow-up|1|||
146151514|NCT03478891|527065743|FG001|Overall Study|Lost to Follow-up|0|||
146151515|NCT03478891|527065744|FG002|Overall Study|Lost to Follow-up|1|||
146151516|NCT04827576|527067704|FG000|Overall Study|Death|5|||
146151517|NCT04827576|527067705|FG001|Overall Study|Death|17|||
146151518|NCT04827576|527067706|FG002|Overall Study|Death|17|||
146151519|NCT04827576|527067707|FG003|Overall Study|Death|32|||
146151520|NCT04827576|527067704|FG000|Overall Study|Study Terminated by Sponsor|2|||
146151521|NCT04827576|527067705|FG001|Overall Study|Study Terminated by Sponsor|9|||
146151522|NCT04827576|527067706|FG002|Overall Study|Study Terminated by Sponsor|7|||
146151523|NCT04827576|527067707|FG003|Overall Study|Study Terminated by Sponsor|5|||
146151524|NCT04827576|527067704|FG000|Overall Study|Investigator's Discretion|1|||
146151525|NCT04827576|527067705|FG001|Overall Study|Investigator's Discretion|0|||
146151526|NCT04827576|527067706|FG002|Overall Study|Investigator's Discretion|2|||
146151527|NCT04827576|527067707|FG003|Overall Study|Investigator's Discretion|5|||
146151528|NCT04827576|527067704|FG000|Overall Study|Withdrew Consent|0|||
146151529|NCT04827576|527067705|FG001|Overall Study|Withdrew Consent|3|||
146151530|NCT04827576|527067706|FG002|Overall Study|Withdrew Consent|0|||
146151531|NCT04827576|527067707|FG003|Overall Study|Withdrew Consent|0|||
146151532|NCT04827576|527067704|FG000|Overall Study|Lost to Follow-up|1|||
146151533|NCT04827576|527067705|FG001|Overall Study|Lost to Follow-up|0|||
146151534|NCT04827576|527067706|FG002|Overall Study|Lost to Follow-up|0|||
146151535|NCT04827576|527067707|FG003|Overall Study|Lost to Follow-up|0|||
146151536|NCT04295564|527067708|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
146151537|NCT04295564|527067709|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
146151538|NCT02527798|527067710|FG000|Overall Study|Physician Decision|1|||
146151539|NCT02527798|527067711|FG001|Overall Study|Physician Decision|0|||
146151540|NCT02527798|527067712|FG002|Overall Study|Physician Decision|1|||
146151541|NCT02527798|527067713|FG003|Overall Study|Physician Decision|1|||
146151542|NCT02527798|527067714|FG004|Overall Study|Physician Decision|0|||
146151543|NCT02527798|527067715|FG005|Overall Study|Physician Decision|0|||
146151544|NCT02527798|527067710|FG000|Overall Study|Death|0|||
146151545|NCT02527798|527067711|FG001|Overall Study|Death|0|||
146151546|NCT02527798|527067712|FG002|Overall Study|Death|1|||
146151547|NCT02527798|527067713|FG003|Overall Study|Death|0|||
146151548|NCT02527798|527067714|FG004|Overall Study|Death|0|||
146151549|NCT02527798|527067715|FG005|Overall Study|Death|0|||
146151550|NCT02527798|527067710|FG000|Overall Study|Withdrawal by Subject|0|||
146151551|NCT02527798|527067711|FG001|Overall Study|Withdrawal by Subject|1|||
146151552|NCT02527798|527067712|FG002|Overall Study|Withdrawal by Subject|2|||
146151553|NCT02527798|527067713|FG003|Overall Study|Withdrawal by Subject|0|||
146151554|NCT02527798|527067714|FG004|Overall Study|Withdrawal by Subject|0|||
146151555|NCT02527798|527067715|FG005|Overall Study|Withdrawal by Subject|0|||
146151556|NCT02527798|527067710|FG000|Overall Study|Reason undisclosed|1|||
146151557|NCT02527798|527067711|FG001|Overall Study|Reason undisclosed|0|||
146305834|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146305835|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146305836|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
146151558|NCT02527798|527067712|FG002|Overall Study|Reason undisclosed|1|||
146305837|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146305838|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146151559|NCT02527798|527067713|FG003|Overall Study|Reason undisclosed|0|||
146151560|NCT02527798|527067714|FG004|Overall Study|Reason undisclosed|0|||
146151561|NCT02527798|527067715|FG005|Overall Study|Reason undisclosed|0|||
146151562|NCT02527798|527067710|FG000|Overall Study|Did not receive intervention|1|||
146151563|NCT02527798|527067711|FG001|Overall Study|Did not receive intervention|1|||
146151564|NCT02527798|527067712|FG002|Overall Study|Did not receive intervention|0|||
146151565|NCT02527798|527067713|FG003|Overall Study|Did not receive intervention|0|||
146151566|NCT02527798|527067714|FG004|Overall Study|Did not receive intervention|0|||
146151567|NCT02527798|527067715|FG005|Overall Study|Did not receive intervention|0|||
146151568|NCT00724282|527067717|FG000|Overall Study|Withdrawal by Subject|3|||
146151569|NCT00724282|527067717|FG000|Overall Study|Physician Decision|1|||
146151570|NCT01808690|527067718|FG000|Overall Study|Withdrawal by Subject|1|||
146151571|NCT01808690|527067719|FG001|Overall Study|Withdrawal by Subject|2|||
146151572|NCT02244944|527067722|FG000|Overall Study|Withdrawal by Subject|1|||
146151573|NCT02244944|527067722|FG000|Overall Study|Study Terminated|1|||
146151574|NCT01928719|527067725|FG000|Overall Study|Lost to Follow-up|26|||
146151575|NCT01928719|527067726|FG001|Overall Study|Lost to Follow-up|11|||
146151576|NCT01928719|527067725|FG000|Overall Study|Withdrawal by Subject|22|||
146151577|NCT01928719|527067726|FG001|Overall Study|Withdrawal by Subject|7|||
146151578|NCT01928719|527067725|FG000|Overall Study|Protocol Violation|3|||
146151579|NCT01928719|527067726|FG001|Overall Study|Protocol Violation|1|||
146151580|NCT01928719|527067725|FG000|Overall Study|Adverse Event|1|||
146151581|NCT01928719|527067726|FG001|Overall Study|Adverse Event|0|||
146151582|NCT00263666|527067727|FG000|Overall Study|Adverse Event|6|||
146151583|NCT00263666|527067728|FG001|Overall Study|Adverse Event|8|||
146151584|NCT00263666|527067727|FG000|Overall Study|Lost to Follow-up|1|||
146151585|NCT00263666|527067728|FG001|Overall Study|Lost to Follow-up|2|||
146151586|NCT00263666|527067727|FG000|Overall Study|Withdrawal by Subject|0|||
146151587|NCT00263666|527067728|FG001|Overall Study|Withdrawal by Subject|1|||
146151588|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
146151589|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
146151590|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
146151591|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
146151592|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
146151593|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
146151594|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
146151595|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
146151596|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
146151597|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
146151598|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
146151599|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
146151600|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
146151601|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
146305839|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146305840|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
146305841|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146305842|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
146305843|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146305844|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146305845|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146305846|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
146305847|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146305848|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
146305849|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146305850|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146305851|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146305852|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146305853|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
146305854|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
146305855|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146305856|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146305857|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146305858|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146305859|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
146305860|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
146305861|NCT00111800|527634109|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146305862|NCT00111800|527634110|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146305863|NCT00111800|527634111|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146305864|NCT00111800|527634112|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146305865|NCT00111800|527634113|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
146305866|NCT00111800|527634114|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
146305867|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146305868|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
146305869|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
146151602|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
146151603|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
146151604|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
146151605|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
146151606|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
146151607|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
146151608|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
146151609|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
146151610|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
146151611|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
146151612|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151613|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151614|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151615|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151616|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151617|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151618|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151619|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151620|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151621|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151622|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151623|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151624|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151625|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151626|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151627|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
146151628|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151629|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151630|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
146151631|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
146151632|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
146151633|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151634|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151635|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151636|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151637|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151638|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151639|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151640|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151641|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151642|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151643|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151644|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151645|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151646|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151647|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
146151648|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
146151649|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
146151650|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
146151651|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
146151652|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
146151653|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
146151654|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
146151655|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
146151656|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
146151657|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
146151658|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
146151659|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
146151660|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
146151661|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
146151662|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
146151663|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
146305870|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
146305871|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146305872|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
146305873|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146305874|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
146305875|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
146305876|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146151664|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
146151665|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
146151666|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
146151667|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
146151668|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
146305877|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146305878|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
146305879|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146305880|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
146305881|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
146305882|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146305883|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
146305884|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
146305885|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146305886|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
146305887|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146305888|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146305889|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
146305890|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
146305891|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305892|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305893|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
146305894|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305895|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305896|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
146305897|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146305898|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
146305899|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146305900|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146305901|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146305902|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
146305903|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146305904|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146305905|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
146305906|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146305907|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146305908|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
146305909|NCT00111800|527634109|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146305910|NCT00111800|527634110|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146305911|NCT00111800|527634111|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
146305912|NCT00111800|527634112|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146305913|NCT00111800|527634113|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146305914|NCT00111800|527634114|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
146305915|NCT00914927|527634115|FG000|Overall Study|Adverse Event|0|||
146305916|NCT00914927|527634116|FG001|Overall Study|Adverse Event|0|||
146305917|NCT00914927|527634117|FG002|Overall Study|Adverse Event|0|||
146305918|NCT00914927|527634118|FG003|Overall Study|Adverse Event|0|||
146305919|NCT00914927|527634119|FG004|Overall Study|Adverse Event|1|||
146305920|NCT00914927|527634120|FG005|Overall Study|Adverse Event|0|||
146305921|NCT00914927|527634121|FG006|Overall Study|Adverse Event|0|||
146305922|NCT00914927|527634115|FG000|Overall Study|Withdrawal by Subject|0|||
146305923|NCT00914927|527634116|FG001|Overall Study|Withdrawal by Subject|1|||
146305924|NCT00914927|527634117|FG002|Overall Study|Withdrawal by Subject|0|||
146305925|NCT00914927|527634118|FG003|Overall Study|Withdrawal by Subject|1|||
146305926|NCT00914927|527634119|FG004|Overall Study|Withdrawal by Subject|0|||
146305927|NCT00914927|527634120|FG005|Overall Study|Withdrawal by Subject|0|||
146305928|NCT00914927|527634121|FG006|Overall Study|Withdrawal by Subject|0|||
146305929|NCT00914927|527634115|FG000|Overall Study|Lost to Follow-up|0|||
146305930|NCT00914927|527634116|FG001|Overall Study|Lost to Follow-up|0|||
146305931|NCT00914927|527634117|FG002|Overall Study|Lost to Follow-up|0|||
146305932|NCT00914927|527634118|FG003|Overall Study|Lost to Follow-up|1|||
146305933|NCT00914927|527634119|FG004|Overall Study|Lost to Follow-up|0|||
146305934|NCT00914927|527634120|FG005|Overall Study|Lost to Follow-up|0|||
146305935|NCT00914927|527634121|FG006|Overall Study|Lost to Follow-up|0|||
146305936|NCT00914927|527634115|FG000|Overall Study|Administrative/Other|2|||
146305937|NCT00914927|527634116|FG001|Overall Study|Administrative/Other|1|||
146305938|NCT00914927|527634117|FG002|Overall Study|Administrative/Other|0|||
146305939|NCT00914927|527634118|FG003|Overall Study|Administrative/Other|0|||
146305940|NCT00914927|527634119|FG004|Overall Study|Administrative/Other|1|||
146305941|NCT00914927|527634120|FG005|Overall Study|Administrative/Other|0|||
146151669|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
146305942|NCT00914927|527634121|FG006|Overall Study|Administrative/Other|0|||
146151670|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151671|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151672|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151673|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151674|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151675|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151676|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151677|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151678|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151679|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151680|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151681|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151682|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151683|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151684|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151685|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151686|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151687|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
146151688|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146151689|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146151690|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151691|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
146151692|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
146305943|NCT00971178|527634127|FG000|Overall Study|Lost to Follow-up|2|||
146305944|NCT00971178|527634128|FG001|Overall Study|Lost to Follow-up|2|||
146305945|NCT00971178|527634129|FG002|Overall Study|Lost to Follow-up|2|||
146305946|NCT00365456|527634130|FG000|Trial Period I (12 Months)|Adverse Event|84|||
146305947|NCT00365456|527634131|FG001|Trial Period I (12 Months)|Adverse Event|0|||
146305948|NCT00365456|527634130|FG000|Trial Period I (12 Months)|Non-compliance|3|||
146305949|NCT00365456|527634131|FG001|Trial Period I (12 Months)|Non-compliance|0|||
146305950|NCT00365456|527634130|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
146305951|NCT00365456|527634131|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
146305952|NCT00365456|527634130|FG000|Trial Period I (12 Months)|Other|11|||
146305953|NCT00365456|527634131|FG001|Trial Period I (12 Months)|Other|0|||
146305954|NCT00365456|527634130|FG000|Trial Period II (12 Months)|Adverse Event|0|||
146305955|NCT00365456|527634131|FG001|Trial Period II (12 Months)|Adverse Event|6|||
146305956|NCT00365456|527634130|FG000|Trial Period II (12 Months)|Non-compliance|0|||
146305957|NCT00365456|527634131|FG001|Trial Period II (12 Months)|Non-compliance|2|||
146305958|NCT00365456|527634130|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
146305959|NCT00365456|527634131|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
146305960|NCT00365456|527634130|FG000|Trial Period II (12 Months)|Other|0|||
146305961|NCT00365456|527634131|FG001|Trial Period II (12 Months)|Other|1|||
146305962|NCT00365456|527634130|FG000|Trial Period III (12 Months)|Adverse Event|13|||
146305963|NCT00365456|527634131|FG001|Trial Period III (12 Months)|Adverse Event|3|||
146305964|NCT00365456|527634130|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
146305965|NCT00365456|527634131|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
146305966|NCT00365456|527634130|FG000|Trial Period III (12 Months)|Other|1|||
146305967|NCT00365456|527634131|FG001|Trial Period III (12 Months)|Other|1|||
146305968|NCT00714285|527634132|FG000|Overall Study|Lost to Follow-up|0|||
146305969|NCT00714285|527634133|FG001|Overall Study|Lost to Follow-up|2|||
146305970|NCT00714285|527634134|FG002|Overall Study|Lost to Follow-up|0|||
146305971|NCT00714285|527634135|FG003|Overall Study|Lost to Follow-up|1|||
146305972|NCT00714285|527634132|FG000|Overall Study|Migrated/moved from study area|0|||
146305973|NCT00714285|527634133|FG001|Overall Study|Migrated/moved from study area|1|||
146305974|NCT00714285|527634134|FG002|Overall Study|Migrated/moved from study area|0|||
146305975|NCT00714285|527634135|FG003|Overall Study|Migrated/moved from study area|0|||
146305976|NCT01131676|527634136|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
146305977|NCT01131676|527634137|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
146305978|NCT01131676|527634138|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
146305979|NCT01131676|527634136|FG000|Discontinuation From Treatment|Not treated|4|||
146305980|NCT01131676|527634137|FG001|Discontinuation From Treatment|Not treated|2|||
146305981|NCT01131676|527634138|FG002|Discontinuation From Treatment|Not treated|2|||
146305982|NCT01131676|527634136|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
146305983|NCT01131676|527634137|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
146305984|NCT01131676|527634138|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
146305985|NCT01131676|527634136|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
146305986|NCT01131676|527634137|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
146151693|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151694|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151695|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146305987|NCT01131676|527634138|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
146305988|NCT01131676|527634136|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
146305989|NCT01131676|527634137|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
146305990|NCT01131676|527634138|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
146305991|NCT01131676|527634136|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
146305992|NCT01131676|527634137|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
146305993|NCT01131676|527634138|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
146305994|NCT01131676|527634136|FG000|Discontinuation From Treatment|Other than those specified|162|||
146305995|NCT01131676|527634137|FG001|Discontinuation From Treatment|Other than those specified|142|||
146305996|NCT01131676|527634138|FG002|Discontinuation From Treatment|Other than those specified|125|||
146305997|NCT01131676|527634136|FG000|Discontinuation From Treatment|Adverse Event|303|||
146305998|NCT01131676|527634137|FG001|Discontinuation From Treatment|Adverse Event|267|||
146305999|NCT01131676|527634138|FG002|Discontinuation From Treatment|Adverse Event|273|||
146306000|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
146306001|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
146306002|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
146306003|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
146306004|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
146306005|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
146306006|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
146306007|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
146306008|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
146306009|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
146306010|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
146306011|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
146306012|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
146306013|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
146306014|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
146306015|NCT01131676|527634136|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
146306016|NCT01131676|527634137|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
146306017|NCT01131676|527634138|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
146306018|NCT04109222|527634139|FG000|Overall Study|Adverse Event|1|||
146306019|NCT04109222|527634140|FG001|Overall Study|Adverse Event|0|||
146306020|NCT04109222|527634141|FG002|Overall Study|Adverse Event|0|||
146306021|NCT02138617|527634142|FG000|Overall Study|Death|1|||
146306022|NCT02138617|527634143|FG001|Overall Study|Death|2|||
146306023|NCT02138617|527634144|FG002|Overall Study|Death|2|||
146306024|NCT02138617|527634142|FG000|Overall Study|Adverse Event|8|||
146306025|NCT02138617|527634143|FG001|Overall Study|Adverse Event|5|||
146306026|NCT02138617|527634144|FG002|Overall Study|Adverse Event|2|||
146306027|NCT02138617|527634142|FG000|Overall Study|Disease Progression|20|||
146306028|NCT02138617|527634143|FG001|Overall Study|Disease Progression|13|||
146306029|NCT02138617|527634144|FG002|Overall Study|Disease Progression|4|||
146306030|NCT02138617|527634142|FG000|Overall Study|Withdrawal by Subject|7|||
146306031|NCT02138617|527634143|FG001|Overall Study|Withdrawal by Subject|10|||
146306032|NCT02138617|527634144|FG002|Overall Study|Withdrawal by Subject|2|||
146306033|NCT02138617|527634142|FG000|Overall Study|other complicating disease|0|||
146306034|NCT02138617|527634143|FG001|Overall Study|other complicating disease|2|||
146306035|NCT02138617|527634144|FG002|Overall Study|other complicating disease|0|||
146306036|NCT02138617|527634142|FG000|Overall Study|Protocol Violation|1|||
146306037|NCT02138617|527634143|FG001|Overall Study|Protocol Violation|0|||
146306038|NCT02138617|527634144|FG002|Overall Study|Protocol Violation|0|||
146306039|NCT02138617|527634142|FG000|Overall Study|Physician Decision|7|||
146306040|NCT02138617|527634143|FG001|Overall Study|Physician Decision|6|||
146306041|NCT02138617|527634144|FG002|Overall Study|Physician Decision|0|||
146306042|NCT02138617|527634142|FG000|Overall Study|financial reason|0|||
146306043|NCT02138617|527634143|FG001|Overall Study|financial reason|1|||
146306044|NCT02138617|527634144|FG002|Overall Study|financial reason|0|||
146306045|NCT02138617|527634142|FG000|Overall Study|other therapy|3|||
146306046|NCT02138617|527634143|FG001|Overall Study|other therapy|4|||
146306047|NCT02138617|527634144|FG002|Overall Study|other therapy|0|||
146306048|NCT01961349|527634148|FG000|Overall Study|Withdrawal by Subject|1|||
146306049|NCT01961349|527634149|FG001|Overall Study|Withdrawal by Subject|4|||
146306050|NCT01961349|527634150|FG002|Overall Study|Withdrawal by Subject|0|||
146306051|NCT01961349|527634148|FG000|Overall Study|Adverse Event|0|||
146306052|NCT01961349|527634149|FG001|Overall Study|Adverse Event|0|||
146306053|NCT01961349|527634150|FG002|Overall Study|Adverse Event|1|||
146306054|NCT01961349|527634148|FG000|Overall Study|registration error, personal reason etc|2|||
146306055|NCT01961349|527634149|FG001|Overall Study|registration error, personal reason etc|2|||
146278945|NCT01142232|527536804|FG000|Overall Study|Withdrawal by Subject|0|||
146278946|NCT01142232|527536805|FG001|Overall Study|Withdrawal by Subject|0|||
146278947|NCT01142232|527536806|FG002|Overall Study|Withdrawal by Subject|0|||
146278948|NCT01142232|527536807|FG003|Overall Study|Withdrawal by Subject|1|||
146278949|NCT01142232|527536808|FG004|Overall Study|Withdrawal by Subject|3|||
146278950|NCT01142232|527536804|FG000|Overall Study|Physician Decision|0|||
146278951|NCT01142232|527536805|FG001|Overall Study|Physician Decision|1|||
146278952|NCT01142232|527536806|FG002|Overall Study|Physician Decision|0|||
146278953|NCT01142232|527536807|FG003|Overall Study|Physician Decision|2|||
146278954|NCT01142232|527536808|FG004|Overall Study|Physician Decision|10|||
146278955|NCT01142232|527536804|FG000|Overall Study|Alternative Therapy|0|||
146278956|NCT01142232|527536805|FG001|Overall Study|Alternative Therapy|1|||
146278957|NCT01142232|527536806|FG002|Overall Study|Alternative Therapy|1|||
146278958|NCT01142232|527536807|FG003|Overall Study|Alternative Therapy|0|||
146278959|NCT01142232|527536808|FG004|Overall Study|Alternative Therapy|1|||
146278960|NCT01142232|527536804|FG000|Overall Study|Off Trt for other complicating disease|0|||
146278961|NCT01142232|527536805|FG001|Overall Study|Off Trt for other complicating disease|0|||
146278962|NCT01142232|527536806|FG002|Overall Study|Off Trt for other complicating disease|0|||
146278963|NCT01142232|527536807|FG003|Overall Study|Off Trt for other complicating disease|0|||
146278964|NCT01142232|527536808|FG004|Overall Study|Off Trt for other complicating disease|1|||
146278965|NCT01142232|527536804|FG000|Overall Study|Noncompliance|0|||
146278966|NCT01142232|527536805|FG001|Overall Study|Noncompliance|0|||
146278967|NCT01142232|527536806|FG002|Overall Study|Noncompliance|0|||
146278968|NCT01142232|527536807|FG003|Overall Study|Noncompliance|0|||
146278969|NCT01142232|527536808|FG004|Overall Study|Noncompliance|2|||
146278970|NCT00626990|527536809|FG000|Overall Study|Lack of Efficacy|6|||
146278971|NCT00626990|527536810|FG001|Overall Study|Lack of Efficacy|7|||
146278972|NCT00626990|527536811|FG002|Overall Study|Lack of Efficacy|49|||
146278973|NCT00626990|527536812|FG003|Overall Study|Lack of Efficacy|40|||
146278974|NCT00626990|527536809|FG000|Overall Study|Adverse Event|1|||
146278975|NCT00626990|527536810|FG001|Overall Study|Adverse Event|7|||
146278976|NCT00626990|527536811|FG002|Overall Study|Adverse Event|14|||
146278977|NCT00626990|527536812|FG003|Overall Study|Adverse Event|28|||
146278978|NCT00626990|527536809|FG000|Overall Study|Death|0|||
146278979|NCT00626990|527536810|FG001|Overall Study|Death|1|||
146278980|NCT00626990|527536811|FG002|Overall Study|Death|0|||
146278981|NCT00626990|527536812|FG003|Overall Study|Death|0|||
146278982|NCT00626990|527536809|FG000|Overall Study|Withdrawal by Subject|3|||
146278983|NCT00626990|527536810|FG001|Overall Study|Withdrawal by Subject|1|||
146278984|NCT00626990|527536811|FG002|Overall Study|Withdrawal by Subject|5|||
146278985|NCT00626990|527536812|FG003|Overall Study|Withdrawal by Subject|11|||
146278986|NCT00626990|527536809|FG000|Overall Study|Protocol Violation|0|||
146278987|NCT00626990|527536810|FG001|Overall Study|Protocol Violation|1|||
146278988|NCT00626990|527536811|FG002|Overall Study|Protocol Violation|1|||
146278989|NCT00626990|527536812|FG003|Overall Study|Protocol Violation|0|||
146278990|NCT00626990|527536809|FG000|Overall Study|Various different reasons/missing|4|||
146278991|NCT00626990|527536810|FG001|Overall Study|Various different reasons/missing|8|||
146278992|NCT00626990|527536811|FG002|Overall Study|Various different reasons/missing|8|||
146278993|NCT00626990|527536812|FG003|Overall Study|Various different reasons/missing|16|||
146278994|NCT04138576|527536813|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
146278995|NCT01994837|527536814|FG000|Overall Study|Progressive disease per protocol|23|||
146278996|NCT01994837|527536814|FG000|Overall Study|Adv event related to progressive disease|3|||
146278997|NCT01994837|527536814|FG000|Overall Study|Fatal progressive disease|2|||
146278998|NCT01994837|527536814|FG000|Overall Study|Adverse event not related to progression|1|||
146278999|NCT01994837|527536814|FG000|Overall Study|Chose palliative care|1|||
146279000|NCT01994837|527536814|FG000|Overall Study|Proceeded to transplant|1|||
146279001|NCT01994837|527536814|FG000|Overall Study|Removed from study due to no response|1|||
146279002|NCT00574873|527536816|FG000|Overall Study|Withdrawal by Subject|18|||
146279003|NCT00574873|527536817|FG001|Overall Study|Withdrawal by Subject|19|||
146279004|NCT00574873|527536816|FG000|Overall Study|Investigator request|18|||
146279005|NCT00574873|527536817|FG001|Overall Study|Investigator request|8|||
146279006|NCT00574873|527536816|FG000|Overall Study|Death|15|||
146279007|NCT00574873|527536817|FG001|Overall Study|Death|14|||
146279008|NCT00574873|527536816|FG000|Overall Study|Lost to Follow-up|14|||
146279009|NCT00574873|527536817|FG001|Overall Study|Lost to Follow-up|5|||
146279010|NCT00574873|527536816|FG000|Overall Study|Other|40|||
146279011|NCT00574873|527536817|FG001|Overall Study|Other|4|||
146279012|NCT00574873|527536816|FG000|Overall Study|Discontinuation of study by sponsor|5|||
146279013|NCT00574873|527536817|FG001|Overall Study|Discontinuation of study by sponsor|199|||
146279014|NCT00574873|527536816|FG000|Overall Study|Blank, site closed per local regulations|2|||
146279015|NCT00574873|527536817|FG001|Overall Study|Blank, site closed per local regulations|2|||
146279016|NCT00574873|527536816|FG000|Overall Study|Extension Study|126|||
146279017|NCT00574873|527536817|FG001|Overall Study|Extension Study|0|||
146279018|NCT00581555|527536819|FG000|Overall Study|Adverse Event|4|||
146279019|NCT00581555|527536820|FG001|Overall Study|Adverse Event|3|||
146279020|NCT00581555|527536819|FG000|Overall Study|Physician Decision|3|||
146151696|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151697|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151698|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151699|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151700|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151701|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151702|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151703|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151704|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151705|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151706|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151707|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
146151708|NCT01490632|527067729|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151709|NCT01490632|527067730|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151710|NCT01490632|527067731|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151711|NCT01490632|527067732|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151712|NCT01490632|527067733|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
146151713|NCT01490632|527067734|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151714|NCT01490632|527067735|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151715|NCT01490632|527067736|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151716|NCT01490632|527067737|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151717|NCT01490632|527067738|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151718|NCT01490632|527067739|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151719|NCT01490632|527067740|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151720|NCT01490632|527067741|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146279021|NCT00581555|527536820|FG001|Overall Study|Physician Decision|2|||
146279022|NCT00581555|527536819|FG000|Overall Study|Withdrawal by Subject|18|||
146279023|NCT00581555|527536820|FG001|Overall Study|Withdrawal by Subject|9|||
146279024|NCT00581555|527536819|FG000|Overall Study|Lost to Follow-up|2|||
146279025|NCT00581555|527536820|FG001|Overall Study|Lost to Follow-up|2|||
146279026|NCT00581555|527536819|FG000|Overall Study|Other reasons|16|||
146279027|NCT00581555|527536820|FG001|Overall Study|Other reasons|4|||
146279028|NCT00201643|527536821|FG000|Overall Study|Withdrawal by Subject|5|||
146279029|NCT00201643|527536822|FG001|Overall Study|Withdrawal by Subject|4|||
146279030|NCT03446781|527536823|FG000|Overall Study|Lost to Follow-up|11|||
146279031|NCT03446781|527536824|FG001|Overall Study|Lost to Follow-up|5|||
146279032|NCT03446781|527536823|FG000|Overall Study|Withdrawal by Subject|9|||
146279033|NCT03446781|527536824|FG001|Overall Study|Withdrawal by Subject|7|||
146279034|NCT03446781|527536823|FG000|Overall Study|Adverse Event|8|||
146279035|NCT03446781|527536824|FG001|Overall Study|Adverse Event|2|||
146279036|NCT03446781|527536823|FG000|Overall Study|Protocol Violation|0|||
146279037|NCT03446781|527536824|FG001|Overall Study|Protocol Violation|3|||
146279038|NCT03568318|527536831|FG000|Overall Study|Adverse Event|3|||
146279039|NCT03568318|527536832|FG001|Overall Study|Adverse Event|1|||
146279040|NCT03568318|527536833|FG002|Overall Study|Adverse Event|1|||
146279041|NCT03568318|527536834|FG003|Overall Study|Adverse Event|0|||
146279042|NCT03568318|527536835|FG004|Overall Study|Adverse Event|1|||
146279043|NCT03568318|527536836|FG005|Overall Study|Adverse Event|0|||
146279044|NCT03568318|527536831|FG000|Overall Study|Withdrawal by Subject|6|||
146279045|NCT03568318|527536832|FG001|Overall Study|Withdrawal by Subject|5|||
146279046|NCT03568318|527536833|FG002|Overall Study|Withdrawal by Subject|2|||
146279047|NCT03568318|527536834|FG003|Overall Study|Withdrawal by Subject|1|||
146279048|NCT03568318|527536835|FG004|Overall Study|Withdrawal by Subject|0|||
146279049|NCT03568318|527536836|FG005|Overall Study|Withdrawal by Subject|0|||
146279050|NCT03568318|527536831|FG000|Overall Study|Lost to Follow-up|3|||
146279051|NCT03568318|527536832|FG001|Overall Study|Lost to Follow-up|2|||
146279052|NCT03568318|527536833|FG002|Overall Study|Lost to Follow-up|2|||
146279053|NCT03568318|527536834|FG003|Overall Study|Lost to Follow-up|2|||
146279054|NCT03568318|527536835|FG004|Overall Study|Lost to Follow-up|1|||
146279055|NCT03568318|527536836|FG005|Overall Study|Lost to Follow-up|0|||
146279056|NCT03568318|527536831|FG000|Overall Study|Other|3|||
146279057|NCT03568318|527536832|FG001|Overall Study|Other|1|||
146279058|NCT03568318|527536833|FG002|Overall Study|Other|3|||
146279059|NCT03568318|527536834|FG003|Overall Study|Other|0|||
146279060|NCT03568318|527536835|FG004|Overall Study|Other|0|||
146279061|NCT03568318|527536836|FG005|Overall Study|Other|0|||
146279062|NCT03568318|527536831|FG000|Overall Study|Ongoing at Time of Analysis|5|||
146279063|NCT03568318|527536832|FG001|Overall Study|Ongoing at Time of Analysis|3|||
146279064|NCT03568318|527536833|FG002|Overall Study|Ongoing at Time of Analysis|2|||
146279065|NCT03568318|527536834|FG003|Overall Study|Ongoing at Time of Analysis|1|||
146306056|NCT01961349|527634150|FG002|Overall Study|registration error, personal reason etc|1|||
146306057|NCT00829179|527634151|FG000|Overall Study|Withdrawal by Subject|1|||
146306058|NCT00596947|527634152|FG000|Overall Study|study halted due to low enrollment|5|||
146306059|NCT00596947|527634153|FG001|Overall Study|study halted due to low enrollment|3|||
146306060|NCT00596947|527634152|FG000|Overall Study|Lost to Follow-up|1|||
146306061|NCT00596947|527634153|FG001|Overall Study|Lost to Follow-up|0|||
146306062|NCT03000179|527634154|FG000|Overall Study|Lost to Follow-up|2|||
146306063|NCT02343159|527634155|FG000|Overall Study|Early Study Termination|16|||
146306064|NCT02343159|527634156|FG001|Overall Study|Early Study Termination|19|||
146306065|NCT02343159|527634157|FG002|Overall Study|Early Study Termination|23|||
146306066|NCT02343159|527634155|FG000|Overall Study|Physician Decision|2|||
146306067|NCT02343159|527634156|FG001|Overall Study|Physician Decision|0|||
146306068|NCT02343159|527634157|FG002|Overall Study|Physician Decision|1|||
146306069|NCT02343159|527634155|FG000|Overall Study|Withdrawal by Subject|3|||
146306070|NCT02343159|527634156|FG001|Overall Study|Withdrawal by Subject|0|||
146306071|NCT02343159|527634157|FG002|Overall Study|Withdrawal by Subject|2|||
146306072|NCT02343159|527634155|FG000|Overall Study|Lost to Follow-up|0|||
146306073|NCT02343159|527634156|FG001|Overall Study|Lost to Follow-up|2|||
146306074|NCT02343159|527634157|FG002|Overall Study|Lost to Follow-up|2|||
146306075|NCT02343159|527634155|FG000|Overall Study|Adverse Event|4|||
146306076|NCT02343159|527634156|FG001|Overall Study|Adverse Event|4|||
146306077|NCT02343159|527634157|FG002|Overall Study|Adverse Event|2|||
146306078|NCT02343159|527634155|FG000|Overall Study|Sponsor Decision|0|||
146306079|NCT02343159|527634156|FG001|Overall Study|Sponsor Decision|1|||
146306080|NCT02343159|527634157|FG002|Overall Study|Sponsor Decision|0|||
146306081|NCT02343159|527634155|FG000|Overall Study|Enrollment Error|1|||
146306082|NCT02343159|527634156|FG001|Overall Study|Enrollment Error|0|||
146306083|NCT02343159|527634157|FG002|Overall Study|Enrollment Error|0|||
146306084|NCT00545064|527634165|FG000|Overall Study|Lost to Follow-up|3|||
146306085|NCT00545064|527634165|FG000|Overall Study|Withdrawal by Subject|2|||
146306086|NCT00545064|527634165|FG000|Overall Study|did not complete course of treatment|1|||
146306087|NCT00545064|527634165|FG000|Overall Study|cancel all appointments, no rebooking|1|||
146306088|NCT00545064|527634165|FG000|Overall Study|inclement weather|1|||
146306089|NCT04688775|527634168|FG000|Placebo-controlled Period|Randomized, not treated|1|||
146306090|NCT04688775|527634169|FG001|Placebo-controlled Period|Randomized, not treated|1|||
146306091|NCT04688775|527634170|FG002|Placebo-controlled Period|Randomized, not treated|0|||
146306092|NCT04688775|527634171|FG003|Placebo-controlled Period|Randomized, not treated|0|||
146306093|NCT04688775|527634168|FG000|Placebo-controlled Period|Adverse Event|2|||
146306094|NCT04688775|527634169|FG001|Placebo-controlled Period|Adverse Event|0|||
146306095|NCT04688775|527634170|FG002|Placebo-controlled Period|Adverse Event|0|||
146306096|NCT04688775|527634171|FG003|Placebo-controlled Period|Adverse Event|0|||
146306097|NCT04688775|527634168|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
146306098|NCT04688775|527634169|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
146306099|NCT04688775|527634170|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
146306100|NCT04688775|527634171|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
146306101|NCT04688775|527634168|FG000|Placebo-controlled Period|Protocol Violation|0|||
146306102|NCT04688775|527634169|FG001|Placebo-controlled Period|Protocol Violation|1|||
146306103|NCT04688775|527634170|FG002|Placebo-controlled Period|Protocol Violation|0|||
146306104|NCT04688775|527634171|FG003|Placebo-controlled Period|Protocol Violation|0|||
146306105|NCT04688775|527634168|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
146306106|NCT04688775|527634169|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
146306107|NCT04688775|527634170|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
146306108|NCT04688775|527634171|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
146306109|NCT04688775|527634168|FG000|Placebo-controlled Period|Other reasons|0|||
146306110|NCT04688775|527634169|FG001|Placebo-controlled Period|Other reasons|1|||
146306111|NCT04688775|527634170|FG002|Placebo-controlled Period|Other reasons|0|||
146306112|NCT04688775|527634171|FG003|Placebo-controlled Period|Other reasons|0|||
146306113|NCT04688775|527634168|FG000|Delayed Start Period|Adverse Event|0|||
146306114|NCT04688775|527634169|FG001|Delayed Start Period|Adverse Event|0|||
146306115|NCT04688775|527634170|FG002|Delayed Start Period|Adverse Event|1|||
146306116|NCT04688775|527634171|FG003|Delayed Start Period|Adverse Event|0|||
146306117|NCT04688775|527634168|FG000|Delayed Start Period|Lack of Efficacy|0|||
146306118|NCT04688775|527634169|FG001|Delayed Start Period|Lack of Efficacy|0|||
146306119|NCT04688775|527634170|FG002|Delayed Start Period|Lack of Efficacy|0|||
146306120|NCT04688775|527634171|FG003|Delayed Start Period|Lack of Efficacy|3|||
146306121|NCT04688775|527634168|FG000|Delayed Start Period|Withdrawal by Subject|0|||
146306122|NCT04688775|527634169|FG001|Delayed Start Period|Withdrawal by Subject|0|||
146306123|NCT04688775|527634170|FG002|Delayed Start Period|Withdrawal by Subject|2|||
146306124|NCT04688775|527634171|FG003|Delayed Start Period|Withdrawal by Subject|4|||
146306125|NCT04688775|527634168|FG000|Delayed Start Period|Lost to Follow-up|0|||
146306126|NCT04688775|527634169|FG001|Delayed Start Period|Lost to Follow-up|0|||
146306127|NCT04688775|527634170|FG002|Delayed Start Period|Lost to Follow-up|2|||
146306128|NCT04688775|527634171|FG003|Delayed Start Period|Lost to Follow-up|1|||
146306129|NCT04688775|527634168|FG000|Delayed Start Period|other reasons|0|||
146306130|NCT04688775|527634169|FG001|Delayed Start Period|other reasons|0|||
146306131|NCT04688775|527634170|FG002|Delayed Start Period|other reasons|1|||
146306132|NCT04688775|527634171|FG003|Delayed Start Period|other reasons|0|||
146306133|NCT01843972|527634172|FG000|Overall Study|Withdrawal by Subject|0|||
146306134|NCT01843972|527634173|FG001|Overall Study|Withdrawal by Subject|0|||
146306135|NCT01843972|527634174|FG002|Overall Study|Withdrawal by Subject|0|||
146306136|NCT01843972|527634175|FG003|Overall Study|Withdrawal by Subject|0|||
146306137|NCT01843972|527634176|FG004|Overall Study|Withdrawal by Subject|1|||
146306138|NCT01843972|527634177|FG005|Overall Study|Withdrawal by Subject|0|||
146306139|NCT01843972|527634178|FG006|Overall Study|Withdrawal by Subject|0|||
146306140|NCT01843972|527634179|FG007|Overall Study|Withdrawal by Subject|0|||
146306141|NCT01843972|527634180|FG008|Overall Study|Withdrawal by Subject|0|||
146306142|NCT01843972|527634181|FG009|Overall Study|Withdrawal by Subject|0|||
146306143|NCT01854645|527634182|FG000|Overall Study|Protocol-Specified Criteria|13|||
146306144|NCT01854645|527634183|FG001|Overall Study|Protocol-Specified Criteria|10|||
146306145|NCT01854645|527634184|FG002|Overall Study|Protocol-Specified Criteria|8|||
146306146|NCT01854645|527634185|FG003|Overall Study|Protocol-Specified Criteria|5|||
146306147|NCT01854645|527634186|FG004|Overall Study|Protocol-Specified Criteria|7|||
146306148|NCT01854645|527634182|FG000|Overall Study|Administrative Reasons / Missing|0|||
146306149|NCT01854645|527634183|FG001|Overall Study|Administrative Reasons / Missing|0|||
146306150|NCT01854645|527634184|FG002|Overall Study|Administrative Reasons / Missing|0|||
146306151|NCT01854645|527634185|FG003|Overall Study|Administrative Reasons / Missing|1|||
146306152|NCT01854645|527634186|FG004|Overall Study|Administrative Reasons / Missing|1|||
146306153|NCT01854645|527634182|FG000|Overall Study|Protocol Violation|3|||
146306154|NCT01854645|527634183|FG001|Overall Study|Protocol Violation|0|||
146306155|NCT01854645|527634184|FG002|Overall Study|Protocol Violation|5|||
146306156|NCT01854645|527634185|FG003|Overall Study|Protocol Violation|4|||
146306157|NCT01854645|527634186|FG004|Overall Study|Protocol Violation|1|||
146306158|NCT01854645|527634182|FG000|Overall Study|Lost to Follow-up|10|||
146306159|NCT01854645|527634183|FG001|Overall Study|Lost to Follow-up|7|||
146306160|NCT01854645|527634184|FG002|Overall Study|Lost to Follow-up|8|||
146306161|NCT01854645|527634185|FG003|Overall Study|Lost to Follow-up|5|||
146306162|NCT01854645|527634186|FG004|Overall Study|Lost to Follow-up|0|||
146306163|NCT01854645|527634182|FG000|Overall Study|Physician Decision|1|||
146306164|NCT01854645|527634183|FG001|Overall Study|Physician Decision|5|||
146306165|NCT01854645|527634184|FG002|Overall Study|Physician Decision|3|||
146306166|NCT01854645|527634185|FG003|Overall Study|Physician Decision|3|||
146306167|NCT01854645|527634186|FG004|Overall Study|Physician Decision|7|||
146306168|NCT01854645|527634182|FG000|Overall Study|Withdrawal by Subject|31|||
146306169|NCT01854645|527634183|FG001|Overall Study|Withdrawal by Subject|41|||
146306170|NCT01854645|527634184|FG002|Overall Study|Withdrawal by Subject|30|||
146306171|NCT01854645|527634185|FG003|Overall Study|Withdrawal by Subject|21|||
146306172|NCT01854645|527634186|FG004|Overall Study|Withdrawal by Subject|24|||
146306173|NCT01854645|527634182|FG000|Overall Study|Lack of Efficacy|7|||
146306174|NCT01854645|527634183|FG001|Overall Study|Lack of Efficacy|12|||
146306175|NCT01854645|527634184|FG002|Overall Study|Lack of Efficacy|9|||
146306176|NCT01854645|527634185|FG003|Overall Study|Lack of Efficacy|3|||
146306177|NCT01854645|527634186|FG004|Overall Study|Lack of Efficacy|9|||
146306178|NCT01854645|527634182|FG000|Overall Study|Adverse Event|33|||
146306179|NCT01854645|527634183|FG001|Overall Study|Adverse Event|31|||
146306180|NCT01854645|527634184|FG002|Overall Study|Adverse Event|19|||
146306181|NCT01854645|527634185|FG003|Overall Study|Adverse Event|20|||
146306182|NCT01854645|527634186|FG004|Overall Study|Adverse Event|11|||
146306183|NCT01846624|527634191|FG000|Overall Study|Died during induction, no midostaurin|1|||
146306184|NCT04702737|527634192|FG000|Overall Study|Decision by Sponsor|1|||
146306185|NCT04702737|527634192|FG000|Overall Study|Withdrawal of Consent from Study|3|||
146306186|NCT04702737|527634192|FG000|Overall Study|Lost to Follow-up|1|||
146306187|NCT04702737|527634192|FG000|Overall Study|Death|35|||
146306188|NCT01177683|527634193|FG000|Study Treatment|Disease Progressions during treatment|2|||
146151721|NCT01490632|527067742|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151722|NCT01490632|527067743|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146306189|NCT01177683|527634194|FG001|Study Treatment|Disease Progressions during treatment|0|||
146306190|NCT01177683|527634195|FG002|Study Treatment|Disease Progressions during treatment|3|||
146151723|NCT01490632|527067744|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151724|NCT01490632|527067745|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146306191|NCT01177683|527634193|FG000|Study Treatment|Adverse Event|0|||
146306192|NCT01177683|527634194|FG001|Study Treatment|Adverse Event|1|||
146306193|NCT01177683|527634195|FG002|Study Treatment|Adverse Event|12|||
146306194|NCT01177683|527634193|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
146306195|NCT01177683|527634194|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
146306196|NCT01177683|527634195|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
146306197|NCT01177683|527634193|FG000|Study Treatment|Alternative therapy|0|||
146306198|NCT01177683|527634194|FG001|Study Treatment|Alternative therapy|0|||
146306199|NCT01177683|527634195|FG002|Study Treatment|Alternative therapy|4|||
146306200|NCT01177683|527634193|FG000|Study Treatment|Physician Decision|1|||
146306201|NCT01177683|527634194|FG001|Study Treatment|Physician Decision|0|||
146151725|NCT01490632|527067746|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151726|NCT01490632|527067747|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151727|NCT01490632|527067748|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
146151728|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151729|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151730|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151731|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151732|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151733|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
146151734|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
146151735|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151736|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151737|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
146151738|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
146151739|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
146151740|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151741|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151742|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151743|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151744|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151745|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151746|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151747|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
146151748|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151749|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151750|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151751|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151752|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151753|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151754|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146151755|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151756|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146151757|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
146151758|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
146151759|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151760|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151761|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151762|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151763|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151764|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151765|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151766|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151767|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
146151768|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151769|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151770|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151771|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151772|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151773|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151774|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
146151775|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151776|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151777|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
146151778|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151779|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151780|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151781|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151782|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151783|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151784|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151785|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151786|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151787|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
146151788|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151789|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151790|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
146306202|NCT01177683|527634195|FG002|Study Treatment|Physician Decision|1|||
146306203|NCT01177683|527634193|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
146306204|NCT01177683|527634194|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
146306205|NCT01177683|527634195|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
146306206|NCT01177683|527634193|FG000|Study Treatment|Symptomatic Deterioration|0|||
146306207|NCT01177683|527634194|FG001|Study Treatment|Symptomatic Deterioration|0|||
146306208|NCT01177683|527634195|FG002|Study Treatment|Symptomatic Deterioration|1|||
146306209|NCT01177683|527634193|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
146306210|NCT01177683|527634194|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
146306211|NCT01177683|527634195|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
146306212|NCT01177683|527634193|FG000|Follow up|Patient lost to follow up|0|||
146306213|NCT01177683|527634194|FG001|Follow up|Patient lost to follow up|0|||
146306214|NCT01177683|527634195|FG002|Follow up|Patient lost to follow up|2|||
146306215|NCT01177683|527634193|FG000|Follow up|Death|2|||
146306216|NCT01177683|527634194|FG001|Follow up|Death|1|||
146306217|NCT01177683|527634195|FG002|Follow up|Death|7|||
146306218|NCT01177683|527634193|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
146306219|NCT01177683|527634194|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
146306220|NCT01177683|527634195|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
146306221|NCT01977820|527634199|FG000|Overall Study|Sponsor terminated the study|1|||
146306222|NCT01977820|527634200|FG001|Overall Study|Sponsor terminated the study|1|||
146306223|NCT02568475|527634204|FG000|Overall Study|Lost to Follow-up|40|||
146306224|NCT02568475|527634205|FG001|Overall Study|Lost to Follow-up|39|||
146306225|NCT02568475|527634204|FG000|Overall Study|Withdrawal by Subject|2|||
146306226|NCT02568475|527634205|FG001|Overall Study|Withdrawal by Subject|0|||
146306227|NCT02568475|527634204|FG000|Overall Study|Discharged home|4|||
146306228|NCT02568475|527634205|FG001|Overall Study|Discharged home|4|||
146306229|NCT02568475|527634204|FG000|Overall Study|Short-term: Discharge location unknown|4|||
146306230|NCT02568475|527634205|FG001|Overall Study|Short-term: Discharge location unknown|0|||
146306231|NCT02568475|527634204|FG000|Overall Study|Transferred to another facility|1|||
146306232|NCT02568475|527634205|FG001|Overall Study|Transferred to another facility|0|||
146306233|NCT02625233|527634206|FG000|Overall Study|Adverse Event|2|||
146306234|NCT02625233|527634207|FG001|Overall Study|Adverse Event|0|||
146306235|NCT04425720|527634215|FG000|Overall Study|Withdrawal by Subject|0|||
146306236|NCT04425720|527634216|FG001|Overall Study|Withdrawal by Subject|20|||
146306237|NCT00290186|527634217|FG000|Overall Study|Adverse Event|1|||
146306238|NCT00290186|527634218|FG001|Overall Study|Adverse Event|1|||
146306239|NCT00290186|527634217|FG000|Overall Study|Lost to Follow-up|3|||
146306240|NCT00290186|527634218|FG001|Overall Study|Lost to Follow-up|2|||
146306241|NCT00290186|527634217|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
146306242|NCT00290186|527634218|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
146306243|NCT00290186|527634217|FG000|Overall Study|Withdrawal by Subject|0|||
146306244|NCT00290186|527634218|FG001|Overall Study|Withdrawal by Subject|1|||
146306245|NCT03184077|527634221|FG000|Overall Study|Lost to Follow-up|21|||
146306246|NCT03184077|527634222|FG001|Overall Study|Lost to Follow-up|21|||
146306247|NCT00262522|527634223|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
146306248|NCT00262522|527634224|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
146306249|NCT00262522|527634225|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
146306250|NCT00262522|527634226|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
146306251|NCT00262522|527634223|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
146306252|NCT00262522|527634224|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
146306253|NCT00262522|527634225|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
146306254|NCT00262522|527634226|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
146306255|NCT00262522|527634223|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
146306256|NCT00262522|527634224|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
146306257|NCT00262522|527634225|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
146306258|NCT00262522|527634226|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
146306259|NCT00262522|527634223|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
146306260|NCT00262522|527634224|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
146306261|NCT00262522|527634225|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
146306262|NCT00262522|527634226|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
146306263|NCT00262522|527634223|FG000|Study Start Through 8 Weeks|Death|1|||
146306264|NCT00262522|527634224|FG001|Study Start Through 8 Weeks|Death|0|||
146306265|NCT00262522|527634225|FG002|Study Start Through 8 Weeks|Death|0|||
146306266|NCT00262522|527634226|FG003|Study Start Through 8 Weeks|Death|0|||
146306267|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
146306268|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
146151791|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151792|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151793|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
146306269|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
146306270|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
146306271|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
146306272|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
146306273|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
146306274|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
146306275|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
146306276|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
146306277|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
146306278|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
146306279|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
146306280|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
146306281|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
146306282|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
146306283|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Death|2|||
146306284|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Death|0|||
146306285|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Death|1|||
146306286|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Death|0|||
146306287|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
146306288|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
146306289|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
146306290|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
146306291|NCT00262522|527634223|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
146306292|NCT00262522|527634224|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
146306293|NCT00262522|527634225|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
146306294|NCT00262522|527634226|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
146306295|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
146306296|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
146306297|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
146306298|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
146306299|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
146306300|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
146306301|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
146306302|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
146306303|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
146306304|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
146306305|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
146306306|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
146306307|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
146306308|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
146306309|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
146306310|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
146306311|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Death|2|||
146306312|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Death|0|||
146306313|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Death|2|||
146306314|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Death|0|||
146306315|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
146306316|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
146306317|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
146306318|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
146306319|NCT00262522|527634223|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
146306320|NCT00262522|527634224|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
146306321|NCT00262522|527634225|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
146306322|NCT00262522|527634226|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
146306323|NCT02269787|527634235|FG000|Overall Study|Lost to Follow-up|20|||
146306324|NCT02269787|527634236|FG001|Overall Study|Lost to Follow-up|6|||
146306325|NCT02269787|527634235|FG000|Overall Study|Death|2|||
146151794|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
146151795|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151796|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151797|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151798|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151799|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151800|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151801|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151802|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151803|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
146306326|NCT02269787|527634236|FG001|Overall Study|Death|3|||
146306327|NCT02269787|527634235|FG000|Overall Study|Incapacitated|0|||
146306328|NCT02269787|527634236|FG001|Overall Study|Incapacitated|1|||
146306329|NCT00798135|527634237|FG000|Overall Study|Disease progression, relapse|11|||
146306330|NCT00798135|527634237|FG000|Overall Study|Disease progression, refractory|1|||
146151804|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151805|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151806|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151807|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
146151808|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151809|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151810|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151811|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151812|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151813|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
146306331|NCT00798135|527634237|FG000|Overall Study|Physician Decision|1|||
146306332|NCT00687440|527634238|FG000|Overall Study|Adverse Event|3|||
146306333|NCT00687440|527634238|FG000|Overall Study|Lost to Follow-up|3|||
146306334|NCT00687440|527634238|FG000|Overall Study|Lack of Efficacy|2|||
146306335|NCT00687440|527634238|FG000|Overall Study|Death|2|||
146306336|NCT00687440|527634238|FG000|Overall Study|Other|1|||
146306337|NCT00687440|527634238|FG000|Overall Study|Missing|1|||
146306338|NCT02228720|527634239|FG000|Open Label - Day 30|Lost to Follow-up|1|||
146306339|NCT04360551|527635708|FG000|Overall Study|Withdrawal by Subject|1|||
146306340|NCT04360551|527635709|FG001|Overall Study|Withdrawal by Subject|0|||
146306341|NCT00404820|527635728|FG000|Overall Study|Adverse Event|4|||
146306342|NCT00404820|527635729|FG001|Overall Study|Adverse Event|16|||
146306343|NCT00404820|527635728|FG000|Overall Study|Withdrawal by Subject|5|||
146306344|NCT00404820|527635729|FG001|Overall Study|Withdrawal by Subject|3|||
146306345|NCT00404820|527635728|FG000|Overall Study|Lost to Follow-up|7|||
146306346|NCT00404820|527635729|FG001|Overall Study|Lost to Follow-up|3|||
146306347|NCT00404820|527635728|FG000|Overall Study|Administrative problems|2|||
146306348|NCT00404820|527635729|FG001|Overall Study|Administrative problems|0|||
146306349|NCT00404820|527635728|FG000|Overall Study|Death|1|||
146306350|NCT00404820|527635729|FG001|Overall Study|Death|0|||
146306351|NCT00404820|527635728|FG000|Overall Study|Other|0|||
146306352|NCT00404820|527635729|FG001|Overall Study|Other|2|||
146306353|NCT01321710|527635731|FG000|Overall Study|Lost to Follow-up|4|||
146306354|NCT01321710|527635732|FG001|Overall Study|Lost to Follow-up|5|||
146306355|NCT01321710|527635733|FG002|Overall Study|Lost to Follow-up|0|||
146306356|NCT01566773|527635735|FG000|Overall Study|Protocol specified criteria|4|||
146306357|NCT01566773|527635735|FG000|Overall Study|Protocol Violation|4|||
146306358|NCT01566773|527635735|FG000|Overall Study|Withdrawal by Subject|9|||
146306359|NCT01566773|527635735|FG000|Overall Study|Administrative reason|1|||
146306360|NCT01566773|527635735|FG000|Overall Study|Adverse Event|10|||
146306361|NCT01566773|527635735|FG000|Overall Study|Physician Decision|2|||
146306362|NCT00003535|527635736|FG000|Overall Study|Not evaluable|5|||
146306363|NCT02289742|527635741|FG000|First Wear Period|Adverse event prior to treatment|0|||
146306364|NCT02289742|527635742|FG001|First Wear Period|Adverse event prior to treatment|1|||
146306365|NCT02289742|527635743|FG002|First Wear Period|Adverse event prior to treatment|0|||
146306366|NCT02289742|527635744|FG003|First Wear Period|Adverse event prior to treatment|0|||
146306367|NCT02289742|527635741|FG000|First Wear Period|Adverse Event|0|||
146306368|NCT02289742|527635742|FG001|First Wear Period|Adverse Event|0|||
146306369|NCT02289742|527635743|FG002|First Wear Period|Adverse Event|1|||
146306370|NCT02289742|527635744|FG003|First Wear Period|Adverse Event|0|||
146306371|NCT02289742|527635741|FG000|First Wear Period|Other prior to treatment|0|||
146306372|NCT02289742|527635742|FG001|First Wear Period|Other prior to treatment|0|||
146306373|NCT02289742|527635743|FG002|First Wear Period|Other prior to treatment|0|||
146306374|NCT02289742|527635744|FG003|First Wear Period|Other prior to treatment|1|||
146306375|NCT02289742|527635741|FG000|Third Wear Period|Adverse Event|0|||
146306376|NCT02289742|527635742|FG001|Third Wear Period|Adverse Event|1|||
146306377|NCT02289742|527635743|FG002|Third Wear Period|Adverse Event|0|||
146306378|NCT02289742|527635744|FG003|Third Wear Period|Adverse Event|0|||
146306379|NCT02289742|527635741|FG000|Third Wear Period|Reason not given|0|||
146306380|NCT02289742|527635742|FG001|Third Wear Period|Reason not given|0|||
146151814|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151815|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151816|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151817|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146306381|NCT02289742|527635743|FG002|Third Wear Period|Reason not given|0|||
146306382|NCT02289742|527635744|FG003|Third Wear Period|Reason not given|1|||
146306383|NCT02865018|527635745|FG000|Overall Study|Withdrawal by Subject|1|||
146306384|NCT01365039|527635746|FG000|Overall Study|Study related symptoms and complaints|1|||
146306385|NCT01365039|527635747|FG001|Overall Study|Study related symptoms and complaints|0|||
146306386|NCT00294060|527635748|FG000|Overall Study|Death|225|||
146306387|NCT00294060|527635748|FG000|Overall Study|Other|59|||
146306388|NCT00294060|527635748|FG000|Overall Study|Lost to Follow-up|55|||
146306389|NCT00294060|527635748|FG000|Overall Study|Withdrawal by Subject|11|||
146306390|NCT00294060|527635748|FG000|Overall Study|Physician Decision|797|||
146306391|NCT00294060|527635748|FG000|Overall Study|Medical condition|3|||
146306392|NCT00294060|527635748|FG000|Overall Study|Device explanted/not replaced|23|||
146306393|NCT00187096|527635749|FG000|Overall Study|unacceptable toxicity|0|||
146306394|NCT00187096|527635750|FG001|Overall Study|unacceptable toxicity|0|||
146306395|NCT00187096|527635751|FG002|Overall Study|unacceptable toxicity|1|||
146306396|NCT00424749|527635760|FG000|Overall Study|Withdrawal by Subject|1|||
146306397|NCT02577406|527635761|FG000|Randomized Period|Death|1|||
146306398|NCT02577406|527635762|FG001|Randomized Period|Death|0|||
146306399|NCT02577406|527635761|FG000|Randomized Period|Other reasons|0|||
146306400|NCT02577406|527635762|FG001|Randomized Period|Other reasons|20|||
146306401|NCT02577406|527635761|FG000|Treatment Period|Death|38|||
146306402|NCT02577406|527635762|FG001|Treatment Period|Death|23|||
146306403|NCT02577406|527635761|FG000|Treatment Period|Adverse Event|17|||
146306404|NCT02577406|527635762|FG001|Treatment Period|Adverse Event|12|||
146306405|NCT02577406|527635761|FG000|Treatment Period|Progressive Disease|53|||
146306406|NCT02577406|527635762|FG001|Treatment Period|Progressive Disease|37|||
146306407|NCT02577406|527635761|FG000|Treatment Period|Withdrawal by Subject|10|||
146306408|NCT02577406|527635762|FG001|Treatment Period|Withdrawal by Subject|24|||
146306409|NCT02577406|527635761|FG000|Treatment Period|Lost to Follow-up|0|||
146306410|NCT02577406|527635762|FG001|Treatment Period|Lost to Follow-up|1|||
146306411|NCT02577406|527635761|FG000|Treatment Period|Transition to commercially available treatment|1|||
146306412|NCT02577406|527635762|FG001|Treatment Period|Transition to commercially available treatment|1|||
146306413|NCT02577406|527635761|FG000|Treatment Period|Physician Decision|1|||
146306414|NCT02577406|527635762|FG001|Treatment Period|Physician Decision|0|||
146306415|NCT02577406|527635761|FG000|Treatment Period|Disease Relapse|28|||
146306416|NCT02577406|527635762|FG001|Treatment Period|Disease Relapse|1|||
146306417|NCT02577406|527635761|FG000|Treatment Period|Protocol Violation|0|||
146306418|NCT02577406|527635762|FG001|Treatment Period|Protocol Violation|1|||
146306419|NCT02577406|527635761|FG000|Treatment Period|Other Reasons|3|||
146306420|NCT02577406|527635762|FG001|Treatment Period|Other Reasons|39|||
146306421|NCT02577406|527635761|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
146306422|NCT02577406|527635762|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
146306423|NCT01111851|527635765|FG000|Overall Study|All planned PET scans were not obtained.|2|||
146306424|NCT01111851|527635766|FG001|Overall Study|All planned PET scans were not obtained.|0|||
146306425|NCT05500274|527635767|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
146306426|NCT05500274|527635768|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
146306427|NCT05500274|527635767|FG000|Overall Study|Lost to Follow-up|76|||
146306428|NCT05500274|527635768|FG001|Overall Study|Lost to Follow-up|51|||
146306429|NCT03073980|527635771|FG000|Overall Study|Lost to Follow-up|10|||
146306430|NCT03073980|527635772|FG001|Overall Study|Lost to Follow-up|2|||
146306431|NCT03073980|527635773|FG002|Overall Study|Lost to Follow-up|9|||
146306432|NCT03073980|527635771|FG000|Overall Study|No post-procedure data|0|||
146306433|NCT03073980|527635772|FG001|Overall Study|No post-procedure data|0|||
146306434|NCT03073980|527635773|FG002|Overall Study|No post-procedure data|2|||
146306435|NCT00609986|527635778|FG000|Overall Study|Did not receive transplant or treatment|8|||
146306436|NCT00609986|527635779|FG001|Overall Study|Did not receive transplant or treatment|3|||
146306437|NCT03159091|527635780|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
146306438|NCT03159091|527635781|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
146306439|NCT03159091|527635780|FG000|Overall Study|Patient has taken no dose of study drug|0|||
146306440|NCT03159091|527635781|FG001|Overall Study|Patient has taken no dose of study drug|1|||
146306441|NCT04814823|527635782|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
146306442|NCT02044133|527635783|FG000|Overall Study|Lost to Follow-up|1|||
146306443|NCT02044133|527635784|FG001|Overall Study|Lost to Follow-up|1|||
146306444|NCT02044133|527635783|FG000|Overall Study|Death|1|||
146306445|NCT02044133|527635784|FG001|Overall Study|Death|0|||
146306446|NCT02044133|527635783|FG000|Overall Study|Release|3|||
146306447|NCT02044133|527635784|FG001|Overall Study|Release|4|||
146306448|NCT02044133|527635783|FG000|Overall Study|Transfer|1|||
146306449|NCT02044133|527635784|FG001|Overall Study|Transfer|0|||
146306450|NCT02044133|527635783|FG000|Overall Study|refusal of blood sampling|0|||
146306451|NCT02044133|527635784|FG001|Overall Study|refusal of blood sampling|1|||
146306452|NCT04085523|527635785|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146306453|NCT04085523|527635786|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146306454|NCT04085523|527635787|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146306455|NCT04085523|527635788|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146306456|NCT04085523|527635789|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
146306457|NCT04085523|527635790|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
146306458|NCT05318937|527635795|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146306459|NCT05318937|527635796|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146306460|NCT05318937|527635795|FG000|Overall Study|Lost to Follow-up|0|||
146306461|NCT05318937|527635796|FG001|Overall Study|Lost to Follow-up|1|||
146306462|NCT05318937|527635795|FG000|Overall Study|Withdrawal by Subject|0|||
146306463|NCT05318937|527635796|FG001|Overall Study|Withdrawal by Subject|2|||
146306464|NCT05318937|527635795|FG000|Overall Study|Protocol Violation|0|||
146306465|NCT05318937|527635796|FG001|Overall Study|Protocol Violation|1|||
146306466|NCT04722042|527635797|FG000|Overall Study|Withdrawal by Subject|2|||
146306467|NCT04722042|527635798|FG001|Overall Study|Withdrawal by Subject|1|||
146306468|NCT04722042|527635799|FG002|Overall Study|Withdrawal by Subject|0|||
146306469|NCT01877915|527635800|FG000|Overall Study|Lost to Follow-up|10|||
146306470|NCT01877915|527635801|FG001|Overall Study|Lost to Follow-up|9|||
146306471|NCT01877915|527635800|FG000|Overall Study|Withdrawal by Subject|42|||
146306472|NCT01877915|527635801|FG001|Overall Study|Withdrawal by Subject|55|||
146306473|NCT01877915|527635800|FG000|Overall Study|Other|2|||
146306474|NCT01877915|527635801|FG001|Overall Study|Other|4|||
146306475|NCT04490018|527635802|FG000|Overall Study|Protocol Violation|0|||
146306476|NCT04490018|527635803|FG001|Overall Study|Protocol Violation|2|||
146306477|NCT04490018|527635804|FG002|Overall Study|Protocol Violation|1|||
146306478|NCT04490018|527635802|FG000|Overall Study|Lost to Follow-up|2|||
146306479|NCT04490018|527635803|FG001|Overall Study|Lost to Follow-up|2|||
146306480|NCT04490018|527635804|FG002|Overall Study|Lost to Follow-up|0|||
146306481|NCT04490018|527635802|FG000|Overall Study|Withdrawal by Subject|2|||
146306482|NCT04490018|527635803|FG001|Overall Study|Withdrawal by Subject|1|||
146306483|NCT04490018|527635804|FG002|Overall Study|Withdrawal by Subject|0|||
146306484|NCT04490018|527635802|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146306485|NCT04490018|527635803|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146306486|NCT04490018|527635804|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146306487|NCT00943579|527635806|FG000|Overall Study|Adverse Event|4|||
146306488|NCT00943579|527635807|FG001|Overall Study|Adverse Event|3|||
146306489|NCT00943579|527635806|FG000|Overall Study|Lack of Efficacy|2|||
146306490|NCT00943579|527635807|FG001|Overall Study|Lack of Efficacy|2|||
146306491|NCT02710136|527635808|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
146306492|NCT02710136|527635809|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
146306493|NCT00418665|527635810|FG000|Treatment Period|Ineligibility determined|1|||
146306494|NCT00418665|527635811|FG001|Treatment Period|Ineligibility determined|1|||
146306495|NCT00418665|527635812|FG002|Treatment Period|Ineligibility determined|0|||
146306496|NCT00418665|527635810|FG000|Treatment Period|Adverse Event|2|||
146306497|NCT00418665|527635811|FG001|Treatment Period|Adverse Event|2|||
146306498|NCT00418665|527635812|FG002|Treatment Period|Adverse Event|0|||
146306499|NCT00418665|527635810|FG000|Treatment Period|Withdrawal by Subject|0|||
146306500|NCT00418665|527635811|FG001|Treatment Period|Withdrawal by Subject|3|||
146306501|NCT00418665|527635812|FG002|Treatment Period|Withdrawal by Subject|1|||
146306502|NCT00418665|527635810|FG000|Treatment Period|Requirement for alternative therapy|1|||
146306503|NCT00418665|527635811|FG001|Treatment Period|Requirement for alternative therapy|0|||
146306504|NCT00418665|527635812|FG002|Treatment Period|Requirement for alternative therapy|0|||
146306505|NCT00418665|527635810|FG000|Treatment Period|Physician Decision|1|||
146306506|NCT00418665|527635811|FG001|Treatment Period|Physician Decision|0|||
146306507|NCT00418665|527635812|FG002|Treatment Period|Physician Decision|3|||
146306508|NCT00418665|527635810|FG000|Treatment Extension|Adverse Event|1|||
146306509|NCT00418665|527635811|FG001|Treatment Extension|Adverse Event|0|||
146306510|NCT00418665|527635812|FG002|Treatment Extension|Adverse Event|0|||
146306511|NCT00418665|527635810|FG000|Treatment Extension|Withdrawal by Subject|1|||
146306512|NCT00418665|527635811|FG001|Treatment Extension|Withdrawal by Subject|0|||
146306513|NCT00418665|527635812|FG002|Treatment Extension|Withdrawal by Subject|0|||
146306514|NCT00418665|527635810|FG000|Treatment Extension|Requirement for alternative therapy|2|||
146306515|NCT00418665|527635811|FG001|Treatment Extension|Requirement for alternative therapy|2|||
146306516|NCT00418665|527635812|FG002|Treatment Extension|Requirement for alternative therapy|0|||
146306517|NCT00418665|527635810|FG000|Treatment Extension|Physician Decision|2|||
146306518|NCT00418665|527635811|FG001|Treatment Extension|Physician Decision|2|||
146306519|NCT00418665|527635812|FG002|Treatment Extension|Physician Decision|1|||
146306520|NCT00418665|527635810|FG000|Treatment Extension|Death|0|||
146306521|NCT00418665|527635811|FG001|Treatment Extension|Death|0|||
146306522|NCT00418665|527635812|FG002|Treatment Extension|Death|1|||
146306523|NCT01133379|527635813|FG000|Overall Study|Withdrawal by Subject|0|||
146306524|NCT01133379|527635814|FG001|Overall Study|Withdrawal by Subject|1|||
146306525|NCT01133379|527635815|FG002|Overall Study|Withdrawal by Subject|1|||
146306526|NCT01133379|527635813|FG000|Overall Study|Lost to Follow-up|1|||
146306527|NCT01133379|527635814|FG001|Overall Study|Lost to Follow-up|1|||
146306528|NCT01133379|527635815|FG002|Overall Study|Lost to Follow-up|1|||
146306529|NCT00591214|527635818|FG000|Overall Study|Physician Decision|7|||
146306530|NCT00591214|527635818|FG000|Overall Study|Withdrawal by Subject|1|||
146306531|NCT04857996|527635821|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
146306532|NCT04857996|527635822|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
146306533|NCT04857996|527635821|FG000|Overall Study|Lost to Follow-up|1|||
146306534|NCT04857996|527635822|FG001|Overall Study|Lost to Follow-up|3|||
146306535|NCT04857996|527635821|FG000|Overall Study|Site Closure|1|||
146306536|NCT04857996|527635822|FG001|Overall Study|Site Closure|0|||
146306537|NCT04857996|527635821|FG000|Overall Study|Withdrawal by Subject|1|||
146306538|NCT04857996|527635822|FG001|Overall Study|Withdrawal by Subject|0|||
146306539|NCT01129921|527635824|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
146306540|NCT01129921|527635825|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
146306541|NCT01129921|527635824|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
146306542|NCT01129921|527635825|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
146306543|NCT01129921|527635824|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
146306544|NCT01129921|527635825|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
146306545|NCT01129921|527635824|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
146306546|NCT01129921|527635825|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
146306547|NCT03337542|527635826|FG000|Overall Study|Withdrew Consent|17|||
146306548|NCT03337542|527635826|FG000|Overall Study|Allergic Adverse Event|1|||
146306549|NCT03337542|527635826|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
146306550|NCT03337542|527635826|FG000|Overall Study|Lost to Follow-up|1|||
146306551|NCT03337542|527635826|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
146306552|NCT00282295|527635827|FG000|Overall Study|Adverse Event|0|||
146306553|NCT00282295|527635828|FG001|Overall Study|Adverse Event|1|||
146306554|NCT00282295|527635829|FG002|Overall Study|Adverse Event|0|||
146306555|NCT00282295|527635827|FG000|Overall Study|Serious Adverse Events|0|||
146306556|NCT00282295|527635828|FG001|Overall Study|Serious Adverse Events|0|||
146306557|NCT00282295|527635829|FG002|Overall Study|Serious Adverse Events|1|||
146306558|NCT00282295|527635827|FG000|Overall Study|Protocol Violation|0|||
146306559|NCT00282295|527635828|FG001|Overall Study|Protocol Violation|2|||
146306560|NCT00282295|527635829|FG002|Overall Study|Protocol Violation|1|||
146306561|NCT00282295|527635827|FG000|Overall Study|Withdrawal by Subject|2|||
146306562|NCT00282295|527635828|FG001|Overall Study|Withdrawal by Subject|6|||
146306563|NCT00282295|527635829|FG002|Overall Study|Withdrawal by Subject|4|||
146306564|NCT00282295|527635827|FG000|Overall Study|Lost to Follow-up|1|||
146306565|NCT00282295|527635828|FG001|Overall Study|Lost to Follow-up|7|||
146306566|NCT00282295|527635829|FG002|Overall Study|Lost to Follow-up|2|||
146306567|NCT00282295|527635827|FG000|Overall Study|Other|0|||
146306568|NCT00282295|527635828|FG001|Overall Study|Other|1|||
146306569|NCT00282295|527635829|FG002|Overall Study|Other|0|||
146306570|NCT01401842|527635830|FG000|Overall Study|Withdrawal by Subject|3|||
146306571|NCT01401842|527635831|FG001|Overall Study|Withdrawal by Subject|2|||
146306572|NCT01401842|527635830|FG000|Overall Study|academic reason|4|||
146306573|NCT01401842|527635831|FG001|Overall Study|academic reason|1|||
146306574|NCT01401842|527635830|FG000|Overall Study|changed companies|20|||
146306575|NCT01401842|527635831|FG001|Overall Study|changed companies|34|||
146306576|NCT01401842|527635830|FG000|Overall Study|discharged from US Army|3|||
146306577|NCT01401842|527635831|FG001|Overall Study|discharged from US Army|4|||
146306578|NCT01401842|527635830|FG000|Overall Study|invalid follow-up strength data|1|||
146306579|NCT01401842|527635831|FG001|Overall Study|invalid follow-up strength data|4|||
146306580|NCT01401842|527635830|FG000|Overall Study|on profile|9|||
146306581|NCT01401842|527635831|FG001|Overall Study|on profile|5|||
146306582|NCT01401842|527635830|FG000|Overall Study|other/unknown|28|||
146306583|NCT01401842|527635831|FG001|Overall Study|other/unknown|17|||
146306584|NCT00583024|527635842|FG000|Overall Study|Lost to Follow-up|4|||
146306585|NCT03977974|527635843|FG000|Period 2|Adverse Event|0|||
146306586|NCT03977974|527635844|FG001|Period 2|Adverse Event|0|||
146306587|NCT03977974|527635845|FG002|Period 2|Adverse Event|0|||
146306588|NCT03977974|527635846|FG003|Period 2|Adverse Event|0|||
146306589|NCT03977974|527635847|FG004|Period 2|Adverse Event|1|||
146306590|NCT03977974|527635848|FG005|Period 2|Adverse Event|0|||
146306591|NCT03977974|527635849|FG006|Period 2|Adverse Event|0|||
146306592|NCT03977974|527635850|FG007|Period 2|Adverse Event|0|||
146306593|NCT03977974|527635851|FG008|Period 2|Adverse Event|0|||
146306594|NCT03977974|527635852|FG009|Period 2|Adverse Event|0|||
146306595|NCT03977974|527635853|FG010|Period 2|Adverse Event|0|||
146306596|NCT03977974|527635854|FG011|Period 2|Adverse Event|0|||
146306597|NCT03977974|527635855|FG012|Period 2|Adverse Event|0|||
146306598|NCT00736255|527637222|FG000|Overall Study|Adverse Event|1|||
146306599|NCT00736255|527637223|FG001|Overall Study|Adverse Event|0|||
146306600|NCT00736255|527637222|FG000|Overall Study|Physician Decision|1|||
146306601|NCT00736255|527637223|FG001|Overall Study|Physician Decision|0|||
146306602|NCT00736255|527637222|FG000|Overall Study|Non-compliance|1|||
146306603|NCT00736255|527637223|FG001|Overall Study|Non-compliance|1|||
146151818|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151819|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146306604|NCT02833974|527637226|FG000|Overall Study|Lost to Follow-up|1|||
146306605|NCT02833974|527637227|FG001|Overall Study|Lost to Follow-up|0|||
146306606|NCT02833974|527637226|FG000|Overall Study|Adverse Event|0|||
146306607|NCT02833974|527637227|FG001|Overall Study|Adverse Event|3|||
146306608|NCT01502709|527637228|FG000|Overall Study|Lost to Follow-up|4|||
146151820|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151821|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151822|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146306609|NCT01502709|527637229|FG001|Overall Study|Lost to Follow-up|0|||
146306610|NCT00307151|527637230|FG000|Overall Study|Death|4|||
146306611|NCT00307151|527637231|FG001|Overall Study|Death|3|||
146306612|NCT00307151|527637232|FG002|Overall Study|Death|10|||
146306613|NCT00307151|527637233|FG003|Overall Study|Death|3|||
146306614|NCT00307151|527637230|FG000|Overall Study|Severe debilitation, unable to continue|1|||
146306615|NCT00307151|527637231|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146306616|NCT00307151|527637232|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146306617|NCT00307151|527637233|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146306618|NCT00307151|527637230|FG000|Overall Study|Subject unable to get to clinic|1|||
146306619|NCT00307151|527637231|FG001|Overall Study|Subject unable to get to clinic|0|||
146306620|NCT00307151|527637232|FG002|Overall Study|Subject unable to get to clinic|6|||
146306621|NCT00307151|527637233|FG003|Overall Study|Subject unable to get to clinic|2|||
146306622|NCT00307151|527637230|FG000|Overall Study|Withdrew consent|0|||
146306623|NCT00307151|527637231|FG001|Overall Study|Withdrew consent|1|||
146306624|NCT00307151|527637232|FG002|Overall Study|Withdrew consent|1|||
146306625|NCT00307151|527637233|FG003|Overall Study|Withdrew consent|3|||
146306626|NCT00307151|527637230|FG000|Overall Study|Not willing to adhere to study reqs|2|||
146306627|NCT00307151|527637231|FG001|Overall Study|Not willing to adhere to study reqs|0|||
146306628|NCT00307151|527637232|FG002|Overall Study|Not willing to adhere to study reqs|2|||
146306629|NCT00307151|527637233|FG003|Overall Study|Not willing to adhere to study reqs|2|||
146306630|NCT00307151|527637230|FG000|Overall Study|Clinic unable to contact subject|3|||
146306631|NCT00307151|527637231|FG001|Overall Study|Clinic unable to contact subject|3|||
146306632|NCT00307151|527637232|FG002|Overall Study|Clinic unable to contact subject|1|||
146306633|NCT00307151|527637233|FG003|Overall Study|Clinic unable to contact subject|1|||
146306634|NCT02966509|527637234|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
146306635|NCT02966509|527637235|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
146306636|NCT02966509|527637234|FG000|Baseline Satisfaction Survey|Death|0|||
146306637|NCT02966509|527637235|FG001|Baseline Satisfaction Survey|Death|1|||
146306638|NCT02966509|527637234|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
146306639|NCT02966509|527637235|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
146306640|NCT02966509|527637234|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
146306641|NCT02966509|527637235|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
146306642|NCT02966509|527637234|FG000|6 Month Satisfaction Decision Survey|Death|22|||
146306643|NCT02966509|527637235|FG001|6 Month Satisfaction Decision Survey|Death|25|||
146306644|NCT02966509|527637234|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
146306645|NCT02966509|527637235|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
146306646|NCT02966509|527637234|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
146306647|NCT02966509|527637235|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
146306648|NCT02966509|527637234|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
146306649|NCT02966509|527637235|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
146306650|NCT02966509|527637234|FG000|6 Month Satisfaction Survey|Death|36|||
146306651|NCT02966509|527637235|FG001|6 Month Satisfaction Survey|Death|33|||
146306652|NCT02966509|527637234|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
146306653|NCT02966509|527637235|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
146306654|NCT02966509|527637234|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
146306655|NCT02966509|527637235|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
146306656|NCT02966509|527637234|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
146306657|NCT02966509|527637235|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
146306658|NCT02966509|527637234|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
146306659|NCT02966509|527637235|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
146306660|NCT02966509|527637234|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
146306661|NCT02966509|527637235|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
146306662|NCT03807349|527637237|FG000|Overall Study|Early Study Termination|9|||
146306663|NCT01360554|527637238|FG000|Overall Study|Death|359|||
146306664|NCT01360554|527637239|FG001|Overall Study|Death|371|||
146306665|NCT01360554|527637238|FG000|Overall Study|Lost to Follow-up|4|||
146306666|NCT01360554|527637239|FG001|Overall Study|Lost to Follow-up|4|||
146306667|NCT01360554|527637238|FG000|Overall Study|Withdrawal by Subject|23|||
146306668|NCT01360554|527637239|FG001|Overall Study|Withdrawal by Subject|24|||
146306669|NCT01360554|527637238|FG000|Overall Study|Study terminated by sponsor|49|||
146306670|NCT01360554|527637239|FG001|Overall Study|Study terminated by sponsor|37|||
146306671|NCT01360554|527637238|FG000|Overall Study|Other, not specified|1|||
146306672|NCT01360554|527637239|FG001|Overall Study|Other, not specified|0|||
146306673|NCT01360554|527637238|FG000|Overall Study|Randomized but not treated.|3|||
146306674|NCT01360554|527637239|FG001|Overall Study|Randomized but not treated.|3|||
146151823|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146306675|NCT03668600|527637240|FG000|Overall Study|Study Terminated by the Sponsor|157|||
146306676|NCT03668600|527637240|FG000|Overall Study|Protocol Violation|1|||
146306677|NCT03668600|527637240|FG000|Overall Study|Pregnancy|1|||
146306678|NCT03668600|527637240|FG000|Overall Study|Lost to Follow-up|7|||
146306679|NCT03668600|527637240|FG000|Overall Study|Withdrawal by Subject|56|||
146306680|NCT03668600|527637240|FG000|Overall Study|Lack of Efficacy|7|||
146306681|NCT03668600|527637240|FG000|Overall Study|Adverse Event|1|||
146306682|NCT01263483|527637242|FG000|Overall Study|Adverse Event|4|||
146151824|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146279066|NCT03568318|527536835|FG004|Overall Study|Ongoing at Time of Analysis|0|||
146279067|NCT03568318|527536836|FG005|Overall Study|Ongoing at Time of Analysis|0|||
146279068|NCT02898077|527536837|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
146279069|NCT02898077|527536838|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
146279070|NCT02898077|527536837|FG000|Overall Study|Lost to Follow-up|4|||
146279071|NCT02898077|527536838|FG001|Overall Study|Lost to Follow-up|3|||
146279072|NCT02898077|527536837|FG000|Overall Study|Physician Decision|0|||
146279073|NCT02898077|527536838|FG001|Overall Study|Physician Decision|2|||
146279074|NCT02898077|527536837|FG000|Overall Study|Sponsor Decision|32|||
146279075|NCT02898077|527536838|FG001|Overall Study|Sponsor Decision|13|||
146279076|NCT02898077|527536837|FG000|Overall Study|Withdrawal by Subject|6|||
146279077|NCT02898077|527536838|FG001|Overall Study|Withdrawal by Subject|3|||
146279078|NCT02898077|527536837|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
146279079|NCT02898077|527536838|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
146279080|NCT02898077|527536837|FG000|Overall Study|Ended extension period|3|||
146279081|NCT02898077|527536838|FG001|Overall Study|Ended extension period|0|||
146279082|NCT04410523|527536839|FG000|Overall Study|Study terminated by sponsor|1|||
146279083|NCT04410523|527536840|FG001|Overall Study|Study terminated by sponsor|3|||
146279084|NCT04410523|527536841|FG002|Overall Study|Study terminated by sponsor|2|||
146279085|NCT04410523|527536842|FG003|Overall Study|Study terminated by sponsor|6|||
146279086|NCT04410523|527536843|FG004|Overall Study|Study terminated by sponsor|3|||
146279087|NCT04410523|527536844|FG005|Overall Study|Study terminated by sponsor|4|||
146279088|NCT04410523|527536839|FG000|Overall Study|Adverse Event|1|||
146279089|NCT04410523|527536840|FG001|Overall Study|Adverse Event|0|||
146279090|NCT04410523|527536841|FG002|Overall Study|Adverse Event|0|||
146279091|NCT04410523|527536842|FG003|Overall Study|Adverse Event|0|||
146279092|NCT04410523|527536843|FG004|Overall Study|Adverse Event|0|||
146279093|NCT04410523|527536844|FG005|Overall Study|Adverse Event|2|||
146279094|NCT04410523|527536839|FG000|Overall Study|Lost to Follow-up|0|||
146279095|NCT04410523|527536840|FG001|Overall Study|Lost to Follow-up|1|||
146279096|NCT04410523|527536841|FG002|Overall Study|Lost to Follow-up|0|||
146279097|NCT04410523|527536842|FG003|Overall Study|Lost to Follow-up|0|||
146279098|NCT04410523|527536843|FG004|Overall Study|Lost to Follow-up|0|||
146279099|NCT04410523|527536844|FG005|Overall Study|Lost to Follow-up|0|||
146279100|NCT04410523|527536839|FG000|Overall Study|Physician Decision|0|||
146279101|NCT04410523|527536840|FG001|Overall Study|Physician Decision|1|||
146279102|NCT04410523|527536841|FG002|Overall Study|Physician Decision|0|||
146279103|NCT04410523|527536842|FG003|Overall Study|Physician Decision|0|||
146279104|NCT04410523|527536843|FG004|Overall Study|Physician Decision|0|||
146279105|NCT04410523|527536844|FG005|Overall Study|Physician Decision|0|||
146279106|NCT04410523|527536839|FG000|Overall Study|Pregnancy|0|||
146279107|NCT04410523|527536840|FG001|Overall Study|Pregnancy|0|||
146279108|NCT04410523|527536841|FG002|Overall Study|Pregnancy|0|||
146279109|NCT04410523|527536842|FG003|Overall Study|Pregnancy|0|||
146279110|NCT04410523|527536843|FG004|Overall Study|Pregnancy|0|||
146279111|NCT04410523|527536844|FG005|Overall Study|Pregnancy|1|||
146279112|NCT04410523|527536839|FG000|Overall Study|Protocol deviation|0|||
146279113|NCT04410523|527536840|FG001|Overall Study|Protocol deviation|0|||
146279114|NCT04410523|527536841|FG002|Overall Study|Protocol deviation|0|||
146279115|NCT04410523|527536842|FG003|Overall Study|Protocol deviation|0|||
146279116|NCT04410523|527536843|FG004|Overall Study|Protocol deviation|0|||
146279117|NCT04410523|527536844|FG005|Overall Study|Protocol deviation|2|||
146279118|NCT04410523|527536839|FG000|Overall Study|Subject decision|2|||
146279119|NCT04410523|527536840|FG001|Overall Study|Subject decision|0|||
146279120|NCT04410523|527536841|FG002|Overall Study|Subject decision|0|||
146279121|NCT04410523|527536842|FG003|Overall Study|Subject decision|1|||
146279122|NCT04410523|527536843|FG004|Overall Study|Subject decision|0|||
146279123|NCT04410523|527536844|FG005|Overall Study|Subject decision|1|||
146279124|NCT01638429|527536847|FG000|Overall Study|Withdrawal by Subject|1|||
146279125|NCT03207451|527536848|FG000|Overall Study|scheduling conflict|1|||
146279126|NCT03207451|527536849|FG001|Overall Study|scheduling conflict|0|||
146279127|NCT03207451|527536850|FG002|Overall Study|scheduling conflict|2|||
146279128|NCT03207451|527536851|FG003|Overall Study|scheduling conflict|2|||
146279129|NCT03207451|527536848|FG000|Overall Study|Adverse Event|0|||
146279130|NCT03207451|527536849|FG001|Overall Study|Adverse Event|0|||
146279131|NCT03207451|527536850|FG002|Overall Study|Adverse Event|0|||
146279132|NCT03207451|527536851|FG003|Overall Study|Adverse Event|1|||
146279133|NCT02040584|527536853|FG000|Overall Study|Adverse Event|13|||
146279134|NCT02040584|527536854|FG001|Overall Study|Adverse Event|6|||
146279135|NCT02040584|527536853|FG000|Overall Study|Protocol Violation|9|||
146279136|NCT02040584|527536854|FG001|Overall Study|Protocol Violation|11|||
146279137|NCT02040584|527536853|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146279138|NCT02040584|527536854|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146279139|NCT02040584|527536853|FG000|Overall Study|Death|6|||
146279140|NCT02040584|527536854|FG001|Overall Study|Death|3|||
146279141|NCT02040584|527536853|FG000|Overall Study|Transplant rejection/retransplant|0|||
146279142|NCT02040584|527536854|FG001|Overall Study|Transplant rejection/retransplant|1|||
146279143|NCT02040584|527536853|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
146279144|NCT02040584|527536854|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
146306683|NCT01263483|527637243|FG001|Overall Study|Adverse Event|0|||
146306684|NCT01263483|527637244|FG002|Overall Study|Adverse Event|3|||
146306685|NCT01263483|527637242|FG000|Overall Study|Withdrawal by Subject|1|||
146306686|NCT01263483|527637243|FG001|Overall Study|Withdrawal by Subject|0|||
146306687|NCT01263483|527637244|FG002|Overall Study|Withdrawal by Subject|0|||
146306688|NCT01263483|527637242|FG000|Overall Study|Lack of Efficacy|2|||
146306689|NCT01263483|527637243|FG001|Overall Study|Lack of Efficacy|0|||
146306690|NCT01263483|527637244|FG002|Overall Study|Lack of Efficacy|0|||
146306691|NCT01263483|527637242|FG000|Overall Study|Protocol Violation|0|||
146306692|NCT01263483|527637243|FG001|Overall Study|Protocol Violation|1|||
146306693|NCT01263483|527637244|FG002|Overall Study|Protocol Violation|1|||
146306694|NCT01263483|527637242|FG000|Overall Study|Participant Unavailability|0|||
146306695|NCT01263483|527637243|FG001|Overall Study|Participant Unavailability|1|||
146306696|NCT01263483|527637244|FG002|Overall Study|Participant Unavailability|1|||
146306697|NCT00326209|527637245|FG000|Overall Study|Adverse Event|28|||
146306698|NCT00326209|527637245|FG000|Overall Study|Withdrawal by Subject|22|||
146306699|NCT00326209|527637245|FG000|Overall Study|Lack of Efficacy|31|||
146306700|NCT00326209|527637245|FG000|Overall Study|Lost to Follow-up|18|||
146306701|NCT00326209|527637245|FG000|Overall Study|Participant non-compliant|6|||
146306702|NCT00326209|527637245|FG000|Overall Study|Sponsor closed study|173|||
146306703|NCT00326209|527637245|FG000|Overall Study|Prohibited medication use|1|||
146306704|NCT00326209|527637245|FG000|Overall Study|Violation of entry criteria|1|||
146306705|NCT00326209|527637245|FG000|Overall Study|Withdrawn in error|1|||
146306706|NCT00326209|527637245|FG000|Overall Study|Pregnancy|1|||
146306707|NCT05807464|527637246|FG000|Overall Study|Adverse Event|1|||
146306708|NCT04451161|527637247|FG000|Overall Study|Lost to Follow-up|28|||
146306709|NCT04451161|527637248|FG001|Overall Study|Lost to Follow-up|37|||
146306710|NCT04451161|527637249|FG002|Overall Study|Lost to Follow-up|22|||
146306711|NCT04451161|527637250|FG003|Overall Study|Lost to Follow-up|13|||
146306712|NCT04451161|527637251|FG004|Overall Study|Lost to Follow-up|11|||
146306713|NCT04451161|527637252|FG005|Overall Study|Lost to Follow-up|14|||
146306714|NCT04451161|527637247|FG000|Overall Study|Withdrawal by Subject|3|||
146306715|NCT04451161|527637248|FG001|Overall Study|Withdrawal by Subject|0|||
146306716|NCT04451161|527637249|FG002|Overall Study|Withdrawal by Subject|0|||
146306717|NCT04451161|527637250|FG003|Overall Study|Withdrawal by Subject|0|||
146306718|NCT04451161|527637251|FG004|Overall Study|Withdrawal by Subject|2|||
146306719|NCT04451161|527637252|FG005|Overall Study|Withdrawal by Subject|4|||
146306720|NCT01555151|527637254|FG000|Overall Study|Withdrawal by Subject|6|||
146306721|NCT01555151|527637255|FG001|Overall Study|Withdrawal by Subject|2|||
146306722|NCT01555151|527637256|FG002|Overall Study|Withdrawal by Subject|0|||
146306723|NCT01555151|527637257|FG003|Overall Study|Withdrawal by Subject|2|||
146306724|NCT01555151|527637254|FG000|Overall Study|Administrative|3|||
146306725|NCT01555151|527637255|FG001|Overall Study|Administrative|1|||
146306726|NCT01555151|527637256|FG002|Overall Study|Administrative|2|||
146306727|NCT01555151|527637257|FG003|Overall Study|Administrative|0|||
146306728|NCT01555151|527637254|FG000|Overall Study|Protocol Violation|3|||
146306729|NCT01555151|527637255|FG001|Overall Study|Protocol Violation|3|||
146306730|NCT01555151|527637256|FG002|Overall Study|Protocol Violation|3|||
146306731|NCT01555151|527637257|FG003|Overall Study|Protocol Violation|5|||
146306732|NCT01555151|527637254|FG000|Overall Study|Adverse Event|1|||
146306733|NCT01555151|527637255|FG001|Overall Study|Adverse Event|2|||
146306734|NCT01555151|527637256|FG002|Overall Study|Adverse Event|1|||
146306735|NCT01555151|527637257|FG003|Overall Study|Adverse Event|2|||
146306736|NCT01555151|527637254|FG000|Overall Study|Lost to Follow-up|0|||
146306737|NCT01555151|527637255|FG001|Overall Study|Lost to Follow-up|0|||
146306738|NCT01555151|527637256|FG002|Overall Study|Lost to Follow-up|0|||
146306739|NCT01555151|527637257|FG003|Overall Study|Lost to Follow-up|1|||
146306740|NCT03596866|527637258|FG000|Overall Study|Site terminated by Sponsor|64|||
146306741|NCT03596866|527637259|FG001|Overall Study|Site terminated by Sponsor|65|||
146151825|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151826|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151827|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
146151828|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151829|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151830|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146306742|NCT03596866|527637258|FG000|Overall Study|Death|37|||
146306743|NCT03596866|527637259|FG001|Overall Study|Death|24|||
146306744|NCT03596866|527637258|FG000|Overall Study|Withdrawal by Subject|4|||
146306745|NCT03596866|527637259|FG001|Overall Study|Withdrawal by Subject|6|||
146306746|NCT03596866|527637258|FG000|Overall Study|Missing|0|||
146306747|NCT03596866|527637259|FG001|Overall Study|Missing|6|||
146306748|NCT03596866|527637258|FG000|Overall Study|Lost to Follow-up|2|||
146306749|NCT03596866|527637259|FG001|Overall Study|Lost to Follow-up|3|||
146306750|NCT03596866|527637258|FG000|Overall Study|Protocol Violation|1|||
146306751|NCT03596866|527637259|FG001|Overall Study|Protocol Violation|0|||
146306752|NCT03596866|527637258|FG000|Overall Study|Reason Not Specified|14|||
146306753|NCT03596866|527637259|FG001|Overall Study|Reason Not Specified|13|||
146306754|NCT01816061|527637260|FG000|Overall Study|Lost to Follow-up|13|||
146306755|NCT01816061|527637261|FG001|Overall Study|Lost to Follow-up|24|||
146306756|NCT01671111|527637263|FG000|Overall Study|Adverse Event|2|||
146306757|NCT01671111|527637263|FG000|Overall Study|Lack of Efficacy|1|||
146306758|NCT01671111|527637263|FG000|Overall Study|Withdrawal by Subject|2|||
146306759|NCT01671111|527637263|FG000|Overall Study|Physician Decision|1|||
146306760|NCT01671111|527637263|FG000|Overall Study|Other|24|||
146306761|NCT02114268|527637266|FG000|Overall Study|Lost to Follow-up|4|||
146306762|NCT02114268|527637267|FG001|Overall Study|Lost to Follow-up|1|||
146306763|NCT02114268|527637268|FG002|Overall Study|Lost to Follow-up|1|||
146306764|NCT02114268|527637269|FG003|Overall Study|Lost to Follow-up|0|||
146306765|NCT02114268|527637270|FG004|Overall Study|Lost to Follow-up|0|||
146306766|NCT02114268|527637271|FG005|Overall Study|Lost to Follow-up|2|||
146306767|NCT02114268|527637266|FG000|Overall Study|Withdrawal by Subject|1|||
146306768|NCT02114268|527637267|FG001|Overall Study|Withdrawal by Subject|0|||
146306769|NCT02114268|527637268|FG002|Overall Study|Withdrawal by Subject|0|||
146306770|NCT02114268|527637269|FG003|Overall Study|Withdrawal by Subject|0|||
146306771|NCT02114268|527637270|FG004|Overall Study|Withdrawal by Subject|0|||
146306772|NCT02114268|527637271|FG005|Overall Study|Withdrawal by Subject|1|||
146306773|NCT02114268|527637266|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
146306774|NCT02114268|527637267|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
146306775|NCT02114268|527637268|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
146306776|NCT02114268|527637269|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
146306777|NCT02114268|527637270|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
146306778|NCT02114268|527637271|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
146306779|NCT01075412|527637278|FG000|Overall Study|Withdrawal by Subject|0|||
146306780|NCT01075412|527637279|FG001|Overall Study|Withdrawal by Subject|1|||
146306781|NCT00865904|527637281|FG000|Overall Study|Randomized but not Treated|2|||
146306782|NCT00865904|527637282|FG001|Overall Study|Randomized but not Treated|0|||
146306783|NCT00865904|527637283|FG002|Overall Study|Randomized but not Treated|0|||
146306784|NCT00865904|527637284|FG003|Overall Study|Randomized but not Treated|1|||
146306785|NCT00865904|527637285|FG004|Overall Study|Randomized but not Treated|1|||
146306786|NCT01431274|527637286|FG000|Overall Study|Adverse Event|51|||
146306787|NCT01431274|527637287|FG001|Overall Study|Adverse Event|37|||
146306788|NCT01431274|527637288|FG002|Overall Study|Adverse Event|43|||
146306789|NCT01431274|527637289|FG003|Overall Study|Adverse Event|30|||
146306790|NCT01431274|527637290|FG004|Overall Study|Adverse Event|37|||
146151831|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151832|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151833|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151834|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146151835|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151836|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146151837|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151838|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
146151839|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
146151840|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151841|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151842|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151843|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151844|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151845|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151846|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151847|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
146151848|NCT01490632|527067729|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151849|NCT01490632|527067730|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151850|NCT01490632|527067731|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151851|NCT01490632|527067732|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151852|NCT01490632|527067733|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151853|NCT01490632|527067734|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
146151854|NCT01490632|527067735|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
146151855|NCT01490632|527067736|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
146151856|NCT01490632|527067737|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
146151857|NCT01490632|527067738|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
146151858|NCT01490632|527067739|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
146151859|NCT01490632|527067740|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
146151860|NCT01490632|527067741|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146306791|NCT01431274|527637286|FG000|Overall Study|Consent withdrawn not due to AE|29|||
146306792|NCT01431274|527637287|FG001|Overall Study|Consent withdrawn not due to AE|20|||
146151861|NCT01490632|527067742|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151862|NCT01490632|527067743|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151863|NCT01490632|527067744|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151864|NCT01490632|527067745|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151865|NCT01490632|527067746|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151866|NCT01490632|527067747|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151867|NCT01490632|527067748|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
146151868|NCT01490632|527067729|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151869|NCT01490632|527067730|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151870|NCT01490632|527067731|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151871|NCT01490632|527067732|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151872|NCT01490632|527067733|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151873|NCT01490632|527067734|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151874|NCT01490632|527067735|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151875|NCT01490632|527067736|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151876|NCT01490632|527067737|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151877|NCT01490632|527067738|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151878|NCT01490632|527067739|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151879|NCT01490632|527067740|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151880|NCT01490632|527067741|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151881|NCT01490632|527067742|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151882|NCT01490632|527067743|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
146151883|NCT01490632|527067744|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
146151884|NCT01490632|527067745|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151885|NCT01490632|527067746|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151886|NCT01490632|527067747|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151887|NCT01490632|527067748|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
146151888|NCT01490632|527067729|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151889|NCT01490632|527067730|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151890|NCT01490632|527067731|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151891|NCT01490632|527067732|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151892|NCT01490632|527067733|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151893|NCT01490632|527067734|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151894|NCT01490632|527067735|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151895|NCT01490632|527067736|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146306793|NCT01431274|527637288|FG002|Overall Study|Consent withdrawn not due to AE|17|||
146306794|NCT01431274|527637289|FG003|Overall Study|Consent withdrawn not due to AE|20|||
146306795|NCT01431274|527637290|FG004|Overall Study|Consent withdrawn not due to AE|11|||
146306796|NCT01431274|527637286|FG000|Overall Study|Non compliant with protocol|5|||
146306797|NCT01431274|527637287|FG001|Overall Study|Non compliant with protocol|8|||
146306798|NCT01431274|527637288|FG002|Overall Study|Non compliant with protocol|4|||
146306799|NCT01431274|527637289|FG003|Overall Study|Non compliant with protocol|4|||
146306800|NCT01431274|527637290|FG004|Overall Study|Non compliant with protocol|4|||
146306801|NCT01431274|527637286|FG000|Overall Study|Lost to Follow-up|6|||
146306802|NCT01431274|527637287|FG001|Overall Study|Lost to Follow-up|7|||
146306803|NCT01431274|527637288|FG002|Overall Study|Lost to Follow-up|1|||
146306804|NCT01431274|527637289|FG003|Overall Study|Lost to Follow-up|4|||
146306805|NCT01431274|527637290|FG004|Overall Study|Lost to Follow-up|0|||
146306806|NCT01431274|527637286|FG000|Overall Study|Other reason not stated above|6|||
146306807|NCT01431274|527637287|FG001|Overall Study|Other reason not stated above|5|||
146306808|NCT01431274|527637288|FG002|Overall Study|Other reason not stated above|7|||
146306809|NCT01431274|527637289|FG003|Overall Study|Other reason not stated above|2|||
146306810|NCT01431274|527637290|FG004|Overall Study|Other reason not stated above|4|||
146306811|NCT01378858|527637291|FG000|Overall Study|Withdrawal by Subject|4|||
146306812|NCT01378858|527637292|FG001|Overall Study|Withdrawal by Subject|4|||
146306813|NCT02664272|527637293|FG000|Overall Study|Fluoroscopic images not made available|2|||
146306814|NCT01358760|527637294|FG000|Overall Study|Adverse Event|3|||
146306815|NCT01358760|527637295|FG001|Overall Study|Adverse Event|4|||
146306816|NCT01358760|527637296|FG002|Overall Study|Adverse Event|3|||
146306817|NCT01358760|527637294|FG000|Overall Study|Lost to Follow-up|1|||
146306818|NCT01358760|527637295|FG001|Overall Study|Lost to Follow-up|1|||
146151896|NCT01490632|527067737|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151897|NCT01490632|527067738|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151898|NCT01490632|527067739|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151899|NCT01490632|527067740|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146306819|NCT01358760|527637296|FG002|Overall Study|Lost to Follow-up|3|||
146306820|NCT01358760|527637294|FG000|Overall Study|Withdrawal by Subject|5|||
146306821|NCT01358760|527637295|FG001|Overall Study|Withdrawal by Subject|3|||
146306822|NCT01358760|527637296|FG002|Overall Study|Withdrawal by Subject|2|||
146151900|NCT01490632|527067741|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151901|NCT01490632|527067742|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
146151902|NCT01490632|527067743|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151903|NCT01490632|527067744|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151904|NCT01490632|527067745|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151905|NCT01490632|527067746|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151906|NCT01490632|527067747|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151907|NCT01490632|527067748|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
146151908|NCT01490632|527067729|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151909|NCT01490632|527067730|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151910|NCT01490632|527067731|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151911|NCT01490632|527067732|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151912|NCT01490632|527067733|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151913|NCT01490632|527067734|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151914|NCT01490632|527067735|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151915|NCT01490632|527067736|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151916|NCT01490632|527067737|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151917|NCT01490632|527067738|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151918|NCT01490632|527067739|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151919|NCT01490632|527067740|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151920|NCT01490632|527067741|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151921|NCT01490632|527067742|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151922|NCT01490632|527067743|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
146151923|NCT01490632|527067744|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
146151924|NCT01490632|527067745|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151925|NCT01490632|527067746|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151926|NCT01490632|527067747|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151927|NCT01490632|527067748|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
146151928|NCT01490632|527067729|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151929|NCT01490632|527067730|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151930|NCT01490632|527067731|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151931|NCT01490632|527067732|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151932|NCT01490632|527067733|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151933|NCT01490632|527067734|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151934|NCT01490632|527067735|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151935|NCT01490632|527067736|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151936|NCT01490632|527067737|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151937|NCT01490632|527067738|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151938|NCT01490632|527067739|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151939|NCT01490632|527067740|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151940|NCT01490632|527067741|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
146151941|NCT01490632|527067742|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
146151942|NCT01490632|527067743|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
146151943|NCT01490632|527067744|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
146151944|NCT01490632|527067745|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151945|NCT01490632|527067746|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151946|NCT01490632|527067747|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151947|NCT01490632|527067748|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
146151948|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
146151949|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
146151950|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
146151951|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
146151952|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
146151953|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
146151954|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
146151955|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
146151956|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
146151957|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
146151958|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
146151959|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
146151960|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
146151961|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
146151962|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
146151963|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
146151964|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
146151965|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
146151966|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
146151967|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
146151968|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Death|0|||
146151969|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Death|0|||
146151970|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Death|0|||
146151971|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Death|0|||
146151972|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Death|0|||
146151973|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Death|0|||
146151974|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Death|0|||
146151975|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Death|0|||
146151976|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Death|0|||
146151977|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Death|0|||
146151978|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Death|0|||
146151979|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Death|0|||
146151980|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Death|0|||
146151981|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Death|0|||
146151982|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Death|0|||
146151983|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Death|0|||
146151984|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Death|0|||
146151985|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Death|0|||
146151986|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Death|1|||
146151987|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Death|0|||
146151988|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151989|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151990|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151991|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151992|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151993|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151994|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151995|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151996|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151997|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151998|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146151999|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152000|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152001|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152002|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152003|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152004|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
146152005|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
146152006|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
146152007|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
146152008|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152009|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152010|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152011|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152012|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152013|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152014|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152015|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152016|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152017|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152018|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152019|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152020|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152021|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146306823|NCT01358760|527637294|FG000|Overall Study|Physician Decision|1|||
146306824|NCT01358760|527637295|FG001|Overall Study|Physician Decision|0|||
146306825|NCT01358760|527637296|FG002|Overall Study|Physician Decision|1|||
146152022|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146306826|NCT01358760|527637294|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
146152023|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152024|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152025|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152026|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
146152027|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
146152028|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
146152029|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
146152030|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
146152031|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
146152032|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
146152033|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
146152034|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
146152035|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
146152036|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
146152037|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
146152038|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
146152039|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
146152040|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
146152041|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
146152042|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
146152043|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
146152044|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
146152045|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
146152046|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
146152047|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
146152048|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
146152049|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
146152050|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
146306827|NCT01358760|527637295|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
146306828|NCT01358760|527637296|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
146152051|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
146152052|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
146152053|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
146152054|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
146152055|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
146152056|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
146152057|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
146152058|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
146152059|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
146152060|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
146152061|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
146152062|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
146152063|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
146152064|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
146152065|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
146152066|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
146152067|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
146152068|NCT01490632|527067729|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152069|NCT01490632|527067730|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152070|NCT01490632|527067731|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152071|NCT01490632|527067732|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152072|NCT01490632|527067733|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152073|NCT01490632|527067734|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152074|NCT01490632|527067735|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152075|NCT01490632|527067736|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152076|NCT01490632|527067737|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152077|NCT01490632|527067738|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152078|NCT01490632|527067739|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152079|NCT01490632|527067740|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152080|NCT01490632|527067741|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152081|NCT01490632|527067742|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152082|NCT01490632|527067743|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152083|NCT01490632|527067744|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152084|NCT01490632|527067745|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
146152085|NCT01490632|527067746|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146152086|NCT01490632|527067747|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146152087|NCT01490632|527067748|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
146152088|NCT05732454|527067750|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
146152089|NCT05732454|527067751|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
146152090|NCT05732454|527067750|FG000|Part 1: DB Period|Adverse Event|1|||
146152091|NCT05732454|527067751|FG001|Part 1: DB Period|Adverse Event|0|||
146152092|NCT05732454|527067750|FG000|Part 1: DB Period|Lost to Follow-up|1|||
146152093|NCT05732454|527067751|FG001|Part 1: DB Period|Lost to Follow-up|0|||
146152094|NCT05732454|527067750|FG000|Part 1: DB Period|Protocol Violation|0|||
146152095|NCT05732454|527067751|FG001|Part 1: DB Period|Protocol Violation|1|||
146152096|NCT05732454|527067750|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
146152097|NCT05732454|527067751|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
146152098|NCT05732454|527067750|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
146152099|NCT05732454|527067751|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
146152100|NCT05732454|527067750|FG000|Part 1: OLE Period|Adverse Event|0|||
146306829|NCT01506960|527637297|FG000|Overall Study|Did not meet angiographic criteria|47|||
146152101|NCT05732454|527067751|FG001|Part 1: OLE Period|Adverse Event|1|||
146152102|NCT05732454|527067750|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
146152103|NCT05732454|527067751|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
146152104|NCT01153633|527067752|FG000|Overall Study|Protocol Violation|1|||
146152105|NCT01153633|527067753|FG001|Overall Study|Protocol Violation|1|||
146152106|NCT01153633|527067752|FG000|Overall Study|Therapeutic failure|3|||
146152107|NCT01153633|527067753|FG001|Overall Study|Therapeutic failure|3|||
146152108|NCT01003899|527067758|FG000|Overall Study|Other Adverse Event|8|||
146152109|NCT01003899|527067758|FG000|Overall Study|Not entered|4|||
146152110|NCT01003899|527067758|FG000|Overall Study|Not treated|1|||
146152111|NCT01003899|527067758|FG000|Overall Study|Progressive disease|34|||
146152112|NCT00352365|527067759|FG000|Induction Therapy|Adverse Event|7|||
146152113|NCT00352365|527067759|FG000|Induction Therapy|Progression/Relapse|8|||
146152114|NCT00352365|527067759|FG000|Induction Therapy|Death|7|||
146152115|NCT00352365|527067759|FG000|Induction Therapy|Not protocol specified|1|||
146152116|NCT00352365|527067759|FG000|Induction Therapy|Not eligible|3|||
146152117|NCT00352365|527067759|FG000|Induction Therapy|Death before starting protocol therapy|1|||
146152118|NCT00352365|527067759|FG000|Maintenance Therapy|Progression/Relapse|3|||
146152119|NCT00352365|527067759|FG000|Maintenance Therapy|Death|2|||
146152120|NCT00352365|527067759|FG000|Maintenance Therapy|Not protocol specified|3|||
146152121|NCT00352365|527067759|FG000|Maintenance Therapy|Not eligible|4|||
146152122|NCT01262651|527067760|FG000|Overall Study|Adverse Event|40|||
146152123|NCT01262651|527067761|FG001|Overall Study|Adverse Event|35|||
146152124|NCT01262651|527067760|FG000|Overall Study|Withdrawal by Subject|15|||
146152125|NCT01262651|527067761|FG001|Overall Study|Withdrawal by Subject|11|||
146152126|NCT01262651|527067760|FG000|Overall Study|Withdrawal by Investigator|2|||
146152127|NCT01262651|527067761|FG001|Overall Study|Withdrawal by Investigator|2|||
146152128|NCT01262651|527067760|FG000|Overall Study|Met Withdrawal Criteria|1|||
146152129|NCT01262651|527067761|FG001|Overall Study|Met Withdrawal Criteria|0|||
146152130|NCT04969783|527067765|FG000|Overall Study|Lost to Follow-up|2|||
146152131|NCT04969783|527067766|FG001|Overall Study|Lost to Follow-up|0|||
146152132|NCT04969783|527067765|FG000|Overall Study|Withdrawal by Subject|4|||
146152133|NCT04969783|527067766|FG001|Overall Study|Withdrawal by Subject|0|||
146152134|NCT04969783|527067765|FG000|Overall Study|Physician Decision|6|||
146152135|NCT04969783|527067766|FG001|Overall Study|Physician Decision|0|||
146152136|NCT03422250|527067767|FG000|Intervention|Adverse Event|0|||
146152137|NCT03422250|527067768|FG001|Intervention|Adverse Event|1|||
146152138|NCT03422250|527067769|FG002|Intervention|Adverse Event|0|||
146152139|NCT03422250|527067770|FG003|Intervention|Adverse Event|1|||
146152140|NCT03422250|527067767|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
146152141|NCT03422250|527067768|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
146152142|NCT03422250|527067769|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
146152143|NCT03422250|527067770|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
146152144|NCT03422250|527067767|FG000|Follow-up|Withdrawal by Subject|0|||
146152145|NCT03422250|527067768|FG001|Follow-up|Withdrawal by Subject|0|||
146152146|NCT03422250|527067769|FG002|Follow-up|Withdrawal by Subject|0|||
146152147|NCT03422250|527067770|FG003|Follow-up|Withdrawal by Subject|1|||
146152148|NCT03422250|527067767|FG000|Follow-up|Adverse Event|0|||
146152149|NCT03422250|527067768|FG001|Follow-up|Adverse Event|0|||
146152150|NCT03422250|527067769|FG002|Follow-up|Adverse Event|0|||
146152151|NCT03422250|527067770|FG003|Follow-up|Adverse Event|1|||
146152152|NCT00377819|527067771|FG000|Overall Study|Adverse Event|2|||
146152153|NCT00377819|527067772|FG001|Overall Study|Adverse Event|3|||
146152154|NCT00377819|527067771|FG000|Overall Study|Withdrawal by Subject|10|||
146152155|NCT00377819|527067772|FG001|Overall Study|Withdrawal by Subject|4|||
146152156|NCT00377819|527067771|FG000|Overall Study|Death|0|||
146152157|NCT00377819|527067772|FG001|Overall Study|Death|1|||
146152158|NCT00377819|527067771|FG000|Overall Study|Lost to Follow-up|0|||
146152159|NCT00377819|527067772|FG001|Overall Study|Lost to Follow-up|1|||
146152160|NCT00377819|527067771|FG000|Overall Study|Protocol Violation|1|||
146152161|NCT00377819|527067772|FG001|Overall Study|Protocol Violation|1|||
146152162|NCT01917526|527067779|FG000|Overall Study|Protocol Violation|1|||
146152163|NCT01917526|527067780|FG001|Overall Study|Protocol Violation|1|||
146152164|NCT02261363|527067781|FG000|Overall Study|Lost to Follow-up|21|||
146152165|NCT01517802|527067782|FG000|Overall Study|Death|1|||
146152166|NCT04827212|527067788|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
146152167|NCT04827212|527067789|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
146152168|NCT04827212|527067788|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
146152169|NCT04827212|527067789|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
146152170|NCT00563784|527067792|FG000|Overall Study|Withdrawal by Subject|2|||
146152171|NCT00563784|527067792|FG000|Overall Study|Screen Failures|20|||
146152172|NCT00148343|527067793|FG000|Overall Study|Withdrawal by Subject|12|||
146152173|NCT00148343|527067794|FG001|Overall Study|Withdrawal by Subject|7|||
146152174|NCT00148343|527067793|FG000|Overall Study|Physician Decision|3|||
146152175|NCT00148343|527067794|FG001|Overall Study|Physician Decision|4|||
146306830|NCT02047253|527637300|FG000|Overall Study|Lost to Follow-up|8|||
146152176|NCT02528214|527067797|FG000|Overall Study|Protocol Violation|0|||
146152177|NCT02528214|527067798|FG001|Overall Study|Protocol Violation|1|||
146152178|NCT02528214|527067797|FG000|Overall Study|Adverse Event|0|||
146152179|NCT02528214|527067798|FG001|Overall Study|Adverse Event|1|||
146152180|NCT02528214|527067797|FG000|Overall Study|Other than specified above|0|||
146152181|NCT02528214|527067798|FG001|Overall Study|Other than specified above|1|||
146152182|NCT01380327|527067799|FG000|Overall Study|Lost to Follow-up|0|||
146152183|NCT01380327|527067800|FG001|Overall Study|Lost to Follow-up|1|||
146152184|NCT01380327|527067801|FG002|Overall Study|Lost to Follow-up|1|||
146152185|NCT01380327|527067799|FG000|Overall Study|Protocol Violation|3|||
146152186|NCT01380327|527067800|FG001|Overall Study|Protocol Violation|2|||
146152187|NCT01380327|527067801|FG002|Overall Study|Protocol Violation|3|||
146152188|NCT01380327|527067799|FG000|Overall Study|Withdrawal by Subject|0|||
146152189|NCT01380327|527067800|FG001|Overall Study|Withdrawal by Subject|0|||
146152190|NCT01380327|527067801|FG002|Overall Study|Withdrawal by Subject|1|||
146152191|NCT01380327|527067799|FG000|Overall Study|Housing situation precluded ability to k|0|||
146152192|NCT01380327|527067800|FG001|Overall Study|Housing situation precluded ability to k|0|||
146152193|NCT01380327|527067801|FG002|Overall Study|Housing situation precluded ability to k|1|||
146152194|NCT01380327|527067799|FG000|Overall Study|Questionable onset of epilepsy|0|||
146152195|NCT01380327|527067800|FG001|Overall Study|Questionable onset of epilepsy|0|||
146152196|NCT01380327|527067801|FG002|Overall Study|Questionable onset of epilepsy|1|||
146152197|NCT06027216|527067802|FG000|Overall Study|Did not qualify|8|||
146152198|NCT02504294|527067803|FG000|Overall Study|Adverse Event|15|||
146152199|NCT02504294|527067804|FG001|Overall Study|Adverse Event|12|||
146152200|NCT02504294|527067803|FG000|Overall Study|Withdrawal by Subject|7|||
146152201|NCT02504294|527067804|FG001|Overall Study|Withdrawal by Subject|1|||
146152202|NCT02504294|527067803|FG000|Overall Study|Protocol Violation|27|||
146152203|NCT02504294|527067804|FG001|Overall Study|Protocol Violation|26|||
146152204|NCT02504294|527067803|FG000|Overall Study|Physician Decision|1|||
146152205|NCT02504294|527067804|FG001|Overall Study|Physician Decision|2|||
146152206|NCT02504294|527067803|FG000|Overall Study|Lost to Follow-up|6|||
146152207|NCT02504294|527067804|FG001|Overall Study|Lost to Follow-up|7|||
146152208|NCT02252211|527067810|FG000|Overall Study|Adverse Event|0|||
146152209|NCT02252211|527067811|FG001|Overall Study|Adverse Event|1|||
146152210|NCT02252211|527067812|FG002|Overall Study|Adverse Event|0|||
146152211|NCT02252211|527067810|FG000|Overall Study|Progressive disease|3|||
146152212|NCT02252211|527067811|FG001|Overall Study|Progressive disease|2|||
146152213|NCT02252211|527067812|FG002|Overall Study|Progressive disease|0|||
146152214|NCT02252211|527067810|FG000|Overall Study|Withdrawal by Subject|1|||
146152215|NCT02252211|527067811|FG001|Overall Study|Withdrawal by Subject|0|||
146152216|NCT02252211|527067812|FG002|Overall Study|Withdrawal by Subject|0|||
146152217|NCT02252211|527067810|FG000|Overall Study|Serious Adverse Event During Screening|1|||
146152218|NCT02252211|527067811|FG001|Overall Study|Serious Adverse Event During Screening|0|||
146152219|NCT02252211|527067812|FG002|Overall Study|Serious Adverse Event During Screening|1|||
146152220|NCT01953926|527067816|FG000|Overall Study|Withdrawal by Subject|23|||
146152221|NCT01953926|527067817|FG001|Overall Study|Withdrawal by Subject|3|||
146152222|NCT01953926|527067818|FG002|Overall Study|Withdrawal by Subject|3|||
146152223|NCT01953926|527067819|FG003|Overall Study|Withdrawal by Subject|5|||
146152224|NCT01953926|527067820|FG004|Overall Study|Withdrawal by Subject|6|||
146152225|NCT01953926|527067821|FG005|Overall Study|Withdrawal by Subject|0|||
146152226|NCT01953926|527067822|FG006|Overall Study|Withdrawal by Subject|1|||
146152227|NCT01953926|527067816|FG000|Overall Study|Physician Decision|1|||
146152228|NCT01953926|527067817|FG001|Overall Study|Physician Decision|0|||
146152229|NCT01953926|527067818|FG002|Overall Study|Physician Decision|0|||
146152230|NCT01953926|527067819|FG003|Overall Study|Physician Decision|0|||
146152231|NCT01953926|527067820|FG004|Overall Study|Physician Decision|2|||
146152232|NCT01953926|527067821|FG005|Overall Study|Physician Decision|0|||
146152233|NCT01953926|527067822|FG006|Overall Study|Physician Decision|0|||
146152234|NCT01953926|527067816|FG000|Overall Study|Lost to Follow-up|18|||
146152235|NCT01953926|527067817|FG001|Overall Study|Lost to Follow-up|3|||
146152236|NCT01953926|527067818|FG002|Overall Study|Lost to Follow-up|0|||
146152237|NCT01953926|527067819|FG003|Overall Study|Lost to Follow-up|5|||
146152238|NCT01953926|527067820|FG004|Overall Study|Lost to Follow-up|3|||
146152239|NCT01953926|527067821|FG005|Overall Study|Lost to Follow-up|0|||
146152240|NCT01953926|527067822|FG006|Overall Study|Lost to Follow-up|0|||
146152241|NCT01953926|527067816|FG000|Overall Study|Protocol Violation|1|||
146152242|NCT01953926|527067817|FG001|Overall Study|Protocol Violation|0|||
146152243|NCT01953926|527067818|FG002|Overall Study|Protocol Violation|0|||
146152244|NCT01953926|527067819|FG003|Overall Study|Protocol Violation|0|||
146152245|NCT01953926|527067820|FG004|Overall Study|Protocol Violation|0|||
146152246|NCT01953926|527067821|FG005|Overall Study|Protocol Violation|0|||
146152247|NCT01953926|527067822|FG006|Overall Study|Protocol Violation|0|||
146152248|NCT01953926|527067816|FG000|Overall Study|Other, Disease progression|2|||
146152249|NCT01953926|527067817|FG001|Overall Study|Other, Disease progression|1|||
146152250|NCT01953926|527067818|FG002|Overall Study|Other, Disease progression|0|||
146152251|NCT01953926|527067819|FG003|Overall Study|Other, Disease progression|0|||
146152252|NCT01953926|527067820|FG004|Overall Study|Other, Disease progression|1|||
146152253|NCT01953926|527067821|FG005|Overall Study|Other, Disease progression|0|||
146152254|NCT01953926|527067822|FG006|Overall Study|Other, Disease progression|0|||
146152255|NCT01953926|527067816|FG000|Overall Study|Discontinuation of study by sponsor|41|||
146152256|NCT01953926|527067817|FG001|Overall Study|Discontinuation of study by sponsor|7|||
146152257|NCT01953926|527067818|FG002|Overall Study|Discontinuation of study by sponsor|5|||
146152258|NCT01953926|527067819|FG003|Overall Study|Discontinuation of study by sponsor|12|||
146152259|NCT01953926|527067820|FG004|Overall Study|Discontinuation of study by sponsor|46|||
146152260|NCT01953926|527067821|FG005|Overall Study|Discontinuation of study by sponsor|5|||
146152261|NCT01953926|527067822|FG006|Overall Study|Discontinuation of study by sponsor|6|||
146152262|NCT01953926|527067816|FG000|Overall Study|Not Treated|1|||
146152263|NCT01953926|527067817|FG001|Overall Study|Not Treated|0|||
146152264|NCT01953926|527067818|FG002|Overall Study|Not Treated|1|||
146152265|NCT01953926|527067819|FG003|Overall Study|Not Treated|0|||
146152266|NCT01953926|527067820|FG004|Overall Study|Not Treated|0|||
146152267|NCT01953926|527067821|FG005|Overall Study|Not Treated|0|||
146152268|NCT01953926|527067822|FG006|Overall Study|Not Treated|0|||
146152269|NCT01949480|527067824|FG000|Overall Study|Physician Decision|5|||
146306831|NCT03574753|527637301|FG000|Overall Study|Adverse Event|3|||
146306832|NCT03574753|527637301|FG000|Overall Study|Progression/relapse|19|||
146306833|NCT03574753|527637301|FG000|Overall Study|Death|1|||
146306834|NCT00789880|527637302|FG000|Overall Study|Adverse Event|0|||
146306835|NCT00789880|527637303|FG001|Overall Study|Adverse Event|0|||
146306836|NCT00789880|527637304|FG002|Overall Study|Adverse Event|0|||
146306837|NCT00789880|527637305|FG003|Overall Study|Adverse Event|0|||
146306838|NCT00789880|527637306|FG004|Overall Study|Adverse Event|1|||
146306839|NCT00789880|527637307|FG005|Overall Study|Adverse Event|0|||
146306840|NCT00789880|527637302|FG000|Overall Study|Protocol Violation|0|||
146152270|NCT01949480|527067825|FG001|Overall Study|Physician Decision|8|||
146152271|NCT00144339|527067826|FG000|Overall Study|Adverse Event|746|||
146152272|NCT00144339|527067827|FG001|Overall Study|Adverse Event|627|||
146306841|NCT00789880|527637303|FG001|Overall Study|Protocol Violation|1|||
146306842|NCT00789880|527637304|FG002|Overall Study|Protocol Violation|0|||
146306843|NCT00789880|527637305|FG003|Overall Study|Protocol Violation|1|||
146306844|NCT00789880|527637306|FG004|Overall Study|Protocol Violation|0|||
146306845|NCT00789880|527637307|FG005|Overall Study|Protocol Violation|0|||
146306846|NCT00789880|527637302|FG000|Overall Study|Withdrawal by Subject|1|||
146306847|NCT00789880|527637303|FG001|Overall Study|Withdrawal by Subject|0|||
146306848|NCT00789880|527637304|FG002|Overall Study|Withdrawal by Subject|0|||
146306849|NCT00789880|527637305|FG003|Overall Study|Withdrawal by Subject|0|||
146306850|NCT00789880|527637306|FG004|Overall Study|Withdrawal by Subject|2|||
146306851|NCT00789880|527637307|FG005|Overall Study|Withdrawal by Subject|0|||
146306852|NCT05678257|527637313|FG000|Overall Study|Withdrawal by Subject|2|||
146306853|NCT05678257|527637314|FG001|Overall Study|Withdrawal by Subject|0|||
146306854|NCT05678257|527637315|FG002|Overall Study|Withdrawal by Subject|5|||
146306855|NCT05678257|527637313|FG000|Overall Study|Physician Decision|1|||
146306856|NCT05678257|527637314|FG001|Overall Study|Physician Decision|0|||
146306857|NCT05678257|527637315|FG002|Overall Study|Physician Decision|1|||
146306858|NCT05678257|527637313|FG000|Overall Study|Adverse Event|1|||
146306859|NCT05678257|527637314|FG001|Overall Study|Adverse Event|3|||
146152273|NCT00144339|527067826|FG000|Overall Study|Protocol Violation|75|||
146152274|NCT00144339|527067827|FG001|Overall Study|Protocol Violation|48|||
146152275|NCT00144339|527067826|FG000|Overall Study|Withdrawal by Subject|403|||
146152276|NCT00144339|527067827|FG001|Overall Study|Withdrawal by Subject|300|||
146152277|NCT00144339|527067826|FG000|Overall Study|Lost to Follow-up|76|||
146152278|NCT00144339|527067827|FG001|Overall Study|Lost to Follow-up|64|||
146152279|NCT00144339|527067826|FG000|Overall Study|Other|58|||
146152280|NCT00144339|527067827|FG001|Overall Study|Other|60|||
146152281|NCT02265237|527067837|FG000|As Treated (Overall Study)|Adverse Event|1|||
146152282|NCT02265237|527067838|FG001|As Treated (Overall Study)|Adverse Event|1|||
146152283|NCT02265237|527067839|FG002|As Treated (Overall Study)|Adverse Event|0|||
146152284|NCT02265237|527067840|FG003|As Treated (Overall Study)|Adverse Event|0|||
146152285|NCT02265237|527067837|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
146152286|NCT02265237|527067838|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
146152287|NCT02265237|527067839|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
146152288|NCT02265237|527067840|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
146152289|NCT02265237|527067837|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
146152290|NCT02265237|527067838|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
146152291|NCT02265237|527067839|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
146152292|NCT02265237|527067840|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
146152293|NCT02265237|527067837|FG000|As Treated (Overall Study)|Other|2|||
146152294|NCT02265237|527067838|FG001|As Treated (Overall Study)|Other|0|||
146152295|NCT02265237|527067839|FG002|As Treated (Overall Study)|Other|3|||
146306860|NCT05678257|527637315|FG002|Overall Study|Adverse Event|1|||
146306861|NCT05678257|527637313|FG000|Overall Study|Progressive disease|11|||
146306862|NCT05678257|527637314|FG001|Overall Study|Progressive disease|18|||
146306863|NCT05678257|527637315|FG002|Overall Study|Progressive disease|7|||
146306864|NCT05678257|527637313|FG000|Overall Study|No longer clinically benefitting|2|||
146306865|NCT05678257|527637314|FG001|Overall Study|No longer clinically benefitting|1|||
146152296|NCT02265237|527067840|FG003|As Treated (Overall Study)|Other|1|||
146152297|NCT01178853|527067842|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
146152298|NCT01178853|527067843|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
146152299|NCT01178853|527067842|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
146152300|NCT01178853|527067843|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
146152301|NCT01178853|527067842|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
146152302|NCT01178853|527067843|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
146152303|NCT01178853|527067842|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
146152304|NCT01178853|527067843|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
146152305|NCT01178853|527067842|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
146152306|NCT01178853|527067843|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
146152307|NCT03550313|527067844|FG000|Overall Study|Adverse Event|0|||
146152308|NCT03550313|527067845|FG001|Overall Study|Adverse Event|1|||
146152309|NCT03550313|527067846|FG002|Overall Study|Adverse Event|0|||
146152310|NCT03550313|527067844|FG000|Overall Study|Lost to Follow-up|5|||
146152311|NCT03550313|527067845|FG001|Overall Study|Lost to Follow-up|7|||
146152312|NCT03550313|527067846|FG002|Overall Study|Lost to Follow-up|12|||
146152313|NCT03550313|527067844|FG000|Overall Study|Study terminated by sponsor|44|||
146152314|NCT03550313|527067845|FG001|Overall Study|Study terminated by sponsor|37|||
146152315|NCT03550313|527067846|FG002|Overall Study|Study terminated by sponsor|48|||
146152316|NCT03550313|527067844|FG000|Overall Study|No longer met eligibility criteria|3|||
146152317|NCT03550313|527067845|FG001|Overall Study|No longer met eligibility criteria|5|||
146152318|NCT03550313|527067846|FG002|Overall Study|No longer met eligibility criteria|6|||
146152319|NCT03550313|527067844|FG000|Overall Study|Withdrawal by parent/guardian|20|||
146152320|NCT03550313|527067845|FG001|Overall Study|Withdrawal by parent/guardian|18|||
146152321|NCT03550313|527067846|FG002|Overall Study|Withdrawal by parent/guardian|26|||
146152322|NCT03550313|527067844|FG000|Overall Study|Other|4|||
146152323|NCT03550313|527067845|FG001|Overall Study|Other|2|||
146152324|NCT03550313|527067846|FG002|Overall Study|Other|2|||
146152325|NCT03550313|527067844|FG000|Overall Study|Randomized but not vaccinated|3|||
146152326|NCT03550313|527067845|FG001|Overall Study|Randomized but not vaccinated|23|||
146152327|NCT03550313|527067846|FG002|Overall Study|Randomized but not vaccinated|2|||
146152328|NCT03550313|527067844|FG000|Overall Study|Sites terminated due to quality issues|18|||
146152329|NCT03550313|527067845|FG001|Overall Study|Sites terminated due to quality issues|17|||
146152330|NCT03550313|527067846|FG002|Overall Study|Sites terminated due to quality issues|18|||
146152331|NCT00839072|527067847|FG000|First Intervention Period|Withdrawal by Subject|1|||
146152332|NCT00839072|527067848|FG001|First Intervention Period|Withdrawal by Subject|0|||
146152333|NCT00839072|527067847|FG000|First Intervention Period|Adverse Event|1|||
146152334|NCT00839072|527067848|FG001|First Intervention Period|Adverse Event|1|||
146152335|NCT00839072|527067847|FG000|Second Intervention Period|Withdrawal by Subject|1|||
146152336|NCT00839072|527067848|FG001|Second Intervention Period|Withdrawal by Subject|0|||
146152337|NCT01682837|527067849|FG000|Baseline|Withdrawal by Subject|5|||
146152338|NCT01664078|527067852|FG000|Overall Study|Death|9|||
146152339|NCT01664078|527067852|FG000|Overall Study|Withdrawal by Subject|4|||
146152340|NCT01664078|527067852|FG000|Overall Study|Lost to Follow-up|2|||
146152341|NCT01664078|527067852|FG000|Overall Study|missed 5 year visit|1|||
146152342|NCT01664078|527067852|FG000|Overall Study|Other|53|||
146152343|NCT02720484|527067858|FG000|Treatment on Study|Adverse Event|1|||
146152344|NCT02720484|527067858|FG000|Treatment on Study|Withdrawal by Subject|1|||
146152345|NCT02720484|527067858|FG000|Treatment on Study|Progressive Disease|4|||
146152346|NCT02720484|527067858|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
146152347|NCT02720484|527067858|FG000|Follow Up for 2 Years|Death|3|||
146152348|NCT02720484|527067858|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
146152349|NCT05070897|527067862|FG000|Overall Study|Protocol Violation|123|||
146152350|NCT05070897|527067863|FG001|Overall Study|Protocol Violation|68|||
146152351|NCT01617629|527067866|FG000|Overall Study|Death|2|||
146152352|NCT01617629|527067866|FG000|Overall Study|Investigator's Clinical Judgement|1|||
146152353|NCT01617629|527067866|FG000|Overall Study|Reason Not Specified|1|||
146152354|NCT01617629|527067866|FG000|Overall Study|Participant Withdrew Consent|2|||
146152355|NCT01663636|527067867|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
146152356|NCT01663636|527067868|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
146279145|NCT01802567|527536855|FG000|Overall Study|Withdrawal by Subject|2|||
146279146|NCT01802567|527536855|FG000|Overall Study|Physician Decision|1|||
146279147|NCT01802567|527536855|FG000|Overall Study|Lack of Efficacy|7|||
146279148|NCT01802567|527536855|FG000|Overall Study|Consented but did not start therapy|7|||
146279149|NCT01802567|527536855|FG000|Overall Study|Protocol Violation|1|||
146279150|NCT01940939|527536856|FG000|Overall Study|Withdrawal by Subject|2|||
146279151|NCT01940939|527536857|FG001|Overall Study|Withdrawal by Subject|8|||
146306866|NCT05678257|527637315|FG002|Overall Study|No longer clinically benefitting|0|||
146152357|NCT03832946|527067869|FG000|Overall Study|Adverse Event|3|||
146152358|NCT03832946|527067870|FG001|Overall Study|Adverse Event|1|||
146152359|NCT03832946|527067869|FG000|Overall Study|Lost to Follow-up|1|||
146152360|NCT03832946|527067870|FG001|Overall Study|Lost to Follow-up|0|||
146279152|NCT03896152|527536861|FG000|Overall Study|Patient/guardian decision|1|||
146279153|NCT03896152|527536862|FG001|Overall Study|Patient/guardian decision|1|||
146152361|NCT03832946|527067869|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
146152362|NCT03832946|527067870|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
146152363|NCT03832946|527067869|FG000|Overall Study|Lack of Efficacy|1|||
146152364|NCT03832946|527067870|FG001|Overall Study|Lack of Efficacy|0|||
146152365|NCT03832946|527067869|FG000|Overall Study|Withdrawal by Subject|12|||
146152366|NCT03832946|527067870|FG001|Overall Study|Withdrawal by Subject|9|||
146152367|NCT02715765|527067871|FG000|Overall Study|Study Termination|3|||
146152368|NCT02715765|527067872|FG001|Overall Study|Study Termination|0|||
146152369|NCT02715765|527067873|FG002|Overall Study|Study Termination|0|||
146152370|NCT02838017|527067875|FG000|Overall Study|Lost to Follow-up|14|||
146152371|NCT02838017|527067876|FG001|Overall Study|Lost to Follow-up|11|||
146152372|NCT01692197|527067877|FG000|Overall Study|Failed Screening|3|||
146152373|NCT02120924|527067878|FG000|Overall Study|Lack of Efficacy|1|||
146152374|NCT02120924|527067879|FG001|Overall Study|Lack of Efficacy|2|||
146152375|NCT02120924|527067880|FG002|Overall Study|Lack of Efficacy|3|||
146152376|NCT02120924|527067878|FG000|Overall Study|Adverse Event|0|||
146152377|NCT02120924|527067879|FG001|Overall Study|Adverse Event|1|||
146152378|NCT02120924|527067880|FG002|Overall Study|Adverse Event|3|||
146152379|NCT02120924|527067878|FG000|Overall Study|Withdrawal by Subject|16|||
146152380|NCT02120924|527067879|FG001|Overall Study|Withdrawal by Subject|20|||
146152381|NCT02120924|527067880|FG002|Overall Study|Withdrawal by Subject|8|||
146152382|NCT02120924|527067878|FG000|Overall Study|Lost to Follow-up|14|||
146152383|NCT02120924|527067879|FG001|Overall Study|Lost to Follow-up|14|||
146152384|NCT02120924|527067880|FG002|Overall Study|Lost to Follow-up|11|||
146152385|NCT02120924|527067878|FG000|Overall Study|Pregnancy|2|||
146152386|NCT02120924|527067879|FG001|Overall Study|Pregnancy|0|||
146152387|NCT02120924|527067880|FG002|Overall Study|Pregnancy|0|||
146152388|NCT02120924|527067878|FG000|Overall Study|Protocol Violation|3|||
146152389|NCT02120924|527067879|FG001|Overall Study|Protocol Violation|7|||
146152390|NCT02120924|527067880|FG002|Overall Study|Protocol Violation|2|||
146152391|NCT02120924|527067878|FG000|Overall Study|Physician Decision|0|||
146152392|NCT02120924|527067879|FG001|Overall Study|Physician Decision|1|||
146152393|NCT02120924|527067880|FG002|Overall Study|Physician Decision|1|||
146152394|NCT02120924|527067878|FG000|Overall Study|Death|1|||
146152395|NCT02120924|527067879|FG001|Overall Study|Death|0|||
146152396|NCT02120924|527067880|FG002|Overall Study|Death|0|||
146152397|NCT02120924|527067878|FG000|Overall Study|Compliance with IP|5|||
146152398|NCT02120924|527067879|FG001|Overall Study|Compliance with IP|1|||
146152399|NCT02120924|527067880|FG002|Overall Study|Compliance with IP|1|||
146152400|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
146152401|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
146152402|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
146152403|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
146152404|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
146152405|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
146152406|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
146152407|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
146152408|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
146152409|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
146152410|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
146152411|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
146152412|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
146152413|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
146152414|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
146152415|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146152416|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
146152417|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146152418|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
146152419|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
146152420|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
146279154|NCT03896152|527536861|FG000|Overall Study|Adverse Event|0|||
146279155|NCT03896152|527536862|FG001|Overall Study|Adverse Event|1|||
146279156|NCT03896152|527536861|FG000|Overall Study|Physician Decision|1|||
146279157|NCT03896152|527536862|FG001|Overall Study|Physician Decision|0|||
146279158|NCT03896152|527536861|FG000|Overall Study|Technical problems|1|||
146279159|NCT03896152|527536862|FG001|Overall Study|Technical problems|0|||
146279160|NCT00436852|527536863|FG000|Overall Study|Death|23|||
146279161|NCT00436852|527536864|FG001|Overall Study|Death|34|||
146279162|NCT00436852|527536863|FG000|Overall Study|Lack of Efficacy|9|||
146279163|NCT00436852|527536864|FG001|Overall Study|Lack of Efficacy|7|||
146279164|NCT00436852|527536863|FG000|Overall Study|Withdrawal by Subject|2|||
146279165|NCT00436852|527536864|FG001|Overall Study|Withdrawal by Subject|4|||
146279166|NCT00436852|527536863|FG000|Overall Study|Ineligible|1|||
146279167|NCT00436852|527536864|FG001|Overall Study|Ineligible|0|||
146279168|NCT00370682|527536865|FG000|Overall Study|Moved from area|0|||
146279169|NCT00370682|527536866|FG001|Overall Study|Moved from area|2|||
146279170|NCT00370682|527536867|FG002|Overall Study|Moved from area|0|||
146152421|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
146152422|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
146152423|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
146152424|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
146152425|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
146152426|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
146152427|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
146152428|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
146152429|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
146152430|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
146152431|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
146152432|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
146152433|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
146152434|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
146152435|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
146152436|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
146152437|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
146152438|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
146152439|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
146152440|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
146152441|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
146152442|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
146152443|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
146152444|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
146152445|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
146152446|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
146152447|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
146152448|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
146152449|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
146152450|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
146152451|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
146152452|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
146152453|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
146152454|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
146152455|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
146152456|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
146152457|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
146152458|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
146152459|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
146152460|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
146152461|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
146152462|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
146152463|NCT01884350|527067881|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
146152464|NCT01884350|527067882|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
146152465|NCT01884350|527067883|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
146152466|NCT03712917|527067888|FG000|Overall Study|Pregnancy|0|||
146152467|NCT03712917|527067889|FG001|Overall Study|Pregnancy|0|||
146152468|NCT03712917|527067890|FG002|Overall Study|Pregnancy|1|||
146152469|NCT03712917|527067888|FG000|Overall Study|Adverse Event|0|||
146152470|NCT03712917|527067889|FG001|Overall Study|Adverse Event|4|||
146152471|NCT03712917|527067890|FG002|Overall Study|Adverse Event|3|||
146152472|NCT03712917|527067888|FG000|Overall Study|Lost to Follow-up|9|||
146152473|NCT03712917|527067889|FG001|Overall Study|Lost to Follow-up|4|||
146152474|NCT03712917|527067890|FG002|Overall Study|Lost to Follow-up|5|||
146152475|NCT04537923|527069789|FG000|Overall Study|Adverse Event|2|||
146152476|NCT04537923|527069790|FG001|Overall Study|Adverse Event|1|||
146152477|NCT04537923|527069791|FG002|Overall Study|Adverse Event|2|||
146152478|NCT04537923|527069792|FG003|Overall Study|Adverse Event|4|||
146152479|NCT04537923|527069789|FG000|Overall Study|Death|3|||
146152480|NCT04537923|527069790|FG001|Overall Study|Death|3|||
146152481|NCT04537923|527069791|FG002|Overall Study|Death|1|||
146152482|NCT04537923|527069792|FG003|Overall Study|Death|11|||
146152483|NCT04537923|527069789|FG000|Overall Study|Lost to Follow-up|1|||
146152484|NCT04537923|527069790|FG001|Overall Study|Lost to Follow-up|2|||
146152485|NCT04537923|527069791|FG002|Overall Study|Lost to Follow-up|1|||
146152486|NCT04537923|527069792|FG003|Overall Study|Lost to Follow-up|6|||
146152487|NCT04537923|527069789|FG000|Overall Study|Physician Decision|1|||
146152488|NCT04537923|527069790|FG001|Overall Study|Physician Decision|0|||
146152489|NCT04537923|527069791|FG002|Overall Study|Physician Decision|2|||
146306867|NCT05678257|527637313|FG000|Overall Study|Sponsor decision|5|||
146306868|NCT05678257|527637314|FG001|Overall Study|Sponsor decision|9|||
146306869|NCT05678257|527637315|FG002|Overall Study|Sponsor decision|8|||
146306870|NCT05678257|527637313|FG000|Overall Study|Protocol Violation|0|||
146306871|NCT05678257|527637314|FG001|Overall Study|Protocol Violation|0|||
146306872|NCT05678257|527637315|FG002|Overall Study|Protocol Violation|1|||
146306873|NCT05678257|527637313|FG000|Overall Study|Patient non-compliance|0|||
146306874|NCT05678257|527637314|FG001|Overall Study|Patient non-compliance|0|||
146306875|NCT05678257|527637315|FG002|Overall Study|Patient non-compliance|3|||
146306876|NCT02046096|527637316|FG000|Overall Study|Death|28|||
146306877|NCT02046096|527637317|FG001|Overall Study|Death|45|||
146306878|NCT02046096|527637316|FG000|Overall Study|Lost to Follow-up|9|||
146152490|NCT04537923|527069792|FG003|Overall Study|Physician Decision|5|||
146152491|NCT04537923|527069789|FG000|Overall Study|Pregnancy|1|||
146152492|NCT04537923|527069790|FG001|Overall Study|Pregnancy|0|||
146306879|NCT02046096|527637317|FG001|Overall Study|Lost to Follow-up|20|||
146306880|NCT02046096|527637316|FG000|Overall Study|Withdrawal by Subject|5|||
146306881|NCT02046096|527637317|FG001|Overall Study|Withdrawal by Subject|17|||
146306882|NCT02046096|527637316|FG000|Overall Study|Other endpoint|2|||
146152493|NCT04537923|527069791|FG002|Overall Study|Pregnancy|0|||
146152494|NCT04537923|527069792|FG003|Overall Study|Pregnancy|0|||
146306883|NCT02046096|527637317|FG001|Overall Study|Other endpoint|19|||
146306884|NCT03520959|527637318|FG000|Overall Study|Study terminated by Sponsor|0|||
146306885|NCT03520959|527637319|FG001|Overall Study|Study terminated by Sponsor|1|||
146306886|NCT01449461|527637320|FG000|Overall Study|Adverse Event|0|||
146306887|NCT01449461|527637321|FG001|Overall Study|Adverse Event|3|||
146306888|NCT01449461|527637322|FG002|Overall Study|Adverse Event|2|||
146306889|NCT01449461|527637323|FG003|Overall Study|Adverse Event|3|||
146306890|NCT01449461|527637324|FG004|Overall Study|Adverse Event|4|||
146306891|NCT01449461|527637325|FG005|Overall Study|Adverse Event|4|||
146306892|NCT01449461|527637320|FG000|Overall Study|Death|0|||
146306893|NCT01449461|527637321|FG001|Overall Study|Death|2|||
146306894|NCT01449461|527637322|FG002|Overall Study|Death|0|||
146306895|NCT01449461|527637323|FG003|Overall Study|Death|0|||
146306896|NCT01449461|527637324|FG004|Overall Study|Death|7|||
146306897|NCT01449461|527637325|FG005|Overall Study|Death|1|||
146306898|NCT01449461|527637320|FG000|Overall Study|Physician Decision|0|||
146306899|NCT01449461|527637321|FG001|Overall Study|Physician Decision|1|||
146306900|NCT01449461|527637322|FG002|Overall Study|Physician Decision|0|||
146306901|NCT01449461|527637323|FG003|Overall Study|Physician Decision|4|||
146306902|NCT01449461|527637324|FG004|Overall Study|Physician Decision|1|||
146306903|NCT01449461|527637325|FG005|Overall Study|Physician Decision|0|||
146306904|NCT01449461|527637320|FG000|Overall Study|Documented Progressive Disease|4|||
146152495|NCT04537923|527069789|FG000|Overall Study|Withdrawal by Subject|4|||
146152496|NCT04537923|527069790|FG001|Overall Study|Withdrawal by Subject|4|||
146152497|NCT04537923|527069791|FG002|Overall Study|Withdrawal by Subject|4|||
146152498|NCT04537923|527069792|FG003|Overall Study|Withdrawal by Subject|58|||
146152499|NCT04537923|527069789|FG000|Overall Study|Missed study visits|2|||
146152500|NCT04537923|527069790|FG001|Overall Study|Missed study visits|0|||
146152501|NCT04537923|527069791|FG002|Overall Study|Missed study visits|0|||
146152502|NCT04537923|527069792|FG003|Overall Study|Missed study visits|3|||
146152503|NCT04537923|527069789|FG000|Overall Study|Sponsor's decision|0|||
146152504|NCT04537923|527069790|FG001|Overall Study|Sponsor's decision|0|||
146152505|NCT04537923|527069791|FG002|Overall Study|Sponsor's decision|1|||
146152506|NCT04537923|527069792|FG003|Overall Study|Sponsor's decision|1|||
146152507|NCT04537923|527069789|FG000|Overall Study|Safety reasons|1|||
146152508|NCT04537923|527069790|FG001|Overall Study|Safety reasons|0|||
146152509|NCT04537923|527069791|FG002|Overall Study|Safety reasons|0|||
146152510|NCT04537923|527069792|FG003|Overall Study|Safety reasons|0|||
146152511|NCT01261611|527069793|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
146152512|NCT01261611|527069794|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
146152513|NCT01261611|527069795|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
146152514|NCT01261611|527069793|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
146152515|NCT01261611|527069794|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
146306905|NCT01449461|527637321|FG001|Overall Study|Documented Progressive Disease|7|||
146152516|NCT01261611|527069795|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
146152517|NCT01261611|527069793|FG000|Treatment Cycle 1|Adverse Event|0|||
146152518|NCT01261611|527069794|FG001|Treatment Cycle 1|Adverse Event|1|||
146306906|NCT01449461|527637322|FG002|Overall Study|Documented Progressive Disease|14|||
146306907|NCT01449461|527637323|FG003|Overall Study|Documented Progressive Disease|15|||
146306908|NCT01449461|527637324|FG004|Overall Study|Documented Progressive Disease|24|||
146306909|NCT01449461|527637325|FG005|Overall Study|Documented Progressive Disease|5|||
146306910|NCT01449461|527637320|FG000|Overall Study|Clinical Progressive Disease|2|||
146306911|NCT01449461|527637321|FG001|Overall Study|Clinical Progressive Disease|2|||
146152519|NCT01261611|527069795|FG002|Treatment Cycle 1|Adverse Event|0|||
146152520|NCT01261611|527069793|FG000|Treatment Cycle 1|Protocol Violation|0|||
146152521|NCT01261611|527069794|FG001|Treatment Cycle 1|Protocol Violation|0|||
146152522|NCT01261611|527069795|FG002|Treatment Cycle 1|Protocol Violation|2|||
146152523|NCT01261611|527069793|FG000|Treatment Cycle 2|Completed study|4|||
146152524|NCT01261611|527069794|FG001|Treatment Cycle 2|Completed study|0|||
146152525|NCT01261611|527069795|FG002|Treatment Cycle 2|Completed study|0|||
146152526|NCT01261611|527069793|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
146152527|NCT01261611|527069794|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
146152528|NCT01261611|527069795|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
146152529|NCT01261611|527069793|FG000|Treatment Cycle 2|Adverse Event|1|||
146152530|NCT01261611|527069794|FG001|Treatment Cycle 2|Adverse Event|0|||
146152531|NCT01261611|527069795|FG002|Treatment Cycle 2|Adverse Event|0|||
146152532|NCT01261611|527069793|FG000|Treatment Cycle 2|Protocol Violation|2|||
146152533|NCT01261611|527069794|FG001|Treatment Cycle 2|Protocol Violation|0|||
146152534|NCT01261611|527069795|FG002|Treatment Cycle 2|Protocol Violation|0|||
146152535|NCT01261611|527069793|FG000|Treatment Cycle 2|Not otherwise specified|2|||
146152536|NCT01261611|527069794|FG001|Treatment Cycle 2|Not otherwise specified|0|||
146152537|NCT01261611|527069795|FG002|Treatment Cycle 2|Not otherwise specified|0|||
146152538|NCT01261611|527069793|FG000|Treatment Cycle 3|Completed study|24|||
146152539|NCT01261611|527069794|FG001|Treatment Cycle 3|Completed study|0|||
146152540|NCT01261611|527069795|FG002|Treatment Cycle 3|Completed study|0|||
146152541|NCT01261611|527069793|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
146152542|NCT01261611|527069794|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
146152543|NCT01261611|527069795|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
146152544|NCT01261611|527069793|FG000|Treatment Cycle 3|Adverse Event|1|||
146152545|NCT01261611|527069794|FG001|Treatment Cycle 3|Adverse Event|0|||
146152546|NCT01261611|527069795|FG002|Treatment Cycle 3|Adverse Event|0|||
146152547|NCT01261611|527069793|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
146152548|NCT01261611|527069794|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
146152549|NCT01261611|527069795|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
146152550|NCT01261611|527069793|FG000|Treatment Cycle 4|Completed study|87|||
146152551|NCT01261611|527069794|FG001|Treatment Cycle 4|Completed study|0|||
146152552|NCT01261611|527069795|FG002|Treatment Cycle 4|Completed study|0|||
146152553|NCT01261611|527069793|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
146152554|NCT01261611|527069794|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
146152555|NCT01261611|527069795|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
146152556|NCT01261611|527069793|FG000|Treatment Cycle 4|Adverse Event|1|||
146152557|NCT01261611|527069794|FG001|Treatment Cycle 4|Adverse Event|0|||
146152558|NCT01261611|527069795|FG002|Treatment Cycle 4|Adverse Event|0|||
146152559|NCT01261611|527069793|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
146152560|NCT01261611|527069794|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
146152561|NCT01261611|527069795|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
146152562|NCT01261611|527069793|FG000|Treatment Cycle 4|Not otherwise specified|3|||
146152563|NCT01261611|527069794|FG001|Treatment Cycle 4|Not otherwise specified|0|||
146152564|NCT01261611|527069795|FG002|Treatment Cycle 4|Not otherwise specified|0|||
146152565|NCT01261611|527069793|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
146152566|NCT01261611|527069794|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
146152567|NCT01261611|527069795|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
146152568|NCT01261611|527069793|FG000|Treatment Cycle 5|Adverse Event|1|||
146152569|NCT01261611|527069794|FG001|Treatment Cycle 5|Adverse Event|0|||
146152570|NCT01261611|527069795|FG002|Treatment Cycle 5|Adverse Event|0|||
146152571|NCT01261611|527069793|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
146152572|NCT01261611|527069794|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
146152573|NCT01261611|527069795|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
146152574|NCT03586648|527069799|FG000|Period 1|Withdrawal by Subject|0|||
146152575|NCT03586648|527069800|FG001|Period 1|Withdrawal by Subject|1|||
146152576|NCT03586648|527069799|FG000|Period 1|Lost to Follow-up|1|||
146152577|NCT03586648|527069800|FG001|Period 1|Lost to Follow-up|1|||
146152578|NCT03586648|527069799|FG000|Period 1|Adverse Event|1|||
146152579|NCT03586648|527069800|FG001|Period 1|Adverse Event|0|||
146152580|NCT03586648|527069799|FG000|Period 1|Study related symptoms or complaints|2|||
146152581|NCT03586648|527069800|FG001|Period 1|Study related symptoms or complaints|1|||
146152582|NCT03586648|527069799|FG000|Period 1|Physician Decision|0|||
146152583|NCT03586648|527069800|FG001|Period 1|Physician Decision|1|||
146152584|NCT03586648|527069799|FG000|Period 2|Adverse Event|1|||
146152585|NCT03586648|527069800|FG001|Period 2|Adverse Event|0|||
146152586|NCT02395120|527069801|FG000|Overall Study|Missed follow-up dental exam|57|||
146152587|NCT02395120|527069802|FG001|Overall Study|Missed follow-up dental exam|62|||
146152588|NCT02395120|527069803|FG002|Overall Study|Missed follow-up dental exam|6|||
146152589|NCT02395120|527069804|FG003|Overall Study|Missed follow-up dental exam|6|||
146152590|NCT02395120|527069805|FG004|Overall Study|Missed follow-up dental exam|51|||
146152591|NCT00377234|527069806|FG000|Overall Study|Adverse Event|14|||
146152592|NCT00377234|527069807|FG001|Overall Study|Adverse Event|17|||
146152593|NCT00377234|527069806|FG000|Overall Study|Withdrawal by Subject|11|||
146152594|NCT00377234|527069807|FG001|Overall Study|Withdrawal by Subject|9|||
146152595|NCT00377234|527069806|FG000|Overall Study|Lost to Follow-up|4|||
146306912|NCT01449461|527637322|FG002|Overall Study|Clinical Progressive Disease|0|||
146306913|NCT01449461|527637323|FG003|Overall Study|Clinical Progressive Disease|3|||
146152596|NCT00377234|527069807|FG001|Overall Study|Lost to Follow-up|2|||
146152597|NCT00377234|527069806|FG000|Overall Study|Administrative|2|||
146152598|NCT00377234|527069807|FG001|Overall Study|Administrative|1|||
146152599|NCT00377234|527069806|FG000|Overall Study|Not assigned|3|||
146152600|NCT00377234|527069807|FG001|Overall Study|Not assigned|2|||
146152601|NCT01159691|527069811|FG000|Overall Study|Lost to Follow-up|2|||
146152602|NCT01159691|527069811|FG000|Overall Study|Unknown reasons|1|||
146152603|NCT01159691|527069811|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
146152604|NCT01159691|527069811|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
146152605|NCT01159691|527069811|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
146152606|NCT01159691|527069811|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
146152607|NCT01159691|527069811|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
146152608|NCT01159691|527069811|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
146152609|NCT00896168|527069812|FG000|Overall Study|Adverse Event|4|||
146152610|NCT00896168|527069813|FG001|Overall Study|Adverse Event|7|||
146152611|NCT00896168|527069812|FG000|Overall Study|Treatment failure|8|||
146152612|NCT00896168|527069813|FG001|Overall Study|Treatment failure|10|||
146152613|NCT00896168|527069812|FG000|Overall Study|Lost to Follow-up|1|||
146152614|NCT00896168|527069813|FG001|Overall Study|Lost to Follow-up|1|||
146152615|NCT00896168|527069812|FG000|Overall Study|Other|1|||
146152616|NCT00896168|527069813|FG001|Overall Study|Other|1|||
146152617|NCT00384085|527069814|FG000|Overall Study|Adverse Event|5|||
146152618|NCT00384085|527069815|FG001|Overall Study|Adverse Event|5|||
146152619|NCT00384085|527069816|FG002|Overall Study|Adverse Event|4|||
146152620|NCT00384085|527069814|FG000|Overall Study|Lack of Efficacy|0|||
146152621|NCT00384085|527069815|FG001|Overall Study|Lack of Efficacy|3|||
146152622|NCT00384085|527069816|FG002|Overall Study|Lack of Efficacy|2|||
146152623|NCT00384085|527069814|FG000|Overall Study|No longer Requires Study Treatment|1|||
146152624|NCT00384085|527069815|FG001|Overall Study|No longer Requires Study Treatment|0|||
146152625|NCT00384085|527069816|FG002|Overall Study|No longer Requires Study Treatment|1|||
146152626|NCT00384085|527069814|FG000|Overall Study|Protocol Violation|2|||
146152627|NCT00384085|527069815|FG001|Overall Study|Protocol Violation|2|||
146152628|NCT00384085|527069816|FG002|Overall Study|Protocol Violation|2|||
146152629|NCT00384085|527069814|FG000|Overall Study|Lost to Follow-up|9|||
146152630|NCT00384085|527069815|FG001|Overall Study|Lost to Follow-up|9|||
146152631|NCT00384085|527069816|FG002|Overall Study|Lost to Follow-up|10|||
146152632|NCT00384085|527069814|FG000|Overall Study|Progressive Disease|0|||
146152633|NCT00384085|527069815|FG001|Overall Study|Progressive Disease|1|||
146152634|NCT00384085|527069816|FG002|Overall Study|Progressive Disease|0|||
146152635|NCT00384085|527069814|FG000|Overall Study|Withdrawal by Subject|14|||
146152636|NCT00384085|527069815|FG001|Overall Study|Withdrawal by Subject|19|||
146152637|NCT00384085|527069816|FG002|Overall Study|Withdrawal by Subject|29|||
146152638|NCT00384085|527069814|FG000|Overall Study|Patient non-compliant|4|||
146152639|NCT00384085|527069815|FG001|Overall Study|Patient non-compliant|4|||
146152640|NCT00384085|527069816|FG002|Overall Study|Patient non-compliant|5|||
146152641|NCT00384085|527069814|FG000|Overall Study|Physician Decision|1|||
146152642|NCT00384085|527069815|FG001|Overall Study|Physician Decision|0|||
146152643|NCT00384085|527069816|FG002|Overall Study|Physician Decision|0|||
146152644|NCT00384085|527069814|FG000|Overall Study|Loss of site personnel|1|||
146152645|NCT00384085|527069815|FG001|Overall Study|Loss of site personnel|0|||
146152646|NCT00384085|527069816|FG002|Overall Study|Loss of site personnel|1|||
146152647|NCT00384085|527069814|FG000|Overall Study|Sponsor decision|1|||
146152648|NCT00384085|527069815|FG001|Overall Study|Sponsor decision|2|||
146152649|NCT00384085|527069816|FG002|Overall Study|Sponsor decision|1|||
146152650|NCT00384085|527069814|FG000|Overall Study|Patient moved|1|||
146152651|NCT00384085|527069815|FG001|Overall Study|Patient moved|0|||
146152652|NCT00384085|527069816|FG002|Overall Study|Patient moved|1|||
146152653|NCT00384085|527069814|FG000|Overall Study|Patient required surgery|0|||
146152654|NCT00384085|527069815|FG001|Overall Study|Patient required surgery|1|||
146152655|NCT00384085|527069816|FG002|Overall Study|Patient required surgery|0|||
146152656|NCT03725982|527069817|FG000|First Intervention|Withdrawal by Subject|0|||
146152657|NCT03725982|527069818|FG001|First Intervention|Withdrawal by Subject|1|||
146152658|NCT03725982|527069817|FG000|First Intervention|Physician Decision|1|||
146152659|NCT03725982|527069818|FG001|First Intervention|Physician Decision|1|||
146152660|NCT01944631|527069820|FG000|Overall Study|Adverse Event|1|||
146152661|NCT01944631|527069821|FG001|Overall Study|Adverse Event|0|||
146306914|NCT01449461|527637324|FG004|Overall Study|Clinical Progressive Disease|4|||
146306915|NCT01449461|527637325|FG005|Overall Study|Clinical Progressive Disease|2|||
146152662|NCT01944631|527069820|FG000|Overall Study|Lost to Follow-up|3|||
146152663|NCT01944631|527069821|FG001|Overall Study|Lost to Follow-up|1|||
146152664|NCT01944631|527069820|FG000|Overall Study|Withdrawal by Subject|0|||
146152665|NCT01944631|527069821|FG001|Overall Study|Withdrawal by Subject|1|||
146152666|NCT00838110|527069822|FG000|Overall Study|Death|0|||
146152667|NCT00838110|527069823|FG001|Overall Study|Death|0|||
146152668|NCT00838110|527069824|FG002|Overall Study|Death|1|||
146152669|NCT00838110|527069825|FG003|Overall Study|Death|2|||
146152670|NCT00838110|527069822|FG000|Overall Study|Adverse Event|11|||
146152671|NCT00838110|527069823|FG001|Overall Study|Adverse Event|10|||
146152672|NCT00838110|527069824|FG002|Overall Study|Adverse Event|8|||
146152673|NCT00838110|527069825|FG003|Overall Study|Adverse Event|7|||
146152674|NCT00838110|527069822|FG000|Overall Study|Withdrawal by Subject|5|||
146152675|NCT00838110|527069823|FG001|Overall Study|Withdrawal by Subject|6|||
146152676|NCT00838110|527069824|FG002|Overall Study|Withdrawal by Subject|3|||
146152677|NCT00838110|527069825|FG003|Overall Study|Withdrawal by Subject|4|||
146152678|NCT00838110|527069822|FG000|Overall Study|Other|3|||
146152679|NCT00838110|527069823|FG001|Overall Study|Other|3|||
146152680|NCT00838110|527069824|FG002|Overall Study|Other|3|||
146152681|NCT00838110|527069825|FG003|Overall Study|Other|2|||
146152682|NCT00838110|527069822|FG000|Overall Study|Protocol Violation|0|||
146152683|NCT00838110|527069823|FG001|Overall Study|Protocol Violation|2|||
146152684|NCT00838110|527069824|FG002|Overall Study|Protocol Violation|1|||
146152685|NCT00838110|527069825|FG003|Overall Study|Protocol Violation|1|||
146152686|NCT00838110|527069822|FG000|Overall Study|Lost to Follow-up|3|||
146152687|NCT00838110|527069823|FG001|Overall Study|Lost to Follow-up|0|||
146152688|NCT00838110|527069824|FG002|Overall Study|Lost to Follow-up|0|||
146152689|NCT00838110|527069825|FG003|Overall Study|Lost to Follow-up|0|||
146152690|NCT00838110|527069822|FG000|Overall Study|Did not meet eligibility criteria|0|||
146152691|NCT00838110|527069823|FG001|Overall Study|Did not meet eligibility criteria|0|||
146152692|NCT00838110|527069824|FG002|Overall Study|Did not meet eligibility criteria|1|||
146152693|NCT00838110|527069825|FG003|Overall Study|Did not meet eligibility criteria|2|||
146152694|NCT00838110|527069822|FG000|Overall Study|Randomized but not treated|0|||
146152695|NCT00838110|527069823|FG001|Overall Study|Randomized but not treated|1|||
146152696|NCT00838110|527069824|FG002|Overall Study|Randomized but not treated|0|||
146152697|NCT00838110|527069825|FG003|Overall Study|Randomized but not treated|0|||
146152698|NCT02811861|527069826|FG000|Overall Study|Radiological Disease Progression|123|||
146152699|NCT02811861|527069827|FG001|Overall Study|Radiological Disease Progression|97|||
146152700|NCT02811861|527069828|FG002|Overall Study|Radiological Disease Progression|174|||
146152701|NCT02811861|527069826|FG000|Overall Study|Clinical Disease Progression|20|||
146152702|NCT02811861|527069827|FG001|Overall Study|Clinical Disease Progression|19|||
146152703|NCT02811861|527069828|FG002|Overall Study|Clinical Disease Progression|22|||
146152704|NCT02811861|527069826|FG000|Overall Study|Adverse Event|63|||
146306916|NCT01449461|527637320|FG000|Overall Study|Protocol Violation|0|||
146306917|NCT01449461|527637321|FG001|Overall Study|Protocol Violation|0|||
146306918|NCT01449461|527637322|FG002|Overall Study|Protocol Violation|0|||
146306919|NCT01449461|527637323|FG003|Overall Study|Protocol Violation|1|||
146306920|NCT01449461|527637324|FG004|Overall Study|Protocol Violation|0|||
146306921|NCT01449461|527637325|FG005|Overall Study|Protocol Violation|0|||
146306922|NCT01449461|527637320|FG000|Overall Study|Site Terminated by Sponsor|0|||
146306923|NCT01449461|527637321|FG001|Overall Study|Site Terminated by Sponsor|1|||
146306924|NCT01449461|527637322|FG002|Overall Study|Site Terminated by Sponsor|2|||
146306925|NCT01449461|527637323|FG003|Overall Study|Site Terminated by Sponsor|3|||
146306926|NCT01449461|527637324|FG004|Overall Study|Site Terminated by Sponsor|4|||
146306927|NCT01449461|527637325|FG005|Overall Study|Site Terminated by Sponsor|1|||
146306928|NCT01449461|527637320|FG000|Overall Study|Withdrawal by Subject|0|||
146306929|NCT01449461|527637321|FG001|Overall Study|Withdrawal by Subject|1|||
146306930|NCT01449461|527637322|FG002|Overall Study|Withdrawal by Subject|0|||
146306931|NCT01449461|527637323|FG003|Overall Study|Withdrawal by Subject|0|||
146306932|NCT01449461|527637324|FG004|Overall Study|Withdrawal by Subject|2|||
146306933|NCT01449461|527637325|FG005|Overall Study|Withdrawal by Subject|1|||
146306934|NCT01449461|527637320|FG000|Overall Study|Reason not Specified|0|||
146306935|NCT01449461|527637321|FG001|Overall Study|Reason not Specified|1|||
146306936|NCT01449461|527637322|FG002|Overall Study|Reason not Specified|0|||
146306937|NCT01449461|527637323|FG003|Overall Study|Reason not Specified|3|||
146306938|NCT01449461|527637324|FG004|Overall Study|Reason not Specified|2|||
146306939|NCT01449461|527637325|FG005|Overall Study|Reason not Specified|1|||
146152705|NCT02811861|527069827|FG001|Overall Study|Adverse Event|60|||
146152706|NCT02811861|527069828|FG002|Overall Study|Adverse Event|41|||
146152707|NCT02811861|527069826|FG000|Overall Study|Lost to Follow-up|0|||
146152708|NCT02811861|527069827|FG001|Overall Study|Lost to Follow-up|0|||
146152709|NCT02811861|527069828|FG002|Overall Study|Lost to Follow-up|1|||
146152710|NCT02811861|527069826|FG000|Overall Study|Subject Choice|29|||
146152711|NCT02811861|527069827|FG001|Overall Study|Subject Choice|17|||
146152712|NCT02811861|527069828|FG002|Overall Study|Subject Choice|23|||
146306940|NCT05314517|527637327|FG000|Double-blind Period|Adverse Event|4|||
146152713|NCT02811861|527069826|FG000|Overall Study|Withdrawal by Subject|4|||
146306941|NCT05314517|527637328|FG001|Double-blind Period|Adverse Event|0|||
146306942|NCT05314517|527637329|FG002|Double-blind Period|Adverse Event|0|||
146306943|NCT05314517|527637330|FG003|Double-blind Period|Adverse Event|0|||
146152714|NCT02811861|527069827|FG001|Overall Study|Withdrawal by Subject|4|||
146152715|NCT02811861|527069828|FG002|Overall Study|Withdrawal by Subject|9|||
146152716|NCT02811861|527069826|FG000|Overall Study|Other|4|||
146306944|NCT05314517|527637327|FG000|Double-blind Period|Noncompliance|0|||
146306945|NCT05314517|527637328|FG001|Double-blind Period|Noncompliance|1|||
146306946|NCT05314517|527637329|FG002|Double-blind Period|Noncompliance|0|||
146152717|NCT02811861|527069827|FG001|Overall Study|Other|13|||
146152718|NCT02811861|527069828|FG002|Overall Study|Other|3|||
146306947|NCT05314517|527637330|FG003|Double-blind Period|Noncompliance|0|||
146152719|NCT02811861|527069826|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
146152720|NCT02811861|527069827|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
146152721|NCT02811861|527069828|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
146152722|NCT02811861|527069826|FG000|Overall Study|Randomized but not treated|2|||
146152723|NCT02811861|527069827|FG001|Overall Study|Randomized but not treated|3|||
146306948|NCT05314517|527637327|FG000|Double-blind Period|Randomized, not treated|1|||
146306949|NCT05314517|527637328|FG001|Double-blind Period|Randomized, not treated|0|||
146306950|NCT05314517|527637329|FG002|Double-blind Period|Randomized, not treated|0|||
146306951|NCT05314517|527637330|FG003|Double-blind Period|Randomized, not treated|0|||
146306952|NCT05314517|527637327|FG000|Open-label Extension|Adverse Event|0|||
146306953|NCT05314517|527637328|FG001|Open-label Extension|Adverse Event|0|||
146306954|NCT05314517|527637329|FG002|Open-label Extension|Adverse Event|1|||
146306955|NCT05314517|527637330|FG003|Open-label Extension|Adverse Event|2|||
146306956|NCT05314517|527637327|FG000|Open-label Extension|Investigator decision|0|||
146306957|NCT05314517|527637328|FG001|Open-label Extension|Investigator decision|0|||
146306958|NCT05314517|527637329|FG002|Open-label Extension|Investigator decision|1|||
146306959|NCT05314517|527637330|FG003|Open-label Extension|Investigator decision|0|||
146306960|NCT05314517|527637327|FG000|Open-label Extension|Lost to Follow-up|0|||
146152724|NCT02811861|527069828|FG002|Overall Study|Randomized but not treated|17|||
146152725|NCT04743908|527069829|FG000|Overall Study|Death|1|||
146152726|NCT04743908|527069830|FG001|Overall Study|Death|0|||
146152727|NCT04743908|527069829|FG000|Overall Study|Lost to Follow-up|181|||
146152728|NCT04743908|527069830|FG001|Overall Study|Lost to Follow-up|180|||
146152729|NCT04743908|527069829|FG000|Overall Study|Withdrawal by Subject|1|||
146152730|NCT04743908|527069830|FG001|Overall Study|Withdrawal by Subject|2|||
146152731|NCT00467870|527069833|FG000|Overall Study|Adverse Event|13|||
146152732|NCT00467870|527069834|FG001|Overall Study|Adverse Event|9|||
146152733|NCT00467870|527069835|FG002|Overall Study|Adverse Event|1|||
146152734|NCT00467870|527069836|FG003|Overall Study|Adverse Event|15|||
146152735|NCT00467870|527069837|FG004|Overall Study|Adverse Event|15|||
146152736|NCT00467870|527069838|FG005|Overall Study|Adverse Event|1|||
146152737|NCT00467870|527069833|FG000|Overall Study|Protocol Violation|2|||
146152738|NCT00467870|527069834|FG001|Overall Study|Protocol Violation|1|||
146152739|NCT00467870|527069835|FG002|Overall Study|Protocol Violation|1|||
146152740|NCT00467870|527069836|FG003|Overall Study|Protocol Violation|2|||
146152741|NCT00467870|527069837|FG004|Overall Study|Protocol Violation|0|||
146152742|NCT00467870|527069838|FG005|Overall Study|Protocol Violation|0|||
146152743|NCT00467870|527069833|FG000|Overall Study|Withdrawal by Subject|14|||
146152744|NCT00467870|527069834|FG001|Overall Study|Withdrawal by Subject|21|||
146152745|NCT00467870|527069835|FG002|Overall Study|Withdrawal by Subject|0|||
146152746|NCT00467870|527069836|FG003|Overall Study|Withdrawal by Subject|9|||
146152747|NCT00467870|527069837|FG004|Overall Study|Withdrawal by Subject|10|||
146152748|NCT00467870|527069838|FG005|Overall Study|Withdrawal by Subject|1|||
146152749|NCT00467870|527069833|FG000|Overall Study|Lost to Follow-up|5|||
146152750|NCT00467870|527069834|FG001|Overall Study|Lost to Follow-up|3|||
146152751|NCT00467870|527069835|FG002|Overall Study|Lost to Follow-up|1|||
146152752|NCT00467870|527069836|FG003|Overall Study|Lost to Follow-up|1|||
146152753|NCT00467870|527069837|FG004|Overall Study|Lost to Follow-up|3|||
146152754|NCT00467870|527069838|FG005|Overall Study|Lost to Follow-up|0|||
146152755|NCT00467870|527069833|FG000|Overall Study|Subject Non-compliance|3|||
146152756|NCT00467870|527069834|FG001|Overall Study|Subject Non-compliance|4|||
146152757|NCT00467870|527069835|FG002|Overall Study|Subject Non-compliance|0|||
146152758|NCT00467870|527069836|FG003|Overall Study|Subject Non-compliance|1|||
146152759|NCT00467870|527069837|FG004|Overall Study|Subject Non-compliance|5|||
146152760|NCT00467870|527069838|FG005|Overall Study|Subject Non-compliance|0|||
146152761|NCT00467870|527069833|FG000|Overall Study|Other/Unknown|8|||
146152762|NCT00467870|527069834|FG001|Overall Study|Other/Unknown|5|||
146152763|NCT00467870|527069835|FG002|Overall Study|Other/Unknown|1|||
146152764|NCT00467870|527069836|FG003|Overall Study|Other/Unknown|5|||
146152765|NCT00467870|527069837|FG004|Overall Study|Other/Unknown|4|||
146152766|NCT00467870|527069838|FG005|Overall Study|Other/Unknown|0|||
146152767|NCT03268811|527069841|FG000|Overall Study|Adverse Event|0|||
146152768|NCT03268811|527069842|FG001|Overall Study|Adverse Event|1|||
146152769|NCT02031276|527069843|FG000|Period 1 Double-blind IV|Adverse Event|6|||
146306961|NCT05314517|527637328|FG001|Open-label Extension|Lost to Follow-up|0|||
146306962|NCT05314517|527637329|FG002|Open-label Extension|Lost to Follow-up|0|||
146152770|NCT02031276|527069844|FG001|Period 1 Double-blind IV|Adverse Event|5|||
146152771|NCT02031276|527069845|FG002|Period 1 Double-blind IV|Adverse Event|1|||
146152772|NCT02031276|527069843|FG000|Period 1 Double-blind IV|Other|0|||
146152773|NCT02031276|527069844|FG001|Period 1 Double-blind IV|Other|1|||
146152774|NCT02031276|527069845|FG002|Period 1 Double-blind IV|Other|0|||
146152775|NCT02031276|527069843|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
146152776|NCT02031276|527069844|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
146152777|NCT02031276|527069845|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
146152778|NCT02031276|527069843|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
146306963|NCT05314517|527637330|FG003|Open-label Extension|Lost to Follow-up|1|||
146306964|NCT05314517|527637327|FG000|Open-label Extension|Withdrawal by Subject|0|||
146306965|NCT05314517|527637328|FG001|Open-label Extension|Withdrawal by Subject|0|||
146306966|NCT05314517|527637329|FG002|Open-label Extension|Withdrawal by Subject|1|||
146306967|NCT05314517|527637330|FG003|Open-label Extension|Withdrawal by Subject|2|||
146306968|NCT05314517|527637327|FG000|Open-label Extension|Use of prohibited medication|0|||
146306969|NCT05314517|527637328|FG001|Open-label Extension|Use of prohibited medication|0|||
146306970|NCT05314517|527637329|FG002|Open-label Extension|Use of prohibited medication|1|||
146306971|NCT05314517|527637330|FG003|Open-label Extension|Use of prohibited medication|0|||
146306972|NCT05314517|527637327|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
146306973|NCT05314517|527637328|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
146152779|NCT02031276|527069844|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
146152780|NCT02031276|527069845|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
146152781|NCT02031276|527069843|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
146152782|NCT02031276|527069844|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
146152783|NCT02031276|527069845|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
146152784|NCT02031276|527069843|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
146152785|NCT02031276|527069844|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
146152786|NCT02031276|527069845|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
146152787|NCT02031276|527069843|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
146152788|NCT02031276|527069844|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
146152789|NCT02031276|527069845|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
146152790|NCT02031276|527069843|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146152791|NCT02031276|527069844|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146152792|NCT02031276|527069845|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
146152793|NCT02031276|527069843|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
146152794|NCT02031276|527069844|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
146152795|NCT02031276|527069845|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
146152796|NCT04726709|527069852|FG000|Overall Study|Withdrawal by Subject|2|||
146152797|NCT04726709|527069853|FG001|Overall Study|Withdrawal by Subject|2|||
146152798|NCT03073603|527069855|FG000|Overall Study|Noncompliance|3|||
146152799|NCT03073603|527069856|FG001|Overall Study|Noncompliance|1|||
146152800|NCT03073603|527069855|FG000|Overall Study|Adverse Event|5|||
146152801|NCT03073603|527069856|FG001|Overall Study|Adverse Event|3|||
146152802|NCT03073603|527069855|FG000|Overall Study|Physician Decision|1|||
146152803|NCT03073603|527069856|FG001|Overall Study|Physician Decision|2|||
146152804|NCT03073603|527069855|FG000|Overall Study|Required treatment not allowed by protocol|1|||
146152805|NCT03073603|527069856|FG001|Overall Study|Required treatment not allowed by protocol|0|||
146152806|NCT03073603|527069855|FG000|Overall Study|Financial or insurance-related|8|||
146152807|NCT03073603|527069856|FG001|Overall Study|Financial or insurance-related|0|||
146152808|NCT03073603|527069855|FG000|Overall Study|Withdrawal by Subject|0|||
146152809|NCT03073603|527069856|FG001|Overall Study|Withdrawal by Subject|1|||
146152810|NCT03073603|527069855|FG000|Overall Study|Discontinued DMT|4|||
146152811|NCT03073603|527069856|FG001|Overall Study|Discontinued DMT|0|||
146152812|NCT03073603|527069855|FG000|Overall Study|Restarted DMT|0|||
146152813|NCT03073603|527069856|FG001|Overall Study|Restarted DMT|1|||
146152814|NCT04757649|527069857|FG000|Overall Study|Withdrawal by Subject|1|||
146152815|NCT04757649|527069857|FG000|Overall Study|Adverse Event|1|||
146152816|NCT01286779|527069858|FG000|Overall Study|Withdrawal by Subject|9|||
146152817|NCT01286779|527069858|FG000|Overall Study|Protocol Violation|5|||
146152818|NCT01286779|527069858|FG000|Overall Study|Physician Decision|2|||
146152819|NCT01286779|527069858|FG000|Overall Study|Participant had scheduled surgery|1|||
146152820|NCT01286779|527069858|FG000|Overall Study|Participant moved to another country|1|||
146152821|NCT01286779|527069858|FG000|Overall Study|Discontinued by sponsor|1|||
146152822|NCT00574080|527069863|FG000|Overall Study|Death|10|||
146152823|NCT00574080|527069864|FG001|Overall Study|Death|10|||
146152824|NCT02862106|527069865|FG000|Overall Study|Adverse Event|4|||
146152825|NCT02862106|527069866|FG001|Overall Study|Adverse Event|0|||
146152826|NCT02862106|527069865|FG000|Overall Study|Protocol Violation|16|||
146152827|NCT02862106|527069866|FG001|Overall Study|Protocol Violation|1|||
146152828|NCT02862106|527069865|FG000|Overall Study|Lost to Follow-up|15|||
146152829|NCT02862106|527069866|FG001|Overall Study|Lost to Follow-up|5|||
146152830|NCT02862106|527069865|FG000|Overall Study|Withdrawal by Subject|2|||
146152831|NCT02862106|527069866|FG001|Overall Study|Withdrawal by Subject|0|||
146152832|NCT02862106|527069865|FG000|Overall Study|Subjects moved to other city|1|||
146152833|NCT02862106|527069866|FG001|Overall Study|Subjects moved to other city|0|||
146152834|NCT04360824|527069867|FG000|Overall Study|Withdrawal by Subject|2|||
146152835|NCT04360824|527069868|FG001|Overall Study|Withdrawal by Subject|1|||
146152836|NCT04360824|527069867|FG000|Overall Study|Did not receive assigned treatment|1|||
146306974|NCT05314517|527637329|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
146306975|NCT05314517|527637330|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
146306976|NCT04969276|527637331|FG000|Overall Study|Protocol Deviation|0|||
146152837|NCT04360824|527069868|FG001|Overall Study|Did not receive assigned treatment|3|||
146152838|NCT00304070|527069869|FG000|Overall Study|Death|0|||
146152839|NCT00304070|527069870|FG001|Overall Study|Death|0|||
146152840|NCT00304070|527069871|FG002|Overall Study|Death|3|||
146152841|NCT00304070|527069869|FG000|Overall Study|Lost to Follow-up|0|||
146152842|NCT00304070|527069870|FG001|Overall Study|Lost to Follow-up|0|||
146152843|NCT00304070|527069871|FG002|Overall Study|Lost to Follow-up|1|||
146152844|NCT00304070|527069869|FG000|Overall Study|Physician Decision|0|||
146152845|NCT00304070|527069870|FG001|Overall Study|Physician Decision|0|||
146152846|NCT00304070|527069871|FG002|Overall Study|Physician Decision|3|||
146152847|NCT00304070|527069869|FG000|Overall Study|Withdrawal by Subject|0|||
146152848|NCT00304070|527069870|FG001|Overall Study|Withdrawal by Subject|0|||
146152849|NCT00304070|527069871|FG002|Overall Study|Withdrawal by Subject|1|||
146152850|NCT00304070|527069869|FG000|Overall Study|Progressive Disease|3|||
146152851|NCT00304070|527069870|FG001|Overall Study|Progressive Disease|7|||
146152852|NCT00304070|527069871|FG002|Overall Study|Progressive Disease|4|||
146152853|NCT00377676|527069872|FG000|Overall Study|Adverse Event|498|||
146152854|NCT00377676|527069873|FG001|Overall Study|Adverse Event|107|||
146152855|NCT00377676|527069872|FG000|Overall Study|Protocol Violation|33|||
146152856|NCT00377676|527069873|FG001|Overall Study|Protocol Violation|27|||
146152857|NCT00377676|527069872|FG000|Overall Study|Death|5|||
146152858|NCT00377676|527069873|FG001|Overall Study|Death|2|||
146152859|NCT00377676|527069872|FG000|Overall Study|Withdrawal by Subject|187|||
146152860|NCT00377676|527069873|FG001|Overall Study|Withdrawal by Subject|72|||
146152861|NCT00377676|527069872|FG000|Overall Study|Lost to Follow-up|120|||
146152862|NCT00377676|527069873|FG001|Overall Study|Lost to Follow-up|56|||
146152863|NCT00377676|527069872|FG000|Overall Study|Other|118|||
146152864|NCT00377676|527069873|FG001|Overall Study|Other|58|||
146152865|NCT05348681|527069882|FG000|Overall Study|Study terminated by Sponsor|8|||
146152866|NCT05348681|527069883|FG001|Overall Study|Study terminated by Sponsor|3|||
146152867|NCT05348681|527069882|FG000|Overall Study|Withdrawal by Subject|1|||
146152868|NCT05348681|527069883|FG001|Overall Study|Withdrawal by Subject|1|||
146152869|NCT05348681|527069882|FG000|Overall Study|Lost to Follow-up|1|||
146152870|NCT05348681|527069883|FG001|Overall Study|Lost to Follow-up|1|||
146152871|NCT05348681|527069882|FG000|Overall Study|Adverse Event|1|||
146152872|NCT05348681|527069883|FG001|Overall Study|Adverse Event|0|||
146152873|NCT05348681|527069882|FG000|Overall Study|Other|2|||
146152874|NCT05348681|527069883|FG001|Overall Study|Other|1|||
146152875|NCT03646513|527069887|FG000|Overall Study|Premature study termination|4|||
146152876|NCT00782340|527069888|FG000|Open Label Titration|Adverse Event|12|||
146152877|NCT00782340|527069889|FG001|Open Label Titration|Adverse Event|0|||
146152878|NCT00782340|527069890|FG002|Open Label Titration|Adverse Event|0|||
146152879|NCT00782340|527069888|FG000|Open Label Titration|Treatment failure|50|||
146152880|NCT00782340|527069889|FG001|Open Label Titration|Treatment failure|0|||
146152881|NCT00782340|527069890|FG002|Open Label Titration|Treatment failure|0|||
146152882|NCT00782340|527069888|FG000|Open Label Titration|Protocol Violation|5|||
146152883|NCT00782340|527069889|FG001|Open Label Titration|Protocol Violation|0|||
146152884|NCT00782340|527069890|FG002|Open Label Titration|Protocol Violation|0|||
146152885|NCT00782340|527069888|FG000|Open Label Titration|Withdrawal by Subject|5|||
146152886|NCT00782340|527069889|FG001|Open Label Titration|Withdrawal by Subject|0|||
146152887|NCT00782340|527069890|FG002|Open Label Titration|Withdrawal by Subject|0|||
146152888|NCT00782340|527069888|FG000|Open Label Titration|Enrollment capped|16|||
146152889|NCT00782340|527069889|FG001|Open Label Titration|Enrollment capped|0|||
146152890|NCT00782340|527069890|FG002|Open Label Titration|Enrollment capped|0|||
146152891|NCT00782340|527069888|FG000|Open Label Titration|Did not meet responder criteria|2|||
146152892|NCT00782340|527069889|FG001|Open Label Titration|Did not meet responder criteria|0|||
146152893|NCT00782340|527069890|FG002|Open Label Titration|Did not meet responder criteria|0|||
146152894|NCT00782340|527069888|FG000|Open Label Titration|Lost to Follow-up|5|||
146152895|NCT00782340|527069889|FG001|Open Label Titration|Lost to Follow-up|0|||
146152896|NCT00782340|527069890|FG002|Open Label Titration|Lost to Follow-up|0|||
146152897|NCT00782340|527069888|FG000|Open Label Titration|Randomized in error|6|||
146152898|NCT00782340|527069889|FG001|Open Label Titration|Randomized in error|0|||
146152899|NCT00782340|527069890|FG002|Open Label Titration|Randomized in error|0|||
146152900|NCT04667117|527069895|FG000|Investigational Period|Lost to Follow-up|0|||
146152901|NCT04667117|527069896|FG001|Investigational Period|Lost to Follow-up|0|||
146152902|NCT04667117|527069897|FG002|Investigational Period|Lost to Follow-up|1|||
146152903|NCT04667117|527069895|FG000|Investigational Period|Protocol Deviation|0|||
146152904|NCT04667117|527069896|FG001|Investigational Period|Protocol Deviation|1|||
146152905|NCT04667117|527069897|FG002|Investigational Period|Protocol Deviation|0|||
146152906|NCT04667117|527069895|FG000|Extension Period|Lost to Follow-up|1|||
146152907|NCT04667117|527069896|FG001|Extension Period|Lost to Follow-up|0|||
146152908|NCT04667117|527069897|FG002|Extension Period|Lost to Follow-up|0|||
146152909|NCT03359096|527069898|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
146152910|NCT03359096|527069899|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
146152911|NCT03359096|527069898|FG000|First Intervention (4 Weeks)|Death|1|||
146152912|NCT03359096|527069899|FG001|First Intervention (4 Weeks)|Death|0|||
146152913|NCT03359096|527069898|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
146152914|NCT03359096|527069899|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
146152915|NCT01306162|527069900|FG000|Period 1|Adverse Event|0|||
146152916|NCT01306162|527069901|FG001|Period 1|Adverse Event|0|||
146152917|NCT01306162|527069902|FG002|Period 1|Adverse Event|0|||
146152918|NCT01306162|527069903|FG003|Period 1|Adverse Event|1|||
146152919|NCT01306162|527069900|FG000|Washout 1|Non-compliance to protocol|0|||
146306977|NCT04969276|527637332|FG001|Overall Study|Protocol Deviation|1|||
146306978|NCT04969276|527637333|FG002|Overall Study|Protocol Deviation|0|||
146306979|NCT04969276|527637331|FG000|Overall Study|Withdrawal by Subject|1|||
146306980|NCT04969276|527637332|FG001|Overall Study|Withdrawal by Subject|10|||
146306981|NCT04969276|527637333|FG002|Overall Study|Withdrawal by Subject|0|||
146152920|NCT01306162|527069901|FG001|Washout 1|Non-compliance to protocol|1|||
146152921|NCT01306162|527069902|FG002|Washout 1|Non-compliance to protocol|0|||
146152922|NCT01306162|527069903|FG003|Washout 1|Non-compliance to protocol|0|||
146152923|NCT02952924|527069907|FG000|Overall Study|Protocol Violation|0|||
146152924|NCT02952924|527069908|FG001|Overall Study|Protocol Violation|0|||
146152925|NCT02952924|527069909|FG002|Overall Study|Protocol Violation|0|||
146152926|NCT02952924|527069910|FG003|Overall Study|Protocol Violation|0|||
146152927|NCT02952924|527069911|FG004|Overall Study|Protocol Violation|0|||
146152928|NCT02952924|527069912|FG005|Overall Study|Protocol Violation|0|||
146152929|NCT02952924|527069913|FG006|Overall Study|Protocol Violation|0|||
146152930|NCT02952924|527069914|FG007|Overall Study|Protocol Violation|0|||
146152931|NCT02952924|527069915|FG008|Overall Study|Protocol Violation|0|||
146152932|NCT02952924|527069916|FG009|Overall Study|Protocol Violation|0|||
146152933|NCT02952924|527069917|FG010|Overall Study|Protocol Violation|0|||
146152934|NCT02952924|527069918|FG011|Overall Study|Protocol Violation|0|||
146306982|NCT04969276|527637331|FG000|Overall Study|Lost to Follow-up|0|||
146306983|NCT04969276|527637332|FG001|Overall Study|Lost to Follow-up|1|||
146306984|NCT04969276|527637333|FG002|Overall Study|Lost to Follow-up|0|||
146306985|NCT05248295|527637337|FG000|Overall Study|found ineligible|4|||
146306986|NCT05248295|527637338|FG001|Overall Study|found ineligible|1|||
146306987|NCT05248295|527637337|FG000|Overall Study|Withdrawal by Subject|0|||
146306988|NCT05248295|527637338|FG001|Overall Study|Withdrawal by Subject|1|||
146306989|NCT05248295|527637337|FG000|Overall Study|Data loss: audio recording error|1|||
146306990|NCT05248295|527637338|FG001|Overall Study|Data loss: audio recording error|1|||
146306991|NCT04655144|527637339|FG000|Overall Study|Consumed THC|1|||
146306992|NCT04655144|527637340|FG001|Overall Study|Consumed THC|0|||
146306993|NCT04655144|527637339|FG000|Overall Study|Unilateral embolization|0|||
146306994|NCT04655144|527637340|FG001|Overall Study|Unilateral embolization|1|||
146306995|NCT01484977|527637343|FG000|Overall Study|Adverse Event|8|||
146306996|NCT01484977|527637343|FG000|Overall Study|Lack of Efficacy|4|||
146306997|NCT01484977|527637343|FG000|Overall Study|Protocol Violation|6|||
146306998|NCT01484977|527637343|FG000|Overall Study|Lost to Follow-up|1|||
146306999|NCT01484977|527637343|FG000|Overall Study|Withdrawal by Subject|4|||
146307000|NCT01484977|527637343|FG000|Overall Study|Subject Protocol Non-compliant|1|||
146307001|NCT01484977|527637343|FG000|Overall Study|Moving Overseas|1|||
146307002|NCT01484977|527637343|FG000|Overall Study|Low White Blood Cell Count|1|||
146307003|NCT01484977|527637343|FG000|Overall Study|Lack of Compliance|1|||
146307004|NCT01392677|527637344|FG000|Overall Study|Adverse Event|3|||
146307005|NCT01392677|527637345|FG001|Overall Study|Adverse Event|1|||
146307006|NCT01392677|527637344|FG000|Overall Study|Withdrawal by Subject|0|||
146307007|NCT01392677|527637345|FG001|Overall Study|Withdrawal by Subject|2|||
146307008|NCT01392677|527637344|FG000|Overall Study|Incorrect enrollment|2|||
146307009|NCT01392677|527637345|FG001|Overall Study|Incorrect enrollment|3|||
146307010|NCT01392677|527637344|FG000|Overall Study|Other reason|3|||
146307011|NCT01392677|527637345|FG001|Overall Study|Other reason|2|||
146307012|NCT00121108|527637348|FG000|Overall Study|Lost to Follow-up|10|||
146307013|NCT00121108|527637349|FG001|Overall Study|Lost to Follow-up|22|||
146307014|NCT00121108|527637348|FG000|Overall Study|Withdrawal by Subject|106|||
146307015|NCT00121108|527637349|FG001|Overall Study|Withdrawal by Subject|195|||
146307016|NCT00121108|527637348|FG000|Overall Study|Death|5|||
146307017|NCT00121108|527637349|FG001|Overall Study|Death|8|||
146307018|NCT01380379|527637352|FG000|Overall Study|Pregnancy|1|||
146307019|NCT01357577|527637355|FG000|Overall Study|Lost to Follow-up|20|||
146307020|NCT01357577|527637356|FG001|Overall Study|Lost to Follow-up|16|||
146307021|NCT01357577|527637355|FG000|Overall Study|Withdrawal by Subject|16|||
146152935|NCT02952924|527069919|FG012|Overall Study|Protocol Violation|0|||
146152936|NCT02952924|527069920|FG013|Overall Study|Protocol Violation|0|||
146152937|NCT02952924|527069921|FG014|Overall Study|Protocol Violation|0|||
146152938|NCT02952924|527069922|FG015|Overall Study|Protocol Violation|0|||
146152939|NCT02952924|527069923|FG016|Overall Study|Protocol Violation|0|||
146152940|NCT02952924|527069924|FG017|Overall Study|Protocol Violation|0|||
146307022|NCT01357577|527637356|FG001|Overall Study|Withdrawal by Subject|8|||
146307023|NCT01357577|527637355|FG000|Overall Study|look at data in database?|1|||
146307024|NCT01357577|527637356|FG001|Overall Study|look at data in database?|2|||
146307025|NCT03080883|527637357|FG000|Overall Study|Withdrawal by Subject|11|||
146152941|NCT02952924|527069925|FG018|Overall Study|Protocol Violation|0|||
146152942|NCT02952924|527069926|FG019|Overall Study|Protocol Violation|1|||
146152943|NCT02952924|527069927|FG020|Overall Study|Protocol Violation|0|||
146307026|NCT03080883|527637358|FG001|Overall Study|Withdrawal by Subject|15|||
146307027|NCT03080883|527637357|FG000|Overall Study|Adverse Event|22|||
146307028|NCT03080883|527637358|FG001|Overall Study|Adverse Event|22|||
146307029|NCT03080883|527637357|FG000|Overall Study|Alternative Therapy|0|||
146307030|NCT03080883|527637358|FG001|Overall Study|Alternative Therapy|3|||
146307031|NCT03080883|527637357|FG000|Overall Study|Other Complicating Disease|9|||
146307032|NCT03080883|527637358|FG001|Overall Study|Other Complicating Disease|5|||
146307033|NCT03080883|527637357|FG000|Overall Study|Death|21|||
146307034|NCT03080883|527637358|FG001|Overall Study|Death|16|||
146307035|NCT03080883|527637357|FG000|Overall Study|Physician Decision|2|||
146307036|NCT03080883|527637358|FG001|Overall Study|Physician Decision|2|||
146307037|NCT03080883|527637357|FG000|Overall Study|Disease Progression|2|||
146307038|NCT03080883|527637358|FG001|Overall Study|Disease Progression|8|||
146307039|NCT03080883|527637357|FG000|Overall Study|Lost to Follow-up|1|||
146307040|NCT03080883|527637358|FG001|Overall Study|Lost to Follow-up|1|||
146307041|NCT00847145|527638519|FG000|Overall Study|AE or Death|0|||
146307042|NCT00847145|527638520|FG001|Overall Study|AE or Death|1|||
146307043|NCT00847145|527638521|FG002|Overall Study|AE or Death|1|||
146152944|NCT02952924|527069928|FG021|Overall Study|Protocol Violation|0|||
146152945|NCT02952924|527069907|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
146307044|NCT00847145|527638522|FG003|Overall Study|AE or Death|0|||
146307045|NCT00847145|527638523|FG004|Overall Study|AE or Death|0|||
146307046|NCT00847145|527638524|FG005|Overall Study|AE or Death|0|||
146152946|NCT02952924|527069908|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
146152947|NCT02952924|527069909|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
146152948|NCT02952924|527069910|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
146152949|NCT02952924|527069911|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
146307047|NCT00847145|527638525|FG006|Overall Study|AE or Death|0|||
146307048|NCT00847145|527638526|FG007|Overall Study|AE or Death|0|||
146307049|NCT00847145|527638519|FG000|Overall Study|Withdrawal by Subject|3|||
146307050|NCT00847145|527638520|FG001|Overall Study|Withdrawal by Subject|4|||
146307051|NCT00847145|527638521|FG002|Overall Study|Withdrawal by Subject|6|||
146307052|NCT00847145|527638522|FG003|Overall Study|Withdrawal by Subject|1|||
146307053|NCT00847145|527638523|FG004|Overall Study|Withdrawal by Subject|0|||
146307054|NCT00847145|527638524|FG005|Overall Study|Withdrawal by Subject|0|||
146307055|NCT00847145|527638525|FG006|Overall Study|Withdrawal by Subject|1|||
146307056|NCT00847145|527638526|FG007|Overall Study|Withdrawal by Subject|1|||
146307057|NCT00847145|527638519|FG000|Overall Study|Lost to Follow-up|3|||
146307058|NCT00847145|527638520|FG001|Overall Study|Lost to Follow-up|1|||
146307059|NCT00847145|527638521|FG002|Overall Study|Lost to Follow-up|1|||
146307060|NCT00847145|527638522|FG003|Overall Study|Lost to Follow-up|0|||
146307061|NCT00847145|527638523|FG004|Overall Study|Lost to Follow-up|4|||
146307062|NCT00847145|527638524|FG005|Overall Study|Lost to Follow-up|4|||
146307063|NCT00847145|527638525|FG006|Overall Study|Lost to Follow-up|8|||
146307064|NCT00847145|527638526|FG007|Overall Study|Lost to Follow-up|2|||
146307065|NCT00847145|527638519|FG000|Overall Study|Inappropriate enrollment|0|||
146152950|NCT02952924|527069912|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
146152951|NCT02952924|527069913|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
146152952|NCT02952924|527069914|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
146152953|NCT02952924|527069915|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
146152954|NCT02952924|527069916|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
146152955|NCT02952924|527069917|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
146152956|NCT02952924|527069918|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
146152957|NCT02952924|527069919|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
146152958|NCT02952924|527069920|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
146152959|NCT02952924|527069921|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
146152960|NCT02952924|527069922|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
146152961|NCT02952924|527069923|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
146152962|NCT02952924|527069924|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
146152963|NCT02952924|527069925|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
146152964|NCT02952924|527069926|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
146152965|NCT02952924|527069927|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
146152966|NCT02952924|527069928|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
146152967|NCT02952924|527069907|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152968|NCT02952924|527069908|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
146307066|NCT00847145|527638520|FG001|Overall Study|Inappropriate enrollment|0|||
146307067|NCT00847145|527638521|FG002|Overall Study|Inappropriate enrollment|0|||
146307068|NCT00847145|527638522|FG003|Overall Study|Inappropriate enrollment|0|||
146307069|NCT00847145|527638523|FG004|Overall Study|Inappropriate enrollment|1|||
146307070|NCT00847145|527638524|FG005|Overall Study|Inappropriate enrollment|0|||
146307071|NCT00847145|527638525|FG006|Overall Study|Inappropriate enrollment|0|||
146307072|NCT00847145|527638526|FG007|Overall Study|Inappropriate enrollment|0|||
146307073|NCT00847145|527638519|FG000|Overall Study|Protocol Violation|0|||
146307074|NCT00847145|527638520|FG001|Overall Study|Protocol Violation|0|||
146307075|NCT00847145|527638521|FG002|Overall Study|Protocol Violation|3|||
146307076|NCT00847145|527638522|FG003|Overall Study|Protocol Violation|0|||
146152969|NCT02952924|527069909|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152970|NCT02952924|527069910|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152971|NCT02952924|527069911|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152972|NCT02952924|527069912|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152973|NCT02952924|527069913|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152974|NCT02952924|527069914|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152975|NCT02952924|527069915|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152976|NCT02952924|527069916|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152977|NCT02952924|527069917|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152978|NCT02952924|527069918|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152979|NCT02952924|527069919|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152980|NCT02952924|527069920|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152981|NCT02952924|527069921|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152982|NCT02952924|527069922|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152983|NCT02952924|527069923|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152984|NCT02952924|527069924|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152985|NCT02952924|527069925|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152986|NCT02952924|527069926|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152987|NCT02952924|527069927|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
146152988|NCT02952924|527069928|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
146152989|NCT02952924|527069907|FG000|Overall Study|Noncompliance with study drug|0|||
146152990|NCT02952924|527069908|FG001|Overall Study|Noncompliance with study drug|0|||
146152991|NCT02952924|527069909|FG002|Overall Study|Noncompliance with study drug|0|||
146152992|NCT02952924|527069910|FG003|Overall Study|Noncompliance with study drug|0|||
146152993|NCT02952924|527069911|FG004|Overall Study|Noncompliance with study drug|0|||
146152994|NCT02952924|527069912|FG005|Overall Study|Noncompliance with study drug|0|||
146152995|NCT02952924|527069913|FG006|Overall Study|Noncompliance with study drug|0|||
146152996|NCT02952924|527069914|FG007|Overall Study|Noncompliance with study drug|0|||
146152997|NCT02952924|527069915|FG008|Overall Study|Noncompliance with study drug|0|||
146152998|NCT02952924|527069916|FG009|Overall Study|Noncompliance with study drug|0|||
146152999|NCT02952924|527069917|FG010|Overall Study|Noncompliance with study drug|0|||
146153000|NCT02952924|527069918|FG011|Overall Study|Noncompliance with study drug|0|||
146153001|NCT02952924|527069919|FG012|Overall Study|Noncompliance with study drug|0|||
146153002|NCT02952924|527069920|FG013|Overall Study|Noncompliance with study drug|0|||
146153003|NCT02952924|527069921|FG014|Overall Study|Noncompliance with study drug|0|||
146153004|NCT02952924|527069922|FG015|Overall Study|Noncompliance with study drug|0|||
146153005|NCT02952924|527069923|FG016|Overall Study|Noncompliance with study drug|0|||
146153006|NCT02952924|527069924|FG017|Overall Study|Noncompliance with study drug|0|||
146153007|NCT02952924|527069925|FG018|Overall Study|Noncompliance with study drug|0|||
146153008|NCT02952924|527069926|FG019|Overall Study|Noncompliance with study drug|0|||
146153009|NCT02952924|527069927|FG020|Overall Study|Noncompliance with study drug|0|||
146153010|NCT02952924|527069928|FG021|Overall Study|Noncompliance with study drug|1|||
146153011|NCT00759109|527069930|FG000|Overall Study|Adverse Event|17|||
146153012|NCT00759109|527069931|FG001|Overall Study|Adverse Event|12|||
146153013|NCT00759109|527069930|FG000|Overall Study|Inability to comply|1|||
146153014|NCT00759109|527069931|FG001|Overall Study|Inability to comply|1|||
146153015|NCT00759109|527069930|FG000|Overall Study|Withdrawal by Subject|9|||
146153016|NCT00759109|527069931|FG001|Overall Study|Withdrawal by Subject|5|||
146153017|NCT00759109|527069930|FG000|Overall Study|Death|4|||
146153018|NCT00759109|527069931|FG001|Overall Study|Death|3|||
146153019|NCT00759109|527069930|FG000|Overall Study|Lost to Follow-up|4|||
146153020|NCT00759109|527069931|FG001|Overall Study|Lost to Follow-up|6|||
146153021|NCT00759109|527069930|FG000|Overall Study|Started new therapy|2|||
146153022|NCT00759109|527069931|FG001|Overall Study|Started new therapy|6|||
146153023|NCT00759109|527069930|FG000|Overall Study|HCV RNA negative|1|||
146153024|NCT00759109|527069931|FG001|Overall Study|HCV RNA negative|0|||
146153025|NCT00759109|527069930|FG000|Overall Study|Participant moved to a different city|0|||
146153026|NCT00759109|527069931|FG001|Overall Study|Participant moved to a different city|1|||
146153027|NCT00759109|527069930|FG000|Overall Study|Participant had a liver transplant|0|||
146153028|NCT00759109|527069931|FG001|Overall Study|Participant had a liver transplant|1|||
146153029|NCT00759109|527069930|FG000|Overall Study|Lost during study|1|||
146153030|NCT00759109|527069931|FG001|Overall Study|Lost during study|0|||
146153031|NCT01660763|527069934|FG000|Overall Study|Lack of Efficacy|45|||
146153032|NCT01660763|527069935|FG001|Overall Study|Lack of Efficacy|50|||
146153033|NCT01660763|527069934|FG000|Overall Study|Adverse Event|22|||
146153034|NCT01660763|527069935|FG001|Overall Study|Adverse Event|7|||
146153035|NCT01660763|527069934|FG000|Overall Study|Protocol Violation|1|||
146307077|NCT00847145|527638523|FG004|Overall Study|Protocol Violation|1|||
146307078|NCT00847145|527638524|FG005|Overall Study|Protocol Violation|0|||
146153036|NCT01660763|527069935|FG001|Overall Study|Protocol Violation|0|||
146153037|NCT01660763|527069934|FG000|Overall Study|Withdrawal by Subject|4|||
146153038|NCT01660763|527069935|FG001|Overall Study|Withdrawal by Subject|0|||
146153039|NCT01660763|527069934|FG000|Overall Study|Patient ready for early discharge|28|||
146153040|NCT01660763|527069935|FG001|Overall Study|Patient ready for early discharge|4|||
146153041|NCT01910519|527069936|FG000|Overall Study|Withdrawal by Subject|2|||
146153042|NCT01910519|527069937|FG001|Overall Study|Withdrawal by Subject|0|||
146153043|NCT01910519|527069936|FG000|Overall Study|Adverse Event|2|||
146153044|NCT01910519|527069937|FG001|Overall Study|Adverse Event|0|||
146153045|NCT04266028|527069938|FG000|Overall Study|Adverse Event|0|||
146153046|NCT04266028|527069939|FG001|Overall Study|Adverse Event|0|||
146153047|NCT04266028|527069940|FG002|Overall Study|Adverse Event|1|||
146153048|NCT04266028|527069941|FG003|Overall Study|Adverse Event|0|||
146153049|NCT04266028|527069942|FG004|Overall Study|Adverse Event|1|||
146153050|NCT04266028|527069943|FG005|Overall Study|Adverse Event|0|||
146153051|NCT04266028|527069944|FG006|Overall Study|Adverse Event|2|||
146153052|NCT04266028|527069945|FG007|Overall Study|Adverse Event|0|||
146153053|NCT04266028|527069938|FG000|Overall Study|temporary halt of the study|0|||
146153054|NCT04266028|527069939|FG001|Overall Study|temporary halt of the study|0|||
146153055|NCT04266028|527069940|FG002|Overall Study|temporary halt of the study|0|||
146153056|NCT04266028|527069941|FG003|Overall Study|temporary halt of the study|0|||
146153057|NCT04266028|527069942|FG004|Overall Study|temporary halt of the study|0|||
146153058|NCT04266028|527069943|FG005|Overall Study|temporary halt of the study|0|||
146153059|NCT04266028|527069944|FG006|Overall Study|temporary halt of the study|2|||
146153060|NCT04266028|527069945|FG007|Overall Study|temporary halt of the study|1|||
146153061|NCT04266028|527069938|FG000|Overall Study|Onset of birch pollen season|0|||
146153062|NCT04266028|527069939|FG001|Overall Study|Onset of birch pollen season|0|||
146153063|NCT04266028|527069940|FG002|Overall Study|Onset of birch pollen season|0|||
146153064|NCT04266028|527069941|FG003|Overall Study|Onset of birch pollen season|0|||
146153065|NCT04266028|527069942|FG004|Overall Study|Onset of birch pollen season|1|||
146153066|NCT04266028|527069943|FG005|Overall Study|Onset of birch pollen season|0|||
146153067|NCT04266028|527069944|FG006|Overall Study|Onset of birch pollen season|0|||
146153068|NCT04266028|527069945|FG007|Overall Study|Onset of birch pollen season|0|||
146153069|NCT00380068|527069947|FG000|Overall Study|Adverse Event|40|||
146153070|NCT00380068|527069947|FG000|Overall Study|Withdrawal by Subject|10|||
146153071|NCT00380068|527069947|FG000|Overall Study|Not compliant|6|||
146153072|NCT00380068|527069947|FG000|Overall Study|Lost to Follow-up|1|||
146153073|NCT00380068|527069947|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
146153074|NCT00380068|527069947|FG000|Overall Study|Lung transplant|3|||
146153075|NCT00380068|527069947|FG000|Overall Study|Physician Decision|2|||
146153076|NCT00380068|527069947|FG000|Overall Study|Partipant moved away|1|||
146153077|NCT00380068|527069947|FG000|Overall Study|Lack of Efficacy|5|||
146153078|NCT01458574|527069948|FG000|Overall Study|Adverse Event|5|||
146153079|NCT01458574|527069949|FG001|Overall Study|Adverse Event|9|||
146153080|NCT01458574|527069950|FG002|Overall Study|Adverse Event|7|||
146153081|NCT01458574|527069948|FG000|Overall Study|Lack of Efficacy|70|||
146153082|NCT01458574|527069949|FG001|Overall Study|Lack of Efficacy|53|||
146153083|NCT01458574|527069950|FG002|Overall Study|Lack of Efficacy|132|||
146307079|NCT00847145|527638525|FG006|Overall Study|Protocol Violation|0|||
146307080|NCT00847145|527638526|FG007|Overall Study|Protocol Violation|1|||
146307081|NCT01439282|527638527|FG000|Overall Study|Adverse Event|5|||
146307082|NCT01439282|527638528|FG001|Overall Study|Adverse Event|0|||
146307083|NCT01439282|527638527|FG000|Overall Study|Withdrawal by Subject|2|||
146307084|NCT01439282|527638528|FG001|Overall Study|Withdrawal by Subject|0|||
146307085|NCT01439282|527638527|FG000|Overall Study|Other|1|||
146153084|NCT01458574|527069948|FG000|Overall Study|Lost to Follow-up|3|||
146153085|NCT01458574|527069949|FG001|Overall Study|Lost to Follow-up|2|||
146153086|NCT01458574|527069950|FG002|Overall Study|Lost to Follow-up|1|||
146153087|NCT01458574|527069948|FG000|Overall Study|Pregnancy|1|||
146153088|NCT01458574|527069949|FG001|Overall Study|Pregnancy|1|||
146153089|NCT01458574|527069950|FG002|Overall Study|Pregnancy|0|||
146153090|NCT01458574|527069948|FG000|Overall Study|Protocol Violation|0|||
146153091|NCT01458574|527069949|FG001|Overall Study|Protocol Violation|1|||
146307086|NCT01439282|527638528|FG001|Overall Study|Other|1|||
146307087|NCT04419610|527638529|FG000|Overall Study|Withdrawal by Subject|3|||
146153092|NCT01458574|527069950|FG002|Overall Study|Protocol Violation|0|||
146153093|NCT01458574|527069948|FG000|Overall Study|Withdrawal by Subject|6|||
146153094|NCT01458574|527069949|FG001|Overall Study|Withdrawal by Subject|3|||
146153095|NCT01458574|527069950|FG002|Overall Study|Withdrawal by Subject|5|||
146307088|NCT04419610|527638530|FG001|Overall Study|Withdrawal by Subject|1|||
146153096|NCT01458574|527069948|FG000|Overall Study|Other|2|||
146153097|NCT01458574|527069949|FG001|Overall Study|Other|1|||
146153098|NCT01458574|527069950|FG002|Overall Study|Other|0|||
146153099|NCT01458574|527069948|FG000|Overall Study|Randomized but not treated|0|||
146153100|NCT01458574|527069949|FG001|Overall Study|Randomized but not treated|1|||
146153101|NCT01458574|527069950|FG002|Overall Study|Randomized but not treated|0|||
146153102|NCT02125786|527069951|FG000|Overall Study|Still in Follow-up|3|||
146307089|NCT04419610|527638529|FG000|Overall Study|Adverse Event|1|||
146153103|NCT02125786|527069951|FG000|Overall Study|Screen Failure|2|||
146153104|NCT02125786|527069951|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
146153105|NCT02125786|527069951|FG000|Overall Study|Progressive Disease|44|||
146153106|NCT02125786|527069951|FG000|Overall Study|Death|8|||
146153107|NCT04964089|527069954|FG000|Overall Study|Adverse Event|8|||
146153108|NCT04964089|527069955|FG001|Overall Study|Adverse Event|6|||
146153109|NCT04964089|527069954|FG000|Overall Study|Non-compliance with study schedule|1|||
146153110|NCT04964089|527069955|FG001|Overall Study|Non-compliance with study schedule|0|||
146153111|NCT04964089|527069954|FG000|Overall Study|Withdrawal by Subject|6|||
146153112|NCT04964089|527069955|FG001|Overall Study|Withdrawal by Subject|5|||
146153113|NCT04964089|527069954|FG000|Overall Study|Lost to Follow-up|1|||
146153114|NCT04964089|527069955|FG001|Overall Study|Lost to Follow-up|1|||
146153115|NCT04964089|527069954|FG000|Overall Study|Progressive disease|4|||
146153116|NCT04964089|527069955|FG001|Overall Study|Progressive disease|0|||
146153117|NCT04964089|527069954|FG000|Overall Study|Physician Decision|1|||
146153118|NCT04964089|527069955|FG001|Overall Study|Physician Decision|0|||
146153119|NCT04964089|527069954|FG000|Overall Study|Participant did not want to continue study treatment|1|||
146153120|NCT04964089|527069955|FG001|Overall Study|Participant did not want to continue study treatment|0|||
146153121|NCT04964089|527069954|FG000|Overall Study|Participant moved to different state|1|||
146153122|NCT04964089|527069955|FG001|Overall Study|Participant moved to different state|0|||
146153123|NCT04964089|527069954|FG000|Overall Study|Participant decided to discontinue|0|||
146153124|NCT04964089|527069955|FG001|Overall Study|Participant decided to discontinue|1|||
146153125|NCT03588572|527069958|FG000|Visitation 1|Lack of Efficacy|1|||
146153126|NCT03588572|527069959|FG001|Visitation 1|Lack of Efficacy|1|||
146307090|NCT04419610|527638530|FG001|Overall Study|Adverse Event|0|||
146307091|NCT04419610|527638529|FG000|Overall Study|discharged early|1|||
146307092|NCT04419610|527638530|FG001|Overall Study|discharged early|1|||
146307093|NCT00346073|527638534|FG000|Overall Study|Serious Adverse Event|2|||
146307094|NCT00346073|527638535|FG001|Overall Study|Serious Adverse Event|0|||
146307095|NCT00346073|527638534|FG000|Overall Study|Lost to Follow-up|39|||
146307096|NCT00346073|527638535|FG001|Overall Study|Lost to Follow-up|24|||
146307097|NCT00980200|527638537|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
146307098|NCT00980200|527638538|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
146307099|NCT00980200|527638539|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
146307100|NCT00980200|527638540|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
146307101|NCT00980200|527638541|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
146307102|NCT00980200|527638537|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
146307103|NCT00980200|527638538|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
146307104|NCT00980200|527638539|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
146307105|NCT00980200|527638540|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
146307106|NCT00980200|527638541|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
146307107|NCT04179734|527638545|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
146307108|NCT04179734|527638546|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
146307109|NCT04179734|527638545|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
146307110|NCT04179734|527638546|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
146307111|NCT00937937|527638547|FG000|Overall Study|Adverse Event|6|||
146307112|NCT00937937|527638547|FG000|Overall Study|Withdrawal by Subject|2|||
146307113|NCT00937937|527638547|FG000|Overall Study|Progression/relapse|61|||
146307114|NCT00937937|527638547|FG000|Overall Study|Death|1|||
146307115|NCT00937937|527638547|FG000|Overall Study|Other|2|||
146307116|NCT00054704|527638548|FG000|Overall Study|Lack of Efficacy|2|||
146307117|NCT00054704|527638549|FG001|Overall Study|Lack of Efficacy|3|||
146307118|NCT00054704|527638548|FG000|Overall Study|Adverse Event|3|||
146307119|NCT00054704|527638549|FG001|Overall Study|Adverse Event|1|||
146307120|NCT00054704|527638548|FG000|Overall Study|Lost to Follow-up|0|||
146307121|NCT00054704|527638549|FG001|Overall Study|Lost to Follow-up|1|||
146307122|NCT00362414|527638550|FG000|Overall Study|Death|2|||
146307123|NCT00362414|527638550|FG000|Overall Study|Adverse Event|1|||
146307124|NCT01761292|527638553|FG000|Part 1|Adverse Event|1|||
146307125|NCT01761292|527638553|FG000|Part 1|not receiving treatment in Part 1|1|||
146307126|NCT01761292|527638553|FG000|Extension 1|Withdrawal by Subject|1|||
146307127|NCT02181816|527638554|FG000|Overall Study|Case Report Forms Uncollected|38|||
146307128|NCT02181816|527638554|FG000|Overall Study|Protocol Deviation|21|||
146307129|NCT01911442|527638557|FG000|Overall Study|Adverse Event|2|||
146307130|NCT01911442|527638558|FG001|Overall Study|Adverse Event|2|||
146307131|NCT01911442|527638559|FG002|Overall Study|Adverse Event|4|||
146307132|NCT01911442|527638557|FG000|Overall Study|Lack of Efficacy|1|||
146307133|NCT01911442|527638558|FG001|Overall Study|Lack of Efficacy|1|||
146153127|NCT03588572|527069958|FG000|Visitation 2|Lost to Follow-up|1|||
146153128|NCT03588572|527069959|FG001|Visitation 2|Lost to Follow-up|1|||
146153129|NCT03588572|527069958|FG000|Visitation 2|Lack of Efficacy|0|||
146153130|NCT03588572|527069959|FG001|Visitation 2|Lack of Efficacy|1|||
146153131|NCT03588572|527069958|FG000|Visitation 2|Withdrawal by Subject|1|||
146153132|NCT03588572|527069959|FG001|Visitation 2|Withdrawal by Subject|0|||
146153133|NCT03588572|527069958|FG000|Visitation 3|Lost to Follow-up|1|||
146307134|NCT01911442|527638559|FG002|Overall Study|Lack of Efficacy|1|||
146307135|NCT01911442|527638557|FG000|Overall Study|Lost to Follow-up|2|||
146307136|NCT01911442|527638558|FG001|Overall Study|Lost to Follow-up|0|||
146307137|NCT01911442|527638559|FG002|Overall Study|Lost to Follow-up|1|||
146307138|NCT01911442|527638557|FG000|Overall Study|Withdrawal by Subject|1|||
146307139|NCT01911442|527638558|FG001|Overall Study|Withdrawal by Subject|0|||
146307140|NCT01911442|527638559|FG002|Overall Study|Withdrawal by Subject|6|||
146307141|NCT01911442|527638557|FG000|Overall Study|Mother's Work Schedule|0|||
146307142|NCT01911442|527638558|FG001|Overall Study|Mother's Work Schedule|1|||
146307143|NCT01911442|527638559|FG002|Overall Study|Mother's Work Schedule|0|||
146307144|NCT00253643|527638560|FG000|Overall Study|Withdrawal by Subject|0|||
146307145|NCT00253643|527638561|FG001|Overall Study|Withdrawal by Subject|0|||
146307146|NCT00253643|527638562|FG002|Overall Study|Withdrawal by Subject|1|||
146307147|NCT00253643|527638563|FG003|Overall Study|Withdrawal by Subject|1|||
146307148|NCT00253643|527638560|FG000|Overall Study|Non-Compliance|0|||
146307149|NCT00253643|527638561|FG001|Overall Study|Non-Compliance|0|||
146307150|NCT00253643|527638562|FG002|Overall Study|Non-Compliance|0|||
146307151|NCT00253643|527638563|FG003|Overall Study|Non-Compliance|2|||
146307152|NCT01368536|527638564|FG000|Overall Study|Adverse Event|5|||
146307153|NCT01368536|527638565|FG001|Overall Study|Adverse Event|6|||
146307154|NCT01368536|527638566|FG002|Overall Study|Adverse Event|8|||
146307155|NCT01368536|527638564|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146307156|NCT01368536|527638565|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146307157|NCT01368536|527638566|FG002|Overall Study|Abnormal laboratory value(s)|2|||
146307158|NCT01368536|527638564|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146307159|NCT01368536|527638565|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146307160|NCT01368536|527638566|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146307161|NCT01368536|527638564|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
146307162|NCT01368536|527638565|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146307163|NCT01368536|527638566|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146307164|NCT01368536|527638564|FG000|Overall Study|No longer required study medication|0|||
146307165|NCT01368536|527638565|FG001|Overall Study|No longer required study medication|0|||
146307166|NCT01368536|527638566|FG002|Overall Study|No longer required study medication|1|||
146307167|NCT01368536|527638564|FG000|Overall Study|Withdrawal by Subject|2|||
146307168|NCT01368536|527638565|FG001|Overall Study|Withdrawal by Subject|5|||
146307169|NCT01368536|527638566|FG002|Overall Study|Withdrawal by Subject|4|||
146307170|NCT01368536|527638564|FG000|Overall Study|Lost to Follow-up|3|||
146307171|NCT01368536|527638565|FG001|Overall Study|Lost to Follow-up|3|||
146307172|NCT01368536|527638566|FG002|Overall Study|Lost to Follow-up|5|||
146307173|NCT01368536|527638564|FG000|Overall Study|Administrative problems|34|||
146307174|NCT01368536|527638565|FG001|Overall Study|Administrative problems|39|||
146307175|NCT01368536|527638566|FG002|Overall Study|Administrative problems|35|||
146307176|NCT01368536|527638564|FG000|Overall Study|Protocol deviation|0|||
146307177|NCT01368536|527638565|FG001|Overall Study|Protocol deviation|3|||
146307178|NCT01368536|527638566|FG002|Overall Study|Protocol deviation|1|||
146307179|NCT00383084|527638567|FG000|Overall Study|Withdrawal by Subject|12|||
146307180|NCT00383084|527638568|FG001|Overall Study|Withdrawal by Subject|10|||
146307181|NCT02113436|527638569|FG000|Period 1: 8 Weeks|Adverse Event|1|||
146307182|NCT02113436|527638570|FG001|Period 1: 8 Weeks|Adverse Event|0|||
146307183|NCT02113436|527638571|FG002|Period 1: 8 Weeks|Adverse Event|0|||
146307184|NCT02113436|527638572|FG003|Period 1: 8 Weeks|Adverse Event|0|||
146307185|NCT02113436|527638569|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
146307186|NCT02113436|527638570|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
146307187|NCT02113436|527638571|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
146307188|NCT02113436|527638572|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
146307189|NCT02113436|527638569|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
146307190|NCT02113436|527638570|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
146307191|NCT02113436|527638571|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
146307192|NCT02113436|527638572|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
146307193|NCT02113436|527638569|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
146307194|NCT02113436|527638570|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146307195|NCT02113436|527638571|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146307196|NCT02113436|527638572|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
146307197|NCT02113436|527638569|FG000|Period 2: 16 Weeks|Adverse Event|0|||
146307198|NCT02113436|527638570|FG001|Period 2: 16 Weeks|Adverse Event|0|||
146307199|NCT02113436|527638571|FG002|Period 2: 16 Weeks|Adverse Event|4|||
146307200|NCT02113436|527638572|FG003|Period 2: 16 Weeks|Adverse Event|5|||
146307201|NCT02113436|527638569|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
146307202|NCT02113436|527638570|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
146307203|NCT02113436|527638571|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
146307204|NCT02113436|527638572|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
146307205|NCT02113436|527638569|FG000|Period 2: 16 Weeks|Physician Decision|0|||
146307206|NCT02113436|527638570|FG001|Period 2: 16 Weeks|Physician Decision|0|||
146307207|NCT02113436|527638571|FG002|Period 2: 16 Weeks|Physician Decision|2|||
146307208|NCT02113436|527638572|FG003|Period 2: 16 Weeks|Physician Decision|0|||
146153134|NCT03588572|527069959|FG001|Visitation 3|Lost to Follow-up|1|||
146307209|NCT02113436|527638569|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
146307210|NCT02113436|527638570|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
146307211|NCT02113436|527638571|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
146307212|NCT02113436|527638572|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
146307213|NCT01648790|527638573|FG000|Treatment 3|Withdrawal by Subject|0|||
146307214|NCT01648790|527638574|FG001|Treatment 3|Withdrawal by Subject|0|||
146307215|NCT01648790|527638575|FG002|Treatment 3|Withdrawal by Subject|0|||
146307216|NCT01648790|527638576|FG003|Treatment 3|Withdrawal by Subject|1|||
146307217|NCT01648790|527638577|FG004|Treatment 3|Withdrawal by Subject|0|||
146307218|NCT02159729|527638578|FG000|Overall Study|Adverse Event|0|||
146307219|NCT02159729|527638579|FG001|Overall Study|Adverse Event|1|||
146307220|NCT02159729|527638578|FG000|Overall Study|Subject's Request|13|||
146307221|NCT02159729|527638579|FG001|Overall Study|Subject's Request|10|||
146307222|NCT02159729|527638578|FG000|Overall Study|Lost to Follow-up|24|||
146307223|NCT02159729|527638579|FG001|Overall Study|Lost to Follow-up|9|||
146307224|NCT02159729|527638578|FG000|Overall Study|Non compliance|2|||
146307225|NCT02159729|527638579|FG001|Overall Study|Non compliance|0|||
146307226|NCT02159729|527638578|FG000|Overall Study|Other Unspecified|3|||
146307227|NCT02159729|527638579|FG001|Overall Study|Other Unspecified|1|||
146307228|NCT02636582|527638580|FG000|Overall Study|Surgical Pathology|1|||
146307229|NCT02636582|527638581|FG001|Overall Study|Surgical Pathology|0|||
146307230|NCT01148537|527638582|FG000|Overall Study|Withdrawal by Subject|1|||
146307231|NCT01148537|527638583|FG001|Overall Study|Withdrawal by Subject|0|||
146307232|NCT01148537|527638584|FG002|Overall Study|Withdrawal by Subject|2|||
146307233|NCT01148537|527638582|FG000|Overall Study|Adverse Event|2|||
146307234|NCT01148537|527638583|FG001|Overall Study|Adverse Event|0|||
146307235|NCT01148537|527638584|FG002|Overall Study|Adverse Event|1|||
146307236|NCT00454857|527638585|FG000|Overall Study|Withdrawal by Subject|15|||
146307237|NCT00454857|527638585|FG000|Overall Study|Lost to Follow-up|16|||
146307238|NCT00454857|527638585|FG000|Overall Study|Noncompliance|6|||
146307239|NCT00454857|527638585|FG000|Overall Study|Death|5|||
146307240|NCT00454857|527638585|FG000|Overall Study|Other|11|||
146307241|NCT00454857|527638585|FG000|Overall Study|Reason unknown|1|||
146307242|NCT00632099|527638586|FG000|Overall Study|Lost to Follow-up|3|||
146307243|NCT00632099|527638587|FG001|Overall Study|Lost to Follow-up|3|||
146307244|NCT04712110|527638590|FG000|Overall Study|Lost to Follow-up|0|||
146307245|NCT04712110|527638591|FG001|Overall Study|Lost to Follow-up|1|||
146307246|NCT04712110|527638590|FG000|Overall Study|Withdrawal by Subject|0|||
146307247|NCT04712110|527638591|FG001|Overall Study|Withdrawal by Subject|4|||
146307248|NCT04712110|527638590|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
146307249|NCT04712110|527638591|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
146307250|NCT03625687|527638602|FG000|Overall Study|Death|1|||
146307251|NCT04206605|527638603|FG000|Overall Study|Adverse Event|0|||
146307252|NCT04206605|527638604|FG001|Overall Study|Adverse Event|1|||
146153135|NCT03588572|527069958|FG000|Visitation 3|Physician Decision|1|||
146153136|NCT03588572|527069959|FG001|Visitation 3|Physician Decision|1|||
146307253|NCT04206605|527638603|FG000|Overall Study|Withdrawal by Subject|1|||
146307254|NCT04206605|527638604|FG001|Overall Study|Withdrawal by Subject|0|||
146307255|NCT00827606|527638609|FG000|Overall Study|Protocol Violation|4|||
146307256|NCT00827606|527638610|FG001|Overall Study|Protocol Violation|3|||
146307257|NCT00827606|527638609|FG000|Overall Study|Lost to Follow-up|3|||
146307258|NCT00827606|527638610|FG001|Overall Study|Lost to Follow-up|1|||
146307259|NCT00827606|527638609|FG000|Overall Study|Withdrawal by Subject|7|||
146307260|NCT00827606|527638610|FG001|Overall Study|Withdrawal by Subject|6|||
146307261|NCT00827606|527638609|FG000|Overall Study|Pregnancy|0|||
146307262|NCT00827606|527638610|FG001|Overall Study|Pregnancy|1|||
146307263|NCT00827606|527638609|FG000|Overall Study|Other|5|||
146307264|NCT00827606|527638610|FG001|Overall Study|Other|13|||
146307265|NCT00827606|527638609|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
146307266|NCT00827606|527638610|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
146307267|NCT00827606|527638609|FG000|Overall Study|Adverse Event|4|||
146307268|NCT00827606|527638610|FG001|Overall Study|Adverse Event|2|||
146307269|NCT00589420|527638613|FG000|Overall Study|screen failure|1|||
146307270|NCT00243386|527638614|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
146307271|NCT00243386|527638615|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
146307272|NCT00243386|527638616|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
146307273|NCT00243386|527638614|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
146307274|NCT00243386|527638615|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
146307275|NCT00243386|527638616|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
146153137|NCT03588572|527069958|FG000|Visitation 3|Withdrawal by Subject|1|||
146307276|NCT00243386|527638614|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
146307277|NCT00243386|527638615|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
146307278|NCT00243386|527638616|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
146153138|NCT03588572|527069959|FG001|Visitation 3|Withdrawal by Subject|0|||
146307279|NCT00243386|527638614|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
146307280|NCT00243386|527638615|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
146307281|NCT00243386|527638616|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
146307282|NCT00243386|527638614|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
146307283|NCT00243386|527638615|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
146307284|NCT00243386|527638616|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
146307285|NCT00243386|527638614|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
146307286|NCT00243386|527638615|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
146307287|NCT00243386|527638616|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
146307288|NCT00243386|527638614|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
146307289|NCT00243386|527638615|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
146307290|NCT00243386|527638616|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
146307291|NCT00243386|527638614|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
146307292|NCT00243386|527638615|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
146307293|NCT00243386|527638616|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
146307294|NCT04037748|527638617|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146307295|NCT04037748|527638618|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146307296|NCT04037748|527638617|FG000|Treatment Period 1|Adverse Event|1|||
146307297|NCT04037748|527638618|FG001|Treatment Period 1|Adverse Event|1|||
146307298|NCT04037748|527638617|FG000|Treatment Period 1|Protocol Violation|4|||
146307299|NCT04037748|527638618|FG001|Treatment Period 1|Protocol Violation|5|||
146307300|NCT04037748|527638617|FG000|Treatment Period 2|Adverse Event|0|||
146307301|NCT04037748|527638618|FG001|Treatment Period 2|Adverse Event|1|||
146307302|NCT04037748|527638617|FG000|Treatment Period 2|Protocol Violation|2|||
146307303|NCT04037748|527638618|FG001|Treatment Period 2|Protocol Violation|0|||
146307304|NCT00133991|527638619|FG000|Overall Study|Death|4|||
146307305|NCT04995055|527638623|FG000|Period 1|COVID-19 Related|1|||
146307306|NCT04995055|527638624|FG001|Period 1|COVID-19 Related|0|||
146307307|NCT04995055|527638623|FG000|Period 1|Withdrawal by Subject|0|||
146307308|NCT04995055|527638624|FG001|Period 1|Withdrawal by Subject|1|||
146307309|NCT04995055|527638623|FG000|Period 1|Subject discontinued due to timing|4|||
146307310|NCT04995055|527638624|FG001|Period 1|Subject discontinued due to timing|4|||
146307311|NCT04695392|527638625|FG000|Overall Study|Withdrawn by parent/guardian|0|||
146307312|NCT04695392|527638626|FG001|Overall Study|Withdrawn by parent/guardian|1|||
146307313|NCT04695392|527638625|FG000|Overall Study|Withdrawn by physician|0|||
146307314|NCT04695392|527638626|FG001|Overall Study|Withdrawn by physician|1|||
146307315|NCT00450723|527638628|FG000|Overall Study|Physician Decision|5|||
146307316|NCT01987960|527638629|FG000|Period 1|Adverse Event|24|||
146307317|NCT01987960|527638630|FG001|Period 1|Adverse Event|0|||
146307318|NCT01987960|527638631|FG002|Period 1|Adverse Event|0|||
146307319|NCT01987960|527638632|FG003|Period 1|Adverse Event|0|||
146307320|NCT01987960|527638629|FG000|Period 1|Lack of Efficacy|4|||
146307321|NCT01987960|527638630|FG001|Period 1|Lack of Efficacy|0|||
146307322|NCT01987960|527638631|FG002|Period 1|Lack of Efficacy|0|||
146307323|NCT01987960|527638632|FG003|Period 1|Lack of Efficacy|0|||
146307324|NCT01987960|527638629|FG000|Period 1|Non-compliance with IMP|6|||
146307325|NCT01987960|527638630|FG001|Period 1|Non-compliance with IMP|0|||
146307326|NCT01987960|527638631|FG002|Period 1|Non-compliance with IMP|0|||
146307327|NCT01987960|527638632|FG003|Period 1|Non-compliance with IMP|0|||
146307328|NCT01987960|527638629|FG000|Period 1|Protocol Violation|12|||
146307329|NCT01987960|527638630|FG001|Period 1|Protocol Violation|0|||
146307330|NCT01987960|527638631|FG002|Period 1|Protocol Violation|0|||
146307331|NCT01987960|527638632|FG003|Period 1|Protocol Violation|0|||
146307332|NCT01987960|527638629|FG000|Period 1|Withdrawal by Subject|21|||
146307333|NCT01987960|527638630|FG001|Period 1|Withdrawal by Subject|0|||
146307334|NCT01987960|527638631|FG002|Period 1|Withdrawal by Subject|0|||
146307335|NCT01987960|527638632|FG003|Period 1|Withdrawal by Subject|0|||
146307336|NCT01987960|527638629|FG000|Period 1|Lost to Follow-up|40|||
146307337|NCT01987960|527638630|FG001|Period 1|Lost to Follow-up|0|||
146307338|NCT01987960|527638631|FG002|Period 1|Lost to Follow-up|0|||
146307339|NCT01987960|527638632|FG003|Period 1|Lost to Follow-up|0|||
146307340|NCT01987960|527638629|FG000|Period 1|administrative or other reason|75|||
146307341|NCT01987960|527638630|FG001|Period 1|administrative or other reason|0|||
146307342|NCT01987960|527638631|FG002|Period 1|administrative or other reason|0|||
146307343|NCT01987960|527638632|FG003|Period 1|administrative or other reason|0|||
146307344|NCT01987960|527638629|FG000|Period 1|Withdrawal of consent before treatment|4|||
146307345|NCT01987960|527638630|FG001|Period 1|Withdrawal of consent before treatment|0|||
146307346|NCT01987960|527638631|FG002|Period 1|Withdrawal of consent before treatment|0|||
146307347|NCT01987960|527638632|FG003|Period 1|Withdrawal of consent before treatment|0|||
146307348|NCT01987960|527638629|FG000|Period 2|Adverse Event|0|||
146307349|NCT01987960|527638630|FG001|Period 2|Adverse Event|0|||
146307350|NCT01987960|527638631|FG002|Period 2|Adverse Event|1|||
146307351|NCT01987960|527638632|FG003|Period 2|Adverse Event|0|||
146307352|NCT01987960|527638629|FG000|Period 2|Withdrawal by Subject|0|||
146307353|NCT01987960|527638630|FG001|Period 2|Withdrawal by Subject|0|||
146307354|NCT01987960|527638631|FG002|Period 2|Withdrawal by Subject|1|||
146307355|NCT01987960|527638632|FG003|Period 2|Withdrawal by Subject|0|||
146307356|NCT01987960|527638629|FG000|Period 2|Administrative or other reason|0|||
146307357|NCT01987960|527638630|FG001|Period 2|Administrative or other reason|5|||
146307358|NCT01987960|527638631|FG002|Period 2|Administrative or other reason|7|||
146307359|NCT01987960|527638632|FG003|Period 2|Administrative or other reason|0|||
146307360|NCT01987960|527638629|FG000|Period 3|Adverse Event|0|||
146307361|NCT01987960|527638630|FG001|Period 3|Adverse Event|0|||
146307362|NCT01987960|527638631|FG002|Period 3|Adverse Event|0|||
146307363|NCT01987960|527638632|FG003|Period 3|Adverse Event|7|||
146307364|NCT01987960|527638629|FG000|Period 3|Non-compliance with IMP|0|||
146307365|NCT01987960|527638630|FG001|Period 3|Non-compliance with IMP|0|||
146307366|NCT01987960|527638631|FG002|Period 3|Non-compliance with IMP|0|||
146307367|NCT01987960|527638632|FG003|Period 3|Non-compliance with IMP|1|||
146307368|NCT01987960|527638629|FG000|Period 3|Protocol Violation|0|||
146307369|NCT01987960|527638630|FG001|Period 3|Protocol Violation|0|||
146307370|NCT01987960|527638631|FG002|Period 3|Protocol Violation|0|||
146307371|NCT01987960|527638632|FG003|Period 3|Protocol Violation|6|||
146307372|NCT01987960|527638629|FG000|Period 3|Withdrawal by Subject|0|||
146307373|NCT01987960|527638630|FG001|Period 3|Withdrawal by Subject|0|||
146307374|NCT01987960|527638631|FG002|Period 3|Withdrawal by Subject|0|||
146307375|NCT01987960|527638632|FG003|Period 3|Withdrawal by Subject|9|||
146307376|NCT01987960|527638629|FG000|Period 3|Lost to Follow-up|0|||
146307377|NCT01987960|527638630|FG001|Period 3|Lost to Follow-up|0|||
146307378|NCT01987960|527638631|FG002|Period 3|Lost to Follow-up|0|||
146307379|NCT01987960|527638632|FG003|Period 3|Lost to Follow-up|5|||
146307380|NCT01987960|527638629|FG000|Period 3|Administrative or other reason|0|||
146307381|NCT01987960|527638630|FG001|Period 3|Administrative or other reason|0|||
146307382|NCT01987960|527638631|FG002|Period 3|Administrative or other reason|0|||
146307383|NCT01987960|527638632|FG003|Period 3|Administrative or other reason|43|||
146307384|NCT01279850|527638633|FG000|Overall Study|Protocol Violation|50|||
146307385|NCT01279850|527638633|FG000|Overall Study|No Drug Administration Information|7|||
146307386|NCT01279850|527638633|FG000|Overall Study|No Visit After Treatment|34|||
146307387|NCT01131520|527638634|FG000|Overall Study|Computer problem|1|||
146307388|NCT01131520|527638635|FG001|Overall Study|Computer problem|0|||
146307389|NCT01131520|527638634|FG000|Overall Study|Counselor not available|0|||
146307390|NCT01131520|527638635|FG001|Overall Study|Counselor not available|3|||
146307391|NCT01131520|527638634|FG000|Overall Study|Subject changed history after enrollment|0|||
146307392|NCT01131520|527638635|FG001|Overall Study|Subject changed history after enrollment|1|||
146307393|NCT01436084|527638636|FG000|Overall Study|Disease Progression|2|||
146307394|NCT01436084|527638636|FG000|Overall Study|Withdrawal by Subject|1|||
146307395|NCT01436084|527638636|FG000|Overall Study|Early Closure of Study|1|||
146307396|NCT00807742|527638637|FG000|Overall Study|Death|9|||
146307397|NCT00807742|527638638|FG001|Overall Study|Death|2|||
146307398|NCT00807742|527638637|FG000|Overall Study|Withdrawal by Subject|2|||
146307399|NCT00807742|527638638|FG001|Overall Study|Withdrawal by Subject|1|||
146307400|NCT00807742|527638637|FG000|Overall Study|Lost to Follow-up|35|||
146307401|NCT00807742|527638638|FG001|Overall Study|Lost to Follow-up|51|||
146307402|NCT03834519|527638639|FG000|Overall Study|Lost to Follow-up|2|||
146307403|NCT03834519|527638640|FG001|Overall Study|Lost to Follow-up|1|||
146307404|NCT03834519|527638639|FG000|Overall Study|Withdrawal by Subject|5|||
146307405|NCT03834519|527638640|FG001|Overall Study|Withdrawal by Subject|8|||
146307406|NCT03834519|527638639|FG000|Overall Study|Death|368|||
146307407|NCT03834519|527638640|FG001|Overall Study|Death|174|||
146307408|NCT03834519|527638639|FG000|Overall Study|Physician Decision|5|||
146307409|NCT03834519|527638640|FG001|Overall Study|Physician Decision|1|||
146307410|NCT03834519|527638639|FG000|Overall Study|Sponsor decision|149|||
146307411|NCT03834519|527638640|FG001|Overall Study|Sponsor decision|80|||
146307412|NCT00853749|527638641|FG000|Overall Study|Lost to Follow-up|0|||
146307413|NCT00853749|527638642|FG001|Overall Study|Lost to Follow-up|1|||
146307414|NCT01538628|527638645|FG000|Overall Study|Withdrawal by Subject|1|||
146307415|NCT01538628|527638646|FG001|Overall Study|Withdrawal by Subject|1|||
146307416|NCT01538628|527638645|FG000|Overall Study|Lost to Follow-up|0|||
146307417|NCT01538628|527638646|FG001|Overall Study|Lost to Follow-up|1|||
146307418|NCT03703882|527640403|FG000|Overall Study|Adverse Event|1|||
146307419|NCT03703882|527640404|FG001|Overall Study|Adverse Event|0|||
146307420|NCT03703882|527640403|FG000|Overall Study|Lost to Follow-up|0|||
146307421|NCT03703882|527640404|FG001|Overall Study|Lost to Follow-up|2|||
146307422|NCT03703882|527640403|FG000|Overall Study|Non-compliance with study drug|0|||
146307423|NCT03703882|527640404|FG001|Overall Study|Non-compliance with study drug|1|||
146307424|NCT03703882|527640403|FG000|Overall Study|Physician Decision|0|||
146307425|NCT03703882|527640404|FG001|Overall Study|Physician Decision|1|||
146307426|NCT03703882|527640403|FG000|Overall Study|Progressive disease|1|||
146307427|NCT03703882|527640404|FG001|Overall Study|Progressive disease|0|||
146307428|NCT03703882|527640403|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146307429|NCT03703882|527640404|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146307430|NCT03703882|527640403|FG000|Overall Study|Starting another treatment|0|||
146307431|NCT03703882|527640404|FG001|Overall Study|Starting another treatment|1|||
146307432|NCT03703882|527640403|FG000|Overall Study|noncompliance with study procedures|0|||
146307433|NCT03703882|527640404|FG001|Overall Study|noncompliance with study procedures|1|||
146307434|NCT01617460|527640405|FG000|Overall Study|Adverse Event|10|||
146307435|NCT01617460|527640405|FG000|Overall Study|Physician Decision|16|||
146307436|NCT01617460|527640405|FG000|Overall Study|Protocol Violation|5|||
146307437|NCT01617460|527640405|FG000|Overall Study|Withdrawal by Subject|9|||
146307438|NCT00457015|527640409|FG000|Overall Study|Left study site against medical advice|0|||
146307439|NCT00457015|527640410|FG001|Overall Study|Left study site against medical advice|1|||
146307440|NCT00075023|527640411|FG000|Pilot Study|Physician Decision|1|||
146307441|NCT00075023|527640412|FG001|Pilot Study|Physician Decision|2|||
146307442|NCT00075023|527640411|FG000|Pilot Study|Withdrawal by Subject|1|||
146307443|NCT00075023|527640412|FG001|Pilot Study|Withdrawal by Subject|0|||
146307444|NCT03670953|527640413|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
146307445|NCT03670953|527640414|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146307446|NCT03670953|527640415|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146307447|NCT03670953|527640416|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
146307448|NCT03670953|527640413|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
146307449|NCT03670953|527640414|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146307450|NCT03670953|527640415|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146307451|NCT03670953|527640416|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
146307452|NCT03670953|527640413|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
146307453|NCT03670953|527640414|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146307454|NCT03670953|527640415|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146307455|NCT03670953|527640416|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
146307456|NCT03670953|527640413|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
146307457|NCT03670953|527640414|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146307458|NCT03670953|527640415|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146307459|NCT03670953|527640416|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
146307460|NCT03670953|527640413|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
146307461|NCT03670953|527640414|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146307462|NCT03670953|527640415|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146307463|NCT03670953|527640416|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
146307464|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146307465|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
146307466|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146307467|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
146307468|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146307469|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
146307470|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146307471|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
146307472|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146307473|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
146307474|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146307475|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
146307476|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146307477|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
146307478|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146307479|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
146307480|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146307481|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
146307482|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146307483|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
146307484|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146307485|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
146307486|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146307487|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
146307488|NCT03670953|527640413|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146307489|NCT03670953|527640414|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
146307490|NCT03670953|527640415|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146307491|NCT03670953|527640416|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
146307492|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
146307493|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
146307494|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
146307495|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
146307496|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
146307497|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
146307498|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
146307499|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
146307500|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
146307501|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
146307502|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
146307503|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
146307504|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146307505|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146307506|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
146307507|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
146307508|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
146307509|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
146307510|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
146307511|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
146307512|NCT03670953|527640413|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146307513|NCT03670953|527640414|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146307514|NCT03670953|527640415|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
146307515|NCT03670953|527640416|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
146307516|NCT02982954|527640419|FG000|Overall Study|Death|55|||
146307517|NCT02982954|527640420|FG001|Overall Study|Death|29|||
146307518|NCT02982954|527640421|FG002|Overall Study|Death|15|||
146307519|NCT02982954|527640422|FG003|Overall Study|Death|20|||
146307520|NCT02982954|527640419|FG000|Overall Study|Lost to Follow-up|2|||
146307521|NCT02982954|527640420|FG001|Overall Study|Lost to Follow-up|1|||
146307522|NCT02982954|527640421|FG002|Overall Study|Lost to Follow-up|0|||
146307523|NCT02982954|527640422|FG003|Overall Study|Lost to Follow-up|0|||
146307524|NCT02982954|527640419|FG000|Overall Study|Participant withdrew consent|7|||
146307525|NCT02982954|527640420|FG001|Overall Study|Participant withdrew consent|5|||
146307526|NCT02982954|527640421|FG002|Overall Study|Participant withdrew consent|1|||
146307527|NCT02982954|527640422|FG003|Overall Study|Participant withdrew consent|1|||
146307528|NCT02982954|527640419|FG000|Overall Study|Other reasons|42|||
146307529|NCT02982954|527640420|FG001|Overall Study|Other reasons|17|||
146307530|NCT02982954|527640421|FG002|Overall Study|Other reasons|12|||
146307531|NCT02982954|527640422|FG003|Overall Study|Other reasons|3|||
146307532|NCT02982954|527640419|FG000|Overall Study|Premature site closure|0|||
146307533|NCT02982954|527640420|FG001|Overall Study|Premature site closure|0|||
146307534|NCT02982954|527640421|FG002|Overall Study|Premature site closure|0|||
146307535|NCT02982954|527640422|FG003|Overall Study|Premature site closure|1|||
146307536|NCT00516048|527640423|FG000|Overall Study|Death|0|||
146307537|NCT00516048|527640424|FG001|Overall Study|Death|0|||
146307538|NCT00516048|527640425|FG002|Overall Study|Death|1|||
146307539|NCT00516048|527640423|FG000|Overall Study|Subject Decision|0|||
146307540|NCT00516048|527640424|FG001|Overall Study|Subject Decision|2|||
146307541|NCT00516048|527640425|FG002|Overall Study|Subject Decision|0|||
146307542|NCT02263079|527640426|FG000|Overall Study|Physician Decision|1|||
146307543|NCT02263079|527640427|FG001|Overall Study|Physician Decision|0|||
146307544|NCT02263079|527640428|FG002|Overall Study|Physician Decision|0|||
146307545|NCT02263079|527640426|FG000|Overall Study|Withdrawal by Subject|2|||
146307546|NCT02263079|527640427|FG001|Overall Study|Withdrawal by Subject|8|||
146307547|NCT02263079|527640428|FG002|Overall Study|Withdrawal by Subject|0|||
146307548|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
146307549|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
146307550|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
146307551|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146307552|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
146307553|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
146307554|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Death|2|||
146307555|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Death|0|||
146307556|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
146307557|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
146307558|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
146307559|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
146307560|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
146307561|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
146307562|NCT02603120|527640429|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
146307563|NCT02603120|527640430|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
146307564|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
146307565|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
146307566|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
146307567|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
146307568|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
146307569|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
146307570|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
146307571|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
146307572|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
146307573|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
146307574|NCT02603120|527640429|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
146307575|NCT02603120|527640430|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
146307576|NCT01469182|527640433|FG000|Overall Study|Adverse Event|21|||
146307577|NCT01469182|527640434|FG001|Overall Study|Adverse Event|3|||
146307578|NCT01469182|527640433|FG000|Overall Study|Lost to Follow-up|3|||
146307579|NCT01469182|527640434|FG001|Overall Study|Lost to Follow-up|0|||
146307580|NCT01469182|527640433|FG000|Overall Study|Withdrawal by Subject|4|||
146307581|NCT01469182|527640434|FG001|Overall Study|Withdrawal by Subject|1|||
146307582|NCT01469182|527640433|FG000|Overall Study|Protocol Violation|4|||
146307583|NCT01469182|527640434|FG001|Overall Study|Protocol Violation|2|||
146307584|NCT01469182|527640433|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
146307585|NCT01469182|527640434|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
146307586|NCT01227187|527640436|FG000|Overall Study|Physician Decision|0|||
146307587|NCT01227187|527640437|FG001|Overall Study|Physician Decision|0|||
146307588|NCT01227187|527640438|FG002|Overall Study|Physician Decision|0|||
146307589|NCT01227187|527640439|FG003|Overall Study|Physician Decision|1|||
146307590|NCT00840086|527640440|FG000|Overall Study|Adverse Event|1|||
146307591|NCT00840086|527640440|FG000|Overall Study|Protocol Violation|2|||
146307592|NCT00840086|527640440|FG000|Overall Study|Lost to Follow-up|1|||
146307593|NCT03332498|527640441|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
146307594|NCT03332498|527640442|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
146307595|NCT03332498|527640443|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
146307596|NCT02554019|527640444|FG000|Overall Study|Withdrawal by Subject|1|||
146307597|NCT02554019|527640445|FG001|Overall Study|Withdrawal by Subject|0|||
146307598|NCT02554019|527640446|FG002|Overall Study|Withdrawal by Subject|2|||
146307599|NCT02554019|527640444|FG000|Overall Study|Adverse Event|1|||
146307600|NCT02554019|527640445|FG001|Overall Study|Adverse Event|0|||
146307601|NCT02554019|527640446|FG002|Overall Study|Adverse Event|0|||
146307602|NCT02463409|527640447|FG000|Overall Study|Withdrawal by Subject|1|||
146307603|NCT02463409|527640447|FG000|Overall Study|Screen failure|1|||
146307604|NCT00916357|527640448|FG000|Period 1|Withdrawal by Subject|1|||
146307605|NCT00916357|527640449|FG001|Period 1|Withdrawal by Subject|0|||
146307606|NCT00916357|527640450|FG002|Period 1|Withdrawal by Subject|0|||
146307607|NCT00916357|527640451|FG003|Period 1|Withdrawal by Subject|0|||
146307608|NCT00916357|527640452|FG004|Period 1|Withdrawal by Subject|0|||
146307609|NCT00916357|527640453|FG005|Period 1|Withdrawal by Subject|0|||
146307610|NCT00916357|527640448|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
146307611|NCT00916357|527640449|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
146307612|NCT00916357|527640450|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
146307613|NCT00916357|527640451|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
146307614|NCT00916357|527640452|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
146307615|NCT00916357|527640453|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
146307616|NCT03577730|527640454|FG000|Overall Study|Physician Decision|3|||
146307617|NCT03577730|527640455|FG001|Overall Study|Physician Decision|1|||
146307618|NCT03577730|527640454|FG000|Overall Study|Did not receive allocated intervention|1|||
146307619|NCT03577730|527640455|FG001|Overall Study|Did not receive allocated intervention|0|||
146307620|NCT02634151|527640457|FG000|Overall Study|Withdrawal by Subject|1|||
146307621|NCT02634151|527640458|FG001|Overall Study|Withdrawal by Subject|0|||
146307622|NCT02634151|527640457|FG000|Overall Study|Non-Compliance|0|||
146307623|NCT02634151|527640458|FG001|Overall Study|Non-Compliance|1|||
146307624|NCT02634151|527640457|FG000|Overall Study|Other|0|||
146307625|NCT02634151|527640458|FG001|Overall Study|Other|1|||
146307626|NCT02347098|527640459|FG000|Overall Study|Death|1|||
146307627|NCT02347098|527640460|FG001|Overall Study|Death|0|||
146307628|NCT02347098|527640459|FG000|Overall Study|Withdrawal by Subject|1|||
146307629|NCT02347098|527640460|FG001|Overall Study|Withdrawal by Subject|0|||
146307630|NCT02347098|527640459|FG000|Overall Study|Lost to Follow-up|2|||
146307631|NCT02347098|527640460|FG001|Overall Study|Lost to Follow-up|2|||
146307632|NCT02347098|527640459|FG000|Overall Study|Refuse Follow-up Visit|1|||
146307633|NCT02347098|527640460|FG001|Overall Study|Refuse Follow-up Visit|5|||
146307634|NCT02347098|527640459|FG000|Overall Study|no visit due to illness|2|||
146307635|NCT02347098|527640460|FG001|Overall Study|no visit due to illness|1|||
146307636|NCT01444742|527640461|FG000|Overall Study|Death|1|||
146307637|NCT02187172|527640462|FG000|Overall Study|Lost to Follow-up|1|||
146307638|NCT02187172|527640463|FG001|Overall Study|Lost to Follow-up|2|||
146307639|NCT02187172|527640462|FG000|Overall Study|Lack of Efficacy|1|||
146307640|NCT02187172|527640463|FG001|Overall Study|Lack of Efficacy|2|||
146307641|NCT02187172|527640462|FG000|Overall Study|Adverse Event|0|||
146307642|NCT02187172|527640463|FG001|Overall Study|Adverse Event|1|||
146307643|NCT02187172|527640462|FG000|Overall Study|Physician Decision|1|||
146307644|NCT02187172|527640463|FG001|Overall Study|Physician Decision|1|||
146307645|NCT02830880|527640464|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
146307646|NCT02830880|527640464|FG000|Overall Study|Death|1|||
146307647|NCT02830880|527640464|FG000|Overall Study|Physician Decision|1|||
146307648|NCT02349048|527640469|FG000|Overall Study|Withdrawal by Subject|4|||
146307649|NCT02349048|527640470|FG001|Overall Study|Withdrawal by Subject|0|||
146307650|NCT02349048|527640469|FG000|Overall Study|Lost to Follow-up|1|||
146307651|NCT02349048|527640470|FG001|Overall Study|Lost to Follow-up|0|||
146307652|NCT01549275|527640473|FG000|Overall Study|Lost to Follow-up|1|||
146307653|NCT01549275|527640474|FG001|Overall Study|Lost to Follow-up|0|||
146307654|NCT00122681|527640484|FG000|Overall Study|Adverse Event|20|||
146307655|NCT00122681|527640485|FG001|Overall Study|Adverse Event|16|||
146307656|NCT00122681|527640484|FG000|Overall Study|Lost to Follow-up|1080|||
146307657|NCT00122681|527640485|FG001|Overall Study|Lost to Follow-up|1097|||
146307658|NCT00122681|527640484|FG000|Overall Study|Protocol Violation|7|||
146307659|NCT00122681|527640485|FG001|Overall Study|Protocol Violation|10|||
146307660|NCT00122681|527640484|FG000|Overall Study|Withdrawal by Subject|257|||
146307661|NCT00122681|527640485|FG001|Overall Study|Withdrawal by Subject|251|||
146307662|NCT00122681|527640484|FG000|Overall Study|Personal reasons|150|||
146307663|NCT00122681|527640485|FG001|Overall Study|Personal reasons|147|||
146307664|NCT03179891|527640493|FG000|First Intervention|Withdrawal by Subject|1|||
146307665|NCT03179891|527640494|FG001|First Intervention|Withdrawal by Subject|1|||
146307666|NCT03179891|527640493|FG000|First Intervention|Unspecified reason|1|||
146307667|NCT03179891|527640494|FG001|First Intervention|Unspecified reason|0|||
146307668|NCT03179891|527640493|FG000|First Intervention|Protocol Violation|0|||
146307669|NCT03179891|527640494|FG001|First Intervention|Protocol Violation|1|||
146307670|NCT02969187|527640495|FG000|Overall Study|Physician Decision|12|||
146307671|NCT02969187|527640496|FG001|Overall Study|Physician Decision|13|||
146307672|NCT01486927|527640497|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
146307673|NCT01486927|527640497|FG000|Overall Study|Physician Decision|1|||
146307674|NCT01486927|527640497|FG000|Overall Study|50 Exposure days not reached|2|||
146307675|NCT01486927|527640497|FG000|Overall Study|Withdrawal by Subject|8|||
146307676|NCT01486927|527640497|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
146307677|NCT00573430|527640503|FG000|Overall Study|Incorrect enrollment of randomization|0|||
146307678|NCT00573430|527640504|FG001|Overall Study|Incorrect enrollment of randomization|4|||
146307679|NCT00573430|527640505|FG002|Overall Study|Incorrect enrollment of randomization|3|||
146307680|NCT00573430|527640503|FG000|Overall Study|Adverse Event|0|||
146307681|NCT00573430|527640504|FG001|Overall Study|Adverse Event|0|||
146307682|NCT00573430|527640505|FG002|Overall Study|Adverse Event|2|||
146307683|NCT00573430|527640503|FG000|Overall Study|Withdrawal by Subject|1|||
146307684|NCT00573430|527640504|FG001|Overall Study|Withdrawal by Subject|0|||
146307685|NCT00573430|527640505|FG002|Overall Study|Withdrawal by Subject|1|||
146307686|NCT00573430|527640503|FG000|Overall Study|Protocol Violation|0|||
146307687|NCT00573430|527640504|FG001|Overall Study|Protocol Violation|1|||
146307688|NCT00573430|527640505|FG002|Overall Study|Protocol Violation|1|||
146307689|NCT00573430|527640503|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146307690|NCT00573430|527640504|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146307691|NCT00573430|527640505|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
146307692|NCT03719690|527640506|FG000|Overall Study|Withdrawal by Subject|5|||
146307693|NCT03719690|527640507|FG001|Overall Study|Withdrawal by Subject|10|||
146307694|NCT03719690|527640506|FG000|Overall Study|Death|40|||
146307695|NCT03719690|527640507|FG001|Overall Study|Death|149|||
146307696|NCT03719690|527640506|FG000|Overall Study|Miscellaneous|12|||
146307697|NCT03719690|527640507|FG001|Overall Study|Miscellaneous|56|||
146307698|NCT03719690|527640506|FG000|Overall Study|Lost to Follow-up|2|||
146307699|NCT03719690|527640507|FG001|Overall Study|Lost to Follow-up|18|||
146307700|NCT03719690|527640506|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
146307701|NCT03719690|527640507|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
146307702|NCT01278745|527640508|FG000|Overall Study|Death|2|||
146307703|NCT01278745|527640509|FG001|Overall Study|Death|5|||
146307704|NCT01278745|527640510|FG002|Overall Study|Death|7|||
146307705|NCT01278745|527640511|FG003|Overall Study|Death|0|||
146307706|NCT01278745|527640508|FG000|Overall Study|Physician Decision|1|||
146307707|NCT01278745|527640509|FG001|Overall Study|Physician Decision|0|||
146307708|NCT01278745|527640510|FG002|Overall Study|Physician Decision|0|||
146307709|NCT01278745|527640511|FG003|Overall Study|Physician Decision|9|||
146307710|NCT01278745|527640508|FG000|Overall Study|Withdrawal by Subject|1|||
146307711|NCT01278745|527640509|FG001|Overall Study|Withdrawal by Subject|1|||
146307712|NCT01278745|527640510|FG002|Overall Study|Withdrawal by Subject|5|||
146307713|NCT01278745|527640511|FG003|Overall Study|Withdrawal by Subject|1|||
146307714|NCT01278745|527640508|FG000|Overall Study|Sponsor Decision|1|||
146307715|NCT01278745|527640509|FG001|Overall Study|Sponsor Decision|0|||
146307716|NCT01278745|527640510|FG002|Overall Study|Sponsor Decision|62|||
146307717|NCT01278745|527640511|FG003|Overall Study|Sponsor Decision|6|||
146153139|NCT02663817|527069960|FG000|Overall Study|Screen failure|2|||
146307718|NCT01278745|527640508|FG000|Overall Study|Ineligible|0|||
146307719|NCT01278745|527640509|FG001|Overall Study|Ineligible|0|||
146307720|NCT01278745|527640510|FG002|Overall Study|Ineligible|42|||
146307721|NCT01278745|527640511|FG003|Overall Study|Ineligible|61|||
146307722|NCT01278745|527640508|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
146307723|NCT01278745|527640509|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
146307724|NCT01278745|527640510|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
146153140|NCT01308580|527069962|FG000|Overall Study|Lost to Follow-up|12|||
146307725|NCT01278745|527640511|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
146307726|NCT01471015|527640512|FG000|Overall Study|Death|0|||
146307727|NCT01471015|527640513|FG001|Overall Study|Death|1|||
146307728|NCT01471015|527640514|FG002|Overall Study|Death|1|||
146307729|NCT01843842|527640520|FG000|Overall Study|Do not meet inclusion criteria|1|||
146307730|NCT01843842|527640521|FG001|Overall Study|Do not meet inclusion criteria|1|||
146307731|NCT02953340|527640522|FG000|Overall Study|Death|0|||
146307732|NCT02953340|527640523|FG001|Overall Study|Death|1|||
146307733|NCT02953340|527640522|FG000|Overall Study|Investigator Decision|3|||
146307734|NCT02953340|527640523|FG001|Overall Study|Investigator Decision|3|||
146307735|NCT02953340|527640522|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
146307736|NCT02953340|527640523|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
146307737|NCT02953340|527640522|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
146307738|NCT02953340|527640523|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
146307739|NCT02953340|527640522|FG000|Overall Study|Withdrawal by Subject|9|||
146307740|NCT02953340|527640523|FG001|Overall Study|Withdrawal by Subject|9|||
146307741|NCT02953340|527640522|FG000|Overall Study|Sponsor decision|0|||
146307742|NCT02953340|527640523|FG001|Overall Study|Sponsor decision|2|||
146307743|NCT02953340|527640522|FG000|Overall Study|Lost to Follow-up|3|||
146307744|NCT02953340|527640523|FG001|Overall Study|Lost to Follow-up|2|||
146307745|NCT02953340|527640522|FG000|Overall Study|Reason not specified|2|||
146307746|NCT02953340|527640523|FG001|Overall Study|Reason not specified|2|||
146307747|NCT01376778|527640524|FG000|Overall Study|Lost to Follow-up|3|||
146307748|NCT01376778|527640525|FG001|Overall Study|Lost to Follow-up|2|||
146307749|NCT01197521|527640529|FG000|Overall Study|Not reported|24|||
146307750|NCT01197521|527640530|FG001|Overall Study|Not reported|25|||
146307751|NCT01197521|527640531|FG002|Overall Study|Not reported|21|||
146307752|NCT01197521|527640529|FG000|Overall Study|Enrolment in long term extension|42|||
146307753|NCT01197521|527640530|FG001|Overall Study|Enrolment in long term extension|36|||
146307754|NCT01197521|527640531|FG002|Overall Study|Enrolment in long term extension|87|||
146307755|NCT01197521|527640529|FG000|Overall Study|Severe non-compliance to protocol|1|||
146307756|NCT01197521|527640530|FG001|Overall Study|Severe non-compliance to protocol|3|||
146307757|NCT01197521|527640531|FG002|Overall Study|Severe non-compliance to protocol|3|||
146307758|NCT01197521|527640529|FG000|Overall Study|Lack of therapeutic response|2|||
146307759|NCT01197521|527640530|FG001|Overall Study|Lack of therapeutic response|3|||
146307760|NCT01197521|527640531|FG002|Overall Study|Lack of therapeutic response|4|||
146307761|NCT01197521|527640529|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
146307762|NCT01197521|527640530|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
146307763|NCT01197521|527640531|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
146307764|NCT01197521|527640529|FG000|Overall Study|Lost to Follow-up|3|||
146307765|NCT01197521|527640530|FG001|Overall Study|Lost to Follow-up|2|||
146307766|NCT01197521|527640531|FG002|Overall Study|Lost to Follow-up|2|||
146307767|NCT01197521|527640529|FG000|Overall Study|Adverse Event|25|||
146307768|NCT01197521|527640530|FG001|Overall Study|Adverse Event|28|||
146307769|NCT01197521|527640531|FG002|Overall Study|Adverse Event|24|||
146307770|NCT00271596|527640534|FG000|Overall Study|Protocol Violation|1|||
146307771|NCT00271596|527640535|FG001|Overall Study|Protocol Violation|0|||
146307772|NCT00271596|527640534|FG000|Overall Study|Withdrawal by Subject|0|||
146307773|NCT00271596|527640535|FG001|Overall Study|Withdrawal by Subject|1|||
146307774|NCT04707157|527640536|FG000|Overall Study|Adverse Event|12|||
146307775|NCT04707157|527640537|FG001|Overall Study|Adverse Event|3|||
146307776|NCT04707157|527640536|FG000|Overall Study|Lost to Follow-up|2|||
146307777|NCT04707157|527640537|FG001|Overall Study|Lost to Follow-up|0|||
146307778|NCT04707157|527640536|FG000|Overall Study|Sponsor's decision|1|||
146307779|NCT04707157|527640537|FG001|Overall Study|Sponsor's decision|0|||
146307780|NCT04707157|527640536|FG000|Overall Study|Physician Decision|8|||
146307781|NCT04707157|527640537|FG001|Overall Study|Physician Decision|5|||
146307782|NCT04707157|527640536|FG000|Overall Study|Protocol Deviation|1|||
146307783|NCT04707157|527640537|FG001|Overall Study|Protocol Deviation|0|||
146307784|NCT04707157|527640536|FG000|Overall Study|Withdrawal by Subject|1|||
146307785|NCT04707157|527640537|FG001|Overall Study|Withdrawal by Subject|1|||
146307786|NCT05879107|527640540|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
146307787|NCT05879107|527640541|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
146307788|NCT05879107|527640540|FG000|Overall Study|Migrated / moved from the study area|1|||
146307789|NCT05879107|527640541|FG001|Overall Study|Migrated / moved from the study area|1|||
146307790|NCT05879107|527640540|FG000|Overall Study|Lost to Follow-up|8|||
146307791|NCT05879107|527640541|FG001|Overall Study|Lost to Follow-up|13|||
146307792|NCT05879107|527640540|FG000|Overall Study|Death|0|||
146307793|NCT05879107|527640541|FG001|Overall Study|Death|2|||
146307794|NCT05879107|527640540|FG000|Overall Study|Other|0|||
146307795|NCT05879107|527640541|FG001|Overall Study|Other|3|||
146307796|NCT03710486|527640547|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
146307797|NCT03710486|527640548|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
146307798|NCT03710486|527640547|FG000|Overall Study|Missing|0|||
146307799|NCT03710486|527640548|FG001|Overall Study|Missing|2|||
146307800|NCT01744665|527640555|FG000|Monitoring Phase|Adverse Event|4|||
146307801|NCT01744665|527640555|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
146307802|NCT01744665|527640555|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
146307803|NCT01744665|527640555|FG000|Monitoring Phase|Withdrawal by Subject|5|||
146307804|NCT01744665|527640555|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
146153141|NCT01308580|527069963|FG001|Overall Study|Lost to Follow-up|7|||
146307805|NCT01744665|527640555|FG000|Consolidation Phase|Adverse Event|2|||
146307806|NCT01744665|527640555|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
146307807|NCT01744665|527640555|FG000|Consolidation Phase|Withdrawal by Subject|4|||
146307808|NCT01744665|527640555|FG000|Consolidation Phase|Administrative problems|9|||
146307809|NCT01744665|527640555|FG000|Re-initiation Phase|Administrative problems|10|||
146307810|NCT01744665|527640555|FG000|Re-initiation Phase|Adverse Event|1|||
146307811|NCT01744665|527640555|FG000|Re-initiation Phase|No longer required treatment|1|||
146307812|NCT01744665|527640555|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
146307813|NCT05419128|527640556|FG000|Overall Study|Withdrawal by Subject|1|||
146307814|NCT05419128|527640557|FG001|Overall Study|Withdrawal by Subject|1|||
146307815|NCT05419128|527640558|FG002|Overall Study|Withdrawal by Subject|0|||
146307816|NCT05419128|527640559|FG003|Overall Study|Withdrawal by Subject|1|||
146307817|NCT05419128|527640560|FG004|Overall Study|Withdrawal by Subject|1|||
146307818|NCT05419128|527640561|FG005|Overall Study|Withdrawal by Subject|0|||
146307819|NCT05419128|527640556|FG000|Overall Study|Lost to Follow-up|0|||
146307820|NCT05419128|527640557|FG001|Overall Study|Lost to Follow-up|0|||
146307821|NCT05419128|527640558|FG002|Overall Study|Lost to Follow-up|1|||
146307822|NCT05419128|527640559|FG003|Overall Study|Lost to Follow-up|0|||
146307823|NCT05419128|527640560|FG004|Overall Study|Lost to Follow-up|0|||
146307824|NCT05419128|527640561|FG005|Overall Study|Lost to Follow-up|1|||
146307825|NCT02535715|527642120|FG000|Overall Study|Withdrawal by Subject|0|||
146307826|NCT02535715|527642121|FG001|Overall Study|Withdrawal by Subject|0|||
146307827|NCT02535715|527642122|FG002|Overall Study|Withdrawal by Subject|1|||
146307828|NCT00909181|527642123|FG000|Overall Study|Lost to Follow-up|39|||
146307829|NCT00909181|527642124|FG001|Overall Study|Lost to Follow-up|18|||
146307830|NCT00909181|527642125|FG002|Overall Study|Lost to Follow-up|33|||
146307831|NCT04353284|527642126|FG000|Overall Study|Adverse Event|1|||
146307832|NCT04353284|527642127|FG001|Overall Study|Adverse Event|1|||
146307833|NCT04353284|527642126|FG000|Overall Study|Lost to Follow-up|1|||
146307834|NCT04353284|527642127|FG001|Overall Study|Lost to Follow-up|0|||
146307835|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
146307836|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
146307837|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
146307838|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
146307839|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
146307840|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
146307841|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
146307842|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
146307843|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
146307844|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
146307845|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
146307846|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
146307847|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
146307848|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
146307849|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
146307850|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
146307851|NCT00094770|527642129|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
146307852|NCT00094770|527642130|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
146307853|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
146307854|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
146307855|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
146307856|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
146307857|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
146307858|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
146307859|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
146307860|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
146307861|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
146307862|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
146307863|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
146307864|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
146307865|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
146307866|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
146307867|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
146307868|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
146307869|NCT00094770|527642129|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
146307870|NCT00094770|527642130|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
146307871|NCT01040351|527642133|FG000|Overall Study|poor ovarian response|1|||
146307872|NCT01040351|527642134|FG001|Overall Study|poor ovarian response|2|||
146307873|NCT04773106|527642135|FG000|Overall Study|Withdrawal by Subject|3|||
146307874|NCT04773106|527642135|FG000|Overall Study|Death|1|||
146307875|NCT02819635|527642136|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
146307876|NCT02819635|527642137|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
146307877|NCT02819635|527642138|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
146307878|NCT02819635|527642139|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
146307879|NCT02819635|527642140|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
146307880|NCT02819635|527642141|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
146307881|NCT02819635|527642142|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
146307882|NCT02819635|527642143|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146307883|NCT02819635|527642144|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146307884|NCT02819635|527642145|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146307885|NCT02819635|527642146|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146307886|NCT02819635|527642147|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
146307887|NCT02819635|527642136|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307888|NCT02819635|527642137|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307889|NCT02819635|527642138|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307890|NCT02819635|527642139|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307891|NCT02819635|527642140|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
146307892|NCT02819635|527642141|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
146307893|NCT02819635|527642142|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
146307894|NCT02819635|527642143|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307895|NCT02819635|527642144|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307896|NCT02819635|527642145|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307897|NCT02819635|527642146|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307898|NCT02819635|527642147|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
146307899|NCT02819635|527642136|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307900|NCT02819635|527642137|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307901|NCT02819635|527642138|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307902|NCT02819635|527642139|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307903|NCT02819635|527642140|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307904|NCT02819635|527642141|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
146307905|NCT02819635|527642142|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
146307906|NCT02819635|527642143|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307907|NCT02819635|527642144|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307908|NCT02819635|527642145|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307909|NCT02819635|527642146|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307910|NCT02819635|527642147|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
146307911|NCT02819635|527642136|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307912|NCT02819635|527642137|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307913|NCT02819635|527642138|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307914|NCT02819635|527642139|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307915|NCT02819635|527642140|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307916|NCT02819635|527642141|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307917|NCT02819635|527642142|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
146307918|NCT02819635|527642143|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307919|NCT02819635|527642144|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307920|NCT02819635|527642145|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307921|NCT02819635|527642146|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307922|NCT02819635|527642147|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
146307923|NCT02819635|527642136|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
146307924|NCT02819635|527642137|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
146307925|NCT02819635|527642138|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
146307926|NCT02819635|527642139|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
146307927|NCT02819635|527642140|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
146307928|NCT02819635|527642141|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
146307929|NCT02819635|527642142|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
146307930|NCT02819635|527642143|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146307931|NCT02819635|527642144|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146307932|NCT02819635|527642145|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146307933|NCT02819635|527642146|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146307934|NCT02819635|527642147|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
146307935|NCT02819635|527642136|FG000|Substudy 2, Part 2|Adverse Event|0|||
146307936|NCT02819635|527642137|FG001|Substudy 2, Part 2|Adverse Event|0|||
146307937|NCT02819635|527642138|FG002|Substudy 2, Part 2|Adverse Event|0|||
146307938|NCT02819635|527642139|FG003|Substudy 2, Part 2|Adverse Event|0|||
146307939|NCT02819635|527642140|FG004|Substudy 2, Part 2|Adverse Event|0|||
146307940|NCT02819635|527642141|FG005|Substudy 2, Part 2|Adverse Event|4|||
146307941|NCT02819635|527642142|FG006|Substudy 2, Part 2|Adverse Event|0|||
146307942|NCT02819635|527642143|FG007|Substudy 2, Part 2|Adverse Event|0|||
146307943|NCT02819635|527642144|FG008|Substudy 2, Part 2|Adverse Event|0|||
146153142|NCT01438541|527069964|FG000|Overall Study|Physician Decision|1|||
146153143|NCT01438541|527069964|FG000|Overall Study|Withdrawal by Subject|1|||
146307944|NCT02819635|527642145|FG009|Substudy 2, Part 2|Adverse Event|0|||
146307945|NCT02819635|527642146|FG010|Substudy 2, Part 2|Adverse Event|0|||
146307946|NCT02819635|527642147|FG011|Substudy 2, Part 2|Adverse Event|0|||
146307947|NCT02819635|527642136|FG000|Substudy 2, Part 2|Withdrew consent|0|||
146307948|NCT02819635|527642137|FG001|Substudy 2, Part 2|Withdrew consent|0|||
146307949|NCT02819635|527642138|FG002|Substudy 2, Part 2|Withdrew consent|0|||
146307950|NCT02819635|527642139|FG003|Substudy 2, Part 2|Withdrew consent|0|||
146307951|NCT02819635|527642140|FG004|Substudy 2, Part 2|Withdrew consent|0|||
146307952|NCT02819635|527642141|FG005|Substudy 2, Part 2|Withdrew consent|3|||
146307953|NCT02819635|527642142|FG006|Substudy 2, Part 2|Withdrew consent|1|||
146307954|NCT02819635|527642143|FG007|Substudy 2, Part 2|Withdrew consent|0|||
146307955|NCT02819635|527642144|FG008|Substudy 2, Part 2|Withdrew consent|0|||
146307956|NCT02819635|527642145|FG009|Substudy 2, Part 2|Withdrew consent|0|||
146307957|NCT02819635|527642146|FG010|Substudy 2, Part 2|Withdrew consent|0|||
146307958|NCT02819635|527642147|FG011|Substudy 2, Part 2|Withdrew consent|0|||
146307959|NCT02819635|527642136|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
146307960|NCT02819635|527642137|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
146307961|NCT02819635|527642138|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
146307962|NCT02819635|527642139|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
146307963|NCT02819635|527642140|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
146307964|NCT02819635|527642141|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
146307965|NCT02819635|527642142|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
146307966|NCT02819635|527642143|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
146307967|NCT02819635|527642144|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
146307968|NCT02819635|527642145|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
146307969|NCT02819635|527642146|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
146307970|NCT02819635|527642147|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
146307971|NCT02819635|527642136|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307972|NCT02819635|527642137|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307973|NCT02819635|527642138|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307974|NCT02819635|527642139|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307975|NCT02819635|527642140|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307976|NCT02819635|527642141|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307977|NCT02819635|527642142|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
146307978|NCT02819635|527642143|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307979|NCT02819635|527642144|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307980|NCT02819635|527642145|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307981|NCT02819635|527642146|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307982|NCT02819635|527642147|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
146307983|NCT02819635|527642136|FG000|Substudy 2, Part 2|Other, not specified|0|||
146153144|NCT01438541|527069964|FG000|Overall Study|discharge from the hospital|5|||
146153145|NCT02091167|527069965|FG000|Overall Study|Lost to Follow-up|0|||
146153146|NCT02091167|527069966|FG001|Overall Study|Lost to Follow-up|2|||
146153147|NCT03096782|527069967|FG000|Overall Study|Death|1|||
146153148|NCT03096782|527069967|FG000|Overall Study|Participant Relapsed|1|||
146153149|NCT03822533|527072267|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
146307984|NCT02819635|527642137|FG001|Substudy 2, Part 2|Other, not specified|0|||
146307985|NCT02819635|527642138|FG002|Substudy 2, Part 2|Other, not specified|0|||
146307986|NCT02819635|527642139|FG003|Substudy 2, Part 2|Other, not specified|0|||
146307987|NCT02819635|527642140|FG004|Substudy 2, Part 2|Other, not specified|0|||
146307988|NCT02819635|527642141|FG005|Substudy 2, Part 2|Other, not specified|4|||
146307989|NCT02819635|527642142|FG006|Substudy 2, Part 2|Other, not specified|8|||
146307990|NCT02819635|527642143|FG007|Substudy 2, Part 2|Other, not specified|0|||
146307991|NCT02819635|527642144|FG008|Substudy 2, Part 2|Other, not specified|0|||
146307992|NCT02819635|527642145|FG009|Substudy 2, Part 2|Other, not specified|0|||
146307993|NCT02819635|527642146|FG010|Substudy 2, Part 2|Other, not specified|0|||
146307994|NCT02819635|527642147|FG011|Substudy 2, Part 2|Other, not specified|0|||
146307995|NCT02819635|527642136|FG000|Substudy 3|Adverse Event|0|||
146307996|NCT02819635|527642137|FG001|Substudy 3|Adverse Event|0|||
146307997|NCT02819635|527642138|FG002|Substudy 3|Adverse Event|0|||
146307998|NCT02819635|527642139|FG003|Substudy 3|Adverse Event|0|||
146307999|NCT02819635|527642140|FG004|Substudy 3|Adverse Event|0|||
146153150|NCT03822533|527072268|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
146308000|NCT02819635|527642141|FG005|Substudy 3|Adverse Event|0|||
146308001|NCT02819635|527642142|FG006|Substudy 3|Adverse Event|0|||
146308002|NCT02819635|527642143|FG007|Substudy 3|Adverse Event|0|||
146308003|NCT02819635|527642144|FG008|Substudy 3|Adverse Event|32|||
146308004|NCT02819635|527642145|FG009|Substudy 3|Adverse Event|3|||
146308005|NCT02819635|527642146|FG010|Substudy 3|Adverse Event|12|||
146308006|NCT02819635|527642147|FG011|Substudy 3|Adverse Event|18|||
146308007|NCT02819635|527642136|FG000|Substudy 3|Withdrew consent|0|||
146308008|NCT02819635|527642137|FG001|Substudy 3|Withdrew consent|0|||
146308009|NCT02819635|527642138|FG002|Substudy 3|Withdrew consent|0|||
146308010|NCT02819635|527642139|FG003|Substudy 3|Withdrew consent|0|||
146308011|NCT02819635|527642140|FG004|Substudy 3|Withdrew consent|0|||
146153151|NCT03822533|527072267|FG000|3 Month Follow-up|Lost to Follow-up|2|||
146308012|NCT02819635|527642141|FG005|Substudy 3|Withdrew consent|0|||
146308013|NCT02819635|527642142|FG006|Substudy 3|Withdrew consent|0|||
146153152|NCT03822533|527072268|FG001|3 Month Follow-up|Lost to Follow-up|2|||
146153153|NCT03822533|527072267|FG000|6 Month Follow-up|Lost to Follow-up|3|||
146153154|NCT03822533|527072268|FG001|6 Month Follow-up|Lost to Follow-up|0|||
146153155|NCT03822533|527072267|FG000|12 Month Follow-up|Lost to Follow-up|2|||
146153156|NCT03822533|527072268|FG001|12 Month Follow-up|Lost to Follow-up|3|||
146153157|NCT03822533|527072267|FG000|12 Month Follow-up|Pregnancy|0|||
146153158|NCT03822533|527072268|FG001|12 Month Follow-up|Pregnancy|1|||
146153159|NCT03822533|527072267|FG000|12 Month Follow-up|Surgery|2|||
146153160|NCT03822533|527072268|FG001|12 Month Follow-up|Surgery|0|||
146153161|NCT03822533|527072267|FG000|12 Month Follow-up|Wrong address|1|||
146153162|NCT03822533|527072268|FG001|12 Month Follow-up|Wrong address|0|||
146153163|NCT03822533|527072267|FG000|12 Month Follow-up|No symptoms|1|||
146153164|NCT03822533|527072268|FG001|12 Month Follow-up|No symptoms|0|||
146153165|NCT03822533|527072267|FG000|12 Month Follow-up|Changed primary care center|0|||
146153166|NCT03822533|527072268|FG001|12 Month Follow-up|Changed primary care center|1|||
146153167|NCT02489500|527072269|FG000|Overall Study|Death|1|||
146153168|NCT02489500|527072270|FG001|Overall Study|Death|1|||
146153169|NCT02863926|527072271|FG000|Overall Study|Physician Decision|1|||
146153170|NCT02863926|527072272|FG001|Overall Study|Physician Decision|0|||
146153171|NCT02863926|527072271|FG000|Overall Study|Lost to Follow-up|1|||
146153172|NCT02863926|527072272|FG001|Overall Study|Lost to Follow-up|1|||
146153173|NCT00823719|527072274|FG000|Overall Study|Adverse Event|1|||
146153174|NCT00823719|527072275|FG001|Overall Study|Adverse Event|2|||
146153175|NCT00823719|527072274|FG000|Overall Study|Physician Decision|1|||
146153176|NCT00823719|527072275|FG001|Overall Study|Physician Decision|4|||
146153177|NCT00823719|527072274|FG000|Overall Study|Withdrawal by Subject|0|||
146153178|NCT00823719|527072275|FG001|Overall Study|Withdrawal by Subject|1|||
146153179|NCT00823719|527072274|FG000|Overall Study|Disease Progression|4|||
146153180|NCT00823719|527072275|FG001|Overall Study|Disease Progression|4|||
146308014|NCT02819635|527642143|FG007|Substudy 3|Withdrew consent|0|||
146308015|NCT02819635|527642144|FG008|Substudy 3|Withdrew consent|11|||
146308016|NCT02819635|527642145|FG009|Substudy 3|Withdrew consent|1|||
146308017|NCT02819635|527642146|FG010|Substudy 3|Withdrew consent|4|||
146308018|NCT02819635|527642147|FG011|Substudy 3|Withdrew consent|9|||
146308019|NCT02819635|527642136|FG000|Substudy 3|Lost to Follow-up|0|||
146308020|NCT02819635|527642137|FG001|Substudy 3|Lost to Follow-up|0|||
146308021|NCT02819635|527642138|FG002|Substudy 3|Lost to Follow-up|0|||
146308022|NCT02819635|527642139|FG003|Substudy 3|Lost to Follow-up|0|||
146308023|NCT02819635|527642140|FG004|Substudy 3|Lost to Follow-up|0|||
146308024|NCT02819635|527642141|FG005|Substudy 3|Lost to Follow-up|0|||
146308025|NCT02819635|527642142|FG006|Substudy 3|Lost to Follow-up|0|||
146308026|NCT02819635|527642143|FG007|Substudy 3|Lost to Follow-up|0|||
146308027|NCT02819635|527642144|FG008|Substudy 3|Lost to Follow-up|1|||
146308028|NCT02819635|527642145|FG009|Substudy 3|Lost to Follow-up|0|||
146308029|NCT02819635|527642146|FG010|Substudy 3|Lost to Follow-up|1|||
146308030|NCT02819635|527642147|FG011|Substudy 3|Lost to Follow-up|1|||
146308031|NCT02819635|527642136|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308032|NCT02819635|527642137|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308033|NCT02819635|527642138|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308034|NCT02819635|527642139|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308035|NCT02819635|527642140|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308036|NCT02819635|527642141|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308037|NCT02819635|527642142|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308038|NCT02819635|527642143|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308039|NCT02819635|527642144|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308040|NCT02819635|527642145|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308041|NCT02819635|527642146|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
146308042|NCT02819635|527642147|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
146308043|NCT02819635|527642136|FG000|Substudy 3|Other, not specified|0|||
146153181|NCT03434119|527072276|FG000|Overall Study|Randomized but not treated|1|||
146153182|NCT03434119|527072277|FG001|Overall Study|Randomized but not treated|0|||
146153183|NCT03434119|527072276|FG000|Overall Study|Adverse Event|1|||
146308044|NCT02819635|527642137|FG001|Substudy 3|Other, not specified|0|||
146308045|NCT02819635|527642138|FG002|Substudy 3|Other, not specified|0|||
146308046|NCT02819635|527642139|FG003|Substudy 3|Other, not specified|0|||
146153184|NCT03434119|527072277|FG001|Overall Study|Adverse Event|0|||
146153185|NCT03434119|527072276|FG000|Overall Study|Poor Compliance to Protocol|0|||
146153186|NCT03434119|527072277|FG001|Overall Study|Poor Compliance to Protocol|1|||
146153187|NCT03434119|527072276|FG000|Overall Study|Study Terminated by Sponsor|91|||
146308047|NCT02819635|527642140|FG004|Substudy 3|Other, not specified|0|||
146308048|NCT02819635|527642141|FG005|Substudy 3|Other, not specified|0|||
146308049|NCT02819635|527642142|FG006|Substudy 3|Other, not specified|0|||
146153188|NCT03434119|527072277|FG001|Overall Study|Study Terminated by Sponsor|102|||
146153189|NCT03434119|527072276|FG000|Overall Study|Withdrawal by Subject|7|||
146153190|NCT03434119|527072277|FG001|Overall Study|Withdrawal by Subject|5|||
146308050|NCT02819635|527642143|FG007|Substudy 3|Other, not specified|0|||
146308051|NCT02819635|527642144|FG008|Substudy 3|Other, not specified|202|||
146308052|NCT02819635|527642145|FG009|Substudy 3|Other, not specified|5|||
146308053|NCT02819635|527642146|FG010|Substudy 3|Other, not specified|89|||
146308054|NCT02819635|527642147|FG011|Substudy 3|Other, not specified|39|||
146308055|NCT00530894|527642149|FG000|Overall Study|Death|84|||
146308056|NCT00530894|527642150|FG001|Overall Study|Death|89|||
146308057|NCT00530894|527642151|FG002|Overall Study|Death|55|||
146308058|NCT00530894|527642152|FG003|Overall Study|Death|89|||
146308059|NCT00530894|527642149|FG000|Overall Study|Lost to Follow-up|1|||
146308060|NCT00530894|527642150|FG001|Overall Study|Lost to Follow-up|3|||
146308061|NCT00530894|527642151|FG002|Overall Study|Lost to Follow-up|0|||
146308062|NCT00530894|527642152|FG003|Overall Study|Lost to Follow-up|0|||
146308063|NCT00530894|527642149|FG000|Overall Study|Withdrawal by Subject|1|||
146308064|NCT00530894|527642150|FG001|Overall Study|Withdrawal by Subject|23|||
146308065|NCT00530894|527642151|FG002|Overall Study|Withdrawal by Subject|0|||
146308066|NCT00530894|527642152|FG003|Overall Study|Withdrawal by Subject|5|||
146308067|NCT00530894|527642149|FG000|Overall Study|Alive and censored prior to 1 year|2|||
146308068|NCT00530894|527642150|FG001|Overall Study|Alive and censored prior to 1 year|0|||
146308069|NCT00530894|527642151|FG002|Overall Study|Alive and censored prior to 1 year|0|||
146308070|NCT00530894|527642152|FG003|Overall Study|Alive and censored prior to 1 year|0|||
146308071|NCT01349465|527642153|FG000|Overall Study|Adverse Event|1|||
146308072|NCT01349465|527642154|FG001|Overall Study|Adverse Event|0|||
146308073|NCT01349465|527642153|FG000|Overall Study|Death|3|||
146308074|NCT01349465|527642154|FG001|Overall Study|Death|0|||
146308075|NCT01349465|527642153|FG000|Overall Study|Lost to Follow-up|10|||
146308076|NCT01349465|527642154|FG001|Overall Study|Lost to Follow-up|1|||
146308077|NCT01349465|527642153|FG000|Overall Study|Withdrawal by Subject|4|||
146308078|NCT01349465|527642154|FG001|Overall Study|Withdrawal by Subject|2|||
146308079|NCT01349465|527642153|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
146308080|NCT01349465|527642154|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
146308081|NCT00928889|527642162|FG000|Overall Study|Lost to Follow-up|3|||
146308082|NCT00928889|527642163|FG001|Overall Study|Lost to Follow-up|1|||
146308083|NCT00928889|527642162|FG000|Overall Study|Protocol Violation|0|||
146308084|NCT00928889|527642163|FG001|Overall Study|Protocol Violation|1|||
146308085|NCT00928889|527642162|FG000|Overall Study|Adverse Event|1|||
146308086|NCT00928889|527642163|FG001|Overall Study|Adverse Event|0|||
146308087|NCT00928889|527642162|FG000|Overall Study|Other|1|||
146308088|NCT00928889|527642163|FG001|Overall Study|Other|0|||
146308089|NCT02375724|527642170|FG000|Overall Study|Lack of Efficacy|1|||
146308090|NCT02375724|527642171|FG001|Overall Study|Lack of Efficacy|1|||
146308091|NCT02375724|527642170|FG000|Overall Study|Withdrawal by Subject|1|||
146308092|NCT02375724|527642171|FG001|Overall Study|Withdrawal by Subject|1|||
146308093|NCT02375724|527642170|FG000|Overall Study|Lost to Follow-up|1|||
146308094|NCT02375724|527642171|FG001|Overall Study|Lost to Follow-up|0|||
146308095|NCT02375724|527642170|FG000|Overall Study|Protocol Violation|1|||
146308096|NCT02375724|527642171|FG001|Overall Study|Protocol Violation|0|||
146308097|NCT02375724|527642170|FG000|Overall Study|Adverse Event|2|||
146308098|NCT02375724|527642171|FG001|Overall Study|Adverse Event|4|||
146308099|NCT01517893|527642174|FG000|Overall Study|Withdrawal by Subject|3|||
146308100|NCT01517893|527642175|FG001|Overall Study|Withdrawal by Subject|0|||
146308101|NCT03462576|527642176|FG000|Overall Study|Protocol Violation|5|||
146308102|NCT03462576|527642177|FG001|Overall Study|Protocol Violation|11|||
146308103|NCT03462576|527642178|FG002|Overall Study|Protocol Violation|7|||
146308104|NCT03462576|527642176|FG000|Overall Study|Device Malfunction|0|||
146308105|NCT03462576|527642177|FG001|Overall Study|Device Malfunction|0|||
146308106|NCT03462576|527642178|FG002|Overall Study|Device Malfunction|1|||
146308107|NCT01543828|527642181|FG000|Treatment 2|Lost to Follow-up|1|||
146308108|NCT01543828|527642182|FG001|Treatment 2|Lost to Follow-up|0|||
146308109|NCT01069172|527642185|FG000|Overall Study|Withdrawal by Subject|1|||
146308110|NCT01069172|527642186|FG001|Overall Study|Withdrawal by Subject|0|||
146308111|NCT00711425|527642188|FG000|Overall Study|Protocol Violation|1|||
146308112|NCT00711425|527642188|FG000|Overall Study|Death|2|||
146308113|NCT00711425|527642188|FG000|Overall Study|Lost to Follow-up|1|||
146308114|NCT03901079|527642191|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
146308115|NCT00804570|527642194|FG000|Overall Study|Adverse Event|14|||
146308116|NCT00804570|527642195|FG001|Overall Study|Adverse Event|7|||
146308117|NCT00804570|527642194|FG000|Overall Study|Lack of Efficacy|0|||
146308118|NCT00804570|527642195|FG001|Overall Study|Lack of Efficacy|1|||
146308119|NCT00804570|527642194|FG000|Overall Study|Lost to Follow-up|18|||
146308120|NCT00804570|527642195|FG001|Overall Study|Lost to Follow-up|21|||
146308121|NCT00804570|527642194|FG000|Overall Study|Entry criteria not met|5|||
146308122|NCT00804570|527642195|FG001|Overall Study|Entry criteria not met|5|||
146308123|NCT00804570|527642194|FG000|Overall Study|Protocol Violation|12|||
146308124|NCT00804570|527642195|FG001|Overall Study|Protocol Violation|16|||
146308125|NCT00804570|527642194|FG000|Overall Study|Physician Decision|1|||
146308126|NCT00804570|527642195|FG001|Overall Study|Physician Decision|2|||
146308127|NCT00804570|527642194|FG000|Overall Study|Sponsor decision|1|||
146308128|NCT00804570|527642195|FG001|Overall Study|Sponsor decision|4|||
146308129|NCT00804570|527642194|FG000|Overall Study|Withdrawal by Subject|21|||
146308130|NCT00804570|527642195|FG001|Overall Study|Withdrawal by Subject|38|||
146308131|NCT00290342|527642196|FG000|Overall Study|Other|0|||
146308132|NCT00290342|527642197|FG001|Overall Study|Other|1|||
146308133|NCT00290342|527642196|FG000|Overall Study|Withdrawal by Subject|6|||
146308134|NCT00290342|527642197|FG001|Overall Study|Withdrawal by Subject|4|||
146308135|NCT00290342|527642196|FG000|Overall Study|Lost to Follow-up|1|||
146308136|NCT00290342|527642197|FG001|Overall Study|Lost to Follow-up|0|||
146308137|NCT01056510|527642200|FG000|Overall Study|Dropout Before Start of Treatment|1|||
146308138|NCT01056510|527642201|FG001|Overall Study|Dropout Before Start of Treatment|1|||
146308139|NCT01056510|527642200|FG000|Overall Study|Withdrawal by Subject|4|||
146308140|NCT01056510|527642201|FG001|Overall Study|Withdrawal by Subject|2|||
146308141|NCT01056510|527642200|FG000|Overall Study|Death|29|||
146308142|NCT01056510|527642201|FG001|Overall Study|Death|34|||
146308143|NCT01056510|527642200|FG000|Overall Study|Noncompliance|1|||
146308144|NCT01056510|527642201|FG001|Overall Study|Noncompliance|3|||
146308145|NCT01056510|527642200|FG000|Overall Study|Physician Decision|4|||
146308146|NCT01056510|527642201|FG001|Overall Study|Physician Decision|5|||
146308147|NCT01056510|527642200|FG000|Overall Study|Lost to Follow-up|5|||
146308148|NCT01056510|527642201|FG001|Overall Study|Lost to Follow-up|6|||
146308149|NCT01056510|527642200|FG000|Overall Study|Other|10|||
146308150|NCT01056510|527642201|FG001|Overall Study|Other|12|||
146308151|NCT01056510|527642200|FG000|Overall Study|Missing|0|||
146308152|NCT01056510|527642201|FG001|Overall Study|Missing|1|||
146308153|NCT00912028|527642204|FG000|Overall Study|Lost to Follow-up|2|||
146308154|NCT00912028|527642205|FG001|Overall Study|Lost to Follow-up|3|||
146308155|NCT00912028|527642206|FG002|Overall Study|Lost to Follow-up|0|||
146308156|NCT00912028|527642207|FG003|Overall Study|Lost to Follow-up|1|||
146308157|NCT00912028|527642208|FG004|Overall Study|Lost to Follow-up|3|||
146308158|NCT00912028|527642204|FG000|Overall Study|Withdrawal by Subject|3|||
146308159|NCT00912028|527642205|FG001|Overall Study|Withdrawal by Subject|0|||
146308160|NCT00912028|527642206|FG002|Overall Study|Withdrawal by Subject|0|||
146308161|NCT00912028|527642207|FG003|Overall Study|Withdrawal by Subject|0|||
146308162|NCT00912028|527642208|FG004|Overall Study|Withdrawal by Subject|0|||
146308163|NCT03418129|527642211|FG000|Overall Study|Lost to Follow-up|11|||
146308164|NCT03418129|527642212|FG001|Overall Study|Lost to Follow-up|20|||
146308165|NCT03418129|527642213|FG002|Overall Study|Lost to Follow-up|15|||
146308166|NCT03418129|527642211|FG000|Overall Study|Withdrawal by Subject|3|||
146308167|NCT03418129|527642212|FG001|Overall Study|Withdrawal by Subject|6|||
146308168|NCT03418129|527642213|FG002|Overall Study|Withdrawal by Subject|4|||
146308169|NCT01617070|527642217|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
146308170|NCT00942175|527642218|FG000|Overall Study|Adverse Event|2|||
146308171|NCT00942175|527642219|FG001|Overall Study|Adverse Event|1|||
146308172|NCT00942175|527642220|FG002|Overall Study|Adverse Event|0|||
146308173|NCT00942175|527642221|FG003|Overall Study|Adverse Event|0|||
146308174|NCT00942175|527642218|FG000|Overall Study|Protocol Violation|0|||
146308175|NCT00942175|527642219|FG001|Overall Study|Protocol Violation|1|||
146308176|NCT00942175|527642220|FG002|Overall Study|Protocol Violation|2|||
146308177|NCT00942175|527642221|FG003|Overall Study|Protocol Violation|0|||
146308178|NCT00942175|527642218|FG000|Overall Study|Pregnancy|0|||
146308179|NCT00942175|527642219|FG001|Overall Study|Pregnancy|0|||
146308180|NCT00942175|527642220|FG002|Overall Study|Pregnancy|0|||
146308181|NCT00942175|527642221|FG003|Overall Study|Pregnancy|1|||
146308182|NCT00942175|527642218|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
146308183|NCT00942175|527642219|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
146308184|NCT00942175|527642220|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
146308185|NCT00942175|527642221|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
146308186|NCT00942175|527642218|FG000|Overall Study|Low Platelet Count|0|||
146308187|NCT00942175|527642219|FG001|Overall Study|Low Platelet Count|2|||
146308188|NCT00942175|527642220|FG002|Overall Study|Low Platelet Count|0|||
146308189|NCT00942175|527642221|FG003|Overall Study|Low Platelet Count|0|||
146308190|NCT01066585|527642222|FG000|Overall Study|Protocol Violation|1|||
146308191|NCT01066585|527642223|FG001|Overall Study|Protocol Violation|0|||
146308192|NCT01066585|527642222|FG000|Overall Study|Withdrawal by Subject|0|||
146308193|NCT01066585|527642223|FG001|Overall Study|Withdrawal by Subject|3|||
146308194|NCT00884273|527642226|FG000|Overall Study|Adverse Event|0|||
146308195|NCT00884273|527642227|FG001|Overall Study|Adverse Event|2|||
146308196|NCT00884273|527642226|FG000|Overall Study|Protocol Violation|1|||
146308197|NCT00884273|527642227|FG001|Overall Study|Protocol Violation|3|||
146308198|NCT00884273|527642226|FG000|Overall Study|Practical reasons|1|||
146308199|NCT00884273|527642227|FG001|Overall Study|Practical reasons|0|||
146308200|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
146308201|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
146308202|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
146308203|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
146308204|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
146308205|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
146308206|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146308207|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
146308208|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
146308209|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
146308210|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146308211|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
146308212|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
146308213|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
146308214|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
146308215|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
146308216|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
146308217|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
146308218|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
146308219|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
146308220|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
146308221|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
146308222|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
146308223|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
146308224|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Death|2|||
146308225|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Death|1|||
146308226|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Death|0|||
146308227|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Death|0|||
146308228|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
146308229|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
146308230|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146308231|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
146308232|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
146308233|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
146308234|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
146308235|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
146308236|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
146308237|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
146308238|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146308239|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
146308240|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
146308241|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146308242|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146308243|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
146308244|NCT01940471|527642228|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
146308245|NCT01940471|527642229|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
146308246|NCT01940471|527642230|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
146308247|NCT01940471|527642231|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
146308248|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146308249|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
146308250|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
146308251|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
146308252|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146308253|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
146308254|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
146308255|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
146308256|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146308257|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
146308258|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
146308259|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
146308260|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
146308261|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
146308262|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
146308263|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
146308264|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146308265|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
146308266|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
146308267|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
146308268|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146308269|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
146308270|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
146153191|NCT03434119|527072276|FG000|Overall Study|Other than specified|7|||
146308271|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
146308272|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146308273|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146308274|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
146308275|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
146308276|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146308277|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146308278|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
146308279|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
146308280|NCT01940471|527642228|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146308281|NCT01940471|527642229|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146308282|NCT01940471|527642230|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
146308283|NCT01940471|527642231|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
146308284|NCT00258674|527642232|FG000|Overall Study|Death|32|||
146308285|NCT00258674|527642233|FG001|Overall Study|Death|53|||
146308286|NCT00258674|527642234|FG002|Overall Study|Death|34|||
146308287|NCT03715153|527642235|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
146308288|NCT03715153|527642236|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
146308289|NCT03715153|527642235|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
146308290|NCT03715153|527642236|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
146308291|NCT03715153|527642235|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
146308292|NCT03715153|527642236|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
146308293|NCT03715153|527642235|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
146308294|NCT03715153|527642236|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
146308295|NCT03715153|527642235|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
146308296|NCT03715153|527642236|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
146308297|NCT03715153|527642235|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
146308298|NCT03715153|527642236|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
146308299|NCT02973087|527642239|FG000|Overall Study|Withdrawal by Subject|2|||
146308300|NCT02973087|527642240|FG001|Overall Study|Withdrawal by Subject|1|||
146308301|NCT02973087|527642239|FG000|Overall Study|Adverse Event|1|||
146308302|NCT02973087|527642240|FG001|Overall Study|Adverse Event|0|||
146308303|NCT02973087|527642239|FG000|Overall Study|other|1|||
146308304|NCT02973087|527642240|FG001|Overall Study|other|1|||
146308305|NCT01045798|527642253|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
146308306|NCT01045798|527642254|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
146308307|NCT01045798|527642253|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
146308308|NCT01045798|527642254|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
146308309|NCT01045798|527642253|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
146308310|NCT01045798|527642254|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
146308311|NCT01045798|527642253|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
146308312|NCT01045798|527642254|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
146308313|NCT02090413|527642255|FG000|Overall Study|Adverse Event|11|||
146308314|NCT02090413|527642256|FG001|Overall Study|Adverse Event|15|||
146308315|NCT02090413|527642257|FG002|Overall Study|Adverse Event|20|||
146308316|NCT02090413|527642255|FG000|Overall Study|Flushing event|2|||
146308317|NCT02090413|527642256|FG001|Overall Study|Flushing event|0|||
146308318|NCT02090413|527642257|FG002|Overall Study|Flushing event|1|||
146308319|NCT02090413|527642255|FG000|Overall Study|Withdrawal by Subject|2|||
146308320|NCT02090413|527642256|FG001|Overall Study|Withdrawal by Subject|2|||
146308321|NCT02090413|527642257|FG002|Overall Study|Withdrawal by Subject|2|||
146308322|NCT02090413|527642255|FG000|Overall Study|Investigator Decision|1|||
146308323|NCT02090413|527642256|FG001|Overall Study|Investigator Decision|1|||
146308324|NCT02090413|527642257|FG002|Overall Study|Investigator Decision|0|||
146308325|NCT02090413|527642255|FG000|Overall Study|Other|2|||
146308326|NCT02090413|527642256|FG001|Overall Study|Other|1|||
146308327|NCT02090413|527642257|FG002|Overall Study|Other|0|||
146308328|NCT02090413|527642255|FG000|Overall Study|Lost to Follow-up|1|||
146308329|NCT02090413|527642256|FG001|Overall Study|Lost to Follow-up|1|||
146308330|NCT02090413|527642257|FG002|Overall Study|Lost to Follow-up|0|||
146308331|NCT04506086|527642258|FG000|Overall Study|Withdrawal by Subject|2|||
146308332|NCT02321930|527642264|FG000|Overall Study|Lost to Follow-up|1|||
146308333|NCT01293968|527642265|FG000|Overall Study|non-cooperation|3|||
146308334|NCT01293968|527642266|FG001|Overall Study|non-cooperation|3|||
146308335|NCT03996876|527642267|FG000|Overall Study|Incomplete Data|2|||
146308336|NCT03996876|527642268|FG001|Overall Study|Incomplete Data|4|||
146308337|NCT00597753|527642273|FG000|Overall Study|Adverse Event|6|||
146308338|NCT00597753|527642274|FG001|Overall Study|Adverse Event|2|||
146308339|NCT00597753|527642273|FG000|Overall Study|Death|55|||
146308340|NCT00597753|527642274|FG001|Overall Study|Death|29|||
146308341|NCT00597753|527642273|FG000|Overall Study|Lack of Efficacy|2|||
146308342|NCT00597753|527642274|FG001|Overall Study|Lack of Efficacy|0|||
146308343|NCT00597753|527642273|FG000|Overall Study|Lost to Follow-up|10|||
146308344|NCT00597753|527642274|FG001|Overall Study|Lost to Follow-up|3|||
146308345|NCT00597753|527642273|FG000|Overall Study|Physician Decision|5|||
146308346|NCT00597753|527642274|FG001|Overall Study|Physician Decision|1|||
146308347|NCT00597753|527642273|FG000|Overall Study|Pregnancy|1|||
146308348|NCT00597753|527642274|FG001|Overall Study|Pregnancy|0|||
146308349|NCT00597753|527642273|FG000|Overall Study|Withdrawal by Subject|35|||
146308350|NCT00597753|527642274|FG001|Overall Study|Withdrawal by Subject|12|||
146308351|NCT00597753|527642273|FG000|Overall Study|Discontinued Dialysis|0|||
146308352|NCT00597753|527642274|FG001|Overall Study|Discontinued Dialysis|1|||
146308353|NCT00597753|527642273|FG000|Overall Study|Never dosed|2|||
146308354|NCT00597753|527642274|FG001|Overall Study|Never dosed|0|||
146308355|NCT00597753|527642273|FG000|Overall Study|Noncompliance|2|||
146308356|NCT00597753|527642274|FG001|Overall Study|Noncompliance|1|||
146279171|NCT00370682|527536865|FG000|Overall Study|Lost to Follow-up|0|||
146279172|NCT00370682|527536866|FG001|Overall Study|Lost to Follow-up|1|||
146279173|NCT00370682|527536867|FG002|Overall Study|Lost to Follow-up|1|||
146279174|NCT03167359|527536868|FG000|Overall Study|Physician Decision|1|||
146279175|NCT03167359|527536868|FG000|Overall Study|Lost to Follow-up|1|||
146279176|NCT00943852|527536869|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279177|NCT00943852|527536870|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279178|NCT00943852|527536871|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279179|NCT00943852|527536872|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
146279180|NCT00943852|527536873|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279181|NCT00943852|527536874|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279182|NCT00943852|527536875|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279183|NCT00943852|527536876|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279184|NCT00943852|527536877|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279185|NCT00943852|527536878|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
146279186|NCT00943852|527536869|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279187|NCT00943852|527536870|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279188|NCT00943852|527536871|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279189|NCT00943852|527536872|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279190|NCT00943852|527536873|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279191|NCT00943852|527536874|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
146279192|NCT00943852|527536875|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279193|NCT00943852|527536876|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279194|NCT00943852|527536877|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279195|NCT00943852|527536878|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
146279196|NCT00943852|527536869|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279197|NCT00943852|527536870|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279198|NCT00943852|527536871|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279199|NCT00943852|527536872|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279200|NCT00943852|527536873|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279201|NCT00943852|527536874|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279202|NCT00943852|527536875|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
146279203|NCT00943852|527536876|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279204|NCT00943852|527536877|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279205|NCT00943852|527536878|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
146279206|NCT00943852|527536869|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279207|NCT00943852|527536870|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279208|NCT00943852|527536871|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279209|NCT00943852|527536872|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279210|NCT00943852|527536873|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279211|NCT00943852|527536874|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279212|NCT00943852|527536875|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279213|NCT00943852|527536876|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
146279214|NCT00943852|527536877|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279215|NCT00943852|527536878|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
146279216|NCT00943852|527536869|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146279217|NCT00943852|527536870|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146308357|NCT00597753|527642273|FG000|Overall Study|Relocation|17|||
146308358|NCT00597753|527642274|FG001|Overall Study|Relocation|6|||
146308359|NCT00597753|527642273|FG000|Overall Study|Renal transplant|10|||
146308360|NCT00597753|527642274|FG001|Overall Study|Renal transplant|3|||
146308361|NCT00597753|527642273|FG000|Overall Study|Site closed by sponsor|19|||
146308362|NCT00597753|527642274|FG001|Overall Study|Site closed by sponsor|7|||
146308363|NCT00597753|527642273|FG000|Overall Study|Site elected to close|2|||
146308364|NCT00597753|527642274|FG001|Overall Study|Site elected to close|4|||
146308365|NCT00388973|527644089|FG000|Overall Study|Adverse Event|16|||
146308366|NCT00388973|527644090|FG001|Overall Study|Adverse Event|6|||
146308367|NCT00388973|527644089|FG000|Overall Study|Lack of Efficacy|1|||
146308368|NCT00388973|527644090|FG001|Overall Study|Lack of Efficacy|12|||
146308369|NCT00388973|527644089|FG000|Overall Study|Protocol Violation|3|||
146308370|NCT00388973|527644090|FG001|Overall Study|Protocol Violation|0|||
146308371|NCT00388973|527644089|FG000|Overall Study|Withdrawal by Subject|14|||
146308372|NCT00388973|527644090|FG001|Overall Study|Withdrawal by Subject|17|||
146308373|NCT00388973|527644089|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
146308374|NCT00388973|527644090|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
146308375|NCT00388973|527644089|FG000|Overall Study|Did not complete 61 days of treatment|5|||
146308376|NCT00388973|527644090|FG001|Overall Study|Did not complete 61 days of treatment|4|||
146308377|NCT00388973|527644089|FG000|Overall Study|Left region|0|||
146308378|NCT00388973|527644090|FG001|Overall Study|Left region|1|||
146308379|NCT00388973|527644089|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
146308380|NCT00388973|527644090|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
146308381|NCT01652885|527644103|FG000|Overall Study|Adverse Event|1|||
146308382|NCT00075400|527644104|FG000|Overall Study|Ineligible: wrong primary|1|||
146308383|NCT00075400|527644104|FG000|Overall Study|Never treated|2|||
146308384|NCT03723707|527644106|FG000|Overall Study|Death|32|||
146308385|NCT03723707|527644107|FG001|Overall Study|Death|32|||
146308386|NCT03723707|527644106|FG000|Overall Study|Admitted to long term care|12|||
146308387|NCT03723707|527644107|FG001|Overall Study|Admitted to long term care|12|||
146308388|NCT03723707|527644106|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
146308389|NCT03723707|527644107|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
146308390|NCT03723707|527644106|FG000|Overall Study|Lost to Follow-up|40|||
146308391|NCT03723707|527644107|FG001|Overall Study|Lost to Follow-up|22|||
146308392|NCT03723707|527644106|FG000|Overall Study|Discontinued after study closure|24|||
146308393|NCT03723707|527644107|FG001|Overall Study|Discontinued after study closure|12|||
146308394|NCT04342871|527644108|FG000|Overall Study|Death|4|||
146308395|NCT04342871|527644108|FG000|Overall Study|Clinical deterioration/illness progression|2|||
146308396|NCT04342871|527644108|FG000|Overall Study|Did not complete baseline assessments|5|||
146308397|NCT04342871|527644108|FG000|Overall Study|Lost to Follow-up|13|||
146308398|NCT00666458|527644109|FG000|Overall Study|Adverse Event|8|||
146308399|NCT00666458|527644110|FG001|Overall Study|Adverse Event|7|||
146308400|NCT00666458|527644109|FG000|Overall Study|Withdrawal by Subject|5|||
146308401|NCT00666458|527644110|FG001|Overall Study|Withdrawal by Subject|4|||
146308402|NCT00666458|527644109|FG000|Overall Study|Lost to Follow-up|0|||
146308403|NCT00666458|527644110|FG001|Overall Study|Lost to Follow-up|3|||
146308404|NCT00666458|527644109|FG000|Overall Study|Administrative reason by sponsor|1|||
146308405|NCT00666458|527644110|FG001|Overall Study|Administrative reason by sponsor|1|||
146308406|NCT00666458|527644109|FG000|Overall Study|Incorrect enrollment|7|||
146308407|NCT00666458|527644110|FG001|Overall Study|Incorrect enrollment|1|||
146308408|NCT00666458|527644109|FG000|Overall Study|Study specific discontinuation criteria|14|||
146308409|NCT00666458|527644110|FG001|Overall Study|Study specific discontinuation criteria|7|||
146308410|NCT00666458|527644109|FG000|Overall Study|Severe non-compliance to the protocol|1|||
146308411|NCT00666458|527644110|FG001|Overall Study|Severe non-compliance to the protocol|1|||
146308412|NCT00666458|527644109|FG000|Overall Study|Safety reasons|1|||
146308413|NCT00666458|527644110|FG001|Overall Study|Safety reasons|0|||
146308414|NCT00666458|527644109|FG000|Overall Study|Medical history of anemia|1|||
146308415|NCT00666458|527644110|FG001|Overall Study|Medical history of anemia|0|||
146308416|NCT02222207|527644111|FG000|Overall Study|Death|1|||
146308417|NCT02222207|527644111|FG000|Overall Study|Other reasons|2|||
146308418|NCT02222207|527644111|FG000|Overall Study|Adverse Event|1|||
146308419|NCT04682405|527644113|FG000|Overall Study|Adverse Event|0|||
146308420|NCT04682405|527644114|FG001|Overall Study|Adverse Event|1|||
146308421|NCT01429584|527644118|FG000|Overall Study|Withdrawal by Subject|1|||
146308422|NCT01429584|527644119|FG001|Overall Study|Withdrawal by Subject|0|||
146308423|NCT01429584|527644118|FG000|Overall Study|Protocol Violation|0|||
146308424|NCT01429584|527644119|FG001|Overall Study|Protocol Violation|1|||
146308425|NCT00747643|527644120|FG000|Overall Study|Withdrawal by Subject|36|||
146308426|NCT00747643|527644121|FG001|Overall Study|Withdrawal by Subject|27|||
146308427|NCT00750698|527644122|FG000|Overall Study|Withdrawal by Subject|1|||
146308428|NCT00750698|527644123|FG001|Overall Study|Withdrawal by Subject|0|||
146308429|NCT00750698|527644122|FG000|Overall Study|Progressive disease|5|||
146308430|NCT00750698|527644123|FG001|Overall Study|Progressive disease|2|||
146308431|NCT03557281|527644124|FG000|Overall Study|Investigator discretion|0|||
146308432|NCT03557281|527644125|FG001|Overall Study|Investigator discretion|0|||
146308433|NCT03557281|527644126|FG002|Overall Study|Investigator discretion|1|||
146308434|NCT03557281|527644127|FG003|Overall Study|Investigator discretion|0|||
146308435|NCT03557281|527644128|FG004|Overall Study|Investigator discretion|0|||
146308436|NCT03557281|527644124|FG000|Overall Study|Withdrawal by Subject|0|||
146308437|NCT03557281|527644125|FG001|Overall Study|Withdrawal by Subject|1|||
146308438|NCT03557281|527644126|FG002|Overall Study|Withdrawal by Subject|1|||
146308439|NCT03557281|527644127|FG003|Overall Study|Withdrawal by Subject|1|||
146308440|NCT03557281|527644128|FG004|Overall Study|Withdrawal by Subject|2|||
146308441|NCT03557281|527644124|FG000|Overall Study|Randomized, but did not receive treatment|0|||
146308442|NCT03557281|527644125|FG001|Overall Study|Randomized, but did not receive treatment|0|||
146308443|NCT03557281|527644126|FG002|Overall Study|Randomized, but did not receive treatment|0|||
146308444|NCT03557281|527644127|FG003|Overall Study|Randomized, but did not receive treatment|0|||
146308445|NCT03557281|527644128|FG004|Overall Study|Randomized, but did not receive treatment|1|||
146308446|NCT01999465|527644129|FG000|Overall Study|Lost to Follow-up|0|||
146308447|NCT01999465|527644130|FG001|Overall Study|Lost to Follow-up|2|||
146308448|NCT01999465|527644129|FG000|Overall Study|Protocol Violation|0|||
146308449|NCT01999465|527644130|FG001|Overall Study|Protocol Violation|1|||
146308450|NCT00390546|527644140|FG000|Overall Study|Renal impairment|1|||
146308451|NCT00390546|527644141|FG001|Overall Study|Renal impairment|0|||
146308452|NCT00390546|527644140|FG000|Overall Study|Physician Decision|5|||
146308453|NCT00390546|527644141|FG001|Overall Study|Physician Decision|5|||
146308454|NCT01308008|527644142|FG000|4 Weeks|Illness, disinterest, time|9|||
146308455|NCT01308008|527644143|FG001|4 Weeks|Illness, disinterest, time|2|||
146308456|NCT03357731|527644144|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
146308457|NCT03357731|527644145|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
146308458|NCT03357731|527644146|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
146308459|NCT03357731|527644147|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
146308460|NCT03357731|527644148|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
146308461|NCT03357731|527644149|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
146308462|NCT03357731|527644144|FG000|Overall Study|Acute bradycardia and hypotension|0|||
146308463|NCT03357731|527644145|FG001|Overall Study|Acute bradycardia and hypotension|0|||
146308464|NCT03357731|527644146|FG002|Overall Study|Acute bradycardia and hypotension|0|||
146308465|NCT03357731|527644147|FG003|Overall Study|Acute bradycardia and hypotension|1|||
146308466|NCT03357731|527644148|FG004|Overall Study|Acute bradycardia and hypotension|0|||
146308467|NCT03357731|527644149|FG005|Overall Study|Acute bradycardia and hypotension|0|||
146308468|NCT03357731|527644144|FG000|Overall Study|Adverse Event|0|||
146308469|NCT03357731|527644145|FG001|Overall Study|Adverse Event|0|||
146308470|NCT03357731|527644146|FG002|Overall Study|Adverse Event|0|||
146308471|NCT03357731|527644147|FG003|Overall Study|Adverse Event|0|||
146308472|NCT03357731|527644148|FG004|Overall Study|Adverse Event|0|||
146308473|NCT03357731|527644149|FG005|Overall Study|Adverse Event|1|||
146308474|NCT03357731|527644144|FG000|Overall Study|Hypotension|0|||
146308475|NCT03357731|527644145|FG001|Overall Study|Hypotension|0|||
146308476|NCT03357731|527644146|FG002|Overall Study|Hypotension|1|||
146308477|NCT03357731|527644147|FG003|Overall Study|Hypotension|1|||
146308478|NCT03357731|527644148|FG004|Overall Study|Hypotension|0|||
146308479|NCT03357731|527644149|FG005|Overall Study|Hypotension|0|||
146308480|NCT03357731|527644144|FG000|Overall Study|Lost to Follow-up|0|||
146308481|NCT03357731|527644145|FG001|Overall Study|Lost to Follow-up|0|||
146308482|NCT03357731|527644146|FG002|Overall Study|Lost to Follow-up|0|||
146308483|NCT03357731|527644147|FG003|Overall Study|Lost to Follow-up|1|||
146308484|NCT03357731|527644148|FG004|Overall Study|Lost to Follow-up|0|||
146308485|NCT03357731|527644149|FG005|Overall Study|Lost to Follow-up|0|||
146308486|NCT01417195|527644150|FG000|Overall Study|Stimulation failure|1|||
146308487|NCT01417195|527644151|FG001|Overall Study|Stimulation failure|0|||
146308488|NCT01417195|527644150|FG000|Overall Study|No embryos for transfer|0|||
146308489|NCT01417195|527644151|FG001|Overall Study|No embryos for transfer|1|||
146308490|NCT01417195|527644150|FG000|Overall Study|No transfer due to risk of OHSS|1|||
146308491|NCT01417195|527644151|FG001|Overall Study|No transfer due to risk of OHSS|0|||
146308492|NCT01417195|527644150|FG000|Overall Study|No transfer due to elevated progesterone|1|||
146308493|NCT01417195|527644151|FG001|Overall Study|No transfer due to elevated progesterone|0|||
146308494|NCT01773109|527644152|FG000|Overall Study|Symptomatic Progression|2|||
146308495|NCT01773109|527644152|FG000|Overall Study|Death|1|||
146308496|NCT02325219|527644155|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
146308497|NCT02325219|527644156|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
146308498|NCT02325219|527644157|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146308499|NCT02325219|527644158|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146308500|NCT02325219|527644159|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
146308501|NCT02325219|527644155|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
146308502|NCT02325219|527644156|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
146308503|NCT02325219|527644157|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146308504|NCT02325219|527644158|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146308505|NCT02325219|527644159|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
146308506|NCT02325219|527644155|FG000|Controlled Period (Week 0 - 16)|Other|0|||
146308507|NCT02325219|527644156|FG001|Controlled Period (Week 0 - 16)|Other|0|||
146308508|NCT02325219|527644157|FG002|Controlled Period (Week 0 - 16)|Other|1|||
146308509|NCT02325219|527644158|FG003|Controlled Period (Week 0 - 16)|Other|0|||
146308510|NCT02325219|527644159|FG004|Controlled Period (Week 0 - 16)|Other|0|||
146308511|NCT02325219|527644155|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146308512|NCT02325219|527644156|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146308513|NCT02325219|527644157|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146308514|NCT02325219|527644158|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
146308515|NCT02325219|527644159|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
146308516|NCT02325219|527644155|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146308517|NCT02325219|527644156|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
146308518|NCT02325219|527644157|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146308519|NCT02325219|527644158|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146308520|NCT02325219|527644159|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
146308521|NCT02325219|527644155|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146308522|NCT02325219|527644156|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
146308523|NCT02325219|527644157|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146308524|NCT02325219|527644158|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146308525|NCT02325219|527644159|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
146308526|NCT04036708|527644160|FG000|Overall Study|Lost to Follow-up|14|||
146308527|NCT04036708|527644161|FG001|Overall Study|Lost to Follow-up|4|||
146308528|NCT04036708|527644162|FG002|Overall Study|Lost to Follow-up|14|||
146308529|NCT04036708|527644163|FG003|Overall Study|Lost to Follow-up|4|||
146308530|NCT02918864|527644164|FG000|Overall Study|Withdrawal by Subject|1|||
146308531|NCT02918864|527644165|FG001|Overall Study|Withdrawal by Subject|1|||
146308532|NCT02918864|527644164|FG000|Overall Study|Lost to Follow-up|3|||
146308533|NCT02918864|527644165|FG001|Overall Study|Lost to Follow-up|2|||
146308534|NCT04766021|527644166|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
146308535|NCT04766021|527644166|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
146308536|NCT02257372|527644173|FG000|Overall Study|Adverse Event|3|||
146308537|NCT02257372|527644174|FG001|Overall Study|Adverse Event|7|||
146308538|NCT02257372|527644173|FG000|Overall Study|Lack of Efficacy|2|||
146308539|NCT02257372|527644174|FG001|Overall Study|Lack of Efficacy|1|||
146308540|NCT02257372|527644173|FG000|Overall Study|Protocol Violation|1|||
146308541|NCT02257372|527644174|FG001|Overall Study|Protocol Violation|1|||
146308542|NCT02257372|527644173|FG000|Overall Study|Lost to Follow-up|0|||
146308543|NCT02257372|527644174|FG001|Overall Study|Lost to Follow-up|1|||
146308544|NCT02257372|527644173|FG000|Overall Study|Withdrew consent|1|||
146308545|NCT02257372|527644174|FG001|Overall Study|Withdrew consent|0|||
146308546|NCT01849874|527644176|FG000|Overall Study|Death|89|||
146308547|NCT01849874|527644177|FG001|Overall Study|Death|42|||
146308548|NCT01849874|527644176|FG000|Overall Study|Withdrawal by Subject|17|||
146308549|NCT01849874|527644177|FG001|Overall Study|Withdrawal by Subject|16|||
146308550|NCT01849874|527644176|FG000|Overall Study|Lost to Follow-up|3|||
146308551|NCT01849874|527644177|FG001|Overall Study|Lost to Follow-up|2|||
146308552|NCT01849874|527644176|FG000|Overall Study|Study Termination By Sponsor|93|||
146308553|NCT01849874|527644177|FG001|Overall Study|Study Termination By Sponsor|48|||
146308554|NCT01849874|527644176|FG000|Overall Study|Completed as per protocol amendment 6|3|||
146308555|NCT01849874|527644177|FG001|Overall Study|Completed as per protocol amendment 6|0|||
146308556|NCT01849874|527644176|FG000|Overall Study|Physician Decision|7|||
146308557|NCT01849874|527644177|FG001|Overall Study|Physician Decision|1|||
146308558|NCT01849874|527644176|FG000|Overall Study|Other|16|||
146308559|NCT01849874|527644177|FG001|Overall Study|Other|4|||
146308560|NCT02104583|527644178|FG000|Overall Study|New ICD or CRT-D implanted|2|||
146308561|NCT02104583|527644179|FG001|Overall Study|New ICD or CRT-D implanted|0|||
146308562|NCT02104583|527644180|FG002|Overall Study|New ICD or CRT-D implanted|1|||
146308563|NCT02104583|527644181|FG003|Overall Study|New ICD or CRT-D implanted|0|||
146308564|NCT02104583|527644182|FG004|Overall Study|New ICD or CRT-D implanted|0|||
146308565|NCT02104583|527644178|FG000|Overall Study|Death|2|||
146308566|NCT02104583|527644179|FG001|Overall Study|Death|1|||
146308567|NCT02104583|527644180|FG002|Overall Study|Death|3|||
146308568|NCT02104583|527644181|FG003|Overall Study|Death|3|||
146308569|NCT02104583|527644182|FG004|Overall Study|Death|5|||
146308570|NCT02104583|527644178|FG000|Overall Study|Subject required cardiac ablation|6|||
146308571|NCT02104583|527644179|FG001|Overall Study|Subject required cardiac ablation|4|||
146308572|NCT02104583|527644180|FG002|Overall Study|Subject required cardiac ablation|4|||
146308573|NCT02104583|527644181|FG003|Overall Study|Subject required cardiac ablation|5|||
146308574|NCT02104583|527644182|FG004|Overall Study|Subject required cardiac ablation|4|||
146308575|NCT02104583|527644178|FG000|Overall Study|Subject required prohibited medication|0|||
146308576|NCT02104583|527644179|FG001|Overall Study|Subject required prohibited medication|1|||
146308577|NCT02104583|527644180|FG002|Overall Study|Subject required prohibited medication|1|||
146308578|NCT02104583|527644181|FG003|Overall Study|Subject required prohibited medication|0|||
146308579|NCT02104583|527644182|FG004|Overall Study|Subject required prohibited medication|1|||
146308580|NCT02104583|527644178|FG000|Overall Study|Withdrew Consent|3|||
146308581|NCT02104583|527644179|FG001|Overall Study|Withdrew Consent|2|||
146308582|NCT02104583|527644180|FG002|Overall Study|Withdrew Consent|0|||
146308583|NCT02104583|527644181|FG003|Overall Study|Withdrew Consent|2|||
146308584|NCT02104583|527644182|FG004|Overall Study|Withdrew Consent|1|||
146308585|NCT02104583|527644178|FG000|Overall Study|Investigator's Discretion|1|||
146308586|NCT02104583|527644179|FG001|Overall Study|Investigator's Discretion|0|||
146308587|NCT02104583|527644180|FG002|Overall Study|Investigator's Discretion|0|||
146308588|NCT02104583|527644181|FG003|Overall Study|Investigator's Discretion|0|||
146308589|NCT02104583|527644182|FG004|Overall Study|Investigator's Discretion|0|||
146308590|NCT02104583|527644178|FG000|Overall Study|Protocol Violation|0|||
146308591|NCT02104583|527644179|FG001|Overall Study|Protocol Violation|0|||
146308592|NCT02104583|527644180|FG002|Overall Study|Protocol Violation|1|||
146308593|NCT02104583|527644181|FG003|Overall Study|Protocol Violation|0|||
146308594|NCT02104583|527644182|FG004|Overall Study|Protocol Violation|0|||
146308595|NCT02104583|527644178|FG000|Overall Study|Adverse Event|3|||
146308596|NCT02104583|527644179|FG001|Overall Study|Adverse Event|3|||
146308597|NCT02104583|527644180|FG002|Overall Study|Adverse Event|6|||
146308598|NCT02104583|527644181|FG003|Overall Study|Adverse Event|6|||
146308599|NCT02104583|527644182|FG004|Overall Study|Adverse Event|1|||
146308600|NCT02104583|527644178|FG000|Overall Study|Lost to Follow-up|1|||
146308601|NCT02104583|527644179|FG001|Overall Study|Lost to Follow-up|0|||
146308602|NCT02104583|527644180|FG002|Overall Study|Lost to Follow-up|0|||
146308603|NCT02104583|527644181|FG003|Overall Study|Lost to Follow-up|0|||
146308604|NCT02104583|527644182|FG004|Overall Study|Lost to Follow-up|0|||
146308605|NCT02104583|527644178|FG000|Overall Study|Randomized but Never Treated|0|||
146308606|NCT02104583|527644179|FG001|Overall Study|Randomized but Never Treated|0|||
146308607|NCT02104583|527644180|FG002|Overall Study|Randomized but Never Treated|0|||
146308608|NCT02104583|527644181|FG003|Overall Study|Randomized but Never Treated|1|||
146308609|NCT02104583|527644182|FG004|Overall Study|Randomized but Never Treated|0|||
146308610|NCT04640272|527644184|FG000|Overall Study|Subject moved out of area|1|||
146308611|NCT01923285|527644192|FG000|Overall Study|Withdrawal by Subject|7|||
146308612|NCT01923285|527644193|FG001|Overall Study|Withdrawal by Subject|6|||
146308613|NCT03374189|527644194|FG000|Overall Study|Lost to Follow-up|1|||
146308614|NCT03374189|527644195|FG001|Overall Study|Lost to Follow-up|0|||
146308615|NCT02285777|527644198|FG000|Overall Study|Withdrawal by Subject|1|||
146308616|NCT02285777|527644199|FG001|Overall Study|Withdrawal by Subject|1|||
146308617|NCT02285777|527644198|FG000|Overall Study|Lost to Follow-up|4|||
146308618|NCT02285777|527644199|FG001|Overall Study|Lost to Follow-up|2|||
146308619|NCT03962101|527644200|FG000|Overall Study|Adverse Event|1|||
146308620|NCT03962101|527644200|FG000|Overall Study|Physician Decision|2|||
146308621|NCT03962101|527644200|FG000|Overall Study|Not related to medical events|1|||
146308622|NCT03699007|527644201|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
146308623|NCT03699007|527644202|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
146308624|NCT03699007|527644201|FG000|6-month Follow Up|Lost to Follow-up|2|||
146308625|NCT03699007|527644202|FG001|6-month Follow Up|Lost to Follow-up|3|||
146308626|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
146308627|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
146308628|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Death|0|||
146308629|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Death|1|||
146308630|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
146308631|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
146308632|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
146308633|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
146308634|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
146308635|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
146308636|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
146308637|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
146308638|NCT00843518|527644203|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
146308639|NCT00843518|527644204|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
146308640|NCT04607148|527644207|FG000|Overall Study|Withdrawal by Subject|0|||
146308641|NCT04607148|527644208|FG001|Overall Study|Withdrawal by Subject|4|||
146308642|NCT04607148|527644209|FG002|Overall Study|Withdrawal by Subject|2|||
146308643|NCT04607148|527644210|FG003|Overall Study|Withdrawal by Subject|8|||
146308644|NCT04607148|527644207|FG000|Overall Study|Study Terminated by Sponsor|14|||
146308645|NCT04607148|527644208|FG001|Overall Study|Study Terminated by Sponsor|59|||
146308646|NCT04607148|527644209|FG002|Overall Study|Study Terminated by Sponsor|9|||
146308647|NCT04607148|527644210|FG003|Overall Study|Study Terminated by Sponsor|39|||
146308648|NCT04607148|527644207|FG000|Overall Study|Sponsor Decision|0|||
146308649|NCT04607148|527644208|FG001|Overall Study|Sponsor Decision|0|||
146308650|NCT04607148|527644209|FG002|Overall Study|Sponsor Decision|1|||
146308651|NCT04607148|527644210|FG003|Overall Study|Sponsor Decision|0|||
146308652|NCT04607148|527644207|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146308653|NCT04607148|527644208|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146308654|NCT04607148|527644209|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146308655|NCT04607148|527644210|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146308656|NCT04607148|527644207|FG000|Overall Study|Lost to Follow-up|0|||
146308657|NCT04607148|527644208|FG001|Overall Study|Lost to Follow-up|2|||
146308658|NCT04607148|527644209|FG002|Overall Study|Lost to Follow-up|0|||
146308659|NCT04607148|527644210|FG003|Overall Study|Lost to Follow-up|0|||
146308660|NCT04607148|527644207|FG000|Overall Study|Death|0|||
146308661|NCT04607148|527644208|FG001|Overall Study|Death|3|||
146308662|NCT04607148|527644209|FG002|Overall Study|Death|0|||
146308663|NCT04607148|527644210|FG003|Overall Study|Death|1|||
146308664|NCT04607148|527644207|FG000|Overall Study|Adverse Event|0|||
146308665|NCT04607148|527644208|FG001|Overall Study|Adverse Event|1|||
146308666|NCT04607148|527644209|FG002|Overall Study|Adverse Event|0|||
146308667|NCT04607148|527644210|FG003|Overall Study|Adverse Event|0|||
146308668|NCT04251910|527644211|FG000|Overall Study|Covid 19 lockdown|0|||
146308669|NCT04251910|527644212|FG001|Overall Study|Covid 19 lockdown|5|||
146308670|NCT04251910|527644213|FG002|Overall Study|Covid 19 lockdown|0|||
146308671|NCT04251910|527644214|FG003|Overall Study|Covid 19 lockdown|4|||
146308672|NCT04251910|527644215|FG004|Overall Study|Covid 19 lockdown|0|||
146308673|NCT04251910|527644216|FG005|Overall Study|Covid 19 lockdown|0|||
146308674|NCT04251910|527644211|FG000|Overall Study|Assisted living facility was closed|0|||
146308675|NCT04251910|527644212|FG001|Overall Study|Assisted living facility was closed|0|||
146308676|NCT04251910|527644213|FG002|Overall Study|Assisted living facility was closed|0|||
146308677|NCT04251910|527644214|FG003|Overall Study|Assisted living facility was closed|0|||
146308678|NCT04251910|527644215|FG004|Overall Study|Assisted living facility was closed|1|||
146308679|NCT04251910|527644216|FG005|Overall Study|Assisted living facility was closed|0|||
146308680|NCT00916149|527644217|FG000|Overall Study|Lost to Follow-up|3|||
146308681|NCT00916149|527644218|FG001|Overall Study|Lost to Follow-up|2|||
146308682|NCT00916149|527644219|FG002|Overall Study|Lost to Follow-up|0|||
146308683|NCT00916149|527644217|FG000|Overall Study|Unable to place scalp EEG leads|1|||
146308684|NCT00916149|527644218|FG001|Overall Study|Unable to place scalp EEG leads|0|||
146308685|NCT00916149|527644219|FG002|Overall Study|Unable to place scalp EEG leads|0|||
146308686|NCT03002155|527644220|FG000|Overall Study|Lost to Follow-up|1|||
146308687|NCT03002155|527644221|FG001|Overall Study|Lost to Follow-up|2|||
146308688|NCT03002155|527644220|FG000|Overall Study|Withdrawal by Subject|1|||
146308689|NCT03002155|527644221|FG001|Overall Study|Withdrawal by Subject|0|||
146308690|NCT03002155|527644220|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
146308691|NCT03002155|527644221|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
146308692|NCT03451084|527644222|FG000|Overall Study|Withdrawal by Subject|2|||
146308693|NCT03451084|527644223|FG001|Overall Study|Withdrawal by Subject|1|||
146308694|NCT03451084|527644224|FG002|Overall Study|Withdrawal by Subject|2|||
146308695|NCT03451084|527644225|FG003|Overall Study|Withdrawal by Subject|1|||
146308696|NCT03451084|527644222|FG000|Overall Study|Disease recurrence|0|||
146308697|NCT03451084|527644223|FG001|Overall Study|Disease recurrence|2|||
146308698|NCT03451084|527644224|FG002|Overall Study|Disease recurrence|0|||
146308699|NCT03451084|527644225|FG003|Overall Study|Disease recurrence|0|||
146308700|NCT03451084|527644222|FG000|Overall Study|Lack of Efficacy|0|||
146308701|NCT03451084|527644223|FG001|Overall Study|Lack of Efficacy|3|||
146308702|NCT03451084|527644224|FG002|Overall Study|Lack of Efficacy|0|||
146308703|NCT03451084|527644225|FG003|Overall Study|Lack of Efficacy|1|||
146308704|NCT03451084|527644222|FG000|Overall Study|Death|1|||
146308705|NCT03451084|527644223|FG001|Overall Study|Death|0|||
146308706|NCT03451084|527644224|FG002|Overall Study|Death|2|||
146308707|NCT03451084|527644225|FG003|Overall Study|Death|0|||
146308708|NCT03451084|527644222|FG000|Overall Study|Physician Decision|0|||
146308709|NCT03451084|527644223|FG001|Overall Study|Physician Decision|0|||
146308710|NCT03451084|527644224|FG002|Overall Study|Physician Decision|2|||
146308711|NCT03451084|527644225|FG003|Overall Study|Physician Decision|2|||
146308712|NCT03451084|527644222|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
146308713|NCT03451084|527644223|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
146308714|NCT03451084|527644224|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
146308715|NCT03451084|527644225|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
146153192|NCT03434119|527072277|FG001|Overall Study|Other than specified|5|||
146153193|NCT00320216|527072278|FG000|Overall Study|Adverse Event|0|||
146308716|NCT05289570|527644233|FG000|Overall Study|Physician Decision|1|||
146308717|NCT04544475|527644234|FG000|Overall Study|Withdrawal by Subject|1|||
146308718|NCT04544475|527644235|FG001|Overall Study|Withdrawal by Subject|3|||
146308719|NCT00808236|527644236|FG000|Overall Study|Was not resuscitated|50|||
146308720|NCT00808236|527644237|FG001|Overall Study|Was not resuscitated|56|||
146308721|NCT00808236|527644236|FG000|Overall Study|Pre-defined exclusion|13|||
146308722|NCT00808236|527644237|FG001|Overall Study|Pre-defined exclusion|3|||
146153194|NCT00320216|527072279|FG001|Overall Study|Adverse Event|6|||
146308723|NCT00808236|527644236|FG000|Overall Study|Lost to Follow-up|1|||
146308724|NCT00808236|527644237|FG001|Overall Study|Lost to Follow-up|1|||
146308725|NCT00808236|527644236|FG000|Overall Study|Physician Decision|0|||
146308726|NCT00808236|527644237|FG001|Overall Study|Physician Decision|1|||
146308727|NCT00808236|527644236|FG000|Overall Study|Death|18|||
146153195|NCT00320216|527072280|FG002|Overall Study|Adverse Event|0|||
146153196|NCT00320216|527072281|FG003|Overall Study|Adverse Event|2|||
146153197|NCT00320216|527072282|FG004|Overall Study|Adverse Event|2|||
146153198|NCT00320216|527072278|FG000|Overall Study|Lack of Efficacy|6|||
146153199|NCT00320216|527072279|FG001|Overall Study|Lack of Efficacy|2|||
146153200|NCT00320216|527072280|FG002|Overall Study|Lack of Efficacy|1|||
146153201|NCT00320216|527072281|FG003|Overall Study|Lack of Efficacy|0|||
146153202|NCT00320216|527072282|FG004|Overall Study|Lack of Efficacy|1|||
146153203|NCT00320216|527072278|FG000|Overall Study|Lost to Follow-up|3|||
146153204|NCT00320216|527072279|FG001|Overall Study|Lost to Follow-up|0|||
146153205|NCT00320216|527072280|FG002|Overall Study|Lost to Follow-up|0|||
146153206|NCT00320216|527072281|FG003|Overall Study|Lost to Follow-up|0|||
146153207|NCT00320216|527072282|FG004|Overall Study|Lost to Follow-up|0|||
146153208|NCT00320216|527072278|FG000|Overall Study|Other|7|||
146153209|NCT00320216|527072279|FG001|Overall Study|Other|2|||
146153210|NCT00320216|527072280|FG002|Overall Study|Other|5|||
146153211|NCT00320216|527072281|FG003|Overall Study|Other|1|||
146153212|NCT00320216|527072282|FG004|Overall Study|Other|3|||
146153213|NCT05046795|527072285|FG000|Overall Study|Adverse Event|13|||
146153214|NCT05046795|527072286|FG001|Overall Study|Adverse Event|15|||
146153215|NCT05046795|527072285|FG000|Overall Study|Withdrawal by Subject|4|||
146153216|NCT05046795|527072286|FG001|Overall Study|Withdrawal by Subject|7|||
146153217|NCT05046795|527072285|FG000|Overall Study|Physician Decision|1|||
146153218|NCT05046795|527072286|FG001|Overall Study|Physician Decision|2|||
146153219|NCT05046795|527072285|FG000|Overall Study|Protocol Violation|1|||
146153220|NCT05046795|527072286|FG001|Overall Study|Protocol Violation|2|||
146308728|NCT00808236|527644237|FG001|Overall Study|Death|30|||
146308729|NCT01147744|527644238|FG000|Overall Study|Protocol Violation|1|||
146308730|NCT01147744|527644239|FG001|Overall Study|Protocol Violation|0|||
146308731|NCT01147744|527644240|FG002|Overall Study|Protocol Violation|1|||
146308732|NCT01147744|527644241|FG003|Overall Study|Protocol Violation|0|||
146308733|NCT01147744|527644242|FG004|Overall Study|Protocol Violation|1|||
146308734|NCT01147744|527644243|FG005|Overall Study|Protocol Violation|3|||
146308735|NCT01147744|527644244|FG006|Overall Study|Protocol Violation|1|||
146308736|NCT01147744|527644238|FG000|Overall Study|Physician Decision|0|||
146308737|NCT01147744|527644239|FG001|Overall Study|Physician Decision|1|||
146308738|NCT01147744|527644240|FG002|Overall Study|Physician Decision|1|||
146308739|NCT01147744|527644241|FG003|Overall Study|Physician Decision|0|||
146308740|NCT01147744|527644242|FG004|Overall Study|Physician Decision|0|||
146308741|NCT01147744|527644243|FG005|Overall Study|Physician Decision|0|||
146308742|NCT01147744|527644244|FG006|Overall Study|Physician Decision|1|||
146308743|NCT01147744|527644238|FG000|Overall Study|Lack of Efficacy|11|||
146308744|NCT01147744|527644239|FG001|Overall Study|Lack of Efficacy|11|||
146308745|NCT01147744|527644240|FG002|Overall Study|Lack of Efficacy|9|||
146308746|NCT01147744|527644241|FG003|Overall Study|Lack of Efficacy|11|||
146308747|NCT01147744|527644242|FG004|Overall Study|Lack of Efficacy|13|||
146308748|NCT01147744|527644243|FG005|Overall Study|Lack of Efficacy|8|||
146308749|NCT01147744|527644244|FG006|Overall Study|Lack of Efficacy|7|||
146308750|NCT01147744|527644238|FG000|Overall Study|Adverse Event|1|||
146308751|NCT01147744|527644239|FG001|Overall Study|Adverse Event|2|||
146308752|NCT01147744|527644240|FG002|Overall Study|Adverse Event|3|||
146308753|NCT01147744|527644241|FG003|Overall Study|Adverse Event|0|||
146308754|NCT01147744|527644242|FG004|Overall Study|Adverse Event|2|||
146308755|NCT01147744|527644243|FG005|Overall Study|Adverse Event|1|||
146308756|NCT01147744|527644244|FG006|Overall Study|Adverse Event|2|||
146308757|NCT01147744|527644238|FG000|Overall Study|Withdrawal by Subject|8|||
146308758|NCT01147744|527644239|FG001|Overall Study|Withdrawal by Subject|4|||
146308759|NCT01147744|527644240|FG002|Overall Study|Withdrawal by Subject|2|||
146308760|NCT01147744|527644241|FG003|Overall Study|Withdrawal by Subject|2|||
146308761|NCT01147744|527644242|FG004|Overall Study|Withdrawal by Subject|2|||
146308762|NCT01147744|527644243|FG005|Overall Study|Withdrawal by Subject|5|||
146308763|NCT01147744|527644244|FG006|Overall Study|Withdrawal by Subject|2|||
146308764|NCT01147744|527644238|FG000|Overall Study|Lost to Follow-up|0|||
146308765|NCT01147744|527644239|FG001|Overall Study|Lost to Follow-up|1|||
146308766|NCT01147744|527644240|FG002|Overall Study|Lost to Follow-up|0|||
146308767|NCT01147744|527644241|FG003|Overall Study|Lost to Follow-up|0|||
146308768|NCT01147744|527644242|FG004|Overall Study|Lost to Follow-up|0|||
146308769|NCT01147744|527644243|FG005|Overall Study|Lost to Follow-up|0|||
146153221|NCT05046795|527072285|FG000|Overall Study|Death|1|||
146153222|NCT05046795|527072286|FG001|Overall Study|Death|0|||
146153223|NCT05046795|527072285|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
146153224|NCT05046795|527072286|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
146308770|NCT01147744|527644244|FG006|Overall Study|Lost to Follow-up|0|||
146308771|NCT01147744|527644238|FG000|Overall Study|Sponsor decision to amend protocol|7|||
146308772|NCT01147744|527644239|FG001|Overall Study|Sponsor decision to amend protocol|4|||
146153225|NCT01127178|527072287|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
146153226|NCT01127178|527072288|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
146308773|NCT01147744|527644240|FG002|Overall Study|Sponsor decision to amend protocol|2|||
146308774|NCT01147744|527644241|FG003|Overall Study|Sponsor decision to amend protocol|5|||
146153227|NCT01127178|527072287|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
146153228|NCT01127178|527072288|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
146153229|NCT01127178|527072287|FG000|Dose Escalation: Treatment Phase|Other|2|||
146153230|NCT01127178|527072288|FG001|Dose Escalation: Treatment Phase|Other|0|||
146153231|NCT01127178|527072287|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
146153232|NCT01127178|527072288|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
146153233|NCT01127178|527072287|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
146153234|NCT01127178|527072288|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
146153235|NCT01127178|527072287|FG000|Dose Escalation: Extension Phase|Other|1|||
146153236|NCT01127178|527072288|FG001|Dose Escalation: Extension Phase|Other|0|||
146153237|NCT00093145|527072290|FG000|Overall Study|Unacceptable Toxicity Only|2|||
146153238|NCT00093145|527072290|FG000|Overall Study|Physician Decision|5|||
146153239|NCT00093145|527072290|FG000|Overall Study|Withdrawal by Subject|9|||
146153240|NCT00093145|527072290|FG000|Overall Study|Other|1|||
146153241|NCT01310036|527072291|FG000|Overall Study|Administrative/other|10|||
146153242|NCT01310036|527072291|FG000|Overall Study|Withdrew Consent|11|||
146153243|NCT01310036|527072291|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
146153244|NCT01310036|527072291|FG000|Overall Study|Progression of Disease|164|||
146153245|NCT01310036|527072291|FG000|Overall Study|Death|1|||
146153246|NCT01310036|527072291|FG000|Overall Study|Adverse event or intercurrent illness|12|||
146153247|NCT00553267|527072292|FG000|Overall Study|Adverse Event|8|||
146153248|NCT00553267|527072293|FG001|Overall Study|Adverse Event|10|||
146153249|NCT00553267|527072294|FG002|Overall Study|Adverse Event|5|||
146153250|NCT00553267|527072292|FG000|Overall Study|Non compliant with protocol|3|||
146153251|NCT00553267|527072293|FG001|Overall Study|Non compliant with protocol|3|||
146153252|NCT00553267|527072294|FG002|Overall Study|Non compliant with protocol|2|||
146153253|NCT00553267|527072292|FG000|Overall Study|Lost to Follow-up|0|||
146153254|NCT00553267|527072293|FG001|Overall Study|Lost to Follow-up|0|||
146153255|NCT00553267|527072294|FG002|Overall Study|Lost to Follow-up|1|||
146153256|NCT00553267|527072292|FG000|Overall Study|Consent withdrawn|2|||
146153257|NCT00553267|527072293|FG001|Overall Study|Consent withdrawn|3|||
146153258|NCT00553267|527072294|FG002|Overall Study|Consent withdrawn|1|||
146153259|NCT00553267|527072292|FG000|Overall Study|Specified category|1|||
146153260|NCT00553267|527072293|FG001|Overall Study|Specified category|2|||
146153261|NCT00553267|527072294|FG002|Overall Study|Specified category|1|||
146153262|NCT04389840|527072295|FG000|Overall Study|Adverse Event|0|||
146153263|NCT04389840|527072296|FG001|Overall Study|Adverse Event|0|||
146153264|NCT04389840|527072297|FG002|Overall Study|Adverse Event|0|||
146153265|NCT04389840|527072298|FG003|Overall Study|Adverse Event|1|||
146153266|NCT04389840|527072299|FG004|Overall Study|Adverse Event|0|||
146153267|NCT04389840|527072300|FG005|Overall Study|Adverse Event|0|||
146153268|NCT04389840|527072295|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
146153269|NCT04389840|527072296|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
146153270|NCT04389840|527072297|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
146153271|NCT04389840|527072298|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
146153272|NCT04389840|527072299|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
146153273|NCT04389840|527072300|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
146153274|NCT04389840|527072295|FG000|Overall Study|Death|0|||
146153275|NCT04389840|527072296|FG001|Overall Study|Death|1|||
146308775|NCT01147744|527644242|FG004|Overall Study|Sponsor decision to amend protocol|7|||
146308776|NCT01147744|527644243|FG005|Overall Study|Sponsor decision to amend protocol|2|||
146308777|NCT01147744|527644244|FG006|Overall Study|Sponsor decision to amend protocol|6|||
146308778|NCT01147744|527644238|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146308779|NCT01147744|527644239|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146308780|NCT01147744|527644240|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146308781|NCT01147744|527644241|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146308782|NCT01147744|527644242|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146308783|NCT01147744|527644243|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146308784|NCT01147744|527644244|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146308785|NCT01342484|527644245|FG000|Overall Study|Other Reasons|1|||
146308786|NCT01342484|527644246|FG001|Overall Study|Other Reasons|0|||
146308787|NCT01342484|527644247|FG002|Overall Study|Other Reasons|0|||
146308788|NCT01342484|527644245|FG000|Overall Study|Protocol Violation|0|||
146308789|NCT01342484|527644246|FG001|Overall Study|Protocol Violation|0|||
146153276|NCT04389840|527072297|FG002|Overall Study|Death|0|||
146153277|NCT04389840|527072298|FG003|Overall Study|Death|0|||
146153278|NCT04389840|527072299|FG004|Overall Study|Death|0|||
146153279|NCT04389840|527072300|FG005|Overall Study|Death|0|||
146153280|NCT02365467|527072306|FG000|Overall Study|Death|3|||
146153281|NCT00709722|527072307|FG000|Overall Study|Adverse Event|1|||
146153282|NCT02043782|527072308|FG000|Period 1|Adverse Event|0|||
146153283|NCT02043782|527072309|FG001|Period 1|Adverse Event|0|||
146153284|NCT02043782|527072310|FG002|Period 1|Adverse Event|1|||
146153285|NCT02043782|527072311|FG003|Period 1|Adverse Event|0|||
146308790|NCT01342484|527644247|FG002|Overall Study|Protocol Violation|1|||
146153286|NCT02043782|527072312|FG004|Period 1|Adverse Event|0|||
146153287|NCT02043782|527072313|FG005|Period 1|Adverse Event|0|||
146153288|NCT00833989|527072314|FG000|Overall Study|Physician Decision|0|||
146153289|NCT00833989|527072315|FG001|Overall Study|Physician Decision|0|||
146153290|NCT00833989|527072316|FG002|Overall Study|Physician Decision|0|||
146153291|NCT00833989|527072317|FG003|Overall Study|Physician Decision|1|||
146153292|NCT00833989|527072314|FG000|Overall Study|Withdrawal by Subject|3|||
146153293|NCT00833989|527072315|FG001|Overall Study|Withdrawal by Subject|0|||
146153294|NCT00833989|527072316|FG002|Overall Study|Withdrawal by Subject|1|||
146153295|NCT00833989|527072317|FG003|Overall Study|Withdrawal by Subject|1|||
146153296|NCT01109992|527072318|FG000|Overall Study|Withdrawal by Subject|0|||
146153297|NCT01109992|527072319|FG001|Overall Study|Withdrawal by Subject|1|||
146153298|NCT01109992|527072318|FG000|Overall Study|Movement during rest scan.|0|||
146153299|NCT01109992|527072319|FG001|Overall Study|Movement during rest scan.|1|||
146153300|NCT00690755|527072322|FG000|Overall Study|Physician Decision|2|||
146153301|NCT00690755|527072323|FG001|Overall Study|Physician Decision|0|||
146153302|NCT00690755|527072324|FG002|Overall Study|Physician Decision|46|||
146153303|NCT00690755|527072325|FG003|Overall Study|Physician Decision|5|||
146153304|NCT00690755|527072326|FG004|Overall Study|Physician Decision|0|||
146153305|NCT00690755|527072327|FG005|Overall Study|Physician Decision|4|||
146153306|NCT00690755|527072328|FG006|Overall Study|Physician Decision|0|||
146153307|NCT00214136|527072331|FG000|Overall Study|Death|5|||
146153308|NCT04287920|527072332|FG000|Overall Study|Lost to Follow-up|1|||
146153309|NCT04287920|527072333|FG001|Overall Study|Lost to Follow-up|1|||
146153310|NCT04287920|527072332|FG000|Overall Study|Withdrawal by Subject|0|||
146153311|NCT04287920|527072333|FG001|Overall Study|Withdrawal by Subject|3|||
146153312|NCT02310750|527072334|FG000|HP Period 1|Lost to Follow-up|0|||
146153313|NCT02310750|527072335|FG001|HP Period 1|Lost to Follow-up|0|||
146153314|NCT02310750|527072336|FG002|HP Period 1|Lost to Follow-up|0|||
146153315|NCT02310750|527072337|FG003|HP Period 1|Lost to Follow-up|0|||
146153316|NCT02310750|527072338|FG004|HP Period 1|Lost to Follow-up|0|||
146153317|NCT02310750|527072339|FG005|HP Period 1|Lost to Follow-up|0|||
146153318|NCT02310750|527072340|FG006|HP Period 1|Lost to Follow-up|1|||
146153319|NCT02310750|527072341|FG007|HP Period 1|Lost to Follow-up|0|||
146153320|NCT02310750|527072342|FG008|HP Period 1|Lost to Follow-up|0|||
146153321|NCT02310750|527072343|FG009|HP Period 1|Lost to Follow-up|0|||
146153322|NCT02310750|527072344|FG010|HP Period 1|Lost to Follow-up|0|||
146153323|NCT02310750|527072345|FG011|HP Period 1|Lost to Follow-up|0|||
146153324|NCT02310750|527072346|FG012|HP Period 1|Lost to Follow-up|0|||
146153325|NCT02310750|527072347|FG013|HP Period 1|Lost to Follow-up|0|||
146153326|NCT02310750|527072348|FG014|HP Period 1|Lost to Follow-up|0|||
146153327|NCT02310750|527072349|FG015|HP Period 1|Lost to Follow-up|0|||
146153328|NCT02310750|527072334|FG000|HP Period 1|Withdrawal by Subject|1|||
146153329|NCT02310750|527072335|FG001|HP Period 1|Withdrawal by Subject|0|||
146153330|NCT02310750|527072336|FG002|HP Period 1|Withdrawal by Subject|0|||
146153331|NCT02310750|527072337|FG003|HP Period 1|Withdrawal by Subject|1|||
146153332|NCT02310750|527072338|FG004|HP Period 1|Withdrawal by Subject|0|||
146153333|NCT02310750|527072339|FG005|HP Period 1|Withdrawal by Subject|0|||
146153334|NCT02310750|527072340|FG006|HP Period 1|Withdrawal by Subject|0|||
146153335|NCT02310750|527072341|FG007|HP Period 1|Withdrawal by Subject|0|||
146153336|NCT02310750|527072342|FG008|HP Period 1|Withdrawal by Subject|0|||
146153337|NCT02310750|527072343|FG009|HP Period 1|Withdrawal by Subject|0|||
146153338|NCT02310750|527072344|FG010|HP Period 1|Withdrawal by Subject|0|||
146153339|NCT02310750|527072345|FG011|HP Period 1|Withdrawal by Subject|0|||
146153340|NCT02310750|527072346|FG012|HP Period 1|Withdrawal by Subject|0|||
146153341|NCT02310750|527072347|FG013|HP Period 1|Withdrawal by Subject|0|||
146153342|NCT02310750|527072348|FG014|HP Period 1|Withdrawal by Subject|0|||
146153343|NCT02310750|527072349|FG015|HP Period 1|Withdrawal by Subject|0|||
146153344|NCT02310750|527072334|FG000|HP Washout 1|Lost to Follow-up|0|||
146308791|NCT01342484|527644245|FG000|Overall Study|Withdrawal by Subject|1|||
146308792|NCT01342484|527644246|FG001|Overall Study|Withdrawal by Subject|0|||
146308793|NCT01342484|527644247|FG002|Overall Study|Withdrawal by Subject|0|||
146308794|NCT05003622|527644248|FG000|Overall Study|Progressive disease|2|||
146308795|NCT05003622|527644248|FG000|Overall Study|Withdrawal by Subject|1|||
146308796|NCT04066491|527644250|FG000|Overall Study|Randomized, not treated|0|||
146153345|NCT02310750|527072335|FG001|HP Washout 1|Lost to Follow-up|0|||
146153346|NCT02310750|527072336|FG002|HP Washout 1|Lost to Follow-up|1|||
146153347|NCT02310750|527072337|FG003|HP Washout 1|Lost to Follow-up|1|||
146153348|NCT02310750|527072338|FG004|HP Washout 1|Lost to Follow-up|2|||
146153349|NCT02310750|527072339|FG005|HP Washout 1|Lost to Follow-up|2|||
146153350|NCT02310750|527072340|FG006|HP Washout 1|Lost to Follow-up|3|||
146153351|NCT02310750|527072341|FG007|HP Washout 1|Lost to Follow-up|0|||
146153352|NCT02310750|527072342|FG008|HP Washout 1|Lost to Follow-up|0|||
146153353|NCT02310750|527072343|FG009|HP Washout 1|Lost to Follow-up|0|||
146153354|NCT02310750|527072344|FG010|HP Washout 1|Lost to Follow-up|0|||
146153355|NCT02310750|527072345|FG011|HP Washout 1|Lost to Follow-up|0|||
146153356|NCT02310750|527072346|FG012|HP Washout 1|Lost to Follow-up|0|||
146153357|NCT02310750|527072347|FG013|HP Washout 1|Lost to Follow-up|0|||
146153358|NCT02310750|527072348|FG014|HP Washout 1|Lost to Follow-up|0|||
146153359|NCT02310750|527072349|FG015|HP Washout 1|Lost to Follow-up|0|||
146153360|NCT02310750|527072334|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153361|NCT02310750|527072335|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153362|NCT02310750|527072336|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153363|NCT02310750|527072337|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
146153364|NCT02310750|527072338|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153365|NCT02310750|527072339|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
146153366|NCT02310750|527072340|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153367|NCT02310750|527072341|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153368|NCT02310750|527072342|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
146153369|NCT02310750|527072343|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
146153370|NCT02310750|527072344|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153371|NCT02310750|527072345|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153372|NCT02310750|527072346|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153373|NCT02310750|527072347|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153374|NCT02310750|527072348|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153375|NCT02310750|527072349|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
146153376|NCT02310750|527072334|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153377|NCT02310750|527072335|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153378|NCT02310750|527072336|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153379|NCT02310750|527072337|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153380|NCT02310750|527072338|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153381|NCT02310750|527072339|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153382|NCT02310750|527072340|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153383|NCT02310750|527072341|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153384|NCT02310750|527072342|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153385|NCT02310750|527072343|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
146153386|NCT02310750|527072344|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153387|NCT02310750|527072345|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153388|NCT02310750|527072346|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153389|NCT02310750|527072347|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153390|NCT02310750|527072348|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153391|NCT02310750|527072349|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
146153392|NCT02310750|527072334|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153393|NCT02310750|527072335|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153394|NCT02310750|527072336|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153395|NCT02310750|527072337|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153396|NCT02310750|527072338|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153397|NCT02310750|527072339|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153398|NCT02310750|527072340|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153399|NCT02310750|527072341|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146153400|NCT02310750|527072342|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146153401|NCT02310750|527072343|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
146153402|NCT02310750|527072344|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153403|NCT02310750|527072345|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153404|NCT02310750|527072346|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153405|NCT02310750|527072347|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153406|NCT02310750|527072348|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153407|NCT02310750|527072349|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
146153408|NCT02310750|527072334|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153409|NCT02310750|527072335|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153410|NCT02310750|527072336|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153411|NCT02310750|527072337|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153412|NCT02310750|527072338|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153413|NCT02310750|527072339|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153414|NCT02310750|527072340|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153415|NCT02310750|527072341|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
146153416|NCT02310750|527072342|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
146153417|NCT02310750|527072343|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153418|NCT02310750|527072344|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153419|NCT02310750|527072345|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153420|NCT02310750|527072346|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146308797|NCT04066491|527644251|FG001|Overall Study|Randomized, not treated|0|||
146308798|NCT04066491|527644252|FG002|Overall Study|Randomized, not treated|2|||
146308799|NCT00402649|527645781|FG000|Overall Study|Lost to Follow-up|1|||
146308800|NCT00402649|527645781|FG000|Overall Study|Withdrawal by Subject|1|||
146308801|NCT01199042|527645782|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
146308802|NCT01199042|527645782|FG000|At Home (3 Months)|Lost to Follow-up|1|||
146153421|NCT02310750|527072347|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153422|NCT02310750|527072348|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153423|NCT02310750|527072349|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
146153424|NCT02310750|527072334|FG000|HP Washout 2|Lost to Follow-up|0|||
146153425|NCT02310750|527072335|FG001|HP Washout 2|Lost to Follow-up|0|||
146153426|NCT02310750|527072336|FG002|HP Washout 2|Lost to Follow-up|0|||
146153427|NCT02310750|527072337|FG003|HP Washout 2|Lost to Follow-up|0|||
146153428|NCT02310750|527072338|FG004|HP Washout 2|Lost to Follow-up|1|||
146153429|NCT02310750|527072339|FG005|HP Washout 2|Lost to Follow-up|0|||
146153430|NCT02310750|527072340|FG006|HP Washout 2|Lost to Follow-up|7|||
146153431|NCT02310750|527072341|FG007|HP Washout 2|Lost to Follow-up|0|||
146153432|NCT02310750|527072342|FG008|HP Washout 2|Lost to Follow-up|0|||
146153433|NCT02310750|527072343|FG009|HP Washout 2|Lost to Follow-up|0|||
146153434|NCT02310750|527072344|FG010|HP Washout 2|Lost to Follow-up|0|||
146153435|NCT02310750|527072345|FG011|HP Washout 2|Lost to Follow-up|0|||
146153436|NCT02310750|527072346|FG012|HP Washout 2|Lost to Follow-up|0|||
146153437|NCT02310750|527072347|FG013|HP Washout 2|Lost to Follow-up|0|||
146153438|NCT02310750|527072348|FG014|HP Washout 2|Lost to Follow-up|0|||
146153439|NCT02310750|527072349|FG015|HP Washout 2|Lost to Follow-up|0|||
146153440|NCT01226745|527072352|FG000|Overall Study|Did not complete schedule of assessments|8|||
146153441|NCT01226745|527072353|FG001|Overall Study|Did not complete schedule of assessments|3|||
146153442|NCT01226745|527072354|FG002|Overall Study|Did not complete schedule of assessments|6|||
146153443|NCT01226745|527072355|FG003|Overall Study|Did not complete schedule of assessments|0|||
146153444|NCT01226745|527072356|FG004|Overall Study|Did not complete schedule of assessments|0|||
146153445|NCT01226745|527072357|FG005|Overall Study|Did not complete schedule of assessments|1|||
146153446|NCT01226745|527072352|FG000|Overall Study|Lost to Follow-up|2|||
146153447|NCT01226745|527072353|FG001|Overall Study|Lost to Follow-up|6|||
146153448|NCT01226745|527072354|FG002|Overall Study|Lost to Follow-up|6|||
146153449|NCT01226745|527072355|FG003|Overall Study|Lost to Follow-up|1|||
146153450|NCT01226745|527072356|FG004|Overall Study|Lost to Follow-up|1|||
146153451|NCT01226745|527072357|FG005|Overall Study|Lost to Follow-up|2|||
146153452|NCT01226745|527072352|FG000|Overall Study|Death|1|||
146153453|NCT01226745|527072353|FG001|Overall Study|Death|0|||
146153454|NCT01226745|527072354|FG002|Overall Study|Death|0|||
146153455|NCT01226745|527072355|FG003|Overall Study|Death|0|||
146153456|NCT01226745|527072356|FG004|Overall Study|Death|0|||
146153457|NCT01226745|527072357|FG005|Overall Study|Death|1|||
146153458|NCT01226745|527072352|FG000|Overall Study|Other|6|||
146153459|NCT01226745|527072353|FG001|Overall Study|Other|7|||
146153460|NCT01226745|527072354|FG002|Overall Study|Other|8|||
146153461|NCT01226745|527072355|FG003|Overall Study|Other|4|||
146153462|NCT01226745|527072356|FG004|Overall Study|Other|3|||
146153463|NCT01226745|527072357|FG005|Overall Study|Other|1|||
146153464|NCT01435577|527072358|FG000|Overall Study|Adverse Event|10|||
146153465|NCT01435577|527072359|FG001|Overall Study|Adverse Event|0|||
146153466|NCT01435577|527072358|FG000|Overall Study|Lack of Efficacy|7|||
146153467|NCT01435577|527072359|FG001|Overall Study|Lack of Efficacy|51|||
146153468|NCT01435577|527072358|FG000|Overall Study|Alternative treatment started|0|||
146153469|NCT01435577|527072359|FG001|Overall Study|Alternative treatment started|1|||
146153470|NCT01934218|527072362|FG000|Double-blind Phase|Adverse Event|8|||
146153471|NCT01934218|527072363|FG001|Double-blind Phase|Adverse Event|8|||
146153472|NCT01934218|527072362|FG000|Double-blind Phase|Lack of Efficacy|6|||
146153473|NCT01934218|527072363|FG001|Double-blind Phase|Lack of Efficacy|7|||
146153474|NCT01934218|527072362|FG000|Double-blind Phase|Lost to Follow-up|7|||
146153475|NCT01934218|527072363|FG001|Double-blind Phase|Lost to Follow-up|14|||
146153476|NCT01934218|527072362|FG000|Double-blind Phase|Physician Decision|1|||
146153477|NCT01934218|527072363|FG001|Double-blind Phase|Physician Decision|2|||
146153478|NCT01934218|527072362|FG000|Double-blind Phase|Protocol Violation|4|||
146153479|NCT01934218|527072363|FG001|Double-blind Phase|Protocol Violation|0|||
146153480|NCT01934218|527072362|FG000|Double-blind Phase|Withdrawal by Subject|16|||
146153481|NCT01934218|527072363|FG001|Double-blind Phase|Withdrawal by Subject|13|||
146153482|NCT01934218|527072362|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
146153483|NCT01934218|527072363|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
146153484|NCT01934218|527072362|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
146153485|NCT01934218|527072363|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
146153486|NCT01934218|527072362|FG000|Open-Label Phase|Adverse Event|2|||
146153487|NCT01934218|527072363|FG001|Open-Label Phase|Adverse Event|4|||
146153488|NCT01934218|527072362|FG000|Open-Label Phase|Lack of Efficacy|1|||
146153489|NCT01934218|527072363|FG001|Open-Label Phase|Lack of Efficacy|4|||
146153490|NCT01934218|527072362|FG000|Open-Label Phase|Lost to Follow-up|4|||
146153491|NCT01934218|527072363|FG001|Open-Label Phase|Lost to Follow-up|2|||
146153492|NCT01934218|527072362|FG000|Open-Label Phase|Physician Decision|1|||
146153493|NCT01934218|527072363|FG001|Open-Label Phase|Physician Decision|0|||
146153494|NCT01934218|527072362|FG000|Open-Label Phase|Protocol Violation|1|||
146153495|NCT01934218|527072363|FG001|Open-Label Phase|Protocol Violation|0|||
146153496|NCT01934218|527072362|FG000|Open-Label Phase|Withdrawal by Subject|13|||
146153497|NCT01934218|527072363|FG001|Open-Label Phase|Withdrawal by Subject|11|||
146153498|NCT01934218|527072362|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
146153499|NCT01934218|527072363|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
146153500|NCT01934218|527072362|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
146153501|NCT01934218|527072363|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
146153502|NCT03538626|527072364|FG000|Overall Study|Withdrawal by Subject|0|||
146153503|NCT03538626|527072365|FG001|Overall Study|Withdrawal by Subject|1|||
146153504|NCT03538626|527072366|FG002|Overall Study|Withdrawal by Subject|0|||
146153505|NCT03538626|527072367|FG003|Overall Study|Withdrawal by Subject|0|||
146153506|NCT03538626|527072368|FG004|Overall Study|Withdrawal by Subject|0|||
146153507|NCT03538626|527072369|FG005|Overall Study|Withdrawal by Subject|0|||
146153508|NCT03538626|527072370|FG006|Overall Study|Withdrawal by Subject|0|||
146153509|NCT03538626|527072371|FG007|Overall Study|Withdrawal by Subject|0|||
146153510|NCT03538626|527072364|FG000|Overall Study|Lost to Follow-up|0|||
146153511|NCT03538626|527072365|FG001|Overall Study|Lost to Follow-up|0|||
146153512|NCT03538626|527072366|FG002|Overall Study|Lost to Follow-up|0|||
146153513|NCT03538626|527072367|FG003|Overall Study|Lost to Follow-up|0|||
146153514|NCT03538626|527072368|FG004|Overall Study|Lost to Follow-up|0|||
146153515|NCT03538626|527072369|FG005|Overall Study|Lost to Follow-up|0|||
146153516|NCT03538626|527072370|FG006|Overall Study|Lost to Follow-up|1|||
146153517|NCT03538626|527072371|FG007|Overall Study|Lost to Follow-up|0|||
146153518|NCT02232893|527072377|FG000|Overall Study|Withdrawal by Subject|4|||
146153519|NCT02232893|527072378|FG001|Overall Study|Withdrawal by Subject|1|||
146153520|NCT02232893|527072377|FG000|Overall Study|Adverse Event|0|||
146153521|NCT02232893|527072378|FG001|Overall Study|Adverse Event|1|||
146153522|NCT02232893|527072377|FG000|Overall Study|Sponsor request early termination|0|||
146153523|NCT02232893|527072378|FG001|Overall Study|Sponsor request early termination|1|||
146153524|NCT02232893|527072377|FG000|Overall Study|Developed exclusion criteria|0|||
146153525|NCT02232893|527072378|FG001|Overall Study|Developed exclusion criteria|1|||
146153526|NCT02232893|527072377|FG000|Overall Study|Other|0|||
146153527|NCT02232893|527072378|FG001|Overall Study|Other|3|||
146153528|NCT02911948|527072379|FG000|Overall Study|Protocol Violation|0|||
146153529|NCT02911948|527072380|FG001|Overall Study|Protocol Violation|1|||
146153530|NCT02911948|527072379|FG000|Overall Study|Withdrawal by Subject|0|||
146153531|NCT02911948|527072380|FG001|Overall Study|Withdrawal by Subject|2|||
146153532|NCT02911948|527072379|FG000|Overall Study|Lack of Efficacy|0|||
146153533|NCT02911948|527072380|FG001|Overall Study|Lack of Efficacy|1|||
146153534|NCT02911948|527072379|FG000|Overall Study|Unclassified|0|||
146153535|NCT02911948|527072380|FG001|Overall Study|Unclassified|3|||
146153536|NCT01090453|527072383|FG000|Overall Study|Withdrawal by Subject|1|||
146153537|NCT01090453|527072384|FG001|Overall Study|Withdrawal by Subject|2|||
146153538|NCT01090453|527072383|FG000|Overall Study|Lost to Follow-up|7|||
146153539|NCT01090453|527072384|FG001|Overall Study|Lost to Follow-up|7|||
146153540|NCT01090453|527072383|FG000|Overall Study|Non serious AEs|1|||
146153541|NCT01090453|527072384|FG001|Overall Study|Non serious AEs|0|||
146153542|NCT01090453|527072383|FG000|Overall Study|Protocol Violation|2|||
146153543|NCT01090453|527072384|FG001|Overall Study|Protocol Violation|0|||
146153544|NCT01090453|527072383|FG000|Overall Study|Other|2|||
146153545|NCT01090453|527072384|FG001|Overall Study|Other|4|||
146153546|NCT01090453|527072383|FG000|Overall Study|Eligibility Criteria|0|||
146153547|NCT01090453|527072384|FG001|Overall Study|Eligibility Criteria|1|||
146153548|NCT00522275|527072385|FG000|Overall Study|Adverse Event|35|||
146153549|NCT00522275|527072385|FG000|Overall Study|Lack of Efficacy|80|||
146153550|NCT00522275|527072385|FG000|Overall Study|Subject withdrew consent|16|||
146153551|NCT00522275|527072385|FG000|Overall Study|Protocol deviation|1|||
146153552|NCT00522275|527072385|FG000|Overall Study|Unsatisfactory compliance|11|||
146153553|NCT00522275|527072385|FG000|Overall Study|Lost to Follow-up|8|||
146153554|NCT00522275|527072385|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
146308803|NCT01239342|527645783|FG000|Overall Study|Adverse Event|1|||
146308804|NCT01239342|527645784|FG001|Overall Study|Adverse Event|0|||
146308805|NCT01239342|527645783|FG000|Overall Study|Withdrawal by Subject|1|||
146308806|NCT01239342|527645784|FG001|Overall Study|Withdrawal by Subject|5|||
146153555|NCT00522275|527072385|FG000|Overall Study|Other: Subject is pregnant|2|||
146153556|NCT00522275|527072385|FG000|Overall Study|Other: Subject relocated|2|||
146153557|NCT00522275|527072385|FG000|Overall Study|Other: Subject arrested|1|||
146153558|NCT00522275|527072385|FG000|Overall Study|Other: Site / clinic closed|4|||
146153559|NCT00522275|527072385|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
146153560|NCT00522275|527072385|FG000|Overall Study|Other: Sponsor request|2|||
146153561|NCT00522275|527072385|FG000|Overall Study|Other: Subject ran out of medication|1|||
146153562|NCT00522275|527072385|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
146153563|NCT03867734|527072387|FG000|Overall Study|Lost to Follow-up|2|||
146153564|NCT03965052|527072388|FG000|Overall Study|Protocol Violation|1|||
146308807|NCT01239342|527645783|FG000|Overall Study|Reason Unknown|1|||
146153565|NCT03965052|527072389|FG001|Overall Study|Protocol Violation|0|||
146153566|NCT04323436|527072395|FG000|Overall Study|Adverse Event|7|||
146153567|NCT04323436|527072396|FG001|Overall Study|Adverse Event|0|||
146153568|NCT04323436|527072397|FG002|Overall Study|Adverse Event|0|||
146308808|NCT01239342|527645784|FG001|Overall Study|Reason Unknown|1|||
146153569|NCT04323436|527072395|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
146153570|NCT04323436|527072396|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
146153571|NCT04323436|527072397|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
146153572|NCT04323436|527072395|FG000|Overall Study|Death|1|||
146153573|NCT04323436|527072396|FG001|Overall Study|Death|0|||
146153574|NCT04323436|527072397|FG002|Overall Study|Death|0|||
146153575|NCT04323436|527072395|FG000|Overall Study|Physician Decision|2|||
146153576|NCT04323436|527072396|FG001|Overall Study|Physician Decision|0|||
146153577|NCT04323436|527072397|FG002|Overall Study|Physician Decision|0|||
146153578|NCT04323436|527072395|FG000|Overall Study|Progressive disease|10|||
146153579|NCT04323436|527072396|FG001|Overall Study|Progressive disease|0|||
146153580|NCT04323436|527072397|FG002|Overall Study|Progressive disease|0|||
146153581|NCT04323436|527072395|FG000|Overall Study|Subject decision|3|||
146153582|NCT04323436|527072396|FG001|Overall Study|Subject decision|0|||
146153583|NCT04323436|527072397|FG002|Overall Study|Subject decision|0|||
146153584|NCT01365494|527072398|FG000|Overall Study|Adverse Event|1|||
146153585|NCT01365494|527072399|FG001|Overall Study|Adverse Event|0|||
146153586|NCT01365494|527072398|FG000|Overall Study|Withdrawal by Subject|0|||
146153587|NCT01365494|527072399|FG001|Overall Study|Withdrawal by Subject|1|||
146153588|NCT01365494|527072398|FG000|Overall Study|Lost to Follow-up|1|||
146153589|NCT01365494|527072399|FG001|Overall Study|Lost to Follow-up|2|||
146153590|NCT03351049|527072400|FG000|Overall Study|Withdrawal|26|||
146153591|NCT03351049|527072401|FG001|Overall Study|Withdrawal|22|||
146153592|NCT03832192|527072404|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
146153593|NCT03832192|527072405|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
146153594|NCT02663128|527072406|FG000|Period 2|Physician Decision|0|||
146153595|NCT02663128|527072407|FG001|Period 2|Physician Decision|0|||
146153596|NCT02663128|527072408|FG002|Period 2|Physician Decision|0|||
146153597|NCT02663128|527072409|FG003|Period 2|Physician Decision|0|||
146153598|NCT02663128|527072410|FG004|Period 2|Physician Decision|1|||
146153599|NCT02663128|527072411|FG005|Period 2|Physician Decision|0|||
146153600|NCT02730819|527072421|FG000|Overall Study|Lost to Follow-up|9|||
146153601|NCT02121847|527072422|FG000|Overall Study|Administrative Reasons|1|||
146153602|NCT02121847|527072422|FG000|Overall Study|Adverse Event|2|||
146153603|NCT01410448|527072428|FG000|Overall Study|No conversion to everolimus|0|||
146153604|NCT01410448|527072429|FG001|Overall Study|No conversion to everolimus|24|||
146153605|NCT01410448|527072428|FG000|Overall Study|Graft loss|4|||
146153606|NCT01410448|527072429|FG001|Overall Study|Graft loss|1|||
146153607|NCT01410448|527072428|FG000|Overall Study|Administrative issues|2|||
146153608|NCT01410448|527072429|FG001|Overall Study|Administrative issues|1|||
146153609|NCT01410448|527072428|FG000|Overall Study|Lost to Follow-up|1|||
146153610|NCT01410448|527072429|FG001|Overall Study|Lost to Follow-up|0|||
146153611|NCT01410448|527072428|FG000|Overall Study|Withdrawal by Subject|3|||
146153612|NCT01410448|527072429|FG001|Overall Study|Withdrawal by Subject|2|||
146153613|NCT01410448|527072428|FG000|Overall Study|Protocol Violation|0|||
146153614|NCT01410448|527072429|FG001|Overall Study|Protocol Violation|4|||
146153615|NCT01410448|527072428|FG000|Overall Study|Death|2|||
146153616|NCT01410448|527072429|FG001|Overall Study|Death|3|||
146153617|NCT00360529|527072430|FG000|Overall Study|Adverse Event|10|||
146153618|NCT00360529|527072431|FG001|Overall Study|Adverse Event|23|||
146153619|NCT00360529|527072432|FG002|Overall Study|Adverse Event|33|||
146153620|NCT00360529|527072430|FG000|Overall Study|Protocol Violation|3|||
146153621|NCT00360529|527072431|FG001|Overall Study|Protocol Violation|3|||
146153622|NCT00360529|527072432|FG002|Overall Study|Protocol Violation|11|||
146153623|NCT00360529|527072430|FG000|Overall Study|Lost to Follow-up|14|||
146153624|NCT00360529|527072431|FG001|Overall Study|Lost to Follow-up|10|||
146153625|NCT00360529|527072432|FG002|Overall Study|Lost to Follow-up|13|||
146153626|NCT00360529|527072430|FG000|Overall Study|Withdrawal by Subject|22|||
146153627|NCT00360529|527072431|FG001|Overall Study|Withdrawal by Subject|14|||
146153628|NCT00360529|527072432|FG002|Overall Study|Withdrawal by Subject|18|||
146153629|NCT00360529|527072430|FG000|Overall Study|Lack of Efficacy|8|||
146153630|NCT00360529|527072431|FG001|Overall Study|Lack of Efficacy|6|||
146308809|NCT04329702|527645785|FG000|Overall Study|illness|3|||
146308810|NCT04329702|527645786|FG001|Overall Study|illness|4|||
146308811|NCT04329702|527645787|FG002|Overall Study|illness|0|||
146308812|NCT04329702|527645785|FG000|Overall Study|Lost to Follow-up|0|||
146153631|NCT00360529|527072432|FG002|Overall Study|Lack of Efficacy|5|||
146153632|NCT00360529|527072430|FG000|Overall Study|Reason discontinued not explained above|4|||
146153633|NCT00360529|527072431|FG001|Overall Study|Reason discontinued not explained above|9|||
146153634|NCT00360529|527072432|FG002|Overall Study|Reason discontinued not explained above|11|||
146153635|NCT02535065|527072433|FG000|Overall Study|Death|13|||
146153636|NCT02535065|527072433|FG000|Overall Study|Lost to Follow-up|1|||
146153637|NCT02535065|527072433|FG000|Overall Study|Withdrawal by Subject|6|||
146153638|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
146153639|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
146308813|NCT04329702|527645786|FG001|Overall Study|Lost to Follow-up|0|||
146153640|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
146308814|NCT04329702|527645787|FG002|Overall Study|Lost to Follow-up|2|||
146308815|NCT04329702|527645785|FG000|Overall Study|Death|0|||
146153641|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
146153642|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
146153643|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
146153644|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
146153645|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
146153646|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
146153647|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
146153648|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
146153649|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
146153650|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
146153651|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
146153652|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
146153653|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
146153654|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
146153655|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
146153656|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
146153657|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
146153658|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
146153659|NCT01781572|527072434|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
146153660|NCT01781572|527072435|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
146153661|NCT01781572|527072436|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
146153662|NCT01781572|527072434|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
146153663|NCT01781572|527072435|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
146153664|NCT01781572|527072436|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
146153665|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
146153666|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
146153667|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
146153668|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
146153669|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
146153670|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
146153671|NCT01781572|527072434|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
146153672|NCT01781572|527072435|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
146153673|NCT01781572|527072436|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
146153674|NCT01781572|527072434|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
146153675|NCT01781572|527072435|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
146153676|NCT01781572|527072436|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
146153677|NCT01781572|527072434|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
146153678|NCT01781572|527072435|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
146153679|NCT01781572|527072436|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
146153680|NCT01781572|527072434|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
146153681|NCT01781572|527072435|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
146153682|NCT01781572|527072436|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
146153683|NCT01781572|527072434|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
146153684|NCT01781572|527072435|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
146153685|NCT01781572|527072436|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
146153686|NCT01781572|527072434|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
146153687|NCT01781572|527072435|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
146153688|NCT01781572|527072436|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
146153689|NCT01781572|527072434|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
146153690|NCT01781572|527072435|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
146153691|NCT01781572|527072436|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
146308816|NCT04329702|527645786|FG001|Overall Study|Death|2|||
146308817|NCT04329702|527645787|FG002|Overall Study|Death|0|||
146308818|NCT00766532|527645788|FG000|Overall Study|Protocol Violation|2|||
146308819|NCT01438489|527645789|FG000|Overall Study|Lost to Follow-up|4|||
146308820|NCT01438489|527645790|FG001|Overall Study|Lost to Follow-up|2|||
146308821|NCT01438489|527645791|FG002|Overall Study|Lost to Follow-up|2|||
146308822|NCT01438489|527645789|FG000|Overall Study|Withdrawal by Subject|11|||
146308823|NCT01438489|527645790|FG001|Overall Study|Withdrawal by Subject|3|||
146308824|NCT01438489|527645791|FG002|Overall Study|Withdrawal by Subject|8|||
146308825|NCT01438489|527645789|FG000|Overall Study|Death|0|||
146308826|NCT01438489|527645790|FG001|Overall Study|Death|0|||
146308827|NCT01438489|527645791|FG002|Overall Study|Death|1|||
146308828|NCT01438489|527645789|FG000|Overall Study|Sponsor decision|4|||
146308829|NCT01438489|527645790|FG001|Overall Study|Sponsor decision|1|||
146308830|NCT01438489|527645791|FG002|Overall Study|Sponsor decision|4|||
146308831|NCT01438489|527645789|FG000|Overall Study|Subject choice/Subject moved|2|||
146153692|NCT03156023|527072439|FG000|Overall Study|Withdrawal by Subject|1|||
146153693|NCT03156023|527072440|FG001|Overall Study|Withdrawal by Subject|0|||
146153694|NCT03156023|527072441|FG002|Overall Study|Withdrawal by Subject|2|||
146153695|NCT03156023|527072442|FG003|Overall Study|Withdrawal by Subject|1|||
146153696|NCT03156023|527072443|FG004|Overall Study|Withdrawal by Subject|1|||
146153697|NCT03156023|527072439|FG000|Overall Study|Lost to Follow-up|0|||
146153698|NCT03156023|527072440|FG001|Overall Study|Lost to Follow-up|0|||
146153699|NCT03156023|527072441|FG002|Overall Study|Lost to Follow-up|0|||
146153700|NCT03156023|527072442|FG003|Overall Study|Lost to Follow-up|0|||
146153701|NCT03156023|527072443|FG004|Overall Study|Lost to Follow-up|1|||
146153702|NCT00932893|527072444|FG000|Overall Study|Death|115|||
146153703|NCT00932893|527072445|FG001|Overall Study|Death|24|||
146153704|NCT00932893|527072444|FG000|Overall Study|Lost to Follow-up|8|||
146153705|NCT00932893|527072445|FG001|Overall Study|Lost to Follow-up|0|||
146153706|NCT00932893|527072444|FG000|Overall Study|Withdrawal by Subject|5|||
146153707|NCT00932893|527072445|FG001|Overall Study|Withdrawal by Subject|2|||
146153708|NCT00932893|527072444|FG000|Overall Study|Other|5|||
146153709|NCT00932893|527072445|FG001|Overall Study|Other|144|||
146153710|NCT02526693|527074110|FG000|Overall Study|Physician Decision|3|||
146153711|NCT02526693|527074111|FG001|Overall Study|Physician Decision|1|||
146153712|NCT01585103|527074113|FG000|Overall Study|Unable to swallow Cytosponge|6|||
146153713|NCT01349569|527074114|FG000|Overall Study|Lack of Efficacy|4|||
146153714|NCT03581305|527074115|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
146153715|NCT03581305|527074116|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
146153716|NCT03581305|527074115|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
146153717|NCT03581305|527074116|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
146153718|NCT03581305|527074115|FG000|Serotonergic Study|Withdrawal by Subject|5|||
146153719|NCT03581305|527074116|FG001|Serotonergic Study|Withdrawal by Subject|1|||
146153720|NCT01798927|527074117|FG000|Overall Study|Withdrawal by Subject|1|||
146153721|NCT00626522|527074118|FG000|Overall Study|Protocol Violation|0|||
146153722|NCT00626522|527074119|FG001|Overall Study|Protocol Violation|0|||
146153723|NCT00626522|527074120|FG002|Overall Study|Protocol Violation|0|||
146153724|NCT00626522|527074121|FG003|Overall Study|Protocol Violation|0|||
146153725|NCT00626522|527074122|FG004|Overall Study|Protocol Violation|1|||
146153726|NCT00626522|527074123|FG005|Overall Study|Protocol Violation|0|||
146153727|NCT00626522|527074118|FG000|Overall Study|Adverse Event|2|||
146153728|NCT00626522|527074119|FG001|Overall Study|Adverse Event|1|||
146153729|NCT00626522|527074120|FG002|Overall Study|Adverse Event|2|||
146153730|NCT00626522|527074121|FG003|Overall Study|Adverse Event|0|||
146153731|NCT00626522|527074122|FG004|Overall Study|Adverse Event|1|||
146153732|NCT00626522|527074123|FG005|Overall Study|Adverse Event|1|||
146153733|NCT00626522|527074118|FG000|Overall Study|Withdrawal by Subject|2|||
146153734|NCT00626522|527074119|FG001|Overall Study|Withdrawal by Subject|5|||
146153735|NCT00626522|527074120|FG002|Overall Study|Withdrawal by Subject|5|||
146153736|NCT00626522|527074121|FG003|Overall Study|Withdrawal by Subject|0|||
146153737|NCT00626522|527074122|FG004|Overall Study|Withdrawal by Subject|4|||
146153738|NCT00626522|527074123|FG005|Overall Study|Withdrawal by Subject|1|||
146153739|NCT00626522|527074118|FG000|Overall Study|COPD exacerbation|0|||
146153740|NCT00626522|527074119|FG001|Overall Study|COPD exacerbation|0|||
146153741|NCT00626522|527074120|FG002|Overall Study|COPD exacerbation|0|||
146153742|NCT00626522|527074121|FG003|Overall Study|COPD exacerbation|1|||
146153743|NCT00626522|527074122|FG004|Overall Study|COPD exacerbation|1|||
146153744|NCT00626522|527074123|FG005|Overall Study|COPD exacerbation|0|||
146153745|NCT00626522|527074118|FG000|Overall Study|Lost to Follow-up|0|||
146153746|NCT00626522|527074119|FG001|Overall Study|Lost to Follow-up|1|||
146153747|NCT00626522|527074120|FG002|Overall Study|Lost to Follow-up|0|||
146153748|NCT00626522|527074121|FG003|Overall Study|Lost to Follow-up|0|||
146153749|NCT00626522|527074122|FG004|Overall Study|Lost to Follow-up|0|||
146153750|NCT00626522|527074123|FG005|Overall Study|Lost to Follow-up|0|||
146153751|NCT00626522|527074118|FG000|Overall Study|Inconsistent reason reported|1|||
146153752|NCT00626522|527074119|FG001|Overall Study|Inconsistent reason reported|0|||
146153753|NCT00626522|527074120|FG002|Overall Study|Inconsistent reason reported|0|||
146153754|NCT00626522|527074121|FG003|Overall Study|Inconsistent reason reported|0|||
146153755|NCT00626522|527074122|FG004|Overall Study|Inconsistent reason reported|0|||
146308832|NCT01438489|527645790|FG001|Overall Study|Subject choice/Subject moved|1|||
146308833|NCT01438489|527645791|FG002|Overall Study|Subject choice/Subject moved|1|||
146308834|NCT01438489|527645789|FG000|Overall Study|Investigator decision|0|||
146308835|NCT01438489|527645790|FG001|Overall Study|Investigator decision|1|||
146308836|NCT01438489|527645791|FG002|Overall Study|Investigator decision|0|||
146153756|NCT00626522|527074123|FG005|Overall Study|Inconsistent reason reported|0|||
146153757|NCT00626522|527074118|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146153758|NCT00626522|527074119|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146308837|NCT01438489|527645789|FG000|Overall Study|AE/SAEs|2|||
146308838|NCT01438489|527645790|FG001|Overall Study|AE/SAEs|1|||
146308839|NCT01438489|527645791|FG002|Overall Study|AE/SAEs|1|||
146153759|NCT00626522|527074120|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146153760|NCT00626522|527074121|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
146153761|NCT00626522|527074122|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146153762|NCT00626522|527074123|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
146153763|NCT00328510|527074130|FG000|Overall Study|Gag disorder, could not use frame|4|||
146153764|NCT00328510|527074131|FG001|Overall Study|Gag disorder, could not use frame|0|||
146308840|NCT01438489|527645789|FG000|Overall Study|Received prohibited medication|1|||
146153765|NCT00328510|527074130|FG000|Overall Study|Dentition problems, could not use frame|1|||
146153766|NCT00328510|527074131|FG001|Overall Study|Dentition problems, could not use frame|0|||
146153767|NCT00328510|527074130|FG000|Overall Study|Withdrawal by Subject|4|||
146153768|NCT00328510|527074131|FG001|Overall Study|Withdrawal by Subject|2|||
146153769|NCT00328510|527074130|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
146153770|NCT00328510|527074131|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
146153771|NCT00328510|527074130|FG000|Overall Study|Treatment changed to a single fraction|1|||
146153772|NCT00328510|527074131|FG001|Overall Study|Treatment changed to a single fraction|1|||
146153773|NCT01990950|527074133|FG000|Overall Study|Death|3|||
146153774|NCT01990950|527074133|FG000|Overall Study|Lost to Follow-up|2|||
146153775|NCT01990950|527074133|FG000|Overall Study|Withdrawal by Subject|6|||
146153776|NCT02349295|527074134|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
146153777|NCT02349295|527074135|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
146153778|NCT02349295|527074136|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
146153779|NCT02349295|527074137|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153780|NCT02349295|527074138|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153781|NCT02349295|527074139|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153782|NCT02349295|527074140|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153783|NCT02349295|527074141|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153784|NCT02349295|527074142|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153785|NCT02349295|527074143|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153786|NCT02349295|527074144|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153787|NCT02349295|527074145|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153788|NCT02349295|527074146|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153789|NCT02349295|527074147|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
146153790|NCT02349295|527074134|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
146153791|NCT02349295|527074135|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
146153792|NCT02349295|527074136|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
146153793|NCT02349295|527074137|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153794|NCT02349295|527074138|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153795|NCT02349295|527074139|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153796|NCT02349295|527074140|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153797|NCT02349295|527074141|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153798|NCT02349295|527074142|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153799|NCT02349295|527074143|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153800|NCT02349295|527074144|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153801|NCT02349295|527074145|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153802|NCT02349295|527074146|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153803|NCT02349295|527074147|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
146153804|NCT02349295|527074134|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
146153805|NCT02349295|527074135|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
146153806|NCT02349295|527074136|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
146153807|NCT02349295|527074137|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153808|NCT02349295|527074138|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153809|NCT02349295|527074139|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153810|NCT02349295|527074140|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153811|NCT02349295|527074141|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153812|NCT02349295|527074142|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153813|NCT02349295|527074143|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153814|NCT02349295|527074144|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153815|NCT02349295|527074145|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153816|NCT02349295|527074146|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153817|NCT02349295|527074147|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
146153818|NCT02349295|527074134|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
146153819|NCT02349295|527074135|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
146153820|NCT02349295|527074136|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
146153821|NCT02349295|527074137|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153822|NCT02349295|527074138|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153823|NCT02349295|527074139|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153824|NCT02349295|527074140|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146308841|NCT01438489|527645790|FG001|Overall Study|Received prohibited medication|0|||
146308842|NCT01438489|527645791|FG002|Overall Study|Received prohibited medication|0|||
146153825|NCT02349295|527074141|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153826|NCT02349295|527074142|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153827|NCT02349295|527074143|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146308843|NCT01438489|527645789|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
146153828|NCT02349295|527074144|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153829|NCT02349295|527074145|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153830|NCT02349295|527074146|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153831|NCT02349295|527074147|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
146153832|NCT02349295|527074134|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153833|NCT02349295|527074135|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
146153834|NCT02349295|527074136|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
146153835|NCT02349295|527074137|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153836|NCT02349295|527074138|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153837|NCT02349295|527074139|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153838|NCT02349295|527074140|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153839|NCT02349295|527074141|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153840|NCT02349295|527074142|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153841|NCT02349295|527074143|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153842|NCT02349295|527074144|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153843|NCT02349295|527074145|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153844|NCT02349295|527074146|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153845|NCT02349295|527074147|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
146153846|NCT02349295|527074134|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
146153847|NCT02349295|527074135|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
146153848|NCT02349295|527074136|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
146153849|NCT02349295|527074137|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
146153850|NCT02349295|527074138|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
146153851|NCT02349295|527074139|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
146153852|NCT02349295|527074140|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
146153853|NCT02349295|527074141|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
146153854|NCT02349295|527074142|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
146153855|NCT02349295|527074143|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
146153856|NCT02349295|527074144|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
146153857|NCT02349295|527074145|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
146153858|NCT02349295|527074146|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
146153859|NCT02349295|527074147|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
146153860|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153861|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153862|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153863|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153864|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153865|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153866|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153867|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
146153868|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
146153869|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
146153870|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
146153871|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153872|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153873|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
146153874|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153875|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153876|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153877|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153878|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153879|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153880|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153881|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
146153882|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
146153883|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
146153884|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
146153885|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153886|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153887|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
146153888|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153889|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153890|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153891|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153892|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153893|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153894|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153895|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
146153896|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153897|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
146153898|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153899|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153900|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153901|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
146153902|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
146153903|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
146153904|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
146153905|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
146153906|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
146153907|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
146153908|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
146153909|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
146153910|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
146153911|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
146153912|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
146153913|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
146153914|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
146153915|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
146153916|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153917|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153918|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153919|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153920|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153921|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153922|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153923|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
146153924|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
146153925|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
146153926|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
146153927|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153928|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153929|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
146153930|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153931|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153932|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153933|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153934|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153935|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153936|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153937|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
146153938|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
146153939|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153940|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146308844|NCT01438489|527645790|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
146308845|NCT01438489|527645791|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
146308846|NCT01438489|527645789|FG000|Overall Study|Inadequate venous access|0|||
146308847|NCT01438489|527645790|FG001|Overall Study|Inadequate venous access|2|||
146308848|NCT01438489|527645791|FG002|Overall Study|Inadequate venous access|0|||
146308849|NCT01476475|527645793|FG000|Overall Study|Adverse Event|6|||
146308850|NCT01476475|527645794|FG001|Overall Study|Adverse Event|0|||
146308851|NCT01476475|527645793|FG000|Overall Study|Poor compliance to protocol|1|||
146308852|NCT01476475|527645794|FG001|Overall Study|Poor compliance to protocol|1|||
146308853|NCT01476475|527645793|FG000|Overall Study|Other reasons|4|||
146308854|NCT01476475|527645794|FG001|Overall Study|Other reasons|2|||
146308855|NCT00751400|527645798|FG000|Overall Study|Lost to Follow-up|10|||
146308856|NCT01372384|527645801|FG000|Overall Study|Progression of disease|3|||
146308857|NCT00441974|527645805|FG000|Overall Study|Adverse Event|6|||
146308858|NCT00441974|527645805|FG000|Overall Study|Consent Withdrawn|35|||
146308859|NCT00441974|527645805|FG000|Overall Study|Lost to Follow-up|80|||
146308860|NCT00441974|527645805|FG000|Overall Study|Protocol Violation|7|||
146308861|NCT00661531|527645808|FG000|Overall Study|Withdrawal by Subject|3|||
146308862|NCT03134599|527645809|FG000|Week 1|Lost to Follow-up|0|||
146308863|NCT03134599|527645810|FG001|Week 1|Lost to Follow-up|0|||
146308864|NCT03134599|527645811|FG002|Week 1|Lost to Follow-up|0|||
146308865|NCT03134599|527645812|FG003|Week 1|Lost to Follow-up|0|||
146308866|NCT03134599|527645813|FG004|Week 1|Lost to Follow-up|1|||
146308867|NCT03134599|527645814|FG005|Week 1|Lost to Follow-up|0|||
146308868|NCT03134599|527645809|FG000|Week 2|Lost to Follow-up|1|||
146308869|NCT03134599|527645810|FG001|Week 2|Lost to Follow-up|0|||
146308870|NCT03134599|527645811|FG002|Week 2|Lost to Follow-up|0|||
146308871|NCT03134599|527645812|FG003|Week 2|Lost to Follow-up|1|||
146308872|NCT03134599|527645813|FG004|Week 2|Lost to Follow-up|1|||
146308873|NCT03134599|527645814|FG005|Week 2|Lost to Follow-up|0|||
146308874|NCT03134599|527645809|FG000|Week 3|Lost to Follow-up|0|||
146308875|NCT03134599|527645810|FG001|Week 3|Lost to Follow-up|0|||
146308876|NCT03134599|527645811|FG002|Week 3|Lost to Follow-up|0|||
146308877|NCT03134599|527645812|FG003|Week 3|Lost to Follow-up|1|||
146308878|NCT03134599|527645813|FG004|Week 3|Lost to Follow-up|0|||
146308879|NCT03134599|527645814|FG005|Week 3|Lost to Follow-up|1|||
146308880|NCT01265615|527645815|FG000|Overall Study|Protocol Violation|2|||
146308881|NCT01265615|527645816|FG001|Overall Study|Protocol Violation|2|||
146308882|NCT01265615|527645817|FG002|Overall Study|Protocol Violation|4|||
146308883|NCT01265615|527645818|FG003|Overall Study|Protocol Violation|3|||
146308884|NCT02576444|527645825|FG000|Overall Study|Death|1|||
146308885|NCT02576444|527645826|FG001|Overall Study|Death|1|||
146308886|NCT02576444|527645827|FG002|Overall Study|Death|0|||
146308887|NCT02576444|527645828|FG003|Overall Study|Death|0|||
146308888|NCT02576444|527645825|FG000|Overall Study|Withdrawal by Subject|0|||
146308889|NCT02576444|527645826|FG001|Overall Study|Withdrawal by Subject|0|||
146308890|NCT02576444|527645827|FG002|Overall Study|Withdrawal by Subject|2|||
146308891|NCT02576444|527645828|FG003|Overall Study|Withdrawal by Subject|0|||
146308892|NCT02576444|527645825|FG000|Overall Study|Adverse Event|0|||
146153941|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153942|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153943|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
146153944|NCT02349295|527074134|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153945|NCT02349295|527074135|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153946|NCT02349295|527074136|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153947|NCT02349295|527074137|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153948|NCT02349295|527074138|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153949|NCT02349295|527074139|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153950|NCT02349295|527074140|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153951|NCT02349295|527074141|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
146153952|NCT02349295|527074142|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
146153953|NCT02349295|527074143|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146308893|NCT02576444|527645826|FG001|Overall Study|Adverse Event|0|||
146308894|NCT02576444|527645827|FG002|Overall Study|Adverse Event|1|||
146308895|NCT02576444|527645828|FG003|Overall Study|Adverse Event|0|||
146308896|NCT02576444|527645825|FG000|Overall Study|Physician Decision|0|||
146308897|NCT02576444|527645826|FG001|Overall Study|Physician Decision|0|||
146308898|NCT02576444|527645827|FG002|Overall Study|Physician Decision|1|||
146308899|NCT02576444|527645828|FG003|Overall Study|Physician Decision|0|||
146308900|NCT03370120|527645831|FG000|Overall Study|Adverse event, non-fatal|24|||
146308901|NCT03370120|527645831|FG000|Overall Study|Withdrawal by Subject|6|||
146308902|NCT03370120|527645831|FG000|Overall Study|Lost to Follow-up|1|||
146308903|NCT03370120|527645831|FG000|Overall Study|Lack of Efficacy|37|||
146308904|NCT03370120|527645831|FG000|Overall Study|Per sponsor's instructions|1|||
146308905|NCT03370120|527645831|FG000|Overall Study|Study was terminated by parent company UCB|2|||
146308906|NCT03370120|527645831|FG000|Overall Study|The study was ended by the promoter|3|||
146308907|NCT03370120|527645831|FG000|Overall Study|Discontinuation of drug development|3|||
146308908|NCT03370120|527645831|FG000|Overall Study|End of project|2|||
146308909|NCT03370120|527645831|FG000|Overall Study|Premature study closure|2|||
146308910|NCT03370120|527645831|FG000|Overall Study|Premature program termination|1|||
146153954|NCT02349295|527074144|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153955|NCT02349295|527074145|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153956|NCT02349295|527074146|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153957|NCT02349295|527074147|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
146153958|NCT02349295|527074134|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146308911|NCT03370120|527645831|FG000|Overall Study|Premature study termination|7|||
146308912|NCT03370120|527645831|FG000|Overall Study|Trial terminated by sponsor|2|||
146308913|NCT03370120|527645831|FG000|Overall Study|Trial discontinued by sponsor|2|||
146308914|NCT03370120|527645831|FG000|Overall Study|Study ended|15|||
146308915|NCT03370120|527645831|FG000|Overall Study|Clinical trial has been cancelled|1|||
146308916|NCT03370120|527645831|FG000|Overall Study|End of study per sponsor decision|2|||
146308917|NCT03370120|527645831|FG000|Overall Study|Promoter's decision|2|||
146308918|NCT03370120|527645831|FG000|Overall Study|The trial has been suspended|3|||
146308919|NCT03370120|527645831|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
146308920|NCT03370120|527645831|FG000|Overall Study|Early termination by order of sponsor|2|||
146308921|NCT03370120|527645831|FG000|Overall Study|Discontinuation of the study|5|||
146308922|NCT03370120|527645831|FG000|Overall Study|End of clinical trial discontinuation|1|||
146308923|NCT03370120|527645831|FG000|Overall Study|Because the clinical trial ended halfway|4|||
146308924|NCT03370120|527645831|FG000|Overall Study|Development discontinued|5|||
146308925|NCT03370120|527645831|FG000|Overall Study|Padsenovil program closed|3|||
146308926|NCT03370120|527645831|FG000|Overall Study|End of project|2|||
146308927|NCT03370120|527645831|FG000|Overall Study|Termination of project|1|||
146308928|NCT03370120|527645831|FG000|Overall Study|The study was interrupted by sponsor|4|||
146308929|NCT03370120|527645831|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
146153959|NCT02349295|527074135|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153960|NCT02349295|527074136|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153961|NCT02349295|527074137|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153962|NCT02349295|527074138|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153963|NCT02349295|527074139|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153964|NCT02349295|527074140|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153965|NCT02349295|527074141|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153966|NCT02349295|527074142|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153967|NCT02349295|527074143|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146153968|NCT02349295|527074144|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
146308930|NCT03370120|527645831|FG000|Overall Study|End of sponsor decision|1|||
146308931|NCT03370120|527645831|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
146308932|NCT03370120|527645831|FG000|Overall Study|Early termination of studies|5|||
146308933|NCT03370120|527645831|FG000|Overall Study|This study is ended early|1|||
146308934|NCT03370120|527645831|FG000|Overall Study|End of padsevonil program|2|||
146308935|NCT03370120|527645831|FG000|Overall Study|Decision of sponsor|6|||
146308936|NCT03370120|527645831|FG000|Overall Study|Asked by the sponsor|3|||
146308937|NCT03370120|527645831|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
146308938|NCT03370120|527645831|FG000|Overall Study|PI decision poor compliance from participant|1|||
146308939|NCT03370120|527645831|FG000|Overall Study|Promoter ended the study|3|||
146308940|NCT03370120|527645831|FG000|Overall Study|Premature study close by sponsor's decision|4|||
146308941|NCT03370120|527645831|FG000|Overall Study|Study terminated by sponsor|33|||
146308942|NCT03370120|527645831|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
146308943|NCT03370120|527645831|FG000|Overall Study|Sponsor decision to terminate study|63|||
146308944|NCT03370120|527645831|FG000|Overall Study|Program closure|3|||
146308945|NCT03370120|527645831|FG000|Overall Study|Study ended prematurely|1|||
146308946|NCT03370120|527645831|FG000|Overall Study|Study stopped by sponsor|2|||
146308947|NCT03370120|527645831|FG000|Overall Study|Program termination|55|||
146308948|NCT03370120|527645831|FG000|Overall Study|Sponsor decision|62|||
146308949|NCT03370120|527645831|FG000|Overall Study|Sponsor study closure|10|||
146308950|NCT02700412|527645832|FG000|Overall Study|Adverse Event|6|||
146308951|NCT02700412|527645832|FG000|Overall Study|Death|1|||
146308952|NCT02700412|527645832|FG000|Overall Study|Lack of Efficacy|19|||
146308953|NCT02700412|527645832|FG000|Overall Study|Protocol Violation|5|||
146308954|NCT02700412|527645832|FG000|Overall Study|Withdrawal by Subject|2|||
146308955|NCT04206020|527645833|FG000|Overall Study|Adverse Event|1|||
146308956|NCT04206020|527645834|FG001|Overall Study|Adverse Event|4|||
146308957|NCT04206020|527645833|FG000|Overall Study|Protocol Violation|2|||
146308958|NCT04206020|527645834|FG001|Overall Study|Protocol Violation|0|||
146308959|NCT04206020|527645833|FG000|Overall Study|Withdrawal by Subject|2|||
146308960|NCT04206020|527645834|FG001|Overall Study|Withdrawal by Subject|0|||
146308961|NCT04206020|527645833|FG000|Overall Study|Lost to Follow-up|2|||
146308962|NCT04206020|527645834|FG001|Overall Study|Lost to Follow-up|0|||
146308963|NCT04206020|527645833|FG000|Overall Study|Pregnancy|0|||
146308964|NCT04206020|527645834|FG001|Overall Study|Pregnancy|1|||
146308965|NCT04206020|527645833|FG000|Overall Study|Unable to attend visits|1|||
146308966|NCT04206020|527645834|FG001|Overall Study|Unable to attend visits|2|||
146308967|NCT04962022|527645838|FG000|Period 1|Withdrawal by Subject|1|||
146308968|NCT04962022|527645839|FG001|Period 1|Withdrawal by Subject|0|||
146308969|NCT04416555|527645840|FG000|Overall Study|Withdrawal by Subject|0|||
146308970|NCT04416555|527645841|FG001|Overall Study|Withdrawal by Subject|3|||
146308971|NCT00530270|527645842|FG000|Overall Study|Protocol Violation|1|||
146308972|NCT00530270|527645843|FG001|Overall Study|Protocol Violation|0|||
146308973|NCT01356407|527645852|FG000|Overall Study|Lost to Follow-up|2|||
146308974|NCT01356407|527645853|FG001|Overall Study|Lost to Follow-up|0|||
146308975|NCT01356407|527645852|FG000|Overall Study|Patient Withdrew Consent|2|||
146308976|NCT01356407|527645853|FG001|Overall Study|Patient Withdrew Consent|1|||
146308977|NCT01356407|527645852|FG000|Overall Study|Could not afford IMP administration|0|||
146308978|NCT01356407|527645853|FG001|Overall Study|Could not afford IMP administration|1|||
146308979|NCT01356407|527645852|FG000|Overall Study|Not complete Endoscopy|2|||
146308980|NCT01356407|527645853|FG001|Overall Study|Not complete Endoscopy|2|||
146308981|NCT01309659|527645854|FG000|Overall Study|Protocol Violation|0|||
146308982|NCT01309659|527645855|FG001|Overall Study|Protocol Violation|1|||
146308983|NCT02018822|527645856|FG000|Overall Study|filling replaced by crown|0|||
146308984|NCT02018822|527645857|FG001|Overall Study|filling replaced by crown|1|||
146308985|NCT02018822|527645858|FG002|Overall Study|filling replaced by crown|0|||
146153969|NCT02349295|527074145|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
146153970|NCT02349295|527074146|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
146153971|NCT02349295|527074147|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
146153972|NCT02349295|527074134|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153973|NCT02349295|527074135|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153974|NCT02349295|527074136|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153975|NCT02349295|527074137|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153976|NCT02349295|527074138|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153977|NCT02349295|527074139|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153978|NCT02349295|527074140|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153979|NCT02349295|527074141|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153980|NCT02349295|527074142|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153981|NCT02349295|527074143|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153982|NCT02349295|527074144|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153983|NCT02349295|527074145|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
146153984|NCT02349295|527074146|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
146153985|NCT02349295|527074147|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
146153986|NCT02349295|527074134|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153987|NCT02349295|527074135|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153988|NCT02349295|527074136|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153989|NCT02349295|527074137|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153990|NCT02349295|527074138|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153991|NCT02349295|527074139|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153992|NCT02349295|527074140|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153993|NCT02349295|527074141|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153994|NCT02349295|527074142|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153995|NCT02349295|527074143|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153996|NCT02349295|527074144|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146153997|NCT02349295|527074145|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
146153998|NCT02349295|527074146|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
146153999|NCT02349295|527074147|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
146154000|NCT02349295|527074134|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154001|NCT02349295|527074135|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154002|NCT02349295|527074136|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154003|NCT02349295|527074137|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154004|NCT02349295|527074138|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154005|NCT02349295|527074139|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154006|NCT02349295|527074140|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154007|NCT02349295|527074141|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154008|NCT02349295|527074142|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154009|NCT02349295|527074143|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154010|NCT02349295|527074144|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154011|NCT02349295|527074145|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
146154012|NCT02349295|527074146|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154013|NCT02349295|527074147|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
146154014|NCT02349295|527074134|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154015|NCT02349295|527074135|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154016|NCT02349295|527074136|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154017|NCT02349295|527074137|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154018|NCT02349295|527074138|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154019|NCT02349295|527074139|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154020|NCT02349295|527074140|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154021|NCT02349295|527074141|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154022|NCT02349295|527074142|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154023|NCT02349295|527074143|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154024|NCT02349295|527074144|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154025|NCT02349295|527074145|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
146154026|NCT02349295|527074146|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154027|NCT02349295|527074147|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
146154028|NCT06111742|527074156|FG000|Overall Study|Did not receive intervention|1|||
146154029|NCT06111742|527074157|FG001|Overall Study|Did not receive intervention|0|||
146154030|NCT06111742|527074158|FG002|Overall Study|Did not receive intervention|0|||
146154031|NCT06111742|527074156|FG000|Overall Study|Withdrawal by Subject|2|||
146154032|NCT06111742|527074157|FG001|Overall Study|Withdrawal by Subject|0|||
146154033|NCT06111742|527074158|FG002|Overall Study|Withdrawal by Subject|0|||
146154034|NCT01914926|527074159|FG000|Overall Study|Adverse Event|1|||
146154035|NCT01914926|527074160|FG001|Overall Study|Adverse Event|0|||
146154036|NCT01914926|527074159|FG000|Overall Study|uncooperative, agitated and removed|0|||
146154037|NCT01914926|527074160|FG001|Overall Study|uncooperative, agitated and removed|1|||
146154038|NCT03489304|527074161|FG000|Overall Study|Lost to Follow-up|4|||
146154039|NCT02239679|527074162|FG000|Overall Study|Lost to Follow-up|1|||
146154040|NCT02239679|527074163|FG001|Overall Study|Lost to Follow-up|0|||
146154041|NCT02239679|527074164|FG002|Overall Study|Lost to Follow-up|0|||
146154042|NCT02239679|527074162|FG000|Overall Study|Withdrawal by Subject|2|||
146154043|NCT02239679|527074163|FG001|Overall Study|Withdrawal by Subject|3|||
146154044|NCT02239679|527074164|FG002|Overall Study|Withdrawal by Subject|1|||
146154045|NCT02605954|527074166|FG000|Overall Study|Adverse Event|5|||
146154046|NCT02605954|527074167|FG001|Overall Study|Adverse Event|1|||
146154047|NCT02605954|527074166|FG000|Overall Study|Investigator's Discretion|1|||
146154048|NCT02605954|527074167|FG001|Overall Study|Investigator's Discretion|0|||
146154049|NCT02605954|527074166|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146154050|NCT02605954|527074167|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146154051|NCT02605954|527074166|FG000|Overall Study|Withdrew Consent|2|||
146154052|NCT02605954|527074167|FG001|Overall Study|Withdrew Consent|2|||
146154053|NCT02605954|527074166|FG000|Overall Study|Lost to Follow-up|3|||
146154054|NCT02605954|527074167|FG001|Overall Study|Lost to Follow-up|0|||
146154055|NCT02605954|527074166|FG000|Overall Study|Randomized but not treated|0|||
146154056|NCT02605954|527074167|FG001|Overall Study|Randomized but not treated|1|||
146154057|NCT02301143|527074168|FG000|Induction Period|Enrolled But Not Treated|1|||
146154058|NCT02301143|527074169|FG001|Induction Period|Enrolled But Not Treated|0|||
146154059|NCT02301143|527074168|FG000|Induction Period|Death|1|||
146154060|NCT02301143|527074169|FG001|Induction Period|Death|0|||
146154061|NCT02301143|527074168|FG000|Induction Period|Adverse Event|22|||
146154062|NCT02301143|527074169|FG001|Induction Period|Adverse Event|0|||
146154063|NCT02301143|527074168|FG000|Induction Period|Progressive Disease|8|||
146154064|NCT02301143|527074169|FG001|Induction Period|Progressive Disease|0|||
146154065|NCT02301143|527074168|FG000|Induction Period|Withdrawal by Subject|3|||
146154066|NCT02301143|527074169|FG001|Induction Period|Withdrawal by Subject|0|||
146154067|NCT02301143|527074168|FG000|Induction Period|Noncompliance with Study Drug|1|||
146154068|NCT02301143|527074169|FG001|Induction Period|Noncompliance with Study Drug|0|||
146154069|NCT02301143|527074168|FG000|Induction Period|Physician Decision|4|||
146154070|NCT02301143|527074169|FG001|Induction Period|Physician Decision|0|||
146154071|NCT02301143|527074168|FG000|Induction Period|Symptomatic Deterioration|2|||
146154072|NCT02301143|527074169|FG001|Induction Period|Symptomatic Deterioration|0|||
146154073|NCT02301143|527074168|FG000|Induction Period|Protocol Violation|2|||
146154074|NCT02301143|527074169|FG001|Induction Period|Protocol Violation|0|||
146154075|NCT02301143|527074168|FG000|Induction Period|Other|1|||
146154076|NCT02301143|527074169|FG001|Induction Period|Other|0|||
146154077|NCT02301143|527074168|FG000|Investigator's Choice|Adverse Event|0|||
146154078|NCT02301143|527074169|FG001|Investigator's Choice|Adverse Event|3|||
146154079|NCT02301143|527074168|FG000|Investigator's Choice|Progressive Disease|0|||
146308986|NCT02018822|527645856|FG000|Overall Study|Physician Decision|0|||
146154080|NCT02301143|527074169|FG001|Investigator's Choice|Progressive Disease|3|||
146154081|NCT02301143|527074168|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
146154082|NCT02301143|527074169|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
146154083|NCT02301143|527074168|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
146154084|NCT02301143|527074169|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
146154085|NCT02301143|527074168|FG000|Investigator's Choice|Other|0|||
146154086|NCT02301143|527074169|FG001|Investigator's Choice|Other|1|||
146154087|NCT02301143|527074168|FG000|Investigator's Choice|Unresectable Surgery|0|||
146308987|NCT02018822|527645857|FG001|Overall Study|Physician Decision|1|||
146308988|NCT02018822|527645858|FG002|Overall Study|Physician Decision|1|||
146308989|NCT02018822|527645856|FG000|Overall Study|Lost to Follow-up|6|||
146154088|NCT02301143|527074169|FG001|Investigator's Choice|Unresectable Surgery|1|||
146154089|NCT03214367|527074170|FG000|Lead-in Period|Withdrawal by Subject|50|||
146154090|NCT03214367|527074171|FG001|Lead-in Period|Withdrawal by Subject|0|||
146154091|NCT03214367|527074172|FG002|Lead-in Period|Withdrawal by Subject|0|||
146154092|NCT03214367|527074173|FG003|Lead-in Period|Withdrawal by Subject|0|||
146154093|NCT03214367|527074174|FG004|Lead-in Period|Withdrawal by Subject|2|||
146308990|NCT02018822|527645857|FG001|Overall Study|Lost to Follow-up|6|||
146154094|NCT03214367|527074175|FG005|Lead-in Period|Withdrawal by Subject|0|||
146154095|NCT03214367|527074176|FG006|Lead-in Period|Withdrawal by Subject|0|||
146154096|NCT03214367|527074177|FG007|Lead-in Period|Withdrawal by Subject|0|||
146154097|NCT03214367|527074170|FG000|Lead-in Period|Adverse Event|3|||
146154098|NCT03214367|527074171|FG001|Lead-in Period|Adverse Event|0|||
146154099|NCT03214367|527074172|FG002|Lead-in Period|Adverse Event|0|||
146154100|NCT03214367|527074173|FG003|Lead-in Period|Adverse Event|0|||
146154101|NCT03214367|527074174|FG004|Lead-in Period|Adverse Event|0|||
146308991|NCT02018822|527645858|FG002|Overall Study|Lost to Follow-up|5|||
146154102|NCT03214367|527074175|FG005|Lead-in Period|Adverse Event|0|||
146154103|NCT03214367|527074176|FG006|Lead-in Period|Adverse Event|0|||
146154104|NCT03214367|527074177|FG007|Lead-in Period|Adverse Event|0|||
146308992|NCT03201458|527645859|FG000|Overall Study|No longer eligible|2|||
146154105|NCT03214367|527074170|FG000|Lead-in Period|Lost to Follow-up|12|||
146154106|NCT03214367|527074171|FG001|Lead-in Period|Lost to Follow-up|0|||
146154107|NCT03214367|527074172|FG002|Lead-in Period|Lost to Follow-up|0|||
146154108|NCT03214367|527074173|FG003|Lead-in Period|Lost to Follow-up|0|||
146154109|NCT03214367|527074174|FG004|Lead-in Period|Lost to Follow-up|0|||
146154110|NCT03214367|527074175|FG005|Lead-in Period|Lost to Follow-up|0|||
146154111|NCT03214367|527074176|FG006|Lead-in Period|Lost to Follow-up|0|||
146154112|NCT03214367|527074177|FG007|Lead-in Period|Lost to Follow-up|0|||
146154113|NCT03214367|527074170|FG000|Lead-in Period|Sponsor Decision|11|||
146154114|NCT03214367|527074171|FG001|Lead-in Period|Sponsor Decision|0|||
146154115|NCT03214367|527074172|FG002|Lead-in Period|Sponsor Decision|0|||
146154116|NCT03214367|527074173|FG003|Lead-in Period|Sponsor Decision|0|||
146154117|NCT03214367|527074174|FG004|Lead-in Period|Sponsor Decision|0|||
146154118|NCT03214367|527074175|FG005|Lead-in Period|Sponsor Decision|0|||
146154119|NCT03214367|527074176|FG006|Lead-in Period|Sponsor Decision|0|||
146154120|NCT03214367|527074177|FG007|Lead-in Period|Sponsor Decision|0|||
146154121|NCT03214367|527074170|FG000|Lead-in Period|Physician Decision|12|||
146154122|NCT03214367|527074171|FG001|Lead-in Period|Physician Decision|0|||
146154123|NCT03214367|527074172|FG002|Lead-in Period|Physician Decision|0|||
146154124|NCT03214367|527074173|FG003|Lead-in Period|Physician Decision|0|||
146154125|NCT03214367|527074174|FG004|Lead-in Period|Physician Decision|0|||
146154126|NCT03214367|527074175|FG005|Lead-in Period|Physician Decision|0|||
146154127|NCT03214367|527074176|FG006|Lead-in Period|Physician Decision|0|||
146154128|NCT03214367|527074177|FG007|Lead-in Period|Physician Decision|0|||
146154129|NCT03214367|527074170|FG000|Lead-in Period|Protocol Violation|5|||
146154130|NCT03214367|527074171|FG001|Lead-in Period|Protocol Violation|0|||
146154131|NCT03214367|527074172|FG002|Lead-in Period|Protocol Violation|0|||
146154132|NCT03214367|527074173|FG003|Lead-in Period|Protocol Violation|0|||
146154133|NCT03214367|527074174|FG004|Lead-in Period|Protocol Violation|0|||
146154134|NCT03214367|527074175|FG005|Lead-in Period|Protocol Violation|0|||
146154135|NCT03214367|527074176|FG006|Lead-in Period|Protocol Violation|0|||
146154136|NCT03214367|527074177|FG007|Lead-in Period|Protocol Violation|0|||
146154137|NCT03214367|527074170|FG000|Lead-in Period|Treatment Interruption|1|||
146154138|NCT03214367|527074171|FG001|Lead-in Period|Treatment Interruption|0|||
146154139|NCT03214367|527074172|FG002|Lead-in Period|Treatment Interruption|0|||
146154140|NCT03214367|527074173|FG003|Lead-in Period|Treatment Interruption|0|||
146154141|NCT03214367|527074174|FG004|Lead-in Period|Treatment Interruption|0|||
146154142|NCT03214367|527074175|FG005|Lead-in Period|Treatment Interruption|0|||
146154143|NCT03214367|527074176|FG006|Lead-in Period|Treatment Interruption|0|||
146154144|NCT03214367|527074177|FG007|Lead-in Period|Treatment Interruption|0|||
146154145|NCT03214367|527074170|FG000|Treatment Period|Adverse Event|0|||
146154146|NCT03214367|527074171|FG001|Treatment Period|Adverse Event|1|||
146154147|NCT03214367|527074172|FG002|Treatment Period|Adverse Event|4|||
146154148|NCT03214367|527074173|FG003|Treatment Period|Adverse Event|2|||
146154149|NCT03214367|527074174|FG004|Treatment Period|Adverse Event|0|||
146154150|NCT03214367|527074175|FG005|Treatment Period|Adverse Event|0|||
146154151|NCT03214367|527074176|FG006|Treatment Period|Adverse Event|0|||
146154152|NCT03214367|527074177|FG007|Treatment Period|Adverse Event|0|||
146154153|NCT03214367|527074170|FG000|Treatment Period|Death|0|||
146154154|NCT03214367|527074171|FG001|Treatment Period|Death|1|||
146154155|NCT03214367|527074172|FG002|Treatment Period|Death|1|||
146154156|NCT03214367|527074173|FG003|Treatment Period|Death|1|||
146154157|NCT03214367|527074174|FG004|Treatment Period|Death|0|||
146154158|NCT03214367|527074175|FG005|Treatment Period|Death|0|||
146154159|NCT03214367|527074176|FG006|Treatment Period|Death|0|||
146154160|NCT03214367|527074177|FG007|Treatment Period|Death|0|||
146154161|NCT03214367|527074170|FG000|Treatment Period|Lost to Follow-up|0|||
146154162|NCT03214367|527074171|FG001|Treatment Period|Lost to Follow-up|5|||
146154163|NCT03214367|527074172|FG002|Treatment Period|Lost to Follow-up|3|||
146154164|NCT03214367|527074173|FG003|Treatment Period|Lost to Follow-up|2|||
146308993|NCT03201458|527645860|FG001|Overall Study|No longer eligible|5|||
146308994|NCT03201458|527645859|FG000|Overall Study|Health event before starting|1|||
146308995|NCT03201458|527645860|FG001|Overall Study|Health event before starting|0|||
146308996|NCT03201458|527645859|FG000|Overall Study|Physician Decision|1|||
146308997|NCT03201458|527645860|FG001|Overall Study|Physician Decision|0|||
146308998|NCT00715026|527645863|FG000|Overall Study|Withdrawal by Subject|5|||
146308999|NCT00715026|527645863|FG000|Overall Study|Lost to Follow-up|3|||
146154165|NCT03214367|527074174|FG004|Treatment Period|Lost to Follow-up|0|||
146154166|NCT03214367|527074175|FG005|Treatment Period|Lost to Follow-up|2|||
146154167|NCT03214367|527074176|FG006|Treatment Period|Lost to Follow-up|1|||
146154168|NCT03214367|527074177|FG007|Treatment Period|Lost to Follow-up|0|||
146154169|NCT03214367|527074170|FG000|Treatment Period|Sponsor Decision|0|||
146309000|NCT00715026|527645863|FG000|Overall Study|Protocol Violation|1|||
146309001|NCT00715026|527645863|FG000|Overall Study|Surgery done on non-study consented hip|1|||
146154170|NCT03214367|527074171|FG001|Treatment Period|Sponsor Decision|3|||
146154171|NCT03214367|527074172|FG002|Treatment Period|Sponsor Decision|0|||
146154172|NCT03214367|527074173|FG003|Treatment Period|Sponsor Decision|0|||
146154173|NCT03214367|527074174|FG004|Treatment Period|Sponsor Decision|0|||
146154174|NCT03214367|527074175|FG005|Treatment Period|Sponsor Decision|0|||
146154175|NCT03214367|527074176|FG006|Treatment Period|Sponsor Decision|0|||
146154176|NCT03214367|527074177|FG007|Treatment Period|Sponsor Decision|0|||
146154177|NCT03214367|527074170|FG000|Treatment Period|Physician Decision|0|||
146154178|NCT03214367|527074171|FG001|Treatment Period|Physician Decision|1|||
146154179|NCT03214367|527074172|FG002|Treatment Period|Physician Decision|2|||
146154180|NCT03214367|527074173|FG003|Treatment Period|Physician Decision|0|||
146154181|NCT03214367|527074174|FG004|Treatment Period|Physician Decision|0|||
146154182|NCT03214367|527074175|FG005|Treatment Period|Physician Decision|0|||
146154183|NCT03214367|527074176|FG006|Treatment Period|Physician Decision|0|||
146154184|NCT03214367|527074177|FG007|Treatment Period|Physician Decision|0|||
146154185|NCT03214367|527074170|FG000|Treatment Period|Protocol Violation|0|||
146154186|NCT03214367|527074171|FG001|Treatment Period|Protocol Violation|3|||
146154187|NCT03214367|527074172|FG002|Treatment Period|Protocol Violation|0|||
146154188|NCT03214367|527074173|FG003|Treatment Period|Protocol Violation|0|||
146154189|NCT03214367|527074174|FG004|Treatment Period|Protocol Violation|0|||
146154190|NCT03214367|527074175|FG005|Treatment Period|Protocol Violation|0|||
146154191|NCT03214367|527074176|FG006|Treatment Period|Protocol Violation|0|||
146154192|NCT03214367|527074177|FG007|Treatment Period|Protocol Violation|0|||
146154193|NCT03214367|527074170|FG000|Treatment Period|Withdrawal by Subject|0|||
146154194|NCT03214367|527074171|FG001|Treatment Period|Withdrawal by Subject|20|||
146154195|NCT03214367|527074172|FG002|Treatment Period|Withdrawal by Subject|23|||
146154196|NCT03214367|527074173|FG003|Treatment Period|Withdrawal by Subject|14|||
146154197|NCT03214367|527074174|FG004|Treatment Period|Withdrawal by Subject|0|||
146154198|NCT03214367|527074175|FG005|Treatment Period|Withdrawal by Subject|1|||
146154199|NCT03214367|527074176|FG006|Treatment Period|Withdrawal by Subject|1|||
146154200|NCT03214367|527074177|FG007|Treatment Period|Withdrawal by Subject|1|||
146154201|NCT03508843|527074178|FG000|Overall Study|Withdrawal by Subject|1|||
146154202|NCT03508843|527074178|FG000|Overall Study|technical difficulties|2|||
146154203|NCT04717596|527074179|FG000|Overall Study|Withdrawal by Subject|4|||
146154204|NCT03555396|527074180|FG000|Overall Study|Death|3|||
146154205|NCT03555396|527074181|FG001|Overall Study|Death|1|||
146154206|NCT03555396|527074180|FG000|Overall Study|Lost to Follow-up|0|||
146154207|NCT03555396|527074181|FG001|Overall Study|Lost to Follow-up|2|||
146154208|NCT02536508|527074182|FG000|Overall Study|Withdrawal by Subject|18|||
146154209|NCT02536508|527074183|FG001|Overall Study|Withdrawal by Subject|13|||
146154210|NCT02536508|527074184|FG002|Overall Study|Withdrawal by Subject|7|||
146154211|NCT02536508|527074182|FG000|Overall Study|Adverse Event|14|||
146154212|NCT02536508|527074183|FG001|Overall Study|Adverse Event|13|||
146154213|NCT02536508|527074184|FG002|Overall Study|Adverse Event|6|||
146154214|NCT02536508|527074182|FG000|Overall Study|Lost to Follow-up|12|||
146154215|NCT02536508|527074183|FG001|Overall Study|Lost to Follow-up|4|||
146154216|NCT02536508|527074184|FG002|Overall Study|Lost to Follow-up|0|||
146154217|NCT02536508|527074182|FG000|Overall Study|Lack of Efficacy|3|||
146154218|NCT02536508|527074183|FG001|Overall Study|Lack of Efficacy|5|||
146154219|NCT02536508|527074184|FG002|Overall Study|Lack of Efficacy|4|||
146154220|NCT02536508|527074182|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
146154221|NCT02536508|527074183|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
146154222|NCT02536508|527074184|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
146154223|NCT02536508|527074182|FG000|Overall Study|Physician Decision|0|||
146154224|NCT02536508|527074183|FG001|Overall Study|Physician Decision|4|||
146154225|NCT02536508|527074184|FG002|Overall Study|Physician Decision|2|||
146154226|NCT02536508|527074182|FG000|Overall Study|Major Protocol Deviation|2|||
146154227|NCT02536508|527074183|FG001|Overall Study|Major Protocol Deviation|2|||
146154228|NCT02536508|527074184|FG002|Overall Study|Major Protocol Deviation|2|||
146154229|NCT02536508|527074182|FG000|Overall Study|Administrative Reasons|0|||
146154230|NCT02536508|527074183|FG001|Overall Study|Administrative Reasons|1|||
146154231|NCT02536508|527074184|FG002|Overall Study|Administrative Reasons|0|||
146154232|NCT02473952|527074186|FG000|Overall Study|Adverse Event|2|||
146154233|NCT02473952|527074187|FG001|Overall Study|Adverse Event|2|||
146154234|NCT02473952|527074186|FG000|Overall Study|Withdrawal by Subject|0|||
146154235|NCT02473952|527074187|FG001|Overall Study|Withdrawal by Subject|6|||
146154236|NCT04955639|527074190|FG000|Overall Study|Withdrawal by Subject|2|||
146154237|NCT04955639|527074191|FG001|Overall Study|Withdrawal by Subject|2|||
146154238|NCT04955639|527074190|FG000|Overall Study|Week 26 survey not completed|2|||
146154239|NCT04955639|527074191|FG001|Overall Study|Week 26 survey not completed|2|||
146154240|NCT01369342|527074192|FG000|Overall Study|Withdrawal by Subject|7|||
146154241|NCT01369342|527074193|FG001|Overall Study|Withdrawal by Subject|7|||
146154242|NCT01369342|527074194|FG002|Overall Study|Withdrawal by Subject|2|||
146154243|NCT01369342|527074192|FG000|Overall Study|Lost to Follow-up|5|||
146154244|NCT01369342|527074193|FG001|Overall Study|Lost to Follow-up|2|||
146154245|NCT01369342|527074194|FG002|Overall Study|Lost to Follow-up|1|||
146154246|NCT01369342|527074192|FG000|Overall Study|Not Treated|1|||
146154247|NCT01369342|527074193|FG001|Overall Study|Not Treated|0|||
146154248|NCT01369342|527074194|FG002|Overall Study|Not Treated|0|||
146154249|NCT03204279|527074198|FG000|Overall Study|Withdrawal by Subject|0|||
146154250|NCT03204279|527074199|FG001|Overall Study|Withdrawal by Subject|1|||
146154251|NCT04969250|527074204|FG000|Overall Study|Protocol Violation|0|||
146154252|NCT04969250|527074205|FG001|Overall Study|Protocol Violation|2|||
146154253|NCT04969250|527074206|FG002|Overall Study|Protocol Violation|3|||
146154254|NCT04969250|527074207|FG003|Overall Study|Protocol Violation|8|||
146154255|NCT04969250|527074204|FG000|Overall Study|Withdrawal by Subject|0|||
146154256|NCT04969250|527074205|FG001|Overall Study|Withdrawal by Subject|1|||
146154257|NCT04969250|527074206|FG002|Overall Study|Withdrawal by Subject|0|||
146154258|NCT04969250|527074207|FG003|Overall Study|Withdrawal by Subject|0|||
146154259|NCT02119416|527074208|FG000|Overall Study|Protocol Violation|1|||
146154260|NCT02119416|527074209|FG001|Overall Study|Protocol Violation|1|||
146154261|NCT02119416|527074210|FG002|Overall Study|Protocol Violation|1|||
146154262|NCT02119416|527074208|FG000|Overall Study|wrong pubertal stage|1|||
146154263|NCT02119416|527074209|FG001|Overall Study|wrong pubertal stage|0|||
146154264|NCT02119416|527074210|FG002|Overall Study|wrong pubertal stage|1|||
146154265|NCT02278328|527074211|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
146154266|NCT02278328|527074212|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
146154267|NCT02278328|527074213|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
146154268|NCT02278328|527074211|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
146154269|NCT02278328|527074212|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
146154270|NCT02278328|527074213|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
146154271|NCT02278328|527074211|FG000|Neuropsych Screening|incomplete consent|0|||
146154272|NCT02278328|527074212|FG001|Neuropsych Screening|incomplete consent|0|||
146154273|NCT02278328|527074213|FG002|Neuropsych Screening|incomplete consent|2|||
146154274|NCT00130533|527074214|FG000|Overall Study|Withdrawal by Subject|33|||
146154275|NCT00130533|527074215|FG001|Overall Study|Withdrawal by Subject|6|||
146154276|NCT00130533|527074214|FG000|Overall Study|Adverse Event|34|||
146154277|NCT00130533|527074215|FG001|Overall Study|Adverse Event|1|||
146309002|NCT00750737|527645864|FG000|Overall Study|Withdrawal by Subject|3|||
146309003|NCT00750737|527645865|FG001|Overall Study|Withdrawal by Subject|3|||
146309004|NCT02614859|527645866|FG000|Overall Study|Physician Decision|0|||
146309005|NCT02614859|527645867|FG001|Overall Study|Physician Decision|1|||
146154278|NCT00130533|527074214|FG000|Overall Study|Disease relapse|9|||
146154279|NCT00130533|527074215|FG001|Overall Study|Disease relapse|13|||
146154280|NCT00130533|527074214|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
146154281|NCT00130533|527074215|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
146154282|NCT00130533|527074214|FG000|Overall Study|Death|4|||
146154283|NCT00130533|527074215|FG001|Overall Study|Death|2|||
146154284|NCT00130533|527074214|FG000|Overall Study|Protocol Violation|5|||
146154285|NCT00130533|527074215|FG001|Overall Study|Protocol Violation|1|||
146154286|NCT00130533|527074214|FG000|Overall Study|Lost to Follow-up|1|||
146154287|NCT00130533|527074215|FG001|Overall Study|Lost to Follow-up|1|||
146154288|NCT00130533|527074214|FG000|Overall Study|Sponsor´s decision|2|||
146154289|NCT00130533|527074215|FG001|Overall Study|Sponsor´s decision|0|||
146154290|NCT00130533|527074214|FG000|Overall Study|Second Primary Malignancy|0|||
146154291|NCT00130533|527074215|FG001|Overall Study|Second Primary Malignancy|1|||
146154292|NCT00130533|527074214|FG000|Overall Study|Other|12|||
146309006|NCT03972969|527645869|FG000|3-month Follow-up|Death|1|||
146154293|NCT00130533|527074215|FG001|Overall Study|Other|5|||
146154294|NCT02384759|527074223|FG000|Overall Study|Patients not treated|3|||
146154295|NCT02384759|527074224|FG001|Overall Study|Patients not treated|2|||
146154296|NCT01605617|527074225|FG000|First Intervention|Adverse Event|0|||
146154297|NCT01605617|527074226|FG001|First Intervention|Adverse Event|1|||
146154298|NCT01605617|527074225|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
146154299|NCT01605617|527074226|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
146154300|NCT02014116|527074228|FG000|Overall Study|Progressive Disease|3|||
146154301|NCT02014116|527074229|FG001|Overall Study|Progressive Disease|4|||
146154302|NCT02014116|527074230|FG002|Overall Study|Progressive Disease|2|||
146154303|NCT02014116|527074231|FG003|Overall Study|Progressive Disease|6|||
146309007|NCT03972969|527645870|FG001|3-month Follow-up|Death|1|||
146309008|NCT03972969|527645871|FG002|3-month Follow-up|Death|0|||
146309009|NCT03972969|527645869|FG000|6-month Follow-up|Death|1|||
146154304|NCT02014116|527074232|FG004|Overall Study|Progressive Disease|1|||
146154305|NCT02014116|527074233|FG005|Overall Study|Progressive Disease|13|||
146154306|NCT02014116|527074234|FG006|Overall Study|Progressive Disease|1|||
146154307|NCT02014116|527074235|FG007|Overall Study|Progressive Disease|3|||
146309010|NCT03972969|527645870|FG001|6-month Follow-up|Death|1|||
146309011|NCT03972969|527645871|FG002|6-month Follow-up|Death|1|||
146154308|NCT02014116|527074236|FG008|Overall Study|Progressive Disease|7|||
146154309|NCT02014116|527074228|FG000|Overall Study|Adverse Event|0|||
146154310|NCT02014116|527074229|FG001|Overall Study|Adverse Event|0|||
146154311|NCT02014116|527074230|FG002|Overall Study|Adverse Event|0|||
146154312|NCT02014116|527074231|FG003|Overall Study|Adverse Event|0|||
146154313|NCT02014116|527074232|FG004|Overall Study|Adverse Event|1|||
146154314|NCT02014116|527074233|FG005|Overall Study|Adverse Event|0|||
146154315|NCT02014116|527074234|FG006|Overall Study|Adverse Event|0|||
146154316|NCT02014116|527074235|FG007|Overall Study|Adverse Event|1|||
146154317|NCT02014116|527074236|FG008|Overall Study|Adverse Event|0|||
146154318|NCT02014116|527074228|FG000|Overall Study|Lost to Follow-up|0|||
146309012|NCT03972969|527645869|FG000|6-month Follow-up|Lost to Follow-up|2|||
146309013|NCT03972969|527645870|FG001|6-month Follow-up|Lost to Follow-up|2|||
146154319|NCT02014116|527074229|FG001|Overall Study|Lost to Follow-up|0|||
146154320|NCT02014116|527074230|FG002|Overall Study|Lost to Follow-up|0|||
146154321|NCT02014116|527074231|FG003|Overall Study|Lost to Follow-up|0|||
146154322|NCT02014116|527074232|FG004|Overall Study|Lost to Follow-up|0|||
146154323|NCT02014116|527074233|FG005|Overall Study|Lost to Follow-up|1|||
146154324|NCT02014116|527074234|FG006|Overall Study|Lost to Follow-up|0|||
146154325|NCT02014116|527074235|FG007|Overall Study|Lost to Follow-up|0|||
146154326|NCT02014116|527074236|FG008|Overall Study|Lost to Follow-up|1|||
146154327|NCT02014116|527074228|FG000|Overall Study|Death|0|||
146154328|NCT02014116|527074229|FG001|Overall Study|Death|0|||
146154329|NCT02014116|527074230|FG002|Overall Study|Death|0|||
146154330|NCT02014116|527074231|FG003|Overall Study|Death|0|||
146154331|NCT02014116|527074232|FG004|Overall Study|Death|0|||
146154332|NCT02014116|527074233|FG005|Overall Study|Death|0|||
146154333|NCT02014116|527074234|FG006|Overall Study|Death|0|||
146154334|NCT02014116|527074235|FG007|Overall Study|Death|1|||
146154335|NCT02014116|527074236|FG008|Overall Study|Death|1|||
146154336|NCT02014116|527074228|FG000|Overall Study|Withdrawal by Subject|0|||
146154337|NCT02014116|527074229|FG001|Overall Study|Withdrawal by Subject|0|||
146154338|NCT02014116|527074230|FG002|Overall Study|Withdrawal by Subject|1|||
146154339|NCT02014116|527074231|FG003|Overall Study|Withdrawal by Subject|1|||
146154340|NCT02014116|527074232|FG004|Overall Study|Withdrawal by Subject|0|||
146154341|NCT02014116|527074233|FG005|Overall Study|Withdrawal by Subject|1|||
146154342|NCT02014116|527074234|FG006|Overall Study|Withdrawal by Subject|0|||
146154343|NCT02014116|527074235|FG007|Overall Study|Withdrawal by Subject|0|||
146154344|NCT02014116|527074236|FG008|Overall Study|Withdrawal by Subject|0|||
146154345|NCT02014116|527074228|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
146154346|NCT02014116|527074229|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
146154347|NCT02014116|527074230|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
146154348|NCT02014116|527074231|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
146154349|NCT02014116|527074232|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
146154350|NCT02014116|527074233|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
146154351|NCT02014116|527074234|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
146154352|NCT02014116|527074235|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
146154353|NCT02014116|527074236|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
146154354|NCT02014116|527074228|FG000|Overall Study|Physician Decision|0|||
146154355|NCT02014116|527074229|FG001|Overall Study|Physician Decision|0|||
146154356|NCT02014116|527074230|FG002|Overall Study|Physician Decision|0|||
146154357|NCT02014116|527074231|FG003|Overall Study|Physician Decision|0|||
146154358|NCT02014116|527074232|FG004|Overall Study|Physician Decision|0|||
146154359|NCT02014116|527074233|FG005|Overall Study|Physician Decision|0|||
146154360|NCT02014116|527074234|FG006|Overall Study|Physician Decision|0|||
146154361|NCT02014116|527074235|FG007|Overall Study|Physician Decision|0|||
146154362|NCT02014116|527074236|FG008|Overall Study|Physician Decision|1|||
146154363|NCT03043664|527074237|FG000|Overall Study|Lost to Follow-up|1|||
146154364|NCT03593655|527074238|FG000|First Product Use Period|Withdrawal by Subject|1|||
146154365|NCT03593655|527074239|FG001|First Product Use Period|Withdrawal by Subject|1|||
146154366|NCT03593655|527074238|FG000|First Product Use Period|Lost to Follow-up|1|||
146154367|NCT03593655|527074239|FG001|First Product Use Period|Lost to Follow-up|3|||
146154368|NCT03593655|527074238|FG000|Second Product Use Period|Withdrawal by Subject|1|||
146154369|NCT03593655|527074239|FG001|Second Product Use Period|Withdrawal by Subject|1|||
146154370|NCT03593655|527074238|FG000|Second Product Use Period|Lost to Follow-up|1|||
146154371|NCT03593655|527074239|FG001|Second Product Use Period|Lost to Follow-up|0|||
146154372|NCT03593655|527074238|FG000|Third Product Use Period|Lost to Follow-up|1|||
146154373|NCT03593655|527074239|FG001|Third Product Use Period|Lost to Follow-up|2|||
146154374|NCT03593655|527074238|FG000|Third Product Use Period|Physician Decision|0|||
146154375|NCT03593655|527074239|FG001|Third Product Use Period|Physician Decision|1|||
146154376|NCT03593655|527074238|FG000|Third Product Use Period|Withdrawal by Subject|0|||
146154377|NCT03593655|527074239|FG001|Third Product Use Period|Withdrawal by Subject|1|||
146154378|NCT03732209|527074240|FG000|Overall Study|Lost to Follow-up|4|||
146154379|NCT03732209|527074241|FG001|Overall Study|Lost to Follow-up|4|||
146309014|NCT03972969|527645871|FG002|6-month Follow-up|Lost to Follow-up|2|||
146309015|NCT01399788|527645875|FG000|First Intervention Period|Adverse Event|1|||
146309016|NCT01399788|527645876|FG001|First Intervention Period|Adverse Event|0|||
146154380|NCT03732209|527074240|FG000|Overall Study|Withdrawal by Subject|8|||
146154381|NCT03732209|527074241|FG001|Overall Study|Withdrawal by Subject|9|||
146154382|NCT04139317|527074242|FG000|Overall Study|Adverse Event|10|||
146154383|NCT04139317|527074243|FG001|Overall Study|Adverse Event|2|||
146154384|NCT04139317|527074242|FG000|Overall Study|Death|6|||
146154385|NCT04139317|527074243|FG001|Overall Study|Death|4|||
146154386|NCT04139317|527074242|FG000|Overall Study|Lost to Follow-up|1|||
146154387|NCT04139317|527074243|FG001|Overall Study|Lost to Follow-up|0|||
146154388|NCT04139317|527074242|FG000|Overall Study|Physician Decision|3|||
146154389|NCT04139317|527074243|FG001|Overall Study|Physician Decision|1|||
146154390|NCT04139317|527074242|FG000|Overall Study|Progressive Disease|19|||
146154391|NCT04139317|527074243|FG001|Overall Study|Progressive Disease|9|||
146154392|NCT04139317|527074242|FG000|Overall Study|Subject Decision|2|||
146154393|NCT04139317|527074243|FG001|Overall Study|Subject Decision|2|||
146154394|NCT03021187|527074248|FG000|Overall Study|Death|0|||
146154395|NCT03021187|527074249|FG001|Overall Study|Death|0|||
146154396|NCT03021187|527074250|FG002|Overall Study|Death|3|||
146154397|NCT03021187|527074251|FG003|Overall Study|Death|0|||
146154398|NCT03021187|527074248|FG000|Overall Study|Withdrawal by Subject|0|||
146154399|NCT03021187|527074249|FG001|Overall Study|Withdrawal by Subject|6|||
146154400|NCT03021187|527074250|FG002|Overall Study|Withdrawal by Subject|2|||
146154401|NCT03021187|527074251|FG003|Overall Study|Withdrawal by Subject|5|||
146154402|NCT03021187|527074248|FG000|Overall Study|Lost to Follow-up|10|||
146154403|NCT03021187|527074249|FG001|Overall Study|Lost to Follow-up|3|||
146154404|NCT03021187|527074250|FG002|Overall Study|Lost to Follow-up|1|||
146154405|NCT03021187|527074251|FG003|Overall Study|Lost to Follow-up|4|||
146154406|NCT00718718|527074252|FG000|Prior to Week 12|Adverse Event|0|||
146154407|NCT00718718|527074253|FG001|Prior to Week 12|Adverse Event|0|||
146154408|NCT00718718|527074254|FG002|Prior to Week 12|Adverse Event|0|||
146154409|NCT00718718|527074255|FG003|Prior to Week 12|Adverse Event|0|||
146154410|NCT00718718|527074256|FG004|Prior to Week 12|Adverse Event|0|||
146154411|NCT00718718|527074257|FG005|Prior to Week 12|Adverse Event|0|||
146154412|NCT00718718|527074258|FG006|Prior to Week 12|Adverse Event|0|||
146154413|NCT00718718|527074259|FG007|Prior to Week 12|Adverse Event|1|||
146309017|NCT02919436|527645877|FG000|Overall Study|Did not undergo surgery|16|||
146309018|NCT02919436|527645878|FG001|Overall Study|Did not undergo surgery|20|||
146309019|NCT02919436|527645877|FG000|Overall Study|Enrolled before trial registration|44|||
146309020|NCT02919436|527645878|FG001|Overall Study|Enrolled before trial registration|33|||
146309021|NCT01389752|527645880|FG000|Study Period 1|Sponsor decision|0|||
146309022|NCT01389752|527645881|FG001|Study Period 1|Sponsor decision|2|||
146309023|NCT01389752|527645880|FG000|Study Period 2|Sponsor decision|1|||
146309024|NCT01389752|527645881|FG001|Study Period 2|Sponsor decision|0|||
146309025|NCT03259074|527645882|FG000|Overall Study|Adverse Event|9|||
146309026|NCT03259074|527645883|FG001|Overall Study|Adverse Event|12|||
146309027|NCT03259074|527645884|FG002|Overall Study|Adverse Event|8|||
146309028|NCT03259074|527645882|FG000|Overall Study|Death|1|||
146309029|NCT03259074|527645883|FG001|Overall Study|Death|1|||
146309030|NCT03259074|527645884|FG002|Overall Study|Death|3|||
146309031|NCT03259074|527645882|FG000|Overall Study|Lost to Follow-up|2|||
146309032|NCT03259074|527645883|FG001|Overall Study|Lost to Follow-up|4|||
146309033|NCT03259074|527645884|FG002|Overall Study|Lost to Follow-up|3|||
146309034|NCT03259074|527645882|FG000|Overall Study|New Therapy For Study Indication|1|||
146309035|NCT03259074|527645883|FG001|Overall Study|New Therapy For Study Indication|2|||
146309036|NCT03259074|527645884|FG002|Overall Study|New Therapy For Study Indication|2|||
146154414|NCT00718718|527074260|FG008|Prior to Week 12|Adverse Event|1|||
146154415|NCT00718718|527074261|FG009|Prior to Week 12|Adverse Event|0|||
146154416|NCT00718718|527074252|FG000|Prior to Week 12|Withdrawal by Subject|0|||
146154417|NCT00718718|527074253|FG001|Prior to Week 12|Withdrawal by Subject|0|||
146154418|NCT00718718|527074254|FG002|Prior to Week 12|Withdrawal by Subject|0|||
146154419|NCT00718718|527074255|FG003|Prior to Week 12|Withdrawal by Subject|0|||
146154420|NCT00718718|527074256|FG004|Prior to Week 12|Withdrawal by Subject|3|||
146154421|NCT00718718|527074257|FG005|Prior to Week 12|Withdrawal by Subject|0|||
146154422|NCT00718718|527074258|FG006|Prior to Week 12|Withdrawal by Subject|1|||
146154423|NCT00718718|527074259|FG007|Prior to Week 12|Withdrawal by Subject|1|||
146309037|NCT03259074|527645882|FG000|Overall Study|Physician Decision|4|||
146309038|NCT03259074|527645883|FG001|Overall Study|Physician Decision|12|||
146154424|NCT00718718|527074260|FG008|Prior to Week 12|Withdrawal by Subject|1|||
146154425|NCT00718718|527074261|FG009|Prior to Week 12|Withdrawal by Subject|0|||
146154426|NCT00718718|527074252|FG000|Prior to Week 12|Other|1|||
146154427|NCT00718718|527074253|FG001|Prior to Week 12|Other|0|||
146154428|NCT00718718|527074254|FG002|Prior to Week 12|Other|1|||
146309039|NCT03259074|527645884|FG002|Overall Study|Physician Decision|10|||
146309040|NCT03259074|527645882|FG000|Overall Study|Pregnancy|1|||
146309041|NCT03259074|527645883|FG001|Overall Study|Pregnancy|1|||
146309042|NCT03259074|527645884|FG002|Overall Study|Pregnancy|0|||
146309043|NCT03259074|527645882|FG000|Overall Study|Progressive Disease|1|||
146309044|NCT03259074|527645883|FG001|Overall Study|Progressive Disease|0|||
146309045|NCT03259074|527645884|FG002|Overall Study|Progressive Disease|0|||
146309046|NCT03259074|527645882|FG000|Overall Study|Protocol Deviation|1|||
146309047|NCT03259074|527645883|FG001|Overall Study|Protocol Deviation|1|||
146154429|NCT00718718|527074255|FG003|Prior to Week 12|Other|0|||
146154430|NCT00718718|527074256|FG004|Prior to Week 12|Other|0|||
146154431|NCT00718718|527074257|FG005|Prior to Week 12|Other|0|||
146154432|NCT00718718|527074258|FG006|Prior to Week 12|Other|0|||
146154433|NCT00718718|527074259|FG007|Prior to Week 12|Other|0|||
146309048|NCT03259074|527645884|FG002|Overall Study|Protocol Deviation|3|||
146309049|NCT03259074|527645882|FG000|Overall Study|Subject/Guardian Decision|13|||
146309050|NCT03259074|527645883|FG001|Overall Study|Subject/Guardian Decision|16|||
146309051|NCT03259074|527645884|FG002|Overall Study|Subject/Guardian Decision|14|||
146154434|NCT00718718|527074260|FG008|Prior to Week 12|Other|0|||
146154435|NCT00718718|527074261|FG009|Prior to Week 12|Other|0|||
146154436|NCT00718718|527074252|FG000|Week 12 to End of Study|Adverse Event|0|||
146154437|NCT00718718|527074253|FG001|Week 12 to End of Study|Adverse Event|0|||
146154438|NCT00718718|527074254|FG002|Week 12 to End of Study|Adverse Event|0|||
146154439|NCT00718718|527074255|FG003|Week 12 to End of Study|Adverse Event|0|||
146154440|NCT00718718|527074256|FG004|Week 12 to End of Study|Adverse Event|0|||
146154441|NCT00718718|527074257|FG005|Week 12 to End of Study|Adverse Event|0|||
146154442|NCT00718718|527074258|FG006|Week 12 to End of Study|Adverse Event|0|||
146154443|NCT00718718|527074259|FG007|Week 12 to End of Study|Adverse Event|1|||
146154444|NCT00718718|527074260|FG008|Week 12 to End of Study|Adverse Event|0|||
146154445|NCT00718718|527074261|FG009|Week 12 to End of Study|Adverse Event|0|||
146154446|NCT00718718|527074252|FG000|Week 12 to End of Study|Death|0|||
146154447|NCT00718718|527074253|FG001|Week 12 to End of Study|Death|0|||
146154448|NCT00718718|527074254|FG002|Week 12 to End of Study|Death|0|||
146154449|NCT00718718|527074255|FG003|Week 12 to End of Study|Death|0|||
146154450|NCT00718718|527074256|FG004|Week 12 to End of Study|Death|0|||
146154451|NCT00718718|527074257|FG005|Week 12 to End of Study|Death|1|||
146154452|NCT00718718|527074258|FG006|Week 12 to End of Study|Death|0|||
146154453|NCT00718718|527074259|FG007|Week 12 to End of Study|Death|0|||
146154454|NCT00718718|527074260|FG008|Week 12 to End of Study|Death|0|||
146154455|NCT00718718|527074261|FG009|Week 12 to End of Study|Death|0|||
146154456|NCT00718718|527074252|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
146154457|NCT00718718|527074253|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
146154458|NCT00718718|527074254|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
146154459|NCT00718718|527074255|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
146154460|NCT00718718|527074256|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
146154461|NCT00718718|527074257|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
146154462|NCT00718718|527074258|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
146154463|NCT00718718|527074259|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
146154464|NCT00718718|527074260|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
146154465|NCT00718718|527074261|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
146154466|NCT00718718|527074252|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
146154467|NCT00718718|527074253|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
146154468|NCT00718718|527074254|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
146154469|NCT00718718|527074255|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
146154470|NCT00718718|527074256|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
146154471|NCT00718718|527074257|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
146154472|NCT00718718|527074258|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
146154473|NCT00718718|527074259|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
146154474|NCT00718718|527074260|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
146154475|NCT00718718|527074261|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
146154476|NCT00718718|527074252|FG000|Week 12 to End of Study|Other|0|||
146154477|NCT00718718|527074253|FG001|Week 12 to End of Study|Other|1|||
146154478|NCT00718718|527074254|FG002|Week 12 to End of Study|Other|0|||
146154479|NCT00718718|527074255|FG003|Week 12 to End of Study|Other|1|||
146154480|NCT00718718|527074256|FG004|Week 12 to End of Study|Other|0|||
146154481|NCT00718718|527074257|FG005|Week 12 to End of Study|Other|0|||
146154482|NCT00718718|527074258|FG006|Week 12 to End of Study|Other|1|||
146154483|NCT00718718|527074259|FG007|Week 12 to End of Study|Other|0|||
146154484|NCT00718718|527074260|FG008|Week 12 to End of Study|Other|0|||
146154485|NCT00718718|527074261|FG009|Week 12 to End of Study|Other|0|||
146309052|NCT00053417|527645895|FG000|Overall Study|Adverse Event|1|||
146309053|NCT00053417|527645896|FG001|Overall Study|Adverse Event|0|||
146309054|NCT00053417|527645897|FG002|Overall Study|Adverse Event|1|||
146309055|NCT00053417|527645898|FG003|Overall Study|Adverse Event|5|||
146309056|NCT00053417|527645895|FG000|Overall Study|Non-Compliance|0|||
146309057|NCT00053417|527645896|FG001|Overall Study|Non-Compliance|0|||
146309058|NCT00053417|527645897|FG002|Overall Study|Non-Compliance|0|||
146309059|NCT00053417|527645898|FG003|Overall Study|Non-Compliance|1|||
146309060|NCT00053417|527645895|FG000|Overall Study|Withdrawal by Subject|0|||
146154486|NCT03394924|527074264|FG000|Overall Study|Adverse Event|0|||
146154487|NCT03394924|527074265|FG001|Overall Study|Adverse Event|5|||
146154488|NCT03394924|527074266|FG002|Overall Study|Adverse Event|0|||
146154489|NCT03394924|527074264|FG000|Overall Study|Withdrawal by Subject|2|||
146154490|NCT03394924|527074265|FG001|Overall Study|Withdrawal by Subject|0|||
146154491|NCT03394924|527074266|FG002|Overall Study|Withdrawal by Subject|0|||
146154492|NCT03394924|527074264|FG000|Overall Study|Lost to Follow-up|0|||
146154493|NCT03394924|527074265|FG001|Overall Study|Lost to Follow-up|1|||
146154494|NCT03394924|527074266|FG002|Overall Study|Lost to Follow-up|0|||
146154495|NCT03394924|527074264|FG000|Overall Study|Did not meet all inclusion criteria|1|||
146154496|NCT03394924|527074265|FG001|Overall Study|Did not meet all inclusion criteria|0|||
146154497|NCT03394924|527074266|FG002|Overall Study|Did not meet all inclusion criteria|0|||
146154498|NCT02276482|527074269|FG000|Overall Study|Adverse Event|1|||
146154499|NCT02276482|527074270|FG001|Overall Study|Adverse Event|0|||
146154500|NCT02276482|527074269|FG000|Overall Study|Withdrawal by Subject|1|||
146154501|NCT02276482|527074270|FG001|Overall Study|Withdrawal by Subject|0|||
146154502|NCT02276482|527074269|FG000|Overall Study|Gram-negative infection|1|||
146154503|NCT02276482|527074270|FG001|Overall Study|Gram-negative infection|0|||
146154504|NCT02276482|527074269|FG000|Overall Study|Reason not specified|0|||
146309061|NCT00053417|527645896|FG001|Overall Study|Withdrawal by Subject|1|||
146309062|NCT00053417|527645897|FG002|Overall Study|Withdrawal by Subject|0|||
146309063|NCT00053417|527645898|FG003|Overall Study|Withdrawal by Subject|0|||
146309064|NCT00053417|527645895|FG000|Overall Study|Lost to Follow-up|1|||
146309065|NCT00053417|527645896|FG001|Overall Study|Lost to Follow-up|1|||
146309066|NCT00053417|527645897|FG002|Overall Study|Lost to Follow-up|0|||
146309067|NCT00053417|527645898|FG003|Overall Study|Lost to Follow-up|0|||
146309068|NCT00705783|527645899|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
146309069|NCT00705783|527645900|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
146309070|NCT00705783|527645901|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
146309071|NCT00705783|527645899|FG000|Conversion Phase|Lost to Follow-up|13|||
146309072|NCT00705783|527645900|FG001|Conversion Phase|Lost to Follow-up|0|||
146309073|NCT00705783|527645901|FG002|Conversion Phase|Lost to Follow-up|0|||
146309074|NCT00705783|527645899|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
146309075|NCT00705783|527645900|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
146309076|NCT00705783|527645901|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
146309077|NCT00705783|527645899|FG000|Conversion Phase|Withdrawn by Investigator|4|||
146309078|NCT00705783|527645900|FG001|Conversion Phase|Withdrawn by Investigator|0|||
146309079|NCT00705783|527645901|FG002|Conversion Phase|Withdrawn by Investigator|0|||
146309080|NCT00705783|527645899|FG000|Conversion Phase|Withdrew Consent|24|||
146309081|NCT00705783|527645900|FG001|Conversion Phase|Withdrew Consent|0|||
146309082|NCT00705783|527645901|FG002|Conversion Phase|Withdrew Consent|0|||
146309083|NCT00705783|527645899|FG000|Conversion Phase|Protocol Deviation|2|||
146309084|NCT00705783|527645900|FG001|Conversion Phase|Protocol Deviation|0|||
146309085|NCT00705783|527645901|FG002|Conversion Phase|Protocol Deviation|0|||
146309086|NCT00705783|527645899|FG000|Conversion Phase|Adverse Event|11|||
146309087|NCT00705783|527645900|FG001|Conversion Phase|Adverse Event|0|||
146309088|NCT00705783|527645901|FG002|Conversion Phase|Adverse Event|0|||
146309089|NCT00705783|527645899|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
146309090|NCT00705783|527645900|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146309091|NCT00705783|527645901|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
146309092|NCT00705783|527645899|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
146309093|NCT00705783|527645900|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146154505|NCT02276482|527074270|FG001|Overall Study|Reason not specified|1|||
146154506|NCT03277313|527074271|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
146154507|NCT03277313|527074272|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
146154508|NCT03277313|527074271|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
146154509|NCT03277313|527074272|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
146154510|NCT03277313|527074271|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
146154511|NCT03277313|527074272|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
146154512|NCT03277313|527074271|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
146154513|NCT03277313|527074272|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
146154514|NCT03277313|527074271|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
146154515|NCT03277313|527074272|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
146154516|NCT02005471|527074275|FG000|Main Study|Adverse Event|0|||
146154517|NCT02005471|527074276|FG001|Main Study|Adverse Event|1|||
146154518|NCT02005471|527074277|FG002|Main Study|Adverse Event|0|||
146154519|NCT02005471|527074278|FG003|Main Study|Adverse Event|0|||
146154520|NCT02005471|527074275|FG000|Main Study|Death|83|||
146154521|NCT02005471|527074276|FG001|Main Study|Death|52|||
146154522|NCT02005471|527074277|FG002|Main Study|Death|0|||
146154523|NCT02005471|527074278|FG003|Main Study|Death|0|||
146154524|NCT02005471|527074275|FG000|Main Study|Lost to Follow-up|4|||
146154525|NCT02005471|527074276|FG001|Main Study|Lost to Follow-up|5|||
146154526|NCT02005471|527074277|FG002|Main Study|Lost to Follow-up|0|||
146154527|NCT02005471|527074278|FG003|Main Study|Lost to Follow-up|0|||
146154528|NCT02005471|527074275|FG000|Main Study|Physician Decision|3|||
146154529|NCT02005471|527074276|FG001|Main Study|Physician Decision|1|||
146154530|NCT02005471|527074277|FG002|Main Study|Physician Decision|0|||
146154531|NCT02005471|527074278|FG003|Main Study|Physician Decision|0|||
146309094|NCT00705783|527645901|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
146154532|NCT02005471|527074275|FG000|Main Study|Withdrawal by Subject|26|||
146154533|NCT02005471|527074276|FG001|Main Study|Withdrawal by Subject|11|||
146154534|NCT02005471|527074277|FG002|Main Study|Withdrawal by Subject|0|||
146154535|NCT02005471|527074278|FG003|Main Study|Withdrawal by Subject|0|||
146309095|NCT00705783|527645899|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
146309096|NCT00705783|527645900|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
146309097|NCT00705783|527645901|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
146309098|NCT00705783|527645899|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
146154536|NCT02005471|527074275|FG000|Main Study|Reason not Specified|0|||
146154537|NCT02005471|527074276|FG001|Main Study|Reason not Specified|6|||
146154538|NCT02005471|527074277|FG002|Main Study|Reason not Specified|0|||
146154539|NCT02005471|527074278|FG003|Main Study|Reason not Specified|0|||
146154540|NCT02005471|527074275|FG000|Main Study|Randomized but not Dosed|8|||
146154541|NCT02005471|527074276|FG001|Main Study|Randomized but not Dosed|0|||
146154542|NCT02005471|527074277|FG002|Main Study|Randomized but not Dosed|0|||
146154543|NCT02005471|527074278|FG003|Main Study|Randomized but not Dosed|0|||
146154544|NCT02005471|527074275|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146154545|NCT02005471|527074276|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146154546|NCT02005471|527074277|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
146154547|NCT02005471|527074278|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
146154548|NCT02005471|527074275|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
146154549|NCT02005471|527074276|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
146154550|NCT02005471|527074277|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
146154551|NCT02005471|527074278|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
146154552|NCT02005471|527074275|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
146154553|NCT02005471|527074276|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
146154554|NCT02005471|527074277|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
146154555|NCT02005471|527074278|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
146154556|NCT00627705|527074280|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
146154557|NCT00627705|527074281|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
146154558|NCT00627705|527074280|FG000|Overall Study|Adverse Event|1|||
146154559|NCT00627705|527074281|FG001|Overall Study|Adverse Event|0|||
146154560|NCT00627705|527074280|FG000|Overall Study|Withdrawal by Subject|0|||
146154561|NCT00627705|527074281|FG001|Overall Study|Withdrawal by Subject|2|||
146154562|NCT00627705|527074280|FG000|Overall Study|Lost to Follow-up|0|||
146154563|NCT00627705|527074281|FG001|Overall Study|Lost to Follow-up|1|||
146154564|NCT00791765|527076303|FG000|Weeks 1 to 12|Adverse Event|0|||
146154565|NCT00791765|527076304|FG001|Weeks 1 to 12|Adverse Event|1|||
146154566|NCT00791765|527076303|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
146154567|NCT00791765|527076304|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
146154568|NCT00791765|527076303|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
146154569|NCT00791765|527076304|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
146309099|NCT00705783|527645900|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
146309100|NCT00705783|527645901|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
146309101|NCT00705783|527645899|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
146309102|NCT00705783|527645900|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146309103|NCT00705783|527645901|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
146309104|NCT00705783|527645899|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
146309105|NCT00705783|527645900|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146309106|NCT00705783|527645901|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
146309107|NCT00705783|527645899|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
146309108|NCT00705783|527645900|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
146309109|NCT00705783|527645901|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
146309110|NCT00705783|527645899|FG000|Oral Stabilization Phase|Adverse Event|14|||
146309111|NCT00705783|527645900|FG001|Oral Stabilization Phase|Adverse Event|0|||
146154570|NCT00791765|527076303|FG000|Weeks 1 to 12|Physician Decision|1|||
146154571|NCT00791765|527076304|FG001|Weeks 1 to 12|Physician Decision|0|||
146154572|NCT00791765|527076303|FG000|Weeks 1 to 12|Disease progression|3|||
146154573|NCT00791765|527076304|FG001|Weeks 1 to 12|Disease progression|0|||
146154574|NCT00791765|527076303|FG000|Weeks 1 to 12|Ineligibility determined|0|||
146154575|NCT00791765|527076304|FG001|Weeks 1 to 12|Ineligibility determined|3|||
146154576|NCT00791765|527076303|FG000|Weeks 13 to 24|Protocol deviation|2|||
146154577|NCT00791765|527076304|FG001|Weeks 13 to 24|Protocol deviation|0|||
146154578|NCT00791765|527076303|FG000|Weeks 13 to 24|Adverse Event|0|||
146154579|NCT00791765|527076304|FG001|Weeks 13 to 24|Adverse Event|3|||
146154580|NCT00791765|527076303|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
146154581|NCT00791765|527076304|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
146154582|NCT00791765|527076303|FG000|Weeks 13 to 24|Disease progression|0|||
146154583|NCT00791765|527076304|FG001|Weeks 13 to 24|Disease progression|1|||
146154584|NCT00791765|527076303|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
146154585|NCT00791765|527076304|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
146154586|NCT00791765|527076303|FG000|Weeks 13 to 24|Other|0|||
146154587|NCT00791765|527076304|FG001|Weeks 13 to 24|Other|1|||
146309112|NCT00705783|527645901|FG002|Oral Stabilization Phase|Adverse Event|0|||
146154588|NCT00924287|527076306|FG000|Overall Study|Death|1|||
146154589|NCT01625897|527076313|FG000|Overall Study|Adverse Event|27|||
146309113|NCT00705783|527645899|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
146309114|NCT00705783|527645900|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146309115|NCT00705783|527645901|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146154590|NCT01625897|527076314|FG001|Overall Study|Adverse Event|10|||
146154591|NCT01625897|527076313|FG000|Overall Study|Physician Decision|0|||
146154592|NCT01625897|527076314|FG001|Overall Study|Physician Decision|1|||
146154593|NCT01625897|527076313|FG000|Overall Study|Withdrawal by Subject|25|||
146154594|NCT01625897|527076314|FG001|Overall Study|Withdrawal by Subject|3|||
146154595|NCT00156065|527076315|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
146154596|NCT00156065|527076316|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
146154597|NCT00156065|527076317|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
146154598|NCT00156065|527076315|FG000|Overall Study|Adverse Event|8|||
146154599|NCT00156065|527076316|FG001|Overall Study|Adverse Event|11|||
146154600|NCT00156065|527076317|FG002|Overall Study|Adverse Event|4|||
146154601|NCT00156065|527076315|FG000|Overall Study|Lack of Efficacy|2|||
146154602|NCT00156065|527076316|FG001|Overall Study|Lack of Efficacy|9|||
146154603|NCT00156065|527076317|FG002|Overall Study|Lack of Efficacy|3|||
146154604|NCT00156065|527076315|FG000|Overall Study|Withdrawal by Subject|13|||
146154605|NCT00156065|527076316|FG001|Overall Study|Withdrawal by Subject|26|||
146154606|NCT00156065|527076317|FG002|Overall Study|Withdrawal by Subject|16|||
146154607|NCT00156065|527076315|FG000|Overall Study|Lost to Follow-up|5|||
146154608|NCT00156065|527076316|FG001|Overall Study|Lost to Follow-up|7|||
146154609|NCT00156065|527076317|FG002|Overall Study|Lost to Follow-up|1|||
146154610|NCT00156065|527076315|FG000|Overall Study|Other|2|||
146154611|NCT00156065|527076316|FG001|Overall Study|Other|9|||
146154612|NCT00156065|527076317|FG002|Overall Study|Other|3|||
146154613|NCT01432366|527076318|FG000|Overall Study|Non-Responder|7|||
146154614|NCT01432366|527076318|FG000|Overall Study|Adverse Event|8|||
146154615|NCT01432366|527076318|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
146154616|NCT01432366|527076318|FG000|Overall Study|Pregnancy|1|||
146154617|NCT01432366|527076318|FG000|Overall Study|Lost to Follow-up|13|||
146154618|NCT01432366|527076318|FG000|Overall Study|Lack of Efficacy|1|||
146154619|NCT01432366|527076318|FG000|Overall Study|Site Closed|20|||
146154620|NCT01432366|527076318|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
146154621|NCT01432366|527076318|FG000|Overall Study|Other|14|||
146154622|NCT02891187|527076319|FG000|Overall Study|Lost to Follow-up|1|||
146154623|NCT02891187|527076320|FG001|Overall Study|Lost to Follow-up|2|||
146154624|NCT04546581|527076321|FG000|Overall Study|Adverse Event|9|||
146154625|NCT04546581|527076322|FG001|Overall Study|Adverse Event|3|||
146154626|NCT04546581|527076321|FG000|Overall Study|Physician Decision|0|||
146154627|NCT04546581|527076322|FG001|Overall Study|Physician Decision|1|||
146154628|NCT04546581|527076321|FG000|Overall Study|Protocol Violation|1|||
146154629|NCT04546581|527076322|FG001|Overall Study|Protocol Violation|2|||
146154630|NCT04546581|527076321|FG000|Overall Study|Withdrawal by Subject|3|||
146154631|NCT04546581|527076322|FG001|Overall Study|Withdrawal by Subject|7|||
146154632|NCT01275625|527076323|FG000|Overall Study|Death|1|||
146154633|NCT01275625|527076323|FG000|Overall Study|Lack of Efficacy|2|||
146154634|NCT01275625|527076323|FG000|Overall Study|Lost to Follow-up|1|||
146154635|NCT01275625|527076323|FG000|Overall Study|Withdrawal by Subject|3|||
146154636|NCT01275625|527076323|FG000|Overall Study|Protocol Violation|1|||
146154637|NCT01275625|527076323|FG000|Overall Study|Adverse Event|4|||
146154638|NCT01275625|527076323|FG000|Overall Study|Other|1|||
146154639|NCT04579757|527076326|FG000|Overall Study|Adverse Event|0|||
146154640|NCT04579757|527076327|FG001|Overall Study|Adverse Event|0|||
146154641|NCT04579757|527076328|FG002|Overall Study|Adverse Event|0|||
146154642|NCT04579757|527076329|FG003|Overall Study|Adverse Event|2|||
146154643|NCT04579757|527076330|FG004|Overall Study|Adverse Event|1|||
146154644|NCT04579757|527076331|FG005|Overall Study|Adverse Event|1|||
146154645|NCT04579757|527076332|FG006|Overall Study|Adverse Event|0|||
146154646|NCT04579757|527076333|FG007|Overall Study|Adverse Event|0|||
146154647|NCT04579757|527076334|FG008|Overall Study|Adverse Event|0|||
146154648|NCT04579757|527076326|FG000|Overall Study|Death|4|||
146154649|NCT04579757|527076327|FG001|Overall Study|Death|1|||
146154650|NCT04579757|527076328|FG002|Overall Study|Death|14|||
146154651|NCT04579757|527076329|FG003|Overall Study|Death|3|||
146154652|NCT04579757|527076330|FG004|Overall Study|Death|2|||
146154653|NCT04579757|527076331|FG005|Overall Study|Death|7|||
146154654|NCT04579757|527076332|FG006|Overall Study|Death|0|||
146154655|NCT04579757|527076333|FG007|Overall Study|Death|1|||
146154656|NCT04579757|527076334|FG008|Overall Study|Death|3|||
146154657|NCT04579757|527076326|FG000|Overall Study|Physician Decision|0|||
146154658|NCT04579757|527076327|FG001|Overall Study|Physician Decision|0|||
146154659|NCT04579757|527076328|FG002|Overall Study|Physician Decision|0|||
146154660|NCT04579757|527076329|FG003|Overall Study|Physician Decision|2|||
146154661|NCT04579757|527076330|FG004|Overall Study|Physician Decision|1|||
146154662|NCT04579757|527076331|FG005|Overall Study|Physician Decision|1|||
146154663|NCT04579757|527076332|FG006|Overall Study|Physician Decision|1|||
146154664|NCT04579757|527076333|FG007|Overall Study|Physician Decision|0|||
146154665|NCT04579757|527076334|FG008|Overall Study|Physician Decision|0|||
146154666|NCT04579757|527076326|FG000|Overall Study|Study Terminated By Sponsor|0|||
146154667|NCT04579757|527076327|FG001|Overall Study|Study Terminated By Sponsor|0|||
146154668|NCT04579757|527076328|FG002|Overall Study|Study Terminated By Sponsor|0|||
146154669|NCT04579757|527076329|FG003|Overall Study|Study Terminated By Sponsor|0|||
146154670|NCT04579757|527076330|FG004|Overall Study|Study Terminated By Sponsor|2|||
146154671|NCT04579757|527076331|FG005|Overall Study|Study Terminated By Sponsor|0|||
146154672|NCT04579757|527076332|FG006|Overall Study|Study Terminated By Sponsor|0|||
146154673|NCT04579757|527076333|FG007|Overall Study|Study Terminated By Sponsor|2|||
146154674|NCT04579757|527076334|FG008|Overall Study|Study Terminated By Sponsor|0|||
146154675|NCT04579757|527076326|FG000|Overall Study|Withdrawal by Subject|1|||
146154676|NCT04579757|527076327|FG001|Overall Study|Withdrawal by Subject|1|||
146154677|NCT04579757|527076328|FG002|Overall Study|Withdrawal by Subject|0|||
146154678|NCT04579757|527076329|FG003|Overall Study|Withdrawal by Subject|0|||
146154679|NCT04579757|527076330|FG004|Overall Study|Withdrawal by Subject|2|||
146154680|NCT04579757|527076331|FG005|Overall Study|Withdrawal by Subject|1|||
146154681|NCT04579757|527076332|FG006|Overall Study|Withdrawal by Subject|0|||
146154682|NCT04579757|527076333|FG007|Overall Study|Withdrawal by Subject|3|||
146154683|NCT04579757|527076334|FG008|Overall Study|Withdrawal by Subject|0|||
146154684|NCT04579757|527076326|FG000|Overall Study|Radiological or Clinical PD|1|||
146154685|NCT04579757|527076327|FG001|Overall Study|Radiological or Clinical PD|4|||
146154686|NCT04579757|527076328|FG002|Overall Study|Radiological or Clinical PD|1|||
146154687|NCT04579757|527076329|FG003|Overall Study|Radiological or Clinical PD|3|||
146154688|NCT04579757|527076330|FG004|Overall Study|Radiological or Clinical PD|9|||
146154689|NCT04579757|527076331|FG005|Overall Study|Radiological or Clinical PD|4|||
146154690|NCT04579757|527076332|FG006|Overall Study|Radiological or Clinical PD|2|||
146154691|NCT04579757|527076333|FG007|Overall Study|Radiological or Clinical PD|2|||
146154692|NCT04579757|527076334|FG008|Overall Study|Radiological or Clinical PD|0|||
146154693|NCT04579757|527076326|FG000|Overall Study|Start of New Therapy|0|||
146154694|NCT04579757|527076327|FG001|Overall Study|Start of New Therapy|0|||
146154695|NCT04579757|527076328|FG002|Overall Study|Start of New Therapy|0|||
146154696|NCT04579757|527076329|FG003|Overall Study|Start of New Therapy|0|||
146154697|NCT04579757|527076330|FG004|Overall Study|Start of New Therapy|2|||
146154698|NCT04579757|527076331|FG005|Overall Study|Start of New Therapy|1|||
146154699|NCT04579757|527076332|FG006|Overall Study|Start of New Therapy|0|||
146154700|NCT04579757|527076333|FG007|Overall Study|Start of New Therapy|0|||
146154701|NCT04579757|527076334|FG008|Overall Study|Start of New Therapy|0|||
146154702|NCT02207816|527076335|FG000|Overall Study|Serious Adverse Event|0|||
146154703|NCT02207816|527076336|FG001|Overall Study|Serious Adverse Event|5|||
146154704|NCT02207816|527076337|FG002|Overall Study|Serious Adverse Event|2|||
146154705|NCT02207816|527076335|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146154706|NCT02207816|527076336|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
146154707|NCT02207816|527076337|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146154708|NCT02207816|527076335|FG000|Overall Study|Withdrawal by Subject|4|||
146154709|NCT02207816|527076336|FG001|Overall Study|Withdrawal by Subject|9|||
146154710|NCT02207816|527076337|FG002|Overall Study|Withdrawal by Subject|7|||
146154711|NCT02207816|527076335|FG000|Overall Study|Migrated/Moved From Study Area|41|||
146154712|NCT02207816|527076336|FG001|Overall Study|Migrated/Moved From Study Area|60|||
146154713|NCT02207816|527076337|FG002|Overall Study|Migrated/Moved From Study Area|51|||
146154714|NCT02207816|527076335|FG000|Overall Study|Lost to Follow-up|3|||
146154715|NCT02207816|527076336|FG001|Overall Study|Lost to Follow-up|9|||
146154716|NCT02207816|527076337|FG002|Overall Study|Lost to Follow-up|1|||
146154717|NCT02207816|527076335|FG000|Overall Study|Other|1|||
146154718|NCT02207816|527076336|FG001|Overall Study|Other|2|||
146154719|NCT02207816|527076337|FG002|Overall Study|Other|4|||
146154720|NCT01412944|527076340|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146154721|NCT01412944|527076341|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146154722|NCT01412944|527076342|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
146154723|NCT01412944|527076343|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146154724|NCT01412944|527076344|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146154725|NCT01412944|527076345|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
146154726|NCT01412944|527076340|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146154727|NCT01412944|527076341|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146154728|NCT01412944|527076342|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146154729|NCT01412944|527076343|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146154730|NCT01412944|527076344|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
146154731|NCT01412944|527076345|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
146154732|NCT01412944|527076340|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146154733|NCT01412944|527076341|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146154734|NCT01412944|527076342|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146154735|NCT01412944|527076343|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146154736|NCT01412944|527076344|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
146154737|NCT01412944|527076345|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
146154738|NCT01412944|527076340|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
146154739|NCT01412944|527076341|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146154740|NCT01412944|527076342|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146154741|NCT01412944|527076343|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146309116|NCT00705783|527645899|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
146154742|NCT01412944|527076344|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146154743|NCT01412944|527076345|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
146154744|NCT01412944|527076340|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
146154745|NCT01412944|527076341|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
146154746|NCT01412944|527076342|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
146154747|NCT01412944|527076343|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
146154748|NCT01412944|527076344|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
146154749|NCT01412944|527076345|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
146154750|NCT01412944|527076340|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146154751|NCT01412944|527076341|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
146154752|NCT01412944|527076342|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146154753|NCT01412944|527076343|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146154754|NCT01412944|527076344|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146154755|NCT01412944|527076345|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
146154756|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154757|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154758|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146154759|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146154760|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146154761|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154762|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Adverse Event|0|||
146154763|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Adverse Event|0|||
146154764|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Adverse Event|0|||
146154765|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Adverse Event|0|||
146154766|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Adverse Event|1|||
146154767|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Adverse Event|0|||
146154768|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
146154769|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
146154770|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
146154771|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
146154772|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
146154773|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
146154774|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154775|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154776|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154777|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154778|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154779|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
146154780|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154781|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154782|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154783|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154784|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
146154785|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154786|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
146154787|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
146154788|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154789|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154790|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154791|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
146154792|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
146154793|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
146154794|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
146154795|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
146154796|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
146154797|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
146154798|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154799|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
146154800|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154801|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154802|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154803|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
146154804|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154805|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
146154806|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154807|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154808|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154809|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
146154810|NCT01412944|527076340|FG000|Entire: IV + Maintenance|Adverse Event|0|||
146154811|NCT01412944|527076341|FG001|Entire: IV + Maintenance|Adverse Event|1|||
146154812|NCT01412944|527076342|FG002|Entire: IV + Maintenance|Adverse Event|0|||
146154813|NCT01412944|527076343|FG003|Entire: IV + Maintenance|Adverse Event|0|||
146154814|NCT01412944|527076344|FG004|Entire: IV + Maintenance|Adverse Event|0|||
146154815|NCT01412944|527076345|FG005|Entire: IV + Maintenance|Adverse Event|0|||
146154816|NCT03240588|527076346|FG000|Overall Study|Death|3|||
146154817|NCT03240588|527076347|FG001|Overall Study|Death|0|||
146154818|NCT03240588|527076348|FG002|Overall Study|Death|0|||
146154819|NCT03240588|527076346|FG000|Overall Study|Adverse Event|5|||
146154820|NCT03240588|527076347|FG001|Overall Study|Adverse Event|4|||
146154821|NCT03240588|527076348|FG002|Overall Study|Adverse Event|0|||
146154822|NCT03240588|527076346|FG000|Overall Study|Lost to Follow-up|9|||
146154823|NCT03240588|527076347|FG001|Overall Study|Lost to Follow-up|4|||
146154824|NCT03240588|527076348|FG002|Overall Study|Lost to Follow-up|0|||
146154825|NCT03240588|527076346|FG000|Overall Study|Physician Decision|3|||
146154826|NCT03240588|527076347|FG001|Overall Study|Physician Decision|2|||
146154827|NCT03240588|527076348|FG002|Overall Study|Physician Decision|0|||
146154828|NCT03240588|527076346|FG000|Overall Study|Did not meet eligibility criteria|0|||
146154829|NCT03240588|527076347|FG001|Overall Study|Did not meet eligibility criteria|6|||
146309117|NCT00705783|527645900|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146309118|NCT00705783|527645901|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146309119|NCT00705783|527645899|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
146309120|NCT00705783|527645900|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
146309121|NCT00705783|527645901|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
146309122|NCT00705783|527645899|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
146309123|NCT00705783|527645900|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
146154830|NCT03240588|527076348|FG002|Overall Study|Did not meet eligibility criteria|0|||
146154831|NCT03240588|527076346|FG000|Overall Study|No longer meets protocol criteria|12|||
146154832|NCT03240588|527076347|FG001|Overall Study|No longer meets protocol criteria|7|||
146154833|NCT03240588|527076348|FG002|Overall Study|No longer meets protocol criteria|0|||
146154834|NCT03240588|527076346|FG000|Overall Study|Withdrawal by Subject|60|||
146154835|NCT03240588|527076347|FG001|Overall Study|Withdrawal by Subject|52|||
146154836|NCT03240588|527076348|FG002|Overall Study|Withdrawal by Subject|7|||
146154837|NCT03240588|527076346|FG000|Overall Study|Other, additional details not available.|0|||
146154838|NCT03240588|527076347|FG001|Overall Study|Other, additional details not available.|12|||
146154839|NCT03240588|527076348|FG002|Overall Study|Other, additional details not available.|1|||
146154840|NCT03240588|527076346|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
146154841|NCT03240588|527076347|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
146154842|NCT03240588|527076348|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
146154843|NCT03240588|527076346|FG000|Overall Study|Closure of study|55|||
146154844|NCT03240588|527076347|FG001|Overall Study|Closure of study|3|||
146154845|NCT03240588|527076348|FG002|Overall Study|Closure of study|0|||
146154846|NCT03240588|527076346|FG000|Overall Study|Subject non-compliance|23|||
146154847|NCT03240588|527076347|FG001|Overall Study|Subject non-compliance|2|||
146154848|NCT03240588|527076348|FG002|Overall Study|Subject non-compliance|1|||
146154849|NCT03240588|527076346|FG000|Overall Study|Device Deficiency|1|||
146154850|NCT03240588|527076347|FG001|Overall Study|Device Deficiency|0|||
146154851|NCT03240588|527076348|FG002|Overall Study|Device Deficiency|0|||
146154852|NCT03240588|527076346|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
146154853|NCT03240588|527076347|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
146154854|NCT03240588|527076348|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
146154855|NCT02091726|527076350|FG000|Overall Study|Lost to Follow-up|6|||
146154856|NCT04066114|527076354|FG000|Overall Study|Adverse Event|1|||
146154857|NCT04066114|527076355|FG001|Overall Study|Adverse Event|0|||
146154858|NCT04066114|527076356|FG002|Overall Study|Adverse Event|0|||
146154859|NCT04066114|527076354|FG000|Overall Study|Withdrawal by Subject|1|||
146154860|NCT04066114|527076355|FG001|Overall Study|Withdrawal by Subject|0|||
146154861|NCT04066114|527076356|FG002|Overall Study|Withdrawal by Subject|0|||
146154862|NCT04066114|527076354|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
146154863|NCT04066114|527076355|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
146154864|NCT04066114|527076356|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
146154865|NCT00434057|527076358|FG000|Overall Study|Withdrawal by Subject|1|||
146154866|NCT00455195|527076361|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
146154867|NCT00455195|527076362|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
146154868|NCT00455195|527076361|FG000|Double-blind Study AGLU02704|Death|1|||
146154869|NCT00455195|527076362|FG001|Double-blind Study AGLU02704|Death|0|||
146154870|NCT00455195|527076361|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
146154871|NCT00455195|527076362|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
146154872|NCT00455195|527076361|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
146154873|NCT00455195|527076362|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
146154874|NCT02148250|527076365|FG000|Screening|Withdrawal by Subject|5|||
146154875|NCT02148250|527076366|FG001|Screening|Withdrawal by Subject|0|||
146154876|NCT00922428|527076367|FG000|Overall Study|retrospective/extremely implausible data|2|||
146154877|NCT00922428|527076367|FG000|Overall Study|no medication use or questionable use|13|||
146154878|NCT00237744|527076372|FG000|Overall Study|Withdrawal by Subject|3|||
146154879|NCT00237744|527076373|FG001|Overall Study|Withdrawal by Subject|1|||
146154880|NCT00237744|527076374|FG002|Overall Study|Withdrawal by Subject|0|||
146154881|NCT04447404|527076375|FG000|Overall Study|Death|2|||
146154882|NCT04447404|527076376|FG001|Overall Study|Death|0|||
146154883|NCT04258020|527076379|FG000|Overall Study|Withdrawal by Subject|1|||
146154884|NCT04258020|527076380|FG001|Overall Study|Withdrawal by Subject|0|||
146154885|NCT02097472|527076381|FG000|Received Vaccination 2|Adverse Event|0|||
146154886|NCT02097472|527076382|FG001|Received Vaccination 2|Adverse Event|0|||
146154887|NCT02097472|527076383|FG002|Received Vaccination 2|Adverse Event|0|||
146154888|NCT02097472|527076384|FG003|Received Vaccination 2|Adverse Event|0|||
146154889|NCT02097472|527076385|FG004|Received Vaccination 2|Adverse Event|0|||
146154890|NCT02097472|527076386|FG005|Received Vaccination 2|Adverse Event|0|||
146154891|NCT02097472|527076387|FG006|Received Vaccination 2|Adverse Event|1|||
146154892|NCT02097472|527076388|FG007|Received Vaccination 2|Adverse Event|0|||
146154893|NCT03305016|527076389|FG000|Overall Study|Withdrawal by Subject|2|||
146154894|NCT01059565|527076390|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
146154895|NCT01059565|527076391|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
146154896|NCT01059565|527076390|FG000|24-Week Randomized Phase|Adverse Event|5|||
146154897|NCT01059565|527076391|FG001|24-Week Randomized Phase|Adverse Event|0|||
146154898|NCT01059565|527076390|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
146154899|NCT01059565|527076391|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
146154900|NCT01059565|527076390|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
146154901|NCT01059565|527076391|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
146154902|NCT01059565|527076390|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
146154903|NCT01059565|527076391|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
146154904|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Adverse Event|2|||
146154905|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Adverse Event|0|||
146154906|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
146154907|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
146154908|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
146154909|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
146154910|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
146154911|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
146154912|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
146154913|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
146154914|NCT01059565|527076390|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
146154915|NCT01059565|527076391|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
146154916|NCT03927950|527076392|FG000|Overall Study|Adverse Event|9|||
146154917|NCT03263429|527076393|FG000|Overall Study|Withdrawal by Subject|0|||
146154918|NCT03263429|527076394|FG001|Overall Study|Withdrawal by Subject|1|||
146154919|NCT03263429|527076395|FG002|Overall Study|Withdrawal by Subject|0|||
146154920|NCT03263429|527076393|FG000|Overall Study|Follow-Up Period Completed|0|||
146154921|NCT03263429|527076394|FG001|Overall Study|Follow-Up Period Completed|2|||
146154922|NCT03263429|527076395|FG002|Overall Study|Follow-Up Period Completed|0|||
146154923|NCT03263429|527076393|FG000|Overall Study|Death|3|||
146154924|NCT03263429|527076394|FG001|Overall Study|Death|5|||
146154925|NCT03263429|527076395|FG002|Overall Study|Death|16|||
146154926|NCT03263429|527076393|FG000|Overall Study|Participant unable to return|0|||
146154927|NCT03263429|527076394|FG001|Overall Study|Participant unable to return|0|||
146154928|NCT03263429|527076395|FG002|Overall Study|Participant unable to return|1|||
146154929|NCT03263429|527076393|FG000|Overall Study|Study Closed|0|||
146154930|NCT03263429|527076394|FG001|Overall Study|Study Closed|0|||
146154931|NCT03263429|527076395|FG002|Overall Study|Study Closed|1|||
146154932|NCT00121238|527076396|FG000|Overall Study|disease progression before intervention|1|||
146154933|NCT00121238|527076396|FG000|Overall Study|Protocol Violation|2|||
146154934|NCT01540851|527076397|FG000|Overall Study|Lost to Follow-up|14|||
146309124|NCT00705783|527645901|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
146309125|NCT00705783|527645899|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
146309126|NCT00705783|527645900|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
146154935|NCT01540851|527076398|FG001|Overall Study|Lost to Follow-up|15|||
146154936|NCT01540851|527076397|FG000|Overall Study|Withdrawal by Subject|7|||
146154937|NCT01540851|527076398|FG001|Overall Study|Withdrawal by Subject|3|||
146154938|NCT00325468|527076399|FG000|Overall Study|Adverse Event|1|||
146154939|NCT00325468|527076400|FG001|Overall Study|Adverse Event|1|||
146154940|NCT00325468|527076401|FG002|Overall Study|Adverse Event|0|||
146154941|NCT00325468|527076402|FG003|Overall Study|Adverse Event|5|||
146154942|NCT00325468|527076403|FG004|Overall Study|Adverse Event|1|||
146154943|NCT00325468|527076399|FG000|Overall Study|Death|2|||
146154944|NCT00325468|527076400|FG001|Overall Study|Death|0|||
146309127|NCT00705783|527645901|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
146154945|NCT00325468|527076401|FG002|Overall Study|Death|2|||
146309128|NCT00705783|527645899|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
146154946|NCT00325468|527076402|FG003|Overall Study|Death|4|||
146154947|NCT00325468|527076403|FG004|Overall Study|Death|0|||
146154948|NCT00325468|527076399|FG000|Overall Study|Lost to Follow-up|0|||
146154949|NCT00325468|527076400|FG001|Overall Study|Lost to Follow-up|0|||
146154950|NCT00325468|527076401|FG002|Overall Study|Lost to Follow-up|1|||
146154951|NCT00325468|527076402|FG003|Overall Study|Lost to Follow-up|2|||
146154952|NCT00325468|527076403|FG004|Overall Study|Lost to Follow-up|2|||
146154953|NCT00325468|527076399|FG000|Overall Study|Physician Decision|1|||
146154954|NCT00325468|527076400|FG001|Overall Study|Physician Decision|1|||
146154955|NCT00325468|527076401|FG002|Overall Study|Physician Decision|0|||
146154956|NCT00325468|527076402|FG003|Overall Study|Physician Decision|1|||
146154957|NCT00325468|527076403|FG004|Overall Study|Physician Decision|0|||
146154958|NCT00325468|527076399|FG000|Overall Study|Withdrawal by Subject|3|||
146154959|NCT00325468|527076400|FG001|Overall Study|Withdrawal by Subject|1|||
146154960|NCT00325468|527076401|FG002|Overall Study|Withdrawal by Subject|0|||
146154961|NCT00325468|527076402|FG003|Overall Study|Withdrawal by Subject|14|||
146154962|NCT00325468|527076403|FG004|Overall Study|Withdrawal by Subject|4|||
146154963|NCT00325468|527076399|FG000|Overall Study|site closure etc|4|||
146309129|NCT00705783|527645900|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
146309130|NCT00705783|527645901|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
146309131|NCT00705783|527645899|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
146309132|NCT00705783|527645900|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
146309133|NCT00705783|527645901|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
146309134|NCT00705783|527645899|FG000|Depot Stabilization Phase|Adverse Event|17|||
146309135|NCT00705783|527645900|FG001|Depot Stabilization Phase|Adverse Event|0|||
146309136|NCT00705783|527645901|FG002|Depot Stabilization Phase|Adverse Event|0|||
146309137|NCT00705783|527645899|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
146309138|NCT00705783|527645900|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146309139|NCT00705783|527645901|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
146309140|NCT00705783|527645899|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
146309141|NCT00705783|527645900|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146309142|NCT00705783|527645901|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
146309143|NCT00705783|527645899|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
146309144|NCT00705783|527645900|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
146309145|NCT00705783|527645901|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
146309146|NCT00705783|527645899|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
146309147|NCT00705783|527645900|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
146309148|NCT00705783|527645901|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
146309149|NCT00705783|527645899|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
146309150|NCT00705783|527645900|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
146309151|NCT00705783|527645901|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
146309152|NCT00705783|527645899|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
146309153|NCT00705783|527645900|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
146309154|NCT00705783|527645901|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
146309155|NCT00705783|527645899|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
146309156|NCT00705783|527645900|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
146309157|NCT00705783|527645901|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
146309158|NCT00705783|527645899|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
146309159|NCT00705783|527645900|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
146309160|NCT00705783|527645901|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
146309161|NCT00705783|527645899|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
146309162|NCT00705783|527645900|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
146309163|NCT00705783|527645901|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
146309164|NCT00705783|527645899|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
146309165|NCT00705783|527645900|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
146309166|NCT00705783|527645901|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
146309167|NCT00705783|527645899|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
146309168|NCT00705783|527645900|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
146309169|NCT00705783|527645901|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
146309170|NCT02285998|527645902|FG000|Overall Study|Adverse Event|9|||
146309171|NCT02285998|527645903|FG001|Overall Study|Adverse Event|8|||
146309172|NCT02285998|527645902|FG000|Overall Study|Physician Decision|1|||
146309173|NCT02285998|527645903|FG001|Overall Study|Physician Decision|2|||
146309174|NCT02285998|527645902|FG000|Overall Study|Lost to Follow-up|176|||
146309175|NCT02285998|527645903|FG001|Overall Study|Lost to Follow-up|172|||
146309176|NCT02285998|527645902|FG000|Overall Study|Withdrawal by Subject|53|||
146309177|NCT02285998|527645903|FG001|Overall Study|Withdrawal by Subject|61|||
146309178|NCT02285998|527645902|FG000|Overall Study|Other Reasons|7|||
146309179|NCT02285998|527645903|FG001|Overall Study|Other Reasons|10|||
146309180|NCT00841568|527645904|FG000|Overall Study|Adverse Event|1|||
146154964|NCT00325468|527076400|FG001|Overall Study|site closure etc|2|||
146309181|NCT00841568|527645904|FG000|Overall Study|Death|1|||
146309182|NCT00841568|527645904|FG000|Overall Study|Withdrawal by Subject|2|||
146309183|NCT00841568|527645904|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
146309184|NCT00545298|527645905|FG000|Overall Study|Issues with Standard of Care|2|||
146309185|NCT00545298|527645906|FG001|Overall Study|Issues with Standard of Care|0|||
146309186|NCT00545298|527645907|FG002|Overall Study|Issues with Standard of Care|1|||
146154965|NCT00325468|527076401|FG002|Overall Study|site closure etc|1|||
146154966|NCT00325468|527076402|FG003|Overall Study|site closure etc|8|||
146154967|NCT00325468|527076403|FG004|Overall Study|site closure etc|1|||
146309187|NCT00978029|527645908|FG000|Overall Study|Adverse Event|1|||
146309188|NCT00978029|527645909|FG001|Overall Study|Adverse Event|2|||
146309189|NCT00978029|527645910|FG002|Overall Study|Adverse Event|5|||
146309190|NCT00978029|527645908|FG000|Overall Study|Withdrawal by Subject|0|||
146309191|NCT00978029|527645909|FG001|Overall Study|Withdrawal by Subject|0|||
146309192|NCT00978029|527645910|FG002|Overall Study|Withdrawal by Subject|1|||
146309193|NCT00978029|527645908|FG000|Overall Study|Protocol Violation|0|||
146309194|NCT00978029|527645909|FG001|Overall Study|Protocol Violation|1|||
146309195|NCT00978029|527645910|FG002|Overall Study|Protocol Violation|0|||
146309196|NCT02830776|527645911|FG000|Overall Study|Lost to Follow-up|1|||
146309197|NCT01793142|527645914|FG000|Overall Study|Randomized not treated|7|||
146309198|NCT05376215|527645919|FG000|Overall Study|Withdrawal by Subject|2|||
146309199|NCT05376215|527645920|FG001|Overall Study|Withdrawal by Subject|1|||
146309200|NCT05376215|527645919|FG000|Overall Study|Lost to Follow-up|0|||
146309201|NCT05376215|527645920|FG001|Overall Study|Lost to Follow-up|1|||
146309202|NCT01301950|527645928|FG000|Overall Study|Surgery was cancelled by patient|0|||
146309203|NCT01301950|527645929|FG001|Overall Study|Surgery was cancelled by patient|1|||
146309204|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
146309205|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
146309206|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
146309207|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
146309208|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
146309209|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
146309210|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
146309211|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
146309212|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
146309213|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
146309214|NCT04041284|527645930|FG000|DB Phase (12 Weeks)|Other than specified|1|||
146309215|NCT04041284|527645931|FG001|DB Phase (12 Weeks)|Other than specified|0|||
146309216|NCT04041284|527645930|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
146309217|NCT04041284|527645931|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
146309218|NCT04041284|527645930|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
146309219|NCT04041284|527645931|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
146309220|NCT04041284|527645930|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
146309221|NCT04041284|527645931|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
146309222|NCT04041284|527645930|FG000|OL Phase (12 Weeks)|Other than specified|6|||
146309223|NCT04041284|527645931|FG001|OL Phase (12 Weeks)|Other than specified|2|||
146309224|NCT00964743|527645932|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
146309225|NCT01549002|527645933|FG000|Overall Study|Excessive pain|0|||
146309226|NCT01549002|527645934|FG001|Overall Study|Excessive pain|2|||
146309227|NCT01549002|527645933|FG000|Overall Study|Moderate sedation required|0|||
146309228|NCT01549002|527645934|FG001|Overall Study|Moderate sedation required|2|||
146309229|NCT01840579|527645935|FG000|Overall Study|Status not recorded|0|||
146309230|NCT01840579|527645936|FG001|Overall Study|Status not recorded|0|||
146309231|NCT01840579|527645937|FG002|Overall Study|Status not recorded|2|||
146309232|NCT01840579|527645938|FG003|Overall Study|Status not recorded|3|||
146309233|NCT01840579|527645939|FG004|Overall Study|Status not recorded|4|||
146309234|NCT01840579|527645940|FG005|Overall Study|Status not recorded|3|||
146309235|NCT01840579|527645941|FG006|Overall Study|Status not recorded|0|||
146309236|NCT01840579|527645942|FG007|Overall Study|Status not recorded|3|||
146309237|NCT01840579|527645943|FG008|Overall Study|Status not recorded|3|||
146309238|NCT01840579|527645944|FG009|Overall Study|Status not recorded|3|||
146154968|NCT02864082|527076404|FG000|Overall Study|Adverse Event|1|||
146309239|NCT01840579|527645935|FG000|Overall Study|Progressive disease|3|||
146309240|NCT01840579|527645936|FG001|Overall Study|Progressive disease|5|||
146309241|NCT01840579|527645937|FG002|Overall Study|Progressive disease|0|||
146309242|NCT01840579|527645938|FG003|Overall Study|Progressive disease|0|||
146309243|NCT01840579|527645939|FG004|Overall Study|Progressive disease|0|||
146309244|NCT01840579|527645940|FG005|Overall Study|Progressive disease|0|||
146309245|NCT01840579|527645941|FG006|Overall Study|Progressive disease|0|||
146309246|NCT01840579|527645942|FG007|Overall Study|Progressive disease|0|||
146309247|NCT01840579|527645943|FG008|Overall Study|Progressive disease|0|||
146309248|NCT01840579|527645944|FG009|Overall Study|Progressive disease|0|||
146309249|NCT01840579|527645935|FG000|Overall Study|Ongoing in study|0|||
146309250|NCT01840579|527645936|FG001|Overall Study|Ongoing in study|1|||
146309251|NCT01840579|527645937|FG002|Overall Study|Ongoing in study|0|||
146309252|NCT01840579|527645938|FG003|Overall Study|Ongoing in study|0|||
146309253|NCT01840579|527645939|FG004|Overall Study|Ongoing in study|0|||
146309254|NCT01840579|527645940|FG005|Overall Study|Ongoing in study|0|||
146309255|NCT01840579|527645941|FG006|Overall Study|Ongoing in study|0|||
146309256|NCT01840579|527645942|FG007|Overall Study|Ongoing in study|0|||
146309257|NCT01840579|527645943|FG008|Overall Study|Ongoing in study|0|||
146309258|NCT01840579|527645944|FG009|Overall Study|Ongoing in study|0|||
146309259|NCT01840579|527645935|FG000|Overall Study|Death|0|||
146309260|NCT01840579|527645936|FG001|Overall Study|Death|0|||
146309261|NCT01840579|527645937|FG002|Overall Study|Death|0|||
146309262|NCT01840579|527645938|FG003|Overall Study|Death|0|||
146309263|NCT01840579|527645939|FG004|Overall Study|Death|0|||
146309264|NCT01840579|527645940|FG005|Overall Study|Death|1|||
146309265|NCT01840579|527645941|FG006|Overall Study|Death|0|||
146309266|NCT01840579|527645942|FG007|Overall Study|Death|0|||
146309267|NCT01840579|527645943|FG008|Overall Study|Death|0|||
146309268|NCT01840579|527645944|FG009|Overall Study|Death|0|||
146309269|NCT01840579|527645935|FG000|Overall Study|Adverse Event|0|||
146309270|NCT01840579|527645936|FG001|Overall Study|Adverse Event|1|||
146309271|NCT01840579|527645937|FG002|Overall Study|Adverse Event|0|||
146309272|NCT01840579|527645938|FG003|Overall Study|Adverse Event|0|||
146309273|NCT01840579|527645939|FG004|Overall Study|Adverse Event|0|||
146309274|NCT01840579|527645940|FG005|Overall Study|Adverse Event|0|||
146309275|NCT01840579|527645941|FG006|Overall Study|Adverse Event|0|||
146309276|NCT01840579|527645942|FG007|Overall Study|Adverse Event|0|||
146309277|NCT01840579|527645943|FG008|Overall Study|Adverse Event|0|||
146309278|NCT01840579|527645944|FG009|Overall Study|Adverse Event|0|||
146309279|NCT01840579|527645935|FG000|Overall Study|Follow-up ended by Sponsor|0|||
146309280|NCT01840579|527645936|FG001|Overall Study|Follow-up ended by Sponsor|0|||
146309281|NCT01840579|527645937|FG002|Overall Study|Follow-up ended by Sponsor|0|||
146309282|NCT01840579|527645938|FG003|Overall Study|Follow-up ended by Sponsor|0|||
146309283|NCT01840579|527645939|FG004|Overall Study|Follow-up ended by Sponsor|0|||
146309284|NCT01840579|527645940|FG005|Overall Study|Follow-up ended by Sponsor|0|||
146309285|NCT01840579|527645941|FG006|Overall Study|Follow-up ended by Sponsor|2|||
146309286|NCT01840579|527645942|FG007|Overall Study|Follow-up ended by Sponsor|0|||
146309287|NCT01840579|527645943|FG008|Overall Study|Follow-up ended by Sponsor|0|||
146309288|NCT01840579|527645944|FG009|Overall Study|Follow-up ended by Sponsor|0|||
146309289|NCT03302975|527645946|FG000|Overall Study|Lost to Follow-up|4|||
146309290|NCT00432042|527645948|FG000|Overall Study|Protocol Violation|2|||
146309291|NCT00432042|527645949|FG001|Overall Study|Protocol Violation|0|||
146309292|NCT00432042|527645950|FG002|Overall Study|Protocol Violation|0|||
146309293|NCT00432042|527645948|FG000|Overall Study|Withdrawal by Subject|0|||
146309294|NCT00432042|527645949|FG001|Overall Study|Withdrawal by Subject|0|||
146309295|NCT00432042|527645950|FG002|Overall Study|Withdrawal by Subject|2|||
146309296|NCT00432042|527645948|FG000|Overall Study|Lost to Follow-up|5|||
146309297|NCT00432042|527645949|FG001|Overall Study|Lost to Follow-up|1|||
146309298|NCT00432042|527645950|FG002|Overall Study|Lost to Follow-up|0|||
146309299|NCT00492752|527645951|FG000|Double Blind Treatment|Death|13|||
146309300|NCT00492752|527645952|FG001|Double Blind Treatment|Death|0|||
146309301|NCT00492752|527645953|FG002|Double Blind Treatment|Death|2|||
146309302|NCT00492752|527645954|FG003|Double Blind Treatment|Death|0|||
146309303|NCT00492752|527645951|FG000|Double Blind Treatment|Adverse Event|1|||
146309304|NCT00492752|527645952|FG001|Double Blind Treatment|Adverse Event|0|||
146309305|NCT00492752|527645953|FG002|Double Blind Treatment|Adverse Event|0|||
146309306|NCT00492752|527645954|FG003|Double Blind Treatment|Adverse Event|0|||
146309307|NCT00492752|527645951|FG000|Double Blind Treatment|Protocol Violation|0|||
146309308|NCT00492752|527645952|FG001|Double Blind Treatment|Protocol Violation|0|||
146309309|NCT00492752|527645953|FG002|Double Blind Treatment|Protocol Violation|1|||
146309310|NCT00492752|527645954|FG003|Double Blind Treatment|Protocol Violation|0|||
146309311|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
146309312|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
146309313|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
146309314|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
146309315|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
146309316|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
146309317|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
146309318|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
146309319|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
146309320|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
146309321|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
146309322|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
146309323|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
146309324|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
146309325|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
146309326|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
146309327|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
146309328|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
146309329|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
146309330|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
146309331|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146309332|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146309333|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
146309334|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
146309335|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146309336|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
146309337|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146309338|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
146309339|NCT00492752|527645951|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
146309340|NCT00492752|527645952|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146309341|NCT00492752|527645953|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146309342|NCT00492752|527645954|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
146309343|NCT01357655|527645955|FG000|Overall Study|Administrative Reason by Sponsor|45|||
146309344|NCT01357655|527645956|FG001|Overall Study|Administrative Reason by Sponsor|0|||
146309345|NCT01357655|527645955|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
146309346|NCT01357655|527645956|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
146309347|NCT01357655|527645955|FG000|Overall Study|Disease Progression|1|||
146309348|NCT01357655|527645956|FG001|Overall Study|Disease Progression|0|||
146309349|NCT01357655|527645955|FG000|Overall Study|Lost to Follow-up|2|||
146309350|NCT01357655|527645956|FG001|Overall Study|Lost to Follow-up|0|||
146309351|NCT01357655|527645955|FG000|Overall Study|Maximum Clinical Benefit|2|||
146309352|NCT01357655|527645956|FG001|Overall Study|Maximum Clinical Benefit|0|||
146309353|NCT01357655|527645955|FG000|Overall Study|Reason Unspecified|1|||
146309354|NCT01357655|527645956|FG001|Overall Study|Reason Unspecified|0|||
146309355|NCT01357655|527645955|FG000|Overall Study|Study Drug Toxicity|11|||
146309356|NCT01357655|527645956|FG001|Overall Study|Study Drug Toxicity|0|||
146309357|NCT01357655|527645955|FG000|Overall Study|Subject Withdrew Consent|1|||
146309358|NCT01357655|527645956|FG001|Overall Study|Subject Withdrew Consent|0|||
146309359|NCT03803059|527645957|FG000|Overall Study|Protocol Violation|2|||
146309360|NCT03803059|527645957|FG000|Overall Study|Lost to Follow-up|1|||
146309361|NCT05885737|527645958|FG000|DB Period|Adverse Event|4|||
146309362|NCT05885737|527645959|FG001|DB Period|Adverse Event|4|||
146309363|NCT05885737|527645958|FG000|DB Period|Lost to Follow-up|0|||
146309364|NCT05885737|527645959|FG001|DB Period|Lost to Follow-up|1|||
146309365|NCT05885737|527645958|FG000|DB Period|Physician Decision|2|||
146309366|NCT05885737|527645959|FG001|DB Period|Physician Decision|0|||
146309367|NCT05885737|527645958|FG000|DB Period|Withdrawal by Subject|12|||
146309368|NCT05885737|527645959|FG001|DB Period|Withdrawal by Subject|6|||
146309369|NCT05885737|527645958|FG000|DB Period|Other: Unspecified|2|||
146309370|NCT05885737|527645959|FG001|DB Period|Other: Unspecified|2|||
146309371|NCT05885737|527645958|FG000|OLE Period|Adverse Event|3|||
146309372|NCT05885737|527645959|FG001|OLE Period|Adverse Event|2|||
146309373|NCT05885737|527645958|FG000|OLE Period|Physician Decision|1|||
146309374|NCT05885737|527645959|FG001|OLE Period|Physician Decision|0|||
146309375|NCT05885737|527645958|FG000|OLE Period|Withdrawal by Subject|5|||
146309376|NCT05885737|527645959|FG001|OLE Period|Withdrawal by Subject|5|||
146309377|NCT05885737|527645958|FG000|OLE Period|Other: Unspecified|2|||
146309378|NCT05885737|527645959|FG001|OLE Period|Other: Unspecified|1|||
146309379|NCT00880399|527647227|FG000|Overall Study|Adverse Event|4|||
146309380|NCT00880399|527647228|FG001|Overall Study|Adverse Event|6|||
146309381|NCT00880399|527647229|FG002|Overall Study|Adverse Event|5|||
146309382|NCT00880399|527647227|FG000|Overall Study|Lack of Efficacy|1|||
146309383|NCT00880399|527647228|FG001|Overall Study|Lack of Efficacy|4|||
146309384|NCT00880399|527647229|FG002|Overall Study|Lack of Efficacy|2|||
146309385|NCT00880399|527647227|FG000|Overall Study|Protocol Violation|4|||
146309386|NCT00880399|527647228|FG001|Overall Study|Protocol Violation|4|||
146309387|NCT00880399|527647229|FG002|Overall Study|Protocol Violation|6|||
146309388|NCT00880399|527647227|FG000|Overall Study|Study closed/terminated|3|||
146309389|NCT00880399|527647228|FG001|Overall Study|Study closed/terminated|7|||
146309390|NCT00880399|527647229|FG002|Overall Study|Study closed/terminated|4|||
146309391|NCT00880399|527647227|FG000|Overall Study|Lost to Follow-up|8|||
146309392|NCT00880399|527647228|FG001|Overall Study|Lost to Follow-up|5|||
146309393|NCT00880399|527647229|FG002|Overall Study|Lost to Follow-up|3|||
146309394|NCT00880399|527647227|FG000|Overall Study|Physician Decision|5|||
146309395|NCT00880399|527647228|FG001|Overall Study|Physician Decision|0|||
146309396|NCT00880399|527647229|FG002|Overall Study|Physician Decision|3|||
146309397|NCT00880399|527647227|FG000|Overall Study|Withdrawal by Subject|6|||
146309398|NCT00880399|527647228|FG001|Overall Study|Withdrawal by Subject|3|||
146309399|NCT00880399|527647229|FG002|Overall Study|Withdrawal by Subject|3|||
146309400|NCT03709654|527647230|FG000|Overall Study|Lost to Follow-up|1|||
146309401|NCT03709654|527647231|FG001|Overall Study|Lost to Follow-up|1|||
146309402|NCT03709654|527647230|FG000|Overall Study|Withdrawal by Subject|1|||
146309403|NCT03709654|527647231|FG001|Overall Study|Withdrawal by Subject|1|||
146309404|NCT03709654|527647230|FG000|Overall Study|Adverse Event|1|||
146309405|NCT03709654|527647231|FG001|Overall Study|Adverse Event|0|||
146309406|NCT01902966|527647232|FG000|Overall Study|Death|1|||
146309407|NCT01902966|527647232|FG000|Overall Study|Physician Decision|1|||
146309408|NCT01902966|527647232|FG000|Overall Study|Withdrawal by Subject|1|||
146309409|NCT01230307|527647233|FG000|Overall Study|LVAD Placement|0|||
146309410|NCT01230307|527647234|FG001|Overall Study|LVAD Placement|2|||
146309411|NCT02256540|527647238|FG000|Overall Study|Withdrawal by Subject|0|||
146309412|NCT02256540|527647239|FG001|Overall Study|Withdrawal by Subject|1|||
146309413|NCT02256540|527647240|FG002|Overall Study|Withdrawal by Subject|1|||
146309414|NCT02256540|527647238|FG000|Overall Study|Back pain preventing exercise|0|||
146309415|NCT02256540|527647239|FG001|Overall Study|Back pain preventing exercise|0|||
146309416|NCT02256540|527647240|FG002|Overall Study|Back pain preventing exercise|1|||
146309417|NCT01230242|527647241|FG000|Overall Study|Physician Decision|2|||
146309418|NCT01230242|527647241|FG000|Overall Study|Withdrawal by Subject|1|||
146309419|NCT03923426|527647242|FG000|Overall Study|Other|19|||
146309420|NCT03923426|527647242|FG000|Overall Study|Lost to Follow-up|16|||
146309421|NCT03923426|527647242|FG000|Overall Study|Death|107|||
146309422|NCT03923426|527647242|FG000|Overall Study|Incomplete response to question|13|||
146309423|NCT01918007|527647243|FG000|Overall Study|Baseline oximetry not acceptable|11|||
146309424|NCT01918007|527647244|FG001|Overall Study|Baseline oximetry not acceptable|7|||
146309425|NCT01918007|527647243|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
146309426|NCT01918007|527647244|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
146309427|NCT01918007|527647243|FG000|Overall Study|Lost to Follow-up|4|||
146309428|NCT01918007|527647244|FG001|Overall Study|Lost to Follow-up|7|||
146309429|NCT01140451|527647246|FG000|Overall Study|Withdrawal by Subject|26|||
146309430|NCT01140451|527647247|FG001|Overall Study|Withdrawal by Subject|33|||
146309431|NCT01140451|527647246|FG000|Overall Study|Adverse Event|2|||
146309432|NCT01140451|527647247|FG001|Overall Study|Adverse Event|6|||
146309433|NCT01140451|527647246|FG000|Overall Study|Physician Decision|5|||
146309434|NCT01140451|527647247|FG001|Overall Study|Physician Decision|3|||
146309435|NCT01140451|527647246|FG000|Overall Study|Lost to Follow-up|2|||
146309436|NCT01140451|527647247|FG001|Overall Study|Lost to Follow-up|0|||
146309437|NCT01140451|527647246|FG000|Overall Study|Participants Planning Pregnancy|3|||
146309438|NCT01140451|527647247|FG001|Overall Study|Participants Planning Pregnancy|0|||
146309439|NCT00552175|527647250|FG000|Overall Study|Lack of Efficacy|2|||
146309440|NCT00552175|527647251|FG001|Overall Study|Lack of Efficacy|0|||
146309441|NCT00552175|527647252|FG002|Overall Study|Lack of Efficacy|1|||
146309442|NCT00552175|527647250|FG000|Overall Study|Adverse Event|9|||
146309443|NCT00552175|527647251|FG001|Overall Study|Adverse Event|9|||
146309444|NCT00552175|527647252|FG002|Overall Study|Adverse Event|10|||
146309445|NCT00552175|527647250|FG000|Overall Study|Withdrawal by Subject|2|||
146309446|NCT00552175|527647251|FG001|Overall Study|Withdrawal by Subject|2|||
146309447|NCT00552175|527647252|FG002|Overall Study|Withdrawal by Subject|1|||
146309448|NCT00552175|527647250|FG000|Overall Study|Lost to Follow-up|0|||
146309449|NCT00552175|527647251|FG001|Overall Study|Lost to Follow-up|0|||
146309450|NCT00552175|527647252|FG002|Overall Study|Lost to Follow-up|1|||
146309451|NCT00552175|527647250|FG000|Overall Study|Entry Criteria Not Met|1|||
146309452|NCT00552175|527647251|FG001|Overall Study|Entry Criteria Not Met|1|||
146309453|NCT00552175|527647252|FG002|Overall Study|Entry Criteria Not Met|0|||
146309454|NCT00552175|527647250|FG000|Overall Study|Reason Not Specified|3|||
146309455|NCT00552175|527647251|FG001|Overall Study|Reason Not Specified|1|||
146309456|NCT00552175|527647252|FG002|Overall Study|Reason Not Specified|1|||
146309457|NCT00283595|527647253|FG000|Overall Study|Withdrawal by Subject|1|||
146309458|NCT00283595|527647254|FG001|Overall Study|Withdrawal by Subject|2|||
146309459|NCT02184195|527647260|FG000|Overall Study|Patient decision|5|||
146309460|NCT02184195|527647261|FG001|Overall Study|Patient decision|2|||
146309461|NCT02184195|527647260|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146309462|NCT02184195|527647261|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146309463|NCT02184195|527647260|FG000|Overall Study|Death|67|||
146309464|NCT02184195|527647261|FG001|Overall Study|Death|44|||
146309465|NCT02184195|527647260|FG000|Overall Study|Lost to Follow-up|1|||
146309466|NCT02184195|527647261|FG001|Overall Study|Lost to Follow-up|5|||
146309467|NCT02184195|527647260|FG000|Overall Study|Other|0|||
146309468|NCT02184195|527647261|FG001|Overall Study|Other|3|||
146309469|NCT01820364|527647262|FG000|Part I: LGX818|Death|1|||
146309470|NCT01820364|527647263|FG001|Part I: LGX818|Death|0|||
146309471|NCT01820364|527647262|FG000|Part I: LGX818|Administrative Problems|3|||
146309472|NCT01820364|527647263|FG001|Part I: LGX818|Administrative Problems|0|||
146309473|NCT01820364|527647262|FG000|Part I: LGX818|Adverse Event|6|||
146309474|NCT01820364|527647263|FG001|Part I: LGX818|Adverse Event|0|||
146309475|NCT01820364|527647262|FG000|Part I: LGX818|Disease Progression|4|||
146309476|NCT01820364|527647263|FG001|Part I: LGX818|Disease Progression|0|||
146309477|NCT01820364|527647262|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
146309478|NCT01820364|527647263|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
146309479|NCT01087775|527647267|FG000|Overall Study|failed inclusion criteria|2|||
146309480|NCT03029143|527647268|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
146309481|NCT03029143|527647269|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
146309482|NCT03029143|527647270|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
146309483|NCT03029143|527647268|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
146309484|NCT03029143|527647269|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
146309485|NCT03029143|527647270|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
146309486|NCT03029143|527647268|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
146309487|NCT03029143|527647269|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
146309488|NCT03029143|527647270|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
146309489|NCT03029143|527647268|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
146309490|NCT03029143|527647269|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
146309491|NCT03029143|527647270|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
146309492|NCT03029143|527647268|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
146309493|NCT03029143|527647269|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
146309494|NCT03029143|527647270|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
146154969|NCT02864082|527076405|FG001|Overall Study|Adverse Event|1|||
146309495|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
146309496|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
146309497|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
146309498|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
146309499|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
146309500|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
146309501|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146309502|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146309503|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
146309504|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
146309505|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
146309506|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
146309507|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146309508|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
146309509|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
146309510|NCT03029143|527647268|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
146309511|NCT03029143|527647269|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
146309512|NCT03029143|527647270|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
146309513|NCT00974675|527647273|FG000|Overall Study|Adverse Event|2|||
146309514|NCT00974675|527647274|FG001|Overall Study|Adverse Event|1|||
146309515|NCT00974675|527647275|FG002|Overall Study|Adverse Event|1|||
146309516|NCT00974675|527647276|FG003|Overall Study|Adverse Event|1|||
146309517|NCT00974675|527647273|FG000|Overall Study|Physician Decision|0|||
146309518|NCT00974675|527647274|FG001|Overall Study|Physician Decision|0|||
146309519|NCT00974675|527647275|FG002|Overall Study|Physician Decision|1|||
146309520|NCT00974675|527647276|FG003|Overall Study|Physician Decision|0|||
146309521|NCT00974675|527647273|FG000|Overall Study|Participant on holiday; unable to attend|0|||
146309522|NCT00974675|527647274|FG001|Overall Study|Participant on holiday; unable to attend|0|||
146309523|NCT00974675|527647275|FG002|Overall Study|Participant on holiday; unable to attend|0|||
146309524|NCT00974675|527647276|FG003|Overall Study|Participant on holiday; unable to attend|1|||
146309525|NCT02121262|527647277|FG000|Overall Study|Adverse Event|6|||
146309526|NCT02121262|527647278|FG001|Overall Study|Adverse Event|3|||
146309527|NCT02121262|527647277|FG000|Overall Study|Lack of Efficacy|3|||
146309528|NCT02121262|527647278|FG001|Overall Study|Lack of Efficacy|0|||
146309529|NCT02121262|527647277|FG000|Overall Study|Personal Reasons|19|||
146309530|NCT02121262|527647278|FG001|Overall Study|Personal Reasons|5|||
146309531|NCT02121262|527647277|FG000|Overall Study|Protocol Violation|1|||
146309532|NCT02121262|527647278|FG001|Overall Study|Protocol Violation|1|||
146309533|NCT02121262|527647277|FG000|Overall Study|Participant Dropped-out|0|||
146309534|NCT02121262|527647278|FG001|Overall Study|Participant Dropped-out|1|||
146309535|NCT02121262|527647277|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
146309536|NCT02121262|527647278|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
146309537|NCT02121262|527647277|FG000|Overall Study|Consent Withdrawn|1|||
146309538|NCT02121262|527647278|FG001|Overall Study|Consent Withdrawn|0|||
146309539|NCT01553188|527647279|FG000|Overall Study|Patient choice|1|||
146309540|NCT01553188|527647280|FG001|Overall Study|Patient choice|0|||
146309541|NCT01553188|527647281|FG002|Overall Study|Patient choice|0|||
146309542|NCT01553188|527647282|FG003|Overall Study|Patient choice|0|||
146309543|NCT01553188|527647279|FG000|Overall Study|Intercurrent illness and adverse event|0|||
146309544|NCT01553188|527647280|FG001|Overall Study|Intercurrent illness and adverse event|1|||
146309545|NCT01553188|527647281|FG002|Overall Study|Intercurrent illness and adverse event|2|||
146309546|NCT01553188|527647282|FG003|Overall Study|Intercurrent illness and adverse event|0|||
146309547|NCT04744207|527647284|FG000|Treatment|Withdrawal by Subject|2|||
146309548|NCT04744207|527647285|FG001|Treatment|Withdrawal by Subject|0|||
146309549|NCT04744207|527647284|FG000|Treatment|Adverse Event|1|||
146309550|NCT04744207|527647285|FG001|Treatment|Adverse Event|2|||
146309551|NCT00777101|527647290|FG000|Overall Study|Death|48|||
146309552|NCT00777101|527647291|FG001|Overall Study|Death|43|||
146154970|NCT02864082|527076404|FG000|Overall Study|Lost to Follow-up|0|||
146154971|NCT02864082|527076405|FG001|Overall Study|Lost to Follow-up|1|||
146309553|NCT00777101|527647290|FG000|Overall Study|Withdrawal by Subject|11|||
146154972|NCT02864082|527076404|FG000|Overall Study|Withdrawal by Subject|2|||
146154973|NCT02864082|527076405|FG001|Overall Study|Withdrawal by Subject|2|||
146154974|NCT03621696|527076406|FG000|Overall Study|Not eligible|0|||
146309554|NCT00777101|527647291|FG001|Overall Study|Withdrawal by Subject|6|||
146309555|NCT00777101|527647290|FG000|Overall Study|Lost to Follow-up|2|||
146309556|NCT00777101|527647291|FG001|Overall Study|Lost to Follow-up|1|||
146309557|NCT00777101|527647290|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146309558|NCT00777101|527647291|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
146309559|NCT00777101|527647290|FG000|Overall Study|Failed to Return|0|||
146309560|NCT00777101|527647291|FG001|Overall Study|Failed to Return|1|||
146309561|NCT00961220|527647292|FG000|Overall Study|Adverse Event|3|||
146309562|NCT00961220|527647292|FG000|Overall Study|Lack of Efficacy|1|||
146309563|NCT00961220|527647292|FG000|Overall Study|No IV access for O6BG|1|||
146309564|NCT00961220|527647292|FG000|Overall Study|O6BG no longer supplied|1|||
146309565|NCT00961220|527647292|FG000|Overall Study|Complete Response prior to 12 courses|1|||
146309566|NCT00282334|527647293|FG000|Overall Study|Withdrawal by Subject|8|||
146309567|NCT00282334|527647294|FG001|Overall Study|Withdrawal by Subject|5|||
146309568|NCT00825162|527647301|FG000|Overall Study|Withdrawal by Subject|11|||
146309569|NCT00825162|527647302|FG001|Overall Study|Withdrawal by Subject|13|||
146309570|NCT00825162|527647303|FG002|Overall Study|Withdrawal by Subject|3|||
146309571|NCT00825162|527647301|FG000|Overall Study|Lost to Follow-up|9|||
146309572|NCT00825162|527647302|FG001|Overall Study|Lost to Follow-up|6|||
146309573|NCT00825162|527647303|FG002|Overall Study|Lost to Follow-up|3|||
146309574|NCT00825162|527647301|FG000|Overall Study|Physician Decision|2|||
146309575|NCT00825162|527647302|FG001|Overall Study|Physician Decision|0|||
146309576|NCT00825162|527647303|FG002|Overall Study|Physician Decision|0|||
146309577|NCT00825162|527647301|FG000|Overall Study|Move away from the study area|1|||
146309578|NCT00825162|527647302|FG001|Overall Study|Move away from the study area|0|||
146309579|NCT00825162|527647303|FG002|Overall Study|Move away from the study area|0|||
146309580|NCT00825162|527647301|FG000|Overall Study|Unable to attend the study visit|5|||
146309581|NCT00825162|527647302|FG001|Overall Study|Unable to attend the study visit|2|||
146309582|NCT00825162|527647303|FG002|Overall Study|Unable to attend the study visit|0|||
146309583|NCT00781911|527647308|FG000|Overall Study|Adverse Event|4|||
146309584|NCT00781911|527647309|FG001|Overall Study|Adverse Event|4|||
146309585|NCT00781911|527647308|FG000|Overall Study|Withdrawal by Subject|1|||
146309586|NCT00781911|527647309|FG001|Overall Study|Withdrawal by Subject|2|||
146309587|NCT00781911|527647308|FG000|Overall Study|Physician Decision|0|||
146309588|NCT00781911|527647309|FG001|Overall Study|Physician Decision|2|||
146309589|NCT00781911|527647308|FG000|Overall Study|Sponsor Decision|1|||
146309590|NCT00781911|527647309|FG001|Overall Study|Sponsor Decision|0|||
146309591|NCT03317795|527647312|FG000|Overall Study|IUD Expulsion|1|||
146309592|NCT03317795|527647313|FG001|Overall Study|IUD Expulsion|0|||
146309593|NCT03317795|527647312|FG000|Overall Study|Lost to Follow-up|1|||
146309594|NCT03317795|527647313|FG001|Overall Study|Lost to Follow-up|3|||
146309595|NCT03317795|527647312|FG000|Overall Study|Treatment change|0|||
146309596|NCT03317795|527647313|FG001|Overall Study|Treatment change|3|||
146309597|NCT03317795|527647312|FG000|Overall Study|Intolerance of medication|0|||
146309598|NCT03317795|527647313|FG001|Overall Study|Intolerance of medication|1|||
146309599|NCT00939783|527647315|FG000|Overall Study|Death|6|||
146309600|NCT00939783|527647315|FG000|Overall Study|Adverse Event|39|||
146309601|NCT00939783|527647315|FG000|Overall Study|Study Terminated by Sponsor|498|||
146309602|NCT00939783|527647315|FG000|Overall Study|Withdrawal by Subject|78|||
146309603|NCT00939783|527647315|FG000|Overall Study|Other|16|||
146309604|NCT00939783|527647315|FG000|Overall Study|Lost to Follow-up|8|||
146309605|NCT00939783|527647315|FG000|Overall Study|Protocol Violation|3|||
146309606|NCT00939783|527647315|FG000|Overall Study|Enrolled but not treated|1|||
146309607|NCT00501007|527647318|FG000|Overall Study|Inclusion criteria not met.|29|||
146309608|NCT00501007|527647319|FG001|Overall Study|Inclusion criteria not met.|25|||
146309609|NCT01892163|527647322|FG000|Overall Study|Death|1|||
146309610|NCT01892163|527647323|FG001|Overall Study|Death|1|||
146309611|NCT01892163|527647322|FG000|Overall Study|Lost to Follow-up|1|||
146309612|NCT01892163|527647323|FG001|Overall Study|Lost to Follow-up|0|||
146309613|NCT01924182|527647324|FG000|Overall Study|Withdrawal by Subject|1|||
146309614|NCT01924182|527647325|FG001|Overall Study|Withdrawal by Subject|0|||
146309615|NCT02577146|527647327|FG000|Overall Study|Lost to Follow-up|8|||
146309616|NCT02577146|527647327|FG000|Overall Study|Physician Decision|3|||
146309617|NCT02577146|527647327|FG000|Overall Study|Screen Failure|17|||
146309618|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
146309619|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
146309620|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
146309621|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
146309622|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
146309623|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
146154975|NCT03621696|527076407|FG001|Overall Study|Not eligible|0|||
146309624|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
146309625|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
146309626|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
146154976|NCT03621696|527076408|FG002|Overall Study|Not eligible|0|||
146154977|NCT03621696|527076409|FG003|Overall Study|Not eligible|5|||
146309627|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
146309628|NCT00219284|527647328|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
146309629|NCT00219284|527647329|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
146309630|NCT00219284|527647328|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
146309631|NCT00219284|527647329|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
146309632|NCT00219284|527647328|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
146309633|NCT00219284|527647329|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
146309634|NCT00219284|527647328|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
146309635|NCT00219284|527647329|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
146309636|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
146309637|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
146309638|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
146309639|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
146309640|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
146309641|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
146309642|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
146309643|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
146309644|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to death|4|||
146309645|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to death|3|||
146309646|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
146309647|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
146309648|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
146309649|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
146309650|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
146309651|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
146309652|NCT02258451|527647332|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
146309653|NCT02258451|527647333|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
146309654|NCT02258451|527647332|FG000|Overall Study|Other reason|1|||
146309655|NCT02258451|527647333|FG001|Overall Study|Other reason|1|||
146309656|NCT02258451|527647332|FG000|Overall Study|Never treated|2|||
146309657|NCT02258451|527647333|FG001|Overall Study|Never treated|3|||
146309658|NCT03021499|527647343|FG000|Overall Study|Adverse Event|1|||
146154978|NCT03621696|527076406|FG000|Overall Study|Withdrawal by Subject|1|||
146154979|NCT03621696|527076407|FG001|Overall Study|Withdrawal by Subject|1|||
146154980|NCT03621696|527076408|FG002|Overall Study|Withdrawal by Subject|1|||
146154981|NCT03621696|527076409|FG003|Overall Study|Withdrawal by Subject|0|||
146154982|NCT03621696|527076406|FG000|Overall Study|Physician Decision|0|||
146154983|NCT03621696|527076407|FG001|Overall Study|Physician Decision|0|||
146154984|NCT03621696|527076408|FG002|Overall Study|Physician Decision|1|||
146154985|NCT03621696|527076409|FG003|Overall Study|Physician Decision|0|||
146309659|NCT03021499|527647344|FG001|Overall Study|Adverse Event|0|||
146309660|NCT03021499|527647343|FG000|Overall Study|Death|1|||
146309661|NCT03021499|527647344|FG001|Overall Study|Death|5|||
146309662|NCT03021499|527647343|FG000|Overall Study|Lack of Efficacy|0|||
146309663|NCT03021499|527647344|FG001|Overall Study|Lack of Efficacy|1|||
146309664|NCT03021499|527647343|FG000|Overall Study|Lost to Follow-up|1|||
146309665|NCT03021499|527647344|FG001|Overall Study|Lost to Follow-up|3|||
146309666|NCT03021499|527647343|FG000|Overall Study|Physician Decision|2|||
146309667|NCT03021499|527647344|FG001|Overall Study|Physician Decision|3|||
146309668|NCT03021499|527647343|FG000|Overall Study|Pregnancy|1|||
146309669|NCT03021499|527647344|FG001|Overall Study|Pregnancy|0|||
146309670|NCT03021499|527647343|FG000|Overall Study|Withdrawal by Subject|7|||
146309671|NCT03021499|527647344|FG001|Overall Study|Withdrawal by Subject|14|||
146309672|NCT03021499|527647343|FG000|Overall Study|Prohibited medication required|1|||
146309673|NCT03021499|527647344|FG001|Overall Study|Prohibited medication required|0|||
146309674|NCT03021499|527647343|FG000|Overall Study|Protocol non-compliance|1|||
146309675|NCT03021499|527647344|FG001|Overall Study|Protocol non-compliance|1|||
146309676|NCT03021499|527647343|FG000|Overall Study|None of the above|0|||
146309677|NCT03021499|527647344|FG001|Overall Study|None of the above|4|||
146309678|NCT03021499|527647343|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
146309679|NCT03021499|527647344|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
146309680|NCT01210690|527647345|FG000|Overall Study|Adverse Event|7|||
146309681|NCT01210690|527647345|FG000|Overall Study|Lack of Efficacy|12|||
146309682|NCT01210690|527647345|FG000|Overall Study|Lost to Follow-up|3|||
146309683|NCT01210690|527647345|FG000|Overall Study|Disease Remission|1|||
146309684|NCT01210690|527647345|FG000|Overall Study|Withdrawal by Subject|1|||
146309685|NCT01210690|527647345|FG000|Overall Study|Patient refused to swallow|1|||
146309686|NCT01210690|527647345|FG000|Overall Study|Patient could not take glucose|1|||
146309687|NCT00820950|527647346|FG000|Overall Study|Scheduling Conflict|0|||
146309688|NCT00820950|527647347|FG001|Overall Study|Scheduling Conflict|0|||
146309689|NCT00820950|527647348|FG002|Overall Study|Scheduling Conflict|0|||
146309690|NCT00820950|527647349|FG003|Overall Study|Scheduling Conflict|0|||
146309691|NCT00820950|527647350|FG004|Overall Study|Scheduling Conflict|0|||
146309692|NCT00820950|527647351|FG005|Overall Study|Scheduling Conflict|0|||
146309693|NCT00820950|527647352|FG006|Overall Study|Scheduling Conflict|1|||
146309694|NCT00820950|527647353|FG007|Overall Study|Scheduling Conflict|1|||
146309695|NCT00820950|527647354|FG008|Overall Study|Scheduling Conflict|0|||
146309696|NCT00820950|527647355|FG009|Overall Study|Scheduling Conflict|0|||
146309697|NCT00820950|527647346|FG000|Overall Study|Protocol Violation|1|||
146309698|NCT00820950|527647347|FG001|Overall Study|Protocol Violation|1|||
146309699|NCT00820950|527647348|FG002|Overall Study|Protocol Violation|0|||
146309700|NCT00820950|527647349|FG003|Overall Study|Protocol Violation|0|||
146309701|NCT00820950|527647350|FG004|Overall Study|Protocol Violation|0|||
146309702|NCT00820950|527647351|FG005|Overall Study|Protocol Violation|0|||
146309703|NCT00820950|527647352|FG006|Overall Study|Protocol Violation|0|||
146309704|NCT00820950|527647353|FG007|Overall Study|Protocol Violation|0|||
146309705|NCT00820950|527647354|FG008|Overall Study|Protocol Violation|0|||
146309706|NCT00820950|527647355|FG009|Overall Study|Protocol Violation|0|||
146309707|NCT00528021|527647356|FG000|Overall Study|Lack of Efficacy|17|||
146309708|NCT00528021|527647357|FG001|Overall Study|Lack of Efficacy|13|||
146309709|NCT00528021|527647358|FG002|Overall Study|Lack of Efficacy|7|||
146309710|NCT00528021|527647359|FG003|Overall Study|Lack of Efficacy|9|||
146309711|NCT05264740|527647360|FG000|Baseline|Withdrawal by Subject|0|||
146309712|NCT05264740|527647361|FG001|Baseline|Withdrawal by Subject|1|||
146309713|NCT05264740|527647360|FG000|Follow Up 1|Lost to Follow-up|1|||
146309714|NCT05264740|527647361|FG001|Follow Up 1|Lost to Follow-up|1|||
146309715|NCT05264740|527647360|FG000|Follow Up 1|Withdrawal by Subject|0|||
146309716|NCT05264740|527647361|FG001|Follow Up 1|Withdrawal by Subject|1|||
146309717|NCT05264740|527647360|FG000|Follow Up 2|Lost to Follow-up|1|||
146309718|NCT05264740|527647361|FG001|Follow Up 2|Lost to Follow-up|4|||
146309719|NCT05264740|527647360|FG000|Follow Up 3|Lost to Follow-up|7|||
146309720|NCT05264740|527647361|FG001|Follow Up 3|Lost to Follow-up|4|||
146309721|NCT02037295|527648595|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
146309722|NCT02037295|527648596|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
146309723|NCT02037295|527648597|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
146309724|NCT02037295|527648598|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
146309725|NCT02004262|527648604|FG000|Overall Study|Death|67|||
146309726|NCT02004262|527648605|FG001|Overall Study|Death|64|||
146309727|NCT02004262|527648606|FG002|Overall Study|Death|66|||
146309728|NCT02004262|527648607|FG003|Overall Study|Death|28|||
146309729|NCT02004262|527648608|FG004|Overall Study|Death|29|||
146309730|NCT02004262|527648609|FG005|Overall Study|Death|22|||
146309731|NCT02004262|527648604|FG000|Overall Study|Withdrawal by Subject|1|||
146309732|NCT02004262|527648605|FG001|Overall Study|Withdrawal by Subject|0|||
146309733|NCT02004262|527648606|FG002|Overall Study|Withdrawal by Subject|4|||
146309734|NCT02004262|527648607|FG003|Overall Study|Withdrawal by Subject|0|||
146309735|NCT02004262|527648608|FG004|Overall Study|Withdrawal by Subject|1|||
146309736|NCT02004262|527648609|FG005|Overall Study|Withdrawal by Subject|3|||
146309737|NCT02004262|527648604|FG000|Overall Study|Lost to Follow-up|1|||
146309738|NCT02004262|527648605|FG001|Overall Study|Lost to Follow-up|1|||
146309739|NCT02004262|527648606|FG002|Overall Study|Lost to Follow-up|0|||
146309740|NCT02004262|527648607|FG003|Overall Study|Lost to Follow-up|0|||
146309741|NCT02004262|527648608|FG004|Overall Study|Lost to Follow-up|0|||
146309742|NCT02004262|527648609|FG005|Overall Study|Lost to Follow-up|0|||
146309743|NCT02004262|527648604|FG000|Overall Study|Study Terminated by Sponsor|4|||
146309744|NCT02004262|527648605|FG001|Overall Study|Study Terminated by Sponsor|3|||
146309745|NCT02004262|527648606|FG002|Overall Study|Study Terminated by Sponsor|2|||
146309746|NCT02004262|527648607|FG003|Overall Study|Study Terminated by Sponsor|1|||
146309747|NCT02004262|527648608|FG004|Overall Study|Study Terminated by Sponsor|1|||
146309748|NCT02004262|527648609|FG005|Overall Study|Study Terminated by Sponsor|5|||
146309749|NCT01146873|527648610|FG000|Overall Study|Transfer out|0|||
146309750|NCT01146873|527648611|FG001|Overall Study|Transfer out|6|||
146309751|NCT03200366|527648614|FG000|Patient Navigation Intervention Given|Death|0|||
146309752|NCT03200366|527648615|FG001|Patient Navigation Intervention Given|Death|2|||
146309753|NCT03200366|527648616|FG002|Patient Navigation Intervention Given|Death|0|||
146309754|NCT03200366|527648614|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
146309755|NCT03200366|527648615|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
146309756|NCT03200366|527648616|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
146309757|NCT03200366|527648614|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
146154986|NCT05177770|527076410|FG000|Overall Study|Death|4|||
146309758|NCT03200366|527648615|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
146309759|NCT03200366|527648616|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
146309760|NCT03200366|527648614|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
146309761|NCT03200366|527648615|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
146154987|NCT05177770|527076410|FG000|Overall Study|Withdrawal by Subject|1|||
146309762|NCT03200366|527648616|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
146154988|NCT05177770|527076410|FG000|Overall Study|Adverse Event prior to dosing|1|||
146309763|NCT03200366|527648614|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
146309764|NCT03200366|527648615|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
146309765|NCT03200366|527648616|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
146309766|NCT03200366|527648614|FG000|6 Month Post-Baseline Interview|Death|1|||
146309767|NCT03200366|527648615|FG001|6 Month Post-Baseline Interview|Death|1|||
146309768|NCT03200366|527648616|FG002|6 Month Post-Baseline Interview|Death|1|||
146309769|NCT03200366|527648614|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
146309770|NCT03200366|527648615|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
146309771|NCT03200366|527648616|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
146309772|NCT03200366|527648614|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
146309773|NCT03200366|527648615|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
146309774|NCT03200366|527648616|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
146309775|NCT03200366|527648614|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
146309776|NCT03200366|527648615|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
146309777|NCT03200366|527648616|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
146309778|NCT03200366|527648614|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
146309779|NCT03200366|527648615|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
146309780|NCT03200366|527648616|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
146309781|NCT03200366|527648614|FG000|9 Month Post-Baseline Interview|Death|1|||
146309782|NCT03200366|527648615|FG001|9 Month Post-Baseline Interview|Death|1|||
146309783|NCT03200366|527648616|FG002|9 Month Post-Baseline Interview|Death|1|||
146309784|NCT03200366|527648614|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
146309785|NCT03200366|527648615|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
146309786|NCT03200366|527648616|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
146309787|NCT03200366|527648614|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
146309788|NCT03200366|527648615|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
146309789|NCT03200366|527648616|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
146309790|NCT03200366|527648614|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
146309791|NCT03200366|527648615|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
146309792|NCT03200366|527648616|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
146309793|NCT04677959|527648617|FG000|Overall Study|Adverse Event|1|||
146309794|NCT04677959|527648618|FG001|Overall Study|Adverse Event|9|||
146309795|NCT04677959|527648617|FG000|Overall Study|Withdrawal by Subject|2|||
146309796|NCT04677959|527648618|FG001|Overall Study|Withdrawal by Subject|15|||
146309797|NCT04677959|527648617|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146309798|NCT04677959|527648618|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146309799|NCT04677959|527648617|FG000|Overall Study|Non-compliance with study drug|0|||
146309800|NCT04677959|527648618|FG001|Overall Study|Non-compliance with study drug|2|||
146309801|NCT04677959|527648617|FG000|Overall Study|Protocol deviation|0|||
146309802|NCT04677959|527648618|FG001|Overall Study|Protocol deviation|11|||
146309803|NCT04677959|527648617|FG000|Overall Study|Lost to Follow-up|9|||
146309804|NCT04677959|527648618|FG001|Overall Study|Lost to Follow-up|13|||
146309805|NCT04677959|527648617|FG000|Overall Study|Other than specified|0|||
146309806|NCT04677959|527648618|FG001|Overall Study|Other than specified|8|||
146309807|NCT00732303|527648619|FG000|Overall Study|Study Terminated|2|||
146309808|NCT00264875|527648626|FG000|Overall Study|Adverse Event|6|||
146309809|NCT00264875|527648626|FG000|Overall Study|Lost to Follow-up|6|||
146309810|NCT00264875|527648626|FG000|Overall Study|Protocol Violation|11|||
146309811|NCT00264875|527648626|FG000|Overall Study|Withdrawal by Subject|7|||
146309812|NCT01074190|527648627|FG000|Overall Study|Emergency Cesarean Delivery|1|||
146309813|NCT01074190|527648628|FG001|Overall Study|Emergency Cesarean Delivery|2|||
146309814|NCT01074190|527648629|FG002|Overall Study|Emergency Cesarean Delivery|1|||
146309815|NCT01074190|527648627|FG000|Overall Study|Protocol Violation|2|||
146309816|NCT01074190|527648628|FG001|Overall Study|Protocol Violation|1|||
146309817|NCT01074190|527648629|FG002|Overall Study|Protocol Violation|0|||
146309818|NCT01074190|527648627|FG000|Overall Study|Delivered in under 90 minutes|0|||
146309819|NCT01074190|527648628|FG001|Overall Study|Delivered in under 90 minutes|2|||
146309820|NCT01074190|527648629|FG002|Overall Study|Delivered in under 90 minutes|1|||
146309821|NCT01074190|527648627|FG000|Overall Study|Subject withdrew consent|1|||
146309822|NCT01074190|527648628|FG001|Overall Study|Subject withdrew consent|1|||
146309823|NCT01074190|527648629|FG002|Overall Study|Subject withdrew consent|1|||
146309824|NCT01500278|527648630|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
146309825|NCT01500278|527648631|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
146309826|NCT01500278|527648630|FG000|Week 0 - Week 12|Protocol Violation|10|||
146309827|NCT01500278|527648631|FG001|Week 0 - Week 12|Protocol Violation|16|||
146309828|NCT01500278|527648630|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
146309829|NCT01500278|527648631|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
146309830|NCT01500278|527648630|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
146309831|NCT01500278|527648631|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
146309832|NCT01500278|527648630|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
146309833|NCT01500278|527648631|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
146309834|NCT01500278|527648630|FG000|Week 0 - Week 12|Patient decision|1|||
146309835|NCT01500278|527648631|FG001|Week 0 - Week 12|Patient decision|0|||
146309836|NCT01500278|527648630|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
146309837|NCT01500278|527648631|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
146309838|NCT01500278|527648630|FG000|Week 0 - Week 12|Investigator decision|1|||
146309839|NCT01500278|527648631|FG001|Week 0 - Week 12|Investigator decision|0|||
146309840|NCT01500278|527648630|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
146309841|NCT01500278|527648631|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
146309842|NCT01500278|527648630|FG000|Week 0 - Week 12|Sponsor decision|1|||
146309843|NCT01500278|527648631|FG001|Week 0 - Week 12|Sponsor decision|0|||
146309844|NCT01500278|527648630|FG000|Week 0 - Week 12|Personal reason|0|||
146309845|NCT01500278|527648631|FG001|Week 0 - Week 12|Personal reason|1|||
146309846|NCT01500278|527648630|FG000|Week 0 - Week 12|Other serious disease|0|||
146309847|NCT01500278|527648631|FG001|Week 0 - Week 12|Other serious disease|1|||
146309848|NCT01500278|527648630|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
146309849|NCT01500278|527648631|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
146309850|NCT01500278|527648630|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
146309851|NCT01500278|527648631|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
146309852|NCT01500278|527648630|FG000|Week 13 - Week 104|Protocol Violation|6|||
146309853|NCT01500278|527648631|FG001|Week 13 - Week 104|Protocol Violation|6|||
146309854|NCT01500278|527648630|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
146309855|NCT01500278|527648631|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
146309856|NCT01500278|527648630|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
146309857|NCT01500278|527648631|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
146309858|NCT01500278|527648630|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
146309859|NCT01500278|527648631|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
146309860|NCT01500278|527648630|FG000|Week 13 - Week 104|Non/bad compliance|7|||
146309861|NCT01500278|527648631|FG001|Week 13 - Week 104|Non/bad compliance|5|||
146309862|NCT01500278|527648630|FG000|Week 13 - Week 104|Recurrent infections|1|||
146309863|NCT01500278|527648631|FG001|Week 13 - Week 104|Recurrent infections|0|||
146309864|NCT01500278|527648630|FG000|Week 13 - Week 104|False positive test|1|||
146309865|NCT01500278|527648631|FG001|Week 13 - Week 104|False positive test|2|||
146309866|NCT01500278|527648630|FG000|Week 13 - Week 104|Sponsor request|4|||
146309867|NCT01500278|527648631|FG001|Week 13 - Week 104|Sponsor request|0|||
146309868|NCT01500278|527648630|FG000|Week 13 - Week 104|Withdrawn in error|1|||
146309869|NCT01500278|527648631|FG001|Week 13 - Week 104|Withdrawn in error|0|||
146309870|NCT01500278|527648630|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
146309871|NCT01500278|527648631|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
146309872|NCT01500278|527648630|FG000|Week 13 - Week 104|Protocol deviation|1|||
146309873|NCT01500278|527648631|FG001|Week 13 - Week 104|Protocol deviation|0|||
146309874|NCT01500278|527648630|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
146309875|NCT01500278|527648631|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
146309876|NCT01500278|527648630|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
146309877|NCT01500278|527648631|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
146309878|NCT01500278|527648630|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
146309879|NCT01500278|527648631|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
146309880|NCT01500278|527648630|FG000|Week 13 - Week 104|Relocation|0|||
146309881|NCT01500278|527648631|FG001|Week 13 - Week 104|Relocation|1|||
146309882|NCT01500278|527648630|FG000|Week 13 - Week 104|Sponsor decision|0|||
146309883|NCT01500278|527648631|FG001|Week 13 - Week 104|Sponsor decision|2|||
146309884|NCT01500278|527648630|FG000|Week 13 - Week 104|Medical monitor decision|0|||
146309885|NCT01500278|527648631|FG001|Week 13 - Week 104|Medical monitor decision|2|||
146309886|NCT01500278|527648630|FG000|Week 13 - Week 104|Personal reason|0|||
146309887|NCT01500278|527648631|FG001|Week 13 - Week 104|Personal reason|1|||
146309888|NCT01500278|527648630|FG000|Week 13 - Week 104|Not completed|0|||
146309889|NCT01500278|527648631|FG001|Week 13 - Week 104|Not completed|1|||
146309890|NCT01500278|527648630|FG000|Week 13 - Week 104|Death|2|||
146309891|NCT01500278|527648631|FG001|Week 13 - Week 104|Death|4|||
146309892|NCT01500278|527648630|FG000|Week 13 - Week 104|Adverse Event|54|||
146309893|NCT01500278|527648631|FG001|Week 13 - Week 104|Adverse Event|54|||
146309894|NCT04718974|527648635|FG000|Overall Study|Death|0|||
146309895|NCT04718974|527648636|FG001|Overall Study|Death|2|||
146309896|NCT04718974|527648635|FG000|Overall Study|Lost to Follow-up|10|||
146309897|NCT04718974|527648636|FG001|Overall Study|Lost to Follow-up|20|||
146309898|NCT04718974|527648635|FG000|Overall Study|Transferred out|2|||
146309899|NCT04718974|527648636|FG001|Overall Study|Transferred out|4|||
146309900|NCT01709435|527648637|FG000|Overall Study|Adverse Event|1|||
146309901|NCT01709435|527648638|FG001|Overall Study|Adverse Event|1|||
146309902|NCT01709435|527648639|FG002|Overall Study|Adverse Event|1|||
146309903|NCT01709435|527648640|FG003|Overall Study|Adverse Event|0|||
146309904|NCT01709435|527648641|FG004|Overall Study|Adverse Event|0|||
146309905|NCT01709435|527648642|FG005|Overall Study|Adverse Event|1|||
146309906|NCT01709435|527648637|FG000|Overall Study|Lack of Efficacy|5|||
146309907|NCT01709435|527648638|FG001|Overall Study|Lack of Efficacy|7|||
146309908|NCT01709435|527648639|FG002|Overall Study|Lack of Efficacy|2|||
146309909|NCT01709435|527648640|FG003|Overall Study|Lack of Efficacy|2|||
146309910|NCT01709435|527648641|FG004|Overall Study|Lack of Efficacy|6|||
146309911|NCT01709435|527648642|FG005|Overall Study|Lack of Efficacy|3|||
146309912|NCT01709435|527648637|FG000|Overall Study|Physician Decision|0|||
146309913|NCT01709435|527648638|FG001|Overall Study|Physician Decision|1|||
146309914|NCT01709435|527648639|FG002|Overall Study|Physician Decision|0|||
146309915|NCT01709435|527648640|FG003|Overall Study|Physician Decision|1|||
146309916|NCT01709435|527648641|FG004|Overall Study|Physician Decision|2|||
146309917|NCT01709435|527648642|FG005|Overall Study|Physician Decision|0|||
146309918|NCT01709435|527648637|FG000|Overall Study|Withdrawal by Subject|0|||
146309919|NCT01709435|527648638|FG001|Overall Study|Withdrawal by Subject|0|||
146309920|NCT01709435|527648639|FG002|Overall Study|Withdrawal by Subject|3|||
146154989|NCT03585244|527076413|FG000|Overall Study|Withdrawal by Subject|15|||
146154990|NCT02105948|527076414|FG000|Overall Study|Adverse Event|10|||
146154991|NCT02105948|527076415|FG001|Overall Study|Adverse Event|7|||
146154992|NCT02105948|527076416|FG002|Overall Study|Adverse Event|11|||
146154993|NCT02105948|527076417|FG003|Overall Study|Adverse Event|11|||
146154994|NCT02105948|527076414|FG000|Overall Study|Lack of Efficacy|0|||
146154995|NCT02105948|527076415|FG001|Overall Study|Lack of Efficacy|1|||
146154996|NCT02105948|527076416|FG002|Overall Study|Lack of Efficacy|3|||
146154997|NCT02105948|527076417|FG003|Overall Study|Lack of Efficacy|2|||
146154998|NCT02105948|527076414|FG000|Overall Study|Lost to Follow-up|0|||
146154999|NCT02105948|527076415|FG001|Overall Study|Lost to Follow-up|0|||
146155000|NCT02105948|527076416|FG002|Overall Study|Lost to Follow-up|2|||
146155001|NCT02105948|527076417|FG003|Overall Study|Lost to Follow-up|1|||
146155002|NCT02105948|527076414|FG000|Overall Study|Physician Decision|2|||
146155003|NCT02105948|527076415|FG001|Overall Study|Physician Decision|2|||
146155004|NCT02105948|527076416|FG002|Overall Study|Physician Decision|2|||
146155005|NCT02105948|527076417|FG003|Overall Study|Physician Decision|2|||
146155006|NCT02105948|527076414|FG000|Overall Study|Withdrawal by Subject|15|||
146155007|NCT02105948|527076415|FG001|Overall Study|Withdrawal by Subject|10|||
146155008|NCT02105948|527076416|FG002|Overall Study|Withdrawal by Subject|10|||
146155009|NCT02105948|527076417|FG003|Overall Study|Withdrawal by Subject|11|||
146155010|NCT03273946|527076422|FG000|Overall Study|Withdrawal by Subject|5|||
146155011|NCT03273946|527076422|FG000|Overall Study|Unwillingness of the guardian|1|||
146155012|NCT03273946|527076422|FG000|Overall Study|Participant refused to use the drug|2|||
146155013|NCT03273946|527076422|FG000|Overall Study|Participant relative refused to use drug|1|||
146155014|NCT01220557|527076424|FG000|Overall Study|Lost to Follow-up|5|||
146155015|NCT01220557|527076425|FG001|Overall Study|Lost to Follow-up|3|||
146155016|NCT01220557|527076424|FG000|Overall Study|attended less than 6 lessons|1|||
146155017|NCT01220557|527076425|FG001|Overall Study|attended less than 6 lessons|2|||
146155018|NCT02199028|527076426|FG000|Week 1|Adverse Event|1|||
146155019|NCT02199028|527076427|FG001|Week 1|Adverse Event|0|||
146155020|NCT02199028|527076426|FG000|Week 3|Adverse Event|1|||
146155021|NCT02199028|527076427|FG001|Week 3|Adverse Event|0|||
146155022|NCT04072159|527076430|FG000|Overall Study|Lost to Follow-up|6|||
146155023|NCT04072159|527076431|FG001|Overall Study|Lost to Follow-up|6|||
146155024|NCT04072159|527076430|FG000|Overall Study|Withdrawal by Subject|2|||
146155025|NCT04072159|527076431|FG001|Overall Study|Withdrawal by Subject|0|||
146155026|NCT00695669|527076432|FG000|Overall Study|Adverse Event|0|||
146155027|NCT00695669|527076433|FG001|Overall Study|Adverse Event|0|||
146155028|NCT00695669|527076434|FG002|Overall Study|Adverse Event|2|||
146155029|NCT00695669|527076435|FG003|Overall Study|Adverse Event|0|||
146155030|NCT00695669|527076432|FG000|Overall Study|Lost to Follow-up|4|||
146155031|NCT00695669|527076433|FG001|Overall Study|Lost to Follow-up|4|||
146155032|NCT00695669|527076434|FG002|Overall Study|Lost to Follow-up|1|||
146155033|NCT00695669|527076435|FG003|Overall Study|Lost to Follow-up|4|||
146155034|NCT05045625|527076436|FG000|Overall Study|Lost to Follow-up|3|||
146155035|NCT01196975|527076438|FG000|Overall Study|Adverse Event|2|||
146155036|NCT01196975|527076439|FG001|Overall Study|Adverse Event|2|||
146155037|NCT01196975|527076440|FG002|Overall Study|Adverse Event|0|||
146155038|NCT01196975|527076441|FG003|Overall Study|Adverse Event|0|||
146155039|NCT01196975|527076442|FG004|Overall Study|Adverse Event|2|||
146155040|NCT01196975|527076438|FG000|Overall Study|Withdrawal by Subject|2|||
146155041|NCT01196975|527076439|FG001|Overall Study|Withdrawal by Subject|1|||
146155042|NCT01196975|527076440|FG002|Overall Study|Withdrawal by Subject|0|||
146155043|NCT01196975|527076441|FG003|Overall Study|Withdrawal by Subject|1|||
146309921|NCT01709435|527648640|FG003|Overall Study|Withdrawal by Subject|0|||
146155044|NCT01196975|527076442|FG004|Overall Study|Withdrawal by Subject|0|||
146155045|NCT01196975|527076438|FG000|Overall Study|Lost to Follow-up|11|||
146155046|NCT01196975|527076439|FG001|Overall Study|Lost to Follow-up|6|||
146155047|NCT01196975|527076440|FG002|Overall Study|Lost to Follow-up|5|||
146155048|NCT01196975|527076441|FG003|Overall Study|Lost to Follow-up|5|||
146155049|NCT01196975|527076442|FG004|Overall Study|Lost to Follow-up|11|||
146155050|NCT03738150|527076443|FG000|Base Study|Withdrawal by Subject|1|||
146155051|NCT03738150|527076443|FG000|Extension Study|Withdrawal by Subject|1|||
146155052|NCT01358526|527076452|FG000|Open-label Titration Period|Adverse Event|95|||
146155053|NCT01358526|527076453|FG001|Open-label Titration Period|Adverse Event|0|||
146309922|NCT01709435|527648641|FG004|Overall Study|Withdrawal by Subject|2|||
146155054|NCT01358526|527076454|FG002|Open-label Titration Period|Adverse Event|0|||
146155055|NCT01358526|527076452|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
146155056|NCT01358526|527076453|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146155057|NCT01358526|527076454|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146155058|NCT01358526|527076452|FG000|Open-label Titration Period|Lost to Follow-up|25|||
146155059|NCT01358526|527076453|FG001|Open-label Titration Period|Lost to Follow-up|0|||
146155060|NCT01358526|527076454|FG002|Open-label Titration Period|Lost to Follow-up|0|||
146155061|NCT01358526|527076452|FG000|Open-label Titration Period|Lack of Efficacy|107|||
146155062|NCT01358526|527076453|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146155063|NCT01358526|527076454|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146155064|NCT01358526|527076452|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
146155065|NCT01358526|527076453|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
146155066|NCT01358526|527076454|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
146155067|NCT01358526|527076452|FG000|Open-label Titration Period|Administrative|8|||
146155068|NCT01358526|527076453|FG001|Open-label Titration Period|Administrative|0|||
146155069|NCT01358526|527076454|FG002|Open-label Titration Period|Administrative|0|||
146155070|NCT01358526|527076452|FG000|Open-label Titration Period|Did not qualify|178|||
146155071|NCT01358526|527076453|FG001|Open-label Titration Period|Did not qualify|0|||
146155072|NCT01358526|527076454|FG002|Open-label Titration Period|Did not qualify|0|||
146155073|NCT01358526|527076452|FG000|Double-blind Phase|Adverse Event|0|||
146155074|NCT01358526|527076453|FG001|Double-blind Phase|Adverse Event|24|||
146155075|NCT01358526|527076454|FG002|Double-blind Phase|Adverse Event|23|||
146155076|NCT01358526|527076452|FG000|Double-blind Phase|Withdrawal by Subject|0|||
146155077|NCT01358526|527076453|FG001|Double-blind Phase|Withdrawal by Subject|10|||
146155078|NCT01358526|527076454|FG002|Double-blind Phase|Withdrawal by Subject|8|||
146155079|NCT01358526|527076452|FG000|Double-blind Phase|Lost to Follow-up|0|||
146155080|NCT01358526|527076453|FG001|Double-blind Phase|Lost to Follow-up|4|||
146155081|NCT01358526|527076454|FG002|Double-blind Phase|Lost to Follow-up|1|||
146155082|NCT01358526|527076452|FG000|Double-blind Phase|Lack of Efficacy|0|||
146155083|NCT01358526|527076453|FG001|Double-blind Phase|Lack of Efficacy|31|||
146155084|NCT01358526|527076454|FG002|Double-blind Phase|Lack of Efficacy|73|||
146155085|NCT01358526|527076452|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
146155086|NCT01358526|527076453|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
146155087|NCT01358526|527076454|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
146155088|NCT01358526|527076452|FG000|Double-blind Phase|Administrative|0|||
146155089|NCT01358526|527076453|FG001|Double-blind Phase|Administrative|6|||
146155090|NCT01358526|527076454|FG002|Double-blind Phase|Administrative|10|||
146155091|NCT01462344|527076455|FG000|Overall Study|Withdrawal by Subject|245|||
146155092|NCT01462344|527076456|FG001|Overall Study|Withdrawal by Subject|226|||
146155093|NCT01462344|527076455|FG000|Overall Study|Adverse Event|24|||
146155094|NCT01462344|527076456|FG001|Overall Study|Adverse Event|23|||
146155095|NCT01462344|527076455|FG000|Overall Study|Asthma Exacerbation|34|||
146155096|NCT01462344|527076456|FG001|Overall Study|Asthma Exacerbation|35|||
146155097|NCT01462344|527076455|FG000|Overall Study|Lack of Efficacy|5|||
146155098|NCT01462344|527076456|FG001|Overall Study|Lack of Efficacy|6|||
146155099|NCT01462344|527076455|FG000|Overall Study|Protocol Violation|68|||
146155100|NCT01462344|527076456|FG001|Overall Study|Protocol Violation|53|||
146155101|NCT01462344|527076455|FG000|Overall Study|Lost to Follow-up|7|||
146155102|NCT01462344|527076456|FG001|Overall Study|Lost to Follow-up|7|||
146155103|NCT00809757|527076459|FG000|Overall Study|Adverse Event|2|||
146155104|NCT00809757|527076460|FG001|Overall Study|Adverse Event|3|||
146155105|NCT00809757|527076461|FG002|Overall Study|Adverse Event|3|||
146155106|NCT00809757|527076459|FG000|Overall Study|Lost to Follow-up|0|||
146155107|NCT00809757|527076460|FG001|Overall Study|Lost to Follow-up|0|||
146155108|NCT00809757|527076461|FG002|Overall Study|Lost to Follow-up|1|||
146155109|NCT00809757|527076459|FG000|Overall Study|Protocol Violation|1|||
146155110|NCT00809757|527076460|FG001|Overall Study|Protocol Violation|1|||
146155111|NCT00809757|527076461|FG002|Overall Study|Protocol Violation|1|||
146155112|NCT00809757|527076459|FG000|Overall Study|Withdrawal by Subject|2|||
146155113|NCT00809757|527076460|FG001|Overall Study|Withdrawal by Subject|1|||
146155114|NCT00809757|527076461|FG002|Overall Study|Withdrawal by Subject|3|||
146155115|NCT00809757|527076459|FG000|Overall Study|Subject Uncooperative|1|||
146155116|NCT00809757|527076460|FG001|Overall Study|Subject Uncooperative|0|||
146155117|NCT00809757|527076461|FG002|Overall Study|Subject Uncooperative|2|||
146155118|NCT00809757|527076459|FG000|Overall Study|Noncompliance with Medication|0|||
146155119|NCT00809757|527076460|FG001|Overall Study|Noncompliance with Medication|0|||
146155120|NCT00809757|527076461|FG002|Overall Study|Noncompliance with Medication|1|||
146155121|NCT00253864|527076462|FG000|Overall Study|Lost to Follow-up|5|||
146155122|NCT00253864|527076463|FG001|Overall Study|Lost to Follow-up|8|||
146155123|NCT00110617|527076469|FG000|Overall Study|Adverse Event|2|||
146155124|NCT00110617|527076470|FG001|Overall Study|Adverse Event|4|||
146155125|NCT00110617|527076469|FG000|Overall Study|Abnormal Laboratory Value|4|||
146155126|NCT00110617|527076470|FG001|Overall Study|Abnormal Laboratory Value|2|||
146155127|NCT00110617|527076469|FG000|Overall Study|Lack of Efficacy|1|||
146155128|NCT00110617|527076470|FG001|Overall Study|Lack of Efficacy|0|||
146155129|NCT00110617|527076469|FG000|Overall Study|Patient no longer requires study drug|1|||
146155130|NCT00110617|527076470|FG001|Overall Study|Patient no longer requires study drug|0|||
146155131|NCT00110617|527076469|FG000|Overall Study|Protocol Violation|5|||
146155132|NCT00110617|527076470|FG001|Overall Study|Protocol Violation|0|||
146155133|NCT00110617|527076469|FG000|Overall Study|Withdrawal by Subject|10|||
146155134|NCT00110617|527076470|FG001|Overall Study|Withdrawal by Subject|4|||
146155135|NCT00110617|527076469|FG000|Overall Study|Lost to Follow-up|9|||
146155136|NCT00110617|527076470|FG001|Overall Study|Lost to Follow-up|1|||
146155137|NCT00110617|527076469|FG000|Overall Study|Administrative problems|6|||
146155138|NCT00110617|527076470|FG001|Overall Study|Administrative problems|5|||
146155139|NCT00110617|527076469|FG000|Overall Study|Death|1|||
146155140|NCT00110617|527076470|FG001|Overall Study|Death|1|||
146155141|NCT00110617|527076469|FG000|Overall Study|Did not receive study drug|0|||
146155142|NCT00110617|527076470|FG001|Overall Study|Did not receive study drug|12|||
146155143|NCT00045110|527076474|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
146155144|NCT00045110|527076475|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
146155145|NCT00045110|527076476|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
146155146|NCT00045110|527076474|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
146155147|NCT00045110|527076475|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
146155148|NCT00045110|527076476|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
146155149|NCT00045110|527076474|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
146155150|NCT00045110|527076475|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
146155151|NCT00045110|527076476|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
146155152|NCT03662750|527076480|FG000|Overall Study|Withdrawal by Subject|1|||
146155153|NCT03069482|527078835|FG000|Overall Study|Lost to Follow-up|0|||
146155154|NCT03069482|527078836|FG001|Overall Study|Lost to Follow-up|1|||
146155155|NCT03069482|527078835|FG000|Overall Study|Physician Decision|1|||
146155156|NCT03069482|527078836|FG001|Overall Study|Physician Decision|0|||
146155157|NCT01983293|527078842|FG000|Overall Study|Withdrawal by Subject|29|||
146155158|NCT01983293|527078843|FG001|Overall Study|Withdrawal by Subject|15|||
146155159|NCT01983293|527078842|FG000|Overall Study|Missing 12-month visit|3|||
146155160|NCT01983293|527078843|FG001|Overall Study|Missing 12-month visit|3|||
146155161|NCT01983293|527078842|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
146155162|NCT01983293|527078843|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
146155163|NCT03461003|527078848|FG000|Overall Study|Lost to Follow-up|2|||
146155164|NCT03461003|527078849|FG001|Overall Study|Lost to Follow-up|2|||
146155165|NCT03461003|527078848|FG000|Overall Study|Withdrawal by Subject|3|||
146155166|NCT03461003|527078849|FG001|Overall Study|Withdrawal by Subject|1|||
146155167|NCT02047045|527078850|FG000|Baseline|Withdrawal by Subject|3|||
146155168|NCT02047045|527078851|FG001|Baseline|Withdrawal by Subject|2|||
146155169|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
146155170|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
146155171|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
146155172|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
146155173|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
146155174|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
146155175|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
146155176|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
146155177|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
146155178|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
146155179|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
146155180|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
146155181|NCT02047045|527078850|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
146155182|NCT02047045|527078851|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
146155183|NCT02047045|527078850|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
146155184|NCT02047045|527078851|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
146155185|NCT00856856|527078852|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
146155186|NCT00856856|527078852|FG000|4-year Clinical Follow-up|Missed visit|1|||
146155187|NCT02117570|527078855|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
146155188|NCT02117570|527078856|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
146155189|NCT02117570|527078857|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
146155190|NCT02117570|527078855|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
146155191|NCT02117570|527078856|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
146155192|NCT02117570|527078857|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
146155193|NCT02117570|527078855|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
146155194|NCT02117570|527078856|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
146155195|NCT02117570|527078857|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
146155196|NCT02117570|527078855|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
146155197|NCT02117570|527078856|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
146155198|NCT02117570|527078857|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
146155199|NCT02117570|527078855|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
146155200|NCT02117570|527078856|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
146155201|NCT02117570|527078857|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
146155202|NCT02117570|527078855|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
146155203|NCT02117570|527078856|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
146155204|NCT02117570|527078857|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
146155205|NCT02117570|527078855|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
146155206|NCT02117570|527078856|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
146155207|NCT02117570|527078857|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
146155208|NCT03701555|527078869|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
146155209|NCT03701555|527078870|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
146155210|NCT03701555|527078871|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
146155211|NCT03701555|527078872|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
146155212|NCT03701555|527078873|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
146155213|NCT03701555|527078874|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
146155214|NCT03701555|527078875|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
146155215|NCT03701555|527078876|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
146155216|NCT03701555|527078877|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
146155217|NCT03701555|527078878|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
146155218|NCT03701555|527078879|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
146155219|NCT03701555|527078880|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
146155220|NCT03701555|527078881|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
146155221|NCT03701555|527078882|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
146155222|NCT03701555|527078883|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
146155223|NCT03701555|527078884|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
146155224|NCT03701555|527078885|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
146155225|NCT03701555|527078886|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
146155226|NCT03701555|527078887|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
146155227|NCT03701555|527078888|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
146155228|NCT03701555|527078889|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
146155229|NCT03701555|527078890|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
146155230|NCT03701555|527078891|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
146155231|NCT03701555|527078892|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
146155232|NCT03701555|527078893|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
146155233|NCT03701555|527078894|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
146155234|NCT03701555|527078895|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
146155235|NCT03701555|527078896|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
146155236|NCT03701555|527078897|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
146155237|NCT03701555|527078898|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
146155238|NCT03701555|527078899|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
146155239|NCT03701555|527078900|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
146155240|NCT03701555|527078901|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
146155241|NCT03701555|527078902|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
146155242|NCT03701555|527078903|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
146155243|NCT03701555|527078904|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
146155244|NCT03701555|527078869|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
146155245|NCT03701555|527078870|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
146155246|NCT03701555|527078871|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
146155247|NCT03701555|527078872|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
146155248|NCT03701555|527078873|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
146155249|NCT03701555|527078874|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
146155250|NCT03701555|527078875|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
146155251|NCT03701555|527078876|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
146155252|NCT03701555|527078877|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
146155253|NCT03701555|527078878|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
146155254|NCT03701555|527078879|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
146155255|NCT03701555|527078880|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
146155256|NCT03701555|527078881|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
146155257|NCT03701555|527078882|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
146155258|NCT03701555|527078883|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
146155259|NCT03701555|527078884|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
146155260|NCT03701555|527078885|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
146155261|NCT03701555|527078886|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
146155262|NCT03701555|527078887|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
146155263|NCT03701555|527078888|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
146155264|NCT03701555|527078889|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
146155265|NCT03701555|527078890|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
146155266|NCT03701555|527078891|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
146155267|NCT03701555|527078892|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
146155268|NCT03701555|527078893|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
146155269|NCT03701555|527078894|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
146155270|NCT03701555|527078895|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
146155271|NCT03701555|527078896|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
146155272|NCT03701555|527078897|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
146309923|NCT01709435|527648642|FG005|Overall Study|Withdrawal by Subject|2|||
146155273|NCT03701555|527078898|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
146309924|NCT02409290|527648643|FG000|Overall Study|Protocol Violation|3|||
146155274|NCT03701555|527078899|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
146155275|NCT03701555|527078900|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
146155276|NCT03701555|527078901|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
146155277|NCT03701555|527078902|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
146155278|NCT03701555|527078903|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
146155279|NCT03701555|527078904|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
146155280|NCT03701555|527078869|FG000|Part 2 (Day 1)|Other|0|||
146155281|NCT03701555|527078870|FG001|Part 2 (Day 1)|Other|0|||
146155282|NCT03701555|527078871|FG002|Part 2 (Day 1)|Other|0|||
146155283|NCT03701555|527078872|FG003|Part 2 (Day 1)|Other|0|||
146155284|NCT03701555|527078873|FG004|Part 2 (Day 1)|Other|0|||
146155285|NCT03701555|527078874|FG005|Part 2 (Day 1)|Other|0|||
146155286|NCT03701555|527078875|FG006|Part 2 (Day 1)|Other|0|||
146155287|NCT03701555|527078876|FG007|Part 2 (Day 1)|Other|0|||
146155288|NCT03701555|527078877|FG008|Part 2 (Day 1)|Other|0|||
146155289|NCT03701555|527078878|FG009|Part 2 (Day 1)|Other|0|||
146155290|NCT03701555|527078879|FG010|Part 2 (Day 1)|Other|3|||
146155291|NCT03701555|527078880|FG011|Part 2 (Day 1)|Other|1|||
146155292|NCT03701555|527078881|FG012|Part 2 (Day 1)|Other|0|||
146155293|NCT03701555|527078882|FG013|Part 2 (Day 1)|Other|1|||
146155294|NCT03701555|527078883|FG014|Part 2 (Day 1)|Other|0|||
146155295|NCT03701555|527078884|FG015|Part 2 (Day 1)|Other|2|||
146155296|NCT03701555|527078885|FG016|Part 2 (Day 1)|Other|2|||
146155297|NCT03701555|527078886|FG017|Part 2 (Day 1)|Other|0|||
146155298|NCT03701555|527078887|FG018|Part 2 (Day 1)|Other|0|||
146155299|NCT03701555|527078888|FG019|Part 2 (Day 1)|Other|0|||
146155300|NCT03701555|527078889|FG020|Part 2 (Day 1)|Other|0|||
146155301|NCT03701555|527078890|FG021|Part 2 (Day 1)|Other|0|||
146155302|NCT03701555|527078891|FG022|Part 2 (Day 1)|Other|0|||
146155303|NCT03701555|527078892|FG023|Part 2 (Day 1)|Other|0|||
146155304|NCT03701555|527078893|FG024|Part 2 (Day 1)|Other|0|||
146155305|NCT03701555|527078894|FG025|Part 2 (Day 1)|Other|0|||
146155306|NCT03701555|527078895|FG026|Part 2 (Day 1)|Other|0|||
146155307|NCT03701555|527078896|FG027|Part 2 (Day 1)|Other|0|||
146155308|NCT03701555|527078897|FG028|Part 2 (Day 1)|Other|0|||
146155309|NCT03701555|527078898|FG029|Part 2 (Day 1)|Other|0|||
146155310|NCT03701555|527078899|FG030|Part 2 (Day 1)|Other|0|||
146155311|NCT03701555|527078900|FG031|Part 2 (Day 1)|Other|0|||
146155312|NCT03701555|527078901|FG032|Part 2 (Day 1)|Other|0|||
146155313|NCT03701555|527078902|FG033|Part 2 (Day 1)|Other|0|||
146155314|NCT03701555|527078903|FG034|Part 2 (Day 1)|Other|0|||
146155315|NCT03701555|527078904|FG035|Part 2 (Day 1)|Other|0|||
146155316|NCT03701555|527078869|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
146155317|NCT03701555|527078870|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
146155318|NCT03701555|527078871|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
146155319|NCT03701555|527078872|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
146155320|NCT03701555|527078873|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
146155321|NCT03701555|527078874|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
146155322|NCT03701555|527078875|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
146155323|NCT03701555|527078876|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
146155324|NCT03701555|527078877|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
146155325|NCT03701555|527078878|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
146155326|NCT03701555|527078879|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
146155327|NCT03701555|527078880|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
146155328|NCT03701555|527078881|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
146155329|NCT03701555|527078882|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
146155330|NCT03701555|527078883|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
146155331|NCT03701555|527078884|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
146155332|NCT03701555|527078885|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
146155333|NCT03701555|527078886|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
146155334|NCT03701555|527078887|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
146155335|NCT03701555|527078888|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
146155336|NCT03701555|527078889|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
146155337|NCT03701555|527078890|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
146155338|NCT03701555|527078891|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
146155339|NCT03701555|527078892|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
146155340|NCT03701555|527078893|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
146155341|NCT03701555|527078894|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
146155342|NCT03701555|527078895|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
146155343|NCT03701555|527078896|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
146155344|NCT03701555|527078897|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
146155345|NCT03701555|527078898|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
146155346|NCT03701555|527078899|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
146155347|NCT03701555|527078900|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
146309925|NCT02409290|527648644|FG001|Overall Study|Protocol Violation|6|||
146309926|NCT02409290|527648645|FG002|Overall Study|Protocol Violation|9|||
146155348|NCT03701555|527078901|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
146155349|NCT03701555|527078902|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
146155350|NCT03701555|527078903|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
146155351|NCT03701555|527078904|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
146155352|NCT03701555|527078869|FG000|Part 3 (Day 1)|Subject Decision|0|||
146155353|NCT03701555|527078870|FG001|Part 3 (Day 1)|Subject Decision|0|||
146155354|NCT03701555|527078871|FG002|Part 3 (Day 1)|Subject Decision|0|||
146155355|NCT03701555|527078872|FG003|Part 3 (Day 1)|Subject Decision|0|||
146155356|NCT03701555|527078873|FG004|Part 3 (Day 1)|Subject Decision|0|||
146155357|NCT03701555|527078874|FG005|Part 3 (Day 1)|Subject Decision|0|||
146155358|NCT03701555|527078875|FG006|Part 3 (Day 1)|Subject Decision|0|||
146155359|NCT03701555|527078876|FG007|Part 3 (Day 1)|Subject Decision|0|||
146155360|NCT03701555|527078877|FG008|Part 3 (Day 1)|Subject Decision|0|||
146155361|NCT03701555|527078878|FG009|Part 3 (Day 1)|Subject Decision|0|||
146155362|NCT03701555|527078879|FG010|Part 3 (Day 1)|Subject Decision|0|||
146155363|NCT03701555|527078880|FG011|Part 3 (Day 1)|Subject Decision|0|||
146155364|NCT03701555|527078881|FG012|Part 3 (Day 1)|Subject Decision|0|||
146155365|NCT03701555|527078882|FG013|Part 3 (Day 1)|Subject Decision|0|||
146155366|NCT03701555|527078883|FG014|Part 3 (Day 1)|Subject Decision|0|||
146155367|NCT03701555|527078884|FG015|Part 3 (Day 1)|Subject Decision|0|||
146155368|NCT03701555|527078885|FG016|Part 3 (Day 1)|Subject Decision|0|||
146155369|NCT03701555|527078886|FG017|Part 3 (Day 1)|Subject Decision|0|||
146155370|NCT03701555|527078887|FG018|Part 3 (Day 1)|Subject Decision|0|||
146155371|NCT03701555|527078888|FG019|Part 3 (Day 1)|Subject Decision|0|||
146155372|NCT03701555|527078889|FG020|Part 3 (Day 1)|Subject Decision|0|||
146155373|NCT03701555|527078890|FG021|Part 3 (Day 1)|Subject Decision|0|||
146155374|NCT03701555|527078891|FG022|Part 3 (Day 1)|Subject Decision|0|||
146155375|NCT03701555|527078892|FG023|Part 3 (Day 1)|Subject Decision|0|||
146155376|NCT03701555|527078893|FG024|Part 3 (Day 1)|Subject Decision|0|||
146155377|NCT03701555|527078894|FG025|Part 3 (Day 1)|Subject Decision|0|||
146155378|NCT03701555|527078895|FG026|Part 3 (Day 1)|Subject Decision|1|||
146155379|NCT03701555|527078896|FG027|Part 3 (Day 1)|Subject Decision|0|||
146155380|NCT03701555|527078897|FG028|Part 3 (Day 1)|Subject Decision|0|||
146155381|NCT03701555|527078898|FG029|Part 3 (Day 1)|Subject Decision|0|||
146155382|NCT03701555|527078899|FG030|Part 3 (Day 1)|Subject Decision|0|||
146155383|NCT03701555|527078900|FG031|Part 3 (Day 1)|Subject Decision|2|||
146155384|NCT03701555|527078901|FG032|Part 3 (Day 1)|Subject Decision|1|||
146155385|NCT03701555|527078902|FG033|Part 3 (Day 1)|Subject Decision|1|||
146155386|NCT03701555|527078903|FG034|Part 3 (Day 1)|Subject Decision|0|||
146155387|NCT03701555|527078904|FG035|Part 3 (Day 1)|Subject Decision|0|||
146155388|NCT03701555|527078869|FG000|Part 3 (Day 1)|Other|0|||
146155389|NCT03701555|527078870|FG001|Part 3 (Day 1)|Other|0|||
146155390|NCT03701555|527078871|FG002|Part 3 (Day 1)|Other|0|||
146155391|NCT03701555|527078872|FG003|Part 3 (Day 1)|Other|0|||
146155392|NCT03701555|527078873|FG004|Part 3 (Day 1)|Other|0|||
146155393|NCT03701555|527078874|FG005|Part 3 (Day 1)|Other|0|||
146155394|NCT03701555|527078875|FG006|Part 3 (Day 1)|Other|0|||
146155395|NCT03701555|527078876|FG007|Part 3 (Day 1)|Other|0|||
146155396|NCT03701555|527078877|FG008|Part 3 (Day 1)|Other|0|||
146155397|NCT03701555|527078878|FG009|Part 3 (Day 1)|Other|0|||
146155398|NCT03701555|527078879|FG010|Part 3 (Day 1)|Other|0|||
146155399|NCT03701555|527078880|FG011|Part 3 (Day 1)|Other|0|||
146155400|NCT03701555|527078881|FG012|Part 3 (Day 1)|Other|0|||
146155401|NCT03701555|527078882|FG013|Part 3 (Day 1)|Other|0|||
146155402|NCT03701555|527078883|FG014|Part 3 (Day 1)|Other|0|||
146155403|NCT03701555|527078884|FG015|Part 3 (Day 1)|Other|0|||
146155404|NCT03701555|527078885|FG016|Part 3 (Day 1)|Other|0|||
146155405|NCT03701555|527078886|FG017|Part 3 (Day 1)|Other|0|||
146155406|NCT03701555|527078887|FG018|Part 3 (Day 1)|Other|0|||
146155407|NCT03701555|527078888|FG019|Part 3 (Day 1)|Other|0|||
146155408|NCT03701555|527078889|FG020|Part 3 (Day 1)|Other|0|||
146155409|NCT03701555|527078890|FG021|Part 3 (Day 1)|Other|0|||
146155410|NCT03701555|527078891|FG022|Part 3 (Day 1)|Other|0|||
146155411|NCT03701555|527078892|FG023|Part 3 (Day 1)|Other|0|||
146155412|NCT03701555|527078893|FG024|Part 3 (Day 1)|Other|1|||
146155413|NCT03701555|527078894|FG025|Part 3 (Day 1)|Other|1|||
146155414|NCT03701555|527078895|FG026|Part 3 (Day 1)|Other|0|||
146155415|NCT03701555|527078896|FG027|Part 3 (Day 1)|Other|0|||
146155416|NCT03701555|527078897|FG028|Part 3 (Day 1)|Other|0|||
146155417|NCT03701555|527078898|FG029|Part 3 (Day 1)|Other|1|||
146155418|NCT03701555|527078899|FG030|Part 3 (Day 1)|Other|1|||
146155419|NCT03701555|527078900|FG031|Part 3 (Day 1)|Other|0|||
146155420|NCT03701555|527078901|FG032|Part 3 (Day 1)|Other|1|||
146155421|NCT03701555|527078902|FG033|Part 3 (Day 1)|Other|1|||
146155422|NCT03701555|527078903|FG034|Part 3 (Day 1)|Other|0|||
146155423|NCT03701555|527078904|FG035|Part 3 (Day 1)|Other|0|||
146155424|NCT00321854|527078909|FG000|Overall Study|Adverse Event|41|||
146155425|NCT00321854|527078910|FG001|Overall Study|Adverse Event|43|||
146155426|NCT00321854|527078909|FG000|Overall Study|Lack of Efficacy|9|||
146155427|NCT00321854|527078910|FG001|Overall Study|Lack of Efficacy|14|||
146155428|NCT00321854|527078909|FG000|Overall Study|Protocol Violation|6|||
146155429|NCT00321854|527078910|FG001|Overall Study|Protocol Violation|5|||
146155430|NCT00321854|527078909|FG000|Overall Study|Lost to Follow-up|0|||
146155431|NCT00321854|527078910|FG001|Overall Study|Lost to Follow-up|2|||
146155432|NCT00321854|527078909|FG000|Overall Study|Withdrawal by Subject|6|||
146155433|NCT00321854|527078910|FG001|Overall Study|Withdrawal by Subject|17|||
146155434|NCT00321854|527078909|FG000|Overall Study|Other|1|||
146155435|NCT00321854|527078910|FG001|Overall Study|Other|1|||
146155436|NCT04723576|527078911|FG000|Overall Study|Withdrawal by Subject|2133|||
146155437|NCT04723576|527078912|FG001|Overall Study|Withdrawal by Subject|3234|||
146155438|NCT00413153|527078913|FG000|Overall Study|Withdrawal by Subject|1|||
146155439|NCT00413153|527078914|FG001|Overall Study|Withdrawal by Subject|1|||
146155440|NCT00413153|527078913|FG000|Overall Study|Adverse Event|1|||
146155441|NCT00413153|527078914|FG001|Overall Study|Adverse Event|0|||
146155442|NCT01064739|527078915|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
146155443|NCT00454051|527078916|FG000|Overall Study|Adverse Event|1|||
146155444|NCT00454051|527078917|FG001|Overall Study|Adverse Event|2|||
146155445|NCT00454051|527078916|FG000|Overall Study|Withdrawal by Subject|1|||
146155446|NCT00454051|527078917|FG001|Overall Study|Withdrawal by Subject|0|||
146155447|NCT00454051|527078916|FG000|Overall Study|Protocol Violation|1|||
146155448|NCT00454051|527078917|FG001|Overall Study|Protocol Violation|1|||
146155449|NCT03966157|527078918|FG000|Overall Study|Physician Decision|1|||
146155450|NCT03966157|527078919|FG001|Overall Study|Physician Decision|0|||
146155451|NCT04004611|527078920|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155452|NCT04004611|527078921|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155453|NCT04004611|527078922|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155454|NCT04004611|527078923|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155455|NCT04004611|527078924|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155456|NCT04004611|527078925|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155457|NCT04004611|527078926|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155458|NCT04004611|527078927|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
146155459|NCT04004611|527078928|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
146155460|NCT04004611|527078920|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155461|NCT04004611|527078921|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155462|NCT04004611|527078922|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155463|NCT04004611|527078923|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155464|NCT04004611|527078924|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155465|NCT04004611|527078925|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
146155466|NCT04004611|527078926|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
146155467|NCT04004611|527078927|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
146155468|NCT04004611|527078928|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
146155469|NCT04004611|527078920|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155470|NCT04004611|527078921|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155471|NCT04004611|527078922|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155472|NCT04004611|527078923|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155473|NCT04004611|527078924|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
146155474|NCT04004611|527078925|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155475|NCT04004611|527078926|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155476|NCT04004611|527078927|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155477|NCT04004611|527078928|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
146155478|NCT04004611|527078920|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
146155479|NCT04004611|527078921|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
146155480|NCT04004611|527078922|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
146155481|NCT04004611|527078923|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
146155482|NCT04004611|527078924|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
146155483|NCT04004611|527078925|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
146155484|NCT04004611|527078926|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
146155485|NCT04004611|527078927|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
146155486|NCT04004611|527078928|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
146155487|NCT04004611|527078920|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
146155488|NCT04004611|527078921|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155489|NCT04004611|527078922|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
146155490|NCT04004611|527078923|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155491|NCT04004611|527078924|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155492|NCT04004611|527078925|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155493|NCT04004611|527078926|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155494|NCT04004611|527078927|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155495|NCT04004611|527078928|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
146155496|NCT04004611|527078920|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155497|NCT04004611|527078921|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
146155498|NCT04004611|527078922|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155499|NCT04004611|527078923|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146309927|NCT02409290|527648646|FG003|Overall Study|Protocol Violation|4|||
146155500|NCT04004611|527078924|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155501|NCT04004611|527078925|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155502|NCT04004611|527078926|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155503|NCT04004611|527078927|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155504|NCT04004611|527078928|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
146155505|NCT04420689|527078929|FG000|Overall Study|COVID-19 related hospitalization|0|||
146155506|NCT04420689|527078930|FG001|Overall Study|COVID-19 related hospitalization|0|||
146155507|NCT04420689|527078931|FG002|Overall Study|COVID-19 related hospitalization|0|||
146155508|NCT04420689|527078932|FG003|Overall Study|COVID-19 related hospitalization|0|||
146155509|NCT04420689|527078933|FG004|Overall Study|COVID-19 related hospitalization|1|||
146155510|NCT04420689|527078934|FG005|Overall Study|COVID-19 related hospitalization|0|||
146155511|NCT04420689|527078935|FG006|Overall Study|COVID-19 related hospitalization|0|||
146155512|NCT04420689|527078929|FG000|Overall Study|Physician Decision|0|||
146155513|NCT04420689|527078930|FG001|Overall Study|Physician Decision|0|||
146155514|NCT04420689|527078931|FG002|Overall Study|Physician Decision|0|||
146155515|NCT04420689|527078932|FG003|Overall Study|Physician Decision|0|||
146155516|NCT04420689|527078933|FG004|Overall Study|Physician Decision|0|||
146155517|NCT04420689|527078934|FG005|Overall Study|Physician Decision|1|||
146155518|NCT04420689|527078935|FG006|Overall Study|Physician Decision|0|||
146155519|NCT03834779|527078947|FG000|Overall Study|Death|1|||
146155520|NCT03834779|527078948|FG001|Overall Study|Death|2|||
146155521|NCT03834779|527078947|FG000|Overall Study|Lost to Follow-up|6|||
146155522|NCT03834779|527078948|FG001|Overall Study|Lost to Follow-up|4|||
146155523|NCT01519206|527078953|FG000|Overall Study|Lost to Follow-up|3|||
146155524|NCT01519206|527078953|FG000|Overall Study|Missed Visit|2|||
146155525|NCT03579563|527078957|FG000|Overall Study|Lost to Follow-up|0|||
146155526|NCT03579563|527078958|FG001|Overall Study|Lost to Follow-up|0|||
146155527|NCT03579563|527078959|FG002|Overall Study|Lost to Follow-up|0|||
146155528|NCT03579563|527078960|FG003|Overall Study|Lost to Follow-up|0|||
146155529|NCT03579563|527078961|FG004|Overall Study|Lost to Follow-up|1|||
146155530|NCT03579563|527078962|FG005|Overall Study|Lost to Follow-up|0|||
146155531|NCT03579563|527078957|FG000|Overall Study|Lack of Efficacy|1|||
146155532|NCT03579563|527078958|FG001|Overall Study|Lack of Efficacy|1|||
146155533|NCT03579563|527078959|FG002|Overall Study|Lack of Efficacy|4|||
146155534|NCT03579563|527078960|FG003|Overall Study|Lack of Efficacy|1|||
146155535|NCT03579563|527078961|FG004|Overall Study|Lack of Efficacy|2|||
146155536|NCT03579563|527078962|FG005|Overall Study|Lack of Efficacy|3|||
146155537|NCT03579563|527078957|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146155538|NCT03579563|527078958|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146155539|NCT03579563|527078959|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
146155540|NCT03579563|527078960|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
146155541|NCT03579563|527078961|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146155542|NCT03579563|527078962|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
146155543|NCT03579563|527078957|FG000|Overall Study|Time/distance concern|0|||
146155544|NCT03579563|527078958|FG001|Overall Study|Time/distance concern|0|||
146155545|NCT03579563|527078959|FG002|Overall Study|Time/distance concern|1|||
146155546|NCT03579563|527078960|FG003|Overall Study|Time/distance concern|0|||
146155547|NCT03579563|527078961|FG004|Overall Study|Time/distance concern|0|||
146155548|NCT03579563|527078962|FG005|Overall Study|Time/distance concern|1|||
146155549|NCT03579563|527078957|FG000|Overall Study|COVID shutdown|2|||
146155550|NCT03579563|527078958|FG001|Overall Study|COVID shutdown|3|||
146155551|NCT03579563|527078959|FG002|Overall Study|COVID shutdown|4|||
146155552|NCT03579563|527078960|FG003|Overall Study|COVID shutdown|3|||
146155553|NCT03579563|527078961|FG004|Overall Study|COVID shutdown|1|||
146155554|NCT03579563|527078962|FG005|Overall Study|COVID shutdown|2|||
146155555|NCT03579563|527078957|FG000|Overall Study|Protocol administration error|1|||
146155556|NCT03579563|527078958|FG001|Overall Study|Protocol administration error|0|||
146155557|NCT03579563|527078959|FG002|Overall Study|Protocol administration error|1|||
146155558|NCT03579563|527078960|FG003|Overall Study|Protocol administration error|0|||
146155559|NCT03579563|527078961|FG004|Overall Study|Protocol administration error|1|||
146155560|NCT03579563|527078962|FG005|Overall Study|Protocol administration error|5|||
146155561|NCT04349553|527078966|FG000|Overall Study|Withdrawal by Subject|1|||
146155562|NCT04349553|527078967|FG001|Overall Study|Withdrawal by Subject|0|||
146155563|NCT04349553|527078968|FG002|Overall Study|Withdrawal by Subject|1|||
146155564|NCT04349553|527078969|FG003|Overall Study|Withdrawal by Subject|0|||
146155565|NCT03526250|527078970|FG000|Overall Study|Adverse Event|4|||
146155566|NCT03526250|527078970|FG000|Overall Study|Progressive Disease|16|||
146155567|NCT03526250|527078970|FG000|Overall Study|No Treatment|3|||
146155568|NCT04420221|527078971|FG000|Overall Study|Withdrawal by Subject|0|||
146155569|NCT04420221|527078972|FG001|Overall Study|Withdrawal by Subject|0|||
146155570|NCT04420221|527078973|FG002|Overall Study|Withdrawal by Subject|0|||
146155571|NCT04420221|527078974|FG003|Overall Study|Withdrawal by Subject|0|||
146155572|NCT04420221|527078975|FG004|Overall Study|Withdrawal by Subject|0|||
146155573|NCT04420221|527078976|FG005|Overall Study|Withdrawal by Subject|20|||
146155574|NCT04420221|527078977|FG006|Overall Study|Withdrawal by Subject|5|||
146155575|NCT04420221|527078971|FG000|Overall Study|Other|0|||
146155576|NCT04420221|527078972|FG001|Overall Study|Other|0|||
146155577|NCT04420221|527078973|FG002|Overall Study|Other|0|||
146155578|NCT04420221|527078974|FG003|Overall Study|Other|0|||
146155579|NCT04420221|527078975|FG004|Overall Study|Other|0|||
146155580|NCT04420221|527078976|FG005|Overall Study|Other|1|||
146155581|NCT04420221|527078977|FG006|Overall Study|Other|1|||
146155582|NCT04420221|527078971|FG000|Overall Study|Lost to Follow-up|0|||
146155583|NCT04420221|527078972|FG001|Overall Study|Lost to Follow-up|0|||
146155584|NCT04420221|527078973|FG002|Overall Study|Lost to Follow-up|0|||
146155585|NCT04420221|527078974|FG003|Overall Study|Lost to Follow-up|0|||
146155586|NCT04420221|527078975|FG004|Overall Study|Lost to Follow-up|0|||
146155587|NCT04420221|527078976|FG005|Overall Study|Lost to Follow-up|3|||
146155588|NCT04420221|527078977|FG006|Overall Study|Lost to Follow-up|2|||
146155589|NCT04420221|527078971|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
146155590|NCT04420221|527078972|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
146155591|NCT04420221|527078973|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
146155592|NCT04420221|527078974|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
146155593|NCT04420221|527078975|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
146155594|NCT04420221|527078976|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
146155595|NCT04420221|527078977|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
146155596|NCT02219932|527078978|FG000|Overall Study|Other|5|||
146155597|NCT02219932|527078979|FG001|Overall Study|Other|11|||
146155598|NCT02219932|527078978|FG000|Overall Study|Death|1|||
146155599|NCT02219932|527078979|FG001|Overall Study|Death|1|||
146155600|NCT02219932|527078978|FG000|Overall Study|Investigator Decision|0|||
146155601|NCT02219932|527078979|FG001|Overall Study|Investigator Decision|1|||
146155602|NCT02219932|527078978|FG000|Overall Study|Consent Withdrawn|11|||
146155603|NCT02219932|527078979|FG001|Overall Study|Consent Withdrawn|7|||
146155604|NCT02219932|527078978|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
146155605|NCT02219932|527078979|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
146155606|NCT02219932|527078978|FG000|Overall Study|Protocol Violation|10|||
146155607|NCT02219932|527078979|FG001|Overall Study|Protocol Violation|6|||
146155608|NCT02219932|527078978|FG000|Overall Study|Pregnancy|1|||
146155609|NCT02219932|527078979|FG001|Overall Study|Pregnancy|0|||
146155610|NCT02219932|527078978|FG000|Overall Study|Lost to Follow-up|4|||
146155611|NCT02219932|527078979|FG001|Overall Study|Lost to Follow-up|2|||
146155612|NCT02219932|527078978|FG000|Overall Study|Adverse Event|23|||
146155613|NCT02219932|527078979|FG001|Overall Study|Adverse Event|21|||
146155614|NCT01618864|527078980|FG000|Overall Study|Withdrawal by Subject|2|||
146155615|NCT01618864|527078980|FG000|Overall Study|Lost to Follow-up|2|||
146155616|NCT02372396|527078986|FG000|Overall Study|Lost to Follow-up|7|||
146155617|NCT02372396|527078987|FG001|Overall Study|Lost to Follow-up|9|||
146155618|NCT01272934|527078988|FG000|Overall Study|Adverse Event|0|||
146155619|NCT01272934|527078989|FG001|Overall Study|Adverse Event|1|||
146155620|NCT01272934|527078988|FG000|Overall Study|Abnormal Laboratory Value|0|||
146155621|NCT01272934|527078989|FG001|Overall Study|Abnormal Laboratory Value|1|||
146155622|NCT04313634|527078990|FG000|Overall Study|Adverse Event|2|||
146155623|NCT04313634|527078991|FG001|Overall Study|Adverse Event|2|||
146155624|NCT04313634|527078992|FG002|Overall Study|Adverse Event|0|||
146155625|NCT04313634|527078990|FG000|Overall Study|Withdrawal by Subject|1|||
146155626|NCT04313634|527078991|FG001|Overall Study|Withdrawal by Subject|0|||
146155627|NCT04313634|527078992|FG002|Overall Study|Withdrawal by Subject|1|||
146155628|NCT04313634|527078990|FG000|Overall Study|Protocol Violation|0|||
146155629|NCT04313634|527078991|FG001|Overall Study|Protocol Violation|0|||
146155630|NCT04313634|527078992|FG002|Overall Study|Protocol Violation|1|||
146155631|NCT01881126|527079007|FG000|Overall Study|Non-compliance|1|||
146155632|NCT01881126|527079008|FG001|Overall Study|Non-compliance|1|||
146155633|NCT01881126|527079007|FG000|Overall Study|Adverse Event|0|||
146155634|NCT01881126|527079008|FG001|Overall Study|Adverse Event|1|||
146155635|NCT00047879|527079011|FG000|Overall Study|Progressive disease|4|||
146155636|NCT00047879|527079012|FG001|Overall Study|Progressive disease|3|||
146155637|NCT04558346|527079020|FG000|Overall Study|Withdrawal by Subject|2|||
146155638|NCT04558346|527079021|FG001|Overall Study|Withdrawal by Subject|0|||
146155639|NCT04558346|527079020|FG000|Overall Study|Lost to Follow-up|0|||
146155640|NCT04558346|527079021|FG001|Overall Study|Lost to Follow-up|1|||
146155641|NCT04558346|527079020|FG000|Overall Study|Adverse Event|0|||
146155642|NCT04558346|527079021|FG001|Overall Study|Adverse Event|1|||
146155643|NCT01962974|527079024|FG000|Overall Study|Study termination|7|||
146155644|NCT03086447|527079025|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146309928|NCT02409290|527648643|FG000|Overall Study|No positive culture/no baseline sample|3|||
146155645|NCT03086447|527079026|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
146155646|NCT03086447|527079025|FG000|Overall Study|Lost Lens|2|||
146155647|NCT03086447|527079026|FG001|Overall Study|Lost Lens|5|||
146155648|NCT03086447|527079025|FG000|Overall Study|Product quality complaint|0|||
146309929|NCT02409290|527648644|FG001|Overall Study|No positive culture/no baseline sample|9|||
146155649|NCT03086447|527079026|FG001|Overall Study|Product quality complaint|1|||
146155650|NCT03086447|527079025|FG000|Overall Study|Lens Damage|1|||
146155651|NCT03086447|527079026|FG001|Overall Study|Lens Damage|6|||
146155652|NCT03086447|527079025|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
146155653|NCT03086447|527079026|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
146155654|NCT03086447|527079025|FG000|Overall Study|Test Article No Longer Available|1|||
146155655|NCT03086447|527079026|FG001|Overall Study|Test Article No Longer Available|0|||
146155656|NCT03086447|527079025|FG000|Overall Study|Protocol Violation|2|||
146155657|NCT03086447|527079026|FG001|Overall Study|Protocol Violation|4|||
146155658|NCT03086447|527079025|FG000|Overall Study|Lost to Follow-up|0|||
146155659|NCT03086447|527079026|FG001|Overall Study|Lost to Follow-up|1|||
146155660|NCT03086447|527079025|FG000|Overall Study|Adverse Event|3|||
146155661|NCT03086447|527079026|FG001|Overall Study|Adverse Event|0|||
146155662|NCT03086447|527079025|FG000|Overall Study|Lens Discomfort|2|||
146155663|NCT03086447|527079026|FG001|Overall Study|Lens Discomfort|1|||
146155664|NCT00659334|527079028|FG000|Overall Study|Screen Failure|8|||
146155665|NCT00659334|527079029|FG001|Overall Study|Screen Failure|5|||
146155666|NCT00659334|527079030|FG002|Overall Study|Screen Failure|0|||
146155667|NCT00659334|527079031|FG003|Overall Study|Screen Failure|0|||
146155668|NCT00659334|527079032|FG004|Overall Study|Screen Failure|0|||
146155669|NCT00659334|527079033|FG005|Overall Study|Screen Failure|0|||
146155670|NCT00659334|527079034|FG006|Overall Study|Screen Failure|1|||
146155671|NCT01174342|527079035|FG000|Overall Study|Conversion to cesarean section|4|||
146155672|NCT01218438|527079037|FG000|Epoch 1|Physician Decision|2|||
146155673|NCT01218438|527079037|FG000|Epoch 1|Adverse Event|1|||
146155674|NCT01218438|527079037|FG000|Epoch 3|Withdrawal by Subject|3|||
146155675|NCT01218438|527079037|FG000|Epoch 3|Adverse Event|1|||
146155676|NCT01218438|527079037|FG000|Epoch 4|Physician Decision|1|||
146155677|NCT01218438|527079037|FG000|Epoch 4|Withdrawal by Subject|2|||
146155678|NCT02075593|527079038|FG000|Overall Study|Withdrawal by Subject|1|||
146155679|NCT05819749|527079039|FG000|Overall Study|Lost to Follow-up|1|||
146155680|NCT00726752|527079040|FG000|Overall Study|Lack of Efficacy|6|||
146155681|NCT03147248|527081198|FG000|Overall Study|Adverse Event|0|||
146155682|NCT03147248|527081199|FG001|Overall Study|Adverse Event|2|||
146155683|NCT03147248|527081200|FG002|Overall Study|Adverse Event|2|||
146155684|NCT03147248|527081201|FG003|Overall Study|Adverse Event|2|||
146155685|NCT03147248|527081202|FG004|Overall Study|Adverse Event|6|||
146155686|NCT03147248|527081203|FG005|Overall Study|Adverse Event|11|||
146155687|NCT03147248|527081198|FG000|Overall Study|Disease progression|1|||
146155688|NCT03147248|527081199|FG001|Overall Study|Disease progression|0|||
146155689|NCT03147248|527081200|FG002|Overall Study|Disease progression|0|||
146155690|NCT03147248|527081201|FG003|Overall Study|Disease progression|0|||
146155691|NCT03147248|527081202|FG004|Overall Study|Disease progression|0|||
146155692|NCT03147248|527081203|FG005|Overall Study|Disease progression|2|||
146155693|NCT03147248|527081198|FG000|Overall Study|Withdrawal by Subject|0|||
146155694|NCT03147248|527081199|FG001|Overall Study|Withdrawal by Subject|0|||
146155695|NCT03147248|527081200|FG002|Overall Study|Withdrawal by Subject|0|||
146155696|NCT03147248|527081201|FG003|Overall Study|Withdrawal by Subject|0|||
146155697|NCT03147248|527081202|FG004|Overall Study|Withdrawal by Subject|12|||
146155698|NCT03147248|527081203|FG005|Overall Study|Withdrawal by Subject|9|||
146155699|NCT03147248|527081198|FG000|Overall Study|Protocol Violation|0|||
146155700|NCT03147248|527081199|FG001|Overall Study|Protocol Violation|0|||
146155701|NCT03147248|527081200|FG002|Overall Study|Protocol Violation|0|||
146155702|NCT03147248|527081201|FG003|Overall Study|Protocol Violation|0|||
146155703|NCT03147248|527081202|FG004|Overall Study|Protocol Violation|2|||
146155704|NCT03147248|527081203|FG005|Overall Study|Protocol Violation|0|||
146155705|NCT03147248|527081198|FG000|Overall Study|Lost to Follow-up|0|||
146155706|NCT03147248|527081199|FG001|Overall Study|Lost to Follow-up|0|||
146155707|NCT03147248|527081200|FG002|Overall Study|Lost to Follow-up|0|||
146155708|NCT03147248|527081201|FG003|Overall Study|Lost to Follow-up|0|||
146155709|NCT03147248|527081202|FG004|Overall Study|Lost to Follow-up|2|||
146155710|NCT03147248|527081203|FG005|Overall Study|Lost to Follow-up|0|||
146155711|NCT03147248|527081198|FG000|Overall Study|Pregnancy|0|||
146155712|NCT03147248|527081199|FG001|Overall Study|Pregnancy|0|||
146155713|NCT03147248|527081200|FG002|Overall Study|Pregnancy|0|||
146155714|NCT03147248|527081201|FG003|Overall Study|Pregnancy|0|||
146155715|NCT03147248|527081202|FG004|Overall Study|Pregnancy|1|||
146155716|NCT03147248|527081203|FG005|Overall Study|Pregnancy|0|||
146155717|NCT03147248|527081198|FG000|Overall Study|Death|0|||
146155718|NCT03147248|527081199|FG001|Overall Study|Death|0|||
146155719|NCT03147248|527081200|FG002|Overall Study|Death|0|||
146155720|NCT03147248|527081201|FG003|Overall Study|Death|0|||
146155721|NCT03147248|527081202|FG004|Overall Study|Death|0|||
146155722|NCT03147248|527081203|FG005|Overall Study|Death|4|||
146155723|NCT03147248|527081198|FG000|Overall Study|Physician Decision|0|||
146155724|NCT03147248|527081199|FG001|Overall Study|Physician Decision|0|||
146155725|NCT03147248|527081200|FG002|Overall Study|Physician Decision|0|||
146155726|NCT03147248|527081201|FG003|Overall Study|Physician Decision|0|||
146155727|NCT03147248|527081202|FG004|Overall Study|Physician Decision|2|||
146155728|NCT03147248|527081203|FG005|Overall Study|Physician Decision|4|||
146155729|NCT03147248|527081198|FG000|Overall Study|Prolonged Dosing Interval|0|||
146155730|NCT03147248|527081199|FG001|Overall Study|Prolonged Dosing Interval|0|||
146155731|NCT03147248|527081200|FG002|Overall Study|Prolonged Dosing Interval|0|||
146155732|NCT03147248|527081201|FG003|Overall Study|Prolonged Dosing Interval|0|||
146155733|NCT03147248|527081202|FG004|Overall Study|Prolonged Dosing Interval|1|||
146155734|NCT03147248|527081203|FG005|Overall Study|Prolonged Dosing Interval|1|||
146155735|NCT03750552|527081204|FG000|Overall Study|Adverse Event|5|||
146155736|NCT03750552|527081205|FG001|Overall Study|Adverse Event|1|||
146155737|NCT03750552|527081204|FG000|Overall Study|Withdrawal by Subject|1|||
146155738|NCT03750552|527081205|FG001|Overall Study|Withdrawal by Subject|1|||
146155739|NCT03750552|527081204|FG000|Overall Study|Other|2|||
146155740|NCT03750552|527081205|FG001|Overall Study|Other|0|||
146155741|NCT02062632|527081206|FG000|Overall Study|No treatment data|1|||
146155742|NCT00773968|527081209|FG000|Overall Study|Adverse Event|2|||
146155743|NCT00773968|527081209|FG000|Overall Study|Death|1|||
146155744|NCT00773968|527081209|FG000|Overall Study|Failure to Return|2|||
146155745|NCT00773968|527081209|FG000|Overall Study|Lack of Efficacy|3|||
146155746|NCT00773968|527081209|FG000|Overall Study|Protocol Violation|1|||
146155747|NCT00773968|527081209|FG000|Overall Study|Withdrawal by Subject|11|||
146155748|NCT00773968|527081209|FG000|Overall Study|Screen Failure|17|||
146155749|NCT00773968|527081209|FG000|Overall Study|Other|8|||
146155750|NCT02008890|527081217|FG000|Period 1|Withdrawal by Subject|7|||
146155751|NCT02008890|527081218|FG001|Period 1|Withdrawal by Subject|7|||
146155752|NCT02008890|527081219|FG002|Period 1|Withdrawal by Subject|5|||
146155753|NCT02008890|527081220|FG003|Period 1|Withdrawal by Subject|0|||
146155754|NCT02008890|527081221|FG004|Period 1|Withdrawal by Subject|0|||
146155755|NCT02008890|527081217|FG000|Period 1|Pregnancy|1|||
146155756|NCT02008890|527081218|FG001|Period 1|Pregnancy|0|||
146155757|NCT02008890|527081219|FG002|Period 1|Pregnancy|0|||
146155758|NCT02008890|527081220|FG003|Period 1|Pregnancy|0|||
146155759|NCT02008890|527081221|FG004|Period 1|Pregnancy|0|||
146155760|NCT02008890|527081217|FG000|Period 1|Physician Decision|1|||
146155761|NCT02008890|527081218|FG001|Period 1|Physician Decision|0|||
146155762|NCT02008890|527081219|FG002|Period 1|Physician Decision|1|||
146155763|NCT02008890|527081220|FG003|Period 1|Physician Decision|0|||
146155764|NCT02008890|527081221|FG004|Period 1|Physician Decision|0|||
146155765|NCT02008890|527081217|FG000|Period 1|Adverse Event|6|||
146155766|NCT02008890|527081218|FG001|Period 1|Adverse Event|8|||
146155767|NCT02008890|527081219|FG002|Period 1|Adverse Event|6|||
146155768|NCT02008890|527081220|FG003|Period 1|Adverse Event|0|||
146155769|NCT02008890|527081221|FG004|Period 1|Adverse Event|0|||
146155770|NCT02008890|527081217|FG000|Period 2|Adverse Event|12|||
146155771|NCT02008890|527081218|FG001|Period 2|Adverse Event|7|||
146155772|NCT02008890|527081219|FG002|Period 2|Adverse Event|0|||
146155773|NCT02008890|527081220|FG003|Period 2|Adverse Event|5|||
146155774|NCT02008890|527081221|FG004|Period 2|Adverse Event|5|||
146155775|NCT02008890|527081217|FG000|Period 2|Withdrawal by Subject|11|||
146155776|NCT02008890|527081218|FG001|Period 2|Withdrawal by Subject|8|||
146155777|NCT02008890|527081219|FG002|Period 2|Withdrawal by Subject|0|||
146155778|NCT02008890|527081220|FG003|Period 2|Withdrawal by Subject|7|||
146155779|NCT02008890|527081221|FG004|Period 2|Withdrawal by Subject|2|||
146155780|NCT02008890|527081217|FG000|Period 2|Physician Decision|4|||
146155781|NCT02008890|527081218|FG001|Period 2|Physician Decision|0|||
146155782|NCT02008890|527081219|FG002|Period 2|Physician Decision|0|||
146155783|NCT02008890|527081220|FG003|Period 2|Physician Decision|2|||
146155784|NCT02008890|527081221|FG004|Period 2|Physician Decision|1|||
146155785|NCT02008890|527081217|FG000|Period 2|Lost to Follow-up|0|||
146155786|NCT02008890|527081218|FG001|Period 2|Lost to Follow-up|0|||
146155787|NCT02008890|527081219|FG002|Period 2|Lost to Follow-up|1|||
146155788|NCT02008890|527081220|FG003|Period 2|Lost to Follow-up|0|||
146155789|NCT02008890|527081221|FG004|Period 2|Lost to Follow-up|0|||
146155790|NCT02008890|527081217|FG000|Extension Period|Withdrawal by Subject|3|||
146155791|NCT02008890|527081218|FG001|Extension Period|Withdrawal by Subject|2|||
146155792|NCT02008890|527081219|FG002|Extension Period|Withdrawal by Subject|0|||
146155793|NCT02008890|527081220|FG003|Extension Period|Withdrawal by Subject|4|||
146155794|NCT02008890|527081221|FG004|Extension Period|Withdrawal by Subject|2|||
146155795|NCT02008890|527081217|FG000|Extension Period|Lost to Follow-up|1|||
146155796|NCT02008890|527081218|FG001|Extension Period|Lost to Follow-up|0|||
146155797|NCT02008890|527081219|FG002|Extension Period|Lost to Follow-up|0|||
146155798|NCT02008890|527081220|FG003|Extension Period|Lost to Follow-up|0|||
146309930|NCT02409290|527648645|FG002|Overall Study|No positive culture/no baseline sample|6|||
146309931|NCT02409290|527648646|FG003|Overall Study|No positive culture/no baseline sample|5|||
146309932|NCT02409290|527648643|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
146309933|NCT02409290|527648644|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146155799|NCT02008890|527081221|FG004|Extension Period|Lost to Follow-up|0|||
146155800|NCT02008890|527081217|FG000|Extension Period|Adverse Event|1|||
146155801|NCT02008890|527081218|FG001|Extension Period|Adverse Event|3|||
146155802|NCT02008890|527081219|FG002|Extension Period|Adverse Event|0|||
146155803|NCT02008890|527081220|FG003|Extension Period|Adverse Event|0|||
146155804|NCT02008890|527081221|FG004|Extension Period|Adverse Event|2|||
146155805|NCT02332720|527081222|FG000|Part A and Part B|Lost to Follow-up|1|||
146155806|NCT02332720|527081223|FG001|Part A and Part B|Lost to Follow-up|0|||
146155807|NCT02332720|527081224|FG002|Part A and Part B|Lost to Follow-up|0|||
146155808|NCT02332720|527081225|FG003|Part A and Part B|Lost to Follow-up|0|||
146155809|NCT02332720|527081226|FG004|Part A and Part B|Lost to Follow-up|0|||
146155810|NCT02332720|527081227|FG005|Part A and Part B|Lost to Follow-up|2|||
146155811|NCT02332720|527081228|FG006|Part A and Part B|Lost to Follow-up|1|||
146155812|NCT02332720|527081229|FG007|Part A and Part B|Lost to Follow-up|1|||
146155813|NCT02332720|527081230|FG008|Part A and Part B|Lost to Follow-up|0|||
146155814|NCT02332720|527081231|FG009|Part A and Part B|Lost to Follow-up|0|||
146155815|NCT02332720|527081232|FG010|Part A and Part B|Lost to Follow-up|0|||
146155816|NCT02332720|527081233|FG011|Part A and Part B|Lost to Follow-up|0|||
146155817|NCT02332720|527081234|FG012|Part A and Part B|Lost to Follow-up|0|||
146155818|NCT02332720|527081235|FG013|Part A and Part B|Lost to Follow-up|0|||
146155819|NCT02332720|527081236|FG014|Part A and Part B|Lost to Follow-up|0|||
146155820|NCT02332720|527081237|FG015|Part A and Part B|Lost to Follow-up|1|||
146155821|NCT02332720|527081238|FG016|Part A and Part B|Lost to Follow-up|0|||
146155822|NCT02332720|527081239|FG017|Part A and Part B|Lost to Follow-up|0|||
146155823|NCT02332720|527081240|FG018|Part A and Part B|Lost to Follow-up|0|||
146155824|NCT02332720|527081241|FG019|Part A and Part B|Lost to Follow-up|0|||
146155825|NCT02332720|527081242|FG020|Part A and Part B|Lost to Follow-up|0|||
146155826|NCT02332720|527081243|FG021|Part A and Part B|Lost to Follow-up|0|||
146155827|NCT02332720|527081244|FG022|Part A and Part B|Lost to Follow-up|0|||
146155828|NCT02332720|527081222|FG000|Part A and Part B|Adverse Event|0|||
146155829|NCT02332720|527081223|FG001|Part A and Part B|Adverse Event|0|||
146155830|NCT02332720|527081224|FG002|Part A and Part B|Adverse Event|0|||
146155831|NCT02332720|527081225|FG003|Part A and Part B|Adverse Event|0|||
146155832|NCT02332720|527081226|FG004|Part A and Part B|Adverse Event|0|||
146155833|NCT02332720|527081227|FG005|Part A and Part B|Adverse Event|0|||
146155834|NCT02332720|527081228|FG006|Part A and Part B|Adverse Event|0|||
146155835|NCT02332720|527081229|FG007|Part A and Part B|Adverse Event|0|||
146155836|NCT02332720|527081230|FG008|Part A and Part B|Adverse Event|0|||
146155837|NCT02332720|527081231|FG009|Part A and Part B|Adverse Event|0|||
146155838|NCT02332720|527081232|FG010|Part A and Part B|Adverse Event|0|||
146155839|NCT02332720|527081233|FG011|Part A and Part B|Adverse Event|0|||
146155840|NCT02332720|527081234|FG012|Part A and Part B|Adverse Event|0|||
146155841|NCT02332720|527081235|FG013|Part A and Part B|Adverse Event|0|||
146155842|NCT02332720|527081236|FG014|Part A and Part B|Adverse Event|0|||
146155843|NCT02332720|527081237|FG015|Part A and Part B|Adverse Event|0|||
146155844|NCT02332720|527081238|FG016|Part A and Part B|Adverse Event|0|||
146155845|NCT02332720|527081239|FG017|Part A and Part B|Adverse Event|1|||
146155846|NCT02332720|527081240|FG018|Part A and Part B|Adverse Event|0|||
146155847|NCT02332720|527081241|FG019|Part A and Part B|Adverse Event|0|||
146155848|NCT02332720|527081242|FG020|Part A and Part B|Adverse Event|0|||
146155849|NCT02332720|527081243|FG021|Part A and Part B|Adverse Event|0|||
146155850|NCT02332720|527081244|FG022|Part A and Part B|Adverse Event|0|||
146155851|NCT02332720|527081222|FG000|Part A and Part B|Physician Decision|0|||
146155852|NCT02332720|527081223|FG001|Part A and Part B|Physician Decision|0|||
146155853|NCT02332720|527081224|FG002|Part A and Part B|Physician Decision|0|||
146155854|NCT02332720|527081225|FG003|Part A and Part B|Physician Decision|0|||
146155855|NCT02332720|527081226|FG004|Part A and Part B|Physician Decision|0|||
146155856|NCT02332720|527081227|FG005|Part A and Part B|Physician Decision|0|||
146155857|NCT02332720|527081228|FG006|Part A and Part B|Physician Decision|0|||
146155858|NCT02332720|527081229|FG007|Part A and Part B|Physician Decision|0|||
146155859|NCT02332720|527081230|FG008|Part A and Part B|Physician Decision|0|||
146155860|NCT02332720|527081231|FG009|Part A and Part B|Physician Decision|0|||
146155861|NCT02332720|527081232|FG010|Part A and Part B|Physician Decision|0|||
146155862|NCT02332720|527081233|FG011|Part A and Part B|Physician Decision|0|||
146155863|NCT02332720|527081234|FG012|Part A and Part B|Physician Decision|0|||
146155864|NCT02332720|527081235|FG013|Part A and Part B|Physician Decision|0|||
146155865|NCT02332720|527081236|FG014|Part A and Part B|Physician Decision|0|||
146155866|NCT02332720|527081237|FG015|Part A and Part B|Physician Decision|0|||
146155867|NCT02332720|527081238|FG016|Part A and Part B|Physician Decision|0|||
146155868|NCT02332720|527081239|FG017|Part A and Part B|Physician Decision|0|||
146155869|NCT02332720|527081240|FG018|Part A and Part B|Physician Decision|1|||
146155870|NCT02332720|527081241|FG019|Part A and Part B|Physician Decision|0|||
146155871|NCT02332720|527081242|FG020|Part A and Part B|Physician Decision|0|||
146155872|NCT02332720|527081243|FG021|Part A and Part B|Physician Decision|0|||
146155873|NCT02332720|527081244|FG022|Part A and Part B|Physician Decision|0|||
146155874|NCT02332720|527081222|FG000|Part A and Part B|Withdrawal by Subject|0|||
146155875|NCT02332720|527081223|FG001|Part A and Part B|Withdrawal by Subject|0|||
146155876|NCT02332720|527081224|FG002|Part A and Part B|Withdrawal by Subject|0|||
146155877|NCT02332720|527081225|FG003|Part A and Part B|Withdrawal by Subject|0|||
146155878|NCT02332720|527081226|FG004|Part A and Part B|Withdrawal by Subject|0|||
146155879|NCT02332720|527081227|FG005|Part A and Part B|Withdrawal by Subject|1|||
146155880|NCT02332720|527081228|FG006|Part A and Part B|Withdrawal by Subject|0|||
146155881|NCT02332720|527081229|FG007|Part A and Part B|Withdrawal by Subject|0|||
146155882|NCT02332720|527081230|FG008|Part A and Part B|Withdrawal by Subject|0|||
146155883|NCT02332720|527081231|FG009|Part A and Part B|Withdrawal by Subject|0|||
146155884|NCT02332720|527081232|FG010|Part A and Part B|Withdrawal by Subject|0|||
146155885|NCT02332720|527081233|FG011|Part A and Part B|Withdrawal by Subject|0|||
146155886|NCT02332720|527081234|FG012|Part A and Part B|Withdrawal by Subject|0|||
146155887|NCT02332720|527081235|FG013|Part A and Part B|Withdrawal by Subject|0|||
146155888|NCT02332720|527081236|FG014|Part A and Part B|Withdrawal by Subject|0|||
146155889|NCT02332720|527081237|FG015|Part A and Part B|Withdrawal by Subject|0|||
146155890|NCT02332720|527081238|FG016|Part A and Part B|Withdrawal by Subject|0|||
146155891|NCT02332720|527081239|FG017|Part A and Part B|Withdrawal by Subject|0|||
146155892|NCT02332720|527081240|FG018|Part A and Part B|Withdrawal by Subject|0|||
146155893|NCT02332720|527081241|FG019|Part A and Part B|Withdrawal by Subject|1|||
146155894|NCT02332720|527081242|FG020|Part A and Part B|Withdrawal by Subject|0|||
146155895|NCT02332720|527081243|FG021|Part A and Part B|Withdrawal by Subject|0|||
146155896|NCT02332720|527081244|FG022|Part A and Part B|Withdrawal by Subject|0|||
146155897|NCT05912400|527081245|FG000|Overall Study|Lost to Follow-up|1|||
146155898|NCT05912400|527081246|FG001|Overall Study|Lost to Follow-up|0|||
146155899|NCT05912400|527081245|FG000|Overall Study|Physician Decision|6|||
146155900|NCT05912400|527081246|FG001|Overall Study|Physician Decision|0|||
146155901|NCT05912400|527081245|FG000|Overall Study|Withdrawal by Subject|1|||
146155902|NCT05912400|527081246|FG001|Overall Study|Withdrawal by Subject|0|||
146155903|NCT02522494|527081249|FG000|Overall Study|Lost to Follow-up|6|||
146155904|NCT02522494|527081250|FG001|Overall Study|Lost to Follow-up|2|||
146155905|NCT02522494|527081249|FG000|Overall Study|Withdrawal by Subject|1|||
146155906|NCT02522494|527081250|FG001|Overall Study|Withdrawal by Subject|0|||
146155907|NCT02522494|527081249|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
146155908|NCT02522494|527081250|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
146155909|NCT02522494|527081249|FG000|Overall Study|Participant did not watch the video|1|||
146155910|NCT02522494|527081250|FG001|Overall Study|Participant did not watch the video|0|||
146155911|NCT02522494|527081249|FG000|Overall Study|Death|0|||
146155912|NCT02522494|527081250|FG001|Overall Study|Death|1|||
146155913|NCT02508311|527081253|FG000|Overall Study|Withdrawal by Subject|1|||
146155914|NCT02508311|527081254|FG001|Overall Study|Withdrawal by Subject|0|||
146155915|NCT00448539|527081255|FG000|Overall Study|Medication non-compliance|4|||
146155916|NCT00448539|527081256|FG001|Overall Study|Medication non-compliance|1|||
146155917|NCT00448539|527081255|FG000|Overall Study|Protocol Violation|1|||
146155918|NCT00448539|527081256|FG001|Overall Study|Protocol Violation|0|||
146155919|NCT00448539|527081255|FG000|Overall Study|Request of the investigator or sponsor|67|||
146155920|NCT00448539|527081256|FG001|Overall Study|Request of the investigator or sponsor|54|||
146155921|NCT00448539|527081255|FG000|Overall Study|Withdrawal by Subject|20|||
146155922|NCT00448539|527081256|FG001|Overall Study|Withdrawal by Subject|24|||
146155923|NCT00448539|527081255|FG000|Overall Study|Diary non-compliance|1|||
146155924|NCT00448539|527081256|FG001|Overall Study|Diary non-compliance|0|||
146155925|NCT00448539|527081255|FG000|Overall Study|Adverse Event|9|||
146155926|NCT00448539|527081256|FG001|Overall Study|Adverse Event|26|||
146155927|NCT00448539|527081255|FG000|Overall Study|Lack of Efficacy|27|||
146155928|NCT00448539|527081256|FG001|Overall Study|Lack of Efficacy|40|||
146155929|NCT00448539|527081255|FG000|Overall Study|Miscellaneous|2|||
146155930|NCT00448539|527081256|FG001|Overall Study|Miscellaneous|1|||
146155931|NCT00448539|527081255|FG000|Overall Study|Change of meds|2|||
146155932|NCT00448539|527081256|FG001|Overall Study|Change of meds|3|||
146155933|NCT00448539|527081255|FG000|Overall Study|Lost to Follow-up|1|||
146155934|NCT00448539|527081256|FG001|Overall Study|Lost to Follow-up|3|||
146155935|NCT04862143|527081257|FG000|Overall Study|Adverse Event|1|||
146155936|NCT04862143|527081257|FG000|Overall Study|Study terminated by sponsor|1|||
146155937|NCT02103439|527081258|FG000|Overall Study|Adverse Event|0|||
146155938|NCT02103439|527081259|FG001|Overall Study|Adverse Event|2|||
146155939|NCT02103439|527081258|FG000|Overall Study|Withdrawal by Subject|3|||
146155940|NCT02103439|527081259|FG001|Overall Study|Withdrawal by Subject|1|||
146155941|NCT02370602|527081260|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146155942|NCT02370602|527081261|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146155943|NCT02370602|527081262|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146155944|NCT02370602|527081263|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146155945|NCT02370602|527081264|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146155946|NCT02370602|527081265|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
146155947|NCT03349710|527081266|FG000|Treatment Period|Death|0|||
146155948|NCT03349710|527081267|FG001|Treatment Period|Death|0|||
146155949|NCT03349710|527081268|FG002|Treatment Period|Death|1|||
146155950|NCT03349710|527081269|FG003|Treatment Period|Death|0|||
146155951|NCT03349710|527081266|FG000|Treatment Period|Disease Progression|0|||
146155952|NCT03349710|527081267|FG001|Treatment Period|Disease Progression|2|||
146155953|NCT03349710|527081268|FG002|Treatment Period|Disease Progression|0|||
146155954|NCT03349710|527081269|FG003|Treatment Period|Disease Progression|1|||
146155955|NCT03349710|527081266|FG000|Treatment Period|Study Drug Toxicity|1|||
146155956|NCT03349710|527081267|FG001|Treatment Period|Study Drug Toxicity|0|||
146155957|NCT03349710|527081268|FG002|Treatment Period|Study Drug Toxicity|1|||
146155958|NCT03349710|527081269|FG003|Treatment Period|Study Drug Toxicity|1|||
146155959|NCT03349710|527081266|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
146155960|NCT03349710|527081267|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
146155961|NCT03349710|527081268|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
146155962|NCT03349710|527081269|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
146155963|NCT03349710|527081266|FG000|Treatment Period|admin reason by sponsor|0|||
146155964|NCT03349710|527081267|FG001|Treatment Period|admin reason by sponsor|7|||
146155965|NCT03349710|527081268|FG002|Treatment Period|admin reason by sponsor|0|||
146155966|NCT03349710|527081269|FG003|Treatment Period|admin reason by sponsor|19|||
146155967|NCT03349710|527081266|FG000|Treatment Period|Other Reason|2|||
146155968|NCT03349710|527081267|FG001|Treatment Period|Other Reason|0|||
146155969|NCT03349710|527081268|FG002|Treatment Period|Other Reason|2|||
146155970|NCT03349710|527081269|FG003|Treatment Period|Other Reason|1|||
146155971|NCT03349710|527081266|FG000|Treatment Period|completed|6|||
146155972|NCT03349710|527081267|FG001|Treatment Period|completed|0|||
146155973|NCT03349710|527081268|FG002|Treatment Period|completed|18|||
146155974|NCT03349710|527081269|FG003|Treatment Period|completed|1|||
146155975|NCT03349710|527081266|FG000|Treatment Period|participant request to discontinue|0|||
146155976|NCT03349710|527081267|FG001|Treatment Period|participant request to discontinue|0|||
146155977|NCT03349710|527081268|FG002|Treatment Period|participant request to discontinue|4|||
146155978|NCT03349710|527081269|FG003|Treatment Period|participant request to discontinue|0|||
146155979|NCT03349710|527081266|FG000|Treatment Period|participant withdrew consent|1|||
146155980|NCT03349710|527081267|FG001|Treatment Period|participant withdrew consent|0|||
146155981|NCT03349710|527081268|FG002|Treatment Period|participant withdrew consent|0|||
146155982|NCT03349710|527081269|FG003|Treatment Period|participant withdrew consent|0|||
146155983|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
146155984|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
146155985|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
146155986|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
146155987|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
146155988|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
146155989|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
146155990|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
146155991|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
146155992|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
146155993|NCT00695903|527081270|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
146155994|NCT00695903|527081271|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
146155995|NCT00695903|527081270|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
146155996|NCT00695903|527081271|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
146155997|NCT00695903|527081270|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
146155998|NCT00695903|527081271|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
146155999|NCT00695903|527081270|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
146156000|NCT00695903|527081271|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
146156001|NCT02696317|527081272|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
146156002|NCT02696317|527081273|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
146156003|NCT02696317|527081272|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
146156004|NCT02696317|527081273|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
146156005|NCT01343368|527081274|FG000|Overall Study|Death|1|||
146156006|NCT01343368|527081275|FG001|Overall Study|Death|0|||
146156007|NCT01343368|527081274|FG000|Overall Study|Lost to Follow-up|1|||
146156008|NCT01343368|527081275|FG001|Overall Study|Lost to Follow-up|0|||
146156009|NCT01296568|527081278|FG000|Continued Access Phase|Lost to Follow-up|1|||
146156010|NCT01296568|527081278|FG000|Continued Access Phase|Withdrawal by Subject|1|||
146156011|NCT01296568|527081278|FG000|Continued Access Phase|Disease Progression|1|||
146156012|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
146156013|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
146156014|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
146156015|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
146156016|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
146156017|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
146156018|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
146156019|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
146156020|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
146156021|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
146156022|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
146156023|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
146156024|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
146156025|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
146156026|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
146156027|NCT01571362|527081282|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
146156028|NCT01571362|527081283|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
146309934|NCT02409290|527648645|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146309935|NCT02409290|527648646|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
146309936|NCT01394627|527648647|FG000|First Intervention (1 Day)|poor intravenous access|0|||
146156029|NCT01571362|527081284|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
146156030|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146156031|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
146156032|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
146156033|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146156034|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
146156035|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
146156036|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146156037|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Adverse Event|9|||
146156038|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Adverse Event|14|||
146156039|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146156040|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
146156041|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
146156042|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
146156043|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
146156044|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
146156045|NCT01571362|527081282|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
146156046|NCT01571362|527081283|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
146156047|NCT01571362|527081284|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
146156048|NCT03117738|527081285|FG000|Overall Study|Withdrawal by Subject|3|||
146156049|NCT03117738|527081286|FG001|Overall Study|Withdrawal by Subject|1|||
146156050|NCT03117738|527081285|FG000|Overall Study|Lost to Follow-up|1|||
146156051|NCT03117738|527081286|FG001|Overall Study|Lost to Follow-up|4|||
146156052|NCT01669629|527081287|FG000|Period 1|protocol deviation|1|||
146156053|NCT01669629|527081288|FG001|Period 1|protocol deviation|2|||
146156054|NCT01221597|527081289|FG000|Overall Study|Adverse Event|4|||
146156055|NCT01221597|527081290|FG001|Overall Study|Adverse Event|1|||
146156056|NCT01221597|527081289|FG000|Overall Study|Withdrawal by Subject|20|||
146156057|NCT01221597|527081290|FG001|Overall Study|Withdrawal by Subject|6|||
146156058|NCT01221597|527081289|FG000|Overall Study|Lost to Follow-up|6|||
146156059|NCT01221597|527081290|FG001|Overall Study|Lost to Follow-up|5|||
146156060|NCT01221597|527081289|FG000|Overall Study|Protocol Violation|1|||
146156061|NCT01221597|527081290|FG001|Overall Study|Protocol Violation|0|||
146156062|NCT01221597|527081289|FG000|Overall Study|Other|3|||
146156063|NCT01221597|527081290|FG001|Overall Study|Other|4|||
146156064|NCT01221597|527081289|FG000|Overall Study|Death|2|||
146156065|NCT01221597|527081290|FG001|Overall Study|Death|0|||
146156066|NCT01292928|527081292|FG000|Overall Study|Death|8|||
146156067|NCT01292928|527081292|FG000|Overall Study|Withdrawal by Subject|8|||
146156068|NCT01292928|527081292|FG000|Overall Study|Lost to Follow-up|6|||
146156069|NCT01292928|527081292|FG000|Overall Study|Physician Decision|2|||
146156070|NCT04530448|527081293|FG000|Overall Study|Physician Decision|3|||
146156071|NCT04530448|527081294|FG001|Overall Study|Physician Decision|0|||
146156072|NCT01491854|527081295|FG000|Overall Study|mainly due to premature termination|93|||
146156073|NCT01491854|527081295|FG000|Overall Study|Death|1|||
146156074|NCT01491854|527081295|FG000|Overall Study|Withdrawal by Subject|3|||
146156075|NCT01491854|527081295|FG000|Overall Study|Lost to Follow-up|33|||
146156076|NCT01026974|527081307|FG000|Overall Study|Withdrawal by Subject|0|||
146156077|NCT01026974|527081308|FG001|Overall Study|Withdrawal by Subject|1|||
146309937|NCT01394627|527648648|FG001|First Intervention (1 Day)|poor intravenous access|1|||
146156078|NCT01026974|527081309|FG002|Overall Study|Withdrawal by Subject|7|||
146156079|NCT01026974|527081310|FG003|Overall Study|Withdrawal by Subject|2|||
146156080|NCT01026974|527081307|FG000|Overall Study|Lost to Follow-up|1|||
146156081|NCT01026974|527081308|FG001|Overall Study|Lost to Follow-up|1|||
146156082|NCT01026974|527081309|FG002|Overall Study|Lost to Follow-up|4|||
146156083|NCT01026974|527081310|FG003|Overall Study|Lost to Follow-up|0|||
146156084|NCT01026974|527081307|FG000|Overall Study|Adverse Event|0|||
146156085|NCT01026974|527081308|FG001|Overall Study|Adverse Event|0|||
146156086|NCT01026974|527081309|FG002|Overall Study|Adverse Event|0|||
146156087|NCT01026974|527081310|FG003|Overall Study|Adverse Event|1|||
146156088|NCT01026974|527081307|FG000|Overall Study|Inappropriate enrollment|0|||
146156089|NCT01026974|527081308|FG001|Overall Study|Inappropriate enrollment|0|||
146156090|NCT01026974|527081309|FG002|Overall Study|Inappropriate enrollment|1|||
146156091|NCT01026974|527081310|FG003|Overall Study|Inappropriate enrollment|0|||
146156092|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
146156093|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
146309938|NCT01394627|527648647|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
146156094|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
146156095|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
146156096|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
146156097|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146156098|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146156099|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
146156100|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
146156101|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146156102|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146156103|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
146156104|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
146156105|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146156106|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146156107|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
146156108|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
146156109|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146156110|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146156111|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
146156112|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
146156113|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146156114|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146156115|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
146156116|NCT01715805|527081312|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
146156117|NCT01715805|527081313|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146156118|NCT01715805|527081314|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146156119|NCT01715805|527081315|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
146156120|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146156121|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146156122|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
146156123|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
146156124|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
146156125|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
146156126|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
146156127|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
146156128|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
146156129|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
146156130|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
146156131|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
146156132|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
146156133|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
146156134|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
146156135|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
146156136|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
146156137|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
146156138|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
146156139|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
146156140|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
146156141|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
146156142|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
146156143|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
146156144|NCT01715805|527081312|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146156145|NCT01715805|527081313|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
146156146|NCT01715805|527081314|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146156147|NCT01715805|527081315|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
146156148|NCT02647359|527081318|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
146156149|NCT02647359|527081319|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
146156150|NCT02647359|527081318|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
146156151|NCT02647359|527081319|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
146156152|NCT02647359|527081318|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
146156153|NCT02647359|527081319|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
146156154|NCT02647359|527081318|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
146156155|NCT02647359|527081319|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
146156156|NCT02647359|527081318|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
146156157|NCT02647359|527081319|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
146156158|NCT02647359|527081318|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
146156159|NCT02647359|527081319|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
146156160|NCT04642638|527081320|FG000|Overall Study|Withdrawal by Subject|23|||
146156161|NCT04642638|527081321|FG001|Overall Study|Withdrawal by Subject|29|||
146156162|NCT04642638|527081322|FG002|Overall Study|Withdrawal by Subject|9|||
146156163|NCT04642638|527081323|FG003|Overall Study|Withdrawal by Subject|7|||
146309939|NCT01394627|527648648|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
146309940|NCT03223428|527648649|FG000|Overall Study|No longer taking Xermelo|27|||
146156164|NCT04642638|527081324|FG004|Overall Study|Withdrawal by Subject|61|||
146156165|NCT04642638|527081325|FG005|Overall Study|Withdrawal by Subject|27|||
146156166|NCT04642638|527081320|FG000|Overall Study|Lost to Follow-up|17|||
146156167|NCT04642638|527081321|FG001|Overall Study|Lost to Follow-up|18|||
146156168|NCT04642638|527081322|FG002|Overall Study|Lost to Follow-up|5|||
146156169|NCT04642638|527081323|FG003|Overall Study|Lost to Follow-up|5|||
146156170|NCT04642638|527081324|FG004|Overall Study|Lost to Follow-up|6|||
146156171|NCT04642638|527081325|FG005|Overall Study|Lost to Follow-up|3|||
146156172|NCT04642638|527081320|FG000|Overall Study|Adverse Event|0|||
146156173|NCT04642638|527081321|FG001|Overall Study|Adverse Event|0|||
146156174|NCT04642638|527081322|FG002|Overall Study|Adverse Event|1|||
146156175|NCT04642638|527081323|FG003|Overall Study|Adverse Event|0|||
146156176|NCT04642638|527081324|FG004|Overall Study|Adverse Event|10|||
146156177|NCT04642638|527081325|FG005|Overall Study|Adverse Event|3|||
146156178|NCT04642638|527081320|FG000|Overall Study|Reason Not Specified|1|||
146156179|NCT04642638|527081321|FG001|Overall Study|Reason Not Specified|4|||
146156180|NCT04642638|527081322|FG002|Overall Study|Reason Not Specified|0|||
146156181|NCT04642638|527081323|FG003|Overall Study|Reason Not Specified|0|||
146156182|NCT04642638|527081324|FG004|Overall Study|Reason Not Specified|38|||
146156183|NCT04642638|527081325|FG005|Overall Study|Reason Not Specified|16|||
146156184|NCT04642638|527081320|FG000|Overall Study|Physician Decision|0|||
146156185|NCT04642638|527081321|FG001|Overall Study|Physician Decision|0|||
146156186|NCT04642638|527081322|FG002|Overall Study|Physician Decision|0|||
146156187|NCT04642638|527081323|FG003|Overall Study|Physician Decision|0|||
146156188|NCT04642638|527081324|FG004|Overall Study|Physician Decision|2|||
146156189|NCT04642638|527081325|FG005|Overall Study|Physician Decision|1|||
146156190|NCT04642638|527081320|FG000|Overall Study|Protocol Deviation|0|||
146156191|NCT04642638|527081321|FG001|Overall Study|Protocol Deviation|0|||
146156192|NCT04642638|527081322|FG002|Overall Study|Protocol Deviation|0|||
146156193|NCT04642638|527081323|FG003|Overall Study|Protocol Deviation|0|||
146156194|NCT04642638|527081324|FG004|Overall Study|Protocol Deviation|1|||
146156195|NCT04642638|527081325|FG005|Overall Study|Protocol Deviation|3|||
146156196|NCT04642638|527081320|FG000|Overall Study|Study Terminated|0|||
146156197|NCT04642638|527081321|FG001|Overall Study|Study Terminated|0|||
146156198|NCT04642638|527081322|FG002|Overall Study|Study Terminated|0|||
146156199|NCT04642638|527081323|FG003|Overall Study|Study Terminated|0|||
146156200|NCT04642638|527081324|FG004|Overall Study|Study Terminated|484|||
146156201|NCT04642638|527081325|FG005|Overall Study|Study Terminated|250|||
146156202|NCT04642638|527081320|FG000|Overall Study|Pregnancy|0|||
146156203|NCT04642638|527081321|FG001|Overall Study|Pregnancy|0|||
146156204|NCT04642638|527081322|FG002|Overall Study|Pregnancy|0|||
146156205|NCT04642638|527081323|FG003|Overall Study|Pregnancy|0|||
146156206|NCT04642638|527081324|FG004|Overall Study|Pregnancy|1|||
146156207|NCT04642638|527081325|FG005|Overall Study|Pregnancy|0|||
146156208|NCT00511004|527081326|FG000|Overall Study|Lost to Follow-up|0|||
146156209|NCT00511004|527081327|FG001|Overall Study|Lost to Follow-up|0|||
146156210|NCT00511004|527081328|FG002|Overall Study|Lost to Follow-up|4|||
146156211|NCT00990652|527081329|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
146156212|NCT00990652|527081329|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
146156213|NCT01672801|527081330|FG000|Overall Study|Screen Failure|0|||
146156214|NCT01672801|527081331|FG001|Overall Study|Screen Failure|1|||
146156215|NCT02384954|527081338|FG000|Phase 1|Progressive Disease|2|||
146156216|NCT02384954|527081339|FG001|Phase 1|Progressive Disease|0|||
146156217|NCT02384954|527081340|FG002|Phase 1|Progressive Disease|1|||
146156218|NCT02384954|527081341|FG003|Phase 1|Progressive Disease|1|||
146156219|NCT02384954|527081342|FG004|Phase 1|Progressive Disease|0|||
146156220|NCT02384954|527081343|FG005|Phase 1|Progressive Disease|0|||
146156221|NCT02384954|527081344|FG006|Phase 1|Progressive Disease|0|||
146156222|NCT02384954|527081345|FG007|Phase 1|Progressive Disease|0|||
146156223|NCT02384954|527081346|FG008|Phase 1|Progressive Disease|0|||
146156224|NCT02384954|527081338|FG000|Phase 1|Adverse Event|0|||
146156225|NCT02384954|527081339|FG001|Phase 1|Adverse Event|0|||
146156226|NCT02384954|527081340|FG002|Phase 1|Adverse Event|1|||
146156227|NCT02384954|527081341|FG003|Phase 1|Adverse Event|0|||
146156228|NCT02384954|527081342|FG004|Phase 1|Adverse Event|0|||
146156229|NCT02384954|527081343|FG005|Phase 1|Adverse Event|0|||
146156230|NCT02384954|527081344|FG006|Phase 1|Adverse Event|0|||
146156231|NCT02384954|527081345|FG007|Phase 1|Adverse Event|0|||
146156232|NCT02384954|527081346|FG008|Phase 1|Adverse Event|0|||
146156233|NCT02384954|527081338|FG000|Phase 2|Progressive Disease|0|||
146156234|NCT02384954|527081339|FG001|Phase 2|Progressive Disease|0|||
146156235|NCT02384954|527081340|FG002|Phase 2|Progressive Disease|0|||
146156236|NCT02384954|527081341|FG003|Phase 2|Progressive Disease|0|||
146156237|NCT02384954|527081342|FG004|Phase 2|Progressive Disease|0|||
146156238|NCT02384954|527081343|FG005|Phase 2|Progressive Disease|0|||
146156239|NCT02384954|527081344|FG006|Phase 2|Progressive Disease|0|||
146156240|NCT02384954|527081345|FG007|Phase 2|Progressive Disease|1|||
146156241|NCT02384954|527081346|FG008|Phase 2|Progressive Disease|2|||
146156242|NCT02384954|527081338|FG000|Phase 2|Adverse Event|0|||
146156243|NCT02384954|527081339|FG001|Phase 2|Adverse Event|0|||
146156244|NCT02384954|527081340|FG002|Phase 2|Adverse Event|0|||
146156245|NCT02384954|527081341|FG003|Phase 2|Adverse Event|0|||
146156246|NCT02384954|527081342|FG004|Phase 2|Adverse Event|0|||
146156247|NCT02384954|527081343|FG005|Phase 2|Adverse Event|0|||
146156248|NCT02384954|527081344|FG006|Phase 2|Adverse Event|0|||
146156249|NCT02384954|527081345|FG007|Phase 2|Adverse Event|1|||
146156250|NCT02384954|527081346|FG008|Phase 2|Adverse Event|1|||
146156251|NCT02384954|527081338|FG000|Phase 2|Failure to meet continuation criteria|0|||
146156252|NCT02384954|527081339|FG001|Phase 2|Failure to meet continuation criteria|0|||
146156253|NCT02384954|527081340|FG002|Phase 2|Failure to meet continuation criteria|0|||
146156254|NCT02384954|527081341|FG003|Phase 2|Failure to meet continuation criteria|0|||
146156255|NCT02384954|527081342|FG004|Phase 2|Failure to meet continuation criteria|0|||
146156256|NCT02384954|527081343|FG005|Phase 2|Failure to meet continuation criteria|0|||
146156257|NCT02384954|527081344|FG006|Phase 2|Failure to meet continuation criteria|0|||
146156258|NCT02384954|527081345|FG007|Phase 2|Failure to meet continuation criteria|1|||
146156259|NCT02384954|527081346|FG008|Phase 2|Failure to meet continuation criteria|0|||
146156260|NCT03595904|527081352|FG000|Overall Study|Protocol Violation|3|||
146156261|NCT03595904|527081353|FG001|Overall Study|Protocol Violation|1|||
146156262|NCT03595904|527081352|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
146156263|NCT03595904|527081353|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
146156264|NCT03595904|527081352|FG000|Overall Study|Insurance complications|1|||
146156265|NCT03595904|527081353|FG001|Overall Study|Insurance complications|0|||
146156266|NCT03595904|527081352|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
146156267|NCT03595904|527081353|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
146156268|NCT00295750|527081354|FG000|Overall Study|Adverse Event|19|||
146156269|NCT00295750|527081355|FG001|Overall Study|Adverse Event|15|||
146156270|NCT00295750|527081356|FG002|Overall Study|Adverse Event|12|||
146156271|NCT00295750|527081354|FG000|Overall Study|Lack of Efficacy|1|||
146156272|NCT00295750|527081355|FG001|Overall Study|Lack of Efficacy|1|||
146156273|NCT00295750|527081356|FG002|Overall Study|Lack of Efficacy|0|||
146156274|NCT00295750|527081354|FG000|Overall Study|Lost to Follow-up|1|||
146156275|NCT00295750|527081355|FG001|Overall Study|Lost to Follow-up|4|||
146156276|NCT00295750|527081356|FG002|Overall Study|Lost to Follow-up|1|||
146156277|NCT00295750|527081354|FG000|Overall Study|Taking prohibited therapy|2|||
146156278|NCT00295750|527081355|FG001|Overall Study|Taking prohibited therapy|3|||
146156279|NCT00295750|527081356|FG002|Overall Study|Taking prohibited therapy|2|||
146156280|NCT00295750|527081354|FG000|Overall Study|Administrative errors|2|||
146156281|NCT00295750|527081355|FG001|Overall Study|Administrative errors|4|||
146156282|NCT00295750|527081356|FG002|Overall Study|Administrative errors|5|||
146156283|NCT00295750|527081354|FG000|Overall Study|Trial drug errors|1|||
146156284|NCT00295750|527081355|FG001|Overall Study|Trial drug errors|1|||
146156285|NCT00295750|527081356|FG002|Overall Study|Trial drug errors|0|||
146156286|NCT00295750|527081354|FG000|Overall Study|Disease progression|2|||
146156287|NCT00295750|527081355|FG001|Overall Study|Disease progression|1|||
146156288|NCT00295750|527081356|FG002|Overall Study|Disease progression|0|||
146156289|NCT00295750|527081354|FG000|Overall Study|Personal reasons|0|||
146156290|NCT00295750|527081355|FG001|Overall Study|Personal reasons|1|||
146156291|NCT00295750|527081356|FG002|Overall Study|Personal reasons|0|||
146156292|NCT00295750|527081354|FG000|Overall Study|Randomized but never received trial drug|4|||
146156293|NCT00295750|527081355|FG001|Overall Study|Randomized but never received trial drug|3|||
146156294|NCT00295750|527081356|FG002|Overall Study|Randomized but never received trial drug|3|||
146156295|NCT00295750|527081354|FG000|Overall Study|Withdrawal by Subject|9|||
146156296|NCT00295750|527081355|FG001|Overall Study|Withdrawal by Subject|4|||
146156297|NCT00295750|527081356|FG002|Overall Study|Withdrawal by Subject|7|||
146156298|NCT00295750|527081354|FG000|Overall Study|Protocol Violation|2|||
146156299|NCT00295750|527081355|FG001|Overall Study|Protocol Violation|4|||
146156300|NCT00295750|527081356|FG002|Overall Study|Protocol Violation|2|||
146156301|NCT01650259|527081357|FG000|Overall Study|Improvement|105|||
146156302|NCT01650259|527081358|FG001|Overall Study|Improvement|0|||
146156303|NCT01650259|527081357|FG000|Overall Study|Adverse Event|127|||
146156304|NCT01650259|527081358|FG001|Overall Study|Adverse Event|0|||
146156305|NCT01650259|527081357|FG000|Overall Study|Lack of Efficacy|143|||
146156306|NCT01650259|527081358|FG001|Overall Study|Lack of Efficacy|0|||
146156307|NCT01650259|527081357|FG000|Overall Study|Lost to Follow-up|435|||
146156308|NCT01650259|527081358|FG001|Overall Study|Lost to Follow-up|0|||
146156309|NCT01650259|527081357|FG000|Overall Study|Patients had no visit after entry|70|||
146156310|NCT01650259|527081358|FG001|Overall Study|Patients had no visit after entry|0|||
146156311|NCT01650259|527081357|FG000|Overall Study|CRF not collected|98|||
146156312|NCT01650259|527081358|FG001|Overall Study|CRF not collected|82|||
146156313|NCT01650259|527081357|FG000|Overall Study|Not treated|1|||
146156314|NCT01650259|527081358|FG001|Overall Study|Not treated|7|||
146156315|NCT01650259|527081357|FG000|Overall Study|Other than listed|64|||
146156316|NCT01650259|527081358|FG001|Overall Study|Other than listed|146|||
146309941|NCT03223428|527648649|FG000|Overall Study|Declined Consent|1|||
146156317|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
146156318|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
146156319|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
146156320|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
146156321|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
146156322|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
146156323|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
146156324|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
146156325|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
146156326|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
146156327|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
146156328|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
146156329|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
146156330|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
146156331|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
146156332|NCT00355082|527081364|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
146156333|NCT00355082|527081365|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
146156334|NCT00355082|527081366|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
146156335|NCT00355082|527081364|FG000|Continuation Phase|Adverse Event|2|||
146156336|NCT00355082|527081365|FG001|Continuation Phase|Adverse Event|0|||
146156337|NCT00355082|527081366|FG002|Continuation Phase|Adverse Event|1|||
146156338|NCT00355082|527081364|FG000|Continuation Phase|Lost to Follow-up|2|||
146156339|NCT00355082|527081365|FG001|Continuation Phase|Lost to Follow-up|0|||
146156340|NCT00355082|527081366|FG002|Continuation Phase|Lost to Follow-up|1|||
146156341|NCT00355082|527081364|FG000|Continuation Phase|Protocol Violation|1|||
146156342|NCT00355082|527081365|FG001|Continuation Phase|Protocol Violation|0|||
146156343|NCT00355082|527081366|FG002|Continuation Phase|Protocol Violation|1|||
146156344|NCT00355082|527081364|FG000|Continuation Phase|Withdrawal by Subject|4|||
146156345|NCT00355082|527081365|FG001|Continuation Phase|Withdrawal by Subject|0|||
146156346|NCT00355082|527081366|FG002|Continuation Phase|Withdrawal by Subject|0|||
146156347|NCT00355082|527081364|FG000|Continuation Phase|Lack of Efficacy|5|||
146156348|NCT00355082|527081365|FG001|Continuation Phase|Lack of Efficacy|0|||
146156349|NCT00355082|527081366|FG002|Continuation Phase|Lack of Efficacy|0|||
146156350|NCT00355082|527081364|FG000|Continuation Phase|Site Closed by Sponsor|8|||
146156351|NCT00355082|527081365|FG001|Continuation Phase|Site Closed by Sponsor|0|||
146156352|NCT00355082|527081366|FG002|Continuation Phase|Site Closed by Sponsor|0|||
146156353|NCT00355082|527081364|FG000|Continuation Phase|Scheduling Error|1|||
146156354|NCT00355082|527081365|FG001|Continuation Phase|Scheduling Error|0|||
146156355|NCT00355082|527081366|FG002|Continuation Phase|Scheduling Error|0|||
146156356|NCT00355082|527081364|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
146156357|NCT00355082|527081365|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
146156358|NCT00355082|527081366|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
146156359|NCT00724971|527081376|FG000|Overall Study|Adverse Event|5|||
146156360|NCT00724971|527081376|FG000|Overall Study|Withdrawal by Subject|1|||
146156361|NCT01003249|527081377|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146156362|NCT01003249|527081378|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
146156363|NCT01003249|527081377|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
146156364|NCT01003249|527081378|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
146156365|NCT01003249|527081377|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
146156366|NCT01003249|527081378|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
146156367|NCT01003249|527081377|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
146156368|NCT01003249|527081378|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
146156369|NCT02132611|527081383|FG000|Overall Study|Death|2|||
146156370|NCT03387852|527081384|FG000|Overall Study|Adverse event (AE)|3|||
146156371|NCT03387852|527081385|FG001|Overall Study|Adverse event (AE)|0|||
146156372|NCT03387852|527081386|FG002|Overall Study|Adverse event (AE)|2|||
146156373|NCT03387852|527081387|FG003|Overall Study|Adverse event (AE)|0|||
146156374|NCT03387852|527081384|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
146156375|NCT03387852|527081385|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
146156376|NCT03387852|527081386|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
146156377|NCT03387852|527081387|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
146156378|NCT03387852|527081384|FG000|Overall Study|Withdrawal by participant|1|||
146156379|NCT03387852|527081385|FG001|Overall Study|Withdrawal by participant|1|||
146156380|NCT03387852|527081386|FG002|Overall Study|Withdrawal by participant|3|||
146156381|NCT03387852|527081387|FG003|Overall Study|Withdrawal by participant|2|||
146156382|NCT03387852|527081384|FG000|Overall Study|Other- Unspecified|1|||
146156383|NCT03387852|527081385|FG001|Overall Study|Other- Unspecified|1|||
146156384|NCT03387852|527081386|FG002|Overall Study|Other- Unspecified|2|||
146156385|NCT03387852|527081387|FG003|Overall Study|Other- Unspecified|1|||
146156386|NCT03387852|527081384|FG000|Overall Study|Poor compliance to protocol|0|||
146156387|NCT03387852|527081385|FG001|Overall Study|Poor compliance to protocol|0|||
146156388|NCT03387852|527081386|FG002|Overall Study|Poor compliance to protocol|0|||
146156389|NCT03387852|527081387|FG003|Overall Study|Poor compliance to protocol|1|||
146156390|NCT03387852|527081384|FG000|Overall Study|Randomized and not treated|0|||
146156391|NCT03387852|527081385|FG001|Overall Study|Randomized and not treated|0|||
146156392|NCT03387852|527081386|FG002|Overall Study|Randomized and not treated|0|||
146156393|NCT03387852|527081387|FG003|Overall Study|Randomized and not treated|1|||
146156394|NCT02194621|527081388|FG000|Overall Study|6 withdrew prior to randomization|2|||
146156395|NCT02194621|527081389|FG001|Overall Study|6 withdrew prior to randomization|2|||
146156396|NCT02194621|527081390|FG002|Overall Study|6 withdrew prior to randomization|2|||
146156397|NCT02194621|527081388|FG000|Overall Study|Withdrawal by Subject|4|||
146156398|NCT02194621|527081389|FG001|Overall Study|Withdrawal by Subject|4|||
146156399|NCT02194621|527081390|FG002|Overall Study|Withdrawal by Subject|7|||
146156400|NCT02763384|527081398|FG000|Overall Study|Physician Decision|1|||
146156401|NCT02763384|527081398|FG000|Overall Study|Rapid decline - went on hospice|1|||
146156402|NCT02493127|527081399|FG000|Overall Study|Lost to Follow-up|1|||
146156403|NCT02493127|527081400|FG001|Overall Study|Lost to Follow-up|1|||
146156404|NCT02096900|527081401|FG000|Overall Study|Did not receive medication|3|||
146156405|NCT02096900|527081402|FG001|Overall Study|Did not receive medication|1|||
146156406|NCT02096900|527081401|FG000|Overall Study|Surgery cancelled- medication received|1|||
146156407|NCT02096900|527081402|FG001|Overall Study|Surgery cancelled- medication received|1|||
146156408|NCT00808808|527081406|FG000|Overall Study|Vaccinated; survey not completed|131|||
146156409|NCT00808808|527081407|FG001|Overall Study|Vaccinated; survey not completed|169|||
146156410|NCT00808808|527081408|FG002|Overall Study|Vaccinated; survey not completed|302|||
146156411|NCT00808808|527081406|FG000|Overall Study|Employee was not vaccinated.|2686|||
146156412|NCT00808808|527081407|FG001|Overall Study|Employee was not vaccinated.|2268|||
146156413|NCT00808808|527081408|FG002|Overall Study|Employee was not vaccinated.|2255|||
146156414|NCT02298192|527081409|FG000|Overall Study|Unclassified|3|||
146156415|NCT02298192|527081410|FG001|Overall Study|Unclassified|2|||
146156416|NCT02298192|527081409|FG000|Overall Study|Withdrawal criteria|2|||
146156417|NCT02298192|527081410|FG001|Overall Study|Withdrawal criteria|0|||
146156418|NCT02298192|527081409|FG000|Overall Study|Withdrawal by Subject|6|||
146156419|NCT02298192|527081410|FG001|Overall Study|Withdrawal by Subject|1|||
146156420|NCT02298192|527081409|FG000|Overall Study|Lost to Follow-up|2|||
146156421|NCT02298192|527081410|FG001|Overall Study|Lost to Follow-up|1|||
146156422|NCT02298192|527081409|FG000|Overall Study|Adverse Event|6|||
146156423|NCT02298192|527081410|FG001|Overall Study|Adverse Event|2|||
146156424|NCT04764396|527081413|FG000|Overall Study|Physician Decision|1|||
146156425|NCT04764396|527081414|FG001|Overall Study|Physician Decision|0|||
146156426|NCT03230916|527081415|FG000|Overall Study|Withdrawal by Subject|0|||
146156427|NCT03230916|527081416|FG001|Overall Study|Withdrawal by Subject|0|||
146156428|NCT03230916|527081417|FG002|Overall Study|Withdrawal by Subject|0|||
146156429|NCT03230916|527081418|FG003|Overall Study|Withdrawal by Subject|0|||
146156430|NCT03230916|527081419|FG004|Overall Study|Withdrawal by Subject|0|||
146156431|NCT03230916|527081420|FG005|Overall Study|Withdrawal by Subject|1|||
146156432|NCT03230916|527081421|FG006|Overall Study|Withdrawal by Subject|0|||
146156433|NCT03230916|527081422|FG007|Overall Study|Withdrawal by Subject|0|||
146156434|NCT03230916|527081423|FG008|Overall Study|Withdrawal by Subject|0|||
146156435|NCT03230916|527081424|FG009|Overall Study|Withdrawal by Subject|0|||
146156436|NCT03230916|527081425|FG010|Overall Study|Withdrawal by Subject|0|||
146156437|NCT01128413|527081427|FG000|Overall Study|Withdrawal by Subject|1|||
146156438|NCT01128413|527081428|FG001|Overall Study|Withdrawal by Subject|0|||
146156439|NCT01128413|527081427|FG000|Overall Study|NICOM Monitor Problems|2|||
146156440|NCT01128413|527081428|FG001|Overall Study|NICOM Monitor Problems|1|||
146156441|NCT01128413|527081427|FG000|Overall Study|Pt made DNR|1|||
146156442|NCT01128413|527081428|FG001|Overall Study|Pt made DNR|0|||
146156443|NCT01218646|527081431|FG000|Overall Study|Adverse Event|0|||
146156444|NCT01218646|527081432|FG001|Overall Study|Adverse Event|0|||
146156445|NCT01218646|527081433|FG002|Overall Study|Adverse Event|1|||
146156446|NCT01218646|527081434|FG003|Overall Study|Adverse Event|0|||
146156447|NCT01218646|527081431|FG000|Overall Study|Lost to Follow-up|1|||
146156448|NCT01218646|527081432|FG001|Overall Study|Lost to Follow-up|0|||
146156449|NCT01218646|527081433|FG002|Overall Study|Lost to Follow-up|0|||
146156450|NCT01218646|527081434|FG003|Overall Study|Lost to Follow-up|0|||
146156451|NCT01218646|527081431|FG000|Overall Study|Protocol Violation|0|||
146156452|NCT01218646|527081432|FG001|Overall Study|Protocol Violation|0|||
146156453|NCT01218646|527081433|FG002|Overall Study|Protocol Violation|1|||
146156454|NCT01218646|527081434|FG003|Overall Study|Protocol Violation|1|||
146156455|NCT00722761|527081435|FG000|Overall Study|Lost to Follow-up|1|||
146156456|NCT00722761|527081436|FG001|Overall Study|Lost to Follow-up|4|||
146156457|NCT00722761|527081435|FG000|Overall Study|Withdrawal by Subject|5|||
146156458|NCT00722761|527081436|FG001|Overall Study|Withdrawal by Subject|2|||
146156459|NCT02693665|527081437|FG000|Overall Study|Death|3|||
146156460|NCT02693665|527081438|FG001|Overall Study|Death|2|||
146156461|NCT02693665|527081437|FG000|Overall Study|Lost to Follow-up|7|||
146156462|NCT02693665|527081438|FG001|Overall Study|Lost to Follow-up|3|||
146156463|NCT02693665|527081437|FG000|Overall Study|Protocol Violation|1|||
146309942|NCT03223428|527648649|FG000|Overall Study|Non-responders|56|||
146156464|NCT02693665|527081438|FG001|Overall Study|Protocol Violation|0|||
146156465|NCT02693665|527081437|FG000|Overall Study|Withdrawal by Subject|2|||
146156466|NCT02693665|527081438|FG001|Overall Study|Withdrawal by Subject|0|||
146156467|NCT02693665|527081437|FG000|Overall Study|patient wanted to leave it behind|1|||
146156468|NCT02693665|527081438|FG001|Overall Study|patient wanted to leave it behind|0|||
146156469|NCT02693665|527081437|FG000|Overall Study|anxiety|1|||
146156470|NCT02693665|527081438|FG001|Overall Study|anxiety|0|||
146156471|NCT02693665|527081437|FG000|Overall Study|family issues|1|||
146156472|NCT02693665|527081438|FG001|Overall Study|family issues|0|||
146156473|NCT02693665|527081437|FG000|Overall Study|no reason given|1|||
146156474|NCT02693665|527081438|FG001|Overall Study|no reason given|0|||
146156475|NCT04414696|527081441|FG000|3-month Follow up|Withdrawal by Subject|1|||
146156476|NCT04414696|527081442|FG001|3-month Follow up|Withdrawal by Subject|0|||
146156477|NCT04414696|527081441|FG000|3-month Follow up|Lost to Follow-up|22|||
146156478|NCT04414696|527081442|FG001|3-month Follow up|Lost to Follow-up|23|||
146156479|NCT04414696|527081441|FG000|6-month Follow up|Withdrawal by Subject|1|||
146156480|NCT04414696|527081442|FG001|6-month Follow up|Withdrawal by Subject|2|||
146156481|NCT04414696|527081441|FG000|6-month Follow up|Lost to Follow-up|5|||
146156482|NCT04414696|527081442|FG001|6-month Follow up|Lost to Follow-up|2|||
146156483|NCT06167031|527081443|FG000|Overall Study|Lost to Follow-up|5|||
146156484|NCT06167031|527081444|FG001|Overall Study|Lost to Follow-up|1|||
146156485|NCT01877408|527084335|FG000|Overall Study|Lost to Follow-up|0|||
146156486|NCT01877408|527084336|FG001|Overall Study|Lost to Follow-up|2|||
146156487|NCT02621931|527084337|FG000|Overall Study|Death|0|||
146156488|NCT02621931|527084338|FG001|Overall Study|Death|1|||
146156489|NCT02621931|527084339|FG002|Overall Study|Death|0|||
146156490|NCT02621931|527084337|FG000|Overall Study|Adverse Event|8|||
146156491|NCT02621931|527084338|FG001|Overall Study|Adverse Event|5|||
146156492|NCT02621931|527084339|FG002|Overall Study|Adverse Event|7|||
146156493|NCT02621931|527084337|FG000|Overall Study|Withdrawal by Subject|12|||
146156494|NCT02621931|527084338|FG001|Overall Study|Withdrawal by Subject|10|||
146156495|NCT02621931|527084339|FG002|Overall Study|Withdrawal by Subject|11|||
146156496|NCT02621931|527084337|FG000|Overall Study|Protocol Violation|2|||
146156497|NCT02621931|527084338|FG001|Overall Study|Protocol Violation|2|||
146156498|NCT02621931|527084339|FG002|Overall Study|Protocol Violation|2|||
146156499|NCT02621931|527084337|FG000|Overall Study|Pregnancy|2|||
146156500|NCT02621931|527084338|FG001|Overall Study|Pregnancy|0|||
146156501|NCT02621931|527084339|FG002|Overall Study|Pregnancy|0|||
146156502|NCT02621931|527084337|FG000|Overall Study|Noncompliance to study procedures|0|||
146156503|NCT02621931|527084338|FG001|Overall Study|Noncompliance to study procedures|1|||
146156504|NCT02621931|527084339|FG002|Overall Study|Noncompliance to study procedures|2|||
146156505|NCT02621931|527084337|FG000|Overall Study|Lost to Follow-up|8|||
146156506|NCT02621931|527084338|FG001|Overall Study|Lost to Follow-up|7|||
146156507|NCT02621931|527084339|FG002|Overall Study|Lost to Follow-up|10|||
146156508|NCT02621931|527084337|FG000|Overall Study|Lack of Efficacy|0|||
146156509|NCT02621931|527084338|FG001|Overall Study|Lack of Efficacy|0|||
146156510|NCT02621931|527084339|FG002|Overall Study|Lack of Efficacy|1|||
146156511|NCT02621931|527084337|FG000|Overall Study|Other|1|||
146156512|NCT02621931|527084338|FG001|Overall Study|Other|1|||
146156513|NCT02621931|527084339|FG002|Overall Study|Other|3|||
146156514|NCT00920426|527084340|FG000|ITZ111451|Adverse Event|1|||
146156515|NCT00920426|527084341|FG001|ITZ111451|Adverse Event|0|||
146156516|NCT00920426|527084342|FG002|ITZ111451|Adverse Event|0|||
146156517|NCT00920426|527084343|FG003|ITZ111451|Adverse Event|0|||
146156518|NCT01292603|527084344|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146156519|NCT01292603|527084345|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146156520|NCT01292603|527084346|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146156521|NCT01292603|527084347|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
146156522|NCT01292603|527084348|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146156523|NCT01292603|527084349|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
146156524|NCT01292603|527084344|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
146156525|NCT01292603|527084345|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
146156526|NCT01292603|527084346|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
146156527|NCT01292603|527084347|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
146156528|NCT01292603|527084348|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
146156529|NCT01292603|527084349|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
146156530|NCT01292603|527084344|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146156531|NCT01292603|527084345|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146156532|NCT01292603|527084346|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146156533|NCT01292603|527084347|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
146156534|NCT01292603|527084348|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146156535|NCT01292603|527084349|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
146156536|NCT01292603|527084344|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146156537|NCT01292603|527084345|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146156538|NCT01292603|527084346|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146156539|NCT01292603|527084347|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
146156540|NCT01292603|527084348|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146156541|NCT01292603|527084349|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
146156542|NCT01292603|527084344|FG000|Part 1: Regular Follow-Up Period|Death|3|||
146156543|NCT01292603|527084345|FG001|Part 1: Regular Follow-Up Period|Death|1|||
146156544|NCT01292603|527084346|FG002|Part 1: Regular Follow-Up Period|Death|3|||
146156545|NCT01292603|527084347|FG003|Part 1: Regular Follow-Up Period|Death|1|||
146156546|NCT01292603|527084348|FG004|Part 1: Regular Follow-Up Period|Death|0|||
146156547|NCT01292603|527084349|FG005|Part 1: Regular Follow-Up Period|Death|0|||
146156548|NCT01292603|527084344|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
146156549|NCT01292603|527084345|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
146156550|NCT01292603|527084346|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
146156551|NCT01292603|527084347|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146156552|NCT01292603|527084348|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146156553|NCT01292603|527084349|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
146156554|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Death|0|||
146156555|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Death|0|||
146156556|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Death|0|||
146156557|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Death|0|||
146156558|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Death|1|||
146156559|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Death|0|||
146156560|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
146156561|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
146156562|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
146156563|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
146156564|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
146156565|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
146156566|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146156567|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146156568|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146156569|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
146156570|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
146156571|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
146156572|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
146156573|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
146156574|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
146156575|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
146156576|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
146156577|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
146156578|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146156579|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146156580|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146156581|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
146156582|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
146156583|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
146156584|NCT01292603|527084344|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146156585|NCT01292603|527084345|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146156586|NCT01292603|527084346|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146156587|NCT01292603|527084347|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146156588|NCT01292603|527084348|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
146156589|NCT01292603|527084349|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
146156590|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Death|0|||
146156591|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Death|0|||
146156592|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Death|0|||
146156593|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Death|0|||
146156594|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Death|6|||
146156595|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Death|3|||
146156596|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
146156597|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
146156598|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
146156599|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
146156600|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
146156601|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
146156602|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
146156603|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
146156604|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
146156605|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
146156606|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
146156607|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
146156608|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146156609|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146156610|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146156611|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146309943|NCT03223428|527648649|FG000|Overall Study|Withdrawal by Subject|14|||
146156612|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
146156613|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
146309944|NCT02230384|527648650|FG000|Phase 1|Lost to Follow-up|1|||
146156614|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
146156615|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
146156616|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
146156617|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
146156618|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
146156619|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
146156620|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
146156621|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
146156622|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
146156623|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
146156624|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
146156625|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
146156626|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146156627|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146156628|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146156629|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
146156630|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
146156631|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
146156632|NCT01292603|527084344|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
146156633|NCT01292603|527084345|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
146156634|NCT01292603|527084346|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
146156635|NCT01292603|527084347|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
146156636|NCT01292603|527084348|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
146156637|NCT01292603|527084349|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
146156638|NCT01292603|527084344|FG000|Overall Survival Status|Death|3|||
146156639|NCT01292603|527084345|FG001|Overall Survival Status|Death|1|||
146156640|NCT01292603|527084346|FG002|Overall Survival Status|Death|3|||
146156641|NCT01292603|527084347|FG003|Overall Survival Status|Death|1|||
146156642|NCT01292603|527084348|FG004|Overall Survival Status|Death|16|||
146156643|NCT01292603|527084349|FG005|Overall Survival Status|Death|10|||
146156644|NCT03870763|527084352|FG000|Overall Study|Study terminated by sponsor|0|||
146156645|NCT03870763|527084353|FG001|Overall Study|Study terminated by sponsor|2|||
146156646|NCT03870763|527084354|FG002|Overall Study|Study terminated by sponsor|0|||
146156647|NCT03870763|527084352|FG000|Overall Study|Withdrawal by Subject|0|||
146156648|NCT03870763|527084353|FG001|Overall Study|Withdrawal by Subject|1|||
146156649|NCT03870763|527084354|FG002|Overall Study|Withdrawal by Subject|0|||
146156650|NCT03870763|527084352|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
146156651|NCT03870763|527084353|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
146156652|NCT03870763|527084354|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
146156653|NCT01912612|527084363|FG000|Overall Study|Adverse Event|4|||
146156654|NCT01912612|527084364|FG001|Overall Study|Adverse Event|0|||
146156655|NCT01912612|527084365|FG002|Overall Study|Adverse Event|0|||
146156656|NCT01912612|527084363|FG000|Overall Study|Withdrew consent|1|||
146156657|NCT01912612|527084364|FG001|Overall Study|Withdrew consent|0|||
146156658|NCT01912612|527084365|FG002|Overall Study|Withdrew consent|0|||
146156659|NCT01912612|527084363|FG000|Overall Study|Study design change|0|||
146156660|NCT01912612|527084364|FG001|Overall Study|Study design change|0|||
146156661|NCT01912612|527084365|FG002|Overall Study|Study design change|3|||
146156662|NCT01588184|527084366|FG000|Overall Study|Death|1|||
146156663|NCT01588184|527084367|FG001|Overall Study|Death|0|||
146156664|NCT01588184|527084368|FG002|Overall Study|Death|0|||
146156665|NCT01588184|527084369|FG003|Overall Study|Death|1|||
146156666|NCT01588184|527084370|FG004|Overall Study|Death|1|||
146156667|NCT01588184|527084371|FG005|Overall Study|Death|1|||
146156668|NCT01588184|527084366|FG000|Overall Study|Withdrawal by Subject|2|||
146156669|NCT01588184|527084367|FG001|Overall Study|Withdrawal by Subject|4|||
146156670|NCT01588184|527084368|FG002|Overall Study|Withdrawal by Subject|0|||
146156671|NCT01588184|527084369|FG003|Overall Study|Withdrawal by Subject|1|||
146156672|NCT01588184|527084370|FG004|Overall Study|Withdrawal by Subject|0|||
146156673|NCT01588184|527084371|FG005|Overall Study|Withdrawal by Subject|0|||
146156674|NCT01588184|527084366|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
146309945|NCT02230384|527648651|FG001|Phase 1|Lost to Follow-up|0|||
146156675|NCT01588184|527084367|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
146156676|NCT01588184|527084368|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
146156677|NCT01588184|527084369|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
146156678|NCT01588184|527084370|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
146156679|NCT01588184|527084371|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
146156680|NCT01588184|527084366|FG000|Overall Study|multiple reasons|0|||
146309946|NCT02230384|527648650|FG000|Phase 1|Physician Decision|0|||
146156681|NCT01588184|527084367|FG001|Overall Study|multiple reasons|3|||
146156682|NCT01588184|527084368|FG002|Overall Study|multiple reasons|0|||
146156683|NCT01588184|527084369|FG003|Overall Study|multiple reasons|1|||
146156684|NCT01588184|527084370|FG004|Overall Study|multiple reasons|0|||
146156685|NCT01588184|527084371|FG005|Overall Study|multiple reasons|0|||
146156686|NCT00907153|527084372|FG000|Overall Study|Lost to Follow-up|1|||
146156687|NCT00907153|527084373|FG001|Overall Study|Lost to Follow-up|1|||
146156688|NCT00907153|527084372|FG000|Overall Study|Withdrawal by Subject|1|||
146156689|NCT00907153|527084373|FG001|Overall Study|Withdrawal by Subject|3|||
146156690|NCT02120027|527084376|FG000|Overall Study|Adverse Event|4|||
146156691|NCT02120027|527084377|FG001|Overall Study|Adverse Event|5|||
146156692|NCT02120027|527084376|FG000|Overall Study|Lack of Efficacy|3|||
146156693|NCT02120027|527084377|FG001|Overall Study|Lack of Efficacy|5|||
146156694|NCT02120027|527084376|FG000|Overall Study|Lost to Follow-up|5|||
146156695|NCT02120027|527084377|FG001|Overall Study|Lost to Follow-up|13|||
146156696|NCT02120027|527084376|FG000|Overall Study|Other|4|||
146156697|NCT02120027|527084377|FG001|Overall Study|Other|0|||
146156698|NCT02120027|527084376|FG000|Overall Study|Physician Decision|4|||
146156699|NCT02120027|527084377|FG001|Overall Study|Physician Decision|3|||
146156700|NCT02120027|527084376|FG000|Overall Study|Protocol Violation|18|||
146156701|NCT02120027|527084377|FG001|Overall Study|Protocol Violation|21|||
146156702|NCT02120027|527084376|FG000|Overall Study|Study terminated by Sponsor|45|||
146156703|NCT02120027|527084377|FG001|Overall Study|Study terminated by Sponsor|47|||
146156704|NCT02120027|527084376|FG000|Overall Study|Withdrawal by Subject|33|||
146156705|NCT02120027|527084377|FG001|Overall Study|Withdrawal by Subject|25|||
146156706|NCT03393000|527084380|FG000|Overall Study|Death|11|||
146156707|NCT03393000|527084380|FG000|Overall Study|Withdrawal by Subject|2|||
146156708|NCT03393000|527084380|FG000|Overall Study|Physician Decision|1|||
146156709|NCT01773070|527084381|FG000|Overall Study|Withdrawal by Subject|24|||
146156710|NCT01773070|527084381|FG000|Overall Study|Lost to Follow-up|39|||
146156711|NCT01773070|527084381|FG000|Overall Study|Other|15|||
146156712|NCT01773070|527084381|FG000|Overall Study|Death (unrelated to study procedures)|3|||
146156713|NCT01843192|527084382|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
146156714|NCT01843192|527084383|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
146156715|NCT01843192|527084384|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
146156716|NCT01471054|527084385|FG000|Overall Study|Study terminated prematurely|4|||
146156717|NCT01471054|527084386|FG001|Overall Study|Study terminated prematurely|0|||
146156718|NCT01559844|527084387|FG000|Overall Study|Consent Withdrawn|7|||
146156719|NCT01559844|527084387|FG000|Overall Study|Death|5|||
146156720|NCT01559844|527084387|FG000|Overall Study|Efficacy Failure|10|||
146156721|NCT01559844|527084387|FG000|Overall Study|No Longer A Transplant Candidate|3|||
146156722|NCT02181803|527084388|FG000|Overall Study|Withdrawal by Subject|0|||
146156723|NCT02181803|527084389|FG001|Overall Study|Withdrawal by Subject|2|||
146156724|NCT02181803|527084390|FG002|Overall Study|Withdrawal by Subject|0|||
146156725|NCT02181803|527084391|FG003|Overall Study|Withdrawal by Subject|0|||
146156726|NCT02181803|527084392|FG004|Overall Study|Withdrawal by Subject|0|||
146156727|NCT02181803|527084393|FG005|Overall Study|Withdrawal by Subject|0|||
146156728|NCT02181803|527084394|FG006|Overall Study|Withdrawal by Subject|0|||
146156729|NCT02181803|527084395|FG007|Overall Study|Withdrawal by Subject|0|||
146156730|NCT02181803|527084396|FG008|Overall Study|Withdrawal by Subject|0|||
146156731|NCT02181803|527084388|FG000|Overall Study|Physician Decision|0|||
146156732|NCT02181803|527084389|FG001|Overall Study|Physician Decision|0|||
146156733|NCT02181803|527084390|FG002|Overall Study|Physician Decision|0|||
146156734|NCT02181803|527084391|FG003|Overall Study|Physician Decision|1|||
146156735|NCT02181803|527084392|FG004|Overall Study|Physician Decision|0|||
146156736|NCT02181803|527084393|FG005|Overall Study|Physician Decision|0|||
146156737|NCT02181803|527084394|FG006|Overall Study|Physician Decision|0|||
146156738|NCT02181803|527084395|FG007|Overall Study|Physician Decision|1|||
146156739|NCT02181803|527084396|FG008|Overall Study|Physician Decision|0|||
146156740|NCT02181803|527084388|FG000|Overall Study|Adverse Event|0|||
146156741|NCT02181803|527084389|FG001|Overall Study|Adverse Event|2|||
146156742|NCT02181803|527084390|FG002|Overall Study|Adverse Event|0|||
146156743|NCT02181803|527084391|FG003|Overall Study|Adverse Event|1|||
146156744|NCT02181803|527084392|FG004|Overall Study|Adverse Event|0|||
146156745|NCT02181803|527084393|FG005|Overall Study|Adverse Event|0|||
146156746|NCT02181803|527084394|FG006|Overall Study|Adverse Event|1|||
146156747|NCT02181803|527084395|FG007|Overall Study|Adverse Event|0|||
146156748|NCT02181803|527084396|FG008|Overall Study|Adverse Event|0|||
146156749|NCT00951041|527084397|FG000|Overall Study|Withdrawal by Subject|1|||
146156750|NCT00951041|527084398|FG001|Overall Study|Withdrawal by Subject|1|||
146156751|NCT00951041|527084397|FG000|Overall Study|Lost to Follow-up|1|||
146156752|NCT00951041|527084398|FG001|Overall Study|Lost to Follow-up|0|||
146156753|NCT00951041|527084397|FG000|Overall Study|Other|3|||
146156754|NCT00951041|527084398|FG001|Overall Study|Other|0|||
146156755|NCT01259713|527084399|FG000|Overall Study|Adverse Event|54|||
146156756|NCT01259713|527084400|FG001|Overall Study|Adverse Event|23|||
146156757|NCT01259713|527084399|FG000|Overall Study|Death Not Related to IFI|8|||
146156758|NCT01259713|527084400|FG001|Overall Study|Death Not Related to IFI|1|||
146156759|NCT01259713|527084399|FG000|Overall Study|Investigators Discretion|14|||
146156760|NCT01259713|527084400|FG001|Overall Study|Investigators Discretion|6|||
146156761|NCT01259713|527084399|FG000|Overall Study|Lack of Efficacy|2|||
146156762|NCT01259713|527084400|FG001|Overall Study|Lack of Efficacy|0|||
146156763|NCT01259713|527084399|FG000|Overall Study|Protocol Violation|5|||
146156764|NCT01259713|527084400|FG001|Overall Study|Protocol Violation|4|||
146156765|NCT01259713|527084399|FG000|Overall Study|Subject Withdrew Consent|12|||
146156766|NCT01259713|527084400|FG001|Overall Study|Subject Withdrew Consent|7|||
146156767|NCT02388724|527084402|FG000|Overall Study|Reason not Specified|0|||
146156768|NCT02388724|527084403|FG001|Overall Study|Reason not Specified|1|||
146156769|NCT02388724|527084402|FG000|Overall Study|Major Protocol Deviation|3|||
146156770|NCT02388724|527084403|FG001|Overall Study|Major Protocol Deviation|3|||
146156771|NCT02388724|527084402|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
146156772|NCT02388724|527084403|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
146156773|NCT02388724|527084402|FG000|Overall Study|Voluntary Withdrawal|6|||
146156774|NCT02388724|527084403|FG001|Overall Study|Voluntary Withdrawal|5|||
146156775|NCT02388724|527084402|FG000|Overall Study|Randomized but not Treated|0|||
146156776|NCT02388724|527084403|FG001|Overall Study|Randomized but not Treated|2|||
146156777|NCT01217073|527084404|FG000|Base Period|Adverse Event|1|||
146156778|NCT01217073|527084405|FG001|Base Period|Adverse Event|0|||
146156779|NCT01217073|527084406|FG002|Base Period|Adverse Event|1|||
146156780|NCT01217073|527084407|FG003|Base Period|Adverse Event|0|||
146156781|NCT01217073|527084408|FG004|Base Period|Adverse Event|4|||
146156782|NCT01217073|527084409|FG005|Base Period|Adverse Event|1|||
146156783|NCT01217073|527084410|FG006|Base Period|Adverse Event|0|||
146156784|NCT01217073|527084411|FG007|Base Period|Adverse Event|0|||
146156785|NCT01217073|527084404|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
146156786|NCT01217073|527084405|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156787|NCT01217073|527084406|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156788|NCT01217073|527084407|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156789|NCT01217073|527084408|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156790|NCT01217073|527084409|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156791|NCT01217073|527084410|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156792|NCT01217073|527084411|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
146156793|NCT01217073|527084404|FG000|Base Period|Excluded medication|0|||
146156794|NCT01217073|527084405|FG001|Base Period|Excluded medication|0|||
146156795|NCT01217073|527084406|FG002|Base Period|Excluded medication|0|||
146156796|NCT01217073|527084407|FG003|Base Period|Excluded medication|0|||
146156797|NCT01217073|527084408|FG004|Base Period|Excluded medication|1|||
146156798|NCT01217073|527084409|FG005|Base Period|Excluded medication|0|||
146156799|NCT01217073|527084410|FG006|Base Period|Excluded medication|0|||
146156800|NCT01217073|527084411|FG007|Base Period|Excluded medication|0|||
146156801|NCT01217073|527084404|FG000|Base Period|Lack of Efficacy|0|||
146156802|NCT01217073|527084405|FG001|Base Period|Lack of Efficacy|0|||
146156803|NCT01217073|527084406|FG002|Base Period|Lack of Efficacy|0|||
146156804|NCT01217073|527084407|FG003|Base Period|Lack of Efficacy|0|||
146156805|NCT01217073|527084408|FG004|Base Period|Lack of Efficacy|0|||
146156806|NCT01217073|527084409|FG005|Base Period|Lack of Efficacy|1|||
146156807|NCT01217073|527084410|FG006|Base Period|Lack of Efficacy|0|||
146156808|NCT01217073|527084411|FG007|Base Period|Lack of Efficacy|0|||
146156809|NCT01217073|527084404|FG000|Base Period|Lost to Follow-up|0|||
146156810|NCT01217073|527084405|FG001|Base Period|Lost to Follow-up|0|||
146156811|NCT01217073|527084406|FG002|Base Period|Lost to Follow-up|1|||
146156812|NCT01217073|527084407|FG003|Base Period|Lost to Follow-up|1|||
146156813|NCT01217073|527084408|FG004|Base Period|Lost to Follow-up|3|||
146156814|NCT01217073|527084409|FG005|Base Period|Lost to Follow-up|0|||
146156815|NCT01217073|527084410|FG006|Base Period|Lost to Follow-up|0|||
146156816|NCT01217073|527084411|FG007|Base Period|Lost to Follow-up|0|||
146156817|NCT01217073|527084404|FG000|Base Period|Physician Decision|0|||
146156818|NCT01217073|527084405|FG001|Base Period|Physician Decision|0|||
146156819|NCT01217073|527084406|FG002|Base Period|Physician Decision|0|||
146156820|NCT01217073|527084407|FG003|Base Period|Physician Decision|0|||
146156821|NCT01217073|527084408|FG004|Base Period|Physician Decision|1|||
146156822|NCT01217073|527084409|FG005|Base Period|Physician Decision|0|||
146156823|NCT01217073|527084410|FG006|Base Period|Physician Decision|0|||
146156824|NCT01217073|527084411|FG007|Base Period|Physician Decision|0|||
146156825|NCT01217073|527084404|FG000|Base Period|Protocol Violation|1|||
146156826|NCT01217073|527084405|FG001|Base Period|Protocol Violation|0|||
146156827|NCT01217073|527084406|FG002|Base Period|Protocol Violation|0|||
146156828|NCT01217073|527084407|FG003|Base Period|Protocol Violation|0|||
146156829|NCT01217073|527084408|FG004|Base Period|Protocol Violation|1|||
146156830|NCT01217073|527084409|FG005|Base Period|Protocol Violation|2|||
146156831|NCT01217073|527084410|FG006|Base Period|Protocol Violation|0|||
146156832|NCT01217073|527084411|FG007|Base Period|Protocol Violation|0|||
146156833|NCT01217073|527084404|FG000|Base Period|Withdrawal by Subject|4|||
146156834|NCT01217073|527084405|FG001|Base Period|Withdrawal by Subject|5|||
146156835|NCT01217073|527084406|FG002|Base Period|Withdrawal by Subject|5|||
146309947|NCT02230384|527648651|FG001|Phase 1|Physician Decision|1|||
146156836|NCT01217073|527084407|FG003|Base Period|Withdrawal by Subject|1|||
146156837|NCT01217073|527084408|FG004|Base Period|Withdrawal by Subject|5|||
146156838|NCT01217073|527084409|FG005|Base Period|Withdrawal by Subject|5|||
146156839|NCT01217073|527084410|FG006|Base Period|Withdrawal by Subject|0|||
146156840|NCT01217073|527084411|FG007|Base Period|Withdrawal by Subject|0|||
146156841|NCT01217073|527084404|FG000|Extension Period|Adverse Event|0|||
146156842|NCT01217073|527084405|FG001|Extension Period|Adverse Event|0|||
146156843|NCT01217073|527084406|FG002|Extension Period|Adverse Event|0|||
146156844|NCT01217073|527084407|FG003|Extension Period|Adverse Event|0|||
146156845|NCT01217073|527084408|FG004|Extension Period|Adverse Event|0|||
146156846|NCT01217073|527084409|FG005|Extension Period|Adverse Event|0|||
146156847|NCT01217073|527084410|FG006|Extension Period|Adverse Event|19|||
146156848|NCT01217073|527084411|FG007|Extension Period|Adverse Event|5|||
146156849|NCT01217073|527084404|FG000|Extension Period|ALT/AST|0|||
146156850|NCT01217073|527084405|FG001|Extension Period|ALT/AST|0|||
146156851|NCT01217073|527084406|FG002|Extension Period|ALT/AST|0|||
146156852|NCT01217073|527084407|FG003|Extension Period|ALT/AST|0|||
146156853|NCT01217073|527084408|FG004|Extension Period|ALT/AST|0|||
146156854|NCT01217073|527084409|FG005|Extension Period|ALT/AST|0|||
146156855|NCT01217073|527084410|FG006|Extension Period|ALT/AST|2|||
146156856|NCT01217073|527084411|FG007|Extension Period|ALT/AST|0|||
146156857|NCT01217073|527084404|FG000|Extension Period|Contraindication to study medication|0|||
146156858|NCT01217073|527084405|FG001|Extension Period|Contraindication to study medication|0|||
146156859|NCT01217073|527084406|FG002|Extension Period|Contraindication to study medication|0|||
146156860|NCT01217073|527084407|FG003|Extension Period|Contraindication to study medication|0|||
146156861|NCT01217073|527084408|FG004|Extension Period|Contraindication to study medication|0|||
146156862|NCT01217073|527084409|FG005|Extension Period|Contraindication to study medication|0|||
146156863|NCT01217073|527084410|FG006|Extension Period|Contraindication to study medication|1|||
146309948|NCT02230384|527648650|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
146309949|NCT02230384|527648651|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
146309950|NCT02230384|527648650|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
146309951|NCT02230384|527648651|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
146309952|NCT02230384|527648650|FG000|Phase 2 - Switch|Adverse Event|2|||
146156864|NCT01217073|527084411|FG007|Extension Period|Contraindication to study medication|0|||
146156865|NCT01217073|527084404|FG000|Extension Period|Creatinine/eGFR|0|||
146156866|NCT01217073|527084405|FG001|Extension Period|Creatinine/eGFR|0|||
146156867|NCT01217073|527084406|FG002|Extension Period|Creatinine/eGFR|0|||
146156868|NCT01217073|527084407|FG003|Extension Period|Creatinine/eGFR|0|||
146156869|NCT01217073|527084408|FG004|Extension Period|Creatinine/eGFR|0|||
146156870|NCT01217073|527084409|FG005|Extension Period|Creatinine/eGFR|0|||
146156871|NCT01217073|527084410|FG006|Extension Period|Creatinine/eGFR|11|||
146156872|NCT01217073|527084411|FG007|Extension Period|Creatinine/eGFR|1|||
146156873|NCT01217073|527084404|FG000|Extension Period|Death|0|||
146156874|NCT01217073|527084405|FG001|Extension Period|Death|0|||
146156875|NCT01217073|527084406|FG002|Extension Period|Death|0|||
146156876|NCT01217073|527084407|FG003|Extension Period|Death|0|||
146156877|NCT01217073|527084408|FG004|Extension Period|Death|0|||
146156878|NCT01217073|527084409|FG005|Extension Period|Death|0|||
146156879|NCT01217073|527084410|FG006|Extension Period|Death|1|||
146156880|NCT01217073|527084411|FG007|Extension Period|Death|0|||
146156881|NCT01217073|527084404|FG000|Extension Period|Excluded medication|0|||
146156882|NCT01217073|527084405|FG001|Extension Period|Excluded medication|0|||
146156883|NCT01217073|527084406|FG002|Extension Period|Excluded medication|0|||
146156884|NCT01217073|527084407|FG003|Extension Period|Excluded medication|0|||
146156885|NCT01217073|527084408|FG004|Extension Period|Excluded medication|0|||
146156886|NCT01217073|527084409|FG005|Extension Period|Excluded medication|0|||
146156887|NCT01217073|527084410|FG006|Extension Period|Excluded medication|2|||
146156888|NCT01217073|527084411|FG007|Extension Period|Excluded medication|0|||
146156889|NCT01217073|527084404|FG000|Extension Period|Lack of Efficacy|0|||
146156890|NCT01217073|527084405|FG001|Extension Period|Lack of Efficacy|0|||
146156891|NCT01217073|527084406|FG002|Extension Period|Lack of Efficacy|0|||
146156892|NCT01217073|527084407|FG003|Extension Period|Lack of Efficacy|0|||
146156893|NCT01217073|527084408|FG004|Extension Period|Lack of Efficacy|0|||
146156894|NCT01217073|527084409|FG005|Extension Period|Lack of Efficacy|0|||
146156895|NCT01217073|527084410|FG006|Extension Period|Lack of Efficacy|3|||
146156896|NCT01217073|527084411|FG007|Extension Period|Lack of Efficacy|0|||
146156897|NCT01217073|527084404|FG000|Extension Period|Lost to Follow-up|0|||
146156898|NCT01217073|527084405|FG001|Extension Period|Lost to Follow-up|0|||
146156899|NCT01217073|527084406|FG002|Extension Period|Lost to Follow-up|0|||
146156900|NCT01217073|527084407|FG003|Extension Period|Lost to Follow-up|0|||
146156901|NCT01217073|527084408|FG004|Extension Period|Lost to Follow-up|0|||
146156902|NCT01217073|527084409|FG005|Extension Period|Lost to Follow-up|0|||
146156903|NCT01217073|527084410|FG006|Extension Period|Lost to Follow-up|9|||
146156904|NCT01217073|527084411|FG007|Extension Period|Lost to Follow-up|1|||
146156905|NCT01217073|527084404|FG000|Extension Period|Non-compliance with study drug|0|||
146156906|NCT01217073|527084405|FG001|Extension Period|Non-compliance with study drug|0|||
146156907|NCT01217073|527084406|FG002|Extension Period|Non-compliance with study drug|0|||
146156908|NCT01217073|527084407|FG003|Extension Period|Non-compliance with study drug|0|||
146156909|NCT01217073|527084408|FG004|Extension Period|Non-compliance with study drug|0|||
146156910|NCT01217073|527084409|FG005|Extension Period|Non-compliance with study drug|0|||
146156911|NCT01217073|527084410|FG006|Extension Period|Non-compliance with study drug|0|||
146156912|NCT01217073|527084411|FG007|Extension Period|Non-compliance with study drug|1|||
146156913|NCT01217073|527084404|FG000|Extension Period|Physician Decision|0|||
146156914|NCT01217073|527084405|FG001|Extension Period|Physician Decision|0|||
146156915|NCT01217073|527084406|FG002|Extension Period|Physician Decision|0|||
146156916|NCT01217073|527084407|FG003|Extension Period|Physician Decision|0|||
146156917|NCT01217073|527084408|FG004|Extension Period|Physician Decision|0|||
146156918|NCT01217073|527084409|FG005|Extension Period|Physician Decision|0|||
146156919|NCT01217073|527084410|FG006|Extension Period|Physician Decision|4|||
146156920|NCT01217073|527084411|FG007|Extension Period|Physician Decision|1|||
146156921|NCT01217073|527084404|FG000|Extension Period|Protocol Violation|0|||
146156922|NCT01217073|527084405|FG001|Extension Period|Protocol Violation|0|||
146156923|NCT01217073|527084406|FG002|Extension Period|Protocol Violation|0|||
146156924|NCT01217073|527084407|FG003|Extension Period|Protocol Violation|0|||
146156925|NCT01217073|527084408|FG004|Extension Period|Protocol Violation|0|||
146156926|NCT01217073|527084409|FG005|Extension Period|Protocol Violation|0|||
146156927|NCT01217073|527084410|FG006|Extension Period|Protocol Violation|2|||
146156928|NCT01217073|527084411|FG007|Extension Period|Protocol Violation|1|||
146156929|NCT01217073|527084404|FG000|Extension Period|Site discontinued study participation|0|||
146156930|NCT01217073|527084405|FG001|Extension Period|Site discontinued study participation|0|||
146156931|NCT01217073|527084406|FG002|Extension Period|Site discontinued study participation|0|||
146156932|NCT01217073|527084407|FG003|Extension Period|Site discontinued study participation|0|||
146156933|NCT01217073|527084408|FG004|Extension Period|Site discontinued study participation|0|||
146156934|NCT01217073|527084409|FG005|Extension Period|Site discontinued study participation|0|||
146156935|NCT01217073|527084410|FG006|Extension Period|Site discontinued study participation|7|||
146156936|NCT01217073|527084411|FG007|Extension Period|Site discontinued study participation|2|||
146156937|NCT01217073|527084404|FG000|Extension Period|Withdrawal by Subject|0|||
146156938|NCT01217073|527084405|FG001|Extension Period|Withdrawal by Subject|0|||
146156939|NCT01217073|527084406|FG002|Extension Period|Withdrawal by Subject|0|||
146156940|NCT01217073|527084407|FG003|Extension Period|Withdrawal by Subject|0|||
146156941|NCT01217073|527084408|FG004|Extension Period|Withdrawal by Subject|0|||
146156942|NCT01217073|527084409|FG005|Extension Period|Withdrawal by Subject|0|||
146156943|NCT01217073|527084410|FG006|Extension Period|Withdrawal by Subject|30|||
146156944|NCT01217073|527084411|FG007|Extension Period|Withdrawal by Subject|8|||
146156945|NCT00620750|527084412|FG000|Overall Study|Lost to Follow-up|25|||
146156946|NCT04477187|527084413|FG000|Overall Study|Lost to Follow-up|2|||
146156947|NCT00765843|527084415|FG000|Overall Study|Lost to Follow-up|1|||
146156948|NCT00765843|527084416|FG001|Overall Study|Lost to Follow-up|3|||
146156949|NCT00765843|527084417|FG002|Overall Study|Lost to Follow-up|2|||
146156950|NCT00765843|527084415|FG000|Overall Study|did not return to receive intervention|0|||
146156951|NCT00765843|527084416|FG001|Overall Study|did not return to receive intervention|1|||
146156952|NCT00765843|527084417|FG002|Overall Study|did not return to receive intervention|0|||
146156953|NCT00765843|527084415|FG000|Overall Study|Adverse Event|0|||
146156954|NCT00765843|527084416|FG001|Overall Study|Adverse Event|0|||
146156955|NCT00765843|527084417|FG002|Overall Study|Adverse Event|1|||
146156956|NCT02460991|527084418|FG000|Overall Study|Withdrawal by Subject|0|||
146156957|NCT02460991|527084419|FG001|Overall Study|Withdrawal by Subject|2|||
146156958|NCT02564523|527084420|FG000|Overall Study|Withdrawal by Subject|3|||
146156959|NCT02564523|527084421|FG001|Overall Study|Withdrawal by Subject|0|||
146156960|NCT02564523|527084422|FG002|Overall Study|Withdrawal by Subject|1|||
146156961|NCT02564523|527084423|FG003|Overall Study|Withdrawal by Subject|0|||
146156962|NCT02564523|527084424|FG004|Overall Study|Withdrawal by Subject|1|||
146156963|NCT02564523|527084425|FG005|Overall Study|Withdrawal by Subject|0|||
146156964|NCT02564523|527084426|FG006|Overall Study|Withdrawal by Subject|1|||
146156965|NCT02564523|527084427|FG007|Overall Study|Withdrawal by Subject|0|||
146156966|NCT02564523|527084428|FG008|Overall Study|Withdrawal by Subject|0|||
146156967|NCT02564523|527084429|FG009|Overall Study|Withdrawal by Subject|0|||
146156968|NCT02564523|527084430|FG010|Overall Study|Withdrawal by Subject|1|||
146156969|NCT02564523|527084431|FG011|Overall Study|Withdrawal by Subject|0|||
146156970|NCT02564523|527084432|FG012|Overall Study|Withdrawal by Subject|1|||
146156971|NCT02564523|527084433|FG013|Overall Study|Withdrawal by Subject|0|||
146156972|NCT02564523|527084434|FG014|Overall Study|Withdrawal by Subject|0|||
146156973|NCT02564523|527084435|FG015|Overall Study|Withdrawal by Subject|0|||
146156974|NCT02564523|527084436|FG016|Overall Study|Withdrawal by Subject|0|||
146156975|NCT02564523|527084437|FG017|Overall Study|Withdrawal by Subject|0|||
146156976|NCT02564523|527084420|FG000|Overall Study|Adverse Event|0|||
146156977|NCT02564523|527084421|FG001|Overall Study|Adverse Event|0|||
146156978|NCT02564523|527084422|FG002|Overall Study|Adverse Event|0|||
146156979|NCT02564523|527084423|FG003|Overall Study|Adverse Event|0|||
146156980|NCT02564523|527084424|FG004|Overall Study|Adverse Event|0|||
146156981|NCT02564523|527084425|FG005|Overall Study|Adverse Event|0|||
146156982|NCT02564523|527084426|FG006|Overall Study|Adverse Event|0|||
146156983|NCT02564523|527084427|FG007|Overall Study|Adverse Event|0|||
146156984|NCT02564523|527084428|FG008|Overall Study|Adverse Event|0|||
146156985|NCT02564523|527084429|FG009|Overall Study|Adverse Event|0|||
146156986|NCT02564523|527084430|FG010|Overall Study|Adverse Event|0|||
146156987|NCT02564523|527084431|FG011|Overall Study|Adverse Event|0|||
146156988|NCT02564523|527084432|FG012|Overall Study|Adverse Event|0|||
146156989|NCT02564523|527084433|FG013|Overall Study|Adverse Event|0|||
146156990|NCT02564523|527084434|FG014|Overall Study|Adverse Event|0|||
146156991|NCT02564523|527084435|FG015|Overall Study|Adverse Event|0|||
146156992|NCT02564523|527084436|FG016|Overall Study|Adverse Event|0|||
146156993|NCT02564523|527084437|FG017|Overall Study|Adverse Event|1|||
146156994|NCT02564523|527084420|FG000|Overall Study|Death|0|||
146156995|NCT02564523|527084421|FG001|Overall Study|Death|0|||
146156996|NCT02564523|527084422|FG002|Overall Study|Death|0|||
146156997|NCT02564523|527084423|FG003|Overall Study|Death|0|||
146156998|NCT02564523|527084424|FG004|Overall Study|Death|0|||
146156999|NCT02564523|527084425|FG005|Overall Study|Death|0|||
146157000|NCT02564523|527084426|FG006|Overall Study|Death|1|||
146157001|NCT02564523|527084427|FG007|Overall Study|Death|0|||
146157002|NCT02564523|527084428|FG008|Overall Study|Death|0|||
146157003|NCT02564523|527084429|FG009|Overall Study|Death|0|||
146157004|NCT02564523|527084430|FG010|Overall Study|Death|1|||
146157005|NCT02564523|527084431|FG011|Overall Study|Death|0|||
146157006|NCT02564523|527084432|FG012|Overall Study|Death|0|||
146157007|NCT02564523|527084433|FG013|Overall Study|Death|0|||
146157008|NCT02564523|527084434|FG014|Overall Study|Death|0|||
146157009|NCT02564523|527084435|FG015|Overall Study|Death|0|||
146157010|NCT02564523|527084436|FG016|Overall Study|Death|0|||
146157011|NCT02564523|527084437|FG017|Overall Study|Death|0|||
146157012|NCT02564523|527084420|FG000|Overall Study|Lost to Follow-up|2|||
146157013|NCT02564523|527084421|FG001|Overall Study|Lost to Follow-up|1|||
146157014|NCT02564523|527084422|FG002|Overall Study|Lost to Follow-up|4|||
146157015|NCT02564523|527084423|FG003|Overall Study|Lost to Follow-up|0|||
146157016|NCT02564523|527084424|FG004|Overall Study|Lost to Follow-up|1|||
146157017|NCT02564523|527084425|FG005|Overall Study|Lost to Follow-up|0|||
146157018|NCT02564523|527084426|FG006|Overall Study|Lost to Follow-up|1|||
146157019|NCT02564523|527084427|FG007|Overall Study|Lost to Follow-up|0|||
146157020|NCT02564523|527084428|FG008|Overall Study|Lost to Follow-up|0|||
146157021|NCT02564523|527084429|FG009|Overall Study|Lost to Follow-up|0|||
146157022|NCT02564523|527084430|FG010|Overall Study|Lost to Follow-up|0|||
146157023|NCT02564523|527084431|FG011|Overall Study|Lost to Follow-up|1|||
146157024|NCT02564523|527084432|FG012|Overall Study|Lost to Follow-up|1|||
146157025|NCT02564523|527084433|FG013|Overall Study|Lost to Follow-up|0|||
146157026|NCT02564523|527084434|FG014|Overall Study|Lost to Follow-up|0|||
146157027|NCT02564523|527084435|FG015|Overall Study|Lost to Follow-up|0|||
146157028|NCT02564523|527084436|FG016|Overall Study|Lost to Follow-up|0|||
146157029|NCT02564523|527084437|FG017|Overall Study|Lost to Follow-up|0|||
146157030|NCT02564523|527084420|FG000|Overall Study|Physician Decision|0|||
146157031|NCT02564523|527084421|FG001|Overall Study|Physician Decision|0|||
146157032|NCT02564523|527084422|FG002|Overall Study|Physician Decision|0|||
146157033|NCT02564523|527084423|FG003|Overall Study|Physician Decision|0|||
146157034|NCT02564523|527084424|FG004|Overall Study|Physician Decision|1|||
146157035|NCT02564523|527084425|FG005|Overall Study|Physician Decision|0|||
146157036|NCT02564523|527084426|FG006|Overall Study|Physician Decision|0|||
146157037|NCT02564523|527084427|FG007|Overall Study|Physician Decision|0|||
146157038|NCT02564523|527084428|FG008|Overall Study|Physician Decision|0|||
146157039|NCT02564523|527084429|FG009|Overall Study|Physician Decision|0|||
146157040|NCT02564523|527084430|FG010|Overall Study|Physician Decision|1|||
146157041|NCT02564523|527084431|FG011|Overall Study|Physician Decision|0|||
146157042|NCT02564523|527084432|FG012|Overall Study|Physician Decision|0|||
146157043|NCT02564523|527084433|FG013|Overall Study|Physician Decision|0|||
146157044|NCT02564523|527084434|FG014|Overall Study|Physician Decision|0|||
146157045|NCT02564523|527084435|FG015|Overall Study|Physician Decision|0|||
146157046|NCT02564523|527084436|FG016|Overall Study|Physician Decision|0|||
146157047|NCT02564523|527084437|FG017|Overall Study|Physician Decision|0|||
146157048|NCT02564523|527084420|FG000|Overall Study|Protocol Violation|2|||
146157049|NCT02564523|527084421|FG001|Overall Study|Protocol Violation|2|||
146157050|NCT02564523|527084422|FG002|Overall Study|Protocol Violation|5|||
146157051|NCT02564523|527084423|FG003|Overall Study|Protocol Violation|0|||
146157052|NCT02564523|527084424|FG004|Overall Study|Protocol Violation|1|||
146157053|NCT02564523|527084425|FG005|Overall Study|Protocol Violation|0|||
146157054|NCT02564523|527084426|FG006|Overall Study|Protocol Violation|0|||
146157055|NCT02564523|527084427|FG007|Overall Study|Protocol Violation|0|||
146157056|NCT02564523|527084428|FG008|Overall Study|Protocol Violation|0|||
146157057|NCT02564523|527084429|FG009|Overall Study|Protocol Violation|0|||
146157058|NCT02564523|527084430|FG010|Overall Study|Protocol Violation|0|||
146157059|NCT02564523|527084431|FG011|Overall Study|Protocol Violation|0|||
146157060|NCT02564523|527084432|FG012|Overall Study|Protocol Violation|0|||
146157061|NCT02564523|527084433|FG013|Overall Study|Protocol Violation|0|||
146157062|NCT02564523|527084434|FG014|Overall Study|Protocol Violation|0|||
146157063|NCT02564523|527084435|FG015|Overall Study|Protocol Violation|0|||
146157064|NCT02564523|527084436|FG016|Overall Study|Protocol Violation|0|||
146157065|NCT02564523|527084437|FG017|Overall Study|Protocol Violation|0|||
146157066|NCT02564523|527084420|FG000|Overall Study|Other|3|||
146157067|NCT02564523|527084421|FG001|Overall Study|Other|0|||
146157068|NCT02564523|527084422|FG002|Overall Study|Other|0|||
146157069|NCT02564523|527084423|FG003|Overall Study|Other|1|||
146157070|NCT02564523|527084424|FG004|Overall Study|Other|0|||
146157071|NCT02564523|527084425|FG005|Overall Study|Other|0|||
146157072|NCT02564523|527084426|FG006|Overall Study|Other|0|||
146157073|NCT02564523|527084427|FG007|Overall Study|Other|0|||
146157074|NCT02564523|527084428|FG008|Overall Study|Other|0|||
146157075|NCT02564523|527084429|FG009|Overall Study|Other|0|||
146157076|NCT02564523|527084430|FG010|Overall Study|Other|0|||
146157077|NCT02564523|527084431|FG011|Overall Study|Other|0|||
146157078|NCT02564523|527084432|FG012|Overall Study|Other|0|||
146157079|NCT02564523|527084433|FG013|Overall Study|Other|0|||
146157080|NCT02564523|527084434|FG014|Overall Study|Other|0|||
146157081|NCT02564523|527084435|FG015|Overall Study|Other|0|||
146157082|NCT02564523|527084436|FG016|Overall Study|Other|0|||
146157083|NCT02564523|527084437|FG017|Overall Study|Other|0|||
146157084|NCT01816594|527084440|FG000|Overall Study|Local Progress|0|||
146157085|NCT01816594|527084441|FG001|Overall Study|Local Progress|2|||
146157086|NCT01816594|527084440|FG000|Overall Study|Adverse Event|9|||
146157087|NCT01816594|527084441|FG001|Overall Study|Adverse Event|0|||
146157088|NCT01816594|527084440|FG000|Overall Study|Withdrawal by Subject|1|||
146157089|NCT01816594|527084441|FG001|Overall Study|Withdrawal by Subject|0|||
146157090|NCT01816594|527084440|FG000|Overall Study|Physician Decision|1|||
146157091|NCT01816594|527084441|FG001|Overall Study|Physician Decision|0|||
146157092|NCT03905655|527084442|FG000|Overall Study|Adverse Event|1|||
146157093|NCT03905655|527084443|FG001|Overall Study|Adverse Event|0|||
146157094|NCT03905655|527084444|FG002|Overall Study|Adverse Event|1|||
146157095|NCT03905655|527084445|FG003|Overall Study|Adverse Event|1|||
146157096|NCT02566031|527084446|FG000|Overall Study|Patient/guardian decision|14|||
146157097|NCT02566031|527084447|FG001|Overall Study|Patient/guardian decision|7|||
146157098|NCT02566031|527084446|FG000|Overall Study|Protocol deviation|2|||
146157099|NCT02566031|527084447|FG001|Overall Study|Protocol deviation|3|||
146157100|NCT02566031|527084446|FG000|Overall Study|Adverse Event|3|||
146157101|NCT02566031|527084447|FG001|Overall Study|Adverse Event|1|||
146157102|NCT02566031|527084446|FG000|Overall Study|Lost to Follow-up|1|||
146157103|NCT02566031|527084447|FG001|Overall Study|Lost to Follow-up|1|||
146157104|NCT02277106|527084448|FG000|Stage 2|Adverse Event|0|||
146157105|NCT02277106|527084449|FG001|Stage 2|Adverse Event|0|||
146157106|NCT02277106|527084450|FG002|Stage 2|Adverse Event|1|||
146157107|NCT03031938|527084451|FG000|Overall Study|Death|1|||
146157108|NCT03031938|527084452|FG001|Overall Study|Death|0|||
146157109|NCT02479412|527084455|FG000|Overall Study|Adverse Event|0|||
146157110|NCT02479412|527084456|FG001|Overall Study|Adverse Event|0|||
146157111|NCT02479412|527084457|FG002|Overall Study|Adverse Event|1|||
146157112|NCT02479412|527084458|FG003|Overall Study|Adverse Event|0|||
146157113|NCT02479412|527084459|FG004|Overall Study|Adverse Event|0|||
146157114|NCT02479412|527084460|FG005|Overall Study|Adverse Event|0|||
146157115|NCT02479412|527084461|FG006|Overall Study|Adverse Event|0|||
146157116|NCT02479412|527084462|FG007|Overall Study|Adverse Event|0|||
146157117|NCT02479412|527084463|FG008|Overall Study|Adverse Event|0|||
146157118|NCT02479412|527084455|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146157119|NCT02479412|527084456|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146157120|NCT02479412|527084457|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146157121|NCT02479412|527084458|FG003|Overall Study|Study-specific withdrawal criteria|1|||
146157122|NCT02479412|527084459|FG004|Overall Study|Study-specific withdrawal criteria|0|||
146157123|NCT02479412|527084460|FG005|Overall Study|Study-specific withdrawal criteria|0|||
146157124|NCT02479412|527084461|FG006|Overall Study|Study-specific withdrawal criteria|0|||
146157125|NCT02479412|527084462|FG007|Overall Study|Study-specific withdrawal criteria|1|||
146157126|NCT02479412|527084463|FG008|Overall Study|Study-specific withdrawal criteria|1|||
146157127|NCT02479412|527084455|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
146157128|NCT02479412|527084456|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
146157129|NCT02479412|527084457|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
146157130|NCT02479412|527084458|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
146157131|NCT02479412|527084459|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
146157132|NCT02479412|527084460|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
146157133|NCT02479412|527084461|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
146157134|NCT02479412|527084462|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
146157135|NCT02479412|527084463|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
146157136|NCT00515502|527084464|FG000|Treatment Period 1|Adverse Event|0|||
146157137|NCT00515502|527084465|FG001|Treatment Period 1|Adverse Event|0|||
146157138|NCT00515502|527084466|FG002|Treatment Period 1|Adverse Event|0|||
146157139|NCT00515502|527084467|FG003|Treatment Period 1|Adverse Event|0|||
146157140|NCT00515502|527084468|FG004|Treatment Period 1|Adverse Event|0|||
146157141|NCT00515502|527084469|FG005|Treatment Period 1|Adverse Event|0|||
146157142|NCT00515502|527084470|FG006|Treatment Period 1|Adverse Event|1|||
146157143|NCT00515502|527084471|FG007|Treatment Period 1|Adverse Event|0|||
146157144|NCT00515502|527084472|FG008|Treatment Period 1|Adverse Event|1|||
146157145|NCT00515502|527084473|FG009|Treatment Period 1|Adverse Event|0|||
146157146|NCT00515502|527084474|FG010|Treatment Period 1|Adverse Event|0|||
146157147|NCT00515502|527084475|FG011|Treatment Period 1|Adverse Event|1|||
146157148|NCT00515502|527084464|FG000|Treatment Period 2|Adverse Event|0|||
146157149|NCT00515502|527084465|FG001|Treatment Period 2|Adverse Event|1|||
146157150|NCT00515502|527084466|FG002|Treatment Period 2|Adverse Event|0|||
146157151|NCT00515502|527084467|FG003|Treatment Period 2|Adverse Event|0|||
146157152|NCT00515502|527084468|FG004|Treatment Period 2|Adverse Event|0|||
146157153|NCT00515502|527084469|FG005|Treatment Period 2|Adverse Event|0|||
146157154|NCT00515502|527084470|FG006|Treatment Period 2|Adverse Event|0|||
146157155|NCT00515502|527084471|FG007|Treatment Period 2|Adverse Event|0|||
146157156|NCT00515502|527084472|FG008|Treatment Period 2|Adverse Event|0|||
146157157|NCT00515502|527084473|FG009|Treatment Period 2|Adverse Event|0|||
146157158|NCT00515502|527084474|FG010|Treatment Period 2|Adverse Event|0|||
146157159|NCT00515502|527084475|FG011|Treatment Period 2|Adverse Event|0|||
146157160|NCT02732938|527084479|FG000|Overall Study|Death|0|||
146157161|NCT02732938|527084480|FG001|Overall Study|Death|11|||
146157162|NCT02732938|527084481|FG002|Overall Study|Death|0|||
146157163|NCT02732938|527084479|FG000|Overall Study|Randomized but did not receive treatment|0|||
146157164|NCT02732938|527084480|FG001|Overall Study|Randomized but did not receive treatment|1|||
146157165|NCT02732938|527084481|FG002|Overall Study|Randomized but did not receive treatment|0|||
146157166|NCT02732938|527084479|FG000|Overall Study|Refused further follow-up|1|||
146157167|NCT02732938|527084480|FG001|Overall Study|Refused further follow-up|0|||
146157168|NCT02732938|527084481|FG002|Overall Study|Refused further follow-up|0|||
146157169|NCT02732938|527084479|FG000|Overall Study|Study terminated by sponsor|3|||
146157170|NCT02732938|527084480|FG001|Overall Study|Study terminated by sponsor|6|||
146157171|NCT02732938|527084481|FG002|Overall Study|Study terminated by sponsor|0|||
146157172|NCT01613248|527084482|FG000|Overall Study|Adverse Event|0|||
146157173|NCT01613248|527084483|FG001|Overall Study|Adverse Event|0|||
146157174|NCT01613248|527084484|FG002|Overall Study|Adverse Event|0|||
146157175|NCT01613248|527084485|FG003|Overall Study|Adverse Event|1|||
146157176|NCT01613248|527084486|FG004|Overall Study|Adverse Event|0|||
146157177|NCT01613248|527084487|FG005|Overall Study|Adverse Event|0|||
146157178|NCT01613248|527084482|FG000|Overall Study|Withdrawal by Subject|3|||
146157179|NCT01613248|527084483|FG001|Overall Study|Withdrawal by Subject|2|||
146157180|NCT01613248|527084484|FG002|Overall Study|Withdrawal by Subject|2|||
146157181|NCT01613248|527084485|FG003|Overall Study|Withdrawal by Subject|5|||
146157182|NCT01613248|527084486|FG004|Overall Study|Withdrawal by Subject|0|||
146157183|NCT01613248|527084487|FG005|Overall Study|Withdrawal by Subject|1|||
146157184|NCT01613248|527084482|FG000|Overall Study|Lost to Follow-up|5|||
146157185|NCT01613248|527084483|FG001|Overall Study|Lost to Follow-up|7|||
146157186|NCT01613248|527084484|FG002|Overall Study|Lost to Follow-up|4|||
146157187|NCT01613248|527084485|FG003|Overall Study|Lost to Follow-up|8|||
146157188|NCT01613248|527084486|FG004|Overall Study|Lost to Follow-up|4|||
146157189|NCT01613248|527084487|FG005|Overall Study|Lost to Follow-up|2|||
146157190|NCT01613248|527084482|FG000|Overall Study|Study Terminated by Sponsor|4|||
146157191|NCT01613248|527084483|FG001|Overall Study|Study Terminated by Sponsor|6|||
146157192|NCT01613248|527084484|FG002|Overall Study|Study Terminated by Sponsor|8|||
146157193|NCT01613248|527084485|FG003|Overall Study|Study Terminated by Sponsor|8|||
146157194|NCT01613248|527084486|FG004|Overall Study|Study Terminated by Sponsor|9|||
146157195|NCT01613248|527084487|FG005|Overall Study|Study Terminated by Sponsor|11|||
146157196|NCT01613248|527084482|FG000|Overall Study|Physician Decision|8|||
146157197|NCT01613248|527084483|FG001|Overall Study|Physician Decision|8|||
146157198|NCT01613248|527084484|FG002|Overall Study|Physician Decision|9|||
146157199|NCT01613248|527084485|FG003|Overall Study|Physician Decision|4|||
146157200|NCT01613248|527084486|FG004|Overall Study|Physician Decision|7|||
146157201|NCT01613248|527084487|FG005|Overall Study|Physician Decision|6|||
146157202|NCT01613248|527084482|FG000|Overall Study|Lack of Qualifying Event|9|||
146157203|NCT01613248|527084483|FG001|Overall Study|Lack of Qualifying Event|11|||
146157204|NCT01613248|527084484|FG002|Overall Study|Lack of Qualifying Event|10|||
146157205|NCT01613248|527084485|FG003|Overall Study|Lack of Qualifying Event|11|||
146157206|NCT01613248|527084486|FG004|Overall Study|Lack of Qualifying Event|15|||
146157207|NCT01613248|527084487|FG005|Overall Study|Lack of Qualifying Event|18|||
146157208|NCT01613248|527084482|FG000|Overall Study|Pregnancy|0|||
146157209|NCT01613248|527084483|FG001|Overall Study|Pregnancy|0|||
146157210|NCT01613248|527084484|FG002|Overall Study|Pregnancy|0|||
146157211|NCT01613248|527084485|FG003|Overall Study|Pregnancy|1|||
146157212|NCT01613248|527084486|FG004|Overall Study|Pregnancy|0|||
146157213|NCT01613248|527084487|FG005|Overall Study|Pregnancy|0|||
146157214|NCT03280121|527084489|FG000|Overall Study|Physician Decision|1|||
146157215|NCT03280121|527084489|FG000|Overall Study|Lost to Follow-up|1|||
146157216|NCT03280121|527084489|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
146157217|NCT03449030|527084506|FG000|Overall Study|Withdrawal by Subject|0|||
146157218|NCT03449030|527084507|FG001|Overall Study|Withdrawal by Subject|0|||
146157219|NCT03449030|527084508|FG002|Overall Study|Withdrawal by Subject|0|||
146157220|NCT03449030|527084509|FG003|Overall Study|Withdrawal by Subject|1|||
146157221|NCT03449030|527084510|FG004|Overall Study|Withdrawal by Subject|1|||
146157222|NCT03449030|527084511|FG005|Overall Study|Withdrawal by Subject|1|||
146157223|NCT03449030|527084512|FG006|Overall Study|Withdrawal by Subject|1|||
146157224|NCT03449030|527084513|FG007|Overall Study|Withdrawal by Subject|2|||
146157225|NCT03449030|527084514|FG008|Overall Study|Withdrawal by Subject|0|||
146157226|NCT03449030|527084515|FG009|Overall Study|Withdrawal by Subject|0|||
146157227|NCT03449030|527084506|FG000|Overall Study|Symptomatic Deterioration|0|||
146157228|NCT03449030|527084507|FG001|Overall Study|Symptomatic Deterioration|1|||
146157229|NCT03449030|527084508|FG002|Overall Study|Symptomatic Deterioration|0|||
146157230|NCT03449030|527084509|FG003|Overall Study|Symptomatic Deterioration|0|||
146157231|NCT03449030|527084510|FG004|Overall Study|Symptomatic Deterioration|0|||
146157232|NCT03449030|527084511|FG005|Overall Study|Symptomatic Deterioration|1|||
146157233|NCT03449030|527084512|FG006|Overall Study|Symptomatic Deterioration|1|||
146157234|NCT03449030|527084513|FG007|Overall Study|Symptomatic Deterioration|0|||
146157235|NCT03449030|527084514|FG008|Overall Study|Symptomatic Deterioration|2|||
146157236|NCT03449030|527084515|FG009|Overall Study|Symptomatic Deterioration|0|||
146157237|NCT03449030|527084506|FG000|Overall Study|Progressive Disease|1|||
146157238|NCT03449030|527084507|FG001|Overall Study|Progressive Disease|0|||
146157239|NCT03449030|527084508|FG002|Overall Study|Progressive Disease|1|||
146157240|NCT03449030|527084509|FG003|Overall Study|Progressive Disease|4|||
146157241|NCT03449030|527084510|FG004|Overall Study|Progressive Disease|5|||
146157242|NCT03449030|527084511|FG005|Overall Study|Progressive Disease|3|||
146157243|NCT03449030|527084512|FG006|Overall Study|Progressive Disease|0|||
146157244|NCT03449030|527084513|FG007|Overall Study|Progressive Disease|1|||
146157245|NCT03449030|527084514|FG008|Overall Study|Progressive Disease|1|||
146157246|NCT03449030|527084515|FG009|Overall Study|Progressive Disease|1|||
146157247|NCT03449030|527084506|FG000|Overall Study|Adverse Event|0|||
146157248|NCT03449030|527084507|FG001|Overall Study|Adverse Event|0|||
146157249|NCT03449030|527084508|FG002|Overall Study|Adverse Event|0|||
146157250|NCT03449030|527084509|FG003|Overall Study|Adverse Event|0|||
146157251|NCT03449030|527084510|FG004|Overall Study|Adverse Event|0|||
146157252|NCT03449030|527084511|FG005|Overall Study|Adverse Event|2|||
146157253|NCT03449030|527084512|FG006|Overall Study|Adverse Event|0|||
146157254|NCT03449030|527084513|FG007|Overall Study|Adverse Event|0|||
146157255|NCT03449030|527084514|FG008|Overall Study|Adverse Event|0|||
146157256|NCT03449030|527084515|FG009|Overall Study|Adverse Event|0|||
146157257|NCT03449030|527084506|FG000|Overall Study|Death|0|||
146157258|NCT03449030|527084507|FG001|Overall Study|Death|0|||
146157259|NCT03449030|527084508|FG002|Overall Study|Death|0|||
146157260|NCT03449030|527084509|FG003|Overall Study|Death|0|||
146157261|NCT03449030|527084510|FG004|Overall Study|Death|1|||
146157262|NCT03449030|527084511|FG005|Overall Study|Death|0|||
146157263|NCT03449030|527084512|FG006|Overall Study|Death|0|||
146157264|NCT03449030|527084513|FG007|Overall Study|Death|0|||
146157265|NCT03449030|527084514|FG008|Overall Study|Death|0|||
146157266|NCT03449030|527084515|FG009|Overall Study|Death|0|||
146157267|NCT01581281|527084516|FG000|Overall Study|Early Study Closure|15|||
146157268|NCT01581281|527084517|FG001|Overall Study|Early Study Closure|6|||
146157269|NCT01581281|527084518|FG002|Overall Study|Early Study Closure|12|||
146157270|NCT00700401|527084527|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
146157271|NCT00700401|527084527|FG000|Overall Study|Adverse Event|5|||
146157272|NCT00700401|527084527|FG000|Overall Study|Refused Treatment|2|||
146157273|NCT00700401|527084527|FG000|Overall Study|Lost to Follow-up|1|||
146157274|NCT00700401|527084527|FG000|Overall Study|Treatment never started|1|||
146157275|NCT00700401|527084527|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
146157276|NCT00700401|527084527|FG000|Overall Study|Withdrawal by Subject|2|||
146157277|NCT02653482|527084533|FG000|Overall Study|Death|1|||
146157278|NCT02653482|527084534|FG001|Overall Study|Death|1|||
146157279|NCT06273774|527084536|FG000|Overall Study|Participant was out of state.|0|||
146157280|NCT06273774|527084537|FG001|Overall Study|Participant was out of state.|0|||
146157281|NCT06273774|527084538|FG002|Overall Study|Participant was out of state.|0|||
146157282|NCT06273774|527084539|FG003|Overall Study|Participant was out of state.|0|||
146157283|NCT06273774|527084540|FG004|Overall Study|Participant was out of state.|0|||
146157284|NCT06273774|527084541|FG005|Overall Study|Participant was out of state.|1|||
146157285|NCT06273774|527084536|FG000|Overall Study|Lost to Follow-up|0|||
146157286|NCT06273774|527084537|FG001|Overall Study|Lost to Follow-up|0|||
146157287|NCT06273774|527084538|FG002|Overall Study|Lost to Follow-up|0|||
146157288|NCT06273774|527084539|FG003|Overall Study|Lost to Follow-up|0|||
146157289|NCT06273774|527084540|FG004|Overall Study|Lost to Follow-up|1|||
146157290|NCT06273774|527084541|FG005|Overall Study|Lost to Follow-up|0|||
146157291|NCT02010060|527084542|FG000|Overall Study|Lost to Follow-up|1|||
146157292|NCT02010060|527084543|FG001|Overall Study|Lost to Follow-up|2|||
146157293|NCT02010060|527084544|FG002|Overall Study|Lost to Follow-up|2|||
146157294|NCT02010060|527084542|FG000|Overall Study|Injury|0|||
146157295|NCT02010060|527084543|FG001|Overall Study|Injury|1|||
146157296|NCT02010060|527084544|FG002|Overall Study|Injury|0|||
146157297|NCT00660010|527084547|FG000|Overall Study|Withdrawal by Subject|2|||
146157298|NCT00660010|527084547|FG000|Overall Study|Lost to Follow-up|3|||
146157299|NCT00660010|527084547|FG000|Overall Study|Adverse Event|1|||
146157300|NCT00660010|527084547|FG000|Overall Study|Noncompliance with visit schedule|3|||
146157301|NCT00844857|527086653|FG000|Overall Study|Adverse Event|24|||
146157302|NCT00844857|527086654|FG001|Overall Study|Adverse Event|5|||
146157303|NCT00844857|527086653|FG000|Overall Study|Sponsor Decision|1|||
146157304|NCT00844857|527086654|FG001|Overall Study|Sponsor Decision|1|||
146157305|NCT00844857|527086653|FG000|Overall Study|Physician Decision|2|||
146157306|NCT00844857|527086654|FG001|Overall Study|Physician Decision|0|||
146157307|NCT00844857|527086653|FG000|Overall Study|Parent/Caregiver Decision|6|||
146157308|NCT00844857|527086654|FG001|Overall Study|Parent/Caregiver Decision|2|||
146157309|NCT00844857|527086653|FG000|Overall Study|Withdrawal by Subject|8|||
146157310|NCT00844857|527086654|FG001|Overall Study|Withdrawal by Subject|7|||
146157311|NCT00844857|527086653|FG000|Overall Study|Protocol Violation|6|||
146157312|NCT00844857|527086654|FG001|Overall Study|Protocol Violation|0|||
146157313|NCT00844857|527086653|FG000|Overall Study|Lack of Efficacy|5|||
146157314|NCT00844857|527086654|FG001|Overall Study|Lack of Efficacy|5|||
146157315|NCT00844857|527086653|FG000|Overall Study|Clinical Relapse|0|||
146157316|NCT00844857|527086654|FG001|Overall Study|Clinical Relapse|1|||
146157317|NCT00844857|527086653|FG000|Overall Study|Entry Criteria Not Met|0|||
146157318|NCT00844857|527086654|FG001|Overall Study|Entry Criteria Not Met|1|||
146157319|NCT00844857|527086653|FG000|Overall Study|Lost to Follow-up|2|||
146157320|NCT00844857|527086654|FG001|Overall Study|Lost to Follow-up|3|||
146157321|NCT00844857|527086653|FG000|Overall Study|Did Not Take Study Drug|3|||
146157322|NCT00844857|527086654|FG001|Overall Study|Did Not Take Study Drug|1|||
146157323|NCT00844857|527086653|FG000|Overall Study|Good Clinical Practice Violations|21|||
146157324|NCT00844857|527086654|FG001|Overall Study|Good Clinical Practice Violations|11|||
146157325|NCT00570674|527086655|FG000|Overall Study|Withdrawal by Subject|0|||
146157326|NCT00570674|527086656|FG001|Overall Study|Withdrawal by Subject|0|||
146157327|NCT00570674|527086657|FG002|Overall Study|Withdrawal by Subject|1|||
146157328|NCT00570674|527086658|FG003|Overall Study|Withdrawal by Subject|0|||
146157329|NCT00570674|527086659|FG004|Overall Study|Withdrawal by Subject|0|||
146157330|NCT00570674|527086660|FG005|Overall Study|Withdrawal by Subject|0|||
146157331|NCT00570674|527086661|FG006|Overall Study|Withdrawal by Subject|0|||
146157332|NCT03667053|527086663|FG000|Overall Study|Withdrawal by Subject|1|||
146157333|NCT03667053|527086664|FG001|Overall Study|Withdrawal by Subject|0|||
146157334|NCT03667053|527086665|FG002|Overall Study|Withdrawal by Subject|0|||
146157335|NCT03638141|527086675|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
146157336|NCT03996473|527086676|FG000|Treatment Assignment|Withdrawal by Subject|1|||
146157337|NCT03996473|527086676|FG000|Treatment Assignment|Progressive disease|6|||
146157338|NCT03996473|527086676|FG000|Treatment Assignment|Study drug never administered|1|||
146157339|NCT03996473|527086676|FG000|Active Follow-up|Death|1|||
146157340|NCT03996473|527086676|FG000|Long-term Follow-up|Death|5|||
146157341|NCT03759873|527086677|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
146157342|NCT03759873|527086678|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
146157343|NCT03759873|527086679|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
146157344|NCT03759873|527086680|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
146157345|NCT03759873|527086677|FG000|Overall Study|Moved outside eligible area|0|||
146157346|NCT03759873|527086678|FG001|Overall Study|Moved outside eligible area|2|||
146157347|NCT03759873|527086679|FG002|Overall Study|Moved outside eligible area|0|||
146157348|NCT03759873|527086680|FG003|Overall Study|Moved outside eligible area|0|||
146157349|NCT03759873|527086677|FG000|Overall Study|Withdrawal by Subject|0|||
146157350|NCT03759873|527086678|FG001|Overall Study|Withdrawal by Subject|0|||
146157351|NCT03759873|527086679|FG002|Overall Study|Withdrawal by Subject|1|||
146157352|NCT03759873|527086680|FG003|Overall Study|Withdrawal by Subject|0|||
146157353|NCT06116591|527086683|FG000|Overall Study|No longer met eligibility criteria|0|||
146157354|NCT06116591|527086684|FG001|Overall Study|No longer met eligibility criteria|1|||
146157355|NCT06116591|527086683|FG000|Overall Study|Other: Change in life situation|0|||
146157356|NCT06116591|527086684|FG001|Overall Study|Other: Change in life situation|1|||
146157357|NCT05585307|527086685|FG000|Overall Study|Lost to Follow-up|0|||
146157358|NCT05585307|527086686|FG001|Overall Study|Lost to Follow-up|0|||
146157359|NCT05585307|527086687|FG002|Overall Study|Lost to Follow-up|0|||
146157360|NCT05585307|527086688|FG003|Overall Study|Lost to Follow-up|0|||
146157361|NCT05585307|527086689|FG004|Overall Study|Lost to Follow-up|0|||
146157362|NCT05585307|527086690|FG005|Overall Study|Lost to Follow-up|0|||
146157363|NCT05585307|527086691|FG006|Overall Study|Lost to Follow-up|1|||
146157364|NCT05585307|527086692|FG007|Overall Study|Lost to Follow-up|0|||
146157365|NCT01869491|527086693|FG000|Overall Study|Adverse Event|3|||
146157366|NCT01869491|527086694|FG001|Overall Study|Adverse Event|5|||
146157367|NCT01869491|527086693|FG000|Overall Study|Lack of Efficacy|0|||
146157368|NCT01869491|527086694|FG001|Overall Study|Lack of Efficacy|3|||
146157369|NCT01869491|527086693|FG000|Overall Study|Withdrawal by Subject|6|||
146157370|NCT01869491|527086694|FG001|Overall Study|Withdrawal by Subject|7|||
146157371|NCT01869491|527086693|FG000|Overall Study|Lost to Follow-up|11|||
146157372|NCT01869491|527086694|FG001|Overall Study|Lost to Follow-up|9|||
146157373|NCT01869491|527086693|FG000|Overall Study|No further need of investigational product|1|||
146157374|NCT01869491|527086694|FG001|Overall Study|No further need of investigational product|0|||
146157375|NCT01362140|527086695|FG000|Overall Study|Noncompliance|1|||
146157376|NCT01362140|527086696|FG001|Overall Study|Noncompliance|0|||
146157377|NCT01362140|527086695|FG000|Overall Study|Adverse Event|2|||
146157378|NCT01362140|527086696|FG001|Overall Study|Adverse Event|2|||
146157379|NCT01362140|527086695|FG000|Overall Study|Withdrawal by Subject|3|||
146309953|NCT02230384|527648651|FG001|Phase 2 - Switch|Adverse Event|0|||
146157380|NCT01362140|527086696|FG001|Overall Study|Withdrawal by Subject|3|||
146157381|NCT01362140|527086695|FG000|Overall Study|Administrative Decision|0|||
146157382|NCT01362140|527086696|FG001|Overall Study|Administrative Decision|1|||
146157383|NCT01362140|527086695|FG000|Overall Study|Death|2|||
146157384|NCT01362140|527086696|FG001|Overall Study|Death|1|||
146157385|NCT01362140|527086695|FG000|Overall Study|Other|1|||
146157386|NCT01362140|527086696|FG001|Overall Study|Other|1|||
146157387|NCT01362140|527086695|FG000|Overall Study|Protocol-specified Criteria|1|||
146157388|NCT01362140|527086696|FG001|Overall Study|Protocol-specified Criteria|2|||
146157389|NCT01362140|527086695|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
146157390|NCT01362140|527086696|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
146157391|NCT06476366|527086697|FG000|Overall Study|Lost to Follow-up|1|||
146157392|NCT06476366|527086698|FG001|Overall Study|Lost to Follow-up|3|||
146157393|NCT06476366|527086697|FG000|Overall Study|Adverse Event|1|||
146157394|NCT06476366|527086698|FG001|Overall Study|Adverse Event|0|||
146157395|NCT01910129|527086701|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
146157396|NCT01910129|527086702|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
146157397|NCT01910129|527086703|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
146157398|NCT01910129|527086701|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
146157399|NCT01910129|527086702|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
146157400|NCT01910129|527086703|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
146157401|NCT02195986|527086704|FG000|Overall Study|Adverse Event|3|||
146157402|NCT02195986|527086705|FG001|Overall Study|Adverse Event|0|||
146157403|NCT02195986|527086706|FG002|Overall Study|Adverse Event|0|||
146157404|NCT02195986|527086704|FG000|Overall Study|Withdrawal by Subject|0|||
146157405|NCT02195986|527086705|FG001|Overall Study|Withdrawal by Subject|3|||
146157406|NCT02195986|527086706|FG002|Overall Study|Withdrawal by Subject|0|||
146157407|NCT02195986|527086704|FG000|Overall Study|Family Emergency|0|||
146157408|NCT02195986|527086705|FG001|Overall Study|Family Emergency|0|||
146157409|NCT02195986|527086706|FG002|Overall Study|Family Emergency|1|||
146157410|NCT02195986|527086704|FG000|Overall Study|Protocol Violation|0|||
146157411|NCT02195986|527086705|FG001|Overall Study|Protocol Violation|1|||
146157412|NCT02195986|527086706|FG002|Overall Study|Protocol Violation|1|||
146157413|NCT02195986|527086704|FG000|Overall Study|Non-compliance|0|||
146157414|NCT02195986|527086705|FG001|Overall Study|Non-compliance|1|||
146157415|NCT02195986|527086706|FG002|Overall Study|Non-compliance|0|||
146157416|NCT00319098|527086707|FG000|Overall Study|Serious adverse event|3|||
146157417|NCT00319098|527086708|FG001|Overall Study|Serious adverse event|0|||
146157418|NCT00319098|527086707|FG000|Overall Study|Adverse Event|20|||
146157419|NCT00319098|527086708|FG001|Overall Study|Adverse Event|1|||
146157420|NCT00319098|527086707|FG000|Overall Study|Withdrawal by Subject|37|||
146157421|NCT00319098|527086708|FG001|Overall Study|Withdrawal by Subject|8|||
146157422|NCT00319098|527086707|FG000|Overall Study|Migrated/moved from study area|2|||
146157423|NCT00319098|527086708|FG001|Overall Study|Migrated/moved from study area|1|||
146157424|NCT00319098|527086707|FG000|Overall Study|Lost to Follow-up|37|||
146157425|NCT00319098|527086708|FG001|Overall Study|Lost to Follow-up|13|||
146157426|NCT00319098|527086707|FG000|Overall Study|Others|33|||
146157427|NCT00319098|527086708|FG001|Overall Study|Others|8|||
146157428|NCT00319098|527086707|FG000|Overall Study|Protocol Violation|3|||
146157429|NCT00319098|527086708|FG001|Overall Study|Protocol Violation|1|||
146157430|NCT02834780|527086709|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
146157431|NCT02834780|527086710|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146157432|NCT02834780|527086711|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
146157433|NCT02834780|527086712|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
146157434|NCT02834780|527086713|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
146157435|NCT02834780|527086714|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
146157436|NCT02834780|527086715|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
146157437|NCT02834780|527086716|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
146157438|NCT02834780|527086717|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146157439|NCT02834780|527086718|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
146157440|NCT02834780|527086719|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
146157441|NCT02834780|527086720|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
146157442|NCT02834780|527086721|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
146157443|NCT02834780|527086709|FG000|Overall Study|Withdrawal by Subject|0|||
146157444|NCT02834780|527086710|FG001|Overall Study|Withdrawal by Subject|0|||
146157445|NCT02834780|527086711|FG002|Overall Study|Withdrawal by Subject|1|||
146157446|NCT02834780|527086712|FG003|Overall Study|Withdrawal by Subject|0|||
146157447|NCT02834780|527086713|FG004|Overall Study|Withdrawal by Subject|0|||
146157448|NCT02834780|527086714|FG005|Overall Study|Withdrawal by Subject|0|||
146157449|NCT02834780|527086715|FG006|Overall Study|Withdrawal by Subject|0|||
146157450|NCT02834780|527086716|FG007|Overall Study|Withdrawal by Subject|0|||
146157451|NCT02834780|527086717|FG008|Overall Study|Withdrawal by Subject|0|||
146157452|NCT02834780|527086718|FG009|Overall Study|Withdrawal by Subject|0|||
146157453|NCT02834780|527086719|FG010|Overall Study|Withdrawal by Subject|1|||
146157454|NCT02834780|527086720|FG011|Overall Study|Withdrawal by Subject|0|||
146157455|NCT02834780|527086721|FG012|Overall Study|Withdrawal by Subject|0|||
146157456|NCT02834780|527086709|FG000|Overall Study|Adverse Event|0|||
146157457|NCT02834780|527086710|FG001|Overall Study|Adverse Event|0|||
146157458|NCT02834780|527086711|FG002|Overall Study|Adverse Event|0|||
146157459|NCT02834780|527086712|FG003|Overall Study|Adverse Event|0|||
146157460|NCT02834780|527086713|FG004|Overall Study|Adverse Event|1|||
146157461|NCT02834780|527086714|FG005|Overall Study|Adverse Event|0|||
146157462|NCT02834780|527086715|FG006|Overall Study|Adverse Event|1|||
146157463|NCT02834780|527086716|FG007|Overall Study|Adverse Event|1|||
146157464|NCT02834780|527086717|FG008|Overall Study|Adverse Event|0|||
146157465|NCT02834780|527086718|FG009|Overall Study|Adverse Event|2|||
146157466|NCT02834780|527086719|FG010|Overall Study|Adverse Event|0|||
146157467|NCT02834780|527086720|FG011|Overall Study|Adverse Event|3|||
146157468|NCT02834780|527086721|FG012|Overall Study|Adverse Event|2|||
146157469|NCT02834780|527086709|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157470|NCT02834780|527086710|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
146157471|NCT02834780|527086711|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
146157472|NCT02834780|527086712|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157473|NCT02834780|527086713|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157474|NCT02834780|527086714|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157475|NCT02834780|527086715|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157476|NCT02834780|527086716|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
146157477|NCT02834780|527086717|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
146157478|NCT02834780|527086718|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
146157479|NCT02834780|527086719|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
146157480|NCT02834780|527086720|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
146157481|NCT02834780|527086721|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
146157482|NCT02834780|527086709|FG000|Overall Study|Other|1|||
146157483|NCT02834780|527086710|FG001|Overall Study|Other|0|||
146157484|NCT02834780|527086711|FG002|Overall Study|Other|1|||
146157485|NCT02834780|527086712|FG003|Overall Study|Other|2|||
146157486|NCT02834780|527086713|FG004|Overall Study|Other|0|||
146157487|NCT02834780|527086714|FG005|Overall Study|Other|0|||
146157488|NCT02834780|527086715|FG006|Overall Study|Other|0|||
146157489|NCT02834780|527086716|FG007|Overall Study|Other|0|||
146157490|NCT02834780|527086717|FG008|Overall Study|Other|0|||
146157491|NCT02834780|527086718|FG009|Overall Study|Other|0|||
146157492|NCT02834780|527086719|FG010|Overall Study|Other|0|||
146157493|NCT02834780|527086720|FG011|Overall Study|Other|0|||
146157494|NCT02834780|527086721|FG012|Overall Study|Other|1|||
146157495|NCT03150056|527086722|FG000|Overall Study|Withdrawal by Subject|0|||
146157496|NCT03150056|527086723|FG001|Overall Study|Withdrawal by Subject|0|||
146157497|NCT03150056|527086724|FG002|Overall Study|Withdrawal by Subject|0|||
146157498|NCT03150056|527086725|FG003|Overall Study|Withdrawal by Subject|0|||
146157499|NCT03150056|527086726|FG004|Overall Study|Withdrawal by Subject|0|||
146157500|NCT03150056|527086727|FG005|Overall Study|Withdrawal by Subject|2|||
146157501|NCT03150056|527086722|FG000|Overall Study|Study terminated by Sponsor|1|||
146157502|NCT03150056|527086723|FG001|Overall Study|Study terminated by Sponsor|3|||
146157503|NCT03150056|527086724|FG002|Overall Study|Study terminated by Sponsor|1|||
146157504|NCT03150056|527086725|FG003|Overall Study|Study terminated by Sponsor|1|||
146157505|NCT03150056|527086726|FG004|Overall Study|Study terminated by Sponsor|5|||
146157506|NCT03150056|527086727|FG005|Overall Study|Study terminated by Sponsor|6|||
146157507|NCT03150056|527086722|FG000|Overall Study|Death|9|||
146157508|NCT03150056|527086723|FG001|Overall Study|Death|2|||
146157509|NCT03150056|527086724|FG002|Overall Study|Death|2|||
146157510|NCT03150056|527086725|FG003|Overall Study|Death|7|||
146157511|NCT03150056|527086726|FG004|Overall Study|Death|8|||
146157512|NCT03150056|527086727|FG005|Overall Study|Death|10|||
146157513|NCT00965523|527086728|FG000|Study 221|Progressive Disease|4|||
146157514|NCT00965523|527086728|FG000|Study 221|Physician Decision|3|||
146157515|NCT00965523|527086728|FG000|Study 224|Progressive Disease|5|||
146157516|NCT00965523|527086728|FG000|Study 224|Physician Decision|1|||
146157517|NCT02415400|527086729|FG000|Overall Study|Adverse Event|0|||
146157518|NCT02415400|527086730|FG001|Overall Study|Adverse Event|1|||
146157519|NCT02415400|527086731|FG002|Overall Study|Adverse Event|1|||
146157520|NCT02415400|527086732|FG003|Overall Study|Adverse Event|2|||
146157521|NCT02415400|527086729|FG000|Overall Study|Participant request to stop therapy|4|||
146157522|NCT02415400|527086730|FG001|Overall Study|Participant request to stop therapy|3|||
146157523|NCT02415400|527086731|FG002|Overall Study|Participant request to stop therapy|8|||
146157524|NCT02415400|527086732|FG003|Overall Study|Participant request to stop therapy|6|||
146157525|NCT02415400|527086729|FG000|Overall Study|Participant withdrew consent|14|||
146157526|NCT02415400|527086730|FG001|Overall Study|Participant withdrew consent|12|||
146157527|NCT02415400|527086731|FG002|Overall Study|Participant withdrew consent|30|||
146157528|NCT02415400|527086732|FG003|Overall Study|Participant withdrew consent|21|||
146157529|NCT02415400|527086729|FG000|Overall Study|Death|39|||
146157530|NCT02415400|527086730|FG001|Overall Study|Death|41|||
146157531|NCT02415400|527086731|FG002|Overall Study|Death|35|||
146157532|NCT02415400|527086732|FG003|Overall Study|Death|42|||
146157533|NCT02415400|527086729|FG000|Overall Study|Lost to Follow-up|3|||
146157534|NCT02415400|527086730|FG001|Overall Study|Lost to Follow-up|3|||
146157535|NCT02415400|527086731|FG002|Overall Study|Lost to Follow-up|2|||
146157536|NCT02415400|527086732|FG003|Overall Study|Lost to Follow-up|5|||
146157537|NCT02415400|527086729|FG000|Overall Study|Poor/Non-Compliance|0|||
146157538|NCT02415400|527086730|FG001|Overall Study|Poor/Non-Compliance|1|||
146157539|NCT02415400|527086731|FG002|Overall Study|Poor/Non-Compliance|3|||
146157540|NCT02415400|527086732|FG003|Overall Study|Poor/Non-Compliance|4|||
146157541|NCT02415400|527086729|FG000|Overall Study|Participant no longer meets criteria|2|||
146157542|NCT02415400|527086730|FG001|Overall Study|Participant no longer meets criteria|0|||
146157543|NCT02415400|527086731|FG002|Overall Study|Participant no longer meets criteria|0|||
146157544|NCT02415400|527086732|FG003|Overall Study|Participant no longer meets criteria|1|||
146157545|NCT02415400|527086729|FG000|Overall Study|Participant doesn't answer phone|1|||
146157546|NCT02415400|527086730|FG001|Overall Study|Participant doesn't answer phone|0|||
146157547|NCT02415400|527086731|FG002|Overall Study|Participant doesn't answer phone|0|||
146157548|NCT02415400|527086732|FG003|Overall Study|Participant doesn't answer phone|0|||
146157549|NCT02415400|527086729|FG000|Overall Study|Participant wanted home visits|1|||
146157550|NCT02415400|527086730|FG001|Overall Study|Participant wanted home visits|0|||
146157551|NCT02415400|527086731|FG002|Overall Study|Participant wanted home visits|0|||
146157552|NCT02415400|527086732|FG003|Overall Study|Participant wanted home visits|0|||
146157553|NCT02415400|527086729|FG000|Overall Study|Randomized in error|2|||
146157554|NCT02415400|527086730|FG001|Overall Study|Randomized in error|0|||
146157555|NCT02415400|527086731|FG002|Overall Study|Randomized in error|0|||
146157556|NCT02415400|527086732|FG003|Overall Study|Randomized in error|0|||
146157557|NCT02415400|527086729|FG000|Overall Study|No study drug on site|0|||
146157558|NCT02415400|527086730|FG001|Overall Study|No study drug on site|1|||
146157559|NCT02415400|527086731|FG002|Overall Study|No study drug on site|0|||
146157560|NCT02415400|527086732|FG003|Overall Study|No study drug on site|0|||
146157561|NCT02415400|527086729|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
146157562|NCT02415400|527086730|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
146157563|NCT02415400|527086731|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
146157564|NCT02415400|527086732|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
146157565|NCT02415400|527086729|FG000|Overall Study|Coagulation values cannot be set|0|||
146157566|NCT02415400|527086730|FG001|Overall Study|Coagulation values cannot be set|0|||
146157567|NCT02415400|527086731|FG002|Overall Study|Coagulation values cannot be set|1|||
146157568|NCT02415400|527086732|FG003|Overall Study|Coagulation values cannot be set|0|||
146157569|NCT02415400|527086729|FG000|Overall Study|State regulations prevent participation|0|||
146157570|NCT02415400|527086730|FG001|Overall Study|State regulations prevent participation|0|||
146157571|NCT02415400|527086731|FG002|Overall Study|State regulations prevent participation|1|||
146157572|NCT02415400|527086732|FG003|Overall Study|State regulations prevent participation|0|||
146157573|NCT02415400|527086729|FG000|Overall Study|Poor treatment monitoring|0|||
146157574|NCT02415400|527086730|FG001|Overall Study|Poor treatment monitoring|0|||
146157575|NCT02415400|527086731|FG002|Overall Study|Poor treatment monitoring|1|||
146157576|NCT02415400|527086732|FG003|Overall Study|Poor treatment monitoring|0|||
146157577|NCT02415400|527086729|FG000|Overall Study|Participant in jail|0|||
146157578|NCT02415400|527086730|FG001|Overall Study|Participant in jail|0|||
146157579|NCT02415400|527086731|FG002|Overall Study|Participant in jail|1|||
146157580|NCT02415400|527086732|FG003|Overall Study|Participant in jail|0|||
146157581|NCT02415400|527086729|FG000|Overall Study|Investigator decision|0|||
146157582|NCT02415400|527086730|FG001|Overall Study|Investigator decision|0|||
146157583|NCT02415400|527086731|FG002|Overall Study|Investigator decision|1|||
146157584|NCT02415400|527086732|FG003|Overall Study|Investigator decision|1|||
146157585|NCT02415400|527086729|FG000|Overall Study|Site closure; participant won't transfer|0|||
146157586|NCT02415400|527086730|FG001|Overall Study|Site closure; participant won't transfer|0|||
146157587|NCT02415400|527086731|FG002|Overall Study|Site closure; participant won't transfer|0|||
146157588|NCT02415400|527086732|FG003|Overall Study|Site closure; participant won't transfer|1|||
146157589|NCT02270450|527086737|FG000|Overall Study|Refusal unrelated to adverse event|3|||
146157590|NCT02270450|527086738|FG001|Overall Study|Refusal unrelated to adverse event|1|||
146157591|NCT02270450|527086739|FG002|Overall Study|Refusal unrelated to adverse event|5|||
146157592|NCT02270450|527086740|FG003|Overall Study|Refusal unrelated to adverse event|14|||
146157593|NCT02270450|527086737|FG000|Overall Study|Progression/relapse|1|||
146157594|NCT02270450|527086738|FG001|Overall Study|Progression/relapse|2|||
146157595|NCT02270450|527086739|FG002|Overall Study|Progression/relapse|4|||
146157596|NCT02270450|527086740|FG003|Overall Study|Progression/relapse|9|||
146157597|NCT02270450|527086737|FG000|Overall Study|Death|19|||
146157598|NCT02270450|527086738|FG001|Overall Study|Death|19|||
146157599|NCT02270450|527086739|FG002|Overall Study|Death|31|||
146157600|NCT02270450|527086740|FG003|Overall Study|Death|59|||
146157601|NCT02363738|527086742|FG000|Overall Study|Adverse Event|5|||
146157602|NCT02363738|527086743|FG001|Overall Study|Adverse Event|2|||
146157603|NCT02363738|527086742|FG000|Overall Study|Lack of Efficacy|1|||
146157604|NCT02363738|527086743|FG001|Overall Study|Lack of Efficacy|2|||
146157605|NCT02363738|527086742|FG000|Overall Study|Lost to Follow-up|2|||
146157606|NCT02363738|527086743|FG001|Overall Study|Lost to Follow-up|1|||
146157607|NCT02187991|527086744|FG000|Overall Study|Adverse Event|13|||
146157608|NCT02187991|527086745|FG001|Overall Study|Adverse Event|14|||
146157609|NCT02187991|527086746|FG002|Overall Study|Adverse Event|3|||
146157610|NCT02187991|527086747|FG003|Overall Study|Adverse Event|2|||
146157611|NCT02187991|527086744|FG000|Overall Study|Withdrawal by Subject|9|||
146157612|NCT02187991|527086745|FG001|Overall Study|Withdrawal by Subject|6|||
146157613|NCT02187991|527086746|FG002|Overall Study|Withdrawal by Subject|3|||
146157614|NCT02187991|527086747|FG003|Overall Study|Withdrawal by Subject|2|||
146157615|NCT02187991|527086744|FG000|Overall Study|Physician Decision|4|||
146157616|NCT02187991|527086745|FG001|Overall Study|Physician Decision|4|||
146157617|NCT02187991|527086746|FG002|Overall Study|Physician Decision|0|||
146157618|NCT02187991|527086747|FG003|Overall Study|Physician Decision|2|||
146157619|NCT02187991|527086744|FG000|Overall Study|Other, unrelated complication|7|||
146157620|NCT02187991|527086745|FG001|Overall Study|Other, unrelated complication|1|||
146157621|NCT02187991|527086746|FG002|Overall Study|Other, unrelated complication|1|||
146157622|NCT02187991|527086747|FG003|Overall Study|Other, unrelated complication|2|||
146157623|NCT02187991|527086744|FG000|Overall Study|Death|1|||
146157624|NCT02187991|527086745|FG001|Overall Study|Death|3|||
146157625|NCT02187991|527086746|FG002|Overall Study|Death|0|||
146157626|NCT02187991|527086747|FG003|Overall Study|Death|0|||
146157627|NCT01392560|527086748|FG000|Overall Study|Adverse Event|2|||
146157628|NCT01392560|527086748|FG000|Overall Study|not entered|8|||
146157629|NCT01392560|527086748|FG000|Overall Study|discontinued during placebo run-in|2|||
146157630|NCT02081846|527086751|FG000|Overall Study|Withdrawal by Subject|1|||
146157631|NCT02081846|527086752|FG001|Overall Study|Withdrawal by Subject|0|||
146157632|NCT02081846|527086751|FG000|Overall Study|invalid consent|1|||
146157633|NCT02081846|527086752|FG001|Overall Study|invalid consent|0|||
146157634|NCT01939028|527086753|FG000|Overall Study|Withdrawal by Subject|5|||
146157635|NCT01939028|527086753|FG000|Overall Study|Physician Decision|7|||
146157636|NCT00092131|527086758|FG000|Treatment Period I|Adverse Event|1|||
146157637|NCT00092131|527086759|FG001|Treatment Period I|Adverse Event|0|||
146157638|NCT00092131|527086758|FG000|Treatment Period II|Adverse Event|0|||
146157639|NCT00092131|527086759|FG001|Treatment Period II|Adverse Event|1|||
146157640|NCT02372409|527086762|FG000|Overall Study|Lost to Follow-up|1|||
146157641|NCT02372409|527086763|FG001|Overall Study|Lost to Follow-up|0|||
146157642|NCT02372409|527086762|FG000|Overall Study|Disease progression|1|||
146157643|NCT02372409|527086763|FG001|Overall Study|Disease progression|1|||
146157644|NCT01808313|527086764|FG000|Overall Study|Adverse Event|5|||
146157645|NCT01808313|527086764|FG000|Overall Study|Protocol Violation|2|||
146157646|NCT01808313|527086764|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146157647|NCT01808313|527086764|FG000|Overall Study|Lost to Follow-up|1|||
146157648|NCT01808313|527086764|FG000|Overall Study|Physician Decision|1|||
146157649|NCT04656847|527086767|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
146157650|NCT03301051|527086768|FG000|Overall Study|Adverse Event|0|||
146157651|NCT03301051|527086769|FG001|Overall Study|Adverse Event|4|||
146157652|NCT03301051|527086768|FG000|Overall Study|Withdrawal by Subject|59|||
146157653|NCT03301051|527086769|FG001|Overall Study|Withdrawal by Subject|65|||
146157654|NCT03301051|527086768|FG000|Overall Study|Lost to Follow-up|263|||
146157655|NCT03301051|527086769|FG001|Overall Study|Lost to Follow-up|282|||
146157656|NCT03301051|527086768|FG000|Overall Study|Protocol Violation|1|||
146157657|NCT03301051|527086769|FG001|Overall Study|Protocol Violation|3|||
146157658|NCT03301051|527086768|FG000|Overall Study|Physician Decision|1|||
146157659|NCT03301051|527086769|FG001|Overall Study|Physician Decision|3|||
146157660|NCT03301051|527086768|FG000|Overall Study|Death|1|||
146157661|NCT03301051|527086769|FG001|Overall Study|Death|1|||
146157662|NCT03301051|527086768|FG000|Overall Study|Miscellaneous|8|||
146157663|NCT03301051|527086769|FG001|Overall Study|Miscellaneous|4|||
146157664|NCT03301051|527086768|FG000|Overall Study|Randomized, not vaccinated|13|||
146157665|NCT03301051|527086769|FG001|Overall Study|Randomized, not vaccinated|10|||
146157666|NCT00622167|527086770|FG000|Overall Study|Did not meet angiographic criteria|20|||
146157667|NCT03943095|527086773|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
146157668|NCT03943095|527086774|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
146157669|NCT03943095|527086773|FG000|Overall Study|Withdrawal by Subject|1|||
146157670|NCT03943095|527086774|FG001|Overall Study|Withdrawal by Subject|0|||
146157671|NCT03034577|527086785|FG000|Overall Study|Withdrawal by Subject|6|||
146157672|NCT03034577|527086786|FG001|Overall Study|Withdrawal by Subject|9|||
146157673|NCT03034577|527086785|FG000|Overall Study|Lost to Follow-up|25|||
146157674|NCT03034577|527086786|FG001|Overall Study|Lost to Follow-up|26|||
146157675|NCT04177758|527086787|FG000|Overall Study|Lost to Follow-up|19|||
146157676|NCT04177758|527086788|FG001|Overall Study|Lost to Follow-up|11|||
146157677|NCT02625623|527086789|FG000|Overall Study|Participants randomized but not treated|9|||
146157678|NCT02625623|527086790|FG001|Overall Study|Participants randomized but not treated|1|||
146157679|NCT03826667|527086791|FG000|Overall Study|Protocol deviation|21|||
146157680|NCT02352948|527086795|FG000|Overall Study|Death|47|||
146157681|NCT02352948|527086796|FG001|Overall Study|Death|48|||
146157682|NCT02352948|527086797|FG002|Overall Study|Death|114|||
146157683|NCT02352948|527086798|FG003|Overall Study|Death|74|||
146157684|NCT02352948|527086799|FG004|Overall Study|Death|77|||
146157685|NCT02352948|527086800|FG005|Overall Study|Death|44|||
146157686|NCT02352948|527086795|FG000|Overall Study|Lost to Follow-up|1|||
146157687|NCT02352948|527086796|FG001|Overall Study|Lost to Follow-up|0|||
146157688|NCT02352948|527086797|FG002|Overall Study|Lost to Follow-up|2|||
146157689|NCT02352948|527086798|FG003|Overall Study|Lost to Follow-up|1|||
146157690|NCT02352948|527086799|FG004|Overall Study|Lost to Follow-up|2|||
146157691|NCT02352948|527086800|FG005|Overall Study|Lost to Follow-up|1|||
146157692|NCT02352948|527086795|FG000|Overall Study|Withdrawal by Subject|1|||
146157693|NCT02352948|527086796|FG001|Overall Study|Withdrawal by Subject|10|||
146157694|NCT02352948|527086797|FG002|Overall Study|Withdrawal by Subject|11|||
146157695|NCT02352948|527086798|FG003|Overall Study|Withdrawal by Subject|23|||
146157696|NCT02352948|527086799|FG004|Overall Study|Withdrawal by Subject|9|||
146157697|NCT02352948|527086800|FG005|Overall Study|Withdrawal by Subject|4|||
146157698|NCT02352948|527086795|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146157699|NCT02352948|527086796|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146157700|NCT02352948|527086797|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
146157701|NCT02352948|527086798|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
146157702|NCT02352948|527086799|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
146157703|NCT02352948|527086800|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
146157704|NCT02352948|527086795|FG000|Overall Study|Other|0|||
146157705|NCT02352948|527086796|FG001|Overall Study|Other|0|||
146157706|NCT02352948|527086797|FG002|Overall Study|Other|2|||
146157707|NCT02352948|527086798|FG003|Overall Study|Other|0|||
146157708|NCT02352948|527086799|FG004|Overall Study|Other|0|||
146157709|NCT02352948|527086800|FG005|Overall Study|Other|0|||
146157710|NCT00679939|527086801|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
146157711|NCT00679939|527086802|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
146157712|NCT00679939|527086801|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
146157713|NCT00679939|527086802|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
146157714|NCT00679939|527086801|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
146157715|NCT00679939|527086802|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
146157716|NCT00679939|527086801|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
146157717|NCT00679939|527086802|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
146157718|NCT00679939|527086801|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
146157719|NCT00679939|527086802|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
146157720|NCT00679939|527086801|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
146157721|NCT00679939|527086802|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
146157722|NCT00679939|527086801|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
146157723|NCT00679939|527086802|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
146157724|NCT00679939|527086801|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
146157725|NCT00679939|527086802|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
146157726|NCT00679939|527086801|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
146157727|NCT00679939|527086802|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
146157728|NCT00679939|527086801|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
146157729|NCT00679939|527086802|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
146157730|NCT02313428|527086806|FG000|Overall Study|Lost to Follow-up|1|||
146157731|NCT02313428|527086807|FG001|Overall Study|Lost to Follow-up|1|||
146157732|NCT05374421|527086808|FG000|Overall Study|Withdrawal by Subject|3|||
146157733|NCT05374421|527086809|FG001|Overall Study|Withdrawal by Subject|4|||
146157734|NCT04370054|527086812|FG000|Treatment Phase|Lost to Follow-up|1|||
146157735|NCT04370054|527086812|FG000|Treatment Phase|Withdrawal by Subject|1|||
146157736|NCT04370054|527086812|FG000|Follow-Up Phase|Ongoing|75|||
146157737|NCT04657211|527086813|FG000|Overall Study|Withdrawal by Subject|21|||
146157738|NCT04657211|527086813|FG000|Overall Study|Lost to Follow-up|113|||
146157739|NCT04657211|527086813|FG000|Overall Study|Death|47|||
146157740|NCT04657211|527086813|FG000|Overall Study|Transfer to another institution|21|||
146157741|NCT04657211|527086813|FG000|Overall Study|Other|29|||
146157742|NCT01962493|527086815|FG000|Overall Study|Adverse Event|1|||
146157743|NCT01962493|527086816|FG001|Overall Study|Adverse Event|2|||
146157744|NCT01962493|527086815|FG000|Overall Study|Protocol Violation|0|||
146157745|NCT01962493|527086816|FG001|Overall Study|Protocol Violation|1|||
146157746|NCT01962493|527086815|FG000|Overall Study|Withdrawal by Subject|4|||
146157747|NCT01962493|527086816|FG001|Overall Study|Withdrawal by Subject|2|||
146157748|NCT02979639|527088568|FG000|Overall Study|Withdrawal based on medical judgement|1|||
146157749|NCT02979639|527088568|FG000|Overall Study|Lost to Follow-up|8|||
146157750|NCT02979639|527088568|FG000|Overall Study|Withdrawal by Subject|3|||
146157751|NCT02979639|527088568|FG000|Overall Study|Adverse Event|2|||
146157752|NCT02985866|527088579|FG000|Overall Study|Poor CGM data|1|||
146157753|NCT02985866|527088580|FG001|Overall Study|Poor CGM data|1|||
146157754|NCT04402866|527088587|FG000|Overall Study|Discontinued Prior to Treatment|0|||
146157755|NCT04402866|527088588|FG001|Overall Study|Discontinued Prior to Treatment|0|||
146157756|NCT04402866|527088589|FG002|Overall Study|Discontinued Prior to Treatment|0|||
146157757|NCT04402866|527088590|FG003|Overall Study|Discontinued Prior to Treatment|0|||
146157758|NCT04402866|527088591|FG004|Overall Study|Discontinued Prior to Treatment|2|||
146157759|NCT04402866|527088592|FG005|Overall Study|Discontinued Prior to Treatment|3|||
146157760|NCT04402866|527088587|FG000|Overall Study|Adverse Event|2|||
146157761|NCT04402866|527088588|FG001|Overall Study|Adverse Event|1|||
146157762|NCT04402866|527088589|FG002|Overall Study|Adverse Event|0|||
146157763|NCT04402866|527088590|FG003|Overall Study|Adverse Event|0|||
146157764|NCT04402866|527088591|FG004|Overall Study|Adverse Event|13|||
146157765|NCT04402866|527088592|FG005|Overall Study|Adverse Event|8|||
146157766|NCT04402866|527088587|FG000|Overall Study|Miscellaneous|0|||
146157767|NCT04402866|527088588|FG001|Overall Study|Miscellaneous|0|||
146157768|NCT04402866|527088589|FG002|Overall Study|Miscellaneous|1|||
146157769|NCT04402866|527088590|FG003|Overall Study|Miscellaneous|0|||
146157770|NCT04402866|527088591|FG004|Overall Study|Miscellaneous|0|||
146157771|NCT04402866|527088592|FG005|Overall Study|Miscellaneous|0|||
146157772|NCT04402866|527088587|FG000|Overall Study|Lost to Follow-up|0|||
146157773|NCT04402866|527088588|FG001|Overall Study|Lost to Follow-up|0|||
146157774|NCT04402866|527088589|FG002|Overall Study|Lost to Follow-up|0|||
146157775|NCT04402866|527088590|FG003|Overall Study|Lost to Follow-up|0|||
146157776|NCT04402866|527088591|FG004|Overall Study|Lost to Follow-up|0|||
146157777|NCT04402866|527088592|FG005|Overall Study|Lost to Follow-up|1|||
146157778|NCT04402866|527088587|FG000|Overall Study|Withdrawal by Subject|0|||
146157779|NCT04402866|527088588|FG001|Overall Study|Withdrawal by Subject|0|||
146157780|NCT04402866|527088589|FG002|Overall Study|Withdrawal by Subject|0|||
146157781|NCT04402866|527088590|FG003|Overall Study|Withdrawal by Subject|0|||
146157782|NCT04402866|527088591|FG004|Overall Study|Withdrawal by Subject|0|||
146157783|NCT04402866|527088592|FG005|Overall Study|Withdrawal by Subject|2|||
146157784|NCT03647501|527088593|FG000|Overall Study|Lost to Follow-up|1|||
146157785|NCT03647501|527088594|FG001|Overall Study|Lost to Follow-up|1|||
146157786|NCT03647501|527088593|FG000|Overall Study|Withdrawal by Subject|0|||
146157787|NCT03647501|527088594|FG001|Overall Study|Withdrawal by Subject|1|||
146157788|NCT01324271|527088603|FG000|Overall Study|Lost to Follow-up|3|||
146157789|NCT01324271|527088604|FG001|Overall Study|Lost to Follow-up|0|||
146157790|NCT01324271|527088603|FG000|Overall Study|Physician Decision|1|||
146157791|NCT01324271|527088604|FG001|Overall Study|Physician Decision|0|||
146157792|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
146157793|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
146157794|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
146157795|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
146157796|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
146157797|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
146157798|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
146157799|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
146157800|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
146157801|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
146157802|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
146157803|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
146157804|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
146157805|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
146157806|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
146157807|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
146157808|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
146157809|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
146157810|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
146157811|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
146157812|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
146157813|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146157814|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146157815|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
146157816|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
146157817|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146157818|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146157819|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
146157820|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146157821|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146157822|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
146157823|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
146157824|NCT04818346|527088605|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146157825|NCT04818346|527088606|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146157826|NCT04818346|527088607|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
146157827|NCT04818346|527088608|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
146157828|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
146157829|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
146309954|NCT03917823|527648656|FG000|Overall Study|Lost to Follow-up|1|||
146157830|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
146157831|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
146157832|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146157833|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
146157834|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146157835|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
146157836|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
146157837|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
146157838|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
146157839|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
146157840|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
146157841|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
146157842|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
146157843|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
146157844|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146157845|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
146157846|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146157847|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
146157848|NCT04818346|527088605|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146157849|NCT04818346|527088606|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146157850|NCT04818346|527088607|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
146157851|NCT04818346|527088608|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
146157852|NCT00492284|527088609|FG000|Overall Study|Adverse Event|0|||
146157853|NCT00492284|527088610|FG001|Overall Study|Adverse Event|1|||
146157854|NCT00492284|527088611|FG002|Overall Study|Adverse Event|1|||
146157855|NCT00492284|527088612|FG003|Overall Study|Adverse Event|2|||
146157856|NCT00492284|527088609|FG000|Overall Study|Lost to Follow-up|0|||
146157857|NCT00492284|527088610|FG001|Overall Study|Lost to Follow-up|0|||
146157858|NCT00492284|527088611|FG002|Overall Study|Lost to Follow-up|3|||
146157859|NCT00492284|527088612|FG003|Overall Study|Lost to Follow-up|1|||
146157860|NCT00492284|527088609|FG000|Overall Study|Death|0|||
146157861|NCT00492284|527088610|FG001|Overall Study|Death|3|||
146157862|NCT00492284|527088611|FG002|Overall Study|Death|2|||
146157863|NCT00492284|527088612|FG003|Overall Study|Death|5|||
146157864|NCT00492284|527088609|FG000|Overall Study|Withdrawal by Subject|1|||
146157865|NCT00492284|527088610|FG001|Overall Study|Withdrawal by Subject|0|||
146157866|NCT00492284|527088611|FG002|Overall Study|Withdrawal by Subject|0|||
146157867|NCT00492284|527088612|FG003|Overall Study|Withdrawal by Subject|2|||
146157868|NCT03695172|527088613|FG000|Overall Study|Withdrawal by Subject|1|||
146157869|NCT03695172|527088614|FG001|Overall Study|Withdrawal by Subject|1|||
146157870|NCT03695172|527088615|FG002|Overall Study|Withdrawal by Subject|0|||
146157871|NCT02734212|527088616|FG000|Overall Study|Lost to Follow-up|5|||
146157872|NCT02734212|527088617|FG001|Overall Study|Lost to Follow-up|10|||
146157873|NCT04313881|527088620|FG000|Overall Study|Death|138|||
146157874|NCT04313881|527088621|FG001|Overall Study|Death|126|||
146157875|NCT04313881|527088620|FG000|Overall Study|Study terminated by sponsor|108|||
146157876|NCT04313881|527088621|FG001|Overall Study|Study terminated by sponsor|129|||
146157877|NCT04313881|527088620|FG000|Overall Study|Consent withdrawn|19|||
146157878|NCT04313881|527088621|FG001|Overall Study|Consent withdrawn|15|||
146157879|NCT04313881|527088620|FG000|Overall Study|Reason not Specified|3|||
146157880|NCT04313881|527088621|FG001|Overall Study|Reason not Specified|1|||
146157881|NCT00727272|527088622|FG000|Washout Period A|Adverse Event|0|||
146157882|NCT00727272|527088623|FG001|Washout Period A|Adverse Event|0|||
146157883|NCT00727272|527088624|FG002|Washout Period A|Adverse Event|1|||
146157884|NCT00727272|527088622|FG000|Washout Period B|Withdrawal by Subject|0|||
146157885|NCT00727272|527088623|FG001|Washout Period B|Withdrawal by Subject|0|||
146157886|NCT00727272|527088624|FG002|Washout Period B|Withdrawal by Subject|1|||
146157887|NCT00651664|527088625|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
146157888|NCT00651664|527088626|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
146157889|NCT00651664|527088627|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
146157890|NCT00651664|527088628|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
146309955|NCT03917823|527648657|FG001|Overall Study|Lost to Follow-up|1|||
146309956|NCT03917823|527648656|FG000|Overall Study|Withdrawal by Subject|0|||
146157891|NCT00651664|527088629|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
146157892|NCT00651664|527088630|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
146157893|NCT00651664|527088631|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
146157894|NCT00651664|527088632|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
146157895|NCT00651664|527088633|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
146157896|NCT00651664|527088634|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
146157897|NCT00651664|527088625|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157898|NCT00651664|527088626|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157899|NCT00651664|527088627|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157900|NCT00651664|527088628|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157901|NCT00651664|527088629|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
146157902|NCT00651664|527088630|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
146157903|NCT00651664|527088631|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157904|NCT00651664|527088632|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
146157905|NCT00651664|527088633|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
146157906|NCT00651664|527088634|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
146157907|NCT00651664|527088625|FG000|Overall Study|Progressive Disease|3|||
146157908|NCT00651664|527088626|FG001|Overall Study|Progressive Disease|3|||
146157909|NCT00651664|527088627|FG002|Overall Study|Progressive Disease|3|||
146157910|NCT00651664|527088628|FG003|Overall Study|Progressive Disease|12|||
146157911|NCT00651664|527088629|FG004|Overall Study|Progressive Disease|4|||
146157912|NCT00651664|527088630|FG005|Overall Study|Progressive Disease|1|||
146157913|NCT00651664|527088631|FG006|Overall Study|Progressive Disease|3|||
146157914|NCT00651664|527088632|FG007|Overall Study|Progressive Disease|6|||
146157915|NCT00651664|527088633|FG008|Overall Study|Progressive Disease|5|||
146157916|NCT00651664|527088634|FG009|Overall Study|Progressive Disease|5|||
146157917|NCT00651664|527088625|FG000|Overall Study|Patient Declined Further Treatment|0|||
146157918|NCT00651664|527088626|FG001|Overall Study|Patient Declined Further Treatment|0|||
146157919|NCT00651664|527088627|FG002|Overall Study|Patient Declined Further Treatment|0|||
146157920|NCT00651664|527088628|FG003|Overall Study|Patient Declined Further Treatment|1|||
146157921|NCT00651664|527088629|FG004|Overall Study|Patient Declined Further Treatment|1|||
146157922|NCT00651664|527088630|FG005|Overall Study|Patient Declined Further Treatment|1|||
146157923|NCT00651664|527088631|FG006|Overall Study|Patient Declined Further Treatment|0|||
146157924|NCT00651664|527088632|FG007|Overall Study|Patient Declined Further Treatment|0|||
146157925|NCT00651664|527088633|FG008|Overall Study|Patient Declined Further Treatment|0|||
146157926|NCT00651664|527088634|FG009|Overall Study|Patient Declined Further Treatment|1|||
146157927|NCT00651664|527088625|FG000|Overall Study|Symptomatic Deterioration|0|||
146157928|NCT00651664|527088626|FG001|Overall Study|Symptomatic Deterioration|0|||
146157929|NCT00651664|527088627|FG002|Overall Study|Symptomatic Deterioration|0|||
146157930|NCT00651664|527088628|FG003|Overall Study|Symptomatic Deterioration|1|||
146157931|NCT00651664|527088629|FG004|Overall Study|Symptomatic Deterioration|0|||
146157932|NCT00651664|527088630|FG005|Overall Study|Symptomatic Deterioration|0|||
146157933|NCT00651664|527088631|FG006|Overall Study|Symptomatic Deterioration|1|||
146157934|NCT00651664|527088632|FG007|Overall Study|Symptomatic Deterioration|0|||
146157935|NCT00651664|527088633|FG008|Overall Study|Symptomatic Deterioration|1|||
146157936|NCT00651664|527088634|FG009|Overall Study|Symptomatic Deterioration|0|||
146157937|NCT00651664|527088625|FG000|Overall Study|Reason not Specified|0|||
146157938|NCT00651664|527088626|FG001|Overall Study|Reason not Specified|0|||
146157939|NCT00651664|527088627|FG002|Overall Study|Reason not Specified|0|||
146157940|NCT00651664|527088628|FG003|Overall Study|Reason not Specified|0|||
146157941|NCT00651664|527088629|FG004|Overall Study|Reason not Specified|0|||
146157942|NCT00651664|527088630|FG005|Overall Study|Reason not Specified|0|||
146157943|NCT00651664|527088631|FG006|Overall Study|Reason not Specified|1|||
146157944|NCT00651664|527088632|FG007|Overall Study|Reason not Specified|0|||
146157945|NCT00651664|527088633|FG008|Overall Study|Reason not Specified|0|||
146157946|NCT00651664|527088634|FG009|Overall Study|Reason not Specified|0|||
146157947|NCT00688636|527088635|FG000|Overall Study|Adverse Event|2|||
146157948|NCT00688636|527088636|FG001|Overall Study|Adverse Event|1|||
146157949|NCT01572727|527088637|FG000|Overall Study|Adverse Event|43|||
146157950|NCT01572727|527088638|FG001|Overall Study|Adverse Event|15|||
146157951|NCT01572727|527088637|FG000|Overall Study|Lost to Follow-up|1|||
146157952|NCT01572727|527088638|FG001|Overall Study|Lost to Follow-up|1|||
146157953|NCT01572727|527088637|FG000|Overall Study|Physician Decision|23|||
146157954|NCT01572727|527088638|FG001|Overall Study|Physician Decision|9|||
146157955|NCT01572727|527088637|FG000|Overall Study|Progressive disease|59|||
146157956|NCT01572727|527088638|FG001|Overall Study|Progressive disease|82|||
146157957|NCT01572727|527088637|FG000|Overall Study|Protocol Violation|0|||
146157958|NCT01572727|527088638|FG001|Overall Study|Protocol Violation|1|||
146157959|NCT01572727|527088637|FG000|Overall Study|Study terminated by sponsor|61|||
146157960|NCT01572727|527088638|FG001|Overall Study|Study terminated by sponsor|83|||
146157961|NCT01572727|527088637|FG000|Overall Study|Parent/guardian decision|14|||
146157962|NCT01572727|527088638|FG001|Overall Study|Parent/guardian decision|9|||
146157963|NCT01572727|527088637|FG000|Overall Study|Death|2|||
146157964|NCT01572727|527088638|FG001|Overall Study|Death|2|||
146157965|NCT01572727|527088637|FG000|Overall Study|Untreated|4|||
146157966|NCT01572727|527088638|FG001|Overall Study|Untreated|7|||
146157967|NCT04053764|527088639|FG000|Overall Study|Withdrawal by Subject|6|||
146157968|NCT04053764|527088640|FG001|Overall Study|Withdrawal by Subject|2|||
146157969|NCT04053764|527088639|FG000|Overall Study|Physician Decision|2|||
146157970|NCT04053764|527088640|FG001|Overall Study|Physician Decision|1|||
146157971|NCT04053764|527088639|FG000|Overall Study|Adverse Event|1|||
146157972|NCT04053764|527088640|FG001|Overall Study|Adverse Event|0|||
146157973|NCT04053764|527088639|FG000|Overall Study|Pregnancy|1|||
146157974|NCT04053764|527088640|FG001|Overall Study|Pregnancy|0|||
146157975|NCT04732286|527088641|FG000|Overall Study|Progressive Disease|2|||
146157976|NCT04732286|527088641|FG000|Overall Study|Physician Decision|1|||
146157977|NCT04732286|527088641|FG000|Overall Study|Study Terminated by Sponsor|31|||
146157978|NCT04732286|527088641|FG000|Overall Study|Withdrawal by Subject|10|||
146157979|NCT04732286|527088641|FG000|Overall Study|Non-compliance With Study Drug|1|||
146157980|NCT04732286|527088641|FG000|Overall Study|Lost to Follow-up|4|||
146157981|NCT04732286|527088641|FG000|Overall Study|Death|51|||
146157982|NCT01474681|527088642|FG000|Overall Study|Death|0|||
146157983|NCT01474681|527088643|FG001|Overall Study|Death|3|||
146157984|NCT01474681|527088644|FG002|Overall Study|Death|2|||
146157985|NCT01474681|527088645|FG003|Overall Study|Death|6|||
146157986|NCT00322348|527088650|FG000|Overall Study|Adverse Event|0|||
146157987|NCT00322348|527088651|FG001|Overall Study|Adverse Event|1|||
146157988|NCT00322348|527088650|FG000|Overall Study|Withdrawal by Subject|1|||
146157989|NCT00322348|527088651|FG001|Overall Study|Withdrawal by Subject|4|||
146157990|NCT00322348|527088650|FG000|Overall Study|Lost to Follow-up|1|||
146157991|NCT00322348|527088651|FG001|Overall Study|Lost to Follow-up|0|||
146157992|NCT00322348|527088650|FG000|Overall Study|Death|0|||
146157993|NCT00322348|527088651|FG001|Overall Study|Death|2|||
146157994|NCT00322348|527088650|FG000|Overall Study|Disease Progression|30|||
146157995|NCT00322348|527088651|FG001|Overall Study|Disease Progression|25|||
146157996|NCT00322348|527088650|FG000|Overall Study|Reasons not specified|5|||
146157997|NCT00322348|527088651|FG001|Overall Study|Reasons not specified|1|||
146157998|NCT00936858|527088652|FG000|Overall Study|Death|3|||
146157999|NCT00936858|527088652|FG000|Overall Study|Progression|29|||
146158000|NCT00936858|527088652|FG000|Overall Study|Withdrawal by Subject|5|||
146158001|NCT00936858|527088652|FG000|Overall Study|Adverse Event|1|||
146158002|NCT00936858|527088652|FG000|Overall Study|Physician Decision|7|||
146158003|NCT00936858|527088652|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
146158004|NCT00936858|527088652|FG000|Overall Study|Lost to Follow-up|1|||
146158005|NCT00989287|527088664|FG000|Overall Study|Adverse Event|1|||
146158006|NCT00989287|527088665|FG001|Overall Study|Adverse Event|0|||
146158007|NCT00989287|527088664|FG000|Overall Study|Lost to Follow-up|0|||
146158008|NCT00989287|527088665|FG001|Overall Study|Lost to Follow-up|1|||
146158009|NCT02341417|527088666|FG000|Overall Study|Withdrawal by Subject|0|||
146158010|NCT02341417|527088667|FG001|Overall Study|Withdrawal by Subject|2|||
146158011|NCT02341417|527088668|FG002|Overall Study|Withdrawal by Subject|0|||
146158012|NCT02341417|527088666|FG000|Overall Study|Decision by sponsor|2|||
146158013|NCT02341417|527088667|FG001|Overall Study|Decision by sponsor|0|||
146158014|NCT02341417|527088668|FG002|Overall Study|Decision by sponsor|0|||
146158015|NCT02341417|527088666|FG000|Overall Study|Death|0|||
146158016|NCT02341417|527088667|FG001|Overall Study|Death|0|||
146158017|NCT02341417|527088668|FG002|Overall Study|Death|1|||
146158018|NCT01857531|527088682|FG000|Overall Study|Withdrawal by Subject|4|||
146158019|NCT02576067|527088683|FG000|Overall Study|Death|0|||
146158020|NCT02576067|527088684|FG001|Overall Study|Death|1|||
146158021|NCT02576067|527088683|FG000|Overall Study|Lack of Efficacy|1|||
146158022|NCT02576067|527088684|FG001|Overall Study|Lack of Efficacy|0|||
146158023|NCT02576067|527088683|FG000|Overall Study|Lost to Follow-up|11|||
146158024|NCT02576067|527088684|FG001|Overall Study|Lost to Follow-up|0|||
146158025|NCT02576067|527088683|FG000|Overall Study|Withdrawal by Subject|11|||
146158026|NCT02576067|527088684|FG001|Overall Study|Withdrawal by Subject|2|||
146158027|NCT02576067|527088683|FG000|Overall Study|study closure of main CIRT trial)|0|||
146158028|NCT02576067|527088684|FG001|Overall Study|study closure of main CIRT trial)|8|||
146158029|NCT02576067|527088683|FG000|Overall Study|not randomized, failed run-in|7|||
146158030|NCT02576067|527088684|FG001|Overall Study|not randomized, failed run-in|0|||
146158031|NCT02576067|527088683|FG000|Overall Study|screen failure/ re-enrolled|0|||
146158032|NCT02576067|527088684|FG001|Overall Study|screen failure/ re-enrolled|25|||
146158033|NCT02576067|527088683|FG000|Overall Study|Physician Decision|4|||
146158034|NCT02576067|527088684|FG001|Overall Study|Physician Decision|0|||
146158035|NCT03570619|527088685|FG000|Overall Study|Adverse Event|2|||
146158036|NCT03570619|527088686|FG001|Overall Study|Adverse Event|0|||
146158037|NCT03570619|527088687|FG002|Overall Study|Adverse Event|1|||
146158038|NCT03570619|527088685|FG000|Overall Study|new diagnosis of new malignancy|1|||
146158039|NCT03570619|527088686|FG001|Overall Study|new diagnosis of new malignancy|0|||
146158040|NCT03570619|527088687|FG002|Overall Study|new diagnosis of new malignancy|0|||
146158041|NCT03570619|527088685|FG000|Overall Study|Physician Decision|1|||
146158042|NCT03570619|527088686|FG001|Overall Study|Physician Decision|1|||
146158043|NCT03570619|527088687|FG002|Overall Study|Physician Decision|0|||
146158044|NCT03570619|527088685|FG000|Overall Study|Withdrawal by Subject|0|||
146158045|NCT03570619|527088686|FG001|Overall Study|Withdrawal by Subject|2|||
146158046|NCT03570619|527088687|FG002|Overall Study|Withdrawal by Subject|0|||
146158047|NCT04773587|527088688|FG000|Overall Study|Lost to Follow-up|11|||
146158048|NCT04773587|527088689|FG001|Overall Study|Lost to Follow-up|3|||
146158049|NCT04773587|527088688|FG000|Overall Study|Adverse Event|6|||
146158050|NCT04773587|527088689|FG001|Overall Study|Adverse Event|3|||
146158051|NCT04773587|527088688|FG000|Overall Study|Lack of Efficacy|5|||
146158052|NCT04773587|527088689|FG001|Overall Study|Lack of Efficacy|2|||
146158053|NCT04773587|527088688|FG000|Overall Study|Withdrawal by Subject|4|||
146158054|NCT04773587|527088689|FG001|Overall Study|Withdrawal by Subject|5|||
146158055|NCT04773587|527088688|FG000|Overall Study|Noncompliance|1|||
146158056|NCT04773587|527088689|FG001|Overall Study|Noncompliance|0|||
146158057|NCT04773587|527088688|FG000|Overall Study|Protocol Violation|1|||
146158058|NCT04773587|527088689|FG001|Overall Study|Protocol Violation|0|||
146158059|NCT04773587|527088688|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
146158060|NCT04773587|527088689|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
146158061|NCT02820623|527088690|FG000|Overall Study|Withdrawal by Subject|1|||
146158062|NCT02820623|527088691|FG001|Overall Study|Withdrawal by Subject|3|||
146158063|NCT02820623|527088692|FG002|Overall Study|Withdrawal by Subject|3|||
146158064|NCT02820623|527088690|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
146158065|NCT02820623|527088691|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
146158066|NCT02820623|527088692|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
146158067|NCT02820623|527088690|FG000|Overall Study|Therapist unable to enroll clients|1|||
146158068|NCT02820623|527088691|FG001|Overall Study|Therapist unable to enroll clients|1|||
146158069|NCT02820623|527088692|FG002|Overall Study|Therapist unable to enroll clients|3|||
146158070|NCT02820623|527088690|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
146158071|NCT02820623|527088691|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
146158072|NCT02820623|527088692|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
146158073|NCT01954017|527088704|FG000|Overall Study|Adverse Event|0|||
146158074|NCT01954017|527088705|FG001|Overall Study|Adverse Event|0|||
146158075|NCT01954017|527088706|FG002|Overall Study|Adverse Event|1|||
146158076|NCT01954017|527088704|FG000|Overall Study|Death|2|||
146158077|NCT01954017|527088705|FG001|Overall Study|Death|1|||
146158078|NCT01954017|527088706|FG002|Overall Study|Death|1|||
146158079|NCT01954017|527088704|FG000|Overall Study|Withdrawal by Subject|0|||
146158080|NCT01954017|527088705|FG001|Overall Study|Withdrawal by Subject|1|||
146158081|NCT01954017|527088706|FG002|Overall Study|Withdrawal by Subject|0|||
146158082|NCT01954017|527088704|FG000|Overall Study|Protocol Violation|0|||
146158083|NCT01954017|527088705|FG001|Overall Study|Protocol Violation|3|||
146158084|NCT01954017|527088706|FG002|Overall Study|Protocol Violation|2|||
146158085|NCT01954017|527088704|FG000|Overall Study|Necrotizing enterocolitis|1|||
146158086|NCT01954017|527088705|FG001|Overall Study|Necrotizing enterocolitis|0|||
146158087|NCT01954017|527088706|FG002|Overall Study|Necrotizing enterocolitis|1|||
146158088|NCT01954017|527088704|FG000|Overall Study|Enteral intake stopped >7 days|0|||
146158089|NCT01954017|527088705|FG001|Overall Study|Enteral intake stopped >7 days|1|||
146158090|NCT01954017|527088706|FG002|Overall Study|Enteral intake stopped >7 days|1|||
146158091|NCT01954017|527088704|FG000|Overall Study|All other reasons|2|||
146158092|NCT01954017|527088705|FG001|Overall Study|All other reasons|2|||
146158093|NCT01954017|527088706|FG002|Overall Study|All other reasons|7|||
146158094|NCT04598152|527088707|FG000|Overall Study|Lost to Follow-up|0|||
146158095|NCT04598152|527088708|FG001|Overall Study|Lost to Follow-up|1|||
146158096|NCT03346759|527088709|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
146158097|NCT03346759|527088710|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
146158098|NCT03346759|527088709|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
146158099|NCT03346759|527088710|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
146158100|NCT03346759|527088709|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
146158101|NCT03346759|527088710|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
146158102|NCT00435370|527088711|FG000|Overall Study|Adverse Event|8|||
146158103|NCT00435370|527088712|FG001|Overall Study|Adverse Event|8|||
146158104|NCT00435370|527088711|FG000|Overall Study|Withdrawal by Subject|10|||
146158105|NCT00435370|527088712|FG001|Overall Study|Withdrawal by Subject|10|||
146158106|NCT00435370|527088711|FG000|Overall Study|Antipsychotic medication changed|4|||
146158107|NCT00435370|527088712|FG001|Overall Study|Antipsychotic medication changed|2|||
146158108|NCT01965834|527088714|FG000|Overall Study|Lack of Efficacy|4|||
146158109|NCT03674177|527088717|FG000|Overall Study|Lost to Follow-up|2|||
146158110|NCT03674177|527088718|FG001|Overall Study|Lost to Follow-up|1|||
146158111|NCT03674177|527088719|FG002|Overall Study|Lost to Follow-up|0|||
146158112|NCT03674177|527088720|FG003|Overall Study|Lost to Follow-up|2|||
146158113|NCT00714168|527088721|FG000|Overall Study|Pregnancy|5|||
146158114|NCT00714168|527088722|FG001|Overall Study|Pregnancy|4|||
146158115|NCT00714168|527088721|FG000|Overall Study|Lost to Follow-up|32|||
146158116|NCT00714168|527088722|FG001|Overall Study|Lost to Follow-up|50|||
146158117|NCT00714168|527088721|FG000|Overall Study|Relocation|4|||
146158118|NCT00714168|527088722|FG001|Overall Study|Relocation|3|||
146158119|NCT00714168|527088721|FG000|Overall Study|Non-study medical condition|3|||
146158120|NCT00714168|527088722|FG001|Overall Study|Non-study medical condition|2|||
146309957|NCT03917823|527648657|FG001|Overall Study|Withdrawal by Subject|1|||
146309958|NCT00135668|527648658|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
146309959|NCT00135668|527648659|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
146309960|NCT00135668|527648660|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
146158121|NCT04988308|527088723|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
146158122|NCT04988308|527088724|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146158123|NCT04988308|527088725|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
146158124|NCT04988308|527088726|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146158125|NCT04988308|527088727|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146158126|NCT04988308|527088728|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
146158127|NCT04988308|527088723|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146158128|NCT04988308|527088724|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146158129|NCT04988308|527088725|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
146158130|NCT04988308|527088726|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146158131|NCT04988308|527088727|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146158132|NCT04988308|527088728|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
146158133|NCT04988308|527088723|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
146158134|NCT04988308|527088724|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
146158135|NCT04988308|527088725|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146158136|NCT04988308|527088726|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146158137|NCT04988308|527088727|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146158138|NCT04988308|527088728|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
146158139|NCT04988308|527088723|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
146158140|NCT04988308|527088724|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
146158141|NCT04988308|527088725|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
146158142|NCT04988308|527088726|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146158143|NCT04988308|527088727|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146158144|NCT04988308|527088728|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
146158145|NCT04988308|527088723|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
146158146|NCT04988308|527088724|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
146158147|NCT04988308|527088725|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
146158148|NCT04988308|527088726|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146158149|NCT04988308|527088727|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146158150|NCT04988308|527088728|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
146158151|NCT04988308|527088723|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146158152|NCT04988308|527088724|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146158153|NCT04988308|527088725|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
146158154|NCT04988308|527088726|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
146158155|NCT04988308|527088727|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
146158156|NCT04988308|527088728|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
146158157|NCT04988308|527088723|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146158158|NCT04988308|527088724|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146158159|NCT04988308|527088725|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
146158160|NCT04988308|527088726|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146158161|NCT04988308|527088727|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
146158162|NCT04988308|527088728|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
146158163|NCT04988308|527088723|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146158164|NCT04988308|527088724|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146158165|NCT04988308|527088725|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
146158166|NCT04988308|527088726|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
146158167|NCT04988308|527088727|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
146158168|NCT04988308|527088728|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
146158169|NCT04988308|527088723|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146158170|NCT04988308|527088724|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146158171|NCT04988308|527088725|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
146158172|NCT04988308|527088726|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
146158173|NCT04988308|527088727|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
146158174|NCT04988308|527088728|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
146158175|NCT00744653|527088733|FG000|Overall Study|antineoplastic treatment|11|||
146158176|NCT00744653|527088733|FG000|Overall Study|Death|1|||
146158177|NCT00744653|527088733|FG000|Overall Study|Lost to Follow-up|1|||
146158178|NCT00744653|527088733|FG000|Overall Study|Physician Decision|3|||
146158179|NCT01453595|527088735|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146158180|NCT01453595|527088736|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146158181|NCT01453595|527088737|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146158182|NCT01864564|527088743|FG000|Overall Study|Lost to Follow-up|17|||
146158183|NCT01864564|527088744|FG001|Overall Study|Lost to Follow-up|23|||
146158184|NCT01864564|527088743|FG000|Overall Study|Withdrawal by Subject|20|||
146158185|NCT01864564|527088744|FG001|Overall Study|Withdrawal by Subject|11|||
146158186|NCT01864564|527088743|FG000|Overall Study|Protocol Violation|0|||
146158187|NCT01864564|527088744|FG001|Overall Study|Protocol Violation|27|||
146158188|NCT01864564|527088743|FG000|Overall Study|not reported|0|||
146158189|NCT01864564|527088744|FG001|Overall Study|not reported|34|||
146158190|NCT03077724|527088745|FG000|Overall Study|Lost to Follow-up|5|||
146158191|NCT03077724|527088746|FG001|Overall Study|Lost to Follow-up|1|||
146158192|NCT03077724|527088745|FG000|Overall Study|Withdrawal by Subject|3|||
146158193|NCT03077724|527088746|FG001|Overall Study|Withdrawal by Subject|1|||
146158194|NCT02269670|527088747|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
146158195|NCT00710424|527088750|FG000|Overall Study|Adverse Event|30|||
146158196|NCT00710424|527088751|FG001|Overall Study|Adverse Event|12|||
146158197|NCT00710424|527088750|FG000|Overall Study|Lack of Efficacy|4|||
146158198|NCT00710424|527088751|FG001|Overall Study|Lack of Efficacy|5|||
146158199|NCT00710424|527088750|FG000|Overall Study|Withdrawal by Subject|5|||
146158200|NCT00710424|527088751|FG001|Overall Study|Withdrawal by Subject|3|||
146158201|NCT00710424|527088750|FG000|Overall Study|Lost to Follow-up|0|||
146158202|NCT00710424|527088751|FG001|Overall Study|Lost to Follow-up|1|||
146158203|NCT00710424|527088750|FG000|Overall Study|Refused medication, no side effects|1|||
146158204|NCT00710424|527088751|FG001|Overall Study|Refused medication, no side effects|0|||
146158205|NCT00710424|527088750|FG000|Overall Study|Non-compliance with stable analgesia|1|||
146158206|NCT00710424|527088751|FG001|Overall Study|Non-compliance with stable analgesia|0|||
146158207|NCT00710424|527088750|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
146158208|NCT00710424|527088751|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
146158209|NCT00710424|527088750|FG000|Overall Study|Subject thought medication changed|1|||
146158210|NCT00710424|527088751|FG001|Overall Study|Subject thought medication changed|0|||
146158211|NCT00710424|527088750|FG000|Overall Study|Ceased treatment due to travel|1|||
146158212|NCT00710424|527088751|FG001|Overall Study|Ceased treatment due to travel|0|||
146158213|NCT00710424|527088750|FG000|Overall Study|Subject preferred paracetamol|0|||
146158214|NCT00710424|527088751|FG001|Overall Study|Subject preferred paracetamol|1|||
146158215|NCT00710424|527088750|FG000|Overall Study|Felt good so stopped treatment|0|||
146158216|NCT00710424|527088751|FG001|Overall Study|Felt good so stopped treatment|1|||
146158217|NCT01738984|527090546|FG000|Overall Study|Pregnancy|4|||
146158218|NCT01738984|527090547|FG001|Overall Study|Pregnancy|0|||
146158219|NCT01738984|527090546|FG000|Overall Study|Withdrawal by Subject|1|||
146158220|NCT01738984|527090547|FG001|Overall Study|Withdrawal by Subject|0|||
146158221|NCT01738984|527090546|FG000|Overall Study|Lost to Follow-up|59|||
146158222|NCT01738984|527090547|FG001|Overall Study|Lost to Follow-up|39|||
146158223|NCT00955357|527090553|FG000|Titration Phase|Adverse Event|9|||
146158224|NCT00955357|527090554|FG001|Titration Phase|Adverse Event|46|||
146158225|NCT00955357|527090553|FG000|Titration Phase|Lack of Efficacy|0|||
146158226|NCT00955357|527090554|FG001|Titration Phase|Lack of Efficacy|2|||
146158227|NCT00955357|527090553|FG000|Titration Phase|Protocol Violation|3|||
146158228|NCT00955357|527090554|FG001|Titration Phase|Protocol Violation|7|||
146158229|NCT00955357|527090553|FG000|Titration Phase|Lost to Follow-up|1|||
146158230|NCT00955357|527090554|FG001|Titration Phase|Lost to Follow-up|3|||
146158231|NCT00955357|527090553|FG000|Titration Phase|Withdrawal by Subject|3|||
146158232|NCT00955357|527090554|FG001|Titration Phase|Withdrawal by Subject|5|||
146158233|NCT00955357|527090553|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
146158234|NCT00955357|527090554|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
146158235|NCT00955357|527090553|FG000|Titration Phase|Study medication not tolerated|0|||
146158236|NCT00955357|527090554|FG001|Titration Phase|Study medication not tolerated|1|||
146158237|NCT00955357|527090553|FG000|Titration Phase|Non compliance to study procedures|0|||
146158238|NCT00955357|527090554|FG001|Titration Phase|Non compliance to study procedures|1|||
146158239|NCT00955357|527090553|FG000|Maintenance Phase|Adverse Event|3|||
146158240|NCT00955357|527090554|FG001|Maintenance Phase|Adverse Event|23|||
146158241|NCT00955357|527090553|FG000|Maintenance Phase|Lack of Efficacy|0|||
146158242|NCT00955357|527090554|FG001|Maintenance Phase|Lack of Efficacy|4|||
146158243|NCT00955357|527090553|FG000|Maintenance Phase|Protocol Violation|2|||
146158244|NCT00955357|527090554|FG001|Maintenance Phase|Protocol Violation|6|||
146158245|NCT00955357|527090553|FG000|Maintenance Phase|Lost to Follow-up|2|||
146158246|NCT00955357|527090554|FG001|Maintenance Phase|Lost to Follow-up|7|||
146158247|NCT00955357|527090553|FG000|Maintenance Phase|Withdrawal by Subject|4|||
146158248|NCT00955357|527090554|FG001|Maintenance Phase|Withdrawal by Subject|4|||
146158249|NCT00955357|527090553|FG000|Maintenance Phase|Patient moving out of area|0|||
146158250|NCT00955357|527090554|FG001|Maintenance Phase|Patient moving out of area|1|||
146158251|NCT00955357|527090553|FG000|Maintenance Phase|Non compliance to study procedures|1|||
146158252|NCT00955357|527090554|FG001|Maintenance Phase|Non compliance to study procedures|0|||
146158253|NCT01258608|527090555|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
146158254|NCT01258608|527090556|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
146158255|NCT01258608|527090555|FG000|Overall Study|Clinical progression|1|||
146158256|NCT01258608|527090556|FG001|Overall Study|Clinical progression|0|||
146158257|NCT01258608|527090555|FG000|Overall Study|Sponsor decision|0|||
146309961|NCT00135668|527648661|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
146309962|NCT02424253|527648664|FG000|Overall Study|Other, unspecified|1|||
146309963|NCT02424253|527648665|FG001|Overall Study|Other, unspecified|0|||
146309964|NCT02424253|527648664|FG000|Overall Study|Compliance problems|1|||
146158258|NCT01258608|527090556|FG001|Overall Study|Sponsor decision|1|||
146158259|NCT01258608|527090555|FG000|Overall Study|Physician Decision|6|||
146158260|NCT01258608|527090556|FG001|Overall Study|Physician Decision|1|||
146158261|NCT01258608|527090555|FG000|Overall Study|Lost to Follow-up|0|||
146158262|NCT01258608|527090556|FG001|Overall Study|Lost to Follow-up|1|||
146158263|NCT01258608|527090555|FG000|Overall Study|Lack of compliance|1|||
146158264|NCT01258608|527090556|FG001|Overall Study|Lack of compliance|0|||
146158265|NCT01258608|527090555|FG000|Overall Study|Lack of Efficacy|0|||
146158266|NCT01258608|527090556|FG001|Overall Study|Lack of Efficacy|1|||
146158267|NCT01258608|527090555|FG000|Overall Study|Adverse Event|6|||
146158268|NCT01258608|527090556|FG001|Overall Study|Adverse Event|10|||
146158269|NCT01258608|527090555|FG000|Overall Study|Withdrawal by Subject|6|||
146158270|NCT01258608|527090556|FG001|Overall Study|Withdrawal by Subject|5|||
146158271|NCT02943408|527090562|FG000|Overall Study|Lost to Follow-up|7|||
146158272|NCT02943408|527090563|FG001|Overall Study|Lost to Follow-up|1|||
146158273|NCT02943408|527090562|FG000|Overall Study|Withdrawal by Subject|0|||
146158274|NCT02943408|527090563|FG001|Overall Study|Withdrawal by Subject|1|||
146158275|NCT01621126|527090568|FG000|Overall Study|Physician Decision|6|||
146158276|NCT01949311|527090569|FG000|Overall Study|Lost to Follow-up|73|||
146158277|NCT01949311|527090569|FG000|Overall Study|Terminated by Sponsor|708|||
146158278|NCT01949311|527090569|FG000|Overall Study|Withdrawal by Subject|375|||
146158279|NCT01949311|527090569|FG000|Overall Study|Lack of Efficacy|50|||
146158280|NCT01949311|527090569|FG000|Overall Study|Protocol Deviation|34|||
146158281|NCT01949311|527090569|FG000|Overall Study|Pregnancy|20|||
146158282|NCT01949311|527090569|FG000|Overall Study|Physician Decision|9|||
146158283|NCT01949311|527090569|FG000|Overall Study|Other|4|||
146158284|NCT01949311|527090569|FG000|Overall Study|Adverse Event|107|||
146158285|NCT02338154|527090570|FG000|Overall Study|Death|46|||
146158286|NCT02338154|527090570|FG000|Overall Study|Valve Implant Failure|17|||
146158287|NCT02338154|527090570|FG000|Overall Study|Valve Explant|11|||
146158288|NCT02338154|527090570|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
146158289|NCT02338154|527090570|FG000|Overall Study|Lost to Follow-up|8|||
146158290|NCT02338154|527090570|FG000|Overall Study|Other Reason|3|||
146158291|NCT02338154|527090570|FG000|Overall Study|Patients Without Exit Form|47|||
146158292|NCT02338154|527090570|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
146158293|NCT04279314|527090571|FG000|Overall Study|Adverse Event|55|||
146158294|NCT04279314|527090571|FG000|Overall Study|Withdrawal by Subject|5|||
146158295|NCT04279314|527090571|FG000|Overall Study|Lack of Efficacy|5|||
146158296|NCT04279314|527090571|FG000|Overall Study|Protocol Violation|3|||
146158297|NCT04279314|527090571|FG000|Overall Study|Other (not COVID-19 related)|2|||
146158298|NCT03166618|527090576|FG000|Overall Study|Study was Terminated|0|||
146158299|NCT03166618|527090577|FG001|Overall Study|Study was Terminated|1|||
146158300|NCT01925950|527090578|FG000|Part 2|Withdrawal by Subject|1|||
146158301|NCT01925950|527090579|FG001|Part 2|Withdrawal by Subject|0|||
146158302|NCT03137303|527090581|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
146158303|NCT03137303|527090582|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
146158304|NCT03137303|527090581|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
146158305|NCT03137303|527090582|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
146158306|NCT03137303|527090581|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
146158307|NCT03137303|527090582|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
146158308|NCT03137303|527090581|FG000|T3: 9-month Follow-up|Death|1|||
146158309|NCT03137303|527090582|FG001|T3: 9-month Follow-up|Death|0|||
146158310|NCT03137303|527090581|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
146158311|NCT03137303|527090582|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
146158312|NCT03137303|527090581|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
146158313|NCT03137303|527090582|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
146158314|NCT03137303|527090581|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
146158315|NCT03137303|527090582|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
146158316|NCT03561090|527090583|FG000|Overall Study|Adverse Event|11|||
146158317|NCT03561090|527090584|FG001|Overall Study|Adverse Event|7|||
146158318|NCT03561090|527090583|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146158319|NCT03561090|527090584|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146158320|NCT03561090|527090583|FG000|Overall Study|Protocol Violation|2|||
146158321|NCT03561090|527090584|FG001|Overall Study|Protocol Violation|2|||
146158322|NCT03561090|527090583|FG000|Overall Study|Withdrawal by Subject|7|||
146158323|NCT03561090|527090584|FG001|Overall Study|Withdrawal by Subject|7|||
146158324|NCT03561090|527090583|FG000|Overall Study|Lost to Follow-up|7|||
146158325|NCT03561090|527090584|FG001|Overall Study|Lost to Follow-up|2|||
146158326|NCT03561090|527090583|FG000|Overall Study|Study Terminated by Sponsor|10|||
146158327|NCT03561090|527090584|FG001|Overall Study|Study Terminated by Sponsor|15|||
146158328|NCT03561090|527090583|FG000|Overall Study|Randomized by Mistake|1|||
146158329|NCT03561090|527090584|FG001|Overall Study|Randomized by Mistake|1|||
146158330|NCT03561090|527090583|FG000|Overall Study|Other Not Specified|0|||
146158331|NCT03561090|527090584|FG001|Overall Study|Other Not Specified|2|||
146158332|NCT02015676|527090595|FG000|Overall Study|Adverse Event|2|||
146158333|NCT02015676|527090596|FG001|Overall Study|Adverse Event|18|||
146158334|NCT02015676|527090597|FG002|Overall Study|Adverse Event|0|||
146158335|NCT02015676|527090595|FG000|Overall Study|Lack of Efficacy|2|||
146158336|NCT02015676|527090596|FG001|Overall Study|Lack of Efficacy|4|||
146309965|NCT02424253|527648665|FG001|Overall Study|Compliance problems|0|||
146158337|NCT02015676|527090597|FG002|Overall Study|Lack of Efficacy|0|||
146158338|NCT02015676|527090595|FG000|Overall Study|Protocol Violation|1|||
146158339|NCT02015676|527090596|FG001|Overall Study|Protocol Violation|0|||
146158340|NCT02015676|527090597|FG002|Overall Study|Protocol Violation|0|||
146158341|NCT02015676|527090595|FG000|Overall Study|Withdrawal by Subject|1|||
146158342|NCT02015676|527090596|FG001|Overall Study|Withdrawal by Subject|7|||
146158343|NCT02015676|527090597|FG002|Overall Study|Withdrawal by Subject|1|||
146158344|NCT02015676|527090595|FG000|Overall Study|Administrative reasons|0|||
146158345|NCT02015676|527090596|FG001|Overall Study|Administrative reasons|3|||
146158346|NCT02015676|527090597|FG002|Overall Study|Administrative reasons|1|||
146158347|NCT02015676|527090595|FG000|Overall Study|Death|0|||
146158348|NCT02015676|527090596|FG001|Overall Study|Death|1|||
146158349|NCT02015676|527090597|FG002|Overall Study|Death|0|||
146158350|NCT02015676|527090595|FG000|Overall Study|Disease progression|3|||
146158351|NCT02015676|527090596|FG001|Overall Study|Disease progression|1|||
146158352|NCT02015676|527090597|FG002|Overall Study|Disease progression|1|||
146158353|NCT03321396|527090598|FG000|Overall Study|Physician Decision|1|||
146158354|NCT01654549|527090599|FG000|Overall Study|H.pylori eradication not successful|0|||
146158355|NCT01654549|527090600|FG001|Overall Study|H.pylori eradication not successful|1|||
146158356|NCT02633137|527090605|FG000|Overall Study|Adverse Event|1|||
146158357|NCT02633137|527090605|FG000|Overall Study|Lack of Efficacy|2|||
146158358|NCT02633137|527090605|FG000|Overall Study|Withdrawal by Subject|1|||
146158359|NCT03152526|527090606|FG000|Overall Study|Withdrawal by Subject|0|||
146158360|NCT03152526|527090607|FG001|Overall Study|Withdrawal by Subject|1|||
146158361|NCT04307004|527090608|FG000|Randomization 1|Withdrawal by Subject|25|||
146158362|NCT04307004|527090609|FG001|Randomization 1|Withdrawal by Subject|26|||
146158363|NCT04307004|527090610|FG002|Randomization 1|Withdrawal by Subject|0|||
146158364|NCT04307004|527090611|FG003|Randomization 1|Withdrawal by Subject|0|||
146158365|NCT04307004|527090608|FG000|Randomization 2|Withdrawal by Subject|0|||
146158366|NCT04307004|527090609|FG001|Randomization 2|Withdrawal by Subject|0|||
146158367|NCT04307004|527090610|FG002|Randomization 2|Withdrawal by Subject|28|||
146158368|NCT04307004|527090611|FG003|Randomization 2|Withdrawal by Subject|23|||
146158369|NCT05545072|527090612|FG000|Overall Study|Lost to Follow-up|1|||
146158370|NCT05545072|527090613|FG001|Overall Study|Lost to Follow-up|0|||
146158371|NCT05545072|527090612|FG000|Overall Study|Study ended prematurely due to funding|2|||
146158372|NCT05545072|527090613|FG001|Overall Study|Study ended prematurely due to funding|2|||
146158373|NCT02395042|527090614|FG000|Treatment 1 Period|Adverse Event|1|||
146158374|NCT02395042|527090615|FG001|Treatment 1 Period|Adverse Event|3|||
146158375|NCT02395042|527090616|FG002|Treatment 1 Period|Adverse Event|1|||
146158376|NCT02395042|527090614|FG000|Treatment 1 Period|Lack of Efficacy|1|||
146158377|NCT02395042|527090615|FG001|Treatment 1 Period|Lack of Efficacy|1|||
146158378|NCT02395042|527090616|FG002|Treatment 1 Period|Lack of Efficacy|0|||
146158379|NCT02395042|527090614|FG000|Treatment 1 Period|Lost to Follow-up|1|||
146158380|NCT02395042|527090615|FG001|Treatment 1 Period|Lost to Follow-up|0|||
146158381|NCT02395042|527090616|FG002|Treatment 1 Period|Lost to Follow-up|0|||
146158382|NCT02395042|527090614|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
146158383|NCT02395042|527090615|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
146158384|NCT02395042|527090616|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
146158385|NCT02395042|527090614|FG000|Treatment 2 Period|Lack of Efficacy|1|||
146158386|NCT02395042|527090615|FG001|Treatment 2 Period|Lack of Efficacy|1|||
146158387|NCT02395042|527090616|FG002|Treatment 2 Period|Lack of Efficacy|0|||
146158388|NCT02807558|527090617|FG000|Overall Study|Consent withdrawn by participant|4|||
146158389|NCT02807558|527090618|FG001|Overall Study|Consent withdrawn by participant|0|||
146158390|NCT02807558|527090619|FG002|Overall Study|Consent withdrawn by participant|4|||
146158391|NCT02807558|527090620|FG003|Overall Study|Consent withdrawn by participant|2|||
146158392|NCT02807558|527090621|FG004|Overall Study|Consent withdrawn by participant|1|||
146158393|NCT02807558|527090622|FG005|Overall Study|Consent withdrawn by participant|0|||
146158394|NCT02807558|527090617|FG000|Overall Study|Non-compliance with Study Drug|0|||
146158395|NCT02807558|527090618|FG001|Overall Study|Non-compliance with Study Drug|0|||
146158396|NCT02807558|527090619|FG002|Overall Study|Non-compliance with Study Drug|1|||
146158397|NCT02807558|527090620|FG003|Overall Study|Non-compliance with Study Drug|0|||
146158398|NCT02807558|527090621|FG004|Overall Study|Non-compliance with Study Drug|0|||
146158399|NCT02807558|527090622|FG005|Overall Study|Non-compliance with Study Drug|0|||
146158400|NCT02807558|527090617|FG000|Overall Study|Adverse Event|0|||
146158401|NCT02807558|527090618|FG001|Overall Study|Adverse Event|0|||
146158402|NCT02807558|527090619|FG002|Overall Study|Adverse Event|9|||
146158403|NCT02807558|527090620|FG003|Overall Study|Adverse Event|0|||
146158404|NCT02807558|527090621|FG004|Overall Study|Adverse Event|0|||
146158405|NCT02807558|527090622|FG005|Overall Study|Adverse Event|0|||
146158406|NCT02807558|527090617|FG000|Overall Study|Death|23|||
146158407|NCT02807558|527090618|FG001|Overall Study|Death|2|||
146158408|NCT02807558|527090619|FG002|Overall Study|Death|3|||
146158409|NCT02807558|527090620|FG003|Overall Study|Death|43|||
146158410|NCT02807558|527090621|FG004|Overall Study|Death|24|||
146158411|NCT02807558|527090622|FG005|Overall Study|Death|15|||
146309966|NCT02424253|527648664|FG000|Overall Study|Physician Decision|2|||
146309967|NCT02424253|527648665|FG001|Overall Study|Physician Decision|0|||
146158412|NCT02807558|527090617|FG000|Overall Study|Progressive Disease|0|||
146309968|NCT02424253|527648664|FG000|Overall Study|Lack of Efficacy|0|||
146158413|NCT02807558|527090618|FG001|Overall Study|Progressive Disease|0|||
146158414|NCT02807558|527090619|FG002|Overall Study|Progressive Disease|1|||
146158415|NCT02807558|527090620|FG003|Overall Study|Progressive Disease|0|||
146158416|NCT02807558|527090621|FG004|Overall Study|Progressive Disease|0|||
146158417|NCT02807558|527090622|FG005|Overall Study|Progressive Disease|0|||
146158418|NCT02807558|527090617|FG000|Overall Study|Other than specified|1|||
146158419|NCT02807558|527090618|FG001|Overall Study|Other than specified|0|||
146158420|NCT02807558|527090619|FG002|Overall Study|Other than specified|2|||
146158421|NCT02807558|527090620|FG003|Overall Study|Other than specified|0|||
146158422|NCT02807558|527090621|FG004|Overall Study|Other than specified|1|||
146158423|NCT02807558|527090622|FG005|Overall Study|Other than specified|1|||
146158424|NCT02807558|527090617|FG000|Overall Study|Lack of Efficacy|0|||
146158425|NCT02807558|527090618|FG001|Overall Study|Lack of Efficacy|0|||
146158426|NCT02807558|527090619|FG002|Overall Study|Lack of Efficacy|9|||
146158427|NCT02807558|527090620|FG003|Overall Study|Lack of Efficacy|0|||
146158428|NCT02807558|527090621|FG004|Overall Study|Lack of Efficacy|0|||
146158429|NCT02807558|527090622|FG005|Overall Study|Lack of Efficacy|0|||
146158430|NCT01972841|527090623|FG000|Overall Study|Randomized but Never Received Treatment|2|||
146158431|NCT01972841|527090624|FG001|Overall Study|Randomized but Never Received Treatment|5|||
146158432|NCT01972841|527090625|FG002|Overall Study|Randomized but Never Received Treatment|4|||
146158433|NCT01972841|527090626|FG003|Overall Study|Randomized but Never Received Treatment|2|||
146158434|NCT01972841|527090627|FG004|Overall Study|Randomized but Never Received Treatment|6|||
146158435|NCT01972841|527090628|FG005|Overall Study|Randomized but Never Received Treatment|13|||
146158436|NCT01972841|527090623|FG000|Overall Study|Adverse Event|13|||
146158437|NCT01972841|527090624|FG001|Overall Study|Adverse Event|8|||
146158438|NCT01972841|527090625|FG002|Overall Study|Adverse Event|12|||
146158439|NCT01972841|527090626|FG003|Overall Study|Adverse Event|9|||
146158440|NCT01972841|527090627|FG004|Overall Study|Adverse Event|21|||
146158441|NCT01972841|527090628|FG005|Overall Study|Adverse Event|26|||
146158442|NCT01972841|527090623|FG000|Overall Study|Lack of Efficacy|1|||
146158443|NCT01972841|527090624|FG001|Overall Study|Lack of Efficacy|0|||
146158444|NCT01972841|527090625|FG002|Overall Study|Lack of Efficacy|0|||
146158445|NCT01972841|527090626|FG003|Overall Study|Lack of Efficacy|2|||
146158446|NCT01972841|527090627|FG004|Overall Study|Lack of Efficacy|4|||
146158447|NCT01972841|527090628|FG005|Overall Study|Lack of Efficacy|1|||
146158448|NCT01972841|527090623|FG000|Overall Study|Lost to Follow-up|4|||
146158449|NCT01972841|527090624|FG001|Overall Study|Lost to Follow-up|2|||
146158450|NCT01972841|527090625|FG002|Overall Study|Lost to Follow-up|4|||
146158451|NCT01972841|527090626|FG003|Overall Study|Lost to Follow-up|2|||
146158452|NCT01972841|527090627|FG004|Overall Study|Lost to Follow-up|9|||
146158453|NCT01972841|527090628|FG005|Overall Study|Lost to Follow-up|3|||
146158454|NCT01972841|527090623|FG000|Overall Study|Protocol Violation|2|||
146158455|NCT01972841|527090624|FG001|Overall Study|Protocol Violation|2|||
146158456|NCT01972841|527090625|FG002|Overall Study|Protocol Violation|3|||
146158457|NCT01972841|527090626|FG003|Overall Study|Protocol Violation|5|||
146158458|NCT01972841|527090627|FG004|Overall Study|Protocol Violation|9|||
146158459|NCT01972841|527090628|FG005|Overall Study|Protocol Violation|4|||
146158460|NCT01972841|527090623|FG000|Overall Study|Withdrawal by participants|21|||
146158461|NCT01972841|527090624|FG001|Overall Study|Withdrawal by participants|27|||
146158462|NCT01972841|527090625|FG002|Overall Study|Withdrawal by participants|23|||
146158463|NCT01972841|527090626|FG003|Overall Study|Withdrawal by participants|16|||
146158464|NCT01972841|527090627|FG004|Overall Study|Withdrawal by participants|33|||
146158465|NCT01972841|527090628|FG005|Overall Study|Withdrawal by participants|34|||
146158466|NCT01972841|527090623|FG000|Overall Study|Miscellaneous|0|||
146158467|NCT01972841|527090624|FG001|Overall Study|Miscellaneous|0|||
146158468|NCT01972841|527090625|FG002|Overall Study|Miscellaneous|4|||
146158469|NCT01972841|527090626|FG003|Overall Study|Miscellaneous|1|||
146158470|NCT01972841|527090627|FG004|Overall Study|Miscellaneous|0|||
146158471|NCT01972841|527090628|FG005|Overall Study|Miscellaneous|4|||
146158472|NCT01972841|527090623|FG000|Overall Study|Did not have end of treatment page|0|||
146158473|NCT01972841|527090624|FG001|Overall Study|Did not have end of treatment page|0|||
146158474|NCT01972841|527090625|FG002|Overall Study|Did not have end of treatment page|0|||
146158475|NCT01972841|527090626|FG003|Overall Study|Did not have end of treatment page|0|||
146158476|NCT01972841|527090627|FG004|Overall Study|Did not have end of treatment page|1|||
146158477|NCT01972841|527090628|FG005|Overall Study|Did not have end of treatment page|0|||
146158478|NCT04969198|527090631|FG000|Overall Study|Withdrawal by Subject|20|||
146158479|NCT04969198|527090631|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
146158480|NCT04969198|527090631|FG000|Overall Study|Lost to Follow-up|20|||
146158481|NCT04009291|527090632|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146158482|NCT04009291|527090633|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146158483|NCT04009291|527090634|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146158484|NCT04009291|527090635|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
146158485|NCT04009291|527090636|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
146158486|NCT04009291|527090632|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146158487|NCT04009291|527090633|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146158488|NCT04009291|527090634|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146158489|NCT04009291|527090635|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
146158490|NCT04009291|527090636|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
146158491|NCT01270347|527090637|FG000|Core Phase|Adverse Event|1|||
146158492|NCT01270347|527090638|FG001|Core Phase|Adverse Event|6|||
146158493|NCT01270347|527090637|FG000|Core Phase|Withdrawal by Subject|1|||
146158494|NCT01270347|527090638|FG001|Core Phase|Withdrawal by Subject|2|||
146158495|NCT01270347|527090637|FG000|Core Phase|Lost to Follow-up|0|||
146158496|NCT01270347|527090638|FG001|Core Phase|Lost to Follow-up|1|||
146158497|NCT01270347|527090637|FG000|Core Phase|Miscellaneous|8|||
146158498|NCT01270347|527090638|FG001|Core Phase|Miscellaneous|14|||
146158499|NCT01270347|527090637|FG000|Extension Phase|Adverse Event|1|||
146158500|NCT01270347|527090638|FG001|Extension Phase|Adverse Event|3|||
146158501|NCT01270347|527090637|FG000|Extension Phase|Withdrawal by Subject|3|||
146158502|NCT01270347|527090638|FG001|Extension Phase|Withdrawal by Subject|4|||
146158503|NCT01270347|527090637|FG000|Extension Phase|Miscellaneous|2|||
146158504|NCT01270347|527090638|FG001|Extension Phase|Miscellaneous|2|||
146158505|NCT01556438|527090641|FG000|Overall Study|Adverse Event|4|||
146158506|NCT01556438|527090642|FG001|Overall Study|Adverse Event|2|||
146158507|NCT01556438|527090641|FG000|Overall Study|Sponsor Decision|0|||
146158508|NCT01556438|527090642|FG001|Overall Study|Sponsor Decision|2|||
146158509|NCT01556438|527090641|FG000|Overall Study|Progressive Disease|0|||
146158510|NCT01556438|527090642|FG001|Overall Study|Progressive Disease|6|||
146158511|NCT01556438|527090641|FG000|Overall Study|Death|0|||
146158512|NCT01556438|527090642|FG001|Overall Study|Death|1|||
146158513|NCT03206203|527090645|FG000|Treatment|Death|38|||
146158514|NCT03206203|527090646|FG001|Treatment|Death|26|||
146158515|NCT03206203|527090647|FG002|Treatment|Death|0|||
146158516|NCT03206203|527090645|FG000|Treatment|Withdrawal by Subject|1|||
146158517|NCT03206203|527090646|FG001|Treatment|Withdrawal by Subject|0|||
146158518|NCT03206203|527090647|FG002|Treatment|Withdrawal by Subject|0|||
146158519|NCT03206203|527090645|FG000|Treatment|Lost to Follow-up|4|||
146158520|NCT03206203|527090646|FG001|Treatment|Lost to Follow-up|0|||
146158521|NCT03206203|527090647|FG002|Treatment|Lost to Follow-up|0|||
146158522|NCT03206203|527090645|FG000|Treatment|N/A in Follow-Up|8|||
146158523|NCT03206203|527090646|FG001|Treatment|N/A in Follow-Up|1|||
146158524|NCT03206203|527090647|FG002|Treatment|N/A in Follow-Up|0|||
146158525|NCT03206203|527090645|FG000|Treatment|Disease progression|0|||
146158526|NCT03206203|527090646|FG001|Treatment|Disease progression|1|||
146158527|NCT03206203|527090647|FG002|Treatment|Disease progression|0|||
146158528|NCT03206203|527090645|FG000|Treatment|Refused follow-up|0|||
146158529|NCT03206203|527090646|FG001|Treatment|Refused follow-up|1|||
146158530|NCT03206203|527090647|FG002|Treatment|Refused follow-up|0|||
146158531|NCT03206203|527090645|FG000|Treatment|Cross over to Arm 1|0|||
146158532|NCT03206203|527090646|FG001|Treatment|Cross over to Arm 1|19|||
146158533|NCT03206203|527090647|FG002|Treatment|Cross over to Arm 1|0|||
146158534|NCT03206203|527090645|FG000|Optional Cross-Over|Death|0|||
146158535|NCT03206203|527090646|FG001|Optional Cross-Over|Death|0|||
146158536|NCT03206203|527090647|FG002|Optional Cross-Over|Death|14|||
146158537|NCT03206203|527090645|FG000|Optional Cross-Over|Refused follow-up|0|||
146158538|NCT03206203|527090646|FG001|Optional Cross-Over|Refused follow-up|0|||
146158539|NCT03206203|527090647|FG002|Optional Cross-Over|Refused follow-up|2|||
146158540|NCT03998618|527090648|FG000|Overall Study|Death|7|||
146158541|NCT03998618|527090649|FG001|Overall Study|Death|11|||
146158542|NCT03998618|527090648|FG000|Overall Study|hospice enrollment|3|||
146158543|NCT03998618|527090649|FG001|Overall Study|hospice enrollment|3|||
146158544|NCT03998618|527090648|FG000|Overall Study|Not feeling well/health problems|3|||
146158545|NCT03998618|527090649|FG001|Overall Study|Not feeling well/health problems|5|||
146158546|NCT03998618|527090648|FG000|Overall Study|Lost to Follow-up|6|||
146158547|NCT03998618|527090649|FG001|Overall Study|Lost to Follow-up|6|||
146158548|NCT03998618|527090648|FG000|Overall Study|Withdrawal by Subject|0|||
146158549|NCT03998618|527090649|FG001|Overall Study|Withdrawal by Subject|4|||
146158550|NCT01483924|527090650|FG000|Overall Study|Withdrawal by Subject|2|||
146158551|NCT01483924|527090651|FG001|Overall Study|Withdrawal by Subject|0|||
146158552|NCT01483924|527090652|FG002|Overall Study|Withdrawal by Subject|0|||
146158553|NCT01483924|527090653|FG003|Overall Study|Withdrawal by Subject|1|||
146158554|NCT01483924|527090654|FG004|Overall Study|Withdrawal by Subject|1|||
146158555|NCT01483924|527090650|FG000|Overall Study|Adverse Event|0|||
146158556|NCT01483924|527090651|FG001|Overall Study|Adverse Event|0|||
146158557|NCT01483924|527090652|FG002|Overall Study|Adverse Event|1|||
146158558|NCT01483924|527090653|FG003|Overall Study|Adverse Event|1|||
146158559|NCT01483924|527090654|FG004|Overall Study|Adverse Event|0|||
146158560|NCT01483924|527090650|FG000|Overall Study|Non-compliance|0|||
146158561|NCT01483924|527090651|FG001|Overall Study|Non-compliance|0|||
146158562|NCT01483924|527090652|FG002|Overall Study|Non-compliance|0|||
146309969|NCT02424253|527648665|FG001|Overall Study|Lack of Efficacy|7|||
146158563|NCT01483924|527090653|FG003|Overall Study|Non-compliance|1|||
146158564|NCT01483924|527090654|FG004|Overall Study|Non-compliance|1|||
146158565|NCT01483924|527090650|FG000|Overall Study|Sponsor concern over ECG result|0|||
146158566|NCT01483924|527090651|FG001|Overall Study|Sponsor concern over ECG result|0|||
146158567|NCT01483924|527090652|FG002|Overall Study|Sponsor concern over ECG result|0|||
146158568|NCT01483924|527090653|FG003|Overall Study|Sponsor concern over ECG result|1|||
146158569|NCT01483924|527090654|FG004|Overall Study|Sponsor concern over ECG result|0|||
146158570|NCT00003298|527090655|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
146158571|NCT00003298|527090655|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
146158572|NCT00003298|527090655|FG000|Surgery|Unresectable at surgery|3|||
146158573|NCT00003298|527090655|FG000|Surgery|Progression before surgery|2|||
146158574|NCT00003298|527090655|FG000|Surgery|Unevaluable and off study|2|||
146158575|NCT00003298|527090655|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
146158576|NCT00003298|527090655|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
146158577|NCT00003298|527090655|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
146158578|NCT00003298|527090655|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
146158579|NCT00003298|527090655|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
146158580|NCT00003298|527090655|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
146158581|NCT00003298|527090655|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
146158582|NCT00003298|527090655|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
146158583|NCT00003298|527090655|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
146158584|NCT00003298|527090655|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
146158585|NCT00335322|527090657|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
146158586|NCT00335322|527090658|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
146158587|NCT00335322|527090659|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
146158588|NCT03282227|527090661|FG000|Overall Study|Exposure Goals Achieved|60|||
146158589|NCT03282227|527090661|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
146158590|NCT03282227|527090661|FG000|Overall Study|Adverse Event|15|||
146158591|NCT03282227|527090661|FG000|Overall Study|Lost to Follow-up|21|||
146158592|NCT03282227|527090661|FG000|Overall Study|Withdrawal by Subject|20|||
146158593|NCT03282227|527090661|FG000|Overall Study|Lack of Efficacy|12|||
146158594|NCT03282227|527090661|FG000|Overall Study|Sponsor decision|3|||
146158595|NCT03282227|527090661|FG000|Overall Study|Physician Decision|2|||
146158596|NCT03282227|527090661|FG000|Overall Study|Pregnancy|2|||
146158597|NCT03282227|527090661|FG000|Overall Study|Other|1|||
146158598|NCT02491671|527090664|FG000|Overall Study|Adverse Event|6|||
146158599|NCT02491671|527090665|FG001|Overall Study|Adverse Event|8|||
146158600|NCT02491671|527090664|FG000|Overall Study|Death|0|||
146158601|NCT02491671|527090665|FG001|Overall Study|Death|2|||
146158602|NCT02491671|527090664|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
146158603|NCT02491671|527090665|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
146158604|NCT02251990|527090666|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
146158605|NCT02251990|527090667|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
146158606|NCT02251990|527090666|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
146158607|NCT02251990|527090667|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
146158608|NCT02251990|527090666|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
146158609|NCT02251990|527090667|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
146158610|NCT02251990|527090666|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
146158611|NCT02251990|527090667|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
146158612|NCT02251990|527090666|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
146158613|NCT02251990|527090667|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
146158614|NCT02251990|527090666|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
146158615|NCT02251990|527090667|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
146158616|NCT03265600|527090668|FG000|Overall Study|Lost to Follow-up|17|||
146158617|NCT03265600|527090669|FG001|Overall Study|Lost to Follow-up|5|||
146158618|NCT03265600|527090668|FG000|Overall Study|Withdrawal by Subject|4|||
146158619|NCT03265600|527090669|FG001|Overall Study|Withdrawal by Subject|2|||
146158620|NCT03265600|527090668|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
146158621|NCT03265600|527090669|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
146158622|NCT00535730|527090670|FG000|Overall Study|Adverse Event|1|||
146158623|NCT00535730|527090671|FG001|Overall Study|Adverse Event|1|||
146158624|NCT00535730|527090670|FG000|Overall Study|Lost to Follow-up|0|||
146158625|NCT00535730|527090671|FG001|Overall Study|Lost to Follow-up|1|||
146158626|NCT00535730|527090670|FG000|Overall Study|Physician Decision|0|||
146158627|NCT00535730|527090671|FG001|Overall Study|Physician Decision|1|||
146158628|NCT00535730|527090670|FG000|Overall Study|Protocol Violation|1|||
146158629|NCT00535730|527090671|FG001|Overall Study|Protocol Violation|0|||
146158630|NCT00535730|527090670|FG000|Overall Study|Withdrawal by Subject|0|||
146158631|NCT00535730|527090671|FG001|Overall Study|Withdrawal by Subject|4|||
146158632|NCT04330638|527090672|FG000|Overall Study|Adverse Event|9|||
146158633|NCT04330638|527090673|FG001|Overall Study|Adverse Event|10|||
146158634|NCT04330638|527090674|FG002|Overall Study|Adverse Event|15|||
146158635|NCT04330638|527090675|FG003|Overall Study|Adverse Event|6|||
146158636|NCT04330638|527090676|FG004|Overall Study|Adverse Event|10|||
146158637|NCT04330638|527090677|FG005|Overall Study|Adverse Event|5|||
146158638|NCT04330638|527090672|FG000|Overall Study|Other|2|||
146158639|NCT04330638|527090673|FG001|Overall Study|Other|2|||
146158640|NCT04330638|527090674|FG002|Overall Study|Other|5|||
146158641|NCT04330638|527090675|FG003|Overall Study|Other|1|||
146158642|NCT04330638|527090676|FG004|Overall Study|Other|3|||
146158643|NCT04330638|527090677|FG005|Overall Study|Other|2|||
146158644|NCT04330638|527090672|FG000|Overall Study|Withdrawal by Subject|4|||
146158645|NCT04330638|527090673|FG001|Overall Study|Withdrawal by Subject|0|||
146158646|NCT04330638|527090674|FG002|Overall Study|Withdrawal by Subject|0|||
146158647|NCT04330638|527090675|FG003|Overall Study|Withdrawal by Subject|0|||
146158648|NCT04330638|527090676|FG004|Overall Study|Withdrawal by Subject|0|||
146158649|NCT04330638|527090677|FG005|Overall Study|Withdrawal by Subject|0|||
146158650|NCT04330638|527090672|FG000|Overall Study|Lost to Follow-up|3|||
146158651|NCT04330638|527090673|FG001|Overall Study|Lost to Follow-up|2|||
146158652|NCT04330638|527090674|FG002|Overall Study|Lost to Follow-up|3|||
146158653|NCT04330638|527090675|FG003|Overall Study|Lost to Follow-up|2|||
146158654|NCT04330638|527090676|FG004|Overall Study|Lost to Follow-up|3|||
146158655|NCT04330638|527090677|FG005|Overall Study|Lost to Follow-up|0|||
146158656|NCT02293538|527090678|FG000|Overall Study|Adverse Event|0|||
146158657|NCT02293538|527090679|FG001|Overall Study|Adverse Event|1|||
146158658|NCT02293538|527090678|FG000|Overall Study|Lost to Follow-up|1|||
146158659|NCT02293538|527090679|FG001|Overall Study|Lost to Follow-up|0|||
146158660|NCT02293538|527090678|FG000|Overall Study|Withdrawal by Subject|0|||
146158661|NCT02293538|527090679|FG001|Overall Study|Withdrawal by Subject|1|||
146158662|NCT00584727|527090681|FG000|First Intervention|Discontinuation|0|||
146158663|NCT00584727|527090682|FG001|First Intervention|Discontinuation|0|||
146158664|NCT00584727|527090683|FG002|First Intervention|Discontinuation|1|||
146158665|NCT00584727|527090684|FG003|First Intervention|Discontinuation|0|||
146158666|NCT00584727|527090685|FG004|First Intervention|Discontinuation|0|||
146158667|NCT00584727|527090686|FG005|First Intervention|Discontinuation|0|||
146158668|NCT00584727|527090681|FG000|Third Intervention|Protocol Violation|0|||
146158669|NCT00584727|527090682|FG001|Third Intervention|Protocol Violation|0|||
146158670|NCT00584727|527090683|FG002|Third Intervention|Protocol Violation|1|||
146158671|NCT00584727|527090684|FG003|Third Intervention|Protocol Violation|0|||
146158672|NCT00584727|527090685|FG004|Third Intervention|Protocol Violation|4|||
146158673|NCT00584727|527090686|FG005|Third Intervention|Protocol Violation|2|||
146158674|NCT00729833|527090689|FG000|Overall Study|Death|5|||
146158675|NCT00729833|527090690|FG001|Overall Study|Death|1|||
146158676|NCT00729833|527090691|FG002|Overall Study|Death|3|||
146158677|NCT00729833|527090692|FG003|Overall Study|Death|5|||
146158678|NCT00729833|527090689|FG000|Overall Study|Study Terminated by Sponsor|0|||
146158679|NCT00729833|527090690|FG001|Overall Study|Study Terminated by Sponsor|0|||
146158680|NCT00729833|527090691|FG002|Overall Study|Study Terminated by Sponsor|1|||
146158681|NCT00729833|527090692|FG003|Overall Study|Study Terminated by Sponsor|0|||
146158682|NCT00729833|527090689|FG000|Overall Study|Lost to Follow-up|1|||
146158683|NCT00729833|527090690|FG001|Overall Study|Lost to Follow-up|0|||
146158684|NCT00729833|527090691|FG002|Overall Study|Lost to Follow-up|0|||
146158685|NCT00729833|527090692|FG003|Overall Study|Lost to Follow-up|0|||
146158686|NCT00729833|527090689|FG000|Overall Study|Withdrawal by Subject|3|||
146158687|NCT00729833|527090690|FG001|Overall Study|Withdrawal by Subject|1|||
146158688|NCT00729833|527090691|FG002|Overall Study|Withdrawal by Subject|3|||
146158689|NCT00729833|527090692|FG003|Overall Study|Withdrawal by Subject|0|||
146158690|NCT00729833|527090689|FG000|Overall Study|Unspecified Reasons|11|||
146158691|NCT00729833|527090690|FG001|Overall Study|Unspecified Reasons|5|||
146158692|NCT00729833|527090691|FG002|Overall Study|Unspecified Reasons|5|||
146158693|NCT00729833|527090692|FG003|Overall Study|Unspecified Reasons|1|||
146158694|NCT03336619|527090693|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
146158695|NCT03336619|527090694|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
146158696|NCT03336619|527090693|FG000|Overall Study|Withdrawal by Subject|17|||
146158697|NCT03336619|527090694|FG001|Overall Study|Withdrawal by Subject|16|||
146158698|NCT03336619|527090693|FG000|Overall Study|Adverse Event|2|||
146158699|NCT03336619|527090694|FG001|Overall Study|Adverse Event|5|||
146158700|NCT03336619|527090693|FG000|Overall Study|Physician Decision|3|||
146158701|NCT03336619|527090694|FG001|Overall Study|Physician Decision|0|||
146158702|NCT00983073|527090695|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
146158703|NCT00983073|527090695|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
146158704|NCT00983073|527090695|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
146158705|NCT00983073|527090695|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
146158706|NCT00983073|527090695|FG000|Titration and Optimal Dose Period|Other reason|4|||
146158707|NCT00983073|527090695|FG000|Maintenance Period|Adverse Event|5|||
146158708|NCT00983073|527090695|FG000|Maintenance Period|Withdrawal by Subject|2|||
146158709|NCT00983073|527090695|FG000|Maintenance Period|Lack of Efficacy|2|||
146158710|NCT00983073|527090695|FG000|Maintenance Period|Other Reason|7|||
146158711|NCT00234065|527090696|FG000|Overall Study|Adverse Event|268|||
146158712|NCT00234065|527090697|FG001|Overall Study|Adverse Event|166|||
146158713|NCT00234065|527090696|FG000|Overall Study|Withdrawal by Subject|73|||
146158714|NCT00234065|527090697|FG001|Overall Study|Withdrawal by Subject|56|||
146158715|NCT00234065|527090696|FG000|Overall Study|Physician Decision|23|||
146158716|NCT00234065|527090697|FG001|Overall Study|Physician Decision|22|||
146158717|NCT00234065|527090696|FG000|Overall Study|Not Classified|111|||
146158718|NCT00234065|527090697|FG001|Overall Study|Not Classified|112|||
146158719|NCT05557942|527090698|FG000|Overall Study|Death|0|||
146158720|NCT05557942|527090699|FG001|Overall Study|Death|0|||
146158721|NCT05557942|527090700|FG002|Overall Study|Death|0|||
146158722|NCT05557942|527090701|FG003|Overall Study|Death|2|||
146158723|NCT05557942|527090702|FG004|Overall Study|Death|1|||
146158724|NCT05557942|527090703|FG005|Overall Study|Death|1|||
146158725|NCT05557942|527090698|FG000|Overall Study|Physician Decision|1|||
146158726|NCT05557942|527090699|FG001|Overall Study|Physician Decision|1|||
146158727|NCT05557942|527090700|FG002|Overall Study|Physician Decision|2|||
146158728|NCT05557942|527090701|FG003|Overall Study|Physician Decision|3|||
146158729|NCT05557942|527090702|FG004|Overall Study|Physician Decision|0|||
146158730|NCT05557942|527090703|FG005|Overall Study|Physician Decision|2|||
146158731|NCT05557942|527090698|FG000|Overall Study|Study terminated by sponsor|17|||
146158732|NCT05557942|527090699|FG001|Overall Study|Study terminated by sponsor|17|||
146158733|NCT05557942|527090700|FG002|Overall Study|Study terminated by sponsor|14|||
146158734|NCT05557942|527090701|FG003|Overall Study|Study terminated by sponsor|40|||
146158735|NCT05557942|527090702|FG004|Overall Study|Study terminated by sponsor|45|||
146158736|NCT05557942|527090703|FG005|Overall Study|Study terminated by sponsor|37|||
146158737|NCT05557942|527090698|FG000|Overall Study|Protocol Violation|0|||
146158738|NCT05557942|527090699|FG001|Overall Study|Protocol Violation|0|||
146158739|NCT05557942|527090700|FG002|Overall Study|Protocol Violation|0|||
146158740|NCT05557942|527090701|FG003|Overall Study|Protocol Violation|0|||
146158741|NCT05557942|527090702|FG004|Overall Study|Protocol Violation|0|||
146158742|NCT05557942|527090703|FG005|Overall Study|Protocol Violation|1|||
146309970|NCT02424253|527648664|FG000|Overall Study|Adverse Event|2|||
146309971|NCT02424253|527648665|FG001|Overall Study|Adverse Event|0|||
146309972|NCT02424253|527648664|FG000|Overall Study|Consent withdrawn by subject|4|||
146309973|NCT02424253|527648665|FG001|Overall Study|Consent withdrawn by subject|1|||
146309974|NCT02424253|527648664|FG000|Overall Study|Lost to Follow-up|1|||
146309975|NCT02424253|527648665|FG001|Overall Study|Lost to Follow-up|1|||
146309976|NCT02290873|527648668|FG000|Overall Study|Withdrawal by Subject|0|||
146309977|NCT02290873|527648669|FG001|Overall Study|Withdrawal by Subject|1|||
146309978|NCT02290873|527648670|FG002|Overall Study|Withdrawal by Subject|1|||
146309979|NCT02290873|527648668|FG000|Overall Study|Nellcor device error|1|||
146309980|NCT02290873|527648669|FG001|Overall Study|Nellcor device error|0|||
146309981|NCT02290873|527648670|FG002|Overall Study|Nellcor device error|0|||
146309982|NCT02290873|527648668|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
146309983|NCT02290873|527648669|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
146309984|NCT02290873|527648670|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
146309985|NCT02290873|527648668|FG000|Overall Study|Protocol Violation|0|||
146309986|NCT02290873|527648669|FG001|Overall Study|Protocol Violation|0|||
146309987|NCT02290873|527648670|FG002|Overall Study|Protocol Violation|1|||
146309988|NCT01378104|527648673|FG000|Overall Study|Adverse Event|8|||
146158743|NCT05557942|527090698|FG000|Overall Study|Withdrawal by Subject|0|||
146158744|NCT05557942|527090699|FG001|Overall Study|Withdrawal by Subject|0|||
146158745|NCT05557942|527090700|FG002|Overall Study|Withdrawal by Subject|0|||
146158746|NCT05557942|527090701|FG003|Overall Study|Withdrawal by Subject|0|||
146158747|NCT05557942|527090702|FG004|Overall Study|Withdrawal by Subject|2|||
146158748|NCT05557942|527090703|FG005|Overall Study|Withdrawal by Subject|0|||
146158749|NCT03776136|527090704|FG000|Overall Study|Death|85|||
146158750|NCT03776136|527090704|FG000|Overall Study|Withdrawal by Subject|3|||
146158751|NCT03776136|527090704|FG000|Overall Study|Sponsor Decision|15|||
146158752|NCT01986881|527092685|FG000|Overall Study|Death|228|||
146158753|NCT01986881|527092686|FG001|Overall Study|Death|233|||
146158754|NCT01986881|527092687|FG002|Overall Study|Death|247|||
146158755|NCT01986881|527092685|FG000|Overall Study|Lost to Follow-up|51|||
146158756|NCT01986881|527092686|FG001|Overall Study|Lost to Follow-up|44|||
146158757|NCT01986881|527092687|FG002|Overall Study|Lost to Follow-up|55|||
146158758|NCT01986881|527092685|FG000|Overall Study|Physician Decision|7|||
146158759|NCT01986881|527092686|FG001|Overall Study|Physician Decision|4|||
146158760|NCT01986881|527092687|FG002|Overall Study|Physician Decision|6|||
146158761|NCT01986881|527092685|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
146158762|NCT01986881|527092686|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
146158763|NCT01986881|527092687|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
146309989|NCT01378104|527648674|FG001|Overall Study|Adverse Event|8|||
146309990|NCT01378104|527648673|FG000|Overall Study|Lack of Efficacy|7|||
146309991|NCT01378104|527648674|FG001|Overall Study|Lack of Efficacy|5|||
146309992|NCT01378104|527648673|FG000|Overall Study|Withdrawal by Subject|12|||
146158764|NCT01986881|527092685|FG000|Overall Study|Withdrawal by Subject|41|||
146158765|NCT01986881|527092686|FG001|Overall Study|Withdrawal by Subject|60|||
146158766|NCT01986881|527092687|FG002|Overall Study|Withdrawal by Subject|45|||
146158767|NCT01986881|527092685|FG000|Overall Study|Subject Moved|0|||
146158768|NCT01986881|527092686|FG001|Overall Study|Subject Moved|1|||
146158769|NCT01986881|527092687|FG002|Overall Study|Subject Moved|0|||
146158770|NCT01986881|527092685|FG000|Overall Study|Other|1|||
146158771|NCT01986881|527092686|FG001|Overall Study|Other|2|||
146158772|NCT01986881|527092687|FG002|Overall Study|Other|2|||
146158773|NCT02057874|527092688|FG000|Overall Study|participant did not return for scan|1|||
146158774|NCT04205630|527092689|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
146279218|NCT00943852|527536871|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146279219|NCT00943852|527536872|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146279220|NCT00943852|527536873|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146279221|NCT00943852|527536874|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146279222|NCT00943852|527536875|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
146279223|NCT00943852|527536876|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146279224|NCT00943852|527536877|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146279225|NCT00943852|527536878|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
146279226|NCT00772330|527536879|FG000|Overall Study|Lost to Follow-up|3|||
146279227|NCT01519089|527536880|FG000|Overall Study|Adverse Event|4|||
146279228|NCT01519089|527536881|FG001|Overall Study|Adverse Event|4|||
146279229|NCT01519089|527536880|FG000|Overall Study|Lack of Efficacy|0|||
146279230|NCT01519089|527536881|FG001|Overall Study|Lack of Efficacy|2|||
146279231|NCT01519089|527536880|FG000|Overall Study|Lost to Follow-up|1|||
146279232|NCT01519089|527536881|FG001|Overall Study|Lost to Follow-up|0|||
146279233|NCT01519089|527536880|FG000|Overall Study|Withdrawal by Subject|0|||
146279234|NCT01519089|527536881|FG001|Overall Study|Withdrawal by Subject|2|||
146279235|NCT01519089|527536880|FG000|Overall Study|Other|2|||
146279236|NCT01519089|527536881|FG001|Overall Study|Other|6|||
146279237|NCT01519089|527536880|FG000|Overall Study|Not received study drug|0|||
146279238|NCT01519089|527536881|FG001|Overall Study|Not received study drug|1|||
146279239|NCT00127205|527536882|FG000|Overall Study|Adverse Event|228|||
146279240|NCT00127205|527536883|FG001|Overall Study|Adverse Event|387|||
146279241|NCT00127205|527536884|FG002|Overall Study|Adverse Event|273|||
146279242|NCT00127205|527536882|FG000|Overall Study|Death|8|||
146279243|NCT00127205|527536883|FG001|Overall Study|Death|6|||
146279244|NCT00127205|527536884|FG002|Overall Study|Death|5|||
146279245|NCT00127205|527536882|FG000|Overall Study|Withdrawal by Subject|318|||
146279246|NCT00127205|527536883|FG001|Overall Study|Withdrawal by Subject|310|||
146279247|NCT00127205|527536884|FG002|Overall Study|Withdrawal by Subject|172|||
146279248|NCT00127205|527536882|FG000|Overall Study|Other-non protocol specified|142|||
146279249|NCT00127205|527536883|FG001|Overall Study|Other-non protocol specified|129|||
146279250|NCT00127205|527536884|FG002|Overall Study|Other-non protocol specified|77|||
146279251|NCT00127205|527536882|FG000|Overall Study|Data not reported|6|||
146279252|NCT00127205|527536883|FG001|Overall Study|Data not reported|10|||
146279253|NCT00127205|527536884|FG002|Overall Study|Data not reported|1|||
146279254|NCT00127205|527536882|FG000|Overall Study|Progression|127|||
146279255|NCT00127205|527536883|FG001|Overall Study|Progression|131|||
146279256|NCT00127205|527536884|FG002|Overall Study|Progression|84|||
146279257|NCT05032872|527536885|FG000|Overall Study|Adverse Event|1|||
146279258|NCT05032872|527536886|FG001|Overall Study|Adverse Event|0|||
146279259|NCT05032872|527536885|FG000|Overall Study|Lost to Follow-up|2|||
146279260|NCT05032872|527536886|FG001|Overall Study|Lost to Follow-up|4|||
146279261|NCT05032872|527536885|FG000|Overall Study|Withdrawal by Subject|4|||
146279262|NCT05032872|527536886|FG001|Overall Study|Withdrawal by Subject|3|||
146279263|NCT00910039|527536887|FG000|Overall Study|Physician Decision|1|||
146279264|NCT00406692|527536888|FG000|Overall Study|Withdrawal by Subject|4|||
146279265|NCT00406692|527536888|FG000|Overall Study|Physician Decision|1|||
146279266|NCT00406692|527536888|FG000|Overall Study|Adverse Event|1|||
146279267|NCT00406692|527536888|FG000|Overall Study|Lack of Efficacy|1|||
146279268|NCT00400725|527536893|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
146279269|NCT00400725|527536894|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
146279270|NCT00400725|527536895|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
146279271|NCT00400725|527536893|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
146279272|NCT00400725|527536894|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
146279273|NCT00400725|527536895|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
146279274|NCT00400725|527536893|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
146279275|NCT00400725|527536894|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
146279276|NCT00400725|527536895|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
146279277|NCT00400725|527536893|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
146279278|NCT00400725|527536894|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
146279279|NCT00400725|527536895|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
146279280|NCT00400725|527536893|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
146279281|NCT00400725|527536894|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
146279282|NCT00400725|527536895|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
146279283|NCT00400725|527536893|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
146279284|NCT00400725|527536894|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
146279285|NCT00400725|527536895|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
146279286|NCT00400725|527536893|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
146279287|NCT00400725|527536894|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
146279288|NCT00400725|527536895|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
146279289|NCT00400725|527536893|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
146279290|NCT00400725|527536894|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
146279291|NCT00400725|527536895|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
146279292|NCT00400725|527536893|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
146279293|NCT00400725|527536894|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
146279294|NCT00400725|527536895|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
146279295|NCT03547739|527536896|FG000|Overall Study|Death|0|||
146279296|NCT03547739|527536897|FG001|Overall Study|Death|1|||
146279297|NCT03547739|527536898|FG002|Overall Study|Death|5|||
146279298|NCT03547739|527536896|FG000|Overall Study|Adverse Event|24|||
146279299|NCT03547739|527536897|FG001|Overall Study|Adverse Event|11|||
146279300|NCT03547739|527536898|FG002|Overall Study|Adverse Event|13|||
146279301|NCT03547739|527536896|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
146279302|NCT03547739|527536897|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
146279303|NCT03547739|527536898|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
146279304|NCT03547739|527536896|FG000|Overall Study|Lost to Follow-up|80|||
146279305|NCT03547739|527536897|FG001|Overall Study|Lost to Follow-up|84|||
146279306|NCT03547739|527536898|FG002|Overall Study|Lost to Follow-up|116|||
146279307|NCT00635661|527536910|FG000|Overall Study|Withdrawal by Subject|4|||
146279308|NCT01641159|527536924|FG000|Overall Study|Lost to Follow-up|2|||
146279309|NCT01641159|527536925|FG001|Overall Study|Lost to Follow-up|1|||
146279310|NCT01641159|527536924|FG000|Overall Study|Withdrawal by Subject|0|||
146279311|NCT01641159|527536925|FG001|Overall Study|Withdrawal by Subject|1|||
146279312|NCT05330676|527536928|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
146279313|NCT05330676|527536929|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
146279314|NCT02229851|527536932|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
146279315|NCT02229851|527536933|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
146279316|NCT02229851|527536934|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
146279317|NCT02229851|527536935|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
146279318|NCT02229851|527536936|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
146279319|NCT02229851|527536937|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
146279320|NCT02229851|527536938|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
146279321|NCT02229851|527536932|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279322|NCT02229851|527536933|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
146279323|NCT02229851|527536934|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279324|NCT02229851|527536935|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279325|NCT02229851|527536936|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279326|NCT02229851|527536937|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279327|NCT02229851|527536938|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
146279328|NCT02229851|527536932|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
146279329|NCT02229851|527536933|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
146279330|NCT02229851|527536934|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
146279331|NCT02229851|527536935|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146279332|NCT02229851|527536936|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146279333|NCT02229851|527536937|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146279334|NCT02229851|527536938|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
146279335|NCT02229851|527536932|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279336|NCT02229851|527536933|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279337|NCT02229851|527536934|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
146279338|NCT02229851|527536935|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279339|NCT02229851|527536936|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279340|NCT02229851|527536937|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279341|NCT02229851|527536938|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
146279342|NCT02229851|527536932|FG000|Main Phase (Double-blind Phase)|Death|1|||
146279343|NCT02229851|527536933|FG001|Main Phase (Double-blind Phase)|Death|1|||
146279344|NCT02229851|527536934|FG002|Main Phase (Double-blind Phase)|Death|0|||
146279345|NCT02229851|527536935|FG003|Main Phase (Double-blind Phase)|Death|0|||
146279346|NCT02229851|527536936|FG004|Main Phase (Double-blind Phase)|Death|0|||
146279347|NCT02229851|527536937|FG005|Main Phase (Double-blind Phase)|Death|0|||
146279348|NCT02229851|527536938|FG006|Main Phase (Double-blind Phase)|Death|0|||
146279349|NCT02229851|527536932|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146279350|NCT02229851|527536933|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146279351|NCT02229851|527536934|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146279352|NCT02229851|527536935|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
146279353|NCT02229851|527536936|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146279354|NCT02229851|527536937|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146279355|NCT02229851|527536938|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
146279356|NCT02229851|527536932|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146279357|NCT02229851|527536933|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146279358|NCT02229851|527536934|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
146279359|NCT02229851|527536935|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
146158775|NCT04205630|527092689|FG000|Overall Study|Disease clinical progression|7|||
146158776|NCT04205630|527092689|FG000|Overall Study|Withdrawal by Subject|2|||
146158777|NCT04205630|527092689|FG000|Overall Study|Adverse Event|17|||
146158778|NCT04205630|527092689|FG000|Overall Study|Other|1|||
146158779|NCT03224182|527092690|FG000|Overall Study|Study Drug Not Instilled|6|||
146158780|NCT03224182|527092691|FG001|Overall Study|Study Drug Not Instilled|1|||
146158781|NCT03224182|527092690|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
146158782|NCT03224182|527092691|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
146279360|NCT02229851|527536936|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
146279361|NCT02229851|527536937|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
146279362|NCT02229851|527536938|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
146279363|NCT02229851|527536932|FG000|Extension Phase (Open-label Phase)|Death|0|||
146279364|NCT02229851|527536933|FG001|Extension Phase (Open-label Phase)|Death|0|||
146279365|NCT02229851|527536934|FG002|Extension Phase (Open-label Phase)|Death|0|||
146279366|NCT02229851|527536935|FG003|Extension Phase (Open-label Phase)|Death|1|||
146279367|NCT02229851|527536936|FG004|Extension Phase (Open-label Phase)|Death|0|||
146279368|NCT02229851|527536937|FG005|Extension Phase (Open-label Phase)|Death|1|||
146279369|NCT02229851|527536938|FG006|Extension Phase (Open-label Phase)|Death|1|||
146279370|NCT03541200|527536939|FG000|Overall Study|Adverse Event|19|||
146279371|NCT03541200|527536939|FG000|Overall Study|Death|1|||
146279372|NCT03541200|527536939|FG000|Overall Study|Lost to Follow-up|10|||
146279373|NCT03541200|527536939|FG000|Overall Study|Physician Decision|1|||
146279374|NCT03541200|527536939|FG000|Overall Study|Protocol Violation|51|||
146279375|NCT03541200|527536939|FG000|Overall Study|Withdrawal by Subject|23|||
146279376|NCT03541200|527536939|FG000|Overall Study|other|8|||
146279377|NCT01607476|527536941|FG000|Overall Study|Withdrawal by Subject|1|||
146279378|NCT01607476|527536942|FG001|Overall Study|Withdrawal by Subject|0|||
146279379|NCT01607476|527536943|FG002|Overall Study|Withdrawal by Subject|1|||
146279380|NCT01607476|527536941|FG000|Overall Study|Lost to Follow-up|0|||
146279381|NCT01607476|527536942|FG001|Overall Study|Lost to Follow-up|0|||
146279382|NCT01607476|527536943|FG002|Overall Study|Lost to Follow-up|2|||
146279383|NCT04445987|527536944|FG000|Overall Study|Adverse Event|0|||
146279384|NCT04445987|527536945|FG001|Overall Study|Adverse Event|0|||
146279385|NCT04445987|527536946|FG002|Overall Study|Adverse Event|1|||
146279386|NCT04445987|527536947|FG003|Overall Study|Adverse Event|0|||
146279387|NCT04445987|527536948|FG004|Overall Study|Adverse Event|4|||
146279388|NCT04445987|527536949|FG005|Overall Study|Adverse Event|0|||
146279389|NCT04445987|527536944|FG000|Overall Study|Lost to Follow-up|4|||
146279390|NCT04445987|527536945|FG001|Overall Study|Lost to Follow-up|3|||
146279391|NCT04445987|527536946|FG002|Overall Study|Lost to Follow-up|1|||
146279392|NCT04445987|527536947|FG003|Overall Study|Lost to Follow-up|1|||
146279393|NCT04445987|527536948|FG004|Overall Study|Lost to Follow-up|29|||
146279394|NCT04445987|527536949|FG005|Overall Study|Lost to Follow-up|0|||
146279395|NCT04445987|527536944|FG000|Overall Study|Physician Decision|0|||
146279396|NCT04445987|527536945|FG001|Overall Study|Physician Decision|0|||
146279397|NCT04445987|527536946|FG002|Overall Study|Physician Decision|0|||
146279398|NCT04445987|527536947|FG003|Overall Study|Physician Decision|0|||
146279399|NCT04445987|527536948|FG004|Overall Study|Physician Decision|1|||
146279400|NCT04445987|527536949|FG005|Overall Study|Physician Decision|0|||
146279401|NCT04445987|527536944|FG000|Overall Study|Protocol Violation|1|||
146279402|NCT04445987|527536945|FG001|Overall Study|Protocol Violation|0|||
146279403|NCT04445987|527536946|FG002|Overall Study|Protocol Violation|0|||
146279404|NCT04445987|527536947|FG003|Overall Study|Protocol Violation|0|||
146279405|NCT04445987|527536948|FG004|Overall Study|Protocol Violation|2|||
146279406|NCT04445987|527536949|FG005|Overall Study|Protocol Violation|0|||
146279407|NCT04445987|527536944|FG000|Overall Study|Withdrawal by Subject|4|||
146279408|NCT04445987|527536945|FG001|Overall Study|Withdrawal by Subject|0|||
146279409|NCT04445987|527536946|FG002|Overall Study|Withdrawal by Subject|1|||
146279410|NCT04445987|527536947|FG003|Overall Study|Withdrawal by Subject|0|||
146279411|NCT04445987|527536948|FG004|Overall Study|Withdrawal by Subject|18|||
146279412|NCT04445987|527536949|FG005|Overall Study|Withdrawal by Subject|1|||
146279413|NCT04445987|527536944|FG000|Overall Study|Other reason|0|||
146279414|NCT04445987|527536945|FG001|Overall Study|Other reason|0|||
146158783|NCT03224182|527092690|FG000|Overall Study|Withdrew of Consent|4|||
146158784|NCT03224182|527092691|FG001|Overall Study|Withdrew of Consent|2|||
146279415|NCT04445987|527536946|FG002|Overall Study|Other reason|1|||
146279416|NCT04445987|527536947|FG003|Overall Study|Other reason|0|||
146279417|NCT04445987|527536948|FG004|Overall Study|Other reason|2|||
146279418|NCT04445987|527536949|FG005|Overall Study|Other reason|0|||
146279419|NCT00293059|527536952|FG000|Overall Study|Adverse Event|12|||
146279420|NCT00293059|527536953|FG001|Overall Study|Adverse Event|4|||
146279421|NCT00293059|527536952|FG000|Overall Study|Lack of Efficacy|2|||
146279422|NCT00293059|527536953|FG001|Overall Study|Lack of Efficacy|0|||
146279423|NCT00293059|527536952|FG000|Overall Study|Lost to Follow-up|2|||
146279424|NCT00293059|527536953|FG001|Overall Study|Lost to Follow-up|3|||
146279425|NCT00293059|527536952|FG000|Overall Study|Pregnancy|1|||
146279426|NCT00293059|527536953|FG001|Overall Study|Pregnancy|1|||
146279427|NCT00293059|527536952|FG000|Overall Study|Protocol Violation|2|||
146158785|NCT03224182|527092690|FG000|Overall Study|Investigator Decision|3|||
146158786|NCT03224182|527092691|FG001|Overall Study|Investigator Decision|1|||
146158787|NCT03224182|527092690|FG000|Overall Study|Sponsor Decision|26|||
146158788|NCT03224182|527092691|FG001|Overall Study|Sponsor Decision|12|||
146158789|NCT03224182|527092690|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
146158790|NCT03224182|527092691|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
146158791|NCT03224182|527092690|FG000|Overall Study|Lost to Follow-up|1|||
146158792|NCT03224182|527092691|FG001|Overall Study|Lost to Follow-up|0|||
146158793|NCT03224182|527092690|FG000|Overall Study|Participant Had Recurrence|11|||
146158794|NCT03224182|527092691|FG001|Overall Study|Participant Had Recurrence|5|||
146158795|NCT03224182|527092690|FG000|Overall Study|Death|0|||
146158796|NCT03224182|527092691|FG001|Overall Study|Death|1|||
146158797|NCT03224182|527092690|FG000|Overall Study|Reason not Specified|3|||
146158798|NCT03224182|527092691|FG001|Overall Study|Reason not Specified|3|||
146158799|NCT03224182|527092690|FG000|Overall Study|Other|1|||
146309993|NCT01378104|527648674|FG001|Overall Study|Withdrawal by Subject|13|||
146309994|NCT02700997|527648675|FG000|Overall Study|Did not undergo CT imaging|1|||
146309995|NCT02700997|527648675|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
146309996|NCT00455013|527648679|FG000|Short Term Period|Adverse Event|2|||
146309997|NCT00455013|527648680|FG001|Short Term Period|Adverse Event|5|||
146309998|NCT00455013|527648681|FG002|Short Term Period|Adverse Event|0|||
146309999|NCT00455013|527648679|FG000|Short Term Period|Withdrawal by Subject|0|||
146310000|NCT00455013|527648680|FG001|Short Term Period|Withdrawal by Subject|0|||
146310001|NCT00455013|527648681|FG002|Short Term Period|Withdrawal by Subject|1|||
146310002|NCT00455013|527648679|FG000|Short Term Period|Lack of Efficacy|4|||
146310003|NCT00455013|527648680|FG001|Short Term Period|Lack of Efficacy|0|||
146310004|NCT00455013|527648681|FG002|Short Term Period|Lack of Efficacy|0|||
146310005|NCT00455013|527648679|FG000|Short Term Period|Other|0|||
146310006|NCT00455013|527648680|FG001|Short Term Period|Other|0|||
146310007|NCT00455013|527648681|FG002|Short Term Period|Other|1|||
146310008|NCT00455013|527648679|FG000|Long Term Extension (LTE)|Adverse Event|0|||
146310009|NCT00455013|527648680|FG001|Long Term Extension (LTE)|Adverse Event|1|||
146310010|NCT00455013|527648681|FG002|Long Term Extension (LTE)|Adverse Event|1|||
146310011|NCT00455013|527648679|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
146310012|NCT00455013|527648680|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
146310013|NCT00455013|527648681|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
146310014|NCT00455013|527648679|FG000|Long Term Extension (LTE)|Death|1|||
146310015|NCT00455013|527648680|FG001|Long Term Extension (LTE)|Death|1|||
146310016|NCT00455013|527648681|FG002|Long Term Extension (LTE)|Death|0|||
146310017|NCT00455013|527648679|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
146310018|NCT00455013|527648680|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
146310019|NCT00455013|527648681|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
146310020|NCT00455013|527648679|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
146310021|NCT00455013|527648680|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
146310022|NCT00455013|527648681|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
146310023|NCT00455013|527648679|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
146310024|NCT00455013|527648680|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
146310025|NCT00455013|527648681|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
146310026|NCT00455013|527648679|FG000|Long Term Extension (LTE)|non-specified|0|||
146310027|NCT00455013|527648680|FG001|Long Term Extension (LTE)|non-specified|0|||
146310028|NCT00455013|527648681|FG002|Long Term Extension (LTE)|non-specified|1|||
146310029|NCT01445951|527648682|FG000|Overall Study|Adverse Event|16|||
146310030|NCT01445951|527648683|FG001|Overall Study|Adverse Event|9|||
146310031|NCT01445951|527648684|FG002|Overall Study|Adverse Event|0|||
146310032|NCT01445951|527648682|FG000|Overall Study|Protocol Violation|2|||
146310033|NCT01445951|527648683|FG001|Overall Study|Protocol Violation|2|||
146158800|NCT03224182|527092691|FG001|Overall Study|Other|0|||
146158801|NCT02481310|527092692|FG000|Follow up|Still in follow up|0|||
146158802|NCT02481310|527092693|FG001|Follow up|Still in follow up|3|||
146310034|NCT01445951|527648684|FG002|Overall Study|Protocol Violation|2|||
146310035|NCT01445951|527648682|FG000|Overall Study|Withdrawal by Subject|21|||
146310036|NCT01445951|527648683|FG001|Overall Study|Withdrawal by Subject|16|||
146310037|NCT01445951|527648684|FG002|Overall Study|Withdrawal by Subject|8|||
146310038|NCT01445951|527648682|FG000|Overall Study|Physician Decision|3|||
146310039|NCT01445951|527648683|FG001|Overall Study|Physician Decision|1|||
146310040|NCT01445951|527648684|FG002|Overall Study|Physician Decision|0|||
146310041|NCT01445951|527648682|FG000|Overall Study|Lost to Follow-up|1|||
146158803|NCT02481310|527092694|FG002|Follow up|Still in follow up|0|||
146310042|NCT01445951|527648683|FG001|Overall Study|Lost to Follow-up|2|||
146310043|NCT01445951|527648684|FG002|Overall Study|Lost to Follow-up|4|||
146310044|NCT01445951|527648682|FG000|Overall Study|Pregnancy|0|||
146310045|NCT01445951|527648683|FG001|Overall Study|Pregnancy|1|||
146310046|NCT01445951|527648684|FG002|Overall Study|Pregnancy|4|||
146310047|NCT01445951|527648682|FG000|Overall Study|Death|0|||
146310048|NCT01445951|527648683|FG001|Overall Study|Death|0|||
146158804|NCT02925455|527092699|FG000|Overall Study|Withdrawal by Subject|2|||
146310049|NCT01445951|527648684|FG002|Overall Study|Death|1|||
146310050|NCT01445951|527648682|FG000|Overall Study|Non-compliance with study drug|1|||
146310051|NCT01445951|527648683|FG001|Overall Study|Non-compliance with study drug|2|||
146310052|NCT01445951|527648684|FG002|Overall Study|Non-compliance with study drug|0|||
146310053|NCT01445951|527648682|FG000|Overall Study|Non-compliance with protocol|0|||
146310054|NCT01445951|527648683|FG001|Overall Study|Non-compliance with protocol|1|||
146310055|NCT01445951|527648684|FG002|Overall Study|Non-compliance with protocol|0|||
146310056|NCT01445951|527648682|FG000|Overall Study|Sponsor decision - subject travel|0|||
146310057|NCT01445951|527648683|FG001|Overall Study|Sponsor decision - subject travel|1|||
146310058|NCT01445951|527648684|FG002|Overall Study|Sponsor decision - subject travel|0|||
146310059|NCT01445951|527648682|FG000|Overall Study|Cough|0|||
146310060|NCT01445951|527648683|FG001|Overall Study|Cough|1|||
146310061|NCT01445951|527648684|FG002|Overall Study|Cough|0|||
146310062|NCT01519765|527648687|FG000|Overall Study|Adverse Event|0|||
146310063|NCT01519765|527648688|FG001|Overall Study|Adverse Event|1|||
146310064|NCT01519765|527648687|FG000|Overall Study|Lack of Efficacy|2|||
146310065|NCT01519765|527648688|FG001|Overall Study|Lack of Efficacy|0|||
146310066|NCT01519765|527648687|FG000|Overall Study|Protocol Violation|1|||
146310067|NCT01519765|527648688|FG001|Overall Study|Protocol Violation|0|||
146310068|NCT01519765|527648687|FG000|Overall Study|Withdrawal by Subject|0|||
146310069|NCT01519765|527648688|FG001|Overall Study|Withdrawal by Subject|1|||
146310070|NCT00078325|527648689|FG000|Overall Study|Adverse Event|15|||
146310071|NCT00078325|527648690|FG001|Overall Study|Adverse Event|10|||
146310072|NCT00078325|527648691|FG002|Overall Study|Adverse Event|5|||
146310073|NCT00078325|527648689|FG000|Overall Study|Protocol Violation|2|||
146310074|NCT00078325|527648690|FG001|Overall Study|Protocol Violation|2|||
146310075|NCT00078325|527648691|FG002|Overall Study|Protocol Violation|0|||
146310076|NCT00078325|527648689|FG000|Overall Study|Withdrawal by Subject|1|||
146310077|NCT00078325|527648690|FG001|Overall Study|Withdrawal by Subject|5|||
146310078|NCT00078325|527648691|FG002|Overall Study|Withdrawal by Subject|3|||
146310079|NCT00078325|527648689|FG000|Overall Study|Lost to Follow-up|0|||
146310080|NCT00078325|527648690|FG001|Overall Study|Lost to Follow-up|1|||
146310081|NCT00078325|527648691|FG002|Overall Study|Lost to Follow-up|1|||
146310082|NCT00078325|527648689|FG000|Overall Study|Physician Decision|2|||
146310083|NCT00078325|527648690|FG001|Overall Study|Physician Decision|0|||
146310084|NCT00078325|527648691|FG002|Overall Study|Physician Decision|1|||
146310085|NCT00078325|527648689|FG000|Overall Study|Miscellaneous|1|||
146310086|NCT00078325|527648690|FG001|Overall Study|Miscellaneous|1|||
146310087|NCT00078325|527648691|FG002|Overall Study|Miscellaneous|1|||
146310088|NCT02739620|527648692|FG000|Overall Study|Lost to Follow-up|3|||
146310089|NCT02739620|527648693|FG001|Overall Study|Lost to Follow-up|1|||
146310090|NCT02739620|527648692|FG000|Overall Study|Adverse Event|0|||
146310091|NCT02739620|527648693|FG001|Overall Study|Adverse Event|1|||
146310092|NCT04126083|527648697|FG000|Overall Study|Withdrawal by Subject|1|||
146310093|NCT02354222|527648698|FG000|Overall Study|Adverse Event|0|||
146310094|NCT02354222|527648699|FG001|Overall Study|Adverse Event|3|||
146310095|NCT02354222|527648698|FG000|Overall Study|Physician Decision|1|||
146310096|NCT02354222|527648699|FG001|Overall Study|Physician Decision|1|||
146310097|NCT02354222|527648698|FG000|Overall Study|Pregnancy|1|||
146310098|NCT02354222|527648699|FG001|Overall Study|Pregnancy|0|||
146310099|NCT02354222|527648698|FG000|Overall Study|Withdrawal by Subject|2|||
146310100|NCT02354222|527648699|FG001|Overall Study|Withdrawal by Subject|3|||
146310101|NCT02354222|527648698|FG000|Overall Study|Conflict with the stopping criteria|0|||
146310102|NCT02354222|527648699|FG001|Overall Study|Conflict with the stopping criteria|4|||
146310103|NCT00786565|527648700|FG000|Enrollment Prior to Surgery|Site Closed|3|||
146310104|NCT00786565|527648700|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
146310105|NCT00786565|527648700|FG000|Post Surgery|Abnormal macular pucker|1|||
146310106|NCT00786565|527648700|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
146310107|NCT00578136|527648701|FG000|Overall Study|Not given intervention|1|||
146310108|NCT00578136|527648702|FG001|Overall Study|Not given intervention|1|||
146310109|NCT00754793|527648705|FG000|Overall Study|voluntary withdrawn from study|0|||
146310110|NCT00754793|527648706|FG001|Overall Study|voluntary withdrawn from study|1|||
146310111|NCT00932360|527648708|FG000|Washout (One Week)|Withdrawal by Subject|0|||
146310112|NCT00932360|527648709|FG001|Washout (One Week)|Withdrawal by Subject|0|||
146310113|NCT00932360|527648710|FG002|Washout (One Week)|Withdrawal by Subject|0|||
146310114|NCT00932360|527648711|FG003|Washout (One Week)|Withdrawal by Subject|0|||
146310115|NCT00932360|527648712|FG004|Washout (One Week)|Withdrawal by Subject|2|||
146310116|NCT00932360|527648713|FG005|Washout (One Week)|Withdrawal by Subject|0|||
146310117|NCT02536313|527648714|FG000|Overall Study|Lack of Efficacy|0|||
146310118|NCT02536313|527648715|FG001|Overall Study|Lack of Efficacy|1|||
146310119|NCT02437864|527648723|FG000|Overall Study|Protocol Violation|4|||
146310120|NCT02437864|527648724|FG001|Overall Study|Protocol Violation|0|||
146310121|NCT00645593|527648726|FG000|Overall Study|Later found to be ineligible|1|||
146310122|NCT00645593|527648727|FG001|Overall Study|Later found to be ineligible|0|||
146310123|NCT01585272|527648728|FG000|Overall Study|Adverse Event|22|||
146310124|NCT01585272|527648728|FG000|Overall Study|Protocol Violation|7|||
146310125|NCT01585272|527648728|FG000|Overall Study|Withdrawal by Subject|10|||
146310126|NCT00993265|527648733|FG000|Overall Study|Adverse Event|1|||
146310127|NCT00993265|527648734|FG001|Overall Study|Adverse Event|0|||
146310128|NCT00993265|527648733|FG000|Overall Study|Changed dose of concomitant drug|2|||
146310129|NCT00993265|527648734|FG001|Overall Study|Changed dose of concomitant drug|0|||
146310130|NCT00993265|527648733|FG000|Overall Study|Non-compliant with study medication|1|||
146310131|NCT00993265|527648734|FG001|Overall Study|Non-compliant with study medication|0|||
146310132|NCT03765138|527648735|FG000|Overall Study|Lost to Follow-up|1|||
146310133|NCT00470054|527648738|FG000|Overall Study|Ineligible|1|||
146310134|NCT00733954|527648742|FG000|Overall Study|Lost to Follow-up|5|||
146310135|NCT00733954|527648743|FG001|Overall Study|Lost to Follow-up|2|||
146310136|NCT00733954|527648742|FG000|Overall Study|Protocol Violation|1|||
146310137|NCT00733954|527648743|FG001|Overall Study|Protocol Violation|0|||
146310138|NCT00733954|527648742|FG000|Overall Study|Withdrawal by Subject|2|||
146310139|NCT00733954|527648743|FG001|Overall Study|Withdrawal by Subject|0|||
146310140|NCT02663453|527648744|FG000|Overall Study|Death|4|||
146310141|NCT02663453|527648745|FG001|Overall Study|Death|4|||
146310142|NCT02663453|527648744|FG000|Overall Study|Withdrawal by Subject|1|||
146310143|NCT02663453|527648745|FG001|Overall Study|Withdrawal by Subject|0|||
146310144|NCT00609791|527650129|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
146310145|NCT04218201|527650130|FG000|Overall Study|Death|0|||
146310146|NCT04218201|527650131|FG001|Overall Study|Death|0|||
146310147|NCT04218201|527650132|FG002|Overall Study|Death|2|||
146310148|NCT04218201|527650133|FG003|Overall Study|Death|0|||
146310149|NCT04218201|527650130|FG000|Overall Study|Unable to contact participant|4|||
146310150|NCT04218201|527650131|FG001|Overall Study|Unable to contact participant|0|||
146310151|NCT04218201|527650132|FG002|Overall Study|Unable to contact participant|3|||
146310152|NCT04218201|527650133|FG003|Overall Study|Unable to contact participant|0|||
146310153|NCT04218201|527650130|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
146310154|NCT04218201|527650131|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146310155|NCT04218201|527650132|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146310156|NCT04218201|527650133|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
146310157|NCT04218201|527650130|FG000|Overall Study|Withdrawal by Subject|2|||
146310158|NCT04218201|527650131|FG001|Overall Study|Withdrawal by Subject|0|||
146310159|NCT04218201|527650132|FG002|Overall Study|Withdrawal by Subject|0|||
146310160|NCT04218201|527650133|FG003|Overall Study|Withdrawal by Subject|0|||
146310161|NCT04218201|527650130|FG000|Overall Study|PCP plans to leave practice|0|||
146310162|NCT04218201|527650131|FG001|Overall Study|PCP plans to leave practice|8|||
146310163|NCT04218201|527650132|FG002|Overall Study|PCP plans to leave practice|0|||
146310164|NCT04218201|527650133|FG003|Overall Study|PCP plans to leave practice|5|||
146310165|NCT04218201|527650130|FG000|Overall Study|Reduced panel|0|||
146310166|NCT04218201|527650131|FG001|Overall Study|Reduced panel|0|||
146310167|NCT04218201|527650132|FG002|Overall Study|Reduced panel|0|||
146310168|NCT04218201|527650133|FG003|Overall Study|Reduced panel|1|||
146310169|NCT04218201|527650130|FG000|Overall Study|No longer interested in participating|0|||
146310170|NCT04218201|527650131|FG001|Overall Study|No longer interested in participating|1|||
146310171|NCT04218201|527650132|FG002|Overall Study|No longer interested in participating|0|||
146310172|NCT04218201|527650133|FG003|Overall Study|No longer interested in participating|0|||
146310173|NCT04649255|527650134|FG000|Overall Study|Death|9|||
146310174|NCT04649255|527650134|FG000|Overall Study|Withdrawal by Subject|1|||
146310175|NCT02484911|527650135|FG000|Overall Study|Withdrawal by Subject|2|||
146310176|NCT02484911|527650136|FG001|Overall Study|Withdrawal by Subject|1|||
146310177|NCT02484911|527650135|FG000|Overall Study|Protocol Violation|2|||
146310178|NCT02484911|527650136|FG001|Overall Study|Protocol Violation|1|||
146310179|NCT00490568|527650142|FG000|Overall Study|Adverse Event|116|||
146310180|NCT00490568|527650142|FG000|Overall Study|Lost to Follow-up|13|||
146310181|NCT00490568|527650142|FG000|Overall Study|Protocol Violation|45|||
146310182|NCT00490568|527650142|FG000|Overall Study|Withdrawal by Subject|135|||
146310183|NCT00490568|527650142|FG000|Overall Study|Still in the study at termination|974|||
146310184|NCT00490568|527650142|FG000|Overall Study|Other|1|||
146310185|NCT00490568|527650142|FG000|Overall Study|Exclusion criteria met|1|||
146158805|NCT02925455|527092700|FG001|Overall Study|Withdrawal by Subject|0|||
146158806|NCT00686166|527092701|FG000|Overall Study|Adverse Event|7|||
146310186|NCT00490568|527650142|FG000|Overall Study|Caregiver related|20|||
146310187|NCT00490568|527650142|FG000|Overall Study|Abnormal ECG|25|||
146310188|NCT00490568|527650142|FG000|Overall Study|Participant refused follow-up|9|||
146310189|NCT00490568|527650142|FG000|Overall Study|Legal representative withdrew consent|1|||
146310190|NCT00490568|527650142|FG000|Overall Study|Disease progression|4|||
146310191|NCT00490568|527650142|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
146310192|NCT00490568|527650142|FG000|Overall Study|Investigator decision|3|||
146310193|NCT00490568|527650142|FG000|Overall Study|Non-Compliance|7|||
146310194|NCT00490568|527650142|FG000|Overall Study|Efficacy related|3|||
146310195|NCT00490568|527650142|FG000|Overall Study|Participant died|1|||
146310196|NCT00490568|527650142|FG000|Overall Study|Participant withdrawal due to surgery|1|||
146158807|NCT00686166|527092701|FG000|Overall Study|Withdrawal by Subject|1|||
146310197|NCT00105443|527650145|FG000|Double-Blind Treatment|Adverse Event|1|||
146310198|NCT00105443|527650146|FG001|Double-Blind Treatment|Adverse Event|0|||
146310199|NCT00105443|527650147|FG002|Double-Blind Treatment|Adverse Event|0|||
146310200|NCT00105443|527650148|FG003|Double-Blind Treatment|Adverse Event|0|||
146310201|NCT00105443|527650145|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
146310202|NCT00105443|527650146|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
146310203|NCT00105443|527650147|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
146310204|NCT00105443|527650148|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
146310205|NCT00105443|527650145|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
146310206|NCT00105443|527650146|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
146310207|NCT00105443|527650147|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
146310208|NCT00105443|527650148|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
146310209|NCT00105443|527650145|FG000|Double-Blind Treatment|Physician Decision|1|||
146310210|NCT00105443|527650146|FG001|Double-Blind Treatment|Physician Decision|0|||
146310211|NCT00105443|527650147|FG002|Double-Blind Treatment|Physician Decision|2|||
146310212|NCT00105443|527650148|FG003|Double-Blind Treatment|Physician Decision|0|||
146310213|NCT00105443|527650145|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
146310214|NCT00105443|527650146|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
146310215|NCT00105443|527650147|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
146310216|NCT00105443|527650148|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
146310217|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
146310218|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
146310219|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
146310220|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
146310221|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
146310222|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
146310223|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
146310224|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
146310225|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
146310226|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
146310227|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
146310228|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
146310229|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
146310230|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
146310231|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
146310232|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
146310233|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
146310234|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
146310235|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
146310236|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
146310237|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146310238|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
146310239|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146310240|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
146310241|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
146310242|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
146310243|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
146310244|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
146310245|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
146310246|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
146310247|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
146310248|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
146310249|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
146310250|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
146158808|NCT00686166|527092701|FG000|Overall Study|Progression/Relapse|1|||
146158809|NCT00686166|527092701|FG000|Overall Study|Death|1|||
146158810|NCT00686166|527092701|FG000|Overall Study|Not Protocol Specified|1|||
146310251|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
146310252|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
146310253|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146310254|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146310255|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
146310256|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
146310257|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
146310258|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146310259|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146158811|NCT00686166|527092701|FG000|Overall Study|Ineligible|5|||
146310260|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
146310261|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146310262|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146310263|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
146310264|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
146310265|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
146310266|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
146310267|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
146310268|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
146310269|NCT00105443|527650145|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
146310270|NCT00105443|527650146|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
146310271|NCT00105443|527650147|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
146310272|NCT00105443|527650148|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
146310273|NCT01157078|527650149|FG000|Overall Study|Withdrawal by Subject|12|||
146310274|NCT01157078|527650150|FG001|Overall Study|Withdrawal by Subject|14|||
146310275|NCT01157078|527650149|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146310276|NCT01157078|527650150|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146310277|NCT01157078|527650149|FG000|Overall Study|Adverse Event|6|||
146310278|NCT01157078|527650150|FG001|Overall Study|Adverse Event|6|||
146310279|NCT01157078|527650149|FG000|Overall Study|Severe non-compliance to protocol|2|||
146310280|NCT01157078|527650150|FG001|Overall Study|Severe non-compliance to protocol|4|||
146310281|NCT01157078|527650149|FG000|Overall Study|Condition under investigation worsened|0|||
146310282|NCT01157078|527650150|FG001|Overall Study|Condition under investigation worsened|1|||
146310283|NCT01157078|527650149|FG000|Overall Study|Lack of Efficacy|2|||
146310284|NCT01157078|527650150|FG001|Overall Study|Lack of Efficacy|0|||
146310285|NCT01157078|527650149|FG000|Overall Study|Study-specific withdrawal criteria|2|||
146310286|NCT01157078|527650150|FG001|Overall Study|Study-specific withdrawal criteria|2|||
146310287|NCT01157078|527650149|FG000|Overall Study|Lost to Follow-up|7|||
146310288|NCT01157078|527650150|FG001|Overall Study|Lost to Follow-up|5|||
146310289|NCT01157078|527650149|FG000|Overall Study|Other|2|||
146310290|NCT01157078|527650150|FG001|Overall Study|Other|4|||
146310291|NCT01324232|527650158|FG000|Overall Study|Protocol Violation|0|||
146310292|NCT01324232|527650159|FG001|Overall Study|Protocol Violation|0|||
146310293|NCT01324232|527650160|FG002|Overall Study|Protocol Violation|0|||
146310294|NCT01324232|527650161|FG003|Overall Study|Protocol Violation|2|||
146310295|NCT01324232|527650158|FG000|Overall Study|Missing|0|||
146310296|NCT01324232|527650159|FG001|Overall Study|Missing|0|||
146310297|NCT01324232|527650160|FG002|Overall Study|Missing|1|||
146310298|NCT01324232|527650161|FG003|Overall Study|Missing|0|||
146310299|NCT01324232|527650158|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
146310300|NCT01324232|527650159|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
146310301|NCT01324232|527650160|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
146310302|NCT01324232|527650161|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
146310303|NCT01324232|527650158|FG000|Overall Study|Lack of Efficacy|2|||
146310304|NCT01324232|527650159|FG001|Overall Study|Lack of Efficacy|1|||
146310305|NCT01324232|527650160|FG002|Overall Study|Lack of Efficacy|2|||
146310306|NCT01324232|527650161|FG003|Overall Study|Lack of Efficacy|2|||
146310307|NCT01324232|527650158|FG000|Overall Study|Participant Refused Medication|0|||
146310308|NCT01324232|527650159|FG001|Overall Study|Participant Refused Medication|1|||
146310309|NCT01324232|527650160|FG002|Overall Study|Participant Refused Medication|0|||
146310310|NCT01324232|527650161|FG003|Overall Study|Participant Refused Medication|0|||
146310311|NCT01324232|527650158|FG000|Overall Study|Intercurrent illness|0|||
146310312|NCT01324232|527650159|FG001|Overall Study|Intercurrent illness|0|||
146310313|NCT01324232|527650160|FG002|Overall Study|Intercurrent illness|0|||
146310314|NCT01324232|527650161|FG003|Overall Study|Intercurrent illness|1|||
146310315|NCT01324232|527650158|FG000|Overall Study|Adverse Event|2|||
146310316|NCT01324232|527650159|FG001|Overall Study|Adverse Event|5|||
146310317|NCT01324232|527650160|FG002|Overall Study|Adverse Event|6|||
146310318|NCT01324232|527650161|FG003|Overall Study|Adverse Event|6|||
146310319|NCT01324232|527650158|FG000|Overall Study|Withdrawal by Subject|0|||
146310320|NCT01324232|527650159|FG001|Overall Study|Withdrawal by Subject|3|||
146310321|NCT01324232|527650160|FG002|Overall Study|Withdrawal by Subject|4|||
146310322|NCT01324232|527650161|FG003|Overall Study|Withdrawal by Subject|0|||
146310323|NCT01324232|527650158|FG000|Overall Study|Lost to Follow-up|1|||
146310324|NCT01324232|527650159|FG001|Overall Study|Lost to Follow-up|0|||
146310325|NCT01324232|527650160|FG002|Overall Study|Lost to Follow-up|0|||
146310326|NCT01324232|527650161|FG003|Overall Study|Lost to Follow-up|0|||
146310327|NCT05440539|527650162|FG000|Overall Study|Lost to Follow-up|4|||
146310328|NCT05440539|527650163|FG001|Overall Study|Lost to Follow-up|4|||
146310329|NCT05440539|527650162|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
146310330|NCT05440539|527650163|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
146310331|NCT00393887|527650164|FG000|Overall Study|Physician Decision|5|||
146310332|NCT00393887|527650165|FG001|Overall Study|Physician Decision|0|||
146310333|NCT00393887|527650164|FG000|Overall Study|Lost to Follow-up|11|||
146310334|NCT00393887|527650165|FG001|Overall Study|Lost to Follow-up|9|||
146310335|NCT01967628|527650168|FG000|Overall Study|Withdrawal by Subject|2|||
146310336|NCT01967628|527650169|FG001|Overall Study|Withdrawal by Subject|0|||
146310337|NCT01967628|527650168|FG000|Overall Study|Unable to complete bronchoscopy|4|||
146310338|NCT01967628|527650169|FG001|Overall Study|Unable to complete bronchoscopy|6|||
146310339|NCT01967628|527650168|FG000|Overall Study|Lost to Follow-up|1|||
146310340|NCT01967628|527650169|FG001|Overall Study|Lost to Follow-up|0|||
146310341|NCT01967628|527650168|FG000|Overall Study|Low protein concentration in sample|20|||
146310342|NCT01967628|527650169|FG001|Overall Study|Low protein concentration in sample|25|||
146310343|NCT00838331|527650170|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
146310344|NCT02055820|527650171|FG000|Phase I: Dose-Finding|Death|1|||
146310345|NCT02055820|527650172|FG001|Phase I: Dose-Finding|Death|0|||
146310346|NCT02055820|527650173|FG002|Phase I: Dose-Finding|Death|1|||
146310347|NCT02055820|527650174|FG003|Phase I: Dose-Finding|Death|2|||
146310348|NCT02055820|527650175|FG004|Phase I: Dose-Finding|Death|0|||
146310349|NCT02055820|527650176|FG005|Phase I: Dose-Finding|Death|1|||
146310350|NCT02055820|527650177|FG006|Phase I: Dose-Finding|Death|1|||
146310351|NCT02055820|527650178|FG007|Phase I: Dose-Finding|Death|0|||
146310352|NCT02055820|527650179|FG008|Phase I: Dose-Finding|Death|0|||
146310353|NCT02055820|527650180|FG009|Phase I: Dose-Finding|Death|0|||
146310354|NCT02055820|527650171|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310355|NCT02055820|527650172|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310356|NCT02055820|527650173|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310357|NCT02055820|527650174|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310358|NCT02055820|527650175|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310359|NCT02055820|527650176|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
146310360|NCT02055820|527650177|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310361|NCT02055820|527650178|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310362|NCT02055820|527650179|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310363|NCT02055820|527650180|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
146310364|NCT02055820|527650171|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310365|NCT02055820|527650172|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310366|NCT02055820|527650173|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310367|NCT02055820|527650174|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
146310368|NCT02055820|527650175|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310369|NCT02055820|527650176|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310370|NCT02055820|527650177|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
146310371|NCT02055820|527650178|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310372|NCT02055820|527650179|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310373|NCT02055820|527650180|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
146310374|NCT02055820|527650171|FG000|Phase II: Expansion|Death|0|||
146310375|NCT02055820|527650172|FG001|Phase II: Expansion|Death|0|||
146310376|NCT02055820|527650173|FG002|Phase II: Expansion|Death|0|||
146310377|NCT02055820|527650174|FG003|Phase II: Expansion|Death|0|||
146310378|NCT02055820|527650175|FG004|Phase II: Expansion|Death|33|||
146310379|NCT02055820|527650176|FG005|Phase II: Expansion|Death|0|||
146310380|NCT02055820|527650177|FG006|Phase II: Expansion|Death|0|||
146310381|NCT02055820|527650178|FG007|Phase II: Expansion|Death|0|||
146310382|NCT02055820|527650179|FG008|Phase II: Expansion|Death|0|||
146310383|NCT02055820|527650180|FG009|Phase II: Expansion|Death|0|||
146310384|NCT02055820|527650171|FG000|Phase II: Expansion|Lost to Follow-up|0|||
146310385|NCT02055820|527650172|FG001|Phase II: Expansion|Lost to Follow-up|0|||
146310386|NCT02055820|527650173|FG002|Phase II: Expansion|Lost to Follow-up|0|||
146310387|NCT02055820|527650174|FG003|Phase II: Expansion|Lost to Follow-up|0|||
146310388|NCT02055820|527650175|FG004|Phase II: Expansion|Lost to Follow-up|4|||
146310389|NCT02055820|527650176|FG005|Phase II: Expansion|Lost to Follow-up|0|||
146310390|NCT02055820|527650177|FG006|Phase II: Expansion|Lost to Follow-up|0|||
146158812|NCT00686166|527092701|FG000|Overall Study|Did not begin protocol therapy|4|||
146158813|NCT01514448|527092702|FG000|Overall Study|Death|7|||
146158814|NCT01514448|527092703|FG001|Overall Study|Death|8|||
146310391|NCT02055820|527650178|FG007|Phase II: Expansion|Lost to Follow-up|0|||
146310392|NCT02055820|527650179|FG008|Phase II: Expansion|Lost to Follow-up|0|||
146310393|NCT02055820|527650180|FG009|Phase II: Expansion|Lost to Follow-up|0|||
146310394|NCT02055820|527650171|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
146310395|NCT02055820|527650172|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
146310396|NCT02055820|527650173|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
146310397|NCT02055820|527650174|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
146310398|NCT02055820|527650175|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
146310399|NCT02055820|527650176|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
146310400|NCT02055820|527650177|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
146310401|NCT02055820|527650178|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
146310402|NCT02055820|527650179|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
146310403|NCT02055820|527650180|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
146310404|NCT00930761|527650183|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
146310405|NCT00930761|527650184|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
146279428|NCT00293059|527536953|FG001|Overall Study|Protocol Violation|0|||
146279429|NCT00293059|527536952|FG000|Overall Study|Withdrawal by Subject|11|||
146279430|NCT00293059|527536953|FG001|Overall Study|Withdrawal by Subject|5|||
146279431|NCT00293059|527536952|FG000|Overall Study|Participant moved out of state|1|||
146279432|NCT00293059|527536953|FG001|Overall Study|Participant moved out of state|0|||
146279433|NCT00293059|527536952|FG000|Overall Study|Participant stopped study drug|1|||
146279434|NCT00293059|527536953|FG001|Overall Study|Participant stopped study drug|0|||
146279435|NCT00293059|527536952|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
146279436|NCT00293059|527536953|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
146279437|NCT00293059|527536952|FG000|Overall Study|missing|3|||
146279438|NCT00293059|527536953|FG001|Overall Study|missing|5|||
146279439|NCT02001064|527536954|FG000|Overall Study|Withdrawal by Subject|2|||
146279440|NCT02001064|527536955|FG001|Overall Study|Withdrawal by Subject|1|||
146279441|NCT00680992|527536956|FG000|Overall Study|Complete Resection (as per protocol)|25|||
146279442|NCT00680992|527536957|FG001|Overall Study|Complete Resection (as per protocol)|121|||
146279443|NCT00680992|527536958|FG002|Overall Study|Complete Resection (as per protocol)|0|||
146279444|NCT00680992|527536956|FG000|Overall Study|Administrative Decision|83|||
146279445|NCT00680992|527536957|FG001|Overall Study|Administrative Decision|42|||
146279446|NCT00680992|527536958|FG002|Overall Study|Administrative Decision|5|||
146279447|NCT00680992|527536956|FG000|Overall Study|End of Trial|32|||
146279448|NCT00680992|527536957|FG001|Overall Study|End of Trial|12|||
146279449|NCT00680992|527536958|FG002|Overall Study|End of Trial|3|||
146279450|NCT00680992|527536956|FG000|Overall Study|Withdrawal by Subject|33|||
146279451|NCT00680992|527536957|FG001|Overall Study|Withdrawal by Subject|11|||
146279452|NCT00680992|527536958|FG002|Overall Study|Withdrawal by Subject|1|||
146279453|NCT00680992|527536956|FG000|Overall Study|Adverse Event|21|||
146279454|NCT00680992|527536957|FG001|Overall Study|Adverse Event|19|||
146279455|NCT00680992|527536958|FG002|Overall Study|Adverse Event|1|||
146279456|NCT00680992|527536956|FG000|Overall Study|Other|19|||
146279457|NCT00680992|527536957|FG001|Overall Study|Other|14|||
146279458|NCT00680992|527536958|FG002|Overall Study|Other|1|||
146279459|NCT00680992|527536956|FG000|Overall Study|Disease Progression|21|||
146279460|NCT00680992|527536957|FG001|Overall Study|Disease Progression|9|||
146279461|NCT00680992|527536958|FG002|Overall Study|Disease Progression|0|||
146279462|NCT00680992|527536956|FG000|Overall Study|Lost to Follow-up|12|||
146279463|NCT00680992|527536957|FG001|Overall Study|Lost to Follow-up|14|||
146279464|NCT00680992|527536958|FG002|Overall Study|Lost to Follow-up|0|||
146279465|NCT00680992|527536956|FG000|Overall Study|Noncompliance|4|||
146279466|NCT00680992|527536957|FG001|Overall Study|Noncompliance|6|||
146279467|NCT00680992|527536958|FG002|Overall Study|Noncompliance|0|||
146279468|NCT00680992|527536956|FG000|Overall Study|Requirement for Alternative Therapy|8|||
146279469|NCT00680992|527536957|FG001|Overall Study|Requirement for Alternative Therapy|2|||
146279470|NCT00680992|527536958|FG002|Overall Study|Requirement for Alternative Therapy|0|||
146279471|NCT00680992|527536956|FG000|Overall Study|Pregnancy|5|||
146279472|NCT00680992|527536957|FG001|Overall Study|Pregnancy|0|||
146279473|NCT00680992|527536958|FG002|Overall Study|Pregnancy|1|||
146279474|NCT00680992|527536956|FG000|Overall Study|Death|5|||
146279475|NCT00680992|527536957|FG001|Overall Study|Death|1|||
146279476|NCT00680992|527536958|FG002|Overall Study|Death|0|||
146279477|NCT00680992|527536956|FG000|Overall Study|Ineligibility Determined|0|||
146279478|NCT00680992|527536957|FG001|Overall Study|Ineligibility Determined|1|||
146279479|NCT00680992|527536958|FG002|Overall Study|Ineligibility Determined|0|||
146279480|NCT02425904|527536959|FG000|Overall Study|Lost to Follow-up|1|||
146279481|NCT02425904|527536960|FG001|Overall Study|Lost to Follow-up|0|||
146279482|NCT02425904|527536959|FG000|Overall Study|Withdrawal by Subject|2|||
146279483|NCT02425904|527536960|FG001|Overall Study|Withdrawal by Subject|0|||
146279484|NCT02425904|527536959|FG000|Overall Study|Death|0|||
146158815|NCT01514448|527092702|FG000|Overall Study|Withdrawal by Subject|2|||
146158816|NCT01514448|527092703|FG001|Overall Study|Withdrawal by Subject|0|||
146158817|NCT01514448|527092702|FG000|Overall Study|Lost to Follow-up|2|||
146158818|NCT01514448|527092703|FG001|Overall Study|Lost to Follow-up|0|||
146158819|NCT01514448|527092702|FG000|Overall Study|New Cancer Therapy|1|||
146158820|NCT01514448|527092703|FG001|Overall Study|New Cancer Therapy|0|||
146158821|NCT02314624|527092704|FG000|Overall Study|No participating patient|16|||
146158822|NCT02314624|527092705|FG001|Overall Study|No participating patient|13|||
146158823|NCT02314624|527092704|FG000|Overall Study|Participant withdrew|7|||
146279485|NCT02425904|527536960|FG001|Overall Study|Death|3|||
146279486|NCT05148962|527536961|FG000|Overall Study|Withdrawal by Subject|1|||
146279487|NCT05148962|527536962|FG001|Overall Study|Withdrawal by Subject|1|||
146279488|NCT05148962|527536963|FG002|Overall Study|Withdrawal by Subject|0|||
146158824|NCT02314624|527092705|FG001|Overall Study|Participant withdrew|2|||
146158825|NCT02314624|527092704|FG000|Overall Study|Lost to Follow-up|2|||
146158826|NCT02314624|527092705|FG001|Overall Study|Lost to Follow-up|5|||
146279489|NCT05148962|527536964|FG003|Overall Study|Withdrawal by Subject|1|||
146279490|NCT05148962|527536965|FG004|Overall Study|Withdrawal by Subject|0|||
146279491|NCT05148962|527536961|FG000|Overall Study|Participant was early terminated per protocol|0|||
146279492|NCT05148962|527536962|FG001|Overall Study|Participant was early terminated per protocol|0|||
146310406|NCT00930761|527650183|FG000|Overall Study|less than 3 music therapy sessions|0|||
146310407|NCT00930761|527650184|FG001|Overall Study|less than 3 music therapy sessions|3|||
146310408|NCT00631020|527650185|FG000|Overall Study|Lost to Follow-up|7|||
146310409|NCT00631020|527650185|FG000|Overall Study|Incarcerated|1|||
146310410|NCT03548935|527650187|FG000|Overall Study|Withdrawal by Subject|26|||
146310411|NCT03548935|527650188|FG001|Overall Study|Withdrawal by Subject|17|||
146310412|NCT03548935|527650187|FG000|Overall Study|Lost to Follow-up|39|||
146310413|NCT03548935|527650188|FG001|Overall Study|Lost to Follow-up|28|||
146310414|NCT03548935|527650187|FG000|Overall Study|Death|1|||
146310415|NCT03548935|527650188|FG001|Overall Study|Death|1|||
146310416|NCT03571646|527650189|FG000|Overall Study|Adverse Event|1|||
146310417|NCT03571646|527650190|FG001|Overall Study|Adverse Event|0|||
146310418|NCT03571646|527650189|FG000|Overall Study|Withdrawal by Subject|1|||
146310419|NCT03571646|527650190|FG001|Overall Study|Withdrawal by Subject|1|||
146310420|NCT01970995|527650191|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146310421|NCT01970995|527650192|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146310422|NCT01970995|527650193|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
146310423|NCT01970995|527650191|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
146310424|NCT01970995|527650192|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
146310425|NCT01970995|527650193|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
146310426|NCT01157364|527650196|FG000|Overall Study|Other Reasons|1|||
146310427|NCT01157364|527650197|FG001|Overall Study|Other Reasons|1|||
146310428|NCT01157364|527650198|FG002|Overall Study|Other Reasons|2|||
146310429|NCT01157364|527650199|FG003|Overall Study|Other Reasons|1|||
146310430|NCT01157364|527650200|FG004|Overall Study|Other Reasons|0|||
146310431|NCT01157364|527650201|FG005|Overall Study|Other Reasons|0|||
146310432|NCT01157364|527650196|FG000|Overall Study|Personal Reasons|0|||
146310433|NCT01157364|527650197|FG001|Overall Study|Personal Reasons|2|||
146310434|NCT01157364|527650198|FG002|Overall Study|Personal Reasons|0|||
146310435|NCT01157364|527650199|FG003|Overall Study|Personal Reasons|0|||
146310436|NCT01157364|527650200|FG004|Overall Study|Personal Reasons|1|||
146310437|NCT01157364|527650201|FG005|Overall Study|Personal Reasons|1|||
146310438|NCT01157364|527650196|FG000|Overall Study|Lost to Follow-up|1|||
146310439|NCT01157364|527650197|FG001|Overall Study|Lost to Follow-up|0|||
146310440|NCT01157364|527650198|FG002|Overall Study|Lost to Follow-up|1|||
146310441|NCT01157364|527650199|FG003|Overall Study|Lost to Follow-up|0|||
146310442|NCT01157364|527650200|FG004|Overall Study|Lost to Follow-up|0|||
146310443|NCT01157364|527650201|FG005|Overall Study|Lost to Follow-up|0|||
146310444|NCT01157364|527650196|FG000|Overall Study|Lack of Efficacy|0|||
146310445|NCT01157364|527650197|FG001|Overall Study|Lack of Efficacy|0|||
146310446|NCT01157364|527650198|FG002|Overall Study|Lack of Efficacy|0|||
146310447|NCT01157364|527650199|FG003|Overall Study|Lack of Efficacy|1|||
146310448|NCT01157364|527650200|FG004|Overall Study|Lack of Efficacy|0|||
146310449|NCT01157364|527650201|FG005|Overall Study|Lack of Efficacy|0|||
146310450|NCT01157364|527650196|FG000|Overall Study|Adverse Event|0|||
146310451|NCT01157364|527650197|FG001|Overall Study|Adverse Event|1|||
146310452|NCT01157364|527650198|FG002|Overall Study|Adverse Event|1|||
146310453|NCT01157364|527650199|FG003|Overall Study|Adverse Event|0|||
146158827|NCT02314624|527092704|FG000|Overall Study|Dropped/Excluded by PI|6|||
146310454|NCT01157364|527650200|FG004|Overall Study|Adverse Event|1|||
146310455|NCT01157364|527650201|FG005|Overall Study|Adverse Event|0|||
146310456|NCT01780662|527650202|FG000|Overall Study|Adverse Event|1|||
146310457|NCT01780662|527650203|FG001|Overall Study|Adverse Event|0|||
146310458|NCT01780662|527650204|FG002|Overall Study|Adverse Event|2|||
146310459|NCT01780662|527650202|FG000|Overall Study|Physician Decision|0|||
146310460|NCT01780662|527650203|FG001|Overall Study|Physician Decision|5|||
146310461|NCT01780662|527650204|FG002|Overall Study|Physician Decision|7|||
146310462|NCT01780662|527650202|FG000|Overall Study|Protocol Violation|0|||
146310463|NCT01780662|527650203|FG001|Overall Study|Protocol Violation|1|||
146310464|NCT01780662|527650204|FG002|Overall Study|Protocol Violation|0|||
146310465|NCT01780662|527650202|FG000|Overall Study|Ineligible|0|||
146310466|NCT01780662|527650203|FG001|Overall Study|Ineligible|0|||
146310467|NCT01780662|527650204|FG002|Overall Study|Ineligible|1|||
146310468|NCT01263639|527650205|FG000|Overall Study|Lost to Follow-up|66|||
146310469|NCT01263639|527650206|FG001|Overall Study|Lost to Follow-up|70|||
146310470|NCT01263639|527650205|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
146310471|NCT01263639|527650206|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
146158828|NCT02314624|527092705|FG001|Overall Study|Dropped/Excluded by PI|6|||
146310472|NCT00586495|527650207|FG000|Treatment Period|Adverse Event|11|||
146310473|NCT00586495|527650207|FG000|Treatment Period|Death|1|||
146310474|NCT00586495|527650207|FG000|Treatment Period|Protocol Violation|1|||
146310475|NCT00586495|527650207|FG000|Treatment Period|Withdrawal by Subject|1|||
146310476|NCT00586495|527650207|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
146310477|NCT00586495|527650207|FG000|Treatment Period|Switch to commercial drug|10|||
146310478|NCT00586495|527650207|FG000|Follow-up|Death|40|||
146310479|NCT00586495|527650207|FG000|Follow-up|Lost to Follow-up|1|||
146310480|NCT00586495|527650207|FG000|Follow-up|Withdrawal by Subject|4|||
146310481|NCT00586495|527650207|FG000|Follow-up|Protocol driven decision point|37|||
146158829|NCT03912259|527092706|FG000|Overall Study|Adverse Event (AE)|2|||
146158830|NCT03912259|527092707|FG001|Overall Study|Adverse Event (AE)|4|||
146158831|NCT03912259|527092706|FG000|Overall Study|Lack of Efficacy|4|||
146279493|NCT05148962|527536963|FG002|Overall Study|Participant was early terminated per protocol|3|||
146279494|NCT05148962|527536964|FG003|Overall Study|Participant was early terminated per protocol|5|||
146279495|NCT05148962|527536965|FG004|Overall Study|Participant was early terminated per protocol|2|||
146279496|NCT05148962|527536961|FG000|Overall Study|Miscellaneous|0|||
146279497|NCT05148962|527536962|FG001|Overall Study|Miscellaneous|0|||
146279498|NCT05148962|527536963|FG002|Overall Study|Miscellaneous|0|||
146279499|NCT05148962|527536964|FG003|Overall Study|Miscellaneous|1|||
146279500|NCT05148962|527536965|FG004|Overall Study|Miscellaneous|0|||
146279501|NCT00095056|527538605|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
146279502|NCT00095056|527538606|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
146279503|NCT00095056|527538605|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
146279504|NCT00095056|527538606|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
146279505|NCT00095056|527538605|FG000|Phase A (Weeks 0-12)|Death|1|||
146279506|NCT00095056|527538606|FG001|Phase A (Weeks 0-12)|Death|0|||
146279507|NCT00095056|527538605|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
146279508|NCT00095056|527538606|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
146279509|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
146279510|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
146279511|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
146279512|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
146279513|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
146279514|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
146279515|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
146279516|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
146279517|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Death|3|||
146279518|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Death|1|||
146279519|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
146279520|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
146279521|NCT00095056|527538605|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
146279522|NCT00095056|527538606|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
146279523|NCT02731690|527538612|FG000|Overall Study|Adverse Event|1|||
146279524|NCT02731690|527538612|FG000|Overall Study|Withdrawal by Subject|3|||
146279525|NCT02731690|527538612|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
146279526|NCT02735577|527538613|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
146279527|NCT02735577|527538613|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
146279528|NCT02141620|527538617|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
146279529|NCT02141620|527538618|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
146279530|NCT01353859|527538621|FG000|Overall Study|Adverse Event|3|||
146279531|NCT01353859|527538621|FG000|Overall Study|Lack of Efficacy|1|||
146279532|NCT01659853|527538622|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
146279533|NCT01659853|527538623|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
146279534|NCT01659853|527538622|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
146279535|NCT01659853|527538623|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
146279536|NCT01744392|527538627|FG000|Overall Study|Physician Decision|1|||
146279537|NCT01365481|527538628|FG000|Overall Study|Adverse Event|6|||
146279538|NCT01365481|527538629|FG001|Overall Study|Adverse Event|9|||
146279539|NCT01365481|527538630|FG002|Overall Study|Adverse Event|0|||
146158832|NCT03912259|527092707|FG001|Overall Study|Lack of Efficacy|1|||
146158833|NCT03912259|527092706|FG000|Overall Study|Withdrawal by Subject|11|||
146158834|NCT03912259|527092707|FG001|Overall Study|Withdrawal by Subject|1|||
146158835|NCT00360308|527092708|FG000|Overall Study|Adverse Event|15|||
146158836|NCT00360308|527092709|FG001|Overall Study|Adverse Event|14|||
146158837|NCT00360308|527092710|FG002|Overall Study|Adverse Event|25|||
146158838|NCT00360308|527092708|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146158839|NCT00360308|527092709|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
146158840|NCT00360308|527092710|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
146158841|NCT00360308|527092708|FG000|Overall Study|Protocol Violation|2|||
146158842|NCT00360308|527092709|FG001|Overall Study|Protocol Violation|1|||
146158843|NCT00360308|527092710|FG002|Overall Study|Protocol Violation|2|||
146158844|NCT00360308|527092708|FG000|Overall Study|Withdrawal by Subject|11|||
146158845|NCT00360308|527092709|FG001|Overall Study|Withdrawal by Subject|7|||
146158846|NCT00360308|527092710|FG002|Overall Study|Withdrawal by Subject|14|||
146158847|NCT00360308|527092708|FG000|Overall Study|Lack of Efficacy|3|||
146158848|NCT00360308|527092709|FG001|Overall Study|Lack of Efficacy|0|||
146279540|NCT01365481|527538631|FG003|Overall Study|Adverse Event|2|||
146279541|NCT01365481|527538628|FG000|Overall Study|Withdrawal by Subject|0|||
146279542|NCT01365481|527538629|FG001|Overall Study|Withdrawal by Subject|2|||
146279543|NCT01365481|527538630|FG002|Overall Study|Withdrawal by Subject|1|||
146279544|NCT01365481|527538631|FG003|Overall Study|Withdrawal by Subject|1|||
146279545|NCT01365481|527538628|FG000|Overall Study|Lost to Follow-up|1|||
146279546|NCT01365481|527538629|FG001|Overall Study|Lost to Follow-up|1|||
146279547|NCT01365481|527538630|FG002|Overall Study|Lost to Follow-up|2|||
146279548|NCT01365481|527538631|FG003|Overall Study|Lost to Follow-up|3|||
146310482|NCT00586495|527650207|FG000|Follow-up|Switch to commercial drug|10|||
146310483|NCT00886600|527650215|FG000|Double-blind Monotherapy|Adverse Event|1|||
146310484|NCT00886600|527650216|FG001|Double-blind Monotherapy|Adverse Event|1|||
146310485|NCT00886600|527650217|FG002|Double-blind Monotherapy|Adverse Event|1|||
146310486|NCT00886600|527650218|FG003|Double-blind Monotherapy|Adverse Event|1|||
146310487|NCT00886600|527650215|FG000|Double-blind Monotherapy|Protocol Violation|0|||
146310488|NCT00886600|527650216|FG001|Double-blind Monotherapy|Protocol Violation|0|||
146310489|NCT00886600|527650217|FG002|Double-blind Monotherapy|Protocol Violation|0|||
146310490|NCT00886600|527650218|FG003|Double-blind Monotherapy|Protocol Violation|1|||
146310491|NCT00886600|527650215|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
146310492|NCT00886600|527650216|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
146310493|NCT00886600|527650217|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
146310494|NCT00886600|527650218|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
146310495|NCT00886600|527650215|FG000|Combination Therapy Period|Adverse Event|0|||
146310496|NCT00886600|527650216|FG001|Combination Therapy Period|Adverse Event|0|||
146310497|NCT00886600|527650217|FG002|Combination Therapy Period|Adverse Event|1|||
146310498|NCT00886600|527650218|FG003|Combination Therapy Period|Adverse Event|0|||
146310499|NCT00886600|527650215|FG000|Combination Therapy Period|Protocol Violation|0|||
146310500|NCT00886600|527650216|FG001|Combination Therapy Period|Protocol Violation|0|||
146310501|NCT00886600|527650217|FG002|Combination Therapy Period|Protocol Violation|1|||
146310502|NCT00886600|527650218|FG003|Combination Therapy Period|Protocol Violation|0|||
146310503|NCT00473343|527650220|FG000|Overall Study|Adverse Event|9|||
146310504|NCT00473343|527650220|FG000|Overall Study|Lost to Follow-up|8|||
146310505|NCT00473343|527650220|FG000|Overall Study|Treatment failure|27|||
146310506|NCT00473343|527650220|FG000|Overall Study|Withdrew consent|3|||
146310507|NCT00473343|527650220|FG000|Overall Study|Other un-specified reason|3|||
146310508|NCT00361270|527650222|FG000|Overall Study|Death|0|||
146310509|NCT00361270|527650223|FG001|Overall Study|Death|0|||
146310510|NCT00361270|527650224|FG002|Overall Study|Death|0|||
146310511|NCT00361270|527650225|FG003|Overall Study|Death|2|||
146310512|NCT00361270|527650222|FG000|Overall Study|Lost to Follow-up|4|||
146310513|NCT00361270|527650223|FG001|Overall Study|Lost to Follow-up|1|||
146310514|NCT00361270|527650224|FG002|Overall Study|Lost to Follow-up|0|||
146310515|NCT00361270|527650225|FG003|Overall Study|Lost to Follow-up|0|||
146310516|NCT00361270|527650222|FG000|Overall Study|Physician Decision|0|||
146310517|NCT00361270|527650223|FG001|Overall Study|Physician Decision|0|||
146310518|NCT00361270|527650224|FG002|Overall Study|Physician Decision|1|||
146310519|NCT00361270|527650225|FG003|Overall Study|Physician Decision|0|||
146310520|NCT00361270|527650222|FG000|Overall Study|Protocol Violation|9|||
146310521|NCT00361270|527650223|FG001|Overall Study|Protocol Violation|4|||
146310522|NCT00361270|527650224|FG002|Overall Study|Protocol Violation|5|||
146310523|NCT00361270|527650225|FG003|Overall Study|Protocol Violation|4|||
146310524|NCT00361270|527650222|FG000|Overall Study|Withdrawal by Subject|6|||
146310525|NCT00361270|527650223|FG001|Overall Study|Withdrawal by Subject|6|||
146310526|NCT00361270|527650224|FG002|Overall Study|Withdrawal by Subject|3|||
146310527|NCT00361270|527650225|FG003|Overall Study|Withdrawal by Subject|7|||
146310528|NCT00361270|527650222|FG000|Overall Study|Afraid of Hypnosis|1|||
146310529|NCT00361270|527650223|FG001|Overall Study|Afraid of Hypnosis|2|||
146310530|NCT00361270|527650224|FG002|Overall Study|Afraid of Hypnosis|0|||
146310531|NCT00361270|527650225|FG003|Overall Study|Afraid of Hypnosis|0|||
146310532|NCT00361270|527650222|FG000|Overall Study|Problems with Transportation|4|||
146310533|NCT00361270|527650223|FG001|Overall Study|Problems with Transportation|0|||
146310534|NCT00361270|527650224|FG002|Overall Study|Problems with Transportation|0|||
146310535|NCT00361270|527650225|FG003|Overall Study|Problems with Transportation|0|||
146310536|NCT00361270|527650222|FG000|Overall Study|Adverse Event|0|||
146310537|NCT00361270|527650223|FG001|Overall Study|Adverse Event|1|||
146310538|NCT00361270|527650224|FG002|Overall Study|Adverse Event|1|||
146310539|NCT00361270|527650225|FG003|Overall Study|Adverse Event|0|||
146310540|NCT03116698|527650227|FG000|Overall Study|Adverse Event|1|||
146310541|NCT03116698|527650228|FG001|Overall Study|Adverse Event|1|||
146310542|NCT03116698|527650229|FG002|Overall Study|Adverse Event|1|||
146310543|NCT03116698|527650230|FG003|Overall Study|Adverse Event|0|||
146310544|NCT03116698|527650227|FG000|Overall Study|Withdrawal by Subject|1|||
146310545|NCT03116698|527650228|FG001|Overall Study|Withdrawal by Subject|4|||
146310546|NCT03116698|527650229|FG002|Overall Study|Withdrawal by Subject|5|||
146310547|NCT03116698|527650230|FG003|Overall Study|Withdrawal by Subject|2|||
146310548|NCT03116698|527650227|FG000|Overall Study|Lost to Follow-up|2|||
146310549|NCT03116698|527650228|FG001|Overall Study|Lost to Follow-up|0|||
146310550|NCT03116698|527650229|FG002|Overall Study|Lost to Follow-up|0|||
146310551|NCT03116698|527650230|FG003|Overall Study|Lost to Follow-up|0|||
146310552|NCT03116698|527650227|FG000|Overall Study|Physician Decision|1|||
146310553|NCT03116698|527650228|FG001|Overall Study|Physician Decision|1|||
146310554|NCT03116698|527650229|FG002|Overall Study|Physician Decision|0|||
146310555|NCT03116698|527650230|FG003|Overall Study|Physician Decision|0|||
146310556|NCT03116698|527650227|FG000|Overall Study|Protocol Violation|1|||
146310557|NCT03116698|527650228|FG001|Overall Study|Protocol Violation|0|||
146310558|NCT03116698|527650229|FG002|Overall Study|Protocol Violation|0|||
146310559|NCT03116698|527650230|FG003|Overall Study|Protocol Violation|0|||
146310560|NCT03116698|527650227|FG000|Overall Study|Death|0|||
146158849|NCT00360308|527092710|FG002|Overall Study|Lack of Efficacy|2|||
146158850|NCT00360308|527092708|FG000|Overall Study|Other|2|||
146310561|NCT03116698|527650228|FG001|Overall Study|Death|0|||
146310562|NCT03116698|527650229|FG002|Overall Study|Death|2|||
146310563|NCT03116698|527650230|FG003|Overall Study|Death|0|||
146310564|NCT03099187|527650233|FG000|Double-blind Treatment|Adverse Event|19|||
146310565|NCT03099187|527650234|FG001|Double-blind Treatment|Adverse Event|1|||
146310566|NCT03099187|527650235|FG002|Double-blind Treatment|Adverse Event|0|||
146310567|NCT03099187|527650236|FG003|Double-blind Treatment|Adverse Event|0|||
146310568|NCT03099187|527650233|FG000|Double-blind Treatment|Death|1|||
146310569|NCT03099187|527650234|FG001|Double-blind Treatment|Death|3|||
146310570|NCT03099187|527650235|FG002|Double-blind Treatment|Death|0|||
146310571|NCT03099187|527650236|FG003|Double-blind Treatment|Death|0|||
146310572|NCT03099187|527650233|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146310573|NCT03099187|527650234|FG001|Double-blind Treatment|Lack of Efficacy|0|||
146310574|NCT03099187|527650235|FG002|Double-blind Treatment|Lack of Efficacy|0|||
146310575|NCT03099187|527650236|FG003|Double-blind Treatment|Lack of Efficacy|0|||
146310576|NCT03099187|527650233|FG000|Double-blind Treatment|Physician Decision|2|||
146310577|NCT03099187|527650234|FG001|Double-blind Treatment|Physician Decision|1|||
146310578|NCT03099187|527650235|FG002|Double-blind Treatment|Physician Decision|0|||
146310579|NCT03099187|527650236|FG003|Double-blind Treatment|Physician Decision|0|||
146310580|NCT03099187|527650233|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
146310581|NCT03099187|527650234|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
146310582|NCT03099187|527650235|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
146310583|NCT03099187|527650236|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
146310584|NCT03099187|527650233|FG000|Double-blind Treatment|Lung transplantation|0|||
146310585|NCT03099187|527650234|FG001|Double-blind Treatment|Lung transplantation|1|||
146310586|NCT03099187|527650235|FG002|Double-blind Treatment|Lung transplantation|0|||
146310587|NCT03099187|527650236|FG003|Double-blind Treatment|Lung transplantation|0|||
146310588|NCT03099187|527650233|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
146310589|NCT03099187|527650234|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
146310590|NCT03099187|527650235|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
146310591|NCT03099187|527650236|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
146310592|NCT03099187|527650233|FG000|Double-blind Treatment|Disease progression|0|||
146310593|NCT03099187|527650234|FG001|Double-blind Treatment|Disease progression|1|||
146310594|NCT03099187|527650235|FG002|Double-blind Treatment|Disease progression|0|||
146310595|NCT03099187|527650236|FG003|Double-blind Treatment|Disease progression|0|||
146310596|NCT03099187|527650233|FG000|Double-blind Treatment|Randomization error|0|||
146310597|NCT03099187|527650234|FG001|Double-blind Treatment|Randomization error|2|||
146310598|NCT03099187|527650235|FG002|Double-blind Treatment|Randomization error|0|||
146310599|NCT03099187|527650236|FG003|Double-blind Treatment|Randomization error|0|||
146310600|NCT03099187|527650233|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
146310601|NCT03099187|527650234|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
146310602|NCT03099187|527650235|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
146310603|NCT03099187|527650236|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
146310604|NCT03099187|527650233|FG000|12-month Safety Follow-up|Adverse Event|0|||
146310605|NCT03099187|527650234|FG001|12-month Safety Follow-up|Adverse Event|0|||
146310606|NCT03099187|527650235|FG002|12-month Safety Follow-up|Adverse Event|5|||
146310607|NCT03099187|527650236|FG003|12-month Safety Follow-up|Adverse Event|12|||
146310608|NCT03099187|527650233|FG000|12-month Safety Follow-up|Death|0|||
146310609|NCT03099187|527650234|FG001|12-month Safety Follow-up|Death|0|||
146310610|NCT03099187|527650235|FG002|12-month Safety Follow-up|Death|7|||
146310611|NCT03099187|527650236|FG003|12-month Safety Follow-up|Death|9|||
146310612|NCT03099187|527650233|FG000|12-month Safety Follow-up|Lung transplantation|0|||
146310613|NCT03099187|527650234|FG001|12-month Safety Follow-up|Lung transplantation|0|||
146310614|NCT03099187|527650235|FG002|12-month Safety Follow-up|Lung transplantation|2|||
146310615|NCT03099187|527650236|FG003|12-month Safety Follow-up|Lung transplantation|1|||
146310616|NCT03099187|527650233|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
146310617|NCT03099187|527650234|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
146310618|NCT03099187|527650235|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
146310619|NCT03099187|527650236|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
146310620|NCT03099187|527650233|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
146310621|NCT03099187|527650234|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
146310622|NCT03099187|527650235|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
146310623|NCT03099187|527650236|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
146310624|NCT03099187|527650233|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
146310625|NCT03099187|527650234|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
146310626|NCT03099187|527650235|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
146310627|NCT03099187|527650236|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
146158851|NCT00360308|527092709|FG001|Overall Study|Other|1|||
146310628|NCT03099187|527650233|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
146310629|NCT03099187|527650234|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
146310630|NCT03099187|527650235|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
146310631|NCT03099187|527650236|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
146310632|NCT00517751|527650237|FG000|Overall Study|Death|3|||
146310633|NCT00517751|527650237|FG000|Overall Study|Withdrawal by Subject|37|||
146310634|NCT00517751|527650237|FG000|Overall Study|Lost to Follow-up|4|||
146310635|NCT00517751|527650237|FG000|Overall Study|patient not over due|6|||
146310636|NCT00517751|527650237|FG000|Overall Study|Patient not due for visit|76|||
146310637|NCT00517751|527650237|FG000|Overall Study|Missing|3|||
146310638|NCT00495820|527650238|FG000|Overall Study|Adverse Event|1|||
146310639|NCT00495820|527650239|FG001|Overall Study|Adverse Event|1|||
146310640|NCT02581202|527650245|FG000|Overall Study|Lack of Efficacy|2|||
146310641|NCT02581202|527650245|FG000|Overall Study|Withdrawal by Subject|4|||
146310642|NCT02581202|527650245|FG000|Overall Study|Lost to Follow-up|5|||
146310643|NCT02581202|527650245|FG000|Overall Study|Pregnancy|3|||
146310644|NCT04050982|527650246|FG000|Overall Study|Did not meet eligibility criteria|0|||
146310645|NCT04050982|527650247|FG001|Overall Study|Did not meet eligibility criteria|1|||
146310646|NCT04050982|527650248|FG002|Overall Study|Did not meet eligibility criteria|0|||
146310647|NCT04050982|527650246|FG000|Overall Study|Withdrawal by Subject|1|||
146310648|NCT04050982|527650247|FG001|Overall Study|Withdrawal by Subject|0|||
146310649|NCT04050982|527650248|FG002|Overall Study|Withdrawal by Subject|0|||
146310650|NCT04050982|527650246|FG000|Overall Study|Unable to enroll on platform|1|||
146310651|NCT04050982|527650247|FG001|Overall Study|Unable to enroll on platform|0|||
146310652|NCT04050982|527650248|FG002|Overall Study|Unable to enroll on platform|0|||
146310653|NCT01246583|527650249|FG000|Overall Study|Lost to Follow-up|0|||
146310654|NCT01246583|527650250|FG001|Overall Study|Lost to Follow-up|0|||
146310655|NCT01246583|527650251|FG002|Overall Study|Lost to Follow-up|0|||
146310656|NCT01246583|527650252|FG003|Overall Study|Lost to Follow-up|1|||
146310657|NCT01246583|527650249|FG000|Overall Study|Protocol Violation|0|||
146310658|NCT01246583|527650250|FG001|Overall Study|Protocol Violation|0|||
146310659|NCT01246583|527650251|FG002|Overall Study|Protocol Violation|1|||
146310660|NCT01246583|527650252|FG003|Overall Study|Protocol Violation|0|||
146310661|NCT01246583|527650249|FG000|Overall Study|Withdrawal by Subject|1|||
146310662|NCT01246583|527650250|FG001|Overall Study|Withdrawal by Subject|0|||
146310663|NCT01246583|527650251|FG002|Overall Study|Withdrawal by Subject|0|||
146310664|NCT01246583|527650252|FG003|Overall Study|Withdrawal by Subject|0|||
146310665|NCT02116777|527650253|FG000|Overall Study|Adverse Event|0|||
146310666|NCT02116777|527650254|FG001|Overall Study|Adverse Event|0|||
146310667|NCT02116777|527650255|FG002|Overall Study|Adverse Event|0|||
146310668|NCT02116777|527650256|FG003|Overall Study|Adverse Event|0|||
146310669|NCT02116777|527650257|FG004|Overall Study|Adverse Event|2|||
146310670|NCT02116777|527650258|FG005|Overall Study|Adverse Event|2|||
146310671|NCT02116777|527650259|FG006|Overall Study|Adverse Event|0|||
146310672|NCT02116777|527650253|FG000|Overall Study|Death|0|||
146310673|NCT02116777|527650254|FG001|Overall Study|Death|0|||
146310674|NCT02116777|527650255|FG002|Overall Study|Death|0|||
146310675|NCT02116777|527650256|FG003|Overall Study|Death|1|||
146310676|NCT02116777|527650257|FG004|Overall Study|Death|0|||
146310677|NCT02116777|527650258|FG005|Overall Study|Death|0|||
146310678|NCT02116777|527650259|FG006|Overall Study|Death|0|||
146310679|NCT02116777|527650253|FG000|Overall Study|Lack of Efficacy|3|||
146310680|NCT02116777|527650254|FG001|Overall Study|Lack of Efficacy|3|||
146310681|NCT02116777|527650255|FG002|Overall Study|Lack of Efficacy|3|||
146310682|NCT02116777|527650256|FG003|Overall Study|Lack of Efficacy|8|||
146310683|NCT02116777|527650257|FG004|Overall Study|Lack of Efficacy|4|||
146310684|NCT02116777|527650258|FG005|Overall Study|Lack of Efficacy|1|||
146310685|NCT02116777|527650259|FG006|Overall Study|Lack of Efficacy|9|||
146310686|NCT02116777|527650253|FG000|Overall Study|Physician Decision|0|||
146310687|NCT02116777|527650254|FG001|Overall Study|Physician Decision|0|||
146310688|NCT02116777|527650255|FG002|Overall Study|Physician Decision|0|||
146310689|NCT02116777|527650256|FG003|Overall Study|Physician Decision|2|||
146310690|NCT02116777|527650257|FG004|Overall Study|Physician Decision|0|||
146310691|NCT02116777|527650258|FG005|Overall Study|Physician Decision|0|||
146310692|NCT02116777|527650259|FG006|Overall Study|Physician Decision|0|||
146310693|NCT02116777|527650253|FG000|Overall Study|Protocol Violation|0|||
146310694|NCT02116777|527650254|FG001|Overall Study|Protocol Violation|0|||
146310695|NCT02116777|527650255|FG002|Overall Study|Protocol Violation|0|||
146310696|NCT02116777|527650256|FG003|Overall Study|Protocol Violation|1|||
146310697|NCT02116777|527650257|FG004|Overall Study|Protocol Violation|0|||
146310698|NCT02116777|527650258|FG005|Overall Study|Protocol Violation|0|||
146310699|NCT02116777|527650259|FG006|Overall Study|Protocol Violation|0|||
146310700|NCT02116777|527650253|FG000|Overall Study|Withdrawal by Subject|0|||
146310701|NCT02116777|527650254|FG001|Overall Study|Withdrawal by Subject|0|||
146310702|NCT02116777|527650255|FG002|Overall Study|Withdrawal by Subject|0|||
146310703|NCT02116777|527650256|FG003|Overall Study|Withdrawal by Subject|1|||
146310704|NCT02116777|527650257|FG004|Overall Study|Withdrawal by Subject|0|||
146310705|NCT02116777|527650258|FG005|Overall Study|Withdrawal by Subject|0|||
146310706|NCT02116777|527650259|FG006|Overall Study|Withdrawal by Subject|0|||
146310707|NCT01423851|527650261|FG000|Whole Study|Disease progression|2|||
146310708|NCT01423851|527650262|FG001|Whole Study|Disease progression|1|||
146310709|NCT01423851|527650263|FG002|Whole Study|Disease progression|1|||
146310710|NCT01423851|527650264|FG003|Whole Study|Disease progression|4|||
146310711|NCT01423851|527650265|FG004|Whole Study|Disease progression|1|||
146310712|NCT01423851|527650266|FG005|Whole Study|Disease progression|3|||
146310713|NCT01423851|527650267|FG006|Whole Study|Disease progression|1|||
146310714|NCT01423851|527650268|FG007|Whole Study|Disease progression|4|||
146310715|NCT01423851|527650269|FG008|Whole Study|Disease progression|0|||
146310716|NCT01423851|527650270|FG009|Whole Study|Disease progression|2|||
146310717|NCT01423851|527650271|FG010|Whole Study|Disease progression|10|||
146310718|NCT01423851|527650261|FG000|Whole Study|Physician Decision|0|||
146310719|NCT01423851|527650262|FG001|Whole Study|Physician Decision|1|||
146310720|NCT01423851|527650263|FG002|Whole Study|Physician Decision|2|||
146310721|NCT01423851|527650264|FG003|Whole Study|Physician Decision|0|||
146310722|NCT01423851|527650265|FG004|Whole Study|Physician Decision|2|||
146310723|NCT01423851|527650266|FG005|Whole Study|Physician Decision|0|||
146310724|NCT01423851|527650267|FG006|Whole Study|Physician Decision|2|||
146310725|NCT01423851|527650268|FG007|Whole Study|Physician Decision|1|||
146310726|NCT01423851|527650269|FG008|Whole Study|Physician Decision|3|||
146310727|NCT01423851|527650270|FG009|Whole Study|Physician Decision|4|||
146310728|NCT01423851|527650271|FG010|Whole Study|Physician Decision|12|||
146310729|NCT01423851|527650261|FG000|Whole Study|Withdrawal by Subject|1|||
146310730|NCT01423851|527650262|FG001|Whole Study|Withdrawal by Subject|1|||
146310731|NCT01423851|527650263|FG002|Whole Study|Withdrawal by Subject|0|||
146310732|NCT01423851|527650264|FG003|Whole Study|Withdrawal by Subject|0|||
146310733|NCT01423851|527650265|FG004|Whole Study|Withdrawal by Subject|0|||
146310734|NCT01423851|527650266|FG005|Whole Study|Withdrawal by Subject|0|||
146310735|NCT01423851|527650267|FG006|Whole Study|Withdrawal by Subject|0|||
146310736|NCT01423851|527650268|FG007|Whole Study|Withdrawal by Subject|0|||
146310737|NCT01423851|527650269|FG008|Whole Study|Withdrawal by Subject|2|||
146310738|NCT01423851|527650270|FG009|Whole Study|Withdrawal by Subject|0|||
146310739|NCT01423851|527650271|FG010|Whole Study|Withdrawal by Subject|4|||
146310740|NCT01423851|527650261|FG000|Whole Study|Adverse Event|0|||
146158852|NCT00360308|527092710|FG002|Overall Study|Other|1|||
146158853|NCT00360308|527092708|FG000|Overall Study|Study termination by sponsor|43|||
146158854|NCT00360308|527092709|FG001|Overall Study|Study termination by sponsor|55|||
146158855|NCT00360308|527092710|FG002|Overall Study|Study termination by sponsor|44|||
146158856|NCT04786444|527092711|FG000|Overall Study|Withdrawal by Subject|4|||
146158857|NCT04786444|527092712|FG001|Overall Study|Withdrawal by Subject|7|||
146158858|NCT04786444|527092713|FG002|Overall Study|Withdrawal by Subject|2|||
146158859|NCT04786444|527092711|FG000|Overall Study|Lost to Follow-up|11|||
146158860|NCT04786444|527092712|FG001|Overall Study|Lost to Follow-up|9|||
146158861|NCT04786444|527092713|FG002|Overall Study|Lost to Follow-up|10|||
146158862|NCT04786444|527092711|FG000|Overall Study|Subject would like to become pregnant|0|||
146158863|NCT04786444|527092712|FG001|Overall Study|Subject would like to become pregnant|1|||
146158864|NCT04786444|527092713|FG002|Overall Study|Subject would like to become pregnant|0|||
146158865|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
146158866|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
146158867|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
146158868|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
146158869|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
146158870|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
146158871|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
146158872|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
146158873|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
146158874|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
146158875|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
146158876|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
146158877|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
146158878|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
146158879|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
146158880|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
146158881|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
146310741|NCT01423851|527650262|FG001|Whole Study|Adverse Event|0|||
146310742|NCT01423851|527650263|FG002|Whole Study|Adverse Event|0|||
146310743|NCT01423851|527650264|FG003|Whole Study|Adverse Event|2|||
146310744|NCT01423851|527650265|FG004|Whole Study|Adverse Event|0|||
146310745|NCT01423851|527650266|FG005|Whole Study|Adverse Event|0|||
146310746|NCT01423851|527650267|FG006|Whole Study|Adverse Event|0|||
146310747|NCT01423851|527650268|FG007|Whole Study|Adverse Event|3|||
146310748|NCT01423851|527650269|FG008|Whole Study|Adverse Event|3|||
146310749|NCT01423851|527650270|FG009|Whole Study|Adverse Event|2|||
146310750|NCT01423851|527650271|FG010|Whole Study|Adverse Event|3|||
146310751|NCT03416153|527650275|FG000|Overall Study|Physician Decision|1|||
146310752|NCT03416153|527650276|FG001|Overall Study|Physician Decision|1|||
146310753|NCT03416153|527650275|FG000|Overall Study|Withdrawal by Subject|1|||
146310754|NCT03416153|527650276|FG001|Overall Study|Withdrawal by Subject|0|||
146158882|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
146158883|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
146158884|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
146158885|NCT04162769|527092714|FG000|Double-blind Treatment (12-Week)|Other|0|||
146158886|NCT04162769|527092715|FG001|Double-blind Treatment (12-Week)|Other|1|||
146158887|NCT04162769|527092716|FG002|Double-blind Treatment (12-Week)|Other|1|||
146158888|NCT04162769|527092717|FG003|Double-blind Treatment (12-Week)|Other|0|||
146158889|NCT04162769|527092714|FG000|OLE Period (52-Week)|Adverse Event|0|||
146158890|NCT04162769|527092715|FG001|OLE Period (52-Week)|Adverse Event|0|||
146158891|NCT04162769|527092716|FG002|OLE Period (52-Week)|Adverse Event|0|||
146158892|NCT04162769|527092717|FG003|OLE Period (52-Week)|Adverse Event|5|||
146158893|NCT04162769|527092714|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
146158894|NCT04162769|527092715|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
146158895|NCT04162769|527092716|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
146158896|NCT04162769|527092717|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
146158897|NCT04162769|527092714|FG000|OLE Period (52-Week)|Physician Decision|0|||
146158898|NCT04162769|527092715|FG001|OLE Period (52-Week)|Physician Decision|0|||
146158899|NCT04162769|527092716|FG002|OLE Period (52-Week)|Physician Decision|0|||
146158900|NCT04162769|527092717|FG003|OLE Period (52-Week)|Physician Decision|1|||
146158901|NCT04162769|527092714|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
146158902|NCT04162769|527092715|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
146158903|NCT04162769|527092716|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
146158904|NCT04162769|527092717|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
146158905|NCT04162769|527092714|FG000|OLE Period (52-Week)|Protocol deviation|0|||
146158906|NCT04162769|527092715|FG001|OLE Period (52-Week)|Protocol deviation|0|||
146158907|NCT04162769|527092716|FG002|OLE Period (52-Week)|Protocol deviation|0|||
146158908|NCT04162769|527092717|FG003|OLE Period (52-Week)|Protocol deviation|2|||
146158909|NCT00713648|527092718|FG000|Overall Study|Adverse Event|1|||
146158910|NCT00713648|527092718|FG000|Overall Study|Unclassified|2|||
146158911|NCT00713648|527092718|FG000|Overall Study|According to Protocol|2|||
146158912|NCT00713648|527092718|FG000|Overall Study|Development of antibodies|3|||
146158913|NCT00082173|527092719|FG000|Overall Study|Withdrawal by Subject|3|||
146158914|NCT00082173|527092720|FG001|Overall Study|Withdrawal by Subject|5|||
146158915|NCT00082173|527092719|FG000|Overall Study|Lost to Follow-up|1|||
146158916|NCT00082173|527092720|FG001|Overall Study|Lost to Follow-up|0|||
146158917|NCT00082173|527092719|FG000|Overall Study|Adverse Event|1|||
146158918|NCT00082173|527092720|FG001|Overall Study|Adverse Event|0|||
146158919|NCT00082173|527092719|FG000|Overall Study|Culture negative or resistant at baselin|5|||
146158920|NCT00082173|527092720|FG001|Overall Study|Culture negative or resistant at baselin|6|||
146158921|NCT00464815|527092723|FG000|Overall Study|Withdrawal by Subject|6|||
146279549|NCT01365481|527538628|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146279550|NCT01365481|527538629|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146279551|NCT01365481|527538630|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146279552|NCT01365481|527538631|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146279553|NCT01365481|527538628|FG000|Overall Study|Administrative problems|0|||
146279554|NCT01365481|527538629|FG001|Overall Study|Administrative problems|1|||
146279555|NCT01365481|527538630|FG002|Overall Study|Administrative problems|0|||
146279556|NCT01365481|527538631|FG003|Overall Study|Administrative problems|0|||
146279557|NCT01365481|527538628|FG000|Overall Study|Protocol deviation|0|||
146279558|NCT01365481|527538629|FG001|Overall Study|Protocol deviation|1|||
146279559|NCT01365481|527538630|FG002|Overall Study|Protocol deviation|0|||
146279560|NCT01365481|527538631|FG003|Overall Study|Protocol deviation|1|||
146279561|NCT01365481|527538628|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146279562|NCT01365481|527538629|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146279563|NCT01365481|527538630|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146279564|NCT01365481|527538631|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146279565|NCT00958841|527538636|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146279566|NCT00958841|527538636|FG000|Overall Study|Abnormal test procedure result(s)|3|||
146279567|NCT00958841|527538636|FG000|Overall Study|Administrative problems|1|||
146158922|NCT00464815|527092724|FG001|Overall Study|Withdrawal by Subject|3|||
146158923|NCT00487162|527092728|FG000|Overall Study|Adverse Event|0|||
146158924|NCT00487162|527092729|FG001|Overall Study|Adverse Event|1|||
146158925|NCT00487162|527092728|FG000|Overall Study|Physician Decision|0|||
146158926|NCT00487162|527092729|FG001|Overall Study|Physician Decision|1|||
146158927|NCT00487162|527092728|FG000|Overall Study|Withdrawal by Subject|2|||
146158928|NCT00487162|527092729|FG001|Overall Study|Withdrawal by Subject|3|||
146158929|NCT00815295|527092732|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
146158930|NCT00815295|527092733|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
146158931|NCT00815295|527092734|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
146158932|NCT01433354|527092739|FG000|Overall Study|Adverse Event|6|||
146158933|NCT01433354|527092739|FG000|Overall Study|Lost to Follow-up|1|||
146279568|NCT00958841|527538636|FG000|Overall Study|Adverse Event|8|||
146279569|NCT00958841|527538636|FG000|Overall Study|New cancer therapy|5|||
146279570|NCT00958841|527538636|FG000|Overall Study|Withdrawal by Subject|1|||
146310755|NCT04129528|527651773|FG000|Overall Study|Adverse Event|1|||
146158934|NCT01433354|527092739|FG000|Overall Study|Administrative problems|90|||
146158935|NCT01433354|527092739|FG000|Overall Study|Protocol Violation|2|||
146158936|NCT01433354|527092739|FG000|Overall Study|Lack of Efficacy|17|||
146158937|NCT01433354|527092739|FG000|Overall Study|Subject Withdrew Consent|3|||
146158938|NCT01618162|527092744|FG000|Overall Study|Protocol Violation|13|||
146158939|NCT01618162|527092745|FG001|Overall Study|Protocol Violation|10|||
146158940|NCT01618162|527092744|FG000|Overall Study|Adverse Event|9|||
146158941|NCT01618162|527092745|FG001|Overall Study|Adverse Event|2|||
146158942|NCT01618162|527092744|FG000|Overall Study|Withdrawal Criteria|2|||
146279571|NCT00958841|527538636|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
146279572|NCT00958841|527538636|FG000|Overall Study|Completed M6/did not enter extension|27|||
146279573|NCT00958841|527538636|FG000|Overall Study|Discontinued prior to M*|28|||
146279574|NCT00403767|527538637|FG000|Overall Study|Adverse Event|993|||
146279575|NCT00403767|527538638|FG001|Overall Study|Adverse Event|919|||
146279576|NCT00403767|527538637|FG000|Overall Study|Non-compliant with study medication|134|||
146279577|NCT00403767|527538638|FG001|Overall Study|Non-compliant with study medication|164|||
146279578|NCT00403767|527538637|FG000|Overall Study|Consent withdrawn|671|||
146279579|NCT00403767|527538638|FG001|Overall Study|Consent withdrawn|673|||
146279580|NCT00403767|527538637|FG000|Overall Study|Investigator dec./not protocol-related|191|||
146279581|NCT00403767|527538638|FG001|Overall Study|Investigator dec./not protocol-related|178|||
146279582|NCT00403767|527538637|FG000|Overall Study|Lost to Follow-up|6|||
146279583|NCT00403767|527538638|FG001|Overall Study|Lost to Follow-up|8|||
146279584|NCT00403767|527538637|FG000|Overall Study|Protocol Violation|142|||
146279585|NCT00403767|527538638|FG001|Overall Study|Protocol Violation|124|||
146279586|NCT00403767|527538637|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
146279587|NCT00403767|527538638|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
146279588|NCT00403767|527538637|FG000|Overall Study|Study terminated by sponsor|82|||
146279589|NCT00403767|527538638|FG001|Overall Study|Study terminated by sponsor|69|||
146279590|NCT00403767|527538637|FG000|Overall Study|Missing/incomplete data|1|||
146279591|NCT00403767|527538638|FG001|Overall Study|Missing/incomplete data|1|||
146279592|NCT03192475|527538639|FG000|Overall Study|Death|0|||
146279593|NCT03192475|527538640|FG001|Overall Study|Death|1|||
146279594|NCT03192475|527538639|FG000|Overall Study|Lost to Follow-up|13|||
146279595|NCT03192475|527538640|FG001|Overall Study|Lost to Follow-up|8|||
146279596|NCT00798590|527538641|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
146279597|NCT00798590|527538642|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
146279598|NCT00436605|527538646|FG000|Overall Study|Protocol Violation|3|||
146279599|NCT03014011|527538647|FG000|First Intervention|Withdrawal by Subject|1|||
146279600|NCT03014011|527538648|FG001|First Intervention|Withdrawal by Subject|0|||
146279601|NCT03014011|527538647|FG000|Washout|Withdrawal by Subject|1|||
146279602|NCT03014011|527538648|FG001|Washout|Withdrawal by Subject|0|||
146279603|NCT00573859|527538651|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
146279604|NCT00573859|527538651|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
146279605|NCT01259089|527538665|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146279606|NCT01259089|527538666|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146279607|NCT01259089|527538667|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146279608|NCT01259089|527538668|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146279609|NCT01259089|527538669|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
146279610|NCT01259089|527538670|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
146279611|NCT01259089|527538665|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
146279612|NCT01259089|527538666|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
146279613|NCT01259089|527538667|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
146279614|NCT01259089|527538668|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
146279615|NCT01259089|527538669|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
146279616|NCT01259089|527538670|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
146279617|NCT01259089|527538665|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146279618|NCT01259089|527538666|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146279619|NCT01259089|527538667|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146279620|NCT01259089|527538668|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146279621|NCT01259089|527538669|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
146279622|NCT01259089|527538670|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
146279623|NCT01259089|527538665|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
146279624|NCT01259089|527538666|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
146279625|NCT01259089|527538667|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
146158943|NCT01618162|527092745|FG001|Overall Study|Withdrawal Criteria|10|||
146158944|NCT01618162|527092744|FG000|Overall Study|Unclassified|14|||
146158945|NCT01618162|527092745|FG001|Overall Study|Unclassified|13|||
146279626|NCT01259089|527538668|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
146279627|NCT01259089|527538669|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
146279628|NCT01259089|527538670|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
146279629|NCT01259089|527538665|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
146279630|NCT01259089|527538666|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
146279631|NCT01259089|527538667|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
146158946|NCT00476476|527092746|FG000|Overall Study|Adverse Event|2|||
146158947|NCT00476476|527092747|FG001|Overall Study|Adverse Event|7|||
146158948|NCT00476476|527092746|FG000|Overall Study|Progressive Disease|0|||
146158949|NCT00476476|527092747|FG001|Overall Study|Progressive Disease|17|||
146158950|NCT04794803|527092749|FG000|Overall Study|Death|1|||
146279632|NCT01259089|527538668|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
146279633|NCT01259089|527538669|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
146279634|NCT01259089|527538670|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
146279635|NCT01259089|527538665|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
146279636|NCT01259089|527538666|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146279637|NCT01259089|527538667|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146279638|NCT01259089|527538668|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146279639|NCT01259089|527538669|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146279640|NCT01259089|527538670|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
146279641|NCT01259089|527538665|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
146279642|NCT01259089|527538666|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
146279643|NCT01259089|527538667|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
146279644|NCT01259089|527538668|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
146279645|NCT01259089|527538669|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
146279646|NCT01259089|527538670|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
146279647|NCT01259089|527538665|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
146279648|NCT01259089|527538666|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
146279649|NCT01259089|527538667|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
146279650|NCT01259089|527538668|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
146279651|NCT01259089|527538669|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
146279652|NCT01259089|527538670|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
146279653|NCT01259089|527538665|FG000|Survival Follow up for Two Years|Death|3|||
146279654|NCT01259089|527538666|FG001|Survival Follow up for Two Years|Death|2|||
146279655|NCT01259089|527538667|FG002|Survival Follow up for Two Years|Death|2|||
146279656|NCT01259089|527538668|FG003|Survival Follow up for Two Years|Death|3|||
146279657|NCT01259089|527538669|FG004|Survival Follow up for Two Years|Death|6|||
146279658|NCT01259089|527538670|FG005|Survival Follow up for Two Years|Death|13|||
146279659|NCT01259089|527538665|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
146279660|NCT01259089|527538666|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
146279661|NCT01259089|527538667|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
146279662|NCT01259089|527538668|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
146279663|NCT01259089|527538669|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
146279664|NCT01259089|527538670|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
146279665|NCT01259089|527538665|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146279666|NCT01259089|527538666|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146279667|NCT01259089|527538667|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146279668|NCT01259089|527538668|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146279669|NCT01259089|527538669|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
146279670|NCT01259089|527538670|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
146279671|NCT02310100|527538671|FG000|Overall Study|Physician Decision|3|||
146279672|NCT02310100|527538671|FG000|Overall Study|Withdrawal by Subject|10|||
146279673|NCT02310100|527538671|FG000|Overall Study|Enrollment closure|1|||
146279674|NCT02310100|527538671|FG000|Overall Study|Unapproved ablation operator|1|||
146279675|NCT02310100|527538671|FG000|Overall Study|Visit compliance|1|||
146279676|NCT02310100|527538671|FG000|Overall Study|Lost to Follow-up|2|||
146279677|NCT00688870|527538672|FG000|Infant Series|Parent or legal guardian request|4|||
146279678|NCT00688870|527538673|FG001|Infant Series|Parent or legal guardian request|0|||
146279679|NCT01253018|527538679|FG000|Overall Study|Lost to Follow-up|1|||
146279680|NCT01253018|527538680|FG001|Overall Study|Lost to Follow-up|1|||
146279681|NCT01253018|527538679|FG000|Overall Study|Robot Repair Issues|2|||
146279682|NCT01253018|527538680|FG001|Overall Study|Robot Repair Issues|0|||
146279683|NCT01253018|527538679|FG000|Overall Study|Withdrawal by Subject|1|||
146279684|NCT01253018|527538680|FG001|Overall Study|Withdrawal by Subject|1|||
146279685|NCT03449901|527538681|FG000|Overall Study|Progression|57|||
146279686|NCT03449901|527538682|FG001|Overall Study|Progression|12|||
146279687|NCT03449901|527538681|FG000|Overall Study|Adverse Event|3|||
146279688|NCT03449901|527538682|FG001|Overall Study|Adverse Event|0|||
146279689|NCT03449901|527538681|FG000|Overall Study|Death|6|||
146279690|NCT03449901|527538682|FG001|Overall Study|Death|2|||
146279691|NCT03449901|527538681|FG000|Overall Study|Withdrawal by Subject|12|||
146279692|NCT03449901|527538682|FG001|Overall Study|Withdrawal by Subject|1|||
146279693|NCT03449901|527538681|FG000|Overall Study|Physician Decision|1|||
146279694|NCT03449901|527538682|FG001|Overall Study|Physician Decision|0|||
146158951|NCT04794803|527092750|FG001|Overall Study|Death|3|||
146158952|NCT04794803|527092749|FG000|Overall Study|Lost to Follow-up|2|||
146279695|NCT03449901|527538681|FG000|Overall Study|Patient elected for surgical intervention|1|||
146279696|NCT03449901|527538682|FG001|Overall Study|Patient elected for surgical intervention|0|||
146310756|NCT04129528|527651774|FG001|Overall Study|Adverse Event|0|||
146310757|NCT04129528|527651773|FG000|Overall Study|Physician Decision|1|||
146310758|NCT04129528|527651774|FG001|Overall Study|Physician Decision|1|||
146310759|NCT04129528|527651773|FG000|Overall Study|Withdrawal by Subject|1|||
146310760|NCT04129528|527651774|FG001|Overall Study|Withdrawal by Subject|1|||
146310761|NCT01395394|527651778|FG000|Baseline Study Visit|Protocol Violation|1|||
146310762|NCT01395394|527651779|FG001|Baseline Study Visit|Protocol Violation|0|||
146310763|NCT01395394|527651780|FG002|Baseline Study Visit|Protocol Violation|0|||
146310764|NCT05121480|527651781|FG000|Overall Study|Lack of Efficacy|2|||
146310765|NCT05121480|527651782|FG001|Overall Study|Lack of Efficacy|2|||
146310766|NCT05121480|527651783|FG002|Overall Study|Lack of Efficacy|1|||
146310767|NCT05121480|527651784|FG003|Overall Study|Lack of Efficacy|4|||
146310768|NCT05121480|527651785|FG004|Overall Study|Lack of Efficacy|0|||
146310769|NCT05121480|527651786|FG005|Overall Study|Lack of Efficacy|1|||
146310770|NCT05121480|527651787|FG006|Overall Study|Lack of Efficacy|0|||
146310771|NCT05121480|527651788|FG007|Overall Study|Lack of Efficacy|2|||
146310772|NCT05121480|527651781|FG000|Overall Study|Treatment Failure|0|||
146310773|NCT05121480|527651782|FG001|Overall Study|Treatment Failure|2|||
146310774|NCT05121480|527651783|FG002|Overall Study|Treatment Failure|0|||
146310775|NCT05121480|527651784|FG003|Overall Study|Treatment Failure|1|||
146310776|NCT05121480|527651785|FG004|Overall Study|Treatment Failure|0|||
146310777|NCT05121480|527651786|FG005|Overall Study|Treatment Failure|0|||
146310778|NCT05121480|527651787|FG006|Overall Study|Treatment Failure|0|||
146310779|NCT05121480|527651788|FG007|Overall Study|Treatment Failure|0|||
146310780|NCT05121480|527651781|FG000|Overall Study|Adverse Event|0|||
146310781|NCT05121480|527651782|FG001|Overall Study|Adverse Event|1|||
146310782|NCT05121480|527651783|FG002|Overall Study|Adverse Event|0|||
146310783|NCT05121480|527651784|FG003|Overall Study|Adverse Event|5|||
146310784|NCT05121480|527651785|FG004|Overall Study|Adverse Event|3|||
146310785|NCT05121480|527651786|FG005|Overall Study|Adverse Event|2|||
146310786|NCT05121480|527651787|FG006|Overall Study|Adverse Event|0|||
146310787|NCT05121480|527651788|FG007|Overall Study|Adverse Event|4|||
146310788|NCT05121480|527651781|FG000|Overall Study|Withdrawal by Subject|4|||
146310789|NCT05121480|527651782|FG001|Overall Study|Withdrawal by Subject|9|||
146310790|NCT05121480|527651783|FG002|Overall Study|Withdrawal by Subject|1|||
146310791|NCT05121480|527651784|FG003|Overall Study|Withdrawal by Subject|8|||
146310792|NCT05121480|527651785|FG004|Overall Study|Withdrawal by Subject|0|||
146310793|NCT05121480|527651786|FG005|Overall Study|Withdrawal by Subject|9|||
146310794|NCT05121480|527651787|FG006|Overall Study|Withdrawal by Subject|0|||
146310795|NCT05121480|527651788|FG007|Overall Study|Withdrawal by Subject|4|||
146310796|NCT05121480|527651781|FG000|Overall Study|Non-compliance with the protocol|0|||
146310797|NCT05121480|527651782|FG001|Overall Study|Non-compliance with the protocol|0|||
146310798|NCT05121480|527651783|FG002|Overall Study|Non-compliance with the protocol|0|||
146310799|NCT05121480|527651784|FG003|Overall Study|Non-compliance with the protocol|0|||
146310800|NCT05121480|527651785|FG004|Overall Study|Non-compliance with the protocol|1|||
146310801|NCT05121480|527651786|FG005|Overall Study|Non-compliance with the protocol|6|||
146310802|NCT05121480|527651787|FG006|Overall Study|Non-compliance with the protocol|0|||
146310803|NCT05121480|527651788|FG007|Overall Study|Non-compliance with the protocol|1|||
146310804|NCT05121480|527651781|FG000|Overall Study|Lost to Follow-up|0|||
146310805|NCT05121480|527651782|FG001|Overall Study|Lost to Follow-up|4|||
146310806|NCT05121480|527651783|FG002|Overall Study|Lost to Follow-up|1|||
146310807|NCT05121480|527651784|FG003|Overall Study|Lost to Follow-up|3|||
146310808|NCT05121480|527651785|FG004|Overall Study|Lost to Follow-up|1|||
146310809|NCT05121480|527651786|FG005|Overall Study|Lost to Follow-up|1|||
146310810|NCT05121480|527651787|FG006|Overall Study|Lost to Follow-up|1|||
146310811|NCT05121480|527651788|FG007|Overall Study|Lost to Follow-up|4|||
146310812|NCT05121480|527651781|FG000|Overall Study|Physician Decision|0|||
146310813|NCT05121480|527651782|FG001|Overall Study|Physician Decision|0|||
146310814|NCT05121480|527651783|FG002|Overall Study|Physician Decision|0|||
146310815|NCT05121480|527651784|FG003|Overall Study|Physician Decision|0|||
146310816|NCT05121480|527651785|FG004|Overall Study|Physician Decision|0|||
146310817|NCT05121480|527651786|FG005|Overall Study|Physician Decision|1|||
146310818|NCT05121480|527651787|FG006|Overall Study|Physician Decision|0|||
146310819|NCT05121480|527651788|FG007|Overall Study|Physician Decision|1|||
146310820|NCT05121480|527651781|FG000|Overall Study|Other Reason|0|||
146310821|NCT05121480|527651782|FG001|Overall Study|Other Reason|0|||
146310822|NCT05121480|527651783|FG002|Overall Study|Other Reason|0|||
146310823|NCT05121480|527651784|FG003|Overall Study|Other Reason|0|||
146310824|NCT05121480|527651785|FG004|Overall Study|Other Reason|0|||
146310825|NCT05121480|527651786|FG005|Overall Study|Other Reason|1|||
146310826|NCT05121480|527651787|FG006|Overall Study|Other Reason|1|||
146310827|NCT05121480|527651788|FG007|Overall Study|Other Reason|1|||
146310828|NCT00772954|527651789|FG000|Overall Study|Adverse Event|0|||
146310829|NCT00772954|527651790|FG001|Overall Study|Adverse Event|0|||
146310830|NCT00772954|527651791|FG002|Overall Study|Adverse Event|1|||
146310831|NCT00789529|527651797|FG000|Overall Study|Withdrawal by Subject|0|||
146310832|NCT00789529|527651798|FG001|Overall Study|Withdrawal by Subject|1|||
146310833|NCT00789529|527651797|FG000|Overall Study|Other Reason|1|||
146310834|NCT00789529|527651798|FG001|Overall Study|Other Reason|0|||
146310835|NCT01135498|527651799|FG000|Overall Study|Adverse Event|20|||
146310836|NCT01135498|527651799|FG000|Overall Study|Progressive disease|38|||
146310837|NCT01135498|527651799|FG000|Overall Study|Investigator judgement|25|||
146310838|NCT01135498|527651799|FG000|Overall Study|Withdrawal by Subject|4|||
146310839|NCT01135498|527651799|FG000|Overall Study|Death|1|||
146310840|NCT01135498|527651799|FG000|Overall Study|Ongoing at time of analysis|2|||
146310841|NCT00129766|527651800|FG000|Overall Study|Death|3|||
146310842|NCT00129766|527651801|FG001|Overall Study|Death|8|||
146310843|NCT00129766|527651800|FG000|Overall Study|Withdrawal of consent|31|||
146310844|NCT00129766|527651801|FG001|Overall Study|Withdrawal of consent|30|||
146310845|NCT00129766|527651800|FG000|Overall Study|Lost to Follow-up|26|||
146310846|NCT00129766|527651801|FG001|Overall Study|Lost to Follow-up|21|||
146310847|NCT01081912|527651803|FG000|Conversion/Titration|Adverse Event|47|||
146310848|NCT01081912|527651804|FG001|Conversion/Titration|Adverse Event|0|||
146310849|NCT01081912|527651805|FG002|Conversion/Titration|Adverse Event|0|||
146310850|NCT01081912|527651803|FG000|Conversion/Titration|Lack of Efficacy|17|||
146310851|NCT01081912|527651804|FG001|Conversion/Titration|Lack of Efficacy|0|||
146310852|NCT01081912|527651805|FG002|Conversion/Titration|Lack of Efficacy|0|||
146310853|NCT01081912|527651803|FG000|Conversion/Titration|Lost to Follow-up|5|||
146310854|NCT01081912|527651804|FG001|Conversion/Titration|Lost to Follow-up|0|||
146310855|NCT01081912|527651805|FG002|Conversion/Titration|Lost to Follow-up|0|||
146310856|NCT01081912|527651803|FG000|Conversion/Titration|Physician Decision|2|||
146310857|NCT01081912|527651804|FG001|Conversion/Titration|Physician Decision|0|||
146310858|NCT01081912|527651805|FG002|Conversion/Titration|Physician Decision|0|||
146158953|NCT04794803|527092750|FG001|Overall Study|Lost to Follow-up|2|||
146158954|NCT04794803|527092749|FG000|Overall Study|Withdrawal by Subject|1|||
146158955|NCT04794803|527092750|FG001|Overall Study|Withdrawal by Subject|0|||
146310859|NCT01081912|527651803|FG000|Conversion/Titration|Protocol Violation|67|||
146310860|NCT01081912|527651804|FG001|Conversion/Titration|Protocol Violation|0|||
146310861|NCT01081912|527651805|FG002|Conversion/Titration|Protocol Violation|0|||
146310862|NCT01081912|527651803|FG000|Conversion/Titration|Withdrawal by Subject|23|||
146310863|NCT01081912|527651804|FG001|Conversion/Titration|Withdrawal by Subject|0|||
146310864|NCT01081912|527651805|FG002|Conversion/Titration|Withdrawal by Subject|0|||
146310865|NCT01081912|527651803|FG000|Conversion/Titration|Non-Compliance|47|||
146310866|NCT01081912|527651804|FG001|Conversion/Titration|Non-Compliance|0|||
146310867|NCT01081912|527651805|FG002|Conversion/Titration|Non-Compliance|0|||
146310868|NCT01081912|527651803|FG000|Maintenance Treatment|Adverse Event|0|||
146310869|NCT01081912|527651804|FG001|Maintenance Treatment|Adverse Event|2|||
146310870|NCT01081912|527651805|FG002|Maintenance Treatment|Adverse Event|12|||
146310871|NCT01081912|527651803|FG000|Maintenance Treatment|Lack of Efficacy|0|||
146310872|NCT01081912|527651804|FG001|Maintenance Treatment|Lack of Efficacy|14|||
146310873|NCT01081912|527651805|FG002|Maintenance Treatment|Lack of Efficacy|64|||
146310874|NCT01081912|527651803|FG000|Maintenance Treatment|Lost to Follow-up|0|||
146310875|NCT01081912|527651804|FG001|Maintenance Treatment|Lost to Follow-up|1|||
146310876|NCT01081912|527651805|FG002|Maintenance Treatment|Lost to Follow-up|0|||
146310877|NCT01081912|527651803|FG000|Maintenance Treatment|Physician Decision|0|||
146310878|NCT01081912|527651804|FG001|Maintenance Treatment|Physician Decision|0|||
146310879|NCT01081912|527651805|FG002|Maintenance Treatment|Physician Decision|1|||
146310880|NCT01081912|527651803|FG000|Maintenance Treatment|Protocol Violation|0|||
146310881|NCT01081912|527651804|FG001|Maintenance Treatment|Protocol Violation|1|||
146310882|NCT01081912|527651805|FG002|Maintenance Treatment|Protocol Violation|2|||
146310883|NCT01081912|527651803|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
146310884|NCT01081912|527651804|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
146310885|NCT01081912|527651805|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
146310886|NCT01081912|527651803|FG000|Maintenance Treatment|Non-Compliance|0|||
146310887|NCT01081912|527651804|FG001|Maintenance Treatment|Non-Compliance|4|||
146158956|NCT04794803|527092749|FG000|Overall Study|Physician Decision|1|||
146158957|NCT04794803|527092750|FG001|Overall Study|Physician Decision|1|||
146158958|NCT04794803|527092749|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
146310888|NCT01081912|527651805|FG002|Maintenance Treatment|Non-Compliance|7|||
146310889|NCT01081912|527651803|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
146310890|NCT01081912|527651804|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
146310891|NCT01081912|527651805|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
146310892|NCT02770547|527651809|FG000|Overall Study|Patient non-compliant|1|||
146310893|NCT02770547|527651810|FG001|Overall Study|Patient non-compliant|0|||
146310894|NCT02770547|527651809|FG000|Overall Study|Adverse Event|0|||
146310895|NCT02770547|527651810|FG001|Overall Study|Adverse Event|1|||
146310896|NCT01732796|527651811|FG000|Overall Study|Adverse Event|16|||
146310897|NCT01732796|527651812|FG001|Overall Study|Adverse Event|16|||
146310898|NCT01732796|527651813|FG002|Overall Study|Adverse Event|4|||
146310899|NCT01732796|527651811|FG000|Overall Study|Lack of Efficacy|21|||
146310900|NCT01732796|527651812|FG001|Overall Study|Lack of Efficacy|18|||
146310901|NCT01732796|527651813|FG002|Overall Study|Lack of Efficacy|5|||
146310902|NCT01732796|527651811|FG000|Overall Study|Lost to Follow-up|2|||
146310903|NCT01732796|527651812|FG001|Overall Study|Lost to Follow-up|0|||
146310904|NCT01732796|527651813|FG002|Overall Study|Lost to Follow-up|0|||
146310905|NCT01732796|527651811|FG000|Overall Study|Withdrawal by Subject|6|||
146310906|NCT01732796|527651812|FG001|Overall Study|Withdrawal by Subject|8|||
146310907|NCT01732796|527651813|FG002|Overall Study|Withdrawal by Subject|2|||
146310908|NCT01732796|527651811|FG000|Overall Study|Other reason not defined above|1|||
146310909|NCT01732796|527651812|FG001|Overall Study|Other reason not defined above|0|||
146310910|NCT01732796|527651813|FG002|Overall Study|Other reason not defined above|2|||
146310911|NCT01379274|527651816|FG000|Overall Study|funding withdrawn|1|||
146310912|NCT04081363|527651820|FG000|Overall Study|Withdrawal by Subject|1|||
146310913|NCT04081363|527651821|FG001|Overall Study|Withdrawal by Subject|0|||
146310914|NCT00708500|527651822|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
146310915|NCT00708500|527651823|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
146310916|NCT00708500|527651824|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
146310917|NCT00708500|527651822|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
146310918|NCT00708500|527651823|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
146310919|NCT00708500|527651824|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
146310920|NCT00708500|527651822|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
146310921|NCT00708500|527651823|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
146310922|NCT00708500|527651824|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
146310923|NCT00708500|527651822|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
146310924|NCT00708500|527651823|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
146310925|NCT00708500|527651824|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
146310926|NCT00708500|527651822|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
146310927|NCT00708500|527651823|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
146310928|NCT00708500|527651824|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
146310929|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
146310930|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
146310931|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
146310932|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
146310933|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
146310934|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
146310935|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
146310936|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
146310937|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
146310938|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
146310939|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
146310940|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
146310941|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
146310942|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
146310943|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
146310944|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
146310945|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
146310946|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
146310947|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
146310948|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
146310949|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
146310950|NCT00708500|527651822|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
146310951|NCT00708500|527651823|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
146310952|NCT00708500|527651824|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
146310953|NCT00708500|527651822|FG000|FOLLOWUP|Adverse Event|0|||
146310954|NCT00708500|527651823|FG001|FOLLOWUP|Adverse Event|1|||
146310955|NCT00708500|527651824|FG002|FOLLOWUP|Adverse Event|0|||
146310956|NCT00708500|527651822|FG000|FOLLOWUP|Lost to Follow-up|1|||
146310957|NCT00708500|527651823|FG001|FOLLOWUP|Lost to Follow-up|6|||
146158959|NCT04794803|527092750|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
146158960|NCT04794803|527092749|FG000|Overall Study|Refused to continue the treatment|1|||
146158961|NCT04794803|527092750|FG001|Overall Study|Refused to continue the treatment|0|||
146158962|NCT04794803|527092749|FG000|Overall Study|Patient admitted to ICU|0|||
146310958|NCT00708500|527651824|FG002|FOLLOWUP|Lost to Follow-up|4|||
146310959|NCT00708500|527651822|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
146310960|NCT00708500|527651823|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
146310961|NCT00708500|527651824|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
146310962|NCT00708500|527651822|FG000|FOLLOWUP|Subject withdrew consent|31|||
146310963|NCT00708500|527651823|FG001|FOLLOWUP|Subject withdrew consent|4|||
146310964|NCT00708500|527651824|FG002|FOLLOWUP|Subject withdrew consent|5|||
146310965|NCT00708500|527651822|FG000|FOLLOWUP|Non-compliance with protocol|5|||
146310966|NCT00708500|527651823|FG001|FOLLOWUP|Non-compliance with protocol|0|||
146310967|NCT00708500|527651824|FG002|FOLLOWUP|Non-compliance with protocol|1|||
146310968|NCT03975920|527651827|FG000|Overall Study|Lost to Follow-up|1|||
146310969|NCT03975920|527651828|FG001|Overall Study|Lost to Follow-up|2|||
146310970|NCT03975920|527651827|FG000|Overall Study|Protocol Violation|1|||
146310971|NCT03975920|527651828|FG001|Overall Study|Protocol Violation|1|||
146310972|NCT03975920|527651827|FG000|Overall Study|Did not complete survey|2|||
146310973|NCT03975920|527651828|FG001|Overall Study|Did not complete survey|1|||
146310974|NCT02182687|527651835|FG000|Overall Study|Withdrawal by Subject|4|||
146310975|NCT02182687|527651836|FG001|Overall Study|Withdrawal by Subject|0|||
146310976|NCT02182687|527651835|FG000|Overall Study|Adverse Event|1|||
146310977|NCT02182687|527651836|FG001|Overall Study|Adverse Event|0|||
146310978|NCT02182687|527651835|FG000|Overall Study|Lost to Follow-up|0|||
146310979|NCT02182687|527651836|FG001|Overall Study|Lost to Follow-up|1|||
146310980|NCT03882970|527651839|FG000|Overall Study|Adverse Event|5|||
146310981|NCT03882970|527651840|FG001|Overall Study|Adverse Event|7|||
146310982|NCT03882970|527651841|FG002|Overall Study|Adverse Event|3|||
146310983|NCT03882970|527651842|FG003|Overall Study|Adverse Event|1|||
146310984|NCT03882970|527651839|FG000|Overall Study|Death|1|||
146310985|NCT03882970|527651840|FG001|Overall Study|Death|2|||
146310986|NCT03882970|527651841|FG002|Overall Study|Death|1|||
146310987|NCT03882970|527651842|FG003|Overall Study|Death|1|||
146310988|NCT03882970|527651839|FG000|Overall Study|Lost to Follow-up|8|||
146310989|NCT03882970|527651840|FG001|Overall Study|Lost to Follow-up|9|||
146310990|NCT03882970|527651841|FG002|Overall Study|Lost to Follow-up|5|||
146310991|NCT03882970|527651842|FG003|Overall Study|Lost to Follow-up|5|||
146310992|NCT03882970|527651839|FG000|Overall Study|Physician Decision|0|||
146310993|NCT03882970|527651840|FG001|Overall Study|Physician Decision|2|||
146310994|NCT03882970|527651841|FG002|Overall Study|Physician Decision|2|||
146310995|NCT03882970|527651842|FG003|Overall Study|Physician Decision|2|||
146310996|NCT03882970|527651839|FG000|Overall Study|Protocol Violation|2|||
146310997|NCT03882970|527651840|FG001|Overall Study|Protocol Violation|0|||
146310998|NCT03882970|527651841|FG002|Overall Study|Protocol Violation|0|||
146310999|NCT03882970|527651842|FG003|Overall Study|Protocol Violation|0|||
146311000|NCT03882970|527651839|FG000|Overall Study|Withdrawal by Subject|8|||
146311001|NCT03882970|527651840|FG001|Overall Study|Withdrawal by Subject|17|||
146311002|NCT03882970|527651841|FG002|Overall Study|Withdrawal by Subject|7|||
146311003|NCT03882970|527651842|FG003|Overall Study|Withdrawal by Subject|22|||
146158963|NCT04794803|527092750|FG001|Overall Study|Patient admitted to ICU|1|||
146158964|NCT00971048|527092751|FG000|Overall Study|Protocol Violation|1|||
146158965|NCT00971048|527092752|FG001|Overall Study|Protocol Violation|2|||
146158966|NCT00971048|527092753|FG002|Overall Study|Protocol Violation|0|||
146158967|NCT00971048|527092754|FG003|Overall Study|Protocol Violation|1|||
146158968|NCT00971048|527092751|FG000|Overall Study|Adverse Event|0|||
146158969|NCT00971048|527092752|FG001|Overall Study|Adverse Event|0|||
146158970|NCT00971048|527092753|FG002|Overall Study|Adverse Event|1|||
146158971|NCT00971048|527092754|FG003|Overall Study|Adverse Event|0|||
146158972|NCT00971048|527092751|FG000|Overall Study|Physician Decision|0|||
146158973|NCT00971048|527092752|FG001|Overall Study|Physician Decision|0|||
146158974|NCT00971048|527092753|FG002|Overall Study|Physician Decision|0|||
146158975|NCT00971048|527092754|FG003|Overall Study|Physician Decision|1|||
146158976|NCT00937924|527092762|FG000|Overall Study|Lost to Follow-up|44|||
146158977|NCT00937924|527092763|FG001|Overall Study|Lost to Follow-up|44|||
146158978|NCT00937924|527092764|FG002|Overall Study|Lost to Follow-up|41|||
146158979|NCT03644186|527092779|FG000|Overall Study|Withdrawal by Subject|1|||
146158980|NCT03644186|527092780|FG001|Overall Study|Withdrawal by Subject|1|||
146158981|NCT02701985|527092783|FG000|Overall Study|Withdrawal by Subject|1|||
146158982|NCT02701985|527092784|FG001|Overall Study|Withdrawal by Subject|1|||
146158983|NCT02701985|527092783|FG000|Overall Study|Lost to Follow-up|1|||
146158984|NCT02701985|527092784|FG001|Overall Study|Lost to Follow-up|0|||
146311004|NCT03882970|527651839|FG000|Overall Study|Personal Reason|2|||
146311005|NCT03882970|527651840|FG001|Overall Study|Personal Reason|3|||
146311006|NCT03882970|527651841|FG002|Overall Study|Personal Reason|1|||
146311007|NCT03882970|527651842|FG003|Overall Study|Personal Reason|3|||
146311008|NCT02716987|527651858|FG000|Overall Study|Ligand synthesis failure|0|||
146311009|NCT02716987|527651859|FG001|Overall Study|Ligand synthesis failure|0|||
146311010|NCT02716987|527651860|FG002|Overall Study|Ligand synthesis failure|1|||
146311011|NCT02716987|527651861|FG003|Overall Study|Ligand synthesis failure|0|||
146311012|NCT02716987|527651862|FG004|Overall Study|Ligand synthesis failure|0|||
146158985|NCT02701985|527092783|FG000|Overall Study|Death|1|||
146158986|NCT02701985|527092784|FG001|Overall Study|Death|0|||
146311013|NCT02716987|527651863|FG005|Overall Study|Ligand synthesis failure|0|||
146311014|NCT02716987|527651858|FG000|Overall Study|Withdrawal by Subject|0|||
146311015|NCT02716987|527651859|FG001|Overall Study|Withdrawal by Subject|0|||
146311016|NCT02716987|527651860|FG002|Overall Study|Withdrawal by Subject|0|||
146311017|NCT02716987|527651861|FG003|Overall Study|Withdrawal by Subject|0|||
146158987|NCT02701985|527092783|FG000|Overall Study|Adverse Event|0|||
146158988|NCT02701985|527092784|FG001|Overall Study|Adverse Event|5|||
146311018|NCT02716987|527651862|FG004|Overall Study|Withdrawal by Subject|1|||
146311019|NCT02716987|527651863|FG005|Overall Study|Withdrawal by Subject|1|||
146311020|NCT02829138|527651864|FG000|Overall Study|Withdrawal by Subject|1|||
146311021|NCT02829138|527651865|FG001|Overall Study|Withdrawal by Subject|0|||
146158989|NCT04391023|527092785|FG000|Overall Study|Withdrawal by Subject|2|||
146158990|NCT04391023|527092786|FG001|Overall Study|Withdrawal by Subject|2|||
146158991|NCT02085408|527092790|FG000|Step 1: Induction|Disease Progression|19|||
146311022|NCT01765920|527651868|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
146311023|NCT01765920|527651869|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
146311024|NCT01765920|527651868|FG000|Overall Study|Patient code disclosure|0|||
146311025|NCT01765920|527651869|FG001|Overall Study|Patient code disclosure|1|||
146311026|NCT01081249|527651870|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
146311027|NCT01081249|527651871|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
146311028|NCT02025907|527651872|FG000|Overall Study|Lack of Efficacy|1|||
146311029|NCT02025907|527651873|FG001|Overall Study|Lack of Efficacy|0|||
146311030|NCT02025907|527651872|FG000|Overall Study|Withdrawal by Subject|15|||
146311031|NCT02025907|527651873|FG001|Overall Study|Withdrawal by Subject|8|||
146311032|NCT02025907|527651872|FG000|Overall Study|Protocol Violation|2|||
146311033|NCT02025907|527651873|FG001|Overall Study|Protocol Violation|0|||
146311034|NCT02025907|527651872|FG000|Overall Study|Physician Decision|2|||
146311035|NCT02025907|527651873|FG001|Overall Study|Physician Decision|0|||
146311036|NCT02025907|527651872|FG000|Overall Study|Lost to Follow-up|2|||
146311037|NCT02025907|527651873|FG001|Overall Study|Lost to Follow-up|2|||
146311038|NCT02025907|527651872|FG000|Overall Study|Adverse Event|3|||
146311039|NCT02025907|527651873|FG001|Overall Study|Adverse Event|1|||
146311040|NCT02025907|527651872|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
146311041|NCT02025907|527651873|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
146311042|NCT02411539|527651874|FG000|Overall Study|Lost to Follow-up|2|||
146311043|NCT02411539|527651875|FG001|Overall Study|Lost to Follow-up|0|||
146311044|NCT02411539|527651874|FG000|Overall Study|Confounding medical condition|0|||
146311045|NCT02411539|527651875|FG001|Overall Study|Confounding medical condition|1|||
146311046|NCT03631732|527651883|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
146311047|NCT03631732|527651884|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
146311048|NCT03631732|527651883|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
146311049|NCT03631732|527651884|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
146311050|NCT03631732|527651883|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
146311051|NCT03631732|527651884|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
146311052|NCT03631732|527651883|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
146311053|NCT03631732|527651884|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
146311054|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
146311055|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
146311056|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
146311057|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
146311058|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
146311059|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
146311060|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
146311061|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
146311062|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
146311063|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
146311064|NCT03631732|527651883|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
146311065|NCT03631732|527651884|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
146311066|NCT02255409|527651885|FG000|Overall Study|Administrative Reason|3|||
146311067|NCT02255409|527651886|FG001|Overall Study|Administrative Reason|7|||
146311068|NCT02255409|527651885|FG000|Overall Study|Withdrawal by Subject|1|||
146311069|NCT02255409|527651886|FG001|Overall Study|Withdrawal by Subject|5|||
146311070|NCT02255409|527651885|FG000|Overall Study|Lost to Follow-up|10|||
146311071|NCT02255409|527651886|FG001|Overall Study|Lost to Follow-up|19|||
146311072|NCT01251367|527651887|FG000|Overall Study|Protocol Violation|1|||
146311073|NCT01251367|527651887|FG000|Overall Study|Lack of Efficacy|2|||
146311074|NCT01251367|527651887|FG000|Overall Study|Adverse Event|19|||
146311075|NCT01251367|527651887|FG000|Overall Study|Withdrawal by Subject|36|||
146311076|NCT01251367|527651887|FG000|Overall Study|Lost to Follow-up|5|||
146311077|NCT01251367|527651887|FG000|Overall Study|Subject Required Alternative Treatment|7|||
146311078|NCT01251367|527651887|FG000|Overall Study|No Study Drug Available|1|||
146158992|NCT02085408|527092791|FG001|Step 1: Induction|Disease Progression|19|||
146158993|NCT02085408|527092790|FG000|Step 1: Induction|Adverse Event|18|||
146158994|NCT02085408|527092791|FG001|Step 1: Induction|Adverse Event|17|||
146311079|NCT01251367|527651887|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
146311080|NCT01251367|527651887|FG000|Overall Study|End of Study Visit Performed in Error|1|||
146311081|NCT03775421|527651890|FG000|Overall Study|Lost to Follow-up|2|||
146311082|NCT03775421|527651890|FG000|Overall Study|Withdrawal by Subject|10|||
146158995|NCT02085408|527092790|FG000|Step 1: Induction|Death|33|||
146311083|NCT03775421|527651890|FG000|Overall Study|Physician Decision|3|||
146311084|NCT03775421|527651890|FG000|Overall Study|Death|1|||
146311085|NCT03775421|527651890|FG000|Overall Study|Study Terminated by Sponsor|94|||
146311086|NCT02016820|527651891|FG000|Overall Study|Lost to Follow-up|2|||
146311087|NCT02016820|527651892|FG001|Overall Study|Lost to Follow-up|4|||
146158996|NCT02085408|527092791|FG001|Step 1: Induction|Death|30|||
146158997|NCT02085408|527092790|FG000|Step 1: Induction|Withdrawal by Subject|16|||
146158998|NCT02085408|527092791|FG001|Step 1: Induction|Withdrawal by Subject|8|||
146158999|NCT02085408|527092790|FG000|Step 1: Induction|Alternative Therapy|15|||
146159000|NCT02085408|527092791|FG001|Step 1: Induction|Alternative Therapy|19|||
146159001|NCT02085408|527092790|FG000|Step 1: Induction|Complicating Disease|2|||
146159002|NCT02085408|527092791|FG001|Step 1: Induction|Complicating Disease|3|||
146159003|NCT02085408|527092790|FG000|Step 1: Induction|Other|27|||
146159004|NCT02085408|527092791|FG001|Step 1: Induction|Other|39|||
146159005|NCT02085408|527092790|FG000|Step 1: Induction|Never started treatment|6|||
146159006|NCT02085408|527092791|FG001|Step 1: Induction|Never started treatment|4|||
146159007|NCT02085408|527092790|FG000|Step 2: Consolidation|Disease Progression|5|||
146159008|NCT02085408|527092791|FG001|Step 2: Consolidation|Disease Progression|20|||
146159009|NCT02085408|527092790|FG000|Step 2: Consolidation|Adverse Event|9|||
146159010|NCT02085408|527092791|FG001|Step 2: Consolidation|Adverse Event|8|||
146159011|NCT02085408|527092790|FG000|Step 2: Consolidation|Death|4|||
146159012|NCT02085408|527092791|FG001|Step 2: Consolidation|Death|3|||
146159013|NCT02085408|527092790|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
146159014|NCT02085408|527092791|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
146159015|NCT02085408|527092790|FG000|Step 2: Consolidation|Alternative Therapy|9|||
146159016|NCT02085408|527092791|FG001|Step 2: Consolidation|Alternative Therapy|3|||
146159017|NCT02085408|527092790|FG000|Step 2: Consolidation|Complicating Disease|0|||
146159018|NCT02085408|527092791|FG001|Step 2: Consolidation|Complicating Disease|2|||
146159019|NCT02085408|527092790|FG000|Step 2: Consolidation|Other|6|||
146159020|NCT02085408|527092791|FG001|Step 2: Consolidation|Other|6|||
146159021|NCT02085408|527092790|FG000|Step 2: Consolidation|Never started treatment|4|||
146159022|NCT02085408|527092791|FG001|Step 2: Consolidation|Never started treatment|3|||
146159023|NCT02085408|527092790|FG000|Step 3: Maintenance|Disease Progression|13|||
146159024|NCT02085408|527092791|FG001|Step 3: Maintenance|Disease Progression|11|||
146159025|NCT02085408|527092790|FG000|Step 3: Maintenance|Adverse Event|2|||
146159026|NCT02085408|527092791|FG001|Step 3: Maintenance|Adverse Event|4|||
146159027|NCT02085408|527092790|FG000|Step 3: Maintenance|Death|1|||
146159028|NCT02085408|527092791|FG001|Step 3: Maintenance|Death|2|||
146159029|NCT02085408|527092790|FG000|Step 3: Maintenance|Alternative Therapy|1|||
146159030|NCT02085408|527092791|FG001|Step 3: Maintenance|Alternative Therapy|1|||
146159031|NCT02085408|527092790|FG000|Step 3: Maintenance|Complicating Disease|0|||
146159032|NCT02085408|527092791|FG001|Step 3: Maintenance|Complicating Disease|1|||
146159033|NCT02085408|527092790|FG000|Step 3: Maintenance|Other|3|||
146159034|NCT02085408|527092791|FG001|Step 3: Maintenance|Other|2|||
146159035|NCT02085408|527092790|FG000|Step 3: Maintenance|Never started treatment|5|||
146159036|NCT02085408|527092791|FG001|Step 3: Maintenance|Never started treatment|1|||
146311088|NCT02370615|527651895|FG000|Overall Study|Adverse Event|1|||
146311089|NCT02370615|527651896|FG001|Overall Study|Adverse Event|0|||
146311090|NCT02287623|527651900|FG000|Overall Study|Protocol Violation|0|||
146311091|NCT02287623|527651901|FG001|Overall Study|Protocol Violation|1|||
146311092|NCT00506883|527651904|FG000|Overall Study|Lost to Follow-up|1|||
146311093|NCT00506883|527651905|FG001|Overall Study|Lost to Follow-up|1|||
146311094|NCT00506883|527651906|FG002|Overall Study|Lost to Follow-up|1|||
146311095|NCT00506883|527651904|FG000|Overall Study|Withdrawal by Subject|1|||
146311096|NCT00506883|527651905|FG001|Overall Study|Withdrawal by Subject|0|||
146311097|NCT00506883|527651906|FG002|Overall Study|Withdrawal by Subject|1|||
146311098|NCT00506883|527651904|FG000|Overall Study|Lack of Efficacy|0|||
146311099|NCT00506883|527651905|FG001|Overall Study|Lack of Efficacy|1|||
146311100|NCT00506883|527651906|FG002|Overall Study|Lack of Efficacy|1|||
146311101|NCT00506883|527651904|FG000|Overall Study|Other|5|||
146311102|NCT00506883|527651905|FG001|Overall Study|Other|1|||
146311103|NCT00506883|527651906|FG002|Overall Study|Other|1|||
146311104|NCT01473563|527651907|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
146311105|NCT03610724|527651908|FG000|Overall Study|Death|17|||
146311106|NCT03610724|527651908|FG000|Overall Study|Lost to Follow-up|1|||
146311107|NCT03610724|527651908|FG000|Overall Study|Physician Decision|1|||
146311108|NCT03610724|527651908|FG000|Overall Study|Died prior to infusion|1|||
146311109|NCT02943564|527651909|FG000|Overall Study|Miscellaneous Reasons|0|||
146311110|NCT02943564|527651910|FG001|Overall Study|Miscellaneous Reasons|0|||
146311111|NCT02943564|527651911|FG002|Overall Study|Miscellaneous Reasons|3|||
146311112|NCT02943564|527651909|FG000|Overall Study|Site terminated by sponsor|0|||
146159037|NCT02189798|527092792|FG000|Extended Use Phase|Withdrawal by Subject|0|||
146159038|NCT02189798|527092793|FG001|Extended Use Phase|Withdrawal by Subject|4|||
146159039|NCT02189798|527092792|FG000|Extended Use Phase|Physician Decision|1|||
146159040|NCT02189798|527092793|FG001|Extended Use Phase|Physician Decision|0|||
146159041|NCT02189798|527092792|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
146159042|NCT02189798|527092793|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
146311113|NCT02943564|527651910|FG001|Overall Study|Site terminated by sponsor|1|||
146311114|NCT02943564|527651911|FG002|Overall Study|Site terminated by sponsor|0|||
146311115|NCT02943564|527651909|FG000|Overall Study|Non-compliance with study drug|0|||
146311116|NCT02943564|527651910|FG001|Overall Study|Non-compliance with study drug|1|||
146311117|NCT02943564|527651911|FG002|Overall Study|Non-compliance with study drug|0|||
146311118|NCT02943564|527651909|FG000|Overall Study|Pregnancy|0|||
146311119|NCT02943564|527651910|FG001|Overall Study|Pregnancy|1|||
146311120|NCT02943564|527651911|FG002|Overall Study|Pregnancy|1|||
146311121|NCT02943564|527651909|FG000|Overall Study|Protocol Violation|2|||
146311122|NCT02943564|527651910|FG001|Overall Study|Protocol Violation|2|||
146311123|NCT02943564|527651911|FG002|Overall Study|Protocol Violation|2|||
146311124|NCT02943564|527651909|FG000|Overall Study|Lost to Follow-up|1|||
146311125|NCT02943564|527651910|FG001|Overall Study|Lost to Follow-up|0|||
146311126|NCT02943564|527651911|FG002|Overall Study|Lost to Follow-up|0|||
146311127|NCT02943564|527651909|FG000|Overall Study|Withdrawal by Subject|6|||
146311128|NCT02943564|527651910|FG001|Overall Study|Withdrawal by Subject|5|||
146311129|NCT02943564|527651911|FG002|Overall Study|Withdrawal by Subject|2|||
146311130|NCT02943564|527651909|FG000|Overall Study|Adverse Event|1|||
146311131|NCT02943564|527651910|FG001|Overall Study|Adverse Event|2|||
146311132|NCT02943564|527651911|FG002|Overall Study|Adverse Event|1|||
146311133|NCT02943564|527651909|FG000|Overall Study|Lack of Efficacy|0|||
146311134|NCT02943564|527651910|FG001|Overall Study|Lack of Efficacy|1|||
146311135|NCT02943564|527651911|FG002|Overall Study|Lack of Efficacy|0|||
146311136|NCT04143009|527651912|FG000|Pilot Trial|Lost to Follow-up|0|||
146311137|NCT04143009|527651913|FG001|Pilot Trial|Lost to Follow-up|1|||
146311138|NCT04143009|527651914|FG002|Pilot Trial|Lost to Follow-up|1|||
146311139|NCT04013529|527651917|FG000|Overall Study|Withdrawal by Subject|1|||
146311140|NCT04013529|527651918|FG001|Overall Study|Withdrawal by Subject|1|||
146311141|NCT00788372|527651919|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
146311142|NCT00788372|527651919|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
146311143|NCT00788372|527651919|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
146311144|NCT00788372|527651919|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
146311145|NCT00788372|527651919|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
146311146|NCT00788372|527651919|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
146311147|NCT00788372|527651919|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
146311148|NCT01439555|527651924|FG000|Overall Study|Protocol Violation|1|||
146311149|NCT04869345|527651928|FG000|Overall Study|Lost to Follow-up|8|||
146311150|NCT04869345|527651929|FG001|Overall Study|Lost to Follow-up|3|||
146311151|NCT01908101|527653391|FG000|Overall Study|Physician Decision|1|||
146311152|NCT01908101|527653391|FG000|Overall Study|Withdrawal by Subject|1|||
146311153|NCT01908101|527653391|FG000|Overall Study|Incorrect Diagnosis|2|||
146311154|NCT01908101|527653391|FG000|Overall Study|Incorrect Starting Dose|1|||
146311155|NCT01908101|527653391|FG000|Overall Study|Did not complete the first cycle|4|||
146311156|NCT02356562|527653395|FG000|Overall Study|Withdrawal by Subject|0|||
146311157|NCT02356562|527653396|FG001|Overall Study|Withdrawal by Subject|1|||
146311158|NCT02356562|527653395|FG000|Overall Study|Re-entered treatment in a previous study|1|||
146311159|NCT02356562|527653396|FG001|Overall Study|Re-entered treatment in a previous study|0|||
146311160|NCT02356562|527653395|FG000|Overall Study|site closure|1|||
146311161|NCT02356562|527653396|FG001|Overall Study|site closure|0|||
146311162|NCT00150592|527653397|FG000|Overall Study|Adverse Event|4|||
146311163|NCT00150592|527653398|FG001|Overall Study|Adverse Event|1|||
146311164|NCT00150592|527653397|FG000|Overall Study|Protocol Violation|1|||
146311165|NCT00150592|527653398|FG001|Overall Study|Protocol Violation|0|||
146311166|NCT00150592|527653397|FG000|Overall Study|Withdrawal by Subject|1|||
146311167|NCT00150592|527653398|FG001|Overall Study|Withdrawal by Subject|2|||
146311168|NCT00150592|527653397|FG000|Overall Study|Non-compliance|1|||
146311169|NCT00150592|527653398|FG001|Overall Study|Non-compliance|0|||
146311170|NCT00412750|527653401|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146311171|NCT00412750|527653402|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146311172|NCT00412750|527653403|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146311173|NCT00412750|527653401|FG000|Overall Study|Administrative problems|21|||
146311174|NCT00412750|527653402|FG001|Overall Study|Administrative problems|17|||
146311175|NCT00412750|527653403|FG002|Overall Study|Administrative problems|14|||
146311176|NCT00412750|527653401|FG000|Overall Study|Adverse Event|8|||
146311177|NCT00412750|527653402|FG001|Overall Study|Adverse Event|3|||
146311178|NCT00412750|527653403|FG002|Overall Study|Adverse Event|3|||
146311179|NCT00412750|527653401|FG000|Overall Study|Lost to Follow-up|1|||
146311180|NCT00412750|527653402|FG001|Overall Study|Lost to Follow-up|0|||
146311181|NCT00412750|527653403|FG002|Overall Study|Lost to Follow-up|1|||
146311182|NCT00412750|527653401|FG000|Overall Study|Withdrawal by Subject|0|||
146311183|NCT00412750|527653402|FG001|Overall Study|Withdrawal by Subject|1|||
146311184|NCT00412750|527653403|FG002|Overall Study|Withdrawal by Subject|2|||
146311185|NCT00412750|527653401|FG000|Overall Study|Lack of Efficacy|0|||
146311186|NCT00412750|527653402|FG001|Overall Study|Lack of Efficacy|0|||
146311187|NCT00412750|527653403|FG002|Overall Study|Lack of Efficacy|3|||
146311188|NCT00874120|527653409|FG000|First Intervention|Adverse Event|0|||
146311189|NCT00874120|527653410|FG001|First Intervention|Adverse Event|1|||
146311190|NCT00874120|527653409|FG000|First Intervention|Withdrawal by Subject|2|||
146311191|NCT00874120|527653410|FG001|First Intervention|Withdrawal by Subject|0|||
146311192|NCT00874120|527653409|FG000|First Intervention|Lost to Follow-up|0|||
146311193|NCT00874120|527653410|FG001|First Intervention|Lost to Follow-up|1|||
146159043|NCT02189798|527092792|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
146159044|NCT02189798|527092793|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
146159045|NCT02189798|527092792|FG000|Extended Use Phase|Travel Issues|2|||
146279697|NCT03449901|527538681|FG000|Overall Study|Patient off for other complicating disease|1|||
146279698|NCT03449901|527538682|FG001|Overall Study|Patient off for other complicating disease|0|||
146279699|NCT00744757|527538683|FG000|Overall Study|Objective disease progression|7|||
146279700|NCT00744757|527538683|FG000|Overall Study|Physician Decision|5|||
146279701|NCT00744757|527538683|FG000|Overall Study|Withdrawal by Subject|1|||
146279702|NCT00744757|527538683|FG000|Overall Study|Death|6|||
146279703|NCT00744757|527538683|FG000|Overall Study|Adverse Event|2|||
146279704|NCT03682302|527538684|FG000|Overall Study|Lost to Follow-up|1|||
146279705|NCT03682302|527538685|FG001|Overall Study|Lost to Follow-up|2|||
146279706|NCT03682302|527538686|FG002|Overall Study|Lost to Follow-up|0|||
146279707|NCT03682302|527538687|FG003|Overall Study|Lost to Follow-up|1|||
146279708|NCT03682302|527538684|FG000|Overall Study|Study drug was not administered|0|||
146279709|NCT03682302|527538685|FG001|Overall Study|Study drug was not administered|0|||
146279710|NCT03682302|527538686|FG002|Overall Study|Study drug was not administered|1|||
146279711|NCT03682302|527538687|FG003|Overall Study|Study drug was not administered|1|||
146279712|NCT00532493|527538688|FG000|Overall Study|Death|1|||
146279713|NCT00532493|527538689|FG001|Overall Study|Death|1|||
146279714|NCT00532493|527538688|FG000|Overall Study|Lost to Follow-up|10|||
146279715|NCT00532493|527538689|FG001|Overall Study|Lost to Follow-up|7|||
146279716|NCT00532493|527538688|FG000|Overall Study|Withdrawal by Subject|7|||
146279717|NCT00532493|527538689|FG001|Overall Study|Withdrawal by Subject|9|||
146279718|NCT00532493|527538688|FG000|Overall Study|Physician Decision|1|||
146279719|NCT00532493|527538689|FG001|Overall Study|Physician Decision|6|||
146279720|NCT00532493|527538688|FG000|Overall Study|Adverse Event|6|||
146279721|NCT00532493|527538689|FG001|Overall Study|Adverse Event|5|||
146279722|NCT00532493|527538688|FG000|Overall Study|Protocol Deviation|1|||
146279723|NCT00532493|527538689|FG001|Overall Study|Protocol Deviation|0|||
146279724|NCT00532493|527538688|FG000|Overall Study|Subject Moved Away|3|||
146279725|NCT00532493|527538689|FG001|Overall Study|Subject Moved Away|1|||
146279726|NCT00532493|527538688|FG000|Overall Study|Contraindicative Medication|1|||
146279727|NCT00532493|527538689|FG001|Overall Study|Contraindicative Medication|0|||
146279728|NCT01769326|527538695|FG000|Overall Study|Lost to Follow-up|1|||
146279729|NCT01769326|527538696|FG001|Overall Study|Lost to Follow-up|2|||
146279730|NCT01769326|527538697|FG002|Overall Study|Lost to Follow-up|0|||
146279731|NCT01769326|527538698|FG003|Overall Study|Lost to Follow-up|0|||
146279732|NCT01769326|527538695|FG000|Overall Study|unrelated injry|1|||
146279733|NCT01769326|527538696|FG001|Overall Study|unrelated injry|1|||
146279734|NCT01769326|527538697|FG002|Overall Study|unrelated injry|0|||
146279735|NCT01769326|527538698|FG003|Overall Study|unrelated injry|0|||
146279736|NCT01769326|527538695|FG000|Overall Study|got a job|0|||
146279737|NCT01769326|527538696|FG001|Overall Study|got a job|1|||
146279738|NCT01769326|527538697|FG002|Overall Study|got a job|0|||
146279739|NCT01769326|527538698|FG003|Overall Study|got a job|0|||
146279740|NCT01769326|527538695|FG000|Overall Study|Got sick and could not complete study|0|||
146279741|NCT01769326|527538696|FG001|Overall Study|Got sick and could not complete study|0|||
146279742|NCT01769326|527538697|FG002|Overall Study|Got sick and could not complete study|1|||
146279743|NCT01769326|527538698|FG003|Overall Study|Got sick and could not complete study|0|||
146279744|NCT00888927|527538699|FG000|Overall Study|Adverse Event|0|||
146279745|NCT00888927|527538700|FG001|Overall Study|Adverse Event|0|||
146279746|NCT00888927|527538701|FG002|Overall Study|Adverse Event|0|||
146279747|NCT00888927|527538702|FG003|Overall Study|Adverse Event|1|||
146279748|NCT00888927|527538699|FG000|Overall Study|Withdrawal of consent|0|||
146279749|NCT00888927|527538700|FG001|Overall Study|Withdrawal of consent|0|||
146279750|NCT00888927|527538701|FG002|Overall Study|Withdrawal of consent|0|||
146279751|NCT00888927|527538702|FG003|Overall Study|Withdrawal of consent|1|||
146279752|NCT03459443|527538703|FG000|Overall Study|Lack of Efficacy|3|||
146279753|NCT03459443|527538703|FG000|Overall Study|Adverse Event|1|||
146279754|NCT03459443|527538703|FG000|Overall Study|Sponsor's decision to close the study|18|||
146279755|NCT02153073|527538704|FG000|Overall Study|Case Report Forms Uncollected|230|||
146279756|NCT02153073|527538704|FG000|Overall Study|Protocol Deviation|68|||
146279757|NCT03702231|527538705|FG000|Overall Study|Withdrawal by Subject|1|||
146279758|NCT03702231|527538706|FG001|Overall Study|Withdrawal by Subject|0|||
146279759|NCT03702231|527538707|FG002|Overall Study|Withdrawal by Subject|0|||
146279760|NCT03702231|527538705|FG000|Overall Study|Protocol Violation|0|||
146279761|NCT03702231|527538706|FG001|Overall Study|Protocol Violation|0|||
146279762|NCT03702231|527538707|FG002|Overall Study|Protocol Violation|1|||
146279763|NCT03702231|527538705|FG000|Overall Study|Change in CLL Treatment|0|||
146279764|NCT03702231|527538706|FG001|Overall Study|Change in CLL Treatment|0|||
146279765|NCT03702231|527538707|FG002|Overall Study|Change in CLL Treatment|1|||
146279766|NCT03702231|527538705|FG000|Overall Study|COVID Pandemic|1|||
146279767|NCT03702231|527538706|FG001|Overall Study|COVID Pandemic|4|||
146279768|NCT03702231|527538707|FG002|Overall Study|COVID Pandemic|1|||
146279769|NCT03702231|527538705|FG000|Overall Study|Non-compliance|0|||
146279770|NCT03702231|527538706|FG001|Overall Study|Non-compliance|0|||
146159046|NCT02189798|527092793|FG001|Extended Use Phase|Travel Issues|1|||
146279771|NCT03702231|527538707|FG002|Overall Study|Non-compliance|1|||
146279772|NCT01609062|527538711|FG000|Extension Phase|Terminated by Sponsor|14|||
146279773|NCT01609062|527538712|FG001|Extension Phase|Terminated by Sponsor|9|||
146279774|NCT01609062|527538711|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
146279775|NCT01609062|527538712|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
146279776|NCT01609062|527538711|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
146279777|NCT01609062|527538712|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
146279778|NCT03772587|527538713|FG000|Overall Study|COVID-19|0|||
146279779|NCT03772587|527538714|FG001|Overall Study|COVID-19|0|||
146279780|NCT03772587|527538715|FG002|Overall Study|COVID-19|1|||
146279781|NCT03772587|527538716|FG003|Overall Study|COVID-19|1|||
146279782|NCT03772587|527538717|FG004|Overall Study|COVID-19|0|||
146279783|NCT03772587|527538713|FG000|Overall Study|Withdrawal by Subject|1|||
146279784|NCT03772587|527538714|FG001|Overall Study|Withdrawal by Subject|0|||
146279785|NCT03772587|527538715|FG002|Overall Study|Withdrawal by Subject|0|||
146279786|NCT03772587|527538716|FG003|Overall Study|Withdrawal by Subject|0|||
146279787|NCT03772587|527538717|FG004|Overall Study|Withdrawal by Subject|0|||
146279788|NCT05260021|527538718|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
146279789|NCT05260021|527538719|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
146279790|NCT05260021|527538720|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
146279791|NCT05260021|527538718|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
146279792|NCT05260021|527538719|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
146279793|NCT05260021|527538720|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
146279794|NCT05260021|527538718|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
146279795|NCT05260021|527538719|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
146279796|NCT05260021|527538720|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
146279797|NCT05260021|527538718|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
146279798|NCT05260021|527538719|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
146279799|NCT05260021|527538720|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
146279800|NCT05260021|527538718|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
146279801|NCT05260021|527538719|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
146279802|NCT05260021|527538720|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
146279803|NCT03842358|527538721|FG000|Overall Study|Poor DOT probe contact with breast|2|||
146279804|NCT03842358|527538721|FG000|Overall Study|DOT system problem|1|||
146279805|NCT03842358|527538721|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
146279806|NCT03842358|527538721|FG000|Overall Study|No biopsy after physician review|4|||
146279807|NCT03842358|527538721|FG000|Overall Study|Patient withdrew|2|||
146279808|NCT02626455|527538722|FG000|Overall Study|Other|1|||
146279809|NCT02626455|527538723|FG001|Overall Study|Other|1|||
146279810|NCT02626455|527538724|FG002|Overall Study|Other|0|||
146279811|NCT02626455|527538725|FG003|Overall Study|Other|0|||
146279812|NCT02626455|527538726|FG004|Overall Study|Other|0|||
146279813|NCT02626455|527538727|FG005|Overall Study|Other|17|||
146279814|NCT02626455|527538728|FG006|Overall Study|Other|23|||
146279815|NCT02626455|527538722|FG000|Overall Study|Withdrawal by Subject|1|||
146279816|NCT02626455|527538723|FG001|Overall Study|Withdrawal by Subject|0|||
146279817|NCT02626455|527538724|FG002|Overall Study|Withdrawal by Subject|0|||
146279818|NCT02626455|527538725|FG003|Overall Study|Withdrawal by Subject|0|||
146279819|NCT02626455|527538726|FG004|Overall Study|Withdrawal by Subject|0|||
146279820|NCT02626455|527538727|FG005|Overall Study|Withdrawal by Subject|10|||
146279821|NCT02626455|527538728|FG006|Overall Study|Withdrawal by Subject|6|||
146279822|NCT02626455|527538722|FG000|Overall Study|Physician Decision|0|||
146279823|NCT02626455|527538723|FG001|Overall Study|Physician Decision|2|||
146279824|NCT02626455|527538724|FG002|Overall Study|Physician Decision|2|||
146279825|NCT02626455|527538725|FG003|Overall Study|Physician Decision|2|||
146279826|NCT02626455|527538726|FG004|Overall Study|Physician Decision|1|||
146279827|NCT02626455|527538727|FG005|Overall Study|Physician Decision|10|||
146279828|NCT02626455|527538728|FG006|Overall Study|Physician Decision|3|||
146279829|NCT02626455|527538722|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279830|NCT02626455|527538723|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279831|NCT02626455|527538724|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279832|NCT02626455|527538725|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279833|NCT02626455|527538726|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279834|NCT02626455|527538727|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
146279835|NCT02626455|527538728|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
146279836|NCT02626455|527538722|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146279837|NCT02626455|527538723|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146279838|NCT02626455|527538724|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146279839|NCT02626455|527538725|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146279840|NCT02626455|527538726|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146279841|NCT02626455|527538727|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
146311194|NCT00874120|527653409|FG000|First Intervention|Protocol Violation|3|||
146311195|NCT00874120|527653410|FG001|First Intervention|Protocol Violation|0|||
146311196|NCT00874120|527653409|FG000|First Intervention|positive drug test|1|||
146311197|NCT00874120|527653410|FG001|First Intervention|positive drug test|0|||
146311198|NCT00874120|527653409|FG000|Second Intervention|Withdrawal by Subject|1|||
146311199|NCT00874120|527653410|FG001|Second Intervention|Withdrawal by Subject|0|||
146311200|NCT00874120|527653409|FG000|Second Intervention|Protocol Violation|1|||
146311201|NCT00874120|527653410|FG001|Second Intervention|Protocol Violation|0|||
146311202|NCT01823679|527653411|FG000|Overall Study|Death|1|||
146311203|NCT02135692|527653419|FG000|Overall Study|Adverse Event|3|||
146311204|NCT02135692|527653419|FG000|Overall Study|Lack of Efficacy|2|||
146311205|NCT02135692|527653419|FG000|Overall Study|Protocol Violation|2|||
146311206|NCT02135692|527653419|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
146311207|NCT02135692|527653419|FG000|Overall Study|Product commercially available|159|||
146311208|NCT02135692|527653419|FG000|Overall Study|Study closed/terminated|153|||
146311209|NCT02135692|527653419|FG000|Overall Study|Lost to Follow-up|4|||
146311210|NCT02135692|527653419|FG000|Overall Study|Withdrawal by Subject|15|||
146311211|NCT01611974|527653422|FG000|Overall Study|Death|10|||
146311212|NCT01611974|527653423|FG001|Overall Study|Death|12|||
146311213|NCT01611974|527653424|FG002|Overall Study|Death|10|||
146311214|NCT01611974|527653422|FG000|Overall Study|Lost to Follow-up|0|||
146311215|NCT01611974|527653423|FG001|Overall Study|Lost to Follow-up|1|||
146311216|NCT01611974|527653424|FG002|Overall Study|Lost to Follow-up|0|||
146311217|NCT01611974|527653422|FG000|Overall Study|Physician Decision|5|||
146311218|NCT01611974|527653423|FG001|Overall Study|Physician Decision|1|||
146311219|NCT01611974|527653424|FG002|Overall Study|Physician Decision|2|||
146311220|NCT01611974|527653422|FG000|Overall Study|Withdrawal by Subject|0|||
146311221|NCT01611974|527653423|FG001|Overall Study|Withdrawal by Subject|1|||
146311222|NCT01611974|527653424|FG002|Overall Study|Withdrawal by Subject|4|||
146311223|NCT01097746|527653425|FG000|Overall Study|Adverse Event|4|||
146311224|NCT01097746|527653425|FG000|Overall Study|taken off study before any treatment given|1|||
146311225|NCT00522431|527653426|FG000|Overall Study|Adverse Event|5|||
146311226|NCT00522431|527653426|FG000|Overall Study|Protocol Violation|2|||
146311227|NCT00522431|527653426|FG000|Overall Study|Withdrawal by Subject|2|||
146311228|NCT00522431|527653426|FG000|Overall Study|Subject non-compliance|1|||
146311229|NCT00522431|527653426|FG000|Overall Study|Other/unknown|1|||
146311230|NCT02495844|527653427|FG000|Overall Study|Lack of Efficacy|1|||
146311231|NCT02495844|527653428|FG001|Overall Study|Lack of Efficacy|2|||
146311232|NCT02495844|527653427|FG000|Overall Study|AE, non-fatal|0|||
146311233|NCT02495844|527653428|FG001|Overall Study|AE, non-fatal|1|||
146311234|NCT02495844|527653427|FG000|Overall Study|Hepatitis Positivity|0|||
146311235|NCT02495844|527653428|FG001|Overall Study|Hepatitis Positivity|1|||
146311236|NCT03927105|527653429|FG000|Overall Study|Death|1|||
146311237|NCT03927105|527653429|FG000|Overall Study|In observation for potential re-treatment|2|||
146311238|NCT03927105|527653429|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
146311239|NCT02145741|527653431|FG000|Overall Study|Progressive disease|3|||
146311240|NCT02145741|527653432|FG001|Overall Study|Progressive disease|6|||
146311241|NCT02145741|527653433|FG002|Overall Study|Progressive disease|6|||
146311242|NCT02145741|527653431|FG000|Overall Study|quality issue with the administered drug|3|||
146311243|NCT02145741|527653432|FG001|Overall Study|quality issue with the administered drug|0|||
146311244|NCT02145741|527653433|FG002|Overall Study|quality issue with the administered drug|0|||
146311245|NCT05634577|527653434|FG000|Overall Study|Lost to Follow-up|1|||
146311246|NCT05634577|527653434|FG000|Overall Study|Withdrawal by Subject|1|||
146311247|NCT02699892|527653436|FG000|Overall Study|Other|36|||
146311248|NCT00847912|527653437|FG000|Overall Study|Protocol Violation|6|||
146311249|NCT00847912|527653438|FG001|Overall Study|Protocol Violation|7|||
146311250|NCT00847912|527653437|FG000|Overall Study|Withdrawal by Subject|3|||
146311251|NCT00847912|527653438|FG001|Overall Study|Withdrawal by Subject|6|||
146311252|NCT02311153|527653441|FG000|Overall Study|Lost to Follow-up|5|||
146311253|NCT02311153|527653442|FG001|Overall Study|Lost to Follow-up|7|||
146311254|NCT00405067|527653447|FG000|Overall Study|Adverse Event|4|||
146311255|NCT00405067|527653448|FG001|Overall Study|Adverse Event|9|||
146311256|NCT00405067|527653449|FG002|Overall Study|Adverse Event|4|||
146311257|NCT00405067|527653447|FG000|Overall Study|Lost to Follow-up|0|||
146311258|NCT00405067|527653448|FG001|Overall Study|Lost to Follow-up|0|||
146311259|NCT00405067|527653449|FG002|Overall Study|Lost to Follow-up|1|||
146311260|NCT01650636|527653450|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
146311261|NCT01650636|527653451|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
146311262|NCT01650636|527653450|FG000|Washout up to 5 Months|Physician Decision|2|||
146311263|NCT01650636|527653451|FG001|Washout up to 5 Months|Physician Decision|2|||
146311264|NCT01650636|527653450|FG000|Washout up to 5 Months|Death|1|||
146311265|NCT01650636|527653451|FG001|Washout up to 5 Months|Death|0|||
146311266|NCT01650636|527653450|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
146311267|NCT01650636|527653451|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
146311268|NCT01650636|527653450|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
146311269|NCT01650636|527653451|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
146311270|NCT01650636|527653450|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
146159047|NCT02189798|527092792|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
146159048|NCT02189798|527092793|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
146159049|NCT05553808|527092796|FG000|Overall Study|Death|25|||
146159050|NCT05553808|527092797|FG001|Overall Study|Death|62|||
146159051|NCT05553808|527092796|FG000|Overall Study|Site Closed|6|||
146159052|NCT05553808|527092797|FG001|Overall Study|Site Closed|6|||
146279842|NCT02626455|527538728|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
146279843|NCT02626455|527538722|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146279844|NCT02626455|527538723|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146279845|NCT02626455|527538724|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146279846|NCT02626455|527538725|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146279847|NCT02626455|527538726|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
146279848|NCT02626455|527538727|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
146279849|NCT02626455|527538728|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
146279850|NCT02626455|527538722|FG000|Overall Study|Patient decision|0|||
146279851|NCT02626455|527538723|FG001|Overall Study|Patient decision|1|||
146279852|NCT02626455|527538724|FG002|Overall Study|Patient decision|0|||
146279853|NCT02626455|527538725|FG003|Overall Study|Patient decision|0|||
146279854|NCT02626455|527538726|FG004|Overall Study|Patient decision|1|||
146279855|NCT02626455|527538727|FG005|Overall Study|Patient decision|36|||
146279856|NCT02626455|527538728|FG006|Overall Study|Patient decision|22|||
146279857|NCT02626455|527538722|FG000|Overall Study|Protocol Violation|0|||
146279858|NCT02626455|527538723|FG001|Overall Study|Protocol Violation|0|||
146279859|NCT02626455|527538724|FG002|Overall Study|Protocol Violation|0|||
146279860|NCT02626455|527538725|FG003|Overall Study|Protocol Violation|0|||
146279861|NCT02626455|527538726|FG004|Overall Study|Protocol Violation|0|||
146279862|NCT02626455|527538727|FG005|Overall Study|Protocol Violation|0|||
146279863|NCT02626455|527538728|FG006|Overall Study|Protocol Violation|1|||
146279864|NCT02626455|527538722|FG000|Overall Study|Progressive disease - radiological progression|0|||
146279865|NCT02626455|527538723|FG001|Overall Study|Progressive disease - radiological progression|0|||
146279866|NCT02626455|527538724|FG002|Overall Study|Progressive disease - radiological progression|0|||
146279867|NCT02626455|527538725|FG003|Overall Study|Progressive disease - radiological progression|0|||
146279868|NCT02626455|527538726|FG004|Overall Study|Progressive disease - radiological progression|0|||
146279869|NCT02626455|527538727|FG005|Overall Study|Progressive disease - radiological progression|11|||
146279870|NCT02626455|527538728|FG006|Overall Study|Progressive disease - radiological progression|22|||
146279871|NCT02626455|527538722|FG000|Overall Study|Progressive disease - clinical progression|0|||
146279872|NCT02626455|527538723|FG001|Overall Study|Progressive disease - clinical progression|0|||
146279873|NCT02626455|527538724|FG002|Overall Study|Progressive disease - clinical progression|0|||
146279874|NCT02626455|527538725|FG003|Overall Study|Progressive disease - clinical progression|0|||
146279875|NCT02626455|527538726|FG004|Overall Study|Progressive disease - clinical progression|0|||
146279876|NCT02626455|527538727|FG005|Overall Study|Progressive disease - clinical progression|1|||
146279877|NCT02626455|527538728|FG006|Overall Study|Progressive disease - clinical progression|2|||
146279878|NCT02626455|527538722|FG000|Overall Study|Lost to Follow-up|0|||
146279879|NCT02626455|527538723|FG001|Overall Study|Lost to Follow-up|0|||
146279880|NCT02626455|527538724|FG002|Overall Study|Lost to Follow-up|0|||
146279881|NCT02626455|527538725|FG003|Overall Study|Lost to Follow-up|0|||
146279882|NCT02626455|527538726|FG004|Overall Study|Lost to Follow-up|0|||
146279883|NCT02626455|527538727|FG005|Overall Study|Lost to Follow-up|1|||
146279884|NCT02626455|527538728|FG006|Overall Study|Lost to Follow-up|0|||
146279885|NCT02626455|527538722|FG000|Overall Study|AE not associated with clinical disease progression|1|||
146279886|NCT02626455|527538723|FG001|Overall Study|AE not associated with clinical disease progression|1|||
146279887|NCT02626455|527538724|FG002|Overall Study|AE not associated with clinical disease progression|0|||
146279888|NCT02626455|527538725|FG003|Overall Study|AE not associated with clinical disease progression|2|||
146279889|NCT02626455|527538726|FG004|Overall Study|AE not associated with clinical disease progression|1|||
146279890|NCT02626455|527538727|FG005|Overall Study|AE not associated with clinical disease progression|65|||
146279891|NCT02626455|527538728|FG006|Overall Study|AE not associated with clinical disease progression|21|||
146279892|NCT02626455|527538722|FG000|Overall Study|AE associated with clinical disease progression|0|||
146279893|NCT02626455|527538723|FG001|Overall Study|AE associated with clinical disease progression|0|||
146279894|NCT02626455|527538724|FG002|Overall Study|AE associated with clinical disease progression|0|||
146279895|NCT02626455|527538725|FG003|Overall Study|AE associated with clinical disease progression|0|||
146279896|NCT02626455|527538726|FG004|Overall Study|AE associated with clinical disease progression|0|||
146279897|NCT02626455|527538727|FG005|Overall Study|AE associated with clinical disease progression|1|||
146159053|NCT05553808|527092796|FG000|Overall Study|Lost to Follow-up|1|||
146279898|NCT02626455|527538728|FG006|Overall Study|AE associated with clinical disease progression|2|||
146279899|NCT02626455|527538722|FG000|Overall Study|Study intervention never administered|0|||
146279900|NCT02626455|527538723|FG001|Overall Study|Study intervention never administered|0|||
146279901|NCT02626455|527538724|FG002|Overall Study|Study intervention never administered|0|||
146159054|NCT05553808|527092797|FG001|Overall Study|Lost to Follow-up|0|||
146159055|NCT05553808|527092796|FG000|Overall Study|Withdrawal by Subject|3|||
146159056|NCT05553808|527092797|FG001|Overall Study|Withdrawal by Subject|2|||
146159057|NCT02273141|527092798|FG000|Overall Study|Adverse Event|0|||
146159058|NCT02273141|527092799|FG001|Overall Study|Adverse Event|1|||
146159059|NCT02273141|527092798|FG000|Overall Study|Lost to Follow-up|1|||
146159060|NCT02273141|527092799|FG001|Overall Study|Lost to Follow-up|3|||
146159061|NCT02273141|527092798|FG000|Overall Study|Withdrawal by Subject|10|||
146159062|NCT02273141|527092799|FG001|Overall Study|Withdrawal by Subject|15|||
146279902|NCT02626455|527538725|FG003|Overall Study|Study intervention never administered|0|||
146279903|NCT02626455|527538726|FG004|Overall Study|Study intervention never administered|0|||
146279904|NCT02626455|527538727|FG005|Overall Study|Study intervention never administered|1|||
146279905|NCT02626455|527538728|FG006|Overall Study|Study intervention never administered|3|||
146279906|NCT06665919|527538729|FG000|Overall Study|Withdrawal by Subject|4|||
146279907|NCT06665919|527538730|FG001|Overall Study|Withdrawal by Subject|4|||
146279908|NCT06665919|527538731|FG002|Overall Study|Withdrawal by Subject|4|||
146279909|NCT06665919|527538729|FG000|Overall Study|Non-compliance to Treatment|4|||
146279910|NCT06665919|527538730|FG001|Overall Study|Non-compliance to Treatment|1|||
146279911|NCT06665919|527538731|FG002|Overall Study|Non-compliance to Treatment|6|||
146279912|NCT06665919|527538729|FG000|Overall Study|Lost to Follow-up|3|||
146279913|NCT06665919|527538730|FG001|Overall Study|Lost to Follow-up|0|||
146279914|NCT06665919|527538731|FG002|Overall Study|Lost to Follow-up|2|||
146279915|NCT06665919|527538729|FG000|Overall Study|Physician Decision|4|||
146279916|NCT06665919|527538730|FG001|Overall Study|Physician Decision|0|||
146279917|NCT06665919|527538731|FG002|Overall Study|Physician Decision|1|||
146279918|NCT01200290|527538732|FG000|Treatment Period|Adverse Event|1|||
146279919|NCT01200290|527538732|FG000|Post-Treatment Follow-Up Period|Death|2|||
146279920|NCT01144377|527538733|FG000|52 Week Treatment Period|Adverse Event|0|||
146279921|NCT01144377|527538734|FG001|52 Week Treatment Period|Adverse Event|0|||
146279922|NCT01144377|527538735|FG002|52 Week Treatment Period|Adverse Event|3|||
146279923|NCT01144377|527538736|FG003|52 Week Treatment Period|Adverse Event|2|||
146279924|NCT01144377|527538737|FG004|52 Week Treatment Period|Adverse Event|1|||
146279925|NCT01144377|527538733|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
146279926|NCT01144377|527538734|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
146279927|NCT01144377|527538735|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
146279928|NCT01144377|527538736|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
146279929|NCT01144377|527538737|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
146279930|NCT01144377|527538733|FG000|52 Week Treatment Period|Protocol Violation|0|||
146279931|NCT01144377|527538734|FG001|52 Week Treatment Period|Protocol Violation|0|||
146279932|NCT01144377|527538735|FG002|52 Week Treatment Period|Protocol Violation|0|||
146279933|NCT01144377|527538736|FG003|52 Week Treatment Period|Protocol Violation|0|||
146279934|NCT01144377|527538737|FG004|52 Week Treatment Period|Protocol Violation|1|||
146279935|NCT01144377|527538733|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
146279936|NCT01144377|527538734|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
146279937|NCT01144377|527538735|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
146279938|NCT01144377|527538736|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
146279939|NCT01144377|527538737|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
146279940|NCT01144377|527538733|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
146279941|NCT01144377|527538734|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
146279942|NCT01144377|527538735|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
146279943|NCT01144377|527538736|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
146279944|NCT01144377|527538737|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
146279945|NCT01144377|527538733|FG000|52 Week Treatment Period|Sponsor Decision|0|||
146279946|NCT01144377|527538734|FG001|52 Week Treatment Period|Sponsor Decision|0|||
146279947|NCT01144377|527538735|FG002|52 Week Treatment Period|Sponsor Decision|0|||
146279948|NCT01144377|527538736|FG003|52 Week Treatment Period|Sponsor Decision|0|||
146279949|NCT01144377|527538737|FG004|52 Week Treatment Period|Sponsor Decision|1|||
146279950|NCT01144377|527538733|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
146279951|NCT01144377|527538734|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
146279952|NCT01144377|527538735|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
146279953|NCT01144377|527538736|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
146279954|NCT01144377|527538737|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
146279955|NCT01144377|527538733|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146279956|NCT01144377|527538734|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146279957|NCT01144377|527538735|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146279958|NCT01144377|527538736|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
146279959|NCT01144377|527538737|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
146279960|NCT01144377|527538733|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
146279961|NCT01144377|527538734|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146159063|NCT02273141|527092798|FG000|Overall Study|Various|6|||
146279962|NCT01144377|527538735|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146279963|NCT01144377|527538736|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146159064|NCT02273141|527092799|FG001|Overall Study|Various|6|||
146159065|NCT00529399|527092800|FG000|Overall Study|Lost to Follow-up|1|||
146159066|NCT00529399|527092801|FG001|Overall Study|Lost to Follow-up|0|||
146159067|NCT00529399|527092802|FG002|Overall Study|Lost to Follow-up|1|||
146159068|NCT00529399|527092800|FG000|Overall Study|Withdrawal by Subject|1|||
146159069|NCT00529399|527092801|FG001|Overall Study|Withdrawal by Subject|0|||
146159070|NCT00529399|527092802|FG002|Overall Study|Withdrawal by Subject|1|||
146159071|NCT00529399|527092800|FG000|Overall Study|Non-compliant|0|||
146159072|NCT00529399|527092801|FG001|Overall Study|Non-compliant|1|||
146159073|NCT00529399|527092802|FG002|Overall Study|Non-compliant|0|||
146159074|NCT01041638|527092822|FG000|Overall Study|Adverse Event|4|||
146159075|NCT01041638|527092822|FG000|Overall Study|Death|1|||
146159076|NCT01041638|527092822|FG000|Overall Study|Lack of Efficacy|7|||
146159077|NCT01041638|527092822|FG000|Overall Study|Physician Decision|4|||
146159078|NCT01041638|527092822|FG000|Overall Study|Withdrawal by Subject|11|||
146159079|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
146159080|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
146159081|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
146159082|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
146159083|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
146159084|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146159085|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
146159086|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146159087|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146159088|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
146159089|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
146311271|NCT01650636|527653451|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
146311272|NCT01560780|527653452|FG000|Overall Study|Death|2|||
146311273|NCT01560780|527653453|FG001|Overall Study|Death|1|||
146311274|NCT01560780|527653452|FG000|Overall Study|Patient Preference|11|||
146311275|NCT01560780|527653453|FG001|Overall Study|Patient Preference|11|||
146311276|NCT01577186|527653454|FG000|Overall Study|Adverse Event|23|||
146311277|NCT01577186|527653454|FG000|Overall Study|Death|1|||
146311278|NCT01577186|527653454|FG000|Overall Study|Lost to Follow-up|28|||
146311279|NCT01577186|527653454|FG000|Overall Study|Withdrawal by Subject|35|||
146311280|NCT01577186|527653454|FG000|Overall Study|Insufficient Response|18|||
146311281|NCT01577186|527653454|FG000|Overall Study|Ineligible to Continue|15|||
146311282|NCT01577186|527653454|FG000|Overall Study|Non-Compliant|8|||
146311283|NCT01577186|527653454|FG000|Overall Study|Other|2|||
146311284|NCT03287219|527653455|FG000|Overall Study|Protocol Violation|0|||
146311285|NCT03287219|527653456|FG001|Overall Study|Protocol Violation|2|||
146311286|NCT00957008|527653457|FG000|Overall Study|Withdrawal by Subject|13|||
146311287|NCT00957008|527653458|FG001|Overall Study|Withdrawal by Subject|10|||
146311288|NCT00957008|527653459|FG002|Overall Study|Withdrawal by Subject|12|||
146311289|NCT00957008|527653460|FG003|Overall Study|Withdrawal by Subject|16|||
146311290|NCT00957008|527653457|FG000|Overall Study|Lost to Follow-up|3|||
146311291|NCT00957008|527653458|FG001|Overall Study|Lost to Follow-up|1|||
146311292|NCT00957008|527653459|FG002|Overall Study|Lost to Follow-up|3|||
146311293|NCT00957008|527653460|FG003|Overall Study|Lost to Follow-up|4|||
146311294|NCT00957008|527653457|FG000|Overall Study|Physician Decision|1|||
146311295|NCT00957008|527653458|FG001|Overall Study|Physician Decision|0|||
146311296|NCT00957008|527653459|FG002|Overall Study|Physician Decision|1|||
146311297|NCT00957008|527653460|FG003|Overall Study|Physician Decision|1|||
146311298|NCT00957008|527653457|FG000|Overall Study|Relocated; Family conflict|4|||
146311299|NCT00957008|527653458|FG001|Overall Study|Relocated; Family conflict|1|||
146311300|NCT00957008|527653459|FG002|Overall Study|Relocated; Family conflict|1|||
146311301|NCT00957008|527653460|FG003|Overall Study|Relocated; Family conflict|3|||
146311302|NCT01118351|527653461|FG000|Overall Study|Adverse Event|3|||
146311303|NCT01118351|527653461|FG000|Overall Study|Withdrawal by Subject|1|||
146311304|NCT00811135|527653462|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
146311305|NCT00811135|527653462|FG000|Overall Study|Death|3|||
146311306|NCT00811135|527653462|FG000|Overall Study|Protocol Violation|2|||
146311307|NCT00811135|527653462|FG000|Overall Study|Violation of Selection Criteria|1|||
146311308|NCT00811135|527653462|FG000|Overall Study|Refused Treatment|1|||
146311309|NCT00811135|527653462|FG000|Overall Study|Withdrawal by Subject|3|||
146159090|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
146159091|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
146311310|NCT00811135|527653462|FG000|Overall Study|Administrative/Other Unspecified|11|||
146311311|NCT00811135|527653462|FG000|Overall Study|Ongoing|59|||
146311312|NCT02797808|527653472|FG000|Overall Study|Withdrawal by Subject|1|||
146311313|NCT02797808|527653473|FG001|Overall Study|Withdrawal by Subject|1|||
146159092|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
146311314|NCT02797808|527653472|FG000|Overall Study|Physician Decision|6|||
146311315|NCT02797808|527653473|FG001|Overall Study|Physician Decision|2|||
146311316|NCT02192827|527653474|FG000|Overall Study|Lost to Follow-up|25|||
146311317|NCT02192827|527653475|FG001|Overall Study|Lost to Follow-up|27|||
146311318|NCT02192827|527653474|FG000|Overall Study|Given additional steroids with admission|13|||
146311319|NCT02192827|527653475|FG001|Overall Study|Given additional steroids with admission|11|||
146311320|NCT00845728|527653476|FG000|Overall Study|Abnormal laboratory value (s)|2|||
146311321|NCT00845728|527653477|FG001|Overall Study|Abnormal laboratory value (s)|2|||
146311322|NCT00845728|527653476|FG000|Overall Study|Patient's inability to use the device|4|||
146311323|NCT00845728|527653477|FG001|Overall Study|Patient's inability to use the device|6|||
146311324|NCT00845728|527653476|FG000|Overall Study|Abnormal test procedure result (s)|7|||
146311325|NCT00845728|527653477|FG001|Overall Study|Abnormal test procedure result (s)|2|||
146311326|NCT00845728|527653476|FG000|Overall Study|Lost to Follow-up|22|||
146311327|NCT00845728|527653477|FG001|Overall Study|Lost to Follow-up|13|||
146311328|NCT00845728|527653476|FG000|Overall Study|Death|24|||
146311329|NCT00845728|527653477|FG001|Overall Study|Death|26|||
146311330|NCT00845728|527653476|FG000|Overall Study|Administrative Problems|34|||
146311331|NCT00845728|527653477|FG001|Overall Study|Administrative Problems|26|||
146311332|NCT00845728|527653476|FG000|Overall Study|Protocol Violation|36|||
146311333|NCT00845728|527653477|FG001|Overall Study|Protocol Violation|24|||
146311334|NCT00845728|527653476|FG000|Overall Study|Lack of Efficacy|51|||
146311335|NCT00845728|527653477|FG001|Overall Study|Lack of Efficacy|39|||
146311336|NCT00845728|527653476|FG000|Overall Study|Adverse Event|101|||
146311337|NCT00845728|527653477|FG001|Overall Study|Adverse Event|96|||
146311338|NCT00845728|527653476|FG000|Overall Study|Withdrawal by Subject|105|||
146311339|NCT00845728|527653477|FG001|Overall Study|Withdrawal by Subject|108|||
146311340|NCT01576549|527653480|FG000|Overall Study|Sponsor Decision|2|||
146311341|NCT01439204|527653483|FG000|Overall Study|Withdrawal by Subject|0|||
146311342|NCT01439204|527653484|FG001|Overall Study|Withdrawal by Subject|1|||
146311343|NCT01439204|527653483|FG000|Overall Study|Lost to Follow-up|0|||
146311344|NCT01439204|527653484|FG001|Overall Study|Lost to Follow-up|2|||
146311345|NCT01439204|527653483|FG000|Overall Study|No longer meets study criteria|1|||
146311346|NCT01439204|527653484|FG001|Overall Study|No longer meets study criteria|0|||
146311347|NCT01439204|527653483|FG000|Overall Study|poor/non-compliance|3|||
146311348|NCT01439204|527653484|FG001|Overall Study|poor/non-compliance|0|||
146311349|NCT01227044|527653488|FG000|Overall Study|Lost to Follow-up|5|||
146311350|NCT01227044|527653489|FG001|Overall Study|Lost to Follow-up|7|||
146311351|NCT01227044|527653488|FG000|Overall Study|Discontinued Intervention|1|||
146311352|NCT01227044|527653489|FG001|Overall Study|Discontinued Intervention|2|||
146311353|NCT00205855|527653500|FG000|Overall Study|Only received temporary implants|16|||
146311354|NCT00205855|527653500|FG000|Overall Study|Withdrawal by Subject|5|||
146311355|NCT01073267|527653503|FG000|Overall Study|Disease Progression|3|||
146311356|NCT00917150|527653504|FG000|Overall Study|Adverse Event|12|||
146311357|NCT00917150|527653505|FG001|Overall Study|Adverse Event|7|||
146311358|NCT00917150|527653506|FG002|Overall Study|Adverse Event|12|||
146311359|NCT00917150|527653507|FG003|Overall Study|Adverse Event|11|||
146311360|NCT00917150|527653504|FG000|Overall Study|Death|1|||
146311361|NCT00917150|527653505|FG001|Overall Study|Death|4|||
146311362|NCT00917150|527653506|FG002|Overall Study|Death|3|||
146311363|NCT00917150|527653507|FG003|Overall Study|Death|2|||
146311364|NCT00917150|527653504|FG000|Overall Study|Lost to Follow-up|1|||
146311365|NCT00917150|527653505|FG001|Overall Study|Lost to Follow-up|0|||
146311366|NCT00917150|527653506|FG002|Overall Study|Lost to Follow-up|4|||
146311367|NCT00917150|527653507|FG003|Overall Study|Lost to Follow-up|2|||
146311368|NCT00917150|527653504|FG000|Overall Study|Physician Decision|0|||
146311369|NCT00917150|527653505|FG001|Overall Study|Physician Decision|2|||
146311370|NCT00917150|527653506|FG002|Overall Study|Physician Decision|0|||
146311371|NCT00917150|527653507|FG003|Overall Study|Physician Decision|1|||
146311372|NCT00917150|527653504|FG000|Overall Study|Protocol Violation|5|||
146311373|NCT00917150|527653505|FG001|Overall Study|Protocol Violation|5|||
146311374|NCT00917150|527653506|FG002|Overall Study|Protocol Violation|3|||
146311375|NCT00917150|527653507|FG003|Overall Study|Protocol Violation|5|||
146311376|NCT00917150|527653504|FG000|Overall Study|Withdrawal by Subject|15|||
146311377|NCT00917150|527653505|FG001|Overall Study|Withdrawal by Subject|16|||
146159093|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
146159094|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146311378|NCT00917150|527653506|FG002|Overall Study|Withdrawal by Subject|18|||
146311379|NCT00917150|527653507|FG003|Overall Study|Withdrawal by Subject|11|||
146311380|NCT00917150|527653504|FG000|Overall Study|Other than specified|3|||
146311381|NCT00917150|527653505|FG001|Overall Study|Other than specified|3|||
146311382|NCT00917150|527653506|FG002|Overall Study|Other than specified|2|||
146311383|NCT00917150|527653507|FG003|Overall Study|Other than specified|2|||
146311384|NCT03891264|527653508|FG000|Overall Study|Adverse Event|1|||
146159095|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146159096|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146311385|NCT03891264|527653508|FG000|Overall Study|Withdrawal by Subject|2|||
146311386|NCT03891264|527653508|FG000|Overall Study|Physician Decision|2|||
146311387|NCT01505634|527653509|FG000|Overall Study|Withdrawal by Subject|2|||
146311388|NCT01505634|527653510|FG001|Overall Study|Withdrawal by Subject|5|||
146311389|NCT01505634|527653511|FG002|Overall Study|Withdrawal by Subject|1|||
146311390|NCT01505634|527653509|FG000|Overall Study|Physician Decision|1|||
146311391|NCT01505634|527653510|FG001|Overall Study|Physician Decision|1|||
146311392|NCT01505634|527653511|FG002|Overall Study|Physician Decision|0|||
146311393|NCT01505634|527653509|FG000|Overall Study|Adverse Event|1|||
146311394|NCT01505634|527653510|FG001|Overall Study|Adverse Event|0|||
146311395|NCT01505634|527653511|FG002|Overall Study|Adverse Event|0|||
146311396|NCT01505634|527653509|FG000|Overall Study|Insufficient supply of drug at site|1|||
146311397|NCT01505634|527653510|FG001|Overall Study|Insufficient supply of drug at site|0|||
146311398|NCT01505634|527653511|FG002|Overall Study|Insufficient supply of drug at site|0|||
146311399|NCT01505634|527653509|FG000|Overall Study|Protocol Violation|2|||
146311400|NCT01505634|527653510|FG001|Overall Study|Protocol Violation|0|||
146311401|NCT01505634|527653511|FG002|Overall Study|Protocol Violation|0|||
146311402|NCT01505634|527653509|FG000|Overall Study|Lost to Follow-up|1|||
146311403|NCT01505634|527653510|FG001|Overall Study|Lost to Follow-up|4|||
146311404|NCT01505634|527653511|FG002|Overall Study|Lost to Follow-up|4|||
146311405|NCT01505634|527653509|FG000|Overall Study|Death|1|||
146311406|NCT01505634|527653510|FG001|Overall Study|Death|0|||
146311407|NCT01505634|527653511|FG002|Overall Study|Death|0|||
146311408|NCT01505634|527653509|FG000|Overall Study|In a conflict zone|0|||
146311409|NCT01505634|527653510|FG001|Overall Study|In a conflict zone|0|||
146311410|NCT01505634|527653511|FG002|Overall Study|In a conflict zone|1|||
146311411|NCT01624662|527653515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
146311412|NCT01624662|527653516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146311413|NCT01624662|527653517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146311414|NCT01624662|527653518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
146311415|NCT01624662|527653515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
146311416|NCT01624662|527653516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
146311417|NCT01624662|527653517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146311418|NCT01624662|527653518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146311419|NCT01624662|527653515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146311420|NCT01624662|527653516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
146311421|NCT01624662|527653517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146311422|NCT01624662|527653518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146311423|NCT01624662|527653515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
146311424|NCT01624662|527653516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146311425|NCT01624662|527653517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
146311426|NCT01624662|527653518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146311427|NCT01624662|527653515|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146311428|NCT01624662|527653516|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146311429|NCT01624662|527653517|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146311430|NCT01624662|527653518|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146311431|NCT01624662|527653515|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146311432|NCT01624662|527653516|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
146311433|NCT01624662|527653517|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146311434|NCT01624662|527653518|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146311435|NCT01624662|527653515|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146311436|NCT01624662|527653516|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146311437|NCT01624662|527653517|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146311438|NCT01624662|527653518|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146311439|NCT01714687|527653521|FG000|Overall Study|Withdrawal by Subject|1|||
146311440|NCT01714687|527653522|FG001|Overall Study|Withdrawal by Subject|0|||
146311441|NCT01714687|527653521|FG000|Overall Study|Lost to Follow-up|2|||
146311442|NCT01714687|527653522|FG001|Overall Study|Lost to Follow-up|4|||
146311443|NCT05054114|527653533|FG000|Overall Study|Protocol Violation|13|||
146311444|NCT05054114|527653534|FG001|Overall Study|Protocol Violation|1|||
146311445|NCT05054114|527653533|FG000|Overall Study|Pregnancy|0|||
146311446|NCT05054114|527653534|FG001|Overall Study|Pregnancy|1|||
146311447|NCT01806779|527653535|FG000|Overall Study|Physician Decision|2|||
146311448|NCT01806779|527653536|FG001|Overall Study|Physician Decision|0|||
146311449|NCT01806779|527653537|FG002|Overall Study|Physician Decision|1|||
146311450|NCT01806779|527653535|FG000|Overall Study|Lack of Efficacy|1|||
146311451|NCT01806779|527653536|FG001|Overall Study|Lack of Efficacy|1|||
146311452|NCT01806779|527653537|FG002|Overall Study|Lack of Efficacy|0|||
146311453|NCT01806779|527653535|FG000|Overall Study|Lost to Follow-up|19|||
146311454|NCT01806779|527653536|FG001|Overall Study|Lost to Follow-up|20|||
146311455|NCT01806779|527653537|FG002|Overall Study|Lost to Follow-up|0|||
146311456|NCT01806779|527653535|FG000|Overall Study|Withdrawal by Subject|20|||
146311457|NCT01806779|527653536|FG001|Overall Study|Withdrawal by Subject|23|||
146311458|NCT01806779|527653537|FG002|Overall Study|Withdrawal by Subject|22|||
146311459|NCT02595450|527653538|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
146311460|NCT02595450|527653538|FG000|Overall Study|Enrolled, but not treated|8|||
146311461|NCT01934556|527653542|FG000|Overall Study|Withdrawal by Subject|0|||
146311462|NCT01934556|527653543|FG001|Overall Study|Withdrawal by Subject|1|||
146311463|NCT01934556|527653544|FG002|Overall Study|Withdrawal by Subject|1|||
146311464|NCT01934556|527653542|FG000|Overall Study|Lost to Follow-up|4|||
146311465|NCT01934556|527653543|FG001|Overall Study|Lost to Follow-up|10|||
146311466|NCT01934556|527653544|FG002|Overall Study|Lost to Follow-up|7|||
146311467|NCT01934556|527653542|FG000|Overall Study|Death|1|||
146311468|NCT01934556|527653543|FG001|Overall Study|Death|5|||
146311469|NCT01934556|527653544|FG002|Overall Study|Death|2|||
146311470|NCT00102960|527653547|FG000|Overall Study|Death|23|||
146311471|NCT00102960|527653548|FG001|Overall Study|Death|11|||
146311472|NCT00102960|527653549|FG002|Overall Study|Death|11|||
146311473|NCT00102960|527653547|FG000|Overall Study|Lost to Follow-up|6|||
146311474|NCT00102960|527653548|FG001|Overall Study|Lost to Follow-up|12|||
146311475|NCT00102960|527653549|FG002|Overall Study|Lost to Follow-up|16|||
146311476|NCT00102960|527653547|FG000|Overall Study|Withdrawal by Subject|1|||
146311477|NCT00102960|527653548|FG001|Overall Study|Withdrawal by Subject|0|||
146311478|NCT00102960|527653549|FG002|Overall Study|Withdrawal by Subject|1|||
146311479|NCT01192022|527655418|FG000|Overall Study|Withdrawal of Consent|3|||
146311480|NCT01192022|527655419|FG001|Overall Study|Withdrawal of Consent|1|||
146311481|NCT01192022|527655420|FG002|Overall Study|Withdrawal of Consent|0|||
146311482|NCT01192022|527655421|FG003|Overall Study|Withdrawal of Consent|0|||
146311483|NCT01192022|527655422|FG004|Overall Study|Withdrawal of Consent|0|||
146311484|NCT01192022|527655418|FG000|Overall Study|Lost to Follow-up|4|||
146311485|NCT01192022|527655419|FG001|Overall Study|Lost to Follow-up|2|||
146311486|NCT01192022|527655420|FG002|Overall Study|Lost to Follow-up|1|||
146311487|NCT01192022|527655421|FG003|Overall Study|Lost to Follow-up|1|||
146311488|NCT01192022|527655422|FG004|Overall Study|Lost to Follow-up|0|||
146311489|NCT01192022|527655418|FG000|Overall Study|Adverse Event|1|||
146311490|NCT01192022|527655419|FG001|Overall Study|Adverse Event|0|||
146311491|NCT01192022|527655420|FG002|Overall Study|Adverse Event|0|||
146311492|NCT01192022|527655421|FG003|Overall Study|Adverse Event|0|||
146311493|NCT01192022|527655422|FG004|Overall Study|Adverse Event|0|||
146311494|NCT01192022|527655418|FG000|Overall Study|Fatal Adverse Event|4|||
146311495|NCT01192022|527655419|FG001|Overall Study|Fatal Adverse Event|6|||
146311496|NCT01192022|527655420|FG002|Overall Study|Fatal Adverse Event|0|||
146311497|NCT01192022|527655421|FG003|Overall Study|Fatal Adverse Event|0|||
146311498|NCT01192022|527655422|FG004|Overall Study|Fatal Adverse Event|1|||
146311499|NCT01192022|527655418|FG000|Overall Study|Physician withdrew-patient hardship|1|||
146311500|NCT01192022|527655419|FG001|Overall Study|Physician withdrew-patient hardship|0|||
146311501|NCT01192022|527655420|FG002|Overall Study|Physician withdrew-patient hardship|0|||
146311502|NCT01192022|527655421|FG003|Overall Study|Physician withdrew-patient hardship|0|||
146311503|NCT01192022|527655422|FG004|Overall Study|Physician withdrew-patient hardship|0|||
146311504|NCT01192022|527655418|FG000|Overall Study|Patient too sick from chemotherapy|0|||
146311505|NCT01192022|527655419|FG001|Overall Study|Patient too sick from chemotherapy|1|||
146311506|NCT01192022|527655420|FG002|Overall Study|Patient too sick from chemotherapy|0|||
146311507|NCT01192022|527655421|FG003|Overall Study|Patient too sick from chemotherapy|0|||
146311508|NCT01192022|527655422|FG004|Overall Study|Patient too sick from chemotherapy|0|||
146311509|NCT01192022|527655418|FG000|Overall Study|Patient needed surgery|0|||
146311510|NCT01192022|527655419|FG001|Overall Study|Patient needed surgery|1|||
146311511|NCT01192022|527655420|FG002|Overall Study|Patient needed surgery|0|||
146311512|NCT01192022|527655421|FG003|Overall Study|Patient needed surgery|0|||
146311513|NCT01192022|527655422|FG004|Overall Study|Patient needed surgery|0|||
146311514|NCT01192022|527655418|FG000|Overall Study|Parents did not allow all follow up|0|||
146311515|NCT01192022|527655419|FG001|Overall Study|Parents did not allow all follow up|0|||
146311516|NCT01192022|527655420|FG002|Overall Study|Parents did not allow all follow up|0|||
146311517|NCT01192022|527655421|FG003|Overall Study|Parents did not allow all follow up|1|||
146311518|NCT01192022|527655422|FG004|Overall Study|Parents did not allow all follow up|0|||
146311519|NCT01351389|527655423|FG000|Overall Study|Withdrawal by Subject|7|||
146311520|NCT01351389|527655424|FG001|Overall Study|Withdrawal by Subject|0|||
146311521|NCT01351389|527655423|FG000|Overall Study|did not complete intervention|23|||
146311522|NCT01351389|527655424|FG001|Overall Study|did not complete intervention|15|||
146311523|NCT04839978|527655425|FG000|Overall Study|Lost to Follow-up|135|||
146311524|NCT04839978|527655426|FG001|Overall Study|Lost to Follow-up|147|||
146311525|NCT00623480|527655427|FG000|Overall Study|Lost to Follow-up|0|||
146311526|NCT00623480|527655428|FG001|Overall Study|Lost to Follow-up|1|||
146311527|NCT00623480|527655427|FG000|Overall Study|Withdrawal by Subject|2|||
146311528|NCT00623480|527655428|FG001|Overall Study|Withdrawal by Subject|4|||
146311529|NCT00623480|527655427|FG000|Overall Study|Lack of Efficacy|1|||
146311530|NCT00623480|527655428|FG001|Overall Study|Lack of Efficacy|0|||
146311531|NCT00623480|527655427|FG000|Overall Study|Non-compliant with study medication|4|||
146311532|NCT00623480|527655428|FG001|Overall Study|Non-compliant with study medication|0|||
146311533|NCT00623480|527655427|FG000|Overall Study|Protocol Violation|0|||
146311534|NCT00623480|527655428|FG001|Overall Study|Protocol Violation|1|||
146311535|NCT00623480|527655427|FG000|Overall Study|Site closed by sponsor|0|||
146311536|NCT00623480|527655428|FG001|Overall Study|Site closed by sponsor|1|||
146311537|NCT03551509|527655429|FG000|Overall Study|Lost to Follow-up|0|||
146311538|NCT03551509|527655430|FG001|Overall Study|Lost to Follow-up|1|||
146311539|NCT03551509|527655431|FG002|Overall Study|Lost to Follow-up|0|||
146311540|NCT02631200|527655432|FG000|First Period|Death|1|||
146311541|NCT02631200|527655433|FG001|First Period|Death|2|||
146311542|NCT02631200|527655432|FG000|First Period|Patient ill-health|2|||
146311543|NCT02631200|527655433|FG001|First Period|Patient ill-health|4|||
146311544|NCT02631200|527655432|FG000|First Period|Withdrawal by Subject|4|||
146311545|NCT02631200|527655433|FG001|First Period|Withdrawal by Subject|1|||
146311546|NCT02631200|527655432|FG000|Deferred Period|Death|0|||
146311547|NCT02631200|527655433|FG001|Deferred Period|Death|1|||
146311548|NCT02631200|527655432|FG000|Deferred Period|Received kidney transplant|0|||
146311549|NCT02631200|527655433|FG001|Deferred Period|Received kidney transplant|1|||
146311550|NCT02631200|527655432|FG000|Deferred Period|Withdrawal by Subject|0|||
146311551|NCT02631200|527655433|FG001|Deferred Period|Withdrawal by Subject|2|||
146311552|NCT02631200|527655432|FG000|Deferred Period|Lost to Follow-up|0|||
146311553|NCT02631200|527655433|FG001|Deferred Period|Lost to Follow-up|1|||
146311554|NCT01877187|527655434|FG000|Overall Study|Death|2|||
146311555|NCT01877187|527655434|FG000|Overall Study|Withdrawal by Subject|4|||
146311556|NCT01877187|527655434|FG000|Overall Study|Lost to Follow-up|3|||
146311557|NCT01877187|527655434|FG000|Overall Study|Declining clinical status|11|||
146311558|NCT01877187|527655434|FG000|Overall Study|Liver transplant|2|||
146311559|NCT00769002|527655436|FG000|Overall Study|Study was not completed, no data|9|||
146311560|NCT00769002|527655437|FG001|Overall Study|Study was not completed, no data|9|||
146311561|NCT04091087|527655439|FG000|Overall Study|Not treated|1|||
146311562|NCT04091087|527655440|FG001|Overall Study|Not treated|0|||
146311563|NCT04091087|527655439|FG000|Overall Study|Adverse Event|4|||
146311564|NCT04091087|527655440|FG001|Overall Study|Adverse Event|4|||
146311565|NCT04091087|527655439|FG000|Overall Study|Protocol Violation|0|||
146311566|NCT04091087|527655440|FG001|Overall Study|Protocol Violation|1|||
146311567|NCT04091087|527655439|FG000|Overall Study|Withdrawal by Subject|5|||
146311568|NCT04091087|527655440|FG001|Overall Study|Withdrawal by Subject|2|||
146311569|NCT04677712|527655441|FG000|Overall Study|Lost to Follow-up|0|||
146311570|NCT04677712|527655442|FG001|Overall Study|Lost to Follow-up|1|||
146311571|NCT04677712|527655443|FG002|Overall Study|Lost to Follow-up|0|||
146311572|NCT04677712|527655444|FG003|Overall Study|Lost to Follow-up|0|||
146311573|NCT04677712|527655445|FG004|Overall Study|Lost to Follow-up|0|||
146311574|NCT04677712|527655446|FG005|Overall Study|Lost to Follow-up|0|||
146311575|NCT00711100|527655447|FG000|Overall Study|Lack of Efficacy|5|||
146311576|NCT00711100|527655447|FG000|Overall Study|Withdrawal by Subject|8|||
146311577|NCT00783094|527655448|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
146311578|NCT00783094|527655449|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
146311579|NCT00783094|527655450|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
146311580|NCT00783094|527655448|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
146311581|NCT00783094|527655449|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
146311582|NCT00783094|527655450|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
146311583|NCT00783094|527655448|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
146311584|NCT00783094|527655449|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
146311585|NCT00783094|527655450|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
146311586|NCT00783094|527655448|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
146311587|NCT00783094|527655449|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
146311588|NCT00783094|527655450|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
146311589|NCT00783094|527655448|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
146311590|NCT00783094|527655449|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
146311591|NCT00783094|527655450|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
146311592|NCT00783094|527655448|FG000|Open-Label Extension Period|Adverse Event|12|||
146311593|NCT00783094|527655449|FG001|Open-Label Extension Period|Adverse Event|7|||
146311594|NCT00783094|527655450|FG002|Open-Label Extension Period|Adverse Event|16|||
146311595|NCT00783094|527655448|FG000|Open-Label Extension Period|Death|0|||
146311596|NCT00783094|527655449|FG001|Open-Label Extension Period|Death|0|||
146311597|NCT00783094|527655450|FG002|Open-Label Extension Period|Death|1|||
146311598|NCT00783094|527655448|FG000|Open-Label Extension Period|Protocol Violation|4|||
146311599|NCT00783094|527655449|FG001|Open-Label Extension Period|Protocol Violation|5|||
146311600|NCT00783094|527655450|FG002|Open-Label Extension Period|Protocol Violation|7|||
146311601|NCT00783094|527655448|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
146311602|NCT00783094|527655449|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
146311603|NCT00783094|527655450|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
146311604|NCT00783094|527655448|FG000|Open-Label Extension Period|Physician Decision|4|||
146311605|NCT00783094|527655449|FG001|Open-Label Extension Period|Physician Decision|2|||
146311606|NCT00783094|527655450|FG002|Open-Label Extension Period|Physician Decision|3|||
146311607|NCT00783094|527655448|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
146311608|NCT00783094|527655449|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
146311609|NCT00783094|527655450|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
146311610|NCT02513329|527655451|FG000|Overall Study|Lost to Follow-up|5|||
146311611|NCT02513329|527655452|FG001|Overall Study|Lost to Follow-up|2|||
146311612|NCT01294670|527655453|FG000|Overall Study|Not treated|1|||
146311613|NCT01294670|527655454|FG001|Overall Study|Not treated|0|||
146311614|NCT01294670|527655455|FG002|Overall Study|Not treated|0|||
146311615|NCT01294670|527655456|FG003|Overall Study|Not treated|0|||
146311616|NCT01294670|527655457|FG004|Overall Study|Not treated|0|||
146279964|NCT01144377|527538737|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
146279965|NCT00607724|527538738|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
146279966|NCT00607724|527538739|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
146279967|NCT00607724|527538740|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
146279968|NCT00607724|527538741|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146279969|NCT00607724|527538742|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146279970|NCT00607724|527538743|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146279971|NCT00607724|527538744|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
146279972|NCT00607724|527538738|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
146279973|NCT00607724|527538739|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
146279974|NCT00607724|527538740|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
146279975|NCT00607724|527538741|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
146279976|NCT00607724|527538742|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
146279977|NCT00607724|527538743|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
146279978|NCT00607724|527538744|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
146279979|NCT00607724|527538738|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
146279980|NCT00607724|527538739|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
146279981|NCT00607724|527538740|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
146279982|NCT00607724|527538741|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
146279983|NCT00607724|527538742|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
146279984|NCT00607724|527538743|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
146279985|NCT00607724|527538744|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
146279986|NCT00607724|527538738|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
146279987|NCT00607724|527538739|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
146279988|NCT00607724|527538740|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
146279989|NCT00607724|527538741|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
146279990|NCT00607724|527538742|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
146279991|NCT00607724|527538743|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
146279992|NCT00607724|527538744|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
146279993|NCT00607724|527538738|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146279994|NCT00607724|527538739|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146279995|NCT00607724|527538740|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146279996|NCT00607724|527538741|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
146279997|NCT00607724|527538742|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146279998|NCT00607724|527538743|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146279999|NCT00607724|527538744|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
146280000|NCT00151281|527538745|FG000|Overall Study|Not evaluable|3|||
146280001|NCT01133418|527538748|FG000|Overall Study|Lost to Follow-up|5|||
146280002|NCT01133418|527538749|FG001|Overall Study|Lost to Follow-up|6|||
146280003|NCT04150068|527538750|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
146280004|NCT04150068|527538751|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
146280005|NCT04150068|527538752|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
146280006|NCT04150068|527538750|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
146280007|NCT04150068|527538751|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
146280008|NCT04150068|527538752|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
146280009|NCT05316701|527538753|FG000|Overall Study|Adverse Event|0|||
146280010|NCT05316701|527538754|FG001|Overall Study|Adverse Event|1|||
146280011|NCT05316701|527538753|FG000|Overall Study|Death|3|||
146280012|NCT05316701|527538754|FG001|Overall Study|Death|9|||
146280013|NCT05316701|527538753|FG000|Overall Study|Lost to Follow-up|1|||
146280014|NCT05316701|527538754|FG001|Overall Study|Lost to Follow-up|0|||
146280015|NCT05316701|527538753|FG000|Overall Study|Physician Decision|1|||
146280016|NCT05316701|527538754|FG001|Overall Study|Physician Decision|4|||
146280017|NCT05316701|527538753|FG000|Overall Study|Withdrawal by Subject|3|||
146280018|NCT05316701|527538754|FG001|Overall Study|Withdrawal by Subject|5|||
146280019|NCT05316701|527538753|FG000|Overall Study|Progression/Relapse|14|||
146280020|NCT05316701|527538754|FG001|Overall Study|Progression/Relapse|9|||
146280021|NCT05316701|527538753|FG000|Overall Study|Received Standard of Care|1|||
146280022|NCT05316701|527538754|FG001|Overall Study|Received Standard of Care|0|||
146280023|NCT05316701|527538753|FG000|Overall Study|Ongoing|70|||
146280024|NCT05316701|527538754|FG001|Overall Study|Ongoing|64|||
146280025|NCT04679935|527538755|FG000|Overall Study|Death|0|||
146280026|NCT04679935|527538756|FG001|Overall Study|Death|1|||
146280027|NCT04362189|527538760|FG000|Overall Study|Lost to Follow-up|0|||
146280028|NCT04362189|527538761|FG001|Overall Study|Lost to Follow-up|1|||
146280029|NCT04362189|527538760|FG000|Overall Study|Withdrawal by Subject|1|||
146280030|NCT04362189|527538761|FG001|Overall Study|Withdrawal by Subject|0|||
146280031|NCT04362189|527538760|FG000|Overall Study|FDA Clinical Hold|7|||
146280032|NCT04362189|527538761|FG001|Overall Study|FDA Clinical Hold|2|||
146280033|NCT04362189|527538760|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
146280034|NCT04362189|527538761|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
146280035|NCT04362189|527538760|FG000|Overall Study|Adverse Event|0|||
146280036|NCT04362189|527538761|FG001|Overall Study|Adverse Event|2|||
146280037|NCT04362189|527538760|FG000|Overall Study|Death|4|||
146280038|NCT04362189|527538761|FG001|Overall Study|Death|1|||
146280039|NCT02111681|527538762|FG000|Overall Study|Death|5|||
146280040|NCT02111681|527538762|FG000|Overall Study|Lack of Efficacy|2|||
146280041|NCT02111681|527538762|FG000|Overall Study|Progression of disease|4|||
146280042|NCT00969709|527539897|FG000|Overall Study|Adverse Event|3|||
146280043|NCT00969709|527539898|FG001|Overall Study|Adverse Event|13|||
146280044|NCT00969709|527539899|FG002|Overall Study|Adverse Event|26|||
146280045|NCT00969709|527539900|FG003|Overall Study|Adverse Event|12|||
146280046|NCT00969709|527539897|FG000|Overall Study|Lack of Efficacy|7|||
146280047|NCT00969709|527539898|FG001|Overall Study|Lack of Efficacy|4|||
146280048|NCT00969709|527539899|FG002|Overall Study|Lack of Efficacy|1|||
146280049|NCT00969709|527539900|FG003|Overall Study|Lack of Efficacy|3|||
146280050|NCT00969709|527539897|FG000|Overall Study|Protocol Violation|9|||
146280051|NCT00969709|527539898|FG001|Overall Study|Protocol Violation|5|||
146280052|NCT00969709|527539899|FG002|Overall Study|Protocol Violation|9|||
146280053|NCT00969709|527539900|FG003|Overall Study|Protocol Violation|10|||
146280054|NCT00969709|527539897|FG000|Overall Study|Withdrawal by Subject|9|||
146280055|NCT00969709|527539898|FG001|Overall Study|Withdrawal by Subject|12|||
146280056|NCT00969709|527539899|FG002|Overall Study|Withdrawal by Subject|11|||
146280057|NCT00969709|527539900|FG003|Overall Study|Withdrawal by Subject|23|||
146280058|NCT00969709|527539897|FG000|Overall Study|Lost to Follow-up|10|||
146280059|NCT00969709|527539898|FG001|Overall Study|Lost to Follow-up|14|||
146280060|NCT00969709|527539899|FG002|Overall Study|Lost to Follow-up|8|||
146280061|NCT00969709|527539900|FG003|Overall Study|Lost to Follow-up|15|||
146280062|NCT00969709|527539897|FG000|Overall Study|Other reasons|0|||
146280063|NCT00969709|527539898|FG001|Overall Study|Other reasons|0|||
146280064|NCT00969709|527539899|FG002|Overall Study|Other reasons|3|||
146280065|NCT00969709|527539900|FG003|Overall Study|Other reasons|0|||
146280066|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Adverse Event|6|||
146280067|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Adverse Event|6|||
146280068|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Death|1|||
146280069|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Death|1|||
146280070|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146280071|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146280072|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
146280073|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
146280074|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Physician Decision|1|||
146280075|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Physician Decision|4|||
146280076|NCT03828747|527539908|FG000|Double-Blind Treatment Period|Various reasons|5|||
146280077|NCT03828747|527539909|FG001|Double-Blind Treatment Period|Various reasons|3|||
146280078|NCT03828747|527539908|FG000|Open-Label Extension|Adverse Event|9|||
146280079|NCT03828747|527539909|FG001|Open-Label Extension|Adverse Event|7|||
146280080|NCT03828747|527539908|FG000|Open-Label Extension|Death|0|||
146280081|NCT03828747|527539909|FG001|Open-Label Extension|Death|2|||
146280082|NCT03828747|527539908|FG000|Open-Label Extension|Lost to Follow-up|4|||
146280083|NCT03828747|527539909|FG001|Open-Label Extension|Lost to Follow-up|0|||
146280084|NCT03828747|527539908|FG000|Open-Label Extension|Withdrawal by Subject|31|||
146280085|NCT03828747|527539909|FG001|Open-Label Extension|Withdrawal by Subject|30|||
146280086|NCT03828747|527539908|FG000|Open-Label Extension|Various reasons|4|||
146280087|NCT03828747|527539909|FG001|Open-Label Extension|Various reasons|4|||
146280088|NCT03828747|527539908|FG000|Open-Label Extension|Physician Decision|6|||
146280089|NCT03828747|527539909|FG001|Open-Label Extension|Physician Decision|2|||
146280090|NCT00836745|527539914|FG000|Overall Study|Death|2|||
146280091|NCT00836745|527539914|FG000|Overall Study|Lost to Follow-up|10|||
146280092|NCT00836745|527539914|FG000|Overall Study|Adverse Event|3|||
146280093|NCT00836745|527539914|FG000|Overall Study|Objective progression or relapse|4|||
146280094|NCT00836745|527539914|FG000|Overall Study|Other|2|||
146280095|NCT02366468|527539915|FG000|Overall Study|Adverse Event|2|||
146280096|NCT02366468|527539916|FG001|Overall Study|Adverse Event|0|||
146280097|NCT02366468|527539915|FG000|Overall Study|Withdrawal by Subject|1|||
146280098|NCT02366468|527539916|FG001|Overall Study|Withdrawal by Subject|5|||
146280099|NCT02366468|527539915|FG000|Overall Study|Lost to Follow-up|2|||
146280100|NCT02366468|527539916|FG001|Overall Study|Lost to Follow-up|0|||
146280101|NCT02366468|527539915|FG000|Overall Study|Death|1|||
146280102|NCT02366468|527539916|FG001|Overall Study|Death|2|||
146311617|NCT03808077|527655458|FG000|Overall Study|Physician Decision|2|||
146280103|NCT02366468|527539915|FG000|Overall Study|Other|0|||
146280104|NCT02366468|527539916|FG001|Overall Study|Other|2|||
146280105|NCT00490490|527539917|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
146280106|NCT00490490|527539917|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
146280107|NCT05540717|527539918|FG000|Overall Study|Lost to Follow-up|2|||
146280108|NCT05540717|527539919|FG001|Overall Study|Lost to Follow-up|5|||
146280109|NCT05540717|527539918|FG000|Overall Study|Withdrawal by Subject|6|||
146280110|NCT05540717|527539919|FG001|Overall Study|Withdrawal by Subject|6|||
146280111|NCT05540717|527539918|FG000|Overall Study|Sponsor request|1|||
146280112|NCT05540717|527539919|FG001|Overall Study|Sponsor request|0|||
146311618|NCT03808077|527655459|FG001|Overall Study|Physician Decision|3|||
146311619|NCT03808077|527655458|FG000|Overall Study|Withdrawal by Subject|1|||
146311620|NCT03808077|527655459|FG001|Overall Study|Withdrawal by Subject|0|||
146311621|NCT03808077|527655458|FG000|Overall Study|Equipment Issues|2|||
146311622|NCT03808077|527655459|FG001|Overall Study|Equipment Issues|1|||
146311623|NCT04152161|527655460|FG000|Overall Study|Death|0|||
146311624|NCT04152161|527655461|FG001|Overall Study|Death|1|||
146311625|NCT04152161|527655460|FG000|Overall Study|Physician Decision|0|||
146311626|NCT04152161|527655461|FG001|Overall Study|Physician Decision|1|||
146311627|NCT04152161|527655460|FG000|Overall Study|Lost to Follow-up|9|||
146311628|NCT04152161|527655461|FG001|Overall Study|Lost to Follow-up|3|||
146311629|NCT04152161|527655460|FG000|Overall Study|Protocol Violation|1|||
146311630|NCT04152161|527655461|FG001|Overall Study|Protocol Violation|0|||
146311631|NCT04152161|527655460|FG000|Overall Study|Withdrawal by Subject|29|||
146311632|NCT04152161|527655461|FG001|Overall Study|Withdrawal by Subject|28|||
146311633|NCT04152161|527655460|FG000|Overall Study|Sponsor termination of study|750|||
146311634|NCT04152161|527655461|FG001|Overall Study|Sponsor termination of study|755|||
146311635|NCT04152161|527655460|FG000|Overall Study|Other|20|||
146311636|NCT04152161|527655461|FG001|Overall Study|Other|18|||
146311637|NCT00001379|527655462|FG000|Initial Treatment|Disease progression|21|||
146311638|NCT00001379|527655463|FG001|Initial Treatment|Disease progression|3|||
146311639|NCT00001379|527655464|FG002|Initial Treatment|Disease progression|0|||
146311640|NCT00001379|527655465|FG003|Initial Treatment|Disease progression|0|||
146311641|NCT00001379|527655462|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
146311642|NCT00001379|527655463|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
146311643|NCT00001379|527655464|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
146311644|NCT00001379|527655465|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
146311645|NCT00001379|527655462|FG000|Initial Treatment|Received alternative treatment|2|||
146311646|NCT00001379|527655463|FG001|Initial Treatment|Received alternative treatment|1|||
146311647|NCT00001379|527655464|FG002|Initial Treatment|Received alternative treatment|0|||
146311648|NCT00001379|527655465|FG003|Initial Treatment|Received alternative treatment|0|||
146311649|NCT00001379|527655462|FG000|Initial Treatment|Refused further treatment|2|||
146311650|NCT00001379|527655463|FG001|Initial Treatment|Refused further treatment|0|||
146311651|NCT00001379|527655464|FG002|Initial Treatment|Refused further treatment|0|||
146311652|NCT00001379|527655465|FG003|Initial Treatment|Refused further treatment|0|||
146311653|NCT00001379|527655462|FG000|Initial Treatment|Did not receive protocol treatment|0|||
146311654|NCT00001379|527655463|FG001|Initial Treatment|Did not receive protocol treatment|0|||
146311655|NCT00001379|527655464|FG002|Initial Treatment|Did not receive protocol treatment|5|||
146311656|NCT00001379|527655465|FG003|Initial Treatment|Did not receive protocol treatment|0|||
146311657|NCT00001379|527655462|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146311658|NCT00001379|527655463|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146311659|NCT00001379|527655464|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
146311660|NCT00001379|527655465|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
146311661|NCT00001379|527655462|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
146311662|NCT00001379|527655463|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
146311663|NCT00001379|527655464|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
146311664|NCT00001379|527655465|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
146311665|NCT00001379|527655462|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
146311666|NCT00001379|527655463|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
146311667|NCT00001379|527655464|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
146311668|NCT00001379|527655465|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
146311669|NCT00001379|527655462|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
146311670|NCT00001379|527655463|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146311671|NCT00001379|527655464|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146311672|NCT00001379|527655465|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
146311673|NCT00001379|527655462|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
146311674|NCT00001379|527655463|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
146311675|NCT00001379|527655464|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
146311676|NCT00001379|527655465|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
146311677|NCT03703102|527655469|FG000|Overall Study|Adverse Event|4|||
146311678|NCT03703102|527655470|FG001|Overall Study|Adverse Event|3|||
146159097|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146159098|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146159099|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146159100|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146159101|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
146311679|NCT03703102|527655471|FG002|Overall Study|Adverse Event|7|||
146311680|NCT03703102|527655472|FG003|Overall Study|Adverse Event|3|||
146311681|NCT03703102|527655473|FG004|Overall Study|Adverse Event|13|||
146311682|NCT03703102|527655469|FG000|Overall Study|Lack of Efficacy|4|||
146311683|NCT03703102|527655470|FG001|Overall Study|Lack of Efficacy|0|||
146311684|NCT03703102|527655471|FG002|Overall Study|Lack of Efficacy|1|||
146311685|NCT03703102|527655472|FG003|Overall Study|Lack of Efficacy|4|||
146311686|NCT03703102|527655473|FG004|Overall Study|Lack of Efficacy|1|||
146311687|NCT03703102|527655469|FG000|Overall Study|Lost to Follow-up|0|||
146311688|NCT03703102|527655470|FG001|Overall Study|Lost to Follow-up|0|||
146311689|NCT03703102|527655471|FG002|Overall Study|Lost to Follow-up|1|||
146311690|NCT03703102|527655472|FG003|Overall Study|Lost to Follow-up|2|||
146311691|NCT03703102|527655473|FG004|Overall Study|Lost to Follow-up|2|||
146311692|NCT03703102|527655469|FG000|Overall Study|Physician Decision|2|||
146311693|NCT03703102|527655470|FG001|Overall Study|Physician Decision|2|||
146311694|NCT03703102|527655471|FG002|Overall Study|Physician Decision|2|||
146311695|NCT03703102|527655472|FG003|Overall Study|Physician Decision|2|||
146311696|NCT03703102|527655473|FG004|Overall Study|Physician Decision|4|||
146311697|NCT03703102|527655469|FG000|Overall Study|Withdrawal by Subject|7|||
146311698|NCT03703102|527655470|FG001|Overall Study|Withdrawal by Subject|5|||
146311699|NCT03703102|527655471|FG002|Overall Study|Withdrawal by Subject|5|||
146311700|NCT03703102|527655472|FG003|Overall Study|Withdrawal by Subject|5|||
146311701|NCT03703102|527655473|FG004|Overall Study|Withdrawal by Subject|9|||
146311702|NCT03703102|527655469|FG000|Overall Study|Ineligibility|0|||
146311703|NCT03703102|527655470|FG001|Overall Study|Ineligibility|0|||
146311704|NCT03703102|527655471|FG002|Overall Study|Ineligibility|1|||
146311705|NCT03703102|527655472|FG003|Overall Study|Ineligibility|0|||
146311706|NCT03703102|527655473|FG004|Overall Study|Ineligibility|0|||
146311707|NCT03703102|527655469|FG000|Overall Study|Protocol Deviation|4|||
146311708|NCT03703102|527655470|FG001|Overall Study|Protocol Deviation|4|||
146311709|NCT03703102|527655471|FG002|Overall Study|Protocol Deviation|3|||
146311710|NCT03703102|527655472|FG003|Overall Study|Protocol Deviation|0|||
146311711|NCT03703102|527655473|FG004|Overall Study|Protocol Deviation|0|||
146311712|NCT03703102|527655469|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146311713|NCT03703102|527655470|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146311714|NCT03703102|527655471|FG002|Overall Study|Non-Compliance with Study Drug|2|||
146311715|NCT03703102|527655472|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146311716|NCT03703102|527655473|FG004|Overall Study|Non-Compliance with Study Drug|4|||
146311717|NCT00876187|527655474|FG000|Overall Study|Adverse Event|14|||
146311718|NCT00876187|527655475|FG001|Overall Study|Adverse Event|12|||
146311719|NCT00876187|527655476|FG002|Overall Study|Adverse Event|19|||
146311720|NCT00876187|527655477|FG003|Overall Study|Adverse Event|29|||
146311721|NCT00876187|527655478|FG004|Overall Study|Adverse Event|10|||
146311722|NCT00876187|527655474|FG000|Overall Study|Lack of Efficacy|59|||
146311723|NCT00876187|527655475|FG001|Overall Study|Lack of Efficacy|34|||
146311724|NCT00876187|527655476|FG002|Overall Study|Lack of Efficacy|45|||
146311725|NCT00876187|527655477|FG003|Overall Study|Lack of Efficacy|34|||
146311726|NCT00876187|527655478|FG004|Overall Study|Lack of Efficacy|59|||
146311727|NCT00876187|527655474|FG000|Overall Study|Lost to Follow-up|9|||
146311728|NCT00876187|527655475|FG001|Overall Study|Lost to Follow-up|10|||
146311729|NCT00876187|527655476|FG002|Overall Study|Lost to Follow-up|8|||
146311730|NCT00876187|527655477|FG003|Overall Study|Lost to Follow-up|8|||
146311731|NCT00876187|527655478|FG004|Overall Study|Lost to Follow-up|11|||
146311732|NCT00876187|527655474|FG000|Overall Study|Protocol Violation|6|||
146311733|NCT00876187|527655475|FG001|Overall Study|Protocol Violation|7|||
146311734|NCT00876187|527655476|FG002|Overall Study|Protocol Violation|7|||
146311735|NCT00876187|527655477|FG003|Overall Study|Protocol Violation|6|||
146311736|NCT00876187|527655478|FG004|Overall Study|Protocol Violation|3|||
146311737|NCT00876187|527655474|FG000|Overall Study|Withdrawal by Subject|16|||
146311738|NCT00876187|527655475|FG001|Overall Study|Withdrawal by Subject|26|||
146311739|NCT00876187|527655476|FG002|Overall Study|Withdrawal by Subject|32|||
146311740|NCT00876187|527655477|FG003|Overall Study|Withdrawal by Subject|38|||
146311741|NCT00876187|527655478|FG004|Overall Study|Withdrawal by Subject|37|||
146311742|NCT00876187|527655474|FG000|Overall Study|Entered extension study|101|||
146311743|NCT00876187|527655475|FG001|Overall Study|Entered extension study|120|||
146311744|NCT00876187|527655476|FG002|Overall Study|Entered extension study|156|||
146311745|NCT00876187|527655477|FG003|Overall Study|Entered extension study|151|||
146311746|NCT00876187|527655478|FG004|Overall Study|Entered extension study|144|||
146311747|NCT00876187|527655474|FG000|Overall Study|Randomized but not treated|3|||
146311748|NCT00876187|527655475|FG001|Overall Study|Randomized but not treated|1|||
146311749|NCT00876187|527655476|FG002|Overall Study|Randomized but not treated|3|||
146311750|NCT00876187|527655477|FG003|Overall Study|Randomized but not treated|2|||
146311751|NCT00876187|527655478|FG004|Overall Study|Randomized but not treated|3|||
146311752|NCT00876187|527655474|FG000|Overall Study|Other|2|||
146311753|NCT00876187|527655475|FG001|Overall Study|Other|5|||
146311754|NCT00876187|527655476|FG002|Overall Study|Other|9|||
146311755|NCT00876187|527655477|FG003|Overall Study|Other|7|||
146311756|NCT00876187|527655478|FG004|Overall Study|Other|4|||
146311757|NCT00794677|527655481|FG000|First Intervention|Withdrawal by Subject|2|||
146311758|NCT00794677|527655482|FG001|First Intervention|Withdrawal by Subject|0|||
146311759|NCT02863809|527655483|FG000|Overall Study|Adverse Event|8|||
146311760|NCT02863809|527655484|FG001|Overall Study|Adverse Event|8|||
146311761|NCT02863809|527655483|FG000|Overall Study|Withdrawal by Subject|0|||
146311762|NCT02863809|527655484|FG001|Overall Study|Withdrawal by Subject|1|||
146311763|NCT02863809|527655483|FG000|Overall Study|Lost to Follow-up|1|||
146311764|NCT02863809|527655484|FG001|Overall Study|Lost to Follow-up|1|||
146311765|NCT02863809|527655483|FG000|Overall Study|Death|1|||
146311766|NCT02863809|527655484|FG001|Overall Study|Death|0|||
146311767|NCT00607386|527655485|FG000|Overall Study|Physician Decision|1|||
146311768|NCT01422915|527655488|FG000|Overall Study|Adverse Event|1|||
146311769|NCT01265797|527655489|FG000|Run-in Month|Withdrawal by Subject|0|||
146311770|NCT01265797|527655490|FG001|Run-in Month|Withdrawal by Subject|4|||
146311771|NCT01265797|527655489|FG000|Run-in Month|1st seizure during run-in month|0|||
146311772|NCT01265797|527655490|FG001|Run-in Month|1st seizure during run-in month|1|||
146311773|NCT01265797|527655489|FG000|Blinded Month|Lack of Efficacy|5|||
146311774|NCT01265797|527655490|FG001|Blinded Month|Lack of Efficacy|0|||
146311775|NCT01265797|527655489|FG000|Blinded Month|Lost to Follow-up|1|||
146311776|NCT01265797|527655490|FG001|Blinded Month|Lost to Follow-up|0|||
146311777|NCT01265797|527655489|FG000|Blinded Month|Protocol Violation|2|||
146311778|NCT01265797|527655490|FG001|Blinded Month|Protocol Violation|1|||
146311779|NCT01265797|527655489|FG000|Blinded Month|Adverse Event|2|||
146311780|NCT01265797|527655490|FG001|Blinded Month|Adverse Event|0|||
146311781|NCT01265797|527655489|FG000|Blinded Month|Diary data incomplete|0|||
146311782|NCT01265797|527655490|FG001|Blinded Month|Diary data incomplete|1|||
146311783|NCT01265797|527655489|FG000|Open Label Month|Lost to Follow-up|0|||
146311784|NCT01265797|527655490|FG001|Open Label Month|Lost to Follow-up|1|||
146311785|NCT02980224|527655491|FG000|Overall Study|Adverse Event|4|||
146311786|NCT02980224|527655492|FG001|Overall Study|Adverse Event|1|||
146311787|NCT02980224|527655491|FG000|Overall Study|Withdrawal by Subject|0|||
146311788|NCT02980224|527655492|FG001|Overall Study|Withdrawal by Subject|2|||
146311789|NCT04247061|527655493|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
146311790|NCT04247061|527655493|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
146159102|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146159103|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
146159104|NCT03152552|527092823|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146159105|NCT03152552|527092824|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146159106|NCT03152552|527092825|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146159107|NCT03152552|527092826|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
146159108|NCT03152552|527092827|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
146159109|NCT03152552|527092823|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
146311791|NCT04247061|527655493|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
146311792|NCT05513625|527655494|FG000|Overall Study|Withdrawal by Subject|1|||
146311793|NCT02039375|527655500|FG000|Overall Study|Lost to Follow-up|2|||
146311794|NCT00542269|527655505|FG000|Overall Study|Adverse Event|10|||
146311795|NCT00542269|527655506|FG001|Overall Study|Adverse Event|4|||
146311796|NCT00542269|527655507|FG002|Overall Study|Adverse Event|5|||
146311797|NCT00542269|527655505|FG000|Overall Study|Protocol Violation|1|||
146311798|NCT00542269|527655506|FG001|Overall Study|Protocol Violation|1|||
146311799|NCT00542269|527655507|FG002|Overall Study|Protocol Violation|0|||
146311800|NCT00542269|527655505|FG000|Overall Study|Withdrawal by Subject|1|||
146311801|NCT00542269|527655506|FG001|Overall Study|Withdrawal by Subject|0|||
146311802|NCT00542269|527655507|FG002|Overall Study|Withdrawal by Subject|0|||
146311803|NCT00542269|527655505|FG000|Overall Study|Administrative problems|1|||
146311804|NCT00542269|527655506|FG001|Overall Study|Administrative problems|1|||
146311805|NCT00542269|527655507|FG002|Overall Study|Administrative problems|1|||
146311806|NCT03873714|527655508|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
146311807|NCT00708123|527655511|FG000|Period 1|Protocol Violation|0|||
146311808|NCT00708123|527655512|FG001|Period 1|Protocol Violation|1|||
146159110|NCT03152552|527092824|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
146159111|NCT03152552|527092825|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
146159112|NCT03152552|527092826|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
146159113|NCT03152552|527092827|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
146159114|NCT04084314|527092830|FG000|Overall Study|Subject/guardian decision|91|||
146311809|NCT00708123|527655513|FG002|Period 1|Protocol Violation|0|||
146159115|NCT04084314|527092830|FG000|Overall Study|Adverse Event|24|||
146311810|NCT00708123|527655514|FG003|Period 1|Protocol Violation|1|||
146311811|NCT00708123|527655515|FG004|Period 1|Protocol Violation|0|||
146311812|NCT00708123|527655511|FG000|Period 1|Adverse Event|0|||
146311813|NCT00708123|527655512|FG001|Period 1|Adverse Event|0|||
146311814|NCT00708123|527655513|FG002|Period 1|Adverse Event|1|||
146311815|NCT00708123|527655514|FG003|Period 1|Adverse Event|0|||
146311816|NCT00708123|527655515|FG004|Period 1|Adverse Event|0|||
146311817|NCT00708123|527655511|FG000|Period 2|Protocol Violation|0|||
146311818|NCT00708123|527655512|FG001|Period 2|Protocol Violation|0|||
146311819|NCT00708123|527655513|FG002|Period 2|Protocol Violation|0|||
146311820|NCT00708123|527655514|FG003|Period 2|Protocol Violation|1|||
146311821|NCT00708123|527655515|FG004|Period 2|Protocol Violation|0|||
146311822|NCT00708123|527655511|FG000|Period 2|Other Reason|1|||
146311823|NCT00708123|527655512|FG001|Period 2|Other Reason|0|||
146311824|NCT00708123|527655513|FG002|Period 2|Other Reason|0|||
146311825|NCT00708123|527655514|FG003|Period 2|Other Reason|0|||
146311826|NCT00708123|527655515|FG004|Period 2|Other Reason|0|||
146311827|NCT00708123|527655511|FG000|Period 3|Lost to Follow-up|0|||
146311828|NCT00708123|527655512|FG001|Period 3|Lost to Follow-up|0|||
146311829|NCT00708123|527655513|FG002|Period 3|Lost to Follow-up|1|||
146311830|NCT00708123|527655514|FG003|Period 3|Lost to Follow-up|1|||
146311831|NCT00708123|527655515|FG004|Period 3|Lost to Follow-up|0|||
146311832|NCT00708123|527655511|FG000|Period 4|Protocol Violation|0|||
146311833|NCT00708123|527655512|FG001|Period 4|Protocol Violation|1|||
146311834|NCT00708123|527655513|FG002|Period 4|Protocol Violation|0|||
146311835|NCT00708123|527655514|FG003|Period 4|Protocol Violation|0|||
146311836|NCT00708123|527655515|FG004|Period 4|Protocol Violation|0|||
146311837|NCT00401375|527655518|FG000|Overall Study|Protocol Violation|2|||
146311838|NCT00401375|527655519|FG001|Overall Study|Protocol Violation|2|||
146311839|NCT00401375|527655520|FG002|Overall Study|Protocol Violation|1|||
146311840|NCT00401375|527655518|FG000|Overall Study|Adverse Event|6|||
146311841|NCT00401375|527655519|FG001|Overall Study|Adverse Event|11|||
146311842|NCT00401375|527655520|FG002|Overall Study|Adverse Event|10|||
146311843|NCT00401375|527655518|FG000|Overall Study|Withdrawal by Subject|9|||
146311844|NCT00401375|527655519|FG001|Overall Study|Withdrawal by Subject|7|||
146311845|NCT00401375|527655520|FG002|Overall Study|Withdrawal by Subject|7|||
146311846|NCT00401375|527655518|FG000|Overall Study|Lost to Follow-up|0|||
146311847|NCT00401375|527655519|FG001|Overall Study|Lost to Follow-up|1|||
146311848|NCT00401375|527655520|FG002|Overall Study|Lost to Follow-up|1|||
146311849|NCT00401375|527655518|FG000|Overall Study|Other than specified|2|||
146311850|NCT00401375|527655519|FG001|Overall Study|Other than specified|1|||
146311851|NCT00401375|527655520|FG002|Overall Study|Other than specified|3|||
146311852|NCT00401375|527655518|FG000|Overall Study|Randomized but not treated|3|||
146311853|NCT00401375|527655519|FG001|Overall Study|Randomized but not treated|3|||
146311854|NCT00401375|527655520|FG002|Overall Study|Randomized but not treated|3|||
146311855|NCT00677014|527655521|FG000|Overall Study|Lost to Follow-up|20|||
146311856|NCT00677014|527655522|FG001|Overall Study|Lost to Follow-up|12|||
146311857|NCT00677014|527655523|FG002|Overall Study|Lost to Follow-up|24|||
146311858|NCT00677014|527655521|FG000|Overall Study|Death|6|||
146311859|NCT00677014|527655522|FG001|Overall Study|Death|15|||
146311860|NCT00677014|527655523|FG002|Overall Study|Death|7|||
146311861|NCT00677014|527655521|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
146311862|NCT00677014|527655522|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
146311863|NCT00677014|527655523|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
146311864|NCT02821715|527655524|FG000|Overall Study|Protocol Violation|1|||
146311865|NCT02821715|527655525|FG001|Overall Study|Protocol Violation|0|||
146311866|NCT02821715|527655526|FG002|Overall Study|Protocol Violation|0|||
146311867|NCT02821715|527655527|FG003|Overall Study|Protocol Violation|0|||
146311868|NCT02821715|527655528|FG004|Overall Study|Protocol Violation|0|||
146311869|NCT02821715|527655529|FG005|Overall Study|Protocol Violation|0|||
146311870|NCT00640328|527655530|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146311871|NCT00640328|527655531|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
146311872|NCT00640328|527655532|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146311873|NCT00640328|527655533|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146311874|NCT00640328|527655534|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146311875|NCT00640328|527655535|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
146311876|NCT00640328|527655530|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146311877|NCT00640328|527655531|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146311878|NCT00640328|527655532|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146311879|NCT00640328|527655533|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146311880|NCT00640328|527655534|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
146311881|NCT00640328|527655535|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
146311882|NCT00640328|527655530|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146159116|NCT04084314|527092830|FG000|Overall Study|Lost to Follow-up|19|||
146159117|NCT04084314|527092830|FG000|Overall Study|New therapy for study indication|9|||
146311883|NCT00640328|527655531|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146159118|NCT04084314|527092830|FG000|Overall Study|Pregnancy|9|||
146311884|NCT00640328|527655532|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
146311885|NCT00640328|527655533|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146311886|NCT00640328|527655534|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146311887|NCT00640328|527655535|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
146311888|NCT00640328|527655530|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146311889|NCT00640328|527655531|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
146311890|NCT00640328|527655532|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146311891|NCT00640328|527655533|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
146311892|NCT00640328|527655534|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146311893|NCT00640328|527655535|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
146311894|NCT04294719|527655536|FG000|Overall Study|Withdrawal by Subject|1|||
146311895|NCT00081159|527655538|FG000|Overall Study|Withdrawal by Subject|0|||
146311896|NCT00081159|527655539|FG001|Overall Study|Withdrawal by Subject|3|||
146311897|NCT00081159|527655538|FG000|Overall Study|Myelosuppression prior to treatment|0|||
146311898|NCT00081159|527655539|FG001|Overall Study|Myelosuppression prior to treatment|1|||
146311899|NCT00081159|527655538|FG000|Overall Study|Lost to Follow-up|2|||
146311900|NCT00081159|527655539|FG001|Overall Study|Lost to Follow-up|1|||
146311901|NCT01883635|527655540|FG000|Overall Study|Withdrawal by Subject|4|||
146311902|NCT01883635|527655541|FG001|Overall Study|Withdrawal by Subject|0|||
146311903|NCT01187953|527655542|FG000|Overall Study|Death|11|||
146311904|NCT01187953|527655543|FG001|Overall Study|Death|13|||
146311905|NCT01187953|527655542|FG000|Overall Study|Adverse Event|1|||
146311906|NCT01187953|527655543|FG001|Overall Study|Adverse Event|2|||
146311907|NCT01187953|527655542|FG000|Overall Study|Lost to Follow-up|0|||
146311908|NCT01187953|527655543|FG001|Overall Study|Lost to Follow-up|3|||
146311909|NCT01187953|527655542|FG000|Overall Study|Withdrawal by Subject|3|||
146311910|NCT01187953|527655543|FG001|Overall Study|Withdrawal by Subject|3|||
146311911|NCT01464307|527655544|FG000|Main Period|Death|0|||
146311912|NCT01464307|527655545|FG001|Main Period|Death|1|||
146311913|NCT01464307|527655544|FG000|Main Period|Adverse Event|6|||
146311914|NCT01464307|527655545|FG001|Main Period|Adverse Event|1|||
146311915|NCT01464307|527655544|FG000|Main Period|Lack of Efficacy|2|||
146311916|NCT01464307|527655545|FG001|Main Period|Lack of Efficacy|0|||
146311917|NCT01464307|527655544|FG000|Main Period|Withdrawal by Subject|5|||
146311918|NCT01464307|527655545|FG001|Main Period|Withdrawal by Subject|2|||
146311919|NCT01464307|527655544|FG000|Main Period|Predefined discontinuation criteria|2|||
146311920|NCT01464307|527655545|FG001|Main Period|Predefined discontinuation criteria|1|||
146311921|NCT01464307|527655544|FG000|Open-Label Extension Period|Adverse Event|15|||
146311922|NCT01464307|527655545|FG001|Open-Label Extension Period|Adverse Event|0|||
146311923|NCT01464307|527655544|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
146311924|NCT01464307|527655545|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
146311925|NCT01464307|527655544|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
146311926|NCT01464307|527655545|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
146311927|NCT01464307|527655544|FG000|Open-Label Extension Period|Death|1|||
146311928|NCT01464307|527655545|FG001|Open-Label Extension Period|Death|0|||
146311929|NCT01464307|527655544|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
146311930|NCT01464307|527655545|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
146311931|NCT01464307|527655544|FG000|Open-Label Extension Period|Non-compliance|9|||
146311932|NCT01464307|527655545|FG001|Open-Label Extension Period|Non-compliance|0|||
146311933|NCT01464307|527655544|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
146311934|NCT01464307|527655545|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
146311935|NCT00761514|527655548|FG000|Overall Study|Adverse Event|1|||
146311936|NCT00761514|527655548|FG000|Overall Study|Withdrawal by Subject|2|||
146311937|NCT00761514|527655548|FG000|Overall Study|Lost to Follow-up|1|||
146311938|NCT00761514|527655548|FG000|Overall Study|Health insurance didn't cover study drug|1|||
146311939|NCT00761514|527655548|FG000|Overall Study|Problem complying with study visit|1|||
146311940|NCT00761514|527655548|FG000|Overall Study|Unable to pay for medications|1|||
146311941|NCT02457637|527655551|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
146311942|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Death|3|||
146311943|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Death|0|||
146311944|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Adverse Event|12|||
146311945|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Adverse Event|6|||
146311946|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
146311947|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
146311948|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
146311949|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
146311950|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
146311951|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
146311952|NCT00159861|527655552|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
146311953|NCT00159861|527655553|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
146311954|NCT00159861|527655552|FG000|Extension Study - up to 3 Years|Death|24|||
146311955|NCT00159861|527655553|FG001|Extension Study - up to 3 Years|Death|28|||
146311956|NCT00159861|527655552|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
146311957|NCT00159861|527655553|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
146311958|NCT00159861|527655552|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
146311959|NCT00159861|527655553|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
146311960|NCT00159861|527655552|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
146311961|NCT00159861|527655553|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
146311962|NCT00159861|527655552|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
146311963|NCT00159861|527655553|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
146311964|NCT01553136|527655555|FG000|Overall Study|Adverse Event|3|||
146311965|NCT01553136|527655556|FG001|Overall Study|Adverse Event|2|||
146311966|NCT01553136|527655555|FG000|Overall Study|Withdrawal by Subject|2|||
146311967|NCT01553136|527655556|FG001|Overall Study|Withdrawal by Subject|3|||
146311968|NCT01553136|527655555|FG000|Overall Study|Lost to Follow-up|4|||
146311969|NCT01553136|527655556|FG001|Overall Study|Lost to Follow-up|10|||
146311970|NCT01553136|527655555|FG000|Overall Study|Physician Decision|2|||
146311971|NCT01553136|527655556|FG001|Overall Study|Physician Decision|3|||
146311972|NCT01553136|527655555|FG000|Overall Study|Scheduling Difficulties|5|||
146311973|NCT01553136|527655556|FG001|Overall Study|Scheduling Difficulties|4|||
146311974|NCT03885089|527655557|FG000|Overall Study|No informed consent for publication of study results|2|||
146311975|NCT03349099|527655560|FG000|Overall Study|Physician Decision|3|||
146311976|NCT03349099|527655561|FG001|Overall Study|Physician Decision|4|||
146311977|NCT03349099|527655560|FG000|Overall Study|Stone migrated from the kidney|1|||
146311978|NCT03349099|527655561|FG001|Overall Study|Stone migrated from the kidney|0|||
146311979|NCT00278993|527655562|FG000|Overall Study|Adverse Event|24|||
146311980|NCT00278993|527655562|FG000|Overall Study|Withdrawal by Subject|5|||
146311981|NCT00278993|527655562|FG000|Overall Study|Progressive Disease|65|||
146311982|NCT00278993|527655562|FG000|Overall Study|Physician Decision|9|||
146311983|NCT00278993|527655562|FG000|Overall Study|Not Otherwise Specified|4|||
146311984|NCT01979536|527655566|FG000|Overall Study|Physician Decision|2|||
146311985|NCT01979536|527655567|FG001|Overall Study|Physician Decision|3|||
146311986|NCT01979536|527655566|FG000|Overall Study|Withdrawal by Subject|0|||
146311987|NCT01979536|527655567|FG001|Overall Study|Withdrawal by Subject|1|||
146159119|NCT04084314|527092830|FG000|Overall Study|Withdrawal of informed consent|8|||
146159120|NCT04084314|527092830|FG000|Overall Study|Physician Decision|4|||
146159121|NCT04084314|527092830|FG000|Overall Study|Protocol Deviation|3|||
146159122|NCT01300546|527092831|FG000|Overall Study|Withdrawal by Subject|1|||
146159123|NCT01300546|527092832|FG001|Overall Study|Withdrawal by Subject|0|||
146159124|NCT01300546|527092831|FG000|Overall Study|Lost to Follow-up|0|||
146159125|NCT01300546|527092832|FG001|Overall Study|Lost to Follow-up|2|||
146159126|NCT01300546|527092831|FG000|Overall Study|Lack of Efficacy|0|||
146280113|NCT05540717|527539918|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
146280114|NCT05540717|527539919|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
146280115|NCT05540717|527539918|FG000|Overall Study|Other|0|||
146280116|NCT05540717|527539919|FG001|Overall Study|Other|1|||
146280117|NCT03651622|527539920|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
146280118|NCT03651622|527539921|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
146280119|NCT03651622|527539922|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
146280120|NCT03651622|527539920|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
146280121|NCT03651622|527539921|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
146280122|NCT03651622|527539922|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
146280123|NCT03651622|527539920|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
146280124|NCT03651622|527539921|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
146280125|NCT03651622|527539922|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
146280126|NCT03651622|527539920|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
146280127|NCT03651622|527539921|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
146280128|NCT03651622|527539922|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
146280129|NCT03651622|527539920|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
146280130|NCT03651622|527539921|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
146280131|NCT03651622|527539922|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
146280132|NCT00307684|527539923|FG000|Open Label Phase|Lack of Efficacy|0|||
146280133|NCT00307684|527539924|FG001|Open Label Phase|Lack of Efficacy|0|||
146280134|NCT00307684|527539925|FG002|Open Label Phase|Lack of Efficacy|3|||
146280135|NCT00307684|527539923|FG000|Open Label Phase|Adverse Event|0|||
146280136|NCT00307684|527539924|FG001|Open Label Phase|Adverse Event|0|||
146280137|NCT00307684|527539925|FG002|Open Label Phase|Adverse Event|16|||
146280138|NCT00307684|527539923|FG000|Open Label Phase|Withdrawal by Subject|0|||
146280139|NCT00307684|527539924|FG001|Open Label Phase|Withdrawal by Subject|0|||
146280140|NCT00307684|527539925|FG002|Open Label Phase|Withdrawal by Subject|15|||
146280141|NCT00307684|527539923|FG000|Open Label Phase|Lost to Follow-up|0|||
146280142|NCT00307684|527539924|FG001|Open Label Phase|Lost to Follow-up|0|||
146280143|NCT00307684|527539925|FG002|Open Label Phase|Lost to Follow-up|11|||
146280144|NCT00307684|527539923|FG000|Open Label Phase|non compliance|0|||
146280145|NCT00307684|527539924|FG001|Open Label Phase|non compliance|0|||
146280146|NCT00307684|527539925|FG002|Open Label Phase|non compliance|5|||
146280147|NCT00307684|527539923|FG000|Open Label Phase|other|0|||
146280148|NCT00307684|527539924|FG001|Open Label Phase|other|0|||
146280149|NCT00307684|527539925|FG002|Open Label Phase|other|6|||
146280150|NCT00307684|527539923|FG000|Double Blind Phase|Lack of Efficacy|2|||
146311988|NCT01979536|527655566|FG000|Overall Study|Refusal|0|||
146311989|NCT01979536|527655567|FG001|Overall Study|Refusal|1|||
146280151|NCT00307684|527539924|FG001|Double Blind Phase|Lack of Efficacy|5|||
146280152|NCT00307684|527539925|FG002|Double Blind Phase|Lack of Efficacy|0|||
146280153|NCT02580305|527539926|FG000|Overall Study|Adverse Event|15|||
146280154|NCT02580305|527539927|FG001|Overall Study|Adverse Event|19|||
146311990|NCT01979536|527655566|FG000|Overall Study|Relapse|0|||
146280155|NCT02580305|527539928|FG002|Overall Study|Adverse Event|10|||
146280156|NCT02580305|527539926|FG000|Overall Study|Lack of Efficacy|5|||
146280157|NCT02580305|527539927|FG001|Overall Study|Lack of Efficacy|0|||
146280158|NCT02580305|527539928|FG002|Overall Study|Lack of Efficacy|2|||
146280159|NCT02580305|527539926|FG000|Overall Study|Protocol Violation|4|||
146280160|NCT02580305|527539927|FG001|Overall Study|Protocol Violation|9|||
146280161|NCT02580305|527539928|FG002|Overall Study|Protocol Violation|6|||
146280162|NCT02580305|527539926|FG000|Overall Study|Lost to Follow-up|4|||
146280163|NCT02580305|527539927|FG001|Overall Study|Lost to Follow-up|4|||
146280164|NCT02580305|527539928|FG002|Overall Study|Lost to Follow-up|2|||
146280165|NCT02580305|527539926|FG000|Overall Study|Withdrawal by Subject|11|||
146280166|NCT02580305|527539927|FG001|Overall Study|Withdrawal by Subject|9|||
146280167|NCT02580305|527539928|FG002|Overall Study|Withdrawal by Subject|7|||
146280168|NCT02580305|527539926|FG000|Overall Study|Randomized in error and never treated|4|||
146280169|NCT02580305|527539927|FG001|Overall Study|Randomized in error and never treated|8|||
146280170|NCT02580305|527539928|FG002|Overall Study|Randomized in error and never treated|5|||
146280171|NCT00224887|527539929|FG000|Overall Study|Pregnancy|6|||
146280172|NCT00224887|527539930|FG001|Overall Study|Pregnancy|6|||
146280173|NCT03582943|527539933|FG000|Allocated to Groups|Withdrawal by Subject|1|||
146280174|NCT03582943|527539934|FG001|Allocated to Groups|Withdrawal by Subject|1|||
146280175|NCT03582943|527539933|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
146280176|NCT03582943|527539934|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
146280177|NCT03582943|527539933|FG000|Analyzed|Protocol Violation|4|||
146280178|NCT03582943|527539934|FG001|Analyzed|Protocol Violation|1|||
146280179|NCT03527550|527539935|FG000|Overall Study|Lost to Follow-up|4|||
146280180|NCT03527550|527539936|FG001|Overall Study|Lost to Follow-up|2|||
146280181|NCT03527550|527539935|FG000|Overall Study|Withdrawal by Subject|4|||
146280182|NCT03527550|527539936|FG001|Overall Study|Withdrawal by Subject|1|||
146280183|NCT03527550|527539935|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
146280184|NCT03527550|527539936|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
146280185|NCT04032613|527539937|FG000|Overall Study|Did not complete post-program assessment|5|||
146280186|NCT04032613|527539938|FG001|Overall Study|Did not complete post-program assessment|2|||
146280187|NCT03053518|527539941|FG000|Overall Study|Withdrawal by Subject|3|||
146280188|NCT03053518|527539941|FG000|Overall Study|Lost to Follow-up|2|||
146280189|NCT03053518|527539941|FG000|Overall Study|Ineligible|5|||
146280190|NCT02683876|527539942|FG000|Overall Study|samples damaged during shipping|2|||
146280191|NCT02683876|527539943|FG001|Overall Study|samples damaged during shipping|0|||
146280192|NCT02071290|527539944|FG000|Overall Study|Death|1|||
146280193|NCT02071290|527539945|FG001|Overall Study|Death|0|||
146280194|NCT02071290|527539944|FG000|Overall Study|Withdrawal by Subject|0|||
146280195|NCT02071290|527539945|FG001|Overall Study|Withdrawal by Subject|1|||
146280196|NCT02071290|527539944|FG000|Overall Study|Protocol Violation|3|||
146280197|NCT02071290|527539945|FG001|Overall Study|Protocol Violation|5|||
146280198|NCT02071290|527539944|FG000|Overall Study|Physician Decision|0|||
146280199|NCT02071290|527539945|FG001|Overall Study|Physician Decision|1|||
146280200|NCT00939822|527539946|FG000|Overall Study|Lost to Follow-up|1|||
146280201|NCT00939822|527539947|FG001|Overall Study|Lost to Follow-up|0|||
146280202|NCT00939822|527539946|FG000|Overall Study|withdrew from study due to busy schedule|1|||
146280203|NCT00939822|527539947|FG001|Overall Study|withdrew from study due to busy schedule|1|||
146280204|NCT00939822|527539946|FG000|Overall Study|Mental health issues|0|||
146280205|NCT00939822|527539947|FG001|Overall Study|Mental health issues|2|||
146280206|NCT01232738|527539948|FG000|Overall Study|Death|3|||
146280207|NCT01232738|527539948|FG000|Overall Study|Physician Decision|2|||
146280208|NCT01232738|527539948|FG000|Overall Study|Lost to Follow-up|1|||
146280209|NCT01232738|527539948|FG000|Overall Study|Withdrawal by Subject|2|||
146280210|NCT01232738|527539948|FG000|Overall Study|Adverse Event|5|||
146280211|NCT00488475|527539952|FG000|Overall Study|Other|1754|||
146280212|NCT00757627|527539964|FG000|Overall Study|Adverse Event|15|||
146280213|NCT00757627|527539964|FG000|Overall Study|Lack of Efficacy|10|||
146280214|NCT00757627|527539964|FG000|Overall Study|Lost to Follow-up|28|||
146280215|NCT00757627|527539964|FG000|Overall Study|Withdrawal by Subject|27|||
146280216|NCT00757627|527539964|FG000|Overall Study|Other|1|||
146280217|NCT01696955|527539968|FG000|Main Study|Protocol Violation|1|||
146280218|NCT01696955|527539969|FG001|Main Study|Protocol Violation|0|||
146280219|NCT01696955|527539968|FG000|Main Study|Withdrawal by Subject|1|||
146280220|NCT01696955|527539969|FG001|Main Study|Withdrawal by Subject|1|||
146280221|NCT02755818|527539970|FG000|Overall Study|Withdrawal by Subject|0|||
146280222|NCT02755818|527539971|FG001|Overall Study|Withdrawal by Subject|0|||
146280223|NCT02755818|527539972|FG002|Overall Study|Withdrawal by Subject|0|||
146280224|NCT02755818|527539973|FG003|Overall Study|Withdrawal by Subject|2|||
146280225|NCT02755818|527539970|FG000|Overall Study|withdrawal by PI|0|||
146280226|NCT02755818|527539971|FG001|Overall Study|withdrawal by PI|0|||
146280227|NCT02755818|527539972|FG002|Overall Study|withdrawal by PI|1|||
146280228|NCT02755818|527539973|FG003|Overall Study|withdrawal by PI|1|||
146280229|NCT02416453|527539974|FG000|Overall Study|Adverse Event|0|||
146280230|NCT02416453|527539975|FG001|Overall Study|Adverse Event|0|||
146280231|NCT02416453|527539976|FG002|Overall Study|Adverse Event|0|||
146280232|NCT02416453|527539977|FG003|Overall Study|Adverse Event|2|||
146280233|NCT02416453|527539978|FG004|Overall Study|Adverse Event|0|||
146280234|NCT02416453|527539979|FG005|Overall Study|Adverse Event|1|||
146280235|NCT02416453|527539980|FG006|Overall Study|Adverse Event|0|||
146280236|NCT02416453|527539981|FG007|Overall Study|Adverse Event|0|||
146280237|NCT02416453|527539982|FG008|Overall Study|Adverse Event|0|||
146280238|NCT02416453|527539983|FG009|Overall Study|Adverse Event|0|||
146280239|NCT02416453|527539984|FG010|Overall Study|Adverse Event|0|||
146280240|NCT02416453|527539974|FG000|Overall Study|Lost to Follow-up|1|||
146280241|NCT02416453|527539975|FG001|Overall Study|Lost to Follow-up|3|||
146280242|NCT02416453|527539976|FG002|Overall Study|Lost to Follow-up|0|||
146280243|NCT02416453|527539977|FG003|Overall Study|Lost to Follow-up|8|||
146280244|NCT02416453|527539978|FG004|Overall Study|Lost to Follow-up|0|||
146280245|NCT02416453|527539979|FG005|Overall Study|Lost to Follow-up|5|||
146280246|NCT02416453|527539980|FG006|Overall Study|Lost to Follow-up|1|||
146280247|NCT02416453|527539981|FG007|Overall Study|Lost to Follow-up|3|||
146280248|NCT02416453|527539982|FG008|Overall Study|Lost to Follow-up|1|||
146280249|NCT02416453|527539983|FG009|Overall Study|Lost to Follow-up|0|||
146280250|NCT02416453|527539984|FG010|Overall Study|Lost to Follow-up|0|||
146280251|NCT02416453|527539974|FG000|Overall Study|Physician Decision|0|||
146280252|NCT02416453|527539975|FG001|Overall Study|Physician Decision|0|||
146280253|NCT02416453|527539976|FG002|Overall Study|Physician Decision|0|||
146280254|NCT02416453|527539977|FG003|Overall Study|Physician Decision|0|||
146280255|NCT02416453|527539978|FG004|Overall Study|Physician Decision|0|||
146280256|NCT02416453|527539979|FG005|Overall Study|Physician Decision|1|||
146280257|NCT02416453|527539980|FG006|Overall Study|Physician Decision|1|||
146280258|NCT02416453|527539981|FG007|Overall Study|Physician Decision|1|||
146280259|NCT02416453|527539982|FG008|Overall Study|Physician Decision|0|||
146280260|NCT02416453|527539983|FG009|Overall Study|Physician Decision|0|||
146280261|NCT02416453|527539984|FG010|Overall Study|Physician Decision|0|||
146280262|NCT02416453|527539974|FG000|Overall Study|Withdrawal by Subject|2|||
146280263|NCT02416453|527539975|FG001|Overall Study|Withdrawal by Subject|0|||
146280264|NCT02416453|527539976|FG002|Overall Study|Withdrawal by Subject|0|||
146280265|NCT02416453|527539977|FG003|Overall Study|Withdrawal by Subject|5|||
146280266|NCT02416453|527539978|FG004|Overall Study|Withdrawal by Subject|1|||
146280267|NCT02416453|527539979|FG005|Overall Study|Withdrawal by Subject|8|||
146280268|NCT02416453|527539980|FG006|Overall Study|Withdrawal by Subject|0|||
146280269|NCT02416453|527539981|FG007|Overall Study|Withdrawal by Subject|8|||
146280270|NCT02416453|527539982|FG008|Overall Study|Withdrawal by Subject|4|||
146280271|NCT02416453|527539983|FG009|Overall Study|Withdrawal by Subject|0|||
146280272|NCT02416453|527539984|FG010|Overall Study|Withdrawal by Subject|0|||
146280273|NCT02416453|527539974|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280274|NCT02416453|527539975|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280275|NCT02416453|527539976|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
146280276|NCT02416453|527539977|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280277|NCT02416453|527539978|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280278|NCT02416453|527539979|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280279|NCT02416453|527539980|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280280|NCT02416453|527539981|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280281|NCT02416453|527539982|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280282|NCT02416453|527539983|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280283|NCT02416453|527539984|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
146280284|NCT02416453|527539974|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280285|NCT02416453|527539975|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280286|NCT02416453|527539976|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280287|NCT02416453|527539977|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280288|NCT02416453|527539978|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280289|NCT02416453|527539979|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
146280290|NCT02416453|527539980|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280291|NCT02416453|527539981|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280292|NCT02416453|527539982|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280293|NCT02416453|527539983|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280294|NCT02416453|527539984|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
146280295|NCT01280357|527539989|FG000|Overall Study|Excluded no internal monitoring|14|||
146280296|NCT01280357|527539989|FG000|Overall Study|IInsufficient data/No data supplied|12|||
146280297|NCT00992225|527539990|FG000|Overall Study|Entry Criteria Not Met|8|||
146280298|NCT00992225|527539990|FG000|Overall Study|Adverse Event|2|||
146280299|NCT01036438|527539994|FG000|Overall Study|Adverse Event|7|||
146280300|NCT01036438|527539995|FG001|Overall Study|Adverse Event|8|||
146280301|NCT01036438|527539994|FG000|Overall Study|Death|0|||
146311991|NCT01979536|527655567|FG001|Overall Study|Relapse|1|||
146159127|NCT01300546|527092832|FG001|Overall Study|Lack of Efficacy|3|||
146280302|NCT01036438|527539995|FG001|Overall Study|Death|1|||
146280303|NCT01036438|527539994|FG000|Overall Study|No effect of study treatment|3|||
146280304|NCT01036438|527539995|FG001|Overall Study|No effect of study treatment|1|||
146311992|NCT01979536|527655566|FG000|Overall Study|Study terminated by Sponsor|0|||
146311993|NCT01979536|527655567|FG001|Overall Study|Study terminated by Sponsor|1|||
146311994|NCT01979536|527655566|FG000|Overall Study|Did not start treatment|0|||
146311995|NCT01979536|527655567|FG001|Overall Study|Did not start treatment|1|||
146311996|NCT03077685|527655568|FG000|Overall Study|Lost to Follow-up|0|||
146311997|NCT03077685|527655569|FG001|Overall Study|Lost to Follow-up|0|||
146311998|NCT03077685|527655570|FG002|Overall Study|Lost to Follow-up|0|||
146280305|NCT03592745|527539996|FG000|Overall Study|Adverse Event|0|||
146280306|NCT03592745|527539997|FG001|Overall Study|Adverse Event|2|||
146280307|NCT03592745|527539996|FG000|Overall Study|Lost to Follow-up|2|||
146280308|NCT03592745|527539997|FG001|Overall Study|Lost to Follow-up|0|||
146280309|NCT03592745|527539996|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
146280310|NCT03592745|527539997|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
146280311|NCT02729831|527539999|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
146280312|NCT02729831|527540000|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
146280313|NCT02729831|527540001|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
146280314|NCT02729831|527540002|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
146280315|NCT02729831|527539999|FG000|1 Week Post-visit|Lost to Follow-up|43|||
146280316|NCT02729831|527540000|FG001|1 Week Post-visit|Lost to Follow-up|40|||
146280317|NCT02729831|527540001|FG002|1 Week Post-visit|Lost to Follow-up|38|||
146280318|NCT02729831|527540002|FG003|1 Week Post-visit|Lost to Follow-up|36|||
146280319|NCT02729831|527539999|FG000|6 Month Follow-up|Lost to Follow-up|54|||
146280320|NCT02729831|527540000|FG001|6 Month Follow-up|Lost to Follow-up|51|||
146280321|NCT02729831|527540001|FG002|6 Month Follow-up|Lost to Follow-up|48|||
146280322|NCT02729831|527540002|FG003|6 Month Follow-up|Lost to Follow-up|42|||
146280323|NCT02729831|527539999|FG000|6 Month Follow-up|Death|1|||
146280324|NCT02729831|527540000|FG001|6 Month Follow-up|Death|3|||
146280325|NCT02729831|527540001|FG002|6 Month Follow-up|Death|0|||
146280326|NCT02729831|527540002|FG003|6 Month Follow-up|Death|1|||
146280327|NCT01413503|527540003|FG000|Overall Study|Lost to Follow-up|1|||
146280328|NCT05051462|527540010|FG000|Overall Study|Lost to Follow-up|1|||
146280329|NCT05051462|527540011|FG001|Overall Study|Lost to Follow-up|8|||
146280330|NCT05051462|527540010|FG000|Overall Study|Withdrawal by Subject|1|||
146280331|NCT05051462|527540011|FG001|Overall Study|Withdrawal by Subject|0|||
146280332|NCT05051462|527540010|FG000|Overall Study|Protocol Violation|0|||
146280333|NCT05051462|527540011|FG001|Overall Study|Protocol Violation|2|||
146280334|NCT05597787|527540017|FG000|Overall Study|Withdrawal by Subject|0|||
146280335|NCT05597787|527540018|FG001|Overall Study|Withdrawal by Subject|0|||
146280336|NCT05597787|527540019|FG002|Overall Study|Withdrawal by Subject|1|||
146280337|NCT01241604|527540020|FG000|Screening Period|Screen Failure|3|||
146280338|NCT01241604|527540021|FG001|Screening Period|Screen Failure|0|||
146280339|NCT01241604|527540022|FG002|Screening Period|Screen Failure|0|||
146280340|NCT04349631|527540024|FG000|Overall Study|Lost to Follow-up|3|||
146280341|NCT04349631|527540024|FG000|Overall Study|Withdrawal by Subject|7|||
146280342|NCT00775463|527541524|FG000|Overall Study|Withdrawal by Subject|0|||
146280343|NCT00775463|527541525|FG001|Overall Study|Withdrawal by Subject|1|||
146280344|NCT00775463|527541524|FG000|Overall Study|Adverse Event|7|||
146280345|NCT00775463|527541525|FG001|Overall Study|Adverse Event|9|||
146280346|NCT00775463|527541524|FG000|Overall Study|Protocol Violation|2|||
146280347|NCT00775463|527541525|FG001|Overall Study|Protocol Violation|2|||
146280348|NCT00775463|527541524|FG000|Overall Study|Lost to Follow-up|1|||
146280349|NCT00775463|527541525|FG001|Overall Study|Lost to Follow-up|0|||
146280350|NCT00775463|527541524|FG000|Overall Study|Lack of Efficacy|1|||
146280351|NCT00775463|527541525|FG001|Overall Study|Lack of Efficacy|1|||
146280352|NCT03377699|527541529|FG000|Overall Study|Withdrawal by Subject|2|||
146280353|NCT03377699|527541530|FG001|Overall Study|Withdrawal by Subject|9|||
146280354|NCT03377699|527541529|FG000|Overall Study|Lost to Follow-up|1|||
146280355|NCT03377699|527541530|FG001|Overall Study|Lost to Follow-up|1|||
146280356|NCT03377699|527541529|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
146280357|NCT03377699|527541530|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
146280358|NCT03377699|527541529|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
146280359|NCT03377699|527541530|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
146280360|NCT03377699|527541529|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
146280361|NCT03377699|527541530|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
146280362|NCT03377699|527541529|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
146280363|NCT03377699|527541530|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
146280364|NCT00774930|527541533|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
146280365|NCT00774930|527541534|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
146280366|NCT00774930|527541533|FG000|DB Phase|Adverse Event|1|||
146280367|NCT00774930|527541534|FG001|DB Phase|Adverse Event|2|||
146280368|NCT00774930|527541533|FG000|DB Phase|Subject Decision|1|||
146280369|NCT00774930|527541534|FG001|DB Phase|Subject Decision|5|||
146311999|NCT03077685|527655571|FG003|Overall Study|Lost to Follow-up|0|||
146312000|NCT03077685|527655572|FG004|Overall Study|Lost to Follow-up|1|||
146312001|NCT03077685|527655568|FG000|Overall Study|Death|0|||
146312002|NCT03077685|527655569|FG001|Overall Study|Death|0|||
146312003|NCT03077685|527655570|FG002|Overall Study|Death|1|||
146312004|NCT03077685|527655571|FG003|Overall Study|Death|1|||
146312005|NCT03077685|527655572|FG004|Overall Study|Death|3|||
146312006|NCT03077685|527655568|FG000|Overall Study|Withdrawal by Subject|0|||
146312007|NCT03077685|527655569|FG001|Overall Study|Withdrawal by Subject|0|||
146312008|NCT03077685|527655570|FG002|Overall Study|Withdrawal by Subject|0|||
146312009|NCT03077685|527655571|FG003|Overall Study|Withdrawal by Subject|2|||
146312010|NCT03077685|527655572|FG004|Overall Study|Withdrawal by Subject|1|||
146312011|NCT03077685|527655568|FG000|Overall Study|Physician Decision|0|||
146312012|NCT03077685|527655569|FG001|Overall Study|Physician Decision|0|||
146312013|NCT03077685|527655570|FG002|Overall Study|Physician Decision|1|||
146312014|NCT03077685|527655571|FG003|Overall Study|Physician Decision|0|||
146312015|NCT03077685|527655572|FG004|Overall Study|Physician Decision|3|||
146312016|NCT03077685|527655568|FG000|Overall Study|Disease Progression|1|||
146312017|NCT03077685|527655569|FG001|Overall Study|Disease Progression|0|||
146312018|NCT03077685|527655570|FG002|Overall Study|Disease Progression|0|||
146312019|NCT03077685|527655571|FG003|Overall Study|Disease Progression|2|||
146312020|NCT03077685|527655572|FG004|Overall Study|Disease Progression|1|||
146312021|NCT03077685|527655568|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
146312022|NCT03077685|527655569|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
146312023|NCT03077685|527655570|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
146312024|NCT03077685|527655571|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
146312025|NCT03077685|527655572|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
146312026|NCT03077685|527655568|FG000|Overall Study|Subject entered hospice care|0|||
146312027|NCT03077685|527655569|FG001|Overall Study|Subject entered hospice care|0|||
146312028|NCT03077685|527655570|FG002|Overall Study|Subject entered hospice care|0|||
146312029|NCT03077685|527655571|FG003|Overall Study|Subject entered hospice care|0|||
146312030|NCT03077685|527655572|FG004|Overall Study|Subject entered hospice care|1|||
146312031|NCT04194528|527655574|FG000|Overall Study|Adverse Event|1|||
146312032|NCT03921424|527655575|FG000|Overall Study|Lost to Follow-up|0|||
146312033|NCT03921424|527655576|FG001|Overall Study|Lost to Follow-up|1|||
146312034|NCT03921424|527655575|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
146312035|NCT03921424|527655576|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
146312036|NCT04294901|527655585|FG000|Overall Study|Death|86|||
146312037|NCT04294901|527655586|FG001|Overall Study|Death|110|||
146312038|NCT04294901|527655585|FG000|Overall Study|Provider did not have historical control patients|581|||
146312039|NCT04294901|527655586|FG001|Overall Study|Provider did not have historical control patients|0|||
146312040|NCT04294901|527655585|FG000|Overall Study|Provider did not have intervention patients|0|||
146312041|NCT04294901|527655586|FG001|Overall Study|Provider did not have intervention patients|98|||
146312042|NCT05038020|527655588|FG000|Overall Study|Early Termination|3|||
146312043|NCT05038020|527655589|FG001|Overall Study|Early Termination|0|||
146312044|NCT03770260|527657706|FG000|Overall Study|Disease progression|0|||
146312045|NCT03770260|527657707|FG001|Overall Study|Disease progression|1|||
146312046|NCT03770260|527657708|FG002|Overall Study|Disease progression|0|||
146312047|NCT03770260|527657709|FG003|Overall Study|Disease progression|0|||
146312048|NCT03468855|527657711|FG000|Overall Study|Adverse Event|2|||
146312049|NCT03468855|527657711|FG000|Overall Study|Lost to Follow-up|5|||
146312050|NCT03468855|527657711|FG000|Overall Study|Withdrawal by Subject|3|||
146312051|NCT03468855|527657711|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
146312052|NCT01623271|527657717|FG000|Overall Study|Withdrawal by Subject|2|||
146312053|NCT00879229|527657724|FG000|Overall Study|Study terminated by Sponsor|13|||
146312054|NCT00879229|527657725|FG001|Overall Study|Study terminated by Sponsor|12|||
146312055|NCT00879229|527657724|FG000|Overall Study|Death|4|||
146312056|NCT00879229|527657725|FG001|Overall Study|Death|2|||
146312057|NCT00879229|527657724|FG000|Overall Study|Adverse Event|2|||
146312058|NCT00879229|527657725|FG001|Overall Study|Adverse Event|0|||
146312059|NCT00879229|527657724|FG000|Overall Study|Withdrawal by Subject|1|||
146312060|NCT00879229|527657725|FG001|Overall Study|Withdrawal by Subject|0|||
146312061|NCT00879229|527657724|FG000|Overall Study|Clinical status did not improve|1|||
146312062|NCT00879229|527657725|FG001|Overall Study|Clinical status did not improve|0|||
146312063|NCT00879229|527657724|FG000|Overall Study|Other|1|||
146312064|NCT00879229|527657725|FG001|Overall Study|Other|0|||
146312065|NCT00513409|527657729|FG000|Overall Study|Adverse Event|0|||
146312066|NCT00513409|527657730|FG001|Overall Study|Adverse Event|1|||
146312067|NCT00513409|527657729|FG000|Overall Study|Withdrawal by Subject|0|||
146312068|NCT00513409|527657730|FG001|Overall Study|Withdrawal by Subject|2|||
146312069|NCT00513409|527657729|FG000|Overall Study|Lost to Follow-up|0|||
146312070|NCT00513409|527657730|FG001|Overall Study|Lost to Follow-up|1|||
146312071|NCT00513409|527657729|FG000|Overall Study|Physician Decision|1|||
146312072|NCT00513409|527657730|FG001|Overall Study|Physician Decision|0|||
146312073|NCT00513409|527657729|FG000|Overall Study|Visit 3 not done|1|||
146312074|NCT00513409|527657730|FG001|Overall Study|Visit 3 not done|2|||
146312075|NCT01049035|527657731|FG000|Overall Study|Serious adverse event|0|||
146312076|NCT01049035|527657732|FG001|Overall Study|Serious adverse event|1|||
146159128|NCT01300546|527092831|FG000|Overall Study|Adverse Event|0|||
146159129|NCT01300546|527092832|FG001|Overall Study|Adverse Event|1|||
146159130|NCT05245864|527092842|FG000|Overall Study|Withdrawal by Subject|1|||
146159131|NCT05245864|527092843|FG001|Overall Study|Withdrawal by Subject|1|||
146159132|NCT01329029|527092844|FG000|Overall Study|Withdrawal by Subject|117|||
146159133|NCT01329029|527092845|FG001|Overall Study|Withdrawal by Subject|87|||
146159134|NCT01329029|527092844|FG000|Overall Study|Adverse Event|82|||
146159135|NCT01329029|527092845|FG001|Overall Study|Adverse Event|29|||
146159136|NCT01329029|527092844|FG000|Overall Study|Death|16|||
146159137|NCT01329029|527092845|FG001|Overall Study|Death|19|||
146159138|NCT01329029|527092844|FG000|Overall Study|Other|14|||
146159139|NCT01329029|527092845|FG001|Overall Study|Other|20|||
146159140|NCT01329029|527092844|FG000|Overall Study|COPD Exacerbation|11|||
146159141|NCT01329029|527092845|FG001|Overall Study|COPD Exacerbation|18|||
146159142|NCT01329029|527092844|FG000|Overall Study|Physician Decision|16|||
146159143|NCT01329029|527092845|FG001|Overall Study|Physician Decision|13|||
146159144|NCT01329029|527092844|FG000|Overall Study|Lost to Follow-up|8|||
146159145|NCT01329029|527092845|FG001|Overall Study|Lost to Follow-up|5|||
146159146|NCT01329029|527092844|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
146280370|NCT00774930|527541533|FG000|DB Phase|Sponsor Decision|0|||
146280371|NCT00774930|527541534|FG001|DB Phase|Sponsor Decision|1|||
146280372|NCT00774930|527541533|FG000|DB Phase|Disease Progression|1|||
146280373|NCT00774930|527541534|FG001|DB Phase|Disease Progression|1|||
146280374|NCT00774930|527541533|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
146280375|NCT00774930|527541534|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
146280376|NCT00774930|527541533|FG000|IOL Phase|Adverse Event|1|||
146280377|NCT00774930|527541534|FG001|IOL Phase|Adverse Event|1|||
146280378|NCT00774930|527541533|FG000|IOL Phase|Subject Decision|4|||
146280379|NCT00774930|527541534|FG001|IOL Phase|Subject Decision|3|||
146280380|NCT00774930|527541533|FG000|IOL Phase|Physician Decision|3|||
146280381|NCT00774930|527541534|FG001|IOL Phase|Physician Decision|2|||
146280382|NCT00774930|527541533|FG000|IOL Phase|Sponsor Decision|1|||
146280383|NCT00774930|527541534|FG001|IOL Phase|Sponsor Decision|0|||
146280384|NCT00774930|527541533|FG000|IOL Phase|Disease Progression|2|||
146280385|NCT00774930|527541534|FG001|IOL Phase|Disease Progression|1|||
146280386|NCT00774930|527541533|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
146280387|NCT00774930|527541534|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
146280388|NCT00774930|527541533|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
146280389|NCT00774930|527541534|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
146280390|NCT00774930|527541533|FG000|IOL Phase|Other|1|||
146280391|NCT00774930|527541534|FG001|IOL Phase|Other|0|||
146280392|NCT00774930|527541533|FG000|IOL Phase|Brain radiation|0|||
146280393|NCT00774930|527541534|FG001|IOL Phase|Brain radiation|1|||
146280394|NCT00774930|527541533|FG000|LTOLE Phase|Adverse Event|7|||
146280395|NCT00774930|527541534|FG001|LTOLE Phase|Adverse Event|3|||
146280396|NCT00774930|527541533|FG000|LTOLE Phase|Subject decision|0|||
146280397|NCT00774930|527541534|FG001|LTOLE Phase|Subject decision|5|||
146280398|NCT00774930|527541533|FG000|LTOLE Phase|Physician Decision|4|||
146280399|NCT00774930|527541534|FG001|LTOLE Phase|Physician Decision|1|||
146280400|NCT00774930|527541533|FG000|LTOLE Phase|Sponsor decision|2|||
146280401|NCT00774930|527541534|FG001|LTOLE Phase|Sponsor decision|1|||
146280402|NCT00774930|527541533|FG000|LTOLE Phase|Disease Progression|2|||
146280403|NCT00774930|527541534|FG001|LTOLE Phase|Disease Progression|5|||
146280404|NCT00774930|527541533|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
146280405|NCT00774930|527541534|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
146280406|NCT00774930|527541533|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
146280407|NCT00774930|527541534|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
146280408|NCT01153321|527541535|FG000|Overall Study|Development of study withdrawal criteria|0|||
146280409|NCT01153321|527541536|FG001|Overall Study|Development of study withdrawal criteria|1|||
146280410|NCT01153321|527541535|FG000|Overall Study|Withdrawal by Subject|0|||
146280411|NCT01153321|527541536|FG001|Overall Study|Withdrawal by Subject|1|||
146280412|NCT01153321|527541535|FG000|Overall Study|Adverse Event|1|||
146280413|NCT01153321|527541536|FG001|Overall Study|Adverse Event|1|||
146280414|NCT01177800|527541537|FG000|Overall Study|Adverse Event|9|||
146280415|NCT01177800|527541538|FG001|Overall Study|Adverse Event|3|||
146280416|NCT01177800|527541537|FG000|Overall Study|Protocol Violation|0|||
146280417|NCT01177800|527541538|FG001|Overall Study|Protocol Violation|1|||
146159147|NCT01329029|527092845|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
146159148|NCT00003508|527094461|FG000|Overall Study|Not evaluable|5|||
146159149|NCT02160314|527094462|FG000|Overall Study|Adverse Event|0|||
146280418|NCT01177800|527541537|FG000|Overall Study|Physician Decision|1|||
146312077|NCT01049035|527657733|FG002|Overall Study|Serious adverse event|1|||
146312078|NCT01049035|527657734|FG003|Overall Study|Serious adverse event|2|||
146159150|NCT02160314|527094463|FG001|Overall Study|Adverse Event|6|||
146280419|NCT01177800|527541538|FG001|Overall Study|Physician Decision|0|||
146280420|NCT01177800|527541537|FG000|Overall Study|Withdrawal of informed consent|0|||
146280421|NCT01177800|527541538|FG001|Overall Study|Withdrawal of informed consent|1|||
146280422|NCT05560243|527541543|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
146312079|NCT01049035|527657735|FG004|Overall Study|Serious adverse event|0|||
146312080|NCT01049035|527657736|FG005|Overall Study|Serious adverse event|0|||
146312081|NCT01049035|527657737|FG006|Overall Study|Serious adverse event|0|||
146312082|NCT01049035|527657731|FG000|Overall Study|Other adverse event (AE)|0|||
146312083|NCT01049035|527657732|FG001|Overall Study|Other adverse event (AE)|0|||
146312084|NCT01049035|527657733|FG002|Overall Study|Other adverse event (AE)|0|||
146312085|NCT01049035|527657734|FG003|Overall Study|Other adverse event (AE)|1|||
146312086|NCT01049035|527657735|FG004|Overall Study|Other adverse event (AE)|0|||
146312087|NCT01049035|527657736|FG005|Overall Study|Other adverse event (AE)|0|||
146312088|NCT01049035|527657737|FG006|Overall Study|Other adverse event (AE)|0|||
146312089|NCT01049035|527657731|FG000|Overall Study|Non-compliance with the protocol|12|||
146312090|NCT01049035|527657732|FG001|Overall Study|Non-compliance with the protocol|6|||
146312091|NCT01049035|527657733|FG002|Overall Study|Non-compliance with the protocol|14|||
146312092|NCT01049035|527657734|FG003|Overall Study|Non-compliance with the protocol|5|||
146312093|NCT01049035|527657735|FG004|Overall Study|Non-compliance with the protocol|3|||
146312094|NCT01049035|527657736|FG005|Overall Study|Non-compliance with the protocol|4|||
146312095|NCT01049035|527657737|FG006|Overall Study|Non-compliance with the protocol|10|||
146312096|NCT01049035|527657731|FG000|Overall Study|Lost to Follow-up|5|||
146312097|NCT01049035|527657732|FG001|Overall Study|Lost to Follow-up|4|||
146312098|NCT01049035|527657733|FG002|Overall Study|Lost to Follow-up|4|||
146312099|NCT01049035|527657734|FG003|Overall Study|Lost to Follow-up|1|||
146312100|NCT01049035|527657735|FG004|Overall Study|Lost to Follow-up|0|||
146312101|NCT01049035|527657736|FG005|Overall Study|Lost to Follow-up|3|||
146312102|NCT01049035|527657737|FG006|Overall Study|Lost to Follow-up|3|||
146312103|NCT01049035|527657731|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
146312104|NCT01049035|527657732|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
146312105|NCT01049035|527657733|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
146312106|NCT01049035|527657734|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
146312107|NCT01049035|527657735|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
146312108|NCT01049035|527657736|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
146312109|NCT01049035|527657737|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
146312110|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
146312111|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146312112|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146312113|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
146312114|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
146312115|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146312116|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146312117|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
146312118|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
146312119|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146312120|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146312121|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
146312122|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
146312123|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146312124|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146312125|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
146312126|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
146312127|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146312128|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146159151|NCT02160314|527094462|FG000|Overall Study|Protocol Violation|0|||
146159152|NCT02160314|527094463|FG001|Overall Study|Protocol Violation|4|||
146159153|NCT02160314|527094462|FG000|Overall Study|Withdrawal by Subject|1|||
146159154|NCT02160314|527094463|FG001|Overall Study|Withdrawal by Subject|2|||
146159155|NCT02160314|527094462|FG000|Overall Study|Lost to Follow-up|0|||
146159156|NCT02160314|527094463|FG001|Overall Study|Lost to Follow-up|1|||
146159157|NCT00593567|527094464|FG000|Overall Study|Adverse Event|2|||
146159158|NCT00593567|527094465|FG001|Overall Study|Adverse Event|0|||
146159159|NCT00593567|527094464|FG000|Overall Study|Physician Decision|2|||
146159160|NCT00593567|527094465|FG001|Overall Study|Physician Decision|0|||
146159161|NCT00593567|527094464|FG000|Overall Study|Protocol Violation|13|||
146159162|NCT00593567|527094465|FG001|Overall Study|Protocol Violation|7|||
146159163|NCT00593567|527094464|FG000|Overall Study|Lack of Efficacy|2|||
146159164|NCT00593567|527094465|FG001|Overall Study|Lack of Efficacy|1|||
146159165|NCT00593567|527094464|FG000|Overall Study|Withdrawal by Subject|1|||
146159166|NCT00593567|527094465|FG001|Overall Study|Withdrawal by Subject|2|||
146159167|NCT03576768|527094469|FG000|Overall Study|Lost to Follow-up|3|||
146159168|NCT03576768|527094470|FG001|Overall Study|Lost to Follow-up|3|||
146159169|NCT03576768|527094471|FG002|Overall Study|Lost to Follow-up|0|||
146159170|NCT03576768|527094472|FG003|Overall Study|Lost to Follow-up|0|||
146159171|NCT00590902|527094473|FG000|Overall Study|Death|1|||
146159172|NCT00785291|527094474|FG000|Overall Study|Never began treatment|8|||
146312129|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
146312130|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
146312131|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146312132|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146312133|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
146312134|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
146312135|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146312136|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146312137|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
146312138|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
146312139|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146312140|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146312141|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
146312142|NCT03605680|527657743|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
146312143|NCT03605680|527657744|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146312144|NCT03605680|527657745|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146312145|NCT03605680|527657746|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
146312146|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
146312147|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
146312148|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
146312149|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
146312150|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
146312151|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
146312152|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
146312153|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
146312154|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146312155|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146312156|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146312157|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146312158|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146312159|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146312160|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
146312161|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
146312162|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
146312163|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
146312164|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
146312165|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
146312166|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
146312167|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
146312168|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
146312169|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
146312170|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
146312171|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146312172|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
146312173|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
146312174|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
146312175|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
146312176|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
146312177|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
146312178|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
146312179|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
146312180|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
146312181|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
146312182|NCT03605680|527657743|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
146312183|NCT03605680|527657744|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
146312184|NCT03605680|527657745|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
146312185|NCT03605680|527657746|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
146312186|NCT03189446|527657747|FG000|Overall Study|Adverse Event|2|||
146312187|NCT03189446|527657747|FG000|Overall Study|Withdrawal by Subject|2|||
146159173|NCT00785291|527094475|FG001|Overall Study|Never began treatment|4|||
146159174|NCT00785291|527094476|FG002|Overall Study|Never began treatment|4|||
146159175|NCT00785291|527094474|FG000|Overall Study|Adverse Event|39|||
146159176|NCT00785291|527094475|FG001|Overall Study|Adverse Event|70|||
146312188|NCT03189446|527657747|FG000|Overall Study|Physician Decision|1|||
146312189|NCT00647556|527657748|FG000|Overall Study|Adverse Event|0|||
146312190|NCT00647556|527657749|FG001|Overall Study|Adverse Event|1|||
146312191|NCT00647556|527657748|FG000|Overall Study|Lost to Follow-up|1|||
146312192|NCT00647556|527657749|FG001|Overall Study|Lost to Follow-up|0|||
146312193|NCT00647556|527657748|FG000|Overall Study|Protocol Violation|0|||
146312194|NCT00647556|527657749|FG001|Overall Study|Protocol Violation|1|||
146312195|NCT00647556|527657748|FG000|Overall Study|Withdrawal by Subject|1|||
146312196|NCT00647556|527657749|FG001|Overall Study|Withdrawal by Subject|0|||
146312197|NCT00647556|527657748|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
146312198|NCT00647556|527657749|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
146312199|NCT05594173|527657750|FG000|Overall Study|Adverse Event|1|||
146312200|NCT05594173|527657750|FG000|Overall Study|COVID-19 Pandemic|2|||
146312201|NCT03865706|527657751|FG000|Overall Study|Death|0|||
146312202|NCT03865706|527657752|FG001|Overall Study|Death|3|||
146312203|NCT03865706|527657753|FG002|Overall Study|Death|1|||
146312204|NCT02095535|527657754|FG000|Recruitment|Protocol Violation|2|||
146312205|NCT02646982|527657755|FG000|Overall Study|Adverse Event|1|||
146312206|NCT02646982|527657756|FG001|Overall Study|Adverse Event|1|||
146312207|NCT02646982|527657755|FG000|Overall Study|Withdrawal by Subject|2|||
146312208|NCT02646982|527657756|FG001|Overall Study|Withdrawal by Subject|1|||
146312209|NCT00713700|527657757|FG000|Overall Study|Lost to Follow-up|3|||
146312210|NCT00713700|527657757|FG000|Overall Study|Withdrawal by Subject|1|||
146312211|NCT00781456|527657758|FG000|Overall Study|Adverse Event|3|||
146312212|NCT00781456|527657759|FG001|Overall Study|Adverse Event|3|||
146312213|NCT00781456|527657758|FG000|Overall Study|Withdrawal by Subject|3|||
146312214|NCT00781456|527657759|FG001|Overall Study|Withdrawal by Subject|5|||
146312215|NCT00781456|527657758|FG000|Overall Study|Protocol Violation|4|||
146312216|NCT00781456|527657759|FG001|Overall Study|Protocol Violation|1|||
146280423|NCT05870228|527541544|FG000|Overall Study|Lost to Follow-up|2|||
146280424|NCT05870228|527541545|FG001|Overall Study|Lost to Follow-up|0|||
146280425|NCT05870228|527541544|FG000|Overall Study|Withdrawal by Subject|1|||
146280426|NCT05870228|527541545|FG001|Overall Study|Withdrawal by Subject|0|||
146280427|NCT03231800|527541546|FG000|Overall Study|Lost to Follow-up|0|||
146280428|NCT03231800|527541547|FG001|Overall Study|Lost to Follow-up|2|||
146280429|NCT03231800|527541546|FG000|Overall Study|Protocol Violation|1|||
146280430|NCT03231800|527541547|FG001|Overall Study|Protocol Violation|1|||
146280431|NCT03231800|527541546|FG000|Overall Study|reason not provided|2|||
146280432|NCT03231800|527541547|FG001|Overall Study|reason not provided|0|||
146280433|NCT00859222|527541549|FG000|Overall Study|Adverse Event|2|||
146280434|NCT00859222|527541550|FG001|Overall Study|Adverse Event|3|||
146280435|NCT00859222|527541551|FG002|Overall Study|Adverse Event|6|||
146280436|NCT00859222|527541552|FG003|Overall Study|Adverse Event|24|||
146280437|NCT00859222|527541553|FG004|Overall Study|Adverse Event|15|||
146280438|NCT00859222|527541549|FG000|Overall Study|DLT|1|||
146280439|NCT00859222|527541550|FG001|Overall Study|DLT|0|||
146280440|NCT00859222|527541551|FG002|Overall Study|DLT|0|||
146280441|NCT00859222|527541552|FG003|Overall Study|DLT|0|||
146280442|NCT00859222|527541553|FG004|Overall Study|DLT|0|||
146280443|NCT00941070|527541554|FG000|Overall Study|Patient non-compliant|1|||
146280444|NCT03174431|527541555|FG000|Overall Study|Withdrawal by Subject|14|||
146280445|NCT03174431|527541556|FG001|Overall Study|Withdrawal by Subject|11|||
146280446|NCT03174431|527541555|FG000|Overall Study|alternative treatment|2|||
146280447|NCT03174431|527541556|FG001|Overall Study|alternative treatment|0|||
146280448|NCT03174431|527541555|FG000|Overall Study|Lost to Follow-up|1|||
146280449|NCT03174431|527541556|FG001|Overall Study|Lost to Follow-up|5|||
146280450|NCT04075994|527541559|FG000|Overall Study|Withdrawal by Subject|8|||
146280451|NCT04075994|527541560|FG001|Overall Study|Withdrawal by Subject|9|||
146280452|NCT04075994|527541559|FG000|Overall Study|Adverse Event|2|||
146280453|NCT04075994|527541560|FG001|Overall Study|Adverse Event|2|||
146280454|NCT04075994|527541559|FG000|Overall Study|Investigator withdrew|3|||
146280455|NCT04075994|527541560|FG001|Overall Study|Investigator withdrew|1|||
146280456|NCT01941719|527541568|FG000|Overall Study|Lost to Follow-up|20|||
146280457|NCT01941719|527541569|FG001|Overall Study|Lost to Follow-up|19|||
146280458|NCT00252577|527541570|FG000|Overall Study|Lost to Follow-up|20|||
146280459|NCT02797080|527541573|FG000|Overall Study|Lost to Follow-up|1|||
146280460|NCT02797080|527541573|FG000|Overall Study|Withdrawal by Subject|1|||
146312217|NCT00781456|527657758|FG000|Overall Study|Noncompliance With Protocol|1|||
146312218|NCT00781456|527657759|FG001|Overall Study|Noncompliance With Protocol|1|||
146312219|NCT00781456|527657758|FG000|Overall Study|Lost to Follow-up|10|||
146280461|NCT04035499|527541576|FG000|Overall Study|Death|2|||
146280462|NCT04035499|527541576|FG000|Overall Study|Withdrawal by Subject|1|||
146280463|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Adverse Event|1|||
146280464|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Adverse Event|1|||
146280465|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Adverse Event|2|||
146280466|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Adverse Event|5|||
146312220|NCT00781456|527657759|FG001|Overall Study|Lost to Follow-up|5|||
146312221|NCT00781456|527657758|FG000|Overall Study|Other Reason, Unknown|0|||
146312222|NCT00781456|527657759|FG001|Overall Study|Other Reason, Unknown|1|||
146312223|NCT01594853|527657760|FG000|Overall Study|Withdrawal by Subject|1|||
146280467|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Adverse Event|0|||
146280468|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
146280469|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
146280470|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
146280471|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
146280472|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
146280473|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
146280474|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
146280475|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
146280476|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
146280477|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
146280478|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146280479|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146280480|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146280481|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
146280482|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
146280483|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
146280484|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
146280485|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
146280486|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
146280487|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
146280488|NCT00951015|527541577|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146280489|NCT00951015|527541578|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
146280490|NCT00951015|527541579|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
146280491|NCT00951015|527541580|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
146280492|NCT00951015|527541581|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
146280493|NCT00951015|527541577|FG000|Open-label Phase|Adverse Event|0|||
146280494|NCT00951015|527541578|FG001|Open-label Phase|Adverse Event|0|||
146280495|NCT00951015|527541579|FG002|Open-label Phase|Adverse Event|0|||
146280496|NCT00951015|527541580|FG003|Open-label Phase|Adverse Event|0|||
146280497|NCT00951015|527541581|FG004|Open-label Phase|Adverse Event|3|||
146280498|NCT00951015|527541577|FG000|Open-label Phase|Lack of Efficacy|0|||
146280499|NCT00951015|527541578|FG001|Open-label Phase|Lack of Efficacy|0|||
146280500|NCT00951015|527541579|FG002|Open-label Phase|Lack of Efficacy|0|||
146280501|NCT00951015|527541580|FG003|Open-label Phase|Lack of Efficacy|0|||
146280502|NCT00951015|527541581|FG004|Open-label Phase|Lack of Efficacy|1|||
146280503|NCT00951015|527541577|FG000|Open-label Phase|Protocol Violation|0|||
146280504|NCT00951015|527541578|FG001|Open-label Phase|Protocol Violation|0|||
146280505|NCT00951015|527541579|FG002|Open-label Phase|Protocol Violation|0|||
146280506|NCT00951015|527541580|FG003|Open-label Phase|Protocol Violation|0|||
146280507|NCT00951015|527541581|FG004|Open-label Phase|Protocol Violation|12|||
146280508|NCT00951015|527541577|FG000|Open-label Phase|Lost to Follow-up|0|||
146280509|NCT00951015|527541578|FG001|Open-label Phase|Lost to Follow-up|0|||
146280510|NCT00951015|527541579|FG002|Open-label Phase|Lost to Follow-up|0|||
146280511|NCT00951015|527541580|FG003|Open-label Phase|Lost to Follow-up|0|||
146280512|NCT00951015|527541581|FG004|Open-label Phase|Lost to Follow-up|12|||
146280513|NCT00951015|527541577|FG000|Open-label Phase|Withdrawal by Subject|0|||
146280514|NCT00951015|527541578|FG001|Open-label Phase|Withdrawal by Subject|0|||
146280515|NCT00951015|527541579|FG002|Open-label Phase|Withdrawal by Subject|0|||
146280516|NCT00951015|527541580|FG003|Open-label Phase|Withdrawal by Subject|0|||
146280517|NCT00951015|527541581|FG004|Open-label Phase|Withdrawal by Subject|14|||
146280518|NCT00951015|527541577|FG000|Open-label Phase|Physician Decision|0|||
146280519|NCT00951015|527541578|FG001|Open-label Phase|Physician Decision|0|||
146280520|NCT00951015|527541579|FG002|Open-label Phase|Physician Decision|0|||
146280521|NCT00951015|527541580|FG003|Open-label Phase|Physician Decision|0|||
146280522|NCT00951015|527541581|FG004|Open-label Phase|Physician Decision|8|||
146280523|NCT03819634|527541583|FG000|Overall Study|Physician Decision|2|||
146280524|NCT00299494|527541584|FG000|Overall Study|Withdrawal by Subject|0|||
146280525|NCT00299494|527541585|FG001|Overall Study|Withdrawal by Subject|0|||
146280526|NCT00299494|527541586|FG002|Overall Study|Withdrawal by Subject|0|||
146280527|NCT00299494|527541587|FG003|Overall Study|Withdrawal by Subject|3|||
146280528|NCT00299494|527541588|FG004|Overall Study|Withdrawal by Subject|1|||
146280529|NCT00299494|527541589|FG005|Overall Study|Withdrawal by Subject|4|||
146280530|NCT00299494|527541584|FG000|Overall Study|Physician Decision|0|||
146280531|NCT00299494|527541585|FG001|Overall Study|Physician Decision|0|||
146280532|NCT00299494|527541586|FG002|Overall Study|Physician Decision|0|||
146280533|NCT00299494|527541587|FG003|Overall Study|Physician Decision|0|||
146280534|NCT00299494|527541588|FG004|Overall Study|Physician Decision|1|||
146280535|NCT00299494|527541589|FG005|Overall Study|Physician Decision|0|||
146280536|NCT00299494|527541584|FG000|Overall Study|Death|3|||
146280537|NCT00299494|527541585|FG001|Overall Study|Death|1|||
146280538|NCT00299494|527541586|FG002|Overall Study|Death|4|||
146312224|NCT01594853|527657761|FG001|Overall Study|Withdrawal by Subject|1|||
146280539|NCT00299494|527541587|FG003|Overall Study|Death|6|||
146280540|NCT00299494|527541588|FG004|Overall Study|Death|18|||
146280541|NCT00299494|527541589|FG005|Overall Study|Death|19|||
146280542|NCT00299494|527541584|FG000|Overall Study|Lost to Follow-up|0|||
146280543|NCT00299494|527541585|FG001|Overall Study|Lost to Follow-up|0|||
146280544|NCT00299494|527541586|FG002|Overall Study|Lost to Follow-up|0|||
146280545|NCT00299494|527541587|FG003|Overall Study|Lost to Follow-up|0|||
146280546|NCT00299494|527541588|FG004|Overall Study|Lost to Follow-up|3|||
146280547|NCT00299494|527541589|FG005|Overall Study|Lost to Follow-up|1|||
146280548|NCT00299494|527541584|FG000|Overall Study|Other - Unspecified|0|||
146280549|NCT00299494|527541585|FG001|Overall Study|Other - Unspecified|0|||
146280550|NCT00299494|527541586|FG002|Overall Study|Other - Unspecified|0|||
146280551|NCT00299494|527541587|FG003|Overall Study|Other - Unspecified|0|||
146280552|NCT00299494|527541588|FG004|Overall Study|Other - Unspecified|3|||
146280553|NCT00299494|527541589|FG005|Overall Study|Other - Unspecified|1|||
146280554|NCT00299494|527541584|FG000|Overall Study|Other - site closure|0|||
146280555|NCT00299494|527541585|FG001|Overall Study|Other - site closure|0|||
146280556|NCT00299494|527541586|FG002|Overall Study|Other - site closure|0|||
146280557|NCT00299494|527541587|FG003|Overall Study|Other - site closure|1|||
146280558|NCT00299494|527541588|FG004|Overall Study|Other - site closure|1|||
146280559|NCT00299494|527541589|FG005|Overall Study|Other - site closure|1|||
146280560|NCT01417104|527541593|FG000|Overall Study|Withdrawal by Subject|5|||
146280561|NCT01417104|527541594|FG001|Overall Study|Withdrawal by Subject|1|||
146280562|NCT01417104|527541593|FG000|Overall Study|Failure to make contact|0|||
146280563|NCT01417104|527541594|FG001|Overall Study|Failure to make contact|1|||
146280564|NCT01417104|527541593|FG000|Overall Study|Adverse Event|1|||
146280565|NCT01417104|527541594|FG001|Overall Study|Adverse Event|0|||
146280566|NCT01416389|527541595|FG000|Overall Study|Lost to Follow-up|1|||
146280567|NCT01416389|527541596|FG001|Overall Study|Lost to Follow-up|0|||
146280568|NCT01416389|527541595|FG000|Overall Study|Started New Therapy|2|||
146280569|NCT01416389|527541596|FG001|Overall Study|Started New Therapy|0|||
146280570|NCT01125514|527541597|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
146280571|NCT01125514|527541597|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
146280572|NCT01125514|527541597|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
146280573|NCT01125514|527541597|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
146280574|NCT01125514|527541597|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
146280575|NCT01125514|527541597|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
146280576|NCT00858364|527541598|FG000|Overall Study|Administrative Decision|3|||
146280577|NCT00858364|527541599|FG001|Overall Study|Administrative Decision|2|||
146280578|NCT00858364|527541598|FG000|Overall Study|Adverse Event|5|||
146280579|NCT00858364|527541599|FG001|Overall Study|Adverse Event|2|||
146280580|NCT00858364|527541598|FG000|Overall Study|Withdrawal by Subject|44|||
146280581|NCT00858364|527541599|FG001|Overall Study|Withdrawal by Subject|118|||
146280582|NCT00858364|527541598|FG000|Overall Study|Ineligibility Determined|1|||
146280583|NCT00858364|527541599|FG001|Overall Study|Ineligibility Determined|10|||
146280584|NCT00858364|527541598|FG000|Overall Study|Lost to Follow-up|24|||
146280585|NCT00858364|527541599|FG001|Overall Study|Lost to Follow-up|54|||
146280586|NCT00858364|527541598|FG000|Overall Study|Noncompliance|3|||
146280587|NCT00858364|527541599|FG001|Overall Study|Noncompliance|4|||
146280588|NCT00858364|527541598|FG000|Overall Study|Protocol Deviation|0|||
146280589|NCT00858364|527541599|FG001|Overall Study|Protocol Deviation|2|||
146280590|NCT00858364|527541598|FG000|Overall Study|Other|9|||
146280591|NCT00858364|527541599|FG001|Overall Study|Other|17|||
146280592|NCT00858364|527541598|FG000|Overall Study|Missing|1|||
146280593|NCT00858364|527541599|FG001|Overall Study|Missing|1|||
146280594|NCT00858364|527541598|FG000|Overall Study|Still on-study|114|||
146280595|NCT00858364|527541599|FG001|Overall Study|Still on-study|247|||
146280596|NCT03980808|527541600|FG000|Overall Study|Lost to Follow-up|2|||
146280597|NCT03980808|527541601|FG001|Overall Study|Lost to Follow-up|2|||
146280598|NCT01655693|527541602|FG000|Overall Study|Progression of Disease|92|||
146280599|NCT01655693|527541603|FG001|Overall Study|Progression of Disease|76|||
146280600|NCT01655693|527541604|FG002|Overall Study|Progression of Disease|58|||
146280601|NCT01655693|527541602|FG000|Overall Study|Death|8|||
146280602|NCT01655693|527541603|FG001|Overall Study|Death|9|||
146280603|NCT01655693|527541604|FG002|Overall Study|Death|12|||
146312225|NCT01594853|527657760|FG000|Overall Study|Lost to Follow-up|1|||
146312226|NCT01594853|527657761|FG001|Overall Study|Lost to Follow-up|1|||
146280604|NCT01655693|527541602|FG000|Overall Study|Serious Adverse Event|3|||
146280605|NCT01655693|527541603|FG001|Overall Study|Serious Adverse Event|15|||
146280606|NCT01655693|527541604|FG002|Overall Study|Serious Adverse Event|11|||
146280607|NCT01655693|527541602|FG000|Overall Study|Withdrawal by Subject|3|||
146280608|NCT01655693|527541603|FG001|Overall Study|Withdrawal by Subject|2|||
146280609|NCT01655693|527541604|FG002|Overall Study|Withdrawal by Subject|20|||
146280610|NCT01655693|527541602|FG000|Overall Study|Adverse Event|3|||
146280611|NCT01655693|527541603|FG001|Overall Study|Adverse Event|11|||
146280612|NCT01655693|527541604|FG002|Overall Study|Adverse Event|3|||
146280613|NCT01655693|527541602|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
146280614|NCT01655693|527541603|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
146280615|NCT01655693|527541604|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
146312227|NCT01594853|527657760|FG000|Overall Study|noncompliance with exercise|0|||
146312228|NCT01594853|527657761|FG001|Overall Study|noncompliance with exercise|1|||
146312229|NCT02083380|527657766|FG000|Overall Study|Lack of Efficacy|68|||
146312230|NCT02083380|527657767|FG001|Overall Study|Lack of Efficacy|79|||
146312231|NCT02083380|527657768|FG002|Overall Study|Lack of Efficacy|64|||
146312232|NCT02083380|527657766|FG000|Overall Study|Withdrawal by Subject|9|||
146312233|NCT02083380|527657767|FG001|Overall Study|Withdrawal by Subject|3|||
146312234|NCT02083380|527657768|FG002|Overall Study|Withdrawal by Subject|7|||
146312235|NCT02083380|527657766|FG000|Overall Study|Physician Decision|1|||
146312236|NCT02083380|527657767|FG001|Overall Study|Physician Decision|6|||
146312237|NCT02083380|527657768|FG002|Overall Study|Physician Decision|3|||
146312238|NCT02083380|527657766|FG000|Overall Study|Adverse Event|0|||
146312239|NCT02083380|527657767|FG001|Overall Study|Adverse Event|0|||
146312240|NCT02083380|527657768|FG002|Overall Study|Adverse Event|1|||
146312241|NCT02083380|527657766|FG000|Overall Study|Lost to Follow-up|5|||
146312242|NCT02083380|527657767|FG001|Overall Study|Lost to Follow-up|3|||
146312243|NCT02083380|527657768|FG002|Overall Study|Lost to Follow-up|3|||
146312244|NCT02083380|527657766|FG000|Overall Study|Other|8|||
146312245|NCT02083380|527657767|FG001|Overall Study|Other|4|||
146312246|NCT02083380|527657768|FG002|Overall Study|Other|6|||
146312247|NCT02412787|527657769|FG000|Overall Study|Withdrawal by Subject|9|||
146312248|NCT02412787|527657769|FG000|Overall Study|Participation Terminated by Investigator|1|||
146312249|NCT02412787|527657769|FG000|Overall Study|Site Terminated by Sponsor|21|||
146312250|NCT02412787|527657769|FG000|Overall Study|Technical Problems|1|||
146312251|NCT02412787|527657769|FG000|Overall Study|Reason Not Specified|1|||
146312252|NCT03246958|527657770|FG000|Overall Study|Withdrawal by Subject|0|||
146312253|NCT03246958|527657771|FG001|Overall Study|Withdrawal by Subject|1|||
146312254|NCT03246958|527657772|FG002|Overall Study|Withdrawal by Subject|0|||
146312255|NCT03246958|527657773|FG003|Overall Study|Withdrawal by Subject|0|||
146312256|NCT03246958|527657774|FG004|Overall Study|Withdrawal by Subject|0|||
146159177|NCT00785291|527094476|FG002|Overall Study|Adverse Event|56|||
146280616|NCT01655693|527541602|FG000|Overall Study|Non-Compliance|0|||
146280617|NCT01655693|527541603|FG001|Overall Study|Non-Compliance|0|||
146280618|NCT01655693|527541604|FG002|Overall Study|Non-Compliance|7|||
146280619|NCT01655693|527541602|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
146280620|NCT01655693|527541603|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
146280621|NCT01655693|527541604|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
146280622|NCT01655693|527541602|FG000|Overall Study|Protocol Violation|1|||
146280623|NCT01655693|527541603|FG001|Overall Study|Protocol Violation|0|||
146280624|NCT01655693|527541604|FG002|Overall Study|Protocol Violation|3|||
146280625|NCT01655693|527541602|FG000|Overall Study|Lost to Follow-up|1|||
146280626|NCT01655693|527541603|FG001|Overall Study|Lost to Follow-up|0|||
146280627|NCT01655693|527541604|FG002|Overall Study|Lost to Follow-up|1|||
146280628|NCT01655693|527541602|FG000|Overall Study|Screening Failure|1|||
146280629|NCT01655693|527541603|FG001|Overall Study|Screening Failure|0|||
146280630|NCT01655693|527541604|FG002|Overall Study|Screening Failure|0|||
146280631|NCT01655693|527541602|FG000|Overall Study|Other|8|||
146280632|NCT01655693|527541603|FG001|Overall Study|Other|6|||
146280633|NCT01655693|527541604|FG002|Overall Study|Other|15|||
146280634|NCT00929110|527541607|FG000|Overall Study|Adverse Event|40|||
146280635|NCT00929110|527541608|FG001|Overall Study|Adverse Event|29|||
146280636|NCT00929110|527541609|FG002|Overall Study|Adverse Event|18|||
146280637|NCT00929110|527541607|FG000|Overall Study|Subject withdrew consent|40|||
146280638|NCT00929110|527541608|FG001|Overall Study|Subject withdrew consent|23|||
146280639|NCT00929110|527541609|FG002|Overall Study|Subject withdrew consent|26|||
146280640|NCT00929110|527541607|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
146280641|NCT00929110|527541608|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
146159178|NCT00785291|527094474|FG000|Overall Study|Death|7|||
146159179|NCT00785291|527094475|FG001|Overall Study|Death|4|||
146159180|NCT00785291|527094476|FG002|Overall Study|Death|3|||
146159181|NCT00785291|527094474|FG000|Overall Study|Withdrawal by Subject|35|||
146159182|NCT00785291|527094475|FG001|Overall Study|Withdrawal by Subject|36|||
146159183|NCT00785291|527094476|FG002|Overall Study|Withdrawal by Subject|17|||
146159184|NCT00785291|527094474|FG000|Overall Study|Alternative Therapy|12|||
146159185|NCT00785291|527094475|FG001|Overall Study|Alternative Therapy|6|||
146159186|NCT00785291|527094476|FG002|Overall Study|Alternative Therapy|7|||
146280642|NCT00929110|527541609|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
146280643|NCT00929110|527541607|FG000|Overall Study|Lost to Follow-up|7|||
146280644|NCT00929110|527541608|FG001|Overall Study|Lost to Follow-up|7|||
146280645|NCT00929110|527541609|FG002|Overall Study|Lost to Follow-up|3|||
146312257|NCT03246958|527657775|FG005|Overall Study|Withdrawal by Subject|1|||
146312258|NCT03246958|527657776|FG006|Overall Study|Withdrawal by Subject|0|||
146312259|NCT03246958|527657770|FG000|Overall Study|Progression|13|||
146312260|NCT03246958|527657771|FG001|Overall Study|Progression|9|||
146312261|NCT03246958|527657772|FG002|Overall Study|Progression|3|||
146159187|NCT00785291|527094474|FG000|Overall Study|Complicating illness|6|||
146280646|NCT00929110|527541607|FG000|Overall Study|Protocol deviation|5|||
146280647|NCT00929110|527541608|FG001|Overall Study|Protocol deviation|2|||
146312262|NCT03246958|527657773|FG003|Overall Study|Progression|2|||
146159188|NCT00785291|527094475|FG001|Overall Study|Complicating illness|4|||
146159189|NCT00785291|527094476|FG002|Overall Study|Complicating illness|4|||
146159190|NCT00785291|527094474|FG000|Overall Study|Other Medical Reasons|29|||
146159191|NCT00785291|527094475|FG001|Overall Study|Other Medical Reasons|25|||
146280648|NCT00929110|527541609|FG002|Overall Study|Protocol deviation|4|||
146280649|NCT00929110|527541607|FG000|Overall Study|Administrative problems|4|||
146280650|NCT00929110|527541608|FG001|Overall Study|Administrative problems|1|||
146280651|NCT00929110|527541609|FG002|Overall Study|Administrative problems|2|||
146280652|NCT00929110|527541607|FG000|Overall Study|Death|2|||
146280653|NCT00929110|527541608|FG001|Overall Study|Death|2|||
146280654|NCT00929110|527541609|FG002|Overall Study|Death|2|||
146280655|NCT00929110|527541607|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146280656|NCT00929110|527541608|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146280657|NCT00929110|527541609|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146280658|NCT00929110|527541607|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146280659|NCT00929110|527541608|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146280660|NCT00929110|527541609|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146280661|NCT00929110|527541607|FG000|Overall Study|Patient inability to use the device|0|||
146280662|NCT00929110|527541608|FG001|Overall Study|Patient inability to use the device|1|||
146280663|NCT00929110|527541609|FG002|Overall Study|Patient inability to use the device|0|||
146280664|NCT01163292|527541613|FG000|Overall Study|Lack of Efficacy|9|||
146280665|NCT01163292|527541614|FG001|Overall Study|Lack of Efficacy|0|||
146280666|NCT01163292|527541613|FG000|Overall Study|Adverse Event|6|||
146280667|NCT01163292|527541614|FG001|Overall Study|Adverse Event|0|||
146280668|NCT01163292|527541613|FG000|Overall Study|Initiation of biological therapy|0|||
146280669|NCT01163292|527541614|FG001|Overall Study|Initiation of biological therapy|15|||
146280670|NCT01163292|527541613|FG000|Overall Study|Sufficient response to adalimumab|8|||
146280671|NCT01163292|527541614|FG001|Overall Study|Sufficient response to adalimumab|0|||
146280672|NCT01163292|527541613|FG000|Overall Study|Refusal to receive adalimumab|7|||
146280673|NCT01163292|527541614|FG001|Overall Study|Refusal to receive adalimumab|0|||
146280674|NCT01163292|527541613|FG000|Overall Study|Economic reasons|6|||
146280675|NCT01163292|527541614|FG001|Overall Study|Economic reasons|0|||
146280676|NCT01163292|527541613|FG000|Overall Study|No further visits|5|||
146280677|NCT01163292|527541614|FG001|Overall Study|No further visits|7|||
146280678|NCT01258595|527541615|FG000|Overall Study|Lost to Follow-up|1|||
146280679|NCT01258595|527541616|FG001|Overall Study|Lost to Follow-up|0|||
146280680|NCT01258595|527541615|FG000|Overall Study|Withdrawal by Subject|0|||
146280681|NCT01258595|527541616|FG001|Overall Study|Withdrawal by Subject|1|||
146280682|NCT01012414|527541617|FG000|Overall Study|Withdrawal by Subject|2|||
146280683|NCT01012414|527541617|FG000|Overall Study|Lost to Follow-up|1|||
146280684|NCT01012414|527541617|FG000|Overall Study|Trial was stopped before completed|7|||
146280685|NCT01215188|527541618|FG000|Overall Study|Lost to Follow-up|22|||
146280686|NCT01215188|527541619|FG001|Overall Study|Lost to Follow-up|22|||
146280687|NCT01215188|527541620|FG002|Overall Study|Lost to Follow-up|16|||
146280688|NCT01215188|527541618|FG000|Overall Study|Adverse Event|1|||
146280689|NCT01215188|527541619|FG001|Overall Study|Adverse Event|1|||
146280690|NCT01215188|527541620|FG002|Overall Study|Adverse Event|3|||
146280691|NCT01215188|527541618|FG000|Overall Study|Physician Decision|2|||
146280692|NCT01215188|527541619|FG001|Overall Study|Physician Decision|1|||
146280693|NCT01215188|527541620|FG002|Overall Study|Physician Decision|0|||
146280694|NCT01215188|527541618|FG000|Overall Study|Lack of Efficacy|0|||
146280695|NCT01215188|527541619|FG001|Overall Study|Lack of Efficacy|0|||
146280696|NCT01215188|527541620|FG002|Overall Study|Lack of Efficacy|1|||
146280697|NCT01215188|527541618|FG000|Overall Study|Protocol Violation|1|||
146280698|NCT01215188|527541619|FG001|Overall Study|Protocol Violation|1|||
146280699|NCT01215188|527541620|FG002|Overall Study|Protocol Violation|1|||
146280700|NCT01215188|527541618|FG000|Overall Study|Withdrawal by Subject|32|||
146280701|NCT01215188|527541619|FG001|Overall Study|Withdrawal by Subject|34|||
146280702|NCT01215188|527541620|FG002|Overall Study|Withdrawal by Subject|31|||
146280703|NCT02601300|527541621|FG000|Induction Phase|Lack of Efficacy|2|||
146280704|NCT02601300|527541621|FG000|Induction Phase|Protocol Violation|1|||
146280705|NCT02601300|527541621|FG000|Extension Phase|Withdrawal by Subject|3|||
146280706|NCT02601300|527541621|FG000|Extension Phase|Adverse Event|4|||
146280707|NCT02601300|527541621|FG000|Extension Phase|Lack of Efficacy|10|||
146280708|NCT01127763|527541622|FG000|Overall Study|Adverse Event|2|||
146280709|NCT01127763|527541622|FG000|Overall Study|Withdrawal by Subject|1|||
146280710|NCT01127763|527541622|FG000|Overall Study|Physician Decision|2|||
146280711|NCT00528931|527541623|FG000|Overall Study|Lost to Follow-up|1|||
146280712|NCT02285153|527541629|FG000|Overall Study|Adverse Event|1|||
146280713|NCT02285153|527541630|FG001|Overall Study|Adverse Event|0|||
146280714|NCT01489891|527541633|FG000|Overall Study|Endoscopy failure|1|||
146280715|NCT01489891|527541634|FG001|Overall Study|Endoscopy failure|0|||
146280716|NCT02576587|527541635|FG000|Baseline|Equipment failure|0|||
146280717|NCT02576587|527541636|FG001|Baseline|Equipment failure|1|||
146280718|NCT02576587|527541635|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
146280719|NCT02576587|527541636|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
146159192|NCT00785291|527094476|FG002|Overall Study|Other Medical Reasons|15|||
146312263|NCT03246958|527657774|FG004|Overall Study|Progression|1|||
146312264|NCT03246958|527657775|FG005|Overall Study|Progression|2|||
146312265|NCT03246958|527657776|FG006|Overall Study|Progression|1|||
146312266|NCT03246958|527657770|FG000|Overall Study|Adverse Event|2|||
146312267|NCT03246958|527657771|FG001|Overall Study|Adverse Event|2|||
146312268|NCT03246958|527657772|FG002|Overall Study|Adverse Event|0|||
146312269|NCT03246958|527657773|FG003|Overall Study|Adverse Event|1|||
146312270|NCT03246958|527657774|FG004|Overall Study|Adverse Event|1|||
146312271|NCT03246958|527657775|FG005|Overall Study|Adverse Event|0|||
146312272|NCT03246958|527657776|FG006|Overall Study|Adverse Event|2|||
146312273|NCT03246958|527657770|FG000|Overall Study|Death|0|||
146312274|NCT03246958|527657771|FG001|Overall Study|Death|1|||
146312275|NCT03246958|527657772|FG002|Overall Study|Death|0|||
146312276|NCT03246958|527657773|FG003|Overall Study|Death|0|||
146312277|NCT03246958|527657774|FG004|Overall Study|Death|0|||
146312278|NCT03246958|527657775|FG005|Overall Study|Death|0|||
146312279|NCT03246958|527657776|FG006|Overall Study|Death|0|||
146312280|NCT03246958|527657770|FG000|Overall Study|Physician Decision|0|||
146312281|NCT03246958|527657771|FG001|Overall Study|Physician Decision|0|||
146312282|NCT03246958|527657772|FG002|Overall Study|Physician Decision|0|||
146312283|NCT03246958|527657773|FG003|Overall Study|Physician Decision|1|||
146312284|NCT03246958|527657774|FG004|Overall Study|Physician Decision|0|||
146312285|NCT03246958|527657775|FG005|Overall Study|Physician Decision|0|||
146312286|NCT03246958|527657776|FG006|Overall Study|Physician Decision|0|||
146312287|NCT03246958|527657770|FG000|Overall Study|Never start treatment|1|||
146312288|NCT03246958|527657771|FG001|Overall Study|Never start treatment|0|||
146312289|NCT03246958|527657772|FG002|Overall Study|Never start treatment|0|||
146312290|NCT03246958|527657773|FG003|Overall Study|Never start treatment|0|||
146312291|NCT03246958|527657774|FG004|Overall Study|Never start treatment|0|||
146312292|NCT03246958|527657775|FG005|Overall Study|Never start treatment|0|||
146312293|NCT03246958|527657776|FG006|Overall Study|Never start treatment|0|||
146312294|NCT03246958|527657770|FG000|Overall Study|Over enrollment|0|||
146312295|NCT03246958|527657771|FG001|Overall Study|Over enrollment|2|||
146312296|NCT03246958|527657772|FG002|Overall Study|Over enrollment|0|||
146312297|NCT03246958|527657773|FG003|Overall Study|Over enrollment|0|||
146312298|NCT03246958|527657774|FG004|Overall Study|Over enrollment|0|||
146312299|NCT03246958|527657775|FG005|Overall Study|Over enrollment|0|||
146312300|NCT03246958|527657776|FG006|Overall Study|Over enrollment|0|||
146312301|NCT01032915|527657779|FG000|Overall Study|Adverse Event|2|||
146312302|NCT01032915|527657780|FG001|Overall Study|Adverse Event|2|||
146312303|NCT01032915|527657781|FG002|Overall Study|Adverse Event|1|||
146312304|NCT01032915|527657782|FG003|Overall Study|Adverse Event|1|||
146312305|NCT01032915|527657779|FG000|Overall Study|Abnormal test procedure result|0|||
146312306|NCT01032915|527657780|FG001|Overall Study|Abnormal test procedure result|0|||
146312307|NCT01032915|527657781|FG002|Overall Study|Abnormal test procedure result|1|||
146312308|NCT01032915|527657782|FG003|Overall Study|Abnormal test procedure result|0|||
146312309|NCT01032915|527657779|FG000|Overall Study|Withdrawal by Subject|0|||
146312310|NCT01032915|527657780|FG001|Overall Study|Withdrawal by Subject|3|||
146312311|NCT01032915|527657781|FG002|Overall Study|Withdrawal by Subject|1|||
146312312|NCT01032915|527657782|FG003|Overall Study|Withdrawal by Subject|1|||
146312313|NCT01032915|527657779|FG000|Overall Study|Administrative reasons|5|||
146312314|NCT01032915|527657780|FG001|Overall Study|Administrative reasons|6|||
146312315|NCT01032915|527657781|FG002|Overall Study|Administrative reasons|4|||
146312316|NCT01032915|527657782|FG003|Overall Study|Administrative reasons|4|||
146312317|NCT01032915|527657779|FG000|Overall Study|Protocol Violation|1|||
146312318|NCT01032915|527657780|FG001|Overall Study|Protocol Violation|0|||
146312319|NCT01032915|527657781|FG002|Overall Study|Protocol Violation|0|||
146312320|NCT01032915|527657782|FG003|Overall Study|Protocol Violation|1|||
146312321|NCT03363321|527657783|FG000|Overall Study|Withdrawal by Subject|0|||
146312322|NCT03363321|527657784|FG001|Overall Study|Withdrawal by Subject|1|||
146312323|NCT03363321|527657785|FG002|Overall Study|Withdrawal by Subject|0|||
146312324|NCT03363321|527657786|FG003|Overall Study|Withdrawal by Subject|1|||
146312325|NCT03363321|527657787|FG004|Overall Study|Withdrawal by Subject|0|||
146312326|NCT02915523|527657788|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
146312327|NCT02915523|527657789|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
146312328|NCT02915523|527657790|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
146312329|NCT02915523|527657791|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
146312330|NCT02915523|527657788|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
146312331|NCT02915523|527657789|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
146312332|NCT02915523|527657790|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
146312333|NCT02915523|527657791|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
146312334|NCT02915523|527657788|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146312335|NCT02915523|527657789|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
146312336|NCT02915523|527657790|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146312337|NCT02915523|527657791|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
146312338|NCT02915523|527657788|FG000|Expansion Phase (Phase 2)|Death|0|||
146312339|NCT02915523|527657789|FG001|Expansion Phase (Phase 2)|Death|0|||
146312340|NCT02915523|527657790|FG002|Expansion Phase (Phase 2)|Death|26|||
146280720|NCT02576587|527541635|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
146280721|NCT02576587|527541636|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
146280722|NCT02576587|527541635|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
146280723|NCT02576587|527541636|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
146280724|NCT00777088|527541637|FG000|Overall Study|PED Treatment not attempted|1|||
146280725|NCT01278173|527541638|FG000|Overall Study|Lack of Efficacy|13|||
146280726|NCT01278173|527541638|FG000|Overall Study|Adverse Event|8|||
146280727|NCT01278173|527541638|FG000|Overall Study|Administrative or other reason|4|||
146280728|NCT01278173|527541638|FG000|Overall Study|Protocol Violation|1|||
146280729|NCT01278173|527541638|FG000|Overall Study|Withdrawal by Subject|1|||
146280730|NCT02546921|527541639|FG000|Overall Study|Adverse Event|0|||
146280731|NCT02546921|527541640|FG001|Overall Study|Adverse Event|5|||
146280732|NCT02546921|527541641|FG002|Overall Study|Adverse Event|2|||
146280733|NCT02546921|527541642|FG003|Overall Study|Adverse Event|0|||
146280734|NCT02546921|527541643|FG004|Overall Study|Adverse Event|0|||
146280735|NCT02546921|527541644|FG005|Overall Study|Adverse Event|0|||
146280736|NCT02546921|527541645|FG006|Overall Study|Adverse Event|0|||
146280737|NCT02546921|527541639|FG000|Overall Study|Evidence of Disease Progression|1|||
146280738|NCT02546921|527541640|FG001|Overall Study|Evidence of Disease Progression|0|||
146280739|NCT02546921|527541641|FG002|Overall Study|Evidence of Disease Progression|0|||
146280740|NCT02546921|527541642|FG003|Overall Study|Evidence of Disease Progression|0|||
146280741|NCT02546921|527541643|FG004|Overall Study|Evidence of Disease Progression|1|||
146280742|NCT02546921|527541644|FG005|Overall Study|Evidence of Disease Progression|0|||
146280743|NCT02546921|527541645|FG006|Overall Study|Evidence of Disease Progression|0|||
146280744|NCT02546921|527541639|FG000|Overall Study|Patient Choice|0|||
146280745|NCT02546921|527541640|FG001|Overall Study|Patient Choice|1|||
146280746|NCT02546921|527541641|FG002|Overall Study|Patient Choice|0|||
146280747|NCT02546921|527541642|FG003|Overall Study|Patient Choice|0|||
146280748|NCT02546921|527541643|FG004|Overall Study|Patient Choice|0|||
146280749|NCT02546921|527541644|FG005|Overall Study|Patient Choice|1|||
146280750|NCT02546921|527541645|FG006|Overall Study|Patient Choice|0|||
146280751|NCT02091206|527541646|FG000|Treatment Period|Adverse Event|0|||
146280752|NCT02091206|527541647|FG001|Treatment Period|Adverse Event|1|||
146280753|NCT02091206|527541648|FG002|Treatment Period|Adverse Event|0|||
146280754|NCT02091206|527541649|FG003|Treatment Period|Adverse Event|0|||
146280755|NCT02091206|527541646|FG000|Treatment Period|Met withdrawal criteria|0|||
146280756|NCT02091206|527541647|FG001|Treatment Period|Met withdrawal criteria|0|||
146280757|NCT02091206|527541648|FG002|Treatment Period|Met withdrawal criteria|1|||
146280758|NCT02091206|527541649|FG003|Treatment Period|Met withdrawal criteria|0|||
146280759|NCT02091206|527541646|FG000|Taper Period|Participant refused study drug|1|||
146280760|NCT02091206|527541647|FG001|Taper Period|Participant refused study drug|0|||
146280761|NCT02091206|527541648|FG002|Taper Period|Participant refused study drug|0|||
146280762|NCT02091206|527541649|FG003|Taper Period|Participant refused study drug|1|||
146280763|NCT02091206|527541646|FG000|Taper Period|Lost to Follow-up|0|||
146280764|NCT02091206|527541647|FG001|Taper Period|Lost to Follow-up|0|||
146280765|NCT02091206|527541648|FG002|Taper Period|Lost to Follow-up|0|||
146280766|NCT02091206|527541649|FG003|Taper Period|Lost to Follow-up|1|||
146280767|NCT02980731|527542905|FG000|Overall Study|Death|63|||
146280768|NCT02980731|527542905|FG000|Overall Study|Withdrawal by Subject|6|||
146280769|NCT02980731|527542905|FG000|Overall Study|Lost to Follow-up|5|||
146280770|NCT02980731|527542905|FG000|Overall Study|Study terminated by Sponsor|4|||
146280771|NCT02980731|527542905|FG000|Overall Study|Completed survival follow-up period|65|||
146280772|NCT02980731|527542905|FG000|Overall Study|COVID-19 infection|1|||
146280773|NCT02980731|527542905|FG000|Overall Study|Other, not specified|66|||
146280774|NCT03037931|527542906|FG000|Overall Study|Death|354|||
146280775|NCT03037931|527542907|FG001|Overall Study|Death|367|||
146280776|NCT03037931|527542906|FG000|Overall Study|Lost to Follow-up|7|||
146280777|NCT03037931|527542907|FG001|Overall Study|Lost to Follow-up|4|||
146280778|NCT03037931|527542906|FG000|Overall Study|Withdrawal by Subject|48|||
146280779|NCT03037931|527542907|FG001|Overall Study|Withdrawal by Subject|41|||
146280780|NCT02075476|527542908|FG000|Overall Study|Death|2|||
146280781|NCT02075476|527542909|FG001|Overall Study|Death|2|||
146280782|NCT02075476|527542908|FG000|Overall Study|Lost to Follow-up|1|||
146280783|NCT02075476|527542909|FG001|Overall Study|Lost to Follow-up|3|||
146280784|NCT00091169|527542912|FG000|Overall Study|Disease progression|3|||
146280785|NCT00091169|527542913|FG001|Overall Study|Disease progression|1|||
146280786|NCT00091169|527542912|FG000|Overall Study|Adverse Event|11|||
146280787|NCT00091169|527542913|FG001|Overall Study|Adverse Event|17|||
146280788|NCT00091169|527542912|FG000|Overall Study|Death|4|||
146280789|NCT00091169|527542913|FG001|Overall Study|Death|1|||
146280790|NCT00091169|527542912|FG000|Overall Study|Withdrawal by Subject|10|||
146280791|NCT00091169|527542913|FG001|Overall Study|Withdrawal by Subject|13|||
146280792|NCT00091169|527542912|FG000|Overall Study|Other|3|||
146280793|NCT00091169|527542913|FG001|Overall Study|Other|4|||
146280794|NCT00091169|527542912|FG000|Overall Study|Not start protocol therapy|26|||
146280795|NCT00091169|527542913|FG001|Overall Study|Not start protocol therapy|17|||
146280796|NCT03809429|527542914|FG000|Overall Study|Withdrawal by Subject|7|||
146312341|NCT02915523|527657791|FG003|Expansion Phase (Phase 2)|Death|53|||
146312342|NCT02915523|527657788|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
146312343|NCT02915523|527657789|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
146312344|NCT02915523|527657790|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
146312345|NCT02915523|527657791|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
146312346|NCT02915523|527657788|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
146312347|NCT02915523|527657789|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
146312348|NCT02915523|527657790|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
146312349|NCT02915523|527657791|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
146312350|NCT02915523|527657788|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146312351|NCT02915523|527657789|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146312352|NCT02915523|527657790|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
146312353|NCT02915523|527657791|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
146312354|NCT00414453|527657793|FG000|Overall Study|Abnormal lab work|16|||
146312355|NCT01780831|527657794|FG000|Overall Study|Withdrawal by Subject|0|||
146312356|NCT01780831|527657795|FG001|Overall Study|Withdrawal by Subject|0|||
146312357|NCT01780831|527657796|FG002|Overall Study|Withdrawal by Subject|4|||
146312358|NCT01780831|527657797|FG003|Overall Study|Withdrawal by Subject|0|||
146312359|NCT01780831|527657794|FG000|Overall Study|Lost to Follow-up|0|||
146312360|NCT01780831|527657795|FG001|Overall Study|Lost to Follow-up|0|||
146312361|NCT01780831|527657796|FG002|Overall Study|Lost to Follow-up|0|||
146312362|NCT01780831|527657797|FG003|Overall Study|Lost to Follow-up|1|||
146312363|NCT00183274|527657798|FG000|Phase 1: Open-Label|Adverse Event|31|||
146312364|NCT00183274|527657799|FG001|Phase 1: Open-Label|Adverse Event|0|||
146312365|NCT00183274|527657800|FG002|Phase 1: Open-Label|Adverse Event|0|||
146312366|NCT00183274|527657801|FG003|Phase 1: Open-Label|Adverse Event|0|||
146312367|NCT00183274|527657802|FG004|Phase 1: Open-Label|Adverse Event|0|||
146312368|NCT00183274|527657803|FG005|Phase 1: Open-Label|Adverse Event|0|||
146312369|NCT00183274|527657798|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
146312370|NCT00183274|527657799|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
146312371|NCT00183274|527657800|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
146312372|NCT00183274|527657801|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
146312373|NCT00183274|527657802|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
146312374|NCT00183274|527657803|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
146312375|NCT00183274|527657798|FG000|Phase 1: Open-Label|Protocol Violation|11|||
146312376|NCT00183274|527657799|FG001|Phase 1: Open-Label|Protocol Violation|0|||
146312377|NCT00183274|527657800|FG002|Phase 1: Open-Label|Protocol Violation|0|||
146312378|NCT00183274|527657801|FG003|Phase 1: Open-Label|Protocol Violation|0|||
146312379|NCT00183274|527657802|FG004|Phase 1: Open-Label|Protocol Violation|0|||
146312380|NCT00183274|527657803|FG005|Phase 1: Open-Label|Protocol Violation|0|||
146312381|NCT00183274|527657798|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
146312382|NCT00183274|527657799|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
146312383|NCT00183274|527657800|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
146312384|NCT00183274|527657801|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
146312385|NCT00183274|527657802|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
146312386|NCT00183274|527657803|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
146312387|NCT00183274|527657798|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
146312388|NCT00183274|527657799|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
146312389|NCT00183274|527657800|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
146312390|NCT00183274|527657801|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
146312391|NCT00183274|527657802|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
146312392|NCT00183274|527657803|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
146312393|NCT00183274|527657798|FG000|Phase 1: Open-Label|Other|9|||
146312394|NCT00183274|527657799|FG001|Phase 1: Open-Label|Other|0|||
146312395|NCT00183274|527657800|FG002|Phase 1: Open-Label|Other|0|||
146312396|NCT00183274|527657801|FG003|Phase 1: Open-Label|Other|0|||
146312397|NCT00183274|527657802|FG004|Phase 1: Open-Label|Other|0|||
146312398|NCT00183274|527657803|FG005|Phase 1: Open-Label|Other|0|||
146312399|NCT00183274|527657798|FG000|Phase 2: Double-Blind|Relapsed|0|||
146312400|NCT00183274|527657799|FG001|Phase 2: Double-Blind|Relapsed|8|||
146312401|NCT00183274|527657800|FG002|Phase 2: Double-Blind|Relapsed|29|||
146312402|NCT00183274|527657801|FG003|Phase 2: Double-Blind|Relapsed|0|||
146312403|NCT00183274|527657802|FG004|Phase 2: Double-Blind|Relapsed|0|||
146312404|NCT00183274|527657803|FG005|Phase 2: Double-Blind|Relapsed|0|||
146312405|NCT00183274|527657798|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146312406|NCT00183274|527657799|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
146312407|NCT00183274|527657800|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
146312408|NCT00183274|527657801|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146312409|NCT00183274|527657802|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146312410|NCT00183274|527657803|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
146312411|NCT00183274|527657798|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146312412|NCT00183274|527657799|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146312413|NCT00183274|527657800|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
146312414|NCT00183274|527657801|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
146312415|NCT00183274|527657802|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
146312416|NCT00183274|527657803|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
146312417|NCT00183274|527657798|FG000|Phase 3: Double-Blind|Relapsed|0|||
146312418|NCT00183274|527657799|FG001|Phase 3: Double-Blind|Relapsed|0|||
146312419|NCT00183274|527657800|FG002|Phase 3: Double-Blind|Relapsed|0|||
146312420|NCT00183274|527657801|FG003|Phase 3: Double-Blind|Relapsed|1|||
146312421|NCT00183274|527657802|FG004|Phase 3: Double-Blind|Relapsed|11|||
146312422|NCT00183274|527657803|FG005|Phase 3: Double-Blind|Relapsed|2|||
146312423|NCT00879645|527657806|FG000|Overall Study|Adverse Event|1|||
146312424|NCT00879645|527657807|FG001|Overall Study|Adverse Event|0|||
146312425|NCT00879645|527657808|FG002|Overall Study|Adverse Event|0|||
146312426|NCT00879645|527657809|FG003|Overall Study|Adverse Event|0|||
146312427|NCT04288154|527657810|FG000|Overall Study|Withdrawal by Subject|9|||
146312428|NCT04288154|527657811|FG001|Overall Study|Withdrawal by Subject|9|||
146312429|NCT00996944|527657812|FG000|Double-blind Treatment Period|Adverse Event|2|||
146312430|NCT00996944|527657813|FG001|Double-blind Treatment Period|Adverse Event|1|||
146312431|NCT00996944|527657812|FG000|Double-blind Treatment Period|Protocol Violation|1|||
146312432|NCT00996944|527657813|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146312433|NCT00996944|527657812|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
146312434|NCT00996944|527657813|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
146312435|NCT00996944|527657812|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146312436|NCT00996944|527657813|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
146312437|NCT00996944|527657812|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
146312438|NCT00996944|527657813|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
146312439|NCT00769184|527657814|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
146312440|NCT00769184|527657815|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
146312441|NCT00769184|527657814|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
146312442|NCT00769184|527657815|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
146312443|NCT00769184|527657814|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
146312444|NCT00769184|527657815|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
146312445|NCT00385255|527657816|FG000|Overall Study|Serious Adverse Event|1|||
146312446|NCT00385255|527657817|FG001|Overall Study|Serious Adverse Event|2|||
146312447|NCT00385255|527657816|FG000|Overall Study|Protocol Violation|0|||
146312448|NCT00385255|527657817|FG001|Overall Study|Protocol Violation|4|||
146312449|NCT00385255|527657816|FG000|Overall Study|Withdrawal by Subject|0|||
146312450|NCT00385255|527657817|FG001|Overall Study|Withdrawal by Subject|8|||
146312451|NCT00385255|527657816|FG000|Overall Study|Migrated/moved from study area|0|||
146312452|NCT00385255|527657817|FG001|Overall Study|Migrated/moved from study area|1|||
146312453|NCT00385255|527657816|FG000|Overall Study|Lost to Follow-up|20|||
146312454|NCT00385255|527657817|FG001|Overall Study|Lost to Follow-up|58|||
146312455|NCT00583362|527657818|FG000|Overall Study|Adverse Event|44|||
146312456|NCT00583362|527657818|FG000|Overall Study|Lack of Efficacy|22|||
146312457|NCT00583362|527657818|FG000|Overall Study|Lost to Follow-up|4|||
146312458|NCT00583362|527657818|FG000|Overall Study|Non-compliance with study drug|28|||
146312459|NCT00583362|527657818|FG000|Overall Study|Pregnancy|7|||
146312460|NCT00583362|527657818|FG000|Overall Study|Miscommunication of visit window|5|||
146312461|NCT00583362|527657818|FG000|Overall Study|Current site closed|7|||
146312462|NCT00583362|527657818|FG000|Overall Study|Subject not dosed in LBSL99|1|||
146312463|NCT00583362|527657818|FG000|Overall Study|Subject moved out of the country/state|2|||
146312464|NCT00583362|527657818|FG000|Overall Study|Missed visits due to staff changes|1|||
146312465|NCT00583362|527657818|FG000|Overall Study|Misunderstanding of protocol|1|||
146312466|NCT00583362|527657818|FG000|Overall Study|Behavioral problems and non-compliance|1|||
146312467|NCT00583362|527657818|FG000|Overall Study|Sponsor request due to missed doses|1|||
146312468|NCT00583362|527657818|FG000|Overall Study|Physician Decision|19|||
146312469|NCT00583362|527657818|FG000|Overall Study|Protocol Violation|2|||
146312470|NCT00583362|527657818|FG000|Overall Study|Withdrawal by Subject|57|||
146312471|NCT01136655|527657823|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
146312472|NCT01136655|527657823|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
146312473|NCT01136655|527657823|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
146312474|NCT01136655|527657823|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
146312475|NCT02873936|527657826|FG000|Overall Study|Withdrew Consent|4|||
146312476|NCT02873936|527657827|FG001|Overall Study|Withdrew Consent|11|||
146312477|NCT02873936|527657828|FG002|Overall Study|Withdrew Consent|20|||
146312478|NCT02873936|527657826|FG000|Overall Study|Investigator's Discretion|3|||
146312479|NCT02873936|527657827|FG001|Overall Study|Investigator's Discretion|5|||
146312480|NCT02873936|527657828|FG002|Overall Study|Investigator's Discretion|4|||
146159193|NCT02119260|527094477|FG000|Overall Study|Adverse Event|1|||
146159194|NCT02119260|527094478|FG001|Overall Study|Adverse Event|0|||
146312481|NCT02873936|527657826|FG000|Overall Study|Adverse Event|3|||
146312482|NCT02873936|527657827|FG001|Overall Study|Adverse Event|5|||
146312483|NCT02873936|527657828|FG002|Overall Study|Adverse Event|3|||
146312484|NCT02873936|527657826|FG000|Overall Study|Protocol Violation|0|||
146312485|NCT02873936|527657827|FG001|Overall Study|Protocol Violation|1|||
146312486|NCT02873936|527657828|FG002|Overall Study|Protocol Violation|3|||
146312487|NCT02873936|527657826|FG000|Overall Study|Lost to Follow-up|1|||
146312488|NCT02873936|527657827|FG001|Overall Study|Lost to Follow-up|1|||
146312489|NCT02873936|527657828|FG002|Overall Study|Lost to Follow-up|1|||
146312490|NCT02873936|527657826|FG000|Overall Study|Non-compliance With Study Drug|1|||
146312491|NCT02873936|527657827|FG001|Overall Study|Non-compliance With Study Drug|0|||
146312492|NCT02873936|527657828|FG002|Overall Study|Non-compliance With Study Drug|1|||
146312493|NCT02873936|527657826|FG000|Overall Study|Randomized but not Dosed|1|||
146312494|NCT02873936|527657827|FG001|Overall Study|Randomized but not Dosed|0|||
146312495|NCT02873936|527657828|FG002|Overall Study|Randomized but not Dosed|0|||
146312496|NCT01015768|527657829|FG000|Overall Study|Some subject data unuseable|4|||
146312497|NCT01015768|527657830|FG001|Overall Study|Some subject data unuseable|4|||
146312498|NCT01225731|527657831|FG000|Part 1|Did not meet eligibility criteria|1|||
146312499|NCT01225731|527657832|FG001|Part 1|Did not meet eligibility criteria|0|||
146312500|NCT01225731|527657833|FG002|Part 1|Did not meet eligibility criteria|0|||
146312501|NCT01225731|527657834|FG003|Part 1|Did not meet eligibility criteria|0|||
146312502|NCT01225731|527657835|FG004|Part 1|Did not meet eligibility criteria|1|||
146312503|NCT01225731|527657836|FG005|Part 1|Did not meet eligibility criteria|0|||
146312504|NCT01225731|527657837|FG006|Part 1|Did not meet eligibility criteria|0|||
146312505|NCT01225731|527657838|FG007|Part 1|Did not meet eligibility criteria|0|||
146312506|NCT01225731|527657839|FG008|Part 1|Did not meet eligibility criteria|0|||
146312507|NCT01225731|527657840|FG009|Part 1|Did not meet eligibility criteria|0|||
146312508|NCT01225731|527657841|FG010|Part 1|Did not meet eligibility criteria|0|||
146312509|NCT01225731|527657842|FG011|Part 1|Did not meet eligibility criteria|0|||
146312510|NCT01225731|527657843|FG012|Part 1|Did not meet eligibility criteria|0|||
146312511|NCT01225731|527657831|FG000|Part 1|Adverse Event|1|||
146312512|NCT01225731|527657832|FG001|Part 1|Adverse Event|2|||
146312513|NCT01225731|527657833|FG002|Part 1|Adverse Event|1|||
146312514|NCT01225731|527657834|FG003|Part 1|Adverse Event|1|||
146312515|NCT01225731|527657835|FG004|Part 1|Adverse Event|1|||
146312516|NCT01225731|527657836|FG005|Part 1|Adverse Event|0|||
146312517|NCT01225731|527657837|FG006|Part 1|Adverse Event|0|||
146312518|NCT01225731|527657838|FG007|Part 1|Adverse Event|0|||
146312519|NCT01225731|527657839|FG008|Part 1|Adverse Event|0|||
146312520|NCT01225731|527657840|FG009|Part 1|Adverse Event|0|||
146312521|NCT01225731|527657841|FG010|Part 1|Adverse Event|0|||
146312522|NCT01225731|527657842|FG011|Part 1|Adverse Event|0|||
146312523|NCT01225731|527657843|FG012|Part 1|Adverse Event|0|||
146312524|NCT01225731|527657831|FG000|Part 1|Withdrawal by Subject|0|||
146312525|NCT01225731|527657832|FG001|Part 1|Withdrawal by Subject|3|||
146312526|NCT01225731|527657833|FG002|Part 1|Withdrawal by Subject|0|||
146280797|NCT03809429|527542915|FG001|Overall Study|Withdrawal by Subject|3|||
146280798|NCT03809429|527542914|FG000|Overall Study|Adverse Event|6|||
146280799|NCT03809429|527542915|FG001|Overall Study|Adverse Event|9|||
146280800|NCT03809429|527542914|FG000|Overall Study|COVID-19|3|||
146280801|NCT03809429|527542915|FG001|Overall Study|COVID-19|1|||
146280802|NCT03809429|527542914|FG000|Overall Study|Participant was discontinued by investigator|12|||
146280803|NCT03809429|527542915|FG001|Overall Study|Participant was discontinued by investigator|7|||
146280804|NCT00901186|527542916|FG000|Overall Study|Lack of Efficacy|0|||
146280805|NCT00901186|527542917|FG001|Overall Study|Lack of Efficacy|1|||
146280806|NCT00901186|527542916|FG000|Overall Study|Abnormal laboratory values|0|||
146280807|NCT00901186|527542917|FG001|Overall Study|Abnormal laboratory values|1|||
146280808|NCT00901186|527542916|FG000|Overall Study|Lost to Follow-up|2|||
146280809|NCT00901186|527542917|FG001|Overall Study|Lost to Follow-up|0|||
146280810|NCT00901186|527542916|FG000|Overall Study|Adverse Event|2|||
146280811|NCT00901186|527542917|FG001|Overall Study|Adverse Event|4|||
146280812|NCT00901186|527542916|FG000|Overall Study|Administration problems|0|||
146280813|NCT00901186|527542917|FG001|Overall Study|Administration problems|1|||
146280814|NCT00901186|527542916|FG000|Overall Study|Protocol deviations|5|||
146280815|NCT00901186|527542917|FG001|Overall Study|Protocol deviations|4|||
146280816|NCT00424385|527542923|FG000|Cohort 0|Withdrawal by Subject|5|||
146280817|NCT00424385|527542923|FG000|Cohort 0|Physician Decision|1|||
146280818|NCT00424385|527542923|FG000|Cohort 1|Withdrawal by Subject|1|||
146280819|NCT02535091|527542928|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
146280820|NCT02535091|527542929|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
146280821|NCT02535091|527542930|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
146280822|NCT02535091|527542928|FG000|Overall Study|Withdrawal by Subject|14|||
146280823|NCT02535091|527542929|FG001|Overall Study|Withdrawal by Subject|5|||
146280824|NCT02535091|527542930|FG002|Overall Study|Withdrawal by Subject|121|||
146280825|NCT02535091|527542928|FG000|Overall Study|Adverse Event|9|||
146312527|NCT01225731|527657834|FG003|Part 1|Withdrawal by Subject|0|||
146312528|NCT01225731|527657835|FG004|Part 1|Withdrawal by Subject|4|||
146312529|NCT01225731|527657836|FG005|Part 1|Withdrawal by Subject|0|||
146312530|NCT01225731|527657837|FG006|Part 1|Withdrawal by Subject|0|||
146312531|NCT01225731|527657838|FG007|Part 1|Withdrawal by Subject|0|||
146312532|NCT01225731|527657839|FG008|Part 1|Withdrawal by Subject|0|||
146312533|NCT01225731|527657840|FG009|Part 1|Withdrawal by Subject|0|||
146312534|NCT01225731|527657841|FG010|Part 1|Withdrawal by Subject|0|||
146312535|NCT01225731|527657842|FG011|Part 1|Withdrawal by Subject|0|||
146312536|NCT01225731|527657843|FG012|Part 1|Withdrawal by Subject|0|||
146312537|NCT01225731|527657831|FG000|Part 1|Protocol Violation|0|||
146312538|NCT01225731|527657832|FG001|Part 1|Protocol Violation|0|||
146312539|NCT01225731|527657833|FG002|Part 1|Protocol Violation|0|||
146312540|NCT01225731|527657834|FG003|Part 1|Protocol Violation|1|||
146312541|NCT01225731|527657835|FG004|Part 1|Protocol Violation|0|||
146312542|NCT01225731|527657836|FG005|Part 1|Protocol Violation|0|||
146312543|NCT01225731|527657837|FG006|Part 1|Protocol Violation|0|||
146312544|NCT01225731|527657838|FG007|Part 1|Protocol Violation|0|||
146312545|NCT01225731|527657839|FG008|Part 1|Protocol Violation|0|||
146312546|NCT01225731|527657840|FG009|Part 1|Protocol Violation|0|||
146312547|NCT01225731|527657841|FG010|Part 1|Protocol Violation|0|||
146312548|NCT01225731|527657842|FG011|Part 1|Protocol Violation|0|||
146312549|NCT01225731|527657843|FG012|Part 1|Protocol Violation|0|||
146312550|NCT01225731|527657831|FG000|Part 2|Protocol Violation|0|||
146312551|NCT01225731|527657832|FG001|Part 2|Protocol Violation|0|||
146312552|NCT01225731|527657833|FG002|Part 2|Protocol Violation|0|||
146312553|NCT01225731|527657834|FG003|Part 2|Protocol Violation|0|||
146312554|NCT01225731|527657835|FG004|Part 2|Protocol Violation|0|||
146312555|NCT01225731|527657836|FG005|Part 2|Protocol Violation|1|||
146312556|NCT01225731|527657837|FG006|Part 2|Protocol Violation|0|||
146312557|NCT01225731|527657838|FG007|Part 2|Protocol Violation|0|||
146312558|NCT01225731|527657839|FG008|Part 2|Protocol Violation|1|||
146312559|NCT01225731|527657840|FG009|Part 2|Protocol Violation|0|||
146312560|NCT01225731|527657841|FG010|Part 2|Protocol Violation|0|||
146312561|NCT01225731|527657842|FG011|Part 2|Protocol Violation|0|||
146312562|NCT01225731|527657843|FG012|Part 2|Protocol Violation|0|||
146312563|NCT01225731|527657831|FG000|Part 2|Adverse Event|0|||
146312564|NCT01225731|527657832|FG001|Part 2|Adverse Event|0|||
146312565|NCT01225731|527657833|FG002|Part 2|Adverse Event|0|||
146312566|NCT01225731|527657834|FG003|Part 2|Adverse Event|0|||
146312567|NCT01225731|527657835|FG004|Part 2|Adverse Event|0|||
146312568|NCT01225731|527657836|FG005|Part 2|Adverse Event|0|||
146312569|NCT01225731|527657837|FG006|Part 2|Adverse Event|4|||
146312570|NCT01225731|527657838|FG007|Part 2|Adverse Event|4|||
146312571|NCT01225731|527657839|FG008|Part 2|Adverse Event|2|||
146312572|NCT01225731|527657840|FG009|Part 2|Adverse Event|0|||
146312573|NCT01225731|527657841|FG010|Part 2|Adverse Event|0|||
146312574|NCT01225731|527657842|FG011|Part 2|Adverse Event|0|||
146312575|NCT01225731|527657843|FG012|Part 2|Adverse Event|0|||
146312576|NCT01225731|527657831|FG000|Part 2|Lack of Efficacy|0|||
146312577|NCT01225731|527657832|FG001|Part 2|Lack of Efficacy|0|||
146312578|NCT01225731|527657833|FG002|Part 2|Lack of Efficacy|0|||
146312579|NCT01225731|527657834|FG003|Part 2|Lack of Efficacy|0|||
146312580|NCT01225731|527657835|FG004|Part 2|Lack of Efficacy|0|||
146312581|NCT01225731|527657836|FG005|Part 2|Lack of Efficacy|1|||
146312582|NCT01225731|527657837|FG006|Part 2|Lack of Efficacy|0|||
146312583|NCT01225731|527657838|FG007|Part 2|Lack of Efficacy|12|||
146312584|NCT01225731|527657839|FG008|Part 2|Lack of Efficacy|3|||
146312585|NCT01225731|527657840|FG009|Part 2|Lack of Efficacy|0|||
146312586|NCT01225731|527657841|FG010|Part 2|Lack of Efficacy|0|||
146312587|NCT01225731|527657842|FG011|Part 2|Lack of Efficacy|0|||
146312588|NCT01225731|527657843|FG012|Part 2|Lack of Efficacy|0|||
146312589|NCT01225731|527657831|FG000|Part 2|Pregnancy|0|||
146312590|NCT01225731|527657832|FG001|Part 2|Pregnancy|0|||
146312591|NCT01225731|527657833|FG002|Part 2|Pregnancy|0|||
146312592|NCT01225731|527657834|FG003|Part 2|Pregnancy|0|||
146312593|NCT01225731|527657835|FG004|Part 2|Pregnancy|0|||
146312594|NCT01225731|527657836|FG005|Part 2|Pregnancy|0|||
146312595|NCT01225731|527657837|FG006|Part 2|Pregnancy|1|||
146312596|NCT01225731|527657838|FG007|Part 2|Pregnancy|0|||
146312597|NCT01225731|527657839|FG008|Part 2|Pregnancy|1|||
146312598|NCT01225731|527657840|FG009|Part 2|Pregnancy|0|||
146159195|NCT02119260|527094479|FG002|Overall Study|Adverse Event|0|||
146159196|NCT02119260|527094480|FG003|Overall Study|Adverse Event|0|||
146159197|NCT02119260|527094481|FG004|Overall Study|Adverse Event|0|||
146159198|NCT02119260|527094482|FG005|Overall Study|Adverse Event|0|||
146159199|NCT02119260|527094483|FG006|Overall Study|Adverse Event|0|||
146159200|NCT02119260|527094477|FG000|Overall Study|Withdrew consent|0|||
146159201|NCT02119260|527094478|FG001|Overall Study|Withdrew consent|1|||
146312599|NCT01225731|527657841|FG010|Part 2|Pregnancy|0|||
146312600|NCT01225731|527657842|FG011|Part 2|Pregnancy|0|||
146312601|NCT01225731|527657843|FG012|Part 2|Pregnancy|0|||
146312602|NCT01225731|527657831|FG000|Part 2|Lost to Follow-up|0|||
146312603|NCT01225731|527657832|FG001|Part 2|Lost to Follow-up|0|||
146312604|NCT01225731|527657833|FG002|Part 2|Lost to Follow-up|0|||
146312605|NCT01225731|527657834|FG003|Part 2|Lost to Follow-up|0|||
146312606|NCT01225731|527657835|FG004|Part 2|Lost to Follow-up|0|||
146312607|NCT01225731|527657836|FG005|Part 2|Lost to Follow-up|0|||
146312608|NCT01225731|527657837|FG006|Part 2|Lost to Follow-up|0|||
146312609|NCT01225731|527657838|FG007|Part 2|Lost to Follow-up|3|||
146312610|NCT01225731|527657839|FG008|Part 2|Lost to Follow-up|1|||
146312611|NCT01225731|527657840|FG009|Part 2|Lost to Follow-up|0|||
146312612|NCT01225731|527657841|FG010|Part 2|Lost to Follow-up|0|||
146312613|NCT01225731|527657842|FG011|Part 2|Lost to Follow-up|0|||
146312614|NCT01225731|527657843|FG012|Part 2|Lost to Follow-up|0|||
146312615|NCT01225731|527657831|FG000|Part 2|Physician Decision|0|||
146312616|NCT01225731|527657832|FG001|Part 2|Physician Decision|0|||
146312617|NCT01225731|527657833|FG002|Part 2|Physician Decision|0|||
146312618|NCT01225731|527657834|FG003|Part 2|Physician Decision|0|||
146312619|NCT01225731|527657835|FG004|Part 2|Physician Decision|0|||
146312620|NCT01225731|527657836|FG005|Part 2|Physician Decision|0|||
146312621|NCT01225731|527657837|FG006|Part 2|Physician Decision|0|||
146312622|NCT01225731|527657838|FG007|Part 2|Physician Decision|2|||
146312623|NCT01225731|527657839|FG008|Part 2|Physician Decision|2|||
146312624|NCT01225731|527657840|FG009|Part 2|Physician Decision|0|||
146312625|NCT01225731|527657841|FG010|Part 2|Physician Decision|0|||
146312626|NCT01225731|527657842|FG011|Part 2|Physician Decision|0|||
146312627|NCT01225731|527657843|FG012|Part 2|Physician Decision|0|||
146312628|NCT01225731|527657831|FG000|Part 2|Withdrawal by Subject|0|||
146312629|NCT01225731|527657832|FG001|Part 2|Withdrawal by Subject|0|||
146312630|NCT01225731|527657833|FG002|Part 2|Withdrawal by Subject|0|||
146312631|NCT01225731|527657834|FG003|Part 2|Withdrawal by Subject|0|||
146312632|NCT01225731|527657835|FG004|Part 2|Withdrawal by Subject|0|||
146312633|NCT01225731|527657836|FG005|Part 2|Withdrawal by Subject|1|||
146312634|NCT01225731|527657837|FG006|Part 2|Withdrawal by Subject|3|||
146312635|NCT01225731|527657838|FG007|Part 2|Withdrawal by Subject|4|||
146312636|NCT01225731|527657839|FG008|Part 2|Withdrawal by Subject|1|||
146312637|NCT01225731|527657840|FG009|Part 2|Withdrawal by Subject|0|||
146312638|NCT01225731|527657841|FG010|Part 2|Withdrawal by Subject|0|||
146312639|NCT01225731|527657842|FG011|Part 2|Withdrawal by Subject|0|||
146312640|NCT01225731|527657843|FG012|Part 2|Withdrawal by Subject|0|||
146312641|NCT01225731|527657831|FG000|Part 3|Adverse Event|0|||
146312642|NCT01225731|527657832|FG001|Part 3|Adverse Event|0|||
146312643|NCT01225731|527657833|FG002|Part 3|Adverse Event|0|||
146312644|NCT01225731|527657834|FG003|Part 3|Adverse Event|0|||
146312645|NCT01225731|527657835|FG004|Part 3|Adverse Event|0|||
146312646|NCT01225731|527657836|FG005|Part 3|Adverse Event|0|||
146312647|NCT01225731|527657837|FG006|Part 3|Adverse Event|0|||
146312648|NCT01225731|527657838|FG007|Part 3|Adverse Event|0|||
146312649|NCT01225731|527657839|FG008|Part 3|Adverse Event|0|||
146312650|NCT01225731|527657840|FG009|Part 3|Adverse Event|0|||
146312651|NCT01225731|527657841|FG010|Part 3|Adverse Event|1|||
146312652|NCT01225731|527657842|FG011|Part 3|Adverse Event|1|||
146312653|NCT01225731|527657843|FG012|Part 3|Adverse Event|0|||
146312654|NCT01225731|527657831|FG000|Part 3|Lost to Follow-up|0|||
146312655|NCT01225731|527657832|FG001|Part 3|Lost to Follow-up|0|||
146312656|NCT01225731|527657833|FG002|Part 3|Lost to Follow-up|0|||
146312657|NCT01225731|527657834|FG003|Part 3|Lost to Follow-up|0|||
146312658|NCT01225731|527657835|FG004|Part 3|Lost to Follow-up|0|||
146312659|NCT01225731|527657836|FG005|Part 3|Lost to Follow-up|0|||
146312660|NCT01225731|527657837|FG006|Part 3|Lost to Follow-up|0|||
146312661|NCT01225731|527657838|FG007|Part 3|Lost to Follow-up|0|||
146312662|NCT01225731|527657839|FG008|Part 3|Lost to Follow-up|0|||
146312663|NCT01225731|527657840|FG009|Part 3|Lost to Follow-up|0|||
146312664|NCT01225731|527657841|FG010|Part 3|Lost to Follow-up|1|||
146312665|NCT01225731|527657842|FG011|Part 3|Lost to Follow-up|2|||
146312666|NCT01225731|527657843|FG012|Part 3|Lost to Follow-up|1|||
146312667|NCT01225731|527657831|FG000|Part 3|Physician Decision|0|||
146312668|NCT01225731|527657832|FG001|Part 3|Physician Decision|0|||
146312669|NCT01225731|527657833|FG002|Part 3|Physician Decision|0|||
146312670|NCT01225731|527657834|FG003|Part 3|Physician Decision|0|||
146312671|NCT01225731|527657835|FG004|Part 3|Physician Decision|0|||
146312672|NCT01225731|527657836|FG005|Part 3|Physician Decision|0|||
146312673|NCT01225731|527657837|FG006|Part 3|Physician Decision|0|||
146312674|NCT01225731|527657838|FG007|Part 3|Physician Decision|0|||
146312675|NCT01225731|527657839|FG008|Part 3|Physician Decision|0|||
146312676|NCT01225731|527657840|FG009|Part 3|Physician Decision|0|||
146312677|NCT01225731|527657841|FG010|Part 3|Physician Decision|0|||
146312678|NCT01225731|527657842|FG011|Part 3|Physician Decision|1|||
146312679|NCT01225731|527657843|FG012|Part 3|Physician Decision|2|||
146312680|NCT01225731|527657831|FG000|Part 3|Withdrawal by Subject|0|||
146312681|NCT01225731|527657832|FG001|Part 3|Withdrawal by Subject|0|||
146312682|NCT01225731|527657833|FG002|Part 3|Withdrawal by Subject|0|||
146312683|NCT01225731|527657834|FG003|Part 3|Withdrawal by Subject|0|||
146312684|NCT01225731|527657835|FG004|Part 3|Withdrawal by Subject|0|||
146312685|NCT01225731|527657836|FG005|Part 3|Withdrawal by Subject|0|||
146312686|NCT01225731|527657837|FG006|Part 3|Withdrawal by Subject|0|||
146312687|NCT01225731|527657838|FG007|Part 3|Withdrawal by Subject|0|||
146312688|NCT01225731|527657839|FG008|Part 3|Withdrawal by Subject|0|||
146312689|NCT01225731|527657840|FG009|Part 3|Withdrawal by Subject|0|||
146312690|NCT01225731|527657841|FG010|Part 3|Withdrawal by Subject|4|||
146312691|NCT01225731|527657842|FG011|Part 3|Withdrawal by Subject|6|||
146312692|NCT01225731|527657843|FG012|Part 3|Withdrawal by Subject|4|||
146312693|NCT00577642|527657844|FG000|Overall Study|Clinical Disease Progression|1|||
146312694|NCT04770389|527657845|FG000|Overall Study|Adverse Event|1|||
146312695|NCT04770389|527657846|FG001|Overall Study|Adverse Event|2|||
146312696|NCT04770389|527657847|FG002|Overall Study|Adverse Event|0|||
146312697|NCT04770389|527657848|FG003|Overall Study|Adverse Event|1|||
146312698|NCT04770389|527657845|FG000|Overall Study|Withdrawal by Subject|0|||
146312699|NCT04770389|527657846|FG001|Overall Study|Withdrawal by Subject|2|||
146312700|NCT04770389|527657847|FG002|Overall Study|Withdrawal by Subject|1|||
146312701|NCT04770389|527657848|FG003|Overall Study|Withdrawal by Subject|0|||
146312702|NCT04770389|527657845|FG000|Overall Study|Failed attempt to draw blood|1|||
146312703|NCT04770389|527657846|FG001|Overall Study|Failed attempt to draw blood|0|||
146312704|NCT04770389|527657847|FG002|Overall Study|Failed attempt to draw blood|0|||
146312705|NCT04770389|527657848|FG003|Overall Study|Failed attempt to draw blood|0|||
146312706|NCT04770389|527657845|FG000|Overall Study|Left the country|0|||
146312707|NCT04770389|527657846|FG001|Overall Study|Left the country|0|||
146312708|NCT04770389|527657847|FG002|Overall Study|Left the country|1|||
146312709|NCT04770389|527657848|FG003|Overall Study|Left the country|2|||
146312710|NCT04770389|527657845|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
146312711|NCT04770389|527657846|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
146312712|NCT04770389|527657847|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
146312713|NCT04770389|527657848|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
146312714|NCT04770389|527657845|FG000|Overall Study|Lost to Follow-up|0|||
146312715|NCT04770389|527657846|FG001|Overall Study|Lost to Follow-up|0|||
146312716|NCT04770389|527657847|FG002|Overall Study|Lost to Follow-up|0|||
146312717|NCT04770389|527657848|FG003|Overall Study|Lost to Follow-up|1|||
146312718|NCT04770389|527657845|FG000|Overall Study|Moved away from study site|0|||
146312719|NCT04770389|527657846|FG001|Overall Study|Moved away from study site|1|||
146312720|NCT04770389|527657847|FG002|Overall Study|Moved away from study site|0|||
146312721|NCT04770389|527657848|FG003|Overall Study|Moved away from study site|0|||
146312722|NCT01970501|527657856|FG000|Overall Study|Discontinuation of study by sponsor|16|||
146312723|NCT01970501|527657857|FG001|Overall Study|Discontinuation of study by sponsor|14|||
146312724|NCT01970501|527657856|FG000|Overall Study|Withdrawal by Subject|6|||
146312725|NCT01970501|527657857|FG001|Overall Study|Withdrawal by Subject|7|||
146312726|NCT01970501|527657856|FG000|Overall Study|Adverse Event|2|||
146312727|NCT01970501|527657857|FG001|Overall Study|Adverse Event|4|||
146312728|NCT01970501|527657856|FG000|Overall Study|Death|1|||
146312729|NCT01970501|527657857|FG001|Overall Study|Death|3|||
146312730|NCT01970501|527657856|FG000|Overall Study|Physician Decision|2|||
146312731|NCT01970501|527657857|FG001|Overall Study|Physician Decision|0|||
146312732|NCT00794157|527657858|FG000|Overall Study|Adverse Event|4|||
146312733|NCT00794157|527657859|FG001|Overall Study|Adverse Event|1|||
146312734|NCT00794157|527657860|FG002|Overall Study|Adverse Event|8|||
146312735|NCT00794157|527657858|FG000|Overall Study|Subject withdrew consent|2|||
146312736|NCT00794157|527657859|FG001|Overall Study|Subject withdrew consent|0|||
146312737|NCT00794157|527657860|FG002|Overall Study|Subject withdrew consent|3|||
146312738|NCT00794157|527657858|FG000|Overall Study|Lost to Follow-up|2|||
146312739|NCT00794157|527657859|FG001|Overall Study|Lost to Follow-up|0|||
146312740|NCT00794157|527657860|FG002|Overall Study|Lost to Follow-up|1|||
146312741|NCT00794157|527657858|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146312742|NCT00794157|527657859|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146312743|NCT00794157|527657860|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
146312744|NCT00794157|527657858|FG000|Overall Study|Administrative problems|1|||
146312745|NCT00794157|527657859|FG001|Overall Study|Administrative problems|7|||
146312746|NCT00794157|527657860|FG002|Overall Study|Administrative problems|4|||
146312747|NCT00794157|527657858|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146312748|NCT00794157|527657859|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146312749|NCT00794157|527657860|FG002|Overall Study|Abnormal test procedure result(s)|0|||
146312750|NCT00794157|527657858|FG000|Overall Study|Protocol deviation|0|||
146312751|NCT00794157|527657859|FG001|Overall Study|Protocol deviation|1|||
146312752|NCT00794157|527657860|FG002|Overall Study|Protocol deviation|1|||
146312753|NCT01692275|527657861|FG000|Overall Study|Lost to Follow-up|57|||
146312754|NCT01692275|527657862|FG001|Overall Study|Lost to Follow-up|48|||
146312755|NCT01692275|527657861|FG000|Overall Study|Withdrawal by Subject|9|||
146312756|NCT01692275|527657862|FG001|Overall Study|Withdrawal by Subject|11|||
146312757|NCT00845650|527657863|FG000|Overall Study|Withdrawal by Subject|0|||
146312758|NCT00845650|527657864|FG001|Overall Study|Withdrawal by Subject|0|||
146312759|NCT00845650|527657865|FG002|Overall Study|Withdrawal by Subject|0|||
146312760|NCT00845650|527657866|FG003|Overall Study|Withdrawal by Subject|0|||
146312761|NCT00845650|527657867|FG004|Overall Study|Withdrawal by Subject|2|||
146312762|NCT00845650|527657868|FG005|Overall Study|Withdrawal by Subject|0|||
146312763|NCT00845650|527657863|FG000|Overall Study|Lost to Follow-up|0|||
146312764|NCT00845650|527657864|FG001|Overall Study|Lost to Follow-up|0|||
146312765|NCT00845650|527657865|FG002|Overall Study|Lost to Follow-up|3|||
146312766|NCT00845650|527657866|FG003|Overall Study|Lost to Follow-up|1|||
146312767|NCT00845650|527657867|FG004|Overall Study|Lost to Follow-up|0|||
146312768|NCT00845650|527657868|FG005|Overall Study|Lost to Follow-up|1|||
146312769|NCT00845650|527657863|FG000|Overall Study|Sponsor hold on dosing|0|||
146312770|NCT00845650|527657864|FG001|Overall Study|Sponsor hold on dosing|0|||
146312771|NCT00845650|527657865|FG002|Overall Study|Sponsor hold on dosing|0|||
146312772|NCT00845650|527657866|FG003|Overall Study|Sponsor hold on dosing|0|||
146312773|NCT00845650|527657867|FG004|Overall Study|Sponsor hold on dosing|1|||
146312774|NCT00845650|527657868|FG005|Overall Study|Sponsor hold on dosing|1|||
146312775|NCT00845650|527657863|FG000|Overall Study|Unable to access IV line|1|||
146312776|NCT00845650|527657864|FG001|Overall Study|Unable to access IV line|0|||
146312777|NCT00845650|527657865|FG002|Overall Study|Unable to access IV line|0|||
146312778|NCT00845650|527657866|FG003|Overall Study|Unable to access IV line|0|||
146312779|NCT00845650|527657867|FG004|Overall Study|Unable to access IV line|0|||
146312780|NCT00845650|527657868|FG005|Overall Study|Unable to access IV line|0|||
146312781|NCT00814892|527657869|FG000|Overall Study|Disease Progression|1|||
146312782|NCT00814892|527657869|FG000|Overall Study|Study Termination|1|||
146312783|NCT04486950|527657870|FG000|Overall Study|Lost to Follow-up|0|||
146312784|NCT04486950|527657871|FG001|Overall Study|Lost to Follow-up|0|||
146312785|NCT04486950|527657872|FG002|Overall Study|Lost to Follow-up|0|||
146312786|NCT04486950|527657873|FG003|Overall Study|Lost to Follow-up|0|||
146312787|NCT04486950|527657874|FG004|Overall Study|Lost to Follow-up|0|||
146312788|NCT04486950|527657875|FG005|Overall Study|Lost to Follow-up|1|||
146312789|NCT04486950|527657876|FG006|Overall Study|Lost to Follow-up|0|||
146312790|NCT00950664|527657877|FG000|First Intervention|Lost to Follow-up|1|||
146312791|NCT00950664|527657878|FG001|First Intervention|Lost to Follow-up|3|||
146312792|NCT00950664|527657877|FG000|First Intervention|Withdrawal by Subject|2|||
146312793|NCT00950664|527657878|FG001|First Intervention|Withdrawal by Subject|2|||
146312794|NCT02374099|527657881|FG000|Overall Study|Adverse Event|1|||
146312795|NCT02374099|527657882|FG001|Overall Study|Adverse Event|0|||
146312796|NCT02374099|527657881|FG000|Overall Study|Progressive Disease|35|||
146312797|NCT02374099|527657882|FG001|Overall Study|Progressive Disease|40|||
146312798|NCT02374099|527657881|FG000|Overall Study|Withdrawal by Subject|5|||
146312799|NCT02374099|527657882|FG001|Overall Study|Withdrawal by Subject|1|||
146312800|NCT02374099|527657881|FG000|Overall Study|Miscellaneous|2|||
146312801|NCT02374099|527657882|FG001|Overall Study|Miscellaneous|3|||
146312802|NCT02374099|527657881|FG000|Overall Study|Randomized, but not treated|2|||
146312803|NCT02374099|527657882|FG001|Overall Study|Randomized, but not treated|1|||
146312804|NCT02374099|527657881|FG000|Overall Study|Study Terminated by Sponsor|3|||
146312805|NCT02374099|527657882|FG001|Overall Study|Study Terminated by Sponsor|4|||
146312806|NCT01033825|527657883|FG000|Overall Study|Withdrawal by Subject|2|||
146312807|NCT01033825|527657884|FG001|Overall Study|Withdrawal by Subject|3|||
146312808|NCT01033825|527657885|FG002|Overall Study|Withdrawal by Subject|2|||
146312809|NCT01033825|527657886|FG003|Overall Study|Withdrawal by Subject|1|||
146312810|NCT01033825|527657887|FG004|Overall Study|Withdrawal by Subject|1|||
146312811|NCT01033825|527657888|FG005|Overall Study|Withdrawal by Subject|0|||
146312812|NCT01033825|527657889|FG006|Overall Study|Withdrawal by Subject|0|||
146312813|NCT01033825|527657883|FG000|Overall Study|Adverse Event|0|||
146312814|NCT01033825|527657884|FG001|Overall Study|Adverse Event|0|||
146312815|NCT01033825|527657885|FG002|Overall Study|Adverse Event|0|||
146312816|NCT01033825|527657886|FG003|Overall Study|Adverse Event|1|||
146312817|NCT01033825|527657887|FG004|Overall Study|Adverse Event|0|||
146312818|NCT01033825|527657888|FG005|Overall Study|Adverse Event|0|||
146312819|NCT01033825|527657889|FG006|Overall Study|Adverse Event|0|||
146312820|NCT01033825|527657883|FG000|Overall Study|Protocol Violation|1|||
146312821|NCT01033825|527657884|FG001|Overall Study|Protocol Violation|0|||
146312822|NCT01033825|527657885|FG002|Overall Study|Protocol Violation|0|||
146312823|NCT01033825|527657886|FG003|Overall Study|Protocol Violation|0|||
146312824|NCT01033825|527657887|FG004|Overall Study|Protocol Violation|0|||
146312825|NCT01033825|527657888|FG005|Overall Study|Protocol Violation|0|||
146312826|NCT01033825|527657889|FG006|Overall Study|Protocol Violation|0|||
146312827|NCT01033825|527657883|FG000|Overall Study|Other|0|||
146312828|NCT01033825|527657884|FG001|Overall Study|Other|0|||
146312829|NCT01033825|527657885|FG002|Overall Study|Other|0|||
146312830|NCT01033825|527657886|FG003|Overall Study|Other|0|||
146312831|NCT01033825|527657887|FG004|Overall Study|Other|1|||
146312832|NCT01033825|527657888|FG005|Overall Study|Other|0|||
146312833|NCT01033825|527657889|FG006|Overall Study|Other|0|||
146312834|NCT03693625|527657890|FG000|Overall Study|Adverse Event|2|||
146312835|NCT03693625|527657891|FG001|Overall Study|Adverse Event|0|||
146312836|NCT03693625|527657890|FG000|Overall Study|Study Terminated By Sponsor|20|||
146312837|NCT03693625|527657891|FG001|Overall Study|Study Terminated By Sponsor|7|||
146312838|NCT03693625|527657890|FG000|Overall Study|Withdrawal by Subject|1|||
146312839|NCT03693625|527657891|FG001|Overall Study|Withdrawal by Subject|1|||
146312840|NCT03451773|527659258|FG000|Overall Study|Death on study|1|||
146312841|NCT03451773|527659259|FG001|Overall Study|Death on study|5|||
146312842|NCT03451773|527659258|FG000|Overall Study|Death during follow-up period|0|||
146312843|NCT03451773|527659259|FG001|Overall Study|Death during follow-up period|1|||
146312844|NCT01964352|527659260|FG000|Overall Study|Adverse Event|13|||
146312845|NCT01964352|527659261|FG001|Overall Study|Adverse Event|3|||
146312846|NCT01964352|527659262|FG002|Overall Study|Adverse Event|4|||
146312847|NCT01964352|527659263|FG003|Overall Study|Adverse Event|3|||
146312848|NCT01964352|527659260|FG000|Overall Study|Lack of Efficacy|6|||
146312849|NCT01964352|527659261|FG001|Overall Study|Lack of Efficacy|0|||
146312850|NCT01964352|527659262|FG002|Overall Study|Lack of Efficacy|0|||
146312851|NCT01964352|527659263|FG003|Overall Study|Lack of Efficacy|0|||
146312852|NCT01964352|527659260|FG000|Overall Study|Protocol Violation|2|||
146159202|NCT02119260|527094479|FG002|Overall Study|Withdrew consent|1|||
146312853|NCT01964352|527659261|FG001|Overall Study|Protocol Violation|4|||
146312854|NCT01964352|527659262|FG002|Overall Study|Protocol Violation|0|||
146312855|NCT01964352|527659263|FG003|Overall Study|Protocol Violation|2|||
146312856|NCT01964352|527659260|FG000|Overall Study|Lost to Follow-up|1|||
146312857|NCT01964352|527659261|FG001|Overall Study|Lost to Follow-up|0|||
146312858|NCT01964352|527659262|FG002|Overall Study|Lost to Follow-up|0|||
146312859|NCT01964352|527659263|FG003|Overall Study|Lost to Follow-up|1|||
146312860|NCT01964352|527659260|FG000|Overall Study|Withdrawal by Subject|4|||
146312861|NCT01964352|527659261|FG001|Overall Study|Withdrawal by Subject|2|||
146312862|NCT01964352|527659262|FG002|Overall Study|Withdrawal by Subject|1|||
146312863|NCT01964352|527659263|FG003|Overall Study|Withdrawal by Subject|0|||
146312864|NCT01964352|527659260|FG000|Overall Study|Other than stated above|0|||
146312865|NCT01964352|527659261|FG001|Overall Study|Other than stated above|2|||
146312866|NCT01964352|527659262|FG002|Overall Study|Other than stated above|1|||
146312867|NCT01964352|527659263|FG003|Overall Study|Other than stated above|2|||
146312868|NCT01394939|527659264|FG000|Overall Study|Adverse Event|1|||
146312869|NCT01394939|527659265|FG001|Overall Study|Adverse Event|3|||
146312870|NCT01394939|527659266|FG002|Overall Study|Adverse Event|0|||
146312871|NCT01394939|527659267|FG003|Overall Study|Adverse Event|2|||
146312872|NCT01394939|527659264|FG000|Overall Study|Death|0|||
146312873|NCT01394939|527659265|FG001|Overall Study|Death|2|||
146312874|NCT01394939|527659266|FG002|Overall Study|Death|0|||
146312875|NCT01394939|527659267|FG003|Overall Study|Death|0|||
146312876|NCT01394939|527659264|FG000|Overall Study|Physician Decision|0|||
146312877|NCT01394939|527659265|FG001|Overall Study|Physician Decision|1|||
146312878|NCT01394939|527659266|FG002|Overall Study|Physician Decision|0|||
146312879|NCT01394939|527659267|FG003|Overall Study|Physician Decision|0|||
146312880|NCT01394939|527659264|FG000|Overall Study|Withdrawal by Subject|0|||
146312881|NCT01394939|527659265|FG001|Overall Study|Withdrawal by Subject|2|||
146312882|NCT01394939|527659266|FG002|Overall Study|Withdrawal by Subject|0|||
146312883|NCT01394939|527659267|FG003|Overall Study|Withdrawal by Subject|2|||
146312884|NCT01394939|527659264|FG000|Overall Study|Others|0|||
146312885|NCT01394939|527659265|FG001|Overall Study|Others|2|||
146312886|NCT01394939|527659266|FG002|Overall Study|Others|0|||
146312887|NCT01394939|527659267|FG003|Overall Study|Others|3|||
146312888|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
146312889|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
146312890|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146312891|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146312892|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
146312893|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
146312894|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
146312895|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146312896|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146312897|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
146312898|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
146312899|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
146312900|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146312901|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146312902|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
146312903|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
146312904|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
146312905|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146312906|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146312907|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
146312908|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
146312909|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
146312910|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146312911|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146312912|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
146312913|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
146312914|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
146312915|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146312916|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146312917|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
146312918|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
146312919|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
146312920|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146312921|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146312922|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
146312923|NCT02831673|527659268|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
146312924|NCT02831673|527659269|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
146312925|NCT02831673|527659270|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146312926|NCT02831673|527659271|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146312927|NCT02831673|527659272|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
146312928|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146312929|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146159203|NCT02119260|527094480|FG003|Overall Study|Withdrew consent|0|||
146159204|NCT02119260|527094481|FG004|Overall Study|Withdrew consent|0|||
146280826|NCT02535091|527542929|FG001|Overall Study|Adverse Event|4|||
146280827|NCT02535091|527542930|FG002|Overall Study|Adverse Event|170|||
146280828|NCT02535091|527542928|FG000|Overall Study|Other|4|||
146280829|NCT02535091|527542929|FG001|Overall Study|Other|3|||
146280830|NCT02535091|527542930|FG002|Overall Study|Other|81|||
146280831|NCT02535091|527542928|FG000|Overall Study|Lost to Follow-up|0|||
146280832|NCT02535091|527542929|FG001|Overall Study|Lost to Follow-up|1|||
146280833|NCT02535091|527542930|FG002|Overall Study|Lost to Follow-up|19|||
146280834|NCT02535091|527542928|FG000|Overall Study|Protocol Violation|0|||
146280835|NCT02535091|527542929|FG001|Overall Study|Protocol Violation|1|||
146280836|NCT02535091|527542930|FG002|Overall Study|Protocol Violation|11|||
146280837|NCT02535091|527542928|FG000|Overall Study|Pregnancy|0|||
146280838|NCT02535091|527542929|FG001|Overall Study|Pregnancy|0|||
146280839|NCT02535091|527542930|FG002|Overall Study|Pregnancy|7|||
146280840|NCT03223662|527542931|FG000|Overall Study|Physician Decision|1|||
146280841|NCT03223662|527542931|FG000|Overall Study|Study closure|1|||
146280842|NCT02643472|527542932|FG000|Overall Study|Death|2|||
146280843|NCT02643472|527542933|FG001|Overall Study|Death|5|||
146280844|NCT02643472|527542932|FG000|Overall Study|Withdrawal by Subject|3|||
146280845|NCT02643472|527542933|FG001|Overall Study|Withdrawal by Subject|2|||
146280846|NCT02643472|527542932|FG000|Overall Study|Protocol Violation|0|||
146280847|NCT02643472|527542933|FG001|Overall Study|Protocol Violation|1|||
146280848|NCT02643472|527542932|FG000|Overall Study|Lost to Follow-up|22|||
146280849|NCT02643472|527542933|FG001|Overall Study|Lost to Follow-up|26|||
146280850|NCT00291642|527542936|FG000|Overall Study|Adverse Event|1|||
146280851|NCT00291642|527542937|FG001|Overall Study|Adverse Event|0|||
146280852|NCT00291642|527542938|FG002|Overall Study|Adverse Event|1|||
146280853|NCT00291642|527542939|FG003|Overall Study|Adverse Event|0|||
146280854|NCT00291642|527542940|FG004|Overall Study|Adverse Event|1|||
146280855|NCT00291642|527542936|FG000|Overall Study|Patient missed visit|0|||
146280856|NCT00291642|527542937|FG001|Overall Study|Patient missed visit|0|||
146280857|NCT00291642|527542938|FG002|Overall Study|Patient missed visit|1|||
146280858|NCT00291642|527542939|FG003|Overall Study|Patient missed visit|0|||
146280859|NCT00291642|527542940|FG004|Overall Study|Patient missed visit|0|||
146280860|NCT00291642|527542936|FG000|Overall Study|Intake of prohibited medication|1|||
146280861|NCT00291642|527542937|FG001|Overall Study|Intake of prohibited medication|0|||
146280862|NCT00291642|527542938|FG002|Overall Study|Intake of prohibited medication|0|||
146280863|NCT00291642|527542939|FG003|Overall Study|Intake of prohibited medication|0|||
146280864|NCT00291642|527542940|FG004|Overall Study|Intake of prohibited medication|0|||
146280865|NCT00735475|527542941|FG000|Overall Study|Adverse Event|0|||
146280866|NCT00735475|527542942|FG001|Overall Study|Adverse Event|1|||
146280867|NCT00735475|527542941|FG000|Overall Study|Death|1|||
146280868|NCT00735475|527542942|FG001|Overall Study|Death|1|||
146280869|NCT00735475|527542941|FG000|Overall Study|Lost to Follow-up|3|||
146280870|NCT00735475|527542942|FG001|Overall Study|Lost to Follow-up|3|||
146280871|NCT00735475|527542941|FG000|Overall Study|Physician Decision|0|||
146280872|NCT00735475|527542942|FG001|Overall Study|Physician Decision|1|||
146280873|NCT00735475|527542941|FG000|Overall Study|Withdrawal by Subject|4|||
146280874|NCT00735475|527542942|FG001|Overall Study|Withdrawal by Subject|5|||
146280875|NCT00548262|527542945|FG000|Overall Study|Death|21|||
146280876|NCT00548262|527542945|FG000|Overall Study|Adverse Event|2|||
146280877|NCT00548262|527542945|FG000|Overall Study|Lack of Efficacy|4|||
146280878|NCT00548262|527542945|FG000|Overall Study|Lost to Follow-up|1|||
146280879|NCT00548262|527542945|FG000|Overall Study|Other|3|||
146280880|NCT00548262|527542945|FG000|Overall Study|Withdrawal by Subject|1|||
146280881|NCT01712659|527542946|FG000|Dose Escalation|Physician Decision|0|||
146280882|NCT01712659|527542947|FG001|Dose Escalation|Physician Decision|1|||
146280883|NCT01712659|527542948|FG002|Dose Escalation|Physician Decision|0|||
146280884|NCT01712659|527542949|FG003|Dose Escalation|Physician Decision|0|||
146280885|NCT01712659|527542950|FG004|Dose Escalation|Physician Decision|0|||
146280886|NCT01712659|527542946|FG000|Dose Escalation|Unable to take study drug|0|||
146280887|NCT01712659|527542947|FG001|Dose Escalation|Unable to take study drug|1|||
146280888|NCT01712659|527542948|FG002|Dose Escalation|Unable to take study drug|0|||
146280889|NCT01712659|527542949|FG003|Dose Escalation|Unable to take study drug|0|||
146280890|NCT01712659|527542950|FG004|Dose Escalation|Unable to take study drug|0|||
146280891|NCT01712659|527542946|FG000|Dose Expansion|Early disease progression|1|||
146280892|NCT01712659|527542947|FG001|Dose Expansion|Early disease progression|0|||
146280893|NCT01712659|527542948|FG002|Dose Expansion|Early disease progression|0|||
146280894|NCT01712659|527542949|FG003|Dose Expansion|Early disease progression|0|||
146280895|NCT01712659|527542950|FG004|Dose Expansion|Early disease progression|0|||
146280896|NCT01712659|527542946|FG000|Dose Expansion|Physician Decision|1|||
146280897|NCT01712659|527542947|FG001|Dose Expansion|Physician Decision|0|||
146280898|NCT01712659|527542948|FG002|Dose Expansion|Physician Decision|0|||
146280899|NCT01712659|527542949|FG003|Dose Expansion|Physician Decision|0|||
146280900|NCT01712659|527542950|FG004|Dose Expansion|Physician Decision|0|||
146280901|NCT00844532|527542955|FG000|Overall Study|Death|16|||
146280902|NCT00844532|527542955|FG000|Overall Study|Withdrawal by Subject|16|||
146159205|NCT02119260|527094482|FG005|Overall Study|Withdrew consent|0|||
146159206|NCT02119260|527094483|FG006|Overall Study|Withdrew consent|0|||
146159207|NCT00886340|527094484|FG000|Overall Study|Withdrawal by Subject|0|||
146159208|NCT00886340|527094485|FG001|Overall Study|Withdrawal by Subject|7|||
146312930|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
146312931|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
146312932|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
146312933|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146312934|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146312935|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
146312936|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
146312937|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
146312938|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146312939|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146312940|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146312941|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
146312942|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
146312943|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146312944|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146312945|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
146312946|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
146312947|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
146312948|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146312949|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146312950|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
146312951|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
146312952|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
146312953|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146312954|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146312955|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
146312956|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
146312957|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
146312958|NCT02831673|527659268|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146312959|NCT02831673|527659269|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146312960|NCT02831673|527659270|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
146312961|NCT02831673|527659271|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
146312962|NCT02831673|527659272|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
146312963|NCT02831673|527659268|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146312964|NCT02831673|527659269|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146312965|NCT02831673|527659270|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146312966|NCT02831673|527659271|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
146312967|NCT02831673|527659272|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
146312968|NCT02831673|527659268|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146312969|NCT02831673|527659269|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146312970|NCT02831673|527659270|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146312971|NCT02831673|527659271|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
146312972|NCT02831673|527659272|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
146312973|NCT02831673|527659268|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146312974|NCT02831673|527659269|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146312975|NCT02831673|527659270|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146312976|NCT02831673|527659271|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
146312977|NCT02831673|527659272|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
146312978|NCT02831673|527659268|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146312979|NCT02831673|527659269|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146312980|NCT02831673|527659270|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146312981|NCT02831673|527659271|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
146159209|NCT01549613|527094496|FG000|Overall Study|Lost to Follow-up|11|||
146312982|NCT02831673|527659272|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
146312983|NCT02831673|527659268|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146312984|NCT02831673|527659269|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146312985|NCT02831673|527659270|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146312986|NCT02831673|527659271|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
146159210|NCT01549613|527094497|FG001|Overall Study|Lost to Follow-up|11|||
146312987|NCT02831673|527659272|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
146312988|NCT00477165|527659273|FG000|Overall Study|Adverse Event|7|||
146312989|NCT00477165|527659274|FG001|Overall Study|Adverse Event|2|||
146312990|NCT00631371|527659276|FG000|Overall Study|Lost to Follow-up|24|||
146312991|NCT00631371|527659277|FG001|Overall Study|Lost to Follow-up|19|||
146312992|NCT00631371|527659276|FG000|Overall Study|Other reason|5|||
146312993|NCT00631371|527659277|FG001|Overall Study|Other reason|12|||
146312994|NCT00631371|527659276|FG000|Overall Study|subject request|38|||
146312995|NCT00631371|527659277|FG001|Overall Study|subject request|45|||
146312996|NCT00631371|527659276|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
146312997|NCT00631371|527659277|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
146312998|NCT00631371|527659276|FG000|Overall Study|Death|263|||
146312999|NCT00631371|527659277|FG001|Overall Study|Death|239|||
146313000|NCT00812214|527659280|FG000|Overall Study|Lost to Follow-up|3|||
146313001|NCT00812214|527659281|FG001|Overall Study|Lost to Follow-up|1|||
146313002|NCT01659320|527659282|FG000|Overall Study|Withdrawal by Subject|2|||
146313003|NCT01659320|527659282|FG000|Overall Study|Physician Decision|1|||
146313004|NCT01514682|527659283|FG000|Overall Study|Withdrawal by Subject|2|||
146313005|NCT01514682|527659284|FG001|Overall Study|Withdrawal by Subject|3|||
146313006|NCT01514682|527659283|FG000|Overall Study|Physician Decision|4|||
146313007|NCT01514682|527659284|FG001|Overall Study|Physician Decision|3|||
146313008|NCT00590590|527659285|FG000|Overall Study|Lack of Efficacy|1|||
146313009|NCT00590590|527659286|FG001|Overall Study|Lack of Efficacy|2|||
146313010|NCT00590590|527659287|FG002|Overall Study|Lack of Efficacy|0|||
146313011|NCT00590590|527659285|FG000|Overall Study|Adverse Event|1|||
146313012|NCT00590590|527659286|FG001|Overall Study|Adverse Event|0|||
146313013|NCT00590590|527659287|FG002|Overall Study|Adverse Event|0|||
146313014|NCT00590590|527659285|FG000|Overall Study|Protocol Violation|0|||
146313015|NCT00590590|527659286|FG001|Overall Study|Protocol Violation|0|||
146313016|NCT00590590|527659287|FG002|Overall Study|Protocol Violation|2|||
146313017|NCT00590590|527659285|FG000|Overall Study|Lost to Follow-up|4|||
146313018|NCT00590590|527659286|FG001|Overall Study|Lost to Follow-up|1|||
146313019|NCT00590590|527659287|FG002|Overall Study|Lost to Follow-up|2|||
146313020|NCT00590590|527659285|FG000|Overall Study|Withdrawal by Subject|0|||
146313021|NCT00590590|527659286|FG001|Overall Study|Withdrawal by Subject|1|||
146313022|NCT00590590|527659287|FG002|Overall Study|Withdrawal by Subject|1|||
146313023|NCT00590590|527659285|FG000|Overall Study|Did not complete due to study closure|1|||
146313024|NCT00590590|527659286|FG001|Overall Study|Did not complete due to study closure|1|||
146313025|NCT00590590|527659287|FG002|Overall Study|Did not complete due to study closure|1|||
146313026|NCT00590590|527659285|FG000|Overall Study|Did not complete study|0|||
146313027|NCT00590590|527659286|FG001|Overall Study|Did not complete study|1|||
146313028|NCT00590590|527659287|FG002|Overall Study|Did not complete study|0|||
146313029|NCT00132132|527659288|FG000|Overall Study|Lost to Follow-up|7|||
146313030|NCT00132132|527659289|FG001|Overall Study|Lost to Follow-up|2|||
146313031|NCT01870401|527659290|FG000|Overall Study|Death|48|||
146313032|NCT01870401|527659291|FG001|Overall Study|Death|24|||
146313033|NCT01870401|527659290|FG000|Overall Study|Withdrawal by Subject|39|||
146313034|NCT01870401|527659291|FG001|Overall Study|Withdrawal by Subject|26|||
146313035|NCT01870401|527659290|FG000|Overall Study|Lost to Follow-up|19|||
146313036|NCT01870401|527659291|FG001|Overall Study|Lost to Follow-up|14|||
146313037|NCT01870401|527659290|FG000|Overall Study|Other|9|||
146159211|NCT02216123|527094498|FG000|Overall Study|Lost to Follow-up|4|||
146159212|NCT02216123|527094499|FG001|Overall Study|Lost to Follow-up|2|||
146313038|NCT01870401|527659291|FG001|Overall Study|Other|7|||
146313039|NCT01870401|527659290|FG000|Overall Study|On-going in the Study|35|||
146313040|NCT01870401|527659291|FG001|Overall Study|On-going in the Study|25|||
146313041|NCT03776175|527659296|FG000|Treatment Period (42 Days)|Adverse Event|0|||
146159213|NCT02216123|527094498|FG000|Overall Study|Withdrawal by Subject|2|||
146313042|NCT03776175|527659297|FG001|Treatment Period (42 Days)|Adverse Event|1|||
146313043|NCT03776175|527659298|FG002|Treatment Period (42 Days)|Adverse Event|1|||
146313044|NCT03776175|527659299|FG003|Treatment Period (42 Days)|Adverse Event|0|||
146313045|NCT03776175|527659296|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
146313046|NCT03776175|527659297|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
146313047|NCT03776175|527659298|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
146313048|NCT03776175|527659299|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
146313049|NCT03776175|527659296|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
146313050|NCT03776175|527659297|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
146313051|NCT03776175|527659298|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
146313052|NCT03776175|527659299|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
146313053|NCT03776175|527659296|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
146313054|NCT03776175|527659297|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
146313055|NCT03776175|527659298|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
146313056|NCT03776175|527659299|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
146313057|NCT03776175|527659296|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
146313058|NCT03776175|527659297|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
146313059|NCT03776175|527659298|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
146313060|NCT03776175|527659299|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
146313061|NCT03776175|527659296|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146313062|NCT03776175|527659297|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146313063|NCT03776175|527659298|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
146313064|NCT03776175|527659299|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
146313065|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
146313066|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
146313067|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
146313068|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
146313069|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
146313070|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
146313071|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
146313072|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
146313073|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
146313074|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
146313075|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
146313076|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
146313077|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
146313078|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
146313079|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
146313080|NCT00960661|527659300|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
146313081|NCT00960661|527659301|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
146313082|NCT00960661|527659302|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
146313083|NCT00960661|527659300|FG000|Interventional Phase|Adverse Event|0|||
146313084|NCT00960661|527659301|FG001|Interventional Phase|Adverse Event|17|||
146313085|NCT00960661|527659302|FG002|Interventional Phase|Adverse Event|8|||
146313086|NCT00960661|527659300|FG000|Interventional Phase|Death|0|||
146313087|NCT00960661|527659301|FG001|Interventional Phase|Death|1|||
146313088|NCT00960661|527659302|FG002|Interventional Phase|Death|0|||
146313089|NCT00960661|527659300|FG000|Interventional Phase|Lost to Follow-up|0|||
146313090|NCT00960661|527659301|FG001|Interventional Phase|Lost to Follow-up|0|||
146313091|NCT00960661|527659302|FG002|Interventional Phase|Lost to Follow-up|2|||
146313092|NCT00960661|527659300|FG000|Interventional Phase|entry criteria not met|0|||
146313093|NCT00960661|527659301|FG001|Interventional Phase|entry criteria not met|3|||
146313094|NCT00960661|527659302|FG002|Interventional Phase|entry criteria not met|0|||
146313095|NCT00960661|527659300|FG000|Interventional Phase|Protocol Violation|0|||
146313096|NCT00960661|527659301|FG001|Interventional Phase|Protocol Violation|7|||
146313097|NCT00960661|527659302|FG002|Interventional Phase|Protocol Violation|2|||
146313098|NCT00960661|527659300|FG000|Interventional Phase|Withdrawal by Subject|0|||
146313099|NCT00960661|527659301|FG001|Interventional Phase|Withdrawal by Subject|18|||
146313100|NCT00960661|527659302|FG002|Interventional Phase|Withdrawal by Subject|29|||
146313101|NCT00960661|527659300|FG000|Interventional Phase|Physician Decision|0|||
146313102|NCT00960661|527659301|FG001|Interventional Phase|Physician Decision|3|||
146313103|NCT00960661|527659302|FG002|Interventional Phase|Physician Decision|5|||
146313104|NCT00960661|527659300|FG000|Interventional Phase|sponsor decision|0|||
146313105|NCT00960661|527659301|FG001|Interventional Phase|sponsor decision|1|||
146313106|NCT00960661|527659302|FG002|Interventional Phase|sponsor decision|0|||
146313107|NCT00960661|527659300|FG000|Interventional Phase|Lack of Efficacy|0|||
146313108|NCT00960661|527659301|FG001|Interventional Phase|Lack of Efficacy|2|||
146313109|NCT00960661|527659302|FG002|Interventional Phase|Lack of Efficacy|0|||
146313110|NCT03273166|527659303|FG000|Overall Study|Withdrawn prior to Completion|31|||
146313111|NCT00915681|527659307|FG000|Overall Study|Screening failures|46|||
146313112|NCT03221751|527659308|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
146313113|NCT03221751|527659309|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
146313114|NCT00535132|527659315|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
146313115|NCT00535132|527659316|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
146313116|NCT00535132|527659315|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
146313117|NCT00535132|527659316|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
146313118|NCT00763815|527659317|FG000|Overall Study|Adverse Event|14|||
146313119|NCT00763815|527659318|FG001|Overall Study|Adverse Event|29|||
146313120|NCT00763815|527659317|FG000|Overall Study|Lack of Efficacy|10|||
146313121|NCT00763815|527659318|FG001|Overall Study|Lack of Efficacy|11|||
146313122|NCT00763815|527659317|FG000|Overall Study|Poor Compliance to Protocol|6|||
146313123|NCT00763815|527659318|FG001|Overall Study|Poor Compliance to Protocol|6|||
146313124|NCT00763815|527659317|FG000|Overall Study|Lost to Follow-up|2|||
146313125|NCT00763815|527659318|FG001|Overall Study|Lost to Follow-up|4|||
146313126|NCT00763815|527659317|FG000|Overall Study|Early Termination|1|||
146313127|NCT00763815|527659318|FG001|Overall Study|Early Termination|0|||
146313128|NCT00763815|527659317|FG000|Overall Study|Familial and Personal Reasons|9|||
146313129|NCT00763815|527659318|FG001|Overall Study|Familial and Personal Reasons|16|||
146313130|NCT00763815|527659317|FG000|Overall Study|Physician Decision|1|||
146313131|NCT00763815|527659318|FG001|Overall Study|Physician Decision|0|||
146313132|NCT00763815|527659317|FG000|Overall Study|Withdrawal by Subject|7|||
146313133|NCT00763815|527659318|FG001|Overall Study|Withdrawal by Subject|12|||
146313134|NCT00763815|527659317|FG000|Overall Study|Protocol Violation|2|||
146313135|NCT00763815|527659318|FG001|Overall Study|Protocol Violation|5|||
146313136|NCT00763815|527659317|FG000|Overall Study|Sponsor's Decision|0|||
146313137|NCT00763815|527659318|FG001|Overall Study|Sponsor's Decision|1|||
146313138|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
146313139|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
146313140|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
146313141|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
146313142|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
146313143|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
146313144|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
146313145|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
146313146|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
146313147|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
146313148|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
146313149|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
146313150|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
146313151|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
146313152|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
146313153|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
146313154|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
146313155|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
146313156|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
146313157|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
146313158|NCT02706873|527659323|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
146313159|NCT02706873|527659324|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
146313160|NCT02706873|527659325|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
146313161|NCT02706873|527659326|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
146313162|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
146313163|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
146313164|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
146313165|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
146313166|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
146313167|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
146313168|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
146313169|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
146313170|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
146313171|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
146313172|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
146313173|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
146313174|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
146313175|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
146313176|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
146313177|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
146313178|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146313179|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146313180|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
146313181|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
146313182|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
146313183|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
146313184|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
146313185|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
146313186|NCT02706873|527659323|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
146313187|NCT02706873|527659324|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
146313188|NCT02706873|527659325|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
146313189|NCT02706873|527659326|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
146313190|NCT00618410|527659331|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
146313191|NCT00618410|527659332|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
146313192|NCT01965262|527659338|FG000|Second Intervention (7 Days)|Discontinued|0|||
146313193|NCT01965262|527659339|FG001|Second Intervention (7 Days)|Discontinued|1|||
146313194|NCT01965262|527659338|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
146313195|NCT01965262|527659339|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
146313196|NCT01965262|527659338|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
146313197|NCT01965262|527659339|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
146313198|NCT00513500|527659349|FG000|Overall Study|Lost to Follow-up|35|||
146313199|NCT00513500|527659350|FG001|Overall Study|Lost to Follow-up|39|||
146313200|NCT00513500|527659349|FG000|Overall Study|Death|2|||
146313201|NCT00513500|527659350|FG001|Overall Study|Death|1|||
146313202|NCT00513500|527659349|FG000|Overall Study|Hospitalized|4|||
146313203|NCT00513500|527659350|FG001|Overall Study|Hospitalized|14|||
146313204|NCT00749996|527659351|FG000|Overall Study|Lost to Follow-up|7|||
146313205|NCT00749996|527659352|FG001|Overall Study|Lost to Follow-up|4|||
146313206|NCT00749996|527659351|FG000|Overall Study|Withdrawal by Subject|5|||
146313207|NCT00749996|527659352|FG001|Overall Study|Withdrawal by Subject|4|||
146313208|NCT00749996|527659351|FG000|Overall Study|Protocol Violation|2|||
146313209|NCT00749996|527659352|FG001|Overall Study|Protocol Violation|3|||
146313210|NCT00749996|527659351|FG000|Overall Study|Physician Decision|2|||
146313211|NCT00749996|527659352|FG001|Overall Study|Physician Decision|0|||
146313212|NCT00749996|527659351|FG000|Overall Study|Pregnancy|0|||
146313213|NCT00749996|527659352|FG001|Overall Study|Pregnancy|2|||
146313214|NCT00749996|527659351|FG000|Overall Study|Adverse Event|1|||
146313215|NCT00749996|527659352|FG001|Overall Study|Adverse Event|0|||
146313216|NCT00749996|527659351|FG000|Overall Study|Death|1|||
146313217|NCT00749996|527659352|FG001|Overall Study|Death|0|||
146313218|NCT02199080|527659356|FG000|Overall Study|Protocol Violation|12|||
146313219|NCT02443883|527659357|FG000|Overall Study|Adverse Event|0|||
146313220|NCT02443883|527659358|FG001|Overall Study|Adverse Event|1|||
146313221|NCT02443883|527659359|FG002|Overall Study|Adverse Event|0|||
146313222|NCT02443883|527659360|FG003|Overall Study|Adverse Event|0|||
146313223|NCT02443883|527659357|FG000|Overall Study|Lost to Follow-up|3|||
146313224|NCT02443883|527659358|FG001|Overall Study|Lost to Follow-up|2|||
146313225|NCT02443883|527659359|FG002|Overall Study|Lost to Follow-up|1|||
146313226|NCT02443883|527659360|FG003|Overall Study|Lost to Follow-up|0|||
146313227|NCT02443883|527659357|FG000|Overall Study|Physician Decision|1|||
146313228|NCT02443883|527659358|FG001|Overall Study|Physician Decision|1|||
146313229|NCT02443883|527659359|FG002|Overall Study|Physician Decision|0|||
146313230|NCT02443883|527659360|FG003|Overall Study|Physician Decision|3|||
146313231|NCT02443883|527659357|FG000|Overall Study|Withdrawal by Subject|1|||
146313232|NCT02443883|527659358|FG001|Overall Study|Withdrawal by Subject|0|||
146313233|NCT02443883|527659359|FG002|Overall Study|Withdrawal by Subject|0|||
146313234|NCT02443883|527659360|FG003|Overall Study|Withdrawal by Subject|2|||
146313235|NCT02443883|527659357|FG000|Overall Study|Randomized, but never treated|1|||
146313236|NCT02443883|527659358|FG001|Overall Study|Randomized, but never treated|0|||
146313237|NCT02443883|527659359|FG002|Overall Study|Randomized, but never treated|0|||
146313238|NCT02443883|527659360|FG003|Overall Study|Randomized, but never treated|0|||
146313239|NCT02250274|527659361|FG000|Overall Study|Insufficient blood draw amount|7|||
146313240|NCT02250274|527659362|FG001|Overall Study|Insufficient blood draw amount|6|||
146313241|NCT00446511|527659365|FG000|Overall Study|Adverse Event|7|||
146313242|NCT00446511|527659366|FG001|Overall Study|Adverse Event|2|||
146313243|NCT00446511|527659367|FG002|Overall Study|Adverse Event|3|||
146313244|NCT00446511|527659368|FG003|Overall Study|Adverse Event|1|||
146313245|NCT00446511|527659365|FG000|Overall Study|Protocol Violation|0|||
146313246|NCT00446511|527659366|FG001|Overall Study|Protocol Violation|0|||
146313247|NCT00446511|527659367|FG002|Overall Study|Protocol Violation|0|||
146313248|NCT00446511|527659368|FG003|Overall Study|Protocol Violation|1|||
146313249|NCT00446511|527659365|FG000|Overall Study|Withdrawal by Subject|0|||
146313250|NCT00446511|527659366|FG001|Overall Study|Withdrawal by Subject|0|||
146313251|NCT00446511|527659367|FG002|Overall Study|Withdrawal by Subject|0|||
146313252|NCT00446511|527659368|FG003|Overall Study|Withdrawal by Subject|3|||
146313253|NCT00446511|527659365|FG000|Overall Study|Administrative Problems|3|||
146313254|NCT00446511|527659366|FG001|Overall Study|Administrative Problems|0|||
146313255|NCT00446511|527659367|FG002|Overall Study|Administrative Problems|4|||
146313256|NCT00446511|527659368|FG003|Overall Study|Administrative Problems|1|||
146313257|NCT00835237|527659371|FG000|Overall Study|Lost to Follow-up|4|||
146313258|NCT00835237|527659372|FG001|Overall Study|Lost to Follow-up|0|||
146313259|NCT00835237|527659371|FG000|Overall Study|Withdrawal by Subject|2|||
146313260|NCT00835237|527659372|FG001|Overall Study|Withdrawal by Subject|0|||
146313261|NCT01265550|527659375|FG000|Pre Randomization|Withdrawal by Subject|0|||
146313262|NCT01265550|527659376|FG001|Pre Randomization|Withdrawal by Subject|0|||
146313263|NCT01265550|527659377|FG002|Pre Randomization|Withdrawal by Subject|0|||
146313264|NCT01265550|527659378|FG003|Pre Randomization|Withdrawal by Subject|70|||
146313265|NCT01265550|527659375|FG000|Pre Randomization|Technical Exclusions|0|||
146313266|NCT01265550|527659376|FG001|Pre Randomization|Technical Exclusions|0|||
146313267|NCT01265550|527659377|FG002|Pre Randomization|Technical Exclusions|0|||
146313268|NCT01265550|527659378|FG003|Pre Randomization|Technical Exclusions|54|||
146313269|NCT01265550|527659375|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
146313270|NCT01265550|527659376|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
146313271|NCT01265550|527659377|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
146313272|NCT01265550|527659378|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
146313273|NCT01265550|527659375|FG000|Pre Randomization|Non-GERD organic disorders|0|||
146313274|NCT01265550|527659376|FG001|Pre Randomization|Non-GERD organic disorders|0|||
146313275|NCT01265550|527659377|FG002|Pre Randomization|Non-GERD organic disorders|0|||
146313276|NCT01265550|527659378|FG003|Pre Randomization|Non-GERD organic disorders|23|||
146313277|NCT01265550|527659375|FG000|Pre Randomization|Functional heartburn|0|||
146313278|NCT01265550|527659376|FG001|Pre Randomization|Functional heartburn|0|||
146313279|NCT01265550|527659377|FG002|Pre Randomization|Functional heartburn|0|||
146313280|NCT01265550|527659378|FG003|Pre Randomization|Functional heartburn|99|||
146313281|NCT01627860|527659381|FG000|Overall Study|Adverse Event|9|||
146313282|NCT01627860|527659382|FG001|Overall Study|Adverse Event|4|||
146313283|NCT01627860|527659381|FG000|Overall Study|Withdrawal by Subject|2|||
146313284|NCT01627860|527659382|FG001|Overall Study|Withdrawal by Subject|1|||
146313285|NCT01627860|527659381|FG000|Overall Study|Seizure frequency doubled|0|||
146313286|NCT01627860|527659382|FG001|Overall Study|Seizure frequency doubled|1|||
146313287|NCT01627860|527659381|FG000|Overall Study|Protocol Violation|1|||
146313288|NCT01627860|527659382|FG001|Overall Study|Protocol Violation|0|||
146313289|NCT01326546|527659383|FG000|Overall Study|Lost to Follow-up|8|||
146313290|NCT01326546|527659384|FG001|Overall Study|Lost to Follow-up|7|||
146313291|NCT01326546|527659383|FG000|Overall Study|Protocol Violation|3|||
146313292|NCT01326546|527659384|FG001|Overall Study|Protocol Violation|4|||
146313293|NCT01326546|527659383|FG000|Overall Study|Pregnancy|0|||
146313294|NCT01326546|527659384|FG001|Overall Study|Pregnancy|1|||
146313295|NCT01326546|527659383|FG000|Overall Study|Adverse Event|1|||
146313296|NCT01326546|527659384|FG001|Overall Study|Adverse Event|0|||
146313297|NCT01326546|527659383|FG000|Overall Study|Withdrawal by Subject|5|||
146313298|NCT01326546|527659384|FG001|Overall Study|Withdrawal by Subject|1|||
146313299|NCT03152019|527659385|FG000|Overall Study|Adverse Event|0|||
146313300|NCT03152019|527659386|FG001|Overall Study|Adverse Event|1|||
146313301|NCT00923130|527659391|FG000|Overall Study|Stopped treatment due to progression|17|||
146313302|NCT00923130|527659391|FG000|Overall Study|Death|1|||
146313303|NCT00923130|527659391|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
146313304|NCT00923130|527659391|FG000|Overall Study|Switched to alternative treatment|2|||
146313305|NCT00923130|527659391|FG000|Overall Study|Refused further treatment|2|||
146313306|NCT00894556|527659392|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
146313307|NCT00894556|527659393|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
146313308|NCT00894556|527659394|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
146313309|NCT00894556|527659395|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
146313310|NCT00894556|527659392|FG000|Treatment Phase|Lost to Follow-up|2|||
146313311|NCT00894556|527659393|FG001|Treatment Phase|Lost to Follow-up|3|||
146313312|NCT00894556|527659394|FG002|Treatment Phase|Lost to Follow-up|1|||
146313313|NCT00894556|527659395|FG003|Treatment Phase|Lost to Follow-up|0|||
146313314|NCT00894556|527659392|FG000|Treatment Phase|Lack of Qualifying Event|2|||
146313315|NCT00894556|527659393|FG001|Treatment Phase|Lack of Qualifying Event|1|||
146313316|NCT00894556|527659394|FG002|Treatment Phase|Lack of Qualifying Event|0|||
146313317|NCT00894556|527659395|FG003|Treatment Phase|Lack of Qualifying Event|0|||
146313318|NCT01014689|527659398|FG000|Overall Study|Lack of Efficacy|0|||
146313319|NCT01014689|527659399|FG001|Overall Study|Lack of Efficacy|1|||
146313320|NCT01014689|527659398|FG000|Overall Study|Adverse Event|3|||
146313321|NCT01014689|527659399|FG001|Overall Study|Adverse Event|0|||
146313322|NCT01014689|527659398|FG000|Overall Study|Withdrawal by Subject|5|||
146313323|NCT01014689|527659399|FG001|Overall Study|Withdrawal by Subject|4|||
146313324|NCT01014689|527659398|FG000|Overall Study|Protocol Violation|1|||
146313325|NCT01014689|527659399|FG001|Overall Study|Protocol Violation|1|||
146313326|NCT01014689|527659398|FG000|Overall Study|Lost to Follow-up|3|||
146313327|NCT01014689|527659399|FG001|Overall Study|Lost to Follow-up|7|||
146313328|NCT01014689|527659398|FG000|Overall Study|Pregnancy|1|||
146313329|NCT01014689|527659399|FG001|Overall Study|Pregnancy|0|||
146313330|NCT00333359|527659402|FG000|Overall Study|Adverse Event|29|||
146313331|NCT00333359|527659403|FG001|Overall Study|Adverse Event|35|||
146313332|NCT00333359|527659402|FG000|Overall Study|Withdrawal by Subject|19|||
146313333|NCT00333359|527659403|FG001|Overall Study|Withdrawal by Subject|37|||
146313334|NCT00333359|527659402|FG000|Overall Study|Physician Decision|2|||
146313335|NCT00333359|527659403|FG001|Overall Study|Physician Decision|2|||
146313336|NCT00333359|527659402|FG000|Overall Study|Protocol Non-compliance|2|||
146313337|NCT00333359|527659403|FG001|Overall Study|Protocol Non-compliance|8|||
146313338|NCT00333359|527659402|FG000|Overall Study|Lost to Follow-up|15|||
146313339|NCT00333359|527659403|FG001|Overall Study|Lost to Follow-up|25|||
146313340|NCT00333359|527659402|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
146313341|NCT00333359|527659403|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
146313342|NCT00333359|527659402|FG000|Overall Study|Treatment Failure|3|||
146313343|NCT00333359|527659403|FG001|Overall Study|Treatment Failure|8|||
146313344|NCT00333359|527659402|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
146313345|NCT00333359|527659403|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
146332890|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146332891|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146332892|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146159214|NCT02216123|527094499|FG001|Overall Study|Withdrawal by Subject|0|||
146332893|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
146332894|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
146159215|NCT02131272|527094500|FG000|Overall Study|Withdrawal by parent|0|||
146332895|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146332896|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146332897|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146332898|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146159216|NCT02131272|527094501|FG001|Overall Study|Withdrawal by parent|1|||
146159217|NCT02131272|527094500|FG000|Overall Study|Withdrawal by Subject|0|||
146159218|NCT02131272|527094501|FG001|Overall Study|Withdrawal by Subject|1|||
146159219|NCT02131272|527094500|FG000|Overall Study|Withdrawal Criteria|1|||
146159220|NCT02131272|527094501|FG001|Overall Study|Withdrawal Criteria|0|||
146159221|NCT00381940|527094502|FG000|Overall Study|Lack of Efficacy|3|||
146159222|NCT00381940|527094502|FG000|Overall Study|Protocol Violation|1|||
146159223|NCT00381940|527094502|FG000|Overall Study|Ineligible|1|||
146159224|NCT03162224|527094503|FG000|Overall Study|Death|4|||
146313346|NCT04311502|527660936|FG000|Overall Study|Death|1|||
146313347|NCT04311502|527660937|FG001|Overall Study|Death|1|||
146313348|NCT04311502|527660938|FG002|Overall Study|Death|1|||
146313349|NCT04311502|527660936|FG000|Overall Study|Lost to Follow-up|2|||
146313350|NCT04311502|527660937|FG001|Overall Study|Lost to Follow-up|3|||
146313351|NCT04311502|527660938|FG002|Overall Study|Lost to Follow-up|0|||
146313352|NCT04311502|527660936|FG000|Overall Study|Participant is in prison|1|||
146313353|NCT04311502|527660937|FG001|Overall Study|Participant is in prison|0|||
146313354|NCT04311502|527660938|FG002|Overall Study|Participant is in prison|0|||
146313355|NCT04311502|527660936|FG000|Overall Study|Participant moved out of country|1|||
146313356|NCT04311502|527660937|FG001|Overall Study|Participant moved out of country|0|||
146313357|NCT04311502|527660938|FG002|Overall Study|Participant moved out of country|0|||
146313358|NCT04311502|527660936|FG000|Overall Study|Withdrawal by Subject|2|||
146313359|NCT04311502|527660937|FG001|Overall Study|Withdrawal by Subject|0|||
146313360|NCT04311502|527660938|FG002|Overall Study|Withdrawal by Subject|0|||
146313361|NCT04311502|527660936|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
146313362|NCT04311502|527660937|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
146313363|NCT04311502|527660938|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
146313364|NCT03040999|527660939|FG000|Overall Study|Lost to Follow-up|2|||
146313365|NCT03040999|527660940|FG001|Overall Study|Lost to Follow-up|2|||
146313366|NCT03040999|527660939|FG000|Overall Study|Withdrawal by Subject|12|||
146313367|NCT03040999|527660940|FG001|Overall Study|Withdrawal by Subject|13|||
146313368|NCT03040999|527660939|FG000|Overall Study|Death|155|||
146313369|NCT03040999|527660940|FG001|Overall Study|Death|171|||
146313370|NCT03040999|527660939|FG000|Overall Study|Physician Decision|0|||
146313371|NCT03040999|527660940|FG001|Overall Study|Physician Decision|3|||
146313372|NCT01979523|527660941|FG000|Overall Study|Withdrawal by Subject|1|||
146159225|NCT03162224|527094504|FG001|Overall Study|Death|5|||
146159226|NCT03162224|527094505|FG002|Overall Study|Death|8|||
146313373|NCT01979523|527660942|FG001|Overall Study|Withdrawal by Subject|0|||
146313374|NCT01137773|527660943|FG000|Overall Study|Death|3|||
146313375|NCT01137773|527660944|FG001|Overall Study|Death|3|||
146313376|NCT01137773|527660943|FG000|Overall Study|Lost to Follow-up|6|||
146313377|NCT01137773|527660944|FG001|Overall Study|Lost to Follow-up|0|||
146313378|NCT03548051|527660945|FG000|Overall Study|Death|1|||
146313379|NCT03548051|527660946|FG001|Overall Study|Death|1|||
146313380|NCT03548051|527660945|FG000|Overall Study|Withdrawal by Subject|1|||
146313381|NCT03548051|527660946|FG001|Overall Study|Withdrawal by Subject|0|||
146313382|NCT00817531|527660948|FG000|Overall Study|Adverse Event|1|||
146313383|NCT00817531|527660948|FG000|Overall Study|Lack of Efficacy|1|||
146313384|NCT02239939|527660949|FG000|Overall Study|Adverse Event|1|||
146313385|NCT02239939|527660950|FG001|Overall Study|Adverse Event|0|||
146313386|NCT02239939|527660949|FG000|Overall Study|Withdrawal by Subject|1|||
146313387|NCT02239939|527660950|FG001|Overall Study|Withdrawal by Subject|1|||
146313388|NCT02239939|527660949|FG000|Overall Study|Lost to Follow-up|0|||
146313389|NCT02239939|527660950|FG001|Overall Study|Lost to Follow-up|1|||
146313390|NCT03325673|527660952|FG000|Overall Study|Adverse Event|4|||
146313391|NCT03325673|527660953|FG001|Overall Study|Adverse Event|0|||
146313392|NCT02559687|527660954|FG000|Overall Study|Death|112|||
146313393|NCT02559687|527660954|FG000|Overall Study|Sponsor Decision|5|||
146313394|NCT02559687|527660954|FG000|Overall Study|Withdrawal by Subject|4|||
146313395|NCT05630937|527660957|FG000|Overall Study|Study terminated by sponsor|1|||
146313396|NCT05630937|527660958|FG001|Overall Study|Study terminated by sponsor|1|||
146313397|NCT05630937|527660959|FG002|Overall Study|Study terminated by sponsor|8|||
146313398|NCT05630937|527660960|FG003|Overall Study|Study terminated by sponsor|0|||
146313399|NCT05630937|527660957|FG000|Overall Study|Lost to Follow-up|0|||
146313400|NCT05630937|527660958|FG001|Overall Study|Lost to Follow-up|0|||
146313401|NCT05630937|527660959|FG002|Overall Study|Lost to Follow-up|1|||
146313402|NCT05630937|527660960|FG003|Overall Study|Lost to Follow-up|0|||
146313403|NCT05630937|527660957|FG000|Overall Study|Enrolled but not treated|0|||
146313404|NCT05630937|527660958|FG001|Overall Study|Enrolled but not treated|0|||
146313405|NCT05630937|527660959|FG002|Overall Study|Enrolled but not treated|0|||
146313406|NCT05630937|527660960|FG003|Overall Study|Enrolled but not treated|1|||
146313407|NCT03245450|527660964|FG000|Overall Study|Radiological disease progression|3|||
146313408|NCT03245450|527660965|FG001|Overall Study|Radiological disease progression|3|||
146313409|NCT03245450|527660966|FG002|Overall Study|Radiological disease progression|2|||
146313410|NCT03245450|527660967|FG003|Overall Study|Radiological disease progression|2|||
146159227|NCT03162224|527094503|FG000|Overall Study|Withdrawal by Subject|1|||
146159228|NCT03162224|527094504|FG001|Overall Study|Withdrawal by Subject|0|||
146313411|NCT03245450|527660968|FG004|Overall Study|Radiological disease progression|7|||
146313412|NCT03245450|527660969|FG005|Overall Study|Radiological disease progression|6|||
146313413|NCT03245450|527660970|FG006|Overall Study|Radiological disease progression|6|||
146313414|NCT03245450|527660964|FG000|Overall Study|Clinical disease progression|0|||
146313415|NCT03245450|527660965|FG001|Overall Study|Clinical disease progression|0|||
146313416|NCT03245450|527660966|FG002|Overall Study|Clinical disease progression|1|||
146313417|NCT03245450|527660967|FG003|Overall Study|Clinical disease progression|0|||
146313418|NCT03245450|527660968|FG004|Overall Study|Clinical disease progression|0|||
146313419|NCT03245450|527660969|FG005|Overall Study|Clinical disease progression|2|||
146313420|NCT03245450|527660970|FG006|Overall Study|Clinical disease progression|0|||
146159229|NCT03162224|527094505|FG002|Overall Study|Withdrawal by Subject|1|||
146159230|NCT03162224|527094503|FG000|Overall Study|Lost to Follow-up|0|||
146159231|NCT03162224|527094504|FG001|Overall Study|Lost to Follow-up|1|||
146159232|NCT03162224|527094505|FG002|Overall Study|Lost to Follow-up|0|||
146159233|NCT03162224|527094503|FG000|Overall Study|Other|6|||
146159234|NCT03162224|527094504|FG001|Overall Study|Other|2|||
146159235|NCT03162224|527094505|FG002|Overall Study|Other|1|||
146159236|NCT05159622|527094506|FG000|Overall Study|Lost to Follow-up|4|||
146159237|NCT05159622|527094507|FG001|Overall Study|Lost to Follow-up|5|||
146159238|NCT00725452|527094509|FG000|Overall Study|Adverse Event|3|||
146159239|NCT00725452|527094509|FG000|Overall Study|Lack of Efficacy|2|||
146159240|NCT00725452|527094509|FG000|Overall Study|Reason not specified|1|||
146159241|NCT00725452|527094509|FG000|Overall Study|Physician Decision|1|||
146159242|NCT00725452|527094509|FG000|Overall Study|Withdrawal by Subject|3|||
146159243|NCT00725452|527094509|FG000|Overall Study|Lost to Follow-up|1|||
146159244|NCT02163733|527094510|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
146159245|NCT02163733|527094511|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
146159246|NCT02163733|527094512|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
146159247|NCT02163733|527094510|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
146159248|NCT02163733|527094511|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
146159249|NCT02163733|527094512|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
146159250|NCT02723864|527094513|FG000|Overall Study|Refused further treatment|1|||
146159251|NCT02723864|527094514|FG001|Overall Study|Refused further treatment|0|||
146159252|NCT02723864|527094515|FG002|Overall Study|Refused further treatment|0|||
146159253|NCT02723864|527094516|FG003|Overall Study|Refused further treatment|0|||
146159254|NCT02723864|527094517|FG004|Overall Study|Refused further treatment|1|||
146159255|NCT02723864|527094518|FG005|Overall Study|Refused further treatment|2|||
146159256|NCT02723864|527094519|FG006|Overall Study|Refused further treatment|0|||
146159257|NCT02723864|527094513|FG000|Overall Study|Exceed treatment hold time|0|||
146159258|NCT02723864|527094514|FG001|Overall Study|Exceed treatment hold time|1|||
146159259|NCT02723864|527094515|FG002|Overall Study|Exceed treatment hold time|0|||
146159260|NCT02723864|527094516|FG003|Overall Study|Exceed treatment hold time|0|||
146159261|NCT02723864|527094517|FG004|Overall Study|Exceed treatment hold time|0|||
146159262|NCT02723864|527094518|FG005|Overall Study|Exceed treatment hold time|0|||
146159263|NCT02723864|527094519|FG006|Overall Study|Exceed treatment hold time|0|||
146159264|NCT02723864|527094513|FG000|Overall Study|Clinical progression|0|||
146159265|NCT02723864|527094514|FG001|Overall Study|Clinical progression|0|||
146159266|NCT02723864|527094515|FG002|Overall Study|Clinical progression|1|||
146159267|NCT02723864|527094516|FG003|Overall Study|Clinical progression|0|||
146159268|NCT02723864|527094517|FG004|Overall Study|Clinical progression|0|||
146159269|NCT02723864|527094518|FG005|Overall Study|Clinical progression|3|||
146159270|NCT02723864|527094519|FG006|Overall Study|Clinical progression|1|||
146159271|NCT02723864|527094513|FG000|Overall Study|Physician Decision|0|||
146159272|NCT02723864|527094514|FG001|Overall Study|Physician Decision|0|||
146159273|NCT02723864|527094515|FG002|Overall Study|Physician Decision|0|||
146159274|NCT02723864|527094516|FG003|Overall Study|Physician Decision|0|||
146159275|NCT02723864|527094517|FG004|Overall Study|Physician Decision|0|||
146313421|NCT03245450|527660964|FG000|Overall Study|Other|0|||
146313422|NCT03245450|527660965|FG001|Overall Study|Other|0|||
146313423|NCT03245450|527660966|FG002|Overall Study|Other|0|||
146313424|NCT03245450|527660967|FG003|Overall Study|Other|1|||
146313425|NCT03245450|527660968|FG004|Overall Study|Other|1|||
146159276|NCT02723864|527094518|FG005|Overall Study|Physician Decision|0|||
146159277|NCT02723864|527094519|FG006|Overall Study|Physician Decision|1|||
146159278|NCT02723864|527094513|FG000|Overall Study|Changes in patient condition|0|||
146159279|NCT02723864|527094514|FG001|Overall Study|Changes in patient condition|0|||
146159280|NCT02723864|527094515|FG002|Overall Study|Changes in patient condition|0|||
146159281|NCT02723864|527094516|FG003|Overall Study|Changes in patient condition|0|||
146313426|NCT03245450|527660969|FG005|Overall Study|Other|1|||
146313427|NCT03245450|527660970|FG006|Overall Study|Other|1|||
146159282|NCT02723864|527094517|FG004|Overall Study|Changes in patient condition|0|||
146159283|NCT02723864|527094518|FG005|Overall Study|Changes in patient condition|1|||
146159284|NCT02723864|527094519|FG006|Overall Study|Changes in patient condition|0|||
146159285|NCT02723864|527094513|FG000|Overall Study|Patient choice|0|||
146313428|NCT03245450|527660964|FG000|Overall Study|Withdrawal by Subject|0|||
146313429|NCT03245450|527660965|FG001|Overall Study|Withdrawal by Subject|1|||
146313430|NCT03245450|527660966|FG002|Overall Study|Withdrawal by Subject|0|||
146313431|NCT03245450|527660967|FG003|Overall Study|Withdrawal by Subject|0|||
146313432|NCT03245450|527660968|FG004|Overall Study|Withdrawal by Subject|0|||
146313433|NCT03245450|527660969|FG005|Overall Study|Withdrawal by Subject|0|||
146313434|NCT03245450|527660970|FG006|Overall Study|Withdrawal by Subject|0|||
146313435|NCT03245450|527660964|FG000|Overall Study|Adverse Event|0|||
146313436|NCT03245450|527660965|FG001|Overall Study|Adverse Event|0|||
146313437|NCT03245450|527660966|FG002|Overall Study|Adverse Event|0|||
146313438|NCT03245450|527660967|FG003|Overall Study|Adverse Event|0|||
146313439|NCT03245450|527660968|FG004|Overall Study|Adverse Event|1|||
146313440|NCT03245450|527660969|FG005|Overall Study|Adverse Event|0|||
146313441|NCT03245450|527660970|FG006|Overall Study|Adverse Event|2|||
146313442|NCT00267748|527660971|FG000|Non-randomized Period|Progressive disease|10|||
146313443|NCT00267748|527660972|FG001|Non-randomized Period|Progressive disease|0|||
146313444|NCT00267748|527660973|FG002|Non-randomized Period|Progressive disease|0|||
146313445|NCT00267748|527660971|FG000|Non-randomized Period|Adverse Event|8|||
146313446|NCT00267748|527660972|FG001|Non-randomized Period|Adverse Event|0|||
146313447|NCT00267748|527660973|FG002|Non-randomized Period|Adverse Event|0|||
146313448|NCT00267748|527660971|FG000|Non-randomized Period|Death|1|||
146313449|NCT00267748|527660972|FG001|Non-randomized Period|Death|0|||
146313450|NCT00267748|527660973|FG002|Non-randomized Period|Death|0|||
146313451|NCT00267748|527660971|FG000|Non-randomized Period|Participant not willing to participate|1|||
146313452|NCT00267748|527660972|FG001|Non-randomized Period|Participant not willing to participate|0|||
146313453|NCT00267748|527660973|FG002|Non-randomized Period|Participant not willing to participate|0|||
146313454|NCT00267748|527660971|FG000|Non-randomized Period|Other|3|||
146313455|NCT00267748|527660972|FG001|Non-randomized Period|Other|0|||
146313456|NCT00267748|527660973|FG002|Non-randomized Period|Other|0|||
146313457|NCT00267748|527660971|FG000|Randomized Period|Death|0|||
146313458|NCT00267748|527660972|FG001|Randomized Period|Death|2|||
146313459|NCT00267748|527660973|FG002|Randomized Period|Death|3|||
146313460|NCT00267748|527660971|FG000|Randomized Period|Adverse Event|0|||
146313461|NCT00267748|527660972|FG001|Randomized Period|Adverse Event|23|||
146313462|NCT00267748|527660973|FG002|Randomized Period|Adverse Event|25|||
146313463|NCT00267748|527660971|FG000|Randomized Period|Global deterioration of health status|0|||
146313464|NCT00267748|527660972|FG001|Randomized Period|Global deterioration of health status|6|||
146313465|NCT00267748|527660973|FG002|Randomized Period|Global deterioration of health status|7|||
146313466|NCT00267748|527660971|FG000|Randomized Period|Lost to Follow-up|0|||
146313467|NCT00267748|527660972|FG001|Randomized Period|Lost to Follow-up|1|||
146313468|NCT00267748|527660973|FG002|Randomized Period|Lost to Follow-up|0|||
146313469|NCT00267748|527660971|FG000|Randomized Period|Objective progression or relapse|0|||
146313470|NCT00267748|527660972|FG001|Randomized Period|Objective progression or relapse|77|||
146313471|NCT00267748|527660973|FG002|Randomized Period|Objective progression or relapse|86|||
146313472|NCT00267748|527660971|FG000|Randomized Period|Withdrawal by Subject|0|||
146313473|NCT00267748|527660972|FG001|Randomized Period|Withdrawal by Subject|9|||
146313474|NCT00267748|527660973|FG002|Randomized Period|Withdrawal by Subject|2|||
146313475|NCT00267748|527660971|FG000|Randomized Period|Other|0|||
146313476|NCT00267748|527660972|FG001|Randomized Period|Other|9|||
146313477|NCT00267748|527660973|FG002|Randomized Period|Other|6|||
146313478|NCT00267748|527660971|FG000|Randomized Period|randomized but not treated|0|||
146313479|NCT00267748|527660972|FG001|Randomized Period|randomized but not treated|0|||
146313480|NCT00267748|527660973|FG002|Randomized Period|randomized but not treated|3|||
146159286|NCT02723864|527094514|FG001|Overall Study|Patient choice|0|||
146159287|NCT02723864|527094515|FG002|Overall Study|Patient choice|0|||
146159288|NCT02723864|527094516|FG003|Overall Study|Patient choice|0|||
146159289|NCT02723864|527094517|FG004|Overall Study|Patient choice|0|||
146159290|NCT02723864|527094518|FG005|Overall Study|Patient choice|1|||
146159291|NCT02723864|527094519|FG006|Overall Study|Patient choice|0|||
146159292|NCT02723864|527094513|FG000|Overall Study|Adverse Event|0|||
146159293|NCT02723864|527094514|FG001|Overall Study|Adverse Event|0|||
146159294|NCT02723864|527094515|FG002|Overall Study|Adverse Event|0|||
146159295|NCT02723864|527094516|FG003|Overall Study|Adverse Event|0|||
146313481|NCT05098041|527660978|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
146313482|NCT00464334|527660979|FG000|Overall Study|Adverse Event|0|||
146313483|NCT00464334|527660980|FG001|Overall Study|Adverse Event|0|||
146313484|NCT00464334|527660981|FG002|Overall Study|Adverse Event|0|||
146313485|NCT00464334|527660982|FG003|Overall Study|Adverse Event|1|||
146313486|NCT00464334|527660983|FG004|Overall Study|Adverse Event|1|||
146313487|NCT00464334|527660984|FG005|Overall Study|Adverse Event|1|||
146313488|NCT00464334|527660985|FG006|Overall Study|Adverse Event|0|||
146313489|NCT00464334|527660986|FG007|Overall Study|Adverse Event|0|||
146159296|NCT02723864|527094517|FG004|Overall Study|Adverse Event|0|||
146159297|NCT02723864|527094518|FG005|Overall Study|Adverse Event|1|||
146313490|NCT00464334|527660987|FG008|Overall Study|Adverse Event|2|||
146313491|NCT00464334|527660988|FG009|Overall Study|Adverse Event|1|||
146313492|NCT00464334|527660989|FG010|Overall Study|Adverse Event|2|||
146159298|NCT02723864|527094519|FG006|Overall Study|Adverse Event|0|||
146159299|NCT02723864|527094513|FG000|Overall Study|Started new treatment|0|||
146159300|NCT02723864|527094514|FG001|Overall Study|Started new treatment|0|||
146159301|NCT02723864|527094515|FG002|Overall Study|Started new treatment|0|||
146159302|NCT02723864|527094516|FG003|Overall Study|Started new treatment|0|||
146159303|NCT02723864|527094517|FG004|Overall Study|Started new treatment|0|||
146159304|NCT02723864|527094518|FG005|Overall Study|Started new treatment|1|||
146280903|NCT00844532|527542955|FG000|Overall Study|Lost to Follow-up|7|||
146280904|NCT00948766|527542956|FG000|Core Study|Adverse Event|73|||
146280905|NCT00948766|527542957|FG001|Core Study|Adverse Event|51|||
146280906|NCT00948766|527542956|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
146280907|NCT00948766|527542957|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
146280908|NCT00948766|527542956|FG000|Core Study|Patient Withdrew Consent|27|||
146280909|NCT00948766|527542957|FG001|Core Study|Patient Withdrew Consent|46|||
146280910|NCT00948766|527542956|FG000|Core Study|Lost to Follow-up|3|||
146280911|NCT00948766|527542957|FG001|Core Study|Lost to Follow-up|2|||
146280912|NCT00948766|527542956|FG000|Core Study|Administrative Problems|2|||
146280913|NCT00948766|527542957|FG001|Core Study|Administrative Problems|2|||
146280914|NCT00948766|527542956|FG000|Core Study|Death|1|||
146280915|NCT00948766|527542957|FG001|Core Study|Death|1|||
146280916|NCT00948766|527542956|FG000|Core Study|Protocol Deviation|8|||
146280917|NCT00948766|527542957|FG001|Core Study|Protocol Deviation|10|||
146280918|NCT00948766|527542956|FG000|Extension Study|Adverse Event|43|||
146280919|NCT00948766|527542957|FG001|Extension Study|Adverse Event|0|||
146280920|NCT00948766|527542956|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
146280921|NCT00948766|527542957|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
146280922|NCT00948766|527542956|FG000|Extension Study|Study Drug No Longer Required|1|||
146280923|NCT00948766|527542957|FG001|Extension Study|Study Drug No Longer Required|0|||
146280924|NCT00948766|527542956|FG000|Extension Study|Patient Withdrew Consent|32|||
146280925|NCT00948766|527542957|FG001|Extension Study|Patient Withdrew Consent|0|||
146280926|NCT00948766|527542956|FG000|Extension Study|Lost to Follow-up|8|||
146280927|NCT00948766|527542957|FG001|Extension Study|Lost to Follow-up|0|||
146280928|NCT00948766|527542956|FG000|Extension Study|Administrative Problems|1|||
146280929|NCT00948766|527542957|FG001|Extension Study|Administrative Problems|0|||
146280930|NCT00948766|527542956|FG000|Extension Study|Death|4|||
146280931|NCT00948766|527542957|FG001|Extension Study|Death|0|||
146280932|NCT05017103|527542958|FG000|Overall Study|Death|2|||
146280933|NCT01373151|527542969|FG000|Period 1|Lack of Efficacy|3|||
146280934|NCT01373151|527542970|FG001|Period 1|Lack of Efficacy|0|||
146280935|NCT01373151|527542971|FG002|Period 1|Lack of Efficacy|0|||
146280936|NCT01373151|527542972|FG003|Period 1|Lack of Efficacy|0|||
146280937|NCT01373151|527542973|FG004|Period 1|Lack of Efficacy|1|||
146280938|NCT01373151|527542974|FG005|Period 1|Lack of Efficacy|0|||
146280939|NCT01373151|527542975|FG006|Period 1|Lack of Efficacy|0|||
146280940|NCT01373151|527542969|FG000|Period 1|Adverse Event|0|||
146280941|NCT01373151|527542970|FG001|Period 1|Adverse Event|0|||
146280942|NCT01373151|527542971|FG002|Period 1|Adverse Event|1|||
146280943|NCT01373151|527542972|FG003|Period 1|Adverse Event|0|||
146280944|NCT01373151|527542973|FG004|Period 1|Adverse Event|4|||
146280945|NCT01373151|527542974|FG005|Period 1|Adverse Event|3|||
146280946|NCT01373151|527542975|FG006|Period 1|Adverse Event|0|||
146280947|NCT01373151|527542969|FG000|Period 1|Withdrawal by Subject|2|||
146280948|NCT01373151|527542970|FG001|Period 1|Withdrawal by Subject|0|||
146280949|NCT01373151|527542971|FG002|Period 1|Withdrawal by Subject|3|||
146280950|NCT01373151|527542972|FG003|Period 1|Withdrawal by Subject|1|||
146280951|NCT01373151|527542973|FG004|Period 1|Withdrawal by Subject|0|||
146280952|NCT01373151|527542974|FG005|Period 1|Withdrawal by Subject|1|||
146280953|NCT01373151|527542975|FG006|Period 1|Withdrawal by Subject|0|||
146280954|NCT01373151|527542969|FG000|Period 2|Lack of Efficacy|9|||
146280955|NCT01373151|527542970|FG001|Period 2|Lack of Efficacy|0|||
146280956|NCT01373151|527542971|FG002|Period 2|Lack of Efficacy|0|||
146280957|NCT01373151|527542972|FG003|Period 2|Lack of Efficacy|1|||
146280958|NCT01373151|527542973|FG004|Period 2|Lack of Efficacy|2|||
146280959|NCT01373151|527542974|FG005|Period 2|Lack of Efficacy|0|||
146280960|NCT01373151|527542975|FG006|Period 2|Lack of Efficacy|3|||
146280961|NCT01373151|527542969|FG000|Period 2|Adverse Event|0|||
146280962|NCT01373151|527542970|FG001|Period 2|Adverse Event|0|||
146280963|NCT01373151|527542971|FG002|Period 2|Adverse Event|3|||
146280964|NCT01373151|527542972|FG003|Period 2|Adverse Event|3|||
146280965|NCT01373151|527542973|FG004|Period 2|Adverse Event|0|||
146280966|NCT01373151|527542974|FG005|Period 2|Adverse Event|0|||
146280967|NCT01373151|527542975|FG006|Period 2|Adverse Event|1|||
146280968|NCT01373151|527542969|FG000|Period 2|subject request to discontinue|0|||
146280969|NCT01373151|527542970|FG001|Period 2|subject request to discontinue|1|||
146280970|NCT01373151|527542971|FG002|Period 2|subject request to discontinue|0|||
146280971|NCT01373151|527542972|FG003|Period 2|subject request to discontinue|0|||
146280972|NCT01373151|527542973|FG004|Period 2|subject request to discontinue|0|||
146280973|NCT01373151|527542974|FG005|Period 2|subject request to discontinue|0|||
146280974|NCT01373151|527542975|FG006|Period 2|subject request to discontinue|0|||
146280975|NCT01373151|527542969|FG000|Period 2|Withdrawal by Subject|0|||
146280976|NCT01373151|527542970|FG001|Period 2|Withdrawal by Subject|0|||
146280977|NCT01373151|527542971|FG002|Period 2|Withdrawal by Subject|0|||
146159305|NCT02723864|527094519|FG006|Overall Study|Started new treatment|0|||
146280978|NCT01373151|527542972|FG003|Period 2|Withdrawal by Subject|1|||
146159306|NCT02723864|527094513|FG000|Overall Study|Switched to alternative treatment|0|||
146159307|NCT02723864|527094514|FG001|Overall Study|Switched to alternative treatment|0|||
146159308|NCT02723864|527094515|FG002|Overall Study|Switched to alternative treatment|0|||
146159309|NCT02723864|527094516|FG003|Overall Study|Switched to alternative treatment|0|||
146159310|NCT02723864|527094517|FG004|Overall Study|Switched to alternative treatment|0|||
146159311|NCT02723864|527094518|FG005|Overall Study|Switched to alternative treatment|1|||
146159312|NCT02723864|527094519|FG006|Overall Study|Switched to alternative treatment|0|||
146159313|NCT02723864|527094513|FG000|Overall Study|Late determination of ineligibility|0|||
146280979|NCT01373151|527542973|FG004|Period 2|Withdrawal by Subject|0|||
146280980|NCT01373151|527542974|FG005|Period 2|Withdrawal by Subject|0|||
146280981|NCT01373151|527542975|FG006|Period 2|Withdrawal by Subject|0|||
146280982|NCT01373151|527542969|FG000|Period 2|Other|0|||
146280983|NCT01373151|527542970|FG001|Period 2|Other|0|||
146280984|NCT01373151|527542971|FG002|Period 2|Other|1|||
146280985|NCT01373151|527542972|FG003|Period 2|Other|0|||
146280986|NCT01373151|527542973|FG004|Period 2|Other|0|||
146280987|NCT01373151|527542974|FG005|Period 2|Other|0|||
146280988|NCT01373151|527542975|FG006|Period 2|Other|1|||
146280989|NCT03026075|527542980|FG000|Overall Study|Physician Decision|1|||
146280990|NCT03381339|527542983|FG000|Overall Study|Protocol Violation|4|||
146280991|NCT03381339|527542984|FG001|Overall Study|Protocol Violation|3|||
146280992|NCT03381339|527542983|FG000|Overall Study|Lost to Follow-up|0|||
146280993|NCT03381339|527542984|FG001|Overall Study|Lost to Follow-up|1|||
146280994|NCT04927247|527542986|FG000|Overall Study|Other|2|||
146280995|NCT04927247|527542987|FG001|Overall Study|Other|1|||
146280996|NCT04927247|527542986|FG000|Overall Study|Physician Decision|0|||
146280997|NCT04927247|527542987|FG001|Overall Study|Physician Decision|1|||
146280998|NCT04927247|527542986|FG000|Overall Study|Adverse Event|1|||
146280999|NCT04927247|527542987|FG001|Overall Study|Adverse Event|0|||
146281000|NCT04828837|527542989|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
146281001|NCT04828837|527542990|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
146281002|NCT04828837|527542989|FG000|Overall Study|Lost to Follow-up|2|||
146281003|NCT04828837|527542990|FG001|Overall Study|Lost to Follow-up|6|||
146281004|NCT04828837|527542989|FG000|Overall Study|Lack of Efficacy|1|||
146281005|NCT04828837|527542990|FG001|Overall Study|Lack of Efficacy|0|||
146281006|NCT04828837|527542989|FG000|Overall Study|Admitted due to pneumothorax.|1|||
146281007|NCT04828837|527542990|FG001|Overall Study|Admitted due to pneumothorax.|0|||
146281008|NCT04828837|527542989|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
146281009|NCT04828837|527542990|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
146281010|NCT01397422|527542991|FG000|Overall Study|Adverse Event|0|||
146281011|NCT01397422|527542992|FG001|Overall Study|Adverse Event|3|||
146281012|NCT01397422|527542993|FG002|Overall Study|Adverse Event|3|||
146281013|NCT01397422|527542994|FG003|Overall Study|Adverse Event|8|||
146281014|NCT01397422|527542991|FG000|Overall Study|Withdrawal by Subject|1|||
146281015|NCT01397422|527542992|FG001|Overall Study|Withdrawal by Subject|0|||
146281016|NCT01397422|527542993|FG002|Overall Study|Withdrawal by Subject|0|||
146281017|NCT01397422|527542994|FG003|Overall Study|Withdrawal by Subject|0|||
146281018|NCT01397422|527542991|FG000|Overall Study|Increased bradykinesia related to PD|1|||
146281019|NCT01397422|527542992|FG001|Overall Study|Increased bradykinesia related to PD|0|||
146281020|NCT01397422|527542993|FG002|Overall Study|Increased bradykinesia related to PD|0|||
146281021|NCT01397422|527542994|FG003|Overall Study|Increased bradykinesia related to PD|0|||
146281022|NCT00545753|527542995|FG000|Overall Study|Withdrawal by Subject|0|||
146281023|NCT00545753|527542996|FG001|Overall Study|Withdrawal by Subject|1|||
146281024|NCT00545753|527542997|FG002|Overall Study|Withdrawal by Subject|10|||
146281025|NCT00545753|527542995|FG000|Overall Study|Lost to Follow-up|13|||
146281026|NCT00545753|527542996|FG001|Overall Study|Lost to Follow-up|3|||
146281027|NCT00545753|527542997|FG002|Overall Study|Lost to Follow-up|12|||
146281028|NCT00545753|527542995|FG000|Overall Study|Protocol Violation|3|||
146281029|NCT00545753|527542996|FG001|Overall Study|Protocol Violation|1|||
146281030|NCT00545753|527542997|FG002|Overall Study|Protocol Violation|4|||
146281031|NCT02489968|527543008|FG000|Open-label Treatment Period|Adverse Event|14|||
146281032|NCT02489968|527543009|FG001|Open-label Treatment Period|Adverse Event|7|||
146281033|NCT02489968|527543010|FG002|Open-label Treatment Period|Adverse Event|0|||
146281034|NCT02489968|527543011|FG003|Open-label Treatment Period|Adverse Event|0|||
146281035|NCT02489968|527543012|FG004|Open-label Treatment Period|Adverse Event|0|||
146281036|NCT02489968|527543013|FG005|Open-label Treatment Period|Adverse Event|0|||
146281037|NCT02489968|527543008|FG000|Open-label Treatment Period|Protocol Violation|2|||
146281038|NCT02489968|527543009|FG001|Open-label Treatment Period|Protocol Violation|2|||
146281039|NCT02489968|527543010|FG002|Open-label Treatment Period|Protocol Violation|0|||
146313493|NCT00464334|527660979|FG000|Overall Study|Lack of Efficacy|0|||
146159314|NCT02723864|527094514|FG001|Overall Study|Late determination of ineligibility|0|||
146281040|NCT02489968|527543011|FG003|Open-label Treatment Period|Protocol Violation|0|||
146281041|NCT02489968|527543012|FG004|Open-label Treatment Period|Protocol Violation|0|||
146281042|NCT02489968|527543013|FG005|Open-label Treatment Period|Protocol Violation|0|||
146281043|NCT02489968|527543008|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
146281044|NCT02489968|527543009|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
146313494|NCT00464334|527660980|FG001|Overall Study|Lack of Efficacy|1|||
146313495|NCT00464334|527660981|FG002|Overall Study|Lack of Efficacy|0|||
146313496|NCT00464334|527660982|FG003|Overall Study|Lack of Efficacy|0|||
146313497|NCT00464334|527660983|FG004|Overall Study|Lack of Efficacy|0|||
146313498|NCT00464334|527660984|FG005|Overall Study|Lack of Efficacy|0|||
146313499|NCT00464334|527660985|FG006|Overall Study|Lack of Efficacy|0|||
146313500|NCT00464334|527660986|FG007|Overall Study|Lack of Efficacy|0|||
146313501|NCT00464334|527660987|FG008|Overall Study|Lack of Efficacy|0|||
146313502|NCT00464334|527660988|FG009|Overall Study|Lack of Efficacy|0|||
146313503|NCT00464334|527660989|FG010|Overall Study|Lack of Efficacy|0|||
146313504|NCT00464334|527660979|FG000|Overall Study|Lost to Follow-up|0|||
146313505|NCT00464334|527660980|FG001|Overall Study|Lost to Follow-up|0|||
146313506|NCT00464334|527660981|FG002|Overall Study|Lost to Follow-up|1|||
146313507|NCT00464334|527660982|FG003|Overall Study|Lost to Follow-up|0|||
146313508|NCT00464334|527660983|FG004|Overall Study|Lost to Follow-up|1|||
146313509|NCT00464334|527660984|FG005|Overall Study|Lost to Follow-up|0|||
146313510|NCT00464334|527660985|FG006|Overall Study|Lost to Follow-up|1|||
146313511|NCT00464334|527660986|FG007|Overall Study|Lost to Follow-up|0|||
146313512|NCT00464334|527660987|FG008|Overall Study|Lost to Follow-up|0|||
146313513|NCT00464334|527660988|FG009|Overall Study|Lost to Follow-up|0|||
146313514|NCT00464334|527660989|FG010|Overall Study|Lost to Follow-up|2|||
146313515|NCT00464334|527660979|FG000|Overall Study|Progressive Disease|0|||
146313516|NCT00464334|527660980|FG001|Overall Study|Progressive Disease|0|||
146313517|NCT00464334|527660981|FG002|Overall Study|Progressive Disease|0|||
146313518|NCT00464334|527660982|FG003|Overall Study|Progressive Disease|0|||
146313519|NCT00464334|527660983|FG004|Overall Study|Progressive Disease|0|||
146313520|NCT00464334|527660984|FG005|Overall Study|Progressive Disease|1|||
146313521|NCT00464334|527660985|FG006|Overall Study|Progressive Disease|0|||
146313522|NCT00464334|527660986|FG007|Overall Study|Progressive Disease|0|||
146313523|NCT00464334|527660987|FG008|Overall Study|Progressive Disease|1|||
146313524|NCT00464334|527660988|FG009|Overall Study|Progressive Disease|0|||
146313525|NCT00464334|527660989|FG010|Overall Study|Progressive Disease|0|||
146313526|NCT00464334|527660979|FG000|Overall Study|Study Terminated by Sponsor|0|||
146313527|NCT00464334|527660980|FG001|Overall Study|Study Terminated by Sponsor|0|||
146313528|NCT00464334|527660981|FG002|Overall Study|Study Terminated by Sponsor|0|||
146313529|NCT00464334|527660982|FG003|Overall Study|Study Terminated by Sponsor|1|||
146313530|NCT00464334|527660983|FG004|Overall Study|Study Terminated by Sponsor|0|||
146313531|NCT00464334|527660984|FG005|Overall Study|Study Terminated by Sponsor|0|||
146313532|NCT00464334|527660985|FG006|Overall Study|Study Terminated by Sponsor|0|||
146313533|NCT00464334|527660986|FG007|Overall Study|Study Terminated by Sponsor|0|||
146313534|NCT00464334|527660987|FG008|Overall Study|Study Terminated by Sponsor|0|||
146313535|NCT00464334|527660988|FG009|Overall Study|Study Terminated by Sponsor|0|||
146313536|NCT00464334|527660989|FG010|Overall Study|Study Terminated by Sponsor|0|||
146313537|NCT00464334|527660979|FG000|Overall Study|Withdrawal by Subject|1|||
146313538|NCT00464334|527660980|FG001|Overall Study|Withdrawal by Subject|7|||
146313539|NCT00464334|527660981|FG002|Overall Study|Withdrawal by Subject|4|||
146313540|NCT00464334|527660982|FG003|Overall Study|Withdrawal by Subject|2|||
146313541|NCT00464334|527660983|FG004|Overall Study|Withdrawal by Subject|2|||
146313542|NCT00464334|527660984|FG005|Overall Study|Withdrawal by Subject|2|||
146313543|NCT00464334|527660985|FG006|Overall Study|Withdrawal by Subject|2|||
146313544|NCT00464334|527660986|FG007|Overall Study|Withdrawal by Subject|1|||
146313545|NCT00464334|527660987|FG008|Overall Study|Withdrawal by Subject|3|||
146313546|NCT00464334|527660988|FG009|Overall Study|Withdrawal by Subject|0|||
146313547|NCT00464334|527660989|FG010|Overall Study|Withdrawal by Subject|0|||
146313548|NCT03948178|527660992|FG000|Overall Study|Protocol Violation|1|||
146313549|NCT03948178|527660992|FG000|Overall Study|Lost to Follow-up|2|||
146313550|NCT03948178|527660992|FG000|Overall Study|Withdrawal by Subject|2|||
146313551|NCT03948178|527660992|FG000|Overall Study|Reason not known|2|||
146313552|NCT03948178|527660992|FG000|Overall Study|Personal reason|14|||
146313553|NCT03948178|527660992|FG000|Overall Study|Disease progression|30|||
146313554|NCT03948178|527660992|FG000|Overall Study|Adverse Event|12|||
146313555|NCT03948178|527660992|FG000|Overall Study|Sponsor terminated study|164|||
146313556|NCT01297270|527660993|FG000|Overall Study|Adverse Event|19|||
146313557|NCT01297270|527660994|FG001|Overall Study|Adverse Event|32|||
146313558|NCT01297270|527660995|FG002|Overall Study|Adverse Event|5|||
146313559|NCT01297270|527660993|FG000|Overall Study|Lack of Efficacy|15|||
146313560|NCT01297270|527660994|FG001|Overall Study|Lack of Efficacy|17|||
146313561|NCT01297270|527660995|FG002|Overall Study|Lack of Efficacy|15|||
146313562|NCT01297270|527660993|FG000|Overall Study|Lost to Follow-up|1|||
146313563|NCT01297270|527660994|FG001|Overall Study|Lost to Follow-up|2|||
146313564|NCT01297270|527660995|FG002|Overall Study|Lost to Follow-up|1|||
146313565|NCT01297270|527660993|FG000|Overall Study|Protocol Violation|0|||
146313566|NCT01297270|527660994|FG001|Overall Study|Protocol Violation|2|||
146313567|NCT01297270|527660995|FG002|Overall Study|Protocol Violation|0|||
146313568|NCT01297270|527660993|FG000|Overall Study|Withdrawal by Subject|7|||
146313569|NCT01297270|527660994|FG001|Overall Study|Withdrawal by Subject|15|||
146313570|NCT01297270|527660995|FG002|Overall Study|Withdrawal by Subject|7|||
146313571|NCT01297270|527660993|FG000|Overall Study|Other reason not defined above|3|||
146313572|NCT01297270|527660994|FG001|Overall Study|Other reason not defined above|3|||
146313573|NCT01297270|527660995|FG002|Overall Study|Other reason not defined above|1|||
146159315|NCT02723864|527094515|FG002|Overall Study|Late determination of ineligibility|0|||
146159316|NCT02723864|527094516|FG003|Overall Study|Late determination of ineligibility|0|||
146159317|NCT02723864|527094517|FG004|Overall Study|Late determination of ineligibility|0|||
146159318|NCT02723864|527094518|FG005|Overall Study|Late determination of ineligibility|1|||
146159319|NCT02723864|527094519|FG006|Overall Study|Late determination of ineligibility|0|||
146159320|NCT01733732|527094522|FG000|Overall Study|Adverse Event|1|||
146281045|NCT02489968|527543010|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
146281046|NCT02489968|527543011|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
146281047|NCT02489968|527543012|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
146281048|NCT02489968|527543013|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
146281049|NCT02489968|527543008|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
146281050|NCT02489968|527543009|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
146281051|NCT02489968|527543010|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
146281052|NCT02489968|527543011|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
146281053|NCT02489968|527543012|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
146281054|NCT02489968|527543013|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
146281055|NCT02489968|527543008|FG000|Open-label Treatment Period|Other than specified above|204|||
146281056|NCT02489968|527543009|FG001|Open-label Treatment Period|Other than specified above|189|||
146281057|NCT02489968|527543010|FG002|Open-label Treatment Period|Other than specified above|0|||
146281058|NCT02489968|527543011|FG003|Open-label Treatment Period|Other than specified above|0|||
146281059|NCT02489968|527543012|FG004|Open-label Treatment Period|Other than specified above|0|||
146281060|NCT02489968|527543013|FG005|Open-label Treatment Period|Other than specified above|0|||
146281061|NCT02489968|527543008|FG000|Double-blind Treatment Period|Adverse Event|0|||
146281062|NCT02489968|527543009|FG001|Double-blind Treatment Period|Adverse Event|0|||
146281063|NCT02489968|527543010|FG002|Double-blind Treatment Period|Adverse Event|2|||
146281064|NCT02489968|527543011|FG003|Double-blind Treatment Period|Adverse Event|6|||
146281065|NCT02489968|527543012|FG004|Double-blind Treatment Period|Adverse Event|4|||
146281066|NCT02489968|527543013|FG005|Double-blind Treatment Period|Adverse Event|5|||
146281067|NCT02489968|527543008|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146281068|NCT02489968|527543009|FG001|Double-blind Treatment Period|Protocol Violation|0|||
146281069|NCT02489968|527543010|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146281070|NCT02489968|527543011|FG003|Double-blind Treatment Period|Protocol Violation|0|||
146281071|NCT02489968|527543012|FG004|Double-blind Treatment Period|Protocol Violation|1|||
146281072|NCT02489968|527543013|FG005|Double-blind Treatment Period|Protocol Violation|1|||
146281073|NCT02489968|527543008|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
146281074|NCT02489968|527543009|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146281075|NCT02489968|527543010|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146281076|NCT02489968|527543011|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
146281077|NCT02489968|527543012|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
146281078|NCT02489968|527543013|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
146281079|NCT02489968|527543008|FG000|Double-blind Treatment Period|Other than specified above|0|||
146281080|NCT02489968|527543009|FG001|Double-blind Treatment Period|Other than specified above|0|||
146281081|NCT02489968|527543010|FG002|Double-blind Treatment Period|Other than specified above|0|||
146281082|NCT02489968|527543011|FG003|Double-blind Treatment Period|Other than specified above|0|||
146281083|NCT02489968|527543012|FG004|Double-blind Treatment Period|Other than specified above|1|||
146281084|NCT02489968|527543013|FG005|Double-blind Treatment Period|Other than specified above|0|||
146281085|NCT04577001|527543014|FG000|Overall Study|Subject became ineligible|0|||
146281086|NCT04577001|527543015|FG001|Overall Study|Subject became ineligible|1|||
146281087|NCT01593787|527543016|FG000|Overall Study|Adverse Event|1|||
146281088|NCT01593787|527543017|FG001|Overall Study|Adverse Event|0|||
146281089|NCT01593787|527543018|FG002|Overall Study|Adverse Event|0|||
146281090|NCT01022112|527543024|FG000|Overall Study|Adverse Event|1|||
146281091|NCT01022112|527543025|FG001|Overall Study|Adverse Event|2|||
146281092|NCT01022112|527543026|FG002|Overall Study|Adverse Event|0|||
146281093|NCT01022112|527543027|FG003|Overall Study|Adverse Event|1|||
146281094|NCT01022112|527543028|FG004|Overall Study|Adverse Event|0|||
146281095|NCT01022112|527543024|FG000|Overall Study|Lack of Efficacy|1|||
146281096|NCT01022112|527543025|FG001|Overall Study|Lack of Efficacy|0|||
146281097|NCT01022112|527543026|FG002|Overall Study|Lack of Efficacy|0|||
146281098|NCT01022112|527543027|FG003|Overall Study|Lack of Efficacy|0|||
146281099|NCT01022112|527543028|FG004|Overall Study|Lack of Efficacy|1|||
146281100|NCT01022112|527543024|FG000|Overall Study|Physician Decision|0|||
146281101|NCT01022112|527543025|FG001|Overall Study|Physician Decision|0|||
146281102|NCT01022112|527543026|FG002|Overall Study|Physician Decision|1|||
146281103|NCT01022112|527543027|FG003|Overall Study|Physician Decision|0|||
146281104|NCT01022112|527543028|FG004|Overall Study|Physician Decision|1|||
146281105|NCT01022112|527543024|FG000|Overall Study|Withdrawal by Subject|0|||
146281106|NCT01022112|527543025|FG001|Overall Study|Withdrawal by Subject|1|||
146313574|NCT01297270|527660993|FG000|Overall Study|Not treated|0|||
146281107|NCT01022112|527543026|FG002|Overall Study|Withdrawal by Subject|2|||
146313575|NCT01297270|527660994|FG001|Overall Study|Not treated|1|||
146159321|NCT01733732|527094523|FG001|Overall Study|Adverse Event|0|||
146159322|NCT01733732|527094522|FG000|Overall Study|Did not attend all study visits|1|||
146159323|NCT01733732|527094523|FG001|Overall Study|Did not attend all study visits|0|||
146159324|NCT00746590|527094524|FG000|Overall Study|Death|1|||
146159325|NCT02633800|527094529|FG000|Overall Study|Death|3|||
146281108|NCT01022112|527543027|FG003|Overall Study|Withdrawal by Subject|2|||
146281109|NCT01022112|527543028|FG004|Overall Study|Withdrawal by Subject|1|||
146281110|NCT01022112|527543024|FG000|Overall Study|Fasting plasma glucose level increased|1|||
146281111|NCT01022112|527543025|FG001|Overall Study|Fasting plasma glucose level increased|0|||
146281112|NCT01022112|527543026|FG002|Overall Study|Fasting plasma glucose level increased|0|||
146281113|NCT01022112|527543027|FG003|Overall Study|Fasting plasma glucose level increased|0|||
146281114|NCT01022112|527543028|FG004|Overall Study|Fasting plasma glucose level increased|7|||
146281115|NCT01982448|527543029|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146281116|NCT01982448|527543030|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
146281117|NCT01982448|527543029|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
146281118|NCT01982448|527543030|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
146281119|NCT01982448|527543029|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
146281120|NCT01982448|527543030|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
146281121|NCT01982448|527543029|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
146281122|NCT01982448|527543030|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
146281123|NCT00872989|527544588|FG000|Overall Study|Adverse Event|7|||
146281124|NCT00872989|527544589|FG001|Overall Study|Adverse Event|15|||
146281125|NCT00872989|527544588|FG000|Overall Study|Withdrawal by Subject|8|||
146281126|NCT00872989|527544589|FG001|Overall Study|Withdrawal by Subject|5|||
146281127|NCT00872989|527544588|FG000|Overall Study|Progression/relapse|47|||
146281128|NCT00872989|527544589|FG001|Overall Study|Progression/relapse|35|||
146281129|NCT00872989|527544588|FG000|Overall Study|Not protocol specified|3|||
146281130|NCT00872989|527544589|FG001|Overall Study|Not protocol specified|8|||
146281131|NCT02407990|527544590|FG000|Overall Study|Death|2|||
146281132|NCT02407990|527544591|FG001|Overall Study|Death|22|||
146281133|NCT02407990|527544592|FG002|Overall Study|Death|23|||
146281134|NCT02407990|527544593|FG003|Overall Study|Death|7|||
146281135|NCT02407990|527544594|FG004|Overall Study|Death|17|||
146281136|NCT02407990|527544595|FG005|Overall Study|Death|16|||
146281137|NCT02407990|527544596|FG006|Overall Study|Death|10|||
146281138|NCT02407990|527544597|FG007|Overall Study|Death|248|||
146281139|NCT02407990|527544590|FG000|Overall Study|Lost to Follow-up|0|||
146281140|NCT02407990|527544591|FG001|Overall Study|Lost to Follow-up|1|||
146281141|NCT02407990|527544592|FG002|Overall Study|Lost to Follow-up|0|||
146281142|NCT02407990|527544593|FG003|Overall Study|Lost to Follow-up|0|||
146281143|NCT02407990|527544594|FG004|Overall Study|Lost to Follow-up|0|||
146281144|NCT02407990|527544595|FG005|Overall Study|Lost to Follow-up|0|||
146281145|NCT02407990|527544596|FG006|Overall Study|Lost to Follow-up|0|||
146281146|NCT02407990|527544597|FG007|Overall Study|Lost to Follow-up|17|||
146281147|NCT02407990|527544590|FG000|Overall Study|Progressive Disease|0|||
146281148|NCT02407990|527544591|FG001|Overall Study|Progressive Disease|0|||
146281149|NCT02407990|527544592|FG002|Overall Study|Progressive Disease|0|||
146281150|NCT02407990|527544593|FG003|Overall Study|Progressive Disease|0|||
146281151|NCT02407990|527544594|FG004|Overall Study|Progressive Disease|0|||
146281152|NCT02407990|527544595|FG005|Overall Study|Progressive Disease|0|||
146281153|NCT02407990|527544596|FG006|Overall Study|Progressive Disease|0|||
146281154|NCT02407990|527544597|FG007|Overall Study|Progressive Disease|1|||
146281155|NCT02407990|527544590|FG000|Overall Study|Withdrawal by Subject|0|||
146281156|NCT02407990|527544591|FG001|Overall Study|Withdrawal by Subject|0|||
146281157|NCT02407990|527544592|FG002|Overall Study|Withdrawal by Subject|0|||
146281158|NCT02407990|527544593|FG003|Overall Study|Withdrawal by Subject|0|||
146281159|NCT02407990|527544594|FG004|Overall Study|Withdrawal by Subject|1|||
146281160|NCT02407990|527544595|FG005|Overall Study|Withdrawal by Subject|0|||
146281161|NCT02407990|527544596|FG006|Overall Study|Withdrawal by Subject|0|||
146281162|NCT02407990|527544597|FG007|Overall Study|Withdrawal by Subject|30|||
146281163|NCT02407990|527544590|FG000|Overall Study|Study Terminated by Sponsor|1|||
146281164|NCT02407990|527544591|FG001|Overall Study|Study Terminated by Sponsor|3|||
146281165|NCT02407990|527544592|FG002|Overall Study|Study Terminated by Sponsor|3|||
146281166|NCT02407990|527544593|FG003|Overall Study|Study Terminated by Sponsor|0|||
146281167|NCT02407990|527544594|FG004|Overall Study|Study Terminated by Sponsor|3|||
146281168|NCT02407990|527544595|FG005|Overall Study|Study Terminated by Sponsor|4|||
146281169|NCT02407990|527544596|FG006|Overall Study|Study Terminated by Sponsor|3|||
146281170|NCT02407990|527544597|FG007|Overall Study|Study Terminated by Sponsor|37|||
146281171|NCT02407990|527544590|FG000|Overall Study|Logistics|0|||
146281172|NCT02407990|527544591|FG001|Overall Study|Logistics|0|||
146281173|NCT02407990|527544592|FG002|Overall Study|Logistics|0|||
146281174|NCT02407990|527544593|FG003|Overall Study|Logistics|0|||
146281175|NCT02407990|527544594|FG004|Overall Study|Logistics|0|||
146281176|NCT02407990|527544595|FG005|Overall Study|Logistics|0|||
146281177|NCT02407990|527544596|FG006|Overall Study|Logistics|0|||
146281178|NCT02407990|527544597|FG007|Overall Study|Logistics|1|||
146281179|NCT02407990|527544590|FG000|Overall Study|Rolled into long-term extension study|0|||
146281180|NCT02407990|527544591|FG001|Overall Study|Rolled into long-term extension study|0|||
146159326|NCT02633800|527094530|FG001|Overall Study|Death|3|||
146159327|NCT02633800|527094529|FG000|Overall Study|Reason not provided|1|||
146281181|NCT02407990|527544592|FG002|Overall Study|Rolled into long-term extension study|0|||
146281182|NCT02407990|527544593|FG003|Overall Study|Rolled into long-term extension study|0|||
146281183|NCT02407990|527544594|FG004|Overall Study|Rolled into long-term extension study|0|||
146281184|NCT02407990|527544595|FG005|Overall Study|Rolled into long-term extension study|0|||
146281185|NCT02407990|527544596|FG006|Overall Study|Rolled into long-term extension study|0|||
146281186|NCT02407990|527544597|FG007|Overall Study|Rolled into long-term extension study|1|||
146281187|NCT00923260|527544598|FG000|Overall Study|Lost to Follow-up|1|||
146281188|NCT00923260|527544599|FG001|Overall Study|Lost to Follow-up|1|||
146281189|NCT01238900|527544600|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
146281190|NCT01238900|527544600|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
146281191|NCT00591721|527544601|FG000|Overall Study|Withdrawal by Subject|10|||
146281192|NCT00591721|527544602|FG001|Overall Study|Withdrawal by Subject|10|||
146281193|NCT00591721|527544601|FG000|Overall Study|Lost to Follow-up|1|||
146281194|NCT00591721|527544602|FG001|Overall Study|Lost to Follow-up|4|||
146281195|NCT00591721|527544601|FG000|Overall Study|Intervention not received|10|||
146281196|NCT00591721|527544602|FG001|Overall Study|Intervention not received|8|||
146281197|NCT03725085|527544603|FG000|Overall Study|Lost to Follow-up|2|||
146281198|NCT02704754|527544604|FG000|Overall Study|Lost to Follow-up|1|||
146281199|NCT02704754|527544605|FG001|Overall Study|Lost to Follow-up|1|||
146281200|NCT02704754|527544604|FG000|Overall Study|Lack of Efficacy|1|||
146281201|NCT02704754|527544605|FG001|Overall Study|Lack of Efficacy|0|||
146281202|NCT02704754|527544604|FG000|Overall Study|Withdrawal by Subject|1|||
146281203|NCT02704754|527544605|FG001|Overall Study|Withdrawal by Subject|0|||
146281204|NCT00423943|527544606|FG000|Overall Study|Withdrawal by Subject|3|||
146281205|NCT00423943|527544607|FG001|Overall Study|Withdrawal by Subject|1|||
146281206|NCT02134977|527544608|FG000|Overall Study|Protocol Deviation|102|||
146281207|NCT02383056|527544617|FG000|Overall Study|Adverse Event|1|||
146281208|NCT02383056|527544618|FG001|Overall Study|Adverse Event|0|||
146281209|NCT02383056|527544617|FG000|Overall Study|Lost to Follow-up|0|||
146281210|NCT02383056|527544618|FG001|Overall Study|Lost to Follow-up|2|||
146281211|NCT04187989|527544619|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
146281212|NCT04187989|527544620|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
146281213|NCT04187989|527544619|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
146281214|NCT04187989|527544620|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
146281215|NCT03646656|527544621|FG000|Overall Study|Lost to Follow-up|1|||
146281216|NCT03646656|527544622|FG001|Overall Study|Lost to Follow-up|0|||
146281217|NCT03646656|527544621|FG000|Overall Study|Withdrawal by Subject|2|||
146281218|NCT03646656|527544622|FG001|Overall Study|Withdrawal by Subject|0|||
146281219|NCT03900416|527544623|FG000|Six Week Follow-up|Lost to Follow-up|1|||
146281220|NCT03900416|527544624|FG001|Six Week Follow-up|Lost to Follow-up|0|||
146281221|NCT03900416|527544623|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
146281222|NCT03900416|527544624|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
146281223|NCT03900416|527544623|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
146281224|NCT03900416|527544624|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
146281225|NCT03900416|527544623|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
146281226|NCT03900416|527544624|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
146281227|NCT03900416|527544623|FG000|Twelve Week Follow-up|Adverse Event|1|||
146281228|NCT03900416|527544624|FG001|Twelve Week Follow-up|Adverse Event|1|||
146281229|NCT03900416|527544623|FG000|Six Month Follow-up|Lost to Follow-up|4|||
146281230|NCT03900416|527544624|FG001|Six Month Follow-up|Lost to Follow-up|3|||
146281231|NCT03900416|527544623|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
146281232|NCT03900416|527544624|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
146281233|NCT03507777|527544625|FG000|Overall Study|Lost to Follow-up|5|||
146281234|NCT03507777|527544626|FG001|Overall Study|Lost to Follow-up|7|||
146281235|NCT03507777|527544625|FG000|Overall Study|Withdrawal by Subject|6|||
146281236|NCT03507777|527544626|FG001|Overall Study|Withdrawal by Subject|11|||
146281237|NCT03507777|527544625|FG000|Overall Study|Death|30|||
146281238|NCT03507777|527544626|FG001|Overall Study|Death|44|||
146281239|NCT03507777|527544625|FG000|Overall Study|Other Reasons|3|||
146281240|NCT03507777|527544626|FG001|Overall Study|Other Reasons|8|||
146281241|NCT02245737|527544627|FG000|Overall Study|Adverse Event|23|||
146281242|NCT02245737|527544628|FG001|Overall Study|Adverse Event|26|||
146281243|NCT02245737|527544629|FG002|Overall Study|Adverse Event|33|||
146281244|NCT02245737|527544627|FG000|Overall Study|Condition Worsened|9|||
146281245|NCT02245737|527544628|FG001|Overall Study|Condition Worsened|10|||
146281246|NCT02245737|527544629|FG002|Overall Study|Condition Worsened|9|||
146281247|NCT02245737|527544627|FG000|Overall Study|Death|2|||
146281248|NCT02245737|527544628|FG001|Overall Study|Death|4|||
146281249|NCT02245737|527544629|FG002|Overall Study|Death|4|||
146281250|NCT02245737|527544627|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
146281251|NCT02245737|527544628|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
146281252|NCT02245737|527544629|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
146159328|NCT02633800|527094530|FG001|Overall Study|Reason not provided|0|||
146281253|NCT02245737|527544627|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
146159329|NCT02633800|527094529|FG000|Overall Study|Radiologic(al) progression|23|||
146159330|NCT02633800|527094530|FG001|Overall Study|Radiologic(al) progression|23|||
146159331|NCT02633800|527094529|FG000|Overall Study|Clinical progression|3|||
146159332|NCT02633800|527094530|FG001|Overall Study|Clinical progression|6|||
146159333|NCT02633800|527094529|FG000|Overall Study|Study terminated by sponsor|6|||
146159334|NCT02633800|527094530|FG001|Overall Study|Study terminated by sponsor|5|||
146159335|NCT02633800|527094529|FG000|Overall Study|Adverse event, non-fatal|7|||
146159336|NCT02633800|527094530|FG001|Overall Study|Adverse event, non-fatal|2|||
146159337|NCT02633800|527094529|FG000|Overall Study|Withdrawal by Subject|0|||
146159338|NCT02633800|527094530|FG001|Overall Study|Withdrawal by Subject|3|||
146159339|NCT02633800|527094529|FG000|Overall Study|Patient Request|1|||
146159340|NCT02633800|527094530|FG001|Overall Study|Patient Request|1|||
146159341|NCT00254982|527094531|FG000|Overall Study|Other|2|||
146159342|NCT00254982|527094532|FG001|Overall Study|Other|1|||
146159343|NCT00254982|527094531|FG000|Overall Study|Lack of Efficacy|5|||
146159344|NCT00254982|527094532|FG001|Overall Study|Lack of Efficacy|3|||
146159345|NCT00254982|527094531|FG000|Overall Study|Lost to Follow-up|5|||
146159346|NCT00254982|527094532|FG001|Overall Study|Lost to Follow-up|3|||
146159347|NCT00254982|527094531|FG000|Overall Study|Adverse Event|18|||
146159348|NCT00254982|527094532|FG001|Overall Study|Adverse Event|16|||
146159349|NCT00254982|527094531|FG000|Overall Study|Withdrawal by Subject|1|||
146159350|NCT00254982|527094532|FG001|Overall Study|Withdrawal by Subject|1|||
146159351|NCT00254982|527094531|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
146159352|NCT00254982|527094532|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
146159353|NCT00254982|527094531|FG000|Overall Study|Protocol deviation|1|||
146159354|NCT00254982|527094532|FG001|Overall Study|Protocol deviation|1|||
146159355|NCT00254982|527094531|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
146159356|NCT00254982|527094532|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
146159357|NCT00254982|527094531|FG000|Overall Study|Malignancy|0|||
146159358|NCT00254982|527094532|FG001|Overall Study|Malignancy|2|||
146159359|NCT00254982|527094531|FG000|Overall Study|Opportunistic infection|1|||
146159360|NCT00254982|527094532|FG001|Overall Study|Opportunistic infection|0|||
146281254|NCT02245737|527544628|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
146281255|NCT02245737|527544629|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
146281256|NCT02245737|527544627|FG000|Overall Study|Lost to Follow-up|2|||
146281257|NCT02245737|527544628|FG001|Overall Study|Lost to Follow-up|5|||
146281258|NCT02245737|527544629|FG002|Overall Study|Lost to Follow-up|4|||
146281259|NCT02245737|527544627|FG000|Overall Study|Other-determined by Investigator|9|||
146281260|NCT02245737|527544628|FG001|Overall Study|Other-determined by Investigator|10|||
146281261|NCT02245737|527544629|FG002|Overall Study|Other-determined by Investigator|10|||
146281262|NCT02245737|527544627|FG000|Overall Study|Physician Decision|6|||
146281263|NCT02245737|527544628|FG001|Overall Study|Physician Decision|3|||
146281264|NCT02245737|527544629|FG002|Overall Study|Physician Decision|6|||
146281265|NCT02245737|527544627|FG000|Overall Study|Protocol Violation|3|||
146281266|NCT02245737|527544628|FG001|Overall Study|Protocol Violation|2|||
146281267|NCT02245737|527544629|FG002|Overall Study|Protocol Violation|3|||
146281268|NCT02245737|527544627|FG000|Overall Study|Withdrawal by Subject|40|||
146281269|NCT02245737|527544628|FG001|Overall Study|Withdrawal by Subject|41|||
146281270|NCT02245737|527544629|FG002|Overall Study|Withdrawal by Subject|44|||
146281271|NCT02245737|527544627|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
146281272|NCT02245737|527544628|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
146281273|NCT02245737|527544629|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
146281274|NCT02245737|527544627|FG000|Overall Study|Sponsor Decision|445|||
146281275|NCT02245737|527544628|FG001|Overall Study|Sponsor Decision|430|||
146281276|NCT02245737|527544629|FG002|Overall Study|Sponsor Decision|432|||
146281277|NCT04988867|527544635|FG000|Overall Study|Study terminated by Sponsor|12|||
146281278|NCT04988867|527544635|FG000|Overall Study|Adverse Event|2|||
146281279|NCT04988867|527544635|FG000|Overall Study|Study drug noncompliance|1|||
146281280|NCT01327495|527544636|FG000|Overall Study|Adverse Event|2|||
146281281|NCT01327495|527544637|FG001|Overall Study|Adverse Event|1|||
146281282|NCT01327495|527544638|FG002|Overall Study|Adverse Event|1|||
146281283|NCT01327495|527544639|FG003|Overall Study|Adverse Event|0|||
146281284|NCT01327495|527544640|FG004|Overall Study|Adverse Event|0|||
146281285|NCT01327495|527544641|FG005|Overall Study|Adverse Event|2|||
146281286|NCT01327495|527544636|FG000|Overall Study|Withdrawal by Subject|0|||
146159361|NCT00254982|527094531|FG000|Overall Study|Abnormal liver function tests|2|||
146159362|NCT00254982|527094532|FG001|Overall Study|Abnormal liver function tests|1|||
146159363|NCT03643952|527094535|FG000|Overall Study|Lack of Efficacy|1|||
146159364|NCT01358968|527094536|FG000|Period 2|Adverse Event|0|||
146159365|NCT01358968|527094537|FG001|Period 2|Adverse Event|1|||
146159366|NCT01358968|527094538|FG002|Period 2|Adverse Event|0|||
146281287|NCT01327495|527544637|FG001|Overall Study|Withdrawal by Subject|1|||
146281288|NCT01327495|527544638|FG002|Overall Study|Withdrawal by Subject|1|||
146281289|NCT01327495|527544639|FG003|Overall Study|Withdrawal by Subject|0|||
146281290|NCT01327495|527544640|FG004|Overall Study|Withdrawal by Subject|1|||
146281291|NCT01327495|527544641|FG005|Overall Study|Withdrawal by Subject|0|||
146281292|NCT01327495|527544636|FG000|Overall Study|Physician Decision|0|||
146313576|NCT01297270|527660995|FG002|Overall Study|Not treated|0|||
146313577|NCT00401752|527660996|FG000|Overall Study|Adverse Event|2|||
146313578|NCT00401752|527660997|FG001|Overall Study|Adverse Event|5|||
146313579|NCT00401752|527660996|FG000|Overall Study|Withdrawal by Subject|2|||
146313580|NCT00401752|527660997|FG001|Overall Study|Withdrawal by Subject|6|||
146313581|NCT00401752|527660996|FG000|Overall Study|Lost to Follow-up|1|||
146313582|NCT00401752|527660997|FG001|Overall Study|Lost to Follow-up|4|||
146313583|NCT00401752|527660996|FG000|Overall Study|Development of any exclusion criteria|4|||
146313584|NCT00401752|527660997|FG001|Overall Study|Development of any exclusion criteria|2|||
146313585|NCT00401752|527660996|FG000|Overall Study|Physician Decision|1|||
146313586|NCT00401752|527660997|FG001|Overall Study|Physician Decision|1|||
146313587|NCT00382993|527660998|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
146313588|NCT00382993|527660999|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
146313589|NCT00382993|527660998|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
146313590|NCT00382993|527660999|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
146313591|NCT00382993|527660998|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
146313592|NCT00382993|527660999|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
146313593|NCT00382993|527660998|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
146313594|NCT00382993|527660999|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
146313595|NCT00382993|527660998|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
146313596|NCT00382993|527660999|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
146313597|NCT00382993|527660998|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
146313598|NCT00382993|527660999|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
146313599|NCT00382993|527660998|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
146313600|NCT00382993|527660999|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
146313601|NCT00382993|527660998|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
146313602|NCT00382993|527660999|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
146313603|NCT00382993|527660998|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
146313604|NCT00382993|527660999|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
146313605|NCT00382993|527660998|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
146313606|NCT00382993|527660999|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
146313607|NCT01029366|527661006|FG000|Overall Study|Withdrawal by Subject|1|||
146313608|NCT01029366|527661007|FG001|Overall Study|Withdrawal by Subject|0|||
146313609|NCT01029366|527661006|FG000|Overall Study|Death|1|||
146313610|NCT01029366|527661007|FG001|Overall Study|Death|1|||
146313611|NCT01029366|527661006|FG000|Overall Study|disease progression|2|||
146313612|NCT01029366|527661007|FG001|Overall Study|disease progression|0|||
146313613|NCT01029366|527661006|FG000|Overall Study|manufacturing failure|0|||
146313614|NCT01029366|527661007|FG001|Overall Study|manufacturing failure|1|||
146313615|NCT00906087|527661008|FG000|Initial Washout|Withdrawal by Subject|1|||
146313616|NCT00906087|527661008|FG000|Initial Washout|Physician Decision|1|||
146313617|NCT01827670|527661017|FG000|Overall Study|Withdrawal of Consent|3|||
146313618|NCT01827670|527661018|FG001|Overall Study|Withdrawal of Consent|2|||
146313619|NCT01827670|527661017|FG000|Overall Study|Lost to Follow-up|0|||
146313620|NCT01827670|527661018|FG001|Overall Study|Lost to Follow-up|1|||
146313621|NCT03681119|527661023|FG000|Overall Study|No specific reason|4|||
146313622|NCT03681119|527661024|FG001|Overall Study|No specific reason|0|||
146313623|NCT03681119|527661023|FG000|Overall Study|Sickness|2|||
146313624|NCT03681119|527661024|FG001|Overall Study|Sickness|0|||
146313625|NCT02970292|527661025|FG000|Overall Study|Physician Decision|1|||
146313626|NCT02970292|527661026|FG001|Overall Study|Physician Decision|1|||
146313627|NCT02970292|527661025|FG000|Overall Study|Withdrawal by Subject|11|||
146313628|NCT02970292|527661026|FG001|Overall Study|Withdrawal by Subject|5|||
146313629|NCT02970292|527661025|FG000|Overall Study|Noncompliance with study drug|2|||
146313630|NCT02970292|527661026|FG001|Overall Study|Noncompliance with study drug|2|||
146313631|NCT02970292|527661025|FG000|Overall Study|Adverse Event|5|||
146313632|NCT02970292|527661026|FG001|Overall Study|Adverse Event|0|||
146313633|NCT02970292|527661025|FG000|Overall Study|Lack of Efficacy|1|||
146313634|NCT02970292|527661026|FG001|Overall Study|Lack of Efficacy|0|||
146313635|NCT02970292|527661025|FG000|Overall Study|Lost to Follow-up|1|||
146313636|NCT02970292|527661026|FG001|Overall Study|Lost to Follow-up|0|||
146313637|NCT02970292|527661025|FG000|Overall Study|Protocol Violation|2|||
146313638|NCT02970292|527661026|FG001|Overall Study|Protocol Violation|0|||
146313639|NCT02970292|527661025|FG000|Overall Study|Other|1|||
146313640|NCT02970292|527661026|FG001|Overall Study|Other|0|||
146313641|NCT02941627|527661035|FG000|Overall Study|Death|1|||
146313642|NCT02941627|527661035|FG000|Overall Study|Surgical failure|1|||
146313643|NCT02941627|527661035|FG000|Overall Study|cholesteatoma prevented implantation|1|||
146313644|NCT00606320|527661036|FG000|Overall Study|Adverse Event|3|||
146313645|NCT00606320|527661036|FG000|Overall Study|Lack of Efficacy|5|||
146313646|NCT00606320|527661036|FG000|Overall Study|Physician Decision|7|||
146313647|NCT00606320|527661036|FG000|Overall Study|Protocol Violation|8|||
146313648|NCT00606320|527661036|FG000|Overall Study|Withdrawal by Subject|10|||
146313649|NCT00606320|527661036|FG000|Overall Study|Progression to depressive phase|4|||
146159367|NCT01358968|527094539|FG003|Period 2|Adverse Event|0|||
146159368|NCT01358968|527094536|FG000|Continued Access Phase|Progression of Disease|0|||
146159369|NCT01358968|527094537|FG001|Continued Access Phase|Progression of Disease|0|||
146159370|NCT01358968|527094538|FG002|Continued Access Phase|Progression of Disease|8|||
146159371|NCT01358968|527094539|FG003|Continued Access Phase|Progression of Disease|4|||
146159372|NCT01358968|527094536|FG000|Continued Access Phase|Protocol Violation|0|||
146159373|NCT01358968|527094537|FG001|Continued Access Phase|Protocol Violation|0|||
146159374|NCT01358968|527094538|FG002|Continued Access Phase|Protocol Violation|0|||
146159375|NCT01358968|527094539|FG003|Continued Access Phase|Protocol Violation|2|||
146159376|NCT01358968|527094536|FG000|Continued Access Phase|Withdrawal by Subject|0|||
146159377|NCT01358968|527094537|FG001|Continued Access Phase|Withdrawal by Subject|0|||
146159378|NCT01358968|527094538|FG002|Continued Access Phase|Withdrawal by Subject|3|||
146159379|NCT01358968|527094539|FG003|Continued Access Phase|Withdrawal by Subject|0|||
146281293|NCT01327495|527544637|FG001|Overall Study|Physician Decision|0|||
146281294|NCT01327495|527544638|FG002|Overall Study|Physician Decision|0|||
146281295|NCT01327495|527544639|FG003|Overall Study|Physician Decision|0|||
146281296|NCT01327495|527544640|FG004|Overall Study|Physician Decision|2|||
146281297|NCT01327495|527544641|FG005|Overall Study|Physician Decision|0|||
146281298|NCT03020576|527544648|FG000|Overall Study|Withdrawal by Subject|1|||
146281299|NCT03020576|527544649|FG001|Overall Study|Withdrawal by Subject|2|||
146281300|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
146281301|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146281302|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146281303|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146281304|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
146281305|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
146281306|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146281307|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146281308|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146281309|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
146281310|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
146281311|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146281312|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146281313|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146281314|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
146281315|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
146281316|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146281317|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146281318|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146281319|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
146281320|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
146281321|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146281322|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146281323|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146281324|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
146281325|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
146281326|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146281327|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146281328|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146281329|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
146281330|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
146281331|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146281332|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146281333|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146281334|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
146281335|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
146281336|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146281337|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146281338|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146281339|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
146281340|NCT00700427|527544652|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
146281341|NCT00700427|527544653|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146281342|NCT00700427|527544654|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146281343|NCT00700427|527544655|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146281344|NCT00700427|527544656|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
146281345|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146281346|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
146281347|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146281348|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146281349|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
146281350|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146281351|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
146281352|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146281353|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146281354|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
146281355|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146281356|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
146281357|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146281358|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146281359|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
146281360|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146281361|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
146281362|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146281363|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146281364|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
146281365|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146281366|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
146281367|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146281368|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146281369|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
146281370|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146281371|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
146281372|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146281373|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146281374|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
146281375|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146281376|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
146281377|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146281378|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146281379|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
146281380|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146281381|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
146281382|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146281383|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146281384|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
146281385|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146281386|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
146281387|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146281388|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146281389|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
146281390|NCT00700427|527544652|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146281391|NCT00700427|527544653|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
146281392|NCT00700427|527544654|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146281393|NCT00700427|527544655|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146281394|NCT00700427|527544656|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
146281395|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146281396|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146281397|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
146281398|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
146281399|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
146281400|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
146281401|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
146281402|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
146281403|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
146281404|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
146281405|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
146281406|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
146281407|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
146313650|NCT00563186|527661037|FG000|Overall Study|LOS<48 hours|97|||
146313651|NCT00563186|527661038|FG001|Overall Study|LOS<48 hours|74|||
146313652|NCT00563186|527661037|FG000|Overall Study|Incomplete data|1|||
146159380|NCT01358968|527094536|FG000|Continued Access Phase|Death|0|||
146159381|NCT01358968|527094537|FG001|Continued Access Phase|Death|0|||
146159382|NCT01358968|527094538|FG002|Continued Access Phase|Death|1|||
146159383|NCT01358968|527094539|FG003|Continued Access Phase|Death|1|||
146159384|NCT04052204|527094542|FG000|Overall Study|Death|1|||
146159385|NCT04052204|527094543|FG001|Overall Study|Death|0|||
146159386|NCT04052204|527094544|FG002|Overall Study|Death|0|||
146159387|NCT04052204|527094542|FG000|Overall Study|Progressive disease|1|||
146159388|NCT04052204|527094543|FG001|Overall Study|Progressive disease|0|||
146159389|NCT04052204|527094544|FG002|Overall Study|Progressive disease|0|||
146159390|NCT04052204|527094542|FG000|Overall Study|Other|1|||
146159391|NCT04052204|527094543|FG001|Overall Study|Other|0|||
146159392|NCT04052204|527094544|FG002|Overall Study|Other|0|||
146159393|NCT04124926|527094563|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
146159394|NCT04124926|527094564|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
146159395|NCT04124926|527094565|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146159396|NCT04124926|527094566|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146159397|NCT04124926|527094567|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
146159398|NCT04124926|527094563|FG000|Healing Phase|Protocol Violation|0|||
146159399|NCT04124926|527094564|FG001|Healing Phase|Protocol Violation|1|||
146159400|NCT04124926|527094565|FG002|Healing Phase|Protocol Violation|0|||
146159401|NCT04124926|527094566|FG003|Healing Phase|Protocol Violation|0|||
146159402|NCT04124926|527094567|FG004|Healing Phase|Protocol Violation|0|||
146159403|NCT04124926|527094563|FG000|Healing Phase|Lost to Follow-up|5|||
146159404|NCT04124926|527094564|FG001|Healing Phase|Lost to Follow-up|4|||
146159405|NCT04124926|527094565|FG002|Healing Phase|Lost to Follow-up|0|||
146159406|NCT04124926|527094566|FG003|Healing Phase|Lost to Follow-up|0|||
146159407|NCT04124926|527094567|FG004|Healing Phase|Lost to Follow-up|0|||
146159408|NCT04124926|527094563|FG000|Healing Phase|Voluntary Withdrawal|10|||
146159409|NCT04124926|527094564|FG001|Healing Phase|Voluntary Withdrawal|7|||
146159410|NCT04124926|527094565|FG002|Healing Phase|Voluntary Withdrawal|0|||
146159411|NCT04124926|527094566|FG003|Healing Phase|Voluntary Withdrawal|0|||
146159412|NCT04124926|527094567|FG004|Healing Phase|Voluntary Withdrawal|0|||
146281408|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
146313653|NCT00563186|527661038|FG001|Overall Study|Incomplete data|1|||
146281409|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
146281410|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146281411|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146281412|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
146281413|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
146281414|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
146281415|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146281416|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146281417|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
146281418|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
146281419|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
146281420|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146281421|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146281422|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146281423|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
146281424|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
146281425|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146281426|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146281427|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146281428|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
146281429|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
146281430|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
146281431|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
146281432|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
146281433|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
146281434|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
146313654|NCT01152021|527661039|FG000|Overall Study|Adverse Event|4|||
146313655|NCT01152021|527661040|FG001|Overall Study|Adverse Event|4|||
146313656|NCT01152021|527661039|FG000|Overall Study|Study drug had expired|1|||
146313657|NCT01152021|527661040|FG001|Overall Study|Study drug had expired|0|||
146313658|NCT01152021|527661039|FG000|Overall Study|Physician Decision|1|||
146313659|NCT01152021|527661040|FG001|Overall Study|Physician Decision|1|||
146313660|NCT01152021|527661039|FG000|Overall Study|No access to study drug in Pharmacy|0|||
146313661|NCT01152021|527661040|FG001|Overall Study|No access to study drug in Pharmacy|1|||
146159413|NCT04124926|527094563|FG000|Healing Phase|Withdrawal of Consent|5|||
146159414|NCT04124926|527094564|FG001|Healing Phase|Withdrawal of Consent|3|||
146313662|NCT02595723|527661041|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
146313663|NCT02595723|527661042|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
146313664|NCT02595723|527661043|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
146313665|NCT02595723|527661041|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
146313666|NCT02595723|527661042|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
146313667|NCT02595723|527661043|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
146313668|NCT04839380|527661044|FG000|Overall Study|Withdrawal by Subject|2|||
146313669|NCT04839380|527661044|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
146313670|NCT01087905|527661045|FG000|Overall Study|Lost to Follow-up|24|||
146313671|NCT01087905|527661046|FG001|Overall Study|Lost to Follow-up|28|||
146313672|NCT01087905|527661047|FG002|Overall Study|Lost to Follow-up|18|||
146313673|NCT01087905|527661048|FG003|Overall Study|Lost to Follow-up|31|||
146313674|NCT01087905|527661049|FG004|Overall Study|Lost to Follow-up|27|||
146313675|NCT01087905|527661050|FG005|Overall Study|Lost to Follow-up|25|||
146313676|NCT01087905|527661051|FG006|Overall Study|Lost to Follow-up|20|||
146313677|NCT01087905|527661052|FG007|Overall Study|Lost to Follow-up|24|||
146313678|NCT01087905|527661045|FG000|Overall Study|Withdrawal by Subject|5|||
146313679|NCT01087905|527661046|FG001|Overall Study|Withdrawal by Subject|4|||
146313680|NCT01087905|527661047|FG002|Overall Study|Withdrawal by Subject|4|||
146313681|NCT01087905|527661048|FG003|Overall Study|Withdrawal by Subject|5|||
146313682|NCT01087905|527661049|FG004|Overall Study|Withdrawal by Subject|4|||
146313683|NCT01087905|527661050|FG005|Overall Study|Withdrawal by Subject|3|||
146313684|NCT01087905|527661051|FG006|Overall Study|Withdrawal by Subject|3|||
146313685|NCT01087905|527661052|FG007|Overall Study|Withdrawal by Subject|5|||
146313686|NCT01347554|527661053|FG000|Overall Study|Lack of Efficacy|7|||
146313687|NCT01347554|527661054|FG001|Overall Study|Lack of Efficacy|11|||
146313688|NCT00004259|527661058|FG000|Overall Study|Protocol Violation|1|||
146313689|NCT00004259|527661059|FG001|Overall Study|Protocol Violation|2|||
146313690|NCT00004259|527661060|FG002|Overall Study|Protocol Violation|0|||
146313691|NCT00004259|527661061|FG003|Overall Study|Protocol Violation|0|||
146313692|NCT00004259|527661058|FG000|Overall Study|Withdrawal by Subject|0|||
146313693|NCT00004259|527661059|FG001|Overall Study|Withdrawal by Subject|2|||
146313694|NCT00004259|527661060|FG002|Overall Study|Withdrawal by Subject|0|||
146313695|NCT00004259|527661061|FG003|Overall Study|Withdrawal by Subject|0|||
146313696|NCT01902290|527661066|FG000|Overall Study|Withdrawal by Subject|19|||
146313697|NCT01902290|527661067|FG001|Overall Study|Withdrawal by Subject|27|||
146313698|NCT01902290|527661066|FG000|Overall Study|Lost to Follow-up|2|||
146313699|NCT01902290|527661067|FG001|Overall Study|Lost to Follow-up|2|||
146313700|NCT01902290|527661066|FG000|Overall Study|Death|1|||
146313701|NCT01902290|527661067|FG001|Overall Study|Death|0|||
146313702|NCT01902290|527661066|FG000|Overall Study|Sponsor Decision|26|||
146313703|NCT01902290|527661067|FG001|Overall Study|Sponsor Decision|24|||
146313704|NCT00517829|527661068|FG000|Overall Study|Adverse Event|22|||
146313705|NCT00517829|527661069|FG001|Overall Study|Adverse Event|34|||
146313706|NCT00517829|527661068|FG000|Overall Study|Disease Progression|39|||
146313707|NCT00517829|527661069|FG001|Overall Study|Disease Progression|32|||
146313708|NCT00517829|527661068|FG000|Overall Study|Patient Request|6|||
146313709|NCT00517829|527661069|FG001|Overall Study|Patient Request|5|||
146313710|NCT00517829|527661068|FG000|Overall Study|Investigator Request|5|||
146313711|NCT00517829|527661069|FG001|Overall Study|Investigator Request|3|||
146313712|NCT00517829|527661068|FG000|Overall Study|Other|3|||
146313713|NCT00517829|527661069|FG001|Overall Study|Other|1|||
146313714|NCT00109707|527661074|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
146313715|NCT00109707|527661075|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
146313716|NCT00109707|527661076|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
146313717|NCT00109707|527661074|FG000|Overall Study|Abnormal laboratory values|1|||
146313718|NCT00109707|527661075|FG001|Overall Study|Abnormal laboratory values|0|||
146313719|NCT00109707|527661076|FG002|Overall Study|Abnormal laboratory values|0|||
146313720|NCT00109707|527661074|FG000|Overall Study|Administrative problems|2|||
146313721|NCT00109707|527661075|FG001|Overall Study|Administrative problems|0|||
146313722|NCT00109707|527661076|FG002|Overall Study|Administrative problems|1|||
146313723|NCT00109707|527661074|FG000|Overall Study|Adverse Event|10|||
146313724|NCT00109707|527661075|FG001|Overall Study|Adverse Event|2|||
146313725|NCT00109707|527661076|FG002|Overall Study|Adverse Event|3|||
146313726|NCT00109707|527661074|FG000|Overall Study|Death|4|||
146313727|NCT00109707|527661075|FG001|Overall Study|Death|0|||
146313728|NCT00109707|527661076|FG002|Overall Study|Death|0|||
146313729|NCT00109707|527661074|FG000|Overall Study|Disease progression|12|||
146313730|NCT00109707|527661075|FG001|Overall Study|Disease progression|4|||
146313731|NCT00109707|527661076|FG002|Overall Study|Disease progression|3|||
146313732|NCT00109707|527661074|FG000|Overall Study|Lost to Follow-up|3|||
146313733|NCT00109707|527661075|FG001|Overall Study|Lost to Follow-up|0|||
146313734|NCT00109707|527661076|FG002|Overall Study|Lost to Follow-up|0|||
146313735|NCT00109707|527661074|FG000|Overall Study|Protocol Violation|1|||
146313736|NCT00109707|527661075|FG001|Overall Study|Protocol Violation|0|||
146313737|NCT00109707|527661076|FG002|Overall Study|Protocol Violation|0|||
146313738|NCT00109707|527661074|FG000|Overall Study|Patient withdrew consent|6|||
146313739|NCT00109707|527661075|FG001|Overall Study|Patient withdrew consent|1|||
146313740|NCT00109707|527661076|FG002|Overall Study|Patient withdrew consent|0|||
146313741|NCT03436862|527661079|FG000|Overall Study|Adverse Event|4|||
146313742|NCT03436862|527661079|FG000|Overall Study|Progressive Disease|2|||
146313743|NCT02937818|527661080|FG000|Overall Study|Participants decision|2|||
146313744|NCT02937818|527661081|FG001|Overall Study|Participants decision|1|||
146159415|NCT04124926|527094565|FG002|Healing Phase|Withdrawal of Consent|0|||
146159416|NCT04124926|527094566|FG003|Healing Phase|Withdrawal of Consent|0|||
146159417|NCT04124926|527094567|FG004|Healing Phase|Withdrawal of Consent|0|||
146159418|NCT04124926|527094563|FG000|Healing Phase|Miscellaneous|8|||
146159419|NCT04124926|527094564|FG001|Healing Phase|Miscellaneous|7|||
146159420|NCT04124926|527094565|FG002|Healing Phase|Miscellaneous|0|||
146159421|NCT04124926|527094566|FG003|Healing Phase|Miscellaneous|0|||
146159422|NCT04124926|527094567|FG004|Healing Phase|Miscellaneous|0|||
146159423|NCT04124926|527094563|FG000|Healing Phase|Randomized but not Treated|0|||
146159424|NCT04124926|527094564|FG001|Healing Phase|Randomized but not Treated|3|||
146159425|NCT04124926|527094565|FG002|Healing Phase|Randomized but not Treated|0|||
146159426|NCT04124926|527094566|FG003|Healing Phase|Randomized but not Treated|0|||
146159427|NCT04124926|527094567|FG004|Healing Phase|Randomized but not Treated|0|||
146159428|NCT04124926|527094563|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
146159429|NCT04124926|527094564|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
146159430|NCT04124926|527094565|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
146159431|NCT04124926|527094566|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
146159432|NCT04124926|527094567|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
146159433|NCT04124926|527094563|FG000|Maintenance Phase|Protocol Violation|0|||
146159434|NCT04124926|527094564|FG001|Maintenance Phase|Protocol Violation|0|||
146159435|NCT04124926|527094565|FG002|Maintenance Phase|Protocol Violation|3|||
146159436|NCT04124926|527094566|FG003|Maintenance Phase|Protocol Violation|0|||
146159437|NCT04124926|527094567|FG004|Maintenance Phase|Protocol Violation|0|||
146159438|NCT04124926|527094563|FG000|Maintenance Phase|Lost to Follow-up|0|||
146159439|NCT04124926|527094564|FG001|Maintenance Phase|Lost to Follow-up|0|||
146159440|NCT04124926|527094565|FG002|Maintenance Phase|Lost to Follow-up|7|||
146159441|NCT04124926|527094566|FG003|Maintenance Phase|Lost to Follow-up|8|||
146313745|NCT02937818|527661082|FG002|Overall Study|Participants decision|1|||
146159442|NCT04124926|527094567|FG004|Maintenance Phase|Lost to Follow-up|9|||
146159443|NCT04124926|527094563|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
146159444|NCT04124926|527094564|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
146159445|NCT04124926|527094565|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
146159446|NCT04124926|527094566|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
146159447|NCT04124926|527094567|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
146159448|NCT04124926|527094563|FG000|Maintenance Phase|Pregnancy|0|||
146159449|NCT04124926|527094564|FG001|Maintenance Phase|Pregnancy|0|||
146159450|NCT04124926|527094565|FG002|Maintenance Phase|Pregnancy|0|||
146159451|NCT04124926|527094566|FG003|Maintenance Phase|Pregnancy|1|||
146159452|NCT04124926|527094567|FG004|Maintenance Phase|Pregnancy|0|||
146159453|NCT04124926|527094563|FG000|Maintenance Phase|Lack of Efficacy|0|||
146159454|NCT04124926|527094564|FG001|Maintenance Phase|Lack of Efficacy|0|||
146159455|NCT04124926|527094565|FG002|Maintenance Phase|Lack of Efficacy|0|||
146159456|NCT04124926|527094566|FG003|Maintenance Phase|Lack of Efficacy|0|||
146159457|NCT04124926|527094567|FG004|Maintenance Phase|Lack of Efficacy|1|||
146159458|NCT04124926|527094563|FG000|Maintenance Phase|Withdrawal of Consent|0|||
146159459|NCT04124926|527094564|FG001|Maintenance Phase|Withdrawal of Consent|0|||
146159460|NCT04124926|527094565|FG002|Maintenance Phase|Withdrawal of Consent|5|||
146159461|NCT04124926|527094566|FG003|Maintenance Phase|Withdrawal of Consent|5|||
146159462|NCT04124926|527094567|FG004|Maintenance Phase|Withdrawal of Consent|5|||
146159463|NCT04124926|527094563|FG000|Maintenance Phase|Miscellaneous|0|||
146159464|NCT04124926|527094564|FG001|Maintenance Phase|Miscellaneous|0|||
146159465|NCT04124926|527094565|FG002|Maintenance Phase|Miscellaneous|1|||
146159466|NCT04124926|527094566|FG003|Maintenance Phase|Miscellaneous|2|||
146159467|NCT04124926|527094567|FG004|Maintenance Phase|Miscellaneous|4|||
146159468|NCT04124926|527094563|FG000|Maintenance Phase|Randomized but not Treated|0|||
146159469|NCT04124926|527094564|FG001|Maintenance Phase|Randomized but not Treated|0|||
146159470|NCT04124926|527094565|FG002|Maintenance Phase|Randomized but not Treated|2|||
146159471|NCT04124926|527094566|FG003|Maintenance Phase|Randomized but not Treated|2|||
146159472|NCT04124926|527094567|FG004|Maintenance Phase|Randomized but not Treated|0|||
146159473|NCT02013622|527094573|FG000|Overall Study|Lost to Follow-up|10|||
146159474|NCT02013622|527094573|FG000|Overall Study|Adverse Event|3|||
146159475|NCT02013622|527094573|FG000|Overall Study|Met Withdrawal Criteria|3|||
146159476|NCT02013622|527094573|FG000|Overall Study|Withdrawal by Subject|6|||
146159477|NCT02013622|527094573|FG000|Overall Study|Protocol Deviation|1|||
146159478|NCT02013622|527094573|FG000|Overall Study|Lack of Efficacy|1|||
146159479|NCT05130970|527094576|FG000|Overall Study|Adverse Event|1|||
146159480|NCT05130970|527094577|FG001|Overall Study|Adverse Event|1|||
146313746|NCT02937818|527661083|FG003|Overall Study|Participants decision|1|||
146159481|NCT05130970|527094576|FG000|Overall Study|Death|0|||
146159482|NCT05130970|527094577|FG001|Overall Study|Death|1|||
146159483|NCT05130970|527094576|FG000|Overall Study|Lost to Follow-up|0|||
146159484|NCT05130970|527094577|FG001|Overall Study|Lost to Follow-up|1|||
146159485|NCT05130970|527094576|FG000|Overall Study|Physician Decision|0|||
146159486|NCT05130970|527094577|FG001|Overall Study|Physician Decision|1|||
146159487|NCT05130970|527094576|FG000|Overall Study|Withdrawal by Subject|1|||
146159488|NCT05130970|527094577|FG001|Overall Study|Withdrawal by Subject|1|||
146159489|NCT01388816|527094578|FG000|Overall Study|Adverse Event|0|||
146159490|NCT01388816|527094579|FG001|Overall Study|Adverse Event|2|||
146159491|NCT01388816|527094580|FG002|Overall Study|Adverse Event|0|||
146159492|NCT01388816|527094581|FG003|Overall Study|Adverse Event|0|||
146159493|NCT01388816|527094578|FG000|Overall Study|Lost to Follow-up|0|||
146159494|NCT01388816|527094579|FG001|Overall Study|Lost to Follow-up|1|||
146159495|NCT01388816|527094580|FG002|Overall Study|Lost to Follow-up|0|||
146159496|NCT01388816|527094581|FG003|Overall Study|Lost to Follow-up|0|||
146159497|NCT01388816|527094578|FG000|Overall Study|Withdrawal by Subject|2|||
146159498|NCT01388816|527094579|FG001|Overall Study|Withdrawal by Subject|1|||
146159499|NCT01388816|527094580|FG002|Overall Study|Withdrawal by Subject|1|||
146159500|NCT01388816|527094581|FG003|Overall Study|Withdrawal by Subject|0|||
146281435|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146281436|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146281437|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
146281438|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146281439|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
146281440|NCT00700427|527544652|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
146281441|NCT00700427|527544653|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
146281442|NCT00700427|527544654|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
146281443|NCT00700427|527544655|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
146281444|NCT00700427|527544656|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
146281445|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146281446|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146281447|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146281448|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
146281449|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
146281450|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
146281451|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
146281452|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
146281453|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
146281454|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
146281455|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146281456|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146281457|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146281458|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
146281459|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
146281460|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146281461|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146281462|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146281463|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
146281464|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
146281465|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146281466|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146281467|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146281468|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
146281469|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
146281470|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146281471|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146281472|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146281473|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
146281474|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
146281475|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146281476|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146281477|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146281478|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
146281479|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
146281480|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146159501|NCT01388816|527094578|FG000|Overall Study|Protocol Violation|0|||
146159502|NCT01388816|527094579|FG001|Overall Study|Protocol Violation|0|||
146159503|NCT01388816|527094580|FG002|Overall Study|Protocol Violation|2|||
146159504|NCT01388816|527094581|FG003|Overall Study|Protocol Violation|0|||
146159505|NCT00743366|527094582|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
146313747|NCT02937818|527661080|FG000|Overall Study|Adverse Event|2|||
146313748|NCT02937818|527661081|FG001|Overall Study|Adverse Event|4|||
146313749|NCT02937818|527661082|FG002|Overall Study|Adverse Event|1|||
146313750|NCT02937818|527661083|FG003|Overall Study|Adverse Event|1|||
146313751|NCT02937818|527661080|FG000|Overall Study|Disease progression|17|||
146313752|NCT02937818|527661081|FG001|Overall Study|Disease progression|15|||
146313753|NCT02937818|527661082|FG002|Overall Study|Disease progression|7|||
146313754|NCT02937818|527661083|FG003|Overall Study|Disease progression|19|||
146313755|NCT02937818|527661080|FG000|Overall Study|Condition under investigation worsened|0|||
146313756|NCT02937818|527661081|FG001|Overall Study|Condition under investigation worsened|0|||
146313757|NCT02937818|527661082|FG002|Overall Study|Condition under investigation worsened|1|||
146313758|NCT02937818|527661083|FG003|Overall Study|Condition under investigation worsened|0|||
146313759|NCT02054897|527661085|FG000|Overall Study|Withdrawal by Subject|2|||
146313760|NCT02054897|527661086|FG001|Overall Study|Withdrawal by Subject|0|||
146313761|NCT02054897|527661087|FG002|Overall Study|Withdrawal by Subject|2|||
146313762|NCT02054897|527661085|FG000|Overall Study|Missing follow-up information|3|||
146313763|NCT02054897|527661086|FG001|Overall Study|Missing follow-up information|5|||
146313764|NCT02054897|527661087|FG002|Overall Study|Missing follow-up information|3|||
146313765|NCT02054897|527661085|FG000|Overall Study|Lost to Follow-up|4|||
146313766|NCT02054897|527661086|FG001|Overall Study|Lost to Follow-up|2|||
146313767|NCT02054897|527661087|FG002|Overall Study|Lost to Follow-up|7|||
146313768|NCT02054897|527661085|FG000|Overall Study|Randomized but not exposed|1|||
146313769|NCT02054897|527661086|FG001|Overall Study|Randomized but not exposed|0|||
146313770|NCT02054897|527661087|FG002|Overall Study|Randomized but not exposed|0|||
146313771|NCT01119248|527661088|FG000|Overall Study|Physician Decision|5|||
146313772|NCT00550680|527661089|FG000|Overall Study|Administrative Reasons|1|||
146313773|NCT00550680|527661089|FG000|Overall Study|Adverse Event|5|||
146313774|NCT00550680|527661089|FG000|Overall Study|Death|3|||
146313775|NCT00550680|527661089|FG000|Overall Study|Early Improvement|1|||
146313776|NCT00550680|527661089|FG000|Overall Study|Lost to Follow-up|3|||
146313777|NCT00550680|527661089|FG000|Overall Study|Lack of Efficacy|1|||
146313778|NCT00550680|527661089|FG000|Overall Study|Other|10|||
146313779|NCT00550680|527661089|FG000|Overall Study|Protocol Violation|7|||
146313780|NCT00550680|527661089|FG000|Overall Study|Refused Treatment|19|||
146313781|NCT00550680|527661089|FG000|Overall Study|Screen Failure|6|||
146313782|NCT01967550|527661090|FG000|Overall Study|Withdrawal by Subject|1|||
146313783|NCT01967550|527661091|FG001|Overall Study|Withdrawal by Subject|0|||
146313784|NCT01967550|527661090|FG000|Overall Study|Adverse Event|2|||
146313785|NCT01967550|527661091|FG001|Overall Study|Adverse Event|0|||
146313786|NCT01967550|527661090|FG000|Overall Study|Protocol Violation|2|||
146313787|NCT01967550|527661091|FG001|Overall Study|Protocol Violation|1|||
146313788|NCT01967550|527661090|FG000|Overall Study|Non Compliance|0|||
146313789|NCT01967550|527661091|FG001|Overall Study|Non Compliance|1|||
146313790|NCT01100437|527661092|FG000|Titration/Stabilization|Adverse Event|0|||
146313791|NCT01100437|527661093|FG001|Titration/Stabilization|Adverse Event|0|||
146313792|NCT01100437|527661094|FG002|Titration/Stabilization|Adverse Event|4|||
146313793|NCT01100437|527661092|FG000|Titration/Stabilization|Non-compliance|0|||
146313794|NCT01100437|527661093|FG001|Titration/Stabilization|Non-compliance|0|||
146313795|NCT01100437|527661094|FG002|Titration/Stabilization|Non-compliance|1|||
146313796|NCT01100437|527661092|FG000|Titration/Stabilization|Sponsor canceled study|0|||
146313797|NCT01100437|527661093|FG001|Titration/Stabilization|Sponsor canceled study|0|||
146313798|NCT01100437|527661094|FG002|Titration/Stabilization|Sponsor canceled study|1|||
146313799|NCT01100437|527661092|FG000|Maintenance|Withdrawal by Subject|0|||
146313800|NCT01100437|527661093|FG001|Maintenance|Withdrawal by Subject|0|||
146313801|NCT01100437|527661094|FG002|Maintenance|Withdrawal by Subject|1|||
146313802|NCT01100437|527661092|FG000|Maintenance|Sponsor termination of study|0|||
146313803|NCT01100437|527661093|FG001|Maintenance|Sponsor termination of study|0|||
146313804|NCT01100437|527661094|FG002|Maintenance|Sponsor termination of study|1|||
146313805|NCT00805480|527661103|FG000|Overall Study|Withdrawal by Subject|13|||
146313806|NCT00805480|527661104|FG001|Overall Study|Withdrawal by Subject|5|||
146313807|NCT00805480|527661105|FG002|Overall Study|Withdrawal by Subject|11|||
146159506|NCT00743366|527094583|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
146159507|NCT02308748|527094586|FG000|Period 1|Withdrawal by Subject|0|||
146313808|NCT00805480|527661106|FG003|Overall Study|Withdrawal by Subject|5|||
146313809|NCT00805480|527661103|FG000|Overall Study|Lost to Follow-up|1|||
146313810|NCT00805480|527661104|FG001|Overall Study|Lost to Follow-up|2|||
146313811|NCT00805480|527661105|FG002|Overall Study|Lost to Follow-up|0|||
146313812|NCT00805480|527661106|FG003|Overall Study|Lost to Follow-up|0|||
146313813|NCT00805480|527661103|FG000|Overall Study|Adverse Event|0|||
146313814|NCT00805480|527661104|FG001|Overall Study|Adverse Event|0|||
146313815|NCT00805480|527661105|FG002|Overall Study|Adverse Event|1|||
146313816|NCT00805480|527661106|FG003|Overall Study|Adverse Event|0|||
146313817|NCT01534533|527661107|FG000|Overall Study|Lost to Follow-up|3|||
146313818|NCT01534533|527661108|FG001|Overall Study|Lost to Follow-up|0|||
146313819|NCT01534533|527661109|FG002|Overall Study|Lost to Follow-up|4|||
146313820|NCT01534533|527661110|FG003|Overall Study|Lost to Follow-up|3|||
146313821|NCT01534533|527661107|FG000|Overall Study|Withdrawal by Subject|5|||
146313822|NCT01534533|527661108|FG001|Overall Study|Withdrawal by Subject|3|||
146313823|NCT01534533|527661109|FG002|Overall Study|Withdrawal by Subject|4|||
146313824|NCT01534533|527661110|FG003|Overall Study|Withdrawal by Subject|1|||
146313825|NCT05032157|527662764|FG000|Overall Study|Adverse Event|12|||
146313826|NCT05032157|527662765|FG001|Overall Study|Adverse Event|7|||
146313827|NCT05032157|527662764|FG000|Overall Study|Pregnancy|0|||
146313828|NCT05032157|527662765|FG001|Overall Study|Pregnancy|2|||
146313829|NCT05032157|527662764|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146313830|NCT05032157|527662765|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
146313831|NCT05032157|527662764|FG000|Overall Study|Protocol Deviation|8|||
146313832|NCT05032157|527662765|FG001|Overall Study|Protocol Deviation|4|||
146313833|NCT05032157|527662764|FG000|Overall Study|Lost to Follow-up|1|||
146313834|NCT05032157|527662765|FG001|Overall Study|Lost to Follow-up|3|||
146313835|NCT05032157|527662764|FG000|Overall Study|Physician Decision|7|||
146313836|NCT05032157|527662765|FG001|Overall Study|Physician Decision|2|||
146313837|NCT05032157|527662764|FG000|Overall Study|Patient Decision|38|||
146313838|NCT05032157|527662765|FG001|Overall Study|Patient Decision|19|||
146313839|NCT03657043|527662766|FG000|Overall Study|Withdrawal by Subject|1|||
146313840|NCT03657043|527662767|FG001|Overall Study|Withdrawal by Subject|1|||
146313841|NCT03657043|527662768|FG002|Overall Study|Withdrawal by Subject|0|||
146313842|NCT03657043|527662769|FG003|Overall Study|Withdrawal by Subject|0|||
146313843|NCT03657043|527662770|FG004|Overall Study|Withdrawal by Subject|4|||
146313844|NCT03657043|527662766|FG000|Overall Study|Study closure by Sponsor|0|||
146313845|NCT03657043|527662767|FG001|Overall Study|Study closure by Sponsor|2|||
146313846|NCT03657043|527662768|FG002|Overall Study|Study closure by Sponsor|0|||
146313847|NCT03657043|527662769|FG003|Overall Study|Study closure by Sponsor|0|||
146313848|NCT03657043|527662770|FG004|Overall Study|Study closure by Sponsor|17|||
146313849|NCT03657043|527662766|FG000|Overall Study|Lost to Follow-up|0|||
146313850|NCT03657043|527662767|FG001|Overall Study|Lost to Follow-up|0|||
146313851|NCT03657043|527662768|FG002|Overall Study|Lost to Follow-up|0|||
146313852|NCT03657043|527662769|FG003|Overall Study|Lost to Follow-up|0|||
146313853|NCT03657043|527662770|FG004|Overall Study|Lost to Follow-up|4|||
146313854|NCT03657043|527662766|FG000|Overall Study|Death|6|||
146313855|NCT03657043|527662767|FG001|Overall Study|Death|5|||
146313856|NCT03657043|527662768|FG002|Overall Study|Death|0|||
146313857|NCT03657043|527662769|FG003|Overall Study|Death|0|||
146313858|NCT03657043|527662770|FG004|Overall Study|Death|53|||
146313859|NCT03657043|527662766|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
146313860|NCT03657043|527662767|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
146313861|NCT03657043|527662768|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
146313862|NCT03657043|527662769|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
146313863|NCT03657043|527662770|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
146313864|NCT03657043|527662766|FG000|Overall Study|Adverse Event|0|||
146313865|NCT03657043|527662767|FG001|Overall Study|Adverse Event|0|||
146313866|NCT03657043|527662768|FG002|Overall Study|Adverse Event|0|||
146313867|NCT03657043|527662769|FG003|Overall Study|Adverse Event|0|||
146313868|NCT03657043|527662770|FG004|Overall Study|Adverse Event|2|||
146313869|NCT03657043|527662766|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
146313870|NCT03657043|527662767|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
146313871|NCT03657043|527662768|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
146313872|NCT03657043|527662769|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
146313873|NCT03657043|527662770|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
146313874|NCT03657043|527662766|FG000|Overall Study|Withdrawal - declined follow-up|0|||
146313875|NCT03657043|527662767|FG001|Overall Study|Withdrawal - declined follow-up|0|||
146313876|NCT03657043|527662768|FG002|Overall Study|Withdrawal - declined follow-up|0|||
146313877|NCT03657043|527662769|FG003|Overall Study|Withdrawal - declined follow-up|0|||
146313878|NCT03657043|527662770|FG004|Overall Study|Withdrawal - declined follow-up|1|||
146313879|NCT03047980|527662771|FG000|Overall Study|Adverse Event|1|||
146313880|NCT02627495|527662774|FG000|Overall Study|Withdrawal by Subject|4|||
146313881|NCT00880893|527662775|FG000|Overall Study|Protocol Violation|13|||
146313882|NCT00880893|527662776|FG001|Overall Study|Protocol Violation|1|||
146159508|NCT02308748|527094587|FG001|Period 1|Withdrawal by Subject|0|||
146313883|NCT00880893|527662775|FG000|Overall Study|Withdrawal by Subject|15|||
146159509|NCT02308748|527094588|FG002|Period 1|Withdrawal by Subject|1|||
146313884|NCT00880893|527662776|FG001|Overall Study|Withdrawal by Subject|11|||
146313885|NCT00880893|527662775|FG000|Overall Study|Lost to Follow-up|76|||
146313886|NCT00880893|527662776|FG001|Overall Study|Lost to Follow-up|33|||
146313887|NCT00880893|527662775|FG000|Overall Study|Serious adverse event|3|||
146313888|NCT00880893|527662776|FG001|Overall Study|Serious adverse event|0|||
146313889|NCT00112905|527662777|FG000|Overall Study|Adverse Event|4|||
146313890|NCT00112905|527662777|FG000|Overall Study|Death|1|||
146313891|NCT00112905|527662777|FG000|Overall Study|Ineligibility|5|||
146313892|NCT00112905|527662777|FG000|Overall Study|Alternative treatment|1|||
146313893|NCT00112905|527662777|FG000|Overall Study|performance status was deteiorating|1|||
146313894|NCT02600507|527662778|FG000|Overall Study|Adverse Event|3|||
146313895|NCT02600507|527662779|FG001|Overall Study|Adverse Event|15|||
146159510|NCT02308748|527094589|FG003|Period 1|Withdrawal by Subject|0|||
146313896|NCT02600507|527662780|FG002|Overall Study|Adverse Event|5|||
146313897|NCT02600507|527662778|FG000|Overall Study|Lack of Efficacy|3|||
146313898|NCT02600507|527662779|FG001|Overall Study|Lack of Efficacy|8|||
146313899|NCT02600507|527662780|FG002|Overall Study|Lack of Efficacy|5|||
146313900|NCT02600507|527662778|FG000|Overall Study|Lost to Follow-up|3|||
146313901|NCT02600507|527662779|FG001|Overall Study|Lost to Follow-up|5|||
146313902|NCT02600507|527662780|FG002|Overall Study|Lost to Follow-up|2|||
146313903|NCT02600507|527662778|FG000|Overall Study|Protocol Violation|12|||
146313904|NCT02600507|527662779|FG001|Overall Study|Protocol Violation|4|||
146313905|NCT02600507|527662780|FG002|Overall Study|Protocol Violation|4|||
146313906|NCT02600507|527662778|FG000|Overall Study|Physician Decision|1|||
146313907|NCT02600507|527662779|FG001|Overall Study|Physician Decision|0|||
146313908|NCT02600507|527662780|FG002|Overall Study|Physician Decision|1|||
146313909|NCT02600507|527662778|FG000|Overall Study|Withdrawal by Subject|7|||
146313910|NCT02600507|527662779|FG001|Overall Study|Withdrawal by Subject|11|||
146313911|NCT02600507|527662780|FG002|Overall Study|Withdrawal by Subject|7|||
146313912|NCT02600507|527662778|FG000|Overall Study|Other|0|||
146313913|NCT02600507|527662779|FG001|Overall Study|Other|1|||
146313914|NCT02600507|527662780|FG002|Overall Study|Other|1|||
146313915|NCT04541004|527662785|FG000|Overall Study|Adverse Event|2|||
146313916|NCT00621504|527662786|FG000|Overall Study|Adverse Event|1|||
146313917|NCT00621504|527662787|FG001|Overall Study|Adverse Event|3|||
146313918|NCT00621504|527662786|FG000|Overall Study|At the request of sponsor/investigator|1|||
146313919|NCT00621504|527662787|FG001|Overall Study|At the request of sponsor/investigator|0|||
146313920|NCT00621504|527662786|FG000|Overall Study|Withdrew consent|9|||
146313921|NCT00621504|527662787|FG001|Overall Study|Withdrew consent|6|||
146313922|NCT00621504|527662786|FG000|Overall Study|Lost to Follow-up|8|||
146313923|NCT00621504|527662787|FG001|Overall Study|Lost to Follow-up|10|||
146313924|NCT00621504|527662786|FG000|Overall Study|Other|1|||
146313925|NCT00621504|527662787|FG001|Overall Study|Other|0|||
146313926|NCT00621504|527662786|FG000|Overall Study|Death|6|||
146313927|NCT00621504|527662787|FG001|Overall Study|Death|6|||
146313928|NCT00605085|527662788|FG000|Overall Study|Withdrawal by Subject|8|||
146313929|NCT00605085|527662789|FG001|Overall Study|Withdrawal by Subject|5|||
146313930|NCT00605085|527662788|FG000|Overall Study|Adverse Event|9|||
146313931|NCT00605085|527662789|FG001|Overall Study|Adverse Event|5|||
146313932|NCT00605085|527662788|FG000|Overall Study|Pregnancy|2|||
146313933|NCT00605085|527662789|FG001|Overall Study|Pregnancy|0|||
146313934|NCT00605085|527662788|FG000|Overall Study|Protocol Violation|3|||
146313935|NCT00605085|527662789|FG001|Overall Study|Protocol Violation|2|||
146313936|NCT00605085|527662788|FG000|Overall Study|Lost to Follow-up|10|||
146313937|NCT00605085|527662789|FG001|Overall Study|Lost to Follow-up|5|||
146313938|NCT00605085|527662788|FG000|Overall Study|administrative reasons|18|||
146313939|NCT00605085|527662789|FG001|Overall Study|administrative reasons|8|||
146313940|NCT01982292|527662792|FG000|Overall Study|Adverse Event|2|||
146313941|NCT01982292|527662793|FG001|Overall Study|Adverse Event|0|||
146313942|NCT01982292|527662792|FG000|Overall Study|Death|1|||
146313943|NCT01982292|527662793|FG001|Overall Study|Death|0|||
146313944|NCT01982292|527662792|FG000|Overall Study|Lost to Follow-up|2|||
146313945|NCT01982292|527662793|FG001|Overall Study|Lost to Follow-up|0|||
146313946|NCT01982292|527662792|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
146313947|NCT01982292|527662793|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
146313948|NCT01982292|527662792|FG000|Overall Study|Protocol Deviation|1|||
146313949|NCT01982292|527662793|FG001|Overall Study|Protocol Deviation|0|||
146313950|NCT01982292|527662792|FG000|Overall Study|Patient/Guardian Decision|3|||
146313951|NCT01982292|527662793|FG001|Overall Study|Patient/Guardian Decision|1|||
146313952|NCT01982292|527662792|FG000|Overall Study|Technical Problems|2|||
146313953|NCT01982292|527662793|FG001|Overall Study|Technical Problems|0|||
146313954|NCT01339559|527662801|FG000|Overall Study|Adverse Event|92|||
146313955|NCT01339559|527662801|FG000|Overall Study|Death|5|||
146313956|NCT01339559|527662801|FG000|Overall Study|Lack of Efficacy|164|||
146159511|NCT02308748|527094590|FG004|Period 1|Withdrawal by Subject|0|||
146159512|NCT02308748|527094591|FG005|Period 1|Withdrawal by Subject|0|||
146159513|NCT02308748|527094592|FG006|Period 1|Withdrawal by Subject|0|||
146313957|NCT01339559|527662801|FG000|Overall Study|Lost to Follow-up|22|||
146313958|NCT01339559|527662801|FG000|Overall Study|Subject choice|89|||
146313959|NCT01339559|527662801|FG000|Overall Study|Protocol Violation|15|||
146313960|NCT01339559|527662801|FG000|Overall Study|Study closure at site|1|||
146159514|NCT02308748|527094593|FG007|Period 1|Withdrawal by Subject|0|||
146313961|NCT01339559|527662801|FG000|Overall Study|Incarcerated|2|||
146313962|NCT01339559|527662801|FG000|Overall Study|Epilepsy surgery|1|||
146313963|NCT01339559|527662801|FG000|Overall Study|Pregnancy planned|2|||
146313964|NCT01339559|527662801|FG000|Overall Study|Left the country|1|||
146313965|NCT01339559|527662801|FG000|Overall Study|Investigator decision|2|||
146313966|NCT01339559|527662801|FG000|Overall Study|Patient didn't wish to continue|1|||
146313967|NCT01339559|527662801|FG000|Overall Study|PI decision|1|||
146313968|NCT00971945|527662802|FG000|Overall Study|Progressive Disease|3|||
146313969|NCT00971945|527662802|FG000|Overall Study|Change in treatment policy|1|||
146313970|NCT00971945|527662802|FG000|Overall Study|Other reasons|2|||
146313971|NCT03354663|527662803|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
146313972|NCT03354663|527662803|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
146313973|NCT03354663|527662803|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
146313974|NCT03354663|527662803|FG000|Completed 30-day Visit|Missed Visit|1|||
146313975|NCT01661140|527662804|FG000|Open-Label Period|Adverse Event|44|||
146313976|NCT01661140|527662805|FG001|Open-Label Period|Adverse Event|0|||
146313977|NCT01661140|527662806|FG002|Open-Label Period|Adverse Event|0|||
146313978|NCT01661140|527662804|FG000|Open-Label Period|Protocol Violation|3|||
146313979|NCT01661140|527662805|FG001|Open-Label Period|Protocol Violation|0|||
146313980|NCT01661140|527662806|FG002|Open-Label Period|Protocol Violation|0|||
146313981|NCT01661140|527662804|FG000|Open-Label Period|Withdrawal by Subject|5|||
146313982|NCT01661140|527662805|FG001|Open-Label Period|Withdrawal by Subject|0|||
146313983|NCT01661140|527662806|FG002|Open-Label Period|Withdrawal by Subject|0|||
146313984|NCT01661140|527662804|FG000|Open-Label Period|Investigator Decision|3|||
146313985|NCT01661140|527662805|FG001|Open-Label Period|Investigator Decision|0|||
146313986|NCT01661140|527662806|FG002|Open-Label Period|Investigator Decision|0|||
146313987|NCT01661140|527662804|FG000|Open-Label Period|Death|1|||
146313988|NCT01661140|527662805|FG001|Open-Label Period|Death|0|||
146313989|NCT01661140|527662806|FG002|Open-Label Period|Death|0|||
146313990|NCT01661140|527662804|FG000|Open-Label Period|Administrative/Other|1|||
146313991|NCT01661140|527662805|FG001|Open-Label Period|Administrative/Other|0|||
146313992|NCT01661140|527662806|FG002|Open-Label Period|Administrative/Other|0|||
146313993|NCT01661140|527662804|FG000|Open-Label Period|Sponsor termination|16|||
146313994|NCT01661140|527662805|FG001|Open-Label Period|Sponsor termination|0|||
146313995|NCT01661140|527662806|FG002|Open-Label Period|Sponsor termination|0|||
146313996|NCT01661140|527662804|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
146313997|NCT01661140|527662805|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
146313998|NCT01661140|527662806|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
146313999|NCT01661140|527662804|FG000|Open-Label Period|Lost to Follow-up|2|||
146314000|NCT01661140|527662805|FG001|Open-Label Period|Lost to Follow-up|0|||
146314001|NCT01661140|527662806|FG002|Open-Label Period|Lost to Follow-up|0|||
146314002|NCT01661140|527662804|FG000|Double-Blind Period|Refused Treatment|0|||
146314003|NCT01661140|527662805|FG001|Double-Blind Period|Refused Treatment|0|||
146314004|NCT01661140|527662806|FG002|Double-Blind Period|Refused Treatment|1|||
146314005|NCT01661140|527662804|FG000|Double-Blind Period|Adverse Event|0|||
146314006|NCT01661140|527662805|FG001|Double-Blind Period|Adverse Event|16|||
146314007|NCT01661140|527662806|FG002|Double-Blind Period|Adverse Event|18|||
146314008|NCT01661140|527662804|FG000|Double-Blind Period|Protocol Violation|0|||
146314009|NCT01661140|527662805|FG001|Double-Blind Period|Protocol Violation|2|||
146314010|NCT01661140|527662806|FG002|Double-Blind Period|Protocol Violation|3|||
146314011|NCT01661140|527662804|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146314012|NCT01661140|527662805|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146314013|NCT01661140|527662806|FG002|Double-Blind Period|Withdrawal by Subject|3|||
146314014|NCT01661140|527662804|FG000|Double-Blind Period|Investigator's Decision|0|||
146314015|NCT01661140|527662805|FG001|Double-Blind Period|Investigator's Decision|1|||
146314016|NCT01661140|527662806|FG002|Double-Blind Period|Investigator's Decision|2|||
146314017|NCT01661140|527662804|FG000|Double-Blind Period|Sponsor Termination|0|||
146314018|NCT01661140|527662805|FG001|Double-Blind Period|Sponsor Termination|14|||
146314019|NCT01661140|527662806|FG002|Double-Blind Period|Sponsor Termination|17|||
146314020|NCT01661140|527662804|FG000|Double-Blind Period|Administrative/Other|0|||
146314021|NCT01661140|527662805|FG001|Double-Blind Period|Administrative/Other|7|||
146314022|NCT01661140|527662806|FG002|Double-Blind Period|Administrative/Other|6|||
146314023|NCT02590588|527662809|FG000|Overall Study|Adverse Event|1|||
146314024|NCT01784861|527662819|FG000|Overall Study|Adverse Event|0|||
146314025|NCT01784861|527662820|FG001|Overall Study|Adverse Event|0|||
146314026|NCT01784861|527662821|FG002|Overall Study|Adverse Event|1|||
146314027|NCT01784861|527662822|FG003|Overall Study|Adverse Event|2|||
146314028|NCT01784861|527662823|FG004|Overall Study|Adverse Event|1|||
146314029|NCT01784861|527662824|FG005|Overall Study|Adverse Event|0|||
146314030|NCT01784861|527662819|FG000|Overall Study|Withdrawal by Subject|0|||
146159515|NCT02308748|527094594|FG008|Period 1|Withdrawal by Subject|0|||
146159516|NCT02308748|527094595|FG009|Period 1|Withdrawal by Subject|0|||
146159517|NCT02308748|527094586|FG000|Period 2|Adverse Event|0|||
146314031|NCT01784861|527662820|FG001|Overall Study|Withdrawal by Subject|0|||
146314032|NCT01784861|527662821|FG002|Overall Study|Withdrawal by Subject|0|||
146314033|NCT01784861|527662822|FG003|Overall Study|Withdrawal by Subject|1|||
146314034|NCT01784861|527662823|FG004|Overall Study|Withdrawal by Subject|0|||
146314035|NCT01784861|527662824|FG005|Overall Study|Withdrawal by Subject|0|||
146314036|NCT01784861|527662819|FG000|Overall Study|Physician Decision|0|||
146314037|NCT01784861|527662820|FG001|Overall Study|Physician Decision|0|||
146314038|NCT01784861|527662821|FG002|Overall Study|Physician Decision|0|||
146314039|NCT01784861|527662822|FG003|Overall Study|Physician Decision|2|||
146314040|NCT01784861|527662823|FG004|Overall Study|Physician Decision|0|||
146159518|NCT02308748|527094587|FG001|Period 2|Adverse Event|0|||
146314041|NCT01784861|527662824|FG005|Overall Study|Physician Decision|1|||
146314042|NCT02432235|527662825|FG000|Overall Study|Death|1|||
146314043|NCT02432235|527662826|FG001|Overall Study|Death|1|||
146159519|NCT02308748|527094588|FG002|Period 2|Adverse Event|0|||
146314044|NCT02432235|527662827|FG002|Overall Study|Death|2|||
146314045|NCT02432235|527662828|FG003|Overall Study|Death|2|||
146314046|NCT02432235|527662829|FG004|Overall Study|Death|1|||
146314047|NCT02432235|527662830|FG005|Overall Study|Death|3|||
146314048|NCT02432235|527662831|FG006|Overall Study|Death|11|||
146314049|NCT02432235|527662832|FG007|Overall Study|Death|15|||
146314050|NCT02432235|527662833|FG008|Overall Study|Death|15|||
146314051|NCT02432235|527662834|FG009|Overall Study|Death|3|||
146314052|NCT02432235|527662835|FG010|Overall Study|Death|1|||
146314053|NCT02432235|527662836|FG011|Overall Study|Death|0|||
146314054|NCT02432235|527662825|FG000|Overall Study|Withdrawal by Subject|0|||
146314055|NCT02432235|527662826|FG001|Overall Study|Withdrawal by Subject|1|||
146314056|NCT02432235|527662827|FG002|Overall Study|Withdrawal by Subject|0|||
146314057|NCT02432235|527662828|FG003|Overall Study|Withdrawal by Subject|0|||
146314058|NCT02432235|527662829|FG004|Overall Study|Withdrawal by Subject|0|||
146314059|NCT02432235|527662830|FG005|Overall Study|Withdrawal by Subject|2|||
146314060|NCT02432235|527662831|FG006|Overall Study|Withdrawal by Subject|5|||
146314061|NCT02432235|527662832|FG007|Overall Study|Withdrawal by Subject|3|||
146314062|NCT02432235|527662833|FG008|Overall Study|Withdrawal by Subject|1|||
146314063|NCT02432235|527662834|FG009|Overall Study|Withdrawal by Subject|0|||
146314064|NCT02432235|527662835|FG010|Overall Study|Withdrawal by Subject|0|||
146314065|NCT02432235|527662836|FG011|Overall Study|Withdrawal by Subject|0|||
146314066|NCT02432235|527662825|FG000|Overall Study|Lost to Follow-up|0|||
146314067|NCT02432235|527662826|FG001|Overall Study|Lost to Follow-up|0|||
146314068|NCT02432235|527662827|FG002|Overall Study|Lost to Follow-up|0|||
146314069|NCT02432235|527662828|FG003|Overall Study|Lost to Follow-up|0|||
146314070|NCT02432235|527662829|FG004|Overall Study|Lost to Follow-up|0|||
146314071|NCT02432235|527662830|FG005|Overall Study|Lost to Follow-up|1|||
146314072|NCT02432235|527662831|FG006|Overall Study|Lost to Follow-up|0|||
146314073|NCT02432235|527662832|FG007|Overall Study|Lost to Follow-up|0|||
146314074|NCT02432235|527662833|FG008|Overall Study|Lost to Follow-up|1|||
146314075|NCT02432235|527662834|FG009|Overall Study|Lost to Follow-up|0|||
146314076|NCT02432235|527662835|FG010|Overall Study|Lost to Follow-up|0|||
146314077|NCT02432235|527662836|FG011|Overall Study|Lost to Follow-up|0|||
146314078|NCT02432235|527662825|FG000|Overall Study|Miscellaneous|0|||
146314079|NCT02432235|527662826|FG001|Overall Study|Miscellaneous|0|||
146314080|NCT02432235|527662827|FG002|Overall Study|Miscellaneous|0|||
146314081|NCT02432235|527662828|FG003|Overall Study|Miscellaneous|0|||
146314082|NCT02432235|527662829|FG004|Overall Study|Miscellaneous|1|||
146314083|NCT02432235|527662830|FG005|Overall Study|Miscellaneous|6|||
146314084|NCT02432235|527662831|FG006|Overall Study|Miscellaneous|2|||
146314085|NCT02432235|527662832|FG007|Overall Study|Miscellaneous|2|||
146314086|NCT02432235|527662833|FG008|Overall Study|Miscellaneous|4|||
146314087|NCT02432235|527662834|FG009|Overall Study|Miscellaneous|0|||
146314088|NCT02432235|527662835|FG010|Overall Study|Miscellaneous|0|||
146314089|NCT02432235|527662836|FG011|Overall Study|Miscellaneous|1|||
146314090|NCT01895322|527662837|FG000|Overall Study|Adverse Event|1|||
146314091|NCT01895322|527662837|FG000|Overall Study|Withdrawal by Subject|2|||
146314092|NCT01895322|527662837|FG000|Overall Study|Protocol Violation|10|||
146314093|NCT00143312|527662840|FG000|Overall Study|Death|11|||
146314094|NCT00143312|527662840|FG000|Overall Study|Adverse Event|2|||
146314095|NCT00143312|527662840|FG000|Overall Study|Lost to Follow-up|1|||
146314096|NCT00143312|527662840|FG000|Overall Study|Other|1|||
146314097|NCT00143312|527662840|FG000|Overall Study|Withdrawal by Subject|1|||
146314098|NCT00440947|527662841|FG000|36-Week Induction Phase|Adverse Event|16|||
146314099|NCT00440947|527662842|FG001|36-Week Induction Phase|Adverse Event|0|||
146314100|NCT00440947|527662843|FG002|36-Week Induction Phase|Adverse Event|0|||
146314101|NCT00440947|527662844|FG003|36-Week Induction Phase|Adverse Event|0|||
146314102|NCT00440947|527662845|FG004|36-Week Induction Phase|Adverse Event|0|||
146159520|NCT02308748|527094589|FG003|Period 2|Adverse Event|0|||
146159521|NCT02308748|527094590|FG004|Period 2|Adverse Event|0|||
146159522|NCT02308748|527094591|FG005|Period 2|Adverse Event|0|||
146159523|NCT02308748|527094592|FG006|Period 2|Adverse Event|0|||
146314103|NCT00440947|527662841|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
146314104|NCT00440947|527662842|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146314105|NCT00440947|527662843|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146159524|NCT02308748|527094593|FG007|Period 2|Adverse Event|1|||
146314106|NCT00440947|527662844|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146314107|NCT00440947|527662845|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
146314108|NCT00440947|527662841|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
146314109|NCT00440947|527662842|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146159525|NCT02308748|527094594|FG008|Period 2|Adverse Event|0|||
146159526|NCT02308748|527094595|FG009|Period 2|Adverse Event|0|||
146314110|NCT00440947|527662843|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146314111|NCT00440947|527662844|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146314112|NCT00440947|527662845|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
146314113|NCT00440947|527662841|FG000|36-Week Induction Phase|Non-compliance|10|||
146314114|NCT00440947|527662842|FG001|36-Week Induction Phase|Non-compliance|0|||
146314115|NCT00440947|527662843|FG002|36-Week Induction Phase|Non-compliance|0|||
146314116|NCT00440947|527662844|FG003|36-Week Induction Phase|Non-compliance|0|||
146314117|NCT00440947|527662845|FG004|36-Week Induction Phase|Non-compliance|0|||
146314118|NCT00440947|527662841|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
146314119|NCT00440947|527662842|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
146314120|NCT00440947|527662843|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
146314121|NCT00440947|527662844|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
146314122|NCT00440947|527662845|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
146314123|NCT00440947|527662841|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
146314124|NCT00440947|527662842|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
146314125|NCT00440947|527662843|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
146314126|NCT00440947|527662844|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
146314127|NCT00440947|527662845|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
146314128|NCT00440947|527662841|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
146314129|NCT00440947|527662842|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146314130|NCT00440947|527662843|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146314131|NCT00440947|527662844|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146314132|NCT00440947|527662845|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
146314133|NCT00440947|527662841|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
146314134|NCT00440947|527662842|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
146314135|NCT00440947|527662843|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
146314136|NCT00440947|527662844|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
146314137|NCT00440947|527662845|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
146314138|NCT00440947|527662841|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
146314139|NCT00440947|527662842|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146314140|NCT00440947|527662843|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146314141|NCT00440947|527662844|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146314142|NCT00440947|527662845|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
146314143|NCT00440947|527662841|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
146314144|NCT00440947|527662842|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146314145|NCT00440947|527662843|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146314146|NCT00440947|527662844|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146314147|NCT00440947|527662845|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
146314148|NCT00440947|527662841|FG000|36-Week Induction Phase|Incarceration|3|||
146314149|NCT00440947|527662842|FG001|36-Week Induction Phase|Incarceration|0|||
146314150|NCT00440947|527662843|FG002|36-Week Induction Phase|Incarceration|0|||
146314151|NCT00440947|527662844|FG003|36-Week Induction Phase|Incarceration|0|||
146314152|NCT00440947|527662845|FG004|36-Week Induction Phase|Incarceration|0|||
146314153|NCT00440947|527662841|FG000|36-Week Induction Phase|Pregnancy|1|||
146314154|NCT00440947|527662842|FG001|36-Week Induction Phase|Pregnancy|0|||
146314155|NCT00440947|527662843|FG002|36-Week Induction Phase|Pregnancy|0|||
146314156|NCT00440947|527662844|FG003|36-Week Induction Phase|Pregnancy|0|||
146314157|NCT00440947|527662845|FG004|36-Week Induction Phase|Pregnancy|0|||
146314158|NCT00440947|527662841|FG000|48-Week Randomization Phase|Adverse Event|0|||
146314159|NCT00440947|527662842|FG001|48-Week Randomization Phase|Adverse Event|2|||
146314160|NCT00440947|527662843|FG002|48-Week Randomization Phase|Adverse Event|5|||
146314161|NCT00440947|527662844|FG003|48-Week Randomization Phase|Adverse Event|0|||
146314162|NCT00440947|527662845|FG004|48-Week Randomization Phase|Adverse Event|0|||
146314163|NCT00440947|527662841|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146314164|NCT00440947|527662842|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
146314165|NCT00440947|527662843|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
146314166|NCT00440947|527662844|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146314167|NCT00440947|527662845|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
146314168|NCT00440947|527662841|FG000|48-Week Randomization Phase|Non-compliance|0|||
146314169|NCT00440947|527662842|FG001|48-Week Randomization Phase|Non-compliance|3|||
146314170|NCT00440947|527662843|FG002|48-Week Randomization Phase|Non-compliance|4|||
146314171|NCT00440947|527662844|FG003|48-Week Randomization Phase|Non-compliance|0|||
146314172|NCT00440947|527662845|FG004|48-Week Randomization Phase|Non-compliance|0|||
146314173|NCT00440947|527662841|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
146314174|NCT00440947|527662842|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
146314175|NCT00440947|527662843|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
146314176|NCT00440947|527662844|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
146314177|NCT00440947|527662845|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
146314178|NCT00440947|527662841|FG000|48-Week Randomization Phase|Protocol Violation|0|||
146314179|NCT00440947|527662842|FG001|48-Week Randomization Phase|Protocol Violation|0|||
146314180|NCT00440947|527662843|FG002|48-Week Randomization Phase|Protocol Violation|1|||
146314181|NCT00440947|527662844|FG003|48-Week Randomization Phase|Protocol Violation|0|||
146314182|NCT00440947|527662845|FG004|48-Week Randomization Phase|Protocol Violation|0|||
146314183|NCT00440947|527662841|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
146314184|NCT00440947|527662842|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
146314185|NCT00440947|527662843|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
146314186|NCT00440947|527662844|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
146314187|NCT00440947|527662845|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
146314188|NCT00440947|527662841|FG000|48-Week Randomization Phase|Pregnancy|0|||
146314189|NCT00440947|527662842|FG001|48-Week Randomization Phase|Pregnancy|0|||
146314190|NCT00440947|527662843|FG002|48-Week Randomization Phase|Pregnancy|1|||
146159527|NCT02308748|527094586|FG000|Period 3|Protocol Violation|0|||
146159528|NCT02308748|527094587|FG001|Period 3|Protocol Violation|0|||
146159529|NCT02308748|527094588|FG002|Period 3|Protocol Violation|0|||
146159530|NCT02308748|527094589|FG003|Period 3|Protocol Violation|0|||
146159531|NCT02308748|527094590|FG004|Period 3|Protocol Violation|0|||
146159532|NCT02308748|527094591|FG005|Period 3|Protocol Violation|0|||
146159533|NCT02308748|527094592|FG006|Period 3|Protocol Violation|0|||
146159534|NCT02308748|527094593|FG007|Period 3|Protocol Violation|0|||
146159535|NCT02308748|527094594|FG008|Period 3|Protocol Violation|0|||
146159536|NCT02308748|527094595|FG009|Period 3|Protocol Violation|1|||
146159537|NCT02308748|527094586|FG000|Period 5|Adverse Event|1|||
146159538|NCT02308748|527094587|FG001|Period 5|Adverse Event|0|||
146159539|NCT02308748|527094588|FG002|Period 5|Adverse Event|0|||
146314191|NCT00440947|527662844|FG003|48-Week Randomization Phase|Pregnancy|0|||
146314192|NCT00440947|527662845|FG004|48-Week Randomization Phase|Pregnancy|0|||
146314193|NCT00440947|527662841|FG000|48-Week Randomization Phase|Incarceration|0|||
146314194|NCT00440947|527662842|FG001|48-Week Randomization Phase|Incarceration|3|||
146314195|NCT00440947|527662843|FG002|48-Week Randomization Phase|Incarceration|0|||
146314196|NCT00440947|527662844|FG003|48-Week Randomization Phase|Incarceration|0|||
146314197|NCT00440947|527662845|FG004|48-Week Randomization Phase|Incarceration|0|||
146314198|NCT00440947|527662841|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146314199|NCT00440947|527662842|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
146314200|NCT00440947|527662843|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146314201|NCT00440947|527662844|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146314202|NCT00440947|527662845|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
146314203|NCT00440947|527662841|FG000|48-Week Randomization Phase|Physician Decision|0|||
146314204|NCT00440947|527662842|FG001|48-Week Randomization Phase|Physician Decision|2|||
146314205|NCT00440947|527662843|FG002|48-Week Randomization Phase|Physician Decision|0|||
146314206|NCT00440947|527662844|FG003|48-Week Randomization Phase|Physician Decision|0|||
146314207|NCT00440947|527662845|FG004|48-Week Randomization Phase|Physician Decision|0|||
146314208|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
146314209|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
146314210|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
146314211|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
146314212|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
146159540|NCT02308748|527094589|FG003|Period 5|Adverse Event|0|||
146159541|NCT02308748|527094590|FG004|Period 5|Adverse Event|0|||
146159542|NCT02308748|527094591|FG005|Period 5|Adverse Event|0|||
146159543|NCT02308748|527094592|FG006|Period 5|Adverse Event|0|||
146159544|NCT02308748|527094593|FG007|Period 5|Adverse Event|0|||
146159545|NCT02308748|527094594|FG008|Period 5|Adverse Event|1|||
146159546|NCT02308748|527094595|FG009|Period 5|Adverse Event|0|||
146159547|NCT01994954|527094596|FG000|Overall Study|Death|1|||
146159548|NCT01994954|527094597|FG001|Overall Study|Death|0|||
146159549|NCT01994954|527094596|FG000|Overall Study|Withdrawal by Subject|9|||
146159550|NCT01994954|527094597|FG001|Overall Study|Withdrawal by Subject|14|||
146159551|NCT01994954|527094596|FG000|Overall Study|Physician Decision|2|||
146159552|NCT01994954|527094597|FG001|Overall Study|Physician Decision|2|||
146159553|NCT01994954|527094596|FG000|Overall Study|Lost to Follow-up|8|||
146159554|NCT01994954|527094597|FG001|Overall Study|Lost to Follow-up|10|||
146159555|NCT01994954|527094596|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
146159556|NCT01994954|527094597|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
146159557|NCT02576678|527094598|FG000|Overall Study|Adverse Event|0|||
146159558|NCT02576678|527094599|FG001|Overall Study|Adverse Event|0|||
146159559|NCT02576678|527094600|FG002|Overall Study|Adverse Event|2|||
146159560|NCT02576678|527094598|FG000|Overall Study|Withdrawal by Subject|3|||
146159561|NCT02576678|527094599|FG001|Overall Study|Withdrawal by Subject|1|||
146159562|NCT02576678|527094600|FG002|Overall Study|Withdrawal by Subject|2|||
146159563|NCT02576678|527094598|FG000|Overall Study|Lost to Follow-up|0|||
146159564|NCT02576678|527094599|FG001|Overall Study|Lost to Follow-up|0|||
146159565|NCT02576678|527094600|FG002|Overall Study|Lost to Follow-up|1|||
146159566|NCT02576678|527094598|FG000|Overall Study|Miscellaneous|2|||
146159567|NCT02576678|527094599|FG001|Overall Study|Miscellaneous|0|||
146159568|NCT02576678|527094600|FG002|Overall Study|Miscellaneous|0|||
146314213|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146314214|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146159569|NCT01454583|527094601|FG000|1st Year|Lost to Follow-up|1057|||
146159570|NCT01454583|527094602|FG001|1st Year|Lost to Follow-up|318|||
146159571|NCT01454583|527094603|FG002|1st Year|Lost to Follow-up|180|||
146159572|NCT01454583|527094601|FG000|2nd Year|Lost to Follow-up|3965|||
146159573|NCT01454583|527094602|FG001|2nd Year|Lost to Follow-up|1049|||
146159574|NCT01454583|527094603|FG002|2nd Year|Lost to Follow-up|737|||
146159575|NCT01454583|527094601|FG000|3rd Year|Lost to Follow-up|1959|||
146159576|NCT01454583|527094602|FG001|3rd Year|Lost to Follow-up|512|||
146159577|NCT01454583|527094603|FG002|3rd Year|Lost to Follow-up|297|||
146159578|NCT00417079|527094613|FG000|Overall Study|Disease progression|267|||
146159579|NCT00417079|527094614|FG001|Overall Study|Disease progression|180|||
146159580|NCT00417079|527094613|FG000|Overall Study|Adverse Event|32|||
146159581|NCT00417079|527094614|FG001|Overall Study|Adverse Event|67|||
146159582|NCT00417079|527094613|FG000|Overall Study|Non-compliance to protocol|0|||
146159583|NCT00417079|527094614|FG001|Overall Study|Non-compliance to protocol|1|||
146159584|NCT00417079|527094613|FG000|Overall Study|Lost to Follow-up|2|||
146159585|NCT00417079|527094614|FG001|Overall Study|Lost to Follow-up|0|||
146159586|NCT00417079|527094613|FG000|Overall Study|Withdrawal by Subject|17|||
146159587|NCT00417079|527094614|FG001|Overall Study|Withdrawal by Subject|8|||
146314215|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
146314216|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
146314217|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
146314218|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146314219|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146314220|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
146314221|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
146314222|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
146314223|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
146314224|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
146314225|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
146314226|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
146314227|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
146314228|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146314229|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146314230|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
146314231|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
146314232|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
146314233|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
146314234|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
146314235|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
146314236|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
146314237|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
146314238|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146314239|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146314240|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
146314241|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
146314242|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
146314243|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
146314244|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
146314245|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
146314246|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
146314247|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
146314248|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
146314249|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
146314250|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
146314251|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
146314252|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
146314253|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
146159588|NCT00417079|527094613|FG000|Overall Study|Not treated|6|||
146159589|NCT00417079|527094614|FG001|Overall Study|Not treated|7|||
146159590|NCT00417079|527094613|FG000|Overall Study|Screened failure|2|||
146159591|NCT00417079|527094614|FG001|Overall Study|Screened failure|1|||
146159592|NCT00417079|527094613|FG000|Overall Study|Investigator's decision|1|||
146159593|NCT00417079|527094614|FG001|Overall Study|Investigator's decision|4|||
146159594|NCT00417079|527094613|FG000|Overall Study|Non-confirmed Disease progression|1|||
146159595|NCT00417079|527094614|FG001|Overall Study|Non-confirmed Disease progression|1|||
146314254|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
146314255|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
146314256|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
146159596|NCT00417079|527094613|FG000|Overall Study|Clinical deterioration|1|||
146159597|NCT00417079|527094614|FG001|Overall Study|Clinical deterioration|0|||
146159598|NCT00417079|527094613|FG000|Overall Study|Screening error|2|||
146159599|NCT00417079|527094614|FG001|Overall Study|Screening error|1|||
146159600|NCT00417079|527094613|FG000|Overall Study|Withdrawal by subject's family|0|||
146159601|NCT00417079|527094614|FG001|Overall Study|Withdrawal by subject's family|1|||
146159602|NCT00417079|527094613|FG000|Overall Study|Patient unable to come to the clinic|0|||
146159603|NCT00417079|527094614|FG001|Overall Study|Patient unable to come to the clinic|1|||
146159604|NCT00417079|527094613|FG000|Overall Study|abnormal liver function tests|0|||
146159605|NCT00417079|527094614|FG001|Overall Study|abnormal liver function tests|1|||
146159606|NCT01022762|527094615|FG000|Overall Study|Adverse Event|3|||
146159607|NCT01022762|527094616|FG001|Overall Study|Adverse Event|1|||
146159608|NCT01022762|527094615|FG000|Overall Study|Lack of Efficacy|0|||
146159609|NCT01022762|527094616|FG001|Overall Study|Lack of Efficacy|1|||
146159610|NCT01022762|527094615|FG000|Overall Study|Protocol Violation|7|||
146159611|NCT01022762|527094616|FG001|Overall Study|Protocol Violation|6|||
146159612|NCT01022762|527094615|FG000|Overall Study|Unclassified|12|||
146159613|NCT01022762|527094616|FG001|Overall Study|Unclassified|20|||
146159614|NCT01565707|527094617|FG000|Overall Study|Adverse Event|1|||
146159615|NCT01565707|527094618|FG001|Overall Study|Adverse Event|6|||
146159616|NCT01565707|527094619|FG002|Overall Study|Adverse Event|2|||
146159617|NCT01565707|527094620|FG003|Overall Study|Adverse Event|1|||
146159618|NCT01565707|527094617|FG000|Overall Study|Lost to Follow-up|1|||
146159619|NCT01565707|527094618|FG001|Overall Study|Lost to Follow-up|0|||
146159620|NCT01565707|527094619|FG002|Overall Study|Lost to Follow-up|0|||
146159621|NCT01565707|527094620|FG003|Overall Study|Lost to Follow-up|0|||
146159622|NCT01565707|527094617|FG000|Overall Study|Protocol Violation|1|||
146159623|NCT01565707|527094618|FG001|Overall Study|Protocol Violation|0|||
146159624|NCT01565707|527094619|FG002|Overall Study|Protocol Violation|0|||
146159625|NCT01565707|527094620|FG003|Overall Study|Protocol Violation|1|||
146159626|NCT01565707|527094617|FG000|Overall Study|Withdrawal by Subject|3|||
146159627|NCT01565707|527094618|FG001|Overall Study|Withdrawal by Subject|1|||
146159628|NCT01565707|527094619|FG002|Overall Study|Withdrawal by Subject|1|||
146159629|NCT01565707|527094620|FG003|Overall Study|Withdrawal by Subject|1|||
146159630|NCT01565707|527094617|FG000|Overall Study|Randomized but not evaluable|2|||
146159631|NCT01565707|527094618|FG001|Overall Study|Randomized but not evaluable|0|||
146159632|NCT01565707|527094619|FG002|Overall Study|Randomized but not evaluable|0|||
146159633|NCT01565707|527094620|FG003|Overall Study|Randomized but not evaluable|0|||
146159634|NCT01565707|527094617|FG000|Overall Study|Miscellaneous|1|||
146159635|NCT01565707|527094618|FG001|Overall Study|Miscellaneous|1|||
146159636|NCT01565707|527094619|FG002|Overall Study|Miscellaneous|0|||
146159637|NCT01565707|527094620|FG003|Overall Study|Miscellaneous|2|||
146159638|NCT05207813|527094621|FG000|Overall Study|Lost to Follow-up|2|||
146159639|NCT01261338|527094627|FG000|Overall Study|Withdrawal by Subject|3|||
146159640|NCT01261338|527094628|FG001|Overall Study|Withdrawal by Subject|2|||
146159641|NCT03754803|527094629|FG000|Overall Study|Withdrawal by Subject|2|||
146159642|NCT00447057|527096270|FG000|Overall Study|Adverse Event|4|||
146159643|NCT00447057|527096271|FG001|Overall Study|Adverse Event|10|||
146159644|NCT00447057|527096272|FG002|Overall Study|Adverse Event|0|||
146159645|NCT00447057|527096273|FG003|Overall Study|Adverse Event|3|||
146159646|NCT00447057|527096270|FG000|Overall Study|Death due to study disease|6|||
146159647|NCT00447057|527096271|FG001|Overall Study|Death due to study disease|4|||
146159648|NCT00447057|527096272|FG002|Overall Study|Death due to study disease|1|||
146159649|NCT00447057|527096273|FG003|Overall Study|Death due to study disease|1|||
146159650|NCT00447057|527096270|FG000|Overall Study|Lost to Follow-up|0|||
146159651|NCT00447057|527096271|FG001|Overall Study|Lost to Follow-up|1|||
146314257|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
146314258|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146314259|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146314260|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
146314261|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
146314262|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
146314263|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Other|0|||
146314264|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Other|0|||
146314265|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Other|0|||
146314266|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Other|1|||
146314267|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Other|0|||
146314268|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
146314269|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
146159652|NCT00447057|527096272|FG002|Overall Study|Lost to Follow-up|0|||
146159653|NCT00447057|527096273|FG003|Overall Study|Lost to Follow-up|0|||
146159654|NCT00447057|527096270|FG000|Overall Study|Entry criteria not met|1|||
146159655|NCT00447057|527096271|FG001|Overall Study|Entry criteria not met|1|||
146159656|NCT00447057|527096272|FG002|Overall Study|Entry criteria not met|0|||
146159657|NCT00447057|527096273|FG003|Overall Study|Entry criteria not met|0|||
146159658|NCT00447057|527096270|FG000|Overall Study|Protocol Violation|0|||
146159659|NCT00447057|527096271|FG001|Overall Study|Protocol Violation|1|||
146159660|NCT00447057|527096272|FG002|Overall Study|Protocol Violation|0|||
146159661|NCT00447057|527096273|FG003|Overall Study|Protocol Violation|0|||
146314270|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
146159662|NCT00447057|527096270|FG000|Overall Study|Withdrawal by Subject|4|||
146159663|NCT00447057|527096271|FG001|Overall Study|Withdrawal by Subject|5|||
146159664|NCT00447057|527096272|FG002|Overall Study|Withdrawal by Subject|1|||
146159665|NCT00447057|527096273|FG003|Overall Study|Withdrawal by Subject|1|||
146159666|NCT00447057|527096270|FG000|Overall Study|Physician Decision|9|||
146159667|NCT00447057|527096271|FG001|Overall Study|Physician Decision|6|||
146159668|NCT00447057|527096272|FG002|Overall Study|Physician Decision|3|||
146159669|NCT00447057|527096273|FG003|Overall Study|Physician Decision|1|||
146159670|NCT00447057|527096270|FG000|Overall Study|Sponsor decision|1|||
146159671|NCT00447057|527096271|FG001|Overall Study|Sponsor decision|1|||
146159672|NCT00447057|527096272|FG002|Overall Study|Sponsor decision|0|||
146159673|NCT00447057|527096273|FG003|Overall Study|Sponsor decision|0|||
146159674|NCT00447057|527096270|FG000|Overall Study|Progressive disease|58|||
146281481|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146281482|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146281483|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
146281484|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
146281485|NCT00700427|527544652|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146281486|NCT00700427|527544653|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146281487|NCT00700427|527544654|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146281488|NCT00700427|527544655|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
146281489|NCT00700427|527544656|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
146281490|NCT00506441|527544661|FG000|Period 1; Open-label Period|Adverse Event|21|||
146281491|NCT00506441|527544662|FG001|Period 1; Open-label Period|Adverse Event|0|||
146281492|NCT00506441|527544661|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
146281493|NCT00506441|527544662|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
146281494|NCT00506441|527544661|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
146281495|NCT00506441|527544662|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
146281496|NCT00506441|527544661|FG000|Period 1; Open-label Period|Physician Decision|5|||
146281497|NCT00506441|527544662|FG001|Period 1; Open-label Period|Physician Decision|0|||
146281498|NCT00506441|527544661|FG000|Period 1; Open-label Period|Protocol Violation|9|||
146281499|NCT00506441|527544662|FG001|Period 1; Open-label Period|Protocol Violation|0|||
146281500|NCT00506441|527544661|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
146281501|NCT00506441|527544662|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
146281502|NCT00506441|527544661|FG000|Period 1; Open-label Period|Other Reasons|13|||
146281503|NCT00506441|527544662|FG001|Period 1; Open-label Period|Other Reasons|0|||
146281504|NCT00506441|527544661|FG000|Period 2; Double-blind Period|Adverse Event|0|||
146281505|NCT00506441|527544662|FG001|Period 2; Double-blind Period|Adverse Event|1|||
146281506|NCT00506441|527544661|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
146281507|NCT00506441|527544662|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
146281508|NCT00506441|527544661|FG000|Period 2; Double-blind Period|Physician Decision|1|||
146281509|NCT00506441|527544662|FG001|Period 2; Double-blind Period|Physician Decision|1|||
146281510|NCT00506441|527544661|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
146281511|NCT00506441|527544662|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
146281512|NCT00506441|527544661|FG000|Period 2; Double-blind Period|Other Reason|1|||
146281513|NCT00506441|527544662|FG001|Period 2; Double-blind Period|Other Reason|1|||
146281514|NCT03122223|527544664|FG000|Overall Study|Withdrawal by Subject|2|||
146281515|NCT03122223|527544665|FG001|Overall Study|Withdrawal by Subject|2|||
146281516|NCT03122223|527544666|FG002|Overall Study|Withdrawal by Subject|1|||
146281517|NCT03122223|527544667|FG003|Overall Study|Withdrawal by Subject|0|||
146281518|NCT03122223|527544664|FG000|Overall Study|Lost to Follow-up|0|||
146281519|NCT03122223|527544665|FG001|Overall Study|Lost to Follow-up|2|||
146281520|NCT03122223|527544666|FG002|Overall Study|Lost to Follow-up|2|||
146281521|NCT03122223|527544667|FG003|Overall Study|Lost to Follow-up|0|||
146281522|NCT03122223|527544664|FG000|Overall Study|Participant unable to adhere|1|||
146281523|NCT03122223|527544665|FG001|Overall Study|Participant unable to adhere|1|||
146281524|NCT03122223|527544666|FG002|Overall Study|Participant unable to adhere|1|||
146281525|NCT03122223|527544667|FG003|Overall Study|Participant unable to adhere|0|||
146281526|NCT01151410|527544668|FG000|Overall Study|Withdrawal by Subject|3|||
146281527|NCT01151410|527544669|FG001|Overall Study|Withdrawal by Subject|5|||
146281528|NCT01151410|527544668|FG000|Overall Study|Lost to Follow-up|3|||
146281529|NCT01151410|527544669|FG001|Overall Study|Lost to Follow-up|4|||
146281530|NCT01151410|527544668|FG000|Overall Study|Adverse Event|1|||
146281531|NCT01151410|527544669|FG001|Overall Study|Adverse Event|2|||
146281532|NCT01151410|527544668|FG000|Overall Study|Protocol deviation|2|||
146281533|NCT01151410|527544669|FG001|Overall Study|Protocol deviation|1|||
146281534|NCT01151410|527544668|FG000|Overall Study|Administrative problems|1|||
146281535|NCT01151410|527544669|FG001|Overall Study|Administrative problems|1|||
146281536|NCT01151410|527544668|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146159675|NCT00447057|527096271|FG001|Overall Study|Progressive disease|43|||
146159676|NCT00447057|527096272|FG002|Overall Study|Progressive disease|13|||
146159677|NCT00447057|527096273|FG003|Overall Study|Progressive disease|18|||
146281537|NCT01151410|527544669|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
146314271|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
146314272|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
146314273|NCT00440947|527662841|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146314274|NCT00440947|527662842|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146314275|NCT00440947|527662843|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146314276|NCT00440947|527662844|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
146314277|NCT00440947|527662845|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
146314278|NCT02898259|527662846|FG000|Overall Study|Adverse Event|0|||
146314279|NCT02898259|527662847|FG001|Overall Study|Adverse Event|0|||
146314280|NCT02898259|527662848|FG002|Overall Study|Adverse Event|1|||
146314281|NCT02898259|527662849|FG003|Overall Study|Adverse Event|0|||
146314282|NCT02898259|527662850|FG004|Overall Study|Adverse Event|0|||
146314283|NCT02898259|527662846|FG000|Overall Study|Lack of Efficacy|1|||
146314284|NCT02898259|527662847|FG001|Overall Study|Lack of Efficacy|1|||
146314285|NCT02898259|527662848|FG002|Overall Study|Lack of Efficacy|3|||
146314286|NCT02898259|527662849|FG003|Overall Study|Lack of Efficacy|0|||
146314287|NCT02898259|527662850|FG004|Overall Study|Lack of Efficacy|0|||
146314288|NCT02898259|527662846|FG000|Overall Study|Lost to Follow-up|0|||
146314289|NCT02898259|527662847|FG001|Overall Study|Lost to Follow-up|0|||
146314290|NCT02898259|527662848|FG002|Overall Study|Lost to Follow-up|1|||
146314291|NCT02898259|527662849|FG003|Overall Study|Lost to Follow-up|0|||
146314292|NCT02898259|527662850|FG004|Overall Study|Lost to Follow-up|0|||
146314293|NCT02898259|527662846|FG000|Overall Study|Transformation before study began|0|||
146314294|NCT02898259|527662847|FG001|Overall Study|Transformation before study began|0|||
146314295|NCT02898259|527662848|FG002|Overall Study|Transformation before study began|0|||
146314296|NCT02898259|527662849|FG003|Overall Study|Transformation before study began|1|||
146314297|NCT02898259|527662850|FG004|Overall Study|Transformation before study began|0|||
146314298|NCT01046877|527662854|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
146314299|NCT01046877|527662854|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
146314300|NCT01834274|527662855|FG000|Overall Study|Study Termination|41|||
146314301|NCT01834274|527662856|FG001|Overall Study|Study Termination|38|||
146314302|NCT01834274|527662855|FG000|Overall Study|Withdrawal by Subject|1|||
146314303|NCT01834274|527662856|FG001|Overall Study|Withdrawal by Subject|1|||
146314304|NCT01834274|527662855|FG000|Overall Study|Lost to Follow-up|3|||
146314305|NCT01834274|527662856|FG001|Overall Study|Lost to Follow-up|1|||
146314306|NCT01834274|527662855|FG000|Overall Study|Other|2|||
146314307|NCT01834274|527662856|FG001|Overall Study|Other|1|||
146314308|NCT03016325|527662861|FG000|Treatment Period|Participant withdrew consent|0|||
146314309|NCT03016325|527662862|FG001|Treatment Period|Participant withdrew consent|1|||
146314310|NCT03016325|527662863|FG002|Treatment Period|Participant withdrew consent|0|||
146314311|NCT03016325|527662864|FG003|Treatment Period|Participant withdrew consent|0|||
146314312|NCT03016325|527662865|FG004|Treatment Period|Participant withdrew consent|0|||
146314313|NCT03016325|527662866|FG005|Treatment Period|Participant withdrew consent|0|||
146314314|NCT03016325|527662867|FG006|Treatment Period|Participant withdrew consent|0|||
146314315|NCT03016325|527662868|FG007|Treatment Period|Participant withdrew consent|0|||
146314316|NCT03016325|527662861|FG000|Treatment Period|Death|0|||
146314317|NCT03016325|527662862|FG001|Treatment Period|Death|0|||
146314318|NCT03016325|527662863|FG002|Treatment Period|Death|0|||
146314319|NCT03016325|527662864|FG003|Treatment Period|Death|0|||
146314320|NCT03016325|527662865|FG004|Treatment Period|Death|2|||
146314321|NCT03016325|527662866|FG005|Treatment Period|Death|0|||
146314322|NCT03016325|527662867|FG006|Treatment Period|Death|0|||
146314323|NCT03016325|527662868|FG007|Treatment Period|Death|0|||
146314324|NCT03016325|527662861|FG000|Treatment Period|Participant refuses assessments|0|||
146314325|NCT03016325|527662862|FG001|Treatment Period|Participant refuses assessments|0|||
146314326|NCT03016325|527662863|FG002|Treatment Period|Participant refuses assessments|1|||
146314327|NCT03016325|527662864|FG003|Treatment Period|Participant refuses assessments|0|||
146314328|NCT03016325|527662865|FG004|Treatment Period|Participant refuses assessments|0|||
146314329|NCT03016325|527662866|FG005|Treatment Period|Participant refuses assessments|0|||
146314330|NCT03016325|527662867|FG006|Treatment Period|Participant refuses assessments|0|||
146314331|NCT03016325|527662868|FG007|Treatment Period|Participant refuses assessments|0|||
146314332|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Death|2|||
146314333|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Death|0|||
146314334|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Death|5|||
146159678|NCT00447057|527096270|FG000|Overall Study|Death due to adverse event|0|||
146314335|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Death|6|||
146314336|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Death|3|||
146314337|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Death|0|||
146314338|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Death|0|||
146314339|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Death|0|||
146314340|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
146314341|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
146314342|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
146314343|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
146314344|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
146314345|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
146314346|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
146314347|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
146314348|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
146314349|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
146314350|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
146314351|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
146314352|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
146314353|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
146314354|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
146314355|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
146314356|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
146314357|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
146314358|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
146314359|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
146314360|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
146314361|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
146314362|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
146314363|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
146314364|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314365|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314366|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314367|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314368|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
146314369|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314370|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
146314371|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
146314372|NCT03016325|527662861|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314373|NCT03016325|527662862|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314374|NCT03016325|527662863|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
146314375|NCT03016325|527662864|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314376|NCT03016325|527662865|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314377|NCT03016325|527662866|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314378|NCT03016325|527662867|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314379|NCT03016325|527662868|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
146314380|NCT03016325|527662861|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314381|NCT03016325|527662862|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
146314382|NCT03016325|527662863|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314383|NCT03016325|527662864|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314384|NCT03016325|527662865|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314385|NCT03016325|527662866|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314386|NCT03016325|527662867|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314387|NCT03016325|527662868|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
146314388|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Death|3|||
146314389|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Death|3|||
146314390|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Death|11|||
146314391|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Death|12|||
146314392|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Death|9|||
146314393|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Death|0|||
146314394|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Death|0|||
146314395|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Death|1|||
146314396|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
146314397|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314398|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314399|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314400|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314401|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314402|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314403|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
146314404|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314405|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314406|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314407|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314408|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
146314409|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314410|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
146159679|NCT00447057|527096271|FG001|Overall Study|Death due to adverse event|0|||
146159680|NCT00447057|527096272|FG002|Overall Study|Death due to adverse event|1|||
146159681|NCT00447057|527096273|FG003|Overall Study|Death due to adverse event|2|||
146159682|NCT00447057|527096270|FG000|Overall Study|Death, study drug related|0|||
146159683|NCT00447057|527096271|FG001|Overall Study|Death, study drug related|1|||
146159684|NCT00447057|527096272|FG002|Overall Study|Death, study drug related|0|||
146159685|NCT00447057|527096273|FG003|Overall Study|Death, study drug related|0|||
146159686|NCT02794285|527096276|FG000|Overall Study|Adverse Event|11|||
146159687|NCT02794285|527096277|FG001|Overall Study|Adverse Event|4|||
146159688|NCT02794285|527096278|FG002|Overall Study|Adverse Event|5|||
146159689|NCT02794285|527096279|FG003|Overall Study|Adverse Event|8|||
146159690|NCT02794285|527096276|FG000|Overall Study|Condition Under Investigation Improved|1|||
146159691|NCT02794285|527096277|FG001|Overall Study|Condition Under Investigation Improved|0|||
146159692|NCT02794285|527096278|FG002|Overall Study|Condition Under Investigation Improved|0|||
146159693|NCT02794285|527096279|FG003|Overall Study|Condition Under Investigation Improved|0|||
146159694|NCT02794285|527096276|FG000|Overall Study|Condition Under Investigation Worsened|0|||
146159695|NCT02794285|527096277|FG001|Overall Study|Condition Under Investigation Worsened|2|||
146159696|NCT02794285|527096278|FG002|Overall Study|Condition Under Investigation Worsened|1|||
146159697|NCT02794285|527096279|FG003|Overall Study|Condition Under Investigation Worsened|0|||
146159698|NCT02794285|527096276|FG000|Overall Study|Death|2|||
146159699|NCT02794285|527096277|FG001|Overall Study|Death|1|||
146159700|NCT02794285|527096278|FG002|Overall Study|Death|2|||
146159701|NCT02794285|527096279|FG003|Overall Study|Death|0|||
146159702|NCT02794285|527096276|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
146159703|NCT02794285|527096277|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
146159704|NCT02794285|527096278|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
146159705|NCT02794285|527096279|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
146159706|NCT02794285|527096276|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
146159707|NCT02794285|527096277|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
146159708|NCT02794285|527096278|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
146159709|NCT02794285|527096279|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
146159710|NCT02794285|527096276|FG000|Overall Study|Lack of Efficacy|10|||
146159711|NCT02794285|527096277|FG001|Overall Study|Lack of Efficacy|6|||
146159712|NCT02794285|527096278|FG002|Overall Study|Lack of Efficacy|3|||
146159713|NCT02794285|527096279|FG003|Overall Study|Lack of Efficacy|3|||
146159714|NCT02794285|527096276|FG000|Overall Study|Lost to Follow-up|5|||
146159715|NCT02794285|527096277|FG001|Overall Study|Lost to Follow-up|6|||
146159716|NCT02794285|527096278|FG002|Overall Study|Lost to Follow-up|3|||
146159717|NCT02794285|527096279|FG003|Overall Study|Lost to Follow-up|1|||
146159718|NCT02794285|527096276|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
146159719|NCT02794285|527096277|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
146159720|NCT02794285|527096278|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
146159721|NCT02794285|527096279|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
146159722|NCT02794285|527096276|FG000|Overall Study|Withdrawal by Subject|38|||
146159723|NCT02794285|527096277|FG001|Overall Study|Withdrawal by Subject|29|||
146159724|NCT02794285|527096278|FG002|Overall Study|Withdrawal by Subject|20|||
146159725|NCT02794285|527096279|FG003|Overall Study|Withdrawal by Subject|12|||
146159726|NCT02794285|527096276|FG000|Overall Study|Missing|1|||
146159727|NCT02794285|527096277|FG001|Overall Study|Missing|0|||
146159728|NCT02794285|527096278|FG002|Overall Study|Missing|0|||
146159729|NCT02794285|527096279|FG003|Overall Study|Missing|0|||
146159730|NCT02794285|527096276|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
146159731|NCT02794285|527096277|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
146159732|NCT02794285|527096278|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
146159733|NCT02794285|527096279|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
146159734|NCT02794285|527096276|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
146159735|NCT02794285|527096277|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
146159736|NCT02794285|527096278|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
146159737|NCT02794285|527096279|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
146159738|NCT03252587|527096280|FG000|Overall Study|Adverse Event|3|||
146159739|NCT03252587|527096281|FG001|Overall Study|Adverse Event|8|||
146159740|NCT03252587|527096282|FG002|Overall Study|Adverse Event|6|||
146159741|NCT03252587|527096283|FG003|Overall Study|Adverse Event|12|||
146159742|NCT03252587|527096280|FG000|Overall Study|Lack of Efficacy|7|||
146159743|NCT03252587|527096281|FG001|Overall Study|Lack of Efficacy|2|||
146159744|NCT03252587|527096282|FG002|Overall Study|Lack of Efficacy|2|||
146159745|NCT03252587|527096283|FG003|Overall Study|Lack of Efficacy|4|||
146159746|NCT03252587|527096280|FG000|Overall Study|Lost to Follow-up|2|||
146159747|NCT03252587|527096281|FG001|Overall Study|Lost to Follow-up|0|||
146159748|NCT03252587|527096282|FG002|Overall Study|Lost to Follow-up|0|||
146159749|NCT03252587|527096283|FG003|Overall Study|Lost to Follow-up|2|||
146159750|NCT03252587|527096280|FG000|Overall Study|Pregnancy|2|||
146159751|NCT03252587|527096281|FG001|Overall Study|Pregnancy|1|||
146159752|NCT03252587|527096282|FG002|Overall Study|Pregnancy|0|||
146159753|NCT03252587|527096283|FG003|Overall Study|Pregnancy|1|||
146314411|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
146314412|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314413|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314414|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314415|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314416|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
146314417|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314418|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314419|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
146314420|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314421|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314422|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314423|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314424|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
146314425|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314426|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314427|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
146314428|NCT03016325|527662861|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314429|NCT03016325|527662862|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314430|NCT03016325|527662863|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314431|NCT03016325|527662864|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
146314432|NCT03016325|527662865|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314433|NCT03016325|527662866|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314434|NCT03016325|527662867|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314435|NCT03016325|527662868|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
146314436|NCT03016325|527662861|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314437|NCT03016325|527662862|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
146314438|NCT03016325|527662863|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314439|NCT03016325|527662864|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314440|NCT03016325|527662865|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314441|NCT03016325|527662866|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314442|NCT03016325|527662867|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314443|NCT03016325|527662868|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
146314444|NCT03016325|527662861|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146314445|NCT03016325|527662862|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146314446|NCT03016325|527662863|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146314447|NCT03016325|527662864|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146314448|NCT03016325|527662865|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
146314449|NCT03016325|527662866|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
146314450|NCT03016325|527662867|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
146314451|NCT03016325|527662868|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
146314452|NCT02813694|527662871|FG000|Overall Study|Physician Decision|0|||
146314453|NCT02813694|527662872|FG001|Overall Study|Physician Decision|1|||
146314454|NCT02813694|527662871|FG000|Overall Study|Withdrawal by Subject|10|||
146314455|NCT02813694|527662872|FG001|Overall Study|Withdrawal by Subject|9|||
146314456|NCT02813694|527662871|FG000|Overall Study|Lost to Follow-up|1|||
146314457|NCT02813694|527662872|FG001|Overall Study|Lost to Follow-up|1|||
146314458|NCT02813694|527662871|FG000|Overall Study|Death|3|||
146314459|NCT02813694|527662872|FG001|Overall Study|Death|3|||
146314460|NCT02813694|527662871|FG000|Overall Study|Randomized- did not receive study drug|2|||
146314461|NCT02813694|527662872|FG001|Overall Study|Randomized- did not receive study drug|0|||
146314462|NCT02813694|527662871|FG000|Overall Study|Patient hospitalized|1|||
146314463|NCT02813694|527662872|FG001|Overall Study|Patient hospitalized|0|||
146314464|NCT01618214|527662876|FG000|Overall Study|Adverse Event|3|||
146314465|NCT01618214|527662877|FG001|Overall Study|Adverse Event|1|||
146314466|NCT01618214|527662876|FG000|Overall Study|Lack of Efficacy|1|||
146314467|NCT01618214|527662877|FG001|Overall Study|Lack of Efficacy|1|||
146314468|NCT01618214|527662876|FG000|Overall Study|Protocol Violation|1|||
146314469|NCT01618214|527662877|FG001|Overall Study|Protocol Violation|4|||
146314470|NCT01618214|527662876|FG000|Overall Study|Withdrawal Criteria|1|||
146314471|NCT01618214|527662877|FG001|Overall Study|Withdrawal Criteria|2|||
146314472|NCT01618214|527662876|FG000|Overall Study|Unclassified|4|||
146314473|NCT01618214|527662877|FG001|Overall Study|Unclassified|5|||
146314474|NCT00606086|527662878|FG000|Overall Study|Adverse Event|1|||
146314475|NCT00606086|527662879|FG001|Overall Study|Adverse Event|1|||
146314476|NCT00606086|527662878|FG000|Overall Study|Lost to Follow-up|4|||
146314477|NCT00606086|527662879|FG001|Overall Study|Lost to Follow-up|8|||
146314478|NCT00606086|527662878|FG000|Overall Study|Protocol Violation|1|||
146314479|NCT00606086|527662879|FG001|Overall Study|Protocol Violation|0|||
146314480|NCT00606086|527662878|FG000|Overall Study|Withdrawal by Subject|5|||
146314481|NCT00606086|527662879|FG001|Overall Study|Withdrawal by Subject|3|||
146159754|NCT03252587|527096280|FG000|Overall Study|Withdrawal by Subject|8|||
146159755|NCT03252587|527096281|FG001|Overall Study|Withdrawal by Subject|4|||
146159756|NCT03252587|527096282|FG002|Overall Study|Withdrawal by Subject|4|||
146159757|NCT03252587|527096283|FG003|Overall Study|Withdrawal by Subject|4|||
146159758|NCT03252587|527096280|FG000|Overall Study|Other Reasons|2|||
146159759|NCT03252587|527096281|FG001|Overall Study|Other Reasons|5|||
146159760|NCT03252587|527096282|FG002|Overall Study|Other Reasons|5|||
146159761|NCT03252587|527096283|FG003|Overall Study|Other Reasons|4|||
146159762|NCT00449176|527096288|FG000|Overall Study|Withdrawal by Subject|39|||
146159763|NCT00449176|527096289|FG001|Overall Study|Withdrawal by Subject|43|||
146159764|NCT00449176|527096290|FG002|Overall Study|Withdrawal by Subject|59|||
146159765|NCT00449176|527096288|FG000|Overall Study|Lost to Follow-up|13|||
146159766|NCT00449176|527096289|FG001|Overall Study|Lost to Follow-up|8|||
146159767|NCT00449176|527096290|FG002|Overall Study|Lost to Follow-up|12|||
146159768|NCT00449176|527096288|FG000|Overall Study|Adverse Event|51|||
146159769|NCT00449176|527096289|FG001|Overall Study|Adverse Event|107|||
146159770|NCT00449176|527096290|FG002|Overall Study|Adverse Event|15|||
146159771|NCT00449176|527096288|FG000|Overall Study|Lack of Efficacy|13|||
146159772|NCT00449176|527096289|FG001|Overall Study|Lack of Efficacy|7|||
146159773|NCT00449176|527096290|FG002|Overall Study|Lack of Efficacy|50|||
146159774|NCT00449176|527096288|FG000|Overall Study|Study drug non-compliant|14|||
146159775|NCT00449176|527096289|FG001|Overall Study|Study drug non-compliant|11|||
146159776|NCT00449176|527096290|FG002|Overall Study|Study drug non-compliant|11|||
146314482|NCT00606086|527662878|FG000|Overall Study|Non-compliance|0|||
146314483|NCT00606086|527662879|FG001|Overall Study|Non-compliance|1|||
146314484|NCT00606086|527662878|FG000|Overall Study|Randomized, not treated|1|||
146314485|NCT00606086|527662879|FG001|Overall Study|Randomized, not treated|2|||
146314486|NCT01929408|527662884|FG000|Overall Study|received HCT as initial treatment|8|||
146314487|NCT00391222|527662887|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146314488|NCT00391222|527662888|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146314489|NCT00391222|527662889|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
146314490|NCT00391222|527662890|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
146314491|NCT00391222|527662887|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146314492|NCT00391222|527662888|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146314493|NCT00391222|527662889|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
146314494|NCT00391222|527662890|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
146314495|NCT00391222|527662887|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146314496|NCT00391222|527662888|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146314497|NCT00391222|527662889|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
146314498|NCT00391222|527662890|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
146314499|NCT00391222|527662887|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146314500|NCT00391222|527662888|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146314501|NCT00391222|527662889|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
146314502|NCT00391222|527662890|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
146314503|NCT00391222|527662887|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
146314504|NCT00391222|527662888|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
146314505|NCT00391222|527662889|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
146314506|NCT00391222|527662890|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
146314507|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
146314508|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
146314509|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
146314510|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
146314511|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
146314512|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
146314513|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
146314514|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
146314515|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
146314516|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
146314517|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
146314518|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
146314519|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
146314520|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
146314521|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
146314522|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
146314523|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
146159777|NCT00449176|527096288|FG000|Overall Study|all other|22|||
146159778|NCT00449176|527096289|FG001|Overall Study|all other|19|||
146159779|NCT00449176|527096290|FG002|Overall Study|all other|20|||
146159780|NCT00675766|527096291|FG000|Overall Study|Lost to Follow-up|6|||
146159781|NCT00675766|527096292|FG001|Overall Study|Lost to Follow-up|5|||
146159782|NCT00675766|527096293|FG002|Overall Study|Lost to Follow-up|21|||
146159783|NCT00675766|527096294|FG003|Overall Study|Lost to Follow-up|26|||
146159784|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
146159785|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
146159786|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|disease progression|58|||
146314524|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
146314525|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
146314526|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
146314527|NCT00391222|527662887|FG000|Period III (Double-Blind Treatment)|Other|6|||
146314528|NCT00391222|527662888|FG001|Period III (Double-Blind Treatment)|Other|1|||
146314529|NCT00391222|527662889|FG002|Period III (Double-Blind Treatment)|Other|6|||
146314530|NCT00391222|527662890|FG003|Period III (Double-Blind Treatment)|Other|0|||
146314531|NCT00689871|527662894|FG000|Overall Study|Lost to Follow-up|123|||
146314532|NCT00689871|527662895|FG001|Overall Study|Lost to Follow-up|13|||
146314533|NCT00689871|527662896|FG002|Overall Study|Lost to Follow-up|37|||
146314534|NCT00689871|527662897|FG003|Overall Study|Lost to Follow-up|1|||
146314535|NCT00689871|527662894|FG000|Overall Study|Explanted of All Study Devices|36|||
146314536|NCT00689871|527662895|FG001|Overall Study|Explanted of All Study Devices|25|||
146314537|NCT00689871|527662896|FG002|Overall Study|Explanted of All Study Devices|29|||
146314538|NCT00689871|527662897|FG003|Overall Study|Explanted of All Study Devices|3|||
146314539|NCT00689871|527662894|FG000|Overall Study|Withdrawal by Subject|13|||
146314540|NCT00689871|527662895|FG001|Overall Study|Withdrawal by Subject|3|||
146314541|NCT00689871|527662896|FG002|Overall Study|Withdrawal by Subject|4|||
146314542|NCT00689871|527662897|FG003|Overall Study|Withdrawal by Subject|1|||
146314543|NCT00689871|527662894|FG000|Overall Study|Death|1|||
146314544|NCT00689871|527662895|FG001|Overall Study|Death|10|||
146314545|NCT00689871|527662896|FG002|Overall Study|Death|2|||
146314546|NCT00689871|527662897|FG003|Overall Study|Death|2|||
146314547|NCT00689871|527662894|FG000|Overall Study|Physician Decision|2|||
146314548|NCT00689871|527662895|FG001|Overall Study|Physician Decision|1|||
146314549|NCT00689871|527662896|FG002|Overall Study|Physician Decision|1|||
146314550|NCT00689871|527662897|FG003|Overall Study|Physician Decision|0|||
146314551|NCT00960843|527662898|FG000|Overall Study|Lost to Follow-up|2|||
146314552|NCT00960843|527662899|FG001|Overall Study|Lost to Follow-up|0|||
146314553|NCT00960843|527662898|FG000|Overall Study|Protocol Violation|0|||
146314554|NCT00960843|527662899|FG001|Overall Study|Protocol Violation|4|||
146314555|NCT00960843|527662898|FG000|Overall Study|Repeated needle dislodgment|0|||
146314556|NCT00960843|527662899|FG001|Overall Study|Repeated needle dislodgment|1|||
146314557|NCT00652366|527662900|FG000|Overall Study|Adverse Event|8|||
146314558|NCT00652366|527662901|FG001|Overall Study|Adverse Event|4|||
146314559|NCT00652366|527662902|FG002|Overall Study|Adverse Event|7|||
146314560|NCT00652366|527662903|FG003|Overall Study|Adverse Event|17|||
146314561|NCT00652366|527662904|FG004|Overall Study|Adverse Event|13|||
146314562|NCT00652366|527662900|FG000|Overall Study|Death|5|||
146314563|NCT00652366|527662901|FG001|Overall Study|Death|4|||
146314564|NCT00652366|527662902|FG002|Overall Study|Death|1|||
146314565|NCT00652366|527662903|FG003|Overall Study|Death|8|||
146314566|NCT00652366|527662904|FG004|Overall Study|Death|5|||
146314567|NCT00652366|527662900|FG000|Overall Study|Lack of Efficacy|84|||
146314568|NCT00652366|527662901|FG001|Overall Study|Lack of Efficacy|58|||
146314569|NCT00652366|527662902|FG002|Overall Study|Lack of Efficacy|53|||
146314570|NCT00652366|527662903|FG003|Overall Study|Lack of Efficacy|133|||
146314571|NCT00652366|527662904|FG004|Overall Study|Lack of Efficacy|13|||
146314572|NCT00652366|527662900|FG000|Overall Study|Violation of Selection Criteria|0|||
146314573|NCT00652366|527662901|FG001|Overall Study|Violation of Selection Criteria|0|||
146314574|NCT00652366|527662902|FG002|Overall Study|Violation of Selection Criteria|1|||
146314575|NCT00652366|527662903|FG003|Overall Study|Violation of Selection Criteria|0|||
146314576|NCT00652366|527662904|FG004|Overall Study|Violation of Selection Criteria|0|||
146314577|NCT00652366|527662900|FG000|Overall Study|Protocol Violation|1|||
146314578|NCT00652366|527662901|FG001|Overall Study|Protocol Violation|0|||
146314579|NCT00652366|527662902|FG002|Overall Study|Protocol Violation|0|||
146314580|NCT00652366|527662903|FG003|Overall Study|Protocol Violation|0|||
146314581|NCT00652366|527662904|FG004|Overall Study|Protocol Violation|0|||
146314582|NCT00652366|527662900|FG000|Overall Study|Refused treatment|3|||
146314583|NCT00652366|527662901|FG001|Overall Study|Refused treatment|7|||
146314584|NCT00652366|527662902|FG002|Overall Study|Refused treatment|6|||
146159787|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|disease progression|47|||
146159788|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Death|3|||
146314585|NCT00652366|527662903|FG003|Overall Study|Refused treatment|17|||
146159789|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Death|6|||
146159790|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
146159791|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
146314586|NCT00652366|527662904|FG004|Overall Study|Refused treatment|5|||
146314587|NCT00652366|527662900|FG000|Overall Study|Other|5|||
146314588|NCT00652366|527662901|FG001|Overall Study|Other|2|||
146314589|NCT00652366|527662902|FG002|Overall Study|Other|3|||
146314590|NCT00652366|527662903|FG003|Overall Study|Other|4|||
146314591|NCT00652366|527662904|FG004|Overall Study|Other|0|||
146314592|NCT00889265|527662905|FG000|Overall Study|Adverse Event|1|||
146314593|NCT00889265|527662905|FG000|Overall Study|Lost to Follow-up|5|||
146314594|NCT00889265|527662905|FG000|Overall Study|Protocol Violation|1|||
146314595|NCT02069899|527662906|FG000|Overall Study|Adverse Event|6|||
146314596|NCT02069899|527662907|FG001|Overall Study|Adverse Event|0|||
146314597|NCT02069899|527662908|FG002|Overall Study|Adverse Event|1|||
146314598|NCT02069899|527662906|FG000|Overall Study|Withdrawal by Participant|2|||
146314599|NCT02069899|527662907|FG001|Overall Study|Withdrawal by Participant|0|||
146314600|NCT02069899|527662908|FG002|Overall Study|Withdrawal by Participant|0|||
146314601|NCT02069899|527662906|FG000|Overall Study|Lost to Follow-up|1|||
146314602|NCT02069899|527662907|FG001|Overall Study|Lost to Follow-up|0|||
146314603|NCT02069899|527662908|FG002|Overall Study|Lost to Follow-up|1|||
146159792|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
146159793|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
146159794|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
146159795|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
146159796|NCT02472964|527096295|FG000|Part 1 (up to Week 24)|Other|2|||
146159797|NCT02472964|527096296|FG001|Part 1 (up to Week 24)|Other|1|||
146159798|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
146159799|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
146159800|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
146159801|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
146159802|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Death|0|||
146159803|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Death|1|||
146159804|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
146159805|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
146159806|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
146159807|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
146159808|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
146159809|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
146159810|NCT02472964|527096295|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
146159811|NCT02472964|527096296|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
146159812|NCT01749982|527096301|FG000|Overall Study|Physician Decision|0|||
146159813|NCT01749982|527096302|FG001|Overall Study|Physician Decision|0|||
146314604|NCT02069899|527662906|FG000|Overall Study|Other|4|||
146314605|NCT02069899|527662907|FG001|Overall Study|Other|0|||
146314606|NCT02069899|527662908|FG002|Overall Study|Other|0|||
146314607|NCT02069899|527662906|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
146314608|NCT02069899|527662907|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
146314609|NCT02069899|527662908|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
146314610|NCT02069899|527662906|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
146314611|NCT02069899|527662907|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
146314612|NCT02069899|527662908|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
146314613|NCT00531752|527662911|FG000|First Double-blind Intervention Period|Adverse Event|2|||
146314614|NCT00531752|527662912|FG001|First Double-blind Intervention Period|Adverse Event|0|||
146314615|NCT00531752|527662913|FG002|First Double-blind Intervention Period|Adverse Event|1|||
146314616|NCT00531752|527662914|FG003|First Double-blind Intervention Period|Adverse Event|1|||
146314617|NCT00531752|527662911|FG000|First Double-blind Intervention Period|Other|1|||
146314618|NCT00531752|527662912|FG001|First Double-blind Intervention Period|Other|4|||
146314619|NCT00531752|527662913|FG002|First Double-blind Intervention Period|Other|4|||
146314620|NCT00531752|527662914|FG003|First Double-blind Intervention Period|Other|0|||
146314621|NCT00531752|527662911|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
146314622|NCT00531752|527662912|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
146314623|NCT00531752|527662913|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
146314624|NCT00531752|527662914|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
146314625|NCT00531752|527662911|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
146314626|NCT00531752|527662912|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
146314627|NCT00531752|527662913|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
146314628|NCT00531752|527662914|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
146159814|NCT01749982|527096303|FG002|Overall Study|Physician Decision|0|||
146159815|NCT01749982|527096304|FG003|Overall Study|Physician Decision|1|||
146159816|NCT01749982|527096301|FG000|Overall Study|Lost to Follow-up|0|||
146159817|NCT01749982|527096302|FG001|Overall Study|Lost to Follow-up|0|||
146314629|NCT00531752|527662911|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
146159818|NCT01749982|527096303|FG002|Overall Study|Lost to Follow-up|0|||
146159819|NCT01749982|527096304|FG003|Overall Study|Lost to Follow-up|1|||
146159820|NCT01749982|527096301|FG000|Overall Study|Withdrawal by Subject|0|||
146159821|NCT01749982|527096302|FG001|Overall Study|Withdrawal by Subject|0|||
146159822|NCT01749982|527096303|FG002|Overall Study|Withdrawal by Subject|0|||
146159823|NCT01749982|527096304|FG003|Overall Study|Withdrawal by Subject|1|||
146159824|NCT01967732|527096305|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146159825|NCT01967732|527096306|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
146159826|NCT01967732|527096307|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146159827|NCT01967732|527096308|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
146159828|NCT01967732|527096305|FG000|First Intervention (Day 1)|Poor venous access|0|||
146159829|NCT01967732|527096306|FG001|First Intervention (Day 1)|Poor venous access|1|||
146159830|NCT01967732|527096307|FG002|First Intervention (Day 1)|Poor venous access|0|||
146159831|NCT01967732|527096308|FG003|First Intervention (Day 1)|Poor venous access|0|||
146159832|NCT01988779|527096310|FG000|Overall Study|Withdrawal by Subject|2|||
146159833|NCT01988779|527096311|FG001|Overall Study|Withdrawal by Subject|2|||
146159834|NCT01988779|527096310|FG000|Overall Study|Protocol Violation|1|||
146159835|NCT01988779|527096311|FG001|Overall Study|Protocol Violation|0|||
146159836|NCT00377403|527096312|FG000|Overall Study|Unable to contact for telephone intervie|4|||
146159837|NCT00377403|527096313|FG001|Overall Study|Unable to contact for telephone intervie|7|||
146159838|NCT01687257|527096317|FG000|Overall Study|Efficacy Failure|6|||
146159839|NCT01687257|527096318|FG001|Overall Study|Efficacy Failure|0|||
146159840|NCT01687257|527096319|FG002|Overall Study|Efficacy Failure|5|||
146159841|NCT01687257|527096317|FG000|Overall Study|Subject Withdrew Consent|1|||
146159842|NCT01687257|527096318|FG001|Overall Study|Subject Withdrew Consent|1|||
146159843|NCT01687257|527096319|FG002|Overall Study|Subject Withdrew Consent|1|||
146159844|NCT01687257|527096317|FG000|Overall Study|Adverse Event|1|||
146159845|NCT01687257|527096318|FG001|Overall Study|Adverse Event|0|||
146159846|NCT01687257|527096319|FG002|Overall Study|Adverse Event|0|||
146159847|NCT01687257|527096317|FG000|Overall Study|Investigator's Discretion|0|||
146159848|NCT01687257|527096318|FG001|Overall Study|Investigator's Discretion|3|||
146159849|NCT01687257|527096319|FG002|Overall Study|Investigator's Discretion|0|||
146159850|NCT04403698|527096320|FG000|Overall Study|Adverse Event|1|||
146159851|NCT04403698|527096321|FG001|Overall Study|Adverse Event|1|||
146159852|NCT04403698|527096320|FG000|Overall Study|Lost to Follow-up|1|||
146159853|NCT04403698|527096321|FG001|Overall Study|Lost to Follow-up|0|||
146159854|NCT04403698|527096320|FG000|Overall Study|Protocol Violation|0|||
146159855|NCT04403698|527096321|FG001|Overall Study|Protocol Violation|1|||
146159856|NCT01922076|527096322|FG000|Overall Study|Adverse Event|0|||
146159857|NCT01922076|527096323|FG001|Overall Study|Adverse Event|0|||
146159858|NCT01922076|527096324|FG002|Overall Study|Adverse Event|0|||
146159859|NCT01922076|527096325|FG003|Overall Study|Adverse Event|0|||
146159860|NCT01922076|527096326|FG004|Overall Study|Adverse Event|1|||
146159861|NCT01922076|527096327|FG005|Overall Study|Adverse Event|0|||
146159862|NCT01922076|527096328|FG006|Overall Study|Adverse Event|0|||
146159863|NCT01922076|527096322|FG000|Overall Study|Physician Decision|0|||
146159864|NCT01922076|527096323|FG001|Overall Study|Physician Decision|0|||
146159865|NCT01922076|527096324|FG002|Overall Study|Physician Decision|1|||
146159866|NCT01922076|527096325|FG003|Overall Study|Physician Decision|0|||
146159867|NCT01922076|527096326|FG004|Overall Study|Physician Decision|0|||
146159868|NCT01922076|527096327|FG005|Overall Study|Physician Decision|0|||
146159869|NCT01922076|527096328|FG006|Overall Study|Physician Decision|0|||
146159870|NCT01922076|527096322|FG000|Overall Study|Withdrawal by Subject|0|||
146159871|NCT01922076|527096323|FG001|Overall Study|Withdrawal by Subject|0|||
146159872|NCT01922076|527096324|FG002|Overall Study|Withdrawal by Subject|0|||
146159873|NCT01922076|527096325|FG003|Overall Study|Withdrawal by Subject|1|||
146159874|NCT01922076|527096326|FG004|Overall Study|Withdrawal by Subject|0|||
146159875|NCT01922076|527096327|FG005|Overall Study|Withdrawal by Subject|1|||
146159876|NCT01922076|527096328|FG006|Overall Study|Withdrawal by Subject|1|||
146159877|NCT04899349|527096331|FG000|Overall Study|Study terminated by Sponsor|2|||
146159878|NCT04899349|527096332|FG001|Overall Study|Study terminated by Sponsor|0|||
146159879|NCT01018394|527096333|FG000|Overall Study|Withdrawal by Subject|5|||
146159880|NCT01018394|527096334|FG001|Overall Study|Withdrawal by Subject|5|||
146159881|NCT01018394|527096333|FG000|Overall Study|Lost to Follow-up|4|||
146159882|NCT01018394|527096334|FG001|Overall Study|Lost to Follow-up|3|||
146159883|NCT03792126|527096335|FG000|Overall Study|Adverse Event|1|||
146159884|NCT03792126|527096336|FG001|Overall Study|Adverse Event|2|||
146159885|NCT03792126|527096335|FG000|Overall Study|Death|0|||
146159886|NCT03792126|527096336|FG001|Overall Study|Death|1|||
146159887|NCT03792126|527096335|FG000|Overall Study|Lost to Follow-up|1|||
146159888|NCT03792126|527096336|FG001|Overall Study|Lost to Follow-up|0|||
146159889|NCT03792126|527096335|FG000|Overall Study|Withdrawal by Subject|0|||
146281538|NCT01151410|527544668|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146281539|NCT01151410|527544669|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146281540|NCT01820585|527544671|FG000|Overall Study|Adverse Event|9|||
146281541|NCT01820585|527544672|FG001|Overall Study|Adverse Event|13|||
146281542|NCT01820585|527544673|FG002|Overall Study|Adverse Event|23|||
146281543|NCT01820585|527544674|FG003|Overall Study|Adverse Event|34|||
146281544|NCT01820585|527544671|FG000|Overall Study|Lack of Efficacy|9|||
146281545|NCT01820585|527544672|FG001|Overall Study|Lack of Efficacy|7|||
146281546|NCT01820585|527544673|FG002|Overall Study|Lack of Efficacy|5|||
146281547|NCT01820585|527544674|FG003|Overall Study|Lack of Efficacy|1|||
146281548|NCT01820585|527544671|FG000|Overall Study|Withdrawal by Subject|3|||
146281549|NCT01820585|527544672|FG001|Overall Study|Withdrawal by Subject|7|||
146159890|NCT03792126|527096336|FG001|Overall Study|Withdrawal by Subject|1|||
146159891|NCT03792126|527096335|FG000|Overall Study|COVID-19 Restrictions|1|||
146159892|NCT03792126|527096336|FG001|Overall Study|COVID-19 Restrictions|3|||
146159893|NCT03792126|527096335|FG000|Overall Study|Symptoms resolved|0|||
146159894|NCT03792126|527096336|FG001|Overall Study|Symptoms resolved|3|||
146159895|NCT00683644|527096337|FG000|Overall Study|Withdrawal by Subject|4|||
146159896|NCT00683644|527096338|FG001|Overall Study|Withdrawal by Subject|2|||
146159897|NCT00683644|527096337|FG000|Overall Study|Lost to Follow-up|1|||
146159898|NCT00683644|527096338|FG001|Overall Study|Lost to Follow-up|4|||
146159899|NCT00683644|527096337|FG000|Overall Study|Adverse Event|1|||
146159900|NCT00683644|527096338|FG001|Overall Study|Adverse Event|2|||
146159901|NCT00683644|527096337|FG000|Overall Study|Low copper, other health problems,|7|||
146159902|NCT00683644|527096338|FG001|Overall Study|Low copper, other health problems,|6|||
146159903|NCT00441090|527096340|FG000|Overall Study|Adverse Event|0|||
146159904|NCT00441090|527096341|FG001|Overall Study|Adverse Event|1|||
146159905|NCT00441090|527096342|FG002|Overall Study|Adverse Event|1|||
146159906|NCT00441090|527096343|FG003|Overall Study|Adverse Event|0|||
146159907|NCT00441090|527096344|FG004|Overall Study|Adverse Event|0|||
146159908|NCT00441090|527096340|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146159909|NCT00441090|527096341|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146159910|NCT00441090|527096342|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146159911|NCT00441090|527096343|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
146159912|NCT00441090|527096344|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
146159913|NCT00441090|527096340|FG000|Overall Study|Withdrawal by Subject|1|||
146159914|NCT00441090|527096341|FG001|Overall Study|Withdrawal by Subject|0|||
146159915|NCT00441090|527096342|FG002|Overall Study|Withdrawal by Subject|1|||
146159916|NCT00441090|527096343|FG003|Overall Study|Withdrawal by Subject|0|||
146159917|NCT00441090|527096344|FG004|Overall Study|Withdrawal by Subject|0|||
146159918|NCT00441090|527096340|FG000|Overall Study|Lack of Efficacy|1|||
146159919|NCT00441090|527096341|FG001|Overall Study|Lack of Efficacy|0|||
146159920|NCT00441090|527096342|FG002|Overall Study|Lack of Efficacy|0|||
146159921|NCT00441090|527096343|FG003|Overall Study|Lack of Efficacy|0|||
146159922|NCT00441090|527096344|FG004|Overall Study|Lack of Efficacy|0|||
146159923|NCT03085485|527096345|FG000|Overall Study|Death|1|||
146159924|NCT03085485|527096346|FG001|Overall Study|Death|0|||
146159925|NCT03085485|527096345|FG000|Overall Study|Lost to Follow-up|1|||
146159926|NCT03085485|527096346|FG001|Overall Study|Lost to Follow-up|0|||
146281550|NCT01820585|527544673|FG002|Overall Study|Withdrawal by Subject|3|||
146281551|NCT01820585|527544674|FG003|Overall Study|Withdrawal by Subject|8|||
146281552|NCT01820585|527544671|FG000|Overall Study|Lost to Follow-up|3|||
146281553|NCT01820585|527544672|FG001|Overall Study|Lost to Follow-up|3|||
146281554|NCT01820585|527544673|FG002|Overall Study|Lost to Follow-up|0|||
146281555|NCT01820585|527544674|FG003|Overall Study|Lost to Follow-up|3|||
146281556|NCT01820585|527544671|FG000|Overall Study|Protocol Violation|3|||
146281557|NCT01820585|527544672|FG001|Overall Study|Protocol Violation|1|||
146281558|NCT01820585|527544673|FG002|Overall Study|Protocol Violation|1|||
146281559|NCT01820585|527544674|FG003|Overall Study|Protocol Violation|1|||
146281560|NCT01820585|527544671|FG000|Overall Study|Subject non-compliance|0|||
146281561|NCT01820585|527544672|FG001|Overall Study|Subject non-compliance|0|||
146281562|NCT01820585|527544673|FG002|Overall Study|Subject non-compliance|1|||
146281563|NCT01820585|527544674|FG003|Overall Study|Subject non-compliance|2|||
146281564|NCT01820585|527544671|FG000|Overall Study|at sponsor request|0|||
146281565|NCT01820585|527544672|FG001|Overall Study|at sponsor request|0|||
146281566|NCT01820585|527544673|FG002|Overall Study|at sponsor request|1|||
146281567|NCT01820585|527544674|FG003|Overall Study|at sponsor request|0|||
146281568|NCT01820585|527544671|FG000|Overall Study|Pregnancy|0|||
146281569|NCT01820585|527544672|FG001|Overall Study|Pregnancy|1|||
146281570|NCT01820585|527544673|FG002|Overall Study|Pregnancy|0|||
146281571|NCT01820585|527544674|FG003|Overall Study|Pregnancy|0|||
146281572|NCT02544451|527544676|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
146281573|NCT02544451|527544677|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
146281574|NCT02544451|527544678|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
146281575|NCT02544451|527544679|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
146281576|NCT02544451|527544676|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
146281577|NCT02544451|527544677|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
146281578|NCT02544451|527544678|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
146159927|NCT01302119|527096347|FG000|Overall Study|Withdrawal by Subject|30|||
146159928|NCT01302119|527096348|FG001|Overall Study|Withdrawal by Subject|20|||
146159929|NCT01302119|527096347|FG000|Overall Study|Lost to Follow-up|10|||
146159930|NCT01302119|527096348|FG001|Overall Study|Lost to Follow-up|4|||
146159931|NCT01302119|527096347|FG000|Overall Study|Adverse Event|2|||
146159932|NCT01302119|527096348|FG001|Overall Study|Adverse Event|1|||
146159933|NCT01302119|527096347|FG000|Overall Study|Non-compliance|4|||
146159934|NCT01302119|527096348|FG001|Overall Study|Non-compliance|2|||
146159935|NCT01302119|527096347|FG000|Overall Study|Non-specific|4|||
146281579|NCT02544451|527544679|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
146159936|NCT01302119|527096348|FG001|Overall Study|Non-specific|1|||
146159937|NCT01775904|527096352|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
146159938|NCT01775904|527096352|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
146314630|NCT00531752|527662912|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
146314631|NCT00531752|527662913|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
146314632|NCT00531752|527662914|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
146314633|NCT00531752|527662911|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
146314634|NCT00531752|527662912|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
146314635|NCT00531752|527662913|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
146314636|NCT00531752|527662914|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
146314637|NCT00531752|527662911|FG000|Second Double-blind Intervention Period|Other|1|||
146314638|NCT00531752|527662912|FG001|Second Double-blind Intervention Period|Other|1|||
146314639|NCT00531752|527662913|FG002|Second Double-blind Intervention Period|Other|0|||
146314640|NCT00531752|527662914|FG003|Second Double-blind Intervention Period|Other|0|||
146314641|NCT00531752|527662911|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146314642|NCT00531752|527662912|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146314643|NCT00531752|527662913|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
146314644|NCT00531752|527662914|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
146314645|NCT00531752|527662911|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146314646|NCT00531752|527662912|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146314647|NCT00531752|527662913|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
146314648|NCT00531752|527662914|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
146314649|NCT00490451|527662915|FG000|Overall Study|Adverse Event|3|||
146314650|NCT00490451|527662916|FG001|Overall Study|Adverse Event|3|||
146314651|NCT00490451|527662915|FG000|Overall Study|Death|3|||
146314652|NCT00490451|527662916|FG001|Overall Study|Death|1|||
146314653|NCT00490451|527662915|FG000|Overall Study|Withdrawal by Subject|2|||
146314654|NCT00490451|527662916|FG001|Overall Study|Withdrawal by Subject|0|||
146314655|NCT00490451|527662915|FG000|Overall Study|Investigator Decision|1|||
146314656|NCT00490451|527662916|FG001|Overall Study|Investigator Decision|0|||
146314657|NCT00490451|527662915|FG000|Overall Study|Protocol Violation|1|||
146314658|NCT00490451|527662916|FG001|Overall Study|Protocol Violation|0|||
146314659|NCT00490451|527662915|FG000|Overall Study|Progressive Disease|53|||
146314660|NCT00490451|527662916|FG001|Overall Study|Progressive Disease|34|||
146314661|NCT01181011|527662917|FG000|Overall Study|Adverse Event|2|||
146314662|NCT01181011|527662917|FG000|Overall Study|Lost to Follow-up|1|||
146314663|NCT04703075|527662918|FG000|Overall Study|Adverse Event|11|||
146314664|NCT04703075|527662919|FG001|Overall Study|Adverse Event|7|||
146314665|NCT04703075|527662918|FG000|Overall Study|Lost to Follow-up|6|||
146314666|NCT04703075|527662919|FG001|Overall Study|Lost to Follow-up|12|||
146314667|NCT04703075|527662918|FG000|Overall Study|Physician Decision|3|||
146314668|NCT04703075|527662919|FG001|Overall Study|Physician Decision|0|||
146314669|NCT04703075|527662918|FG000|Overall Study|Moved|0|||
146314670|NCT04703075|527662919|FG001|Overall Study|Moved|2|||
146314671|NCT04703075|527662918|FG000|Overall Study|Index INH Resistant|0|||
146314672|NCT04703075|527662919|FG001|Overall Study|Index INH Resistant|1|||
146314673|NCT04703075|527662918|FG000|Overall Study|Lack of Efficacy|6|||
146314674|NCT04703075|527662919|FG001|Overall Study|Lack of Efficacy|18|||
146314675|NCT00254501|527662922|FG000|Overall Study|Lost to Follow-up|1|||
146314676|NCT00254501|527662923|FG001|Overall Study|Lost to Follow-up|1|||
146314677|NCT00250835|527662928|FG000|Overall Study|Withdrawal by Subject|1|||
146314678|NCT01035905|527662932|FG000|Overall Study|Lack of Efficacy|1|||
146314679|NCT01035905|527662933|FG001|Overall Study|Lack of Efficacy|1|||
146314680|NCT04942925|527662934|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
146314681|NCT04942925|527662935|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
146314682|NCT04942925|527662934|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
146314683|NCT04942925|527662935|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
146314684|NCT04099251|527664482|FG000|Pre-Treatment|Other reasons|1|||
146314685|NCT04099251|527664483|FG001|Pre-Treatment|Other reasons|0|||
146314686|NCT04099251|527664482|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
146314687|NCT04099251|527664483|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
146314688|NCT04099251|527664482|FG000|Blinded Treatment Phase|Other reasons|16|||
146159939|NCT04891419|527096353|FG000|Overall Study|Withdrawal by Subject|4|||
146159940|NCT04891419|527096354|FG001|Overall Study|Withdrawal by Subject|0|||
146159941|NCT04891419|527096353|FG000|Overall Study|Lost to Follow-up|1|||
146159942|NCT04891419|527096354|FG001|Overall Study|Lost to Follow-up|3|||
146314689|NCT04099251|527664483|FG001|Blinded Treatment Phase|Other reasons|7|||
146314690|NCT04099251|527664482|FG000|Blinded Treatment Phase|Disease recurrence|26|||
146314691|NCT04099251|527664483|FG001|Blinded Treatment Phase|Disease recurrence|41|||
146314692|NCT04099251|527664482|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
146314693|NCT04099251|527664483|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
146159943|NCT00827918|527096358|FG000|Overall Study|Adverse Event|4|||
146159944|NCT00827918|527096359|FG001|Overall Study|Adverse Event|0|||
146159945|NCT00827918|527096360|FG002|Overall Study|Adverse Event|0|||
146159946|NCT00827918|527096358|FG000|Overall Study|Lack of Efficacy|16|||
146159947|NCT00827918|527096359|FG001|Overall Study|Lack of Efficacy|4|||
146159948|NCT00827918|527096360|FG002|Overall Study|Lack of Efficacy|15|||
146159949|NCT00827918|527096358|FG000|Overall Study|Physician Decision|1|||
146159950|NCT00827918|527096359|FG001|Overall Study|Physician Decision|0|||
146159951|NCT00827918|527096360|FG002|Overall Study|Physician Decision|0|||
146159952|NCT00827918|527096358|FG000|Overall Study|Pregnancy|0|||
146159953|NCT00827918|527096359|FG001|Overall Study|Pregnancy|1|||
146159954|NCT00827918|527096360|FG002|Overall Study|Pregnancy|0|||
146159955|NCT00827918|527096358|FG000|Overall Study|Progressive Disease|1|||
146159956|NCT00827918|527096359|FG001|Overall Study|Progressive Disease|1|||
146159957|NCT00827918|527096360|FG002|Overall Study|Progressive Disease|0|||
146159958|NCT00827918|527096358|FG000|Overall Study|Protocol Violation|0|||
146159959|NCT00827918|527096359|FG001|Overall Study|Protocol Violation|1|||
146314694|NCT04099251|527664482|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
146314695|NCT04099251|527664483|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
146314696|NCT04099251|527664482|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
146314697|NCT04099251|527664483|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
146314698|NCT04099251|527664482|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
146159960|NCT00827918|527096360|FG002|Overall Study|Protocol Violation|0|||
146159961|NCT00827918|527096358|FG000|Overall Study|Withdrawal by Subject|6|||
146159962|NCT00827918|527096359|FG001|Overall Study|Withdrawal by Subject|2|||
146159963|NCT00827918|527096360|FG002|Overall Study|Withdrawal by Subject|6|||
146159964|NCT00802074|527096361|FG000|Overall Study|Adverse Event|1|||
146159965|NCT00802074|527096362|FG001|Overall Study|Adverse Event|1|||
146159966|NCT00802074|527096363|FG002|Overall Study|Adverse Event|1|||
146159967|NCT00802074|527096364|FG003|Overall Study|Adverse Event|0|||
146159968|NCT00802074|527096365|FG004|Overall Study|Adverse Event|0|||
146159969|NCT00802074|527096366|FG005|Overall Study|Adverse Event|0|||
146159970|NCT00802074|527096361|FG000|Overall Study|Withdrawal by Subject|1|||
146314699|NCT04099251|527664483|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
146314700|NCT04099251|527664482|FG000|Blinded Treatment Phase|Death|6|||
146314701|NCT04099251|527664483|FG001|Blinded Treatment Phase|Death|2|||
146314702|NCT04099251|527664482|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
146314703|NCT04099251|527664483|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
146314704|NCT04099251|527664482|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
146314705|NCT04099251|527664483|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
146314706|NCT04099251|527664482|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
146314707|NCT04099251|527664483|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
146314708|NCT04099251|527664482|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
146314709|NCT04099251|527664483|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
146314710|NCT04099251|527664482|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
146314711|NCT04099251|527664483|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
146314712|NCT04099251|527664482|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
146314713|NCT04099251|527664483|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
146314714|NCT04099251|527664482|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
146314715|NCT04099251|527664483|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
146314716|NCT04099251|527664482|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
146314717|NCT04099251|527664483|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
146314718|NCT04099251|527664482|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
146314719|NCT04099251|527664483|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
146314720|NCT02068547|527664484|FG000|Overall Study|Lost to Follow-up|3|||
146314721|NCT02068547|527664485|FG001|Overall Study|Lost to Follow-up|3|||
146314722|NCT02068547|527664484|FG000|Overall Study|Physician Decision|1|||
146314723|NCT02068547|527664485|FG001|Overall Study|Physician Decision|0|||
146314724|NCT02404103|527664486|FG000|Overall Study|Adverse Event|1|||
146314725|NCT02404103|527664487|FG001|Overall Study|Adverse Event|0|||
146314726|NCT02404103|527664486|FG000|Overall Study|Lost to Follow-up|3|||
146314727|NCT02404103|527664487|FG001|Overall Study|Lost to Follow-up|3|||
146314728|NCT01995071|527664488|FG000|Overall Study|Adverse Event|0|||
146314729|NCT01995071|527664489|FG001|Overall Study|Adverse Event|0|||
146314730|NCT01995071|527664490|FG002|Overall Study|Adverse Event|0|||
146159971|NCT00802074|527096362|FG001|Overall Study|Withdrawal by Subject|0|||
146159972|NCT00802074|527096363|FG002|Overall Study|Withdrawal by Subject|0|||
146159973|NCT00802074|527096364|FG003|Overall Study|Withdrawal by Subject|0|||
146159974|NCT00802074|527096365|FG004|Overall Study|Withdrawal by Subject|0|||
146314731|NCT01995071|527664491|FG003|Overall Study|Adverse Event|0|||
146314732|NCT01995071|527664492|FG004|Overall Study|Adverse Event|0|||
146159975|NCT00802074|527096366|FG005|Overall Study|Withdrawal by Subject|0|||
146159976|NCT03743038|527096369|FG000|Overall Study|Physician Decision|1|||
146159977|NCT00617344|527096370|FG000|Overall Study|Serious adverse event|1|||
146159978|NCT00617344|527096371|FG001|Overall Study|Serious adverse event|0|||
146159979|NCT00617344|527096372|FG002|Overall Study|Serious adverse event|0|||
146159980|NCT00617344|527096370|FG000|Overall Study|Other Adverse Event|1|||
146159981|NCT00617344|527096371|FG001|Overall Study|Other Adverse Event|1|||
146159982|NCT00617344|527096372|FG002|Overall Study|Other Adverse Event|0|||
146159983|NCT00617344|527096370|FG000|Overall Study|Protocol Violation|10|||
146159984|NCT00617344|527096371|FG001|Overall Study|Protocol Violation|8|||
146159985|NCT00617344|527096372|FG002|Overall Study|Protocol Violation|5|||
146159986|NCT00617344|527096370|FG000|Overall Study|Lost to Follow-up|5|||
146159987|NCT00617344|527096371|FG001|Overall Study|Lost to Follow-up|4|||
146159988|NCT00617344|527096372|FG002|Overall Study|Lost to Follow-up|1|||
146159989|NCT00617344|527096370|FG000|Overall Study|Withdrawal by Subject|8|||
146159990|NCT00617344|527096371|FG001|Overall Study|Withdrawal by Subject|9|||
146159991|NCT00617344|527096372|FG002|Overall Study|Withdrawal by Subject|2|||
146159992|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
146159993|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
146159994|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
146159995|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
146159996|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
146159997|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
146159998|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
146159999|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
146160000|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
146160001|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
146160002|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
146160003|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
146160004|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146160005|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146160006|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
146160007|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
146160008|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
146160009|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
146160010|NCT00833638|527096373|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
146160011|NCT00833638|527096374|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
146160012|NCT00833638|527096375|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
146160013|NCT00833638|527096373|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
146160014|NCT00833638|527096374|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
146160015|NCT00833638|527096375|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
146160016|NCT00833638|527096373|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
146160017|NCT00833638|527096374|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
146160018|NCT00833638|527096375|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
146160019|NCT00490646|527096376|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
146160020|NCT00490646|527096377|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
146160021|NCT00490646|527096376|FG000|Overall Study|Never Treated (had an adverse event)|1|||
146160022|NCT00490646|527096377|FG001|Overall Study|Never Treated (had an adverse event)|0|||
146160023|NCT00490646|527096376|FG000|Overall Study|Never Treated (withdrew consent)|0|||
146160024|NCT00490646|527096377|FG001|Overall Study|Never Treated (withdrew consent)|1|||
146160025|NCT01178086|527096378|FG000|Overall Study|Participant refusal|7|||
146160026|NCT01178086|527096378|FG000|Overall Study|Physician Decision|44|||
146281580|NCT02544451|527544676|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
146281581|NCT02544451|527544677|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146281582|NCT02544451|527544678|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146281583|NCT02544451|527544679|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
146281584|NCT02544451|527544676|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
146281585|NCT02544451|527544677|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146281586|NCT02544451|527544678|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146281587|NCT02544451|527544679|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
146281588|NCT02544451|527544676|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
146281589|NCT02544451|527544677|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
146281590|NCT02544451|527544678|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
146281591|NCT02544451|527544679|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
146281592|NCT02544451|527544676|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146281593|NCT02544451|527544677|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146281594|NCT02544451|527544678|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
146281595|NCT02544451|527544679|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
146160027|NCT01178086|527096378|FG000|Overall Study|Switch to other CLL therapy|113|||
146160028|NCT01178086|527096378|FG000|Overall Study|Death|59|||
146160029|NCT01178086|527096378|FG000|Overall Study|Other unspecified|89|||
146160030|NCT01178086|527096378|FG000|Overall Study|Excluded from EAS|20|||
146160031|NCT02137369|527096379|FG000|Overall Study|Withdrawal by Subject|3|||
146160032|NCT02137369|527096380|FG001|Overall Study|Withdrawal by Subject|2|||
146160033|NCT02137369|527096379|FG000|Overall Study|Adverse Event|2|||
146160034|NCT02137369|527096380|FG001|Overall Study|Adverse Event|0|||
146160035|NCT02137369|527096379|FG000|Overall Study|Lost to Follow-up|1|||
146160036|NCT02137369|527096380|FG001|Overall Study|Lost to Follow-up|0|||
146160037|NCT02137369|527096379|FG000|Overall Study|Moved away|2|||
146160038|NCT02137369|527096380|FG001|Overall Study|Moved away|0|||
146160039|NCT03762473|527096382|FG000|Overall Study|Death|1|||
146160040|NCT03762473|527096383|FG001|Overall Study|Death|0|||
146160041|NCT02962908|527096384|FG000|Overall Study|Lost to Follow-up|0|||
146160042|NCT02962908|527096385|FG001|Overall Study|Lost to Follow-up|3|||
146160043|NCT02962908|527096386|FG002|Overall Study|Lost to Follow-up|0|||
146160044|NCT02962908|527096387|FG003|Overall Study|Lost to Follow-up|1|||
146160045|NCT02962908|527096384|FG000|Overall Study|Withdrawal by Subject|0|||
146160046|NCT02962908|527096385|FG001|Overall Study|Withdrawal by Subject|3|||
146160047|NCT02962908|527096386|FG002|Overall Study|Withdrawal by Subject|0|||
146160048|NCT02962908|527096387|FG003|Overall Study|Withdrawal by Subject|2|||
146160049|NCT02962908|527096384|FG000|Overall Study|Protocol Violation|0|||
146160050|NCT02962908|527096385|FG001|Overall Study|Protocol Violation|1|||
146160051|NCT02962908|527096386|FG002|Overall Study|Protocol Violation|0|||
146160052|NCT02962908|527096387|FG003|Overall Study|Protocol Violation|0|||
146160053|NCT02962908|527096384|FG000|Overall Study|Physician Decision|0|||
146160054|NCT02962908|527096385|FG001|Overall Study|Physician Decision|1|||
146160055|NCT02962908|527096386|FG002|Overall Study|Physician Decision|0|||
146160056|NCT02962908|527096387|FG003|Overall Study|Physician Decision|0|||
146160057|NCT00126438|527096388|FG000|Overall Study|Withdrawal due to adverse event|1|||
146160058|NCT00126438|527096389|FG001|Overall Study|Withdrawal due to adverse event|0|||
146160059|NCT00126438|527096388|FG000|Overall Study|Lost to Follow-up|22|||
146160060|NCT00126438|527096389|FG001|Overall Study|Lost to Follow-up|0|||
146160061|NCT00126438|527096388|FG000|Overall Study|Protocol Violation|8|||
146160062|NCT00126438|527096389|FG001|Overall Study|Protocol Violation|8|||
146160063|NCT00126438|527096388|FG000|Overall Study|Withdrawal by Subject|3|||
146160064|NCT00126438|527096389|FG001|Overall Study|Withdrawal by Subject|2|||
146160065|NCT02899728|527096393|FG000|Overall Study|Withdrawal by Subject|1|||
146160066|NCT02899728|527096394|FG001|Overall Study|Withdrawal by Subject|1|||
146160067|NCT02626780|527096396|FG000|Overall Study|Withdrawal by Subject|3|||
146160068|NCT04304833|527096397|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
146160069|NCT04304833|527096398|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
146160070|NCT01951625|527096399|FG000|Treatment Period|Protocol Violation|2|||
146160071|NCT01951625|527096400|FG001|Treatment Period|Protocol Violation|0|||
146160072|NCT01951625|527096401|FG002|Treatment Period|Protocol Violation|1|||
146160073|NCT01951625|527096402|FG003|Treatment Period|Protocol Violation|3|||
146160074|NCT01951625|527096403|FG004|Treatment Period|Protocol Violation|2|||
146160075|NCT01951625|527096399|FG000|Treatment Period|Physician Decision|0|||
146160076|NCT01951625|527096400|FG001|Treatment Period|Physician Decision|0|||
146160077|NCT01951625|527096401|FG002|Treatment Period|Physician Decision|0|||
146160078|NCT01951625|527096402|FG003|Treatment Period|Physician Decision|0|||
146160079|NCT01951625|527096403|FG004|Treatment Period|Physician Decision|1|||
146160080|NCT01951625|527096399|FG000|Treatment Period|Protocol driven decision point|0|||
146160081|NCT01951625|527096400|FG001|Treatment Period|Protocol driven decision point|5|||
146160082|NCT01951625|527096401|FG002|Treatment Period|Protocol driven decision point|0|||
146160083|NCT01951625|527096402|FG003|Treatment Period|Protocol driven decision point|2|||
146160084|NCT01951625|527096403|FG004|Treatment Period|Protocol driven decision point|1|||
146160085|NCT01951625|527096399|FG000|Treatment Period|Non compliance with study drug|1|||
146160086|NCT01951625|527096400|FG001|Treatment Period|Non compliance with study drug|2|||
146160087|NCT01951625|527096401|FG002|Treatment Period|Non compliance with study drug|2|||
146160088|NCT01951625|527096402|FG003|Treatment Period|Non compliance with study drug|0|||
146160089|NCT01951625|527096403|FG004|Treatment Period|Non compliance with study drug|0|||
146160090|NCT01951625|527096399|FG000|Treatment Period|Death|3|||
146160091|NCT01951625|527096400|FG001|Treatment Period|Death|2|||
146160092|NCT01951625|527096401|FG002|Treatment Period|Death|2|||
146160093|NCT01951625|527096402|FG003|Treatment Period|Death|1|||
146160094|NCT01951625|527096403|FG004|Treatment Period|Death|2|||
146160095|NCT01951625|527096399|FG000|Treatment Period|Adverse Event|7|||
146281596|NCT03189745|527544682|FG000|Overall Study|Conflict in work schedule of participant|1|||
146160096|NCT01951625|527096400|FG001|Treatment Period|Adverse Event|10|||
146160097|NCT01951625|527096401|FG002|Treatment Period|Adverse Event|9|||
146160098|NCT01951625|527096402|FG003|Treatment Period|Adverse Event|8|||
146160099|NCT01951625|527096403|FG004|Treatment Period|Adverse Event|8|||
146160100|NCT01951625|527096399|FG000|Treatment Period|Withdrawal by Subject|5|||
146160101|NCT01951625|527096400|FG001|Treatment Period|Withdrawal by Subject|2|||
146160102|NCT01951625|527096401|FG002|Treatment Period|Withdrawal by Subject|1|||
146160103|NCT01951625|527096402|FG003|Treatment Period|Withdrawal by Subject|7|||
146160104|NCT01951625|527096403|FG004|Treatment Period|Withdrawal by Subject|3|||
146160105|NCT01951625|527096399|FG000|Treatment Period|Lost to Follow-up|1|||
146160106|NCT01951625|527096400|FG001|Treatment Period|Lost to Follow-up|0|||
146160107|NCT01951625|527096401|FG002|Treatment Period|Lost to Follow-up|0|||
146160108|NCT01951625|527096402|FG003|Treatment Period|Lost to Follow-up|1|||
146160109|NCT01951625|527096403|FG004|Treatment Period|Lost to Follow-up|0|||
146160110|NCT01951625|527096399|FG000|Follow Up Period|Non-compliance with study drug|1|||
146160111|NCT01951625|527096400|FG001|Follow Up Period|Non-compliance with study drug|0|||
146160112|NCT01951625|527096401|FG002|Follow Up Period|Non-compliance with study drug|0|||
146160113|NCT01951625|527096402|FG003|Follow Up Period|Non-compliance with study drug|0|||
146160114|NCT01951625|527096403|FG004|Follow Up Period|Non-compliance with study drug|0|||
146160115|NCT01951625|527096399|FG000|Follow Up Period|Death|1|||
146160116|NCT01951625|527096400|FG001|Follow Up Period|Death|3|||
146160117|NCT01951625|527096401|FG002|Follow Up Period|Death|2|||
146160118|NCT01951625|527096402|FG003|Follow Up Period|Death|2|||
146160119|NCT01951625|527096403|FG004|Follow Up Period|Death|1|||
146160120|NCT01951625|527096399|FG000|Follow Up Period|Logistical difficulties|1|||
146160121|NCT01951625|527096400|FG001|Follow Up Period|Logistical difficulties|2|||
146160122|NCT01951625|527096401|FG002|Follow Up Period|Logistical difficulties|0|||
146160123|NCT01951625|527096402|FG003|Follow Up Period|Logistical difficulties|0|||
146160124|NCT01951625|527096403|FG004|Follow Up Period|Logistical difficulties|0|||
146160125|NCT01951625|527096399|FG000|Follow Up Period|Adverse Event|0|||
146160126|NCT01951625|527096400|FG001|Follow Up Period|Adverse Event|3|||
146160127|NCT01951625|527096401|FG002|Follow Up Period|Adverse Event|2|||
146160128|NCT01951625|527096402|FG003|Follow Up Period|Adverse Event|3|||
146160129|NCT01951625|527096403|FG004|Follow Up Period|Adverse Event|5|||
146160130|NCT01951625|527096399|FG000|Follow Up Period|Withdrawal by Subject|4|||
146160131|NCT01951625|527096400|FG001|Follow Up Period|Withdrawal by Subject|1|||
146160132|NCT01951625|527096401|FG002|Follow Up Period|Withdrawal by Subject|0|||
146160133|NCT01951625|527096402|FG003|Follow Up Period|Withdrawal by Subject|5|||
146160134|NCT01951625|527096403|FG004|Follow Up Period|Withdrawal by Subject|3|||
146160135|NCT01951625|527096399|FG000|Follow Up Period|Lost to Follow-up|1|||
146160136|NCT01951625|527096400|FG001|Follow Up Period|Lost to Follow-up|0|||
146160137|NCT01951625|527096401|FG002|Follow Up Period|Lost to Follow-up|0|||
146160138|NCT01951625|527096402|FG003|Follow Up Period|Lost to Follow-up|1|||
146160139|NCT01951625|527096403|FG004|Follow Up Period|Lost to Follow-up|1|||
146160140|NCT00613951|527096407|FG000|Overall Study|Adverse Event|1|||
146160141|NCT00613951|527096408|FG001|Overall Study|Adverse Event|0|||
146160142|NCT00613951|527096409|FG002|Overall Study|Adverse Event|1|||
146160143|NCT00613951|527096407|FG000|Overall Study|Lack of Efficacy|0|||
146160144|NCT00613951|527096408|FG001|Overall Study|Lack of Efficacy|1|||
146160145|NCT00613951|527096409|FG002|Overall Study|Lack of Efficacy|1|||
146160146|NCT00613951|527096407|FG000|Overall Study|Protocol Violation|1|||
146160147|NCT00613951|527096408|FG001|Overall Study|Protocol Violation|1|||
146160148|NCT00613951|527096409|FG002|Overall Study|Protocol Violation|1|||
146160149|NCT00613951|527096407|FG000|Overall Study|Unclassified|5|||
146160150|NCT00613951|527096408|FG001|Overall Study|Unclassified|3|||
146160151|NCT00613951|527096409|FG002|Overall Study|Unclassified|2|||
146160152|NCT05540522|527096410|FG000|Overall Study|Adverse Event|1|||
146160153|NCT05540522|527096411|FG001|Overall Study|Adverse Event|0|||
146160154|NCT05540522|527096412|FG002|Overall Study|Adverse Event|2|||
146160155|NCT05540522|527096413|FG003|Overall Study|Adverse Event|5|||
146160156|NCT05540522|527096410|FG000|Overall Study|Lost to Follow-up|487|||
146160157|NCT05540522|527096411|FG001|Overall Study|Lost to Follow-up|427|||
146160158|NCT05540522|527096412|FG002|Overall Study|Lost to Follow-up|146|||
146160159|NCT05540522|527096413|FG003|Overall Study|Lost to Follow-up|166|||
146160160|NCT05540522|527096410|FG000|Overall Study|Physician Decision|11|||
146160161|NCT05540522|527096411|FG001|Overall Study|Physician Decision|19|||
146160162|NCT05540522|527096412|FG002|Overall Study|Physician Decision|8|||
146160163|NCT05540522|527096413|FG003|Overall Study|Physician Decision|13|||
146160164|NCT05540522|527096410|FG000|Overall Study|Pregnancy|1|||
146160165|NCT05540522|527096411|FG001|Overall Study|Pregnancy|0|||
146160166|NCT05540522|527096412|FG002|Overall Study|Pregnancy|0|||
146160167|NCT05540522|527096413|FG003|Overall Study|Pregnancy|0|||
146160168|NCT05540522|527096410|FG000|Overall Study|Protocol Violation|3|||
146281597|NCT03189745|527544683|FG001|Overall Study|Conflict in work schedule of participant|1|||
146281598|NCT05086276|527544684|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
146160169|NCT05540522|527096411|FG001|Overall Study|Protocol Violation|1|||
146160170|NCT05540522|527096412|FG002|Overall Study|Protocol Violation|9|||
146160171|NCT05540522|527096413|FG003|Overall Study|Protocol Violation|7|||
146160172|NCT05540522|527096410|FG000|Overall Study|Withdrawal by Subject|168|||
146160173|NCT05540522|527096411|FG001|Overall Study|Withdrawal by Subject|134|||
146160174|NCT05540522|527096412|FG002|Overall Study|Withdrawal by Subject|331|||
146160175|NCT05540522|527096413|FG003|Overall Study|Withdrawal by Subject|322|||
146160176|NCT05540522|527096410|FG000|Overall Study|Death|7|||
146281599|NCT05086276|527544685|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
146160177|NCT05540522|527096411|FG001|Overall Study|Death|9|||
146160178|NCT05540522|527096412|FG002|Overall Study|Death|49|||
146160179|NCT05540522|527096413|FG003|Overall Study|Death|46|||
146160180|NCT05540522|527096410|FG000|Overall Study|Not vaccinated|34|||
146160181|NCT05540522|527096411|FG001|Overall Study|Not vaccinated|53|||
146160182|NCT05540522|527096412|FG002|Overall Study|Not vaccinated|57|||
146160183|NCT05540522|527096413|FG003|Overall Study|Not vaccinated|50|||
146160184|NCT05540522|527096410|FG000|Overall Study|No longer meets eligibility criteria|0|||
146160185|NCT05540522|527096411|FG001|Overall Study|No longer meets eligibility criteria|0|||
146160186|NCT05540522|527096412|FG002|Overall Study|No longer meets eligibility criteria|3|||
146160187|NCT05540522|527096413|FG003|Overall Study|No longer meets eligibility criteria|2|||
146160188|NCT05540522|527096410|FG000|Overall Study|Other (Unspecified)|8|||
146160189|NCT05540522|527096411|FG001|Overall Study|Other (Unspecified)|10|||
146160190|NCT05540522|527096412|FG002|Overall Study|Other (Unspecified)|4|||
146160191|NCT05540522|527096413|FG003|Overall Study|Other (Unspecified)|2|||
146160192|NCT04348604|527096414|FG000|Week 8|Withdrawal by Subject|1|||
146160193|NCT04348604|527096415|FG001|Week 8|Withdrawal by Subject|1|||
146160194|NCT04348604|527096414|FG000|Week 8|Lost to Follow-up|1|||
146160195|NCT04348604|527096415|FG001|Week 8|Lost to Follow-up|2|||
146160196|NCT04348604|527096414|FG000|Week 8|Suspended|0|||
146160197|NCT04348604|527096415|FG001|Week 8|Suspended|1|||
146160198|NCT04348604|527096414|FG000|Week 12|Lost to Follow-up|1|||
146160199|NCT04348604|527096415|FG001|Week 12|Lost to Follow-up|2|||
146160200|NCT04348604|527096414|FG000|Week 12|Withdrawal by Subject|1|||
146160201|NCT04348604|527096415|FG001|Week 12|Withdrawal by Subject|0|||
146160202|NCT04348604|527096414|FG000|Week 24|Lost to Follow-up|2|||
146160203|NCT04348604|527096415|FG001|Week 24|Lost to Follow-up|1|||
146160204|NCT02097108|527096416|FG000|Overall Study|Adverse Event|1|||
146160205|NCT02097108|527096416|FG000|Overall Study|patient was abroad for 6 months|1|||
146160206|NCT00127608|527096419|FG000|Overall Study|VZV DNA negative|1|||
146160207|NCT00680407|527096427|FG000|Overall Study|Lost to Follow-up|3|||
146160208|NCT00680407|527096428|FG001|Overall Study|Lost to Follow-up|3|||
146160209|NCT00680407|527096429|FG002|Overall Study|Lost to Follow-up|1|||
146160210|NCT00680407|527096427|FG000|Overall Study|Withdrawal by Subject|5|||
146160211|NCT00680407|527096428|FG001|Overall Study|Withdrawal by Subject|2|||
146160212|NCT00680407|527096429|FG002|Overall Study|Withdrawal by Subject|2|||
146160213|NCT00506493|527096430|FG000|Overall Study|Death|6|||
146160214|NCT00506493|527096430|FG000|Overall Study|Withdrawal by Subject|5|||
146160215|NCT04918784|527098470|FG000|Overall Study|Amputation - no longer eligible|1|||
146160216|NCT04918784|527098471|FG001|Overall Study|Amputation - no longer eligible|2|||
146160217|NCT04918784|527098470|FG000|Overall Study|Death|1|||
146160218|NCT04918784|527098471|FG001|Overall Study|Death|0|||
146160219|NCT04918784|527098470|FG000|Overall Study|patient non-compliance|3|||
146160220|NCT04918784|527098471|FG001|Overall Study|patient non-compliance|1|||
146160221|NCT04918784|527098470|FG000|Overall Study|Adverse Event|1|||
146160222|NCT04918784|527098471|FG001|Overall Study|Adverse Event|0|||
146160223|NCT01712009|527098472|FG000|Overall Study|Withdrawal by Subject|24|||
146160224|NCT01712009|527098473|FG001|Overall Study|Withdrawal by Subject|15|||
146160225|NCT01712009|527098474|FG002|Overall Study|Withdrawal by Subject|8|||
146160226|NCT01712009|527098472|FG000|Overall Study|Lost to Follow-up|2|||
146160227|NCT01712009|527098473|FG001|Overall Study|Lost to Follow-up|0|||
146160228|NCT01712009|527098474|FG002|Overall Study|Lost to Follow-up|1|||
146160229|NCT01712009|527098472|FG000|Overall Study|Decision by Sponsor|12|||
146160230|NCT01712009|527098473|FG001|Overall Study|Decision by Sponsor|14|||
146160231|NCT01712009|527098474|FG002|Overall Study|Decision by Sponsor|12|||
146160232|NCT04050865|527098482|FG000|Overall Study|Adverse Event|1|||
146160233|NCT04050865|527098483|FG001|Overall Study|Adverse Event|0|||
146160234|NCT04050865|527098482|FG000|Overall Study|no insert|1|||
146160235|NCT04050865|527098483|FG001|Overall Study|no insert|0|||
146160236|NCT04050865|527098482|FG000|Overall Study|Only 1 insert|2|||
146160237|NCT04050865|527098483|FG001|Overall Study|Only 1 insert|3|||
146160238|NCT04050865|527098482|FG000|Overall Study|Physician Decision|0|||
146160239|NCT04050865|527098483|FG001|Overall Study|Physician Decision|1|||
146160240|NCT04050865|527098482|FG000|Overall Study|Withdrawal by Subject|0|||
146160241|NCT04050865|527098483|FG001|Overall Study|Withdrawal by Subject|1|||
146160242|NCT00857207|527098484|FG000|Overall Study|Withdrawal by Subject|13|||
146160243|NCT00857207|527098485|FG001|Overall Study|Withdrawal by Subject|0|||
146160244|NCT00857207|527098484|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
146160245|NCT00857207|527098485|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
146160246|NCT00857207|527098484|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
146160247|NCT00857207|527098485|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
146160248|NCT02822222|527098486|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
146160249|NCT02822222|527098487|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
146160250|NCT00643916|527098488|FG000|Overall Study|Protocol Violation|0|||
146160251|NCT00643916|527098489|FG001|Overall Study|Protocol Violation|1|||
146160252|NCT00643916|527098490|FG002|Overall Study|Protocol Violation|1|||
146160253|NCT00643916|527098491|FG003|Overall Study|Protocol Violation|1|||
146160254|NCT00643916|527098492|FG004|Overall Study|Protocol Violation|0|||
146160255|NCT00643916|527098493|FG005|Overall Study|Protocol Violation|0|||
146160256|NCT00643916|527098488|FG000|Overall Study|Lost to Follow-up|0|||
146160257|NCT00643916|527098489|FG001|Overall Study|Lost to Follow-up|1|||
146160258|NCT00643916|527098490|FG002|Overall Study|Lost to Follow-up|0|||
146160259|NCT00643916|527098491|FG003|Overall Study|Lost to Follow-up|0|||
146160260|NCT00643916|527098492|FG004|Overall Study|Lost to Follow-up|0|||
146160261|NCT00643916|527098493|FG005|Overall Study|Lost to Follow-up|0|||
146160262|NCT00643916|527098488|FG000|Overall Study|Withdrawal by Subject|2|||
146160263|NCT00643916|527098489|FG001|Overall Study|Withdrawal by Subject|2|||
146160264|NCT00643916|527098490|FG002|Overall Study|Withdrawal by Subject|2|||
146160265|NCT00643916|527098491|FG003|Overall Study|Withdrawal by Subject|1|||
146160266|NCT00643916|527098492|FG004|Overall Study|Withdrawal by Subject|0|||
146160267|NCT00643916|527098493|FG005|Overall Study|Withdrawal by Subject|1|||
146160268|NCT00643916|527098488|FG000|Overall Study|Not Vaccinated|2|||
146160269|NCT00643916|527098489|FG001|Overall Study|Not Vaccinated|2|||
146160270|NCT00643916|527098490|FG002|Overall Study|Not Vaccinated|3|||
146160271|NCT00643916|527098491|FG003|Overall Study|Not Vaccinated|0|||
146160272|NCT00643916|527098492|FG004|Overall Study|Not Vaccinated|2|||
146160273|NCT00643916|527098493|FG005|Overall Study|Not Vaccinated|0|||
146160274|NCT00428090|527098494|FG000|Overall Study|Adverse Event|10|||
146160275|NCT00428090|527098495|FG001|Overall Study|Adverse Event|8|||
146160276|NCT00428090|527098496|FG002|Overall Study|Adverse Event|10|||
146160277|NCT00428090|527098497|FG003|Overall Study|Adverse Event|11|||
146160278|NCT00428090|527098494|FG000|Overall Study|Lost to Follow-up|3|||
146160279|NCT00428090|527098495|FG001|Overall Study|Lost to Follow-up|6|||
146160280|NCT00428090|527098496|FG002|Overall Study|Lost to Follow-up|1|||
146160281|NCT00428090|527098497|FG003|Overall Study|Lost to Follow-up|4|||
146160282|NCT00428090|527098494|FG000|Overall Study|Protocol Violation|3|||
146160283|NCT00428090|527098495|FG001|Overall Study|Protocol Violation|1|||
146160284|NCT00428090|527098496|FG002|Overall Study|Protocol Violation|3|||
146160285|NCT00428090|527098497|FG003|Overall Study|Protocol Violation|3|||
146160286|NCT00428090|527098494|FG000|Overall Study|Withdrawal by Subject|10|||
146160287|NCT00428090|527098495|FG001|Overall Study|Withdrawal by Subject|12|||
146160288|NCT00428090|527098496|FG002|Overall Study|Withdrawal by Subject|15|||
146160289|NCT00428090|527098497|FG003|Overall Study|Withdrawal by Subject|5|||
146160290|NCT00428090|527098494|FG000|Overall Study|Sponsor terminated study|0|||
146160291|NCT00428090|527098495|FG001|Overall Study|Sponsor terminated study|1|||
146160292|NCT00428090|527098496|FG002|Overall Study|Sponsor terminated study|0|||
146160293|NCT00428090|527098497|FG003|Overall Study|Sponsor terminated study|0|||
146160294|NCT00428090|527098494|FG000|Overall Study|Non-compliance|4|||
146160295|NCT00428090|527098495|FG001|Overall Study|Non-compliance|0|||
146160296|NCT00428090|527098496|FG002|Overall Study|Non-compliance|1|||
146160297|NCT00428090|527098497|FG003|Overall Study|Non-compliance|3|||
146160298|NCT00428090|527098494|FG000|Overall Study|Par. did not returned to visit|1|||
146160299|NCT00428090|527098495|FG001|Overall Study|Par. did not returned to visit|0|||
146160300|NCT00428090|527098496|FG002|Overall Study|Par. did not returned to visit|0|||
146160301|NCT00428090|527098497|FG003|Overall Study|Par. did not returned to visit|1|||
146160302|NCT00428090|527098494|FG000|Overall Study|Follow-Up visit not possible|1|||
146160303|NCT00428090|527098495|FG001|Overall Study|Follow-Up visit not possible|0|||
146160304|NCT00428090|527098496|FG002|Overall Study|Follow-Up visit not possible|0|||
146160305|NCT00428090|527098497|FG003|Overall Study|Follow-Up visit not possible|0|||
146160306|NCT00428090|527098494|FG000|Overall Study|Prohibited medication used for SAE|1|||
146160307|NCT00428090|527098495|FG001|Overall Study|Prohibited medication used for SAE|0|||
146160308|NCT00428090|527098496|FG002|Overall Study|Prohibited medication used for SAE|0|||
146160309|NCT00428090|527098497|FG003|Overall Study|Prohibited medication used for SAE|0|||
146160310|NCT00428090|527098494|FG000|Overall Study|Death of par.|1|||
146160311|NCT00428090|527098495|FG001|Overall Study|Death of par.|0|||
146160312|NCT00428090|527098496|FG002|Overall Study|Death of par.|1|||
146160313|NCT00428090|527098497|FG003|Overall Study|Death of par.|0|||
146160314|NCT00428090|527098494|FG000|Overall Study|Visit 7 exceed the visit window|0|||
146160315|NCT00428090|527098495|FG001|Overall Study|Visit 7 exceed the visit window|1|||
146160316|NCT00428090|527098496|FG002|Overall Study|Visit 7 exceed the visit window|0|||
146160317|NCT00428090|527098497|FG003|Overall Study|Visit 7 exceed the visit window|0|||
146160318|NCT00428090|527098494|FG000|Overall Study|Medical monitor terminated par.|0|||
146160319|NCT00428090|527098495|FG001|Overall Study|Medical monitor terminated par.|1|||
146160320|NCT00428090|527098496|FG002|Overall Study|Medical monitor terminated par.|0|||
146160321|NCT00428090|527098497|FG003|Overall Study|Medical monitor terminated par.|0|||
146160322|NCT00428090|527098494|FG000|Overall Study|Mental status of par. was|0|||
146160323|NCT00428090|527098495|FG001|Overall Study|Mental status of par. was|1|||
146160324|NCT00428090|527098496|FG002|Overall Study|Mental status of par. was|0|||
146160325|NCT00428090|527098497|FG003|Overall Study|Mental status of par. was|0|||
146160326|NCT00428090|527098494|FG000|Overall Study|Worsening of AD|0|||
146160327|NCT00428090|527098495|FG001|Overall Study|Worsening of AD|0|||
146160328|NCT00428090|527098496|FG002|Overall Study|Worsening of AD|1|||
146160329|NCT00428090|527098497|FG003|Overall Study|Worsening of AD|0|||
146160330|NCT00428090|527098494|FG000|Overall Study|Excluded for concerning QTc value|0|||
146160331|NCT00428090|527098495|FG001|Overall Study|Excluded for concerning QTc value|0|||
146160332|NCT00428090|527098496|FG002|Overall Study|Excluded for concerning QTc value|1|||
146281600|NCT03590366|527544686|FG000|Overall Study|Adverse Event|0|||
146160333|NCT00428090|527098497|FG003|Overall Study|Excluded for concerning QTc value|0|||
146160334|NCT00428090|527098494|FG000|Overall Study|Insufficient AD documentation|0|||
146160335|NCT00428090|527098495|FG001|Overall Study|Insufficient AD documentation|0|||
146281601|NCT03590366|527544687|FG001|Overall Study|Adverse Event|3|||
146160336|NCT00428090|527098496|FG002|Overall Study|Insufficient AD documentation|1|||
146160337|NCT00428090|527098497|FG003|Overall Study|Insufficient AD documentation|0|||
146160338|NCT00428090|527098494|FG000|Overall Study|High MMSE scores|0|||
146160339|NCT00428090|527098495|FG001|Overall Study|High MMSE scores|0|||
146160340|NCT00428090|527098496|FG002|Overall Study|High MMSE scores|1|||
146160341|NCT00428090|527098497|FG003|Overall Study|High MMSE scores|0|||
146160342|NCT00428090|527098494|FG000|Overall Study|Deterioration of cognitive status|0|||
146160343|NCT00428090|527098495|FG001|Overall Study|Deterioration of cognitive status|0|||
146160344|NCT00428090|527098496|FG002|Overall Study|Deterioration of cognitive status|1|||
146160345|NCT00428090|527098497|FG003|Overall Study|Deterioration of cognitive status|0|||
146160346|NCT00428090|527098494|FG000|Overall Study|Serious adverse event|0|||
146160347|NCT00428090|527098495|FG001|Overall Study|Serious adverse event|0|||
146160348|NCT00428090|527098496|FG002|Overall Study|Serious adverse event|1|||
146160349|NCT00428090|527098497|FG003|Overall Study|Serious adverse event|0|||
146160350|NCT00428090|527098494|FG000|Overall Study|Excluded for heart insufficiency|0|||
146160351|NCT00428090|527098495|FG001|Overall Study|Excluded for heart insufficiency|0|||
146160352|NCT00428090|527098496|FG002|Overall Study|Excluded for heart insufficiency|1|||
146160353|NCT00428090|527098497|FG003|Overall Study|Excluded for heart insufficiency|0|||
146160354|NCT00428090|527098494|FG000|Overall Study|Raised Creatinine Value|0|||
146160355|NCT00428090|527098495|FG001|Overall Study|Raised Creatinine Value|0|||
146160356|NCT00428090|527098496|FG002|Overall Study|Raised Creatinine Value|0|||
146160357|NCT00428090|527098497|FG003|Overall Study|Raised Creatinine Value|1|||
146160358|NCT00440531|527098500|FG000|Overall Study|Adverse Event|1|||
146160359|NCT00440531|527098501|FG001|Overall Study|Adverse Event|0|||
146160360|NCT00440531|527098502|FG002|Overall Study|Adverse Event|2|||
146160361|NCT00440531|527098500|FG000|Overall Study|Withdrawal by Subject|2|||
146160362|NCT00440531|527098501|FG001|Overall Study|Withdrawal by Subject|0|||
146160363|NCT00440531|527098502|FG002|Overall Study|Withdrawal by Subject|0|||
146160364|NCT00440531|527098500|FG000|Overall Study|Protocol Violation|1|||
146160365|NCT00440531|527098501|FG001|Overall Study|Protocol Violation|2|||
146160366|NCT00440531|527098502|FG002|Overall Study|Protocol Violation|0|||
146160367|NCT00440531|527098500|FG000|Overall Study|Lost to Follow-up|4|||
146160368|NCT00440531|527098501|FG001|Overall Study|Lost to Follow-up|3|||
146160369|NCT00440531|527098502|FG002|Overall Study|Lost to Follow-up|5|||
146160370|NCT00440531|527098500|FG000|Overall Study|see pre-assignment details|2|||
146160371|NCT00440531|527098501|FG001|Overall Study|see pre-assignment details|0|||
146160372|NCT00440531|527098502|FG002|Overall Study|see pre-assignment details|0|||
146160373|NCT00677833|527098505|FG000|Overall Study|Withdrawal by Subject|4|||
146160374|NCT00677833|527098506|FG001|Overall Study|Withdrawal by Subject|0|||
146160375|NCT00677833|527098507|FG002|Overall Study|Withdrawal by Subject|1|||
146160376|NCT00677833|527098508|FG003|Overall Study|Withdrawal by Subject|3|||
146160377|NCT00677833|527098505|FG000|Overall Study|Lost to Follow-up|0|||
146160378|NCT00677833|527098506|FG001|Overall Study|Lost to Follow-up|0|||
146160379|NCT00677833|527098507|FG002|Overall Study|Lost to Follow-up|1|||
146160380|NCT00677833|527098508|FG003|Overall Study|Lost to Follow-up|0|||
146160381|NCT02606279|527098509|FG000|Overall Study|Lost to Follow-up|0|||
146160382|NCT02606279|527098510|FG001|Overall Study|Lost to Follow-up|1|||
146160383|NCT02184611|527098511|FG000|Overall Study|Lack of Efficacy|11|||
146160384|NCT02184611|527098512|FG001|Overall Study|Lack of Efficacy|15|||
146160385|NCT02184611|527098511|FG000|Overall Study|Withdrawal by Subject|5|||
146160386|NCT02184611|527098512|FG001|Overall Study|Withdrawal by Subject|6|||
146160387|NCT02184611|527098511|FG000|Overall Study|Adverse Event|4|||
146160388|NCT02184611|527098512|FG001|Overall Study|Adverse Event|5|||
146160389|NCT02184611|527098511|FG000|Overall Study|Protocol Violation|1|||
146160390|NCT02184611|527098512|FG001|Overall Study|Protocol Violation|1|||
146160391|NCT02184611|527098511|FG000|Overall Study|Protocol defined stopping criteria|0|||
146160392|NCT02184611|527098512|FG001|Overall Study|Protocol defined stopping criteria|1|||
146160393|NCT00160680|527098513|FG000|Overall Study|Adverse Event|0|||
146160394|NCT00160680|527098514|FG001|Overall Study|Adverse Event|1|||
146160395|NCT00160680|527098513|FG000|Overall Study|Lack of Efficacy|2|||
146160396|NCT00160680|527098514|FG001|Overall Study|Lack of Efficacy|1|||
146160397|NCT00160680|527098513|FG000|Overall Study|Lost to Follow-up|3|||
146160398|NCT00160680|527098514|FG001|Overall Study|Lost to Follow-up|2|||
146160399|NCT00160680|527098513|FG000|Overall Study|Withdrawal by Subject|4|||
146160400|NCT00160680|527098514|FG001|Overall Study|Withdrawal by Subject|9|||
146160401|NCT04493216|527098515|FG000|Overall Study|Study terminated by sponsor|30|||
146160402|NCT04493216|527098516|FG001|Overall Study|Study terminated by sponsor|33|||
146160403|NCT04493216|527098517|FG002|Overall Study|Study terminated by sponsor|28|||
146160404|NCT04493216|527098518|FG003|Overall Study|Study terminated by sponsor|27|||
146160405|NCT04493216|527098515|FG000|Overall Study|Withdrawal by Subject|2|||
146314733|NCT01995071|527664493|FG005|Overall Study|Adverse Event|0|||
146160406|NCT04493216|527098516|FG001|Overall Study|Withdrawal by Subject|1|||
146160407|NCT04493216|527098517|FG002|Overall Study|Withdrawal by Subject|1|||
146160408|NCT04493216|527098518|FG003|Overall Study|Withdrawal by Subject|2|||
146160409|NCT04493216|527098515|FG000|Overall Study|Protocol Violation|1|||
146160410|NCT04493216|527098516|FG001|Overall Study|Protocol Violation|2|||
146160411|NCT04493216|527098517|FG002|Overall Study|Protocol Violation|0|||
146160412|NCT04493216|527098518|FG003|Overall Study|Protocol Violation|2|||
146160413|NCT04493216|527098515|FG000|Overall Study|Physician Decision|0|||
146160414|NCT04493216|527098516|FG001|Overall Study|Physician Decision|0|||
146160415|NCT04493216|527098517|FG002|Overall Study|Physician Decision|1|||
146160416|NCT04493216|527098518|FG003|Overall Study|Physician Decision|0|||
146160417|NCT04493216|527098515|FG000|Overall Study|Lost to Follow-up|2|||
146160418|NCT04493216|527098516|FG001|Overall Study|Lost to Follow-up|1|||
146160419|NCT04493216|527098517|FG002|Overall Study|Lost to Follow-up|0|||
146160420|NCT04493216|527098518|FG003|Overall Study|Lost to Follow-up|1|||
146160421|NCT04493216|527098515|FG000|Overall Study|Adverse Event|1|||
146160422|NCT04493216|527098516|FG001|Overall Study|Adverse Event|4|||
146160423|NCT04493216|527098517|FG002|Overall Study|Adverse Event|5|||
146160424|NCT04493216|527098518|FG003|Overall Study|Adverse Event|2|||
146160425|NCT04493216|527098515|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
146160426|NCT04493216|527098516|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
146160427|NCT04493216|527098517|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
146160428|NCT04493216|527098518|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
146160429|NCT00985725|527098521|FG000|Overall Study|Adverse Event|4|||
146160430|NCT00985725|527098522|FG001|Overall Study|Adverse Event|1|||
146160431|NCT00985725|527098521|FG000|Overall Study|Protocol Violation|1|||
146160432|NCT00985725|527098522|FG001|Overall Study|Protocol Violation|3|||
146160433|NCT00985725|527098521|FG000|Overall Study|Withdrawal by Subject|4|||
146160434|NCT00985725|527098522|FG001|Overall Study|Withdrawal by Subject|4|||
146160435|NCT00985725|527098521|FG000|Overall Study|Lost to Follow-up|1|||
146160436|NCT00985725|527098522|FG001|Overall Study|Lost to Follow-up|1|||
146160437|NCT00985725|527098521|FG000|Overall Study|Lack of Efficacy|0|||
146160438|NCT00985725|527098522|FG001|Overall Study|Lack of Efficacy|1|||
146160439|NCT00985725|527098521|FG000|Overall Study|Non-compliance|1|||
146160440|NCT00985725|527098522|FG001|Overall Study|Non-compliance|2|||
146160441|NCT00985725|527098521|FG000|Overall Study|Out-of-window visits|0|||
146160442|NCT00985725|527098522|FG001|Overall Study|Out-of-window visits|1|||
146160443|NCT03151005|527098526|FG000|Overall Study|Lost to Follow-up|5|||
146160444|NCT03151005|527098527|FG001|Overall Study|Lost to Follow-up|5|||
146160445|NCT03318523|527098530|FG000|PC Period: Up to Year 1|Adverse Event|1|||
146160446|NCT03318523|527098531|FG001|PC Period: Up to Year 1|Adverse Event|0|||
146160447|NCT03318523|527098532|FG002|PC Period: Up to Year 1|Adverse Event|2|||
146160448|NCT03318523|527098533|FG003|PC Period: Up to Year 1|Adverse Event|0|||
146160449|NCT03318523|527098534|FG004|PC Period: Up to Year 1|Adverse Event|0|||
146160450|NCT03318523|527098535|FG005|PC Period: Up to Year 1|Adverse Event|0|||
146160451|NCT03318523|527098536|FG006|PC Period: Up to Year 1|Adverse Event|0|||
146160452|NCT03318523|527098537|FG007|PC Period: Up to Year 1|Adverse Event|0|||
146160453|NCT03318523|527098538|FG008|PC Period: Up to Year 1|Adverse Event|0|||
146160454|NCT03318523|527098539|FG009|PC Period: Up to Year 1|Adverse Event|0|||
146160455|NCT03318523|527098530|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
146160456|NCT03318523|527098531|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
146160457|NCT03318523|527098532|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160458|NCT03318523|527098533|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
146160459|NCT03318523|527098534|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160460|NCT03318523|527098535|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160461|NCT03318523|527098536|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160462|NCT03318523|527098537|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160463|NCT03318523|527098538|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160464|NCT03318523|527098539|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
146160465|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160466|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160467|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160468|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160469|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
146160470|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146281602|NCT03590366|527544686|FG000|Overall Study|Lost to Follow-up|3|||
146281603|NCT03590366|527544687|FG001|Overall Study|Lost to Follow-up|3|||
146281604|NCT03590366|527544686|FG000|Overall Study|Withdrawal by Subject|0|||
146281605|NCT03590366|527544687|FG001|Overall Study|Withdrawal by Subject|2|||
146281606|NCT00738894|527544689|FG000|Overall Study|Lost to Follow-up|23|||
146281607|NCT00738894|527544690|FG001|Overall Study|Lost to Follow-up|13|||
146281608|NCT00738894|527544689|FG000|Overall Study|Withdrawal by Subject|10|||
146281609|NCT00738894|527544690|FG001|Overall Study|Withdrawal by Subject|15|||
146281610|NCT00738894|527544689|FG000|Overall Study|Physician Decision|4|||
146160471|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160472|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
146160473|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
146160474|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
146160475|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146160476|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146281611|NCT00738894|527544690|FG001|Overall Study|Physician Decision|5|||
146160477|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146160478|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146160479|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
146160480|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146160481|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
146160482|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
146160483|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
146160484|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
146160485|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160486|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160487|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160488|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160489|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160490|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
146160491|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160492|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160493|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160494|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
146160495|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160496|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160497|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160498|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160499|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160500|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160501|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160502|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160503|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
146160504|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
146160505|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146160506|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146160507|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146160508|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
146160509|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
146160510|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
146160511|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
146160512|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
146160513|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
146160514|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
146160515|NCT03318523|527098530|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160516|NCT03318523|527098531|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160517|NCT03318523|527098532|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160518|NCT03318523|527098533|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160519|NCT03318523|527098534|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
146160520|NCT03318523|527098535|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160521|NCT03318523|527098536|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160522|NCT03318523|527098537|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
146160523|NCT03318523|527098538|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
146160524|NCT03318523|527098539|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
146160525|NCT03232983|527098542|FG000|Period 1|Physician Decision|0|||
146160526|NCT03232983|527098543|FG001|Period 1|Physician Decision|0|||
146160527|NCT03232983|527098544|FG002|Period 1|Physician Decision|1|||
146160528|NCT03232983|527098545|FG003|Period 1|Physician Decision|0|||
146160529|NCT03232983|527098542|FG000|Washout Period 2|Physician Decision|0|||
146160530|NCT03232983|527098543|FG001|Washout Period 2|Physician Decision|0|||
146160531|NCT03232983|527098544|FG002|Washout Period 2|Physician Decision|1|||
146160532|NCT03232983|527098545|FG003|Washout Period 2|Physician Decision|0|||
146160533|NCT03232983|527098542|FG000|Washout Period 2|Withdrawal by Subject|0|||
146160534|NCT03232983|527098543|FG001|Washout Period 2|Withdrawal by Subject|0|||
146160535|NCT03232983|527098544|FG002|Washout Period 2|Withdrawal by Subject|0|||
146160536|NCT03232983|527098545|FG003|Washout Period 2|Withdrawal by Subject|1|||
146160537|NCT03232983|527098542|FG000|Period 4|Withdrawal by Subject|1|||
146281612|NCT00738894|527544689|FG000|Overall Study|Death|2|||
146281613|NCT00738894|527544690|FG001|Overall Study|Death|0|||
146281614|NCT02656329|527544691|FG000|Overall Study|Lost to Follow-up|2|||
146281615|NCT02656329|527544692|FG001|Overall Study|Lost to Follow-up|3|||
146281616|NCT02656329|527544691|FG000|Overall Study|Withdrawal by Subject|7|||
146281617|NCT02656329|527544692|FG001|Overall Study|Withdrawal by Subject|6|||
146314734|NCT01995071|527664494|FG006|Overall Study|Adverse Event|1|||
146160538|NCT03232983|527098543|FG001|Period 4|Withdrawal by Subject|0|||
146160539|NCT03232983|527098544|FG002|Period 4|Withdrawal by Subject|0|||
146314735|NCT01995071|527664495|FG007|Overall Study|Adverse Event|0|||
146160540|NCT03232983|527098545|FG003|Period 4|Withdrawal by Subject|0|||
146160541|NCT01615328|527098546|FG000|Overall Study|Lost to Follow-up|3|||
146160542|NCT01615328|527098547|FG001|Overall Study|Lost to Follow-up|5|||
146160543|NCT00863655|527098548|FG000|Overall Study|Protocol Violation|4|||
146160544|NCT00863655|527098549|FG001|Overall Study|Protocol Violation|0|||
146160545|NCT00863655|527098548|FG000|Overall Study|Adverse Event|52|||
146160546|NCT00863655|527098549|FG001|Overall Study|Adverse Event|8|||
146160547|NCT00863655|527098548|FG000|Overall Study|Withdrawal by Subject|47|||
146160548|NCT00863655|527098549|FG001|Overall Study|Withdrawal by Subject|7|||
146160549|NCT00863655|527098548|FG000|Overall Study|Administrative problems|1|||
146160550|NCT00863655|527098549|FG001|Overall Study|Administrative problems|0|||
146160551|NCT00863655|527098548|FG000|Overall Study|Death|7|||
146160552|NCT00863655|527098549|FG001|Overall Study|Death|1|||
146160553|NCT00863655|527098548|FG000|Overall Study|New cancer therapy|5|||
146160554|NCT00863655|527098549|FG001|Overall Study|New cancer therapy|1|||
146160555|NCT00863655|527098548|FG000|Overall Study|Disease progression|364|||
146160556|NCT00863655|527098549|FG001|Overall Study|Disease progression|221|||
146160557|NCT00863655|527098548|FG000|Overall Study|Treatment completed as per protocol|5|||
146160558|NCT00863655|527098549|FG001|Overall Study|Treatment completed as per protocol|1|||
146160559|NCT02261493|527098550|FG000|Overall Study|Noncompliance|0|||
146160560|NCT02261493|527098551|FG001|Overall Study|Noncompliance|0|||
146160561|NCT02261493|527098552|FG002|Overall Study|Noncompliance|2|||
146160562|NCT02261493|527098550|FG000|Overall Study|Physician Decision|0|||
146160563|NCT02261493|527098551|FG001|Overall Study|Physician Decision|1|||
146160564|NCT02261493|527098552|FG002|Overall Study|Physician Decision|0|||
146160565|NCT02261493|527098550|FG000|Overall Study|Undisclosed alcohol abuse|0|||
146160566|NCT02261493|527098551|FG001|Overall Study|Undisclosed alcohol abuse|1|||
146160567|NCT02261493|527098552|FG002|Overall Study|Undisclosed alcohol abuse|0|||
146160568|NCT02261493|527098550|FG000|Overall Study|Protocol Violation|1|||
146160569|NCT02261493|527098551|FG001|Overall Study|Protocol Violation|0|||
146160570|NCT02261493|527098552|FG002|Overall Study|Protocol Violation|0|||
146160571|NCT02261493|527098550|FG000|Overall Study|Personal Reasons|14|||
146160572|NCT02261493|527098551|FG001|Overall Study|Personal Reasons|14|||
146160573|NCT02261493|527098552|FG002|Overall Study|Personal Reasons|16|||
146160574|NCT02261493|527098550|FG000|Overall Study|Lost to Follow-up|14|||
146160575|NCT02261493|527098551|FG001|Overall Study|Lost to Follow-up|27|||
146160576|NCT02261493|527098552|FG002|Overall Study|Lost to Follow-up|8|||
146160577|NCT02261493|527098550|FG000|Overall Study|Pregnancy|1|||
146160578|NCT02261493|527098551|FG001|Overall Study|Pregnancy|2|||
146160579|NCT02261493|527098552|FG002|Overall Study|Pregnancy|0|||
146160580|NCT02261493|527098550|FG000|Overall Study|Lack of Efficacy|0|||
146160581|NCT02261493|527098551|FG001|Overall Study|Lack of Efficacy|1|||
146160582|NCT02261493|527098552|FG002|Overall Study|Lack of Efficacy|0|||
146160583|NCT02261493|527098550|FG000|Overall Study|Adverse Event|0|||
146160584|NCT02261493|527098551|FG001|Overall Study|Adverse Event|1|||
146160585|NCT02261493|527098552|FG002|Overall Study|Adverse Event|0|||
146160586|NCT01597050|527098553|FG000|Overall Study|Withdrawal by Subject|1|||
146160587|NCT01597050|527098554|FG001|Overall Study|Withdrawal by Subject|0|||
146160588|NCT00483184|527098555|FG000|Overall Study|Withdrawal by Subject|2|||
146160589|NCT00483184|527098556|FG001|Overall Study|Withdrawal by Subject|2|||
146160590|NCT00483184|527098557|FG002|Overall Study|Withdrawal by Subject|0|||
146160591|NCT00483184|527098555|FG000|Overall Study|Lost to Follow-up|1|||
146160592|NCT00483184|527098556|FG001|Overall Study|Lost to Follow-up|0|||
146160593|NCT00483184|527098557|FG002|Overall Study|Lost to Follow-up|0|||
146160594|NCT00483184|527098555|FG000|Overall Study|Adverse Event|1|||
146281618|NCT02656329|527544691|FG000|Overall Study|Study termination by Sponsor|150|||
146281619|NCT02656329|527544692|FG001|Overall Study|Study termination by Sponsor|142|||
146281620|NCT02656329|527544691|FG000|Overall Study|Other than specified above|5|||
146281621|NCT02656329|527544692|FG001|Overall Study|Other than specified above|6|||
146281622|NCT01081665|527544694|FG000|Overall Study|Death|41|||
146281623|NCT01081665|527544694|FG000|Overall Study|Lost to Follow-up|18|||
146281624|NCT01081665|527544694|FG000|Overall Study|Withdrawal by Subject|17|||
146314736|NCT01995071|527664496|FG008|Overall Study|Adverse Event|0|||
146160595|NCT00483184|527098556|FG001|Overall Study|Adverse Event|2|||
146160596|NCT00483184|527098557|FG002|Overall Study|Adverse Event|2|||
146160597|NCT00483184|527098555|FG000|Overall Study|Protocol Violation|1|||
146160598|NCT00483184|527098556|FG001|Overall Study|Protocol Violation|0|||
146160599|NCT00483184|527098557|FG002|Overall Study|Protocol Violation|1|||
146281625|NCT01081665|527544694|FG000|Overall Study|Change of dialysis unit|10|||
146160600|NCT02065336|527098558|FG000|Extension Phase|Study Terminated by Sponsor|0|||
146160601|NCT02065336|527098559|FG001|Extension Phase|Study Terminated by Sponsor|0|||
146160602|NCT02065336|527098560|FG002|Extension Phase|Study Terminated by Sponsor|0|||
146160603|NCT02065336|527098561|FG003|Extension Phase|Study Terminated by Sponsor|0|||
146160604|NCT02065336|527098562|FG004|Extension Phase|Study Terminated by Sponsor|0|||
146160605|NCT02065336|527098563|FG005|Extension Phase|Study Terminated by Sponsor|0|||
146281626|NCT01081665|527544694|FG000|Overall Study|Regulation of iPTH|5|||
146160606|NCT02065336|527098564|FG006|Extension Phase|Study Terminated by Sponsor|0|||
146160607|NCT02065336|527098565|FG007|Extension Phase|Study Terminated by Sponsor|0|||
146160608|NCT02065336|527098566|FG008|Extension Phase|Study Terminated by Sponsor|2|||
146160609|NCT02065336|527098567|FG009|Extension Phase|Study Terminated by Sponsor|8|||
146160610|NCT00530855|527098568|FG000|Overall Study|Lack of Efficacy|20|||
146160611|NCT00530855|527098568|FG000|Overall Study|Withdrawal by Subject|30|||
146160612|NCT00530855|527098568|FG000|Overall Study|Fatal Serious AE|3|||
146160613|NCT00530855|527098568|FG000|Overall Study|Non Fatal Serious AE|7|||
146160614|NCT00530855|527098568|FG000|Overall Study|Non Fatal Non Serious AE|12|||
146160615|NCT00530855|527098568|FG000|Overall Study|Protocol Violation|3|||
146160616|NCT00530855|527098568|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
146160617|NCT00530855|527098568|FG000|Overall Study|Lost to Follow-up|9|||
146160618|NCT00530855|527098568|FG000|Overall Study|Other reason for premature termination|17|||
146160619|NCT01627327|527098569|FG000|Overall Study|Adverse Event|6|||
146160620|NCT01627327|527098570|FG001|Overall Study|Adverse Event|12|||
146160621|NCT01627327|527098569|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
146160622|NCT01627327|527098570|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
146160623|NCT01627327|527098569|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
146160624|NCT01627327|527098570|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
146160625|NCT01627327|527098569|FG000|Overall Study|Protocol Violation|4|||
146160626|NCT01627327|527098570|FG001|Overall Study|Protocol Violation|10|||
146160627|NCT01627327|527098569|FG000|Overall Study|Lost to Follow-up|1|||
146160628|NCT01627327|527098570|FG001|Overall Study|Lost to Follow-up|3|||
146160629|NCT01627327|527098569|FG000|Overall Study|Physician Decision|1|||
146160630|NCT01627327|527098570|FG001|Overall Study|Physician Decision|0|||
146160631|NCT01627327|527098569|FG000|Overall Study|Withdrawal by Subject|3|||
146160632|NCT01627327|527098570|FG001|Overall Study|Withdrawal by Subject|3|||
146160633|NCT00868439|527098574|FG000|Overall Study|Adverse Event|4|||
146160634|NCT00868439|527098575|FG001|Overall Study|Adverse Event|3|||
146160635|NCT00868439|527098574|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
146160636|NCT00868439|527098575|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
146160637|NCT00868439|527098574|FG000|Overall Study|Death|0|||
146160638|NCT00868439|527098575|FG001|Overall Study|Death|1|||
146160639|NCT00868439|527098574|FG000|Overall Study|Protocol Violation|1|||
146160640|NCT00868439|527098575|FG001|Overall Study|Protocol Violation|1|||
146160641|NCT00868439|527098574|FG000|Overall Study|Physician Decision|1|||
146160642|NCT00868439|527098575|FG001|Overall Study|Physician Decision|0|||
146160643|NCT00868439|527098574|FG000|Overall Study|Withdrawal by Subject|0|||
146160644|NCT00868439|527098575|FG001|Overall Study|Withdrawal by Subject|1|||
146160645|NCT00423176|527098576|FG000|Overall Study|Adverse Event|4|||
146160646|NCT00423176|527098577|FG001|Overall Study|Adverse Event|6|||
146160647|NCT00423176|527098576|FG000|Overall Study|Treatment Failure|1|||
146160648|NCT00423176|527098577|FG001|Overall Study|Treatment Failure|6|||
146160649|NCT00423176|527098576|FG000|Overall Study|Lost to Follow-up|4|||
146160650|NCT00423176|527098577|FG001|Overall Study|Lost to Follow-up|7|||
146160651|NCT00423176|527098576|FG000|Overall Study|Withdrawal by Subject|4|||
146160652|NCT00423176|527098577|FG001|Overall Study|Withdrawal by Subject|3|||
146160653|NCT00423176|527098576|FG000|Overall Study|Protocol Violation|1|||
146160654|NCT00423176|527098577|FG001|Overall Study|Protocol Violation|3|||
146160655|NCT00423176|527098576|FG000|Overall Study|Did not meet protocol eligibility|2|||
146160656|NCT00423176|527098577|FG001|Overall Study|Did not meet protocol eligibility|4|||
146160657|NCT00224874|527098580|FG000|Overall Study|Withdrawal by Subject|0|||
146160658|NCT00224874|527098581|FG001|Overall Study|Withdrawal by Subject|0|||
146160659|NCT00224874|527098582|FG002|Overall Study|Withdrawal by Subject|1|||
146160660|NCT00224874|527098583|FG003|Overall Study|Withdrawal by Subject|0|||
146160661|NCT00911534|527098584|FG000|Overall Study|Adverse Event|4|||
146160662|NCT00911534|527098585|FG001|Overall Study|Adverse Event|4|||
146160663|NCT00911534|527098584|FG000|Overall Study|Lost to Follow-up|2|||
146160664|NCT00911534|527098585|FG001|Overall Study|Lost to Follow-up|4|||
146160665|NCT00911534|527098584|FG000|Overall Study|Withdrawal by Subject|2|||
146160666|NCT00911534|527098585|FG001|Overall Study|Withdrawal by Subject|1|||
146160667|NCT00911534|527098584|FG000|Overall Study|Lack of Efficacy|4|||
146160668|NCT00911534|527098585|FG001|Overall Study|Lack of Efficacy|1|||
146314737|NCT01995071|527664497|FG009|Overall Study|Adverse Event|0|||
146160669|NCT00911534|527098584|FG000|Overall Study|Withdrawal of consent|1|||
146160670|NCT00911534|527098585|FG001|Overall Study|Withdrawal of consent|4|||
146160671|NCT00911534|527098584|FG000|Overall Study|Other|2|||
146160672|NCT00911534|527098585|FG001|Overall Study|Other|2|||
146160673|NCT05072080|527098586|FG000|Overall Study|Death|0|||
146160674|NCT05072080|527098587|FG001|Overall Study|Death|0|||
146160675|NCT05072080|527098588|FG002|Overall Study|Death|1|||
146160676|NCT05072080|527098589|FG003|Overall Study|Death|0|||
146160677|NCT05072080|527098586|FG000|Overall Study|Lost to Follow-up|65|||
146160678|NCT05072080|527098587|FG001|Overall Study|Lost to Follow-up|70|||
146160679|NCT05072080|527098588|FG002|Overall Study|Lost to Follow-up|58|||
146160680|NCT05072080|527098589|FG003|Overall Study|Lost to Follow-up|23|||
146160681|NCT05072080|527098586|FG000|Overall Study|Physician Decision|2|||
146160682|NCT05072080|527098587|FG001|Overall Study|Physician Decision|1|||
146160683|NCT05072080|527098588|FG002|Overall Study|Physician Decision|1|||
146160684|NCT05072080|527098589|FG003|Overall Study|Physician Decision|0|||
146160685|NCT05072080|527098586|FG000|Overall Study|Withdrawal by Subject|45|||
146160686|NCT05072080|527098587|FG001|Overall Study|Withdrawal by Subject|30|||
146160687|NCT05072080|527098588|FG002|Overall Study|Withdrawal by Subject|27|||
146160688|NCT05072080|527098589|FG003|Overall Study|Withdrawal by Subject|7|||
146160689|NCT05072080|527098586|FG000|Overall Study|Sponsor Decision|0|||
146160690|NCT05072080|527098587|FG001|Overall Study|Sponsor Decision|1|||
146160691|NCT05072080|527098588|FG002|Overall Study|Sponsor Decision|0|||
146160692|NCT05072080|527098589|FG003|Overall Study|Sponsor Decision|0|||
146160693|NCT05072080|527098586|FG000|Overall Study|Subject moved|1|||
146160694|NCT05072080|527098587|FG001|Overall Study|Subject moved|3|||
146160695|NCT05072080|527098588|FG002|Overall Study|Subject moved|5|||
146160696|NCT05072080|527098589|FG003|Overall Study|Subject moved|2|||
146160697|NCT05072080|527098586|FG000|Overall Study|Withdrawal by parent|0|||
146160698|NCT05072080|527098587|FG001|Overall Study|Withdrawal by parent|0|||
146160699|NCT05072080|527098588|FG002|Overall Study|Withdrawal by parent|1|||
146160700|NCT05072080|527098589|FG003|Overall Study|Withdrawal by parent|0|||
146160701|NCT05072080|527098586|FG000|Overall Study|Subject was deployed|0|||
146160702|NCT05072080|527098587|FG001|Overall Study|Subject was deployed|1|||
146160703|NCT05072080|527098588|FG002|Overall Study|Subject was deployed|0|||
146160704|NCT05072080|527098589|FG003|Overall Study|Subject was deployed|0|||
146160705|NCT05072080|527098586|FG000|Overall Study|Subject left site without receiving dose|0|||
146160706|NCT05072080|527098587|FG001|Overall Study|Subject left site without receiving dose|1|||
146160707|NCT05072080|527098588|FG002|Overall Study|Subject left site without receiving dose|0|||
146314738|NCT01995071|527664498|FG010|Overall Study|Adverse Event|0|||
146314739|NCT01995071|527664499|FG011|Overall Study|Adverse Event|0|||
146314740|NCT01995071|527664488|FG000|Overall Study|Moved|0|||
146314741|NCT01995071|527664489|FG001|Overall Study|Moved|0|||
146314742|NCT01995071|527664490|FG002|Overall Study|Moved|1|||
146314743|NCT01995071|527664491|FG003|Overall Study|Moved|0|||
146314744|NCT01995071|527664492|FG004|Overall Study|Moved|1|||
146160708|NCT05072080|527098589|FG003|Overall Study|Subject left site without receiving dose|0|||
146160709|NCT05072080|527098586|FG000|Overall Study|Subject incarcerated|0|||
146160710|NCT05072080|527098587|FG001|Overall Study|Subject incarcerated|1|||
146160711|NCT05072080|527098588|FG002|Overall Study|Subject incarcerated|0|||
146160712|NCT05072080|527098589|FG003|Overall Study|Subject incarcerated|1|||
146160713|NCT05072080|527098586|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
146160714|NCT05072080|527098587|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
146160715|NCT05072080|527098588|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
146160716|NCT05072080|527098589|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
146160717|NCT05072080|527098586|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
146160718|NCT05072080|527098587|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
146160719|NCT05072080|527098588|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
146160720|NCT05072080|527098589|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
146160721|NCT04867369|527098590|FG000|Overall Study|Withdrawal by Subject|1|||
146160722|NCT04867369|527098591|FG001|Overall Study|Withdrawal by Subject|0|||
146160723|NCT05554237|527098592|FG000|Part 2 (7 Days)|Adverse Event|0|||
146160724|NCT05554237|527098593|FG001|Part 2 (7 Days)|Adverse Event|0|||
146160725|NCT05554237|527098594|FG002|Part 2 (7 Days)|Adverse Event|0|||
146160726|NCT05554237|527098595|FG003|Part 2 (7 Days)|Adverse Event|0|||
146160727|NCT05554237|527098596|FG004|Part 2 (7 Days)|Adverse Event|2|||
146160728|NCT05554237|527098597|FG005|Part 2 (7 Days)|Adverse Event|0|||
146160729|NCT05554237|527098598|FG006|Part 2 (7 Days)|Adverse Event|0|||
146160730|NCT05554237|527098599|FG007|Part 2 (7 Days)|Adverse Event|0|||
146160731|NCT05554237|527098600|FG008|Part 2 (7 Days)|Adverse Event|0|||
146160732|NCT05554237|527098601|FG009|Part 2 (7 Days)|Adverse Event|1|||
146160733|NCT05554237|527098602|FG010|Part 2 (7 Days)|Adverse Event|0|||
146160734|NCT05554237|527098603|FG011|Part 2 (7 Days)|Adverse Event|0|||
146160735|NCT05554237|527098604|FG012|Part 2 (7 Days)|Adverse Event|1|||
146160736|NCT05554237|527098605|FG013|Part 2 (7 Days)|Adverse Event|0|||
146160737|NCT01640808|527098607|FG000|Overall Study|Unable to continue dynamic CT|14|||
146160738|NCT01640808|527098608|FG001|Overall Study|Unable to continue dynamic CT|4|||
146160739|NCT01640808|527098607|FG000|Overall Study|Withdrawal by Subject|12|||
146314745|NCT01995071|527664493|FG005|Overall Study|Moved|0|||
146314746|NCT01995071|527664494|FG006|Overall Study|Moved|0|||
146314747|NCT01995071|527664495|FG007|Overall Study|Moved|0|||
146160740|NCT01640808|527098608|FG001|Overall Study|Withdrawal by Subject|4|||
146160741|NCT01640808|527098607|FG000|Overall Study|Lost to Follow-up|4|||
146160742|NCT01640808|527098608|FG001|Overall Study|Lost to Follow-up|0|||
146160743|NCT01640808|527098607|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
146160744|NCT01640808|527098608|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
146160745|NCT01640808|527098607|FG000|Overall Study|Administration of anticancer drugs|2|||
146160746|NCT01640808|527098608|FG001|Overall Study|Administration of anticancer drugs|1|||
146160747|NCT01640808|527098607|FG000|Overall Study|Physician Decision|19|||
146314748|NCT01995071|527664496|FG008|Overall Study|Moved|0|||
146160748|NCT01640808|527098608|FG001|Overall Study|Physician Decision|5|||
146160749|NCT01640808|527098607|FG000|Overall Study|Randomized but not treated|4|||
146160750|NCT01640808|527098608|FG001|Overall Study|Randomized but not treated|2|||
146160751|NCT02477111|527098609|FG000|Overall Study|Death|28|||
146160752|NCT02477111|527098609|FG000|Overall Study|Withdrawal by Subject|19|||
146160753|NCT02477111|527098609|FG000|Overall Study|Lost to Follow-up|4|||
146160754|NCT02192502|527098611|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
146160755|NCT02192502|527098612|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
146314749|NCT01995071|527664497|FG009|Overall Study|Moved|0|||
146314750|NCT01995071|527664498|FG010|Overall Study|Moved|1|||
146314751|NCT01995071|527664499|FG011|Overall Study|Moved|0|||
146314752|NCT01995071|527664488|FG000|Overall Study|Lost to Follow-up|1|||
146314753|NCT01995071|527664489|FG001|Overall Study|Lost to Follow-up|0|||
146314754|NCT01995071|527664490|FG002|Overall Study|Lost to Follow-up|0|||
146314755|NCT01995071|527664491|FG003|Overall Study|Lost to Follow-up|0|||
146314756|NCT01995071|527664492|FG004|Overall Study|Lost to Follow-up|0|||
146314757|NCT01995071|527664493|FG005|Overall Study|Lost to Follow-up|0|||
146314758|NCT01995071|527664494|FG006|Overall Study|Lost to Follow-up|0|||
146314759|NCT01995071|527664495|FG007|Overall Study|Lost to Follow-up|1|||
146314760|NCT01995071|527664496|FG008|Overall Study|Lost to Follow-up|1|||
146314761|NCT01995071|527664497|FG009|Overall Study|Lost to Follow-up|0|||
146314762|NCT01995071|527664498|FG010|Overall Study|Lost to Follow-up|0|||
146314763|NCT01995071|527664499|FG011|Overall Study|Lost to Follow-up|0|||
146160756|NCT02192502|527098611|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
146160757|NCT02192502|527098612|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
146160758|NCT02192502|527098611|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
146160759|NCT02192502|527098612|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
146160760|NCT01381692|527098613|FG000|Overall Study|Adverse Event|1|||
146160761|NCT01381692|527098614|FG001|Overall Study|Adverse Event|0|||
146160762|NCT01381692|527098615|FG002|Overall Study|Adverse Event|0|||
146160763|NCT01381692|527098616|FG003|Overall Study|Adverse Event|0|||
146160764|NCT01381692|527098617|FG004|Overall Study|Adverse Event|0|||
146160765|NCT01381692|527098618|FG005|Overall Study|Adverse Event|0|||
146160766|NCT03896035|527098620|FG000|Overall Study|Lost to Follow-up|2|||
146160767|NCT03896035|527098621|FG001|Overall Study|Lost to Follow-up|6|||
146160768|NCT03896035|527098620|FG000|Overall Study|Withdrawal by Subject|0|||
146160769|NCT03896035|527098621|FG001|Overall Study|Withdrawal by Subject|1|||
146160770|NCT03896035|527098620|FG000|Overall Study|Health/family health issues during COVID|0|||
146160771|NCT03896035|527098621|FG001|Overall Study|Health/family health issues during COVID|4|||
146160772|NCT01506193|527098624|FG000|Overall Study|Protocol Violation|1|||
146160773|NCT01506193|527098625|FG001|Overall Study|Protocol Violation|0|||
146160774|NCT01506193|527098626|FG002|Overall Study|Protocol Violation|1|||
146160775|NCT01506193|527098624|FG000|Overall Study|Migrated/moved from study area|0|||
146160776|NCT01506193|527098625|FG001|Overall Study|Migrated/moved from study area|0|||
146160777|NCT01506193|527098626|FG002|Overall Study|Migrated/moved from study area|1|||
146160778|NCT01506193|527098624|FG000|Overall Study|Adverse event, non-fatal|0|||
146160779|NCT01506193|527098625|FG001|Overall Study|Adverse event, non-fatal|0|||
146160780|NCT01506193|527098626|FG002|Overall Study|Adverse event, non-fatal|1|||
146160781|NCT01506193|527098624|FG000|Overall Study|Withdrawal by Subject|5|||
146160782|NCT01506193|527098625|FG001|Overall Study|Withdrawal by Subject|1|||
146160783|NCT01506193|527098626|FG002|Overall Study|Withdrawal by Subject|8|||
146281627|NCT01081665|527544694|FG000|Overall Study|Change in renal replacement therapy|2|||
146281628|NCT01081665|527544694|FG000|Overall Study|Adverse Event|1|||
146281629|NCT01081665|527544694|FG000|Overall Study|Lack of Efficacy|1|||
146281630|NCT01747551|527544697|FG000|Overall Study|Progressive Disease|24|||
146281631|NCT01747551|527544698|FG001|Overall Study|Progressive Disease|17|||
146281632|NCT01747551|527544697|FG000|Overall Study|Death|3|||
146281633|NCT01747551|527544698|FG001|Overall Study|Death|1|||
146281634|NCT01747551|527544697|FG000|Overall Study|Adverse Event|7|||
146281635|NCT01747551|527544698|FG001|Overall Study|Adverse Event|1|||
146281636|NCT01747551|527544697|FG000|Overall Study|Prolonged Treatment Delay|2|||
146281637|NCT01747551|527544698|FG001|Overall Study|Prolonged Treatment Delay|0|||
146281638|NCT01747551|527544697|FG000|Overall Study|Withdrawal by Subject|3|||
146281639|NCT01747551|527544698|FG001|Overall Study|Withdrawal by Subject|1|||
146281640|NCT01747551|527544697|FG000|Overall Study|Physician Decision|2|||
146281641|NCT01747551|527544698|FG001|Overall Study|Physician Decision|1|||
146281642|NCT01747551|527544697|FG000|Overall Study|Other|2|||
146281643|NCT01747551|527544698|FG001|Overall Study|Other|0|||
146281644|NCT03117998|527544702|FG000|Overall Study|Adverse Event|1|||
146281645|NCT03117998|527544703|FG001|Overall Study|Adverse Event|0|||
146281646|NCT03117998|527544704|FG002|Overall Study|Adverse Event|0|||
146281647|NCT03117998|527544705|FG003|Overall Study|Adverse Event|0|||
146281648|NCT03117998|527544706|FG004|Overall Study|Adverse Event|0|||
146281649|NCT03117998|527544707|FG005|Overall Study|Adverse Event|0|||
146160784|NCT01506193|527098624|FG000|Overall Study|Lost to Follow-up|8|||
146281650|NCT03117998|527544702|FG000|Overall Study|Withdrawal by Subject|0|||
146314764|NCT01995071|527664488|FG000|Overall Study|Incarcerated|0|||
146160785|NCT01506193|527098625|FG001|Overall Study|Lost to Follow-up|3|||
146160786|NCT01506193|527098626|FG002|Overall Study|Lost to Follow-up|3|||
146160787|NCT04575467|527098630|FG000|Overall Study|Adverse Event|0|||
146160788|NCT04575467|527098631|FG001|Overall Study|Adverse Event|1|||
146160789|NCT04575467|527098632|FG002|Overall Study|Adverse Event|0|||
146160790|NCT04575467|527098633|FG003|Overall Study|Adverse Event|0|||
146160791|NCT01328574|527098634|FG000|Overall Study|Refused further treatment|1|||
146160792|NCT01152580|527098637|FG000|Overall Study|Withdrawal by Subject|0|||
146160793|NCT01152580|527098638|FG001|Overall Study|Withdrawal by Subject|1|||
146160794|NCT00113568|527098646|FG000|Overall Study|Adverse Event|97|||
146160795|NCT00113568|527098646|FG000|Overall Study|Death|1|||
146160796|NCT00113568|527098646|FG000|Overall Study|Lack of Efficacy|30|||
146160797|NCT00113568|527098646|FG000|Overall Study|Lost to Follow-up|156|||
146160798|NCT00113568|527098646|FG000|Overall Study|Protocol Violation|32|||
146160799|NCT00113568|527098646|FG000|Overall Study|Withdrawal by Subject|117|||
146160800|NCT00113568|527098646|FG000|Overall Study|Other|112|||
146160801|NCT00736645|527098647|FG000|Overall Study|Adverse Event|0|||
146160802|NCT00736645|527098648|FG001|Overall Study|Adverse Event|2|||
146160803|NCT00736645|527098649|FG002|Overall Study|Adverse Event|0|||
146160804|NCT00736645|527098650|FG003|Overall Study|Adverse Event|0|||
146160805|NCT01441102|527098651|FG000|Overall Study|Adverse Event|1|||
146160806|NCT01441102|527098651|FG000|Overall Study|Withdrawal by Subject|2|||
146160807|NCT00518115|527098652|FG000|Overall Study|Adverse Event|6|||
146160808|NCT00518115|527098653|FG001|Overall Study|Adverse Event|1|||
146160809|NCT00518115|527098654|FG002|Overall Study|Adverse Event|5|||
146160810|NCT00518115|527098655|FG003|Overall Study|Adverse Event|6|||
146160811|NCT00518115|527098656|FG004|Overall Study|Adverse Event|5|||
146160812|NCT00518115|527098657|FG005|Overall Study|Adverse Event|5|||
146160813|NCT00518115|527098658|FG006|Overall Study|Adverse Event|5|||
146160814|NCT00518115|527098659|FG007|Overall Study|Adverse Event|10|||
146160815|NCT00518115|527098660|FG008|Overall Study|Adverse Event|2|||
146160816|NCT00518115|527098661|FG009|Overall Study|Adverse Event|9|||
146160817|NCT00518115|527098652|FG000|Overall Study|Lost to Follow-up|0|||
146160818|NCT00518115|527098653|FG001|Overall Study|Lost to Follow-up|0|||
146160819|NCT00518115|527098654|FG002|Overall Study|Lost to Follow-up|2|||
146160820|NCT00518115|527098655|FG003|Overall Study|Lost to Follow-up|3|||
146160821|NCT00518115|527098656|FG004|Overall Study|Lost to Follow-up|1|||
146160822|NCT00518115|527098657|FG005|Overall Study|Lost to Follow-up|3|||
146160823|NCT00518115|527098658|FG006|Overall Study|Lost to Follow-up|0|||
146160824|NCT00518115|527098659|FG007|Overall Study|Lost to Follow-up|1|||
146160825|NCT00518115|527098660|FG008|Overall Study|Lost to Follow-up|1|||
146160826|NCT00518115|527098661|FG009|Overall Study|Lost to Follow-up|1|||
146160827|NCT00518115|527098652|FG000|Overall Study|Protocol Violation|1|||
146160828|NCT00518115|527098653|FG001|Overall Study|Protocol Violation|3|||
146160829|NCT00518115|527098654|FG002|Overall Study|Protocol Violation|1|||
146160830|NCT00518115|527098655|FG003|Overall Study|Protocol Violation|0|||
146160831|NCT00518115|527098656|FG004|Overall Study|Protocol Violation|0|||
146160832|NCT00518115|527098657|FG005|Overall Study|Protocol Violation|0|||
146160833|NCT00518115|527098658|FG006|Overall Study|Protocol Violation|0|||
146160834|NCT00518115|527098659|FG007|Overall Study|Protocol Violation|0|||
146160835|NCT00518115|527098660|FG008|Overall Study|Protocol Violation|0|||
146160836|NCT00518115|527098661|FG009|Overall Study|Protocol Violation|0|||
146160837|NCT00518115|527098652|FG000|Overall Study|Withdrawal by Subject|1|||
146160838|NCT00518115|527098653|FG001|Overall Study|Withdrawal by Subject|1|||
146160839|NCT00518115|527098654|FG002|Overall Study|Withdrawal by Subject|5|||
146160840|NCT00518115|527098655|FG003|Overall Study|Withdrawal by Subject|0|||
146160841|NCT00518115|527098656|FG004|Overall Study|Withdrawal by Subject|2|||
146160842|NCT00518115|527098657|FG005|Overall Study|Withdrawal by Subject|1|||
146160843|NCT00518115|527098658|FG006|Overall Study|Withdrawal by Subject|0|||
146160844|NCT00518115|527098659|FG007|Overall Study|Withdrawal by Subject|2|||
146160845|NCT00518115|527098660|FG008|Overall Study|Withdrawal by Subject|1|||
146160846|NCT00518115|527098661|FG009|Overall Study|Withdrawal by Subject|3|||
146160847|NCT00518115|527098652|FG000|Overall Study|Lack of Efficacy|1|||
146160848|NCT00518115|527098653|FG001|Overall Study|Lack of Efficacy|0|||
146160849|NCT00518115|527098654|FG002|Overall Study|Lack of Efficacy|1|||
146160850|NCT00518115|527098655|FG003|Overall Study|Lack of Efficacy|1|||
146160851|NCT00518115|527098656|FG004|Overall Study|Lack of Efficacy|0|||
146160852|NCT00518115|527098657|FG005|Overall Study|Lack of Efficacy|0|||
146160853|NCT00518115|527098658|FG006|Overall Study|Lack of Efficacy|0|||
146160854|NCT00518115|527098659|FG007|Overall Study|Lack of Efficacy|1|||
146160855|NCT00518115|527098660|FG008|Overall Study|Lack of Efficacy|0|||
146281651|NCT03117998|527544703|FG001|Overall Study|Withdrawal by Subject|0|||
146160856|NCT00518115|527098661|FG009|Overall Study|Lack of Efficacy|0|||
146281652|NCT03117998|527544704|FG002|Overall Study|Withdrawal by Subject|2|||
146281653|NCT03117998|527544705|FG003|Overall Study|Withdrawal by Subject|3|||
146281654|NCT03117998|527544706|FG004|Overall Study|Withdrawal by Subject|3|||
146281655|NCT03117998|527544707|FG005|Overall Study|Withdrawal by Subject|0|||
146281656|NCT03117998|527544702|FG000|Overall Study|Physician Decision|0|||
146281657|NCT03117998|527544703|FG001|Overall Study|Physician Decision|1|||
146160857|NCT00518115|527098652|FG000|Overall Study|Non-Compliance|1|||
146160858|NCT00518115|527098653|FG001|Overall Study|Non-Compliance|0|||
146160859|NCT00518115|527098654|FG002|Overall Study|Non-Compliance|1|||
146160860|NCT00518115|527098655|FG003|Overall Study|Non-Compliance|0|||
146160861|NCT00518115|527098656|FG004|Overall Study|Non-Compliance|1|||
146160862|NCT00518115|527098657|FG005|Overall Study|Non-Compliance|1|||
146160863|NCT00518115|527098658|FG006|Overall Study|Non-Compliance|1|||
146160864|NCT00518115|527098659|FG007|Overall Study|Non-Compliance|1|||
146160865|NCT00518115|527098660|FG008|Overall Study|Non-Compliance|0|||
146160866|NCT00518115|527098661|FG009|Overall Study|Non-Compliance|1|||
146160867|NCT00518115|527098652|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
146160868|NCT00518115|527098653|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
146160869|NCT00518115|527098654|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160870|NCT00518115|527098655|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160871|NCT00518115|527098656|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160872|NCT00518115|527098657|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
146160873|NCT00518115|527098658|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160874|NCT00518115|527098659|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160875|NCT00518115|527098660|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160876|NCT00518115|527098661|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
146160877|NCT00518115|527098652|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
146160878|NCT00518115|527098653|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160879|NCT00518115|527098654|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160880|NCT00518115|527098655|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160881|NCT00518115|527098656|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160882|NCT00518115|527098657|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160883|NCT00518115|527098658|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160884|NCT00518115|527098659|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160885|NCT00518115|527098660|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160886|NCT00518115|527098661|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
146160887|NCT00518115|527098652|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160888|NCT00518115|527098653|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160889|NCT00518115|527098654|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
146160890|NCT00518115|527098655|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160891|NCT00518115|527098656|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160892|NCT00518115|527098657|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160893|NCT00518115|527098658|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160894|NCT00518115|527098659|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160895|NCT00518115|527098660|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
146160896|NCT00518115|527098661|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
146160897|NCT00518115|527098652|FG000|Overall Study|Wrong Monotherapy Administered|0|||
146160898|NCT00518115|527098653|FG001|Overall Study|Wrong Monotherapy Administered|0|||
146160899|NCT00518115|527098654|FG002|Overall Study|Wrong Monotherapy Administered|1|||
146160900|NCT00518115|527098655|FG003|Overall Study|Wrong Monotherapy Administered|0|||
146160901|NCT00518115|527098656|FG004|Overall Study|Wrong Monotherapy Administered|0|||
146160902|NCT00518115|527098657|FG005|Overall Study|Wrong Monotherapy Administered|0|||
146160903|NCT00518115|527098658|FG006|Overall Study|Wrong Monotherapy Administered|1|||
146160904|NCT00518115|527098659|FG007|Overall Study|Wrong Monotherapy Administered|0|||
146160905|NCT00518115|527098660|FG008|Overall Study|Wrong Monotherapy Administered|0|||
146160906|NCT00518115|527098661|FG009|Overall Study|Wrong Monotherapy Administered|0|||
146160907|NCT00518115|527098652|FG000|Overall Study|Violation of Exclusion Criteria|0|||
146160908|NCT00518115|527098653|FG001|Overall Study|Violation of Exclusion Criteria|0|||
146160909|NCT00518115|527098654|FG002|Overall Study|Violation of Exclusion Criteria|0|||
146160910|NCT00518115|527098655|FG003|Overall Study|Violation of Exclusion Criteria|1|||
146160911|NCT00518115|527098656|FG004|Overall Study|Violation of Exclusion Criteria|0|||
146160912|NCT00518115|527098657|FG005|Overall Study|Violation of Exclusion Criteria|0|||
146160913|NCT00518115|527098658|FG006|Overall Study|Violation of Exclusion Criteria|1|||
146160914|NCT00518115|527098659|FG007|Overall Study|Violation of Exclusion Criteria|0|||
146160915|NCT00518115|527098660|FG008|Overall Study|Violation of Exclusion Criteria|0|||
146160916|NCT00518115|527098661|FG009|Overall Study|Violation of Exclusion Criteria|0|||
146160917|NCT00518115|527098652|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
146160918|NCT00518115|527098653|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
146160919|NCT00518115|527098654|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
146160920|NCT00518115|527098655|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
146160921|NCT00518115|527098656|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
146160922|NCT00518115|527098657|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
146160923|NCT00518115|527098658|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
146160924|NCT00518115|527098659|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
146160925|NCT00518115|527098660|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
146160926|NCT00518115|527098661|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
146160927|NCT00518115|527098652|FG000|Overall Study|Withdrew Consent|0|||
146160928|NCT00518115|527098653|FG001|Overall Study|Withdrew Consent|0|||
146160929|NCT00518115|527098654|FG002|Overall Study|Withdrew Consent|0|||
146160930|NCT00518115|527098655|FG003|Overall Study|Withdrew Consent|0|||
146160931|NCT00518115|527098656|FG004|Overall Study|Withdrew Consent|0|||
146160932|NCT00518115|527098657|FG005|Overall Study|Withdrew Consent|1|||
146160933|NCT00518115|527098658|FG006|Overall Study|Withdrew Consent|0|||
146160934|NCT00518115|527098659|FG007|Overall Study|Withdrew Consent|0|||
146160935|NCT00518115|527098660|FG008|Overall Study|Withdrew Consent|0|||
146160936|NCT00518115|527098661|FG009|Overall Study|Withdrew Consent|0|||
146160937|NCT00518115|527098652|FG000|Overall Study|Moved Out of State|0|||
146160938|NCT00518115|527098653|FG001|Overall Study|Moved Out of State|0|||
146160939|NCT00518115|527098654|FG002|Overall Study|Moved Out of State|0|||
146160940|NCT00518115|527098655|FG003|Overall Study|Moved Out of State|0|||
146160941|NCT00518115|527098656|FG004|Overall Study|Moved Out of State|0|||
146160942|NCT00518115|527098657|FG005|Overall Study|Moved Out of State|0|||
146160943|NCT00518115|527098658|FG006|Overall Study|Moved Out of State|0|||
146160944|NCT00518115|527098659|FG007|Overall Study|Moved Out of State|0|||
146160945|NCT00518115|527098660|FG008|Overall Study|Moved Out of State|0|||
146160946|NCT00518115|527098661|FG009|Overall Study|Moved Out of State|1|||
146160947|NCT00843167|527098662|FG000|Treatment Period|Adverse Event|1|||
146160948|NCT00843167|527098663|FG001|Treatment Period|Adverse Event|5|||
146160949|NCT00843167|527098662|FG000|Treatment Period|Withdrawal by Subject|2|||
146160950|NCT00843167|527098663|FG001|Treatment Period|Withdrawal by Subject|3|||
146160951|NCT01266850|527100684|FG000|Overall Study|Lost to Follow-up|19|||
146160952|NCT01266850|527100685|FG001|Overall Study|Lost to Follow-up|19|||
146160953|NCT01266850|527100686|FG002|Overall Study|Lost to Follow-up|13|||
146160954|NCT01266850|527100687|FG003|Overall Study|Lost to Follow-up|13|||
146160955|NCT01266850|527100688|FG004|Overall Study|Lost to Follow-up|12|||
146160956|NCT01266850|527100684|FG000|Overall Study|Withdrawal by Subject|8|||
146160957|NCT01266850|527100685|FG001|Overall Study|Withdrawal by Subject|9|||
146160958|NCT01266850|527100686|FG002|Overall Study|Withdrawal by Subject|6|||
146160959|NCT01266850|527100687|FG003|Overall Study|Withdrawal by Subject|9|||
146160960|NCT01266850|527100688|FG004|Overall Study|Withdrawal by Subject|12|||
146160961|NCT01266850|527100684|FG000|Overall Study|Physician Decision|3|||
146160962|NCT01266850|527100685|FG001|Overall Study|Physician Decision|6|||
146160963|NCT01266850|527100686|FG002|Overall Study|Physician Decision|4|||
146160964|NCT01266850|527100687|FG003|Overall Study|Physician Decision|4|||
146160965|NCT01266850|527100688|FG004|Overall Study|Physician Decision|3|||
146160966|NCT01266850|527100684|FG000|Overall Study|Protocol Violation|0|||
146160967|NCT01266850|527100685|FG001|Overall Study|Protocol Violation|1|||
146160968|NCT01266850|527100686|FG002|Overall Study|Protocol Violation|0|||
146160969|NCT01266850|527100687|FG003|Overall Study|Protocol Violation|1|||
146160970|NCT01266850|527100688|FG004|Overall Study|Protocol Violation|2|||
146160971|NCT01266850|527100684|FG000|Overall Study|Adverse Event|0|||
146160972|NCT01266850|527100685|FG001|Overall Study|Adverse Event|0|||
146160973|NCT01266850|527100686|FG002|Overall Study|Adverse Event|0|||
146160974|NCT01266850|527100687|FG003|Overall Study|Adverse Event|0|||
146160975|NCT01266850|527100688|FG004|Overall Study|Adverse Event|1|||
146160976|NCT01266850|527100684|FG000|Overall Study|Site Closure|0|||
146160977|NCT01266850|527100685|FG001|Overall Study|Site Closure|1|||
146160978|NCT01266850|527100686|FG002|Overall Study|Site Closure|1|||
146160979|NCT01266850|527100687|FG003|Overall Study|Site Closure|1|||
146160980|NCT01266850|527100688|FG004|Overall Study|Site Closure|0|||
146160981|NCT03409666|527100689|FG000|Overall Study|Physician Decision|0|||
146160982|NCT03409666|527100690|FG001|Overall Study|Physician Decision|1|||
146160983|NCT03409666|527100689|FG000|Overall Study|Protocol Violation|0|||
146160984|NCT03409666|527100690|FG001|Overall Study|Protocol Violation|3|||
146160985|NCT03563716|527100694|FG000|Overall Study|Death|20|||
146160986|NCT03563716|527100695|FG001|Overall Study|Death|14|||
146160987|NCT03563716|527100694|FG000|Overall Study|Withdrawal by Subject|3|||
146160988|NCT03563716|527100695|FG001|Overall Study|Withdrawal by Subject|3|||
146160989|NCT03563716|527100694|FG000|Overall Study|Still on Study|45|||
146160990|NCT03563716|527100695|FG001|Overall Study|Still on Study|50|||
146160991|NCT04605978|527100696|FG000|Overall Study|Adverse Event|2|||
146160992|NCT04605978|527100697|FG001|Overall Study|Adverse Event|1|||
146160993|NCT04605978|527100696|FG000|Overall Study|Withdrawal nonmedical reason|1|||
146160994|NCT04605978|527100697|FG001|Overall Study|Withdrawal nonmedical reason|1|||
146160995|NCT02583425|527100698|FG000|Screening|Did not meet entry criteria|12|||
146160996|NCT02583425|527100698|FG000|Baseline|Did not meet continued criteria|5|||
146160997|NCT02583425|527100698|FG000|Treatment Period|Adverse Event|1|||
146160998|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
146160999|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
146161000|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
146161001|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
146161002|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
146161003|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
146161004|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
146161005|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
146161006|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
146161007|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
146161008|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
146161009|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
146161010|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Death|6|||
146161011|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Death|3|||
146161012|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Death|0|||
146161013|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Death|1|||
146161014|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Death|1|||
146161015|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Death|0|||
146161016|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
146161017|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
146161018|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
146161019|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
146161020|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
146161021|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
146161022|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146161023|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
146161024|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
146161025|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146161026|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146161027|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
146161028|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
146161029|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
146161030|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
146161031|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
146161032|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
146161033|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
146161034|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
146161035|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
146161036|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
146161037|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
146161038|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
146161039|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
146161040|NCT03104699|527100699|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
146161041|NCT03104699|527100700|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
146161042|NCT03104699|527100701|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
146161043|NCT03104699|527100702|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
146161044|NCT03104699|527100703|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
146161045|NCT03104699|527100704|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
146161046|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146161047|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146161048|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146161049|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146161050|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
146161051|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
146161052|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Death|0|||
146161053|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Death|0|||
146161054|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Death|0|||
146161055|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Death|0|||
146161056|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Death|0|||
146161057|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Death|107|||
146161058|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146161059|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146161060|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146161061|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146161062|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
146161063|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
146161064|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146161065|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146161066|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146161067|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
146161068|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145943215|NCT00483704|526300456|FG000|Randomization|Lack of qualifying migraines|21|||
146161069|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
146161070|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146161071|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146161072|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146161073|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146161074|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
146161075|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
146161076|NCT03104699|527100699|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
146161077|NCT03104699|527100700|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
146161078|NCT03104699|527100701|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
146161079|NCT03104699|527100702|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
146161080|NCT03104699|527100703|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
146161081|NCT03104699|527100704|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
146161082|NCT01644734|527100705|FG000|Overall Study|Adverse Event|4|||
146161083|NCT01644734|527100705|FG000|Overall Study|Lost to Follow-up|17|||
146161084|NCT01644734|527100705|FG000|Overall Study|Reasons other than stated above|7|||
146161085|NCT01644734|527100705|FG000|Overall Study|Missing documentation|238|||
146161086|NCT02157779|527100710|FG000|Overall Study|Logistical|9|||
146161087|NCT02157779|527100711|FG001|Overall Study|Logistical|3|||
146161088|NCT02157779|527100710|FG000|Overall Study|Stopped attending, reason unknown|11|||
146161089|NCT02157779|527100711|FG001|Overall Study|Stopped attending, reason unknown|7|||
146161090|NCT02157779|527100710|FG000|Overall Study|No response to outreach after Baseline|1|||
146161091|NCT02157779|527100711|FG001|Overall Study|No response to outreach after Baseline|1|||
146161092|NCT02157779|527100710|FG000|Overall Study|Moved|1|||
146161093|NCT02157779|527100711|FG001|Overall Study|Moved|0|||
146161094|NCT02157779|527100710|FG000|Overall Study|Medical|1|||
146161095|NCT02157779|527100711|FG001|Overall Study|Medical|0|||
146161096|NCT02157779|527100710|FG000|Overall Study|Legal issue|1|||
146161097|NCT02157779|527100711|FG001|Overall Study|Legal issue|0|||
146161098|NCT02548455|527100713|FG000|Overall Study|Withdrawal by Subject|27|||
146161099|NCT02548455|527100713|FG000|Overall Study|Death|26|||
146161100|NCT02548455|527100713|FG000|Overall Study|Lost to Follow-up|14|||
146161101|NCT02548455|527100713|FG000|Overall Study|Visit not completed|173|||
146161102|NCT01292876|527100717|FG000|Overall Study|Physician Decision|4|||
146161103|NCT04528069|527100723|FG000|Overall Study|Adverse Event|1|||
146161104|NCT04528069|527100723|FG000|Overall Study|Lost to Follow-up|1|||
146161105|NCT04528069|527100723|FG000|Overall Study|Patient Unable to Come|1|||
146161106|NCT04528069|527100723|FG000|Overall Study|Patient Unable to Attend|1|||
146161107|NCT01137474|527100724|FG000|Overall Study|Adverse Event|3|||
146161108|NCT01137474|527100725|FG001|Overall Study|Adverse Event|5|||
146161109|NCT01137474|527100726|FG002|Overall Study|Adverse Event|1|||
146161110|NCT01137474|527100727|FG003|Overall Study|Adverse Event|3|||
146161111|NCT01137474|527100724|FG000|Overall Study|Withdrawal by Subject|7|||
146161112|NCT01137474|527100725|FG001|Overall Study|Withdrawal by Subject|2|||
146161113|NCT01137474|527100726|FG002|Overall Study|Withdrawal by Subject|6|||
146161114|NCT01137474|527100727|FG003|Overall Study|Withdrawal by Subject|9|||
146161115|NCT01137474|527100724|FG000|Overall Study|No longer met study criteria|6|||
146161116|NCT01137474|527100725|FG001|Overall Study|No longer met study criteria|1|||
146161117|NCT01137474|527100726|FG002|Overall Study|No longer met study criteria|0|||
146161118|NCT01137474|527100727|FG003|Overall Study|No longer met study criteria|5|||
146161119|NCT01137474|527100724|FG000|Overall Study|Lost to Follow-up|5|||
146161120|NCT01137474|527100725|FG001|Overall Study|Lost to Follow-up|1|||
146161121|NCT01137474|527100726|FG002|Overall Study|Lost to Follow-up|0|||
146161122|NCT01137474|527100727|FG003|Overall Study|Lost to Follow-up|2|||
146161123|NCT01137474|527100724|FG000|Overall Study|Lack of Efficacy|0|||
146161124|NCT01137474|527100725|FG001|Overall Study|Lack of Efficacy|0|||
146161125|NCT01137474|527100726|FG002|Overall Study|Lack of Efficacy|0|||
146161126|NCT01137474|527100727|FG003|Overall Study|Lack of Efficacy|2|||
146161127|NCT01137474|527100724|FG000|Overall Study|Other|3|||
146161128|NCT01137474|527100725|FG001|Overall Study|Other|1|||
146161129|NCT01137474|527100726|FG002|Overall Study|Other|0|||
146161130|NCT01137474|527100727|FG003|Overall Study|Other|0|||
146161131|NCT01137474|527100724|FG000|Overall Study|Pregnancy|0|||
146161132|NCT01137474|527100725|FG001|Overall Study|Pregnancy|1|||
146161133|NCT01137474|527100726|FG002|Overall Study|Pregnancy|0|||
146161134|NCT01137474|527100727|FG003|Overall Study|Pregnancy|0|||
146161135|NCT01137474|527100724|FG000|Overall Study|Administrative reason by sponsor|0|||
146161136|NCT01137474|527100725|FG001|Overall Study|Administrative reason by sponsor|1|||
146161137|NCT01137474|527100726|FG002|Overall Study|Administrative reason by sponsor|0|||
145943216|NCT00483704|526300457|FG001|Randomization|Lack of qualifying migraines|25|||
146161138|NCT01137474|527100727|FG003|Overall Study|Administrative reason by sponsor|0|||
146161139|NCT02525874|527100728|FG000|Overall Study|Other|1|||
146161140|NCT02525874|527100728|FG000|Overall Study|Investigator Decision|1|||
146161141|NCT02525874|527100728|FG000|Overall Study|Consent withdrawn|22|||
146161142|NCT02525874|527100728|FG000|Overall Study|Non-compliance with study drug|3|||
146161143|NCT02525874|527100728|FG000|Overall Study|Adverse Event|17|||
146161144|NCT02525874|527100728|FG000|Overall Study|Lost to Follow-up|7|||
146161145|NCT02525874|527100728|FG000|Overall Study|Disease progression, defined by protocol|2|||
146161146|NCT02525874|527100728|FG000|Overall Study|Disease relapse|4|||
146161147|NCT02525874|527100728|FG000|Overall Study|Alternative Treatment for MS|2|||
146161148|NCT02525874|527100728|FG000|Overall Study|New lesions in Brain|1|||
146161149|NCT01814371|527100731|FG000|Overall Study|Lost to Follow-up|30|||
146161150|NCT01814371|527100732|FG001|Overall Study|Lost to Follow-up|27|||
146161151|NCT01692782|527100733|FG000|Overall Study|Adverse Event|12|||
146314765|NCT01995071|527664489|FG001|Overall Study|Incarcerated|0|||
146161152|NCT01692782|527100734|FG001|Overall Study|Adverse Event|32|||
146161153|NCT01692782|527100735|FG002|Overall Study|Adverse Event|2|||
146161154|NCT01692782|527100733|FG000|Overall Study|Lack of Efficacy|1|||
146161155|NCT01692782|527100734|FG001|Overall Study|Lack of Efficacy|2|||
146161156|NCT01692782|527100735|FG002|Overall Study|Lack of Efficacy|0|||
146161157|NCT01692782|527100733|FG000|Overall Study|Lost to Follow-up|2|||
146161158|NCT01692782|527100734|FG001|Overall Study|Lost to Follow-up|7|||
146161159|NCT01692782|527100735|FG002|Overall Study|Lost to Follow-up|1|||
146161160|NCT01692782|527100733|FG000|Overall Study|Pregnancy|1|||
146161161|NCT01692782|527100734|FG001|Overall Study|Pregnancy|0|||
146161162|NCT01692782|527100735|FG002|Overall Study|Pregnancy|0|||
146161163|NCT01692782|527100733|FG000|Overall Study|Protocol Violation|1|||
146161164|NCT01692782|527100734|FG001|Overall Study|Protocol Violation|0|||
146161165|NCT01692782|527100735|FG002|Overall Study|Protocol Violation|2|||
146161166|NCT01692782|527100733|FG000|Overall Study|Non-complance with study drug|0|||
146161167|NCT01692782|527100734|FG001|Overall Study|Non-complance with study drug|4|||
146161168|NCT01692782|527100735|FG002|Overall Study|Non-complance with study drug|1|||
146161169|NCT01692782|527100733|FG000|Overall Study|Non-compliant with study visits|0|||
146161170|NCT01692782|527100734|FG001|Overall Study|Non-compliant with study visits|0|||
146161171|NCT01692782|527100735|FG002|Overall Study|Non-compliant with study visits|1|||
146161172|NCT01692782|527100733|FG000|Overall Study|SAE not related to study drug|0|||
146161173|NCT01692782|527100734|FG001|Overall Study|SAE not related to study drug|1|||
146161174|NCT01692782|527100735|FG002|Overall Study|SAE not related to study drug|0|||
146161175|NCT01692782|527100733|FG000|Overall Study|Withdrawal by Subject|3|||
146161176|NCT01692782|527100734|FG001|Overall Study|Withdrawal by Subject|10|||
146161177|NCT01692782|527100735|FG002|Overall Study|Withdrawal by Subject|3|||
146161178|NCT03945188|527100741|FG000|Overall Study|Protocol Violation|1|||
146161179|NCT03945188|527100742|FG001|Overall Study|Protocol Violation|0|||
146161180|NCT03945188|527100741|FG000|Overall Study|Disease worsening|79|||
146161181|NCT03945188|527100742|FG001|Overall Study|Disease worsening|73|||
146161182|NCT03945188|527100741|FG000|Overall Study|Physician Decision|2|||
146161183|NCT03945188|527100742|FG001|Overall Study|Physician Decision|2|||
146161184|NCT03945188|527100741|FG000|Overall Study|Lack of Efficacy|7|||
146161185|NCT03945188|527100742|FG001|Overall Study|Lack of Efficacy|4|||
146161186|NCT03945188|527100741|FG000|Overall Study|Pregnancy|2|||
146161187|NCT03945188|527100742|FG001|Overall Study|Pregnancy|0|||
146161188|NCT03945188|527100741|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
146161189|NCT03945188|527100742|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
146161190|NCT03945188|527100741|FG000|Overall Study|Adverse Event|10|||
146161191|NCT03945188|527100742|FG001|Overall Study|Adverse Event|5|||
146161192|NCT03945188|527100741|FG000|Overall Study|Other|2|||
146161193|NCT03945188|527100742|FG001|Overall Study|Other|2|||
146161194|NCT03945188|527100741|FG000|Overall Study|Lost to Follow-up|1|||
146161195|NCT03945188|527100742|FG001|Overall Study|Lost to Follow-up|2|||
146161196|NCT02677116|527100756|FG000|Overall Study|Adverse Event|0|||
146161197|NCT02677116|527100757|FG001|Overall Study|Adverse Event|1|||
146161198|NCT02677116|527100758|FG002|Overall Study|Adverse Event|0|||
146161199|NCT02677116|527100759|FG003|Overall Study|Adverse Event|0|||
146161200|NCT02677116|527100760|FG004|Overall Study|Adverse Event|0|||
146314766|NCT01995071|527664490|FG002|Overall Study|Incarcerated|0|||
146314767|NCT01995071|527664491|FG003|Overall Study|Incarcerated|0|||
146314768|NCT01995071|527664492|FG004|Overall Study|Incarcerated|0|||
146314769|NCT01995071|527664493|FG005|Overall Study|Incarcerated|0|||
146314770|NCT01995071|527664494|FG006|Overall Study|Incarcerated|0|||
146314771|NCT01995071|527664495|FG007|Overall Study|Incarcerated|1|||
146314772|NCT01995071|527664496|FG008|Overall Study|Incarcerated|0|||
146314773|NCT01995071|527664497|FG009|Overall Study|Incarcerated|0|||
146314774|NCT01995071|527664498|FG010|Overall Study|Incarcerated|0|||
146314775|NCT01995071|527664499|FG011|Overall Study|Incarcerated|0|||
146314776|NCT01783678|527664500|FG000|Overall Study|Randomized but Not Treated|0|||
146314777|NCT01783678|527664501|FG001|Overall Study|Randomized but Not Treated|0|||
146314778|NCT01783678|527664502|FG002|Overall Study|Randomized but Not Treated|0|||
146314779|NCT01783678|527664503|FG003|Overall Study|Randomized but Not Treated|1|||
146314780|NCT01783678|527664504|FG004|Overall Study|Randomized but Not Treated|0|||
146161201|NCT02677116|527100761|FG005|Overall Study|Adverse Event|1|||
146161202|NCT02677116|527100762|FG006|Overall Study|Adverse Event|1|||
146161203|NCT02677116|527100763|FG007|Overall Study|Adverse Event|0|||
146161204|NCT02677116|527100764|FG008|Overall Study|Adverse Event|0|||
146161205|NCT02677116|527100756|FG000|Overall Study|Physician Decision|0|||
146161206|NCT02677116|527100757|FG001|Overall Study|Physician Decision|2|||
146314781|NCT01783678|527664505|FG005|Overall Study|Randomized but Not Treated|0|||
146314782|NCT01783678|527664500|FG000|Overall Study|Lack of Efficacy|1|||
146161207|NCT02677116|527100758|FG002|Overall Study|Physician Decision|3|||
146161208|NCT02677116|527100759|FG003|Overall Study|Physician Decision|2|||
146161209|NCT02677116|527100760|FG004|Overall Study|Physician Decision|1|||
146161210|NCT02677116|527100761|FG005|Overall Study|Physician Decision|3|||
146161211|NCT02677116|527100762|FG006|Overall Study|Physician Decision|1|||
146161212|NCT02677116|527100763|FG007|Overall Study|Physician Decision|1|||
146314783|NCT01783678|527664501|FG001|Overall Study|Lack of Efficacy|13|||
146314784|NCT01783678|527664502|FG002|Overall Study|Lack of Efficacy|1|||
146161213|NCT02677116|527100764|FG008|Overall Study|Physician Decision|2|||
146161214|NCT02677116|527100756|FG000|Overall Study|Withdrawal by parent or guardian|2|||
146161215|NCT02677116|527100757|FG001|Overall Study|Withdrawal by parent or guardian|1|||
146161216|NCT02677116|527100758|FG002|Overall Study|Withdrawal by parent or guardian|0|||
146161217|NCT02677116|527100759|FG003|Overall Study|Withdrawal by parent or guardian|1|||
146161218|NCT02677116|527100760|FG004|Overall Study|Withdrawal by parent or guardian|0|||
146161219|NCT02677116|527100761|FG005|Overall Study|Withdrawal by parent or guardian|0|||
146161220|NCT02677116|527100762|FG006|Overall Study|Withdrawal by parent or guardian|2|||
146161221|NCT02677116|527100763|FG007|Overall Study|Withdrawal by parent or guardian|1|||
146161222|NCT02677116|527100764|FG008|Overall Study|Withdrawal by parent or guardian|0|||
146161223|NCT02677116|527100756|FG000|Overall Study|Withdrawal by Subject|1|||
146161224|NCT02677116|527100757|FG001|Overall Study|Withdrawal by Subject|0|||
146161225|NCT02677116|527100758|FG002|Overall Study|Withdrawal by Subject|0|||
146161226|NCT02677116|527100759|FG003|Overall Study|Withdrawal by Subject|0|||
146161227|NCT02677116|527100760|FG004|Overall Study|Withdrawal by Subject|0|||
146161228|NCT02677116|527100761|FG005|Overall Study|Withdrawal by Subject|0|||
146161229|NCT02677116|527100762|FG006|Overall Study|Withdrawal by Subject|0|||
146161230|NCT02677116|527100763|FG007|Overall Study|Withdrawal by Subject|0|||
146161231|NCT02677116|527100764|FG008|Overall Study|Withdrawal by Subject|0|||
146314785|NCT01783678|527664503|FG003|Overall Study|Lack of Efficacy|3|||
146314786|NCT01783678|527664504|FG004|Overall Study|Lack of Efficacy|6|||
146314787|NCT01783678|527664505|FG005|Overall Study|Lack of Efficacy|5|||
146314788|NCT01783678|527664500|FG000|Overall Study|Lost to Follow-up|0|||
146314789|NCT01783678|527664501|FG001|Overall Study|Lost to Follow-up|4|||
146314790|NCT01783678|527664502|FG002|Overall Study|Lost to Follow-up|0|||
146314791|NCT01783678|527664503|FG003|Overall Study|Lost to Follow-up|2|||
146314792|NCT01783678|527664504|FG004|Overall Study|Lost to Follow-up|1|||
146314793|NCT01783678|527664505|FG005|Overall Study|Lost to Follow-up|0|||
146314794|NCT01783678|527664500|FG000|Overall Study|Withdrew Consent|1|||
146314795|NCT01783678|527664501|FG001|Overall Study|Withdrew Consent|1|||
146314796|NCT01783678|527664502|FG002|Overall Study|Withdrew Consent|0|||
146314797|NCT01783678|527664503|FG003|Overall Study|Withdrew Consent|2|||
146314798|NCT01783678|527664504|FG004|Overall Study|Withdrew Consent|0|||
146314799|NCT01783678|527664505|FG005|Overall Study|Withdrew Consent|0|||
146314800|NCT01042600|527664506|FG000|Overall Study|Ineligible|1|||
146314801|NCT01042600|527664507|FG001|Overall Study|Ineligible|0|||
146314802|NCT03311711|527664510|FG000|Overall Study|Death|1|||
146314803|NCT03311711|527664511|FG001|Overall Study|Death|0|||
146314804|NCT03311711|527664512|FG002|Overall Study|Death|0|||
146314805|NCT03311711|527664513|FG003|Overall Study|Death|0|||
146314806|NCT03311711|527664514|FG004|Overall Study|Death|0|||
146314807|NCT03311711|527664515|FG005|Overall Study|Death|0|||
146161232|NCT03182868|527100765|FG000|Overall Study|Protocol Violation|3|||
146161233|NCT03182868|527100766|FG001|Overall Study|Protocol Violation|0|||
146161234|NCT03182868|527100767|FG002|Overall Study|Protocol Violation|4|||
146161235|NCT03182868|527100768|FG003|Overall Study|Protocol Violation|1|||
146161236|NCT03182868|527100769|FG004|Overall Study|Protocol Violation|8|||
146161237|NCT03213158|527100776|FG000|Overall Study|Withdrawal by Subject|1|||
146161238|NCT03213158|527100776|FG000|Overall Study|Physician Decision|2|||
146161239|NCT01569438|527100783|FG000|Overall Study|Lack of Efficacy|1|||
146161240|NCT01569438|527100784|FG001|Overall Study|Lack of Efficacy|2|||
146161241|NCT01569438|527100783|FG000|Overall Study|Withdrawal by Subject|0|||
146161242|NCT01569438|527100784|FG001|Overall Study|Withdrawal by Subject|3|||
146161243|NCT01569438|527100783|FG000|Overall Study|Adverse Event|2|||
146161244|NCT01569438|527100784|FG001|Overall Study|Adverse Event|15|||
146161245|NCT01569438|527100783|FG000|Overall Study|Protocol Violation|2|||
146161246|NCT01569438|527100784|FG001|Overall Study|Protocol Violation|0|||
146161247|NCT01569438|527100783|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
146161248|NCT01569438|527100784|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
146161249|NCT01569438|527100783|FG000|Overall Study|Sponsor/Physician decision|1|||
146161250|NCT01569438|527100784|FG001|Overall Study|Sponsor/Physician decision|1|||
146161251|NCT01569438|527100783|FG000|Overall Study|Unable to adhere to study schedule|0|||
146161252|NCT01569438|527100784|FG001|Overall Study|Unable to adhere to study schedule|1|||
146161253|NCT01207102|527100785|FG000|Overall Study|Withdrawal by Subject|5|||
146314808|NCT03311711|527664516|FG006|Overall Study|Death|1|||
146161254|NCT01207102|527100785|FG000|Overall Study|Adverse Event|2|||
146161255|NCT01207102|527100785|FG000|Overall Study|progression|2|||
146161256|NCT01207102|527100785|FG000|Overall Study|Withdrawal by Treating Physician|1|||
146314809|NCT03311711|527664517|FG007|Overall Study|Death|0|||
146161257|NCT03649230|527100786|FG000|Overall Study|Adverse Event|12|||
146161258|NCT03649230|527100786|FG000|Overall Study|Death|8|||
146161259|NCT03649230|527100786|FG000|Overall Study|Withdrawal by Subject|6|||
146161260|NCT03649230|527100786|FG000|Overall Study|Physician Decision|5|||
146314810|NCT03311711|527664518|FG008|Overall Study|Death|1|||
146314811|NCT03311711|527664519|FG009|Overall Study|Death|0|||
146314812|NCT03311711|527664510|FG000|Overall Study|Death of dyad partner|0|||
146314813|NCT03311711|527664511|FG001|Overall Study|Death of dyad partner|1|||
146314814|NCT03311711|527664512|FG002|Overall Study|Death of dyad partner|0|||
146314815|NCT03311711|527664513|FG003|Overall Study|Death of dyad partner|0|||
146314816|NCT03311711|527664514|FG004|Overall Study|Death of dyad partner|0|||
146314817|NCT03311711|527664515|FG005|Overall Study|Death of dyad partner|0|||
146314818|NCT03311711|527664516|FG006|Overall Study|Death of dyad partner|0|||
146314819|NCT03311711|527664517|FG007|Overall Study|Death of dyad partner|1|||
146314820|NCT03311711|527664518|FG008|Overall Study|Death of dyad partner|0|||
146314821|NCT03311711|527664519|FG009|Overall Study|Death of dyad partner|1|||
146314822|NCT03311711|527664510|FG000|Overall Study|Lost to Follow-up|2|||
146161261|NCT03649230|527100786|FG000|Overall Study|Disease progression|5|||
146161262|NCT03649230|527100786|FG000|Overall Study|Switched to non-HEC|5|||
146161263|NCT03649230|527100786|FG000|Overall Study|Chemotherapy discontinued|4|||
146161264|NCT03649230|527100786|FG000|Overall Study|Received only 3 HEC cycles|4|||
146161265|NCT03649230|527100786|FG000|Overall Study|Screen Failure|3|||
146161266|NCT03649230|527100786|FG000|Overall Study|Patient stopped treatment|2|||
146161267|NCT03649230|527100786|FG000|Overall Study|Protocol Violation|1|||
146161268|NCT03649230|527100786|FG000|Overall Study|Non-compliance|1|||
146161269|NCT03649230|527100786|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
146161270|NCT01693068|527100788|FG000|Randomization Period|On-study|2|||
146161271|NCT01693068|527100789|FG001|Randomization Period|On-study|5|||
146161272|NCT01693068|527100790|FG002|Randomization Period|On-study|0|||
146161273|NCT01693068|527100788|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
146161274|NCT01693068|527100789|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
146161275|NCT01693068|527100790|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
146161276|NCT00295022|527100794|FG000|Overall Study|Adverse Event|1|||
146161277|NCT00295022|527100795|FG001|Overall Study|Adverse Event|1|||
146161278|NCT00295022|527100796|FG002|Overall Study|Adverse Event|2|||
146161279|NCT00295022|527100794|FG000|Overall Study|Lost to Follow-up|0|||
146161280|NCT00295022|527100795|FG001|Overall Study|Lost to Follow-up|0|||
146161281|NCT00295022|527100796|FG002|Overall Study|Lost to Follow-up|1|||
146161282|NCT00295022|527100794|FG000|Overall Study|Withdrawal by Subject|0|||
146161283|NCT00295022|527100795|FG001|Overall Study|Withdrawal by Subject|0|||
146161284|NCT00295022|527100796|FG002|Overall Study|Withdrawal by Subject|2|||
146161285|NCT00734630|527100798|FG000|Overall Study|Lack of Efficacy|4|||
146161286|NCT00734630|527100799|FG001|Overall Study|Lack of Efficacy|4|||
146161287|NCT00734630|527100798|FG000|Overall Study|Withdrawal by Subject|7|||
146161288|NCT00734630|527100799|FG001|Overall Study|Withdrawal by Subject|9|||
146161289|NCT00734630|527100798|FG000|Overall Study|Lost to Follow-up|13|||
146161290|NCT00734630|527100799|FG001|Overall Study|Lost to Follow-up|7|||
146161291|NCT00734630|527100798|FG000|Overall Study|Protocol Violation|0|||
146161292|NCT00734630|527100799|FG001|Overall Study|Protocol Violation|3|||
146161293|NCT00734630|527100798|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146161294|NCT00734630|527100799|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
146161295|NCT00734630|527100798|FG000|Overall Study|Adverse Event|3|||
146161296|NCT00734630|527100799|FG001|Overall Study|Adverse Event|6|||
146161297|NCT00734630|527100798|FG000|Overall Study|Randomized in Error|0|||
146161298|NCT00734630|527100799|FG001|Overall Study|Randomized in Error|1|||
146161299|NCT00734630|527100798|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
146314823|NCT03311711|527664511|FG001|Overall Study|Lost to Follow-up|2|||
146314824|NCT03311711|527664512|FG002|Overall Study|Lost to Follow-up|0|||
146314825|NCT03311711|527664513|FG003|Overall Study|Lost to Follow-up|0|||
146314826|NCT03311711|527664514|FG004|Overall Study|Lost to Follow-up|0|||
146161300|NCT00734630|527100799|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
146161301|NCT00734630|527100798|FG000|Overall Study|Poor Compliance|1|||
146161302|NCT00734630|527100799|FG001|Overall Study|Poor Compliance|1|||
146161303|NCT01239030|527100800|FG000|Double Blind|Adverse Event|0|||
146161304|NCT01239030|527100801|FG001|Double Blind|Adverse Event|1|||
146161305|NCT01239030|527100802|FG002|Double Blind|Adverse Event|0|||
146161306|NCT01239030|527100803|FG003|Double Blind|Adverse Event|2|||
146314827|NCT03311711|527664515|FG005|Overall Study|Lost to Follow-up|0|||
146314828|NCT03311711|527664516|FG006|Overall Study|Lost to Follow-up|1|||
146314829|NCT03311711|527664517|FG007|Overall Study|Lost to Follow-up|1|||
146314830|NCT03311711|527664518|FG008|Overall Study|Lost to Follow-up|0|||
146314831|NCT03311711|527664519|FG009|Overall Study|Lost to Follow-up|0|||
146314832|NCT03311711|527664510|FG000|Overall Study|Withdrawal by Subject|1|||
146161307|NCT01239030|527100804|FG004|Double Blind|Adverse Event|0|||
146161308|NCT01239030|527100800|FG000|Double Blind|Withdrawal by Subject|0|||
146161309|NCT01239030|527100801|FG001|Double Blind|Withdrawal by Subject|1|||
146161310|NCT01239030|527100802|FG002|Double Blind|Withdrawal by Subject|1|||
146161311|NCT01239030|527100803|FG003|Double Blind|Withdrawal by Subject|0|||
146161312|NCT01239030|527100804|FG004|Double Blind|Withdrawal by Subject|1|||
146161313|NCT01239030|527100800|FG000|Double Blind|Lost to Follow-up|1|||
146161314|NCT01239030|527100801|FG001|Double Blind|Lost to Follow-up|1|||
146161315|NCT01239030|527100802|FG002|Double Blind|Lost to Follow-up|0|||
146161316|NCT01239030|527100803|FG003|Double Blind|Lost to Follow-up|0|||
146161317|NCT01239030|527100804|FG004|Double Blind|Lost to Follow-up|0|||
146314833|NCT03311711|527664511|FG001|Overall Study|Withdrawal by Subject|1|||
146161318|NCT01239030|527100800|FG000|Double Blind|Physician Decision|0|||
146161319|NCT01239030|527100801|FG001|Double Blind|Physician Decision|1|||
146161320|NCT01239030|527100802|FG002|Double Blind|Physician Decision|0|||
146161321|NCT01239030|527100803|FG003|Double Blind|Physician Decision|0|||
146161322|NCT01239030|527100804|FG004|Double Blind|Physician Decision|0|||
146314834|NCT03311711|527664512|FG002|Overall Study|Withdrawal by Subject|0|||
146314835|NCT03311711|527664513|FG003|Overall Study|Withdrawal by Subject|0|||
146314836|NCT03311711|527664514|FG004|Overall Study|Withdrawal by Subject|0|||
146314837|NCT03311711|527664515|FG005|Overall Study|Withdrawal by Subject|0|||
146314838|NCT03311711|527664516|FG006|Overall Study|Withdrawal by Subject|3|||
146314839|NCT03311711|527664517|FG007|Overall Study|Withdrawal by Subject|3|||
146314840|NCT03311711|527664518|FG008|Overall Study|Withdrawal by Subject|0|||
146314841|NCT03311711|527664519|FG009|Overall Study|Withdrawal by Subject|0|||
146314842|NCT02229552|527664520|FG000|Baseline|Withdrawal by Subject|6|||
146314843|NCT02229552|527664520|FG000|1-year Follow up|Withdrawal by Subject|7|||
146314844|NCT02229552|527664520|FG000|1-year Follow up|Lost to Follow-up|18|||
146314845|NCT02229552|527664520|FG000|2-Year Follow up|Withdrawal by Subject|9|||
146314846|NCT02229552|527664520|FG000|2-Year Follow up|Lost to Follow-up|17|||
146314847|NCT01496885|527664522|FG000|Overall Study|Lost to Follow-up|13|||
146314848|NCT01496885|527664522|FG000|Overall Study|Withdrawal by Subject|7|||
146314849|NCT01496885|527664522|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
146314850|NCT01496885|527664522|FG000|Overall Study|Death|1|||
146314851|NCT02669017|527664524|FG000|Overall Study|Death|1|||
146314852|NCT02669017|527664525|FG001|Overall Study|Death|2|||
146314853|NCT02669017|527664526|FG002|Overall Study|Death|2|||
146314854|NCT02669017|527664527|FG003|Overall Study|Death|3|||
146314855|NCT02669017|527664528|FG004|Overall Study|Death|8|||
146314856|NCT02669017|527664529|FG005|Overall Study|Death|18|||
146314857|NCT02669017|527664530|FG006|Overall Study|Death|10|||
146314858|NCT02669017|527664531|FG007|Overall Study|Death|47|||
146314859|NCT02669017|527664532|FG008|Overall Study|Death|20|||
146314860|NCT02669017|527664524|FG000|Overall Study|Withdrawal by Subject|0|||
146314861|NCT02669017|527664525|FG001|Overall Study|Withdrawal by Subject|0|||
146314862|NCT02669017|527664526|FG002|Overall Study|Withdrawal by Subject|0|||
146314863|NCT02669017|527664527|FG003|Overall Study|Withdrawal by Subject|1|||
146314864|NCT02669017|527664528|FG004|Overall Study|Withdrawal by Subject|2|||
146314865|NCT02669017|527664529|FG005|Overall Study|Withdrawal by Subject|0|||
146314866|NCT02669017|527664530|FG006|Overall Study|Withdrawal by Subject|0|||
146314867|NCT02669017|527664531|FG007|Overall Study|Withdrawal by Subject|2|||
146314868|NCT02669017|527664532|FG008|Overall Study|Withdrawal by Subject|2|||
146314869|NCT02669017|527664524|FG000|Overall Study|Lost to Follow-up|0|||
146314870|NCT02669017|527664525|FG001|Overall Study|Lost to Follow-up|0|||
146314871|NCT02669017|527664526|FG002|Overall Study|Lost to Follow-up|0|||
146314872|NCT02669017|527664527|FG003|Overall Study|Lost to Follow-up|0|||
146314873|NCT02669017|527664528|FG004|Overall Study|Lost to Follow-up|0|||
146314874|NCT02669017|527664529|FG005|Overall Study|Lost to Follow-up|0|||
146314875|NCT02669017|527664530|FG006|Overall Study|Lost to Follow-up|0|||
146314876|NCT02669017|527664531|FG007|Overall Study|Lost to Follow-up|0|||
146314877|NCT02669017|527664532|FG008|Overall Study|Lost to Follow-up|1|||
146314878|NCT02669017|527664524|FG000|Overall Study|Miscellaneous|0|||
146314879|NCT02669017|527664525|FG001|Overall Study|Miscellaneous|0|||
146314880|NCT02669017|527664526|FG002|Overall Study|Miscellaneous|0|||
146314881|NCT02669017|527664527|FG003|Overall Study|Miscellaneous|0|||
146314882|NCT02669017|527664528|FG004|Overall Study|Miscellaneous|2|||
146314883|NCT02669017|527664529|FG005|Overall Study|Miscellaneous|1|||
146314884|NCT02669017|527664530|FG006|Overall Study|Miscellaneous|1|||
146314885|NCT02669017|527664531|FG007|Overall Study|Miscellaneous|13|||
146314886|NCT02669017|527664532|FG008|Overall Study|Miscellaneous|2|||
146314887|NCT01289015|527664533|FG000|Overall Study|Protocol Violation|12|||
146314888|NCT01289015|527664534|FG001|Overall Study|Protocol Violation|9|||
146314889|NCT01289015|527664533|FG000|Overall Study|Adverse Event|3|||
146314890|NCT01289015|527664534|FG001|Overall Study|Adverse Event|0|||
146314891|NCT01289015|527664533|FG000|Overall Study|Lost to Follow-up|33|||
146161323|NCT01239030|527100800|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
146314892|NCT01289015|527664534|FG001|Overall Study|Lost to Follow-up|17|||
146314893|NCT01289015|527664533|FG000|Overall Study|Withdrawal by Subject|17|||
146314894|NCT01289015|527664534|FG001|Overall Study|Withdrawal by Subject|8|||
146314895|NCT01289015|527664533|FG000|Overall Study|Disease progression|1|||
146314896|NCT01289015|527664534|FG001|Overall Study|Disease progression|0|||
146314897|NCT01289015|527664533|FG000|Overall Study|Negative baseline culture and others|33|||
146314898|NCT01289015|527664534|FG001|Overall Study|Negative baseline culture and others|20|||
146314899|NCT01485627|527664538|FG000|Overall Study|Patient withdrew|6|||
146161324|NCT01239030|527100801|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
146161325|NCT01239030|527100802|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
146314900|NCT01485627|527664539|FG001|Overall Study|Patient withdrew|5|||
146314901|NCT01485627|527664538|FG000|Overall Study|Patient died|3|||
146314902|NCT01485627|527664539|FG001|Overall Study|Patient died|1|||
146161326|NCT01239030|527100803|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
146314903|NCT01485627|527664538|FG000|Overall Study|Patient lost to followup|0|||
146314904|NCT01485627|527664539|FG001|Overall Study|Patient lost to followup|1|||
146161327|NCT01239030|527100804|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
146161328|NCT01239030|527100800|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
146161329|NCT01239030|527100801|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
146161330|NCT01239030|527100802|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
146161331|NCT01239030|527100803|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
146161332|NCT01239030|527100804|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
146161333|NCT01239030|527100800|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146314905|NCT01485627|527664538|FG000|Overall Study|Caregiver withdrew|3|||
146314906|NCT01485627|527664539|FG001|Overall Study|Caregiver withdrew|3|||
146314907|NCT01485627|527664538|FG000|Overall Study|Caregiver lost to follow up|11|||
146314908|NCT01485627|527664539|FG001|Overall Study|Caregiver lost to follow up|12|||
146314909|NCT01485627|527664538|FG000|Overall Study|Caregiver died|1|||
146314910|NCT01485627|527664539|FG001|Overall Study|Caregiver died|0|||
146314911|NCT01485627|527664538|FG000|Overall Study|caregiver was not bereaved|42|||
146314912|NCT01485627|527664539|FG001|Overall Study|caregiver was not bereaved|35|||
146314913|NCT01709149|527664541|FG000|Open-label Lead-in Phase|Adverse Event|109|||
146314914|NCT01709149|527664542|FG001|Open-label Lead-in Phase|Adverse Event|0|||
146314915|NCT01709149|527664543|FG002|Open-label Lead-in Phase|Adverse Event|0|||
146314916|NCT01709149|527664541|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
146314917|NCT01709149|527664542|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
146161334|NCT01239030|527100801|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146161335|NCT01239030|527100802|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
146161336|NCT01239030|527100803|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
146161337|NCT01239030|527100804|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
146161338|NCT01239030|527100800|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
146161339|NCT01239030|527100801|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
146161340|NCT01239030|527100802|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
146161341|NCT01239030|527100803|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
146161342|NCT01239030|527100804|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
146314918|NCT01709149|527664543|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
146314919|NCT01709149|527664541|FG000|Open-label Lead-in Phase|Death|1|||
146314920|NCT01709149|527664542|FG001|Open-label Lead-in Phase|Death|0|||
146314921|NCT01709149|527664543|FG002|Open-label Lead-in Phase|Death|0|||
146314922|NCT01709149|527664541|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
146314923|NCT01709149|527664542|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
146314924|NCT01709149|527664543|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
146314925|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
146314926|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
146314927|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
146314928|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
146314929|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
146314930|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
146314931|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
146314932|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
146314933|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
146314934|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
146314935|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
146314936|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
146314937|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
146314938|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
146314939|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
146314940|NCT01709149|527664541|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146314941|NCT01709149|527664542|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
146314942|NCT01709149|527664543|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
146314943|NCT03509350|527664544|FG000|Overall Study|Withdrawal by Subject|0|||
146314944|NCT03509350|527664545|FG001|Overall Study|Withdrawal by Subject|2|||
146314945|NCT01425203|527664546|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
146314946|NCT01425203|527664547|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
146314947|NCT01425203|527664548|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
146314948|NCT01425203|527664546|FG000|Treatment Phase|Failure at futility timepoint|8|||
146314949|NCT01425203|527664547|FG001|Treatment Phase|Failure at futility timepoint|27|||
146314950|NCT01425203|527664548|FG002|Treatment Phase|Failure at futility timepoint|0|||
146314951|NCT01425203|527664546|FG000|Treatment Phase|Other virologic failure criteria|5|||
146314952|NCT01425203|527664547|FG001|Treatment Phase|Other virologic failure criteria|3|||
146314953|NCT01425203|527664548|FG002|Treatment Phase|Other virologic failure criteria|0|||
146314954|NCT01425203|527664546|FG000|Treatment Phase|Unidentified reasons|11|||
146314955|NCT01425203|527664547|FG001|Treatment Phase|Unidentified reasons|5|||
146314956|NCT01425203|527664548|FG002|Treatment Phase|Unidentified reasons|0|||
146161343|NCT00977665|527100805|FG000|Overall Study|Withdrawal by Subject|1|||
146161344|NCT00977665|527100806|FG001|Overall Study|Withdrawal by Subject|3|||
146161345|NCT00977665|527100805|FG000|Overall Study|Physician Decision|2|||
146161346|NCT00977665|527100806|FG001|Overall Study|Physician Decision|1|||
146161347|NCT00977665|527100805|FG000|Overall Study|Sponsor requested withdrawal|0|||
146161348|NCT00977665|527100806|FG001|Overall Study|Sponsor requested withdrawal|1|||
146161349|NCT00977665|527100805|FG000|Overall Study|Lost to Follow-up|1|||
146161350|NCT00977665|527100806|FG001|Overall Study|Lost to Follow-up|0|||
146161351|NCT00977665|527100805|FG000|Overall Study|Death|3|||
146161352|NCT00977665|527100806|FG001|Overall Study|Death|2|||
146161353|NCT00977665|527100805|FG000|Overall Study|Adverse Event|14|||
146161354|NCT00977665|527100806|FG001|Overall Study|Adverse Event|7|||
146161355|NCT00977665|527100805|FG000|Overall Study|Treatment failure|0|||
146161356|NCT00977665|527100806|FG001|Overall Study|Treatment failure|1|||
146161357|NCT01330433|527100807|FG000|Overall Study|Death|1|||
146161358|NCT01330433|527100808|FG001|Overall Study|Death|3|||
146161359|NCT01330433|527100807|FG000|Overall Study|Lost to Follow-up|1|||
146161360|NCT01330433|527100808|FG001|Overall Study|Lost to Follow-up|0|||
146161361|NCT03240692|527100819|FG000|Overall Study|Physician Decision|1|||
146161362|NCT03240692|527100819|FG000|Overall Study|Withdrawal by Subject|1|||
146161363|NCT02300220|527100820|FG000|Overall Study|Lost to Follow-up|1|||
146161364|NCT02300220|527100821|FG001|Overall Study|Lost to Follow-up|2|||
146161365|NCT02300220|527100820|FG000|Overall Study|Death|1|||
146161366|NCT02300220|527100821|FG001|Overall Study|Death|1|||
146161367|NCT02300220|527100820|FG000|Overall Study|Adverse Event|1|||
146161368|NCT02300220|527100821|FG001|Overall Study|Adverse Event|1|||
146161369|NCT02300220|527100820|FG000|Overall Study|Protocol Violation|1|||
146161370|NCT02300220|527100821|FG001|Overall Study|Protocol Violation|0|||
146161371|NCT02300220|527100820|FG000|Overall Study|Withdrawal by Subject|0|||
146161372|NCT02300220|527100821|FG001|Overall Study|Withdrawal by Subject|2|||
146161373|NCT02300220|527100820|FG000|Overall Study|Did not tolerate IMP|0|||
146161374|NCT02300220|527100821|FG001|Overall Study|Did not tolerate IMP|1|||
146161375|NCT04322682|527100822|FG000|Overall Study|Withdrawal by Subject|33|||
146161376|NCT04322682|527100823|FG001|Overall Study|Withdrawal by Subject|47|||
146161377|NCT04322682|527100822|FG000|Overall Study|Death|5|||
146161378|NCT04322682|527100823|FG001|Overall Study|Death|9|||
146161379|NCT04322682|527100822|FG000|Overall Study|Lost to Follow-up|4|||
146161380|NCT04322682|527100823|FG001|Overall Study|Lost to Follow-up|8|||
146161381|NCT04322682|527100822|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
146161382|NCT04322682|527100823|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
146161383|NCT02238379|527100824|FG000|Overall Study|Lost to Follow-up|1|||
146161384|NCT02238379|527100825|FG001|Overall Study|Lost to Follow-up|0|||
146161385|NCT04123067|527100826|FG000|Overall Study|Lost to Follow-up|0|||
146161386|NCT04123067|527100827|FG001|Overall Study|Lost to Follow-up|1|||
146161387|NCT00605280|527100828|FG000|Year 1|Protocol Violation|0|||
146161388|NCT00605280|527100829|FG001|Year 1|Protocol Violation|0|||
146161389|NCT00605280|527100830|FG002|Year 1|Protocol Violation|0|||
146161390|NCT00605280|527100831|FG003|Year 1|Protocol Violation|1|||
146161391|NCT00605280|527100828|FG000|Year 1|Adverse Event|3|||
146161392|NCT00605280|527100829|FG001|Year 1|Adverse Event|1|||
146281658|NCT03117998|527544704|FG002|Overall Study|Physician Decision|1|||
146281659|NCT03117998|527544705|FG003|Overall Study|Physician Decision|0|||
146281660|NCT03117998|527544706|FG004|Overall Study|Physician Decision|0|||
146281661|NCT03117998|527544707|FG005|Overall Study|Physician Decision|0|||
146281662|NCT03117998|527544702|FG000|Overall Study|Lost to Follow-up|0|||
146281663|NCT03117998|527544703|FG001|Overall Study|Lost to Follow-up|0|||
146281664|NCT03117998|527544704|FG002|Overall Study|Lost to Follow-up|0|||
146281665|NCT03117998|527544705|FG003|Overall Study|Lost to Follow-up|1|||
146281666|NCT03117998|527544706|FG004|Overall Study|Lost to Follow-up|4|||
146281667|NCT03117998|527544707|FG005|Overall Study|Lost to Follow-up|0|||
146281668|NCT03117998|527544702|FG000|Overall Study|Subject noncompliance|0|||
146281669|NCT03117998|527544703|FG001|Overall Study|Subject noncompliance|0|||
146281670|NCT03117998|527544704|FG002|Overall Study|Subject noncompliance|1|||
146281671|NCT03117998|527544705|FG003|Overall Study|Subject noncompliance|0|||
146161393|NCT00605280|527100830|FG002|Year 1|Adverse Event|1|||
146161394|NCT00605280|527100831|FG003|Year 1|Adverse Event|5|||
146161395|NCT00605280|527100828|FG000|Year 1|Physician Decision|7|||
146161396|NCT00605280|527100829|FG001|Year 1|Physician Decision|4|||
146281672|NCT03117998|527544706|FG004|Overall Study|Subject noncompliance|0|||
146281673|NCT03117998|527544707|FG005|Overall Study|Subject noncompliance|2|||
146281674|NCT03117998|527544702|FG000|Overall Study|Protocol Violation|0|||
146281675|NCT03117998|527544703|FG001|Overall Study|Protocol Violation|0|||
146281676|NCT03117998|527544704|FG002|Overall Study|Protocol Violation|0|||
146281677|NCT03117998|527544705|FG003|Overall Study|Protocol Violation|0|||
146314957|NCT01425203|527664546|FG000|Treatment Phase|Did not receive treatment|0|||
146161397|NCT00605280|527100830|FG002|Year 1|Physician Decision|0|||
146161398|NCT00605280|527100831|FG003|Year 1|Physician Decision|6|||
146161399|NCT00605280|527100828|FG000|Year 1|Withdrawal by Subject|2|||
146161400|NCT00605280|527100829|FG001|Year 1|Withdrawal by Subject|4|||
146161401|NCT00605280|527100830|FG002|Year 1|Withdrawal by Subject|0|||
146161402|NCT00605280|527100831|FG003|Year 1|Withdrawal by Subject|4|||
146161403|NCT00605280|527100828|FG000|Year 1|Other|2|||
146161404|NCT00605280|527100829|FG001|Year 1|Other|1|||
146161405|NCT00605280|527100830|FG002|Year 1|Other|0|||
146161406|NCT00605280|527100831|FG003|Year 1|Other|1|||
146161407|NCT00605280|527100828|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
146161408|NCT00605280|527100829|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
146161409|NCT00605280|527100830|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
146161410|NCT00605280|527100831|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
146161411|NCT00605280|527100828|FG000|Year 2|Adverse Event|4|||
146161412|NCT00605280|527100829|FG001|Year 2|Adverse Event|0|||
146161413|NCT00605280|527100830|FG002|Year 2|Adverse Event|2|||
146161414|NCT00605280|527100831|FG003|Year 2|Adverse Event|4|||
146161415|NCT00605280|527100828|FG000|Year 2|Physician Decision|11|||
146161416|NCT00605280|527100829|FG001|Year 2|Physician Decision|6|||
146161417|NCT00605280|527100830|FG002|Year 2|Physician Decision|4|||
146161418|NCT00605280|527100831|FG003|Year 2|Physician Decision|11|||
146161419|NCT00605280|527100828|FG000|Year 2|Withdrawal by Subject|4|||
146161420|NCT00605280|527100829|FG001|Year 2|Withdrawal by Subject|0|||
146161421|NCT00605280|527100830|FG002|Year 2|Withdrawal by Subject|0|||
146161422|NCT00605280|527100831|FG003|Year 2|Withdrawal by Subject|4|||
146161423|NCT00605280|527100828|FG000|Year 2|Other|1|||
146161424|NCT00605280|527100829|FG001|Year 2|Other|0|||
146161425|NCT00605280|527100830|FG002|Year 2|Other|0|||
146161426|NCT00605280|527100831|FG003|Year 2|Other|1|||
146161427|NCT00605280|527100828|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
146161428|NCT00605280|527100829|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
146161429|NCT00605280|527100830|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
146161430|NCT00605280|527100831|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
146161431|NCT00605280|527100828|FG000|Year 3 Extension|Adverse Event|2|||
146161432|NCT00605280|527100829|FG001|Year 3 Extension|Adverse Event|0|||
146161433|NCT00605280|527100830|FG002|Year 3 Extension|Adverse Event|0|||
146161434|NCT00605280|527100831|FG003|Year 3 Extension|Adverse Event|2|||
146161435|NCT00605280|527100828|FG000|Year 3 Extension|Physician Decision|0|||
146161436|NCT00605280|527100829|FG001|Year 3 Extension|Physician Decision|0|||
146161437|NCT00605280|527100830|FG002|Year 3 Extension|Physician Decision|0|||
146161438|NCT00605280|527100831|FG003|Year 3 Extension|Physician Decision|2|||
146161439|NCT00605280|527100828|FG000|Year 3 Extension|Withdrawal by Subject|2|||
146161440|NCT00605280|527100829|FG001|Year 3 Extension|Withdrawal by Subject|0|||
146161441|NCT00605280|527100830|FG002|Year 3 Extension|Withdrawal by Subject|0|||
146161442|NCT00605280|527100831|FG003|Year 3 Extension|Withdrawal by Subject|5|||
146161443|NCT00605280|527100828|FG000|Year 3 Extension|Other|2|||
146161444|NCT00605280|527100829|FG001|Year 3 Extension|Other|0|||
146161445|NCT00605280|527100830|FG002|Year 3 Extension|Other|0|||
146161446|NCT00605280|527100831|FG003|Year 3 Extension|Other|0|||
146161447|NCT00605280|527100828|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
146161448|NCT00605280|527100829|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146161449|NCT00605280|527100830|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146161450|NCT00605280|527100831|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
146161451|NCT02291614|527100832|FG000|Overall Study|Lost to Follow-up|0|||
146161452|NCT02291614|527100833|FG001|Overall Study|Lost to Follow-up|0|||
146161453|NCT02291614|527100834|FG002|Overall Study|Lost to Follow-up|0|||
146161454|NCT02291614|527100835|FG003|Overall Study|Lost to Follow-up|0|||
146161455|NCT02291614|527100836|FG004|Overall Study|Lost to Follow-up|0|||
146161456|NCT02291614|527100837|FG005|Overall Study|Lost to Follow-up|0|||
146161457|NCT02291614|527100838|FG006|Overall Study|Lost to Follow-up|0|||
146161458|NCT02291614|527100839|FG007|Overall Study|Lost to Follow-up|1|||
146161459|NCT02291614|527100840|FG008|Overall Study|Lost to Follow-up|0|||
146161460|NCT02291614|527100841|FG009|Overall Study|Lost to Follow-up|0|||
146161461|NCT02291614|527100842|FG010|Overall Study|Lost to Follow-up|0|||
146161462|NCT02291614|527100832|FG000|Overall Study|Withdrawal by Subject|0|||
146161463|NCT02291614|527100833|FG001|Overall Study|Withdrawal by Subject|1|||
146161464|NCT02291614|527100834|FG002|Overall Study|Withdrawal by Subject|0|||
146161465|NCT02291614|527100835|FG003|Overall Study|Withdrawal by Subject|0|||
146161466|NCT02291614|527100836|FG004|Overall Study|Withdrawal by Subject|0|||
146161467|NCT02291614|527100837|FG005|Overall Study|Withdrawal by Subject|0|||
146161468|NCT02291614|527100838|FG006|Overall Study|Withdrawal by Subject|0|||
146161469|NCT02291614|527100839|FG007|Overall Study|Withdrawal by Subject|0|||
146161470|NCT02291614|527100840|FG008|Overall Study|Withdrawal by Subject|0|||
146161471|NCT02291614|527100841|FG009|Overall Study|Withdrawal by Subject|2|||
146161472|NCT02291614|527100842|FG010|Overall Study|Withdrawal by Subject|2|||
146161473|NCT02291614|527100832|FG000|Overall Study|Decision by sponsor|0|||
146161474|NCT02291614|527100833|FG001|Overall Study|Decision by sponsor|0|||
146161475|NCT02291614|527100834|FG002|Overall Study|Decision by sponsor|0|||
146161476|NCT02291614|527100835|FG003|Overall Study|Decision by sponsor|1|||
146161477|NCT02291614|527100836|FG004|Overall Study|Decision by sponsor|0|||
146161478|NCT02291614|527100837|FG005|Overall Study|Decision by sponsor|0|||
146161479|NCT02291614|527100838|FG006|Overall Study|Decision by sponsor|0|||
146161480|NCT02291614|527100839|FG007|Overall Study|Decision by sponsor|0|||
146161481|NCT02291614|527100840|FG008|Overall Study|Decision by sponsor|0|||
146161482|NCT02291614|527100841|FG009|Overall Study|Decision by sponsor|0|||
146161483|NCT02291614|527100842|FG010|Overall Study|Decision by sponsor|0|||
146161484|NCT02291614|527100832|FG000|Overall Study|Death|0|||
146161485|NCT02291614|527100833|FG001|Overall Study|Death|0|||
146161486|NCT02291614|527100834|FG002|Overall Study|Death|1|||
146161487|NCT02291614|527100835|FG003|Overall Study|Death|0|||
146161488|NCT02291614|527100836|FG004|Overall Study|Death|1|||
146161489|NCT02291614|527100837|FG005|Overall Study|Death|1|||
146161490|NCT02291614|527100838|FG006|Overall Study|Death|1|||
146161491|NCT02291614|527100839|FG007|Overall Study|Death|0|||
146161492|NCT02291614|527100840|FG008|Overall Study|Death|0|||
146161493|NCT02291614|527100841|FG009|Overall Study|Death|0|||
146161494|NCT02291614|527100842|FG010|Overall Study|Death|0|||
146161495|NCT00127101|527100843|FG000|Base Protocol|Adverse Event|0|||
146161496|NCT00127101|527100844|FG001|Base Protocol|Adverse Event|2|||
146161497|NCT00127101|527100845|FG002|Base Protocol|Adverse Event|1|||
146161498|NCT00127101|527100846|FG003|Base Protocol|Adverse Event|0|||
146161499|NCT00127101|527100847|FG004|Base Protocol|Adverse Event|0|||
146161500|NCT00127101|527100848|FG005|Base Protocol|Adverse Event|0|||
146161501|NCT00127101|527100843|FG000|Base Protocol|Lack of Efficacy|1|||
146161502|NCT00127101|527100844|FG001|Base Protocol|Lack of Efficacy|0|||
146161503|NCT00127101|527100845|FG002|Base Protocol|Lack of Efficacy|0|||
146161504|NCT00127101|527100846|FG003|Base Protocol|Lack of Efficacy|0|||
146161505|NCT00127101|527100847|FG004|Base Protocol|Lack of Efficacy|2|||
146161506|NCT00127101|527100848|FG005|Base Protocol|Lack of Efficacy|0|||
146161507|NCT00127101|527100843|FG000|Base Protocol|Withdrawal by Subject|1|||
146161508|NCT00127101|527100844|FG001|Base Protocol|Withdrawal by Subject|2|||
146161509|NCT00127101|527100845|FG002|Base Protocol|Withdrawal by Subject|1|||
146161510|NCT00127101|527100846|FG003|Base Protocol|Withdrawal by Subject|0|||
146161511|NCT00127101|527100847|FG004|Base Protocol|Withdrawal by Subject|0|||
146161512|NCT00127101|527100848|FG005|Base Protocol|Withdrawal by Subject|1|||
146161513|NCT00127101|527100843|FG000|Continuation Phase|Adverse Event|0|||
146161514|NCT00127101|527100844|FG001|Continuation Phase|Adverse Event|0|||
146161515|NCT00127101|527100845|FG002|Continuation Phase|Adverse Event|0|||
146161516|NCT00127101|527100846|FG003|Continuation Phase|Adverse Event|0|||
146161517|NCT00127101|527100847|FG004|Continuation Phase|Adverse Event|1|||
146161518|NCT00127101|527100848|FG005|Continuation Phase|Adverse Event|1|||
146161519|NCT00127101|527100843|FG000|Continuation Phase|Lack of Efficacy|0|||
146161520|NCT00127101|527100844|FG001|Continuation Phase|Lack of Efficacy|0|||
146161521|NCT00127101|527100845|FG002|Continuation Phase|Lack of Efficacy|0|||
146161522|NCT00127101|527100846|FG003|Continuation Phase|Lack of Efficacy|0|||
146161523|NCT00127101|527100847|FG004|Continuation Phase|Lack of Efficacy|0|||
146161524|NCT00127101|527100848|FG005|Continuation Phase|Lack of Efficacy|1|||
146161525|NCT00127101|527100843|FG000|Continuation Phase|Withdrawal by Subject|0|||
146161526|NCT00127101|527100844|FG001|Continuation Phase|Withdrawal by Subject|0|||
146161527|NCT00127101|527100845|FG002|Continuation Phase|Withdrawal by Subject|1|||
146161528|NCT00127101|527100846|FG003|Continuation Phase|Withdrawal by Subject|0|||
146161529|NCT00127101|527100847|FG004|Continuation Phase|Withdrawal by Subject|2|||
146161530|NCT00127101|527100848|FG005|Continuation Phase|Withdrawal by Subject|1|||
146161531|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
146161532|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
146161533|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
146161534|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
146281678|NCT03117998|527544706|FG004|Overall Study|Protocol Violation|0|||
146281679|NCT03117998|527544707|FG005|Overall Study|Protocol Violation|1|||
146281680|NCT01468181|527544708|FG000|Overall Study|Adverse Event|8|||
146281681|NCT01468181|527544709|FG001|Overall Study|Adverse Event|1|||
146281682|NCT01468181|527544710|FG002|Overall Study|Adverse Event|6|||
146161535|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
146161536|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
146161537|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146161538|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146161539|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146161540|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
146161541|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
146161542|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146161543|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146161544|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146161545|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
146161546|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
146161547|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
146161548|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
146161549|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
146161550|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
146161551|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
146281683|NCT01468181|527544711|FG003|Overall Study|Adverse Event|2|||
146281684|NCT01468181|527544712|FG004|Overall Study|Adverse Event|2|||
146281685|NCT01468181|527544708|FG000|Overall Study|Protocol Violation|2|||
146161552|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146161553|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146161554|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146161555|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
146161556|NCT01662310|527100849|FG000|Run-In or Stabilization Phase|Other|1|||
146161557|NCT01662310|527100850|FG001|Run-In or Stabilization Phase|Other|0|||
146161558|NCT01662310|527100851|FG002|Run-In or Stabilization Phase|Other|0|||
146161559|NCT01662310|527100852|FG003|Run-In or Stabilization Phase|Other|0|||
146161560|NCT01662310|527100853|FG004|Run-In or Stabilization Phase|Other|0|||
146161561|NCT01662310|527100849|FG000|Double-Blind Phase|Adverse Event|0|||
146161562|NCT01662310|527100850|FG001|Double-Blind Phase|Adverse Event|0|||
146161563|NCT01662310|527100851|FG002|Double-Blind Phase|Adverse Event|1|||
146161564|NCT01662310|527100852|FG003|Double-Blind Phase|Adverse Event|0|||
146161565|NCT01662310|527100853|FG004|Double-Blind Phase|Adverse Event|0|||
146161566|NCT01662310|527100849|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146161567|NCT01662310|527100850|FG001|Double-Blind Phase|Lost to Follow-up|3|||
146161568|NCT01662310|527100851|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146161569|NCT01662310|527100852|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146161570|NCT01662310|527100853|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146161571|NCT01662310|527100849|FG000|Double-Blind Phase|Pregnancy|0|||
146161572|NCT01662310|527100850|FG001|Double-Blind Phase|Pregnancy|2|||
146161573|NCT01662310|527100851|FG002|Double-Blind Phase|Pregnancy|0|||
146161574|NCT01662310|527100852|FG003|Double-Blind Phase|Pregnancy|0|||
146161575|NCT01662310|527100853|FG004|Double-Blind Phase|Pregnancy|0|||
146161576|NCT01662310|527100849|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146161577|NCT01662310|527100850|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
146161578|NCT01662310|527100851|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
146161579|NCT01662310|527100852|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146161580|NCT01662310|527100853|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146161581|NCT01662310|527100849|FG000|Double-Blind Phase|Other|0|||
146161582|NCT01662310|527100850|FG001|Double-Blind Phase|Other|0|||
146161583|NCT01662310|527100851|FG002|Double-Blind Phase|Other|1|||
146161584|NCT01662310|527100852|FG003|Double-Blind Phase|Other|0|||
146161585|NCT01662310|527100853|FG004|Double-Blind Phase|Other|0|||
146161586|NCT01662310|527100849|FG000|Double-Blind Phase|Randomized but not treated|0|||
146161587|NCT01662310|527100850|FG001|Double-Blind Phase|Randomized but not treated|1|||
146161588|NCT01662310|527100851|FG002|Double-Blind Phase|Randomized but not treated|0|||
146161589|NCT01662310|527100852|FG003|Double-Blind Phase|Randomized but not treated|0|||
146161590|NCT01662310|527100853|FG004|Double-Blind Phase|Randomized but not treated|0|||
146161591|NCT01662310|527100849|FG000|Open-Label Extension Phase|Adverse Event|0|||
146161592|NCT01662310|527100850|FG001|Open-Label Extension Phase|Adverse Event|0|||
146161593|NCT01662310|527100851|FG002|Open-Label Extension Phase|Adverse Event|0|||
146161594|NCT01662310|527100852|FG003|Open-Label Extension Phase|Adverse Event|3|||
146161595|NCT01662310|527100853|FG004|Open-Label Extension Phase|Adverse Event|0|||
146161596|NCT01662310|527100849|FG000|Open-Label Extension Phase|Death|0|||
146161597|NCT01662310|527100850|FG001|Open-Label Extension Phase|Death|0|||
146161598|NCT01662310|527100851|FG002|Open-Label Extension Phase|Death|0|||
146161599|NCT01662310|527100852|FG003|Open-Label Extension Phase|Death|1|||
146161600|NCT01662310|527100853|FG004|Open-Label Extension Phase|Death|0|||
146161601|NCT01662310|527100849|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
146161602|NCT01662310|527100850|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
146161603|NCT01662310|527100851|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
146161604|NCT01662310|527100852|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
146161605|NCT01662310|527100853|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
146161606|NCT01662310|527100849|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
146161607|NCT01662310|527100850|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
146161608|NCT01662310|527100851|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
146161609|NCT01662310|527100852|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
146161610|NCT01662310|527100853|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
146161611|NCT01662310|527100849|FG000|Open-Label Extension Phase|Pregnancy|0|||
146314958|NCT01425203|527664547|FG001|Treatment Phase|Did not receive treatment|1|||
146161612|NCT01662310|527100850|FG001|Open-Label Extension Phase|Pregnancy|0|||
146161613|NCT01662310|527100851|FG002|Open-Label Extension Phase|Pregnancy|0|||
146161614|NCT01662310|527100852|FG003|Open-Label Extension Phase|Pregnancy|1|||
146161615|NCT01662310|527100853|FG004|Open-Label Extension Phase|Pregnancy|0|||
146161616|NCT01662310|527100849|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
146161617|NCT01662310|527100850|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
146161618|NCT01662310|527100851|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
146161619|NCT01662310|527100852|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
146161620|NCT01662310|527100853|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
146161621|NCT02432105|527100855|FG000|Overall Study|Lost to Follow-up|1|||
146161622|NCT02432105|527100856|FG001|Overall Study|Lost to Follow-up|1|||
146161623|NCT02432105|527100857|FG002|Overall Study|Lost to Follow-up|0|||
146314959|NCT01425203|527664548|FG002|Treatment Phase|Did not receive treatment|0|||
146161624|NCT02432105|527100855|FG000|Overall Study|Withdrawal by Subject|1|||
146161625|NCT02432105|527100856|FG001|Overall Study|Withdrawal by Subject|0|||
146161626|NCT02432105|527100857|FG002|Overall Study|Withdrawal by Subject|1|||
146161627|NCT02432105|527100855|FG000|Overall Study|Culture positive for yeast|0|||
146161628|NCT02432105|527100856|FG001|Overall Study|Culture positive for yeast|1|||
146161629|NCT02432105|527100857|FG002|Overall Study|Culture positive for yeast|0|||
146161630|NCT02432105|527100855|FG000|Overall Study|Randomized in error|0|||
146161631|NCT02432105|527100856|FG001|Overall Study|Randomized in error|0|||
146161632|NCT02432105|527100857|FG002|Overall Study|Randomized in error|2|||
146161633|NCT04302350|527100858|FG000|Overall Study|Physician Decision|1|||
146161634|NCT04302350|527100859|FG001|Overall Study|Physician Decision|1|||
146161635|NCT04302350|527100860|FG002|Overall Study|Physician Decision|2|||
146161636|NCT04302350|527100858|FG000|Overall Study|Lack of Efficacy|1|||
146161637|NCT04302350|527100859|FG001|Overall Study|Lack of Efficacy|1|||
146161638|NCT04302350|527100860|FG002|Overall Study|Lack of Efficacy|4|||
146161639|NCT04302350|527100858|FG000|Overall Study|Adverse Event|0|||
146161640|NCT04302350|527100859|FG001|Overall Study|Adverse Event|1|||
146161641|NCT04302350|527100860|FG002|Overall Study|Adverse Event|2|||
146161642|NCT01400503|527100861|FG000|Overall Study|Withdrawal by Subject|1|||
146161643|NCT01400503|527100861|FG000|Overall Study|Study Terminated by Sponsor|58|||
146161644|NCT01400503|527100861|FG000|Overall Study|Other|1|||
146161645|NCT01669122|527100862|FG000|Period I|Lost to Follow-up|1|||
146161646|NCT01669122|527100862|FG000|Washout Period II|Protocol Violation|2|||
146161647|NCT03543254|527100863|FG000|Overall Study|Lost to Follow-up|1|||
146161648|NCT02077166|527100864|FG000|Overall Study|Death|6|||
146161649|NCT02077166|527100865|FG001|Overall Study|Death|7|||
146161650|NCT02077166|527100866|FG002|Overall Study|Death|5|||
146161651|NCT02077166|527100867|FG003|Overall Study|Death|6|||
146161652|NCT02077166|527100868|FG004|Overall Study|Death|4|||
146161653|NCT02077166|527100869|FG005|Overall Study|Death|32|||
146161654|NCT02077166|527100870|FG006|Overall Study|Death|22|||
146161655|NCT02077166|527100864|FG000|Overall Study|Study Closure by Sponsor|3|||
146161656|NCT02077166|527100865|FG001|Overall Study|Study Closure by Sponsor|0|||
146161657|NCT02077166|527100866|FG002|Overall Study|Study Closure by Sponsor|2|||
146161658|NCT02077166|527100867|FG003|Overall Study|Study Closure by Sponsor|2|||
146161659|NCT02077166|527100868|FG004|Overall Study|Study Closure by Sponsor|2|||
146161660|NCT02077166|527100869|FG005|Overall Study|Study Closure by Sponsor|12|||
146161661|NCT02077166|527100870|FG006|Overall Study|Study Closure by Sponsor|4|||
146161662|NCT02077166|527100864|FG000|Overall Study|Lost to Follow-up|0|||
146161663|NCT02077166|527100865|FG001|Overall Study|Lost to Follow-up|0|||
146161664|NCT02077166|527100866|FG002|Overall Study|Lost to Follow-up|0|||
146161665|NCT02077166|527100867|FG003|Overall Study|Lost to Follow-up|0|||
146161666|NCT02077166|527100868|FG004|Overall Study|Lost to Follow-up|0|||
146161667|NCT02077166|527100869|FG005|Overall Study|Lost to Follow-up|1|||
146161668|NCT02077166|527100870|FG006|Overall Study|Lost to Follow-up|0|||
146161669|NCT02077166|527100864|FG000|Overall Study|Withdrawal by Subject|3|||
146161670|NCT02077166|527100865|FG001|Overall Study|Withdrawal by Subject|0|||
146161671|NCT02077166|527100866|FG002|Overall Study|Withdrawal by Subject|1|||
146161672|NCT02077166|527100867|FG003|Overall Study|Withdrawal by Subject|1|||
146161673|NCT02077166|527100868|FG004|Overall Study|Withdrawal by Subject|1|||
146161674|NCT02077166|527100869|FG005|Overall Study|Withdrawal by Subject|3|||
146161675|NCT02077166|527100870|FG006|Overall Study|Withdrawal by Subject|0|||
146161676|NCT02077166|527100864|FG000|Overall Study|Other, Not Specified|0|||
146161677|NCT02077166|527100865|FG001|Overall Study|Other, Not Specified|0|||
146161678|NCT02077166|527100866|FG002|Overall Study|Other, Not Specified|1|||
146161679|NCT02077166|527100867|FG003|Overall Study|Other, Not Specified|0|||
146161680|NCT02077166|527100868|FG004|Overall Study|Other, Not Specified|1|||
146161681|NCT02077166|527100869|FG005|Overall Study|Other, Not Specified|7|||
146161682|NCT02077166|527100870|FG006|Overall Study|Other, Not Specified|8|||
146161683|NCT03519854|527100871|FG000|Overall Study|Technical Error|0|||
146161684|NCT03519854|527100872|FG001|Overall Study|Technical Error|0|||
146161685|NCT03519854|527100873|FG002|Overall Study|Technical Error|1|||
146161686|NCT03519854|527100874|FG003|Overall Study|Technical Error|0|||
146161687|NCT03519854|527100875|FG004|Overall Study|Technical Error|0|||
146161688|NCT03519854|527100876|FG005|Overall Study|Technical Error|0|||
146161689|NCT03519854|527100877|FG006|Overall Study|Technical Error|0|||
146161690|NCT03519854|527100878|FG007|Overall Study|Technical Error|0|||
146161691|NCT03519854|527100879|FG008|Overall Study|Technical Error|0|||
146161692|NCT03519854|527100880|FG009|Overall Study|Technical Error|0|||
146161693|NCT03519854|527100881|FG010|Overall Study|Technical Error|0|||
146161694|NCT03519854|527100882|FG011|Overall Study|Technical Error|0|||
146161695|NCT03519854|527100883|FG012|Overall Study|Technical Error|0|||
146161696|NCT03519854|527100884|FG013|Overall Study|Technical Error|0|||
146161697|NCT03519854|527100885|FG014|Overall Study|Technical Error|0|||
146161698|NCT03519854|527100886|FG015|Overall Study|Technical Error|0|||
146161699|NCT03519854|527100887|FG016|Overall Study|Technical Error|0|||
146161700|NCT03519854|527100888|FG017|Overall Study|Technical Error|0|||
146161701|NCT00941330|527100889|FG000|Overall Study|Other|1|||
146281686|NCT01468181|527544709|FG001|Overall Study|Protocol Violation|0|||
146161702|NCT00941330|527100890|FG001|Overall Study|Other|0|||
146161703|NCT00941330|527100889|FG000|Overall Study|Physician Decision|0|||
146161704|NCT00941330|527100890|FG001|Overall Study|Physician Decision|2|||
146161705|NCT02747238|527100891|FG000|Overall Study|Lack of Efficacy|0|||
146161706|NCT02747238|527100892|FG001|Overall Study|Lack of Efficacy|1|||
146161707|NCT02747238|527100891|FG000|Overall Study|Data lost|3|||
146161708|NCT02747238|527100892|FG001|Overall Study|Data lost|5|||
146161709|NCT05132699|527100893|FG000|Overall Study|Withdrawal by Subject|3|||
146161710|NCT05132699|527100894|FG001|Overall Study|Withdrawal by Subject|0|||
146161711|NCT00655980|527100897|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
146161712|NCT00655980|527100898|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
146161713|NCT00655980|527100899|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
146161714|NCT02858895|527100901|FG000|Overall Study|Disease progression|31|||
146161715|NCT02858895|527100901|FG000|Overall Study|Death|2|||
146161716|NCT02858895|527100901|FG000|Overall Study|Adverse Event|1|||
146161717|NCT02858895|527100901|FG000|Overall Study|Withdrawal by Subject|3|||
146161718|NCT02858895|527100901|FG000|Overall Study|hospice,|1|||
146161719|NCT02858895|527100901|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
146161720|NCT05338333|527100904|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
146161721|NCT05338333|527100905|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
146161722|NCT01475136|527100906|FG000|Overall Study|Sponsor Decision|0|||
146161723|NCT01475136|527100907|FG001|Overall Study|Sponsor Decision|1|||
146161724|NCT01475136|527100908|FG002|Overall Study|Sponsor Decision|0|||
146161725|NCT01475136|527100909|FG003|Overall Study|Sponsor Decision|0|||
146161726|NCT01475136|527100906|FG000|Overall Study|Entry Criteria Not Met|0|||
146161727|NCT01475136|527100907|FG001|Overall Study|Entry Criteria Not Met|2|||
146161728|NCT01475136|527100908|FG002|Overall Study|Entry Criteria Not Met|3|||
146161729|NCT01475136|527100909|FG003|Overall Study|Entry Criteria Not Met|1|||
146161730|NCT01475136|527100906|FG000|Overall Study|Withdrawal by Subject|0|||
146161731|NCT01475136|527100907|FG001|Overall Study|Withdrawal by Subject|0|||
146161732|NCT01475136|527100908|FG002|Overall Study|Withdrawal by Subject|0|||
146161733|NCT01475136|527100909|FG003|Overall Study|Withdrawal by Subject|2|||
146161734|NCT01475136|527100906|FG000|Overall Study|Adverse Event|1|||
146161735|NCT01475136|527100907|FG001|Overall Study|Adverse Event|0|||
146161736|NCT01475136|527100908|FG002|Overall Study|Adverse Event|0|||
146161737|NCT01475136|527100909|FG003|Overall Study|Adverse Event|1|||
146161738|NCT01475136|527100906|FG000|Overall Study|Death|0|||
146161739|NCT01475136|527100907|FG001|Overall Study|Death|0|||
146161740|NCT01475136|527100908|FG002|Overall Study|Death|0|||
146161741|NCT01475136|527100909|FG003|Overall Study|Death|1|||
146161742|NCT01266642|527100917|FG000|Overall Study|Protocol Violation|0|||
146161743|NCT01266642|527100918|FG001|Overall Study|Protocol Violation|1|||
146161744|NCT01323530|527102512|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
146161745|NCT01323530|527102513|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146161746|NCT01323530|527102514|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146161747|NCT01323530|527102515|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146161748|NCT01323530|527102516|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146161749|NCT01323530|527102517|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
146161750|NCT01323530|527102518|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
146161751|NCT01323530|527102512|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146161752|NCT01323530|527102513|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146161753|NCT01323530|527102514|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
146161754|NCT01323530|527102515|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146161755|NCT01323530|527102516|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
146161756|NCT01323530|527102517|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146161757|NCT01323530|527102518|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
146161758|NCT01323530|527102512|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146161759|NCT01323530|527102513|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146161760|NCT01323530|527102514|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146161761|NCT01323530|527102515|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146161762|NCT01323530|527102516|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146161763|NCT01323530|527102517|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
146161764|NCT01323530|527102518|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
146161765|NCT01323530|527102512|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161766|NCT01323530|527102513|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161767|NCT01323530|527102514|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161768|NCT01323530|527102515|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161769|NCT01323530|527102516|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161770|NCT01323530|527102517|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
146161771|NCT01323530|527102518|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
146161772|NCT01323530|527102512|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161773|NCT01323530|527102513|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161774|NCT01323530|527102514|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161775|NCT01323530|527102515|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161776|NCT01323530|527102516|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161777|NCT01323530|527102517|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
146161778|NCT01323530|527102518|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
146161779|NCT01323530|527102512|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161780|NCT01323530|527102513|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161781|NCT01323530|527102514|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161782|NCT01323530|527102515|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161783|NCT01323530|527102516|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161784|NCT01323530|527102517|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
146161785|NCT01323530|527102518|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
146161786|NCT01323530|527102512|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161787|NCT01323530|527102513|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161788|NCT01323530|527102514|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161789|NCT01323530|527102515|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161790|NCT01323530|527102516|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161791|NCT01323530|527102517|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
146161792|NCT01323530|527102518|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
146161793|NCT01323530|527102512|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161794|NCT01323530|527102513|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161795|NCT01323530|527102514|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161796|NCT01323530|527102515|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161797|NCT01323530|527102516|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161798|NCT01323530|527102517|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
146161799|NCT01323530|527102518|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
146161800|NCT01194570|527102519|FG000|Overall Study|Adverse Event|22|||
146161801|NCT01194570|527102520|FG001|Overall Study|Adverse Event|40|||
146161802|NCT01194570|527102519|FG000|Overall Study|Death|6|||
146161803|NCT01194570|527102520|FG001|Overall Study|Death|20|||
146161804|NCT01194570|527102519|FG000|Overall Study|Lack of Efficacy|32|||
146161805|NCT01194570|527102520|FG001|Overall Study|Lack of Efficacy|33|||
146161806|NCT01194570|527102519|FG000|Overall Study|Lost to Follow-up|4|||
146161807|NCT01194570|527102520|FG001|Overall Study|Lost to Follow-up|15|||
146161808|NCT01194570|527102519|FG000|Overall Study|Non-Compliance|2|||
146161809|NCT01194570|527102520|FG001|Overall Study|Non-Compliance|2|||
146161810|NCT01194570|527102519|FG000|Overall Study|Non-Compliance With Study Drug|2|||
146161811|NCT01194570|527102520|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146161812|NCT01194570|527102519|FG000|Overall Study|Other|18|||
146161813|NCT01194570|527102520|FG001|Overall Study|Other|47|||
146161814|NCT01194570|527102519|FG000|Overall Study|Physician Decision|10|||
146161815|NCT01194570|527102520|FG001|Overall Study|Physician Decision|25|||
146161816|NCT01194570|527102519|FG000|Overall Study|Protocol Violation|1|||
146161817|NCT01194570|527102520|FG001|Overall Study|Protocol Violation|2|||
146161818|NCT01194570|527102519|FG000|Overall Study|Study Terminated By Sponsor|0|||
146161819|NCT01194570|527102520|FG001|Overall Study|Study Terminated By Sponsor|1|||
146161820|NCT01194570|527102519|FG000|Overall Study|Withdrawal by Subject|57|||
146161821|NCT01194570|527102520|FG001|Overall Study|Withdrawal by Subject|82|||
146161822|NCT01194570|527102519|FG000|Overall Study|Pregnancy|1|||
146161823|NCT01194570|527102520|FG001|Overall Study|Pregnancy|1|||
146161824|NCT00289887|527102522|FG000|Overall Study|Adverse Event|3|||
146161825|NCT00289887|527102523|FG001|Overall Study|Adverse Event|3|||
146161826|NCT00289887|527102522|FG000|Overall Study|Lack of Efficacy|3|||
146161827|NCT00289887|527102523|FG001|Overall Study|Lack of Efficacy|11|||
146161828|NCT00289887|527102522|FG000|Overall Study|Lost to Follow-up|3|||
146161829|NCT00289887|527102523|FG001|Overall Study|Lost to Follow-up|3|||
146161830|NCT00289887|527102522|FG000|Overall Study|Protocol Violation|3|||
146161831|NCT00289887|527102523|FG001|Overall Study|Protocol Violation|1|||
146161832|NCT00289887|527102522|FG000|Overall Study|Withdrawal by Subject|3|||
146161833|NCT00289887|527102523|FG001|Overall Study|Withdrawal by Subject|8|||
146161834|NCT00289887|527102522|FG000|Overall Study|Other|7|||
146161835|NCT00289887|527102523|FG001|Overall Study|Other|3|||
146161836|NCT02035332|527102525|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
146161837|NCT02030015|527102528|FG000|Overall Study|Withdrawal by Subject|3|||
146161838|NCT02030015|527102528|FG000|Overall Study|Death|13|||
146161839|NCT00833560|527102529|FG000|Overall Study|Toxicity|13|||
146314960|NCT01425203|527664546|FG000|Crossover Phase|Failure at futility timepoint|0|||
146161840|NCT00833560|527102529|FG000|Overall Study|Adverse Event|11|||
146161841|NCT00833560|527102529|FG000|Overall Study|Protocol Violation|6|||
146161842|NCT00833560|527102529|FG000|Overall Study|Lack of Efficacy|4|||
146161843|NCT00833560|527102529|FG000|Overall Study|Death|2|||
146161844|NCT00833560|527102529|FG000|Overall Study|Pregression of other disease|1|||
146161845|NCT00833560|527102529|FG000|Overall Study|Other|5|||
146161846|NCT00499031|527102530|FG000|Overall Study|Improper pre-protocol treatment|1|||
146161847|NCT00499031|527102530|FG000|Overall Study|Required test not done|1|||
146161848|NCT00499031|527102530|FG000|Overall Study|Never treated|1|||
146161849|NCT00512148|527102539|FG000|Primay Study Period|Withdrawal by Subject|1|||
146161850|NCT02690974|527102546|FG000|Overall Study|Adverse Event|16|||
146161851|NCT02690974|527102546|FG000|Overall Study|Death|9|||
146161852|NCT02690974|527102546|FG000|Overall Study|Subject/guardian decision|4|||
146161853|NCT02690974|527102546|FG000|Overall Study|Lost to Follow-up|3|||
146161854|NCT02690974|527102546|FG000|Overall Study|Withdrawal of Informed Consent|3|||
146161855|NCT02690974|527102546|FG000|Overall Study|Physician Decision|2|||
146161856|NCT02690974|527102546|FG000|Overall Study|Non-compliance with study treatment|1|||
146161857|NCT02690974|527102546|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146161858|NCT02690974|527102546|FG000|Overall Study|Protocol Deviation|1|||
146161859|NCT01666951|527102553|FG000|Overall Study|Not dosed|1|||
146161860|NCT01666951|527102554|FG001|Overall Study|Not dosed|1|||
146161861|NCT02623322|527102558|FG000|Overall Study|Lost to Follow-up|2|||
146161862|NCT02623322|527102559|FG001|Overall Study|Lost to Follow-up|1|||
146161863|NCT02623322|527102560|FG002|Overall Study|Lost to Follow-up|0|||
146161864|NCT03284788|527102561|FG000|Overall Study|Withdrawal by Subject|2|||
146161865|NCT01690130|527102565|FG000|Overall Study|Subject have cancelled visit.|1|||
146161866|NCT01690130|527102566|FG001|Overall Study|Subject have cancelled visit.|0|||
146161867|NCT02462876|527102567|FG000|Overall Study|Death|3|||
146161868|NCT02462876|527102567|FG000|Overall Study|Lost to Follow-up|7|||
146161869|NCT02462876|527102567|FG000|Overall Study|Surgical Bypass|9|||
146161870|NCT02462876|527102567|FG000|Overall Study|Amputation Above the Metatarsals|1|||
146161871|NCT02462876|527102567|FG000|Overall Study|36 months follow-up visit missed|1|||
146161872|NCT02462876|527102567|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
146281687|NCT01468181|527544710|FG002|Overall Study|Protocol Violation|1|||
146281688|NCT01468181|527544711|FG003|Overall Study|Protocol Violation|0|||
146281689|NCT01468181|527544712|FG004|Overall Study|Protocol Violation|1|||
146281690|NCT01468181|527544708|FG000|Overall Study|Physician Decision|0|||
146281691|NCT01468181|527544709|FG001|Overall Study|Physician Decision|0|||
146281692|NCT01468181|527544710|FG002|Overall Study|Physician Decision|0|||
146281693|NCT01468181|527544711|FG003|Overall Study|Physician Decision|1|||
146281694|NCT01468181|527544712|FG004|Overall Study|Physician Decision|1|||
146281695|NCT01468181|527544708|FG000|Overall Study|Lost to Follow-up|0|||
146281696|NCT01468181|527544709|FG001|Overall Study|Lost to Follow-up|0|||
146281697|NCT01468181|527544710|FG002|Overall Study|Lost to Follow-up|1|||
146281698|NCT01468181|527544711|FG003|Overall Study|Lost to Follow-up|0|||
146281699|NCT01468181|527544712|FG004|Overall Study|Lost to Follow-up|1|||
146281700|NCT01468181|527544708|FG000|Overall Study|Withdrawal by Subject|0|||
146281701|NCT01468181|527544709|FG001|Overall Study|Withdrawal by Subject|1|||
146281702|NCT01468181|527544710|FG002|Overall Study|Withdrawal by Subject|0|||
146281703|NCT01468181|527544711|FG003|Overall Study|Withdrawal by Subject|0|||
146281704|NCT01468181|527544712|FG004|Overall Study|Withdrawal by Subject|0|||
146281705|NCT04664400|527544713|FG000|Overall Study|Withdrawal by Subject|2|||
146281706|NCT01011153|527544716|FG000|Overall Study|Less than 78 cases completed|8|||
146281707|NCT01011153|527544717|FG001|Overall Study|Less than 78 cases completed|11|||
146281708|NCT01011153|527544718|FG002|Overall Study|Less than 78 cases completed|9|||
146281709|NCT01081132|527544721|FG000|Overall Study|Lack of Efficacy|25|||
146281710|NCT01081132|527544722|FG001|Overall Study|Lack of Efficacy|9|||
146281711|NCT01081132|527544721|FG000|Overall Study|Withdrawal by Subject|13|||
146281712|NCT01081132|527544722|FG001|Overall Study|Withdrawal by Subject|16|||
146281713|NCT01081132|527544721|FG000|Overall Study|Lost to Follow-up|4|||
146281714|NCT01081132|527544722|FG001|Overall Study|Lost to Follow-up|11|||
146281715|NCT01081132|527544721|FG000|Overall Study|Adverse Event|3|||
146281716|NCT01081132|527544722|FG001|Overall Study|Adverse Event|9|||
146281717|NCT01081132|527544721|FG000|Overall Study|Non Compliance|4|||
146281718|NCT01081132|527544722|FG001|Overall Study|Non Compliance|2|||
146281719|NCT01081132|527544721|FG000|Overall Study|Lack Of Compliance|0|||
146281720|NCT01081132|527544722|FG001|Overall Study|Lack Of Compliance|1|||
146281721|NCT01081132|527544721|FG000|Overall Study|Missed Visits|1|||
146281722|NCT01081132|527544722|FG001|Overall Study|Missed Visits|1|||
146281723|NCT01081132|527544721|FG000|Overall Study|Stopped Taking Meds|2|||
146281724|NCT01081132|527544722|FG001|Overall Study|Stopped Taking Meds|0|||
146281725|NCT01081132|527544721|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
146161873|NCT02462876|527102567|FG000|Overall Study|Patient did not come back to the vascular department|1|||
146161874|NCT02462876|527102567|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
146281726|NCT01081132|527544722|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
146281727|NCT01081132|527544721|FG000|Overall Study|Declined Taper Phase|0|||
146281728|NCT01081132|527544722|FG001|Overall Study|Declined Taper Phase|1|||
146281729|NCT01081132|527544721|FG000|Overall Study|Protocol Violation|3|||
146281730|NCT01081132|527544722|FG001|Overall Study|Protocol Violation|1|||
146281731|NCT02297139|527544723|FG000|Overall Study|Disease progression|0|||
146281732|NCT02297139|527544724|FG001|Overall Study|Disease progression|1|||
146281733|NCT02297139|527544723|FG000|Overall Study|Study drug toxicity|0|||
146281734|NCT02297139|527544724|FG001|Overall Study|Study drug toxicity|4|||
146281735|NCT02297139|527544723|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146281736|NCT02297139|527544724|FG001|Overall Study|Participant request to discontinue study treatment|1|||
146281737|NCT02297139|527544723|FG000|Overall Study|Maximum clinical benefit|1|||
146314961|NCT01425203|527664547|FG001|Crossover Phase|Failure at futility timepoint|0|||
146314962|NCT01425203|527664548|FG002|Crossover Phase|Failure at futility timepoint|3|||
146314963|NCT01425203|527664546|FG000|Crossover Phase|Other virologic failure criteria|0|||
146314964|NCT01425203|527664547|FG001|Crossover Phase|Other virologic failure criteria|0|||
146314965|NCT01425203|527664548|FG002|Crossover Phase|Other virologic failure criteria|3|||
146314966|NCT04951037|527664553|FG000|Overall Study|Lost to Follow-up|16|||
146314967|NCT04951037|527664553|FG000|Overall Study|Withdrawal by Subject|5|||
146314968|NCT04951037|527664553|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
146314969|NCT03031301|527664554|FG000|Overall Study|Protocol Violation|4|||
146314970|NCT03031301|527664555|FG001|Overall Study|Protocol Violation|8|||
146314971|NCT03031301|527664554|FG000|Overall Study|Withdrawal by Subject|7|||
146314972|NCT03031301|527664555|FG001|Overall Study|Withdrawal by Subject|4|||
146314973|NCT03031301|527664554|FG000|Overall Study|Lost to Follow-up|4|||
146314974|NCT03031301|527664555|FG001|Overall Study|Lost to Follow-up|12|||
146314975|NCT03031301|527664554|FG000|Overall Study|Noncompliance|1|||
146314976|NCT03031301|527664555|FG001|Overall Study|Noncompliance|3|||
146314977|NCT03031301|527664554|FG000|Overall Study|Technical issue|1|||
146314978|NCT03031301|527664555|FG001|Overall Study|Technical issue|1|||
146314979|NCT03031301|527664554|FG000|Overall Study|Adverse Event|1|||
146314980|NCT03031301|527664555|FG001|Overall Study|Adverse Event|0|||
146314981|NCT02429414|527664557|FG000|Overall Study|Physician Decision|0|||
146314982|NCT02429414|527664558|FG001|Overall Study|Physician Decision|1|||
146314983|NCT01604265|527664562|FG000|Overall Study|Adverse Event|1|||
146314984|NCT01604265|527664563|FG001|Overall Study|Adverse Event|0|||
146314985|NCT01604265|527664562|FG000|Overall Study|Withdrawal by Subject|1|||
146314986|NCT01604265|527664563|FG001|Overall Study|Withdrawal by Subject|0|||
146314987|NCT02599961|527664564|FG000|Overall Study|Withdrawal by Subject|1|||
146314988|NCT02599961|527664564|FG000|Overall Study|Subject Non-Compliance|2|||
146314989|NCT02599961|527664564|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
146314990|NCT02599961|527664564|FG000|Overall Study|Other, Not Specified|3|||
146314991|NCT02228590|527664573|FG000|Overall Study|Withdrawal by Subject|1|||
146314992|NCT02111993|527664574|FG000|Overall Study|Physician Decision|5|||
146314993|NCT02111993|527664575|FG001|Overall Study|Physician Decision|4|||
146314994|NCT01097863|527664576|FG000|Overall Study|Discomfort|1|||
146314995|NCT01097863|527664577|FG001|Overall Study|Discomfort|0|||
146314996|NCT01097863|527664578|FG002|Overall Study|Discomfort|1|||
146314997|NCT01097863|527664576|FG000|Overall Study|Did not return for final visit|0|||
146314998|NCT01097863|527664577|FG001|Overall Study|Did not return for final visit|0|||
146314999|NCT01097863|527664578|FG002|Overall Study|Did not return for final visit|1|||
146315000|NCT00796315|527664579|FG000|Overall Study|Protocol Violation|0|||
146315001|NCT00796315|527664580|FG001|Overall Study|Protocol Violation|1|||
146315002|NCT00796315|527664581|FG002|Overall Study|Protocol Violation|0|||
146315003|NCT01400451|527664588|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
146315004|NCT01400451|527664589|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
146315005|NCT01400451|527664590|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
146315006|NCT01400451|527664588|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
146315007|NCT01400451|527664589|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
146315008|NCT01400451|527664590|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
146315009|NCT01400451|527664588|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
146315010|NCT01400451|527664589|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
146315011|NCT01400451|527664590|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
146315012|NCT01400451|527664588|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
146315013|NCT01400451|527664589|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
146315014|NCT01400451|527664590|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
146315015|NCT01400451|527664588|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
146315016|NCT01400451|527664589|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
146315017|NCT01400451|527664590|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
146315018|NCT03028870|527664597|FG000|Overall Study|Adverse Event|7|||
146315019|NCT03028870|527664598|FG001|Overall Study|Adverse Event|4|||
146315020|NCT03028870|527664599|FG002|Overall Study|Adverse Event|3|||
146315021|NCT03028870|527664600|FG003|Overall Study|Adverse Event|3|||
146315022|NCT03028870|527664597|FG000|Overall Study|Withdrawal by Subject|1|||
146315023|NCT03028870|527664598|FG001|Overall Study|Withdrawal by Subject|1|||
146315024|NCT03028870|527664599|FG002|Overall Study|Withdrawal by Subject|1|||
146315025|NCT03028870|527664600|FG003|Overall Study|Withdrawal by Subject|2|||
146315026|NCT03028870|527664597|FG000|Overall Study|Lost to Follow-up|1|||
146315027|NCT03028870|527664598|FG001|Overall Study|Lost to Follow-up|0|||
146315028|NCT03028870|527664599|FG002|Overall Study|Lost to Follow-up|0|||
146315029|NCT03028870|527664600|FG003|Overall Study|Lost to Follow-up|0|||
146315030|NCT03028870|527664597|FG000|Overall Study|Lack of Efficacy|3|||
146315031|NCT03028870|527664598|FG001|Overall Study|Lack of Efficacy|0|||
146315032|NCT03028870|527664599|FG002|Overall Study|Lack of Efficacy|0|||
146315033|NCT03028870|527664600|FG003|Overall Study|Lack of Efficacy|0|||
146315034|NCT03028870|527664597|FG000|Overall Study|Administrative|5|||
146315035|NCT03028870|527664598|FG001|Overall Study|Administrative|5|||
146315036|NCT03028870|527664599|FG002|Overall Study|Administrative|12|||
146315037|NCT03028870|527664600|FG003|Overall Study|Administrative|4|||
146315038|NCT01273883|527664603|FG000|First Intervention|Adverse Event|2|||
146315039|NCT01273883|527664604|FG001|First Intervention|Adverse Event|1|||
146315040|NCT01273883|527664603|FG000|Second Intervention|Lost to Follow-up|1|||
146315041|NCT01273883|527664604|FG001|Second Intervention|Lost to Follow-up|1|||
146315042|NCT01273883|527664603|FG000|Second Intervention|Lack of Efficacy|1|||
146315043|NCT01273883|527664604|FG001|Second Intervention|Lack of Efficacy|0|||
146315044|NCT04489888|527664607|FG000|Overall Study|Death|75|||
146315045|NCT04489888|527664607|FG000|Overall Study|Sponsor Decision|26|||
146315046|NCT02043548|527664610|FG000|Overall Study|Lack of Efficacy|1|||
146315047|NCT02043548|527664611|FG001|Overall Study|Lack of Efficacy|0|||
146315048|NCT02043548|527664610|FG000|Overall Study|Adverse Event|0|||
146315049|NCT02043548|527664611|FG001|Overall Study|Adverse Event|1|||
146315050|NCT01430455|527664618|FG000|Overall Study|Withdrawal by Subject|1|||
146315051|NCT01430455|527664618|FG000|Overall Study|Switched to follow-up phase|1|||
146315052|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
146315053|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
146315054|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
146315055|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
146315056|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
146315057|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
146315058|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146315059|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146315060|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146315061|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
146315062|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
146315063|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
146315064|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
146315065|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
146315066|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
146315067|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
146315068|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
146315069|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
146315070|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146315071|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
146315072|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
146315073|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
146315074|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
146315075|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
146315076|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
146315077|NCT03829657|527664622|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
146315078|NCT03829657|527664623|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
146315079|NCT03829657|527664624|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
146315080|NCT03829657|527664625|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
146315081|NCT03829657|527664626|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
146315082|NCT03829657|527664622|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146315083|NCT03829657|527664623|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146315084|NCT03829657|527664624|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146315085|NCT03829657|527664625|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
146315086|NCT03829657|527664626|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
146315087|NCT03829657|527664622|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146315088|NCT03829657|527664623|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146315089|NCT03829657|527664624|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
146315090|NCT03829657|527664625|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
146315091|NCT03829657|527664626|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
146315092|NCT03829657|527664622|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146315093|NCT03829657|527664623|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146315094|NCT03829657|527664624|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
146315095|NCT03829657|527664625|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
146315096|NCT03829657|527664626|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
146315097|NCT03829657|527664622|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146315098|NCT03829657|527664623|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146315099|NCT03829657|527664624|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146315100|NCT03829657|527664625|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
146161875|NCT02462876|527102567|FG000|Overall Study|Patient refused to come back|1|||
146161876|NCT02462876|527102567|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
146281738|NCT02297139|527544724|FG001|Overall Study|Maximum clinical benefit|0|||
146281739|NCT02297139|527544723|FG000|Overall Study|Administrative reason by sponsor|0|||
146281740|NCT02297139|527544724|FG001|Overall Study|Administrative reason by sponsor|2|||
146281741|NCT02297139|527544723|FG000|Overall Study|Other reasons|0|||
146281742|NCT02297139|527544724|FG001|Overall Study|Other reasons|8|||
146281743|NCT01865747|527544725|FG000|Overall Study (ITT)|Adverse Event|32|||
146281744|NCT01865747|527544726|FG001|Overall Study (ITT)|Adverse Event|31|||
146281745|NCT01865747|527544725|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
146281746|NCT01865747|527544726|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
146281747|NCT01865747|527544725|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
146281748|NCT01865747|527544726|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
146281749|NCT01865747|527544725|FG000|Overall Study (ITT)|Protocol Violation|1|||
146281750|NCT01865747|527544726|FG001|Overall Study (ITT)|Protocol Violation|1|||
146281751|NCT01865747|527544725|FG000|Overall Study (ITT)|Physician Decision|5|||
146281752|NCT01865747|527544726|FG001|Overall Study (ITT)|Physician Decision|2|||
146281753|NCT01865747|527544725|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
146281754|NCT01865747|527544726|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
146281755|NCT01865747|527544725|FG000|Overall Study (ITT)|Sponsor Decision|0|||
146281756|NCT01865747|527544726|FG001|Overall Study (ITT)|Sponsor Decision|1|||
146281757|NCT01865747|527544725|FG000|Overall Study (ITT)|Progressive Disease|122|||
146281758|NCT01865747|527544726|FG001|Overall Study (ITT)|Progressive Disease|158|||
146281759|NCT01865747|527544725|FG000|Overall Study (ITT)|Reason Not Provided|0|||
146281760|NCT01865747|527544726|FG001|Overall Study (ITT)|Reason Not Provided|1|||
146281761|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
146281762|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
146281763|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
146281764|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
146281765|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
146281766|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
146281767|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
146281768|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
146281769|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
146281770|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
146281771|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
146281772|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
146281773|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
146281774|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
146281775|NCT01865747|527544725|FG000|Primary Intent to Treat (PITT)|Other|0|||
146281776|NCT01865747|527544726|FG001|Primary Intent to Treat (PITT)|Other|1|||
146281777|NCT03973931|527544727|FG000|Overall Study|Lost to Follow-up|47|||
146281778|NCT03973931|527544728|FG001|Overall Study|Lost to Follow-up|63|||
146281779|NCT03973931|527544729|FG002|Overall Study|Lost to Follow-up|51|||
146281780|NCT03973931|527544730|FG003|Overall Study|Lost to Follow-up|54|||
146281781|NCT03973931|527544727|FG000|Overall Study|opted out|6|||
146281782|NCT03973931|527544728|FG001|Overall Study|opted out|5|||
146281783|NCT03973931|527544729|FG002|Overall Study|opted out|5|||
146281784|NCT03973931|527544730|FG003|Overall Study|opted out|1|||
146281785|NCT02516332|527546377|FG000|Overall Study|Withdrawal by Subject|2|||
146281786|NCT02516332|527546378|FG001|Overall Study|Withdrawal by Subject|1|||
146281787|NCT02516332|527546379|FG002|Overall Study|Withdrawal by Subject|2|||
146281788|NCT03695237|527546380|FG000|Overall Study|Withdrawal by Subject|1|||
146281789|NCT03695237|527546381|FG001|Overall Study|Withdrawal by Subject|3|||
146281790|NCT03695237|527546380|FG000|Overall Study|Lost to Follow-up|1|||
146281791|NCT03695237|527546381|FG001|Overall Study|Lost to Follow-up|2|||
146281792|NCT03695237|527546380|FG000|Overall Study|Other, Not Specified|8|||
146281793|NCT03695237|527546381|FG001|Overall Study|Other, Not Specified|2|||
146281794|NCT03541174|527546384|FG000|Part 1 Double-Blind|Adverse Event|6|||
146281795|NCT03541174|527546385|FG001|Part 1 Double-Blind|Adverse Event|5|||
146281796|NCT03541174|527546386|FG002|Part 1 Double-Blind|Adverse Event|2|||
146281797|NCT03541174|527546387|FG003|Part 1 Double-Blind|Adverse Event|0|||
146281798|NCT03541174|527546388|FG004|Part 1 Double-Blind|Adverse Event|0|||
146281799|NCT03541174|527546389|FG005|Part 1 Double-Blind|Adverse Event|0|||
146161877|NCT02462876|527102567|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
146161878|NCT01786512|527102568|FG000|Overall Study|Lost to Follow-up|0|||
146281800|NCT03541174|527546384|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
146281801|NCT03541174|527546385|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
146281802|NCT03541174|527546386|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
146281803|NCT03541174|527546387|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
146281804|NCT03541174|527546388|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
146281805|NCT03541174|527546389|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
146281806|NCT03541174|527546384|FG000|Part 1 Double-Blind|Other reasons|3|||
146281807|NCT03541174|527546385|FG001|Part 1 Double-Blind|Other reasons|2|||
146161879|NCT01786512|527102569|FG001|Overall Study|Lost to Follow-up|0|||
146161880|NCT01786512|527102570|FG002|Overall Study|Lost to Follow-up|0|||
146161881|NCT01786512|527102571|FG003|Overall Study|Lost to Follow-up|0|||
146281808|NCT03541174|527546386|FG002|Part 1 Double-Blind|Other reasons|3|||
146281809|NCT03541174|527546387|FG003|Part 1 Double-Blind|Other reasons|0|||
146281810|NCT03541174|527546388|FG004|Part 1 Double-Blind|Other reasons|0|||
146281811|NCT03541174|527546389|FG005|Part 1 Double-Blind|Other reasons|0|||
146281812|NCT03541174|527546384|FG000|Part 2 Single-Blind|Adverse Event|0|||
146281813|NCT03541174|527546385|FG001|Part 2 Single-Blind|Adverse Event|0|||
146281814|NCT03541174|527546386|FG002|Part 2 Single-Blind|Adverse Event|0|||
146281815|NCT03541174|527546387|FG003|Part 2 Single-Blind|Adverse Event|25|||
146281816|NCT03541174|527546388|FG004|Part 2 Single-Blind|Adverse Event|0|||
146281817|NCT03541174|527546389|FG005|Part 2 Single-Blind|Adverse Event|0|||
146281818|NCT03541174|527546384|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
146281819|NCT03541174|527546385|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
146281820|NCT03541174|527546386|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
146281821|NCT03541174|527546387|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
146281822|NCT03541174|527546388|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
146281823|NCT03541174|527546389|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
146281824|NCT03541174|527546384|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
146281825|NCT03541174|527546385|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
146281826|NCT03541174|527546386|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
146281827|NCT03541174|527546387|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
146281828|NCT03541174|527546388|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
146281829|NCT03541174|527546389|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
146281830|NCT03541174|527546384|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
146281831|NCT03541174|527546385|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
146281832|NCT03541174|527546386|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
146281833|NCT03541174|527546387|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
146281834|NCT03541174|527546388|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
146281835|NCT03541174|527546389|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
146281836|NCT03541174|527546384|FG000|Part 2 Single-Blind|Death|0|||
146281837|NCT03541174|527546385|FG001|Part 2 Single-Blind|Death|0|||
146281838|NCT03541174|527546386|FG002|Part 2 Single-Blind|Death|0|||
146281839|NCT03541174|527546387|FG003|Part 2 Single-Blind|Death|5|||
146281840|NCT03541174|527546388|FG004|Part 2 Single-Blind|Death|0|||
146281841|NCT03541174|527546389|FG005|Part 2 Single-Blind|Death|0|||
146281842|NCT03541174|527546384|FG000|Part 2 Single-Blind|Pregnancy|0|||
146281843|NCT03541174|527546385|FG001|Part 2 Single-Blind|Pregnancy|0|||
146281844|NCT03541174|527546386|FG002|Part 2 Single-Blind|Pregnancy|0|||
146281845|NCT03541174|527546387|FG003|Part 2 Single-Blind|Pregnancy|1|||
146281846|NCT03541174|527546388|FG004|Part 2 Single-Blind|Pregnancy|0|||
146281847|NCT03541174|527546389|FG005|Part 2 Single-Blind|Pregnancy|0|||
146281848|NCT03541174|527546384|FG000|Part 2 Single-Blind|Other reasons|0|||
146281849|NCT03541174|527546385|FG001|Part 2 Single-Blind|Other reasons|0|||
146281850|NCT03541174|527546386|FG002|Part 2 Single-Blind|Other reasons|0|||
146281851|NCT03541174|527546387|FG003|Part 2 Single-Blind|Other reasons|32|||
146281852|NCT03541174|527546388|FG004|Part 2 Single-Blind|Other reasons|0|||
146281853|NCT03541174|527546389|FG005|Part 2 Single-Blind|Other reasons|0|||
146281854|NCT03541174|527546384|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146281855|NCT03541174|527546385|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146281856|NCT03541174|527546386|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146281857|NCT03541174|527546387|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
146281858|NCT03541174|527546388|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
146281859|NCT03541174|527546389|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
146281860|NCT03541174|527546384|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146281861|NCT03541174|527546385|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146281862|NCT03541174|527546386|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146281863|NCT03541174|527546387|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
146281864|NCT03541174|527546388|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
146281865|NCT03541174|527546389|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
146281866|NCT03541174|527546384|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146281867|NCT03541174|527546385|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146281868|NCT03541174|527546386|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146161882|NCT01786512|527102572|FG004|Overall Study|Lost to Follow-up|0|||
146281869|NCT03541174|527546387|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146281870|NCT03541174|527546388|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
146281871|NCT03541174|527546389|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
146281872|NCT03541174|527546384|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
146281873|NCT03541174|527546385|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
146281874|NCT03541174|527546386|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
146281875|NCT03541174|527546387|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
146161883|NCT01786512|527102573|FG005|Overall Study|Lost to Follow-up|0|||
146281876|NCT03541174|527546388|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
146281877|NCT03541174|527546389|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
146281878|NCT03541174|527546384|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146315101|NCT03829657|527664626|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
146161884|NCT01786512|527102574|FG006|Overall Study|Lost to Follow-up|0|||
146161885|NCT01786512|527102575|FG007|Overall Study|Lost to Follow-up|0|||
146161886|NCT01786512|527102576|FG008|Overall Study|Lost to Follow-up|0|||
146315102|NCT04418076|527664628|FG000|Overall Study|Death|1|||
146315103|NCT04418076|527664629|FG001|Overall Study|Death|0|||
146315104|NCT04418076|527664630|FG002|Overall Study|Death|0|||
146315105|NCT04418076|527664631|FG003|Overall Study|Death|0|||
146315106|NCT04418076|527664628|FG000|Overall Study|Lost to Follow-up|2|||
146315107|NCT04418076|527664629|FG001|Overall Study|Lost to Follow-up|5|||
146315108|NCT04418076|527664630|FG002|Overall Study|Lost to Follow-up|1|||
146315109|NCT04418076|527664631|FG003|Overall Study|Lost to Follow-up|2|||
146315110|NCT04418076|527664628|FG000|Overall Study|Withdrawal by Subject|1|||
146315111|NCT04418076|527664629|FG001|Overall Study|Withdrawal by Subject|0|||
146315112|NCT04418076|527664630|FG002|Overall Study|Withdrawal by Subject|1|||
146315113|NCT04418076|527664631|FG003|Overall Study|Withdrawal by Subject|1|||
146315114|NCT04418076|527664628|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
146315115|NCT04418076|527664629|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
146315116|NCT04418076|527664630|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
146315117|NCT04418076|527664631|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
146315118|NCT01425008|527664632|FG000|Dose Escalation Phase|Progressive Disease|2|||
146315119|NCT01425008|527664633|FG001|Dose Escalation Phase|Progressive Disease|3|||
146315120|NCT01425008|527664634|FG002|Dose Escalation Phase|Progressive Disease|2|||
146315121|NCT01425008|527664635|FG003|Dose Escalation Phase|Progressive Disease|3|||
146315122|NCT01425008|527664636|FG004|Dose Escalation Phase|Progressive Disease|5|||
146315123|NCT01425008|527664637|FG005|Dose Escalation Phase|Progressive Disease|4|||
146315124|NCT01425008|527664638|FG006|Dose Escalation Phase|Progressive Disease|0|||
146315125|NCT01425008|527664639|FG007|Dose Escalation Phase|Progressive Disease|2|||
146315126|NCT01425008|527664640|FG008|Dose Escalation Phase|Progressive Disease|6|||
146315127|NCT01425008|527664641|FG009|Dose Escalation Phase|Progressive Disease|2|||
146315128|NCT01425008|527664642|FG010|Dose Escalation Phase|Progressive Disease|0|||
146315129|NCT01425008|527664643|FG011|Dose Escalation Phase|Progressive Disease|0|||
146315130|NCT01425008|527664644|FG012|Dose Escalation Phase|Progressive Disease|0|||
146315131|NCT01425008|527664645|FG013|Dose Escalation Phase|Progressive Disease|0|||
146315132|NCT01425008|527664646|FG014|Dose Escalation Phase|Progressive Disease|0|||
146315133|NCT01425008|527664647|FG015|Dose Escalation Phase|Progressive Disease|0|||
146315134|NCT01425008|527664648|FG016|Dose Escalation Phase|Progressive Disease|0|||
146315135|NCT01425008|527664649|FG017|Dose Escalation Phase|Progressive Disease|0|||
146315136|NCT01425008|527664650|FG018|Dose Escalation Phase|Progressive Disease|0|||
146315137|NCT01425008|527664632|FG000|Dose Escalation Phase|Adverse Event|2|||
146315138|NCT01425008|527664633|FG001|Dose Escalation Phase|Adverse Event|0|||
146315139|NCT01425008|527664634|FG002|Dose Escalation Phase|Adverse Event|0|||
146315140|NCT01425008|527664635|FG003|Dose Escalation Phase|Adverse Event|0|||
146315141|NCT01425008|527664636|FG004|Dose Escalation Phase|Adverse Event|0|||
146315142|NCT01425008|527664637|FG005|Dose Escalation Phase|Adverse Event|2|||
146315143|NCT01425008|527664638|FG006|Dose Escalation Phase|Adverse Event|0|||
146315144|NCT01425008|527664639|FG007|Dose Escalation Phase|Adverse Event|0|||
146315145|NCT01425008|527664640|FG008|Dose Escalation Phase|Adverse Event|2|||
146315146|NCT01425008|527664641|FG009|Dose Escalation Phase|Adverse Event|0|||
146315147|NCT01425008|527664642|FG010|Dose Escalation Phase|Adverse Event|0|||
146315148|NCT01425008|527664643|FG011|Dose Escalation Phase|Adverse Event|0|||
146315149|NCT01425008|527664644|FG012|Dose Escalation Phase|Adverse Event|0|||
146315150|NCT01425008|527664645|FG013|Dose Escalation Phase|Adverse Event|0|||
146161887|NCT01786512|527102577|FG009|Overall Study|Lost to Follow-up|1|||
146161888|NCT01786512|527102578|FG010|Overall Study|Lost to Follow-up|0|||
146161889|NCT01786512|527102568|FG000|Overall Study|Decision by sponsor|0|||
146161890|NCT01786512|527102569|FG001|Overall Study|Decision by sponsor|0|||
146161891|NCT01786512|527102570|FG002|Overall Study|Decision by sponsor|0|||
146161892|NCT01786512|527102571|FG003|Overall Study|Decision by sponsor|0|||
146161893|NCT01786512|527102572|FG004|Overall Study|Decision by sponsor|0|||
146161894|NCT01786512|527102573|FG005|Overall Study|Decision by sponsor|0|||
146161895|NCT01786512|527102574|FG006|Overall Study|Decision by sponsor|0|||
146161896|NCT01786512|527102575|FG007|Overall Study|Decision by sponsor|0|||
146315151|NCT01425008|527664646|FG014|Dose Escalation Phase|Adverse Event|0|||
146315152|NCT01425008|527664647|FG015|Dose Escalation Phase|Adverse Event|0|||
146315153|NCT01425008|527664648|FG016|Dose Escalation Phase|Adverse Event|0|||
146161897|NCT01786512|527102576|FG008|Overall Study|Decision by sponsor|0|||
146161898|NCT01786512|527102577|FG009|Overall Study|Decision by sponsor|0|||
146315154|NCT01425008|527664649|FG017|Dose Escalation Phase|Adverse Event|0|||
146315155|NCT01425008|527664650|FG018|Dose Escalation Phase|Adverse Event|0|||
146315156|NCT01425008|527664632|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315157|NCT01425008|527664633|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315158|NCT01425008|527664634|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315159|NCT01425008|527664635|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315160|NCT01425008|527664636|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146315161|NCT01425008|527664637|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315162|NCT01425008|527664638|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
146315163|NCT01425008|527664639|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146315164|NCT01425008|527664640|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146315165|NCT01425008|527664641|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315166|NCT01425008|527664642|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315167|NCT01425008|527664643|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315168|NCT01425008|527664644|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315169|NCT01425008|527664645|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315170|NCT01425008|527664646|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315171|NCT01425008|527664647|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315172|NCT01425008|527664648|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315173|NCT01425008|527664649|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315174|NCT01425008|527664650|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146315175|NCT01425008|527664632|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146315176|NCT01425008|527664633|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146315177|NCT01425008|527664634|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146315178|NCT01425008|527664635|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146315179|NCT01425008|527664636|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
146315180|NCT01425008|527664637|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
146315181|NCT01425008|527664638|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
146315182|NCT01425008|527664639|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
146315183|NCT01425008|527664640|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
146315184|NCT01425008|527664641|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
146315185|NCT01425008|527664642|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
146315186|NCT01425008|527664643|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
146315187|NCT01425008|527664644|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
146315188|NCT01425008|527664645|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
146315189|NCT01425008|527664646|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
146315190|NCT01425008|527664647|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
146315191|NCT01425008|527664648|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
146315192|NCT01425008|527664649|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
146315193|NCT01425008|527664650|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
146315194|NCT01425008|527664632|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315195|NCT01425008|527664633|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315196|NCT01425008|527664634|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
146315197|NCT01425008|527664635|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
146161899|NCT01786512|527102578|FG010|Overall Study|Decision by sponsor|2|||
146315198|NCT01425008|527664636|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315199|NCT01425008|527664637|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315200|NCT01425008|527664638|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315201|NCT01425008|527664639|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315202|NCT01425008|527664640|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
146315203|NCT01425008|527664641|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
146315204|NCT01425008|527664642|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315205|NCT01425008|527664643|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315206|NCT01425008|527664644|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315207|NCT01425008|527664645|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315208|NCT01425008|527664646|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315209|NCT01425008|527664647|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
146161900|NCT01786512|527102568|FG000|Overall Study|Withdrawal by Subject|0|||
146161901|NCT01786512|527102569|FG001|Overall Study|Withdrawal by Subject|1|||
146161902|NCT01786512|527102570|FG002|Overall Study|Withdrawal by Subject|0|||
146161903|NCT01786512|527102571|FG003|Overall Study|Withdrawal by Subject|0|||
146161904|NCT01786512|527102572|FG004|Overall Study|Withdrawal by Subject|0|||
146161905|NCT01786512|527102573|FG005|Overall Study|Withdrawal by Subject|0|||
146161906|NCT01786512|527102574|FG006|Overall Study|Withdrawal by Subject|1|||
146161907|NCT01786512|527102575|FG007|Overall Study|Withdrawal by Subject|0|||
146161908|NCT01786512|527102576|FG008|Overall Study|Withdrawal by Subject|0|||
146161909|NCT01786512|527102577|FG009|Overall Study|Withdrawal by Subject|3|||
146161910|NCT01786512|527102578|FG010|Overall Study|Withdrawal by Subject|7|||
146161911|NCT01786512|527102568|FG000|Overall Study|Death|0|||
146161912|NCT01786512|527102569|FG001|Overall Study|Death|0|||
146161913|NCT01786512|527102570|FG002|Overall Study|Death|0|||
146315210|NCT01425008|527664648|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315211|NCT01425008|527664649|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315212|NCT01425008|527664650|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
146315213|NCT01425008|527664632|FG000|Dose Escalation Phase|Other|0|||
146315214|NCT01425008|527664633|FG001|Dose Escalation Phase|Other|0|||
146161914|NCT01786512|527102571|FG003|Overall Study|Death|0|||
146161915|NCT01786512|527102572|FG004|Overall Study|Death|0|||
146315215|NCT01425008|527664634|FG002|Dose Escalation Phase|Other|0|||
146315216|NCT01425008|527664635|FG003|Dose Escalation Phase|Other|0|||
146315217|NCT01425008|527664636|FG004|Dose Escalation Phase|Other|0|||
146315218|NCT01425008|527664637|FG005|Dose Escalation Phase|Other|0|||
146315219|NCT01425008|527664638|FG006|Dose Escalation Phase|Other|0|||
146315220|NCT01425008|527664639|FG007|Dose Escalation Phase|Other|0|||
146315221|NCT01425008|527664640|FG008|Dose Escalation Phase|Other|1|||
146315222|NCT01425008|527664641|FG009|Dose Escalation Phase|Other|0|||
146315223|NCT01425008|527664642|FG010|Dose Escalation Phase|Other|0|||
146315224|NCT01425008|527664643|FG011|Dose Escalation Phase|Other|0|||
146315225|NCT01425008|527664644|FG012|Dose Escalation Phase|Other|0|||
146315226|NCT01425008|527664645|FG013|Dose Escalation Phase|Other|0|||
146315227|NCT01425008|527664646|FG014|Dose Escalation Phase|Other|0|||
146315228|NCT01425008|527664647|FG015|Dose Escalation Phase|Other|0|||
146315229|NCT01425008|527664648|FG016|Dose Escalation Phase|Other|0|||
146315230|NCT01425008|527664649|FG017|Dose Escalation Phase|Other|0|||
146315231|NCT01425008|527664650|FG018|Dose Escalation Phase|Other|0|||
146315232|NCT01425008|527664632|FG000|Dose Expansion Phase|Progressive Disease|0|||
146315233|NCT01425008|527664633|FG001|Dose Expansion Phase|Progressive Disease|0|||
146315234|NCT01425008|527664634|FG002|Dose Expansion Phase|Progressive Disease|0|||
146315235|NCT01425008|527664635|FG003|Dose Expansion Phase|Progressive Disease|0|||
146315236|NCT01425008|527664636|FG004|Dose Expansion Phase|Progressive Disease|0|||
146315237|NCT01425008|527664637|FG005|Dose Expansion Phase|Progressive Disease|0|||
146315238|NCT01425008|527664638|FG006|Dose Expansion Phase|Progressive Disease|0|||
146315239|NCT01425008|527664639|FG007|Dose Expansion Phase|Progressive Disease|0|||
146315240|NCT01425008|527664640|FG008|Dose Expansion Phase|Progressive Disease|0|||
146315241|NCT01425008|527664641|FG009|Dose Expansion Phase|Progressive Disease|0|||
146315242|NCT01425008|527664642|FG010|Dose Expansion Phase|Progressive Disease|10|||
146315243|NCT01425008|527664643|FG011|Dose Expansion Phase|Progressive Disease|4|||
146315244|NCT01425008|527664644|FG012|Dose Expansion Phase|Progressive Disease|12|||
146315245|NCT01425008|527664645|FG013|Dose Expansion Phase|Progressive Disease|1|||
146315246|NCT01425008|527664646|FG014|Dose Expansion Phase|Progressive Disease|5|||
146315247|NCT01425008|527664647|FG015|Dose Expansion Phase|Progressive Disease|8|||
146315248|NCT01425008|527664648|FG016|Dose Expansion Phase|Progressive Disease|9|||
146315249|NCT01425008|527664649|FG017|Dose Expansion Phase|Progressive Disease|2|||
146315250|NCT01425008|527664650|FG018|Dose Expansion Phase|Progressive Disease|10|||
146315251|NCT01425008|527664632|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
146315252|NCT01425008|527664633|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
146315253|NCT01425008|527664634|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
146315254|NCT01425008|527664635|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
146315255|NCT01425008|527664636|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
146315256|NCT01425008|527664637|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
146315257|NCT01425008|527664638|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
146315258|NCT01425008|527664639|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
146315259|NCT01425008|527664640|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
146315260|NCT01425008|527664641|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
146161916|NCT01786512|527102573|FG005|Overall Study|Death|0|||
146161917|NCT01786512|527102574|FG006|Overall Study|Death|0|||
146161918|NCT01786512|527102575|FG007|Overall Study|Death|0|||
146161919|NCT01786512|527102576|FG008|Overall Study|Death|4|||
146161920|NCT01786512|527102577|FG009|Overall Study|Death|1|||
146161921|NCT01786512|527102578|FG010|Overall Study|Death|3|||
146161922|NCT02450331|527102579|FG000|Overall Study|Death|162|||
146161923|NCT02450331|527102580|FG001|Overall Study|Death|171|||
146315261|NCT01425008|527664642|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
146315262|NCT01425008|527664643|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
146315263|NCT01425008|527664644|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
146315264|NCT01425008|527664645|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
146315265|NCT01425008|527664646|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
146315266|NCT01425008|527664647|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
146315267|NCT01425008|527664648|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
146161924|NCT02450331|527102579|FG000|Overall Study|Lost to Follow-up|14|||
146161925|NCT02450331|527102580|FG001|Overall Study|Lost to Follow-up|12|||
146161926|NCT02450331|527102579|FG000|Overall Study|Withdrawal by Subject|55|||
146161927|NCT02450331|527102580|FG001|Overall Study|Withdrawal by Subject|44|||
146315268|NCT01425008|527664649|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
146315269|NCT01425008|527664650|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
146315270|NCT01425008|527664632|FG000|Dose Expansion Phase|Other|0|||
146315271|NCT01425008|527664633|FG001|Dose Expansion Phase|Other|0|||
146315272|NCT01425008|527664634|FG002|Dose Expansion Phase|Other|0|||
146315273|NCT01425008|527664635|FG003|Dose Expansion Phase|Other|0|||
146315274|NCT01425008|527664636|FG004|Dose Expansion Phase|Other|0|||
146161928|NCT02450331|527102579|FG000|Overall Study|Non-specified other|1|||
146161929|NCT02450331|527102580|FG001|Overall Study|Non-specified other|1|||
146315275|NCT01425008|527664637|FG005|Dose Expansion Phase|Other|0|||
146315276|NCT01425008|527664638|FG006|Dose Expansion Phase|Other|0|||
146161930|NCT03581981|527102581|FG000|Overall Study|Withdrawal by Subject|12|||
146161931|NCT03581981|527102582|FG001|Overall Study|Withdrawal by Subject|13|||
146161932|NCT03581981|527102581|FG000|Overall Study|Physician Decision|1|||
146161933|NCT03581981|527102582|FG001|Overall Study|Physician Decision|2|||
146161934|NCT03581981|527102581|FG000|Overall Study|Lost to Follow-up|0|||
146161935|NCT03581981|527102582|FG001|Overall Study|Lost to Follow-up|4|||
146161936|NCT03342638|527102589|FG000|Overall Study|Withdrawal by Subject|1|||
146161937|NCT03342638|527102590|FG001|Overall Study|Withdrawal by Subject|0|||
146161938|NCT03342638|527102589|FG000|Overall Study|Physician Decision|0|||
146281879|NCT03541174|527546385|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146281880|NCT03541174|527546386|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146281881|NCT03541174|527546387|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146281882|NCT03541174|527546388|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
146281883|NCT03541174|527546389|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
146281884|NCT00605215|527546390|FG000|Overall Study|Death|0|||
146281885|NCT00605215|527546391|FG001|Overall Study|Death|0|||
146281886|NCT00605215|527546392|FG002|Overall Study|Death|1|||
146281887|NCT00605215|527546390|FG000|Overall Study|Adverse Event|19|||
146281888|NCT00605215|527546391|FG001|Overall Study|Adverse Event|21|||
146281889|NCT00605215|527546392|FG002|Overall Study|Adverse Event|26|||
146281890|NCT00605215|527546390|FG000|Overall Study|Refusal to sign the re-consent form|8|||
146281891|NCT00605215|527546391|FG001|Overall Study|Refusal to sign the re-consent form|3|||
146281892|NCT00605215|527546392|FG002|Overall Study|Refusal to sign the re-consent form|3|||
146281893|NCT00605215|527546390|FG000|Overall Study|Withdrawal by Subject|39|||
146281894|NCT00605215|527546391|FG001|Overall Study|Withdrawal by Subject|37|||
146281895|NCT00605215|527546392|FG002|Overall Study|Withdrawal by Subject|27|||
146281896|NCT00605215|527546390|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
146281897|NCT00605215|527546391|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
146281898|NCT00605215|527546392|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
146281899|NCT00605215|527546390|FG000|Overall Study|Protocol Violation|3|||
146281900|NCT00605215|527546391|FG001|Overall Study|Protocol Violation|4|||
146281901|NCT00605215|527546392|FG002|Overall Study|Protocol Violation|1|||
146281902|NCT00605215|527546390|FG000|Overall Study|Pregnancy|8|||
146281903|NCT00605215|527546391|FG001|Overall Study|Pregnancy|5|||
146281904|NCT00605215|527546392|FG002|Overall Study|Pregnancy|4|||
146281905|NCT00605215|527546390|FG000|Overall Study|Lost to Follow-up|8|||
146281906|NCT00605215|527546391|FG001|Overall Study|Lost to Follow-up|5|||
146281907|NCT00605215|527546392|FG002|Overall Study|Lost to Follow-up|2|||
146281908|NCT00605215|527546390|FG000|Overall Study|Other than specified|0|||
146281909|NCT00605215|527546391|FG001|Overall Study|Other than specified|2|||
146281910|NCT00605215|527546392|FG002|Overall Study|Other than specified|1|||
146281911|NCT01342341|527546393|FG000|Overall Study|Lost to Follow-up|4|||
146281912|NCT01342341|527546394|FG001|Overall Study|Lost to Follow-up|4|||
146281913|NCT01789567|527546395|FG000|Overall Study|Death|6|||
146281914|NCT02914275|527546396|FG000|Overall Study|Lost to Follow-up|84|||
146281915|NCT02914275|527546397|FG001|Overall Study|Lost to Follow-up|29|||
146281916|NCT02914275|527546396|FG000|Overall Study|Withdrawal by Subject|26|||
146281917|NCT02914275|527546397|FG001|Overall Study|Withdrawal by Subject|10|||
146281918|NCT02914275|527546396|FG000|Overall Study|Protocol Violation|1|||
146281919|NCT02914275|527546397|FG001|Overall Study|Protocol Violation|1|||
146281920|NCT02914275|527546396|FG000|Overall Study|Physician Decision|3|||
146281921|NCT02914275|527546397|FG001|Overall Study|Physician Decision|1|||
146281922|NCT02914275|527546396|FG000|Overall Study|Other|4|||
146281923|NCT02914275|527546397|FG001|Overall Study|Other|1|||
146281924|NCT02914275|527546396|FG000|Overall Study|Excluded due to invalid informed consent|3|||
146281925|NCT02914275|527546397|FG001|Overall Study|Excluded due to invalid informed consent|0|||
146281926|NCT01302067|527546402|FG000|Overall Study|Death|0|||
146281927|NCT01302067|527546403|FG001|Overall Study|Death|0|||
146281928|NCT01302067|527546404|FG002|Overall Study|Death|1|||
146281929|NCT01302067|527546402|FG000|Overall Study|Physician Decision|9|||
146281930|NCT01302067|527546403|FG001|Overall Study|Physician Decision|5|||
146281931|NCT01302067|527546404|FG002|Overall Study|Physician Decision|14|||
146281932|NCT01302067|527546402|FG000|Overall Study|Lack of Efficacy|8|||
146281933|NCT01302067|527546403|FG001|Overall Study|Lack of Efficacy|4|||
146281934|NCT01302067|527546404|FG002|Overall Study|Lack of Efficacy|2|||
146281935|NCT01302067|527546402|FG000|Overall Study|Lost to Follow-up|9|||
146281936|NCT01302067|527546403|FG001|Overall Study|Lost to Follow-up|4|||
146281937|NCT01302067|527546404|FG002|Overall Study|Lost to Follow-up|15|||
146281938|NCT01302067|527546402|FG000|Overall Study|Withdrawal by Subject|13|||
146281939|NCT01302067|527546403|FG001|Overall Study|Withdrawal by Subject|6|||
146281940|NCT01302067|527546404|FG002|Overall Study|Withdrawal by Subject|10|||
146281941|NCT01302067|527546402|FG000|Overall Study|Other|1|||
146161939|NCT03342638|527102590|FG001|Overall Study|Physician Decision|1|||
146161940|NCT02275065|527102592|FG000|Overall Study|Randomized but not treated|1|||
146281942|NCT01302067|527546403|FG001|Overall Study|Other|1|||
146281943|NCT01302067|527546404|FG002|Overall Study|Other|3|||
146281944|NCT01302067|527546402|FG000|Overall Study|Protocol Violation|11|||
146281945|NCT01302067|527546403|FG001|Overall Study|Protocol Violation|0|||
146315277|NCT01425008|527664639|FG007|Dose Expansion Phase|Other|0|||
146315278|NCT01425008|527664640|FG008|Dose Expansion Phase|Other|0|||
146315279|NCT01425008|527664641|FG009|Dose Expansion Phase|Other|0|||
146161941|NCT02275065|527102593|FG001|Overall Study|Randomized but not treated|0|||
146161942|NCT02275065|527102594|FG002|Overall Study|Randomized but not treated|1|||
146161943|NCT02275065|527102595|FG003|Overall Study|Randomized but not treated|1|||
146161944|NCT02275065|527102596|FG004|Overall Study|Randomized but not treated|0|||
146161945|NCT02012491|527102602|FG000|Overall Study|Lost to Follow-up|1|||
146161946|NCT02012491|527102603|FG001|Overall Study|Lost to Follow-up|0|||
146161947|NCT02012491|527102602|FG000|Overall Study|Protocol Violation|0|||
146161948|NCT02012491|527102603|FG001|Overall Study|Protocol Violation|1|||
146161949|NCT02012491|527102602|FG000|Overall Study|Withdrawal by Subject|1|||
146161950|NCT02012491|527102603|FG001|Overall Study|Withdrawal by Subject|0|||
146315280|NCT01425008|527664642|FG010|Dose Expansion Phase|Other|0|||
146315281|NCT01425008|527664643|FG011|Dose Expansion Phase|Other|0|||
146315282|NCT01425008|527664644|FG012|Dose Expansion Phase|Other|1|||
146315283|NCT01425008|527664645|FG013|Dose Expansion Phase|Other|0|||
146315284|NCT01425008|527664646|FG014|Dose Expansion Phase|Other|0|||
146315285|NCT01425008|527664647|FG015|Dose Expansion Phase|Other|0|||
146315286|NCT01425008|527664648|FG016|Dose Expansion Phase|Other|2|||
146315287|NCT01425008|527664649|FG017|Dose Expansion Phase|Other|0|||
146315288|NCT01425008|527664650|FG018|Dose Expansion Phase|Other|4|||
146315289|NCT01425008|527664632|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315290|NCT01425008|527664633|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315291|NCT01425008|527664634|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315292|NCT01425008|527664635|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315293|NCT01425008|527664636|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315294|NCT01425008|527664637|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315295|NCT01425008|527664638|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315296|NCT01425008|527664639|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315297|NCT01425008|527664640|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315298|NCT01425008|527664641|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315299|NCT01425008|527664642|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
146315300|NCT01425008|527664643|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
146315301|NCT01425008|527664644|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315302|NCT01425008|527664645|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315303|NCT01425008|527664646|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315304|NCT01425008|527664647|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
146315305|NCT01425008|527664648|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
146315306|NCT01425008|527664649|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
146315307|NCT01425008|527664650|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
146315308|NCT01425008|527664632|FG000|Dose Expansion Phase|Adverse Event|0|||
146315309|NCT01425008|527664633|FG001|Dose Expansion Phase|Adverse Event|0|||
146315310|NCT01425008|527664634|FG002|Dose Expansion Phase|Adverse Event|0|||
146315311|NCT01425008|527664635|FG003|Dose Expansion Phase|Adverse Event|0|||
146315312|NCT01425008|527664636|FG004|Dose Expansion Phase|Adverse Event|0|||
146315313|NCT01425008|527664637|FG005|Dose Expansion Phase|Adverse Event|0|||
146315314|NCT01425008|527664638|FG006|Dose Expansion Phase|Adverse Event|0|||
146315315|NCT01425008|527664639|FG007|Dose Expansion Phase|Adverse Event|0|||
146315316|NCT01425008|527664640|FG008|Dose Expansion Phase|Adverse Event|0|||
146315317|NCT01425008|527664641|FG009|Dose Expansion Phase|Adverse Event|0|||
146315318|NCT01425008|527664642|FG010|Dose Expansion Phase|Adverse Event|2|||
146315319|NCT01425008|527664643|FG011|Dose Expansion Phase|Adverse Event|3|||
146315320|NCT01425008|527664644|FG012|Dose Expansion Phase|Adverse Event|3|||
146315321|NCT01425008|527664645|FG013|Dose Expansion Phase|Adverse Event|0|||
146315322|NCT01425008|527664646|FG014|Dose Expansion Phase|Adverse Event|1|||
146315323|NCT01425008|527664647|FG015|Dose Expansion Phase|Adverse Event|1|||
146315324|NCT01425008|527664648|FG016|Dose Expansion Phase|Adverse Event|5|||
146315325|NCT01425008|527664649|FG017|Dose Expansion Phase|Adverse Event|0|||
146315326|NCT01425008|527664650|FG018|Dose Expansion Phase|Adverse Event|3|||
146315327|NCT01425008|527664632|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
146315328|NCT01425008|527664633|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
146315329|NCT01425008|527664634|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
146161951|NCT05608629|527102614|FG000|Overall Study|Lost to Follow-up|2|||
146315330|NCT01425008|527664635|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
146315331|NCT01425008|527664636|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
146315332|NCT01425008|527664637|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
146315333|NCT01425008|527664638|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
146315334|NCT01425008|527664639|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
146161952|NCT03969719|527102615|FG000|Overall Study|Other reasons not specified|1|||
146315335|NCT01425008|527664640|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
146315336|NCT01425008|527664641|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
146315337|NCT01425008|527664642|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
146315338|NCT01425008|527664643|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
146315339|NCT01425008|527664644|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
146315340|NCT01425008|527664645|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
146315341|NCT01425008|527664646|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
146315342|NCT01425008|527664647|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
146315343|NCT01425008|527664648|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
146315344|NCT01425008|527664649|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
146315345|NCT01425008|527664650|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
146315346|NCT01425008|527664632|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315347|NCT01425008|527664633|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315348|NCT01425008|527664634|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315349|NCT01425008|527664635|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146161953|NCT03969719|527102616|FG001|Overall Study|Other reasons not specified|1|||
146161954|NCT03969719|527102617|FG002|Overall Study|Other reasons not specified|3|||
146161955|NCT03969719|527102615|FG000|Overall Study|Withdrawal by Subject|2|||
146161956|NCT03969719|527102616|FG001|Overall Study|Withdrawal by Subject|3|||
146161957|NCT03969719|527102617|FG002|Overall Study|Withdrawal by Subject|2|||
146161958|NCT03969719|527102615|FG000|Overall Study|Protocol Violation|1|||
146315350|NCT01425008|527664636|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315351|NCT01425008|527664637|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315352|NCT01425008|527664638|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315353|NCT01425008|527664639|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315354|NCT01425008|527664640|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315355|NCT01425008|527664641|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315356|NCT01425008|527664642|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315357|NCT01425008|527664643|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315358|NCT01425008|527664644|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315359|NCT01425008|527664645|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315360|NCT01425008|527664646|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315361|NCT01425008|527664647|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146161959|NCT03969719|527102616|FG001|Overall Study|Protocol Violation|2|||
146161960|NCT03969719|527102617|FG002|Overall Study|Protocol Violation|0|||
146161961|NCT03969719|527102615|FG000|Overall Study|Adverse Event|0|||
146161962|NCT03969719|527102616|FG001|Overall Study|Adverse Event|2|||
146161963|NCT03969719|527102617|FG002|Overall Study|Adverse Event|0|||
146161964|NCT03969719|527102615|FG000|Overall Study|Lost to Follow-up|0|||
146315362|NCT01425008|527664648|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315363|NCT01425008|527664649|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146315364|NCT01425008|527664650|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
146315365|NCT00264238|527664651|FG000|Overall Study|Protocol Violation|1|||
146161965|NCT03969719|527102616|FG001|Overall Study|Lost to Follow-up|1|||
146161966|NCT03969719|527102617|FG002|Overall Study|Lost to Follow-up|0|||
146161967|NCT02130193|527102618|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
146161968|NCT02130193|527102619|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
146315366|NCT00562588|527664654|FG000|Overall Study|Adverse Event|40|||
146315367|NCT00562588|527664655|FG001|Overall Study|Adverse Event|58|||
146315368|NCT00562588|527664654|FG000|Overall Study|Protocol Violation|30|||
146315369|NCT00562588|527664655|FG001|Overall Study|Protocol Violation|26|||
146315370|NCT00562588|527664654|FG000|Overall Study|Lost to Follow-up|12|||
146315371|NCT00562588|527664655|FG001|Overall Study|Lost to Follow-up|4|||
146315372|NCT00562588|527664654|FG000|Overall Study|Withdrawal by Subject|10|||
146315373|NCT00562588|527664655|FG001|Overall Study|Withdrawal by Subject|9|||
146315374|NCT00562588|527664654|FG000|Overall Study|Other|0|||
146315375|NCT00562588|527664655|FG001|Overall Study|Other|2|||
146315376|NCT01452152|527664656|FG000|Overall Study|Study termination by sponsor|5|||
146315377|NCT01452152|527664657|FG001|Overall Study|Study termination by sponsor|0|||
146315378|NCT01452152|527664658|FG002|Overall Study|Study termination by sponsor|4|||
146315379|NCT02867995|527664661|FG000|Overall Study|Withdrawal by Subject|0|||
146315380|NCT02867995|527664662|FG001|Overall Study|Withdrawal by Subject|1|||
146161969|NCT02130193|527102620|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
146161970|NCT02130193|527102618|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
146161971|NCT02130193|527102619|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
146315381|NCT02867995|527664661|FG000|Overall Study|Lost to Follow-up|0|||
146315382|NCT02867995|527664662|FG001|Overall Study|Lost to Follow-up|2|||
146315383|NCT03368170|527665995|FG000|Overall Study|Adverse Event|2|||
146315384|NCT03368170|527665996|FG001|Overall Study|Adverse Event|1|||
146315385|NCT02164981|527666000|FG000|Started|Withdrawal by Subject|2|||
146315386|NCT02164981|527666001|FG001|Started|Withdrawal by Subject|1|||
146315387|NCT02164981|527666002|FG002|Started|Withdrawal by Subject|0|||
146315388|NCT02164981|527666000|FG000|Started|Protocol Violation|2|||
146315389|NCT02164981|527666001|FG001|Started|Protocol Violation|0|||
146315390|NCT02164981|527666002|FG002|Started|Protocol Violation|0|||
146315391|NCT02164981|527666000|FG000|Started|Adverse Event|1|||
146315392|NCT02164981|527666001|FG001|Started|Adverse Event|2|||
146161972|NCT02130193|527102620|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
146161973|NCT02130193|527102618|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
146161974|NCT02130193|527102619|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
146161975|NCT02130193|527102620|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
146161976|NCT02130193|527102618|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
146161977|NCT02130193|527102619|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
146161978|NCT02130193|527102620|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
146281946|NCT01302067|527546404|FG002|Overall Study|Protocol Violation|8|||
146281947|NCT01302067|527546402|FG000|Overall Study|Adverse Event|27|||
146281948|NCT01302067|527546403|FG001|Overall Study|Adverse Event|14|||
146281949|NCT01302067|527546404|FG002|Overall Study|Adverse Event|45|||
146281950|NCT02738203|527546406|FG000|Overall Study|Failed IUD Insertion|2|||
146281951|NCT02738203|527546407|FG001|Overall Study|Failed IUD Insertion|2|||
146281952|NCT02738203|527546406|FG000|Overall Study|Protocol Violation|0|||
146281953|NCT02738203|527546407|FG001|Overall Study|Protocol Violation|1|||
146281954|NCT00266227|527546408|FG000|Initial Treatment|Adverse Event|0|||
146281955|NCT00266227|527546409|FG001|Initial Treatment|Adverse Event|0|||
146281956|NCT00266227|527546410|FG002|Initial Treatment|Adverse Event|13|||
146281957|NCT00266227|527546408|FG000|Initial Treatment|Lost to Follow-up|0|||
146281958|NCT00266227|527546409|FG001|Initial Treatment|Lost to Follow-up|0|||
146281959|NCT00266227|527546410|FG002|Initial Treatment|Lost to Follow-up|6|||
146281960|NCT00266227|527546408|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
146281961|NCT00266227|527546409|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
146281962|NCT00266227|527546410|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
146281963|NCT00266227|527546408|FG000|Initial Treatment|Physician decision to withdraw|0|||
146281964|NCT00266227|527546409|FG001|Initial Treatment|Physician decision to withdraw|0|||
146281965|NCT00266227|527546410|FG002|Initial Treatment|Physician decision to withdraw|12|||
146281966|NCT00266227|527546408|FG000|Initial Treatment|Pregnancy|0|||
146281967|NCT00266227|527546409|FG001|Initial Treatment|Pregnancy|0|||
146281968|NCT00266227|527546410|FG002|Initial Treatment|Pregnancy|1|||
146281969|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Death|1|||
146281970|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Death|0|||
146281971|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Death|0|||
146281972|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
146281973|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
146281974|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
146281975|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
146281976|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
146281977|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
146281978|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
146281979|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
146281980|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
146281981|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
146281982|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
146281983|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
146281984|NCT00266227|527546408|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
146281985|NCT00266227|527546409|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
146281986|NCT00266227|527546410|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
146281987|NCT00266227|527546408|FG000|Retreatment: Week 48 to Week 72|Death|1|||
146281988|NCT00266227|527546409|FG001|Retreatment: Week 48 to Week 72|Death|1|||
146281989|NCT00266227|527546410|FG002|Retreatment: Week 48 to Week 72|Death|0|||
146281990|NCT00266227|527546408|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
146281991|NCT00266227|527546409|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
146281992|NCT00266227|527546410|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
146281993|NCT00266227|527546408|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
146281994|NCT00266227|527546409|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
146281995|NCT00266227|527546410|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
146281996|NCT00266227|527546408|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
146281997|NCT00266227|527546409|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
146281998|NCT00266227|527546410|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
146281999|NCT00266227|527546408|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
146282000|NCT00266227|527546409|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
146282001|NCT00266227|527546410|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
146282002|NCT03241927|527546411|FG000|Overall Study|study terminated|1|||
146282003|NCT03241927|527546412|FG001|Overall Study|study terminated|0|||
146282004|NCT01198756|527546413|FG000|Overall Study|Adverse Event|0|||
146282005|NCT01198756|527546414|FG001|Overall Study|Adverse Event|0|||
146282006|NCT01198756|527546415|FG002|Overall Study|Adverse Event|0|||
146282007|NCT01198756|527546416|FG003|Overall Study|Adverse Event|1|||
146282008|NCT01198756|527546413|FG000|Overall Study|Protocol Violation|0|||
146282009|NCT01198756|527546414|FG001|Overall Study|Protocol Violation|0|||
146282010|NCT01198756|527546415|FG002|Overall Study|Protocol Violation|0|||
146282011|NCT01198756|527546416|FG003|Overall Study|Protocol Violation|2|||
146282012|NCT01198756|527546413|FG000|Overall Study|Withdrawal by Subject|9|||
146315393|NCT02164981|527666002|FG002|Started|Adverse Event|0|||
146315394|NCT02164981|527666000|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
146315395|NCT02164981|527666001|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
146315396|NCT02164981|527666002|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
146315397|NCT02164981|527666000|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
146315398|NCT02164981|527666001|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
146315399|NCT02164981|527666002|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
146315400|NCT02164981|527666000|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
146315401|NCT02164981|527666001|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
146315402|NCT02164981|527666002|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
146315403|NCT01736579|527666003|FG000|Overall Study|Termination of Study by Sponsor|2|||
146315404|NCT01736579|527666004|FG001|Overall Study|Termination of Study by Sponsor|2|||
146315405|NCT02543528|527666016|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146315406|NCT02543528|527666017|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146315407|NCT02543528|527666018|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146315408|NCT02543528|527666019|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
146315409|NCT02543528|527666020|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
146315410|NCT02543528|527666016|FG000|Adaptation Period|Lens Handling Difficultes|0|||
146315411|NCT02543528|527666017|FG001|Adaptation Period|Lens Handling Difficultes|0|||
146315412|NCT02543528|527666018|FG002|Adaptation Period|Lens Handling Difficultes|0|||
146315413|NCT02543528|527666019|FG003|Adaptation Period|Lens Handling Difficultes|0|||
146315414|NCT02543528|527666020|FG004|Adaptation Period|Lens Handling Difficultes|8|||
146315415|NCT02543528|527666016|FG000|Adaptation Period|Lost to Follow-up|0|||
146315416|NCT02543528|527666017|FG001|Adaptation Period|Lost to Follow-up|0|||
146315417|NCT02543528|527666018|FG002|Adaptation Period|Lost to Follow-up|0|||
146315418|NCT02543528|527666019|FG003|Adaptation Period|Lost to Follow-up|0|||
146315419|NCT02543528|527666020|FG004|Adaptation Period|Lost to Follow-up|14|||
146315420|NCT02543528|527666016|FG000|Adaptation Period|Adverse Event|0|||
146315421|NCT02543528|527666017|FG001|Adaptation Period|Adverse Event|0|||
146315422|NCT02543528|527666018|FG002|Adaptation Period|Adverse Event|0|||
146315423|NCT02543528|527666019|FG003|Adaptation Period|Adverse Event|0|||
146315424|NCT02543528|527666020|FG004|Adaptation Period|Adverse Event|2|||
146315425|NCT02543528|527666016|FG000|Extended Wear Period|Adverse Event|17|||
146315426|NCT02543528|527666017|FG001|Extended Wear Period|Adverse Event|11|||
146315427|NCT02543528|527666018|FG002|Extended Wear Period|Adverse Event|16|||
146315428|NCT02543528|527666019|FG003|Extended Wear Period|Adverse Event|3|||
146315429|NCT02543528|527666020|FG004|Extended Wear Period|Adverse Event|0|||
146315430|NCT02543528|527666016|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
146315431|NCT02543528|527666017|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
146315432|NCT02543528|527666018|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
146315433|NCT02543528|527666019|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
146315434|NCT02543528|527666020|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
146315435|NCT02543528|527666016|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
146161979|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
146161980|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
146161981|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
146161982|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161983|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161984|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161985|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161986|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161987|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146161988|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
146161989|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
146161990|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
146161991|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161992|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161993|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161994|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161995|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161996|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146161997|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
146315436|NCT02543528|527666017|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146161998|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146315437|NCT02543528|527666018|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146315438|NCT02543528|527666019|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146315439|NCT02543528|527666020|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
146315440|NCT02543528|527666016|FG000|Extended Wear Period|Lost to Follow-up|0|||
146315441|NCT02543528|527666017|FG001|Extended Wear Period|Lost to Follow-up|1|||
146315442|NCT02543528|527666018|FG002|Extended Wear Period|Lost to Follow-up|2|||
146161999|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
146162000|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146282013|NCT01198756|527546414|FG001|Overall Study|Withdrawal by Subject|4|||
146282014|NCT01198756|527546415|FG002|Overall Study|Withdrawal by Subject|7|||
146282015|NCT01198756|527546416|FG003|Overall Study|Withdrawal by Subject|5|||
146282016|NCT01198756|527546413|FG000|Overall Study|Lost to Follow-up|29|||
146282017|NCT01198756|527546414|FG001|Overall Study|Lost to Follow-up|36|||
146282018|NCT01198756|527546415|FG002|Overall Study|Lost to Follow-up|23|||
146282019|NCT01198756|527546416|FG003|Overall Study|Lost to Follow-up|18|||
146282020|NCT02915302|527546419|FG000|Overall Study|Adverse Event|3|||
146282021|NCT02915302|527546420|FG001|Overall Study|Adverse Event|0|||
146282022|NCT02915302|527546419|FG000|Overall Study|Protocol Violation|20|||
146282023|NCT02915302|527546420|FG001|Overall Study|Protocol Violation|27|||
146282024|NCT02915302|527546419|FG000|Overall Study|Lost to Follow-up|19|||
146282025|NCT02915302|527546420|FG001|Overall Study|Lost to Follow-up|22|||
146282026|NCT02915302|527546419|FG000|Overall Study|Withdrawal by Subject|22|||
146282027|NCT02915302|527546420|FG001|Overall Study|Withdrawal by Subject|29|||
146282028|NCT02915302|527546419|FG000|Overall Study|Other|1|||
146282029|NCT02915302|527546420|FG001|Overall Study|Other|0|||
146282030|NCT04343872|527546424|FG000|Overall Study|Lost to Follow-up|6|||
146282031|NCT04343872|527546425|FG001|Overall Study|Lost to Follow-up|3|||
146282032|NCT01850446|527546426|FG000|Overall Study|Lack of Efficacy|1|||
146282033|NCT01850446|527546427|FG001|Overall Study|Lack of Efficacy|0|||
146282034|NCT01850446|527546426|FG000|Overall Study|Withdrawal by Subject|4|||
146282035|NCT01850446|527546427|FG001|Overall Study|Withdrawal by Subject|0|||
146282036|NCT01850446|527546426|FG000|Overall Study|Protocol Violation|0|||
146282037|NCT01850446|527546427|FG001|Overall Study|Protocol Violation|2|||
146282038|NCT01290315|527546428|FG000|Overall Study|Adverse Event|0|||
146282039|NCT01290315|527546429|FG001|Overall Study|Adverse Event|0|||
146282040|NCT01290315|527546430|FG002|Overall Study|Adverse Event|0|||
146282041|NCT01290315|527546431|FG003|Overall Study|Adverse Event|3|||
146282042|NCT01290315|527546428|FG000|Overall Study|Selection criteria/compliance|2|||
146282043|NCT01290315|527546429|FG001|Overall Study|Selection criteria/compliance|1|||
146282044|NCT01290315|527546430|FG002|Overall Study|Selection criteria/compliance|0|||
146282045|NCT01290315|527546431|FG003|Overall Study|Selection criteria/compliance|2|||
146282046|NCT01290315|527546428|FG000|Overall Study|Lost to Follow-up|0|||
146282047|NCT01290315|527546429|FG001|Overall Study|Lost to Follow-up|1|||
146282048|NCT01290315|527546430|FG002|Overall Study|Lost to Follow-up|0|||
146282049|NCT01290315|527546431|FG003|Overall Study|Lost to Follow-up|0|||
146282050|NCT01290315|527546428|FG000|Overall Study|Withdrawal by Subject|1|||
146282051|NCT01290315|527546429|FG001|Overall Study|Withdrawal by Subject|1|||
146282052|NCT01290315|527546430|FG002|Overall Study|Withdrawal by Subject|0|||
146282053|NCT01290315|527546431|FG003|Overall Study|Withdrawal by Subject|0|||
146282054|NCT00621777|527546433|FG000|Open Phase|Adverse Event|20|||
146282055|NCT00621777|527546434|FG001|Open Phase|Adverse Event|0|||
146282056|NCT00621777|527546433|FG000|Open Phase|Did not abstain during open phase|56|||
146282057|NCT00621777|527546434|FG001|Open Phase|Did not abstain during open phase|0|||
146282058|NCT00621777|527546433|FG000|Open Phase|Withdrawal by Subject|17|||
146282059|NCT00621777|527546434|FG001|Open Phase|Withdrawal by Subject|0|||
146282060|NCT00621777|527546433|FG000|Open Phase|administrative|13|||
146282061|NCT00621777|527546434|FG001|Open Phase|administrative|0|||
146282062|NCT00621777|527546433|FG000|Open Phase|Lost to Follow-up|10|||
146282063|NCT00621777|527546434|FG001|Open Phase|Lost to Follow-up|0|||
146282064|NCT00621777|527546433|FG000|Randomized Phase|Adverse Event|3|||
146282065|NCT00621777|527546434|FG001|Randomized Phase|Adverse Event|3|||
146282066|NCT00621777|527546433|FG000|Randomized Phase|Lost to Follow-up|3|||
146282067|NCT00621777|527546434|FG001|Randomized Phase|Lost to Follow-up|3|||
146282068|NCT00621777|527546433|FG000|Randomized Phase|Withdrawal by Subject|1|||
146282069|NCT00621777|527546434|FG001|Randomized Phase|Withdrawal by Subject|9|||
146282070|NCT00621777|527546433|FG000|Randomized Phase|administrative|0|||
146282071|NCT00621777|527546434|FG001|Randomized Phase|administrative|3|||
146282072|NCT00621777|527546433|FG000|Randomized Phase|Death|0|||
146282073|NCT00621777|527546434|FG001|Randomized Phase|Death|1|||
146282074|NCT00446043|527546435|FG000|Overall Study|Adverse Event|9|||
146282075|NCT00446043|527546435|FG000|Overall Study|Withdrawal by Subject|70|||
146282076|NCT00446043|527546435|FG000|Overall Study|Protocol Violation|2|||
146282077|NCT00446043|527546435|FG000|Overall Study|Lost to Follow-up|42|||
146282078|NCT00446043|527546435|FG000|Overall Study|Pregnancy|2|||
146282079|NCT01239043|527546436|FG000|Overall Study|Protocol Violation|2|||
146162001|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146282080|NCT01239043|527546437|FG001|Overall Study|Protocol Violation|1|||
146282081|NCT02929329|527546440|FG000|Overall Study|Withdrawal by Subject|24|||
146282082|NCT02929329|527546441|FG001|Overall Study|Withdrawal by Subject|21|||
146282083|NCT02929329|527546440|FG000|Overall Study|Lost to Follow-up|26|||
146282084|NCT02929329|527546441|FG001|Overall Study|Lost to Follow-up|20|||
146282085|NCT02929329|527546440|FG000|Overall Study|Death|1054|||
146282086|NCT02929329|527546441|FG001|Overall Study|Death|1051|||
146282087|NCT02121301|527546442|FG000|Overall Study|Protocol Violation|1|||
146282088|NCT02121301|527546443|FG001|Overall Study|Protocol Violation|4|||
146162002|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146162003|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146162004|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146162005|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146162006|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146162007|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162008|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
146162009|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162010|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162011|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162012|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162013|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162014|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146162015|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162016|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162017|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146162018|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162019|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162020|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162021|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162022|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146162023|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146282089|NCT02121301|527546444|FG002|Overall Study|Protocol Violation|1|||
146282090|NCT02663518|527546447|FG000|Part 1: Phase 1a Escalation|Death|0|||
146282091|NCT02663518|527546448|FG001|Part 1: Phase 1a Escalation|Death|0|||
146282092|NCT02663518|527546449|FG002|Part 1: Phase 1a Escalation|Death|1|||
146282093|NCT02663518|527546450|FG003|Part 1: Phase 1a Escalation|Death|0|||
146282094|NCT02663518|527546451|FG004|Part 1: Phase 1a Escalation|Death|0|||
146282095|NCT02663518|527546452|FG005|Part 1: Phase 1a Escalation|Death|0|||
146282096|NCT02663518|527546453|FG006|Part 1: Phase 1a Escalation|Death|0|||
146282097|NCT02663518|527546454|FG007|Part 1: Phase 1a Escalation|Death|0|||
146282098|NCT02663518|527546455|FG008|Part 1: Phase 1a Escalation|Death|0|||
146282099|NCT02663518|527546456|FG009|Part 1: Phase 1a Escalation|Death|0|||
146282100|NCT02663518|527546457|FG010|Part 1: Phase 1a Escalation|Death|0|||
146282101|NCT02663518|527546458|FG011|Part 1: Phase 1a Escalation|Death|0|||
146282102|NCT02663518|527546459|FG012|Part 1: Phase 1a Escalation|Death|0|||
146282103|NCT02663518|527546460|FG013|Part 1: Phase 1a Escalation|Death|0|||
146282104|NCT02663518|527546447|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282105|NCT02663518|527546448|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282106|NCT02663518|527546449|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
146282107|NCT02663518|527546450|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282108|NCT02663518|527546451|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282109|NCT02663518|527546452|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282110|NCT02663518|527546453|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282111|NCT02663518|527546454|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282112|NCT02663518|527546455|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282113|NCT02663518|527546456|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282114|NCT02663518|527546457|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282115|NCT02663518|527546458|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282116|NCT02663518|527546459|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282117|NCT02663518|527546460|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
146282118|NCT02663518|527546447|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
146282119|NCT02663518|527546448|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
146282120|NCT02663518|527546449|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
146282121|NCT02663518|527546450|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
146282122|NCT02663518|527546451|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282123|NCT02663518|527546452|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282124|NCT02663518|527546453|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282125|NCT02663518|527546454|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282126|NCT02663518|527546455|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282127|NCT02663518|527546456|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282128|NCT02663518|527546457|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282129|NCT02663518|527546458|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282130|NCT02663518|527546459|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282131|NCT02663518|527546460|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
146282132|NCT02663518|527546447|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
146282133|NCT02663518|527546448|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146162024|NCT01212770|527102621|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
146282134|NCT02663518|527546449|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
146282135|NCT02663518|527546450|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
146162025|NCT01212770|527102622|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
146162026|NCT01212770|527102623|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
146162027|NCT01212770|527102624|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162028|NCT01212770|527102625|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162029|NCT01212770|527102626|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162030|NCT01212770|527102627|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162031|NCT01212770|527102628|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162032|NCT01212770|527102629|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
146162033|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146162034|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
146162035|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
146162036|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
146162037|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146162038|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146162039|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
146162040|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146162041|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
146162042|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146162043|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
146162044|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
146162045|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
146162046|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
146162047|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
146162048|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146162049|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146162050|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
146162051|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146162052|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
146162053|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
146162054|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
146162055|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146315443|NCT02543528|527666019|FG003|Extended Wear Period|Lost to Follow-up|1|||
146315444|NCT02543528|527666020|FG004|Extended Wear Period|Lost to Follow-up|0|||
146315445|NCT02543528|527666016|FG000|Extended Wear Period|Withdrawal by Subject|10|||
146315446|NCT02543528|527666017|FG001|Extended Wear Period|Withdrawal by Subject|9|||
146315447|NCT02543528|527666018|FG002|Extended Wear Period|Withdrawal by Subject|4|||
146315448|NCT02543528|527666019|FG003|Extended Wear Period|Withdrawal by Subject|5|||
146315449|NCT02543528|527666020|FG004|Extended Wear Period|Withdrawal by Subject|0|||
146315450|NCT01408147|527666021|FG000|Overall Study|Withdrawal by Subject|0|||
146315451|NCT01408147|527666022|FG001|Overall Study|Withdrawal by Subject|1|||
146315452|NCT01761266|527666023|FG000|Overall Study|Death|415|||
146315453|NCT01761266|527666024|FG001|Overall Study|Death|402|||
146315454|NCT01761266|527666023|FG000|Overall Study|Lost to Follow-up|8|||
146315455|NCT01761266|527666024|FG001|Overall Study|Lost to Follow-up|12|||
146315456|NCT01761266|527666023|FG000|Overall Study|Withdrawal by Subject|14|||
146315457|NCT01761266|527666024|FG001|Overall Study|Withdrawal by Subject|10|||
146315458|NCT01761266|527666023|FG000|Overall Study|Sponsor Decision|41|||
146315459|NCT01761266|527666024|FG001|Overall Study|Sponsor Decision|52|||
146315460|NCT05048719|527666025|FG000|Overall Study|Withdrawal by Subject|2|||
146315461|NCT05048719|527666026|FG001|Overall Study|Withdrawal by Subject|1|||
146315462|NCT05048719|527666027|FG002|Overall Study|Withdrawal by Subject|3|||
146315463|NCT05048719|527666028|FG003|Overall Study|Withdrawal by Subject|1|||
146315464|NCT05048719|527666029|FG004|Overall Study|Withdrawal by Subject|0|||
146315465|NCT05048719|527666030|FG005|Overall Study|Withdrawal by Subject|2|||
146315466|NCT05048719|527666031|FG006|Overall Study|Withdrawal by Subject|1|||
146315467|NCT05048719|527666032|FG007|Overall Study|Withdrawal by Subject|1|||
146315468|NCT05048719|527666033|FG008|Overall Study|Withdrawal by Subject|0|||
146315469|NCT05048719|527666025|FG000|Overall Study|Death|1|||
146315470|NCT05048719|527666026|FG001|Overall Study|Death|0|||
146315471|NCT05048719|527666027|FG002|Overall Study|Death|0|||
146315472|NCT05048719|527666028|FG003|Overall Study|Death|0|||
146315473|NCT05048719|527666029|FG004|Overall Study|Death|0|||
146315474|NCT05048719|527666030|FG005|Overall Study|Death|0|||
146315475|NCT05048719|527666031|FG006|Overall Study|Death|0|||
146315476|NCT05048719|527666032|FG007|Overall Study|Death|0|||
146315477|NCT05048719|527666033|FG008|Overall Study|Death|0|||
146315478|NCT05048719|527666025|FG000|Overall Study|Adverse Event|0|||
146315479|NCT05048719|527666026|FG001|Overall Study|Adverse Event|1|||
146315480|NCT05048719|527666027|FG002|Overall Study|Adverse Event|2|||
146315481|NCT05048719|527666028|FG003|Overall Study|Adverse Event|0|||
146315482|NCT05048719|527666029|FG004|Overall Study|Adverse Event|1|||
146315483|NCT05048719|527666030|FG005|Overall Study|Adverse Event|0|||
146315484|NCT05048719|527666031|FG006|Overall Study|Adverse Event|0|||
146315485|NCT05048719|527666032|FG007|Overall Study|Adverse Event|0|||
146315486|NCT05048719|527666033|FG008|Overall Study|Adverse Event|0|||
146315487|NCT05048719|527666025|FG000|Overall Study|Lost to Follow-up|0|||
146315488|NCT05048719|527666026|FG001|Overall Study|Lost to Follow-up|0|||
146315489|NCT05048719|527666027|FG002|Overall Study|Lost to Follow-up|1|||
146315490|NCT05048719|527666028|FG003|Overall Study|Lost to Follow-up|3|||
146315491|NCT05048719|527666029|FG004|Overall Study|Lost to Follow-up|1|||
146315492|NCT05048719|527666030|FG005|Overall Study|Lost to Follow-up|1|||
146315493|NCT05048719|527666031|FG006|Overall Study|Lost to Follow-up|1|||
146315494|NCT05048719|527666032|FG007|Overall Study|Lost to Follow-up|1|||
146315495|NCT05048719|527666033|FG008|Overall Study|Lost to Follow-up|0|||
146315496|NCT05048719|527666025|FG000|Overall Study|Physician Decision|0|||
146315497|NCT05048719|527666026|FG001|Overall Study|Physician Decision|0|||
146315498|NCT05048719|527666027|FG002|Overall Study|Physician Decision|0|||
146315499|NCT05048719|527666028|FG003|Overall Study|Physician Decision|0|||
146315500|NCT05048719|527666029|FG004|Overall Study|Physician Decision|0|||
146315501|NCT05048719|527666030|FG005|Overall Study|Physician Decision|0|||
146315502|NCT05048719|527666031|FG006|Overall Study|Physician Decision|0|||
146315503|NCT05048719|527666032|FG007|Overall Study|Physician Decision|1|||
146315504|NCT05048719|527666033|FG008|Overall Study|Physician Decision|1|||
146315505|NCT05048719|527666025|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
146315506|NCT05048719|527666026|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315507|NCT05048719|527666027|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315508|NCT05048719|527666028|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315509|NCT05048719|527666029|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315510|NCT05048719|527666030|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315511|NCT05048719|527666031|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315512|NCT05048719|527666032|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315513|NCT05048719|527666033|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
146315514|NCT05048719|527666025|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315515|NCT05048719|527666026|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
146315516|NCT05048719|527666027|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315517|NCT05048719|527666028|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315518|NCT05048719|527666029|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315519|NCT05048719|527666030|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315520|NCT05048719|527666031|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315521|NCT05048719|527666032|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315522|NCT05048719|527666033|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
146315523|NCT05048719|527666025|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315524|NCT05048719|527666026|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
146315525|NCT05048719|527666027|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315526|NCT05048719|527666028|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315527|NCT05048719|527666029|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315528|NCT05048719|527666030|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315529|NCT05048719|527666031|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315530|NCT05048719|527666032|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315531|NCT05048719|527666033|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
146315532|NCT05048719|527666025|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315533|NCT05048719|527666026|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315534|NCT05048719|527666027|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315535|NCT05048719|527666028|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
146315536|NCT05048719|527666029|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315537|NCT05048719|527666030|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315538|NCT05048719|527666031|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315539|NCT05048719|527666032|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315540|NCT05048719|527666033|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
146315541|NCT05048719|527666025|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315542|NCT05048719|527666026|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315543|NCT05048719|527666027|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315544|NCT05048719|527666028|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315545|NCT05048719|527666029|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315546|NCT05048719|527666030|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
146315547|NCT05048719|527666031|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315548|NCT05048719|527666032|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315549|NCT05048719|527666033|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
146315550|NCT03257267|527666036|FG000|Overall Study|Adverse Event|17|||
146315551|NCT03257267|527666037|FG001|Overall Study|Adverse Event|7|||
146315552|NCT03257267|527666036|FG000|Overall Study|Death|96|||
146315553|NCT03257267|527666037|FG001|Overall Study|Death|98|||
146315554|NCT03257267|527666036|FG000|Overall Study|Lost to Follow-up|2|||
146315555|NCT03257267|527666037|FG001|Overall Study|Lost to Follow-up|2|||
146315556|NCT03257267|527666036|FG000|Overall Study|Non-compliance with Study Drug|0|||
146315557|NCT03257267|527666037|FG001|Overall Study|Non-compliance with Study Drug|2|||
146315558|NCT03257267|527666036|FG000|Overall Study|Participant Decision|35|||
146315559|NCT03257267|527666037|FG001|Overall Study|Participant Decision|43|||
146315560|NCT03257267|527666036|FG000|Overall Study|Sponsor Decision|1|||
146315561|NCT03257267|527666037|FG001|Overall Study|Sponsor Decision|0|||
146315562|NCT03257267|527666036|FG000|Overall Study|Physician Decision|1|||
146315563|NCT03257267|527666037|FG001|Overall Study|Physician Decision|3|||
146315564|NCT03257267|527666036|FG000|Overall Study|Disease Progression|109|||
146315565|NCT03257267|527666037|FG001|Overall Study|Disease Progression|121|||
146315566|NCT03257267|527666036|FG000|Overall Study|Withdrawal by Subject|8|||
146315567|NCT03257267|527666037|FG001|Overall Study|Withdrawal by Subject|26|||
146315568|NCT03257267|527666036|FG000|Overall Study|Other|0|||
146315569|NCT03257267|527666037|FG001|Overall Study|Other|2|||
146315570|NCT03445000|527666038|FG000|Overall Study|Disease progression|8|||
146315571|NCT03445000|527666038|FG000|Overall Study|Adverse Event|3|||
146315572|NCT03445000|527666038|FG000|Overall Study|Death|2|||
146162056|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146162057|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
146162058|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146162059|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
146162060|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162061|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162062|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
146162063|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162064|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162065|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146315573|NCT03445000|527666038|FG000|Overall Study|Physician Decision|1|||
146315574|NCT00706134|527666039|FG000|Overall Study|Adverse Event|8|||
146315575|NCT00706134|527666040|FG001|Overall Study|Adverse Event|7|||
146315576|NCT00706134|527666041|FG002|Overall Study|Adverse Event|2|||
146315577|NCT00706134|527666042|FG003|Overall Study|Adverse Event|3|||
146315578|NCT00706134|527666039|FG000|Overall Study|Lost to Follow-up|0|||
146315579|NCT00706134|527666040|FG001|Overall Study|Lost to Follow-up|1|||
146315580|NCT00706134|527666041|FG002|Overall Study|Lost to Follow-up|0|||
146315581|NCT00706134|527666042|FG003|Overall Study|Lost to Follow-up|0|||
146315582|NCT00706134|527666039|FG000|Overall Study|Protocol Violation|0|||
146162066|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162067|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162068|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
146162069|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162070|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162071|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162072|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
146162073|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162074|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162075|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162076|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162077|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
146162078|NCT01212770|527102621|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162079|NCT01212770|527102622|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162080|NCT01212770|527102623|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
146162081|NCT01212770|527102624|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
146315583|NCT00706134|527666040|FG001|Overall Study|Protocol Violation|6|||
146315584|NCT00706134|527666041|FG002|Overall Study|Protocol Violation|0|||
146315585|NCT00706134|527666042|FG003|Overall Study|Protocol Violation|3|||
146315586|NCT00706134|527666039|FG000|Overall Study|Withdrawal by Subject|1|||
146315587|NCT00706134|527666040|FG001|Overall Study|Withdrawal by Subject|2|||
146315588|NCT00706134|527666041|FG002|Overall Study|Withdrawal by Subject|1|||
146315589|NCT00706134|527666042|FG003|Overall Study|Withdrawal by Subject|0|||
146315590|NCT00706134|527666039|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146315591|NCT00706134|527666040|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146162082|NCT01212770|527102625|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162083|NCT01212770|527102626|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162084|NCT01212770|527102627|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162085|NCT01212770|527102628|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162086|NCT01212770|527102629|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
146162087|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162088|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
146162089|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
146162090|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162091|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162092|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162093|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162094|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
146162095|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
146162096|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146162097|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
146162098|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
146162099|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146162100|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146162101|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146162102|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146162103|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
146162104|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
146162105|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162106|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
146162107|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162108|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162109|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146315592|NCT00706134|527666041|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
146315593|NCT00706134|527666042|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
146315594|NCT00706134|527666039|FG000|Overall Study|Did not meet study criteria|2|||
146315595|NCT00706134|527666040|FG001|Overall Study|Did not meet study criteria|0|||
146315596|NCT00706134|527666041|FG002|Overall Study|Did not meet study criteria|0|||
146315597|NCT00706134|527666042|FG003|Overall Study|Did not meet study criteria|0|||
146315598|NCT00746252|527666045|FG000|Overall Study|weight gain >7.5 %|1|||
146162110|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162111|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162112|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162113|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
146162114|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146162115|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
146162116|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
146162117|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146162118|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146162119|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146162120|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146162121|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146162122|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
146162123|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146162124|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
146162125|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146162126|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146162127|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146162128|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146162129|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
146162130|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146162131|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
146162132|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162133|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
146162134|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146162135|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162136|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162137|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162138|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162139|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146162140|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146162141|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146162142|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146162143|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146162144|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146162145|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146162146|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146162147|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146162148|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146162149|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
146162150|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146162151|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
146162152|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
146162153|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146162154|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146162155|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146162156|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146162157|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146162158|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146162159|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146162160|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
146162161|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
146315599|NCT00746252|527666046|FG001|Overall Study|weight gain >7.5 %|2|||
146315600|NCT01391000|527666047|FG000|Overall Study|Lost to Follow-up|2|||
146315601|NCT01391000|527666048|FG001|Overall Study|Lost to Follow-up|0|||
146315602|NCT00082888|527666049|FG000|Overall Study|Ineligible|1|||
146315603|NCT00082888|527666050|FG001|Overall Study|Ineligible|0|||
146315604|NCT00082888|527666051|FG002|Overall Study|Ineligible|0|||
146315605|NCT02684981|527666054|FG000|Overall Study|Permanently discontinued the treatment|157|||
146315606|NCT02684981|527666055|FG001|Overall Study|Permanently discontinued the treatment|161|||
146315607|NCT02684981|527666056|FG002|Overall Study|Permanently discontinued the treatment|110|||
146315608|NCT02684981|527666054|FG000|Overall Study|Other|83|||
146315609|NCT02684981|527666055|FG001|Overall Study|Other|49|||
146315610|NCT02684981|527666056|FG002|Overall Study|Other|17|||
146315611|NCT00820898|527666059|FG000|Overall Study|Inelgible - wrong primary site|1|||
146315612|NCT02921971|527666062|FG000|Overall Study|Adverse Event|1|||
146315613|NCT02921971|527666063|FG001|Overall Study|Adverse Event|2|||
146315614|NCT02921971|527666062|FG000|Overall Study|Lack of Efficacy|3|||
146315615|NCT02921971|527666063|FG001|Overall Study|Lack of Efficacy|1|||
146315616|NCT02921971|527666062|FG000|Overall Study|Other than specified above|2|||
146315617|NCT02921971|527666063|FG001|Overall Study|Other than specified above|1|||
146315618|NCT00452699|527666064|FG000|Overall Study|Adverse Event|10|||
146315619|NCT00452699|527666065|FG001|Overall Study|Adverse Event|3|||
146315620|NCT00452699|527666064|FG000|Overall Study|Lack of Efficacy|6|||
146315621|NCT00452699|527666065|FG001|Overall Study|Lack of Efficacy|4|||
146315622|NCT00452699|527666064|FG000|Overall Study|Lost to Follow-up|6|||
146315623|NCT00452699|527666065|FG001|Overall Study|Lost to Follow-up|9|||
146315624|NCT00452699|527666064|FG000|Overall Study|Protocol Violation|21|||
146315625|NCT00452699|527666065|FG001|Overall Study|Protocol Violation|25|||
146315626|NCT00452699|527666064|FG000|Overall Study|Withdrawal by Subject|26|||
146315627|NCT00452699|527666065|FG001|Overall Study|Withdrawal by Subject|25|||
146315628|NCT00452699|527666064|FG000|Overall Study|Other|12|||
146315629|NCT00452699|527666065|FG001|Overall Study|Other|7|||
146315630|NCT03468309|527666072|FG000|Overall Study|Lost to Follow-up|4|||
146315631|NCT03468309|527666072|FG000|Overall Study|Withdrawal by Subject|2|||
146315632|NCT00179309|527666075|FG000|Treatment|Toxicity|2|||
146315633|NCT00179309|527666076|FG001|Treatment|Toxicity|3|||
146315634|NCT00179309|527666075|FG000|Treatment|Withdrawal by Subject|1|||
146315635|NCT00179309|527666076|FG001|Treatment|Withdrawal by Subject|2|||
146315636|NCT00179309|527666075|FG000|Treatment|Allergy|1|||
146162162|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146162163|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146315637|NCT00179309|527666076|FG001|Treatment|Allergy|0|||
146315638|NCT00488982|527666077|FG000|Course 1|Physician Decision|0|||
146315639|NCT00488982|527666078|FG001|Course 1|Physician Decision|2|||
146315640|NCT00488982|527666079|FG002|Course 1|Physician Decision|4|||
146315641|NCT00488982|527666077|FG000|Course 1|Withdrawal by Subject|0|||
146315642|NCT00488982|527666078|FG001|Course 1|Withdrawal by Subject|8|||
146315643|NCT00488982|527666079|FG002|Course 1|Withdrawal by Subject|2|||
146315644|NCT00488982|527666077|FG000|Course 1|nonprotocol therapy|0|||
146315645|NCT00488982|527666078|FG001|Course 1|nonprotocol therapy|2|||
146315646|NCT00488982|527666079|FG002|Course 1|nonprotocol therapy|2|||
146315647|NCT00488982|527666077|FG000|Course 1|Adverse Event|0|||
146315648|NCT00488982|527666078|FG001|Course 1|Adverse Event|0|||
146315649|NCT00488982|527666079|FG002|Course 1|Adverse Event|6|||
146315650|NCT01777152|527666082|FG000|Overall Study|Withdrawal by Subject|22|||
146315651|NCT01777152|527666083|FG001|Overall Study|Withdrawal by Subject|16|||
146315652|NCT01777152|527666082|FG000|Overall Study|Lost to Follow-up|3|||
146315653|NCT01777152|527666083|FG001|Overall Study|Lost to Follow-up|5|||
146315654|NCT01777152|527666082|FG000|Overall Study|Death|68|||
146315655|NCT01777152|527666083|FG001|Overall Study|Death|89|||
146315656|NCT01777152|527666082|FG000|Overall Study|Not eligible, no study drug received|1|||
146315657|NCT01777152|527666083|FG001|Overall Study|Not eligible, no study drug received|0|||
146315658|NCT01777152|527666082|FG000|Overall Study|Change of diagnosis|1|||
146315659|NCT01777152|527666083|FG001|Overall Study|Change of diagnosis|0|||
146162164|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146162165|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146162166|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146162167|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
146162168|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162169|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146162170|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162171|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162172|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162173|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146315660|NCT03548558|527666084|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
146315661|NCT03548558|527666085|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
146315662|NCT03548558|527666086|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146315663|NCT03548558|527666087|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
146315664|NCT03548558|527666088|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146315665|NCT03548558|527666089|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146315666|NCT03548558|527666090|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
146315667|NCT03548558|527666084|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
146315668|NCT03548558|527666085|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
146315669|NCT03548558|527666086|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
146315670|NCT03548558|527666087|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
146315671|NCT03548558|527666088|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
146315672|NCT03548558|527666089|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
146315673|NCT03548558|527666090|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
146315674|NCT03548558|527666084|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
146315675|NCT03548558|527666085|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
146315676|NCT03548558|527666086|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
146315677|NCT03548558|527666087|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
146315678|NCT03548558|527666088|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
146315679|NCT03548558|527666089|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
146315680|NCT03548558|527666090|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
146315681|NCT03548558|527666084|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146315682|NCT03548558|527666085|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146315683|NCT03548558|527666086|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146315684|NCT03548558|527666087|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
146315685|NCT03548558|527666088|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
146315686|NCT03548558|527666089|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
146315687|NCT03548558|527666090|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
146315688|NCT03548558|527666084|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146315689|NCT03548558|527666085|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146315690|NCT03548558|527666086|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146315691|NCT03548558|527666087|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
146315692|NCT03548558|527666088|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
146315693|NCT03548558|527666089|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
146315694|NCT03548558|527666090|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
146315695|NCT03548558|527666084|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146315696|NCT03548558|527666085|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146315697|NCT03548558|527666086|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146315698|NCT03548558|527666087|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
146315699|NCT03548558|527666088|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
146315700|NCT03548558|527666089|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
146315701|NCT03548558|527666090|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
146315702|NCT01903837|527666100|FG000|Part A|Withdrawal by Subject|4|||
146315703|NCT01903837|527666101|FG001|Part A|Withdrawal by Subject|9|||
146315704|NCT01903837|527666102|FG002|Part A|Withdrawal by Subject|8|||
146315705|NCT01903837|527666103|FG003|Part A|Withdrawal by Subject|5|||
146315706|NCT01903837|527666100|FG000|Part A|Adverse Event|3|||
146315707|NCT01903837|527666101|FG001|Part A|Adverse Event|6|||
146162174|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162175|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146162176|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146315708|NCT01903837|527666102|FG002|Part A|Adverse Event|9|||
146315709|NCT01903837|527666103|FG003|Part A|Adverse Event|6|||
146315710|NCT01903837|527666100|FG000|Part A|Lost to Follow-up|9|||
146315711|NCT01903837|527666101|FG001|Part A|Lost to Follow-up|7|||
146315712|NCT01903837|527666102|FG002|Part A|Lost to Follow-up|7|||
146315713|NCT01903837|527666103|FG003|Part A|Lost to Follow-up|2|||
146315714|NCT01903837|527666100|FG000|Part A|Non-compliance with study drug|1|||
146315715|NCT01903837|527666101|FG001|Part A|Non-compliance with study drug|4|||
146315716|NCT01903837|527666102|FG002|Part A|Non-compliance with study drug|4|||
146315717|NCT01903837|527666103|FG003|Part A|Non-compliance with study drug|0|||
146315718|NCT01903837|527666100|FG000|Part A|Physician Decision|1|||
146315719|NCT01903837|527666101|FG001|Part A|Physician Decision|1|||
146315720|NCT01903837|527666102|FG002|Part A|Physician Decision|0|||
146315721|NCT01903837|527666103|FG003|Part A|Physician Decision|0|||
146315722|NCT01903837|527666100|FG000|Part A|Protocol Violation|1|||
146315723|NCT01903837|527666101|FG001|Part A|Protocol Violation|1|||
146315724|NCT01903837|527666102|FG002|Part A|Protocol Violation|0|||
146315725|NCT01903837|527666103|FG003|Part A|Protocol Violation|0|||
146315726|NCT01903837|527666100|FG000|Part B|Lost to Follow-up|0|||
146315727|NCT01903837|527666101|FG001|Part B|Lost to Follow-up|3|||
146315728|NCT01903837|527666102|FG002|Part B|Lost to Follow-up|3|||
146315729|NCT01903837|527666103|FG003|Part B|Lost to Follow-up|4|||
146315730|NCT01903837|527666100|FG000|Part B|Withdrawal by Subject|1|||
146315731|NCT01903837|527666101|FG001|Part B|Withdrawal by Subject|2|||
146315732|NCT01903837|527666102|FG002|Part B|Withdrawal by Subject|0|||
146315733|NCT01903837|527666103|FG003|Part B|Withdrawal by Subject|3|||
146315734|NCT01903837|527666100|FG000|Part B|Adverse Event|3|||
146315735|NCT01903837|527666101|FG001|Part B|Adverse Event|0|||
146315736|NCT01903837|527666102|FG002|Part B|Adverse Event|2|||
146315737|NCT01903837|527666103|FG003|Part B|Adverse Event|0|||
146315738|NCT01903837|527666100|FG000|Part B|Non-compliance with study drug|2|||
146315739|NCT01903837|527666101|FG001|Part B|Non-compliance with study drug|0|||
146315740|NCT01903837|527666102|FG002|Part B|Non-compliance with study drug|0|||
146315741|NCT01903837|527666103|FG003|Part B|Non-compliance with study drug|1|||
146315742|NCT01903837|527666100|FG000|Part B|Incarceration|2|||
146315743|NCT01903837|527666101|FG001|Part B|Incarceration|0|||
146315744|NCT01903837|527666102|FG002|Part B|Incarceration|0|||
146315745|NCT01903837|527666103|FG003|Part B|Incarceration|1|||
146315746|NCT01903837|527666100|FG000|Part B|Physician Decision|1|||
146315747|NCT01903837|527666101|FG001|Part B|Physician Decision|0|||
146315748|NCT01903837|527666102|FG002|Part B|Physician Decision|0|||
146315749|NCT01903837|527666103|FG003|Part B|Physician Decision|2|||
146315750|NCT01903837|527666100|FG000|Part B|Lack of Efficacy|0|||
146315751|NCT01903837|527666101|FG001|Part B|Lack of Efficacy|1|||
146315752|NCT01903837|527666102|FG002|Part B|Lack of Efficacy|0|||
146315753|NCT01903837|527666103|FG003|Part B|Lack of Efficacy|0|||
146315754|NCT01857869|527666107|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
146315755|NCT01857869|527666108|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
146315756|NCT01857869|527666109|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
146315757|NCT01857869|527666110|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
146315758|NCT01857869|527666111|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
146315759|NCT01857869|527666112|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
146315760|NCT01857869|527666113|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
146315761|NCT01857869|527666114|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
146315762|NCT01857869|527666115|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
146315763|NCT01857869|527666116|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
146315764|NCT01857869|527666107|FG000|Primary/Challenge Phase|Pregnancy|1|||
146315765|NCT01857869|527666108|FG001|Primary/Challenge Phase|Pregnancy|0|||
146315766|NCT01857869|527666109|FG002|Primary/Challenge Phase|Pregnancy|0|||
146315767|NCT01857869|527666110|FG003|Primary/Challenge Phase|Pregnancy|0|||
146315768|NCT01857869|527666111|FG004|Primary/Challenge Phase|Pregnancy|0|||
146315769|NCT01857869|527666112|FG005|Primary/Challenge Phase|Pregnancy|0|||
146315770|NCT01857869|527666113|FG006|Primary/Challenge Phase|Pregnancy|0|||
146315771|NCT01857869|527666114|FG007|Primary/Challenge Phase|Pregnancy|0|||
146315772|NCT01857869|527666115|FG008|Primary/Challenge Phase|Pregnancy|0|||
146315773|NCT01857869|527666116|FG009|Primary/Challenge Phase|Pregnancy|0|||
146315774|NCT01857869|527666107|FG000|Primary/Challenge Phase|Protocol Violation|1|||
146315775|NCT01857869|527666108|FG001|Primary/Challenge Phase|Protocol Violation|0|||
146315776|NCT01857869|527666109|FG002|Primary/Challenge Phase|Protocol Violation|0|||
146315777|NCT01857869|527666110|FG003|Primary/Challenge Phase|Protocol Violation|0|||
146315778|NCT01857869|527666111|FG004|Primary/Challenge Phase|Protocol Violation|0|||
146315779|NCT01857869|527666112|FG005|Primary/Challenge Phase|Protocol Violation|0|||
146315780|NCT01857869|527666113|FG006|Primary/Challenge Phase|Protocol Violation|0|||
146315781|NCT01857869|527666114|FG007|Primary/Challenge Phase|Protocol Violation|0|||
146315782|NCT01857869|527666115|FG008|Primary/Challenge Phase|Protocol Violation|0|||
146315783|NCT01857869|527666116|FG009|Primary/Challenge Phase|Protocol Violation|0|||
146315784|NCT01857869|527666107|FG000|Primary/Challenge Phase|Other|1|||
146315785|NCT01857869|527666108|FG001|Primary/Challenge Phase|Other|1|||
146315786|NCT01857869|527666109|FG002|Primary/Challenge Phase|Other|0|||
146315787|NCT01857869|527666110|FG003|Primary/Challenge Phase|Other|0|||
146315788|NCT01857869|527666111|FG004|Primary/Challenge Phase|Other|0|||
146315789|NCT01857869|527666112|FG005|Primary/Challenge Phase|Other|0|||
146315790|NCT01857869|527666113|FG006|Primary/Challenge Phase|Other|0|||
146315791|NCT01857869|527666114|FG007|Primary/Challenge Phase|Other|0|||
146315792|NCT01857869|527666115|FG008|Primary/Challenge Phase|Other|0|||
146315793|NCT01857869|527666116|FG009|Primary/Challenge Phase|Other|0|||
146315794|NCT01857869|527666107|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315795|NCT01857869|527666108|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315796|NCT01857869|527666109|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315797|NCT01857869|527666110|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
146315798|NCT01857869|527666111|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315799|NCT01857869|527666112|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315800|NCT01857869|527666113|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315801|NCT01857869|527666114|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315802|NCT01857869|527666115|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315803|NCT01857869|527666116|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
146315804|NCT01857869|527666107|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315805|NCT01857869|527666108|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315806|NCT01857869|527666109|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315807|NCT01857869|527666110|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
146315808|NCT01857869|527666111|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315809|NCT01857869|527666112|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315810|NCT01857869|527666113|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315811|NCT01857869|527666114|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315812|NCT01857869|527666115|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315813|NCT01857869|527666116|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
146315814|NCT00774345|527666120|FG000|Pre-treatment|Other reasons|2|||
146315815|NCT00774345|527666121|FG001|Pre-treatment|Other reasons|0|||
146315816|NCT00774345|527666120|FG000|Treatment|Adverse Event|61|||
146315817|NCT00774345|527666121|FG001|Treatment|Adverse Event|15|||
146315818|NCT00774345|527666120|FG000|Treatment|Progressive Disease without histologic transformation|51|||
146315819|NCT00774345|527666121|FG001|Treatment|Progressive Disease without histologic transformation|111|||
146315820|NCT00774345|527666120|FG000|Treatment|Progressive Disease with histologic transformation|4|||
146315821|NCT00774345|527666121|FG001|Treatment|Progressive Disease with histologic transformation|2|||
146315822|NCT00774345|527666120|FG000|Treatment|Withdrawal by Subject|5|||
146315823|NCT00774345|527666121|FG001|Treatment|Withdrawal by Subject|2|||
146315824|NCT00774345|527666120|FG000|Treatment|Lost to Follow-up|1|||
146315825|NCT00774345|527666121|FG001|Treatment|Lost to Follow-up|1|||
146315826|NCT00774345|527666120|FG000|Treatment|Death|4|||
146315827|NCT00774345|527666121|FG001|Treatment|Death|0|||
146315828|NCT00774345|527666120|FG000|Treatment|Other Reasons|32|||
146315829|NCT00774345|527666121|FG001|Treatment|Other Reasons|26|||
146315830|NCT00075504|527666122|FG000|Overall Study|Withdrawal by Subject|9|||
146315831|NCT00075504|527666123|FG001|Overall Study|Withdrawal by Subject|7|||
146315832|NCT02788747|527666124|FG000|Overall Study|Adverse Event|1|||
146315833|NCT02788747|527666125|FG001|Overall Study|Adverse Event|0|||
146315834|NCT02788747|527666126|FG002|Overall Study|Adverse Event|0|||
146315835|NCT00879697|527666132|FG000|Overall Study|Physician Decision|2|||
146315836|NCT00879697|527666133|FG001|Overall Study|Physician Decision|2|||
146315837|NCT02500121|527666134|FG000|Overall Study|Lost to Follow-up|0|||
146315838|NCT02500121|527666135|FG001|Overall Study|Lost to Follow-up|1|||
146315839|NCT02500121|527666134|FG000|Overall Study|Withdrawal by Subject|1|||
146315840|NCT02500121|527666135|FG001|Overall Study|Withdrawal by Subject|1|||
146315841|NCT02500121|527666134|FG000|Overall Study|Death|26|||
146315842|NCT02500121|527666135|FG001|Overall Study|Death|24|||
146315843|NCT01437397|527666137|FG000|Overall Study|Lost to Follow-up|9|||
146315844|NCT01437397|527666138|FG001|Overall Study|Lost to Follow-up|4|||
146315845|NCT01437397|527666139|FG002|Overall Study|Lost to Follow-up|2|||
146315846|NCT01437397|527666140|FG003|Overall Study|Lost to Follow-up|4|||
146315847|NCT01437397|527666141|FG004|Overall Study|Lost to Follow-up|5|||
146315848|NCT01437397|527666137|FG000|Overall Study|Withdrawal by Subject|11|||
146315849|NCT01437397|527666138|FG001|Overall Study|Withdrawal by Subject|12|||
146315850|NCT01437397|527666139|FG002|Overall Study|Withdrawal by Subject|24|||
146315851|NCT01437397|527666140|FG003|Overall Study|Withdrawal by Subject|11|||
146315852|NCT01437397|527666141|FG004|Overall Study|Withdrawal by Subject|22|||
146315853|NCT01437397|527666137|FG000|Overall Study|Protocol Violation|10|||
146315854|NCT01437397|527666138|FG001|Overall Study|Protocol Violation|12|||
146162177|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162178|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146315855|NCT01437397|527666139|FG002|Overall Study|Protocol Violation|13|||
146315856|NCT01437397|527666140|FG003|Overall Study|Protocol Violation|21|||
146315857|NCT01437397|527666141|FG004|Overall Study|Protocol Violation|19|||
146315858|NCT01437397|527666137|FG000|Overall Study|Lack of Efficacy|5|||
146315859|NCT01437397|527666138|FG001|Overall Study|Lack of Efficacy|4|||
146315860|NCT01437397|527666139|FG002|Overall Study|Lack of Efficacy|8|||
146315861|NCT01437397|527666140|FG003|Overall Study|Lack of Efficacy|10|||
146315862|NCT01437397|527666141|FG004|Overall Study|Lack of Efficacy|20|||
146315863|NCT01437397|527666137|FG000|Overall Study|Adverse Event|21|||
146315864|NCT01437397|527666138|FG001|Overall Study|Adverse Event|22|||
146162179|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162180|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162181|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162182|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162183|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162184|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
146162185|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
146162186|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146162187|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
146162188|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146162189|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146162190|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146162191|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146162192|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146162193|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146162194|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146162195|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162196|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146162197|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146162198|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162199|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162200|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162201|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162202|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146162203|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
146162204|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162205|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146162206|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
146162207|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162208|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162209|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162210|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162211|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
146162212|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146162213|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162214|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146162215|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146162216|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162217|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162218|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162219|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162220|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
146162221|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
146162222|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162223|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
146162224|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
146162225|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162226|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162227|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162228|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162229|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162230|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146162231|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162232|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162233|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
146162234|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162235|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146315865|NCT01437397|527666139|FG002|Overall Study|Adverse Event|16|||
146315866|NCT01437397|527666140|FG003|Overall Study|Adverse Event|14|||
146315867|NCT01437397|527666141|FG004|Overall Study|Adverse Event|21|||
146315868|NCT01437397|527666137|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
146315869|NCT01437397|527666138|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
146315870|NCT01437397|527666139|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
146315871|NCT01437397|527666140|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
146315872|NCT01437397|527666141|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
146315873|NCT01836783|527666144|FG000|Overall Study|Withdrawal by Subject|0|||
146315874|NCT01836783|527666145|FG001|Overall Study|Withdrawal by Subject|2|||
146315875|NCT03315871|527666150|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
146162236|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162237|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162238|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162239|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146162240|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162241|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146162242|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162243|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162244|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162245|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162246|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162247|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146162248|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146162249|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
146162250|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
146162251|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
146162252|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
146162253|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
146162254|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
146162255|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
146162256|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
146162257|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
146162258|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162259|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162260|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
146162261|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162262|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162263|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162264|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162265|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162266|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146162267|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162268|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162269|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
146162270|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162271|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162272|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162273|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162274|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146162275|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146162276|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162277|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162278|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
146162279|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162280|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162281|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162282|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162283|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162284|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146162285|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146162286|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
146162287|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146162288|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146162289|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146162290|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146315876|NCT03315871|527666151|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
146315877|NCT03315871|527666152|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
146315878|NCT03315871|527666150|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
146315879|NCT03315871|527666151|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
146315880|NCT03315871|527666152|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
146315881|NCT03315871|527666150|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
146315882|NCT03315871|527666151|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
146315883|NCT03315871|527666152|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
146315884|NCT03315871|527666150|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
146315885|NCT03315871|527666151|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
146315886|NCT03315871|527666152|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
146315887|NCT03315871|527666150|FG000|PROSTVAC + CV301|Progressive disease|0|||
146315888|NCT03315871|527666151|FG001|PROSTVAC + CV301|Progressive disease|0|||
146315889|NCT03315871|527666152|FG002|PROSTVAC + CV301|Progressive disease|1|||
146162291|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146162292|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146162293|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146162294|NCT01212770|527102621|FG000|Long-term Safety Phase (Year 5)|Death|0|||
146162295|NCT01212770|527102622|FG001|Long-term Safety Phase (Year 5)|Death|0|||
146162296|NCT01212770|527102623|FG002|Long-term Safety Phase (Year 5)|Death|0|||
146162297|NCT01212770|527102624|FG003|Long-term Safety Phase (Year 5)|Death|0|||
146162298|NCT01212770|527102625|FG004|Long-term Safety Phase (Year 5)|Death|0|||
146162299|NCT01212770|527102626|FG005|Long-term Safety Phase (Year 5)|Death|0|||
146162300|NCT01212770|527102627|FG006|Long-term Safety Phase (Year 5)|Death|0|||
146162301|NCT01212770|527102628|FG007|Long-term Safety Phase (Year 5)|Death|1|||
146162302|NCT01212770|527102629|FG008|Long-term Safety Phase (Year 5)|Death|0|||
146162303|NCT00344461|527102634|FG000|Overall Study|Adverse Event|6|||
146162304|NCT00344461|527102634|FG000|Overall Study|Death|1|||
146162305|NCT00344461|527102634|FG000|Overall Study|Lack of Efficacy|2|||
146162306|NCT00344461|527102634|FG000|Overall Study|Lost to Follow-up|2|||
146162307|NCT00344461|527102634|FG000|Overall Study|Physician Decision|2|||
146162308|NCT00344461|527102634|FG000|Overall Study|Protocol Violation|6|||
146162309|NCT00344461|527102634|FG000|Overall Study|Withdrawal by Subject|2|||
146162310|NCT00829387|527102635|FG000|Overall Study|Withdrawal by Subject|2|||
146162311|NCT00829387|527102636|FG001|Overall Study|Withdrawal by Subject|3|||
146162312|NCT00829387|527102635|FG000|Overall Study|Disqualified by PI|1|||
146162313|NCT00829387|527102636|FG001|Overall Study|Disqualified by PI|0|||
146162314|NCT00707031|527102646|FG000|Overall Study|Adverse Event|45|||
146162315|NCT00707031|527102647|FG001|Overall Study|Adverse Event|45|||
146162316|NCT00707031|527102646|FG000|Overall Study|Lack of Efficacy|19|||
146162317|NCT00707031|527102647|FG001|Overall Study|Lack of Efficacy|6|||
146162318|NCT00707031|527102646|FG000|Overall Study|Lost to Follow-up|2|||
146162319|NCT00707031|527102647|FG001|Overall Study|Lost to Follow-up|1|||
146162320|NCT00707031|527102646|FG000|Overall Study|Protocol Violation|1|||
146162321|NCT00707031|527102647|FG001|Overall Study|Protocol Violation|0|||
146162322|NCT00707031|527102646|FG000|Overall Study|Withdrawal by Subject|7|||
146162323|NCT00707031|527102647|FG001|Overall Study|Withdrawal by Subject|8|||
146162324|NCT00707031|527102646|FG000|Overall Study|Poor Compliance to Protocol|7|||
146162325|NCT00707031|527102647|FG001|Overall Study|Poor Compliance to Protocol|13|||
146162326|NCT00707031|527102646|FG000|Overall Study|Familial or Personal Reasons|12|||
146162327|NCT00707031|527102647|FG001|Overall Study|Familial or Personal Reasons|15|||
146162328|NCT00707031|527102646|FG000|Overall Study|Serious Noncompliance|2|||
146162329|NCT00707031|527102647|FG001|Overall Study|Serious Noncompliance|3|||
146162330|NCT00707031|527102646|FG000|Overall Study|Sponsor Decision|9|||
146162331|NCT00707031|527102647|FG001|Overall Study|Sponsor Decision|8|||
146162332|NCT00951275|527102648|FG000|Overall Study|Administrative Reason|1|||
146282136|NCT02663518|527546451|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282137|NCT02663518|527546452|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282138|NCT02663518|527546453|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282139|NCT02663518|527546454|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282140|NCT02663518|527546455|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282141|NCT02663518|527546456|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282142|NCT02663518|527546457|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282143|NCT02663518|527546458|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282144|NCT02663518|527546459|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282145|NCT02663518|527546460|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
146282146|NCT02663518|527546447|FG000|Part 1: Phase 1a Escalation|Other|0|||
146282147|NCT02663518|527546448|FG001|Part 1: Phase 1a Escalation|Other|0|||
146282148|NCT02663518|527546449|FG002|Part 1: Phase 1a Escalation|Other|2|||
146282149|NCT02663518|527546450|FG003|Part 1: Phase 1a Escalation|Other|0|||
146282150|NCT02663518|527546451|FG004|Part 1: Phase 1a Escalation|Other|0|||
146282151|NCT02663518|527546452|FG005|Part 1: Phase 1a Escalation|Other|0|||
146282152|NCT02663518|527546453|FG006|Part 1: Phase 1a Escalation|Other|0|||
146282153|NCT02663518|527546454|FG007|Part 1: Phase 1a Escalation|Other|0|||
146282154|NCT02663518|527546455|FG008|Part 1: Phase 1a Escalation|Other|0|||
146282155|NCT02663518|527546456|FG009|Part 1: Phase 1a Escalation|Other|0|||
146282156|NCT02663518|527546457|FG010|Part 1: Phase 1a Escalation|Other|0|||
146282157|NCT02663518|527546458|FG011|Part 1: Phase 1a Escalation|Other|0|||
146282158|NCT02663518|527546459|FG012|Part 1: Phase 1a Escalation|Other|0|||
146282159|NCT02663518|527546460|FG013|Part 1: Phase 1a Escalation|Other|0|||
146282160|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282161|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282162|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
146332899|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
146162333|NCT00951275|527102648|FG000|Overall Study|Adverse Event|7|||
146162334|NCT00951275|527102648|FG000|Overall Study|Withdrawal by Subject|4|||
146162335|NCT00951275|527102648|FG000|Overall Study|Protocol Violation|1|||
146162336|NCT00541450|527102649|FG000|Phase A|Adverse Event|3|||
146162337|NCT00541450|527102650|FG001|Phase A|Adverse Event|0|||
146282163|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
146162338|NCT00541450|527102649|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
146162339|NCT00541450|527102650|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
146162340|NCT00541450|527102649|FG000|Phase A|Hyperglycemia|0|||
146162341|NCT00541450|527102650|FG001|Phase A|Hyperglycemia|1|||
146162342|NCT00541450|527102649|FG000|Phase A|Lost to Follow-up|6|||
146162343|NCT00541450|527102650|FG001|Phase A|Lost to Follow-up|4|||
146162344|NCT00541450|527102649|FG000|Phase A|Physician Decision|2|||
146162345|NCT00541450|527102650|FG001|Phase A|Physician Decision|0|||
146162346|NCT00541450|527102649|FG000|Phase A|Protocol Violation|2|||
146162347|NCT00541450|527102650|FG001|Phase A|Protocol Violation|3|||
146162348|NCT00541450|527102649|FG000|Phase A|Withdrawal by Subject|7|||
146162349|NCT00541450|527102650|FG001|Phase A|Withdrawal by Subject|7|||
146162350|NCT00541450|527102649|FG000|Phase B|Adverse Event|6|||
146162351|NCT00541450|527102650|FG001|Phase B|Adverse Event|6|||
146162352|NCT00541450|527102649|FG000|Phase B|Hyperglycemia|10|||
146162353|NCT00541450|527102650|FG001|Phase B|Hyperglycemia|9|||
146162354|NCT00541450|527102649|FG000|Phase B|Lost to Follow-up|6|||
146162355|NCT00541450|527102650|FG001|Phase B|Lost to Follow-up|4|||
146162356|NCT00541450|527102649|FG000|Phase B|Physician Decision|4|||
146162357|NCT00541450|527102650|FG001|Phase B|Physician Decision|2|||
146162358|NCT00541450|527102649|FG000|Phase B|Pregnancy|0|||
146162359|NCT00541450|527102650|FG001|Phase B|Pregnancy|1|||
146162360|NCT00541450|527102649|FG000|Phase B|Protocol Violation|3|||
146162361|NCT00541450|527102650|FG001|Phase B|Protocol Violation|3|||
146162362|NCT00541450|527102649|FG000|Phase B|Withdrawal by Subject|8|||
146162363|NCT00541450|527102650|FG001|Phase B|Withdrawal by Subject|6|||
146162364|NCT03645759|527102654|FG000|Overall Study|Lost to Follow-up|3|||
146162365|NCT03645759|527102655|FG001|Overall Study|Lost to Follow-up|2|||
146162366|NCT01389973|527102656|FG000|Overall Study|Lost to Follow-up|1|||
146162367|NCT01389973|527102656|FG000|Overall Study|Trial Stopped by Sponsor|9|||
146162368|NCT01389973|527102656|FG000|Overall Study|Other|10|||
146162369|NCT02693743|527102657|FG000|Overall Study|Physician Decision|1|||
146162370|NCT02693743|527102658|FG001|Overall Study|Physician Decision|0|||
146162371|NCT02459574|527102664|FG000|Overall Study|Withdrawal by Subject|6|||
146162372|NCT02459574|527102665|FG001|Overall Study|Withdrawal by Subject|6|||
146162373|NCT02459574|527102666|FG002|Overall Study|Withdrawal by Subject|2|||
146162374|NCT02459574|527102664|FG000|Overall Study|Lost to Follow-up|1|||
146162375|NCT02459574|527102665|FG001|Overall Study|Lost to Follow-up|1|||
146162376|NCT02459574|527102666|FG002|Overall Study|Lost to Follow-up|0|||
146162377|NCT02459574|527102664|FG000|Overall Study|Death|0|||
146162378|NCT02459574|527102665|FG001|Overall Study|Death|1|||
146162379|NCT02459574|527102666|FG002|Overall Study|Death|0|||
146162380|NCT00251745|527102667|FG000|Overall Study|Adverse Event|7|||
146162381|NCT00251745|527102668|FG001|Overall Study|Adverse Event|9|||
146162382|NCT00251745|527102669|FG002|Overall Study|Adverse Event|11|||
146162383|NCT00251745|527102667|FG000|Overall Study|Lost to Follow-up|4|||
146162384|NCT00251745|527102668|FG001|Overall Study|Lost to Follow-up|2|||
146162385|NCT00251745|527102669|FG002|Overall Study|Lost to Follow-up|5|||
146162386|NCT00251745|527102667|FG000|Overall Study|Withdrawal by Subject|13|||
146162387|NCT00251745|527102668|FG001|Overall Study|Withdrawal by Subject|7|||
146162388|NCT00251745|527102669|FG002|Overall Study|Withdrawal by Subject|3|||
146162389|NCT00251745|527102667|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
146162390|NCT00251745|527102668|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
146162391|NCT00251745|527102669|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
146162392|NCT00251745|527102667|FG000|Overall Study|Lack of Efficacy|3|||
146162393|NCT00251745|527102668|FG001|Overall Study|Lack of Efficacy|0|||
146162394|NCT00251745|527102669|FG002|Overall Study|Lack of Efficacy|0|||
146162395|NCT00251745|527102667|FG000|Overall Study|Noncompliant|0|||
146162396|NCT00251745|527102668|FG001|Overall Study|Noncompliant|2|||
146162397|NCT00251745|527102669|FG002|Overall Study|Noncompliant|2|||
146162398|NCT00251745|527102667|FG000|Overall Study|Pregnancy|0|||
146162399|NCT00251745|527102668|FG001|Overall Study|Pregnancy|1|||
146162400|NCT00251745|527102669|FG002|Overall Study|Pregnancy|0|||
146162401|NCT00251745|527102667|FG000|Overall Study|Per Subject Request|0|||
146162402|NCT00251745|527102668|FG001|Overall Study|Per Subject Request|0|||
146162403|NCT00251745|527102669|FG002|Overall Study|Per Subject Request|1|||
146162404|NCT00251745|527102667|FG000|Overall Study|Per Investigator Request|1|||
146162405|NCT00251745|527102668|FG001|Overall Study|Per Investigator Request|0|||
146162406|NCT00251745|527102669|FG002|Overall Study|Per Investigator Request|0|||
146162407|NCT04508699|527102672|FG000|Overall Study|Lack of Efficacy|2|||
146162408|NCT04508699|527102673|FG001|Overall Study|Lack of Efficacy|15|||
146162409|NCT04508699|527102672|FG000|Overall Study|Withdrawal by Subject|0|||
146162410|NCT04508699|527102673|FG001|Overall Study|Withdrawal by Subject|2|||
146162411|NCT03355326|527102674|FG000|Overall Study|Protocol Violation|3|||
146162412|NCT03355326|527102675|FG001|Overall Study|Protocol Violation|3|||
146162413|NCT01377480|527104687|FG000|Overall Study|Protocol Violation|0|||
146162414|NCT01377480|527104688|FG001|Overall Study|Protocol Violation|0|||
146162415|NCT01377480|527104689|FG002|Overall Study|Protocol Violation|0|||
146162416|NCT01377480|527104690|FG003|Overall Study|Protocol Violation|4|||
146162417|NCT01377480|527104687|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
146162418|NCT01377480|527104688|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
146162419|NCT01377480|527104689|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
146162420|NCT01377480|527104690|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
146162421|NCT01377480|527104687|FG000|Overall Study|Withdrawal by Subject|0|||
146162422|NCT01377480|527104688|FG001|Overall Study|Withdrawal by Subject|0|||
146162423|NCT01377480|527104689|FG002|Overall Study|Withdrawal by Subject|1|||
146162424|NCT01377480|527104690|FG003|Overall Study|Withdrawal by Subject|0|||
146162425|NCT01377480|527104687|FG000|Overall Study|Serious adverse event|0|||
146162426|NCT01377480|527104688|FG001|Overall Study|Serious adverse event|0|||
146162427|NCT01377480|527104689|FG002|Overall Study|Serious adverse event|1|||
146162428|NCT01377480|527104690|FG003|Overall Study|Serious adverse event|1|||
146162429|NCT01377480|527104687|FG000|Overall Study|Other|0|||
146162430|NCT01377480|527104688|FG001|Overall Study|Other|0|||
146162431|NCT01377480|527104689|FG002|Overall Study|Other|7|||
146162432|NCT01377480|527104690|FG003|Overall Study|Other|6|||
146162433|NCT01111123|527104694|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
146162434|NCT01111123|527104695|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
146162435|NCT01111123|527104694|FG000|Maintenance Phase|Lost to Follow-up|0|||
146162436|NCT01111123|527104695|FG001|Maintenance Phase|Lost to Follow-up|2|||
146162437|NCT01735201|527104696|FG000|Overall Study|Adverse Event|1|||
146162438|NCT01735201|527104697|FG001|Overall Study|Adverse Event|1|||
146162439|NCT01735201|527104698|FG002|Overall Study|Adverse Event|0|||
146162440|NCT01735201|527104699|FG003|Overall Study|Adverse Event|1|||
146162441|NCT01735201|527104700|FG004|Overall Study|Adverse Event|1|||
146162442|NCT01735201|527104701|FG005|Overall Study|Adverse Event|3|||
146162443|NCT01735201|527104702|FG006|Overall Study|Adverse Event|2|||
146162444|NCT01735201|527104703|FG007|Overall Study|Adverse Event|1|||
146162445|NCT01735201|527104696|FG000|Overall Study|Personal Reasons|1|||
146162446|NCT01735201|527104697|FG001|Overall Study|Personal Reasons|0|||
146162447|NCT01735201|527104698|FG002|Overall Study|Personal Reasons|0|||
146162448|NCT01735201|527104699|FG003|Overall Study|Personal Reasons|0|||
146162449|NCT01735201|527104700|FG004|Overall Study|Personal Reasons|0|||
146162450|NCT01735201|527104701|FG005|Overall Study|Personal Reasons|0|||
146162451|NCT01735201|527104702|FG006|Overall Study|Personal Reasons|0|||
146162452|NCT01735201|527104703|FG007|Overall Study|Personal Reasons|0|||
146162453|NCT01735201|527104696|FG000|Overall Study|Protocol Violation|1|||
146162454|NCT01735201|527104697|FG001|Overall Study|Protocol Violation|0|||
146162455|NCT01735201|527104698|FG002|Overall Study|Protocol Violation|0|||
146162456|NCT01735201|527104699|FG003|Overall Study|Protocol Violation|0|||
146162457|NCT01735201|527104700|FG004|Overall Study|Protocol Violation|0|||
146162458|NCT01735201|527104701|FG005|Overall Study|Protocol Violation|0|||
146162459|NCT01735201|527104702|FG006|Overall Study|Protocol Violation|0|||
146162460|NCT01735201|527104703|FG007|Overall Study|Protocol Violation|0|||
146162461|NCT01735201|527104696|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146162462|NCT01735201|527104697|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146162463|NCT01735201|527104698|FG002|Overall Study|Other Miscellaneous Reasons|0|||
146162464|NCT01735201|527104699|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146162465|NCT01735201|527104700|FG004|Overall Study|Other Miscellaneous Reasons|0|||
146162466|NCT01735201|527104701|FG005|Overall Study|Other Miscellaneous Reasons|2|||
146162467|NCT01735201|527104702|FG006|Overall Study|Other Miscellaneous Reasons|1|||
146162468|NCT01735201|527104703|FG007|Overall Study|Other Miscellaneous Reasons|1|||
146315890|NCT03315871|527666150|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
146315891|NCT03315871|527666151|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
146315892|NCT03315871|527666152|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
146315893|NCT00328627|527669392|FG000|Overall Study|Hyperglycemic Rescue|41|||
146315894|NCT00328627|527669393|FG001|Overall Study|Hyperglycemic Rescue|18|||
146315895|NCT00328627|527669394|FG002|Overall Study|Hyperglycemic Rescue|16|||
146315896|NCT00328627|527669395|FG003|Overall Study|Hyperglycemic Rescue|13|||
146162469|NCT01203930|527104708|FG000|Overall Study|Disease Progression|0|||
146162470|NCT01203930|527104709|FG001|Overall Study|Disease Progression|4|||
146162471|NCT01203930|527104708|FG000|Overall Study|Death|3|||
146162472|NCT01203930|527104709|FG001|Overall Study|Death|1|||
146162473|NCT01203930|527104708|FG000|Overall Study|Withdrew Consent|1|||
146162474|NCT01203930|527104709|FG001|Overall Study|Withdrew Consent|10|||
146162475|NCT01203930|527104708|FG000|Overall Study|Investigator Request|0|||
146162476|NCT01203930|527104709|FG001|Overall Study|Investigator Request|8|||
146162477|NCT01203930|527104708|FG000|Overall Study|Study Terminated by Sponsor|0|||
146162478|NCT01203930|527104709|FG001|Overall Study|Study Terminated by Sponsor|12|||
146162479|NCT01203930|527104708|FG000|Overall Study|Poor tolerance of study drug|0|||
146162480|NCT01203930|527104709|FG001|Overall Study|Poor tolerance of study drug|1|||
146162481|NCT01203930|527104708|FG000|Overall Study|Adverse Event|17|||
146162482|NCT01203930|527104709|FG001|Overall Study|Adverse Event|5|||
146162483|NCT04128293|527104712|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146162484|NCT04128293|527104713|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146162485|NCT04128293|527104714|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146162486|NCT04128293|527104715|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
146162487|NCT03014674|527104719|FG000|Overall Study|Withdrawal by Subject|1|||
146315897|NCT00328627|527669396|FG004|Overall Study|Hyperglycemic Rescue|6|||
146315898|NCT00328627|527669397|FG005|Overall Study|Hyperglycemic Rescue|5|||
146315899|NCT00328627|527669398|FG006|Overall Study|Hyperglycemic Rescue|19|||
146315900|NCT00328627|527669399|FG007|Overall Study|Hyperglycemic Rescue|6|||
146315901|NCT00328627|527669400|FG008|Overall Study|Hyperglycemic Rescue|6|||
146315902|NCT00328627|527669401|FG009|Overall Study|Hyperglycemic Rescue|11|||
146315903|NCT00328627|527669402|FG010|Overall Study|Hyperglycemic Rescue|3|||
146315904|NCT00328627|527669403|FG011|Overall Study|Hyperglycemic Rescue|2|||
146315905|NCT00328627|527669392|FG000|Overall Study|Adverse Event|3|||
146315906|NCT00328627|527669393|FG001|Overall Study|Adverse Event|1|||
146315907|NCT00328627|527669394|FG002|Overall Study|Adverse Event|2|||
146315908|NCT00328627|527669395|FG003|Overall Study|Adverse Event|3|||
146315909|NCT00328627|527669396|FG004|Overall Study|Adverse Event|1|||
146315910|NCT00328627|527669397|FG005|Overall Study|Adverse Event|2|||
146315911|NCT00328627|527669398|FG006|Overall Study|Adverse Event|1|||
146315912|NCT00328627|527669399|FG007|Overall Study|Adverse Event|2|||
146315913|NCT00328627|527669400|FG008|Overall Study|Adverse Event|0|||
146315914|NCT00328627|527669401|FG009|Overall Study|Adverse Event|7|||
146315915|NCT00328627|527669402|FG010|Overall Study|Adverse Event|5|||
146315916|NCT00328627|527669403|FG011|Overall Study|Adverse Event|4|||
146315917|NCT00328627|527669392|FG000|Overall Study|Protocol Violation|2|||
146315918|NCT00328627|527669393|FG001|Overall Study|Protocol Violation|2|||
146315919|NCT00328627|527669394|FG002|Overall Study|Protocol Violation|2|||
146315920|NCT00328627|527669395|FG003|Overall Study|Protocol Violation|8|||
146315921|NCT00328627|527669396|FG004|Overall Study|Protocol Violation|5|||
146315922|NCT00328627|527669397|FG005|Overall Study|Protocol Violation|5|||
146315923|NCT00328627|527669398|FG006|Overall Study|Protocol Violation|6|||
146315924|NCT00328627|527669399|FG007|Overall Study|Protocol Violation|2|||
146315925|NCT00328627|527669400|FG008|Overall Study|Protocol Violation|1|||
146315926|NCT00328627|527669401|FG009|Overall Study|Protocol Violation|4|||
146315927|NCT00328627|527669402|FG010|Overall Study|Protocol Violation|6|||
146315928|NCT00328627|527669403|FG011|Overall Study|Protocol Violation|2|||
146315929|NCT00328627|527669392|FG000|Overall Study|Lost to Follow-up|4|||
146315930|NCT00328627|527669393|FG001|Overall Study|Lost to Follow-up|2|||
146315931|NCT00328627|527669394|FG002|Overall Study|Lost to Follow-up|2|||
146315932|NCT00328627|527669395|FG003|Overall Study|Lost to Follow-up|4|||
146315933|NCT00328627|527669396|FG004|Overall Study|Lost to Follow-up|0|||
146315934|NCT00328627|527669397|FG005|Overall Study|Lost to Follow-up|2|||
146315935|NCT00328627|527669398|FG006|Overall Study|Lost to Follow-up|3|||
146315936|NCT00328627|527669399|FG007|Overall Study|Lost to Follow-up|0|||
146315937|NCT00328627|527669400|FG008|Overall Study|Lost to Follow-up|3|||
146315938|NCT00328627|527669401|FG009|Overall Study|Lost to Follow-up|2|||
146315939|NCT00328627|527669402|FG010|Overall Study|Lost to Follow-up|0|||
146315940|NCT00328627|527669403|FG011|Overall Study|Lost to Follow-up|1|||
146315941|NCT00328627|527669392|FG000|Overall Study|Withdrawal by Subject|5|||
146315942|NCT00328627|527669393|FG001|Overall Study|Withdrawal by Subject|4|||
146315943|NCT00328627|527669394|FG002|Overall Study|Withdrawal by Subject|5|||
146315944|NCT00328627|527669395|FG003|Overall Study|Withdrawal by Subject|6|||
146315945|NCT00328627|527669396|FG004|Overall Study|Withdrawal by Subject|2|||
146315946|NCT00328627|527669397|FG005|Overall Study|Withdrawal by Subject|5|||
146315947|NCT00328627|527669398|FG006|Overall Study|Withdrawal by Subject|4|||
146315948|NCT00328627|527669399|FG007|Overall Study|Withdrawal by Subject|4|||
146315949|NCT00328627|527669400|FG008|Overall Study|Withdrawal by Subject|4|||
146315950|NCT00328627|527669401|FG009|Overall Study|Withdrawal by Subject|5|||
146315951|NCT00328627|527669402|FG010|Overall Study|Withdrawal by Subject|2|||
146315952|NCT00328627|527669403|FG011|Overall Study|Withdrawal by Subject|7|||
146315953|NCT00328627|527669392|FG000|Overall Study|Pregnancy|0|||
146315954|NCT00328627|527669393|FG001|Overall Study|Pregnancy|1|||
146315955|NCT00328627|527669394|FG002|Overall Study|Pregnancy|0|||
146315956|NCT00328627|527669395|FG003|Overall Study|Pregnancy|0|||
146315957|NCT00328627|527669396|FG004|Overall Study|Pregnancy|0|||
146315958|NCT00328627|527669397|FG005|Overall Study|Pregnancy|0|||
146315959|NCT00328627|527669398|FG006|Overall Study|Pregnancy|0|||
146315960|NCT00328627|527669399|FG007|Overall Study|Pregnancy|0|||
146315961|NCT00328627|527669400|FG008|Overall Study|Pregnancy|0|||
146162488|NCT03014674|527104720|FG001|Overall Study|Withdrawal by Subject|0|||
146315962|NCT00328627|527669401|FG009|Overall Study|Pregnancy|0|||
146315963|NCT00328627|527669402|FG010|Overall Study|Pregnancy|0|||
146315964|NCT00328627|527669403|FG011|Overall Study|Pregnancy|0|||
146315965|NCT00328627|527669392|FG000|Overall Study|Physician Decision|4|||
146315966|NCT00328627|527669393|FG001|Overall Study|Physician Decision|3|||
146315967|NCT00328627|527669394|FG002|Overall Study|Physician Decision|1|||
146315968|NCT00328627|527669395|FG003|Overall Study|Physician Decision|2|||
146315969|NCT00328627|527669396|FG004|Overall Study|Physician Decision|1|||
146315970|NCT00328627|527669397|FG005|Overall Study|Physician Decision|1|||
146315971|NCT00328627|527669398|FG006|Overall Study|Physician Decision|1|||
146315972|NCT00328627|527669399|FG007|Overall Study|Physician Decision|0|||
146315973|NCT00328627|527669400|FG008|Overall Study|Physician Decision|3|||
146162489|NCT03014674|527104721|FG002|Overall Study|Withdrawal by Subject|0|||
146315974|NCT00328627|527669401|FG009|Overall Study|Physician Decision|2|||
146315975|NCT00328627|527669402|FG010|Overall Study|Physician Decision|1|||
146315976|NCT00328627|527669403|FG011|Overall Study|Physician Decision|0|||
146315977|NCT00328627|527669392|FG000|Overall Study|Other|0|||
146315978|NCT00328627|527669393|FG001|Overall Study|Other|0|||
146315979|NCT00328627|527669394|FG002|Overall Study|Other|0|||
146315980|NCT00328627|527669395|FG003|Overall Study|Other|1|||
146315981|NCT00328627|527669396|FG004|Overall Study|Other|0|||
146315982|NCT00328627|527669397|FG005|Overall Study|Other|0|||
146315983|NCT00328627|527669398|FG006|Overall Study|Other|1|||
146315984|NCT00328627|527669399|FG007|Overall Study|Other|0|||
146315985|NCT00328627|527669400|FG008|Overall Study|Other|0|||
146315986|NCT00328627|527669401|FG009|Overall Study|Other|1|||
146315987|NCT00328627|527669402|FG010|Overall Study|Other|1|||
146315988|NCT00328627|527669403|FG011|Overall Study|Other|0|||
146315989|NCT03409744|527669404|FG000|Overall Study|Death|2|||
146315990|NCT03409744|527669404|FG000|Overall Study|Physician Decision|5|||
146315991|NCT03409744|527669404|FG000|Overall Study|Pregnancy|1|||
146315992|NCT03409744|527669404|FG000|Overall Study|Lost to Follow-up|1|||
146315993|NCT03409744|527669404|FG000|Overall Study|Protocol Violation|1|||
146315994|NCT00264004|527669406|FG000|Overall Study|Adverse Event|2|||
146315995|NCT00264004|527669407|FG001|Overall Study|Adverse Event|3|||
146315996|NCT00264004|527669408|FG002|Overall Study|Adverse Event|6|||
146315997|NCT00264004|527669409|FG003|Overall Study|Adverse Event|4|||
146315998|NCT00264004|527669406|FG000|Overall Study|Withdrawal by Subject|0|||
146315999|NCT00264004|527669407|FG001|Overall Study|Withdrawal by Subject|1|||
146316000|NCT00264004|527669408|FG002|Overall Study|Withdrawal by Subject|2|||
146316001|NCT00264004|527669409|FG003|Overall Study|Withdrawal by Subject|2|||
146316002|NCT00264004|527669406|FG000|Overall Study|Other|2|||
146316003|NCT00264004|527669407|FG001|Overall Study|Other|2|||
146316004|NCT00264004|527669408|FG002|Overall Study|Other|0|||
146316005|NCT00264004|527669409|FG003|Overall Study|Other|3|||
146316006|NCT00264004|527669406|FG000|Overall Study|Development study specific disc. crit.|1|||
146316007|NCT00264004|527669407|FG001|Overall Study|Development study specific disc. crit.|0|||
146316008|NCT00264004|527669408|FG002|Overall Study|Development study specific disc. crit.|1|||
146316009|NCT00264004|527669409|FG003|Overall Study|Development study specific disc. crit.|0|||
146316010|NCT00264004|527669406|FG000|Overall Study|Cond. under inv. worsened|9|||
146316011|NCT00264004|527669407|FG001|Overall Study|Cond. under inv. worsened|5|||
146316012|NCT00264004|527669408|FG002|Overall Study|Cond. under inv. worsened|3|||
146316013|NCT00264004|527669409|FG003|Overall Study|Cond. under inv. worsened|4|||
146316014|NCT00264004|527669406|FG000|Overall Study|Not treated|3|||
146316015|NCT00264004|527669407|FG001|Overall Study|Not treated|0|||
146316016|NCT00264004|527669408|FG002|Overall Study|Not treated|2|||
146316017|NCT00264004|527669409|FG003|Overall Study|Not treated|2|||
146316018|NCT00272038|527669412|FG000|Overall Study|withdrew before they received 2 cycles|7|||
146316019|NCT00356278|527669413|FG000|Overall Study|Withdrawal by Subject|25|||
146316020|NCT00356278|527669414|FG001|Overall Study|Withdrawal by Subject|15|||
146316021|NCT00356278|527669415|FG002|Overall Study|Withdrawal by Subject|19|||
146316022|NCT00527605|527669416|FG000|Overall Study|Adverse Event|3|||
146316023|NCT00527605|527669417|FG001|Overall Study|Adverse Event|0|||
146316024|NCT00527605|527669416|FG000|Overall Study|Withdrawal by Subject|3|||
146316025|NCT00527605|527669417|FG001|Overall Study|Withdrawal by Subject|7|||
146316026|NCT00527605|527669416|FG000|Overall Study|Lost to Follow-up|6|||
146316027|NCT00527605|527669417|FG001|Overall Study|Lost to Follow-up|2|||
146316028|NCT00527605|527669416|FG000|Overall Study|Protocol Violation|1|||
146316029|NCT00527605|527669417|FG001|Overall Study|Protocol Violation|2|||
146316030|NCT04986202|527669418|FG000|Overall Study|Death|10|||
146316031|NCT04986202|527669419|FG001|Overall Study|Death|3|||
146316032|NCT04986202|527669420|FG002|Overall Study|Death|10|||
146316033|NCT04986202|527669418|FG000|Overall Study|Physician Decision|3|||
146316034|NCT04986202|527669419|FG001|Overall Study|Physician Decision|1|||
146316035|NCT04986202|527669420|FG002|Overall Study|Physician Decision|2|||
146316036|NCT04986202|527669418|FG000|Overall Study|Withdrawal by Subject|4|||
146316037|NCT04986202|527669419|FG001|Overall Study|Withdrawal by Subject|2|||
146316038|NCT04986202|527669420|FG002|Overall Study|Withdrawal by Subject|4|||
146316039|NCT02118792|527669421|FG000|Overall Study|Withdrawal by Subject|6|||
146316040|NCT02118792|527669422|FG001|Overall Study|Withdrawal by Subject|3|||
146316041|NCT02118792|527669421|FG000|Overall Study|Lost to Follow-up|4|||
146316042|NCT02118792|527669422|FG001|Overall Study|Lost to Follow-up|4|||
146316043|NCT02118792|527669421|FG000|Overall Study|Adverse Event|5|||
146316044|NCT02118792|527669422|FG001|Overall Study|Adverse Event|4|||
146316045|NCT02118792|527669421|FG000|Overall Study|Withdrawal by parent/guardian|14|||
146316046|NCT02118792|527669422|FG001|Overall Study|Withdrawal by parent/guardian|20|||
146316047|NCT02118792|527669421|FG000|Overall Study|Other|1|||
146316048|NCT02118792|527669422|FG001|Overall Study|Other|6|||
146316049|NCT02118792|527669421|FG000|Overall Study|Randomised but not treated|1|||
146316050|NCT02118792|527669422|FG001|Overall Study|Randomised but not treated|0|||
146316051|NCT05131204|527669423|FG000|Overall Study|Sponsor request|2|||
146316052|NCT05131204|527669424|FG001|Overall Study|Sponsor request|1|||
146316053|NCT05980299|527669428|FG000|Overall Study|Death|28|||
146316054|NCT05980299|527669429|FG001|Overall Study|Death|0|||
146316055|NCT05980299|527669428|FG000|Overall Study|Discharged from Nursing Home|9|||
146316056|NCT05980299|527669429|FG001|Overall Study|Discharged from Nursing Home|0|||
146316057|NCT05980299|527669428|FG000|Overall Study|Lost to Follow-up|0|||
146316058|NCT05980299|527669429|FG001|Overall Study|Lost to Follow-up|10|||
146316059|NCT00290433|527669432|FG000|Overall Study|Disease Progression|13|||
146316060|NCT00290433|527669432|FG000|Overall Study|Adverse Event|14|||
146316061|NCT00290433|527669432|FG000|Overall Study|Withdrawal by Subject|1|||
146316062|NCT00290433|527669432|FG000|Overall Study|Non-Compliance|1|||
146162490|NCT01332227|527104722|FG000|Overall Study|Adverse Event|4|||
146162491|NCT01332227|527104723|FG001|Overall Study|Adverse Event|1|||
146162492|NCT01332227|527104722|FG000|Overall Study|Withdrawal by Subject|5|||
146162493|NCT01332227|527104723|FG001|Overall Study|Withdrawal by Subject|1|||
146162494|NCT01332227|527104722|FG000|Overall Study|Lost to Follow-up|2|||
146162495|NCT01332227|527104723|FG001|Overall Study|Lost to Follow-up|0|||
146162496|NCT01332227|527104722|FG000|Overall Study|Lack of Efficacy|3|||
146162497|NCT01332227|527104723|FG001|Overall Study|Lack of Efficacy|1|||
146162498|NCT01332227|527104722|FG000|Overall Study|Poor compliance/noncompliance|1|||
146162499|NCT01332227|527104723|FG001|Overall Study|Poor compliance/noncompliance|1|||
146162500|NCT01332227|527104722|FG000|Overall Study|Patient moved from area|1|||
146162501|NCT01332227|527104723|FG001|Overall Study|Patient moved from area|0|||
146162502|NCT01332227|527104722|FG000|Overall Study|Patient began prohibited medication|0|||
146162503|NCT01332227|527104723|FG001|Overall Study|Patient began prohibited medication|1|||
146162504|NCT00514943|527104724|FG000|Stage 1|Progressive disease|4|||
146162505|NCT00514943|527104725|FG001|Stage 1|Progressive disease|8|||
146162506|NCT00514943|527104724|FG000|Stage 1|Other Adverse Event|16|||
146162507|NCT00514943|527104725|FG001|Stage 1|Other Adverse Event|6|||
146162508|NCT00514943|527104724|FG000|Stage 1|Not treated|1|||
146162509|NCT00514943|527104725|FG001|Stage 1|Not treated|2|||
146162510|NCT00514943|527104724|FG000|Stage 1|Patient refused to continue study meds|8|||
146162511|NCT00514943|527104725|FG001|Stage 1|Patient refused to continue study meds|3|||
146316063|NCT00290433|527669432|FG000|Overall Study|Congestive Heart Failure|1|||
146316064|NCT00290433|527669432|FG000|Overall Study|Transplant in CR|5|||
146316065|NCT00290433|527669432|FG000|Overall Study|Unrelated Infection/Death|1|||
146316066|NCT02264990|527669437|FG000|Overall Study|Death|255|||
146316067|NCT02264990|527669438|FG001|Overall Study|Death|250|||
146316068|NCT02264990|527669437|FG000|Overall Study|Withdrawal by Subject|4|||
146316069|NCT02264990|527669438|FG001|Overall Study|Withdrawal by Subject|5|||
146316070|NCT02264990|527669437|FG000|Overall Study|Lost to Follow-up|1|||
146316071|NCT02264990|527669438|FG001|Overall Study|Lost to Follow-up|3|||
146316072|NCT02264990|527669437|FG000|Overall Study|Other|0|||
146316073|NCT02264990|527669438|FG001|Overall Study|Other|1|||
146316074|NCT01098071|527669447|FG000|Overall Study|Surgery (adenoidectomy)|2|||
146316075|NCT01098071|527669447|FG000|Overall Study|Lost to Follow-up|13|||
146316076|NCT00705939|527669448|FG000|Overall Study|Protocol Violation|0|||
146316077|NCT00705939|527669449|FG001|Overall Study|Protocol Violation|0|||
146316078|NCT00705939|527669450|FG002|Overall Study|Protocol Violation|1|||
146316079|NCT00705939|527669448|FG000|Overall Study|Withdrawal by Subject|0|||
146316080|NCT00705939|527669449|FG001|Overall Study|Withdrawal by Subject|1|||
146162512|NCT00514943|527104724|FG000|Stage 1|Other than stated above|1|||
146316081|NCT00705939|527669450|FG002|Overall Study|Withdrawal by Subject|3|||
146316082|NCT00705939|527669448|FG000|Overall Study|Physician Decision|0|||
146316083|NCT00705939|527669449|FG001|Overall Study|Physician Decision|1|||
146316084|NCT00705939|527669450|FG002|Overall Study|Physician Decision|0|||
146316085|NCT01662895|527669451|FG000|Overall Study|Lost to Follow-up|0|||
146316086|NCT01662895|527669452|FG001|Overall Study|Lost to Follow-up|1|||
146316087|NCT05048342|527669453|FG000|Overall Study|Adverse Event|1|||
146316088|NCT05048342|527669453|FG000|Overall Study|Subject decision|2|||
146316089|NCT01441063|527669454|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
146316090|NCT01441063|527669454|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
146316091|NCT00797732|527669458|FG000|Overall Study|Withdrawal by Subject|3|||
146316092|NCT00797732|527669459|FG001|Overall Study|Withdrawal by Subject|3|||
146316093|NCT00797732|527669460|FG002|Overall Study|Withdrawal by Subject|0|||
146162513|NCT00514943|527104725|FG001|Stage 1|Other than stated above|7|||
146162514|NCT00514943|527104724|FG000|Stage 2|Progressive disease|27|||
146316094|NCT00797732|527669458|FG000|Overall Study|Lost to Follow-up|1|||
146316095|NCT00797732|527669459|FG001|Overall Study|Lost to Follow-up|0|||
146316096|NCT00797732|527669460|FG002|Overall Study|Lost to Follow-up|0|||
146316097|NCT00797732|527669458|FG000|Overall Study|Death|1|||
146316098|NCT00797732|527669459|FG001|Overall Study|Death|0|||
146316099|NCT00797732|527669460|FG002|Overall Study|Death|0|||
146316100|NCT00797732|527669458|FG000|Overall Study|Not meet inclusion criteria|0|||
146316101|NCT00797732|527669459|FG001|Overall Study|Not meet inclusion criteria|0|||
146316102|NCT00797732|527669460|FG002|Overall Study|Not meet inclusion criteria|7|||
146162515|NCT00514943|527104725|FG001|Stage 2|Progressive disease|24|||
146162516|NCT00514943|527104724|FG000|Stage 2|Other Adverse Event|3|||
146162517|NCT00514943|527104725|FG001|Stage 2|Other Adverse Event|10|||
146162518|NCT00514943|527104724|FG000|Stage 2|Patient refused to continue study meds|2|||
146162519|NCT00514943|527104725|FG001|Stage 2|Patient refused to continue study meds|0|||
146316103|NCT00797732|527669458|FG000|Overall Study|Excluded due to time constraints|0|||
146316104|NCT00797732|527669459|FG001|Overall Study|Excluded due to time constraints|0|||
146316105|NCT00797732|527669460|FG002|Overall Study|Excluded due to time constraints|24|||
146316106|NCT00797732|527669458|FG000|Overall Study|Refused to Participate|0|||
146316107|NCT00797732|527669459|FG001|Overall Study|Refused to Participate|0|||
146316108|NCT00797732|527669460|FG002|Overall Study|Refused to Participate|123|||
146316109|NCT02275338|527669467|FG000|Overall Study|Adverse Event|15|||
146316110|NCT02275338|527669467|FG000|Overall Study|Lack of Efficacy|3|||
146316111|NCT02275338|527669467|FG000|Overall Study|Withdrawal by Subject|4|||
146316112|NCT02275338|527669467|FG000|Overall Study|Disease progression (death)|1|||
146316113|NCT02275338|527669467|FG000|Overall Study|Ineligible to start Phase 2|4|||
146316114|NCT02275338|527669467|FG000|Overall Study|Reason not specified|5|||
146316115|NCT02275338|527669467|FG000|Overall Study|Does not meet entry criteria|1|||
146316116|NCT04607733|527669471|FG000|Overall Study|Lost to Follow-up|1|||
146316117|NCT04607733|527669472|FG001|Overall Study|Lost to Follow-up|0|||
146316118|NCT04607733|527669473|FG002|Overall Study|Lost to Follow-up|0|||
146316119|NCT04607733|527669474|FG003|Overall Study|Lost to Follow-up|1|||
146316120|NCT04607733|527669475|FG004|Overall Study|Lost to Follow-up|1|||
146316121|NCT04607733|527669476|FG005|Overall Study|Lost to Follow-up|0|||
146316122|NCT04607733|527669471|FG000|Overall Study|Withdrawal by Subject|0|||
146316123|NCT04607733|527669472|FG001|Overall Study|Withdrawal by Subject|0|||
146316124|NCT04607733|527669473|FG002|Overall Study|Withdrawal by Subject|0|||
146316125|NCT04607733|527669474|FG003|Overall Study|Withdrawal by Subject|0|||
146316126|NCT04607733|527669475|FG004|Overall Study|Withdrawal by Subject|1|||
146316127|NCT04607733|527669476|FG005|Overall Study|Withdrawal by Subject|0|||
146316128|NCT01665807|527669477|FG000|Overall Study|Withdrawal by Subject|2|||
146316129|NCT01665807|527669478|FG001|Overall Study|Withdrawal by Subject|0|||
146316130|NCT01665807|527669479|FG002|Overall Study|Withdrawal by Subject|1|||
146316131|NCT03504397|527669480|FG000|Overall Study|Progressive Disease|151|||
146316132|NCT03504397|527669481|FG001|Overall Study|Progressive Disease|199|||
146316133|NCT03504397|527669480|FG000|Overall Study|Withdrawal by Subject|29|||
146316134|NCT03504397|527669481|FG001|Overall Study|Withdrawal by Subject|17|||
146316135|NCT03504397|527669480|FG000|Overall Study|Lost to Follow-up|1|||
146316136|NCT03504397|527669481|FG001|Overall Study|Lost to Follow-up|0|||
146316137|NCT03504397|527669480|FG000|Overall Study|Death|14|||
146316138|NCT03504397|527669481|FG001|Overall Study|Death|16|||
146316139|NCT03504397|527669480|FG000|Overall Study|Adverse Event|40|||
146316140|NCT03504397|527669481|FG001|Overall Study|Adverse Event|14|||
146316141|NCT03504397|527669480|FG000|Overall Study|miscellaneous|17|||
146316142|NCT03504397|527669481|FG001|Overall Study|miscellaneous|15|||
146316143|NCT03504397|527669480|FG000|Overall Study|Protocol deviation|1|||
146316144|NCT03504397|527669481|FG001|Overall Study|Protocol deviation|0|||
146316145|NCT03504397|527669480|FG000|Overall Study|Participants who did not take the study drug|4|||
146316146|NCT03504397|527669481|FG001|Overall Study|Participants who did not take the study drug|4|||
146316147|NCT03603496|527669484|FG000|Overall Study|Death|19|||
146316148|NCT03603496|527669485|FG001|Overall Study|Death|24|||
146316149|NCT03603496|527669484|FG000|Overall Study|Lost to Follow-up|141|||
146316150|NCT03603496|527669485|FG001|Overall Study|Lost to Follow-up|141|||
146316151|NCT03603496|527669484|FG000|Overall Study|Withdrawal by Subject|26|||
146316152|NCT03603496|527669485|FG001|Overall Study|Withdrawal by Subject|20|||
146316153|NCT03594227|527669486|FG000|Overall Study|Adverse Event|2|||
146316154|NCT03594227|527669487|FG001|Overall Study|Adverse Event|1|||
146316155|NCT03594227|527669488|FG002|Overall Study|Adverse Event|0|||
146316156|NCT03594227|527669489|FG003|Overall Study|Adverse Event|2|||
146316157|NCT03594227|527669486|FG000|Overall Study|Lost to Follow-up|1|||
146316158|NCT03594227|527669487|FG001|Overall Study|Lost to Follow-up|1|||
146316159|NCT03594227|527669488|FG002|Overall Study|Lost to Follow-up|1|||
146316160|NCT03594227|527669489|FG003|Overall Study|Lost to Follow-up|0|||
146316161|NCT03594227|527669486|FG000|Overall Study|Withdrawal by Subject|1|||
146316162|NCT03594227|527669487|FG001|Overall Study|Withdrawal by Subject|1|||
146316163|NCT03594227|527669488|FG002|Overall Study|Withdrawal by Subject|1|||
146316164|NCT03594227|527669489|FG003|Overall Study|Withdrawal by Subject|1|||
146316165|NCT03594227|527669486|FG000|Overall Study|Pregnancy|0|||
146316166|NCT03594227|527669487|FG001|Overall Study|Pregnancy|1|||
146316167|NCT03594227|527669488|FG002|Overall Study|Pregnancy|0|||
146316168|NCT03594227|527669489|FG003|Overall Study|Pregnancy|0|||
146316169|NCT03594227|527669486|FG000|Overall Study|Sponsor Decision|0|||
146316170|NCT03594227|527669487|FG001|Overall Study|Sponsor Decision|0|||
146316171|NCT03594227|527669488|FG002|Overall Study|Sponsor Decision|0|||
146316172|NCT03594227|527669489|FG003|Overall Study|Sponsor Decision|1|||
146316173|NCT03594227|527669486|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
146316174|NCT03594227|527669487|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
146316175|NCT03594227|527669488|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
146316176|NCT03594227|527669489|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
146316177|NCT00790907|527669490|FG000|Overall Study|Adverse Event|9|||
146316178|NCT00790907|527669491|FG001|Overall Study|Adverse Event|7|||
146316179|NCT00790907|527669492|FG002|Overall Study|Adverse Event|6|||
146316180|NCT00790907|527669490|FG000|Overall Study|Physician Decision|304|||
146282164|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
146282165|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282166|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
146282167|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
146282168|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282169|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282170|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282171|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282172|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282173|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
146282174|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282175|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282176|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282177|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282178|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
146282179|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282180|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
146282181|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
146282182|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282183|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282184|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146316181|NCT00790907|527669491|FG001|Overall Study|Physician Decision|271|||
146316182|NCT00790907|527669492|FG002|Overall Study|Physician Decision|255|||
146316183|NCT00790907|527669490|FG000|Overall Study|Withdrawal by Subject|1|||
146316184|NCT00790907|527669491|FG001|Overall Study|Withdrawal by Subject|7|||
146316185|NCT00790907|527669492|FG002|Overall Study|Withdrawal by Subject|5|||
146316186|NCT00790907|527669490|FG000|Overall Study|Bleeding Event|11|||
146316187|NCT00790907|527669491|FG001|Overall Study|Bleeding Event|16|||
146316188|NCT00790907|527669492|FG002|Overall Study|Bleeding Event|21|||
146316189|NCT00790907|527669490|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
146316190|NCT00790907|527669491|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
146316191|NCT00790907|527669492|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
146316192|NCT00790907|527669490|FG000|Overall Study|Qualifying Condition Not Present|29|||
146316193|NCT00790907|527669491|FG001|Overall Study|Qualifying Condition Not Present|14|||
146316194|NCT00790907|527669492|FG002|Overall Study|Qualifying Condition Not Present|16|||
146316195|NCT00790907|527669490|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
146316196|NCT00790907|527669491|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
146316197|NCT00790907|527669492|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
146316198|NCT00790907|527669490|FG000|Overall Study|Did Not Receive Study Drug|10|||
146316199|NCT00790907|527669491|FG001|Overall Study|Did Not Receive Study Drug|0|||
146282185|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282186|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282187|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
146282188|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282189|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282190|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282191|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282192|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
146282193|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282194|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282195|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282196|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282197|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282198|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282199|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282200|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282201|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
146282202|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282203|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282204|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282205|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282206|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
146282207|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
146282208|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
146282209|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
146282210|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282211|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282212|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146316200|NCT00790907|527669492|FG002|Overall Study|Did Not Receive Study Drug|0|||
146316201|NCT01888640|527669493|FG000|Overall Study|Lost to Follow-up|1|||
146316202|NCT01888640|527669494|FG001|Overall Study|Lost to Follow-up|2|||
146316203|NCT01888640|527669495|FG002|Overall Study|Lost to Follow-up|0|||
146316204|NCT01888640|527669493|FG000|Overall Study|Withdrawal by Subject|15|||
146316205|NCT01888640|527669494|FG001|Overall Study|Withdrawal by Subject|11|||
146316206|NCT01888640|527669495|FG002|Overall Study|Withdrawal by Subject|4|||
146316207|NCT01888640|527669493|FG000|Overall Study|Minimum dose not met|10|||
146316208|NCT01888640|527669494|FG001|Overall Study|Minimum dose not met|16|||
146316209|NCT01888640|527669495|FG002|Overall Study|Minimum dose not met|0|||
146316210|NCT01888640|527669493|FG000|Overall Study|Given wrong unit (placebo)|1|||
146316211|NCT01888640|527669494|FG001|Overall Study|Given wrong unit (placebo)|0|||
146316212|NCT01888640|527669495|FG002|Overall Study|Given wrong unit (placebo)|0|||
146316213|NCT01888640|527669493|FG000|Overall Study|Excluded for prior TENS|0|||
146316214|NCT01888640|527669494|FG001|Overall Study|Excluded for prior TENS|1|||
146316215|NCT01888640|527669495|FG002|Overall Study|Excluded for prior TENS|0|||
146316216|NCT01888640|527669493|FG000|Overall Study|Researcher Termination of Participant|0|||
146316217|NCT01888640|527669494|FG001|Overall Study|Researcher Termination of Participant|1|||
146316218|NCT01888640|527669495|FG002|Overall Study|Researcher Termination of Participant|1|||
146316219|NCT01277549|527669496|FG000|Overall Study|Failed to meet eligibility criteria|13|||
146316220|NCT01277549|527669497|FG001|Overall Study|Failed to meet eligibility criteria|9|||
146316221|NCT01277549|527669496|FG000|Overall Study|Withdrawal by Subject|1|||
146316222|NCT01277549|527669497|FG001|Overall Study|Withdrawal by Subject|3|||
146316223|NCT01277549|527669496|FG000|Overall Study|Protocol Violation|10|||
146316224|NCT01277549|527669497|FG001|Overall Study|Protocol Violation|1|||
146316225|NCT01277549|527669496|FG000|Overall Study|Physician Decision|2|||
146316226|NCT01277549|527669497|FG001|Overall Study|Physician Decision|1|||
146316227|NCT02109484|527669498|FG000|Overall Study|Lost to Follow-up|0|||
146316228|NCT02109484|527669499|FG001|Overall Study|Lost to Follow-up|0|||
146316229|NCT02109484|527669500|FG002|Overall Study|Lost to Follow-up|0|||
146316230|NCT02109484|527669501|FG003|Overall Study|Lost to Follow-up|1|||
146316231|NCT02109484|527669502|FG004|Overall Study|Lost to Follow-up|1|||
146316232|NCT02109484|527669503|FG005|Overall Study|Lost to Follow-up|0|||
146316233|NCT02109484|527669504|FG006|Overall Study|Lost to Follow-up|1|||
146316234|NCT02109484|527669505|FG007|Overall Study|Lost to Follow-up|0|||
146316235|NCT02109484|527669498|FG000|Overall Study|Withdrawal by Subject|0|||
146316236|NCT02109484|527669499|FG001|Overall Study|Withdrawal by Subject|0|||
146316237|NCT02109484|527669500|FG002|Overall Study|Withdrawal by Subject|0|||
146316238|NCT02109484|527669501|FG003|Overall Study|Withdrawal by Subject|0|||
146316239|NCT02109484|527669502|FG004|Overall Study|Withdrawal by Subject|1|||
146316240|NCT02109484|527669503|FG005|Overall Study|Withdrawal by Subject|1|||
146316241|NCT02109484|527669504|FG006|Overall Study|Withdrawal by Subject|1|||
146316242|NCT02109484|527669505|FG007|Overall Study|Withdrawal by Subject|0|||
146316243|NCT02109484|527669498|FG000|Overall Study|Physician Decision|0|||
146316244|NCT02109484|527669499|FG001|Overall Study|Physician Decision|0|||
146316245|NCT02109484|527669500|FG002|Overall Study|Physician Decision|0|||
146316246|NCT02109484|527669501|FG003|Overall Study|Physician Decision|0|||
146316247|NCT02109484|527669502|FG004|Overall Study|Physician Decision|2|||
146316248|NCT02109484|527669503|FG005|Overall Study|Physician Decision|0|||
146316249|NCT02109484|527669504|FG006|Overall Study|Physician Decision|0|||
146316250|NCT02109484|527669505|FG007|Overall Study|Physician Decision|0|||
146316251|NCT02109484|527669498|FG000|Overall Study|Death|0|||
146316252|NCT02109484|527669499|FG001|Overall Study|Death|0|||
146316253|NCT02109484|527669500|FG002|Overall Study|Death|0|||
146316254|NCT02109484|527669501|FG003|Overall Study|Death|0|||
146316255|NCT02109484|527669502|FG004|Overall Study|Death|0|||
146316256|NCT02109484|527669503|FG005|Overall Study|Death|0|||
146316257|NCT02109484|527669504|FG006|Overall Study|Death|0|||
146316258|NCT02109484|527669505|FG007|Overall Study|Death|2|||
146316259|NCT02109484|527669498|FG000|Overall Study|Moved away from study area|0|||
146316260|NCT02109484|527669499|FG001|Overall Study|Moved away from study area|0|||
146316261|NCT02109484|527669500|FG002|Overall Study|Moved away from study area|0|||
146316262|NCT02109484|527669501|FG003|Overall Study|Moved away from study area|0|||
146316263|NCT02109484|527669502|FG004|Overall Study|Moved away from study area|0|||
146316264|NCT02109484|527669503|FG005|Overall Study|Moved away from study area|0|||
146316265|NCT02109484|527669504|FG006|Overall Study|Moved away from study area|1|||
146316266|NCT02109484|527669505|FG007|Overall Study|Moved away from study area|1|||
146316267|NCT03215771|527669514|FG000|Overall Study|Withdrawal by Subject|2|||
146316268|NCT03215771|527669514|FG000|Overall Study|Physician Decision|1|||
146316269|NCT00574275|527669519|FG000|Overall Study|Randomized but not treated|2|||
146316270|NCT00574275|527669520|FG001|Overall Study|Randomized but not treated|3|||
146162520|NCT00514943|527104724|FG000|Stage 2|Other than stated above|0|||
146162521|NCT00514943|527104725|FG001|Stage 2|Other than stated above|2|||
146162522|NCT03751631|527104731|FG000|Overall Study|Withdrawal by Subject|0|||
146316271|NCT00574275|527669519|FG000|Overall Study|Adverse Event|32|||
146316272|NCT00574275|527669520|FG001|Overall Study|Adverse Event|76|||
146316273|NCT00574275|527669519|FG000|Overall Study|Disease progression|160|||
146316274|NCT00574275|527669520|FG001|Overall Study|Disease progression|146|||
146282213|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282214|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282215|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
146282216|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282217|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282218|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282219|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282220|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
146282221|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282222|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
146282223|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282224|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282225|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282226|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282227|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282228|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282229|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
146282230|NCT02663518|527546447|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282231|NCT02663518|527546448|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282232|NCT02663518|527546449|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282233|NCT02663518|527546450|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282234|NCT02663518|527546451|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282235|NCT02663518|527546452|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282236|NCT02663518|527546453|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
146282237|NCT02663518|527546454|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282238|NCT02663518|527546455|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282239|NCT02663518|527546456|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282240|NCT02663518|527546457|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146316275|NCT00574275|527669519|FG000|Overall Study|Lost to Follow-up|2|||
146316276|NCT00574275|527669520|FG001|Overall Study|Lost to Follow-up|1|||
146316277|NCT00574275|527669519|FG000|Overall Study|Study stopped based on DMC decision|62|||
146316278|NCT00574275|527669520|FG001|Overall Study|Study stopped based on DMC decision|23|||
146316279|NCT00574275|527669519|FG000|Overall Study|Withdrawal by Subject|15|||
146316280|NCT00574275|527669520|FG001|Overall Study|Withdrawal by Subject|17|||
146316281|NCT00574275|527669519|FG000|Overall Study|Error calculating tumor measurement|1|||
146316282|NCT00574275|527669520|FG001|Overall Study|Error calculating tumor measurement|0|||
146316283|NCT00574275|527669519|FG000|Overall Study|Physician Decision|1|||
146316284|NCT00574275|527669520|FG001|Overall Study|Physician Decision|1|||
146316285|NCT00574275|527669519|FG000|Overall Study|Protocol Violation|0|||
146316286|NCT00574275|527669520|FG001|Overall Study|Protocol Violation|1|||
146316287|NCT00574275|527669519|FG000|Overall Study|Patient and Investigator decision|0|||
146316288|NCT00574275|527669520|FG001|Overall Study|Patient and Investigator decision|1|||
146316289|NCT00574275|527669519|FG000|Overall Study|Insurance change|0|||
146316290|NCT00574275|527669520|FG001|Overall Study|Insurance change|1|||
146316291|NCT00574275|527669519|FG000|Overall Study|Operation for curative intent|0|||
146316292|NCT00574275|527669520|FG001|Overall Study|Operation for curative intent|1|||
146316293|NCT02703311|527669521|FG000|Overall Study|Death|5|||
146316294|NCT02703311|527669521|FG000|Overall Study|Withdrawal by Subject|3|||
146316295|NCT01967537|527669524|FG000|Overall Study|Withdrawal by Subject|52|||
146316296|NCT01967537|527669524|FG000|Overall Study|Refuse treatment|2|||
146316297|NCT01967537|527669524|FG000|Overall Study|Lost to Follow-up|6|||
146316298|NCT00137111|527669525|FG000|Total Therapy|Death|35|||
146316299|NCT00137111|527669526|FG001|Total Therapy|Death|0|||
146316300|NCT00137111|527669527|FG002|Total Therapy|Death|0|||
146316301|NCT00137111|527669528|FG003|Total Therapy|Death|0|||
146316302|NCT00137111|527669525|FG000|Total Therapy|Non Compliance|5|||
146316303|NCT00137111|527669526|FG001|Total Therapy|Non Compliance|0|||
146316304|NCT00137111|527669527|FG002|Total Therapy|Non Compliance|0|||
146316305|NCT00137111|527669528|FG003|Total Therapy|Non Compliance|0|||
146316306|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
146316307|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
146316308|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
146316309|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
146316310|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
146316311|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
146316312|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
146316313|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
146316314|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
146316315|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
146316316|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
146316317|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
146316318|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
146316319|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
146316320|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
146316321|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
146316322|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
146316323|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
146316324|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
146316325|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
146316326|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
146316327|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
146316328|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
146316329|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
146316330|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
146316331|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
146316332|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
146316333|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
146316334|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
146316335|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
146316336|NCT00784654|527669529|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
146316337|NCT00784654|527669530|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
146316338|NCT00784654|527669531|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
146316339|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
146316340|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
146316341|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
146316342|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
146316343|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
146316344|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
146316345|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146316346|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146316347|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
146316348|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
146316349|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
146316350|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
146316351|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146316352|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Adverse Event|1|||
146316353|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Adverse Event|1|||
146316354|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
146316355|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
146316356|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
146316357|NCT00784654|527669529|FG000|Randomized Withdrawal Period|Family reasons|0|||
146316358|NCT00784654|527669530|FG001|Randomized Withdrawal Period|Family reasons|0|||
146316359|NCT00784654|527669531|FG002|Randomized Withdrawal Period|Family reasons|1|||
146316360|NCT00562354|527669532|FG000|Overall Study|Physician Decision|0|||
146316361|NCT00562354|527669533|FG001|Overall Study|Physician Decision|1|||
146316362|NCT00562354|527669532|FG000|Overall Study|Lost to Follow-up|0|||
146316363|NCT00562354|527669533|FG001|Overall Study|Lost to Follow-up|1|||
146316364|NCT00317109|527669534|FG000|Overall Study|Withdrawal by Subject|2|||
146316365|NCT00317109|527669535|FG001|Overall Study|Withdrawal by Subject|0|||
146316366|NCT00317109|527669534|FG000|Overall Study|Migated/moved from study area|1|||
146316367|NCT00317109|527669535|FG001|Overall Study|Migated/moved from study area|0|||
146316368|NCT01026831|527669537|FG000|Overall Study|Adverse Event|4|||
146316369|NCT01026831|527669538|FG001|Overall Study|Adverse Event|3|||
146316370|NCT01026831|527669537|FG000|Overall Study|Lost to Follow-up|2|||
146316371|NCT01026831|527669538|FG001|Overall Study|Lost to Follow-up|0|||
146316372|NCT01026831|527669537|FG000|Overall Study|Physician Decision|1|||
146316373|NCT01026831|527669538|FG001|Overall Study|Physician Decision|1|||
146316374|NCT01026831|527669537|FG000|Overall Study|Protocol Violation|0|||
146316375|NCT01026831|527669538|FG001|Overall Study|Protocol Violation|2|||
146316376|NCT01026831|527669537|FG000|Overall Study|Withdrawal by Subject|7|||
146316377|NCT01026831|527669538|FG001|Overall Study|Withdrawal by Subject|5|||
146316378|NCT01079182|527669539|FG000|Overall Study|Lost to Follow-up|1634|||
146316379|NCT01079182|527669539|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
146316380|NCT01079182|527669539|FG000|Overall Study|Lack of Efficacy|514|||
146316381|NCT01079182|527669539|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
146316382|NCT01079182|527669539|FG000|Overall Study|Reasons not Evaluated|271|||
146316383|NCT04417894|527669540|FG000|Overall Study|Lost to Follow-up|3|||
146316384|NCT04417894|527669541|FG001|Overall Study|Lost to Follow-up|0|||
146316385|NCT04417894|527669540|FG000|Overall Study|Withdrawal by Subject|7|||
146316386|NCT04417894|527669541|FG001|Overall Study|Withdrawal by Subject|6|||
146316387|NCT04417894|527669540|FG000|Overall Study|Lack of Efficacy|3|||
146316388|NCT04417894|527669541|FG001|Overall Study|Lack of Efficacy|1|||
146316389|NCT01508702|527669542|FG000|Overall Study|Adverse Event|7|||
146316390|NCT01508702|527669543|FG001|Overall Study|Adverse Event|3|||
146316391|NCT01508702|527669542|FG000|Overall Study|Gout flare|2|||
146316392|NCT01508702|527669543|FG001|Overall Study|Gout flare|0|||
146162523|NCT03751631|527104732|FG001|Overall Study|Withdrawal by Subject|0|||
146162524|NCT03751631|527104733|FG002|Overall Study|Withdrawal by Subject|1|||
146162525|NCT03751631|527104734|FG003|Overall Study|Withdrawal by Subject|1|||
146162526|NCT03751631|527104735|FG004|Overall Study|Withdrawal by Subject|0|||
146162527|NCT03751631|527104736|FG005|Overall Study|Withdrawal by Subject|0|||
146162528|NCT03382782|527104737|FG000|Cohort 1|Withdrawal by Subject|11|||
146162529|NCT03382782|527104738|FG001|Cohort 1|Withdrawal by Subject|5|||
146162530|NCT03382782|527104739|FG002|Cohort 1|Withdrawal by Subject|0|||
146162531|NCT03382782|527104737|FG000|Cohort 2|Withdrawal by Subject|1|||
146316393|NCT01508702|527669542|FG000|Overall Study|Protocol Violation|2|||
146316394|NCT01508702|527669543|FG001|Overall Study|Protocol Violation|1|||
146316395|NCT01508702|527669542|FG000|Overall Study|Lost to Follow-up|1|||
146316396|NCT01508702|527669543|FG001|Overall Study|Lost to Follow-up|2|||
146316397|NCT01508702|527669542|FG000|Overall Study|Withdrawal by Subject|11|||
146316398|NCT01508702|527669543|FG001|Overall Study|Withdrawal by Subject|7|||
146316399|NCT03461757|527669544|FG000|Overall Study|Adverse Event|1|||
146316400|NCT03461757|527669545|FG001|Overall Study|Adverse Event|0|||
146316401|NCT03461757|527669544|FG000|Overall Study|Lost to Follow-up|13|||
146316402|NCT03461757|527669545|FG001|Overall Study|Lost to Follow-up|7|||
146316403|NCT03461757|527669544|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
146316404|NCT03461757|527669545|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
146316405|NCT03461757|527669544|FG000|Overall Study|Non-compliance with study treatment|0|||
146316406|NCT03461757|527669545|FG001|Overall Study|Non-compliance with study treatment|1|||
146316407|NCT03461757|527669544|FG000|Overall Study|Pregnancy|2|||
146316408|NCT03461757|527669545|FG001|Overall Study|Pregnancy|0|||
146316409|NCT03461757|527669544|FG000|Overall Study|Protocol Violation|1|||
146316410|NCT03461757|527669545|FG001|Overall Study|Protocol Violation|1|||
146316411|NCT03461757|527669544|FG000|Overall Study|Withdrawal by Subject|7|||
146316412|NCT03461757|527669545|FG001|Overall Study|Withdrawal by Subject|7|||
146316413|NCT03461757|527669544|FG000|Overall Study|Other Reasons|1|||
146316414|NCT03461757|527669545|FG001|Overall Study|Other Reasons|4|||
146316415|NCT02425826|527669546|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
146316416|NCT02425826|527669547|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
146316417|NCT02425826|527669548|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
146316418|NCT02425826|527669546|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
146316419|NCT02425826|527669547|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
146316420|NCT02425826|527669548|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
146316421|NCT02425826|527669546|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
146316422|NCT02425826|527669547|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
146316423|NCT02425826|527669548|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
146316424|NCT02425826|527669546|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
146316425|NCT02425826|527669547|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
146316426|NCT02425826|527669548|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
146316427|NCT02425826|527669546|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
146316428|NCT02425826|527669547|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
146316429|NCT02425826|527669548|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
146316430|NCT02425826|527669546|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
146316431|NCT02425826|527669547|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
146316432|NCT02425826|527669548|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
146316433|NCT02425826|527669546|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
146316434|NCT02425826|527669547|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
146316435|NCT02425826|527669548|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
146316436|NCT02425826|527669546|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
146316437|NCT02425826|527669547|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
146316438|NCT02425826|527669548|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
146316439|NCT02425826|527669546|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
146316440|NCT02425826|527669547|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
146316441|NCT02425826|527669548|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
146316442|NCT02425826|527669546|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
146316443|NCT02425826|527669547|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
146316444|NCT02425826|527669548|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
146316445|NCT03861559|527669549|FG000|Overall Study|Adverse Event|0|||
146316446|NCT03861559|527669550|FG001|Overall Study|Adverse Event|2|||
146162532|NCT03382782|527104738|FG001|Cohort 2|Withdrawal by Subject|1|||
146162533|NCT03382782|527104739|FG002|Cohort 2|Withdrawal by Subject|0|||
146162534|NCT03382782|527104737|FG000|Cohort 3|Withdrawal by Subject|1|||
146316447|NCT03861559|527669549|FG000|Overall Study|Treatment failure|0|||
146316448|NCT03861559|527669550|FG001|Overall Study|Treatment failure|2|||
146316449|NCT03861559|527669549|FG000|Overall Study|Noncompliance|1|||
146316450|NCT03861559|527669550|FG001|Overall Study|Noncompliance|1|||
146316451|NCT03861559|527669549|FG000|Overall Study|Did not meet eligibility requirements|1|||
146316452|NCT03861559|527669550|FG001|Overall Study|Did not meet eligibility requirements|0|||
146316453|NCT00903175|527669554|FG000|Period 1 - First Line|Adverse Event|36|||
146316454|NCT00903175|527669555|FG001|Period 1 - First Line|Adverse Event|50|||
146316455|NCT00903175|527669554|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
146316456|NCT00903175|527669555|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
146316457|NCT00903175|527669554|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
146316458|NCT00903175|527669555|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
146316459|NCT00903175|527669554|FG000|Period 1 - First Line|Protocol Violation|3|||
146316460|NCT00903175|527669555|FG001|Period 1 - First Line|Protocol Violation|3|||
146162535|NCT03382782|527104738|FG001|Cohort 3|Withdrawal by Subject|2|||
146162536|NCT03382782|527104739|FG002|Cohort 3|Withdrawal by Subject|0|||
146162537|NCT01791725|527104740|FG000|Overall Study|Withdrawal by Subject|0|||
146162538|NCT01791725|527104741|FG001|Overall Study|Withdrawal by Subject|1|||
146162539|NCT01791725|527104742|FG002|Overall Study|Withdrawal by Subject|0|||
146162540|NCT02366910|527104743|FG000|Overall Study|Withdrawal by Subject|2|||
146162541|NCT02366910|527104743|FG000|Overall Study|Screen Failure|3|||
146162542|NCT03813238|527104744|FG000|Overall Study|Adverse Event|0|||
146162543|NCT03813238|527104745|FG001|Overall Study|Adverse Event|6|||
146162544|NCT03813238|527104744|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146162545|NCT03813238|527104745|FG001|Overall Study|Withdrawal by parent/guardian|2|||
146162546|NCT03813238|527104744|FG000|Overall Study|Lost to Follow-up|0|||
146162547|NCT03813238|527104745|FG001|Overall Study|Lost to Follow-up|1|||
146162548|NCT03813238|527104744|FG000|Overall Study|Other than specified|1|||
146162549|NCT03813238|527104745|FG001|Overall Study|Other than specified|2|||
146162550|NCT02080871|527104746|FG000|Overall Study|Death|1|||
146162551|NCT02080871|527104746|FG000|Overall Study|Lost to Follow-up|1|||
146162552|NCT00234052|527104747|FG000|Treatment|Withdrawal by Subject|3|||
146162553|NCT00234052|527104747|FG000|Treatment|Adverse Event|5|||
146162554|NCT00234052|527104747|FG000|Treatment|Death|2|||
146162555|NCT00234052|527104747|FG000|Treatment|Progressive Disease|11|||
146162556|NCT00234052|527104747|FG000|Follow-up for 5 Years|Death|41|||
146162557|NCT00234052|527104747|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
146162558|NCT00234052|527104747|FG000|Follow-up for 5 Years|Other|7|||
146162559|NCT00420199|527104748|FG000|Overall Study|Participant no longer met study criteria|1|||
146162560|NCT00420199|527104749|FG001|Overall Study|Participant no longer met study criteria|0|||
146162561|NCT00002558|527104758|FG000|Overall Study|Withdrawal by Subject|0|||
146162562|NCT00002558|527104759|FG001|Overall Study|Withdrawal by Subject|1|||
146162563|NCT01260350|527104760|FG000|Overall Study|Lack of Efficacy|0|||
146162564|NCT01260350|527104761|FG001|Overall Study|Lack of Efficacy|0|||
146162565|NCT01260350|527104762|FG002|Overall Study|Lack of Efficacy|0|||
146162566|NCT01260350|527104763|FG003|Overall Study|Lack of Efficacy|0|||
146162567|NCT01260350|527104764|FG004|Overall Study|Lack of Efficacy|0|||
146162568|NCT01260350|527104765|FG005|Overall Study|Lack of Efficacy|0|||
146162569|NCT01260350|527104766|FG006|Overall Study|Lack of Efficacy|0|||
146162570|NCT01260350|527104767|FG007|Overall Study|Lack of Efficacy|0|||
146162571|NCT01260350|527104768|FG008|Overall Study|Lack of Efficacy|0|||
146162572|NCT01260350|527104769|FG009|Overall Study|Lack of Efficacy|0|||
146162573|NCT01260350|527104770|FG010|Overall Study|Lack of Efficacy|0|||
146162574|NCT01260350|527104771|FG011|Overall Study|Lack of Efficacy|0|||
146162575|NCT01260350|527104772|FG012|Overall Study|Lack of Efficacy|0|||
146316461|NCT00903175|527669554|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
146316462|NCT00903175|527669555|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
146316463|NCT00903175|527669554|FG000|Period 1 - First Line|Administrative problems|12|||
146316464|NCT00903175|527669555|FG001|Period 1 - First Line|Administrative problems|13|||
146316465|NCT00903175|527669554|FG000|Period 1 - First Line|Death|17|||
146316466|NCT00903175|527669555|FG001|Period 1 - First Line|Death|10|||
146316467|NCT00903175|527669554|FG000|Period 2 - Second Line|Missing|1|||
146316468|NCT00903175|527669555|FG001|Period 2 - Second Line|Missing|0|||
146162576|NCT01260350|527104773|FG013|Overall Study|Lack of Efficacy|0|||
146316469|NCT00903175|527669554|FG000|Period 2 - Second Line|Adverse Event|16|||
146316470|NCT00903175|527669555|FG001|Period 2 - Second Line|Adverse Event|20|||
146316471|NCT00903175|527669554|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
146316472|NCT00903175|527669555|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
146162577|NCT01260350|527104774|FG014|Overall Study|Lack of Efficacy|0|||
146162578|NCT01260350|527104775|FG015|Overall Study|Lack of Efficacy|0|||
146162579|NCT01260350|527104776|FG016|Overall Study|Lack of Efficacy|0|||
146162580|NCT01260350|527104777|FG017|Overall Study|Lack of Efficacy|1|||
146162581|NCT01260350|527104778|FG018|Overall Study|Lack of Efficacy|0|||
146162582|NCT01260350|527104779|FG019|Overall Study|Lack of Efficacy|0|||
146162583|NCT01260350|527104780|FG020|Overall Study|Lack of Efficacy|3|||
146162584|NCT01260350|527104781|FG021|Overall Study|Lack of Efficacy|0|||
146162585|NCT01260350|527104760|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162586|NCT01260350|527104761|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162587|NCT01260350|527104762|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162588|NCT01260350|527104763|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162589|NCT01260350|527104764|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162590|NCT01260350|527104765|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162591|NCT01260350|527104766|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162592|NCT01260350|527104767|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162593|NCT01260350|527104768|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
146162594|NCT01260350|527104769|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162595|NCT01260350|527104770|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162596|NCT01260350|527104771|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162597|NCT01260350|527104772|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162598|NCT01260350|527104773|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162599|NCT01260350|527104774|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162600|NCT01260350|527104775|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162601|NCT01260350|527104776|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162602|NCT01260350|527104777|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162603|NCT01260350|527104778|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162604|NCT01260350|527104779|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162605|NCT01260350|527104780|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162606|NCT01260350|527104781|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
146162607|NCT00558428|527104784|FG000|Overall Study|Adverse Event|6|||
146162608|NCT00558428|527104785|FG001|Overall Study|Adverse Event|22|||
146162609|NCT00558428|527104786|FG002|Overall Study|Adverse Event|3|||
146162610|NCT00558428|527104787|FG003|Overall Study|Adverse Event|4|||
146162611|NCT00558428|527104784|FG000|Overall Study|Lost to Follow-up|0|||
146162612|NCT00558428|527104785|FG001|Overall Study|Lost to Follow-up|1|||
146162613|NCT00558428|527104786|FG002|Overall Study|Lost to Follow-up|0|||
146162614|NCT00558428|527104787|FG003|Overall Study|Lost to Follow-up|0|||
146162615|NCT00558428|527104784|FG000|Overall Study|Lack of Efficacy|0|||
146162616|NCT00558428|527104785|FG001|Overall Study|Lack of Efficacy|0|||
146162617|NCT00558428|527104786|FG002|Overall Study|Lack of Efficacy|1|||
146162618|NCT00558428|527104787|FG003|Overall Study|Lack of Efficacy|2|||
146162619|NCT00558428|527104784|FG000|Overall Study|Non compliant with protocol|1|||
146316473|NCT00903175|527669554|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
146316474|NCT00903175|527669555|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
146316475|NCT00903175|527669554|FG000|Period 2 - Second Line|Administrative problems|19|||
146316476|NCT00903175|527669555|FG001|Period 2 - Second Line|Administrative problems|9|||
146316477|NCT00903175|527669554|FG000|Period 2 - Second Line|Death|5|||
146316478|NCT00903175|527669555|FG001|Period 2 - Second Line|Death|2|||
146316479|NCT03074474|527669556|FG000|Overall Study|Lost to Follow-up|10|||
146316480|NCT03074474|527669556|FG000|Overall Study|Withdrawal by Subject|10|||
146316481|NCT03074474|527669556|FG000|Overall Study|Death|4|||
146316482|NCT03074474|527669556|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
146316483|NCT02124564|527669562|FG000|Treatment Period|Adverse Event|2|||
146316484|NCT02124564|527669562|FG000|Treatment Period|Lack of Efficacy|3|||
146316485|NCT02124564|527669562|FG000|Treatment Period|Withdrawal by Subject|2|||
146316486|NCT01344876|527669564|FG000|Overall Study|Adverse Event|0|||
146316487|NCT01344876|527669565|FG001|Overall Study|Adverse Event|0|||
146316488|NCT01344876|527669566|FG002|Overall Study|Adverse Event|0|||
146316489|NCT01344876|527669567|FG003|Overall Study|Adverse Event|0|||
146316490|NCT01344876|527669568|FG004|Overall Study|Adverse Event|1|||
146316491|NCT01344876|527669564|FG000|Overall Study|Withdrawal by Subject|0|||
146316492|NCT01344876|527669565|FG001|Overall Study|Withdrawal by Subject|0|||
146316493|NCT01344876|527669566|FG002|Overall Study|Withdrawal by Subject|1|||
146316494|NCT01344876|527669567|FG003|Overall Study|Withdrawal by Subject|0|||
146316495|NCT01344876|527669568|FG004|Overall Study|Withdrawal by Subject|0|||
146316496|NCT01344876|527669564|FG000|Overall Study|Definite progression of primary disease|1|||
146316497|NCT01344876|527669565|FG001|Overall Study|Definite progression of primary disease|0|||
146316498|NCT01344876|527669566|FG002|Overall Study|Definite progression of primary disease|0|||
146316499|NCT01344876|527669567|FG003|Overall Study|Definite progression of primary disease|3|||
146316500|NCT01344876|527669568|FG004|Overall Study|Definite progression of primary disease|0|||
146316501|NCT05107765|527669569|FG000|Overall Study|Lost to Follow-up|4|||
146316502|NCT05107765|527669570|FG001|Overall Study|Lost to Follow-up|1|||
146316503|NCT05107765|527669569|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
146316504|NCT05107765|527669570|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
146316505|NCT05107765|527669569|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
146316506|NCT05107765|527669570|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
146316507|NCT02049944|527670901|FG000|Overall Study|Protocol Violation|2|||
146316508|NCT01765673|527670902|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
146316509|NCT01284114|527670903|FG000|Overall Study|viral infection|1|||
146316510|NCT01284114|527670903|FG000|Overall Study|From the results of ALLTITUDE study|1|||
146316511|NCT01284114|527670903|FG000|Overall Study|Symptomatic hypotension|1|||
146162620|NCT00558428|527104785|FG001|Overall Study|Non compliant with protocol|0|||
146162621|NCT00558428|527104786|FG002|Overall Study|Non compliant with protocol|0|||
146162622|NCT00558428|527104787|FG003|Overall Study|Non compliant with protocol|3|||
146162623|NCT00558428|527104784|FG000|Overall Study|Consent withdrawn|2|||
146162624|NCT00558428|527104785|FG001|Overall Study|Consent withdrawn|1|||
146162625|NCT00558428|527104786|FG002|Overall Study|Consent withdrawn|0|||
146162626|NCT00558428|527104787|FG003|Overall Study|Consent withdrawn|1|||
146162627|NCT00558428|527104784|FG000|Overall Study|Other|3|||
146162628|NCT00558428|527104785|FG001|Overall Study|Other|0|||
146162629|NCT00558428|527104786|FG002|Overall Study|Other|0|||
146162630|NCT00558428|527104787|FG003|Overall Study|Other|1|||
146162631|NCT00626028|527104788|FG000|Overall Study|Adverse Event|1|||
146162632|NCT00626028|527104789|FG001|Overall Study|Adverse Event|1|||
146162633|NCT00626028|527104788|FG000|Overall Study|Device Failure|0|||
146162634|NCT00626028|527104789|FG001|Overall Study|Device Failure|1|||
146162635|NCT00626028|527104788|FG000|Overall Study|Physician Decision|2|||
146162636|NCT00626028|527104789|FG001|Overall Study|Physician Decision|1|||
146162637|NCT00626028|527104788|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
146162638|NCT00626028|527104789|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
146162639|NCT05224050|527104790|FG000|Overall Study|Withdrawal by Subject|9|||
146162640|NCT05224050|527104790|FG000|Overall Study|Lost to Follow-up|3|||
146162641|NCT02436330|527104791|FG000|Cohort 1|Lost to Follow-up|5|||
146162642|NCT02436330|527104792|FG001|Cohort 1|Lost to Follow-up|2|||
146162643|NCT02436330|527104791|FG000|Cohort 1|Withdrawal by Subject|0|||
146162644|NCT02436330|527104792|FG001|Cohort 1|Withdrawal by Subject|1|||
146162645|NCT02436330|527104791|FG000|Cohort 2|Lost to Follow-up|2|||
146162646|NCT02436330|527104792|FG001|Cohort 2|Lost to Follow-up|0|||
146162647|NCT02436330|527104791|FG000|Cohort 2|Withdrawal by Subject|2|||
146162648|NCT02436330|527104792|FG001|Cohort 2|Withdrawal by Subject|3|||
146162649|NCT02436330|527104791|FG000|Cohort 3|Lost to Follow-up|1|||
146162650|NCT02436330|527104792|FG001|Cohort 3|Lost to Follow-up|0|||
146162651|NCT02436330|527104791|FG000|Cohort 3|Withdrawal by Subject|4|||
146162652|NCT02436330|527104792|FG001|Cohort 3|Withdrawal by Subject|0|||
146162653|NCT02436330|527104791|FG000|Cohort 4|Lost to Follow-up|1|||
146162654|NCT02436330|527104792|FG001|Cohort 4|Lost to Follow-up|0|||
146162655|NCT02436330|527104791|FG000|Cohort 4|Withdrawal by Subject|1|||
146162656|NCT02436330|527104792|FG001|Cohort 4|Withdrawal by Subject|0|||
146162657|NCT02436330|527104791|FG000|Cohort 5|Lost to Follow-up|3|||
146162658|NCT02436330|527104792|FG001|Cohort 5|Lost to Follow-up|2|||
146162659|NCT02436330|527104791|FG000|Cohort 5|Withdrawal by Subject|3|||
146162660|NCT02436330|527104792|FG001|Cohort 5|Withdrawal by Subject|2|||
146162661|NCT02436330|527104791|FG000|Cohort 6|Lost to Follow-up|2|||
146162662|NCT02436330|527104792|FG001|Cohort 6|Lost to Follow-up|0|||
146162663|NCT02436330|527104791|FG000|Cohort 6|Withdrawal by Subject|1|||
146162664|NCT02436330|527104792|FG001|Cohort 6|Withdrawal by Subject|1|||
146162665|NCT00338884|527104793|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
146162666|NCT00338884|527104793|FG000|Overall Study|Adverse Event|14|||
146162667|NCT00338884|527104793|FG000|Overall Study|Death|8|||
146162668|NCT00338884|527104793|FG000|Overall Study|Other|4|||
146162669|NCT00338884|527104793|FG000|Overall Study|Global Deterioration of Health Status|3|||
146162670|NCT00338884|527104793|FG000|Overall Study|Withdrawal by Subject|3|||
146162671|NCT00338884|527104793|FG000|Overall Study|Lost to Follow-up|1|||
146162672|NCT00338884|527104793|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
146162673|NCT04535947|527104794|FG000|Overall Study|Adverse Event|1|||
146162674|NCT04535947|527104795|FG001|Overall Study|Adverse Event|4|||
146162675|NCT04535947|527104794|FG000|Overall Study|Other reasons not specified|2|||
146162676|NCT04535947|527104795|FG001|Overall Study|Other reasons not specified|0|||
146162677|NCT04535947|527104794|FG000|Overall Study|Withdrawal by Subject|1|||
146162678|NCT04535947|527104795|FG001|Overall Study|Withdrawal by Subject|1|||
146162679|NCT02355002|527104798|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
146162680|NCT02355002|527104799|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
146162681|NCT02355002|527104798|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
146162682|NCT02355002|527104799|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
146162683|NCT02355002|527104798|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
146162684|NCT02355002|527104799|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
146162685|NCT02355002|527104798|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
146162686|NCT02355002|527104799|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
146162687|NCT02355002|527104798|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
146162688|NCT02355002|527104799|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
146162689|NCT02355002|527104798|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
146162690|NCT02355002|527104799|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
146162691|NCT02355002|527104798|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
146162692|NCT02355002|527104799|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
146162693|NCT03205371|527104805|FG000|Overall Study|Withdrawal by Subject|4|||
146162694|NCT03205371|527104806|FG001|Overall Study|Withdrawal by Subject|1|||
146162695|NCT03205371|527104807|FG002|Overall Study|Withdrawal by Subject|0|||
146162696|NCT03205371|527104808|FG003|Overall Study|Withdrawal by Subject|0|||
146162697|NCT03205371|527104809|FG004|Overall Study|Withdrawal by Subject|0|||
146162698|NCT03205371|527104810|FG005|Overall Study|Withdrawal by Subject|0|||
146162699|NCT03205371|527104811|FG006|Overall Study|Withdrawal by Subject|4|||
146162700|NCT03205371|527104812|FG007|Overall Study|Withdrawal by Subject|0|||
146162701|NCT03205371|527104813|FG008|Overall Study|Withdrawal by Subject|2|||
146162702|NCT03205371|527104814|FG009|Overall Study|Withdrawal by Subject|0|||
146162703|NCT03205371|527104815|FG010|Overall Study|Withdrawal by Subject|0|||
146162704|NCT03205371|527104816|FG011|Overall Study|Withdrawal by Subject|1|||
146162705|NCT03205371|527104805|FG000|Overall Study|Lost to Follow-up|0|||
146162706|NCT03205371|527104806|FG001|Overall Study|Lost to Follow-up|0|||
146162707|NCT03205371|527104807|FG002|Overall Study|Lost to Follow-up|0|||
146162708|NCT03205371|527104808|FG003|Overall Study|Lost to Follow-up|0|||
146162709|NCT03205371|527104809|FG004|Overall Study|Lost to Follow-up|0|||
146162710|NCT03205371|527104810|FG005|Overall Study|Lost to Follow-up|0|||
146162711|NCT03205371|527104811|FG006|Overall Study|Lost to Follow-up|5|||
146162712|NCT03205371|527104812|FG007|Overall Study|Lost to Follow-up|2|||
146162713|NCT03205371|527104813|FG008|Overall Study|Lost to Follow-up|3|||
146162714|NCT03205371|527104814|FG009|Overall Study|Lost to Follow-up|0|||
146162715|NCT03205371|527104815|FG010|Overall Study|Lost to Follow-up|0|||
146162716|NCT03205371|527104816|FG011|Overall Study|Lost to Follow-up|0|||
146162717|NCT03205371|527104805|FG000|Overall Study|Protocol Violation|0|||
146162718|NCT03205371|527104806|FG001|Overall Study|Protocol Violation|0|||
146162719|NCT03205371|527104807|FG002|Overall Study|Protocol Violation|0|||
146162720|NCT03205371|527104808|FG003|Overall Study|Protocol Violation|0|||
146162721|NCT03205371|527104809|FG004|Overall Study|Protocol Violation|0|||
146162722|NCT03205371|527104810|FG005|Overall Study|Protocol Violation|0|||
146162723|NCT03205371|527104811|FG006|Overall Study|Protocol Violation|1|||
146162724|NCT03205371|527104812|FG007|Overall Study|Protocol Violation|0|||
146162725|NCT03205371|527104813|FG008|Overall Study|Protocol Violation|0|||
146162726|NCT03205371|527104814|FG009|Overall Study|Protocol Violation|0|||
146162727|NCT03205371|527104815|FG010|Overall Study|Protocol Violation|0|||
146162728|NCT03205371|527104816|FG011|Overall Study|Protocol Violation|0|||
146162729|NCT03205371|527104805|FG000|Overall Study|Adverse Event|0|||
146162730|NCT03205371|527104806|FG001|Overall Study|Adverse Event|0|||
146162731|NCT03205371|527104807|FG002|Overall Study|Adverse Event|0|||
146162732|NCT03205371|527104808|FG003|Overall Study|Adverse Event|0|||
146316512|NCT01284114|527670903|FG000|Overall Study|dizziness|1|||
146316513|NCT04872101|527670904|FG000|Overall Study|Withdrawal by Subject|10|||
146316514|NCT04872101|527670905|FG001|Overall Study|Withdrawal by Subject|16|||
146316515|NCT04872101|527670904|FG000|Overall Study|Lack of Efficacy|6|||
146316516|NCT04872101|527670905|FG001|Overall Study|Lack of Efficacy|14|||
146316517|NCT04872101|527670904|FG000|Overall Study|Adverse Event|1|||
146316518|NCT04872101|527670905|FG001|Overall Study|Adverse Event|6|||
146316519|NCT04872101|527670904|FG000|Overall Study|Lost to Follow-up|2|||
146316520|NCT04872101|527670905|FG001|Overall Study|Lost to Follow-up|1|||
146316521|NCT04872101|527670904|FG000|Overall Study|Pregnancy|2|||
146316522|NCT04872101|527670905|FG001|Overall Study|Pregnancy|0|||
146316523|NCT04872101|527670904|FG000|Overall Study|Prohibited Medication|1|||
146316524|NCT04872101|527670905|FG001|Overall Study|Prohibited Medication|0|||
146316525|NCT04872101|527670904|FG000|Overall Study|Not dosed|1|||
146316526|NCT04872101|527670905|FG001|Overall Study|Not dosed|0|||
146316527|NCT03691974|527670906|FG000|Overall Study|Physician Decision|1|||
146316528|NCT03691974|527670907|FG001|Overall Study|Physician Decision|0|||
146316529|NCT03691974|527670906|FG000|Overall Study|Adverse Event|1|||
146316530|NCT03691974|527670907|FG001|Overall Study|Adverse Event|0|||
146316531|NCT03691974|527670906|FG000|Overall Study|Withdrawal by Subject|11|||
146316532|NCT03691974|527670907|FG001|Overall Study|Withdrawal by Subject|9|||
146316533|NCT03691974|527670906|FG000|Overall Study|Protocol Violation|1|||
146316534|NCT03691974|527670907|FG001|Overall Study|Protocol Violation|0|||
146162733|NCT03205371|527104809|FG004|Overall Study|Adverse Event|0|||
146162734|NCT03205371|527104810|FG005|Overall Study|Adverse Event|0|||
146162735|NCT03205371|527104811|FG006|Overall Study|Adverse Event|0|||
146162736|NCT03205371|527104812|FG007|Overall Study|Adverse Event|1|||
146162737|NCT03205371|527104813|FG008|Overall Study|Adverse Event|0|||
146316535|NCT03691974|527670906|FG000|Overall Study|Lost to Follow-up|8|||
146316536|NCT03691974|527670907|FG001|Overall Study|Lost to Follow-up|7|||
146316537|NCT00691483|527670908|FG000|Overall Study|Adverse Event|14|||
146316538|NCT00691483|527670909|FG001|Overall Study|Adverse Event|6|||
146316539|NCT00691483|527670908|FG000|Overall Study|Lost to Follow-up|17|||
146316540|NCT00691483|527670909|FG001|Overall Study|Lost to Follow-up|10|||
146316541|NCT00691483|527670908|FG000|Overall Study|Withdrawal by Subject|24|||
146162738|NCT03205371|527104814|FG009|Overall Study|Adverse Event|0|||
146162739|NCT03205371|527104815|FG010|Overall Study|Adverse Event|0|||
146162740|NCT03205371|527104816|FG011|Overall Study|Adverse Event|0|||
146162741|NCT05711641|527104818|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
146162742|NCT05711641|527104819|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
146316542|NCT00691483|527670909|FG001|Overall Study|Withdrawal by Subject|7|||
146162743|NCT05711641|527104818|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
146162744|NCT05711641|527104819|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
146162745|NCT00262821|527104824|FG000|Overall Study|Ineligible - wrong stage|0|||
146162746|NCT00262821|527104825|FG001|Overall Study|Ineligible - wrong stage|3|||
146162747|NCT00262821|527104824|FG000|Overall Study|Ineligible - wrong cell type|2|||
146162748|NCT00262821|527104825|FG001|Overall Study|Ineligible - wrong cell type|2|||
146162749|NCT00262821|527104824|FG000|Overall Study|Ineligible - wrong primary|0|||
146162750|NCT00262821|527104825|FG001|Overall Study|Ineligible - wrong primary|1|||
146162751|NCT00262821|527104824|FG000|Overall Study|Ineligible - inadequate pathology|1|||
146162752|NCT00262821|527104825|FG001|Overall Study|Ineligible - inadequate pathology|3|||
146162753|NCT00262821|527104824|FG000|Overall Study|Ineligible - elevated creatinine|0|||
146162754|NCT00262821|527104825|FG001|Overall Study|Ineligible - elevated creatinine|2|||
146162755|NCT00262821|527104824|FG000|Overall Study|Ineligible - required test not done|1|||
146162756|NCT00262821|527104825|FG001|Overall Study|Ineligible - required test not done|4|||
146162757|NCT00262821|527104824|FG000|Overall Study|Inevaluable - inadequate data|0|||
146162758|NCT00262821|527104825|FG001|Overall Study|Inevaluable - inadequate data|4|||
146162759|NCT00587964|527104826|FG000|Overall Study|Withdrawal by Subject|1|||
146162760|NCT00587964|527104826|FG000|Overall Study|Lost to Follow-up|1|||
146162761|NCT00587964|527104826|FG000|Overall Study|Patient found to be ineligible|1|||
146162762|NCT00587964|527104826|FG000|Overall Study|Patient did not receive intervention|5|||
146162763|NCT00587964|527104826|FG000|Overall Study|Progression of Disease|4|||
146162764|NCT01302847|527104832|FG000|Overall Study|Death|0|||
146162765|NCT01302847|527104833|FG001|Overall Study|Death|1|||
146162766|NCT01302847|527104834|FG002|Overall Study|Death|0|||
146162767|NCT01302847|527104835|FG003|Overall Study|Death|0|||
146162768|NCT01302847|527104836|FG004|Overall Study|Death|0|||
146162769|NCT01302847|527104837|FG005|Overall Study|Death|1|||
146162770|NCT01302847|527104838|FG006|Overall Study|Death|1|||
146162771|NCT01302847|527104839|FG007|Overall Study|Death|0|||
146162772|NCT01302847|527104832|FG000|Overall Study|Pregnancy|2|||
146162773|NCT01302847|527104833|FG001|Overall Study|Pregnancy|0|||
146162774|NCT01302847|527104834|FG002|Overall Study|Pregnancy|0|||
146162775|NCT01302847|527104835|FG003|Overall Study|Pregnancy|0|||
146162776|NCT01302847|527104836|FG004|Overall Study|Pregnancy|0|||
146162777|NCT01302847|527104837|FG005|Overall Study|Pregnancy|0|||
146162778|NCT01302847|527104838|FG006|Overall Study|Pregnancy|0|||
146162779|NCT01302847|527104839|FG007|Overall Study|Pregnancy|0|||
146162780|NCT01302847|527104832|FG000|Overall Study|Virologic failure|0|||
146162781|NCT01302847|527104833|FG001|Overall Study|Virologic failure|2|||
146162782|NCT01302847|527104834|FG002|Overall Study|Virologic failure|0|||
146162783|NCT01302847|527104835|FG003|Overall Study|Virologic failure|2|||
146162784|NCT01302847|527104836|FG004|Overall Study|Virologic failure|1|||
146162785|NCT01302847|527104837|FG005|Overall Study|Virologic failure|3|||
146316543|NCT00691483|527670908|FG000|Overall Study|Other known cause|6|||
146316544|NCT00691483|527670909|FG001|Overall Study|Other known cause|1|||
146316545|NCT00691483|527670908|FG000|Overall Study|Randomized by not treated|7|||
146316546|NCT00691483|527670909|FG001|Overall Study|Randomized by not treated|1|||
146316547|NCT03860961|527670911|FG000|Overall Study|Withdrawal by Subject|6|||
146316548|NCT03860961|527670912|FG001|Overall Study|Withdrawal by Subject|11|||
146316549|NCT03860961|527670911|FG000|Overall Study|Death|10|||
146316550|NCT03860961|527670912|FG001|Overall Study|Death|6|||
146316551|NCT03860961|527670911|FG000|Overall Study|Incomplete two-year data|4|||
146316552|NCT03860961|527670912|FG001|Overall Study|Incomplete two-year data|0|||
146316553|NCT02475681|527670913|FG000|Overall Study|Death|16|||
146316554|NCT02475681|527670914|FG001|Overall Study|Death|6|||
146316555|NCT02475681|527670915|FG002|Overall Study|Death|9|||
146316556|NCT02475681|527670913|FG000|Overall Study|Physician Decision|0|||
146316557|NCT02475681|527670914|FG001|Overall Study|Physician Decision|3|||
146316558|NCT02475681|527670915|FG002|Overall Study|Physician Decision|1|||
146316559|NCT02475681|527670913|FG000|Overall Study|Withdrawal by Subject|12|||
146316560|NCT02475681|527670914|FG001|Overall Study|Withdrawal by Subject|6|||
146316561|NCT02475681|527670915|FG002|Overall Study|Withdrawal by Subject|9|||
146316562|NCT02475681|527670913|FG000|Overall Study|Lost to Follow-up|2|||
146316563|NCT02475681|527670914|FG001|Overall Study|Lost to Follow-up|1|||
146316564|NCT02475681|527670915|FG002|Overall Study|Lost to Follow-up|3|||
146316565|NCT02475681|527670913|FG000|Overall Study|Ongoing in Study|0|||
146162786|NCT01302847|527104838|FG006|Overall Study|Virologic failure|1|||
146162787|NCT01302847|527104839|FG007|Overall Study|Virologic failure|2|||
146162788|NCT01302847|527104832|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146162789|NCT01302847|527104833|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146162790|NCT01302847|527104834|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146162791|NCT01302847|527104835|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146162792|NCT01302847|527104836|FG004|Overall Study|Severe debilitation, unable to continue|0|||
146162793|NCT01302847|527104837|FG005|Overall Study|Severe debilitation, unable to continue|1|||
146162794|NCT01302847|527104838|FG006|Overall Study|Severe debilitation, unable to continue|1|||
146162795|NCT01302847|527104839|FG007|Overall Study|Severe debilitation, unable to continue|0|||
146316566|NCT02475681|527670914|FG001|Overall Study|Ongoing in Study|163|||
146162796|NCT01302847|527104832|FG000|Overall Study|Not able to get to clinic|1|||
146162797|NCT01302847|527104833|FG001|Overall Study|Not able to get to clinic|1|||
146162798|NCT01302847|527104834|FG002|Overall Study|Not able to get to clinic|0|||
146162799|NCT01302847|527104835|FG003|Overall Study|Not able to get to clinic|0|||
146162800|NCT01302847|527104836|FG004|Overall Study|Not able to get to clinic|0|||
146162801|NCT01302847|527104837|FG005|Overall Study|Not able to get to clinic|0|||
146162802|NCT01302847|527104838|FG006|Overall Study|Not able to get to clinic|0|||
146162803|NCT01302847|527104839|FG007|Overall Study|Not able to get to clinic|0|||
146162804|NCT01302847|527104832|FG000|Overall Study|Site closing|2|||
146162805|NCT01302847|527104833|FG001|Overall Study|Site closing|2|||
146162806|NCT01302847|527104834|FG002|Overall Study|Site closing|0|||
146162807|NCT01302847|527104835|FG003|Overall Study|Site closing|0|||
146162808|NCT01302847|527104836|FG004|Overall Study|Site closing|0|||
146162809|NCT01302847|527104837|FG005|Overall Study|Site closing|0|||
146162810|NCT01302847|527104838|FG006|Overall Study|Site closing|0|||
146162811|NCT01302847|527104839|FG007|Overall Study|Site closing|0|||
146162812|NCT01302847|527104832|FG000|Overall Study|Withdrawal by Subject|1|||
146162813|NCT01302847|527104833|FG001|Overall Study|Withdrawal by Subject|0|||
146162814|NCT01302847|527104834|FG002|Overall Study|Withdrawal by Subject|0|||
146162815|NCT01302847|527104835|FG003|Overall Study|Withdrawal by Subject|0|||
146162816|NCT01302847|527104836|FG004|Overall Study|Withdrawal by Subject|1|||
146162817|NCT01302847|527104837|FG005|Overall Study|Withdrawal by Subject|0|||
146162818|NCT01302847|527104838|FG006|Overall Study|Withdrawal by Subject|0|||
146162819|NCT01302847|527104839|FG007|Overall Study|Withdrawal by Subject|1|||
146162820|NCT01302847|527104832|FG000|Overall Study|Not willing to adhere to requirements|5|||
146162821|NCT01302847|527104833|FG001|Overall Study|Not willing to adhere to requirements|0|||
146162822|NCT01302847|527104834|FG002|Overall Study|Not willing to adhere to requirements|1|||
146162823|NCT01302847|527104835|FG003|Overall Study|Not willing to adhere to requirements|0|||
146162824|NCT01302847|527104836|FG004|Overall Study|Not willing to adhere to requirements|0|||
146162825|NCT01302847|527104837|FG005|Overall Study|Not willing to adhere to requirements|0|||
146162826|NCT01302847|527104838|FG006|Overall Study|Not willing to adhere to requirements|0|||
146162827|NCT01302847|527104839|FG007|Overall Study|Not willing to adhere to requirements|2|||
146162828|NCT01302847|527104832|FG000|Overall Study|Site unable to contact participant|2|||
146162829|NCT01302847|527104833|FG001|Overall Study|Site unable to contact participant|1|||
146162830|NCT01302847|527104834|FG002|Overall Study|Site unable to contact participant|0|||
146162831|NCT01302847|527104835|FG003|Overall Study|Site unable to contact participant|0|||
146162832|NCT01302847|527104836|FG004|Overall Study|Site unable to contact participant|0|||
146162833|NCT01302847|527104837|FG005|Overall Study|Site unable to contact participant|0|||
146162834|NCT01302847|527104838|FG006|Overall Study|Site unable to contact participant|2|||
146162835|NCT01302847|527104839|FG007|Overall Study|Site unable to contact participant|0|||
146162836|NCT01371851|527104840|FG000|Overall Study|Lost to Follow-up|5|||
146162837|NCT01371851|527104841|FG001|Overall Study|Lost to Follow-up|8|||
146162838|NCT01371851|527104840|FG000|Overall Study|was arrested and put in jail|0|||
146162839|NCT01371851|527104841|FG001|Overall Study|was arrested and put in jail|1|||
146162840|NCT01371851|527104840|FG000|Overall Study|non study related adverse event|1|||
146162841|NCT01371851|527104841|FG001|Overall Study|non study related adverse event|0|||
146162842|NCT01371851|527104840|FG000|Overall Study|Blood Pressure outside study parameters|2|||
146162843|NCT01371851|527104841|FG001|Overall Study|Blood Pressure outside study parameters|0|||
146162844|NCT00450411|527104842|FG000|Overall Study|Protocol Violation|6|||
146162845|NCT00450411|527104842|FG000|Overall Study|No protocol treatment|2|||
146162846|NCT00818753|527104843|FG000|Overall Study|Protocol Violation|1|||
146162847|NCT00818753|527104844|FG001|Overall Study|Protocol Violation|0|||
146162848|NCT00818753|527104845|FG002|Overall Study|Protocol Violation|0|||
146162849|NCT00818753|527104843|FG000|Overall Study|Other reason (not specified)|0|||
146162850|NCT00818753|527104844|FG001|Overall Study|Other reason (not specified)|0|||
146162851|NCT00818753|527104845|FG002|Overall Study|Other reason (not specified)|1|||
146162852|NCT00818753|527104843|FG000|Overall Study|Randomised and not treated|2|||
146162853|NCT00818753|527104844|FG001|Overall Study|Randomised and not treated|0|||
146162854|NCT00818753|527104845|FG002|Overall Study|Randomised and not treated|0|||
146162855|NCT00725296|527104846|FG000|Overall Study|Adverse Event|11|||
146162856|NCT00725296|527104846|FG000|Overall Study|Lack of Efficacy|7|||
146162857|NCT00725296|527104846|FG000|Overall Study|Withdrawal by Subject|3|||
146162858|NCT00725296|527104846|FG000|Overall Study|Non-Compliance|2|||
146162859|NCT00725296|527104846|FG000|Overall Study|Lost to Follow-up|1|||
146162860|NCT00725296|527104846|FG000|Overall Study|Other|38|||
146162861|NCT03360942|527104847|FG000|Overall Study|Device explanted|2|||
146316567|NCT02475681|527670915|FG002|Overall Study|Ongoing in Study|157|||
146316568|NCT02475681|527670913|FG000|Overall Study|Reasons other than above listed|2|||
146316569|NCT02475681|527670914|FG001|Overall Study|Reasons other than above listed|0|||
146316570|NCT02475681|527670915|FG002|Overall Study|Reasons other than above listed|0|||
146316571|NCT02105454|527670926|FG000|Overall Study|Withdrawal by Subject|1|||
146162862|NCT03360942|527104847|FG000|Overall Study|Study closure|1|||
146162863|NCT03360942|527104847|FG000|Overall Study|Withdrawal by Subject|2|||
146316572|NCT00493870|527670927|FG000|Overall Study|Lost to Follow-up|12|||
146162864|NCT04866017|527104851|FG000|Overall Study|Study Terminated by Sponsor|13|||
146162865|NCT04866017|527104852|FG001|Overall Study|Study Terminated by Sponsor|14|||
146162866|NCT04866017|527104853|FG002|Overall Study|Study Terminated by Sponsor|13|||
146162867|NCT04866017|527104851|FG000|Overall Study|Death|8|||
146162868|NCT04866017|527104852|FG001|Overall Study|Death|4|||
146162869|NCT04866017|527104853|FG002|Overall Study|Death|8|||
146162870|NCT04866017|527104851|FG000|Overall Study|Withdrawal by Subject|1|||
146162871|NCT04866017|527104852|FG001|Overall Study|Withdrawal by Subject|0|||
146162872|NCT04866017|527104853|FG002|Overall Study|Withdrawal by Subject|1|||
146162873|NCT04866017|527104851|FG000|Overall Study|Physician Decision|0|||
146162874|NCT04866017|527104852|FG001|Overall Study|Physician Decision|1|||
146162875|NCT04866017|527104853|FG002|Overall Study|Physician Decision|0|||
146162876|NCT00605293|527106584|FG000|Overall Study|Death|2|||
146162877|NCT00605293|527106585|FG001|Overall Study|Death|1|||
146162878|NCT00605293|527106584|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146162879|NCT00605293|527106585|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146162880|NCT00605293|527106584|FG000|Overall Study|Adverse Event|1|||
146162881|NCT00605293|527106585|FG001|Overall Study|Adverse Event|0|||
146162882|NCT00605293|527106584|FG000|Overall Study|Holidays Dialysis Out|1|||
146162883|NCT00605293|527106585|FG001|Overall Study|Holidays Dialysis Out|0|||
146162884|NCT00605293|527106584|FG000|Overall Study|Blood Transfusion|7|||
146162885|NCT00605293|527106585|FG001|Overall Study|Blood Transfusion|1|||
146162886|NCT00605293|527106584|FG000|Overall Study|Renal Transplantation|3|||
146162887|NCT00605293|527106585|FG001|Overall Study|Renal Transplantation|1|||
146162888|NCT00605293|527106584|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
146162889|NCT00605293|527106585|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
146162890|NCT00605293|527106584|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
146162891|NCT00605293|527106585|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
146162892|NCT00605293|527106584|FG000|Overall Study|Principal Investigator Decision|0|||
146162893|NCT00605293|527106585|FG001|Overall Study|Principal Investigator Decision|1|||
146162894|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
146162895|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
146162896|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
146162897|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
146162898|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
146162899|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
146162900|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
146162901|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
146162902|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Other|18|||
146162903|NCT02565914|527106586|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
146162904|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
146162905|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Other|1|||
146162906|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
146162907|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
146162908|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
146162909|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
146162910|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
146162911|NCT02565914|527106586|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
146162912|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
146162913|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
146162914|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
146162915|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
146162916|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
146162917|NCT02565914|527106586|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
146162918|NCT01410474|527106590|FG000|Overall Study|Withdrawal by Subject|0|||
146162919|NCT01410474|527106591|FG001|Overall Study|Withdrawal by Subject|1|||
146162920|NCT02428296|527106592|FG000|Overall Study|Adverse Event|7|||
146162921|NCT02428296|527106592|FG000|Overall Study|Withdrawal by Subject|2|||
146162922|NCT00828984|527106593|FG000|Overall Study|Adverse Event|2|||
146162923|NCT00828984|527106594|FG001|Overall Study|Adverse Event|3|||
146162924|NCT00828984|527106595|FG002|Overall Study|Adverse Event|0|||
146162925|NCT00828984|527106593|FG000|Overall Study|Lost to Follow-up|5|||
146162926|NCT00828984|527106594|FG001|Overall Study|Lost to Follow-up|3|||
146162927|NCT00828984|527106595|FG002|Overall Study|Lost to Follow-up|1|||
146162928|NCT00828984|527106593|FG000|Overall Study|Withdrawal by Subject|4|||
146162929|NCT00828984|527106594|FG001|Overall Study|Withdrawal by Subject|4|||
146162930|NCT00828984|527106595|FG002|Overall Study|Withdrawal by Subject|4|||
146162931|NCT00828984|527106593|FG000|Overall Study|Ineligable|1|||
146162932|NCT00828984|527106594|FG001|Overall Study|Ineligable|2|||
146162933|NCT00828984|527106595|FG002|Overall Study|Ineligable|0|||
146162934|NCT00828984|527106593|FG000|Overall Study|Medical Contraindication|0|||
146162935|NCT00828984|527106594|FG001|Overall Study|Medical Contraindication|1|||
146162936|NCT00828984|527106595|FG002|Overall Study|Medical Contraindication|0|||
146162937|NCT00828984|527106593|FG000|Overall Study|Noncompliant|1|||
146162938|NCT00828984|527106594|FG001|Overall Study|Noncompliant|2|||
146162939|NCT00828984|527106595|FG002|Overall Study|Noncompliant|3|||
146162940|NCT00828984|527106593|FG000|Overall Study|ConMed|1|||
146162941|NCT00828984|527106594|FG001|Overall Study|ConMed|1|||
146162942|NCT00828984|527106595|FG002|Overall Study|ConMed|1|||
146162943|NCT00831779|527106600|FG000|Overall Study|Lost to Follow-up|1|||
146162944|NCT00831779|527106601|FG001|Overall Study|Lost to Follow-up|0|||
146162945|NCT00831779|527106600|FG000|Overall Study|No longer met criteria|0|||
146162946|NCT00831779|527106601|FG001|Overall Study|No longer met criteria|1|||
146162947|NCT02219048|527106602|FG000|Overall Study|Adverse Event|2|||
146162948|NCT02219048|527106603|FG001|Overall Study|Adverse Event|5|||
146162949|NCT02219048|527106602|FG000|Overall Study|No longer meets eligibility criteria|1|||
146162950|NCT02219048|527106603|FG001|Overall Study|No longer meets eligibility criteria|0|||
146162951|NCT02219048|527106602|FG000|Overall Study|Study terminated by sponsor|16|||
146162952|NCT02219048|527106603|FG001|Overall Study|Study terminated by sponsor|15|||
146162953|NCT02219048|527106602|FG000|Overall Study|Withdrawal by Subject|2|||
146162954|NCT02219048|527106603|FG001|Overall Study|Withdrawal by Subject|0|||
146162955|NCT02219048|527106602|FG000|Overall Study|Other|0|||
146162956|NCT02219048|527106603|FG001|Overall Study|Other|1|||
146162957|NCT02054806|527106604|FG000|Overall Study|Sponsor Decision|31|||
146162958|NCT02054806|527106604|FG000|Overall Study|Withdrawal by Subject|43|||
146162959|NCT02054806|527106604|FG000|Overall Study|Protocol Violation|2|||
146162960|NCT02054806|527106604|FG000|Overall Study|Lost to Follow-up|10|||
146162961|NCT02054806|527106604|FG000|Overall Study|Death|391|||
146162962|NCT00952367|527106605|FG000|Overall Study|Withdrawal by Subject|2|||
146162963|NCT00952367|527106605|FG000|Overall Study|Noncoordination|1|||
146162964|NCT00952367|527106605|FG000|Overall Study|Protocol Violation|3|||
146162965|NCT02230956|527106606|FG000|Overall Study|Adverse Event|1|||
146162966|NCT02230956|527106607|FG001|Overall Study|Adverse Event|1|||
146162967|NCT02230956|527106608|FG002|Overall Study|Adverse Event|0|||
146162968|NCT02230956|527106606|FG000|Overall Study|Lack of Efficacy|1|||
146162969|NCT02230956|527106607|FG001|Overall Study|Lack of Efficacy|1|||
146162970|NCT02230956|527106608|FG002|Overall Study|Lack of Efficacy|1|||
146162971|NCT02230956|527106606|FG000|Overall Study|Lost to Follow-up|1|||
146162972|NCT02230956|527106607|FG001|Overall Study|Lost to Follow-up|1|||
146162973|NCT02230956|527106608|FG002|Overall Study|Lost to Follow-up|2|||
146162974|NCT02230956|527106606|FG000|Overall Study|Personal Reasons|2|||
146162975|NCT02230956|527106607|FG001|Overall Study|Personal Reasons|1|||
146162976|NCT02230956|527106608|FG002|Overall Study|Personal Reasons|1|||
146162977|NCT02230956|527106606|FG000|Overall Study|Protocol Violation|0|||
146162978|NCT02230956|527106607|FG001|Overall Study|Protocol Violation|1|||
146162979|NCT02230956|527106608|FG002|Overall Study|Protocol Violation|1|||
146162980|NCT02230956|527106606|FG000|Overall Study|Other Miscellaneous Reason|0|||
146162981|NCT02230956|527106607|FG001|Overall Study|Other Miscellaneous Reason|1|||
146162982|NCT02230956|527106608|FG002|Overall Study|Other Miscellaneous Reason|2|||
146162983|NCT00781391|527106609|FG000|Overall Study|never received study drug|24|||
146162984|NCT00781391|527106610|FG001|Overall Study|never received study drug|23|||
146162985|NCT00781391|527106611|FG002|Overall Study|never received study drug|32|||
146162986|NCT00781391|527106609|FG000|Overall Study|Protocol Violation|19|||
146162987|NCT00781391|527106610|FG001|Overall Study|Protocol Violation|17|||
146162988|NCT00781391|527106611|FG002|Overall Study|Protocol Violation|20|||
146162989|NCT00781391|527106609|FG000|Overall Study|Death|789|||
146162990|NCT00781391|527106610|FG001|Overall Study|Death|730|||
146316573|NCT00493870|527670928|FG001|Overall Study|Lost to Follow-up|15|||
146316574|NCT02721355|527670929|FG000|Overall Study|Lost to Follow-up|6|||
146316575|NCT02721355|527670930|FG001|Overall Study|Lost to Follow-up|1|||
146316576|NCT00883337|527670933|FG000|Core Treatment Period|Adverse Event|9|||
146316577|NCT00883337|527670934|FG001|Core Treatment Period|Adverse Event|12|||
146316578|NCT00883337|527670935|FG002|Core Treatment Period|Adverse Event|22|||
146316579|NCT00883337|527670933|FG000|Core Treatment Period|Lack of Efficacy|7|||
146316580|NCT00883337|527670934|FG001|Core Treatment Period|Lack of Efficacy|4|||
146316581|NCT00883337|527670935|FG002|Core Treatment Period|Lack of Efficacy|2|||
146162991|NCT00781391|527106611|FG002|Overall Study|Death|706|||
146162992|NCT00781391|527106609|FG000|Overall Study|Withdrawal by Subject|47|||
146162993|NCT00781391|527106610|FG001|Overall Study|Withdrawal by Subject|37|||
146162994|NCT00781391|527106611|FG002|Overall Study|Withdrawal by Subject|25|||
146316582|NCT00883337|527670933|FG000|Core Treatment Period|Lost to Follow-up|1|||
146316583|NCT00883337|527670934|FG001|Core Treatment Period|Lost to Follow-up|1|||
146162995|NCT00781391|527106609|FG000|Overall Study|Lost to Follow-up|0|||
146162996|NCT00781391|527106610|FG001|Overall Study|Lost to Follow-up|0|||
146162997|NCT00781391|527106611|FG002|Overall Study|Lost to Follow-up|1|||
146162998|NCT03575325|527106624|FG000|Overall Study|Death|1|||
146316584|NCT00883337|527670935|FG002|Core Treatment Period|Lost to Follow-up|0|||
146316585|NCT00883337|527670933|FG000|Core Treatment Period|Withdrawal by Subject|2|||
146162999|NCT04575051|527106625|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
146316586|NCT00883337|527670934|FG001|Core Treatment Period|Withdrawal by Subject|2|||
146163000|NCT04575051|527106626|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
146316587|NCT00883337|527670935|FG002|Core Treatment Period|Withdrawal by Subject|6|||
146316588|NCT00883337|527670933|FG000|Core Treatment Period|Wish to be pregnant|1|||
146316589|NCT00883337|527670934|FG001|Core Treatment Period|Wish to be pregnant|2|||
146316590|NCT00883337|527670935|FG002|Core Treatment Period|Wish to be pregnant|1|||
146316591|NCT00883337|527670933|FG000|Core Treatment Period|Poor compliance to protocol|0|||
146316592|NCT00883337|527670934|FG001|Core Treatment Period|Poor compliance to protocol|0|||
146316593|NCT00883337|527670935|FG002|Core Treatment Period|Poor compliance to protocol|1|||
146316594|NCT00883337|527670933|FG000|Core Treatment Period|Other than above|0|||
146316595|NCT00883337|527670934|FG001|Core Treatment Period|Other than above|1|||
146316596|NCT00883337|527670935|FG002|Core Treatment Period|Other than above|1|||
146316597|NCT00883337|527670933|FG000|Extension Treatment Period|Adverse Event|8|||
146316598|NCT00883337|527670934|FG001|Extension Treatment Period|Adverse Event|5|||
146316599|NCT00883337|527670935|FG002|Extension Treatment Period|Adverse Event|5|||
146316600|NCT00883337|527670933|FG000|Extension Treatment Period|Lack of Efficacy|8|||
146316601|NCT00883337|527670934|FG001|Extension Treatment Period|Lack of Efficacy|8|||
146316602|NCT00883337|527670935|FG002|Extension Treatment Period|Lack of Efficacy|8|||
146316603|NCT00883337|527670933|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
146316604|NCT00883337|527670934|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
146316605|NCT00883337|527670935|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
146316606|NCT00883337|527670933|FG000|Extension Treatment Period|Lost to Follow-up|1|||
146316607|NCT00883337|527670934|FG001|Extension Treatment Period|Lost to Follow-up|0|||
146316608|NCT00883337|527670935|FG002|Extension Treatment Period|Lost to Follow-up|0|||
146316609|NCT00883337|527670933|FG000|Extension Treatment Period|Other than above|10|||
146316610|NCT00883337|527670934|FG001|Extension Treatment Period|Other than above|9|||
146316611|NCT00883337|527670935|FG002|Extension Treatment Period|Other than above|5|||
146316612|NCT01652287|527670937|FG000|Overall Study|Withdrawal by Subject|2|||
146316613|NCT01652287|527670938|FG001|Overall Study|Withdrawal by Subject|0|||
146316614|NCT00763139|527670944|FG000|Overall Study|Adverse Event|4|||
146316615|NCT00763139|527670945|FG001|Overall Study|Adverse Event|2|||
146316616|NCT00763139|527670944|FG000|Overall Study|Withdrawal by Subject|0|||
146316617|NCT00763139|527670945|FG001|Overall Study|Withdrawal by Subject|1|||
146316618|NCT00763139|527670944|FG000|Overall Study|med change not allowed by protocol|1|||
146316619|NCT00763139|527670945|FG001|Overall Study|med change not allowed by protocol|0|||
146316620|NCT01592760|527670946|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
146316621|NCT01592760|527670947|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
146316622|NCT01592760|527670948|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
146316623|NCT04312009|527670949|FG000|Overall Study|Withdrawal by Subject|2|||
146316624|NCT04312009|527670950|FG001|Overall Study|Withdrawal by Subject|1|||
146163001|NCT04575051|527106627|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
146163002|NCT04575051|527106628|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
146163003|NCT04575051|527106629|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
146163004|NCT04575051|527106625|FG000|Time Period 1|Missing follow up|1|||
146163005|NCT04575051|527106626|FG001|Time Period 1|Missing follow up|3|||
146163006|NCT04575051|527106627|FG002|Time Period 1|Missing follow up|1|||
146163007|NCT04575051|527106628|FG003|Time Period 1|Missing follow up|3|||
146163008|NCT04575051|527106629|FG004|Time Period 1|Missing follow up|2|||
146163009|NCT04575051|527106625|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
146163010|NCT04575051|527106626|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
146163011|NCT04575051|527106627|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
146163012|NCT04575051|527106628|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
146163013|NCT04575051|527106629|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
146163014|NCT04575051|527106625|FG000|Time Period 2|Missing follow up|1|||
146163015|NCT04575051|527106626|FG001|Time Period 2|Missing follow up|8|||
146163016|NCT04575051|527106627|FG002|Time Period 2|Missing follow up|7|||
146316625|NCT01363986|527670953|FG000|Overall Study|Disease progression|1|||
146316626|NCT01637142|527670954|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
146316627|NCT02354703|527670955|FG000|Overall Study|Withdrawal by Subject|1|||
146163017|NCT04575051|527106628|FG003|Time Period 2|Missing follow up|0|||
146316628|NCT02354703|527670956|FG001|Overall Study|Withdrawal by Subject|1|||
146316629|NCT02354703|527670957|FG002|Overall Study|Withdrawal by Subject|1|||
146316630|NCT02354703|527670958|FG003|Overall Study|Withdrawal by Subject|1|||
146316631|NCT02354703|527670955|FG000|Overall Study|Lost to Follow-up|2|||
146163018|NCT04575051|527106629|FG004|Time Period 2|Missing follow up|1|||
146316632|NCT02354703|527670956|FG001|Overall Study|Lost to Follow-up|7|||
146163019|NCT04575051|527106625|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
146316633|NCT02354703|527670957|FG002|Overall Study|Lost to Follow-up|9|||
146316634|NCT02354703|527670958|FG003|Overall Study|Lost to Follow-up|2|||
146316635|NCT02354703|527670955|FG000|Overall Study|Adverse Event|0|||
146316636|NCT02354703|527670956|FG001|Overall Study|Adverse Event|0|||
146316637|NCT02354703|527670957|FG002|Overall Study|Adverse Event|1|||
146316638|NCT02354703|527670958|FG003|Overall Study|Adverse Event|0|||
146316639|NCT04681170|527670963|FG000|Stratified Enrolment & run-in|Death|1|||
146316640|NCT04681170|527670964|FG001|Stratified Enrolment & run-in|Death|0|||
146316641|NCT04681170|527670963|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
146316642|NCT04681170|527670964|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
146316643|NCT04681170|527670963|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
146316644|NCT04681170|527670964|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
146316645|NCT04681170|527670963|FG000|Open Label Efficacy Phase|Adverse Event|0|||
146316646|NCT04681170|527670964|FG001|Open Label Efficacy Phase|Adverse Event|2|||
146316647|NCT04681170|527670963|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
146316648|NCT04681170|527670964|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
146316649|NCT04681170|527670963|FG000|Open Label Safety Phase|AEs and none compliance|0|||
146316650|NCT04681170|527670964|FG001|Open Label Safety Phase|AEs and none compliance|1|||
146316651|NCT02468648|527670965|FG000|Overall Study|Death|1|||
146316652|NCT04232696|527670966|FG000|Overall Study|Implant attempted but not completed|5|||
146316653|NCT04232696|527670967|FG001|Overall Study|Implant attempted but not completed|2|||
146316654|NCT04232696|527670966|FG000|Overall Study|Not satisfied with therapy outcome|0|||
146316655|NCT04232696|527670967|FG001|Overall Study|Not satisfied with therapy outcome|8|||
146316656|NCT04232696|527670966|FG000|Overall Study|Adverse Event|0|||
146316657|NCT04232696|527670967|FG001|Overall Study|Adverse Event|3|||
146316658|NCT04232696|527670966|FG000|Overall Study|Withdrawal by Subject|0|||
146316659|NCT04232696|527670967|FG001|Overall Study|Withdrawal by Subject|3|||
146316660|NCT04232696|527670966|FG000|Overall Study|Missed Visit|0|||
146316661|NCT04232696|527670967|FG001|Overall Study|Missed Visit|2|||
146316662|NCT04232696|527670966|FG000|Overall Study|Other reason|0|||
146316663|NCT04232696|527670967|FG001|Overall Study|Other reason|1|||
146316664|NCT02787863|527670968|FG000|Overall Study|Death|1|||
146316665|NCT02787863|527670969|FG001|Overall Study|Death|0|||
146316666|NCT02787863|527670970|FG002|Overall Study|Death|1|||
146316667|NCT02787863|527670971|FG003|Overall Study|Death|0|||
146316668|NCT02787863|527670972|FG004|Overall Study|Death|0|||
146316669|NCT02787863|527670973|FG005|Overall Study|Death|0|||
146316670|NCT02787863|527670974|FG006|Overall Study|Death|0|||
146316671|NCT02787863|527670975|FG007|Overall Study|Death|0|||
146316672|NCT02787863|527670968|FG000|Overall Study|Withdrawal by Subject|0|||
146316673|NCT02787863|527670969|FG001|Overall Study|Withdrawal by Subject|1|||
146316674|NCT02787863|527670970|FG002|Overall Study|Withdrawal by Subject|1|||
146316675|NCT02787863|527670971|FG003|Overall Study|Withdrawal by Subject|0|||
146316676|NCT02787863|527670972|FG004|Overall Study|Withdrawal by Subject|0|||
146316677|NCT02787863|527670973|FG005|Overall Study|Withdrawal by Subject|0|||
146316678|NCT02787863|527670974|FG006|Overall Study|Withdrawal by Subject|0|||
146316679|NCT02787863|527670975|FG007|Overall Study|Withdrawal by Subject|0|||
146316680|NCT01368835|527670976|FG000|Overall Study|Inclusion criteria/photography quality|22|||
146316681|NCT01368835|527670976|FG000|Overall Study|Lost to Follow-up|11|||
146316682|NCT01678144|527670977|FG000|Stage 1: MAR Classic|Adverse Event|1|||
146316683|NCT03118297|527670978|FG000|Overall Study|Lost to Follow-up|0|||
146316684|NCT03118297|527670979|FG001|Overall Study|Lost to Follow-up|2|||
146316685|NCT02754726|527670980|FG000|Overall Study|Progressive Disease by RECIST|13|||
146316686|NCT02754726|527670980|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
146316687|NCT02754726|527670980|FG000|Overall Study|Clinical Disease Progression|5|||
146316688|NCT02754726|527670980|FG000|Overall Study|Adverse Event|3|||
146316689|NCT02754726|527670980|FG000|Overall Study|Withdrawal by Subject|1|||
146316690|NCT02754726|527670980|FG000|Overall Study|Tolerability|1|||
146316691|NCT01885000|527670981|FG000|Overall Study|Adverse Event|1|||
146316692|NCT01885000|527670982|FG001|Overall Study|Adverse Event|0|||
146316693|NCT01885000|527670981|FG000|Overall Study|Withdrawal by Subject|1|||
146316694|NCT01885000|527670982|FG001|Overall Study|Withdrawal by Subject|1|||
146316695|NCT01885000|527670981|FG000|Overall Study|Protocol Violation|0|||
146316696|NCT01885000|527670982|FG001|Overall Study|Protocol Violation|1|||
146316697|NCT02162732|527670983|FG000|Overall Study|Biopsy not performed.|18|||
146316698|NCT02363686|527670984|FG000|Overall Study|Withdrawal by Subject|22|||
146316699|NCT02363686|527670984|FG000|Overall Study|incomplete FEES examinations|13|||
146316700|NCT03446885|527670993|FG000|Overall Study|Lost to Follow-up|1|||
146316701|NCT03446885|527670994|FG001|Overall Study|Lost to Follow-up|0|||
146316702|NCT03446885|527670993|FG000|Overall Study|Did not complete entire visit|1|||
146316703|NCT03446885|527670994|FG001|Overall Study|Did not complete entire visit|0|||
146316704|NCT05882318|527671001|FG000|Overall Study|Withdrawal by Subject|1|||
146316705|NCT05882318|527671002|FG001|Overall Study|Withdrawal by Subject|0|||
146316706|NCT05882318|527671001|FG000|Overall Study|Protocol Violation|0|||
146316707|NCT05882318|527671002|FG001|Overall Study|Protocol Violation|1|||
146316708|NCT04735653|527671005|FG000|Overall Study|Lost to Follow-up|17|||
146316709|NCT04735653|527671006|FG001|Overall Study|Lost to Follow-up|7|||
146316710|NCT04735653|527671005|FG000|Overall Study|Withdrawal by Subject|8|||
146316711|NCT04735653|527671006|FG001|Overall Study|Withdrawal by Subject|2|||
146316712|NCT04735653|527671005|FG000|Overall Study|Death|0|||
145943217|NCT00483704|526300458|FG002|Randomization|Lack of qualifying migraines|31|||
146316713|NCT04735653|527671006|FG001|Overall Study|Death|2|||
146316714|NCT04735653|527671005|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
146316715|NCT04735653|527671006|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
146316716|NCT00252057|527671013|FG000|Overall Study|Withdrawal by Subject|2|||
146316717|NCT00252057|527671014|FG001|Overall Study|Withdrawal by Subject|5|||
146316718|NCT00252057|527671013|FG000|Overall Study|Death|1|||
146316719|NCT00252057|527671014|FG001|Overall Study|Death|2|||
146316720|NCT00252057|527671013|FG000|Overall Study|Participant previously enrolled|0|||
146316721|NCT00252057|527671014|FG001|Overall Study|Participant previously enrolled|1|||
146316722|NCT00623428|527671019|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
146316723|NCT00623428|527671020|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
146316724|NCT00623428|527671019|FG000|Treatment Period|Death|0|||
146316725|NCT00623428|527671020|FG001|Treatment Period|Death|1|||
146316726|NCT00623428|527671019|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
146316727|NCT00623428|527671020|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
146316728|NCT00623428|527671019|FG000|Treatment Period|Insufficient therapeutic response|0|||
146316729|NCT00623428|527671020|FG001|Treatment Period|Insufficient therapeutic response|2|||
146316730|NCT00623428|527671019|FG000|Treatment Period|Other|0|||
146316731|NCT00623428|527671020|FG001|Treatment Period|Other|1|||
146316732|NCT00623428|527671019|FG000|Treatment Period|Withdrawal by Subject|0|||
146316733|NCT00623428|527671020|FG001|Treatment Period|Withdrawal by Subject|1|||
146316734|NCT00623428|527671019|FG000|Follow-up Period|Relapse post-treatment|11|||
146316735|NCT00623428|527671020|FG001|Follow-up Period|Relapse post-treatment|3|||
146316736|NCT00623428|527671019|FG000|Follow-up Period|Failure to return|10|||
146316737|NCT00623428|527671020|FG001|Follow-up Period|Failure to return|2|||
146316738|NCT00623428|527671019|FG000|Follow-up Period|Patient withdrew consent|5|||
146316739|NCT00623428|527671020|FG001|Follow-up Period|Patient withdrew consent|4|||
146316740|NCT00623428|527671019|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
146316741|NCT00623428|527671020|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
146316742|NCT00623428|527671019|FG000|Follow-up Period|Did not cooperate|0|||
146316743|NCT00623428|527671020|FG001|Follow-up Period|Did not cooperate|3|||
146316744|NCT00623428|527671019|FG000|Follow-up Period|Reason not specified|1|||
146163020|NCT04575051|527106626|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
146163021|NCT04575051|527106627|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
146316745|NCT00623428|527671020|FG001|Follow-up Period|Reason not specified|1|||
146316746|NCT00623428|527671019|FG000|Follow-up Period|Death|0|||
146316747|NCT00623428|527671020|FG001|Follow-up Period|Death|1|||
146316748|NCT01692301|527671023|FG000|Overall Study|Adverse Event|15|||
146316749|NCT01692301|527671024|FG001|Overall Study|Adverse Event|12|||
146316750|NCT01692301|527671023|FG000|Overall Study|Death|1|||
146316751|NCT01692301|527671024|FG001|Overall Study|Death|2|||
146316752|NCT01692301|527671023|FG000|Overall Study|Lack of Efficacy|0|||
146316753|NCT01692301|527671024|FG001|Overall Study|Lack of Efficacy|5|||
146316754|NCT01692301|527671023|FG000|Overall Study|Non-compliance with study treatment|1|||
146163022|NCT04575051|527106628|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
146163023|NCT04575051|527106629|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
146163024|NCT04575051|527106625|FG000|Time Period 3|Missing follow up|8|||
146163025|NCT04575051|527106626|FG001|Time Period 3|Missing follow up|6|||
146163026|NCT04575051|527106627|FG002|Time Period 3|Missing follow up|4|||
146163027|NCT04575051|527106628|FG003|Time Period 3|Missing follow up|3|||
146163028|NCT04575051|527106629|FG004|Time Period 3|Missing follow up|0|||
146163029|NCT04575051|527106625|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
146163030|NCT04575051|527106626|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
146163031|NCT04575051|527106627|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
146163032|NCT04575051|527106628|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
146163033|NCT04575051|527106629|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
146163034|NCT04575051|527106625|FG000|Time Period 4|Missing follow up|17|||
146163035|NCT04575051|527106626|FG001|Time Period 4|Missing follow up|3|||
146163036|NCT04575051|527106627|FG002|Time Period 4|Missing follow up|4|||
146163037|NCT04575051|527106628|FG003|Time Period 4|Missing follow up|2|||
146163038|NCT04575051|527106629|FG004|Time Period 4|Missing follow up|1|||
146163039|NCT04575051|527106625|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
146163040|NCT04575051|527106626|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
146163041|NCT04575051|527106627|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
146163042|NCT04575051|527106628|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
146316755|NCT01692301|527671024|FG001|Overall Study|Non-compliance with study treatment|2|||
146163043|NCT04575051|527106629|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
146316756|NCT01692301|527671023|FG000|Overall Study|Protocol deviation|9|||
146316757|NCT01692301|527671024|FG001|Overall Study|Protocol deviation|2|||
146316758|NCT01692301|527671023|FG000|Overall Study|Patient/guardian decision|16|||
146316759|NCT01692301|527671024|FG001|Overall Study|Patient/guardian decision|15|||
146316760|NCT01692301|527671023|FG000|Overall Study|Technical problems|0|||
146316761|NCT01692301|527671024|FG001|Overall Study|Technical problems|1|||
146316762|NCT01692301|527671023|FG000|Overall Study|Physician Decision|2|||
146316763|NCT01692301|527671024|FG001|Overall Study|Physician Decision|2|||
146316764|NCT01692301|527671023|FG000|Overall Study|Lost to Follow-up|1|||
146163044|NCT04575051|527106625|FG000|Time Period 5|Missing follow up|11|||
146163045|NCT04575051|527106626|FG001|Time Period 5|Missing follow up|8|||
146163046|NCT04575051|527106627|FG002|Time Period 5|Missing follow up|12|||
146163047|NCT04575051|527106628|FG003|Time Period 5|Missing follow up|3|||
146163048|NCT04575051|527106629|FG004|Time Period 5|Missing follow up|11|||
146163049|NCT03492281|527106630|FG000|Overall Study|Withdrawal by Subject|21|||
146163050|NCT03492281|527106631|FG001|Overall Study|Withdrawal by Subject|14|||
146163051|NCT03492281|527106632|FG002|Overall Study|Withdrawal by Subject|13|||
146163052|NCT03492281|527106630|FG000|Overall Study|Lost to Follow-up|14|||
146163053|NCT03492281|527106631|FG001|Overall Study|Lost to Follow-up|15|||
146163054|NCT03492281|527106632|FG002|Overall Study|Lost to Follow-up|10|||
146163055|NCT03492281|527106630|FG000|Overall Study|Adverse Event|6|||
146163056|NCT03492281|527106631|FG001|Overall Study|Adverse Event|8|||
146163057|NCT03492281|527106632|FG002|Overall Study|Adverse Event|13|||
146163058|NCT03492281|527106630|FG000|Overall Study|Lack of Efficacy|3|||
146163059|NCT03492281|527106631|FG001|Overall Study|Lack of Efficacy|0|||
146163060|NCT03492281|527106632|FG002|Overall Study|Lack of Efficacy|1|||
146163061|NCT03492281|527106630|FG000|Overall Study|Physician Decision|1|||
146163062|NCT03492281|527106631|FG001|Overall Study|Physician Decision|0|||
146163063|NCT03492281|527106632|FG002|Overall Study|Physician Decision|3|||
146163064|NCT03492281|527106630|FG000|Overall Study|Protocol Violation|0|||
146163065|NCT03492281|527106631|FG001|Overall Study|Protocol Violation|2|||
146163066|NCT03492281|527106632|FG002|Overall Study|Protocol Violation|1|||
146163067|NCT03492281|527106630|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
146163068|NCT03492281|527106631|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
146163069|NCT03492281|527106632|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
146163070|NCT03492281|527106630|FG000|Overall Study|Death|0|||
146163071|NCT03492281|527106631|FG001|Overall Study|Death|0|||
146163072|NCT03492281|527106632|FG002|Overall Study|Death|1|||
146163073|NCT03492281|527106630|FG000|Overall Study|Captured as Other in Database|8|||
146163074|NCT03492281|527106631|FG001|Overall Study|Captured as Other in Database|6|||
146163075|NCT03492281|527106632|FG002|Overall Study|Captured as Other in Database|3|||
146163076|NCT03624504|527106633|FG000|Overall Study|Unsuccessful Implant|1|||
146163077|NCT02862457|527106634|FG000|Overall Study|Death|1|||
146163078|NCT02862457|527106635|FG001|Overall Study|Death|3|||
146163079|NCT02862457|527106636|FG002|Overall Study|Death|2|||
146163080|NCT02862457|527106637|FG003|Overall Study|Death|3|||
146163081|NCT02862457|527106638|FG004|Overall Study|Death|0|||
146163082|NCT02862457|527106639|FG005|Overall Study|Death|2|||
146163083|NCT02862457|527106640|FG006|Overall Study|Death|1|||
146163084|NCT02862457|527106634|FG000|Overall Study|Lost to Follow-up|1|||
146163085|NCT02862457|527106635|FG001|Overall Study|Lost to Follow-up|0|||
146163086|NCT02862457|527106636|FG002|Overall Study|Lost to Follow-up|0|||
146163087|NCT02862457|527106637|FG003|Overall Study|Lost to Follow-up|1|||
146163088|NCT02862457|527106638|FG004|Overall Study|Lost to Follow-up|0|||
146163089|NCT02862457|527106639|FG005|Overall Study|Lost to Follow-up|0|||
146163090|NCT02862457|527106640|FG006|Overall Study|Lost to Follow-up|0|||
146163091|NCT02862457|527106634|FG000|Overall Study|Withdrawal by Subject|0|||
146163092|NCT02862457|527106635|FG001|Overall Study|Withdrawal by Subject|0|||
146163093|NCT02862457|527106636|FG002|Overall Study|Withdrawal by Subject|1|||
146163094|NCT02862457|527106637|FG003|Overall Study|Withdrawal by Subject|0|||
146163095|NCT02862457|527106638|FG004|Overall Study|Withdrawal by Subject|0|||
146163096|NCT02862457|527106639|FG005|Overall Study|Withdrawal by Subject|1|||
146163097|NCT02862457|527106640|FG006|Overall Study|Withdrawal by Subject|0|||
146163098|NCT00951483|527106643|FG000|Overall Study|Physician Decision|4|||
146163099|NCT00951483|527106644|FG001|Overall Study|Physician Decision|0|||
146163100|NCT00951483|527106643|FG000|Overall Study|Withdrawal by Subject|15|||
146163101|NCT00951483|527106644|FG001|Overall Study|Withdrawal by Subject|0|||
146163102|NCT03565887|527106645|FG000|Overall Study|Adverse Event|1|||
146163103|NCT03565887|527106646|FG001|Overall Study|Adverse Event|0|||
146163104|NCT03565887|527106645|FG000|Overall Study|Withdrawal by Subject|0|||
146163105|NCT03565887|527106646|FG001|Overall Study|Withdrawal by Subject|2|||
146163106|NCT03364751|527106647|FG000|Overall Study|Withdrawal by Subject|1|||
146163107|NCT03364751|527106648|FG001|Overall Study|Withdrawal by Subject|0|||
146163108|NCT03364751|527106649|FG002|Overall Study|Withdrawal by Subject|0|||
146163109|NCT03364751|527106650|FG003|Overall Study|Withdrawal by Subject|0|||
146163110|NCT03364751|527106647|FG000|Overall Study|Lost to Follow-up|0|||
146163111|NCT03364751|527106648|FG001|Overall Study|Lost to Follow-up|1|||
146163112|NCT03364751|527106649|FG002|Overall Study|Lost to Follow-up|0|||
146163113|NCT03364751|527106650|FG003|Overall Study|Lost to Follow-up|0|||
146163114|NCT02975973|527106651|FG000|Overall Study|Adverse Event|1|||
146163115|NCT02975973|527106652|FG001|Overall Study|Adverse Event|1|||
146163116|NCT02975973|527106653|FG002|Overall Study|Adverse Event|1|||
146163117|NCT02975973|527106654|FG003|Overall Study|Adverse Event|0|||
146163118|NCT03804710|527106656|FG000|Overall Study|Adverse Event|0|||
146163119|NCT03804710|527106657|FG001|Overall Study|Adverse Event|3|||
146163120|NCT03804710|527106656|FG000|Overall Study|Withdrawal by Subject|2|||
146163121|NCT03804710|527106657|FG001|Overall Study|Withdrawal by Subject|1|||
146163122|NCT03804710|527106656|FG000|Overall Study|Other|0|||
146163123|NCT03804710|527106657|FG001|Overall Study|Other|1|||
146163124|NCT04542018|527106658|FG000|Overall Study|Withdrawal by Subject|0|||
146163125|NCT04542018|527106659|FG001|Overall Study|Withdrawal by Subject|0|||
146163126|NCT04542018|527106660|FG002|Overall Study|Withdrawal by Subject|4|||
146163127|NCT04542018|527106658|FG000|Overall Study|Protocol Violation|0|||
146163128|NCT04542018|527106659|FG001|Overall Study|Protocol Violation|0|||
146163129|NCT04542018|527106660|FG002|Overall Study|Protocol Violation|2|||
146163130|NCT03583554|527106661|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
146163131|NCT03583554|527106662|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
146163132|NCT03583554|527106663|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
146163133|NCT03178266|527106664|FG000|Overall Study|Death|0|||
146163134|NCT03178266|527106665|FG001|Overall Study|Death|1|||
146163135|NCT03178266|527106664|FG000|Overall Study|Disont. Early|0|||
146163136|NCT03178266|527106665|FG001|Overall Study|Disont. Early|1|||
146163137|NCT03178266|527106664|FG000|Overall Study|Withdrawal by Subject|0|||
146163138|NCT03178266|527106665|FG001|Overall Study|Withdrawal by Subject|2|||
146163139|NCT02363946|527106671|FG000|Overall Study|Lost to Follow-up|0|||
146163140|NCT02363946|527106672|FG001|Overall Study|Lost to Follow-up|0|||
146163141|NCT02363946|527106673|FG002|Overall Study|Lost to Follow-up|0|||
146163142|NCT02363946|527106674|FG003|Overall Study|Lost to Follow-up|0|||
146163143|NCT02363946|527106675|FG004|Overall Study|Lost to Follow-up|0|||
146163144|NCT02363946|527106676|FG005|Overall Study|Lost to Follow-up|0|||
146163145|NCT02363946|527106677|FG006|Overall Study|Lost to Follow-up|0|||
146163146|NCT02363946|527106678|FG007|Overall Study|Lost to Follow-up|1|||
146163147|NCT02363946|527106679|FG008|Overall Study|Lost to Follow-up|0|||
146163148|NCT02363946|527106680|FG009|Overall Study|Lost to Follow-up|0|||
146163149|NCT02363946|527106681|FG010|Overall Study|Lost to Follow-up|0|||
146163150|NCT02363946|527106682|FG011|Overall Study|Lost to Follow-up|0|||
146163151|NCT02363946|527106683|FG012|Overall Study|Lost to Follow-up|0|||
146163152|NCT01292239|527106684|FG000|Overall Study|Other|1|||
146163153|NCT01292239|527106685|FG001|Overall Study|Other|1|||
146163154|NCT01292239|527106684|FG000|Overall Study|Withdrawal by Subject|3|||
146163155|NCT01292239|527106685|FG001|Overall Study|Withdrawal by Subject|6|||
146163156|NCT00765388|527106686|FG000|Period 1|Lack of Efficacy|1|||
146163157|NCT00765388|527106687|FG001|Period 1|Lack of Efficacy|2|||
146316765|NCT01692301|527671024|FG001|Overall Study|Lost to Follow-up|1|||
146316766|NCT01142726|527671025|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
146316767|NCT01142726|527671026|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
146316768|NCT01142726|527671027|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
146316769|NCT01142726|527671025|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
146316770|NCT01142726|527671026|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
146316771|NCT01142726|527671027|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
146316772|NCT01142726|527671025|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
146316773|NCT01142726|527671026|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
146316774|NCT01142726|527671027|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
146316775|NCT01142726|527671025|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
146316776|NCT01142726|527671026|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
146316777|NCT01142726|527671027|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
146316778|NCT01142726|527671025|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
146316779|NCT01142726|527671026|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
146316780|NCT01142726|527671027|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
146316781|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
146316782|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
146316783|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
146316784|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
146316785|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
146316786|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
146316787|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
146316788|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
146316789|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
146316790|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
146316791|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
146316792|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
146316793|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
146163158|NCT00765388|527106686|FG000|Period 1|Lost to Follow-up|0|||
146163159|NCT00765388|527106687|FG001|Period 1|Lost to Follow-up|1|||
146163160|NCT00765388|527106686|FG000|Period 1|Herpes Zoster|0|||
146163161|NCT00765388|527106687|FG001|Period 1|Herpes Zoster|1|||
146163162|NCT00765388|527106686|FG000|Period 1|Hip operation|0|||
146163163|NCT00765388|527106687|FG001|Period 1|Hip operation|1|||
146163164|NCT03923933|527106691|FG000|Overall Study|Lost to Follow-up|1|||
146163165|NCT03923933|527106692|FG001|Overall Study|Lost to Follow-up|0|||
146163166|NCT03923933|527106691|FG000|Overall Study|Withdrawal by Subject|0|||
146163167|NCT03923933|527106692|FG001|Overall Study|Withdrawal by Subject|1|||
146163168|NCT00765674|527106693|FG000|Overall Study|Adverse Event|7|||
146163169|NCT00765674|527106694|FG001|Overall Study|Adverse Event|2|||
146163170|NCT00765674|527106695|FG002|Overall Study|Adverse Event|8|||
146163171|NCT00765674|527106696|FG003|Overall Study|Adverse Event|11|||
146163172|NCT00765674|527106693|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
146163173|NCT00765674|527106694|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
146163174|NCT00765674|527106695|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
146163175|NCT00765674|527106696|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
146163176|NCT00765674|527106693|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
146163177|NCT00765674|527106694|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
146163178|NCT00765674|527106695|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
146163179|NCT00765674|527106696|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
146163180|NCT00765674|527106693|FG000|Overall Study|Lack of Efficacy|2|||
146163181|NCT00765674|527106694|FG001|Overall Study|Lack of Efficacy|3|||
146163182|NCT00765674|527106695|FG002|Overall Study|Lack of Efficacy|1|||
146163183|NCT00765674|527106696|FG003|Overall Study|Lack of Efficacy|2|||
146163184|NCT00765674|527106693|FG000|Overall Study|Protocol Violation|2|||
146163185|NCT00765674|527106694|FG001|Overall Study|Protocol Violation|0|||
146163186|NCT00765674|527106695|FG002|Overall Study|Protocol Violation|1|||
146163187|NCT00765674|527106696|FG003|Overall Study|Protocol Violation|0|||
146163188|NCT00765674|527106693|FG000|Overall Study|Withdrawal by Subject|5|||
146163189|NCT00765674|527106694|FG001|Overall Study|Withdrawal by Subject|7|||
146163190|NCT00765674|527106695|FG002|Overall Study|Withdrawal by Subject|3|||
146163191|NCT00765674|527106696|FG003|Overall Study|Withdrawal by Subject|8|||
146163192|NCT00765674|527106693|FG000|Overall Study|Lost to Follow-up|4|||
146163193|NCT00765674|527106694|FG001|Overall Study|Lost to Follow-up|6|||
146163194|NCT00765674|527106695|FG002|Overall Study|Lost to Follow-up|2|||
146163195|NCT00765674|527106696|FG003|Overall Study|Lost to Follow-up|1|||
146163196|NCT00765674|527106693|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
146163197|NCT00765674|527106694|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
146163198|NCT00765674|527106695|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
146163199|NCT00765674|527106696|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
146163200|NCT03015402|527106697|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146163201|NCT03015402|527106698|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
146163202|NCT03015402|527106697|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
146163203|NCT03015402|527106698|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
146163204|NCT01813474|527106699|FG000|Overall Study|Withdrawal by Subject|0|||
146163205|NCT01813474|527106700|FG001|Overall Study|Withdrawal by Subject|0|||
146163206|NCT01813474|527106701|FG002|Overall Study|Withdrawal by Subject|1|||
146163207|NCT01813474|527106699|FG000|Overall Study|Adverse Event|1|||
146163208|NCT01813474|527106700|FG001|Overall Study|Adverse Event|1|||
146163209|NCT01813474|527106701|FG002|Overall Study|Adverse Event|0|||
146163210|NCT01813474|527106699|FG000|Overall Study|Lack of Efficacy|2|||
146163211|NCT01813474|527106700|FG001|Overall Study|Lack of Efficacy|6|||
146163212|NCT01813474|527106701|FG002|Overall Study|Lack of Efficacy|9|||
146163213|NCT01813474|527106699|FG000|Overall Study|Death|0|||
146163214|NCT01813474|527106700|FG001|Overall Study|Death|0|||
146163215|NCT01813474|527106701|FG002|Overall Study|Death|1|||
146163216|NCT00316082|527106707|FG000|Overall Study|Lack of Efficacy|2|||
146163217|NCT00316082|527106708|FG001|Overall Study|Lack of Efficacy|3|||
146163218|NCT00316082|527106709|FG002|Overall Study|Lack of Efficacy|3|||
146163219|NCT00316082|527106710|FG003|Overall Study|Lack of Efficacy|4|||
146163220|NCT00316082|527106711|FG004|Overall Study|Lack of Efficacy|6|||
146163221|NCT00316082|527106707|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
146163222|NCT00316082|527106708|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
146163223|NCT00316082|527106709|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
146163224|NCT00316082|527106710|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
146163225|NCT00316082|527106711|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
146163226|NCT00316082|527106707|FG000|Overall Study|Lost to Follow-up|7|||
146163227|NCT00316082|527106708|FG001|Overall Study|Lost to Follow-up|6|||
146163228|NCT00316082|527106709|FG002|Overall Study|Lost to Follow-up|7|||
146163229|NCT00316082|527106710|FG003|Overall Study|Lost to Follow-up|8|||
146163230|NCT00316082|527106711|FG004|Overall Study|Lost to Follow-up|6|||
146163231|NCT00316082|527106707|FG000|Overall Study|Poor/noncompliance|6|||
146163232|NCT00316082|527106708|FG001|Overall Study|Poor/noncompliance|1|||
146163233|NCT00316082|527106709|FG002|Overall Study|Poor/noncompliance|4|||
146163234|NCT00316082|527106710|FG003|Overall Study|Poor/noncompliance|1|||
146163235|NCT00316082|527106711|FG004|Overall Study|Poor/noncompliance|4|||
146163236|NCT00316082|527106707|FG000|Overall Study|Adverse Event|4|||
146163237|NCT00316082|527106708|FG001|Overall Study|Adverse Event|2|||
146163238|NCT00316082|527106709|FG002|Overall Study|Adverse Event|5|||
146163239|NCT00316082|527106710|FG003|Overall Study|Adverse Event|1|||
146316794|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
146163240|NCT00316082|527106711|FG004|Overall Study|Adverse Event|3|||
146163241|NCT00316082|527106707|FG000|Overall Study|Subject no longer meets study criteria|3|||
146163242|NCT00316082|527106708|FG001|Overall Study|Subject no longer meets study criteria|1|||
146163243|NCT00316082|527106709|FG002|Overall Study|Subject no longer meets study criteria|2|||
146163244|NCT00316082|527106710|FG003|Overall Study|Subject no longer meets study criteria|2|||
146163245|NCT00316082|527106711|FG004|Overall Study|Subject no longer meets study criteria|1|||
146163246|NCT00316082|527106707|FG000|Overall Study|Physician Decision|1|||
146163247|NCT00316082|527106708|FG001|Overall Study|Physician Decision|1|||
146163248|NCT00316082|527106709|FG002|Overall Study|Physician Decision|2|||
146163249|NCT00316082|527106710|FG003|Overall Study|Physician Decision|1|||
146163250|NCT00316082|527106711|FG004|Overall Study|Physician Decision|1|||
146163251|NCT00316082|527106707|FG000|Overall Study|Death|0|||
146163252|NCT00316082|527106708|FG001|Overall Study|Death|0|||
146163253|NCT00316082|527106709|FG002|Overall Study|Death|1|||
146163254|NCT00316082|527106710|FG003|Overall Study|Death|0|||
146163255|NCT00316082|527106711|FG004|Overall Study|Death|0|||
146163256|NCT00316082|527106707|FG000|Overall Study|Administrative reason by sponsor|0|||
146163257|NCT00316082|527106708|FG001|Overall Study|Administrative reason by sponsor|0|||
146163258|NCT00316082|527106709|FG002|Overall Study|Administrative reason by sponsor|1|||
146163259|NCT00316082|527106710|FG003|Overall Study|Administrative reason by sponsor|0|||
146163260|NCT00316082|527106711|FG004|Overall Study|Administrative reason by sponsor|0|||
146163261|NCT00528775|527106712|FG000|Overall Study|Other not specified|1|||
146316795|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
146316796|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
146316797|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
146316798|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
146163262|NCT01995461|527106715|FG000|Overall Study|Death|1|||
146163263|NCT01995461|527106715|FG000|Overall Study|Lost to Follow-up|2|||
146163264|NCT01995461|527106715|FG000|Overall Study|Withdrawal by Subject|2|||
146163265|NCT00540124|527106716|FG000|Overall Study|Adverse Event|0|||
146163266|NCT00540124|527106717|FG001|Overall Study|Adverse Event|2|||
146163267|NCT00540124|527106718|FG002|Overall Study|Adverse Event|1|||
146163268|NCT00540124|527106716|FG000|Overall Study|Entry Criteria Not Met|2|||
146163269|NCT00540124|527106717|FG001|Overall Study|Entry Criteria Not Met|0|||
146163270|NCT00540124|527106718|FG002|Overall Study|Entry Criteria Not Met|0|||
146163271|NCT00540124|527106716|FG000|Overall Study|Lack of Efficacy|1|||
146163272|NCT00540124|527106717|FG001|Overall Study|Lack of Efficacy|0|||
146163273|NCT00540124|527106718|FG002|Overall Study|Lack of Efficacy|0|||
146163274|NCT00540124|527106716|FG000|Overall Study|Withdrawal by Subject|1|||
146163275|NCT00540124|527106717|FG001|Overall Study|Withdrawal by Subject|1|||
146163276|NCT00540124|527106718|FG002|Overall Study|Withdrawal by Subject|0|||
146163277|NCT01777854|527106725|FG000|Overall Study|Physician Decision|3|||
146163278|NCT01777854|527106726|FG001|Overall Study|Physician Decision|3|||
146163279|NCT03311373|527106729|FG000|Overall Study|Adverse Event|1|||
146163280|NCT03311373|527106729|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
146163281|NCT03311373|527106729|FG000|Overall Study|Lost to Follow-up|1|||
146163282|NCT03311373|527106729|FG000|Overall Study|Physician Decision|1|||
146163283|NCT03311373|527106729|FG000|Overall Study|Withdrawal by Subject|3|||
146163284|NCT01830127|527106734|FG000|Overall Study|Adverse Event|1|||
146163285|NCT01830127|527106735|FG001|Overall Study|Adverse Event|6|||
146163286|NCT01830127|527106734|FG000|Overall Study|Lack of Efficacy|3|||
146163287|NCT01830127|527106735|FG001|Overall Study|Lack of Efficacy|0|||
146163288|NCT01830127|527106734|FG000|Overall Study|Withdrawal by Subject|1|||
146163289|NCT01830127|527106735|FG001|Overall Study|Withdrawal by Subject|1|||
146163290|NCT01830127|527106734|FG000|Overall Study|Other reason not defined above|0|||
146163291|NCT01830127|527106735|FG001|Overall Study|Other reason not defined above|2|||
146163292|NCT00374322|527106742|FG000|Overall Study|Lost to Follow-up|92|||
146163293|NCT00374322|527106743|FG001|Overall Study|Lost to Follow-up|90|||
146163294|NCT00374322|527106742|FG000|Overall Study|Protocol Violation|8|||
146163295|NCT00374322|527106743|FG001|Overall Study|Protocol Violation|3|||
146163296|NCT00374322|527106742|FG000|Overall Study|Withdrawal by Subject|235|||
146163297|NCT00374322|527106743|FG001|Overall Study|Withdrawal by Subject|167|||
146163298|NCT00374322|527106742|FG000|Overall Study|Sponsor Terminated Study|866|||
146163299|NCT00374322|527106743|FG001|Overall Study|Sponsor Terminated Study|990|||
146163300|NCT00374322|527106742|FG000|Overall Study|Physician Decision|36|||
146163301|NCT00374322|527106743|FG001|Overall Study|Physician Decision|32|||
146163302|NCT00374322|527106742|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
146163303|NCT00374322|527106743|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
146163304|NCT00374322|527106742|FG000|Overall Study|Sponsor Decision|2|||
146163305|NCT00374322|527106743|FG001|Overall Study|Sponsor Decision|3|||
146163306|NCT00374322|527106742|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
146163307|NCT00374322|527106743|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
146163308|NCT00374322|527106742|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
146163309|NCT00374322|527106743|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
146163310|NCT00374322|527106742|FG000|Overall Study|Severe Toxicity|1|||
146163311|NCT00374322|527106743|FG001|Overall Study|Severe Toxicity|0|||
146163312|NCT00374322|527106742|FG000|Overall Study|Site Closed|2|||
146163313|NCT00374322|527106743|FG001|Overall Study|Site Closed|2|||
146163314|NCT00374322|527106742|FG000|Overall Study|Participant Changed Physician|1|||
146163315|NCT00374322|527106743|FG001|Overall Study|Participant Changed Physician|0|||
146163316|NCT00374322|527106742|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
146163317|NCT00374322|527106743|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
146163318|NCT00374322|527106742|FG000|Overall Study|Noncompliance with Study Requirements|0|||
146163319|NCT00374322|527106743|FG001|Overall Study|Noncompliance with Study Requirements|1|||
146163320|NCT00374322|527106742|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
146163321|NCT00374322|527106743|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
146163322|NCT00374322|527106742|FG000|Overall Study|Did Not Receive Study Medication|8|||
146163323|NCT00374322|527106743|FG001|Overall Study|Did Not Receive Study Medication|6|||
146163324|NCT01297959|527106746|FG000|Overall Study|Adverse Event|0|||
146163325|NCT01297959|527106747|FG001|Overall Study|Adverse Event|1|||
146163326|NCT01297959|527106746|FG000|Overall Study|Protocol Violation|2|||
146163327|NCT01297959|527106747|FG001|Overall Study|Protocol Violation|1|||
146163328|NCT01297959|527106746|FG000|Overall Study|Withdrawal by Subject|5|||
146163329|NCT01297959|527106747|FG001|Overall Study|Withdrawal by Subject|4|||
146163330|NCT01297959|527106746|FG000|Overall Study|Physician Decision|0|||
146163331|NCT01297959|527106747|FG001|Overall Study|Physician Decision|1|||
146163332|NCT01297959|527106746|FG000|Overall Study|Unrelated medical illness / complication|0|||
146163333|NCT01297959|527106747|FG001|Overall Study|Unrelated medical illness / complication|2|||
146163334|NCT01297959|527106746|FG000|Overall Study|Other|13|||
146163335|NCT01297959|527106747|FG001|Overall Study|Other|7|||
146163336|NCT01667432|527106748|FG000|Overall Study|Premature Study Termination|26|||
146163337|NCT01667432|527106748|FG000|Overall Study|Failure to Return|10|||
146163338|NCT01667432|527106748|FG000|Overall Study|Moved to Another Center|3|||
146163339|NCT01667432|527106748|FG000|Overall Study|Lost to Follow-up|3|||
146163340|NCT01667432|527106748|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
146163341|NCT01667432|527106748|FG000|Overall Study|Insufficient Therapeutic Response|4|||
146163342|NCT01667432|527106748|FG000|Overall Study|Adverse Event|1|||
146163343|NCT01667432|527106748|FG000|Overall Study|Protocol Deviation|2|||
146163344|NCT01667432|527106748|FG000|Overall Study|Principal Investigator Decision|1|||
146163345|NCT01667432|527106748|FG000|Overall Study|Reason Not Specified|2|||
146163346|NCT01667432|527106748|FG000|Overall Study|Missing Information|4|||
146163347|NCT00671931|527106753|FG000|Overall Study|Physician Decision|1|||
146163348|NCT00671931|527106754|FG001|Overall Study|Physician Decision|0|||
146163349|NCT00671931|527106755|FG002|Overall Study|Physician Decision|0|||
146163350|NCT00671931|527106756|FG003|Overall Study|Physician Decision|2|||
146163351|NCT00671931|527106757|FG004|Overall Study|Physician Decision|1|||
146163352|NCT02048072|527106758|FG000|Overall Study|Adverse Event|3|||
146163353|NCT02048072|527106758|FG000|Overall Study|Lost to Follow-up|1|||
146163354|NCT01112579|527106759|FG000|Overall Study|Missed Visit|1|||
146163355|NCT01112579|527106760|FG001|Overall Study|Missed Visit|1|||
146163356|NCT01112579|527106759|FG000|Overall Study|Death|0|||
146163357|NCT01112579|527106760|FG001|Overall Study|Death|2|||
146163358|NCT01648270|527106761|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
146163359|NCT01553318|527108649|FG000|Overall Study|Protocol Violation|3|||
146163360|NCT01553318|527108650|FG001|Overall Study|Protocol Violation|2|||
146163361|NCT02178059|527108652|FG000|Washout|Physician Decision|1|||
146163362|NCT02178059|527108653|FG001|Washout|Physician Decision|0|||
146163363|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
146163364|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
146163365|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
146163366|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
146163367|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
146163368|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
146163369|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Death|1|||
146163370|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Death|0|||
146163371|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Adverse Event|1|||
146163372|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Adverse Event|0|||
146163373|NCT02586025|527108656|FG000|Neoadjuvant Treatment|Physician Decision|2|||
146163374|NCT02586025|527108657|FG001|Neoadjuvant Treatment|Physician Decision|1|||
146163375|NCT02586025|527108656|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
146163376|NCT02586025|527108657|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
146163377|NCT02586025|527108656|FG000|Adjuvant Treatment|Recurrent Disease|4|||
146163378|NCT02586025|527108657|FG001|Adjuvant Treatment|Recurrent Disease|5|||
146163379|NCT02586025|527108656|FG000|Adjuvant Treatment|Physician Decision|0|||
146163380|NCT02586025|527108657|FG001|Adjuvant Treatment|Physician Decision|1|||
146163381|NCT02586025|527108656|FG000|Adjuvant Treatment|Pregnancy|1|||
146163382|NCT02586025|527108657|FG001|Adjuvant Treatment|Pregnancy|0|||
146163383|NCT02586025|527108656|FG000|Treatment-Free Follow-Up|Death|11|||
146163384|NCT02586025|527108657|FG001|Treatment-Free Follow-Up|Death|11|||
146163385|NCT02586025|527108656|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
146163386|NCT02586025|527108657|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
146163387|NCT02586025|527108656|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
146163388|NCT02586025|527108657|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
146163389|NCT02586025|527108656|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
146163390|NCT02586025|527108657|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
146163391|NCT02586025|527108656|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
146163392|NCT02586025|527108657|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
146163393|NCT03597568|527108658|FG000|Overall Study|Withdrawal by Subject|1|||
146163394|NCT03597568|527108659|FG001|Overall Study|Withdrawal by Subject|1|||
146163395|NCT03597568|527108658|FG000|Overall Study|Unable to analyze vascular data|1|||
146163396|NCT03597568|527108659|FG001|Overall Study|Unable to analyze vascular data|1|||
146163397|NCT00999466|527108662|FG000|Main Part|Withdrawal by Subject|0|||
146163398|NCT00999466|527108663|FG001|Main Part|Withdrawal by Subject|0|||
146163399|NCT00999466|527108664|FG002|Main Part|Withdrawal by Subject|2|||
146163400|NCT00999466|527108662|FG000|Main Part|Adverse Event|0|||
146163401|NCT00999466|527108663|FG001|Main Part|Adverse Event|4|||
146163402|NCT00999466|527108664|FG002|Main Part|Adverse Event|2|||
146163403|NCT03255824|527108665|FG000|Overall Study|Under-sedation|2|||
146163404|NCT03255824|527108666|FG001|Overall Study|Under-sedation|1|||
146163405|NCT02001194|527108668|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
146163406|NCT02001194|527108669|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
146163407|NCT02001194|527108670|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
146163408|NCT02001194|527108671|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
146163409|NCT02001194|527108668|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
146163410|NCT02001194|527108669|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
146163411|NCT02001194|527108670|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
146163412|NCT02001194|527108671|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
146163413|NCT03040713|527108673|FG000|Overall Study|Positive amyloid scan|3|||
146163414|NCT02570126|527108680|FG000|Overall Study|Lost to Follow-up|2|||
146163415|NCT02570126|527108681|FG001|Overall Study|Lost to Follow-up|0|||
146163416|NCT02570126|527108680|FG000|Overall Study|Unable To Arrange Visit 3|1|||
146163417|NCT02570126|527108681|FG001|Overall Study|Unable To Arrange Visit 3|0|||
146163418|NCT02570126|527108680|FG000|Overall Study|Violation Of Procedures GSK|0|||
146163419|NCT02570126|527108681|FG001|Overall Study|Violation Of Procedures GSK|1|||
146163420|NCT02570126|527108680|FG000|Overall Study|Protocol Violation|0|||
146163421|NCT02570126|527108681|FG001|Overall Study|Protocol Violation|1|||
146163422|NCT02570126|527108680|FG000|Overall Study|Withdrawal by Subject|3|||
146163423|NCT02570126|527108681|FG001|Overall Study|Withdrawal by Subject|7|||
146163424|NCT04683926|527108683|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
146163425|NCT04683926|527108684|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
146163426|NCT04683926|527108685|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
146163427|NCT04683926|527108686|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
146163428|NCT04385368|527108688|FG000|Overall Study|Death|5|||
146163429|NCT04385368|527108689|FG001|Overall Study|Death|5|||
146163430|NCT04385368|527108688|FG000|Overall Study|Physician Decision|3|||
146163431|NCT04385368|527108689|FG001|Overall Study|Physician Decision|0|||
146163432|NCT04385368|527108688|FG000|Overall Study|Withdrawal by Subject|4|||
146163433|NCT04385368|527108689|FG001|Overall Study|Withdrawal by Subject|3|||
146163434|NCT02123108|527108692|FG000|Overall Study|Death|2|||
146163435|NCT02123108|527108693|FG001|Overall Study|Death|3|||
146163436|NCT00716092|527108694|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
146163437|NCT00716092|527108695|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
146163438|NCT00716092|527108696|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
146163439|NCT01132326|527108697|FG000|Overall Study|Lack of Efficacy|25|||
146163440|NCT01132326|527108697|FG000|Overall Study|Adverse Event|37|||
146163441|NCT01132326|527108697|FG000|Overall Study|Protocol Violation|1|||
146163442|NCT01132326|527108697|FG000|Overall Study|Lost to Follow-up|16|||
146163443|NCT01132326|527108697|FG000|Overall Study|Withdrawal by Subject|40|||
146163444|NCT01132326|527108697|FG000|Overall Study|Physician Decision|10|||
146163445|NCT01132326|527108697|FG000|Overall Study|Study Termination|80|||
146163446|NCT01132326|527108697|FG000|Overall Study|Declining Health|1|||
146163447|NCT01132326|527108697|FG000|Overall Study|Pregnancy|1|||
146163448|NCT01132326|527108697|FG000|Overall Study|Caregiver Withdrew Consent|1|||
146163449|NCT01132326|527108697|FG000|Overall Study|Death|5|||
146163450|NCT01132326|527108697|FG000|Overall Study|Subject Unable to Come To Visits|1|||
146163451|NCT00677235|527108698|FG000|Overall Study|Withdrawal by Subject|1|||
146163452|NCT00677235|527108699|FG001|Overall Study|Withdrawal by Subject|1|||
146163453|NCT00677235|527108698|FG000|Overall Study|Lost to Follow-up|2|||
146163454|NCT00677235|527108699|FG001|Overall Study|Lost to Follow-up|1|||
146163455|NCT00677235|527108698|FG000|Overall Study|Death|37|||
146316799|NCT01142726|527671025|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
146316800|NCT01142726|527671026|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
146316801|NCT01142726|527671027|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
146316802|NCT01142726|527671025|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
146316803|NCT01142726|527671026|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
146316804|NCT01142726|527671027|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
146316805|NCT01142726|527671025|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146316806|NCT01142726|527671026|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146316807|NCT01142726|527671027|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
146316808|NCT01142726|527671025|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
146163456|NCT00677235|527108699|FG001|Overall Study|Death|36|||
146163457|NCT00677235|527108698|FG000|Overall Study|Adverse Experience|1|||
146163458|NCT00677235|527108699|FG001|Overall Study|Adverse Experience|0|||
146163459|NCT01040260|527108700|FG000|Overall Study|Withdrawal by Subject|12|||
146163460|NCT01040260|527108701|FG001|Overall Study|Withdrawal by Subject|6|||
146163461|NCT01040260|527108700|FG000|Overall Study|Lost to Follow-up|3|||
146163462|NCT01040260|527108701|FG001|Overall Study|Lost to Follow-up|5|||
146163463|NCT01113502|527108705|FG000|Overall Study|Withdrawal by Subject|1|||
146163464|NCT01113502|527108706|FG001|Overall Study|Withdrawal by Subject|0|||
146163465|NCT01113502|527108707|FG002|Overall Study|Withdrawal by Subject|1|||
146163466|NCT01113502|527108708|FG003|Overall Study|Withdrawal by Subject|1|||
146163467|NCT01113502|527108709|FG004|Overall Study|Withdrawal by Subject|0|||
146163468|NCT01113502|527108705|FG000|Overall Study|Adverse Event|0|||
146163469|NCT01113502|527108706|FG001|Overall Study|Adverse Event|0|||
146163470|NCT01113502|527108707|FG002|Overall Study|Adverse Event|3|||
146163471|NCT01113502|527108708|FG003|Overall Study|Adverse Event|2|||
146163472|NCT01113502|527108709|FG004|Overall Study|Adverse Event|0|||
146163473|NCT01970982|527108712|FG000|Overall Study|Withdrawal by Subject|0|||
146163474|NCT01970982|527108713|FG001|Overall Study|Withdrawal by Subject|0|||
146163475|NCT01970982|527108714|FG002|Overall Study|Withdrawal by Subject|2|||
146163476|NCT00708916|527108717|FG000|Overall Study|Subject Noncompliance|2|||
146163477|NCT00708916|527108717|FG000|Overall Study|Adverse Event|2|||
146163478|NCT01362439|527108718|FG000|Overall Study|Adverse Event|1|||
146163479|NCT01362439|527108718|FG000|Overall Study|Lack of Efficacy|3|||
146163480|NCT01362439|527108718|FG000|Overall Study|Lost to Follow-up|2|||
146163481|NCT01362439|527108718|FG000|Overall Study|Study medication non-compliant|1|||
146163482|NCT01362439|527108718|FG000|Overall Study|Participant who withdrew consent|8|||
146163483|NCT01984684|527108721|FG000|Overall Study|Lost to Follow-up|25|||
146163484|NCT01984684|527108722|FG001|Overall Study|Lost to Follow-up|24|||
146163485|NCT01984684|527108721|FG000|Overall Study|Adverse Event|8|||
146163486|NCT01984684|527108722|FG001|Overall Study|Adverse Event|12|||
146163487|NCT01984684|527108721|FG000|Overall Study|Withdrawal by Subject|9|||
146163488|NCT01984684|527108722|FG001|Overall Study|Withdrawal by Subject|9|||
146163489|NCT01984684|527108721|FG000|Overall Study|Lack of Efficacy|3|||
146163490|NCT01984684|527108722|FG001|Overall Study|Lack of Efficacy|6|||
146163491|NCT01984684|527108721|FG000|Overall Study|Physician Decision|4|||
146163492|NCT01984684|527108722|FG001|Overall Study|Physician Decision|2|||
146163493|NCT01984684|527108721|FG000|Overall Study|Protocol Violation|4|||
146163494|NCT01984684|527108722|FG001|Overall Study|Protocol Violation|2|||
146163495|NCT01984684|527108721|FG000|Overall Study|Death|0|||
146163496|NCT01984684|527108722|FG001|Overall Study|Death|1|||
146163497|NCT01984684|527108721|FG000|Overall Study|Noncompliance with study drug|2|||
146163498|NCT01984684|527108722|FG001|Overall Study|Noncompliance with study drug|1|||
146163499|NCT01984684|527108721|FG000|Overall Study|Subject incarcerated|1|||
146316809|NCT01142726|527671026|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
146316810|NCT01142726|527671027|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
146316811|NCT01142726|527671025|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
146316812|NCT01142726|527671026|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
146316813|NCT01142726|527671027|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
146316814|NCT00293579|527671031|FG000|Overall Study|Withdrawal by Subject|1|||
146163500|NCT01984684|527108722|FG001|Overall Study|Subject incarcerated|0|||
146163501|NCT01984684|527108721|FG000|Overall Study|Study drug not available at site|1|||
146163502|NCT01984684|527108722|FG001|Overall Study|Study drug not available at site|1|||
146163503|NCT01984684|527108721|FG000|Overall Study|Subject had inadequate IV access|0|||
146163504|NCT01984684|527108722|FG001|Overall Study|Subject had inadequate IV access|1|||
146163505|NCT02835339|527108726|FG000|Overall Study|Did not receive allocated intervention|13|||
146163506|NCT02835339|527108727|FG001|Overall Study|Did not receive allocated intervention|16|||
146163507|NCT01077544|527108728|FG000|Overall Study|New Cancer Therapy|3|||
146163508|NCT01077544|527108729|FG001|Overall Study|New Cancer Therapy|3|||
146163509|NCT01077544|527108728|FG000|Overall Study|Adverse Event|0|||
146163510|NCT01077544|527108729|FG001|Overall Study|Adverse Event|1|||
146163511|NCT01077544|527108728|FG000|Overall Study|Disease Progression|0|||
146163512|NCT01077544|527108729|FG001|Overall Study|Disease Progression|1|||
146163513|NCT03923959|527108738|FG000|Overall Study|Death|16|||
146163514|NCT03923959|527108739|FG001|Overall Study|Death|12|||
146163515|NCT03923959|527108738|FG000|Overall Study|Lost to Follow-up|56|||
146316815|NCT00419380|527671032|FG000|Overall Study|Lack of Efficacy|1|||
146316816|NCT00419380|527671033|FG001|Overall Study|Lack of Efficacy|7|||
146163516|NCT03923959|527108739|FG001|Overall Study|Lost to Follow-up|56|||
146163517|NCT03923959|527108738|FG000|Overall Study|Withdrawal by Subject|1|||
146163518|NCT03923959|527108739|FG001|Overall Study|Withdrawal by Subject|1|||
146163519|NCT03923959|527108738|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
146163520|NCT03923959|527108739|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
146316817|NCT00419380|527671032|FG000|Overall Study|Physician Decision|0|||
146316818|NCT00419380|527671033|FG001|Overall Study|Physician Decision|1|||
146163521|NCT04918147|527108740|FG000|Overall Study|Disease flare as defined in protocol|0|||
146163522|NCT04918147|527108741|FG001|Overall Study|Disease flare as defined in protocol|2|||
146163523|NCT03574597|527108743|FG000|Overall Study|Withdrawal by Subject|67|||
146163524|NCT03574597|527108744|FG001|Overall Study|Withdrawal by Subject|96|||
146163525|NCT03574597|527108743|FG000|Overall Study|Lost to Follow-up|192|||
146163526|NCT03574597|527108744|FG001|Overall Study|Lost to Follow-up|188|||
146163527|NCT02355743|527108745|FG000|Overall Study|Withdrawal by Subject|1|||
146163528|NCT02355743|527108745|FG000|Overall Study|Lost to Follow-up|1|||
146163529|NCT00689221|527108749|FG000|Overall Study|Ongoing at cut-off date|39|||
146163530|NCT00689221|527108750|FG001|Overall Study|Ongoing at cut-off date|36|||
146163531|NCT01812655|527108754|FG000|Overall Study|Protocol Violation|1|||
146163532|NCT01812655|527108755|FG001|Overall Study|Protocol Violation|1|||
146163533|NCT01812655|527108756|FG002|Overall Study|Protocol Violation|0|||
146163534|NCT04435665|527108758|FG000|Overall Study|Lost to Follow-up|0|||
146163535|NCT04435665|527108759|FG001|Overall Study|Lost to Follow-up|0|||
146163536|NCT04435665|527108760|FG002|Overall Study|Lost to Follow-up|0|||
146163537|NCT04435665|527108761|FG003|Overall Study|Lost to Follow-up|1|||
146163538|NCT00419263|527108762|FG000|Overall Study|Lost to Follow-up|2|||
146163539|NCT00419263|527108763|FG001|Overall Study|Lost to Follow-up|1|||
146163540|NCT00419263|527108764|FG002|Overall Study|Lost to Follow-up|1|||
146163541|NCT00419263|527108762|FG000|Overall Study|Randomized in Error, Not Treated|1|||
146163542|NCT00419263|527108763|FG001|Overall Study|Randomized in Error, Not Treated|1|||
146163543|NCT00419263|527108764|FG002|Overall Study|Randomized in Error, Not Treated|0|||
146163544|NCT00419263|527108762|FG000|Overall Study|Adverse Event|0|||
146163545|NCT00419263|527108763|FG001|Overall Study|Adverse Event|0|||
146163546|NCT00419263|527108764|FG002|Overall Study|Adverse Event|1|||
146163547|NCT00419263|527108762|FG000|Overall Study|Withdrawal by Subject|0|||
146163548|NCT00419263|527108763|FG001|Overall Study|Withdrawal by Subject|0|||
146163549|NCT00419263|527108764|FG002|Overall Study|Withdrawal by Subject|1|||
146163550|NCT02342886|527108765|FG000|Overall Study|Treatment non-compliance|1|||
146163551|NCT02342886|527108766|FG001|Overall Study|Treatment non-compliance|0|||
146163552|NCT02342886|527108767|FG002|Overall Study|Treatment non-compliance|0|||
146163553|NCT02342886|527108768|FG003|Overall Study|Treatment non-compliance|1|||
146163554|NCT02342886|527108769|FG004|Overall Study|Treatment non-compliance|0|||
146163555|NCT02342886|527108765|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
146163556|NCT02342886|527108766|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
146163557|NCT02342886|527108767|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
146163558|NCT02342886|527108768|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
146163559|NCT02342886|527108769|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
146163560|NCT02342886|527108765|FG000|Overall Study|Adverse event/specific toxicity|4|||
146163561|NCT02342886|527108766|FG001|Overall Study|Adverse event/specific toxicity|3|||
146163562|NCT02342886|527108767|FG002|Overall Study|Adverse event/specific toxicity|11|||
146163563|NCT02342886|527108768|FG003|Overall Study|Adverse event/specific toxicity|2|||
146163564|NCT02342886|527108769|FG004|Overall Study|Adverse event/specific toxicity|1|||
146163565|NCT02342886|527108765|FG000|Overall Study|Lost to Follow-up|1|||
146163566|NCT02342886|527108766|FG001|Overall Study|Lost to Follow-up|0|||
146163567|NCT02342886|527108767|FG002|Overall Study|Lost to Follow-up|0|||
146163568|NCT02342886|527108768|FG003|Overall Study|Lost to Follow-up|0|||
146163569|NCT02342886|527108769|FG004|Overall Study|Lost to Follow-up|0|||
146163570|NCT02342886|527108765|FG000|Overall Study|Death|1|||
146163571|NCT02342886|527108766|FG001|Overall Study|Death|2|||
146163572|NCT02342886|527108767|FG002|Overall Study|Death|1|||
146163573|NCT02342886|527108768|FG003|Overall Study|Death|0|||
146163574|NCT02342886|527108769|FG004|Overall Study|Death|1|||
146163575|NCT02342886|527108765|FG000|Overall Study|Withdrawal by Subject|0|||
146163576|NCT02342886|527108766|FG001|Overall Study|Withdrawal by Subject|1|||
146163577|NCT02342886|527108767|FG002|Overall Study|Withdrawal by Subject|0|||
146163578|NCT02342886|527108768|FG003|Overall Study|Withdrawal by Subject|1|||
146163579|NCT02342886|527108769|FG004|Overall Study|Withdrawal by Subject|0|||
146163580|NCT02342886|527108765|FG000|Overall Study|Investigator/sponsor decision|0|||
146163581|NCT02342886|527108766|FG001|Overall Study|Investigator/sponsor decision|2|||
146163582|NCT02342886|527108767|FG002|Overall Study|Investigator/sponsor decision|0|||
146163583|NCT02342886|527108768|FG003|Overall Study|Investigator/sponsor decision|3|||
146163584|NCT02342886|527108769|FG004|Overall Study|Investigator/sponsor decision|1|||
146163585|NCT02342886|527108765|FG000|Overall Study|Pregnancy|0|||
146163586|NCT02342886|527108766|FG001|Overall Study|Pregnancy|0|||
146316819|NCT00419380|527671032|FG000|Overall Study|Lost to Follow-up|0|||
146316820|NCT00419380|527671033|FG001|Overall Study|Lost to Follow-up|1|||
146316821|NCT00419380|527671032|FG000|Overall Study|Withdrawal by Subject|0|||
146163587|NCT02342886|527108767|FG002|Overall Study|Pregnancy|2|||
146163588|NCT02342886|527108768|FG003|Overall Study|Pregnancy|0|||
146163589|NCT02342886|527108769|FG004|Overall Study|Pregnancy|0|||
146163590|NCT02342886|527108765|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146163591|NCT02342886|527108766|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146163592|NCT02342886|527108767|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
146316822|NCT00419380|527671033|FG001|Overall Study|Withdrawal by Subject|1|||
146163593|NCT02342886|527108768|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146163594|NCT02342886|527108769|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
146163595|NCT02342886|527108765|FG000|Overall Study|Protocol Violation|0|||
146163596|NCT02342886|527108766|FG001|Overall Study|Protocol Violation|0|||
146163597|NCT02342886|527108767|FG002|Overall Study|Protocol Violation|0|||
146163598|NCT02342886|527108768|FG003|Overall Study|Protocol Violation|2|||
146163599|NCT02342886|527108769|FG004|Overall Study|Protocol Violation|0|||
146163600|NCT01328080|527108770|FG000|Overall Study|Lost to Follow-up|5|||
146163601|NCT00862134|527108771|FG000|Overall Study|Death|1|||
146163602|NCT00862134|527108772|FG001|Overall Study|Death|0|||
146163603|NCT00862134|527108771|FG000|Overall Study|Physician Decision|0|||
146163604|NCT00862134|527108772|FG001|Overall Study|Physician Decision|1|||
146163605|NCT00862134|527108771|FG000|Overall Study|Withdrawal by Subject|1|||
146163606|NCT00862134|527108772|FG001|Overall Study|Withdrawal by Subject|2|||
146163607|NCT00862134|527108771|FG000|Overall Study|Sponsor terminated study|5|||
146163608|NCT00862134|527108772|FG001|Overall Study|Sponsor terminated study|7|||
146163609|NCT00862134|527108771|FG000|Overall Study|Adverse Event|2|||
146163610|NCT00862134|527108772|FG001|Overall Study|Adverse Event|2|||
146316823|NCT03099707|527671034|FG000|Overall Study|Withdrawal by Subject|0|||
146316824|NCT03099707|527671035|FG001|Overall Study|Withdrawal by Subject|3|||
146316825|NCT03099707|527671034|FG000|Overall Study|Lost to Follow-up|0|||
146316826|NCT03099707|527671035|FG001|Overall Study|Lost to Follow-up|1|||
146316827|NCT04428424|527671036|FG000|Overall Study|Does not meet entrance criteria|132|||
146316828|NCT04428424|527671036|FG000|Overall Study|Lost to Follow-up|115|||
146163611|NCT00862134|527108771|FG000|Overall Study|Withdrew prior to dosing|2|||
146163612|NCT00862134|527108772|FG001|Overall Study|Withdrew prior to dosing|0|||
146163613|NCT02191267|527108773|FG000|Overall Study|Withdrawal by Subject|1|||
146163614|NCT02191267|527108774|FG001|Overall Study|Withdrawal by Subject|0|||
146163615|NCT02191267|527108775|FG002|Overall Study|Withdrawal by Subject|0|||
146163616|NCT00538590|527108776|FG000|Overall Study|Death|1|||
146163617|NCT00538590|527108777|FG001|Overall Study|Death|0|||
146163618|NCT00567190|527108778|FG000|Overall Study|Death|235|||
146163619|NCT00567190|527108779|FG001|Overall Study|Death|280|||
146163620|NCT00567190|527108778|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
146163621|NCT00567190|527108779|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
146163622|NCT00636610|527108780|FG000|Overall Study|Adverse Event|4|||
146163623|NCT00636610|527108781|FG001|Overall Study|Adverse Event|4|||
146163624|NCT00636610|527108780|FG000|Overall Study|Death|6|||
146163625|NCT00636610|527108781|FG001|Overall Study|Death|3|||
146163626|NCT00636610|527108780|FG000|Overall Study|Physician decision to withdraw patient|15|||
146163627|NCT00636610|527108781|FG001|Overall Study|Physician decision to withdraw patient|9|||
146163628|NCT00636610|527108780|FG000|Overall Study|Subject decision to withdraw|15|||
146163629|NCT00636610|527108781|FG001|Overall Study|Subject decision to withdraw|11|||
146316829|NCT01662440|527672625|FG000|Overall Study|Adverse Event|1|||
146316830|NCT01662440|527672626|FG001|Overall Study|Adverse Event|0|||
146316831|NCT01662440|527672627|FG002|Overall Study|Adverse Event|0|||
146316832|NCT01662440|527672628|FG003|Overall Study|Adverse Event|1|||
146316833|NCT01662440|527672625|FG000|Overall Study|Death|0|||
146316834|NCT01662440|527672626|FG001|Overall Study|Death|1|||
146316835|NCT01662440|527672627|FG002|Overall Study|Death|0|||
146316836|NCT01662440|527672628|FG003|Overall Study|Death|0|||
146316837|NCT01662440|527672625|FG000|Overall Study|Lost to Follow-up|2|||
146316838|NCT01662440|527672626|FG001|Overall Study|Lost to Follow-up|2|||
146316839|NCT01662440|527672627|FG002|Overall Study|Lost to Follow-up|4|||
146316840|NCT01662440|527672628|FG003|Overall Study|Lost to Follow-up|1|||
146316841|NCT01662440|527672625|FG000|Overall Study|Subject moved to another country.|0|||
146316842|NCT01662440|527672626|FG001|Overall Study|Subject moved to another country.|1|||
146163630|NCT00636610|527108780|FG000|Overall Study|Disease progression - radiographic|41|||
146163631|NCT00636610|527108781|FG001|Overall Study|Disease progression - radiographic|51|||
146163632|NCT00636610|527108780|FG000|Overall Study|Disease progression - clinical|8|||
146163633|NCT00636610|527108781|FG001|Overall Study|Disease progression - clinical|3|||
146163634|NCT00636610|527108780|FG000|Overall Study|Reason for discontinuation not available|3|||
146163635|NCT00636610|527108781|FG001|Overall Study|Reason for discontinuation not available|2|||
146163636|NCT00553696|527108786|FG000|Overall Study|Adverse Event|2|||
146163637|NCT00553696|527108787|FG001|Overall Study|Adverse Event|4|||
146163638|NCT00553696|527108788|FG002|Overall Study|Adverse Event|0|||
146163639|NCT00553696|527108789|FG003|Overall Study|Adverse Event|1|||
146316843|NCT01662440|527672627|FG002|Overall Study|Subject moved to another country.|0|||
146316844|NCT01662440|527672628|FG003|Overall Study|Subject moved to another country.|0|||
146316845|NCT01662440|527672625|FG000|Overall Study|Protocol Violation|1|||
146316846|NCT01662440|527672626|FG001|Overall Study|Protocol Violation|0|||
146316847|NCT01662440|527672627|FG002|Overall Study|Protocol Violation|0|||
146316848|NCT01662440|527672628|FG003|Overall Study|Protocol Violation|0|||
146316849|NCT01662440|527672625|FG000|Overall Study|Withdrawal by Subject|5|||
146163640|NCT00553696|527108786|FG000|Overall Study|Global deterioration of health status|0|||
146163641|NCT00553696|527108787|FG001|Overall Study|Global deterioration of health status|2|||
146163642|NCT00553696|527108788|FG002|Overall Study|Global deterioration of health status|0|||
146316850|NCT01662440|527672626|FG001|Overall Study|Withdrawal by Subject|2|||
146163643|NCT00553696|527108789|FG003|Overall Study|Global deterioration of health status|0|||
146163644|NCT00553696|527108786|FG000|Overall Study|Objective progression or relapse|2|||
146163645|NCT00553696|527108787|FG001|Overall Study|Objective progression or relapse|9|||
146163646|NCT00553696|527108788|FG002|Overall Study|Objective progression or relapse|6|||
146163647|NCT00553696|527108789|FG003|Overall Study|Objective progression or relapse|0|||
146163648|NCT00553696|527108786|FG000|Overall Study|Withdrawal by Subject|0|||
146163649|NCT00553696|527108787|FG001|Overall Study|Withdrawal by Subject|1|||
146163650|NCT00553696|527108788|FG002|Overall Study|Withdrawal by Subject|0|||
146163651|NCT00553696|527108789|FG003|Overall Study|Withdrawal by Subject|0|||
146163652|NCT02085252|527108790|FG000|Overall Study|Withdrawal of Consent|1|||
146163653|NCT02085252|527108791|FG001|Overall Study|Withdrawal of Consent|0|||
146163654|NCT02085252|527108790|FG000|Overall Study|Adverse Event|0|||
146163655|NCT02085252|527108791|FG001|Overall Study|Adverse Event|1|||
146163656|NCT02085252|527108790|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
146163657|NCT02085252|527108791|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
146163658|NCT02085252|527108790|FG000|Overall Study|Reason Not Specified|0|||
146163659|NCT02085252|527108791|FG001|Overall Study|Reason Not Specified|1|||
146163660|NCT02085252|527108790|FG000|Overall Study|Reason Unknown|0|||
146163661|NCT02085252|527108791|FG001|Overall Study|Reason Unknown|1|||
146163662|NCT00981084|527108792|FG000|Post Intervention (Data Analysis)|poor effort|1|||
146163663|NCT00981084|527108793|FG001|Post Intervention (Data Analysis)|poor effort|1|||
146163664|NCT00981084|527108792|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
146163665|NCT00981084|527108793|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
146163666|NCT00902694|527108794|FG000|Overall Study|Death|1|||
146163667|NCT00902694|527108795|FG001|Overall Study|Death|3|||
146163668|NCT00902694|527108794|FG000|Overall Study|Lost to Follow-up|1|||
146163669|NCT00902694|527108795|FG001|Overall Study|Lost to Follow-up|0|||
146163670|NCT00902694|527108794|FG000|Overall Study|Censored per protocol|3|||
146163671|NCT00902694|527108795|FG001|Overall Study|Censored per protocol|1|||
146163672|NCT00902694|527108794|FG000|Overall Study|Pregnancy|1|||
146163673|NCT00902694|527108795|FG001|Overall Study|Pregnancy|1|||
146163674|NCT00902694|527108794|FG000|Overall Study|Incarceration|1|||
146163675|NCT00902694|527108795|FG001|Overall Study|Incarceration|0|||
146163676|NCT04969263|527108796|FG000|Overall Study|Death|1|||
146163677|NCT04969263|527108796|FG000|Overall Study|Lost to Follow-up|2|||
146163678|NCT04969263|527108796|FG000|Overall Study|Withdrawal by Subject|5|||
146163679|NCT04969263|527108796|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
146163680|NCT03456700|527108797|FG000|Overall Study|Withdrawal by Subject|1|||
146163681|NCT04154787|527108798|FG000|Overall Study|Adverse Event|0|||
146163682|NCT04154787|527108799|FG001|Overall Study|Adverse Event|1|||
146163683|NCT04154787|527108800|FG002|Overall Study|Adverse Event|0|||
146163684|NCT04154787|527108798|FG000|Overall Study|Patient Requires Other Treatment|0|||
146163685|NCT04154787|527108799|FG001|Overall Study|Patient Requires Other Treatment|1|||
146163686|NCT04154787|527108800|FG002|Overall Study|Patient Requires Other Treatment|0|||
146163687|NCT04154787|527108798|FG000|Overall Study|Study Terminated By Sponsor|0|||
146163688|NCT04154787|527108799|FG001|Overall Study|Study Terminated By Sponsor|6|||
146163689|NCT04154787|527108800|FG002|Overall Study|Study Terminated By Sponsor|1|||
146163690|NCT04154787|527108798|FG000|Overall Study|Subject Decision|0|||
146163691|NCT04154787|527108799|FG001|Overall Study|Subject Decision|1|||
146163692|NCT04154787|527108800|FG002|Overall Study|Subject Decision|0|||
146163693|NCT04154787|527108798|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
146316851|NCT01662440|527672627|FG002|Overall Study|Withdrawal by Subject|2|||
146316852|NCT01662440|527672628|FG003|Overall Study|Withdrawal by Subject|2|||
146316853|NCT01745146|527672629|FG000|Overall Study|Withdrawal by Subject|1|||
146163694|NCT04154787|527108799|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
146163695|NCT04154787|527108800|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
146316854|NCT01745146|527672630|FG001|Overall Study|Withdrawal by Subject|3|||
146163696|NCT03053050|527108801|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
146163697|NCT03053050|527108802|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
146163698|NCT03053050|527108803|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
146163699|NCT03053050|527108804|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
146163700|NCT03053050|527108801|FG000|Randomized Phase|Withdrew Consent|16|||
146163701|NCT03053050|527108802|FG001|Randomized Phase|Withdrew Consent|8|||
146163702|NCT03053050|527108803|FG002|Randomized Phase|Withdrew Consent|9|||
146163703|NCT03053050|527108804|FG003|Randomized Phase|Withdrew Consent|0|||
146163704|NCT03053050|527108801|FG000|Randomized Phase|Investigator's Discretion|6|||
146163705|NCT03053050|527108802|FG001|Randomized Phase|Investigator's Discretion|6|||
146163706|NCT03053050|527108803|FG002|Randomized Phase|Investigator's Discretion|3|||
146163707|NCT03053050|527108804|FG003|Randomized Phase|Investigator's Discretion|0|||
146316855|NCT01745146|527672629|FG000|Overall Study|Lost to Follow-up|2|||
146316856|NCT01745146|527672630|FG001|Overall Study|Lost to Follow-up|0|||
146316857|NCT04623242|527672631|FG000|Overall Study|Withdrawal by Subject|7|||
146316858|NCT04623242|527672632|FG001|Overall Study|Withdrawal by Subject|12|||
146316859|NCT04623242|527672633|FG002|Overall Study|Withdrawal by Subject|5|||
146316860|NCT04623242|527672634|FG003|Overall Study|Withdrawal by Subject|7|||
146163708|NCT03053050|527108801|FG000|Randomized Phase|Lost to Follow-up|5|||
146163709|NCT03053050|527108802|FG001|Randomized Phase|Lost to Follow-up|1|||
146163710|NCT03053050|527108803|FG002|Randomized Phase|Lost to Follow-up|1|||
146163711|NCT03053050|527108804|FG003|Randomized Phase|Lost to Follow-up|0|||
146163712|NCT03053050|527108801|FG000|Randomized Phase|Adverse Event|0|||
146163713|NCT03053050|527108802|FG001|Randomized Phase|Adverse Event|1|||
146163714|NCT03053050|527108803|FG002|Randomized Phase|Adverse Event|0|||
146163715|NCT03053050|527108804|FG003|Randomized Phase|Adverse Event|0|||
146163716|NCT03053050|527108801|FG000|Randomized Phase|Randomized but Never Treated|2|||
146163717|NCT03053050|527108802|FG001|Randomized Phase|Randomized but Never Treated|2|||
146163718|NCT03053050|527108803|FG002|Randomized Phase|Randomized but Never Treated|2|||
146163719|NCT03053050|527108804|FG003|Randomized Phase|Randomized but Never Treated|0|||
146163720|NCT03053050|527108801|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
146163721|NCT03053050|527108802|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
146163722|NCT03053050|527108803|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
146163723|NCT03053050|527108804|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
146163724|NCT03053050|527108801|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
146163725|NCT03053050|527108802|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
146163726|NCT03053050|527108803|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
146163727|NCT03053050|527108804|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
146163728|NCT03053050|527108801|FG000|Open-label Phase|Withdrew Consent|0|||
146163729|NCT03053050|527108802|FG001|Open-label Phase|Withdrew Consent|0|||
146163730|NCT03053050|527108803|FG002|Open-label Phase|Withdrew Consent|0|||
146163731|NCT03053050|527108804|FG003|Open-label Phase|Withdrew Consent|6|||
146163732|NCT03053050|527108801|FG000|Open-label Phase|Investigator's Discretion|0|||
146163733|NCT03053050|527108802|FG001|Open-label Phase|Investigator's Discretion|0|||
146163734|NCT03053050|527108803|FG002|Open-label Phase|Investigator's Discretion|0|||
146163735|NCT03053050|527108804|FG003|Open-label Phase|Investigator's Discretion|4|||
146163736|NCT03703466|527108805|FG000|Overall Study|Death|2|||
146163737|NCT03703466|527108806|FG001|Overall Study|Death|1|||
146163738|NCT03703466|527108807|FG002|Overall Study|Death|0|||
146163739|NCT03703466|527108805|FG000|Overall Study|Withdrawal by Subject|0|||
146163740|NCT03703466|527108806|FG001|Overall Study|Withdrawal by Subject|3|||
146163741|NCT03703466|527108807|FG002|Overall Study|Withdrawal by Subject|0|||
146163742|NCT03703466|527108805|FG000|Overall Study|Completed < 3 Cycles|2|||
146163743|NCT03703466|527108806|FG001|Overall Study|Completed < 3 Cycles|2|||
146163744|NCT03703466|527108807|FG002|Overall Study|Completed < 3 Cycles|2|||
146163745|NCT02543658|527110515|FG000|Overall Study|Lack of Efficacy|0|||
146163746|NCT02543658|527110516|FG001|Overall Study|Lack of Efficacy|4|||
146163747|NCT00437645|527110523|FG000|Overall Study|Adverse Event|15|||
146163748|NCT00437645|527110524|FG001|Overall Study|Adverse Event|84|||
146163749|NCT00437645|527110523|FG000|Overall Study|Withdrawal by Subject|10|||
146163750|NCT00437645|527110524|FG001|Overall Study|Withdrawal by Subject|22|||
146163751|NCT00437645|527110523|FG000|Overall Study|Protocol Violation|3|||
146163752|NCT00437645|527110524|FG001|Overall Study|Protocol Violation|3|||
146163753|NCT00437645|527110523|FG000|Overall Study|Lost to Follow-up|2|||
146163754|NCT00437645|527110524|FG001|Overall Study|Lost to Follow-up|3|||
146163755|NCT00437645|527110523|FG000|Overall Study|Administrative problems|2|||
146163756|NCT00437645|527110524|FG001|Overall Study|Administrative problems|1|||
146163757|NCT00437645|527110523|FG000|Overall Study|Lack of Efficacy|2|||
146163758|NCT00437645|527110524|FG001|Overall Study|Lack of Efficacy|1|||
146163759|NCT00437645|527110523|FG000|Overall Study|Condition no longer requires study drug|1|||
146163760|NCT00437645|527110524|FG001|Overall Study|Condition no longer requires study drug|1|||
146163761|NCT03966053|527110525|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
146163762|NCT00175825|527110526|FG000|Overall Study|Adverse Event|3|||
146316861|NCT04623242|527672635|FG004|Overall Study|Withdrawal by Subject|0|||
146163763|NCT00175825|527110527|FG001|Overall Study|Adverse Event|2|||
146163764|NCT00175825|527110528|FG002|Overall Study|Adverse Event|1|||
146163765|NCT00175825|527110529|FG003|Overall Study|Adverse Event|1|||
146163766|NCT00175825|527110526|FG000|Overall Study|Lost to Follow-up|1|||
146163767|NCT00175825|527110527|FG001|Overall Study|Lost to Follow-up|2|||
146163768|NCT00175825|527110528|FG002|Overall Study|Lost to Follow-up|0|||
146163769|NCT00175825|527110529|FG003|Overall Study|Lost to Follow-up|0|||
146163770|NCT00175825|527110526|FG000|Overall Study|Withdrawal by Subject|1|||
146163771|NCT00175825|527110527|FG001|Overall Study|Withdrawal by Subject|0|||
146163772|NCT00175825|527110528|FG002|Overall Study|Withdrawal by Subject|0|||
146163773|NCT00175825|527110529|FG003|Overall Study|Withdrawal by Subject|0|||
146163774|NCT04586569|527110530|FG000|Overall Study|Withdrawal by Subject|0|||
146163775|NCT04586569|527110531|FG001|Overall Study|Withdrawal by Subject|2|||
146163776|NCT04586569|527110530|FG000|Overall Study|No longer eligible|2|||
146163777|NCT04586569|527110531|FG001|Overall Study|No longer eligible|3|||
146163778|NCT04586569|527110530|FG000|Overall Study|Physician Decision|1|||
146163779|NCT04586569|527110531|FG001|Overall Study|Physician Decision|0|||
146163780|NCT04098406|527110533|FG000|Overall Study|Adverse Event|2|||
146163781|NCT04098406|527110534|FG001|Overall Study|Adverse Event|1|||
146163782|NCT04098406|527110533|FG000|Overall Study|Withdrawal by Subject|1|||
146163783|NCT04098406|527110534|FG001|Overall Study|Withdrawal by Subject|0|||
146163784|NCT03548207|527110535|FG000|Overall Study|Death|10|||
146163785|NCT03548207|527110536|FG001|Overall Study|Death|23|||
146163786|NCT03548207|527110537|FG002|Overall Study|Death|3|||
146163787|NCT03548207|527110535|FG000|Overall Study|Lost to Follow-up|0|||
146163788|NCT03548207|527110536|FG001|Overall Study|Lost to Follow-up|2|||
146163789|NCT03548207|527110537|FG002|Overall Study|Lost to Follow-up|0|||
146163790|NCT03548207|527110535|FG000|Overall Study|Withdrawal by Subject|0|||
146163791|NCT03548207|527110536|FG001|Overall Study|Withdrawal by Subject|3|||
146163792|NCT03548207|527110537|FG002|Overall Study|Withdrawal by Subject|0|||
146163793|NCT03548207|527110535|FG000|Overall Study|Sponsor decision|19|||
146163794|NCT03548207|527110536|FG001|Overall Study|Sponsor decision|40|||
146163795|NCT03548207|527110537|FG002|Overall Study|Sponsor decision|6|||
146163796|NCT03548207|527110535|FG000|Overall Study|Randomized but not treated|6|||
146163797|NCT03548207|527110536|FG001|Overall Study|Randomized but not treated|10|||
146163798|NCT03548207|527110537|FG002|Overall Study|Randomized but not treated|4|||
146163799|NCT01357616|527110538|FG000|Overall Study|Adverse Event|1|||
146163800|NCT01357616|527110539|FG001|Overall Study|Adverse Event|1|||
146163801|NCT01357616|527110538|FG000|Overall Study|Lost to Follow-up|4|||
146163802|NCT01357616|527110539|FG001|Overall Study|Lost to Follow-up|3|||
146163803|NCT01357616|527110538|FG000|Overall Study|Protocol Violation|0|||
146163804|NCT01357616|527110539|FG001|Overall Study|Protocol Violation|2|||
146163805|NCT01357616|527110538|FG000|Overall Study|Inadequate Control of IOP|1|||
146163806|NCT01357616|527110539|FG001|Overall Study|Inadequate Control of IOP|2|||
146163807|NCT01357616|527110538|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
146163808|NCT01357616|527110539|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
146163809|NCT01357616|527110538|FG000|Overall Study|Withdrawal by Subject|1|||
146163810|NCT01357616|527110539|FG001|Overall Study|Withdrawal by Subject|0|||
146163811|NCT03432364|527110541|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
146163812|NCT00522301|527110542|FG000|Overall Study|Withdrawal by Subject|1|||
146163813|NCT00522301|527110542|FG000|Overall Study|Adverse Event|5|||
146163814|NCT00337272|527110543|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
146163815|NCT00337272|527110544|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
146163816|NCT00337272|527110543|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
146163817|NCT00337272|527110544|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
146163818|NCT00337272|527110543|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
146163819|NCT00337272|527110544|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
146163820|NCT00337272|527110543|FG000|Treatment Period|Non-compliance|1|||
146163821|NCT00337272|527110544|FG001|Treatment Period|Non-compliance|1|||
146163822|NCT00337272|527110543|FG000|Treatment Period|Withdrawal by Subject|0|||
146163823|NCT00337272|527110544|FG001|Treatment Period|Withdrawal by Subject|1|||
146163824|NCT00337272|527110543|FG000|Withdrawal Period|Non-compliance|0|||
146163825|NCT00337272|527110544|FG001|Withdrawal Period|Non-compliance|1|||
146163826|NCT01699022|527110550|FG000|Overall Study|Early discontinuation from the study|3|||
146163827|NCT02066402|527110551|FG000|Overall Study|Adverse Event|1|||
146163828|NCT02066402|527110552|FG001|Overall Study|Adverse Event|2|||
146163829|NCT02066402|527110551|FG000|Overall Study|Lost to Follow-up|11|||
146163830|NCT02066402|527110552|FG001|Overall Study|Lost to Follow-up|8|||
146163831|NCT02066402|527110551|FG000|Overall Study|Withdrawal by Subject|14|||
146163832|NCT02066402|527110552|FG001|Overall Study|Withdrawal by Subject|11|||
146163833|NCT02066402|527110551|FG000|Overall Study|Progressive disease-clinical progression|0|||
146163834|NCT02066402|527110552|FG001|Overall Study|Progressive disease-clinical progression|1|||
146163835|NCT02066402|527110551|FG000|Overall Study|Protocol driven decision point|0|||
146163836|NCT02066402|527110552|FG001|Overall Study|Protocol driven decision point|1|||
146163837|NCT00152464|527110553|FG000|Overall Study|Adverse Event|3|||
146163838|NCT00152464|527110554|FG001|Overall Study|Adverse Event|6|||
146163839|NCT00152464|527110553|FG000|Overall Study|Lost to Follow-up|8|||
146163840|NCT00152464|527110554|FG001|Overall Study|Lost to Follow-up|4|||
146163841|NCT00152464|527110553|FG000|Overall Study|Protocol Violation|3|||
146163842|NCT00152464|527110554|FG001|Overall Study|Protocol Violation|1|||
146316862|NCT04623242|527672631|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
146316863|NCT04623242|527672632|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
146316864|NCT04623242|527672633|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
146316865|NCT04623242|527672634|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
146316866|NCT04623242|527672635|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
146316867|NCT04623242|527672631|FG000|Overall Study|Subject unblinded to mutation status|0|||
146316868|NCT04623242|527672632|FG001|Overall Study|Subject unblinded to mutation status|0|||
146316869|NCT04623242|527672633|FG002|Overall Study|Subject unblinded to mutation status|0|||
146316870|NCT04623242|527672634|FG003|Overall Study|Subject unblinded to mutation status|13|||
146316871|NCT04623242|527672635|FG004|Overall Study|Subject unblinded to mutation status|0|||
146316872|NCT00326898|527672636|FG000|Overall Study|Disease progression|52|||
146316873|NCT00326898|527672637|FG001|Overall Study|Disease progression|54|||
146316874|NCT00326898|527672638|FG002|Overall Study|Disease progression|102|||
146163843|NCT00152464|527110553|FG000|Overall Study|Withdrawal by Subject|21|||
146163844|NCT00152464|527110554|FG001|Overall Study|Withdrawal by Subject|22|||
146163845|NCT00152464|527110553|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
146163846|NCT00152464|527110554|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
146163847|NCT00152464|527110553|FG000|Overall Study|Eczema deterioration|0|||
146163848|NCT00152464|527110554|FG001|Overall Study|Eczema deterioration|1|||
146163849|NCT00152464|527110553|FG000|Overall Study|Parent decision|1|||
146163850|NCT00152464|527110554|FG001|Overall Study|Parent decision|1|||
146163851|NCT00152464|527110553|FG000|Overall Study|Investigator decision|1|||
146163852|NCT00152464|527110554|FG001|Overall Study|Investigator decision|0|||
146163853|NCT00152464|527110553|FG000|Overall Study|Lack of Efficacy|1|||
146163854|NCT00152464|527110554|FG001|Overall Study|Lack of Efficacy|0|||
146163855|NCT00152464|527110553|FG000|Overall Study|Eczema poorly controlled|1|||
146163856|NCT00152464|527110554|FG001|Overall Study|Eczema poorly controlled|0|||
146163857|NCT00152464|527110553|FG000|Overall Study|Patient relocated|1|||
146163858|NCT00152464|527110554|FG001|Overall Study|Patient relocated|0|||
146163859|NCT04465357|527110556|FG000|Overall Study|Adverse Event|2|||
146163860|NCT04465357|527110556|FG000|Overall Study|Lack of Efficacy|1|||
146163861|NCT04465357|527110556|FG000|Overall Study|Lost to Follow-up|2|||
146163862|NCT04465357|527110556|FG000|Overall Study|Withdrawal by Subject|6|||
146163863|NCT04465357|527110556|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
146163864|NCT01754467|527110558|FG000|Overall Study|Lost to Follow-up|1|||
146163865|NCT01970462|527110559|FG000|Overall Study|Lost to Follow-up|0|||
146163866|NCT01970462|527110560|FG001|Overall Study|Lost to Follow-up|2|||
146163867|NCT00917579|527110561|FG000|Washout >= 2 Weeks|Adverse Event|1|||
146163868|NCT00917579|527110562|FG001|Washout >= 2 Weeks|Adverse Event|0|||
146163869|NCT00917579|527110561|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
146163870|NCT00917579|527110562|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
146163871|NCT00754338|527110563|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146163872|NCT00754338|527110564|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
146163873|NCT00754338|527110565|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
146163874|NCT00754338|527110566|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146163875|NCT00754338|527110563|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146163876|NCT00754338|527110564|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
146163877|NCT00754338|527110565|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
146163878|NCT00754338|527110566|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
146163879|NCT04020341|527110569|FG000|Overall Study|Adverse Event|8|||
146163880|NCT04020341|527110570|FG001|Overall Study|Adverse Event|6|||
146163881|NCT04020341|527110569|FG000|Overall Study|Lost to Follow-up|8|||
146163882|NCT04020341|527110570|FG001|Overall Study|Lost to Follow-up|2|||
146163883|NCT04020341|527110569|FG000|Overall Study|Withdrawal by Subject|16|||
146163884|NCT04020341|527110570|FG001|Overall Study|Withdrawal by Subject|16|||
146163885|NCT04020341|527110569|FG000|Overall Study|Participant not able to swallow the tablet|1|||
146316875|NCT00326898|527672636|FG000|Overall Study|Adverse Event|124|||
146316876|NCT00326898|527672637|FG001|Overall Study|Adverse Event|128|||
146316877|NCT00326898|527672638|FG002|Overall Study|Adverse Event|33|||
146316878|NCT00326898|527672636|FG000|Overall Study|Death|2|||
146316879|NCT00326898|527672637|FG001|Overall Study|Death|0|||
146316880|NCT00326898|527672638|FG002|Overall Study|Death|0|||
146316881|NCT00326898|527672636|FG000|Overall Study|Withdrawal by Subject|134|||
146316882|NCT00326898|527672637|FG001|Overall Study|Withdrawal by Subject|128|||
146316883|NCT00326898|527672638|FG002|Overall Study|Withdrawal by Subject|32|||
146316884|NCT00326898|527672636|FG000|Overall Study|Alternative therapy|1|||
146316885|NCT00326898|527672637|FG001|Overall Study|Alternative therapy|0|||
146316886|NCT00326898|527672638|FG002|Overall Study|Alternative therapy|0|||
146316887|NCT00326898|527672636|FG000|Overall Study|Other complicating disease|5|||
146316888|NCT00326898|527672637|FG001|Overall Study|Other complicating disease|5|||
146316889|NCT00326898|527672638|FG002|Overall Study|Other complicating disease|4|||
146316890|NCT00326898|527672636|FG000|Overall Study|Other/Missing/Unknown|33|||
146316891|NCT00326898|527672637|FG001|Overall Study|Other/Missing/Unknown|28|||
146316892|NCT00326898|527672638|FG002|Overall Study|Other/Missing/Unknown|32|||
146316893|NCT03847987|527672639|FG000|Overall Study|Lost to Follow-up|1|||
146316894|NCT03847987|527672640|FG001|Overall Study|Lost to Follow-up|0|||
146316895|NCT03847987|527672639|FG000|Overall Study|Adverse Event|2|||
146316896|NCT03847987|527672640|FG001|Overall Study|Adverse Event|0|||
146316897|NCT02605642|527672644|FG000|Overall Study|Other|11|||
146316898|NCT02605642|527672645|FG001|Overall Study|Other|1|||
146316899|NCT02605642|527672644|FG000|Overall Study|Participant non-compliance|2|||
146316900|NCT02605642|527672645|FG001|Overall Study|Participant non-compliance|4|||
146163886|NCT04020341|527110570|FG001|Overall Study|Participant not able to swallow the tablet|0|||
146163887|NCT04020341|527110569|FG000|Overall Study|Physician Decision|0|||
146163888|NCT04020341|527110570|FG001|Overall Study|Physician Decision|2|||
146163889|NCT04020341|527110569|FG000|Overall Study|Protocol Deviation|0|||
146163890|NCT04020341|527110570|FG001|Overall Study|Protocol Deviation|2|||
146316901|NCT02605642|527672644|FG000|Overall Study|Physician Decision|10|||
146316902|NCT02605642|527672645|FG001|Overall Study|Physician Decision|0|||
146163891|NCT05763628|527110571|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
146163892|NCT05763628|527110572|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
146163893|NCT05763628|527110571|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
146163894|NCT05763628|527110572|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
146163895|NCT05763628|527110571|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
146163896|NCT05763628|527110572|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
146163897|NCT00162370|527110579|FG000|Efficacy Population|Lost to Follow-up|51|||
146163898|NCT04040751|527110590|FG000|Overall Study|Withdrawal by Subject|2|||
146163899|NCT04040751|527110591|FG001|Overall Study|Withdrawal by Subject|0|||
146163900|NCT04040751|527110592|FG002|Overall Study|Withdrawal by Subject|2|||
146163901|NCT04040751|527110593|FG003|Overall Study|Withdrawal by Subject|0|||
146163902|NCT04212091|527110596|FG000|Overall Study|Lost to Follow-up|0|||
146163903|NCT04212091|527110597|FG001|Overall Study|Lost to Follow-up|0|||
146163904|NCT04212091|527110598|FG002|Overall Study|Lost to Follow-up|0|||
146163905|NCT04212091|527110599|FG003|Overall Study|Lost to Follow-up|0|||
146163906|NCT04212091|527110600|FG004|Overall Study|Lost to Follow-up|1|||
146163907|NCT04212091|527110601|FG005|Overall Study|Lost to Follow-up|1|||
146163908|NCT04212091|527110596|FG000|Overall Study|Participant unable to adhere to visit|0|||
146163909|NCT04212091|527110597|FG001|Overall Study|Participant unable to adhere to visit|0|||
146163910|NCT04212091|527110598|FG002|Overall Study|Participant unable to adhere to visit|0|||
146163911|NCT04212091|527110599|FG003|Overall Study|Participant unable to adhere to visit|0|||
146163912|NCT04212091|527110600|FG004|Overall Study|Participant unable to adhere to visit|1|||
146163913|NCT04212091|527110601|FG005|Overall Study|Participant unable to adhere to visit|0|||
146163914|NCT02712905|527110602|FG000|Monotherapy|Death|2|||
146163915|NCT02712905|527110603|FG001|Monotherapy|Death|5|||
146163916|NCT02712905|527110604|FG002|Monotherapy|Death|0|||
146163917|NCT02712905|527110605|FG003|Monotherapy|Death|3|||
146163918|NCT02712905|527110606|FG004|Monotherapy|Death|15|||
146163919|NCT02712905|527110607|FG005|Monotherapy|Death|1|||
146163920|NCT02712905|527110608|FG006|Monotherapy|Death|3|||
146163921|NCT02712905|527110609|FG007|Monotherapy|Death|3|||
146163922|NCT02712905|527110610|FG008|Monotherapy|Death|0|||
146163923|NCT02712905|527110611|FG009|Monotherapy|Death|27|||
146163924|NCT02712905|527110612|FG010|Monotherapy|Death|2|||
146163925|NCT02712905|527110613|FG011|Monotherapy|Death|5|||
146163926|NCT02712905|527110614|FG012|Monotherapy|Death|0|||
146163927|NCT02712905|527110615|FG013|Monotherapy|Death|0|||
146163928|NCT02712905|527110616|FG014|Monotherapy|Death|0|||
146163929|NCT02712905|527110617|FG015|Monotherapy|Death|0|||
146163930|NCT02712905|527110618|FG016|Monotherapy|Death|0|||
146163931|NCT02712905|527110619|FG017|Monotherapy|Death|0|||
146163932|NCT02712905|527110602|FG000|Monotherapy|Lost to Follow-up|0|||
146163933|NCT02712905|527110603|FG001|Monotherapy|Lost to Follow-up|1|||
146163934|NCT02712905|527110604|FG002|Monotherapy|Lost to Follow-up|0|||
146163935|NCT02712905|527110605|FG003|Monotherapy|Lost to Follow-up|1|||
146163936|NCT02712905|527110606|FG004|Monotherapy|Lost to Follow-up|0|||
146163937|NCT02712905|527110607|FG005|Monotherapy|Lost to Follow-up|0|||
146163938|NCT02712905|527110608|FG006|Monotherapy|Lost to Follow-up|0|||
146163939|NCT02712905|527110609|FG007|Monotherapy|Lost to Follow-up|0|||
146163940|NCT02712905|527110610|FG008|Monotherapy|Lost to Follow-up|0|||
146163941|NCT02712905|527110611|FG009|Monotherapy|Lost to Follow-up|2|||
146163942|NCT02712905|527110612|FG010|Monotherapy|Lost to Follow-up|0|||
146163943|NCT02712905|527110613|FG011|Monotherapy|Lost to Follow-up|0|||
146163944|NCT02712905|527110614|FG012|Monotherapy|Lost to Follow-up|0|||
146163945|NCT02712905|527110615|FG013|Monotherapy|Lost to Follow-up|0|||
146163946|NCT02712905|527110616|FG014|Monotherapy|Lost to Follow-up|0|||
146163947|NCT02712905|527110617|FG015|Monotherapy|Lost to Follow-up|0|||
146163948|NCT02712905|527110618|FG016|Monotherapy|Lost to Follow-up|0|||
146163949|NCT02712905|527110619|FG017|Monotherapy|Lost to Follow-up|0|||
146316903|NCT02605642|527672644|FG000|Overall Study|Lost to Follow-up|12|||
146316904|NCT02605642|527672645|FG001|Overall Study|Lost to Follow-up|1|||
146316905|NCT02605642|527672644|FG000|Overall Study|Adverse Event|14|||
146316906|NCT02605642|527672645|FG001|Overall Study|Adverse Event|2|||
146316907|NCT02605642|527672644|FG000|Overall Study|Withdrawal by Subject|23|||
146163950|NCT02712905|527110602|FG000|Monotherapy|Physician Decision|1|||
146163951|NCT02712905|527110603|FG001|Monotherapy|Physician Decision|0|||
146163952|NCT02712905|527110604|FG002|Monotherapy|Physician Decision|0|||
146163953|NCT02712905|527110605|FG003|Monotherapy|Physician Decision|1|||
146163954|NCT02712905|527110606|FG004|Monotherapy|Physician Decision|0|||
146316908|NCT02605642|527672645|FG001|Overall Study|Withdrawal by Subject|2|||
146163955|NCT02712905|527110607|FG005|Monotherapy|Physician Decision|0|||
146163956|NCT02712905|527110608|FG006|Monotherapy|Physician Decision|0|||
146163957|NCT02712905|527110609|FG007|Monotherapy|Physician Decision|0|||
146163958|NCT02712905|527110610|FG008|Monotherapy|Physician Decision|0|||
146163959|NCT02712905|527110611|FG009|Monotherapy|Physician Decision|1|||
146163960|NCT02712905|527110612|FG010|Monotherapy|Physician Decision|0|||
146163961|NCT02712905|527110613|FG011|Monotherapy|Physician Decision|0|||
146163962|NCT02712905|527110614|FG012|Monotherapy|Physician Decision|0|||
146163963|NCT02712905|527110615|FG013|Monotherapy|Physician Decision|0|||
146163964|NCT02712905|527110616|FG014|Monotherapy|Physician Decision|0|||
146163965|NCT02712905|527110617|FG015|Monotherapy|Physician Decision|0|||
146163966|NCT02712905|527110618|FG016|Monotherapy|Physician Decision|0|||
146163967|NCT02712905|527110619|FG017|Monotherapy|Physician Decision|0|||
146163968|NCT02712905|527110602|FG000|Monotherapy|Study Terminated by Sponsor|0|||
146163969|NCT02712905|527110603|FG001|Monotherapy|Study Terminated by Sponsor|0|||
146163970|NCT02712905|527110604|FG002|Monotherapy|Study Terminated by Sponsor|0|||
146163971|NCT02712905|527110605|FG003|Monotherapy|Study Terminated by Sponsor|0|||
146163972|NCT02712905|527110606|FG004|Monotherapy|Study Terminated by Sponsor|1|||
146163973|NCT02712905|527110607|FG005|Monotherapy|Study Terminated by Sponsor|0|||
146163974|NCT02712905|527110608|FG006|Monotherapy|Study Terminated by Sponsor|0|||
146163975|NCT02712905|527110609|FG007|Monotherapy|Study Terminated by Sponsor|0|||
146163976|NCT02712905|527110610|FG008|Monotherapy|Study Terminated by Sponsor|0|||
146163977|NCT02712905|527110611|FG009|Monotherapy|Study Terminated by Sponsor|2|||
146163978|NCT02712905|527110612|FG010|Monotherapy|Study Terminated by Sponsor|0|||
146163979|NCT02712905|527110613|FG011|Monotherapy|Study Terminated by Sponsor|0|||
146163980|NCT02712905|527110614|FG012|Monotherapy|Study Terminated by Sponsor|0|||
146163981|NCT02712905|527110615|FG013|Monotherapy|Study Terminated by Sponsor|0|||
146163982|NCT02712905|527110616|FG014|Monotherapy|Study Terminated by Sponsor|0|||
146163983|NCT02712905|527110617|FG015|Monotherapy|Study Terminated by Sponsor|0|||
146163984|NCT02712905|527110618|FG016|Monotherapy|Study Terminated by Sponsor|0|||
146163985|NCT02712905|527110619|FG017|Monotherapy|Study Terminated by Sponsor|0|||
146163986|NCT02712905|527110602|FG000|Monotherapy|Withdrawal by Subject|0|||
146163987|NCT02712905|527110603|FG001|Monotherapy|Withdrawal by Subject|0|||
146163988|NCT02712905|527110604|FG002|Monotherapy|Withdrawal by Subject|1|||
146163989|NCT02712905|527110605|FG003|Monotherapy|Withdrawal by Subject|0|||
146163990|NCT02712905|527110606|FG004|Monotherapy|Withdrawal by Subject|2|||
146163991|NCT02712905|527110607|FG005|Monotherapy|Withdrawal by Subject|0|||
146163992|NCT02712905|527110608|FG006|Monotherapy|Withdrawal by Subject|0|||
146163993|NCT02712905|527110609|FG007|Monotherapy|Withdrawal by Subject|0|||
146163994|NCT02712905|527110610|FG008|Monotherapy|Withdrawal by Subject|0|||
146163995|NCT02712905|527110611|FG009|Monotherapy|Withdrawal by Subject|4|||
146163996|NCT02712905|527110612|FG010|Monotherapy|Withdrawal by Subject|1|||
146163997|NCT02712905|527110613|FG011|Monotherapy|Withdrawal by Subject|2|||
146163998|NCT02712905|527110614|FG012|Monotherapy|Withdrawal by Subject|0|||
146163999|NCT02712905|527110615|FG013|Monotherapy|Withdrawal by Subject|0|||
146164000|NCT02712905|527110616|FG014|Monotherapy|Withdrawal by Subject|0|||
146164001|NCT02712905|527110617|FG015|Monotherapy|Withdrawal by Subject|0|||
146164002|NCT02712905|527110618|FG016|Monotherapy|Withdrawal by Subject|0|||
146164003|NCT02712905|527110619|FG017|Monotherapy|Withdrawal by Subject|0|||
146164004|NCT02712905|527110602|FG000|Monotherapy|Started New Cancer Drug|0|||
146164005|NCT02712905|527110603|FG001|Monotherapy|Started New Cancer Drug|0|||
146164006|NCT02712905|527110604|FG002|Monotherapy|Started New Cancer Drug|0|||
146164007|NCT02712905|527110605|FG003|Monotherapy|Started New Cancer Drug|0|||
146164008|NCT02712905|527110606|FG004|Monotherapy|Started New Cancer Drug|0|||
146164009|NCT02712905|527110607|FG005|Monotherapy|Started New Cancer Drug|1|||
146164010|NCT02712905|527110608|FG006|Monotherapy|Started New Cancer Drug|0|||
146164011|NCT02712905|527110609|FG007|Monotherapy|Started New Cancer Drug|0|||
146164012|NCT02712905|527110610|FG008|Monotherapy|Started New Cancer Drug|0|||
146164013|NCT02712905|527110611|FG009|Monotherapy|Started New Cancer Drug|0|||
146164014|NCT02712905|527110612|FG010|Monotherapy|Started New Cancer Drug|0|||
146164015|NCT02712905|527110613|FG011|Monotherapy|Started New Cancer Drug|0|||
146164016|NCT02712905|527110614|FG012|Monotherapy|Started New Cancer Drug|0|||
146164017|NCT02712905|527110615|FG013|Monotherapy|Started New Cancer Drug|0|||
146164018|NCT02712905|527110616|FG014|Monotherapy|Started New Cancer Drug|0|||
146164019|NCT02712905|527110617|FG015|Monotherapy|Started New Cancer Drug|0|||
146164020|NCT02712905|527110618|FG016|Monotherapy|Started New Cancer Drug|0|||
146164021|NCT02712905|527110619|FG017|Monotherapy|Started New Cancer Drug|0|||
146164022|NCT02712905|527110602|FG000|Monotherapy|Adverse Event|0|||
146164023|NCT02712905|527110603|FG001|Monotherapy|Adverse Event|0|||
146164024|NCT02712905|527110604|FG002|Monotherapy|Adverse Event|0|||
146164025|NCT02712905|527110605|FG003|Monotherapy|Adverse Event|0|||
146164026|NCT02712905|527110606|FG004|Monotherapy|Adverse Event|0|||
146164027|NCT02712905|527110607|FG005|Monotherapy|Adverse Event|0|||
146164028|NCT02712905|527110608|FG006|Monotherapy|Adverse Event|0|||
146164029|NCT02712905|527110609|FG007|Monotherapy|Adverse Event|0|||
146164030|NCT02712905|527110610|FG008|Monotherapy|Adverse Event|1|||
146316909|NCT02605642|527672644|FG000|Overall Study|Lack of response|24|||
146316910|NCT02605642|527672645|FG001|Overall Study|Lack of response|11|||
146316911|NCT02111564|527672654|FG000|Overall Study|Death|109|||
146316912|NCT02111564|527672655|FG001|Overall Study|Death|120|||
146316913|NCT02111564|527672654|FG000|Overall Study|Lost to Follow-up|2|||
146316914|NCT02111564|527672655|FG001|Overall Study|Lost to Follow-up|3|||
146316915|NCT02111564|527672654|FG000|Overall Study|Withdrawal by Subject|20|||
146164031|NCT02712905|527110611|FG009|Monotherapy|Adverse Event|0|||
146164032|NCT02712905|527110612|FG010|Monotherapy|Adverse Event|0|||
146164033|NCT02712905|527110613|FG011|Monotherapy|Adverse Event|0|||
146164034|NCT02712905|527110614|FG012|Monotherapy|Adverse Event|0|||
146164035|NCT02712905|527110615|FG013|Monotherapy|Adverse Event|0|||
146164036|NCT02712905|527110616|FG014|Monotherapy|Adverse Event|0|||
146316916|NCT02111564|527672655|FG001|Overall Study|Withdrawal by Subject|20|||
146164037|NCT02712905|527110617|FG015|Monotherapy|Adverse Event|0|||
146164038|NCT02712905|527110618|FG016|Monotherapy|Adverse Event|0|||
146164039|NCT02712905|527110619|FG017|Monotherapy|Adverse Event|0|||
146164040|NCT02712905|527110602|FG000|Combination Therapy|Death|0|||
146164041|NCT02712905|527110603|FG001|Combination Therapy|Death|0|||
146164042|NCT02712905|527110604|FG002|Combination Therapy|Death|0|||
146164043|NCT02712905|527110605|FG003|Combination Therapy|Death|0|||
146164044|NCT02712905|527110606|FG004|Combination Therapy|Death|0|||
146164045|NCT02712905|527110607|FG005|Combination Therapy|Death|0|||
146164046|NCT02712905|527110608|FG006|Combination Therapy|Death|0|||
146164047|NCT02712905|527110609|FG007|Combination Therapy|Death|0|||
146164048|NCT02712905|527110610|FG008|Combination Therapy|Death|0|||
146164049|NCT02712905|527110611|FG009|Combination Therapy|Death|0|||
146164050|NCT02712905|527110612|FG010|Combination Therapy|Death|0|||
146164051|NCT02712905|527110613|FG011|Combination Therapy|Death|0|||
146164052|NCT02712905|527110614|FG012|Combination Therapy|Death|5|||
146164053|NCT02712905|527110615|FG013|Combination Therapy|Death|6|||
146164054|NCT02712905|527110616|FG014|Combination Therapy|Death|1|||
146164055|NCT02712905|527110617|FG015|Combination Therapy|Death|3|||
146164056|NCT02712905|527110618|FG016|Combination Therapy|Death|1|||
146164057|NCT02712905|527110619|FG017|Combination Therapy|Death|3|||
146164058|NCT02712905|527110602|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
146164059|NCT02712905|527110603|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
146164060|NCT02712905|527110604|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
146164061|NCT02712905|527110605|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
146164062|NCT02712905|527110606|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
146164063|NCT02712905|527110607|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
146164064|NCT02712905|527110608|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
146164065|NCT02712905|527110609|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
146164066|NCT02712905|527110610|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
146164067|NCT02712905|527110611|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
146164068|NCT02712905|527110612|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
146164069|NCT02712905|527110613|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
146164070|NCT02712905|527110614|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
146164071|NCT02712905|527110615|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
146164072|NCT02712905|527110616|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
146164073|NCT02712905|527110617|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
146164074|NCT02712905|527110618|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
146164075|NCT02712905|527110619|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
146164076|NCT02712905|527110602|FG000|Combination Therapy|Withdrawal by Subject|0|||
146164077|NCT02712905|527110603|FG001|Combination Therapy|Withdrawal by Subject|0|||
146164078|NCT02712905|527110604|FG002|Combination Therapy|Withdrawal by Subject|0|||
146164079|NCT02712905|527110605|FG003|Combination Therapy|Withdrawal by Subject|0|||
146164080|NCT02712905|527110606|FG004|Combination Therapy|Withdrawal by Subject|0|||
146164081|NCT02712905|527110607|FG005|Combination Therapy|Withdrawal by Subject|0|||
146164082|NCT02712905|527110608|FG006|Combination Therapy|Withdrawal by Subject|0|||
146164083|NCT02712905|527110609|FG007|Combination Therapy|Withdrawal by Subject|0|||
146164084|NCT02712905|527110610|FG008|Combination Therapy|Withdrawal by Subject|0|||
146164085|NCT02712905|527110611|FG009|Combination Therapy|Withdrawal by Subject|0|||
146164086|NCT02712905|527110612|FG010|Combination Therapy|Withdrawal by Subject|0|||
146164087|NCT02712905|527110613|FG011|Combination Therapy|Withdrawal by Subject|0|||
146164088|NCT02712905|527110614|FG012|Combination Therapy|Withdrawal by Subject|0|||
146164089|NCT02712905|527110615|FG013|Combination Therapy|Withdrawal by Subject|0|||
146164090|NCT02712905|527110616|FG014|Combination Therapy|Withdrawal by Subject|0|||
146164091|NCT02712905|527110617|FG015|Combination Therapy|Withdrawal by Subject|1|||
146164092|NCT02712905|527110618|FG016|Combination Therapy|Withdrawal by Subject|0|||
146164093|NCT02712905|527110619|FG017|Combination Therapy|Withdrawal by Subject|2|||
146164094|NCT02712905|527110602|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164095|NCT02712905|527110603|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146316917|NCT00687362|527672656|FG000|Overall Study|Protocol Violation|2|||
146316918|NCT00687362|527672656|FG000|Overall Study|Withdrawal by Subject|1|||
146316919|NCT00699348|527672661|FG000|Overall Study|Death|6|||
146164096|NCT02712905|527110604|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164097|NCT02712905|527110605|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146316920|NCT00699348|527672661|FG000|Overall Study|Adverse Event|15|||
146316921|NCT00699348|527672661|FG000|Overall Study|Withdrawal by Subject|11|||
146316922|NCT00699348|527672661|FG000|Overall Study|Protocol Violation|10|||
146316923|NCT00699348|527672661|FG000|Overall Study|Lack of Efficacy|8|||
146164098|NCT02712905|527110606|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146316924|NCT00699348|527672661|FG000|Overall Study|Failure to return|1|||
146164099|NCT02712905|527110607|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164100|NCT02712905|527110608|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146316925|NCT00699348|527672661|FG000|Overall Study|Blood transfusion|24|||
146316926|NCT00699348|527672661|FG000|Overall Study|Renal transplantation|10|||
146164101|NCT02712905|527110609|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164102|NCT02712905|527110610|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164103|NCT02712905|527110611|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164104|NCT02712905|527110612|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164105|NCT02712905|527110613|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164106|NCT02712905|527110614|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164107|NCT02712905|527110615|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164108|NCT02712905|527110616|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164109|NCT02712905|527110617|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
146164110|NCT02712905|527110618|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164111|NCT02712905|527110619|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
146164112|NCT03721965|527110620|FG000|Overall Study|Death|1|||
146164113|NCT03721965|527110620|FG000|Overall Study|Study Terminated by Sponsor|1|||
146164114|NCT02612311|527110621|FG000|Overall Study|Adverse Event|16|||
146164115|NCT02612311|527110622|FG001|Overall Study|Adverse Event|12|||
146164116|NCT02612311|527110623|FG002|Overall Study|Adverse Event|7|||
146164117|NCT02612311|527110624|FG003|Overall Study|Adverse Event|13|||
146164118|NCT02612311|527110621|FG000|Overall Study|Death|29|||
146164119|NCT02612311|527110622|FG001|Overall Study|Death|10|||
146164120|NCT02612311|527110623|FG002|Overall Study|Death|11|||
146164121|NCT02612311|527110624|FG003|Overall Study|Death|11|||
146164122|NCT02612311|527110621|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
146164123|NCT02612311|527110622|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
146164124|NCT02612311|527110623|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
146164125|NCT02612311|527110624|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
146164126|NCT02612311|527110621|FG000|Overall Study|Investigator's Decision|11|||
146164127|NCT02612311|527110622|FG001|Overall Study|Investigator's Decision|15|||
146164128|NCT02612311|527110623|FG002|Overall Study|Investigator's Decision|6|||
146164129|NCT02612311|527110624|FG003|Overall Study|Investigator's Decision|6|||
146164130|NCT02612311|527110621|FG000|Overall Study|Lack of Efficacy|0|||
146164131|NCT02612311|527110622|FG001|Overall Study|Lack of Efficacy|0|||
146164132|NCT02612311|527110623|FG002|Overall Study|Lack of Efficacy|1|||
146164133|NCT02612311|527110624|FG003|Overall Study|Lack of Efficacy|1|||
146164134|NCT02612311|527110621|FG000|Overall Study|Lost to Follow-up|2|||
146164135|NCT02612311|527110622|FG001|Overall Study|Lost to Follow-up|2|||
146164136|NCT02612311|527110623|FG002|Overall Study|Lost to Follow-up|1|||
146164137|NCT02612311|527110624|FG003|Overall Study|Lost to Follow-up|2|||
146164138|NCT02612311|527110621|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
146164139|NCT02612311|527110622|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
146164140|NCT02612311|527110623|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
146164141|NCT02612311|527110624|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
146164142|NCT02612311|527110621|FG000|Overall Study|Site Terminated by Sponsor|29|||
146164143|NCT02612311|527110622|FG001|Overall Study|Site Terminated by Sponsor|12|||
146164144|NCT02612311|527110623|FG002|Overall Study|Site Terminated by Sponsor|13|||
146164145|NCT02612311|527110624|FG003|Overall Study|Site Terminated by Sponsor|5|||
146164146|NCT02612311|527110621|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
146164147|NCT02612311|527110622|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
146164148|NCT02612311|527110623|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
146164149|NCT02612311|527110624|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
146164150|NCT02612311|527110621|FG000|Overall Study|Reason Not Specified|3|||
146164151|NCT02612311|527110622|FG001|Overall Study|Reason Not Specified|7|||
146164152|NCT02612311|527110623|FG002|Overall Study|Reason Not Specified|4|||
146164153|NCT02612311|527110624|FG003|Overall Study|Reason Not Specified|5|||
146164154|NCT02612311|527110621|FG000|Overall Study|Unknown/Missing|10|||
146164155|NCT02612311|527110622|FG001|Overall Study|Unknown/Missing|13|||
146164156|NCT02612311|527110623|FG002|Overall Study|Unknown/Missing|4|||
146164157|NCT02612311|527110624|FG003|Overall Study|Unknown/Missing|0|||
146164158|NCT02612311|527110621|FG000|Overall Study|Non-Compliance with Study|1|||
146164159|NCT02612311|527110622|FG001|Overall Study|Non-Compliance with Study|0|||
146164160|NCT02612311|527110623|FG002|Overall Study|Non-Compliance with Study|0|||
146164161|NCT02612311|527110624|FG003|Overall Study|Non-Compliance with Study|0|||
146164162|NCT04085328|527110625|FG000|Overall Study|Witihdrew Consent|16|||
146164163|NCT04085328|527110626|FG001|Overall Study|Witihdrew Consent|16|||
146164164|NCT04085328|527110625|FG000|Overall Study|Adverse Event|8|||
146164165|NCT04085328|527110626|FG001|Overall Study|Adverse Event|7|||
146164166|NCT04085328|527110625|FG000|Overall Study|Lost to Follow-up|7|||
146164167|NCT04085328|527110626|FG001|Overall Study|Lost to Follow-up|2|||
146164168|NCT04085328|527110625|FG000|Overall Study|Physician Decision|0|||
146164169|NCT04085328|527110626|FG001|Overall Study|Physician Decision|1|||
146164170|NCT04085328|527110625|FG000|Overall Study|Pregnancy|0|||
146164171|NCT04085328|527110626|FG001|Overall Study|Pregnancy|1|||
146164172|NCT04085328|527110625|FG000|Overall Study|Reasons Related to COVID-19|5|||
146164173|NCT04085328|527110626|FG001|Overall Study|Reasons Related to COVID-19|8|||
146164174|NCT04085328|527110625|FG000|Overall Study|Did not meet inclusion criteria|1|||
146164175|NCT04085328|527110626|FG001|Overall Study|Did not meet inclusion criteria|1|||
146164176|NCT04085328|527110625|FG000|Overall Study|Early termination|1|||
146164177|NCT04085328|527110626|FG001|Overall Study|Early termination|0|||
146164178|NCT01596582|527110627|FG000|Overall Study|Deemed ineligible after study visit|3|||
146164179|NCT01596582|527110628|FG001|Overall Study|Deemed ineligible after study visit|6|||
146164180|NCT01596582|527110627|FG000|Overall Study|Missing all outcome data|1|||
146164181|NCT01596582|527110628|FG001|Overall Study|Missing all outcome data|1|||
146164182|NCT01428076|527110629|FG000|Overall Study|Adverse Event|0|||
146164183|NCT01428076|527110630|FG001|Overall Study|Adverse Event|1|||
146164184|NCT02454101|527110631|FG000|Overall Study|Adverse Event|2|||
146164185|NCT02454101|527110632|FG001|Overall Study|Adverse Event|3|||
146164186|NCT02454101|527110631|FG000|Overall Study|Lost to Follow-up|3|||
146164187|NCT02454101|527110632|FG001|Overall Study|Lost to Follow-up|4|||
146164188|NCT02216773|527110636|FG000|Overall Study|Disease progression|4|||
146164189|NCT02216773|527110637|FG001|Overall Study|Disease progression|2|||
146164190|NCT02216773|527110636|FG000|Overall Study|Insufficient FLRV|4|||
146164191|NCT02216773|527110637|FG001|Overall Study|Insufficient FLRV|0|||
146164192|NCT02216773|527110636|FG000|Overall Study|Abandoned|4|||
146164193|NCT02216773|527110637|FG001|Overall Study|Abandoned|3|||
146164194|NCT02124265|527110641|FG000|Overall Study|Adverse Event|1|||
146164195|NCT04510675|527110644|FG000|Overall Study|Withdrawal by Subject|5|||
146164196|NCT00810264|527110645|FG000|Overall Study|Lost to Follow-up|191|||
146164197|NCT00810264|527110645|FG000|Overall Study|Withdrawal by subject or physician|721|||
146164198|NCT00810264|527110645|FG000|Overall Study|Death|641|||
146164199|NCT01563536|527110646|FG000|Overall Study|Withdrawal by Subject|0|||
146164200|NCT01563536|527110647|FG001|Overall Study|Withdrawal by Subject|2|||
146164201|NCT01563536|527110646|FG000|Overall Study|Lost to Follow-up|1|||
146164202|NCT01563536|527110647|FG001|Overall Study|Lost to Follow-up|0|||
146164203|NCT00058123|527110663|FG000|Overall Study|Wrong histology|9|||
146164204|NCT00058123|527110663|FG000|Overall Study|Received >3 prior treatments|1|||
146164205|NCT00313820|527110664|FG000|Assigned to Treatment|Other|1|||
146164206|NCT00313820|527110665|FG001|Assigned to Treatment|Other|0|||
146164207|NCT00313820|527110664|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
146164208|NCT00313820|527110665|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
146164209|NCT00313820|527110664|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
146164210|NCT00313820|527110665|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
146164211|NCT00313820|527110664|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
146164212|NCT00313820|527110665|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
146164213|NCT00313820|527110664|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
146164214|NCT00313820|527110665|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
146164215|NCT00313820|527110664|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
146164216|NCT00313820|527110665|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
146164217|NCT00686881|527110666|FG000|Overall Study|Withdrawal by Subject|11|||
146164218|NCT00686881|527110667|FG001|Overall Study|Withdrawal by Subject|18|||
146164219|NCT00686881|527110666|FG000|Overall Study|Lost to Follow-up|0|||
146164220|NCT00686881|527110667|FG001|Overall Study|Lost to Follow-up|1|||
146164221|NCT00686881|527110666|FG000|Overall Study|Treatment-related adverse event|10|||
146164222|NCT00686881|527110667|FG001|Overall Study|Treatment-related adverse event|9|||
146164223|NCT00686881|527110666|FG000|Overall Study|Met discontinuation criteria|5|||
146164224|NCT00686881|527110667|FG001|Overall Study|Met discontinuation criteria|0|||
146164225|NCT00686881|527110666|FG000|Overall Study|Onset of malignant tumor|11|||
146164226|NCT00686881|527110667|FG001|Overall Study|Onset of malignant tumor|11|||
146164227|NCT00686881|527110666|FG000|Overall Study|Lack of Efficacy|4|||
146164228|NCT00686881|527110667|FG001|Overall Study|Lack of Efficacy|3|||
146164229|NCT00686881|527110666|FG000|Overall Study|Physician Decision|1|||
146164230|NCT00686881|527110667|FG001|Overall Study|Physician Decision|0|||
146164231|NCT00686881|527110666|FG000|Overall Study|Circumstances of site|1|||
146164232|NCT00686881|527110667|FG001|Overall Study|Circumstances of site|1|||
146164233|NCT00686881|527110666|FG000|Overall Study|Did not meet protocol eligibility|1|||
146164234|NCT00686881|527110667|FG001|Overall Study|Did not meet protocol eligibility|0|||
146164235|NCT00686881|527110666|FG000|Overall Study|Irregular visits|1|||
146164236|NCT00686881|527110667|FG001|Overall Study|Irregular visits|0|||
146164237|NCT00686881|527110666|FG000|Overall Study|Study discontinuation|35|||
146164238|NCT00686881|527110667|FG001|Overall Study|Study discontinuation|32|||
146164239|NCT00686881|527110666|FG000|Overall Study|Never received study drug|2|||
146164240|NCT00686881|527110667|FG001|Overall Study|Never received study drug|6|||
146164241|NCT01298999|527110669|FG000|Overall Study|Physician Decision|0|||
146164242|NCT01298999|527110670|FG001|Overall Study|Physician Decision|1|||
146164243|NCT01298999|527110669|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
146164244|NCT01298999|527110670|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
146164245|NCT02151266|527110671|FG000|Overall Study|Lost to Follow-up|1|||
146164246|NCT02151266|527110672|FG001|Overall Study|Lost to Follow-up|4|||
146164247|NCT02151266|527110673|FG002|Overall Study|Lost to Follow-up|1|||
146164248|NCT02151266|527110671|FG000|Overall Study|Did NOT receive intervention|3|||
146316927|NCT00699348|527672661|FG000|Overall Study|Other|5|||
146316928|NCT01268293|527672662|FG000|Overall Study|Disease progression|7|||
146316929|NCT01268293|527672662|FG000|Overall Study|Adverse Event|1|||
146316930|NCT01268293|527672662|FG000|Overall Study|Subject choice|1|||
146316931|NCT02597855|527672665|FG000|Overall Study|Lost to Follow-up|2|||
146316932|NCT02597855|527672666|FG001|Overall Study|Lost to Follow-up|1|||
146316933|NCT03704194|527672672|FG000|Overall Study|Withdrawal by Subject|0|||
146316934|NCT03704194|527672673|FG001|Overall Study|Withdrawal by Subject|1|||
146316935|NCT00925015|527672674|FG000|Overall Study|Adverse Event|1|||
146316936|NCT00925015|527672675|FG001|Overall Study|Adverse Event|2|||
146316937|NCT00925015|527672676|FG002|Overall Study|Adverse Event|1|||
146316938|NCT00925015|527672674|FG000|Overall Study|Physician Decision|0|||
146316939|NCT00925015|527672675|FG001|Overall Study|Physician Decision|1|||
146316940|NCT00925015|527672676|FG002|Overall Study|Physician Decision|0|||
146316941|NCT00925015|527672674|FG000|Overall Study|Progressive Disease|7|||
146316942|NCT00925015|527672675|FG001|Overall Study|Progressive Disease|3|||
146164249|NCT02151266|527110672|FG001|Overall Study|Did NOT receive intervention|6|||
146164250|NCT02151266|527110673|FG002|Overall Study|Did NOT receive intervention|2|||
146164251|NCT02151266|527110671|FG000|Overall Study|Not able to exercise|4|||
146164252|NCT02151266|527110672|FG001|Overall Study|Not able to exercise|5|||
146164253|NCT02151266|527110673|FG002|Overall Study|Not able to exercise|4|||
146164254|NCT04839965|527110675|FG000|Overall Study|Death|6|||
146164255|NCT04839965|527110676|FG001|Overall Study|Death|6|||
146164256|NCT04839965|527110675|FG000|Overall Study|Lost to Follow-up|1|||
146164257|NCT04839965|527110676|FG001|Overall Study|Lost to Follow-up|0|||
146164258|NCT02291679|527110677|FG000|Overall Study|Adverse Event|2|||
146164259|NCT02291679|527110678|FG001|Overall Study|Adverse Event|12|||
146164260|NCT02291679|527110679|FG002|Overall Study|Adverse Event|19|||
146164261|NCT02291679|527110677|FG000|Overall Study|Protocol Violation|5|||
146164262|NCT02291679|527110678|FG001|Overall Study|Protocol Violation|1|||
146164263|NCT02291679|527110679|FG002|Overall Study|Protocol Violation|7|||
146164264|NCT02291679|527110677|FG000|Overall Study|Withdrew Consent|18|||
146164265|NCT02291679|527110678|FG001|Overall Study|Withdrew Consent|10|||
146164266|NCT02291679|527110679|FG002|Overall Study|Withdrew Consent|15|||
146164267|NCT02291679|527110677|FG000|Overall Study|Lost to Follow-up|12|||
146164268|NCT02291679|527110678|FG001|Overall Study|Lost to Follow-up|10|||
146164269|NCT02291679|527110679|FG002|Overall Study|Lost to Follow-up|9|||
146164270|NCT02291679|527110677|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146164271|NCT02291679|527110678|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146164272|NCT02291679|527110679|FG002|Overall Study|Insufficient Therapeutic Response|7|||
146164273|NCT02291679|527110677|FG000|Overall Study|Other|2|||
146164274|NCT02291679|527110678|FG001|Overall Study|Other|4|||
146164275|NCT02291679|527110679|FG002|Overall Study|Other|2|||
146164276|NCT02276222|527110680|FG000|Overall Study|Adverse Event|62|||
146164277|NCT02276222|527110681|FG001|Overall Study|Adverse Event|11|||
146164278|NCT02276222|527110680|FG000|Overall Study|Death|3|||
146164279|NCT02276222|527110681|FG001|Overall Study|Death|4|||
146164280|NCT02276222|527110680|FG000|Overall Study|Lack of Efficacy|13|||
146164281|NCT02276222|527110681|FG001|Overall Study|Lack of Efficacy|3|||
146164282|NCT02276222|527110680|FG000|Overall Study|Protocol Violation|3|||
146164283|NCT02276222|527110681|FG001|Overall Study|Protocol Violation|2|||
146164284|NCT02276222|527110680|FG000|Overall Study|Withdrawal by Subject|79|||
146164285|NCT02276222|527110681|FG001|Overall Study|Withdrawal by Subject|33|||
146164286|NCT02276222|527110680|FG000|Overall Study|non compliance with study medication|6|||
146164287|NCT02276222|527110681|FG001|Overall Study|non compliance with study medication|2|||
146164288|NCT02276222|527110680|FG000|Overall Study|sponsor decision|0|||
146164289|NCT02276222|527110681|FG001|Overall Study|sponsor decision|3|||
146164290|NCT02276222|527110680|FG000|Overall Study|Lost to Follow-up|15|||
146164291|NCT02276222|527110681|FG001|Overall Study|Lost to Follow-up|5|||
146164292|NCT02276222|527110680|FG000|Overall Study|Physician Decision|2|||
146316943|NCT00925015|527672676|FG002|Overall Study|Progressive Disease|4|||
146316944|NCT00925015|527672674|FG000|Overall Study|Withdrawal by Subject|0|||
146164293|NCT02276222|527110681|FG001|Overall Study|Physician Decision|1|||
146164294|NCT02276222|527110680|FG000|Overall Study|sheduling conflict|1|||
146164295|NCT02276222|527110681|FG001|Overall Study|sheduling conflict|0|||
146164296|NCT02276222|527110680|FG000|Overall Study|subject withdrew after randomization|1|||
146164297|NCT02276222|527110681|FG001|Overall Study|subject withdrew after randomization|0|||
146164298|NCT02170025|527110682|FG000|Overall Study|Adverse Event|2|||
146316945|NCT00925015|527672675|FG001|Overall Study|Withdrawal by Subject|0|||
146316946|NCT00925015|527672676|FG002|Overall Study|Withdrawal by Subject|1|||
146316947|NCT01407926|527672677|FG000|Overall Study|Lost to Follow-up|55|||
146316948|NCT02814565|527672678|FG000|Overall Study|Lack of Efficacy|0|||
146164299|NCT02170025|527110683|FG001|Overall Study|Adverse Event|0|||
146164300|NCT01756352|527112504|FG000|Overall Study|moved away and lost to followup|1|||
146316949|NCT02814565|527672679|FG001|Overall Study|Lack of Efficacy|1|||
146316950|NCT02814565|527672678|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
146316951|NCT02814565|527672679|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
146316952|NCT02469090|527672682|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
146316953|NCT02469090|527672683|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
146316954|NCT02469090|527672684|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
146316955|NCT02469090|527672682|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
146316956|NCT02469090|527672683|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
146316957|NCT02469090|527672684|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
146316958|NCT02469090|527672682|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
146316959|NCT02469090|527672683|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
146316960|NCT02469090|527672684|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
146316961|NCT02469090|527672682|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
146316962|NCT02469090|527672683|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
146316963|NCT02469090|527672684|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
146316964|NCT02469090|527672682|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
146316965|NCT02469090|527672683|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
146316966|NCT02469090|527672684|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
146316967|NCT02469090|527672682|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
146316968|NCT02469090|527672683|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
146316969|NCT02469090|527672684|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
146316970|NCT02469090|527672682|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
146316971|NCT02469090|527672683|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
146316972|NCT02469090|527672684|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
146316973|NCT02469090|527672682|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
146316974|NCT02469090|527672683|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
146316975|NCT02469090|527672684|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
146316976|NCT03823391|527672690|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
146316977|NCT03823391|527672691|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
146316978|NCT03823391|527672690|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
146316979|NCT03823391|527672691|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
146164301|NCT00415610|527112505|FG000|Overall Study|Death|3|||
146164302|NCT00415610|527112506|FG001|Overall Study|Death|2|||
146164303|NCT00415610|527112507|FG002|Overall Study|Death|5|||
146164304|NCT05131165|527112509|FG000|Overall Study|Death|1|||
146316980|NCT05030311|527672692|FG000|Overall Study|Technical problems|0|||
146316981|NCT05030311|527672693|FG001|Overall Study|Technical problems|1|||
146316982|NCT05030311|527672692|FG000|Overall Study|Withdrawal by Subject|31|||
146316983|NCT05030311|527672693|FG001|Overall Study|Withdrawal by Subject|17|||
146316984|NCT05030311|527672692|FG000|Overall Study|Adverse Event|13|||
146316985|NCT05030311|527672693|FG001|Overall Study|Adverse Event|5|||
146316986|NCT05030311|527672692|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146316987|NCT05030311|527672693|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146316988|NCT05030311|527672692|FG000|Overall Study|Physician Decision|5|||
146316989|NCT05030311|527672693|FG001|Overall Study|Physician Decision|2|||
146316990|NCT05030311|527672692|FG000|Overall Study|Lost to Follow-up|5|||
146316991|NCT05030311|527672693|FG001|Overall Study|Lost to Follow-up|1|||
146316992|NCT05030311|527672692|FG000|Overall Study|Protocol Violation|4|||
146316993|NCT05030311|527672693|FG001|Overall Study|Protocol Violation|4|||
146316994|NCT03042468|527672695|FG000|Overall Study|Death|0|||
146316995|NCT03042468|527672696|FG001|Overall Study|Death|1|||
146316996|NCT03042468|527672697|FG002|Overall Study|Death|1|||
146316997|NCT03042468|527672698|FG003|Overall Study|Death|0|||
146316998|NCT03042468|527672699|FG004|Overall Study|Death|0|||
146316999|NCT03042468|527672700|FG005|Overall Study|Death|0|||
146317000|NCT03042468|527672695|FG000|Overall Study|Withdrawal by Subject|0|||
146317001|NCT03042468|527672696|FG001|Overall Study|Withdrawal by Subject|0|||
146317002|NCT03042468|527672697|FG002|Overall Study|Withdrawal by Subject|0|||
146317003|NCT03042468|527672698|FG003|Overall Study|Withdrawal by Subject|0|||
146317004|NCT03042468|527672699|FG004|Overall Study|Withdrawal by Subject|0|||
146317005|NCT03042468|527672700|FG005|Overall Study|Withdrawal by Subject|1|||
146317006|NCT03042468|527672695|FG000|Overall Study|Lost to Follow-up|0|||
146164305|NCT05131165|527112510|FG001|Overall Study|Death|1|||
146317007|NCT03042468|527672696|FG001|Overall Study|Lost to Follow-up|0|||
146317008|NCT03042468|527672697|FG002|Overall Study|Lost to Follow-up|0|||
146317009|NCT03042468|527672698|FG003|Overall Study|Lost to Follow-up|0|||
146317010|NCT03042468|527672699|FG004|Overall Study|Lost to Follow-up|1|||
146317011|NCT03042468|527672700|FG005|Overall Study|Lost to Follow-up|1|||
146317012|NCT03557359|527672703|FG000|Dose 1: 240 mg|Adverse Event|1|||
146317013|NCT03557359|527672704|FG001|Dose 1: 240 mg|Adverse Event|0|||
146317014|NCT03092726|527672705|FG000|Overall Study|Adverse Event|3|||
146317015|NCT03092726|527672706|FG001|Overall Study|Adverse Event|10|||
146317016|NCT03092726|527672705|FG000|Overall Study|Lack of Efficacy|0|||
146317017|NCT03092726|527672706|FG001|Overall Study|Lack of Efficacy|1|||
146164306|NCT05131165|527112511|FG002|Overall Study|Death|0|||
146164307|NCT05131165|527112509|FG000|Overall Study|Lost to Follow-up|2|||
146164308|NCT05131165|527112510|FG001|Overall Study|Lost to Follow-up|2|||
146164309|NCT05131165|527112511|FG002|Overall Study|Lost to Follow-up|5|||
146164310|NCT05131165|527112509|FG000|Overall Study|Transferred out of clinic|1|||
146164311|NCT05131165|527112510|FG001|Overall Study|Transferred out of clinic|0|||
146164312|NCT05131165|527112511|FG002|Overall Study|Transferred out of clinic|3|||
146164313|NCT05131165|527112509|FG000|Overall Study|Dropped out|1|||
146164314|NCT05131165|527112510|FG001|Overall Study|Dropped out|2|||
146164315|NCT05131165|527112511|FG002|Overall Study|Dropped out|0|||
146164316|NCT03320018|527112517|FG000|Treatment Period|Withdrawal by Subject|1|||
146164317|NCT03320018|527112518|FG001|Treatment Period|Withdrawal by Subject|0|||
146164318|NCT03320018|527112517|FG000|Day 90 Follow up|Death|0|||
146164319|NCT03320018|527112518|FG001|Day 90 Follow up|Death|1|||
146164320|NCT04539821|527112519|FG000|Overall Study|Withdrawal by Subject|2|||
146164321|NCT04539821|527112519|FG000|Overall Study|continued care with their physician|20|||
146164322|NCT04539821|527112519|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
146164323|NCT02691182|527112520|FG000|Overall Study|Withdrawal by Subject|4|||
146164324|NCT02691182|527112521|FG001|Overall Study|Withdrawal by Subject|7|||
146164325|NCT02691182|527112522|FG002|Overall Study|Withdrawal by Subject|6|||
146164326|NCT02691182|527112523|FG003|Overall Study|Withdrawal by Subject|8|||
146164327|NCT02691182|527112520|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
146164328|NCT02691182|527112521|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
146164329|NCT02691182|527112522|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
146164330|NCT02691182|527112523|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
146164331|NCT02691182|527112520|FG000|Overall Study|Lost to Follow-up|8|||
146164332|NCT02691182|527112521|FG001|Overall Study|Lost to Follow-up|33|||
146164333|NCT02691182|527112522|FG002|Overall Study|Lost to Follow-up|19|||
146164334|NCT02691182|527112523|FG003|Overall Study|Lost to Follow-up|22|||
146164335|NCT02691182|527112520|FG000|Overall Study|Adverse Event|3|||
146164336|NCT02691182|527112521|FG001|Overall Study|Adverse Event|10|||
146164337|NCT02691182|527112522|FG002|Overall Study|Adverse Event|10|||
146164338|NCT02691182|527112523|FG003|Overall Study|Adverse Event|11|||
146164339|NCT02691182|527112520|FG000|Overall Study|Physician Decision|3|||
146164340|NCT02691182|527112521|FG001|Overall Study|Physician Decision|7|||
146164341|NCT02691182|527112522|FG002|Overall Study|Physician Decision|14|||
146164342|NCT02691182|527112523|FG003|Overall Study|Physician Decision|8|||
146164343|NCT02691182|527112520|FG000|Overall Study|Lack of Efficacy|0|||
146317018|NCT03092726|527672705|FG000|Overall Study|Lost to Follow-up|1|||
146317019|NCT03092726|527672706|FG001|Overall Study|Lost to Follow-up|0|||
146317020|NCT03092726|527672705|FG000|Overall Study|Withdrawal by Subject|5|||
146317021|NCT03092726|527672706|FG001|Overall Study|Withdrawal by Subject|3|||
146164344|NCT02691182|527112521|FG001|Overall Study|Lack of Efficacy|0|||
146164345|NCT02691182|527112522|FG002|Overall Study|Lack of Efficacy|0|||
146164346|NCT02691182|527112523|FG003|Overall Study|Lack of Efficacy|4|||
146317022|NCT01294800|527672707|FG000|Overall Study|Adverse Event|7|||
146317023|NCT01294800|527672708|FG001|Overall Study|Adverse Event|6|||
146317024|NCT01294800|527672709|FG002|Overall Study|Adverse Event|12|||
146317025|NCT01294800|527672710|FG003|Overall Study|Adverse Event|5|||
146317026|NCT01294800|527672707|FG000|Overall Study|Subject Withdrew Consent|2|||
146317027|NCT01294800|527672708|FG001|Overall Study|Subject Withdrew Consent|2|||
146317028|NCT01294800|527672709|FG002|Overall Study|Subject Withdrew Consent|2|||
146317029|NCT01294800|527672710|FG003|Overall Study|Subject Withdrew Consent|11|||
146317030|NCT01294800|527672707|FG000|Overall Study|Lost to Follow-up|0|||
146317031|NCT01294800|527672708|FG001|Overall Study|Lost to Follow-up|0|||
146317032|NCT01294800|527672709|FG002|Overall Study|Lost to Follow-up|1|||
146317033|NCT01294800|527672710|FG003|Overall Study|Lost to Follow-up|0|||
146317034|NCT01294800|527672707|FG000|Overall Study|Non-compliance With Protocol|0|||
146317035|NCT01294800|527672708|FG001|Overall Study|Non-compliance With Protocol|1|||
146317036|NCT01294800|527672709|FG002|Overall Study|Non-compliance With Protocol|1|||
146317037|NCT01294800|527672710|FG003|Overall Study|Non-compliance With Protocol|0|||
146317038|NCT01294800|527672707|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
146317039|NCT01294800|527672708|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
146317040|NCT01294800|527672709|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
146317041|NCT01294800|527672710|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
146317042|NCT00493038|527672711|FG000|Treatment|Adverse Event|8|||
146317043|NCT00493038|527672712|FG001|Treatment|Adverse Event|4|||
146317044|NCT00493038|527672711|FG000|Treatment|Lost to Follow-up|5|||
146317045|NCT00493038|527672712|FG001|Treatment|Lost to Follow-up|3|||
146317046|NCT00493038|527672711|FG000|Treatment|Withdrawal by Subject|11|||
146317047|NCT00493038|527672712|FG001|Treatment|Withdrawal by Subject|12|||
146317048|NCT00493038|527672711|FG000|Treatment|Other|0|||
146317049|NCT00493038|527672712|FG001|Treatment|Other|1|||
146317050|NCT00493038|527672711|FG000|Follow-up|Lost to Follow-up|1|||
146317051|NCT00493038|527672712|FG001|Follow-up|Lost to Follow-up|0|||
146317052|NCT03345472|527672713|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
146317053|NCT03345472|527672713|FG000|Implant to 3 Months|Physician Decision|1|||
146317054|NCT03345472|527672713|FG000|Implant to 3 Months|Adverse Event|1|||
146317055|NCT03345472|527672713|FG000|3 Months to 12 Months|Physician Decision|3|||
146317056|NCT03345472|527672713|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
146164347|NCT02691182|527112520|FG000|Overall Study|Protocol Violation|2|||
146164348|NCT02691182|527112521|FG001|Overall Study|Protocol Violation|6|||
146164349|NCT02691182|527112522|FG002|Overall Study|Protocol Violation|6|||
146164350|NCT02691182|527112523|FG003|Overall Study|Protocol Violation|8|||
146164351|NCT02691182|527112520|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
146164352|NCT02691182|527112521|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
146164353|NCT02691182|527112522|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
146164354|NCT02691182|527112523|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
146164355|NCT02691182|527112520|FG000|Overall Study|Missing|0|||
146164356|NCT02691182|527112521|FG001|Overall Study|Missing|5|||
146164357|NCT02691182|527112522|FG002|Overall Study|Missing|1|||
146164358|NCT02691182|527112523|FG003|Overall Study|Missing|5|||
146164359|NCT02563002|527112528|FG000|Overall Study|Death|72|||
146164360|NCT02563002|527112529|FG001|Overall Study|Death|87|||
146164361|NCT02563002|527112528|FG000|Overall Study|Lost to Follow-up|5|||
146164362|NCT02563002|527112529|FG001|Overall Study|Lost to Follow-up|0|||
146164363|NCT02563002|527112528|FG000|Overall Study|Physician Decision|0|||
146164364|NCT02563002|527112529|FG001|Overall Study|Physician Decision|2|||
146164365|NCT02563002|527112528|FG000|Overall Study|Withdrawal by Subject|2|||
146164366|NCT02563002|527112529|FG001|Overall Study|Withdrawal by Subject|10|||
146164367|NCT02563002|527112528|FG000|Overall Study|Sponsor decision|74|||
146164368|NCT02563002|527112529|FG001|Overall Study|Sponsor decision|55|||
146164369|NCT05453110|527112538|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
146164370|NCT05453110|527112539|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
146164371|NCT05453110|527112540|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
146164372|NCT05906368|527112541|FG000|Overall Study|Withdrawal by Subject|1|||
146164373|NCT05906368|527112542|FG001|Overall Study|Withdrawal by Subject|1|||
146164374|NCT05906368|527112541|FG000|Overall Study|Ineligibility criteria identified|2|||
146164375|NCT05906368|527112542|FG001|Overall Study|Ineligibility criteria identified|0|||
146164376|NCT04493931|527112543|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
146164377|NCT04493931|527112544|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164378|NCT04493931|527112545|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164379|NCT04493931|527112546|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164380|NCT04493931|527112547|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164381|NCT04493931|527112548|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164382|NCT04493931|527112549|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
146164383|NCT04493931|527112543|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164384|NCT04493931|527112544|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
146164385|NCT04493931|527112545|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164386|NCT04493931|527112546|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164387|NCT04493931|527112547|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164388|NCT04493931|527112548|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164389|NCT04493931|527112549|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
146164390|NCT04493931|527112543|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164391|NCT04493931|527112544|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
146164392|NCT04493931|527112545|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164393|NCT04493931|527112546|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164394|NCT04493931|527112547|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164395|NCT04493931|527112548|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164396|NCT04493931|527112549|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
146164397|NCT04493931|527112543|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164398|NCT04493931|527112544|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164399|NCT04493931|527112545|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
146164400|NCT04493931|527112546|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164401|NCT04493931|527112547|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164402|NCT04493931|527112548|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164403|NCT04493931|527112549|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
146164404|NCT03338894|527112550|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
146164405|NCT00266825|527112557|FG000|Completed Follow-Up|Lost to Follow-up|14|||
146164406|NCT00266825|527112558|FG001|Completed Follow-Up|Lost to Follow-up|19|||
146164407|NCT00266825|527112557|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
146164408|NCT00266825|527112558|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
146164409|NCT00430248|527112559|FG000|Overall Study|Adverse Event|49|||
146164410|NCT00430248|527112560|FG001|Overall Study|Adverse Event|61|||
146164411|NCT00430248|527112561|FG002|Overall Study|Adverse Event|64|||
146164412|NCT00430248|527112559|FG000|Overall Study|Protocol Violation|10|||
146317057|NCT03345472|527672713|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
146164413|NCT00430248|527112560|FG001|Overall Study|Protocol Violation|2|||
146164414|NCT00430248|527112561|FG002|Overall Study|Protocol Violation|4|||
146164415|NCT00430248|527112559|FG000|Overall Study|Personal Reasons|12|||
146164416|NCT00430248|527112560|FG001|Overall Study|Personal Reasons|24|||
146164417|NCT00430248|527112561|FG002|Overall Study|Personal Reasons|9|||
146164418|NCT00430248|527112559|FG000|Overall Study|Lost to Follow-up|28|||
146164419|NCT00430248|527112560|FG001|Overall Study|Lost to Follow-up|33|||
146164420|NCT00430248|527112561|FG002|Overall Study|Lost to Follow-up|28|||
146164421|NCT00430248|527112559|FG000|Overall Study|Therapeutic Failure|1|||
146164422|NCT00430248|527112560|FG001|Overall Study|Therapeutic Failure|1|||
146164423|NCT00430248|527112561|FG002|Overall Study|Therapeutic Failure|1|||
146164424|NCT00430248|527112559|FG000|Overall Study|Withdrawal by Subject|14|||
146164425|NCT00430248|527112560|FG001|Overall Study|Withdrawal by Subject|20|||
146164426|NCT00430248|527112561|FG002|Overall Study|Withdrawal by Subject|16|||
146164427|NCT00430248|527112559|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146164428|NCT00430248|527112560|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
146164429|NCT00430248|527112561|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146164430|NCT00430248|527112559|FG000|Overall Study|Gout Flare|3|||
146164431|NCT00430248|527112560|FG001|Overall Study|Gout Flare|7|||
146164432|NCT00430248|527112561|FG002|Overall Study|Gout Flare|2|||
146164433|NCT00430248|527112559|FG000|Overall Study|Reason Not Specified|8|||
146164434|NCT00430248|527112560|FG001|Overall Study|Reason Not Specified|8|||
146164435|NCT00430248|527112561|FG002|Overall Study|Reason Not Specified|11|||
146164436|NCT01127646|527112564|FG000|Overall Study|Entry Criteria Not Met|1|||
146164437|NCT01127646|527112565|FG001|Overall Study|Entry Criteria Not Met|0|||
146164438|NCT01127646|527112564|FG000|Overall Study|Protocol Violation|0|||
146164439|NCT01127646|527112565|FG001|Overall Study|Protocol Violation|1|||
146317058|NCT03345472|527672713|FG000|3 Months to 12 Months|Adverse Event|1|||
146317059|NCT03345472|527672713|FG000|3 Months to 12 Months|Death|1|||
146317060|NCT02728830|527672743|FG000|Overall Study|Exclusionary Surgery|9|||
146317061|NCT02728830|527672743|FG000|Overall Study|Exclusionary Pathology|6|||
146317062|NCT02728830|527672743|FG000|Overall Study|Physician Decision|3|||
146317063|NCT02728830|527672743|FG000|Overall Study|Withdrawal by Subject|2|||
146317064|NCT02728830|527672743|FG000|Overall Study|Lost to Follow-up|1|||
146317065|NCT02728830|527672743|FG000|Overall Study|Exclusionary Lab Values|1|||
146317066|NCT02728830|527672743|FG000|Overall Study|Contraindicated Illness|1|||
146317067|NCT02728830|527672743|FG000|Overall Study|Language Barrier|1|||
146317068|NCT01568593|527672745|FG000|Overall Study|Lack of Efficacy|4|||
146317069|NCT01568593|527672746|FG001|Overall Study|Lack of Efficacy|1|||
146317070|NCT01568593|527672745|FG000|Overall Study|Adverse Event|3|||
146317071|NCT01568593|527672746|FG001|Overall Study|Adverse Event|2|||
146317072|NCT02780648|527672747|FG000|Overall Study|Disease Progression|1|||
146317073|NCT02780648|527672748|FG001|Overall Study|Disease Progression|0|||
146317074|NCT03167073|527672753|FG000|Overall Study|Stillbirth|1|||
146317075|NCT03167073|527672754|FG001|Overall Study|Stillbirth|0|||
146317076|NCT01276236|527672755|FG000|Overall Study|Lack of Efficacy|2|||
146317077|NCT01276236|527672755|FG000|Overall Study|Withdrawal by Subject|4|||
146317078|NCT03127384|527672757|FG000|Overall Study|Lost to Follow-up|4|||
146317079|NCT03127384|527672757|FG000|Overall Study|Subject request|2|||
146317080|NCT01294579|527672758|FG000|Overall Study|Disease progression|12|||
146317081|NCT01294579|527672758|FG000|Overall Study|Adverse Event|11|||
146317082|NCT01294579|527672758|FG000|Overall Study|Study closed/terminated|3|||
146317083|NCT01294579|527672758|FG000|Overall Study|Lost to Follow-up|1|||
146317084|NCT01294579|527672758|FG000|Overall Study|Physician Decision|3|||
146317085|NCT01294579|527672758|FG000|Overall Study|Withdrawal by Subject|5|||
146317086|NCT01180660|527672759|FG000|Overall Study|Changed to open surgery|1|||
146317087|NCT01180660|527672760|FG001|Overall Study|Changed to open surgery|0|||
146317088|NCT00262873|527672761|FG000|Overall Study|Adverse Event|3|||
146317089|NCT00262873|527672761|FG000|Overall Study|Withdrawal by Subject|5|||
146317090|NCT00844753|527672762|FG000|Overall Study|Lack of Efficacy|1|||
146317091|NCT00844753|527672763|FG001|Overall Study|Lack of Efficacy|0|||
146317092|NCT00844753|527672764|FG002|Overall Study|Lack of Efficacy|2|||
146317093|NCT00844753|527672765|FG003|Overall Study|Lack of Efficacy|2|||
146317094|NCT00844753|527672762|FG000|Overall Study|Adverse Event|3|||
146317095|NCT00844753|527672763|FG001|Overall Study|Adverse Event|2|||
146317096|NCT00844753|527672764|FG002|Overall Study|Adverse Event|5|||
146317097|NCT00844753|527672765|FG003|Overall Study|Adverse Event|5|||
146317098|NCT00844753|527672762|FG000|Overall Study|Lost to Follow-up|1|||
146317099|NCT00844753|527672763|FG001|Overall Study|Lost to Follow-up|1|||
146317100|NCT00844753|527672764|FG002|Overall Study|Lost to Follow-up|0|||
146317101|NCT00844753|527672765|FG003|Overall Study|Lost to Follow-up|1|||
146317102|NCT00844753|527672762|FG000|Overall Study|could not swallow medication|2|||
146317103|NCT00844753|527672763|FG001|Overall Study|could not swallow medication|0|||
146317104|NCT00844753|527672764|FG002|Overall Study|could not swallow medication|0|||
146164440|NCT03466086|527112566|FG000|Period 1|Sponsor decision due to study timeline|1|||
146164441|NCT03466086|527112567|FG001|Period 1|Sponsor decision due to study timeline|0|||
146317105|NCT00844753|527672765|FG003|Overall Study|could not swallow medication|0|||
146317106|NCT00844753|527672762|FG000|Overall Study|Withdrawal by Subject|1|||
146317107|NCT00844753|527672763|FG001|Overall Study|Withdrawal by Subject|0|||
146317108|NCT00844753|527672764|FG002|Overall Study|Withdrawal by Subject|0|||
146317109|NCT00844753|527672765|FG003|Overall Study|Withdrawal by Subject|3|||
146317110|NCT03440814|527672768|FG000|Overall Study|Adverse Event|2|||
146317111|NCT03440814|527672769|FG001|Overall Study|Adverse Event|1|||
146317112|NCT03440814|527672768|FG000|Overall Study|Lost to Follow-up|2|||
146317113|NCT03440814|527672769|FG001|Overall Study|Lost to Follow-up|0|||
146317114|NCT03440814|527672768|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
146317115|NCT03440814|527672769|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
146317116|NCT00088374|527672770|FG000|Overall Study|patient did not receive any 17AAG|1|||
146317117|NCT00088374|527672770|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
146317118|NCT00852995|527672771|FG000|Overall Study|Adverse Event|1|||
146317119|NCT00852995|527672772|FG001|Overall Study|Adverse Event|0|||
146317120|NCT00852995|527672773|FG002|Overall Study|Adverse Event|4|||
146317121|NCT00852995|527672774|FG003|Overall Study|Adverse Event|0|||
146317122|NCT00852995|527672775|FG004|Overall Study|Adverse Event|0|||
146317123|NCT00852995|527672771|FG000|Overall Study|Lost to Follow-up|0|||
146317124|NCT00852995|527672772|FG001|Overall Study|Lost to Follow-up|1|||
146317125|NCT00852995|527672773|FG002|Overall Study|Lost to Follow-up|1|||
146317126|NCT00852995|527672774|FG003|Overall Study|Lost to Follow-up|0|||
146317127|NCT00852995|527672775|FG004|Overall Study|Lost to Follow-up|0|||
146317128|NCT00852995|527672771|FG000|Overall Study|Withdrawal by Subject|4|||
146317129|NCT00852995|527672772|FG001|Overall Study|Withdrawal by Subject|0|||
146317130|NCT00852995|527672773|FG002|Overall Study|Withdrawal by Subject|0|||
146317131|NCT00852995|527672774|FG003|Overall Study|Withdrawal by Subject|1|||
146317132|NCT00852995|527672775|FG004|Overall Study|Withdrawal by Subject|2|||
146317133|NCT00852995|527672771|FG000|Overall Study|Non-Compliance|0|||
146317134|NCT00852995|527672772|FG001|Overall Study|Non-Compliance|0|||
146317135|NCT00852995|527672773|FG002|Overall Study|Non-Compliance|0|||
146317136|NCT00852995|527672774|FG003|Overall Study|Non-Compliance|2|||
146317137|NCT00852995|527672775|FG004|Overall Study|Non-Compliance|0|||
146317138|NCT00852995|527672771|FG000|Overall Study|Progressive Disease|1|||
146317139|NCT00852995|527672772|FG001|Overall Study|Progressive Disease|0|||
146317140|NCT00852995|527672773|FG002|Overall Study|Progressive Disease|0|||
146317141|NCT00852995|527672774|FG003|Overall Study|Progressive Disease|2|||
146317142|NCT00852995|527672775|FG004|Overall Study|Progressive Disease|1|||
146317143|NCT00852995|527672771|FG000|Overall Study|Physician Decision|1|||
146317144|NCT00852995|527672772|FG001|Overall Study|Physician Decision|0|||
146317145|NCT00852995|527672773|FG002|Overall Study|Physician Decision|0|||
146317146|NCT00852995|527672774|FG003|Overall Study|Physician Decision|0|||
146317147|NCT00852995|527672775|FG004|Overall Study|Physician Decision|0|||
146317148|NCT00852995|527672771|FG000|Overall Study|Protocol Violation|0|||
146317149|NCT00852995|527672772|FG001|Overall Study|Protocol Violation|0|||
146317150|NCT00852995|527672773|FG002|Overall Study|Protocol Violation|0|||
146317151|NCT00852995|527672774|FG003|Overall Study|Protocol Violation|0|||
146317152|NCT00852995|527672775|FG004|Overall Study|Protocol Violation|1|||
146317153|NCT00852995|527672771|FG000|Overall Study|Moved Out of Area|1|||
146317154|NCT00852995|527672772|FG001|Overall Study|Moved Out of Area|0|||
146317155|NCT00852995|527672773|FG002|Overall Study|Moved Out of Area|0|||
146317156|NCT00852995|527672774|FG003|Overall Study|Moved Out of Area|0|||
146317157|NCT00852995|527672775|FG004|Overall Study|Moved Out of Area|0|||
146317158|NCT03595553|527672776|FG000|Overall Study|Withdrawal by Subject|20|||
146164442|NCT03466086|527112566|FG000|Period 1|Withdrawal by Subject|1|||
146164443|NCT03466086|527112567|FG001|Period 1|Withdrawal by Subject|0|||
146164444|NCT04721925|527112572|FG000|2-Month Assessment|Lost to Follow-up|5|||
146164445|NCT04721925|527112573|FG001|2-Month Assessment|Lost to Follow-up|3|||
146164446|NCT04721925|527112572|FG000|4-Month Assessment|Lost to Follow-up|3|||
146164447|NCT04721925|527112573|FG001|4-Month Assessment|Lost to Follow-up|6|||
146164448|NCT04570436|527112577|FG000|Overall Study|Adverse Event|0|||
146317159|NCT03595553|527672777|FG001|Overall Study|Withdrawal by Subject|8|||
146317160|NCT03595553|527672776|FG000|Overall Study|Physician Decision|3|||
146317161|NCT03595553|527672777|FG001|Overall Study|Physician Decision|2|||
146317162|NCT03595553|527672776|FG000|Overall Study|Adverse Event|2|||
146317163|NCT03595553|527672777|FG001|Overall Study|Adverse Event|5|||
146317164|NCT03595553|527672776|FG000|Overall Study|Death|24|||
146317165|NCT03595553|527672777|FG001|Overall Study|Death|22|||
146317166|NCT03595553|527672776|FG000|Overall Study|Lost to Follow-up|6|||
146317167|NCT03595553|527672777|FG001|Overall Study|Lost to Follow-up|7|||
146317168|NCT03595553|527672776|FG000|Overall Study|Other as indicated in CSR|3|||
146317169|NCT03595553|527672777|FG001|Overall Study|Other as indicated in CSR|3|||
146317170|NCT03595553|527672776|FG000|Overall Study|Sponsor Decision|0|||
146317171|NCT03595553|527672777|FG001|Overall Study|Sponsor Decision|1|||
146317172|NCT02158091|527672790|FG000|Overall Study|DLT|2|||
146317173|NCT02158091|527672791|FG001|Overall Study|DLT|1|||
146317174|NCT02158091|527672792|FG002|Overall Study|DLT|0|||
146317175|NCT04518462|527672793|FG000|Overall Study|Withdrawal by Subject|0|||
146164449|NCT04570436|527112578|FG001|Overall Study|Adverse Event|0|||
146164450|NCT04570436|527112579|FG002|Overall Study|Adverse Event|1|||
146317176|NCT04518462|527672794|FG001|Overall Study|Withdrawal by Subject|0|||
146317177|NCT04518462|527672795|FG002|Overall Study|Withdrawal by Subject|1|||
146317178|NCT04518462|527672793|FG000|Overall Study|Physician Decision|1|||
146317179|NCT04518462|527672794|FG001|Overall Study|Physician Decision|1|||
146317180|NCT04518462|527672795|FG002|Overall Study|Physician Decision|0|||
146317181|NCT01003210|527672796|FG000|Overall Study|Lost to Follow-up|1|||
146317182|NCT01003210|527672797|FG001|Overall Study|Lost to Follow-up|3|||
146317183|NCT00271817|527672798|FG000|Part 1|Adverse Event|68|||
146317184|NCT00271817|527672799|FG001|Part 1|Adverse Event|25|||
146317185|NCT00271817|527672800|FG002|Part 1|Adverse Event|156|||
146317186|NCT00271817|527672798|FG000|Part 1|Lost to Follow-up|6|||
146317187|NCT00271817|527672799|FG001|Part 1|Lost to Follow-up|8|||
146317188|NCT00271817|527672800|FG002|Part 1|Lost to Follow-up|24|||
146317189|NCT00271817|527672798|FG000|Part 1|Protocol Violation|5|||
146317190|NCT00271817|527672799|FG001|Part 1|Protocol Violation|4|||
146317191|NCT00271817|527672800|FG002|Part 1|Protocol Violation|7|||
146317192|NCT00271817|527672798|FG000|Part 1|Patient Moved|3|||
146317193|NCT00271817|527672799|FG001|Part 1|Patient Moved|1|||
146317194|NCT00271817|527672800|FG002|Part 1|Patient Moved|5|||
146317195|NCT00271817|527672798|FG000|Part 1|Withdrawal by Subject|23|||
146317196|NCT00271817|527672799|FG001|Part 1|Withdrawal by Subject|17|||
146317197|NCT00271817|527672800|FG002|Part 1|Withdrawal by Subject|45|||
146317198|NCT00271817|527672798|FG000|Part 1|LDL < 50 mg/dL|1|||
146317199|NCT00271817|527672799|FG001|Part 1|LDL < 50 mg/dL|4|||
146317200|NCT00271817|527672800|FG002|Part 1|LDL < 50 mg/dL|48|||
146317201|NCT00271817|527672798|FG000|Part 2|Adverse Event|0|||
146317202|NCT00271817|527672799|FG001|Part 2|Adverse Event|17|||
146317203|NCT00271817|527672800|FG002|Part 2|Adverse Event|33|||
146317204|NCT00271817|527672798|FG000|Part 2|Lack of Efficacy|0|||
146317205|NCT00271817|527672799|FG001|Part 2|Lack of Efficacy|1|||
146317206|NCT00271817|527672800|FG002|Part 2|Lack of Efficacy|6|||
146317207|NCT00271817|527672798|FG000|Part 2|Lost to Follow-up|0|||
146317208|NCT00271817|527672799|FG001|Part 2|Lost to Follow-up|6|||
146317209|NCT00271817|527672800|FG002|Part 2|Lost to Follow-up|18|||
146317210|NCT00271817|527672798|FG000|Part 2|Protocol Violation|0|||
146317211|NCT00271817|527672799|FG001|Part 2|Protocol Violation|3|||
146317212|NCT00271817|527672800|FG002|Part 2|Protocol Violation|5|||
146317213|NCT00271817|527672798|FG000|Part 2|Patient Moved|0|||
146317214|NCT00271817|527672799|FG001|Part 2|Patient Moved|0|||
146317215|NCT00271817|527672800|FG002|Part 2|Patient Moved|5|||
146317216|NCT00271817|527672798|FG000|Part 2|Withdrawal by Subject|0|||
146317217|NCT00271817|527672799|FG001|Part 2|Withdrawal by Subject|2|||
146317218|NCT00271817|527672800|FG002|Part 2|Withdrawal by Subject|13|||
146317219|NCT00271817|527672798|FG000|Part 2|LDL < 50 mg/dL|0|||
146317220|NCT00271817|527672799|FG001|Part 2|LDL < 50 mg/dL|3|||
146317221|NCT00271817|527672800|FG002|Part 2|LDL < 50 mg/dL|4|||
146317222|NCT01471782|527672801|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
146317223|NCT01471782|527672802|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
146317224|NCT01471782|527672803|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
146317225|NCT01471782|527672804|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
146317226|NCT01471782|527672805|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
146317227|NCT01471782|527672806|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
146317228|NCT01471782|527672801|FG000|Overall Study|Lack of Efficacy|1|||
146317229|NCT01471782|527672802|FG001|Overall Study|Lack of Efficacy|2|||
146317230|NCT01471782|527672803|FG002|Overall Study|Lack of Efficacy|1|||
146317231|NCT01471782|527672804|FG003|Overall Study|Lack of Efficacy|1|||
146317232|NCT01471782|527672805|FG004|Overall Study|Lack of Efficacy|5|||
146317233|NCT01471782|527672806|FG005|Overall Study|Lack of Efficacy|18|||
146317234|NCT01471782|527672801|FG000|Overall Study|Adverse Event|1|||
146317235|NCT01471782|527672802|FG001|Overall Study|Adverse Event|1|||
146317236|NCT01471782|527672803|FG002|Overall Study|Adverse Event|2|||
146317237|NCT01471782|527672804|FG003|Overall Study|Adverse Event|2|||
146317238|NCT01471782|527672805|FG004|Overall Study|Adverse Event|3|||
146317239|NCT01471782|527672806|FG005|Overall Study|Adverse Event|1|||
146317240|NCT01471782|527672801|FG000|Overall Study|Other|0|||
146317241|NCT01471782|527672802|FG001|Overall Study|Other|0|||
146317242|NCT01471782|527672803|FG002|Overall Study|Other|1|||
146317243|NCT01471782|527672804|FG003|Overall Study|Other|1|||
146317244|NCT01471782|527672805|FG004|Overall Study|Other|6|||
146317245|NCT01471782|527672806|FG005|Overall Study|Other|5|||
146317246|NCT01471782|527672801|FG000|Overall Study|Change of Chemotherapy|1|||
146317247|NCT01471782|527672802|FG001|Overall Study|Change of Chemotherapy|1|||
146317248|NCT01471782|527672803|FG002|Overall Study|Change of Chemotherapy|0|||
146317249|NCT01471782|527672804|FG003|Overall Study|Change of Chemotherapy|0|||
146317250|NCT01471782|527672805|FG004|Overall Study|Change of Chemotherapy|1|||
146317251|NCT01471782|527672806|FG005|Overall Study|Change of Chemotherapy|4|||
146317252|NCT01471782|527672801|FG000|Overall Study|Disease Relapse|0|||
146317253|NCT01471782|527672802|FG001|Overall Study|Disease Relapse|0|||
146317254|NCT01471782|527672803|FG002|Overall Study|Disease Relapse|0|||
146317255|NCT01471782|527672804|FG003|Overall Study|Disease Relapse|1|||
146317256|NCT01471782|527672805|FG004|Overall Study|Disease Relapse|2|||
146317257|NCT01471782|527672806|FG005|Overall Study|Disease Relapse|1|||
146317258|NCT01471782|527672801|FG000|Overall Study|Physician Decision|0|||
146317259|NCT01471782|527672802|FG001|Overall Study|Physician Decision|0|||
146317260|NCT01471782|527672803|FG002|Overall Study|Physician Decision|0|||
146317261|NCT01471782|527672804|FG003|Overall Study|Physician Decision|0|||
146317262|NCT01471782|527672805|FG004|Overall Study|Physician Decision|3|||
146317263|NCT01471782|527672806|FG005|Overall Study|Physician Decision|8|||
146317264|NCT01471782|527672801|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146317265|NCT01471782|527672802|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146317266|NCT01471782|527672803|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146317267|NCT01471782|527672804|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146317268|NCT01471782|527672805|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
146317269|NCT01471782|527672806|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146317270|NCT01471782|527672801|FG000|Overall Study|Death|0|||
146317271|NCT01471782|527672802|FG001|Overall Study|Death|0|||
146317272|NCT01471782|527672803|FG002|Overall Study|Death|0|||
146317273|NCT01471782|527672804|FG003|Overall Study|Death|0|||
146317274|NCT01471782|527672805|FG004|Overall Study|Death|0|||
146317275|NCT01471782|527672806|FG005|Overall Study|Death|1|||
146317276|NCT00936208|527672807|FG000|Overall Study|Protocol Violation|37|||
146317277|NCT00936208|527672808|FG001|Overall Study|Protocol Violation|22|||
146317278|NCT00861744|527672809|FG000|Overall Study|Adverse Event|0|||
146317279|NCT00861744|527672810|FG001|Overall Study|Adverse Event|0|||
146317280|NCT00861744|527672811|FG002|Overall Study|Adverse Event|0|||
146317281|NCT00861744|527672812|FG003|Overall Study|Adverse Event|1|||
146317282|NCT00861744|527672809|FG000|Overall Study|Lost to Follow-up|7|||
146317283|NCT00861744|527672810|FG001|Overall Study|Lost to Follow-up|19|||
146317284|NCT00861744|527672811|FG002|Overall Study|Lost to Follow-up|17|||
146317285|NCT00861744|527672812|FG003|Overall Study|Lost to Follow-up|12|||
146317286|NCT00861744|527672809|FG000|Overall Study|Withdrawal by Subject|10|||
146317287|NCT00861744|527672810|FG001|Overall Study|Withdrawal by Subject|6|||
146317288|NCT00861744|527672811|FG002|Overall Study|Withdrawal by Subject|6|||
146317289|NCT00861744|527672812|FG003|Overall Study|Withdrawal by Subject|19|||
146317290|NCT00861744|527672809|FG000|Overall Study|Protocol Violation|0|||
146317291|NCT00861744|527672810|FG001|Overall Study|Protocol Violation|1|||
146317292|NCT00861744|527672811|FG002|Overall Study|Protocol Violation|0|||
146317293|NCT00861744|527672812|FG003|Overall Study|Protocol Violation|0|||
146317294|NCT00861744|527672809|FG000|Overall Study|Migration from study area|0|||
146317295|NCT00861744|527672810|FG001|Overall Study|Migration from study area|3|||
146317296|NCT00861744|527672811|FG002|Overall Study|Migration from study area|1|||
146317297|NCT00861744|527672812|FG003|Overall Study|Migration from study area|0|||
146317298|NCT00861744|527672809|FG000|Overall Study|Blood draws|0|||
146317299|NCT00861744|527672810|FG001|Overall Study|Blood draws|0|||
146317300|NCT00861744|527672811|FG002|Overall Study|Blood draws|0|||
146317301|NCT00861744|527672812|FG003|Overall Study|Blood draws|1|||
146317302|NCT01411085|527672813|FG000|Overall Study|Physician Decision|1|||
146317303|NCT01411085|527672813|FG000|Overall Study|Protocol Violation|1|||
146317304|NCT01411085|527672813|FG000|Overall Study|Adverse Event|1|||
146317305|NCT04818593|527672814|FG000|Overall Study|Low Oocyte Yield|8|||
146317306|NCT04818593|527672815|FG001|Overall Study|Low Oocyte Yield|8|||
146317307|NCT04818593|527672814|FG000|Overall Study|Not ICSI Insemination|7|||
146317308|NCT04818593|527672815|FG001|Overall Study|Not ICSI Insemination|7|||
146317309|NCT04818593|527672814|FG000|Overall Study|Poor Sperm Quality|2|||
146317310|NCT04818593|527672815|FG001|Overall Study|Poor Sperm Quality|2|||
146317311|NCT04818593|527672814|FG000|Overall Study|Withdrawal by Subject|2|||
146317312|NCT04818593|527672815|FG001|Overall Study|Withdrawal by Subject|2|||
146317313|NCT04818593|527672814|FG000|Overall Study|Conversion to IUI due to low response|1|||
146317314|NCT04818593|527672815|FG001|Overall Study|Conversion to IUI due to low response|1|||
146317315|NCT01564862|527672816|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
146317316|NCT01564862|527672817|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
146317317|NCT01564862|527672818|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
146317318|NCT01564862|527672816|FG000|Overall Study|Major Protocol Deviation|3|||
146317319|NCT01564862|527672817|FG001|Overall Study|Major Protocol Deviation|3|||
146317320|NCT01564862|527672818|FG002|Overall Study|Major Protocol Deviation|4|||
146317321|NCT01564862|527672816|FG000|Overall Study|Lost to Follow-up|10|||
146317322|NCT01564862|527672817|FG001|Overall Study|Lost to Follow-up|8|||
146317323|NCT01564862|527672818|FG002|Overall Study|Lost to Follow-up|6|||
146317324|NCT01564862|527672816|FG000|Overall Study|Voluntary Withdrawal|9|||
146164451|NCT04570436|527112580|FG003|Overall Study|Adverse Event|0|||
146164452|NCT04570436|527112581|FG004|Overall Study|Adverse Event|0|||
146164453|NCT04570436|527112582|FG005|Overall Study|Adverse Event|0|||
146317325|NCT01564862|527672817|FG001|Overall Study|Voluntary Withdrawal|6|||
146164454|NCT04570436|527112583|FG006|Overall Study|Adverse Event|0|||
146164455|NCT04570436|527112584|FG007|Overall Study|Adverse Event|0|||
146164456|NCT04570436|527112585|FG008|Overall Study|Adverse Event|0|||
146317326|NCT01564862|527672818|FG002|Overall Study|Voluntary Withdrawal|8|||
146317327|NCT01564862|527672816|FG000|Overall Study|Lack of Efficacy|1|||
146317328|NCT01564862|527672817|FG001|Overall Study|Lack of Efficacy|5|||
146317329|NCT01564862|527672818|FG002|Overall Study|Lack of Efficacy|6|||
146317330|NCT01564862|527672816|FG000|Overall Study|Other reason(s)|1|||
146317331|NCT01564862|527672817|FG001|Overall Study|Other reason(s)|0|||
146317332|NCT01564862|527672818|FG002|Overall Study|Other reason(s)|0|||
146317333|NCT03809611|527672819|FG000|Overall Study|Withdrawal by Subject|1|||
146317334|NCT03809611|527672820|FG001|Overall Study|Withdrawal by Subject|1|||
146317335|NCT01262365|527675150|FG000|Overall Study|Lack of Efficacy|35|||
146317336|NCT01262365|527675151|FG001|Overall Study|Lack of Efficacy|30|||
146317337|NCT01262365|527675152|FG002|Overall Study|Lack of Efficacy|47|||
146317338|NCT01262365|527675150|FG000|Overall Study|Protocol Violation|3|||
146317339|NCT01262365|527675151|FG001|Overall Study|Protocol Violation|1|||
146317340|NCT01262365|527675152|FG002|Overall Study|Protocol Violation|1|||
146317341|NCT01262365|527675150|FG000|Overall Study|Lost to Follow-up|3|||
146317342|NCT01262365|527675151|FG001|Overall Study|Lost to Follow-up|7|||
146317343|NCT01262365|527675152|FG002|Overall Study|Lost to Follow-up|6|||
146317344|NCT01262365|527675150|FG000|Overall Study|Withdrawal by Subject|17|||
146317345|NCT01262365|527675151|FG001|Overall Study|Withdrawal by Subject|22|||
146317346|NCT01262365|527675152|FG002|Overall Study|Withdrawal by Subject|22|||
146317347|NCT01262365|527675150|FG000|Overall Study|Death|1|||
146317348|NCT01262365|527675151|FG001|Overall Study|Death|2|||
146317349|NCT01262365|527675152|FG002|Overall Study|Death|1|||
146317350|NCT01262365|527675150|FG000|Overall Study|Adverse Event|26|||
146317351|NCT01262365|527675151|FG001|Overall Study|Adverse Event|16|||
146317352|NCT01262365|527675152|FG002|Overall Study|Adverse Event|11|||
146317353|NCT01262365|527675150|FG000|Overall Study|sponsor decision|1|||
146317354|NCT01262365|527675151|FG001|Overall Study|sponsor decision|1|||
146317355|NCT01262365|527675152|FG002|Overall Study|sponsor decision|0|||
146317356|NCT01262365|527675150|FG000|Overall Study|Randomization error|1|||
146317357|NCT01262365|527675151|FG001|Overall Study|Randomization error|0|||
146317358|NCT01262365|527675152|FG002|Overall Study|Randomization error|2|||
146317359|NCT01262365|527675150|FG000|Overall Study|Non-compliance|1|||
146317360|NCT01262365|527675151|FG001|Overall Study|Non-compliance|0|||
146317361|NCT01262365|527675152|FG002|Overall Study|Non-compliance|2|||
146317362|NCT01262365|527675150|FG000|Overall Study|Suspected pregnancy|1|||
146317363|NCT01262365|527675151|FG001|Overall Study|Suspected pregnancy|0|||
146317364|NCT01262365|527675152|FG002|Overall Study|Suspected pregnancy|0|||
146317365|NCT01262365|527675150|FG000|Overall Study|Patient pregnant|1|||
146317366|NCT01262365|527675151|FG001|Overall Study|Patient pregnant|0|||
146317367|NCT01262365|527675152|FG002|Overall Study|Patient pregnant|1|||
146317368|NCT01262365|527675150|FG000|Overall Study|Toxicity related to study drug|0|||
146317369|NCT01262365|527675151|FG001|Overall Study|Toxicity related to study drug|1|||
146317370|NCT01262365|527675152|FG002|Overall Study|Toxicity related to study drug|0|||
146317371|NCT01262365|527675150|FG000|Overall Study|Cannot tolerate the protocol|0|||
146317372|NCT01262365|527675151|FG001|Overall Study|Cannot tolerate the protocol|1|||
146317373|NCT01262365|527675152|FG002|Overall Study|Cannot tolerate the protocol|0|||
146317374|NCT01262365|527675150|FG000|Overall Study|Patient unavailable|0|||
146317375|NCT01262365|527675151|FG001|Overall Study|Patient unavailable|0|||
146317376|NCT01262365|527675152|FG002|Overall Study|Patient unavailable|1|||
146317377|NCT02792842|527675159|FG000|Overall Study|Adverse Event|4|||
146317378|NCT02792842|527675160|FG001|Overall Study|Adverse Event|2|||
146317379|NCT02792842|527675161|FG002|Overall Study|Adverse Event|3|||
146317380|NCT02792842|527675159|FG000|Overall Study|Withdrawal by Subject|0|||
146317381|NCT02792842|527675160|FG001|Overall Study|Withdrawal by Subject|1|||
146317382|NCT02792842|527675161|FG002|Overall Study|Withdrawal by Subject|2|||
146317383|NCT02792842|527675159|FG000|Overall Study|Lost to Follow-up|0|||
146317384|NCT02792842|527675160|FG001|Overall Study|Lost to Follow-up|0|||
146317385|NCT02792842|527675161|FG002|Overall Study|Lost to Follow-up|1|||
146317386|NCT02792842|527675159|FG000|Overall Study|Schedule delay|0|||
146317387|NCT02792842|527675160|FG001|Overall Study|Schedule delay|1|||
146317388|NCT02792842|527675161|FG002|Overall Study|Schedule delay|1|||
146317389|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
146317390|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
146317391|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
146164457|NCT04570436|527112586|FG009|Overall Study|Adverse Event|0|||
146164458|NCT04570436|527112577|FG000|Overall Study|Physician Decision|1|||
146164459|NCT04570436|527112578|FG001|Overall Study|Physician Decision|0|||
146164460|NCT04570436|527112579|FG002|Overall Study|Physician Decision|0|||
146164461|NCT04570436|527112580|FG003|Overall Study|Physician Decision|0|||
146164462|NCT04570436|527112581|FG004|Overall Study|Physician Decision|0|||
146317392|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
146317393|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
146317394|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
146317395|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
146164463|NCT04570436|527112582|FG005|Overall Study|Physician Decision|0|||
146317396|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
146317397|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
146317398|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
146317399|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
146164464|NCT04570436|527112583|FG006|Overall Study|Physician Decision|0|||
146317400|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
146317401|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
146317402|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
146317403|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
146317404|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
146317405|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
146317406|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
146317407|NCT04418765|527675162|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
146317408|NCT04418765|527675163|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
146317409|NCT04418765|527675164|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
146317410|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
146317411|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
146317412|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
146317413|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
146317414|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
146317415|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
146317416|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
146317417|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
146317418|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
146317419|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
146317420|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
146317421|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
146317422|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
146317423|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
146317424|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
146317425|NCT04418765|527675162|FG000|Extension Period (48 Weeks)|Other than specified|0|||
146317426|NCT04418765|527675163|FG001|Extension Period (48 Weeks)|Other than specified|5|||
146317427|NCT04418765|527675164|FG002|Extension Period (48 Weeks)|Other than specified|2|||
146317428|NCT01926782|527675165|FG000|Overall Study|Participant moved|2|||
146317429|NCT01926782|527675166|FG001|Overall Study|Participant moved|0|||
146317430|NCT01926782|527675167|FG002|Overall Study|Participant moved|1|||
146317431|NCT01926782|527675168|FG003|Overall Study|Participant moved|1|||
146317432|NCT01926782|527675169|FG004|Overall Study|Participant moved|0|||
146317433|NCT01926782|527675170|FG005|Overall Study|Participant moved|3|||
146317434|NCT01926782|527675165|FG000|Overall Study|Physician Decision|0|||
146317435|NCT01926782|527675166|FG001|Overall Study|Physician Decision|2|||
146317436|NCT01926782|527675167|FG002|Overall Study|Physician Decision|1|||
146317437|NCT01926782|527675168|FG003|Overall Study|Physician Decision|1|||
146317438|NCT01926782|527675169|FG004|Overall Study|Physician Decision|0|||
146317439|NCT01926782|527675170|FG005|Overall Study|Physician Decision|0|||
146317440|NCT01926782|527675165|FG000|Overall Study|Other than specified|2|||
146317441|NCT01926782|527675166|FG001|Overall Study|Other than specified|3|||
146317442|NCT01926782|527675167|FG002|Overall Study|Other than specified|5|||
146317443|NCT01926782|527675168|FG003|Overall Study|Other than specified|12|||
146317444|NCT01926782|527675169|FG004|Overall Study|Other than specified|4|||
146317445|NCT01926782|527675170|FG005|Overall Study|Other than specified|11|||
146317446|NCT01926782|527675165|FG000|Overall Study|Adverse Event|13|||
146317447|NCT01926782|527675166|FG001|Overall Study|Adverse Event|4|||
146317448|NCT01926782|527675167|FG002|Overall Study|Adverse Event|17|||
146317449|NCT01926782|527675168|FG003|Overall Study|Adverse Event|4|||
146317450|NCT01926782|527675169|FG004|Overall Study|Adverse Event|3|||
146317451|NCT01926782|527675170|FG005|Overall Study|Adverse Event|14|||
146317452|NCT01926782|527675165|FG000|Overall Study|Poor compliance to protocol|5|||
146317453|NCT01926782|527675166|FG001|Overall Study|Poor compliance to protocol|3|||
146317454|NCT01926782|527675167|FG002|Overall Study|Poor compliance to protocol|8|||
146317455|NCT01926782|527675168|FG003|Overall Study|Poor compliance to protocol|0|||
146317456|NCT01926782|527675169|FG004|Overall Study|Poor compliance to protocol|1|||
146317457|NCT01926782|527675170|FG005|Overall Study|Poor compliance to protocol|6|||
146317458|NCT01926782|527675165|FG000|Overall Study|Randomized and not treated|0|||
146317459|NCT01926782|527675166|FG001|Overall Study|Randomized and not treated|0|||
146317460|NCT01926782|527675167|FG002|Overall Study|Randomized and not treated|0|||
146317461|NCT01926782|527675168|FG003|Overall Study|Randomized and not treated|1|||
146317462|NCT01926782|527675169|FG004|Overall Study|Randomized and not treated|0|||
146317463|NCT01926782|527675170|FG005|Overall Study|Randomized and not treated|0|||
146317464|NCT01926782|527675165|FG000|Overall Study|Withdrawal by Subject|6|||
146317465|NCT01926782|527675166|FG001|Overall Study|Withdrawal by Subject|1|||
146317466|NCT01926782|527675167|FG002|Overall Study|Withdrawal by Subject|8|||
146317467|NCT01926782|527675168|FG003|Overall Study|Withdrawal by Subject|1|||
146317468|NCT01926782|527675169|FG004|Overall Study|Withdrawal by Subject|0|||
146317469|NCT01926782|527675170|FG005|Overall Study|Withdrawal by Subject|5|||
146317470|NCT01926782|527675165|FG000|Overall Study|Related to study drug administration|0|||
146317471|NCT01926782|527675166|FG001|Overall Study|Related to study drug administration|0|||
146317472|NCT01926782|527675167|FG002|Overall Study|Related to study drug administration|0|||
146317473|NCT01926782|527675168|FG003|Overall Study|Related to study drug administration|0|||
146317474|NCT01926782|527675169|FG004|Overall Study|Related to study drug administration|0|||
146317475|NCT01926782|527675170|FG005|Overall Study|Related to study drug administration|2|||
146317476|NCT01100944|527675171|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
146317477|NCT01100944|527675172|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
146317478|NCT01100944|527675173|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
146317479|NCT01100944|527675171|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
146317480|NCT01100944|527675172|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
146317481|NCT01100944|527675173|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
146317482|NCT01100944|527675171|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
146317483|NCT01100944|527675172|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
146317484|NCT01100944|527675173|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
146317485|NCT01100944|527675171|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
146317486|NCT01100944|527675172|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
146317487|NCT01100944|527675173|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
146317488|NCT00577993|527675174|FG000|Overall Study|Adverse Event|1|||
146317489|NCT00577993|527675175|FG001|Overall Study|Adverse Event|0|||
146317490|NCT00577993|527675176|FG002|Overall Study|Adverse Event|0|||
146317491|NCT00577993|527675174|FG000|Overall Study|Death|0|||
146317492|NCT00577993|527675175|FG001|Overall Study|Death|1|||
146317493|NCT00577993|527675176|FG002|Overall Study|Death|1|||
146317494|NCT00577993|527675174|FG000|Overall Study|Lack of Efficacy|0|||
146317495|NCT00577993|527675175|FG001|Overall Study|Lack of Efficacy|1|||
146317496|NCT00577993|527675176|FG002|Overall Study|Lack of Efficacy|0|||
146317497|NCT00577993|527675174|FG000|Overall Study|Protocol Violation|2|||
146317498|NCT00577993|527675175|FG001|Overall Study|Protocol Violation|3|||
146317499|NCT00577993|527675176|FG002|Overall Study|Protocol Violation|0|||
146317500|NCT00577993|527675174|FG000|Overall Study|Withdrawal by Subject|1|||
146317501|NCT00577993|527675175|FG001|Overall Study|Withdrawal by Subject|0|||
146317502|NCT00577993|527675176|FG002|Overall Study|Withdrawal by Subject|2|||
146317503|NCT00577993|527675174|FG000|Overall Study|Conversion|2|||
146317504|NCT00577993|527675175|FG001|Overall Study|Conversion|5|||
146317505|NCT00577993|527675176|FG002|Overall Study|Conversion|0|||
146317506|NCT00577993|527675174|FG000|Overall Study|Uninsured|1|||
146317507|NCT00577993|527675175|FG001|Overall Study|Uninsured|0|||
146317508|NCT00577993|527675176|FG002|Overall Study|Uninsured|0|||
146317509|NCT02296242|527675177|FG000|Overall Study|Death|1|||
146317510|NCT02296242|527675178|FG001|Overall Study|Death|1|||
146317511|NCT02296242|527675179|FG002|Overall Study|Death|1|||
146317512|NCT02296242|527675180|FG003|Overall Study|Death|1|||
146317513|NCT02296242|527675181|FG004|Overall Study|Death|1|||
146317514|NCT02296242|527675177|FG000|Overall Study|Withdrawal by Subject|0|||
146317515|NCT02296242|527675178|FG001|Overall Study|Withdrawal by Subject|0|||
146317516|NCT02296242|527675179|FG002|Overall Study|Withdrawal by Subject|1|||
146317517|NCT02296242|527675180|FG003|Overall Study|Withdrawal by Subject|1|||
146317518|NCT02296242|527675181|FG004|Overall Study|Withdrawal by Subject|3|||
146317519|NCT02296242|527675177|FG000|Overall Study|Disease Progression|1|||
146317520|NCT02296242|527675178|FG001|Overall Study|Disease Progression|3|||
146317521|NCT02296242|527675179|FG002|Overall Study|Disease Progression|2|||
146317522|NCT02296242|527675180|FG003|Overall Study|Disease Progression|8|||
146317523|NCT02296242|527675181|FG004|Overall Study|Disease Progression|11|||
146317524|NCT02296242|527675177|FG000|Overall Study|Unacceptable Toxicity|0|||
146317525|NCT02296242|527675178|FG001|Overall Study|Unacceptable Toxicity|0|||
146317526|NCT02296242|527675179|FG002|Overall Study|Unacceptable Toxicity|0|||
146317527|NCT02296242|527675180|FG003|Overall Study|Unacceptable Toxicity|0|||
146317528|NCT02296242|527675181|FG004|Overall Study|Unacceptable Toxicity|1|||
146317529|NCT02296242|527675177|FG000|Overall Study|Patient Condition Changed|0|||
146317530|NCT02296242|527675178|FG001|Overall Study|Patient Condition Changed|0|||
146317531|NCT02296242|527675179|FG002|Overall Study|Patient Condition Changed|2|||
146317532|NCT02296242|527675180|FG003|Overall Study|Patient Condition Changed|0|||
146164465|NCT04570436|527112584|FG007|Overall Study|Physician Decision|0|||
146164466|NCT04570436|527112585|FG008|Overall Study|Physician Decision|0|||
146164467|NCT04570436|527112586|FG009|Overall Study|Physician Decision|0|||
146317533|NCT02296242|527675181|FG004|Overall Study|Patient Condition Changed|1|||
146317534|NCT02296242|527675177|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
146317535|NCT02296242|527675178|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
146164468|NCT03002610|527112587|FG000|Overall Study|Withdrawal by Subject|6|||
146164469|NCT03002610|527112588|FG001|Overall Study|Withdrawal by Subject|25|||
146164470|NCT03002610|527112589|FG002|Overall Study|Withdrawal by Subject|13|||
146164471|NCT03802123|527112590|FG000|Overall Study|Withdrawal by Subject|3|||
146317536|NCT02296242|527675179|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
146317537|NCT02296242|527675180|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
146317538|NCT02296242|527675181|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
146317539|NCT02296242|527675177|FG000|Overall Study|Lost to Follow-up|1|||
146317540|NCT02296242|527675178|FG001|Overall Study|Lost to Follow-up|0|||
146317541|NCT02296242|527675179|FG002|Overall Study|Lost to Follow-up|0|||
146317542|NCT02296242|527675180|FG003|Overall Study|Lost to Follow-up|0|||
146317543|NCT02296242|527675181|FG004|Overall Study|Lost to Follow-up|0|||
146317544|NCT02296242|527675177|FG000|Overall Study|Need for Hydroxyurea|2|||
146317545|NCT02296242|527675178|FG001|Overall Study|Need for Hydroxyurea|0|||
146317546|NCT02296242|527675179|FG002|Overall Study|Need for Hydroxyurea|0|||
146317547|NCT02296242|527675180|FG003|Overall Study|Need for Hydroxyurea|0|||
146317548|NCT02296242|527675181|FG004|Overall Study|Need for Hydroxyurea|0|||
146317549|NCT02296242|527675177|FG000|Overall Study|Screened for Other Protocol|0|||
146317550|NCT02296242|527675178|FG001|Overall Study|Screened for Other Protocol|1|||
146317551|NCT02296242|527675179|FG002|Overall Study|Screened for Other Protocol|0|||
146317552|NCT02296242|527675180|FG003|Overall Study|Screened for Other Protocol|0|||
146317553|NCT02296242|527675181|FG004|Overall Study|Screened for Other Protocol|0|||
146317554|NCT02296242|527675177|FG000|Overall Study|Physician Decision|0|||
146317555|NCT02296242|527675178|FG001|Overall Study|Physician Decision|1|||
146317556|NCT02296242|527675179|FG002|Overall Study|Physician Decision|0|||
146317557|NCT02296242|527675180|FG003|Overall Study|Physician Decision|1|||
146317558|NCT02296242|527675181|FG004|Overall Study|Physician Decision|0|||
146317559|NCT02296242|527675177|FG000|Overall Study|Alternative Treatment|0|||
146317560|NCT02296242|527675178|FG001|Overall Study|Alternative Treatment|0|||
146317561|NCT02296242|527675179|FG002|Overall Study|Alternative Treatment|0|||
146317562|NCT02296242|527675180|FG003|Overall Study|Alternative Treatment|1|||
146317563|NCT02296242|527675181|FG004|Overall Study|Alternative Treatment|0|||
146317564|NCT02296242|527675177|FG000|Overall Study|Adverse Event|0|||
146317565|NCT02296242|527675178|FG001|Overall Study|Adverse Event|0|||
146317566|NCT02296242|527675179|FG002|Overall Study|Adverse Event|0|||
146317567|NCT02296242|527675180|FG003|Overall Study|Adverse Event|1|||
146317568|NCT02296242|527675181|FG004|Overall Study|Adverse Event|0|||
146317569|NCT02296242|527675177|FG000|Overall Study|Lack of Efficacy|0|||
146317570|NCT02296242|527675178|FG001|Overall Study|Lack of Efficacy|0|||
146317571|NCT02296242|527675179|FG002|Overall Study|Lack of Efficacy|0|||
146317572|NCT02296242|527675180|FG003|Overall Study|Lack of Efficacy|0|||
146317573|NCT02296242|527675181|FG004|Overall Study|Lack of Efficacy|3|||
146317574|NCT02217566|527675182|FG000|Overall Study|Lost to Follow-up|2|||
146317575|NCT02217566|527675182|FG000|Overall Study|Death|3|||
146317576|NCT02217566|527675182|FG000|Overall Study|Early study termination|6|||
146317577|NCT01639833|527675183|FG000|Overall Study|Death|4|||
146317578|NCT01639833|527675184|FG001|Overall Study|Death|2|||
146317579|NCT01639833|527675183|FG000|Overall Study|Withdrawal by Subject|2|||
146317580|NCT01639833|527675184|FG001|Overall Study|Withdrawal by Subject|2|||
146317581|NCT00070941|527675186|FG000|Overall Study|Adverse Event|10|||
146317582|NCT00070941|527675187|FG001|Overall Study|Adverse Event|8|||
146317583|NCT00070941|527675188|FG002|Overall Study|Adverse Event|4|||
146317584|NCT02064387|527675189|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317585|NCT02064387|527675190|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317586|NCT02064387|527675191|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317587|NCT02064387|527675192|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317588|NCT02064387|527675193|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317589|NCT02064387|527675194|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317590|NCT02064387|527675195|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317591|NCT02064387|527675196|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
146317592|NCT02064387|527675197|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317593|NCT02064387|527675198|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
146317594|NCT02064387|527675199|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317595|NCT02064387|527675200|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
146317596|NCT02064387|527675189|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317597|NCT02064387|527675190|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317598|NCT02064387|527675191|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317599|NCT02064387|527675192|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317600|NCT02064387|527675193|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317601|NCT02064387|527675194|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317602|NCT02064387|527675195|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317603|NCT02064387|527675196|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
146317604|NCT02064387|527675197|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317605|NCT02064387|527675198|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317606|NCT02064387|527675199|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317607|NCT02064387|527675200|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
146317608|NCT02064387|527675189|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317609|NCT02064387|527675190|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317610|NCT02064387|527675191|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317611|NCT02064387|527675192|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317612|NCT02064387|527675193|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145943218|NCT00483704|526300456|FG000|Treatment|Lack of qualifying migraines|101|||
145943219|NCT00483704|526300457|FG001|Treatment|Lack of qualifying migraines|99|||
146317613|NCT02064387|527675194|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317614|NCT02064387|527675195|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317615|NCT02064387|527675196|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317616|NCT02064387|527675197|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
146317617|NCT02064387|527675198|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317618|NCT02064387|527675199|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317619|NCT02064387|527675200|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
146317620|NCT02064387|527675189|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
146317621|NCT02064387|527675190|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
146317622|NCT02064387|527675191|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
146317623|NCT02064387|527675192|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
146317624|NCT02064387|527675193|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
146317625|NCT02064387|527675194|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
146317626|NCT02064387|527675195|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
146317627|NCT02064387|527675196|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
146317628|NCT02064387|527675197|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
146317629|NCT02064387|527675198|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
146317630|NCT02064387|527675199|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
146317631|NCT02064387|527675200|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
146317632|NCT02064387|527675189|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317633|NCT02064387|527675190|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317634|NCT02064387|527675191|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317635|NCT02064387|527675192|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317636|NCT02064387|527675193|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317637|NCT02064387|527675194|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317638|NCT02064387|527675195|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317639|NCT02064387|527675196|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317640|NCT02064387|527675197|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317641|NCT02064387|527675198|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317642|NCT02064387|527675199|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
146317643|NCT02064387|527675200|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
146317644|NCT02499029|527675201|FG000|Overall Study|Lost to Follow-up|2|||
146317645|NCT02499029|527675202|FG001|Overall Study|Lost to Follow-up|2|||
146317646|NCT02499029|527675201|FG000|Overall Study|Physician Decision|2|||
146317647|NCT02499029|527675202|FG001|Overall Study|Physician Decision|1|||
146317648|NCT02499029|527675201|FG000|Overall Study|Death|1|||
146317649|NCT02499029|527675202|FG001|Overall Study|Death|0|||
146317650|NCT01707693|527675203|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
146317651|NCT01707693|527675204|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
146317652|NCT01707693|527675203|FG000|Overall Study Allocation|Protocol Violation|4|||
146317653|NCT01707693|527675204|FG001|Overall Study Allocation|Protocol Violation|3|||
146317654|NCT01707693|527675203|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
146317655|NCT01707693|527675204|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
146317656|NCT01707693|527675203|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
146317657|NCT01707693|527675204|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
146317658|NCT03115151|527675205|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
146317659|NCT03115151|527675206|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
146317660|NCT03115151|527675205|FG000|Overall Study|Epidural catheter removal|1|||
146317661|NCT03115151|527675206|FG001|Overall Study|Epidural catheter removal|0|||
146317662|NCT03115151|527675205|FG000|Overall Study|Withdrawal by Subject|0|||
146317663|NCT03115151|527675206|FG001|Overall Study|Withdrawal by Subject|1|||
146164472|NCT03802123|527112590|FG000|Overall Study|Physician Decision|1|||
146164473|NCT03802123|527112590|FG000|Overall Study|Subject moved to hospice care|1|||
146164474|NCT03802123|527112590|FG000|Overall Study|technician error|1|||
146164475|NCT03802123|527112590|FG000|Overall Study|Death|3|||
146164476|NCT01274182|527112591|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
146317664|NCT03115151|527675205|FG000|Overall Study|Intervention not received according to the protocol.|1|||
146317665|NCT03115151|527675206|FG001|Overall Study|Intervention not received according to the protocol.|1|||
146317666|NCT03115151|527675205|FG000|Overall Study|Physician Decision|1|||
146317667|NCT03115151|527675206|FG001|Overall Study|Physician Decision|0|||
146317668|NCT03115151|527675205|FG000|Overall Study|Randomization not applied|1|||
146317669|NCT03115151|527675206|FG001|Overall Study|Randomization not applied|1|||
146317670|NCT00044512|527675207|FG000|Follow Up|Lost to Follow-up|2|||
146317671|NCT00343889|527675215|FG000|Overall Study|Lost to Follow-up|2|||
146317672|NCT00343889|527675216|FG001|Overall Study|Lost to Follow-up|0|||
146317673|NCT00343889|527675215|FG000|Overall Study|Withdrawal by Subject|0|||
146164477|NCT01274182|527112592|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146164478|NCT01274182|527112593|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
146164479|NCT01274182|527112591|FG000|Overall Study|Adverse Event|4|||
146317674|NCT00343889|527675216|FG001|Overall Study|Withdrawal by Subject|1|||
146317675|NCT00343889|527675215|FG000|Overall Study|Protocol Violation|1|||
146317676|NCT00343889|527675216|FG001|Overall Study|Protocol Violation|0|||
146317677|NCT04472429|527675219|FG000|Randomized Period|Ongoing|90|||
146317678|NCT04472429|527675220|FG001|Randomized Period|Ongoing|40|||
146317679|NCT04472429|527675221|FG002|Randomized Period|Ongoing|0|||
146317680|NCT04472429|527675219|FG000|Randomized Period|Death|52|||
146317681|NCT04472429|527675220|FG001|Randomized Period|Death|37|||
146317682|NCT04472429|527675221|FG002|Randomized Period|Death|0|||
146317683|NCT04472429|527675219|FG000|Randomized Period|Lost to Follow-up|4|||
146317684|NCT04472429|527675220|FG001|Randomized Period|Lost to Follow-up|0|||
146317685|NCT04472429|527675221|FG002|Randomized Period|Lost to Follow-up|0|||
146317686|NCT04472429|527675219|FG000|Randomized Period|Physician Decision|1|||
146317687|NCT04472429|527675220|FG001|Randomized Period|Physician Decision|2|||
146317688|NCT04472429|527675221|FG002|Randomized Period|Physician Decision|0|||
146317689|NCT04472429|527675219|FG000|Randomized Period|Withdrawal by Subject|6|||
146317690|NCT04472429|527675220|FG001|Randomized Period|Withdrawal by Subject|5|||
146317691|NCT04472429|527675221|FG002|Randomized Period|Withdrawal by Subject|0|||
146317692|NCT04472429|527675219|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
146317693|NCT04472429|527675220|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
146317694|NCT04472429|527675221|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
146317695|NCT04472429|527675219|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
146317696|NCT04472429|527675220|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
146317697|NCT04472429|527675221|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
146317698|NCT04472429|527675219|FG000|Open-label Monotherapy Period|Ongoing|0|||
146317699|NCT04472429|527675220|FG001|Open-label Monotherapy Period|Ongoing|0|||
146317700|NCT04472429|527675221|FG002|Open-label Monotherapy Period|Ongoing|32|||
146317701|NCT04472429|527675219|FG000|Open-label Monotherapy Period|Death|0|||
146317702|NCT04472429|527675220|FG001|Open-label Monotherapy Period|Death|0|||
146317703|NCT04472429|527675221|FG002|Open-label Monotherapy Period|Death|35|||
146317704|NCT04472429|527675219|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
146317705|NCT04472429|527675220|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
146317706|NCT04472429|527675221|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
146317707|NCT05130463|527675222|FG000|Overall Study|Unspecified reasons|2|||
146164480|NCT01274182|527112592|FG001|Overall Study|Adverse Event|5|||
146164481|NCT01274182|527112593|FG002|Overall Study|Adverse Event|3|||
146164482|NCT01274182|527112591|FG000|Overall Study|Withdrawal by Subject|5|||
146164483|NCT01274182|527112592|FG001|Overall Study|Withdrawal by Subject|5|||
146164484|NCT01274182|527112593|FG002|Overall Study|Withdrawal by Subject|3|||
146164485|NCT01274182|527112591|FG000|Overall Study|Lost to Follow-up|2|||
146164486|NCT01274182|527112592|FG001|Overall Study|Lost to Follow-up|3|||
146164487|NCT01274182|527112593|FG002|Overall Study|Lost to Follow-up|1|||
146164488|NCT01274182|527112591|FG000|Overall Study|Protocol Violation|3|||
146317708|NCT05130463|527675222|FG000|Overall Study|off-label indication dose|435|||
146317709|NCT02751502|527675223|FG000|Overall Study|Lack of funding|4|||
146317710|NCT02573155|527675224|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
146317711|NCT02573155|527675225|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
146317712|NCT02573155|527675224|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
146317713|NCT02573155|527675225|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
146317714|NCT02573155|527675224|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
146317715|NCT02573155|527675225|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
146317716|NCT02573155|527675224|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
146317717|NCT02573155|527675225|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
146317718|NCT02573155|527675224|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
146317719|NCT02573155|527675225|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
146164489|NCT01274182|527112592|FG001|Overall Study|Protocol Violation|2|||
146164490|NCT01274182|527112593|FG002|Overall Study|Protocol Violation|0|||
146164491|NCT01274182|527112591|FG000|Overall Study|Death|1|||
146317720|NCT02573155|527675224|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
146317721|NCT02573155|527675225|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
146317722|NCT02573155|527675224|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
146317723|NCT02573155|527675225|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
146317724|NCT02573155|527675224|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
146317725|NCT02573155|527675225|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
146317726|NCT00371865|527675226|FG000|Overall Study|Lack of Efficacy|0|||
146317727|NCT00371865|527675227|FG001|Overall Study|Lack of Efficacy|2|||
146317728|NCT00371865|527675226|FG000|Overall Study|Protocol Violation|3|||
146164492|NCT01274182|527112592|FG001|Overall Study|Death|0|||
146164493|NCT01274182|527112593|FG002|Overall Study|Death|1|||
146164494|NCT01822587|527112594|FG000|Overall Study|Lost to Follow-up|7|||
146164495|NCT01822587|527112595|FG001|Overall Study|Lost to Follow-up|9|||
146164496|NCT01822587|527112596|FG002|Overall Study|Lost to Follow-up|12|||
146164497|NCT01822587|527112594|FG000|Overall Study|Physician Decision|9|||
146164498|NCT01822587|527112595|FG001|Overall Study|Physician Decision|6|||
146164499|NCT01822587|527112596|FG002|Overall Study|Physician Decision|6|||
146164500|NCT00658567|527112597|FG000|Overall Study|Adverse Event|5|||
146164501|NCT00658567|527112598|FG001|Overall Study|Adverse Event|2|||
146164502|NCT00658567|527112599|FG002|Overall Study|Adverse Event|3|||
146164503|NCT00658567|527112597|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
146164504|NCT00658567|527112598|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
146317729|NCT00371865|527675227|FG001|Overall Study|Protocol Violation|2|||
146317730|NCT00371865|527675226|FG000|Overall Study|Withdrawal by Subject|12|||
146317731|NCT00371865|527675227|FG001|Overall Study|Withdrawal by Subject|10|||
146317732|NCT05073458|527675231|FG000|24-week Double-blind Period|Adverse Event|1|||
146317733|NCT05073458|527675232|FG001|24-week Double-blind Period|Adverse Event|0|||
146317734|NCT05073458|527675231|FG000|24-week Double-blind Period|Physician Decision|1|||
146317735|NCT05073458|527675232|FG001|24-week Double-blind Period|Physician Decision|0|||
146317736|NCT05073458|527675231|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
146317737|NCT05073458|527675232|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
146317738|NCT05073458|527675231|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
146317739|NCT05073458|527675232|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
146317740|NCT05073458|527675231|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
146317741|NCT05073458|527675232|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
146317742|NCT05073458|527675231|FG000|24-week Open-label Period|Adverse Event|1|||
146317743|NCT05073458|527675232|FG001|24-week Open-label Period|Adverse Event|2|||
146317744|NCT01632566|527675233|FG000|Overall Study|Withdrawal by Subject|0|||
146317745|NCT01632566|527675234|FG001|Overall Study|Withdrawal by Subject|1|||
146317746|NCT01632566|527675235|FG002|Overall Study|Withdrawal by Subject|0|||
146317747|NCT01632566|527675236|FG003|Overall Study|Withdrawal by Subject|0|||
146317748|NCT01632566|527675237|FG004|Overall Study|Withdrawal by Subject|0|||
146317749|NCT01632566|527675233|FG000|Overall Study|Sponsor Decision|0|||
146317750|NCT01632566|527675234|FG001|Overall Study|Sponsor Decision|2|||
146317751|NCT01632566|527675235|FG002|Overall Study|Sponsor Decision|9|||
146317752|NCT01632566|527675236|FG003|Overall Study|Sponsor Decision|2|||
146317753|NCT01632566|527675237|FG004|Overall Study|Sponsor Decision|2|||
146317754|NCT05913232|527675239|FG000|Overall Study|Adverse Event|0|||
146317755|NCT05913232|527675240|FG001|Overall Study|Adverse Event|2|||
146317756|NCT05913232|527675241|FG002|Overall Study|Adverse Event|1|||
146317757|NCT05913232|527675242|FG003|Overall Study|Adverse Event|1|||
146317758|NCT01318109|527675243|FG000|Overall Study|Adverse Event|0|||
146317759|NCT01318109|527675244|FG001|Overall Study|Adverse Event|2|||
146317760|NCT01318109|527675245|FG002|Overall Study|Adverse Event|0|||
146317761|NCT01318109|527675243|FG000|Overall Study|Withdrawal by Subject|1|||
146317762|NCT01318109|527675244|FG001|Overall Study|Withdrawal by Subject|0|||
146317763|NCT01318109|527675245|FG002|Overall Study|Withdrawal by Subject|0|||
146317764|NCT01318109|527675243|FG000|Overall Study|Schedule Conflict|0|||
146317765|NCT01318109|527675244|FG001|Overall Study|Schedule Conflict|1|||
146317766|NCT01318109|527675245|FG002|Overall Study|Schedule Conflict|0|||
146317767|NCT01328951|527675246|FG000|Overall Study|Disease Progression|17|||
146317768|NCT01328951|527675247|FG001|Overall Study|Disease Progression|14|||
146317769|NCT01328951|527675246|FG000|Overall Study|Adverse Event|2|||
146317770|NCT01328951|527675247|FG001|Overall Study|Adverse Event|0|||
146317771|NCT01328951|527675246|FG000|Overall Study|Death|243|||
146317772|NCT01328951|527675247|FG001|Overall Study|Death|258|||
146317773|NCT01328951|527675246|FG000|Overall Study|Lost to Follow-up|6|||
146317774|NCT01328951|527675247|FG001|Overall Study|Lost to Follow-up|7|||
146317775|NCT01328951|527675246|FG000|Overall Study|Withdrawal by Subject|6|||
146317776|NCT01328951|527675247|FG001|Overall Study|Withdrawal by Subject|6|||
146317777|NCT01328951|527675246|FG000|Overall Study|Study Closed by the Sponsor|36|||
146317778|NCT01328951|527675247|FG001|Overall Study|Study Closed by the Sponsor|31|||
146317779|NCT01328951|527675246|FG000|Overall Study|Other|11|||
146317780|NCT01328951|527675247|FG001|Overall Study|Other|6|||
146317781|NCT01627899|527675255|FG000|Overall Study|Study terminated early by sponsor.|5|||
146164505|NCT00658567|527112599|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
146164506|NCT00658567|527112597|FG000|Overall Study|Physician Decision|0|||
146317782|NCT05103332|527675256|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317783|NCT05103332|527675257|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
146317784|NCT05103332|527675258|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
146317785|NCT05103332|527675259|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317786|NCT05103332|527675260|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317787|NCT05103332|527675261|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
146317788|NCT05103332|527675262|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317789|NCT05103332|527675263|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317790|NCT05103332|527675264|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317791|NCT05103332|527675265|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317792|NCT05103332|527675266|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317793|NCT05103332|527675267|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317794|NCT05103332|527675268|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146164507|NCT00658567|527112598|FG001|Overall Study|Physician Decision|1|||
146164508|NCT00658567|527112599|FG002|Overall Study|Physician Decision|0|||
146164509|NCT00658567|527112597|FG000|Overall Study|At Discretion of Sponsor|1|||
146317795|NCT05103332|527675269|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317796|NCT05103332|527675270|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317797|NCT05103332|527675271|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317798|NCT05103332|527675272|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317799|NCT05103332|527675273|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317800|NCT05103332|527675256|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317801|NCT05103332|527675257|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
146317802|NCT05103332|527675258|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317803|NCT05103332|527675259|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
146317804|NCT05103332|527675260|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317805|NCT05103332|527675261|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317806|NCT05103332|527675262|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317807|NCT05103332|527675263|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317808|NCT05103332|527675264|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317809|NCT05103332|527675265|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317810|NCT05103332|527675266|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317811|NCT05103332|527675267|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317812|NCT05103332|527675268|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317813|NCT05103332|527675269|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317814|NCT05103332|527675270|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317815|NCT05103332|527675271|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317816|NCT05103332|527675272|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317817|NCT05103332|527675273|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
146317818|NCT05103332|527675256|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
146317819|NCT05103332|527675257|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146317820|NCT05103332|527675258|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
146317821|NCT05103332|527675259|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146317822|NCT05103332|527675260|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146317823|NCT05103332|527675261|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
146317824|NCT05103332|527675262|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317825|NCT05103332|527675263|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317826|NCT05103332|527675264|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317827|NCT05103332|527675265|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317828|NCT05103332|527675266|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317829|NCT05103332|527675267|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317830|NCT05103332|527675268|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317831|NCT05103332|527675269|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317832|NCT05103332|527675270|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317833|NCT05103332|527675271|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317834|NCT05103332|527675272|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317835|NCT05103332|527675273|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317836|NCT05103332|527675256|FG000|DB Period (6 Months=168 Days)|Other|0|||
146317837|NCT05103332|527675257|FG001|DB Period (6 Months=168 Days)|Other|0|||
146317838|NCT05103332|527675258|FG002|DB Period (6 Months=168 Days)|Other|0|||
146317839|NCT05103332|527675259|FG003|DB Period (6 Months=168 Days)|Other|1|||
146317840|NCT05103332|527675260|FG004|DB Period (6 Months=168 Days)|Other|0|||
146317841|NCT05103332|527675261|FG005|DB Period (6 Months=168 Days)|Other|0|||
146317842|NCT05103332|527675262|FG006|DB Period (6 Months=168 Days)|Other|0|||
146317843|NCT05103332|527675263|FG007|DB Period (6 Months=168 Days)|Other|0|||
146317844|NCT05103332|527675264|FG008|DB Period (6 Months=168 Days)|Other|0|||
146317845|NCT05103332|527675265|FG009|DB Period (6 Months=168 Days)|Other|0|||
146317846|NCT05103332|527675266|FG010|DB Period (6 Months=168 Days)|Other|0|||
146317847|NCT05103332|527675267|FG011|DB Period (6 Months=168 Days)|Other|0|||
146317848|NCT05103332|527675268|FG012|DB Period (6 Months=168 Days)|Other|0|||
146317849|NCT05103332|527675269|FG013|DB Period (6 Months=168 Days)|Other|0|||
146317850|NCT05103332|527675270|FG014|DB Period (6 Months=168 Days)|Other|0|||
146317851|NCT05103332|527675271|FG015|DB Period (6 Months=168 Days)|Other|0|||
146317852|NCT05103332|527675272|FG016|DB Period (6 Months=168 Days)|Other|0|||
146317853|NCT05103332|527675273|FG017|DB Period (6 Months=168 Days)|Other|0|||
146164510|NCT00658567|527112598|FG001|Overall Study|At Discretion of Sponsor|1|||
146317854|NCT05103332|527675256|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317855|NCT05103332|527675257|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317856|NCT05103332|527675258|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317857|NCT05103332|527675259|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317858|NCT05103332|527675260|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317859|NCT05103332|527675261|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317860|NCT05103332|527675262|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317861|NCT05103332|527675263|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317862|NCT05103332|527675264|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317863|NCT05103332|527675265|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317864|NCT05103332|527675266|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
146317865|NCT05103332|527675267|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317866|NCT05103332|527675268|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317867|NCT05103332|527675269|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317868|NCT05103332|527675270|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317869|NCT05103332|527675271|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317870|NCT05103332|527675272|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317871|NCT05103332|527675273|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
146317872|NCT05103332|527675256|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317873|NCT05103332|527675257|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317874|NCT05103332|527675258|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317875|NCT05103332|527675259|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317876|NCT05103332|527675260|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317877|NCT05103332|527675261|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317878|NCT05103332|527675262|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317879|NCT05103332|527675263|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317880|NCT05103332|527675264|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
146317881|NCT05103332|527675265|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317882|NCT05103332|527675266|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317883|NCT05103332|527675267|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317884|NCT05103332|527675268|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317885|NCT05103332|527675269|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317886|NCT05103332|527675270|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317887|NCT05103332|527675271|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317888|NCT05103332|527675272|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317889|NCT05103332|527675273|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
146317890|NCT05103332|527675256|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317891|NCT05103332|527675257|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317892|NCT05103332|527675258|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317893|NCT05103332|527675259|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317894|NCT05103332|527675260|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317895|NCT05103332|527675261|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317896|NCT05103332|527675262|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317897|NCT05103332|527675263|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317898|NCT05103332|527675264|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317899|NCT05103332|527675265|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317900|NCT05103332|527675266|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317901|NCT05103332|527675267|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
146317902|NCT05103332|527675268|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317903|NCT05103332|527675269|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317904|NCT05103332|527675270|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317905|NCT05103332|527675271|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317906|NCT05103332|527675272|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317907|NCT05103332|527675273|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
146317908|NCT05103332|527675256|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317909|NCT05103332|527675257|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317910|NCT05103332|527675258|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317911|NCT05103332|527675259|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317912|NCT05103332|527675260|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317913|NCT05103332|527675261|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317914|NCT05103332|527675262|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
146317915|NCT05103332|527675263|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
146317916|NCT05103332|527675264|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317917|NCT05103332|527675265|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
146317918|NCT05103332|527675266|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
146317919|NCT05103332|527675267|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
146317920|NCT05103332|527675268|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317921|NCT05103332|527675269|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317922|NCT05103332|527675270|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317923|NCT05103332|527675271|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317924|NCT05103332|527675272|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317925|NCT05103332|527675273|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
146317926|NCT05103332|527675256|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317927|NCT05103332|527675257|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317928|NCT05103332|527675258|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317929|NCT05103332|527675259|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317930|NCT05103332|527675260|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317931|NCT05103332|527675261|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317932|NCT05103332|527675262|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317933|NCT05103332|527675263|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317934|NCT05103332|527675264|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317935|NCT05103332|527675265|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317936|NCT05103332|527675266|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317937|NCT05103332|527675267|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
146317938|NCT05103332|527675268|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
146317939|NCT05103332|527675269|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
146317940|NCT05103332|527675270|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
146317941|NCT05103332|527675271|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
146317942|NCT05103332|527675272|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
146317943|NCT05103332|527675273|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
146317944|NCT05103332|527675256|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317945|NCT05103332|527675257|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317946|NCT05103332|527675258|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317947|NCT05103332|527675259|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317948|NCT05103332|527675260|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317949|NCT05103332|527675261|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317950|NCT05103332|527675262|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317951|NCT05103332|527675263|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317952|NCT05103332|527675264|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317953|NCT05103332|527675265|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317954|NCT05103332|527675266|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317955|NCT05103332|527675267|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317956|NCT05103332|527675268|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317957|NCT05103332|527675269|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317958|NCT05103332|527675270|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317959|NCT05103332|527675271|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317960|NCT05103332|527675272|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
146317961|NCT05103332|527675273|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
146317962|NCT05103332|527675256|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317963|NCT05103332|527675257|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317964|NCT05103332|527675258|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317965|NCT05103332|527675259|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317966|NCT05103332|527675260|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317967|NCT05103332|527675261|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317968|NCT05103332|527675262|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317969|NCT05103332|527675263|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317970|NCT05103332|527675264|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317971|NCT05103332|527675265|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317972|NCT05103332|527675266|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317973|NCT05103332|527675267|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
146317974|NCT05103332|527675268|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
146317975|NCT05103332|527675269|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
146317976|NCT05103332|527675270|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
146317977|NCT05103332|527675271|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
146317978|NCT05103332|527675272|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
146317979|NCT05103332|527675273|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
146317980|NCT05103332|527675256|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317981|NCT05103332|527675257|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317982|NCT05103332|527675258|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317983|NCT05103332|527675259|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317984|NCT05103332|527675260|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317985|NCT05103332|527675261|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317986|NCT05103332|527675262|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317987|NCT05103332|527675263|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317988|NCT05103332|527675264|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317989|NCT05103332|527675265|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317990|NCT05103332|527675266|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317991|NCT05103332|527675267|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317992|NCT05103332|527675268|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317993|NCT05103332|527675269|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317994|NCT05103332|527675270|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
146317995|NCT05103332|527675271|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
146317996|NCT05103332|527675272|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
146317997|NCT05103332|527675273|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
146317998|NCT05103332|527675256|FG000|SFU Period (6 Months=168 Days)|Death|0|||
146317999|NCT05103332|527675257|FG001|SFU Period (6 Months=168 Days)|Death|0|||
146318000|NCT05103332|527675258|FG002|SFU Period (6 Months=168 Days)|Death|0|||
146318001|NCT05103332|527675259|FG003|SFU Period (6 Months=168 Days)|Death|0|||
146318002|NCT05103332|527675260|FG004|SFU Period (6 Months=168 Days)|Death|0|||
146318003|NCT05103332|527675261|FG005|SFU Period (6 Months=168 Days)|Death|0|||
146318004|NCT05103332|527675262|FG006|SFU Period (6 Months=168 Days)|Death|0|||
146318005|NCT05103332|527675263|FG007|SFU Period (6 Months=168 Days)|Death|0|||
146318006|NCT05103332|527675264|FG008|SFU Period (6 Months=168 Days)|Death|0|||
146318007|NCT05103332|527675265|FG009|SFU Period (6 Months=168 Days)|Death|0|||
146318008|NCT05103332|527675266|FG010|SFU Period (6 Months=168 Days)|Death|0|||
146318009|NCT05103332|527675267|FG011|SFU Period (6 Months=168 Days)|Death|0|||
146318010|NCT05103332|527675268|FG012|SFU Period (6 Months=168 Days)|Death|0|||
146318011|NCT05103332|527675269|FG013|SFU Period (6 Months=168 Days)|Death|0|||
146318012|NCT05103332|527675270|FG014|SFU Period (6 Months=168 Days)|Death|1|||
146318013|NCT05103332|527675271|FG015|SFU Period (6 Months=168 Days)|Death|0|||
146318014|NCT05103332|527675272|FG016|SFU Period (6 Months=168 Days)|Death|0|||
146318015|NCT05103332|527675273|FG017|SFU Period (6 Months=168 Days)|Death|1|||
146318016|NCT04428476|527675274|FG000|Overall Study|Withdrawal by Subject|1|||
146318017|NCT04428476|527675274|FG000|Overall Study|Still on treatment|12|||
146318018|NCT04982250|527675276|FG000|Overall Study|Lost to Follow-up|0|||
146318019|NCT04982250|527675277|FG001|Overall Study|Lost to Follow-up|26|||
146318020|NCT04982250|527675278|FG002|Overall Study|Lost to Follow-up|0|||
146318021|NCT04982250|527675279|FG003|Overall Study|Lost to Follow-up|0|||
146318022|NCT04982250|527675280|FG004|Overall Study|Lost to Follow-up|72|||
146318023|NCT04982250|527675281|FG005|Overall Study|Lost to Follow-up|69|||
146318024|NCT04982250|527675276|FG000|Overall Study|Not Eligible to Enroll|0|||
146318025|NCT04982250|527675277|FG001|Overall Study|Not Eligible to Enroll|0|||
146318026|NCT04982250|527675278|FG002|Overall Study|Not Eligible to Enroll|0|||
146318027|NCT04982250|527675279|FG003|Overall Study|Not Eligible to Enroll|0|||
146318028|NCT04982250|527675280|FG004|Overall Study|Not Eligible to Enroll|10|||
146318029|NCT04982250|527675281|FG005|Overall Study|Not Eligible to Enroll|7|||
146318030|NCT01358864|527675291|FG000|Overall Study|Adverse Event|0|||
146318031|NCT01358864|527675292|FG001|Overall Study|Adverse Event|6|||
146318032|NCT01358864|527675293|FG002|Overall Study|Adverse Event|9|||
146318033|NCT01358864|527675294|FG003|Overall Study|Adverse Event|0|||
146318034|NCT01358864|527675295|FG004|Overall Study|Adverse Event|4|||
146318035|NCT01358864|527675296|FG005|Overall Study|Adverse Event|8|||
146318036|NCT01358864|527675297|FG006|Overall Study|Adverse Event|12|||
146318037|NCT01358864|527675298|FG007|Overall Study|Adverse Event|7|||
146318038|NCT01358864|527675291|FG000|Overall Study|Lack of Efficacy|26|||
146318039|NCT01358864|527675292|FG001|Overall Study|Lack of Efficacy|3|||
146318040|NCT01358864|527675293|FG002|Overall Study|Lack of Efficacy|4|||
146318041|NCT01358864|527675294|FG003|Overall Study|Lack of Efficacy|19|||
146318042|NCT01358864|527675295|FG004|Overall Study|Lack of Efficacy|7|||
146318043|NCT01358864|527675296|FG005|Overall Study|Lack of Efficacy|4|||
146318044|NCT01358864|527675297|FG006|Overall Study|Lack of Efficacy|49|||
146318045|NCT01358864|527675298|FG007|Overall Study|Lack of Efficacy|44|||
146318046|NCT01358864|527675291|FG000|Overall Study|Lost to Follow-up|0|||
146318047|NCT01358864|527675292|FG001|Overall Study|Lost to Follow-up|0|||
146318048|NCT01358864|527675293|FG002|Overall Study|Lost to Follow-up|1|||
146318049|NCT01358864|527675294|FG003|Overall Study|Lost to Follow-up|0|||
146318050|NCT01358864|527675295|FG004|Overall Study|Lost to Follow-up|0|||
146318051|NCT01358864|527675296|FG005|Overall Study|Lost to Follow-up|0|||
146318052|NCT01358864|527675297|FG006|Overall Study|Lost to Follow-up|0|||
146318053|NCT01358864|527675298|FG007|Overall Study|Lost to Follow-up|1|||
146318054|NCT01358864|527675291|FG000|Overall Study|Withdrawal by Subject|3|||
146164511|NCT00658567|527112599|FG002|Overall Study|At Discretion of Sponsor|1|||
146164512|NCT00691938|527112600|FG000|Overall Study|QTc prolongation|1|||
146164513|NCT00691938|527112601|FG001|Overall Study|QTc prolongation|0|||
146318055|NCT01358864|527675292|FG001|Overall Study|Withdrawal by Subject|4|||
146318056|NCT01358864|527675293|FG002|Overall Study|Withdrawal by Subject|2|||
146318057|NCT01358864|527675294|FG003|Overall Study|Withdrawal by Subject|0|||
146318058|NCT01358864|527675295|FG004|Overall Study|Withdrawal by Subject|0|||
146318059|NCT01358864|527675296|FG005|Overall Study|Withdrawal by Subject|1|||
146318060|NCT01358864|527675297|FG006|Overall Study|Withdrawal by Subject|1|||
146164514|NCT00691938|527112602|FG002|Overall Study|QTc prolongation|0|||
146318061|NCT01358864|527675298|FG007|Overall Study|Withdrawal by Subject|3|||
146318062|NCT01358864|527675291|FG000|Overall Study|Other reason not defined above|2|||
146318063|NCT01358864|527675292|FG001|Overall Study|Other reason not defined above|0|||
146318064|NCT01358864|527675293|FG002|Overall Study|Other reason not defined above|0|||
146318065|NCT01358864|527675294|FG003|Overall Study|Other reason not defined above|0|||
146318066|NCT01358864|527675295|FG004|Overall Study|Other reason not defined above|0|||
146318067|NCT01358864|527675296|FG005|Overall Study|Other reason not defined above|0|||
146318068|NCT01358864|527675297|FG006|Overall Study|Other reason not defined above|2|||
146318069|NCT01358864|527675298|FG007|Overall Study|Other reason not defined above|0|||
146318070|NCT01358864|527675291|FG000|Overall Study|Not treated|0|||
146318071|NCT01358864|527675292|FG001|Overall Study|Not treated|0|||
146318072|NCT01358864|527675293|FG002|Overall Study|Not treated|0|||
146318073|NCT01358864|527675294|FG003|Overall Study|Not treated|0|||
146318074|NCT01358864|527675295|FG004|Overall Study|Not treated|0|||
146318075|NCT01358864|527675296|FG005|Overall Study|Not treated|0|||
146318076|NCT01358864|527675297|FG006|Overall Study|Not treated|1|||
146318077|NCT01358864|527675298|FG007|Overall Study|Not treated|0|||
146318078|NCT04042103|527675305|FG000|Overall Study|Lost to Follow-up|1|||
146318079|NCT04042103|527675305|FG000|Overall Study|Withdrawal by Subject|1|||
146318080|NCT04209855|527675307|FG000|Overall Study|Death|161|||
146318081|NCT04209855|527675308|FG001|Overall Study|Death|177|||
146318082|NCT04209855|527675307|FG000|Overall Study|PI Discretion|1|||
146318083|NCT04209855|527675308|FG001|Overall Study|PI Discretion|1|||
146318084|NCT04209855|527675307|FG000|Overall Study|Lost to Follow-up|5|||
146318085|NCT04209855|527675308|FG001|Overall Study|Lost to Follow-up|2|||
146318086|NCT04209855|527675307|FG000|Overall Study|Withdrew consent|10|||
146318087|NCT04209855|527675308|FG001|Overall Study|Withdrew consent|24|||
146318088|NCT04209855|527675307|FG000|Overall Study|Sponsor decision|44|||
146318089|NCT04209855|527675308|FG001|Overall Study|Sponsor decision|18|||
146318090|NCT04209855|527675307|FG000|Overall Study|Other than specified|6|||
146318091|NCT04209855|527675308|FG001|Overall Study|Other than specified|4|||
146318092|NCT02289950|527675309|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
146318093|NCT02289950|527675310|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
146318094|NCT02289950|527675309|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
146318095|NCT02289950|527675310|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
146318096|NCT02289950|527675309|FG000|Overall Study|Lost to Follow-up|1|||
146318097|NCT02289950|527675310|FG001|Overall Study|Lost to Follow-up|0|||
146318098|NCT02289950|527675309|FG000|Overall Study|Physician Decision|9|||
146318099|NCT02289950|527675310|FG001|Overall Study|Physician Decision|3|||
146318100|NCT02289950|527675309|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
146318101|NCT02289950|527675310|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
146318102|NCT02289950|527675309|FG000|Overall Study|Withdrawal by Subject|1|||
146318103|NCT02289950|527675310|FG001|Overall Study|Withdrawal by Subject|3|||
146318104|NCT02289950|527675309|FG000|Overall Study|Test article held for greater than 28 days|0|||
146318105|NCT02289950|527675310|FG001|Overall Study|Test article held for greater than 28 days|1|||
146318106|NCT02289950|527675309|FG000|Overall Study|Adverse Event|11|||
146318107|NCT02289950|527675310|FG001|Overall Study|Adverse Event|3|||
146318108|NCT02289950|527675309|FG000|Overall Study|Death|1|||
146318109|NCT02289950|527675310|FG001|Overall Study|Death|1|||
146318110|NCT02289950|527675309|FG000|Overall Study|Other|5|||
146318111|NCT02289950|527675310|FG001|Overall Study|Other|2|||
146318112|NCT02289950|527675309|FG000|Overall Study|Not Treated|2|||
146318113|NCT02289950|527675310|FG001|Overall Study|Not Treated|1|||
146318114|NCT04153188|527675315|FG000|Overall Study|Lost to Follow-up|1|||
146318115|NCT04153188|527675316|FG001|Overall Study|Lost to Follow-up|1|||
146164515|NCT00691938|527112603|FG003|Overall Study|QTc prolongation|0|||
146164516|NCT00691938|527112604|FG004|Overall Study|QTc prolongation|0|||
146318116|NCT04153188|527675315|FG000|Overall Study|Withdrawal by Subject|2|||
146318117|NCT04153188|527675316|FG001|Overall Study|Withdrawal by Subject|0|||
146318118|NCT04153188|527675315|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
146318119|NCT04153188|527675316|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
146318120|NCT02193074|527675320|FG000|Overall Study|Withdrawal by Subject|1|||
146318121|NCT02193074|527675321|FG001|Overall Study|Withdrawal by Subject|2|||
146318122|NCT02193074|527675320|FG000|Overall Study|Adverse Event|16|||
146318123|NCT02193074|527675321|FG001|Overall Study|Adverse Event|13|||
146318124|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
146318125|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
146318126|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
146164517|NCT00691938|527112605|FG005|Overall Study|QTc prolongation|0|||
146164518|NCT00691938|527112606|FG006|Overall Study|QTc prolongation|0|||
146318127|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
146318128|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
146318129|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
146318130|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
146318131|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
146318132|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
146318133|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
146318134|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
146318135|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
146318136|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
146318137|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
146318138|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
146318139|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
146318140|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
146318141|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
146318142|NCT02600494|527675329|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
146318143|NCT02600494|527675330|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
146318144|NCT02600494|527675331|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
146318145|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
146318146|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
146318147|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
146318148|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
146318149|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
146318150|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
146318151|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
146318152|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
146318153|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
146318154|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
146318155|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
146318156|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
146318157|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
146318158|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
146318159|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
146318160|NCT02600494|527675329|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
146318161|NCT02600494|527675330|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
146318162|NCT02600494|527675331|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
146318163|NCT03124563|527675332|FG000|Overall Study|Lost to Follow-up|1|||
146318164|NCT03124563|527675333|FG001|Overall Study|Lost to Follow-up|1|||
146318165|NCT03124563|527675332|FG000|Overall Study|Withdrawal by Subject|1|||
146318166|NCT03124563|527675333|FG001|Overall Study|Withdrawal by Subject|1|||
146318167|NCT02396589|527675341|FG000|Intervention|Lost to Follow-up|1|||
146318168|NCT02396589|527675342|FG001|Intervention|Lost to Follow-up|0|||
146318169|NCT02396589|527675341|FG000|6 Month Follow-up|change in health status|0|||
146318170|NCT02396589|527675342|FG001|6 Month Follow-up|change in health status|1|||
146318171|NCT02396589|527675341|FG000|9 Month Follow-up|Death|0|||
146318172|NCT02396589|527675342|FG001|9 Month Follow-up|Death|1|||
146318173|NCT02396589|527675341|FG000|12 Month Follow up|Lost to Follow-up|0|||
146318174|NCT02396589|527675342|FG001|12 Month Follow up|Lost to Follow-up|2|||
146318175|NCT04179175|527676904|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
146318176|NCT04179175|527676905|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
146318177|NCT04179175|527676906|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
146318178|NCT04179175|527676907|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
146318179|NCT04179175|527676908|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
146318180|NCT04179175|527676909|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
146318181|NCT04179175|527676904|FG000|Overall Study|Adverse Event|5|||
146318182|NCT04179175|527676905|FG001|Overall Study|Adverse Event|3|||
146318183|NCT04179175|527676906|FG002|Overall Study|Adverse Event|3|||
146318184|NCT04179175|527676907|FG003|Overall Study|Adverse Event|4|||
146318185|NCT04179175|527676908|FG004|Overall Study|Adverse Event|6|||
146318186|NCT04179175|527676909|FG005|Overall Study|Adverse Event|6|||
146318187|NCT04179175|527676904|FG000|Overall Study|Lack of Efficacy|5|||
146318188|NCT04179175|527676905|FG001|Overall Study|Lack of Efficacy|1|||
146318189|NCT04179175|527676906|FG002|Overall Study|Lack of Efficacy|3|||
146318190|NCT04179175|527676907|FG003|Overall Study|Lack of Efficacy|2|||
146318191|NCT04179175|527676908|FG004|Overall Study|Lack of Efficacy|18|||
146318192|NCT04179175|527676909|FG005|Overall Study|Lack of Efficacy|7|||
146318193|NCT04179175|527676904|FG000|Overall Study|Lost to Follow-up|5|||
146318194|NCT04179175|527676905|FG001|Overall Study|Lost to Follow-up|3|||
146318195|NCT04179175|527676906|FG002|Overall Study|Lost to Follow-up|2|||
146318196|NCT04179175|527676907|FG003|Overall Study|Lost to Follow-up|2|||
146318197|NCT04179175|527676908|FG004|Overall Study|Lost to Follow-up|4|||
146318198|NCT04179175|527676909|FG005|Overall Study|Lost to Follow-up|5|||
146318199|NCT04179175|527676904|FG000|Overall Study|Physician Decision|2|||
146318200|NCT04179175|527676905|FG001|Overall Study|Physician Decision|0|||
146318201|NCT04179175|527676906|FG002|Overall Study|Physician Decision|2|||
146318202|NCT04179175|527676907|FG003|Overall Study|Physician Decision|3|||
146318203|NCT04179175|527676908|FG004|Overall Study|Physician Decision|1|||
146318204|NCT04179175|527676909|FG005|Overall Study|Physician Decision|1|||
146318205|NCT04179175|527676904|FG000|Overall Study|Pregnancy|3|||
146318206|NCT04179175|527676905|FG001|Overall Study|Pregnancy|0|||
146318207|NCT04179175|527676906|FG002|Overall Study|Pregnancy|3|||
146318208|NCT04179175|527676907|FG003|Overall Study|Pregnancy|0|||
146318209|NCT04179175|527676908|FG004|Overall Study|Pregnancy|1|||
146318210|NCT04179175|527676909|FG005|Overall Study|Pregnancy|2|||
146318211|NCT04179175|527676904|FG000|Overall Study|Withdrawal by Subject|22|||
146318212|NCT04179175|527676905|FG001|Overall Study|Withdrawal by Subject|10|||
146318213|NCT04179175|527676906|FG002|Overall Study|Withdrawal by Subject|12|||
146318214|NCT04179175|527676907|FG003|Overall Study|Withdrawal by Subject|8|||
146318215|NCT04179175|527676908|FG004|Overall Study|Withdrawal by Subject|23|||
146318216|NCT04179175|527676909|FG005|Overall Study|Withdrawal by Subject|31|||
146318217|NCT04179175|527676904|FG000|Overall Study|Technical problems|0|||
146318218|NCT04179175|527676905|FG001|Overall Study|Technical problems|0|||
146318219|NCT04179175|527676906|FG002|Overall Study|Technical problems|1|||
146318220|NCT04179175|527676907|FG003|Overall Study|Technical problems|1|||
146318221|NCT04179175|527676908|FG004|Overall Study|Technical problems|0|||
146318222|NCT04179175|527676909|FG005|Overall Study|Technical problems|0|||
146318223|NCT05593016|527676910|FG000|Overall Study|Death|1|||
146318224|NCT05593016|527676911|FG001|Overall Study|Death|1|||
146318225|NCT05593016|527676912|FG002|Overall Study|Death|1|||
146318226|NCT05593016|527676913|FG003|Overall Study|Death|0|||
146318227|NCT05593016|527676914|FG004|Overall Study|Death|0|||
146318228|NCT05593016|527676910|FG000|Overall Study|Lost to Follow-up|1|||
146318229|NCT05593016|527676911|FG001|Overall Study|Lost to Follow-up|1|||
146318230|NCT05593016|527676912|FG002|Overall Study|Lost to Follow-up|1|||
146318231|NCT05593016|527676913|FG003|Overall Study|Lost to Follow-up|2|||
146318232|NCT05593016|527676914|FG004|Overall Study|Lost to Follow-up|0|||
146318233|NCT04705051|527676915|FG000|Overall Study|Enrolled but not treated|1|||
146318234|NCT04705051|527676915|FG000|Overall Study|Study terminated by sponsor|23|||
146318235|NCT00598975|527676916|FG000|Overall Study|Adverse Event|1|||
146318236|NCT00598975|527676917|FG001|Overall Study|Adverse Event|1|||
146318237|NCT00598975|527676916|FG000|Overall Study|Brain metastases|1|||
146318238|NCT00598975|527676917|FG001|Overall Study|Brain metastases|0|||
146318239|NCT00598975|527676916|FG000|Overall Study|Withdrawal by Subject|1|||
146318240|NCT00598975|527676917|FG001|Overall Study|Withdrawal by Subject|1|||
146318241|NCT00598975|527676916|FG000|Overall Study|Withdrawal of consent|0|||
146318242|NCT00598975|527676917|FG001|Overall Study|Withdrawal of consent|1|||
146318243|NCT00598975|527676916|FG000|Overall Study|Disease progression|8|||
146318244|NCT00598975|527676917|FG001|Overall Study|Disease progression|3|||
146318245|NCT00598975|527676916|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
146318246|NCT00598975|527676917|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
146318247|NCT01178138|527676918|FG000|Overall Study|Lost to Follow-up|8|||
146318248|NCT01178138|527676918|FG000|Overall Study|Withdrawal by Subject|7|||
146318249|NCT01178138|527676918|FG000|Overall Study|Physician Decision|8|||
146318250|NCT01241708|527676919|FG000|Overall Study|Withdrawal by Subject|6|||
146318251|NCT01241708|527676919|FG000|Overall Study|Screen Failure|6|||
146318252|NCT01241708|527676919|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
146318253|NCT01241708|527676919|FG000|Overall Study|Lost to Follow-up|5|||
146318254|NCT01790503|527676922|FG000|Overall Study|Adverse Event|1|||
146318255|NCT01790503|527676923|FG001|Overall Study|Adverse Event|0|||
146318256|NCT01790503|527676924|FG002|Overall Study|Adverse Event|0|||
146318257|NCT01790503|527676925|FG003|Overall Study|Adverse Event|0|||
146318258|NCT01790503|527676926|FG004|Overall Study|Adverse Event|0|||
146318259|NCT01790503|527676927|FG005|Overall Study|Adverse Event|2|||
146318260|NCT01790503|527676928|FG006|Overall Study|Adverse Event|0|||
146318261|NCT01790503|527676929|FG007|Overall Study|Adverse Event|0|||
146318262|NCT01790503|527676930|FG008|Overall Study|Adverse Event|2|||
146318263|NCT01790503|527676931|FG009|Overall Study|Adverse Event|4|||
146318264|NCT01790503|527676932|FG010|Overall Study|Adverse Event|7|||
146318265|NCT01790503|527676922|FG000|Overall Study|Withdrawal by Subject|0|||
146318266|NCT01790503|527676923|FG001|Overall Study|Withdrawal by Subject|0|||
146318267|NCT01790503|527676924|FG002|Overall Study|Withdrawal by Subject|1|||
146318268|NCT01790503|527676925|FG003|Overall Study|Withdrawal by Subject|1|||
146318269|NCT01790503|527676926|FG004|Overall Study|Withdrawal by Subject|1|||
146318270|NCT01790503|527676927|FG005|Overall Study|Withdrawal by Subject|2|||
146318271|NCT01790503|527676928|FG006|Overall Study|Withdrawal by Subject|1|||
146318272|NCT01790503|527676929|FG007|Overall Study|Withdrawal by Subject|0|||
146318273|NCT01790503|527676930|FG008|Overall Study|Withdrawal by Subject|0|||
146318274|NCT01790503|527676931|FG009|Overall Study|Withdrawal by Subject|0|||
146318275|NCT01790503|527676932|FG010|Overall Study|Withdrawal by Subject|1|||
146318276|NCT01790503|527676922|FG000|Overall Study|Disease progression|2|||
146318277|NCT01790503|527676923|FG001|Overall Study|Disease progression|1|||
146318278|NCT01790503|527676924|FG002|Overall Study|Disease progression|0|||
146318279|NCT01790503|527676925|FG003|Overall Study|Disease progression|1|||
146318280|NCT01790503|527676926|FG004|Overall Study|Disease progression|2|||
146318281|NCT01790503|527676927|FG005|Overall Study|Disease progression|1|||
146318282|NCT01790503|527676928|FG006|Overall Study|Disease progression|0|||
146318283|NCT01790503|527676929|FG007|Overall Study|Disease progression|1|||
146318284|NCT01790503|527676930|FG008|Overall Study|Disease progression|0|||
146318285|NCT01790503|527676931|FG009|Overall Study|Disease progression|17|||
146318286|NCT01790503|527676932|FG010|Overall Study|Disease progression|7|||
146318287|NCT01790503|527676922|FG000|Overall Study|Protocol Violation|0|||
146318288|NCT01790503|527676923|FG001|Overall Study|Protocol Violation|0|||
146318289|NCT01790503|527676924|FG002|Overall Study|Protocol Violation|0|||
146318290|NCT01790503|527676925|FG003|Overall Study|Protocol Violation|0|||
146318291|NCT01790503|527676926|FG004|Overall Study|Protocol Violation|0|||
146318292|NCT01790503|527676927|FG005|Overall Study|Protocol Violation|0|||
146318293|NCT01790503|527676928|FG006|Overall Study|Protocol Violation|0|||
146318294|NCT01790503|527676929|FG007|Overall Study|Protocol Violation|0|||
146318295|NCT01790503|527676930|FG008|Overall Study|Protocol Violation|0|||
146318296|NCT01790503|527676931|FG009|Overall Study|Protocol Violation|1|||
146318297|NCT01790503|527676932|FG010|Overall Study|Protocol Violation|0|||
146318298|NCT01790503|527676922|FG000|Overall Study|Physician Decision|0|||
146318299|NCT01790503|527676923|FG001|Overall Study|Physician Decision|0|||
146318300|NCT01790503|527676924|FG002|Overall Study|Physician Decision|0|||
146318301|NCT01790503|527676925|FG003|Overall Study|Physician Decision|0|||
146318302|NCT01790503|527676926|FG004|Overall Study|Physician Decision|0|||
146318303|NCT01790503|527676927|FG005|Overall Study|Physician Decision|0|||
146318304|NCT01790503|527676928|FG006|Overall Study|Physician Decision|0|||
146318305|NCT01790503|527676929|FG007|Overall Study|Physician Decision|0|||
146318306|NCT01790503|527676930|FG008|Overall Study|Physician Decision|0|||
146318307|NCT01790503|527676931|FG009|Overall Study|Physician Decision|1|||
146318308|NCT01790503|527676932|FG010|Overall Study|Physician Decision|1|||
146318309|NCT01790503|527676922|FG000|Overall Study|Death|0|||
146318310|NCT01790503|527676923|FG001|Overall Study|Death|0|||
146318311|NCT01790503|527676924|FG002|Overall Study|Death|0|||
146318312|NCT01790503|527676925|FG003|Overall Study|Death|0|||
146318313|NCT01790503|527676926|FG004|Overall Study|Death|0|||
146318314|NCT01790503|527676927|FG005|Overall Study|Death|0|||
146318315|NCT01790503|527676928|FG006|Overall Study|Death|0|||
146318316|NCT01790503|527676929|FG007|Overall Study|Death|0|||
146318317|NCT01790503|527676930|FG008|Overall Study|Death|0|||
146318318|NCT01790503|527676931|FG009|Overall Study|Death|1|||
146318319|NCT01790503|527676932|FG010|Overall Study|Death|0|||
146318320|NCT01790503|527676922|FG000|Overall Study|Non Compliance|0|||
146318321|NCT01790503|527676923|FG001|Overall Study|Non Compliance|0|||
146318322|NCT01790503|527676924|FG002|Overall Study|Non Compliance|0|||
146318323|NCT01790503|527676925|FG003|Overall Study|Non Compliance|0|||
146318324|NCT01790503|527676926|FG004|Overall Study|Non Compliance|1|||
146318325|NCT01790503|527676927|FG005|Overall Study|Non Compliance|0|||
146318326|NCT01790503|527676928|FG006|Overall Study|Non Compliance|0|||
146318327|NCT01790503|527676929|FG007|Overall Study|Non Compliance|0|||
146318328|NCT01790503|527676930|FG008|Overall Study|Non Compliance|0|||
146318329|NCT01790503|527676931|FG009|Overall Study|Non Compliance|0|||
146318330|NCT01790503|527676932|FG010|Overall Study|Non Compliance|0|||
146318331|NCT01790503|527676922|FG000|Overall Study|Other|0|||
146318332|NCT01790503|527676923|FG001|Overall Study|Other|0|||
146318333|NCT01790503|527676924|FG002|Overall Study|Other|0|||
146318334|NCT01790503|527676925|FG003|Overall Study|Other|0|||
146318335|NCT01790503|527676926|FG004|Overall Study|Other|1|||
146318336|NCT01790503|527676927|FG005|Overall Study|Other|0|||
146318337|NCT01790503|527676928|FG006|Overall Study|Other|0|||
146318338|NCT01790503|527676929|FG007|Overall Study|Other|0|||
146318339|NCT01790503|527676930|FG008|Overall Study|Other|1|||
146318340|NCT01790503|527676931|FG009|Overall Study|Other|2|||
146318341|NCT01790503|527676932|FG010|Overall Study|Other|0|||
146318342|NCT00049673|527676933|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
146318343|NCT00049673|527676934|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
146318344|NCT01535729|527676935|FG000|Overall Study|Withdrawal by Subject|2|||
146318345|NCT01535729|527676935|FG000|Overall Study|Disease progression|230|||
146318346|NCT01535729|527676935|FG000|Overall Study|Discontinued treatment|25|||
146164519|NCT04860518|527112607|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
146318347|NCT01535729|527676935|FG000|Overall Study|Lost to Follow-up|8|||
146318348|NCT01535729|527676935|FG000|Overall Study|Death|52|||
146318349|NCT01535729|527676935|FG000|Overall Study|Other|19|||
146318350|NCT01535729|527676935|FG000|Overall Study|Did not sign informed consent|1|||
146318351|NCT01535729|527676935|FG000|Overall Study|No previous chemotherapy|33|||
146318352|NCT01535729|527676935|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
146164520|NCT04860518|527112608|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
146318353|NCT01535729|527676935|FG000|Overall Study|Protocol Violation|11|||
146318354|NCT01535729|527676935|FG000|Overall Study|Screening failure|1|||
146318355|NCT01535729|527676935|FG000|Overall Study|Not treated|9|||
146318356|NCT01535729|527676935|FG000|Overall Study|No participant record available|5|||
146318357|NCT02787850|527676938|FG000|Overall Study|Withdrawal by Subject|0|||
146318358|NCT02787850|527676939|FG001|Overall Study|Withdrawal by Subject|1|||
146318359|NCT00494091|527676940|FG000|Overall Study|Death|5|||
146318360|NCT00494091|527676941|FG001|Overall Study|Death|54|||
146318361|NCT00494091|527676940|FG000|Overall Study|Lost to Follow-up|0|||
146318362|NCT00494091|527676941|FG001|Overall Study|Lost to Follow-up|4|||
146318363|NCT00494091|527676940|FG000|Overall Study|Other|1|||
146318364|NCT00494091|527676941|FG001|Overall Study|Other|11|||
146318365|NCT00494091|527676940|FG000|Overall Study|Withdrawal by Subject|0|||
146318366|NCT00494091|527676941|FG001|Overall Study|Withdrawal by Subject|7|||
146318367|NCT02322710|527676944|FG000|Overall Study|No efficacy assessment post-baseline|0|||
146318368|NCT02322710|527676945|FG001|Overall Study|No efficacy assessment post-baseline|1|||
146318369|NCT02322710|527676944|FG000|Overall Study|Protocol Violation|20|||
146318370|NCT02322710|527676945|FG001|Overall Study|Protocol Violation|25|||
146318371|NCT04161131|527676946|FG000|Overall Study|Ineligible|2|||
146318372|NCT04161131|527676946|FG000|Overall Study|Lost to Follow-up|4|||
146318373|NCT03733392|527676950|FG000|Overall Study|Withdrawal by Subject|11|||
146318374|NCT03733392|527676951|FG001|Overall Study|Withdrawal by Subject|1|||
146318375|NCT03733392|527676950|FG000|Overall Study|Death|1|||
146318376|NCT03733392|527676951|FG001|Overall Study|Death|0|||
146318377|NCT03733392|527676950|FG000|Overall Study|Lost to Follow-up|5|||
146318378|NCT03733392|527676951|FG001|Overall Study|Lost to Follow-up|0|||
146318379|NCT03733392|527676950|FG000|Overall Study|Protocol Violation|0|||
146318380|NCT03733392|527676951|FG001|Overall Study|Protocol Violation|1|||
146318381|NCT03733392|527676950|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
146318382|NCT03733392|527676951|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
146318383|NCT03733392|527676950|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
146318384|NCT03733392|527676951|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
146318385|NCT03733392|527676950|FG000|Overall Study|Patient Non-Compliance|2|||
146318386|NCT03733392|527676951|FG001|Overall Study|Patient Non-Compliance|1|||
146318387|NCT03733392|527676950|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
146318388|NCT03733392|527676951|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
146318389|NCT03733392|527676950|FG000|Overall Study|Withdrawal prior to procedure|5|||
146318390|NCT03733392|527676951|FG001|Overall Study|Withdrawal prior to procedure|2|||
146318391|NCT00984204|527676953|FG000|Overall Study|Death|1|||
146318392|NCT00984204|527676953|FG000|Overall Study|Lost to Follow-up|4|||
146318393|NCT00984204|527676953|FG000|Overall Study|Lack of Efficacy|10|||
146318394|NCT00559507|527676965|FG000|Overall Study|Not treated, patient ineligible|3|||
146318395|NCT01191697|527676968|FG000|Overall Study|Death|1|||
146318396|NCT01191697|527676968|FG000|Overall Study|Physician Decision|2|||
146318397|NCT01191697|527676968|FG000|Overall Study|Pursue chemoradiation|2|||
146318398|NCT01191697|527676968|FG000|Overall Study|Break from chemotherapy|2|||
146318399|NCT01191697|527676968|FG000|Overall Study|Withdrawal by Subject|1|||
146318400|NCT01191697|527676968|FG000|Overall Study|Surveillance|1|||
146318401|NCT01191697|527676968|FG000|Overall Study|Adverse Event|2|||
146318402|NCT01191697|527676968|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
146318403|NCT01191697|527676968|FG000|Overall Study|Not completed but analyzed|25|||
146318404|NCT04227899|527676971|FG000|Overall Study|Withdrawal by Subject|6|||
146318405|NCT04227899|527676972|FG001|Overall Study|Withdrawal by Subject|3|||
146318406|NCT04227899|527676971|FG000|Overall Study|Death|12|||
146318407|NCT04227899|527676972|FG001|Overall Study|Death|6|||
146318408|NCT04227899|527676971|FG000|Overall Study|Lost to Follow-up|2|||
146318409|NCT04227899|527676972|FG001|Overall Study|Lost to Follow-up|1|||
146318410|NCT02479802|527676973|FG000|Overall Study|Lost to Follow-up|1|||
146318411|NCT02479802|527676973|FG000|Overall Study|Adverse Event|1|||
146318412|NCT05702515|527676974|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
146318413|NCT01784965|527676975|FG000|Overall Study|Withdrawal by Subject|6|||
146318414|NCT01784965|527676976|FG001|Overall Study|Withdrawal by Subject|3|||
146318415|NCT01784965|527676975|FG000|Overall Study|Adverse Event|0|||
146318416|NCT01784965|527676976|FG001|Overall Study|Adverse Event|8|||
146318417|NCT03757988|527676979|FG000|Overall Study|Withdrawal by Subject|1|||
146318418|NCT03806127|527676980|FG000|Overall Study|Withdrawal by Subject|4|||
146318419|NCT03806127|527676981|FG001|Overall Study|Withdrawal by Subject|5|||
146318420|NCT03806127|527676980|FG000|Overall Study|Protocol Violation|3|||
146318421|NCT03806127|527676981|FG001|Overall Study|Protocol Violation|1|||
146318422|NCT03806127|527676980|FG000|Overall Study|Adverse Event|3|||
146318423|NCT03806127|527676981|FG001|Overall Study|Adverse Event|0|||
146318424|NCT03806127|527676980|FG000|Overall Study|Unable to Complete Procedures|0|||
146318425|NCT03806127|527676981|FG001|Overall Study|Unable to Complete Procedures|1|||
146318426|NCT03806127|527676980|FG000|Overall Study|Pregnancy|0|||
146318427|NCT03806127|527676981|FG001|Overall Study|Pregnancy|1|||
146318428|NCT03806127|527676980|FG000|Overall Study|Lost to Follow-up|5|||
146318429|NCT03806127|527676981|FG001|Overall Study|Lost to Follow-up|1|||
146318430|NCT03806127|527676980|FG000|Overall Study|Physician Decision|1|||
146318431|NCT03806127|527676981|FG001|Overall Study|Physician Decision|1|||
146318432|NCT03806127|527676980|FG000|Overall Study|Could Not Come Due to Covid|1|||
146318433|NCT03806127|527676981|FG001|Overall Study|Could Not Come Due to Covid|0|||
146318434|NCT03806127|527676980|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
145943220|NCT00483704|526300458|FG002|Treatment|Lack of qualifying migraines|116|||
146318435|NCT03806127|527676981|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
146318436|NCT03806127|527676980|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
146318437|NCT03806127|527676981|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
146318438|NCT03806127|527676980|FG000|Overall Study|Covid 19 Restrictions|2|||
146318439|NCT03806127|527676981|FG001|Overall Study|Covid 19 Restrictions|0|||
146318440|NCT03806127|527676980|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
146318441|NCT03806127|527676981|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
146318442|NCT03806127|527676980|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
146318443|NCT03806127|527676981|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
146318444|NCT04372927|527676982|FG000|Overall Study|Death|1|||
146318445|NCT00608985|527676989|FG000|Overall Study|Adverse Event|2|||
146318446|NCT00608985|527676990|FG001|Overall Study|Adverse Event|7|||
146318447|NCT00608985|527676991|FG002|Overall Study|Adverse Event|4|||
146318448|NCT00608985|527676992|FG003|Overall Study|Adverse Event|6|||
146318449|NCT00608985|527676989|FG000|Overall Study|Administrative/Other|7|||
146318450|NCT00608985|527676990|FG001|Overall Study|Administrative/Other|4|||
146318451|NCT00608985|527676991|FG002|Overall Study|Administrative/Other|1|||
146318452|NCT00608985|527676992|FG003|Overall Study|Administrative/Other|2|||
146318453|NCT00608985|527676989|FG000|Overall Study|Withdrawal of Consent|5|||
146318454|NCT00608985|527676990|FG001|Overall Study|Withdrawal of Consent|1|||
146318455|NCT00608985|527676991|FG002|Overall Study|Withdrawal of Consent|1|||
146318456|NCT00608985|527676992|FG003|Overall Study|Withdrawal of Consent|1|||
146318457|NCT00608985|527676989|FG000|Overall Study|Lost to Follow-up|2|||
146318458|NCT00608985|527676990|FG001|Overall Study|Lost to Follow-up|1|||
146318459|NCT00608985|527676991|FG002|Overall Study|Lost to Follow-up|0|||
146318460|NCT00608985|527676992|FG003|Overall Study|Lost to Follow-up|0|||
146318461|NCT03033745|527676993|FG000|Overall Study|Protocol Violation|0|||
146318462|NCT03033745|527676994|FG001|Overall Study|Protocol Violation|0|||
146318463|NCT03033745|527676995|FG002|Overall Study|Protocol Violation|1|||
146318464|NCT03033745|527676993|FG000|Overall Study|Adverse Event|1|||
146318465|NCT03033745|527676994|FG001|Overall Study|Adverse Event|0|||
146318466|NCT03033745|527676995|FG002|Overall Study|Adverse Event|1|||
146318467|NCT03033745|527676993|FG000|Overall Study|Withdrawal by Subject|0|||
146318468|NCT03033745|527676994|FG001|Overall Study|Withdrawal by Subject|1|||
146318469|NCT03033745|527676995|FG002|Overall Study|Withdrawal by Subject|0|||
146318470|NCT02462473|527676996|FG000|Overall Study|Death|1|||
146318471|NCT02462473|527676996|FG000|Overall Study|Other|3|||
146318472|NCT00661271|527676997|FG000|Overall Study|Lost to Follow-up|28|||
146318473|NCT00661271|527676998|FG001|Overall Study|Lost to Follow-up|25|||
146318474|NCT03728309|527677002|FG000|Overall Study|Randomized but not Treated|0|||
146318475|NCT03728309|527677003|FG001|Overall Study|Randomized but not Treated|1|||
146318476|NCT03728309|527677002|FG000|Overall Study|Adverse Event|0|||
146318477|NCT03728309|527677003|FG001|Overall Study|Adverse Event|1|||
146318478|NCT03728309|527677002|FG000|Overall Study|Withdrawal by Subject|2|||
146318479|NCT03728309|527677003|FG001|Overall Study|Withdrawal by Subject|8|||
146318480|NCT03728309|527677002|FG000|Overall Study|Lost to Follow-up|9|||
146318481|NCT03728309|527677003|FG001|Overall Study|Lost to Follow-up|10|||
146318482|NCT03728309|527677002|FG000|Overall Study|Protocol Deviation|0|||
146318483|NCT03728309|527677003|FG001|Overall Study|Protocol Deviation|1|||
146318484|NCT03728309|527677002|FG000|Overall Study|Due to COVID|1|||
146318485|NCT03728309|527677003|FG001|Overall Study|Due to COVID|3|||
146318486|NCT02436876|527677004|FG000|Overall Study|Lost to Follow-up|0|||
146318487|NCT02436876|527677005|FG001|Overall Study|Lost to Follow-up|1|||
146318488|NCT02436876|527677006|FG002|Overall Study|Lost to Follow-up|1|||
146318489|NCT02436876|527677007|FG003|Overall Study|Lost to Follow-up|1|||
146318490|NCT02436876|527677004|FG000|Overall Study|Withdrawal by Subject|1|||
146318491|NCT02436876|527677005|FG001|Overall Study|Withdrawal by Subject|0|||
146318492|NCT02436876|527677006|FG002|Overall Study|Withdrawal by Subject|0|||
146318493|NCT02436876|527677007|FG003|Overall Study|Withdrawal by Subject|1|||
146318494|NCT02436876|527677004|FG000|Overall Study|Physician Decision|0|||
146318495|NCT02436876|527677005|FG001|Overall Study|Physician Decision|2|||
146318496|NCT02436876|527677006|FG002|Overall Study|Physician Decision|1|||
146318497|NCT02436876|527677007|FG003|Overall Study|Physician Decision|0|||
146318498|NCT02436876|527677004|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
146318499|NCT02436876|527677005|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
146318500|NCT02436876|527677006|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
146318501|NCT02436876|527677007|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
146318502|NCT00999908|527677010|FG000|Treatment Period 1|Subject withdrew consent|2|||
146318503|NCT00999908|527677011|FG001|Treatment Period 1|Subject withdrew consent|0|||
146318504|NCT00999908|527677012|FG002|Treatment Period 1|Subject withdrew consent|0|||
146318505|NCT00999908|527677010|FG000|Treatment Period 2|Protocol Violation|1|||
146318506|NCT00999908|527677011|FG001|Treatment Period 2|Protocol Violation|0|||
146318507|NCT00999908|527677012|FG002|Treatment Period 2|Protocol Violation|0|||
146318508|NCT00927095|527677014|FG000|Overall Study|Adverse Event|3|||
146318509|NCT00927095|527677015|FG001|Overall Study|Adverse Event|1|||
145943221|NCT00483704|526300456|FG000|Treatment|Adverse Event|3|||
146164521|NCT04555096|527112612|FG000|Overall Study|Death|4|||
146164522|NCT04555096|527112613|FG001|Overall Study|Death|4|||
146164523|NCT04555096|527112612|FG000|Overall Study|Withdrawal by Subject|1|||
146164524|NCT04555096|527112613|FG001|Overall Study|Withdrawal by Subject|0|||
146318510|NCT00927095|527677016|FG002|Overall Study|Adverse Event|0|||
146318511|NCT00927095|527677014|FG000|Overall Study|Withdrawal by Subject|2|||
146318512|NCT00927095|527677015|FG001|Overall Study|Withdrawal by Subject|1|||
146318513|NCT00927095|527677016|FG002|Overall Study|Withdrawal by Subject|1|||
146318514|NCT00927095|527677014|FG000|Overall Study|Physician Decision|1|||
146318515|NCT00927095|527677015|FG001|Overall Study|Physician Decision|2|||
146318516|NCT00927095|527677016|FG002|Overall Study|Physician Decision|1|||
146318517|NCT01290692|527677021|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
146318518|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
146318519|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
146318520|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
146318521|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
146318522|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146318523|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146318524|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
146318525|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146318526|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
146318527|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146318528|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146318529|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146318530|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
146318531|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
146318532|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
146318533|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
146318534|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
146318535|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
146318536|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
146318537|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
146318538|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146318539|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146318540|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146318541|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
146318542|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
146318543|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146318544|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146318545|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146318546|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146318547|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
146318548|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146318549|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
146318550|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146318551|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146318552|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146318553|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
146318554|NCT03403205|527677025|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
146318555|NCT03403205|527677026|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146318556|NCT03403205|527677027|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
146318557|NCT03403205|527677028|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
146318558|NCT03403205|527677029|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146318559|NCT03403205|527677030|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
146318560|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
146318561|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
146318562|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
146318563|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
146318564|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
146318565|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
146318566|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
146318567|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
146318568|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
146318569|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
146318570|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
146318571|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
146318572|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Death|1|||
146318573|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Death|0|||
146318574|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Death|0|||
146318575|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Death|0|||
146318576|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Death|0|||
146318577|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Death|0|||
146318578|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
146318579|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146318580|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146318581|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146318582|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146318583|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
146318584|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
146318585|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
146318586|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
146318587|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
146318588|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
146318589|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
146318590|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
146318591|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146318592|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146318593|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146318594|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146318595|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
146318596|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
146318597|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
146318598|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
146318599|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
146318600|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
146318601|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
146318602|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
146318603|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
146318604|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
146318605|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
146318606|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
146318607|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
146318608|NCT03403205|527677025|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
146318609|NCT03403205|527677026|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
146318610|NCT03403205|527677027|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
146318611|NCT03403205|527677028|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
146318612|NCT03403205|527677029|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
146318613|NCT03403205|527677030|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
146318614|NCT00706030|527677031|FG000|Overall Study|Disease Progression|4|||
146318615|NCT00706030|527677032|FG001|Overall Study|Disease Progression|6|||
146318616|NCT00706030|527677033|FG002|Overall Study|Disease Progression|46|||
146318617|NCT00706030|527677034|FG003|Overall Study|Disease Progression|12|||
146318618|NCT00706030|527677031|FG000|Overall Study|Adverse Event|1|||
146318619|NCT00706030|527677032|FG001|Overall Study|Adverse Event|0|||
146318620|NCT00706030|527677033|FG002|Overall Study|Adverse Event|4|||
146318621|NCT00706030|527677034|FG003|Overall Study|Adverse Event|2|||
146318622|NCT00706030|527677031|FG000|Overall Study|Withdrawal by Subject|1|||
146318623|NCT00706030|527677032|FG001|Overall Study|Withdrawal by Subject|0|||
146318624|NCT00706030|527677033|FG002|Overall Study|Withdrawal by Subject|2|||
146318625|NCT00706030|527677034|FG003|Overall Study|Withdrawal by Subject|0|||
146318626|NCT00706030|527677031|FG000|Overall Study|Physician Decision|0|||
146318627|NCT00706030|527677032|FG001|Overall Study|Physician Decision|0|||
146318628|NCT00706030|527677033|FG002|Overall Study|Physician Decision|2|||
146318629|NCT00706030|527677034|FG003|Overall Study|Physician Decision|0|||
146318630|NCT00706030|527677031|FG000|Overall Study|Not recorded|0|||
146318631|NCT00706030|527677032|FG001|Overall Study|Not recorded|0|||
146318632|NCT00706030|527677033|FG002|Overall Study|Not recorded|2|||
146318633|NCT00706030|527677034|FG003|Overall Study|Not recorded|0|||
146318634|NCT00706030|527677031|FG000|Overall Study|Protocol Violation|0|||
146318635|NCT00706030|527677032|FG001|Overall Study|Protocol Violation|0|||
146318636|NCT00706030|527677033|FG002|Overall Study|Protocol Violation|1|||
146318637|NCT00706030|527677034|FG003|Overall Study|Protocol Violation|1|||
146318638|NCT00706030|527677031|FG000|Overall Study|Failed to return|0|||
146318639|NCT00706030|527677032|FG001|Overall Study|Failed to return|0|||
146318640|NCT00706030|527677033|FG002|Overall Study|Failed to return|1|||
146318641|NCT00706030|527677034|FG003|Overall Study|Failed to return|0|||
146318642|NCT00706030|527677031|FG000|Overall Study|Symptomatic Deterioration|0|||
146318643|NCT00706030|527677032|FG001|Overall Study|Symptomatic Deterioration|0|||
146318644|NCT00706030|527677033|FG002|Overall Study|Symptomatic Deterioration|1|||
146318645|NCT00706030|527677034|FG003|Overall Study|Symptomatic Deterioration|0|||
146318646|NCT00706030|527677031|FG000|Overall Study|No treatment received|0|||
146318647|NCT00706030|527677032|FG001|Overall Study|No treatment received|0|||
146318648|NCT00706030|527677033|FG002|Overall Study|No treatment received|0|||
146318649|NCT00706030|527677034|FG003|Overall Study|No treatment received|1|||
146318650|NCT00706030|527677031|FG000|Overall Study|Death|0|||
146318651|NCT00706030|527677032|FG001|Overall Study|Death|0|||
146318652|NCT00706030|527677033|FG002|Overall Study|Death|1|||
146318653|NCT00706030|527677034|FG003|Overall Study|Death|0|||
146318654|NCT05779072|527677035|FG000|Overall Study|Lost to Follow-up|0|||
146318655|NCT05779072|527677036|FG001|Overall Study|Lost to Follow-up|1|||
146318656|NCT05779072|527677035|FG000|Overall Study|Withdrawal by Subject|1|||
146318657|NCT05779072|527677036|FG001|Overall Study|Withdrawal by Subject|5|||
146318658|NCT02682901|527677037|FG000|Overall Study|Adverse Event|10|||
146318659|NCT02682901|527677038|FG001|Overall Study|Adverse Event|3|||
146318660|NCT02682901|527677037|FG000|Overall Study|Lack of Efficacy|0|||
146318661|NCT02682901|527677038|FG001|Overall Study|Lack of Efficacy|1|||
146318662|NCT03713944|527677039|FG000|Study Treatment|Patient non-compliance|1|||
146318663|NCT03713944|527677039|FG000|Study Treatment|Alternative Cancer Therapy|3|||
146318664|NCT03713944|527677039|FG000|Study Treatment|Disease Progression|18|||
146318665|NCT03713944|527677039|FG000|Study Treatment|AE/Side Effects/Complications|2|||
146318666|NCT03713944|527677039|FG000|Study Treatment|Death|2|||
146318667|NCT03713944|527677039|FG000|Study Treatment|Withdrawal by Subject|1|||
146318668|NCT03713944|527677039|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
146318669|NCT03713944|527677039|FG000|Study Treatment|Symptomatic Deterioration|2|||
146318670|NCT03713944|527677039|FG000|Follow up|Withdrawal by Subject|2|||
146318671|NCT03713944|527677039|FG000|Follow up|Death|11|||
146318672|NCT03713944|527677039|FG000|Follow up|Study Terminated|3|||
146318673|NCT03847610|527677040|FG000|Overall Study|Withdrawal by Subject|1|||
146318674|NCT03298022|527677041|FG000|Overall Study|Lack of Efficacy|4|||
146318675|NCT03298022|527677041|FG000|Overall Study|Withdrawal by Subject|7|||
146318676|NCT03298022|527677041|FG000|Overall Study|Adverse Event|1|||
146318677|NCT03298022|527677041|FG000|Overall Study|disease relapse|1|||
146318678|NCT01445769|527677042|FG000|Overall Study|Consent Withdrawn|2|||
146318679|NCT01445769|527677042|FG000|Overall Study|Disease Progression|1|||
146318680|NCT01445769|527677042|FG000|Overall Study|Lost to Follow-up|5|||
146318681|NCT03694925|527677043|FG000|Overall Study|Inadequate laboratory testing|0|||
146318682|NCT03694925|527677044|FG001|Overall Study|Inadequate laboratory testing|3|||
146318683|NCT03694925|527677045|FG002|Overall Study|Inadequate laboratory testing|0|||
146318684|NCT03652662|527677046|FG000|Overall Study|Withdrawal by Subject|2|||
146318685|NCT03652662|527677047|FG001|Overall Study|Withdrawal by Subject|1|||
146318686|NCT03652662|527677046|FG000|Overall Study|Lost to Follow-up|1|||
146318687|NCT03652662|527677047|FG001|Overall Study|Lost to Follow-up|0|||
146318688|NCT00487539|527677048|FG000|Overall Study|Adverse Event|3|||
146318689|NCT00487539|527677049|FG001|Overall Study|Adverse Event|2|||
146318690|NCT00487539|527677050|FG002|Overall Study|Adverse Event|1|||
146318691|NCT00487539|527677051|FG003|Overall Study|Adverse Event|1|||
146318692|NCT00487539|527677048|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146318693|NCT00487539|527677049|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146318694|NCT00487539|527677050|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146318695|NCT00487539|527677051|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
146318696|NCT00487539|527677048|FG000|Overall Study|Other|3|||
146318697|NCT00487539|527677049|FG001|Overall Study|Other|1|||
146318698|NCT00487539|527677050|FG002|Overall Study|Other|2|||
146318699|NCT00487539|527677051|FG003|Overall Study|Other|2|||
146318700|NCT02695628|527677052|FG000|Overall Study|Withdrawal by Subject|1|||
146318701|NCT02678390|527677053|FG000|AE (1 Day)|Withdrawal by Subject|0|||
146318702|NCT02678390|527677054|FG001|AE (1 Day)|Withdrawal by Subject|1|||
146318703|NCT03499028|527677055|FG000|Overall Study|Lost to Follow-up|12|||
146318704|NCT03499028|527677056|FG001|Overall Study|Lost to Follow-up|9|||
146318705|NCT03499028|527677055|FG000|Overall Study|Withdrawal by Subject|5|||
146318706|NCT03499028|527677056|FG001|Overall Study|Withdrawal by Subject|8|||
146318707|NCT03499028|527677055|FG000|Overall Study|Unplanned SNF discharge|5|||
146318708|NCT03499028|527677056|FG001|Overall Study|Unplanned SNF discharge|8|||
146318709|NCT00720109|527677057|FG000|Induction Period|Did not meet eligibility criteria|3|||
146318710|NCT00720109|527677058|FG001|Induction Period|Did not meet eligibility criteria|0|||
146318711|NCT00720109|527677059|FG002|Induction Period|Did not meet eligibility criteria|0|||
146318712|NCT00720109|527677057|FG000|Induction Period|Bone Marrow Transplant|2|||
146318713|NCT00720109|527677058|FG001|Induction Period|Bone Marrow Transplant|0|||
146318714|NCT00720109|527677059|FG002|Induction Period|Bone Marrow Transplant|0|||
146318715|NCT00720109|527677057|FG000|Induction Period|Physician Decision|1|||
146318716|NCT00720109|527677058|FG001|Induction Period|Physician Decision|0|||
146318717|NCT00720109|527677059|FG002|Induction Period|Physician Decision|0|||
146318718|NCT00720109|527677057|FG000|Risk Stratification Period|Adverse Event|0|||
146318719|NCT00720109|527677058|FG001|Risk Stratification Period|Adverse Event|1|||
146318720|NCT00720109|527677059|FG002|Risk Stratification Period|Adverse Event|0|||
146318721|NCT00720109|527677057|FG000|Risk Stratification Period|Physician Decision|0|||
146318722|NCT00720109|527677058|FG001|Risk Stratification Period|Physician Decision|2|||
146318723|NCT00720109|527677059|FG002|Risk Stratification Period|Physician Decision|1|||
146318724|NCT00720109|527677057|FG000|Risk Stratification Period|Bone marrow transplant|0|||
146318725|NCT00720109|527677058|FG001|Risk Stratification Period|Bone marrow transplant|9|||
146318726|NCT00720109|527677059|FG002|Risk Stratification Period|Bone marrow transplant|7|||
146318727|NCT00720109|527677057|FG000|Risk Stratification Period|Disease progression or relapse|0|||
146318728|NCT00720109|527677058|FG001|Risk Stratification Period|Disease progression or relapse|2|||
146318729|NCT00720109|527677059|FG002|Risk Stratification Period|Disease progression or relapse|0|||
146318730|NCT00720109|527677057|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
146318731|NCT00720109|527677058|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
146318732|NCT00720109|527677059|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
146318733|NCT03467958|527677060|FG000|Overall Study|Adverse Event|20|||
146318734|NCT03467958|527677061|FG001|Overall Study|Adverse Event|32|||
146318735|NCT03467958|527677062|FG002|Overall Study|Adverse Event|5|||
146318736|NCT03467958|527677063|FG003|Overall Study|Adverse Event|3|||
146318737|NCT03467958|527677064|FG004|Overall Study|Adverse Event|3|||
146318738|NCT03467958|527677065|FG005|Overall Study|Adverse Event|3|||
146318739|NCT03467958|527677066|FG006|Overall Study|Adverse Event|6|||
146318740|NCT03467958|527677067|FG007|Overall Study|Adverse Event|5|||
146318741|NCT03467958|527677068|FG008|Overall Study|Adverse Event|0|||
146318742|NCT03467958|527677060|FG000|Overall Study|Lack of Efficacy|59|||
146318743|NCT03467958|527677061|FG001|Overall Study|Lack of Efficacy|120|||
146318744|NCT03467958|527677062|FG002|Overall Study|Lack of Efficacy|6|||
146318745|NCT03467958|527677063|FG003|Overall Study|Lack of Efficacy|9|||
146318746|NCT03467958|527677064|FG004|Overall Study|Lack of Efficacy|8|||
146318747|NCT03467958|527677065|FG005|Overall Study|Lack of Efficacy|9|||
146318748|NCT03467958|527677066|FG006|Overall Study|Lack of Efficacy|11|||
146318749|NCT03467958|527677067|FG007|Overall Study|Lack of Efficacy|9|||
146318750|NCT03467958|527677068|FG008|Overall Study|Lack of Efficacy|3|||
146318751|NCT03467958|527677060|FG000|Overall Study|Lost to Follow-up|1|||
146318752|NCT03467958|527677061|FG001|Overall Study|Lost to Follow-up|2|||
146318753|NCT03467958|527677062|FG002|Overall Study|Lost to Follow-up|1|||
146318754|NCT03467958|527677063|FG003|Overall Study|Lost to Follow-up|0|||
146318755|NCT03467958|527677064|FG004|Overall Study|Lost to Follow-up|4|||
146318756|NCT03467958|527677065|FG005|Overall Study|Lost to Follow-up|0|||
146318757|NCT03467958|527677066|FG006|Overall Study|Lost to Follow-up|0|||
146318758|NCT03467958|527677067|FG007|Overall Study|Lost to Follow-up|0|||
146318759|NCT03467958|527677068|FG008|Overall Study|Lost to Follow-up|0|||
146318760|NCT03467958|527677060|FG000|Overall Study|Other reasons|8|||
146318761|NCT03467958|527677061|FG001|Overall Study|Other reasons|14|||
146318762|NCT03467958|527677062|FG002|Overall Study|Other reasons|2|||
146318763|NCT03467958|527677063|FG003|Overall Study|Other reasons|1|||
146318764|NCT03467958|527677064|FG004|Overall Study|Other reasons|4|||
146318765|NCT03467958|527677065|FG005|Overall Study|Other reasons|0|||
146318766|NCT03467958|527677066|FG006|Overall Study|Other reasons|1|||
146318767|NCT03467958|527677067|FG007|Overall Study|Other reasons|0|||
146318768|NCT03467958|527677068|FG008|Overall Study|Other reasons|1|||
146318769|NCT03467958|527677060|FG000|Overall Study|Pregnancy|1|||
146318770|NCT03467958|527677061|FG001|Overall Study|Pregnancy|0|||
146318771|NCT03467958|527677062|FG002|Overall Study|Pregnancy|0|||
146318772|NCT03467958|527677063|FG003|Overall Study|Pregnancy|0|||
146318773|NCT03467958|527677064|FG004|Overall Study|Pregnancy|0|||
146318774|NCT03467958|527677065|FG005|Overall Study|Pregnancy|1|||
146318775|NCT03467958|527677066|FG006|Overall Study|Pregnancy|0|||
146318776|NCT03467958|527677067|FG007|Overall Study|Pregnancy|0|||
146318777|NCT03467958|527677068|FG008|Overall Study|Pregnancy|0|||
146318778|NCT03467958|527677060|FG000|Overall Study|Study terminated by sponsor|65|||
146318779|NCT03467958|527677061|FG001|Overall Study|Study terminated by sponsor|117|||
146318780|NCT03467958|527677062|FG002|Overall Study|Study terminated by sponsor|45|||
146318781|NCT03467958|527677063|FG003|Overall Study|Study terminated by sponsor|64|||
146318782|NCT03467958|527677064|FG004|Overall Study|Study terminated by sponsor|66|||
146318783|NCT03467958|527677065|FG005|Overall Study|Study terminated by sponsor|17|||
146318784|NCT03467958|527677066|FG006|Overall Study|Study terminated by sponsor|11|||
146318785|NCT03467958|527677067|FG007|Overall Study|Study terminated by sponsor|5|||
146318786|NCT03467958|527677068|FG008|Overall Study|Study terminated by sponsor|5|||
146318787|NCT03467958|527677060|FG000|Overall Study|Withdrawal by Subject|25|||
146318788|NCT03467958|527677061|FG001|Overall Study|Withdrawal by Subject|44|||
146164525|NCT04555096|527112612|FG000|Overall Study|Other|0|||
146164526|NCT04555096|527112613|FG001|Overall Study|Other|1|||
146164527|NCT03172702|527112616|FG000|Overall Study|Adverse Event|9|||
146318789|NCT03467958|527677062|FG002|Overall Study|Withdrawal by Subject|7|||
146318790|NCT03467958|527677063|FG003|Overall Study|Withdrawal by Subject|8|||
146164528|NCT03172702|527112616|FG000|Overall Study|Death|2|||
146318791|NCT03467958|527677064|FG004|Overall Study|Withdrawal by Subject|6|||
146318792|NCT03467958|527677065|FG005|Overall Study|Withdrawal by Subject|8|||
146318793|NCT03467958|527677066|FG006|Overall Study|Withdrawal by Subject|4|||
146318794|NCT03467958|527677067|FG007|Overall Study|Withdrawal by Subject|1|||
146318795|NCT03467958|527677068|FG008|Overall Study|Withdrawal by Subject|4|||
146318796|NCT00866307|527677070|FG000|Induction|Adverse Event|5|||
146318797|NCT00866307|527677071|FG001|Induction|Adverse Event|0|||
146318798|NCT00866307|527677072|FG002|Induction|Adverse Event|0|||
146318799|NCT00866307|527677070|FG000|Induction|Death|2|||
146318800|NCT00866307|527677071|FG001|Induction|Death|0|||
146318801|NCT00866307|527677072|FG002|Induction|Death|0|||
146318802|NCT00866307|527677070|FG000|Induction|Physician Decision|5|||
146318803|NCT00866307|527677071|FG001|Induction|Physician Decision|0|||
146318804|NCT00866307|527677072|FG002|Induction|Physician Decision|0|||
146318805|NCT00866307|527677070|FG000|Induction|Progressive Disease|1|||
146318806|NCT00866307|527677071|FG001|Induction|Progressive Disease|0|||
146318807|NCT00866307|527677072|FG002|Induction|Progressive Disease|0|||
146318808|NCT00866307|527677070|FG000|Induction|Identification of Patients with Day 29 M|3|||
146318809|NCT00866307|527677071|FG001|Induction|Identification of Patients with Day 29 M|0|||
146318810|NCT00866307|527677072|FG002|Induction|Identification of Patients with Day 29 M|0|||
146318811|NCT00866307|527677070|FG000|Induction|Inadequate cytognetic samples th|1|||
146318812|NCT00866307|527677071|FG001|Induction|Inadequate cytognetic samples th|0|||
146318813|NCT00866307|527677072|FG002|Induction|Inadequate cytognetic samples th|0|||
146318814|NCT00866307|527677070|FG000|Induction|Improper post-induction consent|2|||
146318815|NCT00866307|527677071|FG001|Induction|Improper post-induction consent|0|||
146318816|NCT00866307|527677072|FG002|Induction|Improper post-induction consent|0|||
146318817|NCT00866307|527677070|FG000|Induction|Study was closed at the time|1|||
146318818|NCT00866307|527677071|FG001|Induction|Study was closed at the time|0|||
146318819|NCT00866307|527677072|FG002|Induction|Study was closed at the time|0|||
146318820|NCT00866307|527677070|FG000|Consolidation/Maintenance|Adverse Event|0|||
146318821|NCT00866307|527677071|FG001|Consolidation/Maintenance|Adverse Event|0|||
146318822|NCT00866307|527677072|FG002|Consolidation/Maintenance|Adverse Event|8|||
146318823|NCT00866307|527677070|FG000|Consolidation/Maintenance|Death|0|||
146318824|NCT00866307|527677071|FG001|Consolidation/Maintenance|Death|0|||
146318825|NCT00866307|527677072|FG002|Consolidation/Maintenance|Death|1|||
146318826|NCT00866307|527677070|FG000|Consolidation/Maintenance|Physician Decision|0|||
146318827|NCT00866307|527677071|FG001|Consolidation/Maintenance|Physician Decision|3|||
146318828|NCT00866307|527677072|FG002|Consolidation/Maintenance|Physician Decision|2|||
146318829|NCT00866307|527677070|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
146318830|NCT00866307|527677071|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
146318831|NCT00866307|527677072|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
146318832|NCT00866307|527677070|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
146318833|NCT00866307|527677071|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
146318834|NCT00866307|527677072|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
146318835|NCT00866307|527677070|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
146318836|NCT00866307|527677071|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
146318837|NCT00866307|527677072|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
146318838|NCT00866307|527677070|FG000|Consolidation/Maintenance|Therapy error|0|||
146318839|NCT00866307|527677071|FG001|Consolidation/Maintenance|Therapy error|1|||
146318840|NCT00866307|527677072|FG002|Consolidation/Maintenance|Therapy error|0|||
146318841|NCT00866307|527677070|FG000|Consolidation/Maintenance|Non-compliance|0|||
146318842|NCT00866307|527677071|FG001|Consolidation/Maintenance|Non-compliance|0|||
146318843|NCT00866307|527677072|FG002|Consolidation/Maintenance|Non-compliance|1|||
146318844|NCT00866307|527677070|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
146318845|NCT00866307|527677071|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
146318846|NCT00866307|527677072|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
146318847|NCT02925156|527677073|FG000|Overall Study|Lost to Follow-up|27|||
146318848|NCT02925156|527677074|FG001|Overall Study|Lost to Follow-up|53|||
146318849|NCT02925156|527677075|FG002|Overall Study|Lost to Follow-up|51|||
146318850|NCT02925156|527677076|FG003|Overall Study|Lost to Follow-up|59|||
146318851|NCT02925156|527677077|FG004|Overall Study|Lost to Follow-up|89|||
146318852|NCT02925156|527677078|FG005|Overall Study|Lost to Follow-up|107|||
146318853|NCT02925156|527677079|FG006|Overall Study|Lost to Follow-up|34|||
146318854|NCT02925156|527677080|FG007|Overall Study|Lost to Follow-up|36|||
146318855|NCT02925156|527677081|FG008|Overall Study|Lost to Follow-up|73|||
146318856|NCT02925156|527677082|FG009|Overall Study|Lost to Follow-up|34|||
146318857|NCT01687712|527677083|FG000|Cycle 1|Not Biochemically Pregnant|386|||
146318858|NCT01687712|527677084|FG001|Cycle 1|Not Biochemically Pregnant|348|||
146318859|NCT01687712|527677083|FG000|Cycle 1|Early Pregnancy Loss|43|||
146318860|NCT01687712|527677084|FG001|Cycle 1|Early Pregnancy Loss|60|||
146164529|NCT03172702|527112616|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
146318861|NCT01687712|527677083|FG000|Cycle 1|Ectopic Pregnancy|5|||
146318862|NCT01687712|527677084|FG001|Cycle 1|Ectopic Pregnancy|5|||
146318863|NCT01687712|527677083|FG000|Cycle 1|Heterotropic Pregnancy|1|||
146318864|NCT01687712|527677084|FG001|Cycle 1|Heterotropic Pregnancy|0|||
146318865|NCT01687712|527677083|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
146318866|NCT01687712|527677084|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
146318867|NCT01687712|527677083|FG000|Cycle 1|Abortion|3|||
146318868|NCT01687712|527677084|FG001|Cycle 1|Abortion|0|||
146318869|NCT01687712|527677083|FG000|Cycle 1|Intrauterine Fetal Death|0|||
146318870|NCT01687712|527677084|FG001|Cycle 1|Intrauterine Fetal Death|1|||
146318871|NCT01687712|527677083|FG000|Cycle 1|Lost to Follow-up|1|||
146318872|NCT01687712|527677084|FG001|Cycle 1|Lost to Follow-up|1|||
146318873|NCT01687712|527677083|FG000|Cycle 2|Not Biochemically Pregnant|74|||
146318874|NCT01687712|527677084|FG001|Cycle 2|Not Biochemically Pregnant|77|||
146318875|NCT01687712|527677083|FG000|Cycle 2|Early Pregnancy Loss|18|||
146318876|NCT01687712|527677084|FG001|Cycle 2|Early Pregnancy Loss|16|||
146318877|NCT01687712|527677083|FG000|Cycle 2|Ectopic Pregnancy|0|||
146318878|NCT01687712|527677084|FG001|Cycle 2|Ectopic Pregnancy|1|||
146318879|NCT01687712|527677083|FG000|Cycle 2|Still Birth|1|||
146318880|NCT01687712|527677084|FG001|Cycle 2|Still Birth|0|||
146318881|NCT01687712|527677083|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
146318882|NCT01687712|527677084|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
146318883|NCT01687712|527677083|FG000|Cycle 3|Not Biochemically Pregnant|21|||
146318884|NCT01687712|527677084|FG001|Cycle 3|Not Biochemically Pregnant|22|||
146318885|NCT01687712|527677083|FG000|Cycle 3|Early Pregnancy Loss|1|||
146318886|NCT01687712|527677084|FG001|Cycle 3|Early Pregnancy Loss|2|||
146318887|NCT01687712|527677083|FG000|Cycle 3|Ectopic Pregnancy|1|||
146318888|NCT01687712|527677084|FG001|Cycle 3|Ectopic Pregnancy|0|||
146318889|NCT01687712|527677083|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
146318890|NCT01687712|527677084|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
146318891|NCT01681433|527677085|FG000|Overall Study|Lack of Efficacy|23|||
146318892|NCT01681433|527677086|FG001|Overall Study|Lack of Efficacy|23|||
146318893|NCT01681433|527677085|FG000|Overall Study|Withdrawal by Subject|5|||
146318894|NCT01681433|527677086|FG001|Overall Study|Withdrawal by Subject|5|||
146318895|NCT01681433|527677085|FG000|Overall Study|Protocol Violation|2|||
146318896|NCT01681433|527677086|FG001|Overall Study|Protocol Violation|0|||
146318897|NCT01681433|527677085|FG000|Overall Study|Adverse Event|2|||
146318898|NCT01681433|527677086|FG001|Overall Study|Adverse Event|4|||
146318899|NCT01681433|527677085|FG000|Overall Study|Lost to Follow-up|0|||
146318900|NCT01681433|527677086|FG001|Overall Study|Lost to Follow-up|1|||
146318901|NCT00903929|527677087|FG000|Overall Study|Withdrawal by Subject|0|||
146318902|NCT00903929|527677088|FG001|Overall Study|Withdrawal by Subject|0|||
146318903|NCT00903929|527677089|FG002|Overall Study|Withdrawal by Subject|1|||
146318904|NCT00903929|527677090|FG003|Overall Study|Withdrawal by Subject|2|||
146318905|NCT00903929|527677087|FG000|Overall Study|Adverse Event|0|||
146318906|NCT00903929|527677088|FG001|Overall Study|Adverse Event|0|||
146318907|NCT00903929|527677089|FG002|Overall Study|Adverse Event|0|||
146318908|NCT00903929|527677090|FG003|Overall Study|Adverse Event|1|||
146318909|NCT04947800|527677092|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
146318910|NCT04947800|527677093|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
146318911|NCT04947800|527677094|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
146318912|NCT03977467|527677095|FG000|Overall Study|Disease Progression|1|||
146318913|NCT03977467|527677096|FG001|Overall Study|Disease Progression|1|||
146318914|NCT03977467|527677097|FG002|Overall Study|Disease Progression|30|||
146318915|NCT03977467|527677098|FG003|Overall Study|Disease Progression|0|||
146318916|NCT03977467|527677095|FG000|Overall Study|Adverse Event|0|||
146318917|NCT03977467|527677096|FG001|Overall Study|Adverse Event|1|||
146318918|NCT03977467|527677097|FG002|Overall Study|Adverse Event|0|||
146318919|NCT03977467|527677098|FG003|Overall Study|Adverse Event|0|||
146318920|NCT03977467|527677095|FG000|Overall Study|Death|0|||
146318921|NCT03977467|527677096|FG001|Overall Study|Death|0|||
146318922|NCT03977467|527677097|FG002|Overall Study|Death|3|||
146318923|NCT03977467|527677098|FG003|Overall Study|Death|0|||
146318924|NCT03977467|527677095|FG000|Overall Study|Lack of Efficacy|0|||
146318925|NCT03977467|527677096|FG001|Overall Study|Lack of Efficacy|0|||
146318926|NCT03977467|527677097|FG002|Overall Study|Lack of Efficacy|1|||
146318927|NCT03977467|527677098|FG003|Overall Study|Lack of Efficacy|0|||
146318928|NCT03977467|527677095|FG000|Overall Study|Withdrawal by Subject|2|||
146318929|NCT03977467|527677096|FG001|Overall Study|Withdrawal by Subject|1|||
146318930|NCT03977467|527677097|FG002|Overall Study|Withdrawal by Subject|4|||
146318931|NCT03977467|527677098|FG003|Overall Study|Withdrawal by Subject|0|||
146318932|NCT03977467|527677095|FG000|Overall Study|Study Terminated|1|||
146164530|NCT03172702|527112616|FG000|Overall Study|Withdrawal by Subject|5|||
146164531|NCT03172702|527112616|FG000|Overall Study|Other|2|||
146164532|NCT02954354|527112617|FG000|Overall Study|Adverse Event|2|||
146164533|NCT02954354|527112618|FG001|Overall Study|Adverse Event|2|||
146318933|NCT03977467|527677096|FG001|Overall Study|Study Terminated|0|||
146318934|NCT03977467|527677097|FG002|Overall Study|Study Terminated|0|||
146318935|NCT03977467|527677098|FG003|Overall Study|Study Terminated|1|||
146318936|NCT01314716|527677099|FG000|Double-Blind Phase|Randomized but not treated|1|||
146318937|NCT01314716|527677100|FG001|Double-Blind Phase|Randomized but not treated|1|||
146318938|NCT01314716|527677099|FG000|Double-Blind Phase|Adverse Event|10|||
146318939|NCT01314716|527677100|FG001|Double-Blind Phase|Adverse Event|4|||
146318940|NCT01314716|527677099|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
146318941|NCT01314716|527677100|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
146318942|NCT01314716|527677099|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146318943|NCT01314716|527677100|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146318944|NCT01314716|527677099|FG000|Double-Blind Phase|Sponsor request|1|||
146318945|NCT01314716|527677100|FG001|Double-Blind Phase|Sponsor request|2|||
146318946|NCT01314716|527677099|FG000|Double-Blind Phase|Physician Decision|0|||
146318947|NCT01314716|527677100|FG001|Double-Blind Phase|Physician Decision|1|||
146318948|NCT01314716|527677099|FG000|Open-Label Phase|Adverse Event|4|||
146318949|NCT01314716|527677100|FG001|Open-Label Phase|Adverse Event|6|||
146318950|NCT01314716|527677099|FG000|Open-Label Phase|Withdrawal by Subject|1|||
146318951|NCT01314716|527677100|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146318952|NCT01314716|527677099|FG000|Open-Label Phase|Physician Decision|5|||
146318953|NCT01314716|527677100|FG001|Open-Label Phase|Physician Decision|4|||
146318954|NCT00700271|527677101|FG000|Overall Study|Adverse Event|4|||
146318955|NCT00700271|527677102|FG001|Overall Study|Adverse Event|6|||
146318956|NCT00700271|527677101|FG000|Overall Study|Protocol Violation|1|||
146318957|NCT00700271|527677102|FG001|Overall Study|Protocol Violation|0|||
146318958|NCT00700271|527677101|FG000|Overall Study|Administrative Reasons|1|||
146318959|NCT00700271|527677102|FG001|Overall Study|Administrative Reasons|0|||
146318960|NCT00700271|527677101|FG000|Overall Study|Withdrawal by Subject|6|||
146318961|NCT00700271|527677102|FG001|Overall Study|Withdrawal by Subject|4|||
146318962|NCT00700271|527677101|FG000|Overall Study|Lost to Follow-up|2|||
146318963|NCT00700271|527677102|FG001|Overall Study|Lost to Follow-up|2|||
146318964|NCT04440592|527677103|FG000|Overall Study|Adverse Event|8|||
146318965|NCT04440592|527677104|FG001|Overall Study|Adverse Event|0|||
146318966|NCT04440592|527677103|FG000|Overall Study|Lost to Follow-up|1|||
146318967|NCT04440592|527677104|FG001|Overall Study|Lost to Follow-up|0|||
146318968|NCT04440592|527677103|FG000|Overall Study|Withdrawal by Subject|1|||
146318969|NCT04440592|527677104|FG001|Overall Study|Withdrawal by Subject|1|||
146318970|NCT04440592|527677103|FG000|Overall Study|Other therapy needed|0|||
146318971|NCT04440592|527677104|FG001|Overall Study|Other therapy needed|1|||
146318972|NCT02028455|527677107|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318973|NCT02028455|527677108|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318974|NCT02028455|527677109|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318975|NCT02028455|527677110|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318976|NCT02028455|527677111|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318977|NCT02028455|527677112|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
146318978|NCT02028455|527677113|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
146318979|NCT02028455|527677114|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
146318980|NCT02028455|527677107|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
146318981|NCT02028455|527677108|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
146318982|NCT02028455|527677109|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
146318983|NCT02028455|527677110|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
146318984|NCT02028455|527677111|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
146318985|NCT02028455|527677112|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
146318986|NCT02028455|527677113|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
146318987|NCT02028455|527677114|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
146318988|NCT02028455|527677107|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318989|NCT02028455|527677108|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318990|NCT02028455|527677109|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318991|NCT02028455|527677110|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318992|NCT02028455|527677111|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318993|NCT02028455|527677112|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
146318994|NCT02028455|527677113|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
146318995|NCT02028455|527677114|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
146318996|NCT02028455|527677107|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146318997|NCT02028455|527677108|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146318998|NCT02028455|527677109|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
146318999|NCT02028455|527677110|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
146319000|NCT02028455|527677111|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146319001|NCT02028455|527677112|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
146319002|NCT02028455|527677113|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
146319003|NCT02028455|527677114|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
146319004|NCT03087955|527679364|FG000|Overall Study|Death|4|||
146319005|NCT03087955|527679365|FG001|Overall Study|Death|0|||
146319006|NCT03087955|527679364|FG000|Overall Study|Lack of Efficacy|2|||
146319007|NCT03087955|527679365|FG001|Overall Study|Lack of Efficacy|0|||
146319008|NCT03087955|527679364|FG000|Overall Study|Lost to Follow-up|1|||
146319009|NCT03087955|527679365|FG001|Overall Study|Lost to Follow-up|0|||
146319010|NCT04441905|527679366|FG000|Overall Study|Lost to Follow-up|1|||
146319011|NCT04441905|527679367|FG001|Overall Study|Lost to Follow-up|0|||
146164534|NCT02954354|527112619|FG002|Overall Study|Adverse Event|4|||
146164535|NCT02954354|527112617|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
146319012|NCT04441905|527679368|FG002|Overall Study|Lost to Follow-up|0|||
146319013|NCT04441905|527679369|FG003|Overall Study|Lost to Follow-up|0|||
146319014|NCT04441905|527679370|FG004|Overall Study|Lost to Follow-up|0|||
146319015|NCT04441905|527679371|FG005|Overall Study|Lost to Follow-up|0|||
146319016|NCT04441905|527679366|FG000|Overall Study|Enrolled but treatment not administered|0|||
146319017|NCT04441905|527679367|FG001|Overall Study|Enrolled but treatment not administered|1|||
146319018|NCT04441905|527679368|FG002|Overall Study|Enrolled but treatment not administered|0|||
146319019|NCT04441905|527679369|FG003|Overall Study|Enrolled but treatment not administered|0|||
146319020|NCT04441905|527679370|FG004|Overall Study|Enrolled but treatment not administered|0|||
146319021|NCT04441905|527679371|FG005|Overall Study|Enrolled but treatment not administered|0|||
146319022|NCT04441905|527679366|FG000|Overall Study|Became ineligible after enrollment|0|||
146319023|NCT04441905|527679367|FG001|Overall Study|Became ineligible after enrollment|0|||
146319024|NCT04441905|527679368|FG002|Overall Study|Became ineligible after enrollment|0|||
146319025|NCT04441905|527679369|FG003|Overall Study|Became ineligible after enrollment|0|||
146319026|NCT04441905|527679370|FG004|Overall Study|Became ineligible after enrollment|1|||
146319027|NCT04441905|527679371|FG005|Overall Study|Became ineligible after enrollment|0|||
146319028|NCT02392429|527679372|FG000|Screening|Screen failure|15|||
146319029|NCT02392429|527679372|FG000|Enrolled Participants|Ineligible due to disease|3|||
146319030|NCT02392429|527679372|FG000|Enrolled Participants|Withdrawal by Subject|4|||
146319031|NCT02392429|527679372|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
146319032|NCT02392429|527679372|FG000|Evaluable|Death|5|||
146319033|NCT02392429|527679372|FG000|Evaluable|Withdrawal by Subject|1|||
146319034|NCT02392429|527679372|FG000|Evaluable|Adverse Event|1|||
146319035|NCT02392429|527679372|FG000|Evaluable|remission bone marrow biopsy|3|||
146319036|NCT02968810|527679376|FG000|Overall Study|Lost to Follow-up|1|||
146319037|NCT02968810|527679377|FG001|Overall Study|Lost to Follow-up|0|||
146319038|NCT02968810|527679376|FG000|Overall Study|Physician Decision|1|||
146319039|NCT02968810|527679377|FG001|Overall Study|Physician Decision|0|||
146319040|NCT02968810|527679376|FG000|Overall Study|Withdrawal by Subject|1|||
146319041|NCT02968810|527679377|FG001|Overall Study|Withdrawal by Subject|3|||
146319042|NCT02968810|527679376|FG000|Overall Study|Disease Progression|0|||
146319043|NCT02968810|527679377|FG001|Overall Study|Disease Progression|1|||
146319044|NCT00130832|527679378|FG000|Overall Study|Adverse Event|1|||
146319045|NCT00130832|527679379|FG001|Overall Study|Adverse Event|1|||
146319046|NCT00130832|527679378|FG000|Overall Study|Lost to Follow-up|1|||
146319047|NCT00130832|527679379|FG001|Overall Study|Lost to Follow-up|2|||
146319048|NCT00130832|527679378|FG000|Overall Study|Protocol Violation|6|||
146319049|NCT00130832|527679379|FG001|Overall Study|Protocol Violation|8|||
146319050|NCT00130832|527679378|FG000|Overall Study|Withdrawal by Subject|6|||
146319051|NCT00130832|527679379|FG001|Overall Study|Withdrawal by Subject|1|||
146319052|NCT00130832|527679378|FG000|Overall Study|Moved|2|||
146319053|NCT00130832|527679379|FG001|Overall Study|Moved|2|||
146319054|NCT00130832|527679378|FG000|Overall Study|Other|0|||
146319055|NCT00130832|527679379|FG001|Overall Study|Other|3|||
146319056|NCT03905863|527679380|FG000|Overall Study|Adverse Event|2|||
146319057|NCT03905863|527679381|FG001|Overall Study|Adverse Event|4|||
146319058|NCT03905863|527679380|FG000|Overall Study|Withdrawal by Subject|2|||
146319059|NCT03905863|527679381|FG001|Overall Study|Withdrawal by Subject|2|||
146319060|NCT03905863|527679380|FG000|Overall Study|Physician Decision|0|||
146319061|NCT03905863|527679381|FG001|Overall Study|Physician Decision|3|||
146319062|NCT03905863|527679380|FG000|Overall Study|Lost to Follow-up|1|||
146319063|NCT03905863|527679381|FG001|Overall Study|Lost to Follow-up|0|||
146319064|NCT03905863|527679380|FG000|Overall Study|Protocol Violation|0|||
146319065|NCT03905863|527679381|FG001|Overall Study|Protocol Violation|2|||
146319066|NCT03905863|527679380|FG000|Overall Study|Death|0|||
146319067|NCT03905863|527679381|FG001|Overall Study|Death|1|||
146319068|NCT00618748|527679382|FG000|Overall Study|Adverse Event|4|||
146319069|NCT00618748|527679383|FG001|Overall Study|Adverse Event|3|||
146319070|NCT00618748|527679384|FG002|Overall Study|Adverse Event|8|||
146319071|NCT00618748|527679382|FG000|Overall Study|Physician Decision|3|||
146319072|NCT00618748|527679383|FG001|Overall Study|Physician Decision|1|||
146319073|NCT00618748|527679384|FG002|Overall Study|Physician Decision|1|||
146319074|NCT00618748|527679382|FG000|Overall Study|Withdrawal by Subject|4|||
146319075|NCT00618748|527679383|FG001|Overall Study|Withdrawal by Subject|1|||
146319076|NCT00618748|527679384|FG002|Overall Study|Withdrawal by Subject|5|||
146319077|NCT04401267|527679385|FG000|Overall Study|Death|0|||
146319078|NCT04401267|527679386|FG001|Overall Study|Death|1|||
146319079|NCT04401267|527679385|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
146319080|NCT04401267|527679386|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
146319081|NCT04401267|527679385|FG000|Overall Study|Found to be Ineligible|1|||
146319082|NCT04401267|527679386|FG001|Overall Study|Found to be Ineligible|0|||
146319083|NCT02770326|527679391|FG000|Overall Study|Death|3|||
146319084|NCT02770326|527679391|FG000|Overall Study|Lost to Follow-up|1|||
146319085|NCT03124784|527679393|FG000|Overall Study|Adverse Event|1|||
146319086|NCT03124784|527679393|FG000|Overall Study|Computer/Equip Malfunction|1|||
146319087|NCT01467492|527679394|FG000|Overall Study|Withdrawal by Subject|6|||
145943222|NCT00483704|526300457|FG001|Treatment|Adverse Event|5|||
145943223|NCT00483704|526300458|FG002|Treatment|Adverse Event|4|||
146319088|NCT01467492|527679395|FG001|Overall Study|Withdrawal by Subject|4|||
146319089|NCT01467492|527679394|FG000|Overall Study|Study Terminated by Sponsor|6|||
146319090|NCT01467492|527679395|FG001|Overall Study|Study Terminated by Sponsor|4|||
146319091|NCT01467492|527679394|FG000|Overall Study|Adverse Event|4|||
146319092|NCT01467492|527679395|FG001|Overall Study|Adverse Event|3|||
146319093|NCT01467492|527679394|FG000|Overall Study|Lost to Follow-up|3|||
146319094|NCT01467492|527679395|FG001|Overall Study|Lost to Follow-up|2|||
146319095|NCT01467492|527679394|FG000|Overall Study|Undefined|2|||
146319096|NCT01467492|527679395|FG001|Overall Study|Undefined|0|||
146319097|NCT01467492|527679394|FG000|Overall Study|Enrolled But Not Treated|1|||
146319098|NCT01467492|527679395|FG001|Overall Study|Enrolled But Not Treated|0|||
146319099|NCT01453855|527679396|FG000|Overall Study|Adverse Event|3|||
146319100|NCT01453855|527679397|FG001|Overall Study|Adverse Event|4|||
146319101|NCT01453855|527679396|FG000|Overall Study|Lost to Follow-up|2|||
146319102|NCT01453855|527679397|FG001|Overall Study|Lost to Follow-up|1|||
146319103|NCT01453855|527679396|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
146319104|NCT01453855|527679397|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
146319105|NCT01453855|527679396|FG000|Overall Study|Noncompliance|1|||
146319106|NCT01453855|527679397|FG001|Overall Study|Noncompliance|0|||
146319107|NCT01453855|527679396|FG000|Overall Study|Inadequate Control of IOP|1|||
146319108|NCT01453855|527679397|FG001|Overall Study|Inadequate Control of IOP|5|||
146319109|NCT01453855|527679396|FG000|Overall Study|Other|0|||
146319110|NCT01453855|527679397|FG001|Overall Study|Other|1|||
146319111|NCT01285908|527679400|FG000|Baseline Measurement|unable to insert catheter|1|||
146319112|NCT01285908|527679401|FG001|Baseline Measurement|unable to insert catheter|0|||
146319113|NCT01285908|527679402|FG002|Baseline Measurement|unable to insert catheter|0|||
146319114|NCT01285908|527679400|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
146319115|NCT01285908|527679401|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
146319116|NCT01285908|527679402|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
146319117|NCT01285908|527679400|FG000|Baseline Measurement|unable to tolerate procedure|1|||
146319118|NCT01285908|527679401|FG001|Baseline Measurement|unable to tolerate procedure|0|||
146319119|NCT01285908|527679402|FG002|Baseline Measurement|unable to tolerate procedure|0|||
146319120|NCT01562548|527679403|FG000|Overall Study|Lost to Follow-up|0|||
146319121|NCT01562548|527679404|FG001|Overall Study|Lost to Follow-up|0|||
146319122|NCT01562548|527679405|FG002|Overall Study|Lost to Follow-up|1|||
146319123|NCT01562548|527679406|FG003|Overall Study|Lost to Follow-up|0|||
146319124|NCT02926209|527679407|FG000|Study Cohort|Poor Bowel Preparation|1|||
146319125|NCT02926209|527679408|FG001|Study Cohort|Poor Bowel Preparation|0|||
146319126|NCT01239160|527679409|FG000|Overall Study|Lost to Follow-up|3|||
146319127|NCT01239160|527679410|FG001|Overall Study|Lost to Follow-up|5|||
146319128|NCT01239160|527679411|FG002|Overall Study|Lost to Follow-up|0|||
146319129|NCT01239160|527679409|FG000|Overall Study|Withdrawal by Subject|17|||
146319130|NCT01239160|527679410|FG001|Overall Study|Withdrawal by Subject|6|||
146319131|NCT01239160|527679411|FG002|Overall Study|Withdrawal by Subject|2|||
146319132|NCT01239160|527679409|FG000|Overall Study|Physician Decision|5|||
146319133|NCT01239160|527679410|FG001|Overall Study|Physician Decision|7|||
146319134|NCT01239160|527679411|FG002|Overall Study|Physician Decision|2|||
146319135|NCT01239160|527679409|FG000|Overall Study|Early Termination Due to Study Closure|0|||
146319136|NCT01239160|527679410|FG001|Overall Study|Early Termination Due to Study Closure|1|||
146319137|NCT01239160|527679411|FG002|Overall Study|Early Termination Due to Study Closure|6|||
146319138|NCT01764633|527679412|FG000|Overall Study|Withdrawal by Subject|105|||
146319139|NCT01764633|527679413|FG001|Overall Study|Withdrawal by Subject|88|||
146319140|NCT01764633|527679412|FG000|Overall Study|Lost to Follow-up|13|||
146164536|NCT02954354|527112618|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
146164537|NCT02954354|527112619|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
146164538|NCT02954354|527112617|FG000|Overall Study|Lack of Efficacy|0|||
146164539|NCT02954354|527112618|FG001|Overall Study|Lack of Efficacy|2|||
146164540|NCT02954354|527112619|FG002|Overall Study|Lack of Efficacy|0|||
146164541|NCT02954354|527112617|FG000|Overall Study|Withdrawal by Subject|17|||
146164542|NCT02954354|527112618|FG001|Overall Study|Withdrawal by Subject|9|||
146164543|NCT02954354|527112619|FG002|Overall Study|Withdrawal by Subject|11|||
146164544|NCT02954354|527112617|FG000|Overall Study|Lost to Follow-up|12|||
146164545|NCT02954354|527112618|FG001|Overall Study|Lost to Follow-up|5|||
146164546|NCT02954354|527112619|FG002|Overall Study|Lost to Follow-up|0|||
146319141|NCT01764633|527679413|FG001|Overall Study|Lost to Follow-up|5|||
146319142|NCT04781816|527679419|FG000|Overall Study|Adverse Event|0|||
146319143|NCT04781816|527679420|FG001|Overall Study|Adverse Event|1|||
146319144|NCT04781816|527679419|FG000|Overall Study|Withdrawal by Subject|1|||
146319145|NCT04781816|527679420|FG001|Overall Study|Withdrawal by Subject|1|||
146319146|NCT04781816|527679419|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
146319147|NCT04781816|527679420|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
146319148|NCT02062658|527679421|FG000|Overall Study|Withdrawal by Subject|1|||
146319149|NCT02062658|527679421|FG000|Overall Study|Lack of Efficacy|1|||
146319150|NCT01121393|527679422|FG000|Overall Study|Progressive disease|201|||
146319151|NCT01121393|527679423|FG001|Overall Study|Progressive disease|20|||
145943224|NCT00483704|526300456|FG000|Treatment|Withdrawal by Subject|16|||
146164547|NCT02954354|527112617|FG000|Overall Study|Miscellaneous|2|||
146164548|NCT02954354|527112618|FG001|Overall Study|Miscellaneous|2|||
146164549|NCT02954354|527112619|FG002|Overall Study|Miscellaneous|1|||
146164550|NCT06134180|527112622|FG000|Overall Study|Lost to Follow-up|4|||
146164551|NCT04495179|527112627|FG000|Overall Study|Lost to Follow-up|0|||
146164552|NCT04495179|527112628|FG001|Overall Study|Lost to Follow-up|1|||
146164553|NCT04495179|527112627|FG000|Overall Study|Withdrawal by Subject|2|||
146164554|NCT04495179|527112628|FG001|Overall Study|Withdrawal by Subject|4|||
146164555|NCT04495179|527112627|FG000|Overall Study|Study terminated by sponsor|0|||
146164556|NCT04495179|527112628|FG001|Overall Study|Study terminated by sponsor|18|||
146164557|NCT04495179|527112627|FG000|Overall Study|Death|0|||
146164558|NCT04495179|527112628|FG001|Overall Study|Death|4|||
146164559|NCT04495179|527112627|FG000|Overall Study|Adverse Event|0|||
146164560|NCT04495179|527112628|FG001|Overall Study|Adverse Event|1|||
146164561|NCT00569582|527112629|FG000|Overall Study|Withdrawal by Subject|5|||
146164562|NCT00569582|527112629|FG000|Overall Study|Death|2|||
146164563|NCT00569582|527112629|FG000|Overall Study|Adverse Event|7|||
146164564|NCT00569582|527112629|FG000|Overall Study|Subject was too ill to travel.|1|||
146164565|NCT00569582|527112629|FG000|Overall Study|Subject was non-compliant.|1|||
146164566|NCT02925676|527112633|FG000|Overall Study|Withdrawal by Subject|1|||
146164567|NCT03260868|527112634|FG000|Overall Study|Poor Compliance to Protocol|0|||
146164568|NCT03260868|527112635|FG001|Overall Study|Poor Compliance to Protocol|2|||
146164569|NCT03260868|527112634|FG000|Overall Study|Study Terminated By Sponsor|2|||
146164570|NCT03260868|527112635|FG001|Overall Study|Study Terminated By Sponsor|1|||
146164571|NCT03260868|527112634|FG000|Overall Study|Other than specified above|1|||
146164572|NCT03260868|527112635|FG001|Overall Study|Other than specified above|0|||
146164573|NCT01169675|527112638|FG000|Overall Study|Progressive disease|13|||
146164574|NCT01169675|527112639|FG001|Overall Study|Progressive disease|2|||
146164575|NCT01169675|527112640|FG002|Overall Study|Progressive disease|5|||
146164576|NCT01169675|527112641|FG003|Overall Study|Progressive disease|15|||
146164577|NCT01169675|527112642|FG004|Overall Study|Progressive disease|1|||
146164578|NCT01169675|527112638|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146164579|NCT01169675|527112639|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146164580|NCT01169675|527112640|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146164581|NCT01169675|527112641|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146164582|NCT01169675|527112642|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146164583|NCT01169675|527112638|FG000|Overall Study|Adverse Event|5|||
146164584|NCT01169675|527112639|FG001|Overall Study|Adverse Event|1|||
146164585|NCT01169675|527112640|FG002|Overall Study|Adverse Event|2|||
146164586|NCT01169675|527112641|FG003|Overall Study|Adverse Event|0|||
146164587|NCT01169675|527112642|FG004|Overall Study|Adverse Event|0|||
146164588|NCT01169675|527112638|FG000|Overall Study|Withdrawal by Subject|1|||
146164589|NCT01169675|527112639|FG001|Overall Study|Withdrawal by Subject|0|||
146164590|NCT01169675|527112640|FG002|Overall Study|Withdrawal by Subject|0|||
146164591|NCT01169675|527112641|FG003|Overall Study|Withdrawal by Subject|1|||
146164592|NCT01169675|527112642|FG004|Overall Study|Withdrawal by Subject|2|||
146164593|NCT01169675|527112638|FG000|Overall Study|Other Reason Not Defined Above|0|||
146164594|NCT01169675|527112639|FG001|Overall Study|Other Reason Not Defined Above|0|||
146164595|NCT01169675|527112640|FG002|Overall Study|Other Reason Not Defined Above|0|||
146164596|NCT01169675|527112641|FG003|Overall Study|Other Reason Not Defined Above|1|||
146164597|NCT01169675|527112642|FG004|Overall Study|Other Reason Not Defined Above|1|||
146164598|NCT02816138|527112645|FG000|Overall Study|Adverse Event|1|||
146164599|NCT02355028|527112646|FG000|Overall Study|Adverse Event|2|||
146164600|NCT02355028|527112647|FG001|Overall Study|Adverse Event|0|||
146164601|NCT02355028|527112646|FG000|Overall Study|Withdrawal by Subject|1|||
146164602|NCT02355028|527112647|FG001|Overall Study|Withdrawal by Subject|1|||
146164603|NCT02355028|527112646|FG000|Overall Study|Deemed ineligible after randomization|8|||
146164604|NCT02355028|527112647|FG001|Overall Study|Deemed ineligible after randomization|4|||
146164605|NCT04102579|527112648|FG000|Overall Study|Withdrawal by Subject|3|||
146164606|NCT04102579|527112649|FG001|Overall Study|Withdrawal by Subject|4|||
146164607|NCT04102579|527112648|FG000|Overall Study|Lost to Follow-up|0|||
146164608|NCT04102579|527112649|FG001|Overall Study|Lost to Follow-up|1|||
146164609|NCT04102579|527112648|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
146164610|NCT04102579|527112649|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
146319152|NCT01121393|527679422|FG000|Overall Study|Other Adverse events|24|||
146319153|NCT01121393|527679423|FG001|Overall Study|Other Adverse events|45|||
146319154|NCT01121393|527679422|FG000|Overall Study|Non-compliant with protocol|0|||
146164611|NCT04102579|527112648|FG000|Overall Study|Other than Specified|1|||
146164612|NCT04102579|527112649|FG001|Overall Study|Other than Specified|0|||
146164613|NCT04102579|527112648|FG000|Overall Study|Not Dosed with Study Drug|0|||
146164614|NCT04102579|527112649|FG001|Overall Study|Not Dosed with Study Drug|1|||
146164615|NCT05899686|527112650|FG000|Overall Study|Protocol Violation|1|||
146319155|NCT01121393|527679423|FG001|Overall Study|Non-compliant with protocol|3|||
146319156|NCT01121393|527679422|FG000|Overall Study|Lost to Follow-up|1|||
146319157|NCT01121393|527679423|FG001|Overall Study|Lost to Follow-up|0|||
146319158|NCT01121393|527679422|FG000|Overall Study|Refused cont. medication|7|||
146319159|NCT01121393|527679423|FG001|Overall Study|Refused cont. medication|7|||
146319160|NCT01121393|527679422|FG000|Overall Study|Not treated|3|||
146319161|NCT01121393|527679423|FG001|Overall Study|Not treated|9|||
146319162|NCT01121393|527679422|FG000|Overall Study|Other than listed|6|||
146319163|NCT01121393|527679423|FG001|Overall Study|Other than listed|0|||
146319164|NCT01847885|527679426|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
146319165|NCT01847885|527679427|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
146319166|NCT01847885|527679428|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
146319167|NCT01847885|527679426|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
146319168|NCT01847885|527679427|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
146319169|NCT01847885|527679428|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
146319170|NCT01847885|527679426|FG000|Initial Enrollment (Consented)|Screen failure|39|||
146319171|NCT01847885|527679427|FG001|Initial Enrollment (Consented)|Screen failure|0|||
146319172|NCT01847885|527679428|FG002|Initial Enrollment (Consented)|Screen failure|0|||
146319173|NCT01847885|527679426|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
146319174|NCT01847885|527679427|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
146319175|NCT01847885|527679428|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
146319176|NCT01847885|527679426|FG000|Randomization|Protocol Violation|0|||
146319177|NCT01847885|527679427|FG001|Randomization|Protocol Violation|1|||
146319178|NCT01847885|527679428|FG002|Randomization|Protocol Violation|0|||
146319179|NCT01847885|527679426|FG000|Randomization|Withdrawal by Subject|0|||
146319180|NCT01847885|527679427|FG001|Randomization|Withdrawal by Subject|0|||
146319181|NCT01847885|527679428|FG002|Randomization|Withdrawal by Subject|2|||
146319182|NCT01847885|527679426|FG000|Randomization|Screen Failure|0|||
146319183|NCT01847885|527679427|FG001|Randomization|Screen Failure|3|||
146319184|NCT01847885|527679428|FG002|Randomization|Screen Failure|0|||
146319185|NCT02574637|527679431|FG000|Double-blind Period|Adverse Event|1|||
146319186|NCT02574637|527679432|FG001|Double-blind Period|Adverse Event|0|||
146319187|NCT02574637|527679433|FG002|Double-blind Period|Adverse Event|0|||
146319188|NCT02574637|527679434|FG003|Double-blind Period|Adverse Event|0|||
146319189|NCT02574637|527679435|FG004|Double-blind Period|Adverse Event|0|||
146319190|NCT02574637|527679436|FG005|Double-blind Period|Adverse Event|0|||
146319191|NCT02574637|527679437|FG006|Double-blind Period|Adverse Event|0|||
146319192|NCT02574637|527679438|FG007|Double-blind Period|Adverse Event|0|||
146319193|NCT02574637|527679439|FG008|Double-blind Period|Adverse Event|0|||
146319194|NCT02574637|527679440|FG009|Double-blind Period|Adverse Event|0|||
146319195|NCT02574637|527679431|FG000|Double-blind Period|Lack of Efficacy|0|||
146319196|NCT02574637|527679432|FG001|Double-blind Period|Lack of Efficacy|0|||
146319197|NCT02574637|527679433|FG002|Double-blind Period|Lack of Efficacy|2|||
146319198|NCT02574637|527679434|FG003|Double-blind Period|Lack of Efficacy|0|||
146319199|NCT02574637|527679435|FG004|Double-blind Period|Lack of Efficacy|0|||
146319200|NCT02574637|527679436|FG005|Double-blind Period|Lack of Efficacy|0|||
146319201|NCT02574637|527679437|FG006|Double-blind Period|Lack of Efficacy|0|||
146319202|NCT02574637|527679438|FG007|Double-blind Period|Lack of Efficacy|0|||
146319203|NCT02574637|527679439|FG008|Double-blind Period|Lack of Efficacy|0|||
146319204|NCT02574637|527679440|FG009|Double-blind Period|Lack of Efficacy|0|||
146319205|NCT02574637|527679431|FG000|Double-blind Period|Protocol Deviation|1|||
146319206|NCT02574637|527679432|FG001|Double-blind Period|Protocol Deviation|0|||
146319207|NCT02574637|527679433|FG002|Double-blind Period|Protocol Deviation|0|||
146319208|NCT02574637|527679434|FG003|Double-blind Period|Protocol Deviation|0|||
146319209|NCT02574637|527679435|FG004|Double-blind Period|Protocol Deviation|0|||
146319210|NCT02574637|527679436|FG005|Double-blind Period|Protocol Deviation|0|||
146319211|NCT02574637|527679437|FG006|Double-blind Period|Protocol Deviation|0|||
146319212|NCT02574637|527679438|FG007|Double-blind Period|Protocol Deviation|0|||
146319213|NCT02574637|527679439|FG008|Double-blind Period|Protocol Deviation|0|||
146319214|NCT02574637|527679440|FG009|Double-blind Period|Protocol Deviation|0|||
146319215|NCT02574637|527679431|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
146319216|NCT02574637|527679432|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
146319217|NCT02574637|527679433|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
146319218|NCT02574637|527679434|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
146319219|NCT02574637|527679435|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
146319220|NCT02574637|527679436|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
146319221|NCT02574637|527679437|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
146319222|NCT02574637|527679438|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
146319223|NCT02574637|527679439|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
146319224|NCT02574637|527679440|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
146319225|NCT02574637|527679431|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
146319226|NCT02574637|527679432|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
146319227|NCT02574637|527679433|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
146319228|NCT02574637|527679434|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
146319229|NCT02574637|527679435|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
146319230|NCT02574637|527679436|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
146319231|NCT02574637|527679437|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
146319232|NCT02574637|527679438|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
146319233|NCT02574637|527679439|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
146319234|NCT02574637|527679440|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
146319235|NCT02574637|527679431|FG000|Double-blind Period|Reason Not Specified|0|||
146319236|NCT02574637|527679432|FG001|Double-blind Period|Reason Not Specified|0|||
146319237|NCT02574637|527679433|FG002|Double-blind Period|Reason Not Specified|0|||
146319238|NCT02574637|527679434|FG003|Double-blind Period|Reason Not Specified|1|||
146319239|NCT02574637|527679435|FG004|Double-blind Period|Reason Not Specified|0|||
146319240|NCT02574637|527679436|FG005|Double-blind Period|Reason Not Specified|0|||
146319241|NCT02574637|527679437|FG006|Double-blind Period|Reason Not Specified|0|||
146319242|NCT02574637|527679438|FG007|Double-blind Period|Reason Not Specified|0|||
146319243|NCT02574637|527679439|FG008|Double-blind Period|Reason Not Specified|0|||
146319244|NCT02574637|527679440|FG009|Double-blind Period|Reason Not Specified|0|||
146319245|NCT02574637|527679431|FG000|Open-label (OL) Period|Adverse Event|0|||
146319246|NCT02574637|527679432|FG001|Open-label (OL) Period|Adverse Event|0|||
146319247|NCT02574637|527679433|FG002|Open-label (OL) Period|Adverse Event|0|||
146319248|NCT02574637|527679434|FG003|Open-label (OL) Period|Adverse Event|0|||
146319249|NCT02574637|527679435|FG004|Open-label (OL) Period|Adverse Event|0|||
146319250|NCT02574637|527679436|FG005|Open-label (OL) Period|Adverse Event|0|||
146319251|NCT02574637|527679437|FG006|Open-label (OL) Period|Adverse Event|0|||
146319252|NCT02574637|527679438|FG007|Open-label (OL) Period|Adverse Event|0|||
146319253|NCT02574637|527679439|FG008|Open-label (OL) Period|Adverse Event|1|||
146319254|NCT02574637|527679440|FG009|Open-label (OL) Period|Adverse Event|0|||
146319255|NCT02574637|527679431|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
146319256|NCT02574637|527679432|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
146319257|NCT02574637|527679433|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
146319258|NCT02574637|527679434|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
146319259|NCT02574637|527679435|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
146319260|NCT02574637|527679436|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
146319261|NCT02574637|527679437|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
146319262|NCT02574637|527679438|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
146319263|NCT02574637|527679439|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
146319264|NCT02574637|527679440|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
146319265|NCT02574637|527679431|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319266|NCT02574637|527679432|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319267|NCT02574637|527679433|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319268|NCT02574637|527679434|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319269|NCT02574637|527679435|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319270|NCT02574637|527679436|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146319271|NCT02574637|527679437|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
146319272|NCT02574637|527679438|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146319273|NCT02574637|527679439|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
146319274|NCT02574637|527679440|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
146319275|NCT04016311|527679441|FG000|Overall Study|Withdrawal by Subject|1|||
146319276|NCT04016311|527679442|FG001|Overall Study|Withdrawal by Subject|0|||
146319277|NCT04029519|527679446|FG000|Overall Study|Protocol Violation|1|||
146319278|NCT04029519|527679446|FG000|Overall Study|Withdrawal by Subject|3|||
146319279|NCT04029519|527679446|FG000|Overall Study|Lost to Follow-up|1|||
146319280|NCT02706730|527679447|FG000|Overall Study|Adverse Event|3|||
146319281|NCT02706730|527679447|FG000|Overall Study|Lack of Efficacy|5|||
146319282|NCT02706730|527679447|FG000|Overall Study|Withdrawal by Subject|11|||
146319283|NCT02706730|527679447|FG000|Overall Study|Study Terminated by Sponsor|11|||
146319284|NCT02706730|527679447|FG000|Overall Study|Subject chose not to receive injection|3|||
146319285|NCT00094055|527679448|FG000|Overall Study|Adverse Event|11|||
146319286|NCT00094055|527679448|FG000|Overall Study|Death|4|||
146319287|NCT00094055|527679448|FG000|Overall Study|Lack of Efficacy|17|||
146319288|NCT00094055|527679448|FG000|Overall Study|Lost to Follow-up|2|||
146319289|NCT00094055|527679448|FG000|Overall Study|progressive disease|2|||
146319290|NCT00094055|527679448|FG000|Overall Study|clinical progression|1|||
146319291|NCT00094055|527679448|FG000|Overall Study|roll-over to another study|14|||
146319292|NCT00094055|527679448|FG000|Overall Study|Withdrawal by Subject|9|||
146319293|NCT01999582|527679449|FG000|Overall Study|Withdrawal by Subject|0|||
146319294|NCT01999582|527679450|FG001|Overall Study|Withdrawal by Subject|0|||
146319295|NCT01999582|527679451|FG002|Overall Study|Withdrawal by Subject|0|||
146319296|NCT01999582|527679452|FG003|Overall Study|Withdrawal by Subject|1|||
146319297|NCT01999582|527679453|FG004|Overall Study|Withdrawal by Subject|0|||
146319298|NCT01999582|527679454|FG005|Overall Study|Withdrawal by Subject|0|||
146164616|NCT00572195|527112651|FG000|Overall Study|Withdrawal by Subject|50|||
146319299|NCT01999582|527679449|FG000|Overall Study|Adverse Event|0|||
146319300|NCT01999582|527679450|FG001|Overall Study|Adverse Event|0|||
146319301|NCT01999582|527679451|FG002|Overall Study|Adverse Event|3|||
146319302|NCT01999582|527679452|FG003|Overall Study|Adverse Event|0|||
146319303|NCT01999582|527679453|FG004|Overall Study|Adverse Event|1|||
146319304|NCT01999582|527679454|FG005|Overall Study|Adverse Event|0|||
146319305|NCT01999582|527679449|FG000|Overall Study|Other Reasons|1|||
146319306|NCT01999582|527679450|FG001|Overall Study|Other Reasons|0|||
146319307|NCT01999582|527679451|FG002|Overall Study|Other Reasons|3|||
146319308|NCT01999582|527679452|FG003|Overall Study|Other Reasons|1|||
146319309|NCT01999582|527679453|FG004|Overall Study|Other Reasons|1|||
146319310|NCT01999582|527679454|FG005|Overall Study|Other Reasons|2|||
146319311|NCT01999582|527679449|FG000|Overall Study|Protocol Violation|1|||
146319312|NCT01999582|527679450|FG001|Overall Study|Protocol Violation|0|||
146319313|NCT01999582|527679451|FG002|Overall Study|Protocol Violation|0|||
146319314|NCT01999582|527679452|FG003|Overall Study|Protocol Violation|0|||
146319315|NCT01999582|527679453|FG004|Overall Study|Protocol Violation|0|||
146319316|NCT01999582|527679454|FG005|Overall Study|Protocol Violation|1|||
146319317|NCT01999582|527679449|FG000|Overall Study|Lack of Efficacy|1|||
146319318|NCT01999582|527679450|FG001|Overall Study|Lack of Efficacy|3|||
146319319|NCT01999582|527679451|FG002|Overall Study|Lack of Efficacy|0|||
146319320|NCT01999582|527679452|FG003|Overall Study|Lack of Efficacy|1|||
146319321|NCT01999582|527679453|FG004|Overall Study|Lack of Efficacy|0|||
146319322|NCT01999582|527679454|FG005|Overall Study|Lack of Efficacy|0|||
146319323|NCT01081795|527679457|FG000|Overall Study|Adverse Event|18|||
146319324|NCT01081795|527679458|FG001|Overall Study|Adverse Event|23|||
146319325|NCT01081795|527679459|FG002|Overall Study|Adverse Event|6|||
146319326|NCT01081795|527679457|FG000|Overall Study|Lack of Efficacy|7|||
146319327|NCT01081795|527679458|FG001|Overall Study|Lack of Efficacy|5|||
146319328|NCT01081795|527679459|FG002|Overall Study|Lack of Efficacy|19|||
146319329|NCT01081795|527679457|FG000|Overall Study|Subject's schedule|1|||
146319330|NCT01081795|527679458|FG001|Overall Study|Subject's schedule|1|||
146319331|NCT01081795|527679459|FG002|Overall Study|Subject's schedule|2|||
146319332|NCT01081795|527679457|FG000|Overall Study|Revocation of informed consent|2|||
146319333|NCT01081795|527679458|FG001|Overall Study|Revocation of informed consent|0|||
146319334|NCT01081795|527679459|FG002|Overall Study|Revocation of informed consent|0|||
146319335|NCT01081795|527679457|FG000|Overall Study|Ineligible for participation|1|||
146319336|NCT01081795|527679458|FG001|Overall Study|Ineligible for participation|0|||
146319337|NCT01081795|527679459|FG002|Overall Study|Ineligible for participation|0|||
146319338|NCT01081795|527679457|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
146319339|NCT01081795|527679458|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
146319340|NCT01081795|527679459|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
146319341|NCT01081795|527679457|FG000|Overall Study|Using drug with restricted days of use|2|||
146319342|NCT01081795|527679458|FG001|Overall Study|Using drug with restricted days of use|3|||
146319343|NCT01081795|527679459|FG002|Overall Study|Using drug with restricted days of use|2|||
146319344|NCT01081795|527679457|FG000|Overall Study|Other|1|||
146319345|NCT01081795|527679458|FG001|Overall Study|Other|2|||
146319346|NCT01081795|527679459|FG002|Overall Study|Other|0|||
146319347|NCT00953758|527679461|FG000|Overall Study|Death|2|||
146319348|NCT00953758|527679462|FG001|Overall Study|Death|0|||
146319349|NCT00953758|527679463|FG002|Overall Study|Death|1|||
146319350|NCT00953758|527679464|FG003|Overall Study|Death|1|||
146319351|NCT00953758|527679465|FG004|Overall Study|Death|1|||
146319352|NCT00953758|527679466|FG005|Overall Study|Death|1|||
146319353|NCT00953758|527679467|FG006|Overall Study|Death|1|||
146319354|NCT00953758|527679468|FG007|Overall Study|Death|3|||
146319355|NCT00953758|527679469|FG008|Overall Study|Death|1|||
146319356|NCT00953758|527679470|FG009|Overall Study|Death|0|||
146319357|NCT00953758|527679461|FG000|Overall Study|Participant refused further follow-up|0|||
146319358|NCT00953758|527679462|FG001|Overall Study|Participant refused further follow-up|0|||
146319359|NCT00953758|527679463|FG002|Overall Study|Participant refused further follow-up|1|||
146319360|NCT00953758|527679464|FG003|Overall Study|Participant refused further follow-up|0|||
146319361|NCT00953758|527679465|FG004|Overall Study|Participant refused further follow-up|3|||
146319362|NCT00953758|527679466|FG005|Overall Study|Participant refused further follow-up|0|||
146319363|NCT00953758|527679467|FG006|Overall Study|Participant refused further follow-up|0|||
146319364|NCT00953758|527679468|FG007|Overall Study|Participant refused further follow-up|0|||
146319365|NCT00953758|527679469|FG008|Overall Study|Participant refused further follow-up|1|||
146319366|NCT00953758|527679470|FG009|Overall Study|Participant refused further follow-up|0|||
146319367|NCT00953758|527679461|FG000|Overall Study|Lost to Follow-up|0|||
146319368|NCT00953758|527679462|FG001|Overall Study|Lost to Follow-up|0|||
146319369|NCT00953758|527679463|FG002|Overall Study|Lost to Follow-up|0|||
146319370|NCT00953758|527679464|FG003|Overall Study|Lost to Follow-up|1|||
146319371|NCT00953758|527679465|FG004|Overall Study|Lost to Follow-up|0|||
146319372|NCT00953758|527679466|FG005|Overall Study|Lost to Follow-up|0|||
146319373|NCT00953758|527679467|FG006|Overall Study|Lost to Follow-up|0|||
146319374|NCT00953758|527679468|FG007|Overall Study|Lost to Follow-up|1|||
146319375|NCT00953758|527679469|FG008|Overall Study|Lost to Follow-up|0|||
146319376|NCT00953758|527679470|FG009|Overall Study|Lost to Follow-up|1|||
146319377|NCT00953758|527679461|FG000|Overall Study|Physician Decision|0|||
146319378|NCT00953758|527679462|FG001|Overall Study|Physician Decision|0|||
146319379|NCT00953758|527679463|FG002|Overall Study|Physician Decision|0|||
146319380|NCT00953758|527679464|FG003|Overall Study|Physician Decision|0|||
146319381|NCT00953758|527679465|FG004|Overall Study|Physician Decision|1|||
146319382|NCT00953758|527679466|FG005|Overall Study|Physician Decision|0|||
146319383|NCT00953758|527679467|FG006|Overall Study|Physician Decision|0|||
146319384|NCT00953758|527679468|FG007|Overall Study|Physician Decision|0|||
146319385|NCT00953758|527679469|FG008|Overall Study|Physician Decision|0|||
146319386|NCT00953758|527679470|FG009|Overall Study|Physician Decision|0|||
146319387|NCT00953758|527679461|FG000|Overall Study|Disease progression|0|||
146319388|NCT00953758|527679462|FG001|Overall Study|Disease progression|0|||
146319389|NCT00953758|527679463|FG002|Overall Study|Disease progression|0|||
146319390|NCT00953758|527679464|FG003|Overall Study|Disease progression|0|||
146319391|NCT00953758|527679465|FG004|Overall Study|Disease progression|1|||
146319392|NCT00953758|527679466|FG005|Overall Study|Disease progression|0|||
146319393|NCT00953758|527679467|FG006|Overall Study|Disease progression|0|||
146319394|NCT00953758|527679468|FG007|Overall Study|Disease progression|0|||
146319395|NCT00953758|527679469|FG008|Overall Study|Disease progression|0|||
146319396|NCT00953758|527679470|FG009|Overall Study|Disease progression|0|||
146319397|NCT00953758|527679461|FG000|Overall Study|Participant went for transplant|0|||
146319398|NCT00953758|527679462|FG001|Overall Study|Participant went for transplant|0|||
146319399|NCT00953758|527679463|FG002|Overall Study|Participant went for transplant|0|||
146319400|NCT00953758|527679464|FG003|Overall Study|Participant went for transplant|0|||
146319401|NCT00953758|527679465|FG004|Overall Study|Participant went for transplant|0|||
146319402|NCT00953758|527679466|FG005|Overall Study|Participant went for transplant|0|||
146319403|NCT00953758|527679467|FG006|Overall Study|Participant went for transplant|0|||
146319404|NCT00953758|527679468|FG007|Overall Study|Participant went for transplant|0|||
146319405|NCT00953758|527679469|FG008|Overall Study|Participant went for transplant|1|||
146164617|NCT00572195|527112651|FG000|Overall Study|Death|9|||
146164618|NCT00572195|527112651|FG000|Overall Study|Adverse Event|4|||
146164619|NCT00572195|527112651|FG000|Overall Study|Lost to Follow-up|5|||
146164620|NCT01525602|527112652|FG000|Overall Study|Adverse Event|1|||
146164621|NCT01525602|527112653|FG001|Overall Study|Adverse Event|0|||
146164622|NCT01525602|527112654|FG002|Overall Study|Adverse Event|1|||
146164623|NCT01525602|527112655|FG003|Overall Study|Adverse Event|1|||
146319406|NCT00953758|527679470|FG009|Overall Study|Participant went for transplant|0|||
146319407|NCT01536860|527679471|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
146319408|NCT01536860|527679472|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
146319409|NCT01536860|527679473|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
146319410|NCT01164722|527679474|FG000|Overall Study|Adverse Event|0|||
146319411|NCT01164722|527679475|FG001|Overall Study|Adverse Event|1|||
146319412|NCT01164722|527679474|FG000|Overall Study|Withdrawal by Subject|3|||
146319413|NCT01164722|527679475|FG001|Overall Study|Withdrawal by Subject|4|||
146319414|NCT01164722|527679474|FG000|Overall Study|Lost to Follow-up|3|||
146319415|NCT01164722|527679475|FG001|Overall Study|Lost to Follow-up|6|||
146319416|NCT01164722|527679474|FG000|Overall Study|met protocol criteria for non-treatment|11|||
146319417|NCT01164722|527679475|FG001|Overall Study|met protocol criteria for non-treatment|1|||
146319418|NCT01164722|527679474|FG000|Overall Study|enrolled on other study, concomitant med|1|||
146319419|NCT01164722|527679475|FG001|Overall Study|enrolled on other study, concomitant med|3|||
146319420|NCT04673786|527679476|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
146319421|NCT04673786|527679477|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
146319422|NCT04673786|527679478|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
146319423|NCT04673786|527679476|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
146319424|NCT04673786|527679477|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
146319425|NCT04673786|527679478|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
146319426|NCT04673786|527679476|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
146319427|NCT04673786|527679477|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
146319428|NCT04673786|527679478|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
146319429|NCT04673786|527679476|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
146319430|NCT04673786|527679477|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
146319431|NCT04673786|527679478|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
146319432|NCT04673786|527679476|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
146319433|NCT04673786|527679477|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
146319434|NCT04673786|527679478|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
146319435|NCT04673786|527679476|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
146319436|NCT04673786|527679477|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
146319437|NCT04673786|527679478|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
146319438|NCT02902120|527679479|FG000|Overall Study|Lack of Efficacy|1|||
146319439|NCT01422239|527679482|FG000|Overall Study|Lost to Follow-up|4|||
146319440|NCT01422239|527679483|FG001|Overall Study|Lost to Follow-up|3|||
146319441|NCT02799069|527679486|FG000|Overall Study|Adverse Event|0|||
146319442|NCT02799069|527679487|FG001|Overall Study|Adverse Event|2|||
146319443|NCT02799069|527679488|FG002|Overall Study|Adverse Event|2|||
146319444|NCT02799069|527679486|FG000|Overall Study|Lack of Efficacy|2|||
146319445|NCT02799069|527679487|FG001|Overall Study|Lack of Efficacy|0|||
146319446|NCT02799069|527679488|FG002|Overall Study|Lack of Efficacy|0|||
146164624|NCT01525602|527112656|FG004|Overall Study|Adverse Event|3|||
146164625|NCT01525602|527112657|FG005|Overall Study|Adverse Event|3|||
146319447|NCT02799069|527679486|FG000|Overall Study|Lost to Follow-up|1|||
146319448|NCT02799069|527679487|FG001|Overall Study|Lost to Follow-up|1|||
146319449|NCT02799069|527679488|FG002|Overall Study|Lost to Follow-up|0|||
146319450|NCT02799069|527679486|FG000|Overall Study|Withdrawal by Subject|4|||
146319451|NCT02799069|527679487|FG001|Overall Study|Withdrawal by Subject|4|||
146319452|NCT02799069|527679488|FG002|Overall Study|Withdrawal by Subject|3|||
146319453|NCT02799069|527679486|FG000|Overall Study|Protocol Violation|1|||
146319454|NCT02799069|527679487|FG001|Overall Study|Protocol Violation|0|||
146319455|NCT02799069|527679488|FG002|Overall Study|Protocol Violation|2|||
146319456|NCT01110200|527679491|FG000|Overall Study|Adverse Event|28|||
146319457|NCT01110200|527679492|FG001|Overall Study|Adverse Event|28|||
146319458|NCT01110200|527679491|FG000|Overall Study|Withdrawal by Subject|25|||
146319459|NCT01110200|527679492|FG001|Overall Study|Withdrawal by Subject|32|||
146319460|NCT01110200|527679491|FG000|Overall Study|Lack of Efficacy|16|||
146319461|NCT01110200|527679492|FG001|Overall Study|Lack of Efficacy|25|||
146319462|NCT01110200|527679491|FG000|Overall Study|Protocol Violation|14|||
146319463|NCT01110200|527679492|FG001|Overall Study|Protocol Violation|12|||
146319464|NCT01110200|527679491|FG000|Overall Study|Physician Decision|13|||
146319465|NCT01110200|527679492|FG001|Overall Study|Physician Decision|17|||
146319466|NCT01110200|527679491|FG000|Overall Study|Lost to Follow-up|10|||
146319467|NCT01110200|527679492|FG001|Overall Study|Lost to Follow-up|7|||
146319468|NCT00730639|527679493|FG000|Overall Study|Adverse Event|3|||
146319469|NCT00730639|527679494|FG001|Overall Study|Adverse Event|0|||
146319470|NCT00730639|527679495|FG002|Overall Study|Adverse Event|9|||
146319471|NCT00730639|527679496|FG003|Overall Study|Adverse Event|8|||
146319472|NCT00730639|527679497|FG004|Overall Study|Adverse Event|23|||
146319473|NCT00730639|527679493|FG000|Overall Study|Complete Response|0|||
146319474|NCT00730639|527679494|FG001|Overall Study|Complete Response|0|||
146319475|NCT00730639|527679495|FG002|Overall Study|Complete Response|2|||
146319476|NCT00730639|527679496|FG003|Overall Study|Complete Response|2|||
146319477|NCT00730639|527679497|FG004|Overall Study|Complete Response|1|||
146319478|NCT00730639|527679493|FG000|Overall Study|Completed Maximum Cycles|0|||
146319479|NCT00730639|527679494|FG001|Overall Study|Completed Maximum Cycles|0|||
146319480|NCT00730639|527679495|FG002|Overall Study|Completed Maximum Cycles|11|||
146319481|NCT00730639|527679496|FG003|Overall Study|Completed Maximum Cycles|3|||
146319482|NCT00730639|527679497|FG004|Overall Study|Completed Maximum Cycles|6|||
146319483|NCT00730639|527679493|FG000|Overall Study|Death|0|||
146319484|NCT00730639|527679494|FG001|Overall Study|Death|0|||
146319485|NCT00730639|527679495|FG002|Overall Study|Death|0|||
146319486|NCT00730639|527679496|FG003|Overall Study|Death|0|||
146319487|NCT00730639|527679497|FG004|Overall Study|Death|2|||
146319488|NCT00730639|527679493|FG000|Overall Study|Disease Progression|12|||
146319489|NCT00730639|527679494|FG001|Overall Study|Disease Progression|13|||
146319490|NCT00730639|527679495|FG002|Overall Study|Disease Progression|48|||
146319491|NCT00730639|527679496|FG003|Overall Study|Disease Progression|32|||
146319492|NCT00730639|527679497|FG004|Overall Study|Disease Progression|88|||
146319493|NCT00730639|527679493|FG000|Overall Study|non-specified|0|||
146319494|NCT00730639|527679494|FG001|Overall Study|non-specified|0|||
146319495|NCT00730639|527679495|FG002|Overall Study|non-specified|4|||
146319496|NCT00730639|527679496|FG003|Overall Study|non-specified|2|||
146319497|NCT00730639|527679497|FG004|Overall Study|non-specified|3|||
146319498|NCT00730639|527679493|FG000|Overall Study|Protocol Violation|0|||
146319499|NCT00730639|527679494|FG001|Overall Study|Protocol Violation|0|||
146319500|NCT00730639|527679495|FG002|Overall Study|Protocol Violation|1|||
146319501|NCT00730639|527679496|FG003|Overall Study|Protocol Violation|0|||
146319502|NCT00730639|527679497|FG004|Overall Study|Protocol Violation|0|||
146319503|NCT00730639|527679493|FG000|Overall Study|Withdrawal by Subject|0|||
146319504|NCT00730639|527679494|FG001|Overall Study|Withdrawal by Subject|0|||
146319505|NCT00730639|527679495|FG002|Overall Study|Withdrawal by Subject|6|||
146319506|NCT00730639|527679496|FG003|Overall Study|Withdrawal by Subject|3|||
146319507|NCT00730639|527679497|FG004|Overall Study|Withdrawal by Subject|4|||
146319508|NCT00730639|527679493|FG000|Overall Study|Treatment on-going|2|||
146319509|NCT00730639|527679494|FG001|Overall Study|Treatment on-going|5|||
146319510|NCT00730639|527679495|FG002|Overall Study|Treatment on-going|5|||
146319511|NCT00730639|527679496|FG003|Overall Study|Treatment on-going|4|||
146319512|NCT00730639|527679497|FG004|Overall Study|Treatment on-going|4|||
146319513|NCT01844895|527679500|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
146319514|NCT01844895|527679500|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
146319515|NCT01844895|527679500|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
146319516|NCT01844895|527679500|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
146319517|NCT01844895|527679500|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
146319518|NCT01844895|527679500|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
146319519|NCT01844895|527679500|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
146319520|NCT02508194|527679501|FG000|Overall Study|Death|5|||
146319521|NCT02508194|527679502|FG001|Overall Study|Death|3|||
146319522|NCT02508194|527679501|FG000|Overall Study|Lost to Follow-up|25|||
146319523|NCT02508194|527679502|FG001|Overall Study|Lost to Follow-up|18|||
146319524|NCT02508194|527679501|FG000|Overall Study|Withdrawal by Subject|20|||
146319525|NCT02508194|527679502|FG001|Overall Study|Withdrawal by Subject|18|||
146319526|NCT02508194|527679501|FG000|Overall Study|Error in Randomization|1|||
146319527|NCT02508194|527679502|FG001|Overall Study|Error in Randomization|3|||
146319528|NCT02508194|527679501|FG000|Overall Study|Principal Investigator Decision|1|||
146319529|NCT02508194|527679502|FG001|Overall Study|Principal Investigator Decision|2|||
146319530|NCT00511355|527679503|FG000|Overall Study|Adverse Event|4|||
146319531|NCT00511355|527679504|FG001|Overall Study|Adverse Event|4|||
146319532|NCT00511355|527679503|FG000|Overall Study|Pregnancy Wish|1|||
146319533|NCT00511355|527679504|FG001|Overall Study|Pregnancy Wish|0|||
146319534|NCT00511355|527679503|FG000|Overall Study|Lost to Follow-up|2|||
146319535|NCT00511355|527679504|FG001|Overall Study|Lost to Follow-up|1|||
146319536|NCT00511355|527679503|FG000|Overall Study|Other Reason|0|||
146319537|NCT00511355|527679504|FG001|Overall Study|Other Reason|1|||
146319538|NCT00511355|527679503|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
146319539|NCT00511355|527679504|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
146319540|NCT00511355|527679503|FG000|Overall Study|Withdrawal of informed consent|0|||
146319541|NCT00511355|527679504|FG001|Overall Study|Withdrawal of informed consent|1|||
146319542|NCT00511355|527679503|FG000|Overall Study|Other reason pre-treatment|0|||
146319543|NCT00511355|527679504|FG001|Overall Study|Other reason pre-treatment|1|||
146319544|NCT00454805|527679508|FG000|Overall Study|Withdrawal by Subject|9|||
146319545|NCT00454805|527679509|FG001|Overall Study|Withdrawal by Subject|2|||
146319546|NCT00454805|527679508|FG000|Overall Study|Death|0|||
146319547|NCT00454805|527679509|FG001|Overall Study|Death|2|||
146319548|NCT00454805|527679508|FG000|Overall Study|Disease progression|16|||
146319549|NCT00454805|527679509|FG001|Overall Study|Disease progression|19|||
146319550|NCT00454805|527679508|FG000|Overall Study|In order to begin radiotherapy|1|||
146319551|NCT00454805|527679509|FG001|Overall Study|In order to begin radiotherapy|0|||
146319552|NCT00217087|527679510|FG000|Overall Study|decided to have esophagectomy|1|||
146319553|NCT00217087|527679511|FG001|Overall Study|decided to have esophagectomy|2|||
146319554|NCT00217087|527679510|FG000|Overall Study|completed less than 12 months return|10|||
146319555|NCT00217087|527679511|FG001|Overall Study|completed less than 12 months return|18|||
146319556|NCT03208231|527679514|FG000|Overall Study|Death|1|||
146319557|NCT03208231|527679515|FG001|Overall Study|Death|2|||
146319558|NCT03208231|527679514|FG000|Overall Study|Moved and unable to get to clinic|1|||
146319559|NCT03208231|527679515|FG001|Overall Study|Moved and unable to get to clinic|0|||
146319560|NCT03208231|527679514|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
146319561|NCT03208231|527679515|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
146319564|NCT01250379|527679528|FG000|Overall Study|Death|141|||
146319565|NCT01250379|527679529|FG001|Overall Study|Death|148|||
146319566|NCT01250379|527679528|FG000|Overall Study|Withdrawal by Subject|32|||
146319567|NCT01250379|527679529|FG001|Overall Study|Withdrawal by Subject|20|||
146319568|NCT01250379|527679528|FG000|Overall Study|Physician Decision|11|||
146319569|NCT01250379|527679529|FG001|Overall Study|Physician Decision|3|||
146319570|NCT01250379|527679528|FG000|Overall Study|Protocol Violation|2|||
146319571|NCT01250379|527679529|FG001|Overall Study|Protocol Violation|8|||
146319572|NCT01250379|527679528|FG000|Overall Study|Lost to Follow-up|9|||
146319573|NCT01250379|527679529|FG001|Overall Study|Lost to Follow-up|6|||
146319574|NCT01250379|527679528|FG000|Overall Study|Adverse Event|5|||
146319575|NCT01250379|527679529|FG001|Overall Study|Adverse Event|4|||
146319576|NCT01250379|527679528|FG000|Overall Study|Other|0|||
146319577|NCT01250379|527679529|FG001|Overall Study|Other|4|||
146319578|NCT01250379|527679528|FG000|Overall Study|Participant noncompliance|2|||
146319579|NCT01250379|527679529|FG001|Overall Study|Participant noncompliance|0|||
146319580|NCT01489527|527679530|FG000|Overall Study|Pregnancy|9|||
146319581|NCT01489527|527679531|FG001|Overall Study|Pregnancy|14|||
146319582|NCT01489527|527679530|FG000|Overall Study|Participant moved|6|||
146319583|NCT01489527|527679531|FG001|Overall Study|Participant moved|7|||
146319584|NCT01489527|527679530|FG000|Overall Study|Withdrawal by Subject|0|||
146319585|NCT01489527|527679531|FG001|Overall Study|Withdrawal by Subject|4|||
146319586|NCT01489527|527679530|FG000|Overall Study|Lost to Follow-up|5|||
146319587|NCT01489527|527679531|FG001|Overall Study|Lost to Follow-up|1|||
146319588|NCT01489527|527679530|FG000|Overall Study|Procedures|1|||
146319589|NCT01489527|527679531|FG001|Overall Study|Procedures|0|||
146319590|NCT01489527|527679530|FG000|Overall Study|Not compliant|1|||
146319591|NCT01489527|527679531|FG001|Overall Study|Not compliant|0|||
146319592|NCT01984268|527679532|FG000|Overall Study|Study Terminated|15|||
146319593|NCT04899232|527679533|FG000|Screening Period|Physician Decision|1|||
146319594|NCT04899232|527679534|FG001|Screening Period|Physician Decision|0|||
146319595|NCT04899232|527679535|FG002|Screening Period|Physician Decision|0|||
146319596|NCT04899232|527679533|FG000|Screening Period|Withdrawal by Subject|1|||
146319597|NCT04899232|527679534|FG001|Screening Period|Withdrawal by Subject|0|||
146319598|NCT04899232|527679535|FG002|Screening Period|Withdrawal by Subject|0|||
146319599|NCT04899232|527679533|FG000|Screening Period|Participant discharged before receiving intervention|3|||
146319600|NCT04899232|527679534|FG001|Screening Period|Participant discharged before receiving intervention|0|||
146319601|NCT04899232|527679535|FG002|Screening Period|Participant discharged before receiving intervention|0|||
146319602|NCT05061719|527679539|FG000|Overall Study|Adverse Event|60|||
146319603|NCT05061719|527679539|FG000|Overall Study|Death|1|||
146319604|NCT05061719|527679539|FG000|Overall Study|Lack of Efficacy|7|||
146319605|NCT05061719|527679539|FG000|Overall Study|Lost to Follow-up|5|||
146319606|NCT05061719|527679539|FG000|Overall Study|Pregnancy|1|||
146319607|NCT05061719|527679539|FG000|Overall Study|Protocol Violation|8|||
146319608|NCT05061719|527679539|FG000|Overall Study|Withdrawal by Subject|41|||
146319609|NCT05061719|527679539|FG000|Overall Study|Site Closure|2|||
146319610|NCT04341948|527679540|FG000|Overall Study|Adverse Event|0|||
146319611|NCT04341948|527679541|FG001|Overall Study|Adverse Event|1|||
146319612|NCT04341948|527679540|FG000|Overall Study|Lost to Follow-up|6|||
146319613|NCT04341948|527679541|FG001|Overall Study|Lost to Follow-up|1|||
146319614|NCT04341948|527679540|FG000|Overall Study|Physician Decision|1|||
146319615|NCT04341948|527679541|FG001|Overall Study|Physician Decision|2|||
146319616|NCT04341948|527679540|FG000|Overall Study|Withdrawal by Participant|6|||
146319617|NCT04341948|527679541|FG001|Overall Study|Withdrawal by Participant|3|||
146319618|NCT04341948|527679540|FG000|Overall Study|Lack of compliance by Participant|1|||
146319619|NCT04341948|527679541|FG001|Overall Study|Lack of compliance by Participant|0|||
146319620|NCT04183335|527681684|FG000|Overall Study|Adverse Event|1|||
146319621|NCT04183335|527681685|FG001|Overall Study|Adverse Event|0|||
146319622|NCT04183335|527681684|FG000|Overall Study|Withdrawal by Subject|12|||
146319623|NCT04183335|527681685|FG001|Overall Study|Withdrawal by Subject|3|||
146319624|NCT02740478|527681687|FG000|Overall Study|Withdrawal by Subject|1|||
146319625|NCT01072344|527681689|FG000|Overall Study|Relasped-reached end point|7|||
146319626|NCT01072344|527681690|FG001|Overall Study|Relasped-reached end point|12|||
146319627|NCT01072344|527681689|FG000|Overall Study|Protocol Violation|1|||
146319628|NCT01072344|527681690|FG001|Overall Study|Protocol Violation|2|||
146319629|NCT01072344|527681689|FG000|Overall Study|Lost to Follow-up|3|||
146319630|NCT01072344|527681690|FG001|Overall Study|Lost to Follow-up|4|||
146319631|NCT01934140|527681691|FG000|Persistence Phase (Year 6-10)|Other|24|||
146319632|NCT01934140|527681692|FG001|Persistence Phase (Year 6-10)|Other|6|||
146164626|NCT01525602|527112658|FG006|Overall Study|Adverse Event|0|||
146164627|NCT01525602|527112659|FG007|Overall Study|Adverse Event|1|||
146164628|NCT01525602|527112652|FG000|Overall Study|Disease progression|6|||
146319633|NCT01934140|527681691|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
146319634|NCT01934140|527681692|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
146319635|NCT01934140|527681691|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
146319636|NCT01934140|527681692|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
146319637|NCT01934140|527681691|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
146319638|NCT01934140|527681692|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
146319639|NCT01934140|527681691|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
146319640|NCT01934140|527681692|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
146319641|NCT01934140|527681691|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
146319642|NCT01934140|527681692|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
146319643|NCT01934140|527681691|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
146319644|NCT01934140|527681692|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
146319645|NCT01934140|527681691|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
146319646|NCT01934140|527681692|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
146319647|NCT02944448|527681693|FG000|Overall Study|Adverse Event|37|||
146319648|NCT02944448|527681694|FG001|Overall Study|Adverse Event|6|||
146319649|NCT02944448|527681693|FG000|Overall Study|Lack of Efficacy|8|||
146319650|NCT02944448|527681694|FG001|Overall Study|Lack of Efficacy|5|||
146319651|NCT02944448|527681693|FG000|Overall Study|Lost to Follow-up|3|||
146319652|NCT02944448|527681694|FG001|Overall Study|Lost to Follow-up|1|||
146319653|NCT02944448|527681693|FG000|Overall Study|Protocol Violation|25|||
146164629|NCT01525602|527112653|FG001|Overall Study|Disease progression|3|||
146164630|NCT01525602|527112654|FG002|Overall Study|Disease progression|2|||
146164631|NCT01525602|527112655|FG003|Overall Study|Disease progression|5|||
146319654|NCT02944448|527681694|FG001|Overall Study|Protocol Violation|7|||
146319655|NCT02944448|527681693|FG000|Overall Study|Withdrawal by Subject|14|||
146319656|NCT02944448|527681694|FG001|Overall Study|Withdrawal by Subject|4|||
146319657|NCT02944448|527681693|FG000|Overall Study|Sponsor did not supply drug in time|0|||
146319658|NCT02944448|527681694|FG001|Overall Study|Sponsor did not supply drug in time|1|||
146319659|NCT02944448|527681693|FG000|Overall Study|Noncompliant with dosing|1|||
146319660|NCT02944448|527681694|FG001|Overall Study|Noncompliant with dosing|0|||
146319661|NCT02944448|527681693|FG000|Overall Study|Abnormal laboratory values|1|||
146319662|NCT02944448|527681694|FG001|Overall Study|Abnormal laboratory values|0|||
146319663|NCT00808444|527681697|FG000|Overall Study|Withdrawal by Subject|1|||
146319664|NCT00808444|527681698|FG001|Overall Study|Withdrawal by Subject|0|||
146164632|NCT01525602|527112656|FG004|Overall Study|Disease progression|22|||
146164633|NCT01525602|527112657|FG005|Overall Study|Disease progression|2|||
146319665|NCT00808444|527681697|FG000|Overall Study|Lost to Follow-up|0|||
146319666|NCT00808444|527681698|FG001|Overall Study|Lost to Follow-up|1|||
146319667|NCT05499559|527681706|FG000|Overall Study|Lost to Follow-up|467|||
146319668|NCT00223496|527681707|FG000|Overall Study|screen failure|9|||
146319669|NCT00223496|527681707|FG000|Overall Study|Lost to Follow-up|4|||
146319670|NCT00223496|527681707|FG000|Overall Study|Lack of Efficacy|6|||
146319671|NCT00223496|527681707|FG000|Overall Study|Withdrawal by Subject|1|||
146319672|NCT00223496|527681707|FG000|Overall Study|Physician Decision|2|||
146319673|NCT02889796|527681708|FG000|Overall Study|Withdrew Consent|18|||
146319674|NCT02889796|527681709|FG001|Overall Study|Withdrew Consent|29|||
146319675|NCT02889796|527681710|FG002|Overall Study|Withdrew Consent|20|||
146319676|NCT02889796|527681711|FG003|Overall Study|Withdrew Consent|1|||
146319677|NCT02889796|527681712|FG004|Overall Study|Withdrew Consent|2|||
146319678|NCT02889796|527681713|FG005|Overall Study|Withdrew Consent|35|||
146319679|NCT02889796|527681708|FG000|Overall Study|Investigator's Discretion|10|||
146319680|NCT02889796|527681709|FG001|Overall Study|Investigator's Discretion|9|||
146319681|NCT02889796|527681710|FG002|Overall Study|Investigator's Discretion|10|||
146319682|NCT02889796|527681711|FG003|Overall Study|Investigator's Discretion|3|||
146319683|NCT02889796|527681712|FG004|Overall Study|Investigator's Discretion|0|||
146319684|NCT02889796|527681713|FG005|Overall Study|Investigator's Discretion|15|||
146319685|NCT02889796|527681708|FG000|Overall Study|Adverse Event|17|||
146319686|NCT02889796|527681709|FG001|Overall Study|Adverse Event|8|||
146319687|NCT02889796|527681710|FG002|Overall Study|Adverse Event|8|||
146319688|NCT02889796|527681711|FG003|Overall Study|Adverse Event|4|||
146319689|NCT02889796|527681712|FG004|Overall Study|Adverse Event|1|||
146319690|NCT02889796|527681713|FG005|Overall Study|Adverse Event|7|||
146319691|NCT02889796|527681708|FG000|Overall Study|Lost to Follow-up|5|||
146319692|NCT02889796|527681709|FG001|Overall Study|Lost to Follow-up|7|||
146319693|NCT02889796|527681710|FG002|Overall Study|Lost to Follow-up|2|||
146319694|NCT02889796|527681711|FG003|Overall Study|Lost to Follow-up|0|||
146319695|NCT02889796|527681712|FG004|Overall Study|Lost to Follow-up|2|||
146319696|NCT02889796|527681713|FG005|Overall Study|Lost to Follow-up|6|||
146319697|NCT02889796|527681708|FG000|Overall Study|Protocol Violation|0|||
146319698|NCT02889796|527681709|FG001|Overall Study|Protocol Violation|1|||
146319699|NCT02889796|527681710|FG002|Overall Study|Protocol Violation|3|||
146319700|NCT02889796|527681711|FG003|Overall Study|Protocol Violation|0|||
146319701|NCT02889796|527681712|FG004|Overall Study|Protocol Violation|0|||
146319702|NCT02889796|527681713|FG005|Overall Study|Protocol Violation|4|||
146319703|NCT02889796|527681708|FG000|Overall Study|Non-compliance With Study Drug|0|||
146319704|NCT02889796|527681709|FG001|Overall Study|Non-compliance With Study Drug|2|||
146319705|NCT02889796|527681710|FG002|Overall Study|Non-compliance With Study Drug|0|||
146319706|NCT02889796|527681711|FG003|Overall Study|Non-compliance With Study Drug|0|||
146319707|NCT02889796|527681712|FG004|Overall Study|Non-compliance With Study Drug|1|||
146319708|NCT02889796|527681713|FG005|Overall Study|Non-compliance With Study Drug|2|||
146319709|NCT02889796|527681708|FG000|Overall Study|Death|1|||
146319710|NCT02889796|527681709|FG001|Overall Study|Death|1|||
146319711|NCT02889796|527681710|FG002|Overall Study|Death|0|||
146319712|NCT02889796|527681711|FG003|Overall Study|Death|1|||
146319713|NCT02889796|527681712|FG004|Overall Study|Death|0|||
146319714|NCT02889796|527681713|FG005|Overall Study|Death|1|||
146319715|NCT02889796|527681708|FG000|Overall Study|Pregnancy|0|||
146319716|NCT02889796|527681709|FG001|Overall Study|Pregnancy|1|||
146319717|NCT02889796|527681710|FG002|Overall Study|Pregnancy|1|||
146319718|NCT02889796|527681711|FG003|Overall Study|Pregnancy|0|||
146319719|NCT02889796|527681712|FG004|Overall Study|Pregnancy|0|||
146319720|NCT02889796|527681713|FG005|Overall Study|Pregnancy|0|||
146319721|NCT02889796|527681708|FG000|Overall Study|Randomized but not Dosed|2|||
146319722|NCT02889796|527681709|FG001|Overall Study|Randomized but not Dosed|0|||
146319723|NCT02889796|527681710|FG002|Overall Study|Randomized but not Dosed|0|||
146319724|NCT02889796|527681711|FG003|Overall Study|Randomized but not Dosed|0|||
146319725|NCT02889796|527681712|FG004|Overall Study|Randomized but not Dosed|0|||
146319726|NCT02889796|527681713|FG005|Overall Study|Randomized but not Dosed|2|||
146319727|NCT04294459|527681714|FG000|Overall Study|Adverse Event|0|||
146319728|NCT04294459|527681715|FG001|Overall Study|Adverse Event|1|||
146319729|NCT04033367|527681716|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
146319730|NCT04033367|527681717|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
146319731|NCT04033367|527681716|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
146319732|NCT04033367|527681717|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
146319733|NCT04033367|527681716|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
146319734|NCT04033367|527681717|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
146319735|NCT04033367|527681716|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
146319736|NCT04033367|527681717|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
146319745|NCT02908880|527681720|FG000|Overall Study|Lost to Follow-up|4|||
146319746|NCT02908880|527681720|FG000|Overall Study|Explantation of the device|1|||
146319747|NCT02908880|527681720|FG000|Overall Study|Withdrawal by Subject|17|||
146319748|NCT02908880|527681720|FG000|Overall Study|Death|5|||
146319749|NCT02421887|527681721|FG000|Overall Study|Lost to Follow-up|5|||
146319750|NCT02421887|527681722|FG001|Overall Study|Lost to Follow-up|0|||
146319751|NCT02421887|527681721|FG000|Overall Study|Withdrawal by Subject|8|||
146319752|NCT02421887|527681722|FG001|Overall Study|Withdrawal by Subject|5|||
146319753|NCT02421887|527681721|FG000|Overall Study|Physician Decision|2|||
146319754|NCT02421887|527681722|FG001|Overall Study|Physician Decision|4|||
146319755|NCT02421887|527681721|FG000|Overall Study|Adverse Event|2|||
146319756|NCT02421887|527681722|FG001|Overall Study|Adverse Event|0|||
146319757|NCT01882907|527681723|FG000|Overall Study|Adverse Event|3|||
146319758|NCT01882907|527681724|FG001|Overall Study|Adverse Event|1|||
146319759|NCT01882907|527681723|FG000|Overall Study|Lack of Efficacy|0|||
146319760|NCT01882907|527681724|FG001|Overall Study|Lack of Efficacy|3|||
146319761|NCT01882907|527681723|FG000|Overall Study|Lost to Follow-up|1|||
146319762|NCT01882907|527681724|FG001|Overall Study|Lost to Follow-up|4|||
146319763|NCT01882907|527681723|FG000|Overall Study|Protocol Violation|10|||
146319764|NCT01882907|527681724|FG001|Overall Study|Protocol Violation|14|||
146319765|NCT01882907|527681723|FG000|Overall Study|Withdrawal by Subject|0|||
146319766|NCT01882907|527681724|FG001|Overall Study|Withdrawal by Subject|6|||
146319767|NCT02450487|527681727|FG000|Overall Study|Lost to Follow-up|3|||
146319768|NCT04269395|527681728|FG000|Overall Study|Lost to Follow-up|1|||
146319769|NCT04269395|527681729|FG001|Overall Study|Lost to Follow-up|0|||
146319770|NCT04269395|527681728|FG000|Overall Study|Study terminated by Sponsor|13|||
146319771|NCT04269395|527681729|FG001|Overall Study|Study terminated by Sponsor|10|||
146319772|NCT01491178|527681730|FG000|Overall Study|Adverse Event|1016|||
146319773|NCT01491178|527681730|FG000|Overall Study|Improvement of NVAF|210|||
146319774|NCT01491178|527681730|FG000|Overall Study|To conduct invasive treatment|59|||
146319775|NCT01491178|527681730|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
146319776|NCT01491178|527681730|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
146319777|NCT01491178|527681730|FG000|Overall Study|To take a contraindication|20|||
146319778|NCT01491178|527681730|FG000|Overall Study|Other than specified above|657|||
146319779|NCT03132636|527681731|FG000|Overall Study|Adverse Event|1|||
146319780|NCT03132636|527681732|FG001|Overall Study|Adverse Event|2|||
146319781|NCT03132636|527681731|FG000|Overall Study|Death|4|||
146319782|NCT03132636|527681732|FG001|Overall Study|Death|7|||
146319783|NCT03132636|527681731|FG000|Overall Study|Lost to Follow-up|3|||
146319784|NCT03132636|527681732|FG001|Overall Study|Lost to Follow-up|2|||
146319785|NCT03132636|527681731|FG000|Overall Study|Non compliance with protocol by participant|1|||
146319786|NCT03132636|527681732|FG001|Overall Study|Non compliance with protocol by participant|1|||
146319787|NCT03132636|527681731|FG000|Overall Study|Subject decision|1|||
146319788|NCT03132636|527681732|FG001|Overall Study|Subject decision|9|||
146319789|NCT03132636|527681731|FG000|Overall Study|Sponsor decision|0|||
146164634|NCT01525602|527112658|FG006|Overall Study|Disease progression|3|||
146164635|NCT01525602|527112659|FG007|Overall Study|Disease progression|3|||
146164636|NCT01525602|527112652|FG000|Overall Study|Clinical progression|2|||
146164637|NCT01525602|527112653|FG001|Overall Study|Clinical progression|0|||
146164638|NCT01525602|527112654|FG002|Overall Study|Clinical progression|0|||
146164639|NCT01525602|527112655|FG003|Overall Study|Clinical progression|0|||
146164640|NCT01525602|527112656|FG004|Overall Study|Clinical progression|0|||
146164641|NCT01525602|527112657|FG005|Overall Study|Clinical progression|0|||
146164642|NCT01525602|527112658|FG006|Overall Study|Clinical progression|1|||
146164643|NCT01525602|527112659|FG007|Overall Study|Clinical progression|1|||
146164644|NCT01525602|527112652|FG000|Overall Study|Non-compliance|0|||
146164645|NCT01525602|527112653|FG001|Overall Study|Non-compliance|0|||
146164646|NCT01525602|527112654|FG002|Overall Study|Non-compliance|0|||
146164647|NCT01525602|527112655|FG003|Overall Study|Non-compliance|0|||
146319790|NCT03132636|527681732|FG001|Overall Study|Sponsor decision|1|||
146319791|NCT03132636|527681731|FG000|Overall Study|Physician Decision|1|||
146319792|NCT03132636|527681732|FG001|Overall Study|Physician Decision|0|||
146319793|NCT03132636|527681731|FG000|Overall Study|Progressive disease|33|||
146164648|NCT01525602|527112656|FG004|Overall Study|Non-compliance|1|||
146319794|NCT03132636|527681732|FG001|Overall Study|Progressive disease|36|||
146319795|NCT03132636|527681731|FG000|Overall Study|Withdrawal of consent|2|||
146319796|NCT03132636|527681732|FG001|Overall Study|Withdrawal of consent|5|||
146319797|NCT03132636|527681731|FG000|Overall Study|Did not re-consent|1|||
146319798|NCT03132636|527681732|FG001|Overall Study|Did not re-consent|0|||
146319799|NCT03132636|527681731|FG000|Overall Study|Lost insurance coverage|1|||
146319800|NCT03132636|527681732|FG001|Overall Study|Lost insurance coverage|0|||
146319801|NCT03132636|527681731|FG000|Overall Study|Related to radiological outcomes|0|||
146319802|NCT03132636|527681732|FG001|Overall Study|Related to radiological outcomes|1|||
146319803|NCT03132636|527681731|FG000|Overall Study|Unable to come to site for continued visits|0|||
146319804|NCT03132636|527681732|FG001|Overall Study|Unable to come to site for continued visits|1|||
146319805|NCT01415752|527681733|FG000|Induction (Step 1)|Ineligible|4|||
146319806|NCT01415752|527681734|FG001|Induction (Step 1)|Ineligible|3|||
146319807|NCT01415752|527681735|FG002|Induction (Step 1)|Ineligible|4|||
146319808|NCT01415752|527681736|FG003|Induction (Step 1)|Ineligible|4|||
146319809|NCT01415752|527681733|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
146319810|NCT01415752|527681734|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
146164649|NCT01525602|527112657|FG005|Overall Study|Non-compliance|0|||
146319811|NCT01415752|527681735|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
146319812|NCT01415752|527681736|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
146319813|NCT01415752|527681733|FG000|Maintenance (Step 2)|Adverse Event|3|||
146319814|NCT01415752|527681734|FG001|Maintenance (Step 2)|Adverse Event|4|||
146319815|NCT01415752|527681735|FG002|Maintenance (Step 2)|Adverse Event|9|||
146319816|NCT01415752|527681736|FG003|Maintenance (Step 2)|Adverse Event|6|||
146319817|NCT01415752|527681733|FG000|Maintenance (Step 2)|Death|1|||
146319818|NCT01415752|527681734|FG001|Maintenance (Step 2)|Death|1|||
146319819|NCT01415752|527681735|FG002|Maintenance (Step 2)|Death|2|||
146319820|NCT01415752|527681736|FG003|Maintenance (Step 2)|Death|0|||
146319821|NCT01415752|527681733|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
146319822|NCT01415752|527681734|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
146319823|NCT01415752|527681735|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
146319824|NCT01415752|527681736|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
146319825|NCT01415752|527681733|FG000|Maintenance (Step 2)|Alternative therapy|0|||
146319826|NCT01415752|527681734|FG001|Maintenance (Step 2)|Alternative therapy|1|||
146319827|NCT01415752|527681735|FG002|Maintenance (Step 2)|Alternative therapy|0|||
146319828|NCT01415752|527681736|FG003|Maintenance (Step 2)|Alternative therapy|0|||
146319829|NCT01415752|527681733|FG000|Maintenance (Step 2)|Other reasons|3|||
146319830|NCT01415752|527681734|FG001|Maintenance (Step 2)|Other reasons|6|||
146319831|NCT01415752|527681735|FG002|Maintenance (Step 2)|Other reasons|4|||
146319832|NCT01415752|527681736|FG003|Maintenance (Step 2)|Other reasons|6|||
146319833|NCT01415752|527681733|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
146319834|NCT01415752|527681734|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
146319835|NCT01415752|527681735|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
146319836|NCT01415752|527681736|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
146319837|NCT01415752|527681733|FG000|Maintenance (Step 2)|ineligible|1|||
146319838|NCT01415752|527681734|FG001|Maintenance (Step 2)|ineligible|1|||
146319839|NCT01415752|527681735|FG002|Maintenance (Step 2)|ineligible|1|||
146319840|NCT01415752|527681736|FG003|Maintenance (Step 2)|ineligible|0|||
146319841|NCT01415752|527681733|FG000|Maintenance (Step 2)|Missing|4|||
146319842|NCT01415752|527681734|FG001|Maintenance (Step 2)|Missing|1|||
146319843|NCT01415752|527681735|FG002|Maintenance (Step 2)|Missing|4|||
146319844|NCT01415752|527681736|FG003|Maintenance (Step 2)|Missing|3|||
146319845|NCT03286842|527681737|FG000|Overall Study|Patients rolled over to another study|80|||
146319846|NCT01391507|527681741|FG000|Overall Study|Death|0|||
146319847|NCT01391507|527681742|FG001|Overall Study|Death|0|||
146319848|NCT01391507|527681743|FG002|Overall Study|Death|0|||
146319849|NCT01391507|527681744|FG003|Overall Study|Death|1|||
146319850|NCT01391507|527681741|FG000|Overall Study|Adverse Event|1|||
146319851|NCT01391507|527681742|FG001|Overall Study|Adverse Event|1|||
146319852|NCT01391507|527681743|FG002|Overall Study|Adverse Event|2|||
146319853|NCT01391507|527681744|FG003|Overall Study|Adverse Event|2|||
146319854|NCT01391507|527681741|FG000|Overall Study|Withdrawal by Subject|1|||
146319855|NCT01391507|527681742|FG001|Overall Study|Withdrawal by Subject|2|||
146319856|NCT01391507|527681743|FG002|Overall Study|Withdrawal by Subject|1|||
146319857|NCT01391507|527681744|FG003|Overall Study|Withdrawal by Subject|1|||
146319858|NCT01391507|527681741|FG000|Overall Study|Lack of Efficacy|0|||
146319859|NCT01391507|527681742|FG001|Overall Study|Lack of Efficacy|0|||
146319860|NCT01391507|527681743|FG002|Overall Study|Lack of Efficacy|0|||
146319861|NCT01391507|527681744|FG003|Overall Study|Lack of Efficacy|1|||
146319862|NCT01391507|527681741|FG000|Overall Study|Protocol Violation|2|||
146319863|NCT01391507|527681742|FG001|Overall Study|Protocol Violation|1|||
146319864|NCT01391507|527681743|FG002|Overall Study|Protocol Violation|1|||
146319865|NCT01391507|527681744|FG003|Overall Study|Protocol Violation|2|||
146319866|NCT03529773|527681749|FG000|Overall Study|Adverse Event|0|||
146319867|NCT03529773|527681750|FG001|Overall Study|Adverse Event|0|||
146319868|NCT03529773|527681751|FG002|Overall Study|Adverse Event|0|||
146319869|NCT03529773|527681752|FG003|Overall Study|Adverse Event|0|||
146319870|NCT03529773|527681753|FG004|Overall Study|Adverse Event|0|||
146164650|NCT01525602|527112658|FG006|Overall Study|Non-compliance|0|||
146164651|NCT01525602|527112659|FG007|Overall Study|Non-compliance|0|||
146319871|NCT03529773|527681754|FG005|Overall Study|Adverse Event|0|||
146319872|NCT03529773|527681755|FG006|Overall Study|Adverse Event|0|||
146319873|NCT03529773|527681756|FG007|Overall Study|Adverse Event|0|||
146319874|NCT03529773|527681757|FG008|Overall Study|Adverse Event|0|||
146319875|NCT03529773|527681758|FG009|Overall Study|Adverse Event|0|||
146319876|NCT03529773|527681759|FG010|Overall Study|Adverse Event|0|||
146319877|NCT03529773|527681760|FG011|Overall Study|Adverse Event|0|||
146319878|NCT03529773|527681761|FG012|Overall Study|Adverse Event|0|||
146319879|NCT03529773|527681762|FG013|Overall Study|Adverse Event|0|||
146319880|NCT03529773|527681763|FG014|Overall Study|Adverse Event|0|||
146319881|NCT03529773|527681764|FG015|Overall Study|Adverse Event|0|||
146319882|NCT03529773|527681765|FG016|Overall Study|Adverse Event|0|||
146319883|NCT03529773|527681766|FG017|Overall Study|Adverse Event|0|||
146319884|NCT03529773|527681767|FG018|Overall Study|Adverse Event|0|||
146319885|NCT03529773|527681768|FG019|Overall Study|Adverse Event|0|||
146319886|NCT03529773|527681769|FG020|Overall Study|Adverse Event|0|||
146319887|NCT03529773|527681770|FG021|Overall Study|Adverse Event|0|||
146319888|NCT03529773|527681771|FG022|Overall Study|Adverse Event|0|||
146319889|NCT03529773|527681772|FG023|Overall Study|Adverse Event|0|||
146319890|NCT03529773|527681773|FG024|Overall Study|Adverse Event|0|||
146319891|NCT03529773|527681774|FG025|Overall Study|Adverse Event|0|||
146319892|NCT03529773|527681775|FG026|Overall Study|Adverse Event|0|||
146319893|NCT03529773|527681776|FG027|Overall Study|Adverse Event|0|||
146319894|NCT03529773|527681777|FG028|Overall Study|Adverse Event|0|||
146319895|NCT03529773|527681778|FG029|Overall Study|Adverse Event|0|||
146319896|NCT03529773|527681779|FG030|Overall Study|Adverse Event|1|||
146319897|NCT03529773|527681780|FG031|Overall Study|Adverse Event|0|||
146319898|NCT03529773|527681781|FG032|Overall Study|Adverse Event|0|||
146319899|NCT03529773|527681782|FG033|Overall Study|Adverse Event|0|||
146319900|NCT03529773|527681783|FG034|Overall Study|Adverse Event|0|||
146319901|NCT03529773|527681784|FG035|Overall Study|Adverse Event|1|||
146319902|NCT03529773|527681785|FG036|Overall Study|Adverse Event|0|||
146319903|NCT03529773|527681786|FG037|Overall Study|Adverse Event|0|||
146319904|NCT03529773|527681787|FG038|Overall Study|Adverse Event|1|||
146319905|NCT03529773|527681788|FG039|Overall Study|Adverse Event|1|||
146319906|NCT03529773|527681749|FG000|Overall Study|Death|0|||
146319907|NCT03529773|527681750|FG001|Overall Study|Death|0|||
146319908|NCT03529773|527681751|FG002|Overall Study|Death|0|||
146319909|NCT03529773|527681752|FG003|Overall Study|Death|0|||
146319910|NCT03529773|527681753|FG004|Overall Study|Death|0|||
146319911|NCT03529773|527681754|FG005|Overall Study|Death|0|||
146319912|NCT03529773|527681755|FG006|Overall Study|Death|0|||
146319913|NCT03529773|527681756|FG007|Overall Study|Death|0|||
146319914|NCT03529773|527681757|FG008|Overall Study|Death|0|||
146319915|NCT03529773|527681758|FG009|Overall Study|Death|0|||
146319916|NCT03529773|527681759|FG010|Overall Study|Death|0|||
146319917|NCT03529773|527681760|FG011|Overall Study|Death|0|||
146319918|NCT03529773|527681761|FG012|Overall Study|Death|1|||
146319919|NCT03529773|527681762|FG013|Overall Study|Death|0|||
146319920|NCT03529773|527681763|FG014|Overall Study|Death|0|||
146319921|NCT03529773|527681764|FG015|Overall Study|Death|0|||
146319922|NCT03529773|527681765|FG016|Overall Study|Death|0|||
146319923|NCT03529773|527681766|FG017|Overall Study|Death|0|||
146319924|NCT03529773|527681767|FG018|Overall Study|Death|0|||
146319925|NCT03529773|527681768|FG019|Overall Study|Death|1|||
146319926|NCT03529773|527681769|FG020|Overall Study|Death|0|||
146319927|NCT03529773|527681770|FG021|Overall Study|Death|0|||
146319928|NCT03529773|527681771|FG022|Overall Study|Death|1|||
146319929|NCT03529773|527681772|FG023|Overall Study|Death|0|||
146319930|NCT03529773|527681773|FG024|Overall Study|Death|0|||
146319931|NCT03529773|527681774|FG025|Overall Study|Death|0|||
146319932|NCT03529773|527681775|FG026|Overall Study|Death|0|||
146319933|NCT03529773|527681776|FG027|Overall Study|Death|0|||
146319934|NCT03529773|527681777|FG028|Overall Study|Death|0|||
146319935|NCT03529773|527681778|FG029|Overall Study|Death|0|||
146319936|NCT03529773|527681779|FG030|Overall Study|Death|0|||
146319937|NCT03529773|527681780|FG031|Overall Study|Death|0|||
146319938|NCT03529773|527681781|FG032|Overall Study|Death|0|||
146319939|NCT03529773|527681782|FG033|Overall Study|Death|1|||
146319940|NCT03529773|527681783|FG034|Overall Study|Death|1|||
146319941|NCT03529773|527681784|FG035|Overall Study|Death|0|||
146319942|NCT03529773|527681785|FG036|Overall Study|Death|1|||
146319943|NCT03529773|527681786|FG037|Overall Study|Death|0|||
146319944|NCT03529773|527681787|FG038|Overall Study|Death|0|||
146319945|NCT03529773|527681788|FG039|Overall Study|Death|0|||
146319946|NCT03529773|527681749|FG000|Overall Study|Lost to Follow-up|0|||
146319947|NCT03529773|527681750|FG001|Overall Study|Lost to Follow-up|0|||
146319948|NCT03529773|527681751|FG002|Overall Study|Lost to Follow-up|1|||
146319949|NCT03529773|527681752|FG003|Overall Study|Lost to Follow-up|0|||
146319950|NCT03529773|527681753|FG004|Overall Study|Lost to Follow-up|1|||
146319951|NCT03529773|527681754|FG005|Overall Study|Lost to Follow-up|1|||
145943225|NCT00483704|526300457|FG001|Treatment|Withdrawal by Subject|12|||
146319952|NCT03529773|527681755|FG006|Overall Study|Lost to Follow-up|0|||
146319953|NCT03529773|527681756|FG007|Overall Study|Lost to Follow-up|0|||
146319954|NCT03529773|527681757|FG008|Overall Study|Lost to Follow-up|0|||
146319955|NCT03529773|527681758|FG009|Overall Study|Lost to Follow-up|0|||
146319956|NCT03529773|527681759|FG010|Overall Study|Lost to Follow-up|0|||
146319957|NCT03529773|527681760|FG011|Overall Study|Lost to Follow-up|0|||
146319958|NCT03529773|527681761|FG012|Overall Study|Lost to Follow-up|0|||
146319959|NCT03529773|527681762|FG013|Overall Study|Lost to Follow-up|1|||
146319960|NCT03529773|527681763|FG014|Overall Study|Lost to Follow-up|4|||
146319961|NCT03529773|527681764|FG015|Overall Study|Lost to Follow-up|1|||
146319962|NCT03529773|527681765|FG016|Overall Study|Lost to Follow-up|1|||
146319963|NCT03529773|527681766|FG017|Overall Study|Lost to Follow-up|0|||
146319964|NCT03529773|527681767|FG018|Overall Study|Lost to Follow-up|1|||
146319965|NCT03529773|527681768|FG019|Overall Study|Lost to Follow-up|1|||
146319966|NCT03529773|527681769|FG020|Overall Study|Lost to Follow-up|2|||
146319967|NCT03529773|527681770|FG021|Overall Study|Lost to Follow-up|4|||
146319968|NCT03529773|527681771|FG022|Overall Study|Lost to Follow-up|3|||
146319969|NCT03529773|527681772|FG023|Overall Study|Lost to Follow-up|4|||
146319970|NCT03529773|527681773|FG024|Overall Study|Lost to Follow-up|3|||
146164652|NCT01525602|527112652|FG000|Overall Study|Withdrawal by Subject|0|||
146164653|NCT01525602|527112653|FG001|Overall Study|Withdrawal by Subject|0|||
146164654|NCT01525602|527112654|FG002|Overall Study|Withdrawal by Subject|0|||
146164655|NCT01525602|527112655|FG003|Overall Study|Withdrawal by Subject|0|||
146319971|NCT03529773|527681774|FG025|Overall Study|Lost to Follow-up|5|||
146319972|NCT03529773|527681775|FG026|Overall Study|Lost to Follow-up|5|||
146319973|NCT03529773|527681776|FG027|Overall Study|Lost to Follow-up|0|||
146319974|NCT03529773|527681777|FG028|Overall Study|Lost to Follow-up|0|||
146319975|NCT03529773|527681778|FG029|Overall Study|Lost to Follow-up|0|||
146319976|NCT03529773|527681779|FG030|Overall Study|Lost to Follow-up|1|||
146319977|NCT03529773|527681780|FG031|Overall Study|Lost to Follow-up|0|||
146319978|NCT03529773|527681781|FG032|Overall Study|Lost to Follow-up|0|||
146319979|NCT03529773|527681782|FG033|Overall Study|Lost to Follow-up|1|||
146319980|NCT03529773|527681783|FG034|Overall Study|Lost to Follow-up|1|||
146319981|NCT03529773|527681784|FG035|Overall Study|Lost to Follow-up|0|||
146319982|NCT03529773|527681785|FG036|Overall Study|Lost to Follow-up|0|||
146319983|NCT03529773|527681786|FG037|Overall Study|Lost to Follow-up|3|||
146319984|NCT03529773|527681787|FG038|Overall Study|Lost to Follow-up|1|||
146319985|NCT03529773|527681788|FG039|Overall Study|Lost to Follow-up|1|||
146319986|NCT03529773|527681749|FG000|Overall Study|No longer meets eligibility criteria|0|||
146319987|NCT03529773|527681750|FG001|Overall Study|No longer meets eligibility criteria|0|||
146319988|NCT03529773|527681751|FG002|Overall Study|No longer meets eligibility criteria|0|||
146319989|NCT03529773|527681752|FG003|Overall Study|No longer meets eligibility criteria|0|||
146319990|NCT03529773|527681753|FG004|Overall Study|No longer meets eligibility criteria|0|||
146319991|NCT03529773|527681754|FG005|Overall Study|No longer meets eligibility criteria|0|||
146319992|NCT03529773|527681755|FG006|Overall Study|No longer meets eligibility criteria|0|||
146319993|NCT03529773|527681756|FG007|Overall Study|No longer meets eligibility criteria|0|||
146319994|NCT03529773|527681757|FG008|Overall Study|No longer meets eligibility criteria|0|||
146319995|NCT03529773|527681758|FG009|Overall Study|No longer meets eligibility criteria|0|||
146319996|NCT03529773|527681759|FG010|Overall Study|No longer meets eligibility criteria|0|||
146319997|NCT03529773|527681760|FG011|Overall Study|No longer meets eligibility criteria|0|||
146319998|NCT03529773|527681761|FG012|Overall Study|No longer meets eligibility criteria|0|||
146319999|NCT03529773|527681762|FG013|Overall Study|No longer meets eligibility criteria|0|||
146320000|NCT03529773|527681763|FG014|Overall Study|No longer meets eligibility criteria|0|||
146320001|NCT03529773|527681764|FG015|Overall Study|No longer meets eligibility criteria|0|||
146320002|NCT03529773|527681765|FG016|Overall Study|No longer meets eligibility criteria|0|||
146320003|NCT03529773|527681766|FG017|Overall Study|No longer meets eligibility criteria|0|||
146320004|NCT03529773|527681767|FG018|Overall Study|No longer meets eligibility criteria|0|||
146320005|NCT03529773|527681768|FG019|Overall Study|No longer meets eligibility criteria|0|||
146320006|NCT03529773|527681769|FG020|Overall Study|No longer meets eligibility criteria|0|||
146320007|NCT03529773|527681770|FG021|Overall Study|No longer meets eligibility criteria|0|||
146320008|NCT03529773|527681771|FG022|Overall Study|No longer meets eligibility criteria|1|||
146320009|NCT03529773|527681772|FG023|Overall Study|No longer meets eligibility criteria|0|||
146320010|NCT03529773|527681773|FG024|Overall Study|No longer meets eligibility criteria|0|||
146320011|NCT03529773|527681774|FG025|Overall Study|No longer meets eligibility criteria|0|||
146320012|NCT03529773|527681775|FG026|Overall Study|No longer meets eligibility criteria|0|||
146320013|NCT03529773|527681776|FG027|Overall Study|No longer meets eligibility criteria|0|||
146320014|NCT03529773|527681777|FG028|Overall Study|No longer meets eligibility criteria|0|||
146320015|NCT03529773|527681778|FG029|Overall Study|No longer meets eligibility criteria|0|||
146320016|NCT03529773|527681779|FG030|Overall Study|No longer meets eligibility criteria|0|||
146320017|NCT03529773|527681780|FG031|Overall Study|No longer meets eligibility criteria|0|||
146320018|NCT03529773|527681781|FG032|Overall Study|No longer meets eligibility criteria|0|||
146320019|NCT03529773|527681782|FG033|Overall Study|No longer meets eligibility criteria|0|||
146320020|NCT03529773|527681783|FG034|Overall Study|No longer meets eligibility criteria|0|||
146320021|NCT03529773|527681784|FG035|Overall Study|No longer meets eligibility criteria|0|||
146320022|NCT03529773|527681785|FG036|Overall Study|No longer meets eligibility criteria|0|||
146320023|NCT03529773|527681786|FG037|Overall Study|No longer meets eligibility criteria|0|||
146320024|NCT03529773|527681787|FG038|Overall Study|No longer meets eligibility criteria|1|||
146320025|NCT03529773|527681788|FG039|Overall Study|No longer meets eligibility criteria|0|||
146320026|NCT03529773|527681749|FG000|Overall Study|Other|0|||
146320027|NCT03529773|527681750|FG001|Overall Study|Other|0|||
146320028|NCT03529773|527681751|FG002|Overall Study|Other|0|||
146320029|NCT03529773|527681752|FG003|Overall Study|Other|0|||
146320030|NCT03529773|527681753|FG004|Overall Study|Other|0|||
146320031|NCT03529773|527681754|FG005|Overall Study|Other|0|||
146320032|NCT03529773|527681755|FG006|Overall Study|Other|0|||
146320033|NCT03529773|527681756|FG007|Overall Study|Other|0|||
146320034|NCT03529773|527681757|FG008|Overall Study|Other|0|||
146164656|NCT01525602|527112656|FG004|Overall Study|Withdrawal by Subject|3|||
146320035|NCT03529773|527681758|FG009|Overall Study|Other|0|||
146320036|NCT03529773|527681759|FG010|Overall Study|Other|0|||
146320037|NCT03529773|527681760|FG011|Overall Study|Other|0|||
146320038|NCT03529773|527681761|FG012|Overall Study|Other|1|||
146320039|NCT03529773|527681762|FG013|Overall Study|Other|0|||
146320040|NCT03529773|527681763|FG014|Overall Study|Other|2|||
146320041|NCT03529773|527681764|FG015|Overall Study|Other|0|||
146320042|NCT03529773|527681765|FG016|Overall Study|Other|0|||
146320043|NCT03529773|527681766|FG017|Overall Study|Other|3|||
146320044|NCT03529773|527681767|FG018|Overall Study|Other|0|||
146320045|NCT03529773|527681768|FG019|Overall Study|Other|0|||
146320046|NCT03529773|527681769|FG020|Overall Study|Other|1|||
146320047|NCT03529773|527681770|FG021|Overall Study|Other|0|||
146320048|NCT03529773|527681771|FG022|Overall Study|Other|1|||
146320049|NCT03529773|527681772|FG023|Overall Study|Other|0|||
146320050|NCT03529773|527681773|FG024|Overall Study|Other|3|||
146320051|NCT03529773|527681774|FG025|Overall Study|Other|2|||
146320052|NCT03529773|527681775|FG026|Overall Study|Other|2|||
146320053|NCT03529773|527681776|FG027|Overall Study|Other|0|||
146320054|NCT03529773|527681777|FG028|Overall Study|Other|0|||
146320055|NCT03529773|527681778|FG029|Overall Study|Other|0|||
146320056|NCT03529773|527681779|FG030|Overall Study|Other|0|||
146320057|NCT03529773|527681780|FG031|Overall Study|Other|0|||
146320058|NCT03529773|527681781|FG032|Overall Study|Other|0|||
146320059|NCT03529773|527681782|FG033|Overall Study|Other|0|||
146320060|NCT03529773|527681783|FG034|Overall Study|Other|1|||
146320061|NCT03529773|527681784|FG035|Overall Study|Other|1|||
146320062|NCT03529773|527681785|FG036|Overall Study|Other|0|||
146320063|NCT03529773|527681786|FG037|Overall Study|Other|0|||
146320064|NCT03529773|527681787|FG038|Overall Study|Other|0|||
146320065|NCT03529773|527681788|FG039|Overall Study|Other|0|||
146320066|NCT03529773|527681749|FG000|Overall Study|Physician Decision|0|||
146320067|NCT03529773|527681750|FG001|Overall Study|Physician Decision|0|||
146320068|NCT03529773|527681751|FG002|Overall Study|Physician Decision|0|||
146320069|NCT03529773|527681752|FG003|Overall Study|Physician Decision|0|||
146320070|NCT03529773|527681753|FG004|Overall Study|Physician Decision|0|||
146320071|NCT03529773|527681754|FG005|Overall Study|Physician Decision|0|||
146320072|NCT03529773|527681755|FG006|Overall Study|Physician Decision|0|||
146320073|NCT03529773|527681756|FG007|Overall Study|Physician Decision|0|||
146320074|NCT03529773|527681757|FG008|Overall Study|Physician Decision|0|||
146320075|NCT03529773|527681758|FG009|Overall Study|Physician Decision|0|||
146320076|NCT03529773|527681759|FG010|Overall Study|Physician Decision|0|||
146320077|NCT03529773|527681760|FG011|Overall Study|Physician Decision|0|||
146320078|NCT03529773|527681761|FG012|Overall Study|Physician Decision|0|||
146320079|NCT03529773|527681762|FG013|Overall Study|Physician Decision|0|||
146320080|NCT03529773|527681763|FG014|Overall Study|Physician Decision|0|||
146320081|NCT03529773|527681764|FG015|Overall Study|Physician Decision|0|||
146320082|NCT03529773|527681765|FG016|Overall Study|Physician Decision|0|||
146320083|NCT03529773|527681766|FG017|Overall Study|Physician Decision|0|||
146320084|NCT03529773|527681767|FG018|Overall Study|Physician Decision|0|||
146320085|NCT03529773|527681768|FG019|Overall Study|Physician Decision|1|||
146320086|NCT03529773|527681769|FG020|Overall Study|Physician Decision|1|||
146320087|NCT03529773|527681770|FG021|Overall Study|Physician Decision|0|||
146320088|NCT03529773|527681771|FG022|Overall Study|Physician Decision|0|||
146320089|NCT03529773|527681772|FG023|Overall Study|Physician Decision|0|||
146320090|NCT03529773|527681773|FG024|Overall Study|Physician Decision|0|||
146320091|NCT03529773|527681774|FG025|Overall Study|Physician Decision|0|||
146320092|NCT03529773|527681775|FG026|Overall Study|Physician Decision|0|||
146320093|NCT03529773|527681776|FG027|Overall Study|Physician Decision|0|||
146320094|NCT03529773|527681777|FG028|Overall Study|Physician Decision|0|||
146320095|NCT03529773|527681778|FG029|Overall Study|Physician Decision|0|||
146320096|NCT03529773|527681779|FG030|Overall Study|Physician Decision|0|||
146320097|NCT03529773|527681780|FG031|Overall Study|Physician Decision|0|||
146320098|NCT03529773|527681781|FG032|Overall Study|Physician Decision|0|||
146320099|NCT03529773|527681782|FG033|Overall Study|Physician Decision|0|||
146320100|NCT03529773|527681783|FG034|Overall Study|Physician Decision|0|||
146320101|NCT03529773|527681784|FG035|Overall Study|Physician Decision|0|||
146320102|NCT03529773|527681785|FG036|Overall Study|Physician Decision|0|||
146320103|NCT03529773|527681786|FG037|Overall Study|Physician Decision|0|||
146320104|NCT03529773|527681787|FG038|Overall Study|Physician Decision|0|||
146320105|NCT03529773|527681788|FG039|Overall Study|Physician Decision|0|||
146320106|NCT03529773|527681749|FG000|Overall Study|Protocol Violation|0|||
146320107|NCT03529773|527681750|FG001|Overall Study|Protocol Violation|0|||
146320108|NCT03529773|527681751|FG002|Overall Study|Protocol Violation|0|||
146320109|NCT03529773|527681752|FG003|Overall Study|Protocol Violation|0|||
146320110|NCT03529773|527681753|FG004|Overall Study|Protocol Violation|0|||
146320111|NCT03529773|527681754|FG005|Overall Study|Protocol Violation|0|||
146320112|NCT03529773|527681755|FG006|Overall Study|Protocol Violation|0|||
146320113|NCT03529773|527681756|FG007|Overall Study|Protocol Violation|0|||
146320114|NCT03529773|527681757|FG008|Overall Study|Protocol Violation|0|||
146320115|NCT03529773|527681758|FG009|Overall Study|Protocol Violation|0|||
146320116|NCT03529773|527681759|FG010|Overall Study|Protocol Violation|0|||
146320117|NCT03529773|527681760|FG011|Overall Study|Protocol Violation|0|||
146320118|NCT03529773|527681761|FG012|Overall Study|Protocol Violation|0|||
146320119|NCT03529773|527681762|FG013|Overall Study|Protocol Violation|0|||
146320120|NCT03529773|527681763|FG014|Overall Study|Protocol Violation|0|||
146320121|NCT03529773|527681764|FG015|Overall Study|Protocol Violation|0|||
146320122|NCT03529773|527681765|FG016|Overall Study|Protocol Violation|0|||
146320123|NCT03529773|527681766|FG017|Overall Study|Protocol Violation|0|||
146320124|NCT03529773|527681767|FG018|Overall Study|Protocol Violation|0|||
146320125|NCT03529773|527681768|FG019|Overall Study|Protocol Violation|0|||
146320126|NCT03529773|527681769|FG020|Overall Study|Protocol Violation|0|||
146320127|NCT03529773|527681770|FG021|Overall Study|Protocol Violation|0|||
146320128|NCT03529773|527681771|FG022|Overall Study|Protocol Violation|0|||
146320129|NCT03529773|527681772|FG023|Overall Study|Protocol Violation|0|||
146320130|NCT03529773|527681773|FG024|Overall Study|Protocol Violation|0|||
146320131|NCT03529773|527681774|FG025|Overall Study|Protocol Violation|0|||
146320132|NCT03529773|527681775|FG026|Overall Study|Protocol Violation|0|||
146320133|NCT03529773|527681776|FG027|Overall Study|Protocol Violation|0|||
146320134|NCT03529773|527681777|FG028|Overall Study|Protocol Violation|0|||
146320135|NCT03529773|527681778|FG029|Overall Study|Protocol Violation|0|||
146320136|NCT03529773|527681779|FG030|Overall Study|Protocol Violation|1|||
146320137|NCT03529773|527681780|FG031|Overall Study|Protocol Violation|0|||
146320138|NCT03529773|527681781|FG032|Overall Study|Protocol Violation|0|||
146320139|NCT03529773|527681782|FG033|Overall Study|Protocol Violation|0|||
146320140|NCT03529773|527681783|FG034|Overall Study|Protocol Violation|0|||
146320141|NCT03529773|527681784|FG035|Overall Study|Protocol Violation|0|||
146320142|NCT03529773|527681785|FG036|Overall Study|Protocol Violation|0|||
146320143|NCT03529773|527681786|FG037|Overall Study|Protocol Violation|0|||
146320144|NCT03529773|527681787|FG038|Overall Study|Protocol Violation|0|||
146320145|NCT03529773|527681788|FG039|Overall Study|Protocol Violation|0|||
146320146|NCT03529773|527681749|FG000|Overall Study|Withdrawal by Subject|0|||
146320147|NCT03529773|527681750|FG001|Overall Study|Withdrawal by Subject|0|||
146320148|NCT03529773|527681751|FG002|Overall Study|Withdrawal by Subject|0|||
146320149|NCT03529773|527681752|FG003|Overall Study|Withdrawal by Subject|0|||
146320150|NCT03529773|527681753|FG004|Overall Study|Withdrawal by Subject|0|||
146320151|NCT03529773|527681754|FG005|Overall Study|Withdrawal by Subject|0|||
146320152|NCT03529773|527681755|FG006|Overall Study|Withdrawal by Subject|0|||
146320153|NCT03529773|527681756|FG007|Overall Study|Withdrawal by Subject|1|||
146320154|NCT03529773|527681757|FG008|Overall Study|Withdrawal by Subject|0|||
146320155|NCT03529773|527681758|FG009|Overall Study|Withdrawal by Subject|1|||
146320156|NCT03529773|527681759|FG010|Overall Study|Withdrawal by Subject|1|||
146320157|NCT03529773|527681760|FG011|Overall Study|Withdrawal by Subject|0|||
146320158|NCT03529773|527681761|FG012|Overall Study|Withdrawal by Subject|0|||
146320159|NCT03529773|527681762|FG013|Overall Study|Withdrawal by Subject|0|||
146320160|NCT03529773|527681763|FG014|Overall Study|Withdrawal by Subject|0|||
146320161|NCT03529773|527681764|FG015|Overall Study|Withdrawal by Subject|3|||
146320162|NCT03529773|527681765|FG016|Overall Study|Withdrawal by Subject|0|||
146320163|NCT03529773|527681766|FG017|Overall Study|Withdrawal by Subject|2|||
146320164|NCT03529773|527681767|FG018|Overall Study|Withdrawal by Subject|3|||
146320165|NCT03529773|527681768|FG019|Overall Study|Withdrawal by Subject|1|||
146320166|NCT03529773|527681769|FG020|Overall Study|Withdrawal by Subject|3|||
146320167|NCT03529773|527681770|FG021|Overall Study|Withdrawal by Subject|1|||
146320168|NCT03529773|527681771|FG022|Overall Study|Withdrawal by Subject|1|||
146320169|NCT03529773|527681772|FG023|Overall Study|Withdrawal by Subject|2|||
146320170|NCT03529773|527681773|FG024|Overall Study|Withdrawal by Subject|2|||
146320171|NCT03529773|527681774|FG025|Overall Study|Withdrawal by Subject|4|||
146320172|NCT03529773|527681775|FG026|Overall Study|Withdrawal by Subject|2|||
146320173|NCT03529773|527681776|FG027|Overall Study|Withdrawal by Subject|1|||
146320174|NCT03529773|527681777|FG028|Overall Study|Withdrawal by Subject|1|||
146320175|NCT03529773|527681778|FG029|Overall Study|Withdrawal by Subject|0|||
146320176|NCT03529773|527681779|FG030|Overall Study|Withdrawal by Subject|0|||
146320177|NCT03529773|527681780|FG031|Overall Study|Withdrawal by Subject|0|||
146320178|NCT03529773|527681781|FG032|Overall Study|Withdrawal by Subject|0|||
146320179|NCT03529773|527681782|FG033|Overall Study|Withdrawal by Subject|0|||
146164657|NCT01525602|527112657|FG005|Overall Study|Withdrawal by Subject|1|||
146164658|NCT01525602|527112658|FG006|Overall Study|Withdrawal by Subject|0|||
146164659|NCT01525602|527112659|FG007|Overall Study|Withdrawal by Subject|1|||
146164660|NCT01525602|527112652|FG000|Overall Study|Physician Decision|0|||
146164661|NCT01525602|527112653|FG001|Overall Study|Physician Decision|0|||
146320180|NCT03529773|527681783|FG034|Overall Study|Withdrawal by Subject|1|||
146320181|NCT03529773|527681784|FG035|Overall Study|Withdrawal by Subject|2|||
146320182|NCT03529773|527681785|FG036|Overall Study|Withdrawal by Subject|0|||
146320183|NCT03529773|527681786|FG037|Overall Study|Withdrawal by Subject|2|||
146320184|NCT03529773|527681787|FG038|Overall Study|Withdrawal by Subject|1|||
146320185|NCT03529773|527681788|FG039|Overall Study|Withdrawal by Subject|1|||
146320186|NCT03529773|527681749|FG000|Overall Study|Screen Failure|0|||
146320187|NCT03529773|527681750|FG001|Overall Study|Screen Failure|0|||
146320188|NCT03529773|527681751|FG002|Overall Study|Screen Failure|0|||
146320189|NCT03529773|527681752|FG003|Overall Study|Screen Failure|0|||
145943226|NCT00483704|526300458|FG002|Treatment|Withdrawal by Subject|21|||
146164662|NCT01525602|527112654|FG002|Overall Study|Physician Decision|0|||
146320190|NCT03529773|527681753|FG004|Overall Study|Screen Failure|0|||
146320191|NCT03529773|527681754|FG005|Overall Study|Screen Failure|0|||
146320192|NCT03529773|527681755|FG006|Overall Study|Screen Failure|0|||
146320193|NCT03529773|527681756|FG007|Overall Study|Screen Failure|0|||
146320194|NCT03529773|527681757|FG008|Overall Study|Screen Failure|0|||
146320195|NCT03529773|527681758|FG009|Overall Study|Screen Failure|0|||
146320196|NCT03529773|527681759|FG010|Overall Study|Screen Failure|0|||
146320197|NCT03529773|527681760|FG011|Overall Study|Screen Failure|0|||
146320198|NCT03529773|527681761|FG012|Overall Study|Screen Failure|0|||
146320199|NCT03529773|527681762|FG013|Overall Study|Screen Failure|0|||
146320200|NCT03529773|527681763|FG014|Overall Study|Screen Failure|0|||
146320201|NCT03529773|527681764|FG015|Overall Study|Screen Failure|0|||
146320202|NCT03529773|527681765|FG016|Overall Study|Screen Failure|0|||
146320203|NCT03529773|527681766|FG017|Overall Study|Screen Failure|0|||
146320204|NCT03529773|527681767|FG018|Overall Study|Screen Failure|0|||
146320205|NCT03529773|527681768|FG019|Overall Study|Screen Failure|0|||
146320206|NCT03529773|527681769|FG020|Overall Study|Screen Failure|0|||
146320207|NCT03529773|527681770|FG021|Overall Study|Screen Failure|0|||
146320208|NCT03529773|527681771|FG022|Overall Study|Screen Failure|0|||
146320209|NCT03529773|527681772|FG023|Overall Study|Screen Failure|0|||
146320210|NCT03529773|527681773|FG024|Overall Study|Screen Failure|0|||
146320211|NCT03529773|527681774|FG025|Overall Study|Screen Failure|0|||
146320212|NCT03529773|527681775|FG026|Overall Study|Screen Failure|0|||
146320213|NCT03529773|527681776|FG027|Overall Study|Screen Failure|0|||
146320214|NCT03529773|527681777|FG028|Overall Study|Screen Failure|0|||
146320215|NCT03529773|527681778|FG029|Overall Study|Screen Failure|0|||
146320216|NCT03529773|527681779|FG030|Overall Study|Screen Failure|0|||
146320217|NCT03529773|527681780|FG031|Overall Study|Screen Failure|0|||
146320218|NCT03529773|527681781|FG032|Overall Study|Screen Failure|0|||
146320219|NCT03529773|527681782|FG033|Overall Study|Screen Failure|0|||
146320220|NCT03529773|527681783|FG034|Overall Study|Screen Failure|0|||
146320221|NCT03529773|527681784|FG035|Overall Study|Screen Failure|0|||
146320222|NCT03529773|527681785|FG036|Overall Study|Screen Failure|1|||
146320223|NCT03529773|527681786|FG037|Overall Study|Screen Failure|1|||
146320224|NCT03529773|527681787|FG038|Overall Study|Screen Failure|0|||
146320225|NCT03529773|527681788|FG039|Overall Study|Screen Failure|1|||
146320226|NCT03529773|527681749|FG000|Overall Study|Randomized but not vaccinated|0|||
146320227|NCT03529773|527681750|FG001|Overall Study|Randomized but not vaccinated|0|||
146320228|NCT03529773|527681751|FG002|Overall Study|Randomized but not vaccinated|0|||
146320229|NCT03529773|527681752|FG003|Overall Study|Randomized but not vaccinated|0|||
146320230|NCT03529773|527681753|FG004|Overall Study|Randomized but not vaccinated|0|||
146320231|NCT03529773|527681754|FG005|Overall Study|Randomized but not vaccinated|0|||
146320232|NCT03529773|527681755|FG006|Overall Study|Randomized but not vaccinated|0|||
146320233|NCT03529773|527681756|FG007|Overall Study|Randomized but not vaccinated|0|||
146320234|NCT03529773|527681757|FG008|Overall Study|Randomized but not vaccinated|0|||
146320235|NCT03529773|527681758|FG009|Overall Study|Randomized but not vaccinated|0|||
146320236|NCT03529773|527681759|FG010|Overall Study|Randomized but not vaccinated|0|||
146320237|NCT03529773|527681760|FG011|Overall Study|Randomized but not vaccinated|0|||
146320238|NCT03529773|527681761|FG012|Overall Study|Randomized but not vaccinated|0|||
146320239|NCT03529773|527681762|FG013|Overall Study|Randomized but not vaccinated|0|||
146320240|NCT03529773|527681763|FG014|Overall Study|Randomized but not vaccinated|0|||
146320241|NCT03529773|527681764|FG015|Overall Study|Randomized but not vaccinated|0|||
146320242|NCT03529773|527681765|FG016|Overall Study|Randomized but not vaccinated|0|||
146320243|NCT03529773|527681766|FG017|Overall Study|Randomized but not vaccinated|1|||
146320244|NCT03529773|527681767|FG018|Overall Study|Randomized but not vaccinated|0|||
146320245|NCT03529773|527681768|FG019|Overall Study|Randomized but not vaccinated|0|||
146320246|NCT03529773|527681769|FG020|Overall Study|Randomized but not vaccinated|0|||
146320247|NCT03529773|527681770|FG021|Overall Study|Randomized but not vaccinated|0|||
146320248|NCT03529773|527681771|FG022|Overall Study|Randomized but not vaccinated|0|||
146320249|NCT03529773|527681772|FG023|Overall Study|Randomized but not vaccinated|0|||
146320250|NCT03529773|527681773|FG024|Overall Study|Randomized but not vaccinated|0|||
146320251|NCT03529773|527681774|FG025|Overall Study|Randomized but not vaccinated|0|||
146320252|NCT03529773|527681775|FG026|Overall Study|Randomized but not vaccinated|0|||
146320253|NCT03529773|527681776|FG027|Overall Study|Randomized but not vaccinated|1|||
146320254|NCT03529773|527681777|FG028|Overall Study|Randomized but not vaccinated|0|||
146320255|NCT03529773|527681778|FG029|Overall Study|Randomized but not vaccinated|0|||
146320256|NCT03529773|527681779|FG030|Overall Study|Randomized but not vaccinated|0|||
146320257|NCT03529773|527681780|FG031|Overall Study|Randomized but not vaccinated|0|||
146320258|NCT03529773|527681781|FG032|Overall Study|Randomized but not vaccinated|0|||
146320259|NCT03529773|527681782|FG033|Overall Study|Randomized but not vaccinated|0|||
146320260|NCT03529773|527681783|FG034|Overall Study|Randomized but not vaccinated|0|||
146320261|NCT03529773|527681784|FG035|Overall Study|Randomized but not vaccinated|0|||
146320262|NCT03529773|527681785|FG036|Overall Study|Randomized but not vaccinated|0|||
146320263|NCT03529773|527681786|FG037|Overall Study|Randomized but not vaccinated|0|||
146320264|NCT03529773|527681787|FG038|Overall Study|Randomized but not vaccinated|0|||
146320265|NCT03529773|527681788|FG039|Overall Study|Randomized but not vaccinated|0|||
146320266|NCT01496066|527681790|FG000|Overall Study|Lost to Follow-up|8|||
146320267|NCT01496066|527681791|FG001|Overall Study|Lost to Follow-up|5|||
146320268|NCT01496066|527681790|FG000|Overall Study|Explant|3|||
146320269|NCT01496066|527681791|FG001|Overall Study|Explant|0|||
146320270|NCT01496066|527681790|FG000|Overall Study|Death|1|||
146320271|NCT01496066|527681791|FG001|Overall Study|Death|4|||
146320272|NCT01587079|527681792|FG000|Overall Study|Protocol-specified criteria|9|||
146320273|NCT01587079|527681792|FG000|Overall Study|Protocol Violation|5|||
146320274|NCT01587079|527681792|FG000|Overall Study|Lost to Follow-up|2|||
146320275|NCT01587079|527681792|FG000|Overall Study|Physician Decision|2|||
146320276|NCT01587079|527681792|FG000|Overall Study|Withdrawal by Subject|7|||
146320277|NCT01587079|527681792|FG000|Overall Study|Adverse Event|14|||
146320278|NCT04142983|527681794|FG000|Overall Study|Lost to Follow-up|73|||
146320279|NCT04142983|527681794|FG000|Overall Study|Withdrawal by Subject|10|||
146320280|NCT04142983|527681794|FG000|Overall Study|Physician Decision|1|||
146320281|NCT04142983|527681794|FG000|Overall Study|Adverse Event|1|||
146320282|NCT04142983|527681794|FG000|Overall Study|No longer eligible|4|||
146320283|NCT04142983|527681794|FG000|Overall Study|Screen Failure|10|||
146320284|NCT01789970|527681796|FG000|Open-label Titration Period|Adverse Event|68|||
146320285|NCT01789970|527681797|FG001|Open-label Titration Period|Adverse Event|0|||
146320286|NCT01789970|527681798|FG002|Open-label Titration Period|Adverse Event|0|||
146320287|NCT01789970|527681796|FG000|Open-label Titration Period|Lack of Efficacy|31|||
146320288|NCT01789970|527681797|FG001|Open-label Titration Period|Lack of Efficacy|0|||
146320289|NCT01789970|527681798|FG002|Open-label Titration Period|Lack of Efficacy|0|||
146320290|NCT01789970|527681796|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
146320291|NCT01789970|527681797|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
146320292|NCT01789970|527681798|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
146320293|NCT01789970|527681796|FG000|Open-label Titration Period|Protocol Violation|18|||
146320294|NCT01789970|527681797|FG001|Open-label Titration Period|Protocol Violation|0|||
146320295|NCT01789970|527681798|FG002|Open-label Titration Period|Protocol Violation|0|||
146320296|NCT01789970|527681796|FG000|Open-label Titration Period|Lost to Follow-up|5|||
146320297|NCT01789970|527681797|FG001|Open-label Titration Period|Lost to Follow-up|0|||
146320298|NCT01789970|527681798|FG002|Open-label Titration Period|Lost to Follow-up|0|||
146320299|NCT01789970|527681796|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
146320300|NCT01789970|527681797|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
146320301|NCT01789970|527681798|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
146320302|NCT01789970|527681796|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
146320303|NCT01789970|527681797|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
146320304|NCT01789970|527681798|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
146320305|NCT01789970|527681796|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
146320306|NCT01789970|527681797|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
146320307|NCT01789970|527681798|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
146320308|NCT01789970|527681796|FG000|Open-label Titration Period|Pregnancy|2|||
146320309|NCT01789970|527681797|FG001|Open-label Titration Period|Pregnancy|0|||
146320310|NCT01789970|527681798|FG002|Open-label Titration Period|Pregnancy|0|||
146320311|NCT01789970|527681796|FG000|Open-label Titration Period|Other|76|||
146320312|NCT01789970|527681797|FG001|Open-label Titration Period|Other|0|||
146320313|NCT01789970|527681798|FG002|Open-label Titration Period|Other|0|||
146320314|NCT01789970|527681796|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
146320315|NCT01789970|527681797|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
146320316|NCT01789970|527681798|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
146320317|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
146320318|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
146320319|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
146320320|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
146320321|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
146320322|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
146320323|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
146320324|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
146320325|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
146320326|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
146320327|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
146320328|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
146320329|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
146320330|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
146320331|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
146320332|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
146320333|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
146320334|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
146320335|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
146320336|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
146320337|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
146320338|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
146320339|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
146320340|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
146320341|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
146320342|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
146320343|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
146320344|NCT01789970|527681796|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
146320345|NCT01789970|527681797|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
146320346|NCT01789970|527681798|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
146320347|NCT00643994|527681799|FG000|Overall Study|Death|24|||
146320348|NCT00643994|527681799|FG000|Overall Study|Lost to Follow-up|72|||
146320349|NCT00430508|527681817|FG000|Overall Study|Adverse Event|2|||
146320350|NCT00430508|527681818|FG001|Overall Study|Adverse Event|3|||
146320351|NCT00430508|527681819|FG002|Overall Study|Adverse Event|5|||
146320352|NCT00430508|527681820|FG003|Overall Study|Adverse Event|3|||
146320353|NCT00430508|527681817|FG000|Overall Study|Withdrawal by Subject|0|||
146320354|NCT00430508|527681818|FG001|Overall Study|Withdrawal by Subject|1|||
146320355|NCT00430508|527681819|FG002|Overall Study|Withdrawal by Subject|1|||
146320356|NCT00430508|527681820|FG003|Overall Study|Withdrawal by Subject|1|||
146320357|NCT00430508|527681817|FG000|Overall Study|responder at visit 4|0|||
146320358|NCT00430508|527681818|FG001|Overall Study|responder at visit 4|0|||
146320359|NCT00430508|527681819|FG002|Overall Study|responder at visit 4|2|||
146320360|NCT00430508|527681820|FG003|Overall Study|responder at visit 4|0|||
146320361|NCT00430508|527681817|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
146320362|NCT00430508|527681818|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
146320363|NCT00430508|527681819|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
146320364|NCT00430508|527681820|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
146320365|NCT00430508|527681817|FG000|Overall Study|Other|1|||
146320366|NCT00430508|527681818|FG001|Overall Study|Other|1|||
146320367|NCT00430508|527681819|FG002|Overall Study|Other|3|||
146320368|NCT00430508|527681820|FG003|Overall Study|Other|0|||
146320369|NCT01703858|527681823|FG000|Overall Study|Withdrawal by Subject|0|||
146320370|NCT01703858|527681824|FG001|Overall Study|Withdrawal by Subject|1|||
146320371|NCT01703858|527681825|FG002|Overall Study|Withdrawal by Subject|0|||
146320372|NCT02556255|527681826|FG000|Overall Study|Lost to Follow-up|4|||
146320373|NCT01543087|527681829|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
146320374|NCT01543087|527681830|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
146320375|NCT01543087|527681831|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
146320376|NCT01543087|527681832|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
146320377|NCT01543087|527681833|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
146320378|NCT01543087|527681834|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
146320379|NCT01543087|527681829|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
146320380|NCT01543087|527681830|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146320381|NCT01543087|527681831|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
146320382|NCT01543087|527681832|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
146320383|NCT01543087|527681833|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146320384|NCT01543087|527681834|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
146320385|NCT01543087|527681829|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
146320386|NCT01543087|527681830|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
146320387|NCT01543087|527681831|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
146320388|NCT01543087|527681832|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
146320389|NCT01543087|527681833|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
146320390|NCT01543087|527681834|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
146320391|NCT01543087|527681829|FG000|Stage 1 (48 Months)|Other than specified|5|||
146320392|NCT01543087|527681830|FG001|Stage 1 (48 Months)|Other than specified|0|||
146320393|NCT01543087|527681831|FG002|Stage 1 (48 Months)|Other than specified|9|||
146320394|NCT01543087|527681832|FG003|Stage 1 (48 Months)|Other than specified|0|||
146320395|NCT01543087|527681833|FG004|Stage 1 (48 Months)|Other than specified|0|||
146320396|NCT01543087|527681834|FG005|Stage 1 (48 Months)|Other than specified|0|||
146320397|NCT01543087|527681829|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
146320398|NCT01543087|527681830|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
146320399|NCT01543087|527681831|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
146320400|NCT01543087|527681832|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
146320401|NCT01543087|527681833|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
146320402|NCT01543087|527681834|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
146320403|NCT01543087|527681829|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146320404|NCT01543087|527681830|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
146320405|NCT01543087|527681831|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
145943227|NCT00483704|526300456|FG000|Treatment|Protocol Violation|6|||
146320406|NCT01543087|527681832|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146320407|NCT01543087|527681833|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
146320408|NCT01543087|527681834|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
146320409|NCT01543087|527681829|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
146320410|NCT01543087|527681830|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
146320411|NCT01543087|527681831|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
146320412|NCT01543087|527681832|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
146320413|NCT01543087|527681833|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
146320414|NCT01543087|527681834|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
146320415|NCT01325428|527681835|FG000|Part A|Progressive disease according to RECIST|9|||
146320416|NCT01325428|527681835|FG000|Part A|Clinical signs, symptoms of progression|2|||
146320417|NCT01325428|527681835|FG000|Part A|Other adverse event|1|||
146320418|NCT01325428|527681835|FG000|Part A|Refused continue taking trial medication|2|||
146320419|NCT01325428|527681835|FG000|Part A|Other reason not defined above|2|||
146320420|NCT01325428|527681835|FG000|Part B|Refused continue taking trial medication|2|||
146320421|NCT01325428|527681835|FG000|Part B|Other reason not defined above|1|||
146320422|NCT02004873|527681837|FG000|Overall Study|Implant unsuccessful|6|||
146320423|NCT02004873|527681837|FG000|Overall Study|Awaiting 6-month visit|390|||
146320424|NCT02004873|527681837|FG000|Overall Study|Missed 6-month visit|4|||
146320425|NCT02004873|527681837|FG000|Overall Study|Death|23|||
146320426|NCT02004873|527681837|FG000|Overall Study|Withdrawal by Subject|1|||
146320427|NCT02665286|527681853|FG000|Overall Study|Lost to Follow-up|3|||
146320428|NCT02665286|527681854|FG001|Overall Study|Lost to Follow-up|2|||
146320429|NCT02665286|527681855|FG002|Overall Study|Lost to Follow-up|1|||
146320430|NCT02926950|527681864|FG000|Overall Study|Adverse Event|4|||
146320431|NCT02926950|527681865|FG001|Overall Study|Adverse Event|6|||
146320432|NCT02926950|527681864|FG000|Overall Study|At the participant's own request|21|||
146320433|NCT02926950|527681865|FG001|Overall Study|At the participant's own request|25|||
146320434|NCT02926950|527681864|FG000|Overall Study|Reason not Specified|17|||
146320435|NCT02926950|527681865|FG001|Overall Study|Reason not Specified|9|||
146320436|NCT02926950|527681864|FG000|Overall Study|Lost to Follow-up|7|||
146320437|NCT02926950|527681865|FG001|Overall Study|Lost to Follow-up|8|||
146320438|NCT05036083|527681866|FG000|Overall Study|Physician Decision|1|||
146320439|NCT05036083|527681866|FG000|Overall Study|Withdrawal by Subject|1|||
146320440|NCT05036083|527681866|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
146320441|NCT05036083|527681866|FG000|Overall Study|IV not sustainable|1|||
146320442|NCT04622046|527681867|FG000|Intervention Period|Adverse Event|1|||
146320443|NCT04622046|527681867|FG000|Intervention Period|Withdrawal by Subject|2|||
146320444|NCT04622046|527681867|FG000|Extension Period|Ongoing in the Extension Period|21|||
146320445|NCT03505021|527681868|FG000|Overall Study|Protocol Violation|1|||
146320446|NCT03505021|527681869|FG001|Overall Study|Protocol Violation|0|||
146320447|NCT03505021|527681868|FG000|Overall Study|Death|9|||
146320448|NCT03505021|527681869|FG001|Overall Study|Death|8|||
146320449|NCT03505021|527681868|FG000|Overall Study|Consent withdrawn by subject|6|||
146320450|NCT03505021|527681869|FG001|Overall Study|Consent withdrawn by subject|1|||
146320451|NCT03505021|527681868|FG000|Overall Study|Lost to Follow-up|5|||
146320452|NCT03505021|527681869|FG001|Overall Study|Lost to Follow-up|3|||
146320453|NCT03505021|527681868|FG000|Overall Study|Adverse Event|26|||
146320454|NCT03505021|527681869|FG001|Overall Study|Adverse Event|9|||
146320455|NCT03505021|527681868|FG000|Overall Study|Disease progression|33|||
146320456|NCT03505021|527681869|FG001|Overall Study|Disease progression|17|||
146320457|NCT03505021|527681868|FG000|Overall Study|Other|11|||
146320458|NCT03505021|527681869|FG001|Overall Study|Other|5|||
146320459|NCT03505021|527681868|FG000|Overall Study|Personal reason|21|||
146320460|NCT03505021|527681869|FG001|Overall Study|Personal reason|12|||
146320461|NCT00482014|527683505|FG000|Overall Study|Withdrawal by Subject|1|||
146320462|NCT00482014|527683506|FG001|Overall Study|Withdrawal by Subject|2|||
146320463|NCT00482014|527683507|FG002|Overall Study|Withdrawal by Subject|3|||
146164663|NCT01525602|527112655|FG003|Overall Study|Physician Decision|0|||
146164664|NCT01525602|527112656|FG004|Overall Study|Physician Decision|3|||
146164665|NCT01525602|527112657|FG005|Overall Study|Physician Decision|0|||
146164666|NCT01525602|527112658|FG006|Overall Study|Physician Decision|1|||
146164667|NCT01525602|527112659|FG007|Overall Study|Physician Decision|0|||
146164668|NCT01525602|527112652|FG000|Overall Study|Death|0|||
146320464|NCT00482014|527683508|FG003|Overall Study|Withdrawal by Subject|4|||
146320465|NCT00482014|527683505|FG000|Overall Study|Adverse Event|3|||
146320466|NCT00482014|527683506|FG001|Overall Study|Adverse Event|0|||
146320467|NCT00482014|527683507|FG002|Overall Study|Adverse Event|2|||
146320468|NCT00482014|527683508|FG003|Overall Study|Adverse Event|8|||
146164669|NCT01525602|527112653|FG001|Overall Study|Death|0|||
146320469|NCT00482014|527683505|FG000|Overall Study|Death|1|||
146320470|NCT00482014|527683506|FG001|Overall Study|Death|2|||
146320471|NCT00482014|527683507|FG002|Overall Study|Death|1|||
146320472|NCT00482014|527683508|FG003|Overall Study|Death|4|||
146320473|NCT00482014|527683505|FG000|Overall Study|Lack of Efficacy|1|||
146164670|NCT01525602|527112654|FG002|Overall Study|Death|0|||
146320474|NCT00482014|527683506|FG001|Overall Study|Lack of Efficacy|0|||
146320475|NCT00482014|527683507|FG002|Overall Study|Lack of Efficacy|4|||
146320476|NCT00482014|527683508|FG003|Overall Study|Lack of Efficacy|6|||
146320477|NCT00482014|527683505|FG000|Overall Study|Sponsor Decision|1|||
146320478|NCT00482014|527683506|FG001|Overall Study|Sponsor Decision|2|||
146320479|NCT00482014|527683507|FG002|Overall Study|Sponsor Decision|1|||
146320480|NCT00482014|527683508|FG003|Overall Study|Sponsor Decision|1|||
146320481|NCT03686397|527683509|FG000|Overall Study|Lack of Efficacy|3|||
146320482|NCT03686397|527683510|FG001|Overall Study|Lack of Efficacy|5|||
146320483|NCT03686397|527683509|FG000|Overall Study|Adverse Event|0|||
146320484|NCT03686397|527683510|FG001|Overall Study|Adverse Event|1|||
146320485|NCT03686397|527683509|FG000|Overall Study|Protocol Violation|0|||
146320486|NCT03686397|527683510|FG001|Overall Study|Protocol Violation|1|||
146320487|NCT03686397|527683509|FG000|Overall Study|Withdrawal by Subject|0|||
146320488|NCT03686397|527683510|FG001|Overall Study|Withdrawal by Subject|1|||
146320489|NCT03686397|527683509|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
146320490|NCT03686397|527683510|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
146320491|NCT04137887|527683515|FG000|Overall Study|Death|102|||
146320492|NCT04137887|527683516|FG001|Overall Study|Death|92|||
146320493|NCT04137887|527683515|FG000|Overall Study|Withdrawal by Subject|2|||
146320494|NCT04137887|527683516|FG001|Overall Study|Withdrawal by Subject|3|||
146320495|NCT04137887|527683515|FG000|Overall Study|Randomized but not treated|0|||
146320496|NCT04137887|527683516|FG001|Overall Study|Randomized but not treated|1|||
146320497|NCT05064059|527683518|FG000|Overall Study|Death|199|||
146320498|NCT05064059|527683519|FG001|Overall Study|Death|196|||
146320499|NCT05064059|527683518|FG000|Overall Study|Physician Decision|4|||
146320500|NCT05064059|527683519|FG001|Overall Study|Physician Decision|2|||
146320501|NCT05064059|527683518|FG000|Overall Study|Sponsor Decision|14|||
146320502|NCT05064059|527683519|FG001|Overall Study|Sponsor Decision|11|||
146320503|NCT05064059|527683518|FG000|Overall Study|Withdrawal by Subject|4|||
146320504|NCT05064059|527683519|FG001|Overall Study|Withdrawal by Subject|11|||
146320505|NCT04316585|527683520|FG000|Overall Study|Adverse Event|2|||
146320506|NCT04316585|527683521|FG001|Overall Study|Adverse Event|1|||
146320507|NCT04316585|527683520|FG000|Overall Study|Lost to Follow-up|1|||
146320508|NCT04316585|527683521|FG001|Overall Study|Lost to Follow-up|0|||
146320509|NCT04316585|527683520|FG000|Overall Study|Withdrawal by Subject|2|||
146320510|NCT04316585|527683521|FG001|Overall Study|Withdrawal by Subject|3|||
146320511|NCT04316585|527683520|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
146320512|NCT04316585|527683521|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
146320513|NCT04316585|527683520|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
146320514|NCT04316585|527683521|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
146320515|NCT01461044|527683529|FG000|Overall Study|Death|58|||
146320516|NCT01461044|527683530|FG001|Overall Study|Death|35|||
146320517|NCT01461044|527683529|FG000|Overall Study|Lost to Follow-up|12|||
146320518|NCT01461044|527683530|FG001|Overall Study|Lost to Follow-up|5|||
146320519|NCT00716976|527683531|FG000|Overall Study|Adverse Event|2|||
146320520|NCT00716976|527683532|FG001|Overall Study|Adverse Event|0|||
146320521|NCT00716976|527683531|FG000|Overall Study|Death|1|||
146320522|NCT00716976|527683532|FG001|Overall Study|Death|0|||
146320523|NCT00716976|527683531|FG000|Overall Study|Physician Decision|2|||
146320524|NCT00716976|527683532|FG001|Overall Study|Physician Decision|2|||
146320525|NCT00716976|527683531|FG000|Overall Study|Withdrawal by Subject|5|||
146320526|NCT00716976|527683532|FG001|Overall Study|Withdrawal by Subject|1|||
146320527|NCT00716976|527683531|FG000|Overall Study|Premature discontinuation cisplatin|5|||
146320528|NCT00716976|527683532|FG001|Overall Study|Premature discontinuation cisplatin|4|||
146320529|NCT00716976|527683531|FG000|Overall Study|Radiation during protocol|1|||
146320530|NCT00716976|527683532|FG001|Overall Study|Radiation during protocol|0|||
146320531|NCT00716976|527683531|FG000|Overall Study|Ineligibles|4|||
146320532|NCT00716976|527683532|FG001|Overall Study|Ineligibles|2|||
146320533|NCT00122135|527683533|FG000|Overall Study|Withdrawal by Subject|3|||
146320534|NCT00122135|527683534|FG001|Overall Study|Withdrawal by Subject|0|||
146320535|NCT03269344|527683535|FG000|Overall Study|Protocol Violation|4|||
146320536|NCT03269344|527683536|FG001|Overall Study|Protocol Violation|3|||
146320537|NCT00200850|527683542|FG000|Overall Study|relocation|1|||
146320538|NCT00200850|527683543|FG001|Overall Study|relocation|0|||
146320539|NCT00200850|527683544|FG002|Overall Study|relocation|1|||
146320540|NCT00200850|527683542|FG000|Overall Study|too busy|1|||
146320541|NCT00200850|527683543|FG001|Overall Study|too busy|0|||
146320542|NCT00200850|527683544|FG002|Overall Study|too busy|0|||
146320543|NCT00200850|527683542|FG000|Overall Study|Pregnancy|0|||
146320544|NCT00200850|527683543|FG001|Overall Study|Pregnancy|0|||
145943228|NCT00483704|526300457|FG001|Treatment|Protocol Violation|3|||
146164671|NCT01525602|527112655|FG003|Overall Study|Death|0|||
146320545|NCT00200850|527683544|FG002|Overall Study|Pregnancy|1|||
146320546|NCT00200850|527683542|FG000|Overall Study|Poor adherence|0|||
146320547|NCT00200850|527683543|FG001|Overall Study|Poor adherence|0|||
146320548|NCT00200850|527683544|FG002|Overall Study|Poor adherence|1|||
146320549|NCT00200850|527683542|FG000|Overall Study|optic neuritis|0|||
146320550|NCT00200850|527683543|FG001|Overall Study|optic neuritis|0|||
146320551|NCT00200850|527683544|FG002|Overall Study|optic neuritis|1|||
146320552|NCT00200850|527683542|FG000|Overall Study|Adverse Event|1|||
146320553|NCT00200850|527683543|FG001|Overall Study|Adverse Event|1|||
146320554|NCT00200850|527683544|FG002|Overall Study|Adverse Event|2|||
146320555|NCT01449708|527683549|FG000|Overall Study|Protocol Violation|0|||
146320556|NCT01449708|527683550|FG001|Overall Study|Protocol Violation|1|||
146320557|NCT01449708|527683549|FG000|Overall Study|surgical complication|1|||
146320558|NCT01449708|527683550|FG001|Overall Study|surgical complication|2|||
146320559|NCT01449708|527683549|FG000|Overall Study|respiratory failure|1|||
146320560|NCT01449708|527683550|FG001|Overall Study|respiratory failure|0|||
146320565|NCT02723201|527683554|FG000|Second Intervention Period|Protocol Violation|1|||
146320566|NCT02723201|527683555|FG001|Second Intervention Period|Protocol Violation|0|||
146320567|NCT02723201|527683556|FG002|Second Intervention Period|Protocol Violation|0|||
146320568|NCT02723201|527683554|FG000|Second Intervention Period|Adverse Event|1|||
146320569|NCT02723201|527683555|FG001|Second Intervention Period|Adverse Event|0|||
146320570|NCT02723201|527683556|FG002|Second Intervention Period|Adverse Event|0|||
146320571|NCT01978093|527683557|FG000|Overall Study|Death|1|||
146320572|NCT01978093|527683558|FG001|Overall Study|Death|0|||
146320573|NCT01978093|527683557|FG000|Overall Study|Adverse Event|0|||
146320574|NCT01978093|527683558|FG001|Overall Study|Adverse Event|5|||
146320575|NCT01978093|527683557|FG000|Overall Study|Protocol Violation|8|||
146320576|NCT01978093|527683558|FG001|Overall Study|Protocol Violation|2|||
146320577|NCT01978093|527683557|FG000|Overall Study|Withdrawal by Subject|29|||
146320578|NCT01978093|527683558|FG001|Overall Study|Withdrawal by Subject|25|||
146320579|NCT01978093|527683557|FG000|Overall Study|Lost to Follow-up|11|||
146320580|NCT01978093|527683558|FG001|Overall Study|Lost to Follow-up|15|||
146320581|NCT01978093|527683557|FG000|Overall Study|Migrated/moved from study area|11|||
146320582|NCT01978093|527683558|FG001|Overall Study|Migrated/moved from study area|13|||
146320583|NCT01978093|527683557|FG000|Overall Study|Loss of kaiser coverage|4|||
146320584|NCT01978093|527683558|FG001|Overall Study|Loss of kaiser coverage|10|||
146320585|NCT01978093|527683557|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
146320586|NCT01978093|527683558|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
146320587|NCT01978093|527683557|FG000|Overall Study|Mother lost custody of child|0|||
146320588|NCT01978093|527683558|FG001|Overall Study|Mother lost custody of child|1|||
146320589|NCT01978093|527683557|FG000|Overall Study|Child was in care of grandmother|0|||
146320590|NCT01978093|527683558|FG001|Overall Study|Child was in care of grandmother|1|||
146320591|NCT01978093|527683557|FG000|Overall Study|N/A for vaccine administration|0|||
146320592|NCT01978093|527683558|FG001|Overall Study|N/A for vaccine administration|1|||
146320593|NCT01396005|527683561|FG000|Overall Study|Withdrawal by Subject|0|||
146320594|NCT01396005|527683562|FG001|Overall Study|Withdrawal by Subject|1|||
146320595|NCT01396005|527683561|FG000|Overall Study|Non-compliance with protocol|0|||
146320596|NCT01396005|527683562|FG001|Overall Study|Non-compliance with protocol|1|||
146320597|NCT00491179|527683563|FG000|Overall Study|Adverse Event|5|||
146320598|NCT00491179|527683564|FG001|Overall Study|Adverse Event|1|||
146320599|NCT00491179|527683563|FG000|Overall Study|Withdrawal by Subject|2|||
146320600|NCT00491179|527683564|FG001|Overall Study|Withdrawal by Subject|1|||
146320601|NCT05689047|527683567|FG000|Overall Study|Lost to Follow-up|0|||
146320602|NCT05689047|527683568|FG001|Overall Study|Lost to Follow-up|1|||
146320603|NCT05689047|527683567|FG000|Overall Study|Protocol Deviation|1|||
146320604|NCT05689047|527683568|FG001|Overall Study|Protocol Deviation|0|||
146320605|NCT01604512|527683569|FG000|Overall Study|Withdrawal by Subject|3|||
146320606|NCT01604512|527683569|FG000|Overall Study|Not treated|4|||
146320607|NCT03083886|527683570|FG000|Overall Study|Withdrawal by Subject|51|||
146320608|NCT03083886|527683571|FG001|Overall Study|Withdrawal by Subject|73|||
146320609|NCT03083886|527683572|FG002|Overall Study|Withdrawal by Subject|104|||
146320610|NCT03083886|527683570|FG000|Overall Study|Missing Baseline data|43|||
146320611|NCT03083886|527683571|FG001|Overall Study|Missing Baseline data|42|||
146320612|NCT03083886|527683572|FG002|Overall Study|Missing Baseline data|31|||
146320613|NCT03083886|527683570|FG000|Overall Study|Investigator terminated|1|||
146320614|NCT03083886|527683571|FG001|Overall Study|Investigator terminated|6|||
146320615|NCT03083886|527683572|FG002|Overall Study|Investigator terminated|3|||
146320616|NCT00209339|527683575|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
146320617|NCT00209339|527683575|FG000|At 12 Months Follow-up|Death|1|||
146320618|NCT00209339|527683575|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
146320619|NCT00209339|527683575|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
146320620|NCT00209339|527683575|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
146320621|NCT00209339|527683575|FG000|At 24 Months Follow-up|Death|1|||
146320622|NCT00209339|527683575|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
146320623|NCT00209339|527683575|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
146320624|NCT00209339|527683575|FG000|At 4 Years Follow-up|Death|1|||
146320625|NCT00209339|527683575|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
146320626|NCT00209339|527683575|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
146320627|NCT00209339|527683575|FG000|At 5 Years Follow-up|Death|1|||
146320628|NCT00429858|527683576|FG000|Overall Study|Withdrawal by Subject|1|||
146320629|NCT00429858|527683576|FG000|Overall Study|Study Termination|1|||
146320630|NCT02268058|527683577|FG000|Overall Study|Protocol Violation|1|||
146320631|NCT02268058|527683578|FG001|Overall Study|Protocol Violation|0|||
146320632|NCT02268058|527683579|FG002|Overall Study|Protocol Violation|0|||
146320633|NCT02268058|527683580|FG003|Overall Study|Protocol Violation|0|||
146320634|NCT02475655|527683581|FG000|Overall Study|Lost to Follow-up|0|||
146320635|NCT02475655|527683582|FG001|Overall Study|Lost to Follow-up|1|||
146320636|NCT00257010|527683583|FG000|Overall Study|Lack of Efficacy|11|||
146320637|NCT00257010|527683583|FG000|Overall Study|Lost to Follow-up|53|||
146320638|NCT00257010|527683583|FG000|Overall Study|Withdrawal by Subject|34|||
146320639|NCT00257010|527683583|FG000|Overall Study|Adverse Event|10|||
146320640|NCT00257010|527683583|FG000|Overall Study|various|11|||
146320641|NCT00257010|527683583|FG000|Overall Study|no headache reported|9|||
146320642|NCT00756938|527683584|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
146320643|NCT00756938|527683585|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
146320644|NCT00756938|527683586|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
146320645|NCT00756938|527683587|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
146320646|NCT00756938|527683584|FG000|12-week Base Study|Protocol Violation|0|||
146320647|NCT00756938|527683585|FG001|12-week Base Study|Protocol Violation|0|||
146320648|NCT00756938|527683586|FG002|12-week Base Study|Protocol Violation|1|||
146320649|NCT00756938|527683587|FG003|12-week Base Study|Protocol Violation|0|||
146320650|NCT00756938|527683584|FG000|12-week Base Study|Lost to Follow-up|1|||
146320651|NCT00756938|527683585|FG001|12-week Base Study|Lost to Follow-up|0|||
146320652|NCT00756938|527683586|FG002|12-week Base Study|Lost to Follow-up|0|||
146320653|NCT00756938|527683587|FG003|12-week Base Study|Lost to Follow-up|0|||
146320654|NCT00756938|527683584|FG000|Optional Extension|Lack of Efficacy|0|||
146320655|NCT00756938|527683585|FG001|Optional Extension|Lack of Efficacy|0|||
146320656|NCT00756938|527683586|FG002|Optional Extension|Lack of Efficacy|0|||
146320657|NCT00756938|527683587|FG003|Optional Extension|Lack of Efficacy|1|||
146320658|NCT00756938|527683584|FG000|Optional Extension|End of Study|0|||
146320659|NCT00756938|527683585|FG001|Optional Extension|End of Study|0|||
146320660|NCT00756938|527683586|FG002|Optional Extension|End of Study|0|||
146320661|NCT00756938|527683587|FG003|Optional Extension|End of Study|11|||
146320662|NCT00756938|527683584|FG000|Optional Extension|Protocol-specific criteria met|0|||
146320663|NCT00756938|527683585|FG001|Optional Extension|Protocol-specific criteria met|0|||
146320664|NCT00756938|527683586|FG002|Optional Extension|Protocol-specific criteria met|0|||
146320665|NCT00756938|527683587|FG003|Optional Extension|Protocol-specific criteria met|9|||
146320666|NCT00756938|527683584|FG000|Optional Extension|Physician Decision|0|||
146320667|NCT00756938|527683585|FG001|Optional Extension|Physician Decision|0|||
146320668|NCT00756938|527683586|FG002|Optional Extension|Physician Decision|0|||
146320669|NCT00756938|527683587|FG003|Optional Extension|Physician Decision|3|||
146320670|NCT00756938|527683584|FG000|Optional Extension|Lost to Follow-up|0|||
146320671|NCT00756938|527683585|FG001|Optional Extension|Lost to Follow-up|0|||
146320672|NCT00756938|527683586|FG002|Optional Extension|Lost to Follow-up|0|||
146320673|NCT00756938|527683587|FG003|Optional Extension|Lost to Follow-up|1|||
146320674|NCT00756938|527683584|FG000|Optional Extension|Protocol Violation|0|||
146320675|NCT00756938|527683585|FG001|Optional Extension|Protocol Violation|0|||
146320676|NCT00756938|527683586|FG002|Optional Extension|Protocol Violation|0|||
146320677|NCT00756938|527683587|FG003|Optional Extension|Protocol Violation|1|||
146320678|NCT00756938|527683584|FG000|Optional Extension|Withdrawal by Subject|0|||
146320679|NCT00756938|527683585|FG001|Optional Extension|Withdrawal by Subject|0|||
146320680|NCT00756938|527683586|FG002|Optional Extension|Withdrawal by Subject|0|||
146320681|NCT00756938|527683587|FG003|Optional Extension|Withdrawal by Subject|10|||
146320682|NCT00756938|527683584|FG000|Optional Extension|Adverse Event|0|||
146320683|NCT00756938|527683585|FG001|Optional Extension|Adverse Event|0|||
146320684|NCT00756938|527683586|FG002|Optional Extension|Adverse Event|0|||
146164672|NCT01525602|527112656|FG004|Overall Study|Death|1|||
146164673|NCT01525602|527112657|FG005|Overall Study|Death|1|||
146164674|NCT01525602|527112658|FG006|Overall Study|Death|0|||
146164675|NCT01525602|527112659|FG007|Overall Study|Death|0|||
146320685|NCT00756938|527683587|FG003|Optional Extension|Adverse Event|1|||
146320686|NCT04823949|527683588|FG000|Overall Study|Withdrawal by Subject|0|||
146320687|NCT04823949|527683589|FG001|Overall Study|Withdrawal by Subject|4|||
146320688|NCT04823949|527683588|FG000|Overall Study|Physician Decision|0|||
146320689|NCT04823949|527683589|FG001|Overall Study|Physician Decision|1|||
146320690|NCT00441545|527683591|FG000|First Intervention|Adverse Event|6|||
146320691|NCT00441545|527683592|FG001|First Intervention|Adverse Event|5|||
146320692|NCT00441545|527683591|FG000|First Intervention|Protocol Violation|2|||
146320693|NCT00441545|527683592|FG001|First Intervention|Protocol Violation|2|||
146320694|NCT00441545|527683591|FG000|First Intervention|Withdrawal by Subject|3|||
146320695|NCT00441545|527683592|FG001|First Intervention|Withdrawal by Subject|3|||
146320696|NCT00441545|527683591|FG000|First Intervention|Kidney transplant|1|||
146164676|NCT01525602|527112652|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
146320697|NCT00441545|527683592|FG001|First Intervention|Kidney transplant|1|||
146320698|NCT00441545|527683591|FG000|First Intervention|Lack of Efficacy|2|||
146320699|NCT00441545|527683592|FG001|First Intervention|Lack of Efficacy|0|||
146320700|NCT00441545|527683591|FG000|First Intervention|Subject exceeded safety criteria|0|||
146320701|NCT00441545|527683592|FG001|First Intervention|Subject exceeded safety criteria|1|||
146320702|NCT00441545|527683591|FG000|First Intervention|Subject met an exclusionary criteria|1|||
146320703|NCT00441545|527683592|FG001|First Intervention|Subject met an exclusionary criteria|0|||
146320704|NCT00441545|527683591|FG000|First Intervention|Extended hospitalization|1|||
146320705|NCT00441545|527683592|FG001|First Intervention|Extended hospitalization|0|||
146320706|NCT00441545|527683591|FG000|First Intervention|Site error|1|||
146320707|NCT00441545|527683592|FG001|First Intervention|Site error|0|||
146320708|NCT00441545|527683591|FG000|First Intervention|Sponsor's request|1|||
146320709|NCT00441545|527683592|FG001|First Intervention|Sponsor's request|0|||
146320710|NCT00441545|527683591|FG000|Second Intervention|Adverse Event|5|||
146320711|NCT00441545|527683592|FG001|Second Intervention|Adverse Event|2|||
146320712|NCT00441545|527683591|FG000|Second Intervention|Protocol Violation|4|||
146320713|NCT00441545|527683592|FG001|Second Intervention|Protocol Violation|1|||
146320714|NCT00441545|527683591|FG000|Second Intervention|Withdrawal by Subject|1|||
146320715|NCT00441545|527683592|FG001|Second Intervention|Withdrawal by Subject|1|||
146320716|NCT00441545|527683591|FG000|Second Intervention|Kidney Transplant|1|||
146164677|NCT01525602|527112653|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
146164678|NCT01525602|527112654|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
146164679|NCT01525602|527112655|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
146164680|NCT01525602|527112656|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
146164681|NCT01525602|527112657|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
146164682|NCT01525602|527112658|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
146164683|NCT01525602|527112659|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
146164684|NCT01024608|527112662|FG000|Overall Study|Adverse Event|1|||
146164685|NCT01024608|527112663|FG001|Overall Study|Adverse Event|0|||
146164686|NCT01024608|527112662|FG000|Overall Study|Withdrawal by Subject|1|||
146164687|NCT01024608|527112663|FG001|Overall Study|Withdrawal by Subject|0|||
146164688|NCT01024608|527112662|FG000|Overall Study|Lost to Follow-up|0|||
146164689|NCT01024608|527112663|FG001|Overall Study|Lost to Follow-up|1|||
146164690|NCT01024608|527112662|FG000|Overall Study|Protocol Violation|0|||
146164691|NCT01024608|527112663|FG001|Overall Study|Protocol Violation|3|||
146164692|NCT01024608|527112662|FG000|Overall Study|Never received study treatment|2|||
146164693|NCT01024608|527112663|FG001|Overall Study|Never received study treatment|0|||
146164694|NCT02532179|527114305|FG000|Overall Study|Lost to Follow-up|1|||
146164695|NCT02532179|527114305|FG000|Overall Study|Pregnancy|1|||
146164696|NCT02532179|527114305|FG000|Overall Study|Subject received depot steroid injection|1|||
146164697|NCT01337674|527114311|FG000|Treatment Period 1|Adverse Event|0|||
146164698|NCT01337674|527114312|FG001|Treatment Period 1|Adverse Event|1|||
146164699|NCT01337674|527114313|FG002|Treatment Period 1|Adverse Event|0|||
146164700|NCT01337674|527114314|FG003|Treatment Period 1|Adverse Event|0|||
146164701|NCT01337674|527114311|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
146164702|NCT01337674|527114312|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
146164703|NCT01337674|527114313|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
146164704|NCT01337674|527114314|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
146164705|NCT01337674|527114311|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146164706|NCT01337674|527114312|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146164707|NCT01337674|527114313|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146164708|NCT01337674|527114314|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146164709|NCT03076970|527114315|FG000|Washout Period 2|Adverse Event|0|||
146164710|NCT03076970|527114316|FG001|Washout Period 2|Adverse Event|0|||
146164711|NCT03076970|527114317|FG002|Washout Period 2|Adverse Event|0|||
146164712|NCT03076970|527114318|FG003|Washout Period 2|Adverse Event|0|||
146164713|NCT03076970|527114319|FG004|Washout Period 2|Adverse Event|1|||
146320717|NCT00441545|527683592|FG001|Second Intervention|Kidney Transplant|1|||
146320718|NCT00441545|527683591|FG000|Second Intervention|Lack of Efficacy|0|||
146320719|NCT00441545|527683592|FG001|Second Intervention|Lack of Efficacy|1|||
146164714|NCT03076970|527114320|FG005|Washout Period 2|Adverse Event|0|||
146164715|NCT03076970|527114315|FG000|Period 3|Withdrawal by Subject|0|||
146164716|NCT03076970|527114316|FG001|Period 3|Withdrawal by Subject|0|||
146164717|NCT03076970|527114317|FG002|Period 3|Withdrawal by Subject|0|||
146164718|NCT03076970|527114318|FG003|Period 3|Withdrawal by Subject|0|||
146164719|NCT03076970|527114319|FG004|Period 3|Withdrawal by Subject|0|||
146320720|NCT00441545|527683591|FG000|Second Intervention|Subject exceeded safety criteria|1|||
146320721|NCT00441545|527683592|FG001|Second Intervention|Subject exceeded safety criteria|0|||
146320722|NCT00441545|527683591|FG000|Second Intervention|Subject moved|0|||
146320723|NCT00441545|527683592|FG001|Second Intervention|Subject moved|1|||
146320724|NCT02347176|527683593|FG000|Overall Study|Lost to Follow-up|2|||
146320725|NCT02347176|527683594|FG001|Overall Study|Lost to Follow-up|3|||
146320726|NCT02347176|527683595|FG002|Overall Study|Lost to Follow-up|1|||
146320727|NCT02347176|527683596|FG003|Overall Study|Lost to Follow-up|1|||
146164720|NCT03076970|527114320|FG005|Period 3|Withdrawal by Subject|1|||
146164721|NCT03076970|527114315|FG000|Period 3|Failure to meet I/E criteria|0|||
146320728|NCT02347176|527683593|FG000|Overall Study|Withdrawal by Subject|9|||
146320729|NCT02347176|527683594|FG001|Overall Study|Withdrawal by Subject|5|||
146164722|NCT03076970|527114316|FG001|Period 3|Failure to meet I/E criteria|0|||
146164723|NCT03076970|527114317|FG002|Period 3|Failure to meet I/E criteria|0|||
146164724|NCT03076970|527114318|FG003|Period 3|Failure to meet I/E criteria|0|||
146164725|NCT03076970|527114319|FG004|Period 3|Failure to meet I/E criteria|1|||
146320730|NCT02347176|527683595|FG002|Overall Study|Withdrawal by Subject|5|||
146320731|NCT02347176|527683596|FG003|Overall Study|Withdrawal by Subject|3|||
146320732|NCT02347176|527683593|FG000|Overall Study|Other|1|||
146320733|NCT02347176|527683594|FG001|Overall Study|Other|2|||
146320734|NCT02347176|527683595|FG002|Overall Study|Other|2|||
146320735|NCT02347176|527683596|FG003|Overall Study|Other|0|||
146320736|NCT00411554|527683597|FG000|Overall Study|Adverse Event|2|||
146320737|NCT00411554|527683598|FG001|Overall Study|Adverse Event|4|||
146320738|NCT00411554|527683597|FG000|Overall Study|Lack of Efficacy|2|||
146320739|NCT00411554|527683598|FG001|Overall Study|Lack of Efficacy|5|||
146320740|NCT00411554|527683597|FG000|Overall Study|Withdrawal by Subject|3|||
146320741|NCT00411554|527683598|FG001|Overall Study|Withdrawal by Subject|0|||
146320742|NCT00411554|527683597|FG000|Overall Study|Patient Moved|1|||
146320743|NCT00411554|527683598|FG001|Overall Study|Patient Moved|0|||
146320744|NCT00699907|527683603|FG000|Overall Study|Withdrawal by Subject|2|||
146320745|NCT00699907|527683604|FG001|Overall Study|Withdrawal by Subject|1|||
146320746|NCT00699907|527683605|FG002|Overall Study|Withdrawal by Subject|0|||
146320747|NCT00699907|527683603|FG000|Overall Study|No usable sample|0|||
146320748|NCT00699907|527683604|FG001|Overall Study|No usable sample|9|||
146320749|NCT00699907|527683605|FG002|Overall Study|No usable sample|8|||
146320750|NCT02161211|527683606|FG000|Overall Study|Lost to Follow-up|21|||
146320751|NCT02161211|527683607|FG001|Overall Study|Lost to Follow-up|27|||
146320752|NCT02161211|527683608|FG002|Overall Study|Lost to Follow-up|21|||
146320753|NCT02161211|527683606|FG000|Overall Study|Dropped|12|||
146320754|NCT02161211|527683607|FG001|Overall Study|Dropped|5|||
146320755|NCT02161211|527683608|FG002|Overall Study|Dropped|9|||
146320756|NCT03889639|527683610|FG000|Overall Study|Withdrawal by Subject|0|||
146320757|NCT03889639|527683611|FG001|Overall Study|Withdrawal by Subject|0|||
146320758|NCT03889639|527683612|FG002|Overall Study|Withdrawal by Subject|0|||
146320759|NCT03889639|527683613|FG003|Overall Study|Withdrawal by Subject|0|||
146320760|NCT03889639|527683614|FG004|Overall Study|Withdrawal by Subject|0|||
146320761|NCT03889639|527683615|FG005|Overall Study|Withdrawal by Subject|0|||
146320762|NCT03889639|527683616|FG006|Overall Study|Withdrawal by Subject|0|||
146320763|NCT03889639|527683617|FG007|Overall Study|Withdrawal by Subject|1|||
146320764|NCT00993031|527683620|FG000|Overall Study|Death|0|||
146320765|NCT00993031|527683621|FG001|Overall Study|Death|1|||
146320766|NCT00993031|527683620|FG000|Overall Study|Physician Decision|0|||
146320767|NCT00993031|527683621|FG001|Overall Study|Physician Decision|2|||
146320768|NCT00993031|527683620|FG000|Overall Study|Withdrawal by Subject|3|||
146320769|NCT00993031|527683621|FG001|Overall Study|Withdrawal by Subject|3|||
146320770|NCT00993031|527683620|FG000|Overall Study|Lost to Follow-up|19|||
146320771|NCT00993031|527683621|FG001|Overall Study|Lost to Follow-up|13|||
146320772|NCT01834729|527683625|FG000|Overall Study|Did not return bowel diaries|0|||
146320773|NCT01834729|527683626|FG001|Overall Study|Did not return bowel diaries|0|||
146320774|NCT01834729|527683627|FG002|Overall Study|Did not return bowel diaries|3|||
146320775|NCT01834729|527683628|FG003|Overall Study|Did not return bowel diaries|0|||
146320776|NCT01834729|527683625|FG000|Overall Study|Withdrawal by Subject|1|||
146320777|NCT01834729|527683626|FG001|Overall Study|Withdrawal by Subject|1|||
146320778|NCT01834729|527683627|FG002|Overall Study|Withdrawal by Subject|0|||
146320779|NCT01834729|527683628|FG003|Overall Study|Withdrawal by Subject|0|||
146320780|NCT01834729|527683625|FG000|Overall Study|Adverse Event|0|||
146320781|NCT01834729|527683626|FG001|Overall Study|Adverse Event|0|||
146320782|NCT01834729|527683627|FG002|Overall Study|Adverse Event|0|||
146320783|NCT01834729|527683628|FG003|Overall Study|Adverse Event|2|||
146320784|NCT00143455|527683630|FG000|Cohort 1|Adverse Event|8|||
146320785|NCT00143455|527683631|FG001|Cohort 1|Adverse Event|4|||
146320786|NCT00143455|527683632|FG002|Cohort 1|Adverse Event|0|||
146320787|NCT00143455|527683633|FG003|Cohort 1|Adverse Event|0|||
146320788|NCT00143455|527683630|FG000|Cohort 1|Death|5|||
146320789|NCT00143455|527683631|FG001|Cohort 1|Death|2|||
146320790|NCT00143455|527683632|FG002|Cohort 1|Death|0|||
146320791|NCT00143455|527683633|FG003|Cohort 1|Death|0|||
146320792|NCT00143455|527683630|FG000|Cohort 1|Progressive Disease|0|||
146320793|NCT00143455|527683631|FG001|Cohort 1|Progressive Disease|6|||
146320794|NCT00143455|527683632|FG002|Cohort 1|Progressive Disease|0|||
146320795|NCT00143455|527683633|FG003|Cohort 1|Progressive Disease|0|||
146320796|NCT00143455|527683630|FG000|Cohort 1|Withdrawal by Subject|1|||
146320797|NCT00143455|527683631|FG001|Cohort 1|Withdrawal by Subject|4|||
146320798|NCT00143455|527683632|FG002|Cohort 1|Withdrawal by Subject|0|||
146320799|NCT00143455|527683633|FG003|Cohort 1|Withdrawal by Subject|0|||
146320800|NCT00143455|527683630|FG000|Cohort 1|Randomized But Not Treated|0|||
146320801|NCT00143455|527683631|FG001|Cohort 1|Randomized But Not Treated|1|||
146320802|NCT00143455|527683632|FG002|Cohort 1|Randomized But Not Treated|0|||
146320803|NCT00143455|527683633|FG003|Cohort 1|Randomized But Not Treated|0|||
146320804|NCT00143455|527683630|FG000|Cohort 2|Adverse Event|0|||
146320805|NCT00143455|527683631|FG001|Cohort 2|Adverse Event|0|||
146320806|NCT00143455|527683632|FG002|Cohort 2|Adverse Event|42|||
146320807|NCT00143455|527683633|FG003|Cohort 2|Adverse Event|30|||
146320808|NCT00143455|527683630|FG000|Cohort 2|No Longer Required Study Treatment|0|||
146320809|NCT00143455|527683631|FG001|Cohort 2|No Longer Required Study Treatment|0|||
146320810|NCT00143455|527683632|FG002|Cohort 2|No Longer Required Study Treatment|1|||
146320811|NCT00143455|527683633|FG003|Cohort 2|No Longer Required Study Treatment|0|||
146320812|NCT00143455|527683630|FG000|Cohort 2|Protocol Violation|0|||
146320813|NCT00143455|527683631|FG001|Cohort 2|Protocol Violation|0|||
146320814|NCT00143455|527683632|FG002|Cohort 2|Protocol Violation|1|||
146320815|NCT00143455|527683633|FG003|Cohort 2|Protocol Violation|1|||
146320816|NCT00143455|527683630|FG000|Cohort 2|Lost to Follow-up|0|||
146320817|NCT00143455|527683631|FG001|Cohort 2|Lost to Follow-up|0|||
146320818|NCT00143455|527683632|FG002|Cohort 2|Lost to Follow-up|1|||
146320819|NCT00143455|527683633|FG003|Cohort 2|Lost to Follow-up|4|||
146320820|NCT00143455|527683630|FG000|Cohort 2|Death|0|||
146320821|NCT00143455|527683631|FG001|Cohort 2|Death|0|||
146320822|NCT00143455|527683632|FG002|Cohort 2|Death|20|||
146320823|NCT00143455|527683633|FG003|Cohort 2|Death|12|||
146320824|NCT00143455|527683630|FG000|Cohort 2|Progressive Disease|0|||
146320825|NCT00143455|527683631|FG001|Cohort 2|Progressive Disease|0|||
146320826|NCT00143455|527683632|FG002|Cohort 2|Progressive Disease|20|||
146320827|NCT00143455|527683633|FG003|Cohort 2|Progressive Disease|27|||
146320828|NCT00143455|527683630|FG000|Cohort 2|Withdrawal by Subject|0|||
146320829|NCT00143455|527683631|FG001|Cohort 2|Withdrawal by Subject|0|||
146320830|NCT00143455|527683632|FG002|Cohort 2|Withdrawal by Subject|13|||
146320831|NCT00143455|527683633|FG003|Cohort 2|Withdrawal by Subject|12|||
146320832|NCT00143455|527683630|FG000|Cohort 2|Other|0|||
146320833|NCT00143455|527683631|FG001|Cohort 2|Other|0|||
146320834|NCT00143455|527683632|FG002|Cohort 2|Other|7|||
146320835|NCT00143455|527683633|FG003|Cohort 2|Other|6|||
146320836|NCT00143455|527683630|FG000|Cohort 2|Randomized But Not Treated|0|||
146320837|NCT00143455|527683631|FG001|Cohort 2|Randomized But Not Treated|0|||
146320838|NCT00143455|527683632|FG002|Cohort 2|Randomized But Not Treated|1|||
146320839|NCT00143455|527683633|FG003|Cohort 2|Randomized But Not Treated|1|||
146320840|NCT01298492|527683634|FG000|Overall Study|Death|2|||
146320841|NCT01298492|527683634|FG000|Overall Study|Insufficient Clinical Response|22|||
146320842|NCT01298492|527683634|FG000|Overall Study|Lost to Follow-up|12|||
146320843|NCT01298492|527683634|FG000|Overall Study|Withdrawal by Subject|47|||
146320844|NCT01298492|527683634|FG000|Overall Study|Other (Unspecified)|7|||
146320845|NCT01298492|527683634|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
146320846|NCT01298492|527683634|FG000|Overall Study|Protocol Violation|2|||
146320847|NCT01298492|527683634|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
146320848|NCT01298492|527683634|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
146320849|NCT03870555|527683635|FG000|Period 3 (2 Days)|Adverse Event|1|||
146164726|NCT03076970|527114320|FG005|Period 3|Failure to meet I/E criteria|0|||
146164727|NCT00789815|527114321|FG000|Overall Study|Protocol Violation|6|||
146164728|NCT00789815|527114322|FG001|Overall Study|Protocol Violation|1|||
146164729|NCT00789815|527114321|FG000|Overall Study|Intubation due to massive bleeding|1|||
146164730|NCT00789815|527114322|FG001|Overall Study|Intubation due to massive bleeding|0|||
146164731|NCT00119405|527114323|FG000|Overall Study|Withdrawal by Subject|1|||
146164732|NCT04958785|527114327|FG000|Overall Study|Study Terminated by Sponsor|4|||
146164733|NCT04958785|527114328|FG001|Overall Study|Study Terminated by Sponsor|10|||
146164734|NCT04958785|527114329|FG002|Overall Study|Study Terminated by Sponsor|7|||
146164735|NCT04958785|527114330|FG003|Overall Study|Study Terminated by Sponsor|6|||
146164736|NCT04958785|527114331|FG004|Overall Study|Study Terminated by Sponsor|34|||
146164737|NCT04958785|527114327|FG000|Overall Study|Death|2|||
146164738|NCT04958785|527114328|FG001|Overall Study|Death|3|||
146164739|NCT04958785|527114329|FG002|Overall Study|Death|4|||
146164740|NCT04958785|527114330|FG003|Overall Study|Death|5|||
146164741|NCT04958785|527114331|FG004|Overall Study|Death|5|||
146320850|NCT03870555|527683636|FG001|Period 3 (2 Days)|Adverse Event|0|||
146320851|NCT03870555|527683637|FG002|Period 3 (2 Days)|Adverse Event|0|||
146320852|NCT01353703|527683638|FG000|Overall Study|Migrated/moved from study area|1|||
146320853|NCT01353703|527683639|FG001|Overall Study|Migrated/moved from study area|0|||
146320854|NCT04925752|527683645|FG000|Overall Study|Still on Study|1826|||
146320855|NCT04925752|527683646|FG001|Overall Study|Still on Study|926|||
146320856|NCT04925752|527683645|FG000|Overall Study|Withdrew Consent|128|||
146320857|NCT04925752|527683646|FG001|Overall Study|Withdrew Consent|59|||
146320858|NCT04925752|527683645|FG000|Overall Study|Lost to Follow-up|73|||
146320859|NCT04925752|527683646|FG001|Overall Study|Lost to Follow-up|47|||
146320860|NCT04925752|527683645|FG000|Overall Study|Randomized but Never Treated|12|||
146320861|NCT04925752|527683646|FG001|Overall Study|Randomized but Never Treated|9|||
146320862|NCT04925752|527683645|FG000|Overall Study|Hiv-1 Infection|6|||
146320863|NCT04925752|527683646|FG001|Overall Study|Hiv-1 Infection|7|||
146320864|NCT04925752|527683645|FG000|Overall Study|Investigator's discretion|8|||
146320865|NCT04925752|527683646|FG001|Overall Study|Investigator's discretion|5|||
146320866|NCT04925752|527683645|FG000|Overall Study|Non-compliance with Study Drug|8|||
146320867|NCT04925752|527683646|FG001|Overall Study|Non-compliance with Study Drug|5|||
146320868|NCT04925752|527683645|FG000|Overall Study|Adverse Event|5|||
146320869|NCT04925752|527683646|FG001|Overall Study|Adverse Event|2|||
146320870|NCT04925752|527683645|FG000|Overall Study|Death|4|||
146320871|NCT04925752|527683646|FG001|Overall Study|Death|2|||
146320872|NCT04925752|527683645|FG000|Overall Study|Protocol Violation|1|||
146320873|NCT04925752|527683646|FG001|Overall Study|Protocol Violation|3|||
146320874|NCT04925752|527683645|FG000|Overall Study|Withdrew Assent|1|||
146320875|NCT04925752|527683646|FG001|Overall Study|Withdrew Assent|0|||
146320876|NCT00516737|527683647|FG000|Overall Study|Lost to Follow-up|2|||
146320877|NCT00516737|527683648|FG001|Overall Study|Lost to Follow-up|0|||
146320878|NCT00516737|527683647|FG000|Overall Study|Physician Decision|0|||
146320879|NCT00516737|527683648|FG001|Overall Study|Physician Decision|1|||
146320880|NCT00516737|527683647|FG000|Overall Study|Withdrawal by Subject|0|||
146320881|NCT00516737|527683648|FG001|Overall Study|Withdrawal by Subject|1|||
146320882|NCT00516737|527683647|FG000|Overall Study|Lack of Qualifying Event|9|||
146320883|NCT00516737|527683648|FG001|Overall Study|Lack of Qualifying Event|6|||
146320884|NCT00512798|527683649|FG000|Overall Study|Death|0|||
146320885|NCT00512798|527683650|FG001|Overall Study|Death|3|||
146320886|NCT00512798|527683649|FG000|Overall Study|Adverse Event|2|||
146320887|NCT00512798|527683650|FG001|Overall Study|Adverse Event|4|||
146320888|NCT00512798|527683649|FG000|Overall Study|Progression of disease|14|||
146320889|NCT00512798|527683650|FG001|Overall Study|Progression of disease|20|||
146320890|NCT00512798|527683649|FG000|Overall Study|Withdrawal by Subject|3|||
146320891|NCT00512798|527683650|FG001|Overall Study|Withdrawal by Subject|0|||
146320902|NCT03266016|527685428|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
146320903|NCT03266016|527685429|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146320904|NCT03266016|527685430|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146320905|NCT03266016|527685431|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
146320906|NCT03266016|527685428|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
146320907|NCT03266016|527685429|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
146320908|NCT03266016|527685430|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
146320909|NCT03266016|527685431|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
146320910|NCT00403260|527685439|FG000|Overall Study|Adverse Event|5|||
146320911|NCT00403260|527685440|FG001|Overall Study|Adverse Event|4|||
146320912|NCT00403260|527685439|FG000|Overall Study|Withdrawal by Subject|5|||
146320913|NCT00403260|527685440|FG001|Overall Study|Withdrawal by Subject|6|||
146320914|NCT00403260|527685439|FG000|Overall Study|Lost to Follow-up|49|||
146320915|NCT00403260|527685440|FG001|Overall Study|Lost to Follow-up|25|||
146320916|NCT00403260|527685439|FG000|Overall Study|Re-appearance of P. falciparum|34|||
146320917|NCT00403260|527685440|FG001|Overall Study|Re-appearance of P. falciparum|25|||
146320918|NCT00403260|527685439|FG000|Overall Study|P. vivax infection|26|||
146320919|NCT00403260|527685440|FG001|Overall Study|P. vivax infection|4|||
146320920|NCT00403260|527685439|FG000|Overall Study|Mixed infection with P. vivax|2|||
146320921|NCT00403260|527685440|FG001|Overall Study|Mixed infection with P. vivax|0|||
146320922|NCT00403260|527685439|FG000|Overall Study|Mixed infection with P. falciparum|1|||
146320923|NCT00403260|527685440|FG001|Overall Study|Mixed infection with P. falciparum|0|||
146320924|NCT00403260|527685439|FG000|Overall Study|P. vivax infection at screening|1|||
146320925|NCT00403260|527685440|FG001|Overall Study|P. vivax infection at screening|0|||
146320926|NCT00403260|527685439|FG000|Overall Study|P. ovale infection|1|||
146320927|NCT00403260|527685440|FG001|Overall Study|P. ovale infection|0|||
146320928|NCT00403260|527685439|FG000|Overall Study|Gametocyte re-appearance|1|||
146320929|NCT00403260|527685440|FG001|Overall Study|Gametocyte re-appearance|1|||
146320930|NCT00403260|527685439|FG000|Overall Study|Withdrawn from study accidentally|0|||
146320931|NCT00403260|527685440|FG001|Overall Study|Withdrawn from study accidentally|1|||
146320932|NCT03718143|527685442|FG000|Overall Study|Death|1|||
146320933|NCT03718143|527685443|FG001|Overall Study|Death|0|||
146320934|NCT03718143|527685444|FG002|Overall Study|Death|0|||
146320935|NCT03718143|527685442|FG000|Overall Study|Progression of Disease|1|||
146320936|NCT03718143|527685443|FG001|Overall Study|Progression of Disease|0|||
146320937|NCT03718143|527685444|FG002|Overall Study|Progression of Disease|0|||
146320938|NCT03718143|527685442|FG000|Overall Study|Withdrawal of Informed Consent|1|||
146320939|NCT03718143|527685443|FG001|Overall Study|Withdrawal of Informed Consent|2|||
146320940|NCT03718143|527685444|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146320941|NCT02615990|527685445|FG000|Overall Study|study terminated|1|||
146320942|NCT02615990|527685446|FG001|Overall Study|study terminated|1|||
146320943|NCT00805740|527685450|FG000|Overall Study|Death|7|||
146320944|NCT00805740|527685451|FG001|Overall Study|Death|4|||
146320945|NCT00805740|527685450|FG000|Overall Study|Withdrawal by Subject|1|||
146320946|NCT00805740|527685451|FG001|Overall Study|Withdrawal by Subject|0|||
146320947|NCT00805740|527685450|FG000|Overall Study|Lost to Follow-up|1|||
146320948|NCT00805740|527685451|FG001|Overall Study|Lost to Follow-up|0|||
146320949|NCT00805740|527685450|FG000|Overall Study|Randomized, but not treated|2|||
146320950|NCT00805740|527685451|FG001|Overall Study|Randomized, but not treated|0|||
146320951|NCT05227690|527685452|FG000|Overall Study|Adverse Event|5|||
146320952|NCT05227690|527685453|FG001|Overall Study|Adverse Event|6|||
146320953|NCT05227690|527685454|FG002|Overall Study|Adverse Event|10|||
146320954|NCT05227690|527685452|FG000|Overall Study|Lack of Efficacy|2|||
146320955|NCT05227690|527685453|FG001|Overall Study|Lack of Efficacy|4|||
146320956|NCT05227690|527685454|FG002|Overall Study|Lack of Efficacy|1|||
146320957|NCT05227690|527685452|FG000|Overall Study|Physician Decision|6|||
146320958|NCT05227690|527685453|FG001|Overall Study|Physician Decision|0|||
146320959|NCT05227690|527685454|FG002|Overall Study|Physician Decision|4|||
146320960|NCT05227690|527685452|FG000|Overall Study|Withdrawal of consent|28|||
146320961|NCT05227690|527685453|FG001|Overall Study|Withdrawal of consent|27|||
146320962|NCT05227690|527685454|FG002|Overall Study|Withdrawal of consent|21|||
146320963|NCT05227690|527685452|FG000|Overall Study|Other, not specified|2|||
146320964|NCT05227690|527685453|FG001|Overall Study|Other, not specified|2|||
146320965|NCT05227690|527685454|FG002|Overall Study|Other, not specified|1|||
146320966|NCT01414257|527685460|FG000|Overall Study|No Visit After First Day of Treatment|12|||
146320967|NCT01414257|527685460|FG000|Overall Study|Protocol Violation|10|||
146320968|NCT01534676|527685461|FG000|Overall Study|Study closed due to poor enrollment|2|||
146320969|NCT01534676|527685462|FG001|Overall Study|Study closed due to poor enrollment|1|||
146320970|NCT02634580|527685463|FG000|Double-blind Treatment Period|Subject Request|1|||
146320971|NCT02634580|527685464|FG001|Double-blind Treatment Period|Subject Request|0|||
146320972|NCT02634580|527685465|FG002|Double-blind Treatment Period|Subject Request|1|||
146320973|NCT02634580|527685466|FG003|Double-blind Treatment Period|Subject Request|1|||
146320974|NCT02634580|527685463|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
146320975|NCT02634580|527685464|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
146320976|NCT02634580|527685465|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
146320977|NCT02634580|527685466|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
146320978|NCT00424827|527685470|FG000|Overall Study|Adverse Event|1|||
146320979|NCT05425563|527685473|FG000|Overall Study|Withdrawal by Subject|17|||
146320980|NCT01790048|527685475|FG000|Overall Study|Incorrect Age|9|||
146320981|NCT01790048|527685476|FG001|Overall Study|Incorrect Age|14|||
146320982|NCT01790048|527685475|FG000|Overall Study|data entry error|0|||
146320983|NCT01790048|527685476|FG001|Overall Study|data entry error|1|||
146320984|NCT01790048|527685475|FG000|Overall Study|Other|0|||
146320985|NCT01790048|527685476|FG001|Overall Study|Other|2|||
146320986|NCT01790048|527685475|FG000|Overall Study|SAM at Enrollment|2|||
146320987|NCT01790048|527685476|FG001|Overall Study|SAM at Enrollment|0|||
146320988|NCT01790048|527685475|FG000|Overall Study|Measurement error|1|||
146320989|NCT01790048|527685476|FG001|Overall Study|Measurement error|0|||
146320990|NCT00584233|527685477|FG000|Overall Study|Withdrawal by Subject|5|||
146320991|NCT00584233|527685477|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
146320992|NCT00159432|527685478|FG000|Overall Study|Adverse Event|1|||
146320993|NCT00159432|527685478|FG000|Overall Study|Death|1|||
146320994|NCT00159432|527685478|FG000|Overall Study|Lack of Efficacy|8|||
146320995|NCT03178487|527685479|FG000|Period 1|Adverse Event|1|||
146320996|NCT03178487|527685480|FG001|Period 1|Adverse Event|2|||
146320997|NCT03178487|527685479|FG000|Period 1|Withdrawal by Subject|2|||
146320998|NCT03178487|527685480|FG001|Period 1|Withdrawal by Subject|1|||
146320999|NCT03178487|527685479|FG000|Period 1|Lost to Follow-up|1|||
146321000|NCT03178487|527685480|FG001|Period 1|Lost to Follow-up|0|||
146321001|NCT03178487|527685479|FG000|Period 1|Other|0|||
146321002|NCT03178487|527685480|FG001|Period 1|Other|1|||
146321003|NCT03178487|527685479|FG000|Period 2|Adverse Event|4|||
146321004|NCT03178487|527685480|FG001|Period 2|Adverse Event|4|||
146321005|NCT03178487|527685479|FG000|Period 2|Withdrawal by Subject|6|||
146321006|NCT03178487|527685480|FG001|Period 2|Withdrawal by Subject|6|||
146321007|NCT03178487|527685479|FG000|Period 2|Lost to Follow-up|2|||
146321008|NCT03178487|527685480|FG001|Period 2|Lost to Follow-up|2|||
146321009|NCT03178487|527685479|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
146321010|NCT03178487|527685480|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
146321011|NCT03178487|527685479|FG000|Period 2|Other|8|||
146321012|NCT03178487|527685480|FG001|Period 2|Other|7|||
146321013|NCT04161495|527685481|FG000|Overall Study|Withdrawal by Subject|3|||
146321014|NCT04161495|527685482|FG001|Overall Study|Withdrawal by Subject|0|||
146321015|NCT04161495|527685481|FG000|Overall Study|Protocol Violation|1|||
146321016|NCT04161495|527685482|FG001|Overall Study|Protocol Violation|0|||
146321017|NCT04161495|527685481|FG000|Overall Study|Prohibited concomitant medication|3|||
146321018|NCT04161495|527685482|FG001|Overall Study|Prohibited concomitant medication|0|||
146321019|NCT04161495|527685481|FG000|Overall Study|Adverse Event|1|||
146321020|NCT04161495|527685482|FG001|Overall Study|Adverse Event|0|||
146321021|NCT04161495|527685481|FG000|Overall Study|Other - Unspecified|1|||
146321022|NCT04161495|527685482|FG001|Overall Study|Other - Unspecified|0|||
146321023|NCT04161495|527685481|FG000|Overall Study|Death|0|||
146321024|NCT04161495|527685482|FG001|Overall Study|Death|1|||
146321025|NCT03655756|527685483|FG000|Overall Study|Death|1|||
146321026|NCT00253630|527685484|FG000|Overall Study|ineligible|2|||
146321027|NCT00094757|527685497|FG000|Overall Study|Adverse Event|11|||
146321028|NCT00094757|527685498|FG001|Overall Study|Adverse Event|9|||
146321029|NCT00094757|527685499|FG002|Overall Study|Adverse Event|6|||
146321030|NCT00094757|527685497|FG000|Overall Study|Lack of Efficacy|11|||
146321031|NCT00094757|527685498|FG001|Overall Study|Lack of Efficacy|15|||
146321032|NCT00094757|527685499|FG002|Overall Study|Lack of Efficacy|8|||
146321033|NCT00094757|527685497|FG000|Overall Study|Lost to Follow-up|3|||
146321034|NCT00094757|527685498|FG001|Overall Study|Lost to Follow-up|5|||
146321035|NCT00094757|527685499|FG002|Overall Study|Lost to Follow-up|6|||
146321036|NCT00094757|527685497|FG000|Overall Study|Patient Moved|2|||
146321037|NCT00094757|527685498|FG001|Overall Study|Patient Moved|1|||
146321038|NCT00094757|527685499|FG002|Overall Study|Patient Moved|1|||
146321039|NCT00094757|527685497|FG000|Overall Study|Protocol Violation|8|||
146321040|NCT00094757|527685498|FG001|Overall Study|Protocol Violation|5|||
146321041|NCT00094757|527685499|FG002|Overall Study|Protocol Violation|3|||
146321042|NCT00094757|527685497|FG000|Overall Study|Withdrawal by Subject|14|||
146321043|NCT00094757|527685498|FG001|Overall Study|Withdrawal by Subject|21|||
146321044|NCT00094757|527685499|FG002|Overall Study|Withdrawal by Subject|5|||
146321045|NCT00094757|527685497|FG000|Overall Study|Other|3|||
146321046|NCT00094757|527685498|FG001|Overall Study|Other|3|||
146321047|NCT00094757|527685499|FG002|Overall Study|Other|1|||
146321048|NCT00094757|527685497|FG000|Overall Study|Protocol specified discontinuation|1|||
146321049|NCT00094757|527685498|FG001|Overall Study|Protocol specified discontinuation|3|||
146321050|NCT00094757|527685499|FG002|Overall Study|Protocol specified discontinuation|0|||
146321051|NCT00288080|527685500|FG000|Overall Study|Withdrawal by Subject|1|||
146321052|NCT00288080|527685501|FG001|Overall Study|Withdrawal by Subject|3|||
146321053|NCT00288080|527685500|FG000|Overall Study|Protocol Violation|25|||
146321054|NCT00288080|527685501|FG001|Overall Study|Protocol Violation|20|||
146321055|NCT03403192|527685502|FG000|Overall Study|Lost to Follow-up|1|||
146321056|NCT03403192|527685503|FG001|Overall Study|Lost to Follow-up|2|||
146321057|NCT03403192|527685504|FG002|Overall Study|Lost to Follow-up|0|||
146321058|NCT03403192|527685505|FG003|Overall Study|Lost to Follow-up|0|||
146321059|NCT03403192|527685502|FG000|Overall Study|Unable to respond|0|||
146321060|NCT03403192|527685503|FG001|Overall Study|Unable to respond|1|||
146321061|NCT03403192|527685504|FG002|Overall Study|Unable to respond|0|||
146321062|NCT03403192|527685505|FG003|Overall Study|Unable to respond|0|||
146321063|NCT03403192|527685502|FG000|Overall Study|Incomplete|3|||
146321064|NCT03403192|527685503|FG001|Overall Study|Incomplete|1|||
146321065|NCT03403192|527685504|FG002|Overall Study|Incomplete|3|||
146321066|NCT03403192|527685505|FG003|Overall Study|Incomplete|6|||
146321067|NCT02387580|527685509|FG000|Overall Study|Withdrawal by Subject|0|||
146321068|NCT02387580|527685510|FG001|Overall Study|Withdrawal by Subject|0|||
146321069|NCT02387580|527685511|FG002|Overall Study|Withdrawal by Subject|0|||
146321070|NCT02387580|527685512|FG003|Overall Study|Withdrawal by Subject|1|||
146321071|NCT02387580|527685513|FG004|Overall Study|Withdrawal by Subject|0|||
146321072|NCT02387580|527685514|FG005|Overall Study|Withdrawal by Subject|0|||
146321073|NCT02340663|527685515|FG000|Overall Study|Lost to Follow-up|1|||
146321074|NCT02340663|527685516|FG001|Overall Study|Lost to Follow-up|0|||
146321075|NCT02340663|527685515|FG000|Overall Study|Protocol Violation|1|||
146321076|NCT02340663|527685516|FG001|Overall Study|Protocol Violation|0|||
146321077|NCT02340663|527685515|FG000|Overall Study|Withdrawal by Subject|3|||
146321078|NCT02340663|527685516|FG001|Overall Study|Withdrawal by Subject|1|||
146321079|NCT00087646|527685517|FG000|Overall Study|Adverse Event|37|||
146321080|NCT00087646|527685518|FG001|Overall Study|Adverse Event|6|||
146321081|NCT00087646|527685519|FG002|Overall Study|Adverse Event|18|||
146321082|NCT00087646|527685520|FG003|Overall Study|Adverse Event|20|||
146321083|NCT00087646|527685517|FG000|Overall Study|Death|0|||
146321084|NCT00087646|527685518|FG001|Overall Study|Death|1|||
146321085|NCT00087646|527685519|FG002|Overall Study|Death|0|||
146321086|NCT00087646|527685520|FG003|Overall Study|Death|0|||
146321087|NCT00087646|527685517|FG000|Overall Study|Withdrawal by Subject|6|||
146164742|NCT04958785|527114327|FG000|Overall Study|Withdrew consent|2|||
146321088|NCT00087646|527685518|FG001|Overall Study|Withdrawal by Subject|1|||
146321089|NCT00087646|527685519|FG002|Overall Study|Withdrawal by Subject|2|||
146321090|NCT00087646|527685520|FG003|Overall Study|Withdrawal by Subject|2|||
146321091|NCT00087646|527685517|FG000|Overall Study|Insufficient therapeutic response|64|||
146321092|NCT00087646|527685518|FG001|Overall Study|Insufficient therapeutic response|24|||
146321093|NCT00087646|527685519|FG002|Overall Study|Insufficient therapeutic response|38|||
146321094|NCT00087646|527685520|FG003|Overall Study|Insufficient therapeutic response|51|||
146321095|NCT00087646|527685517|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
146321096|NCT00087646|527685518|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
146321097|NCT00087646|527685519|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
146321098|NCT00087646|527685520|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
146321099|NCT00087646|527685517|FG000|Overall Study|Failure to Return|5|||
146321100|NCT00087646|527685518|FG001|Overall Study|Failure to Return|2|||
146321101|NCT00087646|527685519|FG002|Overall Study|Failure to Return|2|||
146321102|NCT00087646|527685520|FG003|Overall Study|Failure to Return|3|||
146321103|NCT00087646|527685517|FG000|Overall Study|Administrative/Other|6|||
146321104|NCT00087646|527685518|FG001|Overall Study|Administrative/Other|1|||
146321105|NCT00087646|527685519|FG002|Overall Study|Administrative/Other|1|||
146321106|NCT00087646|527685520|FG003|Overall Study|Administrative/Other|2|||
146321107|NCT00087646|527685517|FG000|Overall Study|Other Protocol Violation|3|||
146321108|NCT00087646|527685518|FG001|Overall Study|Other Protocol Violation|1|||
146321109|NCT00087646|527685519|FG002|Overall Study|Other Protocol Violation|0|||
146321110|NCT00087646|527685520|FG003|Overall Study|Other Protocol Violation|0|||
146321111|NCT00087646|527685517|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146321112|NCT00087646|527685518|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146321113|NCT00087646|527685519|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
146321114|NCT00087646|527685520|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
146321115|NCT03033875|527685535|FG000|Overall Study|Withdrawal by Subject|5|||
146321116|NCT03033875|527685536|FG001|Overall Study|Withdrawal by Subject|9|||
146321117|NCT03033875|527685537|FG002|Overall Study|Withdrawal by Subject|4|||
146321118|NCT03033875|527685535|FG000|Overall Study|Other|14|||
146321119|NCT03033875|527685536|FG001|Overall Study|Other|15|||
146321120|NCT03033875|527685537|FG002|Overall Study|Other|8|||
146321121|NCT02286947|527685538|FG000|Overall Study|Withdrawal by Subject|2|||
146321122|NCT01614093|527685543|FG000|Overall Study|Withdrawal by Subject|1|||
146321123|NCT00848354|527685544|FG000|Phase 1|Adverse Event|5|||
146321124|NCT00848354|527685545|FG001|Phase 1|Adverse Event|4|||
146321125|NCT00848354|527685544|FG000|Phase 1|Discontinuation of study by sponsor|2|||
146321126|NCT00848354|527685545|FG001|Phase 1|Discontinuation of study by sponsor|1|||
146321127|NCT00848354|527685544|FG000|Phase 1|Failed to return|0|||
146321128|NCT00848354|527685545|FG001|Phase 1|Failed to return|1|||
146321129|NCT00848354|527685544|FG000|Phase 1|Lost to Follow-up|1|||
146321130|NCT00848354|527685545|FG001|Phase 1|Lost to Follow-up|1|||
146321131|NCT00848354|527685544|FG000|Phase 1|Unspecified Reason|1|||
146321132|NCT00848354|527685545|FG001|Phase 1|Unspecified Reason|1|||
146321133|NCT00848354|527685544|FG000|Phase 1|Protocol Violation|1|||
146321134|NCT00848354|527685545|FG001|Phase 1|Protocol Violation|1|||
146321135|NCT00848354|527685544|FG000|Phase 1|Withdrawal by Subject|2|||
146321136|NCT00848354|527685545|FG001|Phase 1|Withdrawal by Subject|4|||
146321137|NCT00848354|527685544|FG000|Phase 1|Lack of Efficacy|0|||
146321138|NCT00848354|527685545|FG001|Phase 1|Lack of Efficacy|1|||
146321139|NCT00848354|527685544|FG000|Phase 2 Year 1|Adverse Event|7|||
146321140|NCT00848354|527685545|FG001|Phase 2 Year 1|Adverse Event|2|||
146321141|NCT00848354|527685544|FG000|Phase 2 Year 1|Death|1|||
146321142|NCT00848354|527685545|FG001|Phase 2 Year 1|Death|0|||
146321143|NCT00848354|527685544|FG000|Phase 2 Year 1|Failed to Return|1|||
146321144|NCT00848354|527685545|FG001|Phase 2 Year 1|Failed to Return|1|||
146321145|NCT00848354|527685544|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
146321146|NCT00848354|527685545|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
146321147|NCT00848354|527685544|FG000|Phase 2 Year 1|Unspecified Reason|3|||
146321148|NCT00848354|527685545|FG001|Phase 2 Year 1|Unspecified Reason|0|||
146321149|NCT00848354|527685544|FG000|Phase 2 Year 1|Protocol Violation|4|||
146321150|NCT00848354|527685545|FG001|Phase 2 Year 1|Protocol Violation|1|||
146321151|NCT00848354|527685544|FG000|Phase 2 Year 1|Subject Request|1|||
146321152|NCT00848354|527685545|FG001|Phase 2 Year 1|Subject Request|2|||
146321153|NCT00848354|527685544|FG000|Phase 2 Year 2|Adverse Event|12|||
146321154|NCT00848354|527685545|FG001|Phase 2 Year 2|Adverse Event|2|||
146321155|NCT00848354|527685544|FG000|Phase 2 Year 2|Death|2|||
146321156|NCT00848354|527685545|FG001|Phase 2 Year 2|Death|0|||
146321157|NCT00848354|527685544|FG000|Phase 2 Year 2|Failed to return|3|||
146321158|NCT00848354|527685545|FG001|Phase 2 Year 2|Failed to return|0|||
146321159|NCT00848354|527685544|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
146321160|NCT00848354|527685545|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
146321161|NCT00848354|527685544|FG000|Phase 2 Year 2|Unspecified Reason|1|||
146321162|NCT00848354|527685545|FG001|Phase 2 Year 2|Unspecified Reason|0|||
146164743|NCT04958785|527114328|FG001|Overall Study|Withdrew consent|0|||
146164744|NCT04958785|527114329|FG002|Overall Study|Withdrew consent|3|||
146321163|NCT00848354|527685544|FG000|Phase 2 Year 2|Protocol Violation|1|||
146321164|NCT00848354|527685545|FG001|Phase 2 Year 2|Protocol Violation|1|||
146321165|NCT00848354|527685544|FG000|Phase 2 Year 2|Subject Request|1|||
146321166|NCT00848354|527685545|FG001|Phase 2 Year 2|Subject Request|1|||
146321167|NCT00848354|527685544|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
146321168|NCT00848354|527685545|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
146321169|NCT00915343|527685548|FG000|Part B - Open Label Period|Treatment switch|0|||
146321170|NCT00915343|527685549|FG001|Part B - Open Label Period|Treatment switch|0|||
146321171|NCT00915343|527685550|FG002|Part B - Open Label Period|Treatment switch|1|||
146321172|NCT00915343|527685548|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
146321173|NCT00915343|527685549|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
146321174|NCT00915343|527685550|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
146321175|NCT03920670|527685551|FG000|Overall Study|Protocol Violation|2|||
146321176|NCT03920670|527685552|FG001|Overall Study|Protocol Violation|2|||
146321177|NCT03920670|527685551|FG000|Overall Study|Adverse Event|1|||
146321178|NCT03920670|527685552|FG001|Overall Study|Adverse Event|0|||
146321179|NCT04820309|527685558|FG000|Overall Study|Adverse Event|96|||
146321180|NCT04820309|527685558|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
146321181|NCT04820309|527685558|FG000|Overall Study|Consent Withdrawn|93|||
146321182|NCT04820309|527685558|FG000|Overall Study|failure to adhere to protocol|32|||
146321183|NCT04820309|527685558|FG000|Overall Study|alcohol or drug use|6|||
146321184|NCT04820309|527685558|FG000|Overall Study|Lost to Follow-up|46|||
146321185|NCT04820309|527685558|FG000|Overall Study|Death|2|||
146321186|NCT04820309|527685558|FG000|Overall Study|Pregnancy|1|||
146321187|NCT04820309|527685558|FG000|Overall Study|Other reasons|12|||
146321188|NCT04811716|527685561|FG000|Overall Study|Withdrawal by Subject|2|||
146321189|NCT04811716|527685562|FG001|Overall Study|Withdrawal by Subject|0|||
146164745|NCT04958785|527114330|FG003|Overall Study|Withdrew consent|1|||
146164746|NCT04958785|527114331|FG004|Overall Study|Withdrew consent|0|||
146164747|NCT04958785|527114327|FG000|Overall Study|Investigator's discretion|0|||
146164748|NCT04958785|527114328|FG001|Overall Study|Investigator's discretion|1|||
146164749|NCT04958785|527114329|FG002|Overall Study|Investigator's discretion|0|||
146164750|NCT04958785|527114330|FG003|Overall Study|Investigator's discretion|1|||
146164751|NCT04958785|527114331|FG004|Overall Study|Investigator's discretion|2|||
146164752|NCT04958785|527114327|FG000|Overall Study|Adverse Event|0|||
146164753|NCT04958785|527114328|FG001|Overall Study|Adverse Event|0|||
146164754|NCT04958785|527114329|FG002|Overall Study|Adverse Event|0|||
146164755|NCT04958785|527114330|FG003|Overall Study|Adverse Event|0|||
146164756|NCT04958785|527114331|FG004|Overall Study|Adverse Event|1|||
146164757|NCT04958785|527114327|FG000|Overall Study|Lost to Follow-up|0|||
146164758|NCT04958785|527114328|FG001|Overall Study|Lost to Follow-up|0|||
146164759|NCT04958785|527114329|FG002|Overall Study|Lost to Follow-up|0|||
146164760|NCT04958785|527114330|FG003|Overall Study|Lost to Follow-up|0|||
146164761|NCT04958785|527114331|FG004|Overall Study|Lost to Follow-up|1|||
146164762|NCT01224925|527114332|FG000|Overall Study|Lost to Follow-up|3|||
146164763|NCT01224925|527114333|FG001|Overall Study|Lost to Follow-up|2|||
146164764|NCT00949884|527114336|FG000|Overall Study|Adverse Event|14|||
146164765|NCT00949884|527114337|FG001|Overall Study|Adverse Event|3|||
146164766|NCT00949884|527114338|FG002|Overall Study|Adverse Event|12|||
146164767|NCT00949884|527114336|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
146164768|NCT00949884|527114337|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
146164769|NCT00949884|527114338|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
146164770|NCT00949884|527114336|FG000|Overall Study|Lost to Follow-up|7|||
146164771|NCT00949884|527114337|FG001|Overall Study|Lost to Follow-up|5|||
146164772|NCT00949884|527114338|FG002|Overall Study|Lost to Follow-up|5|||
146164773|NCT00949884|527114336|FG000|Overall Study|Physician Decision|5|||
146164774|NCT00949884|527114337|FG001|Overall Study|Physician Decision|0|||
146164775|NCT00949884|527114338|FG002|Overall Study|Physician Decision|6|||
146164776|NCT00949884|527114336|FG000|Overall Study|Treatment non-compliance|5|||
146164777|NCT00949884|527114337|FG001|Overall Study|Treatment non-compliance|0|||
146164778|NCT00949884|527114338|FG002|Overall Study|Treatment non-compliance|8|||
146164779|NCT00949884|527114336|FG000|Overall Study|Withdrawal by Subject|13|||
146164780|NCT00949884|527114337|FG001|Overall Study|Withdrawal by Subject|4|||
146164781|NCT00949884|527114338|FG002|Overall Study|Withdrawal by Subject|16|||
146164782|NCT00949884|527114336|FG000|Overall Study|Lack of Efficacy|4|||
146164783|NCT00949884|527114337|FG001|Overall Study|Lack of Efficacy|2|||
146164784|NCT00949884|527114338|FG002|Overall Study|Lack of Efficacy|7|||
146164785|NCT00949884|527114336|FG000|Overall Study|Study terminated by sponsor|0|||
146164786|NCT00949884|527114337|FG001|Overall Study|Study terminated by sponsor|0|||
146164787|NCT00949884|527114338|FG002|Overall Study|Study terminated by sponsor|1|||
146164788|NCT00245102|527114339|FG000|Overall Study|Not Treated|1|||
146164789|NCT00245102|527114340|FG001|Overall Study|Not Treated|0|||
146164790|NCT00245102|527114341|FG002|Overall Study|Not Treated|1|||
146164791|NCT00245102|527114342|FG003|Overall Study|Not Treated|0|||
146164792|NCT00245102|527114343|FG004|Overall Study|Not Treated|0|||
146164793|NCT00245102|527114344|FG005|Overall Study|Not Treated|0|||
146164794|NCT00245102|527114339|FG000|Overall Study|Protocol Violation|1|||
146164795|NCT00245102|527114340|FG001|Overall Study|Protocol Violation|0|||
146321190|NCT04202679|527685563|FG000|Overall Study|Adverse Event|2|||
146321191|NCT04202679|527685564|FG001|Overall Study|Adverse Event|0|||
146321192|NCT04202679|527685563|FG000|Overall Study|Poor compliance to protocol|1|||
146321193|NCT04202679|527685564|FG001|Overall Study|Poor compliance to protocol|0|||
146164796|NCT00245102|527114341|FG002|Overall Study|Protocol Violation|0|||
146164797|NCT00245102|527114342|FG003|Overall Study|Protocol Violation|0|||
146164798|NCT00245102|527114343|FG004|Overall Study|Protocol Violation|0|||
146164799|NCT00245102|527114344|FG005|Overall Study|Protocol Violation|0|||
146164800|NCT00245102|527114339|FG000|Overall Study|Death|0|||
146321194|NCT04202679|527685563|FG000|Overall Study|Withdrawal by Subject|23|||
146321195|NCT04202679|527685564|FG001|Overall Study|Withdrawal by Subject|6|||
146164801|NCT00245102|527114340|FG001|Overall Study|Death|0|||
146164802|NCT00245102|527114341|FG002|Overall Study|Death|0|||
146164803|NCT00245102|527114342|FG003|Overall Study|Death|1|||
146164804|NCT00245102|527114343|FG004|Overall Study|Death|0|||
146321196|NCT05902364|527685565|FG000|Overall Study|Adverse Event|1|||
146164805|NCT00245102|527114344|FG005|Overall Study|Death|0|||
146164806|NCT00245102|527114339|FG000|Overall Study|Adverse Event|4|||
146164807|NCT00245102|527114340|FG001|Overall Study|Adverse Event|2|||
146164808|NCT00245102|527114341|FG002|Overall Study|Adverse Event|5|||
146164809|NCT00245102|527114342|FG003|Overall Study|Adverse Event|1|||
146164810|NCT00245102|527114343|FG004|Overall Study|Adverse Event|0|||
146164811|NCT00245102|527114344|FG005|Overall Study|Adverse Event|2|||
146164812|NCT00245102|527114339|FG000|Overall Study|Decline in performance|0|||
146164813|NCT00245102|527114340|FG001|Overall Study|Decline in performance|2|||
146164814|NCT00245102|527114341|FG002|Overall Study|Decline in performance|0|||
146164815|NCT00245102|527114342|FG003|Overall Study|Decline in performance|1|||
146164816|NCT00245102|527114343|FG004|Overall Study|Decline in performance|0|||
146164817|NCT00245102|527114344|FG005|Overall Study|Decline in performance|2|||
146164818|NCT00245102|527114339|FG000|Overall Study|Participant needed surgery|0|||
146164819|NCT00245102|527114340|FG001|Overall Study|Participant needed surgery|0|||
146321197|NCT05902364|527685566|FG001|Overall Study|Adverse Event|0|||
146321198|NCT02270242|527685567|FG000|Overall Study|Withdrawal by Subject|18|||
146321199|NCT02270242|527685568|FG001|Overall Study|Withdrawal by Subject|25|||
146321200|NCT02270242|527685567|FG000|Overall Study|Lost to Follow-up|41|||
146321201|NCT02270242|527685568|FG001|Overall Study|Lost to Follow-up|27|||
146321202|NCT02270242|527685567|FG000|Overall Study|Physician Decision|0|||
146321203|NCT02270242|527685568|FG001|Overall Study|Physician Decision|1|||
146321204|NCT03864653|527685569|FG000|Overall Study|Withdrawal by Subject|1|||
146321205|NCT03048422|527685570|FG000|Overall Study|Death|1|||
146321206|NCT03048422|527685571|FG001|Overall Study|Death|0|||
146321207|NCT03048422|527685572|FG002|Overall Study|Death|0|||
146321208|NCT03048422|527685570|FG000|Overall Study|Lost to Follow-up|5|||
146321209|NCT03048422|527685571|FG001|Overall Study|Lost to Follow-up|0|||
146321210|NCT03048422|527685572|FG002|Overall Study|Lost to Follow-up|1|||
146321211|NCT03048422|527685570|FG000|Overall Study|Withdrawal by Subject|5|||
146321212|NCT03048422|527685571|FG001|Overall Study|Withdrawal by Subject|7|||
146321213|NCT03048422|527685572|FG002|Overall Study|Withdrawal by Subject|4|||
146321214|NCT03048422|527685570|FG000|Overall Study|Moved|3|||
146321215|NCT03048422|527685571|FG001|Overall Study|Moved|2|||
146321216|NCT03048422|527685572|FG002|Overall Study|Moved|2|||
146321217|NCT03048422|527685570|FG000|Overall Study|Noncompliant with Study Requirements|2|||
146321218|NCT03048422|527685571|FG001|Overall Study|Noncompliant with Study Requirements|1|||
146321219|NCT03048422|527685572|FG002|Overall Study|Noncompliant with Study Requirements|2|||
146321220|NCT03048422|527685570|FG000|Overall Study|Not Able to Get to Clinic|1|||
146321221|NCT03048422|527685571|FG001|Overall Study|Not Able to Get to Clinic|0|||
146321222|NCT03048422|527685572|FG002|Overall Study|Not Able to Get to Clinic|0|||
146321223|NCT02482129|527685573|FG000|Overall Study|Adverse Event-prior to treatment|0|||
146321224|NCT02482129|527685574|FG001|Overall Study|Adverse Event-prior to treatment|1|||
146321225|NCT02482129|527685573|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
146321226|NCT02482129|527685574|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
146321227|NCT02482129|527685573|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
146321228|NCT02482129|527685574|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
146321229|NCT02482129|527685573|FG000|Overall Study|Criteria not met-prior to treatment|1|||
146321230|NCT02482129|527685574|FG001|Overall Study|Criteria not met-prior to treatment|0|||
146321231|NCT02482129|527685573|FG000|Overall Study|Adverse Event|1|||
146321232|NCT02482129|527685574|FG001|Overall Study|Adverse Event|0|||
146321233|NCT02482129|527685573|FG000|Overall Study|Withdrawal by Subject|2|||
146321234|NCT02482129|527685574|FG001|Overall Study|Withdrawal by Subject|0|||
146321235|NCT02482129|527685573|FG000|Overall Study|Criteria not met|1|||
146321236|NCT02482129|527685574|FG001|Overall Study|Criteria not met|0|||
146321237|NCT00429585|527685577|FG000|Overall Study|Death|1|||
146321238|NCT00429585|527685578|FG001|Overall Study|Death|0|||
146164820|NCT00245102|527114341|FG002|Overall Study|Participant needed surgery|1|||
146164821|NCT00245102|527114342|FG003|Overall Study|Participant needed surgery|0|||
146321239|NCT00429585|527685577|FG000|Overall Study|Lost to Follow-up|27|||
146321240|NCT00429585|527685578|FG001|Overall Study|Lost to Follow-up|20|||
146164822|NCT00245102|527114343|FG004|Overall Study|Participant needed surgery|0|||
146164823|NCT00245102|527114344|FG005|Overall Study|Participant needed surgery|0|||
146164824|NCT00245102|527114339|FG000|Overall Study|Clinical progression|1|||
146164825|NCT00245102|527114340|FG001|Overall Study|Clinical progression|0|||
146321241|NCT00429585|527685577|FG000|Overall Study|Physician Decision|2|||
146321242|NCT00429585|527685578|FG001|Overall Study|Physician Decision|0|||
146321243|NCT01299766|527686941|FG000|Overall Study|Death|5|||
146164826|NCT00245102|527114341|FG002|Overall Study|Clinical progression|0|||
146164827|NCT00245102|527114342|FG003|Overall Study|Clinical progression|0|||
146164828|NCT00245102|527114343|FG004|Overall Study|Clinical progression|0|||
146164829|NCT00245102|527114344|FG005|Overall Study|Clinical progression|0|||
146321244|NCT01299766|527686942|FG001|Overall Study|Death|4|||
146321245|NCT01299766|527686941|FG000|Overall Study|Withdrawal by Subject|29|||
146321246|NCT01299766|527686942|FG001|Overall Study|Withdrawal by Subject|19|||
146321247|NCT03160560|527686945|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
146321248|NCT03160560|527686946|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146321249|NCT03160560|527686947|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146321250|NCT03160560|527686948|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146321251|NCT03160560|527686945|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146321252|NCT03160560|527686946|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146321253|NCT03160560|527686947|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146321254|NCT03160560|527686948|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146321255|NCT01354028|527686959|FG000|Overall Study|Physician Decision|0|||
146321256|NCT01354028|527686960|FG001|Overall Study|Physician Decision|2|||
146321257|NCT01354028|527686959|FG000|Overall Study|Discharged before study start|2|||
146321258|NCT01354028|527686960|FG001|Overall Study|Discharged before study start|2|||
146321259|NCT01354028|527686959|FG000|Overall Study|No quiet alert state|0|||
146321260|NCT01354028|527686960|FG001|Overall Study|No quiet alert state|1|||
146321261|NCT01777763|527686961|FG000|Overall Study|Adverse Event|2|||
146321262|NCT01777763|527686962|FG001|Overall Study|Adverse Event|32|||
146321263|NCT01777763|527686961|FG000|Overall Study|Protocol Violation|1|||
146321264|NCT01777763|527686962|FG001|Overall Study|Protocol Violation|7|||
146321265|NCT01777763|527686961|FG000|Overall Study|Withdrawal by Subject|0|||
146321266|NCT01777763|527686962|FG001|Overall Study|Withdrawal by Subject|2|||
146321267|NCT01777763|527686961|FG000|Overall Study|Treatment Failure|1|||
146321268|NCT01777763|527686962|FG001|Overall Study|Treatment Failure|6|||
146321269|NCT00975156|527686965|FG000|Overall Study|Protocol Violation|0|||
146321270|NCT00975156|527686966|FG001|Overall Study|Protocol Violation|1|||
146321271|NCT02971202|527686967|FG000|Overall Study|Pregnancy|1|||
146321272|NCT02971202|527686968|FG001|Overall Study|Pregnancy|0|||
146321273|NCT02971202|527686969|FG002|Overall Study|Pregnancy|0|||
146321274|NCT02971202|527686967|FG000|Overall Study|screen fail after consent|1|||
146321275|NCT02971202|527686968|FG001|Overall Study|screen fail after consent|0|||
146321276|NCT02971202|527686969|FG002|Overall Study|screen fail after consent|1|||
146321277|NCT02009878|527686971|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
146321278|NCT02009878|527686972|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
146321279|NCT02009878|527686973|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
146321280|NCT02222714|527686974|FG000|Overall Study|Death|0|||
146321281|NCT02222714|527686975|FG001|Overall Study|Death|2|||
146321282|NCT02222714|527686976|FG002|Overall Study|Death|3|||
146321283|NCT02222714|527686977|FG003|Overall Study|Death|4|||
146321284|NCT02222714|527686978|FG004|Overall Study|Death|6|||
146321285|NCT02222714|527686974|FG000|Overall Study|Withdrawal by Subject|0|||
146321286|NCT02222714|527686975|FG001|Overall Study|Withdrawal by Subject|0|||
146321287|NCT02222714|527686976|FG002|Overall Study|Withdrawal by Subject|1|||
146321288|NCT02222714|527686977|FG003|Overall Study|Withdrawal by Subject|0|||
146321289|NCT02222714|527686978|FG004|Overall Study|Withdrawal by Subject|1|||
146321290|NCT04537208|527686981|FG000|Overall Study|Adverse Event|0|||
146321291|NCT04537208|527686982|FG001|Overall Study|Adverse Event|0|||
146321292|NCT04537208|527686983|FG002|Overall Study|Adverse Event|0|||
146321293|NCT04537208|527686984|FG003|Overall Study|Adverse Event|0|||
146321294|NCT04537208|527686985|FG004|Overall Study|Adverse Event|0|||
146321295|NCT04537208|527686986|FG005|Overall Study|Adverse Event|0|||
146321296|NCT04537208|527686987|FG006|Overall Study|Adverse Event|0|||
146321297|NCT04537208|527686988|FG007|Overall Study|Adverse Event|0|||
146321298|NCT04537208|527686989|FG008|Overall Study|Adverse Event|1|||
146321299|NCT04537208|527686990|FG009|Overall Study|Adverse Event|0|||
146321300|NCT04537208|527686991|FG010|Overall Study|Adverse Event|0|||
146321301|NCT04537208|527686981|FG000|Overall Study|Protocol deviation|0|||
146321302|NCT04537208|527686982|FG001|Overall Study|Protocol deviation|0|||
146321303|NCT04537208|527686983|FG002|Overall Study|Protocol deviation|2|||
146321304|NCT04537208|527686984|FG003|Overall Study|Protocol deviation|0|||
146321305|NCT04537208|527686985|FG004|Overall Study|Protocol deviation|0|||
146321306|NCT04537208|527686986|FG005|Overall Study|Protocol deviation|2|||
146321307|NCT04537208|527686987|FG006|Overall Study|Protocol deviation|4|||
146321308|NCT04537208|527686988|FG007|Overall Study|Protocol deviation|0|||
146321309|NCT04537208|527686989|FG008|Overall Study|Protocol deviation|1|||
146321310|NCT04537208|527686990|FG009|Overall Study|Protocol deviation|0|||
146321311|NCT04537208|527686991|FG010|Overall Study|Protocol deviation|2|||
146321312|NCT04537208|527686981|FG000|Overall Study|Withdrawal by Subject|4|||
146321313|NCT04537208|527686982|FG001|Overall Study|Withdrawal by Subject|2|||
146321314|NCT04537208|527686983|FG002|Overall Study|Withdrawal by Subject|1|||
146321315|NCT04537208|527686984|FG003|Overall Study|Withdrawal by Subject|3|||
146321316|NCT04537208|527686985|FG004|Overall Study|Withdrawal by Subject|5|||
146321317|NCT04537208|527686986|FG005|Overall Study|Withdrawal by Subject|1|||
146321318|NCT04537208|527686987|FG006|Overall Study|Withdrawal by Subject|6|||
146321319|NCT04537208|527686988|FG007|Overall Study|Withdrawal by Subject|1|||
146321320|NCT04537208|527686989|FG008|Overall Study|Withdrawal by Subject|7|||
146321321|NCT04537208|527686990|FG009|Overall Study|Withdrawal by Subject|2|||
146321322|NCT04537208|527686991|FG010|Overall Study|Withdrawal by Subject|4|||
146321323|NCT04537208|527686981|FG000|Overall Study|Lost to Follow-up|4|||
146321324|NCT04537208|527686982|FG001|Overall Study|Lost to Follow-up|1|||
146321325|NCT04537208|527686983|FG002|Overall Study|Lost to Follow-up|3|||
146321326|NCT04537208|527686984|FG003|Overall Study|Lost to Follow-up|4|||
146321327|NCT04537208|527686985|FG004|Overall Study|Lost to Follow-up|3|||
146321328|NCT04537208|527686986|FG005|Overall Study|Lost to Follow-up|2|||
146321329|NCT04537208|527686987|FG006|Overall Study|Lost to Follow-up|3|||
146321330|NCT04537208|527686988|FG007|Overall Study|Lost to Follow-up|2|||
146321331|NCT04537208|527686989|FG008|Overall Study|Lost to Follow-up|7|||
146321332|NCT04537208|527686990|FG009|Overall Study|Lost to Follow-up|2|||
146321333|NCT04537208|527686991|FG010|Overall Study|Lost to Follow-up|2|||
146321334|NCT01340209|527686992|FG000|Overall Study|Adverse Event|1|||
146321335|NCT01340209|527686993|FG001|Overall Study|Adverse Event|1|||
146321336|NCT01340209|527686994|FG002|Overall Study|Adverse Event|2|||
146321337|NCT01340209|527686992|FG000|Overall Study|Protocol Violation|1|||
146321338|NCT01340209|527686993|FG001|Overall Study|Protocol Violation|2|||
146321339|NCT01340209|527686994|FG002|Overall Study|Protocol Violation|1|||
146321340|NCT01340209|527686992|FG000|Overall Study|Withdrawal by Subject|0|||
146321341|NCT01340209|527686993|FG001|Overall Study|Withdrawal by Subject|0|||
146321342|NCT01340209|527686994|FG002|Overall Study|Withdrawal by Subject|1|||
146321343|NCT01340209|527686992|FG000|Overall Study|Other reason not defined above|3|||
146321344|NCT01340209|527686993|FG001|Overall Study|Other reason not defined above|5|||
146321345|NCT01340209|527686994|FG002|Overall Study|Other reason not defined above|4|||
146321346|NCT03237065|527686997|FG000|Overall Study|Adverse Event|0|||
146321347|NCT03237065|527686998|FG001|Overall Study|Adverse Event|2|||
146321348|NCT03237065|527686997|FG000|Overall Study|Protocol Violation|0|||
146321349|NCT03237065|527686998|FG001|Overall Study|Protocol Violation|1|||
146321350|NCT03237065|527686997|FG000|Overall Study|Withdrawal by Subject|3|||
146321351|NCT03237065|527686998|FG001|Overall Study|Withdrawal by Subject|0|||
146321352|NCT03237065|527686997|FG000|Overall Study|Lost to Follow-up|1|||
146321353|NCT03237065|527686998|FG001|Overall Study|Lost to Follow-up|0|||
146321354|NCT03237065|527686997|FG000|Overall Study|Unable to obtain venous access|0|||
146321355|NCT03237065|527686998|FG001|Overall Study|Unable to obtain venous access|1|||
146321356|NCT00704964|527687000|FG000|Overall Study|Not completed on time|328|||
146321357|NCT02161562|527687001|FG000|Overall Study|Withdrawal by Subject|5|||
146321358|NCT02161562|527687002|FG001|Overall Study|Withdrawal by Subject|8|||
146321359|NCT02161562|527687001|FG000|Overall Study|Protocol Violation|9|||
146321360|NCT02161562|527687002|FG001|Overall Study|Protocol Violation|4|||
146321361|NCT02161562|527687001|FG000|Overall Study|Pregnancy|1|||
146321362|NCT02161562|527687002|FG001|Overall Study|Pregnancy|2|||
146321363|NCT02161562|527687001|FG000|Overall Study|Lost to Follow-up|3|||
146321364|NCT02161562|527687002|FG001|Overall Study|Lost to Follow-up|1|||
146321365|NCT02161562|527687001|FG000|Overall Study|Lack of Efficacy|4|||
146321366|NCT02161562|527687002|FG001|Overall Study|Lack of Efficacy|1|||
146321367|NCT02161562|527687001|FG000|Overall Study|Adverse Event|1|||
146321368|NCT02161562|527687002|FG001|Overall Study|Adverse Event|1|||
146321369|NCT02161562|527687001|FG000|Overall Study|Participant moved back to home country|1|||
146321370|NCT02161562|527687002|FG001|Overall Study|Participant moved back to home country|0|||
146321371|NCT02161562|527687001|FG000|Overall Study|Withdrew due to being out of the country|1|||
146321372|NCT02161562|527687002|FG001|Overall Study|Withdrew due to being out of the country|0|||
146321373|NCT02161562|527687001|FG000|Overall Study|Participant moved out of province|1|||
146321374|NCT02161562|527687002|FG001|Overall Study|Participant moved out of province|0|||
146321375|NCT01699087|527687004|FG000|Overall Study|Lost to Follow-up|7|||
146321376|NCT01699087|527687004|FG000|Overall Study|Screen failure (prior to treatment)|15|||
146321377|NCT01699087|527687004|FG000|Overall Study|Unable to make future visits|2|||
146321378|NCT00939692|527687007|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
146321379|NCT00939692|527687008|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
146321380|NCT00939692|527687007|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
146321381|NCT00939692|527687008|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
146321382|NCT04317274|527687013|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
146321383|NCT04317274|527687014|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
146321384|NCT04317274|527687015|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
146321385|NCT04317274|527687016|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
146321386|NCT00797823|527687024|FG000|First Period (Initial Randomization)|Physician Decision|1|||
146321387|NCT00797823|527687025|FG001|First Period (Initial Randomization)|Physician Decision|0|||
146321388|NCT00797823|527687026|FG002|First Period (Initial Randomization)|Physician Decision|0|||
146321389|NCT01580397|527687031|FG000|Overall Study|Lack of Efficacy|14|||
146321390|NCT00357500|527687032|FG000|Overall Study|Adverse Event|3|||
146321391|NCT00357500|527687032|FG000|Overall Study|Withdrawal by Subject|5|||
146321392|NCT00357500|527687032|FG000|Overall Study|Progressive Disease|65|||
146321393|NCT00357500|527687032|FG000|Overall Study|Not Started Protocol Therapy|4|||
146321394|NCT00626093|527687040|FG000|Overall Study|Lost to Follow-up|5|||
146321395|NCT00626093|527687040|FG000|Overall Study|Death|1|||
146321396|NCT00626093|527687040|FG000|Overall Study|Physician Decision|4|||
146321397|NCT00626093|527687040|FG000|Overall Study|Withdrawal by Subject|6|||
146321398|NCT00626093|527687040|FG000|Overall Study|Protocol Violation|1|||
146321399|NCT00626093|527687040|FG000|Overall Study|One of the required devices not implante|6|||
146321400|NCT03064841|527687041|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
146321401|NCT03064841|527687041|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
146321402|NCT03064841|527687041|FG000|Overall Study|Screen failure|2|||
146321403|NCT03434977|527687042|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
146321404|NCT03434977|527687043|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
146321405|NCT01145066|527687044|FG000|Overall Study|To resume NSAIDs|2|||
146321406|NCT01145066|527687045|FG001|Overall Study|To resume NSAIDs|2|||
146321407|NCT01145066|527687046|FG002|Overall Study|To resume NSAIDs|1|||
146321408|NCT01145066|527687044|FG000|Overall Study|Non-related surgery|0|||
146321409|NCT01145066|527687045|FG001|Overall Study|Non-related surgery|0|||
146321410|NCT01145066|527687046|FG002|Overall Study|Non-related surgery|1|||
146321411|NCT01145066|527687044|FG000|Overall Study|Withdrawal by Subject|0|||
146321412|NCT01145066|527687045|FG001|Overall Study|Withdrawal by Subject|0|||
146321413|NCT01145066|527687046|FG002|Overall Study|Withdrawal by Subject|2|||
146321414|NCT01145066|527687044|FG000|Overall Study|To start new med|1|||
146321415|NCT01145066|527687045|FG001|Overall Study|To start new med|0|||
146321416|NCT01145066|527687046|FG002|Overall Study|To start new med|0|||
146321417|NCT01145066|527687044|FG000|Overall Study|problems swallowing capsule|1|||
146321418|NCT01145066|527687045|FG001|Overall Study|problems swallowing capsule|0|||
146321419|NCT01145066|527687046|FG002|Overall Study|problems swallowing capsule|0|||
146321420|NCT01145066|527687044|FG000|Overall Study|Abdominal discomfort|0|||
146321421|NCT01145066|527687045|FG001|Overall Study|Abdominal discomfort|1|||
146321422|NCT01145066|527687046|FG002|Overall Study|Abdominal discomfort|0|||
146321423|NCT01145066|527687044|FG000|Overall Study|Low platelet count|0|||
146321424|NCT01145066|527687045|FG001|Overall Study|Low platelet count|1|||
146321425|NCT01145066|527687046|FG002|Overall Study|Low platelet count|0|||
146321426|NCT03687502|527687047|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
146321427|NCT03687502|527687047|FG000|Overall Study|Lumason not available|1|||
146321428|NCT01724528|527687051|FG000|Overall Study|Death|3|||
146321429|NCT01724528|527687052|FG001|Overall Study|Death|0|||
146321430|NCT01724528|527687051|FG000|Overall Study|Withdrawal by Subject|0|||
146321431|NCT01724528|527687052|FG001|Overall Study|Withdrawal by Subject|2|||
146321432|NCT01724528|527687051|FG000|Overall Study|Protocol Violation|0|||
146321433|NCT01724528|527687052|FG001|Overall Study|Protocol Violation|1|||
146321434|NCT01724528|527687051|FG000|Overall Study|Patient refused to attend last visit|1|||
146321435|NCT01724528|527687052|FG001|Overall Study|Patient refused to attend last visit|0|||
146321436|NCT05574062|527687056|FG000|Pre Run-In|Screening failure|3|||
146321437|NCT05574062|527687057|FG001|Pre Run-In|Screening failure|0|||
146321438|NCT05574062|527687058|FG002|Pre Run-In|Screening failure|0|||
146321439|NCT05574062|527687059|FG003|Pre Run-In|Screening failure|0|||
146321440|NCT05574062|527687060|FG004|Pre Run-In|Screening failure|0|||
146321441|NCT05574062|527687056|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
146321442|NCT05574062|527687057|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
146321443|NCT05574062|527687058|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
146321444|NCT05574062|527687059|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
146321445|NCT05574062|527687060|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
146321446|NCT05574062|527687056|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
146321447|NCT05574062|527687057|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
146321448|NCT05574062|527687058|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
146321449|NCT05574062|527687059|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
146321450|NCT05574062|527687060|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
146321451|NCT05574062|527687056|FG000|Continuation Phase Period 1|Physician Decision|1|||
146321452|NCT05574062|527687057|FG001|Continuation Phase Period 1|Physician Decision|0|||
146321453|NCT05574062|527687058|FG002|Continuation Phase Period 1|Physician Decision|0|||
146321454|NCT05574062|527687059|FG003|Continuation Phase Period 1|Physician Decision|0|||
146321455|NCT05574062|527687060|FG004|Continuation Phase Period 1|Physician Decision|0|||
146321456|NCT05574062|527687056|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
146321457|NCT05574062|527687057|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
146321458|NCT05574062|527687058|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
146321459|NCT05574062|527687059|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
146321460|NCT05574062|527687060|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
146321461|NCT05574062|527687056|FG000|Continuation Phase Period 1|Adverse Event|1|||
146321462|NCT05574062|527687057|FG001|Continuation Phase Period 1|Adverse Event|0|||
146321463|NCT05574062|527687058|FG002|Continuation Phase Period 1|Adverse Event|0|||
146321464|NCT05574062|527687059|FG003|Continuation Phase Period 1|Adverse Event|0|||
146321465|NCT05574062|527687060|FG004|Continuation Phase Period 1|Adverse Event|0|||
146321466|NCT05574062|527687056|FG000|Continuation Phase Period 1|Death|1|||
146321467|NCT05574062|527687057|FG001|Continuation Phase Period 1|Death|0|||
146321468|NCT05574062|527687058|FG002|Continuation Phase Period 1|Death|0|||
146321469|NCT05574062|527687059|FG003|Continuation Phase Period 1|Death|0|||
146321470|NCT05574062|527687060|FG004|Continuation Phase Period 1|Death|0|||
146321471|NCT05574062|527687056|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
146321472|NCT05574062|527687057|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
146321473|NCT05574062|527687058|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
146321474|NCT05574062|527687059|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
146321475|NCT05574062|527687060|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
146321476|NCT02321436|527687067|FG000|Overall Study|Withdrawal by Subject|1|||
146321477|NCT02321436|527687068|FG001|Overall Study|Withdrawal by Subject|0|||
146321478|NCT02321436|527687067|FG000|Overall Study|Lost to Follow-up|0|||
146321479|NCT02321436|527687068|FG001|Overall Study|Lost to Follow-up|1|||
146321480|NCT00644787|527687069|FG000|Period 1: Titration Phase|Adverse Event|11|||
146321481|NCT00644787|527687070|FG001|Period 1: Titration Phase|Adverse Event|0|||
146321482|NCT00644787|527687071|FG002|Period 1: Titration Phase|Adverse Event|0|||
146321483|NCT00644787|527687069|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
146321484|NCT00644787|527687070|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
146321485|NCT00644787|527687071|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
146321486|NCT00644787|527687069|FG000|Period 1: Titration Phase|Physician Decision|1|||
146321487|NCT00644787|527687070|FG001|Period 1: Titration Phase|Physician Decision|0|||
146321488|NCT00644787|527687071|FG002|Period 1: Titration Phase|Physician Decision|0|||
146321489|NCT00644787|527687069|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
146321490|NCT00644787|527687070|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
146321491|NCT00644787|527687071|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
146321492|NCT00644787|527687069|FG000|Period 1: Titration Phase|Worsening of complications|1|||
146321493|NCT00644787|527687070|FG001|Period 1: Titration Phase|Worsening of complications|0|||
146321494|NCT00644787|527687071|FG002|Period 1: Titration Phase|Worsening of complications|0|||
146321495|NCT00644787|527687069|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
146321496|NCT00644787|527687070|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
146321497|NCT00644787|527687071|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
146321498|NCT00644787|527687069|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
146321499|NCT00644787|527687070|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
146321500|NCT00644787|527687071|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
146321501|NCT00644787|527687069|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
146321502|NCT00644787|527687070|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
146321503|NCT00644787|527687071|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
146321504|NCT00644787|527687069|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
146321505|NCT00644787|527687070|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
146321506|NCT00644787|527687071|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
146321507|NCT00644787|527687069|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
146321508|NCT00644787|527687070|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
146321509|NCT00644787|527687071|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
146321510|NCT00644787|527687069|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
146321511|NCT00644787|527687070|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
146321512|NCT00644787|527687071|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
146321513|NCT00644787|527687069|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
146321514|NCT00644787|527687070|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
146321515|NCT00644787|527687071|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
146321516|NCT01928381|527687074|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
146321517|NCT01928381|527687075|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321518|NCT01928381|527687076|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321519|NCT01928381|527687077|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321520|NCT01928381|527687078|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321521|NCT01928381|527687079|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321522|NCT01928381|527687080|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
146321523|NCT01928381|527687074|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
146321524|NCT01928381|527687075|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
146321525|NCT01928381|527687076|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
146321526|NCT01928381|527687077|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
146321527|NCT01928381|527687078|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
146321528|NCT01928381|527687079|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
146321529|NCT01928381|527687080|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
146321530|NCT01928381|527687074|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
146321531|NCT01928381|527687075|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321532|NCT01928381|527687076|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321533|NCT01928381|527687077|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321534|NCT01928381|527687078|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321535|NCT01928381|527687079|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321536|NCT01928381|527687080|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
146321537|NCT01928381|527687074|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
146321538|NCT01928381|527687075|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
146164830|NCT02293395|527114351|FG000|Overall Study|Lost to Follow-up|1|||
146164831|NCT02293395|527114352|FG001|Overall Study|Lost to Follow-up|0|||
146321539|NCT01928381|527687076|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
146321540|NCT01928381|527687077|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
146321541|NCT01928381|527687078|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
146321542|NCT01928381|527687079|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
146321543|NCT01928381|527687080|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
146321544|NCT01928381|527687074|FG000|Part 1 - Pain Training|Protocol Violation|1|||
146321545|NCT01928381|527687075|FG001|Part 1 - Pain Training|Protocol Violation|0|||
146321546|NCT01928381|527687076|FG002|Part 1 - Pain Training|Protocol Violation|0|||
146321547|NCT01928381|527687077|FG003|Part 1 - Pain Training|Protocol Violation|0|||
146321548|NCT01928381|527687078|FG004|Part 1 - Pain Training|Protocol Violation|0|||
146321549|NCT01928381|527687079|FG005|Part 1 - Pain Training|Protocol Violation|0|||
146321550|NCT01928381|527687080|FG006|Part 1 - Pain Training|Protocol Violation|0|||
146321551|NCT01928381|527687074|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
146321552|NCT01928381|527687075|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321553|NCT01928381|527687076|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321554|NCT01928381|527687077|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321555|NCT01928381|527687078|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321556|NCT01928381|527687079|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321557|NCT01928381|527687080|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
146321558|NCT01928381|527687074|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
146321559|NCT01928381|527687075|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321560|NCT01928381|527687076|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321561|NCT01928381|527687077|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321562|NCT01928381|527687078|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321563|NCT01928381|527687079|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321564|NCT01928381|527687080|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
146321565|NCT01928381|527687074|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
146321566|NCT01928381|527687075|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321567|NCT01928381|527687076|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321568|NCT01928381|527687077|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321569|NCT01928381|527687078|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321570|NCT01928381|527687079|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321571|NCT01928381|527687080|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
146321572|NCT01928381|527687074|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
146321573|NCT01928381|527687075|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321574|NCT01928381|527687076|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321575|NCT01928381|527687077|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321576|NCT01928381|527687078|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321577|NCT01928381|527687079|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321578|NCT01928381|527687080|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
146321579|NCT01928381|527687074|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321580|NCT01928381|527687075|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321581|NCT01928381|527687076|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
146321582|NCT01928381|527687077|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321583|NCT01928381|527687078|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321584|NCT01928381|527687079|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321585|NCT01928381|527687080|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
146321586|NCT01928381|527687074|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321587|NCT01928381|527687075|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321588|NCT01928381|527687076|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
146321589|NCT01928381|527687077|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321590|NCT01928381|527687078|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321591|NCT01928381|527687079|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321592|NCT01928381|527687080|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
146321593|NCT01928381|527687074|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
146321594|NCT01928381|527687075|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
146321595|NCT01928381|527687076|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
146321596|NCT01928381|527687077|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
146321597|NCT01928381|527687078|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
146321598|NCT01928381|527687079|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
146321599|NCT01928381|527687080|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
146321600|NCT01928381|527687074|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
146321601|NCT01928381|527687075|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
146321602|NCT01928381|527687076|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
146321603|NCT01928381|527687077|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
146321604|NCT01928381|527687078|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
146321605|NCT01928381|527687079|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
146321606|NCT01928381|527687080|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
146321607|NCT01928381|527687074|FG000|Washout First Intervention|Protocol Violation|0|||
146321608|NCT01928381|527687075|FG001|Washout First Intervention|Protocol Violation|0|||
146321609|NCT01928381|527687076|FG002|Washout First Intervention|Protocol Violation|0|||
146321610|NCT01928381|527687077|FG003|Washout First Intervention|Protocol Violation|0|||
146321611|NCT01928381|527687078|FG004|Washout First Intervention|Protocol Violation|1|||
146321612|NCT01928381|527687079|FG005|Washout First Intervention|Protocol Violation|0|||
146321613|NCT01928381|527687080|FG006|Washout First Intervention|Protocol Violation|0|||
146321614|NCT01928381|527687074|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
146321615|NCT01928381|527687075|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
146321616|NCT01928381|527687076|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
146321617|NCT01928381|527687077|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
146321618|NCT01928381|527687078|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
146321619|NCT01928381|527687079|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
146321620|NCT01928381|527687080|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
146321621|NCT01928381|527687074|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321622|NCT01928381|527687075|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321623|NCT01928381|527687076|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
146321624|NCT01928381|527687077|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321625|NCT01928381|527687078|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321626|NCT01928381|527687079|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321627|NCT01928381|527687080|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
146321628|NCT01877083|527687081|FG000|Treatment Phase|Disease Progression|10|||
146321629|NCT01877083|527687081|FG000|Treatment Phase|Clinical Progression|1|||
146321630|NCT01877083|527687081|FG000|Treatment Phase|Adverse Event|6|||
146321631|NCT01877083|527687081|FG000|Treatment Phase|Withdrawal by Subject|2|||
146321632|NCT01877083|527687081|FG000|Treatment Phase|Lost to Follow-up|1|||
146321633|NCT01877083|527687081|FG000|Extension Phase|Disease Progression|3|||
146321634|NCT01877083|527687081|FG000|Extension Phase|Adverse Event|2|||
146321635|NCT01582308|527687082|FG000|Period 1|Withdrawal by Subject|0|||
146321636|NCT01582308|527687083|FG001|Period 1|Withdrawal by Subject|0|||
146321637|NCT01582308|527687084|FG002|Period 1|Withdrawal by Subject|0|||
146321638|NCT01582308|527687085|FG003|Period 1|Withdrawal by Subject|0|||
146321639|NCT01582308|527687086|FG004|Period 1|Withdrawal by Subject|0|||
146321640|NCT01582308|527687087|FG005|Period 1|Withdrawal by Subject|0|||
146321641|NCT01582308|527687088|FG006|Period 1|Withdrawal by Subject|1|||
146321642|NCT01582308|527687089|FG007|Period 1|Withdrawal by Subject|0|||
146321643|NCT01582308|527687090|FG008|Period 1|Withdrawal by Subject|0|||
146321644|NCT01582308|527687091|FG009|Period 1|Withdrawal by Subject|0|||
146321645|NCT01582308|527687082|FG000|10-day Washout Following Period 1|Physician Decision|0|||
146321646|NCT01582308|527687083|FG001|10-day Washout Following Period 1|Physician Decision|0|||
146321647|NCT01582308|527687084|FG002|10-day Washout Following Period 1|Physician Decision|0|||
146321648|NCT01582308|527687085|FG003|10-day Washout Following Period 1|Physician Decision|0|||
146321649|NCT01582308|527687086|FG004|10-day Washout Following Period 1|Physician Decision|1|||
146321650|NCT01582308|527687087|FG005|10-day Washout Following Period 1|Physician Decision|0|||
146321651|NCT01582308|527687088|FG006|10-day Washout Following Period 1|Physician Decision|0|||
146321652|NCT01582308|527687089|FG007|10-day Washout Following Period 1|Physician Decision|0|||
146321653|NCT01582308|527687090|FG008|10-day Washout Following Period 1|Physician Decision|0|||
146321654|NCT01582308|527687091|FG009|10-day Washout Following Period 1|Physician Decision|0|||
146321655|NCT01582308|527687082|FG000|Period 4|Physician Decision|1|||
146321656|NCT01582308|527687083|FG001|Period 4|Physician Decision|0|||
146321657|NCT01582308|527687084|FG002|Period 4|Physician Decision|0|||
146321658|NCT01582308|527687085|FG003|Period 4|Physician Decision|0|||
146321659|NCT01582308|527687086|FG004|Period 4|Physician Decision|0|||
146321660|NCT01582308|527687087|FG005|Period 4|Physician Decision|1|||
146321661|NCT01582308|527687088|FG006|Period 4|Physician Decision|0|||
146321662|NCT01582308|527687089|FG007|Period 4|Physician Decision|0|||
146321663|NCT01582308|527687090|FG008|Period 4|Physician Decision|0|||
146321664|NCT01582308|527687091|FG009|Period 4|Physician Decision|1|||
146321665|NCT00772668|527687094|FG000|Overall Study|Physician Decision|3|||
146321666|NCT03406897|527687095|FG000|Overall Study|Lost to Follow-up|1|||
146321667|NCT03406897|527687096|FG001|Overall Study|Lost to Follow-up|2|||
146321668|NCT03406897|527687095|FG000|Overall Study|Withdrawal by Subject|4|||
146321669|NCT03406897|527687096|FG001|Overall Study|Withdrawal by Subject|4|||
146321670|NCT03406897|527687095|FG000|Overall Study|Physician Decision|0|||
146321671|NCT03406897|527687096|FG001|Overall Study|Physician Decision|1|||
146321672|NCT00935883|527688765|FG000|Treatment Period|Physician Decision|1|||
146321673|NCT00935883|527688766|FG001|Treatment Period|Physician Decision|0|||
146321674|NCT00935883|527688765|FG000|Treatment Period|Withdrawal by Subject|0|||
146321675|NCT00935883|527688766|FG001|Treatment Period|Withdrawal by Subject|2|||
146321676|NCT01641939|527688769|FG000|Overall Study|Death|90|||
146321677|NCT01641939|527688770|FG001|Overall Study|Death|187|||
146321678|NCT01641939|527688771|FG002|Overall Study|Death|61|||
145943229|NCT00483704|526300458|FG002|Treatment|Protocol Violation|5|||
146321679|NCT01641939|527688769|FG000|Overall Study|Lost to Follow-up|3|||
146321680|NCT01641939|527688770|FG001|Overall Study|Lost to Follow-up|2|||
146321681|NCT01641939|527688771|FG002|Overall Study|Lost to Follow-up|1|||
146321682|NCT01641939|527688769|FG000|Overall Study|Withdrawal by Subject|14|||
146321683|NCT01641939|527688770|FG001|Overall Study|Withdrawal by Subject|11|||
146321684|NCT01641939|527688771|FG002|Overall Study|Withdrawal by Subject|5|||
146321685|NCT01641939|527688769|FG000|Overall Study|Study Terminated by Sponsor|10|||
146321686|NCT01641939|527688770|FG001|Overall Study|Study Terminated by Sponsor|28|||
146321687|NCT01641939|527688771|FG002|Overall Study|Study Terminated by Sponsor|3|||
146321688|NCT02894840|527688772|FG000|Overall Study|Lost to Follow-up|1|||
146321689|NCT02894840|527688773|FG001|Overall Study|Lost to Follow-up|0|||
146321690|NCT02894840|527688774|FG002|Overall Study|Lost to Follow-up|3|||
146321691|NCT02894840|527688775|FG003|Overall Study|Lost to Follow-up|0|||
146321692|NCT03472560|527688781|FG000|Overall Study|Subject transfer to continuation protocol|0|||
146321693|NCT03472560|527688782|FG001|Overall Study|Subject transfer to continuation protocol|1|||
146321694|NCT03472560|527688781|FG000|Overall Study|Withdrawal by Subject|4|||
146321695|NCT03472560|527688782|FG001|Overall Study|Withdrawal by Subject|0|||
146321696|NCT03472560|527688781|FG000|Overall Study|Progressive disease|24|||
146321697|NCT03472560|527688782|FG001|Overall Study|Progressive disease|8|||
146321698|NCT03472560|527688781|FG000|Overall Study|Physician Decision|1|||
146321699|NCT03472560|527688782|FG001|Overall Study|Physician Decision|0|||
146321700|NCT03472560|527688781|FG000|Overall Study|Death|7|||
146321701|NCT03472560|527688782|FG001|Overall Study|Death|4|||
146321702|NCT03472560|527688781|FG000|Overall Study|Adverse Event|5|||
146321703|NCT03472560|527688782|FG001|Overall Study|Adverse Event|3|||
146321704|NCT03472560|527688781|FG000|Overall Study|Global deterioration of health status|0|||
146321705|NCT03472560|527688782|FG001|Overall Study|Global deterioration of health status|4|||
146321706|NCT01946178|527688783|FG000|Overall Study|Pregnancy|1|||
146321707|NCT01946178|527688783|FG000|Overall Study|Lost to Follow-up|1|||
146321708|NCT01537211|527688788|FG000|Overall Study|Lost to Follow-up|0|||
146321709|NCT01537211|527688789|FG001|Overall Study|Lost to Follow-up|1|||
146321710|NCT00343512|527688795|FG000|Overall Study|Withdrawal by Subject|2|||
146321711|NCT00197054|527688796|FG000|Overall Study|Withdrawal by Subject|9|||
146321712|NCT00197054|527688797|FG001|Overall Study|Withdrawal by Subject|3|||
146321713|NCT00197054|527688798|FG002|Overall Study|Withdrawal by Subject|3|||
146321714|NCT00197054|527688796|FG000|Overall Study|Moved from area|7|||
146321715|NCT00197054|527688797|FG001|Overall Study|Moved from area|14|||
146321716|NCT00197054|527688798|FG002|Overall Study|Moved from area|9|||
146321717|NCT00197054|527688796|FG000|Overall Study|Lost to Follow-up|1|||
146321718|NCT00197054|527688797|FG001|Overall Study|Lost to Follow-up|4|||
146321719|NCT00197054|527688798|FG002|Overall Study|Lost to Follow-up|0|||
146321720|NCT00323557|527688799|FG000|Overall Study|Physician Decision|1|||
146321721|NCT00323557|527688800|FG001|Overall Study|Physician Decision|0|||
146321722|NCT00684515|527688801|FG000|Overall Study|Adverse Event|3|||
146321723|NCT00684515|527688802|FG001|Overall Study|Adverse Event|3|||
146321724|NCT00684515|527688803|FG002|Overall Study|Adverse Event|1|||
146321725|NCT00684515|527688801|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
146321726|NCT00684515|527688802|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
146321727|NCT00684515|527688803|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
146321728|NCT02450578|527688804|FG000|Overall Study|ECG abnormality so not treated|1|||
146321729|NCT02450578|527688805|FG001|Overall Study|ECG abnormality so not treated|0|||
146321730|NCT02450578|527688806|FG002|Overall Study|ECG abnormality so not treated|0|||
146321731|NCT02450578|527688807|FG003|Overall Study|ECG abnormality so not treated|0|||
146321732|NCT04428411|527688810|FG000|Overall Study|Lost to Follow-up|114|||
146321733|NCT02918019|527688811|FG000|Overall Study|Death|0|||
146321734|NCT02918019|527688812|FG001|Overall Study|Death|0|||
146321735|NCT02918019|527688813|FG002|Overall Study|Death|1|||
146321736|NCT02918019|527688814|FG003|Overall Study|Death|0|||
146321737|NCT02918019|527688811|FG000|Overall Study|Lost to Follow-up|1|||
146321738|NCT02918019|527688812|FG001|Overall Study|Lost to Follow-up|1|||
146321739|NCT02918019|527688813|FG002|Overall Study|Lost to Follow-up|0|||
146321740|NCT02918019|527688814|FG003|Overall Study|Lost to Follow-up|1|||
146321741|NCT02918019|527688811|FG000|Overall Study|Principal investigator request|0|||
146321742|NCT02918019|527688812|FG001|Overall Study|Principal investigator request|0|||
146321743|NCT02918019|527688813|FG002|Overall Study|Principal investigator request|0|||
146321744|NCT02918019|527688814|FG003|Overall Study|Principal investigator request|1|||
146321745|NCT02918019|527688811|FG000|Overall Study|Physician Decision|1|||
146321746|NCT02918019|527688812|FG001|Overall Study|Physician Decision|3|||
146321747|NCT02918019|527688813|FG002|Overall Study|Physician Decision|2|||
146321748|NCT02918019|527688814|FG003|Overall Study|Physician Decision|0|||
146321749|NCT02918019|527688811|FG000|Overall Study|Protocol deviation|1|||
146321750|NCT02918019|527688812|FG001|Overall Study|Protocol deviation|1|||
146321751|NCT02918019|527688813|FG002|Overall Study|Protocol deviation|0|||
146321752|NCT02918019|527688814|FG003|Overall Study|Protocol deviation|2|||
146321753|NCT02918019|527688811|FG000|Overall Study|Withdrawal by Subject|3|||
146321754|NCT02918019|527688812|FG001|Overall Study|Withdrawal by Subject|4|||
146321755|NCT02918019|527688813|FG002|Overall Study|Withdrawal by Subject|6|||
146321756|NCT02918019|527688814|FG003|Overall Study|Withdrawal by Subject|4|||
146321757|NCT02918019|527688811|FG000|Overall Study|Adverse Event|0|||
146321758|NCT02918019|527688812|FG001|Overall Study|Adverse Event|1|||
146321759|NCT02918019|527688813|FG002|Overall Study|Adverse Event|0|||
146321760|NCT02918019|527688814|FG003|Overall Study|Adverse Event|1|||
146321761|NCT00662792|527688815|FG000|Period 1|Personal Reasons|0|||
146321762|NCT00662792|527688816|FG001|Period 1|Personal Reasons|0|||
146321763|NCT00662792|527688817|FG002|Period 1|Personal Reasons|1|||
146321764|NCT00662792|527688818|FG003|Period 1|Personal Reasons|0|||
146321765|NCT00662792|527688815|FG000|Period 1|Refused continuing medication|0|||
146321766|NCT00662792|527688816|FG001|Period 1|Refused continuing medication|1|||
146321767|NCT00662792|527688817|FG002|Period 1|Refused continuing medication|1|||
146321768|NCT00662792|527688818|FG003|Period 1|Refused continuing medication|0|||
146321769|NCT00662792|527688815|FG000|Period 1|Lost to Follow-up|1|||
146321770|NCT00662792|527688816|FG001|Period 1|Lost to Follow-up|0|||
146321771|NCT00662792|527688817|FG002|Period 1|Lost to Follow-up|0|||
146321772|NCT00662792|527688818|FG003|Period 1|Lost to Follow-up|0|||
146321773|NCT00662792|527688815|FG000|Period 1|Other adverse event (AE)|0|||
146321774|NCT00662792|527688816|FG001|Period 1|Other adverse event (AE)|2|||
146321775|NCT00662792|527688817|FG002|Period 1|Other adverse event (AE)|0|||
146321776|NCT00662792|527688818|FG003|Period 1|Other adverse event (AE)|0|||
146321777|NCT00662792|527688815|FG000|Period 1|Worsening of disease under study (AE)|1|||
146321778|NCT00662792|527688816|FG001|Period 1|Worsening of disease under study (AE)|3|||
146321779|NCT00662792|527688817|FG002|Period 1|Worsening of disease under study (AE)|2|||
146321780|NCT00662792|527688818|FG003|Period 1|Worsening of disease under study (AE)|0|||
146321781|NCT00662792|527688815|FG000|Period 1|Not treated|0|||
146321782|NCT00662792|527688816|FG001|Period 1|Not treated|1|||
146321783|NCT00662792|527688817|FG002|Period 1|Not treated|0|||
146321784|NCT00662792|527688818|FG003|Period 1|Not treated|0|||
146321785|NCT00662792|527688815|FG000|Period 2|Worsening of disease under study|1|||
146321786|NCT00662792|527688816|FG001|Period 2|Worsening of disease under study|0|||
146321787|NCT00662792|527688817|FG002|Period 2|Worsening of disease under study|0|||
146321788|NCT00662792|527688818|FG003|Period 2|Worsening of disease under study|3|||
146321789|NCT00662792|527688815|FG000|Period 3|Refused continuing medication|1|||
146321790|NCT00662792|527688816|FG001|Period 3|Refused continuing medication|0|||
146321791|NCT00662792|527688817|FG002|Period 3|Refused continuing medication|1|||
146321792|NCT00662792|527688818|FG003|Period 3|Refused continuing medication|0|||
146321793|NCT00662792|527688815|FG000|Period 3|Other adverse event (AE)|0|||
146321794|NCT00662792|527688816|FG001|Period 3|Other adverse event (AE)|0|||
146321795|NCT00662792|527688817|FG002|Period 3|Other adverse event (AE)|1|||
146321796|NCT00662792|527688818|FG003|Period 3|Other adverse event (AE)|1|||
146321797|NCT00662792|527688815|FG000|Period 4|Refused continuing medication|0|||
146321798|NCT00662792|527688816|FG001|Period 4|Refused continuing medication|1|||
146321799|NCT00662792|527688817|FG002|Period 4|Refused continuing medication|0|||
146321800|NCT00662792|527688818|FG003|Period 4|Refused continuing medication|0|||
146321801|NCT00662792|527688815|FG000|Period 4|Other adverse event (AE)|1|||
146321802|NCT00662792|527688816|FG001|Period 4|Other adverse event (AE)|0|||
146321803|NCT00662792|527688817|FG002|Period 4|Other adverse event (AE)|0|||
146321804|NCT00662792|527688818|FG003|Period 4|Other adverse event (AE)|0|||
146321805|NCT00662792|527688815|FG000|Period 4|Worsening of disease under study (AE)|0|||
146321806|NCT00662792|527688816|FG001|Period 4|Worsening of disease under study (AE)|0|||
146321807|NCT00662792|527688817|FG002|Period 4|Worsening of disease under study (AE)|0|||
146321808|NCT00662792|527688818|FG003|Period 4|Worsening of disease under study (AE)|1|||
146321809|NCT02474082|527688821|FG000|Overall Study|Adverse Event|2|||
146321810|NCT02474082|527688822|FG001|Overall Study|Adverse Event|32|||
146321811|NCT02474082|527688821|FG000|Overall Study|Withdrawal of informed consent|1|||
146321812|NCT02474082|527688822|FG001|Overall Study|Withdrawal of informed consent|11|||
146321813|NCT02474082|527688821|FG000|Overall Study|Lost to Follow-up|2|||
146321814|NCT02474082|527688822|FG001|Overall Study|Lost to Follow-up|2|||
146321815|NCT02474082|527688821|FG000|Overall Study|Dose tapering not achieved|0|||
146321816|NCT02474082|527688822|FG001|Overall Study|Dose tapering not achieved|4|||
146321817|NCT02474082|527688821|FG000|Overall Study|Participant/guardian decision|1|||
146321818|NCT02474082|527688822|FG001|Overall Study|Participant/guardian decision|2|||
146321819|NCT02474082|527688821|FG000|Overall Study|Non-compliance with study treatment|0|||
146321820|NCT02474082|527688822|FG001|Overall Study|Non-compliance with study treatment|2|||
146321821|NCT02474082|527688821|FG000|Overall Study|Protocol deviation|0|||
146321822|NCT02474082|527688822|FG001|Overall Study|Protocol deviation|1|||
146321823|NCT01528787|527688823|FG000|Overall Study|Withdrawal by Subject|0|||
146321824|NCT01528787|527688824|FG001|Overall Study|Withdrawal by Subject|0|||
146321825|NCT01528787|527688825|FG002|Overall Study|Withdrawal by Subject|0|||
146321826|NCT01528787|527688826|FG003|Overall Study|Withdrawal by Subject|1|||
146321827|NCT01528787|527688823|FG000|Overall Study|Family Emergency|0|||
146321828|NCT01528787|527688824|FG001|Overall Study|Family Emergency|0|||
146321829|NCT01528787|527688825|FG002|Overall Study|Family Emergency|1|||
146321830|NCT01528787|527688826|FG003|Overall Study|Family Emergency|0|||
146321831|NCT03433781|527688827|FG000|Overall Study|Progression of Disease|1|||
146321832|NCT03433781|527688828|FG001|Overall Study|Progression of Disease|0|||
146321833|NCT03433781|527688829|FG002|Overall Study|Progression of Disease|0|||
146321834|NCT03433781|527688827|FG000|Overall Study|Physician Decision|0|||
146321835|NCT03433781|527688828|FG001|Overall Study|Physician Decision|1|||
146321836|NCT03433781|527688829|FG002|Overall Study|Physician Decision|0|||
146321837|NCT00744874|527688830|FG000|Overall Study|Lost to Follow-up|1|||
146321838|NCT00744874|527688830|FG000|Overall Study|Withdrawal by Subject|1|||
146321839|NCT00744874|527688830|FG000|Overall Study|Study Device not available at procedure|1|||
146321840|NCT00744874|527688830|FG000|Overall Study|Unable to accomodate schedule|1|||
146321841|NCT02971670|527688833|FG000|Overall Study|Withdrawal by Subject|4|||
146321842|NCT02971670|527688834|FG001|Overall Study|Withdrawal by Subject|1|||
146321843|NCT02971670|527688835|FG002|Overall Study|Withdrawal by Subject|1|||
146164832|NCT02293395|527114351|FG000|Overall Study|Withdrawal by Subject|8|||
146164833|NCT02293395|527114352|FG001|Overall Study|Withdrawal by Subject|7|||
146164834|NCT00224770|527114358|FG000|Overall Study|Lost to Follow-up|4|||
146164835|NCT00224770|527114359|FG001|Overall Study|Lost to Follow-up|2|||
146164836|NCT00224770|527114360|FG002|Overall Study|Lost to Follow-up|0|||
146164837|NCT01106430|527114361|FG000|Overall Study|Adverse Event|8|||
146164838|NCT01106430|527114362|FG001|Overall Study|Adverse Event|10|||
146164839|NCT01106430|527114361|FG000|Overall Study|Lack of Efficacy|2|||
146164840|NCT01106430|527114362|FG001|Overall Study|Lack of Efficacy|13|||
146164841|NCT01106430|527114361|FG000|Overall Study|Lost to Follow-up|5|||
146164842|NCT01106430|527114362|FG001|Overall Study|Lost to Follow-up|1|||
146164843|NCT01106430|527114361|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
146164844|NCT01106430|527114362|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
146164845|NCT01106430|527114361|FG000|Overall Study|Moved Out Of State|0|||
146164846|NCT01106430|527114362|FG001|Overall Study|Moved Out Of State|1|||
146321844|NCT02971670|527688836|FG003|Overall Study|Withdrawal by Subject|2|||
146321845|NCT02486757|527688837|FG000|Overall Study|Lost to Follow-up|1|||
146321846|NCT02793232|527688838|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321847|NCT02793232|527688839|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321848|NCT02793232|527688840|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321849|NCT02793232|527688841|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321850|NCT02793232|527688842|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
146321851|NCT02793232|527688843|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321852|NCT02793232|527688844|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
146321853|NCT02793232|527688845|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321854|NCT02793232|527688846|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
146321855|NCT04849780|527688847|FG000|Period 1|Covid-19 Related|1|||
146321856|NCT04849780|527688848|FG001|Period 1|Covid-19 Related|0|||
146321857|NCT04849780|527688847|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
146321858|NCT04849780|527688848|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
146321859|NCT04849780|527688847|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
146321860|NCT04849780|527688848|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
146321861|NCT00352105|527688849|FG000|Overall Study|Death|5|||
146321862|NCT00352105|527688849|FG000|Overall Study|Withdrawal by Subject|5|||
146321863|NCT00352105|527688849|FG000|Overall Study|Lack of Efficacy|9|||
146321864|NCT00352105|527688849|FG000|Overall Study|Adverse Event|19|||
146321865|NCT00352105|527688849|FG000|Overall Study|Protocol Violation|2|||
146321866|NCT02979431|527688850|FG000|Overall Study|Parent/guardian withdrew consent|2|||
146321867|NCT02979431|527688851|FG001|Overall Study|Parent/guardian withdrew consent|1|||
146321868|NCT02979431|527688852|FG002|Overall Study|Parent/guardian withdrew consent|1|||
146321869|NCT02979431|527688853|FG003|Overall Study|Parent/guardian withdrew consent|1|||
146321870|NCT02979431|527688850|FG000|Overall Study|Randomized but received no study drug|1|||
146321871|NCT02979431|527688851|FG001|Overall Study|Randomized but received no study drug|1|||
146321872|NCT02979431|527688852|FG002|Overall Study|Randomized but received no study drug|0|||
146321873|NCT02979431|527688853|FG003|Overall Study|Randomized but received no study drug|0|||
146321874|NCT02979431|527688850|FG000|Overall Study|Adverse Event|0|||
146321875|NCT02979431|527688851|FG001|Overall Study|Adverse Event|0|||
146321876|NCT02979431|527688852|FG002|Overall Study|Adverse Event|1|||
146321877|NCT02979431|527688853|FG003|Overall Study|Adverse Event|0|||
146321878|NCT02979431|527688850|FG000|Overall Study|Subject left country after Day14|1|||
146321879|NCT02979431|527688851|FG001|Overall Study|Subject left country after Day14|0|||
146321880|NCT02979431|527688852|FG002|Overall Study|Subject left country after Day14|0|||
146321881|NCT02979431|527688853|FG003|Overall Study|Subject left country after Day14|0|||
146164847|NCT01106430|527114361|FG000|Overall Study|Refused To Take Medication|0|||
146164848|NCT01106430|527114362|FG001|Overall Study|Refused To Take Medication|1|||
146164849|NCT01106430|527114361|FG000|Overall Study|Noncompliance|0|||
146164850|NCT01106430|527114362|FG001|Overall Study|Noncompliance|1|||
146321882|NCT01405053|527688857|FG000|Overall Study|Adverse Event|3|||
146321883|NCT01405053|527688858|FG001|Overall Study|Adverse Event|0|||
146321884|NCT01405053|527688857|FG000|Overall Study|Lost to Follow-up|0|||
146321885|NCT01405053|527688858|FG001|Overall Study|Lost to Follow-up|1|||
146164851|NCT01106430|527114361|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
146164852|NCT01106430|527114362|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
146321886|NCT01405053|527688857|FG000|Overall Study|Participant choice|2|||
146321887|NCT01405053|527688858|FG001|Overall Study|Participant choice|1|||
146321888|NCT01405053|527688857|FG000|Overall Study|Inadequate therapeutic effect|2|||
146321889|NCT01405053|527688858|FG001|Overall Study|Inadequate therapeutic effect|1|||
146321890|NCT01405053|527688857|FG000|Overall Study|Withdrawal by Subject|3|||
146321891|NCT01405053|527688858|FG001|Overall Study|Withdrawal by Subject|4|||
146321892|NCT01405053|527688857|FG000|Overall Study|Other|0|||
146321893|NCT01405053|527688858|FG001|Overall Study|Other|1|||
146321894|NCT03979274|527688872|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146321895|NCT03979274|527688873|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146321896|NCT02301403|527688874|FG000|Overall Study|Withdrawal by Subject|28|||
146321897|NCT02301403|527688875|FG001|Overall Study|Withdrawal by Subject|41|||
146321898|NCT01816243|527688876|FG000|Overall Study|Adverse Event|6|||
146321899|NCT01816243|527688876|FG000|Overall Study|Lost to Follow-up|1|||
146321900|NCT01816243|527688876|FG000|Overall Study|Lack of Efficacy|1|||
146321901|NCT01816243|527688876|FG000|Overall Study|Not eligible for the study|1|||
146321902|NCT01816243|527688876|FG000|Overall Study|Amputation|3|||
146321903|NCT01920711|527688877|FG000|Overall Study|Death|347|||
146321904|NCT01920711|527688878|FG001|Overall Study|Death|356|||
146321905|NCT01920711|527688877|FG000|Overall Study|Lost to Follow-up|13|||
146321906|NCT01920711|527688878|FG001|Overall Study|Lost to Follow-up|14|||
146321907|NCT01920711|527688877|FG000|Overall Study|Withdrawal by Subject|4|||
146321908|NCT01920711|527688878|FG001|Overall Study|Withdrawal by Subject|3|||
146321909|NCT01972074|527688882|FG000|Overall Study|Adverse Event|4|||
146321910|NCT01972074|527688883|FG001|Overall Study|Adverse Event|1|||
146321911|NCT01972074|527688884|FG002|Overall Study|Adverse Event|0|||
146321912|NCT01972074|527688882|FG000|Overall Study|Lack of Efficacy|1|||
146321913|NCT01972074|527688883|FG001|Overall Study|Lack of Efficacy|1|||
146321914|NCT01972074|527688884|FG002|Overall Study|Lack of Efficacy|0|||
146321915|NCT01972074|527688882|FG000|Overall Study|Lost to Follow-up|0|||
146321916|NCT01972074|527688883|FG001|Overall Study|Lost to Follow-up|1|||
146321917|NCT01972074|527688884|FG002|Overall Study|Lost to Follow-up|1|||
146321918|NCT01972074|527688882|FG000|Overall Study|Withdrawal by Subject|1|||
146321919|NCT01972074|527688883|FG001|Overall Study|Withdrawal by Subject|1|||
146321920|NCT01972074|527688884|FG002|Overall Study|Withdrawal by Subject|1|||
146321921|NCT01972074|527688882|FG000|Overall Study|Scanner Unavailable|0|||
146321922|NCT01972074|527688883|FG001|Overall Study|Scanner Unavailable|0|||
146321923|NCT01972074|527688884|FG002|Overall Study|Scanner Unavailable|1|||
146321924|NCT02319044|527688885|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
146321925|NCT02319044|527688886|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
146321926|NCT02319044|527688887|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
146321927|NCT02319044|527688885|FG000|Overall Study|Withdrawal by Subject|3|||
146321928|NCT02319044|527688886|FG001|Overall Study|Withdrawal by Subject|3|||
146321929|NCT02319044|527688887|FG002|Overall Study|Withdrawal by Subject|6|||
146321930|NCT02319044|527688885|FG000|Overall Study|Condition under investigation worsened|100|||
146321931|NCT02319044|527688886|FG001|Overall Study|Condition under investigation worsened|50|||
146321932|NCT02319044|527688887|FG002|Overall Study|Condition under investigation worsened|46|||
146321933|NCT02319044|527688885|FG000|Overall Study|Adverse Event|17|||
146321934|NCT02319044|527688886|FG001|Overall Study|Adverse Event|2|||
146164853|NCT01106430|527114361|FG000|Overall Study|Previous Use Of Marijuana|1|||
146164854|NCT01106430|527114362|FG001|Overall Study|Previous Use Of Marijuana|0|||
146164855|NCT01106430|527114361|FG000|Overall Study|Protocol Violation|7|||
146164856|NCT01106430|527114362|FG001|Overall Study|Protocol Violation|2|||
146164857|NCT01106430|527114361|FG000|Overall Study|Withdrawal by Subject|8|||
146164858|NCT01106430|527114362|FG001|Overall Study|Withdrawal by Subject|4|||
146164859|NCT00662857|527114365|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
146164860|NCT00662857|527114366|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
146164861|NCT00662857|527114365|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
146164862|NCT00662857|527114366|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
146164863|NCT00662857|527114365|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
146164864|NCT00662857|527114366|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
146164865|NCT00989092|527114367|FG000|Overall Study|Physician Decision|9|||
146164866|NCT00989092|527114368|FG001|Overall Study|Physician Decision|6|||
146164867|NCT00989092|527114367|FG000|Overall Study|Adverse Event|20|||
146321935|NCT02319044|527688887|FG002|Overall Study|Adverse Event|8|||
146164868|NCT00989092|527114368|FG001|Overall Study|Adverse Event|1|||
146164869|NCT00989092|527114367|FG000|Overall Study|Chemotherapy initiated|12|||
146164870|NCT00989092|527114368|FG001|Overall Study|Chemotherapy initiated|4|||
146164871|NCT00989092|527114367|FG000|Overall Study|Withdrawal by Subject|17|||
146321936|NCT02319044|527688885|FG000|Overall Study|Study specific discontinuation criteria|2|||
146164872|NCT00989092|527114368|FG001|Overall Study|Withdrawal by Subject|9|||
146164873|NCT00989092|527114367|FG000|Overall Study|Death|14|||
146321937|NCT02319044|527688886|FG001|Overall Study|Study specific discontinuation criteria|2|||
146321938|NCT02319044|527688887|FG002|Overall Study|Study specific discontinuation criteria|1|||
146321939|NCT02319044|527688885|FG000|Overall Study|Not treated|0|||
146321940|NCT02319044|527688886|FG001|Overall Study|Not treated|2|||
146321941|NCT02319044|527688887|FG002|Overall Study|Not treated|2|||
146321942|NCT02317562|527688888|FG000|Overall Study|Physician Decision|1|||
146321943|NCT02317562|527688888|FG000|Overall Study|early termination of the study|8|||
146321944|NCT02317562|527688888|FG000|Overall Study|Lack of Efficacy|4|||
146321945|NCT02317562|527688888|FG000|Overall Study|Withdrawal by Subject|1|||
146321946|NCT03551743|527688889|FG000|Overall Study|Adverse Event|1|||
146321947|NCT03551743|527688890|FG001|Overall Study|Adverse Event|0|||
146321948|NCT03551743|527688891|FG002|Overall Study|Adverse Event|0|||
146321949|NCT03551743|527688892|FG003|Overall Study|Adverse Event|0|||
146321950|NCT03551743|527688889|FG000|Overall Study|Withdrawal by Subject|1|||
146321951|NCT03551743|527688890|FG001|Overall Study|Withdrawal by Subject|0|||
146321952|NCT03551743|527688891|FG002|Overall Study|Withdrawal by Subject|0|||
146321953|NCT03551743|527688892|FG003|Overall Study|Withdrawal by Subject|0|||
146321954|NCT00603915|527688893|FG000|Overall Study|Physician Decision|1|||
146321955|NCT00911989|527688894|FG000|Overall Study|Adverse Event|1|||
146321956|NCT00573794|527688899|FG000|Overall Study|Adverse Event|81|||
146321957|NCT00573794|527688899|FG000|Overall Study|Withdrew Consent|90|||
146321958|NCT00573794|527688899|FG000|Overall Study|Lost to Follow-up|13|||
146321959|NCT00573794|527688899|FG000|Overall Study|Protocol Violation|6|||
146321960|NCT00573794|527688899|FG000|Overall Study|Lack of Efficacy|94|||
146321961|NCT00573794|527688899|FG000|Overall Study|Other|46|||
146321962|NCT01777581|527688900|FG000|Overall Study|Lost to Follow-up|1|||
146321963|NCT01777581|527688901|FG001|Overall Study|Lost to Follow-up|1|||
146321964|NCT01777581|527688900|FG000|Overall Study|Adverse Event|2|||
146321965|NCT01777581|527688901|FG001|Overall Study|Adverse Event|0|||
146321966|NCT01777581|527688900|FG000|Overall Study|Lack of Efficacy|0|||
146321967|NCT01777581|527688901|FG001|Overall Study|Lack of Efficacy|1|||
146321968|NCT03631706|527688912|FG000|Overall Study|Randomized, not treated|1|||
146321969|NCT03631706|527688913|FG001|Overall Study|Randomized, not treated|0|||
146321970|NCT01844986|527688914|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
146321971|NCT01844986|527688915|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
146321972|NCT01844986|527688914|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
146321973|NCT01844986|527688915|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
146321974|NCT01844986|527688914|FG000|Overall Study (Global Cohort)|Death|55|||
146321975|NCT01844986|527688915|FG001|Overall Study (Global Cohort)|Death|26|||
146321976|NCT01844986|527688914|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
146321977|NCT01844986|527688915|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
146321978|NCT01844986|527688914|FG000|Overall Study (China Cohort)|Death|10|||
146321979|NCT01844986|527688915|FG001|Overall Study (China Cohort)|Death|6|||
146321980|NCT00865020|527688917|FG000|Overall Study|Withdrawal by Subject|22|||
146321981|NCT00865020|527688918|FG001|Overall Study|Withdrawal by Subject|16|||
146321982|NCT00865020|527688917|FG000|Overall Study|Adverse Event|9|||
146321983|NCT00865020|527688918|FG001|Overall Study|Adverse Event|14|||
146321984|NCT00865020|527688917|FG000|Overall Study|Abnormal test procedure result(s)|6|||
146321985|NCT00865020|527688918|FG001|Overall Study|Abnormal test procedure result(s)|8|||
146321986|NCT00865020|527688917|FG000|Overall Study|Lost to Follow-up|6|||
146321987|NCT00865020|527688918|FG001|Overall Study|Lost to Follow-up|4|||
146321988|NCT00865020|527688917|FG000|Overall Study|Protocol deviation|4|||
146321989|NCT00865020|527688918|FG001|Overall Study|Protocol deviation|1|||
146321990|NCT00865020|527688917|FG000|Overall Study|Administrative problems|0|||
146321991|NCT00865020|527688918|FG001|Overall Study|Administrative problems|2|||
146321992|NCT00865020|527688917|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146321993|NCT00865020|527688918|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146321994|NCT00865020|527688917|FG000|Overall Study|Death|0|||
146164874|NCT00989092|527114368|FG001|Overall Study|Death|2|||
146164875|NCT00989092|527114367|FG000|Overall Study|Ineligibility determined|3|||
146164876|NCT00989092|527114368|FG001|Overall Study|Ineligibility determined|3|||
146164877|NCT00989092|527114367|FG000|Overall Study|Lost to Follow-up|6|||
146164878|NCT00989092|527114368|FG001|Overall Study|Lost to Follow-up|2|||
146164879|NCT00989092|527114367|FG000|Overall Study|Other|3|||
146164880|NCT00989092|527114368|FG001|Overall Study|Other|1|||
146164881|NCT00989092|527114367|FG000|Overall Study|Protocol deviation|2|||
146164882|NCT00989092|527114368|FG001|Overall Study|Protocol deviation|0|||
146164883|NCT00989092|527114367|FG000|Overall Study|Erythropoietin therapy initiated|2|||
146164884|NCT00989092|527114368|FG001|Overall Study|Erythropoietin therapy initiated|0|||
146164885|NCT00989092|527114367|FG000|Overall Study|Did not receive study drug|2|||
146321995|NCT00865020|527688918|FG001|Overall Study|Death|1|||
146321996|NCT00865020|527688917|FG000|Overall Study|Randomized but discontinued|2|||
146164886|NCT00989092|527114368|FG001|Overall Study|Did not receive study drug|0|||
146164887|NCT02832622|527114370|FG000|Overall Study|MPP not programmed|1259|||
146164888|NCT02832622|527114370|FG000|Overall Study|Withdrawal by Subject|123|||
146321997|NCT00865020|527688918|FG001|Overall Study|Randomized but discontinued|4|||
146321998|NCT00930059|527690788|FG000|Overall Study|Death|1|||
146321999|NCT00930059|527690789|FG001|Overall Study|Death|0|||
146322000|NCT00930059|527690788|FG000|Overall Study|Did not meet entrance criteria|1|||
146322001|NCT00930059|527690789|FG001|Overall Study|Did not meet entrance criteria|1|||
146322002|NCT00930059|527690788|FG000|Overall Study|Withdrawal by Subject|3|||
146322003|NCT00930059|527690789|FG001|Overall Study|Withdrawal by Subject|4|||
146322004|NCT00930059|527690788|FG000|Overall Study|Other|1|||
146164889|NCT02832622|527114370|FG000|Overall Study|Death|119|||
146164890|NCT02832622|527114370|FG000|Overall Study|Unsuccessful CRT implant|93|||
146164891|NCT02832622|527114370|FG000|Overall Study|Lost to Follow-up|45|||
146164892|NCT02832622|527114370|FG000|Overall Study|Patient non-compliance|42|||
146164893|NCT02832622|527114370|FG000|Overall Study|Withdrawal by other reasons|25|||
146164894|NCT02832622|527114370|FG000|Overall Study|System explant|24|||
146164895|NCT02832622|527114370|FG000|Overall Study|Physician Decision|6|||
146164896|NCT02127372|527114371|FG000|Overall Study|Withdrawal by Subject|1|||
146164897|NCT02127372|527114372|FG001|Overall Study|Withdrawal by Subject|0|||
146164898|NCT00594854|527114375|FG000|Overall Study|Study terminated|7|||
146322005|NCT00930059|527690789|FG001|Overall Study|Other|0|||
146322006|NCT00930059|527690788|FG000|Overall Study|1 site terminated by sponsor|1|||
146322007|NCT00930059|527690789|FG001|Overall Study|1 site terminated by sponsor|1|||
146322008|NCT00930059|527690788|FG000|Overall Study|Adverse Event|1|||
146322009|NCT00930059|527690789|FG001|Overall Study|Adverse Event|6|||
146322010|NCT03064763|527690790|FG000|Overall Study|Lost to Follow-up|1|||
146322011|NCT03064763|527690790|FG000|Overall Study|Death|8|||
146322012|NCT02397473|527690793|FG000|Treatment Phase|Adverse Event|1|||
146322013|NCT02397473|527690794|FG001|Treatment Phase|Adverse Event|2|||
146322014|NCT02397473|527690793|FG000|Treatment Phase|Lack of Efficacy|8|||
146322015|NCT02397473|527690794|FG001|Treatment Phase|Lack of Efficacy|1|||
146322016|NCT02397473|527690793|FG000|Treatment Phase|Lost to Follow-up|1|||
146322017|NCT02397473|527690794|FG001|Treatment Phase|Lost to Follow-up|0|||
146322018|NCT02397473|527690793|FG000|Treatment Phase|Withdrawal by Subject|2|||
146322019|NCT02397473|527690794|FG001|Treatment Phase|Withdrawal by Subject|1|||
146322020|NCT02397473|527690793|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
146322021|NCT02397473|527690794|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
146322022|NCT02397473|527690793|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
146322023|NCT02397473|527690794|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
146322024|NCT02397473|527690793|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
146322025|NCT02397473|527690794|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
146322026|NCT02397473|527690793|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
146322027|NCT02397473|527690794|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
146322028|NCT02397473|527690793|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
146322029|NCT02397473|527690794|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
146322030|NCT01337973|527690795|FG000|Overall Study|Lost to Follow-up|2|||
146322031|NCT01337973|527690796|FG001|Overall Study|Lost to Follow-up|4|||
146322032|NCT01337973|527690797|FG002|Overall Study|Lost to Follow-up|3|||
146322033|NCT01337973|527690795|FG000|Overall Study|Death|1|||
146322034|NCT01337973|527690796|FG001|Overall Study|Death|2|||
146322035|NCT01337973|527690797|FG002|Overall Study|Death|1|||
146322036|NCT01337973|527690795|FG000|Overall Study|Withdrawal by Subject|10|||
146322037|NCT01337973|527690796|FG001|Overall Study|Withdrawal by Subject|8|||
146322038|NCT01337973|527690797|FG002|Overall Study|Withdrawal by Subject|4|||
146322039|NCT01337973|527690795|FG000|Overall Study|missing data on primary outcome|3|||
146322040|NCT01337973|527690796|FG001|Overall Study|missing data on primary outcome|1|||
146322041|NCT01337973|527690797|FG002|Overall Study|missing data on primary outcome|3|||
146322042|NCT01001702|527690801|FG000|Overall Study|Lost to Follow-up|7|||
146322043|NCT01001702|527690801|FG000|Overall Study|Adverse Event|7|||
146322044|NCT01001702|527690801|FG000|Overall Study|Sponsor Discontinued Study|4|||
146322045|NCT01001702|527690801|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
146322046|NCT01001702|527690801|FG000|Overall Study|Investigator withdrew Subject|10|||
146322047|NCT01001702|527690801|FG000|Overall Study|Withdrawal by Subject|19|||
146322048|NCT01001702|527690801|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
146322049|NCT02494596|527690804|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146322050|NCT02494596|527690805|FG001|Overall Study|Insufficient Therapeutic Response|3|||
146322051|NCT02494596|527690806|FG002|Overall Study|Insufficient Therapeutic Response|1|||
146322052|NCT02494596|527690804|FG000|Overall Study|Adverse Event|0|||
146322053|NCT02494596|527690805|FG001|Overall Study|Adverse Event|1|||
146322054|NCT02494596|527690806|FG002|Overall Study|Adverse Event|0|||
146322055|NCT02494596|527690804|FG000|Overall Study|Refused Treatment|0|||
146164899|NCT00594854|527114376|FG001|Overall Study|Study terminated|10|||
146164900|NCT03292146|527114379|FG000|Baseline to 12 months|Relocation|1|||
146164901|NCT03292146|527114380|FG001|Baseline to 12 months|Relocation|0|||
146322056|NCT02494596|527690805|FG001|Overall Study|Refused Treatment|1|||
146322057|NCT02494596|527690806|FG002|Overall Study|Refused Treatment|0|||
146322058|NCT00634569|527690809|FG000|Overall Study|Withdrawal by Subject|0|||
146322059|NCT00634569|527690810|FG001|Overall Study|Withdrawal by Subject|4|||
146322060|NCT00634569|527690809|FG000|Overall Study|Physician Decision|0|||
146322061|NCT00634569|527690810|FG001|Overall Study|Physician Decision|1|||
146322062|NCT01163786|527690811|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
146322063|NCT01163786|527690811|FG000|Treatment With Bortezomib|Adverse Event|2|||
146322064|NCT01163786|527690811|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
146322065|NCT01212185|527690812|FG000|Overall Study|Protocol Violation|2|||
146322066|NCT01212185|527690813|FG001|Overall Study|Protocol Violation|1|||
146322067|NCT03021642|527690814|FG000|Washout Period (21 Days)|Adverse Event|1|||
146322068|NCT03021642|527690815|FG001|Washout Period (21 Days)|Adverse Event|1|||
146164902|NCT03292146|527114379|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
146164903|NCT03292146|527114380|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
146164904|NCT03292146|527114379|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
146164905|NCT03292146|527114380|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
146322069|NCT00090545|527690819|FG000|Overall Study|Disease progression on study|21|||
146322070|NCT00090545|527690820|FG001|Overall Study|Disease progression on study|17|||
146322071|NCT00090545|527690819|FG000|Overall Study|Refused further treatment|1|||
146322072|NCT00090545|527690820|FG001|Overall Study|Refused further treatment|4|||
146322073|NCT00090545|527690819|FG000|Overall Study|Death|0|||
146322074|NCT00090545|527690820|FG001|Overall Study|Death|1|||
146322075|NCT00090545|527690819|FG000|Overall Study|Adverse Event|0|||
146322076|NCT00090545|527690820|FG001|Overall Study|Adverse Event|2|||
146322077|NCT01463098|527690823|FG000|Part A (11 Days)|Participant Choice|2|||
146322078|NCT01463098|527690824|FG001|Part A (11 Days)|Participant Choice|0|||
146322079|NCT01463098|527690825|FG002|Part A (11 Days)|Participant Choice|0|||
146322080|NCT01463098|527690826|FG003|Part A (11 Days)|Participant Choice|0|||
146322081|NCT01463098|527690827|FG004|Part A (11 Days)|Participant Choice|0|||
146322082|NCT01463098|527690828|FG005|Part A (11 Days)|Participant Choice|0|||
146322083|NCT01463098|527690829|FG006|Part A (11 Days)|Participant Choice|0|||
146322084|NCT01463098|527690830|FG007|Part A (11 Days)|Participant Choice|0|||
146322085|NCT01463098|527690831|FG008|Part A (11 Days)|Participant Choice|1|||
146322086|NCT01463098|527690832|FG009|Part A (11 Days)|Participant Choice|0|||
146322087|NCT01463098|527690833|FG010|Part A (11 Days)|Participant Choice|0|||
146322088|NCT01463098|527690834|FG011|Part A (11 Days)|Participant Choice|0|||
146322089|NCT01463098|527690835|FG012|Part A (11 Days)|Participant Choice|0|||
146322090|NCT01463098|527690836|FG013|Part A (11 Days)|Participant Choice|0|||
146322091|NCT01463098|527690823|FG000|Part A (11 Days)|Lost to Follow-up|0|||
146322092|NCT01463098|527690824|FG001|Part A (11 Days)|Lost to Follow-up|0|||
146322093|NCT01463098|527690825|FG002|Part A (11 Days)|Lost to Follow-up|0|||
146322094|NCT01463098|527690826|FG003|Part A (11 Days)|Lost to Follow-up|0|||
146322095|NCT01463098|527690827|FG004|Part A (11 Days)|Lost to Follow-up|1|||
146322096|NCT01463098|527690828|FG005|Part A (11 Days)|Lost to Follow-up|0|||
146322097|NCT01463098|527690829|FG006|Part A (11 Days)|Lost to Follow-up|0|||
146322098|NCT01463098|527690830|FG007|Part A (11 Days)|Lost to Follow-up|0|||
146322099|NCT01463098|527690831|FG008|Part A (11 Days)|Lost to Follow-up|0|||
146322100|NCT01463098|527690832|FG009|Part A (11 Days)|Lost to Follow-up|0|||
146322101|NCT01463098|527690833|FG010|Part A (11 Days)|Lost to Follow-up|0|||
146322102|NCT01463098|527690834|FG011|Part A (11 Days)|Lost to Follow-up|0|||
146322103|NCT01463098|527690835|FG012|Part A (11 Days)|Lost to Follow-up|0|||
146322104|NCT01463098|527690836|FG013|Part A (11 Days)|Lost to Follow-up|0|||
146322105|NCT01463098|527690823|FG000|Part B (11 Days)|Participant Choice|0|||
146322106|NCT01463098|527690824|FG001|Part B (11 Days)|Participant Choice|0|||
146322107|NCT01463098|527690825|FG002|Part B (11 Days)|Participant Choice|0|||
146322108|NCT01463098|527690826|FG003|Part B (11 Days)|Participant Choice|0|||
146322109|NCT01463098|527690827|FG004|Part B (11 Days)|Participant Choice|0|||
146322110|NCT01463098|527690828|FG005|Part B (11 Days)|Participant Choice|0|||
146322111|NCT01463098|527690829|FG006|Part B (11 Days)|Participant Choice|0|||
146322112|NCT01463098|527690830|FG007|Part B (11 Days)|Participant Choice|0|||
146322113|NCT01463098|527690831|FG008|Part B (11 Days)|Participant Choice|0|||
146322114|NCT01463098|527690832|FG009|Part B (11 Days)|Participant Choice|0|||
146322115|NCT01463098|527690833|FG010|Part B (11 Days)|Participant Choice|0|||
146322116|NCT01463098|527690834|FG011|Part B (11 Days)|Participant Choice|1|||
146322117|NCT01463098|527690835|FG012|Part B (11 Days)|Participant Choice|0|||
146322118|NCT01463098|527690836|FG013|Part B (11 Days)|Participant Choice|0|||
146322119|NCT02568046|527690837|FG000|Overall Study|Adverse Event|0|||
146322120|NCT02568046|527690838|FG001|Overall Study|Adverse Event|1|||
146322121|NCT02568046|527690837|FG000|Overall Study|Death|2|||
146322122|NCT02568046|527690838|FG001|Overall Study|Death|0|||
146322123|NCT02568046|527690837|FG000|Overall Study|Progressive Disease|1|||
146322124|NCT02568046|527690838|FG001|Overall Study|Progressive Disease|0|||
146322125|NCT02568046|527690837|FG000|Overall Study|Withdrawal by Subject|2|||
146322126|NCT02568046|527690838|FG001|Overall Study|Withdrawal by Subject|1|||
146322127|NCT02568046|527690837|FG000|Overall Study|Other Events|0|||
146322128|NCT02568046|527690838|FG001|Overall Study|Other Events|1|||
146322129|NCT02809833|527690839|FG000|Overall Study|Death|3|||
146322130|NCT02809833|527690839|FG000|Overall Study|Intolerance|54|||
146322131|NCT02809833|527690839|FG000|Overall Study|Lack of Efficacy|89|||
146322132|NCT02809833|527690839|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
146322133|NCT02809833|527690839|FG000|Overall Study|Noncompliance|1|||
146322134|NCT02809833|527690839|FG000|Overall Study|Withdrawal by Subject|34|||
146322135|NCT02809833|527690839|FG000|Overall Study|Lost to Follow-up|35|||
146322136|NCT02809833|527690839|FG000|Overall Study|Adverse Event (AE)|24|||
146322137|NCT02809833|527690839|FG000|Overall Study|Other|5|||
146322138|NCT02809833|527690839|FG000|Overall Study|Missing Information|52|||
146322139|NCT00523991|527690840|FG000|Overall Study|Adverse Event|6|||
146322140|NCT00523991|527690841|FG001|Overall Study|Adverse Event|5|||
146322141|NCT00523991|527690840|FG000|Overall Study|Protocol Violation|1|||
146322142|NCT00523991|527690841|FG001|Overall Study|Protocol Violation|4|||
146322143|NCT00523991|527690840|FG000|Overall Study|Lost to Follow-up|4|||
146322144|NCT00523991|527690841|FG001|Overall Study|Lost to Follow-up|1|||
146322145|NCT00523991|527690840|FG000|Overall Study|Withdrawal by Subject|7|||
146322146|NCT00523991|527690841|FG001|Overall Study|Withdrawal by Subject|17|||
146322147|NCT00523991|527690840|FG000|Overall Study|Other reason (not specified)|3|||
146322148|NCT00523991|527690841|FG001|Overall Study|Other reason (not specified)|0|||
146322149|NCT00193063|527690842|FG000|Overall Study|Lack of Efficacy|3|||
146322150|NCT00193063|527690842|FG000|Overall Study|Adverse Event|1|||
146322151|NCT01700192|527690843|FG000|Overall Study|Adverse Event|73|||
146322152|NCT01700192|527690844|FG001|Overall Study|Adverse Event|18|||
146322153|NCT01700192|527690843|FG000|Overall Study|Lack of Efficacy|1|||
146322154|NCT01700192|527690844|FG001|Overall Study|Lack of Efficacy|0|||
146322155|NCT01700192|527690843|FG000|Overall Study|Lost to Follow-up|42|||
146322156|NCT01700192|527690844|FG001|Overall Study|Lost to Follow-up|29|||
146322157|NCT01700192|527690843|FG000|Overall Study|Noncompliance with study drug|0|||
146322158|NCT01700192|527690844|FG001|Overall Study|Noncompliance with study drug|5|||
146322159|NCT01700192|527690843|FG000|Overall Study|Physician Decision|2|||
146322160|NCT01700192|527690844|FG001|Overall Study|Physician Decision|3|||
146322161|NCT01700192|527690843|FG000|Overall Study|Pregnancy|1|||
146322162|NCT01700192|527690844|FG001|Overall Study|Pregnancy|4|||
146322163|NCT01700192|527690843|FG000|Overall Study|Progressive disease|1|||
146322164|NCT01700192|527690844|FG001|Overall Study|Progressive disease|0|||
146322165|NCT01700192|527690843|FG000|Overall Study|Protocol Violation|3|||
146322166|NCT01700192|527690844|FG001|Overall Study|Protocol Violation|4|||
146322167|NCT01700192|527690843|FG000|Overall Study|Technical problems|0|||
146322168|NCT01700192|527690844|FG001|Overall Study|Technical problems|1|||
146322169|NCT01700192|527690843|FG000|Overall Study|Withdrawal by Subject|56|||
146322170|NCT01700192|527690844|FG001|Overall Study|Withdrawal by Subject|64|||
146322171|NCT01700192|527690843|FG000|Overall Study|Never received study drug|1|||
146322172|NCT01700192|527690844|FG001|Overall Study|Never received study drug|0|||
146322173|NCT01127165|527690849|FG000|Overall Study|Adverse Event|2|||
146322174|NCT01127165|527690850|FG001|Overall Study|Adverse Event|2|||
146322175|NCT01127165|527690849|FG000|Overall Study|Lack of Efficacy|10|||
146322176|NCT01127165|527690850|FG001|Overall Study|Lack of Efficacy|8|||
146322177|NCT01127165|527690849|FG000|Overall Study|Lost to Follow-up|3|||
146322178|NCT01127165|527690850|FG001|Overall Study|Lost to Follow-up|5|||
146322179|NCT01127165|527690849|FG000|Overall Study|Withdrawal by Subject|1|||
146322180|NCT01127165|527690850|FG001|Overall Study|Withdrawal by Subject|3|||
146322181|NCT01127165|527690849|FG000|Overall Study|Protocol Violation|0|||
146322182|NCT01127165|527690850|FG001|Overall Study|Protocol Violation|1|||
146322183|NCT00379795|527690851|FG000|Overall Study|Death|31|||
146322184|NCT00379795|527690852|FG001|Overall Study|Death|8|||
146322185|NCT00379795|527690853|FG002|Overall Study|Death|6|||
146322186|NCT00379795|527690854|FG003|Overall Study|Death|4|||
146322187|NCT00379795|527690855|FG004|Overall Study|Death|7|||
146322188|NCT00379795|527690851|FG000|Overall Study|Adverse Event|17|||
146322189|NCT00379795|527690852|FG001|Overall Study|Adverse Event|3|||
146322190|NCT00379795|527690853|FG002|Overall Study|Adverse Event|3|||
146322191|NCT00379795|527690854|FG003|Overall Study|Adverse Event|1|||
146322192|NCT00379795|527690855|FG004|Overall Study|Adverse Event|4|||
146322193|NCT00379795|527690851|FG000|Overall Study|Lost to Follow-up|8|||
146322194|NCT00379795|527690852|FG001|Overall Study|Lost to Follow-up|1|||
146322195|NCT00379795|527690853|FG002|Overall Study|Lost to Follow-up|2|||
146322196|NCT00379795|527690854|FG003|Overall Study|Lost to Follow-up|1|||
146322197|NCT00379795|527690855|FG004|Overall Study|Lost to Follow-up|4|||
146322198|NCT00379795|527690851|FG000|Overall Study|Physician Decision|25|||
146322199|NCT00379795|527690852|FG001|Overall Study|Physician Decision|0|||
146322200|NCT00379795|527690853|FG002|Overall Study|Physician Decision|2|||
146322201|NCT00379795|527690854|FG003|Overall Study|Physician Decision|2|||
146322202|NCT00379795|527690855|FG004|Overall Study|Physician Decision|2|||
146322203|NCT00379795|527690851|FG000|Overall Study|Withdrawal by Subject|94|||
146322204|NCT00379795|527690852|FG001|Overall Study|Withdrawal by Subject|11|||
146322205|NCT00379795|527690853|FG002|Overall Study|Withdrawal by Subject|19|||
146322206|NCT00379795|527690854|FG003|Overall Study|Withdrawal by Subject|7|||
146322207|NCT00379795|527690855|FG004|Overall Study|Withdrawal by Subject|14|||
146322208|NCT00379795|527690851|FG000|Overall Study|Subject non-compliance|7|||
146322209|NCT00379795|527690852|FG001|Overall Study|Subject non-compliance|2|||
146322210|NCT00379795|527690853|FG002|Overall Study|Subject non-compliance|0|||
146322211|NCT00379795|527690854|FG003|Overall Study|Subject non-compliance|0|||
146322212|NCT00379795|527690855|FG004|Overall Study|Subject non-compliance|1|||
146322213|NCT00379795|527690851|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
146322214|NCT00379795|527690852|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146322215|NCT00379795|527690853|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146322216|NCT00379795|527690854|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
146322217|NCT00379795|527690855|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
146322218|NCT00379795|527690851|FG000|Overall Study|Subjects condition mandated intervention|34|||
146322219|NCT00379795|527690852|FG001|Overall Study|Subjects condition mandated intervention|9|||
146322220|NCT00379795|527690853|FG002|Overall Study|Subjects condition mandated intervention|7|||
146322221|NCT00379795|527690854|FG003|Overall Study|Subjects condition mandated intervention|5|||
146322222|NCT00379795|527690855|FG004|Overall Study|Subjects condition mandated intervention|7|||
146322223|NCT00379795|527690851|FG000|Overall Study|Sponsor's decision|257|||
146322224|NCT00379795|527690852|FG001|Overall Study|Sponsor's decision|17|||
146322225|NCT00379795|527690853|FG002|Overall Study|Sponsor's decision|54|||
146322226|NCT00379795|527690854|FG003|Overall Study|Sponsor's decision|47|||
146322227|NCT00379795|527690855|FG004|Overall Study|Sponsor's decision|10|||
146164906|NCT03292146|527114379|FG000|12 months to 24 months|Planning pregnancy|2|||
146164907|NCT03292146|527114380|FG001|12 months to 24 months|Planning pregnancy|2|||
146164908|NCT03292146|527114379|FG000|12 months to 24 months|Personal reasons|1|||
146164909|NCT03292146|527114380|FG001|12 months to 24 months|Personal reasons|0|||
146164910|NCT03292146|527114379|FG000|12 months to 24 months|Lost to Follow-up|0|||
146164911|NCT03292146|527114380|FG001|12 months to 24 months|Lost to Follow-up|1|||
146164912|NCT03039023|527114381|FG000|Overall Study|Withdrawal by Subject|1|||
146322228|NCT00763321|527690856|FG000|Open-label Period|Adverse Event|24|||
146322229|NCT00763321|527690857|FG001|Open-label Period|Adverse Event|0|||
146322230|NCT00763321|527690858|FG002|Open-label Period|Adverse Event|0|||
146322231|NCT00763321|527690856|FG000|Open-label Period|Lost to Follow-up|14|||
146322232|NCT00763321|527690857|FG001|Open-label Period|Lost to Follow-up|0|||
146322233|NCT00763321|527690858|FG002|Open-label Period|Lost to Follow-up|0|||
146322234|NCT00763321|527690856|FG000|Open-label Period|Withdrawal by Subject|7|||
146322235|NCT00763321|527690857|FG001|Open-label Period|Withdrawal by Subject|0|||
146322236|NCT00763321|527690858|FG002|Open-label Period|Withdrawal by Subject|0|||
146322237|NCT00763321|527690856|FG000|Open-label Period|Subject noncompliant|7|||
146322238|NCT00763321|527690857|FG001|Open-label Period|Subject noncompliant|0|||
146322239|NCT00763321|527690858|FG002|Open-label Period|Subject noncompliant|0|||
146322240|NCT00763321|527690856|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
146322241|NCT00763321|527690857|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
146322242|NCT00763321|527690858|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
146322243|NCT00763321|527690856|FG000|Open-label Period|Lack of Efficacy|2|||
146322244|NCT00763321|527690857|FG001|Open-label Period|Lack of Efficacy|0|||
146164913|NCT03039023|527114382|FG001|Overall Study|Withdrawal by Subject|0|||
146164914|NCT03039023|527114383|FG002|Overall Study|Withdrawal by Subject|1|||
146322245|NCT00763321|527690858|FG002|Open-label Period|Lack of Efficacy|0|||
146322246|NCT00763321|527690856|FG000|Open-label Period|Other|4|||
146322247|NCT00763321|527690857|FG001|Open-label Period|Other|0|||
146322248|NCT00763321|527690858|FG002|Open-label Period|Other|0|||
146322249|NCT00763321|527690856|FG000|Double-blind Period|Lack of Efficacy|0|||
146322250|NCT00763321|527690857|FG001|Double-blind Period|Lack of Efficacy|9|||
146322251|NCT00763321|527690858|FG002|Double-blind Period|Lack of Efficacy|17|||
146322252|NCT00763321|527690856|FG000|Double-blind Period|Adverse Event|0|||
146322253|NCT00763321|527690857|FG001|Double-blind Period|Adverse Event|4|||
146322254|NCT00763321|527690858|FG002|Double-blind Period|Adverse Event|4|||
146322255|NCT00763321|527690856|FG000|Double-blind Period|Lost to Follow-up|0|||
146322256|NCT00763321|527690857|FG001|Double-blind Period|Lost to Follow-up|4|||
146322257|NCT00763321|527690858|FG002|Double-blind Period|Lost to Follow-up|2|||
146322258|NCT00763321|527690856|FG000|Double-blind Period|Withdrawal by Subject|0|||
146322259|NCT00763321|527690857|FG001|Double-blind Period|Withdrawal by Subject|2|||
146322260|NCT00763321|527690858|FG002|Double-blind Period|Withdrawal by Subject|3|||
146322261|NCT00763321|527690856|FG000|Double-blind Period|Other|0|||
146322262|NCT00763321|527690857|FG001|Double-blind Period|Other|2|||
146322263|NCT00763321|527690858|FG002|Double-blind Period|Other|3|||
146322264|NCT02435849|527690859|FG000|Overall Study|Death|23|||
146322265|NCT02435849|527690860|FG001|Overall Study|Death|0|||
146322266|NCT02435849|527690859|FG000|Overall Study|Lack of Efficacy|10|||
146322267|NCT02435849|527690860|FG001|Overall Study|Lack of Efficacy|0|||
146322268|NCT02435849|527690859|FG000|Overall Study|New therapy for study indication|8|||
146322269|NCT02435849|527690860|FG001|Overall Study|New therapy for study indication|0|||
146322270|NCT02435849|527690859|FG000|Overall Study|Subject/guardian decision|5|||
146322271|NCT02435849|527690860|FG001|Overall Study|Subject/guardian decision|1|||
146322272|NCT02435849|527690859|FG000|Overall Study|Lost to Follow-up|1|||
146322273|NCT02435849|527690860|FG001|Overall Study|Lost to Follow-up|0|||
146322274|NCT02435849|527690859|FG000|Overall Study|Physician Decision|1|||
146322275|NCT02435849|527690860|FG001|Overall Study|Physician Decision|0|||
146322276|NCT03175549|527690861|FG000|Overall Study|Lost to Follow-up|2|||
146322277|NCT03175549|527690862|FG001|Overall Study|Lost to Follow-up|2|||
146322278|NCT03175549|527690861|FG000|Overall Study|Medication non-compliance|2|||
146322279|NCT03175549|527690862|FG001|Overall Study|Medication non-compliance|2|||
146322280|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
146322281|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146322282|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146322283|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146322284|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146322285|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
146322286|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
146322287|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
146322288|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
146322289|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
146322290|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
146322291|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146322292|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146322293|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146322294|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
146322295|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
146322296|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146322297|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146322298|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146322299|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146322300|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
146322301|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
146322302|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
146322303|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
146322304|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
146322305|NCT01017952|527690863|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
146322306|NCT01017952|527690864|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146322307|NCT01017952|527690865|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146322308|NCT01017952|527690866|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146322309|NCT01017952|527690867|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146322310|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
146322311|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
146322312|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
146322313|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
146322314|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
146322315|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146322316|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
146322317|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
146322318|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
146322319|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
146322320|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146322321|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
146322322|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
146322323|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
146322324|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
146322325|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
146322326|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146322327|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
146322328|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
146322329|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146322330|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146322331|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
146322332|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146322333|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
146322334|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
146322335|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146322336|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146322337|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146322338|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146322339|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146322340|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146322341|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146322342|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
146322343|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146322344|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
146322345|NCT01017952|527690863|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
146322346|NCT01017952|527690864|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
146322347|NCT01017952|527690865|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
146322348|NCT01017952|527690866|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
146322349|NCT01017952|527690867|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
146322350|NCT01064167|527690868|FG000|Overall Study|Protocol Violation|14|||
146322351|NCT01064167|527690869|FG001|Overall Study|Protocol Violation|15|||
146322352|NCT00725075|527690870|FG000|Overall Study|Use of Excluded Medication|0|||
146322353|NCT00725075|527690871|FG001|Overall Study|Use of Excluded Medication|1|||
146322354|NCT00725075|527690872|FG002|Overall Study|Use of Excluded Medication|0|||
146322355|NCT00725075|527690870|FG000|Overall Study|Protocol Violation|0|||
146322356|NCT00725075|527690871|FG001|Overall Study|Protocol Violation|0|||
146322357|NCT00725075|527690872|FG002|Overall Study|Protocol Violation|1|||
146322358|NCT00725075|527690870|FG000|Overall Study|Lost to Follow-up|1|||
146322359|NCT00725075|527690871|FG001|Overall Study|Lost to Follow-up|0|||
146322360|NCT00725075|527690872|FG002|Overall Study|Lost to Follow-up|0|||
146322361|NCT00725075|527690870|FG000|Overall Study|Withdrawal by Subject|4|||
146322362|NCT00725075|527690871|FG001|Overall Study|Withdrawal by Subject|5|||
146322363|NCT00725075|527690872|FG002|Overall Study|Withdrawal by Subject|4|||
146322364|NCT00725075|527690870|FG000|Overall Study|Adverse Event|2|||
146322365|NCT00725075|527690871|FG001|Overall Study|Adverse Event|1|||
146322366|NCT00725075|527690872|FG002|Overall Study|Adverse Event|1|||
146322367|NCT00725075|527690870|FG000|Overall Study|Worsening of Disease|2|||
146322368|NCT00725075|527690871|FG001|Overall Study|Worsening of Disease|1|||
146322369|NCT00725075|527690872|FG002|Overall Study|Worsening of Disease|2|||
146322370|NCT00725075|527690870|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
146322371|NCT00725075|527690871|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146322372|NCT00725075|527690872|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
146322373|NCT00725075|527690870|FG000|Overall Study|Other|1|||
146322374|NCT00725075|527690871|FG001|Overall Study|Other|0|||
146322375|NCT00725075|527690872|FG002|Overall Study|Other|0|||
146322376|NCT03984305|527690874|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
146322377|NCT03984305|527690875|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
146322378|NCT03984305|527690874|FG000|Overall Study|Withdrawal by Subject|3|||
146322379|NCT03984305|527690875|FG001|Overall Study|Withdrawal by Subject|3|||
146322380|NCT03984305|527690874|FG000|Overall Study|Lost to Follow-up|1|||
146322381|NCT03984305|527690875|FG001|Overall Study|Lost to Follow-up|0|||
146322382|NCT01656434|527690876|FG000|Overall Study|Adverse Event|199|||
146322383|NCT01656434|527690877|FG001|Overall Study|Adverse Event|63|||
146322384|NCT01656434|527690876|FG000|Overall Study|Enrollment terminated at trial site|2|||
146322385|NCT01656434|527690877|FG001|Overall Study|Enrollment terminated at trial site|0|||
146322386|NCT01656434|527690876|FG000|Overall Study|Lost to Follow-up|309|||
146322387|NCT01656434|527690877|FG001|Overall Study|Lost to Follow-up|76|||
146322388|NCT01656434|527690876|FG000|Overall Study|Site discontinued study participation|24|||
146322389|NCT01656434|527690877|FG001|Overall Study|Site discontinued study participation|9|||
146322390|NCT01656434|527690876|FG000|Overall Study|Screen failure|2|||
146322391|NCT01656434|527690877|FG001|Overall Study|Screen failure|0|||
146322392|NCT01656434|527690876|FG000|Overall Study|Protocol Violation|7|||
146322393|NCT01656434|527690877|FG001|Overall Study|Protocol Violation|0|||
146322394|NCT01656434|527690876|FG000|Overall Study|Pregnancy wish|18|||
146322395|NCT01656434|527690877|FG001|Overall Study|Pregnancy wish|6|||
146322396|NCT01656434|527690876|FG000|Overall Study|Pregnancy|45|||
146322397|NCT01656434|527690877|FG001|Overall Study|Pregnancy|10|||
146322398|NCT01656434|527690876|FG000|Overall Study|Physician Decision|7|||
146322399|NCT01656434|527690877|FG001|Overall Study|Physician Decision|2|||
146322400|NCT01656434|527690876|FG000|Overall Study|Non-compliance with study drug|48|||
146322401|NCT01656434|527690877|FG001|Overall Study|Non-compliance with study drug|9|||
146322402|NCT01656434|527690876|FG000|Overall Study|Study terminated by sponsor|1501|||
146322403|NCT01656434|527690877|FG001|Overall Study|Study terminated by sponsor|348|||
146322404|NCT01656434|527690876|FG000|Overall Study|Participant discontinued; drug related|13|||
146164915|NCT03039023|527114384|FG003|Overall Study|Withdrawal by Subject|1|||
146164916|NCT03039023|527114385|FG004|Overall Study|Withdrawal by Subject|0|||
146164917|NCT03039023|527114381|FG000|Overall Study|Physician Decision|0|||
146164918|NCT03039023|527114382|FG001|Overall Study|Physician Decision|0|||
146164919|NCT03039023|527114383|FG002|Overall Study|Physician Decision|0|||
146164920|NCT03039023|527114384|FG003|Overall Study|Physician Decision|1|||
146322405|NCT01656434|527690877|FG001|Overall Study|Participant discontinued; drug related|4|||
146322406|NCT01656434|527690876|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
146322407|NCT01656434|527690877|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
146322408|NCT01656434|527690876|FG000|Overall Study|Non-compliance with protocol|39|||
146322409|NCT01656434|527690877|FG001|Overall Study|Non-compliance with protocol|15|||
146322410|NCT01656434|527690876|FG000|Overall Study|Participant moved|40|||
146322411|NCT01656434|527690877|FG001|Overall Study|Participant moved|12|||
146322412|NCT01656434|527690876|FG000|Overall Study|Participant withdrew consent|28|||
146322413|NCT01656434|527690877|FG001|Overall Study|Participant withdrew consent|9|||
146322414|NCT01656434|527690876|FG000|Overall Study|Withdrawal by Subject|64|||
146322415|NCT01656434|527690877|FG001|Overall Study|Withdrawal by Subject|7|||
146322416|NCT01235962|527690878|FG000|Overall Study|Withdrawal by Subject|20|||
146164921|NCT03039023|527114385|FG004|Overall Study|Physician Decision|0|||
146322417|NCT01235962|527690879|FG001|Overall Study|Withdrawal by Subject|19|||
146322418|NCT01235962|527690880|FG002|Overall Study|Withdrawal by Subject|62|||
146322419|NCT01235962|527690881|FG003|Overall Study|Withdrawal by Subject|49|||
146322420|NCT01235962|527690878|FG000|Overall Study|Lost to Follow-up|21|||
146322421|NCT01235962|527690879|FG001|Overall Study|Lost to Follow-up|16|||
146322422|NCT01235962|527690880|FG002|Overall Study|Lost to Follow-up|47|||
146322423|NCT01235962|527690881|FG003|Overall Study|Lost to Follow-up|32|||
146322424|NCT01235962|527690878|FG000|Overall Study|Physician Decision|5|||
146164922|NCT03701399|527114388|FG000|Overall Study|Adverse Event|3|||
146164923|NCT03701399|527114389|FG001|Overall Study|Adverse Event|5|||
146164924|NCT03701399|527114388|FG000|Overall Study|Withdrawal by Subject|6|||
146164925|NCT03701399|527114389|FG001|Overall Study|Withdrawal by Subject|3|||
146322425|NCT01235962|527690879|FG001|Overall Study|Physician Decision|0|||
146322426|NCT01235962|527690880|FG002|Overall Study|Physician Decision|9|||
146322427|NCT01235962|527690881|FG003|Overall Study|Physician Decision|5|||
146322428|NCT06098729|527690891|FG000|Overall Study|Withdrawal by Subject|1|||
146322429|NCT00993928|527690900|FG000|Overall Study|Withdrawal by Subject|4|||
146322430|NCT00993928|527690901|FG001|Overall Study|Withdrawal by Subject|7|||
146322431|NCT00993928|527690900|FG000|Overall Study|ineligible|1|||
146322432|NCT00993928|527690901|FG001|Overall Study|ineligible|0|||
146322433|NCT01060059|527690902|FG000|Overall Study|Adverse Event|1|||
146322434|NCT01060059|527690903|FG001|Overall Study|Adverse Event|1|||
146322435|NCT01060059|527690902|FG000|Overall Study|Death|2|||
146322436|NCT01060059|527690903|FG001|Overall Study|Death|3|||
146322437|NCT01060059|527690902|FG000|Overall Study|Lost to Follow-up|18|||
146322438|NCT01060059|527690903|FG001|Overall Study|Lost to Follow-up|34|||
146322439|NCT01060059|527690902|FG000|Overall Study|entry criteria not met|4|||
146322440|NCT01060059|527690903|FG001|Overall Study|entry criteria not met|3|||
146322441|NCT01060059|527690902|FG000|Overall Study|Withdrawal by Subject|35|||
146322442|NCT01060059|527690903|FG001|Overall Study|Withdrawal by Subject|23|||
146322443|NCT01060059|527690902|FG000|Overall Study|lack of glycemic control|2|||
146322444|NCT01060059|527690903|FG001|Overall Study|lack of glycemic control|1|||
146322445|NCT01060059|527690902|FG000|Overall Study|lack of compliance|5|||
146322446|NCT01060059|527690903|FG001|Overall Study|lack of compliance|2|||
146322447|NCT02302963|527690904|FG000|Overall Study|Withdrawal by Subject|2|||
146322448|NCT02302963|527690905|FG001|Overall Study|Withdrawal by Subject|1|||
146322449|NCT02302963|527690904|FG000|Overall Study|Steroid injection|0|||
146322450|NCT02302963|527690905|FG001|Overall Study|Steroid injection|1|||
146322451|NCT02302963|527690904|FG000|Overall Study|Physician Decision|1|||
146322452|NCT02302963|527690905|FG001|Overall Study|Physician Decision|0|||
146322453|NCT03891901|527690910|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
146322454|NCT03891901|527690911|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322455|NCT03891901|527690912|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322456|NCT03891901|527690913|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322457|NCT03891901|527690914|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322458|NCT03891901|527690915|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322459|NCT03891901|527690916|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322460|NCT03891901|527690917|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322461|NCT03891901|527690918|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
146322462|NCT03891901|527690910|FG000|Overall Study|Adverse Event|2|||
146322463|NCT03891901|527690911|FG001|Overall Study|Adverse Event|2|||
146322464|NCT03891901|527690912|FG002|Overall Study|Adverse Event|0|||
146322465|NCT03891901|527690913|FG003|Overall Study|Adverse Event|0|||
146322466|NCT03891901|527690914|FG004|Overall Study|Adverse Event|0|||
146322467|NCT03891901|527690915|FG005|Overall Study|Adverse Event|0|||
146322468|NCT03891901|527690916|FG006|Overall Study|Adverse Event|0|||
146322469|NCT03891901|527690917|FG007|Overall Study|Adverse Event|0|||
146322470|NCT03891901|527690918|FG008|Overall Study|Adverse Event|0|||
146322471|NCT03891901|527690910|FG000|Overall Study|Poor venous access|1|||
146322472|NCT03891901|527690911|FG001|Overall Study|Poor venous access|0|||
146322473|NCT03891901|527690912|FG002|Overall Study|Poor venous access|0|||
146322474|NCT03891901|527690913|FG003|Overall Study|Poor venous access|0|||
146322475|NCT03891901|527690914|FG004|Overall Study|Poor venous access|0|||
146322476|NCT03891901|527690915|FG005|Overall Study|Poor venous access|0|||
146322477|NCT03891901|527690916|FG006|Overall Study|Poor venous access|0|||
146322478|NCT03891901|527690917|FG007|Overall Study|Poor venous access|0|||
146322479|NCT03891901|527690918|FG008|Overall Study|Poor venous access|0|||
146322480|NCT03891901|527690910|FG000|Overall Study|Withdrawal by Subject|0|||
145943230|NCT00483704|526300456|FG000|Treatment|Lost to Follow-up|2|||
146322481|NCT03891901|527690911|FG001|Overall Study|Withdrawal by Subject|2|||
146322482|NCT03891901|527690912|FG002|Overall Study|Withdrawal by Subject|0|||
146322483|NCT03891901|527690913|FG003|Overall Study|Withdrawal by Subject|0|||
146322484|NCT03891901|527690914|FG004|Overall Study|Withdrawal by Subject|0|||
146322485|NCT03891901|527690915|FG005|Overall Study|Withdrawal by Subject|0|||
146322486|NCT03891901|527690916|FG006|Overall Study|Withdrawal by Subject|0|||
146322487|NCT03891901|527690917|FG007|Overall Study|Withdrawal by Subject|0|||
146322488|NCT03891901|527690918|FG008|Overall Study|Withdrawal by Subject|0|||
146322489|NCT05702736|527690923|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
146322490|NCT05702736|527690924|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
146322491|NCT05702736|527690923|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
146322492|NCT05702736|527690924|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
146322493|NCT03110900|527690927|FG000|Overall Study|Sponsor withdrew|1|||
146322494|NCT03110900|527690928|FG001|Overall Study|Sponsor withdrew|1|||
146322495|NCT03355300|527690929|FG000|Overall Study|Physician Decision|0|||
146322496|NCT03355300|527690930|FG001|Overall Study|Physician Decision|1|||
146322497|NCT03355300|527690929|FG000|Overall Study|Lack of Efficacy|2|||
146322498|NCT03355300|527690930|FG001|Overall Study|Lack of Efficacy|1|||
146322499|NCT03355300|527690929|FG000|Overall Study|Other reason|1|||
146322500|NCT03355300|527690930|FG001|Overall Study|Other reason|0|||
146322501|NCT00546052|527690931|FG000|Overall Study|Adverse Event|47|||
146322502|NCT00546052|527690931|FG000|Overall Study|Lost to Follow-up|144|||
146322503|NCT00546052|527690931|FG000|Overall Study|Protocol Violation|9|||
146322504|NCT00546052|527690931|FG000|Overall Study|Withdrawal by Subject|20|||
146322505|NCT00546052|527690931|FG000|Overall Study|Non Compliance|7|||
146322506|NCT01031446|527690933|FG000|Overall Study|Disease Progression|38|||
146322507|NCT01031446|527690933|FG000|Overall Study|Adverse Event|9|||
146322508|NCT01031446|527690933|FG000|Overall Study|Physician Decision|4|||
146322509|NCT01031446|527690933|FG000|Overall Study|Withdrawal by Subject|3|||
146322510|NCT01031446|527690933|FG000|Overall Study|Still on treatment|1|||
146322511|NCT00500682|527690934|FG000|Overall Study|Adverse Event|37|||
146322512|NCT00500682|527690935|FG001|Overall Study|Adverse Event|29|||
146322513|NCT00500682|527690934|FG000|Overall Study|Death|25|||
146322514|NCT00500682|527690935|FG001|Overall Study|Death|16|||
146322515|NCT00500682|527690934|FG000|Overall Study|Lost to Follow-up|11|||
146322516|NCT00500682|527690935|FG001|Overall Study|Lost to Follow-up|11|||
146322517|NCT00500682|527690934|FG000|Overall Study|Physician Decision|6|||
146322518|NCT00500682|527690935|FG001|Overall Study|Physician Decision|10|||
146322519|NCT00500682|527690934|FG000|Overall Study|Pregnancy|2|||
146322520|NCT00500682|527690935|FG001|Overall Study|Pregnancy|0|||
146322521|NCT00500682|527690934|FG000|Overall Study|Protocol Violation|1|||
146322522|NCT00500682|527690935|FG001|Overall Study|Protocol Violation|3|||
146322523|NCT00500682|527690934|FG000|Overall Study|Withdrawal by Subject|80|||
146322524|NCT00500682|527690935|FG001|Overall Study|Withdrawal by Subject|74|||
146322525|NCT00500682|527690934|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
146322526|NCT00500682|527690935|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
146322527|NCT02531646|527690936|FG000|Overall Study|equip. image processing issue|5|||
146322528|NCT02531646|527690937|FG001|Overall Study|equip. image processing issue|1|||
146322529|NCT02531646|527690938|FG002|Overall Study|equip. image processing issue|0|||
146322530|NCT03344003|527690939|FG000|Overall Study|Switched to alternative treatment|1|||
146322531|NCT03344003|527690940|FG001|Overall Study|Switched to alternative treatment|0|||
146322532|NCT03344003|527690939|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
146322533|NCT03344003|527690940|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
146322534|NCT00684957|527690949|FG000|Overall Study|Withdrawal by Subject|1|||
146322535|NCT00684957|527690950|FG001|Overall Study|Withdrawal by Subject|1|||
146322536|NCT00684957|527690949|FG000|Overall Study|Lost to Follow-up|1|||
146322537|NCT00684957|527690950|FG001|Overall Study|Lost to Follow-up|0|||
146322538|NCT04484285|527692325|FG000|Overall Study|Unable to operate stimulator|3|||
146322539|NCT04484285|527692326|FG001|Overall Study|Unable to operate stimulator|0|||
146322540|NCT01227902|527692328|FG000|Overall Study|Adverse Event|12|||
146322541|NCT01227902|527692329|FG001|Overall Study|Adverse Event|8|||
146322542|NCT01227902|527692330|FG002|Overall Study|Adverse Event|11|||
146322543|NCT01227902|527692331|FG003|Overall Study|Adverse Event|4|||
146322544|NCT01227902|527692328|FG000|Overall Study|Lack of Efficacy|1|||
146322545|NCT01227902|527692329|FG001|Overall Study|Lack of Efficacy|2|||
146322546|NCT01227902|527692330|FG002|Overall Study|Lack of Efficacy|2|||
146322547|NCT01227902|527692331|FG003|Overall Study|Lack of Efficacy|1|||
146322548|NCT01227902|527692328|FG000|Overall Study|Protocol Violation|1|||
146322549|NCT01227902|527692329|FG001|Overall Study|Protocol Violation|0|||
146164926|NCT03701399|527114388|FG000|Overall Study|Investigators decision|1|||
146322550|NCT01227902|527692330|FG002|Overall Study|Protocol Violation|0|||
146322551|NCT01227902|527692331|FG003|Overall Study|Protocol Violation|0|||
146322552|NCT01227902|527692328|FG000|Overall Study|Lost to Follow-up|0|||
146322553|NCT01227902|527692329|FG001|Overall Study|Lost to Follow-up|0|||
146322554|NCT01227902|527692330|FG002|Overall Study|Lost to Follow-up|1|||
146322555|NCT01227902|527692331|FG003|Overall Study|Lost to Follow-up|2|||
146322556|NCT01227902|527692328|FG000|Overall Study|Physician Decision|0|||
146322557|NCT01227902|527692329|FG001|Overall Study|Physician Decision|1|||
146322558|NCT01227902|527692330|FG002|Overall Study|Physician Decision|1|||
146322559|NCT01227902|527692331|FG003|Overall Study|Physician Decision|0|||
146322560|NCT01227902|527692328|FG000|Overall Study|Withdrawal by Subject|4|||
146322561|NCT01227902|527692329|FG001|Overall Study|Withdrawal by Subject|2|||
146322562|NCT01227902|527692330|FG002|Overall Study|Withdrawal by Subject|4|||
146322563|NCT01227902|527692331|FG003|Overall Study|Withdrawal by Subject|3|||
146322564|NCT05280756|527692332|FG000|Overall Study|Lost to Follow-up|1|||
146322565|NCT05280756|527692333|FG001|Overall Study|Lost to Follow-up|1|||
146322566|NCT02363478|527692334|FG000|Overall Study|Lost to Follow-up|4|||
146322567|NCT02363478|527692334|FG000|Overall Study|Adverse Event|4|||
146322568|NCT00768898|527692335|FG000|Overall Study|Unrelated injury|1|||
146322569|NCT00768898|527692335|FG000|Overall Study|Headache|1|||
146322570|NCT02527707|527692336|FG000|Overall Study|Adverse Event|1|||
146322571|NCT02527707|527692336|FG000|Overall Study|Adverse Event|1|||
146322572|NCT04002310|527692337|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
146322573|NCT04002310|527692338|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
146322574|NCT04002310|527692339|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
146322575|NCT04002310|527692340|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
146322576|NCT04002310|527692341|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
146322577|NCT00542997|527692342|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
146322578|NCT00542997|527692342|FG000|Wash in / Wash Out Period|Adverse Event|3|||
146322579|NCT00542997|527692342|FG000|Efficacy Period|Adverse Event|3|||
146322580|NCT00352534|527692343|FG000|Initial Staging|Ineligible|8|||
146322581|NCT00352534|527692344|FG001|Initial Staging|Ineligible|9|||
146322582|NCT00352534|527692345|FG002|Initial Staging|Ineligible|0|||
146322583|NCT00352534|527692346|FG003|Initial Staging|Ineligible|0|||
146322584|NCT00352534|527692347|FG004|Initial Staging|Ineligible|0|||
146322585|NCT00352534|527692348|FG005|Initial Staging|Ineligible|0|||
146322586|NCT00352534|527692349|FG006|Initial Staging|Ineligible|0|||
146322587|NCT00352534|527692343|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
146322588|NCT00352534|527692344|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
146322589|NCT00352534|527692345|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
146164927|NCT03701399|527114389|FG001|Overall Study|Investigators decision|2|||
146164928|NCT03701399|527114388|FG000|Overall Study|Lost to Follow-up|1|||
146164929|NCT03701399|527114389|FG001|Overall Study|Lost to Follow-up|2|||
146164930|NCT03701399|527114388|FG000|Overall Study|Death|1|||
146164931|NCT03701399|527114389|FG001|Overall Study|Death|1|||
146164932|NCT03701399|527114388|FG000|Overall Study|Randomized but not treated|1|||
146164933|NCT03701399|527114389|FG001|Overall Study|Randomized but not treated|0|||
146164934|NCT00448448|527114390|FG000|Overall Study|Withdrawal by Subject|13|||
146164935|NCT00448448|527114391|FG001|Overall Study|Withdrawal by Subject|2|||
146164936|NCT00448448|527114390|FG000|Overall Study|On protocol when study ended|83|||
146164937|NCT00448448|527114391|FG001|Overall Study|On protocol when study ended|36|||
146164938|NCT00448448|527114390|FG000|Overall Study|Lost to Follow-up|2|||
146164939|NCT00448448|527114391|FG001|Overall Study|Lost to Follow-up|1|||
146164940|NCT00448448|527114390|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
146164941|NCT00448448|527114391|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
146164942|NCT00448448|527114390|FG000|Overall Study|Signed consent lost|0|||
146164943|NCT00448448|527114391|FG001|Overall Study|Signed consent lost|1|||
146322590|NCT00352534|527692346|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
146322591|NCT00352534|527692347|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
146322592|NCT00352534|527692348|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
146322593|NCT00352534|527692349|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
146322594|NCT00352534|527692343|FG000|Final Risk Group Assignment|Physician Decision|0|||
146322595|NCT00352534|527692344|FG001|Final Risk Group Assignment|Physician Decision|0|||
146322596|NCT00352534|527692345|FG002|Final Risk Group Assignment|Physician Decision|0|||
146322597|NCT00352534|527692346|FG003|Final Risk Group Assignment|Physician Decision|0|||
146322598|NCT00352534|527692347|FG004|Final Risk Group Assignment|Physician Decision|0|||
146322599|NCT00352534|527692348|FG005|Final Risk Group Assignment|Physician Decision|8|||
146322600|NCT00352534|527692349|FG006|Final Risk Group Assignment|Physician Decision|0|||
146322601|NCT00352534|527692343|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322602|NCT00352534|527692344|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322603|NCT00352534|527692345|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322604|NCT00352534|527692346|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322605|NCT00352534|527692347|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322606|NCT00352534|527692348|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
146322607|NCT00352534|527692349|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
146322608|NCT00352534|527692343|FG000|Final Risk Group Assignment|Ineligible|0|||
146322609|NCT00352534|527692344|FG001|Final Risk Group Assignment|Ineligible|0|||
146322610|NCT00352534|527692345|FG002|Final Risk Group Assignment|Ineligible|3|||
146322611|NCT00352534|527692346|FG003|Final Risk Group Assignment|Ineligible|1|||
146322612|NCT00352534|527692347|FG004|Final Risk Group Assignment|Ineligible|0|||
146322613|NCT00352534|527692348|FG005|Final Risk Group Assignment|Ineligible|13|||
146322614|NCT00352534|527692349|FG006|Final Risk Group Assignment|Ineligible|0|||
146322615|NCT00352534|527692343|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322616|NCT00352534|527692344|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322617|NCT00352534|527692345|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322618|NCT00352534|527692346|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322619|NCT00352534|527692347|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322620|NCT00352534|527692348|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
146322621|NCT00352534|527692349|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
146322622|NCT00352534|527692343|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322623|NCT00352534|527692344|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322624|NCT00352534|527692345|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322625|NCT00352534|527692346|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322626|NCT00352534|527692347|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322627|NCT00352534|527692348|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
146322628|NCT00352534|527692349|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
146322629|NCT00352534|527692343|FG000|Final Risk Group Assignment|Death|0|||
146322630|NCT00352534|527692344|FG001|Final Risk Group Assignment|Death|0|||
146322631|NCT00352534|527692345|FG002|Final Risk Group Assignment|Death|0|||
146322632|NCT00352534|527692346|FG003|Final Risk Group Assignment|Death|0|||
146322633|NCT00352534|527692347|FG004|Final Risk Group Assignment|Death|0|||
146322634|NCT00352534|527692348|FG005|Final Risk Group Assignment|Death|2|||
146322635|NCT00352534|527692349|FG006|Final Risk Group Assignment|Death|0|||
146322636|NCT00680836|527692352|FG000|Overall Study|Withdrawal by Subject|3|||
146322637|NCT00680836|527692353|FG001|Overall Study|Withdrawal by Subject|0|||
146322638|NCT00680836|527692352|FG000|Overall Study|Lost to Follow-up|3|||
146322639|NCT00680836|527692353|FG001|Overall Study|Lost to Follow-up|1|||
146322640|NCT00680836|527692352|FG000|Overall Study|Physician Decision|2|||
146322641|NCT00680836|527692353|FG001|Overall Study|Physician Decision|1|||
146322642|NCT03786432|527692354|FG000|Overall Study|Screen Failure after consent|1|||
146322643|NCT03786432|527692354|FG000|Overall Study|Lost to Follow-up|4|||
146322644|NCT03786432|527692354|FG000|Overall Study|did not complete 12 month CT scan|1|||
146322645|NCT03038308|527692355|FG000|Overall Study|Surgical resection|1|||
146322646|NCT03038308|527692355|FG000|Overall Study|Withdrawal by Subject|2|||
146322647|NCT03038308|527692355|FG000|Overall Study|Lost to Follow-up|1|||
146322648|NCT00544869|527692357|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
146322649|NCT00544869|527692358|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
146322650|NCT00544869|527692359|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
146322651|NCT00544869|527692357|FG000|Overall Study|Adverse Event|6|||
146322652|NCT00544869|527692358|FG001|Overall Study|Adverse Event|1|||
146322653|NCT00544869|527692359|FG002|Overall Study|Adverse Event|0|||
146322654|NCT00544869|527692357|FG000|Overall Study|Lack of Efficacy|1|||
146322655|NCT00544869|527692358|FG001|Overall Study|Lack of Efficacy|1|||
146322656|NCT00544869|527692359|FG002|Overall Study|Lack of Efficacy|0|||
146322657|NCT00544869|527692357|FG000|Overall Study|Physician Decision|2|||
146322658|NCT00544869|527692358|FG001|Overall Study|Physician Decision|0|||
146322659|NCT00544869|527692359|FG002|Overall Study|Physician Decision|0|||
146322660|NCT00619502|527692360|FG000|Overall Study|Lost to Follow-up|8|||
146322661|NCT00619502|527692361|FG001|Overall Study|Lost to Follow-up|10|||
146322662|NCT03968419|527692362|FG000|Treatment Period|Adverse Event|0|||
146322663|NCT03968419|527692363|FG001|Treatment Period|Adverse Event|0|||
146322664|NCT03968419|527692364|FG002|Treatment Period|Adverse Event|1|||
146322665|NCT03968419|527692362|FG000|Safety Follow-up Period|Death|3|||
146322666|NCT03968419|527692363|FG001|Safety Follow-up Period|Death|2|||
146322667|NCT03968419|527692364|FG002|Safety Follow-up Period|Death|1|||
146322668|NCT03968419|527692362|FG000|Safety Follow-up Period|Subject Decision|2|||
146322669|NCT03968419|527692363|FG001|Safety Follow-up Period|Subject Decision|1|||
146322670|NCT03968419|527692364|FG002|Safety Follow-up Period|Subject Decision|0|||
146322671|NCT00167245|527692365|FG000|Overall Study|Lost to Follow-up|20|||
146322672|NCT00167245|527692366|FG001|Overall Study|Lost to Follow-up|31|||
146322673|NCT00167245|527692365|FG000|Overall Study|Withdrawal by Subject|5|||
146322674|NCT00167245|527692366|FG001|Overall Study|Withdrawal by Subject|8|||
146322675|NCT00167245|527692365|FG000|Overall Study|Incarcerated|3|||
146322676|NCT00167245|527692366|FG001|Overall Study|Incarcerated|2|||
146322677|NCT00167245|527692365|FG000|Overall Study|Drowsy|1|||
146322678|NCT00167245|527692366|FG001|Overall Study|Drowsy|0|||
146322679|NCT00804687|527692369|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
146322680|NCT00804687|527692370|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
146322681|NCT00804687|527692371|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
146322682|NCT00804687|527692372|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
146322683|NCT00804687|527692373|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
146322684|NCT00804687|527692374|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
146322685|NCT00804687|527692369|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
146322686|NCT00804687|527692370|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
146322687|NCT00804687|527692371|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
146322688|NCT00804687|527692372|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
146322689|NCT00804687|527692373|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
146322690|NCT00804687|527692374|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
146322691|NCT00804687|527692369|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
146322692|NCT00804687|527692370|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
146164944|NCT04642898|527114392|FG000|Overall Study|Withdrawal by Subject|2|||
146322693|NCT00804687|527692371|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
146322694|NCT00804687|527692372|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
146322695|NCT00804687|527692373|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
146322696|NCT00804687|527692374|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
146322697|NCT00804687|527692369|FG000|Period 5: Treatment Period|Positive drug test|1|||
146322698|NCT00804687|527692370|FG001|Period 5: Treatment Period|Positive drug test|0|||
146322699|NCT00804687|527692371|FG002|Period 5: Treatment Period|Positive drug test|0|||
146322700|NCT00804687|527692372|FG003|Period 5: Treatment Period|Positive drug test|0|||
146322701|NCT00804687|527692373|FG004|Period 5: Treatment Period|Positive drug test|0|||
146322702|NCT00804687|527692374|FG005|Period 5: Treatment Period|Positive drug test|0|||
146322703|NCT01220414|527692377|FG000|Overall Study|Withdrawal by Subject|1|||
146322704|NCT01220414|527692378|FG001|Overall Study|Withdrawal by Subject|0|||
146322705|NCT01220414|527692379|FG002|Overall Study|Withdrawal by Subject|0|||
146322706|NCT01220414|527692380|FG003|Overall Study|Withdrawal by Subject|1|||
146322707|NCT01748071|527692386|FG000|Overall Study|Adverse Event|2|||
146322708|NCT01748071|527692387|FG001|Overall Study|Adverse Event|2|||
146322709|NCT01748071|527692388|FG002|Overall Study|Adverse Event|0|||
146322710|NCT02624492|527692392|FG000|Overall Study|Adverse Event|2|||
146322711|NCT02624492|527692393|FG001|Overall Study|Adverse Event|2|||
146322712|NCT02624492|527692394|FG002|Overall Study|Adverse Event|2|||
146322713|NCT02624492|527692392|FG000|Overall Study|Progressive disease|0|||
146322714|NCT02624492|527692393|FG001|Overall Study|Progressive disease|2|||
146322715|NCT02624492|527692394|FG002|Overall Study|Progressive disease|3|||
146322716|NCT00191451|527692402|FG000|Overall Study|Withdrawal by Subject|2|||
146322717|NCT00191451|527692403|FG001|Overall Study|Withdrawal by Subject|3|||
146322718|NCT00191451|527692404|FG002|Overall Study|Withdrawal by Subject|5|||
146322719|NCT00191451|527692402|FG000|Overall Study|Physician Decision|2|||
146322720|NCT00191451|527692403|FG001|Overall Study|Physician Decision|9|||
146322721|NCT00191451|527692404|FG002|Overall Study|Physician Decision|6|||
146322722|NCT00191451|527692402|FG000|Overall Study|Sponsor Decision|1|||
146322723|NCT00191451|527692403|FG001|Overall Study|Sponsor Decision|0|||
146322724|NCT00191451|527692404|FG002|Overall Study|Sponsor Decision|0|||
146322725|NCT00191451|527692402|FG000|Overall Study|Ineligible|0|||
146322726|NCT00191451|527692403|FG001|Overall Study|Ineligible|1|||
146322727|NCT00191451|527692404|FG002|Overall Study|Ineligible|0|||
146322728|NCT00191451|527692402|FG000|Overall Study|Reason Not Specified|2|||
146322729|NCT00191451|527692403|FG001|Overall Study|Reason Not Specified|1|||
146322730|NCT00191451|527692404|FG002|Overall Study|Reason Not Specified|3|||
146322731|NCT01262976|527692405|FG000|Up to Month 2|Serious Adverse Event|0|||
146322732|NCT01262976|527692406|FG001|Up to Month 2|Serious Adverse Event|0|||
146322733|NCT01262976|527692407|FG002|Up to Month 2|Serious Adverse Event|1|||
146322734|NCT01262976|527692408|FG003|Up to Month 2|Serious Adverse Event|0|||
146322735|NCT01262976|527692409|FG004|Up to Month 2|Serious Adverse Event|0|||
146322736|NCT01262976|527692410|FG005|Up to Month 2|Serious Adverse Event|0|||
146322737|NCT01262976|527692405|FG000|Up to Month 2|Withdrawal by Subject|1|||
146322738|NCT01262976|527692406|FG001|Up to Month 2|Withdrawal by Subject|0|||
146322739|NCT01262976|527692407|FG002|Up to Month 2|Withdrawal by Subject|0|||
146322740|NCT01262976|527692408|FG003|Up to Month 2|Withdrawal by Subject|0|||
146322741|NCT01262976|527692409|FG004|Up to Month 2|Withdrawal by Subject|0|||
146322742|NCT01262976|527692410|FG005|Up to Month 2|Withdrawal by Subject|0|||
146322743|NCT01262976|527692405|FG000|Up to Month 2|Migrated/moved from study area|0|||
146322744|NCT01262976|527692406|FG001|Up to Month 2|Migrated/moved from study area|1|||
146322745|NCT01262976|527692407|FG002|Up to Month 2|Migrated/moved from study area|0|||
146322746|NCT01262976|527692408|FG003|Up to Month 2|Migrated/moved from study area|0|||
146322747|NCT01262976|527692409|FG004|Up to Month 2|Migrated/moved from study area|1|||
146322748|NCT01262976|527692410|FG005|Up to Month 2|Migrated/moved from study area|1|||
146322749|NCT01262976|527692405|FG000|Up to Month 2|Lost to Follow-up|1|||
146322750|NCT01262976|527692406|FG001|Up to Month 2|Lost to Follow-up|0|||
146322751|NCT01262976|527692407|FG002|Up to Month 2|Lost to Follow-up|0|||
146322752|NCT01262976|527692408|FG003|Up to Month 2|Lost to Follow-up|1|||
146322753|NCT01262976|527692409|FG004|Up to Month 2|Lost to Follow-up|1|||
146322754|NCT01262976|527692410|FG005|Up to Month 2|Lost to Follow-up|1|||
146322755|NCT01262976|527692405|FG000|Up to Month 2|Other|1|||
146322756|NCT01262976|527692406|FG001|Up to Month 2|Other|0|||
146322757|NCT01262976|527692407|FG002|Up to Month 2|Other|0|||
146322758|NCT01262976|527692408|FG003|Up to Month 2|Other|1|||
146322759|NCT01262976|527692409|FG004|Up to Month 2|Other|0|||
146322760|NCT01262976|527692410|FG005|Up to Month 2|Other|2|||
146322761|NCT01262976|527692405|FG000|Up to Month 7|Serious Adverse Event|0|||
146322762|NCT01262976|527692406|FG001|Up to Month 7|Serious Adverse Event|0|||
146322763|NCT01262976|527692407|FG002|Up to Month 7|Serious Adverse Event|2|||
146322764|NCT01262976|527692408|FG003|Up to Month 7|Serious Adverse Event|0|||
146322765|NCT01262976|527692409|FG004|Up to Month 7|Serious Adverse Event|0|||
146322766|NCT01262976|527692410|FG005|Up to Month 7|Serious Adverse Event|0|||
146322767|NCT01262976|527692405|FG000|Up to Month 7|Withdrawal by Subject|1|||
146322768|NCT01262976|527692406|FG001|Up to Month 7|Withdrawal by Subject|0|||
146322769|NCT01262976|527692407|FG002|Up to Month 7|Withdrawal by Subject|0|||
146322770|NCT01262976|527692408|FG003|Up to Month 7|Withdrawal by Subject|0|||
146322771|NCT01262976|527692409|FG004|Up to Month 7|Withdrawal by Subject|0|||
146322772|NCT01262976|527692410|FG005|Up to Month 7|Withdrawal by Subject|0|||
146322773|NCT01262976|527692405|FG000|Up to Month 7|Migrated/moved from study area|0|||
146322774|NCT01262976|527692406|FG001|Up to Month 7|Migrated/moved from study area|0|||
146322775|NCT01262976|527692407|FG002|Up to Month 7|Migrated/moved from study area|1|||
146322776|NCT01262976|527692408|FG003|Up to Month 7|Migrated/moved from study area|3|||
146322777|NCT01262976|527692409|FG004|Up to Month 7|Migrated/moved from study area|1|||
146322778|NCT01262976|527692410|FG005|Up to Month 7|Migrated/moved from study area|1|||
146322779|NCT01262976|527692405|FG000|Up to Month 7|Lost to Follow-up|1|||
146322780|NCT01262976|527692406|FG001|Up to Month 7|Lost to Follow-up|0|||
146322781|NCT01262976|527692407|FG002|Up to Month 7|Lost to Follow-up|1|||
146322782|NCT01262976|527692408|FG003|Up to Month 7|Lost to Follow-up|3|||
146322783|NCT01262976|527692409|FG004|Up to Month 7|Lost to Follow-up|1|||
146322784|NCT01262976|527692410|FG005|Up to Month 7|Lost to Follow-up|3|||
146322785|NCT01262976|527692405|FG000|Up to Month 7|Other|3|||
146322786|NCT01262976|527692406|FG001|Up to Month 7|Other|0|||
146322787|NCT01262976|527692407|FG002|Up to Month 7|Other|2|||
146322788|NCT01262976|527692408|FG003|Up to Month 7|Other|0|||
146322789|NCT01262976|527692409|FG004|Up to Month 7|Other|0|||
146322790|NCT01262976|527692410|FG005|Up to Month 7|Other|0|||
146322791|NCT01262976|527692405|FG000|Up to Year 1|Serious Adverse Event|0|||
146322792|NCT01262976|527692406|FG001|Up to Year 1|Serious Adverse Event|0|||
146322793|NCT01262976|527692407|FG002|Up to Year 1|Serious Adverse Event|2|||
146322794|NCT01262976|527692408|FG003|Up to Year 1|Serious Adverse Event|0|||
146322795|NCT01262976|527692409|FG004|Up to Year 1|Serious Adverse Event|0|||
146322796|NCT01262976|527692410|FG005|Up to Year 1|Serious Adverse Event|0|||
146322797|NCT01262976|527692405|FG000|Up to Year 1|Withdrawal by Subject|1|||
146322798|NCT01262976|527692406|FG001|Up to Year 1|Withdrawal by Subject|0|||
146322799|NCT01262976|527692407|FG002|Up to Year 1|Withdrawal by Subject|0|||
146322800|NCT01262976|527692408|FG003|Up to Year 1|Withdrawal by Subject|0|||
146322801|NCT01262976|527692409|FG004|Up to Year 1|Withdrawal by Subject|0|||
146322802|NCT01262976|527692410|FG005|Up to Year 1|Withdrawal by Subject|0|||
146322803|NCT01262976|527692405|FG000|Up to Year 1|Migrated/moved from study area|1|||
146322804|NCT01262976|527692406|FG001|Up to Year 1|Migrated/moved from study area|0|||
146322805|NCT01262976|527692407|FG002|Up to Year 1|Migrated/moved from study area|0|||
146322806|NCT01262976|527692408|FG003|Up to Year 1|Migrated/moved from study area|3|||
146322807|NCT01262976|527692409|FG004|Up to Year 1|Migrated/moved from study area|3|||
146322808|NCT01262976|527692410|FG005|Up to Year 1|Migrated/moved from study area|2|||
146322809|NCT01262976|527692405|FG000|Up to Year 1|Lost to Follow-up|4|||
146322810|NCT01262976|527692406|FG001|Up to Year 1|Lost to Follow-up|0|||
146322811|NCT01262976|527692407|FG002|Up to Year 1|Lost to Follow-up|0|||
146322812|NCT01262976|527692408|FG003|Up to Year 1|Lost to Follow-up|1|||
146322813|NCT01262976|527692409|FG004|Up to Year 1|Lost to Follow-up|6|||
146322814|NCT01262976|527692410|FG005|Up to Year 1|Lost to Follow-up|5|||
146322815|NCT01262976|527692405|FG000|Up to Year 1|Other|3|||
146322816|NCT01262976|527692406|FG001|Up to Year 1|Other|1|||
146322817|NCT01262976|527692407|FG002|Up to Year 1|Other|0|||
146322818|NCT01262976|527692408|FG003|Up to Year 1|Other|0|||
146322819|NCT01262976|527692409|FG004|Up to Year 1|Other|2|||
146322820|NCT01262976|527692410|FG005|Up to Year 1|Other|1|||
146164945|NCT04642898|527114393|FG001|Overall Study|Withdrawal by Subject|4|||
146164946|NCT04642898|527114394|FG002|Overall Study|Withdrawal by Subject|4|||
146322821|NCT01262976|527692405|FG000|Up to Year 1|Subjects with unknown completion status|0|||
146322822|NCT01262976|527692406|FG001|Up to Year 1|Subjects with unknown completion status|0|||
146322823|NCT01262976|527692407|FG002|Up to Year 1|Subjects with unknown completion status|1|||
146322824|NCT01262976|527692408|FG003|Up to Year 1|Subjects with unknown completion status|0|||
146322825|NCT01262976|527692409|FG004|Up to Year 1|Subjects with unknown completion status|0|||
146322826|NCT01262976|527692410|FG005|Up to Year 1|Subjects with unknown completion status|1|||
146322827|NCT01262976|527692405|FG000|Up to Year 2|Serious Adverse Event|0|||
146322828|NCT01262976|527692406|FG001|Up to Year 2|Serious Adverse Event|0|||
146322829|NCT01262976|527692407|FG002|Up to Year 2|Serious Adverse Event|2|||
146322830|NCT01262976|527692408|FG003|Up to Year 2|Serious Adverse Event|0|||
146322831|NCT01262976|527692409|FG004|Up to Year 2|Serious Adverse Event|0|||
146322832|NCT01262976|527692410|FG005|Up to Year 2|Serious Adverse Event|0|||
146322833|NCT01262976|527692405|FG000|Up to Year 2|Withdrawal by Subject|1|||
146164947|NCT04642898|527114395|FG003|Overall Study|Withdrawal by Subject|6|||
146322834|NCT01262976|527692406|FG001|Up to Year 2|Withdrawal by Subject|0|||
146322835|NCT01262976|527692407|FG002|Up to Year 2|Withdrawal by Subject|0|||
146322836|NCT01262976|527692408|FG003|Up to Year 2|Withdrawal by Subject|0|||
146322837|NCT01262976|527692409|FG004|Up to Year 2|Withdrawal by Subject|0|||
146322838|NCT01262976|527692410|FG005|Up to Year 2|Withdrawal by Subject|0|||
146322839|NCT01262976|527692405|FG000|Up to Year 2|Migrated/moved from study area|0|||
146322840|NCT01262976|527692406|FG001|Up to Year 2|Migrated/moved from study area|0|||
146322841|NCT01262976|527692407|FG002|Up to Year 2|Migrated/moved from study area|0|||
146322842|NCT01262976|527692408|FG003|Up to Year 2|Migrated/moved from study area|2|||
146322843|NCT01262976|527692409|FG004|Up to Year 2|Migrated/moved from study area|1|||
146322844|NCT01262976|527692410|FG005|Up to Year 2|Migrated/moved from study area|2|||
146322845|NCT01262976|527692405|FG000|Up to Year 2|Lost to Follow-up|1|||
146322846|NCT01262976|527692406|FG001|Up to Year 2|Lost to Follow-up|1|||
146322847|NCT01262976|527692407|FG002|Up to Year 2|Lost to Follow-up|2|||
146322848|NCT01262976|527692408|FG003|Up to Year 2|Lost to Follow-up|2|||
146322849|NCT01262976|527692409|FG004|Up to Year 2|Lost to Follow-up|3|||
146322850|NCT01262976|527692410|FG005|Up to Year 2|Lost to Follow-up|3|||
146322851|NCT01262976|527692405|FG000|Up to Year 2|Subjects with unknown completion status|0|||
146322852|NCT01262976|527692406|FG001|Up to Year 2|Subjects with unknown completion status|0|||
146322853|NCT01262976|527692407|FG002|Up to Year 2|Subjects with unknown completion status|1|||
146322854|NCT01262976|527692408|FG003|Up to Year 2|Subjects with unknown completion status|0|||
146322855|NCT01262976|527692409|FG004|Up to Year 2|Subjects with unknown completion status|0|||
146322856|NCT01262976|527692410|FG005|Up to Year 2|Subjects with unknown completion status|0|||
146322857|NCT01262976|527692405|FG000|Up to Year 2|Other|3|||
146322858|NCT01262976|527692406|FG001|Up to Year 2|Other|0|||
146322859|NCT01262976|527692407|FG002|Up to Year 2|Other|0|||
146322860|NCT01262976|527692408|FG003|Up to Year 2|Other|0|||
146322861|NCT01262976|527692409|FG004|Up to Year 2|Other|0|||
146322862|NCT01262976|527692410|FG005|Up to Year 2|Other|0|||
146322863|NCT01262976|527692405|FG000|Up to Year 3|Serious Adverse Event|0|||
146322864|NCT01262976|527692406|FG001|Up to Year 3|Serious Adverse Event|0|||
146322865|NCT01262976|527692407|FG002|Up to Year 3|Serious Adverse Event|2|||
146322866|NCT01262976|527692408|FG003|Up to Year 3|Serious Adverse Event|0|||
146322867|NCT01262976|527692409|FG004|Up to Year 3|Serious Adverse Event|0|||
146322868|NCT01262976|527692410|FG005|Up to Year 3|Serious Adverse Event|0|||
146322869|NCT01262976|527692405|FG000|Up to Year 3|Withdrawal by Subject|1|||
146322870|NCT01262976|527692406|FG001|Up to Year 3|Withdrawal by Subject|0|||
146322871|NCT01262976|527692407|FG002|Up to Year 3|Withdrawal by Subject|0|||
146322872|NCT01262976|527692408|FG003|Up to Year 3|Withdrawal by Subject|0|||
146322873|NCT01262976|527692409|FG004|Up to Year 3|Withdrawal by Subject|0|||
146322874|NCT01262976|527692410|FG005|Up to Year 3|Withdrawal by Subject|0|||
146322875|NCT01262976|527692405|FG000|Up to Year 3|Migrated/moved from study area|0|||
146322876|NCT01262976|527692406|FG001|Up to Year 3|Migrated/moved from study area|0|||
146322877|NCT01262976|527692407|FG002|Up to Year 3|Migrated/moved from study area|0|||
146322878|NCT01262976|527692408|FG003|Up to Year 3|Migrated/moved from study area|2|||
146322879|NCT01262976|527692409|FG004|Up to Year 3|Migrated/moved from study area|1|||
146322880|NCT01262976|527692410|FG005|Up to Year 3|Migrated/moved from study area|1|||
146322881|NCT01262976|527692405|FG000|Up to Year 3|Lost to Follow-up|2|||
146322882|NCT01262976|527692406|FG001|Up to Year 3|Lost to Follow-up|2|||
146322883|NCT01262976|527692407|FG002|Up to Year 3|Lost to Follow-up|4|||
146322884|NCT01262976|527692408|FG003|Up to Year 3|Lost to Follow-up|3|||
146322885|NCT01262976|527692409|FG004|Up to Year 3|Lost to Follow-up|1|||
146322886|NCT01262976|527692410|FG005|Up to Year 3|Lost to Follow-up|3|||
146322887|NCT01262976|527692405|FG000|Up to Year 3|Subjects with unknown completion status|0|||
146322888|NCT01262976|527692406|FG001|Up to Year 3|Subjects with unknown completion status|0|||
146322889|NCT01262976|527692407|FG002|Up to Year 3|Subjects with unknown completion status|1|||
146322890|NCT01262976|527692408|FG003|Up to Year 3|Subjects with unknown completion status|0|||
146322891|NCT01262976|527692409|FG004|Up to Year 3|Subjects with unknown completion status|0|||
146322892|NCT01262976|527692410|FG005|Up to Year 3|Subjects with unknown completion status|0|||
146322893|NCT01262976|527692405|FG000|Up to Year 3|Other|3|||
146322894|NCT01262976|527692406|FG001|Up to Year 3|Other|0|||
146322895|NCT01262976|527692407|FG002|Up to Year 3|Other|0|||
146322896|NCT01262976|527692408|FG003|Up to Year 3|Other|0|||
146322897|NCT01262976|527692409|FG004|Up to Year 3|Other|0|||
146322898|NCT01262976|527692410|FG005|Up to Year 3|Other|0|||
146322899|NCT03261531|527692411|FG000|Overall Study|Withdrawal by Subject|4|||
146322900|NCT01818726|527692420|FG000|Overall Study|Administrative reasons|5|||
146322901|NCT01818726|527692421|FG001|Overall Study|Administrative reasons|1|||
146164948|NCT04642898|527114396|FG004|Overall Study|Withdrawal by Subject|2|||
146164949|NCT04642898|527114397|FG005|Overall Study|Withdrawal by Subject|6|||
146164950|NCT04642898|527114392|FG000|Overall Study|Lost to Follow-up|0|||
146322902|NCT01818726|527692420|FG000|Overall Study|Withdrawal by Subject|0|||
146322903|NCT01818726|527692421|FG001|Overall Study|Withdrawal by Subject|1|||
146322904|NCT01818726|527692420|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
146322905|NCT01818726|527692421|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
146322906|NCT04871711|527692422|FG000|Overall Study|Withdrawal by Subject|11|||
146322907|NCT04871711|527692423|FG001|Overall Study|Withdrawal by Subject|5|||
146322908|NCT04871711|527692422|FG000|Overall Study|Lack of Efficacy|5|||
146322909|NCT04871711|527692423|FG001|Overall Study|Lack of Efficacy|7|||
146322910|NCT04871711|527692422|FG000|Overall Study|Adverse Event|2|||
146322911|NCT04871711|527692423|FG001|Overall Study|Adverse Event|6|||
146322912|NCT04871711|527692422|FG000|Overall Study|Various reasons|2|||
146322913|NCT04871711|527692423|FG001|Overall Study|Various reasons|1|||
146322914|NCT04871711|527692422|FG000|Overall Study|Lost to Follow-up|0|||
146322915|NCT04871711|527692423|FG001|Overall Study|Lost to Follow-up|2|||
146322916|NCT01665144|527692424|FG000|Core Part|Withdrawal by Subject|96|||
146322917|NCT01665144|527692425|FG001|Core Part|Withdrawal by Subject|77|||
146322918|NCT01665144|527692426|FG002|Core Part|Withdrawal by Subject|0|||
146322919|NCT01665144|527692424|FG000|Core Part|Adverse Event|45|||
146322920|NCT01665144|527692425|FG001|Core Part|Adverse Event|18|||
146322921|NCT01665144|527692426|FG002|Core Part|Adverse Event|0|||
146322922|NCT01665144|527692424|FG000|Core Part|Lack of Efficacy|16|||
146322923|NCT01665144|527692425|FG001|Core Part|Lack of Efficacy|11|||
146322924|NCT01665144|527692426|FG002|Core Part|Lack of Efficacy|0|||
146322925|NCT01665144|527692424|FG000|Core Part|Lost to Follow-up|9|||
146322926|NCT01665144|527692425|FG001|Core Part|Lost to Follow-up|8|||
146322927|NCT01665144|527692426|FG002|Core Part|Lost to Follow-up|0|||
146322928|NCT01665144|527692424|FG000|Core Part|Physician Decision|13|||
146322929|NCT01665144|527692425|FG001|Core Part|Physician Decision|1|||
146322930|NCT01665144|527692426|FG002|Core Part|Physician Decision|0|||
146322931|NCT01665144|527692424|FG000|Core Part|Progressive disease|8|||
146322932|NCT01665144|527692425|FG001|Core Part|Progressive disease|4|||
146322933|NCT01665144|527692426|FG002|Core Part|Progressive disease|0|||
146322934|NCT01665144|527692424|FG000|Core Part|Non-compliance with study treatment|5|||
146322935|NCT01665144|527692425|FG001|Core Part|Non-compliance with study treatment|0|||
146322936|NCT01665144|527692426|FG002|Core Part|Non-compliance with study treatment|0|||
146322937|NCT01665144|527692424|FG000|Core Part|Death|3|||
146322938|NCT01665144|527692425|FG001|Core Part|Death|1|||
146322939|NCT01665144|527692426|FG002|Core Part|Death|0|||
146322940|NCT01665144|527692424|FG000|Core Part|Protocol deviation|3|||
146322941|NCT01665144|527692425|FG001|Core Part|Protocol deviation|1|||
146322942|NCT01665144|527692426|FG002|Core Part|Protocol deviation|0|||
146322943|NCT01665144|527692424|FG000|Core Part|New therapy for study indication|2|||
146322944|NCT01665144|527692425|FG001|Core Part|New therapy for study indication|1|||
146322945|NCT01665144|527692426|FG002|Core Part|New therapy for study indication|0|||
146322946|NCT01665144|527692424|FG000|Core Part|Technical problems|2|||
146322947|NCT01665144|527692425|FG001|Core Part|Technical problems|0|||
146322948|NCT01665144|527692426|FG002|Core Part|Technical problems|0|||
146322949|NCT01665144|527692424|FG000|Extension Part|Patient/guardian decision|180|||
146322950|NCT01665144|527692425|FG001|Extension Part|Patient/guardian decision|0|||
146322951|NCT01665144|527692426|FG002|Extension Part|Patient/guardian decision|98|||
146322952|NCT01665144|527692424|FG000|Extension Part|Adverse Event|104|||
146322953|NCT01665144|527692425|FG001|Extension Part|Adverse Event|0|||
146322954|NCT01665144|527692426|FG002|Extension Part|Adverse Event|59|||
146322955|NCT01665144|527692424|FG000|Extension Part|Study closed early|42|||
146322956|NCT01665144|527692425|FG001|Extension Part|Study closed early|0|||
146322957|NCT01665144|527692426|FG002|Extension Part|Study closed early|19|||
146322958|NCT01665144|527692424|FG000|Extension Part|Progressive disease|36|||
146322959|NCT01665144|527692425|FG001|Extension Part|Progressive disease|0|||
146322960|NCT01665144|527692426|FG002|Extension Part|Progressive disease|14|||
146322961|NCT01665144|527692424|FG000|Extension Part|Lack of Efficacy|37|||
146322962|NCT01665144|527692425|FG001|Extension Part|Lack of Efficacy|0|||
146322963|NCT01665144|527692426|FG002|Extension Part|Lack of Efficacy|12|||
146322964|NCT01665144|527692424|FG000|Extension Part|Physician Decision|29|||
146322965|NCT01665144|527692425|FG001|Extension Part|Physician Decision|0|||
146322966|NCT01665144|527692426|FG002|Extension Part|Physician Decision|13|||
146322967|NCT01665144|527692424|FG000|Extension Part|Technical problems|20|||
146322968|NCT01665144|527692425|FG001|Extension Part|Technical problems|0|||
146322969|NCT01665144|527692426|FG002|Extension Part|Technical problems|8|||
146322970|NCT01665144|527692424|FG000|Extension Part|Death|20|||
146322971|NCT01665144|527692425|FG001|Extension Part|Death|0|||
146322972|NCT01665144|527692426|FG002|Extension Part|Death|4|||
146322973|NCT01665144|527692424|FG000|Extension Part|Missing|12|||
146322974|NCT01665144|527692425|FG001|Extension Part|Missing|0|||
146322975|NCT01665144|527692426|FG002|Extension Part|Missing|6|||
146322976|NCT01665144|527692424|FG000|Extension Part|Lost to Follow-up|9|||
146322977|NCT01665144|527692425|FG001|Extension Part|Lost to Follow-up|0|||
146322978|NCT01665144|527692426|FG002|Extension Part|Lost to Follow-up|5|||
146322979|NCT01665144|527692424|FG000|Extension Part|New therapy for study indication|3|||
146322980|NCT01665144|527692425|FG001|Extension Part|New therapy for study indication|0|||
146322981|NCT01665144|527692426|FG002|Extension Part|New therapy for study indication|2|||
146322982|NCT01665144|527692424|FG000|Extension Part|Protocol deviation|3|||
146322983|NCT01665144|527692425|FG001|Extension Part|Protocol deviation|0|||
146322984|NCT01665144|527692426|FG002|Extension Part|Protocol deviation|0|||
146322985|NCT01913483|527692427|FG000|Overall Study|Withdrawal by Subject|1|||
146322986|NCT01913483|527692428|FG001|Overall Study|Withdrawal by Subject|2|||
145943231|NCT00483704|526300457|FG001|Treatment|Lost to Follow-up|7|||
146322987|NCT01913483|527692427|FG000|Overall Study|Lost to Follow-up|6|||
146322988|NCT01913483|527692428|FG001|Overall Study|Lost to Follow-up|3|||
146322989|NCT01913483|527692427|FG000|Overall Study|Death|14|||
146322990|NCT01913483|527692428|FG001|Overall Study|Death|17|||
146322991|NCT02154087|527692436|FG000|Overall Study|Study Termination|1|||
146322992|NCT05168267|527692441|FG000|Overall Study|Withdrawal by Subject|2|||
146322993|NCT05168267|527692442|FG001|Overall Study|Withdrawal by Subject|1|||
146322994|NCT05168267|527692441|FG000|Overall Study|Withdrawn by Therapist|1|||
146322995|NCT05168267|527692442|FG001|Overall Study|Withdrawn by Therapist|1|||
146322996|NCT05168267|527692441|FG000|Overall Study|Left Facility|1|||
146322997|NCT05168267|527692442|FG001|Overall Study|Left Facility|0|||
146322998|NCT00695565|527692443|FG000|Overall Study|Lost to Follow-up|4|||
146322999|NCT00695565|527692444|FG001|Overall Study|Lost to Follow-up|4|||
146323000|NCT00695565|527692443|FG000|Overall Study|Adverse Event|3|||
146323001|NCT00695565|527692444|FG001|Overall Study|Adverse Event|1|||
146323002|NCT00695565|527692443|FG000|Overall Study|Protocol Violation|3|||
146323003|NCT00695565|527692444|FG001|Overall Study|Protocol Violation|1|||
146323004|NCT00695565|527692443|FG000|Overall Study|Withdrawal by Subject|1|||
146323005|NCT00695565|527692444|FG001|Overall Study|Withdrawal by Subject|1|||
146323006|NCT00695565|527692443|FG000|Overall Study|Lack of Efficacy|1|||
146323007|NCT00695565|527692444|FG001|Overall Study|Lack of Efficacy|1|||
146323008|NCT00695565|527692443|FG000|Overall Study|Subject did not follow instructions|1|||
146323009|NCT00695565|527692444|FG001|Overall Study|Subject did not follow instructions|1|||
146323010|NCT02937350|527692445|FG000|Overall Study|Withdrawal by Subject|0|||
146323011|NCT02937350|527692446|FG001|Overall Study|Withdrawal by Subject|1|||
146323012|NCT02937350|527692447|FG002|Overall Study|Withdrawal by Subject|0|||
146323013|NCT01462266|527692448|FG000|Overall Study|Adverse Event|7|||
146323014|NCT01462266|527692449|FG001|Overall Study|Adverse Event|6|||
146323015|NCT01462266|527692448|FG000|Overall Study|Death|2|||
146323016|NCT01462266|527692449|FG001|Overall Study|Death|1|||
146323017|NCT01462266|527692448|FG000|Overall Study|Lack of Efficacy|0|||
146323018|NCT01462266|527692449|FG001|Overall Study|Lack of Efficacy|2|||
146323019|NCT01462266|527692448|FG000|Overall Study|Lost to Follow-up|4|||
146323020|NCT01462266|527692449|FG001|Overall Study|Lost to Follow-up|3|||
146323021|NCT01462266|527692448|FG000|Overall Study|Non-compliance with study drug|3|||
146323022|NCT01462266|527692449|FG001|Overall Study|Non-compliance with study drug|0|||
146323023|NCT01462266|527692448|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
146323024|NCT01462266|527692449|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
146323025|NCT01462266|527692448|FG000|Overall Study|Physician Decision|2|||
146323026|NCT01462266|527692449|FG001|Overall Study|Physician Decision|5|||
146323027|NCT01462266|527692448|FG000|Overall Study|Protocol Violation|1|||
146323028|NCT01462266|527692449|FG001|Overall Study|Protocol Violation|3|||
146323029|NCT01462266|527692448|FG000|Overall Study|Withdrawal by Subject|7|||
146323030|NCT01462266|527692449|FG001|Overall Study|Withdrawal by Subject|2|||
146323031|NCT01462266|527692448|FG000|Overall Study|Screen failure|1|||
146323032|NCT01462266|527692449|FG001|Overall Study|Screen failure|1|||
146323033|NCT01106846|527692450|FG000|Overall Study|Change in surgical procedure|0|||
146323034|NCT01106846|527692451|FG001|Overall Study|Change in surgical procedure|1|||
146323036|NCT02419508|527692458|FG000|Overall Study|Adverse Event|9|||
146323037|NCT02419508|527692459|FG001|Overall Study|Adverse Event|3|||
146323038|NCT02419508|527692458|FG000|Overall Study|Withdrawal by Subject|1|||
146323039|NCT02419508|527692459|FG001|Overall Study|Withdrawal by Subject|0|||
146323040|NCT02419508|527692458|FG000|Overall Study|Other - Reason not specified|0|||
146323041|NCT02419508|527692459|FG001|Overall Study|Other - Reason not specified|1|||
146323042|NCT02320487|527692470|FG000|Overall Study|Reason not Specified|1|||
146323043|NCT02320487|527692470|FG000|Overall Study|Physician Decision|5|||
146323044|NCT02320487|527692470|FG000|Overall Study|Withdrawal by Subject|1|||
146323045|NCT02320487|527692470|FG000|Overall Study|Death|3|||
146323046|NCT02320487|527692470|FG000|Overall Study|Adverse Event|11|||
146323047|NCT06228586|527692471|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
146323048|NCT06228586|527692472|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
146323049|NCT06272370|527694474|FG000|Overall Study|Lost to Follow-up|0|||
146323050|NCT06272370|527694475|FG001|Overall Study|Lost to Follow-up|3|||
146323051|NCT06272370|527694476|FG002|Overall Study|Lost to Follow-up|1|||
146323052|NCT06272370|527694477|FG003|Overall Study|Lost to Follow-up|1|||
146323053|NCT02324270|527694478|FG000|Overall Study|Withdrawal by Subject|0|||
146323054|NCT02324270|527694479|FG001|Overall Study|Withdrawal by Subject|1|||
146323055|NCT02324270|527694480|FG002|Overall Study|Withdrawal by Subject|0|||
146323056|NCT02324270|527694478|FG000|Overall Study|Lost to Follow-up|4|||
146323057|NCT02324270|527694479|FG001|Overall Study|Lost to Follow-up|3|||
146323058|NCT02324270|527694480|FG002|Overall Study|Lost to Follow-up|4|||
146323059|NCT02324270|527694478|FG000|Overall Study|Protocol Violation|0|||
146323060|NCT02324270|527694479|FG001|Overall Study|Protocol Violation|1|||
146323061|NCT02324270|527694480|FG002|Overall Study|Protocol Violation|1|||
146323062|NCT02324270|527694478|FG000|Overall Study|Non Compliance with Study Drug|1|||
146323063|NCT02324270|527694479|FG001|Overall Study|Non Compliance with Study Drug|2|||
146323064|NCT02324270|527694480|FG002|Overall Study|Non Compliance with Study Drug|0|||
146323065|NCT03521791|527694481|FG000|Overall Study|Protocol Violation|7|||
146323066|NCT03521791|527694482|FG001|Overall Study|Protocol Violation|17|||
146323067|NCT01475734|527694483|FG000|Overall Study|Withdrawal by Subject|1|||
146323068|NCT01475734|527694484|FG001|Overall Study|Withdrawal by Subject|0|||
146323069|NCT01475734|527694483|FG000|Overall Study|Protocol Violation|1|||
146323070|NCT01475734|527694484|FG001|Overall Study|Protocol Violation|0|||
146323071|NCT01475734|527694483|FG000|Overall Study|Physician Decision|0|||
146323072|NCT01475734|527694484|FG001|Overall Study|Physician Decision|1|||
146323073|NCT00771472|527694485|FG000|Overall Study|Physician Decision|2|||
146323074|NCT00771472|527694486|FG001|Overall Study|Physician Decision|3|||
146323075|NCT00771472|527694485|FG000|Overall Study|Progressive Disease|3|||
146323076|NCT00771472|527694486|FG001|Overall Study|Progressive Disease|1|||
146323077|NCT00771472|527694485|FG000|Overall Study|Protocol Violation|1|||
146323078|NCT00771472|527694486|FG001|Overall Study|Protocol Violation|0|||
146323079|NCT01231555|527694489|FG000|Overall Study|Study terminated|8|||
146323080|NCT01231555|527694490|FG001|Overall Study|Study terminated|5|||
146323081|NCT01231555|527694491|FG002|Overall Study|Study terminated|8|||
146323082|NCT01231555|527694489|FG000|Overall Study|Withdrawal by Subject|0|||
146323083|NCT01231555|527694490|FG001|Overall Study|Withdrawal by Subject|2|||
146323084|NCT01231555|527694491|FG002|Overall Study|Withdrawal by Subject|0|||
146323085|NCT01773421|527694492|FG000|Treatment Phase|Other|0|||
146323086|NCT01773421|527694493|FG001|Treatment Phase|Other|0|||
146323087|NCT01773421|527694494|FG002|Treatment Phase|Other|2|||
146323088|NCT01773421|527694495|FG003|Treatment Phase|Other|0|||
146323089|NCT01773421|527694496|FG004|Treatment Phase|Other|0|||
146323090|NCT01773421|527694497|FG005|Treatment Phase|Other|0|||
146323091|NCT01773421|527694498|FG006|Treatment Phase|Other|0|||
146323092|NCT01773421|527694492|FG000|Treatment Phase|Adverse Event|0|||
146323093|NCT01773421|527694493|FG001|Treatment Phase|Adverse Event|0|||
146323094|NCT01773421|527694494|FG002|Treatment Phase|Adverse Event|3|||
146323095|NCT01773421|527694495|FG003|Treatment Phase|Adverse Event|1|||
146323096|NCT01773421|527694496|FG004|Treatment Phase|Adverse Event|0|||
146323097|NCT01773421|527694497|FG005|Treatment Phase|Adverse Event|0|||
146323098|NCT01773421|527694498|FG006|Treatment Phase|Adverse Event|0|||
146323099|NCT01773421|527694492|FG000|Treatment Phase|Withdrawal by Subject|0|||
146323100|NCT01773421|527694493|FG001|Treatment Phase|Withdrawal by Subject|0|||
146323101|NCT01773421|527694494|FG002|Treatment Phase|Withdrawal by Subject|1|||
146323102|NCT01773421|527694495|FG003|Treatment Phase|Withdrawal by Subject|1|||
146323103|NCT01773421|527694496|FG004|Treatment Phase|Withdrawal by Subject|0|||
146323104|NCT01773421|527694497|FG005|Treatment Phase|Withdrawal by Subject|0|||
146323105|NCT01773421|527694498|FG006|Treatment Phase|Withdrawal by Subject|0|||
146323106|NCT01773421|527694492|FG000|Extension Phase|Other|0|||
146323107|NCT01773421|527694493|FG001|Extension Phase|Other|0|||
146323108|NCT01773421|527694494|FG002|Extension Phase|Other|0|||
146323109|NCT01773421|527694495|FG003|Extension Phase|Other|0|||
146323110|NCT01773421|527694496|FG004|Extension Phase|Other|1|||
146323111|NCT01773421|527694497|FG005|Extension Phase|Other|2|||
146323112|NCT01773421|527694498|FG006|Extension Phase|Other|0|||
146323113|NCT01773421|527694492|FG000|Extension Phase|Adverse Event|0|||
146323114|NCT01773421|527694493|FG001|Extension Phase|Adverse Event|0|||
146323115|NCT01773421|527694494|FG002|Extension Phase|Adverse Event|0|||
146323116|NCT01773421|527694495|FG003|Extension Phase|Adverse Event|0|||
146323117|NCT01773421|527694496|FG004|Extension Phase|Adverse Event|2|||
146323118|NCT01773421|527694497|FG005|Extension Phase|Adverse Event|0|||
146323119|NCT01773421|527694498|FG006|Extension Phase|Adverse Event|0|||
146323120|NCT00688909|527694499|FG000|Overall Study|Adverse Event|28|||
146323121|NCT00688909|527694499|FG000|Overall Study|Patient withdrew consent|2|||
146323122|NCT00688909|527694499|FG000|Overall Study|Administrative problems|1|||
146323123|NCT00688909|527694499|FG000|Overall Study|Protocol Violation|2|||
146323124|NCT02472847|527694502|FG000|Overall Study|Withdrawal by Subject|1|||
146323125|NCT02472847|527694503|FG001|Overall Study|Withdrawal by Subject|5|||
146323126|NCT00669617|527694504|FG000|Period 1|Withdrawal by Subject|0|||
146323127|NCT00669617|527694505|FG001|Period 1|Withdrawal by Subject|0|||
146323128|NCT00669617|527694506|FG002|Period 1|Withdrawal by Subject|1|||
146323129|NCT00669617|527694507|FG003|Period 1|Withdrawal by Subject|0|||
146323130|NCT00669617|527694508|FG004|Period 1|Withdrawal by Subject|0|||
146323131|NCT00669617|527694504|FG000|Period 1|Protocol Deviation|0|||
146323132|NCT00669617|527694505|FG001|Period 1|Protocol Deviation|0|||
146323133|NCT00669617|527694506|FG002|Period 1|Protocol Deviation|0|||
146323134|NCT00669617|527694507|FG003|Period 1|Protocol Deviation|0|||
146323135|NCT00669617|527694508|FG004|Period 1|Protocol Deviation|1|||
146323136|NCT00669617|527694504|FG000|Period 3|Lost to Follow-up|1|||
146164951|NCT04642898|527114393|FG001|Overall Study|Lost to Follow-up|0|||
146323137|NCT00669617|527694505|FG001|Period 3|Lost to Follow-up|0|||
146323138|NCT00669617|527694506|FG002|Period 3|Lost to Follow-up|0|||
146323139|NCT00669617|527694507|FG003|Period 3|Lost to Follow-up|0|||
146323140|NCT00669617|527694508|FG004|Period 3|Lost to Follow-up|0|||
146323141|NCT00623831|527694509|FG000|Overall Study|Withdrawal by Subject|1|||
146323142|NCT00623831|527694510|FG001|Overall Study|Withdrawal by Subject|0|||
146323143|NCT00623831|527694509|FG000|Overall Study|Progressive Disease|0|||
146323144|NCT00623831|527694510|FG001|Overall Study|Progressive Disease|1|||
146323145|NCT01276821|527694511|FG000|Overall Study|Protocol Violation|0|||
146323146|NCT01276821|527694512|FG001|Overall Study|Protocol Violation|1|||
146323147|NCT03068325|527694515|FG000|Overall Study|Lost to Follow-up|5|||
146323148|NCT00700180|527694516|FG000|Overall Study|Death|99|||
146323149|NCT00700180|527694517|FG001|Overall Study|Death|114|||
146323150|NCT00700180|527694516|FG000|Overall Study|Alive on treatment|5|||
146323151|NCT00700180|527694517|FG001|Overall Study|Alive on treatment|3|||
146323152|NCT00700180|527694516|FG000|Overall Study|Alive in follow-up|46|||
146323153|NCT00700180|527694517|FG001|Overall Study|Alive in follow-up|27|||
146323154|NCT00700180|527694516|FG000|Overall Study|Lost to Follow-up|4|||
146323155|NCT00700180|527694517|FG001|Overall Study|Lost to Follow-up|5|||
146323156|NCT01613326|527694518|FG000|Overall Study|Adverse Event|7|||
146323157|NCT01613326|527694519|FG001|Overall Study|Adverse Event|5|||
146323158|NCT01613326|527694518|FG000|Overall Study|Withdrawal by Subject|3|||
146323159|NCT01613326|527694519|FG001|Overall Study|Withdrawal by Subject|4|||
146323160|NCT01613326|527694518|FG000|Overall Study|Abnormal test procedure result(s)|2|||
146323161|NCT01613326|527694519|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146323162|NCT01613326|527694518|FG000|Overall Study|inability to use device|1|||
146323163|NCT01613326|527694519|FG001|Overall Study|inability to use device|0|||
146323164|NCT01613326|527694518|FG000|Overall Study|Lack of Efficacy|0|||
146323165|NCT01613326|527694519|FG001|Overall Study|Lack of Efficacy|1|||
146323166|NCT01613326|527694518|FG000|Overall Study|Lost to Follow-up|0|||
146323167|NCT01613326|527694519|FG001|Overall Study|Lost to Follow-up|1|||
146323168|NCT01613326|527694518|FG000|Overall Study|Administrative|0|||
146323169|NCT01613326|527694519|FG001|Overall Study|Administrative|2|||
146323170|NCT01613326|527694518|FG000|Overall Study|Protocol Violation|0|||
146323171|NCT01613326|527694519|FG001|Overall Study|Protocol Violation|1|||
146323172|NCT03980938|527694522|FG000|Treatment Period 1|Study Terminated|1|||
146323173|NCT03980938|527694523|FG001|Treatment Period 1|Study Terminated|1|||
146323174|NCT03980938|527694522|FG000|Treatment Period 2|Study Terminated|2|||
146323175|NCT03980938|527694523|FG001|Treatment Period 2|Study Terminated|2|||
146323176|NCT00605267|527694524|FG000|Overall Study|Adverse Event|0|||
146323177|NCT00605267|527694525|FG001|Overall Study|Adverse Event|1|||
146323178|NCT00605267|527694524|FG000|Overall Study|Lack of Efficacy|1|||
146323179|NCT00605267|527694525|FG001|Overall Study|Lack of Efficacy|5|||
146323180|NCT00605267|527694524|FG000|Overall Study|Withdrawal by Subject|2|||
146323181|NCT00605267|527694525|FG001|Overall Study|Withdrawal by Subject|3|||
146323182|NCT03569202|527694529|FG000|Part 3|Physician Decision|1|||
146323183|NCT03569202|527694530|FG001|Part 3|Physician Decision|0|||
146323184|NCT03569202|527694529|FG000|Part 3|Other|1|||
146323185|NCT03569202|527694530|FG001|Part 3|Other|1|||
146323186|NCT00420511|527694531|FG000|Overall Study|Adverse Event|1|||
146323187|NCT00420511|527694532|FG001|Overall Study|Adverse Event|1|||
146323188|NCT00420511|527694531|FG000|Overall Study|Lost to Follow-up|1|||
146323189|NCT00420511|527694532|FG001|Overall Study|Lost to Follow-up|0|||
146323190|NCT00454779|527694534|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
146323191|NCT00454779|527694535|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
146323192|NCT00454779|527694534|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
146323193|NCT00454779|527694535|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
146323194|NCT00454779|527694534|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
146323195|NCT00454779|527694535|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
146323196|NCT00454779|527694534|FG000|First-line Treatment Phase|Protocol Violation|0|||
146323197|NCT00454779|527694535|FG001|First-line Treatment Phase|Protocol Violation|1|||
146323198|NCT00454779|527694534|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
146323199|NCT00454779|527694535|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
146323200|NCT00454779|527694534|FG000|First-line Treatment Phase|Ongoing|1|||
146323201|NCT00454779|527694535|FG001|First-line Treatment Phase|Ongoing|0|||
146323202|NCT00454779|527694534|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
146323203|NCT00454779|527694535|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
146323204|NCT00454779|527694534|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
146323205|NCT00454779|527694535|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
146323206|NCT00454779|527694534|FG000|Second-line Treatment Phase|Ongoing|0|||
146323207|NCT00454779|527694535|FG001|Second-line Treatment Phase|Ongoing|1|||
146323208|NCT00168831|527694536|FG000|Overall Study|Adverse Event|36|||
146323209|NCT00168831|527694537|FG001|Overall Study|Adverse Event|47|||
146323210|NCT00168831|527694538|FG002|Overall Study|Adverse Event|74|||
146323211|NCT00168831|527694536|FG000|Overall Study|Lost to Follow-up|5|||
146323212|NCT00168831|527694537|FG001|Overall Study|Lost to Follow-up|6|||
146323213|NCT00168831|527694538|FG002|Overall Study|Lost to Follow-up|4|||
146323214|NCT00168831|527694536|FG000|Overall Study|Withdrawal by Subject|7|||
146323215|NCT00168831|527694537|FG001|Overall Study|Withdrawal by Subject|14|||
146323216|NCT00168831|527694538|FG002|Overall Study|Withdrawal by Subject|19|||
146164952|NCT04642898|527114394|FG002|Overall Study|Lost to Follow-up|0|||
146164953|NCT04642898|527114395|FG003|Overall Study|Lost to Follow-up|2|||
146164954|NCT04642898|527114396|FG004|Overall Study|Lost to Follow-up|0|||
146164955|NCT04642898|527114397|FG005|Overall Study|Lost to Follow-up|1|||
146323217|NCT00168831|527694536|FG000|Overall Study|Protocol Violation|6|||
146323218|NCT00168831|527694537|FG001|Overall Study|Protocol Violation|11|||
146323219|NCT00168831|527694538|FG002|Overall Study|Protocol Violation|11|||
146323220|NCT00168831|527694536|FG000|Overall Study|Other|6|||
146323221|NCT00168831|527694537|FG001|Overall Study|Other|3|||
146323222|NCT00168831|527694538|FG002|Overall Study|Other|6|||
146323223|NCT01505894|527694539|FG000|Overall Study|Adverse Event|1|||
146323224|NCT01505894|527694540|FG001|Overall Study|Adverse Event|0|||
146323225|NCT01505894|527694541|FG002|Overall Study|Adverse Event|0|||
146323226|NCT01505894|527694542|FG003|Overall Study|Adverse Event|0|||
146323227|NCT01505894|527694543|FG004|Overall Study|Adverse Event|0|||
146323228|NCT01505894|527694544|FG005|Overall Study|Adverse Event|0|||
146323229|NCT01505894|527694545|FG006|Overall Study|Adverse Event|0|||
146323230|NCT01505894|527694546|FG007|Overall Study|Adverse Event|0|||
146323231|NCT01505894|527694547|FG008|Overall Study|Adverse Event|0|||
146323232|NCT01505894|527694539|FG000|Overall Study|Other than specified|0|||
146323233|NCT01505894|527694540|FG001|Overall Study|Other than specified|0|||
146323234|NCT01505894|527694541|FG002|Overall Study|Other than specified|0|||
146323235|NCT01505894|527694542|FG003|Overall Study|Other than specified|0|||
146323236|NCT01505894|527694543|FG004|Overall Study|Other than specified|1|||
146323237|NCT01505894|527694544|FG005|Overall Study|Other than specified|0|||
146323238|NCT01505894|527694545|FG006|Overall Study|Other than specified|0|||
146323239|NCT01505894|527694546|FG007|Overall Study|Other than specified|0|||
146164956|NCT04642898|527114392|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
146164957|NCT04642898|527114393|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
146164958|NCT04642898|527114394|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
146164959|NCT04642898|527114395|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
146164960|NCT04642898|527114396|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
146164961|NCT04642898|527114397|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
146164962|NCT04642898|527114392|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146164963|NCT04642898|527114393|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146164964|NCT04642898|527114394|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146164965|NCT04642898|527114395|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146164966|NCT04642898|527114396|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
146164967|NCT04642898|527114397|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
146323240|NCT01505894|527694547|FG008|Overall Study|Other than specified|0|||
146323241|NCT02522767|527694549|FG000|Double-blind|Withdrawal by Subject|8|||
146323242|NCT02522767|527694550|FG001|Double-blind|Withdrawal by Subject|11|||
146323243|NCT02522767|527694549|FG000|Double-blind|Lost to Follow-up|1|||
146323244|NCT02522767|527694550|FG001|Double-blind|Lost to Follow-up|0|||
146323245|NCT02522767|527694549|FG000|Double-blind|Adverse Event|1|||
146323246|NCT02522767|527694550|FG001|Double-blind|Adverse Event|10|||
146323247|NCT02522767|527694549|FG000|Double-blind|Protocol Violation|0|||
146323248|NCT02522767|527694550|FG001|Double-blind|Protocol Violation|1|||
146323249|NCT02522767|527694549|FG000|Double-blind|Lack of Efficacy|0|||
146323250|NCT02522767|527694550|FG001|Double-blind|Lack of Efficacy|2|||
146323251|NCT02522767|527694549|FG000|Double-blind|Protocol Deviation|1|||
146323252|NCT02522767|527694550|FG001|Double-blind|Protocol Deviation|0|||
146323253|NCT02522767|527694549|FG000|Open-label|Withdrawal by Subject|2|||
146323254|NCT02522767|527694550|FG001|Open-label|Withdrawal by Subject|3|||
146323255|NCT02522767|527694549|FG000|Open-label|Lost to Follow-up|0|||
146323256|NCT02522767|527694550|FG001|Open-label|Lost to Follow-up|1|||
146323257|NCT02522767|527694549|FG000|Open-label|Adverse Event|2|||
146323258|NCT02522767|527694550|FG001|Open-label|Adverse Event|1|||
146323259|NCT02522767|527694549|FG000|Open-label|Lack of Efficacy|1|||
146323260|NCT02522767|527694550|FG001|Open-label|Lack of Efficacy|1|||
146323261|NCT02522767|527694549|FG000|Open-label|Protocol Violation|0|||
146323262|NCT02522767|527694550|FG001|Open-label|Protocol Violation|1|||
146323263|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
146323264|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
146323265|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
146323266|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
146323267|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
146323268|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
146323269|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
146323270|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
146323271|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
146323272|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
146323273|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
146164968|NCT04280562|527114398|FG000|Study|Adverse Event|2|||
146164969|NCT04280562|527114399|FG001|Study|Adverse Event|0|||
146164970|NCT04280562|527114398|FG000|Study|Lost to Follow-up|3|||
146164971|NCT04280562|527114399|FG001|Study|Lost to Follow-up|3|||
146323274|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
146323275|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
146323276|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
146164972|NCT02618967|527114403|FG000|Overall Study|Lost to Follow-up|0|||
146323277|NCT02288247|527694551|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
146323278|NCT02288247|527694552|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
146323279|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
146323280|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
146323281|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
146323282|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
146323283|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
146323284|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
146323285|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
146323286|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
146323287|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
146323288|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
146323289|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
146323290|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
146323291|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
146323292|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
146323293|NCT02288247|527694551|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
146323294|NCT02288247|527694552|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
146323295|NCT03634800|527694553|FG000|Overall Study|Adverse Event|1|||
146323296|NCT03634800|527694553|FG000|Overall Study|Disease Progression|4|||
146323297|NCT03634800|527694553|FG000|Overall Study|Withdrawal by Subject|1|||
146323298|NCT03555266|527694559|FG000|Overall Study|Protocol Violation|6|||
146323299|NCT03555266|527694560|FG001|Overall Study|Protocol Violation|4|||
146323300|NCT03370770|527694564|FG000|Overall Study|Patient was followed in another hospital center|1|||
146323301|NCT03370770|527694564|FG000|Overall Study|Progressive Disease|98|||
146323302|NCT03370770|527694564|FG000|Overall Study|Adverse Event|2|||
146323303|NCT03370770|527694564|FG000|Overall Study|Death|5|||
146323304|NCT02167945|527694565|FG000|Overall Study|Adverse Event|16|||
146323305|NCT02167945|527694565|FG000|Overall Study|Withdrew Consent|42|||
146323306|NCT02167945|527694565|FG000|Overall Study|Lost to Follow-up|122|||
146323307|NCT02167945|527694565|FG000|Overall Study|COVID-19 logistical restrictions|6|||
146323308|NCT02167945|527694565|FG000|Overall Study|Other, not specified|63|||
146323309|NCT00132730|527694566|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
146323310|NCT00132730|527694567|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
146323311|NCT00132730|527694568|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
146323312|NCT00132730|527694569|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
146323313|NCT00132730|527694570|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
146323314|NCT00132730|527694571|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
146323315|NCT00132730|527694566|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
146323316|NCT00132730|527694567|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
146323317|NCT00132730|527694568|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146323318|NCT00132730|527694569|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146323319|NCT00132730|527694570|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146323320|NCT00132730|527694571|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
146323321|NCT00132730|527694566|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
146323322|NCT00132730|527694567|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
146323323|NCT00132730|527694568|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
146323324|NCT00132730|527694569|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
146323325|NCT00132730|527694570|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
146323326|NCT00132730|527694571|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
146323327|NCT00132730|527694566|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146323328|NCT00132730|527694567|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146323329|NCT00132730|527694568|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
146323330|NCT00132730|527694569|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
146323331|NCT00132730|527694570|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146323332|NCT00132730|527694571|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
146323333|NCT00132730|527694566|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146323334|NCT00132730|527694567|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146323335|NCT00132730|527694568|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
146323336|NCT00132730|527694569|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
146323337|NCT00132730|527694570|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146323338|NCT00132730|527694571|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
146323339|NCT00132730|527694566|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146323340|NCT00132730|527694567|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146323341|NCT00132730|527694568|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145943232|NCT00483704|526300458|FG002|Treatment|Lost to Follow-up|5|||
146164973|NCT02618967|527114404|FG001|Overall Study|Lost to Follow-up|0|||
146323342|NCT00132730|527694569|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
146323343|NCT00132730|527694570|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146323344|NCT00132730|527694571|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
146323345|NCT00132730|527694566|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146323346|NCT00132730|527694567|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146323347|NCT00132730|527694568|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
146323348|NCT00132730|527694569|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
146323349|NCT00132730|527694570|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146323350|NCT00132730|527694571|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
146323351|NCT00132730|527694566|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146323352|NCT00132730|527694567|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146323353|NCT00132730|527694568|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146323354|NCT00132730|527694569|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
146323355|NCT00132730|527694570|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
146323356|NCT00132730|527694571|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
146323357|NCT00132730|527694566|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146323358|NCT00132730|527694567|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146323359|NCT00132730|527694568|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146323360|NCT00132730|527694569|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146323361|NCT00132730|527694570|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
146323362|NCT00132730|527694571|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
146164974|NCT02618967|527114405|FG002|Overall Study|Lost to Follow-up|1|||
146164975|NCT02618967|527114406|FG003|Overall Study|Lost to Follow-up|0|||
146164976|NCT02618967|527114407|FG004|Overall Study|Lost to Follow-up|2|||
146164977|NCT02618967|527114408|FG005|Overall Study|Lost to Follow-up|0|||
146323363|NCT00132730|527694566|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146323364|NCT00132730|527694567|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146323365|NCT00132730|527694568|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146323366|NCT00132730|527694569|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146323367|NCT00132730|527694570|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
146323368|NCT00132730|527694571|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
146323369|NCT00132730|527694566|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146323370|NCT00132730|527694567|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146323371|NCT00132730|527694568|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146323372|NCT00132730|527694569|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146323373|NCT00132730|527694570|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
146323374|NCT00132730|527694571|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
146323375|NCT00132730|527694566|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146323376|NCT00132730|527694567|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146323377|NCT00132730|527694568|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146323378|NCT00132730|527694569|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
146323379|NCT00132730|527694570|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
146323380|NCT00132730|527694571|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
146323381|NCT01192347|527694572|FG000|Overall Study|Death|3|||
146323382|NCT01192347|527694572|FG000|Overall Study|Lost to Follow-up|3|||
146323383|NCT01192347|527694572|FG000|Overall Study|Withdrawal by Subject|1|||
146323384|NCT01192347|527694572|FG000|Overall Study|Adverse Event|1|||
146323385|NCT01192347|527694572|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
146323386|NCT01192347|527694572|FG000|Overall Study|Patient seen in different hospital|1|||
146323387|NCT01192347|527694572|FG000|Overall Study|Patient not visiting hospital regularly|1|||
146323388|NCT01192347|527694572|FG000|Overall Study|Patient did not show up for visits|1|||
146323389|NCT02623335|527694573|FG000|Overall Study|Death|8|||
146323390|NCT02623335|527694574|FG001|Overall Study|Death|7|||
146323391|NCT02623335|527694573|FG000|Overall Study|Lost to Follow-up|15|||
146323392|NCT02623335|527694574|FG001|Overall Study|Lost to Follow-up|23|||
146323393|NCT02623335|527694573|FG000|Overall Study|Withdrawal by Subject|2|||
146323394|NCT02623335|527694574|FG001|Overall Study|Withdrawal by Subject|5|||
146323395|NCT02623335|527694573|FG000|Overall Study|Protocol Violation|2|||
146323396|NCT02623335|527694574|FG001|Overall Study|Protocol Violation|1|||
146323397|NCT03739528|527694575|FG000|Overall Study|Not treated|8|||
146323398|NCT03739528|527694576|FG001|Overall Study|Not treated|12|||
146323399|NCT03739528|527694575|FG000|Overall Study|Treatment and study discontinued|6|||
146323400|NCT03739528|527694576|FG001|Overall Study|Treatment and study discontinued|2|||
146323401|NCT03739528|527694575|FG000|Overall Study|Treatment discontinued + study completed|1|||
146323402|NCT03739528|527694576|FG001|Overall Study|Treatment discontinued + study completed|3|||
146164978|NCT02618967|527114409|FG006|Overall Study|Lost to Follow-up|0|||
146164979|NCT02618967|527114410|FG007|Overall Study|Lost to Follow-up|0|||
146164980|NCT02618967|527114403|FG000|Overall Study|Withdrawal by Subject|1|||
146323403|NCT00395967|527694577|FG000|Treatment Period|Failed Mobilization|1|||
146323404|NCT00395967|527694577|FG000|Follow-up Period|Death|1|||
146323405|NCT00395967|527694577|FG000|Follow-up Period|Lost to Follow-up|1|||
146323406|NCT01109940|527694578|FG000|Overall Study|Administrative problems|2|||
146323407|NCT01109940|527694579|FG001|Overall Study|Administrative problems|0|||
146323408|NCT01109940|527694580|FG002|Overall Study|Administrative problems|0|||
146323409|NCT01109940|527694581|FG003|Overall Study|Administrative problems|0|||
146323410|NCT01109940|527694578|FG000|Overall Study|Serious Adverse Event|2|||
146323411|NCT01109940|527694579|FG001|Overall Study|Serious Adverse Event|1|||
146323412|NCT01109940|527694580|FG002|Overall Study|Serious Adverse Event|0|||
146323413|NCT01109940|527694581|FG003|Overall Study|Serious Adverse Event|0|||
146323414|NCT01109940|527694578|FG000|Overall Study|Lost to Follow-up|1|||
146323415|NCT01109940|527694579|FG001|Overall Study|Lost to Follow-up|0|||
146323416|NCT01109940|527694580|FG002|Overall Study|Lost to Follow-up|0|||
146323417|NCT01109940|527694581|FG003|Overall Study|Lost to Follow-up|0|||
146323418|NCT01109940|527694578|FG000|Overall Study|Patient withdrew consent|1|||
146323419|NCT01109940|527694579|FG001|Overall Study|Patient withdrew consent|1|||
146323420|NCT01109940|527694580|FG002|Overall Study|Patient withdrew consent|0|||
146323421|NCT01109940|527694581|FG003|Overall Study|Patient withdrew consent|0|||
146323422|NCT01109940|527694578|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146323423|NCT01109940|527694579|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146323424|NCT01109940|527694580|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
146323425|NCT01109940|527694581|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
146323426|NCT00179959|527694582|FG000|Overall Study|Lost to Follow-up|3|||
146323427|NCT00179959|527694583|FG001|Overall Study|Lost to Follow-up|1|||
146323428|NCT00179959|527694582|FG000|Overall Study|Withdrawal by Subject|3|||
146323429|NCT00179959|527694583|FG001|Overall Study|Withdrawal by Subject|2|||
146323430|NCT02400255|527694584|FG000|Overall Study|Relapse|4|||
146323431|NCT02400255|527694585|FG001|Overall Study|Relapse|1|||
146323432|NCT02400255|527694586|FG002|Overall Study|Relapse|1|||
146323433|NCT02400255|527694587|FG003|Overall Study|Relapse|2|||
146323434|NCT02400255|527694584|FG000|Overall Study|Adverse Event|6|||
146323435|NCT02400255|527694585|FG001|Overall Study|Adverse Event|3|||
146323436|NCT02400255|527694586|FG002|Overall Study|Adverse Event|0|||
146323437|NCT02400255|527694587|FG003|Overall Study|Adverse Event|0|||
146323438|NCT02400255|527694584|FG000|Overall Study|Physician Decision|6|||
146323439|NCT02400255|527694585|FG001|Overall Study|Physician Decision|0|||
146323440|NCT02400255|527694586|FG002|Overall Study|Physician Decision|0|||
146323441|NCT02400255|527694587|FG003|Overall Study|Physician Decision|0|||
146323442|NCT02400255|527694584|FG000|Overall Study|Loss of insurance|1|||
146323443|NCT02400255|527694585|FG001|Overall Study|Loss of insurance|0|||
146323444|NCT02400255|527694586|FG002|Overall Study|Loss of insurance|0|||
146323445|NCT02400255|527694587|FG003|Overall Study|Loss of insurance|0|||
146323446|NCT01961544|527694588|FG000|Overall Study|Protocol Violation|1|||
146323447|NCT01961544|527694588|FG000|Overall Study|Withdrawal by Subject|7|||
146323448|NCT01961544|527694588|FG000|Overall Study|Adverse Event|1|||
146323449|NCT01961544|527694588|FG000|Overall Study|Physician Decision|2|||
146323450|NCT01961544|527694588|FG000|Overall Study|Poor Tolerance|1|||
146323451|NCT01961544|527694588|FG000|Overall Study|Aggravation of Steral Pain|1|||
146323452|NCT02883244|527694590|FG000|Overall Study|Lost to Follow-up|0|||
146323453|NCT02883244|527694591|FG001|Overall Study|Lost to Follow-up|1|||
146323454|NCT02435914|527694592|FG000|Overall Study|Ocular Adverse Event|1|||
146323455|NCT02435914|527694593|FG001|Overall Study|Ocular Adverse Event|0|||
146164981|NCT02618967|527114404|FG001|Overall Study|Withdrawal by Subject|0|||
146164982|NCT02618967|527114405|FG002|Overall Study|Withdrawal by Subject|0|||
146164983|NCT02618967|527114406|FG003|Overall Study|Withdrawal by Subject|0|||
146164984|NCT02618967|527114407|FG004|Overall Study|Withdrawal by Subject|0|||
146164985|NCT02618967|527114408|FG005|Overall Study|Withdrawal by Subject|0|||
146164986|NCT02618967|527114409|FG006|Overall Study|Withdrawal by Subject|0|||
146164987|NCT02618967|527114410|FG007|Overall Study|Withdrawal by Subject|0|||
146164988|NCT01368965|527114411|FG000|Overall Study|Lost to Follow-up|12|||
146164989|NCT04559568|527114415|FG000|Overall Study|Physician Decision|0|||
146164990|NCT04559568|527114416|FG001|Overall Study|Physician Decision|0|||
146323456|NCT02435914|527694594|FG002|Overall Study|Ocular Adverse Event|0|||
146323457|NCT02435914|527694595|FG003|Overall Study|Ocular Adverse Event|0|||
146164991|NCT04559568|527114417|FG002|Overall Study|Physician Decision|0|||
146164992|NCT04559568|527114418|FG003|Overall Study|Physician Decision|0|||
146323458|NCT02435914|527694592|FG000|Overall Study|Withdrawal by Subject|0|||
146323459|NCT02435914|527694593|FG001|Overall Study|Withdrawal by Subject|1|||
146323460|NCT02435914|527694594|FG002|Overall Study|Withdrawal by Subject|0|||
145943233|NCT00483704|526300456|FG000|Treatment|Lack of Efficacy|1|||
146164993|NCT04559568|527114419|FG004|Overall Study|Physician Decision|0|||
146164994|NCT04559568|527114420|FG005|Overall Study|Physician Decision|0|||
146164995|NCT04559568|527114421|FG006|Overall Study|Physician Decision|0|||
146164996|NCT04559568|527114422|FG007|Overall Study|Physician Decision|0|||
146323461|NCT02435914|527694595|FG003|Overall Study|Withdrawal by Subject|0|||
146323462|NCT02435914|527694592|FG000|Overall Study|Other Miscellaneous Reason|0|||
146323463|NCT02435914|527694593|FG001|Overall Study|Other Miscellaneous Reason|0|||
146323464|NCT02435914|527694594|FG002|Overall Study|Other Miscellaneous Reason|1|||
146323465|NCT02435914|527694595|FG003|Overall Study|Other Miscellaneous Reason|0|||
146323466|NCT01727258|527694596|FG000|Overall Study|Adverse Event|0|||
146323467|NCT01727258|527694597|FG001|Overall Study|Adverse Event|2|||
146323468|NCT01727258|527694598|FG002|Overall Study|Adverse Event|0|||
146323469|NCT01727258|527694596|FG000|Overall Study|Noncompliance with Study Drug|0|||
146323470|NCT01727258|527694597|FG001|Overall Study|Noncompliance with Study Drug|0|||
146323471|NCT01727258|527694598|FG002|Overall Study|Noncompliance with Study Drug|1|||
146323472|NCT01727258|527694596|FG000|Overall Study|Withdrawal by Subject|1|||
146323473|NCT01727258|527694597|FG001|Overall Study|Withdrawal by Subject|1|||
146323474|NCT01727258|527694598|FG002|Overall Study|Withdrawal by Subject|0|||
146323475|NCT01727258|527694596|FG000|Overall Study|Lost to Follow-up|1|||
146323476|NCT01727258|527694597|FG001|Overall Study|Lost to Follow-up|0|||
146323477|NCT01727258|527694598|FG002|Overall Study|Lost to Follow-up|0|||
146323478|NCT03604445|527694601|FG000|Overall Study|Death|0|||
146323479|NCT03604445|527694602|FG001|Overall Study|Death|0|||
146323480|NCT03604445|527694603|FG002|Overall Study|Death|0|||
146323481|NCT03604445|527694604|FG003|Overall Study|Death|0|||
146323482|NCT03604445|527694605|FG004|Overall Study|Death|0|||
146323483|NCT03604445|527694606|FG005|Overall Study|Death|0|||
146323484|NCT03604445|527694607|FG006|Overall Study|Death|0|||
146323485|NCT03604445|527694608|FG007|Overall Study|Death|0|||
146323486|NCT03604445|527694609|FG008|Overall Study|Death|1|||
146323487|NCT03604445|527694601|FG000|Overall Study|Withdrawal by Subject|0|||
146323488|NCT03604445|527694602|FG001|Overall Study|Withdrawal by Subject|0|||
146323489|NCT03604445|527694603|FG002|Overall Study|Withdrawal by Subject|0|||
146323490|NCT03604445|527694604|FG003|Overall Study|Withdrawal by Subject|0|||
146323491|NCT03604445|527694605|FG004|Overall Study|Withdrawal by Subject|0|||
146323492|NCT03604445|527694606|FG005|Overall Study|Withdrawal by Subject|0|||
146323493|NCT03604445|527694607|FG006|Overall Study|Withdrawal by Subject|1|||
146323494|NCT03604445|527694608|FG007|Overall Study|Withdrawal by Subject|0|||
146323495|NCT03604445|527694609|FG008|Overall Study|Withdrawal by Subject|0|||
146323496|NCT03604445|527694601|FG000|Overall Study|Missing visit|0|||
146323497|NCT03604445|527694602|FG001|Overall Study|Missing visit|0|||
146323498|NCT03604445|527694603|FG002|Overall Study|Missing visit|0|||
146323499|NCT03604445|527694604|FG003|Overall Study|Missing visit|0|||
146323500|NCT03604445|527694605|FG004|Overall Study|Missing visit|0|||
146323501|NCT03604445|527694606|FG005|Overall Study|Missing visit|1|||
146323502|NCT03604445|527694607|FG006|Overall Study|Missing visit|0|||
146323503|NCT03604445|527694608|FG007|Overall Study|Missing visit|1|||
146323504|NCT03604445|527694609|FG008|Overall Study|Missing visit|0|||
146323505|NCT03604445|527694601|FG000|Overall Study|Adverse Event|0|||
146323506|NCT03604445|527694602|FG001|Overall Study|Adverse Event|0|||
146323507|NCT03604445|527694603|FG002|Overall Study|Adverse Event|0|||
146323508|NCT03604445|527694604|FG003|Overall Study|Adverse Event|1|||
146323509|NCT03604445|527694605|FG004|Overall Study|Adverse Event|0|||
146323510|NCT03604445|527694606|FG005|Overall Study|Adverse Event|0|||
146323511|NCT03604445|527694607|FG006|Overall Study|Adverse Event|0|||
146323512|NCT03604445|527694608|FG007|Overall Study|Adverse Event|0|||
146323513|NCT03604445|527694609|FG008|Overall Study|Adverse Event|1|||
146323514|NCT00773279|527694610|FG000|Period 1|Adverse Event|2|||
146323515|NCT00773279|527694611|FG001|Period 1|Adverse Event|1|||
146323516|NCT00773279|527694610|FG000|Period 1|Lack of Efficacy|0|||
146323517|NCT00773279|527694611|FG001|Period 1|Lack of Efficacy|2|||
146323518|NCT00773279|527694610|FG000|Period 1|Unclassified|5|||
146323519|NCT00773279|527694611|FG001|Period 1|Unclassified|1|||
146323520|NCT00773279|527694610|FG000|Period 2|Adverse Event|0|||
146323521|NCT00773279|527694611|FG001|Period 2|Adverse Event|1|||
146323522|NCT00773279|527694610|FG000|Period 2|Lack of Efficacy|1|||
146323523|NCT00773279|527694611|FG001|Period 2|Lack of Efficacy|0|||
146323524|NCT00773279|527694610|FG000|Period 2|Protocol Violation|0|||
146323525|NCT00773279|527694611|FG001|Period 2|Protocol Violation|3|||
146323526|NCT00773279|527694610|FG000|Period 2|Unclassified|2|||
146323527|NCT00773279|527694611|FG001|Period 2|Unclassified|2|||
146323528|NCT02175680|527694612|FG000|Overall Study|non-compliance|1|||
146323529|NCT02175680|527694612|FG000|Overall Study|other non-medical reason|1|||
146323530|NCT03434379|527694616|FG000|Global Period|Lost to Follow-up|3|||
146323531|NCT03434379|527694617|FG001|Global Period|Lost to Follow-up|6|||
146323532|NCT03434379|527694618|FG002|Global Period|Lost to Follow-up|0|||
146323533|NCT03434379|527694619|FG003|Global Period|Lost to Follow-up|0|||
146323534|NCT03434379|527694616|FG000|Global Period|Death|115|||
146323535|NCT03434379|527694617|FG001|Global Period|Death|228|||
146323536|NCT03434379|527694618|FG002|Global Period|Death|0|||
146323537|NCT03434379|527694619|FG003|Global Period|Death|0|||
146323538|NCT03434379|527694616|FG000|Global Period|Withdrawal by Subject|20|||
146323539|NCT03434379|527694617|FG001|Global Period|Withdrawal by Subject|21|||
146323540|NCT03434379|527694618|FG002|Global Period|Withdrawal by Subject|0|||
146323541|NCT03434379|527694619|FG003|Global Period|Withdrawal by Subject|0|||
146323542|NCT03434379|527694616|FG000|Global Period|Reason Unspecified|0|||
146323543|NCT03434379|527694617|FG001|Global Period|Reason Unspecified|1|||
146323544|NCT03434379|527694618|FG002|Global Period|Reason Unspecified|0|||
146323545|NCT03434379|527694619|FG003|Global Period|Reason Unspecified|0|||
146323546|NCT03434379|527694616|FG000|Global Period|Study Ended by Sponsor|26|||
146323547|NCT03434379|527694617|FG001|Global Period|Study Ended by Sponsor|80|||
146323548|NCT03434379|527694618|FG002|Global Period|Study Ended by Sponsor|0|||
146323549|NCT03434379|527694619|FG003|Global Period|Study Ended by Sponsor|0|||
146323550|NCT03434379|527694616|FG000|Global Period|Physician Decision|1|||
146323551|NCT03434379|527694617|FG001|Global Period|Physician Decision|0|||
146323552|NCT03434379|527694618|FG002|Global Period|Physician Decision|0|||
146323553|NCT03434379|527694619|FG003|Global Period|Physician Decision|0|||
146323554|NCT03434379|527694616|FG000|China Extension Period|Lost to Follow-up|0|||
146323555|NCT03434379|527694617|FG001|China Extension Period|Lost to Follow-up|0|||
146323556|NCT03434379|527694618|FG002|China Extension Period|Lost to Follow-up|2|||
146323557|NCT03434379|527694619|FG003|China Extension Period|Lost to Follow-up|3|||
146323558|NCT03434379|527694616|FG000|China Extension Period|Death|0|||
146323559|NCT03434379|527694617|FG001|China Extension Period|Death|0|||
146323560|NCT03434379|527694618|FG002|China Extension Period|Death|46|||
146323561|NCT03434379|527694619|FG003|China Extension Period|Death|88|||
146323562|NCT03434379|527694616|FG000|China Extension Period|Withdrawal by Subject|0|||
146323563|NCT03434379|527694617|FG001|China Extension Period|Withdrawal by Subject|0|||
146323564|NCT03434379|527694618|FG002|China Extension Period|Withdrawal by Subject|8|||
146323565|NCT03434379|527694619|FG003|China Extension Period|Withdrawal by Subject|6|||
146323566|NCT03434379|527694616|FG000|China Extension Period|Study Ended by Sponsor|0|||
146323567|NCT03434379|527694617|FG001|China Extension Period|Study Ended by Sponsor|0|||
146323568|NCT03434379|527694618|FG002|China Extension Period|Study Ended by Sponsor|5|||
146323569|NCT03434379|527694619|FG003|China Extension Period|Study Ended by Sponsor|36|||
146323570|NCT01469000|527694620|FG000|Overall Study|Withdrawal by Subject|16|||
146323571|NCT01469000|527694621|FG001|Overall Study|Withdrawal by Subject|3|||
146323572|NCT01469000|527694620|FG000|Overall Study|Sponsor Decision|4|||
146323573|NCT01469000|527694621|FG001|Overall Study|Sponsor Decision|1|||
146323574|NCT02026063|527694624|FG000|Overall Study|Physician Decision|0|||
146323575|NCT02026063|527694625|FG001|Overall Study|Physician Decision|10|||
146323576|NCT02026063|527694624|FG000|Overall Study|Noncompliance with Study Drug|1|||
146323577|NCT02026063|527694625|FG001|Overall Study|Noncompliance with Study Drug|1|||
146323578|NCT02026063|527694624|FG000|Overall Study|Withdrawal of Consent|1|||
146323579|NCT02026063|527694625|FG001|Overall Study|Withdrawal of Consent|6|||
146323580|NCT02026063|527694624|FG000|Overall Study|Adverse Event|5|||
146323581|NCT02026063|527694625|FG001|Overall Study|Adverse Event|20|||
146323582|NCT02026063|527694624|FG000|Overall Study|Lack of Efficacy|0|||
146323583|NCT02026063|527694625|FG001|Overall Study|Lack of Efficacy|4|||
146323584|NCT02026063|527694624|FG000|Overall Study|Lost to Follow-up|0|||
146323585|NCT02026063|527694625|FG001|Overall Study|Lost to Follow-up|1|||
146323586|NCT02026063|527694624|FG000|Overall Study|Reason not Specified|2|||
146323587|NCT02026063|527694625|FG001|Overall Study|Reason not Specified|7|||
146323588|NCT00486278|527694626|FG000|Overall Study|Adverse Event|5|||
146323589|NCT00486278|527694626|FG000|Overall Study|Withdrawal by Subject|2|||
146323590|NCT00486278|527694626|FG000|Overall Study|Physician Decision|2|||
146323591|NCT02183519|527694632|FG000|Overall Study|computer error|3|||
146323592|NCT02183519|527694633|FG001|Overall Study|computer error|0|||
146323593|NCT02183519|527694632|FG000|Overall Study|Did not respond to cough inducter|0|||
146323594|NCT02183519|527694633|FG001|Overall Study|Did not respond to cough inducter|3|||
146323595|NCT04556617|527694634|FG000|Overall Study|progressive disease|0|||
146323596|NCT04556617|527694635|FG001|Overall Study|progressive disease|2|||
146323597|NCT04556617|527694636|FG002|Overall Study|progressive disease|2|||
146323598|NCT04556617|527694637|FG003|Overall Study|progressive disease|1|||
146323599|NCT04556617|527694638|FG004|Overall Study|progressive disease|1|||
146323600|NCT04556617|527694634|FG000|Overall Study|Physician Decision|0|||
146323601|NCT04556617|527694635|FG001|Overall Study|Physician Decision|0|||
146323602|NCT04556617|527694636|FG002|Overall Study|Physician Decision|2|||
146323603|NCT04556617|527694637|FG003|Overall Study|Physician Decision|0|||
146323604|NCT04556617|527694638|FG004|Overall Study|Physician Decision|0|||
146323605|NCT04556617|527694634|FG000|Overall Study|Adverse Event|0|||
146323606|NCT04556617|527694635|FG001|Overall Study|Adverse Event|0|||
146323607|NCT04556617|527694636|FG002|Overall Study|Adverse Event|2|||
146323608|NCT04556617|527694637|FG003|Overall Study|Adverse Event|3|||
146323609|NCT04556617|527694638|FG004|Overall Study|Adverse Event|0|||
146323610|NCT04556617|527694634|FG000|Overall Study|Withdrawal by Subject|0|||
146323611|NCT04556617|527694635|FG001|Overall Study|Withdrawal by Subject|2|||
146323612|NCT04556617|527694636|FG002|Overall Study|Withdrawal by Subject|1|||
146323613|NCT04556617|527694637|FG003|Overall Study|Withdrawal by Subject|1|||
146164997|NCT04559568|527114423|FG008|Overall Study|Physician Decision|0|||
146323614|NCT04556617|527694638|FG004|Overall Study|Withdrawal by Subject|0|||
146323615|NCT04556617|527694634|FG000|Overall Study|PSA increase|0|||
146323616|NCT04556617|527694635|FG001|Overall Study|PSA increase|1|||
146323617|NCT04556617|527694636|FG002|Overall Study|PSA increase|0|||
146323618|NCT04556617|527694637|FG003|Overall Study|PSA increase|0|||
146323619|NCT04556617|527694638|FG004|Overall Study|PSA increase|0|||
146323620|NCT04556617|527694634|FG000|Overall Study|Sponsor study termination|1|||
146323621|NCT04556617|527694635|FG001|Overall Study|Sponsor study termination|0|||
146323622|NCT04556617|527694636|FG002|Overall Study|Sponsor study termination|0|||
146323623|NCT04556617|527694637|FG003|Overall Study|Sponsor study termination|0|||
146323624|NCT04556617|527694638|FG004|Overall Study|Sponsor study termination|0|||
146323625|NCT04949841|527694639|FG000|Overall Study|Adverse Event|7|||
146323626|NCT04949841|527694639|FG000|Overall Study|Death|1|||
146323627|NCT04949841|527694639|FG000|Overall Study|Withdrawal by Subject|52|||
146323628|NCT04949841|527694639|FG000|Overall Study|Pregnancy|4|||
146323629|NCT04949841|527694639|FG000|Overall Study|Lost to Follow-up|9|||
146323630|NCT04949841|527694639|FG000|Overall Study|Lack of Efficacy|55|||
146323631|NCT04949841|527694639|FG000|Overall Study|Various reasons|9|||
146323632|NCT03179436|527694640|FG000|Overall Study|Withdrawal by Subject|1|||
146323633|NCT03179436|527694641|FG001|Overall Study|Withdrawal by Subject|0|||
146323634|NCT03179436|527694642|FG002|Overall Study|Withdrawal by Subject|0|||
146323635|NCT03179436|527694643|FG003|Overall Study|Withdrawal by Subject|4|||
146323636|NCT03179436|527694644|FG004|Overall Study|Withdrawal by Subject|2|||
146323637|NCT03179436|527694645|FG005|Overall Study|Withdrawal by Subject|2|||
146323638|NCT03179436|527694646|FG006|Overall Study|Withdrawal by Subject|5|||
146323639|NCT03179436|527694647|FG007|Overall Study|Withdrawal by Subject|0|||
146323640|NCT03179436|527694648|FG008|Overall Study|Withdrawal by Subject|3|||
146323641|NCT03179436|527694649|FG009|Overall Study|Withdrawal by Subject|0|||
146323642|NCT03179436|527694650|FG010|Overall Study|Withdrawal by Subject|0|||
146323643|NCT03179436|527694651|FG011|Overall Study|Withdrawal by Subject|0|||
146323644|NCT03179436|527694640|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146323645|NCT03179436|527694641|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146323646|NCT03179436|527694642|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146323647|NCT03179436|527694643|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146323648|NCT03179436|527694644|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146323649|NCT03179436|527694645|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
146323650|NCT03179436|527694646|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
146323651|NCT03179436|527694647|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
146323652|NCT03179436|527694648|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
146323653|NCT03179436|527694649|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
146323654|NCT03179436|527694650|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
146323655|NCT03179436|527694651|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
146323656|NCT03179436|527694640|FG000|Overall Study|Sponsor Decision|0|||
146323657|NCT03179436|527694641|FG001|Overall Study|Sponsor Decision|0|||
146323658|NCT03179436|527694642|FG002|Overall Study|Sponsor Decision|1|||
146323659|NCT03179436|527694643|FG003|Overall Study|Sponsor Decision|3|||
146323660|NCT03179436|527694644|FG004|Overall Study|Sponsor Decision|9|||
146323661|NCT03179436|527694645|FG005|Overall Study|Sponsor Decision|7|||
146323662|NCT03179436|527694646|FG006|Overall Study|Sponsor Decision|2|||
146323663|NCT03179436|527694647|FG007|Overall Study|Sponsor Decision|4|||
146323664|NCT03179436|527694648|FG008|Overall Study|Sponsor Decision|23|||
146323665|NCT03179436|527694649|FG009|Overall Study|Sponsor Decision|6|||
146323666|NCT03179436|527694650|FG010|Overall Study|Sponsor Decision|7|||
146323667|NCT03179436|527694651|FG011|Overall Study|Sponsor Decision|5|||
146323668|NCT03179436|527694640|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323669|NCT03179436|527694641|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
146323670|NCT03179436|527694642|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323671|NCT03179436|527694643|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323672|NCT03179436|527694644|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323673|NCT03179436|527694645|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
146323674|NCT03179436|527694646|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323675|NCT03179436|527694647|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323676|NCT03179436|527694648|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323677|NCT03179436|527694649|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323678|NCT03179436|527694650|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
146323679|NCT03179436|527694651|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
146164998|NCT04559568|527114424|FG009|Overall Study|Physician Decision|1|||
146164999|NCT04559568|527114425|FG010|Overall Study|Physician Decision|0|||
146165000|NCT04559568|527114415|FG000|Overall Study|Withdrawal by Subject|0|||
146165001|NCT04559568|527114416|FG001|Overall Study|Withdrawal by Subject|0|||
146165002|NCT04559568|527114417|FG002|Overall Study|Withdrawal by Subject|0|||
146165003|NCT04559568|527114418|FG003|Overall Study|Withdrawal by Subject|0|||
146165004|NCT04559568|527114419|FG004|Overall Study|Withdrawal by Subject|0|||
146165005|NCT04559568|527114420|FG005|Overall Study|Withdrawal by Subject|0|||
146165006|NCT04559568|527114421|FG006|Overall Study|Withdrawal by Subject|0|||
146165007|NCT04559568|527114422|FG007|Overall Study|Withdrawal by Subject|0|||
146165008|NCT04559568|527114423|FG008|Overall Study|Withdrawal by Subject|0|||
146165009|NCT04559568|527114424|FG009|Overall Study|Withdrawal by Subject|0|||
146323680|NCT03179436|527694640|FG000|Overall Study|Lost to Follow-up|1|||
146323681|NCT03179436|527694641|FG001|Overall Study|Lost to Follow-up|0|||
145943234|NCT00483704|526300457|FG001|Treatment|Lack of Efficacy|1|||
146323682|NCT03179436|527694642|FG002|Overall Study|Lost to Follow-up|0|||
146323683|NCT03179436|527694643|FG003|Overall Study|Lost to Follow-up|1|||
146323684|NCT03179436|527694644|FG004|Overall Study|Lost to Follow-up|0|||
146323685|NCT03179436|527694645|FG005|Overall Study|Lost to Follow-up|1|||
146323686|NCT03179436|527694646|FG006|Overall Study|Lost to Follow-up|0|||
146323687|NCT03179436|527694647|FG007|Overall Study|Lost to Follow-up|0|||
146323688|NCT03179436|527694648|FG008|Overall Study|Lost to Follow-up|1|||
146323689|NCT03179436|527694649|FG009|Overall Study|Lost to Follow-up|1|||
146323690|NCT03179436|527694650|FG010|Overall Study|Lost to Follow-up|0|||
146323691|NCT03179436|527694651|FG011|Overall Study|Lost to Follow-up|0|||
146323692|NCT03179436|527694640|FG000|Overall Study|Death|12|||
146323693|NCT03179436|527694641|FG001|Overall Study|Death|17|||
146323694|NCT03179436|527694642|FG002|Overall Study|Death|7|||
146323695|NCT03179436|527694643|FG003|Overall Study|Death|32|||
146323696|NCT03179436|527694644|FG004|Overall Study|Death|29|||
146323697|NCT03179436|527694645|FG005|Overall Study|Death|30|||
146323698|NCT03179436|527694646|FG006|Overall Study|Death|33|||
146323699|NCT03179436|527694647|FG007|Overall Study|Death|9|||
146323700|NCT03179436|527694648|FG008|Overall Study|Death|84|||
146323701|NCT03179436|527694649|FG009|Overall Study|Death|33|||
146323702|NCT03179436|527694650|FG010|Overall Study|Death|22|||
146323703|NCT03179436|527694651|FG011|Overall Study|Death|15|||
146323704|NCT01634555|527694662|FG000|Overall Study|Adverse Event|3|||
146323705|NCT01634555|527694662|FG000|Overall Study|Physician Decision|1|||
146323706|NCT01738971|527694665|FG000|Overall Study|Lost to Follow-up|19|||
146323707|NCT01738971|527694666|FG001|Overall Study|Lost to Follow-up|30|||
146323708|NCT01738971|527694667|FG002|Overall Study|Lost to Follow-up|17|||
146323709|NCT04698629|527694670|FG000|Overall Study|Adverse Event|1|||
146323710|NCT01182428|527694671|FG000|Overall Study|Physician Decision|1|||
146323711|NCT01182428|527694672|FG001|Overall Study|Physician Decision|0|||
146323712|NCT01182428|527694671|FG000|Overall Study|Lost to Follow-up|9|||
146323713|NCT01182428|527694672|FG001|Overall Study|Lost to Follow-up|1|||
146323714|NCT01182428|527694671|FG000|Overall Study|Withdrawal by Subject|1|||
146323715|NCT01182428|527694672|FG001|Overall Study|Withdrawal by Subject|0|||
146323716|NCT02949128|527696527|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
146323717|NCT02949128|527696527|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
146323718|NCT02949128|527696527|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
146323719|NCT02949128|527696527|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
146323720|NCT02949128|527696527|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
146323721|NCT02949128|527696527|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
146323722|NCT02949128|527696527|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
146323723|NCT02949128|527696527|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
146323724|NCT02949128|527696527|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
146323725|NCT02949128|527696527|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
146323726|NCT01602341|527696528|FG000|Overall Study|Adverse Event|0|||
146323727|NCT01602341|527696529|FG001|Overall Study|Adverse Event|1|||
146323728|NCT02152345|527696530|FG000|Overall Study|Case Cancellations|2|||
146323729|NCT02152345|527696531|FG001|Overall Study|Case Cancellations|4|||
146323730|NCT02152345|527696530|FG000|Overall Study|Withdrawal by Subject|2|||
146323731|NCT02152345|527696531|FG001|Overall Study|Withdrawal by Subject|1|||
146323732|NCT02554929|527696533|FG000|Overall Study|Lost to Follow-up|4|||
146323733|NCT02554929|527696534|FG001|Overall Study|Lost to Follow-up|4|||
146323734|NCT02554929|527696533|FG000|Overall Study|Withdrawal by Subject|2|||
146323735|NCT02554929|527696534|FG001|Overall Study|Withdrawal by Subject|8|||
146323736|NCT01916980|527696535|FG000|Overall Study|Adverse Event|4|||
146323737|NCT01916980|527696536|FG001|Overall Study|Adverse Event|2|||
146323738|NCT01916980|527696535|FG000|Overall Study|Lack of Efficacy|2|||
146323739|NCT01916980|527696536|FG001|Overall Study|Lack of Efficacy|2|||
146323740|NCT01916980|527696535|FG000|Overall Study|Withdrawal by Subject|1|||
146323741|NCT01916980|527696536|FG001|Overall Study|Withdrawal by Subject|0|||
146323742|NCT00546364|527696537|FG000|Overall Study|Disease progression|5|||
146323743|NCT00546364|527696538|FG001|Overall Study|Disease progression|11|||
146323744|NCT00546364|527696539|FG002|Overall Study|Disease progression|8|||
146323745|NCT00546364|527696537|FG000|Overall Study|Completed and off treatment|1|||
146323746|NCT00546364|527696538|FG001|Overall Study|Completed and off treatment|0|||
146323747|NCT00546364|527696539|FG002|Overall Study|Completed and off treatment|2|||
146323748|NCT00546364|527696537|FG000|Overall Study|Administrative reason by sponsor|1|||
146323749|NCT00546364|527696538|FG001|Overall Study|Administrative reason by sponsor|0|||
146323750|NCT00546364|527696539|FG002|Overall Study|Administrative reason by sponsor|0|||
146323751|NCT00546364|527696537|FG000|Overall Study|Poor compliance/noncompliance|0|||
146323752|NCT00546364|527696538|FG001|Overall Study|Poor compliance/noncompliance|0|||
146323753|NCT00546364|527696539|FG002|Overall Study|Poor compliance/noncompliance|1|||
146323754|NCT00546364|527696537|FG000|Overall Study|No longer meets study criteria|1|||
146323755|NCT00546364|527696538|FG001|Overall Study|No longer meets study criteria|1|||
146323756|NCT00546364|527696539|FG002|Overall Study|No longer meets study criteria|0|||
146323757|NCT00546364|527696537|FG000|Overall Study|Withdrawal by Subject|5|||
146323758|NCT00546364|527696538|FG001|Overall Study|Withdrawal by Subject|6|||
146323759|NCT00546364|527696539|FG002|Overall Study|Withdrawal by Subject|3|||
146323760|NCT00546364|527696537|FG000|Overall Study|Prior taxotere|1|||
146323761|NCT00546364|527696538|FG001|Overall Study|Prior taxotere|0|||
146323762|NCT00546364|527696539|FG002|Overall Study|Prior taxotere|0|||
146323763|NCT00546364|527696537|FG000|Overall Study|Mixed response|1|||
146323764|NCT00546364|527696538|FG001|Overall Study|Mixed response|0|||
146323765|NCT00546364|527696539|FG002|Overall Study|Mixed response|0|||
146323766|NCT00546364|527696537|FG000|Overall Study|Palliative treatment|1|||
146323767|NCT00546364|527696538|FG001|Overall Study|Palliative treatment|0|||
146323768|NCT00546364|527696539|FG002|Overall Study|Palliative treatment|1|||
146323769|NCT00546364|527696537|FG000|Overall Study|Target lesions resected|1|||
146323770|NCT00546364|527696538|FG001|Overall Study|Target lesions resected|0|||
146323771|NCT00546364|527696539|FG002|Overall Study|Target lesions resected|0|||
146323772|NCT00546364|527696537|FG000|Overall Study|Physician Decision|0|||
146165010|NCT04559568|527114425|FG010|Overall Study|Withdrawal by Subject|1|||
146165011|NCT00045305|527114431|FG000|Overall Study|Lack of Efficacy|6|||
146165012|NCT00045305|527114431|FG000|Overall Study|Adverse Event|3|||
146165013|NCT00045305|527114431|FG000|Overall Study|Death|3|||
146323773|NCT00546364|527696538|FG001|Overall Study|Physician Decision|0|||
146323774|NCT00546364|527696539|FG002|Overall Study|Physician Decision|1|||
146323775|NCT00546364|527696537|FG000|Overall Study|Sponsor decision|0|||
146323776|NCT00546364|527696538|FG001|Overall Study|Sponsor decision|0|||
146323777|NCT00546364|527696539|FG002|Overall Study|Sponsor decision|1|||
146323778|NCT02090855|527696540|FG000|Overall Study|no evaluable Standard of Truth results|2|||
146323779|NCT00880750|527696545|FG000|First Intervention|Adverse Event|1|||
146323780|NCT00880750|527696546|FG001|First Intervention|Adverse Event|0|||
146323781|NCT00880750|527696545|FG000|First Intervention|Unable to collect urine|4|||
146323782|NCT00880750|527696546|FG001|First Intervention|Unable to collect urine|0|||
146323783|NCT00880750|527696545|FG000|First Intervention|Non-compliance with meals|0|||
146323784|NCT00880750|527696546|FG001|First Intervention|Non-compliance with meals|1|||
146323785|NCT00880750|527696545|FG000|First Intervention|Withdrawal by Subject|2|||
146323786|NCT00880750|527696546|FG001|First Intervention|Withdrawal by Subject|0|||
146323787|NCT00880750|527696545|FG000|First Intervention|Lost to Follow-up|2|||
146323788|NCT00880750|527696546|FG001|First Intervention|Lost to Follow-up|0|||
146323789|NCT00880750|527696545|FG000|Second Intervention|Withdrawal by Subject|2|||
146323790|NCT00880750|527696546|FG001|Second Intervention|Withdrawal by Subject|2|||
146323791|NCT00880750|527696545|FG000|Second Intervention|Protocol Violation|1|||
146323792|NCT00880750|527696546|FG001|Second Intervention|Protocol Violation|0|||
146323793|NCT00880750|527696545|FG000|Second Intervention|Unable to collect urine|1|||
146323794|NCT00880750|527696546|FG001|Second Intervention|Unable to collect urine|0|||
146323795|NCT00667576|527696549|FG000|Overall Study|Withdrawal by Subject|1|||
146323796|NCT00667576|527696550|FG001|Overall Study|Withdrawal by Subject|0|||
146323797|NCT00667576|527696551|FG002|Overall Study|Withdrawal by Subject|1|||
146323798|NCT00667576|527696552|FG003|Overall Study|Withdrawal by Subject|1|||
146323799|NCT00667576|527696553|FG004|Overall Study|Withdrawal by Subject|1|||
146323800|NCT00667576|527696549|FG000|Overall Study|Adverse Event|1|||
146323801|NCT00667576|527696550|FG001|Overall Study|Adverse Event|1|||
146323802|NCT00667576|527696551|FG002|Overall Study|Adverse Event|0|||
146323803|NCT00667576|527696552|FG003|Overall Study|Adverse Event|0|||
146323804|NCT00667576|527696553|FG004|Overall Study|Adverse Event|0|||
146323805|NCT00667576|527696549|FG000|Overall Study|Lost to Follow-up|0|||
146323806|NCT00667576|527696550|FG001|Overall Study|Lost to Follow-up|0|||
146323807|NCT00667576|527696551|FG002|Overall Study|Lost to Follow-up|1|||
146323808|NCT00667576|527696552|FG003|Overall Study|Lost to Follow-up|0|||
146323809|NCT00667576|527696553|FG004|Overall Study|Lost to Follow-up|0|||
146323810|NCT00667576|527696549|FG000|Overall Study|Protocol Violation|0|||
146323811|NCT00667576|527696550|FG001|Overall Study|Protocol Violation|0|||
146323812|NCT00667576|527696551|FG002|Overall Study|Protocol Violation|0|||
146323813|NCT00667576|527696552|FG003|Overall Study|Protocol Violation|1|||
146323814|NCT00667576|527696553|FG004|Overall Study|Protocol Violation|0|||
146323815|NCT00667576|527696549|FG000|Overall Study|Physician Decision|0|||
146323816|NCT00667576|527696550|FG001|Overall Study|Physician Decision|0|||
146323817|NCT00667576|527696551|FG002|Overall Study|Physician Decision|0|||
146323818|NCT00667576|527696552|FG003|Overall Study|Physician Decision|1|||
146323819|NCT00667576|527696553|FG004|Overall Study|Physician Decision|0|||
146323820|NCT00667576|527696549|FG000|Overall Study|Missed Visit|0|||
146323821|NCT00667576|527696550|FG001|Overall Study|Missed Visit|0|||
146323822|NCT00667576|527696551|FG002|Overall Study|Missed Visit|0|||
146323823|NCT00667576|527696552|FG003|Overall Study|Missed Visit|1|||
146323824|NCT00667576|527696553|FG004|Overall Study|Missed Visit|0|||
146323825|NCT01390389|527696554|FG000|Overall Study|Withdrawal by Subject|2|||
146323826|NCT01390389|527696555|FG001|Overall Study|Withdrawal by Subject|0|||
146323827|NCT01390389|527696554|FG000|Overall Study|Screen Fail|2|||
146323828|NCT01390389|527696555|FG001|Overall Study|Screen Fail|1|||
146323829|NCT03593915|527696556|FG000|Overall Study|Adverse Event|0|||
146165014|NCT00045305|527114431|FG000|Overall Study|site error|2|||
146165015|NCT04274894|527114432|FG000|Overall Study|Adverse Event|7|||
146323830|NCT03593915|527696557|FG001|Overall Study|Adverse Event|0|||
146323831|NCT03593915|527696558|FG002|Overall Study|Adverse Event|0|||
146323832|NCT03593915|527696559|FG003|Overall Study|Adverse Event|1|||
146323833|NCT03593915|527696560|FG004|Overall Study|Adverse Event|0|||
146323834|NCT03593915|527696561|FG005|Overall Study|Adverse Event|0|||
146323835|NCT03593915|527696556|FG000|Overall Study|Physician Decision|0|||
146323836|NCT03593915|527696557|FG001|Overall Study|Physician Decision|0|||
146323837|NCT03593915|527696558|FG002|Overall Study|Physician Decision|0|||
146323838|NCT03593915|527696559|FG003|Overall Study|Physician Decision|0|||
146323839|NCT03593915|527696560|FG004|Overall Study|Physician Decision|0|||
146323840|NCT03593915|527696561|FG005|Overall Study|Physician Decision|1|||
146323841|NCT01583179|527696562|FG000|Overall Study|Screen failure|1|||
146323842|NCT01583179|527696563|FG001|Overall Study|Screen failure|2|||
146323843|NCT01246206|527696564|FG000|Overall Study|Patient did not receive study regiments.|1|||
146323844|NCT02002975|527696565|FG000|Overall Study|Case Report Forms Uncollected|135|||
146323845|NCT02002975|527696565|FG000|Overall Study|Protocol Deviation|437|||
146323846|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
146323847|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
146323848|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
146323849|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
146323850|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
146323851|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
146323852|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
146323853|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
146323854|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
146323855|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
146323856|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
146323857|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
146323858|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
146323859|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
146323860|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
146323861|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
146323862|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
146323863|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
146323864|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
146323865|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
146323866|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
146323867|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
146323868|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
146323869|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
146323870|NCT04660643|527696566|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
146323871|NCT04660643|527696567|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
146323872|NCT04660643|527696568|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
146323873|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
146323874|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
146323875|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
146323876|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
146323877|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
146323878|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
146323879|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
146323880|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
146323881|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
146323882|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
146323883|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
146323884|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
146323885|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
146323886|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
146323887|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
146323888|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
146323889|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
146323890|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
146323891|NCT04660643|527696566|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
146323892|NCT04660643|527696567|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
146323893|NCT04660643|527696568|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
146323894|NCT03988907|527696569|FG000|Overall Study|Unable to complete visit|0|||
146323895|NCT03988907|527696570|FG001|Overall Study|Unable to complete visit|1|||
146165016|NCT04274894|527114432|FG000|Overall Study|Withdrew consent|5|||
146323896|NCT01430442|527696576|FG000|Overall Study|Subject Withdrew Consent|3|||
146323897|NCT01430442|527696577|FG001|Overall Study|Subject Withdrew Consent|0|||
146323898|NCT01430442|527696578|FG002|Overall Study|Subject Withdrew Consent|1|||
146323899|NCT01430442|527696579|FG003|Overall Study|Subject Withdrew Consent|0|||
146323900|NCT01430442|527696580|FG004|Overall Study|Subject Withdrew Consent|2|||
146323901|NCT01430442|527696581|FG005|Overall Study|Subject Withdrew Consent|1|||
146323902|NCT01430442|527696582|FG006|Overall Study|Subject Withdrew Consent|5|||
146323903|NCT01430442|527696583|FG007|Overall Study|Subject Withdrew Consent|2|||
146323904|NCT01430442|527696576|FG000|Overall Study|Lost to Follow-up|2|||
146323905|NCT01430442|527696577|FG001|Overall Study|Lost to Follow-up|0|||
146323906|NCT01430442|527696578|FG002|Overall Study|Lost to Follow-up|1|||
146323907|NCT01430442|527696579|FG003|Overall Study|Lost to Follow-up|2|||
146323908|NCT01430442|527696580|FG004|Overall Study|Lost to Follow-up|2|||
146323909|NCT01430442|527696581|FG005|Overall Study|Lost to Follow-up|1|||
146323910|NCT01430442|527696582|FG006|Overall Study|Lost to Follow-up|5|||
146323911|NCT01430442|527696583|FG007|Overall Study|Lost to Follow-up|1|||
146323912|NCT01430442|527696576|FG000|Overall Study|Pregnancy|1|||
146323913|NCT01430442|527696577|FG001|Overall Study|Pregnancy|0|||
146323914|NCT01430442|527696578|FG002|Overall Study|Pregnancy|0|||
146323915|NCT01430442|527696579|FG003|Overall Study|Pregnancy|0|||
146323916|NCT01430442|527696580|FG004|Overall Study|Pregnancy|0|||
146323917|NCT01430442|527696581|FG005|Overall Study|Pregnancy|1|||
146323918|NCT01430442|527696582|FG006|Overall Study|Pregnancy|0|||
146323919|NCT01430442|527696583|FG007|Overall Study|Pregnancy|0|||
146323920|NCT01430442|527696576|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
146323921|NCT01430442|527696577|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
146323922|NCT01430442|527696578|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
146323923|NCT01430442|527696579|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
146323924|NCT01430442|527696580|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
146323925|NCT01430442|527696581|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
146323926|NCT01430442|527696582|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
146323927|NCT01430442|527696583|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
146323928|NCT00772629|527696585|FG000|Overall Study|Subject was not vaccinated|1|||
146323929|NCT00772629|527696586|FG001|Overall Study|Subject was not vaccinated|0|||
146323930|NCT03609619|527696590|FG000|Overall Study|Adverse Event|1|||
146323931|NCT03609619|527696591|FG001|Overall Study|Adverse Event|0|||
146323932|NCT03609619|527696590|FG000|Overall Study|Lack of Efficacy|1|||
146323933|NCT03609619|527696591|FG001|Overall Study|Lack of Efficacy|2|||
146323934|NCT03609619|527696590|FG000|Overall Study|Protocol Violation|5|||
146323935|NCT03609619|527696591|FG001|Overall Study|Protocol Violation|0|||
146323936|NCT03609619|527696590|FG000|Overall Study|Withdrawal by Subject|2|||
146323937|NCT03609619|527696591|FG001|Overall Study|Withdrawal by Subject|3|||
146323938|NCT03609619|527696590|FG000|Overall Study|Lost to Follow-up|1|||
146323939|NCT03609619|527696591|FG001|Overall Study|Lost to Follow-up|1|||
146323940|NCT00568555|527696594|FG000|Overall Study|Withdrawal by Subject|1|||
146323941|NCT00568555|527696595|FG001|Overall Study|Withdrawal by Subject|1|||
146323942|NCT01871090|527696596|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
146323943|NCT01871090|527696597|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
146323944|NCT01871090|527696596|FG000|Overall Study|Interrogation not completed correctly|1|||
146323945|NCT01871090|527696597|FG001|Overall Study|Interrogation not completed correctly|0|||
146323946|NCT01871090|527696596|FG000|Overall Study|Subject Non-Compliance|0|||
146323947|NCT01871090|527696597|FG001|Overall Study|Subject Non-Compliance|1|||
146323948|NCT03502330|527696598|FG000|Overall Study|Adverse Event|2|||
146323949|NCT03502330|527696599|FG001|Overall Study|Adverse Event|1|||
146323950|NCT03502330|527696600|FG002|Overall Study|Adverse Event|0|||
146323951|NCT03502330|527696601|FG003|Overall Study|Adverse Event|0|||
146323952|NCT03502330|527696602|FG004|Overall Study|Adverse Event|1|||
146323953|NCT03502330|527696603|FG005|Overall Study|Adverse Event|0|||
146323954|NCT03502330|527696604|FG006|Overall Study|Adverse Event|1|||
146323955|NCT03502330|527696605|FG007|Overall Study|Adverse Event|1|||
146323956|NCT03502330|527696606|FG008|Overall Study|Adverse Event|0|||
146323957|NCT03502330|527696598|FG000|Overall Study|Lack of Efficacy|1|||
146323958|NCT03502330|527696599|FG001|Overall Study|Lack of Efficacy|5|||
146323959|NCT03502330|527696600|FG002|Overall Study|Lack of Efficacy|3|||
146323960|NCT03502330|527696601|FG003|Overall Study|Lack of Efficacy|5|||
146323961|NCT03502330|527696602|FG004|Overall Study|Lack of Efficacy|1|||
146323962|NCT03502330|527696603|FG005|Overall Study|Lack of Efficacy|5|||
146323963|NCT03502330|527696604|FG006|Overall Study|Lack of Efficacy|5|||
146323964|NCT03502330|527696605|FG007|Overall Study|Lack of Efficacy|6|||
146323965|NCT03502330|527696606|FG008|Overall Study|Lack of Efficacy|0|||
146323966|NCT03502330|527696598|FG000|Overall Study|Physician Decision|0|||
146323967|NCT03502330|527696599|FG001|Overall Study|Physician Decision|0|||
146323968|NCT03502330|527696600|FG002|Overall Study|Physician Decision|0|||
146323969|NCT03502330|527696601|FG003|Overall Study|Physician Decision|0|||
146323970|NCT03502330|527696602|FG004|Overall Study|Physician Decision|1|||
146323971|NCT03502330|527696603|FG005|Overall Study|Physician Decision|0|||
146323972|NCT03502330|527696604|FG006|Overall Study|Physician Decision|0|||
146323973|NCT03502330|527696605|FG007|Overall Study|Physician Decision|0|||
146323974|NCT03502330|527696606|FG008|Overall Study|Physician Decision|0|||
146323975|NCT03502330|527696598|FG000|Overall Study|Withdrawal by Subject|0|||
146323976|NCT03502330|527696599|FG001|Overall Study|Withdrawal by Subject|0|||
146323977|NCT03502330|527696600|FG002|Overall Study|Withdrawal by Subject|0|||
146323978|NCT03502330|527696601|FG003|Overall Study|Withdrawal by Subject|0|||
146323979|NCT03502330|527696602|FG004|Overall Study|Withdrawal by Subject|0|||
146323980|NCT03502330|527696603|FG005|Overall Study|Withdrawal by Subject|1|||
146323981|NCT03502330|527696604|FG006|Overall Study|Withdrawal by Subject|0|||
146323982|NCT03502330|527696605|FG007|Overall Study|Withdrawal by Subject|1|||
146323983|NCT03502330|527696606|FG008|Overall Study|Withdrawal by Subject|0|||
146323984|NCT03502330|527696598|FG000|Overall Study|Death|0|||
146323985|NCT03502330|527696599|FG001|Overall Study|Death|0|||
146323986|NCT03502330|527696600|FG002|Overall Study|Death|0|||
146323987|NCT03502330|527696601|FG003|Overall Study|Death|0|||
146323988|NCT03502330|527696602|FG004|Overall Study|Death|0|||
146323989|NCT03502330|527696603|FG005|Overall Study|Death|0|||
146323990|NCT03502330|527696604|FG006|Overall Study|Death|2|||
146323991|NCT03502330|527696605|FG007|Overall Study|Death|0|||
146323992|NCT03502330|527696606|FG008|Overall Study|Death|0|||
146323993|NCT00066690|527696612|FG000|Overall Study|Adverse Event|145|||
146323994|NCT00066690|527696613|FG001|Overall Study|Adverse Event|58|||
146323995|NCT00066690|527696614|FG002|Overall Study|Adverse Event|126|||
146323996|NCT00066690|527696612|FG000|Overall Study|Death|3|||
146323997|NCT00066690|527696613|FG001|Overall Study|Death|0|||
146323998|NCT00066690|527696614|FG002|Overall Study|Death|2|||
146323999|NCT00066690|527696612|FG000|Overall Study|Lack of Efficacy|114|||
146324000|NCT00066690|527696613|FG001|Overall Study|Lack of Efficacy|110|||
146324001|NCT00066690|527696614|FG002|Overall Study|Lack of Efficacy|76|||
146324002|NCT00066690|527696612|FG000|Overall Study|Lost to Follow-up|40|||
146324003|NCT00066690|527696613|FG001|Overall Study|Lost to Follow-up|21|||
146324004|NCT00066690|527696614|FG002|Overall Study|Lost to Follow-up|29|||
146324005|NCT00066690|527696612|FG000|Overall Study|Withdrawal by Subject|50|||
146324006|NCT00066690|527696613|FG001|Overall Study|Withdrawal by Subject|55|||
146324007|NCT00066690|527696614|FG002|Overall Study|Withdrawal by Subject|49|||
146324008|NCT00066690|527696612|FG000|Overall Study|Treatment Ongoing|246|||
146324009|NCT00066690|527696613|FG001|Overall Study|Treatment Ongoing|278|||
146324010|NCT00066690|527696614|FG002|Overall Study|Treatment Ongoing|282|||
146324011|NCT02939131|527696615|FG000|Overall Study|Unable to get to clinic|6|||
146324012|NCT02939131|527696616|FG001|Overall Study|Unable to get to clinic|4|||
146324013|NCT02939131|527696615|FG000|Overall Study|Lost to Follow-up|2|||
146324014|NCT02939131|527696616|FG001|Overall Study|Lost to Follow-up|4|||
146324015|NCT02939131|527696615|FG000|Overall Study|severe debilitation|1|||
146324016|NCT02939131|527696616|FG001|Overall Study|severe debilitation|0|||
146324017|NCT02939131|527696615|FG000|Overall Study|Other|0|||
146324018|NCT02939131|527696616|FG001|Overall Study|Other|1|||
146324019|NCT02939131|527696615|FG000|Overall Study|not willing to adhere to protocol|2|||
146324020|NCT02939131|527696616|FG001|Overall Study|not willing to adhere to protocol|0|||
146324021|NCT00840827|527696617|FG000|Overall Study|Adverse Event|1|||
146324022|NCT00840827|527696617|FG000|Overall Study|Lack of Efficacy|4|||
146324023|NCT00840827|527696617|FG000|Overall Study|Physician Decision|1|||
146324024|NCT01445535|527696618|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146324025|NCT01445535|527696619|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146324026|NCT01445535|527696620|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
146324027|NCT01445535|527696621|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
146324028|NCT01445535|527696618|FG000|Overall Study|Disease progression|1|||
146324029|NCT01445535|527696619|FG001|Overall Study|Disease progression|0|||
146324030|NCT01445535|527696620|FG002|Overall Study|Disease progression|1|||
146324031|NCT01445535|527696621|FG003|Overall Study|Disease progression|0|||
146324032|NCT01445535|527696618|FG000|Overall Study|PI discretion|0|||
146324033|NCT01445535|527696619|FG001|Overall Study|PI discretion|0|||
146324034|NCT01445535|527696620|FG002|Overall Study|PI discretion|0|||
146324035|NCT01445535|527696621|FG003|Overall Study|PI discretion|1|||
146324036|NCT02415712|527696624|FG000|Overall Study|Protocol Violation|16|||
146324037|NCT01668654|527696625|FG000|Overall Study|Study Closed/Terminated|3|||
146324038|NCT01668654|527696625|FG000|Overall Study|Withdrawal by Subject|1|||
146324039|NCT04557384|527696626|FG000|Overall Study|Study Terminated by Sponsor|1|||
146324040|NCT04557384|527696626|FG000|Overall Study|Death|1|||
146324041|NCT01622569|527696628|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
145943235|NCT00483704|526300458|FG002|Treatment|Lack of Efficacy|1|||
146324042|NCT01622569|527696629|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
146324043|NCT01622569|527696630|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
146324044|NCT01622569|527696631|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
146324045|NCT01622569|527696628|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146324046|NCT01622569|527696629|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146324047|NCT01622569|527696630|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
146324048|NCT01622569|527696631|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
146324049|NCT01622569|527696628|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
146324050|NCT01622569|527696629|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
146324051|NCT01622569|527696630|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
146324052|NCT01622569|527696631|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
146324053|NCT01622569|527696628|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146324054|NCT01622569|527696629|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
146324055|NCT01622569|527696630|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
146324056|NCT01622569|527696631|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
146324057|NCT01622569|527696628|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146324058|NCT01622569|527696629|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146324059|NCT01622569|527696630|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
146324060|NCT01622569|527696631|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
146324061|NCT01622569|527696628|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146324062|NCT01622569|527696629|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
146324063|NCT01622569|527696630|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
146324064|NCT01622569|527696631|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
146324065|NCT01622569|527696628|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146324066|NCT01622569|527696629|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
146324067|NCT01622569|527696630|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
146324068|NCT01622569|527696631|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
146324069|NCT01622569|527696628|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146324070|NCT01622569|527696629|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146324071|NCT01622569|527696630|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
146324072|NCT01622569|527696631|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
146324073|NCT04173741|527696632|FG000|Overall Study|IVC measurement cannot be done|1|||
146324074|NCT04173741|527696633|FG001|Overall Study|IVC measurement cannot be done|1|||
146324075|NCT00254566|527696634|FG000|Overall Study|Death|1|||
146324076|NCT00254566|527696635|FG001|Overall Study|Death|0|||
146324077|NCT00254566|527696634|FG000|Overall Study|Adverse Event|5|||
146324078|NCT00254566|527696635|FG001|Overall Study|Adverse Event|4|||
146324079|NCT00254566|527696634|FG000|Overall Study|Lack of Efficacy|12|||
146324080|NCT00254566|527696635|FG001|Overall Study|Lack of Efficacy|9|||
146324081|NCT00254566|527696634|FG000|Overall Study|Other|1|||
146324082|NCT00254566|527696635|FG001|Overall Study|Other|5|||
146324083|NCT00254566|527696634|FG000|Overall Study|Withdrawal by Subject|5|||
146324084|NCT00254566|527696635|FG001|Overall Study|Withdrawal by Subject|6|||
146324085|NCT00254566|527696634|FG000|Overall Study|Lost to Follow-up|7|||
146324086|NCT00254566|527696635|FG001|Overall Study|Lost to Follow-up|2|||
146324087|NCT00059202|527696637|FG000|Overall Study|Withdrawal by Subject|5|||
146324088|NCT00059202|527696638|FG001|Overall Study|Withdrawal by Subject|9|||
146324089|NCT00059202|527696637|FG000|Overall Study|Protocol Violation|1|||
146324090|NCT00059202|527696638|FG001|Overall Study|Protocol Violation|3|||
146324091|NCT00059202|527696637|FG000|Overall Study|drug toxicity|0|||
146324092|NCT00059202|527696638|FG001|Overall Study|drug toxicity|3|||
146324093|NCT00548548|527696641|FG000|Overall Study|Death|345|||
146324094|NCT00548548|527696642|FG001|Overall Study|Death|348|||
146324095|NCT00548548|527696641|FG000|Overall Study|Lost to Follow-up|17|||
146324096|NCT00548548|527696642|FG001|Overall Study|Lost to Follow-up|18|||
146324097|NCT01705691|527696644|FG000|Overall Study|Death|1|||
146324098|NCT01705691|527696645|FG001|Overall Study|Death|2|||
146324099|NCT01705691|527696644|FG000|Overall Study|Withdrawal by Subject|1|||
146324100|NCT01705691|527696645|FG001|Overall Study|Withdrawal by Subject|2|||
146324101|NCT01705691|527696644|FG000|Overall Study|Lost to Follow-up|1|||
146324102|NCT01705691|527696645|FG001|Overall Study|Lost to Follow-up|1|||
146324103|NCT01705691|527696644|FG000|Overall Study|Other|0|||
146324104|NCT01705691|527696645|FG001|Overall Study|Other|1|||
146324105|NCT02658448|527696646|FG000|Overall Study|Lost to Follow-up|1|||
146324106|NCT03106779|527696647|FG000|Overall Study|Lack of Efficacy|33|||
146324107|NCT03106779|527696648|FG001|Overall Study|Lack of Efficacy|24|||
146324108|NCT03106779|527696647|FG000|Overall Study|Adverse Event|8|||
146324109|NCT03106779|527696648|FG001|Overall Study|Adverse Event|16|||
146324110|NCT03106779|527696647|FG000|Overall Study|Physician Decision|10|||
146324111|NCT03106779|527696648|FG001|Overall Study|Physician Decision|6|||
146324112|NCT03106779|527696647|FG000|Overall Study|Patient/guardian decision|4|||
146324113|NCT03106779|527696648|FG001|Overall Study|Patient/guardian decision|3|||
146324114|NCT03106779|527696647|FG000|Overall Study|Progressive disease|1|||
146324115|NCT03106779|527696648|FG001|Overall Study|Progressive disease|3|||
146324116|NCT03106779|527696647|FG000|Overall Study|Lost to Follow-up|1|||
146324117|NCT03106779|527696648|FG001|Overall Study|Lost to Follow-up|2|||
146324118|NCT03106779|527696647|FG000|Overall Study|Death|1|||
146324119|NCT03106779|527696648|FG001|Overall Study|Death|0|||
146324120|NCT03106779|527696647|FG000|Overall Study|Protocol Violation|1|||
146324121|NCT03106779|527696648|FG001|Overall Study|Protocol Violation|0|||
146324122|NCT03106779|527696647|FG000|Overall Study|Not treated|1|||
146324123|NCT03106779|527696648|FG001|Overall Study|Not treated|0|||
146324124|NCT04088409|527696649|FG000|Part A|Withdrawal by Subject|2|||
146324125|NCT04088409|527696650|FG001|Part A|Withdrawal by Subject|1|||
146324126|NCT04088409|527696649|FG000|Part A|Did Not Meet Randomization Criteria|2|||
146324127|NCT04088409|527696650|FG001|Part A|Did Not Meet Randomization Criteria|0|||
146324128|NCT04088409|527696649|FG000|Part A|Lack of Efficacy|9|||
146324129|NCT04088409|527696650|FG001|Part A|Lack of Efficacy|0|||
146324130|NCT04088409|527696649|FG000|Part A|Lost to Follow-up|1|||
146324131|NCT04088409|527696650|FG001|Part A|Lost to Follow-up|0|||
146324132|NCT04088409|527696649|FG000|Part A|Adverse Event|1|||
146324133|NCT04088409|527696650|FG001|Part A|Adverse Event|0|||
146324134|NCT04088409|527696649|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
146324135|NCT04088409|527696650|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
146324136|NCT04088409|527696649|FG000|Part B|Ongoing Treatment|10|||
146324137|NCT04088409|527696650|FG001|Part B|Ongoing Treatment|0|||
146324138|NCT04233229|527696651|FG000|Overall Study|Withdrawal by Subject|0|||
146324139|NCT04233229|527696652|FG001|Overall Study|Withdrawal by Subject|1|||
146324140|NCT04233229|527696651|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
146324141|NCT04233229|527696652|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
146324142|NCT04233229|527696651|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
146324143|NCT04233229|527696652|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
146324144|NCT04652804|527696653|FG000|Overall Study|Ineligible post randomization|1|||
146324145|NCT04652804|527696654|FG001|Overall Study|Ineligible post randomization|0|||
146324146|NCT04652804|527696655|FG002|Overall Study|Ineligible post randomization|1|||
146324147|NCT04652804|527696656|FG003|Overall Study|Ineligible post randomization|0|||
146324148|NCT04652804|527696657|FG004|Overall Study|Ineligible post randomization|1|||
146324149|NCT04652804|527696658|FG005|Overall Study|Ineligible post randomization|1|||
146324150|NCT04652804|527696653|FG000|Overall Study|Missing SVR lab results|2|||
146324151|NCT04652804|527696654|FG001|Overall Study|Missing SVR lab results|0|||
146324152|NCT04652804|527696655|FG002|Overall Study|Missing SVR lab results|0|||
146324153|NCT04652804|527696656|FG003|Overall Study|Missing SVR lab results|0|||
146324154|NCT04652804|527696657|FG004|Overall Study|Missing SVR lab results|0|||
146324155|NCT04652804|527696658|FG005|Overall Study|Missing SVR lab results|0|||
146324156|NCT00584194|527696659|FG000|Overall Study|Other|135|||
146324157|NCT04093531|527696660|FG000|Overall Study|failed screening|4|||
146324158|NCT00841763|527696661|FG000|Overall Study|Withdrawal by Subject|60|||
146324159|NCT00841763|527696662|FG001|Overall Study|Withdrawal by Subject|17|||
146324160|NCT00841763|527696663|FG002|Overall Study|Withdrawal by Subject|4|||
146324161|NCT00841763|527696664|FG003|Overall Study|Withdrawal by Subject|1|||
146324162|NCT00841763|527696661|FG000|Overall Study|Adverse Event|9|||
146324163|NCT00841763|527696662|FG001|Overall Study|Adverse Event|10|||
146324164|NCT00841763|527696663|FG002|Overall Study|Adverse Event|3|||
146324165|NCT00841763|527696664|FG003|Overall Study|Adverse Event|2|||
146324166|NCT00841763|527696661|FG000|Overall Study|Lost to Follow-up|63|||
146324167|NCT00841763|527696662|FG001|Overall Study|Lost to Follow-up|25|||
146324168|NCT00841763|527696663|FG002|Overall Study|Lost to Follow-up|0|||
146324169|NCT00841763|527696664|FG003|Overall Study|Lost to Follow-up|0|||
146324170|NCT00841763|527696661|FG000|Overall Study|Protocol Violation|20|||
146324171|NCT00841763|527696662|FG001|Overall Study|Protocol Violation|3|||
146324172|NCT00841763|527696663|FG002|Overall Study|Protocol Violation|1|||
146324173|NCT00841763|527696664|FG003|Overall Study|Protocol Violation|0|||
146324174|NCT00841763|527696661|FG000|Overall Study|Administrative Reasons|3|||
146324175|NCT00841763|527696662|FG001|Overall Study|Administrative Reasons|1|||
146324176|NCT00841763|527696663|FG002|Overall Study|Administrative Reasons|0|||
146324177|NCT00841763|527696664|FG003|Overall Study|Administrative Reasons|0|||
146324178|NCT00841763|527696661|FG000|Overall Study|Unable to Classify|7|||
146324179|NCT00841763|527696662|FG001|Overall Study|Unable to Classify|1|||
146324180|NCT00841763|527696663|FG002|Overall Study|Unable to Classify|0|||
146324181|NCT00841763|527696664|FG003|Overall Study|Unable to Classify|0|||
146324182|NCT00927368|527696667|FG000|Overall Study|enrollment in another study|1|||
146324183|NCT00927368|527696668|FG001|Overall Study|enrollment in another study|1|||
146324184|NCT00927368|527696669|FG002|Overall Study|enrollment in another study|2|||
146324185|NCT00927368|527696667|FG000|Overall Study|Lost to Follow-up|4|||
146324186|NCT00927368|527696668|FG001|Overall Study|Lost to Follow-up|0|||
146324187|NCT00927368|527696669|FG002|Overall Study|Lost to Follow-up|0|||
146324188|NCT00927368|527696667|FG000|Overall Study|equipment failure|1|||
146324189|NCT00927368|527696668|FG001|Overall Study|equipment failure|0|||
146324190|NCT00927368|527696669|FG002|Overall Study|equipment failure|0|||
146324191|NCT00927368|527696667|FG000|Overall Study|ineligible post randomization|0|||
146324192|NCT00927368|527696668|FG001|Overall Study|ineligible post randomization|3|||
146324193|NCT00927368|527696669|FG002|Overall Study|ineligible post randomization|1|||
146324194|NCT00927368|527696667|FG000|Overall Study|cancellation of surgery|0|||
146324195|NCT00927368|527696668|FG001|Overall Study|cancellation of surgery|1|||
146324196|NCT00927368|527696669|FG002|Overall Study|cancellation of surgery|2|||
146324197|NCT00364689|527696670|FG000|Overall Study|Lost to Follow-up|1|||
146324198|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
146165017|NCT04274894|527114432|FG000|Overall Study|Lost to Follow-up|9|||
146324199|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
146324200|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
146324201|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
146324202|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
146324203|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
146324204|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
146324205|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
146324206|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
146324207|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
146324208|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
146324209|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
146324210|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146324211|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146324212|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
146324213|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
146324214|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
146324215|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
146324216|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
146324217|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
146324218|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
146324219|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
146324220|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
146324221|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
146324222|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Death|2|||
146324223|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Death|1|||
146324224|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Death|2|||
146324225|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Graft loss|0|||
146324226|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Graft loss|2|||
146324227|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Graft loss|0|||
146324228|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
146324229|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
146324230|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
146324231|NCT01114529|527696678|FG000|Completed Study Medication at Month 24|Missing|2|||
146324232|NCT01114529|527696679|FG001|Completed Study Medication at Month 24|Missing|0|||
146324233|NCT01114529|527696680|FG002|Completed Study Medication at Month 24|Missing|0|||
146324234|NCT01114529|527696678|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
146324235|NCT01114529|527696679|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
146324236|NCT01114529|527696680|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
146324237|NCT01114529|527696678|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
146324238|NCT01114529|527696679|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
146324239|NCT01114529|527696680|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
146324240|NCT01114529|527696678|FG000|Completed Study Phase at Month 24|Death|8|||
146324241|NCT01114529|527696679|FG001|Completed Study Phase at Month 24|Death|5|||
146324242|NCT01114529|527696680|FG002|Completed Study Phase at Month 24|Death|4|||
146324243|NCT01114529|527696678|FG000|Completed Study Phase at Month 24|Other|2|||
146324244|NCT01114529|527696679|FG001|Completed Study Phase at Month 24|Other|0|||
146324245|NCT01114529|527696680|FG002|Completed Study Phase at Month 24|Other|0|||
146324246|NCT01114529|527696678|FG000|Completed Study Phase at Month 24|Missing|2|||
146324247|NCT01114529|527696679|FG001|Completed Study Phase at Month 24|Missing|0|||
146324248|NCT01114529|527696680|FG002|Completed Study Phase at Month 24|Missing|0|||
146324249|NCT00272987|527696681|FG000|Overall Study|Adverse Event|1|||
146324250|NCT00272987|527696682|FG001|Overall Study|Adverse Event|0|||
146324251|NCT00272987|527696683|FG002|Overall Study|Adverse Event|0|||
146324252|NCT00272987|527696681|FG000|Overall Study|Lost to Follow-up|3|||
146324253|NCT00272987|527696682|FG001|Overall Study|Lost to Follow-up|1|||
146324254|NCT00272987|527696683|FG002|Overall Study|Lost to Follow-up|1|||
146324255|NCT00272987|527696681|FG000|Overall Study|Withdrawal by Subject|1|||
146324256|NCT00272987|527696682|FG001|Overall Study|Withdrawal by Subject|0|||
146324257|NCT00272987|527696683|FG002|Overall Study|Withdrawal by Subject|3|||
146324258|NCT00272987|527696681|FG000|Overall Study|Sponsor Terminated study|0|||
146324259|NCT00272987|527696682|FG001|Overall Study|Sponsor Terminated study|1|||
146324260|NCT00272987|527696683|FG002|Overall Study|Sponsor Terminated study|1|||
146324261|NCT00272987|527696681|FG000|Overall Study|Disease progression|1|||
146324262|NCT00272987|527696682|FG001|Overall Study|Disease progression|1|||
146324263|NCT00272987|527696683|FG002|Overall Study|Disease progression|2|||
146324264|NCT00272987|527696681|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
146324265|NCT00272987|527696682|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
146324266|NCT00272987|527696683|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
146324267|NCT00272987|527696681|FG000|Overall Study|Death|1|||
146324268|NCT00272987|527696682|FG001|Overall Study|Death|0|||
146324269|NCT00272987|527696683|FG002|Overall Study|Death|0|||
146324270|NCT00331409|527696685|FG000|Overall Study|Lack of Efficacy|4|||
146324271|NCT01482910|527696686|FG000|Overall Study|Adverse Event|6|||
146324272|NCT01482910|527696687|FG001|Overall Study|Adverse Event|5|||
146324273|NCT01482910|527696686|FG000|Overall Study|Lost to Follow-up|0|||
146324274|NCT01482910|527696687|FG001|Overall Study|Lost to Follow-up|1|||
146324275|NCT01482910|527696686|FG000|Overall Study|Protocol Violation|1|||
146324276|NCT01482910|527696687|FG001|Overall Study|Protocol Violation|1|||
146324277|NCT01482910|527696686|FG000|Overall Study|Withdrawal by Subject|7|||
146324278|NCT01482910|527696687|FG001|Overall Study|Withdrawal by Subject|2|||
146324279|NCT01482910|527696686|FG000|Overall Study|Death|1|||
146324280|NCT01482910|527696687|FG001|Overall Study|Death|0|||
146324281|NCT03222349|527696690|FG000|Overall Study|Treatment B not done|5|||
146324282|NCT03222349|527696691|FG001|Overall Study|Treatment B not done|0|||
146324283|NCT03222349|527696690|FG000|Overall Study|Lost to Follow-up|1|||
146324284|NCT03222349|527696691|FG001|Overall Study|Lost to Follow-up|2|||
146324285|NCT03222349|527696690|FG000|Overall Study|Withdrawal by Subject|1|||
146324286|NCT03222349|527696691|FG001|Overall Study|Withdrawal by Subject|0|||
146324287|NCT03222349|527696690|FG000|Overall Study|Treatment A not done|0|||
146324288|NCT03222349|527696691|FG001|Overall Study|Treatment A not done|5|||
146324289|NCT03222349|527696690|FG000|Overall Study|Study terminated by sponsor|1|||
146324290|NCT03222349|527696691|FG001|Overall Study|Study terminated by sponsor|0|||
146324291|NCT02614079|527696692|FG000|Overall Study|Withdrawal by Subject|1|||
146324292|NCT03072160|527696695|FG000|Overall Study|Adverse Event|3|||
146324293|NCT03072160|527696696|FG001|Overall Study|Adverse Event|1|||
146324294|NCT03072160|527696695|FG000|Overall Study|Refused further treatment|6|||
146324295|NCT03072160|527696696|FG001|Overall Study|Refused further treatment|1|||
146324296|NCT03072160|527696695|FG000|Overall Study|Physician Decision|1|||
146324297|NCT03072160|527696696|FG001|Overall Study|Physician Decision|0|||
146324298|NCT03072160|527696695|FG000|Overall Study|Disease progression on study|1|||
146324299|NCT03072160|527696696|FG001|Overall Study|Disease progression on study|1|||
146324300|NCT03072160|527696695|FG000|Overall Study|No contact|0|||
146324301|NCT03072160|527696696|FG001|Overall Study|No contact|1|||
146324302|NCT00236080|527696697|FG000|Overall Study|Adverse Event|0|||
146324303|NCT00236080|527696698|FG001|Overall Study|Adverse Event|0|||
146324304|NCT00236080|527696699|FG002|Overall Study|Adverse Event|3|||
146324305|NCT00236080|527696700|FG003|Overall Study|Adverse Event|1|||
146324306|NCT00236080|527696701|FG004|Overall Study|Adverse Event|0|||
146324307|NCT00236080|527696697|FG000|Overall Study|Lost to Follow-up|0|||
146324308|NCT00236080|527696698|FG001|Overall Study|Lost to Follow-up|1|||
146324309|NCT00236080|527696699|FG002|Overall Study|Lost to Follow-up|0|||
146324310|NCT00236080|527696700|FG003|Overall Study|Lost to Follow-up|0|||
146324311|NCT00236080|527696701|FG004|Overall Study|Lost to Follow-up|0|||
146324312|NCT00236080|527696697|FG000|Overall Study|Physician Decision|1|||
146324313|NCT00236080|527696698|FG001|Overall Study|Physician Decision|0|||
146324314|NCT00236080|527696699|FG002|Overall Study|Physician Decision|1|||
146324315|NCT00236080|527696700|FG003|Overall Study|Physician Decision|1|||
146324316|NCT00236080|527696701|FG004|Overall Study|Physician Decision|1|||
146324317|NCT00236080|527696697|FG000|Overall Study|Withdrawal by Subject|1|||
146324318|NCT00236080|527696698|FG001|Overall Study|Withdrawal by Subject|0|||
146324319|NCT00236080|527696699|FG002|Overall Study|Withdrawal by Subject|0|||
146324320|NCT00236080|527696700|FG003|Overall Study|Withdrawal by Subject|0|||
146324321|NCT00236080|527696701|FG004|Overall Study|Withdrawal by Subject|0|||
146324322|NCT00236080|527696697|FG000|Overall Study|Miscellaneous|0|||
146324323|NCT00236080|527696698|FG001|Overall Study|Miscellaneous|0|||
146324324|NCT00236080|527696699|FG002|Overall Study|Miscellaneous|1|||
146324325|NCT00236080|527696700|FG003|Overall Study|Miscellaneous|0|||
146324326|NCT00236080|527696701|FG004|Overall Study|Miscellaneous|0|||
146324327|NCT01214044|527696702|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
146324328|NCT01214044|527696702|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
146324329|NCT01214044|527696702|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
146324330|NCT01214044|527696702|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
146324331|NCT01214044|527696702|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
146324332|NCT01214044|527696702|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
146324333|NCT00408694|527696703|FG000|Overall Study|Ineligible|1|||
146324334|NCT00408694|527696703|FG000|Overall Study|No protocol treatment|1|||
146324335|NCT03543410|527696704|FG000|Overall Study|Adverse Event|10|||
146324336|NCT03543410|527696705|FG001|Overall Study|Adverse Event|8|||
146324337|NCT03543410|527696706|FG002|Overall Study|Adverse Event|2|||
146324338|NCT03543410|527696704|FG000|Overall Study|Lack of Efficacy|0|||
146324339|NCT03543410|527696705|FG001|Overall Study|Lack of Efficacy|1|||
146324340|NCT03543410|527696706|FG002|Overall Study|Lack of Efficacy|0|||
146324341|NCT03543410|527696704|FG000|Overall Study|Lost to Follow-up|0|||
146324342|NCT03543410|527696705|FG001|Overall Study|Lost to Follow-up|1|||
146324343|NCT03543410|527696706|FG002|Overall Study|Lost to Follow-up|0|||
146324344|NCT03543410|527696704|FG000|Overall Study|Withdrawal by Subject|5|||
146324345|NCT03543410|527696705|FG001|Overall Study|Withdrawal by Subject|2|||
146324346|NCT03543410|527696706|FG002|Overall Study|Withdrawal by Subject|8|||
146324347|NCT03543410|527696704|FG000|Overall Study|Protocol Violation|0|||
146324348|NCT03543410|527696705|FG001|Overall Study|Protocol Violation|1|||
146324349|NCT03543410|527696706|FG002|Overall Study|Protocol Violation|0|||
146324350|NCT03543410|527696704|FG000|Overall Study|Due to COVID-19|4|||
146324351|NCT03543410|527696705|FG001|Overall Study|Due to COVID-19|0|||
146324352|NCT03543410|527696706|FG002|Overall Study|Due to COVID-19|2|||
146324353|NCT03543410|527696704|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
146324354|NCT03543410|527696705|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
146324355|NCT03543410|527696706|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
146324356|NCT03543410|527696704|FG000|Overall Study|Not Due to COVID-19|2|||
146324357|NCT03543410|527696705|FG001|Overall Study|Not Due to COVID-19|0|||
146324358|NCT03543410|527696706|FG002|Overall Study|Not Due to COVID-19|1|||
146324359|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
146324360|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
146324361|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
146324362|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Death|28|||
146324363|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Death|0|||
146324364|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Death|0|||
146324365|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
146324366|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
146324367|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
146324368|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
146324369|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
146324370|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
146324371|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
146324372|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
146324373|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
146324374|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
146324375|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
146324376|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
146324377|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
146324378|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
146324379|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
146324380|NCT00820755|527696707|FG000|Period 1: Combination Therapy Phase|Other|11|||
146324381|NCT00820755|527696708|FG001|Period 1: Combination Therapy Phase|Other|0|||
146324382|NCT00820755|527696709|FG002|Period 1: Combination Therapy Phase|Other|0|||
146324383|NCT00820755|527696707|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
146324384|NCT00820755|527696708|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
146324385|NCT00820755|527696709|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
146324386|NCT02251912|527696711|FG000|Overall Study|Withdrawal by Subject|2|||
146324387|NCT02251912|527696712|FG001|Overall Study|Withdrawal by Subject|3|||
146324388|NCT02251912|527696711|FG000|Overall Study|Adverse Event|0|||
146324389|NCT02251912|527696712|FG001|Overall Study|Adverse Event|2|||
146165018|NCT04274894|527114432|FG000|Overall Study|COVID-19 infection|1|||
146165019|NCT04274894|527114432|FG000|Overall Study|Other, not specified|20|||
146165020|NCT01936857|527114433|FG000|Overall Study|Sent to prison or 06 center|11|||
146165021|NCT01936857|527114434|FG001|Overall Study|Sent to prison or 06 center|12|||
146165022|NCT01936857|527114433|FG000|Overall Study|Lost to Follow-up|10|||
146165023|NCT01936857|527114434|FG001|Overall Study|Lost to Follow-up|7|||
146165024|NCT01936857|527114433|FG000|Overall Study|Death|7|||
146165025|NCT01936857|527114434|FG001|Overall Study|Death|3|||
146165026|NCT01936857|527114433|FG000|Overall Study|Moved|2|||
146165027|NCT01936857|527114434|FG001|Overall Study|Moved|1|||
146165028|NCT01936857|527114433|FG000|Overall Study|Withdrawal by Subject|1|||
146165029|NCT01936857|527114434|FG001|Overall Study|Withdrawal by Subject|0|||
146165030|NCT01936857|527114433|FG000|Overall Study|Side effect of medication|1|||
146165031|NCT01936857|527114434|FG001|Overall Study|Side effect of medication|0|||
146165032|NCT01936857|527114433|FG000|Overall Study|Other|2|||
146324390|NCT02551159|527696713|FG000|Overall Study|Death|352|||
146324391|NCT02551159|527696714|FG001|Overall Study|Death|174|||
146324392|NCT02551159|527696715|FG002|Overall Study|Death|161|||
146165033|NCT01936857|527114434|FG001|Overall Study|Other|2|||
146324393|NCT02551159|527696713|FG000|Overall Study|Withdrawal by Subject|8|||
146324394|NCT02551159|527696714|FG001|Overall Study|Withdrawal by Subject|5|||
146324395|NCT02551159|527696715|FG002|Overall Study|Withdrawal by Subject|16|||
146324396|NCT02551159|527696713|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
146324397|NCT02551159|527696714|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
146165034|NCT02279043|527114435|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
146165035|NCT02279043|527114436|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
146165036|NCT02279043|527114437|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
146324398|NCT02551159|527696715|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
146165037|NCT02279043|527114435|FG000|Overall Study|Lost to Follow-up|46|||
146165038|NCT02279043|527114436|FG001|Overall Study|Lost to Follow-up|88|||
146165039|NCT02279043|527114437|FG002|Overall Study|Lost to Follow-up|0|||
146165040|NCT01939548|527114438|FG000|Overall Study|Non compliance|0|||
146165041|NCT01939548|527114439|FG001|Overall Study|Non compliance|2|||
146165042|NCT01939548|527114440|FG002|Overall Study|Non compliance|0|||
146165043|NCT01939548|527114438|FG000|Overall Study|Study Terminated by Sponsor|17|||
146165044|NCT01939548|527114439|FG001|Overall Study|Study Terminated by Sponsor|19|||
146165045|NCT01939548|527114440|FG002|Overall Study|Study Terminated by Sponsor|12|||
146165046|NCT01939548|527114438|FG000|Overall Study|Insufficient Clinical Response|1|||
146165047|NCT01939548|527114439|FG001|Overall Study|Insufficient Clinical Response|0|||
146165048|NCT01939548|527114440|FG002|Overall Study|Insufficient Clinical Response|0|||
146165049|NCT01939548|527114438|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
146324399|NCT04506294|527696716|FG000|Overall Study|Lost to Follow-up|70|||
146324400|NCT04506294|527696717|FG001|Overall Study|Lost to Follow-up|20|||
146324401|NCT04506294|527696716|FG000|Overall Study|Withdrawal by Subject|16|||
146324402|NCT04506294|527696717|FG001|Overall Study|Withdrawal by Subject|2|||
146324403|NCT05888103|527698678|FG000|Overall Study|Participant decision|3|||
146324404|NCT05888103|527698679|FG001|Overall Study|Participant decision|3|||
146324405|NCT05900115|527698680|FG000|Overall Study|Lost to Follow-up|129|||
146324406|NCT05900115|527698681|FG001|Overall Study|Lost to Follow-up|98|||
146324407|NCT00388947|527698683|FG000|Overall Study|Protocol Violation|47|||
146324408|NCT04187092|527698684|FG000|Overall Study|Lost to Follow-up|1|||
146324409|NCT04187092|527698685|FG001|Overall Study|Lost to Follow-up|1|||
146324410|NCT04187092|527698684|FG000|Overall Study|Withdrawal by Subject|1|||
146324411|NCT04187092|527698685|FG001|Overall Study|Withdrawal by Subject|1|||
146324412|NCT04187092|527698684|FG000|Overall Study|Adverse Event|0|||
146324413|NCT04187092|527698685|FG001|Overall Study|Adverse Event|1|||
146324414|NCT00483327|527698695|FG000|Overall Study|Adverse Event|1|||
146324415|NCT00483327|527698695|FG000|Overall Study|Withdrawal by Subject|3|||
146324416|NCT00483327|527698695|FG000|Overall Study|Lost to Follow-up|4|||
146324417|NCT00483327|527698695|FG000|Overall Study|Patient Non Compliance|2|||
146324418|NCT00618722|527698696|FG000|Overall Study|Refusal of Treatment|0|||
146324419|NCT00618722|527698697|FG001|Overall Study|Refusal of Treatment|0|||
146324420|NCT00618722|527698698|FG002|Overall Study|Refusal of Treatment|1|||
146324421|NCT00618722|527698699|FG003|Overall Study|Refusal of Treatment|0|||
146324422|NCT00618722|527698696|FG000|Overall Study|Patient Request|1|||
146324423|NCT00618722|527698697|FG001|Overall Study|Patient Request|1|||
146324424|NCT00618722|527698698|FG002|Overall Study|Patient Request|1|||
146324425|NCT00618722|527698699|FG003|Overall Study|Patient Request|1|||
146324426|NCT00618722|527698696|FG000|Overall Study|Inability to Complete Study Procedure|0|||
146324427|NCT00618722|527698697|FG001|Overall Study|Inability to Complete Study Procedure|1|||
146324428|NCT00618722|527698698|FG002|Overall Study|Inability to Complete Study Procedure|0|||
146324429|NCT00618722|527698699|FG003|Overall Study|Inability to Complete Study Procedure|0|||
146324430|NCT00618722|527698696|FG000|Overall Study|Lost to Follow-up|2|||
146324431|NCT00618722|527698697|FG001|Overall Study|Lost to Follow-up|0|||
146324432|NCT00618722|527698698|FG002|Overall Study|Lost to Follow-up|0|||
146324433|NCT00618722|527698699|FG003|Overall Study|Lost to Follow-up|2|||
146324434|NCT00618722|527698696|FG000|Overall Study|Miscellaneous Reasons|0|||
146324435|NCT00618722|527698697|FG001|Overall Study|Miscellaneous Reasons|0|||
146324436|NCT00618722|527698698|FG002|Overall Study|Miscellaneous Reasons|1|||
146324437|NCT00618722|527698699|FG003|Overall Study|Miscellaneous Reasons|1|||
146324438|NCT00200057|527698700|FG000|Overall Study|Lack of Efficacy|3|||
146324439|NCT00200057|527698700|FG000|Overall Study|Exited due to terminal illness of PI|2|||
146324440|NCT00200057|527698700|FG000|Overall Study|Withdrawal by Subject|1|||
146324441|NCT00200057|527698700|FG000|Overall Study|Change in medical condition|1|||
146324442|NCT00200057|527698700|FG000|Overall Study|Infection|1|||
146324443|NCT00200057|527698700|FG000|Overall Study|Death|1|||
146324444|NCT05512949|527698701|FG000|Overall Study|Lost to Follow-up|4|||
146324445|NCT05512949|527698702|FG001|Overall Study|Lost to Follow-up|6|||
146324446|NCT05512949|527698703|FG002|Overall Study|Lost to Follow-up|2|||
146165050|NCT01939548|527114439|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
146165051|NCT01939548|527114440|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
146324447|NCT05512949|527698701|FG000|Overall Study|Protocol Violation|0|||
146324448|NCT05512949|527698702|FG001|Overall Study|Protocol Violation|0|||
146324449|NCT05512949|527698703|FG002|Overall Study|Protocol Violation|1|||
146324450|NCT05512949|527698701|FG000|Overall Study|Withdrawal by Subject|1|||
146324451|NCT05512949|527698702|FG001|Overall Study|Withdrawal by Subject|1|||
146165052|NCT01939548|527114438|FG000|Overall Study|Withdrawal by Subject|4|||
146324452|NCT05512949|527698703|FG002|Overall Study|Withdrawal by Subject|2|||
146324453|NCT05512949|527698701|FG000|Overall Study|Completion status unknown|1|||
146165053|NCT01939548|527114439|FG001|Overall Study|Withdrawal by Subject|4|||
146165054|NCT01939548|527114440|FG002|Overall Study|Withdrawal by Subject|1|||
146165055|NCT01939548|527114438|FG000|Overall Study|Protocol Violation|7|||
146324454|NCT05512949|527698702|FG001|Overall Study|Completion status unknown|3|||
146324455|NCT05512949|527698703|FG002|Overall Study|Completion status unknown|0|||
146324456|NCT02810964|527698704|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
146324457|NCT02810964|527698705|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
146324458|NCT02810964|527698704|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
146324459|NCT02810964|527698705|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
146324460|NCT02810964|527698704|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
146324461|NCT02810964|527698705|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
146324462|NCT02810964|527698704|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
146324463|NCT02810964|527698705|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
146324464|NCT03523351|527698706|FG000|Overall Study|Death|13|||
146324465|NCT03523351|527698707|FG001|Overall Study|Death|11|||
146324466|NCT03523351|527698706|FG000|Overall Study|Lost to Follow-up|2|||
146324467|NCT03523351|527698707|FG001|Overall Study|Lost to Follow-up|3|||
146324468|NCT03523351|527698706|FG000|Overall Study|Withdrawal by Subject|4|||
146324469|NCT03523351|527698707|FG001|Overall Study|Withdrawal by Subject|0|||
146324470|NCT03523351|527698706|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
146324471|NCT03523351|527698707|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
146324472|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
146324473|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
146324474|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
146324475|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146324476|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146324477|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146324478|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146324479|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146324480|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
146324481|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
146324482|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
146324483|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146324484|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146324485|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146324486|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146324487|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146324488|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
146324489|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
146324490|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
146324491|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146324492|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146324493|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146324494|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146324495|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146324496|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
146324497|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
146324498|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146324499|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146324500|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146324501|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146324502|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146324503|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146324504|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
146324505|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
146324506|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
146324507|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146324508|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146324509|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146324510|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146324511|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146324512|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
146324513|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
146324514|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146324515|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146324516|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146324517|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146324518|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146324519|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146165056|NCT01939548|527114439|FG001|Overall Study|Protocol Violation|6|||
146165057|NCT01939548|527114440|FG002|Overall Study|Protocol Violation|5|||
146165058|NCT01939548|527114438|FG000|Overall Study|Lost to Follow-up|5|||
146165059|NCT01939548|527114439|FG001|Overall Study|Lost to Follow-up|5|||
146165060|NCT01939548|527114440|FG002|Overall Study|Lost to Follow-up|3|||
146165061|NCT01939548|527114438|FG000|Overall Study|Adverse Event|2|||
146324520|NCT01097629|527698711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
146324521|NCT01097629|527698712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
146165062|NCT01939548|527114439|FG001|Overall Study|Adverse Event|9|||
146165063|NCT01939548|527114440|FG002|Overall Study|Adverse Event|7|||
146324522|NCT01097629|527698713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
146324523|NCT01097629|527698714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146324524|NCT01097629|527698715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146324525|NCT01097629|527698716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146324526|NCT01097629|527698717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146324527|NCT01097629|527698718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146324528|NCT01097629|527698711|FG000|DB RO Phase|Withdrawal by Subject|0|||
146324529|NCT01097629|527698712|FG001|DB RO Phase|Withdrawal by Subject|0|||
146324530|NCT01097629|527698713|FG002|DB RO Phase|Withdrawal by Subject|0|||
146324531|NCT01097629|527698714|FG003|DB RO Phase|Withdrawal by Subject|0|||
146324532|NCT01097629|527698715|FG004|DB RO Phase|Withdrawal by Subject|0|||
146324533|NCT01097629|527698716|FG005|DB RO Phase|Withdrawal by Subject|0|||
146324534|NCT01097629|527698717|FG006|DB RO Phase|Withdrawal by Subject|0|||
146324535|NCT01097629|527698718|FG007|DB RO Phase|Withdrawal by Subject|1|||
146324536|NCT01097629|527698711|FG000|DB RO Phase|Protocol Violation|0|||
146324537|NCT01097629|527698712|FG001|DB RO Phase|Protocol Violation|0|||
146324538|NCT01097629|527698713|FG002|DB RO Phase|Protocol Violation|0|||
146324539|NCT01097629|527698714|FG003|DB RO Phase|Protocol Violation|1|||
146324540|NCT01097629|527698715|FG004|DB RO Phase|Protocol Violation|0|||
146324541|NCT01097629|527698716|FG005|DB RO Phase|Protocol Violation|1|||
146324542|NCT01097629|527698717|FG006|DB RO Phase|Protocol Violation|1|||
146324543|NCT01097629|527698718|FG007|DB RO Phase|Protocol Violation|0|||
146324544|NCT01097629|527698711|FG000|DB RO Phase|Lost to Follow-up|0|||
146324545|NCT01097629|527698712|FG001|DB RO Phase|Lost to Follow-up|0|||
146324546|NCT01097629|527698713|FG002|DB RO Phase|Lost to Follow-up|0|||
146324547|NCT01097629|527698714|FG003|DB RO Phase|Lost to Follow-up|0|||
146324548|NCT01097629|527698715|FG004|DB RO Phase|Lost to Follow-up|0|||
146324549|NCT01097629|527698716|FG005|DB RO Phase|Lost to Follow-up|0|||
146324550|NCT01097629|527698717|FG006|DB RO Phase|Lost to Follow-up|2|||
146324551|NCT01097629|527698718|FG007|DB RO Phase|Lost to Follow-up|0|||
146324552|NCT00132041|527698720|FG000|Baseline|Ineligible|6|||
146324553|NCT00132041|527698720|FG000|3 Months Post Ablation|Transplant|1|||
146324554|NCT00132041|527698720|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
146324555|NCT00132041|527698720|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
146324556|NCT00132041|527698720|FG000|6 Months Post Ablation|Death|2|||
146324557|NCT00132041|527698720|FG000|6 Months Post Ablation|Transplant|6|||
146324558|NCT00132041|527698720|FG000|9 Months Post Ablation|Death|1|||
146324559|NCT00132041|527698720|FG000|9 Months Post Ablation|Transplant|1|||
146324560|NCT00132041|527698720|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
146324561|NCT00132041|527698720|FG000|12 Months Post Ablation|Death|1|||
146324562|NCT00132041|527698720|FG000|12 Months Post Ablation|Transplant|1|||
146324563|NCT00132041|527698720|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
146324564|NCT00132041|527698720|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
146324565|NCT00132041|527698720|FG000|15 Months Post Ablation|Death|1|||
146324566|NCT00132041|527698720|FG000|15 Months Post Ablation|Transplant|5|||
146324567|NCT00132041|527698720|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
146324568|NCT00132041|527698720|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
146324569|NCT00132041|527698720|FG000|18 Months Post Ablation|Transplant|1|||
146324570|NCT00132041|527698720|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
146324571|NCT00132041|527698720|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
146324572|NCT05162066|527698722|FG000|Overall Study|Adverse Event|1|||
146324573|NCT05162066|527698723|FG001|Overall Study|Adverse Event|0|||
146324574|NCT05162066|527698724|FG002|Overall Study|Adverse Event|0|||
146324575|NCT05162066|527698722|FG000|Overall Study|Perceived lack of efficacy|1|||
146324576|NCT05162066|527698723|FG001|Overall Study|Perceived lack of efficacy|0|||
146324577|NCT05162066|527698724|FG002|Overall Study|Perceived lack of efficacy|0|||
146324578|NCT01171820|527698725|FG000|Overall Study|Death|3|||
146165064|NCT01939548|527114438|FG000|Overall Study|Death|0|||
146165065|NCT01939548|527114439|FG001|Overall Study|Death|0|||
146324579|NCT01171820|527698726|FG001|Overall Study|Death|3|||
146324580|NCT01171820|527698725|FG000|Overall Study|Lost to Follow-up|0|||
146324581|NCT01171820|527698726|FG001|Overall Study|Lost to Follow-up|1|||
146324582|NCT01171820|527698725|FG000|Overall Study|Withdrawal by Subject|2|||
146324583|NCT01171820|527698726|FG001|Overall Study|Withdrawal by Subject|0|||
146324584|NCT01171820|527698725|FG000|Overall Study|Physician Decision|0|||
146324585|NCT01171820|527698726|FG001|Overall Study|Physician Decision|1|||
146324586|NCT01171820|527698725|FG000|Overall Study|1-Year Missed Visit|1|||
146324587|NCT01171820|527698726|FG001|Overall Study|1-Year Missed Visit|1|||
146324588|NCT03969875|527698727|FG000|Overall Study|did not receive allocated intervention|3|||
146324589|NCT03969875|527698728|FG001|Overall Study|did not receive allocated intervention|3|||
146324590|NCT03969875|527698729|FG002|Overall Study|did not receive allocated intervention|4|||
146324591|NCT03969875|527698727|FG000|Overall Study|Protocol Violation|4|||
146324592|NCT03969875|527698728|FG001|Overall Study|Protocol Violation|2|||
146324593|NCT03969875|527698729|FG002|Overall Study|Protocol Violation|2|||
146324594|NCT01307033|527698730|FG000|8-week Double-blind Period|Adverse Event|2|||
146324595|NCT01307033|527698731|FG001|8-week Double-blind Period|Adverse Event|0|||
146324596|NCT01307033|527698732|FG002|8-week Double-blind Period|Adverse Event|0|||
146324597|NCT01307033|527698733|FG003|8-week Double-blind Period|Adverse Event|0|||
146324598|NCT01307033|527698730|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
146324599|NCT01307033|527698731|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
146324600|NCT01307033|527698732|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
146324601|NCT01307033|527698733|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
146324602|NCT01307033|527698730|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
146324603|NCT01307033|527698731|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
146324604|NCT01307033|527698732|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
146324605|NCT01307033|527698733|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
146324606|NCT01307033|527698730|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146324607|NCT01307033|527698731|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
146324608|NCT01307033|527698732|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146324609|NCT01307033|527698733|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
146324610|NCT01307033|527698730|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
146324611|NCT01307033|527698731|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
146324612|NCT01307033|527698732|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
146324613|NCT01307033|527698733|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
146324614|NCT01307033|527698730|FG000|44-week Open-label Extension|Adverse Event|0|||
146324615|NCT01307033|527698731|FG001|44-week Open-label Extension|Adverse Event|0|||
146324616|NCT01307033|527698732|FG002|44-week Open-label Extension|Adverse Event|2|||
146324617|NCT01307033|527698733|FG003|44-week Open-label Extension|Adverse Event|1|||
146324618|NCT01307033|527698730|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
146324619|NCT01307033|527698731|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
146324620|NCT01307033|527698732|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
146324621|NCT01307033|527698733|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
146324622|NCT01307033|527698730|FG000|44-week Open-label Extension|Physician Decision|0|||
146324623|NCT01307033|527698731|FG001|44-week Open-label Extension|Physician Decision|0|||
146324624|NCT01307033|527698732|FG002|44-week Open-label Extension|Physician Decision|1|||
146324625|NCT01307033|527698733|FG003|44-week Open-label Extension|Physician Decision|0|||
146324626|NCT01307033|527698730|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146324627|NCT01307033|527698731|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146324628|NCT01307033|527698732|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
146324629|NCT01307033|527698733|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
146324630|NCT01307033|527698730|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
146324631|NCT01307033|527698731|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
146324632|NCT01307033|527698732|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
146324633|NCT01307033|527698733|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
146324634|NCT01307033|527698730|FG000|44-week Open-label Extension|Death|0|||
146324635|NCT01307033|527698731|FG001|44-week Open-label Extension|Death|0|||
146324636|NCT01307033|527698732|FG002|44-week Open-label Extension|Death|0|||
146324637|NCT01307033|527698733|FG003|44-week Open-label Extension|Death|1|||
146324638|NCT02327260|527698735|FG000|Overall Study|Lost to Follow-up|2|||
146324639|NCT02327260|527698736|FG001|Overall Study|Lost to Follow-up|3|||
146324640|NCT02327260|527698737|FG002|Overall Study|Lost to Follow-up|2|||
146324641|NCT02327260|527698735|FG000|Overall Study|invalid phone number|1|||
146324642|NCT02327260|527698736|FG001|Overall Study|invalid phone number|1|||
146324643|NCT02327260|527698737|FG002|Overall Study|invalid phone number|0|||
146324644|NCT02327260|527698735|FG000|Overall Study|non-adherence to protocol|2|||
146324645|NCT02327260|527698736|FG001|Overall Study|non-adherence to protocol|0|||
146165066|NCT01939548|527114440|FG002|Overall Study|Death|1|||
146165067|NCT01939548|527114438|FG000|Overall Study|Participant dropped|0|||
146165068|NCT01939548|527114439|FG001|Overall Study|Participant dropped|0|||
146165069|NCT01939548|527114440|FG002|Overall Study|Participant dropped|1|||
146324646|NCT02327260|527698737|FG002|Overall Study|non-adherence to protocol|0|||
146324647|NCT02327260|527698735|FG000|Overall Study|cognitive concerns|1|||
146324648|NCT02327260|527698736|FG001|Overall Study|cognitive concerns|0|||
146324649|NCT02327260|527698737|FG002|Overall Study|cognitive concerns|0|||
146324650|NCT02804763|527698740|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
146324651|NCT02804763|527698741|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146324652|NCT02804763|527698742|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146165070|NCT01939548|527114438|FG000|Overall Study|Participant unwilling to continue|0|||
146165071|NCT01939548|527114439|FG001|Overall Study|Participant unwilling to continue|1|||
146165072|NCT01939548|527114440|FG002|Overall Study|Participant unwilling to continue|0|||
146165073|NCT01939548|527114438|FG000|Overall Study|Participant withdrew consent|0|||
146165074|NCT01939548|527114439|FG001|Overall Study|Participant withdrew consent|2|||
146165075|NCT01939548|527114440|FG002|Overall Study|Participant withdrew consent|0|||
146324653|NCT02804763|527698743|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
146324654|NCT02804763|527698740|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
146324655|NCT02804763|527698741|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
146324656|NCT02804763|527698742|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
146324657|NCT02804763|527698743|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
146324658|NCT02804763|527698740|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146324659|NCT02804763|527698741|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
146324660|NCT02804763|527698742|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146324661|NCT02804763|527698743|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
146324662|NCT02804763|527698740|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
146324663|NCT02804763|527698741|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
146324664|NCT02804763|527698742|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
146324665|NCT02804763|527698743|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
146324666|NCT02804763|527698740|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
146324667|NCT02804763|527698741|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
146324668|NCT02804763|527698742|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
146324669|NCT02804763|527698743|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
146324670|NCT02804763|527698740|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146324671|NCT02804763|527698741|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
146324672|NCT02804763|527698742|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146324673|NCT02804763|527698743|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
146324674|NCT00860158|527698744|FG000|Overall Study|Study Terminated|1|||
146324675|NCT05499520|527698745|FG000|Overall Study|Lost to Follow-up|0|||
146324676|NCT05499520|527698746|FG001|Overall Study|Lost to Follow-up|0|||
146324677|NCT05499520|527698747|FG002|Overall Study|Lost to Follow-up|38|||
146324678|NCT05499520|527698748|FG003|Overall Study|Lost to Follow-up|41|||
146324679|NCT05499520|527698749|FG004|Overall Study|Lost to Follow-up|46|||
146324680|NCT05499520|527698750|FG005|Overall Study|Lost to Follow-up|0|||
146324681|NCT05499520|527698751|FG006|Overall Study|Lost to Follow-up|31|||
146324682|NCT05499520|527698752|FG007|Overall Study|Lost to Follow-up|45|||
146324683|NCT05499520|527698753|FG008|Overall Study|Lost to Follow-up|42|||
146324684|NCT05499520|527698754|FG009|Overall Study|Lost to Follow-up|0|||
146324685|NCT05499520|527698755|FG010|Overall Study|Lost to Follow-up|0|||
146324686|NCT05499520|527698756|FG011|Overall Study|Lost to Follow-up|37|||
146324687|NCT05499520|527698757|FG012|Overall Study|Lost to Follow-up|53|||
146324688|NCT05499520|527698758|FG013|Overall Study|Lost to Follow-up|49|||
146324689|NCT05499520|527698759|FG014|Overall Study|Lost to Follow-up|0|||
146324690|NCT05499520|527698760|FG015|Overall Study|Lost to Follow-up|36|||
146324691|NCT05499520|527698761|FG016|Overall Study|Lost to Follow-up|58|||
146324692|NCT05499520|527698762|FG017|Overall Study|Lost to Follow-up|53|||
146324693|NCT03588741|527698763|FG000|Overall Study|Withdrawal by Subject|1|||
146324694|NCT02769624|527698765|FG000|Overall Study|Lost to Follow-up|0|||
146324695|NCT02769624|527698766|FG001|Overall Study|Lost to Follow-up|1|||
146324696|NCT00448708|527698768|FG000|Overall Study|Death|21|||
146324697|NCT00448708|527698769|FG001|Overall Study|Death|17|||
146324698|NCT00448708|527698768|FG000|Overall Study|Withdrawal by Subject|8|||
146324699|NCT00448708|527698769|FG001|Overall Study|Withdrawal by Subject|4|||
146324700|NCT00448708|527698768|FG000|Overall Study|Lost to Follow-up|6|||
146324701|NCT00448708|527698769|FG001|Overall Study|Lost to Follow-up|8|||
146324702|NCT00448708|527698768|FG000|Overall Study|not listed|0|||
146324703|NCT00448708|527698769|FG001|Overall Study|not listed|2|||
146324704|NCT04698525|527698770|FG000|Overall Study|Lost to Follow-up|1|||
146324705|NCT04698525|527698771|FG001|Overall Study|Lost to Follow-up|2|||
146324706|NCT04698525|527698770|FG000|Overall Study|Three suffered of Covid-19|2|||
146324707|NCT04698525|527698771|FG001|Overall Study|Three suffered of Covid-19|1|||
146324708|NCT00354601|527698772|FG000|Overall Study|Protocol Violation|1|||
146324709|NCT00354601|527698772|FG000|Overall Study|progression|1|||
146324710|NCT00480857|527698773|FG000|Overall Study|Lack of Efficacy|2|||
146165076|NCT01939548|527114438|FG000|Overall Study|Did not complete follow-up|0|||
146324711|NCT00611247|527698774|FG000|Overall Study|Death|1|||
146324712|NCT00611247|527698775|FG001|Overall Study|Death|5|||
146324713|NCT00611247|527698774|FG000|Overall Study|Lack of Efficacy|1|||
146324714|NCT00611247|527698775|FG001|Overall Study|Lack of Efficacy|16|||
146324715|NCT01107444|527698776|FG000|Overall Study|Withdrawal by Subject|8|||
146324716|NCT01107444|527698777|FG001|Overall Study|Withdrawal by Subject|12|||
146324717|NCT01107444|527698776|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
146324718|NCT01107444|527698777|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
146324719|NCT00243659|527698778|FG000|Overall Study|Withdrawal by Subject|1|||
146324720|NCT00243659|527698779|FG001|Overall Study|Withdrawal by Subject|1|||
146324721|NCT00243659|527698778|FG000|Overall Study|Protocol Violation|1|||
146324722|NCT00243659|527698779|FG001|Overall Study|Protocol Violation|2|||
146324723|NCT01890421|527698780|FG000|Overall Study|Adverse Event|1|||
146324724|NCT01890421|527698780|FG000|Overall Study|Other reason|10|||
146324725|NCT00268242|527698781|FG000|Overall Study|Death|1|||
146324726|NCT02526550|527698783|FG000|Overall Study|Lost to Follow-up|1|||
146324727|NCT03969888|527698786|FG000|Overall Study|Never Received Study Drug|0|||
146324728|NCT03969888|527698787|FG001|Overall Study|Never Received Study Drug|0|||
146324729|NCT03969888|527698788|FG002|Overall Study|Never Received Study Drug|1|||
146324730|NCT03969888|527698789|FG003|Overall Study|Never Received Study Drug|0|||
146324731|NCT03969888|527698790|FG004|Overall Study|Never Received Study Drug|0|||
146324732|NCT03969888|527698791|FG005|Overall Study|Never Received Study Drug|0|||
146324733|NCT03969888|527698792|FG006|Overall Study|Never Received Study Drug|1|||
146324734|NCT03969888|527698793|FG007|Overall Study|Never Received Study Drug|0|||
146324735|NCT03969888|527698786|FG000|Overall Study|Reason Not Specified|0|||
146324736|NCT03969888|527698787|FG001|Overall Study|Reason Not Specified|0|||
146324737|NCT03969888|527698788|FG002|Overall Study|Reason Not Specified|0|||
146324738|NCT03969888|527698789|FG003|Overall Study|Reason Not Specified|0|||
146324739|NCT03969888|527698790|FG004|Overall Study|Reason Not Specified|0|||
146324740|NCT03969888|527698791|FG005|Overall Study|Reason Not Specified|0|||
146324741|NCT03969888|527698792|FG006|Overall Study|Reason Not Specified|0|||
146324742|NCT03969888|527698793|FG007|Overall Study|Reason Not Specified|1|||
146324743|NCT00091832|527698795|FG000|Overall Study|Physician Decision|1|||
146324744|NCT00091832|527698796|FG001|Overall Study|Physician Decision|0|||
146324745|NCT00091832|527698797|FG002|Overall Study|Physician Decision|0|||
146324746|NCT00091832|527698798|FG003|Overall Study|Physician Decision|0|||
146324747|NCT00091832|527698799|FG004|Overall Study|Physician Decision|0|||
146324748|NCT00091832|527698800|FG005|Overall Study|Physician Decision|0|||
146324749|NCT00091832|527698795|FG000|Overall Study|Adverse Event|0|||
146324750|NCT00091832|527698796|FG001|Overall Study|Adverse Event|0|||
146324751|NCT00091832|527698797|FG002|Overall Study|Adverse Event|0|||
146324752|NCT00091832|527698798|FG003|Overall Study|Adverse Event|1|||
146324753|NCT00091832|527698799|FG004|Overall Study|Adverse Event|3|||
146324754|NCT00091832|527698800|FG005|Overall Study|Adverse Event|0|||
146324755|NCT00091832|527698795|FG000|Overall Study|Withdrawal by Subject|4|||
146324756|NCT00091832|527698796|FG001|Overall Study|Withdrawal by Subject|5|||
146324757|NCT00091832|527698797|FG002|Overall Study|Withdrawal by Subject|0|||
146324758|NCT00091832|527698798|FG003|Overall Study|Withdrawal by Subject|1|||
146324759|NCT00091832|527698799|FG004|Overall Study|Withdrawal by Subject|3|||
146324760|NCT00091832|527698800|FG005|Overall Study|Withdrawal by Subject|1|||
146324761|NCT00091832|527698795|FG000|Overall Study|Death|6|||
146324762|NCT00091832|527698796|FG001|Overall Study|Death|4|||
146324763|NCT00091832|527698797|FG002|Overall Study|Death|5|||
146324764|NCT00091832|527698798|FG003|Overall Study|Death|8|||
146324765|NCT00091832|527698799|FG004|Overall Study|Death|5|||
146324766|NCT00091832|527698800|FG005|Overall Study|Death|6|||
146324767|NCT00091832|527698795|FG000|Overall Study|Disease Progression|2|||
146324768|NCT00091832|527698796|FG001|Overall Study|Disease Progression|0|||
146324769|NCT00091832|527698797|FG002|Overall Study|Disease Progression|0|||
146324770|NCT00091832|527698798|FG003|Overall Study|Disease Progression|1|||
146324771|NCT00091832|527698799|FG004|Overall Study|Disease Progression|1|||
146324772|NCT00091832|527698800|FG005|Overall Study|Disease Progression|2|||
146324773|NCT00091832|527698795|FG000|Overall Study|Ineligibility Determined|0|||
146324774|NCT00091832|527698796|FG001|Overall Study|Ineligibility Determined|0|||
146324775|NCT00091832|527698797|FG002|Overall Study|Ineligibility Determined|1|||
146324776|NCT00091832|527698798|FG003|Overall Study|Ineligibility Determined|0|||
146324777|NCT00091832|527698799|FG004|Overall Study|Ineligibility Determined|1|||
146324778|NCT00091832|527698800|FG005|Overall Study|Ineligibility Determined|0|||
146324779|NCT00091832|527698795|FG000|Overall Study|Lost to Follow-up|1|||
146324780|NCT00091832|527698796|FG001|Overall Study|Lost to Follow-up|0|||
146324781|NCT00091832|527698797|FG002|Overall Study|Lost to Follow-up|3|||
146324782|NCT00091832|527698798|FG003|Overall Study|Lost to Follow-up|3|||
146324783|NCT00091832|527698799|FG004|Overall Study|Lost to Follow-up|2|||
146324784|NCT00091832|527698800|FG005|Overall Study|Lost to Follow-up|1|||
146324785|NCT00091832|527698795|FG000|Overall Study|Noncompliance|0|||
146324786|NCT00091832|527698796|FG001|Overall Study|Noncompliance|1|||
146324787|NCT00091832|527698797|FG002|Overall Study|Noncompliance|0|||
146324788|NCT00091832|527698798|FG003|Overall Study|Noncompliance|0|||
146324789|NCT00091832|527698799|FG004|Overall Study|Noncompliance|0|||
146324790|NCT00091832|527698800|FG005|Overall Study|Noncompliance|0|||
146324791|NCT00091832|527698795|FG000|Overall Study|Other|0|||
146324792|NCT00091832|527698796|FG001|Overall Study|Other|1|||
146324793|NCT00091832|527698797|FG002|Overall Study|Other|2|||
146324794|NCT00091832|527698798|FG003|Overall Study|Other|0|||
146324795|NCT00091832|527698799|FG004|Overall Study|Other|0|||
146324796|NCT00091832|527698800|FG005|Overall Study|Other|0|||
146324797|NCT00091832|527698795|FG000|Overall Study|Protocol Violation|0|||
146324798|NCT00091832|527698796|FG001|Overall Study|Protocol Violation|0|||
146324799|NCT00091832|527698797|FG002|Overall Study|Protocol Violation|1|||
146324800|NCT00091832|527698798|FG003|Overall Study|Protocol Violation|0|||
146324801|NCT00091832|527698799|FG004|Overall Study|Protocol Violation|0|||
146324802|NCT00091832|527698800|FG005|Overall Study|Protocol Violation|1|||
146324803|NCT00464178|527698806|FG000|Overall Study|Protocol Violation|1|||
146324804|NCT00464178|527698806|FG000|Overall Study|Withdrawal by Subject|1|||
146324805|NCT01557166|527698809|FG000|Overall Study|Adverse Event|20|||
146324806|NCT01557166|527698810|FG001|Overall Study|Adverse Event|6|||
146324807|NCT01557166|527698809|FG000|Overall Study|Lack of Efficacy|2|||
146165077|NCT01939548|527114439|FG001|Overall Study|Did not complete follow-up|1|||
146165078|NCT01939548|527114440|FG002|Overall Study|Did not complete follow-up|0|||
146165079|NCT00490282|527114441|FG000|Overall Study|Withdrawal by Subject|3|||
146165080|NCT01494584|527114447|FG000|Overall Study|Study Closed/Terminated|1|||
146165081|NCT01499082|527114448|FG000|Overall Study|Randomized but not Treated|0|||
146165082|NCT01499082|527114449|FG001|Overall Study|Randomized but not Treated|1|||
146324808|NCT01557166|527698810|FG001|Overall Study|Lack of Efficacy|1|||
146324809|NCT01557166|527698809|FG000|Overall Study|Protocol Violation|8|||
146324810|NCT01557166|527698810|FG001|Overall Study|Protocol Violation|5|||
146324811|NCT01557166|527698809|FG000|Overall Study|Withdrawn consent|12|||
146324812|NCT01557166|527698810|FG001|Overall Study|Withdrawn consent|20|||
146324813|NCT01557166|527698809|FG000|Overall Study|Target dose not tolerated|1|||
146324814|NCT01557166|527698810|FG001|Overall Study|Target dose not tolerated|0|||
146324815|NCT01557166|527698809|FG000|Overall Study|Psychiatric disorder|1|||
146324816|NCT01557166|527698810|FG001|Overall Study|Psychiatric disorder|0|||
146324817|NCT01557166|527698809|FG000|Overall Study|Unclassified|2|||
146324818|NCT01557166|527698810|FG001|Overall Study|Unclassified|5|||
146324819|NCT00946309|527698811|FG000|Overall Study|Protocol Violation|1|||
146324820|NCT00946309|527698812|FG001|Overall Study|Protocol Violation|0|||
146324821|NCT00946309|527698811|FG000|Overall Study|Lost to Follow-up|0|||
146324822|NCT00946309|527698812|FG001|Overall Study|Lost to Follow-up|1|||
146324823|NCT00946309|527698811|FG000|Overall Study|Procedure cancelled/discontinued|0|||
146324824|NCT00946309|527698812|FG001|Overall Study|Procedure cancelled/discontinued|3|||
146324825|NCT01465659|527698814|FG000|Completed 1 Cycle of Treatment|Death|0|||
146324826|NCT01465659|527698815|FG001|Completed 1 Cycle of Treatment|Death|1|||
146324827|NCT01465659|527698816|FG002|Completed 1 Cycle of Treatment|Death|0|||
146324828|NCT01465659|527698817|FG003|Completed 1 Cycle of Treatment|Death|0|||
146324829|NCT01465659|527698814|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
146324830|NCT01465659|527698815|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
146324831|NCT01465659|527698816|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
146165083|NCT01499082|527114448|FG000|Overall Study|Adverse Event|12|||
146165084|NCT01499082|527114449|FG001|Overall Study|Adverse Event|16|||
146165085|NCT01499082|527114448|FG000|Overall Study|Lack of Efficacy|1|||
146165086|NCT01499082|527114449|FG001|Overall Study|Lack of Efficacy|1|||
146165087|NCT01499082|527114448|FG000|Overall Study|Protocol Violation|6|||
146165088|NCT01499082|527114449|FG001|Overall Study|Protocol Violation|8|||
146165089|NCT01499082|527114448|FG000|Overall Study|Diverse Reasons|18|||
146165090|NCT01499082|527114449|FG001|Overall Study|Diverse Reasons|14|||
146165091|NCT01499082|527114448|FG000|Overall Study|Site Closure for Noncompliance|5|||
146165092|NCT01499082|527114449|FG001|Overall Study|Site Closure for Noncompliance|2|||
146165093|NCT01499082|527114448|FG000|Overall Study|Hypoglycemia|2|||
146165094|NCT01499082|527114449|FG001|Overall Study|Hypoglycemia|3|||
146165095|NCT01499082|527114448|FG000|Overall Study|Lost to Follow-up|1|||
146324832|NCT01465659|527698817|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
146324833|NCT01465659|527698814|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146324834|NCT01465659|527698815|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
146324835|NCT01465659|527698816|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146324836|NCT01465659|527698817|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
146324837|NCT01465659|527698814|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
146324838|NCT01465659|527698815|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
146324839|NCT01465659|527698816|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
146324840|NCT01465659|527698817|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
146324841|NCT01465659|527698814|FG000|Completed Follow for 1 Year|Death|6|||
146324842|NCT01465659|527698815|FG001|Completed Follow for 1 Year|Death|3|||
146324843|NCT01465659|527698816|FG002|Completed Follow for 1 Year|Death|2|||
146324844|NCT01465659|527698817|FG003|Completed Follow for 1 Year|Death|4|||
146324845|NCT02445586|527698823|FG000|Overall Study|Death|14|||
146324846|NCT02445586|527698823|FG000|Overall Study|Withdrawal by Subject|13|||
146324847|NCT02445586|527698823|FG000|Overall Study|Disease Progression|10|||
146324848|NCT02445586|527698823|FG000|Overall Study|Protocol Violation|1|||
146324849|NCT02445586|527698823|FG000|Overall Study|Medical Condition|1|||
146324850|NCT00428597|527698824|FG000|Overall Study|Randomized but not treated|3|||
146324851|NCT00428597|527698825|FG001|Overall Study|Randomized but not treated|3|||
146324852|NCT00428597|527698824|FG000|Overall Study|Objective Progression or Relapse|19|||
146165096|NCT01499082|527114449|FG001|Overall Study|Lost to Follow-up|3|||
146165097|NCT05380947|527114455|FG000|Washout Period 1|Not attend visit|1|||
146165098|NCT05380947|527114456|FG001|Washout Period 1|Not attend visit|0|||
146165099|NCT05380947|527114457|FG002|Washout Period 1|Not attend visit|0|||
146324853|NCT00428597|527698825|FG001|Overall Study|Objective Progression or Relapse|47|||
146324854|NCT00428597|527698824|FG000|Overall Study|Study Terminated by Sponsor|41|||
146324855|NCT00428597|527698825|FG001|Overall Study|Study Terminated by Sponsor|16|||
146165100|NCT05380947|527114458|FG003|Washout Period 1|Not attend visit|0|||
146165101|NCT05380947|527114455|FG000|Washout Period 2|Adverse Event|1|||
146165102|NCT05380947|527114456|FG001|Washout Period 2|Adverse Event|0|||
146165103|NCT05380947|527114457|FG002|Washout Period 2|Adverse Event|0|||
146324856|NCT00428597|527698824|FG000|Overall Study|Adverse Event|15|||
146324857|NCT00428597|527698825|FG001|Overall Study|Adverse Event|7|||
146324858|NCT00428597|527698824|FG000|Overall Study|Global Deterioration of Health Status|1|||
146324859|NCT00428597|527698825|FG001|Overall Study|Global Deterioration of Health Status|5|||
146324860|NCT00428597|527698824|FG000|Overall Study|Protocol Violation|2|||
146324861|NCT00428597|527698825|FG001|Overall Study|Protocol Violation|1|||
146324862|NCT00428597|527698824|FG000|Overall Study|Withdrawal by Subject|2|||
146324863|NCT00428597|527698825|FG001|Overall Study|Withdrawal by Subject|1|||
146324864|NCT00428597|527698824|FG000|Overall Study|Other|1|||
146324865|NCT00428597|527698825|FG001|Overall Study|Other|1|||
146324866|NCT00428597|527698824|FG000|Overall Study|Lost to Follow-up|0|||
146324867|NCT00428597|527698825|FG001|Overall Study|Lost to Follow-up|1|||
146324868|NCT00428597|527698824|FG000|Overall Study|Pregnancy|1|||
146324869|NCT00428597|527698825|FG001|Overall Study|Pregnancy|0|||
146324870|NCT00428597|527698824|FG000|Overall Study|Death|1|||
146324871|NCT00428597|527698825|FG001|Overall Study|Death|3|||
146324872|NCT00769119|527698831|FG000|Overall Study|Voluntary discontinuation|0|||
146324873|NCT00769119|527698832|FG001|Overall Study|Voluntary discontinuation|2|||
146324874|NCT00769119|527698831|FG000|Overall Study|Adverse Event|1|||
146324875|NCT00769119|527698832|FG001|Overall Study|Adverse Event|1|||
146324876|NCT00769119|527698831|FG000|Overall Study|Disallowed medication|1|||
146324877|NCT00769119|527698832|FG001|Overall Study|Disallowed medication|0|||
146324878|NCT00686647|527698833|FG000|Overall Study|Lost to Follow-up|1|||
146324879|NCT00686647|527698833|FG000|Overall Study|Death|1|||
146324880|NCT01116544|527698834|FG000|Overall Study|Protocol Violation|1|||
146324881|NCT01116544|527698835|FG001|Overall Study|Protocol Violation|0|||
146324882|NCT01116544|527698834|FG000|Overall Study|Withdrawal by Subject|1|||
146324883|NCT01116544|527698835|FG001|Overall Study|Withdrawal by Subject|1|||
146324884|NCT00578643|527698836|FG000|Overall Study|Death|1|||
146324885|NCT00578643|527698836|FG000|Overall Study|Lost to Follow-up|1|||
146324886|NCT01725750|527698837|FG000|Overall Study|Adverse Event|1|||
146324887|NCT01725750|527698838|FG001|Overall Study|Adverse Event|0|||
146324888|NCT01725750|527698837|FG000|Overall Study|Lost to Follow-up|1|||
146324889|NCT01725750|527698838|FG001|Overall Study|Lost to Follow-up|1|||
146324890|NCT01725750|527698837|FG000|Overall Study|Withdrawal by Subject|0|||
146324891|NCT01725750|527698838|FG001|Overall Study|Withdrawal by Subject|9|||
146324892|NCT03828487|527698843|FG000|Overall Study|Physician Decision|1|||
146324893|NCT01990261|527698846|FG000|Overall Study|Death Before Treatment Start|2|||
146324894|NCT01990261|527698846|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
146324895|NCT01990261|527698846|FG000|Overall Study|Death From other Causes|1|||
146324896|NCT01990261|527698846|FG000|Overall Study|Disease Progression (PD)|8|||
146324897|NCT01990261|527698846|FG000|Overall Study|PD Before Treatment Start|1|||
146324898|NCT01990261|527698846|FG000|Overall Study|Dossier not Approved|1|||
146324899|NCT01990261|527698846|FG000|Overall Study|Lost to Follow-up|2|||
146324900|NCT02887521|527698847|FG000|Overall Study|Withdrawal by Subject|0|||
146324901|NCT02887521|527698848|FG001|Overall Study|Withdrawal by Subject|3|||
146324902|NCT02447848|527698849|FG000|Overall Study|Patient discharged|3|||
146324903|NCT02447848|527698849|FG000|Overall Study|Lack of Efficacy|4|||
146324904|NCT02447848|527698849|FG000|Overall Study|Withdrawal by Subject|4|||
146324905|NCT02307370|527698850|FG000|Overall Study|Death|5|||
146324906|NCT02307370|527698850|FG000|Overall Study|Lost to Follow-up|1|||
146324907|NCT02307370|527698850|FG000|Overall Study|Withdrawal by Subject|1|||
146324908|NCT02307370|527698850|FG000|Overall Study|Declined Addendum ICF|6|||
146324909|NCT02307370|527698850|FG000|Overall Study|No response during telephone contact|5|||
146324910|NCT02307370|527698850|FG000|Overall Study|Protocol Violation|1|||
146324911|NCT00793793|527700758|FG000|Overall Study|Adverse Event|0|||
146324912|NCT00793793|527700759|FG001|Overall Study|Adverse Event|0|||
146324913|NCT00793793|527700760|FG002|Overall Study|Adverse Event|1|||
146324914|NCT00793793|527700761|FG003|Overall Study|Adverse Event|1|||
146165104|NCT05380947|527114458|FG003|Washout Period 2|Adverse Event|0|||
146324915|NCT00793793|527700762|FG004|Overall Study|Adverse Event|0|||
146324916|NCT00793793|527700763|FG005|Overall Study|Adverse Event|1|||
146324917|NCT00793793|527700764|FG006|Overall Study|Adverse Event|2|||
146324918|NCT00793793|527700765|FG007|Overall Study|Adverse Event|0|||
146324919|NCT00793793|527700766|FG008|Overall Study|Adverse Event|0|||
146324920|NCT00793793|527700767|FG009|Overall Study|Adverse Event|0|||
146324921|NCT00793793|527700768|FG010|Overall Study|Adverse Event|0|||
145943236|NCT00483704|526300456|FG000|Treatment|Pregnancy|0|||
146324922|NCT00793793|527700769|FG011|Overall Study|Adverse Event|2|||
146324923|NCT00793793|527700758|FG000|Overall Study|Protocol Violation|0|||
146324924|NCT00793793|527700759|FG001|Overall Study|Protocol Violation|0|||
146324925|NCT00793793|527700760|FG002|Overall Study|Protocol Violation|0|||
146324926|NCT00793793|527700761|FG003|Overall Study|Protocol Violation|1|||
146324927|NCT00793793|527700762|FG004|Overall Study|Protocol Violation|0|||
146324928|NCT00793793|527700763|FG005|Overall Study|Protocol Violation|0|||
146324929|NCT00793793|527700764|FG006|Overall Study|Protocol Violation|0|||
146324930|NCT00793793|527700765|FG007|Overall Study|Protocol Violation|0|||
146324931|NCT00793793|527700766|FG008|Overall Study|Protocol Violation|0|||
146324932|NCT00793793|527700767|FG009|Overall Study|Protocol Violation|0|||
146324933|NCT00793793|527700768|FG010|Overall Study|Protocol Violation|0|||
146324934|NCT00793793|527700769|FG011|Overall Study|Protocol Violation|0|||
146324935|NCT00793793|527700758|FG000|Overall Study|Lost to Follow-up|0|||
146324936|NCT00793793|527700759|FG001|Overall Study|Lost to Follow-up|0|||
146324937|NCT00793793|527700760|FG002|Overall Study|Lost to Follow-up|1|||
146324938|NCT00793793|527700761|FG003|Overall Study|Lost to Follow-up|0|||
146324939|NCT00793793|527700762|FG004|Overall Study|Lost to Follow-up|0|||
146324940|NCT00793793|527700763|FG005|Overall Study|Lost to Follow-up|0|||
146324941|NCT00793793|527700764|FG006|Overall Study|Lost to Follow-up|0|||
146324942|NCT00793793|527700765|FG007|Overall Study|Lost to Follow-up|0|||
146324943|NCT00793793|527700766|FG008|Overall Study|Lost to Follow-up|1|||
146324944|NCT00793793|527700767|FG009|Overall Study|Lost to Follow-up|3|||
146324945|NCT00793793|527700768|FG010|Overall Study|Lost to Follow-up|1|||
146324946|NCT00793793|527700769|FG011|Overall Study|Lost to Follow-up|0|||
146324947|NCT00793793|527700758|FG000|Overall Study|Withdrawal by Subject|0|||
146324948|NCT00793793|527700759|FG001|Overall Study|Withdrawal by Subject|0|||
146324949|NCT00793793|527700760|FG002|Overall Study|Withdrawal by Subject|0|||
146324950|NCT00793793|527700761|FG003|Overall Study|Withdrawal by Subject|0|||
146324951|NCT00793793|527700762|FG004|Overall Study|Withdrawal by Subject|1|||
146324952|NCT00793793|527700763|FG005|Overall Study|Withdrawal by Subject|0|||
146324953|NCT00793793|527700764|FG006|Overall Study|Withdrawal by Subject|0|||
146324954|NCT00793793|527700765|FG007|Overall Study|Withdrawal by Subject|0|||
146324955|NCT00793793|527700766|FG008|Overall Study|Withdrawal by Subject|1|||
146324956|NCT00793793|527700767|FG009|Overall Study|Withdrawal by Subject|0|||
146324957|NCT00793793|527700768|FG010|Overall Study|Withdrawal by Subject|0|||
146324958|NCT00793793|527700769|FG011|Overall Study|Withdrawal by Subject|0|||
146324959|NCT00793793|527700758|FG000|Overall Study|reason not specified|0|||
146324960|NCT00793793|527700759|FG001|Overall Study|reason not specified|1|||
146324961|NCT00793793|527700760|FG002|Overall Study|reason not specified|0|||
146324962|NCT00793793|527700761|FG003|Overall Study|reason not specified|1|||
146324963|NCT00793793|527700762|FG004|Overall Study|reason not specified|1|||
146324964|NCT00793793|527700763|FG005|Overall Study|reason not specified|1|||
146324965|NCT00793793|527700764|FG006|Overall Study|reason not specified|2|||
146324966|NCT00793793|527700765|FG007|Overall Study|reason not specified|0|||
146324967|NCT00793793|527700766|FG008|Overall Study|reason not specified|7|||
146324968|NCT00793793|527700767|FG009|Overall Study|reason not specified|6|||
146324969|NCT00793793|527700768|FG010|Overall Study|reason not specified|2|||
146324970|NCT00793793|527700769|FG011|Overall Study|reason not specified|4|||
146324971|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
146324972|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
146324973|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
146324974|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
146324975|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
146324976|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
146324977|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
146324978|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
146324979|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146324980|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
146324981|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146324982|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
146324983|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
146324984|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146165105|NCT05380947|527114455|FG000|Washout Period 3|Adverse Event|0|||
146324985|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146324986|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
146165106|NCT05380947|527114456|FG001|Washout Period 3|Adverse Event|1|||
146324987|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
146324988|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
146324989|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146324990|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146165107|NCT05380947|527114457|FG002|Washout Period 3|Adverse Event|0|||
146165108|NCT05380947|527114458|FG003|Washout Period 3|Adverse Event|0|||
146165109|NCT05380947|527114455|FG000|Washout Period 3|Not attend visit|0|||
146165110|NCT05380947|527114456|FG001|Washout Period 3|Not attend visit|1|||
146324991|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
146324992|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146324993|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146324994|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146324995|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
146324996|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
146324997|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
146324998|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
146324999|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
146325000|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
146325001|NCT05195528|527700771|FG000|Placebo-controlled Treatment Period|Other|0|||
146325002|NCT05195528|527700772|FG001|Placebo-controlled Treatment Period|Other|0|||
146325003|NCT05195528|527700773|FG002|Placebo-controlled Treatment Period|Other|1|||
146325004|NCT05195528|527700774|FG003|Placebo-controlled Treatment Period|Other|0|||
146325005|NCT05195528|527700775|FG004|Placebo-controlled Treatment Period|Other|0|||
146325006|NCT05195528|527700771|FG000|Extension Period|PTE or AE or SAE|0|||
146325007|NCT05195528|527700772|FG001|Extension Period|PTE or AE or SAE|4|||
146325008|NCT05195528|527700773|FG002|Extension Period|PTE or AE or SAE|5|||
146325009|NCT05195528|527700774|FG003|Extension Period|PTE or AE or SAE|4|||
146325010|NCT05195528|527700775|FG004|Extension Period|PTE or AE or SAE|4|||
146325011|NCT05195528|527700771|FG000|Extension Period|Protocol Violation|0|||
146325012|NCT05195528|527700772|FG001|Extension Period|Protocol Violation|2|||
146325013|NCT05195528|527700773|FG002|Extension Period|Protocol Violation|1|||
146325014|NCT05195528|527700774|FG003|Extension Period|Protocol Violation|0|||
146325015|NCT05195528|527700775|FG004|Extension Period|Protocol Violation|1|||
146325016|NCT05195528|527700771|FG000|Extension Period|Lost to Follow-up|0|||
146325017|NCT05195528|527700772|FG001|Extension Period|Lost to Follow-up|6|||
146325018|NCT05195528|527700773|FG002|Extension Period|Lost to Follow-up|13|||
146325019|NCT05195528|527700774|FG003|Extension Period|Lost to Follow-up|3|||
146325020|NCT05195528|527700775|FG004|Extension Period|Lost to Follow-up|7|||
146325021|NCT05195528|527700771|FG000|Extension Period|Withdrawal by Subject|0|||
146325022|NCT05195528|527700772|FG001|Extension Period|Withdrawal by Subject|12|||
146325023|NCT05195528|527700773|FG002|Extension Period|Withdrawal by Subject|9|||
146325024|NCT05195528|527700774|FG003|Extension Period|Withdrawal by Subject|6|||
146325025|NCT05195528|527700775|FG004|Extension Period|Withdrawal by Subject|5|||
146325026|NCT05195528|527700771|FG000|Extension Period|Lack of Efficacy|0|||
146325027|NCT05195528|527700772|FG001|Extension Period|Lack of Efficacy|3|||
146325028|NCT05195528|527700773|FG002|Extension Period|Lack of Efficacy|0|||
146325029|NCT05195528|527700774|FG003|Extension Period|Lack of Efficacy|0|||
146325030|NCT05195528|527700775|FG004|Extension Period|Lack of Efficacy|2|||
146325031|NCT05195528|527700771|FG000|Extension Period|Not Treated|0|||
146325032|NCT05195528|527700772|FG001|Extension Period|Not Treated|0|||
146325033|NCT05195528|527700773|FG002|Extension Period|Not Treated|2|||
146325034|NCT05195528|527700774|FG003|Extension Period|Not Treated|3|||
146325035|NCT05195528|527700775|FG004|Extension Period|Not Treated|0|||
146325036|NCT05195528|527700771|FG000|Extension Period|Other|0|||
146325037|NCT05195528|527700772|FG001|Extension Period|Other|1|||
146325038|NCT05195528|527700773|FG002|Extension Period|Other|1|||
146325039|NCT05195528|527700774|FG003|Extension Period|Other|0|||
146325040|NCT05195528|527700775|FG004|Extension Period|Other|0|||
146325041|NCT01552902|527700776|FG000|Overall Study|Adverse Event|1|||
146325042|NCT01552902|527700777|FG001|Overall Study|Adverse Event|15|||
146325043|NCT01552902|527700778|FG002|Overall Study|Adverse Event|14|||
146325044|NCT01552902|527700776|FG000|Overall Study|Protocol Violation|3|||
146325045|NCT01552902|527700777|FG001|Overall Study|Protocol Violation|3|||
146325046|NCT01552902|527700778|FG002|Overall Study|Protocol Violation|3|||
146325047|NCT01552902|527700776|FG000|Overall Study|Lack of Efficacy|4|||
146325048|NCT01552902|527700777|FG001|Overall Study|Lack of Efficacy|3|||
146325049|NCT01552902|527700778|FG002|Overall Study|Lack of Efficacy|1|||
146325050|NCT01552902|527700776|FG000|Overall Study|Withdrawal by Subject|1|||
146325051|NCT01552902|527700777|FG001|Overall Study|Withdrawal by Subject|9|||
146325052|NCT01552902|527700778|FG002|Overall Study|Withdrawal by Subject|6|||
146325053|NCT01552902|527700776|FG000|Overall Study|Lost to Follow-up|1|||
146325054|NCT01552902|527700777|FG001|Overall Study|Lost to Follow-up|3|||
146325055|NCT01552902|527700778|FG002|Overall Study|Lost to Follow-up|6|||
146325056|NCT01552902|527700776|FG000|Overall Study|Other|3|||
146325057|NCT01552902|527700777|FG001|Overall Study|Other|4|||
146325058|NCT01552902|527700778|FG002|Overall Study|Other|3|||
146325059|NCT02487108|527700781|FG000|Overall Study|Adverse Event|1|||
146325060|NCT02487108|527700782|FG001|Overall Study|Adverse Event|6|||
146325061|NCT02487108|527700783|FG002|Overall Study|Adverse Event|12|||
146325062|NCT02487108|527700784|FG003|Overall Study|Adverse Event|6|||
146325063|NCT02487108|527700781|FG000|Overall Study|Withdrawal by Subject|8|||
146325064|NCT02487108|527700782|FG001|Overall Study|Withdrawal by Subject|5|||
146325065|NCT02487108|527700783|FG002|Overall Study|Withdrawal by Subject|5|||
146325066|NCT02487108|527700784|FG003|Overall Study|Withdrawal by Subject|0|||
146325067|NCT02487108|527700781|FG000|Overall Study|Non-compliance to study medication|3|||
146165111|NCT05380947|527114457|FG002|Washout Period 3|Not attend visit|0|||
146165112|NCT05380947|527114458|FG003|Washout Period 3|Not attend visit|1|||
146165113|NCT01256567|527114460|FG000|Overall Study|Withdrawal by Subject|1|||
146165114|NCT02453685|527114473|FG000|Overall Study|Adverse Event|0|||
146165115|NCT02453685|527114474|FG001|Overall Study|Adverse Event|1|||
146165116|NCT02453685|527114473|FG000|Overall Study|Protocol Violation|7|||
146325068|NCT02487108|527700782|FG001|Overall Study|Non-compliance to study medication|2|||
146325069|NCT02487108|527700783|FG002|Overall Study|Non-compliance to study medication|5|||
146325070|NCT02487108|527700784|FG003|Overall Study|Non-compliance to study medication|4|||
146325071|NCT02487108|527700781|FG000|Overall Study|Protocol Violation|1|||
146325072|NCT02487108|527700782|FG001|Overall Study|Protocol Violation|1|||
146325073|NCT02487108|527700783|FG002|Overall Study|Protocol Violation|2|||
146325074|NCT02487108|527700784|FG003|Overall Study|Protocol Violation|0|||
146325075|NCT02487108|527700781|FG000|Overall Study|Non-compliance to study procedures|0|||
146325076|NCT02487108|527700782|FG001|Overall Study|Non-compliance to study procedures|0|||
146325077|NCT02487108|527700783|FG002|Overall Study|Non-compliance to study procedures|0|||
146325078|NCT02487108|527700784|FG003|Overall Study|Non-compliance to study procedures|1|||
146325079|NCT02487108|527700781|FG000|Overall Study|Other than specified|3|||
146325080|NCT02487108|527700782|FG001|Overall Study|Other than specified|2|||
146325081|NCT02487108|527700783|FG002|Overall Study|Other than specified|2|||
146325082|NCT02487108|527700784|FG003|Overall Study|Other than specified|0|||
146325083|NCT01940484|527700785|FG000|Overall Study|Withdrawal by Subject|3|||
146325084|NCT01940484|527700785|FG000|Overall Study|Underwent transplantation|4|||
146325085|NCT01940484|527700785|FG000|Overall Study|Death|2|||
146325086|NCT01940484|527700785|FG000|Overall Study|Adverse Event|1|||
146325087|NCT03653390|527700794|FG000|Overall Study|Lost to Follow-up|12|||
146325088|NCT03653390|527700795|FG001|Overall Study|Lost to Follow-up|8|||
146325089|NCT03653390|527700796|FG002|Overall Study|Lost to Follow-up|7|||
146325090|NCT03653390|527700794|FG000|Overall Study|Withdrawal by Subject|6|||
146325091|NCT03653390|527700795|FG001|Overall Study|Withdrawal by Subject|1|||
146325092|NCT03653390|527700796|FG002|Overall Study|Withdrawal by Subject|1|||
146325093|NCT03653390|527700794|FG000|Overall Study|Death|1|||
146325094|NCT03653390|527700795|FG001|Overall Study|Death|0|||
146325095|NCT03653390|527700796|FG002|Overall Study|Death|0|||
146325096|NCT03653390|527700794|FG000|Overall Study|Paper Survey Lost|1|||
146325097|NCT03653390|527700795|FG001|Overall Study|Paper Survey Lost|0|||
146325098|NCT03653390|527700796|FG002|Overall Study|Paper Survey Lost|0|||
146325099|NCT03118947|527700797|FG000|Overall Study|Adverse Event|7|||
146325100|NCT03118947|527700797|FG000|Overall Study|Death|3|||
146325101|NCT03118947|527700797|FG000|Overall Study|Lack of Efficacy|4|||
146325102|NCT03118947|527700797|FG000|Overall Study|Non-compliance with study drug|1|||
146325103|NCT03118947|527700797|FG000|Overall Study|Protocol Violation|2|||
146325104|NCT03118947|527700797|FG000|Overall Study|Withdrawal by Subject|3|||
146325105|NCT03118947|527700797|FG000|Overall Study|Withdrawal by caregiver|3|||
146325106|NCT03118947|527700797|FG000|Overall Study|Change in patient's living situation|4|||
146325107|NCT03118947|527700797|FG000|Overall Study|Lost to Follow-up|2|||
146325108|NCT05099640|527700800|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
146325109|NCT05099640|527700801|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
146325110|NCT05099640|527700802|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
146325111|NCT05099640|527700800|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
146325112|NCT05099640|527700801|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
146325113|NCT05099640|527700802|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
146325114|NCT05099640|527700800|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
146325115|NCT05099640|527700801|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
146325116|NCT05099640|527700802|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
146325117|NCT05099640|527700800|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
146325118|NCT05099640|527700801|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
146325119|NCT05099640|527700802|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
146325120|NCT05099640|527700800|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
146325121|NCT05099640|527700801|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
146325122|NCT05099640|527700802|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
146325123|NCT05099640|527700800|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
146325124|NCT05099640|527700801|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
146325125|NCT05099640|527700802|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
146325126|NCT01552681|527700803|FG000|Overall Study|Withdrawal by Subject|4|||
146325127|NCT01552681|527700804|FG001|Overall Study|Withdrawal by Subject|0|||
146325128|NCT01552681|527700803|FG000|Overall Study|Physician Decision|1|||
146165117|NCT02453685|527114474|FG001|Overall Study|Protocol Violation|4|||
146165118|NCT02453685|527114473|FG000|Overall Study|Lost to Follow-up|0|||
146165119|NCT02453685|527114474|FG001|Overall Study|Lost to Follow-up|1|||
146165120|NCT02453685|527114473|FG000|Overall Study|Withdrawal by Subject|8|||
146325129|NCT01552681|527700804|FG001|Overall Study|Physician Decision|0|||
146325130|NCT01552681|527700803|FG000|Overall Study|Subject moved away|0|||
146325131|NCT01552681|527700804|FG001|Overall Study|Subject moved away|1|||
146325132|NCT01987908|527700805|FG000|Placebo Lead-in Period|Adverse Event|2|||
146325133|NCT01987908|527700806|FG001|Placebo Lead-in Period|Adverse Event|0|||
146325134|NCT01987908|527700807|FG002|Placebo Lead-in Period|Adverse Event|0|||
146325135|NCT01987908|527700805|FG000|Placebo Lead-in Period|Physician Decision|2|||
146325136|NCT01987908|527700806|FG001|Placebo Lead-in Period|Physician Decision|0|||
146325137|NCT01987908|527700807|FG002|Placebo Lead-in Period|Physician Decision|0|||
146325138|NCT01987908|527700805|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
146325139|NCT01987908|527700806|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
146325140|NCT01987908|527700807|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
146325141|NCT01987908|527700805|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
146325142|NCT01987908|527700806|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
146325143|NCT01987908|527700807|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
146325144|NCT01987908|527700805|FG000|Treatment Period|Adverse Event|0|||
146325145|NCT01987908|527700806|FG001|Treatment Period|Adverse Event|1|||
146165121|NCT02453685|527114474|FG001|Overall Study|Withdrawal by Subject|4|||
146165122|NCT02453685|527114473|FG000|Overall Study|Unclassified|4|||
146165123|NCT02453685|527114474|FG001|Overall Study|Unclassified|2|||
146165124|NCT00522626|527114479|FG000|Overall Study|Lost to Follow-up|7|||
146165125|NCT00803452|527114480|FG000|Overall Study|Adverse Event|0|||
146165126|NCT00803452|527114481|FG001|Overall Study|Adverse Event|2|||
146325146|NCT01987908|527700807|FG002|Treatment Period|Adverse Event|1|||
146325147|NCT01987908|527700805|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
146325148|NCT01987908|527700806|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
146325149|NCT01987908|527700807|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
146325150|NCT01987908|527700805|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
146325151|NCT01987908|527700806|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
146325152|NCT01987908|527700807|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
146325153|NCT03603652|527700811|FG000|Overall Study|Death|2|||
146325154|NCT02471716|527700812|FG000|Overall Study|Withdrawal by Subject|0|||
146325155|NCT02471716|527700813|FG001|Overall Study|Withdrawal by Subject|1|||
146325156|NCT02471716|527700814|FG002|Overall Study|Withdrawal by Subject|0|||
146325157|NCT02471716|527700815|FG003|Overall Study|Withdrawal by Subject|2|||
146325158|NCT02471716|527700816|FG004|Overall Study|Withdrawal by Subject|5|||
146325159|NCT02471716|527700812|FG000|Overall Study|Study Terminiated by sponsor|0|||
146325160|NCT02471716|527700813|FG001|Overall Study|Study Terminiated by sponsor|0|||
146325161|NCT02471716|527700814|FG002|Overall Study|Study Terminiated by sponsor|0|||
146325162|NCT02471716|527700815|FG003|Overall Study|Study Terminiated by sponsor|1|||
146325163|NCT02471716|527700816|FG004|Overall Study|Study Terminiated by sponsor|0|||
146325164|NCT02471716|527700812|FG000|Overall Study|Lost to Follow-up|0|||
146325165|NCT02471716|527700813|FG001|Overall Study|Lost to Follow-up|0|||
146325166|NCT02471716|527700814|FG002|Overall Study|Lost to Follow-up|0|||
146325167|NCT02471716|527700815|FG003|Overall Study|Lost to Follow-up|3|||
146325168|NCT02471716|527700816|FG004|Overall Study|Lost to Follow-up|2|||
146325169|NCT02471716|527700812|FG000|Overall Study|Death|0|||
146325170|NCT02471716|527700813|FG001|Overall Study|Death|0|||
146325171|NCT02471716|527700814|FG002|Overall Study|Death|0|||
146325172|NCT02471716|527700815|FG003|Overall Study|Death|1|||
146325173|NCT02471716|527700816|FG004|Overall Study|Death|0|||
146325174|NCT02471716|527700812|FG000|Overall Study|Other|0|||
146325175|NCT02471716|527700813|FG001|Overall Study|Other|0|||
146325176|NCT02471716|527700814|FG002|Overall Study|Other|0|||
146325177|NCT02471716|527700815|FG003|Overall Study|Other|8|||
146325178|NCT02471716|527700816|FG004|Overall Study|Other|9|||
146325179|NCT00130286|527700819|FG000|Overall Study|Withdrawal by Subject|0|||
146325180|NCT00130286|527700820|FG001|Overall Study|Withdrawal by Subject|1|||
146325181|NCT00130286|527700821|FG002|Overall Study|Withdrawal by Subject|2|||
146325182|NCT00130286|527700822|FG003|Overall Study|Withdrawal by Subject|2|||
146325183|NCT00130286|527700819|FG000|Overall Study|Adverse Event|0|||
146325184|NCT00130286|527700820|FG001|Overall Study|Adverse Event|0|||
146325185|NCT00130286|527700821|FG002|Overall Study|Adverse Event|2|||
146325186|NCT00130286|527700822|FG003|Overall Study|Adverse Event|0|||
146325187|NCT00130286|527700819|FG000|Overall Study|Missing lab specimens|0|||
146325188|NCT00130286|527700820|FG001|Overall Study|Missing lab specimens|2|||
146325189|NCT00130286|527700821|FG002|Overall Study|Missing lab specimens|0|||
146325190|NCT00130286|527700822|FG003|Overall Study|Missing lab specimens|0|||
146325191|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
146325192|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146325193|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146325194|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
146325195|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
146325196|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146165127|NCT00803452|527114480|FG000|Overall Study|Lost to Follow-up|0|||
146165128|NCT00803452|527114481|FG001|Overall Study|Lost to Follow-up|3|||
146165129|NCT02412137|527114491|FG000|Overall Study|Withdrawal by Subject|2|||
146165130|NCT02412137|527114492|FG001|Overall Study|Withdrawal by Subject|0|||
146165131|NCT02412137|527114491|FG000|Overall Study|Lost to Follow-up|21|||
146165132|NCT02412137|527114492|FG001|Overall Study|Lost to Follow-up|14|||
146165133|NCT02412137|527114491|FG000|Overall Study|Physician Decision|28|||
146165134|NCT02412137|527114492|FG001|Overall Study|Physician Decision|9|||
146165135|NCT00608582|527114504|FG000|Overall Study|Lost to Follow-up|2|||
146165136|NCT00608582|527114505|FG001|Overall Study|Lost to Follow-up|0|||
146325197|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146325198|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
146325199|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
146325200|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146325201|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146325202|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
146325203|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
146325204|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146325205|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146325206|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
146325207|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
146325208|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146325209|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146325210|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
146325211|NCT01360645|527700825|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
146325212|NCT01360645|527700826|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146325213|NCT01360645|527700827|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146325214|NCT01360645|527700828|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
146325215|NCT01360645|527700825|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
146325216|NCT01360645|527700826|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
146325217|NCT01360645|527700827|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
146325218|NCT01360645|527700828|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
146325219|NCT01360645|527700825|FG000|Phase B (6 Weeks)|Adverse Event|0|||
146325220|NCT01360645|527700826|FG001|Phase B (6 Weeks)|Adverse Event|6|||
146325221|NCT01360645|527700827|FG002|Phase B (6 Weeks)|Adverse Event|0|||
146325222|NCT01360645|527700828|FG003|Phase B (6 Weeks)|Adverse Event|0|||
146325223|NCT01360645|527700825|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146325224|NCT01360645|527700826|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
146325225|NCT01360645|527700827|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
146325226|NCT01360645|527700828|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
146325227|NCT01360645|527700825|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146325228|NCT01360645|527700826|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
146325229|NCT01360645|527700827|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
146325230|NCT01360645|527700828|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
146325231|NCT01360645|527700825|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
146325232|NCT01360645|527700826|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
146325233|NCT01360645|527700827|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
146325234|NCT01360645|527700828|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
146325235|NCT01360645|527700825|FG000|Phase A+|Lost to Follow-up|0|||
146325236|NCT01360645|527700826|FG001|Phase A+|Lost to Follow-up|0|||
146325237|NCT01360645|527700827|FG002|Phase A+|Lost to Follow-up|0|||
146325238|NCT01360645|527700828|FG003|Phase A+|Lost to Follow-up|7|||
146325239|NCT01360645|527700825|FG000|Phase A+|Adverse Event|0|||
146325240|NCT01360645|527700826|FG001|Phase A+|Adverse Event|0|||
146325241|NCT01360645|527700827|FG002|Phase A+|Adverse Event|0|||
146325242|NCT01360645|527700828|FG003|Phase A+|Adverse Event|2|||
146325243|NCT01360645|527700825|FG000|Phase A+|Met Withdrawal Criteria|0|||
146325244|NCT01360645|527700826|FG001|Phase A+|Met Withdrawal Criteria|0|||
146325245|NCT01360645|527700827|FG002|Phase A+|Met Withdrawal Criteria|0|||
146325246|NCT01360645|527700828|FG003|Phase A+|Met Withdrawal Criteria|4|||
146325247|NCT01360645|527700825|FG000|Phase A+|Physician Decision|0|||
146325248|NCT01360645|527700826|FG001|Phase A+|Physician Decision|0|||
146325249|NCT01360645|527700827|FG002|Phase A+|Physician Decision|0|||
146325250|NCT01360645|527700828|FG003|Phase A+|Physician Decision|2|||
146325251|NCT01360645|527700825|FG000|Phase A+|Withdrawal by Subject|0|||
146325252|NCT01360645|527700826|FG001|Phase A+|Withdrawal by Subject|0|||
146325253|NCT01360645|527700827|FG002|Phase A+|Withdrawal by Subject|0|||
146325254|NCT01360645|527700828|FG003|Phase A+|Withdrawal by Subject|5|||
146165137|NCT00608582|527114504|FG000|Overall Study|No Best Response in Phase 1 located|1|||
146165138|NCT00608582|527114505|FG001|Overall Study|No Best Response in Phase 1 located|1|||
146165139|NCT00608582|527114504|FG000|Overall Study|Illicit Drug Use|1|||
146325255|NCT01360645|527700825|FG000|Phase A+|Protocol Deviation|0|||
146325256|NCT01360645|527700826|FG001|Phase A+|Protocol Deviation|0|||
146325257|NCT01360645|527700827|FG002|Phase A+|Protocol Deviation|0|||
146325258|NCT01360645|527700828|FG003|Phase A+|Protocol Deviation|4|||
146325259|NCT01014585|527700829|FG000|Overall Study|Adverse Event|0|||
146325260|NCT01014585|527700830|FG001|Overall Study|Adverse Event|2|||
146325261|NCT01014585|527700831|FG002|Overall Study|Adverse Event|0|||
146325262|NCT01014585|527700832|FG003|Overall Study|Adverse Event|3|||
146325263|NCT01014585|527700829|FG000|Overall Study|Withdrawal by Subject|2|||
146325264|NCT01014585|527700830|FG001|Overall Study|Withdrawal by Subject|0|||
146325265|NCT01014585|527700831|FG002|Overall Study|Withdrawal by Subject|1|||
146325266|NCT01014585|527700832|FG003|Overall Study|Withdrawal by Subject|3|||
146325267|NCT01014585|527700829|FG000|Overall Study|Lost to Follow-up|0|||
146325268|NCT01014585|527700830|FG001|Overall Study|Lost to Follow-up|0|||
146325269|NCT01014585|527700831|FG002|Overall Study|Lost to Follow-up|0|||
146325270|NCT01014585|527700832|FG003|Overall Study|Lost to Follow-up|2|||
146325271|NCT01014585|527700829|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
146325272|NCT01014585|527700830|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
146325273|NCT01014585|527700831|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
146325274|NCT01014585|527700832|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
146325275|NCT02154425|527700833|FG000|Screening Period|Adverse Event|1|||
146325276|NCT02211261|527700843|FG000|Overall Study|Withdrawal by Subject|0|||
146325277|NCT02211261|527700844|FG001|Overall Study|Withdrawal by Subject|0|||
146325278|NCT02211261|527700845|FG002|Overall Study|Withdrawal by Subject|1|||
146325279|NCT02211261|527700846|FG003|Overall Study|Withdrawal by Subject|0|||
146325280|NCT02211261|527700847|FG004|Overall Study|Withdrawal by Subject|2|||
146325281|NCT02211261|527700848|FG005|Overall Study|Withdrawal by Subject|0|||
146325282|NCT02211261|527700849|FG006|Overall Study|Withdrawal by Subject|0|||
146325283|NCT02211261|527700850|FG007|Overall Study|Withdrawal by Subject|0|||
146325284|NCT02211261|527700851|FG008|Overall Study|Withdrawal by Subject|0|||
146325285|NCT02211261|527700852|FG009|Overall Study|Withdrawal by Subject|0|||
146325286|NCT02211261|527700853|FG010|Overall Study|Withdrawal by Subject|0|||
146325287|NCT02211261|527700843|FG000|Overall Study|Other|0|||
146325288|NCT02211261|527700844|FG001|Overall Study|Other|0|||
146325289|NCT02211261|527700845|FG002|Overall Study|Other|0|||
146325290|NCT02211261|527700846|FG003|Overall Study|Other|0|||
146325291|NCT02211261|527700847|FG004|Overall Study|Other|0|||
146325292|NCT02211261|527700848|FG005|Overall Study|Other|1|||
146325293|NCT02211261|527700849|FG006|Overall Study|Other|0|||
146325294|NCT02211261|527700850|FG007|Overall Study|Other|0|||
146325295|NCT02211261|527700851|FG008|Overall Study|Other|0|||
146325296|NCT02211261|527700852|FG009|Overall Study|Other|2|||
146325297|NCT02211261|527700853|FG010|Overall Study|Other|0|||
146325298|NCT02211261|527700843|FG000|Overall Study|Lost to Follow-up|0|||
146325299|NCT02211261|527700844|FG001|Overall Study|Lost to Follow-up|0|||
146325300|NCT02211261|527700845|FG002|Overall Study|Lost to Follow-up|0|||
146325301|NCT02211261|527700846|FG003|Overall Study|Lost to Follow-up|0|||
146325302|NCT02211261|527700847|FG004|Overall Study|Lost to Follow-up|0|||
146325303|NCT02211261|527700848|FG005|Overall Study|Lost to Follow-up|0|||
146325304|NCT02211261|527700849|FG006|Overall Study|Lost to Follow-up|0|||
146325305|NCT02211261|527700850|FG007|Overall Study|Lost to Follow-up|1|||
146325306|NCT02211261|527700851|FG008|Overall Study|Lost to Follow-up|0|||
146325307|NCT02211261|527700852|FG009|Overall Study|Lost to Follow-up|0|||
146325308|NCT02211261|527700853|FG010|Overall Study|Lost to Follow-up|0|||
146325309|NCT00880256|527700854|FG000|Overall Study|Lost to Follow-up|28|||
146325310|NCT02041962|527700855|FG000|Overall Study|Lost Aetna Coverage|43|||
146325311|NCT02041962|527700856|FG001|Overall Study|Lost Aetna Coverage|40|||
146325312|NCT02041962|527700855|FG000|Overall Study|Death|1|||
146325313|NCT02041962|527700856|FG001|Overall Study|Death|1|||
146325314|NCT02041962|527700855|FG000|Overall Study|Lost to Follow-up|37|||
146325315|NCT02041962|527700856|FG001|Overall Study|Lost to Follow-up|32|||
146325316|NCT02041962|527700855|FG000|Overall Study|Withdrawal by Subject|0|||
146325317|NCT02041962|527700856|FG001|Overall Study|Withdrawal by Subject|11|||
146325318|NCT00330187|527700859|FG000|Overall Study|Lost to Follow-up|12|||
146325319|NCT00330187|527700860|FG001|Overall Study|Lost to Follow-up|13|||
146325320|NCT00330187|527700861|FG002|Overall Study|Lost to Follow-up|14|||
146325321|NCT00330187|527700862|FG003|Overall Study|Lost to Follow-up|10|||
146325322|NCT00330187|527700859|FG000|Overall Study|Withdrawal by Subject|8|||
146165140|NCT00608582|527114505|FG001|Overall Study|Illicit Drug Use|0|||
146325323|NCT00330187|527700860|FG001|Overall Study|Withdrawal by Subject|5|||
146325324|NCT00330187|527700861|FG002|Overall Study|Withdrawal by Subject|4|||
146325325|NCT00330187|527700862|FG003|Overall Study|Withdrawal by Subject|4|||
146325326|NCT02908516|527700863|FG000|Overall Study|Study Terminated|3|||
146325327|NCT02908516|527700864|FG001|Overall Study|Study Terminated|3|||
146325328|NCT01225562|527700865|FG000|Overall Study|Withdrawal by Subject|52|||
146165141|NCT00608582|527114504|FG000|Overall Study|Early stage Design Change|0|||
146325329|NCT01225562|527700866|FG001|Overall Study|Withdrawal by Subject|50|||
146165142|NCT00608582|527114505|FG001|Overall Study|Early stage Design Change|3|||
146165143|NCT04233372|527116225|FG000|Overall Study|Lost to Follow-up|104|||
146325330|NCT01225562|527700867|FG002|Overall Study|Withdrawal by Subject|52|||
146325331|NCT01225562|527700865|FG000|Overall Study|Lost to Follow-up|3|||
146325332|NCT01225562|527700866|FG001|Overall Study|Lost to Follow-up|6|||
146325333|NCT01225562|527700867|FG002|Overall Study|Lost to Follow-up|1|||
146325334|NCT01481896|527700868|FG000|Overall Study|Lost to Follow-up|12|||
146325335|NCT01162421|527700876|FG000|Overall Study|Did not receive study drug|2|||
146325336|NCT01162421|527700877|FG001|Overall Study|Did not receive study drug|1|||
146325337|NCT01162421|527700876|FG000|Overall Study|Adverse Event|2|||
146325338|NCT01162421|527700877|FG001|Overall Study|Adverse Event|5|||
146325339|NCT01162421|527700876|FG000|Overall Study|Lost to Follow-up|0|||
146325340|NCT01162421|527700877|FG001|Overall Study|Lost to Follow-up|2|||
146325341|NCT01162421|527700876|FG000|Overall Study|Lack of Efficacy|2|||
146325342|NCT01162421|527700877|FG001|Overall Study|Lack of Efficacy|2|||
146325343|NCT01162421|527700876|FG000|Overall Study|Other|2|||
146325344|NCT01162421|527700877|FG001|Overall Study|Other|3|||
146325345|NCT03336502|527700879|FG000|Overall Study|Physician Decision|0|||
146325346|NCT03336502|527700880|FG001|Overall Study|Physician Decision|1|||
146325347|NCT03336502|527700879|FG000|Overall Study|Prohibited Drugs|1|||
146325348|NCT03336502|527700880|FG001|Overall Study|Prohibited Drugs|1|||
146325349|NCT03336502|527700879|FG000|Overall Study|Death|1|||
146325350|NCT03336502|527700880|FG001|Overall Study|Death|2|||
146325351|NCT03336502|527700879|FG000|Overall Study|Adverse Event|2|||
146325352|NCT03336502|527700880|FG001|Overall Study|Adverse Event|5|||
146325353|NCT01948830|527700884|FG000|Overall Study|Physician Decision|1|||
146325354|NCT01948830|527700885|FG001|Overall Study|Physician Decision|3|||
146325355|NCT01948830|527700884|FG000|Overall Study|Protocol deviation|1|||
146325356|NCT01948830|527700885|FG001|Overall Study|Protocol deviation|2|||
146325357|NCT01948830|527700884|FG000|Overall Study|Lost to Follow-up|5|||
146325358|NCT01948830|527700885|FG001|Overall Study|Lost to Follow-up|4|||
146325359|NCT01948830|527700884|FG000|Overall Study|Withdrawal by Subject|14|||
146325360|NCT01948830|527700885|FG001|Overall Study|Withdrawal by Subject|17|||
146325361|NCT01948830|527700884|FG000|Overall Study|Adverse Event|9|||
146325362|NCT01948830|527700885|FG001|Overall Study|Adverse Event|2|||
146325363|NCT01948830|527700884|FG000|Overall Study|Death|3|||
146325364|NCT01948830|527700885|FG001|Overall Study|Death|4|||
146325365|NCT01446419|527700886|FG000|Overall Study|Death|1|||
146325366|NCT01446419|527700887|FG001|Overall Study|Death|0|||
146325367|NCT01446419|527700886|FG000|Overall Study|Withdrawal by Subject|1|||
146325368|NCT01446419|527700887|FG001|Overall Study|Withdrawal by Subject|1|||
146325369|NCT01446419|527700886|FG000|Overall Study|Terminated per protocol|3|||
146325370|NCT01446419|527700887|FG001|Overall Study|Terminated per protocol|0|||
146325371|NCT02542072|527700891|FG000|First Intervention (1 Month)|Adverse Event|1|||
146325372|NCT02542072|527700892|FG001|First Intervention (1 Month)|Adverse Event|1|||
146325373|NCT02542072|527700891|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
146325374|NCT02542072|527700892|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
146325375|NCT02542072|527700891|FG000|First Intervention (1 Month)|Lens discomfort|1|||
146325376|NCT02542072|527700892|FG001|First Intervention (1 Month)|Lens discomfort|2|||
146325377|NCT02542072|527700891|FG000|First Intervention (1 Month)|Protocol Violation|1|||
146325378|NCT02542072|527700892|FG001|First Intervention (1 Month)|Protocol Violation|0|||
146325379|NCT02542072|527700891|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
146325380|NCT02542072|527700892|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
146325381|NCT02542072|527700891|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
146325382|NCT02542072|527700892|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
146325383|NCT00654498|527700893|FG000|Overall Study|Not Treated|1|||
146325384|NCT00654498|527700894|FG001|Overall Study|Not Treated|0|||
146325385|NCT00654498|527700893|FG000|Overall Study|Adverse Event|6|||
146325386|NCT00654498|527700894|FG001|Overall Study|Adverse Event|1|||
146325387|NCT00654498|527700893|FG000|Overall Study|Protocol Violation|1|||
146325388|NCT00654498|527700894|FG001|Overall Study|Protocol Violation|1|||
146325389|NCT00654498|527700893|FG000|Overall Study|Lost to Follow-up|1|||
146325390|NCT00654498|527700894|FG001|Overall Study|Lost to Follow-up|5|||
146325391|NCT00654498|527700893|FG000|Overall Study|Withdrawal by Subject|1|||
146325392|NCT00654498|527700894|FG001|Overall Study|Withdrawal by Subject|0|||
146325393|NCT00654498|527700893|FG000|Overall Study|Other reason not defined above|4|||
146325394|NCT00654498|527700894|FG001|Overall Study|Other reason not defined above|5|||
146325395|NCT01609842|527700895|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
146325396|NCT01609842|527700896|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
146325397|NCT02474329|527700898|FG000|Overall Study|Withdraw or did not contribute data.|13|||
146325398|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
146325399|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
146325400|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
146325401|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325402|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325403|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325404|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325405|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325406|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
146325407|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
146325408|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
146325409|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
146325410|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325411|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325412|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325413|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325414|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325415|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
146325416|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146325417|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
146325418|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325419|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325420|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325421|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325422|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325423|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325424|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
146325425|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
146325426|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
146325427|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
146325428|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325429|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325430|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325431|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325432|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325433|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
146325434|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
146325435|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
146325436|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325437|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325438|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325439|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325440|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325441|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325442|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
146325443|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325444|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325445|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
146325446|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325447|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325448|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325449|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325450|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325451|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
146325452|NCT01583374|527700899|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325453|NCT01583374|527700900|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
146325454|NCT01583374|527700901|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325455|NCT01583374|527700902|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325456|NCT01583374|527700903|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325457|NCT01583374|527700904|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325458|NCT01583374|527700905|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325459|NCT01583374|527700906|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325460|NCT01583374|527700907|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
146325461|NCT01583374|527700899|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325462|NCT01583374|527700900|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325463|NCT01583374|527700901|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325464|NCT01583374|527700902|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325465|NCT01583374|527700903|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325466|NCT01583374|527700904|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325467|NCT01583374|527700905|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325468|NCT01583374|527700906|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
146325469|NCT01583374|527700907|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146325470|NCT01583374|527700899|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146325471|NCT01583374|527700900|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146325472|NCT01583374|527700901|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
146325473|NCT01583374|527700902|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146325474|NCT01583374|527700903|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146165144|NCT04233372|527116225|FG000|Overall Study|Adverse Event|8|||
146165145|NCT04233372|527116225|FG000|Overall Study|Withdrawal by Subject|2|||
146325475|NCT01583374|527700904|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146325476|NCT01583374|527700905|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146325477|NCT01583374|527700906|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146325478|NCT01583374|527700907|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
146325479|NCT01583374|527700899|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146325480|NCT01583374|527700900|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146325481|NCT01583374|527700901|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146325482|NCT01583374|527700902|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
146325483|NCT01583374|527700903|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
146325484|NCT01583374|527700904|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146325485|NCT01583374|527700905|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
146325486|NCT01583374|527700906|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
146325487|NCT01583374|527700907|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
146325488|NCT01583374|527700899|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325489|NCT01583374|527700900|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
146325490|NCT01583374|527700901|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
146325491|NCT01583374|527700902|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325492|NCT01583374|527700903|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
146325493|NCT01583374|527700904|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325494|NCT01583374|527700905|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325495|NCT01583374|527700906|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325496|NCT01583374|527700907|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
146325497|NCT01583374|527700899|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325498|NCT01583374|527700900|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325499|NCT01583374|527700901|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146325500|NCT01583374|527700902|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325501|NCT01583374|527700903|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146325502|NCT01583374|527700904|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
146325503|NCT01583374|527700905|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325504|NCT01583374|527700906|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325505|NCT01583374|527700907|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146325506|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
146325507|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
146325508|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146325509|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146325510|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
146325511|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146325512|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
146325513|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
146325514|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
146325515|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
146325516|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146325517|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
146325518|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
146325519|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
146325520|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
146325521|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146325522|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
146325523|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
146325524|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325525|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325526|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325527|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325528|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146325529|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325530|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
146325531|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146325532|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
146165146|NCT01090310|527116226|FG000|Core Study|Adverse Event|2|||
146165147|NCT01090310|527116227|FG001|Core Study|Adverse Event|2|||
146165148|NCT01090310|527116228|FG002|Core Study|Adverse Event|1|||
146165149|NCT01090310|527116229|FG003|Core Study|Adverse Event|1|||
146165150|NCT01090310|527116226|FG000|Core Study|Subject withdrew consent|0|||
146165151|NCT01090310|527116227|FG001|Core Study|Subject withdrew consent|3|||
146165152|NCT01090310|527116228|FG002|Core Study|Subject withdrew consent|1|||
146165153|NCT01090310|527116229|FG003|Core Study|Subject withdrew consent|1|||
146325533|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
146325534|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
146325535|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
146325536|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
146165154|NCT01090310|527116226|FG000|Core Study|Abnormal test procedure result|0|||
146165155|NCT01090310|527116227|FG001|Core Study|Abnormal test procedure result|0|||
146165156|NCT01090310|527116228|FG002|Core Study|Abnormal test procedure result|1|||
146165157|NCT01090310|527116229|FG003|Core Study|Abnormal test procedure result|0|||
146165158|NCT01090310|527116226|FG000|Core Study|Administrative reasons|5|||
146165159|NCT01090310|527116227|FG001|Core Study|Administrative reasons|6|||
146165160|NCT01090310|527116228|FG002|Core Study|Administrative reasons|4|||
146165161|NCT01090310|527116229|FG003|Core Study|Administrative reasons|4|||
146165162|NCT01090310|527116226|FG000|Core Study|Protocol deviation|1|||
146165163|NCT01090310|527116227|FG001|Core Study|Protocol deviation|0|||
146165164|NCT01090310|527116228|FG002|Core Study|Protocol deviation|0|||
146165165|NCT01090310|527116229|FG003|Core Study|Protocol deviation|1|||
146165166|NCT01090310|527116226|FG000|Extension Study|Aministrative problems|13|||
146165167|NCT01090310|527116227|FG001|Extension Study|Aministrative problems|15|||
146165168|NCT01090310|527116228|FG002|Extension Study|Aministrative problems|14|||
146165169|NCT01090310|527116229|FG003|Extension Study|Aministrative problems|18|||
146165170|NCT01090310|527116226|FG000|Extension Study|Adverse Event|0|||
146165171|NCT01090310|527116227|FG001|Extension Study|Adverse Event|0|||
146325537|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
146325538|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
146325539|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
146325540|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
146325541|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
146325542|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325543|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325544|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325545|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325546|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
146325547|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325548|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
146325549|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325550|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
146325551|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146325552|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146325553|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146325554|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146325555|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146325556|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146325557|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
146325558|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146325559|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
146325560|NCT01583374|527700899|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146325561|NCT01583374|527700900|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
146325562|NCT01583374|527700901|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146325563|NCT01583374|527700902|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
146325564|NCT01583374|527700903|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146325565|NCT01583374|527700904|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146325566|NCT01583374|527700905|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
146325567|NCT01583374|527700906|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
146325568|NCT01583374|527700907|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
146325569|NCT01506882|527700908|FG000|Overall Study|Lack of Efficacy|4|||
146325570|NCT01506882|527700909|FG001|Overall Study|Lack of Efficacy|3|||
146325571|NCT01506882|527700908|FG000|Overall Study|Lost to Follow-up|1|||
146325572|NCT01506882|527700909|FG001|Overall Study|Lost to Follow-up|0|||
146325573|NCT01506882|527700908|FG000|Overall Study|Withdrawal by Subject|9|||
146325574|NCT01506882|527700909|FG001|Overall Study|Withdrawal by Subject|3|||
146325575|NCT01506882|527700908|FG000|Overall Study|SAE, non-fatal|2|||
146165172|NCT01090310|527116228|FG002|Extension Study|Adverse Event|0|||
146165173|NCT01090310|527116229|FG003|Extension Study|Adverse Event|1|||
146165174|NCT01090310|527116226|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
146165175|NCT01090310|527116227|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
146165176|NCT01090310|527116228|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
146325576|NCT01506882|527700909|FG001|Overall Study|SAE, non-fatal|0|||
146325577|NCT01506882|527700908|FG000|Overall Study|AE, non-serious non-fatal|3|||
146325578|NCT01506882|527700909|FG001|Overall Study|AE, non-serious non-fatal|1|||
146165177|NCT01090310|527116229|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
146325579|NCT01506882|527700908|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
146325580|NCT01506882|527700909|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
146325581|NCT01506882|527700908|FG000|Overall Study|Other Reason|2|||
146325582|NCT01506882|527700909|FG001|Overall Study|Other Reason|0|||
146325583|NCT00950170|527703214|FG000|Overall Study|Parent/Legal Guardian Request|1|||
146325584|NCT00950170|527703214|FG000|Overall Study|Adverse Event|2|||
146325585|NCT00950170|527703214|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
146325586|NCT01254669|527703215|FG000|Overall Study|Withdrawal by Subject|0|||
146325587|NCT01254669|527703216|FG001|Overall Study|Withdrawal by Subject|1|||
146325588|NCT01254669|527703215|FG000|Overall Study|time constraint|2|||
146325589|NCT01254669|527703216|FG001|Overall Study|time constraint|2|||
146325590|NCT01254669|527703215|FG000|Overall Study|called to clinic during intervention|1|||
146325591|NCT01254669|527703216|FG001|Overall Study|called to clinic during intervention|1|||
146325592|NCT02720757|527703217|FG000|Overall Study|Other reason|5|||
146325593|NCT02720757|527703217|FG000|Overall Study|Loss of contact|4|||
146325594|NCT02720757|527703217|FG000|Overall Study|Informed consent withdrawal|1|||
146325595|NCT02720757|527703217|FG000|Overall Study|Patients wish to withdraw|2|||
146325596|NCT02720757|527703217|FG000|Overall Study|Missing|3|||
146325597|NCT02720757|527703217|FG000|Overall Study|General exclusion|3|||
146325598|NCT00883493|527703218|FG000|Overall Study|Adverse Event|11|||
146325599|NCT00883493|527703219|FG001|Overall Study|Adverse Event|12|||
146325600|NCT00883493|527703218|FG000|Overall Study|Lack of Efficacy|4|||
146325601|NCT00883493|527703219|FG001|Overall Study|Lack of Efficacy|3|||
146325602|NCT00883493|527703218|FG000|Overall Study|Lost to Follow-up|7|||
146325603|NCT00883493|527703219|FG001|Overall Study|Lost to Follow-up|6|||
146325604|NCT00883493|527703218|FG000|Overall Study|Withdrawal by Subject|11|||
146325605|NCT00883493|527703219|FG001|Overall Study|Withdrawal by Subject|20|||
146325606|NCT00883493|527703218|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
146325607|NCT00883493|527703219|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
146325608|NCT00883493|527703218|FG000|Overall Study|Study specific disc. criteria|2|||
146325609|NCT00883493|527703219|FG001|Overall Study|Study specific disc. criteria|0|||
146325610|NCT00883493|527703218|FG000|Overall Study|Other|5|||
146325611|NCT00883493|527703219|FG001|Overall Study|Other|3|||
146325612|NCT02357420|527703220|FG000|Overall Study|Adverse Event|3|||
146325613|NCT02357420|527703221|FG001|Overall Study|Adverse Event|3|||
146325614|NCT02357420|527703222|FG002|Overall Study|Adverse Event|8|||
146325615|NCT02357420|527703223|FG003|Overall Study|Adverse Event|9|||
146325616|NCT02357420|527703220|FG000|Overall Study|Investigator Decision|1|||
146325617|NCT02357420|527703221|FG001|Overall Study|Investigator Decision|0|||
146325618|NCT02357420|527703222|FG002|Overall Study|Investigator Decision|0|||
146325619|NCT02357420|527703223|FG003|Overall Study|Investigator Decision|0|||
146325620|NCT02357420|527703220|FG000|Overall Study|Prohibited Medication|1|||
146325621|NCT02357420|527703221|FG001|Overall Study|Prohibited Medication|1|||
146325622|NCT02357420|527703222|FG002|Overall Study|Prohibited Medication|0|||
146325623|NCT02357420|527703223|FG003|Overall Study|Prohibited Medication|0|||
146165178|NCT01090310|527116226|FG000|Extension Study|Subject withdrew consent|0|||
146165179|NCT01090310|527116227|FG001|Extension Study|Subject withdrew consent|1|||
146165180|NCT01090310|527116228|FG002|Extension Study|Subject withdrew consent|0|||
146165181|NCT01090310|527116229|FG003|Extension Study|Subject withdrew consent|0|||
146165182|NCT00695786|527116230|FG000|Overall Study|Adverse Event|0|||
146165183|NCT00695786|527116231|FG001|Overall Study|Adverse Event|3|||
146165184|NCT00695786|527116232|FG002|Overall Study|Adverse Event|4|||
146165185|NCT00695786|527116233|FG003|Overall Study|Adverse Event|2|||
146165186|NCT00695786|527116230|FG000|Overall Study|Lost to Follow-up|0|||
146165187|NCT00695786|527116231|FG001|Overall Study|Lost to Follow-up|5|||
146165188|NCT00695786|527116232|FG002|Overall Study|Lost to Follow-up|1|||
146165189|NCT00695786|527116233|FG003|Overall Study|Lost to Follow-up|1|||
146165190|NCT00695786|527116230|FG000|Overall Study|Withdrawal by Subject|0|||
146165191|NCT00695786|527116231|FG001|Overall Study|Withdrawal by Subject|4|||
146165192|NCT00695786|527116232|FG002|Overall Study|Withdrawal by Subject|3|||
146165193|NCT00695786|527116233|FG003|Overall Study|Withdrawal by Subject|1|||
146165194|NCT00695786|527116230|FG000|Overall Study|Deemed Ineligible|1|||
146165195|NCT00695786|527116231|FG001|Overall Study|Deemed Ineligible|0|||
146325624|NCT02357420|527703220|FG000|Overall Study|Protocol Non-compliance|0|||
146325625|NCT02357420|527703221|FG001|Overall Study|Protocol Non-compliance|0|||
146325626|NCT02357420|527703222|FG002|Overall Study|Protocol Non-compliance|0|||
146325627|NCT02357420|527703223|FG003|Overall Study|Protocol Non-compliance|1|||
146325628|NCT02357420|527703220|FG000|Overall Study|Withdrawn Consent|4|||
146325629|NCT02357420|527703221|FG001|Overall Study|Withdrawn Consent|8|||
146325630|NCT02357420|527703222|FG002|Overall Study|Withdrawn Consent|6|||
146165196|NCT00695786|527116232|FG002|Overall Study|Deemed Ineligible|0|||
146165197|NCT00695786|527116233|FG003|Overall Study|Deemed Ineligible|0|||
146165198|NCT00695786|527116230|FG000|Overall Study|Lack of Efficacy|0|||
146165199|NCT00695786|527116231|FG001|Overall Study|Lack of Efficacy|0|||
146325631|NCT02357420|527703223|FG003|Overall Study|Withdrawn Consent|6|||
146325632|NCT02357420|527703220|FG000|Overall Study|Lost to Follow-up|3|||
146325633|NCT02357420|527703221|FG001|Overall Study|Lost to Follow-up|0|||
146165200|NCT00695786|527116232|FG002|Overall Study|Lack of Efficacy|0|||
146165201|NCT00695786|527116233|FG003|Overall Study|Lack of Efficacy|4|||
146165202|NCT01364922|527116239|FG000|Open-label (OL) Period|Adverse Event|7|||
146165203|NCT01364922|527116240|FG001|Open-label (OL) Period|Adverse Event|0|||
146165204|NCT01364922|527116241|FG002|Open-label (OL) Period|Adverse Event|0|||
146165205|NCT01364922|527116239|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
146165206|NCT01364922|527116240|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
146165207|NCT01364922|527116241|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
146165208|NCT01364922|527116239|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
146165209|NCT01364922|527116240|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
146165210|NCT01364922|527116241|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
146165211|NCT01364922|527116239|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
146165212|NCT01364922|527116240|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
146165213|NCT01364922|527116241|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
146165214|NCT01364922|527116239|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
146165215|NCT01364922|527116240|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
146165216|NCT01364922|527116241|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
146165217|NCT01364922|527116239|FG000|Open-label (OL) Period|Other, Unspecified|1|||
146165218|NCT01364922|527116240|FG001|Open-label (OL) Period|Other, Unspecified|0|||
146165219|NCT01364922|527116241|FG002|Open-label (OL) Period|Other, Unspecified|0|||
146165220|NCT01364922|527116239|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
146165221|NCT01364922|527116240|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
146165222|NCT01364922|527116241|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
146165223|NCT01364922|527116239|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
146165224|NCT01364922|527116240|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
146165225|NCT01364922|527116241|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
146165226|NCT01364922|527116239|FG000|Double-Blind (DB) Period|Adverse Event|0|||
146165227|NCT01364922|527116240|FG001|Double-Blind (DB) Period|Adverse Event|0|||
146165228|NCT01364922|527116241|FG002|Double-Blind (DB) Period|Adverse Event|1|||
146165229|NCT01364922|527116239|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
146165230|NCT01364922|527116240|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
146165231|NCT01364922|527116241|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
146165232|NCT04244396|527116244|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
146165233|NCT04244396|527116244|FG000|Overall Study|Withdrawal by Subject|2|||
146165234|NCT04244396|527116244|FG000|Overall Study|Study termination|37|||
146165235|NCT01787097|527116245|FG000|Overall Study|Withdrawal by Subject|1|||
146165236|NCT01787097|527116246|FG001|Overall Study|Withdrawal by Subject|0|||
146165237|NCT01787097|527116247|FG002|Overall Study|Withdrawal by Subject|0|||
146165238|NCT01787097|527116248|FG003|Overall Study|Withdrawal by Subject|0|||
146165239|NCT05178121|527116249|FG000|Overall Study|Other|4|||
146165240|NCT05178121|527116249|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
146165241|NCT01953003|527116250|FG000|Overall Study|Not treated|0|||
146165242|NCT01953003|527116251|FG001|Overall Study|Not treated|1|||
146165243|NCT01953003|527116250|FG000|Overall Study|Progressive disease|35|||
146165244|NCT01953003|527116251|FG001|Overall Study|Progressive disease|45|||
146165245|NCT01953003|527116250|FG000|Overall Study|Related Adverse events|7|||
146165246|NCT01953003|527116251|FG001|Overall Study|Related Adverse events|2|||
146165247|NCT01953003|527116250|FG000|Overall Study|Non-related adverse events|0|||
146165248|NCT01953003|527116251|FG001|Overall Study|Non-related adverse events|2|||
146165249|NCT01953003|527116250|FG000|Overall Study|Protocol Violation|0|||
146165250|NCT01953003|527116251|FG001|Overall Study|Protocol Violation|1|||
146165251|NCT01953003|527116250|FG000|Overall Study|Withdrawal by Subject|14|||
146165252|NCT01953003|527116251|FG001|Overall Study|Withdrawal by Subject|4|||
146165253|NCT03391765|527116257|FG000|Overall Study|Adverse Event|2|||
146165254|NCT03391765|527116258|FG001|Overall Study|Adverse Event|0|||
146165255|NCT03391765|527116259|FG002|Overall Study|Adverse Event|0|||
146165256|NCT03391765|527116260|FG003|Overall Study|Adverse Event|2|||
146165257|NCT03391765|527116257|FG000|Overall Study|Withdrew consent|5|||
146165258|NCT03391765|527116258|FG001|Overall Study|Withdrew consent|7|||
146325634|NCT02357420|527703222|FG002|Overall Study|Lost to Follow-up|2|||
146325635|NCT02357420|527703223|FG003|Overall Study|Lost to Follow-up|3|||
146325636|NCT01061008|527703224|FG000|Overall Study|Badiocephalic fistula failed|3|||
146325637|NCT01061008|527703225|FG001|Overall Study|Badiocephalic fistula failed|2|||
146165259|NCT03391765|527116259|FG002|Overall Study|Withdrew consent|2|||
146325638|NCT01061008|527703224|FG000|Overall Study|Death|1|||
146165260|NCT03391765|527116260|FG003|Overall Study|Withdrew consent|5|||
146165261|NCT03391765|527116257|FG000|Overall Study|Other, not specified|44|||
146165262|NCT03391765|527116258|FG001|Overall Study|Other, not specified|38|||
146165263|NCT03391765|527116259|FG002|Overall Study|Other, not specified|21|||
146165264|NCT03391765|527116260|FG003|Overall Study|Other, not specified|16|||
146165265|NCT00944658|527116261|FG000|Treatment 12 Weeks|Adverse Event|0|||
146165266|NCT00944658|527116262|FG001|Treatment 12 Weeks|Adverse Event|2|||
146165267|NCT00838682|527116268|FG000|Overall Study|Lost to Follow-up|21|||
146325639|NCT01061008|527703225|FG001|Overall Study|Death|0|||
146165268|NCT00838682|527116269|FG001|Overall Study|Lost to Follow-up|14|||
146165269|NCT00838682|527116268|FG000|Overall Study|detection of exclusion criteria|4|||
146165270|NCT00838682|527116269|FG001|Overall Study|detection of exclusion criteria|3|||
146165271|NCT00838682|527116268|FG000|Overall Study|Protocol Violation|0|||
146165272|NCT00838682|527116269|FG001|Overall Study|Protocol Violation|1|||
146165273|NCT00838682|527116268|FG000|Overall Study|Withdrawal by Subject|0|||
146165274|NCT00838682|527116269|FG001|Overall Study|Withdrawal by Subject|1|||
146165275|NCT03837509|527116274|FG000|Phase 1|Death|5|||
146165276|NCT03837509|527116275|FG001|Phase 1|Death|2|||
146165277|NCT03837509|527116276|FG002|Phase 1|Death|0|||
146165278|NCT03837509|527116277|FG003|Phase 1|Death|0|||
146165279|NCT03837509|527116278|FG004|Phase 1|Death|0|||
146165280|NCT03837509|527116274|FG000|Phase 2|Death|0|||
146165281|NCT03837509|527116275|FG001|Phase 2|Death|0|||
146165282|NCT03837509|527116276|FG002|Phase 2|Death|0|||
146165283|NCT03837509|527116277|FG003|Phase 2|Death|1|||
146165284|NCT03837509|527116278|FG004|Phase 2|Death|1|||
146165285|NCT02173548|527116279|FG000|Overall Study|Lost to Follow-up|0|||
146165286|NCT02173548|527116280|FG001|Overall Study|Lost to Follow-up|2|||
146165287|NCT02173548|527116279|FG000|Overall Study|Withdrawal by Subject|1|||
146165288|NCT02173548|527116280|FG001|Overall Study|Withdrawal by Subject|0|||
146165289|NCT03822117|527116283|FG000|Overall Study|Death|18|||
146165290|NCT03822117|527116284|FG001|Overall Study|Death|17|||
146165291|NCT03822117|527116285|FG002|Overall Study|Death|12|||
146165292|NCT03822117|527116286|FG003|Overall Study|Death|4|||
146165293|NCT03822117|527116283|FG000|Overall Study|Lost to Follow-up|1|||
146165294|NCT03822117|527116284|FG001|Overall Study|Lost to Follow-up|2|||
146165295|NCT03822117|527116285|FG002|Overall Study|Lost to Follow-up|3|||
146165296|NCT03822117|527116286|FG003|Overall Study|Lost to Follow-up|0|||
146165297|NCT03822117|527116283|FG000|Overall Study|Study Terminated by Sponsor|25|||
146165298|NCT03822117|527116284|FG001|Overall Study|Study Terminated by Sponsor|11|||
146165299|NCT03822117|527116285|FG002|Overall Study|Study Terminated by Sponsor|6|||
146165300|NCT03822117|527116286|FG003|Overall Study|Study Terminated by Sponsor|0|||
146165301|NCT03822117|527116283|FG000|Overall Study|Withdrawal by Subject|4|||
146165302|NCT03822117|527116284|FG001|Overall Study|Withdrawal by Subject|0|||
146165303|NCT03822117|527116285|FG002|Overall Study|Withdrawal by Subject|3|||
146165304|NCT03822117|527116286|FG003|Overall Study|Withdrawal by Subject|0|||
146165305|NCT03822117|527116283|FG000|Overall Study|Disease Progression|1|||
146165306|NCT03822117|527116284|FG001|Overall Study|Disease Progression|2|||
146165307|NCT03822117|527116285|FG002|Overall Study|Disease Progression|1|||
146165308|NCT03822117|527116286|FG003|Overall Study|Disease Progression|0|||
146165309|NCT03822117|527116283|FG000|Overall Study|Never Returned to Hospital|0|||
146165310|NCT03822117|527116284|FG001|Overall Study|Never Returned to Hospital|0|||
146165311|NCT03822117|527116285|FG002|Overall Study|Never Returned to Hospital|1|||
146165312|NCT03822117|527116286|FG003|Overall Study|Never Returned to Hospital|0|||
146165313|NCT02799784|527116294|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
146165314|NCT02799784|527116295|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
146165315|NCT02799784|527116294|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
146165316|NCT02799784|527116295|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
146165317|NCT02799784|527116294|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
146165318|NCT02799784|527116295|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
146165319|NCT02799784|527116294|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
146165320|NCT02799784|527116295|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
146165321|NCT02799784|527116294|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
146165322|NCT02799784|527116295|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
146165323|NCT02799784|527116294|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
146165324|NCT02799784|527116295|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
146165325|NCT01804816|527116299|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
146165326|NCT01804816|527116299|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
146165327|NCT01050816|527116300|FG000|Overall Study|Lost to Follow-up|2|||
146165328|NCT01050816|527116300|FG000|Overall Study|patient's refusal|2|||
146165329|NCT03086330|527116301|FG000|Overall Study|Withdrawal by Subject|3|||
146165330|NCT03086330|527116302|FG001|Overall Study|Withdrawal by Subject|2|||
146165331|NCT03086330|527116301|FG000|Overall Study|Lost to Follow-up|1|||
146165332|NCT03086330|527116302|FG001|Overall Study|Lost to Follow-up|2|||
146165333|NCT01256411|527116305|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
146325640|NCT01061008|527703224|FG000|Overall Study|Withdrawal by Subject|1|||
146165334|NCT01256411|527116306|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
146165335|NCT01256411|527116307|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
146165336|NCT01256411|527116308|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
146165337|NCT01256411|527116309|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
146165338|NCT01256411|527116310|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
146165339|NCT01256411|527116305|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
146165340|NCT01256411|527116306|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
146165341|NCT01256411|527116307|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
146165342|NCT01256411|527116308|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
146165343|NCT01256411|527116309|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
146165344|NCT01256411|527116310|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
146165345|NCT01256411|527116305|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
146165346|NCT01256411|527116306|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
146165347|NCT01256411|527116307|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
146165348|NCT01256411|527116308|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146165349|NCT01256411|527116309|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146165350|NCT01256411|527116310|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
146165351|NCT01256411|527116305|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
146165352|NCT01256411|527116306|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
146165353|NCT01256411|527116307|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
146165354|NCT01256411|527116308|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
146165355|NCT01256411|527116309|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
146165356|NCT01256411|527116310|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
146165357|NCT01256411|527116305|FG000|Extension by Maximum Treatment|Adverse Event|4|||
146165358|NCT01256411|527116306|FG001|Extension by Maximum Treatment|Adverse Event|2|||
146165359|NCT01256411|527116307|FG002|Extension by Maximum Treatment|Adverse Event|1|||
146165360|NCT01256411|527116308|FG003|Extension by Maximum Treatment|Adverse Event|0|||
146165361|NCT01256411|527116309|FG004|Extension by Maximum Treatment|Adverse Event|0|||
146165362|NCT01256411|527116310|FG005|Extension by Maximum Treatment|Adverse Event|0|||
146165363|NCT01256411|527116305|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
146165364|NCT01256411|527116306|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
146165365|NCT01256411|527116307|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
146165366|NCT01256411|527116308|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
146165367|NCT01256411|527116309|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
146165368|NCT01256411|527116310|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
146165369|NCT01256411|527116305|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146165370|NCT01256411|527116306|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146165371|NCT01256411|527116307|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146165372|NCT01256411|527116308|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146165373|NCT01256411|527116309|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
146165374|NCT01256411|527116310|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
146165375|NCT01256411|527116305|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146165376|NCT01256411|527116306|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146165377|NCT01256411|527116307|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146165378|NCT01256411|527116308|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146165379|NCT01256411|527116309|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
146165380|NCT01256411|527116310|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
146165381|NCT01256411|527116305|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146165382|NCT01256411|527116306|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146165383|NCT01256411|527116307|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146165384|NCT01256411|527116308|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
146165385|NCT01256411|527116309|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
146165386|NCT01256411|527116310|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
146165387|NCT01256411|527116305|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146165388|NCT01256411|527116306|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146165389|NCT01256411|527116307|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146165390|NCT01256411|527116308|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
146165391|NCT01256411|527116309|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
146165392|NCT01256411|527116310|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
146165393|NCT01445652|527116311|FG000|Overall Study|Not comfortable in lenses|5|||
146165394|NCT01445652|527116312|FG001|Overall Study|Not comfortable in lenses|0|||
146165395|NCT01445652|527116311|FG000|Overall Study|Failed to attend scheduled visit|2|||
146165396|NCT01445652|527116312|FG001|Overall Study|Failed to attend scheduled visit|3|||
146165397|NCT01445652|527116311|FG000|Overall Study|Failed teach session|2|||
146165398|NCT01445652|527116312|FG001|Overall Study|Failed teach session|0|||
146165399|NCT01445652|527116311|FG000|Overall Study|Adverse Event|1|||
146165400|NCT01445652|527116312|FG001|Overall Study|Adverse Event|0|||
146165401|NCT00929162|527116313|FG000|Overall Study|Adverse Event|8|||
146165402|NCT00929162|527116314|FG001|Overall Study|Adverse Event|5|||
146165403|NCT00929162|527116313|FG000|Overall Study|Withdrawal by Subject|3|||
146165404|NCT00929162|527116314|FG001|Overall Study|Withdrawal by Subject|1|||
146165405|NCT00929162|527116313|FG000|Overall Study|Protocol Violation|32|||
146165406|NCT00929162|527116314|FG001|Overall Study|Protocol Violation|30|||
146165407|NCT00929162|527116313|FG000|Overall Study|Other termination reason|5|||
146165408|NCT00929162|527116314|FG001|Overall Study|Other termination reason|6|||
146165409|NCT00117676|527116317|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
146165410|NCT00117676|527116318|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
146165411|NCT00117676|527116317|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
146165412|NCT00117676|527116318|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
146165413|NCT00117676|527116317|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
146165414|NCT00117676|527116318|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
146165415|NCT00117676|527116317|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
146165416|NCT00117676|527116318|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
146165417|NCT00117676|527116317|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
146165418|NCT00117676|527116318|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
146165419|NCT00117676|527116317|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
146165420|NCT00117676|527116318|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
146165421|NCT00117676|527116317|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
146165422|NCT00117676|527116318|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
146165423|NCT00117676|527116317|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
146165424|NCT00117676|527116318|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
146165425|NCT00117676|527116317|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
146165426|NCT00117676|527116318|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
146165427|NCT00117676|527116317|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
146165428|NCT00117676|527116318|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
146165429|NCT00117676|527116317|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
146165430|NCT00117676|527116318|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
146165431|NCT00117676|527116317|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
146165432|NCT00117676|527116318|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
146165433|NCT00117676|527116317|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
146165434|NCT00117676|527116318|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
146165435|NCT00117676|527116317|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
146165436|NCT00117676|527116318|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
146165437|NCT00117676|527116317|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
146165438|NCT00117676|527116318|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
146165439|NCT00117676|527116317|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
146165440|NCT00117676|527116318|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
146165441|NCT00117676|527116317|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
146165442|NCT00117676|527116318|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
146165443|NCT00117676|527116317|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
146165444|NCT00117676|527116318|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
146165445|NCT00117676|527116317|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
146165446|NCT00117676|527116318|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
146165447|NCT00117676|527116317|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
146165448|NCT00117676|527116318|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
146165449|NCT00117676|527116317|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
146165450|NCT00117676|527116318|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
146165451|NCT00117676|527116317|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
146165452|NCT00117676|527116318|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
146165453|NCT00117676|527116317|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
146165454|NCT00117676|527116318|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
146165455|NCT00117676|527116317|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
146165456|NCT00117676|527116318|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
146165457|NCT00117676|527116317|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
146165458|NCT00117676|527116318|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
146165459|NCT00117676|527116317|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
146165460|NCT00117676|527116318|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
146165461|NCT00117676|527116317|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
146165462|NCT00117676|527116318|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
146165463|NCT00117676|527116317|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
146165464|NCT00117676|527116318|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
146165465|NCT00117676|527116317|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
146165466|NCT00117676|527116318|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
146165467|NCT00117676|527116317|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
146165468|NCT00117676|527116318|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
146165469|NCT00117676|527116317|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
146165470|NCT00117676|527116318|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
146165471|NCT00117676|527116317|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
146165472|NCT00117676|527116318|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
146165473|NCT00117676|527116317|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
146165474|NCT00117676|527116318|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
146165475|NCT00117676|527116317|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
146165476|NCT00117676|527116318|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
146165477|NCT00117676|527116317|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
146165478|NCT00117676|527116318|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
146165479|NCT00952822|527116319|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146165480|NCT00952822|527116320|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
146165481|NCT00952822|527116321|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146165482|NCT00952822|527116322|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
146165483|NCT00952822|527116319|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146165484|NCT00952822|527116320|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146165485|NCT00952822|527116321|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
146165486|NCT00952822|527116322|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
146165487|NCT01281644|527116325|FG000|Overall Study|Lost to Follow-up|3|||
146165488|NCT01281644|527116325|FG000|Overall Study|Withdrawal by Subject|2|||
146165489|NCT01755702|527116326|FG000|Wash Out Period I|Other Reason|3|||
146165490|NCT01755702|527116326|FG000|Washout Period II|Other Reason|5|||
146165491|NCT03440372|527116331|FG000|Treatment|Adverse Event|16|||
146165492|NCT03440372|527116332|FG001|Treatment|Adverse Event|8|||
146165493|NCT03440372|527116331|FG000|Treatment|Lack of Efficacy|4|||
146165494|NCT03440372|527116332|FG001|Treatment|Lack of Efficacy|2|||
146165495|NCT03440372|527116331|FG000|Treatment|Withdrawal by Subject|12|||
146165496|NCT03440372|527116332|FG001|Treatment|Withdrawal by Subject|8|||
146165497|NCT03440372|527116331|FG000|Treatment|Lost to Follow-up|1|||
146165498|NCT03440372|527116332|FG001|Treatment|Lost to Follow-up|0|||
146165499|NCT03440372|527116331|FG000|Treatment|Pregnancy|1|||
146165500|NCT03440372|527116332|FG001|Treatment|Pregnancy|0|||
146165501|NCT03440372|527116331|FG000|Treatment|Study Terminated by Sponsor|2|||
146165502|NCT03440372|527116332|FG001|Treatment|Study Terminated by Sponsor|1|||
146165503|NCT03440372|527116331|FG000|Treatment|Other Reason|2|||
146165504|NCT03440372|527116332|FG001|Treatment|Other Reason|3|||
146165505|NCT03945292|527116333|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
146165506|NCT03945292|527116334|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165507|NCT03945292|527116335|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
146165508|NCT03945292|527116336|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165509|NCT03945292|527116337|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165510|NCT03945292|527116338|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165511|NCT03945292|527116339|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165512|NCT03945292|527116340|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
146165513|NCT03945292|527116333|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165514|NCT03945292|527116334|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165515|NCT03945292|527116335|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
146165516|NCT03945292|527116336|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165517|NCT03945292|527116337|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165518|NCT03945292|527116338|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165519|NCT03945292|527116339|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165520|NCT03945292|527116340|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
146165521|NCT03945292|527116333|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165522|NCT03945292|527116334|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165523|NCT03945292|527116335|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165524|NCT03945292|527116336|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165525|NCT03945292|527116337|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165526|NCT03945292|527116338|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165527|NCT03945292|527116339|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
146165528|NCT03945292|527116340|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
146165529|NCT02684006|527116341|FG000|Overall Study|Other|18|||
146165530|NCT02684006|527116342|FG001|Overall Study|Other|6|||
146165531|NCT02684006|527116341|FG000|Overall Study|Protocol Violation|2|||
146165532|NCT02684006|527116342|FG001|Overall Study|Protocol Violation|1|||
146165533|NCT02684006|527116341|FG000|Overall Study|Non-compliance with study drug|1|||
146165534|NCT02684006|527116342|FG001|Overall Study|Non-compliance with study drug|1|||
146165535|NCT02684006|527116341|FG000|Overall Study|No longer met eligibility criteria|6|||
146165536|NCT02684006|527116342|FG001|Overall Study|No longer met eligibility criteria|2|||
146165537|NCT02684006|527116341|FG000|Overall Study|Lost to Follow-up|0|||
146165538|NCT02684006|527116342|FG001|Overall Study|Lost to Follow-up|1|||
146165539|NCT02684006|527116341|FG000|Overall Study|Death|25|||
146165540|NCT02684006|527116342|FG001|Overall Study|Death|22|||
146165541|NCT02684006|527116341|FG000|Overall Study|Global deterioration of health status|18|||
146165542|NCT02684006|527116342|FG001|Overall Study|Global deterioration of health status|20|||
146165543|NCT02684006|527116341|FG000|Overall Study|Physician Decision|15|||
146165544|NCT02684006|527116342|FG001|Overall Study|Physician Decision|8|||
146165545|NCT02684006|527116341|FG000|Overall Study|Adverse Event|86|||
146165546|NCT02684006|527116342|FG001|Overall Study|Adverse Event|65|||
146165547|NCT02684006|527116341|FG000|Overall Study|Withdrawal by Subject|29|||
146165548|NCT02684006|527116342|FG001|Overall Study|Withdrawal by Subject|43|||
146165549|NCT02684006|527116341|FG000|Overall Study|Progressive disease|236|||
146165550|NCT02684006|527116342|FG001|Overall Study|Progressive disease|266|||
146165551|NCT02684006|527116341|FG000|Overall Study|Participation terminated by sponsor|6|||
146165552|NCT02684006|527116342|FG001|Overall Study|Participation terminated by sponsor|9|||
146165553|NCT05103384|527116343|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
146165554|NCT05608499|527116344|FG000|Overall Study|Lack of Efficacy|1|||
146165555|NCT05608499|527116345|FG001|Overall Study|Lack of Efficacy|0|||
146165556|NCT05608499|527116344|FG000|Overall Study|Lost to Follow-up|0|||
146165557|NCT05608499|527116345|FG001|Overall Study|Lost to Follow-up|1|||
146165558|NCT00514735|527116346|FG000|Overall Study|Withdrawal by Subject|13|||
146165559|NCT00514735|527116347|FG001|Overall Study|Withdrawal by Subject|5|||
146165560|NCT00514735|527116346|FG000|Overall Study|Death|1|||
146165561|NCT00514735|527116347|FG001|Overall Study|Death|0|||
146165562|NCT00514735|527116346|FG000|Overall Study|Lost to Follow-up|0|||
146165563|NCT00514735|527116347|FG001|Overall Study|Lost to Follow-up|1|||
146165564|NCT02660827|527116350|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
146165565|NCT02660827|527116350|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
146165566|NCT02660827|527116350|FG000|From Study to End of Continued Access|Adverse Event|3|||
146165567|NCT02660827|527116350|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
146165568|NCT02660827|527116350|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
146165569|NCT02660827|527116350|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
146165570|NCT02660827|527116350|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
146165571|NCT02660827|527116350|FG000|Period 2: Continued Access Period|Adverse Event|3|||
146165572|NCT01422408|527116351|FG000|Overall Study|Adverse Event|1|||
146165573|NCT01422408|527116351|FG000|Overall Study|Withdrawal by Subject|3|||
146165574|NCT04672941|527116352|FG000|Overall Study|Investigator decision|1|||
146165575|NCT04672941|527116352|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
146165576|NCT04672941|527116352|FG000|Overall Study|COVID-19 related but no adverse event|1|||
146165577|NCT04672941|527116352|FG000|Overall Study|Adverse Event|2|||
146165578|NCT04672941|527116352|FG000|Overall Study|Lost to Follow-up|2|||
146165579|NCT02953938|527116353|FG000|Overall Study|Adverse Event|0|||
146165580|NCT02953938|527116354|FG001|Overall Study|Adverse Event|1|||
146165581|NCT02953938|527116353|FG000|Overall Study|Withdrawal by Subject|1|||
146165582|NCT02953938|527116354|FG001|Overall Study|Withdrawal by Subject|1|||
146165583|NCT03848403|527116356|FG000|Period 2 (Day 8)|Adverse Event|1|||
146165584|NCT03848403|527116357|FG001|Period 2 (Day 8)|Adverse Event|2|||
146165585|NCT03848403|527116358|FG002|Period 2 (Day 8)|Adverse Event|2|||
146165586|NCT03848403|527116356|FG000|Period 2 (Day 8)|Physician Decision|0|||
146165587|NCT03848403|527116357|FG001|Period 2 (Day 8)|Physician Decision|1|||
146165588|NCT03848403|527116358|FG002|Period 2 (Day 8)|Physician Decision|0|||
146165589|NCT03848403|527116356|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
146165590|NCT03848403|527116357|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
146165591|NCT03848403|527116358|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
146165592|NCT00168038|527116359|FG000|Overall Study|Adverse Event|1|||
146165593|NCT00168038|527116359|FG000|Overall Study|Therapy failure|1|||
146165594|NCT04198805|527116362|FG000|Overall Study|Death|0|||
146325641|NCT01061008|527703225|FG001|Overall Study|Withdrawal by Subject|3|||
146325642|NCT01061008|527703224|FG000|Overall Study|Unable to exercise following surgery|1|||
146325643|NCT01061008|527703225|FG001|Overall Study|Unable to exercise following surgery|0|||
146325644|NCT01061008|527703224|FG000|Overall Study|Adverse Event|0|||
146165595|NCT04198805|527116363|FG001|Overall Study|Death|0|||
146165596|NCT04198805|527116364|FG002|Overall Study|Death|0|||
146325645|NCT01061008|527703225|FG001|Overall Study|Adverse Event|1|||
146325646|NCT02908100|527703227|FG000|Overall Study|Adverse Event|7|||
146325647|NCT02908100|527703228|FG001|Overall Study|Adverse Event|6|||
146325648|NCT02908100|527703229|FG002|Overall Study|Adverse Event|9|||
146325649|NCT02908100|527703227|FG000|Overall Study|Death|2|||
146325650|NCT02908100|527703228|FG001|Overall Study|Death|0|||
146325651|NCT02908100|527703229|FG002|Overall Study|Death|0|||
146325652|NCT02908100|527703227|FG000|Overall Study|Lack of Efficacy|2|||
146325653|NCT02908100|527703228|FG001|Overall Study|Lack of Efficacy|3|||
146165597|NCT04198805|527116365|FG003|Overall Study|Death|1|||
146165598|NCT04198805|527116362|FG000|Overall Study|Early Termination|8|||
146165599|NCT04198805|527116363|FG001|Overall Study|Early Termination|4|||
146165600|NCT04198805|527116364|FG002|Overall Study|Early Termination|6|||
146165601|NCT04198805|527116365|FG003|Overall Study|Early Termination|9|||
146165602|NCT03599349|527116368|FG000|Overall Study|Lost to Follow-up|1|||
146165603|NCT06213701|527116369|FG000|Overall Study|Withdrawal by Subject|2|||
146165604|NCT06213701|527116370|FG001|Overall Study|Withdrawal by Subject|1|||
146165605|NCT06213701|527116371|FG002|Overall Study|Withdrawal by Subject|0|||
146165606|NCT00453986|527116372|FG000|Overall Study|Lost to Follow-up|6|||
146165607|NCT00453986|527116373|FG001|Overall Study|Lost to Follow-up|5|||
146165608|NCT00453986|527116374|FG002|Overall Study|Lost to Follow-up|6|||
146165609|NCT00453986|527116375|FG003|Overall Study|Lost to Follow-up|2|||
146165610|NCT00453986|527116376|FG004|Overall Study|Lost to Follow-up|0|||
146165611|NCT01659151|527116377|FG000|Overall Study|Inadequate TIL growth|1|||
146165612|NCT02240108|527117944|FG000|Overall Study|Other than specified|8|||
146165613|NCT02240108|527117945|FG001|Overall Study|Other than specified|6|||
146165614|NCT02240108|527117944|FG000|Overall Study|Adverse Event|1|||
146165615|NCT02240108|527117945|FG001|Overall Study|Adverse Event|9|||
146165616|NCT02240108|527117944|FG000|Overall Study|Pregnancy|1|||
146165617|NCT02240108|527117945|FG001|Overall Study|Pregnancy|0|||
146165618|NCT02240108|527117944|FG000|Overall Study|Withdrawal by Subject|4|||
146165619|NCT02240108|527117945|FG001|Overall Study|Withdrawal by Subject|9|||
146165620|NCT02240108|527117944|FG000|Overall Study|StudyTerminated by Sponsor|0|||
146165621|NCT02240108|527117945|FG001|Overall Study|StudyTerminated by Sponsor|1|||
146165622|NCT02472652|527117947|FG000|Overall Study|Lost to Follow-up|1|||
146165623|NCT00998400|527117952|FG000|Overall Study|Lack of interest/motivation|1|||
146165624|NCT00998400|527117953|FG001|Overall Study|Lack of interest/motivation|2|||
146165625|NCT00998400|527117952|FG000|Overall Study|Logistical problems|1|||
146165626|NCT00998400|527117953|FG001|Overall Study|Logistical problems|0|||
146165627|NCT03704584|527117954|FG000|Overall Study|Withdrawal by Subject|1|||
146165628|NCT03704584|527117955|FG001|Overall Study|Withdrawal by Subject|0|||
146165629|NCT03185832|527117956|FG000|Overall Study|Death|9|||
146165630|NCT03185832|527117957|FG001|Overall Study|Death|14|||
146165631|NCT03185832|527117958|FG002|Overall Study|Death|9|||
146165632|NCT03185832|527117959|FG003|Overall Study|Death|7|||
146165633|NCT03185832|527117956|FG000|Overall Study|Withdrawn - vital status available|0|||
146165634|NCT03185832|527117957|FG001|Overall Study|Withdrawn - vital status available|1|||
146165635|NCT03185832|527117958|FG002|Overall Study|Withdrawn - vital status available|1|||
146165636|NCT03185832|527117959|FG003|Overall Study|Withdrawn - vital status available|4|||
146165637|NCT01083641|527117961|FG000|Overall Study|Withdrawal by Subject|2|||
146165638|NCT03439189|527117962|FG000|Overall Study|Protocol Violation|19|||
146165639|NCT03439189|527117962|FG000|Overall Study|Lack of Efficacy|63|||
146165640|NCT03412812|527117963|FG000|Level 1|Death|3|||
146165641|NCT03412812|527117964|FG001|Level 1|Death|0|||
146165642|NCT03412812|527117963|FG000|Level 1|Adverse Event|0|||
146165643|NCT03412812|527117964|FG001|Level 1|Adverse Event|1|||
146165644|NCT01777321|527117965|FG000|Overall Study|Withdrawal by Subject|0|||
146165645|NCT01777321|527117966|FG001|Overall Study|Withdrawal by Subject|1|||
146165646|NCT03928028|527117967|FG000|Overall Study|Physician Decision|9|||
146165647|NCT03928028|527117968|FG001|Overall Study|Physician Decision|6|||
146165648|NCT03928028|527117969|FG002|Overall Study|Physician Decision|3|||
146165649|NCT03928028|527117967|FG000|Overall Study|Withdrawal by Subject|12|||
146165650|NCT03928028|527117968|FG001|Overall Study|Withdrawal by Subject|3|||
146165651|NCT03928028|527117969|FG002|Overall Study|Withdrawal by Subject|3|||
146165652|NCT04525547|527117975|FG000|Overall Study|Not treated with Ofev|2|||
146165653|NCT04525547|527117975|FG000|Overall Study|Off-label use|2|||
146165654|NCT04525547|527117975|FG000|Overall Study|Lost to Follow-up|1|||
146165655|NCT00800202|527117976|FG000|Overall Study|Adverse Event|7|||
146165656|NCT00800202|527117977|FG001|Overall Study|Adverse Event|6|||
146165657|NCT00800202|527117976|FG000|Overall Study|Death|1|||
146165658|NCT00800202|527117977|FG001|Overall Study|Death|0|||
146165659|NCT00800202|527117976|FG000|Overall Study|Other|5|||
146165660|NCT00800202|527117977|FG001|Overall Study|Other|0|||
146165661|NCT00800202|527117976|FG000|Overall Study|Disease Progression|54|||
146165662|NCT00800202|527117977|FG001|Overall Study|Disease Progression|18|||
146165663|NCT03315143|527117986|FG000|Overall Study|Death|240|||
146165664|NCT03315143|527117987|FG001|Overall Study|Death|246|||
146165665|NCT03315143|527117986|FG000|Overall Study|Withdrawal by Subject|57|||
146165666|NCT03315143|527117987|FG001|Overall Study|Withdrawal by Subject|68|||
146165667|NCT03315143|527117986|FG000|Overall Study|Site Terminated by Sponsor|256|||
146165668|NCT03315143|527117987|FG001|Overall Study|Site Terminated by Sponsor|282|||
146165669|NCT03315143|527117986|FG000|Overall Study|Study Terminated by Sponsor|4723|||
146165670|NCT03315143|527117987|FG001|Overall Study|Study Terminated by Sponsor|4664|||
146165671|NCT03315143|527117986|FG000|Overall Study|Reason not Specified|16|||
146325654|NCT02908100|527703229|FG002|Overall Study|Lack of Efficacy|3|||
146165672|NCT03315143|527117987|FG001|Overall Study|Reason not Specified|32|||
146165673|NCT02641392|527117990|FG000|Overall Study|Lost to Follow-up|0|||
146165674|NCT02641392|527117991|FG001|Overall Study|Lost to Follow-up|0|||
146165675|NCT02641392|527117992|FG002|Overall Study|Lost to Follow-up|2|||
146165676|NCT02641392|527117990|FG000|Overall Study|Withdrawal by Subject|0|||
146165677|NCT02641392|527117991|FG001|Overall Study|Withdrawal by Subject|0|||
146165678|NCT02641392|527117992|FG002|Overall Study|Withdrawal by Subject|17|||
146165679|NCT02641392|527117990|FG000|Overall Study|Adverse Event|0|||
146165680|NCT02641392|527117991|FG001|Overall Study|Adverse Event|1|||
146165681|NCT02641392|527117992|FG002|Overall Study|Adverse Event|25|||
146165682|NCT02641392|527117990|FG000|Overall Study|Study Terminated by Sponsor|4|||
146165683|NCT02641392|527117991|FG001|Overall Study|Study Terminated by Sponsor|12|||
146165684|NCT02641392|527117992|FG002|Overall Study|Study Terminated by Sponsor|144|||
146165685|NCT02641392|527117990|FG000|Overall Study|Lack of Efficacy|0|||
146165686|NCT02641392|527117991|FG001|Overall Study|Lack of Efficacy|0|||
146165687|NCT02641392|527117992|FG002|Overall Study|Lack of Efficacy|101|||
146165688|NCT02641392|527117990|FG000|Overall Study|Miscellaneous|0|||
146165689|NCT02641392|527117991|FG001|Overall Study|Miscellaneous|0|||
146165690|NCT02641392|527117992|FG002|Overall Study|Miscellaneous|3|||
146165691|NCT02641392|527117990|FG000|Overall Study|Death|0|||
146165692|NCT02641392|527117991|FG001|Overall Study|Death|0|||
146165693|NCT02641392|527117992|FG002|Overall Study|Death|1|||
146165694|NCT02052310|527117993|FG000|Overall Study|Death|64|||
146165695|NCT02052310|527117994|FG001|Overall Study|Death|54|||
146165696|NCT02052310|527117993|FG000|Overall Study|Withdrawal by Subject|37|||
146165697|NCT02052310|527117994|FG001|Overall Study|Withdrawal by Subject|49|||
146165698|NCT02052310|527117993|FG000|Overall Study|Other than specified|32|||
146165699|NCT02052310|527117994|FG001|Overall Study|Other than specified|29|||
146165700|NCT02052310|527117993|FG000|Overall Study|Adverse Event|29|||
146165701|NCT02052310|527117994|FG001|Overall Study|Adverse Event|22|||
146325655|NCT02908100|527703227|FG000|Overall Study|Lost to Follow-up|0|||
146325656|NCT02908100|527703228|FG001|Overall Study|Lost to Follow-up|1|||
146325657|NCT02908100|527703229|FG002|Overall Study|Lost to Follow-up|2|||
146325658|NCT02908100|527703227|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146325659|NCT02908100|527703228|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146325660|NCT02908100|527703229|FG002|Overall Study|Non-Compliance With Study Drug|2|||
146325661|NCT02908100|527703227|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
146165702|NCT02052310|527117993|FG000|Overall Study|Kidney Transplant|23|||
146165703|NCT02052310|527117994|FG001|Overall Study|Kidney Transplant|29|||
146165704|NCT02052310|527117993|FG000|Overall Study|Physician Decision|14|||
146165705|NCT02052310|527117994|FG001|Overall Study|Physician Decision|7|||
146165706|NCT02052310|527117993|FG000|Overall Study|Lack of Efficacy|6|||
146165707|NCT02052310|527117994|FG001|Overall Study|Lack of Efficacy|1|||
146165708|NCT02052310|527117993|FG000|Overall Study|Site Terminated by Sponsor|5|||
146165709|NCT02052310|527117994|FG001|Overall Study|Site Terminated by Sponsor|13|||
146165710|NCT02052310|527117993|FG000|Overall Study|Lost to Follow-up|4|||
146165711|NCT02052310|527117994|FG001|Overall Study|Lost to Follow-up|2|||
146165712|NCT02052310|527117993|FG000|Overall Study|Protocol Violation|1|||
146165713|NCT02052310|527117994|FG001|Overall Study|Protocol Violation|6|||
146165714|NCT03518125|527117995|FG000|Overall Study|Lost to Follow-up|0|||
146165715|NCT03518125|527117996|FG001|Overall Study|Lost to Follow-up|2|||
146165716|NCT03518125|527117997|FG002|Overall Study|Lost to Follow-up|0|||
146165717|NCT03518125|527117998|FG003|Overall Study|Lost to Follow-up|0|||
146165718|NCT03518125|527117999|FG004|Overall Study|Lost to Follow-up|3|||
146165719|NCT03518125|527118000|FG005|Overall Study|Lost to Follow-up|5|||
146165720|NCT03518125|527117995|FG000|Overall Study|Physician Decision|0|||
146165721|NCT03518125|527117996|FG001|Overall Study|Physician Decision|1|||
146165722|NCT03518125|527117997|FG002|Overall Study|Physician Decision|0|||
146165723|NCT03518125|527117998|FG003|Overall Study|Physician Decision|0|||
146165724|NCT03518125|527117999|FG004|Overall Study|Physician Decision|0|||
146165725|NCT03518125|527118000|FG005|Overall Study|Physician Decision|0|||
146165726|NCT03518125|527117995|FG000|Overall Study|Withdrawal by Subject|1|||
146165727|NCT03518125|527117996|FG001|Overall Study|Withdrawal by Subject|1|||
146165728|NCT03518125|527117997|FG002|Overall Study|Withdrawal by Subject|0|||
146165729|NCT03518125|527117998|FG003|Overall Study|Withdrawal by Subject|1|||
146165730|NCT03518125|527117999|FG004|Overall Study|Withdrawal by Subject|1|||
146165731|NCT03518125|527118000|FG005|Overall Study|Withdrawal by Subject|3|||
146165732|NCT03518125|527117995|FG000|Overall Study|Missed Day 394 Visit|1|||
146165733|NCT03518125|527117996|FG001|Overall Study|Missed Day 394 Visit|0|||
146165734|NCT03518125|527117997|FG002|Overall Study|Missed Day 394 Visit|0|||
146165735|NCT03518125|527117998|FG003|Overall Study|Missed Day 394 Visit|0|||
146165736|NCT03518125|527117999|FG004|Overall Study|Missed Day 394 Visit|0|||
146165737|NCT03518125|527118000|FG005|Overall Study|Missed Day 394 Visit|0|||
146165738|NCT04452877|527118001|FG000|Overall Study|Adverse Event|5|||
146325662|NCT02908100|527703228|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
146165739|NCT04452877|527118001|FG000|Overall Study|Lost to Follow-up|1|||
146165740|NCT04452877|527118001|FG000|Overall Study|Physician Decision|4|||
146165741|NCT04452877|527118001|FG000|Overall Study|Progressive Disease|18|||
146165742|NCT04452877|527118001|FG000|Overall Study|Withdrawal by Subject|3|||
146325663|NCT02908100|527703229|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
146165743|NCT01505387|527118002|FG000|Overall Study|Protocol Violation|1|||
146165744|NCT01505387|527118003|FG001|Overall Study|Protocol Violation|0|||
146325664|NCT02908100|527703227|FG000|Overall Study|Physician Decision|0|||
146165745|NCT01505387|527118002|FG000|Overall Study|Withdrawal by Subject|1|||
146165746|NCT01505387|527118003|FG001|Overall Study|Withdrawal by Subject|1|||
146165747|NCT01301391|527118004|FG000|Overall Study|Death|13|||
146165748|NCT01301391|527118004|FG000|Overall Study|Lost to Follow-up|3|||
146165749|NCT01301391|527118004|FG000|Overall Study|Physician Decision|2|||
146165750|NCT01301391|527118004|FG000|Overall Study|Sponsor's decision|8|||
146165751|NCT00595504|527118005|FG000|Overall Study|Withdrawal by Subject|1|||
146165752|NCT00595504|527118006|FG001|Overall Study|Withdrawal by Subject|3|||
146165753|NCT00595504|527118005|FG000|Overall Study|Physician Decision|1|||
146165754|NCT00595504|527118006|FG001|Overall Study|Physician Decision|0|||
146165755|NCT01949870|527118007|FG000|Overall Study|Lack of Efficacy|2|||
146165756|NCT01949870|527118007|FG000|Overall Study|Adverse Event|1|||
146165757|NCT01949870|527118007|FG000|Overall Study|Study termination|1|||
146165758|NCT01949870|527118007|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
146165759|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
146165760|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
146165761|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146165762|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
146165763|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
146165764|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
146165765|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
146165766|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
146165767|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146165768|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
146165769|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146165770|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
146165771|NCT00293267|527118008|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
146165772|NCT00293267|527118009|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
146165773|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
146165774|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
146165775|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
146165776|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
146165777|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
146165778|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
146165779|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
146165780|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
146165781|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Death|3|||
146165782|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Death|0|||
146165783|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
146165784|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
146165785|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
146165786|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
146165787|NCT00293267|527118008|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
146165788|NCT00293267|527118009|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
146165789|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
146165790|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
146165791|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
146165792|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
146165793|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
146165794|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
146165795|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
146165796|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
146165797|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
146165798|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
146165799|NCT00293267|527118008|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
146165800|NCT00293267|527118009|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
146165801|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
146165802|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
146165803|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
146325665|NCT02908100|527703228|FG001|Overall Study|Physician Decision|1|||
146325666|NCT02908100|527703229|FG002|Overall Study|Physician Decision|0|||
146325667|NCT02908100|527703227|FG000|Overall Study|Pregnancy|1|||
146325668|NCT02908100|527703228|FG001|Overall Study|Pregnancy|2|||
146325669|NCT02908100|527703229|FG002|Overall Study|Pregnancy|0|||
146325670|NCT02908100|527703227|FG000|Overall Study|Withdrawal by Subject|8|||
146325671|NCT02908100|527703228|FG001|Overall Study|Withdrawal by Subject|7|||
146325672|NCT02908100|527703229|FG002|Overall Study|Withdrawal by Subject|5|||
146165804|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
146165805|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
146165806|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
146165807|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
146325673|NCT02908100|527703227|FG000|Overall Study|Randomised in Error|1|||
146325674|NCT02908100|527703228|FG001|Overall Study|Randomised in Error|0|||
146165808|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
146325675|NCT02908100|527703229|FG002|Overall Study|Randomised in Error|0|||
146325676|NCT02024971|527703230|FG000|Overall Study|Data Not Available|30|||
146325677|NCT02024971|527703230|FG000|Overall Study|Lost to Follow-up|6|||
146165809|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
146165810|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
146165811|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
146165812|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
146165813|NCT00293267|527118008|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
146165814|NCT00293267|527118009|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
146165815|NCT02182973|527118010|FG000|Overall Study|Withdrawal by Subject|3|||
146165816|NCT02182973|527118011|FG001|Overall Study|Withdrawal by Subject|0|||
146165817|NCT01235546|527118012|FG000|Overall Study|Staff error, medication not administered|1|||
146165818|NCT01235546|527118013|FG001|Overall Study|Staff error, medication not administered|0|||
146165819|NCT01235546|527118012|FG000|Overall Study|Protocol Violation|1|||
146165820|NCT01235546|527118013|FG001|Overall Study|Protocol Violation|1|||
146165821|NCT01123382|527118014|FG000|Overall Study|Withdrawal by Subject|1|||
146165822|NCT01123382|527118015|FG001|Overall Study|Withdrawal by Subject|4|||
146165823|NCT01123382|527118014|FG000|Overall Study|Lost to Follow-up|1|||
146165824|NCT01123382|527118015|FG001|Overall Study|Lost to Follow-up|2|||
146165825|NCT02740049|527118016|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
146165826|NCT02274857|527118017|FG000|Overall Study|Adverse Event|1|||
146165827|NCT02274857|527118018|FG001|Overall Study|Adverse Event|0|||
146165828|NCT02274857|527118017|FG000|Overall Study|Death|1|||
146165829|NCT02274857|527118018|FG001|Overall Study|Death|2|||
146165830|NCT02274857|527118017|FG000|Overall Study|Lost to Follow-up|3|||
146165831|NCT02274857|527118018|FG001|Overall Study|Lost to Follow-up|0|||
146165832|NCT02274857|527118017|FG000|Overall Study|Physician Decision|2|||
146165833|NCT02274857|527118018|FG001|Overall Study|Physician Decision|0|||
146165834|NCT02274857|527118017|FG000|Overall Study|Trial screen failure|0|||
146165835|NCT02274857|527118018|FG001|Overall Study|Trial screen failure|2|||
146165836|NCT02274857|527118017|FG000|Overall Study|Withdrawal by Subject|11|||
146165837|NCT02274857|527118018|FG001|Overall Study|Withdrawal by Subject|2|||
146165838|NCT02274857|527118017|FG000|Overall Study|Other|2|||
146165839|NCT02274857|527118018|FG001|Overall Study|Other|0|||
146165840|NCT02340026|527118021|FG000|Treatment Phase|Withdrawal by Subject|2|||
146165841|NCT02340026|527118022|FG001|Treatment Phase|Withdrawal by Subject|2|||
146165842|NCT02340026|527118021|FG000|Follow-up Phase|Lost to Follow-up|1|||
146165843|NCT02340026|527118022|FG001|Follow-up Phase|Lost to Follow-up|0|||
146165844|NCT04393441|527118032|FG000|Overall Study|Adverse Event|0|||
146165845|NCT04393441|527118033|FG001|Overall Study|Adverse Event|3|||
146165846|NCT04393441|527118032|FG000|Overall Study|Withdrawal by Subject|5|||
146165847|NCT04393441|527118033|FG001|Overall Study|Withdrawal by Subject|7|||
146165848|NCT04393441|527118032|FG000|Overall Study|Lost to Follow-up|0|||
146165849|NCT04393441|527118033|FG001|Overall Study|Lost to Follow-up|2|||
146165850|NCT04393441|527118032|FG000|Overall Study|Protocol Deviation|2|||
146165851|NCT04393441|527118033|FG001|Overall Study|Protocol Deviation|1|||
146165852|NCT04393441|527118032|FG000|Overall Study|Reason not Specified|1|||
146165853|NCT04393441|527118033|FG001|Overall Study|Reason not Specified|1|||
146165854|NCT02782169|527118034|FG000|Overall Study|Lost to Follow-up|1|||
146165855|NCT02782169|527118035|FG001|Overall Study|Lost to Follow-up|2|||
146165856|NCT04003610|527118036|FG000|Overall Study|Lost to Follow-up|0|||
146165857|NCT04003610|527118037|FG001|Overall Study|Lost to Follow-up|1|||
146165858|NCT04003610|527118038|FG002|Overall Study|Lost to Follow-up|0|||
146165859|NCT04003610|527118036|FG000|Overall Study|Death|0|||
146165860|NCT04003610|527118037|FG001|Overall Study|Death|0|||
146325678|NCT05254418|527703232|FG000|Overall Study|Adverse Event|2|||
146325679|NCT02631538|527703233|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
146325680|NCT02631538|527703234|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
146325681|NCT02631538|527703235|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
146325682|NCT02631538|527703236|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
146325683|NCT02631538|527703233|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
146325684|NCT02631538|527703234|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
146325685|NCT02631538|527703235|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
146325686|NCT02631538|527703236|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
146325687|NCT02631538|527703233|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
146165861|NCT04003610|527118038|FG002|Overall Study|Death|3|||
146325688|NCT02631538|527703234|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
146325689|NCT02631538|527703235|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
146325690|NCT02631538|527703236|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
146325691|NCT02631538|527703233|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
146325692|NCT02631538|527703234|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
146165862|NCT04003610|527118036|FG000|Overall Study|Study Terminated by Sponsor|0|||
146325693|NCT02631538|527703235|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
146165863|NCT04003610|527118037|FG001|Overall Study|Study Terminated by Sponsor|0|||
146165864|NCT04003610|527118038|FG002|Overall Study|Study Terminated by Sponsor|3|||
146165865|NCT00771810|527118039|FG000|Overall Study|Adverse Event|3|||
146165866|NCT00771810|527118040|FG001|Overall Study|Adverse Event|0|||
146165867|NCT00771810|527118041|FG002|Overall Study|Adverse Event|2|||
146165868|NCT00771810|527118039|FG000|Overall Study|Lost to Follow-up|0|||
146165869|NCT00771810|527118040|FG001|Overall Study|Lost to Follow-up|0|||
146165870|NCT00771810|527118041|FG002|Overall Study|Lost to Follow-up|1|||
146165871|NCT00771810|527118039|FG000|Overall Study|Physician Decision|1|||
146165872|NCT00771810|527118040|FG001|Overall Study|Physician Decision|2|||
146165873|NCT00771810|527118041|FG002|Overall Study|Physician Decision|2|||
146325694|NCT02631538|527703236|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
146325695|NCT02631538|527703233|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146325696|NCT02631538|527703234|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146325697|NCT02631538|527703235|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
146325698|NCT02631538|527703236|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
146325699|NCT02631538|527703233|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
146325700|NCT02631538|527703234|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
146325701|NCT02631538|527703235|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
146325702|NCT02631538|527703236|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
146325703|NCT00400400|527703237|FG000|Overall Study|Adverse Event|9|||
146325704|NCT00400400|527703238|FG001|Overall Study|Adverse Event|8|||
146325705|NCT00400400|527703237|FG000|Overall Study|Protocol Violation|2|||
146325706|NCT00400400|527703238|FG001|Overall Study|Protocol Violation|0|||
146325707|NCT00400400|527703237|FG000|Overall Study|Withdrawal by Subject|1|||
146325708|NCT00400400|527703238|FG001|Overall Study|Withdrawal by Subject|3|||
146325709|NCT00400400|527703237|FG000|Overall Study|Administrative Problem|1|||
146325710|NCT00400400|527703238|FG001|Overall Study|Administrative Problem|0|||
146325711|NCT00400400|527703237|FG000|Overall Study|Lost to Follow-up|0|||
146325712|NCT00400400|527703238|FG001|Overall Study|Lost to Follow-up|1|||
146325713|NCT00400400|527703237|FG000|Overall Study|Did not receive study drug|1|||
146165874|NCT00771810|527118039|FG000|Overall Study|Protocol Violation|0|||
146165875|NCT00771810|527118040|FG001|Overall Study|Protocol Violation|1|||
146165876|NCT00771810|527118041|FG002|Overall Study|Protocol Violation|1|||
146165877|NCT00771810|527118039|FG000|Overall Study|Withdrawal by Subject|1|||
146165878|NCT00771810|527118040|FG001|Overall Study|Withdrawal by Subject|2|||
146165879|NCT00771810|527118041|FG002|Overall Study|Withdrawal by Subject|0|||
146165880|NCT00771810|527118039|FG000|Overall Study|Other|0|||
146165881|NCT00771810|527118040|FG001|Overall Study|Other|0|||
146165882|NCT00771810|527118041|FG002|Overall Study|Other|1|||
146165883|NCT04751942|527118047|FG000|Overall Study|Lost to Follow-up|9|||
146165884|NCT04751942|527118048|FG001|Overall Study|Lost to Follow-up|6|||
146165885|NCT00724152|527118052|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
146165886|NCT00724152|527118053|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
146165887|NCT00724152|527118054|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
146165888|NCT00724152|527118052|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
146165889|NCT00724152|527118053|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
146165890|NCT00724152|527118054|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
146165891|NCT03266770|527118055|FG000|Overall Study|Physician Decision|3|||
146165892|NCT03266770|527118055|FG000|Overall Study|Insufficient study supplies|1|||
146165893|NCT03266770|527118055|FG000|Overall Study|Adverse Event|1|||
146165894|NCT02657031|527118059|FG000|Overall Study|Adverse Event|1|||
146165895|NCT02657031|527118060|FG001|Overall Study|Adverse Event|2|||
146165896|NCT03078816|527118061|FG000|Overall Study|Withdrawal by Subject|1|||
146165897|NCT02114151|527118062|FG000|Overall Study|Death|1|||
146165898|NCT02114151|527118062|FG000|Overall Study|Lost to Follow-up|1|||
146165899|NCT02114151|527118062|FG000|Overall Study|Withdrawal by Subject|5|||
146165900|NCT02638948|527118067|FG000|Overall Study|Withdrawal by Subject|4|||
146165901|NCT02638948|527118068|FG001|Overall Study|Withdrawal by Subject|5|||
146165902|NCT02638948|527118069|FG002|Overall Study|Withdrawal by Subject|3|||
146165903|NCT02638948|527118070|FG003|Overall Study|Withdrawal by Subject|1|||
146165904|NCT02638948|527118067|FG000|Overall Study|Administrative Reason by Sponsor|0|||
146282241|NCT02663518|527546458|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282242|NCT02663518|527546459|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146165905|NCT02638948|527118068|FG001|Overall Study|Administrative Reason by Sponsor|1|||
146165906|NCT02638948|527118069|FG002|Overall Study|Administrative Reason by Sponsor|0|||
146282243|NCT02663518|527546460|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
146282244|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
146282245|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
146282246|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
146282247|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
146165907|NCT02638948|527118070|FG003|Overall Study|Administrative Reason by Sponsor|4|||
146165908|NCT02638948|527118067|FG000|Overall Study|Adverse Event|0|||
146165909|NCT02638948|527118068|FG001|Overall Study|Adverse Event|0|||
146165910|NCT02638948|527118069|FG002|Overall Study|Adverse Event|1|||
146165911|NCT02638948|527118070|FG003|Overall Study|Adverse Event|1|||
146165912|NCT02638948|527118067|FG000|Overall Study|Lack of Efficacy|1|||
146165913|NCT02638948|527118068|FG001|Overall Study|Lack of Efficacy|1|||
146165914|NCT02638948|527118069|FG002|Overall Study|Lack of Efficacy|0|||
146165915|NCT02638948|527118070|FG003|Overall Study|Lack of Efficacy|0|||
146165916|NCT02638948|527118067|FG000|Overall Study|Lost to Follow-up|0|||
146165917|NCT02638948|527118068|FG001|Overall Study|Lost to Follow-up|0|||
146165918|NCT02638948|527118069|FG002|Overall Study|Lost to Follow-up|1|||
146165919|NCT02638948|527118070|FG003|Overall Study|Lost to Follow-up|1|||
146165920|NCT02638948|527118067|FG000|Overall Study|Poor/Non-Compliance|0|||
146165921|NCT02638948|527118068|FG001|Overall Study|Poor/Non-Compliance|2|||
146165922|NCT02638948|527118069|FG002|Overall Study|Poor/Non-Compliance|1|||
146165923|NCT02638948|527118070|FG003|Overall Study|Poor/Non-Compliance|0|||
146165924|NCT02638948|527118067|FG000|Overall Study|Participant no longer met study criteria|0|||
146165925|NCT02638948|527118068|FG001|Overall Study|Participant no longer met study criteria|1|||
146165926|NCT02638948|527118069|FG002|Overall Study|Participant no longer met study criteria|0|||
146165927|NCT02638948|527118070|FG003|Overall Study|Participant no longer met study criteria|0|||
146165928|NCT02638948|527118067|FG000|Overall Study|Other than specified above|4|||
146165929|NCT02638948|527118068|FG001|Overall Study|Other than specified above|1|||
146165930|NCT02638948|527118069|FG002|Overall Study|Other than specified above|1|||
146165931|NCT02638948|527118070|FG003|Overall Study|Other than specified above|1|||
146165932|NCT05007392|527118071|FG000|Overall Study|Randomized but not treated|1|||
146165933|NCT05007392|527118072|FG001|Overall Study|Randomized but not treated|2|||
146165934|NCT05007392|527118071|FG000|Overall Study|Other|5|||
146165935|NCT05007392|527118072|FG001|Overall Study|Other|4|||
146165936|NCT05007392|527118071|FG000|Overall Study|Lost to Follow-up|1|||
146165937|NCT05007392|527118072|FG001|Overall Study|Lost to Follow-up|2|||
146165938|NCT05007392|527118071|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
146165939|NCT05007392|527118072|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
146165940|NCT05007392|527118071|FG000|Overall Study|Use of prohibited concomitant drug|1|||
146165941|NCT05007392|527118072|FG001|Overall Study|Use of prohibited concomitant drug|1|||
146165942|NCT05007392|527118071|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
146165943|NCT05007392|527118072|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
146165944|NCT05007392|527118071|FG000|Overall Study|Adverse Event|10|||
146165945|NCT05007392|527118072|FG001|Overall Study|Adverse Event|6|||
146165946|NCT05007392|527118071|FG000|Overall Study|Participant choice|5|||
146165947|NCT05007392|527118072|FG001|Overall Study|Participant choice|10|||
146165948|NCT05007392|527118071|FG000|Overall Study|Withdrawal of consent|5|||
146165949|NCT05007392|527118072|FG001|Overall Study|Withdrawal of consent|4|||
146165950|NCT06223373|527118073|FG000|Overall Study|Lost to Follow-up|1|||
146165951|NCT06223373|527118074|FG001|Overall Study|Lost to Follow-up|2|||
146165952|NCT04981678|527118076|FG000|Overall Study|Lost to Follow-up|0|||
146165953|NCT04981678|527118077|FG001|Overall Study|Lost to Follow-up|1|||
146165954|NCT03421808|527118078|FG000|Overall Study|COVID related problems|2|||
146165955|NCT03421808|527118079|FG001|Overall Study|COVID related problems|0|||
146165956|NCT03421808|527118078|FG000|Overall Study|Withdrawal by Subject|1|||
146165957|NCT03421808|527118079|FG001|Overall Study|Withdrawal by Subject|0|||
146165958|NCT03421808|527118078|FG000|Overall Study|Protocol Violation|0|||
146165959|NCT03421808|527118079|FG001|Overall Study|Protocol Violation|1|||
146165960|NCT03764774|527118080|FG000|Overall Study|Withdrawal by Subject|0|||
146165961|NCT03764774|527118081|FG001|Overall Study|Withdrawal by Subject|0|||
146165962|NCT03764774|527118082|FG002|Overall Study|Withdrawal by Subject|0|||
146165963|NCT03764774|527118083|FG003|Overall Study|Withdrawal by Subject|0|||
146165964|NCT03764774|527118084|FG004|Overall Study|Withdrawal by Subject|0|||
146165965|NCT03764774|527118085|FG005|Overall Study|Withdrawal by Subject|0|||
146165966|NCT03764774|527118086|FG006|Overall Study|Withdrawal by Subject|0|||
146165967|NCT03764774|527118087|FG007|Overall Study|Withdrawal by Subject|0|||
146165968|NCT03764774|527118088|FG008|Overall Study|Withdrawal by Subject|0|||
146165969|NCT03764774|527118089|FG009|Overall Study|Withdrawal by Subject|0|||
146165970|NCT03764774|527118090|FG010|Overall Study|Withdrawal by Subject|1|||
146165971|NCT03764774|527118091|FG011|Overall Study|Withdrawal by Subject|0|||
146165972|NCT03764774|527118092|FG012|Overall Study|Withdrawal by Subject|0|||
146165973|NCT03764774|527118093|FG013|Overall Study|Withdrawal by Subject|0|||
146165974|NCT03764774|527118080|FG000|Overall Study|Adverse Event|0|||
146165975|NCT03764774|527118081|FG001|Overall Study|Adverse Event|0|||
146165976|NCT03764774|527118082|FG002|Overall Study|Adverse Event|0|||
146165977|NCT03764774|527118083|FG003|Overall Study|Adverse Event|0|||
146165978|NCT03764774|527118084|FG004|Overall Study|Adverse Event|0|||
146165979|NCT03764774|527118085|FG005|Overall Study|Adverse Event|0|||
146165980|NCT03764774|527118086|FG006|Overall Study|Adverse Event|0|||
146165981|NCT03764774|527118087|FG007|Overall Study|Adverse Event|0|||
146165982|NCT03764774|527118088|FG008|Overall Study|Adverse Event|0|||
146165983|NCT03764774|527118089|FG009|Overall Study|Adverse Event|0|||
146165984|NCT03764774|527118090|FG010|Overall Study|Adverse Event|0|||
146165985|NCT03764774|527118091|FG011|Overall Study|Adverse Event|0|||
146165986|NCT03764774|527118092|FG012|Overall Study|Adverse Event|2|||
146165987|NCT03764774|527118093|FG013|Overall Study|Adverse Event|0|||
146165988|NCT03764774|527118080|FG000|Overall Study|Lost to Follow-up|0|||
146165989|NCT03764774|527118081|FG001|Overall Study|Lost to Follow-up|0|||
146165990|NCT03764774|527118082|FG002|Overall Study|Lost to Follow-up|0|||
146165991|NCT03764774|527118083|FG003|Overall Study|Lost to Follow-up|0|||
146165992|NCT03764774|527118084|FG004|Overall Study|Lost to Follow-up|0|||
146165993|NCT03764774|527118085|FG005|Overall Study|Lost to Follow-up|0|||
146165994|NCT03764774|527118086|FG006|Overall Study|Lost to Follow-up|0|||
146165995|NCT03764774|527118087|FG007|Overall Study|Lost to Follow-up|0|||
146165996|NCT03764774|527118088|FG008|Overall Study|Lost to Follow-up|0|||
146165997|NCT03764774|527118089|FG009|Overall Study|Lost to Follow-up|0|||
146165998|NCT03764774|527118090|FG010|Overall Study|Lost to Follow-up|0|||
146165999|NCT03764774|527118091|FG011|Overall Study|Lost to Follow-up|0|||
146166000|NCT03764774|527118092|FG012|Overall Study|Lost to Follow-up|0|||
146166001|NCT03764774|527118093|FG013|Overall Study|Lost to Follow-up|1|||
146166002|NCT03764774|527118080|FG000|Overall Study|Physician Decision|0|||
146166003|NCT03764774|527118081|FG001|Overall Study|Physician Decision|0|||
146166004|NCT03764774|527118082|FG002|Overall Study|Physician Decision|0|||
146166005|NCT03764774|527118083|FG003|Overall Study|Physician Decision|0|||
146166006|NCT03764774|527118084|FG004|Overall Study|Physician Decision|0|||
146166007|NCT03764774|527118085|FG005|Overall Study|Physician Decision|0|||
146166008|NCT03764774|527118086|FG006|Overall Study|Physician Decision|0|||
146166009|NCT03764774|527118087|FG007|Overall Study|Physician Decision|0|||
146166010|NCT03764774|527118088|FG008|Overall Study|Physician Decision|0|||
146166011|NCT03764774|527118089|FG009|Overall Study|Physician Decision|4|||
146166012|NCT03764774|527118090|FG010|Overall Study|Physician Decision|1|||
146166013|NCT03764774|527118091|FG011|Overall Study|Physician Decision|4|||
146166014|NCT03764774|527118092|FG012|Overall Study|Physician Decision|9|||
146166015|NCT03764774|527118093|FG013|Overall Study|Physician Decision|0|||
146166016|NCT03764774|527118080|FG000|Overall Study|Study Termination|0|||
146282248|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
146282249|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
146282250|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
146282251|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
146282252|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
146282253|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
146282254|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
146282255|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
146282256|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
146282257|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
146282258|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282259|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282260|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282261|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282262|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282263|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282264|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282265|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282266|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282267|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282268|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282269|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282270|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
146282271|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
146282272|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282273|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282274|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282275|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282276|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282277|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282278|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282279|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282280|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282281|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282282|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282283|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
146282284|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146282285|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
146166017|NCT03764774|527118081|FG001|Overall Study|Study Termination|0|||
146166018|NCT03764774|527118082|FG002|Overall Study|Study Termination|0|||
146166019|NCT03764774|527118083|FG003|Overall Study|Study Termination|0|||
146166020|NCT03764774|527118084|FG004|Overall Study|Study Termination|0|||
146166021|NCT03764774|527118085|FG005|Overall Study|Study Termination|0|||
146166022|NCT03764774|527118086|FG006|Overall Study|Study Termination|0|||
146166023|NCT03764774|527118087|FG007|Overall Study|Study Termination|0|||
146166024|NCT03764774|527118088|FG008|Overall Study|Study Termination|0|||
146166025|NCT03764774|527118089|FG009|Overall Study|Study Termination|1|||
146166026|NCT03764774|527118090|FG010|Overall Study|Study Termination|0|||
146166027|NCT03764774|527118091|FG011|Overall Study|Study Termination|0|||
146166028|NCT03764774|527118092|FG012|Overall Study|Study Termination|0|||
146166029|NCT03764774|527118093|FG013|Overall Study|Study Termination|2|||
146166030|NCT05809596|527118096|FG000|Overall Study|Death|16|||
146166031|NCT05809596|527118096|FG000|Overall Study|Withdrawal by Subject|4|||
146166032|NCT05809596|527118096|FG000|Overall Study|Physician Decision|1|||
146166033|NCT05809596|527118096|FG000|Overall Study|Missed Visit|2|||
146166034|NCT05809596|527118096|FG000|Overall Study|Other|3|||
146166035|NCT03770494|527118098|FG000|Overall Study|Lost to Follow-up|0|||
146166036|NCT03770494|527118099|FG001|Overall Study|Lost to Follow-up|0|||
146166037|NCT03770494|527118100|FG002|Overall Study|Lost to Follow-up|1|||
146166038|NCT03770494|527118101|FG003|Overall Study|Lost to Follow-up|1|||
146166039|NCT03770494|527118102|FG004|Overall Study|Lost to Follow-up|1|||
146166040|NCT03770494|527118103|FG005|Overall Study|Lost to Follow-up|0|||
146166041|NCT03770494|527118104|FG006|Overall Study|Lost to Follow-up|0|||
146166042|NCT03770494|527118105|FG007|Overall Study|Lost to Follow-up|0|||
146166043|NCT03770494|527118106|FG008|Overall Study|Lost to Follow-up|0|||
146166044|NCT03770494|527118107|FG009|Overall Study|Lost to Follow-up|0|||
146166045|NCT03770494|527118108|FG010|Overall Study|Lost to Follow-up|0|||
146166046|NCT03770494|527118109|FG011|Overall Study|Lost to Follow-up|0|||
146166047|NCT03770494|527118110|FG012|Overall Study|Lost to Follow-up|0|||
146166048|NCT03770494|527118111|FG013|Overall Study|Lost to Follow-up|0|||
146166049|NCT03770494|527118098|FG000|Overall Study|Study terminated by sponsor|1|||
146166050|NCT03770494|527118099|FG001|Overall Study|Study terminated by sponsor|2|||
146166051|NCT03770494|527118100|FG002|Overall Study|Study terminated by sponsor|1|||
146166052|NCT03770494|527118101|FG003|Overall Study|Study terminated by sponsor|1|||
146166053|NCT03770494|527118102|FG004|Overall Study|Study terminated by sponsor|1|||
146166054|NCT03770494|527118103|FG005|Overall Study|Study terminated by sponsor|2|||
146166055|NCT03770494|527118104|FG006|Overall Study|Study terminated by sponsor|1|||
146166056|NCT03770494|527118105|FG007|Overall Study|Study terminated by sponsor|2|||
146166057|NCT03770494|527118106|FG008|Overall Study|Study terminated by sponsor|1|||
146166058|NCT03770494|527118107|FG009|Overall Study|Study terminated by sponsor|2|||
146166059|NCT03770494|527118108|FG010|Overall Study|Study terminated by sponsor|1|||
146166060|NCT03770494|527118109|FG011|Overall Study|Study terminated by sponsor|2|||
146166061|NCT03770494|527118110|FG012|Overall Study|Study terminated by sponsor|0|||
146166062|NCT03770494|527118111|FG013|Overall Study|Study terminated by sponsor|0|||
146166063|NCT03770494|527118098|FG000|Overall Study|Withdrawal by Subject|1|||
146166064|NCT03770494|527118099|FG001|Overall Study|Withdrawal by Subject|1|||
146166065|NCT03770494|527118100|FG002|Overall Study|Withdrawal by Subject|0|||
146166066|NCT03770494|527118101|FG003|Overall Study|Withdrawal by Subject|0|||
146166067|NCT03770494|527118102|FG004|Overall Study|Withdrawal by Subject|2|||
146166068|NCT03770494|527118103|FG005|Overall Study|Withdrawal by Subject|2|||
146166069|NCT03770494|527118104|FG006|Overall Study|Withdrawal by Subject|2|||
146166070|NCT03770494|527118105|FG007|Overall Study|Withdrawal by Subject|0|||
146166071|NCT03770494|527118106|FG008|Overall Study|Withdrawal by Subject|2|||
146166072|NCT03770494|527118107|FG009|Overall Study|Withdrawal by Subject|3|||
146166073|NCT03770494|527118108|FG010|Overall Study|Withdrawal by Subject|1|||
146166074|NCT03770494|527118109|FG011|Overall Study|Withdrawal by Subject|0|||
146166075|NCT03770494|527118110|FG012|Overall Study|Withdrawal by Subject|0|||
146166076|NCT03770494|527118111|FG013|Overall Study|Withdrawal by Subject|0|||
146166077|NCT04922554|527118112|FG000|Overall Study|Adverse Event|4|||
146166078|NCT04922554|527118113|FG001|Overall Study|Adverse Event|0|||
146166079|NCT04922554|527118112|FG000|Overall Study|Withdrawal by Subject|1|||
146282286|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282287|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282288|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282289|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146166080|NCT04922554|527118113|FG001|Overall Study|Withdrawal by Subject|0|||
146166081|NCT00939484|527119193|FG000|Overall Study|Progression/Relapse|8|||
146166082|NCT00939484|527119194|FG001|Overall Study|Progression/Relapse|20|||
146166083|NCT00939484|527119195|FG002|Overall Study|Progression/Relapse|3|||
146166084|NCT03938454|527119196|FG000|Overall Study|Protocol Violation|1|||
146166085|NCT03938454|527119196|FG000|Overall Study|Withdrawal by Subject|2|||
146166086|NCT03938454|527119196|FG000|Overall Study|Lost to Follow-up|3|||
146166087|NCT00553501|527119197|FG000|Overall Study|Adverse Event|2|||
146166088|NCT00553501|527119197|FG000|Overall Study|Death|1|||
146166089|NCT00553501|527119197|FG000|Overall Study|Progression|1|||
146166090|NCT01464021|527119198|FG000|Overall Study|Withdrawal by Subject|13|||
146166091|NCT01464021|527119198|FG000|Overall Study|Lost to Follow-up|1|||
146166092|NCT01464021|527119198|FG000|Overall Study|Lack of Efficacy|1|||
146282290|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282291|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282292|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146166093|NCT01464021|527119198|FG000|Overall Study|various|11|||
146166094|NCT01255592|527119200|FG000|Overall Study|Adverse Event|5|||
146166095|NCT01255592|527119201|FG001|Overall Study|Adverse Event|0|||
146166096|NCT01255592|527119200|FG000|Overall Study|Withdrawal by Subject|1|||
146166097|NCT01255592|527119201|FG001|Overall Study|Withdrawal by Subject|0|||
146166098|NCT01255592|527119200|FG000|Overall Study|Other|0|||
146166099|NCT01255592|527119201|FG001|Overall Study|Other|1|||
146166100|NCT01289418|527119202|FG000|Day 8 Survey|email address invalid|283|||
146166101|NCT01289418|527119202|FG000|Day 8 Survey|participants did not complete the survey|1935|||
146166102|NCT01289418|527119202|FG000|Day 29 Survey|email address invalid|283|||
146166103|NCT01289418|527119202|FG000|Day 29 Survey|participants did not complete the survey|2185|||
146166104|NCT01352585|527119204|FG000|Overall Study|Adverse Event|2|||
146166105|NCT01352585|527119205|FG001|Overall Study|Adverse Event|1|||
146166106|NCT01352585|527119204|FG000|Overall Study|Lost to Follow-up|1|||
146166107|NCT01352585|527119205|FG001|Overall Study|Lost to Follow-up|0|||
146166108|NCT01352585|527119204|FG000|Overall Study|Other|5|||
146166109|NCT01352585|527119205|FG001|Overall Study|Other|2|||
146166110|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
146166111|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
146166112|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
146166113|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
146166114|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
146166115|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
146166116|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
146166117|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
146166118|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
146166119|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
146166120|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
146166121|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
146166122|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
146166123|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
146325714|NCT00400400|527703238|FG001|Overall Study|Did not receive study drug|3|||
146325715|NCT00648167|527703239|FG000|Overall Study|Adverse Event|6|||
146325716|NCT00648167|527703239|FG000|Overall Study|unable to swallow tablets|1|||
146325717|NCT01688050|527703240|FG000|Overall Study|Death|7|||
146325718|NCT01688050|527703240|FG000|Overall Study|Conversion to open repair|1|||
146325719|NCT01688050|527703240|FG000|Overall Study|Lost to Follow-up|13|||
146325720|NCT01688050|527703240|FG000|Overall Study|Withdrawal by Subject|10|||
146325721|NCT01554579|527703241|FG000|Overall Study|Adverse Event|6|||
146325722|NCT01554579|527703242|FG001|Overall Study|Adverse Event|25|||
146325723|NCT01554579|527703241|FG000|Overall Study|Lack of Efficacy|2|||
146166124|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
146166125|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
146166126|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
146166127|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
146166128|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
146166129|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
146166130|NCT00549757|527119227|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
146166131|NCT00549757|527119228|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
146166132|NCT00549757|527119227|FG000|Extension Period (in Average 9 Months)|Death|143|||
146166133|NCT00549757|527119228|FG001|Extension Period (in Average 9 Months)|Death|136|||
146166134|NCT00549757|527119227|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
146166135|NCT00549757|527119228|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
146166136|NCT00549757|527119227|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
146166137|NCT00549757|527119228|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
146166138|NCT00549757|527119227|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
146166139|NCT00549757|527119228|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
146166140|NCT01814748|527119231|FG000|Overall Study|Lost to Follow-up|1|||
146166141|NCT01814748|527119232|FG001|Overall Study|Lost to Follow-up|2|||
146166142|NCT01814748|527119231|FG000|Overall Study|Study site terminated by sponsor|1|||
146166143|NCT01814748|527119232|FG001|Overall Study|Study site terminated by sponsor|1|||
146166144|NCT01814748|527119231|FG000|Overall Study|Withdrawal by Subject|6|||
146325724|NCT01554579|527703242|FG001|Overall Study|Lack of Efficacy|1|||
146166145|NCT01814748|527119232|FG001|Overall Study|Withdrawal by Subject|4|||
146325725|NCT01554579|527703241|FG000|Overall Study|Withdrawal by Subject|2|||
146325726|NCT01554579|527703242|FG001|Overall Study|Withdrawal by Subject|1|||
146325727|NCT00234039|527703243|FG000|Overall Study|Adverse Event|2|||
146166146|NCT00330174|527119234|FG000|Overall Study|Withdrawal by Subject|7|||
146166147|NCT00330174|527119235|FG001|Overall Study|Withdrawal by Subject|7|||
146325728|NCT00234039|527703243|FG000|Overall Study|Progression/relapse|34|||
146325729|NCT00234039|527703243|FG000|Overall Study|Other - Not Protocol Specified|3|||
146166148|NCT00330174|527119234|FG000|Overall Study|Lost to Follow-up|4|||
146166149|NCT00330174|527119235|FG001|Overall Study|Lost to Follow-up|1|||
146166150|NCT00330174|527119234|FG000|Overall Study|Clinical deterioration|1|||
146166151|NCT00330174|527119235|FG001|Overall Study|Clinical deterioration|2|||
146166152|NCT00330174|527119234|FG000|Overall Study|Excessive missed visits|3|||
146166153|NCT00330174|527119235|FG001|Overall Study|Excessive missed visits|8|||
146166154|NCT00330174|527119234|FG000|Overall Study|Miscellaneous reasons|7|||
146166155|NCT00330174|527119235|FG001|Overall Study|Miscellaneous reasons|1|||
146166156|NCT02316769|527119238|FG000|Overall Study|Physician Decision|1|||
146166157|NCT02316769|527119239|FG001|Overall Study|Physician Decision|0|||
146166158|NCT02316769|527119238|FG000|Overall Study|Withdrawal by Subject|1|||
146166159|NCT02316769|527119239|FG001|Overall Study|Withdrawal by Subject|0|||
146166160|NCT02403180|527119240|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
146166161|NCT02403180|527119241|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
146166162|NCT02403180|527119240|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
146166163|NCT02403180|527119241|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
146166164|NCT03338829|527119244|FG000|Overall Study|Lost to Follow-up|4|||
146166165|NCT03338829|527119245|FG001|Overall Study|Lost to Follow-up|2|||
146166166|NCT03338829|527119246|FG002|Overall Study|Lost to Follow-up|4|||
146166167|NCT03338829|527119244|FG000|Overall Study|Pregnancy loss|1|||
146166168|NCT03338829|527119245|FG001|Overall Study|Pregnancy loss|1|||
146166169|NCT03338829|527119246|FG002|Overall Study|Pregnancy loss|0|||
146166170|NCT03338829|527119244|FG000|Overall Study|Protocol Violation|0|||
146166171|NCT03338829|527119245|FG001|Overall Study|Protocol Violation|1|||
146166172|NCT03338829|527119246|FG002|Overall Study|Protocol Violation|0|||
146166173|NCT01218126|527119249|FG000|Overall Study|Adverse Event|8|||
146166174|NCT01218126|527119250|FG001|Overall Study|Adverse Event|10|||
146166175|NCT01218126|527119251|FG002|Overall Study|Adverse Event|12|||
146166176|NCT01218126|527119252|FG003|Overall Study|Adverse Event|16|||
146166177|NCT01218126|527119249|FG000|Overall Study|Lack of Efficacy|7|||
146166178|NCT01218126|527119250|FG001|Overall Study|Lack of Efficacy|2|||
146166179|NCT01218126|527119251|FG002|Overall Study|Lack of Efficacy|2|||
146166180|NCT01218126|527119252|FG003|Overall Study|Lack of Efficacy|6|||
146166181|NCT01218126|527119249|FG000|Overall Study|Protocol Violation|5|||
146166182|NCT01218126|527119250|FG001|Overall Study|Protocol Violation|2|||
146166183|NCT01218126|527119251|FG002|Overall Study|Protocol Violation|2|||
146166184|NCT01218126|527119252|FG003|Overall Study|Protocol Violation|3|||
146166185|NCT01218126|527119249|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146166186|NCT01218126|527119250|FG001|Overall Study|Protocol-defined stopping criteria|1|||
146166187|NCT01218126|527119251|FG002|Overall Study|Protocol-defined stopping criteria|0|||
146166188|NCT01218126|527119252|FG003|Overall Study|Protocol-defined stopping criteria|0|||
146166189|NCT01218126|527119249|FG000|Overall Study|Lost to Follow-up|0|||
146166190|NCT01218126|527119250|FG001|Overall Study|Lost to Follow-up|0|||
146166191|NCT01218126|527119251|FG002|Overall Study|Lost to Follow-up|0|||
146166192|NCT01218126|527119252|FG003|Overall Study|Lost to Follow-up|2|||
146166193|NCT01218126|527119249|FG000|Overall Study|Physician Decision|1|||
146166194|NCT01218126|527119250|FG001|Overall Study|Physician Decision|2|||
146166195|NCT01218126|527119251|FG002|Overall Study|Physician Decision|4|||
146166196|NCT01218126|527119252|FG003|Overall Study|Physician Decision|2|||
146166197|NCT01218126|527119249|FG000|Overall Study|Withdrawal by Subject|2|||
146166198|NCT01218126|527119250|FG001|Overall Study|Withdrawal by Subject|5|||
146166199|NCT01218126|527119251|FG002|Overall Study|Withdrawal by Subject|4|||
146166200|NCT01218126|527119252|FG003|Overall Study|Withdrawal by Subject|6|||
146166201|NCT01860703|527119255|FG000|Overall Study|Adverse Event|1|||
146166202|NCT01860703|527119256|FG001|Overall Study|Adverse Event|4|||
146166203|NCT01860703|527119257|FG002|Overall Study|Adverse Event|0|||
146166204|NCT01860703|527119258|FG003|Overall Study|Adverse Event|2|||
146166205|NCT01860703|527119255|FG000|Overall Study|Withdrawal by Subject|0|||
146166206|NCT01860703|527119256|FG001|Overall Study|Withdrawal by Subject|1|||
146325730|NCT00234039|527703243|FG000|Overall Study|Ineligible|9|||
146325731|NCT00234039|527703243|FG000|Overall Study|No Protocol Treatment Received|2|||
146325732|NCT00110019|527703244|FG000|Overall Study|Lack of Efficacy|253|||
146325733|NCT00110019|527703245|FG001|Overall Study|Lack of Efficacy|285|||
146325734|NCT00110019|527703244|FG000|Overall Study|Adverse Event|61|||
146166207|NCT01860703|527119257|FG002|Overall Study|Withdrawal by Subject|0|||
146166208|NCT01860703|527119258|FG003|Overall Study|Withdrawal by Subject|0|||
146325735|NCT00110019|527703245|FG001|Overall Study|Adverse Event|40|||
146166209|NCT01860703|527119255|FG000|Overall Study|Personal reason|1|||
146166210|NCT01860703|527119256|FG001|Overall Study|Personal reason|0|||
146166211|NCT01860703|527119257|FG002|Overall Study|Personal reason|1|||
146166212|NCT01860703|527119258|FG003|Overall Study|Personal reason|0|||
146166213|NCT00696410|527119260|FG000|Overall Study|Lost to Follow-up|2|||
146166214|NCT00696410|527119261|FG001|Overall Study|Lost to Follow-up|0|||
146166215|NCT00696410|527119260|FG000|Overall Study|Withdrawal by Subject|8|||
146166216|NCT00696410|527119261|FG001|Overall Study|Withdrawal by Subject|0|||
146166217|NCT00696410|527119260|FG000|Overall Study|Physician Decision|3|||
146166218|NCT00696410|527119261|FG001|Overall Study|Physician Decision|0|||
146166219|NCT03184792|527119265|FG000|Overall Study|Pandemic|2|||
146166220|NCT03184792|527119266|FG001|Overall Study|Pandemic|2|||
146166221|NCT00265889|527119268|FG000|Overall Study|Physician Decision|1|||
146166222|NCT00265889|527119268|FG000|Overall Study|Protocol Violation|1|||
146166223|NCT00265889|527119268|FG000|Overall Study|Insurance denied the request|3|||
146166224|NCT02134587|527119269|FG000|Overall Study|Did not completed all meetings|30|||
146166225|NCT01515748|527119279|FG000|Overall Study|Withdrawal by Subject|32|||
146166226|NCT01515748|527119280|FG001|Overall Study|Withdrawal by Subject|41|||
146166227|NCT01515748|527119279|FG000|Overall Study|Lost to Follow-up|2|||
146166228|NCT01515748|527119280|FG001|Overall Study|Lost to Follow-up|4|||
146166229|NCT01515748|527119279|FG000|Overall Study|Other than specified above|5|||
146166230|NCT01515748|527119280|FG001|Overall Study|Other than specified above|10|||
146166231|NCT03221387|527119281|FG000|Overall Study|Lost to Follow-up|1|||
146166232|NCT03221387|527119281|FG000|Overall Study|Lung transplant|1|||
146166233|NCT02365519|527119282|FG000|Randomized and Treated|Adverse Event|0|||
146166234|NCT02365519|527119283|FG001|Randomized and Treated|Adverse Event|1|||
146166235|NCT02365519|527119284|FG002|Randomized and Treated|Adverse Event|0|||
146166236|NCT02365519|527119282|FG000|Randomized and Treated|Withdrawal by Subject|0|||
146166237|NCT02365519|527119283|FG001|Randomized and Treated|Withdrawal by Subject|1|||
146166238|NCT02365519|527119284|FG002|Randomized and Treated|Withdrawal by Subject|1|||
146166239|NCT01971723|527119285|FG000|Overall Study|Withdrawal by Subject|1|||
146166240|NCT01971723|527119286|FG001|Overall Study|Withdrawal by Subject|1|||
146166241|NCT01971723|527119285|FG000|Overall Study|Protocol Violation|1|||
146166242|NCT01971723|527119286|FG001|Overall Study|Protocol Violation|2|||
146166243|NCT03188055|527119290|FG000|Overall Study|Unavailable for training|0|||
146166244|NCT03188055|527119291|FG001|Overall Study|Unavailable for training|0|||
146166245|NCT03188055|527119292|FG002|Overall Study|Unavailable for training|19|||
146166246|NCT03188055|527119293|FG003|Overall Study|Unavailable for training|0|||
146166247|NCT03188055|527119294|FG004|Overall Study|Unavailable for training|0|||
146166248|NCT03188055|527119295|FG005|Overall Study|Unavailable for training|0|||
146166249|NCT03188055|527119290|FG000|Overall Study|Lost to Follow-up|0|||
146166250|NCT03188055|527119291|FG001|Overall Study|Lost to Follow-up|18|||
146166251|NCT03188055|527119292|FG002|Overall Study|Lost to Follow-up|0|||
146166252|NCT03188055|527119293|FG003|Overall Study|Lost to Follow-up|11|||
146166253|NCT03188055|527119294|FG004|Overall Study|Lost to Follow-up|0|||
146166254|NCT03188055|527119295|FG005|Overall Study|Lost to Follow-up|0|||
146166255|NCT03188055|527119290|FG000|Overall Study|Withdrawal by Subject|0|||
146166256|NCT03188055|527119291|FG001|Overall Study|Withdrawal by Subject|1|||
146166257|NCT03188055|527119292|FG002|Overall Study|Withdrawal by Subject|0|||
146166258|NCT03188055|527119293|FG003|Overall Study|Withdrawal by Subject|1|||
146166259|NCT03188055|527119294|FG004|Overall Study|Withdrawal by Subject|0|||
146166260|NCT03188055|527119295|FG005|Overall Study|Withdrawal by Subject|0|||
146166261|NCT03657277|527119296|FG000|Overall Study|Physician Decision|2|||
146325736|NCT00110019|527703244|FG000|Overall Study|Death|13|||
146325737|NCT00110019|527703245|FG001|Overall Study|Death|15|||
146325738|NCT00110019|527703244|FG000|Overall Study|Withdrawal by Subject|21|||
146325739|NCT00110019|527703245|FG001|Overall Study|Withdrawal by Subject|9|||
146325740|NCT00110019|527703244|FG000|Overall Study|alternative therapy|5|||
146325741|NCT00110019|527703245|FG001|Overall Study|alternative therapy|1|||
146325742|NCT00110019|527703244|FG000|Overall Study|complicating disease|1|||
146325743|NCT00110019|527703245|FG001|Overall Study|complicating disease|1|||
146325744|NCT00110019|527703244|FG000|Overall Study|symptom deterioration|13|||
146325745|NCT00110019|527703245|FG001|Overall Study|symptom deterioration|16|||
146325746|NCT00110019|527703244|FG000|Overall Study|Not start protocol therapy|17|||
146325747|NCT00110019|527703245|FG001|Overall Study|Not start protocol therapy|16|||
146325748|NCT00110019|527703244|FG000|Overall Study|other reasons|22|||
146325749|NCT00110019|527703245|FG001|Overall Study|other reasons|30|||
146325750|NCT01046695|527703248|FG000|Overall Study|Subject had a pacemaker|0|||
146166262|NCT03657277|527119296|FG000|Overall Study|Lost to Follow-up|1|||
146166263|NCT03657277|527119296|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
146325751|NCT01046695|527703249|FG001|Overall Study|Subject had a pacemaker|1|||
146325752|NCT01046695|527703248|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
146325753|NCT01046695|527703249|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
146166264|NCT02286089|527119299|FG000|Overall Study|Ongoing in Study|1|||
146166265|NCT02286089|527119300|FG001|Overall Study|Ongoing in Study|1|||
146166266|NCT02286089|527119301|FG002|Overall Study|Ongoing in Study|4|||
146166267|NCT02286089|527119302|FG003|Overall Study|Ongoing in Study|10|||
146166268|NCT02286089|527119299|FG000|Overall Study|Withdrawal by Subject|0|||
146166269|NCT02286089|527119300|FG001|Overall Study|Withdrawal by Subject|0|||
146166270|NCT02286089|527119301|FG002|Overall Study|Withdrawal by Subject|2|||
146325754|NCT02239263|527703250|FG000|Overall Study|Protocol Violation|6|||
146166271|NCT02286089|527119302|FG003|Overall Study|Withdrawal by Subject|2|||
146166272|NCT00657618|527119303|FG000|Overall Study|Adverse Event|32|||
146166273|NCT00657618|527119303|FG000|Overall Study|Withdrawal by Subject|8|||
146166274|NCT00657618|527119303|FG000|Overall Study|negative for leishmaniasis|2|||
146325755|NCT04426695|527703251|FG000|Overall Study|Death|2|||
146325756|NCT04426695|527703252|FG001|Overall Study|Death|0|||
146325757|NCT04426695|527703253|FG002|Overall Study|Death|1|||
146325758|NCT04426695|527703254|FG003|Overall Study|Death|27|||
146325759|NCT04426695|527703255|FG004|Overall Study|Death|25|||
146325760|NCT04426695|527703256|FG005|Overall Study|Death|21|||
146325761|NCT04426695|527703257|FG006|Overall Study|Death|42|||
146325762|NCT04426695|527703258|FG007|Overall Study|Death|23|||
146325763|NCT04426695|527703259|FG008|Overall Study|Death|37|||
146325764|NCT04426695|527703260|FG009|Overall Study|Death|14|||
146325765|NCT04426695|527703261|FG010|Overall Study|Death|8|||
146325766|NCT04426695|527703262|FG011|Overall Study|Death|7|||
146325767|NCT04426695|527703263|FG012|Overall Study|Death|13|||
146325768|NCT04426695|527703264|FG013|Overall Study|Death|25|||
146325769|NCT04426695|527703265|FG014|Overall Study|Death|19|||
146325770|NCT04426695|527703266|FG015|Overall Study|Death|7|||
146325771|NCT04426695|527703267|FG016|Overall Study|Death|8|||
146325772|NCT04426695|527703268|FG017|Overall Study|Death|4|||
146325773|NCT04426695|527703251|FG000|Overall Study|Lost to Follow-up|2|||
146325774|NCT04426695|527703252|FG001|Overall Study|Lost to Follow-up|4|||
146325775|NCT04426695|527703253|FG002|Overall Study|Lost to Follow-up|1|||
146325776|NCT04426695|527703254|FG003|Overall Study|Lost to Follow-up|19|||
146325777|NCT04426695|527703255|FG004|Overall Study|Lost to Follow-up|10|||
146325778|NCT04426695|527703256|FG005|Overall Study|Lost to Follow-up|14|||
146325779|NCT04426695|527703257|FG006|Overall Study|Lost to Follow-up|5|||
146325780|NCT04426695|527703258|FG007|Overall Study|Lost to Follow-up|14|||
146325781|NCT04426695|527703259|FG008|Overall Study|Lost to Follow-up|10|||
146325782|NCT04426695|527703260|FG009|Overall Study|Lost to Follow-up|11|||
146325783|NCT04426695|527703261|FG010|Overall Study|Lost to Follow-up|12|||
146325784|NCT04426695|527703262|FG011|Overall Study|Lost to Follow-up|6|||
146325785|NCT04426695|527703263|FG012|Overall Study|Lost to Follow-up|2|||
146325786|NCT04426695|527703264|FG013|Overall Study|Lost to Follow-up|2|||
146325787|NCT04426695|527703265|FG014|Overall Study|Lost to Follow-up|2|||
146166275|NCT00657618|527119303|FG000|Overall Study|didn't start due to schedule conflicts|1|||
146166276|NCT05774197|527119304|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
146166277|NCT05073133|527119306|FG000|Overall Study|Death|2|||
146166278|NCT05002218|527119307|FG000|Overall Study|Lost to Follow-up|5|||
146166279|NCT05002218|527119308|FG001|Overall Study|Lost to Follow-up|6|||
146166280|NCT04120233|527119309|FG000|Overall Study|Adverse Event|0|||
146166281|NCT04120233|527119310|FG001|Overall Study|Adverse Event|0|||
146166282|NCT04120233|527119311|FG002|Overall Study|Adverse Event|0|||
146166283|NCT04120233|527119312|FG003|Overall Study|Adverse Event|0|||
146166284|NCT04120233|527119313|FG004|Overall Study|Adverse Event|1|||
146166285|NCT04120233|527119314|FG005|Overall Study|Adverse Event|0|||
146166286|NCT01345630|527120501|FG000|Overall Study|Adverse Event|22|||
146166287|NCT01345630|527120502|FG001|Overall Study|Adverse Event|23|||
146166288|NCT01345630|527120501|FG000|Overall Study|Lost to Follow-up|17|||
146166289|NCT01345630|527120502|FG001|Overall Study|Lost to Follow-up|16|||
146166290|NCT01345630|527120501|FG000|Overall Study|Protocol Violation|4|||
146166291|NCT01345630|527120502|FG001|Overall Study|Protocol Violation|1|||
146166292|NCT01345630|527120501|FG000|Overall Study|Medication error without associated AE|0|||
146166293|NCT01345630|527120502|FG001|Overall Study|Medication error without associated AE|1|||
146166294|NCT01345630|527120501|FG000|Overall Study|Study terminated by sponsor|254|||
146166295|NCT01345630|527120502|FG001|Overall Study|Study terminated by sponsor|285|||
146166296|NCT01345630|527120501|FG000|Overall Study|Other reasons|6|||
146166297|NCT01345630|527120502|FG001|Overall Study|Other reasons|8|||
146166298|NCT01345630|527120501|FG000|Overall Study|Withdrawn due to pregnancy|1|||
146166299|NCT01345630|527120502|FG001|Overall Study|Withdrawn due to pregnancy|2|||
146166300|NCT01345630|527120501|FG000|Overall Study|No longer willing to participate|9|||
146166301|NCT01345630|527120502|FG001|Overall Study|No longer willing to participate|12|||
146166302|NCT01345630|527120501|FG000|Overall Study|Insufficient clinical response|48|||
146166303|NCT01345630|527120502|FG001|Overall Study|Insufficient clinical response|11|||
146166304|NCT03092375|527120509|FG000|Overall Study|Lack of Efficacy|0|||
146166305|NCT03092375|527120510|FG001|Overall Study|Lack of Efficacy|1|||
146166306|NCT03092375|527120511|FG002|Overall Study|Lack of Efficacy|1|||
146325788|NCT04426695|527703266|FG015|Overall Study|Lost to Follow-up|0|||
146166307|NCT03092375|527120512|FG003|Overall Study|Lack of Efficacy|0|||
146166308|NCT00949715|527120513|FG000|Overall Study|Physician Decision|1|||
146166309|NCT00949715|527120514|FG001|Overall Study|Physician Decision|0|||
146166310|NCT00949715|527120513|FG000|Overall Study|Lost to Follow-up|1|||
146166311|NCT00949715|527120514|FG001|Overall Study|Lost to Follow-up|0|||
146166312|NCT00949715|527120513|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
146166313|NCT00949715|527120514|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
146325789|NCT04426695|527703267|FG016|Overall Study|Lost to Follow-up|0|||
146325790|NCT04426695|527703268|FG017|Overall Study|Lost to Follow-up|0|||
146325791|NCT04426695|527703251|FG000|Overall Study|Participant Decision|1|||
146166314|NCT00861614|527120515|FG000|Overall Study|Disease Progression|182|||
146325792|NCT04426695|527703252|FG001|Overall Study|Participant Decision|2|||
146325793|NCT04426695|527703253|FG002|Overall Study|Participant Decision|2|||
146325794|NCT04426695|527703254|FG003|Overall Study|Participant Decision|12|||
146325795|NCT04426695|527703255|FG004|Overall Study|Participant Decision|18|||
146325796|NCT04426695|527703256|FG005|Overall Study|Participant Decision|22|||
146325797|NCT04426695|527703257|FG006|Overall Study|Participant Decision|13|||
146166315|NCT00861614|527120516|FG001|Overall Study|Disease Progression|263|||
146166316|NCT00861614|527120515|FG000|Overall Study|Study Drug Toxicity|79|||
146166317|NCT00861614|527120516|FG001|Overall Study|Study Drug Toxicity|6|||
146166318|NCT00861614|527120515|FG000|Overall Study|Death|32|||
146166319|NCT00861614|527120516|FG001|Overall Study|Death|19|||
146166320|NCT00861614|527120515|FG000|Overall Study|Adverse Event|27|||
146166321|NCT00861614|527120516|FG001|Overall Study|Adverse Event|23|||
146166322|NCT00861614|527120515|FG000|Overall Study|Withdrawal by Subject|34|||
146166323|NCT00861614|527120516|FG001|Overall Study|Withdrawal by Subject|35|||
146166324|NCT00861614|527120515|FG000|Overall Study|Other|17|||
146166325|NCT00861614|527120516|FG001|Overall Study|Other|22|||
146166326|NCT02243280|527120517|FG000|Treated|Adverse Event|1|||
146166327|NCT02243280|527120518|FG001|Treated|Adverse Event|0|||
146166328|NCT02243280|527120519|FG002|Treated|Adverse Event|0|||
146166329|NCT02243280|527120520|FG003|Treated|Adverse Event|0|||
146166330|NCT02243280|527120521|FG004|Treated|Adverse Event|0|||
146166331|NCT02243280|527120522|FG005|Treated|Adverse Event|0|||
146166332|NCT02243280|527120523|FG006|Treated|Adverse Event|0|||
146166333|NCT02243280|527120524|FG007|Treated|Adverse Event|0|||
146166334|NCT02243280|527120525|FG008|Treated|Adverse Event|0|||
146166335|NCT02243280|527120526|FG009|Treated|Adverse Event|0|||
146166336|NCT02243280|527120527|FG010|Treated|Adverse Event|1|||
146166337|NCT02243280|527120517|FG000|Treated|Lost to Follow-up|0|||
146166338|NCT02243280|527120518|FG001|Treated|Lost to Follow-up|0|||
146166339|NCT02243280|527120519|FG002|Treated|Lost to Follow-up|0|||
146166340|NCT02243280|527120520|FG003|Treated|Lost to Follow-up|0|||
146166341|NCT02243280|527120521|FG004|Treated|Lost to Follow-up|0|||
146166342|NCT02243280|527120522|FG005|Treated|Lost to Follow-up|0|||
146166343|NCT02243280|527120523|FG006|Treated|Lost to Follow-up|0|||
146166344|NCT02243280|527120524|FG007|Treated|Lost to Follow-up|0|||
146166345|NCT02243280|527120525|FG008|Treated|Lost to Follow-up|1|||
146166346|NCT02243280|527120526|FG009|Treated|Lost to Follow-up|0|||
146166347|NCT02243280|527120527|FG010|Treated|Lost to Follow-up|2|||
146166348|NCT01807156|527120528|FG000|Overall Study|Physician Decision|1|||
146166349|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
146166350|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
146166351|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
146166352|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
146166353|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
146166354|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
146166355|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
146166356|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
146166357|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
146166358|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
146166359|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
146166360|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
146166361|NCT01493687|527120532|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
146166362|NCT01493687|527120533|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
146166363|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
146166364|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
146166365|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
146166366|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
146166367|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
146166368|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
146166369|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
146166370|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
146166371|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
146325798|NCT04426695|527703258|FG007|Overall Study|Participant Decision|13|||
146325799|NCT04426695|527703259|FG008|Overall Study|Participant Decision|10|||
146166372|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
146166373|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
146166374|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
146166375|NCT01493687|527120532|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
146166376|NCT01493687|527120533|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
146166377|NCT01493687|527120532|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
146166378|NCT01493687|527120533|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
146166379|NCT02323646|527120537|FG000|Treatment Course 1|Adverse Event|1|||
146166380|NCT02323646|527120538|FG001|Treatment Course 1|Adverse Event|0|||
146166381|NCT02323646|527120539|FG002|Treatment Course 1|Adverse Event|1|||
146166382|NCT02323646|527120537|FG000|Treatment Course 1|Heavy Bleeding|1|||
146166383|NCT02323646|527120538|FG001|Treatment Course 1|Heavy Bleeding|1|||
146166384|NCT02323646|527120539|FG002|Treatment Course 1|Heavy Bleeding|0|||
146166385|NCT02323646|527120537|FG000|Treatment Course 1|Lost to Follow-up|1|||
146166386|NCT02323646|527120538|FG001|Treatment Course 1|Lost to Follow-up|0|||
146166387|NCT02323646|527120539|FG002|Treatment Course 1|Lost to Follow-up|2|||
146166388|NCT02323646|527120537|FG000|Treatment Course 1|Withdrawal by Subject|0|||
146166389|NCT02323646|527120538|FG001|Treatment Course 1|Withdrawal by Subject|2|||
146166390|NCT02323646|527120539|FG002|Treatment Course 1|Withdrawal by Subject|0|||
146166391|NCT02323646|527120537|FG000|Treatment Course 2|Adverse Event|1|||
146166392|NCT02323646|527120538|FG001|Treatment Course 2|Adverse Event|0|||
146166393|NCT02323646|527120539|FG002|Treatment Course 2|Adverse Event|1|||
146166394|NCT02323646|527120537|FG000|Treatment Course 2|Lost to Follow-up|0|||
146166395|NCT02323646|527120538|FG001|Treatment Course 2|Lost to Follow-up|0|||
146166396|NCT02323646|527120539|FG002|Treatment Course 2|Lost to Follow-up|1|||
146166397|NCT02323646|527120537|FG000|Treatment Course 2|Non-compliance|0|||
146166398|NCT02323646|527120538|FG001|Treatment Course 2|Non-compliance|1|||
146166399|NCT02323646|527120539|FG002|Treatment Course 2|Non-compliance|1|||
146166400|NCT00521144|527120540|FG000|Overall Study|Not Treated|0|||
146166401|NCT00521144|527120541|FG001|Overall Study|Not Treated|0|||
146166402|NCT00521144|527120542|FG002|Overall Study|Not Treated|0|||
146166403|NCT00521144|527120543|FG003|Overall Study|Not Treated|1|||
146166404|NCT00521144|527120544|FG004|Overall Study|Not Treated|0|||
146166405|NCT00521144|527120540|FG000|Overall Study|Adverse Event|0|||
146166406|NCT00521144|527120541|FG001|Overall Study|Adverse Event|1|||
146166407|NCT00521144|527120542|FG002|Overall Study|Adverse Event|0|||
146166408|NCT00521144|527120543|FG003|Overall Study|Adverse Event|0|||
146166409|NCT00521144|527120544|FG004|Overall Study|Adverse Event|1|||
146166410|NCT00521144|527120540|FG000|Overall Study|Progressive Disease|4|||
146166411|NCT00521144|527120541|FG001|Overall Study|Progressive Disease|2|||
146166412|NCT00521144|527120542|FG002|Overall Study|Progressive Disease|2|||
146166413|NCT00521144|527120543|FG003|Overall Study|Progressive Disease|0|||
146166414|NCT00521144|527120544|FG004|Overall Study|Progressive Disease|6|||
146166415|NCT01370525|527120545|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
146166416|NCT01370525|527120546|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
146166417|NCT01370525|527120545|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146166418|NCT01370525|527120546|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146166419|NCT01370525|527120545|FG000|Overall Study|Adverse Event|0|||
146166420|NCT01370525|527120546|FG001|Overall Study|Adverse Event|1|||
146166421|NCT01370525|527120545|FG000|Overall Study|Protocol Violation|2|||
146166422|NCT01370525|527120546|FG001|Overall Study|Protocol Violation|1|||
146166423|NCT01370525|527120545|FG000|Overall Study|Lost to follow up|2|||
146166424|NCT01370525|527120546|FG001|Overall Study|Lost to follow up|6|||
146166425|NCT04791761|527120549|FG000|Overall Study|Lost to Follow-up|8|||
146166426|NCT04791761|527120550|FG001|Overall Study|Lost to Follow-up|6|||
146166427|NCT04791761|527120551|FG002|Overall Study|Lost to Follow-up|10|||
146166428|NCT04791761|527120549|FG000|Overall Study|Withdrawal by Subject|0|||
146166429|NCT04791761|527120550|FG001|Overall Study|Withdrawal by Subject|1|||
146166430|NCT04791761|527120551|FG002|Overall Study|Withdrawal by Subject|1|||
146166431|NCT04791761|527120549|FG000|Overall Study|Protocol Violation|0|||
146166432|NCT04791761|527120550|FG001|Overall Study|Protocol Violation|1|||
146166433|NCT04791761|527120551|FG002|Overall Study|Protocol Violation|1|||
146166434|NCT00180479|527120555|FG000|Overall Study|Death|4|||
146166435|NCT00180479|527120556|FG001|Overall Study|Death|2|||
146166436|NCT00180479|527120555|FG000|Overall Study|Lost to Follow-up|9|||
146166437|NCT00180479|527120556|FG001|Overall Study|Lost to Follow-up|7|||
146166438|NCT00180479|527120555|FG000|Overall Study|Withdrawal by Subject|3|||
146166439|NCT00180479|527120556|FG001|Overall Study|Withdrawal by Subject|3|||
146166440|NCT00180479|527120555|FG000|Overall Study|Informed consent not signed|0|||
146166441|NCT00180479|527120556|FG001|Overall Study|Informed consent not signed|1|||
146166442|NCT02459262|527120561|FG000|Overall Study|Withdrawal by Subject|0|||
146166443|NCT02459262|527120562|FG001|Overall Study|Withdrawal by Subject|0|||
146166444|NCT02459262|527120563|FG002|Overall Study|Withdrawal by Subject|0|||
146166445|NCT02459262|527120564|FG003|Overall Study|Withdrawal by Subject|0|||
146166446|NCT02459262|527120565|FG004|Overall Study|Withdrawal by Subject|0|||
146166447|NCT02459262|527120566|FG005|Overall Study|Withdrawal by Subject|0|||
146166448|NCT02459262|527120567|FG006|Overall Study|Withdrawal by Subject|0|||
146166449|NCT02459262|527120568|FG007|Overall Study|Withdrawal by Subject|0|||
146166450|NCT02459262|527120569|FG008|Overall Study|Withdrawal by Subject|0|||
146166451|NCT02459262|527120570|FG009|Overall Study|Withdrawal by Subject|1|||
146166452|NCT02459262|527120571|FG010|Overall Study|Withdrawal by Subject|0|||
146166453|NCT00645164|527120575|FG000|Overall Study|Lost to Follow-up|2|||
146166454|NCT00645164|527120575|FG000|Overall Study|Withdrawal by Subject|4|||
146166455|NCT00645164|527120575|FG000|Overall Study|Protocol Violation|1|||
146166456|NCT00715429|527120578|FG000|Overall Study|Did not complete the study diary|0|||
146166457|NCT00715429|527120579|FG001|Overall Study|Did not complete the study diary|1|||
146325800|NCT04426695|527703260|FG009|Overall Study|Participant Decision|15|||
146166458|NCT04899245|527120583|FG000|Overall Study|Withdrawal by Subject|3|||
146166459|NCT04899245|527120584|FG001|Overall Study|Withdrawal by Subject|5|||
146166460|NCT04899245|527120585|FG002|Overall Study|Withdrawal by Subject|2|||
146166461|NCT04899245|527120583|FG000|Overall Study|No longer eligible - Left staff position|0|||
146166462|NCT04899245|527120584|FG001|Overall Study|No longer eligible - Left staff position|0|||
146166463|NCT04899245|527120585|FG002|Overall Study|No longer eligible - Left staff position|1|||
146166464|NCT04899245|527120583|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
146166465|NCT04899245|527120584|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
146166466|NCT04899245|527120585|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
146166467|NCT04899245|527120583|FG000|Overall Study|No longer eligible - Moved away from area|2|||
146166468|NCT04899245|527120584|FG001|Overall Study|No longer eligible - Moved away from area|2|||
146166469|NCT04899245|527120585|FG002|Overall Study|No longer eligible - Moved away from area|0|||
146166470|NCT00386022|527120593|FG000|Plus Estrogen|Lost to Follow-up|2|||
146166471|NCT00386022|527120594|FG001|Plus Estrogen|Lost to Follow-up|0|||
146166472|NCT00386022|527120593|FG000|Plus Estrogen|Adverse Event|0|||
146166473|NCT00386022|527120594|FG001|Plus Estrogen|Adverse Event|1|||
146166474|NCT01666808|527120600|FG000|Overall Study|Lost to Follow-up|9|||
146166475|NCT01666808|527120601|FG001|Overall Study|Lost to Follow-up|15|||
146166476|NCT01666808|527120600|FG000|Overall Study|Withdrawal by Subject|3|||
146166477|NCT01666808|527120601|FG001|Overall Study|Withdrawal by Subject|1|||
146166478|NCT01666808|527120600|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
146166479|NCT01666808|527120601|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
146166480|NCT03933826|527120602|FG000|Overall Study|Withdrawal by Subject|8|||
146166481|NCT03933826|527120603|FG001|Overall Study|Withdrawal by Subject|1|||
146166482|NCT03933826|527120602|FG000|Overall Study|Death|19|||
146166483|NCT03933826|527120603|FG001|Overall Study|Death|11|||
146166484|NCT03933826|527120602|FG000|Overall Study|Lost to Follow-up|41|||
146166485|NCT03933826|527120603|FG001|Overall Study|Lost to Follow-up|13|||
146166486|NCT01648348|527120609|FG000|Overall Study|Cancel|1|||
146166487|NCT01648348|527120610|FG001|Overall Study|Cancel|0|||
146166488|NCT01648348|527120611|FG002|Overall Study|Cancel|0|||
146166489|NCT01648348|527120612|FG003|Overall Study|Cancel|0|||
146166490|NCT01648348|527120613|FG004|Overall Study|Cancel|3|||
146166491|NCT01648348|527120614|FG005|Overall Study|Cancel|6|||
146166492|NCT01648348|527120609|FG000|Overall Study|Replaced for MTD analysis|1|||
146166493|NCT01648348|527120610|FG001|Overall Study|Replaced for MTD analysis|0|||
146166494|NCT01648348|527120611|FG002|Overall Study|Replaced for MTD analysis|1|||
146166495|NCT01648348|527120612|FG003|Overall Study|Replaced for MTD analysis|0|||
146166496|NCT01648348|527120613|FG004|Overall Study|Replaced for MTD analysis|0|||
146166497|NCT01648348|527120614|FG005|Overall Study|Replaced for MTD analysis|0|||
146166498|NCT02495025|527120618|FG000|Overall Study|Lost to Follow-up|21|||
146166499|NCT02495025|527120619|FG001|Overall Study|Lost to Follow-up|14|||
146166500|NCT02495025|527120618|FG000|Overall Study|Withdrawal by Subject|5|||
146166501|NCT02495025|527120619|FG001|Overall Study|Withdrawal by Subject|0|||
146166502|NCT02778100|527120621|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
146166503|NCT02778100|527120622|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
146166504|NCT01338025|527120624|FG000|Overall Study|Unexpected closure of study|10|||
146166505|NCT01338025|527120625|FG001|Overall Study|Unexpected closure of study|9|||
146166506|NCT01338025|527120624|FG000|Overall Study|Withdrawal by Subject|0|||
146166507|NCT01338025|527120625|FG001|Overall Study|Withdrawal by Subject|2|||
146166508|NCT01338025|527120624|FG000|Overall Study|Found ineligible after starting|1|||
146166509|NCT01338025|527120625|FG001|Overall Study|Found ineligible after starting|0|||
146166510|NCT03017079|527120626|FG000|Overall Study|Physician Decision|1|||
146166511|NCT03017079|527120627|FG001|Overall Study|Physician Decision|1|||
146166512|NCT03017079|527120626|FG000|Overall Study|Death|3|||
146166513|NCT03017079|527120627|FG001|Overall Study|Death|2|||
146166514|NCT03017079|527120626|FG000|Overall Study|Lack of Efficacy|2|||
146166515|NCT03017079|527120627|FG001|Overall Study|Lack of Efficacy|2|||
146166516|NCT03017079|527120626|FG000|Overall Study|Protocol Violation|0|||
146166517|NCT03017079|527120627|FG001|Overall Study|Protocol Violation|1|||
146166518|NCT04349280|527120630|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
146166519|NCT04349280|527120631|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
146166520|NCT04349280|527120630|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
146166521|NCT04349280|527120631|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
146166522|NCT04349280|527120630|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
146166523|NCT04349280|527120631|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
146166524|NCT03779906|527120634|FG000|Overall Study|Lost to Follow-up|7|||
146166525|NCT03779906|527120634|FG000|Overall Study|COVID pandemic|1|||
146166526|NCT02553460|527120635|FG000|Overall Study|Death|3|||
146166527|NCT02553460|527120635|FG000|Overall Study|Withdrawal by Subject|1|||
146166528|NCT02553460|527120635|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
146166529|NCT02553460|527120635|FG000|Overall Study|Relapse or Transplant|14|||
146166530|NCT02553460|527120635|FG000|Overall Study|No response to treatment|2|||
146166531|NCT02553460|527120635|FG000|Overall Study|CAR T cells|2|||
146166532|NCT01984697|527122371|FG000|Overall Study|Adverse Event|0|||
146166533|NCT01984697|527122372|FG001|Overall Study|Adverse Event|0|||
146166534|NCT01984697|527122373|FG002|Overall Study|Adverse Event|2|||
146166535|NCT01984697|527122374|FG003|Overall Study|Adverse Event|0|||
146166536|NCT01984697|527122375|FG004|Overall Study|Adverse Event|0|||
146325801|NCT04426695|527703261|FG010|Overall Study|Participant Decision|16|||
146166537|NCT01984697|527122371|FG000|Overall Study|Lost to Follow-up|14|||
146166538|NCT01984697|527122372|FG001|Overall Study|Lost to Follow-up|5|||
146166539|NCT01984697|527122373|FG002|Overall Study|Lost to Follow-up|10|||
146166540|NCT01984697|527122374|FG003|Overall Study|Lost to Follow-up|6|||
146166541|NCT01984697|527122375|FG004|Overall Study|Lost to Follow-up|21|||
146166542|NCT01984697|527122371|FG000|Overall Study|Physician Decision|3|||
146166543|NCT01984697|527122372|FG001|Overall Study|Physician Decision|0|||
146166544|NCT01984697|527122373|FG002|Overall Study|Physician Decision|0|||
146166545|NCT01984697|527122374|FG003|Overall Study|Physician Decision|1|||
146166546|NCT01984697|527122375|FG004|Overall Study|Physician Decision|0|||
146166547|NCT01984697|527122371|FG000|Overall Study|Protocol Violation|8|||
146166548|NCT01984697|527122372|FG001|Overall Study|Protocol Violation|5|||
146166549|NCT01984697|527122373|FG002|Overall Study|Protocol Violation|3|||
146166550|NCT01984697|527122374|FG003|Overall Study|Protocol Violation|2|||
146166551|NCT01984697|527122375|FG004|Overall Study|Protocol Violation|0|||
146166552|NCT01984697|527122371|FG000|Overall Study|Withdrawal by Subject|15|||
146166553|NCT01984697|527122372|FG001|Overall Study|Withdrawal by Subject|21|||
146166554|NCT01984697|527122373|FG002|Overall Study|Withdrawal by Subject|13|||
146166555|NCT01984697|527122374|FG003|Overall Study|Withdrawal by Subject|11|||
146166556|NCT01984697|527122375|FG004|Overall Study|Withdrawal by Subject|13|||
146166557|NCT01984697|527122371|FG000|Overall Study|Missed last follow-up visit|1|||
146166558|NCT01984697|527122372|FG001|Overall Study|Missed last follow-up visit|0|||
146166559|NCT01984697|527122373|FG002|Overall Study|Missed last follow-up visit|0|||
146166560|NCT01984697|527122374|FG003|Overall Study|Missed last follow-up visit|0|||
146166561|NCT01984697|527122375|FG004|Overall Study|Missed last follow-up visit|0|||
146166562|NCT01984697|527122371|FG000|Overall Study|Death|0|||
146166563|NCT01984697|527122372|FG001|Overall Study|Death|0|||
146166564|NCT01984697|527122373|FG002|Overall Study|Death|0|||
146166565|NCT01984697|527122374|FG003|Overall Study|Death|1|||
146166566|NCT01984697|527122375|FG004|Overall Study|Death|0|||
146166567|NCT01984697|527122371|FG000|Overall Study|Pregnancy|2|||
146166568|NCT01984697|527122372|FG001|Overall Study|Pregnancy|0|||
146166569|NCT01984697|527122373|FG002|Overall Study|Pregnancy|1|||
146166570|NCT01984697|527122374|FG003|Overall Study|Pregnancy|0|||
146166571|NCT01984697|527122375|FG004|Overall Study|Pregnancy|1|||
146166572|NCT04737109|527122377|FG000|Study Treatment|Disease Progression|5|||
146166573|NCT04737109|527122378|FG001|Study Treatment|Disease Progression|0|||
146166574|NCT04737109|527122379|FG002|Study Treatment|Disease Progression|0|||
146166575|NCT04737109|527122380|FG003|Study Treatment|Disease Progression|0|||
146166576|NCT04737109|527122377|FG000|Study Treatment|Death on study|1|||
146166577|NCT04737109|527122378|FG001|Study Treatment|Death on study|0|||
146166578|NCT04737109|527122379|FG002|Study Treatment|Death on study|0|||
146166579|NCT04737109|527122380|FG003|Study Treatment|Death on study|0|||
146166580|NCT01582789|527122382|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
146166581|NCT01582789|527122383|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
146166582|NCT02276066|527122384|FG000|Overall Study|Lost to Follow-up|21|||
146166583|NCT02276066|527122385|FG001|Overall Study|Lost to Follow-up|11|||
146166584|NCT05050578|527122386|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
146166585|NCT05050578|527122387|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
146166586|NCT05050578|527122386|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
146166587|NCT05050578|527122387|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
146166588|NCT05050578|527122386|FG000|Period 2, 30 Days|Protocol Violation|0|||
146166589|NCT05050578|527122387|FG001|Period 2, 30 Days|Protocol Violation|1|||
146166590|NCT03386032|527122389|FG000|Overall Study|Lack of Efficacy|6|||
146166591|NCT03386032|527122390|FG001|Overall Study|Lack of Efficacy|2|||
146166592|NCT03386032|527122391|FG002|Overall Study|Lack of Efficacy|0|||
146166593|NCT03386032|527122389|FG000|Overall Study|Adverse Event|2|||
146166594|NCT03386032|527122390|FG001|Overall Study|Adverse Event|2|||
146166595|NCT03386032|527122391|FG002|Overall Study|Adverse Event|0|||
146166596|NCT03386032|527122389|FG000|Overall Study|Withdrawal by Subject|1|||
146166597|NCT03386032|527122390|FG001|Overall Study|Withdrawal by Subject|0|||
146166598|NCT03386032|527122391|FG002|Overall Study|Withdrawal by Subject|0|||
146166599|NCT03386032|527122389|FG000|Overall Study|Lost to Follow-up|9|||
146166600|NCT03386032|527122390|FG001|Overall Study|Lost to Follow-up|3|||
146166601|NCT03386032|527122391|FG002|Overall Study|Lost to Follow-up|0|||
146166602|NCT02710292|527122396|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
146166603|NCT02710292|527122397|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
146166604|NCT02710292|527122396|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
146166605|NCT02710292|527122397|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
146166606|NCT03122119|527122398|FG000|Overall Study|Did not meet eligibility critria|1|||
146166607|NCT02364180|527122404|FG000|Overall Study|Screen Fail|1|||
146166608|NCT01783418|527122405|FG000|Overall Study|Withdrawal by Subject|1|||
146166609|NCT01783418|527122406|FG001|Overall Study|Withdrawal by Subject|0|||
146166610|NCT00089141|527122407|FG000|Overall Study|Termination of trial|18|||
146166611|NCT00089141|527122408|FG001|Overall Study|Termination of trial|24|||
146166612|NCT00508261|527122409|FG000|Overall Study|Other|0|||
146166613|NCT00508261|527122410|FG001|Overall Study|Other|1|||
146166614|NCT00508261|527122411|FG002|Overall Study|Other|1|||
146166615|NCT00508261|527122412|FG003|Overall Study|Other|0|||
146166616|NCT00508261|527122409|FG000|Overall Study|Serious Adverse Event|0|||
146166617|NCT00508261|527122410|FG001|Overall Study|Serious Adverse Event|1|||
146166618|NCT00508261|527122411|FG002|Overall Study|Serious Adverse Event|0|||
146166619|NCT00508261|527122412|FG003|Overall Study|Serious Adverse Event|0|||
146166620|NCT00508261|527122409|FG000|Overall Study|Withdrawal by Subject|3|||
146166621|NCT00508261|527122410|FG001|Overall Study|Withdrawal by Subject|4|||
146166622|NCT00508261|527122411|FG002|Overall Study|Withdrawal by Subject|4|||
146166623|NCT00508261|527122412|FG003|Overall Study|Withdrawal by Subject|0|||
146166624|NCT00508261|527122409|FG000|Overall Study|Migrated/ moved from study area|0|||
146166625|NCT00508261|527122410|FG001|Overall Study|Migrated/ moved from study area|1|||
146166626|NCT00508261|527122411|FG002|Overall Study|Migrated/ moved from study area|0|||
146166627|NCT00508261|527122412|FG003|Overall Study|Migrated/ moved from study area|0|||
146166628|NCT00508261|527122409|FG000|Overall Study|Lost to Follow-up|0|||
146166629|NCT00508261|527122410|FG001|Overall Study|Lost to Follow-up|1|||
146166630|NCT00508261|527122411|FG002|Overall Study|Lost to Follow-up|1|||
146166631|NCT00508261|527122412|FG003|Overall Study|Lost to Follow-up|1|||
146166632|NCT00526630|527122413|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
146166633|NCT00526630|527122414|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
146166634|NCT00526630|527122413|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
146166635|NCT00526630|527122414|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
146166636|NCT05168579|527122415|FG000|Overall Study|Lack of Consent|1|||
146166637|NCT05168579|527122416|FG001|Overall Study|Lack of Consent|0|||
146166638|NCT05168579|527122415|FG000|Overall Study|Conflicts with time|2|||
146166639|NCT05168579|527122416|FG001|Overall Study|Conflicts with time|0|||
146166640|NCT05168579|527122415|FG000|Overall Study|Time slots were full|3|||
146166641|NCT05168579|527122416|FG001|Overall Study|Time slots were full|0|||
146166642|NCT05168579|527122415|FG000|Overall Study|Lost to Follow-up|0|||
146166643|NCT05168579|527122416|FG001|Overall Study|Lost to Follow-up|15|||
146166644|NCT00840801|527122417|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
146166645|NCT00840801|527122418|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
146166646|NCT00840801|527122419|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
146166647|NCT00840801|527122417|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
146166648|NCT00840801|527122418|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
146166649|NCT00840801|527122419|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
146166650|NCT00840801|527122417|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
146166651|NCT00840801|527122418|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
146166652|NCT00840801|527122419|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
146166653|NCT00840801|527122417|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
146166654|NCT00840801|527122418|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
146166655|NCT00840801|527122419|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
146166656|NCT01242748|527122420|FG000|Overall Study|Adverse Event|10|||
146166657|NCT01242748|527122421|FG001|Overall Study|Adverse Event|5|||
146166658|NCT01242748|527122420|FG000|Overall Study|Lost to Follow-up|6|||
146166659|NCT01242748|527122421|FG001|Overall Study|Lost to Follow-up|2|||
146166660|NCT01242748|527122420|FG000|Overall Study|Physician Decision|3|||
146166661|NCT01242748|527122421|FG001|Overall Study|Physician Decision|2|||
146166662|NCT01242748|527122420|FG000|Overall Study|Protocol Violation|1|||
146166663|NCT01242748|527122421|FG001|Overall Study|Protocol Violation|0|||
146166664|NCT01242748|527122420|FG000|Overall Study|Withdrawal by Subject|10|||
146166665|NCT01242748|527122421|FG001|Overall Study|Withdrawal by Subject|2|||
146166666|NCT01242748|527122420|FG000|Overall Study|Miscellaneous reasons|8|||
146166667|NCT01242748|527122421|FG001|Overall Study|Miscellaneous reasons|3|||
146166668|NCT00335452|527122422|FG000|Overall Study|Death|156|||
146166669|NCT00335452|527122423|FG001|Overall Study|Death|144|||
146166670|NCT00335452|527122424|FG002|Overall Study|Death|158|||
146166671|NCT00335452|527122425|FG003|Overall Study|Death|129|||
146166672|NCT00335452|527122422|FG000|Overall Study|Lost to Follow-up|2|||
146166673|NCT00335452|527122423|FG001|Overall Study|Lost to Follow-up|3|||
146166674|NCT00335452|527122424|FG002|Overall Study|Lost to Follow-up|1|||
146166675|NCT00335452|527122425|FG003|Overall Study|Lost to Follow-up|2|||
146166676|NCT02736825|527122427|FG000|Overall Study|Lost to Follow-up|10|||
146166677|NCT02736825|527122428|FG001|Overall Study|Lost to Follow-up|11|||
146166678|NCT02736825|527122427|FG000|Overall Study|Early Termination|0|||
146166679|NCT02736825|527122428|FG001|Overall Study|Early Termination|1|||
146166680|NCT00790452|527122429|FG000|Overall Study|Drug supply issue|1|||
146166681|NCT00790452|527122430|FG001|Overall Study|Drug supply issue|0|||
146166682|NCT02940574|527122431|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
146325802|NCT04426695|527703262|FG011|Overall Study|Participant Decision|17|||
146166683|NCT02940574|527122432|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
146166684|NCT02940574|527122431|FG000|1-year Follow-up|Lost to Follow-up|3|||
146166685|NCT02940574|527122432|FG001|1-year Follow-up|Lost to Follow-up|4|||
146166686|NCT01750879|527122435|FG000|Overall Study|Adverse Event|8|||
146166687|NCT01750879|527122436|FG001|Overall Study|Adverse Event|0|||
146166688|NCT01750879|527122435|FG000|Overall Study|Lack of Efficacy|1|||
146166689|NCT01750879|527122436|FG001|Overall Study|Lack of Efficacy|0|||
146166690|NCT01750879|527122435|FG000|Overall Study|Withdrawal by Subject|1|||
146166691|NCT01750879|527122436|FG001|Overall Study|Withdrawal by Subject|0|||
146166692|NCT01750879|527122435|FG000|Overall Study|Did not complete per protocol|0|||
146166693|NCT01750879|527122436|FG001|Overall Study|Did not complete per protocol|3|||
146166694|NCT04810221|527122437|FG000|Overall Study|Physician Decision|3|||
146166695|NCT03642938|527122438|FG000|Overall Study|Withdrawal by Subject|0|||
146166696|NCT03642938|527122439|FG001|Overall Study|Withdrawal by Subject|0|||
146166697|NCT03642938|527122440|FG002|Overall Study|Withdrawal by Subject|0|||
146166698|NCT03642938|527122441|FG003|Overall Study|Withdrawal by Subject|1|||
146166699|NCT00105235|527122442|FG000|Overall Study|Death|4|||
146166700|NCT00105235|527122442|FG000|Overall Study|Physician Decision|1|||
146166701|NCT00105235|527122442|FG000|Overall Study|Withdrawal by Subject|2|||
146166702|NCT01964326|527122443|FG000|Overall Study|Adverse Event|48|||
146166703|NCT01964326|527122443|FG000|Overall Study|Death|2|||
146166704|NCT01964326|527122443|FG000|Overall Study|Protocol Violation|4|||
146166705|NCT01964326|527122443|FG000|Overall Study|Lost to Follow-up|88|||
146166706|NCT01964326|527122443|FG000|Overall Study|Withdrawal by Subject|87|||
146166707|NCT01964326|527122443|FG000|Overall Study|Pregnancy|1|||
146166708|NCT01964326|527122443|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
146166709|NCT01964326|527122443|FG000|Overall Study|Physician Decision|55|||
146166710|NCT01964326|527122443|FG000|Overall Study|Investigator Discretion|1|||
146166711|NCT01964326|527122443|FG000|Overall Study|Other|9|||
146166712|NCT01964326|527122443|FG000|Overall Study|Did not meet eligibility criteria|1|||
146166713|NCT02347657|527122444|FG000|Overall Study|Physician Decision|0|||
146166714|NCT02347657|527122445|FG001|Overall Study|Physician Decision|1|||
146166715|NCT02347657|527122444|FG000|Overall Study|Adverse Event|8|||
146166716|NCT02347657|527122445|FG001|Overall Study|Adverse Event|4|||
146166717|NCT02347657|527122444|FG000|Overall Study|Withdrawal by Subject|6|||
146166718|NCT02347657|527122445|FG001|Overall Study|Withdrawal by Subject|7|||
146166719|NCT02347657|527122444|FG000|Overall Study|Randomized but not treated|1|||
146166720|NCT02347657|527122445|FG001|Overall Study|Randomized but not treated|0|||
146166721|NCT02347657|527122444|FG000|Overall Study|Other|3|||
146166722|NCT02347657|527122445|FG001|Overall Study|Other|3|||
146166723|NCT02093663|527122454|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
146166724|NCT02093663|527122455|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146166725|NCT02093663|527122456|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146166726|NCT02093663|527122457|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146166727|NCT02093663|527122458|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
146166728|NCT02093663|527122454|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
146166729|NCT02093663|527122455|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166730|NCT02093663|527122456|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166731|NCT02093663|527122457|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166732|NCT02093663|527122458|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166733|NCT02093663|527122454|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
146166734|NCT02093663|527122455|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
146166735|NCT02093663|527122456|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146166736|NCT02093663|527122457|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146166737|NCT02093663|527122458|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
146166738|NCT02093663|527122454|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146166739|NCT02093663|527122455|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146166740|NCT02093663|527122456|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
146166741|NCT02093663|527122457|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146166742|NCT02093663|527122458|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
146166743|NCT02093663|527122454|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166744|NCT02093663|527122455|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166745|NCT02093663|527122456|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
146166746|NCT02093663|527122457|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166747|NCT02093663|527122458|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
146166748|NCT02093663|527122454|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146166749|NCT02093663|527122455|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146166750|NCT02093663|527122456|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
146166751|NCT02093663|527122457|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
146166752|NCT02093663|527122458|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
146166753|NCT02093663|527122454|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146166754|NCT02093663|527122455|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146166755|NCT02093663|527122456|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
146166756|NCT02093663|527122457|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
146166757|NCT02093663|527122458|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
146166758|NCT02093663|527122454|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146166759|NCT02093663|527122455|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146166760|NCT02093663|527122456|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
146166761|NCT02093663|527122457|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
146325803|NCT04426695|527703263|FG012|Overall Study|Participant Decision|2|||
146325804|NCT04426695|527703264|FG013|Overall Study|Participant Decision|1|||
146325805|NCT04426695|527703265|FG014|Overall Study|Participant Decision|2|||
146325806|NCT04426695|527703266|FG015|Overall Study|Participant Decision|0|||
146325807|NCT04426695|527703267|FG016|Overall Study|Participant Decision|0|||
146325808|NCT04426695|527703268|FG017|Overall Study|Participant Decision|0|||
146325809|NCT04426695|527703251|FG000|Overall Study|Adverse Event|0|||
146325810|NCT04426695|527703252|FG001|Overall Study|Adverse Event|0|||
146325811|NCT04426695|527703253|FG002|Overall Study|Adverse Event|0|||
146325812|NCT04426695|527703254|FG003|Overall Study|Adverse Event|0|||
146325813|NCT04426695|527703255|FG004|Overall Study|Adverse Event|0|||
146325814|NCT04426695|527703256|FG005|Overall Study|Adverse Event|0|||
146325815|NCT04426695|527703257|FG006|Overall Study|Adverse Event|0|||
146325816|NCT04426695|527703258|FG007|Overall Study|Adverse Event|1|||
146325817|NCT04426695|527703259|FG008|Overall Study|Adverse Event|0|||
146325818|NCT04426695|527703260|FG009|Overall Study|Adverse Event|0|||
146325819|NCT04426695|527703261|FG010|Overall Study|Adverse Event|1|||
146325820|NCT04426695|527703262|FG011|Overall Study|Adverse Event|1|||
146325821|NCT04426695|527703263|FG012|Overall Study|Adverse Event|0|||
146325822|NCT04426695|527703264|FG013|Overall Study|Adverse Event|0|||
146325823|NCT04426695|527703265|FG014|Overall Study|Adverse Event|0|||
146325824|NCT04426695|527703266|FG015|Overall Study|Adverse Event|0|||
146325825|NCT04426695|527703267|FG016|Overall Study|Adverse Event|0|||
146325826|NCT04426695|527703268|FG017|Overall Study|Adverse Event|0|||
146325827|NCT04426695|527703251|FG000|Overall Study|Sponsor Request|0|||
146325828|NCT04426695|527703252|FG001|Overall Study|Sponsor Request|0|||
146325829|NCT04426695|527703253|FG002|Overall Study|Sponsor Request|0|||
146325830|NCT04426695|527703254|FG003|Overall Study|Sponsor Request|0|||
146325831|NCT04426695|527703255|FG004|Overall Study|Sponsor Request|0|||
146325832|NCT04426695|527703256|FG005|Overall Study|Sponsor Request|0|||
146325833|NCT04426695|527703257|FG006|Overall Study|Sponsor Request|1|||
146325834|NCT04426695|527703258|FG007|Overall Study|Sponsor Request|0|||
146325835|NCT04426695|527703259|FG008|Overall Study|Sponsor Request|0|||
146325836|NCT04426695|527703260|FG009|Overall Study|Sponsor Request|0|||
146325837|NCT04426695|527703261|FG010|Overall Study|Sponsor Request|0|||
146325838|NCT04426695|527703262|FG011|Overall Study|Sponsor Request|0|||
146325839|NCT04426695|527703263|FG012|Overall Study|Sponsor Request|0|||
146325840|NCT04426695|527703264|FG013|Overall Study|Sponsor Request|0|||
146325841|NCT04426695|527703265|FG014|Overall Study|Sponsor Request|0|||
146325842|NCT04426695|527703266|FG015|Overall Study|Sponsor Request|0|||
146325843|NCT04426695|527703267|FG016|Overall Study|Sponsor Request|0|||
146325844|NCT04426695|527703268|FG017|Overall Study|Sponsor Request|0|||
146325845|NCT04426695|527703251|FG000|Overall Study|Physician Decision|0|||
146325846|NCT04426695|527703252|FG001|Overall Study|Physician Decision|0|||
146325847|NCT04426695|527703253|FG002|Overall Study|Physician Decision|0|||
146325848|NCT04426695|527703254|FG003|Overall Study|Physician Decision|0|||
146325849|NCT04426695|527703255|FG004|Overall Study|Physician Decision|0|||
146325850|NCT04426695|527703256|FG005|Overall Study|Physician Decision|0|||
146325851|NCT04426695|527703257|FG006|Overall Study|Physician Decision|0|||
146325852|NCT04426695|527703258|FG007|Overall Study|Physician Decision|0|||
146325853|NCT04426695|527703259|FG008|Overall Study|Physician Decision|0|||
146325854|NCT04426695|527703260|FG009|Overall Study|Physician Decision|1|||
146325855|NCT04426695|527703261|FG010|Overall Study|Physician Decision|0|||
146325856|NCT04426695|527703262|FG011|Overall Study|Physician Decision|0|||
146325857|NCT04426695|527703263|FG012|Overall Study|Physician Decision|1|||
146325858|NCT04426695|527703264|FG013|Overall Study|Physician Decision|0|||
146325859|NCT04426695|527703265|FG014|Overall Study|Physician Decision|0|||
146325860|NCT04426695|527703266|FG015|Overall Study|Physician Decision|0|||
146325861|NCT04426695|527703267|FG016|Overall Study|Physician Decision|0|||
146325862|NCT04426695|527703268|FG017|Overall Study|Physician Decision|0|||
146325863|NCT04426695|527703251|FG000|Overall Study|Randomized but Never Treated|3|||
146325864|NCT04426695|527703252|FG001|Overall Study|Randomized but Never Treated|1|||
146325865|NCT04426695|527703253|FG002|Overall Study|Randomized but Never Treated|0|||
146325866|NCT04426695|527703254|FG003|Overall Study|Randomized but Never Treated|4|||
146325867|NCT04426695|527703255|FG004|Overall Study|Randomized but Never Treated|5|||
146325868|NCT04426695|527703256|FG005|Overall Study|Randomized but Never Treated|5|||
146325869|NCT04426695|527703257|FG006|Overall Study|Randomized but Never Treated|4|||
146325870|NCT04426695|527703258|FG007|Overall Study|Randomized but Never Treated|6|||
146325871|NCT04426695|527703259|FG008|Overall Study|Randomized but Never Treated|6|||
146325872|NCT04426695|527703260|FG009|Overall Study|Randomized but Never Treated|3|||
146325873|NCT04426695|527703261|FG010|Overall Study|Randomized but Never Treated|3|||
146325874|NCT04426695|527703262|FG011|Overall Study|Randomized but Never Treated|6|||
146325875|NCT04426695|527703263|FG012|Overall Study|Randomized but Never Treated|1|||
146325876|NCT04426695|527703264|FG013|Overall Study|Randomized but Never Treated|2|||
146325877|NCT04426695|527703265|FG014|Overall Study|Randomized but Never Treated|0|||
146325878|NCT04426695|527703266|FG015|Overall Study|Randomized but Never Treated|0|||
146325879|NCT04426695|527703267|FG016|Overall Study|Randomized but Never Treated|0|||
146325880|NCT04426695|527703268|FG017|Overall Study|Randomized but Never Treated|0|||
146325881|NCT04303000|527703269|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
146325882|NCT04303000|527703270|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
146325883|NCT04303000|527703271|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
146325884|NCT04276207|527703273|FG000|Period 1|Withdrawal by Subject|0|||
146325885|NCT04276207|527703274|FG001|Period 1|Withdrawal by Subject|1|||
146325886|NCT05655377|527703275|FG000|Overall Study|Withdrawal by Subject|2|||
146325887|NCT01256177|527703276|FG000|Overall Study|Withdrawal by Subject|23|||
146325888|NCT01256177|527703277|FG001|Overall Study|Withdrawal by Subject|22|||
146325889|NCT01256177|527703276|FG000|Overall Study|Lost to Follow-up|2|||
146325890|NCT01256177|527703277|FG001|Overall Study|Lost to Follow-up|2|||
146325891|NCT01256177|527703276|FG000|Overall Study|Adverse Event|8|||
146325892|NCT01256177|527703277|FG001|Overall Study|Adverse Event|9|||
146325893|NCT01256177|527703276|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
146325894|NCT01256177|527703277|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146325895|NCT01256177|527703276|FG000|Overall Study|Condition under Investigation Worsened|1|||
146325896|NCT01256177|527703277|FG001|Overall Study|Condition under Investigation Worsened|0|||
146325897|NCT01256177|527703276|FG000|Overall Study|Lack of Efficacy|11|||
146325898|NCT01256177|527703277|FG001|Overall Study|Lack of Efficacy|2|||
146325899|NCT01256177|527703276|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
146325900|NCT01256177|527703277|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
146325901|NCT04451330|527703279|FG000|Overall Study|Adverse Event|1|||
146325902|NCT04451330|527703280|FG001|Overall Study|Adverse Event|2|||
146325903|NCT04451330|527703279|FG000|Overall Study|Lost to Follow-up|5|||
146325904|NCT04451330|527703280|FG001|Overall Study|Lost to Follow-up|0|||
146325905|NCT04451330|527703279|FG000|Overall Study|Withdrawal by Subject|3|||
146325906|NCT04451330|527703280|FG001|Overall Study|Withdrawal by Subject|1|||
146325907|NCT04451330|527703279|FG000|Overall Study|Withdrawal by parent/guardian|1|||
146325908|NCT04451330|527703280|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146325909|NCT04451330|527703279|FG000|Overall Study|Other than specified|0|||
146325910|NCT04451330|527703280|FG001|Overall Study|Other than specified|1|||
146325911|NCT02690194|527703281|FG000|Overall Study|Withdrawal by Subject|1|||
146325912|NCT02690194|527703282|FG001|Overall Study|Withdrawal by Subject|4|||
146325913|NCT02690194|527703283|FG002|Overall Study|Withdrawal by Subject|0|||
146325914|NCT00849667|527703295|FG000|Overall Study|Withdrawal by Subject|16|||
146325915|NCT00849667|527703296|FG001|Overall Study|Withdrawal by Subject|33|||
146325916|NCT00849667|527703297|FG002|Overall Study|Withdrawal by Subject|35|||
146325917|NCT00849667|527703295|FG000|Overall Study|Lost to Follow-up|8|||
146325918|NCT00849667|527703296|FG001|Overall Study|Lost to Follow-up|8|||
146325919|NCT00849667|527703297|FG002|Overall Study|Lost to Follow-up|8|||
146325920|NCT00849667|527703295|FG000|Overall Study|Adverse Event|1|||
146325921|NCT00849667|527703296|FG001|Overall Study|Adverse Event|2|||
146325922|NCT00849667|527703297|FG002|Overall Study|Adverse Event|0|||
146325923|NCT00849667|527703295|FG000|Overall Study|Other|18|||
146325924|NCT00849667|527703296|FG001|Overall Study|Other|19|||
146325925|NCT00849667|527703297|FG002|Overall Study|Other|18|||
146325926|NCT00849667|527703295|FG000|Overall Study|Progressive disease|119|||
146325927|NCT00849667|527703296|FG001|Overall Study|Progressive disease|100|||
146325928|NCT00849667|527703297|FG002|Overall Study|Progressive disease|112|||
146325929|NCT00849667|527703295|FG000|Overall Study|Sponsor decision|208|||
146325930|NCT00849667|527703296|FG001|Overall Study|Sponsor decision|204|||
146325931|NCT00849667|527703297|FG002|Overall Study|Sponsor decision|190|||
146325932|NCT00849667|527703295|FG000|Overall Study|Investigator discretion|0|||
146325933|NCT00849667|527703296|FG001|Overall Study|Investigator discretion|0|||
146325934|NCT00849667|527703297|FG002|Overall Study|Investigator discretion|1|||
146325935|NCT00189462|527703298|FG000|Overall Study|Lack of Efficacy|5|||
146325936|NCT00189462|527703299|FG001|Overall Study|Lack of Efficacy|1|||
146325937|NCT00189462|527703298|FG000|Overall Study|Lost to Follow-up|18|||
146325938|NCT00189462|527703299|FG001|Overall Study|Lost to Follow-up|20|||
146325939|NCT00553462|527703300|FG000|Overall Study|Adverse Event|4|||
146325940|NCT00553462|527703300|FG000|Overall Study|Progression|4|||
146325941|NCT00553462|527703300|FG000|Overall Study|Withdrawal by Subject|5|||
146325942|NCT00553462|527703300|FG000|Overall Study|Physician Decision|1|||
146325943|NCT01262625|527703303|FG000|Overall Study|Administrative Error|1|||
146325944|NCT01262625|527703304|FG001|Overall Study|Administrative Error|1|||
146325945|NCT01262625|527703303|FG000|Overall Study|Site Closed|1|||
146325946|NCT01262625|527703304|FG001|Overall Study|Site Closed|0|||
146325947|NCT01869348|527703305|FG000|Overall Study|Withdrawal by Subject|1|||
146325948|NCT01869348|527703306|FG001|Overall Study|Withdrawal by Subject|1|||
146325949|NCT02789657|527703308|FG000|Overall Study|Withdrawal by Subject|2|||
146325950|NCT02789657|527703309|FG001|Overall Study|Withdrawal by Subject|0|||
146325951|NCT02789657|527703310|FG002|Overall Study|Withdrawal by Subject|0|||
146325952|NCT02789657|527703311|FG003|Overall Study|Withdrawal by Subject|0|||
146325953|NCT03075163|527703312|FG000|Overall Study|not eligible for treatment limb|138|||
146325954|NCT03075163|527703313|FG001|Overall Study|not eligible for treatment limb|138|||
146325955|NCT04398732|527703315|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
146325956|NCT03882424|527703316|FG000|Overall Study|Lost to Follow-up|3|||
146325957|NCT03882424|527703317|FG001|Overall Study|Lost to Follow-up|0|||
146325958|NCT03882424|527703318|FG002|Overall Study|Lost to Follow-up|0|||
146325959|NCT03882424|527703316|FG000|Overall Study|schedule conflict|1|||
146325960|NCT03882424|527703317|FG001|Overall Study|schedule conflict|0|||
146325961|NCT03882424|527703318|FG002|Overall Study|schedule conflict|0|||
146325962|NCT02772757|527703324|FG000|Overall Study|Withdrawal by Subject|1|||
146325963|NCT02772757|527703325|FG001|Overall Study|Withdrawal by Subject|0|||
146325964|NCT02772757|527703326|FG002|Overall Study|Withdrawal by Subject|1|||
146325965|NCT02772757|527703324|FG000|Overall Study|Protocol Violation|0|||
146325966|NCT02772757|527703325|FG001|Overall Study|Protocol Violation|0|||
146325967|NCT02772757|527703326|FG002|Overall Study|Protocol Violation|1|||
146325968|NCT02772757|527703324|FG000|Overall Study|Physician Decision|0|||
146325969|NCT02772757|527703325|FG001|Overall Study|Physician Decision|3|||
146325970|NCT02772757|527703326|FG002|Overall Study|Physician Decision|3|||
146325971|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Adverse Event|21|||
146325972|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Adverse Event|6|||
146325973|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
146325974|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
146325975|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
146325976|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
146325977|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
146325978|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
146325979|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Physician Decision|0|||
146325980|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Physician Decision|3|||
146325981|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
146325982|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
146325983|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
146325984|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
146325985|NCT00510276|527703330|FG000|Acute Double-Blind Phase|Subject Decision|26|||
146325986|NCT00510276|527703331|FG001|Acute Double-Blind Phase|Subject Decision|28|||
146325987|NCT00510276|527703330|FG000|Extension Open-Label Phase|Adverse Event|9|||
146325988|NCT00510276|527703331|FG001|Extension Open-Label Phase|Adverse Event|18|||
146325989|NCT00510276|527703330|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
146325990|NCT00510276|527703331|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
146325991|NCT00510276|527703330|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
146325992|NCT00510276|527703331|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
146325993|NCT00510276|527703330|FG000|Extension Open-Label Phase|Physician Decision|2|||
146325994|NCT00510276|527703331|FG001|Extension Open-Label Phase|Physician Decision|3|||
146325995|NCT00510276|527703330|FG000|Extension Open-Label Phase|Protocol Violation|0|||
146325996|NCT00510276|527703331|FG001|Extension Open-Label Phase|Protocol Violation|1|||
146325997|NCT00510276|527703330|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
146325998|NCT00510276|527703331|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
146325999|NCT00510276|527703330|FG000|Extension Open-Label Phase|Subject Decision|7|||
146326000|NCT00510276|527703331|FG001|Extension Open-Label Phase|Subject Decision|9|||
146326001|NCT03486392|527703332|FG000|Overall Study|Lost to Follow-up|0|||
146326002|NCT03486392|527703333|FG001|Overall Study|Lost to Follow-up|0|||
146326003|NCT03486392|527703334|FG002|Overall Study|Lost to Follow-up|8|||
146326004|NCT03486392|527703335|FG003|Overall Study|Lost to Follow-up|5|||
146326005|NCT03486392|527703336|FG004|Overall Study|Lost to Follow-up|2|||
146326006|NCT03486392|527703332|FG000|Overall Study|Withdrawal by Subject|3|||
146326007|NCT03486392|527703333|FG001|Overall Study|Withdrawal by Subject|0|||
146326008|NCT03486392|527703334|FG002|Overall Study|Withdrawal by Subject|6|||
146326009|NCT03486392|527703335|FG003|Overall Study|Withdrawal by Subject|4|||
146326010|NCT03486392|527703336|FG004|Overall Study|Withdrawal by Subject|1|||
146326011|NCT03486392|527703332|FG000|Overall Study|Death|0|||
146326012|NCT03486392|527703333|FG001|Overall Study|Death|0|||
146326013|NCT03486392|527703334|FG002|Overall Study|Death|0|||
146326014|NCT03486392|527703335|FG003|Overall Study|Death|0|||
146166762|NCT02093663|527122458|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
146166763|NCT02093663|527122454|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146166764|NCT02093663|527122455|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146326015|NCT03486392|527703336|FG004|Overall Study|Death|1|||
146326016|NCT01500057|527703339|FG000|Overall Study|Lost to Follow-up|6|||
146326017|NCT01500057|527703340|FG001|Overall Study|Lost to Follow-up|4|||
146326018|NCT00441792|527703341|FG000|Overall Study|Lost to Follow-up|0|||
146326019|NCT00441792|527703342|FG001|Overall Study|Lost to Follow-up|2|||
146326020|NCT01731678|527703343|FG000|Overall Study|Withdrawal by Subject|3|||
146326021|NCT01731678|527703343|FG000|Overall Study|Did not meet inclusion criteria|1|||
146326022|NCT01731678|527703343|FG000|Overall Study|RMT too high, making TMS difficult|3|||
146326023|NCT03665285|527703348|FG000|Overall Study|Started New Anticancer Treatment|1|||
146326024|NCT03665285|527703349|FG001|Overall Study|Started New Anticancer Treatment|1|||
146326025|NCT03665285|527703350|FG002|Overall Study|Started New Anticancer Treatment|2|||
146326026|NCT03665285|527703351|FG003|Overall Study|Started New Anticancer Treatment|4|||
146326027|NCT03665285|527703352|FG004|Overall Study|Started New Anticancer Treatment|1|||
146326028|NCT03665285|527703353|FG005|Overall Study|Started New Anticancer Treatment|1|||
146326029|NCT03665285|527703354|FG006|Overall Study|Started New Anticancer Treatment|2|||
146326030|NCT03665285|527703355|FG007|Overall Study|Started New Anticancer Treatment|15|||
146326031|NCT03665285|527703356|FG008|Overall Study|Started New Anticancer Treatment|1|||
146326032|NCT03665285|527703348|FG000|Overall Study|Disease Progression|0|||
146326033|NCT03665285|527703349|FG001|Overall Study|Disease Progression|0|||
146326034|NCT03665285|527703350|FG002|Overall Study|Disease Progression|3|||
146326035|NCT03665285|527703351|FG003|Overall Study|Disease Progression|1|||
146326036|NCT03665285|527703352|FG004|Overall Study|Disease Progression|0|||
146326037|NCT03665285|527703353|FG005|Overall Study|Disease Progression|0|||
146326038|NCT03665285|527703354|FG006|Overall Study|Disease Progression|0|||
146326039|NCT03665285|527703355|FG007|Overall Study|Disease Progression|7|||
146326040|NCT03665285|527703356|FG008|Overall Study|Disease Progression|1|||
146326041|NCT03665285|527703348|FG000|Overall Study|Hospice|0|||
146326042|NCT03665285|527703349|FG001|Overall Study|Hospice|0|||
146326043|NCT03665285|527703350|FG002|Overall Study|Hospice|0|||
146326044|NCT03665285|527703351|FG003|Overall Study|Hospice|0|||
146326045|NCT03665285|527703352|FG004|Overall Study|Hospice|0|||
146326046|NCT03665285|527703353|FG005|Overall Study|Hospice|0|||
146326047|NCT03665285|527703354|FG006|Overall Study|Hospice|0|||
146326048|NCT03665285|527703355|FG007|Overall Study|Hospice|2|||
146326049|NCT03665285|527703356|FG008|Overall Study|Hospice|0|||
146326050|NCT03665285|527703348|FG000|Overall Study|Withdrawal by Subject|0|||
146326051|NCT03665285|527703349|FG001|Overall Study|Withdrawal by Subject|0|||
146326052|NCT03665285|527703350|FG002|Overall Study|Withdrawal by Subject|0|||
146326053|NCT03665285|527703351|FG003|Overall Study|Withdrawal by Subject|0|||
146326054|NCT03665285|527703352|FG004|Overall Study|Withdrawal by Subject|1|||
146326055|NCT03665285|527703353|FG005|Overall Study|Withdrawal by Subject|0|||
146326056|NCT03665285|527703354|FG006|Overall Study|Withdrawal by Subject|0|||
146326057|NCT03665285|527703355|FG007|Overall Study|Withdrawal by Subject|2|||
146326058|NCT03665285|527703356|FG008|Overall Study|Withdrawal by Subject|0|||
146326059|NCT03665285|527703348|FG000|Overall Study|Physician Decision|0|||
146326060|NCT03665285|527703349|FG001|Overall Study|Physician Decision|0|||
146326061|NCT03665285|527703350|FG002|Overall Study|Physician Decision|0|||
146326062|NCT03665285|527703351|FG003|Overall Study|Physician Decision|0|||
146326063|NCT03665285|527703352|FG004|Overall Study|Physician Decision|0|||
146326064|NCT03665285|527703353|FG005|Overall Study|Physician Decision|0|||
146326065|NCT03665285|527703354|FG006|Overall Study|Physician Decision|0|||
146326066|NCT03665285|527703355|FG007|Overall Study|Physician Decision|2|||
146326067|NCT03665285|527703356|FG008|Overall Study|Physician Decision|0|||
146326068|NCT00888355|527703357|FG000|Overall Study|Adverse Event|10|||
146326069|NCT00888355|527703358|FG001|Overall Study|Adverse Event|0|||
146326070|NCT00888355|527703359|FG002|Overall Study|Adverse Event|3|||
146326071|NCT00888355|527703360|FG003|Overall Study|Adverse Event|3|||
146326072|NCT00888355|527703357|FG000|Overall Study|Lack of Efficacy|9|||
146326073|NCT00888355|527703358|FG001|Overall Study|Lack of Efficacy|2|||
146326074|NCT00888355|527703359|FG002|Overall Study|Lack of Efficacy|5|||
146326075|NCT00888355|527703360|FG003|Overall Study|Lack of Efficacy|2|||
146326076|NCT00888355|527703357|FG000|Overall Study|Lost to Follow-up|0|||
146326077|NCT00888355|527703358|FG001|Overall Study|Lost to Follow-up|2|||
146326078|NCT00888355|527703359|FG002|Overall Study|Lost to Follow-up|2|||
146326079|NCT00888355|527703360|FG003|Overall Study|Lost to Follow-up|0|||
146326080|NCT00888355|527703357|FG000|Overall Study|Protocol Violation|3|||
146326081|NCT00888355|527703358|FG001|Overall Study|Protocol Violation|2|||
146326082|NCT00888355|527703359|FG002|Overall Study|Protocol Violation|1|||
146326083|NCT00888355|527703360|FG003|Overall Study|Protocol Violation|2|||
146326084|NCT00888355|527703357|FG000|Overall Study|Withdrawal by Subject|0|||
146326085|NCT00888355|527703358|FG001|Overall Study|Withdrawal by Subject|3|||
146326086|NCT00888355|527703359|FG002|Overall Study|Withdrawal by Subject|1|||
146326087|NCT00888355|527703360|FG003|Overall Study|Withdrawal by Subject|3|||
146326088|NCT00331006|527703363|FG000|Screening Phase|Withdrawal by Subject|1|||
146326089|NCT00331006|527703363|FG000|Screening Phase|enrollment halted|1|||
146326090|NCT00331006|527703363|FG000|Screening Phase|Lost to Follow-up|1|||
146326091|NCT00331006|527703363|FG000|Screening Phase|Ineligible for treatment phase|4|||
146326092|NCT00331006|527703363|FG000|Treatment Phase|Withdrawal by Subject|1|||
146326093|NCT00331006|527703363|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
146326094|NCT00331006|527703363|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
146326095|NCT03213366|527703368|FG000|Overall Study|Lost to Follow-up|9|||
146326096|NCT03213366|527703369|FG001|Overall Study|Lost to Follow-up|4|||
146326097|NCT02532855|527703373|FG000|Overall Study|Lost to Follow-up|4|||
146326098|NCT02532855|527703374|FG001|Overall Study|Lost to Follow-up|3|||
146326099|NCT02532855|527703373|FG000|Overall Study|Withdrawal by Subject|4|||
146326100|NCT02532855|527703374|FG001|Overall Study|Withdrawal by Subject|8|||
146326101|NCT00666926|527703375|FG000|Overall Study|Adverse Event|0|||
146326102|NCT00666926|527703376|FG001|Overall Study|Adverse Event|0|||
146326103|NCT00666926|527703377|FG002|Overall Study|Adverse Event|0|||
146326104|NCT00666926|527703378|FG003|Overall Study|Adverse Event|0|||
146326105|NCT00666926|527703379|FG004|Overall Study|Adverse Event|0|||
146326106|NCT00666926|527703380|FG005|Overall Study|Adverse Event|0|||
146326107|NCT00666926|527703381|FG006|Overall Study|Adverse Event|0|||
146326108|NCT00666926|527703382|FG007|Overall Study|Adverse Event|0|||
146326109|NCT00666926|527703383|FG008|Overall Study|Adverse Event|0|||
146326110|NCT00666926|527703384|FG009|Overall Study|Adverse Event|2|||
146326111|NCT00666926|527703385|FG010|Overall Study|Adverse Event|2|||
146326112|NCT00666926|527703386|FG011|Overall Study|Adverse Event|2|||
146326113|NCT00666926|527703387|FG012|Overall Study|Adverse Event|0|||
146326114|NCT00666926|527703388|FG013|Overall Study|Adverse Event|1|||
146326115|NCT00666926|527703389|FG014|Overall Study|Adverse Event|0|||
146326116|NCT00666926|527703390|FG015|Overall Study|Adverse Event|0|||
146326117|NCT00666926|527703375|FG000|Overall Study|Laboratory abnormality|0|||
146326118|NCT00666926|527703376|FG001|Overall Study|Laboratory abnormality|0|||
146326119|NCT00666926|527703377|FG002|Overall Study|Laboratory abnormality|0|||
146326120|NCT00666926|527703378|FG003|Overall Study|Laboratory abnormality|0|||
146326121|NCT00666926|527703379|FG004|Overall Study|Laboratory abnormality|0|||
146326122|NCT00666926|527703380|FG005|Overall Study|Laboratory abnormality|0|||
146326123|NCT00666926|527703381|FG006|Overall Study|Laboratory abnormality|0|||
146326124|NCT00666926|527703382|FG007|Overall Study|Laboratory abnormality|0|||
146326125|NCT00666926|527703383|FG008|Overall Study|Laboratory abnormality|0|||
146326126|NCT00666926|527703384|FG009|Overall Study|Laboratory abnormality|0|||
146326127|NCT00666926|527703385|FG010|Overall Study|Laboratory abnormality|1|||
146326128|NCT00666926|527703386|FG011|Overall Study|Laboratory abnormality|0|||
146326129|NCT00666926|527703387|FG012|Overall Study|Laboratory abnormality|0|||
146326130|NCT00666926|527703388|FG013|Overall Study|Laboratory abnormality|0|||
146326131|NCT00666926|527703389|FG014|Overall Study|Laboratory abnormality|0|||
146326132|NCT00666926|527703390|FG015|Overall Study|Laboratory abnormality|1|||
146326133|NCT00666926|527703375|FG000|Overall Study|Lack of Efficacy|0|||
146326134|NCT00666926|527703376|FG001|Overall Study|Lack of Efficacy|0|||
146326135|NCT00666926|527703377|FG002|Overall Study|Lack of Efficacy|0|||
146326136|NCT00666926|527703378|FG003|Overall Study|Lack of Efficacy|0|||
146326137|NCT00666926|527703379|FG004|Overall Study|Lack of Efficacy|0|||
146326138|NCT00666926|527703380|FG005|Overall Study|Lack of Efficacy|1|||
146326139|NCT00666926|527703381|FG006|Overall Study|Lack of Efficacy|0|||
146326140|NCT00666926|527703382|FG007|Overall Study|Lack of Efficacy|0|||
146326141|NCT00666926|527703383|FG008|Overall Study|Lack of Efficacy|0|||
146326142|NCT00666926|527703384|FG009|Overall Study|Lack of Efficacy|0|||
146326143|NCT00666926|527703385|FG010|Overall Study|Lack of Efficacy|0|||
146326144|NCT00666926|527703386|FG011|Overall Study|Lack of Efficacy|1|||
146326145|NCT00666926|527703387|FG012|Overall Study|Lack of Efficacy|0|||
146326146|NCT00666926|527703388|FG013|Overall Study|Lack of Efficacy|0|||
146326147|NCT00666926|527703389|FG014|Overall Study|Lack of Efficacy|0|||
146326148|NCT00666926|527703390|FG015|Overall Study|Lack of Efficacy|0|||
146326149|NCT00666926|527703375|FG000|Overall Study|Lost to Follow-up|0|||
146326150|NCT00666926|527703376|FG001|Overall Study|Lost to Follow-up|0|||
146326151|NCT00666926|527703377|FG002|Overall Study|Lost to Follow-up|0|||
146326152|NCT00666926|527703378|FG003|Overall Study|Lost to Follow-up|1|||
146326153|NCT00666926|527703379|FG004|Overall Study|Lost to Follow-up|0|||
146326154|NCT00666926|527703380|FG005|Overall Study|Lost to Follow-up|0|||
146326155|NCT00666926|527703381|FG006|Overall Study|Lost to Follow-up|0|||
146326156|NCT00666926|527703382|FG007|Overall Study|Lost to Follow-up|0|||
146326157|NCT00666926|527703383|FG008|Overall Study|Lost to Follow-up|0|||
146326158|NCT00666926|527703384|FG009|Overall Study|Lost to Follow-up|0|||
146326159|NCT00666926|527703385|FG010|Overall Study|Lost to Follow-up|0|||
146326160|NCT00666926|527703386|FG011|Overall Study|Lost to Follow-up|0|||
146326161|NCT00666926|527703387|FG012|Overall Study|Lost to Follow-up|0|||
146326162|NCT00666926|527703388|FG013|Overall Study|Lost to Follow-up|0|||
146326163|NCT00666926|527703389|FG014|Overall Study|Lost to Follow-up|0|||
146326164|NCT00666926|527703390|FG015|Overall Study|Lost to Follow-up|0|||
146326165|NCT00666926|527703375|FG000|Overall Study|Other|2|||
146326166|NCT00666926|527703376|FG001|Overall Study|Other|4|||
146326167|NCT00666926|527703377|FG002|Overall Study|Other|3|||
146326168|NCT00666926|527703378|FG003|Overall Study|Other|3|||
146326169|NCT00666926|527703379|FG004|Overall Study|Other|3|||
146326170|NCT00666926|527703380|FG005|Overall Study|Other|3|||
146326171|NCT00666926|527703381|FG006|Overall Study|Other|4|||
146326172|NCT00666926|527703382|FG007|Overall Study|Other|0|||
146326173|NCT00666926|527703383|FG008|Overall Study|Other|3|||
146326174|NCT00666926|527703384|FG009|Overall Study|Other|5|||
146326175|NCT00666926|527703385|FG010|Overall Study|Other|3|||
146326176|NCT00666926|527703386|FG011|Overall Study|Other|26|||
146326177|NCT00666926|527703387|FG012|Overall Study|Other|3|||
146326178|NCT00666926|527703388|FG013|Overall Study|Other|2|||
146326179|NCT00666926|527703389|FG014|Overall Study|Other|4|||
146326180|NCT00666926|527703390|FG015|Overall Study|Other|4|||
146326181|NCT00666926|527703375|FG000|Overall Study|Withdrawal by Subject|0|||
146326182|NCT00666926|527703376|FG001|Overall Study|Withdrawal by Subject|0|||
146326183|NCT00666926|527703377|FG002|Overall Study|Withdrawal by Subject|0|||
146326184|NCT00666926|527703378|FG003|Overall Study|Withdrawal by Subject|0|||
146326185|NCT00666926|527703379|FG004|Overall Study|Withdrawal by Subject|0|||
146326186|NCT00666926|527703380|FG005|Overall Study|Withdrawal by Subject|0|||
146326187|NCT00666926|527703381|FG006|Overall Study|Withdrawal by Subject|0|||
146326188|NCT00666926|527703382|FG007|Overall Study|Withdrawal by Subject|1|||
146326189|NCT00666926|527703383|FG008|Overall Study|Withdrawal by Subject|0|||
146326190|NCT00666926|527703384|FG009|Overall Study|Withdrawal by Subject|3|||
146326191|NCT00666926|527703385|FG010|Overall Study|Withdrawal by Subject|0|||
146326192|NCT00666926|527703386|FG011|Overall Study|Withdrawal by Subject|3|||
146326193|NCT00666926|527703387|FG012|Overall Study|Withdrawal by Subject|0|||
146326194|NCT00666926|527703388|FG013|Overall Study|Withdrawal by Subject|1|||
146326195|NCT00666926|527703389|FG014|Overall Study|Withdrawal by Subject|3|||
146326196|NCT00666926|527703390|FG015|Overall Study|Withdrawal by Subject|3|||
146326197|NCT00666926|527703375|FG000|Overall Study|Death|0|||
146326198|NCT00666926|527703376|FG001|Overall Study|Death|0|||
146326199|NCT00666926|527703377|FG002|Overall Study|Death|0|||
146326200|NCT00666926|527703378|FG003|Overall Study|Death|0|||
146326201|NCT00666926|527703379|FG004|Overall Study|Death|0|||
146326202|NCT00666926|527703380|FG005|Overall Study|Death|0|||
146326203|NCT00666926|527703381|FG006|Overall Study|Death|0|||
146326204|NCT00666926|527703382|FG007|Overall Study|Death|0|||
146326205|NCT00666926|527703383|FG008|Overall Study|Death|0|||
146326206|NCT00666926|527703384|FG009|Overall Study|Death|0|||
146326207|NCT00666926|527703385|FG010|Overall Study|Death|0|||
146326208|NCT00666926|527703386|FG011|Overall Study|Death|1|||
146326209|NCT00666926|527703387|FG012|Overall Study|Death|0|||
146326210|NCT00666926|527703388|FG013|Overall Study|Death|0|||
146326211|NCT00666926|527703389|FG014|Overall Study|Death|0|||
146326212|NCT00666926|527703390|FG015|Overall Study|Death|0|||
146326213|NCT01960855|527703391|FG000|Overall Study|Subject noncompliant|1|||
146326214|NCT01960855|527703392|FG001|Overall Study|Subject noncompliant|0|||
146326215|NCT01960855|527703393|FG002|Overall Study|Subject noncompliant|0|||
146326216|NCT01960855|527703394|FG003|Overall Study|Subject noncompliant|0|||
146326217|NCT01960855|527703395|FG004|Overall Study|Subject noncompliant|0|||
146326218|NCT01960855|527703391|FG000|Overall Study|Adverse Event|2|||
146326219|NCT01960855|527703392|FG001|Overall Study|Adverse Event|0|||
146326220|NCT01960855|527703393|FG002|Overall Study|Adverse Event|6|||
146326221|NCT01960855|527703394|FG003|Overall Study|Adverse Event|2|||
146326222|NCT01960855|527703395|FG004|Overall Study|Adverse Event|2|||
146326223|NCT01960855|527703391|FG000|Overall Study|Lack of Efficacy|1|||
146326224|NCT01960855|527703392|FG001|Overall Study|Lack of Efficacy|1|||
146326225|NCT01960855|527703393|FG002|Overall Study|Lack of Efficacy|0|||
146326226|NCT01960855|527703394|FG003|Overall Study|Lack of Efficacy|0|||
146326227|NCT01960855|527703395|FG004|Overall Study|Lack of Efficacy|0|||
146326228|NCT01960855|527703391|FG000|Overall Study|Other|2|||
146326229|NCT01960855|527703392|FG001|Overall Study|Other|1|||
146326230|NCT01960855|527703393|FG002|Overall Study|Other|1|||
146326231|NCT01960855|527703394|FG003|Overall Study|Other|1|||
146326232|NCT01960855|527703395|FG004|Overall Study|Other|0|||
146326233|NCT01960855|527703391|FG000|Overall Study|Consent withdrawn by subject|3|||
146326234|NCT01960855|527703392|FG001|Overall Study|Consent withdrawn by subject|1|||
146326235|NCT01960855|527703393|FG002|Overall Study|Consent withdrawn by subject|2|||
146326236|NCT01960855|527703394|FG003|Overall Study|Consent withdrawn by subject|1|||
146326237|NCT01960855|527703395|FG004|Overall Study|Consent withdrawn by subject|1|||
146326238|NCT01960855|527703391|FG000|Overall Study|Lost to Follow-up|2|||
146326239|NCT01960855|527703392|FG001|Overall Study|Lost to Follow-up|1|||
146326240|NCT01960855|527703393|FG002|Overall Study|Lost to Follow-up|0|||
146326241|NCT01960855|527703394|FG003|Overall Study|Lost to Follow-up|0|||
146326242|NCT01960855|527703395|FG004|Overall Study|Lost to Follow-up|2|||
146326243|NCT02058147|527703396|FG000|Overall Study|Randomized but not treated|0|||
146326244|NCT02058147|527703397|FG001|Overall Study|Randomized but not treated|0|||
146326245|NCT02058147|527703398|FG002|Overall Study|Randomized but not treated|1|||
146326246|NCT02058147|527703396|FG000|Overall Study|Adverse Event|12|||
146326247|NCT02058147|527703397|FG001|Overall Study|Adverse Event|9|||
146326248|NCT02058147|527703398|FG002|Overall Study|Adverse Event|21|||
146326249|NCT02058147|527703396|FG000|Overall Study|Lack of Efficacy|1|||
146326250|NCT02058147|527703397|FG001|Overall Study|Lack of Efficacy|0|||
146326251|NCT02058147|527703398|FG002|Overall Study|Lack of Efficacy|3|||
146326252|NCT02058147|527703396|FG000|Overall Study|Poor compliance to protocol|8|||
146326253|NCT02058147|527703397|FG001|Overall Study|Poor compliance to protocol|9|||
146326254|NCT02058147|527703398|FG002|Overall Study|Poor compliance to protocol|4|||
146326255|NCT02058147|527703396|FG000|Overall Study|Other than specified|8|||
146326256|NCT02058147|527703397|FG001|Overall Study|Other than specified|9|||
146326257|NCT02058147|527703398|FG002|Overall Study|Other than specified|0|||
146326258|NCT01318122|527703401|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146326259|NCT01318122|527703402|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
146326260|NCT01318122|527703403|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
146326261|NCT01318122|527703404|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
146326262|NCT01318122|527703401|FG000|Enrolled - Long-Term Extension Study|Other|1|||
146326263|NCT01318122|527703402|FG001|Enrolled - Long-Term Extension Study|Other|0|||
146326264|NCT01318122|527703403|FG002|Enrolled - Long-Term Extension Study|Other|0|||
146326265|NCT01318122|527703404|FG003|Enrolled - Long-Term Extension Study|Other|0|||
146326266|NCT01318122|527703401|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
146326267|NCT01318122|527703402|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
146326268|NCT01318122|527703403|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
146326269|NCT01318122|527703404|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
146326270|NCT01318122|527703401|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
146326271|NCT01318122|527703402|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146326272|NCT01318122|527703403|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146326273|NCT01318122|527703404|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
146326274|NCT01318122|527703401|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
146326275|NCT01318122|527703402|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
146326276|NCT01318122|527703403|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
146326277|NCT01318122|527703404|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
146326278|NCT01318122|527703401|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146326279|NCT01318122|527703402|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
146326280|NCT01318122|527703403|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
146326281|NCT01318122|527703404|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
146326282|NCT01486199|527703405|FG000|Two Year Period Between Study Days|Physician Decision|1|||
146326283|NCT01486199|527703406|FG001|Two Year Period Between Study Days|Physician Decision|0|||
146326284|NCT04178772|527703413|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
146326285|NCT04178772|527703413|FG000|Overall Study|study terminated early due to COVID-19|7|||
146326286|NCT01737931|527703416|FG000|Overall Study|Withdrawal by Subject|0|||
146326287|NCT01737931|527703417|FG001|Overall Study|Withdrawal by Subject|1|||
146326288|NCT01737931|527703418|FG002|Overall Study|Withdrawal by Subject|1|||
146326289|NCT01737931|527703416|FG000|Overall Study|Physician Decision|0|||
146326290|NCT01737931|527703417|FG001|Overall Study|Physician Decision|1|||
146326291|NCT01737931|527703418|FG002|Overall Study|Physician Decision|0|||
146326292|NCT04897867|527703419|FG000|Overall Study|Withdrawal of Consent|1|||
146326293|NCT04897867|527703419|FG000|Overall Study|Pregnancy|1|||
146326294|NCT04897867|527703419|FG000|Overall Study|Lost to Follow-up|7|||
146326295|NCT04897867|527703419|FG000|Overall Study|Reason not Specified|2|||
146326296|NCT02817087|527703420|FG000|Overall Study|Withdrawal by Subject|2|||
146326297|NCT02817087|527703421|FG001|Overall Study|Withdrawal by Subject|0|||
146326298|NCT00508391|527703422|FG000|First Treatment|Withdrawal by Subject|6|||
146326299|NCT00508391|527703423|FG001|First Treatment|Withdrawal by Subject|3|||
146326300|NCT00508391|527703422|FG000|Second Treatment|Withdrawal by Subject|2|||
146326301|NCT00508391|527703423|FG001|Second Treatment|Withdrawal by Subject|0|||
146326302|NCT00802360|527703424|FG000|Overall Study|Stimulation failure|4|||
146326303|NCT00802360|527703425|FG001|Overall Study|Stimulation failure|0|||
146326304|NCT00802360|527703426|FG002|Overall Study|Stimulation failure|3|||
146326305|NCT00802360|527703427|FG003|Overall Study|Stimulation failure|3|||
146326306|NCT00802360|527703424|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
146326307|NCT00802360|527703425|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
146326308|NCT00802360|527703426|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
146326309|NCT00802360|527703427|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
146326310|NCT00802360|527703424|FG000|Overall Study|Cycle cancelled|0|||
146326311|NCT00802360|527703425|FG001|Overall Study|Cycle cancelled|1|||
146326312|NCT00802360|527703426|FG002|Overall Study|Cycle cancelled|1|||
146326313|NCT00802360|527703427|FG003|Overall Study|Cycle cancelled|1|||
146326314|NCT00802360|527703424|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146326315|NCT00802360|527703425|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146326316|NCT00802360|527703426|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
146326317|NCT00802360|527703427|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
146326318|NCT00802360|527703424|FG000|Overall Study|No positive serum pregnancy|17|||
146326319|NCT00802360|527703425|FG001|Overall Study|No positive serum pregnancy|20|||
146326320|NCT00802360|527703426|FG002|Overall Study|No positive serum pregnancy|14|||
146326321|NCT00802360|527703427|FG003|Overall Study|No positive serum pregnancy|10|||
146326322|NCT00802360|527703424|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146326323|NCT00802360|527703425|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146326324|NCT00802360|527703426|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
146326325|NCT00802360|527703427|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
146326326|NCT00802360|527703424|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
146326327|NCT00802360|527703425|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
146326328|NCT00802360|527703426|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
146326329|NCT00802360|527703427|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
146326330|NCT00802360|527703424|FG000|Overall Study|Other|2|||
146326331|NCT00802360|527703425|FG001|Overall Study|Other|3|||
146326332|NCT00802360|527703426|FG002|Overall Study|Other|6|||
146326333|NCT00802360|527703427|FG003|Overall Study|Other|3|||
146326334|NCT02601573|527703428|FG000|Overall Study|Lost to Follow-up|0|||
146326335|NCT02601573|527703429|FG001|Overall Study|Lost to Follow-up|3|||
146326336|NCT02601573|527703430|FG002|Overall Study|Lost to Follow-up|1|||
146326337|NCT02601573|527703431|FG003|Overall Study|Lost to Follow-up|0|||
146326338|NCT02601573|527703432|FG004|Overall Study|Lost to Follow-up|2|||
146326339|NCT02601573|527703428|FG000|Overall Study|Withdrawal by Subject|0|||
146166765|NCT02093663|527122456|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146326340|NCT02601573|527703429|FG001|Overall Study|Withdrawal by Subject|1|||
146326341|NCT02601573|527703430|FG002|Overall Study|Withdrawal by Subject|0|||
146326342|NCT02601573|527703431|FG003|Overall Study|Withdrawal by Subject|1|||
146326343|NCT02601573|527703432|FG004|Overall Study|Withdrawal by Subject|0|||
146326344|NCT03310970|527703433|FG000|Overall Study|Withdrawal by Subject|0|||
146326345|NCT03310970|527703434|FG001|Overall Study|Withdrawal by Subject|1|||
146326346|NCT01133171|527703435|FG000|Overall Study|Withdrawal by Subject|1|||
146326347|NCT01133171|527703436|FG001|Overall Study|Withdrawal by Subject|2|||
146326348|NCT01133171|527703437|FG002|Overall Study|Withdrawal by Subject|0|||
146326349|NCT00670007|527705226|FG000|Overall Study|Drug abuse|1|||
146326350|NCT00670007|527705226|FG000|Overall Study|Lung transplant|1|||
146326351|NCT00670007|527705226|FG000|Overall Study|Travel/Vacation|1|||
146326352|NCT00670007|527705226|FG000|Overall Study|Adverse event, serious fatal|1|||
146326353|NCT00670007|527705226|FG000|Overall Study|Adverse Event|1|||
146326354|NCT00670007|527705226|FG000|Overall Study|Withdrawal by Subject|4|||
146326355|NCT00127127|527705227|FG000|Overall Study|Adverse Event|0|||
146326356|NCT00127127|527705228|FG001|Overall Study|Adverse Event|2|||
146326357|NCT00127127|527705229|FG002|Overall Study|Adverse Event|0|||
146326358|NCT00127127|527705230|FG003|Overall Study|Adverse Event|1|||
146326359|NCT00127127|527705227|FG000|Overall Study|Lack of Efficacy|1|||
146326360|NCT00127127|527705228|FG001|Overall Study|Lack of Efficacy|3|||
146326361|NCT00127127|527705229|FG002|Overall Study|Lack of Efficacy|0|||
146326362|NCT00127127|527705230|FG003|Overall Study|Lack of Efficacy|2|||
146326363|NCT01059448|527705232|FG000|Overall Study|Adverse Event|1|||
146326364|NCT01059448|527705233|FG001|Overall Study|Adverse Event|3|||
146326365|NCT01059448|527705234|FG002|Overall Study|Adverse Event|0|||
146326366|NCT01059448|527705235|FG003|Overall Study|Adverse Event|1|||
146326367|NCT01059448|527705232|FG000|Overall Study|Withdrawal by Subject|2|||
146326368|NCT01059448|527705233|FG001|Overall Study|Withdrawal by Subject|0|||
146326369|NCT01059448|527705234|FG002|Overall Study|Withdrawal by Subject|2|||
146326370|NCT01059448|527705235|FG003|Overall Study|Withdrawal by Subject|4|||
146326371|NCT01059448|527705232|FG000|Overall Study|Disease Progression|2|||
146326372|NCT01059448|527705233|FG001|Overall Study|Disease Progression|1|||
146326373|NCT01059448|527705234|FG002|Overall Study|Disease Progression|4|||
146326374|NCT01059448|527705235|FG003|Overall Study|Disease Progression|2|||
146326375|NCT01059448|527705232|FG000|Overall Study|Administrative Decision|43|||
146326376|NCT01059448|527705233|FG001|Overall Study|Administrative Decision|49|||
146326377|NCT01059448|527705234|FG002|Overall Study|Administrative Decision|45|||
146326378|NCT01059448|527705235|FG003|Overall Study|Administrative Decision|46|||
146326379|NCT01059448|527705232|FG000|Overall Study|Lost to Follow-up|0|||
146326380|NCT01059448|527705233|FG001|Overall Study|Lost to Follow-up|0|||
146326381|NCT01059448|527705234|FG002|Overall Study|Lost to Follow-up|2|||
146326382|NCT01059448|527705235|FG003|Overall Study|Lost to Follow-up|0|||
146326383|NCT01059448|527705232|FG000|Overall Study|Death|0|||
146326384|NCT01059448|527705233|FG001|Overall Study|Death|1|||
146326385|NCT01059448|527705234|FG002|Overall Study|Death|0|||
146326386|NCT01059448|527705235|FG003|Overall Study|Death|0|||
146326387|NCT01059448|527705232|FG000|Overall Study|Other|1|||
146326388|NCT01059448|527705233|FG001|Overall Study|Other|1|||
146326389|NCT01059448|527705234|FG002|Overall Study|Other|0|||
146326390|NCT01059448|527705235|FG003|Overall Study|Other|1|||
146326391|NCT00778830|527705236|FG000|Overall Study|Ongoing at data cut-off|0|||
146326392|NCT00778830|527705237|FG001|Overall Study|Ongoing at data cut-off|1|||
146326393|NCT01891643|527705238|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146326394|NCT01891643|527705239|FG001|Overall Study|Adverse event unrelated to study drug|5|||
146326395|NCT01891643|527705238|FG000|Overall Study|Disease Progression|4|||
146326396|NCT01891643|527705239|FG001|Overall Study|Disease Progression|3|||
146326397|NCT01891643|527705238|FG000|Overall Study|Study Drug Toxicity|3|||
146326398|NCT01891643|527705239|FG001|Overall Study|Study Drug Toxicity|0|||
146326399|NCT01891643|527705238|FG000|Overall Study|Maximum Clinical Benefit|0|||
146326400|NCT01891643|527705239|FG001|Overall Study|Maximum Clinical Benefit|1|||
146326401|NCT01891643|527705238|FG000|Overall Study|Poor/Non-compliance|0|||
146326402|NCT01891643|527705239|FG001|Overall Study|Poor/Non-compliance|1|||
146326403|NCT01891643|527705238|FG000|Overall Study|Participant request to discontinue|1|||
146326404|NCT01891643|527705239|FG001|Overall Study|Participant request to discontinue|0|||
146326405|NCT02591615|527705242|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146326406|NCT02591615|527705243|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146326407|NCT02591615|527705244|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
146326408|NCT02591615|527705245|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
146326409|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146326410|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
146326411|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146326412|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
146326413|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
146326414|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
146326415|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
146326416|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
146326417|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
146326418|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
146326419|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
146326420|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
146326421|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
146326422|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
146326423|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
146326424|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
146326425|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146326426|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
146326427|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146326428|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
146326429|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
146326430|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
146326431|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
146326432|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
146326433|NCT02591615|527705242|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
146326434|NCT02591615|527705243|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146326435|NCT02591615|527705244|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146326436|NCT02591615|527705245|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
146326437|NCT02591615|527705242|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
146326438|NCT02591615|527705243|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
146326439|NCT02591615|527705244|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
146326440|NCT02591615|527705245|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
146326441|NCT02591615|527705242|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
146326442|NCT02591615|527705243|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
146326443|NCT02591615|527705244|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
146326444|NCT02591615|527705245|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
146326445|NCT02591615|527705242|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
146326446|NCT02591615|527705243|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
146326447|NCT02591615|527705244|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
146326448|NCT02591615|527705245|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
146326449|NCT02591615|527705242|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146326450|NCT02591615|527705243|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146326451|NCT02591615|527705244|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
146326452|NCT02591615|527705245|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
146326453|NCT02591615|527705242|FG000|Maintenance MK-3475|Adverse Event|0|||
146326454|NCT02591615|527705243|FG001|Maintenance MK-3475|Adverse Event|3|||
146326455|NCT02591615|527705244|FG002|Maintenance MK-3475|Adverse Event|1|||
146326456|NCT02591615|527705245|FG003|Maintenance MK-3475|Adverse Event|2|||
146326457|NCT02591615|527705242|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
146326458|NCT02591615|527705243|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
146326459|NCT02591615|527705244|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
146326460|NCT02591615|527705245|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
146326461|NCT02591615|527705242|FG000|Maintenance MK-3475|Death|0|||
146326462|NCT02591615|527705243|FG001|Maintenance MK-3475|Death|1|||
146326463|NCT02591615|527705244|FG002|Maintenance MK-3475|Death|1|||
146326464|NCT02591615|527705245|FG003|Maintenance MK-3475|Death|0|||
146326465|NCT02591615|527705242|FG000|Maintenance MK-3475|Physician discretion|0|||
146326466|NCT02591615|527705243|FG001|Maintenance MK-3475|Physician discretion|0|||
145943237|NCT00483704|526300457|FG001|Treatment|Pregnancy|1|||
146326467|NCT02591615|527705244|FG002|Maintenance MK-3475|Physician discretion|1|||
146326468|NCT02591615|527705245|FG003|Maintenance MK-3475|Physician discretion|0|||
146326469|NCT02591615|527705242|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
146326470|NCT02591615|527705243|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
146326471|NCT02591615|527705244|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
146326472|NCT02591615|527705245|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
146326473|NCT02591615|527705242|FG000|Maintenance MK-3475|In active treatment|2|||
146326474|NCT02591615|527705243|FG001|Maintenance MK-3475|In active treatment|0|||
146326475|NCT02591615|527705244|FG002|Maintenance MK-3475|In active treatment|0|||
146326476|NCT02591615|527705245|FG003|Maintenance MK-3475|In active treatment|1|||
146326477|NCT04188197|527705246|FG000|Overall Study|Lost to Follow-up|4|||
146326478|NCT04188197|527705247|FG001|Overall Study|Lost to Follow-up|1|||
146326479|NCT04188197|527705246|FG000|Overall Study|Withdrawal by Subject|1|||
146326480|NCT04188197|527705247|FG001|Overall Study|Withdrawal by Subject|1|||
146326481|NCT04188197|527705246|FG000|Overall Study|Pregnancy|0|||
146326482|NCT04188197|527705247|FG001|Overall Study|Pregnancy|1|||
146326483|NCT00956943|527705257|FG000|Overall Study|Lost to Follow-up|9|||
146326484|NCT00956943|527705258|FG001|Overall Study|Lost to Follow-up|10|||
146326485|NCT02613208|527705259|FG000|Overall Study|Withdrawal by Subject|1|||
146326486|NCT02613208|527705259|FG000|Overall Study|Change of address|2|||
146326487|NCT02613208|527705259|FG000|Overall Study|Physician Decision|2|||
146166766|NCT02093663|527122457|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
146166767|NCT02093663|527122458|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
146166768|NCT00508404|527122459|FG000|Overall Study|Ongoing at Data Cut-off|12|||
146166769|NCT00508404|527122459|FG000|Overall Study|Adverse Event|2|||
146166770|NCT00508404|527122459|FG000|Overall Study|Death|16|||
146166771|NCT00508404|527122459|FG000|Overall Study|Physician Decision|2|||
146166772|NCT00508404|527122459|FG000|Overall Study|Withdrawal by Subject|3|||
146166773|NCT00508404|527122459|FG000|Overall Study|Protocol-specified Criteria|2|||
146166774|NCT00508404|527122459|FG000|Overall Study|Lost to Follow-up|2|||
146166775|NCT00508404|527122459|FG000|Overall Study|Other - Not Specified|3|||
146166776|NCT01424930|527122461|FG000|Overall Study|Adverse Event|0|||
146166777|NCT01424930|527122462|FG001|Overall Study|Adverse Event|1|||
146166778|NCT01424930|527122461|FG000|Overall Study|Death|1|||
146166779|NCT01424930|527122462|FG001|Overall Study|Death|0|||
146166780|NCT01424930|527122461|FG000|Overall Study|Progressive Disease|3|||
146166781|NCT01424930|527122462|FG001|Overall Study|Progressive Disease|6|||
146166782|NCT01424930|527122461|FG000|Overall Study|Screen Failure|0|||
146166783|NCT01424930|527122462|FG001|Overall Study|Screen Failure|1|||
146166784|NCT01424930|527122461|FG000|Overall Study|Reason not specified|0|||
146166785|NCT01424930|527122462|FG001|Overall Study|Reason not specified|6|||
146166786|NCT01197508|527122467|FG000|Overall Study|Withdrawal by Subject|8|||
146166787|NCT01197508|527122468|FG001|Overall Study|Withdrawal by Subject|7|||
146166788|NCT01197508|527122469|FG002|Overall Study|Withdrawal by Subject|15|||
146166789|NCT01197508|527122470|FG003|Overall Study|Withdrawal by Subject|4|||
146166790|NCT01197508|527122467|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
146166791|NCT01197508|527122468|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
146166792|NCT01197508|527122469|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
146166793|NCT01197508|527122470|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
146166794|NCT01197508|527122467|FG000|Overall Study|Adverse Event|10|||
146166795|NCT01197508|527122468|FG001|Overall Study|Adverse Event|13|||
146166796|NCT01197508|527122469|FG002|Overall Study|Adverse Event|23|||
146166797|NCT01197508|527122470|FG003|Overall Study|Adverse Event|3|||
146166798|NCT01197508|527122467|FG000|Overall Study|Severe non-compliance to protocol|0|||
146166799|NCT01197508|527122468|FG001|Overall Study|Severe non-compliance to protocol|3|||
146166800|NCT01197508|527122469|FG002|Overall Study|Severe non-compliance to protocol|1|||
146166801|NCT01197508|527122470|FG003|Overall Study|Severe non-compliance to protocol|3|||
146166802|NCT01197508|527122467|FG000|Overall Study|Condition under investigation worsened|1|||
146166803|NCT01197508|527122468|FG001|Overall Study|Condition under investigation worsened|1|||
146326488|NCT02613208|527705259|FG000|Overall Study|Lost to Follow-up|5|||
146326489|NCT02613208|527705259|FG000|Overall Study|Death|37|||
146326490|NCT02663895|527705260|FG000|Overall Study|Adverse Event|3|||
146326491|NCT02663895|527705260|FG000|Overall Study|Physician Decision|2|||
146326492|NCT02663895|527705260|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
146326493|NCT02663895|527705260|FG000|Overall Study|Withdrawal by Subject|1|||
146326494|NCT00809328|527705266|FG000|Overall Study|Lack of Efficacy|18|||
146326495|NCT00809328|527705266|FG000|Overall Study|Adverse Event|6|||
146326496|NCT00809328|527705266|FG000|Overall Study|Protocol Violation|3|||
146326497|NCT00809328|527705266|FG000|Overall Study|Withdrawal by Subject|2|||
146326498|NCT02911688|527705267|FG000|Washout|Lost to Follow-up|1|||
146326499|NCT02911688|527705268|FG001|Washout|Lost to Follow-up|1|||
146326500|NCT02911688|527705267|FG000|Washout|Withdrawal by Subject|0|||
146326501|NCT02911688|527705268|FG001|Washout|Withdrawal by Subject|1|||
146326502|NCT01400932|527705269|FG000|Overall Study|Adverse Event|10|||
146326503|NCT01400932|527705270|FG001|Overall Study|Adverse Event|5|||
146326504|NCT01400932|527705269|FG000|Overall Study|Lack of Efficacy|0|||
146326505|NCT01400932|527705270|FG001|Overall Study|Lack of Efficacy|3|||
146326506|NCT01400932|527705269|FG000|Overall Study|Withdrawal by Subject|2|||
146166804|NCT01197508|527122469|FG002|Overall Study|Condition under investigation worsened|1|||
146166805|NCT01197508|527122470|FG003|Overall Study|Condition under investigation worsened|1|||
146166806|NCT01197508|527122467|FG000|Overall Study|Lack of Efficacy|1|||
146166807|NCT01197508|527122468|FG001|Overall Study|Lack of Efficacy|2|||
146166808|NCT01197508|527122469|FG002|Overall Study|Lack of Efficacy|2|||
146166809|NCT01197508|527122470|FG003|Overall Study|Lack of Efficacy|1|||
146166810|NCT01197508|527122467|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146166811|NCT01197508|527122468|FG001|Overall Study|Study-specific withdrawal criteria|0|||
146166812|NCT01197508|527122469|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146326507|NCT01400932|527705270|FG001|Overall Study|Withdrawal by Subject|6|||
146326508|NCT01400932|527705269|FG000|Overall Study|Lost to Follow-up|1|||
146326509|NCT01400932|527705270|FG001|Overall Study|Lost to Follow-up|0|||
146326510|NCT01400932|527705269|FG000|Overall Study|Protocol Deviation|0|||
146326511|NCT01400932|527705270|FG001|Overall Study|Protocol Deviation|1|||
146326512|NCT01400932|527705269|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146326513|NCT01400932|527705270|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
146326514|NCT04656990|527705271|FG000|Baseline|pandemic|20|||
146326515|NCT04656990|527705272|FG001|Baseline|pandemic|24|||
146326516|NCT04656990|527705271|FG000|Follow Up Period|Lost to Follow-up|61|||
146166813|NCT01197508|527122470|FG003|Overall Study|Study-specific withdrawal criteria|2|||
146166814|NCT01197508|527122467|FG000|Overall Study|Lost to Follow-up|1|||
146166815|NCT01197508|527122468|FG001|Overall Study|Lost to Follow-up|1|||
146166816|NCT01197508|527122469|FG002|Overall Study|Lost to Follow-up|2|||
146166817|NCT01197508|527122470|FG003|Overall Study|Lost to Follow-up|0|||
146166818|NCT01197508|527122467|FG000|Overall Study|Other|2|||
146166819|NCT01197508|527122468|FG001|Overall Study|Other|3|||
146166820|NCT01197508|527122469|FG002|Overall Study|Other|2|||
146166821|NCT01197508|527122470|FG003|Overall Study|Other|2|||
146166822|NCT03286751|527122471|FG000|Washout Period 1|Withdrawal by Subject|0|||
146166823|NCT03286751|527122472|FG001|Washout Period 1|Withdrawal by Subject|0|||
146166824|NCT03286751|527122473|FG002|Washout Period 1|Withdrawal by Subject|0|||
146166825|NCT03286751|527122474|FG003|Washout Period 1|Withdrawal by Subject|0|||
146166826|NCT03286751|527122475|FG004|Washout Period 1|Withdrawal by Subject|1|||
146166827|NCT03286751|527122476|FG005|Washout Period 1|Withdrawal by Subject|0|||
146166828|NCT03286751|527122471|FG000|Washout Period 2|Personal Reasons|0|||
146166829|NCT03286751|527122472|FG001|Washout Period 2|Personal Reasons|1|||
146166830|NCT03286751|527122473|FG002|Washout Period 2|Personal Reasons|0|||
146166831|NCT03286751|527122474|FG003|Washout Period 2|Personal Reasons|0|||
146166832|NCT03286751|527122475|FG004|Washout Period 2|Personal Reasons|0|||
146166833|NCT03286751|527122476|FG005|Washout Period 2|Personal Reasons|0|||
146166834|NCT03286751|527122471|FG000|Washout Period 5|Adverse Event|0|||
146166835|NCT03286751|527122472|FG001|Washout Period 5|Adverse Event|0|||
146166836|NCT03286751|527122473|FG002|Washout Period 5|Adverse Event|0|||
146166837|NCT03286751|527122474|FG003|Washout Period 5|Adverse Event|0|||
146166838|NCT03286751|527122475|FG004|Washout Period 5|Adverse Event|1|||
146166839|NCT03286751|527122476|FG005|Washout Period 5|Adverse Event|0|||
146166840|NCT01078155|527122477|FG000|Overall Study|Adverse Event|7|||
146166841|NCT01078155|527122477|FG000|Overall Study|Lack of Efficacy|16|||
146166842|NCT01078155|527122477|FG000|Overall Study|Participant's Decision|6|||
146166843|NCT01078155|527122477|FG000|Overall Study|Lost to Follow-up|15|||
146166844|NCT01119768|527122478|FG000|Treatment Period|Lack of Efficacy|18|||
146166845|NCT01119768|527122479|FG001|Treatment Period|Lack of Efficacy|25|||
146166846|NCT01059643|527122480|FG000|Overall Study|Adverse Event|3|||
146166847|NCT01059643|527122480|FG000|Overall Study|Withdrawal by Subject|2|||
146166848|NCT01059643|527122480|FG000|Overall Study|Physician Decision|1|||
146166849|NCT01621880|527122481|FG000|Overall Study|Adverse Event|5|||
146166850|NCT01621880|527122482|FG001|Overall Study|Adverse Event|1|||
146166851|NCT01621880|527122481|FG000|Overall Study|Withdrawal by Subject|5|||
146166852|NCT01621880|527122482|FG001|Overall Study|Withdrawal by Subject|4|||
146166853|NCT01662063|527122483|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
146166854|NCT01662063|527122484|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
146166855|NCT01662063|527122485|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
146166856|NCT01662063|527122483|FG000|Overall Study|Lack of Efficacy|1|||
146166857|NCT01662063|527122484|FG001|Overall Study|Lack of Efficacy|6|||
146166858|NCT01662063|527122485|FG002|Overall Study|Lack of Efficacy|0|||
146166859|NCT01662063|527122483|FG000|Overall Study|Lost to Follow-up|0|||
146166860|NCT01662063|527122484|FG001|Overall Study|Lost to Follow-up|4|||
146166861|NCT01662063|527122485|FG002|Overall Study|Lost to Follow-up|0|||
146166862|NCT01662063|527122483|FG000|Overall Study|Protocol Violation|1|||
146166863|NCT01662063|527122484|FG001|Overall Study|Protocol Violation|0|||
146166864|NCT01662063|527122485|FG002|Overall Study|Protocol Violation|0|||
146166865|NCT01662063|527122483|FG000|Overall Study|Withdrawal by Subject|2|||
146166866|NCT01662063|527122484|FG001|Overall Study|Withdrawal by Subject|4|||
146166867|NCT01662063|527122485|FG002|Overall Study|Withdrawal by Subject|1|||
146166868|NCT01662063|527122483|FG000|Overall Study|Physician Decision|0|||
146166869|NCT01662063|527122484|FG001|Overall Study|Physician Decision|2|||
146166870|NCT01662063|527122485|FG002|Overall Study|Physician Decision|0|||
146326517|NCT04656990|527705272|FG001|Follow Up Period|Lost to Follow-up|73|||
146166871|NCT01662063|527122483|FG000|Overall Study|Other|0|||
146326518|NCT03244059|527705273|FG000|Specific Aim 1|Physician Decision|1|||
146326519|NCT03244059|527705274|FG001|Specific Aim 1|Physician Decision|0|||
146326520|NCT03244059|527705273|FG000|Specific Aim 2|Physician Decision|1|||
146326521|NCT03244059|527705274|FG001|Specific Aim 2|Physician Decision|0|||
146326522|NCT00282243|527705276|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
146326523|NCT00282243|527705276|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
146326524|NCT00282243|527705276|FG000|Extension Treatment Period|Adverse Event|15|||
146326525|NCT00282243|527705276|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
146166872|NCT01662063|527122484|FG001|Overall Study|Other|1|||
146166873|NCT01662063|527122485|FG002|Overall Study|Other|0|||
146166874|NCT01477853|527122492|FG000|Phase A|Adverse Event|1|||
146166875|NCT01477853|527122493|FG001|Phase A|Adverse Event|2|||
146166876|NCT01477853|527122494|FG002|Phase A|Adverse Event|2|||
146166877|NCT01477853|527122492|FG000|Phase A|Lost to Follow-up|4|||
146166878|NCT01477853|527122493|FG001|Phase A|Lost to Follow-up|3|||
146166879|NCT01477853|527122494|FG002|Phase A|Lost to Follow-up|2|||
146166880|NCT01477853|527122492|FG000|Phase A|Physician Decision|1|||
146166881|NCT01477853|527122493|FG001|Phase A|Physician Decision|0|||
146166882|NCT01477853|527122494|FG002|Phase A|Physician Decision|1|||
146166883|NCT01477853|527122492|FG000|Phase A|Study terminated by sponsor|37|||
146166884|NCT01477853|527122493|FG001|Phase A|Study terminated by sponsor|40|||
146166885|NCT01477853|527122494|FG002|Phase A|Study terminated by sponsor|39|||
146166886|NCT01477853|527122492|FG000|Phase B|Lost to Follow-up|0|||
146166887|NCT01477853|527122493|FG001|Phase B|Lost to Follow-up|1|||
146166888|NCT01477853|527122494|FG002|Phase B|Lost to Follow-up|0|||
146166889|NCT01477853|527122492|FG000|Phase B|Study terminated by sponsor|12|||
146166890|NCT01477853|527122493|FG001|Phase B|Study terminated by sponsor|10|||
146166891|NCT01477853|527122494|FG002|Phase B|Study terminated by sponsor|11|||
146166892|NCT00677352|527122497|FG000|Treatment Phase|Adverse Event|14|||
146166893|NCT00677352|527122498|FG001|Treatment Phase|Adverse Event|22|||
146166894|NCT00677352|527122497|FG000|Treatment Phase|Lack of Efficacy|2|||
146166895|NCT00677352|527122498|FG001|Treatment Phase|Lack of Efficacy|3|||
146326526|NCT00282243|527705276|FG000|Extension Treatment Period|Non-compliance|2|||
146326527|NCT00282243|527705276|FG000|Extension Treatment Period|Physician Decision|1|||
146326528|NCT00851903|527705277|FG000|Overall Study|Withdrawal by Subject|2|||
146326529|NCT00270894|527705278|FG000|Overall Study|Adverse Event|1|||
146326530|NCT00270894|527705278|FG000|Overall Study|Withdrawal by Subject|1|||
146326531|NCT01070329|527705279|FG000|Overall Study|Adverse Event|13|||
146326532|NCT01070329|527705280|FG001|Overall Study|Adverse Event|10|||
146326533|NCT01070329|527705279|FG000|Overall Study|Lost to Follow-up|22|||
146326534|NCT01070329|527705280|FG001|Overall Study|Lost to Follow-up|12|||
146326535|NCT01070329|527705279|FG000|Overall Study|Withdrawal by Subject|9|||
146326536|NCT01070329|527705280|FG001|Overall Study|Withdrawal by Subject|11|||
146326537|NCT01070329|527705279|FG000|Overall Study|Protocol Violation|3|||
146326538|NCT01070329|527705280|FG001|Overall Study|Protocol Violation|8|||
146326539|NCT01070329|527705279|FG000|Overall Study|Lack of Efficacy|2|||
146326540|NCT01070329|527705280|FG001|Overall Study|Lack of Efficacy|6|||
146326541|NCT01070329|527705279|FG000|Overall Study|Physician Decision|2|||
146326542|NCT01070329|527705280|FG001|Overall Study|Physician Decision|1|||
146326543|NCT01070329|527705279|FG000|Overall Study|Entry Criteria Not Met|1|||
146326544|NCT01070329|527705280|FG001|Overall Study|Entry Criteria Not Met|0|||
146326545|NCT01070329|527705279|FG000|Overall Study|Sponsor Decision|0|||
146326546|NCT01070329|527705280|FG001|Overall Study|Sponsor Decision|1|||
146326547|NCT02863848|527705281|FG000|Overall Study|Lost to Follow-up|1|||
146326548|NCT02863848|527705282|FG001|Overall Study|Lost to Follow-up|1|||
146326549|NCT02863848|527705281|FG000|Overall Study|Protocol Violation|1|||
146326550|NCT02863848|527705282|FG001|Overall Study|Protocol Violation|2|||
146326551|NCT00686127|527705285|FG000|Overall Study|Withdrawal by Subject|14|||
146326552|NCT00686127|527705286|FG001|Overall Study|Withdrawal by Subject|6|||
146326553|NCT06441877|527705287|FG000|Overall Study|Withdrawal by Subject|0|||
146326554|NCT06441877|527705288|FG001|Overall Study|Withdrawal by Subject|2|||
146326555|NCT06441877|527705289|FG002|Overall Study|Withdrawal by Subject|0|||
146326556|NCT06441877|527705290|FG003|Overall Study|Withdrawal by Subject|0|||
146326557|NCT03706365|527705297|FG000|Overall Study|Lost to Follow-up|7|||
146326558|NCT03706365|527705298|FG001|Overall Study|Lost to Follow-up|0|||
146326559|NCT03706365|527705297|FG000|Overall Study|Withdrawal by Subject|17|||
146326560|NCT03706365|527705298|FG001|Overall Study|Withdrawal by Subject|15|||
146326561|NCT03706365|527705297|FG000|Overall Study|On Study Treatment|51|||
146326562|NCT03706365|527705298|FG001|Overall Study|On Study Treatment|51|||
146326563|NCT03116113|527705299|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326564|NCT03116113|527705300|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326565|NCT03116113|527705301|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326566|NCT03116113|527705302|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326567|NCT03116113|527705303|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326568|NCT03116113|527705304|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326569|NCT03116113|527705305|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
146326570|NCT03116113|527705306|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
146326571|NCT03116113|527705307|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
146326572|NCT02159807|527705308|FG000|Overall Study|Adverse Event|0|||
146166896|NCT00677352|527122497|FG000|Treatment Phase|Lost to Follow-up|0|||
146326573|NCT02159807|527705309|FG001|Overall Study|Adverse Event|0|||
146326574|NCT02159807|527705310|FG002|Overall Study|Adverse Event|1|||
146166897|NCT00677352|527122498|FG001|Treatment Phase|Lost to Follow-up|1|||
146326575|NCT02159807|527705308|FG000|Overall Study|No CSF|1|||
146326576|NCT02159807|527705309|FG001|Overall Study|No CSF|1|||
146326577|NCT02159807|527705310|FG002|Overall Study|No CSF|1|||
146326578|NCT02159807|527705308|FG000|Overall Study|elevated blood pressure|0|||
146326579|NCT02159807|527705309|FG001|Overall Study|elevated blood pressure|0|||
146326580|NCT02159807|527705310|FG002|Overall Study|elevated blood pressure|1|||
146326581|NCT02367521|527705311|FG000|Overall Study|severe headache after intervention|2|||
146166898|NCT00677352|527122497|FG000|Treatment Phase|Withdrawal by Subject|7|||
146166899|NCT00677352|527122498|FG001|Treatment Phase|Withdrawal by Subject|7|||
146166900|NCT00677352|527122497|FG000|Treatment Phase|Physician Decision|1|||
146166901|NCT00677352|527122498|FG001|Treatment Phase|Physician Decision|0|||
146326582|NCT02367521|527705312|FG001|Overall Study|severe headache after intervention|0|||
146326583|NCT02367521|527705311|FG000|Overall Study|unable to find transportation|2|||
146326584|NCT02367521|527705312|FG001|Overall Study|unable to find transportation|0|||
146326585|NCT00600171|527705313|FG000|Overall Study|Adverse Event|0|||
146326586|NCT00600171|527705314|FG001|Overall Study|Adverse Event|1|||
146326587|NCT00600171|527705315|FG002|Overall Study|Adverse Event|0|||
146326588|NCT00600171|527705316|FG003|Overall Study|Adverse Event|0|||
146326589|NCT00600171|527705317|FG004|Overall Study|Adverse Event|1|||
146326590|NCT00600171|527705318|FG005|Overall Study|Adverse Event|0|||
146326591|NCT00600171|527705313|FG000|Overall Study|Lack of Efficacy|9|||
146326592|NCT00600171|527705314|FG001|Overall Study|Lack of Efficacy|12|||
146326593|NCT00600171|527705315|FG002|Overall Study|Lack of Efficacy|3|||
146326594|NCT00600171|527705316|FG003|Overall Study|Lack of Efficacy|5|||
146326595|NCT00600171|527705317|FG004|Overall Study|Lack of Efficacy|4|||
146326596|NCT00600171|527705318|FG005|Overall Study|Lack of Efficacy|0|||
146326597|NCT00600171|527705313|FG000|Overall Study|Protocol Violation|1|||
146326598|NCT00600171|527705314|FG001|Overall Study|Protocol Violation|2|||
146326599|NCT00600171|527705315|FG002|Overall Study|Protocol Violation|0|||
146326600|NCT00600171|527705316|FG003|Overall Study|Protocol Violation|1|||
146326601|NCT00600171|527705317|FG004|Overall Study|Protocol Violation|0|||
146326602|NCT00600171|527705318|FG005|Overall Study|Protocol Violation|0|||
146326603|NCT00600171|527705313|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146326604|NCT00600171|527705314|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146326605|NCT00600171|527705315|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
146326606|NCT00600171|527705316|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
146326607|NCT00600171|527705317|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146326608|NCT00600171|527705318|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
146326609|NCT00600171|527705313|FG000|Overall Study|Withdrawal by Subject|3|||
146326610|NCT00600171|527705314|FG001|Overall Study|Withdrawal by Subject|0|||
146326611|NCT00600171|527705315|FG002|Overall Study|Withdrawal by Subject|0|||
146326612|NCT00600171|527705316|FG003|Overall Study|Withdrawal by Subject|1|||
146326613|NCT00600171|527705317|FG004|Overall Study|Withdrawal by Subject|1|||
146326614|NCT00600171|527705318|FG005|Overall Study|Withdrawal by Subject|1|||
146326615|NCT00600171|527705313|FG000|Overall Study|Physician Decision|0|||
146326616|NCT00600171|527705314|FG001|Overall Study|Physician Decision|1|||
146326617|NCT00600171|527705315|FG002|Overall Study|Physician Decision|0|||
146326618|NCT00600171|527705316|FG003|Overall Study|Physician Decision|1|||
146326619|NCT00600171|527705317|FG004|Overall Study|Physician Decision|0|||
146326620|NCT00600171|527705318|FG005|Overall Study|Physician Decision|2|||
146326621|NCT00600171|527705313|FG000|Overall Study|Lost to Follow-up|0|||
146326622|NCT00600171|527705314|FG001|Overall Study|Lost to Follow-up|0|||
146326623|NCT00600171|527705315|FG002|Overall Study|Lost to Follow-up|0|||
146326624|NCT00600171|527705316|FG003|Overall Study|Lost to Follow-up|1|||
146326625|NCT00600171|527705317|FG004|Overall Study|Lost to Follow-up|0|||
146326626|NCT00600171|527705318|FG005|Overall Study|Lost to Follow-up|0|||
146326627|NCT00469612|527705322|FG000|Overall Study|Study terminated before data collected|2|||
146326628|NCT00469612|527705323|FG001|Overall Study|Study terminated before data collected|0|||
146326629|NCT00542191|527705324|FG000|Overall Study|Death|3|||
146326630|NCT00440726|527705327|FG000|Phase 1|Dose-Limiting Toxicity|0|||
146326631|NCT00440726|527705328|FG001|Phase 1|Dose-Limiting Toxicity|1|||
146326632|NCT00440726|527705329|FG002|Phase 1|Dose-Limiting Toxicity|0|||
146326633|NCT00440726|527705327|FG000|Phase 1|Physician Decision|1|||
146326634|NCT00440726|527705328|FG001|Phase 1|Physician Decision|0|||
146326635|NCT00440726|527705329|FG002|Phase 1|Physician Decision|0|||
146326636|NCT00440726|527705327|FG000|Phase 2|Death|0|||
146326637|NCT00440726|527705328|FG001|Phase 2|Death|0|||
146326638|NCT00440726|527705329|FG002|Phase 2|Death|1|||
146326639|NCT00440726|527705327|FG000|Phase 2|Adverse Event|0|||
146326640|NCT00440726|527705328|FG001|Phase 2|Adverse Event|0|||
146326641|NCT00440726|527705329|FG002|Phase 2|Adverse Event|1|||
146326642|NCT03683394|527705330|FG000|Overall Study|Withdrawal by Subject|4|||
146326643|NCT03683394|527705331|FG001|Overall Study|Withdrawal by Subject|8|||
146326644|NCT03683394|527705330|FG000|Overall Study|Lost to Follow-up|7|||
146326645|NCT03683394|527705331|FG001|Overall Study|Lost to Follow-up|0|||
146326646|NCT03683394|527705330|FG000|Overall Study|Death|3|||
146326647|NCT03683394|527705331|FG001|Overall Study|Death|1|||
146326648|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Adverse Event|11|||
146326649|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Adverse Event|15|||
146326650|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
146326651|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
146326652|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
146326653|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
146326654|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
146326655|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
146326656|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
146326657|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
146326658|NCT01058096|527705332|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
146326659|NCT01058096|527705333|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
146326660|NCT01596257|527705336|FG000|Overall Study|Inadequate Collection|23|||
146326661|NCT01596257|527705337|FG001|Overall Study|Inadequate Collection|19|||
146326662|NCT00531960|527705344|FG000|Overall Study|Adverse Event|5|||
146326663|NCT00531960|527705345|FG001|Overall Study|Adverse Event|4|||
146326664|NCT00531960|527705344|FG000|Overall Study|Death|3|||
146326665|NCT00531960|527705345|FG001|Overall Study|Death|2|||
146326666|NCT00531960|527705344|FG000|Overall Study|Lack of Efficacy|42|||
146326667|NCT00531960|527705345|FG001|Overall Study|Lack of Efficacy|41|||
146326668|NCT00531960|527705344|FG000|Overall Study|Violation of Selection Criteria|2|||
146326669|NCT00531960|527705345|FG001|Overall Study|Violation of Selection Criteria|0|||
146326670|NCT00531960|527705344|FG000|Overall Study|Refused Treatment|5|||
146326671|NCT00531960|527705345|FG001|Overall Study|Refused Treatment|6|||
146326672|NCT00531960|527705344|FG000|Overall Study|Other|4|||
146326673|NCT00531960|527705345|FG001|Overall Study|Other|10|||
146326674|NCT03157531|527705349|FG000|Overall Study|Death|2|||
146326675|NCT03157531|527705349|FG000|Overall Study|Lost to Follow-up|4|||
146326676|NCT01879410|527705352|FG000|Overall Study|Adverse Event|9|||
146326677|NCT01879410|527705353|FG001|Overall Study|Adverse Event|14|||
146326678|NCT01879410|527705352|FG000|Overall Study|Lack of Efficacy|4|||
146326679|NCT01879410|527705353|FG001|Overall Study|Lack of Efficacy|6|||
146326680|NCT01879410|527705352|FG000|Overall Study|Protocol Violation|1|||
146326681|NCT01879410|527705353|FG001|Overall Study|Protocol Violation|7|||
146326682|NCT01879410|527705352|FG000|Overall Study|Lost to Follow-up|2|||
146326683|NCT01879410|527705353|FG001|Overall Study|Lost to Follow-up|1|||
146326684|NCT01879410|527705352|FG000|Overall Study|Withdrawal by Subject|7|||
146326685|NCT01879410|527705353|FG001|Overall Study|Withdrawal by Subject|8|||
146326686|NCT01879410|527705352|FG000|Overall Study|Randomised in Error|1|||
146326687|NCT01879410|527705353|FG001|Overall Study|Randomised in Error|2|||
146326688|NCT00713219|527705362|FG000|Overall Study|Death|1|||
146326689|NCT00713219|527705362|FG000|Overall Study|Protocol Violation|1|||
146326690|NCT03183128|527705366|FG000|Overall Study|Adverse Event|1|||
146326691|NCT03183128|527705367|FG001|Overall Study|Adverse Event|2|||
146326692|NCT03183128|527705366|FG000|Overall Study|Withdrawal by Subject|1|||
146326693|NCT03183128|527705367|FG001|Overall Study|Withdrawal by Subject|8|||
146326694|NCT03183128|527705366|FG000|Overall Study|Protocol Violation|2|||
146326695|NCT03183128|527705367|FG001|Overall Study|Protocol Violation|0|||
146326696|NCT03183128|527705366|FG000|Overall Study|Lack of Efficacy|4|||
146326697|NCT03183128|527705367|FG001|Overall Study|Lack of Efficacy|27|||
146326698|NCT03183128|527705366|FG000|Overall Study|Lost to Follow-up|1|||
146326699|NCT03183128|527705367|FG001|Overall Study|Lost to Follow-up|0|||
146326700|NCT03183128|527705366|FG000|Overall Study|Death|2|||
146326701|NCT03183128|527705367|FG001|Overall Study|Death|0|||
146326702|NCT03183128|527705366|FG000|Overall Study|Physician Decision|1|||
146326703|NCT03183128|527705367|FG001|Overall Study|Physician Decision|0|||
146326704|NCT01686568|527705370|FG000|Main Study|Withdrawal by Subject|1|||
146326705|NCT01686568|527705371|FG001|Main Study|Withdrawal by Subject|3|||
146326706|NCT01686568|527705370|FG000|Main Study|Noncompliance with protocol|0|||
146326707|NCT01686568|527705371|FG001|Main Study|Noncompliance with protocol|1|||
146326708|NCT01686568|527705370|FG000|Main Study|Liver enzymes above range of exclusion|1|||
146326709|NCT01686568|527705371|FG001|Main Study|Liver enzymes above range of exclusion|0|||
146326710|NCT01686568|527705370|FG000|Sub-Study|Not consented for sub-study|2|||
146326711|NCT01686568|527705371|FG001|Sub-Study|Not consented for sub-study|2|||
146326712|NCT03258814|527705372|FG000|Overall Study|Early Termination|4|||
146326713|NCT03258814|527705373|FG001|Overall Study|Early Termination|3|||
146326714|NCT03258814|527705374|FG002|Overall Study|Early Termination|10|||
146326715|NCT01573910|527705375|FG000|Overall Study|Adverse Event|4|||
146326716|NCT01573910|527705376|FG001|Overall Study|Adverse Event|4|||
146326717|NCT01573910|527705375|FG000|Overall Study|Lost to Follow-up|2|||
146326718|NCT01573910|527705376|FG001|Overall Study|Lost to Follow-up|1|||
146326719|NCT01573910|527705375|FG000|Overall Study|Withdrawal by Subject|0|||
146326720|NCT01573910|527705376|FG001|Overall Study|Withdrawal by Subject|1|||
146282293|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282294|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282295|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
146282296|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
146282297|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146282298|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146282299|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
146326721|NCT01573910|527705375|FG000|Overall Study|Protocol Violation|3|||
146326722|NCT01573910|527705376|FG001|Overall Study|Protocol Violation|0|||
146326723|NCT01573910|527705375|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
146326724|NCT01573910|527705376|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
146326725|NCT00364182|527705377|FG000|First Intervention|Secondary prophylaxis|1|||
146326726|NCT00364182|527705378|FG001|First Intervention|Secondary prophylaxis|0|||
146326727|NCT00364182|527705379|FG002|First Intervention|Secondary prophylaxis|0|||
146326728|NCT00364182|527705377|FG000|First Intervention|Withdrawal by Subject|2|||
146282300|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
146282301|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
146282302|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
146282303|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
146326729|NCT00364182|527705378|FG001|First Intervention|Withdrawal by Subject|0|||
146326730|NCT00364182|527705379|FG002|First Intervention|Withdrawal by Subject|0|||
146326731|NCT00364182|527705377|FG000|Second Intervention|non-compliance|0|||
146326732|NCT00364182|527705378|FG001|Second Intervention|non-compliance|1|||
146326733|NCT00364182|527705379|FG002|Second Intervention|non-compliance|1|||
146326734|NCT00364182|527705377|FG000|Second Intervention|Protocol Violation|0|||
146326735|NCT00364182|527705378|FG001|Second Intervention|Protocol Violation|1|||
146326736|NCT00364182|527705379|FG002|Second Intervention|Protocol Violation|0|||
146326737|NCT00364182|527705377|FG000|Second Intervention|Adverse Event|0|||
146326738|NCT00364182|527705378|FG001|Second Intervention|Adverse Event|0|||
146326739|NCT00364182|527705379|FG002|Second Intervention|Adverse Event|1|||
146326740|NCT00364182|527705377|FG000|Third Intervention|non-compliance|0|||
146326741|NCT00364182|527705378|FG001|Third Intervention|non-compliance|1|||
146326742|NCT00364182|527705379|FG002|Third Intervention|non-compliance|0|||
146326743|NCT00364182|527705377|FG000|Third Intervention|Lost to Follow-up|0|||
146326744|NCT00364182|527705378|FG001|Third Intervention|Lost to Follow-up|0|||
146326745|NCT00364182|527705379|FG002|Third Intervention|Lost to Follow-up|1|||
146326746|NCT04062214|527705381|FG000|Week 12|Death|1|||
146326747|NCT04062214|527705382|FG001|Week 12|Death|1|||
146326748|NCT04062214|527705381|FG000|Week 12|Withdrawal by Subject|14|||
146326749|NCT04062214|527705382|FG001|Week 12|Withdrawal by Subject|13|||
146326750|NCT04062214|527705381|FG000|Week 12|Lost to Follow-up|55|||
146326751|NCT04062214|527705382|FG001|Week 12|Lost to Follow-up|68|||
146326752|NCT04062214|527705381|FG000|Week 12|Intermittent missing|31|||
146326753|NCT04062214|527705382|FG001|Week 12|Intermittent missing|29|||
146326754|NCT04062214|527705381|FG000|Week 36|Withdrawal by Subject|4|||
146326755|NCT04062214|527705382|FG001|Week 36|Withdrawal by Subject|5|||
146326756|NCT04062214|527705381|FG000|Week 36|Lost to Follow-up|50|||
146326757|NCT04062214|527705382|FG001|Week 36|Lost to Follow-up|46|||
146326758|NCT04062214|527705381|FG000|Week 36|Death|0|||
146326759|NCT04062214|527705382|FG001|Week 36|Death|1|||
146326760|NCT01356589|527705386|FG000|Overall Study|Enrolled, but not treated|3|||
146326761|NCT01356589|527705386|FG000|Overall Study|Dose data not recorded|2|||
146282304|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
146282305|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
146282306|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
146282307|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
146282308|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
146282309|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
146282310|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
146282311|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
146282312|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
146282313|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
146282314|NCT02663518|527546447|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282315|NCT02663518|527546448|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282316|NCT02663518|527546449|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282317|NCT02663518|527546450|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282318|NCT02663518|527546451|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282319|NCT02663518|527546452|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282320|NCT02663518|527546453|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282321|NCT02663518|527546454|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282322|NCT02663518|527546455|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282323|NCT02663518|527546456|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282324|NCT02663518|527546457|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282325|NCT02663518|527546458|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282326|NCT02663518|527546459|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
146282327|NCT02663518|527546460|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
146282328|NCT01144052|527546463|FG000|Overall Study|Withdrawal by Subject|1|||
146282329|NCT01144052|527546464|FG001|Overall Study|Withdrawal by Subject|1|||
146282330|NCT03836716|527546468|FG000|Overall Study|Adverse Event|3|||
146282331|NCT03836716|527546468|FG000|Overall Study|Death|22|||
146282332|NCT03836716|527546468|FG000|Overall Study|Withdrawal by Subject|8|||
146282333|NCT03836716|527546468|FG000|Overall Study|Study terminated by sponsor|87|||
146282334|NCT01879722|527546469|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146282335|NCT01879722|527546470|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146282336|NCT01879722|527546471|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146282337|NCT01879722|527546472|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146282338|NCT01879722|527546473|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
146282339|NCT01879722|527546474|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
146326762|NCT04343651|527705387|FG000|Overall Study|Physician Decision|2|||
146326763|NCT04343651|527705388|FG001|Overall Study|Physician Decision|1|||
146326764|NCT04343651|527705387|FG000|Overall Study|Lost to Follow-up|2|||
146326765|NCT04343651|527705388|FG001|Overall Study|Lost to Follow-up|1|||
146326766|NCT04343651|527705387|FG000|Overall Study|Protocol Violation|4|||
146326767|NCT04343651|527705388|FG001|Overall Study|Protocol Violation|6|||
146326768|NCT04343651|527705387|FG000|Overall Study|Missing|3|||
146326769|NCT04343651|527705388|FG001|Overall Study|Missing|9|||
146326770|NCT04343651|527705387|FG000|Overall Study|Withdrawal by Subject|0|||
146326771|NCT04343651|527705388|FG001|Overall Study|Withdrawal by Subject|4|||
146326772|NCT04343651|527705387|FG000|Overall Study|Death|0|||
146326773|NCT04343651|527705388|FG001|Overall Study|Death|1|||
146326774|NCT04343651|527705387|FG000|Overall Study|Did not start treatment|1|||
146326775|NCT04343651|527705388|FG001|Overall Study|Did not start treatment|1|||
146326776|NCT04343651|527705387|FG000|Overall Study|Patient did not complete visits 3-6|0|||
146326777|NCT04343651|527705388|FG001|Overall Study|Patient did not complete visits 3-6|1|||
146326778|NCT00821678|527705394|FG000|Overall Study|Withdrawal by Subject|8|||
146326779|NCT00821678|527705395|FG001|Overall Study|Withdrawal by Subject|0|||
146326780|NCT00821678|527705394|FG000|Overall Study|Lost to Follow-up|13|||
146326781|NCT00821678|527705395|FG001|Overall Study|Lost to Follow-up|12|||
146326782|NCT00821678|527705394|FG000|Overall Study|Death|0|||
146326783|NCT00821678|527705395|FG001|Overall Study|Death|2|||
146326784|NCT04025632|527707026|FG000|Overall Study|Adverse Event|1|||
146326785|NCT04025632|527707027|FG001|Overall Study|Adverse Event|1|||
146326786|NCT04025632|527707026|FG000|Overall Study|Withdrawal by Subject|1|||
146326787|NCT04025632|527707027|FG001|Overall Study|Withdrawal by Subject|1|||
146326788|NCT04025632|527707026|FG000|Overall Study|Study Terminated by Sponsor|10|||
146326789|NCT04025632|527707027|FG001|Overall Study|Study Terminated by Sponsor|9|||
146326790|NCT04025632|527707026|FG000|Overall Study|Physician Decision|3|||
146326791|NCT04025632|527707027|FG001|Overall Study|Physician Decision|1|||
146326792|NCT00376961|527707028|FG000|Initial Registration|Adverse Event|1|||
146326793|NCT00376961|527707029|FG001|Initial Registration|Adverse Event|0|||
146326794|NCT00376961|527707028|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
146326795|NCT00376961|527707029|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
146326796|NCT00376961|527707028|FG000|Initial Registration|Progression/relapse|1|||
146326797|NCT00376961|527707029|FG001|Initial Registration|Progression/relapse|0|||
146326798|NCT00376961|527707028|FG000|Initial Registration|Ineligible|3|||
146326799|NCT00376961|527707029|FG001|Initial Registration|Ineligible|0|||
146326800|NCT00376961|527707028|FG000|Maintenance|Adverse Event|0|||
146326801|NCT00376961|527707029|FG001|Maintenance|Adverse Event|1|||
146326802|NCT00376961|527707028|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
146326803|NCT00376961|527707029|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
146326804|NCT00376961|527707028|FG000|Maintenance|Progression/relapse|0|||
146326805|NCT00376961|527707029|FG001|Maintenance|Progression/relapse|18|||
146326806|NCT00376961|527707028|FG000|Maintenance|Ineligible|0|||
146326807|NCT00376961|527707029|FG001|Maintenance|Ineligible|3|||
146326808|NCT00925600|527707030|FG000|Overall Study|Withdrawal by Subject|16|||
146326809|NCT00925600|527707031|FG001|Overall Study|Withdrawal by Subject|14|||
146326810|NCT00925600|527707030|FG000|Overall Study|Death|4|||
146326811|NCT00925600|527707031|FG001|Overall Study|Death|3|||
146326812|NCT00925600|527707030|FG000|Overall Study|Lost to Follow-up|2|||
146326813|NCT00925600|527707031|FG001|Overall Study|Lost to Follow-up|2|||
146326814|NCT00925600|527707030|FG000|Overall Study|Disease Progression|1|||
146326815|NCT00925600|527707031|FG001|Overall Study|Disease Progression|3|||
146326816|NCT00925600|527707030|FG000|Overall Study|Administrative Decision|1|||
146326817|NCT00925600|527707031|FG001|Overall Study|Administrative Decision|1|||
146326818|NCT00925600|527707030|FG000|Overall Study|Noncompliance|2|||
146326819|NCT00925600|527707031|FG001|Overall Study|Noncompliance|0|||
146326820|NCT00925600|527707030|FG000|Overall Study|Ineligibility Determined|2|||
146326821|NCT00925600|527707031|FG001|Overall Study|Ineligibility Determined|0|||
146326822|NCT00925600|527707030|FG000|Overall Study|Protocol Deviation|0|||
146326823|NCT00925600|527707031|FG001|Overall Study|Protocol Deviation|1|||
146326824|NCT00925600|527707030|FG000|Overall Study|Requirement for Alternative Therapy|0|||
146326825|NCT00925600|527707031|FG001|Overall Study|Requirement for Alternative Therapy|1|||
146326826|NCT00925600|527707030|FG000|Overall Study|Other|3|||
146326827|NCT00925600|527707031|FG001|Overall Study|Other|1|||
146326828|NCT00925600|527707030|FG000|Overall Study|Adverse Event|1|||
146326829|NCT00925600|527707031|FG001|Overall Study|Adverse Event|2|||
146326830|NCT00947531|527707038|FG000|Overall Study|Withdrawal by Subject|10|||
146326831|NCT00947531|527707039|FG001|Overall Study|Withdrawal by Subject|7|||
146326832|NCT00947531|527707038|FG000|Overall Study|Administrative Reason|0|||
146326833|NCT00947531|527707039|FG001|Overall Study|Administrative Reason|1|||
146326834|NCT00947531|527707038|FG000|Overall Study|Adverse Event|2|||
146326835|NCT00947531|527707039|FG001|Overall Study|Adverse Event|2|||
146326836|NCT00947531|527707038|FG000|Overall Study|Lack of Efficacy|1|||
146326837|NCT00947531|527707039|FG001|Overall Study|Lack of Efficacy|0|||
146326838|NCT00947531|527707038|FG000|Overall Study|Other|1|||
146326839|NCT00947531|527707039|FG001|Overall Study|Other|1|||
146326840|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326841|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146326842|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326843|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326844|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326845|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
146326846|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146326847|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146326848|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
146326849|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
146326850|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146326851|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146326852|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326853|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146326854|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146326855|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146326856|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146326857|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146326858|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
146326859|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
146326860|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326861|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326862|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326863|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146326864|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326865|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146326866|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
146326867|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146326868|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146326869|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146326870|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
146326871|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
146326872|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
146326873|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
146326874|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
146326875|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146326876|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
146326877|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
146326878|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
146326879|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146326880|NCT00289913|527707042|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
146326881|NCT00289913|527707043|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326882|NCT00289913|527707044|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
146326883|NCT00289913|527707045|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326884|NCT00289913|527707046|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326885|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326886|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326887|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146326888|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326889|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326890|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
146326891|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
146326892|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
146326893|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
146326894|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
146326895|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146326896|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
146326897|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146326898|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146326899|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
146326900|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
146166902|NCT00677352|527122497|FG000|Treatment Phase|Pregnancy|0|||
146166903|NCT00677352|527122498|FG001|Treatment Phase|Pregnancy|1|||
146326901|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
146326902|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
146326903|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326904|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326905|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146326906|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326907|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146326908|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326909|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326910|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146326911|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146326912|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
146326913|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
146326914|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
146326915|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
146326916|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
146326917|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
146326918|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
146326919|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
146326920|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146326921|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
146326922|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
146326923|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146326924|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
146326925|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
146166904|NCT00677352|527122497|FG000|Treatment Phase|Protocol Violation|1|||
146326926|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146326927|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146326928|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146326929|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
146326930|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146326931|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146326932|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146326933|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
146326934|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
146326935|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146326936|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146326937|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146326938|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
146326939|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
146326940|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146326941|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146326942|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146166905|NCT00677352|527122498|FG001|Treatment Phase|Protocol Violation|1|||
146166906|NCT00677352|527122497|FG000|Treatment Phase|Transference or work related matter|0|||
146166907|NCT00677352|527122498|FG001|Treatment Phase|Transference or work related matter|5|||
146166908|NCT00677352|527122497|FG000|Treatment Phase|Not treated|0|||
146166909|NCT00677352|527122498|FG001|Treatment Phase|Not treated|2|||
146166910|NCT00677352|527122497|FG000|Tapering Phase|Adverse Event|1|||
146166911|NCT00677352|527122498|FG001|Tapering Phase|Adverse Event|5|||
146166912|NCT00677352|527122497|FG000|Tapering Phase|Withdrawal by Subject|5|||
146166913|NCT00677352|527122498|FG001|Tapering Phase|Withdrawal by Subject|3|||
146166914|NCT00677352|527122497|FG000|Tapering Phase|Pregnancy|0|||
146166915|NCT00677352|527122498|FG001|Tapering Phase|Pregnancy|1|||
146166916|NCT00677352|527122497|FG000|Tapering Phase|Job transfer|0|||
146166917|NCT00677352|527122498|FG001|Tapering Phase|Job transfer|1|||
146166918|NCT04044456|527122504|FG000|Overall Study|Lost to Follow-up|4|||
146166919|NCT04044456|527122505|FG001|Overall Study|Lost to Follow-up|1|||
146166920|NCT04044456|527122504|FG000|Overall Study|Withdrawal by Subject|1|||
146166921|NCT04044456|527122505|FG001|Overall Study|Withdrawal by Subject|0|||
146166922|NCT01972529|527122506|FG000|Overall Study|Adverse Event|0|||
146166923|NCT01972529|527122507|FG001|Overall Study|Adverse Event|1|||
146326943|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
146326944|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
146326945|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146326946|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146326947|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146326948|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
146326949|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
146326950|NCT00289913|527707042|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146326951|NCT00289913|527707043|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146326952|NCT00289913|527707044|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146326953|NCT00289913|527707045|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
146326954|NCT00289913|527707046|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
146326955|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326956|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
146326957|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326958|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326959|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
146326960|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
146326961|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
146326962|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
146326963|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
146326964|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
146326965|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326966|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326967|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326968|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
146326969|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
146326970|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326971|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326972|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326973|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
146326974|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
146326975|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
146326976|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
146326977|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
146326978|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
146326979|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
146326980|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146326981|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
146326982|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
146326983|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146326984|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
146326985|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146326986|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146326987|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146326988|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
146326989|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
146326990|NCT00289913|527707042|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326991|NCT00289913|527707043|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
146326992|NCT00289913|527707044|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326993|NCT00289913|527707045|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326994|NCT00289913|527707046|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
146326995|NCT01808612|527707047|FG000|Treatment Period|Adverse Event|8|||
146326996|NCT01808612|527707048|FG001|Treatment Period|Adverse Event|4|||
146326997|NCT01808612|527707049|FG002|Treatment Period|Adverse Event|3|||
146326998|NCT01808612|527707047|FG000|Treatment Period|Lost to Follow-up|2|||
146326999|NCT01808612|527707048|FG001|Treatment Period|Lost to Follow-up|2|||
146166924|NCT01972529|527122508|FG002|Overall Study|Adverse Event|0|||
146166925|NCT01972529|527122509|FG003|Overall Study|Adverse Event|0|||
146166926|NCT01972529|527122506|FG000|Overall Study|Lost to Follow-up|1|||
146166927|NCT01972529|527122507|FG001|Overall Study|Lost to Follow-up|0|||
146166928|NCT01972529|527122508|FG002|Overall Study|Lost to Follow-up|0|||
146166929|NCT01972529|527122509|FG003|Overall Study|Lost to Follow-up|0|||
146166930|NCT01972529|527122506|FG000|Overall Study|Participant Choice|0|||
146166931|NCT01972529|527122507|FG001|Overall Study|Participant Choice|1|||
146327000|NCT01808612|527707049|FG002|Treatment Period|Lost to Follow-up|1|||
146327001|NCT01808612|527707047|FG000|Treatment Period|Protocol Violation|1|||
146327002|NCT01808612|527707048|FG001|Treatment Period|Protocol Violation|0|||
146327003|NCT01808612|527707049|FG002|Treatment Period|Protocol Violation|0|||
146327004|NCT01808612|527707047|FG000|Treatment Period|Withdrawal by Subject|1|||
146166932|NCT01972529|527122508|FG002|Overall Study|Participant Choice|0|||
146327005|NCT01808612|527707048|FG001|Treatment Period|Withdrawal by Subject|0|||
146327006|NCT01808612|527707049|FG002|Treatment Period|Withdrawal by Subject|4|||
146327007|NCT01808612|527707047|FG000|Treatment Period|Physician Decision|1|||
146327008|NCT01808612|527707048|FG001|Treatment Period|Physician Decision|0|||
146327009|NCT01808612|527707049|FG002|Treatment Period|Physician Decision|4|||
146327010|NCT01808612|527707047|FG000|Treatment Period|Sponsor Decision|1|||
146327011|NCT01808612|527707048|FG001|Treatment Period|Sponsor Decision|0|||
146327012|NCT01808612|527707049|FG002|Treatment Period|Sponsor Decision|0|||
146327013|NCT01808612|527707047|FG000|Treatment Period|Lack of Efficacy|1|||
146327014|NCT01808612|527707048|FG001|Treatment Period|Lack of Efficacy|1|||
146327015|NCT01808612|527707049|FG002|Treatment Period|Lack of Efficacy|2|||
146327016|NCT01808612|527707047|FG000|Discontinuation Period|Adverse Event|1|||
146327017|NCT01808612|527707048|FG001|Discontinuation Period|Adverse Event|0|||
146327018|NCT01808612|527707049|FG002|Discontinuation Period|Adverse Event|0|||
146327019|NCT01808612|527707047|FG000|Discontinuation Period|Physician Decision|1|||
146327020|NCT01808612|527707048|FG001|Discontinuation Period|Physician Decision|0|||
146327021|NCT01808612|527707049|FG002|Discontinuation Period|Physician Decision|0|||
146327022|NCT01808612|527707047|FG000|Discontinuation Period|Lost to Follow-up|0|||
146327023|NCT01808612|527707048|FG001|Discontinuation Period|Lost to Follow-up|1|||
146327024|NCT01808612|527707049|FG002|Discontinuation Period|Lost to Follow-up|0|||
146327025|NCT00559273|527707050|FG000|Correction Period (20 Weeks)|Death|3|||
146327026|NCT00559273|527707051|FG001|Correction Period (20 Weeks)|Death|4|||
146327027|NCT00559273|527707050|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
146327028|NCT00559273|527707051|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
146327029|NCT00559273|527707050|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
146327030|NCT00559273|527707051|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
146327031|NCT00559273|527707050|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
146327032|NCT00559273|527707051|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
146327033|NCT00559273|527707050|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
146327034|NCT00559273|527707051|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
146327035|NCT00559273|527707050|FG000|Evaluation Period (8 Weeks)|Death|1|||
146327036|NCT00559273|527707051|FG001|Evaluation Period (8 Weeks)|Death|3|||
146327037|NCT00559273|527707050|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
146327038|NCT00559273|527707051|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
146327039|NCT00559273|527707050|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
146327040|NCT00559273|527707051|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
146327041|NCT00559273|527707050|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
146327042|NCT00559273|527707051|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
146327043|NCT01299727|527707056|FG000|Overall Study|Withdrawal by Subject|1|||
146327044|NCT01299727|527707057|FG001|Overall Study|Withdrawal by Subject|0|||
146327045|NCT01299727|527707058|FG002|Overall Study|Withdrawal by Subject|0|||
146327046|NCT01299727|527707056|FG000|Overall Study|Adverse Event|0|||
146327047|NCT01299727|527707057|FG001|Overall Study|Adverse Event|0|||
146327048|NCT01299727|527707058|FG002|Overall Study|Adverse Event|1|||
146327049|NCT01299727|527707056|FG000|Overall Study|Completed the Treatment Period|3|||
146327050|NCT01299727|527707057|FG001|Overall Study|Completed the Treatment Period|4|||
146327051|NCT01299727|527707058|FG002|Overall Study|Completed the Treatment Period|3|||
146327052|NCT00944034|527707061|FG000|Overall Study|Inappropriate enrollment|0|||
146327053|NCT00944034|527707062|FG001|Overall Study|Inappropriate enrollment|1|||
146327054|NCT00944034|527707063|FG002|Overall Study|Inappropriate enrollment|0|||
146327055|NCT00944034|527707064|FG003|Overall Study|Inappropriate enrollment|1|||
146327056|NCT00944034|527707065|FG004|Overall Study|Inappropriate enrollment|2|||
146327057|NCT00944034|527707066|FG005|Overall Study|Inappropriate enrollment|1|||
146327058|NCT00944034|527707067|FG006|Overall Study|Inappropriate enrollment|0|||
146327059|NCT00944034|527707068|FG007|Overall Study|Inappropriate enrollment|0|||
146327060|NCT00944034|527707069|FG008|Overall Study|Inappropriate enrollment|1|||
146327061|NCT00944034|527707070|FG009|Overall Study|Inappropriate enrollment|1|||
146327062|NCT00944034|527707071|FG010|Overall Study|Inappropriate enrollment|0|||
146327063|NCT00944034|527707072|FG011|Overall Study|Inappropriate enrollment|0|||
146327064|NCT00944034|527707061|FG000|Overall Study|Withdrawal by Subject|3|||
146327065|NCT00944034|527707062|FG001|Overall Study|Withdrawal by Subject|2|||
146327066|NCT00944034|527707063|FG002|Overall Study|Withdrawal by Subject|6|||
146327067|NCT00944034|527707064|FG003|Overall Study|Withdrawal by Subject|2|||
146327068|NCT00944034|527707065|FG004|Overall Study|Withdrawal by Subject|5|||
146327069|NCT00944034|527707066|FG005|Overall Study|Withdrawal by Subject|8|||
146327070|NCT00944034|527707067|FG006|Overall Study|Withdrawal by Subject|2|||
146327071|NCT00944034|527707068|FG007|Overall Study|Withdrawal by Subject|2|||
146327072|NCT00944034|527707069|FG008|Overall Study|Withdrawal by Subject|3|||
146327073|NCT00944034|527707070|FG009|Overall Study|Withdrawal by Subject|4|||
146327074|NCT00944034|527707071|FG010|Overall Study|Withdrawal by Subject|0|||
146327075|NCT00944034|527707072|FG011|Overall Study|Withdrawal by Subject|4|||
146327076|NCT00944034|527707061|FG000|Overall Study|Lost to Follow-up|0|||
146327077|NCT00944034|527707062|FG001|Overall Study|Lost to Follow-up|4|||
146327078|NCT00944034|527707063|FG002|Overall Study|Lost to Follow-up|2|||
146327079|NCT00944034|527707064|FG003|Overall Study|Lost to Follow-up|0|||
146327080|NCT00944034|527707065|FG004|Overall Study|Lost to Follow-up|5|||
146327081|NCT00944034|527707066|FG005|Overall Study|Lost to Follow-up|7|||
146327082|NCT00944034|527707067|FG006|Overall Study|Lost to Follow-up|0|||
146327083|NCT00944034|527707068|FG007|Overall Study|Lost to Follow-up|1|||
146327084|NCT00944034|527707069|FG008|Overall Study|Lost to Follow-up|5|||
146327085|NCT00944034|527707070|FG009|Overall Study|Lost to Follow-up|1|||
146327086|NCT00944034|527707071|FG010|Overall Study|Lost to Follow-up|1|||
146327087|NCT00944034|527707072|FG011|Overall Study|Lost to Follow-up|0|||
146327088|NCT00944034|527707061|FG000|Overall Study|Death|0|||
146327089|NCT00944034|527707062|FG001|Overall Study|Death|0|||
146327090|NCT00944034|527707063|FG002|Overall Study|Death|1|||
146327091|NCT00944034|527707064|FG003|Overall Study|Death|0|||
146327092|NCT00944034|527707065|FG004|Overall Study|Death|0|||
146327093|NCT00944034|527707066|FG005|Overall Study|Death|0|||
146327094|NCT00944034|527707067|FG006|Overall Study|Death|0|||
146327095|NCT00944034|527707068|FG007|Overall Study|Death|0|||
146327096|NCT00944034|527707069|FG008|Overall Study|Death|0|||
146327097|NCT00944034|527707070|FG009|Overall Study|Death|0|||
146327098|NCT00944034|527707071|FG010|Overall Study|Death|0|||
146327099|NCT00944034|527707072|FG011|Overall Study|Death|0|||
146327100|NCT00944034|527707061|FG000|Overall Study|Protocol Violation|2|||
146327101|NCT00944034|527707062|FG001|Overall Study|Protocol Violation|0|||
146327102|NCT00944034|527707063|FG002|Overall Study|Protocol Violation|0|||
146327103|NCT00944034|527707064|FG003|Overall Study|Protocol Violation|1|||
146327104|NCT00944034|527707065|FG004|Overall Study|Protocol Violation|2|||
146166933|NCT01972529|527122509|FG003|Overall Study|Participant Choice|0|||
146166934|NCT01972529|527122506|FG000|Overall Study|Withdrawl of Consent|1|||
146166935|NCT01972529|527122507|FG001|Overall Study|Withdrawl of Consent|2|||
146166936|NCT01972529|527122508|FG002|Overall Study|Withdrawl of Consent|0|||
146166937|NCT01972529|527122509|FG003|Overall Study|Withdrawl of Consent|1|||
146166938|NCT01972529|527122506|FG000|Overall Study|Other|0|||
146166939|NCT01972529|527122507|FG001|Overall Study|Other|0|||
146166940|NCT01972529|527122508|FG002|Overall Study|Other|0|||
146166941|NCT01972529|527122509|FG003|Overall Study|Other|2|||
146166942|NCT01972529|527122506|FG000|Overall Study|Not treated|0|||
146166943|NCT01972529|527122507|FG001|Overall Study|Not treated|1|||
146166944|NCT01972529|527122508|FG002|Overall Study|Not treated|2|||
146166945|NCT01972529|527122509|FG003|Overall Study|Not treated|1|||
146166946|NCT01201811|527122510|FG000|Overall Study|Adverse Event|6|||
146327105|NCT00944034|527707066|FG005|Overall Study|Protocol Violation|3|||
146327106|NCT00944034|527707067|FG006|Overall Study|Protocol Violation|0|||
146327107|NCT00944034|527707068|FG007|Overall Study|Protocol Violation|1|||
146327108|NCT00944034|527707069|FG008|Overall Study|Protocol Violation|1|||
146327109|NCT00944034|527707070|FG009|Overall Study|Protocol Violation|4|||
146327110|NCT00944034|527707071|FG010|Overall Study|Protocol Violation|0|||
146327111|NCT00944034|527707072|FG011|Overall Study|Protocol Violation|0|||
146327112|NCT00944034|527707061|FG000|Overall Study|Unable to classify|0|||
146327113|NCT00944034|527707062|FG001|Overall Study|Unable to classify|0|||
146327114|NCT00944034|527707063|FG002|Overall Study|Unable to classify|0|||
146327115|NCT00944034|527707064|FG003|Overall Study|Unable to classify|0|||
146327116|NCT00944034|527707065|FG004|Overall Study|Unable to classify|0|||
146327117|NCT00944034|527707066|FG005|Overall Study|Unable to classify|1|||
146327118|NCT00944034|527707067|FG006|Overall Study|Unable to classify|1|||
146327119|NCT00944034|527707068|FG007|Overall Study|Unable to classify|1|||
146327120|NCT00944034|527707069|FG008|Overall Study|Unable to classify|0|||
146327121|NCT00944034|527707070|FG009|Overall Study|Unable to classify|0|||
146327122|NCT00944034|527707071|FG010|Overall Study|Unable to classify|0|||
146327123|NCT00944034|527707072|FG011|Overall Study|Unable to classify|0|||
146327124|NCT00944034|527707061|FG000|Overall Study|Administrative reason|0|||
146327125|NCT00944034|527707062|FG001|Overall Study|Administrative reason|0|||
146327126|NCT00944034|527707063|FG002|Overall Study|Administrative reason|0|||
146327127|NCT00944034|527707064|FG003|Overall Study|Administrative reason|0|||
146327128|NCT00944034|527707065|FG004|Overall Study|Administrative reason|0|||
146327129|NCT00944034|527707066|FG005|Overall Study|Administrative reason|0|||
146327130|NCT00944034|527707067|FG006|Overall Study|Administrative reason|1|||
146327131|NCT00944034|527707068|FG007|Overall Study|Administrative reason|0|||
146327132|NCT00944034|527707069|FG008|Overall Study|Administrative reason|0|||
146327133|NCT00944034|527707070|FG009|Overall Study|Administrative reason|0|||
146327134|NCT00944034|527707071|FG010|Overall Study|Administrative reason|0|||
146166947|NCT01201811|527122510|FG000|Overall Study|Disease progression|3|||
146166948|NCT01201811|527122510|FG000|Overall Study|Withdrawal by Subject|3|||
146327135|NCT00944034|527707072|FG011|Overall Study|Administrative reason|0|||
146327136|NCT01570244|527707073|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
146327137|NCT02978222|527707085|FG000|Overall Study|Withdrawal by Subject|2|||
146327138|NCT02978222|527707086|FG001|Overall Study|Withdrawal by Subject|2|||
146327139|NCT02978222|527707085|FG000|Overall Study|Physician Decision|2|||
146327140|NCT02978222|527707086|FG001|Overall Study|Physician Decision|0|||
146327141|NCT02978222|527707085|FG000|Overall Study|Adverse Event|0|||
146327142|NCT02978222|527707086|FG001|Overall Study|Adverse Event|1|||
146327143|NCT02978222|527707085|FG000|Overall Study|Death|1|||
146166949|NCT01201811|527122510|FG000|Overall Study|Death|4|||
146166950|NCT01201811|527122510|FG000|Overall Study|Treatment Failure|2|||
146166951|NCT01201811|527122510|FG000|Overall Study|Physician Decision|1|||
146327144|NCT02978222|527707086|FG001|Overall Study|Death|0|||
146327145|NCT02978222|527707085|FG000|Overall Study|Disease Progression|32|||
146327146|NCT02978222|527707086|FG001|Overall Study|Disease Progression|32|||
146327147|NCT02978222|527707085|FG000|Overall Study|Early Study Termination|24|||
146327148|NCT02978222|527707086|FG001|Overall Study|Early Study Termination|21|||
146327149|NCT01413958|527707087|FG000|Overall Study|Lost to Follow-up|0|||
146327150|NCT01413958|527707088|FG001|Overall Study|Lost to Follow-up|1|||
146327151|NCT01900002|527707089|FG000|Overall Study|Withdrawal by Subject|2|||
146327152|NCT01900002|527707089|FG000|Overall Study|ineligible for Y-90|4|||
146327153|NCT02928952|527707098|FG000|Overall Study|Lost to Follow-up|5|||
146327154|NCT02928952|527707099|FG001|Overall Study|Lost to Follow-up|5|||
146327155|NCT02928952|527707098|FG000|Overall Study|Withdrawal by Subject|5|||
146327156|NCT02928952|527707099|FG001|Overall Study|Withdrawal by Subject|1|||
146327157|NCT02928952|527707098|FG000|Overall Study|Physician Decision|0|||
146327158|NCT02928952|527707099|FG001|Overall Study|Physician Decision|1|||
146327159|NCT01850615|527707100|FG000|Overall Study|Protocol Violation|4|||
146327160|NCT01850615|527707101|FG001|Overall Study|Protocol Violation|1|||
146327161|NCT01850615|527707100|FG000|Overall Study|Adverse Event|2|||
146327162|NCT01850615|527707101|FG001|Overall Study|Adverse Event|1|||
146327163|NCT01850615|527707100|FG000|Overall Study|Withdrawal by Subject|3|||
146327164|NCT01850615|527707101|FG001|Overall Study|Withdrawal by Subject|1|||
146327165|NCT01850615|527707100|FG000|Overall Study|Lost to Follow-up|0|||
146327166|NCT01850615|527707101|FG001|Overall Study|Lost to Follow-up|1|||
146327167|NCT01850615|527707100|FG000|Overall Study|Unclassified|0|||
146327168|NCT01850615|527707101|FG001|Overall Study|Unclassified|1|||
146327169|NCT00974220|527707102|FG000|Treatment Period 1|Adverse Event|2|||
146327170|NCT00974220|527707103|FG001|Treatment Period 1|Adverse Event|1|||
146327171|NCT00974220|527707102|FG000|Treatment Period 1|noncompliant subjects|0|||
146327172|NCT00974220|527707103|FG001|Treatment Period 1|noncompliant subjects|1|||
146327173|NCT02921425|527707104|FG000|Overall Study|Protocol Violation|9|||
146327174|NCT01227967|527707105|FG000|Overall Study|Protocol Violation|3|||
146327175|NCT01227967|527707106|FG001|Overall Study|Protocol Violation|1|||
146327176|NCT01227967|527707105|FG000|Overall Study|Death|0|||
146327177|NCT01227967|527707106|FG001|Overall Study|Death|1|||
146327178|NCT01227967|527707105|FG000|Overall Study|Lost to Follow-up|8|||
146327179|NCT01227967|527707106|FG001|Overall Study|Lost to Follow-up|3|||
146327180|NCT01227967|527707105|FG000|Overall Study|Withdrawal by Subject|4|||
146327181|NCT01227967|527707106|FG001|Overall Study|Withdrawal by Subject|3|||
146327182|NCT01227967|527707105|FG000|Overall Study|Physician Decision|0|||
146327183|NCT01227967|527707106|FG001|Overall Study|Physician Decision|1|||
146327184|NCT01227967|527707105|FG000|Overall Study|Never Started Treatment|0|||
146327185|NCT01227967|527707106|FG001|Overall Study|Never Started Treatment|4|||
146327186|NCT01227967|527707105|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
146327187|NCT01227967|527707106|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
146327188|NCT03403400|527707107|FG000|Overall Study|Lost to Follow-up|1|||
146327189|NCT03403400|527707108|FG001|Overall Study|Lost to Follow-up|0|||
146327190|NCT03403400|527707109|FG002|Overall Study|Lost to Follow-up|1|||
146327191|NCT03403400|527707107|FG000|Overall Study|Hospitalization|1|||
146327192|NCT03403400|527707108|FG001|Overall Study|Hospitalization|0|||
146327193|NCT03403400|527707109|FG002|Overall Study|Hospitalization|0|||
146327194|NCT03403400|527707107|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
146327195|NCT03403400|527707108|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
146327196|NCT03403400|527707109|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
146327197|NCT00565617|527707113|FG000|Overall Study|Withdrawal by Subject|1|||
146166952|NCT01820559|527122511|FG000|Overall Study|Adverse Event|4|||
146166953|NCT01820559|527122512|FG001|Overall Study|Adverse Event|6|||
146166954|NCT01820559|527122513|FG002|Overall Study|Adverse Event|13|||
146166955|NCT01820559|527122511|FG000|Overall Study|Withdrawal by Subject|1|||
146327198|NCT01145560|527707114|FG000|Overall Study|Withdrawal by Subject|2|||
146327199|NCT01145560|527707115|FG001|Overall Study|Withdrawal by Subject|1|||
146327200|NCT01145560|527707116|FG002|Overall Study|Withdrawal by Subject|0|||
146327201|NCT01145560|527707114|FG000|Overall Study|Lost to Follow-up|1|||
146327202|NCT01145560|527707115|FG001|Overall Study|Lost to Follow-up|1|||
146327203|NCT01145560|527707116|FG002|Overall Study|Lost to Follow-up|1|||
146327204|NCT01145560|527707114|FG000|Overall Study|No study drug by 24h after organ failure|1|||
146327205|NCT01145560|527707115|FG001|Overall Study|No study drug by 24h after organ failure|0|||
146166956|NCT01820559|527122512|FG001|Overall Study|Withdrawal by Subject|2|||
146327206|NCT01145560|527707116|FG002|Overall Study|No study drug by 24h after organ failure|0|||
146327207|NCT01145560|527707114|FG000|Overall Study|Accidental unblinding of study treatment|0|||
146327208|NCT01145560|527707115|FG001|Overall Study|Accidental unblinding of study treatment|1|||
146327209|NCT01145560|527707116|FG002|Overall Study|Accidental unblinding of study treatment|0|||
146327210|NCT01145560|527707114|FG000|Overall Study|False insurance information|0|||
146327211|NCT01145560|527707115|FG001|Overall Study|False insurance information|1|||
146327212|NCT01145560|527707116|FG002|Overall Study|False insurance information|0|||
146327213|NCT01145560|527707114|FG000|Overall Study|Withdrawal of therapy|0|||
146327214|NCT01145560|527707115|FG001|Overall Study|Withdrawal of therapy|0|||
146327215|NCT01145560|527707116|FG002|Overall Study|Withdrawal of therapy|1|||
146327216|NCT00712348|527707117|FG000|Overall Study|Withdrawal by Subject|1|||
146327217|NCT01273064|527707120|FG000|Overall Study|Adverse Event|5|||
146327218|NCT01273064|527707121|FG001|Overall Study|Adverse Event|1|||
146327219|NCT01273064|527707122|FG002|Overall Study|Adverse Event|3|||
146327220|NCT01273064|527707123|FG003|Overall Study|Adverse Event|2|||
146327221|NCT01273064|527707124|FG004|Overall Study|Adverse Event|1|||
146327222|NCT01273064|527707120|FG000|Overall Study|Withdrawal by Subject|4|||
146327223|NCT01273064|527707121|FG001|Overall Study|Withdrawal by Subject|2|||
146327224|NCT01273064|527707122|FG002|Overall Study|Withdrawal by Subject|2|||
146327225|NCT01273064|527707123|FG003|Overall Study|Withdrawal by Subject|2|||
146327226|NCT01273064|527707124|FG004|Overall Study|Withdrawal by Subject|0|||
146327227|NCT01273064|527707120|FG000|Overall Study|Study Termination|13|||
146327228|NCT01273064|527707121|FG001|Overall Study|Study Termination|27|||
146327229|NCT01273064|527707122|FG002|Overall Study|Study Termination|26|||
146327230|NCT01273064|527707123|FG003|Overall Study|Study Termination|16|||
146327231|NCT01273064|527707124|FG004|Overall Study|Study Termination|8|||
146327232|NCT01273064|527707120|FG000|Overall Study|Lost to Follow-up|1|||
146327233|NCT01273064|527707121|FG001|Overall Study|Lost to Follow-up|0|||
146327234|NCT01273064|527707122|FG002|Overall Study|Lost to Follow-up|0|||
146327235|NCT01273064|527707123|FG003|Overall Study|Lost to Follow-up|0|||
146327236|NCT01273064|527707124|FG004|Overall Study|Lost to Follow-up|0|||
146327237|NCT01273064|527707120|FG000|Overall Study|Physician Decision|0|||
146327238|NCT01273064|527707121|FG001|Overall Study|Physician Decision|0|||
146327239|NCT01273064|527707122|FG002|Overall Study|Physician Decision|0|||
146327240|NCT01273064|527707123|FG003|Overall Study|Physician Decision|0|||
146327241|NCT01273064|527707124|FG004|Overall Study|Physician Decision|1|||
146327242|NCT01375764|527707125|FG000|Overall Study|Lost to Follow-up|0|||
146327243|NCT01375764|527707126|FG001|Overall Study|Lost to Follow-up|1|||
146327244|NCT01375764|527707127|FG002|Overall Study|Lost to Follow-up|0|||
146327245|NCT01375764|527707128|FG003|Overall Study|Lost to Follow-up|0|||
146327246|NCT01375764|527707129|FG004|Overall Study|Lost to Follow-up|0|||
146327247|NCT01375764|527707125|FG000|Overall Study|Withdrawal by Subject|2|||
146327248|NCT01375764|527707126|FG001|Overall Study|Withdrawal by Subject|0|||
146327249|NCT01375764|527707127|FG002|Overall Study|Withdrawal by Subject|0|||
146327250|NCT01375764|527707128|FG003|Overall Study|Withdrawal by Subject|0|||
146327251|NCT01375764|527707129|FG004|Overall Study|Withdrawal by Subject|1|||
146327252|NCT01375764|527707125|FG000|Overall Study|Other|0|||
146327253|NCT01375764|527707126|FG001|Overall Study|Other|0|||
146327254|NCT01375764|527707127|FG002|Overall Study|Other|0|||
146327255|NCT01375764|527707128|FG003|Overall Study|Other|1|||
146327256|NCT01375764|527707129|FG004|Overall Study|Other|0|||
146327257|NCT02867761|527707133|FG000|Overall Study|Participant withdrawn by investigator|0|||
146327258|NCT02867761|527707134|FG001|Overall Study|Participant withdrawn by investigator|1|||
146327259|NCT02867761|527707133|FG000|Overall Study|Lost to Follow-up|25|||
146166957|NCT01820559|527122513|FG002|Overall Study|Withdrawal by Subject|5|||
146166958|NCT01820559|527122511|FG000|Overall Study|Protocol Violation|2|||
146166959|NCT01820559|527122512|FG001|Overall Study|Protocol Violation|1|||
146166960|NCT01820559|527122513|FG002|Overall Study|Protocol Violation|3|||
146166961|NCT01820559|527122511|FG000|Overall Study|Subject's non-compliance|1|||
146166962|NCT01820559|527122512|FG001|Overall Study|Subject's non-compliance|0|||
146166963|NCT01820559|527122513|FG002|Overall Study|Subject's non-compliance|2|||
146166964|NCT01820559|527122511|FG000|Overall Study|Lost to Follow-up|3|||
146166965|NCT01820559|527122512|FG001|Overall Study|Lost to Follow-up|2|||
146166966|NCT01820559|527122513|FG002|Overall Study|Lost to Follow-up|2|||
146327260|NCT02867761|527707134|FG001|Overall Study|Lost to Follow-up|18|||
146327261|NCT02867761|527707133|FG000|Overall Study|Unable to complete protocol|3|||
146327262|NCT02867761|527707134|FG001|Overall Study|Unable to complete protocol|7|||
146166967|NCT01820559|527122511|FG000|Overall Study|At sponsor request|0|||
146166968|NCT01820559|527122512|FG001|Overall Study|At sponsor request|0|||
146166969|NCT01820559|527122513|FG002|Overall Study|At sponsor request|1|||
146166970|NCT01820559|527122511|FG000|Overall Study|Lack of Efficacy|3|||
146327263|NCT03595280|527707135|FG000|Overall Study|Lost to Follow-up|6|||
146327264|NCT03595280|527707136|FG001|Overall Study|Lost to Follow-up|9|||
146327265|NCT03595280|527707137|FG002|Overall Study|Lost to Follow-up|15|||
146327266|NCT01512264|527707138|FG000|Overall Study|Lost to Follow-up|0|||
146327267|NCT01512264|527707139|FG001|Overall Study|Lost to Follow-up|0|||
146327268|NCT01512264|527707140|FG002|Overall Study|Lost to Follow-up|0|||
146327269|NCT01512264|527707141|FG003|Overall Study|Lost to Follow-up|1|||
146327270|NCT01194440|527707142|FG000|Baseline (First Dose)|Reason not specified|4|||
146327271|NCT01194440|527707142|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
146327272|NCT01194440|527707142|FG000|Baseline (First Dose)|Change in therapy|1|||
146327273|NCT01194440|527707142|FG000|Baseline (First Dose)|Adverse Event|1|||
146166971|NCT01820559|527122512|FG001|Overall Study|Lack of Efficacy|2|||
146166972|NCT01820559|527122513|FG002|Overall Study|Lack of Efficacy|3|||
146327274|NCT01194440|527707142|FG000|6-months (2nd Dose)|Change in therapy|4|||
146327275|NCT00854828|527707143|FG000|Overall Study|Death|1|||
146327276|NCT00854828|527707144|FG001|Overall Study|Death|0|||
146327277|NCT00854828|527707145|FG002|Overall Study|Death|0|||
146327278|NCT00854828|527707146|FG003|Overall Study|Death|0|||
146327279|NCT00854828|527707143|FG000|Overall Study|Withdrawal by Subject|1|||
146327280|NCT00854828|527707144|FG001|Overall Study|Withdrawal by Subject|1|||
146327281|NCT00854828|527707145|FG002|Overall Study|Withdrawal by Subject|0|||
146327282|NCT00854828|527707146|FG003|Overall Study|Withdrawal by Subject|9|||
146327283|NCT00854828|527707143|FG000|Overall Study|Missed 24mo visit|1|||
146327284|NCT00854828|527707144|FG001|Overall Study|Missed 24mo visit|1|||
146327285|NCT00854828|527707145|FG002|Overall Study|Missed 24mo visit|8|||
146327286|NCT00854828|527707146|FG003|Overall Study|Missed 24mo visit|8|||
146327287|NCT01931059|527707147|FG000|Day 1|Pregnancy|0|||
146327288|NCT01931059|527707148|FG001|Day 1|Pregnancy|1|||
146327289|NCT01931059|527707147|FG000|Day3|Lost to Follow-up|1|||
146327290|NCT01931059|527707148|FG001|Day3|Lost to Follow-up|0|||
146327291|NCT02675075|527707149|FG000|Overall Study|Lost to Follow-up|3|||
146327292|NCT02675075|527707150|FG001|Overall Study|Lost to Follow-up|0|||
146327293|NCT02292212|527707151|FG000|ViE Phase|Withdrawal by Subject|1|||
146327294|NCT02292212|527707151|FG000|ViE Phase|Protocol Violation|2|||
146327295|NCT02411747|527707152|FG000|Overall Study|Withdrawal by Subject|1|||
146327296|NCT02411747|527707153|FG001|Overall Study|Withdrawal by Subject|0|||
146327297|NCT02411747|527707152|FG000|Overall Study|Protocol Violation|2|||
146327298|NCT02411747|527707153|FG001|Overall Study|Protocol Violation|4|||
146327299|NCT02149810|527707154|FG000|Overall Study|Physician Decision|1|||
146327300|NCT02149810|527707155|FG001|Overall Study|Physician Decision|2|||
146327301|NCT02149810|527707154|FG000|Overall Study|Lost to Follow-up|2|||
146327302|NCT02149810|527707155|FG001|Overall Study|Lost to Follow-up|1|||
146327303|NCT02149810|527707154|FG000|Overall Study|Withdrawal by Subject|5|||
146327304|NCT02149810|527707155|FG001|Overall Study|Withdrawal by Subject|1|||
146327305|NCT00675597|527707156|FG000|Overall Study|Withdrawal by Subject|3|||
146327306|NCT01176916|527707157|FG000|Overall Study|Adverse Event|61|||
146327307|NCT01176916|527707157|FG000|Overall Study|Death|1|||
146327308|NCT01176916|527707157|FG000|Overall Study|Lost to Follow-up|15|||
146327309|NCT01176916|527707157|FG000|Overall Study|Objective progression or relapse|17|||
146327310|NCT01176916|527707157|FG000|Overall Study|Protocol Violation|24|||
146327311|NCT01176916|527707157|FG000|Overall Study|Withdrawal by Subject|37|||
146327312|NCT01176916|527707157|FG000|Overall Study|Other|6|||
146327313|NCT01176916|527707157|FG000|Overall Study|Withdrawal prior to Treatment|6|||
146327314|NCT03158220|527707158|FG000|Overall Study|Screen Failure|0|||
146327315|NCT03158220|527707159|FG001|Overall Study|Screen Failure|1|||
146327316|NCT03158220|527707158|FG000|Overall Study|Withdrawal by Subject|8|||
146327317|NCT03158220|527707159|FG001|Overall Study|Withdrawal by Subject|9|||
146327318|NCT03158220|527707158|FG000|Overall Study|Status unknown|0|||
146327319|NCT03158220|527707159|FG001|Overall Study|Status unknown|1|||
146327320|NCT03158220|527707158|FG000|Overall Study|Lost to Follow-up|8|||
146327321|NCT03158220|527707159|FG001|Overall Study|Lost to Follow-up|5|||
146327322|NCT03158220|527707158|FG000|Overall Study|Physician Decision|1|||
146327323|NCT03158220|527707159|FG001|Overall Study|Physician Decision|0|||
146327324|NCT00848120|527707162|FG000|Overall Study|Adverse Event|1|||
146327325|NCT00560755|527707163|FG000|Overall Study|Protocol Violation|15|||
146327326|NCT00560755|527707163|FG000|Overall Study|Withdrawal by Subject|26|||
146327327|NCT00560755|527707163|FG000|Overall Study|Lost to Follow-up|9|||
146327328|NCT00560755|527707163|FG000|Overall Study|Adverse Event|8|||
146327329|NCT00560755|527707163|FG000|Overall Study|Physician Decision|2|||
146327330|NCT01961115|527707174|FG000|Overall Study|Disease Progression|1|||
146327331|NCT01961115|527707175|FG001|Overall Study|Disease Progression|0|||
146327332|NCT01961115|527707176|FG002|Overall Study|Disease Progression|3|||
146327333|NCT01961115|527707174|FG000|Overall Study|Adverse Event|1|||
146327334|NCT01961115|527707175|FG001|Overall Study|Adverse Event|0|||
146327335|NCT01961115|527707176|FG002|Overall Study|Adverse Event|1|||
146327336|NCT01439945|527707177|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146327337|NCT01439945|527707178|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146327338|NCT01439945|527707179|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
146327339|NCT01439945|527707180|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
146327340|NCT01439945|527707177|FG000|Double-Blind Treatment Phase|Ineligible|1|||
146327341|NCT01439945|527707178|FG001|Double-Blind Treatment Phase|Ineligible|2|||
146327342|NCT01439945|527707179|FG002|Double-Blind Treatment Phase|Ineligible|0|||
146327343|NCT01439945|527707180|FG003|Double-Blind Treatment Phase|Ineligible|1|||
146327344|NCT04082663|527707193|FG000|Overall Study|Adverse Event|6|||
146327345|NCT04082663|527707193|FG000|Overall Study|Lost to Follow-up|1|||
146327346|NCT05501119|527707196|FG000|Overall Study|Withdrawal by Subject|2|||
146327347|NCT05501119|527707196|FG000|Overall Study|Lost to Follow-up|5|||
146327348|NCT01752023|527707197|FG000|Overall Study|Physician Decision|2|||
146327349|NCT01752023|527707198|FG001|Overall Study|Physician Decision|1|||
146327350|NCT01445678|527707199|FG000|Overall Study|Adverse Event|12|||
146327351|NCT01445678|527707200|FG001|Overall Study|Adverse Event|8|||
146327352|NCT01445678|527707199|FG000|Overall Study|Lack of Efficacy|0|||
146327353|NCT01445678|527707200|FG001|Overall Study|Lack of Efficacy|2|||
146327354|NCT01445678|527707199|FG000|Overall Study|Lost to Follow-up|8|||
146327355|NCT01445678|527707200|FG001|Overall Study|Lost to Follow-up|5|||
146327356|NCT01445678|527707199|FG000|Overall Study|Protocol Violation|1|||
146327357|NCT01445678|527707200|FG001|Overall Study|Protocol Violation|1|||
146327358|NCT01445678|527707199|FG000|Overall Study|Withdrawal by Subject|9|||
146327359|NCT01445678|527707200|FG001|Overall Study|Withdrawal by Subject|5|||
146327360|NCT01974817|527709102|FG000|Overall Study|Death|4|||
146327361|NCT01974817|527709102|FG000|Overall Study|Lost to Follow-up|2|||
146327362|NCT01974817|527709102|FG000|Overall Study|Protocol Violation|2|||
146327363|NCT04047797|527709108|FG000|Overall Study|Progressive Disease|1|||
146327364|NCT01793792|527709109|FG000|Overall Study|Death|5|||
146327365|NCT01793792|527709109|FG000|Overall Study|Lost to Follow-up|5|||
146327366|NCT01793792|527709109|FG000|Overall Study|Withdrawal by Subject|1|||
146327367|NCT01793792|527709109|FG000|Overall Study|Device Not Implanted|1|||
146327368|NCT05742984|527709114|FG000|Overall Study|Adverse Event|0|||
146327369|NCT05742984|527709115|FG001|Overall Study|Adverse Event|0|||
146327370|NCT05742984|527709116|FG002|Overall Study|Adverse Event|1|||
146327371|NCT05742984|527709117|FG003|Overall Study|Adverse Event|0|||
146327372|NCT05742984|527709118|FG004|Overall Study|Adverse Event|1|||
146327373|NCT05742984|527709119|FG005|Overall Study|Adverse Event|1|||
146327374|NCT05742984|527709114|FG000|Overall Study|Withdrawal by Subject|0|||
146327375|NCT05742984|527709115|FG001|Overall Study|Withdrawal by Subject|1|||
146327376|NCT05742984|527709116|FG002|Overall Study|Withdrawal by Subject|0|||
146327377|NCT05742984|527709117|FG003|Overall Study|Withdrawal by Subject|0|||
146327378|NCT05742984|527709118|FG004|Overall Study|Withdrawal by Subject|0|||
146327379|NCT05742984|527709119|FG005|Overall Study|Withdrawal by Subject|2|||
146327380|NCT02162862|527709120|FG000|Overall Study|Lost to Follow-up|0|||
146327381|NCT02162862|527709121|FG001|Overall Study|Lost to Follow-up|11|||
146327382|NCT02162862|527709122|FG002|Overall Study|Lost to Follow-up|0|||
146327383|NCT02162862|527709120|FG000|Overall Study|Subject did not feel the med was needed|0|||
146327384|NCT02162862|527709121|FG001|Overall Study|Subject did not feel the med was needed|0|||
146327385|NCT02162862|527709122|FG002|Overall Study|Subject did not feel the med was needed|4|||
146327386|NCT00988247|527709125|FG000|Overall Study|Adverse Event|17|||
146327387|NCT00988247|527709126|FG001|Overall Study|Adverse Event|3|||
146327388|NCT00988247|527709125|FG000|Overall Study|Withdrawal by Subject|44|||
146327389|NCT00988247|527709126|FG001|Overall Study|Withdrawal by Subject|13|||
146327390|NCT00988247|527709125|FG000|Overall Study|Pregnancy|1|||
146327391|NCT00988247|527709126|FG001|Overall Study|Pregnancy|2|||
146327392|NCT00988247|527709125|FG000|Overall Study|Lost to Follow-up|11|||
146327393|NCT00988247|527709126|FG001|Overall Study|Lost to Follow-up|2|||
146327394|NCT00988247|527709125|FG000|Overall Study|Protocol Violation|4|||
146327395|NCT00988247|527709126|FG001|Overall Study|Protocol Violation|5|||
146327396|NCT00988247|527709125|FG000|Overall Study|Sponsor requested withdrawal|3|||
146327397|NCT00988247|527709126|FG001|Overall Study|Sponsor requested withdrawal|1|||
146327398|NCT00988247|527709125|FG000|Overall Study|Other|3|||
146327399|NCT00988247|527709126|FG001|Overall Study|Other|0|||
146327400|NCT03822884|527709127|FG000|Overall Study|Withdrawal by Subject|0|||
146327401|NCT03822884|527709128|FG001|Overall Study|Withdrawal by Subject|0|||
146327402|NCT03822884|527709129|FG002|Overall Study|Withdrawal by Subject|0|||
146327403|NCT03822884|527709130|FG003|Overall Study|Withdrawal by Subject|0|||
146327404|NCT03822884|527709131|FG004|Overall Study|Withdrawal by Subject|1|||
146327405|NCT03822884|527709132|FG005|Overall Study|Withdrawal by Subject|0|||
146327406|NCT01427309|527709138|FG000|Overall Study|Lost to Follow-up|130|||
146327407|NCT01427309|527709139|FG001|Overall Study|Lost to Follow-up|145|||
146327408|NCT01427309|527709140|FG002|Overall Study|Lost to Follow-up|122|||
146327409|NCT01427309|527709141|FG003|Overall Study|Lost to Follow-up|135|||
146327410|NCT01427309|527709138|FG000|Overall Study|Protocol Violation|42|||
146327411|NCT01427309|527709139|FG001|Overall Study|Protocol Violation|69|||
146327412|NCT01427309|527709140|FG002|Overall Study|Protocol Violation|125|||
146327413|NCT01427309|527709141|FG003|Overall Study|Protocol Violation|124|||
146327414|NCT01427309|527709138|FG000|Overall Study|Adverse Event|0|||
146327415|NCT01427309|527709139|FG001|Overall Study|Adverse Event|0|||
146327416|NCT01427309|527709140|FG002|Overall Study|Adverse Event|3|||
146327417|NCT01427309|527709141|FG003|Overall Study|Adverse Event|1|||
146166973|NCT02277990|527122514|FG000|Overall Study|Death|170|||
146166974|NCT02277990|527122515|FG001|Overall Study|Death|188|||
146327418|NCT01427309|527709138|FG000|Overall Study|Serious adverse event|52|||
146327419|NCT01427309|527709139|FG001|Overall Study|Serious adverse event|45|||
146166975|NCT02277990|527122514|FG000|Overall Study|Withdrawal by Subject|64|||
146166976|NCT02277990|527122515|FG001|Overall Study|Withdrawal by Subject|53|||
146166977|NCT02277990|527122514|FG000|Overall Study|Physician Decision|40|||
146166978|NCT02277990|527122515|FG001|Overall Study|Physician Decision|34|||
146327420|NCT01427309|527709140|FG002|Overall Study|Serious adverse event|50|||
146327421|NCT01427309|527709141|FG003|Overall Study|Serious adverse event|61|||
146327422|NCT01427309|527709138|FG000|Overall Study|Withdrawal by Subject|148|||
146327423|NCT01427309|527709139|FG001|Overall Study|Withdrawal by Subject|148|||
146327424|NCT01427309|527709140|FG002|Overall Study|Withdrawal by Subject|61|||
146327425|NCT01427309|527709141|FG003|Overall Study|Withdrawal by Subject|55|||
146327426|NCT03617705|527709144|FG000|Overall Study|Withdrawal by Subject|2|||
146327427|NCT03617705|527709144|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
146327428|NCT03617705|527709144|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
146327429|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
146327430|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
146327431|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
146327432|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
146327433|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
146327434|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
146327435|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
146327436|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
146327437|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
146327438|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
146327439|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
146327440|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
146327441|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
146327442|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
146327443|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
146327444|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
146327445|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
146327446|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
146327447|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
146327448|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
146327449|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
146327450|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
146327451|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
146327452|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
146327453|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
146327454|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
146327455|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
146327456|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
146327457|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
146327458|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
146327459|NCT00849017|527709145|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
146327460|NCT00849017|527709146|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
146327461|NCT00849017|527709147|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
146327462|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
146327463|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
146327464|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
146327465|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
146327466|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
146327467|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
146327468|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
146327469|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
146327470|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
146327471|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
146327472|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
146327473|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
146327474|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
146327475|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
146327476|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
146327477|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
146327478|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
146327479|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
146327480|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
146327481|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
146327482|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
146327483|NCT00849017|527709145|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
146327484|NCT00849017|527709146|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
146327485|NCT00849017|527709147|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
146327486|NCT00214461|527709148|FG000|Overall Study|Adverse Event|0|||
146327487|NCT00214461|527709149|FG001|Overall Study|Adverse Event|0|||
146166979|NCT02277990|527122514|FG000|Overall Study|Lost to Follow-up|66|||
146327488|NCT00214461|527709150|FG002|Overall Study|Adverse Event|1|||
146327489|NCT00214461|527709151|FG003|Overall Study|Adverse Event|1|||
146327490|NCT00214461|527709148|FG000|Overall Study|Withdrawal by Subject|0|||
146327491|NCT00214461|527709149|FG001|Overall Study|Withdrawal by Subject|0|||
146327492|NCT00214461|527709150|FG002|Overall Study|Withdrawal by Subject|1|||
146327493|NCT00214461|527709151|FG003|Overall Study|Withdrawal by Subject|0|||
146327494|NCT02913313|527709152|FG000|Overall Study|DISEASE PROGRESSION|1|||
146327495|NCT02913313|527709153|FG001|Overall Study|DISEASE PROGRESSION|2|||
146327496|NCT02913313|527709154|FG002|Overall Study|DISEASE PROGRESSION|2|||
146327497|NCT02913313|527709155|FG003|Overall Study|DISEASE PROGRESSION|4|||
146327498|NCT02913313|527709156|FG004|Overall Study|DISEASE PROGRESSION|6|||
146327499|NCT02913313|527709157|FG005|Overall Study|DISEASE PROGRESSION|4|||
146327500|NCT02913313|527709158|FG006|Overall Study|DISEASE PROGRESSION|19|||
146327501|NCT02913313|527709159|FG007|Overall Study|DISEASE PROGRESSION|3|||
146327502|NCT02913313|527709160|FG008|Overall Study|DISEASE PROGRESSION|4|||
146327503|NCT02913313|527709161|FG009|Overall Study|DISEASE PROGRESSION|4|||
146327504|NCT02913313|527709162|FG010|Overall Study|DISEASE PROGRESSION|11|||
146327505|NCT02913313|527709163|FG011|Overall Study|DISEASE PROGRESSION|5|||
146327506|NCT02913313|527709164|FG012|Overall Study|DISEASE PROGRESSION|14|||
146327507|NCT02913313|527709165|FG013|Overall Study|DISEASE PROGRESSION|3|||
146327508|NCT02913313|527709152|FG000|Overall Study|Not Reported|0|||
146327509|NCT02913313|527709153|FG001|Overall Study|Not Reported|0|||
146327510|NCT02913313|527709154|FG002|Overall Study|Not Reported|0|||
146327511|NCT02913313|527709155|FG003|Overall Study|Not Reported|0|||
146327512|NCT02913313|527709156|FG004|Overall Study|Not Reported|1|||
146327513|NCT02913313|527709157|FG005|Overall Study|Not Reported|0|||
146327514|NCT02913313|527709158|FG006|Overall Study|Not Reported|0|||
146327515|NCT02913313|527709159|FG007|Overall Study|Not Reported|0|||
146327516|NCT02913313|527709160|FG008|Overall Study|Not Reported|0|||
146327517|NCT02913313|527709161|FG009|Overall Study|Not Reported|0|||
146327518|NCT02913313|527709162|FG010|Overall Study|Not Reported|4|||
146327519|NCT02913313|527709163|FG011|Overall Study|Not Reported|0|||
146327520|NCT02913313|527709164|FG012|Overall Study|Not Reported|0|||
146327521|NCT02913313|527709165|FG013|Overall Study|Not Reported|0|||
146327522|NCT02913313|527709152|FG000|Overall Study|Other reasons|0|||
146327523|NCT02913313|527709153|FG001|Overall Study|Other reasons|0|||
146327524|NCT02913313|527709154|FG002|Overall Study|Other reasons|0|||
146327525|NCT02913313|527709155|FG003|Overall Study|Other reasons|0|||
146327526|NCT02913313|527709156|FG004|Overall Study|Other reasons|1|||
146327527|NCT02913313|527709157|FG005|Overall Study|Other reasons|0|||
146327528|NCT02913313|527709158|FG006|Overall Study|Other reasons|0|||
146327529|NCT02913313|527709159|FG007|Overall Study|Other reasons|0|||
146327530|NCT02913313|527709160|FG008|Overall Study|Other reasons|0|||
146327531|NCT02913313|527709161|FG009|Overall Study|Other reasons|0|||
146327532|NCT02913313|527709162|FG010|Overall Study|Other reasons|1|||
146327533|NCT02913313|527709163|FG011|Overall Study|Other reasons|0|||
146327534|NCT02913313|527709164|FG012|Overall Study|Other reasons|0|||
146327535|NCT02913313|527709165|FG013|Overall Study|Other reasons|0|||
146327536|NCT02913313|527709152|FG000|Overall Study|Withdrawal by Subject|0|||
146327537|NCT02913313|527709153|FG001|Overall Study|Withdrawal by Subject|0|||
146327538|NCT02913313|527709154|FG002|Overall Study|Withdrawal by Subject|1|||
146327539|NCT02913313|527709155|FG003|Overall Study|Withdrawal by Subject|0|||
146327540|NCT02913313|527709156|FG004|Overall Study|Withdrawal by Subject|0|||
146327541|NCT02913313|527709157|FG005|Overall Study|Withdrawal by Subject|0|||
146327542|NCT02913313|527709158|FG006|Overall Study|Withdrawal by Subject|1|||
146327543|NCT02913313|527709159|FG007|Overall Study|Withdrawal by Subject|1|||
146327544|NCT02913313|527709160|FG008|Overall Study|Withdrawal by Subject|0|||
146327545|NCT02913313|527709161|FG009|Overall Study|Withdrawal by Subject|0|||
146327546|NCT02913313|527709162|FG010|Overall Study|Withdrawal by Subject|1|||
146327547|NCT02913313|527709163|FG011|Overall Study|Withdrawal by Subject|0|||
146327548|NCT02913313|527709164|FG012|Overall Study|Withdrawal by Subject|0|||
146327549|NCT02913313|527709165|FG013|Overall Study|Withdrawal by Subject|0|||
146327550|NCT02913313|527709152|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327551|NCT02913313|527709153|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327552|NCT02913313|527709154|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327553|NCT02913313|527709155|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327554|NCT02913313|527709156|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327555|NCT02913313|527709157|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327556|NCT02913313|527709158|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327557|NCT02913313|527709159|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327558|NCT02913313|527709160|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327559|NCT02913313|527709161|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327560|NCT02913313|527709162|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146327561|NCT02913313|527709163|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
146327562|NCT02913313|527709164|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146327563|NCT02913313|527709165|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
146327564|NCT02913313|527709152|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
146327565|NCT02913313|527709153|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
146327566|NCT02913313|527709154|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
146166980|NCT02277990|527122515|FG001|Overall Study|Lost to Follow-up|69|||
146327567|NCT02913313|527709155|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
146327568|NCT02913313|527709156|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
146327569|NCT02913313|527709157|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
146327570|NCT02913313|527709158|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
146327571|NCT02913313|527709159|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
146327572|NCT02913313|527709160|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
146327573|NCT02913313|527709161|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
146327574|NCT02913313|527709162|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
146327575|NCT02913313|527709163|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
146327576|NCT02913313|527709164|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
146327577|NCT02913313|527709165|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
146327578|NCT06118385|527709166|FG000|Overall Study|Protocol Violation|0|||
146327579|NCT06118385|527709167|FG001|Overall Study|Protocol Violation|0|||
146327580|NCT06118385|527709168|FG002|Overall Study|Protocol Violation|0|||
146327581|NCT06118385|527709169|FG003|Overall Study|Protocol Violation|0|||
146327582|NCT06118385|527709170|FG004|Overall Study|Protocol Violation|0|||
146327583|NCT06118385|527709171|FG005|Overall Study|Protocol Violation|0|||
146327584|NCT06118385|527709172|FG006|Overall Study|Protocol Violation|0|||
146327585|NCT06118385|527709173|FG007|Overall Study|Protocol Violation|0|||
146327586|NCT06118385|527709174|FG008|Overall Study|Protocol Violation|1|||
146327587|NCT06118385|527709175|FG009|Overall Study|Protocol Violation|0|||
146327588|NCT06118385|527709176|FG010|Overall Study|Protocol Violation|0|||
146327589|NCT06118385|527709177|FG011|Overall Study|Protocol Violation|0|||
146327590|NCT06118385|527709166|FG000|Overall Study|Out-of-range blood tests|0|||
146327591|NCT06118385|527709167|FG001|Overall Study|Out-of-range blood tests|0|||
146327592|NCT06118385|527709168|FG002|Overall Study|Out-of-range blood tests|0|||
146327593|NCT06118385|527709169|FG003|Overall Study|Out-of-range blood tests|0|||
146327594|NCT06118385|527709170|FG004|Overall Study|Out-of-range blood tests|0|||
146327595|NCT06118385|527709171|FG005|Overall Study|Out-of-range blood tests|0|||
146327596|NCT06118385|527709172|FG006|Overall Study|Out-of-range blood tests|0|||
146327597|NCT06118385|527709173|FG007|Overall Study|Out-of-range blood tests|0|||
146327598|NCT06118385|527709174|FG008|Overall Study|Out-of-range blood tests|1|||
146327599|NCT06118385|527709175|FG009|Overall Study|Out-of-range blood tests|0|||
146327600|NCT06118385|527709176|FG010|Overall Study|Out-of-range blood tests|0|||
146327601|NCT06118385|527709177|FG011|Overall Study|Out-of-range blood tests|0|||
146327602|NCT03624946|527709180|FG000|Overall Study|Lost to Follow-up|0|||
146327603|NCT03624946|527709181|FG001|Overall Study|Lost to Follow-up|1|||
146327604|NCT01925209|527709182|FG000|Treatment Epoch|Physician Decision|1|||
146327605|NCT01925209|527709183|FG001|Treatment Epoch|Physician Decision|0|||
146327606|NCT01925209|527709184|FG002|Treatment Epoch|Physician Decision|0|||
146327607|NCT01925209|527709185|FG003|Treatment Epoch|Physician Decision|0|||
146327608|NCT01925209|527709182|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
146327609|NCT01925209|527709183|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
146327610|NCT01925209|527709184|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
146327611|NCT01925209|527709185|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
146327612|NCT01925209|527709182|FG000|Treatment Epoch|Death|1|||
146327613|NCT01925209|527709183|FG001|Treatment Epoch|Death|0|||
146327614|NCT01925209|527709184|FG002|Treatment Epoch|Death|0|||
146327615|NCT01925209|527709185|FG003|Treatment Epoch|Death|0|||
146327616|NCT01925209|527709182|FG000|Treatment Epoch|Protocol deviation|0|||
146327617|NCT01925209|527709183|FG001|Treatment Epoch|Protocol deviation|0|||
146327618|NCT01925209|527709184|FG002|Treatment Epoch|Protocol deviation|1|||
146327619|NCT01925209|527709185|FG003|Treatment Epoch|Protocol deviation|1|||
146327620|NCT01925209|527709182|FG000|Treatment Epoch|Withdrawal by Subject|4|||
146327621|NCT01925209|527709183|FG001|Treatment Epoch|Withdrawal by Subject|3|||
146327622|NCT01925209|527709184|FG002|Treatment Epoch|Withdrawal by Subject|3|||
146327623|NCT01925209|527709185|FG003|Treatment Epoch|Withdrawal by Subject|2|||
146327624|NCT01925209|527709182|FG000|Treatment Epoch|Adverse Event|3|||
146327625|NCT01925209|527709183|FG001|Treatment Epoch|Adverse Event|5|||
146327626|NCT01925209|527709184|FG002|Treatment Epoch|Adverse Event|3|||
146327627|NCT01925209|527709185|FG003|Treatment Epoch|Adverse Event|1|||
146327628|NCT01925209|527709182|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
146327629|NCT01925209|527709183|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
146327630|NCT01925209|527709184|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
146327631|NCT01925209|527709185|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
146327632|NCT01925209|527709182|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
146327633|NCT01925209|527709183|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
146327634|NCT01925209|527709184|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
146327635|NCT01925209|527709185|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
146327636|NCT01925209|527709182|FG000|Follow-up|Adverse Event|1|||
146327637|NCT01925209|527709183|FG001|Follow-up|Adverse Event|4|||
146327638|NCT01925209|527709184|FG002|Follow-up|Adverse Event|0|||
146327639|NCT01925209|527709185|FG003|Follow-up|Adverse Event|1|||
146327640|NCT01925209|527709182|FG000|Follow-up|Physician Decision|0|||
146327641|NCT01925209|527709183|FG001|Follow-up|Physician Decision|0|||
146327642|NCT01925209|527709184|FG002|Follow-up|Physician Decision|1|||
146327643|NCT01925209|527709185|FG003|Follow-up|Physician Decision|0|||
146327644|NCT01925209|527709182|FG000|Follow-up|Non-compliance with study treatment|0|||
146327645|NCT01925209|527709183|FG001|Follow-up|Non-compliance with study treatment|0|||
146327646|NCT01925209|527709184|FG002|Follow-up|Non-compliance with study treatment|0|||
146327647|NCT01925209|527709185|FG003|Follow-up|Non-compliance with study treatment|1|||
146327648|NCT01925209|527709182|FG000|Follow-up|Withdrawal by Subject|0|||
146327649|NCT01925209|527709183|FG001|Follow-up|Withdrawal by Subject|2|||
146327650|NCT01925209|527709184|FG002|Follow-up|Withdrawal by Subject|0|||
146327651|NCT01925209|527709185|FG003|Follow-up|Withdrawal by Subject|2|||
146327652|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
146327653|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
146327654|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|Death|1|||
146327655|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|Death|0|||
146327656|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
146327657|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
146327658|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
146327659|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
146327660|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
146327661|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
146327662|NCT00110994|527709186|FG000|Double-blind (DB) Treatment|other reasons|2|||
146327663|NCT00110994|527709187|FG001|Double-blind (DB) Treatment|other reasons|3|||
146327664|NCT00110994|527709186|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
146327665|NCT00110994|527709187|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
146327666|NCT00110994|527709186|FG000|Active Follow-up|Other reasons|0|||
146327667|NCT00110994|527709187|FG001|Active Follow-up|Other reasons|2|||
146327668|NCT00110994|527709186|FG000|Long Term Follow-up|Death|19|||
146327669|NCT00110994|527709187|FG001|Long Term Follow-up|Death|17|||
146327670|NCT00675025|527709188|FG000|Overall Study|Study Terminated by Sponsor|38|||
146327671|NCT00675025|527709189|FG001|Overall Study|Study Terminated by Sponsor|42|||
146327672|NCT00675025|527709188|FG000|Overall Study|Adverse Event|6|||
146327673|NCT00675025|527709189|FG001|Overall Study|Adverse Event|11|||
146327674|NCT00675025|527709188|FG000|Overall Study|Lost to Follow-up|6|||
146327675|NCT00675025|527709189|FG001|Overall Study|Lost to Follow-up|4|||
146327676|NCT00675025|527709188|FG000|Overall Study|Withdrawal by Subject|4|||
146327677|NCT00675025|527709189|FG001|Overall Study|Withdrawal by Subject|6|||
146327678|NCT01551693|527709191|FG000|Overall Study|Disease Progression|1|||
146327679|NCT01551693|527709192|FG001|Overall Study|Disease Progression|0|||
146327680|NCT01551693|527709191|FG000|Overall Study|Adverse Event|0|||
146327681|NCT01551693|527709192|FG001|Overall Study|Adverse Event|1|||
146327682|NCT01551693|527709191|FG000|Overall Study|Withdrawal by Subject|0|||
146327683|NCT01551693|527709192|FG001|Overall Study|Withdrawal by Subject|1|||
146327684|NCT01950819|527709193|FG000|Overall Study|Graft Loss|35|||
146327685|NCT01950819|527709194|FG001|Overall Study|Graft Loss|30|||
146327686|NCT01950819|527709193|FG000|Overall Study|Death|29|||
146327687|NCT01950819|527709194|FG001|Overall Study|Death|34|||
146327688|NCT01950819|527709193|FG000|Overall Study|Subject / Gardian decision|54|||
146327689|NCT01950819|527709194|FG001|Overall Study|Subject / Gardian decision|51|||
146327690|NCT01950819|527709193|FG000|Overall Study|technical problems|2|||
146327691|NCT01950819|527709194|FG001|Overall Study|technical problems|0|||
146327692|NCT01950819|527709193|FG000|Overall Study|Pregnancy|0|||
146327693|NCT01950819|527709194|FG001|Overall Study|Pregnancy|2|||
146327694|NCT01950819|527709193|FG000|Overall Study|Lost to Follow-up|9|||
146327695|NCT01950819|527709194|FG001|Overall Study|Lost to Follow-up|17|||
146327696|NCT04134494|527709195|FG000|Overall Study|Lost to Follow-up|2|||
146327697|NCT00781365|527709196|FG000|Overall Study|Withdrawal by Subject|13|||
146327698|NCT00781365|527709197|FG001|Overall Study|Withdrawal by Subject|8|||
146327699|NCT00781365|527709196|FG000|Overall Study|Did Not Attend Visit|20|||
146327700|NCT00781365|527709197|FG001|Overall Study|Did Not Attend Visit|28|||
146327701|NCT00781365|527709196|FG000|Overall Study|Language barrier|1|||
146327702|NCT00781365|527709197|FG001|Overall Study|Language barrier|0|||
146327703|NCT00238264|527709198|FG000|Overall Study|Death|7|||
146327704|NCT00238264|527709198|FG000|Overall Study|Lost to Follow-up|18|||
146327705|NCT00238264|527709198|FG000|Overall Study|Withdrawal by Subject|4|||
146327706|NCT00238264|527709198|FG000|Overall Study|Ineligible|7|||
146327707|NCT01756456|527709201|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146327708|NCT01756456|527709202|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146327709|NCT01756456|527709203|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
146327710|NCT01756456|527709204|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146327711|NCT01756456|527709205|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146327712|NCT01756456|527709206|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
146327713|NCT01756456|527709201|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146327714|NCT01756456|527709202|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146327715|NCT01756456|527709203|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146327716|NCT01756456|527709204|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
146327717|NCT01756456|527709205|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
146327718|NCT01756456|527709206|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
146327719|NCT01756456|527709201|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146327720|NCT01756456|527709202|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
146327721|NCT01756456|527709203|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146327722|NCT01756456|527709204|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146327723|NCT01756456|527709205|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146327724|NCT01756456|527709206|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
146327725|NCT01756456|527709201|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
146327726|NCT01756456|527709202|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
146327727|NCT01756456|527709203|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
146327728|NCT01756456|527709204|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
146327729|NCT01756456|527709205|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
146327730|NCT01756456|527709206|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
146327731|NCT01756456|527709201|FG000|Treatment Period: Phase I/II|Other causes|0|||
146327732|NCT01756456|527709202|FG001|Treatment Period: Phase I/II|Other causes|0|||
146327733|NCT01756456|527709203|FG002|Treatment Period: Phase I/II|Other causes|0|||
146327734|NCT01756456|527709204|FG003|Treatment Period: Phase I/II|Other causes|1|||
146327735|NCT01756456|527709205|FG004|Treatment Period: Phase I/II|Other causes|2|||
146327736|NCT01756456|527709206|FG005|Treatment Period: Phase I/II|Other causes|2|||
146327737|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
146327738|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
146327739|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
146327740|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
146327741|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
146327742|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
146327743|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146327744|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
146327745|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146327746|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146327747|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146327748|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
146327749|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146327750|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146327751|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146327752|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146327753|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
146327754|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
146327755|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
146327756|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
146327757|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
146327758|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
146327759|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
146327760|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
146327761|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146327762|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146327763|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
146327764|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
146327765|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
146327766|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
146327767|NCT01756456|527709201|FG000|Follow Up Period Phase I/II|Other causes|0|||
146327768|NCT01756456|527709202|FG001|Follow Up Period Phase I/II|Other causes|0|||
146327769|NCT01756456|527709203|FG002|Follow Up Period Phase I/II|Other causes|0|||
146327770|NCT01756456|527709204|FG003|Follow Up Period Phase I/II|Other causes|1|||
146327771|NCT01756456|527709205|FG004|Follow Up Period Phase I/II|Other causes|3|||
146327772|NCT01756456|527709206|FG005|Follow Up Period Phase I/II|Other causes|5|||
146327773|NCT01838044|527709207|FG000|Overall Study|Adverse Event|4|||
146327774|NCT01838044|527709208|FG001|Overall Study|Adverse Event|6|||
146327775|NCT01838044|527709207|FG000|Overall Study|Protocol Violation|3|||
146327776|NCT01838044|527709208|FG001|Overall Study|Protocol Violation|3|||
146327777|NCT01838044|527709207|FG000|Overall Study|Withdrawal by Subject|0|||
146327778|NCT01838044|527709208|FG001|Overall Study|Withdrawal by Subject|2|||
146327779|NCT01838044|527709207|FG000|Overall Study|Insufficient clinical response|1|||
146327780|NCT01838044|527709208|FG001|Overall Study|Insufficient clinical response|2|||
146327781|NCT01838044|527709207|FG000|Overall Study|Medication error without associated AE|0|||
146327782|NCT01838044|527709208|FG001|Overall Study|Medication error without associated AE|1|||
146327783|NCT01838044|527709207|FG000|Overall Study|Lost to Follow-up|0|||
146327784|NCT01838044|527709208|FG001|Overall Study|Lost to Follow-up|2|||
146327785|NCT01662648|527709209|FG000|Overall Study|Death|1|||
146327786|NCT01662648|527709210|FG001|Overall Study|Death|3|||
146327787|NCT01662648|527709209|FG000|Overall Study|Adverse Event|40|||
146327788|NCT01662648|527709210|FG001|Overall Study|Adverse Event|37|||
146327789|NCT01662648|527709209|FG000|Overall Study|Lack of Efficacy|17|||
146327790|NCT01662648|527709210|FG001|Overall Study|Lack of Efficacy|16|||
146327791|NCT01662648|527709209|FG000|Overall Study|Participant ineligible to continue trial|1|||
146327792|NCT01662648|527709210|FG001|Overall Study|Participant ineligible to continue trial|1|||
146327793|NCT01662648|527709209|FG000|Overall Study|Lost to Follow-up|24|||
146327794|NCT01662648|527709210|FG001|Overall Study|Lost to Follow-up|36|||
146327795|NCT01662648|527709209|FG000|Overall Study|Withdrawal by Subject|36|||
146327796|NCT01662648|527709210|FG001|Overall Study|Withdrawal by Subject|53|||
146327797|NCT01662648|527709209|FG000|Overall Study|Participant non-compliant|16|||
146327798|NCT01662648|527709210|FG001|Overall Study|Participant non-compliant|20|||
146327799|NCT01662648|527709209|FG000|Overall Study|Other|8|||
146327800|NCT01662648|527709210|FG001|Overall Study|Other|11|||
146327801|NCT01662648|527709209|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
146327802|NCT01662648|527709210|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
146327803|NCT01662648|527709209|FG000|Overall Study|LOE and other reason unspecified|1|||
146327804|NCT01662648|527709210|FG001|Overall Study|LOE and other reason unspecified|0|||
146327805|NCT01662648|527709209|FG000|Overall Study|LOE and Participant non-compliant|0|||
146327806|NCT01662648|527709210|FG001|Overall Study|LOE and Participant non-compliant|1|||
146327807|NCT00706628|527709211|FG000|Overall Study|Other Adverse Event|16|||
146327808|NCT00706628|527709212|FG001|Overall Study|Other Adverse Event|5|||
146327809|NCT00706628|527709213|FG002|Overall Study|Other Adverse Event|5|||
146327810|NCT00706628|527709214|FG003|Overall Study|Other Adverse Event|2|||
146327811|NCT00706628|527709211|FG000|Overall Study|Non compliant with protocol|0|||
146327812|NCT00706628|527709212|FG001|Overall Study|Non compliant with protocol|1|||
146327813|NCT00706628|527709213|FG002|Overall Study|Non compliant with protocol|0|||
146327814|NCT00706628|527709214|FG003|Overall Study|Non compliant with protocol|0|||
146327815|NCT00706628|527709211|FG000|Overall Study|Consent withdrawn|6|||
146327816|NCT00706628|527709212|FG001|Overall Study|Consent withdrawn|1|||
146327817|NCT00706628|527709213|FG002|Overall Study|Consent withdrawn|3|||
146327818|NCT00706628|527709214|FG003|Overall Study|Consent withdrawn|0|||
146327819|NCT00706628|527709211|FG000|Overall Study|Progressive disease|20|||
146327820|NCT00706628|527709212|FG001|Overall Study|Progressive disease|13|||
146327821|NCT00706628|527709213|FG002|Overall Study|Progressive disease|8|||
146327822|NCT00706628|527709214|FG003|Overall Study|Progressive disease|1|||
146327823|NCT00706628|527709211|FG000|Overall Study|Other than those stated above|4|||
146327824|NCT00706628|527709212|FG001|Overall Study|Other than those stated above|0|||
146327825|NCT00706628|527709213|FG002|Overall Study|Other than those stated above|0|||
146327826|NCT00706628|527709214|FG003|Overall Study|Other than those stated above|0|||
146327827|NCT00706628|527709211|FG000|Overall Study|Not treated|1|||
146327828|NCT00706628|527709212|FG001|Overall Study|Not treated|1|||
146327829|NCT00706628|527709213|FG002|Overall Study|Not treated|0|||
146327830|NCT00706628|527709214|FG003|Overall Study|Not treated|0|||
146327831|NCT02266433|527709218|FG000|Overall Study|Lost to Follow-up|54|||
146327832|NCT02266433|527709219|FG001|Overall Study|Lost to Follow-up|46|||
146327833|NCT02266433|527709218|FG000|Overall Study|Withdrawal by Subject|5|||
146327834|NCT02266433|527709219|FG001|Overall Study|Withdrawal by Subject|7|||
146327835|NCT03887130|527709225|FG000|Overall Study|Progressive disease|23|||
146327836|NCT03887130|527709226|FG001|Overall Study|Progressive disease|14|||
146327837|NCT03887130|527709227|FG002|Overall Study|Progressive disease|7|||
146327838|NCT03887130|527709225|FG000|Overall Study|Protocol Violation|3|||
146327839|NCT03887130|527709226|FG001|Overall Study|Protocol Violation|1|||
146327840|NCT03887130|527709227|FG002|Overall Study|Protocol Violation|2|||
146327841|NCT03887130|527709225|FG000|Overall Study|Drug related toxicity|7|||
146327842|NCT03887130|527709226|FG001|Overall Study|Drug related toxicity|7|||
146327843|NCT03887130|527709227|FG002|Overall Study|Drug related toxicity|13|||
146327844|NCT03887130|527709225|FG000|Overall Study|Non drug related toxicity|3|||
146327845|NCT03887130|527709226|FG001|Overall Study|Non drug related toxicity|0|||
146327846|NCT03887130|527709227|FG002|Overall Study|Non drug related toxicity|0|||
146327847|NCT03887130|527709225|FG000|Overall Study|Death|2|||
146327848|NCT03887130|527709226|FG001|Overall Study|Death|2|||
146327849|NCT03887130|527709227|FG002|Overall Study|Death|1|||
146327850|NCT03887130|527709225|FG000|Overall Study|Withdrawal by Subject|7|||
146327851|NCT03887130|527709226|FG001|Overall Study|Withdrawal by Subject|6|||
146327852|NCT03887130|527709227|FG002|Overall Study|Withdrawal by Subject|11|||
146327853|NCT03887130|527709225|FG000|Overall Study|other reason|6|||
146327854|NCT03887130|527709226|FG001|Overall Study|other reason|20|||
146327855|NCT03887130|527709227|FG002|Overall Study|other reason|17|||
146327856|NCT00705263|527709228|FG000|Overall Study|Withdrawal by Subject|2|||
146327857|NCT02440581|527709231|FG000|Overall Study|Death|0|||
146327858|NCT02440581|527709232|FG001|Overall Study|Death|0|||
146327859|NCT02440581|527709233|FG002|Overall Study|Death|7|||
146327860|NCT02440581|527709234|FG003|Overall Study|Death|5|||
146166981|NCT02277990|527122514|FG000|Overall Study|Had other reason|26|||
146166982|NCT02277990|527122515|FG001|Overall Study|Had other reason|32|||
146327861|NCT02440581|527709231|FG000|Overall Study|Transplanted|1|||
146327862|NCT02440581|527709232|FG001|Overall Study|Transplanted|0|||
146327863|NCT02440581|527709233|FG002|Overall Study|Transplanted|3|||
146327864|NCT02440581|527709234|FG003|Overall Study|Transplanted|2|||
146327865|NCT02440581|527709231|FG000|Overall Study|Withdrawal by Subject|4|||
146327866|NCT02440581|527709232|FG001|Overall Study|Withdrawal by Subject|11|||
146327867|NCT02440581|527709233|FG002|Overall Study|Withdrawal by Subject|3|||
146327868|NCT02440581|527709234|FG003|Overall Study|Withdrawal by Subject|7|||
146327869|NCT05032950|527709236|FG000|Overall Study|Adverse Event|0|||
146327870|NCT05032950|527709237|FG001|Overall Study|Adverse Event|0|||
146327871|NCT05032950|527709238|FG002|Overall Study|Adverse Event|1|||
146327872|NCT05032950|527709239|FG003|Overall Study|Adverse Event|1|||
146327873|NCT05032950|527709240|FG004|Overall Study|Adverse Event|0|||
146327874|NCT05032950|527709241|FG005|Overall Study|Adverse Event|0|||
146327875|NCT02959814|527709242|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
146327876|NCT02959814|527709242|FG000|Overall Study|Excluded based on anatomical criteria|2|||
146327877|NCT02959814|527709242|FG000|Overall Study|Protocol Violation|7|||
146327878|NCT02959814|527709242|FG000|Overall Study|FFR not measured|2|||
146327879|NCT02959814|527709242|FG000|Overall Study|In-procedure QFR not computed|6|||
146327880|NCT02959814|527709242|FG000|Overall Study|Excluded by FFR core-lab|24|||
146327881|NCT01078805|527709252|FG000|Overall Study|Clinically significant abnormal lab|5|||
146327882|NCT01078805|527709252|FG000|Overall Study|Death|134|||
146327883|NCT01078805|527709252|FG000|Overall Study|Lost to Follow-up|676|||
146327884|NCT01078805|527709252|FG000|Overall Study|Physician Decision|169|||
146327885|NCT01078805|527709252|FG000|Overall Study|Serious adverse event|26|||
146327886|NCT01078805|527709252|FG000|Overall Study|Sponsor decision|46|||
146327887|NCT01078805|527709252|FG000|Overall Study|Withdrawal by Subject|739|||
146327888|NCT01078805|527709252|FG000|Overall Study|Other|173|||
146327889|NCT01078805|527709252|FG000|Overall Study|Didn't take study drug|82|||
146327890|NCT02246621|527709260|FG000|Overall Study|Withdrawal by Subject|28|||
146327891|NCT02246621|527709261|FG001|Overall Study|Withdrawal by Subject|16|||
146327892|NCT02246621|527709260|FG000|Overall Study|Lost to Follow-up|1|||
146327893|NCT02246621|527709261|FG001|Overall Study|Lost to Follow-up|0|||
146327894|NCT02246621|527709260|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
146327895|NCT02246621|527709261|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
146327896|NCT01292057|527709264|FG000|Overall Study|Protocol Violation|1|||
146327897|NCT01292057|527709265|FG001|Overall Study|Protocol Violation|1|||
146327898|NCT01292057|527709264|FG000|Overall Study|Lost to Follow-up|1|||
146327899|NCT01292057|527709265|FG001|Overall Study|Lost to Follow-up|1|||
146327900|NCT01459614|527709266|FG000|Overall Study|Adverse Event|1|||
146327901|NCT01459614|527709267|FG001|Overall Study|Adverse Event|0|||
146327902|NCT02078219|527709277|FG000|Overall Study|Other|2|||
146327903|NCT02078219|527709278|FG001|Overall Study|Other|2|||
146327904|NCT02078219|527709279|FG002|Overall Study|Other|3|||
146327905|NCT02078219|527709280|FG003|Overall Study|Other|0|||
146327906|NCT02078219|527709281|FG004|Overall Study|Other|1|||
146327907|NCT02078219|527709277|FG000|Overall Study|Withdrawal by Subject|0|||
146327908|NCT02078219|527709278|FG001|Overall Study|Withdrawal by Subject|1|||
146327909|NCT02078219|527709279|FG002|Overall Study|Withdrawal by Subject|0|||
146327910|NCT02078219|527709280|FG003|Overall Study|Withdrawal by Subject|1|||
146327911|NCT02078219|527709281|FG004|Overall Study|Withdrawal by Subject|1|||
146327912|NCT02078219|527709277|FG000|Overall Study|Protocol Violation|0|||
146327913|NCT02078219|527709278|FG001|Overall Study|Protocol Violation|0|||
146327914|NCT02078219|527709279|FG002|Overall Study|Protocol Violation|0|||
146327915|NCT02078219|527709280|FG003|Overall Study|Protocol Violation|1|||
146327916|NCT02078219|527709281|FG004|Overall Study|Protocol Violation|0|||
146327917|NCT02078219|527709277|FG000|Overall Study|Death|0|||
146327918|NCT02078219|527709278|FG001|Overall Study|Death|0|||
146327919|NCT02078219|527709279|FG002|Overall Study|Death|0|||
146327920|NCT02078219|527709280|FG003|Overall Study|Death|1|||
146327921|NCT02078219|527709281|FG004|Overall Study|Death|0|||
146327922|NCT02078219|527709277|FG000|Overall Study|Adverse Event|1|||
146327923|NCT02078219|527709278|FG001|Overall Study|Adverse Event|1|||
146327924|NCT02078219|527709279|FG002|Overall Study|Adverse Event|3|||
146327925|NCT02078219|527709280|FG003|Overall Study|Adverse Event|1|||
146327926|NCT02078219|527709281|FG004|Overall Study|Adverse Event|0|||
146327927|NCT03136107|527709282|FG000|Overall Study|Other (Not specified)|1|||
146327928|NCT03283085|527709283|FG000|Overall Study|Adverse Event|18|||
146327929|NCT03283085|527709284|FG001|Overall Study|Adverse Event|3|||
146327930|NCT03283085|527709285|FG002|Overall Study|Adverse Event|13|||
146327931|NCT03283085|527709286|FG003|Overall Study|Adverse Event|0|||
146327932|NCT03283085|527709287|FG004|Overall Study|Adverse Event|0|||
146327933|NCT03283085|527709288|FG005|Overall Study|Adverse Event|5|||
146327934|NCT03283085|527709283|FG000|Overall Study|Death|0|||
146327935|NCT03283085|527709284|FG001|Overall Study|Death|0|||
146327936|NCT03283085|527709285|FG002|Overall Study|Death|3|||
146327937|NCT03283085|527709286|FG003|Overall Study|Death|1|||
146327938|NCT03283085|527709287|FG004|Overall Study|Death|0|||
146327939|NCT03283085|527709288|FG005|Overall Study|Death|0|||
146327940|NCT03283085|527709283|FG000|Overall Study|Withdrawal by Subject|42|||
146327941|NCT03283085|527709284|FG001|Overall Study|Withdrawal by Subject|21|||
146327942|NCT03283085|527709285|FG002|Overall Study|Withdrawal by Subject|66|||
146327943|NCT03283085|527709286|FG003|Overall Study|Withdrawal by Subject|3|||
146327944|NCT03283085|527709287|FG004|Overall Study|Withdrawal by Subject|3|||
146327945|NCT03283085|527709288|FG005|Overall Study|Withdrawal by Subject|5|||
146327946|NCT03283085|527709283|FG000|Overall Study|Physician Decision|14|||
146327947|NCT03283085|527709284|FG001|Overall Study|Physician Decision|8|||
146327948|NCT03283085|527709285|FG002|Overall Study|Physician Decision|19|||
146327949|NCT03283085|527709286|FG003|Overall Study|Physician Decision|0|||
146327950|NCT03283085|527709287|FG004|Overall Study|Physician Decision|0|||
146327951|NCT03283085|527709288|FG005|Overall Study|Physician Decision|2|||
146327952|NCT03283085|527709283|FG000|Overall Study|Site Terminated by Sponsor|1|||
146327953|NCT03283085|527709284|FG001|Overall Study|Site Terminated by Sponsor|0|||
146327954|NCT03283085|527709285|FG002|Overall Study|Site Terminated by Sponsor|3|||
146327955|NCT03283085|527709286|FG003|Overall Study|Site Terminated by Sponsor|0|||
146327956|NCT03283085|527709287|FG004|Overall Study|Site Terminated by Sponsor|0|||
146327957|NCT03283085|527709288|FG005|Overall Study|Site Terminated by Sponsor|0|||
146327958|NCT03283085|527709283|FG000|Overall Study|Lost to Follow-up|2|||
146327959|NCT03283085|527709284|FG001|Overall Study|Lost to Follow-up|0|||
146327960|NCT03283085|527709285|FG002|Overall Study|Lost to Follow-up|2|||
146327961|NCT03283085|527709286|FG003|Overall Study|Lost to Follow-up|0|||
146327962|NCT03283085|527709287|FG004|Overall Study|Lost to Follow-up|0|||
146327963|NCT03283085|527709288|FG005|Overall Study|Lost to Follow-up|1|||
146327964|NCT03283085|527709283|FG000|Overall Study|Pregnancy|0|||
146327965|NCT03283085|527709284|FG001|Overall Study|Pregnancy|0|||
146327966|NCT03283085|527709285|FG002|Overall Study|Pregnancy|1|||
146327967|NCT03283085|527709286|FG003|Overall Study|Pregnancy|0|||
146327968|NCT03283085|527709287|FG004|Overall Study|Pregnancy|0|||
146327969|NCT03283085|527709288|FG005|Overall Study|Pregnancy|0|||
146327970|NCT03283085|527709283|FG000|Overall Study|Lack of Efficacy|12|||
146327971|NCT03283085|527709284|FG001|Overall Study|Lack of Efficacy|6|||
146327972|NCT03283085|527709285|FG002|Overall Study|Lack of Efficacy|24|||
146166983|NCT03351738|527122516|FG000|Overall Study|Withdrawal by Subject|0|||
146166984|NCT03351738|527122517|FG001|Overall Study|Withdrawal by Subject|1|||
146166985|NCT03351738|527122518|FG002|Overall Study|Withdrawal by Subject|0|||
146166986|NCT03351738|527122519|FG003|Overall Study|Withdrawal by Subject|1|||
146166987|NCT03351738|527122520|FG004|Overall Study|Withdrawal by Subject|0|||
146166988|NCT03351738|527122521|FG005|Overall Study|Withdrawal by Subject|0|||
146166989|NCT03641313|527122532|FG000|Overall Study|Death|1|||
146166990|NCT03641313|527122532|FG000|Overall Study|Withdrawal by Subject|2|||
146166991|NCT03641313|527122532|FG000|Overall Study|Declining health|1|||
146166992|NCT03641313|527122532|FG000|Overall Study|Adverse Event|1|||
146166993|NCT03033225|527122533|FG000|Overall Study|Withdrawal by Subject|5|||
146166994|NCT00946296|527122534|FG000|Overall Study|Physician Decision|3|||
146166995|NCT00946296|527122535|FG001|Overall Study|Physician Decision|0|||
146166996|NCT03434678|527122536|FG000|Overall Study|Withdrawal by Subject|13|||
146166997|NCT03434678|527122537|FG001|Overall Study|Withdrawal by Subject|13|||
146166998|NCT03434678|527122536|FG000|Overall Study|Found to be ineligible post randomization|2|||
146166999|NCT03434678|527122537|FG001|Overall Study|Found to be ineligible post randomization|1|||
146167000|NCT06060457|527122540|FG000|Overall Study|Adverse Event|1|||
146167001|NCT06060457|527122541|FG001|Overall Study|Adverse Event|1|||
146167002|NCT06060457|527122540|FG000|Overall Study|Death|2|||
146167003|NCT06060457|527122541|FG001|Overall Study|Death|2|||
146167004|NCT06060457|527122540|FG000|Overall Study|Lost to Follow-up|17|||
146167005|NCT06060457|527122541|FG001|Overall Study|Lost to Follow-up|19|||
146167006|NCT06060457|527122540|FG000|Overall Study|Physician Decision|0|||
146167007|NCT06060457|527122541|FG001|Overall Study|Physician Decision|1|||
146167008|NCT06060457|527122540|FG000|Overall Study|Protocol Violation|1|||
146167009|NCT06060457|527122541|FG001|Overall Study|Protocol Violation|1|||
146167010|NCT06060457|527122540|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
146167011|NCT06060457|527122541|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
146167012|NCT06060457|527122540|FG000|Overall Study|Withdrawal by Subject|12|||
146167013|NCT06060457|527122541|FG001|Overall Study|Withdrawal by Subject|15|||
146167014|NCT06060457|527122540|FG000|Overall Study|Other Than Specified|2|||
146327973|NCT03283085|527709286|FG003|Overall Study|Lack of Efficacy|1|||
146327974|NCT03283085|527709287|FG004|Overall Study|Lack of Efficacy|1|||
145943238|NCT00483704|526300458|FG002|Treatment|Pregnancy|0|||
146167015|NCT06060457|527122541|FG001|Overall Study|Other Than Specified|1|||
146167016|NCT01533493|527122542|FG000|Overall Study|Adverse Event|2|||
146167017|NCT01533493|527122543|FG001|Overall Study|Adverse Event|1|||
146167018|NCT01533493|527122542|FG000|Overall Study|Withdrawal by Subject|1|||
146167019|NCT01533493|527122543|FG001|Overall Study|Withdrawal by Subject|2|||
146167020|NCT01533493|527122542|FG000|Overall Study|Lost to Follow-up|2|||
146167021|NCT01533493|527122543|FG001|Overall Study|Lost to Follow-up|0|||
146167022|NCT03419364|527122554|FG000|Overall Study|Delivery due to maternal condition|2|||
146167023|NCT03419364|527122555|FG001|Overall Study|Delivery due to maternal condition|0|||
146167024|NCT03419364|527122556|FG002|Overall Study|Delivery due to maternal condition|0|||
146167025|NCT00552084|527122557|FG000|Overall Study|Adverse Event|2|||
146167026|NCT00552084|527122558|FG001|Overall Study|Adverse Event|3|||
146167027|NCT00552084|527122557|FG000|Overall Study|Withdrawal by Subject|4|||
146167028|NCT00552084|527122558|FG001|Overall Study|Withdrawal by Subject|5|||
146327975|NCT03283085|527709288|FG005|Overall Study|Lack of Efficacy|0|||
146327976|NCT03283085|527709283|FG000|Overall Study|Reason not Specified|0|||
146327977|NCT03283085|527709284|FG001|Overall Study|Reason not Specified|4|||
146327978|NCT03283085|527709285|FG002|Overall Study|Reason not Specified|8|||
146327979|NCT03283085|527709286|FG003|Overall Study|Reason not Specified|0|||
146327980|NCT03283085|527709287|FG004|Overall Study|Reason not Specified|0|||
146167029|NCT00552084|527122557|FG000|Overall Study|Protocol Violation|1|||
146167030|NCT00552084|527122558|FG001|Overall Study|Protocol Violation|0|||
146167031|NCT00552084|527122557|FG000|Overall Study|change in anti-arrythmic drug|1|||
146167032|NCT00552084|527122558|FG001|Overall Study|change in anti-arrythmic drug|1|||
146167033|NCT00106184|527124297|FG000|Overall Study|Withdrawal by Subject|3|||
146327981|NCT03283085|527709288|FG005|Overall Study|Reason not Specified|1|||
146327982|NCT03641560|527709289|FG000|Overall Study|Withdrawal by Subject|6|||
146327983|NCT03641560|527709289|FG000|Overall Study|Progressive disease|40|||
146327984|NCT03641560|527709289|FG000|Overall Study|Death|6|||
146327985|NCT02689492|527711370|FG000|Overall Study|Lost to Follow-up|61|||
146327986|NCT02689492|527711370|FG000|Overall Study|Withdrawal by Subject|11|||
146327987|NCT02689492|527711370|FG000|Overall Study|Death|9|||
146327988|NCT02689492|527711370|FG000|Overall Study|Physician Decision|2|||
146327989|NCT02689492|527711370|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
146327990|NCT02689492|527711370|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
146327991|NCT02689492|527711370|FG000|Overall Study|Other than listed|1|||
146327992|NCT02732951|527711371|FG000|Overall Study|Other than listed|1|||
146327993|NCT02732951|527711372|FG001|Overall Study|Other than listed|0|||
146327994|NCT02732951|527711371|FG000|Overall Study|Lost to Follow-up|0|||
146327995|NCT02732951|527711372|FG001|Overall Study|Lost to Follow-up|1|||
146327996|NCT02732951|527711371|FG000|Overall Study|Adverse Event|4|||
146327997|NCT02732951|527711372|FG001|Overall Study|Adverse Event|4|||
146327998|NCT02732951|527711371|FG000|Overall Study|Protocol Violation|0|||
146327999|NCT02732951|527711372|FG001|Overall Study|Protocol Violation|1|||
146328000|NCT00110305|527711374|FG000|Overall Study|Adverse Event|46|||
146328001|NCT00110305|527711375|FG001|Overall Study|Adverse Event|13|||
146328002|NCT00110305|527711374|FG000|Overall Study|Sponsors Decision|1|||
146328003|NCT00110305|527711375|FG001|Overall Study|Sponsors Decision|0|||
146328004|NCT00110305|527711374|FG000|Overall Study|Subject Non-Compliant|9|||
146328005|NCT00110305|527711375|FG001|Overall Study|Subject Non-Compliant|2|||
146328006|NCT00110305|527711374|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146328007|NCT00110305|527711375|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
146328008|NCT00110305|527711374|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
146328009|NCT00110305|527711375|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
146328010|NCT00110305|527711374|FG000|Overall Study|Protocol Violation|0|||
146328011|NCT00110305|527711375|FG001|Overall Study|Protocol Violation|1|||
146328012|NCT00110305|527711374|FG000|Overall Study|Withdrawal by Subject|7|||
146328013|NCT00110305|527711375|FG001|Overall Study|Withdrawal by Subject|7|||
146328014|NCT00110305|527711374|FG000|Overall Study|Lost to Follow-up|20|||
146328015|NCT00110305|527711375|FG001|Overall Study|Lost to Follow-up|3|||
146328016|NCT00110305|527711374|FG000|Overall Study|Other|8|||
146328017|NCT00110305|527711375|FG001|Overall Study|Other|2|||
146328018|NCT05047523|527711376|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146328019|NCT05047523|527711377|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146328020|NCT05047523|527711378|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
146328021|NCT05047523|527711379|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146328022|NCT05047523|527711380|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146328023|NCT05047523|527711381|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
146328024|NCT05047523|527711376|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146328025|NCT05047523|527711377|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
146328026|NCT05047523|527711378|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146328027|NCT05047523|527711379|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146328028|NCT05047523|527711380|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146328029|NCT05047523|527711381|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
146328030|NCT05047523|527711376|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
146328031|NCT05047523|527711377|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
146328032|NCT05047523|527711378|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
146328033|NCT05047523|527711379|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
146328034|NCT05047523|527711380|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
146328035|NCT05047523|527711381|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
146328036|NCT05047523|527711376|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
146328037|NCT05047523|527711377|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146328038|NCT05047523|527711378|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146328039|NCT05047523|527711379|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146328040|NCT05047523|527711380|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146328041|NCT05047523|527711381|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
146328042|NCT05047523|527711376|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146328043|NCT05047523|527711377|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146328044|NCT05047523|527711378|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146328045|NCT05047523|527711379|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
146328046|NCT05047523|527711380|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
146328047|NCT05047523|527711381|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
146328048|NCT05047523|527711376|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
146328049|NCT05047523|527711377|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
146328050|NCT05047523|527711378|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
146328051|NCT05047523|527711379|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
146328052|NCT05047523|527711380|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
146328053|NCT05047523|527711381|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
146328054|NCT00365989|527711382|FG000|Overall Study|Withdrawal by Subject|1|||
146328055|NCT00365989|527711382|FG000|Overall Study|Non-compliance|1|||
146328056|NCT00832819|527711385|FG000|Overall Study|Adverse Event|0|||
146328057|NCT00832819|527711386|FG001|Overall Study|Adverse Event|1|||
146328058|NCT00832819|527711387|FG002|Overall Study|Adverse Event|0|||
146328059|NCT00832819|527711385|FG000|Overall Study|Protocol Violation|0|||
146328060|NCT00832819|527711386|FG001|Overall Study|Protocol Violation|0|||
146328061|NCT00832819|527711387|FG002|Overall Study|Protocol Violation|1|||
146328062|NCT00317044|527711388|FG000|Overall Study|Protocol Violation|28|||
146328063|NCT00317044|527711389|FG001|Overall Study|Protocol Violation|22|||
146328064|NCT00317044|527711390|FG002|Overall Study|Protocol Violation|20|||
146328065|NCT00317044|527711388|FG000|Overall Study|Adverse Event|4|||
146328066|NCT00317044|527711389|FG001|Overall Study|Adverse Event|7|||
146328067|NCT00317044|527711390|FG002|Overall Study|Adverse Event|4|||
146328068|NCT00317044|527711388|FG000|Overall Study|Withdrawal by Subject|10|||
146328069|NCT00317044|527711389|FG001|Overall Study|Withdrawal by Subject|7|||
146328070|NCT00317044|527711390|FG002|Overall Study|Withdrawal by Subject|12|||
146328071|NCT00317044|527711388|FG000|Overall Study|Lost to Follow-up|0|||
146328072|NCT00317044|527711389|FG001|Overall Study|Lost to Follow-up|2|||
146328073|NCT00317044|527711390|FG002|Overall Study|Lost to Follow-up|3|||
146328074|NCT00317044|527711388|FG000|Overall Study|Multiple Reasons|6|||
146328075|NCT00317044|527711389|FG001|Overall Study|Multiple Reasons|2|||
146328076|NCT00317044|527711390|FG002|Overall Study|Multiple Reasons|6|||
146328077|NCT02318095|527711391|FG000|Overall Study|Adverse Event|1|||
146328078|NCT01717638|527711392|FG000|Overall Study|Lost to Follow-up|0|||
146328079|NCT01717638|527711393|FG001|Overall Study|Lost to Follow-up|0|||
146328080|NCT01717638|527711394|FG002|Overall Study|Lost to Follow-up|0|||
146328081|NCT01717638|527711395|FG003|Overall Study|Lost to Follow-up|0|||
146328082|NCT01717638|527711396|FG004|Overall Study|Lost to Follow-up|0|||
146328083|NCT01717638|527711397|FG005|Overall Study|Lost to Follow-up|1|||
146328084|NCT01717638|527711398|FG006|Overall Study|Lost to Follow-up|0|||
146328085|NCT01717638|527711399|FG007|Overall Study|Lost to Follow-up|0|||
146328086|NCT01717638|527711400|FG008|Overall Study|Lost to Follow-up|0|||
146328087|NCT01717638|527711401|FG009|Overall Study|Lost to Follow-up|0|||
146328088|NCT01717638|527711402|FG010|Overall Study|Lost to Follow-up|0|||
146328089|NCT01717638|527711403|FG011|Overall Study|Lost to Follow-up|0|||
146328090|NCT01717638|527711404|FG012|Overall Study|Lost to Follow-up|0|||
146328091|NCT01717638|527711392|FG000|Overall Study|Father in hospital|0|||
146328092|NCT01717638|527711393|FG001|Overall Study|Father in hospital|0|||
146328093|NCT01717638|527711394|FG002|Overall Study|Father in hospital|0|||
146328094|NCT01717638|527711395|FG003|Overall Study|Father in hospital|0|||
146328095|NCT01717638|527711396|FG004|Overall Study|Father in hospital|0|||
146328096|NCT01717638|527711397|FG005|Overall Study|Father in hospital|0|||
146328097|NCT01717638|527711398|FG006|Overall Study|Father in hospital|0|||
146328098|NCT01717638|527711399|FG007|Overall Study|Father in hospital|0|||
146328099|NCT01717638|527711400|FG008|Overall Study|Father in hospital|0|||
146328100|NCT01717638|527711401|FG009|Overall Study|Father in hospital|0|||
146328101|NCT01717638|527711402|FG010|Overall Study|Father in hospital|0|||
146328102|NCT01717638|527711403|FG011|Overall Study|Father in hospital|0|||
146328103|NCT01717638|527711404|FG012|Overall Study|Father in hospital|1|||
146328104|NCT01717638|527711392|FG000|Overall Study|Withdrawal by Subject|0|||
146328105|NCT01717638|527711393|FG001|Overall Study|Withdrawal by Subject|1|||
146328106|NCT01717638|527711394|FG002|Overall Study|Withdrawal by Subject|1|||
146328107|NCT01717638|527711395|FG003|Overall Study|Withdrawal by Subject|0|||
146167034|NCT00106184|527124298|FG001|Overall Study|Withdrawal by Subject|2|||
146167035|NCT02313909|527124302|FG000|Overall Study|Consent withdrawn by participant|33|||
146328108|NCT01717638|527711396|FG004|Overall Study|Withdrawal by Subject|1|||
146328109|NCT01717638|527711397|FG005|Overall Study|Withdrawal by Subject|0|||
146328110|NCT01717638|527711398|FG006|Overall Study|Withdrawal by Subject|2|||
146328111|NCT01717638|527711399|FG007|Overall Study|Withdrawal by Subject|1|||
146328112|NCT01717638|527711400|FG008|Overall Study|Withdrawal by Subject|2|||
146328113|NCT01717638|527711401|FG009|Overall Study|Withdrawal by Subject|1|||
146328114|NCT01717638|527711402|FG010|Overall Study|Withdrawal by Subject|0|||
146328115|NCT01717638|527711403|FG011|Overall Study|Withdrawal by Subject|0|||
146328116|NCT01717638|527711404|FG012|Overall Study|Withdrawal by Subject|18|||
146328117|NCT01719757|527711406|FG000|Overall Study|Adverse Event|38|||
146328118|NCT01719757|527711406|FG000|Overall Study|Withdrawal by Subject|15|||
146328119|NCT01719757|527711406|FG000|Overall Study|Lost to Follow-up|20|||
146328120|NCT01719757|527711406|FG000|Overall Study|Protocol Violation|1|||
146328121|NCT01719757|527711406|FG000|Overall Study|well controlled pain|27|||
146328122|NCT02626338|527711407|FG000|Overall Study|Lack of Efficacy|3|||
146328123|NCT02626338|527711408|FG001|Overall Study|Lack of Efficacy|2|||
146328124|NCT02626338|527711409|FG002|Overall Study|Lack of Efficacy|0|||
146328125|NCT01901224|527711410|FG000|Overall Study|study was not funded and terminated|2|||
146328126|NCT02300129|527711411|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146328127|NCT02300129|527711412|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
146328128|NCT02300129|527711413|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146328129|NCT02300129|527711414|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
146328130|NCT02300129|527711411|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146328131|NCT02300129|527711412|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146328132|NCT02300129|527711413|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
146328133|NCT02300129|527711414|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
146328134|NCT02300129|527711411|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
146328135|NCT02300129|527711412|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146328136|NCT02300129|527711413|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146328137|NCT02300129|527711414|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
146328138|NCT00522392|527711418|FG000|Overall Study|Disease progression|0|||
146328139|NCT00522392|527711419|FG001|Overall Study|Disease progression|3|||
146328140|NCT00522392|527711418|FG000|Overall Study|Adverse Event|7|||
146328141|NCT00522392|527711419|FG001|Overall Study|Adverse Event|7|||
146328142|NCT00522392|527711418|FG000|Overall Study|Withdrawal by Subject|1|||
146328143|NCT00522392|527711419|FG001|Overall Study|Withdrawal by Subject|1|||
146328144|NCT00522392|527711418|FG000|Overall Study|Physician Decision|0|||
146328145|NCT00522392|527711419|FG001|Overall Study|Physician Decision|1|||
146328146|NCT00522392|527711418|FG000|Overall Study|Non-compliance|0|||
146328147|NCT00522392|527711419|FG001|Overall Study|Non-compliance|1|||
146328148|NCT00430755|527711425|FG000|Overall Study|Withdrawal by Subject|53|||
146328149|NCT00103012|527711428|FG000|Overall Study|Withdrawal by Subject|2|||
146328150|NCT00103012|527711429|FG001|Overall Study|Withdrawal by Subject|1|||
146328151|NCT00103012|527711430|FG002|Overall Study|Withdrawal by Subject|2|||
146328152|NCT00103012|527711428|FG000|Overall Study|Pregnancy|1|||
146328153|NCT00103012|527711429|FG001|Overall Study|Pregnancy|0|||
146328154|NCT00103012|527711430|FG002|Overall Study|Pregnancy|0|||
146328155|NCT00103012|527711428|FG000|Overall Study|Adverse Event|0|||
146328156|NCT00103012|527711429|FG001|Overall Study|Adverse Event|0|||
146328157|NCT00103012|527711430|FG002|Overall Study|Adverse Event|1|||
146328158|NCT00103012|527711428|FG000|Overall Study|Subject non-compliant with medications|0|||
146328159|NCT00103012|527711429|FG001|Overall Study|Subject non-compliant with medications|0|||
146328160|NCT00103012|527711430|FG002|Overall Study|Subject non-compliant with medications|1|||
146328161|NCT05211336|527711435|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
146328162|NCT05211336|527711436|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
146328163|NCT05211336|527711435|FG000|Overall Study|Progressive disease|0|||
146328164|NCT05211336|527711436|FG001|Overall Study|Progressive disease|4|||
146328165|NCT05211336|527711435|FG000|Overall Study|Death due to myocardial infarction|0|||
146328166|NCT05211336|527711436|FG001|Overall Study|Death due to myocardial infarction|1|||
146328167|NCT05211336|527711435|FG000|Overall Study|Death due to unknown cause|0|||
146328168|NCT05211336|527711436|FG001|Overall Study|Death due to unknown cause|1|||
146328169|NCT05211336|527711435|FG000|Overall Study|Worsening kidney function and quality of response|0|||
146328170|NCT05211336|527711436|FG001|Overall Study|Worsening kidney function and quality of response|1|||
146328171|NCT00393718|527711441|FG000|Overall Study|Adverse Event|20|||
146328172|NCT00393718|527711442|FG001|Overall Study|Adverse Event|8|||
146328173|NCT00393718|527711441|FG000|Overall Study|Protocol Violation|1|||
146328174|NCT00393718|527711442|FG001|Overall Study|Protocol Violation|2|||
146328175|NCT00393718|527711441|FG000|Overall Study|Lack of Efficacy|10|||
146328176|NCT00393718|527711442|FG001|Overall Study|Lack of Efficacy|9|||
146328177|NCT00393718|527711441|FG000|Overall Study|Hypoglycaemia|3|||
146328178|NCT00393718|527711442|FG001|Overall Study|Hypoglycaemia|2|||
146328179|NCT00393718|527711441|FG000|Overall Study|Subject decision|5|||
146328180|NCT00393718|527711442|FG001|Overall Study|Subject decision|0|||
146328181|NCT00393718|527711441|FG000|Overall Study|Withdrawal of consent|2|||
146328182|NCT00393718|527711442|FG001|Overall Study|Withdrawal of consent|1|||
146328183|NCT00393718|527711441|FG000|Overall Study|Missed measurement|1|||
146328184|NCT00393718|527711442|FG001|Overall Study|Missed measurement|0|||
146328185|NCT00393718|527711441|FG000|Overall Study|Move|1|||
146328186|NCT00393718|527711442|FG001|Overall Study|Move|0|||
146328187|NCT01084551|527711447|FG000|Overall Study|Adverse Event|2|||
146328188|NCT01084551|527711448|FG001|Overall Study|Adverse Event|9|||
146328189|NCT01084551|527711449|FG002|Overall Study|Adverse Event|4|||
146328190|NCT01084551|527711447|FG000|Overall Study|Lack of Efficacy|2|||
146328191|NCT01084551|527711448|FG001|Overall Study|Lack of Efficacy|0|||
146328192|NCT01084551|527711449|FG002|Overall Study|Lack of Efficacy|1|||
146328193|NCT01084551|527711447|FG000|Overall Study|Withdrawal by Subject|2|||
146328194|NCT01084551|527711448|FG001|Overall Study|Withdrawal by Subject|1|||
146328195|NCT01084551|527711449|FG002|Overall Study|Withdrawal by Subject|0|||
146328196|NCT01084551|527711447|FG000|Overall Study|Protocol Violation|2|||
146328197|NCT01084551|527711448|FG001|Overall Study|Protocol Violation|4|||
146328198|NCT01084551|527711449|FG002|Overall Study|Protocol Violation|0|||
146328199|NCT01084551|527711447|FG000|Overall Study|Lost to Follow-up|0|||
146328200|NCT01084551|527711448|FG001|Overall Study|Lost to Follow-up|0|||
146328201|NCT01084551|527711449|FG002|Overall Study|Lost to Follow-up|3|||
146328202|NCT01084551|527711447|FG000|Overall Study|Physician Decision|1|||
146328203|NCT01084551|527711448|FG001|Overall Study|Physician Decision|0|||
146328204|NCT01084551|527711449|FG002|Overall Study|Physician Decision|0|||
146328205|NCT03575104|527711450|FG000|Overall Study|Adverse Event|4|||
146328206|NCT03575104|527711451|FG001|Overall Study|Adverse Event|3|||
146328207|NCT03575104|527711452|FG002|Overall Study|Adverse Event|4|||
146328208|NCT03575104|527711450|FG000|Overall Study|Withdrawal by Subject|13|||
146328209|NCT03575104|527711451|FG001|Overall Study|Withdrawal by Subject|16|||
146328210|NCT03575104|527711452|FG002|Overall Study|Withdrawal by Subject|11|||
146328211|NCT03575104|527711450|FG000|Overall Study|Other reasons|6|||
146328212|NCT03575104|527711451|FG001|Overall Study|Other reasons|8|||
146328213|NCT03575104|527711452|FG002|Overall Study|Other reasons|6|||
146328214|NCT03575104|527711450|FG000|Overall Study|Lost to Follow-up|1|||
146328215|NCT03575104|527711451|FG001|Overall Study|Lost to Follow-up|2|||
146328216|NCT03575104|527711452|FG002|Overall Study|Lost to Follow-up|1|||
146328217|NCT04684420|527711453|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146328218|NCT04684420|527711454|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
146328219|NCT04684420|527711455|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
146328220|NCT04684420|527711456|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
146328221|NCT04684420|527711453|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
146328222|NCT04684420|527711454|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
146328223|NCT04684420|527711455|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
146328224|NCT04684420|527711456|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
146328225|NCT00463476|527711457|FG000|Overall Study|Withdrawal by Subject|1|||
146328226|NCT00463476|527711458|FG001|Overall Study|Withdrawal by Subject|2|||
146328227|NCT00463476|527711457|FG000|Overall Study|Lost to Follow-up|1|||
146328228|NCT00463476|527711458|FG001|Overall Study|Lost to Follow-up|1|||
146328229|NCT01409928|527711461|FG000|Overall Study|Physician Decision|12|||
146328230|NCT01703000|527711462|FG000|Overall Study|Death|1|||
146328231|NCT01279057|527711463|FG000|Overall Study|Adverse Event|1|||
146328232|NCT01279057|527711464|FG001|Overall Study|Adverse Event|0|||
146328233|NCT01279057|527711465|FG002|Overall Study|Adverse Event|1|||
146328234|NCT01279057|527711463|FG000|Overall Study|Insufficient therapeutic response|0|||
146328235|NCT01279057|527711464|FG001|Overall Study|Insufficient therapeutic response|0|||
146328236|NCT01279057|527711465|FG002|Overall Study|Insufficient therapeutic response|1|||
146328237|NCT01279057|527711463|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146328238|NCT01279057|527711464|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
146328239|NCT01279057|527711465|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
146328240|NCT01279057|527711463|FG000|Overall Study|Withdrew consent|2|||
146328241|NCT01279057|527711464|FG001|Overall Study|Withdrew consent|0|||
146328242|NCT01279057|527711465|FG002|Overall Study|Withdrew consent|1|||
146328243|NCT01279057|527711463|FG000|Overall Study|Pregnancy|0|||
146328244|NCT01279057|527711464|FG001|Overall Study|Pregnancy|1|||
146328245|NCT01279057|527711465|FG002|Overall Study|Pregnancy|0|||
146328246|NCT01279057|527711463|FG000|Overall Study|Other|3|||
146328247|NCT01279057|527711464|FG001|Overall Study|Other|3|||
146328248|NCT01279057|527711465|FG002|Overall Study|Other|0|||
146328249|NCT03502187|527711468|FG000|Overall Study|Withdrawal by Subject|4|||
146328250|NCT03502187|527711469|FG001|Overall Study|Withdrawal by Subject|3|||
146328251|NCT03502187|527711470|FG002|Overall Study|Withdrawal by Subject|3|||
146328252|NCT03502187|527711468|FG000|Overall Study|Lost to Follow-up|5|||
146328253|NCT03502187|527711469|FG001|Overall Study|Lost to Follow-up|4|||
146328254|NCT03502187|527711470|FG002|Overall Study|Lost to Follow-up|5|||
146328255|NCT02411448|527711474|FG000|Overall Study|Withdrawal by Subject|1|||
146328256|NCT02411448|527711475|FG001|Overall Study|Withdrawal by Subject|14|||
146328257|NCT02411448|527711476|FG002|Overall Study|Withdrawal by Subject|9|||
146328258|NCT02411448|527711474|FG000|Overall Study|Other|0|||
146328259|NCT02411448|527711475|FG001|Overall Study|Other|2|||
146328260|NCT02411448|527711476|FG002|Overall Study|Other|0|||
146328261|NCT02411448|527711474|FG000|Overall Study|Did not receive study treatment|0|||
146328262|NCT02411448|527711475|FG001|Overall Study|Did not receive study treatment|3|||
146328263|NCT02411448|527711476|FG002|Overall Study|Did not receive study treatment|0|||
146328264|NCT02411448|527711474|FG000|Overall Study|Alive on study treatment|3|||
146328265|NCT02411448|527711475|FG001|Overall Study|Alive on study treatment|64|||
146328266|NCT02411448|527711476|FG002|Overall Study|Alive on study treatment|43|||
146328267|NCT01848145|527711477|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
146328268|NCT01848145|527711477|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
146328269|NCT01848145|527711477|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
146328270|NCT01848145|527711477|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
146328271|NCT01848145|527711477|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
146328272|NCT01848145|527711477|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
146328273|NCT01848145|527711477|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
146328274|NCT01728779|527711478|FG000|Overall Study|Withdrawal by Subject|1|||
146328275|NCT00624520|527711479|FG000|Overall Study|Withdrawal by Subject|12|||
146328276|NCT00624520|527711480|FG001|Overall Study|Withdrawal by Subject|7|||
146328277|NCT00624520|527711479|FG000|Overall Study|Death|0|||
146328278|NCT00624520|527711480|FG001|Overall Study|Death|1|||
146328279|NCT02649634|527711487|FG000|Overall Study|Withdrawal by Subject|3|||
146328280|NCT02649634|527711488|FG001|Overall Study|Withdrawal by Subject|5|||
146328281|NCT02649634|527711487|FG000|Overall Study|Lost to Follow-up|0|||
146328282|NCT02649634|527711488|FG001|Overall Study|Lost to Follow-up|1|||
146328283|NCT02658812|527711491|FG000|Overall Study|Disease Progression|7|||
146328284|NCT02658812|527711491|FG000|Overall Study|Unrelated to study treatment|1|||
146328285|NCT02658812|527711491|FG000|Overall Study|Adverse Event|1|||
146328286|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328287|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328288|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328289|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
146328290|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328291|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
146328292|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328293|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328294|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328295|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328296|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328297|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328298|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328299|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328300|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328301|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328302|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328303|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328304|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328305|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328306|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328307|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328308|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
146328309|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146328310|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
146328311|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146328312|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
146328313|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146328314|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146328315|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
146328316|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328317|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328318|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328319|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328320|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328321|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328322|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328323|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328324|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328325|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328326|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328327|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328328|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328329|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328330|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328331|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
146328332|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146328333|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
146328334|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146328335|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
146167036|NCT02313909|527124303|FG001|Overall Study|Consent withdrawn by participant|33|||
146167037|NCT02313909|527124302|FG000|Overall Study|Lost to Follow-up|24|||
146167038|NCT02313909|527124303|FG001|Overall Study|Lost to Follow-up|17|||
146328336|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
146167039|NCT00643123|527124309|FG000|Overall Study|Lost to Follow-up|4|||
146167040|NCT00643123|527124310|FG001|Overall Study|Lost to Follow-up|0|||
146328337|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
146328338|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146328339|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
146328340|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328341|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328342|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328343|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328344|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328345|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328346|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328347|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328348|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328349|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328350|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328351|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328352|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328353|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328354|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
146328355|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328356|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328357|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
146328358|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328359|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
146328360|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328361|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328362|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328363|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328364|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328365|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328366|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328367|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328368|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328369|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328370|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328371|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328372|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328373|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328374|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328375|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328376|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328377|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
146328378|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
146328379|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146167041|NCT00643123|527124309|FG000|Overall Study|Withdrawal by Subject|1|||
146167042|NCT00643123|527124310|FG001|Overall Study|Withdrawal by Subject|1|||
146167043|NCT02309112|527124311|FG000|Overall Study|Withdrawal by Subject|1|||
146167044|NCT02309112|527124312|FG001|Overall Study|Withdrawal by Subject|0|||
146328380|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328381|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
146328382|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328383|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328384|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328385|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328386|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328387|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328388|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328389|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328390|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328391|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328392|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328393|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328394|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146167045|NCT02309112|527124313|FG002|Overall Study|Withdrawal by Subject|1|||
145943239|NCT00483704|526300456|FG000|Treatment|Physician Decision|0|||
146167046|NCT02309112|527124311|FG000|Overall Study|Lost to Follow-up|0|||
146328395|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328396|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328397|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328398|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328399|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328400|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
146328401|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328402|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328403|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
146328404|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328405|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328406|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328407|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328408|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328409|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328410|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328411|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328412|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328413|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328414|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328415|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328416|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328417|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328418|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328419|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328420|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328421|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328422|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328423|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
146328424|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328425|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328426|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
146328427|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328428|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328429|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328430|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328431|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328432|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328433|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328434|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328435|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328436|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328437|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328438|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328439|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328440|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328441|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328442|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328443|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328444|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328445|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328446|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
146328447|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328448|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328449|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328450|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
146328451|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328452|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328453|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328454|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328455|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328456|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328457|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328458|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328459|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328460|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328461|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328462|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328463|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328464|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328465|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328466|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328467|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328468|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328469|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
146328470|NCT00896532|527711502|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328471|NCT00896532|527711503|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146328472|NCT00896532|527711504|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328473|NCT00896532|527711505|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146328474|NCT00896532|527711506|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
146328475|NCT00896532|527711507|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328476|NCT00896532|527711508|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328477|NCT00896532|527711509|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328478|NCT00896532|527711510|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328479|NCT00896532|527711511|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328480|NCT00896532|527711512|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328481|NCT00896532|527711513|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328482|NCT00896532|527711514|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328483|NCT00896532|527711515|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328484|NCT00896532|527711516|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328485|NCT00896532|527711517|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328486|NCT00896532|527711518|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328487|NCT00896532|527711519|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328488|NCT00896532|527711520|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328489|NCT00896532|527711521|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328490|NCT00896532|527711522|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328491|NCT00896532|527711523|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328492|NCT00896532|527711524|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
146328493|NCT00896532|527711502|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328494|NCT00896532|527711503|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328495|NCT00896532|527711504|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328496|NCT00896532|527711505|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328497|NCT00896532|527711506|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328498|NCT00896532|527711507|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328499|NCT00896532|527711508|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328500|NCT00896532|527711509|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328501|NCT00896532|527711510|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
146328502|NCT00896532|527711511|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328503|NCT00896532|527711512|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328504|NCT00896532|527711513|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328505|NCT00896532|527711514|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328506|NCT00896532|527711515|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328507|NCT00896532|527711516|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328508|NCT00896532|527711517|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328509|NCT00896532|527711518|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328510|NCT00896532|527711519|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328511|NCT00896532|527711520|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328512|NCT00896532|527711521|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328513|NCT00896532|527711522|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328514|NCT00896532|527711523|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328515|NCT00896532|527711524|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
146328516|NCT00896532|527711502|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328517|NCT00896532|527711503|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328518|NCT00896532|527711504|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328519|NCT00896532|527711505|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328520|NCT00896532|527711506|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328521|NCT00896532|527711507|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328522|NCT00896532|527711508|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328523|NCT00896532|527711509|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328524|NCT00896532|527711510|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146167047|NCT02309112|527124312|FG001|Overall Study|Lost to Follow-up|1|||
146167048|NCT02309112|527124313|FG002|Overall Study|Lost to Follow-up|0|||
146167049|NCT02133872|527124314|FG000|Overall Study|Withdrawal by Subject|5|||
146167050|NCT02133872|527124315|FG001|Overall Study|Withdrawal by Subject|3|||
146167051|NCT02133872|527124316|FG002|Overall Study|Withdrawal by Subject|0|||
146167052|NCT02923739|527124317|FG000|Overall Study|Withdrawal by Subject|2|||
146167053|NCT02923739|527124318|FG001|Overall Study|Withdrawal by Subject|0|||
146167054|NCT02923739|527124319|FG002|Overall Study|Withdrawal by Subject|0|||
146167055|NCT02923739|527124320|FG003|Overall Study|Withdrawal by Subject|0|||
146167056|NCT02923739|527124317|FG000|Overall Study|Failed Screening|3|||
146167057|NCT02923739|527124318|FG001|Overall Study|Failed Screening|0|||
146167058|NCT02923739|527124319|FG002|Overall Study|Failed Screening|0|||
146167059|NCT02923739|527124320|FG003|Overall Study|Failed Screening|0|||
146167060|NCT02857426|527124325|FG000|Overall Study|Disease progression|34|||
146167061|NCT02857426|527124326|FG001|Overall Study|Disease progression|13|||
146167062|NCT02857426|527124325|FG000|Overall Study|Study drug toxicity|4|||
146167063|NCT02857426|527124326|FG001|Overall Study|Study drug toxicity|1|||
146167064|NCT02857426|527124325|FG000|Overall Study|Death|1|||
146328525|NCT00896532|527711511|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328526|NCT00896532|527711512|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328527|NCT00896532|527711513|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328528|NCT00896532|527711514|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
146328529|NCT00896532|527711515|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328530|NCT00896532|527711516|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328531|NCT00896532|527711517|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328532|NCT00896532|527711518|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328533|NCT00896532|527711519|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328534|NCT00896532|527711520|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328535|NCT00896532|527711521|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328536|NCT00896532|527711522|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328537|NCT00896532|527711523|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328538|NCT00896532|527711524|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
146328539|NCT00896532|527711502|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328540|NCT00896532|527711503|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328541|NCT00896532|527711504|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328542|NCT00896532|527711505|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328543|NCT00896532|527711506|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328544|NCT00896532|527711507|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328545|NCT00896532|527711508|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328546|NCT00896532|527711509|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328547|NCT00896532|527711510|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328548|NCT00896532|527711511|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328549|NCT00896532|527711512|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
146328550|NCT00896532|527711513|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328551|NCT00896532|527711514|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
146328552|NCT00896532|527711515|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328553|NCT00896532|527711516|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328554|NCT00896532|527711517|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328555|NCT00896532|527711518|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328556|NCT00896532|527711519|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328557|NCT00896532|527711520|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328558|NCT00896532|527711521|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328559|NCT00896532|527711522|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328560|NCT00896532|527711523|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328561|NCT00896532|527711524|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
146328562|NCT00896532|527711502|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328563|NCT00896532|527711503|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328564|NCT00896532|527711504|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328565|NCT00896532|527711505|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328566|NCT00896532|527711506|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328567|NCT00896532|527711507|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146167065|NCT02857426|527124326|FG001|Overall Study|Death|0|||
146167066|NCT02857426|527124325|FG000|Overall Study|Adverse event unrelated to study drug|6|||
146167067|NCT02857426|527124326|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146167068|NCT02857426|527124325|FG000|Overall Study|Participant withdrew consent|1|||
146328568|NCT00896532|527711508|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328569|NCT00896532|527711509|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328570|NCT00896532|527711510|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328571|NCT00896532|527711511|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328572|NCT00896532|527711512|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328573|NCT00896532|527711513|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328574|NCT00896532|527711514|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
146167069|NCT02857426|527124326|FG001|Overall Study|Participant withdrew consent|1|||
146167070|NCT02857426|527124325|FG000|Overall Study|Maximum clinical benefit|1|||
146167071|NCT02857426|527124326|FG001|Overall Study|Maximum clinical benefit|0|||
146167072|NCT02857426|527124325|FG000|Overall Study|Completed treatment|0|||
146167073|NCT02857426|527124326|FG001|Overall Study|Completed treatment|2|||
146167074|NCT02634788|527124330|FG000|Overall Study|Adverse Event|0|||
146167075|NCT02634788|527124331|FG001|Overall Study|Adverse Event|8|||
146167076|NCT02634788|527124332|FG002|Overall Study|Adverse Event|3|||
146167077|NCT02634788|527124333|FG003|Overall Study|Adverse Event|1|||
146167078|NCT02634788|527124330|FG000|Overall Study|Lack of Efficacy|4|||
146167079|NCT02634788|527124331|FG001|Overall Study|Lack of Efficacy|0|||
146167080|NCT02634788|527124332|FG002|Overall Study|Lack of Efficacy|1|||
146167081|NCT02634788|527124333|FG003|Overall Study|Lack of Efficacy|4|||
146167082|NCT02634788|527124330|FG000|Overall Study|Lost to Follow-up|0|||
146167083|NCT02634788|527124331|FG001|Overall Study|Lost to Follow-up|1|||
146167084|NCT02634788|527124332|FG002|Overall Study|Lost to Follow-up|0|||
146167085|NCT02634788|527124333|FG003|Overall Study|Lost to Follow-up|0|||
146167086|NCT02634788|527124330|FG000|Overall Study|Withdrawal by Subject|0|||
146167087|NCT02634788|527124331|FG001|Overall Study|Withdrawal by Subject|1|||
146167088|NCT02634788|527124332|FG002|Overall Study|Withdrawal by Subject|1|||
146167089|NCT02634788|527124333|FG003|Overall Study|Withdrawal by Subject|0|||
146167090|NCT00758459|527124334|FG000|Overall Study|Adverse Event|3|||
146167091|NCT00758459|527124335|FG001|Overall Study|Adverse Event|2|||
146328575|NCT00896532|527711515|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
146328576|NCT00896532|527711516|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328577|NCT00896532|527711517|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328578|NCT00896532|527711518|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328579|NCT00896532|527711519|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328580|NCT00896532|527711520|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328581|NCT00896532|527711521|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328582|NCT00896532|527711522|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328583|NCT00896532|527711523|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328584|NCT00896532|527711524|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
146328585|NCT00896532|527711502|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
146328586|NCT00896532|527711503|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
146328587|NCT00896532|527711504|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
146328588|NCT00896532|527711505|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
146328589|NCT00896532|527711506|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
146328590|NCT00896532|527711507|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
146328591|NCT00896532|527711508|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
146328592|NCT00896532|527711509|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
146328593|NCT00896532|527711510|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
146328594|NCT00896532|527711511|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
146328595|NCT00896532|527711512|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
146328596|NCT00896532|527711513|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
146328597|NCT00896532|527711514|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
146328598|NCT00896532|527711515|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
146328599|NCT00896532|527711516|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
146328600|NCT00896532|527711517|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
146328601|NCT00896532|527711518|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
146328602|NCT00896532|527711519|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
146328603|NCT00896532|527711520|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
146328604|NCT00896532|527711521|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
146328605|NCT00896532|527711522|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
146328606|NCT00896532|527711523|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
146328607|NCT00896532|527711524|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
146328608|NCT00896532|527711502|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145943240|NCT00483704|526300457|FG001|Treatment|Physician Decision|1|||
146167092|NCT00758459|527124334|FG000|Overall Study|Protocol Violation|0|||
146167093|NCT00758459|527124335|FG001|Overall Study|Protocol Violation|1|||
146167094|NCT00758459|527124334|FG000|Overall Study|Withdrawal by Subject|0|||
146167095|NCT00758459|527124335|FG001|Overall Study|Withdrawal by Subject|1|||
146167096|NCT02831257|527124337|FG000|Overall Study|Lack of Efficacy|3|||
146328609|NCT00896532|527711503|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328610|NCT00896532|527711504|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328611|NCT00896532|527711505|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328612|NCT00896532|527711506|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328613|NCT00896532|527711507|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328614|NCT00896532|527711508|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328615|NCT00896532|527711509|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328616|NCT00896532|527711510|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328617|NCT00896532|527711511|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328618|NCT00896532|527711512|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328619|NCT00896532|527711513|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328620|NCT00896532|527711514|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328621|NCT00896532|527711515|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328622|NCT00896532|527711516|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328623|NCT00896532|527711517|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
146328624|NCT00896532|527711518|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
146328625|NCT00896532|527711519|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328626|NCT00896532|527711520|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328627|NCT00896532|527711521|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328628|NCT00896532|527711522|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328629|NCT00896532|527711523|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328630|NCT00896532|527711524|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
146328631|NCT00896532|527711502|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328632|NCT00896532|527711503|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328633|NCT00896532|527711504|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328634|NCT00896532|527711505|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328635|NCT00896532|527711506|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328636|NCT00896532|527711507|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328637|NCT00896532|527711508|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328638|NCT00896532|527711509|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328639|NCT00896532|527711510|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328640|NCT00896532|527711511|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328641|NCT00896532|527711512|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328642|NCT00896532|527711513|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328643|NCT00896532|527711514|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328644|NCT00896532|527711515|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328645|NCT00896532|527711516|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328646|NCT00896532|527711517|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
146328647|NCT00896532|527711518|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
146328648|NCT00896532|527711519|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
146328649|NCT00896532|527711520|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328650|NCT00896532|527711521|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328651|NCT00896532|527711522|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328652|NCT00896532|527711523|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328653|NCT00896532|527711524|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
146328654|NCT00896532|527711502|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328655|NCT00896532|527711503|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328656|NCT00896532|527711504|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328657|NCT00896532|527711505|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328658|NCT00896532|527711506|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328659|NCT00896532|527711507|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328660|NCT00896532|527711508|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328661|NCT00896532|527711509|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328662|NCT00896532|527711510|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328663|NCT00896532|527711511|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328664|NCT00896532|527711512|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328665|NCT00896532|527711513|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328666|NCT00896532|527711514|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328667|NCT00896532|527711515|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328668|NCT00896532|527711516|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328669|NCT00896532|527711517|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328670|NCT00896532|527711518|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
146328671|NCT00896532|527711519|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328672|NCT00896532|527711520|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328673|NCT00896532|527711521|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328674|NCT00896532|527711522|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328675|NCT00896532|527711523|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328676|NCT00896532|527711524|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
146328677|NCT00896532|527711502|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
146328678|NCT00896532|527711503|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
146328679|NCT00896532|527711504|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
146328680|NCT00896532|527711505|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
146328681|NCT00896532|527711506|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
146167097|NCT02831257|527124337|FG000|Overall Study|Adverse Event|2|||
146167098|NCT02831257|527124337|FG000|Overall Study|Physician Decision|1|||
146167099|NCT02831257|527124337|FG000|Overall Study|Withdrawal by Subject|6|||
146167100|NCT00611858|527124338|FG000|Overall Study|Adverse Event|2|||
146167101|NCT00611858|527124338|FG000|Overall Study|Withdrawal by Subject|2|||
146167102|NCT00166296|527124340|FG000|Overall Study|Withdrawal by Subject|1|||
146167103|NCT00166296|527124341|FG001|Overall Study|Withdrawal by Subject|3|||
146167104|NCT00166296|527124340|FG000|Overall Study|Adverse Event|2|||
146167105|NCT00166296|527124341|FG001|Overall Study|Adverse Event|4|||
146167106|NCT00166296|527124340|FG000|Overall Study|Lost to Follow-up|4|||
146167107|NCT00166296|527124341|FG001|Overall Study|Lost to Follow-up|2|||
146167108|NCT04035200|527124347|FG000|Overall Study|Lost to Follow-up|0|||
146167109|NCT04035200|527124348|FG001|Overall Study|Lost to Follow-up|1|||
146167110|NCT04035200|527124349|FG002|Overall Study|Lost to Follow-up|0|||
146167111|NCT04035200|527124347|FG000|Overall Study|Withdrawal by Subject|1|||
146167112|NCT04035200|527124348|FG001|Overall Study|Withdrawal by Subject|4|||
146167113|NCT04035200|527124349|FG002|Overall Study|Withdrawal by Subject|4|||
146167114|NCT04035200|527124347|FG000|Overall Study|COVID-19|1|||
146167115|NCT04035200|527124348|FG001|Overall Study|COVID-19|0|||
146167116|NCT04035200|527124349|FG002|Overall Study|COVID-19|0|||
146167117|NCT04035200|527124347|FG000|Overall Study|Early Termination|0|||
146167118|NCT04035200|527124348|FG001|Overall Study|Early Termination|1|||
146167119|NCT04035200|527124349|FG002|Overall Study|Early Termination|0|||
146167120|NCT04035200|527124347|FG000|Overall Study|Non-compliance|0|||
146167121|NCT04035200|527124348|FG001|Overall Study|Non-compliance|1|||
146167122|NCT04035200|527124349|FG002|Overall Study|Non-compliance|0|||
146167123|NCT05479604|527124350|FG000|Overall Study|Lost to Follow-up|1|||
146167124|NCT05479604|527124351|FG001|Overall Study|Lost to Follow-up|5|||
146167125|NCT03138733|527124352|FG000|Overall Study|Death|17|||
146167126|NCT03138733|527124353|FG001|Overall Study|Death|18|||
146167127|NCT03138733|527124352|FG000|Overall Study|Withdrawal by Subject|11|||
146167128|NCT03138733|527124353|FG001|Overall Study|Withdrawal by Subject|6|||
146167129|NCT03138733|527124352|FG000|Overall Study|Lost to Follow-up|3|||
146167130|NCT03138733|527124353|FG001|Overall Study|Lost to Follow-up|2|||
146167131|NCT03138733|527124352|FG000|Overall Study|Adverse Event|1|||
146167132|NCT03138733|527124353|FG001|Overall Study|Adverse Event|0|||
146167133|NCT03138733|527124352|FG000|Overall Study|Protocol Violation|1|||
146167134|NCT03138733|527124353|FG001|Overall Study|Protocol Violation|3|||
146167135|NCT03138733|527124352|FG000|Overall Study|Administrative or logistical reason|1|||
146167136|NCT03138733|527124353|FG001|Overall Study|Administrative or logistical reason|0|||
146167137|NCT03138733|527124352|FG000|Overall Study|The patient was transferred to another hospital|1|||
146167138|NCT03138733|527124353|FG001|Overall Study|The patient was transferred to another hospital|0|||
146167139|NCT02061202|527124357|FG000|Overall Study|Lost to Follow-up|1|||
146167140|NCT02061202|527124358|FG001|Overall Study|Lost to Follow-up|1|||
146167141|NCT05614089|527124361|FG000|Overall Study|Pregnancy|5|||
146167142|NCT05614089|527124362|FG001|Overall Study|Pregnancy|2|||
146167143|NCT05614089|527124361|FG000|Overall Study|Lost to Follow-up|5|||
146167144|NCT05614089|527124362|FG001|Overall Study|Lost to Follow-up|1|||
146167145|NCT05614089|527124361|FG000|Overall Study|Death|0|||
146167146|NCT05614089|527124362|FG001|Overall Study|Death|1|||
146167147|NCT05614089|527124361|FG000|Overall Study|Adverse Event|1|||
146328682|NCT00896532|527711507|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
146167148|NCT05614089|527124362|FG001|Overall Study|Adverse Event|0|||
146167149|NCT05163522|527124363|FG000|Overall Study|Withdrawal by Subject|0|||
146167150|NCT05163522|527124364|FG001|Overall Study|Withdrawal by Subject|0|||
146167151|NCT05163522|527124365|FG002|Overall Study|Withdrawal by Subject|1|||
146167152|NCT05163522|527124366|FG003|Overall Study|Withdrawal by Subject|0|||
146167153|NCT05163522|527124367|FG004|Overall Study|Withdrawal by Subject|0|||
146167154|NCT05163522|527124368|FG005|Overall Study|Withdrawal by Subject|0|||
146167155|NCT05163522|527124369|FG006|Overall Study|Withdrawal by Subject|0|||
146167156|NCT05163522|527124370|FG007|Overall Study|Withdrawal by Subject|0|||
146167157|NCT05163522|527124371|FG008|Overall Study|Withdrawal by Subject|0|||
146167158|NCT05163522|527124372|FG009|Overall Study|Withdrawal by Subject|0|||
146167159|NCT05163522|527124373|FG010|Overall Study|Withdrawal by Subject|0|||
146167160|NCT02521285|527124375|FG000|Overall Study|Lost to Follow-up|1|||
146167161|NCT02521285|527124376|FG001|Overall Study|Lost to Follow-up|1|||
146328683|NCT00896532|527711508|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
146328684|NCT00896532|527711509|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
146167162|NCT02521285|527124375|FG000|Overall Study|Withdrawal by Subject|1|||
146167163|NCT02521285|527124376|FG001|Overall Study|Withdrawal by Subject|1|||
146167164|NCT02521285|527124375|FG000|Overall Study|Adverse Event|0|||
146167165|NCT02521285|527124376|FG001|Overall Study|Adverse Event|1|||
146167166|NCT05701995|527124378|FG000|Pre-Treatment|Randomization Error|1|||
146167167|NCT05701995|527124379|FG001|Pre-Treatment|Randomization Error|1|||
146167168|NCT05701995|527124378|FG000|Treatment|Withdrawal by Subject|8|||
146167169|NCT05701995|527124379|FG001|Treatment|Withdrawal by Subject|4|||
146167170|NCT05701995|527124378|FG000|Treatment|Lost to Follow-up|2|||
146167171|NCT05701995|527124379|FG001|Treatment|Lost to Follow-up|3|||
146167172|NCT05701995|527124378|FG000|Treatment|Adverse Event|3|||
146167173|NCT05701995|527124379|FG001|Treatment|Adverse Event|1|||
146167174|NCT05701995|527124378|FG000|Treatment|Other Reason|1|||
146167175|NCT05701995|527124379|FG001|Treatment|Other Reason|1|||
146167176|NCT05701995|527124378|FG000|Treatment|Death|1|||
146167177|NCT05701995|527124379|FG001|Treatment|Death|0|||
146167178|NCT05701995|527124378|FG000|Treatment|Physician Decision|0|||
146167179|NCT05701995|527124379|FG001|Treatment|Physician Decision|1|||
146167180|NCT02753595|527124387|FG000|Overall Study|Sponsor termination|2|||
146167181|NCT02753595|527124388|FG001|Overall Study|Sponsor termination|2|||
146167182|NCT01570868|527124389|FG000|Overall Study|Adverse Event|8|||
146167183|NCT01570868|527124390|FG001|Overall Study|Adverse Event|1|||
146328685|NCT00896532|527711510|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
146328686|NCT00896532|527711511|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
146328687|NCT00896532|527711512|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
146328688|NCT00896532|527711513|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
146328689|NCT00896532|527711514|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
146328690|NCT00896532|527711515|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
146328691|NCT00896532|527711516|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
146328692|NCT00896532|527711517|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
146328693|NCT00896532|527711518|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
146328694|NCT00896532|527711519|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
146328695|NCT00896532|527711520|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
146328696|NCT00896532|527711521|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
146328697|NCT00896532|527711522|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
146328698|NCT00896532|527711523|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
146328699|NCT00896532|527711524|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
146328700|NCT00896532|527711502|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328701|NCT00896532|527711503|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328702|NCT00896532|527711504|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328703|NCT00896532|527711505|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328704|NCT00896532|527711506|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328705|NCT00896532|527711507|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328706|NCT00896532|527711508|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328707|NCT00896532|527711509|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328708|NCT00896532|527711510|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328709|NCT00896532|527711511|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328710|NCT00896532|527711512|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328711|NCT00896532|527711513|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328712|NCT00896532|527711514|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328713|NCT00896532|527711515|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328714|NCT00896532|527711516|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328715|NCT00896532|527711517|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328716|NCT00896532|527711518|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
146328717|NCT00896532|527711519|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328718|NCT00896532|527711520|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328719|NCT00896532|527711521|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328720|NCT00896532|527711522|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146328721|NCT00896532|527711523|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146167184|NCT01570868|527124389|FG000|Overall Study|FDA Recommendation|23|||
146167185|NCT01570868|527124390|FG001|Overall Study|FDA Recommendation|3|||
146167186|NCT01570868|527124389|FG000|Overall Study|Physician Decision|10|||
146167187|NCT01570868|527124390|FG001|Overall Study|Physician Decision|4|||
146167188|NCT01570868|527124389|FG000|Overall Study|Lost to Follow-up|1|||
146167189|NCT01570868|527124390|FG001|Overall Study|Lost to Follow-up|0|||
146167190|NCT01570868|527124389|FG000|Overall Study|Withdrawal by Subject|1|||
146167191|NCT01570868|527124390|FG001|Overall Study|Withdrawal by Subject|0|||
146167192|NCT03937219|527124394|FG000|Overall Study|Death|223|||
146167193|NCT03937219|527124395|FG001|Overall Study|Death|211|||
146167194|NCT03937219|527124394|FG000|Overall Study|Withdrawal by Subject|17|||
146167195|NCT03937219|527124395|FG001|Overall Study|Withdrawal by Subject|25|||
146167196|NCT03937219|527124394|FG000|Overall Study|Lost to Follow-up|3|||
146167197|NCT03937219|527124395|FG001|Overall Study|Lost to Follow-up|4|||
146167198|NCT02515279|527124398|FG000|Overall Study|Adverse Event|7|||
146167199|NCT02515279|527124398|FG000|Overall Study|Lack of Efficacy|31|||
146167200|NCT02515279|527124398|FG000|Overall Study|Lost to Follow-up|9|||
146167201|NCT02515279|527124398|FG000|Overall Study|Withdrawal by Subject|18|||
146167202|NCT02515279|527124398|FG000|Overall Study|End-of-treatment visit not attended|17|||
146167203|NCT02515279|527124398|FG000|Overall Study|Other|22|||
146167204|NCT01800968|527124399|FG000|Overall Study|Death|23|||
146167205|NCT01800968|527124400|FG001|Overall Study|Death|16|||
146167206|NCT01800968|527124399|FG000|Overall Study|Lost to Follow-up|5|||
146167207|NCT01800968|527124400|FG001|Overall Study|Lost to Follow-up|7|||
146167208|NCT01800968|527124399|FG000|Overall Study|Withdrawal by Subject|7|||
146167209|NCT01800968|527124400|FG001|Overall Study|Withdrawal by Subject|9|||
146167210|NCT01800968|527124399|FG000|Overall Study|Physician Decision|1|||
146167211|NCT01800968|527124400|FG001|Overall Study|Physician Decision|0|||
146167212|NCT03185481|527124404|FG000|Overall Study|Adverse Event|1|||
146167213|NCT03185481|527124404|FG000|Overall Study|Study Terminated by Sponsor|4|||
146167214|NCT00701038|527124408|FG000|Overall Study|study amended pilot group of patients|4|||
146167215|NCT00701038|527124409|FG001|Overall Study|study amended pilot group of patients|4|||
146167216|NCT03371940|527124415|FG000|Overall Study|Withdrawal by Subject|8|||
146167217|NCT03371940|527124416|FG001|Overall Study|Withdrawal by Subject|1|||
146167218|NCT03371940|527124417|FG002|Overall Study|Withdrawal by Subject|3|||
146167219|NCT03371940|527124418|FG003|Overall Study|Withdrawal by Subject|4|||
146167220|NCT05099926|527124419|FG000|Overall Study|Lost to Follow-up|1|||
146167221|NCT00504426|527124424|FG000|Overall Study|Adverse Event|0|||
146167222|NCT00504426|527124425|FG001|Overall Study|Adverse Event|0|||
146167223|NCT00504426|527124426|FG002|Overall Study|Adverse Event|2|||
146167224|NCT00504426|527124427|FG003|Overall Study|Adverse Event|0|||
146167225|NCT00504426|527124424|FG000|Overall Study|Protocol Violation|1|||
146167226|NCT00504426|527124425|FG001|Overall Study|Protocol Violation|1|||
146167227|NCT00504426|527124426|FG002|Overall Study|Protocol Violation|2|||
146167228|NCT00504426|527124427|FG003|Overall Study|Protocol Violation|0|||
146167229|NCT00504426|527124424|FG000|Overall Study|Withdrawal by Subject|2|||
146167230|NCT00504426|527124425|FG001|Overall Study|Withdrawal by Subject|0|||
146167231|NCT00504426|527124426|FG002|Overall Study|Withdrawal by Subject|0|||
146167232|NCT00504426|527124427|FG003|Overall Study|Withdrawal by Subject|0|||
146167233|NCT00031486|527124431|FG000|Overall Study|Adverse Event|1|||
146167234|NCT00031486|527124432|FG001|Overall Study|Adverse Event|0|||
146167235|NCT00031486|527124431|FG000|Overall Study|Lost to Follow-up|0|||
146167236|NCT00031486|527124432|FG001|Overall Study|Lost to Follow-up|1|||
146167237|NCT00031486|527124431|FG000|Overall Study|Withdrawal by Subject|3|||
146167238|NCT00031486|527124432|FG001|Overall Study|Withdrawal by Subject|2|||
146167239|NCT00031486|527124431|FG000|Overall Study|Death|0|||
146167240|NCT00031486|527124432|FG001|Overall Study|Death|3|||
146167241|NCT00031486|527124431|FG000|Overall Study|Non-compliant|0|||
146167242|NCT00031486|527124432|FG001|Overall Study|Non-compliant|4|||
146167243|NCT00031486|527124431|FG000|Overall Study|Did not meet eligibility requirement|2|||
146167244|NCT00031486|527124432|FG001|Overall Study|Did not meet eligibility requirement|1|||
146167245|NCT00031486|527124431|FG000|Overall Study|Other|1|||
146167246|NCT00031486|527124432|FG001|Overall Study|Other|1|||
146167247|NCT03685591|527124435|FG000|Overall Study|Global Deterioration of Health Status|0|||
146167248|NCT03685591|527124436|FG001|Overall Study|Global Deterioration of Health Status|0|||
146167249|NCT03685591|527124437|FG002|Overall Study|Global Deterioration of Health Status|0|||
146167250|NCT03685591|527124438|FG003|Overall Study|Global Deterioration of Health Status|1|||
146167251|NCT03685591|527124439|FG004|Overall Study|Global Deterioration of Health Status|2|||
146167252|NCT03685591|527124440|FG005|Overall Study|Global Deterioration of Health Status|4|||
146167253|NCT03685591|527124441|FG006|Overall Study|Global Deterioration of Health Status|1|||
146167254|NCT03685591|527124442|FG007|Overall Study|Global Deterioration of Health Status|1|||
146167255|NCT03685591|527124443|FG008|Overall Study|Global Deterioration of Health Status|0|||
146328722|NCT00896532|527711524|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
146167256|NCT03685591|527124435|FG000|Overall Study|Progressive Disease|1|||
146167257|NCT03685591|527124436|FG001|Overall Study|Progressive Disease|1|||
146167258|NCT03685591|527124437|FG002|Overall Study|Progressive Disease|0|||
146167259|NCT03685591|527124438|FG003|Overall Study|Progressive Disease|3|||
146167260|NCT03685591|527124439|FG004|Overall Study|Progressive Disease|5|||
146328723|NCT00896532|527711502|FG000|Months 48-72: Follow-on Phase|Death|0|||
146167261|NCT03685591|527124440|FG005|Overall Study|Progressive Disease|4|||
146167262|NCT03685591|527124441|FG006|Overall Study|Progressive Disease|3|||
146167263|NCT03685591|527124442|FG007|Overall Study|Progressive Disease|2|||
146167264|NCT03685591|527124443|FG008|Overall Study|Progressive Disease|1|||
146167265|NCT03685591|527124435|FG000|Overall Study|Other|0|||
146167266|NCT03685591|527124436|FG001|Overall Study|Other|0|||
146167267|NCT03685591|527124437|FG002|Overall Study|Other|1|||
146167268|NCT03685591|527124438|FG003|Overall Study|Other|0|||
146167269|NCT03685591|527124439|FG004|Overall Study|Other|2|||
146167270|NCT03685591|527124440|FG005|Overall Study|Other|3|||
146328724|NCT00896532|527711503|FG001|Months 48-72: Follow-on Phase|Death|0|||
146328725|NCT00896532|527711504|FG002|Months 48-72: Follow-on Phase|Death|0|||
146328726|NCT00896532|527711505|FG003|Months 48-72: Follow-on Phase|Death|0|||
146328727|NCT00896532|527711506|FG004|Months 48-72: Follow-on Phase|Death|0|||
146328728|NCT00896532|527711507|FG005|Months 48-72: Follow-on Phase|Death|0|||
146328729|NCT00896532|527711508|FG006|Months 48-72: Follow-on Phase|Death|0|||
146328730|NCT00896532|527711509|FG007|Months 48-72: Follow-on Phase|Death|0|||
146328731|NCT00896532|527711510|FG008|Months 48-72: Follow-on Phase|Death|0|||
146328732|NCT00896532|527711511|FG009|Months 48-72: Follow-on Phase|Death|0|||
146328733|NCT00896532|527711512|FG010|Months 48-72: Follow-on Phase|Death|0|||
146328734|NCT00896532|527711513|FG011|Months 48-72: Follow-on Phase|Death|0|||
146328735|NCT00896532|527711514|FG012|Months 48-72: Follow-on Phase|Death|0|||
146328736|NCT00896532|527711515|FG013|Months 48-72: Follow-on Phase|Death|0|||
146328737|NCT00896532|527711516|FG014|Months 48-72: Follow-on Phase|Death|0|||
146328738|NCT00896532|527711517|FG015|Months 48-72: Follow-on Phase|Death|0|||
146167271|NCT03685591|527124441|FG006|Overall Study|Other|0|||
146167272|NCT03685591|527124442|FG007|Overall Study|Other|0|||
146167273|NCT03685591|527124443|FG008|Overall Study|Other|0|||
146167274|NCT03685591|527124435|FG000|Overall Study|Withdrawal by Subject|0|||
146167275|NCT03685591|527124436|FG001|Overall Study|Withdrawal by Subject|0|||
146328739|NCT00896532|527711518|FG016|Months 48-72: Follow-on Phase|Death|0|||
146328740|NCT00896532|527711519|FG017|Months 48-72: Follow-on Phase|Death|0|||
146328741|NCT00896532|527711520|FG018|Months 48-72: Follow-on Phase|Death|1|||
146328742|NCT00896532|527711521|FG019|Months 48-72: Follow-on Phase|Death|0|||
146328743|NCT00896532|527711522|FG020|Months 48-72: Follow-on Phase|Death|0|||
146328744|NCT00896532|527711523|FG021|Months 48-72: Follow-on Phase|Death|0|||
146328745|NCT00896532|527711524|FG022|Months 48-72: Follow-on Phase|Death|0|||
146328746|NCT00896532|527711502|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146167276|NCT03685591|527124437|FG002|Overall Study|Withdrawal by Subject|0|||
146167277|NCT03685591|527124438|FG003|Overall Study|Withdrawal by Subject|0|||
146328747|NCT00896532|527711503|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328748|NCT00896532|527711504|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328749|NCT00896532|527711505|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328750|NCT00896532|527711506|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328751|NCT00896532|527711507|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328752|NCT00896532|527711508|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328753|NCT00896532|527711509|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328754|NCT00896532|527711510|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328755|NCT00896532|527711511|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328756|NCT00896532|527711512|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328757|NCT00896532|527711513|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328758|NCT00896532|527711514|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328759|NCT00896532|527711515|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328760|NCT00896532|527711516|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328761|NCT00896532|527711517|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328762|NCT00896532|527711518|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328763|NCT00896532|527711519|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328764|NCT00896532|527711520|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328765|NCT00896532|527711521|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328766|NCT00896532|527711522|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328767|NCT00896532|527711523|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
146328768|NCT00896532|527711524|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
146328769|NCT00896532|527711502|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328770|NCT00896532|527711503|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328771|NCT00896532|527711504|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146167278|NCT03685591|527124439|FG004|Overall Study|Withdrawal by Subject|3|||
146167279|NCT03685591|527124440|FG005|Overall Study|Withdrawal by Subject|2|||
146167280|NCT03685591|527124441|FG006|Overall Study|Withdrawal by Subject|0|||
146328772|NCT00896532|527711505|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328773|NCT00896532|527711506|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328774|NCT00896532|527711507|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146167281|NCT03685591|527124442|FG007|Overall Study|Withdrawal by Subject|0|||
146167282|NCT03685591|527124443|FG008|Overall Study|Withdrawal by Subject|1|||
146167283|NCT03685591|527124435|FG000|Overall Study|Adverse Event|0|||
146328775|NCT00896532|527711508|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328776|NCT00896532|527711509|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328777|NCT00896532|527711510|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146167284|NCT03685591|527124436|FG001|Overall Study|Adverse Event|0|||
146167285|NCT03685591|527124437|FG002|Overall Study|Adverse Event|0|||
146167286|NCT03685591|527124438|FG003|Overall Study|Adverse Event|1|||
146167287|NCT03685591|527124439|FG004|Overall Study|Adverse Event|1|||
146167288|NCT03685591|527124440|FG005|Overall Study|Adverse Event|4|||
146167289|NCT03685591|527124441|FG006|Overall Study|Adverse Event|0|||
146167290|NCT03685591|527124442|FG007|Overall Study|Adverse Event|1|||
146167291|NCT03685591|527124443|FG008|Overall Study|Adverse Event|1|||
146167292|NCT01685138|527124444|FG000|Overall Study|Lost to Follow-up|1|||
146167293|NCT01685138|527124444|FG000|Overall Study|Protocol Violation|1|||
146167294|NCT01685138|527124444|FG000|Overall Study|No longer requires treatment|1|||
146167295|NCT01685138|527124444|FG000|Overall Study|Subject/guardian decision|2|||
146167296|NCT01685138|527124444|FG000|Overall Study|Physician Decision|6|||
146167297|NCT01685138|527124444|FG000|Overall Study|Death|10|||
146167298|NCT01685138|527124444|FG000|Overall Study|Adverse Event|18|||
146167299|NCT01685138|527124444|FG000|Overall Study|Progressive disease|53|||
146167300|NCT02068495|527124447|FG000|Overall Study|Case Report Forms Uncollected|60|||
146167301|NCT02068495|527124447|FG000|Overall Study|Protocol Deviation|49|||
146167302|NCT00689026|527124448|FG000|Overall Study|Withdrawal by Subject|13|||
146167303|NCT00689026|527124449|FG001|Overall Study|Withdrawal by Subject|6|||
146167304|NCT03988166|527124450|FG000|Overall Study|Lost to Follow-up|2|||
146167305|NCT03988166|527124450|FG000|Overall Study|Death|1|||
146167306|NCT02220894|527124452|FG000|Overall Study|Adverse Event|127|||
146167307|NCT02220894|527124453|FG001|Overall Study|Adverse Event|74|||
146167308|NCT02220894|527124452|FG000|Overall Study|Death|418|||
146167309|NCT02220894|527124453|FG001|Overall Study|Death|508|||
146167310|NCT02220894|527124452|FG000|Overall Study|Lost to Follow-up|0|||
146167311|NCT02220894|527124453|FG001|Overall Study|Lost to Follow-up|4|||
146167312|NCT02220894|527124452|FG000|Overall Study|Site Terminated by Sponsor|2|||
146167313|NCT02220894|527124453|FG001|Overall Study|Site Terminated by Sponsor|0|||
146167314|NCT02220894|527124452|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
146167315|NCT02220894|527124453|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
146167316|NCT02220894|527124452|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146167317|NCT02220894|527124453|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146167318|NCT02220894|527124452|FG000|Overall Study|Withdrawal by Subject|10|||
146167319|NCT02220894|527124453|FG001|Overall Study|Withdrawal by Subject|9|||
146167320|NCT04992546|527124454|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
146167321|NCT04992546|527124454|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
146167322|NCT04992546|527124454|FG000|Open-Label Treatment Period|Adverse Event|3|||
146167323|NCT04992546|527124454|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
146167324|NCT02703922|527124455|FG000|Overall Study|Death|5|||
146167325|NCT02703922|527124456|FG001|Overall Study|Death|8|||
146167326|NCT02703922|527124455|FG000|Overall Study|Lost to Follow-up|10|||
146167327|NCT02703922|527124456|FG001|Overall Study|Lost to Follow-up|10|||
146167328|NCT00500903|527124458|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
146167329|NCT00500903|527124459|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
146167330|NCT00500903|527124460|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
146167331|NCT00500903|527124458|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
146167332|NCT00500903|527124459|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146167333|NCT00500903|527124460|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146167334|NCT00500903|527124458|FG000|Overall Study|Progressive Disease|41|||
146167335|NCT00500903|527124459|FG001|Overall Study|Progressive Disease|2|||
146167336|NCT00500903|527124460|FG002|Overall Study|Progressive Disease|15|||
146167337|NCT00500903|527124458|FG000|Overall Study|Patient Declined Further Treatment|0|||
146167338|NCT00500903|527124459|FG001|Overall Study|Patient Declined Further Treatment|0|||
146167339|NCT00500903|527124460|FG002|Overall Study|Patient Declined Further Treatment|3|||
146328778|NCT00896532|527711511|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328779|NCT00896532|527711512|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328780|NCT00896532|527711513|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328781|NCT00896532|527711514|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328782|NCT00896532|527711515|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328783|NCT00896532|527711516|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328784|NCT00896532|527711517|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328785|NCT00896532|527711518|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328786|NCT00896532|527711519|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328787|NCT00896532|527711520|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328788|NCT00896532|527711521|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328789|NCT00896532|527711522|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145943241|NCT00483704|526300458|FG002|Treatment|Physician Decision|4|||
146167340|NCT00500903|527124458|FG000|Overall Study|Symptomatic Deterioration|2|||
146167341|NCT00500903|527124459|FG001|Overall Study|Symptomatic Deterioration|0|||
146167342|NCT00500903|527124460|FG002|Overall Study|Symptomatic Deterioration|0|||
146167343|NCT00500903|527124458|FG000|Overall Study|Reason Not Specified|10|||
146167344|NCT00500903|527124459|FG001|Overall Study|Reason Not Specified|0|||
146167345|NCT00500903|527124460|FG002|Overall Study|Reason Not Specified|2|||
146167346|NCT00717860|527124461|FG000|Overall Study|Clinical adverse experience|5|||
146167347|NCT00717860|527124462|FG001|Overall Study|Clinical adverse experience|9|||
146167348|NCT00717860|527124461|FG000|Overall Study|Laboratory adverse experience|2|||
146167349|NCT00717860|527124462|FG001|Overall Study|Laboratory adverse experience|2|||
146167350|NCT00717860|527124461|FG000|Overall Study|Lack of Efficacy|7|||
146167351|NCT00717860|527124462|FG001|Overall Study|Lack of Efficacy|13|||
146167352|NCT00717860|527124461|FG000|Overall Study|Discontinued for other reason|6|||
146167353|NCT00717860|527124462|FG001|Overall Study|Discontinued for other reason|1|||
146167354|NCT00717860|527124461|FG000|Overall Study|Withdrew consent|7|||
146167355|NCT00717860|527124462|FG001|Overall Study|Withdrew consent|3|||
146167356|NCT04058353|527124463|FG000|Overall Study|Adverse Event|2|||
146167357|NCT04058353|527124464|FG001|Overall Study|Adverse Event|1|||
146167358|NCT04058353|527124463|FG000|Overall Study|Physician Decision|1|||
146167359|NCT04058353|527124464|FG001|Overall Study|Physician Decision|0|||
146167360|NCT04058353|527124463|FG000|Overall Study|Other|1|||
146167361|NCT04058353|527124464|FG001|Overall Study|Other|0|||
146167362|NCT02901626|527126204|FG000|Overall Study|Lost to Follow-up|1|||
146167363|NCT02901626|527126205|FG001|Overall Study|Lost to Follow-up|1|||
146167364|NCT04082884|527126206|FG000|Overall Study|Withdrawal by Subject|1|||
146167365|NCT04857034|527126208|FG000|Placebo-Controlled Period|Request to discontinue|2|||
146167366|NCT04857034|527126209|FG001|Placebo-Controlled Period|Request to discontinue|2|||
146167367|NCT04857034|527126210|FG002|Placebo-Controlled Period|Request to discontinue|0|||
146167368|NCT04857034|527126211|FG003|Placebo-Controlled Period|Request to discontinue|0|||
146167369|NCT04857034|527126212|FG004|Placebo-Controlled Period|Request to discontinue|0|||
146167370|NCT04857034|527126208|FG000|Placebo-Controlled Period|withdrew consent|1|||
146167371|NCT04857034|527126209|FG001|Placebo-Controlled Period|withdrew consent|1|||
146167372|NCT04857034|527126210|FG002|Placebo-Controlled Period|withdrew consent|2|||
146167373|NCT04857034|527126211|FG003|Placebo-Controlled Period|withdrew consent|0|||
146167374|NCT04857034|527126212|FG004|Placebo-Controlled Period|withdrew consent|0|||
146167375|NCT04857034|527126208|FG000|Placebo-Controlled Period|Pregnancy|1|||
146328790|NCT00896532|527711523|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
146328791|NCT00896532|527711524|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
146328792|NCT01282229|527711525|FG000|Overall Study|Protocol Violation|2|||
146328793|NCT01671280|527711528|FG000|Overall Study|Withdrawal by Subject|2|||
146328794|NCT00996203|527711529|FG000|Overall Study|Adverse Event|3|||
146328795|NCT00996203|527711529|FG000|Overall Study|Lost to Follow-up|1|||
146328796|NCT00996203|527711529|FG000|Overall Study|Lack of Efficacy|1|||
146328797|NCT00996203|527711529|FG000|Overall Study|Protocol Violation|2|||
146328798|NCT01959165|527711530|FG000|Overall Study|Adverse Event|0|||
146328799|NCT01959165|527711531|FG001|Overall Study|Adverse Event|0|||
146328800|NCT01959165|527711532|FG002|Overall Study|Adverse Event|0|||
146328801|NCT01959165|527711533|FG003|Overall Study|Adverse Event|1|||
146328802|NCT01959165|527711530|FG000|Overall Study|Lack of Efficacy|1|||
146328803|NCT01959165|527711531|FG001|Overall Study|Lack of Efficacy|0|||
146328804|NCT01959165|527711532|FG002|Overall Study|Lack of Efficacy|0|||
146328805|NCT01959165|527711533|FG003|Overall Study|Lack of Efficacy|0|||
146328806|NCT01959165|527711530|FG000|Overall Study|overdose|0|||
146328807|NCT01959165|527711531|FG001|Overall Study|overdose|0|||
146328808|NCT01959165|527711532|FG002|Overall Study|overdose|0|||
146328809|NCT01959165|527711533|FG003|Overall Study|overdose|1|||
146328810|NCT01959165|527711530|FG000|Overall Study|Welfare recipient|0|||
146328811|NCT01959165|527711531|FG001|Overall Study|Welfare recipient|1|||
146328812|NCT01959165|527711532|FG002|Overall Study|Welfare recipient|0|||
146328813|NCT01959165|527711533|FG003|Overall Study|Welfare recipient|0|||
146328814|NCT03686969|527711534|FG000|Overall Study|Study terminated|1|||
146328815|NCT03686969|527711535|FG001|Overall Study|Study terminated|0|||
146328816|NCT03094195|527711536|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
146328817|NCT03094195|527711537|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
146328818|NCT03094195|527711538|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
146328819|NCT03094195|527711539|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146328820|NCT03094195|527711540|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146328821|NCT03094195|527711541|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146328822|NCT03094195|527711542|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146328823|NCT03094195|527711543|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
146167376|NCT04857034|527126209|FG001|Placebo-Controlled Period|Pregnancy|1|||
146167377|NCT04857034|527126210|FG002|Placebo-Controlled Period|Pregnancy|0|||
146167378|NCT04857034|527126211|FG003|Placebo-Controlled Period|Pregnancy|0|||
146167379|NCT04857034|527126212|FG004|Placebo-Controlled Period|Pregnancy|0|||
146167380|NCT04857034|527126208|FG000|Placebo-Controlled Period|Ongoing study period|0|||
146328824|NCT03094195|527711536|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
146328825|NCT03094195|527711537|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
146328826|NCT03094195|527711538|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
146167381|NCT04857034|527126209|FG001|Placebo-Controlled Period|Ongoing study period|1|||
146167382|NCT04857034|527126210|FG002|Placebo-Controlled Period|Ongoing study period|0|||
146328827|NCT03094195|527711539|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146328828|NCT03094195|527711540|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146167383|NCT04857034|527126211|FG003|Placebo-Controlled Period|Ongoing study period|0|||
146167384|NCT04857034|527126212|FG004|Placebo-Controlled Period|Ongoing study period|0|||
146167385|NCT04857034|527126208|FG000|Active Treatment Period|Lack of Efficacy|1|||
146167386|NCT04857034|527126209|FG001|Active Treatment Period|Lack of Efficacy|0|||
146167387|NCT04857034|527126210|FG002|Active Treatment Period|Lack of Efficacy|0|||
146167388|NCT04857034|527126211|FG003|Active Treatment Period|Lack of Efficacy|0|||
146167389|NCT04857034|527126212|FG004|Active Treatment Period|Lack of Efficacy|0|||
146167390|NCT04857034|527126208|FG000|Active Treatment Period|request to discontinue|0|||
146167391|NCT04857034|527126209|FG001|Active Treatment Period|request to discontinue|1|||
146167392|NCT04857034|527126210|FG002|Active Treatment Period|request to discontinue|0|||
146167393|NCT04857034|527126211|FG003|Active Treatment Period|request to discontinue|1|||
146167394|NCT04857034|527126212|FG004|Active Treatment Period|request to discontinue|0|||
146167395|NCT04857034|527126208|FG000|Active Treatment Period|administrative reason by sponsor|1|||
146167396|NCT04857034|527126209|FG001|Active Treatment Period|administrative reason by sponsor|5|||
146167397|NCT04857034|527126210|FG002|Active Treatment Period|administrative reason by sponsor|0|||
146167398|NCT04857034|527126211|FG003|Active Treatment Period|administrative reason by sponsor|2|||
146167399|NCT04857034|527126212|FG004|Active Treatment Period|administrative reason by sponsor|2|||
146167400|NCT04857034|527126208|FG000|Active Treatment Period|other reasons|1|||
146167401|NCT04857034|527126209|FG001|Active Treatment Period|other reasons|1|||
146167402|NCT04857034|527126210|FG002|Active Treatment Period|other reasons|0|||
146167403|NCT04857034|527126211|FG003|Active Treatment Period|other reasons|0|||
146167404|NCT04857034|527126212|FG004|Active Treatment Period|other reasons|1|||
146167405|NCT04857034|527126208|FG000|Active Treatment Period|Ongoing Study Period|2|||
146167406|NCT04857034|527126209|FG001|Active Treatment Period|Ongoing Study Period|4|||
146167407|NCT04857034|527126210|FG002|Active Treatment Period|Ongoing Study Period|0|||
146167408|NCT04857034|527126211|FG003|Active Treatment Period|Ongoing Study Period|1|||
146167409|NCT04857034|527126212|FG004|Active Treatment Period|Ongoing Study Period|0|||
146167410|NCT00387894|527126213|FG000|Overall Study|Withdrawal by Subject|1|||
146167411|NCT00659490|527126214|FG000|Overall Study|Lost to Follow-up|2|||
146167412|NCT00659490|527126215|FG001|Overall Study|Lost to Follow-up|0|||
146167413|NCT00659490|527126216|FG002|Overall Study|Lost to Follow-up|1|||
146167414|NCT05674890|527126217|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
146167415|NCT05674890|527126218|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
146167416|NCT05674890|527126217|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
146167417|NCT05674890|527126218|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
146167418|NCT05674890|527126217|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
146167419|NCT05674890|527126218|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
146167420|NCT00827541|527126219|FG000|Overall Study|Exitus|1|||
146167421|NCT00827541|527126220|FG001|Overall Study|Exitus|8|||
146167422|NCT00827541|527126219|FG000|Overall Study|Other|1|||
146167423|NCT00827541|527126220|FG001|Overall Study|Other|3|||
146167424|NCT00827541|527126219|FG000|Overall Study|Pathogen not susceptible|1|||
146167425|NCT00827541|527126220|FG001|Overall Study|Pathogen not susceptible|0|||
146167426|NCT00827541|527126219|FG000|Overall Study|Lack of effectiveness|1|||
146167427|NCT00827541|527126220|FG001|Overall Study|Lack of effectiveness|0|||
146167428|NCT01649232|527126221|FG000|Overall Study|Physician Decision|2|||
146167429|NCT01649232|527126222|FG001|Overall Study|Physician Decision|0|||
146167430|NCT02421666|527126223|FG000|6-month Follow-up|Lost to Follow-up|8|||
146328829|NCT03094195|527711541|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146328830|NCT03094195|527711542|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146328831|NCT03094195|527711543|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
146328832|NCT03094195|527711536|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328833|NCT03094195|527711537|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328834|NCT03094195|527711538|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
146328835|NCT03094195|527711539|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328836|NCT03094195|527711540|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328837|NCT03094195|527711541|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328838|NCT03094195|527711542|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328839|NCT03094195|527711543|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
146328840|NCT03094195|527711536|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146328841|NCT03094195|527711537|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
146328842|NCT03094195|527711538|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
146328843|NCT03094195|527711539|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146328844|NCT03094195|527711540|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146328845|NCT03094195|527711541|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146328846|NCT03094195|527711542|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146328847|NCT03094195|527711543|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
146167431|NCT02421666|527126224|FG001|6-month Follow-up|Lost to Follow-up|7|||
146167432|NCT02421666|527126223|FG000|6-month Follow-up|Withdrawal by Subject|5|||
146167433|NCT02421666|527126224|FG001|6-month Follow-up|Withdrawal by Subject|6|||
146167434|NCT02421666|527126223|FG000|12-month Follow-up|Lost to Follow-up|5|||
146167435|NCT02421666|527126224|FG001|12-month Follow-up|Lost to Follow-up|5|||
146167436|NCT02421666|527126223|FG000|12-month Follow-up|Withdrawal by Subject|6|||
146167437|NCT02421666|527126224|FG001|12-month Follow-up|Withdrawal by Subject|11|||
146167438|NCT00246337|527126225|FG000|Overall Study|Lost to Follow-up|3|||
146167439|NCT00246337|527126226|FG001|Overall Study|Lost to Follow-up|0|||
146167440|NCT00246337|527126227|FG002|Overall Study|Lost to Follow-up|0|||
146167441|NCT00246337|527126228|FG003|Overall Study|Lost to Follow-up|0|||
146167442|NCT00246337|527126229|FG004|Overall Study|Lost to Follow-up|2|||
146167443|NCT00246337|527126230|FG005|Overall Study|Lost to Follow-up|2|||
146167444|NCT00246337|527126231|FG006|Overall Study|Lost to Follow-up|1|||
146167445|NCT00246337|527126232|FG007|Overall Study|Lost to Follow-up|2|||
146167446|NCT00246337|527126233|FG008|Overall Study|Lost to Follow-up|0|||
146167447|NCT00246337|527126225|FG000|Overall Study|Protocol Violation|1|||
146167448|NCT00246337|527126226|FG001|Overall Study|Protocol Violation|0|||
146167449|NCT00246337|527126227|FG002|Overall Study|Protocol Violation|0|||
146167450|NCT00246337|527126228|FG003|Overall Study|Protocol Violation|0|||
146167451|NCT00246337|527126229|FG004|Overall Study|Protocol Violation|1|||
146167452|NCT00246337|527126230|FG005|Overall Study|Protocol Violation|0|||
146167453|NCT00246337|527126231|FG006|Overall Study|Protocol Violation|1|||
146167454|NCT00246337|527126232|FG007|Overall Study|Protocol Violation|1|||
146167455|NCT00246337|527126233|FG008|Overall Study|Protocol Violation|0|||
146167456|NCT00246337|527126225|FG000|Overall Study|Withdrawal by Subject|2|||
146167457|NCT00246337|527126226|FG001|Overall Study|Withdrawal by Subject|0|||
146167458|NCT00246337|527126227|FG002|Overall Study|Withdrawal by Subject|0|||
146167459|NCT00246337|527126228|FG003|Overall Study|Withdrawal by Subject|0|||
146167460|NCT00246337|527126229|FG004|Overall Study|Withdrawal by Subject|0|||
146167461|NCT00246337|527126230|FG005|Overall Study|Withdrawal by Subject|0|||
146167462|NCT00246337|527126231|FG006|Overall Study|Withdrawal by Subject|1|||
146167463|NCT00246337|527126232|FG007|Overall Study|Withdrawal by Subject|1|||
146167464|NCT00246337|527126233|FG008|Overall Study|Withdrawal by Subject|0|||
146167465|NCT00246337|527126225|FG000|Overall Study|Lack of Qualifying Event|8|||
146167466|NCT00246337|527126226|FG001|Overall Study|Lack of Qualifying Event|2|||
146167467|NCT00246337|527126227|FG002|Overall Study|Lack of Qualifying Event|1|||
146167468|NCT00246337|527126228|FG003|Overall Study|Lack of Qualifying Event|1|||
146167469|NCT00246337|527126229|FG004|Overall Study|Lack of Qualifying Event|1|||
146167470|NCT00246337|527126230|FG005|Overall Study|Lack of Qualifying Event|3|||
146167471|NCT00246337|527126231|FG006|Overall Study|Lack of Qualifying Event|3|||
146167472|NCT00246337|527126232|FG007|Overall Study|Lack of Qualifying Event|2|||
146167473|NCT00246337|527126233|FG008|Overall Study|Lack of Qualifying Event|5|||
146167474|NCT00246337|527126225|FG000|Overall Study|Site Terminated|10|||
146167475|NCT00246337|527126226|FG001|Overall Study|Site Terminated|0|||
146167476|NCT00246337|527126227|FG002|Overall Study|Site Terminated|0|||
146167477|NCT00246337|527126228|FG003|Overall Study|Site Terminated|0|||
146167478|NCT00246337|527126229|FG004|Overall Study|Site Terminated|0|||
146167479|NCT00246337|527126230|FG005|Overall Study|Site Terminated|7|||
146167480|NCT00246337|527126231|FG006|Overall Study|Site Terminated|1|||
146167481|NCT00246337|527126232|FG007|Overall Study|Site Terminated|6|||
146167482|NCT00246337|527126233|FG008|Overall Study|Site Terminated|2|||
146167483|NCT00246337|527126225|FG000|Overall Study|Abnormal baseline lab values|7|||
146167484|NCT00246337|527126226|FG001|Overall Study|Abnormal baseline lab values|0|||
146167485|NCT00246337|527126227|FG002|Overall Study|Abnormal baseline lab values|2|||
146167486|NCT00246337|527126228|FG003|Overall Study|Abnormal baseline lab values|0|||
146167487|NCT00246337|527126229|FG004|Overall Study|Abnormal baseline lab values|0|||
146167488|NCT00246337|527126230|FG005|Overall Study|Abnormal baseline lab values|2|||
146167489|NCT00246337|527126231|FG006|Overall Study|Abnormal baseline lab values|2|||
146167490|NCT00246337|527126232|FG007|Overall Study|Abnormal baseline lab values|0|||
146167491|NCT00246337|527126233|FG008|Overall Study|Abnormal baseline lab values|4|||
146167492|NCT00246337|527126225|FG000|Overall Study|Overwhelmed|0|||
146167493|NCT00246337|527126226|FG001|Overall Study|Overwhelmed|0|||
146167494|NCT00246337|527126227|FG002|Overall Study|Overwhelmed|0|||
146167495|NCT00246337|527126228|FG003|Overall Study|Overwhelmed|0|||
146167496|NCT00246337|527126229|FG004|Overall Study|Overwhelmed|0|||
146167497|NCT00246337|527126230|FG005|Overall Study|Overwhelmed|1|||
146167498|NCT00246337|527126231|FG006|Overall Study|Overwhelmed|0|||
146167499|NCT00246337|527126232|FG007|Overall Study|Overwhelmed|0|||
146167500|NCT00246337|527126233|FG008|Overall Study|Overwhelmed|0|||
146167501|NCT00246337|527126225|FG000|Overall Study|Protocol Violator|1|||
146167502|NCT00246337|527126226|FG001|Overall Study|Protocol Violator|0|||
146167503|NCT00246337|527126227|FG002|Overall Study|Protocol Violator|0|||
146167504|NCT00246337|527126228|FG003|Overall Study|Protocol Violator|0|||
146167505|NCT00246337|527126229|FG004|Overall Study|Protocol Violator|0|||
146167506|NCT00246337|527126230|FG005|Overall Study|Protocol Violator|0|||
146167507|NCT00246337|527126231|FG006|Overall Study|Protocol Violator|0|||
146167508|NCT00246337|527126232|FG007|Overall Study|Protocol Violator|0|||
146167509|NCT00246337|527126233|FG008|Overall Study|Protocol Violator|0|||
146167510|NCT00246337|527126225|FG000|Overall Study|Reported as completing trial in error|0|||
146167511|NCT00246337|527126226|FG001|Overall Study|Reported as completing trial in error|0|||
146167512|NCT00246337|527126227|FG002|Overall Study|Reported as completing trial in error|0|||
146167513|NCT00246337|527126228|FG003|Overall Study|Reported as completing trial in error|0|||
146167514|NCT00246337|527126229|FG004|Overall Study|Reported as completing trial in error|0|||
146167515|NCT00246337|527126230|FG005|Overall Study|Reported as completing trial in error|0|||
146167516|NCT00246337|527126231|FG006|Overall Study|Reported as completing trial in error|0|||
146167517|NCT00246337|527126232|FG007|Overall Study|Reported as completing trial in error|1|||
146167518|NCT00246337|527126233|FG008|Overall Study|Reported as completing trial in error|0|||
146167519|NCT01226511|527126236|FG000|Acute Treatment Period|Adverse Event|7|||
146167520|NCT01226511|527126237|FG001|Acute Treatment Period|Adverse Event|6|||
146167521|NCT01226511|527126236|FG000|Acute Treatment Period|Lack of Efficacy|2|||
146167522|NCT01226511|527126237|FG001|Acute Treatment Period|Lack of Efficacy|1|||
146167523|NCT01226511|527126236|FG000|Acute Treatment Period|Lost to Follow-up|3|||
146167524|NCT01226511|527126237|FG001|Acute Treatment Period|Lost to Follow-up|6|||
146167525|NCT01226511|527126236|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
146167526|NCT01226511|527126237|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
146167527|NCT01226511|527126236|FG000|Acute Treatment Period|Protocol Violation|5|||
146167528|NCT01226511|527126237|FG001|Acute Treatment Period|Protocol Violation|5|||
146167529|NCT01226511|527126236|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
146167530|NCT01226511|527126237|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
146167531|NCT01226511|527126236|FG000|Extension Treatment Period|Adverse Event|8|||
146167532|NCT01226511|527126237|FG001|Extension Treatment Period|Adverse Event|8|||
146167533|NCT01226511|527126236|FG000|Extension Treatment Period|Lack of Efficacy|3|||
146167534|NCT01226511|527126237|FG001|Extension Treatment Period|Lack of Efficacy|2|||
146167535|NCT01226511|527126236|FG000|Extension Treatment Period|Lost to Follow-up|4|||
146167536|NCT01226511|527126237|FG001|Extension Treatment Period|Lost to Follow-up|3|||
146167537|NCT01226511|527126236|FG000|Extension Treatment Period|Protocol Violation|2|||
146167538|NCT01226511|527126237|FG001|Extension Treatment Period|Protocol Violation|2|||
146167539|NCT01226511|527126236|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
146167540|NCT01226511|527126237|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
146167541|NCT01226511|527126236|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
146167542|NCT01226511|527126237|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
146167543|NCT01226511|527126236|FG000|Extension Treatment Period|Sponsor Decision|1|||
146167544|NCT01226511|527126237|FG001|Extension Treatment Period|Sponsor Decision|1|||
146167545|NCT01226511|527126236|FG000|Taper Period|Adverse Event|1|||
146167546|NCT01226511|527126237|FG001|Taper Period|Adverse Event|0|||
146167547|NCT01226511|527126236|FG000|Taper Period|Lost to Follow-up|2|||
146167548|NCT01226511|527126237|FG001|Taper Period|Lost to Follow-up|2|||
146167549|NCT01226511|527126236|FG000|Taper Period|Protocol Violation|1|||
146167550|NCT01226511|527126237|FG001|Taper Period|Protocol Violation|0|||
146167551|NCT01226511|527126236|FG000|Taper Period|Parent/Caregiver Decision|1|||
146167552|NCT01226511|527126237|FG001|Taper Period|Parent/Caregiver Decision|1|||
146167553|NCT05292534|527126240|FG000|Overall Study|Protocol Violation|3|||
146167554|NCT05292534|527126241|FG001|Overall Study|Protocol Violation|4|||
146167555|NCT05292534|527126240|FG000|Overall Study|Withdrawal by Subject|0|||
146167556|NCT05292534|527126241|FG001|Overall Study|Withdrawal by Subject|1|||
146167557|NCT01538472|527126242|FG000|Overall Study|Disease Progression|3|||
146167558|NCT01538472|527126242|FG000|Overall Study|Death|1|||
146167559|NCT00948974|527126243|FG000|Overall Study|Lost to Follow-up|23|||
146167560|NCT00948974|527126244|FG001|Overall Study|Lost to Follow-up|20|||
146167561|NCT00238433|527126246|FG000|Overall Study|Screen failure|1|||
146167562|NCT00238433|527126246|FG000|Overall Study|Lost to Follow-up|1|||
146167563|NCT00238433|527126246|FG000|Overall Study|Death|1|||
146167564|NCT01591382|527126247|FG000|Overall Study|Discharged Prior to Study Completion|2|||
146167565|NCT01591382|527126248|FG001|Overall Study|Discharged Prior to Study Completion|1|||
146167566|NCT01591382|527126247|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
146167567|NCT01591382|527126248|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
146167568|NCT00409682|527126261|FG000|Open-label Induction Period|Adverse Event|1|||
146167569|NCT00409682|527126262|FG001|Open-label Induction Period|Adverse Event|0|||
146167570|NCT00409682|527126263|FG002|Open-label Induction Period|Adverse Event|0|||
146167571|NCT00409682|527126261|FG000|Open-label Induction Period|Lack of Efficacy|1|||
146167572|NCT00409682|527126262|FG001|Open-label Induction Period|Lack of Efficacy|0|||
146167573|NCT00409682|527126263|FG002|Open-label Induction Period|Lack of Efficacy|0|||
146167574|NCT00409682|527126261|FG000|Open-label Induction Period|Protocol Violation|1|||
146167575|NCT00409682|527126262|FG001|Open-label Induction Period|Protocol Violation|0|||
146167576|NCT00409682|527126263|FG002|Open-label Induction Period|Protocol Violation|0|||
146167577|NCT00409682|527126261|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
146167578|NCT00409682|527126262|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
146167579|NCT00409682|527126263|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
146167580|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
146167581|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
146167582|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
146167583|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
146328848|NCT01988090|527711544|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
146328849|NCT01988090|527711545|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
146328850|NCT01988090|527711544|FG000|Start Treament After Randomization|Protocol Violation|0|||
146328851|NCT01988090|527711545|FG001|Start Treament After Randomization|Protocol Violation|1|||
146328852|NCT01988090|527711544|FG000|Complete Study After Start|Withdrawal by Subject|2|||
146328853|NCT01988090|527711545|FG001|Complete Study After Start|Withdrawal by Subject|0|||
146328854|NCT01988090|527711544|FG000|Complete Study After Start|Protocol Violation|1|||
146328855|NCT01988090|527711545|FG001|Complete Study After Start|Protocol Violation|1|||
146328856|NCT00927563|527711555|FG000|Overall Study|Lost to Follow-up|1|||
146328857|NCT00927563|527711555|FG000|Overall Study|Withdrawal by Subject|1|||
146328858|NCT00787787|527711559|FG000|Overall Study|Lack of Efficacy|4|||
146328859|NCT00787787|527711559|FG000|Overall Study|Adverse Event|3|||
146328860|NCT01468987|527711560|FG000|Overall Study|Adverse Event|12|||
146328861|NCT01468987|527711561|FG001|Overall Study|Adverse Event|9|||
146328862|NCT01468987|527711560|FG000|Overall Study|Death|4|||
146328863|NCT01468987|527711561|FG001|Overall Study|Death|1|||
146328864|NCT01468987|527711560|FG000|Overall Study|Lost to Follow-up|10|||
146328865|NCT01468987|527711561|FG001|Overall Study|Lost to Follow-up|5|||
146328866|NCT01468987|527711560|FG000|Overall Study|Protocol Violation|8|||
146328867|NCT01468987|527711561|FG001|Overall Study|Protocol Violation|2|||
146328868|NCT01468987|527711560|FG000|Overall Study|Withdrawal by Subject|28|||
146328869|NCT01468987|527711561|FG001|Overall Study|Withdrawal by Subject|28|||
146328870|NCT01468987|527711560|FG000|Overall Study|Physician Decision|8|||
146328871|NCT01468987|527711561|FG001|Overall Study|Physician Decision|15|||
146328872|NCT01468987|527711560|FG000|Overall Study|Sponsor Decision|1|||
146328873|NCT01468987|527711561|FG001|Overall Study|Sponsor Decision|0|||
146328874|NCT03430986|527711563|FG000|24-week Control Period|Adverse Event|1|||
146328875|NCT03430986|527711564|FG001|24-week Control Period|Adverse Event|0|||
146328876|NCT03430986|527711563|FG000|24-week Control Period|Lost to Follow-up|2|||
146328877|NCT03430986|527711564|FG001|24-week Control Period|Lost to Follow-up|2|||
146328878|NCT03430986|527711563|FG000|24-week Control Period|Withdrawal by Participant|5|||
146328879|NCT03430986|527711564|FG001|24-week Control Period|Withdrawal by Participant|0|||
146328880|NCT03430986|527711563|FG000|24-week Control Period|Protocol Deviation|0|||
146328881|NCT03430986|527711564|FG001|24-week Control Period|Protocol Deviation|2|||
146328882|NCT03430986|527711563|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
146328883|NCT03430986|527711564|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
146328884|NCT03430986|527711563|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
146328885|NCT03430986|527711564|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
146328886|NCT00961961|527711568|FG000|Phase I|Withdrawal by Subject|7|||
146328887|NCT00961961|527711569|FG001|Phase I|Withdrawal by Subject|0|||
146328888|NCT00961961|527711570|FG002|Phase I|Withdrawal by Subject|0|||
146167584|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
146167585|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
146167586|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
146167587|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
146167588|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
146167589|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
146167590|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
146167591|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
146167592|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
146167593|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
146167594|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
146167595|NCT00409682|527126261|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
146167596|NCT00409682|527126262|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
146167597|NCT00409682|527126263|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
146167598|NCT01896869|527126265|FG000|Overall Study|Withdrawal by Subject|0|||
146167599|NCT01896869|527126266|FG001|Overall Study|Withdrawal by Subject|6|||
146167600|NCT01896869|527126265|FG000|Overall Study|Lost to Follow-up|1|||
146167601|NCT01896869|527126266|FG001|Overall Study|Lost to Follow-up|0|||
146167602|NCT04710927|527126274|FG000|Overall Study|Lost to Follow-up|7|||
146167603|NCT04710927|527126275|FG001|Overall Study|Lost to Follow-up|6|||
146167604|NCT04710927|527126276|FG002|Overall Study|Lost to Follow-up|5|||
146167605|NCT00118716|527126278|FG000|Overall Study|Adverse Event|2|||
146167606|NCT00118716|527126279|FG001|Overall Study|Adverse Event|7|||
146328889|NCT00961961|527711571|FG003|Phase I|Withdrawal by Subject|0|||
146328890|NCT00961961|527711568|FG000|Phase I|Lost to Follow-up|10|||
146328891|NCT00961961|527711569|FG001|Phase I|Lost to Follow-up|0|||
146328892|NCT00961961|527711570|FG002|Phase I|Lost to Follow-up|0|||
146328893|NCT00961961|527711571|FG003|Phase I|Lost to Follow-up|0|||
146328894|NCT00961961|527711568|FG000|Phase I|Lack of Efficacy|94|||
146328895|NCT00961961|527711569|FG001|Phase I|Lack of Efficacy|0|||
146328896|NCT00961961|527711570|FG002|Phase I|Lack of Efficacy|0|||
146328897|NCT00961961|527711571|FG003|Phase I|Lack of Efficacy|0|||
146328898|NCT00961961|527711568|FG000|Phase I|Adverse Event|7|||
146167607|NCT00118716|527126278|FG000|Overall Study|Protocol Violation|5|||
146167608|NCT00118716|527126279|FG001|Overall Study|Protocol Violation|4|||
146167609|NCT00118716|527126278|FG000|Overall Study|Withdrawal by Subject|0|||
146167610|NCT00118716|527126279|FG001|Overall Study|Withdrawal by Subject|1|||
146167611|NCT00118716|527126278|FG000|Overall Study|Exacerbation|2|||
146167612|NCT00118716|527126279|FG001|Overall Study|Exacerbation|2|||
146328899|NCT00961961|527711569|FG001|Phase I|Adverse Event|0|||
146328900|NCT00961961|527711570|FG002|Phase I|Adverse Event|0|||
146167613|NCT00118716|527126278|FG000|Overall Study|Discontinued by sponsor|1|||
146167614|NCT00118716|527126279|FG001|Overall Study|Discontinued by sponsor|1|||
146167615|NCT00118716|527126278|FG000|Overall Study|Non-compliance|1|||
146167616|NCT00118716|527126279|FG001|Overall Study|Non-compliance|3|||
146167617|NCT00118716|527126278|FG000|Overall Study|misrandomized|1|||
146167618|NCT00118716|527126279|FG001|Overall Study|misrandomized|1|||
146167619|NCT00118716|527126278|FG000|Overall Study|Expired drug use|1|||
146167620|NCT00118716|527126279|FG001|Overall Study|Expired drug use|2|||
146167621|NCT00118716|527126278|FG000|Overall Study|Investigator discretion|0|||
146167622|NCT00118716|527126279|FG001|Overall Study|Investigator discretion|1|||
146167623|NCT00855062|527126280|FG000|Step1|Early Study Closure|5|||
146167624|NCT00855062|527126281|FG001|Step1|Early Study Closure|7|||
146167625|NCT00855062|527126280|FG000|Step1|Adverse Event|1|||
146167626|NCT00855062|527126281|FG001|Step1|Adverse Event|1|||
146167627|NCT00855062|527126280|FG000|Step1|Protocol Violation|1|||
146167628|NCT00855062|527126281|FG001|Step1|Protocol Violation|0|||
146167629|NCT00855062|527126280|FG000|Step1|Pregnancy|1|||
146167630|NCT00855062|527126281|FG001|Step1|Pregnancy|0|||
146167631|NCT00855062|527126280|FG000|Step1|Withdrawal by Subject|2|||
146167632|NCT00855062|527126281|FG001|Step1|Withdrawal by Subject|3|||
146167633|NCT00855062|527126280|FG000|Step2|Early Study Closure|6|||
146167634|NCT00855062|527126281|FG001|Step2|Early Study Closure|2|||
146167635|NCT00855062|527126280|FG000|Step2|Adverse Event|0|||
146167636|NCT00855062|527126281|FG001|Step2|Adverse Event|3|||
146167637|NCT00855062|527126280|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
146167638|NCT00855062|527126281|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
146167639|NCT00454571|527126287|FG000|Overall Study|Adverse Event|2|||
146167640|NCT00454571|527126288|FG001|Overall Study|Adverse Event|0|||
146167641|NCT00454571|527126287|FG000|Overall Study|Physician Decision|0|||
146167642|NCT00454571|527126288|FG001|Overall Study|Physician Decision|1|||
146167643|NCT00454571|527126287|FG000|Overall Study|Protocol Violation|1|||
146167644|NCT00454571|527126288|FG001|Overall Study|Protocol Violation|0|||
146167645|NCT00454571|527126287|FG000|Overall Study|Withdrawal by Subject|10|||
146167646|NCT00454571|527126288|FG001|Overall Study|Withdrawal by Subject|5|||
146167647|NCT01376323|527126289|FG000|Overall Study|Adverse Event|1|||
146167648|NCT01376323|527126290|FG001|Overall Study|Adverse Event|0|||
146167649|NCT01376323|527126291|FG002|Overall Study|Adverse Event|0|||
146167650|NCT01376323|527126292|FG003|Overall Study|Adverse Event|2|||
146167651|NCT01376323|527126293|FG004|Overall Study|Adverse Event|0|||
146167652|NCT01376323|527126289|FG000|Overall Study|Lost to Follow-up|0|||
146167653|NCT01376323|527126290|FG001|Overall Study|Lost to Follow-up|0|||
146167654|NCT01376323|527126291|FG002|Overall Study|Lost to Follow-up|0|||
146167655|NCT01376323|527126292|FG003|Overall Study|Lost to Follow-up|2|||
146167656|NCT01376323|527126293|FG004|Overall Study|Lost to Follow-up|0|||
146328901|NCT00961961|527711571|FG003|Phase I|Adverse Event|0|||
146328902|NCT00961961|527711568|FG000|Phase I|Physician Decision|8|||
146328903|NCT00961961|527711569|FG001|Phase I|Physician Decision|0|||
146328904|NCT00961961|527711570|FG002|Phase I|Physician Decision|0|||
146167657|NCT01376323|527126289|FG000|Overall Study|Physician Decision|1|||
146167658|NCT01376323|527126290|FG001|Overall Study|Physician Decision|0|||
146167659|NCT01376323|527126291|FG002|Overall Study|Physician Decision|2|||
146167660|NCT01376323|527126292|FG003|Overall Study|Physician Decision|1|||
146167661|NCT01376323|527126293|FG004|Overall Study|Physician Decision|1|||
146167662|NCT01376323|527126289|FG000|Overall Study|Withdrawal by Subject|0|||
146167663|NCT01376323|527126290|FG001|Overall Study|Withdrawal by Subject|1|||
146167664|NCT01376323|527126291|FG002|Overall Study|Withdrawal by Subject|1|||
146167665|NCT01376323|527126292|FG003|Overall Study|Withdrawal by Subject|0|||
146167666|NCT01376323|527126293|FG004|Overall Study|Withdrawal by Subject|0|||
146167667|NCT04681729|527126294|FG000|Overall Study|Lack of Efficacy|2|||
146328905|NCT00961961|527711571|FG003|Phase I|Physician Decision|0|||
146328906|NCT00961961|527711568|FG000|Phase II|Lost to Follow-up|0|||
146167668|NCT04681729|527126295|FG001|Overall Study|Lack of Efficacy|2|||
146167669|NCT04681729|527126294|FG000|Overall Study|Withdrawal by Subject|8|||
146167670|NCT04681729|527126295|FG001|Overall Study|Withdrawal by Subject|9|||
146167671|NCT02436811|527126296|FG000|Overall Study|Lost to Follow-up|2|||
146167672|NCT02436811|527126297|FG001|Overall Study|Lost to Follow-up|9|||
146167673|NCT02436811|527126298|FG002|Overall Study|Lost to Follow-up|7|||
146167674|NCT03595332|527126299|FG000|Overall Study|Lost to Follow-up|16|||
146167675|NCT03595332|527126300|FG001|Overall Study|Lost to Follow-up|22|||
146167676|NCT03595332|527126299|FG000|Overall Study|Unable to retrieve ID from school|0|||
146328907|NCT00961961|527711569|FG001|Phase II|Lost to Follow-up|0|||
146328908|NCT00961961|527711570|FG002|Phase II|Lost to Follow-up|10|||
146328909|NCT00961961|527711571|FG003|Phase II|Lost to Follow-up|7|||
146167677|NCT03595332|527126300|FG001|Overall Study|Unable to retrieve ID from school|2|||
146167678|NCT02227875|527126301|FG000|Overall Study|Protocol Violation|10|||
146167679|NCT02227875|527126302|FG001|Overall Study|Protocol Violation|7|||
146167680|NCT02227875|527126301|FG000|Overall Study|Other|1|||
146167681|NCT02227875|527126302|FG001|Overall Study|Other|3|||
146167682|NCT02227875|527126301|FG000|Overall Study|Physician Decision|1|||
146167683|NCT02227875|527126302|FG001|Overall Study|Physician Decision|0|||
146167684|NCT02227875|527126301|FG000|Overall Study|Adverse Event|3|||
146167685|NCT02227875|527126302|FG001|Overall Study|Adverse Event|0|||
146167686|NCT02227875|527126301|FG000|Overall Study|Withdrawal by Subject|12|||
146167687|NCT02227875|527126302|FG001|Overall Study|Withdrawal by Subject|13|||
146167688|NCT02227875|527126301|FG000|Overall Study|Lost to Follow-up|10|||
146167689|NCT02227875|527126302|FG001|Overall Study|Lost to Follow-up|10|||
146167690|NCT04209725|527126305|FG000|Overall Study|Adverse Event|1|||
146167691|NCT01089374|527126306|FG000|Overall Study|Lost to Follow-up|3|||
146167692|NCT01089374|527126307|FG001|Overall Study|Lost to Follow-up|0|||
146167693|NCT01089374|527126306|FG000|Overall Study|Withdrawal by Subject|1|||
146328910|NCT00961961|527711568|FG000|Phase II|Adverse Event|0|||
146328911|NCT00961961|527711569|FG001|Phase II|Adverse Event|0|||
146328912|NCT00961961|527711570|FG002|Phase II|Adverse Event|0|||
146328913|NCT00961961|527711571|FG003|Phase II|Adverse Event|1|||
146328914|NCT00961961|527711568|FG000|Phase II|Physician Decision|0|||
146328915|NCT00961961|527711569|FG001|Phase II|Physician Decision|0|||
146328916|NCT00961961|527711570|FG002|Phase II|Physician Decision|1|||
146328917|NCT00961961|527711571|FG003|Phase II|Physician Decision|0|||
146328918|NCT00961961|527711568|FG000|Phase II|Withdrawal by Subject|0|||
146328919|NCT00961961|527711569|FG001|Phase II|Withdrawal by Subject|0|||
146167694|NCT01089374|527126307|FG001|Overall Study|Withdrawal by Subject|0|||
146167695|NCT01089374|527126306|FG000|Overall Study|Study closed early - low accrual|6|||
146167696|NCT01089374|527126307|FG001|Overall Study|Study closed early - low accrual|0|||
146167697|NCT02657317|527126308|FG000|Overall Study|Withdrawal by Subject|2|||
146167698|NCT02657317|527126309|FG001|Overall Study|Withdrawal by Subject|0|||
146167699|NCT02657317|527126308|FG000|Overall Study|Lost to Follow-up|3|||
146167700|NCT02657317|527126309|FG001|Overall Study|Lost to Follow-up|3|||
146167701|NCT02856113|527126310|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146328920|NCT00961961|527711570|FG002|Phase II|Withdrawal by Subject|1|||
146328921|NCT00961961|527711571|FG003|Phase II|Withdrawal by Subject|0|||
146328922|NCT01412957|527711572|FG000|Overall Study|Withdrawal by Subject|6|||
146328923|NCT01412957|527711573|FG001|Overall Study|Withdrawal by Subject|22|||
146328924|NCT01412957|527711572|FG000|Overall Study|Lost to Follow-up|7|||
146328925|NCT01412957|527711573|FG001|Overall Study|Lost to Follow-up|2|||
146328926|NCT01412957|527711572|FG000|Overall Study|Death|136|||
146328927|NCT01412957|527711573|FG001|Overall Study|Death|133|||
146328928|NCT01245673|527711574|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
146328929|NCT04722991|527711575|FG000|Overall Study|Adverse Event|12|||
146328930|NCT04722991|527711576|FG001|Overall Study|Adverse Event|4|||
146328931|NCT04722991|527711575|FG000|Overall Study|Death|2|||
146328932|NCT04722991|527711576|FG001|Overall Study|Death|0|||
146328933|NCT04722991|527711575|FG000|Overall Study|Lost to Follow-up|1|||
146328934|NCT04722991|527711576|FG001|Overall Study|Lost to Follow-up|1|||
146328935|NCT04722991|527711575|FG000|Overall Study|Withdrawal cirterion met|2|||
146328936|NCT04722991|527711576|FG001|Overall Study|Withdrawal cirterion met|2|||
146328937|NCT04722991|527711575|FG000|Overall Study|Other|1|||
146328938|NCT04722991|527711576|FG001|Overall Study|Other|0|||
146328939|NCT04722991|527711575|FG000|Overall Study|Non-compliance|0|||
146328940|NCT04722991|527711576|FG001|Overall Study|Non-compliance|1|||
146328941|NCT04722991|527711575|FG000|Overall Study|Withdrawal by Subject|0|||
146328942|NCT04722991|527711576|FG001|Overall Study|Withdrawal by Subject|1|||
146328943|NCT03186989|527711577|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328944|NCT03186989|527711578|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328945|NCT03186989|527711579|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146328946|NCT03186989|527711580|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146328947|NCT03186989|527711581|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
146167702|NCT02856113|527126311|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146167703|NCT02856113|527126310|FG000|Overall Study|Significant Protocol Deviation|1|||
146328948|NCT03186989|527711582|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328949|NCT03186989|527711583|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146167704|NCT02856113|527126311|FG001|Overall Study|Significant Protocol Deviation|0|||
146167705|NCT02856113|527126310|FG000|Overall Study|Lost to Follow-up|3|||
146167706|NCT02856113|527126311|FG001|Overall Study|Lost to Follow-up|5|||
146167707|NCT02856113|527126310|FG000|Overall Study|Voluntary Withdrawal|3|||
146328950|NCT03186989|527711584|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328951|NCT03186989|527711585|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328952|NCT03186989|527711586|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328953|NCT03186989|527711587|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
146328954|NCT03186989|527711577|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146167708|NCT02856113|527126311|FG001|Overall Study|Voluntary Withdrawal|5|||
146167709|NCT02856113|527126310|FG000|Overall Study|Pregnancy|0|||
146167710|NCT02856113|527126311|FG001|Overall Study|Pregnancy|1|||
146167711|NCT02856113|527126310|FG000|Overall Study|Principal Investigator Discretion|2|||
146167712|NCT02856113|527126311|FG001|Overall Study|Principal Investigator Discretion|1|||
146167713|NCT02856113|527126310|FG000|Overall Study|Randomized but not Treated|1|||
146167714|NCT02856113|527126311|FG001|Overall Study|Randomized but not Treated|0|||
146167715|NCT02856113|527126310|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
146167716|NCT02856113|527126311|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
146167717|NCT03494166|527126312|FG000|Overall Study|Death|0|||
146167718|NCT03494166|527126313|FG001|Overall Study|Death|0|||
146167719|NCT03494166|527126314|FG002|Overall Study|Death|0|||
146167720|NCT03494166|527126315|FG003|Overall Study|Death|1|||
146167721|NCT03494166|527126316|FG004|Overall Study|Death|3|||
146167722|NCT03494166|527126317|FG005|Overall Study|Death|0|||
146167723|NCT03494166|527126312|FG000|Overall Study|Lost to Follow-up|2|||
146167724|NCT03494166|527126313|FG001|Overall Study|Lost to Follow-up|2|||
146167725|NCT03494166|527126314|FG002|Overall Study|Lost to Follow-up|2|||
146167726|NCT03494166|527126315|FG003|Overall Study|Lost to Follow-up|2|||
146167727|NCT03494166|527126316|FG004|Overall Study|Lost to Follow-up|14|||
146167728|NCT03494166|527126317|FG005|Overall Study|Lost to Follow-up|0|||
146167729|NCT03494166|527126312|FG000|Overall Study|Withdrawal by Subject|10|||
146167730|NCT03494166|527126313|FG001|Overall Study|Withdrawal by Subject|7|||
146167731|NCT03494166|527126314|FG002|Overall Study|Withdrawal by Subject|0|||
146167732|NCT03494166|527126315|FG003|Overall Study|Withdrawal by Subject|5|||
146167733|NCT03494166|527126316|FG004|Overall Study|Withdrawal by Subject|3|||
146167734|NCT03494166|527126317|FG005|Overall Study|Withdrawal by Subject|17|||
146167735|NCT03494166|527126312|FG000|Overall Study|Screen failure|1|||
146167736|NCT03494166|527126313|FG001|Overall Study|Screen failure|0|||
146167737|NCT03494166|527126314|FG002|Overall Study|Screen failure|0|||
146167738|NCT03494166|527126315|FG003|Overall Study|Screen failure|0|||
146167739|NCT03494166|527126316|FG004|Overall Study|Screen failure|1|||
146167740|NCT03494166|527126317|FG005|Overall Study|Screen failure|0|||
146167741|NCT01960725|527126318|FG000|Overall Study|Lost to Follow-up|4|||
146167742|NCT01960725|527126319|FG001|Overall Study|Lost to Follow-up|3|||
146167743|NCT01960725|527126318|FG000|Overall Study|Withdrawal by Subject|1|||
146167744|NCT01960725|527126319|FG001|Overall Study|Withdrawal by Subject|0|||
146167745|NCT01960725|527126318|FG000|Overall Study|unable to obtain blood sample|1|||
146167746|NCT01960725|527126319|FG001|Overall Study|unable to obtain blood sample|2|||
146167747|NCT01780935|527126321|FG000|Overall Study|Admin problems due to early termination|321|||
146328955|NCT03186989|527711578|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328956|NCT03186989|527711579|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328957|NCT03186989|527711580|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328958|NCT03186989|527711581|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328959|NCT03186989|527711582|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
146328960|NCT03186989|527711583|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328961|NCT03186989|527711584|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328962|NCT03186989|527711585|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328963|NCT03186989|527711586|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328964|NCT03186989|527711587|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
146328965|NCT03186989|527711577|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328966|NCT03186989|527711578|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328967|NCT03186989|527711579|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328968|NCT03186989|527711580|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328969|NCT03186989|527711581|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328970|NCT03186989|527711582|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328971|NCT03186989|527711583|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
146328972|NCT03186989|527711584|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328973|NCT03186989|527711585|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328974|NCT03186989|527711586|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328975|NCT03186989|527711587|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
146328976|NCT03186989|527711577|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328977|NCT03186989|527711578|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328978|NCT03186989|527711579|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328979|NCT03186989|527711580|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328980|NCT03186989|527711581|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146167748|NCT01780935|527126322|FG001|Overall Study|Admin problems due to early termination|309|||
146167749|NCT01780935|527126321|FG000|Overall Study|Adverse Event|2|||
146167750|NCT01780935|527126322|FG001|Overall Study|Adverse Event|4|||
146167751|NCT01780935|527126321|FG000|Overall Study|Death|1|||
146167752|NCT01780935|527126322|FG001|Overall Study|Death|6|||
146332900|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
146167753|NCT01780935|527126321|FG000|Overall Study|Lost to Follow-up|2|||
146167754|NCT01780935|527126322|FG001|Overall Study|Lost to Follow-up|6|||
146167755|NCT01780935|527126321|FG000|Overall Study|Physician Decision|1|||
146167756|NCT01780935|527126322|FG001|Overall Study|Physician Decision|1|||
146167757|NCT01780935|527126321|FG000|Overall Study|Protocol deviation|0|||
146167758|NCT01780935|527126322|FG001|Overall Study|Protocol deviation|1|||
146167759|NCT01780935|527126321|FG000|Overall Study|Patient withdrew consent|8|||
146167760|NCT01780935|527126322|FG001|Overall Study|Patient withdrew consent|9|||
146167761|NCT00855595|527126323|FG000|Overall Study|Withdrawal by Subject|1|||
146167762|NCT00855595|527126324|FG001|Overall Study|Withdrawal by Subject|2|||
146167763|NCT00855595|527126323|FG000|Overall Study|Lost to Follow-up|3|||
146167764|NCT00855595|527126324|FG001|Overall Study|Lost to Follow-up|3|||
146167765|NCT00855595|527126323|FG000|Overall Study|Adverse Event|1|||
146167766|NCT00855595|527126324|FG001|Overall Study|Adverse Event|1|||
146167767|NCT00855595|527126323|FG000|Overall Study|patient moved out of state|1|||
146167768|NCT00855595|527126324|FG001|Overall Study|patient moved out of state|0|||
146167769|NCT00855595|527126323|FG000|Overall Study|patient left country|0|||
146167770|NCT00855595|527126324|FG001|Overall Study|patient left country|1|||
146167771|NCT01844284|527126325|FG000|Overall Study|Lost to Follow-up|12|||
146167772|NCT01844284|527126326|FG001|Overall Study|Lost to Follow-up|7|||
146167773|NCT02755597|527126328|FG000|Overall Study|Withdrew consent|27|||
146167774|NCT02755597|527126329|FG001|Overall Study|Withdrew consent|11|||
146167775|NCT02755597|527126328|FG000|Overall Study|Lost to Follow-up|1|||
146167776|NCT02755597|527126329|FG001|Overall Study|Lost to Follow-up|0|||
146167777|NCT02755597|527126328|FG000|Overall Study|Death|78|||
146167778|NCT02755597|527126329|FG001|Overall Study|Death|36|||
146167779|NCT02755597|527126328|FG000|Overall Study|Study terminated by Sponsor|67|||
146167780|NCT02755597|527126329|FG001|Overall Study|Study terminated by Sponsor|47|||
146167781|NCT02755597|527126328|FG000|Overall Study|Other, not specified|20|||
146167782|NCT02755597|527126329|FG001|Overall Study|Other, not specified|3|||
146167783|NCT02755597|527126328|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
146167784|NCT02755597|527126329|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
146167785|NCT02390531|527126340|FG000|Overall Study|Death|0|||
146167786|NCT02390531|527126341|FG001|Overall Study|Death|2|||
146167787|NCT02390531|527126342|FG002|Overall Study|Death|0|||
146167788|NCT02390531|527126343|FG003|Overall Study|Death|1|||
146167789|NCT02390531|527126344|FG004|Overall Study|Death|0|||
146167790|NCT02390531|527126345|FG005|Overall Study|Death|0|||
146167791|NCT02390531|527126346|FG006|Overall Study|Death|0|||
146167792|NCT02390531|527126347|FG007|Overall Study|Death|1|||
146167793|NCT02390531|527126340|FG000|Overall Study|Protocol Violation|0|||
146167794|NCT02390531|527126341|FG001|Overall Study|Protocol Violation|0|||
146167795|NCT02390531|527126342|FG002|Overall Study|Protocol Violation|0|||
146167796|NCT02390531|527126343|FG003|Overall Study|Protocol Violation|0|||
146167797|NCT02390531|527126344|FG004|Overall Study|Protocol Violation|1|||
146167798|NCT02390531|527126345|FG005|Overall Study|Protocol Violation|0|||
146167799|NCT02390531|527126346|FG006|Overall Study|Protocol Violation|2|||
146167800|NCT02390531|527126347|FG007|Overall Study|Protocol Violation|0|||
146167801|NCT02618616|527126348|FG000|Overall Study|Lack of Efficacy|4|||
146167802|NCT02618616|527126349|FG001|Overall Study|Lack of Efficacy|0|||
146167803|NCT02618616|527126348|FG000|Overall Study|Pregnancy|0|||
146167804|NCT02618616|527126349|FG001|Overall Study|Pregnancy|1|||
146167805|NCT02618616|527126348|FG000|Overall Study|Adverse Event|8|||
146167806|NCT02618616|527126349|FG001|Overall Study|Adverse Event|0|||
146167807|NCT02618616|527126348|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
146167808|NCT02618616|527126349|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
146167809|NCT02618616|527126348|FG000|Overall Study|Consent withdrawn by subject|8|||
146167810|NCT02618616|527126349|FG001|Overall Study|Consent withdrawn by subject|5|||
146167811|NCT02618616|527126348|FG000|Overall Study|Lost to Follow-up|0|||
146167812|NCT02618616|527126349|FG001|Overall Study|Lost to Follow-up|1|||
146167813|NCT01951638|527126350|FG000|Treatment Period|Protocol Violation|0|||
146167814|NCT01951638|527126351|FG001|Treatment Period|Protocol Violation|0|||
146167815|NCT01951638|527126352|FG002|Treatment Period|Protocol Violation|0|||
146167816|NCT01951638|527126353|FG003|Treatment Period|Protocol Violation|2|||
146167817|NCT01951638|527126354|FG004|Treatment Period|Protocol Violation|0|||
146167818|NCT01951638|527126350|FG000|Treatment Period|Protocol-driven decision point|1|||
146167819|NCT01951638|527126351|FG001|Treatment Period|Protocol-driven decision point|3|||
146328981|NCT03186989|527711582|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146328982|NCT03186989|527711583|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146328983|NCT03186989|527711584|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328984|NCT03186989|527711585|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
146328985|NCT03186989|527711586|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328986|NCT03186989|527711587|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
146328987|NCT00630331|527711591|FG000|Overall Study|Death|2|||
146167820|NCT01951638|527126352|FG002|Treatment Period|Protocol-driven decision point|0|||
146167821|NCT01951638|527126353|FG003|Treatment Period|Protocol-driven decision point|0|||
146167822|NCT01951638|527126354|FG004|Treatment Period|Protocol-driven decision point|0|||
146167823|NCT01951638|527126350|FG000|Treatment Period|Logistical difficulties|0|||
146167824|NCT01951638|527126351|FG001|Treatment Period|Logistical difficulties|1|||
146167825|NCT01951638|527126352|FG002|Treatment Period|Logistical difficulties|1|||
146167826|NCT01951638|527126353|FG003|Treatment Period|Logistical difficulties|0|||
146167827|NCT01951638|527126354|FG004|Treatment Period|Logistical difficulties|0|||
146167828|NCT01951638|527126350|FG000|Treatment Period|Withdrawal by Subject|9|||
146167829|NCT01951638|527126351|FG001|Treatment Period|Withdrawal by Subject|6|||
146167830|NCT01951638|527126352|FG002|Treatment Period|Withdrawal by Subject|4|||
146328988|NCT00630331|527711592|FG001|Overall Study|Death|1|||
146328989|NCT00630331|527711593|FG002|Overall Study|Death|1|||
146328990|NCT00630331|527711591|FG000|Overall Study|Adverse Event|1|||
146328991|NCT00630331|527711592|FG001|Overall Study|Adverse Event|0|||
146328992|NCT00630331|527711593|FG002|Overall Study|Adverse Event|0|||
146328993|NCT00630331|527711591|FG000|Overall Study|Withdrawal by Subject|12|||
146167831|NCT01951638|527126353|FG003|Treatment Period|Withdrawal by Subject|5|||
146167832|NCT01951638|527126354|FG004|Treatment Period|Withdrawal by Subject|4|||
146167833|NCT01951638|527126350|FG000|Treatment Period|Death|0|||
146167834|NCT01951638|527126351|FG001|Treatment Period|Death|0|||
146167835|NCT01951638|527126352|FG002|Treatment Period|Death|0|||
146167836|NCT01951638|527126353|FG003|Treatment Period|Death|3|||
146167837|NCT01951638|527126354|FG004|Treatment Period|Death|1|||
146167838|NCT01951638|527126350|FG000|Treatment Period|Adverse Event|3|||
146328994|NCT00630331|527711592|FG001|Overall Study|Withdrawal by Subject|7|||
146328995|NCT00630331|527711593|FG002|Overall Study|Withdrawal by Subject|5|||
146328996|NCT00630331|527711591|FG000|Overall Study|Lost to Follow-up|175|||
146328997|NCT00630331|527711592|FG001|Overall Study|Lost to Follow-up|143|||
146328998|NCT00630331|527711593|FG002|Overall Study|Lost to Follow-up|170|||
146328999|NCT00630331|527711591|FG000|Overall Study|Inappropriate enrollment|3|||
146167839|NCT01951638|527126351|FG001|Treatment Period|Adverse Event|4|||
146167840|NCT01951638|527126352|FG002|Treatment Period|Adverse Event|8|||
146167841|NCT01951638|527126353|FG003|Treatment Period|Adverse Event|6|||
146167842|NCT01951638|527126354|FG004|Treatment Period|Adverse Event|5|||
146167843|NCT01951638|527126350|FG000|Follow-up Period|Protocol Violation|0|||
146167844|NCT01951638|527126351|FG001|Follow-up Period|Protocol Violation|0|||
146167845|NCT01951638|527126352|FG002|Follow-up Period|Protocol Violation|0|||
146167846|NCT01951638|527126353|FG003|Follow-up Period|Protocol Violation|1|||
146167847|NCT01951638|527126354|FG004|Follow-up Period|Protocol Violation|0|||
146167848|NCT01951638|527126350|FG000|Follow-up Period|Logistical difficulties|0|||
146167849|NCT01951638|527126351|FG001|Follow-up Period|Logistical difficulties|2|||
146167850|NCT01951638|527126352|FG002|Follow-up Period|Logistical difficulties|0|||
146167851|NCT01951638|527126353|FG003|Follow-up Period|Logistical difficulties|0|||
146167852|NCT01951638|527126354|FG004|Follow-up Period|Logistical difficulties|1|||
146167853|NCT01951638|527126350|FG000|Follow-up Period|Withdrawal by Subject|1|||
146167854|NCT01951638|527126351|FG001|Follow-up Period|Withdrawal by Subject|5|||
146167855|NCT01951638|527126352|FG002|Follow-up Period|Withdrawal by Subject|2|||
146329000|NCT00630331|527711592|FG001|Overall Study|Inappropriate enrollment|6|||
146329001|NCT00630331|527711593|FG002|Overall Study|Inappropriate enrollment|3|||
146329002|NCT00630331|527711591|FG000|Overall Study|Unable to classify|9|||
146329003|NCT00630331|527711592|FG001|Overall Study|Unable to classify|4|||
146329004|NCT00630331|527711593|FG002|Overall Study|Unable to classify|3|||
146329005|NCT00630331|527711591|FG000|Overall Study|Protocol Violation|4|||
146329006|NCT00630331|527711592|FG001|Overall Study|Protocol Violation|5|||
146329007|NCT00630331|527711593|FG002|Overall Study|Protocol Violation|6|||
146329008|NCT02425098|527711594|FG000|Overall Study|Lost to Follow-up|7|||
146329009|NCT02425098|527711595|FG001|Overall Study|Lost to Follow-up|7|||
146329010|NCT02425098|527711594|FG000|Overall Study|Withdrawal by Subject|4|||
146167856|NCT01951638|527126353|FG003|Follow-up Period|Withdrawal by Subject|1|||
146167857|NCT01951638|527126354|FG004|Follow-up Period|Withdrawal by Subject|2|||
146167858|NCT01951638|527126350|FG000|Follow-up Period|Lost to Follow-up|0|||
146329011|NCT02425098|527711595|FG001|Overall Study|Withdrawal by Subject|8|||
146329012|NCT02425098|527711594|FG000|Overall Study|Pregnancy|2|||
146329013|NCT02425098|527711595|FG001|Overall Study|Pregnancy|0|||
146329014|NCT02425098|527711594|FG000|Overall Study|Reason not Specified|0|||
146329015|NCT02425098|527711595|FG001|Overall Study|Reason not Specified|1|||
146329016|NCT02292771|527711602|FG000|Overall Study|Withdrawal by Subject|2|||
146167859|NCT01951638|527126351|FG001|Follow-up Period|Lost to Follow-up|1|||
146167860|NCT01951638|527126352|FG002|Follow-up Period|Lost to Follow-up|0|||
146167861|NCT01951638|527126353|FG003|Follow-up Period|Lost to Follow-up|1|||
146167862|NCT01951638|527126354|FG004|Follow-up Period|Lost to Follow-up|0|||
146167863|NCT01951638|527126350|FG000|Follow-up Period|Death|1|||
146167864|NCT01951638|527126351|FG001|Follow-up Period|Death|0|||
146329017|NCT02292771|527711603|FG001|Overall Study|Withdrawal by Subject|1|||
146329018|NCT02292771|527711602|FG000|Overall Study|Lost to Follow-up|2|||
146329019|NCT02292771|527711603|FG001|Overall Study|Lost to Follow-up|1|||
146329020|NCT01468311|527711604|FG000|Overall Study|mobilization failure|1|||
146167865|NCT01951638|527126352|FG002|Follow-up Period|Death|1|||
146167866|NCT01951638|527126353|FG003|Follow-up Period|Death|4|||
146167867|NCT01951638|527126354|FG004|Follow-up Period|Death|1|||
146167868|NCT01951638|527126350|FG000|Follow-up Period|Adverse Event|0|||
146167869|NCT01951638|527126351|FG001|Follow-up Period|Adverse Event|1|||
146167870|NCT01951638|527126352|FG002|Follow-up Period|Adverse Event|2|||
146167871|NCT01951638|527126353|FG003|Follow-up Period|Adverse Event|1|||
146167872|NCT01951638|527126354|FG004|Follow-up Period|Adverse Event|1|||
146167873|NCT04225988|527126357|FG000|Overall Study|Withdrawal by Subject|2|||
146167874|NCT04225988|527126358|FG001|Overall Study|Withdrawal by Subject|0|||
146167875|NCT02044848|527127993|FG000|Overall Study|Administrative Problems|2|||
146167876|NCT02044848|527127994|FG001|Overall Study|Administrative Problems|3|||
146167877|NCT00045708|527127995|FG000|Phase 1|early progressive disease|0|||
146167878|NCT00045708|527127996|FG001|Phase 1|early progressive disease|1|||
146167879|NCT00045708|527127997|FG002|Phase 1|early progressive disease|0|||
146167880|NCT03183388|527127999|FG000|Overall Study|Lost to Follow-up|3|||
146167881|NCT03183388|527128000|FG001|Overall Study|Lost to Follow-up|5|||
146167882|NCT03183388|527127999|FG000|Overall Study|Physician Decision|1|||
146167883|NCT03183388|527128000|FG001|Overall Study|Physician Decision|4|||
146167884|NCT03183388|527127999|FG000|Overall Study|Withdrawal by Subject|4|||
146167885|NCT03183388|527128000|FG001|Overall Study|Withdrawal by Subject|1|||
146167886|NCT03183388|527127999|FG000|Overall Study|Moved|1|||
146167887|NCT03183388|527128000|FG001|Overall Study|Moved|0|||
146167888|NCT03183388|527127999|FG000|Overall Study|Met Exclusion Criteria|2|||
146167889|NCT03183388|527128000|FG001|Overall Study|Met Exclusion Criteria|2|||
146167890|NCT03183388|527127999|FG000|Overall Study|COVID Pandemic Related|2|||
146167891|NCT03183388|527128000|FG001|Overall Study|COVID Pandemic Related|4|||
146167892|NCT01493960|527128003|FG000|Overall Study|Adverse Event|0|||
146167893|NCT01493960|527128004|FG001|Overall Study|Adverse Event|1|||
146167894|NCT01493960|527128003|FG000|Overall Study|Lack of Efficacy|15|||
146167895|NCT01493960|527128004|FG001|Overall Study|Lack of Efficacy|9|||
146167896|NCT01493960|527128003|FG000|Overall Study|Protocol Violation|3|||
146167897|NCT01493960|527128004|FG001|Overall Study|Protocol Violation|0|||
146167898|NCT01493960|527128003|FG000|Overall Study|Withdrawal by Subject|10|||
146167899|NCT01493960|527128004|FG001|Overall Study|Withdrawal by Subject|4|||
146167900|NCT01493960|527128003|FG000|Overall Study|Non-specified|4|||
146167901|NCT01493960|527128004|FG001|Overall Study|Non-specified|4|||
146167902|NCT01679236|527128009|FG000|Overall Study|Lost to Follow-up|15|||
146167903|NCT01679236|527128010|FG001|Overall Study|Lost to Follow-up|15|||
146167904|NCT03935217|527128012|FG000|Overall Study|Adverse Event|1|||
146167905|NCT03935217|527128013|FG001|Overall Study|Adverse Event|0|||
146329021|NCT01468311|527711604|FG000|Overall Study|Withdrawal by Subject|1|||
146329022|NCT03219164|527713809|FG000|Overall Study|Study Terminated by Sponsor|16|||
146329023|NCT03219164|527713810|FG001|Overall Study|Study Terminated by Sponsor|12|||
146329024|NCT03219164|527713809|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
146329025|NCT03219164|527713810|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
146329026|NCT03219164|527713809|FG000|Overall Study|Lost to Follow-up|1|||
146329027|NCT03219164|527713810|FG001|Overall Study|Lost to Follow-up|1|||
146329028|NCT03219164|527713809|FG000|Overall Study|Adverse Event|1|||
146329029|NCT03219164|527713810|FG001|Overall Study|Adverse Event|0|||
146329030|NCT03219164|527713809|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146329031|NCT03219164|527713810|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146329032|NCT03219164|527713809|FG000|Overall Study|Protocol Violation|0|||
146329033|NCT03219164|527713810|FG001|Overall Study|Protocol Violation|1|||
146329034|NCT03219164|527713809|FG000|Overall Study|Withdrew Assent|1|||
146329035|NCT03219164|527713810|FG001|Overall Study|Withdrew Assent|0|||
146329036|NCT01750918|527713811|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
146329037|NCT01750918|527713812|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
146329038|NCT01750918|527713813|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
146329039|NCT01750918|527713814|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
146329040|NCT01750918|527713815|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
146329041|NCT01750918|527713816|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
146329042|NCT01750918|527713817|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
146167906|NCT03935217|527128012|FG000|Overall Study|Lost to Follow-up|0|||
146167907|NCT03935217|527128013|FG001|Overall Study|Lost to Follow-up|1|||
146167908|NCT03935217|527128012|FG000|Overall Study|Withdrawal by Subject|0|||
146167909|NCT03935217|527128013|FG001|Overall Study|Withdrawal by Subject|2|||
146329043|NCT01750918|527713818|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
146329044|NCT01750918|527713811|FG000|Overall Study|Lost to Follow-up|0|||
146329045|NCT01750918|527713812|FG001|Overall Study|Lost to Follow-up|0|||
146167910|NCT00847405|527128014|FG000|First Intervention|Adverse Event|0|||
146167911|NCT00847405|527128015|FG001|First Intervention|Adverse Event|1|||
146167912|NCT00847405|527128014|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
146167913|NCT00847405|527128015|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146167914|NCT01728792|527128016|FG000|Overall Study|Withdrawal of Consent|1|||
146167915|NCT01728792|527128017|FG001|Overall Study|Withdrawal of Consent|1|||
146167916|NCT01728792|527128018|FG002|Overall Study|Withdrawal of Consent|0|||
146167917|NCT01728792|527128019|FG003|Overall Study|Withdrawal of Consent|1|||
146167918|NCT01728792|527128020|FG004|Overall Study|Withdrawal of Consent|0|||
146167919|NCT01728792|527128016|FG000|Overall Study|Lost to Follow-up|2|||
146167920|NCT01728792|527128017|FG001|Overall Study|Lost to Follow-up|1|||
146167921|NCT01728792|527128018|FG002|Overall Study|Lost to Follow-up|4|||
146167922|NCT01728792|527128019|FG003|Overall Study|Lost to Follow-up|2|||
146167923|NCT01728792|527128020|FG004|Overall Study|Lost to Follow-up|0|||
146167924|NCT03559218|527128021|FG000|Overall Study|Withdrawal by Subject|1|||
146167925|NCT03559218|527128022|FG001|Overall Study|Withdrawal by Subject|0|||
146167926|NCT04277455|527128023|FG000|Overall Study|Lost to Follow-up|1|||
146167927|NCT01679301|527128026|FG000|Screening Period|screen failure|3|||
146167928|NCT01679301|527128027|FG001|Screening Period|screen failure|0|||
146167929|NCT01679301|527128028|FG002|Screening Period|screen failure|0|||
146167930|NCT00514683|527128030|FG000|Overall Study|Not treated|2|||
146167931|NCT00514683|527128031|FG001|Overall Study|Not treated|1|||
146167932|NCT00514683|527128032|FG002|Overall Study|Not treated|0|||
146167933|NCT00514683|527128033|FG003|Overall Study|Not treated|0|||
146167934|NCT00514683|527128034|FG004|Overall Study|Not treated|1|||
146167935|NCT00514683|527128030|FG000|Overall Study|Adverse Event|21|||
146167936|NCT00514683|527128031|FG001|Overall Study|Adverse Event|20|||
146167937|NCT00514683|527128032|FG002|Overall Study|Adverse Event|15|||
146167938|NCT00514683|527128033|FG003|Overall Study|Adverse Event|13|||
146167939|NCT00514683|527128034|FG004|Overall Study|Adverse Event|27|||
146167940|NCT00514683|527128030|FG000|Overall Study|Protocol Violation|1|||
146167941|NCT00514683|527128031|FG001|Overall Study|Protocol Violation|1|||
146167942|NCT00514683|527128032|FG002|Overall Study|Protocol Violation|0|||
146167943|NCT00514683|527128033|FG003|Overall Study|Protocol Violation|1|||
146167944|NCT00514683|527128034|FG004|Overall Study|Protocol Violation|0|||
146167945|NCT00514683|527128030|FG000|Overall Study|Withdrawal by Subject|2|||
146167946|NCT00514683|527128031|FG001|Overall Study|Withdrawal by Subject|2|||
146167947|NCT00514683|527128032|FG002|Overall Study|Withdrawal by Subject|1|||
146167948|NCT00514683|527128033|FG003|Overall Study|Withdrawal by Subject|0|||
146167949|NCT00514683|527128034|FG004|Overall Study|Withdrawal by Subject|4|||
146167950|NCT00514683|527128030|FG000|Overall Study|Reason other than listed above|0|||
146167951|NCT00514683|527128031|FG001|Overall Study|Reason other than listed above|1|||
146167952|NCT00514683|527128032|FG002|Overall Study|Reason other than listed above|2|||
146167953|NCT00514683|527128033|FG003|Overall Study|Reason other than listed above|0|||
146167954|NCT00514683|527128034|FG004|Overall Study|Reason other than listed above|1|||
146167955|NCT01564368|527128041|FG000|Overall Study|Ineligible|18|||
146167956|NCT01564368|527128041|FG000|Overall Study|Not Randomized in Parent study|116|||
146167957|NCT01564368|527128041|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
146167958|NCT01564368|527128041|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
146167959|NCT01802437|527128045|FG000|Overall Study|Lost to Follow-up|1|||
146167960|NCT01802437|527128046|FG001|Overall Study|Lost to Follow-up|0|||
146167961|NCT01802437|527128045|FG000|Overall Study|Withdrawal by Subject|3|||
146167962|NCT01802437|527128046|FG001|Overall Study|Withdrawal by Subject|4|||
146167963|NCT02228967|527128047|FG000|Overall Study|Lost to Follow-up|146|||
146167964|NCT02228967|527128048|FG001|Overall Study|Lost to Follow-up|142|||
146167965|NCT02228967|527128047|FG000|Overall Study|Withdrawal by Subject|13|||
146167966|NCT02228967|527128048|FG001|Overall Study|Withdrawal by Subject|18|||
146167967|NCT00520975|527128049|FG000|Overall Study|Disease progression|31|||
146167968|NCT00520975|527128050|FG001|Overall Study|Disease progression|23|||
146167969|NCT00520975|527128049|FG000|Overall Study|Adverse Event|7|||
146167970|NCT00520975|527128050|FG001|Overall Study|Adverse Event|10|||
146167971|NCT00520975|527128049|FG000|Overall Study|Death|0|||
146167972|NCT00520975|527128050|FG001|Overall Study|Death|2|||
146167973|NCT00520975|527128049|FG000|Overall Study|Withdrawal by Subject|3|||
146167974|NCT00520975|527128050|FG001|Overall Study|Withdrawal by Subject|5|||
146167975|NCT00520975|527128049|FG000|Overall Study|Other therapy|2|||
146167976|NCT00520975|527128050|FG001|Overall Study|Other therapy|4|||
146167977|NCT00520975|527128049|FG000|Overall Study|Other reasons|4|||
146167978|NCT00520975|527128050|FG001|Overall Study|Other reasons|2|||
146167979|NCT00520975|527128049|FG000|Overall Study|Not start protocol therapy|1|||
146167980|NCT00520975|527128050|FG001|Overall Study|Not start protocol therapy|2|||
146167981|NCT04998604|527128051|FG000|Overall Study|Adverse Event|3|||
146167982|NCT04998604|527128052|FG001|Overall Study|Adverse Event|2|||
146167983|NCT04998604|527128051|FG000|Overall Study|Withdrawal by Subject|2|||
146167984|NCT04998604|527128052|FG001|Overall Study|Withdrawal by Subject|4|||
146167985|NCT04998604|527128051|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
146167986|NCT04998604|527128052|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
146167987|NCT00642902|527128053|FG000|Overall Study|Adverse Event|0|||
146167988|NCT00642902|527128054|FG001|Overall Study|Adverse Event|1|||
146167989|NCT00642902|527128055|FG002|Overall Study|Adverse Event|3|||
146167990|NCT00642902|527128056|FG003|Overall Study|Adverse Event|1|||
146167991|NCT00642902|527128053|FG000|Overall Study|Lost to Follow-up|1|||
146167992|NCT00642902|527128054|FG001|Overall Study|Lost to Follow-up|1|||
146167993|NCT00642902|527128055|FG002|Overall Study|Lost to Follow-up|0|||
146167994|NCT00642902|527128056|FG003|Overall Study|Lost to Follow-up|0|||
146167995|NCT00642902|527128053|FG000|Overall Study|Lack of Efficacy|0|||
146167996|NCT00642902|527128054|FG001|Overall Study|Lack of Efficacy|3|||
146167997|NCT00642902|527128055|FG002|Overall Study|Lack of Efficacy|3|||
146167998|NCT00642902|527128056|FG003|Overall Study|Lack of Efficacy|0|||
146167999|NCT00642902|527128053|FG000|Overall Study|Death|1|||
146168000|NCT00642902|527128054|FG001|Overall Study|Death|0|||
146168001|NCT00642902|527128055|FG002|Overall Study|Death|0|||
146168002|NCT00642902|527128056|FG003|Overall Study|Death|0|||
146168003|NCT00642902|527128053|FG000|Overall Study|Premature termination of clinical trial|37|||
146168004|NCT00642902|527128054|FG001|Overall Study|Premature termination of clinical trial|32|||
146168005|NCT00642902|527128055|FG002|Overall Study|Premature termination of clinical trial|35|||
146168006|NCT00642902|527128056|FG003|Overall Study|Premature termination of clinical trial|35|||
146168007|NCT00642902|527128053|FG000|Overall Study|Randomized, but not treated|0|||
146168008|NCT00642902|527128054|FG001|Overall Study|Randomized, but not treated|0|||
146168009|NCT00642902|527128055|FG002|Overall Study|Randomized, but not treated|1|||
146168010|NCT00642902|527128056|FG003|Overall Study|Randomized, but not treated|0|||
146168011|NCT00642902|527128053|FG000|Overall Study|Other|1|||
146168012|NCT00642902|527128054|FG001|Overall Study|Other|5|||
146168013|NCT00642902|527128055|FG002|Overall Study|Other|1|||
146168014|NCT00642902|527128056|FG003|Overall Study|Other|4|||
146168015|NCT00429663|527128057|FG000|Overall Study|Lost to Follow-up|24|||
146168016|NCT00429663|527128058|FG001|Overall Study|Lost to Follow-up|31|||
146329046|NCT01750918|527713813|FG002|Overall Study|Lost to Follow-up|2|||
146329047|NCT01750918|527713814|FG003|Overall Study|Lost to Follow-up|2|||
146329048|NCT01750918|527713815|FG004|Overall Study|Lost to Follow-up|0|||
146329049|NCT01750918|527713816|FG005|Overall Study|Lost to Follow-up|0|||
146329050|NCT01750918|527713817|FG006|Overall Study|Lost to Follow-up|0|||
146329051|NCT01750918|527713818|FG007|Overall Study|Lost to Follow-up|1|||
146329052|NCT01750918|527713811|FG000|Overall Study|Withdrawal by Subject|0|||
146329053|NCT01750918|527713812|FG001|Overall Study|Withdrawal by Subject|0|||
146329054|NCT01750918|527713813|FG002|Overall Study|Withdrawal by Subject|1|||
146329055|NCT01750918|527713814|FG003|Overall Study|Withdrawal by Subject|2|||
146329056|NCT01750918|527713815|FG004|Overall Study|Withdrawal by Subject|1|||
146329057|NCT01750918|527713816|FG005|Overall Study|Withdrawal by Subject|1|||
146329058|NCT01750918|527713817|FG006|Overall Study|Withdrawal by Subject|2|||
146329059|NCT01750918|527713818|FG007|Overall Study|Withdrawal by Subject|2|||
146329060|NCT00224016|527713834|FG000|Titration Period|Withdrawal by Subject|0|||
146329061|NCT00224016|527713835|FG001|Titration Period|Withdrawal by Subject|1|||
146329062|NCT00224016|527713834|FG000|Titration Period|Lost to Follow-up|1|||
146329063|NCT00224016|527713835|FG001|Titration Period|Lost to Follow-up|0|||
146329064|NCT00224016|527713834|FG000|Maintenance Period|Withdrawal by Subject|2|||
146329065|NCT00224016|527713835|FG001|Maintenance Period|Withdrawal by Subject|0|||
146329066|NCT00224016|527713834|FG000|Maintenance Period|Lost to Follow-up|0|||
146329067|NCT00224016|527713835|FG001|Maintenance Period|Lost to Follow-up|1|||
146329068|NCT01524991|527713838|FG000|Overall Study|Adverse Event|12|||
146329069|NCT01524991|527713838|FG000|Overall Study|Death|1|||
146329070|NCT01524991|527713838|FG000|Overall Study|Disease ProgressionDu|17|||
146329071|NCT01524991|527713838|FG000|Overall Study|Other complicating disease|1|||
146329072|NCT01524991|527713838|FG000|Overall Study|Withdrawal by Subject|2|||
146329073|NCT01524991|527713838|FG000|Overall Study|Symptomatic Deterioration|1|||
146329074|NCT01805180|527713839|FG000|Lead-in Donor Phase|screen failure|1|||
146329075|NCT01805180|527713840|FG001|Lead-in Donor Phase|screen failure|0|||
146329076|NCT01805180|527713841|FG002|Lead-in Donor Phase|screen failure|0|||
146329077|NCT04574999|527713844|FG000|Overall Study|Adverse Event|1|||
146329078|NCT04574999|527713845|FG001|Overall Study|Adverse Event|0|||
146329079|NCT04574999|527713844|FG000|Overall Study|Lack of Efficacy|2|||
146329080|NCT04574999|527713845|FG001|Overall Study|Lack of Efficacy|3|||
146329081|NCT04574999|527713844|FG000|Overall Study|Protocol Violation|1|||
146329082|NCT04574999|527713845|FG001|Overall Study|Protocol Violation|0|||
146329083|NCT04574999|527713844|FG000|Overall Study|Withdrawal by Subject|2|||
146329084|NCT04574999|527713845|FG001|Overall Study|Withdrawal by Subject|2|||
146329085|NCT04574999|527713844|FG000|Overall Study|Lost to Follow-up|1|||
146329086|NCT04574999|527713845|FG001|Overall Study|Lost to Follow-up|0|||
146329087|NCT04574999|527713844|FG000|Overall Study|Personal problems|1|||
146329088|NCT04574999|527713845|FG001|Overall Study|Personal problems|0|||
146329089|NCT04574999|527713844|FG000|Overall Study|Previous planned surgery|1|||
146329090|NCT04574999|527713845|FG001|Overall Study|Previous planned surgery|0|||
146329091|NCT00206726|527713849|FG000|Overall Study|Delayed recovery of blood counts|1|||
146329092|NCT00206726|527713849|FG000|Overall Study|Progressive disease or relapsed disease|18|||
146329093|NCT00206726|527713849|FG000|Overall Study|Placed on new protocol|1|||
146329094|NCT00206726|527713849|FG000|Overall Study|Bone marrow transplant|1|||
146329095|NCT00206726|527713849|FG000|Overall Study|Adverse Event|17|||
146329096|NCT00206726|527713849|FG000|Overall Study|Death|4|||
146329097|NCT00206726|527713849|FG000|Overall Study|Protocol Violation|1|||
146329098|NCT00206726|527713849|FG000|Overall Study|Withdrawal by Subject|8|||
146329099|NCT00008385|527713866|FG000|Overall Study|Off treatment reasons not reported|79|||
146168017|NCT00429663|527128057|FG000|Overall Study|Physician Decision|6|||
146168018|NCT00429663|527128058|FG001|Overall Study|Physician Decision|3|||
146168019|NCT00429663|527128057|FG000|Overall Study|Withdrawal by Subject|2|||
146329100|NCT00008385|527713867|FG001|Overall Study|Off treatment reasons not reported|70|||
146329101|NCT00008385|527713866|FG000|Overall Study|Progressive disease|52|||
146329102|NCT00008385|527713867|FG001|Overall Study|Progressive disease|117|||
146329103|NCT00008385|527713866|FG000|Overall Study|Adverse Event|8|||
146329104|NCT00008385|527713867|FG001|Overall Study|Adverse Event|20|||
146329105|NCT00008385|527713866|FG000|Overall Study|Death|12|||
146329106|NCT00008385|527713867|FG001|Overall Study|Death|18|||
146329107|NCT00008385|527713866|FG000|Overall Study|Withdrawal by Subject|67|||
146329108|NCT00008385|527713867|FG001|Overall Study|Withdrawal by Subject|157|||
146329109|NCT00008385|527713866|FG000|Overall Study|Start non-protocol therapy|3|||
146329110|NCT00008385|527713867|FG001|Overall Study|Start non-protocol therapy|1|||
146329111|NCT00008385|527713866|FG000|Overall Study|Other complicating disease|17|||
146329112|NCT00008385|527713867|FG001|Overall Study|Other complicating disease|30|||
146329113|NCT00008385|527713866|FG000|Overall Study|Maximum dose reached|0|||
146329114|NCT00008385|527713867|FG001|Overall Study|Maximum dose reached|2|||
146329115|NCT00008385|527713866|FG000|Overall Study|Other|105|||
146329116|NCT00008385|527713867|FG001|Overall Study|Other|212|||
146329117|NCT00008385|527713866|FG000|Overall Study|Not start protocol therapy|44|||
146329118|NCT00008385|527713867|FG001|Overall Study|Not start protocol therapy|175|||
146329119|NCT05148884|527713868|FG000|Overall Study|Withdrawal by Subject|3|||
146329120|NCT05148884|527713869|FG001|Overall Study|Withdrawal by Subject|0|||
146329121|NCT05148884|527713868|FG000|Overall Study|Deep brain stimulation operation|0|||
146329122|NCT05148884|527713869|FG001|Overall Study|Deep brain stimulation operation|1|||
146329123|NCT00582556|527713870|FG000|Overall Study|Withdrawal by Subject|0|||
146329124|NCT00582556|527713871|FG001|Overall Study|Withdrawal by Subject|1|||
146329125|NCT00582556|527713872|FG002|Overall Study|Withdrawal by Subject|1|||
146329126|NCT00582556|527713870|FG000|Overall Study|Physician Decision|0|||
146329127|NCT00582556|527713871|FG001|Overall Study|Physician Decision|0|||
146329128|NCT00582556|527713872|FG002|Overall Study|Physician Decision|1|||
146329129|NCT01993888|527713875|FG000|Overall Study|Death|1|||
146329130|NCT01993888|527713876|FG001|Overall Study|Death|1|||
146329131|NCT01993888|527713875|FG000|Overall Study|Lost to Follow-up|1|||
146329132|NCT01993888|527713876|FG001|Overall Study|Lost to Follow-up|1|||
146329133|NCT01993888|527713875|FG000|Overall Study|Withdrawal by Subject|0|||
146329134|NCT01993888|527713876|FG001|Overall Study|Withdrawal by Subject|1|||
146329135|NCT01341457|527713877|FG000|Overall Study|Adverse Event|2|||
146329136|NCT01341457|527713878|FG001|Overall Study|Adverse Event|0|||
146329137|NCT03902080|527713883|FG000|Overall Study|Adverse Event|17|||
146329138|NCT03902080|527713884|FG001|Overall Study|Adverse Event|15|||
146329139|NCT03902080|527713883|FG000|Overall Study|Withdrawal by Subject|28|||
146329140|NCT03902080|527713884|FG001|Overall Study|Withdrawal by Subject|35|||
146329141|NCT03902080|527713883|FG000|Overall Study|Lost to Follow-up|6|||
146329142|NCT03902080|527713884|FG001|Overall Study|Lost to Follow-up|7|||
146329143|NCT03902080|527713883|FG000|Overall Study|Other|3|||
146329144|NCT03902080|527713884|FG001|Overall Study|Other|5|||
146329145|NCT03902080|527713883|FG000|Overall Study|Non compliance|4|||
146329146|NCT03902080|527713884|FG001|Overall Study|Non compliance|3|||
146329147|NCT03902080|527713883|FG000|Overall Study|Physician Decision|5|||
146329148|NCT03902080|527713884|FG001|Overall Study|Physician Decision|1|||
146329149|NCT03902080|527713883|FG000|Overall Study|Protocol Violation|3|||
146329150|NCT03902080|527713884|FG001|Overall Study|Protocol Violation|3|||
146329151|NCT03902080|527713883|FG000|Overall Study|Lack of Efficacy|1|||
146329152|NCT03902080|527713884|FG001|Overall Study|Lack of Efficacy|3|||
146329153|NCT03902080|527713883|FG000|Overall Study|Withdrawn prior to dosing|0|||
146329154|NCT03902080|527713884|FG001|Overall Study|Withdrawn prior to dosing|1|||
146329155|NCT02661594|527713885|FG000|Overall Study|Protocol Violation|1|||
146329156|NCT02661594|527713886|FG001|Overall Study|Protocol Violation|0|||
146329157|NCT02661594|527713887|FG002|Overall Study|Protocol Violation|1|||
146329158|NCT02661594|527713888|FG003|Overall Study|Protocol Violation|0|||
146329159|NCT00434967|527713891|FG000|Overall Study|Adverse Event|2|||
146329160|NCT00434967|527713892|FG001|Overall Study|Adverse Event|4|||
146329161|NCT00434967|527713893|FG002|Overall Study|Adverse Event|3|||
146329162|NCT00434967|527713894|FG003|Overall Study|Adverse Event|3|||
146329163|NCT00434967|527713891|FG000|Overall Study|Lost to Follow-up|0|||
146329164|NCT00434967|527713892|FG001|Overall Study|Lost to Follow-up|0|||
146329165|NCT00434967|527713893|FG002|Overall Study|Lost to Follow-up|1|||
146329166|NCT00434967|527713894|FG003|Overall Study|Lost to Follow-up|0|||
146329167|NCT00434967|527713891|FG000|Overall Study|Withdrawal by Subject|2|||
146329168|NCT00434967|527713892|FG001|Overall Study|Withdrawal by Subject|2|||
146329169|NCT00434967|527713893|FG002|Overall Study|Withdrawal by Subject|4|||
146329170|NCT00434967|527713894|FG003|Overall Study|Withdrawal by Subject|6|||
146329171|NCT00434967|527713891|FG000|Overall Study|Randomized in error|0|||
146329172|NCT00434967|527713892|FG001|Overall Study|Randomized in error|0|||
146329173|NCT00434967|527713893|FG002|Overall Study|Randomized in error|0|||
146329174|NCT00434967|527713894|FG003|Overall Study|Randomized in error|1|||
146329175|NCT00434967|527713891|FG000|Overall Study|Protocol Violation|0|||
146329176|NCT00434967|527713892|FG001|Overall Study|Protocol Violation|1|||
146329177|NCT00434967|527713893|FG002|Overall Study|Protocol Violation|0|||
146329178|NCT00434967|527713894|FG003|Overall Study|Protocol Violation|1|||
146329179|NCT00434967|527713891|FG000|Overall Study|Physician Decision|1|||
146329180|NCT00434967|527713892|FG001|Overall Study|Physician Decision|1|||
146329181|NCT00434967|527713893|FG002|Overall Study|Physician Decision|1|||
146329182|NCT00434967|527713894|FG003|Overall Study|Physician Decision|0|||
146329183|NCT00434967|527713891|FG000|Overall Study|Patient Disposition Challenges|2|||
146329184|NCT00434967|527713892|FG001|Overall Study|Patient Disposition Challenges|0|||
146329185|NCT00434967|527713893|FG002|Overall Study|Patient Disposition Challenges|0|||
146329186|NCT00434967|527713894|FG003|Overall Study|Patient Disposition Challenges|3|||
146329187|NCT01169779|527713895|FG000|Overall Study|Adverse Event|3|||
146329188|NCT01169779|527713896|FG001|Overall Study|Adverse Event|11|||
146329189|NCT01169779|527713895|FG000|Overall Study|Lack of Efficacy|1|||
146329190|NCT01169779|527713896|FG001|Overall Study|Lack of Efficacy|0|||
146329191|NCT01169779|527713895|FG000|Overall Study|Protocol Violation|1|||
146329192|NCT01169779|527713896|FG001|Overall Study|Protocol Violation|1|||
146329193|NCT01169779|527713895|FG000|Overall Study|Withdrawal by Subject|3|||
146329194|NCT01169779|527713896|FG001|Overall Study|Withdrawal by Subject|2|||
146329195|NCT01169779|527713895|FG000|Overall Study|Familial and personal reasons|3|||
146329196|NCT01169779|527713896|FG001|Overall Study|Familial and personal reasons|3|||
146329197|NCT00928070|527713897|FG000|Overall Study|Lost to Follow-up|1|||
146329198|NCT00928070|527713898|FG001|Overall Study|Lost to Follow-up|2|||
146329199|NCT00928070|527713897|FG000|Overall Study|Withdrawal by Subject|10|||
146329200|NCT00928070|527713898|FG001|Overall Study|Withdrawal by Subject|3|||
146329201|NCT00928070|527713897|FG000|Overall Study|Adverse Event|14|||
146329202|NCT00928070|527713898|FG001|Overall Study|Adverse Event|26|||
146329203|NCT00928070|527713897|FG000|Overall Study|Lack of Efficacy|9|||
146329204|NCT00928070|527713898|FG001|Overall Study|Lack of Efficacy|5|||
146329205|NCT00928070|527713897|FG000|Overall Study|Did not meet entrance criteria|16|||
146329206|NCT00928070|527713898|FG001|Overall Study|Did not meet entrance criteria|9|||
146329207|NCT00928070|527713897|FG000|Overall Study|Protocol Violation|6|||
146329208|NCT00928070|527713898|FG001|Overall Study|Protocol Violation|5|||
146329209|NCT00928070|527713897|FG000|Overall Study|Randomized but not treated|2|||
146329210|NCT00928070|527713898|FG001|Overall Study|Randomized but not treated|2|||
146329211|NCT00928070|527713897|FG000|Overall Study|Other|5|||
146329212|NCT00928070|527713898|FG001|Overall Study|Other|5|||
146329213|NCT00191854|527713899|FG000|Overall Study|Death|26|||
146329214|NCT00191854|527713900|FG001|Overall Study|Death|23|||
146329215|NCT00191854|527713901|FG002|Overall Study|Death|29|||
146329216|NCT00191854|527713899|FG000|Overall Study|Lost to Follow-up|7|||
146329217|NCT00191854|527713900|FG001|Overall Study|Lost to Follow-up|5|||
146329218|NCT00191854|527713901|FG002|Overall Study|Lost to Follow-up|5|||
146329219|NCT00191854|527713899|FG000|Overall Study|Withdrawal by Subject|4|||
146329220|NCT00191854|527713900|FG001|Overall Study|Withdrawal by Subject|2|||
146329221|NCT00191854|527713901|FG002|Overall Study|Withdrawal by Subject|3|||
146329222|NCT00191854|527713899|FG000|Overall Study|Sponsor Decision|0|||
146329223|NCT00191854|527713900|FG001|Overall Study|Sponsor Decision|0|||
146329224|NCT00191854|527713901|FG002|Overall Study|Sponsor Decision|1|||
146329225|NCT00191854|527713899|FG000|Overall Study|Screen Failure|0|||
146329226|NCT00191854|527713900|FG001|Overall Study|Screen Failure|0|||
146329227|NCT00191854|527713901|FG002|Overall Study|Screen Failure|1|||
146329228|NCT00556426|527713903|FG000|Overall Study|Withdrawal by Subject|3|||
146329229|NCT00556426|527713903|FG000|Overall Study|Death|6|||
146329230|NCT02347631|527713904|FG000|First Intervention (2 Months)|Adverse Event|1|||
146329231|NCT02347631|527713905|FG001|First Intervention (2 Months)|Adverse Event|1|||
146329232|NCT02347631|527713904|FG000|First Intervention (2 Months)|Pregnancy|1|||
146329233|NCT02347631|527713905|FG001|First Intervention (2 Months)|Pregnancy|0|||
146329234|NCT02347631|527713904|FG000|First Intervention (2 Months)|Moved out of area|0|||
146329235|NCT02347631|527713905|FG001|First Intervention (2 Months)|Moved out of area|2|||
146329236|NCT02347631|527713904|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
146329237|NCT02347631|527713905|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
146329238|NCT02347631|527713904|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
146329239|NCT02347631|527713905|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
146329240|NCT02347631|527713904|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
146329241|NCT02347631|527713905|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
146329242|NCT02347631|527713904|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
146329243|NCT02347631|527713905|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
146329244|NCT02347631|527713904|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
146329245|NCT02347631|527713905|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
146329246|NCT00934102|527713907|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
146329247|NCT00934102|527713908|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
146329248|NCT00934102|527713909|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
146329249|NCT02318784|527713910|FG000|Overall Study|Adverse Event|13|||
146329250|NCT02318784|527713910|FG000|Overall Study|Death|2|||
146329251|NCT02318784|527713910|FG000|Overall Study|Progressive Disease|37|||
146329252|NCT02318784|527713910|FG000|Overall Study|Withdrawal by Subject|10|||
146329253|NCT02304926|527713911|FG000|Overall Study|Lost to Follow-up|2|||
146329254|NCT02304926|527713912|FG001|Overall Study|Lost to Follow-up|1|||
146332901|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146329255|NCT03804684|527713913|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
146329256|NCT03804684|527713914|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
146329257|NCT02429856|527713915|FG000|Overall Study|Death|12|||
146329258|NCT02429856|527713916|FG001|Overall Study|Death|13|||
146329259|NCT02429856|527713915|FG000|Overall Study|Lost to Follow-up|6|||
146329260|NCT02429856|527713916|FG001|Overall Study|Lost to Follow-up|5|||
146329261|NCT02429856|527713915|FG000|Overall Study|Withdrawal by Subject|1|||
146329262|NCT02429856|527713916|FG001|Overall Study|Withdrawal by Subject|1|||
146329263|NCT00486603|527713918|FG000|Overall Study|Withdrawal by Subject|1|||
146329264|NCT00486603|527713919|FG001|Overall Study|Withdrawal by Subject|0|||
146329265|NCT00486603|527713920|FG002|Overall Study|Withdrawal by Subject|0|||
146329266|NCT00486603|527713921|FG003|Overall Study|Withdrawal by Subject|0|||
146329267|NCT00486603|527713922|FG004|Overall Study|Withdrawal by Subject|0|||
146329268|NCT00486603|527713918|FG000|Overall Study|Physician Decision|0|||
146329269|NCT00486603|527713919|FG001|Overall Study|Physician Decision|1|||
146329270|NCT00486603|527713920|FG002|Overall Study|Physician Decision|0|||
146329271|NCT00486603|527713921|FG003|Overall Study|Physician Decision|0|||
146329272|NCT00486603|527713922|FG004|Overall Study|Physician Decision|0|||
146329273|NCT00763009|527713923|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
146329274|NCT01355289|527713924|FG000|Core Study|Adverse Event, Non-Fatal|1|||
146329275|NCT01355289|527713925|FG001|Core Study|Adverse Event, Non-Fatal|0|||
146329276|NCT01355289|527713926|FG002|Core Study|Adverse Event, Non-Fatal|0|||
146329277|NCT01355289|527713927|FG003|Core Study|Adverse Event, Non-Fatal|0|||
146329278|NCT01355289|527713928|FG004|Core Study|Adverse Event, Non-Fatal|0|||
146329279|NCT01355289|527713924|FG000|Core Study|Inadequate Therapeutic Effect|0|||
146329280|NCT01355289|527713925|FG001|Core Study|Inadequate Therapeutic Effect|0|||
146329281|NCT01355289|527713926|FG002|Core Study|Inadequate Therapeutic Effect|0|||
146329282|NCT01355289|527713927|FG003|Core Study|Inadequate Therapeutic Effect|1|||
146329283|NCT01355289|527713928|FG004|Core Study|Inadequate Therapeutic Effect|0|||
146329284|NCT01355289|527713924|FG000|Core Study|Other|0|||
146329285|NCT01355289|527713925|FG001|Core Study|Other|0|||
146329286|NCT01355289|527713926|FG002|Core Study|Other|0|||
146329287|NCT01355289|527713927|FG003|Core Study|Other|1|||
146329288|NCT01355289|527713928|FG004|Core Study|Other|0|||
146329289|NCT01355289|527713924|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
146329290|NCT01355289|527713925|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
146329291|NCT01355289|527713926|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
146329292|NCT01355289|527713927|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
146329293|NCT01355289|527713928|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
146329294|NCT01355289|527713924|FG000|Open Label Extension|Lost to Follow-up|0|||
146329295|NCT01355289|527713925|FG001|Open Label Extension|Lost to Follow-up|0|||
146329296|NCT01355289|527713926|FG002|Open Label Extension|Lost to Follow-up|0|||
146329297|NCT01355289|527713927|FG003|Open Label Extension|Lost to Follow-up|0|||
146329298|NCT01355289|527713928|FG004|Open Label Extension|Lost to Follow-up|1|||
146329299|NCT01355289|527713924|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
146329300|NCT01355289|527713925|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
146329301|NCT01355289|527713926|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
146329302|NCT01355289|527713927|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
146329303|NCT01355289|527713928|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
146329304|NCT01355289|527713924|FG000|Open Label Extension|Other|0|||
146329305|NCT01355289|527713925|FG001|Open Label Extension|Other|0|||
146329306|NCT01355289|527713926|FG002|Open Label Extension|Other|0|||
146329307|NCT01355289|527713927|FG003|Open Label Extension|Other|0|||
146329308|NCT01355289|527713928|FG004|Open Label Extension|Other|3|||
146329309|NCT03838484|527713929|FG000|Overall Study|Lost to Follow-up|0|||
146329310|NCT03838484|527713930|FG001|Overall Study|Lost to Follow-up|1|||
146329311|NCT03838484|527713931|FG002|Overall Study|Lost to Follow-up|0|||
146329312|NCT03838484|527713932|FG003|Overall Study|Lost to Follow-up|0|||
146329313|NCT00813995|527713933|FG000|Overall Study|Clinical adverse event|9|||
146329314|NCT00813995|527713934|FG001|Overall Study|Clinical adverse event|3|||
146329315|NCT00813995|527713933|FG000|Overall Study|Laboratory adverse event|0|||
146329316|NCT00813995|527713934|FG001|Overall Study|Laboratory adverse event|2|||
146329317|NCT00813995|527713933|FG000|Overall Study|Lack of Efficacy|1|||
146329318|NCT00813995|527713934|FG001|Overall Study|Lack of Efficacy|0|||
146329319|NCT00813995|527713933|FG000|Overall Study|Lost to Follow-up|4|||
146329320|NCT00813995|527713934|FG001|Overall Study|Lost to Follow-up|2|||
146329321|NCT00813995|527713933|FG000|Overall Study|Other reason|2|||
146329322|NCT00813995|527713934|FG001|Overall Study|Other reason|2|||
146329323|NCT00813995|527713933|FG000|Overall Study|Protocol Violation|3|||
146329324|NCT00813995|527713934|FG001|Overall Study|Protocol Violation|2|||
146329325|NCT00813995|527713933|FG000|Overall Study|Subject moved|4|||
146329326|NCT00813995|527713934|FG001|Overall Study|Subject moved|0|||
146329327|NCT00813995|527713933|FG000|Overall Study|Withdrawal by Subject|0|||
146329328|NCT00813995|527713934|FG001|Overall Study|Withdrawal by Subject|5|||
146329329|NCT02507349|527713935|FG000|Overall Study|Death|12|||
146329330|NCT02507349|527713936|FG001|Overall Study|Death|16|||
146329331|NCT02507349|527713935|FG000|Overall Study|Withdrawal by Subject|1|||
146329332|NCT02507349|527713936|FG001|Overall Study|Withdrawal by Subject|1|||
146329333|NCT02507349|527713935|FG000|Overall Study|Lost to Follow-up|174|||
146329334|NCT02507349|527713936|FG001|Overall Study|Lost to Follow-up|144|||
146329335|NCT01614964|527713937|FG000|Overall Study|Withdrawal by Subject|2|||
146329336|NCT01614964|527713938|FG001|Overall Study|Withdrawal by Subject|0|||
146329337|NCT01614964|527713937|FG000|Overall Study|Lost to Follow-up|3|||
146329338|NCT01614964|527713938|FG001|Overall Study|Lost to Follow-up|0|||
146329339|NCT00860470|527713949|FG000|Overall Study|Death|6|||
146329340|NCT00860470|527713950|FG001|Overall Study|Death|10|||
146329341|NCT00860470|527713949|FG000|Overall Study|Moved away|8|||
146329342|NCT00860470|527713950|FG001|Overall Study|Moved away|10|||
146329343|NCT00860470|527713949|FG000|Overall Study|Lost to Follow-up|34|||
146329344|NCT00860470|527713950|FG001|Overall Study|Lost to Follow-up|39|||
146329345|NCT00888238|527713952|FG000|Washout Period After Period 2|Adverse Event|0|||
146329346|NCT00888238|527713953|FG001|Washout Period After Period 2|Adverse Event|0|||
146329347|NCT00888238|527713954|FG002|Washout Period After Period 2|Adverse Event|1|||
146329348|NCT02700984|527713955|FG000|Overall Study|Death|2|||
146329349|NCT02700984|527713956|FG001|Overall Study|Death|1|||
146329350|NCT02700984|527713955|FG000|Overall Study|Lost to Follow-up|2|||
146329351|NCT02700984|527713956|FG001|Overall Study|Lost to Follow-up|1|||
146329352|NCT02700984|527713955|FG000|Overall Study|Physician Decision|0|||
146329353|NCT02700984|527713956|FG001|Overall Study|Physician Decision|1|||
146329354|NCT02700984|527713955|FG000|Overall Study|Withdrawal by Subject|8|||
146329355|NCT02700984|527713956|FG001|Overall Study|Withdrawal by Subject|9|||
146329356|NCT02700984|527713955|FG000|Overall Study|Reason not specified|3|||
146329357|NCT02700984|527713956|FG001|Overall Study|Reason not specified|2|||
146329358|NCT01032629|527713958|FG000|Overall Study|Closed Site|21|||
146329359|NCT01032629|527713959|FG001|Overall Study|Closed Site|18|||
146329360|NCT01032629|527713960|FG002|Overall Study|Closed Site|16|||
146329361|NCT01032629|527713958|FG000|Overall Study|Withdrawal by Subject|50|||
146329362|NCT01032629|527713959|FG001|Overall Study|Withdrawal by Subject|36|||
146329363|NCT01032629|527713960|FG002|Overall Study|Withdrawal by Subject|35|||
146329364|NCT01032629|527713958|FG000|Overall Study|Lost to Follow-up|74|||
146329365|NCT01032629|527713959|FG001|Overall Study|Lost to Follow-up|47|||
146329366|NCT01032629|527713960|FG002|Overall Study|Lost to Follow-up|37|||
146329367|NCT00348140|527713961|FG000|Overall Study|Adverse Event|46|||
146329368|NCT00348140|527713962|FG001|Overall Study|Adverse Event|49|||
146329369|NCT00348140|527713963|FG002|Overall Study|Adverse Event|78|||
146329370|NCT00348140|527713961|FG000|Overall Study|Lost to Follow-up|4|||
146329371|NCT00348140|527713962|FG001|Overall Study|Lost to Follow-up|4|||
146329372|NCT00348140|527713963|FG002|Overall Study|Lost to Follow-up|4|||
146329373|NCT00348140|527713961|FG000|Overall Study|Protocol Violation|12|||
146329374|NCT00348140|527713962|FG001|Overall Study|Protocol Violation|13|||
146329375|NCT00348140|527713963|FG002|Overall Study|Protocol Violation|14|||
146329376|NCT00348140|527713961|FG000|Overall Study|Withdrawal by Subject|32|||
146329377|NCT00348140|527713962|FG001|Overall Study|Withdrawal by Subject|40|||
146329378|NCT00348140|527713963|FG002|Overall Study|Withdrawal by Subject|40|||
146329379|NCT00348140|527713961|FG000|Overall Study|Non-compliance|8|||
146329380|NCT00348140|527713962|FG001|Overall Study|Non-compliance|13|||
146329381|NCT00348140|527713963|FG002|Overall Study|Non-compliance|5|||
146329382|NCT00348140|527713961|FG000|Overall Study|Participant at risk due to study drug|2|||
146329383|NCT00348140|527713962|FG001|Overall Study|Participant at risk due to study drug|0|||
146329384|NCT00348140|527713963|FG002|Overall Study|Participant at risk due to study drug|0|||
146329385|NCT00348140|527713961|FG000|Overall Study|Conditional medication increased dose|1|||
146329386|NCT00348140|527713962|FG001|Overall Study|Conditional medication increased dose|0|||
146329387|NCT00348140|527713963|FG002|Overall Study|Conditional medication increased dose|0|||
146329388|NCT00348140|527713961|FG000|Overall Study|Caregiver related|4|||
146329389|NCT00348140|527713962|FG001|Overall Study|Caregiver related|7|||
146329390|NCT00348140|527713963|FG002|Overall Study|Caregiver related|3|||
146329391|NCT00348140|527713961|FG000|Overall Study|Participant hospitalised|3|||
146329392|NCT00348140|527713962|FG001|Overall Study|Participant hospitalised|0|||
146329393|NCT00348140|527713963|FG002|Overall Study|Participant hospitalised|0|||
146329394|NCT00348140|527713961|FG000|Overall Study|Efficacy related|1|||
146329395|NCT00348140|527713962|FG001|Overall Study|Efficacy related|1|||
146329396|NCT00348140|527713963|FG002|Overall Study|Efficacy related|0|||
146329397|NCT00348140|527713961|FG000|Overall Study|Administration related|3|||
146329398|NCT00348140|527713962|FG001|Overall Study|Administration related|1|||
146329399|NCT00348140|527713963|FG002|Overall Study|Administration related|1|||
146329400|NCT00348140|527713961|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
146329401|NCT00348140|527713962|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
146329402|NCT00348140|527713963|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
146329403|NCT00348140|527713961|FG000|Overall Study|Participant unwell|1|||
146329404|NCT00348140|527713962|FG001|Overall Study|Participant unwell|0|||
146329405|NCT00348140|527713963|FG002|Overall Study|Participant unwell|0|||
146329406|NCT00348140|527713961|FG000|Overall Study|Screen failure|1|||
146329407|NCT00348140|527713962|FG001|Overall Study|Screen failure|0|||
146329408|NCT00348140|527713963|FG002|Overall Study|Screen failure|0|||
146329409|NCT00348140|527713961|FG000|Overall Study|Investigator decided to discontinue|4|||
146329410|NCT00348140|527713962|FG001|Overall Study|Investigator decided to discontinue|1|||
146329411|NCT00348140|527713963|FG002|Overall Study|Investigator decided to discontinue|4|||
146329412|NCT00348140|527713961|FG000|Overall Study|Decided to discontinue on their own|1|||
146329413|NCT00348140|527713962|FG001|Overall Study|Decided to discontinue on their own|4|||
146329414|NCT00348140|527713963|FG002|Overall Study|Decided to discontinue on their own|1|||
146329415|NCT00348140|527713961|FG000|Overall Study|Use of prohibited drug|1|||
146329416|NCT00348140|527713962|FG001|Overall Study|Use of prohibited drug|0|||
146329417|NCT00348140|527713963|FG002|Overall Study|Use of prohibited drug|2|||
146329418|NCT00348140|527713961|FG000|Overall Study|Disease progression|1|||
146329419|NCT00348140|527713962|FG001|Overall Study|Disease progression|2|||
146329420|NCT00348140|527713963|FG002|Overall Study|Disease progression|5|||
146329421|NCT00348140|527713961|FG000|Overall Study|Increased risk of cardiac infarction|0|||
146329422|NCT00348140|527713962|FG001|Overall Study|Increased risk of cardiac infarction|1|||
146329423|NCT00348140|527713963|FG002|Overall Study|Increased risk of cardiac infarction|0|||
146329424|NCT00348140|527713961|FG000|Overall Study|Serious adverse event|0|||
146329425|NCT00348140|527713962|FG001|Overall Study|Serious adverse event|1|||
146329426|NCT00348140|527713963|FG002|Overall Study|Serious adverse event|0|||
146329427|NCT00348140|527713961|FG000|Overall Study|Abnormal ECG|0|||
146329428|NCT00348140|527713962|FG001|Overall Study|Abnormal ECG|1|||
146329429|NCT00348140|527713963|FG002|Overall Study|Abnormal ECG|3|||
146329430|NCT00348140|527713961|FG000|Overall Study|Participant died|0|||
146329431|NCT00348140|527713962|FG001|Overall Study|Participant died|1|||
146329432|NCT00348140|527713963|FG002|Overall Study|Participant died|0|||
146329433|NCT00348140|527713961|FG000|Overall Study|Exclusion criteria met|0|||
146329434|NCT00348140|527713962|FG001|Overall Study|Exclusion criteria met|0|||
146329435|NCT00348140|527713963|FG002|Overall Study|Exclusion criteria met|1|||
146329436|NCT00348140|527713961|FG000|Overall Study|Memory declined|0|||
146329437|NCT00348140|527713962|FG001|Overall Study|Memory declined|0|||
146329438|NCT00348140|527713963|FG002|Overall Study|Memory declined|1|||
146329439|NCT02868892|527713966|FG000|Overall Study|Investigator left site and no follow-up|6|||
146329440|NCT00619957|527713967|FG000|Month 24 Double-Blind|Adverse Event|9|||
146329441|NCT00619957|527713968|FG001|Month 24 Double-Blind|Adverse Event|7|||
146329442|NCT00619957|527713967|FG000|Month 24 Double-Blind|Protocol Violation|1|||
146329443|NCT00619957|527713968|FG001|Month 24 Double-Blind|Protocol Violation|0|||
146329444|NCT00619957|527713967|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
146329445|NCT00619957|527713968|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
146329446|NCT00619957|527713967|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
146329447|NCT00619957|527713968|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
146329448|NCT00619957|527713967|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
146329449|NCT00619957|527713968|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
146329450|NCT00619957|527713967|FG000|Month 48 Open-Label|Adverse Event|4|||
146329451|NCT00619957|527713968|FG001|Month 48 Open-Label|Adverse Event|4|||
146329452|NCT00619957|527713967|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
146329453|NCT00619957|527713968|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
146329454|NCT00619957|527713967|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
146329455|NCT00619957|527713968|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
146329456|NCT00723957|527713969|FG000|Overall Study|Adverse event unrelated to study drug|1|||
146329457|NCT00723957|527713970|FG001|Overall Study|Adverse event unrelated to study drug|4|||
146329458|NCT00723957|527713969|FG000|Overall Study|Death|3|||
146329459|NCT00723957|527713970|FG001|Overall Study|Death|4|||
146329460|NCT00723957|527713969|FG000|Overall Study|Disease progression|27|||
146329461|NCT00723957|527713970|FG001|Overall Study|Disease progression|25|||
146329462|NCT00723957|527713969|FG000|Overall Study|Maximum clinical benefit|4|||
146329463|NCT00723957|527713970|FG001|Overall Study|Maximum clinical benefit|5|||
146329464|NCT00723957|527713969|FG000|Overall Study|Investigator decision|1|||
146329465|NCT00723957|527713970|FG001|Overall Study|Investigator decision|1|||
146329466|NCT00723957|527713969|FG000|Overall Study|Study drug toxicity|4|||
146329467|NCT00723957|527713970|FG001|Overall Study|Study drug toxicity|6|||
146329468|NCT00723957|527713969|FG000|Overall Study|Withdrawal by Subject|7|||
146329469|NCT00723957|527713970|FG001|Overall Study|Withdrawal by Subject|5|||
146329470|NCT00723957|527713969|FG000|Overall Study|Reason not analyzed|1|||
146329471|NCT00723957|527713970|FG001|Overall Study|Reason not analyzed|0|||
146329472|NCT00723957|527713969|FG000|Overall Study|Never received treatment|3|||
146329473|NCT00723957|527713970|FG001|Overall Study|Never received treatment|3|||
146329474|NCT00868790|527713972|FG000|Period 1|Adverse Event|1|||
146329475|NCT00868790|527713973|FG001|Period 1|Adverse Event|0|||
146329476|NCT00868790|527713974|FG002|Period 1|Adverse Event|0|||
146329477|NCT00868790|527713975|FG003|Period 1|Adverse Event|0|||
146168020|NCT00429663|527128058|FG001|Overall Study|Withdrawal by Subject|5|||
146168021|NCT00429663|527128057|FG000|Overall Study|Death|4|||
146168022|NCT00429663|527128058|FG001|Overall Study|Death|0|||
146168023|NCT03953898|527128064|FG000|Overall Study|Lack of Efficacy|8|||
146168024|NCT03953898|527128064|FG000|Overall Study|Death|3|||
146329478|NCT00868790|527713976|FG004|Period 1|Adverse Event|0|||
146329479|NCT00868790|527713977|FG005|Period 1|Adverse Event|0|||
146329480|NCT00868790|527713978|FG006|Period 1|Adverse Event|0|||
146168025|NCT03953898|527128064|FG000|Overall Study|Withdrawal by Subject|2|||
146168026|NCT03953898|527128064|FG000|Overall Study|Adverse Event|1|||
146168027|NCT03261271|527128065|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
146168028|NCT03261271|527128066|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
146329481|NCT00868790|527713979|FG007|Period 1|Adverse Event|3|||
146329482|NCT00868790|527713980|FG008|Period 1|Adverse Event|1|||
146329483|NCT00868790|527713981|FG009|Period 1|Adverse Event|0|||
146329484|NCT00868790|527713982|FG010|Period 1|Adverse Event|0|||
146329485|NCT00868790|527713983|FG011|Period 1|Adverse Event|0|||
146329486|NCT00868790|527713984|FG012|Period 1|Adverse Event|0|||
146329487|NCT00868790|527713985|FG013|Period 1|Adverse Event|1|||
146329488|NCT00868790|527713972|FG000|Period 1|Protocol Violation|1|||
146329489|NCT00868790|527713973|FG001|Period 1|Protocol Violation|0|||
146329490|NCT00868790|527713974|FG002|Period 1|Protocol Violation|0|||
146329491|NCT00868790|527713975|FG003|Period 1|Protocol Violation|0|||
146329492|NCT00868790|527713976|FG004|Period 1|Protocol Violation|0|||
146329493|NCT00868790|527713977|FG005|Period 1|Protocol Violation|0|||
146329494|NCT00868790|527713978|FG006|Period 1|Protocol Violation|0|||
146329495|NCT00868790|527713979|FG007|Period 1|Protocol Violation|0|||
146329496|NCT00868790|527713980|FG008|Period 1|Protocol Violation|0|||
146329497|NCT00868790|527713981|FG009|Period 1|Protocol Violation|0|||
146329498|NCT00868790|527713982|FG010|Period 1|Protocol Violation|0|||
146329499|NCT00868790|527713983|FG011|Period 1|Protocol Violation|0|||
146329500|NCT00868790|527713984|FG012|Period 1|Protocol Violation|0|||
146329501|NCT00868790|527713985|FG013|Period 1|Protocol Violation|0|||
146329502|NCT00868790|527713972|FG000|Period 1|Withdrawal by Subject|0|||
146329503|NCT00868790|527713973|FG001|Period 1|Withdrawal by Subject|1|||
146329504|NCT00868790|527713974|FG002|Period 1|Withdrawal by Subject|0|||
146329505|NCT00868790|527713975|FG003|Period 1|Withdrawal by Subject|0|||
146329506|NCT00868790|527713976|FG004|Period 1|Withdrawal by Subject|0|||
146329507|NCT00868790|527713977|FG005|Period 1|Withdrawal by Subject|0|||
146329508|NCT00868790|527713978|FG006|Period 1|Withdrawal by Subject|0|||
146329509|NCT00868790|527713979|FG007|Period 1|Withdrawal by Subject|0|||
146329510|NCT00868790|527713980|FG008|Period 1|Withdrawal by Subject|0|||
146329511|NCT00868790|527713981|FG009|Period 1|Withdrawal by Subject|0|||
146329512|NCT00868790|527713982|FG010|Period 1|Withdrawal by Subject|0|||
146329513|NCT00868790|527713983|FG011|Period 1|Withdrawal by Subject|0|||
146329514|NCT00868790|527713984|FG012|Period 1|Withdrawal by Subject|0|||
146329515|NCT00868790|527713985|FG013|Period 1|Withdrawal by Subject|1|||
146329516|NCT00868790|527713972|FG000|Period 1|Abnormal Triglycerides|0|||
146329517|NCT00868790|527713973|FG001|Period 1|Abnormal Triglycerides|0|||
146329518|NCT00868790|527713974|FG002|Period 1|Abnormal Triglycerides|0|||
146329519|NCT00868790|527713975|FG003|Period 1|Abnormal Triglycerides|0|||
146329520|NCT00868790|527713976|FG004|Period 1|Abnormal Triglycerides|1|||
146329521|NCT00868790|527713977|FG005|Period 1|Abnormal Triglycerides|0|||
146329522|NCT00868790|527713978|FG006|Period 1|Abnormal Triglycerides|0|||
146329523|NCT00868790|527713979|FG007|Period 1|Abnormal Triglycerides|0|||
146329524|NCT00868790|527713980|FG008|Period 1|Abnormal Triglycerides|0|||
146329525|NCT00868790|527713981|FG009|Period 1|Abnormal Triglycerides|0|||
146329526|NCT00868790|527713982|FG010|Period 1|Abnormal Triglycerides|0|||
146329527|NCT00868790|527713983|FG011|Period 1|Abnormal Triglycerides|0|||
146329528|NCT00868790|527713984|FG012|Period 1|Abnormal Triglycerides|0|||
146329529|NCT00868790|527713985|FG013|Period 1|Abnormal Triglycerides|0|||
146329530|NCT00868790|527713972|FG000|Period 1|Lost to Follow-up|0|||
146329531|NCT00868790|527713973|FG001|Period 1|Lost to Follow-up|0|||
146329532|NCT00868790|527713974|FG002|Period 1|Lost to Follow-up|0|||
146329533|NCT00868790|527713975|FG003|Period 1|Lost to Follow-up|0|||
146329534|NCT00868790|527713976|FG004|Period 1|Lost to Follow-up|0|||
146329535|NCT00868790|527713977|FG005|Period 1|Lost to Follow-up|1|||
146329536|NCT00868790|527713978|FG006|Period 1|Lost to Follow-up|0|||
146329537|NCT00868790|527713979|FG007|Period 1|Lost to Follow-up|0|||
146329538|NCT00868790|527713980|FG008|Period 1|Lost to Follow-up|0|||
146329539|NCT00868790|527713981|FG009|Period 1|Lost to Follow-up|0|||
146329540|NCT00868790|527713982|FG010|Period 1|Lost to Follow-up|0|||
146168029|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
146168030|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
146329541|NCT00868790|527713983|FG011|Period 1|Lost to Follow-up|0|||
146329542|NCT00868790|527713984|FG012|Period 1|Lost to Follow-up|0|||
146329543|NCT00868790|527713985|FG013|Period 1|Lost to Follow-up|0|||
146329544|NCT00868790|527713972|FG000|Period 2|Adverse Event|0|||
146329545|NCT00868790|527713973|FG001|Period 2|Adverse Event|0|||
146329546|NCT00868790|527713974|FG002|Period 2|Adverse Event|0|||
146329547|NCT00868790|527713975|FG003|Period 2|Adverse Event|0|||
146329548|NCT00868790|527713976|FG004|Period 2|Adverse Event|0|||
146329549|NCT00868790|527713977|FG005|Period 2|Adverse Event|0|||
146329550|NCT00868790|527713978|FG006|Period 2|Adverse Event|0|||
146329551|NCT00868790|527713979|FG007|Period 2|Adverse Event|0|||
146329552|NCT00868790|527713980|FG008|Period 2|Adverse Event|1|||
146329553|NCT00868790|527713981|FG009|Period 2|Adverse Event|0|||
146329554|NCT00868790|527713982|FG010|Period 2|Adverse Event|0|||
146329555|NCT00868790|527713983|FG011|Period 2|Adverse Event|0|||
146329556|NCT00868790|527713984|FG012|Period 2|Adverse Event|0|||
146329557|NCT00868790|527713985|FG013|Period 2|Adverse Event|0|||
146329558|NCT00868790|527713972|FG000|Period 2|Lost to Follow-up|0|||
146329559|NCT00868790|527713973|FG001|Period 2|Lost to Follow-up|1|||
146329560|NCT00868790|527713974|FG002|Period 2|Lost to Follow-up|0|||
146329561|NCT00868790|527713975|FG003|Period 2|Lost to Follow-up|0|||
146329562|NCT00868790|527713976|FG004|Period 2|Lost to Follow-up|0|||
146329563|NCT00868790|527713977|FG005|Period 2|Lost to Follow-up|1|||
146329564|NCT00868790|527713978|FG006|Period 2|Lost to Follow-up|0|||
146329565|NCT00868790|527713979|FG007|Period 2|Lost to Follow-up|0|||
146329566|NCT00868790|527713980|FG008|Period 2|Lost to Follow-up|0|||
146329567|NCT00868790|527713981|FG009|Period 2|Lost to Follow-up|0|||
146329568|NCT00868790|527713982|FG010|Period 2|Lost to Follow-up|0|||
146329569|NCT00868790|527713983|FG011|Period 2|Lost to Follow-up|0|||
146329570|NCT00868790|527713984|FG012|Period 2|Lost to Follow-up|0|||
146329571|NCT00868790|527713985|FG013|Period 2|Lost to Follow-up|0|||
146329572|NCT00868790|527713972|FG000|Period 2|Withdrawal by Subject|0|||
146329573|NCT00868790|527713973|FG001|Period 2|Withdrawal by Subject|0|||
146329574|NCT00868790|527713974|FG002|Period 2|Withdrawal by Subject|0|||
146329575|NCT00868790|527713975|FG003|Period 2|Withdrawal by Subject|0|||
146329576|NCT00868790|527713976|FG004|Period 2|Withdrawal by Subject|0|||
146329577|NCT00868790|527713977|FG005|Period 2|Withdrawal by Subject|0|||
146329578|NCT00868790|527713978|FG006|Period 2|Withdrawal by Subject|0|||
146329579|NCT00868790|527713979|FG007|Period 2|Withdrawal by Subject|0|||
146329580|NCT00868790|527713980|FG008|Period 2|Withdrawal by Subject|1|||
146329581|NCT00868790|527713981|FG009|Period 2|Withdrawal by Subject|0|||
146329582|NCT00868790|527713982|FG010|Period 2|Withdrawal by Subject|0|||
146329583|NCT00868790|527713983|FG011|Period 2|Withdrawal by Subject|0|||
146329584|NCT00868790|527713984|FG012|Period 2|Withdrawal by Subject|0|||
146329585|NCT00868790|527713985|FG013|Period 2|Withdrawal by Subject|1|||
146329586|NCT00868790|527713972|FG000|Period 3|Adverse Event|0|||
146329587|NCT00868790|527713973|FG001|Period 3|Adverse Event|0|||
146329588|NCT00868790|527713974|FG002|Period 3|Adverse Event|0|||
146329589|NCT00868790|527713975|FG003|Period 3|Adverse Event|0|||
146329590|NCT00868790|527713976|FG004|Period 3|Adverse Event|0|||
146329591|NCT00868790|527713977|FG005|Period 3|Adverse Event|0|||
146329592|NCT00868790|527713978|FG006|Period 3|Adverse Event|0|||
146329593|NCT00868790|527713979|FG007|Period 3|Adverse Event|0|||
146329594|NCT00868790|527713980|FG008|Period 3|Adverse Event|0|||
146329595|NCT00868790|527713981|FG009|Period 3|Adverse Event|1|||
146329596|NCT00868790|527713982|FG010|Period 3|Adverse Event|0|||
146329597|NCT00868790|527713983|FG011|Period 3|Adverse Event|0|||
146329598|NCT00868790|527713984|FG012|Period 3|Adverse Event|0|||
146329599|NCT00868790|527713985|FG013|Period 3|Adverse Event|0|||
146329600|NCT00868790|527713972|FG000|Period 3|Protocol Violation|0|||
146329601|NCT00868790|527713973|FG001|Period 3|Protocol Violation|0|||
146329602|NCT00868790|527713974|FG002|Period 3|Protocol Violation|0|||
146329603|NCT00868790|527713975|FG003|Period 3|Protocol Violation|0|||
146329604|NCT00868790|527713976|FG004|Period 3|Protocol Violation|0|||
146329605|NCT00868790|527713977|FG005|Period 3|Protocol Violation|0|||
146329606|NCT00868790|527713978|FG006|Period 3|Protocol Violation|0|||
146329607|NCT00868790|527713979|FG007|Period 3|Protocol Violation|0|||
146329608|NCT00868790|527713980|FG008|Period 3|Protocol Violation|0|||
146329609|NCT00868790|527713981|FG009|Period 3|Protocol Violation|0|||
146329610|NCT00868790|527713982|FG010|Period 3|Protocol Violation|1|||
146329611|NCT00868790|527713983|FG011|Period 3|Protocol Violation|0|||
146329612|NCT00868790|527713984|FG012|Period 3|Protocol Violation|0|||
146329613|NCT00868790|527713985|FG013|Period 3|Protocol Violation|0|||
146329614|NCT00868790|527713972|FG000|Period 3|Study Terminated by Sponsor|0|||
146329615|NCT00868790|527713973|FG001|Period 3|Study Terminated by Sponsor|0|||
146329616|NCT00868790|527713974|FG002|Period 3|Study Terminated by Sponsor|0|||
146329617|NCT00868790|527713975|FG003|Period 3|Study Terminated by Sponsor|1|||
146329618|NCT00868790|527713976|FG004|Period 3|Study Terminated by Sponsor|0|||
146329619|NCT00868790|527713977|FG005|Period 3|Study Terminated by Sponsor|0|||
146329620|NCT00868790|527713978|FG006|Period 3|Study Terminated by Sponsor|0|||
146329621|NCT00868790|527713979|FG007|Period 3|Study Terminated by Sponsor|0|||
146329622|NCT00868790|527713980|FG008|Period 3|Study Terminated by Sponsor|0|||
146329623|NCT00868790|527713981|FG009|Period 3|Study Terminated by Sponsor|0|||
146329624|NCT00868790|527713982|FG010|Period 3|Study Terminated by Sponsor|0|||
146329625|NCT00868790|527713983|FG011|Period 3|Study Terminated by Sponsor|0|||
146329626|NCT00868790|527713984|FG012|Period 3|Study Terminated by Sponsor|0|||
146329627|NCT00868790|527713985|FG013|Period 3|Study Terminated by Sponsor|0|||
146329628|NCT00868790|527713972|FG000|Period 4|Adverse Event|0|||
146329629|NCT00868790|527713973|FG001|Period 4|Adverse Event|0|||
146329630|NCT00868790|527713974|FG002|Period 4|Adverse Event|0|||
146329631|NCT00868790|527713975|FG003|Period 4|Adverse Event|0|||
146329632|NCT00868790|527713976|FG004|Period 4|Adverse Event|0|||
146329633|NCT00868790|527713977|FG005|Period 4|Adverse Event|0|||
146329634|NCT00868790|527713978|FG006|Period 4|Adverse Event|0|||
146329635|NCT00868790|527713979|FG007|Period 4|Adverse Event|1|||
146329636|NCT00868790|527713980|FG008|Period 4|Adverse Event|0|||
146329637|NCT00868790|527713981|FG009|Period 4|Adverse Event|0|||
146329638|NCT00868790|527713982|FG010|Period 4|Adverse Event|1|||
146329639|NCT00868790|527713983|FG011|Period 4|Adverse Event|0|||
146329640|NCT00868790|527713984|FG012|Period 4|Adverse Event|1|||
146329641|NCT00868790|527713985|FG013|Period 4|Adverse Event|0|||
146329642|NCT00868790|527713972|FG000|Period 4|Lost to Follow-up|0|||
146329643|NCT00868790|527713973|FG001|Period 4|Lost to Follow-up|0|||
146329644|NCT00868790|527713974|FG002|Period 4|Lost to Follow-up|0|||
146329645|NCT00868790|527713975|FG003|Period 4|Lost to Follow-up|0|||
146329646|NCT00868790|527713976|FG004|Period 4|Lost to Follow-up|0|||
146329647|NCT00868790|527713977|FG005|Period 4|Lost to Follow-up|0|||
146329648|NCT00868790|527713978|FG006|Period 4|Lost to Follow-up|0|||
146329649|NCT00868790|527713979|FG007|Period 4|Lost to Follow-up|1|||
146329650|NCT00868790|527713980|FG008|Period 4|Lost to Follow-up|0|||
146329651|NCT00868790|527713981|FG009|Period 4|Lost to Follow-up|0|||
146329652|NCT00868790|527713982|FG010|Period 4|Lost to Follow-up|0|||
146329653|NCT00868790|527713983|FG011|Period 4|Lost to Follow-up|0|||
146329654|NCT00868790|527713984|FG012|Period 4|Lost to Follow-up|0|||
146329655|NCT00868790|527713985|FG013|Period 4|Lost to Follow-up|0|||
146329656|NCT00868790|527713972|FG000|Period 4|Study Terminated by Sponsor|2|||
146329657|NCT00868790|527713973|FG001|Period 4|Study Terminated by Sponsor|0|||
146329658|NCT00868790|527713974|FG002|Period 4|Study Terminated by Sponsor|0|||
146329659|NCT00868790|527713975|FG003|Period 4|Study Terminated by Sponsor|0|||
146329660|NCT00868790|527713976|FG004|Period 4|Study Terminated by Sponsor|0|||
146329661|NCT00868790|527713977|FG005|Period 4|Study Terminated by Sponsor|0|||
146329662|NCT00868790|527713978|FG006|Period 4|Study Terminated by Sponsor|0|||
146329663|NCT00868790|527713979|FG007|Period 4|Study Terminated by Sponsor|1|||
146329664|NCT00868790|527713980|FG008|Period 4|Study Terminated by Sponsor|2|||
146329665|NCT00868790|527713981|FG009|Period 4|Study Terminated by Sponsor|0|||
146329666|NCT00868790|527713982|FG010|Period 4|Study Terminated by Sponsor|2|||
146329667|NCT00868790|527713983|FG011|Period 4|Study Terminated by Sponsor|1|||
146329668|NCT00868790|527713984|FG012|Period 4|Study Terminated by Sponsor|0|||
146329669|NCT00868790|527713985|FG013|Period 4|Study Terminated by Sponsor|1|||
146329670|NCT00868790|527713972|FG000|Period 4|Abnormal ALT/AST|0|||
146329671|NCT00868790|527713973|FG001|Period 4|Abnormal ALT/AST|0|||
146329672|NCT00868790|527713974|FG002|Period 4|Abnormal ALT/AST|1|||
146329673|NCT00868790|527713975|FG003|Period 4|Abnormal ALT/AST|0|||
146329674|NCT00868790|527713976|FG004|Period 4|Abnormal ALT/AST|0|||
146329675|NCT00868790|527713977|FG005|Period 4|Abnormal ALT/AST|0|||
146329676|NCT00868790|527713978|FG006|Period 4|Abnormal ALT/AST|0|||
146329677|NCT00868790|527713979|FG007|Period 4|Abnormal ALT/AST|0|||
146329678|NCT00868790|527713980|FG008|Period 4|Abnormal ALT/AST|0|||
146329679|NCT00868790|527713981|FG009|Period 4|Abnormal ALT/AST|0|||
146329680|NCT00868790|527713982|FG010|Period 4|Abnormal ALT/AST|0|||
146329681|NCT00868790|527713983|FG011|Period 4|Abnormal ALT/AST|0|||
146329682|NCT00868790|527713984|FG012|Period 4|Abnormal ALT/AST|0|||
146329683|NCT00868790|527713985|FG013|Period 4|Abnormal ALT/AST|0|||
146329684|NCT00868790|527713972|FG000|Post-study|Withdrawal by Subject|0|||
146329685|NCT00868790|527713973|FG001|Post-study|Withdrawal by Subject|0|||
146329686|NCT00868790|527713974|FG002|Post-study|Withdrawal by Subject|0|||
146329687|NCT00868790|527713975|FG003|Post-study|Withdrawal by Subject|0|||
146329688|NCT00868790|527713976|FG004|Post-study|Withdrawal by Subject|1|||
146329689|NCT00868790|527713977|FG005|Post-study|Withdrawal by Subject|0|||
146329690|NCT00868790|527713978|FG006|Post-study|Withdrawal by Subject|0|||
146329691|NCT00868790|527713979|FG007|Post-study|Withdrawal by Subject|0|||
146329692|NCT00868790|527713980|FG008|Post-study|Withdrawal by Subject|0|||
146329693|NCT00868790|527713981|FG009|Post-study|Withdrawal by Subject|0|||
146329694|NCT00868790|527713982|FG010|Post-study|Withdrawal by Subject|0|||
146329695|NCT00868790|527713983|FG011|Post-study|Withdrawal by Subject|0|||
146329696|NCT00868790|527713984|FG012|Post-study|Withdrawal by Subject|0|||
146329697|NCT00868790|527713985|FG013|Post-study|Withdrawal by Subject|0|||
146329698|NCT00868790|527713972|FG000|Post-study|Excluded Medication|0|||
146329699|NCT00868790|527713973|FG001|Post-study|Excluded Medication|0|||
146329700|NCT00868790|527713974|FG002|Post-study|Excluded Medication|0|||
146329701|NCT00868790|527713975|FG003|Post-study|Excluded Medication|0|||
146329702|NCT00868790|527713976|FG004|Post-study|Excluded Medication|0|||
146329703|NCT00868790|527713977|FG005|Post-study|Excluded Medication|0|||
146329704|NCT00868790|527713978|FG006|Post-study|Excluded Medication|0|||
146329705|NCT00868790|527713979|FG007|Post-study|Excluded Medication|2|||
146329706|NCT00868790|527713980|FG008|Post-study|Excluded Medication|0|||
146329707|NCT00868790|527713981|FG009|Post-study|Excluded Medication|1|||
146329708|NCT00868790|527713982|FG010|Post-study|Excluded Medication|0|||
146329709|NCT00868790|527713983|FG011|Post-study|Excluded Medication|0|||
146329710|NCT00868790|527713984|FG012|Post-study|Excluded Medication|0|||
146329711|NCT00868790|527713985|FG013|Post-study|Excluded Medication|0|||
146329712|NCT01763164|527713986|FG000|Treatment Phase|Participant/Guardian decision|26|||
146329713|NCT01763164|527713987|FG001|Treatment Phase|Participant/Guardian decision|14|||
146329714|NCT01763164|527713986|FG000|Treatment Phase|Protocol Violation|1|||
146329715|NCT01763164|527713987|FG001|Treatment Phase|Protocol Violation|1|||
146329716|NCT01763164|527713986|FG000|Treatment Phase|Progressive Disease|142|||
146329717|NCT01763164|527713987|FG001|Treatment Phase|Progressive Disease|76|||
146329718|NCT01763164|527713986|FG000|Treatment Phase|Physician Decision|24|||
146329719|NCT01763164|527713987|FG001|Treatment Phase|Physician Decision|13|||
146329720|NCT01763164|527713986|FG000|Treatment Phase|Death|10|||
146329721|NCT01763164|527713987|FG001|Treatment Phase|Death|1|||
146329722|NCT01763164|527713986|FG000|Treatment Phase|Adverse Event|66|||
146329723|NCT01763164|527713987|FG001|Treatment Phase|Adverse Event|8|||
146329724|NCT01763164|527713986|FG000|Treatment Phase|Randomized but not Treated|0|||
146329725|NCT01763164|527713987|FG001|Treatment Phase|Randomized but not Treated|19|||
146329726|NCT01763164|527713986|FG000|Treatment Phase|Other|0|||
146329727|NCT01763164|527713987|FG001|Treatment Phase|Other|1|||
146329728|NCT01763164|527713986|FG000|Follow up Phase|New therapy for study indication|12|||
146329729|NCT01763164|527713987|FG001|Follow up Phase|New therapy for study indication|3|||
146329730|NCT01763164|527713986|FG000|Follow up Phase|Death|21|||
146329731|NCT01763164|527713987|FG001|Follow up Phase|Death|4|||
146329732|NCT01763164|527713986|FG000|Follow up Phase|Subject/guardian decision|9|||
146329733|NCT01763164|527713987|FG001|Follow up Phase|Subject/guardian decision|2|||
146329734|NCT01763164|527713986|FG000|Follow up Phase|Progressive disease|127|||
146329735|NCT01763164|527713987|FG001|Follow up Phase|Progressive disease|62|||
146329736|NCT01763164|527713986|FG000|Follow up Phase|Physician Decision|10|||
146329737|NCT01763164|527713987|FG001|Follow up Phase|Physician Decision|3|||
146329738|NCT01763164|527713986|FG000|Follow up Phase|Lost to Follow-up|1|||
146329739|NCT01763164|527713987|FG001|Follow up Phase|Lost to Follow-up|0|||
146329740|NCT01763164|527713986|FG000|Follow up Phase|Adverse Event|17|||
146329741|NCT01763164|527713987|FG001|Follow up Phase|Adverse Event|1|||
146329742|NCT01264939|527713988|FG000|Overall Study|Adverse Event|1|||
146329743|NCT01264939|527713989|FG001|Overall Study|Adverse Event|3|||
146329744|NCT01264939|527713988|FG000|Overall Study|Lost to Follow-up|0|||
146329745|NCT01264939|527713989|FG001|Overall Study|Lost to Follow-up|3|||
146329746|NCT01264939|527713988|FG000|Overall Study|Physician Decision|1|||
146329747|NCT01264939|527713989|FG001|Overall Study|Physician Decision|1|||
146329748|NCT01264939|527713988|FG000|Overall Study|Patient/Guardian Decision|8|||
146329749|NCT01264939|527713989|FG001|Overall Study|Patient/Guardian Decision|10|||
146329750|NCT01264939|527713988|FG000|Overall Study|Disease Progression|8|||
146329751|NCT01264939|527713989|FG001|Overall Study|Disease Progression|11|||
146329752|NCT04666038|527713994|FG000|Overall Study|Progressive Disease|2|||
146329753|NCT04666038|527713995|FG001|Overall Study|Progressive Disease|0|||
146329754|NCT04666038|527713994|FG000|Overall Study|Death|38|||
146329755|NCT04666038|527713995|FG001|Overall Study|Death|32|||
146329756|NCT04666038|527713994|FG000|Overall Study|Withdrawal by Subject|10|||
146329757|NCT04666038|527713995|FG001|Overall Study|Withdrawal by Subject|19|||
146329758|NCT04666038|527713994|FG000|Overall Study|Lost to Follow-up|0|||
146329759|NCT04666038|527713995|FG001|Overall Study|Lost to Follow-up|2|||
146329760|NCT04666038|527713994|FG000|Overall Study|On Study Treatment|46|||
146329761|NCT04666038|527713995|FG001|Overall Study|On Study Treatment|5|||
146329762|NCT04666038|527713994|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
146329763|NCT04666038|527713995|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
146329764|NCT04957290|527713997|FG000|Overall Study|Progressive disease|3|||
146329765|NCT04957290|527713998|FG001|Overall Study|Progressive disease|3|||
146329766|NCT04957290|527713999|FG002|Overall Study|Progressive disease|2|||
146329767|NCT04957290|527714000|FG003|Overall Study|Progressive disease|0|||
146329768|NCT04957290|527714001|FG004|Overall Study|Progressive disease|0|||
146329769|NCT04957290|527714002|FG005|Overall Study|Progressive disease|0|||
146329770|NCT04957290|527713997|FG000|Overall Study|Withdrawal by Subject|1|||
146329771|NCT04957290|527713998|FG001|Overall Study|Withdrawal by Subject|0|||
146329772|NCT04957290|527713999|FG002|Overall Study|Withdrawal by Subject|1|||
146329773|NCT04957290|527714000|FG003|Overall Study|Withdrawal by Subject|0|||
146329774|NCT04957290|527714001|FG004|Overall Study|Withdrawal by Subject|0|||
146329775|NCT04957290|527714002|FG005|Overall Study|Withdrawal by Subject|0|||
146329776|NCT04957290|527713997|FG000|Overall Study|Death|0|||
146329777|NCT04957290|527713998|FG001|Overall Study|Death|2|||
146329778|NCT04957290|527713999|FG002|Overall Study|Death|1|||
146329779|NCT04957290|527714000|FG003|Overall Study|Death|0|||
146329780|NCT04957290|527714001|FG004|Overall Study|Death|0|||
146329781|NCT04957290|527714002|FG005|Overall Study|Death|0|||
146329782|NCT04957290|527713997|FG000|Overall Study|non compliance with study drug|0|||
146329783|NCT04957290|527713998|FG001|Overall Study|non compliance with study drug|1|||
146329784|NCT04957290|527713999|FG002|Overall Study|non compliance with study drug|0|||
146329785|NCT04957290|527714000|FG003|Overall Study|non compliance with study drug|0|||
146329786|NCT04957290|527714001|FG004|Overall Study|non compliance with study drug|0|||
146329787|NCT04957290|527714002|FG005|Overall Study|non compliance with study drug|0|||
146329788|NCT04957290|527713997|FG000|Overall Study|none specified.|0|||
146329789|NCT04957290|527713998|FG001|Overall Study|none specified.|1|||
146329790|NCT04957290|527713999|FG002|Overall Study|none specified.|2|||
146329791|NCT04957290|527714000|FG003|Overall Study|none specified.|0|||
146329792|NCT04957290|527714001|FG004|Overall Study|none specified.|0|||
146329793|NCT04957290|527714002|FG005|Overall Study|none specified.|0|||
146329794|NCT04957290|527713997|FG000|Overall Study|unacceptable toxicity|0|||
146329795|NCT04957290|527713998|FG001|Overall Study|unacceptable toxicity|0|||
146329796|NCT04957290|527713999|FG002|Overall Study|unacceptable toxicity|1|||
146329797|NCT04957290|527714000|FG003|Overall Study|unacceptable toxicity|0|||
146329798|NCT04957290|527714001|FG004|Overall Study|unacceptable toxicity|0|||
146329799|NCT04957290|527714002|FG005|Overall Study|unacceptable toxicity|0|||
146329800|NCT04957290|527713997|FG000|Overall Study|Adverse Event|0|||
146329801|NCT04957290|527713998|FG001|Overall Study|Adverse Event|0|||
146329802|NCT04957290|527713999|FG002|Overall Study|Adverse Event|1|||
146329803|NCT04957290|527714000|FG003|Overall Study|Adverse Event|0|||
146329804|NCT04957290|527714001|FG004|Overall Study|Adverse Event|0|||
146329805|NCT04957290|527714002|FG005|Overall Study|Adverse Event|0|||
146329806|NCT04957290|527713997|FG000|Overall Study|study terminated by sponsor|0|||
146329807|NCT04957290|527713998|FG001|Overall Study|study terminated by sponsor|0|||
146329808|NCT04957290|527713999|FG002|Overall Study|study terminated by sponsor|2|||
146329809|NCT04957290|527714000|FG003|Overall Study|study terminated by sponsor|0|||
146329810|NCT04957290|527714001|FG004|Overall Study|study terminated by sponsor|0|||
146329811|NCT04957290|527714002|FG005|Overall Study|study terminated by sponsor|0|||
146329812|NCT02899156|527714003|FG000|Overall Study|Death|1|||
146329813|NCT02899156|527714004|FG001|Overall Study|Death|0|||
146329814|NCT02899156|527714003|FG000|Overall Study|Physician Decision|0|||
146329815|NCT02899156|527714004|FG001|Overall Study|Physician Decision|1|||
146329816|NCT02116621|527714005|FG000|Baseline|Withdrawal by Subject|0|||
146329817|NCT02116621|527714006|FG001|Baseline|Withdrawal by Subject|4|||
146329818|NCT02116621|527714005|FG000|Three Month Follow-up|Death|1|||
146329819|NCT02116621|527714006|FG001|Three Month Follow-up|Death|1|||
146329820|NCT02116621|527714005|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
146329821|NCT02116621|527714006|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
146329822|NCT02116621|527714005|FG000|Three Month Follow-up|Lost to Follow-up|0|||
146329823|NCT02116621|527714006|FG001|Three Month Follow-up|Lost to Follow-up|1|||
146329824|NCT02116621|527714005|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
146329825|NCT02116621|527714006|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
146329826|NCT02116621|527714005|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
146329827|NCT02116621|527714006|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
146329828|NCT02116621|527714005|FG000|Six Month Follow-up|Lost to Follow-up|2|||
146329829|NCT02116621|527714006|FG001|Six Month Follow-up|Lost to Follow-up|1|||
146329830|NCT02116621|527714005|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
146329831|NCT02116621|527714006|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
146329832|NCT02116621|527714005|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
146329833|NCT02116621|527714006|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
146329834|NCT02116621|527714005|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
146329835|NCT02116621|527714006|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
146329836|NCT02116621|527714005|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
146329837|NCT02116621|527714006|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
146329838|NCT02116621|527714005|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
146329839|NCT02116621|527714006|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
146329840|NCT00484315|527714007|FG000|12-Month Clinical Follow-up|Death|6|||
146329841|NCT00484315|527714008|FG001|12-Month Clinical Follow-up|Death|2|||
146329842|NCT00484315|527714007|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
146329843|NCT00484315|527714008|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
146329844|NCT00484315|527714007|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
146329845|NCT00484315|527714008|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
146329846|NCT00484315|527714007|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
146329847|NCT00484315|527714008|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
146329848|NCT00484315|527714007|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
146329849|NCT00484315|527714008|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
146329850|NCT00484315|527714007|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
146329851|NCT00484315|527714008|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
146329852|NCT00484315|527714007|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
146329853|NCT00484315|527714008|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
146329854|NCT00943683|527714009|FG000|Overall Study|Adverse Event|3|||
146329855|NCT00943683|527714010|FG001|Overall Study|Adverse Event|3|||
146329856|NCT00943683|527714009|FG000|Overall Study|Lost to Follow-up|1|||
146329857|NCT00943683|527714010|FG001|Overall Study|Lost to Follow-up|1|||
146329858|NCT00943683|527714009|FG000|Overall Study|Protocol Violation|1|||
146329859|NCT00943683|527714010|FG001|Overall Study|Protocol Violation|2|||
146329860|NCT00943683|527714009|FG000|Overall Study|Withdrawal by Subject|1|||
146329861|NCT00943683|527714010|FG001|Overall Study|Withdrawal by Subject|0|||
146329862|NCT00943683|527714009|FG000|Overall Study|Patient Moved|1|||
146329863|NCT00943683|527714010|FG001|Overall Study|Patient Moved|0|||
146329864|NCT00413959|527714011|FG000|Overall Study|Pt had only one cycle.|1|||
146329865|NCT03538743|527714012|FG000|Overall Study|Adverse Event|0|||
146329866|NCT03538743|527714013|FG001|Overall Study|Adverse Event|0|||
146329867|NCT03538743|527714014|FG002|Overall Study|Adverse Event|1|||
146329868|NCT03538743|527714015|FG003|Overall Study|Adverse Event|1|||
146329869|NCT03538743|527714016|FG004|Overall Study|Adverse Event|0|||
146329870|NCT03538743|527714017|FG005|Overall Study|Adverse Event|0|||
146329871|NCT03538743|527714018|FG006|Overall Study|Adverse Event|0|||
146329872|NCT03538743|527714019|FG007|Overall Study|Adverse Event|0|||
146329873|NCT03538743|527714020|FG008|Overall Study|Adverse Event|0|||
146329874|NCT03538743|527714012|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
146329875|NCT03538743|527714013|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
146329876|NCT03538743|527714014|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
146329877|NCT03538743|527714015|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
146329878|NCT03538743|527714016|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
146329879|NCT03538743|527714017|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
146329880|NCT03538743|527714018|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
146329881|NCT03538743|527714019|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
146329882|NCT03538743|527714020|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
146329883|NCT03538743|527714012|FG000|Overall Study|Withdrawal by Subject|0|||
146329884|NCT03538743|527714013|FG001|Overall Study|Withdrawal by Subject|0|||
146329885|NCT03538743|527714014|FG002|Overall Study|Withdrawal by Subject|0|||
146329886|NCT03538743|527714015|FG003|Overall Study|Withdrawal by Subject|1|||
146329887|NCT03538743|527714016|FG004|Overall Study|Withdrawal by Subject|0|||
146329888|NCT03538743|527714017|FG005|Overall Study|Withdrawal by Subject|0|||
146329889|NCT03538743|527714018|FG006|Overall Study|Withdrawal by Subject|0|||
146329890|NCT03538743|527714019|FG007|Overall Study|Withdrawal by Subject|0|||
146329891|NCT03538743|527714020|FG008|Overall Study|Withdrawal by Subject|0|||
146329892|NCT04840667|527715991|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
146329893|NCT00023322|527715993|FG000|Overall Study|Lost to Follow-up|1|||
146329894|NCT03658889|527715994|FG000|Overall Study|Protocol Violation|2|||
146329895|NCT03658889|527715995|FG001|Overall Study|Protocol Violation|0|||
146329896|NCT04317690|527715997|FG000|Overall Study|did not have complete information for primary outcome|0|||
146329897|NCT04317690|527715998|FG001|Overall Study|did not have complete information for primary outcome|4|||
146329898|NCT04317690|527715999|FG002|Overall Study|did not have complete information for primary outcome|0|||
146329899|NCT04317690|527716000|FG003|Overall Study|did not have complete information for primary outcome|2|||
146329900|NCT04317690|527716001|FG004|Overall Study|did not have complete information for primary outcome|0|||
146329901|NCT01154101|527716002|FG000|Overall Study|Adverse Event|0|||
146329902|NCT01154101|527716003|FG001|Overall Study|Adverse Event|2|||
146329903|NCT01154101|527716004|FG002|Overall Study|Adverse Event|1|||
146329904|NCT01154101|527716005|FG003|Overall Study|Adverse Event|1|||
146329905|NCT01154101|527716006|FG004|Overall Study|Adverse Event|0|||
146329906|NCT01154101|527716002|FG000|Overall Study|Lost to Follow-up|0|||
146329907|NCT01154101|527716003|FG001|Overall Study|Lost to Follow-up|1|||
146329908|NCT01154101|527716004|FG002|Overall Study|Lost to Follow-up|0|||
146329909|NCT01154101|527716005|FG003|Overall Study|Lost to Follow-up|1|||
146329910|NCT01154101|527716006|FG004|Overall Study|Lost to Follow-up|0|||
146329911|NCT01154101|527716002|FG000|Overall Study|Withdrawal by Subject|0|||
146329912|NCT01154101|527716003|FG001|Overall Study|Withdrawal by Subject|1|||
146329913|NCT01154101|527716004|FG002|Overall Study|Withdrawal by Subject|2|||
146329914|NCT01154101|527716005|FG003|Overall Study|Withdrawal by Subject|0|||
146329915|NCT01154101|527716006|FG004|Overall Study|Withdrawal by Subject|1|||
146329916|NCT05019131|527716007|FG000|Overall Study|Lost to Follow-up|0|||
146329917|NCT05019131|527716008|FG001|Overall Study|Lost to Follow-up|3|||
146329918|NCT00432237|527716009|FG000|Overall Study|Adverse Event|0|||
146329919|NCT00432237|527716010|FG001|Overall Study|Adverse Event|0|||
146329920|NCT00432237|527716011|FG002|Overall Study|Adverse Event|0|||
146329921|NCT00432237|527716012|FG003|Overall Study|Adverse Event|1|||
146329922|NCT00432237|527716009|FG000|Overall Study|Lack of Efficacy|0|||
146329923|NCT00432237|527716010|FG001|Overall Study|Lack of Efficacy|0|||
146329924|NCT00432237|527716011|FG002|Overall Study|Lack of Efficacy|0|||
146329925|NCT00432237|527716012|FG003|Overall Study|Lack of Efficacy|1|||
146329926|NCT00432237|527716009|FG000|Overall Study|Lost to Follow-up|10|||
146329927|NCT00432237|527716010|FG001|Overall Study|Lost to Follow-up|10|||
146329928|NCT00432237|527716011|FG002|Overall Study|Lost to Follow-up|18|||
146329929|NCT00432237|527716012|FG003|Overall Study|Lost to Follow-up|18|||
146329930|NCT00432237|527716009|FG000|Overall Study|Physician Decision|1|||
146329931|NCT00432237|527716010|FG001|Overall Study|Physician Decision|3|||
146329932|NCT00432237|527716011|FG002|Overall Study|Physician Decision|2|||
146329933|NCT00432237|527716012|FG003|Overall Study|Physician Decision|1|||
146329934|NCT00432237|527716009|FG000|Overall Study|Pregnancy|0|||
146329935|NCT00432237|527716010|FG001|Overall Study|Pregnancy|1|||
146329936|NCT00432237|527716011|FG002|Overall Study|Pregnancy|0|||
146329937|NCT00432237|527716012|FG003|Overall Study|Pregnancy|0|||
146329938|NCT00432237|527716009|FG000|Overall Study|Protocol Violation|13|||
146329939|NCT00432237|527716010|FG001|Overall Study|Protocol Violation|10|||
146329940|NCT00432237|527716011|FG002|Overall Study|Protocol Violation|11|||
146329941|NCT00432237|527716012|FG003|Overall Study|Protocol Violation|8|||
146329942|NCT00432237|527716009|FG000|Overall Study|Withdrawal by Subject|5|||
146329943|NCT00432237|527716010|FG001|Overall Study|Withdrawal by Subject|6|||
146329944|NCT00432237|527716011|FG002|Overall Study|Withdrawal by Subject|9|||
146329945|NCT00432237|527716012|FG003|Overall Study|Withdrawal by Subject|11|||
146329946|NCT00432237|527716009|FG000|Overall Study|Lack of Qualifying Event|38|||
146329947|NCT00432237|527716010|FG001|Overall Study|Lack of Qualifying Event|71|||
146329948|NCT00432237|527716011|FG002|Overall Study|Lack of Qualifying Event|69|||
146329949|NCT00432237|527716012|FG003|Overall Study|Lack of Qualifying Event|84|||
146329950|NCT01354132|527716013|FG000|Randomization|Physician Decision|1|||
146329951|NCT01354132|527716014|FG001|Randomization|Physician Decision|0|||
146329952|NCT01354132|527716013|FG000|Randomization|Withdrawal by Subject|0|||
146329953|NCT01354132|527716014|FG001|Randomization|Withdrawal by Subject|1|||
146329954|NCT01354132|527716013|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
146329955|NCT01354132|527716014|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
146329956|NCT01354132|527716013|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
146329957|NCT01354132|527716014|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
146329958|NCT01354132|527716013|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
146329959|NCT01354132|527716014|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
146329960|NCT01323478|527716015|FG000|Overall Study|Adverse Event|7|||
146329961|NCT01323478|527716015|FG000|Overall Study|Lack of Efficacy|4|||
146329962|NCT01323478|527716015|FG000|Overall Study|Non-compliance With Study Product|3|||
146329963|NCT01323478|527716015|FG000|Overall Study|Protocol Violation|1|||
146329964|NCT01323478|527716015|FG000|Overall Study|Withdrawal of Consent|1|||
146329965|NCT01323478|527716015|FG000|Overall Study|Administrative or Other Reasons|8|||
146329966|NCT02771522|527716018|FG000|Overall Study|Lost to Follow-up|3|||
146329967|NCT02771522|527716018|FG000|Overall Study|Withdrawal by Subject|2|||
146329968|NCT02771522|527716018|FG000|Overall Study|No white spot lesions|3|||
146329969|NCT00862251|527716019|FG000|Overall Study|Adverse Event|8|||
146329970|NCT00862251|527716020|FG001|Overall Study|Adverse Event|3|||
146329971|NCT00862251|527716021|FG002|Overall Study|Adverse Event|1|||
146329972|NCT00862251|527716019|FG000|Overall Study|Lost to Follow-up|0|||
146329973|NCT00862251|527716020|FG001|Overall Study|Lost to Follow-up|0|||
146329974|NCT00862251|527716021|FG002|Overall Study|Lost to Follow-up|1|||
146329975|NCT00862251|527716019|FG000|Overall Study|Protocol Violation|2|||
146329976|NCT00862251|527716020|FG001|Overall Study|Protocol Violation|0|||
146329977|NCT00862251|527716021|FG002|Overall Study|Protocol Violation|1|||
146329978|NCT00862251|527716019|FG000|Overall Study|Withdrawal by Subject|9|||
146329979|NCT00862251|527716020|FG001|Overall Study|Withdrawal by Subject|2|||
146329980|NCT00862251|527716021|FG002|Overall Study|Withdrawal by Subject|6|||
146329981|NCT02054702|527716028|FG000|Overall Study|Lost to Follow-up|3|||
146329982|NCT02054702|527716029|FG001|Overall Study|Lost to Follow-up|5|||
146329983|NCT02054702|527716028|FG000|Overall Study|Adverse Event|3|||
146329984|NCT02054702|527716029|FG001|Overall Study|Adverse Event|1|||
146329985|NCT02054702|527716028|FG000|Overall Study|Met Withdrawal Criteria|4|||
146329986|NCT02054702|527716029|FG001|Overall Study|Met Withdrawal Criteria|1|||
146329987|NCT02054702|527716028|FG000|Overall Study|Physician Decision|0|||
146329988|NCT02054702|527716029|FG001|Overall Study|Physician Decision|1|||
146329989|NCT02054702|527716028|FG000|Overall Study|Withdrawal by Subject|14|||
146329990|NCT02054702|527716029|FG001|Overall Study|Withdrawal by Subject|4|||
146329991|NCT04258579|527716035|FG000|Overall Study|Withdrawal by Subject|7|||
146329992|NCT04258579|527716035|FG000|Overall Study|Lost to Follow-up|3|||
146329993|NCT04258579|527716035|FG000|Overall Study|Protocol Violation|2|||
146329994|NCT04258579|527716035|FG000|Overall Study|Adverse Event|1|||
146329995|NCT04007159|527716036|FG000|Induction Phase|(missed study visits)|16|||
146329996|NCT04007159|527716036|FG000|Induction Phase|Withdrawal by Subject|4|||
146329997|NCT04007159|527716036|FG000|Induction Phase|Adverse Event|2|||
146329998|NCT04007159|527716036|FG000|Challenge Phase|missed study visits|3|||
146329999|NCT02388295|527716037|FG000|Dose Escalation Week 1|Adverse Event|1|||
146330000|NCT02388295|527716038|FG001|Dose Escalation Week 1|Adverse Event|2|||
146330001|NCT02388295|527716039|FG002|Dose Escalation Week 1|Adverse Event|1|||
146330002|NCT02388295|527716037|FG000|Dose Escalation Week 1|Determined not eligible|1|||
146330003|NCT02388295|527716038|FG001|Dose Escalation Week 1|Determined not eligible|1|||
146330004|NCT02388295|527716039|FG002|Dose Escalation Week 1|Determined not eligible|1|||
146330005|NCT02388295|527716037|FG000|Dose Escalation Week 2|Protocol Violation|0|||
146330006|NCT02388295|527716038|FG001|Dose Escalation Week 2|Protocol Violation|1|||
146330007|NCT02388295|527716039|FG002|Dose Escalation Week 2|Protocol Violation|0|||
146330008|NCT02388295|527716037|FG000|Dose Escalation Week 2|Determined not eligible|1|||
146330009|NCT02388295|527716038|FG001|Dose Escalation Week 2|Determined not eligible|1|||
146168031|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
146330010|NCT02388295|527716039|FG002|Dose Escalation Week 2|Determined not eligible|1|||
146330011|NCT02388295|527716037|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
146330012|NCT02388295|527716038|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
146330013|NCT02388295|527716039|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
146330014|NCT02076165|527716041|FG000|Overall Study|Lost to Follow-up|7|||
146168032|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
146330015|NCT02076165|527716042|FG001|Overall Study|Lost to Follow-up|5|||
146330016|NCT02076165|527716041|FG000|Overall Study|Refused follow-up assessment|1|||
146330017|NCT02076165|527716042|FG001|Overall Study|Refused follow-up assessment|1|||
146330018|NCT02706938|527716048|FG000|First Period, 6 Weeks|Adverse Event|8|||
146330019|NCT02706938|527716049|FG001|First Period, 6 Weeks|Adverse Event|0|||
146330020|NCT02706938|527716048|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
146330021|NCT02706938|527716049|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
146330022|NCT02706938|527716048|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
146330023|NCT02706938|527716049|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
146330024|NCT02706938|527716048|FG000|Second Period, 6 Weeks|Adverse Event|0|||
146330025|NCT02706938|527716049|FG001|Second Period, 6 Weeks|Adverse Event|7|||
146330026|NCT02706938|527716048|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
146330027|NCT02706938|527716049|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
146330028|NCT03377634|527716057|FG000|Study Period|Adverse Event|1|||
146330029|NCT03377634|527716058|FG001|Study Period|Adverse Event|0|||
146330030|NCT03377634|527716057|FG000|Study Period|Withdrawal by Subject|1|||
146330031|NCT03377634|527716058|FG001|Study Period|Withdrawal by Subject|0|||
146330032|NCT01384292|527716062|FG000|Part B|Severe non-compliance to protocol|1|||
146330033|NCT01384292|527716063|FG001|Part B|Severe non-compliance to protocol|0|||
146330034|NCT01384292|527716064|FG002|Part B|Severe non-compliance to protocol|0|||
146330035|NCT01171612|527716066|FG000|Overall Study|Lost to Follow-up|51|||
146330036|NCT00737529|527716067|FG000|Overall Study|Disease Progression|95|||
146330037|NCT00737529|527716067|FG000|Overall Study|Adverse Event|24|||
146330038|NCT00737529|527716067|FG000|Overall Study|Withdrawal by Subject|5|||
146330039|NCT00737529|527716067|FG000|Overall Study|Death|4|||
146330040|NCT00737529|527716067|FG000|Overall Study|Protocol Violation|1|||
146330041|NCT00737529|527716067|FG000|Overall Study|Other|4|||
146330042|NCT04525703|527716068|FG000|Overall Study|Lost to Follow-up|6|||
146330043|NCT04525703|527716069|FG001|Overall Study|Lost to Follow-up|15|||
146330044|NCT04525703|527716070|FG002|Overall Study|Lost to Follow-up|8|||
146330045|NCT01957137|527716071|FG000|Randomized Portion|Adverse Event|1|||
146330046|NCT01957137|527716071|FG000|Randomized Portion|Withdrawal by Subject|1|||
146330047|NCT02497001|527716074|FG000|Overall Study|Lost to Follow-up|10|||
146330048|NCT02497001|527716075|FG001|Overall Study|Lost to Follow-up|2|||
146330049|NCT02497001|527716076|FG002|Overall Study|Lost to Follow-up|0|||
146330050|NCT02497001|527716077|FG003|Overall Study|Lost to Follow-up|2|||
146330051|NCT02497001|527716074|FG000|Overall Study|Adverse Event|28|||
146330052|NCT02497001|527716075|FG001|Overall Study|Adverse Event|30|||
146330053|NCT02497001|527716076|FG002|Overall Study|Adverse Event|11|||
146330054|NCT02497001|527716077|FG003|Overall Study|Adverse Event|11|||
146330055|NCT02497001|527716074|FG000|Overall Study|Withdrawal by Subject|14|||
146330056|NCT02497001|527716075|FG001|Overall Study|Withdrawal by Subject|37|||
146330057|NCT02497001|527716076|FG002|Overall Study|Withdrawal by Subject|19|||
146330058|NCT02497001|527716077|FG003|Overall Study|Withdrawal by Subject|15|||
146330059|NCT02497001|527716074|FG000|Overall Study|Physician Decision|5|||
146330060|NCT02497001|527716075|FG001|Overall Study|Physician Decision|11|||
146330061|NCT02497001|527716076|FG002|Overall Study|Physician Decision|5|||
146330062|NCT02497001|527716077|FG003|Overall Study|Physician Decision|1|||
146330063|NCT02497001|527716074|FG000|Overall Study|subjects that were not treated|1|||
146330064|NCT02497001|527716075|FG001|Overall Study|subjects that were not treated|2|||
146330065|NCT02497001|527716076|FG002|Overall Study|subjects that were not treated|2|||
146330066|NCT02497001|527716077|FG003|Overall Study|subjects that were not treated|1|||
146330067|NCT02497001|527716074|FG000|Overall Study|Major Protocol Deviation|3|||
146330068|NCT02497001|527716075|FG001|Overall Study|Major Protocol Deviation|4|||
146330069|NCT02497001|527716076|FG002|Overall Study|Major Protocol Deviation|4|||
146330070|NCT02497001|527716077|FG003|Overall Study|Major Protocol Deviation|4|||
146330071|NCT02497001|527716074|FG000|Overall Study|Lack of Efficacy|10|||
146330072|NCT02497001|527716075|FG001|Overall Study|Lack of Efficacy|16|||
146330073|NCT02497001|527716076|FG002|Overall Study|Lack of Efficacy|6|||
146330074|NCT02497001|527716077|FG003|Overall Study|Lack of Efficacy|6|||
146330075|NCT02497001|527716074|FG000|Overall Study|Protocol Violation|3|||
146330076|NCT02497001|527716075|FG001|Overall Study|Protocol Violation|1|||
146330077|NCT02497001|527716076|FG002|Overall Study|Protocol Violation|3|||
146330078|NCT02497001|527716077|FG003|Overall Study|Protocol Violation|1|||
146330079|NCT03898063|527716078|FG000|Overall Study|Withdrawal by Subject|10|||
146330080|NCT03898063|527716079|FG001|Overall Study|Withdrawal by Subject|8|||
146330081|NCT01651780|527716080|FG000|Overall Study|Physician decision: No 30-day visit|2|||
146330082|NCT01651780|527716081|FG001|Overall Study|Physician decision: No 30-day visit|1|||
146330083|NCT01651780|527716080|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
146330084|NCT01651780|527716081|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
146330085|NCT01651780|527716080|FG000|Overall Study|Withdrawal by Subject|2|||
146168033|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
146330086|NCT01651780|527716081|FG001|Overall Study|Withdrawal by Subject|0|||
146330087|NCT01651780|527716080|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
146330088|NCT01651780|527716081|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
146330089|NCT01651780|527716080|FG000|Overall Study|Lost to Follow-up|1|||
146330090|NCT01651780|527716081|FG001|Overall Study|Lost to Follow-up|2|||
146330091|NCT01651780|527716080|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
146330092|NCT01651780|527716081|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
146330093|NCT00054132|527716082|FG000|Overall Study|Not Treated|1|||
146330094|NCT01889602|527716085|FG000|First Intervention|Adverse Event|1|||
146330095|NCT01889602|527716086|FG001|First Intervention|Adverse Event|1|||
146330096|NCT01889602|527716087|FG002|First Intervention|Adverse Event|1|||
146330097|NCT01889602|527716085|FG000|First Intervention|Protocol Violation|0|||
146330098|NCT01889602|527716086|FG001|First Intervention|Protocol Violation|1|||
146330099|NCT01889602|527716087|FG002|First Intervention|Protocol Violation|1|||
146330100|NCT01889602|527716085|FG000|First Intervention|Study ending|0|||
146330101|NCT01889602|527716086|FG001|First Intervention|Study ending|1|||
146330102|NCT01889602|527716087|FG002|First Intervention|Study ending|0|||
146330103|NCT01889602|527716085|FG000|Second Intervention|Adverse Event|0|||
146330104|NCT01889602|527716086|FG001|Second Intervention|Adverse Event|0|||
146330105|NCT01889602|527716087|FG002|Second Intervention|Adverse Event|1|||
146330106|NCT01889602|527716085|FG000|Second Intervention|Study ending|1|||
146330107|NCT01889602|527716086|FG001|Second Intervention|Study ending|0|||
146330108|NCT01889602|527716087|FG002|Second Intervention|Study ending|0|||
146330109|NCT01889602|527716085|FG000|Second Intervention|Withdrawal by Subject|0|||
146330110|NCT01889602|527716086|FG001|Second Intervention|Withdrawal by Subject|0|||
146330111|NCT01889602|527716087|FG002|Second Intervention|Withdrawal by Subject|1|||
146330112|NCT01889602|527716085|FG000|Third Intervention|Protocol Violation|1|||
146330113|NCT01889602|527716086|FG001|Third Intervention|Protocol Violation|0|||
146330114|NCT01889602|527716087|FG002|Third Intervention|Protocol Violation|0|||
146330115|NCT01889602|527716085|FG000|Third Intervention|Withdrawal by Subject|2|||
146330116|NCT01889602|527716086|FG001|Third Intervention|Withdrawal by Subject|2|||
146330117|NCT01889602|527716087|FG002|Third Intervention|Withdrawal by Subject|0|||
146330118|NCT03952559|527716096|FG000|Double Blind Treatment Period|Adverse Event|0|||
146330119|NCT03952559|527716097|FG001|Double Blind Treatment Period|Adverse Event|2|||
146330120|NCT03952559|527716098|FG002|Double Blind Treatment Period|Adverse Event|1|||
146330121|NCT03952559|527716099|FG003|Double Blind Treatment Period|Adverse Event|0|||
146330122|NCT03952559|527716100|FG004|Double Blind Treatment Period|Adverse Event|1|||
146330123|NCT03952559|527716096|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
146168034|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
146168035|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
146168036|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146168037|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146168038|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
146168039|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
146330124|NCT03952559|527716097|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
146330125|NCT03952559|527716098|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
146330126|NCT03952559|527716099|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
146330127|NCT03952559|527716100|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
146330128|NCT03952559|527716096|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
146330129|NCT03952559|527716097|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
146330130|NCT03952559|527716098|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
146330131|NCT03952559|527716099|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
146330132|NCT03952559|527716100|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146330133|NCT03952559|527716096|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
146330134|NCT03952559|527716097|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
146330135|NCT03952559|527716098|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
146330136|NCT03952559|527716099|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
146330137|NCT03952559|527716100|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
146330138|NCT02875223|527716101|FG000|Overall Study|Other reasons|0|||
146330139|NCT02875223|527716102|FG001|Overall Study|Other reasons|0|||
146330140|NCT02875223|527716103|FG002|Overall Study|Other reasons|1|||
146330141|NCT02875223|527716104|FG003|Overall Study|Other reasons|0|||
146330142|NCT02875223|527716105|FG004|Overall Study|Other reasons|1|||
146330143|NCT02875223|527716106|FG005|Overall Study|Other reasons|2|||
146330144|NCT02875223|527716107|FG006|Overall Study|Other reasons|0|||
146330145|NCT02875223|527716108|FG007|Overall Study|Other reasons|2|||
146330146|NCT02875223|527716109|FG008|Overall Study|Other reasons|0|||
146330147|NCT02875223|527716110|FG009|Overall Study|Other reasons|0|||
146168040|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
146168041|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146168042|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146168043|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
146168044|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
146168045|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
146168046|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146168047|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146168048|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
146168049|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Death|2|||
146168050|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Death|2|||
146168051|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Death|0|||
146168052|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Death|0|||
146168053|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Death|0|||
146168054|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
146168055|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
146330148|NCT02875223|527716111|FG010|Overall Study|Other reasons|0|||
146330149|NCT02875223|527716112|FG011|Overall Study|Other reasons|0|||
146330150|NCT02875223|527716113|FG012|Overall Study|Other reasons|0|||
146330151|NCT02875223|527716101|FG000|Overall Study|Withdrawal by Subject|0|||
146330152|NCT02875223|527716102|FG001|Overall Study|Withdrawal by Subject|0|||
146330153|NCT02875223|527716103|FG002|Overall Study|Withdrawal by Subject|0|||
146330154|NCT02875223|527716104|FG003|Overall Study|Withdrawal by Subject|0|||
146330155|NCT02875223|527716105|FG004|Overall Study|Withdrawal by Subject|1|||
146330156|NCT02875223|527716106|FG005|Overall Study|Withdrawal by Subject|1|||
146330157|NCT02875223|527716107|FG006|Overall Study|Withdrawal by Subject|0|||
146330158|NCT02875223|527716108|FG007|Overall Study|Withdrawal by Subject|0|||
146330159|NCT02875223|527716109|FG008|Overall Study|Withdrawal by Subject|1|||
146330160|NCT02875223|527716110|FG009|Overall Study|Withdrawal by Subject|0|||
146330161|NCT02875223|527716111|FG010|Overall Study|Withdrawal by Subject|0|||
146330162|NCT02875223|527716112|FG011|Overall Study|Withdrawal by Subject|0|||
146330163|NCT02875223|527716113|FG012|Overall Study|Withdrawal by Subject|0|||
146330164|NCT02875223|527716101|FG000|Overall Study|Progressive disease|0|||
146330165|NCT02875223|527716102|FG001|Overall Study|Progressive disease|0|||
146330166|NCT02875223|527716103|FG002|Overall Study|Progressive disease|1|||
146330167|NCT02875223|527716104|FG003|Overall Study|Progressive disease|0|||
146330168|NCT02875223|527716105|FG004|Overall Study|Progressive disease|0|||
146330169|NCT02875223|527716106|FG005|Overall Study|Progressive disease|0|||
146330170|NCT02875223|527716107|FG006|Overall Study|Progressive disease|0|||
146330171|NCT02875223|527716108|FG007|Overall Study|Progressive disease|0|||
146330172|NCT02875223|527716109|FG008|Overall Study|Progressive disease|0|||
146330173|NCT02875223|527716110|FG009|Overall Study|Progressive disease|12|||
146330174|NCT02875223|527716111|FG010|Overall Study|Progressive disease|2|||
146330175|NCT02875223|527716112|FG011|Overall Study|Progressive disease|3|||
146330176|NCT02875223|527716113|FG012|Overall Study|Progressive disease|6|||
146330177|NCT02875223|527716101|FG000|Overall Study|Death|4|||
146330178|NCT02875223|527716102|FG001|Overall Study|Death|4|||
146330179|NCT02875223|527716103|FG002|Overall Study|Death|3|||
146330180|NCT02875223|527716104|FG003|Overall Study|Death|4|||
146330181|NCT02875223|527716105|FG004|Overall Study|Death|2|||
146330182|NCT02875223|527716106|FG005|Overall Study|Death|3|||
146330183|NCT02875223|527716107|FG006|Overall Study|Death|5|||
146330184|NCT02875223|527716108|FG007|Overall Study|Death|7|||
146330185|NCT02875223|527716109|FG008|Overall Study|Death|3|||
146330186|NCT02875223|527716110|FG009|Overall Study|Death|2|||
146330187|NCT02875223|527716111|FG010|Overall Study|Death|0|||
146330188|NCT02875223|527716112|FG011|Overall Study|Death|0|||
146330189|NCT02875223|527716113|FG012|Overall Study|Death|0|||
146330190|NCT02875223|527716101|FG000|Overall Study|Lost to Follow-up|0|||
146330191|NCT02875223|527716102|FG001|Overall Study|Lost to Follow-up|1|||
146330192|NCT02875223|527716103|FG002|Overall Study|Lost to Follow-up|1|||
146330193|NCT02875223|527716104|FG003|Overall Study|Lost to Follow-up|0|||
146330194|NCT02875223|527716105|FG004|Overall Study|Lost to Follow-up|1|||
146330195|NCT02875223|527716106|FG005|Overall Study|Lost to Follow-up|0|||
146330196|NCT02875223|527716107|FG006|Overall Study|Lost to Follow-up|1|||
146330197|NCT02875223|527716108|FG007|Overall Study|Lost to Follow-up|1|||
146330198|NCT02875223|527716109|FG008|Overall Study|Lost to Follow-up|0|||
146330199|NCT02875223|527716110|FG009|Overall Study|Lost to Follow-up|0|||
146330200|NCT02875223|527716111|FG010|Overall Study|Lost to Follow-up|0|||
146330201|NCT02875223|527716112|FG011|Overall Study|Lost to Follow-up|0|||
146330202|NCT02875223|527716113|FG012|Overall Study|Lost to Follow-up|0|||
146330203|NCT01870739|527716114|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
146330204|NCT01870739|527716115|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
146330205|NCT01870739|527716114|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
146330206|NCT01870739|527716115|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
146330207|NCT01870739|527716114|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
146330208|NCT01870739|527716115|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
146330209|NCT01870739|527716114|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
146330210|NCT01870739|527716115|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
146330211|NCT01870739|527716114|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
146330212|NCT01870739|527716115|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
146330213|NCT01870739|527716114|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
146330214|NCT01870739|527716115|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
146330215|NCT01870739|527716114|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
146330216|NCT01870739|527716115|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
146330217|NCT01986062|527716116|FG000|Overall Study|Lost to Follow-up|1|||
146330218|NCT01986062|527716117|FG001|Overall Study|Lost to Follow-up|0|||
146330219|NCT01986062|527716116|FG000|Overall Study|Withdrawal by Subject|0|||
146330220|NCT01986062|527716117|FG001|Overall Study|Withdrawal by Subject|1|||
146330221|NCT01565980|527716119|FG000|Overall Study|Death|1|||
146330222|NCT01565980|527716120|FG001|Overall Study|Death|0|||
146330223|NCT01565980|527716119|FG000|Overall Study|Lost to Follow-up|1|||
146330224|NCT01565980|527716120|FG001|Overall Study|Lost to Follow-up|0|||
146330225|NCT01565980|527716119|FG000|Overall Study|health complications|1|||
146330226|NCT01565980|527716120|FG001|Overall Study|health complications|1|||
146330227|NCT01565980|527716119|FG000|Overall Study|stopped medical treatment|1|||
146330228|NCT01565980|527716120|FG001|Overall Study|stopped medical treatment|0|||
146330229|NCT01565980|527716119|FG000|Overall Study|Withdrawal by Subject|0|||
146330230|NCT01565980|527716120|FG001|Overall Study|Withdrawal by Subject|3|||
146330231|NCT01929135|527716123|FG000|Overall Study|Lost to Follow-up|1|||
146330232|NCT01929135|527716124|FG001|Overall Study|Lost to Follow-up|1|||
146330233|NCT01926626|527716130|FG000|Overall Study|Withdrawal by Subject|15|||
146330234|NCT01926626|527716130|FG000|Overall Study|Lost to Follow-up|7|||
146330235|NCT01817790|527716131|FG000|Overall Study|Adverse Event|0|||
146330236|NCT01817790|527716132|FG001|Overall Study|Adverse Event|2|||
146330237|NCT01817790|527716131|FG000|Overall Study|Lost to Follow-up|0|||
146330238|NCT01817790|527716132|FG001|Overall Study|Lost to Follow-up|1|||
146330239|NCT01817790|527716131|FG000|Overall Study|Protocol Violation|2|||
146330240|NCT01817790|527716132|FG001|Overall Study|Protocol Violation|1|||
146330241|NCT01817790|527716131|FG000|Overall Study|Withdrawal by Subject|1|||
146330242|NCT01817790|527716132|FG001|Overall Study|Withdrawal by Subject|3|||
146330243|NCT01817790|527716131|FG000|Overall Study|Other: Could not attend appointment|1|||
146330244|NCT01817790|527716132|FG001|Overall Study|Other: Could not attend appointment|1|||
146330245|NCT01671345|527716133|FG000|Overall Study|Lost to Follow-up|10|||
146330246|NCT01671345|527716134|FG001|Overall Study|Lost to Follow-up|6|||
146330247|NCT01671345|527716133|FG000|Overall Study|visit with non-participating physician|3|||
146330248|NCT01671345|527716134|FG001|Overall Study|visit with non-participating physician|3|||
146330249|NCT03636906|527716135|FG000|Overall Study|Adverse Event|0|||
146330250|NCT03636906|527716136|FG001|Overall Study|Adverse Event|0|||
146330251|NCT03636906|527716137|FG002|Overall Study|Adverse Event|1|||
146330252|NCT03636906|527716135|FG000|Overall Study|Lost to Follow-up|1|||
146330253|NCT03636906|527716136|FG001|Overall Study|Lost to Follow-up|0|||
146330254|NCT03636906|527716137|FG002|Overall Study|Lost to Follow-up|0|||
146330255|NCT03636906|527716135|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
146330256|NCT03636906|527716136|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
146330257|NCT03636906|527716137|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
146330258|NCT03636906|527716135|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
146330259|NCT03636906|527716136|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
146330260|NCT03636906|527716137|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
146330261|NCT03636906|527716135|FG000|Overall Study|Other|0|||
146330262|NCT03636906|527716136|FG001|Overall Study|Other|0|||
146330263|NCT03636906|527716137|FG002|Overall Study|Other|1|||
146330264|NCT00891202|527716138|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
146330265|NCT00891202|527716139|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146330266|NCT00891202|527716140|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146330267|NCT00891202|527716141|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
146330268|NCT00891202|527716138|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146330269|NCT00891202|527716139|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146330270|NCT00891202|527716140|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
146330271|NCT00891202|527716141|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
146330272|NCT00891202|527716138|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146330273|NCT00891202|527716139|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146330274|NCT00891202|527716140|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
146330275|NCT00891202|527716141|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
146330276|NCT00891202|527716138|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
146330277|NCT00891202|527716139|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
146330278|NCT00891202|527716140|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
146330279|NCT00891202|527716141|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
146330280|NCT03690869|527716142|FG000|Overall Study|Adverse Event|0|||
146330281|NCT03690869|527716143|FG001|Overall Study|Adverse Event|0|||
146330282|NCT03690869|527716144|FG002|Overall Study|Adverse Event|0|||
146330283|NCT03690869|527716145|FG003|Overall Study|Adverse Event|1|||
146330284|NCT03690869|527716146|FG004|Overall Study|Adverse Event|0|||
146330285|NCT03690869|527716147|FG005|Overall Study|Adverse Event|0|||
146330286|NCT03690869|527716148|FG006|Overall Study|Adverse Event|0|||
146330287|NCT03690869|527716149|FG007|Overall Study|Adverse Event|1|||
146330288|NCT03690869|527716150|FG008|Overall Study|Adverse Event|0|||
146330289|NCT03690869|527716151|FG009|Overall Study|Adverse Event|1|||
146330290|NCT03690869|527716142|FG000|Overall Study|Death|1|||
146330291|NCT03690869|527716143|FG001|Overall Study|Death|1|||
146330292|NCT03690869|527716144|FG002|Overall Study|Death|1|||
146330293|NCT03690869|527716145|FG003|Overall Study|Death|4|||
146330294|NCT03690869|527716146|FG004|Overall Study|Death|2|||
146330295|NCT03690869|527716147|FG005|Overall Study|Death|5|||
146330296|NCT03690869|527716148|FG006|Overall Study|Death|3|||
146330297|NCT03690869|527716149|FG007|Overall Study|Death|2|||
146330298|NCT03690869|527716150|FG008|Overall Study|Death|0|||
146330299|NCT03690869|527716151|FG009|Overall Study|Death|3|||
146330300|NCT03690869|527716142|FG000|Overall Study|Lost to Follow-up|0|||
146330301|NCT03690869|527716143|FG001|Overall Study|Lost to Follow-up|0|||
146330302|NCT03690869|527716144|FG002|Overall Study|Lost to Follow-up|1|||
146330303|NCT03690869|527716145|FG003|Overall Study|Lost to Follow-up|0|||
146330304|NCT03690869|527716146|FG004|Overall Study|Lost to Follow-up|0|||
146330305|NCT03690869|527716147|FG005|Overall Study|Lost to Follow-up|0|||
146330306|NCT03690869|527716148|FG006|Overall Study|Lost to Follow-up|0|||
146330307|NCT03690869|527716149|FG007|Overall Study|Lost to Follow-up|0|||
146330308|NCT03690869|527716150|FG008|Overall Study|Lost to Follow-up|0|||
146330309|NCT03690869|527716151|FG009|Overall Study|Lost to Follow-up|0|||
146330310|NCT03690869|527716142|FG000|Overall Study|Other Treatment|1|||
146330311|NCT03690869|527716143|FG001|Overall Study|Other Treatment|1|||
146330312|NCT03690869|527716144|FG002|Overall Study|Other Treatment|1|||
146330313|NCT03690869|527716145|FG003|Overall Study|Other Treatment|2|||
146330314|NCT03690869|527716146|FG004|Overall Study|Other Treatment|3|||
146330315|NCT03690869|527716147|FG005|Overall Study|Other Treatment|1|||
146330316|NCT03690869|527716148|FG006|Overall Study|Other Treatment|2|||
146330317|NCT03690869|527716149|FG007|Overall Study|Other Treatment|7|||
146330318|NCT03690869|527716150|FG008|Overall Study|Other Treatment|0|||
146330319|NCT03690869|527716151|FG009|Overall Study|Other Treatment|3|||
146330320|NCT03690869|527716142|FG000|Overall Study|Physician Decision|0|||
146330321|NCT03690869|527716143|FG001|Overall Study|Physician Decision|1|||
146330322|NCT03690869|527716144|FG002|Overall Study|Physician Decision|0|||
146330323|NCT03690869|527716145|FG003|Overall Study|Physician Decision|0|||
146330324|NCT03690869|527716146|FG004|Overall Study|Physician Decision|0|||
146330325|NCT03690869|527716147|FG005|Overall Study|Physician Decision|0|||
146330326|NCT03690869|527716148|FG006|Overall Study|Physician Decision|0|||
146330327|NCT03690869|527716149|FG007|Overall Study|Physician Decision|0|||
146330328|NCT03690869|527716150|FG008|Overall Study|Physician Decision|0|||
146330329|NCT03690869|527716151|FG009|Overall Study|Physician Decision|0|||
146330330|NCT03690869|527716142|FG000|Overall Study|Progressive Disease|1|||
146330331|NCT03690869|527716143|FG001|Overall Study|Progressive Disease|2|||
146330332|NCT03690869|527716144|FG002|Overall Study|Progressive Disease|0|||
146330333|NCT03690869|527716145|FG003|Overall Study|Progressive Disease|1|||
146330334|NCT03690869|527716146|FG004|Overall Study|Progressive Disease|0|||
146330335|NCT03690869|527716147|FG005|Overall Study|Progressive Disease|0|||
146330336|NCT03690869|527716148|FG006|Overall Study|Progressive Disease|0|||
146330337|NCT03690869|527716149|FG007|Overall Study|Progressive Disease|0|||
146330338|NCT03690869|527716150|FG008|Overall Study|Progressive Disease|1|||
146330339|NCT03690869|527716151|FG009|Overall Study|Progressive Disease|1|||
146330340|NCT03690869|527716142|FG000|Overall Study|Subject Decision|0|||
146330341|NCT03690869|527716143|FG001|Overall Study|Subject Decision|0|||
146330342|NCT03690869|527716144|FG002|Overall Study|Subject Decision|0|||
146330343|NCT03690869|527716145|FG003|Overall Study|Subject Decision|1|||
146330344|NCT03690869|527716146|FG004|Overall Study|Subject Decision|0|||
146330345|NCT03690869|527716147|FG005|Overall Study|Subject Decision|0|||
146330346|NCT03690869|527716148|FG006|Overall Study|Subject Decision|0|||
146330347|NCT03690869|527716149|FG007|Overall Study|Subject Decision|1|||
146330348|NCT03690869|527716150|FG008|Overall Study|Subject Decision|0|||
146330349|NCT03690869|527716151|FG009|Overall Study|Subject Decision|0|||
146330350|NCT04280081|527716153|FG000|Overall Study|Adverse Event|4|||
146330351|NCT04280081|527716153|FG000|Overall Study|Death|2|||
146330352|NCT04280081|527716153|FG000|Overall Study|Progressive Disease|6|||
146330353|NCT06001307|527717564|FG000|Overall Study|Lost to Follow-up|1|||
146330354|NCT06001307|527717565|FG001|Overall Study|Lost to Follow-up|2|||
146330355|NCT03532100|527717566|FG000|Overall Study|Intervention malfunction|1|||
146330356|NCT04439279|527717567|FG000|Overall Study|Adverse Event|7|||
146330357|NCT04439279|527717567|FG000|Overall Study|Death|4|||
146330358|NCT04439279|527717567|FG000|Overall Study|Disease progression|17|||
146330359|NCT04439279|527717567|FG000|Overall Study|Complicating disease|3|||
146330360|NCT04439279|527717567|FG000|Overall Study|Withdrawal by Subject|2|||
146330361|NCT04439279|527717567|FG000|Overall Study|Ineligible|1|||
146330362|NCT04439279|527717567|FG000|Overall Study|Treatment still ongoing|1|||
146330363|NCT02031679|527717568|FG000|Overall Study|Protocol Violation|0|||
146168056|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
146168057|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
146330364|NCT02031679|527717569|FG001|Overall Study|Protocol Violation|1|||
146330365|NCT02031679|527717568|FG000|Overall Study|Lack of Efficacy|0|||
146330366|NCT02031679|527717569|FG001|Overall Study|Lack of Efficacy|1|||
146330367|NCT03263806|527717570|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
146330368|NCT03263806|527717571|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
146330369|NCT03263806|527717570|FG000|Overall Study|Withdrawal by Subject|0|||
146330370|NCT03263806|527717571|FG001|Overall Study|Withdrawal by Subject|1|||
146330371|NCT03263806|527717570|FG000|Overall Study|Study Termination|5|||
146330372|NCT03263806|527717571|FG001|Overall Study|Study Termination|6|||
146330373|NCT02338843|527717578|FG000|Overall Study|Adverse Event|2|||
146330374|NCT02338843|527717579|FG001|Overall Study|Adverse Event|1|||
146330375|NCT02338843|527717578|FG000|Overall Study|Death|40|||
146330376|NCT02338843|527717579|FG001|Overall Study|Death|53|||
146330377|NCT02338843|527717578|FG000|Overall Study|Physician Decision|1|||
146330378|NCT02338843|527717579|FG001|Overall Study|Physician Decision|0|||
146330379|NCT02338843|527717578|FG000|Overall Study|Withdrawal by Subject|0|||
146330380|NCT02338843|527717579|FG001|Overall Study|Withdrawal by Subject|2|||
146330381|NCT02338843|527717578|FG000|Overall Study|Subject Recovered|0|||
146330382|NCT02338843|527717579|FG001|Overall Study|Subject Recovered|2|||
146330383|NCT02338843|527717578|FG000|Overall Study|Discontinued prior to randomizat|1|||
146330384|NCT02338843|527717579|FG001|Overall Study|Discontinued prior to randomizat|0|||
146330385|NCT01609933|527717584|FG000|Overall Study|Adverse Event|1|||
146330386|NCT01609933|527717584|FG000|Overall Study|Withdrawal by Subject|3|||
146330387|NCT01252966|527717585|FG000|Overall Study|Lost to Follow-up|16|||
146330388|NCT01252966|527717586|FG001|Overall Study|Lost to Follow-up|10|||
146330389|NCT01252966|527717585|FG000|Overall Study|Withdrawal by Subject|7|||
146330390|NCT01252966|527717586|FG001|Overall Study|Withdrawal by Subject|3|||
146330391|NCT05194345|527717591|FG000|Overall Study|Withdrawal by Subject|6|||
146330392|NCT05194345|527717592|FG001|Overall Study|Withdrawal by Subject|4|||
146330393|NCT05194345|527717593|FG002|Overall Study|Withdrawal by Subject|0|||
146330394|NCT05194345|527717591|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
146330395|NCT05194345|527717592|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
146330396|NCT05194345|527717593|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
146330397|NCT03312218|527717600|FG000|Overall Study|Never signed in to access the app|54|||
146330398|NCT03312218|527717601|FG001|Overall Study|Never signed in to access the app|58|||
146330399|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
146330400|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
146330401|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
146330402|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
146330403|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
146330404|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
146330405|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
146330406|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
146330407|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
146330408|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
146330409|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
146330410|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
146330411|NCT02747927|527717602|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
146330412|NCT02747927|527717603|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
146330413|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
146330414|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
146330415|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
146330416|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
146330417|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
146330418|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
146330419|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
146330420|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
146330421|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
146330422|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
146330423|NCT02747927|527717602|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
146330424|NCT02747927|527717603|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
146330425|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
146330426|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
146330427|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
146330428|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
146330429|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
146330430|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
146330431|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
146330432|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
146330433|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
146330434|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
146330435|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
146330436|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
146330437|NCT02747927|527717602|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
146330438|NCT02747927|527717603|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
146330439|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
146330440|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
146330441|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
146330442|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
146330443|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
146330444|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
146330445|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
146330446|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
146330447|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
146330448|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
146330449|NCT02747927|527717602|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
146330450|NCT02747927|527717603|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
146330451|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
146330452|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
146330453|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
146330454|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
146330455|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
146330456|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
146330457|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
146330458|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
146330459|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
146330460|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
146330461|NCT02747927|527717602|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
146330462|NCT02747927|527717603|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
146330463|NCT02360098|527717606|FG000|Overall Study|Physician Decision|7|||
146330464|NCT03293654|527717612|FG000|Overall Study|Lost to Follow-up|0|||
146330465|NCT03293654|527717613|FG001|Overall Study|Lost to Follow-up|1|||
146330466|NCT03293654|527717614|FG002|Overall Study|Lost to Follow-up|0|||
146330467|NCT01919307|527717615|FG000|Overall Study|Withdrawal by Subject|9|||
146330468|NCT06161012|527717617|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
146330469|NCT06161012|527717618|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
146330470|NCT01933932|527717619|FG000|Overall Study|Death|173|||
146330471|NCT01933932|527717620|FG001|Overall Study|Death|163|||
146330472|NCT01933932|527717619|FG000|Overall Study|Withdrawal by Subject|11|||
146330473|NCT01933932|527717620|FG001|Overall Study|Withdrawal by Subject|14|||
146330474|NCT01933932|527717619|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146330475|NCT01933932|527717620|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
146330476|NCT00408005|527717621|FG000|Induction|Adverse Event|19|||
146330477|NCT00408005|527717622|FG001|Induction|Adverse Event|3|||
146330478|NCT00408005|527717623|FG002|Induction|Adverse Event|0|||
146330479|NCT00408005|527717624|FG003|Induction|Adverse Event|0|||
146330480|NCT00408005|527717625|FG004|Induction|Adverse Event|0|||
146330481|NCT00408005|527717626|FG005|Induction|Adverse Event|0|||
146330482|NCT00408005|527717627|FG006|Induction|Adverse Event|0|||
146330483|NCT00408005|527717628|FG007|Induction|Adverse Event|0|||
146330484|NCT00408005|527717621|FG000|Induction|Death|6|||
146330485|NCT00408005|527717622|FG001|Induction|Death|0|||
146330486|NCT00408005|527717623|FG002|Induction|Death|0|||
146330487|NCT00408005|527717624|FG003|Induction|Death|0|||
146330488|NCT00408005|527717625|FG004|Induction|Death|0|||
146330489|NCT00408005|527717626|FG005|Induction|Death|0|||
146330490|NCT00408005|527717627|FG006|Induction|Death|0|||
146330491|NCT00408005|527717628|FG007|Induction|Death|0|||
146330492|NCT00408005|527717621|FG000|Induction|Physician Decision|83|||
146330493|NCT00408005|527717622|FG001|Induction|Physician Decision|9|||
146330494|NCT00408005|527717623|FG002|Induction|Physician Decision|0|||
146330495|NCT00408005|527717624|FG003|Induction|Physician Decision|0|||
146330496|NCT00408005|527717625|FG004|Induction|Physician Decision|0|||
146330497|NCT00408005|527717626|FG005|Induction|Physician Decision|0|||
146330498|NCT00408005|527717627|FG006|Induction|Physician Decision|0|||
146330499|NCT00408005|527717628|FG007|Induction|Physician Decision|0|||
146330500|NCT00408005|527717621|FG000|Induction|Withdrawal by Subject|2|||
146330501|NCT00408005|527717622|FG001|Induction|Withdrawal by Subject|4|||
146330502|NCT00408005|527717623|FG002|Induction|Withdrawal by Subject|0|||
146330503|NCT00408005|527717624|FG003|Induction|Withdrawal by Subject|0|||
146330504|NCT00408005|527717625|FG004|Induction|Withdrawal by Subject|0|||
146330505|NCT00408005|527717626|FG005|Induction|Withdrawal by Subject|0|||
146330506|NCT00408005|527717627|FG006|Induction|Withdrawal by Subject|0|||
146330507|NCT00408005|527717628|FG007|Induction|Withdrawal by Subject|0|||
146330508|NCT00408005|527717621|FG000|Induction|Ineligible|33|||
146330509|NCT00408005|527717622|FG001|Induction|Ineligible|14|||
146330510|NCT00408005|527717623|FG002|Induction|Ineligible|0|||
146330511|NCT00408005|527717624|FG003|Induction|Ineligible|0|||
146330512|NCT00408005|527717625|FG004|Induction|Ineligible|0|||
146330513|NCT00408005|527717626|FG005|Induction|Ineligible|0|||
146330514|NCT00408005|527717627|FG006|Induction|Ineligible|0|||
146330515|NCT00408005|527717628|FG007|Induction|Ineligible|0|||
146330516|NCT00408005|527717621|FG000|Induction|Refusal of Further Protocol Therapy|225|||
146330517|NCT00408005|527717622|FG001|Induction|Refusal of Further Protocol Therapy|44|||
146330518|NCT00408005|527717623|FG002|Induction|Refusal of Further Protocol Therapy|0|||
146330519|NCT00408005|527717624|FG003|Induction|Refusal of Further Protocol Therapy|0|||
146330520|NCT00408005|527717625|FG004|Induction|Refusal of Further Protocol Therapy|0|||
146330521|NCT00408005|527717626|FG005|Induction|Refusal of Further Protocol Therapy|0|||
146330522|NCT00408005|527717627|FG006|Induction|Refusal of Further Protocol Therapy|0|||
146330523|NCT00408005|527717628|FG007|Induction|Refusal of Further Protocol Therapy|0|||
146330524|NCT00408005|527717621|FG000|Induction|Entered another COG therapeutic protocol|4|||
146330525|NCT00408005|527717622|FG001|Induction|Entered another COG therapeutic protocol|0|||
146330526|NCT00408005|527717623|FG002|Induction|Entered another COG therapeutic protocol|0|||
146330527|NCT00408005|527717624|FG003|Induction|Entered another COG therapeutic protocol|0|||
146330528|NCT00408005|527717625|FG004|Induction|Entered another COG therapeutic protocol|0|||
146330529|NCT00408005|527717626|FG005|Induction|Entered another COG therapeutic protocol|0|||
146330530|NCT00408005|527717627|FG006|Induction|Entered another COG therapeutic protocol|0|||
146330531|NCT00408005|527717628|FG007|Induction|Entered another COG therapeutic protocol|0|||
146330532|NCT00408005|527717621|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
146330533|NCT00408005|527717622|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
146330534|NCT00408005|527717623|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
146330535|NCT00408005|527717624|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
146330536|NCT00408005|527717625|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
146330537|NCT00408005|527717626|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
146330538|NCT00408005|527717627|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
146330539|NCT00408005|527717628|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
146330540|NCT00408005|527717621|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
146330541|NCT00408005|527717622|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
146330542|NCT00408005|527717623|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
146330543|NCT00408005|527717624|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
146330544|NCT00408005|527717625|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
146330545|NCT00408005|527717626|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
146330546|NCT00408005|527717627|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
146330547|NCT00408005|527717628|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
146330548|NCT00408005|527717621|FG000|Induction|Progressive Disease|0|||
146330549|NCT00408005|527717622|FG001|Induction|Progressive Disease|1|||
146330550|NCT00408005|527717623|FG002|Induction|Progressive Disease|0|||
146330551|NCT00408005|527717624|FG003|Induction|Progressive Disease|0|||
146330552|NCT00408005|527717625|FG004|Induction|Progressive Disease|0|||
146330553|NCT00408005|527717626|FG005|Induction|Progressive Disease|0|||
146330554|NCT00408005|527717627|FG006|Induction|Progressive Disease|0|||
146330555|NCT00408005|527717628|FG007|Induction|Progressive Disease|0|||
146330556|NCT00408005|527717621|FG000|Induction|Inevaluable|18|||
146330557|NCT00408005|527717622|FG001|Induction|Inevaluable|14|||
146330558|NCT00408005|527717623|FG002|Induction|Inevaluable|0|||
146330559|NCT00408005|527717624|FG003|Induction|Inevaluable|0|||
146330560|NCT00408005|527717625|FG004|Induction|Inevaluable|0|||
146330561|NCT00408005|527717626|FG005|Induction|Inevaluable|0|||
146330562|NCT00408005|527717627|FG006|Induction|Inevaluable|0|||
146330563|NCT00408005|527717628|FG007|Induction|Inevaluable|0|||
146330564|NCT00408005|527717621|FG000|Induction|Failed to Complete Randomization|3|||
146330565|NCT00408005|527717622|FG001|Induction|Failed to Complete Randomization|2|||
146330566|NCT00408005|527717623|FG002|Induction|Failed to Complete Randomization|0|||
146330567|NCT00408005|527717624|FG003|Induction|Failed to Complete Randomization|0|||
146330568|NCT00408005|527717625|FG004|Induction|Failed to Complete Randomization|0|||
146330569|NCT00408005|527717626|FG005|Induction|Failed to Complete Randomization|0|||
146330570|NCT00408005|527717627|FG006|Induction|Failed to Complete Randomization|0|||
146330571|NCT00408005|527717628|FG007|Induction|Failed to Complete Randomization|0|||
146330572|NCT00408005|527717621|FG000|Induction|Protocol Deviation|3|||
146330573|NCT00408005|527717622|FG001|Induction|Protocol Deviation|1|||
146330574|NCT00408005|527717623|FG002|Induction|Protocol Deviation|0|||
146330575|NCT00408005|527717624|FG003|Induction|Protocol Deviation|0|||
146330576|NCT00408005|527717625|FG004|Induction|Protocol Deviation|0|||
146330577|NCT00408005|527717626|FG005|Induction|Protocol Deviation|0|||
146330578|NCT00408005|527717627|FG006|Induction|Protocol Deviation|0|||
146330579|NCT00408005|527717628|FG007|Induction|Protocol Deviation|0|||
146330580|NCT00408005|527717621|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
146330581|NCT00408005|527717622|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330582|NCT00408005|527717623|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330583|NCT00408005|527717624|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330584|NCT00408005|527717625|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330585|NCT00408005|527717626|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330586|NCT00408005|527717627|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330587|NCT00408005|527717628|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
146330588|NCT00408005|527717621|FG000|Induction|Recurrent leukemia|1|||
146330589|NCT00408005|527717622|FG001|Induction|Recurrent leukemia|0|||
146330590|NCT00408005|527717623|FG002|Induction|Recurrent leukemia|0|||
146330591|NCT00408005|527717624|FG003|Induction|Recurrent leukemia|0|||
146330592|NCT00408005|527717625|FG004|Induction|Recurrent leukemia|0|||
146330593|NCT00408005|527717626|FG005|Induction|Recurrent leukemia|0|||
146330594|NCT00408005|527717627|FG006|Induction|Recurrent leukemia|0|||
146330595|NCT00408005|527717628|FG007|Induction|Recurrent leukemia|0|||
146330596|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146330597|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146330598|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
146330599|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
146330600|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
146330601|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
146330602|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
146330603|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
146330604|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
146330605|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
146330606|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
146330607|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
146330608|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
146330609|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
146330610|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
146330611|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
146330612|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330613|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330614|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
146330615|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330616|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
146330617|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330618|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330619|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
146330620|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
146330621|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
146330622|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
146330623|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
146330624|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
146330625|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
146330626|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
146330627|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
146330628|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146330629|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146330630|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
146330631|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
146330632|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146330633|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
146330634|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146330635|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
146330636|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
146330637|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
146330638|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
146330639|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
146330640|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
146330641|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
146330642|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
146330643|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
146330644|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330645|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330646|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330647|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330648|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
146330649|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330650|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330651|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
146330652|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146330653|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146168058|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
146168059|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146330654|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
146330655|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146330656|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146330657|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146330658|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
146330659|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
146330660|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146330661|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146330662|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146330663|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146330664|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
146330665|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
146330666|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
146330667|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
146330668|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330669|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330670|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330671|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330672|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330673|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
146330674|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330675|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
146330676|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146330677|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146330678|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
146330679|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
146330680|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
146330681|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
146330682|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146330683|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
146330684|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330685|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330686|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330687|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330688|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
146330689|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
146330690|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330691|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
146330692|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146330693|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146330694|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
146330695|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
146330696|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
146330697|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
146330698|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
146330699|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
146330700|NCT00408005|527717621|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146330701|NCT00408005|527717622|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146330702|NCT00408005|527717623|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
146330703|NCT00408005|527717624|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146330704|NCT00408005|527717625|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146330705|NCT00408005|527717626|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
146330706|NCT00408005|527717627|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146330707|NCT00408005|527717628|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
146330708|NCT02275533|527717629|FG000|Overall Study|Protocol Violation|2|||
146330709|NCT02275533|527717630|FG001|Overall Study|Protocol Violation|0|||
146330710|NCT02275533|527717629|FG000|Overall Study|Never received study treatment|1|||
146330711|NCT02275533|527717630|FG001|Overall Study|Never received study treatment|0|||
146330712|NCT02157883|527717634|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
146330713|NCT02157883|527717634|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
146168060|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
146330714|NCT02157883|527717634|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
146330715|NCT02157883|527717634|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
146330716|NCT02157883|527717634|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
146330717|NCT04454489|527717635|FG000|Overall Study|Disease progression|12|||
146330718|NCT04454489|527717635|FG000|Overall Study|Death|4|||
146330719|NCT04454489|527717635|FG000|Overall Study|Adverse Event|1|||
146330720|NCT04454489|527717635|FG000|Overall Study|Physician Decision|1|||
146330721|NCT03155997|527717636|FG000|Overall Study|Withdrawal by Subject|119|||
146330722|NCT03155997|527717637|FG001|Overall Study|Withdrawal by Subject|134|||
146330723|NCT03155997|527717636|FG000|Overall Study|Lost to Follow-up|12|||
146330724|NCT03155997|527717637|FG001|Overall Study|Lost to Follow-up|13|||
146330725|NCT03155997|527717636|FG000|Overall Study|Missing disposition data|0|||
146330726|NCT03155997|527717637|FG001|Overall Study|Missing disposition data|1|||
146330727|NCT03155997|527717636|FG000|Overall Study|On study treatment|2027|||
146330728|NCT03155997|527717637|FG001|Overall Study|On study treatment|2074|||
146330729|NCT04067518|527717638|FG000|Overall Study|Adverse Event|1|||
146330730|NCT04067518|527717639|FG001|Overall Study|Adverse Event|3|||
146330731|NCT04067518|527717638|FG000|Overall Study|Screen failures|0|||
146330732|NCT04067518|527717639|FG001|Overall Study|Screen failures|1|||
146330733|NCT04067518|527717638|FG000|Overall Study|Enrolled but not treated|0|||
146330734|NCT04067518|527717639|FG001|Overall Study|Enrolled but not treated|1|||
146330735|NCT02796755|527717642|FG000|Overall Study|Adverse Event|2|||
146330736|NCT02796755|527717643|FG001|Overall Study|Adverse Event|0|||
146330737|NCT01111604|527717651|FG000|Overall Study|Lost to Follow-up|0|||
146330738|NCT01111604|527717652|FG001|Overall Study|Lost to Follow-up|0|||
146330739|NCT01111604|527717653|FG002|Overall Study|Lost to Follow-up|1|||
146330740|NCT01111604|527717651|FG000|Overall Study|Withdrew Consent|3|||
146330741|NCT01111604|527717652|FG001|Overall Study|Withdrew Consent|0|||
146330742|NCT01111604|527717653|FG002|Overall Study|Withdrew Consent|2|||
146330743|NCT01111604|527717651|FG000|Overall Study|Withdrawal by Subject|2|||
146330744|NCT01111604|527717652|FG001|Overall Study|Withdrawal by Subject|0|||
146330745|NCT01111604|527717653|FG002|Overall Study|Withdrawal by Subject|0|||
146330746|NCT01111604|527717651|FG000|Overall Study|Death|1|||
146330747|NCT01111604|527717652|FG001|Overall Study|Death|0|||
146330748|NCT01111604|527717653|FG002|Overall Study|Death|0|||
146330749|NCT01111604|527717651|FG000|Overall Study|Met Exclusion Criteria|2|||
146330750|NCT01111604|527717652|FG001|Overall Study|Met Exclusion Criteria|0|||
146330751|NCT01111604|527717653|FG002|Overall Study|Met Exclusion Criteria|0|||
146330752|NCT01295125|527717655|FG000|Overall Study|Study stopped prematurely|9|||
146330753|NCT03371355|527717656|FG000|Overall Study|Investigator judgment|0|||
146330754|NCT03371355|527717657|FG001|Overall Study|Investigator judgment|0|||
146330755|NCT03371355|527717658|FG002|Overall Study|Investigator judgment|1|||
146330756|NCT03371355|527717659|FG003|Overall Study|Investigator judgment|1|||
146330757|NCT03371355|527717656|FG000|Overall Study|Voluntary withdrawal|1|||
146330758|NCT03371355|527717657|FG001|Overall Study|Voluntary withdrawal|0|||
146330759|NCT03371355|527717658|FG002|Overall Study|Voluntary withdrawal|1|||
146330760|NCT03371355|527717659|FG003|Overall Study|Voluntary withdrawal|2|||
146330761|NCT03371355|527717656|FG000|Overall Study|Adverse Event|0|||
146330762|NCT03371355|527717657|FG001|Overall Study|Adverse Event|1|||
146330763|NCT03371355|527717658|FG002|Overall Study|Adverse Event|2|||
146330764|NCT03371355|527717659|FG003|Overall Study|Adverse Event|3|||
146330765|NCT03371355|527717656|FG000|Overall Study|Reason not Specified|0|||
146330766|NCT03371355|527717657|FG001|Overall Study|Reason not Specified|1|||
146330767|NCT03371355|527717658|FG002|Overall Study|Reason not Specified|0|||
146330768|NCT03371355|527717659|FG003|Overall Study|Reason not Specified|1|||
146330769|NCT01454076|527717664|FG000|Overall Study|Other|2|||
146330770|NCT01454076|527717665|FG001|Overall Study|Other|0|||
146330771|NCT01454076|527717666|FG002|Overall Study|Other|0|||
146330772|NCT01454076|527717667|FG003|Overall Study|Other|1|||
146330773|NCT01454076|527717668|FG004|Overall Study|Other|2|||
146330774|NCT01454076|527717664|FG000|Overall Study|Withdrawal by Subject|3|||
146330775|NCT01454076|527717665|FG001|Overall Study|Withdrawal by Subject|4|||
146330776|NCT01454076|527717666|FG002|Overall Study|Withdrawal by Subject|2|||
146330777|NCT01454076|527717667|FG003|Overall Study|Withdrawal by Subject|1|||
146330778|NCT01454076|527717668|FG004|Overall Study|Withdrawal by Subject|2|||
146330779|NCT01454076|527717664|FG000|Overall Study|Adverse Event|8|||
146330780|NCT01454076|527717665|FG001|Overall Study|Adverse Event|2|||
146330781|NCT01454076|527717666|FG002|Overall Study|Adverse Event|7|||
146330782|NCT01454076|527717667|FG003|Overall Study|Adverse Event|0|||
146330783|NCT01454076|527717668|FG004|Overall Study|Adverse Event|2|||
146330784|NCT00291551|527717670|FG000|Overall Study|Death|7|||
146330785|NCT00291551|527717670|FG000|Overall Study|Withdrawal by Subject|6|||
146330786|NCT02452762|527717671|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
146330787|NCT02452762|527717672|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
146330788|NCT02452762|527717671|FG000|Overall Study|Withdrawal by Subject|1|||
146330789|NCT02452762|527717672|FG001|Overall Study|Withdrawal by Subject|0|||
146330790|NCT00584870|527717673|FG000|Overall Study|Adverse Event|4|||
146330791|NCT00584870|527717674|FG001|Overall Study|Adverse Event|3|||
146330792|NCT00584870|527717675|FG002|Overall Study|Adverse Event|2|||
146330793|NCT00584870|527717673|FG000|Overall Study|Lost to Follow-up|4|||
146330794|NCT00584870|527717674|FG001|Overall Study|Lost to Follow-up|1|||
146330795|NCT00584870|527717675|FG002|Overall Study|Lost to Follow-up|1|||
146330796|NCT00584870|527717673|FG000|Overall Study|Lack of Efficacy|7|||
146330797|NCT00584870|527717674|FG001|Overall Study|Lack of Efficacy|14|||
146330798|NCT00584870|527717675|FG002|Overall Study|Lack of Efficacy|8|||
146330799|NCT00584870|527717673|FG000|Overall Study|Withdrawal by Subject|10|||
146330800|NCT00584870|527717674|FG001|Overall Study|Withdrawal by Subject|5|||
146330801|NCT00584870|527717675|FG002|Overall Study|Withdrawal by Subject|3|||
146330802|NCT00584870|527717673|FG000|Overall Study|Protocol Violation|1|||
146330803|NCT00584870|527717674|FG001|Overall Study|Protocol Violation|1|||
146330804|NCT00584870|527717675|FG002|Overall Study|Protocol Violation|2|||
146330805|NCT00584870|527717673|FG000|Overall Study|Did not met entrance criteria|1|||
146330806|NCT00584870|527717674|FG001|Overall Study|Did not met entrance criteria|0|||
146330807|NCT00584870|527717675|FG002|Overall Study|Did not met entrance criteria|0|||
146330808|NCT00584870|527717673|FG000|Overall Study|Other|2|||
146330809|NCT00584870|527717674|FG001|Overall Study|Other|0|||
146330810|NCT00584870|527717675|FG002|Overall Study|Other|0|||
146330811|NCT00584870|527717673|FG000|Overall Study|Randomized but not treated|0|||
146330812|NCT00584870|527717674|FG001|Overall Study|Randomized but not treated|1|||
146330813|NCT00584870|527717675|FG002|Overall Study|Randomized but not treated|2|||
146330814|NCT03682120|527717676|FG000|Overall Study|Lost to Follow-up|11|||
146330815|NCT03682120|527717677|FG001|Overall Study|Lost to Follow-up|4|||
146330816|NCT03682120|527717678|FG002|Overall Study|Lost to Follow-up|5|||
146330817|NCT03682120|527717679|FG003|Overall Study|Lost to Follow-up|2|||
146330818|NCT03682120|527717676|FG000|Overall Study|Physician Decision|1|||
146330819|NCT03682120|527717677|FG001|Overall Study|Physician Decision|0|||
146330820|NCT03682120|527717678|FG002|Overall Study|Physician Decision|0|||
146330821|NCT03682120|527717679|FG003|Overall Study|Physician Decision|0|||
146330822|NCT03682120|527717676|FG000|Overall Study|Withdrawal by Subject|1|||
146330823|NCT03682120|527717677|FG001|Overall Study|Withdrawal by Subject|2|||
146330824|NCT03682120|527717678|FG002|Overall Study|Withdrawal by Subject|3|||
146330825|NCT03682120|527717679|FG003|Overall Study|Withdrawal by Subject|0|||
146330826|NCT03682120|527717676|FG000|Overall Study|Death|0|||
146330827|NCT03682120|527717677|FG001|Overall Study|Death|1|||
146330828|NCT03682120|527717678|FG002|Overall Study|Death|0|||
146330829|NCT03682120|527717679|FG003|Overall Study|Death|0|||
146330830|NCT03682120|527717676|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
146330831|NCT03682120|527717677|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
146330832|NCT03682120|527717678|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
146330833|NCT03682120|527717679|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
146330834|NCT01015833|527717680|FG000|Overall Study|Death|1|||
146330835|NCT01015833|527717681|FG001|Overall Study|Death|0|||
146330836|NCT01015833|527717680|FG000|Overall Study|Withdrawal by Subject|3|||
146330837|NCT01015833|527717681|FG001|Overall Study|Withdrawal by Subject|2|||
146330838|NCT01015833|527717680|FG000|Overall Study|Adverse Event|0|||
146330839|NCT01015833|527717681|FG001|Overall Study|Adverse Event|1|||
146330840|NCT01015833|527717680|FG000|Overall Study|Physician Decision|2|||
146330841|NCT01015833|527717681|FG001|Overall Study|Physician Decision|0|||
146330842|NCT01015833|527717680|FG000|Overall Study|Symptomatic deterioration|0|||
146330843|NCT01015833|527717681|FG001|Overall Study|Symptomatic deterioration|1|||
146330844|NCT01015833|527717680|FG000|Overall Study|Other|5|||
146330845|NCT01015833|527717681|FG001|Overall Study|Other|1|||
146330846|NCT01015833|527717680|FG000|Overall Study|Motor Vehicle Accidents|1|||
146330847|NCT01015833|527717681|FG001|Overall Study|Motor Vehicle Accidents|0|||
146330848|NCT01015833|527717680|FG000|Overall Study|Did not start treatment|1|||
146330849|NCT01015833|527717681|FG001|Overall Study|Did not start treatment|0|||
146330850|NCT02949830|527717690|FG000|Overall Study|Adverse Event|1|||
146330851|NCT02949830|527717690|FG000|Overall Study|Withdrawal by Subject|1|||
146168061|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146330852|NCT01628926|527717691|FG000|Overall Study|Adverse Event|13|||
146330853|NCT01628926|527717692|FG001|Overall Study|Adverse Event|11|||
146330854|NCT01628926|527717693|FG002|Overall Study|Adverse Event|9|||
146168062|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146330855|NCT01628926|527717691|FG000|Overall Study|Lack of Efficacy|2|||
146330856|NCT01628926|527717692|FG001|Overall Study|Lack of Efficacy|1|||
146330857|NCT01628926|527717693|FG002|Overall Study|Lack of Efficacy|5|||
146330858|NCT01628926|527717691|FG000|Overall Study|Withdrawal by Subject|6|||
146330859|NCT01628926|527717692|FG001|Overall Study|Withdrawal by Subject|4|||
146330860|NCT01628926|527717693|FG002|Overall Study|Withdrawal by Subject|2|||
146330861|NCT01628926|527717691|FG000|Overall Study|Protocol Violation|0|||
146330862|NCT01628926|527717692|FG001|Overall Study|Protocol Violation|1|||
146330863|NCT01628926|527717693|FG002|Overall Study|Protocol Violation|0|||
146330864|NCT01628926|527717691|FG000|Overall Study|Discontinuation criteria|3|||
146330865|NCT01628926|527717692|FG001|Overall Study|Discontinuation criteria|4|||
146330866|NCT01628926|527717693|FG002|Overall Study|Discontinuation criteria|0|||
146330867|NCT01628926|527717691|FG000|Overall Study|Physician Decision|2|||
146330868|NCT01628926|527717692|FG001|Overall Study|Physician Decision|2|||
146330869|NCT01628926|527717693|FG002|Overall Study|Physician Decision|1|||
146330870|NCT01551745|527717694|FG000|Overall Study|Withdrawal by Subject|1|||
146330871|NCT01551745|527717694|FG000|Overall Study|Disease Progression|2|||
146330872|NCT01955707|527717696|FG000|Overall Study|Adverse Event|1|||
146330873|NCT01955707|527717697|FG001|Overall Study|Adverse Event|2|||
146330874|NCT01955707|527717696|FG000|Overall Study|Lost to Follow-up|2|||
146330875|NCT01955707|527717697|FG001|Overall Study|Lost to Follow-up|1|||
146330876|NCT01955707|527717696|FG000|Overall Study|Withdrawal by Subject|0|||
146330877|NCT01955707|527717697|FG001|Overall Study|Withdrawal by Subject|3|||
146330878|NCT01955707|527717696|FG000|Overall Study|Death|13|||
146330879|NCT01955707|527717697|FG001|Overall Study|Death|14|||
146330880|NCT01955707|527717696|FG000|Overall Study|Other|4|||
146330881|NCT01955707|527717697|FG001|Overall Study|Other|2|||
146330882|NCT03896581|527718980|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
146330883|NCT03896581|527718981|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
146330884|NCT03896581|527718980|FG000|Overall Study|Withdrawal by Subject|4|||
146330885|NCT03896581|527718981|FG001|Overall Study|Withdrawal by Subject|1|||
146330886|NCT03896581|527718980|FG000|Overall Study|Lost to Follow-up|1|||
146330887|NCT03896581|527718981|FG001|Overall Study|Lost to Follow-up|0|||
146330888|NCT03896581|527718980|FG000|Overall Study|Lack of Efficacy|2|||
146330889|NCT03896581|527718981|FG001|Overall Study|Lack of Efficacy|1|||
146330890|NCT03896581|527718980|FG000|Overall Study|Adverse event, non-fatal|0|||
146330891|NCT03896581|527718981|FG001|Overall Study|Adverse event, non-fatal|2|||
146330892|NCT04854499|527718982|FG000|Overall Study|Study Terminated by Sponsor|5|||
146330893|NCT04854499|527718983|FG001|Overall Study|Study Terminated by Sponsor|27|||
146330894|NCT04854499|527718984|FG002|Overall Study|Study Terminated by Sponsor|28|||
146330895|NCT04854499|527718985|FG003|Overall Study|Study Terminated by Sponsor|19|||
146330896|NCT04854499|527718986|FG004|Overall Study|Study Terminated by Sponsor|1|||
146330897|NCT04854499|527718987|FG005|Overall Study|Study Terminated by Sponsor|10|||
146330898|NCT04854499|527718982|FG000|Overall Study|Death|1|||
146330899|NCT04854499|527718983|FG001|Overall Study|Death|23|||
146330900|NCT04854499|527718984|FG002|Overall Study|Death|21|||
146330901|NCT04854499|527718985|FG003|Overall Study|Death|7|||
146330902|NCT04854499|527718986|FG004|Overall Study|Death|6|||
146330903|NCT04854499|527718987|FG005|Overall Study|Death|24|||
146330904|NCT04854499|527718982|FG000|Overall Study|Investigator's Discretion|0|||
146330905|NCT04854499|527718983|FG001|Overall Study|Investigator's Discretion|1|||
146330906|NCT04854499|527718984|FG002|Overall Study|Investigator's Discretion|3|||
146330907|NCT04854499|527718985|FG003|Overall Study|Investigator's Discretion|4|||
146330908|NCT04854499|527718986|FG004|Overall Study|Investigator's Discretion|1|||
146330909|NCT04854499|527718987|FG005|Overall Study|Investigator's Discretion|5|||
146330910|NCT04854499|527718982|FG000|Overall Study|Withdrew Consent|0|||
146330911|NCT04854499|527718983|FG001|Overall Study|Withdrew Consent|1|||
146330912|NCT04854499|527718984|FG002|Overall Study|Withdrew Consent|2|||
146330913|NCT04854499|527718985|FG003|Overall Study|Withdrew Consent|2|||
146330914|NCT04854499|527718986|FG004|Overall Study|Withdrew Consent|0|||
146330915|NCT04854499|527718987|FG005|Overall Study|Withdrew Consent|1|||
146330916|NCT04854499|527718982|FG000|Overall Study|Lost to Follow-up|0|||
146330917|NCT04854499|527718983|FG001|Overall Study|Lost to Follow-up|0|||
146330918|NCT04854499|527718984|FG002|Overall Study|Lost to Follow-up|0|||
146330919|NCT04854499|527718985|FG003|Overall Study|Lost to Follow-up|0|||
146330920|NCT04854499|527718986|FG004|Overall Study|Lost to Follow-up|0|||
146330921|NCT04854499|527718987|FG005|Overall Study|Lost to Follow-up|1|||
146330922|NCT05415449|527718988|FG000|Overall Study|Lost to Follow-up|2|||
146330923|NCT05415449|527718988|FG000|Overall Study|Withdrawal by Subject|4|||
146330924|NCT02185521|527718992|FG000|Overall Study|Withdrawal by Subject|1|||
146330925|NCT02185521|527718992|FG000|Overall Study|Protocol Violation|1|||
146330926|NCT00398112|527718993|FG000|Overall Study|Adverse Event|4|||
146330927|NCT00398112|527718993|FG000|Overall Study|Disease progression|9|||
146330928|NCT00398112|527718993|FG000|Overall Study|Alternative treatment|1|||
146330929|NCT00398112|527718993|FG000|Overall Study|Withdrawal by Subject|3|||
146330930|NCT00398112|527718993|FG000|Overall Study|Death|1|||
146330931|NCT01887912|527718995|FG000|Overall Study|Serious adverse event|400|||
146330932|NCT01887912|527718996|FG001|Overall Study|Serious adverse event|198|||
146330933|NCT01887912|527718995|FG000|Overall Study|Other Adverse Event|34|||
146330934|NCT01887912|527718996|FG001|Overall Study|Other Adverse Event|15|||
146330935|NCT01887912|527718995|FG000|Overall Study|Protocol Violation|67|||
146330936|NCT01887912|527718996|FG001|Overall Study|Protocol Violation|37|||
146330937|NCT01887912|527718995|FG000|Overall Study|Lost to Follow-up|163|||
146330938|NCT01887912|527718996|FG001|Overall Study|Lost to Follow-up|74|||
146330939|NCT01887912|527718995|FG000|Overall Study|Withdrawal by Subject|606|||
146330940|NCT01887912|527718996|FG001|Overall Study|Withdrawal by Subject|349|||
146330941|NCT01887912|527718995|FG000|Overall Study|Other|122|||
146330942|NCT01887912|527718996|FG001|Overall Study|Other|58|||
146330943|NCT00450580|527719000|FG000|Overall Study|Adverse Event|5|||
146330944|NCT00450580|527719001|FG001|Overall Study|Adverse Event|7|||
146330945|NCT00450580|527719000|FG000|Overall Study|Lost to Follow-up|4|||
146330946|NCT00450580|527719001|FG001|Overall Study|Lost to Follow-up|5|||
146330947|NCT00450580|527719000|FG000|Overall Study|Withdrawal by Subject|2|||
146330948|NCT00450580|527719001|FG001|Overall Study|Withdrawal by Subject|2|||
146330949|NCT00450580|527719000|FG000|Overall Study|Protocol Violation|1|||
146330950|NCT00450580|527719001|FG001|Overall Study|Protocol Violation|1|||
146330951|NCT00450580|527719000|FG000|Overall Study|Protocol-defined virologic failure|1|||
146330952|NCT00450580|527719001|FG001|Overall Study|Protocol-defined virologic failure|0|||
146330953|NCT00450580|527719000|FG000|Overall Study|Could not comply with scheduled visits|1|||
146330954|NCT00450580|527719001|FG001|Overall Study|Could not comply with scheduled visits|0|||
146330955|NCT00450580|527719000|FG000|Overall Study|Patient went to Brazil|1|||
146330956|NCT00450580|527719001|FG001|Overall Study|Patient went to Brazil|0|||
146330957|NCT00450580|527719000|FG000|Overall Study|Patient could not swallow Norvir|1|||
146330958|NCT00450580|527719001|FG001|Overall Study|Patient could not swallow Norvir|0|||
146330959|NCT00450580|527719000|FG000|Overall Study|Withdrawal due to pregnancy|0|||
146330960|NCT00450580|527719001|FG001|Overall Study|Withdrawal due to pregnancy|1|||
146330961|NCT03932812|527719006|FG000|Overall Study|Lost to Follow-up|12|||
146330962|NCT03932812|527719007|FG001|Overall Study|Lost to Follow-up|14|||
146330963|NCT03932812|527719006|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
146330964|NCT03932812|527719007|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
146330965|NCT01262898|527719010|FG000|Overall Study|Protocol Violation|1|||
146330966|NCT01262898|527719011|FG001|Overall Study|Protocol Violation|1|||
146330967|NCT01262898|527719012|FG002|Overall Study|Protocol Violation|0|||
146330968|NCT01262898|527719013|FG003|Overall Study|Protocol Violation|0|||
146330969|NCT01262898|527719010|FG000|Overall Study|Lost to Follow-up|1|||
146330970|NCT01262898|527719011|FG001|Overall Study|Lost to Follow-up|0|||
146330971|NCT01262898|527719012|FG002|Overall Study|Lost to Follow-up|0|||
146330972|NCT01262898|527719013|FG003|Overall Study|Lost to Follow-up|0|||
146330973|NCT01262898|527719010|FG000|Overall Study|Withdrawal by Subject|1|||
146330974|NCT01262898|527719011|FG001|Overall Study|Withdrawal by Subject|1|||
146330975|NCT01262898|527719012|FG002|Overall Study|Withdrawal by Subject|0|||
146330976|NCT01262898|527719013|FG003|Overall Study|Withdrawal by Subject|0|||
146330977|NCT00792298|527719015|FG000|Treatment Period 1|Adverse Event|0|||
146330978|NCT00792298|527719016|FG001|Treatment Period 1|Adverse Event|1|||
146330979|NCT00792298|527719017|FG002|Treatment Period 1|Adverse Event|0|||
146330980|NCT00792298|527719018|FG003|Treatment Period 1|Adverse Event|1|||
146330981|NCT00792298|527719019|FG004|Treatment Period 1|Adverse Event|0|||
146330982|NCT00792298|527719020|FG005|Treatment Period 1|Adverse Event|1|||
146330983|NCT00792298|527719021|FG006|Treatment Period 1|Adverse Event|1|||
146330984|NCT00792298|527719022|FG007|Treatment Period 1|Adverse Event|0|||
146330985|NCT00792298|527719015|FG000|Treatment Period 1|Lack of Efficacy|0|||
146330986|NCT00792298|527719016|FG001|Treatment Period 1|Lack of Efficacy|0|||
146330987|NCT00792298|527719017|FG002|Treatment Period 1|Lack of Efficacy|1|||
146330988|NCT00792298|527719018|FG003|Treatment Period 1|Lack of Efficacy|0|||
146330989|NCT00792298|527719019|FG004|Treatment Period 1|Lack of Efficacy|0|||
146330990|NCT00792298|527719020|FG005|Treatment Period 1|Lack of Efficacy|0|||
146330991|NCT00792298|527719021|FG006|Treatment Period 1|Lack of Efficacy|0|||
146330992|NCT00792298|527719022|FG007|Treatment Period 1|Lack of Efficacy|0|||
146330993|NCT00792298|527719015|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146330994|NCT00792298|527719016|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146330995|NCT00792298|527719017|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146330996|NCT00792298|527719018|FG003|Treatment Period 1|Withdrawal by Subject|2|||
146330997|NCT00792298|527719019|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146330998|NCT00792298|527719020|FG005|Treatment Period 1|Withdrawal by Subject|2|||
146330999|NCT00792298|527719021|FG006|Treatment Period 1|Withdrawal by Subject|1|||
146331000|NCT00792298|527719022|FG007|Treatment Period 1|Withdrawal by Subject|0|||
146331001|NCT00792298|527719015|FG000|Treatment Period 1|Lost to Follow-up|0|||
146331002|NCT00792298|527719016|FG001|Treatment Period 1|Lost to Follow-up|0|||
146168063|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
146331003|NCT00792298|527719017|FG002|Treatment Period 1|Lost to Follow-up|0|||
146331004|NCT00792298|527719018|FG003|Treatment Period 1|Lost to Follow-up|0|||
146331005|NCT00792298|527719019|FG004|Treatment Period 1|Lost to Follow-up|0|||
146331006|NCT00792298|527719020|FG005|Treatment Period 1|Lost to Follow-up|0|||
146331007|NCT00792298|527719021|FG006|Treatment Period 1|Lost to Follow-up|1|||
146331008|NCT00792298|527719022|FG007|Treatment Period 1|Lost to Follow-up|0|||
146331009|NCT00792298|527719015|FG000|Treatment Period 1|Physician Decision|0|||
146331010|NCT00792298|527719016|FG001|Treatment Period 1|Physician Decision|0|||
146331011|NCT00792298|527719017|FG002|Treatment Period 1|Physician Decision|0|||
146331012|NCT00792298|527719018|FG003|Treatment Period 1|Physician Decision|1|||
146331013|NCT00792298|527719019|FG004|Treatment Period 1|Physician Decision|0|||
146331014|NCT00792298|527719020|FG005|Treatment Period 1|Physician Decision|0|||
146331015|NCT00792298|527719021|FG006|Treatment Period 1|Physician Decision|1|||
146331016|NCT00792298|527719022|FG007|Treatment Period 1|Physician Decision|0|||
146331017|NCT00792298|527719015|FG000|Treatment Period 1|Protocol Violation|0|||
146331018|NCT00792298|527719016|FG001|Treatment Period 1|Protocol Violation|0|||
146331019|NCT00792298|527719017|FG002|Treatment Period 1|Protocol Violation|0|||
146331020|NCT00792298|527719018|FG003|Treatment Period 1|Protocol Violation|0|||
146331021|NCT00792298|527719019|FG004|Treatment Period 1|Protocol Violation|0|||
146331022|NCT00792298|527719020|FG005|Treatment Period 1|Protocol Violation|0|||
146331023|NCT00792298|527719021|FG006|Treatment Period 1|Protocol Violation|0|||
146331024|NCT00792298|527719022|FG007|Treatment Period 1|Protocol Violation|1|||
146331025|NCT00792298|527719015|FG000|Washout|Adverse Event|0|||
146331026|NCT00792298|527719016|FG001|Washout|Adverse Event|0|||
146331027|NCT00792298|527719017|FG002|Washout|Adverse Event|0|||
146331028|NCT00792298|527719018|FG003|Washout|Adverse Event|0|||
146331029|NCT00792298|527719019|FG004|Washout|Adverse Event|0|||
146331030|NCT00792298|527719020|FG005|Washout|Adverse Event|1|||
146331031|NCT00792298|527719021|FG006|Washout|Adverse Event|0|||
146331032|NCT00792298|527719022|FG007|Washout|Adverse Event|0|||
146331033|NCT00792298|527719015|FG000|Washout|Withdrawal by Subject|0|||
146331034|NCT00792298|527719016|FG001|Washout|Withdrawal by Subject|0|||
146331035|NCT00792298|527719017|FG002|Washout|Withdrawal by Subject|1|||
146331036|NCT00792298|527719018|FG003|Washout|Withdrawal by Subject|0|||
146331037|NCT00792298|527719019|FG004|Washout|Withdrawal by Subject|0|||
146331038|NCT00792298|527719020|FG005|Washout|Withdrawal by Subject|1|||
146331039|NCT00792298|527719021|FG006|Washout|Withdrawal by Subject|0|||
146331040|NCT00792298|527719022|FG007|Washout|Withdrawal by Subject|0|||
146331041|NCT00792298|527719015|FG000|Treatment Period 2|Lack of Efficacy|0|||
146331042|NCT00792298|527719016|FG001|Treatment Period 2|Lack of Efficacy|0|||
146331043|NCT00792298|527719017|FG002|Treatment Period 2|Lack of Efficacy|0|||
146331044|NCT00792298|527719018|FG003|Treatment Period 2|Lack of Efficacy|0|||
146331045|NCT00792298|527719019|FG004|Treatment Period 2|Lack of Efficacy|1|||
146331046|NCT00792298|527719020|FG005|Treatment Period 2|Lack of Efficacy|0|||
146331047|NCT00792298|527719021|FG006|Treatment Period 2|Lack of Efficacy|0|||
146331048|NCT00792298|527719022|FG007|Treatment Period 2|Lack of Efficacy|0|||
146331049|NCT00792298|527719015|FG000|Treatment Period 2|Physician Decision|0|||
146331050|NCT00792298|527719016|FG001|Treatment Period 2|Physician Decision|0|||
146331051|NCT00792298|527719017|FG002|Treatment Period 2|Physician Decision|0|||
146331052|NCT00792298|527719018|FG003|Treatment Period 2|Physician Decision|0|||
146331053|NCT00792298|527719019|FG004|Treatment Period 2|Physician Decision|0|||
146331054|NCT00792298|527719020|FG005|Treatment Period 2|Physician Decision|0|||
146331055|NCT00792298|527719021|FG006|Treatment Period 2|Physician Decision|1|||
146331056|NCT00792298|527719022|FG007|Treatment Period 2|Physician Decision|0|||
146331057|NCT00792298|527719015|FG000|Treatment Period 2|Pregnancy|0|||
146331058|NCT00792298|527719016|FG001|Treatment Period 2|Pregnancy|0|||
146331059|NCT00792298|527719017|FG002|Treatment Period 2|Pregnancy|1|||
146331060|NCT00792298|527719018|FG003|Treatment Period 2|Pregnancy|0|||
146331061|NCT00792298|527719019|FG004|Treatment Period 2|Pregnancy|0|||
146331062|NCT00792298|527719020|FG005|Treatment Period 2|Pregnancy|0|||
146331063|NCT00792298|527719021|FG006|Treatment Period 2|Pregnancy|0|||
146331064|NCT00792298|527719022|FG007|Treatment Period 2|Pregnancy|0|||
146331065|NCT00792298|527719015|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146331066|NCT00792298|527719016|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146331067|NCT00792298|527719017|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146331068|NCT00792298|527719018|FG003|Treatment Period 2|Withdrawal by Subject|2|||
146331069|NCT00792298|527719019|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146331070|NCT00792298|527719020|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146331071|NCT00792298|527719021|FG006|Treatment Period 2|Withdrawal by Subject|0|||
146331072|NCT00792298|527719022|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146331073|NCT01756274|527719023|FG000|Overall Study|Protocol Violation|2|||
146331074|NCT01756274|527719023|FG000|Overall Study|Laboratory error|1|||
146331075|NCT03304522|527719024|FG000|Overall Study|Adverse Event|0|||
146331076|NCT03304522|527719025|FG001|Overall Study|Adverse Event|4|||
146331077|NCT03304522|527719024|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146168064|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
146168065|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
146168066|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146168067|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146168068|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
146168069|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
146331078|NCT03304522|527719025|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146331079|NCT03304522|527719024|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
146331080|NCT03304522|527719025|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
146331081|NCT03304522|527719024|FG000|Overall Study|Other|0|||
146331082|NCT03304522|527719025|FG001|Overall Study|Other|1|||
146331083|NCT00755079|527719032|FG000|Overall Study|Lost to Follow-up|1|||
146331084|NCT00755079|527719033|FG001|Overall Study|Lost to Follow-up|3|||
146331085|NCT00755079|527719032|FG000|Overall Study|Adverse Event|0|||
146331086|NCT00755079|527719033|FG001|Overall Study|Adverse Event|1|||
146331087|NCT00755079|527719032|FG000|Overall Study|Withdrawal by Subject|0|||
146331088|NCT00755079|527719033|FG001|Overall Study|Withdrawal by Subject|2|||
146331089|NCT01360996|527719034|FG000|Overall Study|Withdrawal by Subject|4|||
146331090|NCT01360996|527719035|FG001|Overall Study|Withdrawal by Subject|3|||
146331091|NCT01360996|527719036|FG002|Overall Study|Withdrawal by Subject|2|||
146331092|NCT01360996|527719034|FG000|Overall Study|Noncompliant|2|||
146331093|NCT01360996|527719035|FG001|Overall Study|Noncompliant|0|||
146331094|NCT01360996|527719036|FG002|Overall Study|Noncompliant|0|||
146331095|NCT04964258|527719037|FG000|Overall Study|Lost to Follow-up|1|||
146331096|NCT04964258|527719038|FG001|Overall Study|Lost to Follow-up|0|||
146331097|NCT04964258|527719039|FG002|Overall Study|Lost to Follow-up|0|||
146331098|NCT04964258|527719040|FG003|Overall Study|Lost to Follow-up|0|||
146331099|NCT04964258|527719041|FG004|Overall Study|Lost to Follow-up|0|||
146331100|NCT04964258|527719042|FG005|Overall Study|Lost to Follow-up|1|||
146331101|NCT04964258|527719043|FG006|Overall Study|Lost to Follow-up|0|||
146331102|NCT04964258|527719044|FG007|Overall Study|Lost to Follow-up|0|||
146331103|NCT04964258|527719045|FG008|Overall Study|Lost to Follow-up|0|||
146331104|NCT04964258|527719046|FG009|Overall Study|Lost to Follow-up|0|||
146331105|NCT04964258|527719047|FG010|Overall Study|Lost to Follow-up|0|||
146331106|NCT02965378|527719048|FG000|Overall Study|Progression|16|||
146331107|NCT02965378|527719049|FG001|Overall Study|Progression|4|||
146331108|NCT02965378|527719048|FG000|Overall Study|Adverse Event|5|||
146331109|NCT02965378|527719049|FG001|Overall Study|Adverse Event|2|||
146331110|NCT02965378|527719048|FG000|Overall Study|Death|2|||
146331111|NCT02965378|527719049|FG001|Overall Study|Death|0|||
146331112|NCT02965378|527719048|FG000|Overall Study|Refusal|2|||
146331113|NCT02965378|527719049|FG001|Overall Study|Refusal|1|||
146331114|NCT02965378|527719048|FG000|Overall Study|Not protocol specified|0|||
146331115|NCT02965378|527719049|FG001|Overall Study|Not protocol specified|2|||
146331116|NCT02909153|527719050|FG000|Overall Study|Withdrawal by Subject|0|||
146331117|NCT02909153|527719051|FG001|Overall Study|Withdrawal by Subject|1|||
146331118|NCT02909153|527719052|FG002|Overall Study|Withdrawal by Subject|0|||
146331119|NCT02909153|527719053|FG003|Overall Study|Withdrawal by Subject|0|||
146331120|NCT02909153|527719054|FG004|Overall Study|Withdrawal by Subject|0|||
146331121|NCT03040024|527719055|FG000|Overall Study|Adverse Event|0|||
146331122|NCT03040024|527719056|FG001|Overall Study|Adverse Event|1|||
146331123|NCT03040024|527719057|FG002|Overall Study|Adverse Event|0|||
146331124|NCT03040024|527719055|FG000|Overall Study|Death|0|||
146331125|NCT03040024|527719056|FG001|Overall Study|Death|1|||
146331126|NCT03040024|527719057|FG002|Overall Study|Death|0|||
146331127|NCT03040024|527719055|FG000|Overall Study|Physician Decision|0|||
146331128|NCT03040024|527719056|FG001|Overall Study|Physician Decision|0|||
146331129|NCT03040024|527719057|FG002|Overall Study|Physician Decision|1|||
146331130|NCT01526148|527719063|FG000|Overall Study|Adverse Event|6|||
146331131|NCT01526148|527719064|FG001|Overall Study|Adverse Event|5|||
146331132|NCT01526148|527719063|FG000|Overall Study|Lost to Follow-up|3|||
146331133|NCT01526148|527719064|FG001|Overall Study|Lost to Follow-up|6|||
146331134|NCT01526148|527719063|FG000|Overall Study|Withdrawal by Subject|2|||
146331135|NCT01526148|527719064|FG001|Overall Study|Withdrawal by Subject|0|||
146331136|NCT01526148|527719063|FG000|Overall Study|Unstable Medical Condition|1|||
146331137|NCT01526148|527719064|FG001|Overall Study|Unstable Medical Condition|0|||
146331138|NCT01526148|527719063|FG000|Overall Study|Unable to discontinue concomitant med|1|||
146331139|NCT01526148|527719064|FG001|Overall Study|Unable to discontinue concomitant med|0|||
146331140|NCT01526148|527719063|FG000|Overall Study|Moved out of state|1|||
146331141|NCT01526148|527719064|FG001|Overall Study|Moved out of state|0|||
146331142|NCT01526148|527719063|FG000|Overall Study|Incarcerated|0|||
146331143|NCT01526148|527719064|FG001|Overall Study|Incarcerated|2|||
146331144|NCT01173653|527719065|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
146331145|NCT01173653|527719066|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
146331146|NCT03308188|527719067|FG000|Overall Study|Withdrawal by Subject|0|||
146331147|NCT03308188|527719068|FG001|Overall Study|Withdrawal by Subject|3|||
146331148|NCT03308188|527719067|FG000|Overall Study|Death|0|||
146331149|NCT03308188|527719068|FG001|Overall Study|Death|1|||
146331150|NCT01791855|527719069|FG000|Overall Study|Adverse Event|0|||
146331151|NCT01791855|527719070|FG001|Overall Study|Adverse Event|0|||
146331152|NCT01791855|527719071|FG002|Overall Study|Adverse Event|0|||
146331153|NCT01791855|527719072|FG003|Overall Study|Adverse Event|1|||
146331154|NCT01791855|527719069|FG000|Overall Study|Randomized, not treated|0|||
146331155|NCT01791855|527719070|FG001|Overall Study|Randomized, not treated|1|||
146331156|NCT01791855|527719071|FG002|Overall Study|Randomized, not treated|0|||
146331157|NCT01791855|527719072|FG003|Overall Study|Randomized, not treated|0|||
146331158|NCT00772447|527719073|FG000|Overall Study|Withdrawal by Subject|9|||
146331159|NCT00772447|527719074|FG001|Overall Study|Withdrawal by Subject|5|||
146331160|NCT00772447|527719073|FG000|Overall Study|Physician Decision|4|||
146331161|NCT00772447|527719074|FG001|Overall Study|Physician Decision|8|||
146331162|NCT00772447|527719073|FG000|Overall Study|Lost to Follow-up|2|||
146331163|NCT00772447|527719074|FG001|Overall Study|Lost to Follow-up|4|||
146331164|NCT00772447|527719073|FG000|Overall Study|incorrect enrolment|3|||
146331165|NCT00772447|527719074|FG001|Overall Study|incorrect enrolment|4|||
146331166|NCT00772447|527719073|FG000|Overall Study|Protocol Violation|0|||
146331167|NCT00772447|527719074|FG001|Overall Study|Protocol Violation|1|||
146331168|NCT00772447|527719073|FG000|Overall Study|all others|2|||
146331169|NCT00772447|527719074|FG001|Overall Study|all others|2|||
146331170|NCT03529409|527719080|FG000|Randomized|Lost to Follow-up|0|||
146331171|NCT03529409|527719081|FG001|Randomized|Lost to Follow-up|0|||
146331172|NCT03529409|527719082|FG002|Randomized|Lost to Follow-up|4|||
146331173|NCT03529409|527719080|FG000|Randomized|Excluded|0|||
146331174|NCT03529409|527719081|FG001|Randomized|Excluded|0|||
146331175|NCT03529409|527719082|FG002|Randomized|Excluded|1|||
146168070|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146168071|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146168072|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146168073|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
146168074|NCT03420781|527128067|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
146168075|NCT03420781|527128068|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146168076|NCT03420781|527128069|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146331176|NCT03529409|527719080|FG000|Post-treatment Assessment|Death|1|||
146331177|NCT03529409|527719081|FG001|Post-treatment Assessment|Death|0|||
146331178|NCT03529409|527719082|FG002|Post-treatment Assessment|Death|0|||
146331179|NCT03529409|527719080|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
146331180|NCT03529409|527719081|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
146331181|NCT03529409|527719082|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
146331182|NCT03529409|527719080|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
146331183|NCT03529409|527719081|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
146331184|NCT03529409|527719082|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
146331185|NCT03529409|527719080|FG000|Follow-up Assessment|Death|1|||
146331186|NCT03529409|527719081|FG001|Follow-up Assessment|Death|0|||
146331187|NCT03529409|527719082|FG002|Follow-up Assessment|Death|0|||
146331188|NCT03529409|527719080|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
146331189|NCT03529409|527719081|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
146331190|NCT03529409|527719082|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
146331191|NCT01497262|527719083|FG000|Overall Study|Abnormal Lab Values|4|||
146331192|NCT01497262|527719083|FG000|Overall Study|Abnormal Test Procedure Result|1|||
146331193|NCT01497262|527719083|FG000|Overall Study|Physician Decision|1|||
146331194|NCT01497262|527719083|FG000|Overall Study|Withdrawal by Subject|2|||
146331195|NCT01497262|527719083|FG000|Overall Study|Adverse Event|2|||
146331196|NCT01497262|527719083|FG000|Overall Study|Protocol Violation|1|||
146331197|NCT01290887|527719084|FG000|Overall Study|Adverse Event|6|||
146331198|NCT01290887|527719085|FG001|Overall Study|Adverse Event|11|||
146331199|NCT01290887|527719084|FG000|Overall Study|Lack of Efficacy|4|||
146331200|NCT01290887|527719085|FG001|Overall Study|Lack of Efficacy|5|||
146331201|NCT01290887|527719084|FG000|Overall Study|Withdrawal by Subject|26|||
146331202|NCT01290887|527719085|FG001|Overall Study|Withdrawal by Subject|32|||
146331203|NCT01290887|527719084|FG000|Overall Study|Protocol Violation|2|||
146331204|NCT01290887|527719085|FG001|Overall Study|Protocol Violation|1|||
146331205|NCT01290887|527719084|FG000|Overall Study|Lost to Follow-up|4|||
146331206|NCT01290887|527719085|FG001|Overall Study|Lost to Follow-up|4|||
146331207|NCT01290887|527719084|FG000|Overall Study|Non-compliance to study procedures|0|||
146331208|NCT01290887|527719085|FG001|Overall Study|Non-compliance to study procedures|1|||
146331209|NCT01290887|527719084|FG000|Overall Study|Non-compliance to study medications|1|||
146331210|NCT01290887|527719085|FG001|Overall Study|Non-compliance to study medications|0|||
146331211|NCT01290887|527719084|FG000|Overall Study|Sponsor closure of study|420|||
146331212|NCT01290887|527719085|FG001|Overall Study|Sponsor closure of study|476|||
146331213|NCT01290887|527719084|FG000|Overall Study|Other|3|||
146331214|NCT01290887|527719085|FG001|Overall Study|Other|6|||
146331215|NCT03437447|527719088|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146331216|NCT03437447|527719089|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146331217|NCT03437447|527719090|FG002|Treatment Period 1|Withdrawal by Subject|1|||
146331218|NCT02764541|527719093|FG000|Overall Study|Withdrawal by Subject|0|||
146331219|NCT02764541|527719094|FG001|Overall Study|Withdrawal by Subject|0|||
146331220|NCT02764541|527719095|FG002|Overall Study|Withdrawal by Subject|0|||
146331221|NCT02764541|527719096|FG003|Overall Study|Withdrawal by Subject|0|||
146331222|NCT02764541|527719097|FG004|Overall Study|Withdrawal by Subject|1|||
146331223|NCT02764541|527719098|FG005|Overall Study|Withdrawal by Subject|1|||
146331224|NCT02764541|527719099|FG006|Overall Study|Withdrawal by Subject|0|||
146331225|NCT02764541|527719100|FG007|Overall Study|Withdrawal by Subject|1|||
146331226|NCT02764541|527719093|FG000|Overall Study|Adverse Event|1|||
146331227|NCT02764541|527719094|FG001|Overall Study|Adverse Event|0|||
146331228|NCT02764541|527719095|FG002|Overall Study|Adverse Event|0|||
146331229|NCT02764541|527719096|FG003|Overall Study|Adverse Event|0|||
146331230|NCT02764541|527719097|FG004|Overall Study|Adverse Event|0|||
146331231|NCT02764541|527719098|FG005|Overall Study|Adverse Event|0|||
146331232|NCT02764541|527719099|FG006|Overall Study|Adverse Event|1|||
146331233|NCT02764541|527719100|FG007|Overall Study|Adverse Event|0|||
146331234|NCT02764541|527719093|FG000|Overall Study|Metastasis|1|||
146331235|NCT02764541|527719094|FG001|Overall Study|Metastasis|0|||
146331236|NCT02764541|527719095|FG002|Overall Study|Metastasis|0|||
146331237|NCT02764541|527719096|FG003|Overall Study|Metastasis|0|||
146331238|NCT02764541|527719097|FG004|Overall Study|Metastasis|0|||
146331239|NCT02764541|527719098|FG005|Overall Study|Metastasis|0|||
146331240|NCT02764541|527719099|FG006|Overall Study|Metastasis|0|||
146331241|NCT02764541|527719100|FG007|Overall Study|Metastasis|0|||
146331242|NCT02764541|527719093|FG000|Overall Study|Disease progression|1|||
146331243|NCT02764541|527719094|FG001|Overall Study|Disease progression|1|||
146331244|NCT02764541|527719095|FG002|Overall Study|Disease progression|0|||
146331245|NCT02764541|527719096|FG003|Overall Study|Disease progression|0|||
146331246|NCT02764541|527719097|FG004|Overall Study|Disease progression|0|||
146331247|NCT02764541|527719098|FG005|Overall Study|Disease progression|0|||
146331248|NCT02764541|527719099|FG006|Overall Study|Disease progression|0|||
146331249|NCT02764541|527719100|FG007|Overall Study|Disease progression|1|||
146331250|NCT02764541|527719093|FG000|Overall Study|Protocol Violation|0|||
146331251|NCT02764541|527719094|FG001|Overall Study|Protocol Violation|0|||
146331252|NCT02764541|527719095|FG002|Overall Study|Protocol Violation|0|||
146331253|NCT02764541|527719096|FG003|Overall Study|Protocol Violation|1|||
146331254|NCT02764541|527719097|FG004|Overall Study|Protocol Violation|0|||
146331255|NCT02764541|527719098|FG005|Overall Study|Protocol Violation|1|||
146331256|NCT02764541|527719099|FG006|Overall Study|Protocol Violation|0|||
146331257|NCT02764541|527719100|FG007|Overall Study|Protocol Violation|0|||
146331258|NCT02764541|527719093|FG000|Overall Study|Physician Decision|0|||
146331259|NCT02764541|527719094|FG001|Overall Study|Physician Decision|0|||
146331260|NCT02764541|527719095|FG002|Overall Study|Physician Decision|0|||
146331261|NCT02764541|527719096|FG003|Overall Study|Physician Decision|1|||
146331262|NCT02764541|527719097|FG004|Overall Study|Physician Decision|0|||
146331263|NCT02764541|527719098|FG005|Overall Study|Physician Decision|0|||
146331264|NCT02764541|527719099|FG006|Overall Study|Physician Decision|0|||
146331265|NCT02764541|527719100|FG007|Overall Study|Physician Decision|1|||
146331266|NCT02764541|527719093|FG000|Overall Study|Three Cycles completed before surgery|0|||
146331267|NCT02764541|527719094|FG001|Overall Study|Three Cycles completed before surgery|0|||
146331268|NCT02764541|527719095|FG002|Overall Study|Three Cycles completed before surgery|0|||
146331269|NCT02764541|527719096|FG003|Overall Study|Three Cycles completed before surgery|1|||
146331270|NCT02764541|527719097|FG004|Overall Study|Three Cycles completed before surgery|0|||
146331271|NCT02764541|527719098|FG005|Overall Study|Three Cycles completed before surgery|0|||
146331272|NCT02764541|527719099|FG006|Overall Study|Three Cycles completed before surgery|0|||
146331273|NCT02764541|527719100|FG007|Overall Study|Three Cycles completed before surgery|0|||
146331274|NCT02764541|527719093|FG000|Overall Study|Patient Compliance|0|||
146331275|NCT02764541|527719094|FG001|Overall Study|Patient Compliance|0|||
146331276|NCT02764541|527719095|FG002|Overall Study|Patient Compliance|1|||
146331277|NCT02764541|527719096|FG003|Overall Study|Patient Compliance|0|||
146331278|NCT02764541|527719097|FG004|Overall Study|Patient Compliance|0|||
146331279|NCT02764541|527719098|FG005|Overall Study|Patient Compliance|0|||
146331280|NCT02764541|527719099|FG006|Overall Study|Patient Compliance|0|||
146331281|NCT02764541|527719100|FG007|Overall Study|Patient Compliance|0|||
146331282|NCT02764541|527719093|FG000|Overall Study|Death|0|||
146331283|NCT02764541|527719094|FG001|Overall Study|Death|0|||
146331284|NCT02764541|527719095|FG002|Overall Study|Death|0|||
146331285|NCT02764541|527719096|FG003|Overall Study|Death|0|||
146331286|NCT02764541|527719097|FG004|Overall Study|Death|0|||
146331287|NCT02764541|527719098|FG005|Overall Study|Death|0|||
146331288|NCT02764541|527719099|FG006|Overall Study|Death|1|||
146331289|NCT02764541|527719100|FG007|Overall Study|Death|0|||
146331290|NCT02764541|527719093|FG000|Overall Study|Insurance reasons|0|||
146331291|NCT02764541|527719094|FG001|Overall Study|Insurance reasons|0|||
146331292|NCT02764541|527719095|FG002|Overall Study|Insurance reasons|0|||
146331293|NCT02764541|527719096|FG003|Overall Study|Insurance reasons|0|||
146331294|NCT02764541|527719097|FG004|Overall Study|Insurance reasons|0|||
146331295|NCT02764541|527719098|FG005|Overall Study|Insurance reasons|0|||
146331296|NCT02764541|527719099|FG006|Overall Study|Insurance reasons|1|||
146331297|NCT02764541|527719100|FG007|Overall Study|Insurance reasons|0|||
146331298|NCT00749190|527719101|FG000|Overall Study|Adverse Event|0|||
146331299|NCT00749190|527719102|FG001|Overall Study|Adverse Event|2|||
146331300|NCT00749190|527719103|FG002|Overall Study|Adverse Event|0|||
146331301|NCT00749190|527719104|FG003|Overall Study|Adverse Event|4|||
146331302|NCT00749190|527719105|FG004|Overall Study|Adverse Event|0|||
146331303|NCT00749190|527719106|FG005|Overall Study|Adverse Event|3|||
146331304|NCT00749190|527719107|FG006|Overall Study|Adverse Event|0|||
146331305|NCT00749190|527719101|FG000|Overall Study|Lack of Efficacy|3|||
146331306|NCT00749190|527719102|FG001|Overall Study|Lack of Efficacy|1|||
146331307|NCT00749190|527719103|FG002|Overall Study|Lack of Efficacy|1|||
146331308|NCT00749190|527719104|FG003|Overall Study|Lack of Efficacy|0|||
146331309|NCT00749190|527719105|FG004|Overall Study|Lack of Efficacy|0|||
146331310|NCT00749190|527719106|FG005|Overall Study|Lack of Efficacy|1|||
146331311|NCT00749190|527719107|FG006|Overall Study|Lack of Efficacy|0|||
146331312|NCT00749190|527719101|FG000|Overall Study|Withdrawal by Subject|2|||
146331313|NCT00749190|527719102|FG001|Overall Study|Withdrawal by Subject|1|||
146331314|NCT00749190|527719103|FG002|Overall Study|Withdrawal by Subject|0|||
146331315|NCT00749190|527719104|FG003|Overall Study|Withdrawal by Subject|0|||
146331316|NCT00749190|527719105|FG004|Overall Study|Withdrawal by Subject|0|||
146331317|NCT00749190|527719106|FG005|Overall Study|Withdrawal by Subject|1|||
146331318|NCT00749190|527719107|FG006|Overall Study|Withdrawal by Subject|0|||
146331319|NCT00749190|527719101|FG000|Overall Study|Protocol Violation|0|||
146331320|NCT00749190|527719102|FG001|Overall Study|Protocol Violation|1|||
146331321|NCT00749190|527719103|FG002|Overall Study|Protocol Violation|0|||
146331322|NCT00749190|527719104|FG003|Overall Study|Protocol Violation|0|||
146331323|NCT00749190|527719105|FG004|Overall Study|Protocol Violation|0|||
146331324|NCT00749190|527719106|FG005|Overall Study|Protocol Violation|0|||
146331325|NCT00749190|527719107|FG006|Overall Study|Protocol Violation|1|||
146331326|NCT00749190|527719101|FG000|Overall Study|Other reason not defined above|0|||
146331327|NCT00749190|527719102|FG001|Overall Study|Other reason not defined above|0|||
146331328|NCT00749190|527719103|FG002|Overall Study|Other reason not defined above|0|||
146331329|NCT00749190|527719104|FG003|Overall Study|Other reason not defined above|1|||
146331330|NCT00749190|527719105|FG004|Overall Study|Other reason not defined above|0|||
146331331|NCT00749190|527719106|FG005|Overall Study|Other reason not defined above|0|||
146331332|NCT00749190|527719107|FG006|Overall Study|Other reason not defined above|0|||
146331333|NCT00784758|527719108|FG000|Overall Study|Withdrawal by Subject|3|||
146331334|NCT00784758|527719109|FG001|Overall Study|Withdrawal by Subject|0|||
146331335|NCT00784758|527719108|FG000|Overall Study|Adverse Event|1|||
146331336|NCT00784758|527719109|FG001|Overall Study|Adverse Event|0|||
146331337|NCT02040142|527719110|FG000|Overall Study|Lost to Follow-up|5|||
146331338|NCT02040142|527719110|FG000|Overall Study|Death|17|||
146331339|NCT02040142|527719110|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
146331340|NCT04752384|527719111|FG000|Overall Study|Withdrawal by Subject|1|||
146331341|NCT04752384|527719111|FG000|Overall Study|Death|1|||
146331342|NCT02330419|527719116|FG000|Overall Study|Lost to Follow-up|3|||
146331343|NCT02330419|527719117|FG001|Overall Study|Lost to Follow-up|7|||
146331344|NCT04167345|527719124|FG000|Overall Study|Other|1|||
146331345|NCT04167345|527719125|FG001|Overall Study|Other|1|||
146331346|NCT04167345|527719126|FG002|Overall Study|Other|0|||
146331347|NCT04167345|527719127|FG003|Overall Study|Other|0|||
146331348|NCT04167345|527719128|FG004|Overall Study|Other|0|||
146331349|NCT04063384|527720088|FG000|Overall Study|placebo manipulation issue|1|||
146331350|NCT04063384|527720089|FG001|Overall Study|placebo manipulation issue|2|||
146331351|NCT04063384|527720090|FG002|Overall Study|placebo manipulation issue|1|||
146331352|NCT04063384|527720091|FG003|Overall Study|placebo manipulation issue|1|||
146331353|NCT04572633|527720096|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
146331354|NCT00332709|527720097|FG000|Overall Study|Adverse Event|11|||
146331355|NCT00332709|527720098|FG001|Overall Study|Adverse Event|14|||
146331356|NCT00332709|527720097|FG000|Overall Study|Withdrawal by Subject|2|||
146331357|NCT00332709|527720098|FG001|Overall Study|Withdrawal by Subject|3|||
146331358|NCT00332709|527720097|FG000|Overall Study|Lost to Follow-up|2|||
146331359|NCT00332709|527720098|FG001|Overall Study|Lost to Follow-up|0|||
146331360|NCT00332709|527720097|FG000|Overall Study|Administrative Problems|0|||
146331361|NCT00332709|527720098|FG001|Overall Study|Administrative Problems|3|||
146331362|NCT00332709|527720097|FG000|Overall Study|Abnormal test procedure result|1|||
146331363|NCT00332709|527720098|FG001|Overall Study|Abnormal test procedure result|0|||
146331364|NCT03480802|527720099|FG000|Overall Study|Lost to Follow-up|5|||
146331365|NCT03480802|527720100|FG001|Overall Study|Lost to Follow-up|1|||
146331366|NCT03480802|527720099|FG000|Overall Study|Withdrawal by Subject|2|||
146331367|NCT03480802|527720100|FG001|Overall Study|Withdrawal by Subject|1|||
146331368|NCT03480802|527720099|FG000|Overall Study|Relocated|0|||
146331369|NCT03480802|527720100|FG001|Overall Study|Relocated|1|||
146331370|NCT04439266|527720105|FG000|Overall Study|Ineligible|1|||
146331371|NCT04439266|527720105|FG000|Overall Study|Adverse Event|1|||
146331372|NCT04439266|527720105|FG000|Overall Study|Death|1|||
146331373|NCT04439266|527720105|FG000|Overall Study|Disease progression|1|||
146331374|NCT04439266|527720105|FG000|Overall Study|Still on treatment|1|||
146331375|NCT05424276|527720108|FG000|Overall Study|Adverse Event|1|||
146168077|NCT03420781|527128070|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146168078|NCT03420781|527128071|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
146331376|NCT05424276|527720109|FG001|Overall Study|Adverse Event|0|||
146168079|NCT03420781|527128067|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146168080|NCT03420781|527128068|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146168081|NCT03420781|527128069|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146168082|NCT03420781|527128070|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
146168083|NCT03420781|527128071|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
146331377|NCT05424276|527720110|FG002|Overall Study|Adverse Event|0|||
146168084|NCT03420781|527128067|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146331378|NCT05424276|527720111|FG003|Overall Study|Adverse Event|2|||
146331379|NCT05424276|527720108|FG000|Overall Study|Withdrawal by Subject|0|||
146331380|NCT05424276|527720109|FG001|Overall Study|Withdrawal by Subject|0|||
146331381|NCT05424276|527720110|FG002|Overall Study|Withdrawal by Subject|2|||
146331382|NCT05424276|527720111|FG003|Overall Study|Withdrawal by Subject|0|||
146331383|NCT05424276|527720108|FG000|Overall Study|Protocol Violation|0|||
146331384|NCT05424276|527720109|FG001|Overall Study|Protocol Violation|1|||
146331385|NCT05424276|527720110|FG002|Overall Study|Protocol Violation|0|||
146331386|NCT05424276|527720111|FG003|Overall Study|Protocol Violation|0|||
146331387|NCT05424276|527720108|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146331388|NCT05424276|527720109|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
146331389|NCT05424276|527720110|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146331390|NCT05424276|527720111|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
146331391|NCT01701258|527720113|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
146331392|NCT01701258|527720114|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
146331393|NCT01701258|527720115|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
146331394|NCT01701258|527720116|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
146331395|NCT01701258|527720117|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
146331396|NCT01701258|527720118|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
146331397|NCT01701258|527720119|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
146331398|NCT01701258|527720120|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
146331399|NCT01701258|527720121|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
146331400|NCT01701258|527720122|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
146331401|NCT01701258|527720123|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
146331402|NCT01701258|527720124|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
146331403|NCT01701258|527720125|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
146331404|NCT01701258|527720113|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
146331405|NCT01701258|527720114|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
146331406|NCT01701258|527720115|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
146331407|NCT01701258|527720116|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
146331408|NCT01701258|527720117|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
146331409|NCT01701258|527720118|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
146331410|NCT01701258|527720119|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
146331411|NCT01701258|527720120|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
146331412|NCT01701258|527720121|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
146331413|NCT01701258|527720122|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
146331414|NCT01701258|527720123|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
146331415|NCT01701258|527720124|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
146331416|NCT01701258|527720125|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
146331417|NCT01701258|527720113|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
146331418|NCT01701258|527720114|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
146331419|NCT01701258|527720115|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
146331420|NCT01701258|527720116|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
146331421|NCT01701258|527720117|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
146331422|NCT01701258|527720118|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
146331423|NCT01701258|527720119|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
146331424|NCT01701258|527720120|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
146331425|NCT01701258|527720121|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
146331426|NCT01701258|527720122|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
146331427|NCT01701258|527720123|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
146331428|NCT01701258|527720124|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
146331429|NCT01701258|527720125|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
146331430|NCT01701258|527720113|FG000|Assessment and Scheduling|Investigator Terminated|2|||
146331431|NCT01701258|527720114|FG001|Assessment and Scheduling|Investigator Terminated|0|||
146331432|NCT01701258|527720115|FG002|Assessment and Scheduling|Investigator Terminated|0|||
146331433|NCT01701258|527720116|FG003|Assessment and Scheduling|Investigator Terminated|0|||
146331434|NCT01701258|527720117|FG004|Assessment and Scheduling|Investigator Terminated|0|||
146331435|NCT01701258|527720118|FG005|Assessment and Scheduling|Investigator Terminated|0|||
146331436|NCT01701258|527720119|FG006|Assessment and Scheduling|Investigator Terminated|0|||
146331437|NCT01701258|527720120|FG007|Assessment and Scheduling|Investigator Terminated|0|||
146331438|NCT01701258|527720121|FG008|Assessment and Scheduling|Investigator Terminated|0|||
146331439|NCT01701258|527720122|FG009|Assessment and Scheduling|Investigator Terminated|0|||
146331440|NCT01701258|527720123|FG010|Assessment and Scheduling|Investigator Terminated|0|||
146331441|NCT01701258|527720124|FG011|Assessment and Scheduling|Investigator Terminated|0|||
146331442|NCT01701258|527720125|FG012|Assessment and Scheduling|Investigator Terminated|0|||
146331443|NCT03049449|527720126|FG000|Overall Study|Did not receive treatment.|0|||
146331444|NCT03049449|527720127|FG001|Overall Study|Did not receive treatment.|0|||
146331445|NCT03049449|527720128|FG002|Overall Study|Did not receive treatment.|0|||
146331446|NCT03049449|527720129|FG003|Overall Study|Did not receive treatment.|0|||
146331447|NCT03049449|527720130|FG004|Overall Study|Did not receive treatment.|0|||
146168085|NCT03420781|527128068|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146168086|NCT03420781|527128069|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146331448|NCT03049449|527720131|FG005|Overall Study|Did not receive treatment.|0|||
146331449|NCT03049449|527720132|FG006|Overall Study|Did not receive treatment.|0|||
146331450|NCT03049449|527720133|FG007|Overall Study|Did not receive treatment.|0|||
146331451|NCT03049449|527720134|FG008|Overall Study|Did not receive treatment.|1|||
146331452|NCT03049449|527720135|FG009|Overall Study|Did not receive treatment.|0|||
146331453|NCT03049449|527720126|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
146331454|NCT03049449|527720127|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
146331455|NCT03049449|527720128|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
146331456|NCT03049449|527720129|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
146331457|NCT03049449|527720130|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
146331458|NCT03049449|527720131|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
146331459|NCT03049449|527720132|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
146331460|NCT03049449|527720133|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
146331461|NCT03049449|527720134|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
146331462|NCT03049449|527720135|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
146331463|NCT03049449|527720126|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331464|NCT03049449|527720127|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331465|NCT03049449|527720128|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331466|NCT03049449|527720129|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331467|NCT03049449|527720130|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331468|NCT03049449|527720131|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331469|NCT03049449|527720132|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331470|NCT03049449|527720133|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
146331471|NCT03049449|527720134|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
146331472|NCT03049449|527720135|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
146331473|NCT00501228|527720136|FG000|Overall Study|Withdrawal by Subject|1|||
146331474|NCT00885365|527720141|FG000|4 Weeks ON Treatment|Adverse Event|2|||
146331475|NCT00885365|527720142|FG001|4 Weeks ON Treatment|Adverse Event|4|||
146331476|NCT00885365|527720141|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
146331477|NCT00885365|527720142|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
146331478|NCT00885365|527720141|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
146331479|NCT00885365|527720142|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
146331480|NCT01824979|527720143|FG000|Overall Study|Withdrawal by Subject|5|||
146331481|NCT01824979|527720144|FG001|Overall Study|Withdrawal by Subject|0|||
146331482|NCT01824979|527720143|FG000|Overall Study|Physician Decision|2|||
146331483|NCT01824979|527720144|FG001|Overall Study|Physician Decision|0|||
146331484|NCT01824979|527720143|FG000|Overall Study|Protocol Violation|6|||
146331485|NCT01824979|527720144|FG001|Overall Study|Protocol Violation|13|||
146331486|NCT00473876|527720147|FG000|Overall Study|Lost to Follow-up|3|||
146331487|NCT00473876|527720148|FG001|Overall Study|Lost to Follow-up|1|||
146331488|NCT03751111|527720154|FG000|Overall Study|Lack of Efficacy|9|||
146331489|NCT03751111|527720155|FG001|Overall Study|Lack of Efficacy|30|||
146331490|NCT03751111|527720154|FG000|Overall Study|Adverse Event|3|||
146331491|NCT03751111|527720155|FG001|Overall Study|Adverse Event|2|||
146331492|NCT01285349|527720158|FG000|Overall Study|Lost to Follow-up|27|||
146331493|NCT01285349|527720159|FG001|Overall Study|Lost to Follow-up|20|||
146331494|NCT01285349|527720160|FG002|Overall Study|Lost to Follow-up|27|||
146331495|NCT01818297|527720163|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
146331496|NCT01818297|527720164|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
146331497|NCT01818297|527720163|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
146331498|NCT01818297|527720164|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
146331499|NCT01818297|527720163|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
146331500|NCT01818297|527720164|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
146331501|NCT00631137|527720165|FG000|Overall Study|Withdrawal by Subject|1|||
146331502|NCT00631137|527720166|FG001|Overall Study|Withdrawal by Subject|0|||
146331503|NCT04439344|527720167|FG000|Overall Study|Never started threapy|3|||
146331504|NCT04439344|527720167|FG000|Overall Study|Ineligible|3|||
146331505|NCT04439344|527720167|FG000|Overall Study|Adverse Event|13|||
146331506|NCT04439344|527720167|FG000|Overall Study|Death|2|||
146331507|NCT04439344|527720167|FG000|Overall Study|Disease progression|29|||
146331508|NCT04439344|527720167|FG000|Overall Study|Withdrawal by Subject|2|||
146331509|NCT04439344|527720167|FG000|Overall Study|Alternative therapy|1|||
146331510|NCT04373460|527720168|FG000|Overall Study|Did not receive tranfusion|18|||
146331511|NCT04373460|527720169|FG001|Overall Study|Did not receive tranfusion|26|||
146331512|NCT00454207|527720170|FG000|Overall Study|Adverse Event|3|||
146331513|NCT00454207|527720171|FG001|Overall Study|Adverse Event|1|||
146331514|NCT00454207|527720170|FG000|Overall Study|Lack of Efficacy|1|||
146331515|NCT00454207|527720171|FG001|Overall Study|Lack of Efficacy|0|||
146331516|NCT00454207|527720170|FG000|Overall Study|Protocol Violation|0|||
146331517|NCT00454207|527720171|FG001|Overall Study|Protocol Violation|1|||
146331518|NCT01672957|527720172|FG000|Overall Study|Protocol Violation|48|||
146331519|NCT01672957|527720172|FG000|Overall Study|Death|2|||
146331520|NCT01672957|527720172|FG000|Overall Study|ICF Signed After Transplantation|5|||
146331521|NCT01795547|527720175|FG000|Overall Study|Adverse Event|16|||
146331522|NCT01795547|527720176|FG001|Overall Study|Adverse Event|27|||
146331523|NCT01795547|527720175|FG000|Overall Study|Lack of Efficacy|8|||
146331524|NCT01795547|527720176|FG001|Overall Study|Lack of Efficacy|3|||
146331525|NCT01795547|527720175|FG000|Overall Study|Protocol Violation|6|||
146331526|NCT01795547|527720176|FG001|Overall Study|Protocol Violation|4|||
146331527|NCT01795547|527720175|FG000|Overall Study|Lost to Follow-up|2|||
146331528|NCT01795547|527720176|FG001|Overall Study|Lost to Follow-up|5|||
146331529|NCT01795547|527720175|FG000|Overall Study|Withdrawal of consent|7|||
146331530|NCT01795547|527720176|FG001|Overall Study|Withdrawal of consent|12|||
146331531|NCT01795547|527720175|FG000|Overall Study|Not Treated|4|||
146331532|NCT01795547|527720176|FG001|Overall Study|Not Treated|10|||
146331533|NCT01795547|527720175|FG000|Overall Study|Non-compliance with IMP|1|||
146331534|NCT01795547|527720176|FG001|Overall Study|Non-compliance with IMP|1|||
146331535|NCT01795547|527720175|FG000|Overall Study|Others|4|||
146331536|NCT01795547|527720176|FG001|Overall Study|Others|1|||
146331537|NCT01795547|527720175|FG000|Overall Study|Not stated|0|||
146331538|NCT01795547|527720176|FG001|Overall Study|Not stated|1|||
146331539|NCT00151892|527720177|FG000|Overall Study|Lack of Efficacy|50|||
146331540|NCT00151892|527720178|FG001|Overall Study|Lack of Efficacy|57|||
146331541|NCT00151892|527720177|FG000|Overall Study|Patient request|10|||
146331542|NCT00151892|527720178|FG001|Overall Study|Patient request|7|||
146331543|NCT00151892|527720177|FG000|Overall Study|Lost to Follow-up|5|||
146331544|NCT00151892|527720178|FG001|Overall Study|Lost to Follow-up|10|||
146331545|NCT00151892|527720177|FG000|Overall Study|Adverse Event|6|||
146331546|NCT00151892|527720178|FG001|Overall Study|Adverse Event|3|||
146331547|NCT00151892|527720177|FG000|Overall Study|Protocol Violation|3|||
146331548|NCT00151892|527720178|FG001|Overall Study|Protocol Violation|3|||
146331549|NCT00151892|527720177|FG000|Overall Study|Non-compliance|0|||
146331550|NCT00151892|527720178|FG001|Overall Study|Non-compliance|1|||
146331551|NCT00151892|527720177|FG000|Overall Study|Pregnancy|0|||
146331552|NCT00151892|527720178|FG001|Overall Study|Pregnancy|1|||
146331553|NCT00151892|527720177|FG000|Overall Study|Did not return for a visit|1|||
146331554|NCT00151892|527720178|FG001|Overall Study|Did not return for a visit|0|||
146331555|NCT00151892|527720177|FG000|Overall Study|Used prohibited corticosteroids|1|||
146331556|NCT00151892|527720178|FG001|Overall Study|Used prohibited corticosteroids|0|||
146331557|NCT00151892|527720177|FG000|Overall Study|Lack of study medication at center|0|||
146331558|NCT00151892|527720178|FG001|Overall Study|Lack of study medication at center|1|||
146331559|NCT05775289|527720182|FG000|Overall Study|Study Ongoing|20|||
146331560|NCT05775289|527720183|FG001|Overall Study|Study Ongoing|53|||
146331561|NCT05775289|527720184|FG002|Overall Study|Study Ongoing|15|||
146331562|NCT05775289|527720185|FG003|Overall Study|Study Ongoing|55|||
146331563|NCT05775289|527720182|FG000|Overall Study|Death|4|||
146331564|NCT05775289|527720183|FG001|Overall Study|Death|11|||
146331565|NCT05775289|527720184|FG002|Overall Study|Death|8|||
146331566|NCT05775289|527720185|FG003|Overall Study|Death|12|||
146331567|NCT05775289|527720182|FG000|Overall Study|Lost to Follow-up|0|||
146331568|NCT05775289|527720183|FG001|Overall Study|Lost to Follow-up|1|||
146331569|NCT05775289|527720184|FG002|Overall Study|Lost to Follow-up|0|||
146331570|NCT05775289|527720185|FG003|Overall Study|Lost to Follow-up|0|||
146331571|NCT05775289|527720182|FG000|Overall Study|Progressive Disease|0|||
146331572|NCT05775289|527720183|FG001|Overall Study|Progressive Disease|0|||
146331573|NCT05775289|527720184|FG002|Overall Study|Progressive Disease|1|||
146331574|NCT05775289|527720185|FG003|Overall Study|Progressive Disease|0|||
146331575|NCT05775289|527720182|FG000|Overall Study|Withdrawal by Subject|1|||
146331576|NCT05775289|527720183|FG001|Overall Study|Withdrawal by Subject|1|||
146331577|NCT05775289|527720184|FG002|Overall Study|Withdrawal by Subject|0|||
146331578|NCT05775289|527720185|FG003|Overall Study|Withdrawal by Subject|0|||
146331579|NCT04439331|527720186|FG000|Overall Study|Never Start Protocol Therapy|2|||
146331580|NCT04439331|527720186|FG000|Overall Study|Ineligible|2|||
146331581|NCT04439331|527720186|FG000|Overall Study|Mutation Status Not Confirmed|1|||
146331582|NCT04439331|527720186|FG000|Overall Study|Adverse Event|1|||
146331583|NCT04439331|527720186|FG000|Overall Study|Death|1|||
146331584|NCT04439331|527720186|FG000|Overall Study|Disease Progression|20|||
146331585|NCT04439331|527720186|FG000|Overall Study|Withdrawal by Subject|6|||
146331586|NCT04439331|527720186|FG000|Overall Study|Physician Decision|1|||
146331587|NCT04439331|527720186|FG000|Overall Study|Other Complicating Disease|1|||
146331588|NCT03726268|527720187|FG000|Overall Study|Physician Decision|2|||
146331589|NCT03726268|527720188|FG001|Overall Study|Physician Decision|8|||
146331590|NCT03726268|527720189|FG002|Overall Study|Physician Decision|6|||
146331591|NCT03726268|527720190|FG003|Overall Study|Physician Decision|3|||
146331592|NCT03726268|527720187|FG000|Overall Study|Withdrawal by Subject|11|||
146331593|NCT03726268|527720188|FG001|Overall Study|Withdrawal by Subject|5|||
146331594|NCT03726268|527720189|FG002|Overall Study|Withdrawal by Subject|9|||
146331595|NCT03726268|527720190|FG003|Overall Study|Withdrawal by Subject|8|||
146331596|NCT04370509|527720195|FG000|Overall Study|Adverse Event|1|||
146331597|NCT04370509|527720196|FG001|Overall Study|Adverse Event|0|||
146331598|NCT04370509|527720195|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
146331599|NCT04370509|527720196|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
146331600|NCT03498521|527720199|FG000|Overall Study|Death|227|||
146331601|NCT03498521|527720200|FG001|Overall Study|Death|79|||
146331602|NCT03498521|527720201|FG002|Overall Study|Death|84|||
146331603|NCT03498521|527720199|FG000|Overall Study|Exclusion criteria|1|||
146331604|NCT03498521|527720200|FG001|Overall Study|Exclusion criteria|0|||
146331605|NCT03498521|527720201|FG002|Overall Study|Exclusion criteria|0|||
146331606|NCT03498521|527720199|FG000|Overall Study|Lost to Follow-up|4|||
146331607|NCT03498521|527720200|FG001|Overall Study|Lost to Follow-up|3|||
146331608|NCT03498521|527720201|FG002|Overall Study|Lost to Follow-up|3|||
146331609|NCT03498521|527720199|FG000|Overall Study|No profile due to technical failure|1|||
146331610|NCT03498521|527720200|FG001|Overall Study|No profile due to technical failure|0|||
146331611|NCT03498521|527720201|FG002|Overall Study|No profile due to technical failure|0|||
146331612|NCT03498521|527720199|FG000|Overall Study|Physician Decision|3|||
146331613|NCT03498521|527720200|FG001|Overall Study|Physician Decision|1|||
146331614|NCT03498521|527720201|FG002|Overall Study|Physician Decision|0|||
146331615|NCT03498521|527720199|FG000|Overall Study|Withdrawal by Subject|11|||
146331616|NCT03498521|527720200|FG001|Overall Study|Withdrawal by Subject|6|||
146331617|NCT03498521|527720201|FG002|Overall Study|Withdrawal by Subject|2|||
146331618|NCT03498521|527720199|FG000|Overall Study|Study terminated by sponsor|79|||
146331619|NCT03498521|527720200|FG001|Overall Study|Study terminated by sponsor|21|||
146331620|NCT03498521|527720201|FG002|Overall Study|Study terminated by sponsor|4|||
146331621|NCT01445171|527721377|FG000|Overall Study|Lost to Follow-up|11|||
146331622|NCT01445171|527721377|FG000|Overall Study|Withdrawal by Subject|16|||
146331623|NCT01445171|527721377|FG000|Overall Study|Death|51|||
146331624|NCT01445171|527721377|FG000|Overall Study|Subjects declined to return for followup|9|||
146331625|NCT01445171|527721377|FG000|Overall Study|Consented but did not receive device|8|||
146331626|NCT00603239|527721380|FG000|Overall Study|Adverse Event|4|||
146331627|NCT00603239|527721381|FG001|Overall Study|Adverse Event|1|||
146331628|NCT00603239|527721380|FG000|Overall Study|Entry criteria not met|0|||
146331629|NCT00603239|527721381|FG001|Overall Study|Entry criteria not met|1|||
146331630|NCT00603239|527721380|FG000|Overall Study|Loss of glucose control|3|||
146331631|NCT00603239|527721381|FG001|Overall Study|Loss of glucose control|0|||
146331632|NCT00603239|527721380|FG000|Overall Study|Lost to Follow-up|2|||
146331633|NCT00603239|527721381|FG001|Overall Study|Lost to Follow-up|1|||
146331634|NCT00603239|527721380|FG000|Overall Study|Physician Decision|2|||
146331635|NCT00603239|527721381|FG001|Overall Study|Physician Decision|0|||
146331636|NCT00603239|527721380|FG000|Overall Study|Protocol Violation|2|||
146331637|NCT00603239|527721381|FG001|Overall Study|Protocol Violation|0|||
146331638|NCT00603239|527721380|FG000|Overall Study|Subject decision|2|||
146331639|NCT00603239|527721381|FG001|Overall Study|Subject decision|1|||
146331640|NCT01562028|527721383|FG000|Overall Study|Withdrawal by Subject|1|||
146331641|NCT01562028|527721384|FG001|Overall Study|Withdrawal by Subject|1|||
146331642|NCT01562028|527721383|FG000|Overall Study|Lost to Follow-up|2|||
146331643|NCT01562028|527721384|FG001|Overall Study|Lost to Follow-up|1|||
146331644|NCT05052723|527721385|FG000|Overall Study|Death|19|||
146331645|NCT05540652|527721386|FG000|Overall Study|Withdrawal by Subject|1|||
146331646|NCT02542267|527721387|FG000|Overall Study|Withdrawal by Subject|10|||
146331647|NCT02542267|527721387|FG000|Overall Study|Physician Decision|6|||
146331648|NCT02542267|527721387|FG000|Overall Study|Lost to Follow-up|4|||
146331649|NCT02542267|527721387|FG000|Overall Study|Death|13|||
146331650|NCT02542267|527721387|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
146331651|NCT02542267|527721387|FG000|Overall Study|Other|9|||
146331652|NCT00442598|527721388|FG000|Overall Study|Adverse Event|1|||
146331653|NCT00442598|527721389|FG001|Overall Study|Adverse Event|0|||
146331654|NCT00442598|527721390|FG002|Overall Study|Adverse Event|0|||
146331655|NCT00442598|527721388|FG000|Overall Study|Tumor progression|3|||
146331656|NCT00442598|527721389|FG001|Overall Study|Tumor progression|4|||
146331657|NCT00442598|527721390|FG002|Overall Study|Tumor progression|0|||
146331658|NCT00442598|527721388|FG000|Overall Study|Clinical deterioration|1|||
146331659|NCT00442598|527721389|FG001|Overall Study|Clinical deterioration|2|||
146331660|NCT00442598|527721390|FG002|Overall Study|Clinical deterioration|0|||
146331661|NCT00442598|527721388|FG000|Overall Study|CA125 progression|0|||
146331662|NCT00442598|527721389|FG001|Overall Study|CA125 progression|1|||
146331663|NCT00442598|527721390|FG002|Overall Study|CA125 progression|0|||
146331664|NCT00442598|527721388|FG000|Overall Study|Reduced creatinine clearance|1|||
146331665|NCT00442598|527721389|FG001|Overall Study|Reduced creatinine clearance|0|||
146331666|NCT00442598|527721390|FG002|Overall Study|Reduced creatinine clearance|0|||
146331667|NCT00442598|527721388|FG000|Overall Study|Death|0|||
146331668|NCT00442598|527721389|FG001|Overall Study|Death|1|||
146331669|NCT00442598|527721390|FG002|Overall Study|Death|0|||
146331670|NCT01147926|527721391|FG000|Overall Study|Subject Withdrew Consent|9|||
146331671|NCT01147926|527721392|FG001|Overall Study|Subject Withdrew Consent|10|||
146331672|NCT01147926|527721391|FG000|Overall Study|Adverse Event|7|||
146331673|NCT01147926|527721392|FG001|Overall Study|Adverse Event|6|||
146331674|NCT01147926|527721391|FG000|Overall Study|Subject Non-Compliant|5|||
146331675|NCT01147926|527721392|FG001|Overall Study|Subject Non-Compliant|4|||
146331676|NCT01147926|527721391|FG000|Overall Study|Principal investigator left hospital|1|||
146331677|NCT01147926|527721392|FG001|Overall Study|Principal investigator left hospital|3|||
146331678|NCT01147926|527721391|FG000|Overall Study|Selection criteria not met|3|||
146331679|NCT01147926|527721392|FG001|Overall Study|Selection criteria not met|1|||
146331680|NCT01147926|527721391|FG000|Overall Study|Lost to Follow-up|0|||
146331681|NCT01147926|527721392|FG001|Overall Study|Lost to Follow-up|2|||
146331682|NCT01147926|527721391|FG000|Overall Study|Sponsor's Decision|0|||
146331683|NCT01147926|527721392|FG001|Overall Study|Sponsor's Decision|1|||
146331684|NCT01147926|527721391|FG000|Overall Study|Lack of Efficacy|1|||
146331685|NCT01147926|527721392|FG001|Overall Study|Lack of Efficacy|0|||
146331686|NCT01147926|527721391|FG000|Overall Study|Too busy, no time for study|1|||
146331687|NCT01147926|527721392|FG001|Overall Study|Too busy, no time for study|0|||
146331688|NCT01147926|527721391|FG000|Overall Study|Went on holiday|0|||
146331689|NCT01147926|527721392|FG001|Overall Study|Went on holiday|1|||
146331690|NCT01147926|527721391|FG000|Overall Study|Colonoscopy result|0|||
146331691|NCT01147926|527721392|FG001|Overall Study|Colonoscopy result|1|||
146331692|NCT01670994|527721394|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
146331693|NCT01670994|527721395|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
146331694|NCT01670994|527721394|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
146331695|NCT01670994|527721395|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
146331696|NCT01670994|527721394|FG000|Overall Study|Patient experienced DLT|0|||
146331697|NCT01670994|527721395|FG001|Overall Study|Patient experienced DLT|1|||
146331698|NCT02013544|527721397|FG000|Overall Study|Adverse Event|5|||
146331699|NCT02013544|527721398|FG001|Overall Study|Adverse Event|5|||
146331700|NCT02013544|527721397|FG000|Overall Study|Lost to Follow-up|2|||
146331701|NCT02013544|527721398|FG001|Overall Study|Lost to Follow-up|3|||
146331702|NCT02013544|527721397|FG000|Overall Study|Withdrawal by Subject|2|||
146331703|NCT02013544|527721398|FG001|Overall Study|Withdrawal by Subject|8|||
146331704|NCT02013544|527721397|FG000|Overall Study|Physician Decision|0|||
146331705|NCT02013544|527721398|FG001|Overall Study|Physician Decision|1|||
146331706|NCT02013544|527721397|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
146331707|NCT02013544|527721398|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
146331708|NCT03514914|527721399|FG000|Overall Study|Death|3|||
146331709|NCT03514914|527721400|FG001|Overall Study|Death|3|||
146331710|NCT03514914|527721399|FG000|Overall Study|Lost to Follow-up|117|||
146331711|NCT03514914|527721400|FG001|Overall Study|Lost to Follow-up|89|||
146331712|NCT00891735|527721401|FG000|Overall Study|Adverse Event|2|||
146331713|NCT00891735|527721402|FG001|Overall Study|Adverse Event|0|||
146331714|NCT00891735|527721403|FG002|Overall Study|Adverse Event|2|||
146331715|NCT00891735|527721404|FG003|Overall Study|Adverse Event|0|||
146331716|NCT00891735|527721401|FG000|Overall Study|Death|8|||
146331717|NCT00891735|527721402|FG001|Overall Study|Death|5|||
146331718|NCT00891735|527721403|FG002|Overall Study|Death|4|||
146331719|NCT00891735|527721404|FG003|Overall Study|Death|5|||
146331720|NCT00891735|527721401|FG000|Overall Study|Lost to Follow-up|2|||
146331721|NCT00891735|527721402|FG001|Overall Study|Lost to Follow-up|2|||
146331722|NCT00891735|527721403|FG002|Overall Study|Lost to Follow-up|2|||
146331723|NCT00891735|527721404|FG003|Overall Study|Lost to Follow-up|2|||
146331724|NCT00891735|527721401|FG000|Overall Study|Physician's decision to withdraw patient|1|||
146331725|NCT00891735|527721402|FG001|Overall Study|Physician's decision to withdraw patient|0|||
146331726|NCT00891735|527721403|FG002|Overall Study|Physician's decision to withdraw patient|0|||
146331727|NCT00891735|527721404|FG003|Overall Study|Physician's decision to withdraw patient|0|||
146331728|NCT00891735|527721401|FG000|Overall Study|Patient's decision to withdraw|4|||
146331729|NCT00891735|527721402|FG001|Overall Study|Patient's decision to withdraw|9|||
146331730|NCT00891735|527721403|FG002|Overall Study|Patient's decision to withdraw|4|||
146331731|NCT00891735|527721404|FG003|Overall Study|Patient's decision to withdraw|8|||
146331732|NCT01276288|527721406|FG000|Overall Study|Adverse Event|1|||
146331733|NCT01276288|527721407|FG001|Overall Study|Adverse Event|1|||
146331734|NCT01276288|527721408|FG002|Overall Study|Adverse Event|0|||
146331735|NCT01276288|527721409|FG003|Overall Study|Adverse Event|0|||
146331736|NCT01276288|527721406|FG000|Overall Study|not treated|1|||
146331737|NCT01276288|527721407|FG001|Overall Study|not treated|0|||
146331738|NCT01276288|527721408|FG002|Overall Study|not treated|0|||
146331739|NCT01276288|527721409|FG003|Overall Study|not treated|0|||
146331740|NCT00481065|527721415|FG000|Overall Study|Adverse event or death|1|||
146331741|NCT00481065|527721416|FG001|Overall Study|Adverse event or death|1|||
146331742|NCT00481065|527721417|FG002|Overall Study|Adverse event or death|3|||
146331743|NCT00481065|527721418|FG003|Overall Study|Adverse event or death|0|||
146331744|NCT00481065|527721419|FG004|Overall Study|Adverse event or death|2|||
146331745|NCT00481065|527721420|FG005|Overall Study|Adverse event or death|0|||
146331746|NCT00481065|527721421|FG006|Overall Study|Adverse event or death|1|||
146331747|NCT00481065|527721422|FG007|Overall Study|Adverse event or death|1|||
146331748|NCT00481065|527721415|FG000|Overall Study|Withdrawal by Subject|11|||
146331749|NCT00481065|527721416|FG001|Overall Study|Withdrawal by Subject|12|||
146331750|NCT00481065|527721417|FG002|Overall Study|Withdrawal by Subject|7|||
146331751|NCT00481065|527721418|FG003|Overall Study|Withdrawal by Subject|11|||
146331752|NCT00481065|527721419|FG004|Overall Study|Withdrawal by Subject|13|||
146331753|NCT00481065|527721420|FG005|Overall Study|Withdrawal by Subject|12|||
146331754|NCT00481065|527721421|FG006|Overall Study|Withdrawal by Subject|9|||
146331755|NCT00481065|527721422|FG007|Overall Study|Withdrawal by Subject|10|||
146331756|NCT00481065|527721415|FG000|Overall Study|Lost to Follow-up|4|||
146331757|NCT00481065|527721416|FG001|Overall Study|Lost to Follow-up|2|||
146331758|NCT00481065|527721417|FG002|Overall Study|Lost to Follow-up|4|||
146331759|NCT00481065|527721418|FG003|Overall Study|Lost to Follow-up|3|||
146331760|NCT00481065|527721419|FG004|Overall Study|Lost to Follow-up|3|||
146331761|NCT00481065|527721420|FG005|Overall Study|Lost to Follow-up|3|||
146331762|NCT00481065|527721421|FG006|Overall Study|Lost to Follow-up|2|||
146331763|NCT00481065|527721422|FG007|Overall Study|Lost to Follow-up|5|||
146331764|NCT00481065|527721415|FG000|Overall Study|Inappropriate enrollment|4|||
146331765|NCT00481065|527721416|FG001|Overall Study|Inappropriate enrollment|0|||
146331766|NCT00481065|527721417|FG002|Overall Study|Inappropriate enrollment|2|||
146331767|NCT00481065|527721418|FG003|Overall Study|Inappropriate enrollment|0|||
146331768|NCT00481065|527721419|FG004|Overall Study|Inappropriate enrollment|2|||
146331769|NCT00481065|527721420|FG005|Overall Study|Inappropriate enrollment|1|||
146331770|NCT00481065|527721421|FG006|Overall Study|Inappropriate enrollment|0|||
146331771|NCT00481065|527721422|FG007|Overall Study|Inappropriate enrollment|1|||
146331772|NCT00481065|527721415|FG000|Overall Study|Administrative reason|0|||
146331773|NCT00481065|527721416|FG001|Overall Study|Administrative reason|0|||
146331774|NCT00481065|527721417|FG002|Overall Study|Administrative reason|0|||
146331775|NCT00481065|527721418|FG003|Overall Study|Administrative reason|0|||
146331776|NCT00481065|527721419|FG004|Overall Study|Administrative reason|0|||
146331777|NCT00481065|527721420|FG005|Overall Study|Administrative reason|2|||
146331778|NCT00481065|527721421|FG006|Overall Study|Administrative reason|1|||
146331779|NCT00481065|527721422|FG007|Overall Study|Administrative reason|0|||
146331780|NCT00481065|527721415|FG000|Overall Study|Protocol Violation|2|||
146331781|NCT00481065|527721416|FG001|Overall Study|Protocol Violation|1|||
146331782|NCT00481065|527721417|FG002|Overall Study|Protocol Violation|1|||
146331783|NCT00481065|527721418|FG003|Overall Study|Protocol Violation|1|||
146331784|NCT00481065|527721419|FG004|Overall Study|Protocol Violation|2|||
146331785|NCT00481065|527721420|FG005|Overall Study|Protocol Violation|6|||
146331786|NCT00481065|527721421|FG006|Overall Study|Protocol Violation|3|||
146331787|NCT00481065|527721422|FG007|Overall Study|Protocol Violation|2|||
146331788|NCT00481065|527721415|FG000|Overall Study|Unable to classify|0|||
146331789|NCT00481065|527721416|FG001|Overall Study|Unable to classify|1|||
146331790|NCT00481065|527721417|FG002|Overall Study|Unable to classify|2|||
146331791|NCT00481065|527721418|FG003|Overall Study|Unable to classify|0|||
146331792|NCT00481065|527721419|FG004|Overall Study|Unable to classify|1|||
146331793|NCT00481065|527721420|FG005|Overall Study|Unable to classify|0|||
146331794|NCT00481065|527721421|FG006|Overall Study|Unable to classify|0|||
146331795|NCT00481065|527721422|FG007|Overall Study|Unable to classify|0|||
146331796|NCT03770403|527721423|FG000|Overall Study|Adverse Event|8|||
146331797|NCT03770403|527721423|FG000|Overall Study|Death|5|||
146331798|NCT03770403|527721423|FG000|Overall Study|Physician Decision|1|||
146331799|NCT03770403|527721423|FG000|Overall Study|Sponsor decision|1|||
146331800|NCT03770403|527721423|FG000|Overall Study|Study terminated by Sponsor|1|||
146331801|NCT03770403|527721423|FG000|Overall Study|Withdrawal by Subject|13|||
146331802|NCT03770403|527721423|FG000|Overall Study|Other|88|||
146331803|NCT03896295|527721424|FG000|Overall Study|Adverse Event|0|||
146331804|NCT03896295|527721425|FG001|Overall Study|Adverse Event|1|||
146331805|NCT03896295|527721424|FG000|Overall Study|COVID-19|7|||
146331806|NCT03896295|527721425|FG001|Overall Study|COVID-19|29|||
146331807|NCT03029832|527721426|FG000|Overall Study|Safety Follow-Up Completed|2|||
146331808|NCT03029832|527721427|FG001|Overall Study|Safety Follow-Up Completed|0|||
146331809|NCT03029832|527721426|FG000|Overall Study|Death due to Disease Progression|1|||
146168087|NCT03420781|527128070|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
146168088|NCT03420781|527128071|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
146168089|NCT03420781|527128067|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
146331810|NCT03029832|527721427|FG001|Overall Study|Death due to Disease Progression|0|||
146331811|NCT03029832|527721426|FG000|Overall Study|Study Terminated By Sponsor|1|||
146331812|NCT03029832|527721427|FG001|Overall Study|Study Terminated By Sponsor|1|||
146331813|NCT01412229|527721428|FG000|Overall Study|Physician Decision|1|||
146331814|NCT00700804|527721431|FG000|Overall Study|Withdrawal by Subject|1|||
146331815|NCT00700804|527721432|FG001|Overall Study|Withdrawal by Subject|2|||
146331816|NCT00700804|527721431|FG000|Overall Study|Protocol Violation|1|||
146331817|NCT00700804|527721432|FG001|Overall Study|Protocol Violation|1|||
146168090|NCT03420781|527128068|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
146168091|NCT03420781|527128069|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
146168092|NCT03420781|527128070|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
146168093|NCT03420781|527128071|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
146168094|NCT05267600|527128072|FG000|Overall Study|Adverse Event|1|||
146168095|NCT05267600|527128073|FG001|Overall Study|Adverse Event|4|||
146331818|NCT00700804|527721431|FG000|Overall Study|Loose Stools|1|||
146331819|NCT00700804|527721432|FG001|Overall Study|Loose Stools|1|||
146331820|NCT02901431|527721433|FG000|PK Part|Adverse Event|0|||
146331821|NCT02901431|527721434|FG001|PK Part|Adverse Event|1|||
146331822|NCT02901431|527721435|FG002|PK Part|Adverse Event|0|||
146331823|NCT02901431|527721436|FG003|PK Part|Adverse Event|0|||
146331824|NCT02901431|527721437|FG004|PK Part|Adverse Event|0|||
146331825|NCT02901431|527721438|FG005|PK Part|Adverse Event|0|||
146331826|NCT02901431|527721439|FG006|PK Part|Adverse Event|0|||
146331827|NCT02901431|527721440|FG007|PK Part|Adverse Event|0|||
146331828|NCT02901431|527721441|FG008|PK Part|Adverse Event|0|||
146331829|NCT02901431|527721442|FG009|PK Part|Adverse Event|0|||
146331830|NCT02901431|527721443|FG010|PK Part|Adverse Event|0|||
146331831|NCT02901431|527721444|FG011|PK Part|Adverse Event|0|||
146331832|NCT02901431|527721445|FG012|PK Part|Adverse Event|0|||
146331833|NCT02901431|527721433|FG000|PK Part|Lost to Follow-up|0|||
146331834|NCT02901431|527721434|FG001|PK Part|Lost to Follow-up|0|||
146331835|NCT02901431|527721435|FG002|PK Part|Lost to Follow-up|1|||
146331836|NCT02901431|527721436|FG003|PK Part|Lost to Follow-up|0|||
146331837|NCT02901431|527721437|FG004|PK Part|Lost to Follow-up|0|||
146331838|NCT02901431|527721438|FG005|PK Part|Lost to Follow-up|0|||
146331839|NCT02901431|527721439|FG006|PK Part|Lost to Follow-up|0|||
146331840|NCT02901431|527721440|FG007|PK Part|Lost to Follow-up|0|||
146331841|NCT02901431|527721441|FG008|PK Part|Lost to Follow-up|0|||
146331842|NCT02901431|527721442|FG009|PK Part|Lost to Follow-up|0|||
146331843|NCT02901431|527721443|FG010|PK Part|Lost to Follow-up|0|||
146331844|NCT02901431|527721444|FG011|PK Part|Lost to Follow-up|0|||
146331845|NCT02901431|527721445|FG012|PK Part|Lost to Follow-up|0|||
146331846|NCT02901431|527721433|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
146331847|NCT02901431|527721434|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331848|NCT02901431|527721435|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331849|NCT02901431|527721436|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331850|NCT02901431|527721437|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331851|NCT02901431|527721438|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331852|NCT02901431|527721439|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331853|NCT02901431|527721440|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331854|NCT02901431|527721441|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331855|NCT02901431|527721442|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331856|NCT02901431|527721443|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331857|NCT02901431|527721444|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331858|NCT02901431|527721445|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
146331859|NCT02901431|527721433|FG000|PK Part|Pending dose confirmation|0|||
146331860|NCT02901431|527721434|FG001|PK Part|Pending dose confirmation|1|||
146331861|NCT02901431|527721435|FG002|PK Part|Pending dose confirmation|0|||
146331862|NCT02901431|527721436|FG003|PK Part|Pending dose confirmation|0|||
146331863|NCT02901431|527721437|FG004|PK Part|Pending dose confirmation|0|||
146331864|NCT02901431|527721438|FG005|PK Part|Pending dose confirmation|0|||
146331865|NCT02901431|527721439|FG006|PK Part|Pending dose confirmation|0|||
146331866|NCT02901431|527721440|FG007|PK Part|Pending dose confirmation|0|||
146331867|NCT02901431|527721441|FG008|PK Part|Pending dose confirmation|0|||
146331868|NCT02901431|527721442|FG009|PK Part|Pending dose confirmation|0|||
146331869|NCT02901431|527721443|FG010|PK Part|Pending dose confirmation|0|||
146331870|NCT02901431|527721444|FG011|PK Part|Pending dose confirmation|0|||
146331871|NCT02901431|527721445|FG012|PK Part|Pending dose confirmation|0|||
146331872|NCT02901431|527721433|FG000|PK Part|8 weeks of treatment ran out|2|||
146331873|NCT02901431|527721434|FG001|PK Part|8 weeks of treatment ran out|0|||
146331874|NCT02901431|527721435|FG002|PK Part|8 weeks of treatment ran out|0|||
146331875|NCT02901431|527721436|FG003|PK Part|8 weeks of treatment ran out|0|||
146331876|NCT02901431|527721437|FG004|PK Part|8 weeks of treatment ran out|0|||
146331877|NCT02901431|527721438|FG005|PK Part|8 weeks of treatment ran out|0|||
146331878|NCT02901431|527721439|FG006|PK Part|8 weeks of treatment ran out|0|||
146331879|NCT02901431|527721440|FG007|PK Part|8 weeks of treatment ran out|0|||
146331880|NCT02901431|527721441|FG008|PK Part|8 weeks of treatment ran out|0|||
146331881|NCT02901431|527721442|FG009|PK Part|8 weeks of treatment ran out|0|||
146331882|NCT02901431|527721443|FG010|PK Part|8 weeks of treatment ran out|0|||
146331883|NCT02901431|527721444|FG011|PK Part|8 weeks of treatment ran out|0|||
146331884|NCT02901431|527721445|FG012|PK Part|8 weeks of treatment ran out|0|||
146331885|NCT02901431|527721433|FG000|PK Part|Stopped treatment after 8 weeks|1|||
146331886|NCT02901431|527721434|FG001|PK Part|Stopped treatment after 8 weeks|0|||
146331887|NCT02901431|527721435|FG002|PK Part|Stopped treatment after 8 weeks|1|||
146331888|NCT02901431|527721436|FG003|PK Part|Stopped treatment after 8 weeks|0|||
146331889|NCT02901431|527721437|FG004|PK Part|Stopped treatment after 8 weeks|0|||
146331890|NCT02901431|527721438|FG005|PK Part|Stopped treatment after 8 weeks|0|||
146331891|NCT02901431|527721439|FG006|PK Part|Stopped treatment after 8 weeks|0|||
146331892|NCT02901431|527721440|FG007|PK Part|Stopped treatment after 8 weeks|0|||
146331893|NCT02901431|527721441|FG008|PK Part|Stopped treatment after 8 weeks|0|||
146331894|NCT02901431|527721442|FG009|PK Part|Stopped treatment after 8 weeks|0|||
146331895|NCT02901431|527721443|FG010|PK Part|Stopped treatment after 8 weeks|0|||
146331896|NCT02901431|527721444|FG011|PK Part|Stopped treatment after 8 weeks|0|||
146331897|NCT02901431|527721445|FG012|PK Part|Stopped treatment after 8 weeks|0|||
146331898|NCT02901431|527721433|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
146331899|NCT02901431|527721434|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331900|NCT02901431|527721435|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
146331901|NCT02901431|527721436|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331902|NCT02901431|527721437|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331903|NCT02901431|527721438|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331904|NCT02901431|527721439|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331905|NCT02901431|527721440|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331906|NCT02901431|527721441|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331907|NCT02901431|527721442|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331908|NCT02901431|527721443|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331909|NCT02901431|527721444|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331910|NCT02901431|527721445|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
146331911|NCT02901431|527721433|FG000|PK Part|Discontinued per Sponsor|0|||
146331912|NCT02901431|527721434|FG001|PK Part|Discontinued per Sponsor|3|||
146331913|NCT02901431|527721435|FG002|PK Part|Discontinued per Sponsor|0|||
146331914|NCT02901431|527721436|FG003|PK Part|Discontinued per Sponsor|0|||
146331915|NCT02901431|527721437|FG004|PK Part|Discontinued per Sponsor|0|||
146331916|NCT02901431|527721438|FG005|PK Part|Discontinued per Sponsor|0|||
146331917|NCT02901431|527721439|FG006|PK Part|Discontinued per Sponsor|0|||
146331918|NCT02901431|527721440|FG007|PK Part|Discontinued per Sponsor|0|||
146331919|NCT02901431|527721441|FG008|PK Part|Discontinued per Sponsor|0|||
146331920|NCT02901431|527721442|FG009|PK Part|Discontinued per Sponsor|0|||
146331921|NCT02901431|527721443|FG010|PK Part|Discontinued per Sponsor|0|||
146331922|NCT02901431|527721444|FG011|PK Part|Discontinued per Sponsor|0|||
146331923|NCT02901431|527721445|FG012|PK Part|Discontinued per Sponsor|0|||
146331924|NCT02901431|527721433|FG000|PK Part|Withdrawal by Subject|1|||
146331925|NCT02901431|527721434|FG001|PK Part|Withdrawal by Subject|1|||
146331926|NCT02901431|527721435|FG002|PK Part|Withdrawal by Subject|3|||
146331927|NCT02901431|527721436|FG003|PK Part|Withdrawal by Subject|0|||
146331928|NCT02901431|527721437|FG004|PK Part|Withdrawal by Subject|0|||
146331929|NCT02901431|527721438|FG005|PK Part|Withdrawal by Subject|0|||
146331930|NCT02901431|527721439|FG006|PK Part|Withdrawal by Subject|0|||
146331931|NCT02901431|527721440|FG007|PK Part|Withdrawal by Subject|0|||
146331932|NCT02901431|527721441|FG008|PK Part|Withdrawal by Subject|0|||
146331933|NCT02901431|527721442|FG009|PK Part|Withdrawal by Subject|0|||
146331934|NCT02901431|527721443|FG010|PK Part|Withdrawal by Subject|0|||
146331935|NCT02901431|527721444|FG011|PK Part|Withdrawal by Subject|0|||
146331936|NCT02901431|527721445|FG012|PK Part|Withdrawal by Subject|0|||
146331937|NCT02901431|527721433|FG000|Main Treatment Part|Adverse Event|0|||
146331938|NCT02901431|527721434|FG001|Main Treatment Part|Adverse Event|0|||
146331939|NCT02901431|527721435|FG002|Main Treatment Part|Adverse Event|0|||
146331940|NCT02901431|527721436|FG003|Main Treatment Part|Adverse Event|3|||
146331941|NCT02901431|527721437|FG004|Main Treatment Part|Adverse Event|3|||
146331942|NCT02901431|527721438|FG005|Main Treatment Part|Adverse Event|4|||
146331943|NCT02901431|527721439|FG006|Main Treatment Part|Adverse Event|1|||
146331944|NCT02901431|527721440|FG007|Main Treatment Part|Adverse Event|0|||
146331945|NCT02901431|527721441|FG008|Main Treatment Part|Adverse Event|0|||
146331946|NCT02901431|527721442|FG009|Main Treatment Part|Adverse Event|0|||
146331947|NCT02901431|527721443|FG010|Main Treatment Part|Adverse Event|0|||
146331948|NCT02901431|527721444|FG011|Main Treatment Part|Adverse Event|0|||
146331949|NCT02901431|527721445|FG012|Main Treatment Part|Adverse Event|0|||
146331950|NCT02901431|527721433|FG000|Main Treatment Part|Lack of Efficacy|0|||
146331951|NCT02901431|527721434|FG001|Main Treatment Part|Lack of Efficacy|0|||
146331952|NCT02901431|527721435|FG002|Main Treatment Part|Lack of Efficacy|0|||
146331953|NCT02901431|527721436|FG003|Main Treatment Part|Lack of Efficacy|1|||
146331954|NCT02901431|527721437|FG004|Main Treatment Part|Lack of Efficacy|0|||
146331955|NCT02901431|527721438|FG005|Main Treatment Part|Lack of Efficacy|0|||
146331956|NCT02901431|527721439|FG006|Main Treatment Part|Lack of Efficacy|0|||
146331957|NCT02901431|527721440|FG007|Main Treatment Part|Lack of Efficacy|0|||
146331958|NCT02901431|527721441|FG008|Main Treatment Part|Lack of Efficacy|0|||
146331959|NCT02901431|527721442|FG009|Main Treatment Part|Lack of Efficacy|0|||
146331960|NCT02901431|527721443|FG010|Main Treatment Part|Lack of Efficacy|0|||
146331961|NCT02901431|527721444|FG011|Main Treatment Part|Lack of Efficacy|0|||
146331962|NCT02901431|527721445|FG012|Main Treatment Part|Lack of Efficacy|0|||
146331963|NCT02901431|527721433|FG000|Main Treatment Part|Lost to Follow-up|0|||
146331964|NCT02901431|527721434|FG001|Main Treatment Part|Lost to Follow-up|0|||
146331965|NCT02901431|527721435|FG002|Main Treatment Part|Lost to Follow-up|0|||
146331966|NCT02901431|527721436|FG003|Main Treatment Part|Lost to Follow-up|3|||
146331967|NCT02901431|527721437|FG004|Main Treatment Part|Lost to Follow-up|1|||
146331968|NCT02901431|527721438|FG005|Main Treatment Part|Lost to Follow-up|2|||
146331969|NCT02901431|527721439|FG006|Main Treatment Part|Lost to Follow-up|3|||
146331970|NCT02901431|527721440|FG007|Main Treatment Part|Lost to Follow-up|0|||
146331971|NCT02901431|527721441|FG008|Main Treatment Part|Lost to Follow-up|0|||
146331972|NCT02901431|527721442|FG009|Main Treatment Part|Lost to Follow-up|0|||
146331973|NCT02901431|527721443|FG010|Main Treatment Part|Lost to Follow-up|0|||
146331974|NCT02901431|527721444|FG011|Main Treatment Part|Lost to Follow-up|0|||
146331975|NCT02901431|527721445|FG012|Main Treatment Part|Lost to Follow-up|0|||
146331976|NCT02901431|527721433|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
146331977|NCT02901431|527721434|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
146331978|NCT02901431|527721435|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
146331979|NCT02901431|527721436|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
146331980|NCT02901431|527721437|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
146331981|NCT02901431|527721438|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
146331982|NCT02901431|527721439|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
146331983|NCT02901431|527721440|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
146331984|NCT02901431|527721441|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
146331985|NCT02901431|527721442|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
146331986|NCT02901431|527721443|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
146331987|NCT02901431|527721444|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
146331988|NCT02901431|527721445|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
146331989|NCT02901431|527721433|FG000|Main Treatment Part|Physician Decision|0|||
146331990|NCT02901431|527721434|FG001|Main Treatment Part|Physician Decision|0|||
146331991|NCT02901431|527721435|FG002|Main Treatment Part|Physician Decision|0|||
146331992|NCT02901431|527721436|FG003|Main Treatment Part|Physician Decision|1|||
146331993|NCT02901431|527721437|FG004|Main Treatment Part|Physician Decision|0|||
146331994|NCT02901431|527721438|FG005|Main Treatment Part|Physician Decision|0|||
146331995|NCT02901431|527721439|FG006|Main Treatment Part|Physician Decision|1|||
146331996|NCT02901431|527721440|FG007|Main Treatment Part|Physician Decision|0|||
146331997|NCT02901431|527721441|FG008|Main Treatment Part|Physician Decision|0|||
146331998|NCT02901431|527721442|FG009|Main Treatment Part|Physician Decision|0|||
146331999|NCT02901431|527721443|FG010|Main Treatment Part|Physician Decision|0|||
146332000|NCT02901431|527721444|FG011|Main Treatment Part|Physician Decision|0|||
146332001|NCT02901431|527721445|FG012|Main Treatment Part|Physician Decision|0|||
146332002|NCT02901431|527721433|FG000|Main Treatment Part|Withdrawal by Subject|0|||
146332003|NCT02901431|527721434|FG001|Main Treatment Part|Withdrawal by Subject|0|||
146332004|NCT02901431|527721435|FG002|Main Treatment Part|Withdrawal by Subject|0|||
146332005|NCT02901431|527721436|FG003|Main Treatment Part|Withdrawal by Subject|18|||
146332006|NCT02901431|527721437|FG004|Main Treatment Part|Withdrawal by Subject|3|||
146332007|NCT02901431|527721438|FG005|Main Treatment Part|Withdrawal by Subject|5|||
146332008|NCT02901431|527721439|FG006|Main Treatment Part|Withdrawal by Subject|6|||
146332009|NCT02901431|527721440|FG007|Main Treatment Part|Withdrawal by Subject|0|||
146332010|NCT02901431|527721441|FG008|Main Treatment Part|Withdrawal by Subject|0|||
146332011|NCT02901431|527721442|FG009|Main Treatment Part|Withdrawal by Subject|0|||
146332012|NCT02901431|527721443|FG010|Main Treatment Part|Withdrawal by Subject|0|||
146332013|NCT02901431|527721444|FG011|Main Treatment Part|Withdrawal by Subject|0|||
146332014|NCT02901431|527721445|FG012|Main Treatment Part|Withdrawal by Subject|0|||
146332015|NCT02901431|527721433|FG000|Open Label Part|Adverse Event|0|||
146332016|NCT02901431|527721434|FG001|Open Label Part|Adverse Event|0|||
146332017|NCT02901431|527721435|FG002|Open Label Part|Adverse Event|0|||
146332018|NCT02901431|527721436|FG003|Open Label Part|Adverse Event|0|||
146332019|NCT02901431|527721437|FG004|Open Label Part|Adverse Event|0|||
146332020|NCT02901431|527721438|FG005|Open Label Part|Adverse Event|0|||
146332021|NCT02901431|527721439|FG006|Open Label Part|Adverse Event|0|||
146332022|NCT02901431|527721440|FG007|Open Label Part|Adverse Event|0|||
146332023|NCT02901431|527721441|FG008|Open Label Part|Adverse Event|4|||
146332024|NCT02901431|527721442|FG009|Open Label Part|Adverse Event|4|||
146332025|NCT02901431|527721443|FG010|Open Label Part|Adverse Event|0|||
146332026|NCT02901431|527721444|FG011|Open Label Part|Adverse Event|4|||
146332027|NCT02901431|527721445|FG012|Open Label Part|Adverse Event|1|||
146332028|NCT02901431|527721433|FG000|Open Label Part|Lost to Follow-up|0|||
146332029|NCT02901431|527721434|FG001|Open Label Part|Lost to Follow-up|0|||
146332030|NCT02901431|527721435|FG002|Open Label Part|Lost to Follow-up|0|||
146332031|NCT02901431|527721436|FG003|Open Label Part|Lost to Follow-up|0|||
146332032|NCT02901431|527721437|FG004|Open Label Part|Lost to Follow-up|0|||
146332033|NCT02901431|527721438|FG005|Open Label Part|Lost to Follow-up|0|||
146332034|NCT02901431|527721439|FG006|Open Label Part|Lost to Follow-up|0|||
146332035|NCT02901431|527721440|FG007|Open Label Part|Lost to Follow-up|0|||
146332036|NCT02901431|527721441|FG008|Open Label Part|Lost to Follow-up|2|||
146332037|NCT02901431|527721442|FG009|Open Label Part|Lost to Follow-up|2|||
146332038|NCT02901431|527721443|FG010|Open Label Part|Lost to Follow-up|1|||
146332039|NCT02901431|527721444|FG011|Open Label Part|Lost to Follow-up|1|||
146332040|NCT02901431|527721445|FG012|Open Label Part|Lost to Follow-up|1|||
146332041|NCT02901431|527721433|FG000|Open Label Part|Physician Decision|0|||
146332042|NCT02901431|527721434|FG001|Open Label Part|Physician Decision|0|||
146332043|NCT02901431|527721435|FG002|Open Label Part|Physician Decision|0|||
146332044|NCT02901431|527721436|FG003|Open Label Part|Physician Decision|0|||
146332045|NCT02901431|527721437|FG004|Open Label Part|Physician Decision|0|||
146332046|NCT02901431|527721438|FG005|Open Label Part|Physician Decision|0|||
146332047|NCT02901431|527721439|FG006|Open Label Part|Physician Decision|0|||
146332048|NCT02901431|527721440|FG007|Open Label Part|Physician Decision|0|||
146332049|NCT02901431|527721441|FG008|Open Label Part|Physician Decision|1|||
146332050|NCT02901431|527721442|FG009|Open Label Part|Physician Decision|1|||
146332051|NCT02901431|527721443|FG010|Open Label Part|Physician Decision|0|||
146332052|NCT02901431|527721444|FG011|Open Label Part|Physician Decision|0|||
146332053|NCT02901431|527721445|FG012|Open Label Part|Physician Decision|0|||
146332054|NCT02901431|527721433|FG000|Open Label Part|Study Terminated By Sponsor|0|||
146332055|NCT02901431|527721434|FG001|Open Label Part|Study Terminated By Sponsor|0|||
146332056|NCT02901431|527721435|FG002|Open Label Part|Study Terminated By Sponsor|0|||
146332057|NCT02901431|527721436|FG003|Open Label Part|Study Terminated By Sponsor|0|||
146332058|NCT02901431|527721437|FG004|Open Label Part|Study Terminated By Sponsor|0|||
146332059|NCT02901431|527721438|FG005|Open Label Part|Study Terminated By Sponsor|0|||
146332060|NCT02901431|527721439|FG006|Open Label Part|Study Terminated By Sponsor|0|||
146332061|NCT02901431|527721440|FG007|Open Label Part|Study Terminated By Sponsor|0|||
146332062|NCT02901431|527721441|FG008|Open Label Part|Study Terminated By Sponsor|35|||
146332063|NCT02901431|527721442|FG009|Open Label Part|Study Terminated By Sponsor|12|||
146332064|NCT02901431|527721443|FG010|Open Label Part|Study Terminated By Sponsor|21|||
146332065|NCT02901431|527721444|FG011|Open Label Part|Study Terminated By Sponsor|31|||
146332066|NCT02901431|527721445|FG012|Open Label Part|Study Terminated By Sponsor|0|||
146332067|NCT02901431|527721433|FG000|Open Label Part|Withdrawal by Subject|0|||
146332068|NCT02901431|527721434|FG001|Open Label Part|Withdrawal by Subject|0|||
146332069|NCT02901431|527721435|FG002|Open Label Part|Withdrawal by Subject|0|||
146332070|NCT02901431|527721436|FG003|Open Label Part|Withdrawal by Subject|0|||
146332071|NCT02901431|527721437|FG004|Open Label Part|Withdrawal by Subject|0|||
146332072|NCT02901431|527721438|FG005|Open Label Part|Withdrawal by Subject|0|||
146332073|NCT02901431|527721439|FG006|Open Label Part|Withdrawal by Subject|0|||
146332074|NCT02901431|527721440|FG007|Open Label Part|Withdrawal by Subject|0|||
146332075|NCT02901431|527721441|FG008|Open Label Part|Withdrawal by Subject|6|||
146332076|NCT02901431|527721442|FG009|Open Label Part|Withdrawal by Subject|5|||
146332077|NCT02901431|527721443|FG010|Open Label Part|Withdrawal by Subject|7|||
146332078|NCT02901431|527721444|FG011|Open Label Part|Withdrawal by Subject|3|||
146332079|NCT02901431|527721445|FG012|Open Label Part|Withdrawal by Subject|1|||
146332080|NCT04223609|527721446|FG000|Overall Study|Adverse Event|0|||
146332081|NCT04223609|527721447|FG001|Overall Study|Adverse Event|1|||
146332082|NCT04223609|527721446|FG000|Overall Study|Missed last visit|0|||
146332083|NCT04223609|527721447|FG001|Overall Study|Missed last visit|1|||
146332084|NCT00591734|527721450|FG000|Overall Study|Lack of Efficacy|35|||
146332085|NCT00591734|527721450|FG000|Overall Study|Adverse Event|5|||
146332086|NCT00591734|527721450|FG000|Overall Study|Physician Decision|5|||
146332087|NCT00591734|527721450|FG000|Overall Study|Intercurrent Illness|8|||
146332088|NCT02500537|527721451|FG000|Overall Study|Death|2|||
146332089|NCT02500537|527721452|FG001|Overall Study|Death|0|||
146332090|NCT02500537|527721451|FG000|Overall Study|Lost to Follow-up|0|||
146332091|NCT02500537|527721452|FG001|Overall Study|Lost to Follow-up|1|||
146332092|NCT02500537|527721451|FG000|Overall Study|Withdrawal by Subject|1|||
146332093|NCT02500537|527721452|FG001|Overall Study|Withdrawal by Subject|0|||
146332094|NCT01661790|527721453|FG000|Overall Study|Lost to Follow-up|0|||
146332095|NCT01661790|527721454|FG001|Overall Study|Lost to Follow-up|2|||
146332096|NCT00355121|527721459|FG000|Overall Study|Did not receive study vaccine|1|||
146332097|NCT00355121|527721460|FG001|Overall Study|Did not receive study vaccine|0|||
146332098|NCT00355121|527721461|FG002|Overall Study|Did not receive study vaccine|1|||
146332099|NCT00355121|527721459|FG000|Overall Study|Adverse Event|0|||
146332100|NCT00355121|527721460|FG001|Overall Study|Adverse Event|1|||
146332101|NCT00355121|527721461|FG002|Overall Study|Adverse Event|0|||
146332102|NCT00355121|527721459|FG000|Overall Study|Protocol Violation|7|||
146332103|NCT00355121|527721460|FG001|Overall Study|Protocol Violation|9|||
146332104|NCT00355121|527721461|FG002|Overall Study|Protocol Violation|1|||
146332105|NCT00355121|527721459|FG000|Overall Study|Lost to Follow-up|4|||
146332106|NCT00355121|527721460|FG001|Overall Study|Lost to Follow-up|7|||
146332107|NCT00355121|527721461|FG002|Overall Study|Lost to Follow-up|1|||
146332108|NCT00355121|527721459|FG000|Overall Study|Withdrawal by Subject|9|||
146332109|NCT00355121|527721460|FG001|Overall Study|Withdrawal by Subject|10|||
146332110|NCT00355121|527721461|FG002|Overall Study|Withdrawal by Subject|2|||
146332111|NCT00355121|527721459|FG000|Overall Study|Serious adverse events|0|||
146332112|NCT00355121|527721460|FG001|Overall Study|Serious adverse events|2|||
146332113|NCT00355121|527721461|FG002|Overall Study|Serious adverse events|0|||
146332114|NCT04743856|527721463|FG000|Overall Study|Lost to Follow-up|6|||
146332115|NCT04743856|527721464|FG001|Overall Study|Lost to Follow-up|7|||
146332116|NCT04743856|527721463|FG000|Overall Study|Withdrawal by Subject|1|||
146332117|NCT04743856|527721464|FG001|Overall Study|Withdrawal by Subject|0|||
146332118|NCT04696861|527721465|FG000|Overall Study|Death|1|||
146332119|NCT04696861|527721466|FG001|Overall Study|Death|0|||
146332120|NCT04696861|527721465|FG000|Overall Study|Lost to Follow-up|3|||
146332121|NCT04696861|527721466|FG001|Overall Study|Lost to Follow-up|0|||
146332122|NCT04439188|527721467|FG000|Overall Study|Ineligible|3|||
146332123|NCT04439188|527721467|FG000|Overall Study|Adverse Event|4|||
146332124|NCT04439188|527721467|FG000|Overall Study|Death|1|||
146332125|NCT04439188|527721467|FG000|Overall Study|Disease Progression|25|||
146332126|NCT04439188|527721467|FG000|Overall Study|Withdrawal by Subject|2|||
146332127|NCT01813890|527721470|FG000|Overall Study|Adverse Event|0|||
146332128|NCT01813890|527721471|FG001|Overall Study|Adverse Event|3|||
146332129|NCT01813890|527721472|FG002|Overall Study|Adverse Event|4|||
146332130|NCT01813890|527721470|FG000|Overall Study|Lack of Efficacy|9|||
146332131|NCT01813890|527721471|FG001|Overall Study|Lack of Efficacy|1|||
146332132|NCT01813890|527721472|FG002|Overall Study|Lack of Efficacy|2|||
146332133|NCT04482647|527721473|FG000|Overall Study|Time constraints|2|||
146332134|NCT04482647|527721473|FG000|Overall Study|Health issues|1|||
146332135|NCT04482647|527721473|FG000|Overall Study|Death in the family|1|||
146332136|NCT04482647|527721473|FG000|Overall Study|Disliked the intervention|1|||
146332137|NCT04482647|527721473|FG000|Overall Study|No reasons specified|7|||
146332138|NCT01827384|527721474|FG000|Overall Study|Switched to alternative treatment|0|||
146332139|NCT01827384|527721475|FG001|Overall Study|Switched to alternative treatment|0|||
146332140|NCT01827384|527721476|FG002|Overall Study|Switched to alternative treatment|0|||
146332141|NCT01827384|527721477|FG003|Overall Study|Switched to alternative treatment|0|||
146332142|NCT01827384|527721478|FG004|Overall Study|Switched to alternative treatment|0|||
146332143|NCT01827384|527721479|FG005|Overall Study|Switched to alternative treatment|0|||
146332144|NCT01827384|527721480|FG006|Overall Study|Switched to alternative treatment|0|||
146332145|NCT01827384|527721481|FG007|Overall Study|Switched to alternative treatment|0|||
146332146|NCT01827384|527721482|FG008|Overall Study|Switched to alternative treatment|0|||
146332147|NCT01827384|527721483|FG009|Overall Study|Switched to alternative treatment|0|||
146332148|NCT01827384|527721484|FG010|Overall Study|Switched to alternative treatment|0|||
146332149|NCT01827384|527721485|FG011|Overall Study|Switched to alternative treatment|0|||
146332150|NCT01827384|527721486|FG012|Overall Study|Switched to alternative treatment|0|||
146332151|NCT01827384|527721487|FG013|Overall Study|Switched to alternative treatment|2|||
146332152|NCT01827384|527721474|FG000|Overall Study|Disease progression before treatment|0|||
146332153|NCT01827384|527721475|FG001|Overall Study|Disease progression before treatment|0|||
146332154|NCT01827384|527721476|FG002|Overall Study|Disease progression before treatment|0|||
146332155|NCT01827384|527721477|FG003|Overall Study|Disease progression before treatment|0|||
146332156|NCT01827384|527721478|FG004|Overall Study|Disease progression before treatment|0|||
146332157|NCT01827384|527721479|FG005|Overall Study|Disease progression before treatment|0|||
146332158|NCT01827384|527721480|FG006|Overall Study|Disease progression before treatment|0|||
146332159|NCT01827384|527721481|FG007|Overall Study|Disease progression before treatment|0|||
146332160|NCT01827384|527721482|FG008|Overall Study|Disease progression before treatment|0|||
146332161|NCT01827384|527721483|FG009|Overall Study|Disease progression before treatment|0|||
146332162|NCT01827384|527721484|FG010|Overall Study|Disease progression before treatment|0|||
146332163|NCT01827384|527721485|FG011|Overall Study|Disease progression before treatment|0|||
146332164|NCT01827384|527721486|FG012|Overall Study|Disease progression before treatment|0|||
146332165|NCT01827384|527721487|FG013|Overall Study|Disease progression before treatment|4|||
146332166|NCT01827384|527721474|FG000|Overall Study|Ineligible|0|||
146332167|NCT01827384|527721475|FG001|Overall Study|Ineligible|0|||
146332168|NCT01827384|527721476|FG002|Overall Study|Ineligible|0|||
146332169|NCT01827384|527721477|FG003|Overall Study|Ineligible|0|||
146332170|NCT01827384|527721478|FG004|Overall Study|Ineligible|0|||
146332171|NCT01827384|527721479|FG005|Overall Study|Ineligible|0|||
146332172|NCT01827384|527721480|FG006|Overall Study|Ineligible|0|||
146332173|NCT01827384|527721481|FG007|Overall Study|Ineligible|0|||
146332174|NCT01827384|527721482|FG008|Overall Study|Ineligible|0|||
146168096|NCT05267600|527128072|FG000|Overall Study|Death|1|||
146332175|NCT01827384|527721483|FG009|Overall Study|Ineligible|0|||
146332176|NCT01827384|527721484|FG010|Overall Study|Ineligible|0|||
146332177|NCT01827384|527721485|FG011|Overall Study|Ineligible|0|||
146332178|NCT01827384|527721486|FG012|Overall Study|Ineligible|0|||
146332179|NCT01827384|527721487|FG013|Overall Study|Ineligible|19|||
146332180|NCT01827384|527721474|FG000|Overall Study|Participant died before treatment|0|||
146332181|NCT01827384|527721475|FG001|Overall Study|Participant died before treatment|0|||
146332182|NCT01827384|527721476|FG002|Overall Study|Participant died before treatment|0|||
146332183|NCT01827384|527721477|FG003|Overall Study|Participant died before treatment|0|||
146332184|NCT01827384|527721478|FG004|Overall Study|Participant died before treatment|0|||
146332185|NCT01827384|527721479|FG005|Overall Study|Participant died before treatment|0|||
146332186|NCT01827384|527721480|FG006|Overall Study|Participant died before treatment|0|||
146332187|NCT01827384|527721481|FG007|Overall Study|Participant died before treatment|0|||
146332188|NCT01827384|527721482|FG008|Overall Study|Participant died before treatment|0|||
146332189|NCT01827384|527721483|FG009|Overall Study|Participant died before treatment|0|||
146332190|NCT01827384|527721484|FG010|Overall Study|Participant died before treatment|0|||
146332191|NCT01827384|527721485|FG011|Overall Study|Participant died before treatment|0|||
146332192|NCT01827384|527721486|FG012|Overall Study|Participant died before treatment|0|||
146332193|NCT01827384|527721487|FG013|Overall Study|Participant died before treatment|5|||
146332194|NCT01827384|527721474|FG000|Overall Study|Insufficient tumor cells|0|||
146332195|NCT01827384|527721475|FG001|Overall Study|Insufficient tumor cells|0|||
146332196|NCT01827384|527721476|FG002|Overall Study|Insufficient tumor cells|0|||
146332197|NCT01827384|527721477|FG003|Overall Study|Insufficient tumor cells|0|||
146332198|NCT01827384|527721478|FG004|Overall Study|Insufficient tumor cells|0|||
146332199|NCT01827384|527721479|FG005|Overall Study|Insufficient tumor cells|0|||
146332200|NCT01827384|527721480|FG006|Overall Study|Insufficient tumor cells|0|||
146332201|NCT01827384|527721481|FG007|Overall Study|Insufficient tumor cells|0|||
146332202|NCT01827384|527721482|FG008|Overall Study|Insufficient tumor cells|0|||
146332203|NCT01827384|527721483|FG009|Overall Study|Insufficient tumor cells|0|||
146332204|NCT01827384|527721484|FG010|Overall Study|Insufficient tumor cells|0|||
146332205|NCT01827384|527721485|FG011|Overall Study|Insufficient tumor cells|0|||
146332206|NCT01827384|527721486|FG012|Overall Study|Insufficient tumor cells|0|||
146332207|NCT01827384|527721487|FG013|Overall Study|Insufficient tumor cells|13|||
146332208|NCT01827384|527721474|FG000|Overall Study|No actionable mutation|0|||
146332209|NCT01827384|527721475|FG001|Overall Study|No actionable mutation|0|||
146332210|NCT01827384|527721476|FG002|Overall Study|No actionable mutation|0|||
146332211|NCT01827384|527721477|FG003|Overall Study|No actionable mutation|0|||
146332212|NCT01827384|527721478|FG004|Overall Study|No actionable mutation|0|||
146332213|NCT01827384|527721479|FG005|Overall Study|No actionable mutation|0|||
146332214|NCT01827384|527721480|FG006|Overall Study|No actionable mutation|0|||
146332215|NCT01827384|527721481|FG007|Overall Study|No actionable mutation|0|||
146332216|NCT01827384|527721482|FG008|Overall Study|No actionable mutation|0|||
146332217|NCT01827384|527721483|FG009|Overall Study|No actionable mutation|0|||
146332218|NCT01827384|527721484|FG010|Overall Study|No actionable mutation|0|||
146332219|NCT01827384|527721485|FG011|Overall Study|No actionable mutation|0|||
146332220|NCT01827384|527721486|FG012|Overall Study|No actionable mutation|0|||
146332221|NCT01827384|527721487|FG013|Overall Study|No actionable mutation|73|||
146332222|NCT01827384|527721474|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
146332223|NCT01827384|527721475|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
146332224|NCT01827384|527721476|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
146332225|NCT01827384|527721477|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
146332226|NCT01827384|527721478|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
146332227|NCT01827384|527721479|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
146332228|NCT01827384|527721480|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
146332229|NCT01827384|527721481|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
146332230|NCT01827384|527721482|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
146332231|NCT01827384|527721483|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
146332232|NCT01827384|527721484|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
146332233|NCT01827384|527721485|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
146332234|NCT01827384|527721486|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
146332235|NCT01827384|527721487|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
146332236|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
146332237|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
146332238|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
146332239|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146332240|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146332241|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
146332242|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
146332243|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
146332244|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
146332245|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146332246|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146332247|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
146332248|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
146332249|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
146332250|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
146332251|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146332252|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146332253|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
146332254|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
146332255|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146332256|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146332257|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146332258|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146332259|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
146332260|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
146332261|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
146332262|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
146332263|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146332264|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146332265|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
146332266|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
146332267|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
146332268|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
146168097|NCT05267600|527128073|FG001|Overall Study|Death|2|||
146332269|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146332270|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146332271|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
146332272|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
146332273|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
146332274|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
146332275|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
146332276|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
146332277|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
146332278|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
146332279|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
146332280|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
146332281|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146332282|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146332283|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
146332284|NCT01707992|527721490|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
146332285|NCT01707992|527721491|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
146332286|NCT01707992|527721492|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
146332287|NCT01707992|527721493|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146332288|NCT01707992|527721494|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146332289|NCT01707992|527721495|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
146332290|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
146332291|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
146332292|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
146332293|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
146332294|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
146332295|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
146332296|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146332297|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146332298|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
146332299|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
146332300|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
146332301|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
146332302|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146332303|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146332304|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
146332305|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
146332306|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
146332307|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
146332308|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
146332309|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
146332310|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
146332311|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
146332312|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
146332313|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
146332314|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146332315|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146332316|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
146332317|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
146332318|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
146332319|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
146332320|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Death|0|||
146332321|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Death|0|||
146332322|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Death|0|||
146332323|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Death|2|||
146332324|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Death|0|||
146332325|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Death|0|||
146332326|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
146332327|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
146332328|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
146332329|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
146332330|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
146332331|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
146332332|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
146332333|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
146332334|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
146332335|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
146332336|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
146332337|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
146332338|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146332339|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146332340|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
146332341|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
146332342|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
146332343|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
146332344|NCT01707992|527721490|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146332345|NCT01707992|527721491|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146332346|NCT01707992|527721492|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146332347|NCT01707992|527721493|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146332348|NCT01707992|527721494|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
146332349|NCT01707992|527721495|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
146332350|NCT02029976|527723416|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
146332351|NCT02029976|527723417|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
146332352|NCT02029976|527723416|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
146332353|NCT02029976|527723417|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
146332354|NCT02029976|527723416|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
146332355|NCT02029976|527723417|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
146332356|NCT02029976|527723416|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
146332357|NCT02029976|527723417|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
146332358|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
146332359|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
146332360|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146332361|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146332362|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
146332363|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
146332364|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
146332365|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146332366|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146332367|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
146332368|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
146332369|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146332370|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146332371|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146332372|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
146332373|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146332374|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
146332375|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146332376|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146332377|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
146332378|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
146332379|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
146332380|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146332381|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146332382|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
146332383|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
146332384|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
146332385|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146332386|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146332387|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
146332388|NCT02660580|527723420|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
146332389|NCT02660580|527723421|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
146332390|NCT02660580|527723422|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146332391|NCT02660580|527723423|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146332392|NCT02660580|527723424|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
146332393|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146332394|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146332395|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
146332396|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
146332397|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
146332398|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146332399|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146332400|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
146332401|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
146332402|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
146332403|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
146332404|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
146332405|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
146332406|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
146332407|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
146332408|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
146332409|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
146332410|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
146332411|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
146332412|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
146332413|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
146332414|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
146332415|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
146332416|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
146332417|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
146332418|NCT02660580|527723420|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146332419|NCT02660580|527723421|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146332420|NCT02660580|527723422|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
146332421|NCT02660580|527723423|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
146332422|NCT02660580|527723424|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
146332423|NCT03124459|527723432|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146332424|NCT03124459|527723433|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146332425|NCT03124459|527723434|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146332426|NCT03124459|527723435|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146332427|NCT03124459|527723436|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
146332428|NCT03124459|527723437|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
146332429|NCT03124459|527723432|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146332430|NCT03124459|527723433|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146332431|NCT03124459|527723434|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146332432|NCT03124459|527723435|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146332433|NCT03124459|527723436|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
146332434|NCT03124459|527723437|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
146332435|NCT03124459|527723432|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146332436|NCT03124459|527723433|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146332437|NCT03124459|527723434|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146332438|NCT03124459|527723435|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
146332439|NCT03124459|527723436|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
146332440|NCT03124459|527723437|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
146332441|NCT03124459|527723432|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146332442|NCT03124459|527723433|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146332443|NCT03124459|527723434|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146332444|NCT03124459|527723435|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
146332445|NCT03124459|527723436|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
146332446|NCT03124459|527723437|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
146332447|NCT03124459|527723432|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146332448|NCT03124459|527723433|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146332449|NCT03124459|527723434|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146332450|NCT03124459|527723435|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146332451|NCT03124459|527723436|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
146332452|NCT03124459|527723437|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
146332453|NCT03124459|527723432|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146332454|NCT03124459|527723433|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146332455|NCT03124459|527723434|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146332456|NCT03124459|527723435|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146332457|NCT03124459|527723436|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
146332458|NCT03124459|527723437|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
146332459|NCT01028352|527723438|FG000|Overall Study|Ineligible due to baseline average pain|5|||
146332460|NCT01028352|527723438|FG000|Overall Study|Withdrawal by Subject|1|||
146332461|NCT01903876|527723439|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
146332462|NCT01903876|527723440|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
146332463|NCT01903876|527723439|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
146332464|NCT01903876|527723440|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
146332465|NCT02612909|527723441|FG000|Phase 2|Withdrawal by Subject|2|||
146332466|NCT02612909|527723442|FG001|Phase 2|Withdrawal by Subject|5|||
146332467|NCT02612909|527723443|FG002|Phase 2|Withdrawal by Subject|0|||
146332468|NCT02612909|527723444|FG003|Phase 2|Withdrawal by Subject|0|||
146332469|NCT02612909|527723445|FG004|Phase 2|Withdrawal by Subject|0|||
146332470|NCT02612909|527723441|FG000|Phase 2|Pregnancy|0|||
146332471|NCT02612909|527723442|FG001|Phase 2|Pregnancy|0|||
146332472|NCT02612909|527723443|FG002|Phase 2|Pregnancy|1|||
146332473|NCT02612909|527723444|FG003|Phase 2|Pregnancy|0|||
146332474|NCT02612909|527723445|FG004|Phase 2|Pregnancy|0|||
146332475|NCT02612909|527723441|FG000|Phase 3|Withdrawal by Subject|0|||
146332476|NCT02612909|527723442|FG001|Phase 3|Withdrawal by Subject|0|||
146332477|NCT02612909|527723443|FG002|Phase 3|Withdrawal by Subject|0|||
146332478|NCT02612909|527723444|FG003|Phase 3|Withdrawal by Subject|1|||
146332479|NCT02612909|527723445|FG004|Phase 3|Withdrawal by Subject|0|||
146332480|NCT00278629|527723446|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
146332481|NCT00826748|527723449|FG000|Overall Study|Withdrawal by Subject|0|||
146332482|NCT00826748|527723450|FG001|Overall Study|Withdrawal by Subject|0|||
146332483|NCT00826748|527723451|FG002|Overall Study|Withdrawal by Subject|2|||
146332484|NCT00826748|527723449|FG000|Overall Study|Physician Decision|0|||
146332485|NCT00826748|527723450|FG001|Overall Study|Physician Decision|0|||
146332486|NCT00826748|527723451|FG002|Overall Study|Physician Decision|1|||
146332487|NCT00826748|527723449|FG000|Overall Study|Samples Did Not pass QC|0|||
146332488|NCT00826748|527723450|FG001|Overall Study|Samples Did Not pass QC|0|||
146332489|NCT00826748|527723451|FG002|Overall Study|Samples Did Not pass QC|1|||
146332490|NCT05224258|527723454|FG000|Overall Study|Withdrawal by Subject|1|||
146332491|NCT05224258|527723455|FG001|Overall Study|Withdrawal by Subject|1|||
146332492|NCT05224258|527723454|FG000|Overall Study|Physician Decision|1|||
146332493|NCT05224258|527723455|FG001|Overall Study|Physician Decision|1|||
146332494|NCT05224258|527723454|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146332495|NCT05224258|527723455|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146332496|NCT05224258|527723454|FG000|Overall Study|Study Product No Longer in Use|1|||
146332497|NCT05224258|527723455|FG001|Overall Study|Study Product No Longer in Use|0|||
146332498|NCT05224258|527723454|FG000|Overall Study|Adverse Event|0|||
146332499|NCT05224258|527723455|FG001|Overall Study|Adverse Event|1|||
146332500|NCT05224258|527723454|FG000|Overall Study|Protocol Deviation|0|||
146332501|NCT05224258|527723455|FG001|Overall Study|Protocol Deviation|1|||
146332502|NCT05067127|527723456|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146332503|NCT05067127|527723457|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
146332504|NCT05067127|527723458|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146332505|NCT05067127|527723459|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
146332506|NCT05067127|527723456|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146332507|NCT05067127|527723457|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
146332508|NCT05067127|527723458|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146332509|NCT05067127|527723459|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
146332510|NCT05067127|527723456|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
146332511|NCT05067127|527723457|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146332512|NCT05067127|527723458|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146332513|NCT05067127|527723459|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146332514|NCT05067127|527723456|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146332515|NCT05067127|527723457|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
146332516|NCT05067127|527723458|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146332517|NCT05067127|527723459|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
146332518|NCT05067127|527723456|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
146332519|NCT05067127|527723457|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
146332520|NCT05067127|527723458|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
146332521|NCT05067127|527723459|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
146332522|NCT05067127|527723456|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146332523|NCT05067127|527723457|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146332524|NCT05067127|527723458|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
146332525|NCT05067127|527723459|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
146332526|NCT05067127|527723456|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146332527|NCT05067127|527723457|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
146332528|NCT05067127|527723458|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
146332529|NCT05067127|527723459|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
146332530|NCT04462536|527723460|FG000|Overall Study|Withdrawal by Subject|3|||
146332531|NCT04462536|527723461|FG001|Overall Study|Withdrawal by Subject|9|||
146332532|NCT04462536|527723460|FG000|Overall Study|Lost to Follow-up|2|||
146332533|NCT04462536|527723461|FG001|Overall Study|Lost to Follow-up|4|||
146332534|NCT00391976|527723462|FG000|Overall Study|Adverse Event|0|||
146332535|NCT00391976|527723463|FG001|Overall Study|Adverse Event|0|||
146332536|NCT00391976|527723464|FG002|Overall Study|Adverse Event|1|||
146332537|NCT00391976|527723462|FG000|Overall Study|Withdrawal of consent|0|||
146332538|NCT00391976|527723463|FG001|Overall Study|Withdrawal of consent|1|||
146332539|NCT00391976|527723464|FG002|Overall Study|Withdrawal of consent|1|||
146332540|NCT00391976|527723462|FG000|Overall Study|Lost to Follow-up|1|||
146332541|NCT00391976|527723463|FG001|Overall Study|Lost to Follow-up|2|||
146332542|NCT00391976|527723464|FG002|Overall Study|Lost to Follow-up|0|||
146332543|NCT00391976|527723462|FG000|Overall Study|Inappropriate enrollment|1|||
146332544|NCT00391976|527723463|FG001|Overall Study|Inappropriate enrollment|1|||
146332545|NCT00391976|527723464|FG002|Overall Study|Inappropriate enrollment|0|||
146332546|NCT00391976|527723462|FG000|Overall Study|Protocol deviation/violation|4|||
146332547|NCT00391976|527723463|FG001|Overall Study|Protocol deviation/violation|2|||
146332548|NCT00391976|527723464|FG002|Overall Study|Protocol deviation/violation|1|||
146332549|NCT00391976|527723462|FG000|Overall Study|Recurrence/no eradication of infection|21|||
146332550|NCT00391976|527723463|FG001|Overall Study|Recurrence/no eradication of infection|19|||
146332551|NCT00391976|527723464|FG002|Overall Study|Recurrence/no eradication of infection|0|||
146332552|NCT00391976|527723462|FG000|Overall Study|Unable to classify|0|||
146332553|NCT00391976|527723463|FG001|Overall Study|Unable to classify|0|||
146332554|NCT00391976|527723464|FG002|Overall Study|Unable to classify|1|||
146332555|NCT00391976|527723462|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
146332556|NCT00391976|527723463|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
146332557|NCT00391976|527723464|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
146332558|NCT02601950|527723468|FG000|Overall Study|Participant enrolled in rollover study|0|||
146332559|NCT02601950|527723469|FG001|Overall Study|Participant enrolled in rollover study|0|||
146332560|NCT02601950|527723470|FG002|Overall Study|Participant enrolled in rollover study|1|||
146332561|NCT02601950|527723471|FG003|Overall Study|Participant enrolled in rollover study|0|||
146332562|NCT02601950|527723472|FG004|Overall Study|Participant enrolled in rollover study|1|||
146332563|NCT02601950|527723473|FG005|Overall Study|Participant enrolled in rollover study|1|||
146332564|NCT02601950|527723474|FG006|Overall Study|Participant enrolled in rollover study|1|||
146332565|NCT02601950|527723475|FG007|Overall Study|Participant enrolled in rollover study|0|||
146332566|NCT02601950|527723468|FG000|Overall Study|Disease progression - radiological|21|||
146332567|NCT02601950|527723469|FG001|Overall Study|Disease progression - radiological|26|||
146332568|NCT02601950|527723470|FG002|Overall Study|Disease progression - radiological|22|||
146332569|NCT02601950|527723471|FG003|Overall Study|Disease progression - radiological|11|||
146332570|NCT02601950|527723472|FG004|Overall Study|Disease progression - radiological|46|||
146332571|NCT02601950|527723473|FG005|Overall Study|Disease progression - radiological|52|||
146332572|NCT02601950|527723474|FG006|Overall Study|Disease progression - radiological|7|||
146332573|NCT02601950|527723475|FG007|Overall Study|Disease progression - radiological|5|||
146332574|NCT02601950|527723468|FG000|Overall Study|Disease progression - clinical|3|||
146332575|NCT02601950|527723469|FG001|Overall Study|Disease progression - clinical|5|||
146332576|NCT02601950|527723470|FG002|Overall Study|Disease progression - clinical|4|||
146332577|NCT02601950|527723471|FG003|Overall Study|Disease progression - clinical|2|||
146332578|NCT02601950|527723472|FG004|Overall Study|Disease progression - clinical|6|||
146332579|NCT02601950|527723473|FG005|Overall Study|Disease progression - clinical|6|||
146332580|NCT02601950|527723474|FG006|Overall Study|Disease progression - clinical|5|||
146332581|NCT02601950|527723475|FG007|Overall Study|Disease progression - clinical|1|||
146332582|NCT02601950|527723468|FG000|Overall Study|Death|6|||
146332583|NCT02601950|527723469|FG001|Overall Study|Death|0|||
146332584|NCT02601950|527723470|FG002|Overall Study|Death|3|||
146332585|NCT02601950|527723471|FG003|Overall Study|Death|1|||
146332586|NCT02601950|527723472|FG004|Overall Study|Death|4|||
146332587|NCT02601950|527723473|FG005|Overall Study|Death|1|||
146332588|NCT02601950|527723474|FG006|Overall Study|Death|0|||
146332589|NCT02601950|527723475|FG007|Overall Study|Death|0|||
146332590|NCT02601950|527723468|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332591|NCT02601950|527723469|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332592|NCT02601950|527723470|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332593|NCT02601950|527723471|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332594|NCT02601950|527723472|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332595|NCT02601950|527723473|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
146332596|NCT02601950|527723474|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332597|NCT02601950|527723475|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
146332598|NCT02601950|527723468|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
146332599|NCT02601950|527723469|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
146332600|NCT02601950|527723470|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
146332601|NCT02601950|527723471|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
146332602|NCT02601950|527723472|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
146332603|NCT02601950|527723473|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
146332604|NCT02601950|527723474|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
146332605|NCT02601950|527723475|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
146332606|NCT02601950|527723468|FG000|Overall Study|Non-compliance|0|||
146332607|NCT02601950|527723469|FG001|Overall Study|Non-compliance|1|||
146332608|NCT02601950|527723470|FG002|Overall Study|Non-compliance|0|||
146332609|NCT02601950|527723471|FG003|Overall Study|Non-compliance|0|||
146332610|NCT02601950|527723472|FG004|Overall Study|Non-compliance|0|||
146332611|NCT02601950|527723473|FG005|Overall Study|Non-compliance|1|||
146332612|NCT02601950|527723474|FG006|Overall Study|Non-compliance|1|||
146332613|NCT02601950|527723475|FG007|Overall Study|Non-compliance|0|||
146332614|NCT02601950|527723468|FG000|Overall Study|Participant refused further study treatment|0|||
146332615|NCT02601950|527723469|FG001|Overall Study|Participant refused further study treatment|1|||
146332616|NCT02601950|527723470|FG002|Overall Study|Participant refused further study treatment|1|||
146332617|NCT02601950|527723471|FG003|Overall Study|Participant refused further study treatment|0|||
146332618|NCT02601950|527723472|FG004|Overall Study|Participant refused further study treatment|2|||
146332619|NCT02601950|527723473|FG005|Overall Study|Participant refused further study treatment|2|||
146332620|NCT02601950|527723474|FG006|Overall Study|Participant refused further study treatment|2|||
146332621|NCT02601950|527723475|FG007|Overall Study|Participant refused further study treatment|1|||
146332622|NCT02601950|527723468|FG000|Overall Study|Investigator discretion|1|||
146332623|NCT02601950|527723469|FG001|Overall Study|Investigator discretion|0|||
146332624|NCT02601950|527723470|FG002|Overall Study|Investigator discretion|1|||
146332625|NCT02601950|527723471|FG003|Overall Study|Investigator discretion|0|||
146332626|NCT02601950|527723472|FG004|Overall Study|Investigator discretion|1|||
146332627|NCT02601950|527723473|FG005|Overall Study|Investigator discretion|1|||
146332628|NCT02601950|527723474|FG006|Overall Study|Investigator discretion|1|||
146332629|NCT02601950|527723475|FG007|Overall Study|Investigator discretion|0|||
146332630|NCT02601950|527723468|FG000|Overall Study|Other|0|||
146332631|NCT02601950|527723469|FG001|Overall Study|Other|0|||
146332632|NCT02601950|527723470|FG002|Overall Study|Other|0|||
146332633|NCT02601950|527723471|FG003|Overall Study|Other|0|||
146332634|NCT02601950|527723472|FG004|Overall Study|Other|2|||
146332635|NCT02601950|527723473|FG005|Overall Study|Other|2|||
146332636|NCT02601950|527723474|FG006|Overall Study|Other|1|||
146332637|NCT02601950|527723475|FG007|Overall Study|Other|0|||
146332638|NCT05113940|527723476|FG000|Part A (18 Days)|Adverse Event|0|||
146332639|NCT05113940|527723477|FG001|Part A (18 Days)|Adverse Event|0|||
146332640|NCT05113940|527723478|FG002|Part A (18 Days)|Adverse Event|1|||
146332641|NCT05113940|527723479|FG003|Part A (18 Days)|Adverse Event|1|||
146332642|NCT05113940|527723480|FG004|Part A (18 Days)|Adverse Event|1|||
146332643|NCT05113940|527723481|FG005|Part A (18 Days)|Adverse Event|0|||
146332644|NCT05113940|527723482|FG006|Part A (18 Days)|Adverse Event|0|||
146332645|NCT05113940|527723483|FG007|Part A (18 Days)|Adverse Event|0|||
146332646|NCT05113940|527723484|FG008|Part A (18 Days)|Adverse Event|0|||
146332647|NCT05113940|527723485|FG009|Part A (18 Days)|Adverse Event|0|||
146332648|NCT05113940|527723486|FG010|Part A (18 Days)|Adverse Event|0|||
146332649|NCT05113940|527723487|FG011|Part A (18 Days)|Adverse Event|2|||
146332650|NCT05113940|527723488|FG012|Part A (18 Days)|Adverse Event|0|||
146332651|NCT05113940|527723489|FG013|Part A (18 Days)|Adverse Event|0|||
146332652|NCT05113940|527723490|FG014|Part A (18 Days)|Adverse Event|0|||
146332653|NCT05113940|527723476|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332654|NCT05113940|527723477|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332655|NCT05113940|527723478|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332656|NCT05113940|527723479|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332657|NCT05113940|527723480|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332658|NCT05113940|527723481|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332659|NCT05113940|527723482|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332660|NCT05113940|527723483|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332661|NCT05113940|527723484|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332662|NCT05113940|527723485|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332663|NCT05113940|527723486|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332664|NCT05113940|527723487|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332665|NCT05113940|527723488|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332666|NCT05113940|527723489|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
146332667|NCT05113940|527723490|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
146332668|NCT00826514|527723493|FG000|Overall Study|Adverse Event|1|||
146332669|NCT00826514|527723494|FG001|Overall Study|Adverse Event|1|||
146332670|NCT00826514|527723493|FG000|Overall Study|Lack of Efficacy|0|||
146332671|NCT00826514|527723494|FG001|Overall Study|Lack of Efficacy|1|||
146332672|NCT00826514|527723493|FG000|Overall Study|Withdrawal by Subject|2|||
146332673|NCT00826514|527723494|FG001|Overall Study|Withdrawal by Subject|3|||
146332674|NCT01085682|527723495|FG000|Overall Study|Withdrawal by Subject|25|||
146332675|NCT01085682|527723496|FG001|Overall Study|Withdrawal by Subject|25|||
146332676|NCT01451645|527723497|FG000|Overall Study|Protocol Violation|1|||
146332677|NCT01451645|527723498|FG001|Overall Study|Protocol Violation|0|||
146332678|NCT01451645|527723497|FG000|Overall Study|Adverse Event|0|||
146332679|NCT01451645|527723498|FG001|Overall Study|Adverse Event|3|||
146332680|NCT01451645|527723497|FG000|Overall Study|Withdrawal by Subject|4|||
146332681|NCT01451645|527723498|FG001|Overall Study|Withdrawal by Subject|2|||
146332682|NCT01451645|527723497|FG000|Overall Study|Lost to Follow-up|4|||
146332683|NCT01451645|527723498|FG001|Overall Study|Lost to Follow-up|3|||
146332684|NCT00629083|527723503|FG000|Overall Study|Adverse Event|0|||
146332685|NCT00629083|527723504|FG001|Overall Study|Adverse Event|2|||
146332686|NCT00629083|527723503|FG000|Overall Study|Lack of Efficacy|3|||
146332687|NCT00629083|527723504|FG001|Overall Study|Lack of Efficacy|1|||
146332688|NCT00629083|527723503|FG000|Overall Study|Withdrawal by Subject|10|||
146332689|NCT00629083|527723504|FG001|Overall Study|Withdrawal by Subject|2|||
146332690|NCT00629083|527723503|FG000|Overall Study|Lost to Follow-up|12|||
146332691|NCT00629083|527723504|FG001|Overall Study|Lost to Follow-up|8|||
146332692|NCT00629083|527723503|FG000|Overall Study|Moved out of country/state|2|||
146332693|NCT00629083|527723504|FG001|Overall Study|Moved out of country/state|1|||
146332694|NCT00629083|527723503|FG000|Overall Study|Refused to return for 12 month visit|1|||
146332695|NCT00629083|527723504|FG001|Overall Study|Refused to return for 12 month visit|0|||
146332696|NCT01193686|527723505|FG000|Overall Study|Withdrawal by Subject|4|||
146332697|NCT01193686|527723506|FG001|Overall Study|Withdrawal by Subject|1|||
146332698|NCT01193686|527723505|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
146332699|NCT01193686|527723506|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
146332700|NCT03401749|527723507|FG000|Overall Study|Lost to Follow-up|20|||
146332701|NCT03401749|527723508|FG001|Overall Study|Lost to Follow-up|16|||
146332702|NCT03401749|527723509|FG002|Overall Study|Lost to Follow-up|26|||
146332703|NCT01147809|527723512|FG000|Phase I (168 Days)|Adverse Event|0|||
146332704|NCT01147809|527723513|FG001|Phase I (168 Days)|Adverse Event|0|||
146332705|NCT01147809|527723514|FG002|Phase I (168 Days)|Adverse Event|0|||
146332706|NCT01147809|527723515|FG003|Phase I (168 Days)|Adverse Event|1|||
146332707|NCT01147809|527723516|FG004|Phase I (168 Days)|Adverse Event|0|||
146332708|NCT01147809|527723517|FG005|Phase I (168 Days)|Adverse Event|0|||
146332709|NCT01147809|527723512|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
146332710|NCT01147809|527723513|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
146332711|NCT01147809|527723514|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
146332712|NCT01147809|527723515|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
146332713|NCT01147809|527723516|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
146332714|NCT01147809|527723517|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
146332715|NCT01147809|527723512|FG000|Phase I (168 Days)|Physician Decision|0|||
146332716|NCT01147809|527723513|FG001|Phase I (168 Days)|Physician Decision|1|||
146332717|NCT01147809|527723514|FG002|Phase I (168 Days)|Physician Decision|2|||
146332718|NCT01147809|527723515|FG003|Phase I (168 Days)|Physician Decision|0|||
146332719|NCT01147809|527723516|FG004|Phase I (168 Days)|Physician Decision|0|||
146332720|NCT01147809|527723517|FG005|Phase I (168 Days)|Physician Decision|0|||
146332721|NCT01147809|527723512|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
146332722|NCT01147809|527723513|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
146332723|NCT01147809|527723514|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
146332724|NCT01147809|527723515|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
146332725|NCT01147809|527723516|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
146332726|NCT01147809|527723517|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
146332727|NCT01147809|527723512|FG000|Phase II (168 Days)|Adverse Event|0|||
146332728|NCT01147809|527723513|FG001|Phase II (168 Days)|Adverse Event|0|||
146332729|NCT01147809|527723514|FG002|Phase II (168 Days)|Adverse Event|0|||
146332730|NCT01147809|527723515|FG003|Phase II (168 Days)|Adverse Event|0|||
146332731|NCT01147809|527723516|FG004|Phase II (168 Days)|Adverse Event|3|||
146332732|NCT01147809|527723517|FG005|Phase II (168 Days)|Adverse Event|6|||
146332733|NCT01147809|527723512|FG000|Phase II (168 Days)|Protocol Violation|0|||
146332734|NCT01147809|527723513|FG001|Phase II (168 Days)|Protocol Violation|0|||
146332735|NCT01147809|527723514|FG002|Phase II (168 Days)|Protocol Violation|0|||
146332736|NCT01147809|527723515|FG003|Phase II (168 Days)|Protocol Violation|0|||
146332737|NCT01147809|527723516|FG004|Phase II (168 Days)|Protocol Violation|0|||
146332738|NCT01147809|527723517|FG005|Phase II (168 Days)|Protocol Violation|1|||
146332739|NCT01147809|527723512|FG000|Phase II (168 Days)|Physician Decision|0|||
146332740|NCT01147809|527723513|FG001|Phase II (168 Days)|Physician Decision|0|||
146332741|NCT01147809|527723514|FG002|Phase II (168 Days)|Physician Decision|0|||
146332742|NCT01147809|527723515|FG003|Phase II (168 Days)|Physician Decision|0|||
146332743|NCT01147809|527723516|FG004|Phase II (168 Days)|Physician Decision|5|||
146332744|NCT01147809|527723517|FG005|Phase II (168 Days)|Physician Decision|11|||
146332745|NCT01147809|527723512|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
146332746|NCT01147809|527723513|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
146332747|NCT01147809|527723514|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
146332748|NCT01147809|527723515|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
146332749|NCT01147809|527723516|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
146332750|NCT01147809|527723517|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
146332751|NCT01147809|527723512|FG000|Phase II (168 Days)|Ongoing|0|||
146332752|NCT01147809|527723513|FG001|Phase II (168 Days)|Ongoing|0|||
146332753|NCT01147809|527723514|FG002|Phase II (168 Days)|Ongoing|0|||
146332754|NCT01147809|527723515|FG003|Phase II (168 Days)|Ongoing|0|||
146332755|NCT01147809|527723516|FG004|Phase II (168 Days)|Ongoing|1|||
146332756|NCT01147809|527723517|FG005|Phase II (168 Days)|Ongoing|0|||
146332757|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146332758|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
146332759|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
146332760|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332761|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332762|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332763|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332764|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332765|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
146332766|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
146332767|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
146332768|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
146332769|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332770|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332771|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332772|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332773|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332774|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
146332775|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
146332776|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
146332777|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
146332778|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332779|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332780|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332781|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332782|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332783|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
146332784|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332785|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332786|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
146332787|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332788|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332789|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332790|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332791|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332792|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
146332793|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
146332794|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
146332795|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
146332796|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332797|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332798|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332799|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332800|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332801|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
146332802|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
146332803|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332804|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332805|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332806|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332807|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332808|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332809|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332810|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
146332811|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
146332812|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
146332813|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332814|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332815|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332816|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332817|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332818|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146332819|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
146168098|NCT05267600|527128072|FG000|Overall Study|Lack of Efficacy|1|||
146168099|NCT05267600|527128073|FG001|Overall Study|Lack of Efficacy|2|||
146168100|NCT05267600|527128072|FG000|Overall Study|Lost to Follow-up|3|||
146332820|NCT01307423|527723518|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332821|NCT01307423|527723519|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
146332822|NCT01307423|527723520|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
146332823|NCT01307423|527723521|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332824|NCT01307423|527723522|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332825|NCT01307423|527723523|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332826|NCT01307423|527723524|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332827|NCT01307423|527723525|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332828|NCT01307423|527723526|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
146332829|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146332830|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
146332831|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146332832|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146332833|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
146332834|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146332835|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146332836|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146332837|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
146332838|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146332839|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
146332840|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
146332841|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
146332842|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
146332843|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146332844|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146332845|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146332846|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
146332847|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332848|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332849|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332850|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332851|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332852|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
146332853|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332854|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332855|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
146332856|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146332857|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
146332858|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
146332859|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146332860|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146332861|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
146332862|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
146332863|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146332864|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
146332865|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332866|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332867|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332868|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
146332869|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332870|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332871|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332872|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332873|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
146332874|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
146332875|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
146332876|NCT01307423|527723520|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
146332877|NCT01307423|527723521|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
146332878|NCT01307423|527723522|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
146332879|NCT01307423|527723523|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
146332880|NCT01307423|527723524|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
146332881|NCT01307423|527723525|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
146332882|NCT01307423|527723526|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
146332883|NCT01307423|527723518|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146332884|NCT01307423|527723519|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
146332902|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
146332903|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
146332904|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146332905|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146332906|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146332907|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
146332908|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
146332909|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
146332910|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332911|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332912|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
146332913|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332914|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332915|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332916|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332917|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332918|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
146332919|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146332920|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
146332921|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
146332922|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146332923|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146332924|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146332925|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
146332926|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
146332927|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
146332928|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332929|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146332930|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332931|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332932|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332933|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332934|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
146332935|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146332936|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
146332937|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146332938|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
146332939|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
146332940|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146332941|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146332942|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146332943|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
146332944|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
146332945|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
146332946|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146332947|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146332948|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
146332949|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146332950|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146332951|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146332952|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
146332953|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
146332954|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
146332955|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332956|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
146332957|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
146332958|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332959|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332960|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332961|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332962|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146168415|NCT03217747|527128137|FG012|Overall Study|Withdrawal by Subject|0|||
146332963|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
146332964|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146332965|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
146332966|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
146332967|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146168416|NCT03217747|527128138|FG013|Overall Study|Withdrawal by Subject|1|||
146168417|NCT03217747|527128125|FG000|Overall Study|Toxicity and progression|1|||
146168418|NCT03217747|527128126|FG001|Overall Study|Toxicity and progression|0|||
146168419|NCT03217747|527128127|FG002|Overall Study|Toxicity and progression|0|||
146168420|NCT03217747|527128128|FG003|Overall Study|Toxicity and progression|0|||
146332968|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146332969|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146332970|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
146332971|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
146332972|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
146332973|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146332974|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
146332975|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
146332976|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146332977|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146332978|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146332979|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
146332980|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146332981|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
146332982|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332983|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146332984|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332985|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332986|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332987|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332988|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332989|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
146332990|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
146332991|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332992|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
146332993|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332994|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332995|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332996|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332997|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332998|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146332999|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
146333000|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333001|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146333002|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333003|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333004|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333005|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333006|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333007|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
146333008|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
146333009|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146333010|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
146333011|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146333012|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146333013|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146333014|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146333015|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
146333016|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
146333017|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
146333018|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333019|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333020|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
146333021|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333022|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333023|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333024|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333025|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333026|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
146333027|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333028|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333029|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146168421|NCT03217747|527128129|FG004|Overall Study|Toxicity and progression|0|||
146168422|NCT03217747|527128130|FG005|Overall Study|Toxicity and progression|0|||
146333030|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333031|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333032|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333033|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333034|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
146333035|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
146333036|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333037|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146333038|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146333039|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333040|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333041|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333042|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333043|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
146333044|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
146333045|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333046|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
146333047|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
146333048|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333049|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333050|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333051|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333052|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333053|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
146333054|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333055|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
146333056|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
146333057|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333058|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333059|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333060|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333061|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
146333062|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
146333063|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333064|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
146333065|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333066|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333067|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333068|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333069|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333070|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333071|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
146333072|NCT01307423|527723518|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333073|NCT01307423|527723519|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333074|NCT01307423|527723520|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
146333075|NCT01307423|527723521|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333076|NCT01307423|527723522|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333077|NCT01307423|527723523|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333078|NCT01307423|527723524|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
146333079|NCT01307423|527723525|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
146333080|NCT01307423|527723526|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
146333081|NCT03406962|527723527|FG000|Overall Study|Death|2|||
146333082|NCT03406962|527723527|FG000|Overall Study|Adverse Event|1|||
146333083|NCT03853694|527723528|FG000|Overall Study|Protocol Violation|3|||
146333084|NCT03853694|527723529|FG001|Overall Study|Protocol Violation|5|||
146333085|NCT03853694|527723530|FG002|Overall Study|Protocol Violation|3|||
146333086|NCT03853694|527723528|FG000|Overall Study|Delivered early|0|||
146333087|NCT03853694|527723529|FG001|Overall Study|Delivered early|1|||
146333088|NCT03853694|527723530|FG002|Overall Study|Delivered early|0|||
146333089|NCT03853694|527723528|FG000|Overall Study|not suitable to proceed|0|||
146333090|NCT03853694|527723529|FG001|Overall Study|not suitable to proceed|1|||
146333091|NCT03853694|527723530|FG002|Overall Study|not suitable to proceed|0|||
146333092|NCT03853694|527723528|FG000|Overall Study|difficult surgery|0|||
146333093|NCT03853694|527723529|FG001|Overall Study|difficult surgery|0|||
146333094|NCT03853694|527723530|FG002|Overall Study|difficult surgery|1|||
146333095|NCT03853694|527723528|FG000|Overall Study|Lost to Follow-up|0|||
146333096|NCT03853694|527723529|FG001|Overall Study|Lost to Follow-up|1|||
146333097|NCT03853694|527723530|FG002|Overall Study|Lost to Follow-up|0|||
146333098|NCT03853694|527723528|FG000|Overall Study|Withdrawal by Subject|0|||
146333099|NCT03853694|527723529|FG001|Overall Study|Withdrawal by Subject|1|||
146333100|NCT03853694|527723530|FG002|Overall Study|Withdrawal by Subject|0|||
146333101|NCT02209766|527723531|FG000|Overall Study|Withdrawal by Subject|0|||
146333102|NCT02209766|527723532|FG001|Overall Study|Withdrawal by Subject|0|||
146333103|NCT02209766|527723533|FG002|Overall Study|Withdrawal by Subject|0|||
146333104|NCT02209766|527723534|FG003|Overall Study|Withdrawal by Subject|1|||
146333105|NCT02209766|527723535|FG004|Overall Study|Withdrawal by Subject|0|||
146333106|NCT00064701|527723536|FG000|One Year Post-transplant|Did not receive study drug|7|||
146333107|NCT00064701|527723537|FG001|One Year Post-transplant|Did not receive study drug|12|||
146333108|NCT00064701|527723538|FG002|One Year Post-transplant|Did not receive study drug|11|||
146333109|NCT00064701|527723536|FG000|One Year Post-transplant|Adverse Event|23|||
146333110|NCT00064701|527723537|FG001|One Year Post-transplant|Adverse Event|19|||
146333111|NCT00064701|527723538|FG002|One Year Post-transplant|Adverse Event|37|||
146333112|NCT00064701|527723536|FG000|One Year Post-transplant|Rejection|0|||
146333113|NCT00064701|527723537|FG001|One Year Post-transplant|Rejection|1|||
146333114|NCT00064701|527723538|FG002|One Year Post-transplant|Rejection|16|||
146333115|NCT00064701|527723536|FG000|One Year Post-transplant|Non-compliance|4|||
146333116|NCT00064701|527723537|FG001|One Year Post-transplant|Non-compliance|2|||
146333117|NCT00064701|527723538|FG002|One Year Post-transplant|Non-compliance|5|||
146333118|NCT00064701|527723536|FG000|One Year Post-transplant|Graft Failure|3|||
146333119|NCT00064701|527723537|FG001|One Year Post-transplant|Graft Failure|2|||
146333120|NCT00064701|527723538|FG002|One Year Post-transplant|Graft Failure|1|||
146168423|NCT03217747|527128131|FG006|Overall Study|Toxicity and progression|0|||
146168424|NCT03217747|527128132|FG007|Overall Study|Toxicity and progression|0|||
146168425|NCT03217747|527128133|FG008|Overall Study|Toxicity and progression|0|||
146168426|NCT03217747|527128134|FG009|Overall Study|Toxicity and progression|0|||
146168427|NCT03217747|527128135|FG010|Overall Study|Toxicity and progression|0|||
146168428|NCT03217747|527128136|FG011|Overall Study|Toxicity and progression|0|||
146168429|NCT03217747|527128137|FG012|Overall Study|Toxicity and progression|0|||
146168430|NCT03217747|527128138|FG013|Overall Study|Toxicity and progression|0|||
146168431|NCT03217747|527128125|FG000|Overall Study|Removal of sole target lesion|1|||
146168432|NCT03217747|527128126|FG001|Overall Study|Removal of sole target lesion|0|||
146168433|NCT03217747|527128127|FG002|Overall Study|Removal of sole target lesion|0|||
146168434|NCT03217747|527128128|FG003|Overall Study|Removal of sole target lesion|0|||
146168435|NCT03217747|527128129|FG004|Overall Study|Removal of sole target lesion|0|||
146168436|NCT03217747|527128130|FG005|Overall Study|Removal of sole target lesion|0|||
146168437|NCT03217747|527128131|FG006|Overall Study|Removal of sole target lesion|0|||
146168438|NCT03217747|527128132|FG007|Overall Study|Removal of sole target lesion|0|||
146168439|NCT03217747|527128133|FG008|Overall Study|Removal of sole target lesion|0|||
146168440|NCT03217747|527128134|FG009|Overall Study|Removal of sole target lesion|0|||
146168441|NCT03217747|527128135|FG010|Overall Study|Removal of sole target lesion|0|||
146168442|NCT03217747|527128136|FG011|Overall Study|Removal of sole target lesion|0|||
146168443|NCT03217747|527128137|FG012|Overall Study|Removal of sole target lesion|0|||
146168444|NCT03217747|527128138|FG013|Overall Study|Removal of sole target lesion|0|||
146168445|NCT03217747|527128125|FG000|Overall Study|Stroke|0|||
146168446|NCT03217747|527128126|FG001|Overall Study|Stroke|0|||
146168447|NCT03217747|527128127|FG002|Overall Study|Stroke|0|||
146168448|NCT03217747|527128128|FG003|Overall Study|Stroke|0|||
146168449|NCT03217747|527128129|FG004|Overall Study|Stroke|0|||
146168450|NCT03217747|527128130|FG005|Overall Study|Stroke|1|||
146168451|NCT03217747|527128131|FG006|Overall Study|Stroke|0|||
146168452|NCT03217747|527128132|FG007|Overall Study|Stroke|0|||
146168453|NCT03217747|527128133|FG008|Overall Study|Stroke|0|||
146168454|NCT03217747|527128134|FG009|Overall Study|Stroke|0|||
146168455|NCT03217747|527128135|FG010|Overall Study|Stroke|0|||
146168456|NCT03217747|527128136|FG011|Overall Study|Stroke|1|||
146168457|NCT03217747|527128137|FG012|Overall Study|Stroke|0|||
146168458|NCT03217747|527128138|FG013|Overall Study|Stroke|0|||
146168459|NCT03996291|527128139|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
146168460|NCT03996291|527128140|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
146168461|NCT03996291|527128141|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
146168462|NCT03996291|527128142|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
146168463|NCT03996291|527128143|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
146168464|NCT03996291|527128144|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
146168465|NCT03996291|527128145|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
146168466|NCT03996291|527128146|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
146168467|NCT03996291|527128139|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168468|NCT03996291|527128140|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168469|NCT03996291|527128141|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168470|NCT03996291|527128142|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168471|NCT03996291|527128143|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168472|NCT03996291|527128144|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
146168473|NCT03996291|527128145|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
146333121|NCT00064701|527723536|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
146333122|NCT00064701|527723537|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
146333123|NCT00064701|527723538|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
146168474|NCT03996291|527128146|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
146168475|NCT03996291|527128139|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168476|NCT03996291|527128140|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168477|NCT03996291|527128141|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168478|NCT03996291|527128142|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168479|NCT03996291|527128143|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
146168480|NCT03996291|527128144|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168481|NCT03996291|527128145|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
146168482|NCT03996291|527128146|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
146168483|NCT03996291|527128139|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
146168484|NCT03996291|527128140|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
146168485|NCT03996291|527128141|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
146168486|NCT03996291|527128142|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
146168487|NCT03996291|527128143|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
146168488|NCT03996291|527128144|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
146168489|NCT03996291|527128145|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
146168490|NCT03996291|527128146|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
146168491|NCT03996291|527128139|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168492|NCT03996291|527128140|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168493|NCT03996291|527128141|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168494|NCT03996291|527128142|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168495|NCT03996291|527128143|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
146168496|NCT03996291|527128144|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168497|NCT03996291|527128145|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168498|NCT03996291|527128146|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
146168499|NCT03248375|527128147|FG000|Overall Study|Lost to Follow-up|5|||
146168500|NCT04098250|527128148|FG000|Overall Study|Withdrawal by Subject|1|||
146168501|NCT04098250|527128149|FG001|Overall Study|Withdrawal by Subject|0|||
146168502|NCT04098250|527128148|FG000|Overall Study|Lost to Follow-up|0|||
146168503|NCT04098250|527128149|FG001|Overall Study|Lost to Follow-up|1|||
146168504|NCT00394355|527128150|FG000|Overall Study|Adverse Event|10|||
146168505|NCT00394355|527128151|FG001|Overall Study|Adverse Event|6|||
146168506|NCT00394355|527128152|FG002|Overall Study|Adverse Event|7|||
146168507|NCT00394355|527128153|FG003|Overall Study|Adverse Event|8|||
146168508|NCT00394355|527128150|FG000|Overall Study|Did not meet protocol eligibility|1|||
146168509|NCT00394355|527128151|FG001|Overall Study|Did not meet protocol eligibility|5|||
146168510|NCT00394355|527128152|FG002|Overall Study|Did not meet protocol eligibility|4|||
146168511|NCT00394355|527128153|FG003|Overall Study|Did not meet protocol eligibility|2|||
146168512|NCT00394355|527128150|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
146168513|NCT00394355|527128151|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
146168514|NCT00394355|527128152|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
146168515|NCT00394355|527128153|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
146168516|NCT00394355|527128150|FG000|Overall Study|Subject withdrawal - related to drug|1|||
146168517|NCT00394355|527128151|FG001|Overall Study|Subject withdrawal - related to drug|0|||
146168518|NCT00394355|527128152|FG002|Overall Study|Subject withdrawal - related to drug|0|||
146168519|NCT00394355|527128153|FG003|Overall Study|Subject withdrawal - related to drug|0|||
146168520|NCT00394355|527128150|FG000|Overall Study|Lost to Follow-up|7|||
146168521|NCT00394355|527128151|FG001|Overall Study|Lost to Follow-up|5|||
146168522|NCT00394355|527128152|FG002|Overall Study|Lost to Follow-up|4|||
146168523|NCT00394355|527128153|FG003|Overall Study|Lost to Follow-up|3|||
146168524|NCT00394355|527128150|FG000|Overall Study|Noncompliance with protocol|4|||
146168525|NCT00394355|527128151|FG001|Overall Study|Noncompliance with protocol|3|||
146168526|NCT00394355|527128152|FG002|Overall Study|Noncompliance with protocol|10|||
146168527|NCT00394355|527128153|FG003|Overall Study|Noncompliance with protocol|8|||
146168528|NCT00394355|527128150|FG000|Overall Study|Administrative|0|||
146168529|NCT00394355|527128151|FG001|Overall Study|Administrative|1|||
146168530|NCT00394355|527128152|FG002|Overall Study|Administrative|1|||
146168531|NCT00394355|527128153|FG003|Overall Study|Administrative|1|||
146168532|NCT00394355|527128150|FG000|Overall Study|Lack of Efficacy|0|||
146168533|NCT00394355|527128151|FG001|Overall Study|Lack of Efficacy|0|||
146168534|NCT00394355|527128152|FG002|Overall Study|Lack of Efficacy|2|||
146168535|NCT00394355|527128153|FG003|Overall Study|Lack of Efficacy|3|||
146168536|NCT00698646|527128159|FG000|Overall Study|Adverse Event|8|||
146168537|NCT00698646|527128160|FG001|Overall Study|Adverse Event|7|||
146168538|NCT00698646|527128161|FG002|Overall Study|Adverse Event|8|||
146168539|NCT00698646|527128159|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
146168540|NCT00698646|527128160|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
146168541|NCT00698646|527128161|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
146333124|NCT00064701|527723536|FG000|One Year Post-transplant|Lost to Follow-up|1|||
146333125|NCT00064701|527723537|FG001|One Year Post-transplant|Lost to Follow-up|0|||
146168542|NCT00698646|527128159|FG000|Overall Study|Protocol Deviation|6|||
146333126|NCT00064701|527723538|FG002|One Year Post-transplant|Lost to Follow-up|0|||
146333127|NCT00064701|527723536|FG000|One Year Post-transplant|Converted to rapamycin|1|||
146333128|NCT00064701|527723537|FG001|One Year Post-transplant|Converted to rapamycin|0|||
146333129|NCT00064701|527723538|FG002|One Year Post-transplant|Converted to rapamycin|0|||
146333130|NCT00064701|527723536|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
146333131|NCT00064701|527723537|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
146333132|NCT00064701|527723538|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
146333133|NCT00064701|527723536|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
146333134|NCT00064701|527723537|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
146333135|NCT00064701|527723538|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
146333136|NCT00064701|527723536|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
146333137|NCT00064701|527723537|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
146333138|NCT00064701|527723538|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
146333139|NCT00064701|527723536|FG000|One Year Post-transplant|Poor absorption|0|||
146333140|NCT00064701|527723537|FG001|One Year Post-transplant|Poor absorption|1|||
146333141|NCT00064701|527723538|FG002|One Year Post-transplant|Poor absorption|0|||
146333142|NCT00064701|527723536|FG000|One Year Post-transplant|Pancreas transplant|0|||
146333143|NCT00064701|527723537|FG001|One Year Post-transplant|Pancreas transplant|0|||
146333144|NCT00064701|527723538|FG002|One Year Post-transplant|Pancreas transplant|1|||
146333145|NCT00064701|527723536|FG000|Clinical Continuation Phase|Adverse Event|12|||
146333146|NCT00064701|527723537|FG001|Clinical Continuation Phase|Adverse Event|21|||
146333147|NCT00064701|527723538|FG002|Clinical Continuation Phase|Adverse Event|14|||
146333148|NCT00064701|527723536|FG000|Clinical Continuation Phase|Non-compliance|8|||
146333149|NCT00064701|527723537|FG001|Clinical Continuation Phase|Non-compliance|6|||
146333150|NCT00064701|527723538|FG002|Clinical Continuation Phase|Non-compliance|7|||
146333151|NCT00064701|527723536|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
146333152|NCT00064701|527723537|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
146333153|NCT00064701|527723538|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
146333154|NCT00064701|527723536|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
146333155|NCT00064701|527723537|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
146333156|NCT00064701|527723538|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
146333157|NCT00064701|527723536|FG000|Clinical Continuation Phase|Graft Failure|5|||
146333158|NCT00064701|527723537|FG001|Clinical Continuation Phase|Graft Failure|5|||
146333159|NCT00064701|527723538|FG002|Clinical Continuation Phase|Graft Failure|2|||
146333160|NCT00064701|527723536|FG000|Clinical Continuation Phase|Rejection|1|||
146333161|NCT00064701|527723537|FG001|Clinical Continuation Phase|Rejection|2|||
146333162|NCT00064701|527723538|FG002|Clinical Continuation Phase|Rejection|2|||
146333163|NCT00064701|527723536|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
146333164|NCT00064701|527723537|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
146333165|NCT00064701|527723538|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
146333166|NCT00064701|527723536|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
146333167|NCT00064701|527723537|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
146333168|NCT00064701|527723538|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
146333169|NCT00064701|527723536|FG000|Clinical Continuation Phase|Physician Decision|1|||
146333170|NCT00064701|527723537|FG001|Clinical Continuation Phase|Physician Decision|3|||
146333171|NCT00064701|527723538|FG002|Clinical Continuation Phase|Physician Decision|0|||
146333172|NCT00064701|527723536|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
146333173|NCT00064701|527723537|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
146333174|NCT00064701|527723538|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
146333175|NCT00064701|527723536|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
146333176|NCT00064701|527723537|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
146333177|NCT00064701|527723538|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
146333178|NCT00064701|527723536|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
146333179|NCT00064701|527723537|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
146333180|NCT00064701|527723538|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
146333181|NCT00064701|527723536|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
146333182|NCT00064701|527723537|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
146333183|NCT00064701|527723538|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
146333184|NCT00064701|527723536|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
146333185|NCT00064701|527723537|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
146333186|NCT00064701|527723538|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
146333187|NCT00064701|527723536|FG000|Clinical Continuation Phase|Patient opted out|0|||
146333188|NCT00064701|527723537|FG001|Clinical Continuation Phase|Patient opted out|0|||
146333189|NCT00064701|527723538|FG002|Clinical Continuation Phase|Patient opted out|1|||
146333190|NCT03440944|527723542|FG000|Overall Study|Physician Decision|1|||
146333191|NCT03440944|527723543|FG001|Overall Study|Physician Decision|0|||
146333192|NCT03440944|527723542|FG000|Overall Study|No Acceptable Vasculature|0|||
146333193|NCT03440944|527723543|FG001|Overall Study|No Acceptable Vasculature|1|||
146333194|NCT04672083|527723544|FG000|Overall Study|Lost to Follow-up|1|||
146333195|NCT04672083|527723545|FG001|Overall Study|Lost to Follow-up|0|||
146168543|NCT00698646|527128160|FG001|Overall Study|Protocol Deviation|2|||
146168544|NCT00698646|527128161|FG002|Overall Study|Protocol Deviation|3|||
146168545|NCT00698646|527128159|FG000|Overall Study|Withdrawal by Subject|10|||
146168546|NCT00698646|527128160|FG001|Overall Study|Withdrawal by Subject|11|||
146168547|NCT00698646|527128161|FG002|Overall Study|Withdrawal by Subject|8|||
146168548|NCT00698646|527128159|FG000|Overall Study|Lost to Follow-up|0|||
146168549|NCT00698646|527128160|FG001|Overall Study|Lost to Follow-up|0|||
146168550|NCT00698646|527128161|FG002|Overall Study|Lost to Follow-up|2|||
146168551|NCT00698646|527128159|FG000|Overall Study|Administrative problems|1|||
146168552|NCT00698646|527128160|FG001|Overall Study|Administrative problems|0|||
146168553|NCT00698646|527128161|FG002|Overall Study|Administrative problems|1|||
146168554|NCT00511875|527128164|FG000|Overall Study|Lost to Follow-up|4|||
146168555|NCT00511875|527128165|FG001|Overall Study|Lost to Follow-up|0|||
146168556|NCT00511875|527128164|FG000|Overall Study|Missing variables|1|||
146168557|NCT00511875|527128165|FG001|Overall Study|Missing variables|0|||
146168558|NCT00766675|527129368|FG000|Overall Study|Adverse Event|16|||
146333196|NCT04672083|527723546|FG002|Overall Study|Lost to Follow-up|0|||
146333197|NCT04672083|527723547|FG003|Overall Study|Lost to Follow-up|0|||
146333198|NCT04672083|527723548|FG004|Overall Study|Lost to Follow-up|0|||
146333199|NCT00998738|527723552|FG000|Overall Study|Uknown|1|||
146333200|NCT03313050|527723554|FG000|Stage 2: 12 Months|Adverse Event|0|||
146333201|NCT03313050|527723555|FG001|Stage 2: 12 Months|Adverse Event|0|||
146333202|NCT03313050|527723556|FG002|Stage 2: 12 Months|Adverse Event|0|||
146333203|NCT03313050|527723557|FG003|Stage 2: 12 Months|Adverse Event|1|||
146333204|NCT03313050|527723554|FG000|Stage 2: 12 Months|Death|0|||
146333205|NCT03313050|527723555|FG001|Stage 2: 12 Months|Death|0|||
146333206|NCT03313050|527723556|FG002|Stage 2: 12 Months|Death|3|||
146333207|NCT03313050|527723557|FG003|Stage 2: 12 Months|Death|0|||
146333208|NCT03313050|527723554|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
146333209|NCT03313050|527723555|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
146333210|NCT03313050|527723556|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
146333211|NCT03313050|527723557|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
146333212|NCT03313050|527723554|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146333213|NCT03313050|527723555|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146333214|NCT03313050|527723556|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
146333215|NCT03313050|527723557|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
146333216|NCT03313050|527723554|FG000|Stage 2: 12 Months|Protocol deviation|0|||
146333217|NCT03313050|527723555|FG001|Stage 2: 12 Months|Protocol deviation|0|||
146333218|NCT03313050|527723556|FG002|Stage 2: 12 Months|Protocol deviation|7|||
146333219|NCT03313050|527723557|FG003|Stage 2: 12 Months|Protocol deviation|7|||
146333220|NCT03313050|527723554|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
146333221|NCT03313050|527723555|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
146333222|NCT03313050|527723556|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
146333223|NCT03313050|527723557|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
146333224|NCT03313050|527723554|FG000|Stage 2: 12 Months|Other|0|||
146333225|NCT03313050|527723555|FG001|Stage 2: 12 Months|Other|0|||
146333226|NCT03313050|527723556|FG002|Stage 2: 12 Months|Other|0|||
146333227|NCT03313050|527723557|FG003|Stage 2: 12 Months|Other|1|||
146333228|NCT04211337|527723558|FG000|Overall Study|On Treatment|175|||
146333229|NCT04211337|527723559|FG001|Overall Study|On Treatment|40|||
146333230|NCT04211337|527723558|FG000|Overall Study|Withdrawal by Subject|0|||
146333231|NCT04211337|527723559|FG001|Overall Study|Withdrawal by Subject|2|||
146333232|NCT02848833|527723566|FG000|Overall Study|subject who are duplicated|1|||
146333233|NCT02848833|527723566|FG000|Overall Study|have not taken the study drug|11|||
146333234|NCT02848833|527723566|FG000|Overall Study|follow-up failure|6|||
146333235|NCT02848833|527723566|FG000|Overall Study|Protocol Violation|119|||
146333236|NCT02847598|527723567|FG000|Overall Study|Adverse Event|0|||
146168559|NCT00766675|527129368|FG000|Overall Study|Lost to Follow-up|2|||
146333237|NCT02847598|527723568|FG001|Overall Study|Adverse Event|0|||
146333238|NCT02847598|527723569|FG002|Overall Study|Adverse Event|0|||
146333239|NCT02847598|527723570|FG003|Overall Study|Adverse Event|0|||
146333240|NCT02847598|527723571|FG004|Overall Study|Adverse Event|0|||
146333241|NCT02847598|527723572|FG005|Overall Study|Adverse Event|0|||
146333242|NCT02847598|527723573|FG006|Overall Study|Adverse Event|0|||
146333243|NCT02847598|527723574|FG007|Overall Study|Adverse Event|1|||
146168560|NCT00766675|527129368|FG000|Overall Study|Withdrawal by Subject|11|||
146168561|NCT00766675|527129368|FG000|Overall Study|Protocol Violation|8|||
146168562|NCT00766675|527129368|FG000|Overall Study|Participant took prohibited medication|1|||
146168563|NCT00766675|527129368|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
146333244|NCT02847598|527723567|FG000|Overall Study|Consent withdrawn|2|||
146333245|NCT02847598|527723568|FG001|Overall Study|Consent withdrawn|0|||
146333246|NCT02847598|527723569|FG002|Overall Study|Consent withdrawn|0|||
146333247|NCT02847598|527723570|FG003|Overall Study|Consent withdrawn|4|||
146333248|NCT02847598|527723571|FG004|Overall Study|Consent withdrawn|3|||
146333249|NCT02847598|527723572|FG005|Overall Study|Consent withdrawn|2|||
146168564|NCT00766675|527129368|FG000|Overall Study|Insufficient therapy|1|||
146168565|NCT03308825|527129369|FG000|Overall Study|Lost to Follow-up|2|||
146168566|NCT03308825|527129370|FG001|Overall Study|Lost to Follow-up|2|||
146168567|NCT03308825|527129371|FG002|Overall Study|Lost to Follow-up|1|||
146168568|NCT03308825|527129372|FG003|Overall Study|Lost to Follow-up|0|||
146168569|NCT03308825|527129369|FG000|Overall Study|Protocol Violation|0|||
146168570|NCT03308825|527129370|FG001|Overall Study|Protocol Violation|2|||
146168571|NCT03308825|527129371|FG002|Overall Study|Protocol Violation|0|||
146168572|NCT03308825|527129372|FG003|Overall Study|Protocol Violation|0|||
146168573|NCT00685945|527129374|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
146168574|NCT00284141|527129375|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
146168575|NCT00284141|527129375|FG000|Overall Study|Adverse Event|19|||
146168576|NCT00284141|527129375|FG000|Overall Study|Participant's request|9|||
146168577|NCT00284141|527129375|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
146168578|NCT00284141|527129375|FG000|Overall Study|Clinical deterioration / death|2|||
146168579|NCT00284141|527129375|FG000|Overall Study|General decline|1|||
146168580|NCT00284141|527129375|FG000|Overall Study|Pneumonia|1|||
146168581|NCT00284141|527129375|FG000|Overall Study|Did not take study medication|2|||
146168582|NCT00284141|527129375|FG000|Overall Study|Ongoing treatment|2|||
146168583|NCT01160484|527129387|FG000|Overall Study|Lack of Efficacy|9|||
146168584|NCT01160484|527129387|FG000|Overall Study|Adverse Event|6|||
146168585|NCT01160484|527129387|FG000|Overall Study|Withdrawal by Subject|2|||
146168586|NCT01160484|527129387|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
146168587|NCT00803101|527129388|FG000|Overall Study|Death / Serious Adverse Event|4|||
146168588|NCT00803101|527129389|FG001|Overall Study|Death / Serious Adverse Event|6|||
146168589|NCT00803101|527129388|FG000|Overall Study|Withdrawal by Subject|6|||
146168590|NCT00803101|527129389|FG001|Overall Study|Withdrawal by Subject|4|||
146168591|NCT00803101|527129388|FG000|Overall Study|Lost to Follow-up|2|||
146168592|NCT00803101|527129389|FG001|Overall Study|Lost to Follow-up|2|||
146168593|NCT00803101|527129388|FG000|Overall Study|Protocol Violation|1|||
146168594|NCT00803101|527129389|FG001|Overall Study|Protocol Violation|7|||
146168595|NCT00803101|527129388|FG000|Overall Study|Surgery finished outside protocol window|1|||
146168596|NCT00803101|527129389|FG001|Overall Study|Surgery finished outside protocol window|1|||
146168597|NCT00803101|527129388|FG000|Overall Study|Patient died outside SAE report period|1|||
146168598|NCT00803101|527129389|FG001|Overall Study|Patient died outside SAE report period|0|||
146168599|NCT00803101|527129388|FG000|Overall Study|Patient did not attend scheduled visit|2|||
146168600|NCT00803101|527129389|FG001|Overall Study|Patient did not attend scheduled visit|1|||
146168601|NCT00803101|527129388|FG000|Overall Study|Patient did not have surgery|1|||
146168602|NCT00803101|527129389|FG001|Overall Study|Patient did not have surgery|1|||
146168603|NCT01782742|527129390|FG000|Double-blind Treatment Phase|Adverse Event|1|||
146168604|NCT01782742|527129391|FG001|Double-blind Treatment Phase|Adverse Event|0|||
146168605|NCT02790073|527129394|FG000|Overall Study|Death|1|||
146168606|NCT02790073|527129394|FG000|Overall Study|Withdrawal from HD|1|||
146168607|NCT02790073|527129394|FG000|Overall Study|Withdrawal by Subject|1|||
146168608|NCT04170686|527129395|FG000|Screening|Physician Decision|12|||
146168609|NCT04170686|527129396|FG001|Screening|Physician Decision|13|||
146168610|NCT04170686|527129395|FG000|Randomization and Treatment|Lost to Follow-up|26|||
146168611|NCT04170686|527129396|FG001|Randomization and Treatment|Lost to Follow-up|15|||
146168612|NCT03328143|527129397|FG000|Overall Study|Declined|3|||
146168613|NCT03328143|527129397|FG000|Overall Study|Required increased sedation|4|||
146168614|NCT03328143|527129397|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
146168615|NCT03328143|527129397|FG000|Overall Study|Surgery cancelled|1|||
146168616|NCT02259517|527129398|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
146168617|NCT02259517|527129399|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
146168618|NCT02259517|527129400|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
146168619|NCT02259517|527129398|FG000|Overall Study|Withdrawal by Subject|0|||
146168620|NCT02259517|527129399|FG001|Overall Study|Withdrawal by Subject|0|||
146333250|NCT02847598|527723573|FG006|Overall Study|Consent withdrawn|1|||
146333251|NCT02847598|527723574|FG007|Overall Study|Consent withdrawn|3|||
146333252|NCT02847598|527723567|FG000|Overall Study|Death|3|||
146333253|NCT02847598|527723568|FG001|Overall Study|Death|0|||
146333254|NCT02847598|527723569|FG002|Overall Study|Death|0|||
146168621|NCT02259517|527129400|FG002|Overall Study|Withdrawal by Subject|3|||
146333255|NCT02847598|527723570|FG003|Overall Study|Death|0|||
146168622|NCT04770753|527129401|FG000|Overall Study|Randomized, never treated|1|||
146168623|NCT04770753|527129402|FG001|Overall Study|Randomized, never treated|1|||
146168624|NCT04770753|527129401|FG000|Overall Study|Withdrawal by Subject|3|||
146168625|NCT04770753|527129402|FG001|Overall Study|Withdrawal by Subject|1|||
146168626|NCT04770753|527129401|FG000|Overall Study|Adverse Event|2|||
146168627|NCT04770753|527129402|FG001|Overall Study|Adverse Event|0|||
146168628|NCT04770753|527129401|FG000|Overall Study|Pregnancy|1|||
146168629|NCT04770753|527129402|FG001|Overall Study|Pregnancy|0|||
146168630|NCT04770753|527129401|FG000|Overall Study|Other un-specified|1|||
146168631|NCT04770753|527129402|FG001|Overall Study|Other un-specified|0|||
146333256|NCT02847598|527723571|FG004|Overall Study|Death|0|||
146168632|NCT02305381|527129403|FG000|Overall Study|Unclassified|5|||
146168633|NCT02305381|527129404|FG001|Overall Study|Unclassified|5|||
146168634|NCT02305381|527129405|FG002|Overall Study|Unclassified|7|||
146168635|NCT02882282|527129406|FG000|Overall Study|Adverse Event|1|||
146168636|NCT02882282|527129407|FG001|Overall Study|Adverse Event|0|||
146168637|NCT01181726|527129408|FG000|First Intervention|Adverse Event|1|||
146168638|NCT01181726|527129409|FG001|First Intervention|Adverse Event|0|||
146168639|NCT02696564|527129411|FG000|Overall Study|Death|1|||
146168640|NCT02696564|527129412|FG001|Overall Study|Death|2|||
146168641|NCT02696564|527129411|FG000|Overall Study|Withdrawal by Subject|3|||
146168642|NCT02696564|527129412|FG001|Overall Study|Withdrawal by Subject|2|||
146168643|NCT02696564|527129411|FG000|Overall Study|Lost to Follow-up|3|||
146168644|NCT02696564|527129412|FG001|Overall Study|Lost to Follow-up|3|||
146168645|NCT02696564|527129411|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
146168646|NCT02696564|527129412|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
146168647|NCT02696564|527129411|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
146168648|NCT02696564|527129412|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
146168649|NCT02696564|527129411|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
146168650|NCT02696564|527129412|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
146168651|NCT02696564|527129411|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
146168652|NCT02696564|527129412|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
146168653|NCT02696564|527129411|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
146168654|NCT02696564|527129412|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
146168655|NCT03633929|527129413|FG000|Overall Study|Lost to Follow-up|1|||
146168656|NCT03633929|527129413|FG000|Overall Study|Did not login to software. Did not participate|3|||
146168657|NCT01722162|527129414|FG000|Overall Study|Withdrawal by Subject|1|||
146168658|NCT01722162|527129415|FG001|Overall Study|Withdrawal by Subject|1|||
146168659|NCT01722162|527129414|FG000|Overall Study|Found ineligible|1|||
146168660|NCT01722162|527129415|FG001|Overall Study|Found ineligible|0|||
146168661|NCT01722162|527129414|FG000|Overall Study|Unrelated to study adverse event|2|||
146168662|NCT01722162|527129415|FG001|Overall Study|Unrelated to study adverse event|2|||
146168663|NCT01722162|527129414|FG000|Overall Study|Adverse Event|1|||
146168664|NCT01722162|527129415|FG001|Overall Study|Adverse Event|1|||
146168665|NCT01722162|527129414|FG000|Overall Study|Insurance denial post enrollment|0|||
146168666|NCT01722162|527129415|FG001|Overall Study|Insurance denial post enrollment|1|||
146168667|NCT01722162|527129414|FG000|Overall Study|Noncompliance|0|||
146168668|NCT01722162|527129415|FG001|Overall Study|Noncompliance|1|||
146168669|NCT02487810|527129416|FG000|Overall Study|Withdrawal by Subject|1|||
146168670|NCT02487810|527129417|FG001|Overall Study|Withdrawal by Subject|0|||
146168671|NCT00077064|527129420|FG000|Overall Study|Adverse Event|0|||
146168672|NCT00077064|527129421|FG001|Overall Study|Adverse Event|4|||
146168673|NCT00077064|527129420|FG000|Overall Study|Patient refusal|0|||
146168674|NCT00077064|527129421|FG001|Overall Study|Patient refusal|2|||
146168675|NCT01281202|527129435|FG000|Overall Study|Adverse Event|2|||
146168676|NCT01281202|527129436|FG001|Overall Study|Adverse Event|0|||
146168677|NCT01281202|527129435|FG000|Overall Study|Withdrawal by Subject|2|||
146168678|NCT01281202|527129436|FG001|Overall Study|Withdrawal by Subject|2|||
146168679|NCT01281202|527129435|FG000|Overall Study|Protocol Violation|11|||
146168680|NCT01281202|527129436|FG001|Overall Study|Protocol Violation|10|||
146168681|NCT01281202|527129435|FG000|Overall Study|Administrative|2|||
146168682|NCT01281202|527129436|FG001|Overall Study|Administrative|8|||
146168683|NCT01281202|527129435|FG000|Overall Study|Lost to Follow-up|11|||
146168684|NCT01281202|527129436|FG001|Overall Study|Lost to Follow-up|13|||
146168685|NCT01281202|527129435|FG000|Overall Study|Incarceration|0|||
146168686|NCT01281202|527129436|FG001|Overall Study|Incarceration|3|||
146168687|NCT04711603|527129437|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
146168688|NCT04711603|527129438|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
146168689|NCT04711603|527129439|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
146168690|NCT04711603|527129440|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
146168691|NCT04711603|527129437|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146168692|NCT04711603|527129438|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
146168693|NCT04711603|527129439|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146168694|NCT04711603|527129440|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
146168695|NCT04711603|527129437|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146168696|NCT04711603|527129438|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
146168697|NCT04711603|527129439|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146168698|NCT04711603|527129440|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
146168699|NCT04711603|527129437|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146168700|NCT04711603|527129438|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
146168701|NCT04711603|527129439|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146168702|NCT04711603|527129440|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
146168703|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
146333257|NCT02847598|527723572|FG005|Overall Study|Death|0|||
146333258|NCT02847598|527723573|FG006|Overall Study|Death|0|||
146333259|NCT02847598|527723574|FG007|Overall Study|Death|0|||
146333260|NCT02847598|527723567|FG000|Overall Study|Lost to Follow-up|0|||
146333261|NCT02847598|527723568|FG001|Overall Study|Lost to Follow-up|0|||
146333262|NCT02847598|527723569|FG002|Overall Study|Lost to Follow-up|0|||
146333263|NCT02847598|527723570|FG003|Overall Study|Lost to Follow-up|0|||
146333264|NCT02847598|527723571|FG004|Overall Study|Lost to Follow-up|0|||
146333265|NCT02847598|527723572|FG005|Overall Study|Lost to Follow-up|1|||
146333266|NCT02847598|527723573|FG006|Overall Study|Lost to Follow-up|1|||
146333267|NCT02847598|527723574|FG007|Overall Study|Lost to Follow-up|0|||
146333268|NCT04980391|527723575|FG000|Overall Study|Death|0|||
146333269|NCT04980391|527723576|FG001|Overall Study|Death|0|||
146333270|NCT04980391|527723577|FG002|Overall Study|Death|1|||
146333271|NCT04980391|527723578|FG003|Overall Study|Death|1|||
146333272|NCT04980391|527723575|FG000|Overall Study|Lost to Follow-up|3|||
146333273|NCT04980391|527723576|FG001|Overall Study|Lost to Follow-up|3|||
146333274|NCT04980391|527723577|FG002|Overall Study|Lost to Follow-up|2|||
146333275|NCT04980391|527723578|FG003|Overall Study|Lost to Follow-up|3|||
146333276|NCT04980391|527723575|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
146333277|NCT04980391|527723576|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146333278|NCT04980391|527723577|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146333279|NCT04980391|527723578|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
146333280|NCT04980391|527723575|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146333281|NCT04980391|527723576|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146333282|NCT04980391|527723577|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
146333283|NCT04980391|527723578|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146333284|NCT04980391|527723575|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146333285|NCT04980391|527723576|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146333286|NCT04980391|527723577|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
146333287|NCT04980391|527723578|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
146333288|NCT03797001|527725614|FG000|Overall Study|Withdrawn due to COVID19|4|||
146333289|NCT03797001|527725615|FG001|Overall Study|Withdrawn due to COVID19|0|||
146333290|NCT03797001|527725614|FG000|Overall Study|Withdrawal by Subject|7|||
146333291|NCT03797001|527725615|FG001|Overall Study|Withdrawal by Subject|6|||
146333292|NCT03797001|527725614|FG000|Overall Study|Adverse Event|0|||
146333293|NCT03797001|527725615|FG001|Overall Study|Adverse Event|1|||
146333294|NCT05630846|527725618|FG000|Overall Study|Death|1|||
146333295|NCT05630846|527725619|FG001|Overall Study|Death|0|||
146333296|NCT05630846|527725620|FG002|Overall Study|Death|0|||
146333297|NCT05630846|527725621|FG003|Overall Study|Death|0|||
146333298|NCT05630846|527725618|FG000|Overall Study|Withdrawal by Subject|3|||
146333299|NCT05630846|527725619|FG001|Overall Study|Withdrawal by Subject|3|||
146333300|NCT05630846|527725620|FG002|Overall Study|Withdrawal by Subject|4|||
146333301|NCT05630846|527725621|FG003|Overall Study|Withdrawal by Subject|1|||
146333302|NCT05630846|527725618|FG000|Overall Study|Lost to Follow-up|6|||
146333303|NCT05630846|527725619|FG001|Overall Study|Lost to Follow-up|5|||
146333304|NCT05630846|527725620|FG002|Overall Study|Lost to Follow-up|2|||
146333305|NCT05630846|527725621|FG003|Overall Study|Lost to Follow-up|5|||
146333306|NCT05630846|527725618|FG000|Overall Study|Other|1|||
146333307|NCT05630846|527725619|FG001|Overall Study|Other|0|||
146333308|NCT05630846|527725620|FG002|Overall Study|Other|0|||
146333309|NCT05630846|527725621|FG003|Overall Study|Other|0|||
146333310|NCT05556616|527725622|FG000|Overall Study|Withdrawal by Subject|1|||
146333311|NCT05556616|527725623|FG001|Overall Study|Withdrawal by Subject|0|||
146333312|NCT05556616|527725624|FG002|Overall Study|Withdrawal by Subject|0|||
146333313|NCT05556616|527725625|FG003|Overall Study|Withdrawal by Subject|0|||
146333314|NCT05556616|527725626|FG004|Overall Study|Withdrawal by Subject|0|||
146333315|NCT05556616|527725627|FG005|Overall Study|Withdrawal by Subject|0|||
146333316|NCT05556616|527725628|FG006|Overall Study|Withdrawal by Subject|0|||
146333317|NCT05556616|527725622|FG000|Overall Study|Death|0|||
146333318|NCT05556616|527725623|FG001|Overall Study|Death|0|||
146333319|NCT05556616|527725624|FG002|Overall Study|Death|2|||
146333320|NCT05556616|527725625|FG003|Overall Study|Death|1|||
146333321|NCT05556616|527725626|FG004|Overall Study|Death|0|||
146333322|NCT05556616|527725627|FG005|Overall Study|Death|0|||
146333323|NCT05556616|527725628|FG006|Overall Study|Death|0|||
146333324|NCT05556616|527725622|FG000|Overall Study|Study Terminated by Sponsor|0|||
146333325|NCT05556616|527725623|FG001|Overall Study|Study Terminated by Sponsor|3|||
146333326|NCT05556616|527725624|FG002|Overall Study|Study Terminated by Sponsor|0|||
146333327|NCT05556616|527725625|FG003|Overall Study|Study Terminated by Sponsor|0|||
146333328|NCT05556616|527725626|FG004|Overall Study|Study Terminated by Sponsor|0|||
146333329|NCT05556616|527725627|FG005|Overall Study|Study Terminated by Sponsor|0|||
146333330|NCT05556616|527725628|FG006|Overall Study|Study Terminated by Sponsor|0|||
145943270|NCT02326298|526300464|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
146333331|NCT00960076|527725640|FG000|Overall Study|Adverse Event|1|||
146333332|NCT00960076|527725641|FG001|Overall Study|Adverse Event|7|||
146333333|NCT00960076|527725640|FG000|Overall Study|No longer met study criteria|1|||
146395691|NCT00976989|527950896|FG002|Overall Study|Other|1|||
146333334|NCT00960076|527725641|FG001|Overall Study|No longer met study criteria|5|||
146333335|NCT00960076|527725640|FG000|Overall Study|Withdrawal by Subject|1|||
146333336|NCT00960076|527725641|FG001|Overall Study|Withdrawal by Subject|2|||
146333337|NCT00960076|527725640|FG000|Overall Study|Lost to Follow-up|3|||
146333338|NCT00960076|527725641|FG001|Overall Study|Lost to Follow-up|3|||
146333339|NCT00960076|527725640|FG000|Overall Study|Severe non-compliance to protocol|1|||
146333340|NCT00960076|527725641|FG001|Overall Study|Severe non-compliance to protocol|2|||
146333341|NCT00960076|527725640|FG000|Overall Study|Hyperglycemia|1|||
146333342|NCT00960076|527725641|FG001|Overall Study|Hyperglycemia|5|||
146333343|NCT00960076|527725640|FG000|Overall Study|Did not attend the termination visit|0|||
146333344|NCT00960076|527725641|FG001|Overall Study|Did not attend the termination visit|1|||
146333345|NCT00500266|527725642|FG000|Overall Study|Death|3|||
146333346|NCT00500266|527725642|FG000|Overall Study|Lost to Follow-up|3|||
146333347|NCT00500266|527725642|FG000|Overall Study|Withdrawal by Subject|3|||
146333348|NCT00500266|527725642|FG000|Overall Study|Assigned, not treated|4|||
146333349|NCT01431287|527725643|FG000|Overall Study|not treated|0|||
146333350|NCT01431287|527725644|FG001|Overall Study|not treated|0|||
146333351|NCT01431287|527725645|FG002|Overall Study|not treated|1|||
146333352|NCT01431287|527725646|FG003|Overall Study|not treated|0|||
146333353|NCT01431287|527725647|FG004|Overall Study|not treated|0|||
146333354|NCT01431287|527725643|FG000|Overall Study|Adverse Event|59|||
146333355|NCT01431287|527725644|FG001|Overall Study|Adverse Event|57|||
146333356|NCT01431287|527725645|FG002|Overall Study|Adverse Event|53|||
146333357|NCT01431287|527725646|FG003|Overall Study|Adverse Event|33|||
146333358|NCT01431287|527725647|FG004|Overall Study|Adverse Event|41|||
146333359|NCT01431287|527725643|FG000|Overall Study|Non compliant with protocol|6|||
146333360|NCT01431287|527725644|FG001|Overall Study|Non compliant with protocol|6|||
146333361|NCT01431287|527725645|FG002|Overall Study|Non compliant with protocol|5|||
146333362|NCT01431287|527725646|FG003|Overall Study|Non compliant with protocol|6|||
146333363|NCT01431287|527725647|FG004|Overall Study|Non compliant with protocol|5|||
146333364|NCT01431287|527725643|FG000|Overall Study|Lost to Follow-up|0|||
146333365|NCT01431287|527725644|FG001|Overall Study|Lost to Follow-up|3|||
146333366|NCT01431287|527725645|FG002|Overall Study|Lost to Follow-up|2|||
146333367|NCT01431287|527725646|FG003|Overall Study|Lost to Follow-up|3|||
146333368|NCT01431287|527725647|FG004|Overall Study|Lost to Follow-up|1|||
146333369|NCT01431287|527725643|FG000|Overall Study|Consent withdrawn not due to AE|29|||
146333370|NCT01431287|527725644|FG001|Overall Study|Consent withdrawn not due to AE|30|||
146333371|NCT01431287|527725645|FG002|Overall Study|Consent withdrawn not due to AE|34|||
146333372|NCT01431287|527725646|FG003|Overall Study|Consent withdrawn not due to AE|19|||
146333373|NCT01431287|527725647|FG004|Overall Study|Consent withdrawn not due to AE|29|||
146333374|NCT01431287|527725643|FG000|Overall Study|not stated above|4|||
146333375|NCT01431287|527725644|FG001|Overall Study|not stated above|2|||
146333376|NCT01431287|527725645|FG002|Overall Study|not stated above|2|||
146333377|NCT01431287|527725646|FG003|Overall Study|not stated above|2|||
146333378|NCT01431287|527725647|FG004|Overall Study|not stated above|1|||
146333379|NCT00075881|527725648|FG000|Overall Study|Lack of Efficacy|18|||
146333380|NCT00075881|527725648|FG000|Overall Study|Adverse Event|7|||
146333381|NCT00075881|527725648|FG000|Overall Study|Death|1|||
146333382|NCT00075881|527725648|FG000|Overall Study|Withdrawal by Subject|2|||
146333383|NCT00075881|527725648|FG000|Overall Study|Protocol Violation|4|||
146333384|NCT00075881|527725648|FG000|Overall Study|other complicating disease|3|||
146333385|NCT00075881|527725648|FG000|Overall Study|other|4|||
146333386|NCT00075881|527725648|FG000|Overall Study|missing data|2|||
146333387|NCT00075881|527725648|FG000|Overall Study|Ineligible|1|||
146333388|NCT00075881|527725648|FG000|Overall Study|never start protocol therapy|1|||
146333389|NCT02224664|527725649|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
146333390|NCT02224664|527725650|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146333391|NCT02224664|527725651|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146333392|NCT02224664|527725652|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146333393|NCT02224664|527725653|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
146333394|NCT02224664|527725649|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
146333395|NCT02224664|527725650|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
146333396|NCT02224664|527725651|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
146333397|NCT02224664|527725652|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
146333398|NCT02224664|527725653|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
146333399|NCT02224664|527725649|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146333400|NCT02224664|527725650|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146333401|NCT02224664|527725651|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
146333402|NCT02224664|527725652|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
146333403|NCT02224664|527725653|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
146333404|NCT03019549|527725654|FG000|Washout|DId not meet genotype criteria|11|||
146333405|NCT03019549|527725654|FG000|Period 2|Adverse Event|2|||
146333406|NCT03019549|527725654|FG000|Period 2|Physician Decision|2|||
146333407|NCT03019549|527725654|FG000|Period 2|Withdrawal by Subject|1|||
146333408|NCT03195894|527725657|FG000|Overall Study|"An example is Started other treatment."|4|||
146396135|NCT01241591|527954453|FG001|Overall Study|Lost to Follow-up|2|||
146333409|NCT03195894|527725658|FG001|Overall Study|"An example is Started other treatment."|5|||
146333410|NCT03195894|527725657|FG000|Overall Study|Withdrawal by Subject|15|||
146333411|NCT03195894|527725658|FG001|Overall Study|Withdrawal by Subject|4|||
146333412|NCT03195894|527725657|FG000|Overall Study|Lost to Follow-up|14|||
146333413|NCT03195894|527725658|FG001|Overall Study|Lost to Follow-up|19|||
146333414|NCT00162773|527725659|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
146333415|NCT02251743|527725660|FG000|Overall Study|Withdrawal by Subject|1|||
146333416|NCT02251743|527725661|FG001|Overall Study|Withdrawal by Subject|1|||
146333417|NCT00215150|527725662|FG000|Open Label Phase|Lost to Follow-up|7|||
146333418|NCT00215150|527725662|FG000|Open Label Phase|Withdrawal by Subject|1|||
146333419|NCT00215150|527725662|FG000|Open Label Phase|Did not complete a post base visit|13|||
146333420|NCT00215150|527725662|FG000|Open Label Phase|Did not meet randomization criteria|9|||
146333421|NCT00215150|527725662|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
146333422|NCT00215150|527725662|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
146333423|NCT00215150|527725662|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
146333424|NCT00824564|527725663|FG000|Overall Study|Lost to Follow-up|5|||
146333425|NCT00824564|527725664|FG001|Overall Study|Lost to Follow-up|7|||
146333426|NCT00824564|527725663|FG000|Overall Study|Withdrawal by Subject|1|||
146333427|NCT00824564|527725664|FG001|Overall Study|Withdrawal by Subject|1|||
146333428|NCT00824564|527725663|FG000|Overall Study|Other|1|||
146333429|NCT00824564|527725664|FG001|Overall Study|Other|2|||
146333430|NCT00824564|527725663|FG000|Overall Study|Randomized, but not treated|1|||
146333431|NCT00824564|527725664|FG001|Overall Study|Randomized, but not treated|0|||
146333432|NCT05817045|527725670|FG000|Overall Study|Protocol Violation|0|||
146333433|NCT05817045|527725671|FG001|Overall Study|Protocol Violation|3|||
146333434|NCT05817045|527725670|FG000|Overall Study|Withdrawal by Subject|10|||
146333435|NCT05817045|527725671|FG001|Overall Study|Withdrawal by Subject|7|||
146333436|NCT05817045|527725670|FG000|Overall Study|Physician Decision|3|||
146333437|NCT05817045|527725671|FG001|Overall Study|Physician Decision|0|||
146333438|NCT05817045|527725670|FG000|Overall Study|Lost to Follow-up|0|||
146333439|NCT05817045|527725671|FG001|Overall Study|Lost to Follow-up|1|||
146333440|NCT05817045|527725670|FG000|Overall Study|Device Deficiency|1|||
146333441|NCT05817045|527725671|FG001|Overall Study|Device Deficiency|0|||
146333442|NCT05817045|527725670|FG000|Overall Study|System Error|1|||
146333443|NCT05817045|527725671|FG001|Overall Study|System Error|0|||
146333444|NCT00382967|527725672|FG000|Overall Study|Protocol Violation|1|||
146333445|NCT00382967|527725673|FG001|Overall Study|Protocol Violation|1|||
146333446|NCT03367871|527725675|FG000|Overall Study|Lost to Follow-up|1|||
146333447|NCT00607048|527725676|FG000|Overall Study|Adverse Event|0|||
146333448|NCT00607048|527725677|FG001|Overall Study|Adverse Event|1|||
146333449|NCT00607048|527725678|FG002|Overall Study|Adverse Event|0|||
146333450|NCT00607048|527725679|FG003|Overall Study|Adverse Event|0|||
146333451|NCT00607048|527725680|FG004|Overall Study|Adverse Event|4|||
146333452|NCT00607048|527725681|FG005|Overall Study|Adverse Event|0|||
146333453|NCT00607048|527725676|FG000|Overall Study|Global deterioration of health|1|||
146333454|NCT00607048|527725677|FG001|Overall Study|Global deterioration of health|0|||
146333455|NCT00607048|527725678|FG002|Overall Study|Global deterioration of health|0|||
146333456|NCT00607048|527725679|FG003|Overall Study|Global deterioration of health|0|||
146333457|NCT00607048|527725680|FG004|Overall Study|Global deterioration of health|0|||
146333458|NCT00607048|527725681|FG005|Overall Study|Global deterioration of health|0|||
146333459|NCT00607048|527725676|FG000|Overall Study|Objective disease progression - relapse|1|||
146168704|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
146333460|NCT00607048|527725677|FG001|Overall Study|Objective disease progression - relapse|2|||
146333461|NCT00607048|527725678|FG002|Overall Study|Objective disease progression - relapse|4|||
146333462|NCT00607048|527725679|FG003|Overall Study|Objective disease progression - relapse|2|||
146333463|NCT00607048|527725680|FG004|Overall Study|Objective disease progression - relapse|2|||
146168705|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
146333464|NCT00607048|527725681|FG005|Overall Study|Objective disease progression - relapse|2|||
146168706|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
146168707|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146168708|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146168709|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
146168710|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
146168711|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
146168712|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
146168713|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
146168714|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
146168715|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
146333465|NCT00607048|527725676|FG000|Overall Study|Withdrawal by Subject|0|||
146333466|NCT00607048|527725677|FG001|Overall Study|Withdrawal by Subject|0|||
146333467|NCT00607048|527725678|FG002|Overall Study|Withdrawal by Subject|0|||
146333468|NCT00607048|527725679|FG003|Overall Study|Withdrawal by Subject|1|||
146333469|NCT00607048|527725680|FG004|Overall Study|Withdrawal by Subject|0|||
146333470|NCT00607048|527725681|FG005|Overall Study|Withdrawal by Subject|2|||
146333471|NCT00607048|527725676|FG000|Overall Study|Other|1|||
146333472|NCT00607048|527725677|FG001|Overall Study|Other|1|||
146333473|NCT00607048|527725678|FG002|Overall Study|Other|0|||
146333474|NCT00607048|527725679|FG003|Overall Study|Other|0|||
146333475|NCT00607048|527725680|FG004|Overall Study|Other|0|||
146333476|NCT00607048|527725681|FG005|Overall Study|Other|1|||
146333477|NCT01773473|527725682|FG000|Overall Study|Adverse Event|3|||
146333478|NCT01773473|527725683|FG001|Overall Study|Adverse Event|2|||
146333479|NCT01773473|527725682|FG000|Overall Study|Protocol Violation|0|||
146333480|NCT01773473|527725683|FG001|Overall Study|Protocol Violation|4|||
146333481|NCT01773473|527725682|FG000|Overall Study|Physician Decision|3|||
146333482|NCT01773473|527725683|FG001|Overall Study|Physician Decision|5|||
146333483|NCT01773473|527725682|FG000|Overall Study|Sponsor Decision|2|||
146333484|NCT01773473|527725683|FG001|Overall Study|Sponsor Decision|0|||
146333485|NCT01773473|527725682|FG000|Overall Study|Lack of Efficacy|0|||
146333486|NCT01773473|527725683|FG001|Overall Study|Lack of Efficacy|1|||
146333487|NCT01773473|527725682|FG000|Overall Study|Non-Compliance with study drug|1|||
146333488|NCT01773473|527725683|FG001|Overall Study|Non-Compliance with study drug|4|||
146333489|NCT01773473|527725682|FG000|Overall Study|Withdrawal by Subject|5|||
146333490|NCT01773473|527725683|FG001|Overall Study|Withdrawal by Subject|3|||
146333491|NCT01773473|527725682|FG000|Overall Study|Lost to Follow-up|2|||
146333492|NCT01773473|527725683|FG001|Overall Study|Lost to Follow-up|0|||
146333493|NCT01071070|527725686|FG000|Overall Study|Adverse Event|0|||
146333494|NCT01071070|527725687|FG001|Overall Study|Adverse Event|3|||
146333495|NCT01071070|527725686|FG000|Overall Study|Withdrawal by Subject|1|||
146333496|NCT01071070|527725687|FG001|Overall Study|Withdrawal by Subject|0|||
146333497|NCT01071070|527725686|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
146333498|NCT01071070|527725687|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
146333499|NCT01071070|527725686|FG000|Overall Study|Hypercalcemia|1|||
146333500|NCT01071070|527725687|FG001|Overall Study|Hypercalcemia|0|||
146333501|NCT02207907|527725698|FG000|Overall Study|Lost to Follow-up|3|||
146333502|NCT02207907|527725699|FG001|Overall Study|Lost to Follow-up|1|||
146333503|NCT02207907|527725698|FG000|Overall Study|Withdrawal by Subject|5|||
146333504|NCT02207907|527725699|FG001|Overall Study|Withdrawal by Subject|6|||
146333505|NCT02207907|527725698|FG000|Overall Study|Did not meet study criteria|3|||
146333506|NCT02207907|527725699|FG001|Overall Study|Did not meet study criteria|0|||
146333507|NCT02207907|527725698|FG000|Overall Study|Pregnancy|0|||
146333508|NCT02207907|527725699|FG001|Overall Study|Pregnancy|1|||
146333509|NCT00158184|527725700|FG000|Overall Study|personal issues|3|||
146333510|NCT00158184|527725701|FG001|Overall Study|personal issues|1|||
146333511|NCT00158184|527725700|FG000|Overall Study|failed for follow unit/study rules|2|||
146333512|NCT00158184|527725701|FG001|Overall Study|failed for follow unit/study rules|0|||
146333513|NCT00158184|527725700|FG000|Overall Study|Adverse Event|1|||
146333514|NCT00158184|527725701|FG001|Overall Study|Adverse Event|1|||
146333515|NCT02620020|527725712|FG000|Overall Study|Adverse Event|8|||
146333516|NCT02620020|527725713|FG001|Overall Study|Adverse Event|4|||
146333517|NCT02620020|527725714|FG002|Overall Study|Adverse Event|3|||
146333518|NCT02620020|527725715|FG003|Overall Study|Adverse Event|5|||
146333519|NCT02620020|527725712|FG000|Overall Study|Lost to Follow-up|4|||
146333520|NCT02620020|527725713|FG001|Overall Study|Lost to Follow-up|8|||
146333521|NCT02620020|527725714|FG002|Overall Study|Lost to Follow-up|1|||
146333522|NCT02620020|527725715|FG003|Overall Study|Lost to Follow-up|4|||
146333523|NCT02620020|527725712|FG000|Overall Study|Physician Decision|7|||
146333524|NCT02620020|527725713|FG001|Overall Study|Physician Decision|4|||
146333525|NCT02620020|527725714|FG002|Overall Study|Physician Decision|3|||
146333526|NCT02620020|527725715|FG003|Overall Study|Physician Decision|4|||
146333527|NCT02620020|527725712|FG000|Overall Study|Protocol Violation|5|||
146333528|NCT02620020|527725713|FG001|Overall Study|Protocol Violation|2|||
146333529|NCT02620020|527725714|FG002|Overall Study|Protocol Violation|1|||
146333530|NCT02620020|527725715|FG003|Overall Study|Protocol Violation|1|||
146333531|NCT02620020|527725712|FG000|Overall Study|Withdrawal by Subject|20|||
146333532|NCT02620020|527725713|FG001|Overall Study|Withdrawal by Subject|16|||
146333533|NCT02620020|527725714|FG002|Overall Study|Withdrawal by Subject|17|||
146333534|NCT02620020|527725715|FG003|Overall Study|Withdrawal by Subject|12|||
146333535|NCT02620020|527725712|FG000|Overall Study|Death|0|||
146333536|NCT02620020|527725713|FG001|Overall Study|Death|1|||
146333537|NCT02620020|527725714|FG002|Overall Study|Death|0|||
146333538|NCT02620020|527725715|FG003|Overall Study|Death|0|||
146333539|NCT01025635|527725721|FG000|Overall Study|Withdrawal by Subject|6|||
146333540|NCT01025635|527725722|FG001|Overall Study|Withdrawal by Subject|7|||
146333541|NCT01025635|527725721|FG000|Overall Study|Protocol Violation|4|||
146333542|NCT01025635|527725722|FG001|Overall Study|Protocol Violation|2|||
146333543|NCT01025635|527725721|FG000|Overall Study|Lack of Efficacy|0|||
146333544|NCT01025635|527725722|FG001|Overall Study|Lack of Efficacy|1|||
146333545|NCT01025635|527725721|FG000|Overall Study|Lost to Follow-up|9|||
146333546|NCT01025635|527725722|FG001|Overall Study|Lost to Follow-up|13|||
146333547|NCT01025635|527725721|FG000|Overall Study|Reason not known|4|||
146333548|NCT01025635|527725722|FG001|Overall Study|Reason not known|2|||
146333549|NCT02393209|527725723|FG000|Overall Study|Study Terminated by Sponsor|1|||
146333550|NCT02393209|527725724|FG001|Overall Study|Study Terminated by Sponsor|1|||
146333551|NCT02393209|527725725|FG002|Overall Study|Study Terminated by Sponsor|0|||
146333552|NCT02393209|527725726|FG003|Overall Study|Study Terminated by Sponsor|0|||
146333553|NCT02393209|527725723|FG000|Overall Study|Withdrawal by Patient|1|||
146333554|NCT02393209|527725724|FG001|Overall Study|Withdrawal by Patient|0|||
146333555|NCT02393209|527725725|FG002|Overall Study|Withdrawal by Patient|0|||
146168716|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
146168717|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
146168718|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
146168719|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146168720|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146168721|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
146168722|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
146168723|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146168724|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146168725|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
146168726|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
146168727|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146168728|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146168729|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
146168730|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
146168731|NCT04711603|527129437|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146168732|NCT04711603|527129438|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146168733|NCT04711603|527129439|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
146168734|NCT04711603|527129440|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
146168735|NCT05805657|527129441|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
146168736|NCT05805657|527129442|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
146168737|NCT02686034|527129444|FG000|Run-In Period 1|Eligibility|12|||
146168738|NCT02686034|527129445|FG001|Run-In Period 1|Eligibility|10|||
146168739|NCT02686034|527129444|FG000|Run-In Period 1|Withdrawal by Subject|4|||
146168740|NCT02686034|527129445|FG001|Run-In Period 1|Withdrawal by Subject|3|||
146168741|NCT02686034|527129444|FG000|Run-In Period 1|Lost to Follow-up|4|||
146168742|NCT02686034|527129445|FG001|Run-In Period 1|Lost to Follow-up|4|||
146168743|NCT02686034|527129444|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
146168744|NCT02686034|527129445|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
146168745|NCT02686034|527129444|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
146168746|NCT02686034|527129445|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
146168747|NCT02686034|527129444|FG000|Randomized Controlled Period 2|Adverse Event|0|||
146168748|NCT02686034|527129445|FG001|Randomized Controlled Period 2|Adverse Event|2|||
146168749|NCT02686034|527129444|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
146168750|NCT02686034|527129445|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
146168751|NCT02686034|527129444|FG000|Open Label Period 3|Lost to Follow-up|0|||
146168752|NCT02686034|527129445|FG001|Open Label Period 3|Lost to Follow-up|1|||
146168753|NCT00459342|527129446|FG000|Overall Study|Not eligible|1|||
146168754|NCT00542880|527129447|FG000|Period 1|Eligibility criteria not fulfilled|2|||
146168755|NCT00542880|527129448|FG001|Period 1|Eligibility criteria not fulfilled|6|||
146168756|NCT00542880|527129447|FG000|Period 1|Adverse Event|2|||
146168757|NCT00542880|527129448|FG001|Period 1|Adverse Event|2|||
146168758|NCT00542880|527129447|FG000|Period 1|Development of study-specific criteria|1|||
146168759|NCT00542880|527129448|FG001|Period 1|Development of study-specific criteria|2|||
146168760|NCT00542880|527129447|FG000|Period 1|Withdrawal by Subject|1|||
146168761|NCT00542880|527129448|FG001|Period 1|Withdrawal by Subject|1|||
146168762|NCT00542880|527129447|FG000|Period 1|Protocol Violation|0|||
146168763|NCT00542880|527129448|FG001|Period 1|Protocol Violation|1|||
146168764|NCT00542880|527129447|FG000|Period 2|Adverse Event|5|||
146168765|NCT00542880|527129448|FG001|Period 2|Adverse Event|7|||
146168766|NCT00542880|527129447|FG000|Period 2|Eligibility not fulfilled|0|||
146168767|NCT00542880|527129448|FG001|Period 2|Eligibility not fulfilled|1|||
146168768|NCT00542880|527129447|FG000|Period 2|Discontinuation criteria|2|||
146168769|NCT00542880|527129448|FG001|Period 2|Discontinuation criteria|0|||
146333556|NCT02393209|527725726|FG003|Overall Study|Withdrawal by Patient|0|||
146333557|NCT02393209|527725723|FG000|Overall Study|Death|2|||
146333558|NCT02393209|527725724|FG001|Overall Study|Death|2|||
146333559|NCT02393209|527725725|FG002|Overall Study|Death|0|||
145943271|NCT02326298|526300465|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
146168770|NCT00542880|527129447|FG000|Period 2|Severe non-compliance|0|||
146168771|NCT00542880|527129448|FG001|Period 2|Severe non-compliance|1|||
146168772|NCT00542880|527129447|FG000|Period 2|Other|0|||
146168773|NCT00542880|527129448|FG001|Period 2|Other|1|||
146168774|NCT00542880|527129447|FG000|Period 3|Adverse Event|0|||
146333560|NCT02393209|527725726|FG003|Overall Study|Death|0|||
146333561|NCT02393209|527725723|FG000|Overall Study|Death due to Disease Progression|2|||
146333562|NCT02393209|527725724|FG001|Overall Study|Death due to Disease Progression|2|||
146333563|NCT02393209|527725725|FG002|Overall Study|Death due to Disease Progression|0|||
146333564|NCT02393209|527725726|FG003|Overall Study|Death due to Disease Progression|0|||
146333565|NCT02393209|527725723|FG000|Overall Study|Death from Legionella Infection|0|||
146333566|NCT02393209|527725724|FG001|Overall Study|Death from Legionella Infection|1|||
146333567|NCT02393209|527725725|FG002|Overall Study|Death from Legionella Infection|0|||
146333568|NCT02393209|527725726|FG003|Overall Study|Death from Legionella Infection|0|||
146333569|NCT02393209|527725723|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
146333570|NCT02393209|527725724|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
146333571|NCT02393209|527725725|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
146333572|NCT02393209|527725726|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
146333573|NCT02393209|527725723|FG000|Overall Study|Lost to Follow-up|0|||
146333574|NCT02393209|527725724|FG001|Overall Study|Lost to Follow-up|1|||
146333575|NCT02393209|527725725|FG002|Overall Study|Lost to Follow-up|0|||
146333576|NCT02393209|527725726|FG003|Overall Study|Lost to Follow-up|0|||
146333577|NCT00727402|527725727|FG000|Overall Study|Physician Decision|116|||
146333578|NCT03545282|527725728|FG000|Overall Study|Lost to Follow-up|15|||
146333579|NCT03545282|527725729|FG001|Overall Study|Lost to Follow-up|10|||
146333580|NCT03545282|527725728|FG000|Overall Study|Withdrawal by Subject|2|||
146333581|NCT03545282|527725729|FG001|Overall Study|Withdrawal by Subject|2|||
146333582|NCT02209506|527725730|FG000|Overall Study|Withdrawal by Subject|0|||
146333583|NCT02209506|527725731|FG001|Overall Study|Withdrawal by Subject|0|||
146333584|NCT02209506|527725732|FG002|Overall Study|Withdrawal by Subject|0|||
146333585|NCT02209506|527725733|FG003|Overall Study|Withdrawal by Subject|0|||
146333586|NCT02209506|527725734|FG004|Overall Study|Withdrawal by Subject|1|||
146333587|NCT02582671|527725735|FG000|Overall Study|Failure to return|1|||
146333588|NCT02582671|527725735|FG000|Overall Study|Other, not specified|1|||
146333589|NCT02537678|527725738|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
146333590|NCT02537678|527725739|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
146333591|NCT02537678|527725738|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
146333592|NCT02537678|527725739|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
146333593|NCT02537678|527725738|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
146333594|NCT02537678|527725739|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
146333595|NCT02537678|527725738|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
146333596|NCT02537678|527725739|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
146333597|NCT02537678|527725738|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
146333598|NCT02537678|527725739|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
146333599|NCT02537678|527725738|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
146333600|NCT02537678|527725739|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
146333601|NCT02537678|527725738|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
146333602|NCT02537678|527725739|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
146333603|NCT01478958|527725740|FG000|Overall Study|Withdrawal by Subject|1|||
146333604|NCT01478958|527725741|FG001|Overall Study|Withdrawal by Subject|1|||
146333605|NCT01478958|527725742|FG002|Overall Study|Withdrawal by Subject|1|||
146333606|NCT01478958|527725740|FG000|Overall Study|Weight loss|1|||
146333607|NCT01478958|527725741|FG001|Overall Study|Weight loss|0|||
146333608|NCT01478958|527725742|FG002|Overall Study|Weight loss|0|||
146333609|NCT01478958|527725740|FG000|Overall Study|Re-located|0|||
146333610|NCT01478958|527725741|FG001|Overall Study|Re-located|1|||
146333611|NCT01478958|527725742|FG002|Overall Study|Re-located|0|||
146333612|NCT01478958|527725740|FG000|Overall Study|Unable to comply|0|||
146333613|NCT01478958|527725741|FG001|Overall Study|Unable to comply|0|||
146333614|NCT01478958|527725742|FG002|Overall Study|Unable to comply|2|||
146333615|NCT01499290|527725743|FG000|Overall Study|Withdrawal by Subject|22|||
146333616|NCT01499290|527725744|FG001|Overall Study|Withdrawal by Subject|15|||
146333617|NCT01499290|527725743|FG000|Overall Study|Not specified in study report|11|||
146333618|NCT01499290|527725744|FG001|Overall Study|Not specified in study report|5|||
146333619|NCT01499290|527725743|FG000|Overall Study|Condition improved/subject recovered|1|||
146333620|NCT01499290|527725744|FG001|Overall Study|Condition improved/subject recovered|0|||
146333621|NCT01499290|527725743|FG000|Overall Study|Lack of Efficacy|7|||
146333622|NCT01499290|527725744|FG001|Overall Study|Lack of Efficacy|8|||
146333623|NCT01499290|527725743|FG000|Overall Study|Adverse Event|14|||
146333624|NCT01499290|527725744|FG001|Overall Study|Adverse Event|7|||
146333625|NCT00327444|527725745|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
146333626|NCT00327444|527725746|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
146333627|NCT00327444|527725745|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
146333628|NCT00327444|527725746|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
146333629|NCT00327444|527725745|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
146333630|NCT00327444|527725746|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
146333631|NCT00327444|527725745|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
146333632|NCT00327444|527725746|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
146333633|NCT00327444|527725745|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
146333634|NCT00327444|527725746|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
146333635|NCT00327444|527725745|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
146333636|NCT00327444|527725746|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
146333637|NCT00327444|527725745|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
146333638|NCT00327444|527725746|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
146333639|NCT00327444|527725745|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
146333640|NCT00327444|527725746|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
146333641|NCT00805207|527725747|FG000|Overall Study|Protocol Violation|0|||
146333642|NCT00805207|527725748|FG001|Overall Study|Protocol Violation|0|||
146333643|NCT00805207|527725749|FG002|Overall Study|Protocol Violation|1|||
146333644|NCT00805207|527725750|FG003|Overall Study|Protocol Violation|0|||
146333645|NCT00805207|527725751|FG004|Overall Study|Protocol Violation|0|||
146333646|NCT00805207|527725752|FG005|Overall Study|Protocol Violation|0|||
146333647|NCT00805207|527725753|FG006|Overall Study|Protocol Violation|0|||
146333648|NCT00805207|527725754|FG007|Overall Study|Protocol Violation|0|||
146333649|NCT00805207|527725755|FG008|Overall Study|Protocol Violation|0|||
146333650|NCT00805207|527725747|FG000|Overall Study|Physician Decision|0|||
146333651|NCT00805207|527725748|FG001|Overall Study|Physician Decision|1|||
146333652|NCT00805207|527725749|FG002|Overall Study|Physician Decision|0|||
146333653|NCT00805207|527725750|FG003|Overall Study|Physician Decision|0|||
146333654|NCT00805207|527725751|FG004|Overall Study|Physician Decision|0|||
146333655|NCT00805207|527725752|FG005|Overall Study|Physician Decision|1|||
146333656|NCT00805207|527725753|FG006|Overall Study|Physician Decision|0|||
146333657|NCT00805207|527725754|FG007|Overall Study|Physician Decision|0|||
146333658|NCT00805207|527725755|FG008|Overall Study|Physician Decision|0|||
146333659|NCT00805207|527725747|FG000|Overall Study|Withdrawal by Subject|0|||
146333660|NCT00805207|527725748|FG001|Overall Study|Withdrawal by Subject|1|||
146333661|NCT00805207|527725749|FG002|Overall Study|Withdrawal by Subject|0|||
146333662|NCT00805207|527725750|FG003|Overall Study|Withdrawal by Subject|0|||
146333663|NCT00805207|527725751|FG004|Overall Study|Withdrawal by Subject|1|||
146333664|NCT00805207|527725752|FG005|Overall Study|Withdrawal by Subject|2|||
146333665|NCT00805207|527725753|FG006|Overall Study|Withdrawal by Subject|0|||
146333666|NCT00805207|527725754|FG007|Overall Study|Withdrawal by Subject|0|||
146333667|NCT00805207|527725755|FG008|Overall Study|Withdrawal by Subject|0|||
146333668|NCT00552110|527725757|FG000|Overall Study|Serious or Life-Threatening AE|0|||
146333669|NCT00552110|527725758|FG001|Overall Study|Serious or Life-Threatening AE|0|||
146333670|NCT00552110|527725759|FG002|Overall Study|Serious or Life-Threatening AE|1|||
146333671|NCT00552110|527725760|FG003|Overall Study|Serious or Life-Threatening AE|0|||
146333672|NCT00552110|527725761|FG004|Overall Study|Serious or Life-Threatening AE|0|||
146333673|NCT00552110|527725757|FG000|Overall Study|Lack of Efficacy|1|||
146333674|NCT00552110|527725758|FG001|Overall Study|Lack of Efficacy|0|||
146333675|NCT00552110|527725759|FG002|Overall Study|Lack of Efficacy|0|||
146333676|NCT00552110|527725760|FG003|Overall Study|Lack of Efficacy|1|||
146333677|NCT00552110|527725761|FG004|Overall Study|Lack of Efficacy|4|||
146333678|NCT00552110|527725757|FG000|Overall Study|Withdrawal by Subject|0|||
146333679|NCT00552110|527725758|FG001|Overall Study|Withdrawal by Subject|2|||
146333680|NCT00552110|527725759|FG002|Overall Study|Withdrawal by Subject|0|||
146333681|NCT00552110|527725760|FG003|Overall Study|Withdrawal by Subject|3|||
146333682|NCT00552110|527725761|FG004|Overall Study|Withdrawal by Subject|2|||
146333683|NCT00552110|527725757|FG000|Overall Study|Lost to Follow-up|0|||
146333684|NCT00552110|527725758|FG001|Overall Study|Lost to Follow-up|0|||
146333685|NCT00552110|527725759|FG002|Overall Study|Lost to Follow-up|0|||
146333686|NCT00552110|527725760|FG003|Overall Study|Lost to Follow-up|1|||
146333687|NCT00552110|527725761|FG004|Overall Study|Lost to Follow-up|1|||
146333688|NCT00552110|527725757|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
146333689|NCT00552110|527725758|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
146333690|NCT00552110|527725759|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
146333691|NCT00552110|527725760|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
146333692|NCT00552110|527725761|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
146333693|NCT00552110|527725757|FG000|Overall Study|Withdrawn per Sponsor|0|||
146333694|NCT00552110|527725758|FG001|Overall Study|Withdrawn per Sponsor|1|||
146333695|NCT00552110|527725759|FG002|Overall Study|Withdrawn per Sponsor|0|||
146333696|NCT00552110|527725760|FG003|Overall Study|Withdrawn per Sponsor|0|||
146333697|NCT00552110|527725761|FG004|Overall Study|Withdrawn per Sponsor|1|||
146333698|NCT00552110|527725757|FG000|Overall Study|Use of Prohibited Medication|1|||
146168775|NCT00542880|527129448|FG001|Period 3|Adverse Event|2|||
146333699|NCT00552110|527725758|FG001|Overall Study|Use of Prohibited Medication|1|||
146333700|NCT00552110|527725759|FG002|Overall Study|Use of Prohibited Medication|0|||
146333701|NCT00552110|527725760|FG003|Overall Study|Use of Prohibited Medication|0|||
146333702|NCT00552110|527725761|FG004|Overall Study|Use of Prohibited Medication|0|||
146333703|NCT00552110|527725757|FG000|Overall Study|Delay of Study due to Relabeling|0|||
146333704|NCT00552110|527725758|FG001|Overall Study|Delay of Study due to Relabeling|0|||
146333705|NCT00552110|527725759|FG002|Overall Study|Delay of Study due to Relabeling|0|||
146333706|NCT00552110|527725760|FG003|Overall Study|Delay of Study due to Relabeling|1|||
146333707|NCT00552110|527725761|FG004|Overall Study|Delay of Study due to Relabeling|0|||
146333708|NCT00552110|527725757|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
146333709|NCT00552110|527725758|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
146333710|NCT00552110|527725759|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
146333711|NCT00552110|527725760|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
146333712|NCT00552110|527725761|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
146333713|NCT00552110|527725757|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
146333714|NCT00552110|527725758|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
146333715|NCT00552110|527725759|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
146333716|NCT00552110|527725760|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
146333717|NCT00552110|527725761|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
146333718|NCT02048904|527725770|FG000|Overall Study|Withdrawal by Subject|7|||
146333719|NCT02048904|527725770|FG000|Overall Study|Physician Decision|70|||
146333720|NCT03832387|527725771|FG000|Overall Study|Protocol Violation|2|||
146333721|NCT03832387|527725772|FG001|Overall Study|Protocol Violation|6|||
146333722|NCT03832387|527725771|FG000|Overall Study|EXCLUSION CRITERIA|3|||
146333723|NCT03832387|527725772|FG001|Overall Study|EXCLUSION CRITERIA|1|||
146333724|NCT00490542|527725773|FG000|Overall Study|Lost to Follow-up|3|||
146333725|NCT00490542|527725774|FG001|Overall Study|Lost to Follow-up|0|||
146333726|NCT00490542|527725773|FG000|Overall Study|Adverse Event|3|||
146333727|NCT00490542|527725774|FG001|Overall Study|Adverse Event|3|||
146333728|NCT00490542|527725773|FG000|Overall Study|Lack of Efficacy|1|||
146333729|NCT00490542|527725774|FG001|Overall Study|Lack of Efficacy|1|||
146333730|NCT04640766|527725775|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
146333731|NCT00655928|527725776|FG000|Overall Study|Withdrawal by Subject|2|||
146333732|NCT00655928|527725777|FG001|Overall Study|Withdrawal by Subject|1|||
146333733|NCT00655928|527725776|FG000|Overall Study|Physician Decision|1|||
146333734|NCT00655928|527725777|FG001|Overall Study|Physician Decision|1|||
146333735|NCT02654002|527725779|FG000|Overall Study|Adverse Event|0|||
146333736|NCT02654002|527725780|FG001|Overall Study|Adverse Event|0|||
146333737|NCT02654002|527725781|FG002|Overall Study|Adverse Event|0|||
146333738|NCT02654002|527725782|FG003|Overall Study|Adverse Event|0|||
146333739|NCT02654002|527725783|FG004|Overall Study|Adverse Event|0|||
146333740|NCT02654002|527725784|FG005|Overall Study|Adverse Event|0|||
146333741|NCT02654002|527725785|FG006|Overall Study|Adverse Event|1|||
146333742|NCT02654002|527725786|FG007|Overall Study|Adverse Event|0|||
146333743|NCT02654002|527725787|FG008|Overall Study|Adverse Event|0|||
146333744|NCT02654002|527725779|FG000|Overall Study|Withdrew Consent|0|||
146333745|NCT02654002|527725780|FG001|Overall Study|Withdrew Consent|0|||
146333746|NCT02654002|527725781|FG002|Overall Study|Withdrew Consent|0|||
146333747|NCT02654002|527725782|FG003|Overall Study|Withdrew Consent|0|||
146333748|NCT02654002|527725783|FG004|Overall Study|Withdrew Consent|0|||
146333749|NCT02654002|527725784|FG005|Overall Study|Withdrew Consent|1|||
146333750|NCT02654002|527725785|FG006|Overall Study|Withdrew Consent|0|||
146333751|NCT02654002|527725786|FG007|Overall Study|Withdrew Consent|1|||
146333752|NCT02654002|527725787|FG008|Overall Study|Withdrew Consent|0|||
146333753|NCT01587989|527725788|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
146333754|NCT01587989|527725789|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
146333755|NCT01587989|527725790|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
146333756|NCT01587989|527725788|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
146333757|NCT01587989|527725789|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
146333758|NCT01587989|527725790|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
146333759|NCT01587989|527725788|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
146333760|NCT01587989|527725789|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
146333761|NCT01587989|527725790|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
146333762|NCT01587989|527725788|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
146333763|NCT01587989|527725789|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
146333764|NCT01587989|527725790|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
146333765|NCT01587989|527725788|FG000|Randomized Study Treatment|Screening failure|0|||
146333766|NCT01587989|527725789|FG001|Randomized Study Treatment|Screening failure|1|||
146333767|NCT01587989|527725790|FG002|Randomized Study Treatment|Screening failure|0|||
146333768|NCT01587989|527725788|FG000|Randomized Study Treatment|Physician Decision|0|||
146333769|NCT01587989|527725789|FG001|Randomized Study Treatment|Physician Decision|0|||
146333770|NCT01587989|527725790|FG002|Randomized Study Treatment|Physician Decision|1|||
146333771|NCT01291017|527725791|FG000|Overall Study|Lost to Follow-up|2|||
146168776|NCT00696384|527129449|FG000|Open Label Phase|Adverse Event|27|||
146333772|NCT01291017|527725791|FG000|Overall Study|Withdrawal by Subject|3|||
146168777|NCT00696384|527129450|FG001|Open Label Phase|Adverse Event|0|||
146333773|NCT06119191|527725792|FG000|Overall Study|Adverse Event|0|||
146333774|NCT06119191|527725793|FG001|Overall Study|Adverse Event|1|||
146333775|NCT06119191|527725792|FG000|Overall Study|Protocol Violation|1|||
146333776|NCT06119191|527725793|FG001|Overall Study|Protocol Violation|0|||
146333777|NCT04375761|527728282|FG000|Overall Study|Death|1|||
146333778|NCT04375761|527728283|FG001|Overall Study|Death|2|||
146333779|NCT04375761|527728282|FG000|Overall Study|Lost to Follow-up|203|||
146333780|NCT04375761|527728283|FG001|Overall Study|Lost to Follow-up|380|||
146333781|NCT04375761|527728282|FG000|Overall Study|Withdrawal by Subject|47|||
146333782|NCT04375761|527728283|FG001|Overall Study|Withdrawal by Subject|98|||
146333783|NCT04375761|527728282|FG000|Overall Study|Noncompliance with study procedure|121|||
146333784|NCT04375761|527728283|FG001|Overall Study|Noncompliance with study procedure|251|||
146333785|NCT04375761|527728282|FG000|Overall Study|Reimbursement not enough|1|||
146333786|NCT04375761|527728283|FG001|Overall Study|Reimbursement not enough|2|||
146333787|NCT04375761|527728282|FG000|Overall Study|Unforeseen family circumstances|1|||
146333788|NCT04375761|527728283|FG001|Overall Study|Unforeseen family circumstances|3|||
146333789|NCT04375761|527728282|FG000|Overall Study|Test too painful|1|||
146333790|NCT04375761|527728283|FG001|Overall Study|Test too painful|1|||
146333791|NCT04375761|527728282|FG000|Overall Study|Moved|0|||
146333792|NCT04375761|527728283|FG001|Overall Study|Moved|2|||
146333793|NCT04375761|527728282|FG000|Overall Study|Nonresponsive|0|||
146333794|NCT04375761|527728283|FG001|Overall Study|Nonresponsive|5|||
146333795|NCT01412879|527728285|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
146333796|NCT01412879|527728286|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
146333797|NCT01412879|527728287|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
146333798|NCT01412879|527728285|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
146333799|NCT01412879|527728286|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
146333800|NCT01412879|527728287|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
146333801|NCT01412879|527728285|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
146333802|NCT01412879|527728286|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
146333803|NCT01412879|527728287|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
146333804|NCT01412879|527728285|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
146333805|NCT01412879|527728286|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
146333806|NCT01412879|527728287|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
146333807|NCT01412879|527728285|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
146333808|NCT01412879|527728286|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
146333809|NCT01412879|527728287|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
146333810|NCT00496366|527728289|FG000|Overall Study|Death|1|||
146333811|NCT00260208|527728300|FG000|Overall Study|Subject withdrew consent|11|||
146333812|NCT00260208|527728301|FG001|Overall Study|Subject withdrew consent|7|||
146333813|NCT00260208|527728300|FG000|Overall Study|Lost to Follow-up|6|||
146333814|NCT00260208|527728301|FG001|Overall Study|Lost to Follow-up|1|||
146333815|NCT00260208|527728300|FG000|Overall Study|Death|12|||
146333816|NCT00260208|527728301|FG001|Overall Study|Death|10|||
146333817|NCT00260208|527728300|FG000|Overall Study|Missing|18|||
146333818|NCT00260208|527728301|FG001|Overall Study|Missing|16|||
146333819|NCT02091440|527728302|FG000|Overall Study|Death|2|||
146333820|NCT00768222|527728303|FG000|Overall Study|Lost to Follow-up|1|||
146333821|NCT00768222|527728304|FG001|Overall Study|Lost to Follow-up|1|||
146333822|NCT00768222|527728303|FG000|Overall Study|Withdrawal by Subject|3|||
146333823|NCT00768222|527728304|FG001|Overall Study|Withdrawal by Subject|1|||
146333824|NCT00768222|527728303|FG000|Overall Study|Protocol Violation|0|||
146333825|NCT00768222|527728304|FG001|Overall Study|Protocol Violation|2|||
146333826|NCT03323749|527728311|FG000|Double-blind Period|Lost to Follow-up|4|||
146333827|NCT03323749|527728312|FG001|Double-blind Period|Lost to Follow-up|5|||
146333828|NCT03323749|527728311|FG000|Double-blind Period|Adverse Event|3|||
146333829|NCT03323749|527728312|FG001|Double-blind Period|Adverse Event|1|||
146333830|NCT03323749|527728311|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
146168778|NCT00696384|527129451|FG002|Open Label Phase|Adverse Event|0|||
146168779|NCT00696384|527129449|FG000|Open Label Phase|Protocol Violation|18|||
146168780|NCT00696384|527129450|FG001|Open Label Phase|Protocol Violation|0|||
146168781|NCT00696384|527129451|FG002|Open Label Phase|Protocol Violation|0|||
146333831|NCT03323749|527728312|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
146333832|NCT03323749|527728311|FG000|Open-Label Period|Adverse Event|3|||
146333833|NCT03323749|527728312|FG001|Open-Label Period|Adverse Event|10|||
146333834|NCT03323749|527728311|FG000|Open-Label Period|Withdrawal by Subject|7|||
146333835|NCT03323749|527728312|FG001|Open-Label Period|Withdrawal by Subject|5|||
146333836|NCT00506389|527728317|FG000|In-treatment Period|Other|3|||
146168782|NCT00696384|527129449|FG000|Open Label Phase|Lost to Follow-up|24|||
146333837|NCT00506389|527728318|FG001|In-treatment Period|Other|3|||
146333838|NCT00506389|527728319|FG002|In-treatment Period|Other|4|||
146333839|NCT00506389|527728317|FG000|In-treatment Period|Lost to Follow-up|0|||
146333840|NCT00506389|527728318|FG001|In-treatment Period|Lost to Follow-up|0|||
146333841|NCT00506389|527728319|FG002|In-treatment Period|Lost to Follow-up|1|||
146168783|NCT00696384|527129450|FG001|Open Label Phase|Lost to Follow-up|0|||
146333842|NCT00506389|527728317|FG000|In-treatment Period|Lack of compliance|1|||
146333843|NCT00506389|527728318|FG001|In-treatment Period|Lack of compliance|0|||
146333844|NCT00506389|527728319|FG002|In-treatment Period|Lack of compliance|0|||
146333845|NCT00506389|527728317|FG000|In-treatment Period|Reasons not related to trial|4|||
146333846|NCT00506389|527728318|FG001|In-treatment Period|Reasons not related to trial|1|||
146333847|NCT00506389|527728319|FG002|In-treatment Period|Reasons not related to trial|0|||
146333848|NCT00506389|527728317|FG000|In-treatment Period|Withdrawal by Subject|3|||
146333849|NCT00506389|527728318|FG001|In-treatment Period|Withdrawal by Subject|3|||
146333850|NCT00506389|527728319|FG002|In-treatment Period|Withdrawal by Subject|4|||
146333851|NCT00506389|527728317|FG000|In-treatment Period|Lack of Efficacy|0|||
146333852|NCT00506389|527728318|FG001|In-treatment Period|Lack of Efficacy|2|||
146333853|NCT00506389|527728319|FG002|In-treatment Period|Lack of Efficacy|0|||
146333854|NCT00506389|527728317|FG000|In-treatment Period|Adverse Event|11|||
146333855|NCT00506389|527728318|FG001|In-treatment Period|Adverse Event|5|||
146333856|NCT00506389|527728319|FG002|In-treatment Period|Adverse Event|2|||
146333857|NCT00506389|527728317|FG000|In-treatment Period|Randomized but not treated|4|||
146333858|NCT00506389|527728318|FG001|In-treatment Period|Randomized but not treated|1|||
146333859|NCT00506389|527728319|FG002|In-treatment Period|Randomized but not treated|1|||
146333860|NCT03095703|527728321|FG000|Overall Study|Withdrawal by Subject|1|||
146333861|NCT03539432|527728322|FG000|Overall Study|Lost to Follow-up|0|||
146333862|NCT03539432|527728323|FG001|Overall Study|Lost to Follow-up|1|||
146333863|NCT02443402|527728328|FG000|Overall Study|Withdrawal by Subject|3|||
146333864|NCT02443402|527728329|FG001|Overall Study|Withdrawal by Subject|1|||
146333865|NCT02443402|527728328|FG000|Overall Study|Screen Failure|1|||
146168784|NCT00696384|527129451|FG002|Open Label Phase|Lost to Follow-up|0|||
146168785|NCT00696384|527129449|FG000|Open Label Phase|Withdrawal by Subject|37|||
146168786|NCT00696384|527129450|FG001|Open Label Phase|Withdrawal by Subject|0|||
146168787|NCT00696384|527129451|FG002|Open Label Phase|Withdrawal by Subject|0|||
146168788|NCT00696384|527129449|FG000|Open Label Phase|Other|6|||
146168789|NCT00696384|527129450|FG001|Open Label Phase|Other|0|||
146168790|NCT00696384|527129451|FG002|Open Label Phase|Other|0|||
146168791|NCT00696384|527129449|FG000|Open Label Phase|Lack of Efficacy|3|||
146168792|NCT00696384|527129450|FG001|Open Label Phase|Lack of Efficacy|0|||
146168793|NCT00696384|527129451|FG002|Open Label Phase|Lack of Efficacy|0|||
146168794|NCT00696384|527129449|FG000|Open Label Phase|Physician Decision|4|||
146168795|NCT00696384|527129450|FG001|Open Label Phase|Physician Decision|0|||
146168796|NCT00696384|527129451|FG002|Open Label Phase|Physician Decision|0|||
146168797|NCT00696384|527129449|FG000|Double Blind Phase|Adverse Event|0|||
146168798|NCT00696384|527129450|FG001|Double Blind Phase|Adverse Event|2|||
146168799|NCT00696384|527129451|FG002|Double Blind Phase|Adverse Event|2|||
146168800|NCT00696384|527129449|FG000|Double Blind Phase|Lost to Follow-up|0|||
146168801|NCT00696384|527129450|FG001|Double Blind Phase|Lost to Follow-up|2|||
146168802|NCT00696384|527129451|FG002|Double Blind Phase|Lost to Follow-up|1|||
146168803|NCT00696384|527129449|FG000|Double Blind Phase|Withdrawal by Subject|0|||
146168804|NCT00696384|527129450|FG001|Double Blind Phase|Withdrawal by Subject|4|||
146168805|NCT00696384|527129451|FG002|Double Blind Phase|Withdrawal by Subject|3|||
146168806|NCT00696384|527129449|FG000|Double Blind Phase|Lack of Efficacy|0|||
146168807|NCT00696384|527129450|FG001|Double Blind Phase|Lack of Efficacy|1|||
146168808|NCT00696384|527129451|FG002|Double Blind Phase|Lack of Efficacy|0|||
146168809|NCT00696384|527129449|FG000|Double Blind Phase|Physician Decision|0|||
146333866|NCT02443402|527728329|FG001|Overall Study|Screen Failure|2|||
146333867|NCT01934504|527728331|FG000|Overall Study|Protocol Deviation|0|||
146333868|NCT01934504|527728332|FG001|Overall Study|Protocol Deviation|0|||
146333869|NCT01934504|527728333|FG002|Overall Study|Protocol Deviation|0|||
146333870|NCT01934504|527728334|FG003|Overall Study|Protocol Deviation|2|||
146333871|NCT01934504|527728331|FG000|Overall Study|Study Terminated by Sponsor|1|||
146333872|NCT01934504|527728332|FG001|Overall Study|Study Terminated by Sponsor|0|||
146333873|NCT01934504|527728333|FG002|Overall Study|Study Terminated by Sponsor|5|||
146333874|NCT01934504|527728334|FG003|Overall Study|Study Terminated by Sponsor|5|||
146333875|NCT02665689|527728341|FG000|Overall Study|Adverse Event|1|||
146333876|NCT02665689|527728342|FG001|Overall Study|Adverse Event|0|||
146333877|NCT02665689|527728341|FG000|Overall Study|Trial termination|1|||
146333878|NCT02665689|527728342|FG001|Overall Study|Trial termination|1|||
146333879|NCT02665689|527728341|FG000|Overall Study|Lost to Follow-up|0|||
146333880|NCT02665689|527728342|FG001|Overall Study|Lost to Follow-up|1|||
146168810|NCT00696384|527129450|FG001|Double Blind Phase|Physician Decision|2|||
146168811|NCT00696384|527129451|FG002|Double Blind Phase|Physician Decision|0|||
146168812|NCT01678131|527129452|FG000|Overall Study|Adverse Event|0|||
146168813|NCT01678131|527129453|FG001|Overall Study|Adverse Event|1|||
146333881|NCT03615222|527728353|FG000|Overall Study|Ineligible|26|||
146333882|NCT03615222|527728353|FG000|Overall Study|Withdrawal by Subject|7|||
146333883|NCT03615222|527728353|FG000|Overall Study|Death|1|||
146333884|NCT00476086|527728354|FG000|Overall Study|Alternative therapy|1|||
146333885|NCT00476086|527728354|FG000|Overall Study|Progressive Disease|4|||
146333886|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
146333887|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
146333888|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
146168814|NCT01678131|527129454|FG002|Overall Study|Adverse Event|0|||
146333889|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146333890|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146333891|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
146333892|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
146333893|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146333894|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146333895|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146333896|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146333897|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
146333898|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
146333899|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146333900|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146333901|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146333902|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146333903|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
146333904|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
146333905|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
146333906|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
146333907|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146333908|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146333909|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
146333910|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146333911|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
146333912|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146333913|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146333914|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146333915|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
146333916|NCT03895203|527728355|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146333917|NCT03895203|527728356|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
146333918|NCT03895203|527728357|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146333919|NCT03895203|527728358|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146333920|NCT03895203|527728359|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146333921|NCT03895203|527728360|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
146333922|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146333923|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146333924|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146333925|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
146333926|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146333927|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
146333928|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146333929|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146333930|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
146333931|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
146333932|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
146333933|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
146333934|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146333935|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146333936|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
146333937|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
146333938|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
146333939|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
146333940|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146333941|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146333942|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146333943|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
146333944|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
146333945|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
146333946|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146333947|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146333948|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
146333949|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
146333950|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
146333951|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
146396136|NCT01241591|527954454|FG002|Overall Study|Lost to Follow-up|2|||
145943272|NCT02326298|526300466|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146333952|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146333953|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146333954|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146333955|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
146333956|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146333957|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
146333958|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146333959|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146333960|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146333961|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
146333962|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146333963|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
146333964|NCT03895203|527728355|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146333965|NCT03895203|527728356|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146333966|NCT03895203|527728357|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146333967|NCT03895203|527728358|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146333968|NCT03895203|527728359|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
146333969|NCT03895203|527728360|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
146333970|NCT04125680|527728361|FG000|Overall Study|Lost to Follow-up|15|||
146333971|NCT04938648|527728362|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
146333972|NCT04938648|527728363|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
146333973|NCT04938648|527728362|FG000|Overall Study|Patient too ill|0|||
146333974|NCT04938648|527728363|FG001|Overall Study|Patient too ill|1|||
146333975|NCT04938648|527728362|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
146333976|NCT04938648|527728363|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
146333977|NCT04938648|527728362|FG000|Overall Study|Patient did not have memory problems|1|||
146333978|NCT04938648|527728363|FG001|Overall Study|Patient did not have memory problems|1|||
146333979|NCT04938648|527728362|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
146333980|NCT04938648|527728363|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
146333981|NCT04938648|527728362|FG000|Overall Study|Care partner could not be reached|0|||
146333982|NCT04938648|527728363|FG001|Overall Study|Care partner could not be reached|1|||
146333983|NCT04938648|527728362|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
146333984|NCT04938648|527728363|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
146333985|NCT04938648|527728362|FG000|Overall Study|Withdrawal by Subject|2|||
146333986|NCT04938648|527728363|FG001|Overall Study|Withdrawal by Subject|1|||
146333987|NCT00364793|527728364|FG000|Overall Study|Adverse Event|2|||
146333988|NCT00364793|527728365|FG001|Overall Study|Adverse Event|0|||
146333989|NCT00364793|527728366|FG002|Overall Study|Adverse Event|0|||
146333990|NCT00364793|527728367|FG003|Overall Study|Adverse Event|0|||
146333991|NCT00364793|527728364|FG000|Overall Study|Death|1|||
146333992|NCT00364793|527728365|FG001|Overall Study|Death|0|||
146333993|NCT00364793|527728366|FG002|Overall Study|Death|1|||
146333994|NCT00364793|527728367|FG003|Overall Study|Death|0|||
146333995|NCT00364793|527728364|FG000|Overall Study|Lack of Efficacy|3|||
146333996|NCT00364793|527728365|FG001|Overall Study|Lack of Efficacy|3|||
146333997|NCT00364793|527728366|FG002|Overall Study|Lack of Efficacy|1|||
146333998|NCT00364793|527728367|FG003|Overall Study|Lack of Efficacy|1|||
146333999|NCT00364793|527728364|FG000|Overall Study|Lost to Follow-up|1|||
146334000|NCT00364793|527728365|FG001|Overall Study|Lost to Follow-up|0|||
146334001|NCT00364793|527728366|FG002|Overall Study|Lost to Follow-up|2|||
146334002|NCT00364793|527728367|FG003|Overall Study|Lost to Follow-up|0|||
146334003|NCT00364793|527728364|FG000|Overall Study|Poor or non-compliance|1|||
146334004|NCT00364793|527728365|FG001|Overall Study|Poor or non-compliance|1|||
146334005|NCT00364793|527728366|FG002|Overall Study|Poor or non-compliance|0|||
146334006|NCT00364793|527728367|FG003|Overall Study|Poor or non-compliance|1|||
146334007|NCT00364793|527728364|FG000|Overall Study|No longer meets criteria|0|||
146334008|NCT00364793|527728365|FG001|Overall Study|No longer meets criteria|0|||
146334009|NCT00364793|527728366|FG002|Overall Study|No longer meets criteria|0|||
146334010|NCT00364793|527728367|FG003|Overall Study|No longer meets criteria|1|||
146334011|NCT00364793|527728364|FG000|Overall Study|Withdrawal by Subject|0|||
146334012|NCT00364793|527728365|FG001|Overall Study|Withdrawal by Subject|1|||
146334013|NCT00364793|527728366|FG002|Overall Study|Withdrawal by Subject|0|||
146334014|NCT00364793|527728367|FG003|Overall Study|Withdrawal by Subject|0|||
146334015|NCT00049127|527728368|FG000|Overall Study|Withdrawal by Subject|0|||
146334016|NCT00049127|527728369|FG001|Overall Study|Withdrawal by Subject|0|||
146334017|NCT00049127|527728370|FG002|Overall Study|Withdrawal by Subject|1|||
146334018|NCT00049127|527728371|FG003|Overall Study|Withdrawal by Subject|0|||
146334019|NCT00049127|527728372|FG004|Overall Study|Withdrawal by Subject|0|||
146334020|NCT01287754|527728375|FG000|Overall Study|Death|2|||
146334021|NCT01287754|527728376|FG001|Overall Study|Death|12|||
146334022|NCT01287754|527728375|FG000|Overall Study|Lost to Follow-up|1|||
146334023|NCT01287754|527728376|FG001|Overall Study|Lost to Follow-up|6|||
146334024|NCT01287754|527728375|FG000|Overall Study|Protocol Violation|0|||
146334025|NCT01287754|527728376|FG001|Overall Study|Protocol Violation|3|||
146334026|NCT00001337|527728387|FG000|Overall Study|Switched to alternate treatment|2|||
146334027|NCT00001337|527728388|FG001|Overall Study|Switched to alternate treatment|2|||
146334028|NCT00001337|527728389|FG002|Overall Study|Switched to alternate treatment|0|||
146334029|NCT00001337|527728387|FG000|Overall Study|Refused further treatment|2|||
146334030|NCT00001337|527728388|FG001|Overall Study|Refused further treatment|1|||
146334031|NCT00001337|527728389|FG002|Overall Study|Refused further treatment|0|||
146334032|NCT00001337|527728387|FG000|Overall Study|Began other Tx|1|||
146334033|NCT00001337|527728388|FG001|Overall Study|Began other Tx|0|||
146334034|NCT00001337|527728389|FG002|Overall Study|Began other Tx|0|||
146334035|NCT00001337|527728387|FG000|Overall Study|Physician Decision|3|||
146334036|NCT00001337|527728388|FG001|Overall Study|Physician Decision|1|||
146334037|NCT00001337|527728389|FG002|Overall Study|Physician Decision|0|||
146334038|NCT00001337|527728387|FG000|Overall Study|Doesn't have NHL|0|||
146334039|NCT00001337|527728388|FG001|Overall Study|Doesn't have NHL|1|||
146334040|NCT00001337|527728389|FG002|Overall Study|Doesn't have NHL|0|||
146334041|NCT00001337|527728387|FG000|Overall Study|Non protocol tx needed|3|||
146334042|NCT00001337|527728388|FG001|Overall Study|Non protocol tx needed|1|||
146334043|NCT00001337|527728389|FG002|Overall Study|Non protocol tx needed|0|||
146334044|NCT00001337|527728387|FG000|Overall Study|Protocol change|1|||
146334045|NCT00001337|527728388|FG001|Overall Study|Protocol change|0|||
146334046|NCT00001337|527728389|FG002|Overall Study|Protocol change|0|||
146334047|NCT00001337|527728387|FG000|Overall Study|2nd primary disease|0|||
146334048|NCT00001337|527728388|FG001|Overall Study|2nd primary disease|0|||
146334049|NCT00001337|527728389|FG002|Overall Study|2nd primary disease|1|||
146334050|NCT00001337|527728387|FG000|Overall Study|Death during follow up period|9|||
146334051|NCT00001337|527728388|FG001|Overall Study|Death during follow up period|4|||
146334052|NCT00001337|527728389|FG002|Overall Study|Death during follow up period|0|||
146334053|NCT00001337|527728387|FG000|Overall Study|Death on study|19|||
146334054|NCT00001337|527728388|FG001|Overall Study|Death on study|9|||
146334055|NCT00001337|527728389|FG002|Overall Study|Death on study|0|||
146334056|NCT00001337|527728387|FG000|Overall Study|Disease progression during follow-up period|3|||
146334057|NCT00001337|527728388|FG001|Overall Study|Disease progression during follow-up period|1|||
146334058|NCT00001337|527728389|FG002|Overall Study|Disease progression during follow-up period|0|||
146334059|NCT00001337|527728387|FG000|Overall Study|Disease progression on study|33|||
146334060|NCT00001337|527728388|FG001|Overall Study|Disease progression on study|41|||
146334061|NCT00001337|527728389|FG002|Overall Study|Disease progression on study|0|||
146334062|NCT00001337|527728387|FG000|Overall Study|Lost to further follow-up|10|||
146334063|NCT00001337|527728388|FG001|Overall Study|Lost to further follow-up|6|||
146334064|NCT00001337|527728389|FG002|Overall Study|Lost to further follow-up|0|||
146334065|NCT00001337|527728387|FG000|Overall Study|2nd malignancy|1|||
146334066|NCT00001337|527728388|FG001|Overall Study|2nd malignancy|0|||
146334067|NCT00001337|527728389|FG002|Overall Study|2nd malignancy|0|||
146334068|NCT00001337|527728387|FG000|Overall Study|Treatment for second lymphoma|0|||
146334069|NCT00001337|527728388|FG001|Overall Study|Treatment for second lymphoma|1|||
146334070|NCT00001337|527728389|FG002|Overall Study|Treatment for second lymphoma|0|||
146334071|NCT00001337|527728387|FG000|Overall Study|Transfer to transplant|0|||
146334072|NCT00001337|527728388|FG001|Overall Study|Transfer to transplant|1|||
146334073|NCT00001337|527728389|FG002|Overall Study|Transfer to transplant|0|||
146334074|NCT04889209|527728392|FG000|All Cohorts Except 15E|Adverse Event|0|||
146334075|NCT04889209|527728393|FG001|All Cohorts Except 15E|Adverse Event|0|||
146334076|NCT04889209|527728394|FG002|All Cohorts Except 15E|Adverse Event|0|||
146334077|NCT04889209|527728395|FG003|All Cohorts Except 15E|Adverse Event|0|||
146334078|NCT04889209|527728396|FG004|All Cohorts Except 15E|Adverse Event|0|||
146334079|NCT04889209|527728397|FG005|All Cohorts Except 15E|Adverse Event|0|||
146334080|NCT04889209|527728398|FG006|All Cohorts Except 15E|Adverse Event|1|||
146334081|NCT04889209|527728399|FG007|All Cohorts Except 15E|Adverse Event|0|||
146334082|NCT04889209|527728400|FG008|All Cohorts Except 15E|Adverse Event|0|||
146334083|NCT04889209|527728401|FG009|All Cohorts Except 15E|Adverse Event|0|||
146334084|NCT04889209|527728402|FG010|All Cohorts Except 15E|Adverse Event|0|||
146334085|NCT04889209|527728403|FG011|All Cohorts Except 15E|Adverse Event|0|||
146334086|NCT04889209|527728404|FG012|All Cohorts Except 15E|Adverse Event|0|||
146334087|NCT04889209|527728405|FG013|All Cohorts Except 15E|Adverse Event|0|||
146334088|NCT04889209|527728406|FG014|All Cohorts Except 15E|Adverse Event|0|||
146334089|NCT04889209|527728407|FG015|All Cohorts Except 15E|Adverse Event|0|||
146334090|NCT04889209|527728408|FG016|All Cohorts Except 15E|Adverse Event|0|||
146334091|NCT04889209|527728409|FG017|All Cohorts Except 15E|Adverse Event|0|||
146334092|NCT04889209|527728392|FG000|All Cohorts Except 15E|Death|0|||
146334093|NCT04889209|527728393|FG001|All Cohorts Except 15E|Death|1|||
146334094|NCT04889209|527728394|FG002|All Cohorts Except 15E|Death|0|||
146334095|NCT04889209|527728395|FG003|All Cohorts Except 15E|Death|0|||
146334096|NCT04889209|527728396|FG004|All Cohorts Except 15E|Death|0|||
146334097|NCT04889209|527728397|FG005|All Cohorts Except 15E|Death|0|||
146334098|NCT04889209|527728398|FG006|All Cohorts Except 15E|Death|0|||
146334099|NCT04889209|527728399|FG007|All Cohorts Except 15E|Death|0|||
146334100|NCT04889209|527728400|FG008|All Cohorts Except 15E|Death|0|||
146334101|NCT04889209|527728401|FG009|All Cohorts Except 15E|Death|0|||
146334102|NCT04889209|527728402|FG010|All Cohorts Except 15E|Death|0|||
146334103|NCT04889209|527728403|FG011|All Cohorts Except 15E|Death|0|||
146334104|NCT04889209|527728404|FG012|All Cohorts Except 15E|Death|0|||
146334105|NCT04889209|527728405|FG013|All Cohorts Except 15E|Death|0|||
146334106|NCT04889209|527728406|FG014|All Cohorts Except 15E|Death|0|||
146334107|NCT04889209|527728407|FG015|All Cohorts Except 15E|Death|0|||
146334108|NCT04889209|527728408|FG016|All Cohorts Except 15E|Death|0|||
146334109|NCT04889209|527728409|FG017|All Cohorts Except 15E|Death|0|||
146334110|NCT04889209|527728392|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
146334111|NCT04889209|527728393|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
146334112|NCT04889209|527728394|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
146334113|NCT04889209|527728395|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
146334114|NCT04889209|527728396|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
146334115|NCT04889209|527728397|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
146334116|NCT04889209|527728398|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
146334117|NCT04889209|527728399|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
146334118|NCT04889209|527728400|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
146334119|NCT04889209|527728401|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
146334120|NCT04889209|527728402|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
146334121|NCT04889209|527728403|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
146334122|NCT04889209|527728404|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
146334123|NCT04889209|527728405|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
146334124|NCT04889209|527728406|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
146334125|NCT04889209|527728407|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
146334126|NCT04889209|527728408|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
146334127|NCT04889209|527728409|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
146334128|NCT04889209|527728392|FG000|All Cohorts Except 15E|Physician Decision|0|||
146334129|NCT04889209|527728393|FG001|All Cohorts Except 15E|Physician Decision|0|||
146334130|NCT04889209|527728394|FG002|All Cohorts Except 15E|Physician Decision|0|||
146334131|NCT04889209|527728395|FG003|All Cohorts Except 15E|Physician Decision|0|||
146334132|NCT04889209|527728396|FG004|All Cohorts Except 15E|Physician Decision|1|||
146334133|NCT04889209|527728397|FG005|All Cohorts Except 15E|Physician Decision|0|||
146334134|NCT04889209|527728398|FG006|All Cohorts Except 15E|Physician Decision|0|||
146334135|NCT04889209|527728399|FG007|All Cohorts Except 15E|Physician Decision|1|||
146334136|NCT04889209|527728400|FG008|All Cohorts Except 15E|Physician Decision|0|||
146334137|NCT04889209|527728401|FG009|All Cohorts Except 15E|Physician Decision|1|||
146334138|NCT04889209|527728402|FG010|All Cohorts Except 15E|Physician Decision|0|||
146334139|NCT04889209|527728403|FG011|All Cohorts Except 15E|Physician Decision|1|||
146334140|NCT04889209|527728404|FG012|All Cohorts Except 15E|Physician Decision|1|||
146334141|NCT04889209|527728405|FG013|All Cohorts Except 15E|Physician Decision|0|||
146334142|NCT04889209|527728406|FG014|All Cohorts Except 15E|Physician Decision|0|||
146334143|NCT04889209|527728407|FG015|All Cohorts Except 15E|Physician Decision|0|||
146334144|NCT04889209|527728408|FG016|All Cohorts Except 15E|Physician Decision|0|||
146334145|NCT04889209|527728409|FG017|All Cohorts Except 15E|Physician Decision|0|||
146334146|NCT04889209|527728392|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
146334147|NCT04889209|527728393|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
146334148|NCT04889209|527728394|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
146334149|NCT04889209|527728395|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
146334150|NCT04889209|527728396|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
146334151|NCT04889209|527728397|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334152|NCT04889209|527728398|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334153|NCT04889209|527728399|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
146334154|NCT04889209|527728400|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334155|NCT04889209|527728401|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334156|NCT04889209|527728402|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334157|NCT04889209|527728403|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334158|NCT04889209|527728404|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334159|NCT04889209|527728405|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
146334160|NCT04889209|527728406|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
146334161|NCT04889209|527728407|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
146334162|NCT04889209|527728408|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
146334163|NCT04889209|527728409|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
146334164|NCT04889209|527728392|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
146334165|NCT04889209|527728393|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
146334166|NCT04889209|527728394|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334167|NCT04889209|527728395|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334168|NCT04889209|527728396|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334169|NCT04889209|527728397|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146334170|NCT04889209|527728398|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334171|NCT04889209|527728399|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146334172|NCT04889209|527728400|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334173|NCT04889209|527728401|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146334174|NCT04889209|527728402|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334175|NCT04889209|527728403|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334176|NCT04889209|527728404|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334177|NCT04889209|527728405|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334178|NCT04889209|527728406|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334179|NCT04889209|527728407|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334180|NCT04889209|527728408|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
146334181|NCT04889209|527728409|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
146334182|NCT04889209|527728392|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334183|NCT04889209|527728393|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334184|NCT04889209|527728394|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334185|NCT04889209|527728395|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
146334186|NCT04889209|527728396|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334187|NCT04889209|527728397|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334188|NCT04889209|527728398|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334189|NCT04889209|527728399|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334190|NCT04889209|527728400|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334191|NCT04889209|527728401|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334192|NCT04889209|527728402|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334193|NCT04889209|527728403|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334194|NCT04889209|527728404|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334195|NCT04889209|527728405|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334196|NCT04889209|527728406|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334197|NCT04889209|527728407|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334198|NCT04889209|527728408|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334199|NCT04889209|527728409|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
146334200|NCT04889209|527728392|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334201|NCT04889209|527728393|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334202|NCT04889209|527728394|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334203|NCT04889209|527728395|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334204|NCT04889209|527728396|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334205|NCT04889209|527728397|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334206|NCT04889209|527728398|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334207|NCT04889209|527728399|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334208|NCT04889209|527728400|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334209|NCT04889209|527728401|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334210|NCT04889209|527728402|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334211|NCT04889209|527728403|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334212|NCT04889209|527728404|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334213|NCT04889209|527728405|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334214|NCT04889209|527728406|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334215|NCT04889209|527728407|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334216|NCT04889209|527728408|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
146334217|NCT04889209|527728409|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
146334218|NCT04889209|527728392|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334219|NCT04889209|527728393|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334220|NCT04889209|527728394|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334221|NCT04889209|527728395|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334222|NCT04889209|527728396|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334223|NCT04889209|527728397|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334224|NCT04889209|527728398|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334225|NCT04889209|527728399|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146168815|NCT01678131|527129452|FG000|Overall Study|Withdrawal by Subject|0|||
146334226|NCT04889209|527728400|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334227|NCT04889209|527728401|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334228|NCT04889209|527728402|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334229|NCT04889209|527728403|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334230|NCT04889209|527728404|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334231|NCT04889209|527728405|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334232|NCT04889209|527728406|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334233|NCT04889209|527728407|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334234|NCT04889209|527728408|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
146334235|NCT04889209|527728409|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
146334236|NCT04889209|527728392|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334237|NCT04889209|527728393|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334238|NCT04889209|527728394|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334239|NCT04889209|527728395|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334240|NCT04889209|527728396|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334241|NCT04889209|527728397|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334242|NCT04889209|527728398|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334243|NCT04889209|527728399|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334244|NCT04889209|527728400|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334245|NCT04889209|527728401|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334246|NCT04889209|527728402|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334247|NCT04889209|527728403|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334248|NCT04889209|527728404|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334249|NCT04889209|527728405|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334250|NCT04889209|527728406|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334251|NCT04889209|527728407|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334252|NCT04889209|527728408|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
146334253|NCT04889209|527728409|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
146334254|NCT04889209|527728392|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334255|NCT04889209|527728393|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334256|NCT04889209|527728394|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334257|NCT04889209|527728395|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334258|NCT04889209|527728396|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146168816|NCT01678131|527129453|FG001|Overall Study|Withdrawal by Subject|0|||
146168817|NCT01678131|527129454|FG002|Overall Study|Withdrawal by Subject|2|||
146168818|NCT00558064|527129456|FG000|Overall Study|Adverse Event|3|||
146168819|NCT00558064|527129457|FG001|Overall Study|Adverse Event|2|||
146168820|NCT00558064|527129456|FG000|Overall Study|Lack of Efficacy|0|||
146168821|NCT00558064|527129457|FG001|Overall Study|Lack of Efficacy|1|||
146168822|NCT00558064|527129456|FG000|Overall Study|Protocol Violation|1|||
146168823|NCT00558064|527129457|FG001|Overall Study|Protocol Violation|0|||
146168824|NCT00558064|527129456|FG000|Overall Study|Lost to Follow-up|0|||
146168825|NCT00558064|527129457|FG001|Overall Study|Lost to Follow-up|1|||
146168826|NCT00558064|527129456|FG000|Overall Study|Withdrawal by Subject|0|||
146168827|NCT00558064|527129457|FG001|Overall Study|Withdrawal by Subject|1|||
146168828|NCT00558064|527129456|FG000|Overall Study|No visit within allowance period|1|||
146168829|NCT00558064|527129457|FG001|Overall Study|No visit within allowance period|0|||
146168830|NCT02027402|527129458|FG000|Overall Study|Withdrawal by Subject|4|||
146168831|NCT02027402|527129459|FG001|Overall Study|Withdrawal by Subject|1|||
146168832|NCT00941798|527129462|FG000|Overall Study|Withdrawal by Subject|72|||
146168833|NCT00941798|527129463|FG001|Overall Study|Withdrawal by Subject|74|||
146168834|NCT00941798|527129462|FG000|Overall Study|Adverse Event|43|||
146168835|NCT00941798|527129463|FG001|Overall Study|Adverse Event|23|||
146168836|NCT00941798|527129462|FG000|Overall Study|Lost to Follow-up|29|||
146168837|NCT00941798|527129463|FG001|Overall Study|Lost to Follow-up|23|||
146168838|NCT00941798|527129462|FG000|Overall Study|Protocol Violation|17|||
146168839|NCT00941798|527129463|FG001|Overall Study|Protocol Violation|20|||
146168840|NCT00941798|527129462|FG000|Overall Study|Administrative problems|13|||
146168841|NCT00941798|527129463|FG001|Overall Study|Administrative problems|23|||
146168842|NCT00941798|527129462|FG000|Overall Study|Lack of Efficacy|10|||
146168843|NCT00941798|527129463|FG001|Overall Study|Lack of Efficacy|17|||
146168844|NCT00941798|527129462|FG000|Overall Study|Patient's inability to use device|6|||
146168845|NCT00941798|527129463|FG001|Overall Study|Patient's inability to use device|1|||
146168846|NCT00941798|527129462|FG000|Overall Study|Abnormal test procedure results|3|||
146168847|NCT00941798|527129463|FG001|Overall Study|Abnormal test procedure results|1|||
146168848|NCT00941798|527129462|FG000|Overall Study|Abnormal laboratory values|1|||
146168849|NCT00941798|527129463|FG001|Overall Study|Abnormal laboratory values|2|||
146168850|NCT00941798|527129462|FG000|Overall Study|Death|0|||
146168851|NCT00941798|527129463|FG001|Overall Study|Death|1|||
146168852|NCT04179721|527129466|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
146168853|NCT04179721|527129467|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
146334259|NCT04889209|527728397|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334260|NCT04889209|527728398|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334261|NCT04889209|527728399|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334262|NCT04889209|527728400|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334263|NCT04889209|527728401|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334264|NCT04889209|527728402|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334265|NCT04889209|527728403|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334266|NCT04889209|527728404|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334267|NCT04889209|527728405|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334268|NCT04889209|527728406|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
146334269|NCT04889209|527728407|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334270|NCT04889209|527728408|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334271|NCT04889209|527728409|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
146334272|NCT04607408|527728410|FG000|Overall Study|Lost to Follow-up|0|||
146334273|NCT04607408|527728411|FG001|Overall Study|Lost to Follow-up|0|||
146334274|NCT04607408|527728412|FG002|Overall Study|Lost to Follow-up|0|||
146334275|NCT04607408|527728413|FG003|Overall Study|Lost to Follow-up|1|||
146334276|NCT04607408|527728414|FG004|Overall Study|Lost to Follow-up|0|||
146334277|NCT04607408|527728410|FG000|Overall Study|Withdrawal by Subject|0|||
146334278|NCT04607408|527728411|FG001|Overall Study|Withdrawal by Subject|1|||
146334279|NCT04607408|527728412|FG002|Overall Study|Withdrawal by Subject|0|||
146334280|NCT04607408|527728413|FG003|Overall Study|Withdrawal by Subject|1|||
146334281|NCT04607408|527728414|FG004|Overall Study|Withdrawal by Subject|0|||
146334282|NCT01725165|527728417|FG000|Overall Study|Death|11|||
146334283|NCT01725165|527728418|FG001|Overall Study|Death|18|||
146334284|NCT03619213|527728419|FG000|Overall Study|Lost to Follow-up|2|||
146334285|NCT03619213|527728420|FG001|Overall Study|Lost to Follow-up|1|||
146334286|NCT03619213|527728419|FG000|Overall Study|Withdrawal by Subject|8|||
146334287|NCT03619213|527728420|FG001|Overall Study|Withdrawal by Subject|10|||
146334288|NCT03093402|527728421|FG000|Overall Study|Lost to Follow-up|1|||
146334289|NCT03093402|527728422|FG001|Overall Study|Lost to Follow-up|0|||
146334290|NCT03093402|527728423|FG002|Overall Study|Lost to Follow-up|0|||
146334291|NCT03093402|527728424|FG003|Overall Study|Lost to Follow-up|0|||
146334292|NCT03093402|527728421|FG000|Overall Study|Withdrawal by Subject|3|||
146334293|NCT03093402|527728422|FG001|Overall Study|Withdrawal by Subject|3|||
146334294|NCT03093402|527728423|FG002|Overall Study|Withdrawal by Subject|0|||
146334295|NCT03093402|527728424|FG003|Overall Study|Withdrawal by Subject|1|||
146334296|NCT03093402|527728421|FG000|Overall Study|Withdrew prior to dosing|2|||
146334297|NCT03093402|527728422|FG001|Overall Study|Withdrew prior to dosing|1|||
146334298|NCT03093402|527728423|FG002|Overall Study|Withdrew prior to dosing|2|||
146334299|NCT03093402|527728424|FG003|Overall Study|Withdrew prior to dosing|3|||
146334300|NCT03093402|527728421|FG000|Overall Study|Ineligible for study|1|||
146334301|NCT03093402|527728422|FG001|Overall Study|Ineligible for study|0|||
146334302|NCT03093402|527728423|FG002|Overall Study|Ineligible for study|0|||
146334303|NCT03093402|527728424|FG003|Overall Study|Ineligible for study|0|||
146334304|NCT03093402|527728421|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
146334305|NCT03093402|527728422|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
146334306|NCT03093402|527728423|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
146334307|NCT03093402|527728424|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
146334308|NCT02886702|527728427|FG000|Overall Study|Other|4|||
146334309|NCT02886702|527728428|FG001|Overall Study|Other|3|||
146334310|NCT02886702|527728429|FG002|Overall Study|Other|9|||
146334311|NCT02886702|527728427|FG000|Overall Study|Withdrawal by Subject|24|||
146334312|NCT02886702|527728428|FG001|Overall Study|Withdrawal by Subject|18|||
146334313|NCT02886702|527728429|FG002|Overall Study|Withdrawal by Subject|22|||
146334314|NCT02886702|527728427|FG000|Overall Study|Significant Worsening of Condition|0|||
146334315|NCT02886702|527728428|FG001|Overall Study|Significant Worsening of Condition|1|||
146334316|NCT02886702|527728429|FG002|Overall Study|Significant Worsening of Condition|0|||
146334317|NCT02886702|527728427|FG000|Overall Study|Protocol Violation|2|||
146334318|NCT02886702|527728428|FG001|Overall Study|Protocol Violation|2|||
146334319|NCT02886702|527728429|FG002|Overall Study|Protocol Violation|1|||
146334320|NCT02886702|527728427|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146334321|NCT02886702|527728428|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146334322|NCT02886702|527728429|FG002|Overall Study|Non-Compliance With Study Drug|4|||
146334323|NCT02886702|527728427|FG000|Overall Study|Lost to Follow-up|11|||
146334324|NCT02886702|527728428|FG001|Overall Study|Lost to Follow-up|13|||
146334325|NCT02886702|527728429|FG002|Overall Study|Lost to Follow-up|8|||
146334326|NCT02886702|527728427|FG000|Overall Study|Lack of Efficacy|3|||
146334327|NCT02886702|527728428|FG001|Overall Study|Lack of Efficacy|4|||
146334328|NCT02886702|527728429|FG002|Overall Study|Lack of Efficacy|5|||
146334329|NCT02886702|527728427|FG000|Overall Study|Adverse Event|4|||
146334330|NCT02886702|527728428|FG001|Overall Study|Adverse Event|9|||
146334331|NCT02886702|527728429|FG002|Overall Study|Adverse Event|3|||
146334332|NCT02886702|527728427|FG000|Overall Study|Administrative Reasons|0|||
146334333|NCT02886702|527728428|FG001|Overall Study|Administrative Reasons|0|||
146334334|NCT02886702|527728429|FG002|Overall Study|Administrative Reasons|1|||
146334335|NCT01147497|527728432|FG000|Overall Study|failed insertion|2|||
146334336|NCT01147497|527728433|FG001|Overall Study|failed insertion|0|||
146334337|NCT02731742|527728436|FG000|Overall Study|Death|1|||
146334338|NCT02731742|527728437|FG001|Overall Study|Death|2|||
146334339|NCT02731742|527728438|FG002|Overall Study|Death|5|||
146334340|NCT02731742|527728439|FG003|Overall Study|Death|0|||
146334341|NCT02731742|527728436|FG000|Overall Study|Physician Decision|0|||
146334342|NCT02731742|527728437|FG001|Overall Study|Physician Decision|0|||
146334343|NCT02731742|527728438|FG002|Overall Study|Physician Decision|0|||
146334344|NCT02731742|527728439|FG003|Overall Study|Physician Decision|1|||
146334345|NCT02731742|527728436|FG000|Overall Study|Study Terminated by Sponsor|2|||
146334346|NCT02731742|527728437|FG001|Overall Study|Study Terminated by Sponsor|1|||
146334347|NCT02731742|527728438|FG002|Overall Study|Study Terminated by Sponsor|1|||
146334348|NCT02731742|527728439|FG003|Overall Study|Study Terminated by Sponsor|1|||
146334349|NCT04026568|527728442|FG000|Overall Study|study terminated|0|||
146334350|NCT04026568|527728443|FG001|Overall Study|study terminated|1|||
146334351|NCT00461175|527728444|FG000|Overall Study|Protocol Violation|522|||
146334352|NCT00461175|527728445|FG001|Overall Study|Protocol Violation|365|||
146334353|NCT00331760|527728446|FG000|Overall Study|Ineligible / no protocol treatment|15|||
146334354|NCT00331760|527728447|FG001|Overall Study|Ineligible / no protocol treatment|8|||
146334355|NCT03093155|527728449|FG000|Overall Study|Not Eligible|1|||
146334356|NCT03093155|527728450|FG001|Overall Study|Not Eligible|0|||
146334357|NCT03093155|527728449|FG000|Overall Study|Withdrawal by Subject|0|||
146334358|NCT03093155|527728450|FG001|Overall Study|Withdrawal by Subject|1|||
146334359|NCT03417440|527728451|FG000|Overall Study|Lost to Follow-up|0|||
146334360|NCT03417440|527728452|FG001|Overall Study|Lost to Follow-up|1|||
146334361|NCT03417440|527728453|FG002|Overall Study|Lost to Follow-up|0|||
146334362|NCT03417440|527728454|FG003|Overall Study|Lost to Follow-up|0|||
146334363|NCT03417440|527728455|FG004|Overall Study|Lost to Follow-up|1|||
146334364|NCT03417440|527728456|FG005|Overall Study|Lost to Follow-up|0|||
146334365|NCT03417440|527728457|FG006|Overall Study|Lost to Follow-up|0|||
146334366|NCT03417440|527728458|FG007|Overall Study|Lost to Follow-up|0|||
146334367|NCT03417440|527728451|FG000|Overall Study|Withdrawal by Subject|2|||
146334368|NCT03417440|527728452|FG001|Overall Study|Withdrawal by Subject|0|||
146334369|NCT03417440|527728453|FG002|Overall Study|Withdrawal by Subject|2|||
146334370|NCT03417440|527728454|FG003|Overall Study|Withdrawal by Subject|1|||
146334371|NCT03417440|527728455|FG004|Overall Study|Withdrawal by Subject|1|||
146334372|NCT03417440|527728456|FG005|Overall Study|Withdrawal by Subject|0|||
146334373|NCT03417440|527728457|FG006|Overall Study|Withdrawal by Subject|0|||
146334374|NCT03417440|527728458|FG007|Overall Study|Withdrawal by Subject|1|||
146334375|NCT02786901|527728459|FG000|Overall Study|Adverse Event|1|||
146334376|NCT02786901|527728460|FG001|Overall Study|Adverse Event|1|||
146334377|NCT02786901|527728461|FG002|Overall Study|Adverse Event|2|||
146334378|NCT02786901|527728459|FG000|Overall Study|Physician Decision|1|||
146334379|NCT02786901|527728460|FG001|Overall Study|Physician Decision|0|||
146334380|NCT02786901|527728461|FG002|Overall Study|Physician Decision|0|||
146334381|NCT02786901|527728459|FG000|Overall Study|Rescue Therapy Use|71|||
146334382|NCT02786901|527728460|FG001|Overall Study|Rescue Therapy Use|49|||
146334383|NCT02786901|527728461|FG002|Overall Study|Rescue Therapy Use|33|||
146334384|NCT02786901|527728459|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
146334385|NCT02786901|527728460|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
146334386|NCT02786901|527728461|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
146334387|NCT02786901|527728459|FG000|Overall Study|Disallowed medication|1|||
146334388|NCT02786901|527728460|FG001|Overall Study|Disallowed medication|1|||
146334389|NCT02786901|527728461|FG002|Overall Study|Disallowed medication|0|||
146334390|NCT02786901|527728459|FG000|Overall Study|Randomized in error|2|||
146334391|NCT02786901|527728460|FG001|Overall Study|Randomized in error|0|||
146334392|NCT02786901|527728461|FG002|Overall Study|Randomized in error|1|||
146334393|NCT00316264|527728463|FG000|Overall Study|Lost to Follow-up|0|||
146334394|NCT00316264|527728464|FG001|Overall Study|Lost to Follow-up|1|||
146334395|NCT00316264|527728465|FG002|Overall Study|Lost to Follow-up|0|||
146334396|NCT00316264|527728463|FG000|Overall Study|Withdrawal of Consent|3|||
146334397|NCT00316264|527728464|FG001|Overall Study|Withdrawal of Consent|5|||
146334398|NCT00316264|527728465|FG002|Overall Study|Withdrawal of Consent|6|||
146334399|NCT00316264|527728463|FG000|Overall Study|Death|2|||
146334400|NCT00316264|527728464|FG001|Overall Study|Death|0|||
146334401|NCT00316264|527728465|FG002|Overall Study|Death|0|||
146334402|NCT00316264|527728463|FG000|Overall Study|Other|1|||
146334403|NCT00316264|527728464|FG001|Overall Study|Other|1|||
146334404|NCT00316264|527728465|FG002|Overall Study|Other|0|||
146334405|NCT04336163|527728466|FG000|Overall Study|Lost to Follow-up|55|||
145943273|NCT02326298|526300467|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146334406|NCT04336163|527728467|FG001|Overall Study|Lost to Follow-up|0|||
146334407|NCT03926143|527728468|FG000|Overall Study|Physician Decision|3|||
146334408|NCT03926143|527728468|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
146334409|NCT03926143|527728468|FG000|Overall Study|Adverse Event|2|||
146334410|NCT03926143|527728468|FG000|Overall Study|Progressive disease|3|||
146334411|NCT02561156|527728472|FG000|Part 2|Adverse Event|0|||
146334412|NCT02561156|527728473|FG001|Part 2|Adverse Event|0|||
146334413|NCT02561156|527728474|FG002|Part 2|Adverse Event|0|||
146334414|NCT02561156|527728475|FG003|Part 2|Adverse Event|0|||
146334415|NCT02561156|527728476|FG004|Part 2|Adverse Event|0|||
146334416|NCT02561156|527728477|FG005|Part 2|Adverse Event|0|||
146334417|NCT02561156|527728478|FG006|Part 2|Adverse Event|0|||
146334418|NCT02561156|527728479|FG007|Part 2|Adverse Event|0|||
146334419|NCT02561156|527728480|FG008|Part 2|Adverse Event|0|||
146334420|NCT02561156|527728481|FG009|Part 2|Adverse Event|0|||
146334421|NCT02561156|527728482|FG010|Part 2|Adverse Event|0|||
146334422|NCT02561156|527728483|FG011|Part 2|Adverse Event|1|||
146334423|NCT02561156|527728484|FG012|Part 2|Adverse Event|0|||
146334424|NCT00684814|527728491|FG000|Washout Period of 7 Days|Adverse Event|1|||
146334425|NCT00684814|527728492|FG001|Washout Period of 7 Days|Adverse Event|2|||
146334426|NCT00684814|527728491|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146334427|NCT00684814|527728492|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
146334428|NCT00684814|527728491|FG000|Second Intervention|Adverse Event|1|||
146334429|NCT00684814|527728492|FG001|Second Intervention|Adverse Event|0|||
146334430|NCT03168867|527728493|FG000|Overall Study|Withdrawal by Subject|1|||
146334431|NCT03168867|527728494|FG001|Overall Study|Withdrawal by Subject|5|||
146334432|NCT04348851|527728495|FG000|Post-Test 1|Withdrawal by Subject|0|||
146334433|NCT04348851|527728496|FG001|Post-Test 1|Withdrawal by Subject|1|||
146334434|NCT04348851|527728497|FG002|Post-Test 1|Withdrawal by Subject|0|||
146334435|NCT04348851|527728498|FG003|Post-Test 1|Withdrawal by Subject|0|||
146334436|NCT04348851|527728495|FG000|Post-Test 1|Lost to Follow-up|0|||
146334437|NCT04348851|527728496|FG001|Post-Test 1|Lost to Follow-up|1|||
146334438|NCT04348851|527728497|FG002|Post-Test 1|Lost to Follow-up|0|||
146334439|NCT04348851|527728498|FG003|Post-Test 1|Lost to Follow-up|0|||
146334440|NCT04348851|527728495|FG000|Post-Test 2|Stroke survivor death|0|||
146334441|NCT04348851|527728496|FG001|Post-Test 2|Stroke survivor death|1|||
146334442|NCT04348851|527728497|FG002|Post-Test 2|Stroke survivor death|0|||
146334443|NCT04348851|527728498|FG003|Post-Test 2|Stroke survivor death|1|||
146334444|NCT00195650|527728499|FG000|Overall Study|Adverse Event|194|||
146334445|NCT00195650|527728499|FG000|Overall Study|Lack of Efficacy|99|||
146334446|NCT00195650|527728499|FG000|Overall Study|Withdrawal by Subject|67|||
146334447|NCT00195650|527728499|FG000|Overall Study|Lost to Follow-up|44|||
146334448|NCT00195650|527728499|FG000|Overall Study|Death|23|||
146334449|NCT00195650|527728499|FG000|Overall Study|Protocol Violation|15|||
146334450|NCT00195650|527728499|FG000|Overall Study|Administrative reasons|83|||
146334451|NCT05292755|527728500|FG000|Overall Study|Lost to Follow-up|5|||
146334452|NCT05292755|527728501|FG001|Overall Study|Lost to Follow-up|9|||
146334453|NCT04030195|527731368|FG000|Overall Study|Withdrawal by Subject|2|||
146334454|NCT04030195|527731369|FG001|Overall Study|Withdrawal by Subject|0|||
146334455|NCT04030195|527731370|FG002|Overall Study|Withdrawal by Subject|0|||
146334456|NCT02109029|527731371|FG000|Part B|Adverse Event|0|||
146334457|NCT02109029|527731372|FG001|Part B|Adverse Event|0|||
146334458|NCT02109029|527731373|FG002|Part B|Adverse Event|0|||
146334459|NCT02109029|527731374|FG003|Part B|Adverse Event|0|||
146334460|NCT02109029|527731375|FG004|Part B|Adverse Event|1|||
146334461|NCT02109029|527731376|FG005|Part B|Adverse Event|1|||
146334462|NCT01056107|527731380|FG000|Overall Study|Withdrawal by Subject|0|||
146334463|NCT01056107|527731381|FG001|Overall Study|Withdrawal by Subject|1|||
146334464|NCT01056107|527731382|FG002|Overall Study|Withdrawal by Subject|3|||
146334465|NCT01056107|527731383|FG003|Overall Study|Withdrawal by Subject|0|||
146334466|NCT03263091|527731390|FG000|OL Component|Withdrawal by Subject|1|||
146334467|NCT03263091|527731391|FG001|OL Component|Withdrawal by Subject|1|||
146334468|NCT03263091|527731392|FG002|OL Component|Withdrawal by Subject|0|||
146168854|NCT04179721|527129466|FG000|Overall Study|Lost to Follow-up|0|||
146168855|NCT04179721|527129467|FG001|Overall Study|Lost to Follow-up|1|||
146168856|NCT01489189|527129468|FG000|Overall Study|Withdrawal by Subject|20|||
146334469|NCT03263091|527731393|FG003|OL Component|Withdrawal by Subject|0|||
146334470|NCT03263091|527731394|FG004|OL Component|Withdrawal by Subject|0|||
146334471|NCT03263091|527731395|FG005|OL Component|Withdrawal by Subject|0|||
146334472|NCT03263091|527731390|FG000|OL Component|Physician Decision|0|||
146334473|NCT03263091|527731391|FG001|OL Component|Physician Decision|1|||
146334474|NCT03263091|527731392|FG002|OL Component|Physician Decision|2|||
146334475|NCT03263091|527731393|FG003|OL Component|Physician Decision|0|||
146334476|NCT03263091|527731394|FG004|OL Component|Physician Decision|0|||
146334477|NCT03263091|527731395|FG005|OL Component|Physician Decision|0|||
146334478|NCT03263091|527731390|FG000|OL Component|Death|1|||
146334479|NCT03263091|527731391|FG001|OL Component|Death|0|||
146334480|NCT03263091|527731392|FG002|OL Component|Death|0|||
146334481|NCT03263091|527731393|FG003|OL Component|Death|0|||
146334482|NCT03263091|527731394|FG004|OL Component|Death|0|||
146334483|NCT03263091|527731395|FG005|OL Component|Death|0|||
146334484|NCT03263091|527731390|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
146334485|NCT03263091|527731391|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
146334486|NCT03263091|527731392|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
146334487|NCT03263091|527731393|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
146334488|NCT03263091|527731394|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
146334489|NCT03263091|527731395|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
146334490|NCT03263091|527731390|FG000|OL High-EPO Component|Physician Decision|0|||
146334491|NCT03263091|527731391|FG001|OL High-EPO Component|Physician Decision|0|||
146334492|NCT03263091|527731392|FG002|OL High-EPO Component|Physician Decision|0|||
146334493|NCT03263091|527731393|FG003|OL High-EPO Component|Physician Decision|1|||
146334494|NCT03263091|527731394|FG004|OL High-EPO Component|Physician Decision|0|||
146334495|NCT03263091|527731395|FG005|OL High-EPO Component|Physician Decision|0|||
146334496|NCT03263091|527731390|FG000|OL High-EPO Component|Death|0|||
146334497|NCT03263091|527731391|FG001|OL High-EPO Component|Death|0|||
146334498|NCT03263091|527731392|FG002|OL High-EPO Component|Death|0|||
146334499|NCT03263091|527731393|FG003|OL High-EPO Component|Death|3|||
146334500|NCT03263091|527731394|FG004|OL High-EPO Component|Death|0|||
146334501|NCT03263091|527731395|FG005|OL High-EPO Component|Death|0|||
146334502|NCT03263091|527731390|FG000|DB Component|Withdrawal by Subject|0|||
146334503|NCT03263091|527731391|FG001|DB Component|Withdrawal by Subject|0|||
146334504|NCT03263091|527731392|FG002|DB Component|Withdrawal by Subject|0|||
146334505|NCT03263091|527731393|FG003|DB Component|Withdrawal by Subject|0|||
146334506|NCT03263091|527731394|FG004|DB Component|Withdrawal by Subject|22|||
146334507|NCT03263091|527731395|FG005|DB Component|Withdrawal by Subject|8|||
146334508|NCT03263091|527731390|FG000|DB Component|Physician Decision|0|||
146334509|NCT03263091|527731391|FG001|DB Component|Physician Decision|0|||
146334510|NCT03263091|527731392|FG002|DB Component|Physician Decision|0|||
146334511|NCT03263091|527731393|FG003|DB Component|Physician Decision|0|||
146334512|NCT03263091|527731394|FG004|DB Component|Physician Decision|3|||
146334513|NCT03263091|527731395|FG005|DB Component|Physician Decision|1|||
146334514|NCT03263091|527731390|FG000|DB Component|Adverse Event|0|||
146334515|NCT03263091|527731391|FG001|DB Component|Adverse Event|0|||
146334516|NCT03263091|527731392|FG002|DB Component|Adverse Event|0|||
146334517|NCT03263091|527731393|FG003|DB Component|Adverse Event|0|||
146334518|NCT03263091|527731394|FG004|DB Component|Adverse Event|2|||
146334519|NCT03263091|527731395|FG005|DB Component|Adverse Event|1|||
146334520|NCT03263091|527731390|FG000|DB Component|Lost to Follow-up|0|||
146334521|NCT03263091|527731391|FG001|DB Component|Lost to Follow-up|0|||
146334522|NCT03263091|527731392|FG002|DB Component|Lost to Follow-up|0|||
146334523|NCT03263091|527731393|FG003|DB Component|Lost to Follow-up|0|||
146334524|NCT03263091|527731394|FG004|DB Component|Lost to Follow-up|2|||
146334525|NCT03263091|527731395|FG005|DB Component|Lost to Follow-up|1|||
146334526|NCT03263091|527731390|FG000|DB Component|Death|0|||
146334527|NCT03263091|527731391|FG001|DB Component|Death|0|||
146334528|NCT03263091|527731392|FG002|DB Component|Death|0|||
146334529|NCT03263091|527731393|FG003|DB Component|Death|0|||
146334530|NCT03263091|527731394|FG004|DB Component|Death|7|||
146334531|NCT03263091|527731395|FG005|DB Component|Death|4|||
146334532|NCT03263091|527731390|FG000|DB Component|Other than specified|0|||
146334533|NCT03263091|527731391|FG001|DB Component|Other than specified|0|||
146334534|NCT03263091|527731392|FG002|DB Component|Other than specified|0|||
146334535|NCT03263091|527731393|FG003|DB Component|Other than specified|0|||
146334536|NCT03263091|527731394|FG004|DB Component|Other than specified|8|||
146334537|NCT03263091|527731395|FG005|DB Component|Other than specified|6|||
146334538|NCT01821963|527731396|FG000|Overall Study|Adverse Event|1|||
146334539|NCT00783289|527731397|FG000|Overall Study|Protocol Violation|0|||
146334540|NCT00783289|527731398|FG001|Overall Study|Protocol Violation|1|||
146334541|NCT00783289|527731399|FG002|Overall Study|Protocol Violation|0|||
146334542|NCT00783289|527731400|FG003|Overall Study|Protocol Violation|0|||
146334543|NCT01381094|527731402|FG000|Overall Study|Adverse Event|1|||
146334544|NCT01381094|527731403|FG001|Overall Study|Adverse Event|2|||
146334545|NCT01381094|527731404|FG002|Overall Study|Adverse Event|0|||
146334546|NCT01381094|527731405|FG003|Overall Study|Adverse Event|1|||
146334547|NCT01381094|527731406|FG004|Overall Study|Adverse Event|0|||
146334548|NCT01381094|527731402|FG000|Overall Study|Lost to Follow-up|0|||
146334549|NCT01381094|527731403|FG001|Overall Study|Lost to Follow-up|0|||
146334550|NCT01381094|527731404|FG002|Overall Study|Lost to Follow-up|0|||
146334551|NCT01381094|527731405|FG003|Overall Study|Lost to Follow-up|0|||
146334552|NCT01381094|527731406|FG004|Overall Study|Lost to Follow-up|1|||
146334553|NCT01381094|527731402|FG000|Overall Study|Withdrawal of informed consent|0|||
146334554|NCT01381094|527731403|FG001|Overall Study|Withdrawal of informed consent|1|||
146334555|NCT01381094|527731404|FG002|Overall Study|Withdrawal of informed consent|0|||
146334556|NCT01381094|527731405|FG003|Overall Study|Withdrawal of informed consent|0|||
146334557|NCT01381094|527731406|FG004|Overall Study|Withdrawal of informed consent|0|||
146334558|NCT01381094|527731402|FG000|Overall Study|Participant given Aranesp injection|1|||
146334559|NCT01381094|527731403|FG001|Overall Study|Participant given Aranesp injection|0|||
146334560|NCT01381094|527731404|FG002|Overall Study|Participant given Aranesp injection|0|||
146334561|NCT01381094|527731405|FG003|Overall Study|Participant given Aranesp injection|0|||
146334562|NCT01381094|527731406|FG004|Overall Study|Participant given Aranesp injection|0|||
146334563|NCT00486902|527731409|FG000|Overall Study|Withdrawal by Subject|1|||
146334564|NCT00486902|527731410|FG001|Overall Study|Withdrawal by Subject|2|||
146334565|NCT00486902|527731409|FG000|Overall Study|decision for postpartum tubal ligation|3|||
146334566|NCT00486902|527731410|FG001|Overall Study|decision for postpartum tubal ligation|1|||
146334567|NCT00486902|527731409|FG000|Overall Study|spinal anesthetic protocal violation|1|||
146334568|NCT00486902|527731410|FG001|Overall Study|spinal anesthetic protocal violation|1|||
146334569|NCT00486902|527731409|FG000|Overall Study|Did not meet inclusion criteria|1|||
146334570|NCT00486902|527731410|FG001|Overall Study|Did not meet inclusion criteria|0|||
146334571|NCT00486902|527731409|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
146334572|NCT00486902|527731410|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
146334573|NCT01217606|527731413|FG000|Initial Treatment Phase|Other Reasons|0|||
146334574|NCT01217606|527731414|FG001|Initial Treatment Phase|Other Reasons|2|||
146334575|NCT01217606|527731413|FG000|Initial Treatment Phase|Protocol Violation|3|||
146334576|NCT01217606|527731414|FG001|Initial Treatment Phase|Protocol Violation|2|||
146334577|NCT01217606|527731413|FG000|Initial Treatment Phase|Personal Reasons|0|||
146334578|NCT01217606|527731414|FG001|Initial Treatment Phase|Personal Reasons|2|||
146334579|NCT01217606|527731413|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
146334580|NCT01217606|527731414|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
146334581|NCT01217606|527731413|FG000|Initial Treatment Phase|Adverse Event|10|||
146334582|NCT01217606|527731414|FG001|Initial Treatment Phase|Adverse Event|6|||
146334583|NCT01217606|527731413|FG000|9-Month Masked Extension|Adverse Event|3|||
146334584|NCT01217606|527731414|FG001|9-Month Masked Extension|Adverse Event|6|||
146334585|NCT01217606|527731413|FG000|9-Month Masked Extension|Other Reasons|4|||
146334586|NCT01217606|527731414|FG001|9-Month Masked Extension|Other Reasons|4|||
146334587|NCT01217606|527731413|FG000|9-Month Masked Extension|Personal Reasons|2|||
146334588|NCT01217606|527731414|FG001|9-Month Masked Extension|Personal Reasons|1|||
146334589|NCT01217606|527731413|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
146334590|NCT01217606|527731414|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
146334591|NCT01217606|527731413|FG000|9-Month Masked Extension|Pregnancy|1|||
146334592|NCT01217606|527731414|FG001|9-Month Masked Extension|Pregnancy|0|||
146334593|NCT01217606|527731413|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
146334594|NCT01217606|527731414|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
146334595|NCT01552057|527731421|FG000|Overall Study|Adverse Event|14|||
146334596|NCT01552057|527731422|FG001|Overall Study|Adverse Event|15|||
146334597|NCT01552057|527731421|FG000|Overall Study|Lack of Efficacy|8|||
146334598|NCT01552057|527731422|FG001|Overall Study|Lack of Efficacy|23|||
146334599|NCT01552057|527731421|FG000|Overall Study|Withdrawal by Subject|5|||
146334600|NCT01552057|527731422|FG001|Overall Study|Withdrawal by Subject|8|||
146334601|NCT01552057|527731421|FG000|Overall Study|Entry Criteria Not Met|2|||
146334602|NCT01552057|527731422|FG001|Overall Study|Entry Criteria Not Met|2|||
146334603|NCT01552057|527731421|FG000|Overall Study|Physician Decision|1|||
146334604|NCT01552057|527731422|FG001|Overall Study|Physician Decision|0|||
146334605|NCT02900092|527731423|FG000|Overall Study|Adverse Event|1|||
146334606|NCT04178590|527731424|FG000|Overall Study|Pregnancy|1|||
146334607|NCT04178590|527731424|FG000|Overall Study|Lost to Follow-up|1|||
146334608|NCT00996840|527731425|FG000|Overall Study|Adverse Event|0|||
146334609|NCT00996840|527731426|FG001|Overall Study|Adverse Event|1|||
146334610|NCT00996840|527731427|FG002|Overall Study|Adverse Event|0|||
146334611|NCT00996840|527731428|FG003|Overall Study|Adverse Event|0|||
146334612|NCT00996840|527731429|FG004|Overall Study|Adverse Event|0|||
146334613|NCT00996840|527731425|FG000|Overall Study|Physician Decision|0|||
146334614|NCT00996840|527731426|FG001|Overall Study|Physician Decision|0|||
146334615|NCT00996840|527731427|FG002|Overall Study|Physician Decision|1|||
146334616|NCT00996840|527731428|FG003|Overall Study|Physician Decision|1|||
146334617|NCT00996840|527731429|FG004|Overall Study|Physician Decision|2|||
146334618|NCT00996840|527731425|FG000|Overall Study|Withdrawal by Subject|1|||
146168857|NCT01489189|527129469|FG001|Overall Study|Withdrawal by Subject|23|||
146168858|NCT01489189|527129468|FG000|Overall Study|Death|10|||
146168859|NCT01489189|527129469|FG001|Overall Study|Death|8|||
146168860|NCT01489189|527129468|FG000|Overall Study|Missed Visit|1|||
146168861|NCT01489189|527129469|FG001|Overall Study|Missed Visit|4|||
146168862|NCT00112580|527129470|FG000|Overall Study|Adverse Event|1|||
146168863|NCT00112580|527129471|FG001|Overall Study|Adverse Event|2|||
146168864|NCT00112580|527129470|FG000|Overall Study|Disease progression|5|||
146168865|NCT00112580|527129471|FG001|Overall Study|Disease progression|16|||
146168866|NCT00112580|527129470|FG000|Overall Study|Participant withdrew consent|2|||
146168867|NCT00112580|527129471|FG001|Overall Study|Participant withdrew consent|1|||
146168868|NCT05597722|527129474|FG000|Overall Study|Study was terminated|6|||
146168869|NCT05597722|527129475|FG001|Overall Study|Study was terminated|1|||
146168870|NCT00404495|527129476|FG000|Overall Study|Death|37|||
146168871|NCT00404495|527129477|FG001|Overall Study|Death|11|||
146334619|NCT00996840|527731426|FG001|Overall Study|Withdrawal by Subject|1|||
146334620|NCT00996840|527731427|FG002|Overall Study|Withdrawal by Subject|0|||
146334621|NCT00996840|527731428|FG003|Overall Study|Withdrawal by Subject|0|||
146334622|NCT00996840|527731429|FG004|Overall Study|Withdrawal by Subject|0|||
146334623|NCT01389245|527731430|FG000|Overall Study|Protocol Violation|10|||
145943274|NCT02326298|526300468|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146168872|NCT00404495|527129476|FG000|Overall Study|Lost to Follow-up|5|||
146334624|NCT01389245|527731430|FG000|Overall Study|Lost to Follow-up|3|||
146334625|NCT01389245|527731430|FG000|Overall Study|Withdrawal by Subject|2|||
146334626|NCT02292849|527731431|FG000|Overall Study|Lost to Follow-up|0|||
146334627|NCT02292849|527731432|FG001|Overall Study|Lost to Follow-up|2|||
146334628|NCT02292849|527731433|FG002|Overall Study|Lost to Follow-up|2|||
146334629|NCT02292849|527731431|FG000|Overall Study|Physician Decision|4|||
146334630|NCT02292849|527731432|FG001|Overall Study|Physician Decision|0|||
146334631|NCT02292849|527731433|FG002|Overall Study|Physician Decision|0|||
146334632|NCT00097539|527731434|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
146334633|NCT00097539|527731435|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
146334634|NCT00097539|527731436|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
146334635|NCT00097539|527731437|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
146334636|NCT00097539|527731438|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
146334637|NCT00097539|527731439|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
146334638|NCT00097539|527731440|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
146334639|NCT00097539|527731434|FG000|Overall Study|Withdrawal by Subject|925|||
146334640|NCT00097539|527731435|FG001|Overall Study|Withdrawal by Subject|323|||
146334641|NCT00097539|527731436|FG002|Overall Study|Withdrawal by Subject|346|||
146334642|NCT00097539|527731437|FG003|Overall Study|Withdrawal by Subject|217|||
146334643|NCT00097539|527731438|FG004|Overall Study|Withdrawal by Subject|68|||
146334644|NCT00097539|527731439|FG005|Overall Study|Withdrawal by Subject|229|||
146334645|NCT00097539|527731440|FG006|Overall Study|Withdrawal by Subject|3|||
146334646|NCT00097539|527731434|FG000|Overall Study|Participant Non-compliant|2140|||
146334647|NCT00097539|527731435|FG001|Overall Study|Participant Non-compliant|567|||
146334648|NCT00097539|527731436|FG002|Overall Study|Participant Non-compliant|1067|||
146334649|NCT00097539|527731437|FG003|Overall Study|Participant Non-compliant|353|||
146334650|NCT00097539|527731438|FG004|Overall Study|Participant Non-compliant|136|||
146334651|NCT00097539|527731439|FG005|Overall Study|Participant Non-compliant|543|||
146334652|NCT00097539|527731440|FG006|Overall Study|Participant Non-compliant|18|||
146334653|NCT00097539|527731434|FG000|Overall Study|Lack of Efficacy|249|||
146334654|NCT00097539|527731435|FG001|Overall Study|Lack of Efficacy|122|||
146334655|NCT00097539|527731436|FG002|Overall Study|Lack of Efficacy|202|||
146334656|NCT00097539|527731437|FG003|Overall Study|Lack of Efficacy|105|||
146334657|NCT00097539|527731438|FG004|Overall Study|Lack of Efficacy|45|||
146334658|NCT00097539|527731439|FG005|Overall Study|Lack of Efficacy|228|||
146334659|NCT00097539|527731440|FG006|Overall Study|Lack of Efficacy|5|||
146334660|NCT00097539|527731434|FG000|Overall Study|Adverse Event|78|||
146334661|NCT00097539|527731435|FG001|Overall Study|Adverse Event|133|||
146334662|NCT00097539|527731436|FG002|Overall Study|Adverse Event|37|||
146334663|NCT00097539|527731437|FG003|Overall Study|Adverse Event|27|||
146334664|NCT00097539|527731438|FG004|Overall Study|Adverse Event|30|||
146334665|NCT00097539|527731439|FG005|Overall Study|Adverse Event|59|||
146334666|NCT00097539|527731440|FG006|Overall Study|Adverse Event|1|||
146334667|NCT00097539|527731434|FG000|Overall Study|Death|2|||
146334668|NCT00097539|527731435|FG001|Overall Study|Death|7|||
146334669|NCT00097539|527731436|FG002|Overall Study|Death|0|||
146334670|NCT00097539|527731437|FG003|Overall Study|Death|0|||
146334671|NCT00097539|527731438|FG004|Overall Study|Death|1|||
146334672|NCT00097539|527731439|FG005|Overall Study|Death|3|||
146334673|NCT00097539|527731440|FG006|Overall Study|Death|0|||
146334674|NCT00097539|527731434|FG000|Overall Study|Reasons Other Than Above|3602|||
146334675|NCT00097539|527731435|FG001|Overall Study|Reasons Other Than Above|1382|||
146334676|NCT00097539|527731436|FG002|Overall Study|Reasons Other Than Above|1757|||
146334677|NCT00097539|527731437|FG003|Overall Study|Reasons Other Than Above|692|||
146334678|NCT00097539|527731438|FG004|Overall Study|Reasons Other Than Above|361|||
146334679|NCT00097539|527731439|FG005|Overall Study|Reasons Other Than Above|1244|||
146334680|NCT00097539|527731440|FG006|Overall Study|Reasons Other Than Above|34|||
146334681|NCT00097539|527731434|FG000|Overall Study|Reason not Specified|111|||
146334682|NCT00097539|527731435|FG001|Overall Study|Reason not Specified|49|||
146334683|NCT00097539|527731436|FG002|Overall Study|Reason not Specified|53|||
146334684|NCT00097539|527731437|FG003|Overall Study|Reason not Specified|21|||
146334685|NCT00097539|527731438|FG004|Overall Study|Reason not Specified|11|||
146334686|NCT00097539|527731439|FG005|Overall Study|Reason not Specified|40|||
146334687|NCT00097539|527731440|FG006|Overall Study|Reason not Specified|2|||
146334688|NCT05127486|527731441|FG000|Overall Study|Adverse Event|2|||
146334689|NCT05127486|527731442|FG001|Overall Study|Adverse Event|4|||
146334690|NCT05127486|527731441|FG000|Overall Study|Lack of Efficacy|1|||
146334691|NCT05127486|527731442|FG001|Overall Study|Lack of Efficacy|0|||
146334692|NCT05127486|527731441|FG000|Overall Study|Pregnancy|0|||
146334693|NCT05127486|527731442|FG001|Overall Study|Pregnancy|1|||
146334694|NCT05127486|527731441|FG000|Overall Study|Physician Decision|4|||
146334695|NCT05127486|527731442|FG001|Overall Study|Physician Decision|1|||
146334696|NCT05127486|527731441|FG000|Overall Study|Withdrawal by Subject|14|||
146334697|NCT05127486|527731442|FG001|Overall Study|Withdrawal by Subject|13|||
146334698|NCT05127486|527731441|FG000|Overall Study|Lost to Follow-up|5|||
146334699|NCT05127486|527731442|FG001|Overall Study|Lost to Follow-up|8|||
146334700|NCT02582515|527731443|FG000|Overall Study|Withdrawal by Subject|0|||
146334701|NCT02582515|527731444|FG001|Overall Study|Withdrawal by Subject|1|||
146334702|NCT00775021|527731445|FG000|First Intervention|Lost to Follow-up|1|||
146168873|NCT00404495|527129477|FG001|Overall Study|Lost to Follow-up|0|||
146168874|NCT00404495|527129476|FG000|Overall Study|Other|1|||
146168875|NCT00404495|527129477|FG001|Overall Study|Other|0|||
146168876|NCT00404495|527129476|FG000|Overall Study|Withdrawal by Subject|1|||
146168877|NCT00404495|527129477|FG001|Overall Study|Withdrawal by Subject|0|||
146168878|NCT03904043|527129480|FG000|Overall Study|Adverse Event|1|||
146168879|NCT03904043|527129481|FG001|Overall Study|Adverse Event|1|||
146168880|NCT03904043|527129480|FG000|Overall Study|Withdrawal by Subject|1|||
146168881|NCT03904043|527129481|FG001|Overall Study|Withdrawal by Subject|0|||
146168882|NCT03904043|527129480|FG000|Overall Study|Non-compliance|1|||
146168883|NCT03904043|527129481|FG001|Overall Study|Non-compliance|0|||
146168884|NCT03904043|527129480|FG000|Overall Study|Did not start treatment|1|||
146168885|NCT03904043|527129481|FG001|Overall Study|Did not start treatment|0|||
146168886|NCT05619003|527129482|FG000|Overall Study|Adverse Event|1|||
146168887|NCT03538951|527129483|FG000|Overall Study|Withdrawal by Subject|1|||
146168888|NCT03538951|527129484|FG001|Overall Study|Withdrawal by Subject|2|||
146168889|NCT00856167|527129490|FG000|Period 1|Withdrawal by Subject|1|||
146168890|NCT00856167|527129491|FG001|Period 1|Withdrawal by Subject|4|||
146168891|NCT00856167|527129492|FG002|Period 1|Withdrawal by Subject|0|||
146168892|NCT00856167|527129493|FG003|Period 1|Withdrawal by Subject|0|||
146168893|NCT00856167|527129490|FG000|Period 1|Lost to Follow-up|2|||
146168894|NCT00856167|527129491|FG001|Period 1|Lost to Follow-up|1|||
146168895|NCT00856167|527129492|FG002|Period 1|Lost to Follow-up|0|||
146168896|NCT00856167|527129493|FG003|Period 1|Lost to Follow-up|0|||
146168897|NCT00856167|527129490|FG000|Period 2|Lost to Follow-up|0|||
146168898|NCT00856167|527129491|FG001|Period 2|Lost to Follow-up|0|||
146168899|NCT00856167|527129492|FG002|Period 2|Lost to Follow-up|3|||
146168900|NCT00856167|527129493|FG003|Period 2|Lost to Follow-up|1|||
146168901|NCT00856167|527129490|FG000|Period 2|Withdrawal by Subject|0|||
146168902|NCT00856167|527129491|FG001|Period 2|Withdrawal by Subject|0|||
146168903|NCT00856167|527129492|FG002|Period 2|Withdrawal by Subject|2|||
146168904|NCT00856167|527129493|FG003|Period 2|Withdrawal by Subject|4|||
146168905|NCT01529008|527131062|FG000|Bone Marrow Harvesting|Physician Decision|1|||
146168906|NCT01529008|527131063|FG001|Bone Marrow Harvesting|Physician Decision|1|||
146168907|NCT01529008|527131062|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
146168908|NCT01529008|527131063|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
146168909|NCT01529008|527131062|FG000|Treatment|Adverse Event|6|||
146168910|NCT01529008|527131063|FG001|Treatment|Adverse Event|0|||
146168911|NCT01529008|527131062|FG000|Treatment|Other|3|||
146334703|NCT00775021|527731446|FG001|First Intervention|Lost to Follow-up|0|||
146334704|NCT00775021|527731445|FG000|Second Intervention|Adverse Event|0|||
146334705|NCT00775021|527731446|FG001|Second Intervention|Adverse Event|1|||
146334706|NCT00363415|527731447|FG000|Overall Study|Progressive Disease|196|||
146334707|NCT00363415|527731448|FG001|Overall Study|Progressive Disease|107|||
146334708|NCT00363415|527731447|FG000|Overall Study|Sponsor Decision|67|||
146334709|NCT00363415|527731448|FG001|Overall Study|Sponsor Decision|31|||
146334710|NCT00363415|527731447|FG000|Overall Study|Death|32|||
146334711|NCT00363415|527731448|FG001|Overall Study|Death|29|||
146334712|NCT00363415|527731447|FG000|Overall Study|Adverse Event|24|||
146334713|NCT00363415|527731448|FG001|Overall Study|Adverse Event|15|||
146334714|NCT00363415|527731447|FG000|Overall Study|Physician Decision|18|||
146334715|NCT00363415|527731448|FG001|Overall Study|Physician Decision|35|||
146334716|NCT00363415|527731447|FG000|Overall Study|Entry Criteria Not Met|11|||
146334717|NCT00363415|527731448|FG001|Overall Study|Entry Criteria Not Met|10|||
146334718|NCT00363415|527731447|FG000|Overall Study|Withdrawal by Subject|9|||
146334719|NCT00363415|527731448|FG001|Overall Study|Withdrawal by Subject|15|||
146334720|NCT00363415|527731447|FG000|Overall Study|Lost to Follow-up|3|||
146334721|NCT00363415|527731448|FG001|Overall Study|Lost to Follow-up|3|||
146334722|NCT00363415|527731447|FG000|Overall Study|Protocol Violation|1|||
146334723|NCT00363415|527731448|FG001|Overall Study|Protocol Violation|4|||
146334724|NCT05027802|527731451|FG000|Overall Study|Adverse Event|2|||
146334725|NCT05027802|527731451|FG000|Overall Study|Withdrawal by Subject|18|||
146334726|NCT05027802|527731451|FG000|Overall Study|Death|2|||
146334727|NCT05027802|527731451|FG000|Overall Study|Other|1|||
146334728|NCT01506141|527731458|FG000|Overall Study|Adverse Event|0|||
146334729|NCT01506141|527731459|FG001|Overall Study|Adverse Event|2|||
146334730|NCT01506141|527731458|FG000|Overall Study|Participation Terminated by Investigator|1|||
146334731|NCT01506141|527731459|FG001|Overall Study|Participation Terminated by Investigator|1|||
146334732|NCT01506141|527731458|FG000|Overall Study|Site Terminated by Sponsor|2|||
146334733|NCT01506141|527731459|FG001|Overall Study|Site Terminated by Sponsor|0|||
146334734|NCT01506141|527731458|FG000|Overall Study|Reason Not Specified|4|||
146168912|NCT01529008|527131063|FG001|Treatment|Other|1|||
146168913|NCT01529008|527131062|FG000|Efficacy Analysis|Protocol Violation|2|||
146168914|NCT01529008|527131063|FG001|Efficacy Analysis|Protocol Violation|0|||
146168915|NCT01529008|527131062|FG000|Efficacy Analysis|Physician Decision|0|||
146334735|NCT01506141|527731459|FG001|Overall Study|Reason Not Specified|2|||
146334736|NCT02725788|527731470|FG000|Overall Study|Lost to Follow-up|1|||
146168916|NCT01529008|527131063|FG001|Efficacy Analysis|Physician Decision|1|||
146334737|NCT02725788|527731471|FG001|Overall Study|Lost to Follow-up|1|||
146334738|NCT02725788|527731470|FG000|Overall Study|Protocol Violation|0|||
146334739|NCT02725788|527731471|FG001|Overall Study|Protocol Violation|1|||
146334740|NCT05590377|527731472|FG000|Overall Study|Death|1|||
146334741|NCT05590377|527731473|FG001|Overall Study|Death|1|||
146334742|NCT05590377|527731474|FG002|Overall Study|Death|2|||
146334743|NCT05590377|527731475|FG003|Overall Study|Death|0|||
146334744|NCT05590377|527731476|FG004|Overall Study|Death|0|||
146334745|NCT05590377|527731472|FG000|Overall Study|Study Terminated by Sponsor|1|||
146334746|NCT05590377|527731473|FG001|Overall Study|Study Terminated by Sponsor|5|||
146334747|NCT05590377|527731474|FG002|Overall Study|Study Terminated by Sponsor|4|||
146334748|NCT05590377|527731475|FG003|Overall Study|Study Terminated by Sponsor|0|||
146334749|NCT05590377|527731476|FG004|Overall Study|Study Terminated by Sponsor|0|||
146334750|NCT05590377|527731472|FG000|Overall Study|Withdrawal by Subject|1|||
146334751|NCT05590377|527731473|FG001|Overall Study|Withdrawal by Subject|0|||
146334752|NCT05590377|527731474|FG002|Overall Study|Withdrawal by Subject|0|||
146334753|NCT05590377|527731475|FG003|Overall Study|Withdrawal by Subject|0|||
146334754|NCT05590377|527731476|FG004|Overall Study|Withdrawal by Subject|0|||
146334755|NCT02688647|527731477|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
146334756|NCT02688647|527731478|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
146334757|NCT02688647|527731477|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
146334758|NCT02688647|527731478|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
146334759|NCT02688647|527731477|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
146334760|NCT02688647|527731478|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
146334761|NCT02688647|527731477|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
146334762|NCT02688647|527731478|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
146334763|NCT02688647|527731477|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
146334764|NCT02688647|527731478|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
146334765|NCT02688647|527731477|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
146334766|NCT02688647|527731478|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
146334767|NCT02688647|527731477|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
146334768|NCT02688647|527731478|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
146334769|NCT00809133|527731482|FG000|Overall Study|Progressive disease|2|||
146334770|NCT00809133|527731483|FG001|Overall Study|Progressive disease|5|||
146334771|NCT00809133|527731484|FG002|Overall Study|Progressive disease|5|||
146334772|NCT00809133|527731485|FG003|Overall Study|Progressive disease|3|||
146334773|NCT00809133|527731486|FG004|Overall Study|Progressive disease|4|||
146334774|NCT00809133|527731487|FG005|Overall Study|Progressive disease|1|||
146334775|NCT00809133|527731488|FG006|Overall Study|Progressive disease|3|||
146334776|NCT00809133|527731489|FG007|Overall Study|Progressive disease|3|||
146334777|NCT00809133|527731490|FG008|Overall Study|Progressive disease|3|||
146334778|NCT00809133|527731491|FG009|Overall Study|Progressive disease|9|||
146334779|NCT00809133|527731492|FG010|Overall Study|Progressive disease|5|||
146334780|NCT00809133|527731493|FG011|Overall Study|Progressive disease|7|||
146334781|NCT00809133|527731494|FG012|Overall Study|Progressive disease|5|||
146334782|NCT00809133|527731495|FG013|Overall Study|Progressive disease|4|||
146334783|NCT00809133|527731482|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334784|NCT00809133|527731483|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334785|NCT00809133|527731484|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334786|NCT00809133|527731485|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146168917|NCT01529008|527131062|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
146168918|NCT01529008|527131063|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
146168919|NCT00332332|527131064|FG000|Overall Study|Adverse Event|13|||
146168920|NCT00332332|527131064|FG000|Overall Study|Death|1|||
146168921|NCT00332332|527131064|FG000|Overall Study|Withdrawal by Subject|8|||
146168922|NCT00332332|527131064|FG000|Overall Study|Physician Decision|1|||
146334787|NCT00809133|527731486|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334788|NCT00809133|527731487|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146334789|NCT00809133|527731488|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146334790|NCT00809133|527731489|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
146334791|NCT00809133|527731490|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334792|NCT00809133|527731491|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334793|NCT00809133|527731492|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334794|NCT00809133|527731493|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334795|NCT00809133|527731494|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
146334796|NCT00809133|527731495|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
146334797|NCT00809133|527731482|FG000|Overall Study|Other adverse event|1|||
146334798|NCT00809133|527731483|FG001|Overall Study|Other adverse event|1|||
146168923|NCT00332332|527131064|FG000|Overall Study|Lost to Follow-up|3|||
146168924|NCT00332332|527131064|FG000|Overall Study|Protocol deviation|4|||
146334799|NCT00809133|527731484|FG002|Overall Study|Other adverse event|1|||
146334800|NCT00809133|527731485|FG003|Overall Study|Other adverse event|0|||
146334801|NCT00809133|527731486|FG004|Overall Study|Other adverse event|0|||
146334802|NCT00809133|527731487|FG005|Overall Study|Other adverse event|3|||
146168925|NCT00332332|527131064|FG000|Overall Study|Noncompliance|2|||
146334803|NCT00809133|527731488|FG006|Overall Study|Other adverse event|2|||
146334804|NCT00809133|527731489|FG007|Overall Study|Other adverse event|4|||
146334805|NCT00809133|527731490|FG008|Overall Study|Other adverse event|0|||
146334806|NCT00809133|527731491|FG009|Overall Study|Other adverse event|0|||
146334807|NCT00809133|527731492|FG010|Overall Study|Other adverse event|1|||
146334808|NCT00809133|527731493|FG011|Overall Study|Other adverse event|1|||
146334809|NCT00809133|527731494|FG012|Overall Study|Other adverse event|0|||
146334810|NCT00809133|527731495|FG013|Overall Study|Other adverse event|1|||
146334811|NCT00809133|527731482|FG000|Overall Study|Lost to Follow-up|0|||
146334812|NCT00809133|527731483|FG001|Overall Study|Lost to Follow-up|0|||
146334813|NCT00809133|527731484|FG002|Overall Study|Lost to Follow-up|0|||
146334814|NCT00809133|527731485|FG003|Overall Study|Lost to Follow-up|0|||
146334815|NCT00809133|527731486|FG004|Overall Study|Lost to Follow-up|0|||
146334816|NCT00809133|527731487|FG005|Overall Study|Lost to Follow-up|1|||
146334817|NCT00809133|527731488|FG006|Overall Study|Lost to Follow-up|0|||
146334818|NCT00809133|527731489|FG007|Overall Study|Lost to Follow-up|0|||
146334819|NCT00809133|527731490|FG008|Overall Study|Lost to Follow-up|0|||
146334820|NCT00809133|527731491|FG009|Overall Study|Lost to Follow-up|0|||
146334821|NCT00809133|527731492|FG010|Overall Study|Lost to Follow-up|0|||
146334822|NCT00809133|527731493|FG011|Overall Study|Lost to Follow-up|0|||
146334823|NCT00809133|527731494|FG012|Overall Study|Lost to Follow-up|0|||
146334824|NCT00809133|527731495|FG013|Overall Study|Lost to Follow-up|0|||
146334825|NCT00809133|527731482|FG000|Overall Study|Consent withdrawn|0|||
146334826|NCT00809133|527731483|FG001|Overall Study|Consent withdrawn|0|||
146334827|NCT00809133|527731484|FG002|Overall Study|Consent withdrawn|0|||
146334828|NCT00809133|527731485|FG003|Overall Study|Consent withdrawn|0|||
146334829|NCT00809133|527731486|FG004|Overall Study|Consent withdrawn|1|||
146334830|NCT00809133|527731487|FG005|Overall Study|Consent withdrawn|0|||
146334831|NCT00809133|527731488|FG006|Overall Study|Consent withdrawn|0|||
146334832|NCT00809133|527731489|FG007|Overall Study|Consent withdrawn|0|||
146334833|NCT00809133|527731490|FG008|Overall Study|Consent withdrawn|0|||
146334834|NCT00809133|527731491|FG009|Overall Study|Consent withdrawn|0|||
146334835|NCT00809133|527731492|FG010|Overall Study|Consent withdrawn|0|||
146334836|NCT00809133|527731493|FG011|Overall Study|Consent withdrawn|0|||
146334837|NCT00809133|527731494|FG012|Overall Study|Consent withdrawn|0|||
146334838|NCT00809133|527731495|FG013|Overall Study|Consent withdrawn|0|||
146334839|NCT00809133|527731482|FG000|Overall Study|Other not mentioned above|0|||
146334840|NCT00809133|527731483|FG001|Overall Study|Other not mentioned above|1|||
146334841|NCT00809133|527731484|FG002|Overall Study|Other not mentioned above|0|||
146334842|NCT00809133|527731485|FG003|Overall Study|Other not mentioned above|0|||
146334843|NCT00809133|527731486|FG004|Overall Study|Other not mentioned above|0|||
146334844|NCT00809133|527731487|FG005|Overall Study|Other not mentioned above|1|||
146334845|NCT00809133|527731488|FG006|Overall Study|Other not mentioned above|0|||
146334846|NCT00809133|527731489|FG007|Overall Study|Other not mentioned above|0|||
146334847|NCT00809133|527731490|FG008|Overall Study|Other not mentioned above|0|||
146334848|NCT00809133|527731491|FG009|Overall Study|Other not mentioned above|0|||
146334849|NCT00809133|527731492|FG010|Overall Study|Other not mentioned above|0|||
146334850|NCT00809133|527731493|FG011|Overall Study|Other not mentioned above|0|||
146334851|NCT00809133|527731494|FG012|Overall Study|Other not mentioned above|0|||
146334852|NCT00809133|527731495|FG013|Overall Study|Other not mentioned above|0|||
146334853|NCT03663166|527731496|FG000|Overall Study|Withdrawal by Subject|1|||
146334854|NCT04927312|527731499|FG000|Overall Study|Adverse Event|1|||
146334855|NCT04927312|527731499|FG000|Overall Study|Death|1|||
146334856|NCT04927312|527731499|FG000|Overall Study|Withdrawal by Subject|1|||
146334857|NCT04927312|527731499|FG000|Overall Study|Other|1|||
146334858|NCT04919564|527731502|FG000|Overall Study|Lost to Follow-up|1|||
146334859|NCT04919564|527731503|FG001|Overall Study|Lost to Follow-up|0|||
146334860|NCT04919564|527731502|FG000|Overall Study|Physician Decision|1|||
146334861|NCT04919564|527731503|FG001|Overall Study|Physician Decision|1|||
146334862|NCT01287104|527731504|FG000|Overall Study|Patient developed progressive disease|1|||
146334863|NCT01287104|527731505|FG001|Overall Study|Patient developed progressive disease|1|||
146334864|NCT01287104|527731506|FG002|Overall Study|Patient developed progressive disease|3|||
146334865|NCT01287104|527731507|FG003|Overall Study|Patient developed progressive disease|2|||
146334866|NCT01287104|527731504|FG000|Overall Study|Donor anaphylaxis|0|||
146334867|NCT01287104|527731505|FG001|Overall Study|Donor anaphylaxis|1|||
146334868|NCT01287104|527731506|FG002|Overall Study|Donor anaphylaxis|0|||
146334869|NCT01287104|527731507|FG003|Overall Study|Donor anaphylaxis|1|||
146334870|NCT01287104|527731504|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
146334871|NCT01287104|527731505|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
146334872|NCT01287104|527731506|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
146334873|NCT01287104|527731507|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
146334874|NCT01287104|527731504|FG000|Overall Study|Low donor chimerism|0|||
146334875|NCT01287104|527731505|FG001|Overall Study|Low donor chimerism|1|||
146334876|NCT01287104|527731506|FG002|Overall Study|Low donor chimerism|0|||
146334877|NCT01287104|527731507|FG003|Overall Study|Low donor chimerism|0|||
146334878|NCT01287104|527731504|FG000|Overall Study|NK cells did not meet release criteria|0|||
146334879|NCT01287104|527731505|FG001|Overall Study|NK cells did not meet release criteria|1|||
146396137|NCT01241591|527954455|FG003|Overall Study|Lost to Follow-up|2|||
146334880|NCT01287104|527731506|FG002|Overall Study|NK cells did not meet release criteria|0|||
146334881|NCT01287104|527731507|FG003|Overall Study|NK cells did not meet release criteria|0|||
146334882|NCT00098787|527731508|FG000|Overall Study|Never started treatment|3|||
146334883|NCT00098787|527731509|FG001|Overall Study|Never started treatment|2|||
146334884|NCT00098787|527731510|FG002|Overall Study|Never started treatment|1|||
146334885|NCT00098787|527731508|FG000|Overall Study|Ineligible|9|||
146334886|NCT00098787|527731509|FG001|Overall Study|Ineligible|7|||
146334887|NCT00098787|527731510|FG002|Overall Study|Ineligible|3|||
146334888|NCT00098787|527731508|FG000|Overall Study|Disease progression|28|||
146334889|NCT00098787|527731509|FG001|Overall Study|Disease progression|17|||
146334890|NCT00098787|527731510|FG002|Overall Study|Disease progression|23|||
146334891|NCT00098787|527731508|FG000|Overall Study|Adverse Event|8|||
146334892|NCT00098787|527731509|FG001|Overall Study|Adverse Event|17|||
146334893|NCT00098787|527731510|FG002|Overall Study|Adverse Event|8|||
146334894|NCT00098787|527731508|FG000|Overall Study|Death|6|||
146334895|NCT00098787|527731509|FG001|Overall Study|Death|1|||
146334896|NCT00098787|527731510|FG002|Overall Study|Death|0|||
146334897|NCT00098787|527731508|FG000|Overall Study|Withdrawal by Subject|4|||
146334898|NCT00098787|527731509|FG001|Overall Study|Withdrawal by Subject|12|||
146334899|NCT00098787|527731510|FG002|Overall Study|Withdrawal by Subject|6|||
146334900|NCT00098787|527731508|FG000|Overall Study|Alternative therapy|8|||
146334901|NCT00098787|527731509|FG001|Overall Study|Alternative therapy|13|||
146334902|NCT00098787|527731510|FG002|Overall Study|Alternative therapy|13|||
146334903|NCT00098787|527731508|FG000|Overall Study|Other|7|||
146334904|NCT00098787|527731509|FG001|Overall Study|Other|6|||
146334905|NCT00098787|527731510|FG002|Overall Study|Other|9|||
146334906|NCT04052139|527731511|FG000|Overall Study|Lost to Follow-up|2|||
146334907|NCT04052139|527731512|FG001|Overall Study|Lost to Follow-up|0|||
146334908|NCT04052139|527731513|FG002|Overall Study|Lost to Follow-up|0|||
146334909|NCT04052139|527731511|FG000|Overall Study|Withdrawal by Subject|1|||
146334910|NCT04052139|527731512|FG001|Overall Study|Withdrawal by Subject|0|||
146334911|NCT04052139|527731513|FG002|Overall Study|Withdrawal by Subject|0|||
146334912|NCT00707577|527731514|FG000|Overall Study|Withdrawal by Subject|3|||
146334913|NCT00707577|527731515|FG001|Overall Study|Withdrawal by Subject|2|||
146334914|NCT00707577|527731514|FG000|Overall Study|Lost to Follow-up|34|||
146334915|NCT00707577|527731515|FG001|Overall Study|Lost to Follow-up|25|||
146334916|NCT00707577|527731514|FG000|Overall Study|Left employment|13|||
146334917|NCT00707577|527731515|FG001|Overall Study|Left employment|10|||
146334918|NCT00707577|527731514|FG000|Overall Study|Pregnancy|4|||
146334919|NCT00707577|527731515|FG001|Overall Study|Pregnancy|1|||
146334920|NCT00519077|527731516|FG000|Overall Study|Death|6|||
146334921|NCT00519077|527731516|FG000|Overall Study|Other|2|||
146334922|NCT01967225|527731517|FG000|Overall Study|Adverse Event|3|||
146334923|NCT01967225|527731518|FG001|Overall Study|Adverse Event|1|||
146334924|NCT01967225|527731517|FG000|Overall Study|Withdrawal by Subject|2|||
146334925|NCT01967225|527731518|FG001|Overall Study|Withdrawal by Subject|1|||
146334926|NCT01967225|527731517|FG000|Overall Study|Lack of Efficacy|1|||
146334927|NCT01967225|527731518|FG001|Overall Study|Lack of Efficacy|1|||
146334928|NCT01967225|527731517|FG000|Overall Study|Switching to other therapy|2|||
146334929|NCT01967225|527731518|FG001|Overall Study|Switching to other therapy|0|||
146334930|NCT01967225|527731517|FG000|Overall Study|Protocol driven decision point|1|||
146334931|NCT01967225|527731518|FG001|Overall Study|Protocol driven decision point|0|||
146168926|NCT00332332|527131064|FG000|Overall Study|Disease progression|2|||
146168927|NCT00332332|527131064|FG000|Overall Study|Other|18|||
146168928|NCT00332332|527131064|FG000|Overall Study|Did not receive study treatment|16|||
146168929|NCT01382602|527131065|FG000|Overall Study|Protocol Violation|0|||
146168930|NCT01382602|527131066|FG001|Overall Study|Protocol Violation|3|||
146168931|NCT01382602|527131065|FG000|Overall Study|Withdrawal by Subject|0|||
146168932|NCT01382602|527131066|FG001|Overall Study|Withdrawal by Subject|1|||
146168933|NCT04425902|527131071|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
146168934|NCT01191840|527131072|FG000|Overall Study|withdrew consent|2|||
146168935|NCT01191840|527131073|FG001|Overall Study|withdrew consent|1|||
146168936|NCT01191840|527131072|FG000|Overall Study|Subject discontinued treatment|1|||
146168937|NCT01191840|527131073|FG001|Overall Study|Subject discontinued treatment|2|||
146168938|NCT01191840|527131072|FG000|Overall Study|Lost to Follow-up|4|||
146168939|NCT01191840|527131073|FG001|Overall Study|Lost to Follow-up|6|||
146168940|NCT01191840|527131072|FG000|Overall Study|Non Staph Infection|4|||
146334932|NCT01967225|527731517|FG000|Overall Study|Logistical difficulties|1|||
146334933|NCT01967225|527731518|FG001|Overall Study|Logistical difficulties|0|||
146334934|NCT01967225|527731517|FG000|Overall Study|Protocol Violation|2|||
146334935|NCT01967225|527731518|FG001|Overall Study|Protocol Violation|0|||
146334936|NCT02305563|527731519|FG000|Treatment Period|Disease progression|0|||
146334937|NCT02305563|527731520|FG001|Treatment Period|Disease progression|0|||
146334938|NCT02305563|527731521|FG002|Treatment Period|Disease progression|15|||
146334939|NCT02305563|527731522|FG003|Treatment Period|Disease progression|6|||
146334940|NCT02305563|527731523|FG004|Treatment Period|Disease progression|6|||
146334941|NCT02305563|527731519|FG000|Treatment Period|Study drug toxicity|0|||
146334942|NCT02305563|527731520|FG001|Treatment Period|Study drug toxicity|0|||
146334943|NCT02305563|527731521|FG002|Treatment Period|Study drug toxicity|0|||
146334944|NCT02305563|527731522|FG003|Treatment Period|Study drug toxicity|1|||
146334945|NCT02305563|527731523|FG004|Treatment Period|Study drug toxicity|2|||
146334946|NCT02305563|527731519|FG000|Treatment Period|Death|0|||
146334947|NCT02305563|527731520|FG001|Treatment Period|Death|0|||
146334948|NCT02305563|527731521|FG002|Treatment Period|Death|1|||
146334949|NCT02305563|527731522|FG003|Treatment Period|Death|2|||
146334950|NCT02305563|527731523|FG004|Treatment Period|Death|1|||
146334951|NCT02305563|527731519|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
146334952|NCT02305563|527731520|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
146334953|NCT02305563|527731521|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
146334954|NCT02305563|527731522|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
146334955|NCT02305563|527731523|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
146334956|NCT02305563|527731519|FG000|Treatment Period|Participant request to stop therapy|0|||
146334957|NCT02305563|527731520|FG001|Treatment Period|Participant request to stop therapy|2|||
146334958|NCT02305563|527731521|FG002|Treatment Period|Participant request to stop therapy|0|||
146334959|NCT02305563|527731522|FG003|Treatment Period|Participant request to stop therapy|1|||
146334960|NCT02305563|527731523|FG004|Treatment Period|Participant request to stop therapy|0|||
146334961|NCT02305563|527731519|FG000|Treatment Period|Participant withdrew consent|0|||
146334962|NCT02305563|527731520|FG001|Treatment Period|Participant withdrew consent|0|||
146334963|NCT02305563|527731521|FG002|Treatment Period|Participant withdrew consent|1|||
146334964|NCT02305563|527731522|FG003|Treatment Period|Participant withdrew consent|1|||
146334965|NCT02305563|527731523|FG004|Treatment Period|Participant withdrew consent|1|||
146334966|NCT02305563|527731519|FG000|Treatment Period|Maximum clinical benefit|0|||
146334967|NCT02305563|527731520|FG001|Treatment Period|Maximum clinical benefit|0|||
146334968|NCT02305563|527731521|FG002|Treatment Period|Maximum clinical benefit|0|||
146334969|NCT02305563|527731522|FG003|Treatment Period|Maximum clinical benefit|0|||
146334970|NCT02305563|527731523|FG004|Treatment Period|Maximum clinical benefit|1|||
146334971|NCT02305563|527731519|FG000|Treatment Period|Poor/non-compliance|0|||
146334972|NCT02305563|527731520|FG001|Treatment Period|Poor/non-compliance|0|||
146334973|NCT02305563|527731521|FG002|Treatment Period|Poor/non-compliance|0|||
146334974|NCT02305563|527731522|FG003|Treatment Period|Poor/non-compliance|0|||
146334975|NCT02305563|527731523|FG004|Treatment Period|Poor/non-compliance|1|||
146334976|NCT02305563|527731519|FG000|Treatment Period|Administrative reason by Sponsor|0|||
146334977|NCT02305563|527731520|FG001|Treatment Period|Administrative reason by Sponsor|0|||
146334978|NCT02305563|527731521|FG002|Treatment Period|Administrative reason by Sponsor|0|||
146334979|NCT02305563|527731522|FG003|Treatment Period|Administrative reason by Sponsor|0|||
146334980|NCT02305563|527731523|FG004|Treatment Period|Administrative reason by Sponsor|1|||
146334981|NCT02305563|527731519|FG000|Treatment Period|other reason|2|||
146334982|NCT02305563|527731520|FG001|Treatment Period|other reason|0|||
146334983|NCT02305563|527731521|FG002|Treatment Period|other reason|2|||
146334984|NCT02305563|527731522|FG003|Treatment Period|other reason|2|||
146334985|NCT02305563|527731523|FG004|Treatment Period|other reason|1|||
146334986|NCT02305563|527731519|FG000|Treatment Period|Randomized but not treated|0|||
146334987|NCT02305563|527731520|FG001|Treatment Period|Randomized but not treated|0|||
146334988|NCT02305563|527731521|FG002|Treatment Period|Randomized but not treated|0|||
146334989|NCT02305563|527731522|FG003|Treatment Period|Randomized but not treated|0|||
146334990|NCT02305563|527731523|FG004|Treatment Period|Randomized but not treated|2|||
146334991|NCT02305563|527731519|FG000|Treatment Period|added ULO, then disease progression|0|||
146334992|NCT02305563|527731520|FG001|Treatment Period|added ULO, then disease progression|0|||
146334993|NCT02305563|527731521|FG002|Treatment Period|added ULO, then disease progression|0|||
146334994|NCT02305563|527731522|FG003|Treatment Period|added ULO, then disease progression|0|||
146334995|NCT02305563|527731523|FG004|Treatment Period|added ULO, then disease progression|4|||
146334996|NCT02305563|527731519|FG000|Treatment Period|added ULO; then other reason|0|||
146334997|NCT02305563|527731520|FG001|Treatment Period|added ULO; then other reason|0|||
146334998|NCT02305563|527731521|FG002|Treatment Period|added ULO; then other reason|0|||
146334999|NCT02305563|527731522|FG003|Treatment Period|added ULO; then other reason|0|||
146335000|NCT02305563|527731523|FG004|Treatment Period|added ULO; then other reason|1|||
146335001|NCT02305563|527731519|FG000|Treatment Period|added ULO, then request to stop|0|||
146335002|NCT02305563|527731520|FG001|Treatment Period|added ULO, then request to stop|0|||
146335003|NCT02305563|527731521|FG002|Treatment Period|added ULO, then request to stop|0|||
146335004|NCT02305563|527731522|FG003|Treatment Period|added ULO, then request to stop|0|||
146168941|NCT01191840|527131073|FG001|Overall Study|Non Staph Infection|3|||
146335005|NCT02305563|527731523|FG004|Treatment Period|added ULO, then request to stop|1|||
146335006|NCT02305563|527731519|FG000|Follow-up Period|Death|0|||
146335007|NCT02305563|527731520|FG001|Follow-up Period|Death|0|||
146335008|NCT02305563|527731521|FG002|Follow-up Period|Death|5|||
146335009|NCT02305563|527731522|FG003|Follow-up Period|Death|4|||
146335010|NCT02305563|527731523|FG004|Follow-up Period|Death|7|||
146335011|NCT02305563|527731519|FG000|Follow-up Period|Participant withdrew consent|0|||
146335012|NCT02305563|527731520|FG001|Follow-up Period|Participant withdrew consent|0|||
146335013|NCT02305563|527731521|FG002|Follow-up Period|Participant withdrew consent|2|||
146168942|NCT01191840|527131072|FG000|Overall Study|ineligible at enrollment|1|||
146335014|NCT02305563|527731522|FG003|Follow-up Period|Participant withdrew consent|1|||
146335015|NCT02305563|527731523|FG004|Follow-up Period|Participant withdrew consent|0|||
146335016|NCT02305563|527731519|FG000|Follow-up Period|other reason|0|||
146335017|NCT02305563|527731520|FG001|Follow-up Period|other reason|0|||
146335018|NCT02305563|527731521|FG002|Follow-up Period|other reason|0|||
146335019|NCT02305563|527731522|FG003|Follow-up Period|other reason|0|||
146335020|NCT02305563|527731523|FG004|Follow-up Period|other reason|1|||
146335021|NCT02305563|527731519|FG000|Follow-up Period|Followup no longer required per protocol|3|||
146335022|NCT02305563|527731520|FG001|Follow-up Period|Followup no longer required per protocol|3|||
146335023|NCT02305563|527731521|FG002|Follow-up Period|Followup no longer required per protocol|4|||
146335024|NCT02305563|527731522|FG003|Follow-up Period|Followup no longer required per protocol|1|||
146335025|NCT02305563|527731523|FG004|Follow-up Period|Followup no longer required per protocol|4|||
146335026|NCT00642642|527731526|FG000|Treatment & Follow Up|Adverse Event|2|||
146335027|NCT00642642|527731526|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
146335028|NCT00642642|527731526|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
146335029|NCT01275222|527731529|FG000|Phase l by Treatment|Adverse Event|1|||
146335030|NCT01275222|527731530|FG001|Phase l by Treatment|Adverse Event|4|||
146335031|NCT01275222|527731531|FG002|Phase l by Treatment|Adverse Event|2|||
146335032|NCT01275222|527731532|FG003|Phase l by Treatment|Adverse Event|3|||
146335033|NCT01275222|527731533|FG004|Phase l by Treatment|Adverse Event|0|||
146335034|NCT01275222|527731534|FG005|Phase l by Treatment|Adverse Event|0|||
146335035|NCT01275222|527731529|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146335036|NCT01275222|527731530|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146335037|NCT01275222|527731531|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
146335038|NCT01275222|527731532|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146335039|NCT01275222|527731533|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146335040|NCT01275222|527731534|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
146335041|NCT01275222|527731529|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146335042|NCT01275222|527731530|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146335043|NCT01275222|527731531|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146335044|NCT01275222|527731532|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
146335045|NCT01275222|527731533|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146335046|NCT01275222|527731534|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
146335047|NCT01275222|527731529|FG000|Phase l by Treatment|Disease progression|12|||
146335048|NCT01275222|527731530|FG001|Phase l by Treatment|Disease progression|8|||
146335049|NCT01275222|527731531|FG002|Phase l by Treatment|Disease progression|2|||
146335050|NCT01275222|527731532|FG003|Phase l by Treatment|Disease progression|5|||
146335051|NCT01275222|527731533|FG004|Phase l by Treatment|Disease progression|0|||
146335052|NCT01275222|527731534|FG005|Phase l by Treatment|Disease progression|0|||
146335053|NCT01275222|527731529|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
146335054|NCT01275222|527731530|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
146335055|NCT01275222|527731531|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
146335056|NCT01275222|527731532|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
146335057|NCT01275222|527731533|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
146335058|NCT01275222|527731534|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
146335059|NCT01275222|527731529|FG000|Phase l by Treatment|Death|0|||
146335060|NCT01275222|527731530|FG001|Phase l by Treatment|Death|1|||
146335061|NCT01275222|527731531|FG002|Phase l by Treatment|Death|0|||
146335062|NCT01275222|527731532|FG003|Phase l by Treatment|Death|1|||
146335063|NCT01275222|527731533|FG004|Phase l by Treatment|Death|0|||
146335064|NCT01275222|527731534|FG005|Phase l by Treatment|Death|0|||
146335065|NCT01275222|527731529|FG000|Phase ll by Stratum|Adverse Event|0|||
146335066|NCT01275222|527731530|FG001|Phase ll by Stratum|Adverse Event|0|||
146335067|NCT01275222|527731531|FG002|Phase ll by Stratum|Adverse Event|0|||
146335068|NCT01275222|527731532|FG003|Phase ll by Stratum|Adverse Event|0|||
146335069|NCT01275222|527731533|FG004|Phase ll by Stratum|Adverse Event|2|||
146335070|NCT01275222|527731534|FG005|Phase ll by Stratum|Adverse Event|10|||
146335071|NCT01275222|527731529|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
146335072|NCT01275222|527731530|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
146335073|NCT01275222|527731531|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
146335074|NCT01275222|527731532|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
146335075|NCT01275222|527731533|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
146335076|NCT01275222|527731534|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
146335077|NCT01275222|527731529|FG000|Phase ll by Stratum|Disease progression|0|||
146335078|NCT01275222|527731530|FG001|Phase ll by Stratum|Disease progression|0|||
146335079|NCT01275222|527731531|FG002|Phase ll by Stratum|Disease progression|0|||
146335080|NCT01275222|527731532|FG003|Phase ll by Stratum|Disease progression|0|||
146335081|NCT01275222|527731533|FG004|Phase ll by Stratum|Disease progression|23|||
146335082|NCT01275222|527731534|FG005|Phase ll by Stratum|Disease progression|31|||
146335083|NCT01275222|527731529|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
146335084|NCT01275222|527731530|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
146335085|NCT01275222|527731531|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
146335086|NCT01275222|527731532|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
146335087|NCT01275222|527731533|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
146335088|NCT01275222|527731534|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
146335089|NCT01275222|527731529|FG000|Phase ll by Stratum|Death|0|||
146335090|NCT01275222|527731530|FG001|Phase ll by Stratum|Death|0|||
146335091|NCT01275222|527731531|FG002|Phase ll by Stratum|Death|0|||
146335092|NCT01275222|527731532|FG003|Phase ll by Stratum|Death|0|||
146335093|NCT01275222|527731533|FG004|Phase ll by Stratum|Death|1|||
146335094|NCT01275222|527731534|FG005|Phase ll by Stratum|Death|1|||
146335095|NCT01511445|527731535|FG000|Overall Study|Lost to Follow-up|3|||
146335096|NCT01511445|527731536|FG001|Overall Study|Lost to Follow-up|1|||
146335097|NCT01511445|527731535|FG000|Overall Study|Protocol Violation|1|||
146335098|NCT01511445|527731536|FG001|Overall Study|Protocol Violation|3|||
146335099|NCT01511445|527731535|FG000|Overall Study|Protocol Violation|1|||
146335100|NCT01511445|527731536|FG001|Overall Study|Protocol Violation|0|||
146335101|NCT01856114|527731537|FG000|Overall Study|Withdrawal by Subject|1|||
146335102|NCT01856114|527731538|FG001|Overall Study|Withdrawal by Subject|0|||
146335103|NCT01856114|527731537|FG000|Overall Study|Adverse Event|1|||
146335104|NCT01856114|527731538|FG001|Overall Study|Adverse Event|0|||
146335105|NCT00144170|527731539|FG000|Overall Study|Adverse Event|84|||
146335106|NCT00144170|527731540|FG001|Overall Study|Adverse Event|41|||
146335107|NCT00144170|527731539|FG000|Overall Study|Protocol Violation|23|||
146335108|NCT00144170|527731540|FG001|Overall Study|Protocol Violation|16|||
146335109|NCT00144170|527731539|FG000|Overall Study|Lost to Follow-up|5|||
146335110|NCT00144170|527731540|FG001|Overall Study|Lost to Follow-up|10|||
146335111|NCT00144170|527731539|FG000|Overall Study|Withdrawal by Subject|29|||
146335112|NCT00144170|527731540|FG001|Overall Study|Withdrawal by Subject|13|||
146335113|NCT00144170|527731539|FG000|Overall Study|Other reason not defined above|211|||
146335114|NCT00144170|527731540|FG001|Overall Study|Other reason not defined above|316|||
146335115|NCT00818259|527731541|FG000|Part I|Withdrawal by Subject|1|||
146335116|NCT00818259|527731542|FG001|Part I|Withdrawal by Subject|0|||
146335117|NCT00818259|527731543|FG002|Part I|Withdrawal by Subject|0|||
146335118|NCT00818259|527731544|FG003|Part I|Withdrawal by Subject|0|||
146335119|NCT00818259|527731545|FG004|Part I|Withdrawal by Subject|0|||
146335120|NCT00818259|527731546|FG005|Part I|Withdrawal by Subject|0|||
146335121|NCT00818259|527731547|FG006|Part I|Withdrawal by Subject|0|||
146335122|NCT00818259|527731548|FG007|Part I|Withdrawal by Subject|0|||
146335123|NCT00818259|527731549|FG008|Part I|Withdrawal by Subject|0|||
146335124|NCT00818259|527731541|FG000|Part II|Physician Decision|0|||
146335125|NCT00818259|527731542|FG001|Part II|Physician Decision|0|||
146335126|NCT00818259|527731543|FG002|Part II|Physician Decision|1|||
146335127|NCT00818259|527731544|FG003|Part II|Physician Decision|0|||
146335128|NCT00818259|527731545|FG004|Part II|Physician Decision|0|||
146335129|NCT00818259|527731546|FG005|Part II|Physician Decision|0|||
146335130|NCT00818259|527731547|FG006|Part II|Physician Decision|0|||
146335131|NCT00818259|527731548|FG007|Part II|Physician Decision|0|||
146335132|NCT00818259|527731549|FG008|Part II|Physician Decision|0|||
146335133|NCT00818259|527731541|FG000|Part II|Lack of Efficacy|0|||
146335134|NCT00818259|527731542|FG001|Part II|Lack of Efficacy|0|||
146335135|NCT00818259|527731543|FG002|Part II|Lack of Efficacy|0|||
146335136|NCT00818259|527731544|FG003|Part II|Lack of Efficacy|1|||
146335137|NCT00818259|527731545|FG004|Part II|Lack of Efficacy|0|||
146335138|NCT00818259|527731546|FG005|Part II|Lack of Efficacy|0|||
146335139|NCT00818259|527731547|FG006|Part II|Lack of Efficacy|0|||
146335140|NCT00818259|527731548|FG007|Part II|Lack of Efficacy|0|||
146335141|NCT00818259|527731549|FG008|Part II|Lack of Efficacy|0|||
146335142|NCT00818259|527731541|FG000|Part II|Not Treated|0|||
146335143|NCT00818259|527731542|FG001|Part II|Not Treated|0|||
146335144|NCT00818259|527731543|FG002|Part II|Not Treated|0|||
146335145|NCT00818259|527731544|FG003|Part II|Not Treated|1|||
146335146|NCT00818259|527731545|FG004|Part II|Not Treated|0|||
146335147|NCT00818259|527731546|FG005|Part II|Not Treated|0|||
146335148|NCT00818259|527731547|FG006|Part II|Not Treated|0|||
146335149|NCT00818259|527731548|FG007|Part II|Not Treated|0|||
146335150|NCT00818259|527731549|FG008|Part II|Not Treated|0|||
146335151|NCT00818259|527731541|FG000|Part IV|Physician Decision|0|||
146335152|NCT00818259|527731542|FG001|Part IV|Physician Decision|0|||
146335153|NCT00818259|527731543|FG002|Part IV|Physician Decision|0|||
146335154|NCT00818259|527731544|FG003|Part IV|Physician Decision|0|||
146335155|NCT00818259|527731545|FG004|Part IV|Physician Decision|0|||
146335156|NCT00818259|527731546|FG005|Part IV|Physician Decision|1|||
146335157|NCT00818259|527731547|FG006|Part IV|Physician Decision|0|||
146335158|NCT00818259|527731548|FG007|Part IV|Physician Decision|0|||
146335159|NCT00818259|527731549|FG008|Part IV|Physician Decision|0|||
146335160|NCT00818259|527731541|FG000|Part V|Adverse Event|0|||
146335161|NCT00818259|527731542|FG001|Part V|Adverse Event|0|||
146335162|NCT00818259|527731543|FG002|Part V|Adverse Event|0|||
146335163|NCT00818259|527731544|FG003|Part V|Adverse Event|0|||
146335164|NCT00818259|527731545|FG004|Part V|Adverse Event|0|||
146335165|NCT00818259|527731546|FG005|Part V|Adverse Event|0|||
146335166|NCT00818259|527731547|FG006|Part V|Adverse Event|0|||
146335167|NCT00818259|527731548|FG007|Part V|Adverse Event|1|||
146335168|NCT00818259|527731549|FG008|Part V|Adverse Event|0|||
146335169|NCT00686543|527731550|FG000|Overall Study|Adverse Event|9|||
146335170|NCT00686543|527731551|FG001|Overall Study|Adverse Event|1|||
146335171|NCT00686543|527731552|FG002|Overall Study|Adverse Event|3|||
146335172|NCT00686543|527731553|FG003|Overall Study|Adverse Event|2|||
146335173|NCT00686543|527731550|FG000|Overall Study|Withdrawal by Subject|2|||
146335174|NCT00686543|527731551|FG001|Overall Study|Withdrawal by Subject|0|||
146335175|NCT00686543|527731552|FG002|Overall Study|Withdrawal by Subject|0|||
146335176|NCT00686543|527731553|FG003|Overall Study|Withdrawal by Subject|0|||
146335177|NCT00686543|527731550|FG000|Overall Study|Protocol Violation|3|||
146335178|NCT00686543|527731551|FG001|Overall Study|Protocol Violation|0|||
146335179|NCT00686543|527731552|FG002|Overall Study|Protocol Violation|2|||
146335180|NCT00686543|527731553|FG003|Overall Study|Protocol Violation|1|||
146335181|NCT01237951|527731554|FG000|Overall Study|Death|1|||
146335182|NCT00924703|527731557|FG000|Overall Study|Withdrawal by Subject|11|||
146335183|NCT00924703|527731557|FG000|Overall Study|Physician Decision|5|||
146335184|NCT00924703|527731557|FG000|Overall Study|Lost to Follow-up|3|||
146335185|NCT00924703|527731557|FG000|Overall Study|Adverse Event|2|||
146335186|NCT00924703|527731557|FG000|Overall Study|Withdrawal by Sponsor|1|||
146335187|NCT00666562|527731558|FG000|Overall Study|Withdrawal by Subject|0|||
146335188|NCT00666562|527731559|FG001|Overall Study|Withdrawal by Subject|1|||
146335189|NCT00666562|527731560|FG002|Overall Study|Withdrawal by Subject|0|||
146335190|NCT00666562|527731558|FG000|Overall Study|Concomitant Medication|0|||
146335191|NCT00666562|527731559|FG001|Overall Study|Concomitant Medication|1|||
146335192|NCT00666562|527731560|FG002|Overall Study|Concomitant Medication|0|||
146335193|NCT04906707|527731561|FG000|Overall Study|Withdrawal by Subject|2|||
146335194|NCT04906707|527731562|FG001|Overall Study|Withdrawal by Subject|0|||
146335195|NCT04906707|527731561|FG000|Overall Study|Withdrawal due to PI decision|1|||
146335196|NCT04906707|527731562|FG001|Overall Study|Withdrawal due to PI decision|0|||
146335197|NCT04906707|527731561|FG000|Overall Study|Lost to Follow-up|0|||
146335198|NCT04906707|527731562|FG001|Overall Study|Lost to Follow-up|1|||
146335199|NCT01976806|527731563|FG000|Overall Study|Lost to Follow-up|1|||
146335200|NCT01976806|527731564|FG001|Overall Study|Lost to Follow-up|4|||
146335201|NCT01976806|527731563|FG000|Overall Study|Adverse Event|1|||
146335202|NCT01976806|527731564|FG001|Overall Study|Adverse Event|1|||
146335203|NCT01976806|527731563|FG000|Overall Study|Withdrawal by Subject|1|||
146335204|NCT01976806|527731564|FG001|Overall Study|Withdrawal by Subject|1|||
146335205|NCT04429022|527731568|FG000|Overall Study|Protocol Violation|18|||
146335206|NCT04429022|527731569|FG001|Overall Study|Protocol Violation|1|||
146335207|NCT01769105|527731574|FG000|First Intervention|Protocol Violation|2|||
146335208|NCT01769105|527731575|FG001|First Intervention|Protocol Violation|2|||
146335209|NCT01769105|527731574|FG000|Cross-over|Lost to Follow-up|5|||
146335210|NCT01769105|527731575|FG001|Cross-over|Lost to Follow-up|0|||
146335211|NCT00963807|527731576|FG000|Overall Study|Physician Decision|2|||
146335212|NCT00963807|527731576|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
146335213|NCT00963807|527731576|FG000|Overall Study|Disease progression|15|||
146335214|NCT00684177|527731577|FG000|Overall Study|Adverse Event|4|||
146335215|NCT00684177|527731578|FG001|Overall Study|Adverse Event|3|||
146335216|NCT00684177|527731577|FG000|Overall Study|Lack of Efficacy|10|||
146335217|NCT00684177|527731578|FG001|Overall Study|Lack of Efficacy|15|||
146335218|NCT00684177|527731577|FG000|Overall Study|Protocol Violation|1|||
146335219|NCT00684177|527731578|FG001|Overall Study|Protocol Violation|0|||
146335220|NCT00684177|527731577|FG000|Overall Study|Lost to Follow-up|2|||
146335221|NCT00684177|527731578|FG001|Overall Study|Lost to Follow-up|1|||
146335222|NCT00684177|527731577|FG000|Overall Study|Physician Decision|2|||
146335223|NCT00684177|527731578|FG001|Overall Study|Physician Decision|0|||
146335224|NCT00684177|527731577|FG000|Overall Study|Withdrawal by Subject|1|||
146335225|NCT00684177|527731578|FG001|Overall Study|Withdrawal by Subject|2|||
146335226|NCT00684177|527731577|FG000|Overall Study|Other|1|||
146335227|NCT00684177|527731578|FG001|Overall Study|Other|2|||
146335228|NCT00828464|527732515|FG000|Overall Study|Withdrawal by Subject|1|||
146335229|NCT00474240|527732516|FG000|Overall Study|Withdrawal by Subject|1|||
146335230|NCT00474240|527732517|FG001|Overall Study|Withdrawal by Subject|1|||
146335231|NCT00474240|527732518|FG002|Overall Study|Withdrawal by Subject|0|||
146335232|NCT00474240|527732519|FG003|Overall Study|Withdrawal by Subject|2|||
146335233|NCT00474240|527732520|FG004|Overall Study|Withdrawal by Subject|3|||
146335234|NCT00474240|527732521|FG005|Overall Study|Withdrawal by Subject|1|||
146335235|NCT00474240|527732516|FG000|Overall Study|Adverse Event|0|||
146335236|NCT00474240|527732517|FG001|Overall Study|Adverse Event|0|||
146335237|NCT00474240|527732518|FG002|Overall Study|Adverse Event|9|||
146335238|NCT00474240|527732519|FG003|Overall Study|Adverse Event|14|||
146335239|NCT00474240|527732520|FG004|Overall Study|Adverse Event|5|||
146335240|NCT00474240|527732521|FG005|Overall Study|Adverse Event|16|||
146335241|NCT00474240|527732516|FG000|Overall Study|Removed due to lab value|0|||
146335242|NCT00474240|527732517|FG001|Overall Study|Removed due to lab value|0|||
146335243|NCT00474240|527732518|FG002|Overall Study|Removed due to lab value|0|||
146335244|NCT00474240|527732519|FG003|Overall Study|Removed due to lab value|0|||
146335245|NCT00474240|527732520|FG004|Overall Study|Removed due to lab value|0|||
146335246|NCT00474240|527732521|FG005|Overall Study|Removed due to lab value|1|||
146335247|NCT02197377|527732522|FG000|Overall Study|Insertion Failure|0|||
146335248|NCT02197377|527732523|FG001|Overall Study|Insertion Failure|3|||
146335249|NCT00502840|527732524|FG000|Overall Study|Adverse Event|5|||
146335250|NCT00502840|527732524|FG000|Overall Study|Additional or changed therapy|48|||
146335251|NCT00502840|527732524|FG000|Overall Study|Lack of Efficacy|11|||
146335252|NCT00502840|527732524|FG000|Overall Study|Protocol Violation|4|||
146335253|NCT00502840|527732524|FG000|Overall Study|Withdrawal by Subject|5|||
146335254|NCT00502840|527732524|FG000|Overall Study|Lost to Follow-up|6|||
146335255|NCT00502840|527732524|FG000|Overall Study|Administrative problems|1|||
146335256|NCT00502840|527732524|FG000|Overall Study|Other|20|||
146335257|NCT01974323|527732525|FG000|Overall Study|Other Reasons|25|||
146335258|NCT01974323|527732526|FG001|Overall Study|Other Reasons|28|||
146335259|NCT01974323|527732525|FG000|Overall Study|Protocol Violation|2|||
146335260|NCT01974323|527732526|FG001|Overall Study|Protocol Violation|2|||
146335261|NCT01974323|527732525|FG000|Overall Study|Personal Reasons|15|||
146335262|NCT01974323|527732526|FG001|Overall Study|Personal Reasons|19|||
146335263|NCT01974323|527732525|FG000|Overall Study|Lost to Follow-up|45|||
146335264|NCT01974323|527732526|FG001|Overall Study|Lost to Follow-up|40|||
146335265|NCT01974323|527732525|FG000|Overall Study|Pregnancy|2|||
146335266|NCT01974323|527732526|FG001|Overall Study|Pregnancy|1|||
146335267|NCT01974323|527732525|FG000|Overall Study|Lack of Efficacy|1|||
146335268|NCT01974323|527732526|FG001|Overall Study|Lack of Efficacy|1|||
146335269|NCT01974323|527732525|FG000|Overall Study|Adverse Event|2|||
146335270|NCT01974323|527732526|FG001|Overall Study|Adverse Event|2|||
146335271|NCT00833092|527732527|FG000|Overall Study|Withdrawal by Subject|2|||
146335272|NCT00833092|527732528|FG001|Overall Study|Withdrawal by Subject|3|||
146335273|NCT00833092|527732527|FG000|Overall Study|Protocol Violation|2|||
146335274|NCT00833092|527732528|FG001|Overall Study|Protocol Violation|1|||
146335275|NCT00833092|527732527|FG000|Overall Study|Diarrhea|0|||
146335276|NCT00833092|527732528|FG001|Overall Study|Diarrhea|2|||
146335277|NCT00833092|527732527|FG000|Overall Study|constipation|0|||
146335278|NCT00833092|527732528|FG001|Overall Study|constipation|1|||
146335279|NCT00619229|527732529|FG000|Overall Study|Withdrawal by Subject|1|||
146335280|NCT00619229|527732530|FG001|Overall Study|Withdrawal by Subject|1|||
146335281|NCT00619229|527732529|FG000|Overall Study|Lost to Follow-up|1|||
146335282|NCT00619229|527732530|FG001|Overall Study|Lost to Follow-up|0|||
146335283|NCT00619229|527732529|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
146335284|NCT00619229|527732530|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
146335285|NCT00619229|527732529|FG000|Overall Study|Investigator planned Cataract Operation|1|||
146335286|NCT00619229|527732530|FG001|Overall Study|Investigator planned Cataract Operation|0|||
146335287|NCT01700829|527732531|FG000|Overall Study|Withdrawal by Subject|1|||
146335288|NCT01700829|527732532|FG001|Overall Study|Withdrawal by Subject|1|||
146335289|NCT01075178|527732533|FG000|Subject Matching|eligible but not matched|130|||
146335290|NCT01075178|527732534|FG001|Subject Matching|eligible but not matched|403|||
146335291|NCT01075178|527732533|FG000|Subject Chart Review|died before chart review period|0|||
146335292|NCT01075178|527732534|FG001|Subject Chart Review|died before chart review period|2|||
146335293|NCT01075178|527732533|FG000|Subject Chart Review|no data collected due to site closure|3|||
146335294|NCT01075178|527732534|FG001|Subject Chart Review|no data collected due to site closure|4|||
146335295|NCT01075178|527732533|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
146335296|NCT01075178|527732534|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
146335297|NCT02983604|527732535|FG000|Overall Study|Enrolled but not Treated|0|||
146335298|NCT02983604|527732536|FG001|Overall Study|Enrolled but not Treated|0|||
146335299|NCT02983604|527732537|FG002|Overall Study|Enrolled but not Treated|1|||
146335300|NCT02983604|527732538|FG003|Overall Study|Enrolled but not Treated|0|||
146335301|NCT00355264|527732539|FG000|Extension (Variable Duration)|Adverse Event|1|||
146335302|NCT00355264|527732539|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
146335303|NCT00699192|527732540|FG000|Overall Study|Missing|1|||
146335304|NCT00699192|527732541|FG001|Overall Study|Missing|1|||
146335305|NCT00699192|527732542|FG002|Overall Study|Missing|1|||
146335306|NCT00699192|527732540|FG000|Overall Study|Adverse Event|9|||
146335307|NCT00699192|527732541|FG001|Overall Study|Adverse Event|4|||
146335308|NCT00699192|527732542|FG002|Overall Study|Adverse Event|3|||
146335309|NCT00699192|527732540|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146335310|NCT00699192|527732541|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146335311|NCT00699192|527732542|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146335312|NCT00699192|527732540|FG000|Overall Study|Lack of Efficacy|0|||
146335313|NCT00699192|527732541|FG001|Overall Study|Lack of Efficacy|0|||
146335314|NCT00699192|527732542|FG002|Overall Study|Lack of Efficacy|1|||
146335315|NCT00699192|527732540|FG000|Overall Study|Withdrawal by Subject|3|||
146335316|NCT00699192|527732541|FG001|Overall Study|Withdrawal by Subject|2|||
146335317|NCT00699192|527732542|FG002|Overall Study|Withdrawal by Subject|4|||
146335318|NCT00699192|527732540|FG000|Overall Study|Administrative problems|1|||
146335319|NCT00699192|527732541|FG001|Overall Study|Administrative problems|3|||
146168943|NCT01191840|527131073|FG001|Overall Study|ineligible at enrollment|0|||
146335320|NCT00699192|527732542|FG002|Overall Study|Administrative problems|1|||
146335321|NCT00699192|527732540|FG000|Overall Study|Protocol Violation|2|||
145943275|NCT02326298|526300469|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146335322|NCT00699192|527732541|FG001|Overall Study|Protocol Violation|2|||
146335323|NCT00699192|527732542|FG002|Overall Study|Protocol Violation|0|||
146335324|NCT01241786|527732548|FG000|Overall Study|Lack of Efficacy|5|||
146335325|NCT05340504|527732553|FG000|Overall Study|Withdrawal by Subject|1|||
146335326|NCT05340504|527732554|FG001|Overall Study|Withdrawal by Subject|0|||
146335327|NCT00929240|527732555|FG000|Initial Treatment Phase|Adverse Event|31|||
146335328|NCT00929240|527732556|FG001|Initial Treatment Phase|Adverse Event|0|||
146335329|NCT00929240|527732557|FG002|Initial Treatment Phase|Adverse Event|0|||
146335330|NCT00929240|527732555|FG000|Initial Treatment Phase|Disease progression|41|||
146335331|NCT00929240|527732556|FG001|Initial Treatment Phase|Disease progression|0|||
146335332|NCT00929240|527732557|FG002|Initial Treatment Phase|Disease progression|0|||
146335333|NCT00929240|527732555|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
146335334|NCT00929240|527732556|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
146335335|NCT00929240|527732557|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
146335336|NCT00929240|527732555|FG000|Initial Treatment Phase|Protocol Violation|5|||
146335337|NCT00929240|527732556|FG001|Initial Treatment Phase|Protocol Violation|0|||
146335338|NCT00929240|527732557|FG002|Initial Treatment Phase|Protocol Violation|0|||
146335339|NCT00929240|527732555|FG000|Initial Treatment Phase|Death|2|||
146335340|NCT00929240|527732556|FG001|Initial Treatment Phase|Death|0|||
146335341|NCT00929240|527732557|FG002|Initial Treatment Phase|Death|0|||
146335342|NCT00929240|527732555|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
146335343|NCT00929240|527732556|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
146335344|NCT00929240|527732557|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
146335345|NCT00929240|527732555|FG000|Initial Treatment Phase|Physician Decision|4|||
146335346|NCT00929240|527732556|FG001|Initial Treatment Phase|Physician Decision|0|||
146335347|NCT00929240|527732557|FG002|Initial Treatment Phase|Physician Decision|0|||
146335348|NCT00929240|527732555|FG000|Maintenance Phase|Disease progression|0|||
146335349|NCT00929240|527732556|FG001|Maintenance Phase|Disease progression|73|||
146335350|NCT00929240|527732557|FG002|Maintenance Phase|Disease progression|60|||
146335351|NCT00929240|527732555|FG000|Maintenance Phase|Adverse Event|0|||
146335352|NCT00929240|527732556|FG001|Maintenance Phase|Adverse Event|9|||
146335353|NCT00929240|527732557|FG002|Maintenance Phase|Adverse Event|12|||
146335354|NCT00929240|527732555|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146335355|NCT00929240|527732556|FG001|Maintenance Phase|Withdrawal by Subject|2|||
146335356|NCT00929240|527732557|FG002|Maintenance Phase|Withdrawal by Subject|6|||
146335357|NCT00929240|527732555|FG000|Maintenance Phase|Protocol Violation|0|||
146335358|NCT00929240|527732556|FG001|Maintenance Phase|Protocol Violation|1|||
146335359|NCT00929240|527732557|FG002|Maintenance Phase|Protocol Violation|0|||
146335360|NCT00929240|527732555|FG000|Maintenance Phase|Health authority/Study termination|0|||
146335361|NCT00929240|527732556|FG001|Maintenance Phase|Health authority/Study termination|1|||
146335362|NCT00929240|527732557|FG002|Maintenance Phase|Health authority/Study termination|2|||
146335363|NCT00929240|527732555|FG000|Maintenance Phase|Physician Decision|0|||
146335364|NCT00929240|527732556|FG001|Maintenance Phase|Physician Decision|2|||
146335365|NCT00929240|527732557|FG002|Maintenance Phase|Physician Decision|1|||
146335366|NCT00929240|527732555|FG000|Maintenance Phase|Change of treatment|0|||
146335367|NCT00929240|527732556|FG001|Maintenance Phase|Change of treatment|4|||
146335368|NCT00929240|527732557|FG002|Maintenance Phase|Change of treatment|0|||
146335369|NCT00929240|527732555|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
146335370|NCT00929240|527732556|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
146335371|NCT00929240|527732557|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
146335372|NCT00929240|527732555|FG000|Maintenance Phase|Participant not treated|0|||
146335373|NCT00929240|527732556|FG001|Maintenance Phase|Participant not treated|2|||
146335374|NCT00929240|527732557|FG002|Maintenance Phase|Participant not treated|0|||
146335375|NCT03068715|527732558|FG000|Overall Study|No longer met inclusion criteria|1|||
146335376|NCT03068715|527732559|FG001|Overall Study|No longer met inclusion criteria|0|||
146335377|NCT02203149|527732562|FG000|Part 1|Adverse Event|0|||
146335378|NCT02203149|527732563|FG001|Part 1|Adverse Event|1|||
146335379|NCT02203149|527732564|FG002|Part 1|Adverse Event|0|||
146335380|NCT02203149|527732565|FG003|Part 1|Adverse Event|0|||
146335381|NCT02203149|527732566|FG004|Part 1|Adverse Event|0|||
146335382|NCT02203149|527732562|FG000|Part 2|Death|0|||
146335383|NCT02203149|527732563|FG001|Part 2|Death|0|||
146335384|NCT02203149|527732564|FG002|Part 2|Death|1|||
146335385|NCT02203149|527732565|FG003|Part 2|Death|1|||
146335386|NCT02203149|527732566|FG004|Part 2|Death|0|||
146335387|NCT02203149|527732562|FG000|Part 2|Withdrawal by Subject|0|||
146335388|NCT02203149|527732563|FG001|Part 2|Withdrawal by Subject|0|||
146335389|NCT02203149|527732564|FG002|Part 2|Withdrawal by Subject|0|||
146335390|NCT02203149|527732565|FG003|Part 2|Withdrawal by Subject|1|||
146335391|NCT02203149|527732566|FG004|Part 2|Withdrawal by Subject|0|||
146335392|NCT02203149|527732562|FG000|Part 2|Adverse Event|0|||
146335393|NCT02203149|527732563|FG001|Part 2|Adverse Event|0|||
146335394|NCT02203149|527732564|FG002|Part 2|Adverse Event|0|||
146335395|NCT02203149|527732565|FG003|Part 2|Adverse Event|1|||
146335396|NCT02203149|527732566|FG004|Part 2|Adverse Event|1|||
146335397|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
146335398|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
146335399|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
146335400|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
146335401|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
146335402|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
146335403|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
146335404|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
146335405|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
146335406|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
146335407|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
146335408|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
146335409|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
146335410|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
146335411|NCT00446030|527732569|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
146335412|NCT00446030|527732570|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
146335413|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
146335414|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
146335415|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
146335416|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
146335417|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
146335418|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
146335419|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
146335420|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
146335421|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
146335422|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
146335423|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
146335424|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
146335425|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
146335426|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
146335427|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
146335428|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
146335429|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
146335430|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
146335431|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
146335432|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
146335433|NCT00446030|527732569|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
146335434|NCT00446030|527732570|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
146335435|NCT00503399|527732573|FG000|Overall Study|Death|2|||
146335436|NCT00503399|527732574|FG001|Overall Study|Death|1|||
146335437|NCT00503399|527732573|FG000|Overall Study|Protocol Violation|1|||
146335438|NCT00503399|527732574|FG001|Overall Study|Protocol Violation|0|||
146335439|NCT00503399|527732573|FG000|Overall Study|Withdrawal by Subject|4|||
146335440|NCT00503399|527732574|FG001|Overall Study|Withdrawal by Subject|2|||
146335441|NCT00503399|527732573|FG000|Overall Study|Adverse Event|0|||
146335442|NCT00503399|527732574|FG001|Overall Study|Adverse Event|3|||
146335443|NCT00503399|527732573|FG000|Overall Study|Lost to Follow-up|0|||
146335444|NCT00503399|527732574|FG001|Overall Study|Lost to Follow-up|2|||
146335445|NCT00858832|527732575|FG000|Overall Study|became ineligible: delivered vaginally|1|||
146335446|NCT00858832|527732576|FG001|Overall Study|became ineligible: delivered vaginally|0|||
146335447|NCT00858832|527732575|FG000|Overall Study|Adverse Event|0|||
146335448|NCT00858832|527732576|FG001|Overall Study|Adverse Event|1|||
146335449|NCT00432809|527732577|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
146335450|NCT00432809|527732578|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
146335451|NCT00432809|527732579|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
146335452|NCT00432809|527732577|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
146335453|NCT00432809|527732578|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
146335454|NCT00432809|527732579|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
146335455|NCT01709331|527732580|FG000|Overall Study|Adverse Event|1|||
146335456|NCT01243268|527732583|FG000|Overall Study|Lost to Follow-up|4|||
146335457|NCT01243268|527732583|FG000|Overall Study|Protocol Violation|51|||
146335458|NCT01243268|527732583|FG000|Overall Study|Deviation with contract date|7|||
146335459|NCT01243268|527732583|FG000|Overall Study|Duplicate subject|2|||
146335460|NCT01564784|527732584|FG000|Overall Study|Other|1|||
146335461|NCT01564784|527732585|FG001|Overall Study|Other|0|||
146335462|NCT01564784|527732584|FG000|Overall Study|Subject refused further follow-up|1|||
146335463|NCT01564784|527732585|FG001|Overall Study|Subject refused further follow-up|6|||
146335464|NCT01564784|527732584|FG000|Overall Study|Lost to Follow-up|1|||
146335465|NCT01564784|527732585|FG001|Overall Study|Lost to Follow-up|1|||
146335466|NCT01564784|527732584|FG000|Overall Study|Death|131|||
146335467|NCT01564784|527732585|FG001|Overall Study|Death|126|||
146335468|NCT00332202|527732586|FG000|Overall Study|Adverse Event|72|||
146335469|NCT00332202|527732587|FG001|Overall Study|Adverse Event|28|||
146335470|NCT00332202|527732586|FG000|Overall Study|Lost to Follow-up|2|||
146335471|NCT00332202|527732587|FG001|Overall Study|Lost to Follow-up|1|||
146335472|NCT00332202|527732586|FG000|Overall Study|Physician Decision|6|||
146335473|NCT00332202|527732587|FG001|Overall Study|Physician Decision|8|||
146335474|NCT00332202|527732586|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
146335475|NCT00332202|527732587|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
146335476|NCT00332202|527732586|FG000|Overall Study|Protocol Violation|7|||
146335477|NCT00332202|527732587|FG001|Overall Study|Protocol Violation|2|||
146335478|NCT00332202|527732586|FG000|Overall Study|Sponsor Decision|1|||
146335479|NCT00332202|527732587|FG001|Overall Study|Sponsor Decision|2|||
146335480|NCT00332202|527732586|FG000|Overall Study|Withdrawal by Subject|36|||
146335481|NCT00332202|527732587|FG001|Overall Study|Withdrawal by Subject|17|||
146335482|NCT00332202|527732586|FG000|Overall Study|Progressive Disease|106|||
146335483|NCT00332202|527732587|FG001|Overall Study|Progressive Disease|60|||
146335484|NCT00332202|527732586|FG000|Overall Study|Death|5|||
146335485|NCT00332202|527732587|FG001|Overall Study|Death|2|||
146335486|NCT00957853|527732588|FG000|Overall Study|Withdrawal by Subject|1|||
146335487|NCT00957853|527732589|FG001|Overall Study|Withdrawal by Subject|0|||
146335488|NCT00957853|527732590|FG002|Overall Study|Withdrawal by Subject|0|||
146335489|NCT01822561|527732595|FG000|Overall Study|Withdrawal by Subject|2|||
146335490|NCT01523873|527732597|FG000|Overall Study|Protocol Violation|422|||
146335491|NCT00275561|527732600|FG000|Overall Study|Withdrawal by Subject|0|||
146335492|NCT00275561|527732601|FG001|Overall Study|Withdrawal by Subject|1|||
146335493|NCT00275561|527732600|FG000|Overall Study|Travel|1|||
146335494|NCT00275561|527732601|FG001|Overall Study|Travel|1|||
146335495|NCT00275561|527732600|FG000|Overall Study|Scheduling|1|||
146335496|NCT00275561|527732601|FG001|Overall Study|Scheduling|2|||
146335497|NCT00275561|527732600|FG000|Overall Study|Family Issues|0|||
146335498|NCT00275561|527732601|FG001|Overall Study|Family Issues|2|||
146335499|NCT02582658|527732607|FG000|Overall Study|Failure to Return|10|||
146335500|NCT02582658|527732607|FG000|Overall Study|Insufficient Virological Response|2|||
146335501|NCT02582658|527732607|FG000|Overall Study|Withdrawn Consent|1|||
146335502|NCT02582658|527732607|FG000|Overall Study|Death|1|||
146335503|NCT02582658|527732607|FG000|Overall Study|Not further specified|11|||
146335504|NCT02432807|527734394|FG000|Overall Study|Adverse Event|0|||
146335505|NCT02432807|527734395|FG001|Overall Study|Adverse Event|2|||
146335506|NCT02432807|527734394|FG000|Overall Study|Lost to Follow-up|1|||
146335507|NCT02432807|527734395|FG001|Overall Study|Lost to Follow-up|0|||
146335508|NCT02432807|527734394|FG000|Overall Study|Withdrawal by Subject|1|||
146335509|NCT02432807|527734395|FG001|Overall Study|Withdrawal by Subject|1|||
146335510|NCT02432807|527734394|FG000|Overall Study|Other|1|||
146335511|NCT02432807|527734395|FG001|Overall Study|Other|1|||
146335512|NCT03075839|527734396|FG000|Overall Study|Lost to Follow-up|4|||
146335513|NCT04433117|527734397|FG000|Overall Study|Withdrawal by Subject|1|||
146335514|NCT04433117|527734398|FG001|Overall Study|Withdrawal by Subject|0|||
146335515|NCT00190775|527734399|FG000|Overall Study|Adverse Event|57|||
146335516|NCT00190775|527734400|FG001|Overall Study|Adverse Event|22|||
146335517|NCT00190775|527734399|FG000|Overall Study|Satisfactory Response|1|||
146335518|NCT00190775|527734400|FG001|Overall Study|Satisfactory Response|0|||
146335519|NCT00190775|527734399|FG000|Overall Study|Lack of Efficacy|28|||
146335520|NCT00190775|527734400|FG001|Overall Study|Lack of Efficacy|32|||
146335521|NCT00190775|527734399|FG000|Overall Study|Lost to Follow-up|31|||
146335522|NCT00190775|527734400|FG001|Overall Study|Lost to Follow-up|23|||
146335523|NCT00190775|527734399|FG000|Overall Study|Participant Moved|0|||
146335524|NCT00190775|527734400|FG001|Overall Study|Participant Moved|1|||
146335525|NCT00190775|527734399|FG000|Overall Study|Withdrawal by Subject|24|||
146335526|NCT00190775|527734400|FG001|Overall Study|Withdrawal by Subject|13|||
146335527|NCT00190775|527734399|FG000|Overall Study|Sponsor Decision|1|||
146335528|NCT00190775|527734400|FG001|Overall Study|Sponsor Decision|0|||
146335529|NCT00190775|527734399|FG000|Overall Study|Physician Decision|3|||
146335530|NCT00190775|527734400|FG001|Overall Study|Physician Decision|0|||
146335531|NCT00190775|527734399|FG000|Overall Study|Noncompliance|3|||
146335532|NCT00190775|527734400|FG001|Overall Study|Noncompliance|5|||
146335533|NCT00190775|527734399|FG000|Overall Study|Protocol Violation|0|||
146335534|NCT00190775|527734400|FG001|Overall Study|Protocol Violation|1|||
146335535|NCT00190775|527734399|FG000|Overall Study|Exclusion Criteria Met|1|||
146335536|NCT00190775|527734400|FG001|Overall Study|Exclusion Criteria Met|3|||
146335537|NCT01794780|527734401|FG000|Overall Study|Adverse Event|0|||
146335538|NCT01794780|527734402|FG001|Overall Study|Adverse Event|1|||
146335539|NCT01794780|527734403|FG002|Overall Study|Adverse Event|2|||
146335540|NCT01794780|527734404|FG003|Overall Study|Adverse Event|0|||
146335541|NCT01794780|527734405|FG004|Overall Study|Adverse Event|0|||
146335542|NCT01794780|527734406|FG005|Overall Study|Adverse Event|0|||
146335543|NCT01794780|527734407|FG006|Overall Study|Adverse Event|0|||
146335544|NCT01794780|527734408|FG007|Overall Study|Adverse Event|0|||
146335545|NCT01794780|527734401|FG000|Overall Study|Death|0|||
146335546|NCT01794780|527734402|FG001|Overall Study|Death|2|||
146335547|NCT01794780|527734403|FG002|Overall Study|Death|14|||
146335548|NCT01794780|527734404|FG003|Overall Study|Death|1|||
146335549|NCT01794780|527734405|FG004|Overall Study|Death|0|||
146335550|NCT01794780|527734406|FG005|Overall Study|Death|9|||
146335551|NCT01794780|527734407|FG006|Overall Study|Death|4|||
146335552|NCT01794780|527734408|FG007|Overall Study|Death|0|||
146335553|NCT01794780|527734401|FG000|Overall Study|Lost to Follow-up|10|||
146335554|NCT01794780|527734402|FG001|Overall Study|Lost to Follow-up|64|||
146335555|NCT01794780|527734403|FG002|Overall Study|Lost to Follow-up|165|||
146335556|NCT01794780|527734404|FG003|Overall Study|Lost to Follow-up|53|||
146335557|NCT01794780|527734405|FG004|Overall Study|Lost to Follow-up|2|||
146335558|NCT01794780|527734406|FG005|Overall Study|Lost to Follow-up|99|||
146335559|NCT01794780|527734407|FG006|Overall Study|Lost to Follow-up|30|||
146335560|NCT01794780|527734408|FG007|Overall Study|Lost to Follow-up|5|||
146335561|NCT01794780|527734401|FG000|Overall Study|Withdrew informed consent|7|||
146335562|NCT01794780|527734402|FG001|Overall Study|Withdrew informed consent|17|||
146335563|NCT01794780|527734403|FG002|Overall Study|Withdrew informed consent|36|||
146335564|NCT01794780|527734404|FG003|Overall Study|Withdrew informed consent|9|||
146335565|NCT01794780|527734405|FG004|Overall Study|Withdrew informed consent|0|||
146335566|NCT01794780|527734406|FG005|Overall Study|Withdrew informed consent|48|||
146335567|NCT01794780|527734407|FG006|Overall Study|Withdrew informed consent|4|||
146335568|NCT01794780|527734408|FG007|Overall Study|Withdrew informed consent|3|||
146335569|NCT01794780|527734401|FG000|Overall Study|Other|0|||
146335570|NCT01794780|527734402|FG001|Overall Study|Other|12|||
146335571|NCT01794780|527734403|FG002|Overall Study|Other|25|||
146335572|NCT01794780|527734404|FG003|Overall Study|Other|20|||
146335573|NCT01794780|527734405|FG004|Overall Study|Other|1|||
146335574|NCT01794780|527734406|FG005|Overall Study|Other|24|||
146335575|NCT01794780|527734407|FG006|Overall Study|Other|4|||
146335576|NCT01794780|527734408|FG007|Overall Study|Other|1|||
146335577|NCT05089708|527734409|FG000|Overall Study|Lost to Follow-up|9|||
146335578|NCT05089708|527734410|FG001|Overall Study|Lost to Follow-up|7|||
146335579|NCT05089708|527734409|FG000|Overall Study|Withdrawal by Subject|3|||
146335580|NCT05089708|527734410|FG001|Overall Study|Withdrawal by Subject|1|||
146335581|NCT05089708|527734409|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
146335582|NCT05089708|527734410|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
146335583|NCT05089708|527734409|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
146335584|NCT05089708|527734410|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
146335585|NCT01440101|527734411|FG000|Overall Study|Adverse Event|2|||
146335586|NCT01440101|527734412|FG001|Overall Study|Adverse Event|0|||
146335587|NCT01440101|527734413|FG002|Overall Study|Adverse Event|0|||
146335588|NCT01440101|527734411|FG000|Overall Study|Withdrawal by Subject|0|||
146335589|NCT01440101|527734412|FG001|Overall Study|Withdrawal by Subject|3|||
146335590|NCT01440101|527734413|FG002|Overall Study|Withdrawal by Subject|1|||
146335591|NCT01440101|527734411|FG000|Overall Study|Other|0|||
146335592|NCT01440101|527734412|FG001|Overall Study|Other|1|||
146335593|NCT01440101|527734413|FG002|Overall Study|Other|0|||
146335594|NCT02469246|527734414|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
146335595|NCT02469246|527734415|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
146335596|NCT02469246|527734414|FG000|Double-Blind Phase|Adverse Event|12|||
146335597|NCT02469246|527734415|FG001|Double-Blind Phase|Adverse Event|9|||
146335598|NCT02469246|527734414|FG000|Double-Blind Phase|Death|2|||
146335599|NCT02469246|527734415|FG001|Double-Blind Phase|Death|0|||
146335600|NCT02469246|527734414|FG000|Double-Blind Phase|Lack of Efficacy|2|||
146335601|NCT02469246|527734415|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146335602|NCT02469246|527734414|FG000|Double-Blind Phase|Investigator's Discretion|8|||
146335603|NCT02469246|527734415|FG001|Double-Blind Phase|Investigator's Discretion|8|||
146335604|NCT02469246|527734414|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
146335605|NCT02469246|527734415|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146335606|NCT02469246|527734414|FG000|Double-Blind Phase|Protocol Violation|1|||
146335607|NCT02469246|527734415|FG001|Double-Blind Phase|Protocol Violation|1|||
146335608|NCT02469246|527734414|FG000|Double-Blind Phase|Withdrew Consent|25|||
146335609|NCT02469246|527734415|FG001|Double-Blind Phase|Withdrew Consent|25|||
146335610|NCT02469246|527734414|FG000|Double-Blind Phase|Lost to Follow-up|9|||
146335611|NCT02469246|527734415|FG001|Double-Blind Phase|Lost to Follow-up|5|||
146335612|NCT01491945|527734419|FG000|Overall Study|Death|30|||
146335613|NCT01491945|527734419|FG000|Overall Study|Withdrwan/LTF|16|||
146335614|NCT01491945|527734419|FG000|Overall Study|Conversion|4|||
146335615|NCT01491945|527734419|FG000|Overall Study|Missed Visit|1|||
146335616|NCT01658514|527734425|FG000|Overall Study|Protocol Violation|1|||
146335617|NCT01658514|527734426|FG001|Overall Study|Protocol Violation|0|||
146335618|NCT01658514|527734427|FG002|Overall Study|Protocol Violation|2|||
146335619|NCT00749203|527734428|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
146335620|NCT00749203|527734429|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
145943276|NCT02326298|526300470|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146335621|NCT00749203|527734428|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
146335622|NCT00749203|527734429|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
146335623|NCT00749203|527734428|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
146335624|NCT00749203|527734429|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
146335625|NCT00749203|527734428|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
146335626|NCT00749203|527734429|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
146335627|NCT00749203|527734428|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
146335628|NCT00749203|527734429|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
146335629|NCT00749203|527734428|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
146335630|NCT00749203|527734429|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
146335631|NCT04325503|527734443|FG000|Overall Study|Withdrawal by Subject|1|||
146335632|NCT04325503|527734443|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
146335633|NCT02337387|527734444|FG000|Overall Study|Adverse Event|0|||
146335634|NCT02337387|527734445|FG001|Overall Study|Adverse Event|1|||
146335635|NCT02337387|527734446|FG002|Overall Study|Adverse Event|0|||
146335636|NCT02337387|527734447|FG003|Overall Study|Adverse Event|0|||
146335637|NCT02337387|527734444|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
146335638|NCT02337387|527734445|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
146335639|NCT02337387|527734446|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
146335640|NCT02337387|527734447|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
146335641|NCT02853760|527734448|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
146335642|NCT02853760|527734449|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
146335643|NCT02853760|527734450|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
146335644|NCT02853760|527734451|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
146335645|NCT02853760|527734452|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
146335646|NCT02853760|527734453|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
146335647|NCT01642212|527734454|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
146335648|NCT01642212|527734455|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146335649|NCT01642212|527734456|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146335650|NCT01642212|527734457|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146335651|NCT01642212|527734458|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
146335652|NCT01642212|527734454|FG000|Double-blind Treatment|Other|0|||
146335653|NCT01642212|527734455|FG001|Double-blind Treatment|Other|2|||
146335654|NCT01642212|527734456|FG002|Double-blind Treatment|Other|1|||
146335655|NCT01642212|527734457|FG003|Double-blind Treatment|Other|0|||
146335656|NCT01642212|527734458|FG004|Double-blind Treatment|Other|0|||
146335657|NCT01642212|527734454|FG000|Double-blind Treatment|Non-compliance|0|||
146335658|NCT01642212|527734455|FG001|Double-blind Treatment|Non-compliance|1|||
146335659|NCT01642212|527734456|FG002|Double-blind Treatment|Non-compliance|0|||
146335660|NCT01642212|527734457|FG003|Double-blind Treatment|Non-compliance|0|||
146335661|NCT01642212|527734458|FG004|Double-blind Treatment|Non-compliance|0|||
146335662|NCT01642212|527734454|FG000|Double-blind Treatment|Adverse Event|0|||
146335663|NCT01642212|527734455|FG001|Double-blind Treatment|Adverse Event|0|||
146335664|NCT01642212|527734456|FG002|Double-blind Treatment|Adverse Event|1|||
146335665|NCT01642212|527734457|FG003|Double-blind Treatment|Adverse Event|0|||
146335666|NCT01642212|527734458|FG004|Double-blind Treatment|Adverse Event|0|||
146335667|NCT01642212|527734454|FG000|Open-label Extension|Adverse Event|0|||
146335668|NCT01642212|527734455|FG001|Open-label Extension|Adverse Event|0|||
146335669|NCT01642212|527734456|FG002|Open-label Extension|Adverse Event|0|||
146335670|NCT01642212|527734457|FG003|Open-label Extension|Adverse Event|3|||
146335671|NCT01642212|527734458|FG004|Open-label Extension|Adverse Event|0|||
146335672|NCT01642212|527734454|FG000|Open-label Extension|Sponsor Decision|0|||
146335673|NCT01642212|527734455|FG001|Open-label Extension|Sponsor Decision|0|||
146335674|NCT01642212|527734456|FG002|Open-label Extension|Sponsor Decision|0|||
146335675|NCT01642212|527734457|FG003|Open-label Extension|Sponsor Decision|7|||
146335676|NCT01642212|527734458|FG004|Open-label Extension|Sponsor Decision|4|||
146335677|NCT01642212|527734454|FG000|Open-label Extension|Consent Withdrawn|0|||
146335678|NCT01642212|527734455|FG001|Open-label Extension|Consent Withdrawn|0|||
146335679|NCT01642212|527734456|FG002|Open-label Extension|Consent Withdrawn|0|||
146335680|NCT01642212|527734457|FG003|Open-label Extension|Consent Withdrawn|0|||
146335681|NCT01642212|527734458|FG004|Open-label Extension|Consent Withdrawn|2|||
146335682|NCT01642212|527734454|FG000|Open-label Extension|Lost to Follow-up|0|||
146335683|NCT01642212|527734455|FG001|Open-label Extension|Lost to Follow-up|0|||
146335684|NCT01642212|527734456|FG002|Open-label Extension|Lost to Follow-up|0|||
146335685|NCT01642212|527734457|FG003|Open-label Extension|Lost to Follow-up|0|||
146335686|NCT01642212|527734458|FG004|Open-label Extension|Lost to Follow-up|1|||
146335687|NCT01642212|527734454|FG000|Open-label Extension|Other|0|||
146335688|NCT01642212|527734455|FG001|Open-label Extension|Other|0|||
146335689|NCT01642212|527734456|FG002|Open-label Extension|Other|0|||
146335690|NCT01642212|527734457|FG003|Open-label Extension|Other|0|||
146335691|NCT01642212|527734458|FG004|Open-label Extension|Other|1|||
146335692|NCT00981526|527734459|FG000|Overall Study|Withdrawal by Subject|0|||
146335693|NCT00981526|527734460|FG001|Overall Study|Withdrawal by Subject|2|||
146335694|NCT00981526|527734459|FG000|Overall Study|Physician Decision|4|||
146335695|NCT00981526|527734460|FG001|Overall Study|Physician Decision|4|||
146335696|NCT02272790|527734461|FG000|Overall Study|Physician Decision|0|||
146335697|NCT02272790|527734462|FG001|Overall Study|Physician Decision|1|||
146335698|NCT02272790|527734463|FG002|Overall Study|Physician Decision|0|||
146335699|NCT02272790|527734464|FG003|Overall Study|Physician Decision|0|||
146335700|NCT02272790|527734465|FG004|Overall Study|Physician Decision|0|||
146168944|NCT01191840|527131072|FG000|Overall Study|IRB approval lapse|0|||
146335701|NCT02272790|527734466|FG005|Overall Study|Physician Decision|0|||
146335702|NCT00702143|527734467|FG000|Overall Study|Lost to Follow-up|0|||
146335703|NCT00702143|527734468|FG001|Overall Study|Lost to Follow-up|0|||
146335704|NCT00702143|527734469|FG002|Overall Study|Lost to Follow-up|1|||
146335705|NCT03871491|527734474|FG000|Overall Study|Withdrawal by Subject|14|||
146335706|NCT03871491|527734475|FG001|Overall Study|Withdrawal by Subject|14|||
146335707|NCT03871491|527734476|FG002|Overall Study|Withdrawal by Subject|14|||
146335708|NCT03871491|527734477|FG003|Overall Study|Withdrawal by Subject|14|||
146335709|NCT03871491|527734474|FG000|Overall Study|Physician Decision|0|||
146335710|NCT03871491|527734475|FG001|Overall Study|Physician Decision|0|||
146335711|NCT03871491|527734476|FG002|Overall Study|Physician Decision|1|||
146335712|NCT03871491|527734477|FG003|Overall Study|Physician Decision|1|||
146335713|NCT03871491|527734474|FG000|Overall Study|Lost to Follow-up|50|||
146335714|NCT03871491|527734475|FG001|Overall Study|Lost to Follow-up|15|||
146335715|NCT03871491|527734476|FG002|Overall Study|Lost to Follow-up|36|||
146335716|NCT03871491|527734477|FG003|Overall Study|Lost to Follow-up|11|||
146335717|NCT05202808|527734478|FG000|Overall Study|Lost to Follow-up|3|||
146335718|NCT05202808|527734479|FG001|Overall Study|Lost to Follow-up|1|||
146335719|NCT04996797|527734480|FG000|Overall Study|Adverse Event|0|||
146335720|NCT04996797|527734481|FG001|Overall Study|Adverse Event|2|||
146335721|NCT04996797|527734482|FG002|Overall Study|Adverse Event|0|||
146335722|NCT04996797|527734483|FG003|Overall Study|Adverse Event|1|||
146335723|NCT04996797|527734480|FG000|Overall Study|Lack of Efficacy|0|||
146335724|NCT04996797|527734481|FG001|Overall Study|Lack of Efficacy|2|||
146335725|NCT04996797|527734482|FG002|Overall Study|Lack of Efficacy|0|||
146335726|NCT04996797|527734483|FG003|Overall Study|Lack of Efficacy|0|||
146335727|NCT04996797|527734480|FG000|Overall Study|Prohibited Medication|0|||
146335728|NCT04996797|527734481|FG001|Overall Study|Prohibited Medication|1|||
146335729|NCT04996797|527734482|FG002|Overall Study|Prohibited Medication|0|||
146335730|NCT04996797|527734483|FG003|Overall Study|Prohibited Medication|0|||
146335731|NCT04996797|527734480|FG000|Overall Study|Ongoing|68|||
146335732|NCT04996797|527734481|FG001|Overall Study|Ongoing|60|||
146335733|NCT04996797|527734482|FG002|Overall Study|Ongoing|22|||
146335734|NCT04996797|527734483|FG003|Overall Study|Ongoing|20|||
146335735|NCT04996797|527734480|FG000|Overall Study|Withdrawal by Subject|0|||
146335736|NCT04996797|527734481|FG001|Overall Study|Withdrawal by Subject|2|||
146335737|NCT04996797|527734482|FG002|Overall Study|Withdrawal by Subject|0|||
146335738|NCT04996797|527734483|FG003|Overall Study|Withdrawal by Subject|0|||
146335739|NCT02793544|527734484|FG000|Overall Study|Death|10|||
146335740|NCT02793544|527734485|FG001|Overall Study|Death|8|||
146335741|NCT02793544|527734484|FG000|Overall Study|Lost to Follow-up|2|||
146335742|NCT02793544|527734485|FG001|Overall Study|Lost to Follow-up|0|||
146335743|NCT02793544|527734484|FG000|Overall Study|Withdrawal by Subject|1|||
146335744|NCT02793544|527734485|FG001|Overall Study|Withdrawal by Subject|0|||
146335745|NCT04091217|527734488|FG000|Overall Study|Lost to Follow-up|2|||
146335746|NCT02495948|527734491|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
146335747|NCT02495948|527734492|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
146335748|NCT02495948|527734491|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
146335749|NCT02495948|527734492|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
146335750|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
146335751|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146335752|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146335753|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146335754|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
146335755|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
146335756|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146335757|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
146335758|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
146335759|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146335760|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
146335761|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
146335762|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
146168945|NCT01191840|527131073|FG001|Overall Study|IRB approval lapse|2|||
146168946|NCT01191840|527131072|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
146168947|NCT01191840|527131073|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
146168948|NCT01191840|527131072|FG000|Overall Study|Withdrawal by Subject|2|||
146168949|NCT01191840|527131073|FG001|Overall Study|Withdrawal by Subject|0|||
146168950|NCT04669600|527131074|FG000|Overall Study|Withdrawal by Subject|1|||
146168951|NCT04669600|527131074|FG000|Overall Study|Other|6|||
146168952|NCT00710606|527131077|FG000|Overall Study|Adverse Event|0|||
146335763|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
146335764|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146335765|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146335766|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
146335767|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
146335768|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
146335769|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
146335770|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
146335771|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
146335772|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
146335773|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
146335774|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
146335775|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
146335776|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
146335777|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
146335778|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
146335779|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
146335780|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
146335781|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
146335782|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
146335783|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
146335784|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
146335785|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
146335786|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
146335787|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
146335788|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
146335789|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
146335790|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
146335791|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
146335792|NCT00100048|527734493|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146335793|NCT00100048|527734494|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146335794|NCT00100048|527734495|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146335795|NCT00100048|527734496|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
146335796|NCT00100048|527734497|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146335797|NCT00100048|527734498|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
146335798|NCT01624142|527734499|FG000|Overall Study|Withdrawal by Subject|14|||
146335799|NCT01624142|527734500|FG001|Overall Study|Withdrawal by Subject|4|||
146335800|NCT01624142|527734499|FG000|Overall Study|Death|3|||
146335801|NCT01624142|527734500|FG001|Overall Study|Death|6|||
146335802|NCT01624142|527734499|FG000|Overall Study|Study Closure|12|||
146335803|NCT01624142|527734500|FG001|Overall Study|Study Closure|6|||
146335804|NCT01624142|527734499|FG000|Overall Study|Lost to Follow-up|2|||
146335805|NCT01624142|527734500|FG001|Overall Study|Lost to Follow-up|0|||
146335806|NCT01624142|527734499|FG000|Overall Study|Other|1|||
146335807|NCT01624142|527734500|FG001|Overall Study|Other|0|||
146335808|NCT02747004|527734501|FG000|Overall Study|Withdrawal by Subject|8|||
146335809|NCT02747004|527734502|FG001|Overall Study|Withdrawal by Subject|5|||
146335810|NCT02747004|527734503|FG002|Overall Study|Withdrawal by Subject|4|||
146335811|NCT02747004|527734501|FG000|Overall Study|Lost to Follow-up|1|||
146335812|NCT02747004|527734502|FG001|Overall Study|Lost to Follow-up|2|||
146335813|NCT02747004|527734503|FG002|Overall Study|Lost to Follow-up|2|||
146335814|NCT02747004|527734501|FG000|Overall Study|on study treatment/follow-up|48|||
146335815|NCT02747004|527734502|FG001|Overall Study|on study treatment/follow-up|42|||
146335816|NCT02747004|527734503|FG002|Overall Study|on study treatment/follow-up|41|||
146335817|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
146335818|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
146335819|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146335820|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146335821|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
146335822|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
146335823|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
146335824|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146335825|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146335826|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
146335827|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
146335828|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146335829|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146335830|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146335831|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
146335832|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
146335833|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146335834|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146335835|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146335836|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
146335837|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Death|0|||
146335838|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Death|1|||
146335839|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Death|0|||
146335840|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Death|0|||
146335841|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Death|0|||
146335842|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146335843|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
146335844|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146335845|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146335846|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
146335847|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
146335848|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146335849|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146335850|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146335851|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
146335852|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
146335853|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146335854|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146335855|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146335856|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
146335857|NCT05087030|527734504|FG000|Main Period (Week 0 to Week 52)|Other|1|||
146335858|NCT05087030|527734505|FG001|Main Period (Week 0 to Week 52)|Other|2|||
146335859|NCT05087030|527734506|FG002|Main Period (Week 0 to Week 52)|Other|0|||
146335860|NCT05087030|527734507|FG003|Main Period (Week 0 to Week 52)|Other|0|||
146335861|NCT05087030|527734508|FG004|Main Period (Week 0 to Week 52)|Other|0|||
146335862|NCT05087030|527734504|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146335863|NCT05087030|527734505|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146335864|NCT05087030|527734506|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146335865|NCT05087030|527734507|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
146335866|NCT05087030|527734508|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
146335867|NCT01444300|527734509|FG000|Overall Study|Adverse Event|4|||
146335868|NCT01444300|527734510|FG001|Overall Study|Adverse Event|0|||
146335869|NCT04826900|527734511|FG000|Overall Study|Family factor|1|||
146335870|NCT04826900|527734512|FG001|Overall Study|Family factor|1|||
146335871|NCT02722044|527734513|FG000|Overall Study|Adverse Event|2|||
146335872|NCT02722044|527734513|FG000|Overall Study|Physician Decision|1|||
146335873|NCT02722044|527734513|FG000|Overall Study|Withdrawal by Subject|1|||
146335874|NCT02722044|527734513|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
146335875|NCT04885257|527734517|FG000|Overall Study|Withdrawal by Subject|1|||
146335876|NCT04885257|527734518|FG001|Overall Study|Withdrawal by Subject|0|||
146335877|NCT02597062|527734519|FG000|Overall Study|Ineligible|1|||
146335878|NCT03372941|527734520|FG000|Overall Study|Lost to Follow-up|2|||
146335879|NCT03372941|527734521|FG001|Overall Study|Lost to Follow-up|4|||
146335880|NCT00741819|527734522|FG000|Overall Study|Adverse Event|3|||
146335881|NCT00741819|527734522|FG000|Overall Study|Withdrawal by Subject|3|||
146335882|NCT00741819|527734522|FG000|Overall Study|Death|1|||
146335883|NCT00741819|527734522|FG000|Overall Study|Disease progression|1|||
146335884|NCT00609622|527734525|FG000|Overall Study|Adverse Event|14|||
146335885|NCT00609622|527734526|FG001|Overall Study|Adverse Event|10|||
146335886|NCT00609622|527734525|FG000|Overall Study|Withdrawal by Subject|4|||
146335887|NCT00609622|527734526|FG001|Overall Study|Withdrawal by Subject|20|||
146335888|NCT00609622|527734525|FG000|Overall Study|Death|1|||
146335889|NCT00609622|527734526|FG001|Overall Study|Death|4|||
146335890|NCT00609622|527734525|FG000|Overall Study|Protocol Violation|1|||
146335891|NCT00609622|527734526|FG001|Overall Study|Protocol Violation|1|||
146335892|NCT00609622|527734525|FG000|Overall Study|Objective progression or relapse|47|||
146335893|NCT00609622|527734526|FG001|Overall Study|Objective progression or relapse|41|||
146335894|NCT00609622|527734525|FG000|Overall Study|Study terminated by sponsor|16|||
146335895|NCT00609622|527734526|FG001|Overall Study|Study terminated by sponsor|3|||
146335896|NCT00609622|527734525|FG000|Overall Study|Other|7|||
146335897|NCT00609622|527734526|FG001|Overall Study|Other|14|||
146335898|NCT00609622|527734525|FG000|Overall Study|Global deterioration of health status|6|||
146335899|NCT00609622|527734526|FG001|Overall Study|Global deterioration of health status|2|||
146335900|NCT01053429|527734529|FG000|Overall Study|Adverse Event|64|||
146335901|NCT01053429|527734529|FG000|Overall Study|Other|309|||
146335902|NCT01708057|527734530|FG000|Overall Study|Withdrawal due to study termination.|1|||
146335903|NCT01708057|527734531|FG001|Overall Study|Withdrawal due to study termination.|1|||
146335904|NCT01708057|527734532|FG002|Overall Study|Withdrawal due to study termination.|1|||
146335905|NCT00752986|527734533|FG000|Overall Study|Withdrawal by Subject|2|||
146335906|NCT00752986|527734534|FG001|Overall Study|Withdrawal by Subject|1|||
146168953|NCT00710606|527131078|FG001|Overall Study|Adverse Event|2|||
146168954|NCT02487498|527131083|FG000|Period: Period 1|Adverse Event|2|||
146168955|NCT02487498|527131084|FG001|Period: Period 1|Adverse Event|4|||
146168956|NCT02487498|527131083|FG000|Period: Period 1|Subject/guardian decision|2|||
146168957|NCT02487498|527131084|FG001|Period: Period 1|Subject/guardian decision|4|||
146168958|NCT02487498|527131083|FG000|Period: Period 1|Lost to Follow-up|0|||
146168959|NCT02487498|527131084|FG001|Period: Period 1|Lost to Follow-up|2|||
146168960|NCT02487498|527131083|FG000|Period: Period 1|Lack of Efficacy|1|||
146168961|NCT02487498|527131084|FG001|Period: Period 1|Lack of Efficacy|0|||
146168962|NCT02487498|527131083|FG000|Period: Period 1|Physician Decision|0|||
146168963|NCT02487498|527131084|FG001|Period: Period 1|Physician Decision|1|||
146168964|NCT02487498|527131083|FG000|Period: Period 1|Protocol deviation|1|||
146168965|NCT02487498|527131084|FG001|Period: Period 1|Protocol deviation|0|||
146168966|NCT02487498|527131083|FG000|Period: Washout|Subject/guardian decision|0|||
146168967|NCT02487498|527131084|FG001|Period: Washout|Subject/guardian decision|5|||
146168968|NCT02487498|527131083|FG000|Period: Washout|Lack of Efficacy|1|||
146168969|NCT02487498|527131084|FG001|Period: Washout|Lack of Efficacy|1|||
146168970|NCT02487498|527131083|FG000|Period: Washout|Physician Decision|1|||
146168971|NCT02487498|527131084|FG001|Period: Washout|Physician Decision|0|||
146168972|NCT02487498|527131083|FG000|Period: Washout|Non-compliance with study treatment|0|||
146168973|NCT02487498|527131084|FG001|Period: Washout|Non-compliance with study treatment|1|||
146168974|NCT02487498|527131083|FG000|Period: Period 2|Adverse Event|2|||
146168975|NCT02487498|527131084|FG001|Period: Period 2|Adverse Event|2|||
146168976|NCT02487498|527131083|FG000|Period: Period 2|Subject/guardian decision|2|||
146168977|NCT02487498|527131084|FG001|Period: Period 2|Subject/guardian decision|1|||
146168978|NCT02487498|527131083|FG000|Period: Period 2|Lost to Follow-up|1|||
146168979|NCT02487498|527131084|FG001|Period: Period 2|Lost to Follow-up|1|||
146168980|NCT02487498|527131083|FG000|Period: Period 2|Death|0|||
146168981|NCT02487498|527131084|FG001|Period: Period 2|Death|1|||
146168982|NCT02487498|527131083|FG000|Period: Period 2|Physician Decision|1|||
146168983|NCT02487498|527131084|FG001|Period: Period 2|Physician Decision|0|||
146168984|NCT00676130|527131087|FG000|Overall Study|Lost to Follow-up|0|||
146168985|NCT00676130|527131088|FG001|Overall Study|Lost to Follow-up|1|||
146168986|NCT00676130|527131087|FG000|Overall Study|Found ineligible|3|||
146168987|NCT00676130|527131088|FG001|Overall Study|Found ineligible|2|||
146168988|NCT00676130|527131087|FG000|Overall Study|Withdrawal by Subject|0|||
146168989|NCT00676130|527131088|FG001|Overall Study|Withdrawal by Subject|1|||
146168990|NCT00331344|527131093|FG000|Phase I|Adverse Event|0|||
146168991|NCT00331344|527131094|FG001|Phase I|Adverse Event|0|||
146168992|NCT00331344|527131095|FG002|Phase I|Adverse Event|0|||
146168993|NCT00331344|527131096|FG003|Phase I|Adverse Event|1|||
146168994|NCT00331344|527131097|FG004|Phase I|Adverse Event|2|||
146168995|NCT00331344|527131098|FG005|Phase I|Adverse Event|2|||
146168996|NCT00331344|527131099|FG006|Phase I|Adverse Event|0|||
146168997|NCT00331344|527131100|FG007|Phase I|Adverse Event|1|||
146168998|NCT00331344|527131101|FG008|Phase I|Adverse Event|0|||
146168999|NCT00331344|527131093|FG000|Phase II|Death|0|||
146169000|NCT00331344|527131094|FG001|Phase II|Death|0|||
146169001|NCT00331344|527131095|FG002|Phase II|Death|0|||
146169002|NCT00331344|527131096|FG003|Phase II|Death|0|||
146169003|NCT00331344|527131097|FG004|Phase II|Death|0|||
146169004|NCT00331344|527131098|FG005|Phase II|Death|0|||
146169005|NCT00331344|527131099|FG006|Phase II|Death|0|||
146169006|NCT00331344|527131100|FG007|Phase II|Death|0|||
146169007|NCT00331344|527131101|FG008|Phase II|Death|4|||
146335907|NCT00752986|527734535|FG002|Overall Study|Withdrawal by Subject|2|||
146335908|NCT00752986|527734533|FG000|Overall Study|Protocol Violation|3|||
146335909|NCT00752986|527734534|FG001|Overall Study|Protocol Violation|0|||
146335910|NCT00752986|527734535|FG002|Overall Study|Protocol Violation|0|||
146335911|NCT01697345|527734538|FG000|Overall Study|Withdrawal by Subject|1|||
146335912|NCT02970929|527734539|FG000|Overall Study|Adverse Event|18|||
146335913|NCT02970929|527734539|FG000|Overall Study|Lack of Efficacy|8|||
146335914|NCT02970929|527734539|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
146335915|NCT02970929|527734539|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
146335916|NCT02970929|527734539|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
146335917|NCT02970929|527734539|FG000|Overall Study|LOST TO FOLLOWUP|6|||
146335918|NCT02970929|527734539|FG000|Overall Study|MOVED OUT OF STATE|1|||
146335919|NCT02970929|527734539|FG000|Overall Study|Withdrawal by Subject|16|||
146335920|NCT02382133|527734540|FG000|Overall Study|Death|22|||
146335921|NCT02382133|527734540|FG000|Overall Study|transfer out of ICU|4|||
146169008|NCT01373931|527131107|FG000|Lead-in Period|Adverse Event|2|||
146169009|NCT01373931|527131108|FG001|Lead-in Period|Adverse Event|0|||
146169010|NCT01373931|527131107|FG000|Period 1|Adverse Event|2|||
146169011|NCT01373931|527131108|FG001|Period 1|Adverse Event|0|||
146169012|NCT01373931|527131107|FG000|Period 1|Withdrawal by Subject|0|||
146169013|NCT01373931|527131108|FG001|Period 1|Withdrawal by Subject|2|||
146169014|NCT04538144|527131109|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
146169015|NCT04538144|527131110|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
146169016|NCT04538144|527131111|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
146335922|NCT02382133|527734540|FG000|Overall Study|Physician Decision|2|||
146335923|NCT02382133|527734540|FG000|Overall Study|arterial catheter loss|4|||
146335924|NCT02382133|527734540|FG000|Overall Study|pressure injury both sites|1|||
146335925|NCT02370121|527734547|FG000|Overall Study|Lost to Follow-up|1|||
146335926|NCT02370121|527734548|FG001|Overall Study|Lost to Follow-up|1|||
146335927|NCT00045032|527734550|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
146335928|NCT00045032|527734551|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
146335929|NCT00045032|527734552|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
146335930|NCT00045032|527734550|FG000|Overall Study|Death|22|||
146335931|NCT00045032|527734551|FG001|Overall Study|Death|24|||
146335932|NCT00045032|527734552|FG002|Overall Study|Death|17|||
146335933|NCT00045032|527734550|FG000|Overall Study|Insufficient Therapeutic Response|542|||
146335934|NCT00045032|527734551|FG001|Overall Study|Insufficient Therapeutic Response|437|||
146335935|NCT00045032|527734552|FG002|Overall Study|Insufficient Therapeutic Response|445|||
146335936|NCT00045032|527734550|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
146335937|NCT00045032|527734551|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
146335938|NCT00045032|527734552|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
146335939|NCT00045032|527734550|FG000|Overall Study|Other Protocol Violation|2|||
146335940|NCT00045032|527734551|FG001|Overall Study|Other Protocol Violation|0|||
146335941|NCT00045032|527734552|FG002|Overall Study|Other Protocol Violation|1|||
146335942|NCT00045032|527734550|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
146335943|NCT00045032|527734551|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
146335944|NCT00045032|527734552|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
146335945|NCT00045032|527734550|FG000|Overall Study|Failure to Return|57|||
146335946|NCT00045032|527734551|FG001|Overall Study|Failure to Return|62|||
146335947|NCT00045032|527734552|FG002|Overall Study|Failure to Return|61|||
146335948|NCT00045032|527734550|FG000|Overall Study|Other|93|||
146335949|NCT00045032|527734551|FG001|Overall Study|Other|84|||
146335950|NCT00045032|527734552|FG002|Overall Study|Other|105|||
146335951|NCT02770807|527734553|FG000|Overall Study|Adverse Event|3|||
146335952|NCT02770807|527734554|FG001|Overall Study|Adverse Event|3|||
146335953|NCT02770807|527734555|FG002|Overall Study|Adverse Event|1|||
146335954|NCT02770807|527734553|FG000|Overall Study|Withdrawal by Subject|7|||
146335955|NCT02770807|527734554|FG001|Overall Study|Withdrawal by Subject|3|||
146335956|NCT02770807|527734555|FG002|Overall Study|Withdrawal by Subject|4|||
146335957|NCT02770807|527734553|FG000|Overall Study|Other|0|||
146335958|NCT02770807|527734554|FG001|Overall Study|Other|1|||
146335959|NCT02770807|527734555|FG002|Overall Study|Other|0|||
146335960|NCT02770807|527734553|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
146335961|NCT02770807|527734554|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
146335962|NCT02770807|527734555|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
146335963|NCT02770807|527734553|FG000|Overall Study|Physician Decision|0|||
146335964|NCT02770807|527734554|FG001|Overall Study|Physician Decision|0|||
146335965|NCT02770807|527734555|FG002|Overall Study|Physician Decision|1|||
146335966|NCT00222105|527734558|FG000|Overall Study|Removed due to wrong diagnosis|1|||
146335967|NCT00222105|527734558|FG000|Overall Study|Withdrawal by Subject|1|||
146335968|NCT00222105|527734558|FG000|Overall Study|Adverse Event|8|||
146335969|NCT00222105|527734558|FG000|Overall Study|Treatment delays|2|||
146335970|NCT00222105|527734558|FG000|Overall Study|Death|2|||
146335971|NCT00377962|527736049|FG000|Core Study: 0-12 Months|Adverse Event|18|||
146335972|NCT00377962|527736050|FG001|Core Study: 0-12 Months|Adverse Event|2|||
146335973|NCT00377962|527736049|FG000|Core Study: 0-12 Months|Death|3|||
146335974|NCT00377962|527736050|FG001|Core Study: 0-12 Months|Death|0|||
146335975|NCT00377962|527736049|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
146335976|NCT00377962|527736050|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
146335977|NCT00377962|527736049|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
146335978|NCT00377962|527736050|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
146335979|NCT00377962|527736049|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
146335980|NCT00377962|527736050|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
146335981|NCT00377962|527736049|FG000|Extension Study: 12-24 Months|Death|1|||
146335982|NCT00377962|527736050|FG001|Extension Study: 12-24 Months|Death|1|||
146335983|NCT00377962|527736049|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
146335984|NCT00377962|527736050|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
146335985|NCT00377962|527736049|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
146335986|NCT00377962|527736050|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
146335987|NCT00377962|527736049|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
146335988|NCT00377962|527736050|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
146335989|NCT00374556|527736051|FG000|Overall Study|Lost to Follow-up|1|||
146335990|NCT00374556|527736052|FG001|Overall Study|Lost to Follow-up|0|||
146335991|NCT00374556|527736051|FG000|Overall Study|Removed at baseline due to medical cond|0|||
146335992|NCT00374556|527736052|FG001|Overall Study|Removed at baseline due to medical cond|1|||
146335993|NCT00686205|527736058|FG000|Overall Study|Protocol Violation|127|||
146335994|NCT00686205|527736059|FG001|Overall Study|Protocol Violation|0|||
146335995|NCT00686205|527736058|FG000|Overall Study|Withdrawal by Subject|2|||
146335996|NCT00686205|527736059|FG001|Overall Study|Withdrawal by Subject|0|||
146396138|NCT01241591|527954452|FG000|Overall Study|Screen Failure|3|||
146335997|NCT00686205|527736058|FG000|Overall Study|Specimen handling procedure altered|5878|||
146335998|NCT00686205|527736059|FG001|Overall Study|Specimen handling procedure altered|0|||
146335999|NCT00686205|527736058|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
146336000|NCT00686205|527736059|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
146336001|NCT00265941|527736060|FG000|Overall Study|Protocol Violation|22|||
146336002|NCT00265941|527736061|FG001|Overall Study|Protocol Violation|25|||
146336003|NCT00265941|527736060|FG000|Overall Study|Lost to Follow-up|1|||
146336004|NCT00265941|527736061|FG001|Overall Study|Lost to Follow-up|1|||
146336005|NCT03976401|527736070|FG000|Overall Study|Adverse Event|2|||
146336006|NCT03976401|527736071|FG001|Overall Study|Adverse Event|0|||
146336007|NCT03976401|527736072|FG002|Overall Study|Adverse Event|4|||
146336008|NCT03976401|527736073|FG003|Overall Study|Adverse Event|1|||
146336009|NCT03976401|527736074|FG004|Overall Study|Adverse Event|1|||
146336010|NCT03976401|527736075|FG005|Overall Study|Adverse Event|0|||
146336011|NCT03976401|527736070|FG000|Overall Study|Withdrawal by Subject|0|||
146336012|NCT03976401|527736071|FG001|Overall Study|Withdrawal by Subject|1|||
146336013|NCT03976401|527736072|FG002|Overall Study|Withdrawal by Subject|0|||
146336014|NCT03976401|527736073|FG003|Overall Study|Withdrawal by Subject|0|||
146336015|NCT03976401|527736074|FG004|Overall Study|Withdrawal by Subject|0|||
146336016|NCT03976401|527736075|FG005|Overall Study|Withdrawal by Subject|1|||
146336017|NCT03976401|527736070|FG000|Overall Study|Physician Decision|0|||
146336018|NCT03976401|527736071|FG001|Overall Study|Physician Decision|0|||
146336019|NCT03976401|527736072|FG002|Overall Study|Physician Decision|1|||
146336020|NCT03976401|527736073|FG003|Overall Study|Physician Decision|0|||
146336021|NCT03976401|527736074|FG004|Overall Study|Physician Decision|0|||
146336022|NCT03976401|527736075|FG005|Overall Study|Physician Decision|0|||
146336023|NCT03976401|527736070|FG000|Overall Study|Lost to Follow-up|1|||
146336024|NCT03976401|527736071|FG001|Overall Study|Lost to Follow-up|2|||
146336025|NCT03976401|527736072|FG002|Overall Study|Lost to Follow-up|0|||
146336026|NCT03976401|527736073|FG003|Overall Study|Lost to Follow-up|0|||
146336027|NCT03976401|527736074|FG004|Overall Study|Lost to Follow-up|0|||
146336028|NCT03976401|527736075|FG005|Overall Study|Lost to Follow-up|0|||
146336029|NCT03976401|527736070|FG000|Overall Study|Protocol Violation|0|||
146336030|NCT03976401|527736071|FG001|Overall Study|Protocol Violation|1|||
146336031|NCT03976401|527736072|FG002|Overall Study|Protocol Violation|0|||
146336032|NCT03976401|527736073|FG003|Overall Study|Protocol Violation|0|||
146336033|NCT03976401|527736074|FG004|Overall Study|Protocol Violation|0|||
146336034|NCT03976401|527736075|FG005|Overall Study|Protocol Violation|0|||
146336035|NCT03976401|527736070|FG000|Overall Study|Withdrew Consent|0|||
146336036|NCT03976401|527736071|FG001|Overall Study|Withdrew Consent|0|||
146336037|NCT03976401|527736072|FG002|Overall Study|Withdrew Consent|0|||
146336038|NCT03976401|527736073|FG003|Overall Study|Withdrew Consent|1|||
146336039|NCT03976401|527736074|FG004|Overall Study|Withdrew Consent|0|||
146336040|NCT03976401|527736075|FG005|Overall Study|Withdrew Consent|0|||
146336041|NCT00942409|527736077|FG000|Overall Study|Lack of Efficacy|1|||
146336042|NCT00942409|527736077|FG000|Overall Study|study drug unavailable|2|||
146336043|NCT02966314|527736078|FG000|Overall Study|Lost to Follow-up|1|||
146336044|NCT02966314|527736079|FG001|Overall Study|Lost to Follow-up|0|||
146336045|NCT02015819|527736082|FG000|Overall Study|Rickham catheter was misaligned|0|||
146336046|NCT02015819|527736083|FG001|Overall Study|Rickham catheter was misaligned|0|||
146336047|NCT02015819|527736084|FG002|Overall Study|Rickham catheter was misaligned|0|||
146336048|NCT02015819|527736085|FG003|Overall Study|Rickham catheter was misaligned|1|||
146336049|NCT01697215|527736088|FG000|Overall Study|Physician Decision|5|||
146336050|NCT01697215|527736088|FG000|Overall Study|Malfunction|9|||
146336051|NCT01697215|527736088|FG000|Overall Study|CXR not available|9|||
146336052|NCT00466505|527736090|FG000|Overall Study|disease progression|13|||
146336053|NCT00466505|527736090|FG000|Overall Study|Adverse Event|4|||
146336054|NCT02886715|527736091|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146336055|NCT02886715|527736092|FG001|Overall Study|Non-Compliance With Study Drug|2|||
146336056|NCT02886715|527736093|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146336057|NCT02886715|527736091|FG000|Overall Study|Adverse Event|4|||
146336058|NCT02886715|527736092|FG001|Overall Study|Adverse Event|2|||
146336059|NCT02886715|527736093|FG002|Overall Study|Adverse Event|0|||
146336060|NCT02886715|527736091|FG000|Overall Study|Lack of Efficacy|0|||
146336061|NCT02886715|527736092|FG001|Overall Study|Lack of Efficacy|2|||
146336062|NCT02886715|527736093|FG002|Overall Study|Lack of Efficacy|1|||
146336063|NCT02886715|527736091|FG000|Overall Study|Lost to Follow-up|29|||
146336064|NCT02886715|527736092|FG001|Overall Study|Lost to Follow-up|26|||
146336065|NCT02886715|527736093|FG002|Overall Study|Lost to Follow-up|10|||
146336066|NCT02886715|527736091|FG000|Overall Study|Pregnancy|1|||
146336067|NCT02886715|527736092|FG001|Overall Study|Pregnancy|1|||
146336068|NCT02886715|527736093|FG002|Overall Study|Pregnancy|1|||
146336069|NCT02886715|527736091|FG000|Overall Study|Protocol Violation|3|||
146336070|NCT02886715|527736092|FG001|Overall Study|Protocol Violation|2|||
146336071|NCT02886715|527736093|FG002|Overall Study|Protocol Violation|1|||
146336072|NCT02886715|527736091|FG000|Overall Study|Withdrawal by Subject|20|||
146336073|NCT02886715|527736092|FG001|Overall Study|Withdrawal by Subject|18|||
146336074|NCT02886715|527736093|FG002|Overall Study|Withdrawal by Subject|5|||
146336075|NCT02886715|527736091|FG000|Overall Study|missing|7|||
146336076|NCT02886715|527736092|FG001|Overall Study|missing|2|||
146336077|NCT02886715|527736093|FG002|Overall Study|missing|2|||
146336078|NCT01676961|527736094|FG000|Overall Study|Death|3|||
146336079|NCT01676961|527736094|FG000|Overall Study|Lost to Follow-up|1|||
146336080|NCT01676961|527736094|FG000|Overall Study|Withdrawal by Subject|1|||
146336081|NCT00768560|527736097|FG000|Intervention Set 1|Adverse Event|0|||
146336082|NCT00768560|527736098|FG001|Intervention Set 1|Adverse Event|1|||
146336083|NCT00768560|527736099|FG002|Intervention Set 1|Adverse Event|0|||
146336084|NCT00768560|527736100|FG003|Intervention Set 1|Adverse Event|0|||
146336085|NCT00768560|527736101|FG004|Intervention Set 1|Adverse Event|0|||
146336086|NCT00768560|527736102|FG005|Intervention Set 1|Adverse Event|0|||
146336087|NCT00117312|527736103|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
146336088|NCT00117312|527736104|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
146336089|NCT00117312|527736105|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
146336090|NCT00117312|527736106|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
146336091|NCT00117312|527736103|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
146336092|NCT00117312|527736104|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
146336093|NCT00117312|527736105|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
146336094|NCT00117312|527736106|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
146336095|NCT00117312|527736103|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
146336096|NCT00117312|527736104|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
146336097|NCT00117312|527736105|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
146336098|NCT00117312|527736106|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
146336099|NCT00117312|527736103|FG000|Overall Study|Other|0|||
146336100|NCT00117312|527736104|FG001|Overall Study|Other|1|||
146336101|NCT00117312|527736105|FG002|Overall Study|Other|3|||
146336102|NCT00117312|527736106|FG003|Overall Study|Other|1|||
146336103|NCT00117312|527736103|FG000|Overall Study|Patient choice|0|||
146336104|NCT00117312|527736104|FG001|Overall Study|Patient choice|0|||
146336105|NCT00117312|527736105|FG002|Overall Study|Patient choice|2|||
146336106|NCT00117312|527736106|FG003|Overall Study|Patient choice|1|||
146336107|NCT00117312|527736103|FG000|Overall Study|Adverse Event|0|||
146336108|NCT00117312|527736104|FG001|Overall Study|Adverse Event|2|||
146336109|NCT00117312|527736105|FG002|Overall Study|Adverse Event|0|||
146336110|NCT00117312|527736106|FG003|Overall Study|Adverse Event|0|||
146336111|NCT00117312|527736103|FG000|Overall Study|Protocol Violation|0|||
146336112|NCT00117312|527736104|FG001|Overall Study|Protocol Violation|1|||
146336113|NCT00117312|527736105|FG002|Overall Study|Protocol Violation|3|||
146336114|NCT00117312|527736106|FG003|Overall Study|Protocol Violation|0|||
146336115|NCT00117312|527736103|FG000|Overall Study|PSA decrease <=50%|0|||
146336116|NCT00117312|527736104|FG001|Overall Study|PSA decrease <=50%|2|||
146336117|NCT00117312|527736105|FG002|Overall Study|PSA decrease <=50%|2|||
146336118|NCT00117312|527736106|FG003|Overall Study|PSA decrease <=50%|4|||
146336119|NCT00117312|527736103|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
146336120|NCT00117312|527736104|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
146336121|NCT00117312|527736105|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
146336122|NCT00117312|527736106|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
146336123|NCT00117312|527736103|FG000|Overall Study|Hepatic abnormality|0|||
146336124|NCT00117312|527736104|FG001|Overall Study|Hepatic abnormality|1|||
146336125|NCT00117312|527736105|FG002|Overall Study|Hepatic abnormality|0|||
146336126|NCT00117312|527736106|FG003|Overall Study|Hepatic abnormality|1|||
146336127|NCT00117312|527736103|FG000|Overall Study|Withdrawal by Subject|0|||
146336128|NCT00117312|527736104|FG001|Overall Study|Withdrawal by Subject|2|||
146336129|NCT00117312|527736105|FG002|Overall Study|Withdrawal by Subject|0|||
146336130|NCT00117312|527736106|FG003|Overall Study|Withdrawal by Subject|0|||
146336131|NCT01128387|527736107|FG000|Overall Study|Physician Decision|0|||
146336132|NCT01128387|527736108|FG001|Overall Study|Physician Decision|1|||
146336133|NCT01535235|527736110|FG000|Overall Study|Adverse Event|1|||
146336134|NCT01535235|527736111|FG001|Overall Study|Adverse Event|0|||
146336135|NCT00389207|527736112|FG000|Overall Study|Adverse Event|26|||
146336136|NCT00389207|527736113|FG001|Overall Study|Adverse Event|32|||
146336137|NCT00389207|527736114|FG002|Overall Study|Adverse Event|10|||
146336138|NCT00389207|527736112|FG000|Overall Study|Protocol Violation|3|||
146336139|NCT00389207|527736113|FG001|Overall Study|Protocol Violation|1|||
146336140|NCT00389207|527736114|FG002|Overall Study|Protocol Violation|4|||
146336141|NCT00389207|527736112|FG000|Overall Study|Lost to Follow-up|12|||
146336142|NCT00389207|527736113|FG001|Overall Study|Lost to Follow-up|9|||
146336143|NCT00389207|527736114|FG002|Overall Study|Lost to Follow-up|7|||
146336144|NCT00389207|527736112|FG000|Overall Study|Withdrawal by Subject|5|||
146336145|NCT00389207|527736113|FG001|Overall Study|Withdrawal by Subject|7|||
146336146|NCT00389207|527736114|FG002|Overall Study|Withdrawal by Subject|11|||
146336147|NCT00389207|527736112|FG000|Overall Study|Other|17|||
146336148|NCT00389207|527736113|FG001|Overall Study|Other|23|||
146336149|NCT00389207|527736114|FG002|Overall Study|Other|9|||
146336150|NCT00824421|527736116|FG000|Overall Study|Adverse Event|6|||
146336151|NCT00824421|527736117|FG001|Overall Study|Adverse Event|6|||
146336152|NCT00824421|527736118|FG002|Overall Study|Adverse Event|6|||
146336153|NCT00824421|527736116|FG000|Overall Study|Death|0|||
146336154|NCT00824421|527736117|FG001|Overall Study|Death|1|||
146336155|NCT00824421|527736118|FG002|Overall Study|Death|0|||
146336156|NCT00824421|527736116|FG000|Overall Study|Lack of Efficacy|5|||
146336157|NCT00824421|527736117|FG001|Overall Study|Lack of Efficacy|7|||
146336158|NCT00824421|527736118|FG002|Overall Study|Lack of Efficacy|4|||
146336159|NCT00824421|527736116|FG000|Overall Study|Lost to Follow-up|2|||
146336160|NCT00824421|527736117|FG001|Overall Study|Lost to Follow-up|3|||
146336161|NCT00824421|527736118|FG002|Overall Study|Lost to Follow-up|0|||
146336162|NCT00824421|527736116|FG000|Overall Study|Pregnancy|1|||
146336163|NCT00824421|527736117|FG001|Overall Study|Pregnancy|0|||
146336164|NCT00824421|527736118|FG002|Overall Study|Pregnancy|1|||
146336165|NCT00824421|527736116|FG000|Overall Study|Withdrawal by Subject|2|||
146336166|NCT00824421|527736117|FG001|Overall Study|Withdrawal by Subject|3|||
146336167|NCT00824421|527736118|FG002|Overall Study|Withdrawal by Subject|3|||
146336168|NCT00824421|527736116|FG000|Overall Study|Randomized but not Treated|1|||
146336169|NCT00824421|527736117|FG001|Overall Study|Randomized but not Treated|1|||
146336170|NCT00824421|527736118|FG002|Overall Study|Randomized but not Treated|0|||
146336171|NCT00824421|527736116|FG000|Overall Study|Other|0|||
146336172|NCT00824421|527736117|FG001|Overall Study|Other|1|||
146336173|NCT00824421|527736118|FG002|Overall Study|Other|0|||
146336174|NCT02499952|527736119|FG000|Overall Study|Lost to Follow-up|1|||
146336175|NCT02499952|527736119|FG000|Overall Study|Death|9|||
146336176|NCT02286102|527736120|FG000|Overall Study|Screen Failure|1|||
146336177|NCT02286102|527736121|FG001|Overall Study|Screen Failure|1|||
146336178|NCT00659438|527736122|FG000|Overall Study|Withdrawal by Subject|2|||
146336179|NCT00659438|527736123|FG001|Overall Study|Withdrawal by Subject|2|||
146336180|NCT00659438|527736122|FG000|Overall Study|Death|11|||
146336181|NCT00659438|527736123|FG001|Overall Study|Death|6|||
146336182|NCT00659438|527736122|FG000|Overall Study|Lost to Follow-up|1|||
146336183|NCT00659438|527736123|FG001|Overall Study|Lost to Follow-up|0|||
146336184|NCT00201851|527736124|FG000|Overall Study|Lost to Follow-up|2|||
146336185|NCT00201851|527736125|FG001|Overall Study|Lost to Follow-up|1|||
146336186|NCT00201851|527736126|FG002|Overall Study|Lost to Follow-up|0|||
146336187|NCT00201851|527736124|FG000|Overall Study|Ineligible post enrollment|6|||
146336188|NCT00201851|527736125|FG001|Overall Study|Ineligible post enrollment|1|||
146336189|NCT00201851|527736126|FG002|Overall Study|Ineligible post enrollment|1|||
146336190|NCT00636818|527736127|FG000|Overall Study|Adverse Event|1|||
146336191|NCT00636818|527736127|FG000|Overall Study|Lost to Follow-up|2|||
146336192|NCT00636818|527736127|FG000|Overall Study|Entry Criteria Exclusion|3|||
146336193|NCT00636818|527736127|FG000|Overall Study|Protocol Violation|1|||
146336194|NCT00636818|527736127|FG000|Overall Study|Withdrawal by Subject|4|||
146336195|NCT00074958|527736128|FG000|Overall Study|Adverse Event|1|||
146336196|NCT02690701|527736132|FG000|Treatment Period 1|Adverse Event|2|||
146336197|NCT02690701|527736133|FG001|Treatment Period 1|Adverse Event|2|||
146336198|NCT02690701|527736132|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146336199|NCT02690701|527736133|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146336200|NCT02690701|527736132|FG000|Treatment Period 2|Adverse Event|2|||
146336201|NCT02690701|527736133|FG001|Treatment Period 2|Adverse Event|0|||
146336202|NCT02690701|527736132|FG000|Treatment Period 2|Lack of Efficacy|1|||
146336203|NCT02690701|527736133|FG001|Treatment Period 2|Lack of Efficacy|0|||
146336204|NCT02690701|527736132|FG000|Treatment Period 2|Lost to Follow-up|0|||
146336205|NCT02690701|527736133|FG001|Treatment Period 2|Lost to Follow-up|2|||
146336206|NCT02690701|527736132|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146336207|NCT02690701|527736133|FG001|Treatment Period 2|Withdrawal by Subject|2|||
146336208|NCT02690701|527736132|FG000|Treatment Period 2|Protocol Violation|0|||
146336209|NCT02690701|527736133|FG001|Treatment Period 2|Protocol Violation|1|||
146336210|NCT02700451|527736134|FG000|Overall Study|Protocol Violation|2|||
146336211|NCT02700451|527736135|FG001|Overall Study|Protocol Violation|2|||
146169017|NCT04538144|527131112|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
146169018|NCT01682213|527131120|FG000|Overall Study|Withdrawal by Subject|2|||
146169019|NCT01995539|527131121|FG000|Overall Study|Screening Failure|1|||
146169020|NCT01995539|527131121|FG000|Overall Study|Withdrawal by Investigator|15|||
146169021|NCT01995539|527131121|FG000|Overall Study|Withdrawal by Subject|11|||
146336212|NCT02700451|527736136|FG002|Overall Study|Protocol Violation|3|||
146336213|NCT02700451|527736134|FG000|Overall Study|Discontinued intervention|14|||
146336214|NCT02700451|527736135|FG001|Overall Study|Discontinued intervention|15|||
146336215|NCT02700451|527736136|FG002|Overall Study|Discontinued intervention|14|||
146336216|NCT02115308|527736142|FG000|Overall Study|Safety Screening|2|||
146336217|NCT02115308|527736143|FG001|Overall Study|Safety Screening|2|||
146336218|NCT00404092|527736144|FG000|Overall Study|Death|1|||
146336219|NCT00404092|527736145|FG001|Overall Study|Death|0|||
146336220|NCT00404092|527736146|FG002|Overall Study|Death|0|||
146336221|NCT00404092|527736147|FG003|Overall Study|Death|0|||
146336222|NCT00404092|527736144|FG000|Overall Study|Adverse Event|0|||
146336223|NCT00404092|527736145|FG001|Overall Study|Adverse Event|0|||
146169022|NCT01995539|527131121|FG000|Overall Study|Lost to Follow-up|5|||
146336224|NCT00404092|527736146|FG002|Overall Study|Adverse Event|1|||
146336225|NCT00404092|527736147|FG003|Overall Study|Adverse Event|0|||
146336226|NCT02344576|527736151|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
146336227|NCT02344576|527736152|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
146396139|NCT01241591|527954453|FG001|Overall Study|Screen Failure|2|||
146336228|NCT02344576|527736153|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
146336229|NCT02344576|527736154|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
146336230|NCT02344576|527736151|FG000|1-Month Follow-Up|Death|13|||
146336231|NCT02344576|527736152|FG001|1-Month Follow-Up|Death|8|||
146336232|NCT02344576|527736153|FG002|1-Month Follow-Up|Death|0|||
146336233|NCT02344576|527736154|FG003|1-Month Follow-Up|Death|0|||
146336234|NCT02344576|527736151|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
146336235|NCT02344576|527736152|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
146336236|NCT02344576|527736153|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
146336237|NCT02344576|527736154|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
146336238|NCT02344576|527736151|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
146336239|NCT02344576|527736152|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
146336240|NCT02344576|527736153|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
146336241|NCT02344576|527736154|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
146336242|NCT02344576|527736151|FG000|6-Month Follow-Up|Death|14|||
146336243|NCT02344576|527736152|FG001|6-Month Follow-Up|Death|14|||
146336244|NCT02344576|527736153|FG002|6-Month Follow-Up|Death|0|||
146336245|NCT02344576|527736154|FG003|6-Month Follow-Up|Death|0|||
146336246|NCT02344576|527736151|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
146336247|NCT02344576|527736152|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
146336248|NCT02344576|527736153|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
146336249|NCT02344576|527736154|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
146336250|NCT02344576|527736151|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
146336251|NCT02344576|527736152|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
146336252|NCT02344576|527736153|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
146336253|NCT02344576|527736154|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
146336254|NCT04233424|527736156|FG000|Overall Study|Death|15|||
146336255|NCT04233424|527736157|FG001|Overall Study|Death|16|||
146336256|NCT04233424|527736156|FG000|Overall Study|Withdrawal by Subject|2|||
146169023|NCT01995539|527131121|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
146169024|NCT01264380|527131122|FG000|Period C|Disease Progression|0|||
146169025|NCT01264380|527131123|FG001|Period C|Disease Progression|0|||
146336257|NCT04233424|527736157|FG001|Overall Study|Withdrawal by Subject|8|||
146336258|NCT04233424|527736156|FG000|Overall Study|Physician Decision|1|||
146336259|NCT04233424|527736157|FG001|Overall Study|Physician Decision|3|||
146336260|NCT04233424|527736156|FG000|Overall Study|Protocol Violation|3|||
146336261|NCT04233424|527736157|FG001|Overall Study|Protocol Violation|1|||
146336262|NCT04233424|527736156|FG000|Overall Study|Lost to Follow-up|1|||
146336263|NCT04233424|527736157|FG001|Overall Study|Lost to Follow-up|3|||
146336264|NCT04233424|527736156|FG000|Overall Study|subject refuse to visit site|2|||
146336265|NCT04233424|527736157|FG001|Overall Study|subject refuse to visit site|0|||
146336266|NCT02698189|527736158|FG000|Overall Study|Physician Decision|3|||
146336267|NCT02698189|527736159|FG001|Overall Study|Physician Decision|0|||
146336268|NCT02698189|527736158|FG000|Overall Study|Progressive disease|0|||
146336269|NCT02698189|527736159|FG001|Overall Study|Progressive disease|5|||
146336270|NCT02698189|527736158|FG000|Overall Study|Study terminated by sponsor|0|||
146336271|NCT02698189|527736159|FG001|Overall Study|Study terminated by sponsor|1|||
146336272|NCT01126580|527736160|FG000|Overall Study|Adverse Event|14|||
146336273|NCT01126580|527736161|FG001|Overall Study|Adverse Event|8|||
146336274|NCT01126580|527736162|FG002|Overall Study|Adverse Event|12|||
146336275|NCT01126580|527736160|FG000|Overall Study|Withdrawal by Subject|11|||
146336276|NCT01126580|527736161|FG001|Overall Study|Withdrawal by Subject|19|||
146336277|NCT01126580|527736162|FG002|Overall Study|Withdrawal by Subject|14|||
146336278|NCT01126580|527736160|FG000|Overall Study|Sponsor Decision|5|||
146336279|NCT01126580|527736161|FG001|Overall Study|Sponsor Decision|4|||
146336280|NCT01126580|527736162|FG002|Overall Study|Sponsor Decision|7|||
146336281|NCT01126580|527736160|FG000|Overall Study|Physician Decision|1|||
146336282|NCT01126580|527736161|FG001|Overall Study|Physician Decision|1|||
146336283|NCT01126580|527736162|FG002|Overall Study|Physician Decision|2|||
146336284|NCT01126580|527736160|FG000|Overall Study|Entry Criteria Not Met|1|||
146336285|NCT01126580|527736161|FG001|Overall Study|Entry Criteria Not Met|1|||
146336286|NCT01126580|527736162|FG002|Overall Study|Entry Criteria Not Met|2|||
146336287|NCT01126580|527736160|FG000|Overall Study|Lack of Efficacy|2|||
146336288|NCT01126580|527736161|FG001|Overall Study|Lack of Efficacy|3|||
146336289|NCT01126580|527736162|FG002|Overall Study|Lack of Efficacy|4|||
146336290|NCT01126580|527736160|FG000|Overall Study|Protocol Violation|0|||
146336291|NCT01126580|527736161|FG001|Overall Study|Protocol Violation|1|||
146336292|NCT01126580|527736162|FG002|Overall Study|Protocol Violation|2|||
146336293|NCT01126580|527736160|FG000|Overall Study|Lost to Follow-up|15|||
146336294|NCT01126580|527736161|FG001|Overall Study|Lost to Follow-up|13|||
146336295|NCT01126580|527736162|FG002|Overall Study|Lost to Follow-up|9|||
146336296|NCT01126580|527736160|FG000|Overall Study|Treatment Non-compliance|0|||
146336297|NCT01126580|527736161|FG001|Overall Study|Treatment Non-compliance|2|||
146336298|NCT01126580|527736162|FG002|Overall Study|Treatment Non-compliance|3|||
146336299|NCT01731002|527736163|FG000|Overall Study|Adverse Event|0|||
146336300|NCT01731002|527736164|FG001|Overall Study|Adverse Event|2|||
146336301|NCT01731002|527736165|FG002|Overall Study|Adverse Event|2|||
146336302|NCT01731002|527736163|FG000|Overall Study|Non-Compliant|0|||
146169026|NCT01264380|527131124|FG002|Period C|Disease Progression|4|||
146336303|NCT01731002|527736164|FG001|Overall Study|Non-Compliant|1|||
146336304|NCT01731002|527736165|FG002|Overall Study|Non-Compliant|0|||
146336305|NCT01731002|527736163|FG000|Overall Study|Lost to Follow-up|1|||
146336306|NCT01731002|527736164|FG001|Overall Study|Lost to Follow-up|0|||
146336307|NCT01731002|527736165|FG002|Overall Study|Lost to Follow-up|0|||
146336308|NCT01731002|527736163|FG000|Overall Study|Test Agent Discontinuation|0|||
146336309|NCT01731002|527736164|FG001|Overall Study|Test Agent Discontinuation|1|||
146336310|NCT01731002|527736165|FG002|Overall Study|Test Agent Discontinuation|0|||
146336311|NCT01731002|527736163|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
146336312|NCT01731002|527736164|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
146336313|NCT01731002|527736165|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
146336314|NCT01731002|527736163|FG000|Overall Study|Elevated IOP|1|||
146336315|NCT01731002|527736164|FG001|Overall Study|Elevated IOP|0|||
146336316|NCT01731002|527736165|FG002|Overall Study|Elevated IOP|0|||
146336317|NCT01731002|527736163|FG000|Overall Study|Inappropriate use of study medications|0|||
146336318|NCT01731002|527736164|FG001|Overall Study|Inappropriate use of study medications|0|||
146336319|NCT01731002|527736165|FG002|Overall Study|Inappropriate use of study medications|1|||
146336320|NCT00947349|527736166|FG000|Triple Treatment Combination Period|Adverse Event|0|||
146336321|NCT00947349|527736167|FG001|Triple Treatment Combination Period|Adverse Event|1|||
146336322|NCT00947349|527736168|FG002|Triple Treatment Combination Period|Adverse Event|0|||
146336323|NCT00947349|527736169|FG003|Triple Treatment Combination Period|Adverse Event|0|||
146336324|NCT00947349|527736166|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
146336325|NCT00947349|527736167|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
146336326|NCT00947349|527736168|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
146336327|NCT00947349|527736169|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
146336328|NCT00947349|527736166|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
146336329|NCT00947349|527736167|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
146336330|NCT00947349|527736168|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
146336331|NCT00947349|527736169|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
146336332|NCT00947349|527736166|FG000|Overall Study Standard of Care|Other|0|||
146336333|NCT00947349|527736167|FG001|Overall Study Standard of Care|Other|0|||
146336334|NCT00947349|527736168|FG002|Overall Study Standard of Care|Other|0|||
146336335|NCT00947349|527736169|FG003|Overall Study Standard of Care|Other|1|||
146336336|NCT03929250|527736176|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
146336337|NCT03929250|527736177|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
146336338|NCT05262764|527736179|FG000|Overall Study|Case report form not collected|9|||
146336339|NCT05262764|527736179|FG000|Overall Study|No patient visits after entry|23|||
146336340|NCT05262764|527736179|FG000|Overall Study|Registration rule not followed|2|||
146336341|NCT05262764|527736179|FG000|Overall Study|Patient of non-chronic heart failure|1|||
146336342|NCT01392183|527736180|FG000|First Drug Administration|Adverse Event|3|||
146336343|NCT01392183|527736181|FG001|First Drug Administration|Adverse Event|2|||
146336344|NCT01392183|527736180|FG000|First Drug Administration|Death|1|||
146336345|NCT01392183|527736181|FG001|First Drug Administration|Death|0|||
146336346|NCT01392183|527736180|FG000|First Drug Administration|Withdrawal by Subject|10|||
146336347|NCT01392183|527736181|FG001|First Drug Administration|Withdrawal by Subject|17|||
146336348|NCT03972488|527736182|FG000|Overall Study|Progressive disease|42|||
146336349|NCT03972488|527736183|FG001|Overall Study|Progressive disease|44|||
146336350|NCT03972488|527736182|FG000|Overall Study|Physician Decision|13|||
146336351|NCT03972488|527736183|FG001|Overall Study|Physician Decision|7|||
146336352|NCT03972488|527736182|FG000|Overall Study|Adverse Event|8|||
146336353|NCT03972488|527736183|FG001|Overall Study|Adverse Event|1|||
146336354|NCT03972488|527736182|FG000|Overall Study|Death|4|||
146336355|NCT03972488|527736183|FG001|Overall Study|Death|4|||
146336356|NCT03972488|527736182|FG000|Overall Study|Withdrawal by Subject|3|||
146336357|NCT03972488|527736183|FG001|Overall Study|Withdrawal by Subject|4|||
146336358|NCT03972488|527736182|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
146336359|NCT03972488|527736183|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
146336360|NCT03277196|527736189|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
146336361|NCT03277196|527736189|FG000|Overall Study|Lost to Follow-up|3|||
146336362|NCT03277196|527736189|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
146336363|NCT03277196|527736189|FG000|Overall Study|Other|2|||
146336364|NCT01024244|527738868|FG000|Overall Study|Adverse Event|1|||
146336365|NCT01024244|527738869|FG001|Overall Study|Adverse Event|2|||
146336366|NCT01024244|527738870|FG002|Overall Study|Adverse Event|0|||
146336367|NCT01024244|527738871|FG003|Overall Study|Adverse Event|1|||
146336368|NCT01024244|527738872|FG004|Overall Study|Adverse Event|2|||
146336369|NCT01024244|527738868|FG000|Overall Study|Entry Criteria Not Met|0|||
146336370|NCT01024244|527738869|FG001|Overall Study|Entry Criteria Not Met|1|||
146336371|NCT01024244|527738870|FG002|Overall Study|Entry Criteria Not Met|0|||
146336372|NCT01024244|527738871|FG003|Overall Study|Entry Criteria Not Met|0|||
146336373|NCT01024244|527738872|FG004|Overall Study|Entry Criteria Not Met|0|||
146336374|NCT01024244|527738868|FG000|Overall Study|Lack of Efficacy|1|||
146336375|NCT01024244|527738869|FG001|Overall Study|Lack of Efficacy|0|||
146336376|NCT01024244|527738870|FG002|Overall Study|Lack of Efficacy|0|||
146336377|NCT01024244|527738871|FG003|Overall Study|Lack of Efficacy|0|||
146336378|NCT01024244|527738872|FG004|Overall Study|Lack of Efficacy|0|||
146336379|NCT01024244|527738868|FG000|Overall Study|Protocol Violation|1|||
146336380|NCT01024244|527738869|FG001|Overall Study|Protocol Violation|0|||
146336381|NCT01024244|527738870|FG002|Overall Study|Protocol Violation|0|||
146336382|NCT01024244|527738871|FG003|Overall Study|Protocol Violation|0|||
146336383|NCT01024244|527738872|FG004|Overall Study|Protocol Violation|2|||
146336384|NCT01024244|527738868|FG000|Overall Study|Sponsor Decision|14|||
146336385|NCT01024244|527738869|FG001|Overall Study|Sponsor Decision|7|||
146336386|NCT01024244|527738870|FG002|Overall Study|Sponsor Decision|14|||
146336387|NCT01024244|527738871|FG003|Overall Study|Sponsor Decision|12|||
146336388|NCT01024244|527738872|FG004|Overall Study|Sponsor Decision|10|||
146336389|NCT01024244|527738868|FG000|Overall Study|Withdrawal by Subject|0|||
146336390|NCT01024244|527738869|FG001|Overall Study|Withdrawal by Subject|1|||
146336391|NCT01024244|527738870|FG002|Overall Study|Withdrawal by Subject|0|||
146336392|NCT01024244|527738871|FG003|Overall Study|Withdrawal by Subject|0|||
146336393|NCT01024244|527738872|FG004|Overall Study|Withdrawal by Subject|0|||
146336394|NCT00473694|527738876|FG000|Overall Study|Adverse Event|0|||
146336395|NCT00473694|527738877|FG001|Overall Study|Adverse Event|1|||
146336396|NCT00473694|527738878|FG002|Overall Study|Adverse Event|0|||
146336397|NCT00473694|527738879|FG003|Overall Study|Adverse Event|0|||
146336398|NCT00473694|527738876|FG000|Overall Study|Participants did not receive treatment|11|||
146336399|NCT00473694|527738877|FG001|Overall Study|Participants did not receive treatment|3|||
146336400|NCT00473694|527738878|FG002|Overall Study|Participants did not receive treatment|5|||
146336401|NCT00473694|527738879|FG003|Overall Study|Participants did not receive treatment|6|||
146336402|NCT00473694|527738876|FG000|Overall Study|Lost to Follow-up|0|||
146336403|NCT00473694|527738877|FG001|Overall Study|Lost to Follow-up|0|||
146336404|NCT00473694|527738878|FG002|Overall Study|Lost to Follow-up|0|||
146336405|NCT00473694|527738879|FG003|Overall Study|Lost to Follow-up|1|||
146336406|NCT02468193|527738880|FG000|Overall Study|Adverse Event|4|||
146336407|NCT02468193|527738880|FG000|Overall Study|Subject/ Guardian decision|2|||
146336408|NCT00742781|527738881|FG000|Overall Study|Withdrawal by Subject|3|||
146336409|NCT01416181|527738882|FG000|Part 1|Other|10|||
146336410|NCT01416181|527738883|FG001|Part 1|Other|24|||
146336411|NCT01416181|527738882|FG000|Part 1|Death|0|||
146336412|NCT01416181|527738883|FG001|Part 1|Death|1|||
146336413|NCT01416181|527738882|FG000|Part 1|Investigator Decision|7|||
146336414|NCT01416181|527738883|FG001|Part 1|Investigator Decision|6|||
146336415|NCT01416181|527738882|FG000|Part 1|Withdrawal by Subject|74|||
146336416|NCT01416181|527738883|FG001|Part 1|Withdrawal by Subject|48|||
146336417|NCT01416181|527738882|FG000|Part 1|Lack of Efficacy|16|||
146336418|NCT01416181|527738883|FG001|Part 1|Lack of Efficacy|8|||
146336419|NCT01416181|527738882|FG000|Part 1|Lost to Follow-up|1|||
146336420|NCT01416181|527738883|FG001|Part 1|Lost to Follow-up|1|||
146336421|NCT01416181|527738882|FG000|Part 1|Adverse Event|15|||
146336422|NCT01416181|527738883|FG001|Part 1|Adverse Event|18|||
146336423|NCT01416181|527738882|FG000|Part 1|Ongoing in Follow-Up|14|||
146336424|NCT01416181|527738883|FG001|Part 1|Ongoing in Follow-Up|8|||
146336425|NCT01416181|527738882|FG000|Part 2|Adverse Event|11|||
146336426|NCT01416181|527738883|FG001|Part 2|Adverse Event|4|||
146336427|NCT01416181|527738882|FG000|Part 2|Other|234|||
146336428|NCT01416181|527738883|FG001|Part 2|Other|267|||
146336429|NCT01416181|527738882|FG000|Part 2|Investigator Decision|6|||
146336430|NCT01416181|527738883|FG001|Part 2|Investigator Decision|7|||
146336431|NCT01416181|527738882|FG000|Part 2|Withdrawal by Subject|14|||
146336432|NCT01416181|527738883|FG001|Part 2|Withdrawal by Subject|5|||
146336433|NCT01416181|527738882|FG000|Part 2|Lack of Efficacy|4|||
146336434|NCT01416181|527738883|FG001|Part 2|Lack of Efficacy|1|||
146336435|NCT01416181|527738882|FG000|Part 2|Lost to Follow-up|2|||
146336436|NCT01416181|527738883|FG001|Part 2|Lost to Follow-up|2|||
146336437|NCT03874234|527738884|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336438|NCT03874234|527738885|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336439|NCT03874234|527738886|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336440|NCT03874234|527738887|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
146336441|NCT03874234|527738888|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336442|NCT03874234|527738889|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336443|NCT03874234|527738890|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336444|NCT03874234|527738891|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336445|NCT03874234|527738892|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336446|NCT03874234|527738893|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336447|NCT03874234|527738894|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336448|NCT03874234|527738895|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336449|NCT03874234|527738896|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
146336450|NCT03874234|527738884|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
146336451|NCT03874234|527738885|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336452|NCT03874234|527738886|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336453|NCT03874234|527738887|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336454|NCT03874234|527738888|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336455|NCT03874234|527738889|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336456|NCT03874234|527738890|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336457|NCT03874234|527738891|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336458|NCT03874234|527738892|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336459|NCT03874234|527738893|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336460|NCT03874234|527738894|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336461|NCT03874234|527738895|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336462|NCT03874234|527738896|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
146336463|NCT03874234|527738884|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336464|NCT03874234|527738885|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336465|NCT03874234|527738886|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336466|NCT03874234|527738887|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
146336467|NCT03874234|527738888|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336468|NCT03874234|527738889|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336469|NCT03874234|527738890|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336470|NCT03874234|527738891|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336471|NCT03874234|527738892|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336472|NCT03874234|527738893|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336473|NCT03874234|527738894|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336474|NCT03874234|527738895|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336475|NCT03874234|527738896|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
146336476|NCT03874234|527738884|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336477|NCT03874234|527738885|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336478|NCT03874234|527738886|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336479|NCT03874234|527738887|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336480|NCT03874234|527738888|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
146336481|NCT03874234|527738889|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336482|NCT03874234|527738890|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336483|NCT03874234|527738891|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336484|NCT03874234|527738892|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336485|NCT03874234|527738893|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336486|NCT03874234|527738894|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336487|NCT03874234|527738895|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336488|NCT03874234|527738896|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
146336489|NCT03874234|527738884|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336490|NCT03874234|527738885|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336491|NCT03874234|527738886|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336492|NCT03874234|527738887|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336493|NCT03874234|527738888|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336494|NCT03874234|527738889|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336495|NCT03874234|527738890|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336496|NCT03874234|527738891|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
146336497|NCT03874234|527738892|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336498|NCT03874234|527738893|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336499|NCT03874234|527738894|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336500|NCT03874234|527738895|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336501|NCT03874234|527738896|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
146336502|NCT03874234|527738884|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336503|NCT03874234|527738885|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336504|NCT03874234|527738886|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336505|NCT03874234|527738887|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336506|NCT03874234|527738888|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
146336507|NCT03874234|527738889|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
146336508|NCT03874234|527738890|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336509|NCT03874234|527738891|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336510|NCT03874234|527738892|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336511|NCT03874234|527738893|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336512|NCT03874234|527738894|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336513|NCT03874234|527738895|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336514|NCT03874234|527738896|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
146336515|NCT03874234|527738884|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336516|NCT03874234|527738885|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336517|NCT03874234|527738886|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146169027|NCT01264380|527131122|FG000|Period C|Death|0|||
146169028|NCT01264380|527131123|FG001|Period C|Death|0|||
146169029|NCT01264380|527131124|FG002|Period C|Death|2|||
146336518|NCT03874234|527738887|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336519|NCT03874234|527738888|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336520|NCT03874234|527738889|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336521|NCT03874234|527738890|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
146336522|NCT03874234|527738891|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336523|NCT03874234|527738892|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336524|NCT03874234|527738893|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336525|NCT03874234|527738894|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336526|NCT03874234|527738895|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336527|NCT03874234|527738896|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
146336528|NCT03874234|527738884|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336529|NCT03874234|527738885|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336530|NCT03874234|527738886|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336531|NCT03874234|527738887|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336532|NCT03874234|527738888|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
146336533|NCT03874234|527738889|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336534|NCT03874234|527738890|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336535|NCT03874234|527738891|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336536|NCT03874234|527738892|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336537|NCT03874234|527738893|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336538|NCT03874234|527738894|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336539|NCT03874234|527738895|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336540|NCT03874234|527738896|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
146336541|NCT01896232|527738899|FG000|Overall Study|Death|6|||
146336542|NCT01896232|527738900|FG001|Overall Study|Death|10|||
146336543|NCT01896232|527738899|FG000|Overall Study|Withdrawal by Subject|32|||
146336544|NCT01896232|527738900|FG001|Overall Study|Withdrawal by Subject|31|||
146336545|NCT01896232|527738899|FG000|Overall Study|Sponsor Decision|2|||
146336546|NCT01896232|527738900|FG001|Overall Study|Sponsor Decision|0|||
146336547|NCT01896232|527738899|FG000|Overall Study|Lost to Follow-up|9|||
146336548|NCT01896232|527738900|FG001|Overall Study|Lost to Follow-up|12|||
146336549|NCT03816995|527738911|FG000|Overall Study|Withdrawal by Subject|3|||
146336550|NCT03816995|527738912|FG001|Overall Study|Withdrawal by Subject|1|||
146336551|NCT03816995|527738911|FG000|Overall Study|Cancelled Surgery|8|||
146336552|NCT03816995|527738912|FG001|Overall Study|Cancelled Surgery|12|||
146336553|NCT03816995|527738911|FG000|Overall Study|No wound protector used|11|||
146336554|NCT03816995|527738912|FG001|Overall Study|No wound protector used|17|||
146336555|NCT03816995|527738911|FG000|Overall Study|Protocol Violation|2|||
146336556|NCT03816995|527738912|FG001|Overall Study|Protocol Violation|3|||
146336557|NCT00541307|527738914|FG000|Overall Study|Death|5|||
146336558|NCT00541307|527738914|FG000|Overall Study|Physician Decision|3|||
146336559|NCT00541307|527738914|FG000|Overall Study|Withdrawal by Subject|6|||
146336560|NCT00541307|527738914|FG000|Overall Study|Lost to Follow-up|4|||
146336561|NCT00541307|527738914|FG000|Overall Study|Subject returned early (outside window)|1|||
146336562|NCT00541307|527738914|FG000|Overall Study|Surgical Bypass|5|||
146336563|NCT04723537|527738915|FG000|Overall Study|Withdrawal by Subject|3|||
146336564|NCT04723537|527738916|FG001|Overall Study|Withdrawal by Subject|0|||
146336565|NCT04723537|527738917|FG002|Overall Study|Withdrawal by Subject|0|||
146336566|NCT04723537|527738915|FG000|Overall Study|Physician Decision|0|||
146336567|NCT04723537|527738916|FG001|Overall Study|Physician Decision|0|||
146336568|NCT04723537|527738917|FG002|Overall Study|Physician Decision|1|||
146336569|NCT04723537|527738915|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146336570|NCT04723537|527738916|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146336571|NCT04723537|527738917|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
146336572|NCT04645797|527738918|FG000|Overall Study|Disease Progression|3|||
146336573|NCT04645797|527738919|FG001|Overall Study|Disease Progression|3|||
146336574|NCT04645797|527738920|FG002|Overall Study|Disease Progression|1|||
146336575|NCT04645797|527738921|FG003|Overall Study|Disease Progression|0|||
146336576|NCT04645797|527738922|FG004|Overall Study|Disease Progression|0|||
146336577|NCT04645797|527738923|FG005|Overall Study|Disease Progression|0|||
146336578|NCT04645797|527738924|FG006|Overall Study|Disease Progression|0|||
146336579|NCT04645797|527738918|FG000|Overall Study|Death|3|||
146336580|NCT04645797|527738919|FG001|Overall Study|Death|1|||
146169030|NCT01264380|527131122|FG000|Period C|Follow-up for survival status|0|||
146169031|NCT01264380|527131123|FG001|Period C|Follow-up for survival status|0|||
146169032|NCT01264380|527131124|FG002|Period C|Follow-up for survival status|6|||
146336581|NCT04645797|527738920|FG002|Overall Study|Death|0|||
146336582|NCT04645797|527738921|FG003|Overall Study|Death|0|||
146336583|NCT04645797|527738922|FG004|Overall Study|Death|0|||
146336584|NCT04645797|527738923|FG005|Overall Study|Death|0|||
146336585|NCT04645797|527738924|FG006|Overall Study|Death|0|||
146336586|NCT01324830|527738926|FG000|Overall Study|Progressive Disease|3|||
146336587|NCT01324830|527738927|FG001|Overall Study|Progressive Disease|2|||
146336588|NCT01324830|527738928|FG002|Overall Study|Progressive Disease|3|||
146336589|NCT01324830|527738929|FG003|Overall Study|Progressive Disease|3|||
146336590|NCT01324830|527738930|FG004|Overall Study|Progressive Disease|6|||
146336591|NCT01324830|527738931|FG005|Overall Study|Progressive Disease|6|||
146336592|NCT01324830|527738932|FG006|Overall Study|Progressive Disease|3|||
146336593|NCT01324830|527738933|FG007|Overall Study|Progressive Disease|3|||
146336594|NCT01324830|527738934|FG008|Overall Study|Progressive Disease|3|||
146336595|NCT01324830|527738935|FG009|Overall Study|Progressive Disease|6|||
146336596|NCT01324830|527738936|FG010|Overall Study|Progressive Disease|2|||
146336597|NCT01324830|527738937|FG011|Overall Study|Progressive Disease|1|||
146336598|NCT01324830|527738938|FG012|Overall Study|Progressive Disease|1|||
146336599|NCT01324830|527738939|FG013|Overall Study|Progressive Disease|1|||
146336600|NCT01324830|527738940|FG014|Overall Study|Progressive Disease|1|||
146336601|NCT01324830|527738941|FG015|Overall Study|Progressive Disease|3|||
146336602|NCT01324830|527738942|FG016|Overall Study|Progressive Disease|2|||
146336603|NCT01324830|527738943|FG017|Overall Study|Progressive Disease|3|||
146336604|NCT01324830|527738944|FG018|Overall Study|Progressive Disease|4|||
146336605|NCT01324830|527738926|FG000|Overall Study|Dose limiting toxicity|0|||
146336606|NCT01324830|527738927|FG001|Overall Study|Dose limiting toxicity|0|||
146336607|NCT01324830|527738928|FG002|Overall Study|Dose limiting toxicity|0|||
146336608|NCT01324830|527738929|FG003|Overall Study|Dose limiting toxicity|0|||
146336609|NCT01324830|527738930|FG004|Overall Study|Dose limiting toxicity|1|||
146336610|NCT01324830|527738931|FG005|Overall Study|Dose limiting toxicity|0|||
146336611|NCT01324830|527738932|FG006|Overall Study|Dose limiting toxicity|0|||
146336612|NCT01324830|527738933|FG007|Overall Study|Dose limiting toxicity|0|||
146336613|NCT01324830|527738934|FG008|Overall Study|Dose limiting toxicity|0|||
146336614|NCT01324830|527738935|FG009|Overall Study|Dose limiting toxicity|0|||
146336615|NCT01324830|527738936|FG010|Overall Study|Dose limiting toxicity|0|||
146336616|NCT01324830|527738937|FG011|Overall Study|Dose limiting toxicity|0|||
146336617|NCT01324830|527738938|FG012|Overall Study|Dose limiting toxicity|0|||
146336618|NCT01324830|527738939|FG013|Overall Study|Dose limiting toxicity|0|||
146336619|NCT01324830|527738940|FG014|Overall Study|Dose limiting toxicity|0|||
146336620|NCT01324830|527738941|FG015|Overall Study|Dose limiting toxicity|0|||
146336621|NCT01324830|527738942|FG016|Overall Study|Dose limiting toxicity|1|||
146336622|NCT01324830|527738943|FG017|Overall Study|Dose limiting toxicity|1|||
146336623|NCT01324830|527738944|FG018|Overall Study|Dose limiting toxicity|1|||
146336624|NCT01324830|527738926|FG000|Overall Study|Reason not mentioned above|0|||
146336625|NCT01324830|527738927|FG001|Overall Study|Reason not mentioned above|0|||
146336626|NCT01324830|527738928|FG002|Overall Study|Reason not mentioned above|0|||
146336627|NCT01324830|527738929|FG003|Overall Study|Reason not mentioned above|0|||
146336628|NCT01324830|527738930|FG004|Overall Study|Reason not mentioned above|0|||
146336629|NCT01324830|527738931|FG005|Overall Study|Reason not mentioned above|0|||
146336630|NCT01324830|527738932|FG006|Overall Study|Reason not mentioned above|0|||
146336631|NCT01324830|527738933|FG007|Overall Study|Reason not mentioned above|0|||
146336632|NCT01324830|527738934|FG008|Overall Study|Reason not mentioned above|0|||
146336633|NCT01324830|527738935|FG009|Overall Study|Reason not mentioned above|0|||
146336634|NCT01324830|527738936|FG010|Overall Study|Reason not mentioned above|0|||
146336635|NCT01324830|527738937|FG011|Overall Study|Reason not mentioned above|0|||
146336636|NCT01324830|527738938|FG012|Overall Study|Reason not mentioned above|0|||
146336637|NCT01324830|527738939|FG013|Overall Study|Reason not mentioned above|0|||
146336638|NCT01324830|527738940|FG014|Overall Study|Reason not mentioned above|0|||
146336639|NCT01324830|527738941|FG015|Overall Study|Reason not mentioned above|0|||
146336640|NCT01324830|527738942|FG016|Overall Study|Reason not mentioned above|0|||
146336641|NCT01324830|527738943|FG017|Overall Study|Reason not mentioned above|1|||
146336642|NCT01324830|527738944|FG018|Overall Study|Reason not mentioned above|0|||
146336643|NCT01324830|527738926|FG000|Overall Study|Adverse Event, serious fatal|0|||
146336644|NCT01324830|527738927|FG001|Overall Study|Adverse Event, serious fatal|1|||
146336645|NCT01324830|527738928|FG002|Overall Study|Adverse Event, serious fatal|0|||
146336646|NCT01324830|527738929|FG003|Overall Study|Adverse Event, serious fatal|0|||
146336647|NCT01324830|527738930|FG004|Overall Study|Adverse Event, serious fatal|0|||
146336648|NCT01324830|527738931|FG005|Overall Study|Adverse Event, serious fatal|0|||
146336649|NCT01324830|527738932|FG006|Overall Study|Adverse Event, serious fatal|0|||
146336650|NCT01324830|527738933|FG007|Overall Study|Adverse Event, serious fatal|0|||
146336651|NCT01324830|527738934|FG008|Overall Study|Adverse Event, serious fatal|0|||
146336652|NCT01324830|527738935|FG009|Overall Study|Adverse Event, serious fatal|0|||
146336653|NCT01324830|527738936|FG010|Overall Study|Adverse Event, serious fatal|0|||
146336654|NCT01324830|527738937|FG011|Overall Study|Adverse Event, serious fatal|0|||
146336655|NCT01324830|527738938|FG012|Overall Study|Adverse Event, serious fatal|0|||
146336656|NCT01324830|527738939|FG013|Overall Study|Adverse Event, serious fatal|0|||
146336657|NCT01324830|527738940|FG014|Overall Study|Adverse Event, serious fatal|0|||
146336658|NCT01324830|527738941|FG015|Overall Study|Adverse Event, serious fatal|0|||
145943277|NCT02326298|526300471|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146336659|NCT01324830|527738942|FG016|Overall Study|Adverse Event, serious fatal|0|||
146336660|NCT01324830|527738943|FG017|Overall Study|Adverse Event, serious fatal|0|||
146336661|NCT01324830|527738944|FG018|Overall Study|Adverse Event, serious fatal|0|||
146336662|NCT01324830|527738926|FG000|Overall Study|Adverse Event, non-fatal|0|||
146336663|NCT01324830|527738927|FG001|Overall Study|Adverse Event, non-fatal|0|||
146336664|NCT01324830|527738928|FG002|Overall Study|Adverse Event, non-fatal|0|||
146336665|NCT01324830|527738929|FG003|Overall Study|Adverse Event, non-fatal|0|||
146336666|NCT01324830|527738930|FG004|Overall Study|Adverse Event, non-fatal|0|||
146336667|NCT01324830|527738931|FG005|Overall Study|Adverse Event, non-fatal|0|||
146336668|NCT01324830|527738932|FG006|Overall Study|Adverse Event, non-fatal|0|||
146336669|NCT01324830|527738933|FG007|Overall Study|Adverse Event, non-fatal|0|||
146336670|NCT01324830|527738934|FG008|Overall Study|Adverse Event, non-fatal|2|||
146336671|NCT01324830|527738935|FG009|Overall Study|Adverse Event, non-fatal|0|||
146336672|NCT01324830|527738936|FG010|Overall Study|Adverse Event, non-fatal|1|||
146336673|NCT01324830|527738937|FG011|Overall Study|Adverse Event, non-fatal|0|||
146336674|NCT01324830|527738938|FG012|Overall Study|Adverse Event, non-fatal|0|||
146336675|NCT01324830|527738939|FG013|Overall Study|Adverse Event, non-fatal|0|||
146336676|NCT01324830|527738940|FG014|Overall Study|Adverse Event, non-fatal|0|||
146336677|NCT01324830|527738941|FG015|Overall Study|Adverse Event, non-fatal|0|||
146336678|NCT01324830|527738942|FG016|Overall Study|Adverse Event, non-fatal|0|||
146336679|NCT01324830|527738943|FG017|Overall Study|Adverse Event, non-fatal|1|||
146336680|NCT01324830|527738944|FG018|Overall Study|Adverse Event, non-fatal|0|||
146336681|NCT01324830|527738926|FG000|Overall Study|Withdrawal by Subject|0|||
146336682|NCT01324830|527738927|FG001|Overall Study|Withdrawal by Subject|0|||
146336683|NCT01324830|527738928|FG002|Overall Study|Withdrawal by Subject|0|||
146336684|NCT01324830|527738929|FG003|Overall Study|Withdrawal by Subject|0|||
146336685|NCT01324830|527738930|FG004|Overall Study|Withdrawal by Subject|0|||
146336686|NCT01324830|527738931|FG005|Overall Study|Withdrawal by Subject|1|||
146336687|NCT01324830|527738932|FG006|Overall Study|Withdrawal by Subject|0|||
146336688|NCT01324830|527738933|FG007|Overall Study|Withdrawal by Subject|0|||
146336689|NCT01324830|527738934|FG008|Overall Study|Withdrawal by Subject|0|||
146336690|NCT01324830|527738935|FG009|Overall Study|Withdrawal by Subject|0|||
146336691|NCT01324830|527738936|FG010|Overall Study|Withdrawal by Subject|1|||
146336692|NCT01324830|527738937|FG011|Overall Study|Withdrawal by Subject|0|||
146336693|NCT01324830|527738938|FG012|Overall Study|Withdrawal by Subject|0|||
146336694|NCT01324830|527738939|FG013|Overall Study|Withdrawal by Subject|0|||
146336695|NCT01324830|527738940|FG014|Overall Study|Withdrawal by Subject|0|||
146336696|NCT01324830|527738941|FG015|Overall Study|Withdrawal by Subject|0|||
146336697|NCT01324830|527738942|FG016|Overall Study|Withdrawal by Subject|0|||
146336698|NCT01324830|527738943|FG017|Overall Study|Withdrawal by Subject|0|||
146336699|NCT01324830|527738944|FG018|Overall Study|Withdrawal by Subject|1|||
146336700|NCT01485614|527738945|FG000|Randomization|Not Treated|1|||
146336701|NCT01485614|527738946|FG001|Randomization|Not Treated|0|||
146336702|NCT01485614|527738947|FG002|Randomization|Not Treated|0|||
146336703|NCT01485614|527738948|FG003|Randomization|Not Treated|0|||
146336704|NCT01485614|527738945|FG000|Weeks 0-20|Lost to Follow-up|2|||
146336705|NCT01485614|527738946|FG001|Weeks 0-20|Lost to Follow-up|0|||
146336706|NCT01485614|527738947|FG002|Weeks 0-20|Lost to Follow-up|0|||
146336707|NCT01485614|527738948|FG003|Weeks 0-20|Lost to Follow-up|0|||
146336708|NCT01485614|527738945|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
146336709|NCT01485614|527738946|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
146336710|NCT01485614|527738947|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
146336711|NCT01485614|527738948|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
146336712|NCT01485614|527738945|FG000|Weeks 0-20|Withdrawal by Subject|3|||
146336713|NCT01485614|527738946|FG001|Weeks 0-20|Withdrawal by Subject|2|||
146336714|NCT01485614|527738947|FG002|Weeks 0-20|Withdrawal by Subject|1|||
146336715|NCT01485614|527738948|FG003|Weeks 0-20|Withdrawal by Subject|0|||
146336716|NCT01485614|527738945|FG000|Weeks 20-54|Lost to Follow-up|4|||
146336717|NCT01485614|527738946|FG001|Weeks 20-54|Lost to Follow-up|3|||
146336718|NCT01485614|527738947|FG002|Weeks 20-54|Lost to Follow-up|1|||
146336719|NCT01485614|527738948|FG003|Weeks 20-54|Lost to Follow-up|0|||
146336720|NCT01485614|527738945|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
146336721|NCT01485614|527738946|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
146336722|NCT01485614|527738947|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
146336723|NCT01485614|527738948|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
146336724|NCT01485614|527738945|FG000|Weeks 20-54|Withdrawal by Subject|5|||
146336725|NCT01485614|527738946|FG001|Weeks 20-54|Withdrawal by Subject|3|||
146336726|NCT01485614|527738947|FG002|Weeks 20-54|Withdrawal by Subject|0|||
146336727|NCT01485614|527738948|FG003|Weeks 20-54|Withdrawal by Subject|0|||
146336728|NCT00733902|527738949|FG000|Overall Study|Death|0|||
146336729|NCT00733902|527738950|FG001|Overall Study|Death|0|||
146336730|NCT00733902|527738951|FG002|Overall Study|Death|0|||
146336731|NCT00733902|527738952|FG003|Overall Study|Death|1|||
146336732|NCT00733902|527738949|FG000|Overall Study|Adverse Event|3|||
146336733|NCT00733902|527738950|FG001|Overall Study|Adverse Event|4|||
146336734|NCT00733902|527738951|FG002|Overall Study|Adverse Event|7|||
146336735|NCT00733902|527738952|FG003|Overall Study|Adverse Event|11|||
146336736|NCT00733902|527738949|FG000|Overall Study|Lack of Efficacy|56|||
146336737|NCT00733902|527738950|FG001|Overall Study|Lack of Efficacy|21|||
146336738|NCT00733902|527738951|FG002|Overall Study|Lack of Efficacy|34|||
146336739|NCT00733902|527738952|FG003|Overall Study|Lack of Efficacy|23|||
146169033|NCT01264380|527131122|FG000|Period C|Withdrawal by Subject|0|||
146336740|NCT00733902|527738949|FG000|Overall Study|Protocol Violation|4|||
146336741|NCT00733902|527738950|FG001|Overall Study|Protocol Violation|6|||
146336742|NCT00733902|527738951|FG002|Overall Study|Protocol Violation|3|||
146336743|NCT00733902|527738952|FG003|Overall Study|Protocol Violation|3|||
146336744|NCT00733902|527738949|FG000|Overall Study|Withdrawal by Subject|10|||
146336745|NCT00733902|527738950|FG001|Overall Study|Withdrawal by Subject|5|||
146336746|NCT00733902|527738951|FG002|Overall Study|Withdrawal by Subject|4|||
146336747|NCT00733902|527738952|FG003|Overall Study|Withdrawal by Subject|16|||
146336748|NCT00733902|527738949|FG000|Overall Study|Entered extension study|89|||
146336749|NCT00733902|527738950|FG001|Overall Study|Entered extension study|124|||
146336750|NCT00733902|527738951|FG002|Overall Study|Entered extension study|111|||
146336751|NCT00733902|527738952|FG003|Overall Study|Entered extension study|109|||
146336752|NCT00733902|527738949|FG000|Overall Study|Randomized but not treated|2|||
146336753|NCT00733902|527738950|FG001|Overall Study|Randomized but not treated|2|||
146336754|NCT00733902|527738951|FG002|Overall Study|Randomized but not treated|2|||
146336755|NCT00733902|527738952|FG003|Overall Study|Randomized but not treated|1|||
146336756|NCT02210780|527738953|FG000|Overall Study|Adverse Event|0|||
146336757|NCT02210780|527738954|FG001|Overall Study|Adverse Event|5|||
146336758|NCT02210780|527738953|FG000|Overall Study|Lost to Follow-up|2|||
146336759|NCT02210780|527738954|FG001|Overall Study|Lost to Follow-up|1|||
146336760|NCT02210780|527738953|FG000|Overall Study|Withdrawal by Subject|1|||
146336761|NCT02210780|527738954|FG001|Overall Study|Withdrawal by Subject|1|||
146336762|NCT02210780|527738953|FG000|Overall Study|Physician Decision|1|||
146336763|NCT02210780|527738954|FG001|Overall Study|Physician Decision|0|||
146336764|NCT02210780|527738953|FG000|Overall Study|Protocol Violation|1|||
146336765|NCT02210780|527738954|FG001|Overall Study|Protocol Violation|0|||
146336766|NCT02210780|527738953|FG000|Overall Study|Other than specified above|0|||
146336767|NCT02210780|527738954|FG001|Overall Study|Other than specified above|1|||
146336768|NCT01503021|527738959|FG000|Overall Study|Adverse Event|7|||
146336769|NCT01503021|527738960|FG001|Overall Study|Adverse Event|6|||
146336770|NCT01503021|527738959|FG000|Overall Study|Death|0|||
146336771|NCT01503021|527738960|FG001|Overall Study|Death|2|||
146336772|NCT01503021|527738959|FG000|Overall Study|Lost to Follow-up|2|||
146336773|NCT01503021|527738960|FG001|Overall Study|Lost to Follow-up|0|||
146336774|NCT01503021|527738959|FG000|Overall Study|Physician Decision|3|||
146336775|NCT01503021|527738960|FG001|Overall Study|Physician Decision|0|||
146336776|NCT01503021|527738959|FG000|Overall Study|Protocol Violation|1|||
146336777|NCT01503021|527738960|FG001|Overall Study|Protocol Violation|3|||
146336778|NCT01503021|527738959|FG000|Overall Study|Withdrawal by Subject|9|||
146336779|NCT01503021|527738960|FG001|Overall Study|Withdrawal by Subject|8|||
146336780|NCT01503021|527738959|FG000|Overall Study|Moved, received transplant, etc.|5|||
146169034|NCT01264380|527131123|FG001|Period C|Withdrawal by Subject|0|||
146169035|NCT01264380|527131124|FG002|Period C|Withdrawal by Subject|1|||
146169036|NCT01264380|527131122|FG000|Period C|Adverse Event|0|||
146169037|NCT01264380|527131123|FG001|Period C|Adverse Event|0|||
146336781|NCT01503021|527738960|FG001|Overall Study|Moved, received transplant, etc.|7|||
146336782|NCT01242111|527738961|FG000|Overall Study|Adverse Event|1|||
146336783|NCT01242111|527738961|FG000|Overall Study|Withdrawal by Subject|1|||
146336784|NCT01242111|527738961|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
146336785|NCT01929083|527738964|FG000|Intervention 1|Lost to Follow-up|2|||
146336786|NCT01929083|527738965|FG001|Intervention 1|Lost to Follow-up|0|||
146336787|NCT01929083|527738964|FG000|Intervention 1|Nonadherent to study medications|1|||
146336788|NCT01929083|527738965|FG001|Intervention 1|Nonadherent to study medications|0|||
146336789|NCT01929083|527738964|FG000|Intervention 2|Adverse Event|0|||
146336790|NCT01929083|527738965|FG001|Intervention 2|Adverse Event|1|||
146336791|NCT02599402|527738966|FG000|Overall Study|Disease progression|153|||
146336792|NCT02599402|527738966|FG000|Overall Study|Study drug toxicity|201|||
146169038|NCT01264380|527131124|FG002|Period C|Adverse Event|1|||
146169039|NCT01147822|527131125|FG000|Overall Study|Lost to Follow-up|14|||
146169040|NCT01147822|527131126|FG001|Overall Study|Lost to Follow-up|6|||
146169041|NCT01147822|527131125|FG000|Overall Study|Withdrawal by Subject|10|||
146169042|NCT01147822|527131126|FG001|Overall Study|Withdrawal by Subject|16|||
145943278|NCT02326298|526300472|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146169043|NCT01147822|527131125|FG000|Overall Study|Physician Decision|9|||
146169044|NCT01147822|527131126|FG001|Overall Study|Physician Decision|8|||
146169045|NCT01147822|527131125|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
146336793|NCT02599402|527738966|FG000|Overall Study|Death|26|||
146336794|NCT02599402|527738966|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
146336795|NCT02599402|527738966|FG000|Overall Study|Participant request to discontinue study treatment|13|||
146336796|NCT02599402|527738966|FG000|Overall Study|Participant withdrew consent|5|||
146336797|NCT02599402|527738966|FG000|Overall Study|Lost to Follow-up|1|||
146336798|NCT02599402|527738966|FG000|Overall Study|Maximum Clinical Benefit|7|||
146336799|NCT02599402|527738966|FG000|Overall Study|Poor/non-compliance|1|||
146336800|NCT02599402|527738966|FG000|Overall Study|Pregnancy|1|||
146336801|NCT02599402|527738966|FG000|Overall Study|Participant no longer met study criteria|7|||
146336802|NCT02599402|527738966|FG000|Overall Study|Other Reasons|95|||
146336803|NCT00283387|527738971|FG000|First Intervention|Subject non-compliant|1|||
146336804|NCT00283387|527738972|FG001|First Intervention|Subject non-compliant|1|||
146336805|NCT00283387|527738971|FG000|First Intervention|Withdrawal by Subject|0|||
146336806|NCT00283387|527738972|FG001|First Intervention|Withdrawal by Subject|1|||
146336807|NCT00500071|527738976|FG000|Screening and Washout Phase|Protocol Violation|1|||
146336808|NCT00500071|527738976|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
146336809|NCT00500071|527738976|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
146336810|NCT00500071|527738976|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
146336811|NCT00500071|527738976|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
146336812|NCT00500071|527738976|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
146336813|NCT00500071|527738976|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
146336814|NCT01122927|527738977|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
146336815|NCT01122927|527738978|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
146336816|NCT01122927|527738977|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
146336817|NCT01122927|527738978|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
146336818|NCT01122927|527738977|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
146336819|NCT01122927|527738978|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
146336820|NCT01122927|527738977|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
146336821|NCT01122927|527738978|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
146336822|NCT01122927|527738977|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
146169046|NCT01147822|527131126|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
146336823|NCT01122927|527738978|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
146336824|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
146336825|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
146336826|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
146336827|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
146336828|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
146336829|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
146336830|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
146336831|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
146336832|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
146336833|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
146336834|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
146336835|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
146336836|NCT01122927|527738977|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
146336837|NCT01122927|527738978|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
146336838|NCT03182738|527738979|FG000|Overall Study|Lost to Follow-up|9|||
146336839|NCT03182738|527738980|FG001|Overall Study|Lost to Follow-up|3|||
146336840|NCT03182738|527738979|FG000|Overall Study|Pregnancy|0|||
146336841|NCT03182738|527738980|FG001|Overall Study|Pregnancy|1|||
146336842|NCT03182738|527738979|FG000|Overall Study|Withdrawal by Subject|0|||
146336843|NCT03182738|527738980|FG001|Overall Study|Withdrawal by Subject|1|||
146336844|NCT03584009|527738981|FG000|Overall Study|Death|25|||
146336845|NCT03584009|527738982|FG001|Overall Study|Death|18|||
146336846|NCT03584009|527738981|FG000|Overall Study|Lost to Follow-up|0|||
146336847|NCT03584009|527738982|FG001|Overall Study|Lost to Follow-up|1|||
146336848|NCT03584009|527738981|FG000|Overall Study|Physician Decision|1|||
146336849|NCT03584009|527738982|FG001|Overall Study|Physician Decision|1|||
146336850|NCT03584009|527738981|FG000|Overall Study|Study Terminated by Sponsor|22|||
146336851|NCT03584009|527738982|FG001|Overall Study|Study Terminated by Sponsor|30|||
146336852|NCT03584009|527738981|FG000|Overall Study|Withdrawal by Subject|3|||
146336853|NCT03584009|527738982|FG001|Overall Study|Withdrawal by Subject|2|||
146336854|NCT03812510|527738983|FG000|Overall Study|Lost to Follow-up|39|||
146336855|NCT03812510|527738983|FG000|Overall Study|Withdrawal by Subject|42|||
146336856|NCT03812510|527738983|FG000|Overall Study|Physician Decision|2|||
146336857|NCT03812510|527738983|FG000|Overall Study|Study Terminated by Sponsor|9|||
146336858|NCT03812510|527738983|FG000|Overall Study|Did Not Start Study Medication|55|||
146336859|NCT03812510|527738983|FG000|Overall Study|Adverse Event|5|||
146336860|NCT02635204|527738984|FG000|Overall Study|Adverse Event|1|||
146336861|NCT02635204|527738985|FG001|Overall Study|Adverse Event|0|||
146336862|NCT02635204|527738984|FG000|Overall Study|Lost to Follow-up|1|||
145943279|NCT02326298|526300473|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146169047|NCT01147822|527131125|FG000|Overall Study|Protocol Violation|1|||
146169048|NCT01147822|527131126|FG001|Overall Study|Protocol Violation|1|||
146169049|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
146336863|NCT02635204|527738985|FG001|Overall Study|Lost to Follow-up|1|||
146336864|NCT00509106|527738988|FG000|Overall Study|Adverse Event|3|||
146336865|NCT00509106|527738989|FG001|Overall Study|Adverse Event|2|||
146336866|NCT00509106|527738988|FG000|Overall Study|Noncompliance|0|||
146336867|NCT00509106|527738989|FG001|Overall Study|Noncompliance|1|||
146336868|NCT00509106|527738988|FG000|Overall Study|At the request of sponsor/investigator|1|||
146336869|NCT00509106|527738989|FG001|Overall Study|At the request of sponsor/investigator|2|||
146336870|NCT00509106|527738988|FG000|Overall Study|Withdrew consent|4|||
146336871|NCT00509106|527738989|FG001|Overall Study|Withdrew consent|8|||
146336872|NCT00509106|527738988|FG000|Overall Study|Lost to Follow-up|16|||
146336873|NCT00509106|527738989|FG001|Overall Study|Lost to Follow-up|10|||
146336874|NCT00509106|527738988|FG000|Overall Study|Other|1|||
146336875|NCT00509106|527738989|FG001|Overall Study|Other|0|||
146336876|NCT00509106|527738988|FG000|Overall Study|Death|6|||
146336877|NCT00509106|527738989|FG001|Overall Study|Death|6|||
146336878|NCT02371629|527739007|FG000|Overall Study|Patient decision|14|||
146336879|NCT02371629|527739008|FG001|Overall Study|Patient decision|10|||
146336880|NCT02371629|527739007|FG000|Overall Study|Adverse Event|8|||
146336881|NCT02371629|527739008|FG001|Overall Study|Adverse Event|8|||
146336882|NCT02371629|527739007|FG000|Overall Study|Physician Decision|2|||
146336883|NCT02371629|527739008|FG001|Overall Study|Physician Decision|3|||
146336884|NCT02371629|527739007|FG000|Overall Study|Death|1|||
146336885|NCT02371629|527739008|FG001|Overall Study|Death|1|||
146336886|NCT02371629|527739007|FG000|Overall Study|Noncompliance with study treatment|1|||
146336887|NCT02371629|527739008|FG001|Overall Study|Noncompliance with study treatment|0|||
146336888|NCT02371629|527739007|FG000|Overall Study|Lack of Efficacy|0|||
146336889|NCT02371629|527739008|FG001|Overall Study|Lack of Efficacy|2|||
146336890|NCT02371629|527739007|FG000|Overall Study|Protocol deviation|0|||
146336891|NCT02371629|527739008|FG001|Overall Study|Protocol deviation|1|||
146336892|NCT01073943|527739014|FG000|Overall Study|Withdrawal by Subject|8|||
146336893|NCT01073943|527739015|FG001|Overall Study|Withdrawal by Subject|2|||
146336894|NCT01073943|527739014|FG000|Overall Study|Protocol Violation|2|||
146336895|NCT01073943|527739015|FG001|Overall Study|Protocol Violation|1|||
146336896|NCT01073943|527739014|FG000|Overall Study|Adverse Event|1|||
146336897|NCT01073943|527739015|FG001|Overall Study|Adverse Event|1|||
146336898|NCT01073943|527739014|FG000|Overall Study|Lost to Follow-up|0|||
146336899|NCT01073943|527739015|FG001|Overall Study|Lost to Follow-up|2|||
146336900|NCT01073943|527739014|FG000|Overall Study|Power outage; colonoscopy not done|1|||
146336901|NCT01073943|527739015|FG001|Overall Study|Power outage; colonoscopy not done|0|||
146336902|NCT01073943|527739014|FG000|Overall Study|Subject forgot|0|||
146336903|NCT01073943|527739015|FG001|Overall Study|Subject forgot|1|||
146336904|NCT01073943|527739014|FG000|Overall Study|Unable to return for follow-up|0|||
146336905|NCT01073943|527739015|FG001|Overall Study|Unable to return for follow-up|1|||
146336906|NCT01073943|527739014|FG000|Overall Study|Could not tolerate prep|1|||
146336907|NCT01073943|527739015|FG001|Overall Study|Could not tolerate prep|0|||
146336908|NCT01051739|527739019|FG000|Overall Study|Death|3|||
146336909|NCT01051739|527739020|FG001|Overall Study|Death|3|||
146336910|NCT01051739|527739019|FG000|Overall Study|Withdrawal by Subject|25|||
146336911|NCT01051739|527739020|FG001|Overall Study|Withdrawal by Subject|10|||
146336912|NCT03527043|527739022|FG000|Overall Study|Withdrawal by Subject|1|||
146336913|NCT03527043|527739023|FG001|Overall Study|Withdrawal by Subject|0|||
146336914|NCT02120417|527739024|FG000|Overall Study|Death|5|||
146336915|NCT02120417|527739025|FG001|Overall Study|Death|1|||
146336916|NCT02120417|527739024|FG000|Overall Study|Adverse Event|3|||
146336917|NCT02120417|527739025|FG001|Overall Study|Adverse Event|9|||
146336918|NCT02120417|527739024|FG000|Overall Study|Participant decision|4|||
146336919|NCT02120417|527739025|FG001|Overall Study|Participant decision|4|||
146336920|NCT02120417|527739024|FG000|Overall Study|Disease progression|41|||
146336921|NCT02120417|527739025|FG001|Overall Study|Disease progression|45|||
146336922|NCT02120417|527739024|FG000|Overall Study|Noncompliance with study treatment|0|||
146336923|NCT02120417|527739025|FG001|Overall Study|Noncompliance with study treatment|2|||
146336924|NCT02120417|527739024|FG000|Overall Study|Physician Decision|2|||
146336925|NCT02120417|527739025|FG001|Overall Study|Physician Decision|3|||
146336926|NCT02120417|527739024|FG000|Overall Study|Other unspecified|5|||
146336927|NCT02120417|527739025|FG001|Overall Study|Other unspecified|4|||
146336928|NCT00927485|527739026|FG000|Overall Study|Adverse Event|4|||
146336929|NCT00927485|527739027|FG001|Overall Study|Adverse Event|2|||
146336930|NCT00927485|527739026|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
146336931|NCT00927485|527739027|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
146336932|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
146336933|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
146336934|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
146336935|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
146336936|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
146336937|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
146336938|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Personal issues|2|||
146336939|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Personal issues|0|||
146336940|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Personal issues|0|||
146336941|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Too busy|7|||
146336942|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Too busy|1|||
146336943|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Too busy|0|||
146336944|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Pain|2|||
146336945|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Pain|0|||
146336946|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Pain|0|||
146336947|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Moved|1|||
146336948|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Moved|0|||
146336949|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Moved|0|||
146336950|NCT00594399|527739028|FG000|Initial 3 Month Counseling|Family illness|1|||
146336951|NCT00594399|527739029|FG001|Initial 3 Month Counseling|Family illness|0|||
146336952|NCT00594399|527739030|FG002|Initial 3 Month Counseling|Family illness|0|||
146336953|NCT00594399|527739028|FG000|Rerandomization Arm 1 Only|Death|2|||
146336954|NCT00594399|527739029|FG001|Rerandomization Arm 1 Only|Death|1|||
146336955|NCT00594399|527739030|FG002|Rerandomization Arm 1 Only|Death|0|||
146336956|NCT00594399|527739028|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
146336957|NCT00594399|527739029|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
146336958|NCT00594399|527739030|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
146336959|NCT03830281|527739031|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
146336960|NCT03830281|527739032|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
146336961|NCT03830281|527739031|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
146336962|NCT03830281|527739032|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
146336963|NCT03830281|527739031|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
146336964|NCT03830281|527739032|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
146336965|NCT03830281|527739031|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
146336966|NCT03830281|527739032|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
146336967|NCT03830281|527739031|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
146336968|NCT03830281|527739032|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
146336969|NCT03830281|527739031|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
146336970|NCT03830281|527739032|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
146336971|NCT03830281|527739031|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
146336972|NCT03830281|527739032|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
146336973|NCT03830281|527739031|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
146336974|NCT03830281|527739032|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
146336975|NCT03830281|527739031|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
146336976|NCT03830281|527739032|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
146336977|NCT03293680|527739034|FG000|Overall Study|Death|1|||
146336978|NCT03293680|527739034|FG000|Overall Study|Did not meet inclusion criteria|8|||
146336979|NCT00922935|527739035|FG000|Overall Study|Protocol Violation|0|||
146336980|NCT00922935|527739036|FG001|Overall Study|Protocol Violation|3|||
146336981|NCT00922935|527739037|FG002|Overall Study|Protocol Violation|0|||
146336982|NCT00922935|527739035|FG000|Overall Study|Physician Decision|1|||
146336983|NCT00922935|527739036|FG001|Overall Study|Physician Decision|1|||
146336984|NCT00922935|527739037|FG002|Overall Study|Physician Decision|0|||
146336985|NCT00922935|527739035|FG000|Overall Study|Lost to Follow-up|0|||
146336986|NCT00922935|527739036|FG001|Overall Study|Lost to Follow-up|1|||
146336987|NCT00922935|527739037|FG002|Overall Study|Lost to Follow-up|0|||
146336988|NCT02201940|527739038|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
146336989|NCT02201940|527739039|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
146336990|NCT02201940|527739038|FG000|Overall Study|Lack of Efficacy|2|||
146336991|NCT02201940|527739039|FG001|Overall Study|Lack of Efficacy|113|||
146336992|NCT02201940|527739038|FG000|Overall Study|Lost to Follow-up|5|||
146336993|NCT02201940|527739039|FG001|Overall Study|Lost to Follow-up|0|||
146336994|NCT02201940|527739038|FG000|Overall Study|Withdrew Consent|2|||
146336995|NCT02201940|527739039|FG001|Overall Study|Withdrew Consent|1|||
146336996|NCT02201940|527739038|FG000|Overall Study|Investigator's Discretion|1|||
146336997|NCT02201940|527739039|FG001|Overall Study|Investigator's Discretion|1|||
146336998|NCT02201940|527739038|FG000|Overall Study|Death|1|||
146336999|NCT02201940|527739039|FG001|Overall Study|Death|0|||
146337000|NCT02201940|527739038|FG000|Overall Study|Adverse Event|0|||
146337001|NCT02201940|527739039|FG001|Overall Study|Adverse Event|1|||
146337002|NCT00424398|527739043|FG000|Overall Study|Withdrawal by Subject|2|||
146337003|NCT00424398|527739044|FG001|Overall Study|Withdrawal by Subject|1|||
146337004|NCT00424398|527739045|FG002|Overall Study|Withdrawal by Subject|0|||
146337005|NCT00424398|527739043|FG000|Overall Study|Subject met exclusion criteria|1|||
146337006|NCT00424398|527739044|FG001|Overall Study|Subject met exclusion criteria|0|||
146337007|NCT00424398|527739045|FG002|Overall Study|Subject met exclusion criteria|0|||
146337008|NCT01309737|527739047|FG000|Week 0 to 16|Death|1|||
146337009|NCT01309737|527739048|FG001|Week 0 to 16|Death|0|||
146337010|NCT01309737|527739049|FG002|Week 0 to 16|Death|1|||
146337011|NCT01309737|527739050|FG003|Week 0 to 16|Death|0|||
146337012|NCT01309737|527739051|FG004|Week 0 to 16|Death|0|||
146337013|NCT01309737|527739047|FG000|Week 0 to 16|Adverse Event|11|||
146337014|NCT01309737|527739048|FG001|Week 0 to 16|Adverse Event|10|||
146337015|NCT01309737|527739049|FG002|Week 0 to 16|Adverse Event|5|||
146337016|NCT01309737|527739050|FG003|Week 0 to 16|Adverse Event|0|||
146337017|NCT01309737|527739051|FG004|Week 0 to 16|Adverse Event|0|||
146337018|NCT01309737|527739047|FG000|Week 0 to 16|Lack of Efficacy|15|||
146337019|NCT01309737|527739048|FG001|Week 0 to 16|Lack of Efficacy|2|||
146337020|NCT01309737|527739049|FG002|Week 0 to 16|Lack of Efficacy|24|||
146337021|NCT01309737|527739050|FG003|Week 0 to 16|Lack of Efficacy|0|||
146337022|NCT01309737|527739051|FG004|Week 0 to 16|Lack of Efficacy|0|||
146337023|NCT01309737|527739047|FG000|Week 0 to 16|Lost to Follow-up|7|||
146337024|NCT01309737|527739048|FG001|Week 0 to 16|Lost to Follow-up|8|||
146337025|NCT01309737|527739049|FG002|Week 0 to 16|Lost to Follow-up|3|||
146337026|NCT01309737|527739050|FG003|Week 0 to 16|Lost to Follow-up|0|||
146337027|NCT01309737|527739051|FG004|Week 0 to 16|Lost to Follow-up|0|||
146337028|NCT01309737|527739047|FG000|Week 0 to 16|Withdrawal by Subject|7|||
146337029|NCT01309737|527739048|FG001|Week 0 to 16|Withdrawal by Subject|6|||
146337030|NCT01309737|527739049|FG002|Week 0 to 16|Withdrawal by Subject|7|||
146337031|NCT01309737|527739050|FG003|Week 0 to 16|Withdrawal by Subject|0|||
146337032|NCT01309737|527739051|FG004|Week 0 to 16|Withdrawal by Subject|0|||
146337033|NCT01309737|527739047|FG000|Week 0 to 16|Other|10|||
146337034|NCT01309737|527739048|FG001|Week 0 to 16|Other|14|||
146337035|NCT01309737|527739049|FG002|Week 0 to 16|Other|4|||
146337036|NCT01309737|527739050|FG003|Week 0 to 16|Other|0|||
146337037|NCT01309737|527739051|FG004|Week 0 to 16|Other|0|||
146337038|NCT01309737|527739047|FG000|Week 0 to 16|Randomized, but not treated|1|||
146337039|NCT01309737|527739048|FG001|Week 0 to 16|Randomized, but not treated|0|||
146337040|NCT01309737|527739049|FG002|Week 0 to 16|Randomized, but not treated|0|||
146337041|NCT01309737|527739050|FG003|Week 0 to 16|Randomized, but not treated|0|||
146337042|NCT01309737|527739051|FG004|Week 0 to 16|Randomized, but not treated|0|||
146337043|NCT01309737|527739047|FG000|Week 16 to 52|Death|0|||
146337044|NCT01309737|527739048|FG001|Week 16 to 52|Death|0|||
146337045|NCT01309737|527739049|FG002|Week 16 to 52|Death|0|||
146337046|NCT01309737|527739050|FG003|Week 16 to 52|Death|0|||
146337047|NCT01309737|527739051|FG004|Week 16 to 52|Death|1|||
146337048|NCT01309737|527739047|FG000|Week 16 to 52|Adverse Event|7|||
146337049|NCT01309737|527739048|FG001|Week 16 to 52|Adverse Event|7|||
146337050|NCT01309737|527739049|FG002|Week 16 to 52|Adverse Event|0|||
146337051|NCT01309737|527739050|FG003|Week 16 to 52|Adverse Event|6|||
146337052|NCT01309737|527739051|FG004|Week 16 to 52|Adverse Event|5|||
146337053|NCT01309737|527739047|FG000|Week 16 to 52|Lack of Efficacy|107|||
146337054|NCT01309737|527739048|FG001|Week 16 to 52|Lack of Efficacy|76|||
146337055|NCT01309737|527739049|FG002|Week 16 to 52|Lack of Efficacy|0|||
146337056|NCT01309737|527739050|FG003|Week 16 to 52|Lack of Efficacy|25|||
146337057|NCT01309737|527739051|FG004|Week 16 to 52|Lack of Efficacy|21|||
146337058|NCT01309737|527739047|FG000|Week 16 to 52|Lost to Follow-up|4|||
146337059|NCT01309737|527739048|FG001|Week 16 to 52|Lost to Follow-up|2|||
146337060|NCT01309737|527739049|FG002|Week 16 to 52|Lost to Follow-up|0|||
146337061|NCT01309737|527739050|FG003|Week 16 to 52|Lost to Follow-up|1|||
146337062|NCT01309737|527739051|FG004|Week 16 to 52|Lost to Follow-up|4|||
146337063|NCT01309737|527739047|FG000|Week 16 to 52|Withdrawal by Subject|5|||
146337064|NCT01309737|527739048|FG001|Week 16 to 52|Withdrawal by Subject|6|||
146337065|NCT01309737|527739049|FG002|Week 16 to 52|Withdrawal by Subject|0|||
146337066|NCT01309737|527739050|FG003|Week 16 to 52|Withdrawal by Subject|0|||
146337067|NCT01309737|527739051|FG004|Week 16 to 52|Withdrawal by Subject|2|||
146337068|NCT01309737|527739047|FG000|Week 16 to 52|Other|10|||
146337069|NCT01309737|527739048|FG001|Week 16 to 52|Other|12|||
146337070|NCT01309737|527739049|FG002|Week 16 to 52|Other|0|||
146337071|NCT01309737|527739050|FG003|Week 16 to 52|Other|2|||
146337072|NCT01309737|527739051|FG004|Week 16 to 52|Other|0|||
146337073|NCT02240706|527739058|FG000|Overall Study|Lack of Efficacy|2|||
146337074|NCT02240706|527739059|FG001|Overall Study|Lack of Efficacy|2|||
146337075|NCT02240706|527739060|FG002|Overall Study|Lack of Efficacy|2|||
146337076|NCT02240706|527739061|FG003|Overall Study|Lack of Efficacy|2|||
146337077|NCT02240706|527739062|FG004|Overall Study|Lack of Efficacy|5|||
146337078|NCT02240706|527739063|FG005|Overall Study|Lack of Efficacy|0|||
146337079|NCT02240706|527739064|FG006|Overall Study|Lack of Efficacy|0|||
146337080|NCT02240706|527739058|FG000|Overall Study|Adverse Event|1|||
146337081|NCT02240706|527739059|FG001|Overall Study|Adverse Event|0|||
146337082|NCT02240706|527739060|FG002|Overall Study|Adverse Event|1|||
146337083|NCT02240706|527739061|FG003|Overall Study|Adverse Event|0|||
146337084|NCT02240706|527739062|FG004|Overall Study|Adverse Event|2|||
146337085|NCT02240706|527739063|FG005|Overall Study|Adverse Event|0|||
146337086|NCT02240706|527739064|FG006|Overall Study|Adverse Event|0|||
146337087|NCT02240706|527739058|FG000|Overall Study|Progressive disease|0|||
146337088|NCT02240706|527739059|FG001|Overall Study|Progressive disease|0|||
146337089|NCT02240706|527739060|FG002|Overall Study|Progressive disease|0|||
146337090|NCT02240706|527739061|FG003|Overall Study|Progressive disease|0|||
146337091|NCT02240706|527739062|FG004|Overall Study|Progressive disease|1|||
146337092|NCT02240706|527739063|FG005|Overall Study|Progressive disease|0|||
146337093|NCT02240706|527739064|FG006|Overall Study|Progressive disease|0|||
146337094|NCT02240706|527739058|FG000|Overall Study|Dose limiting toxicity|0|||
146337095|NCT02240706|527739059|FG001|Overall Study|Dose limiting toxicity|0|||
146337096|NCT02240706|527739060|FG002|Overall Study|Dose limiting toxicity|0|||
146337097|NCT02240706|527739061|FG003|Overall Study|Dose limiting toxicity|0|||
146337098|NCT02240706|527739062|FG004|Overall Study|Dose limiting toxicity|1|||
146337099|NCT02240706|527739063|FG005|Overall Study|Dose limiting toxicity|0|||
146337100|NCT02240706|527739064|FG006|Overall Study|Dose limiting toxicity|0|||
146337101|NCT02240706|527739058|FG000|Overall Study|Refused to continue taking medication|0|||
146337102|NCT02240706|527739059|FG001|Overall Study|Refused to continue taking medication|1|||
146337103|NCT02240706|527739060|FG002|Overall Study|Refused to continue taking medication|3|||
146337104|NCT02240706|527739061|FG003|Overall Study|Refused to continue taking medication|1|||
146396140|NCT01241591|527954454|FG002|Overall Study|Screen Failure|1|||
146337105|NCT02240706|527739062|FG004|Overall Study|Refused to continue taking medication|2|||
146337106|NCT02240706|527739063|FG005|Overall Study|Refused to continue taking medication|0|||
146337107|NCT02240706|527739064|FG006|Overall Study|Refused to continue taking medication|0|||
146337108|NCT02240706|527739058|FG000|Overall Study|Insurance billing concerns|0|||
146337109|NCT02240706|527739059|FG001|Overall Study|Insurance billing concerns|0|||
146337110|NCT02240706|527739060|FG002|Overall Study|Insurance billing concerns|0|||
146337111|NCT02240706|527739061|FG003|Overall Study|Insurance billing concerns|1|||
146337112|NCT02240706|527739062|FG004|Overall Study|Insurance billing concerns|0|||
146337113|NCT02240706|527739063|FG005|Overall Study|Insurance billing concerns|0|||
146337114|NCT02240706|527739064|FG006|Overall Study|Insurance billing concerns|0|||
146337115|NCT00817414|527740000|FG000|Overall Study|Adverse Event|1|||
146337116|NCT00817414|527740001|FG001|Overall Study|Adverse Event|1|||
146337117|NCT00817414|527740002|FG002|Overall Study|Adverse Event|1|||
146337118|NCT00817414|527740003|FG003|Overall Study|Adverse Event|0|||
146337119|NCT00817414|527740004|FG004|Overall Study|Adverse Event|0|||
146337120|NCT00817414|527740000|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
146337121|NCT00817414|527740001|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
146337122|NCT00817414|527740002|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
146337123|NCT00817414|527740003|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
146337124|NCT00817414|527740004|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
146337125|NCT00817414|527740000|FG000|Overall Study|Withdrawal by Subject|1|||
146337126|NCT00817414|527740001|FG001|Overall Study|Withdrawal by Subject|1|||
146337127|NCT00817414|527740002|FG002|Overall Study|Withdrawal by Subject|0|||
146337128|NCT00817414|527740003|FG003|Overall Study|Withdrawal by Subject|0|||
146337129|NCT00817414|527740004|FG004|Overall Study|Withdrawal by Subject|0|||
146337130|NCT00817414|527740000|FG000|Overall Study|Lost to Follow-up|0|||
146337131|NCT00817414|527740001|FG001|Overall Study|Lost to Follow-up|0|||
146337132|NCT00817414|527740002|FG002|Overall Study|Lost to Follow-up|1|||
146337133|NCT00817414|527740003|FG003|Overall Study|Lost to Follow-up|1|||
146337134|NCT00817414|527740004|FG004|Overall Study|Lost to Follow-up|1|||
146337135|NCT00817414|527740000|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146337136|NCT00817414|527740001|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146337137|NCT00817414|527740002|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146337138|NCT00817414|527740003|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
146337139|NCT00817414|527740004|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
146337140|NCT00817414|527740000|FG000|Overall Study|Protocol Violation|0|||
146337141|NCT00817414|527740001|FG001|Overall Study|Protocol Violation|0|||
146337142|NCT00817414|527740002|FG002|Overall Study|Protocol Violation|0|||
146337143|NCT00817414|527740003|FG003|Overall Study|Protocol Violation|0|||
146337144|NCT00817414|527740004|FG004|Overall Study|Protocol Violation|1|||
146337145|NCT00886938|527740005|FG000|Overall Study|Adverse Event|1|||
146337146|NCT00886938|527740005|FG000|Overall Study|Withdrawal by Subject|1|||
146337147|NCT03941548|527740008|FG000|Overall Study|Adverse Event|0|||
146337148|NCT03941548|527740009|FG001|Overall Study|Adverse Event|1|||
146337149|NCT03941548|527740008|FG000|Overall Study|Lost to Follow-up|0|||
146337150|NCT03941548|527740009|FG001|Overall Study|Lost to Follow-up|1|||
146337151|NCT03941548|527740008|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
146337152|NCT03941548|527740009|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
146337153|NCT00870688|527740011|FG000|Overall Study|Lost to Follow-up|2|||
146337154|NCT00870688|527740011|FG000|Overall Study|Death, Unrelated|1|||
146337155|NCT00870688|527740011|FG000|Overall Study|Granules in the Stools|1|||
146337156|NCT03872180|527740012|FG000|Overall Study|Adverse Event|4|||
146169050|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
146169051|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
146169052|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
146169053|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
146169054|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
146169055|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
146169056|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
146169057|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
146169058|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
146169059|NCT00261495|527131130|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
146169060|NCT00261495|527131131|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
146169061|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
146337157|NCT03872180|527740012|FG000|Overall Study|Lack of Efficacy|2|||
146337158|NCT02945657|527740013|FG000|Overall Study|Adverse Event|1|||
146337159|NCT02945657|527740013|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146337160|NCT00087438|527740016|FG000|Overall Study|Ineligible / No protocol treatment|4|||
146337161|NCT01157117|527740017|FG000|Overall Study|Dosing Symptoms|0|||
146337162|NCT01157117|527740018|FG001|Overall Study|Dosing Symptoms|4|||
146337163|NCT01157117|527740019|FG002|Overall Study|Dosing Symptoms|0|||
146337164|NCT01157117|527740017|FG000|Overall Study|Withdrawal by Subject|4|||
146337165|NCT01157117|527740018|FG001|Overall Study|Withdrawal by Subject|1|||
146337166|NCT01157117|527740019|FG002|Overall Study|Withdrawal by Subject|1|||
146337167|NCT01157117|527740017|FG000|Overall Study|Lack of Efficacy|1|||
146337168|NCT01157117|527740018|FG001|Overall Study|Lack of Efficacy|1|||
146337169|NCT01157117|527740019|FG002|Overall Study|Lack of Efficacy|0|||
146337170|NCT01157117|527740017|FG000|Overall Study|Lost to Follow-up|0|||
146337171|NCT01157117|527740018|FG001|Overall Study|Lost to Follow-up|0|||
146337172|NCT01157117|527740019|FG002|Overall Study|Lost to Follow-up|1|||
146337173|NCT01157117|527740017|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
146337174|NCT01157117|527740018|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
146337175|NCT01157117|527740019|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
146337176|NCT01486264|527740020|FG000|Overall Study|Death|1|||
146337177|NCT01486264|527740021|FG001|Overall Study|Death|1|||
146337178|NCT01486264|527740020|FG000|Overall Study|Adverse Event|3|||
146337179|NCT01486264|527740021|FG001|Overall Study|Adverse Event|3|||
146337180|NCT01486264|527740020|FG000|Overall Study|Lack of Efficacy|6|||
146337181|NCT01486264|527740021|FG001|Overall Study|Lack of Efficacy|10|||
146337182|NCT01486264|527740020|FG000|Overall Study|Withdrawal by Subject|7|||
146337183|NCT01486264|527740021|FG001|Overall Study|Withdrawal by Subject|18|||
146337184|NCT01486264|527740020|FG000|Overall Study|Physician Decision|1|||
146337185|NCT01486264|527740021|FG001|Overall Study|Physician Decision|1|||
146337186|NCT01486264|527740020|FG000|Overall Study|Protocol Violation|3|||
146337187|NCT01486264|527740021|FG001|Overall Study|Protocol Violation|0|||
146337188|NCT01486264|527740020|FG000|Overall Study|Lost to Follow-up|3|||
146337189|NCT01486264|527740021|FG001|Overall Study|Lost to Follow-up|2|||
146337190|NCT01486264|527740020|FG000|Overall Study|Other|5|||
146337191|NCT01486264|527740021|FG001|Overall Study|Other|11|||
146337192|NCT01486264|527740020|FG000|Overall Study|Not treated|0|||
146337193|NCT01486264|527740021|FG001|Overall Study|Not treated|1|||
146337194|NCT00728416|527740030|FG000|Overall Study|Adverse Event|1|||
146337195|NCT00728416|527740031|FG001|Overall Study|Adverse Event|1|||
146337196|NCT00728416|527740030|FG000|Overall Study|Treatment Failure|0|||
146337197|NCT00728416|527740031|FG001|Overall Study|Treatment Failure|1|||
146337198|NCT00728416|527740030|FG000|Overall Study|Withdrawal by Subject|1|||
146337199|NCT00728416|527740031|FG001|Overall Study|Withdrawal by Subject|0|||
146337200|NCT03596164|527740032|FG000|Overall Study|Adverse Event|0|||
146337201|NCT03596164|527740033|FG001|Overall Study|Adverse Event|1|||
146337202|NCT03596164|527740032|FG000|Overall Study|Death|1|||
146337203|NCT03596164|527740033|FG001|Overall Study|Death|0|||
146337204|NCT01120626|527740034|FG000|Overall Study|Withdrawal by Subject|1|||
146337205|NCT01120626|527740035|FG001|Overall Study|Withdrawal by Subject|0|||
146337206|NCT03022461|527740042|FG000|Overall Study|Death|3|||
146337207|NCT01076179|527740043|FG000|Overall Study|Withdrawal by Subject|1|||
146337208|NCT03459040|527740044|FG000|Overall Study|Death|8|||
146337209|NCT03459040|527740044|FG000|Overall Study|Withdrawal by Subject|1|||
146337210|NCT00986349|527740045|FG000|Overall Study|Unsuccessful implant procedure|3|||
146337211|NCT00986349|527740045|FG000|Overall Study|Adverse Event|2|||
146337212|NCT00986349|527740045|FG000|Overall Study|Physician Decision|1|||
146337213|NCT00986349|527740045|FG000|Overall Study|device migration|1|||
146337214|NCT02299934|527740046|FG000|Overall Study|Termination of study|13|||
146337215|NCT03815175|527740047|FG000|Overall Study|Subject Lost to Follow-up|6|||
146337216|NCT03815175|527740047|FG000|Overall Study|Subject Withdrew Consent|48|||
146337217|NCT03815175|527740047|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
146337218|NCT03815175|527740047|FG000|Overall Study|Death|86|||
146337219|NCT03815175|527740047|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
146337220|NCT03815175|527740047|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
146337221|NCT03815175|527740047|FG000|Overall Study|Other Status Change Reason|1|||
146337222|NCT03815175|527740047|FG000|Overall Study|Missed Visit|12|||
146337223|NCT03577990|527740048|FG000|Overall Study|Lost to Follow-up|4|||
146337224|NCT03577990|527740049|FG001|Overall Study|Lost to Follow-up|6|||
146337225|NCT03577990|527740048|FG000|Overall Study|Withdrawal by Subject|4|||
146337226|NCT03577990|527740049|FG001|Overall Study|Withdrawal by Subject|7|||
146337227|NCT03248128|527740050|FG000|Overall Study|Lost to Follow-up|1|||
146337228|NCT03248128|527740051|FG001|Overall Study|Lost to Follow-up|0|||
146337229|NCT03248128|527740050|FG000|Overall Study|Withdrawal by Subject|16|||
146337230|NCT03248128|527740051|FG001|Overall Study|Withdrawal by Subject|14|||
146337231|NCT03248128|527740050|FG000|Overall Study|Site Closed|4|||
146337232|NCT03248128|527740051|FG001|Overall Study|Site Closed|3|||
146337233|NCT03248128|527740050|FG000|Overall Study|Randomized, but did not receive treatment|1|||
146337234|NCT03248128|527740051|FG001|Overall Study|Randomized, but did not receive treatment|3|||
146337235|NCT01914679|527740052|FG000|Overall Study|Lack of Efficacy|1|||
146337236|NCT01914679|527740052|FG000|Overall Study|Sponsor terminated study|4|||
146337237|NCT00256295|527740055|FG000|Overall Study|Withdrawal by Subject|3|||
146337238|NCT00256295|527740055|FG000|Overall Study|Death|1|||
146337239|NCT00538681|527740067|FG000|Overall Study|Progressive Disease|7|||
146337240|NCT00538681|527740068|FG001|Overall Study|Progressive Disease|0|||
146337241|NCT00538681|527740069|FG002|Overall Study|Progressive Disease|1|||
146337242|NCT00538681|527740070|FG003|Overall Study|Progressive Disease|0|||
146337243|NCT00538681|527740067|FG000|Overall Study|Sponsor Decision|1|||
146337244|NCT00538681|527740068|FG001|Overall Study|Sponsor Decision|3|||
146337245|NCT00538681|527740069|FG002|Overall Study|Sponsor Decision|8|||
146337246|NCT00538681|527740070|FG003|Overall Study|Sponsor Decision|9|||
146337247|NCT00538681|527740067|FG000|Overall Study|Adverse Event|1|||
146337248|NCT00538681|527740068|FG001|Overall Study|Adverse Event|1|||
146337249|NCT00538681|527740069|FG002|Overall Study|Adverse Event|1|||
146337250|NCT00538681|527740070|FG003|Overall Study|Adverse Event|0|||
146337251|NCT00538681|527740067|FG000|Overall Study|Death|0|||
146337252|NCT00538681|527740068|FG001|Overall Study|Death|0|||
146337253|NCT00538681|527740069|FG002|Overall Study|Death|1|||
146337254|NCT00538681|527740070|FG003|Overall Study|Death|1|||
146337255|NCT00538681|527740067|FG000|Overall Study|Investigator Decision|0|||
146337256|NCT00538681|527740068|FG001|Overall Study|Investigator Decision|0|||
146337257|NCT00538681|527740069|FG002|Overall Study|Investigator Decision|0|||
146337258|NCT00538681|527740070|FG003|Overall Study|Investigator Decision|1|||
146337259|NCT00628355|527740073|FG000|Overall Study|Withdrawal by Subject|1|||
146337260|NCT00628355|527740074|FG001|Overall Study|Withdrawal by Subject|1|||
146337261|NCT00140855|527740075|FG000|Overall Study|Progressive disease|2|||
146337262|NCT03430310|527740079|FG000|Overall Study|Protocol Violation|2|||
146337263|NCT03430310|527740080|FG001|Overall Study|Protocol Violation|0|||
146337264|NCT03430310|527740079|FG000|Overall Study|Withdrawal by Subject|3|||
146337265|NCT03430310|527740080|FG001|Overall Study|Withdrawal by Subject|2|||
146337266|NCT03430310|527740079|FG000|Overall Study|COVID shutdown March 2020|0|||
146337267|NCT03430310|527740080|FG001|Overall Study|COVID shutdown March 2020|1|||
146337268|NCT01446809|527740081|FG000|Overall Study|Adverse Event|0|||
146337269|NCT01446809|527740082|FG001|Overall Study|Adverse Event|0|||
146337270|NCT01446809|527740083|FG002|Overall Study|Adverse Event|1|||
146337271|NCT01446809|527740081|FG000|Overall Study|Failure to complete study procedures|0|||
146337272|NCT01446809|527740082|FG001|Overall Study|Failure to complete study procedures|0|||
146337273|NCT01446809|527740083|FG002|Overall Study|Failure to complete study procedures|1|||
146337274|NCT01331161|527740084|FG000|Overall Study|Physician Decision|1|||
146337275|NCT01331161|527740085|FG001|Overall Study|Physician Decision|0|||
146337276|NCT01331161|527740084|FG000|Overall Study|Lost to Follow-up|0|||
146337277|NCT01331161|527740085|FG001|Overall Study|Lost to Follow-up|1|||
146337278|NCT01331161|527740084|FG000|Overall Study|Pregnancy|0|||
146337279|NCT01331161|527740085|FG001|Overall Study|Pregnancy|1|||
146337280|NCT04865731|527740086|FG000|Overall Study|Physician Decision|2|||
146337281|NCT04865731|527740087|FG001|Overall Study|Physician Decision|1|||
146337282|NCT04865731|527740086|FG000|Overall Study|Adverse Event|1|||
146337283|NCT04865731|527740087|FG001|Overall Study|Adverse Event|0|||
146337284|NCT04865731|527740086|FG000|Overall Study|Withdrawal by Subject|0|||
146337285|NCT04865731|527740087|FG001|Overall Study|Withdrawal by Subject|1|||
146337286|NCT02581995|527740088|FG000|Overall Study|Unspecified other|3|||
146337287|NCT02581995|527740088|FG000|Overall Study|Adverse Event|6|||
146337288|NCT02581995|527740088|FG000|Overall Study|Lost to Follow-up|5|||
146337289|NCT02581995|527740088|FG000|Overall Study|Withdrawal by participant|12|||
146337290|NCT02581995|527740088|FG000|Overall Study|Physician Decision|1|||
146337291|NCT02581995|527740088|FG000|Overall Study|Death|4|||
146337292|NCT00886821|527742011|FG000|Stage 2|Adverse Event|0|||
146337293|NCT00886821|527742012|FG001|Stage 2|Adverse Event|0|||
146337294|NCT00886821|527742013|FG002|Stage 2|Adverse Event|0|||
146337295|NCT00886821|527742014|FG003|Stage 2|Adverse Event|0|||
146337296|NCT00886821|527742015|FG004|Stage 2|Adverse Event|0|||
146337297|NCT00886821|527742016|FG005|Stage 2|Adverse Event|0|||
146337298|NCT00886821|527742017|FG006|Stage 2|Adverse Event|0|||
146337299|NCT00886821|527742018|FG007|Stage 2|Adverse Event|0|||
146337300|NCT00886821|527742019|FG008|Stage 2|Adverse Event|0|||
146337301|NCT00886821|527742020|FG009|Stage 2|Adverse Event|0|||
146337302|NCT00886821|527742021|FG010|Stage 2|Adverse Event|0|||
146337303|NCT00886821|527742022|FG011|Stage 2|Adverse Event|1|||
146337304|NCT00886821|527742023|FG012|Stage 2|Adverse Event|3|||
146337305|NCT00886821|527742024|FG013|Stage 2|Adverse Event|0|||
146337306|NCT00886821|527742011|FG000|Stage 2|Lost to Follow-up|0|||
146337307|NCT00886821|527742012|FG001|Stage 2|Lost to Follow-up|0|||
146337308|NCT00886821|527742013|FG002|Stage 2|Lost to Follow-up|0|||
146337309|NCT00886821|527742014|FG003|Stage 2|Lost to Follow-up|0|||
146337310|NCT00886821|527742015|FG004|Stage 2|Lost to Follow-up|0|||
146337311|NCT00886821|527742016|FG005|Stage 2|Lost to Follow-up|0|||
146337312|NCT00886821|527742017|FG006|Stage 2|Lost to Follow-up|0|||
146337313|NCT00886821|527742018|FG007|Stage 2|Lost to Follow-up|0|||
146169062|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
146337314|NCT00886821|527742019|FG008|Stage 2|Lost to Follow-up|0|||
146337315|NCT00886821|527742020|FG009|Stage 2|Lost to Follow-up|0|||
146337316|NCT00886821|527742021|FG010|Stage 2|Lost to Follow-up|0|||
146337317|NCT00886821|527742022|FG011|Stage 2|Lost to Follow-up|0|||
146337318|NCT00886821|527742023|FG012|Stage 2|Lost to Follow-up|2|||
146337319|NCT00886821|527742024|FG013|Stage 2|Lost to Follow-up|1|||
146337320|NCT00698516|527742025|FG000|Overall Study|Study Termination|2|||
146337321|NCT00698516|527742025|FG000|Overall Study|Withdrawal by Subject|3|||
146337322|NCT01931865|527742029|FG000|Overall Study|Lost to Follow-up|2|||
146337323|NCT01931865|527742029|FG000|Overall Study|Withdrawal by Subject|2|||
146337324|NCT03215277|527742033|FG000|Overall Study|Adverse Event|2|||
146337325|NCT03215277|527742034|FG001|Overall Study|Adverse Event|3|||
146337326|NCT03215277|527742033|FG000|Overall Study|Death|1|||
146337327|NCT03215277|527742034|FG001|Overall Study|Death|0|||
146337328|NCT03215277|527742033|FG000|Overall Study|Lost to Follow-up|0|||
146337329|NCT03215277|527742034|FG001|Overall Study|Lost to Follow-up|1|||
146337330|NCT03215277|527742033|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
146337331|NCT03215277|527742034|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
146337332|NCT02835495|527742039|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
146337333|NCT02835495|527742040|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
146337334|NCT02835495|527742039|FG000|Overall Study|Declined in-person follow-up visit|4|||
146337335|NCT02835495|527742040|FG001|Overall Study|Declined in-person follow-up visit|2|||
146337336|NCT00356915|527742042|FG000|Overall Study|Non compliance|1|||
146337337|NCT00356915|527742043|FG001|Overall Study|Non compliance|2|||
146337338|NCT00356915|527742044|FG002|Overall Study|Non compliance|1|||
146337339|NCT00356915|527742042|FG000|Overall Study|Protocol Violation|2|||
146337340|NCT00356915|527742043|FG001|Overall Study|Protocol Violation|3|||
146337341|NCT00356915|527742044|FG002|Overall Study|Protocol Violation|2|||
146337342|NCT00356915|527742042|FG000|Overall Study|Withdrawal by Subject|14|||
146337343|NCT00356915|527742043|FG001|Overall Study|Withdrawal by Subject|14|||
146337344|NCT00356915|527742044|FG002|Overall Study|Withdrawal by Subject|10|||
146337345|NCT00356915|527742042|FG000|Overall Study|Lack of Efficacy|0|||
146337346|NCT00356915|527742043|FG001|Overall Study|Lack of Efficacy|0|||
146337347|NCT00356915|527742044|FG002|Overall Study|Lack of Efficacy|3|||
146337348|NCT00356915|527742042|FG000|Overall Study|Lost to Follow-up|27|||
146337349|NCT00356915|527742043|FG001|Overall Study|Lost to Follow-up|34|||
146337350|NCT00356915|527742044|FG002|Overall Study|Lost to Follow-up|14|||
146337351|NCT00356915|527742042|FG000|Overall Study|Administrative Decision|0|||
146337352|NCT00356915|527742043|FG001|Overall Study|Administrative Decision|0|||
146337353|NCT00356915|527742044|FG002|Overall Study|Administrative Decision|1|||
146337354|NCT00356915|527742042|FG000|Overall Study|Physician Decision|0|||
146337355|NCT00356915|527742043|FG001|Overall Study|Physician Decision|2|||
146337356|NCT00356915|527742044|FG002|Overall Study|Physician Decision|0|||
146337357|NCT00356915|527742042|FG000|Overall Study|Adverse Event|21|||
146337358|NCT00356915|527742043|FG001|Overall Study|Adverse Event|31|||
146337359|NCT00356915|527742044|FG002|Overall Study|Adverse Event|8|||
146337360|NCT00356915|527742042|FG000|Overall Study|Miscellaneous reasons|11|||
146337361|NCT00356915|527742043|FG001|Overall Study|Miscellaneous reasons|8|||
146337362|NCT00356915|527742044|FG002|Overall Study|Miscellaneous reasons|3|||
146337363|NCT00488631|527742045|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
146337364|NCT00488631|527742046|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
146337365|NCT00488631|527742047|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
146337366|NCT00488631|527742048|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
146337367|NCT00488631|527742049|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
146337368|NCT00488631|527742050|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
146337369|NCT00488631|527742051|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
146337370|NCT00488631|527742052|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
146337371|NCT00488631|527742053|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
146337372|NCT00488631|527742054|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
146337373|NCT00488631|527742045|FG000|Double Blind Period (Week 0-54)|Death|0|||
146337374|NCT00488631|527742046|FG001|Double Blind Period (Week 0-54)|Death|0|||
146337375|NCT00488631|527742047|FG002|Double Blind Period (Week 0-54)|Death|0|||
146337376|NCT00488631|527742048|FG003|Double Blind Period (Week 0-54)|Death|0|||
146337377|NCT00488631|527742049|FG004|Double Blind Period (Week 0-54)|Death|0|||
146337378|NCT00488631|527742050|FG005|Double Blind Period (Week 0-54)|Death|1|||
146337379|NCT00488631|527742051|FG006|Double Blind Period (Week 0-54)|Death|0|||
146337380|NCT00488631|527742052|FG007|Double Blind Period (Week 0-54)|Death|0|||
146337381|NCT00488631|527742053|FG008|Double Blind Period (Week 0-54)|Death|0|||
146337382|NCT00488631|527742054|FG009|Double Blind Period (Week 0-54)|Death|0|||
146337383|NCT00488631|527742045|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
146337384|NCT00488631|527742046|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
146337385|NCT00488631|527742047|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
146337386|NCT00488631|527742048|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
146337387|NCT00488631|527742049|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
146337388|NCT00488631|527742050|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
146337389|NCT00488631|527742051|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146337390|NCT00488631|527742052|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146337391|NCT00488631|527742053|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146337392|NCT00488631|527742054|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
146337393|NCT00488631|527742045|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
146337394|NCT00488631|527742046|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
146337395|NCT00488631|527742047|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
146337396|NCT00488631|527742048|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146337397|NCT00488631|527742049|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
146337398|NCT00488631|527742050|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
146337399|NCT00488631|527742051|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146337400|NCT00488631|527742052|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146337401|NCT00488631|527742053|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146337402|NCT00488631|527742054|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
146337403|NCT00488631|527742045|FG000|Double Blind Period (Week 0-54)|Other|6|||
146337404|NCT00488631|527742046|FG001|Double Blind Period (Week 0-54)|Other|12|||
146337405|NCT00488631|527742047|FG002|Double Blind Period (Week 0-54)|Other|10|||
146337406|NCT00488631|527742048|FG003|Double Blind Period (Week 0-54)|Other|11|||
146337407|NCT00488631|527742049|FG004|Double Blind Period (Week 0-54)|Other|14|||
146337408|NCT00488631|527742050|FG005|Double Blind Period (Week 0-54)|Other|34|||
146337409|NCT00488631|527742051|FG006|Double Blind Period (Week 0-54)|Other|0|||
146337410|NCT00488631|527742052|FG007|Double Blind Period (Week 0-54)|Other|0|||
146337411|NCT00488631|527742053|FG008|Double Blind Period (Week 0-54)|Other|0|||
146337412|NCT00488631|527742054|FG009|Double Blind Period (Week 0-54)|Other|0|||
146337413|NCT00488631|527742045|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337414|NCT00488631|527742046|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337415|NCT00488631|527742047|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337416|NCT00488631|527742048|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337417|NCT00488631|527742049|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337418|NCT00488631|527742050|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337419|NCT00488631|527742051|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
146337420|NCT00488631|527742052|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
146337421|NCT00488631|527742053|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
146337422|NCT00488631|527742054|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
146337423|NCT00488631|527742045|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
146337424|NCT00488631|527742046|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
146337425|NCT00488631|527742047|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
146337426|NCT00488631|527742048|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
146337427|NCT00488631|527742049|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
146337428|NCT00488631|527742050|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
146337429|NCT00488631|527742051|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
146337430|NCT00488631|527742052|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
146337431|NCT00488631|527742053|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
146337432|NCT00488631|527742054|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
146337433|NCT00488631|527742045|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337434|NCT00488631|527742046|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337435|NCT00488631|527742047|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337436|NCT00488631|527742048|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337437|NCT00488631|527742049|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337438|NCT00488631|527742050|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
146337439|NCT00488631|527742051|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
146337440|NCT00488631|527742052|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
146337441|NCT00488631|527742053|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
146337442|NCT00488631|527742054|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
146337443|NCT00488631|527742045|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337444|NCT00488631|527742046|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337445|NCT00488631|527742047|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337446|NCT00488631|527742048|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337447|NCT00488631|527742049|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337448|NCT00488631|527742050|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337449|NCT00488631|527742051|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
146337450|NCT00488631|527742052|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337451|NCT00488631|527742053|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
146337452|NCT00488631|527742054|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
146337453|NCT00488631|527742045|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337454|NCT00488631|527742046|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337455|NCT00488631|527742047|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337456|NCT00488631|527742048|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337457|NCT00488631|527742049|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337458|NCT00488631|527742050|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337459|NCT00488631|527742051|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
146337460|NCT00488631|527742052|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
146396141|NCT01241591|527954455|FG003|Overall Study|Screen Failure|0|||
145943280|NCT02326298|526300474|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146337461|NCT00488631|527742053|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
146337462|NCT00488631|527742054|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
146337463|NCT05421754|527742055|FG000|Overall Study|Technical issue with sensor|1|||
146337464|NCT01772134|527742060|FG000|Overall Study|Adverse Event|6|||
146337465|NCT01772134|527742061|FG001|Overall Study|Adverse Event|5|||
146337466|NCT01772134|527742062|FG002|Overall Study|Adverse Event|10|||
146337467|NCT01772134|527742060|FG000|Overall Study|Withdrew Consent|3|||
146337468|NCT01772134|527742061|FG001|Overall Study|Withdrew Consent|1|||
146337469|NCT01772134|527742062|FG002|Overall Study|Withdrew Consent|5|||
146337470|NCT01772134|527742060|FG000|Overall Study|Lost to Follow-up|2|||
146337471|NCT01772134|527742061|FG001|Overall Study|Lost to Follow-up|0|||
146337472|NCT01772134|527742062|FG002|Overall Study|Lost to Follow-up|0|||
146337473|NCT01772134|527742060|FG000|Overall Study|Protocol Deviation|4|||
146337474|NCT01772134|527742061|FG001|Overall Study|Protocol Deviation|3|||
146337475|NCT01772134|527742062|FG002|Overall Study|Protocol Deviation|3|||
146337476|NCT01772134|527742060|FG000|Overall Study|Lack of Efficacy|11|||
146337477|NCT01772134|527742061|FG001|Overall Study|Lack of Efficacy|5|||
146337478|NCT01772134|527742062|FG002|Overall Study|Lack of Efficacy|3|||
146337479|NCT01772134|527742060|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
146337480|NCT01772134|527742061|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
146337481|NCT01772134|527742062|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
146337482|NCT01772134|527742060|FG000|Overall Study|Randomized Study Medication Not Received|2|||
146337483|NCT01772134|527742061|FG001|Overall Study|Randomized Study Medication Not Received|0|||
146337484|NCT01772134|527742062|FG002|Overall Study|Randomized Study Medication Not Received|1|||
146337485|NCT02500550|527742063|FG000|Overall Study|Death|7|||
146337486|NCT02604264|527742069|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
146337487|NCT02604264|527742070|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
146337488|NCT03192904|527742071|FG000|Overall Study|Physician Decision|3|||
146337489|NCT03192904|527742072|FG001|Overall Study|Physician Decision|1|||
146337490|NCT03192904|527742071|FG000|Overall Study|Lost to Follow-up|0|||
146337491|NCT03192904|527742072|FG001|Overall Study|Lost to Follow-up|1|||
146337492|NCT01023789|527742073|FG000|3 - Year Visit|Death|29|||
146337493|NCT01023789|527742073|FG000|3 - Year Visit|Withdrawal of consent|1|||
146337494|NCT01023789|527742073|FG000|3 - Year Visit|Lost to Follow-up|13|||
146337495|NCT02034123|527742077|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337496|NCT02034123|527742078|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337497|NCT02034123|527742079|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337498|NCT02034123|527742080|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337499|NCT02034123|527742081|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146337500|NCT02034123|527742082|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337501|NCT02034123|527742083|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337502|NCT02034123|527742084|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146337503|NCT02034123|527742085|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
146337504|NCT02034123|527742086|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337505|NCT02034123|527742087|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337506|NCT02034123|527742088|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337507|NCT02034123|527742089|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337508|NCT02034123|527742090|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337509|NCT02034123|527742091|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337510|NCT02034123|527742092|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337511|NCT02034123|527742093|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337512|NCT02034123|527742094|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
146337513|NCT02034123|527742077|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337514|NCT02034123|527742078|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337515|NCT02034123|527742079|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337516|NCT02034123|527742080|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
146337517|NCT02034123|527742081|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337518|NCT02034123|527742082|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337519|NCT02034123|527742083|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337520|NCT02034123|527742084|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337521|NCT02034123|527742085|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337522|NCT02034123|527742086|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337523|NCT02034123|527742087|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337524|NCT02034123|527742088|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337525|NCT02034123|527742089|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337526|NCT02034123|527742090|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337527|NCT02034123|527742091|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337528|NCT02034123|527742092|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337529|NCT02034123|527742093|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337530|NCT02034123|527742094|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
146337531|NCT02034123|527742077|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337532|NCT02034123|527742078|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337533|NCT02034123|527742079|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337534|NCT02034123|527742080|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337535|NCT02034123|527742081|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337536|NCT02034123|527742082|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337537|NCT02034123|527742083|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337538|NCT02034123|527742084|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337539|NCT02034123|527742085|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
146337540|NCT02034123|527742086|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337541|NCT02034123|527742087|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337542|NCT02034123|527742088|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337543|NCT02034123|527742089|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337544|NCT02034123|527742090|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337545|NCT02034123|527742091|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337546|NCT02034123|527742092|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337547|NCT02034123|527742093|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337548|NCT02034123|527742094|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
146337549|NCT02034123|527742077|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337550|NCT02034123|527742078|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337551|NCT02034123|527742079|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337552|NCT02034123|527742080|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
146337553|NCT02034123|527742081|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
146337554|NCT02034123|527742082|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337555|NCT02034123|527742083|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337556|NCT02034123|527742084|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337557|NCT02034123|527742085|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337558|NCT02034123|527742086|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337559|NCT02034123|527742087|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337560|NCT02034123|527742088|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337561|NCT02034123|527742089|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337562|NCT02034123|527742090|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337563|NCT02034123|527742091|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337564|NCT02034123|527742092|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337565|NCT02034123|527742093|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337566|NCT02034123|527742094|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
146337567|NCT00246259|527742095|FG000|Overall Study|Other|3|||
146337568|NCT00246259|527742096|FG001|Overall Study|Other|3|||
146337569|NCT00246259|527742095|FG000|Overall Study|Not stable by Week 18|2|||
146337570|NCT00246259|527742096|FG001|Overall Study|Not stable by Week 18|1|||
146337571|NCT00246259|527742095|FG000|Overall Study|Participant non-compliant|4|||
146337572|NCT00246259|527742096|FG001|Overall Study|Participant non-compliant|9|||
146337573|NCT00246259|527742095|FG000|Overall Study|Lack of Efficacy|2|||
146337574|NCT00246259|527742096|FG001|Overall Study|Lack of Efficacy|2|||
146337575|NCT00246259|527742095|FG000|Overall Study|Investigator withdrew participant|2|||
146337576|NCT00246259|527742096|FG001|Overall Study|Investigator withdrew participant|0|||
146337577|NCT00246259|527742095|FG000|Overall Study|Adverse Event|5|||
146337578|NCT00246259|527742096|FG001|Overall Study|Adverse Event|0|||
146337579|NCT00246259|527742095|FG000|Overall Study|Lost to Follow-up|3|||
146337580|NCT00246259|527742096|FG001|Overall Study|Lost to Follow-up|4|||
146337581|NCT00246259|527742095|FG000|Overall Study|Withdrawal by Subject|5|||
146337582|NCT00246259|527742096|FG001|Overall Study|Withdrawal by Subject|1|||
146337583|NCT00246259|527742095|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
146337584|NCT00246259|527742096|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
146337585|NCT03301857|527742097|FG000|Overall Study|Death|0|||
146337586|NCT03301857|527742098|FG001|Overall Study|Death|2|||
146337587|NCT03301857|527742097|FG000|Overall Study|Lost to Follow-up|4|||
146337588|NCT03301857|527742098|FG001|Overall Study|Lost to Follow-up|2|||
146337589|NCT03301857|527742097|FG000|Overall Study|Decision by Sponsor|6|||
146337590|NCT03301857|527742098|FG001|Overall Study|Decision by Sponsor|0|||
146337591|NCT03301857|527742097|FG000|Overall Study|Withdrawal by Subject|12|||
146337592|NCT03301857|527742098|FG001|Overall Study|Withdrawal by Subject|4|||
146337593|NCT00855439|527742103|FG000|Overall Study|Withdrawal by Subject|2|||
146169063|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
146169064|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
146337594|NCT00855439|527742104|FG001|Overall Study|Withdrawal by Subject|0|||
146337595|NCT00855439|527742103|FG000|Overall Study|Pregnancy|1|||
146337596|NCT00855439|527742104|FG001|Overall Study|Pregnancy|0|||
146337597|NCT02333227|527742110|FG000|Overall Study|Lost to Follow-up|137|||
146337598|NCT02333227|527742111|FG001|Overall Study|Lost to Follow-up|106|||
146337599|NCT02333227|527742110|FG000|Overall Study|Pregnancy Interrupted|42|||
146337600|NCT02333227|527742111|FG001|Overall Study|Pregnancy Interrupted|89|||
146337601|NCT02333227|527742110|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
146337602|NCT02333227|527742111|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
146337603|NCT01982630|527742112|FG000|Overall Study|Adverse Event|2|||
146337604|NCT01982630|527742113|FG001|Overall Study|Adverse Event|0|||
146337605|NCT01982630|527742114|FG002|Overall Study|Adverse Event|1|||
146337606|NCT01982630|527742115|FG003|Overall Study|Adverse Event|0|||
146337607|NCT01982630|527742116|FG004|Overall Study|Adverse Event|1|||
146337608|NCT01982630|527742117|FG005|Overall Study|Adverse Event|2|||
146337609|NCT01982630|527742118|FG006|Overall Study|Adverse Event|1|||
146337610|NCT01982630|527742119|FG007|Overall Study|Adverse Event|0|||
146337611|NCT01982630|527742112|FG000|Overall Study|Physician Decision|1|||
146337612|NCT01982630|527742113|FG001|Overall Study|Physician Decision|0|||
146337613|NCT01982630|527742114|FG002|Overall Study|Physician Decision|2|||
146337614|NCT01982630|527742115|FG003|Overall Study|Physician Decision|1|||
146337615|NCT01982630|527742116|FG004|Overall Study|Physician Decision|2|||
146337616|NCT01982630|527742117|FG005|Overall Study|Physician Decision|0|||
146337617|NCT01982630|527742118|FG006|Overall Study|Physician Decision|0|||
146337618|NCT01982630|527742119|FG007|Overall Study|Physician Decision|0|||
146337619|NCT01982630|527742112|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337620|NCT01982630|527742113|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337621|NCT01982630|527742114|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
146337622|NCT01982630|527742115|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337623|NCT01982630|527742116|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337624|NCT01982630|527742117|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337625|NCT01982630|527742118|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337626|NCT01982630|527742119|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
146337627|NCT01982630|527742112|FG000|Overall Study|Withdrawal by Subject|0|||
146337628|NCT01982630|527742113|FG001|Overall Study|Withdrawal by Subject|0|||
146337629|NCT01982630|527742114|FG002|Overall Study|Withdrawal by Subject|0|||
146337630|NCT01982630|527742115|FG003|Overall Study|Withdrawal by Subject|0|||
146337631|NCT01982630|527742116|FG004|Overall Study|Withdrawal by Subject|0|||
146337632|NCT01982630|527742117|FG005|Overall Study|Withdrawal by Subject|1|||
146337633|NCT01982630|527742118|FG006|Overall Study|Withdrawal by Subject|0|||
146337634|NCT01982630|527742119|FG007|Overall Study|Withdrawal by Subject|0|||
146337635|NCT00561353|527742120|FG000|Overall Study|Subject reached a virologic endpoint|2|||
146337636|NCT00561353|527742121|FG001|Overall Study|Subject reached a virologic endpoint|1|||
146337637|NCT00561353|527742122|FG002|Overall Study|Subject reached a virologic endpoint|1|||
146337638|NCT00561353|527742123|FG003|Overall Study|Subject reached a virologic endpoint|4|||
146337639|NCT00561353|527742124|FG004|Overall Study|Subject reached a virologic endpoint|1|||
146337640|NCT00561353|527742125|FG005|Overall Study|Subject reached a virologic endpoint|3|||
146337641|NCT00561353|527742126|FG006|Overall Study|Subject reached a virologic endpoint|4|||
146337642|NCT00561353|527742127|FG007|Overall Study|Subject reached a virologic endpoint|4|||
146337643|NCT00561353|527742128|FG008|Overall Study|Subject reached a virologic endpoint|5|||
146337644|NCT00561353|527742129|FG009|Overall Study|Subject reached a virologic endpoint|0|||
146337645|NCT00561353|527742120|FG000|Overall Study|Subject ineligible to continue the trial|0|||
146337646|NCT00561353|527742121|FG001|Overall Study|Subject ineligible to continue the trial|0|||
146337647|NCT00561353|527742122|FG002|Overall Study|Subject ineligible to continue the trial|0|||
146337648|NCT00561353|527742123|FG003|Overall Study|Subject ineligible to continue the trial|0|||
146337649|NCT00561353|527742124|FG004|Overall Study|Subject ineligible to continue the trial|0|||
146337650|NCT00561353|527742125|FG005|Overall Study|Subject ineligible to continue the trial|1|||
146337651|NCT00561353|527742126|FG006|Overall Study|Subject ineligible to continue the trial|1|||
146337652|NCT00561353|527742127|FG007|Overall Study|Subject ineligible to continue the trial|0|||
146337653|NCT00561353|527742128|FG008|Overall Study|Subject ineligible to continue the trial|2|||
146337654|NCT00561353|527742129|FG009|Overall Study|Subject ineligible to continue the trial|1|||
146337655|NCT00561353|527742120|FG000|Overall Study|Other|1|||
146337656|NCT00561353|527742121|FG001|Overall Study|Other|0|||
146337657|NCT00561353|527742122|FG002|Overall Study|Other|1|||
146337658|NCT00561353|527742123|FG003|Overall Study|Other|0|||
146337659|NCT00561353|527742124|FG004|Overall Study|Other|0|||
146337660|NCT00561353|527742125|FG005|Overall Study|Other|2|||
145943281|NCT02326298|526300475|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146337661|NCT00561353|527742126|FG006|Overall Study|Other|0|||
146337662|NCT00561353|527742127|FG007|Overall Study|Other|0|||
146337663|NCT00561353|527742128|FG008|Overall Study|Other|0|||
146337664|NCT00561353|527742129|FG009|Overall Study|Other|0|||
146337665|NCT00561353|527742120|FG000|Overall Study|Adverse Event|0|||
146337666|NCT00561353|527742121|FG001|Overall Study|Adverse Event|0|||
146337667|NCT00561353|527742122|FG002|Overall Study|Adverse Event|0|||
146337668|NCT00561353|527742123|FG003|Overall Study|Adverse Event|2|||
146337669|NCT00561353|527742124|FG004|Overall Study|Adverse Event|0|||
146337670|NCT00561353|527742125|FG005|Overall Study|Adverse Event|0|||
146337671|NCT00561353|527742126|FG006|Overall Study|Adverse Event|1|||
146337672|NCT00561353|527742127|FG007|Overall Study|Adverse Event|0|||
146337673|NCT00561353|527742128|FG008|Overall Study|Adverse Event|0|||
146337674|NCT00561353|527742129|FG009|Overall Study|Adverse Event|1|||
146337675|NCT00561353|527742120|FG000|Overall Study|Lost to Follow-up|2|||
146337676|NCT00561353|527742121|FG001|Overall Study|Lost to Follow-up|0|||
146337677|NCT00561353|527742122|FG002|Overall Study|Lost to Follow-up|1|||
146337678|NCT00561353|527742123|FG003|Overall Study|Lost to Follow-up|0|||
146337679|NCT00561353|527742124|FG004|Overall Study|Lost to Follow-up|0|||
146337680|NCT00561353|527742125|FG005|Overall Study|Lost to Follow-up|0|||
146337681|NCT00561353|527742126|FG006|Overall Study|Lost to Follow-up|0|||
146337682|NCT00561353|527742127|FG007|Overall Study|Lost to Follow-up|0|||
146337683|NCT00561353|527742128|FG008|Overall Study|Lost to Follow-up|0|||
146337684|NCT00561353|527742129|FG009|Overall Study|Lost to Follow-up|0|||
146337685|NCT00561353|527742120|FG000|Overall Study|Withdrawal by Subject|0|||
146337686|NCT00561353|527742121|FG001|Overall Study|Withdrawal by Subject|2|||
146337687|NCT00561353|527742122|FG002|Overall Study|Withdrawal by Subject|0|||
146337688|NCT00561353|527742123|FG003|Overall Study|Withdrawal by Subject|0|||
146337689|NCT00561353|527742124|FG004|Overall Study|Withdrawal by Subject|0|||
146337690|NCT00561353|527742125|FG005|Overall Study|Withdrawal by Subject|0|||
146337691|NCT00561353|527742126|FG006|Overall Study|Withdrawal by Subject|0|||
146337692|NCT00561353|527742127|FG007|Overall Study|Withdrawal by Subject|0|||
146337693|NCT00561353|527742128|FG008|Overall Study|Withdrawal by Subject|0|||
146337694|NCT00561353|527742129|FG009|Overall Study|Withdrawal by Subject|0|||
146337695|NCT01273818|527742130|FG000|Overall Study|Physician Decision|13|||
146337696|NCT01273818|527742131|FG001|Overall Study|Physician Decision|2|||
146337697|NCT01273818|527742132|FG002|Overall Study|Physician Decision|9|||
146337698|NCT03934684|527742133|FG000|Overall Study|Participants continuing in study|11|||
146337699|NCT03934684|527742134|FG001|Overall Study|Participants continuing in study|4|||
146337700|NCT03934684|527742133|FG000|Overall Study|Discontinuation of carfilzomib|20|||
146337701|NCT03934684|527742134|FG001|Overall Study|Discontinuation of carfilzomib|30|||
146337702|NCT03934684|527742133|FG000|Overall Study|Death|2|||
146337703|NCT03934684|527742134|FG001|Overall Study|Death|2|||
146337704|NCT03934684|527742133|FG000|Overall Study|Lost to Follow-up|2|||
146337705|NCT03934684|527742134|FG001|Overall Study|Lost to Follow-up|5|||
146337706|NCT03934684|527742133|FG000|Overall Study|Withdrawal by Subject|7|||
146337707|NCT03934684|527742134|FG001|Overall Study|Withdrawal by Subject|8|||
146337708|NCT05300087|527742135|FG000|Overall Study|Withdrawal by Subject|0|||
146337709|NCT05300087|527742136|FG001|Overall Study|Withdrawal by Subject|1|||
146337710|NCT05662332|527742137|FG000|Overall Study|Death|3|||
146337711|NCT05662332|527742138|FG001|Overall Study|Death|3|||
146337712|NCT05662332|527742137|FG000|Overall Study|Lost to Follow-up|3|||
146337713|NCT05662332|527742138|FG001|Overall Study|Lost to Follow-up|8|||
146337714|NCT05662332|527742137|FG000|Overall Study|Physician Decision|1|||
146337715|NCT05662332|527742138|FG001|Overall Study|Physician Decision|2|||
146337716|NCT05662332|527742137|FG000|Overall Study|Protocol Deviation|2|||
146337717|NCT05662332|527742138|FG001|Overall Study|Protocol Deviation|1|||
146337718|NCT05662332|527742137|FG000|Overall Study|Withdrawal by Subject|14|||
146337719|NCT05662332|527742138|FG001|Overall Study|Withdrawal by Subject|14|||
146337720|NCT05662332|527742137|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146337721|NCT05662332|527742138|FG001|Overall Study|Assigned Treatment by Mistake|7|||
146337722|NCT05662332|527742137|FG000|Overall Study|Non-compliance with study drug|4|||
146337723|NCT05662332|527742138|FG001|Overall Study|Non-compliance with study drug|1|||
146337724|NCT05662332|527742137|FG000|Overall Study|Due to Bariatric surgery|1|||
146337725|NCT05662332|527742138|FG001|Overall Study|Due to Bariatric surgery|0|||
146337726|NCT05662332|527742137|FG000|Overall Study|Subject Moving out of State|0|||
146337727|NCT05662332|527742138|FG001|Overall Study|Subject Moving out of State|1|||
146337728|NCT05662332|527742137|FG000|Overall Study|Subject Missed the Schedule|1|||
146337729|NCT05662332|527742138|FG001|Overall Study|Subject Missed the Schedule|0|||
146337730|NCT05662332|527742137|FG000|Overall Study|The Patient Moved to Another City|1|||
146337731|NCT05662332|527742138|FG001|Overall Study|The Patient Moved to Another City|0|||
146337732|NCT05369806|527742142|FG000|Overall Study|Lost to Follow-up|1|||
146337733|NCT03542682|527742144|FG000|Overall Study|COVID-19 Protocol|0|||
146337734|NCT03542682|527742145|FG001|Overall Study|COVID-19 Protocol|1|||
146337735|NCT04321343|527742147|FG000|Overall Study|Adverse Event|0|||
146337736|NCT04321343|527742148|FG001|Overall Study|Adverse Event|0|||
146337737|NCT04321343|527742149|FG002|Overall Study|Adverse Event|1|||
146337738|NCT04321343|527742150|FG003|Overall Study|Adverse Event|0|||
146337739|NCT04321343|527742147|FG000|Overall Study|Death|0|||
146337740|NCT04321343|527742148|FG001|Overall Study|Death|0|||
146337741|NCT04321343|527742149|FG002|Overall Study|Death|0|||
146337742|NCT04321343|527742150|FG003|Overall Study|Death|1|||
146337743|NCT04321343|527742147|FG000|Overall Study|Pregnancy|1|||
146337744|NCT04321343|527742148|FG001|Overall Study|Pregnancy|0|||
146337745|NCT04321343|527742149|FG002|Overall Study|Pregnancy|0|||
146337746|NCT04321343|527742150|FG003|Overall Study|Pregnancy|0|||
146337747|NCT04321343|527742147|FG000|Overall Study|Protocol Violation|1|||
146337748|NCT04321343|527742148|FG001|Overall Study|Protocol Violation|1|||
146337749|NCT04321343|527742149|FG002|Overall Study|Protocol Violation|1|||
146337750|NCT04321343|527742150|FG003|Overall Study|Protocol Violation|1|||
146337751|NCT04321343|527742147|FG000|Overall Study|Withdrawal by Subject|0|||
146337752|NCT04321343|527742148|FG001|Overall Study|Withdrawal by Subject|6|||
146337753|NCT04321343|527742149|FG002|Overall Study|Withdrawal by Subject|0|||
146337754|NCT04321343|527742150|FG003|Overall Study|Withdrawal by Subject|2|||
146337755|NCT04321343|527742147|FG000|Overall Study|Lost to Follow-up|2|||
146337756|NCT04321343|527742148|FG001|Overall Study|Lost to Follow-up|2|||
146337757|NCT04321343|527742149|FG002|Overall Study|Lost to Follow-up|1|||
146337758|NCT04321343|527742150|FG003|Overall Study|Lost to Follow-up|3|||
146337759|NCT01097044|527742155|FG000|Overall Study|Withdrawal by Subject|4|||
146337760|NCT01097044|527742156|FG001|Overall Study|Withdrawal by Subject|4|||
146337761|NCT01097044|527742155|FG000|Overall Study|Lost to Follow-up|1|||
146337762|NCT01097044|527742156|FG001|Overall Study|Lost to Follow-up|0|||
146337763|NCT01097044|527742155|FG000|Overall Study|Withdrawal by Sponsor|0|||
146337764|NCT01097044|527742156|FG001|Overall Study|Withdrawal by Sponsor|1|||
146337765|NCT01682044|527742160|FG000|Overall Study|Death|1|||
146337766|NCT01682044|527742160|FG000|Overall Study|Progression|3|||
146337767|NCT03232073|527742169|FG000|Overall Study|Death|1|||
146337768|NCT03232073|527742170|FG001|Overall Study|Death|0|||
146337769|NCT03232073|527742169|FG000|Overall Study|Adverse Event|7|||
146337770|NCT03232073|527742170|FG001|Overall Study|Adverse Event|12|||
146337771|NCT03232073|527742169|FG000|Overall Study|Lost to Follow-up|6|||
146337772|NCT03232073|527742170|FG001|Overall Study|Lost to Follow-up|6|||
146337773|NCT03232073|527742169|FG000|Overall Study|Lack of Efficacy|10|||
146337774|NCT03232073|527742170|FG001|Overall Study|Lack of Efficacy|8|||
146337775|NCT03232073|527742169|FG000|Overall Study|Physician Decision|9|||
146337776|NCT03232073|527742170|FG001|Overall Study|Physician Decision|2|||
146337777|NCT03232073|527742169|FG000|Overall Study|Withdrawal by Subject|54|||
146337778|NCT03232073|527742170|FG001|Overall Study|Withdrawal by Subject|39|||
146337779|NCT01672892|527743438|FG000|Overall Study|Protocol Violation|7|||
146337780|NCT01672892|527743439|FG001|Overall Study|Protocol Violation|3|||
146337781|NCT03528681|527743452|FG000|Open-Label Phase|Physician Decision|2|||
146337782|NCT03528681|527743453|FG001|Open-Label Phase|Physician Decision|0|||
146337783|NCT03528681|527743454|FG002|Open-Label Phase|Physician Decision|0|||
146337784|NCT03528681|527743455|FG003|Open-Label Phase|Physician Decision|0|||
146337785|NCT03528681|527743452|FG000|Open-Label Phase|Withdrawal by Subject|8|||
146337786|NCT03528681|527743453|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146337787|NCT03528681|527743454|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146337788|NCT03528681|527743455|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146337789|NCT03528681|527743452|FG000|Open-Label Phase|(Not collected)|4|||
146337790|NCT03528681|527743453|FG001|Open-Label Phase|(Not collected)|0|||
146337791|NCT03528681|527743454|FG002|Open-Label Phase|(Not collected)|0|||
146337792|NCT03528681|527743455|FG003|Open-Label Phase|(Not collected)|0|||
146337793|NCT03528681|527743452|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
146337794|NCT03528681|527743453|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
146337795|NCT03528681|527743454|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
146337796|NCT03528681|527743455|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
146337797|NCT03528681|527743452|FG000|Randomized Treatment Phase|Physician Decision|0|||
146337798|NCT03528681|527743453|FG001|Randomized Treatment Phase|Physician Decision|5|||
146337799|NCT03528681|527743454|FG002|Randomized Treatment Phase|Physician Decision|1|||
146337800|NCT03528681|527743455|FG003|Randomized Treatment Phase|Physician Decision|2|||
146337801|NCT03528681|527743452|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
146337802|NCT03528681|527743453|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
146337803|NCT03528681|527743454|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
146337804|NCT03528681|527743455|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
146337805|NCT03528681|527743452|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
146337806|NCT03528681|527743453|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
146337807|NCT03528681|527743454|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
146337808|NCT03528681|527743455|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
146337809|NCT03528681|527743452|FG000|Randomized Treatment Phase|(Not collected)|0|||
146337810|NCT03528681|527743453|FG001|Randomized Treatment Phase|(Not collected)|4|||
146337811|NCT03528681|527743454|FG002|Randomized Treatment Phase|(Not collected)|6|||
146337812|NCT03528681|527743455|FG003|Randomized Treatment Phase|(Not collected)|5|||
146337813|NCT02017444|527743456|FG000|Overall Study|Physician Decision|1|||
146337814|NCT02017444|527743457|FG001|Overall Study|Physician Decision|0|||
146337815|NCT02017444|527743456|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
146337816|NCT02017444|527743457|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
146337817|NCT01614457|527743458|FG000|Overall Study|Non-Compliance|1|||
146337818|NCT01614457|527743459|FG001|Overall Study|Non-Compliance|0|||
146337819|NCT01614457|527743458|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
146337820|NCT01614457|527743459|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
146337821|NCT02342171|527743461|FG000|Overall Study|Death|4|||
146337822|NCT02342171|527743462|FG001|Overall Study|Death|87|||
146337823|NCT02342171|527743461|FG000|Overall Study|Received favipiravir|10|||
146337824|NCT02342171|527743462|FG001|Overall Study|Received favipiravir|0|||
146337825|NCT02342171|527743461|FG000|Overall Study|Missing cycle treshold value|1|||
146337826|NCT02342171|527743462|FG001|Overall Study|Missing cycle treshold value|0|||
146337827|NCT02342171|527743461|FG000|Overall Study|Unknown outcome|0|||
146337828|NCT02342171|527743462|FG001|Overall Study|Unknown outcome|1|||
146337829|NCT02342171|527743461|FG000|Overall Study|Missing age data|0|||
146337830|NCT02342171|527743462|FG001|Overall Study|Missing age data|1|||
146337831|NCT03518840|527743465|FG000|Overall Study|Lost to Follow-up|6|||
146337832|NCT03311126|527743468|FG000|Induction|Death|1|||
146337833|NCT03311126|527743468|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
146337834|NCT00942162|527743469|FG000|Overall Study|Death|45|||
146337835|NCT00942162|527743470|FG001|Overall Study|Death|35|||
146337836|NCT00942162|527743471|FG002|Overall Study|Death|0|||
146337837|NCT00942162|527743469|FG000|Overall Study|Withdrawal by Subject|7|||
146337838|NCT00942162|527743470|FG001|Overall Study|Withdrawal by Subject|2|||
146337839|NCT00942162|527743471|FG002|Overall Study|Withdrawal by Subject|0|||
146337840|NCT00942162|527743469|FG000|Overall Study|Lost to Follow-up|4|||
146337841|NCT00942162|527743470|FG001|Overall Study|Lost to Follow-up|0|||
146337842|NCT00942162|527743471|FG002|Overall Study|Lost to Follow-up|0|||
146337843|NCT00942162|527743469|FG000|Overall Study|Other|14|||
146337844|NCT00942162|527743470|FG001|Overall Study|Other|13|||
146337845|NCT00942162|527743471|FG002|Overall Study|Other|2|||
146337846|NCT03368859|527743472|FG000|Overall Study|Withdrew Consent|5|||
146337847|NCT03368859|527743473|FG001|Overall Study|Withdrew Consent|4|||
146337848|NCT03368859|527743472|FG000|Overall Study|Death|12|||
146337849|NCT03368859|527743473|FG001|Overall Study|Death|6|||
146337850|NCT03368859|527743472|FG000|Overall Study|Study terminated by Sponsor|18|||
146337851|NCT03368859|527743473|FG001|Overall Study|Study terminated by Sponsor|23|||
146337852|NCT03368859|527743472|FG000|Overall Study|Other|1|||
146337853|NCT03368859|527743473|FG001|Overall Study|Other|1|||
146337854|NCT01713348|527743474|FG000|Overall Study|Withdrawal by Subject|3|||
146337855|NCT01713348|527743475|FG001|Overall Study|Withdrawal by Subject|2|||
146337856|NCT01713348|527743476|FG002|Overall Study|Withdrawal by Subject|2|||
146337857|NCT01713348|527743477|FG003|Overall Study|Withdrawal by Subject|0|||
146337858|NCT01713348|527743474|FG000|Overall Study|Lost to Follow-up|1|||
146337859|NCT01713348|527743475|FG001|Overall Study|Lost to Follow-up|0|||
146337860|NCT01713348|527743476|FG002|Overall Study|Lost to Follow-up|0|||
146337861|NCT01713348|527743477|FG003|Overall Study|Lost to Follow-up|0|||
146337862|NCT00621023|527743478|FG000|Overall Study|Death|5|||
146337863|NCT00621023|527743478|FG000|Overall Study|Follow up discontinued|1|||
146337864|NCT00573131|527743486|FG000|Overall Study|Withdrawal by Subject|10|||
146337865|NCT00573131|527743487|FG001|Overall Study|Withdrawal by Subject|8|||
146337866|NCT03090191|527743488|FG000|Overall Study|Adverse Event|90|||
146337867|NCT03090191|527743489|FG001|Overall Study|Adverse Event|72|||
146337868|NCT03090191|527743488|FG000|Overall Study|Death|365|||
146337869|NCT03090191|527743489|FG001|Overall Study|Death|358|||
146337870|NCT03090191|527743488|FG000|Overall Study|Lost to Follow-up|382|||
146337871|NCT03090191|527743489|FG001|Overall Study|Lost to Follow-up|394|||
146169065|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
146169066|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
146169067|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
146169068|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
146169069|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
146169070|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
146169071|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
146169072|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
146169073|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
146169074|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
146169075|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
146169076|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
146169077|NCT00261495|527131130|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
146169078|NCT00261495|527131131|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
146169079|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
146169080|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
146169081|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
146169082|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
146337872|NCT03090191|527743488|FG000|Overall Study|Physician Decision|77|||
146337873|NCT03090191|527743489|FG001|Overall Study|Physician Decision|66|||
146337874|NCT03090191|527743488|FG000|Overall Study|Protocol Violation|43|||
146337875|NCT03090191|527743489|FG001|Overall Study|Protocol Violation|52|||
146337876|NCT03090191|527743488|FG000|Overall Study|Withdrawal by Subject|2160|||
146337877|NCT03090191|527743489|FG001|Overall Study|Withdrawal by Subject|2133|||
146337878|NCT03090191|527743488|FG000|Overall Study|Site terminated|7|||
146337879|NCT03090191|527743489|FG001|Overall Study|Site terminated|8|||
146337880|NCT03090191|527743488|FG000|Overall Study|Other|66|||
146337881|NCT03090191|527743489|FG001|Overall Study|Other|60|||
146337882|NCT03090191|527743488|FG000|Overall Study|Withdrawn before any study vaccination|43|||
146337883|NCT03090191|527743489|FG001|Overall Study|Withdrawn before any study vaccination|52|||
146337884|NCT00811252|527743500|FG000|Overall Study|Adverse Event|6|||
146337885|NCT00811252|527743501|FG001|Overall Study|Adverse Event|10|||
146337886|NCT00811252|527743502|FG002|Overall Study|Adverse Event|15|||
146337887|NCT00811252|527743500|FG000|Overall Study|Lack of Efficacy|7|||
146337888|NCT00811252|527743501|FG001|Overall Study|Lack of Efficacy|2|||
146337889|NCT00811252|527743502|FG002|Overall Study|Lack of Efficacy|0|||
146337890|NCT00811252|527743500|FG000|Overall Study|Protocol Violation|3|||
146337891|NCT00811252|527743501|FG001|Overall Study|Protocol Violation|3|||
146337892|NCT00811252|527743502|FG002|Overall Study|Protocol Violation|2|||
146337893|NCT00811252|527743500|FG000|Overall Study|Withdrawal of Consent|1|||
146337894|NCT00811252|527743501|FG001|Overall Study|Withdrawal of Consent|2|||
146337895|NCT00811252|527743502|FG002|Overall Study|Withdrawal of Consent|2|||
146337896|NCT00811252|527743500|FG000|Overall Study|Lost to Follow-up|0|||
146337897|NCT00811252|527743501|FG001|Overall Study|Lost to Follow-up|0|||
146337898|NCT00811252|527743502|FG002|Overall Study|Lost to Follow-up|2|||
146337899|NCT00811252|527743500|FG000|Overall Study|Administrative or Other Reasons|0|||
146337900|NCT00811252|527743501|FG001|Overall Study|Administrative or Other Reasons|3|||
146337901|NCT00811252|527743502|FG002|Overall Study|Administrative or Other Reasons|2|||
146337902|NCT00813748|527743504|FG000|Skin Test Substudy|Physician Decision|0|||
146337903|NCT00813748|527743505|FG001|Skin Test Substudy|Physician Decision|1|||
146337904|NCT03185130|527743506|FG000|Overall Study|Withdrawal by Subject|0|||
146337905|NCT03185130|527743507|FG001|Overall Study|Withdrawal by Subject|2|||
146337906|NCT01531725|527743511|FG000|Overall Study|Protocol Violation|5|||
146337907|NCT00472303|527743512|FG000|Titration Phase|Adverse Event|22|||
146337908|NCT00472303|527743513|FG001|Titration Phase|Adverse Event|12|||
146337909|NCT00472303|527743514|FG002|Titration Phase|Adverse Event|0|||
146337910|NCT00472303|527743512|FG000|Titration Phase|Death|4|||
146337911|NCT00472303|527743513|FG001|Titration Phase|Death|2|||
146337912|NCT00472303|527743514|FG002|Titration Phase|Death|0|||
146337913|NCT00472303|527743512|FG000|Titration Phase|Lack of Efficacy|10|||
146337914|NCT00472303|527743513|FG001|Titration Phase|Lack of Efficacy|0|||
146337915|NCT00472303|527743514|FG002|Titration Phase|Lack of Efficacy|0|||
146337916|NCT00472303|527743512|FG000|Titration Phase|Withdrawal by Subject|16|||
146337917|NCT00472303|527743513|FG001|Titration Phase|Withdrawal by Subject|13|||
146337918|NCT00472303|527743514|FG002|Titration Phase|Withdrawal by Subject|0|||
146337919|NCT00472303|527743512|FG000|Titration Phase|Trial Medication non-compliant|4|||
146337920|NCT00472303|527743513|FG001|Titration Phase|Trial Medication non-compliant|1|||
146337921|NCT00472303|527743514|FG002|Titration Phase|Trial Medication non-compliant|0|||
146337922|NCT00472303|527743512|FG000|Titration Phase|Other|3|||
146337923|NCT00472303|527743513|FG001|Titration Phase|Other|1|||
146337924|NCT00472303|527743514|FG002|Titration Phase|Other|0|||
146337925|NCT00472303|527743512|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
146337926|NCT00472303|527743513|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
146337927|NCT00472303|527743514|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
146337928|NCT00472303|527743512|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
146337929|NCT00472303|527743513|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
146337930|NCT00472303|527743514|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
146337931|NCT00472303|527743512|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
146337932|NCT00472303|527743513|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
146337933|NCT00472303|527743514|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
146337934|NCT00472303|527743512|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
146337935|NCT00472303|527743513|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
146337936|NCT00472303|527743514|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
146337937|NCT00472303|527743512|FG000|Discontinuations After Titration Phase|Other|5|||
146337938|NCT00472303|527743513|FG001|Discontinuations After Titration Phase|Other|0|||
146337939|NCT00472303|527743514|FG002|Discontinuations After Titration Phase|Other|0|||
146337940|NCT00472303|527743512|FG000|Maintenance Phase|Adverse Event|5|||
146337941|NCT00472303|527743513|FG001|Maintenance Phase|Adverse Event|6|||
146337942|NCT00472303|527743514|FG002|Maintenance Phase|Adverse Event|6|||
146337943|NCT00472303|527743512|FG000|Maintenance Phase|Death|3|||
146337944|NCT00472303|527743513|FG001|Maintenance Phase|Death|0|||
146337945|NCT00472303|527743514|FG002|Maintenance Phase|Death|2|||
146337946|NCT00472303|527743512|FG000|Maintenance Phase|Lack of Efficacy|2|||
146337947|NCT00472303|527743513|FG001|Maintenance Phase|Lack of Efficacy|2|||
146337948|NCT00472303|527743514|FG002|Maintenance Phase|Lack of Efficacy|4|||
146337949|NCT00472303|527743512|FG000|Maintenance Phase|Withdrawal by Subject|6|||
146337950|NCT00472303|527743513|FG001|Maintenance Phase|Withdrawal by Subject|7|||
146337951|NCT00472303|527743514|FG002|Maintenance Phase|Withdrawal by Subject|3|||
146337952|NCT00472303|527743512|FG000|Maintenance Phase|Trial medication non-compliant|0|||
146337953|NCT00472303|527743513|FG001|Maintenance Phase|Trial medication non-compliant|0|||
146337954|NCT00472303|527743514|FG002|Maintenance Phase|Trial medication non-compliant|1|||
146337955|NCT00472303|527743512|FG000|Maintenance Phase|Resolution of pain|0|||
146337956|NCT00472303|527743513|FG001|Maintenance Phase|Resolution of pain|0|||
146337957|NCT00472303|527743514|FG002|Maintenance Phase|Resolution of pain|1|||
146337958|NCT00472303|527743512|FG000|Maintenance Phase|Other|1|||
146337959|NCT00472303|527743513|FG001|Maintenance Phase|Other|1|||
146337960|NCT00472303|527743514|FG002|Maintenance Phase|Other|0|||
146337961|NCT04112914|527743516|FG000|Overall Study|Lost to Follow-up|13|||
146337962|NCT04112914|527743517|FG001|Overall Study|Lost to Follow-up|9|||
146337963|NCT04112914|527743516|FG000|Overall Study|Withdrawal by Subject|1|||
146337964|NCT04112914|527743517|FG001|Overall Study|Withdrawal by Subject|0|||
146337965|NCT01244737|527743525|FG000|Overall Study|Physician Decision|2|||
146337966|NCT01244737|527743526|FG001|Overall Study|Physician Decision|18|||
146337967|NCT01244737|527743527|FG002|Overall Study|Physician Decision|5|||
146337968|NCT01244737|527743525|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
146337969|NCT01244737|527743526|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
146337970|NCT01244737|527743527|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
146337971|NCT01244737|527743525|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
146337972|NCT01244737|527743526|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
146337973|NCT01244737|527743527|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
146337974|NCT01244737|527743525|FG000|Overall Study|MIB immunopathology results not available|3|||
146337975|NCT01244737|527743526|FG001|Overall Study|MIB immunopathology results not available|2|||
146337976|NCT01244737|527743527|FG002|Overall Study|MIB immunopathology results not available|0|||
146337977|NCT01244737|527743525|FG000|Overall Study|PET data failure|0|||
146337978|NCT01244737|527743526|FG001|Overall Study|PET data failure|1|||
146337979|NCT01244737|527743527|FG002|Overall Study|PET data failure|0|||
146337980|NCT01244737|527743525|FG000|Overall Study|Withdrawal by Subject|0|||
146337981|NCT01244737|527743526|FG001|Overall Study|Withdrawal by Subject|0|||
146337982|NCT01244737|527743527|FG002|Overall Study|Withdrawal by Subject|1|||
146337983|NCT00465569|527743529|FG000|Overall Study|persistent eczema during dose escalation|1|||
146337984|NCT00465569|527743530|FG001|Overall Study|persistent eczema during dose escalation|0|||
146337985|NCT03826914|527743531|FG000|Overall Study|Withdrawal by Subject|1|||
146337986|NCT03826914|527743532|FG001|Overall Study|Withdrawal by Subject|1|||
146337987|NCT01442181|527743537|FG000|Overall Study|patient refused surgery|1|||
146337988|NCT01442181|527743538|FG001|Overall Study|patient refused surgery|0|||
146337989|NCT01442181|527743537|FG000|Overall Study|no insurance for surgery|1|||
146337990|NCT01442181|527743538|FG001|Overall Study|no insurance for surgery|0|||
146337991|NCT01442181|527743537|FG000|Overall Study|low ejection factor|0|||
146337992|NCT01442181|527743538|FG001|Overall Study|low ejection factor|1|||
146337993|NCT01442181|527743537|FG000|Overall Study|Lost to Follow-up|1|||
146337994|NCT01442181|527743538|FG001|Overall Study|Lost to Follow-up|1|||
146337995|NCT01442181|527743537|FG000|Overall Study|patient in an additional study|1|||
146337996|NCT01442181|527743538|FG001|Overall Study|patient in an additional study|0|||
146337997|NCT01442181|527743537|FG000|Overall Study|atrial fibrillation not noted|0|||
146337998|NCT01442181|527743538|FG001|Overall Study|atrial fibrillation not noted|1|||
146337999|NCT00709202|527743539|FG000|Overall Study|Withdrawal by Subject|6|||
146338000|NCT00709202|527743540|FG001|Overall Study|Withdrawal by Subject|6|||
146338001|NCT05502289|527743541|FG000|Period 1|Out Of Window|1|||
146338002|NCT05502289|527743542|FG001|Period 1|Out Of Window|0|||
146338003|NCT00613626|527743543|FG000|Overall Study|Ineligible|0|||
146338004|NCT00613626|527743544|FG001|Overall Study|Ineligible|1|||
146338005|NCT00613626|527743545|FG002|Overall Study|Ineligible|0|||
146338006|NCT00816036|527743550|FG000|Overall Study|Death|47|||
146338007|NCT00816036|527743551|FG001|Overall Study|Death|28|||
146338008|NCT00816036|527743550|FG000|Overall Study|Lost to Follow-up|75|||
146338009|NCT00816036|527743551|FG001|Overall Study|Lost to Follow-up|57|||
146338010|NCT00816036|527743550|FG000|Overall Study|Withdrawal by Subject|54|||
146338011|NCT00816036|527743551|FG001|Overall Study|Withdrawal by Subject|23|||
146338012|NCT01299025|527743552|FG000|Overall Study|Withdrawal by Subject|2|||
146338013|NCT01299025|527743553|FG001|Overall Study|Withdrawal by Subject|1|||
146338014|NCT01299025|527743552|FG000|Overall Study|Lost to Follow-up|1|||
146338015|NCT01299025|527743553|FG001|Overall Study|Lost to Follow-up|0|||
146338016|NCT00004980|527743554|FG000|Overall Study|Withdrawal by Subject|1|||
146338017|NCT00004980|527743555|FG001|Overall Study|Withdrawal by Subject|0|||
146338018|NCT00004980|527743554|FG000|Overall Study|memory difficulties|1|||
146338019|NCT00004980|527743555|FG001|Overall Study|memory difficulties|1|||
146338020|NCT00004980|527743554|FG000|Overall Study|Physician Decision|0|||
146338021|NCT00004980|527743555|FG001|Overall Study|Physician Decision|1|||
146338022|NCT01624194|527743556|FG000|Overall Study|Lost to Follow-up|1|||
146338023|NCT01624194|527743557|FG001|Overall Study|Lost to Follow-up|0|||
146338024|NCT01624194|527743556|FG000|Overall Study|Withdrawal by Subject|1|||
146338025|NCT01624194|527743557|FG001|Overall Study|Withdrawal by Subject|0|||
146338026|NCT03212261|527743558|FG000|Overall Study|Became ineligible d/t tech|2|||
146338027|NCT03212261|527743558|FG000|Overall Study|Tech Trouble- No first study visit|1|||
146338028|NCT03212261|527743558|FG000|Overall Study|Lost to Follow-up|7|||
146338029|NCT03212261|527743558|FG000|Overall Study|Family Emergency|1|||
146338030|NCT03212261|527743558|FG000|Overall Study|Too busy/ No time|5|||
146338031|NCT05480514|527743559|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
146338032|NCT05480514|527743560|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
146338033|NCT05480514|527743559|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
146338034|NCT05480514|527743560|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
146338035|NCT05480514|527743559|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146338036|NCT05480514|527743560|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146338037|NCT05480514|527743559|FG000|Period 1|Covid-19 Related|1|||
146338038|NCT05480514|527743560|FG001|Period 1|Covid-19 Related|0|||
146338039|NCT05480514|527743559|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
146338040|NCT05480514|527743560|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
146338041|NCT00820040|527743561|FG000|Overall Study|Death|1|||
146338042|NCT00820040|527743561|FG000|Overall Study|Sponsor terminated study|1|||
146338043|NCT00820040|527743561|FG000|Overall Study|Screen failure|1|||
146338044|NCT00761215|527743564|FG000|Overall Study|Randomized but didn't receive drug|1|||
146338045|NCT00761215|527743565|FG001|Overall Study|Randomized but didn't receive drug|1|||
146338046|NCT00761215|527743566|FG002|Overall Study|Randomized but didn't receive drug|2|||
146338047|NCT00761215|527743564|FG000|Overall Study|Lost to Follow-up|6|||
146338048|NCT00761215|527743565|FG001|Overall Study|Lost to Follow-up|3|||
146338049|NCT00761215|527743566|FG002|Overall Study|Lost to Follow-up|6|||
146338050|NCT00761215|527743564|FG000|Overall Study|Withdrawal by Subject|1|||
146338051|NCT00761215|527743565|FG001|Overall Study|Withdrawal by Subject|0|||
146338052|NCT00761215|527743566|FG002|Overall Study|Withdrawal by Subject|0|||
146338053|NCT00761215|527743564|FG000|Overall Study|Bacteremia|1|||
146338054|NCT00761215|527743565|FG001|Overall Study|Bacteremia|0|||
146338055|NCT00761215|527743566|FG002|Overall Study|Bacteremia|0|||
146338056|NCT00667277|527743567|FG000|Overall Study|Withdrawal by Subject|2|||
146338057|NCT00519532|527743568|FG000|Overall Study|Adverse Event|11|||
146338058|NCT00519532|527743568|FG000|Overall Study|Withdrawal by Subject|5|||
146338059|NCT00519532|527743568|FG000|Overall Study|Lost to Follow-up|2|||
146338060|NCT03885284|527743570|FG000|Overall Study|Disease Progression|1|||
146338061|NCT03885284|527743571|FG001|Overall Study|Disease Progression|3|||
146338062|NCT03885284|527743570|FG000|Overall Study|Physician Decision|0|||
146338063|NCT03885284|527743571|FG001|Overall Study|Physician Decision|1|||
146338064|NCT00002850|527743576|FG000|Overall Study|Death|4|||
146338065|NCT00002850|527743577|FG001|Overall Study|Death|1|||
146338066|NCT00002850|527743578|FG002|Overall Study|Death|3|||
146338067|NCT00002850|527743576|FG000|Overall Study|Protocol Violation|1|||
146338068|NCT00002850|527743577|FG001|Overall Study|Protocol Violation|0|||
146338069|NCT00002850|527743578|FG002|Overall Study|Protocol Violation|1|||
146338070|NCT00002850|527743576|FG000|Overall Study|Withdrawal by Subject|0|||
146338071|NCT00002850|527743577|FG001|Overall Study|Withdrawal by Subject|1|||
146338072|NCT00002850|527743578|FG002|Overall Study|Withdrawal by Subject|0|||
146338073|NCT02932267|527743579|FG000|Overall Study|Withdrawal by Subject|3|||
146338074|NCT02932267|527743579|FG000|Overall Study|Lost to Follow-up|4|||
146338075|NCT02932267|527743579|FG000|Overall Study|Pregnancy|1|||
146338076|NCT03476239|527743580|FG000|Overall Study|Withdrawal by Subject|10|||
146338077|NCT03476239|527743580|FG000|Overall Study|Death|80|||
146338078|NCT03476239|527743580|FG000|Overall Study|Lost to Follow-up|8|||
146338079|NCT04909463|527745150|FG000|Overall Study|Withdrawal by Subject|0|||
146338080|NCT04909463|527745151|FG001|Overall Study|Withdrawal by Subject|1|||
146338081|NCT04909463|527745152|FG002|Overall Study|Withdrawal by Subject|0|||
146338082|NCT04909463|527745153|FG003|Overall Study|Withdrawal by Subject|0|||
146338083|NCT04909463|527745150|FG000|Overall Study|Lost to Follow-up|2|||
146338084|NCT04909463|527745151|FG001|Overall Study|Lost to Follow-up|1|||
146338085|NCT04909463|527745152|FG002|Overall Study|Lost to Follow-up|1|||
146338086|NCT04909463|527745153|FG003|Overall Study|Lost to Follow-up|0|||
146338087|NCT00853632|527745154|FG000|Overall Study|Death|88|||
146338088|NCT00853632|527745154|FG000|Overall Study|Withdrawal by Subject|45|||
146338089|NCT00853632|527745154|FG000|Overall Study|Lost to Follow-up|30|||
146338090|NCT00853632|527745154|FG000|Overall Study|Reoperation/Explant|17|||
146338091|NCT00853632|527745154|FG000|Overall Study|Exit with other reason|22|||
146338092|NCT04493619|527745156|FG000|Overall Study|Death|4|||
146338093|NCT04493619|527745157|FG001|Overall Study|Death|3|||
146338094|NCT04493619|527745158|FG002|Overall Study|Death|3|||
146338095|NCT04493619|527745159|FG003|Overall Study|Death|4|||
146338096|NCT04493619|527745156|FG000|Overall Study|Study discontinued early|10|||
146338097|NCT04493619|527745157|FG001|Overall Study|Study discontinued early|0|||
146338098|NCT04493619|527745158|FG002|Overall Study|Study discontinued early|4|||
146338099|NCT04493619|527745159|FG003|Overall Study|Study discontinued early|8|||
146338100|NCT04493619|527745156|FG000|Overall Study|Lost to Follow-up|0|||
146338101|NCT04493619|527745157|FG001|Overall Study|Lost to Follow-up|0|||
146338102|NCT04493619|527745158|FG002|Overall Study|Lost to Follow-up|0|||
146338103|NCT04493619|527745159|FG003|Overall Study|Lost to Follow-up|1|||
146338104|NCT00875420|527745170|FG000|Overall Study|Adverse Event|0|||
146338105|NCT00875420|527745171|FG001|Overall Study|Adverse Event|1|||
146338106|NCT00875420|527745172|FG002|Overall Study|Adverse Event|1|||
146338107|NCT00875420|527745173|FG003|Overall Study|Adverse Event|0|||
146338108|NCT00875420|527745174|FG004|Overall Study|Adverse Event|0|||
146338109|NCT00875420|527745170|FG000|Overall Study|Inability to complete study procedures|1|||
146338110|NCT00875420|527745171|FG001|Overall Study|Inability to complete study procedures|0|||
146338111|NCT00875420|527745172|FG002|Overall Study|Inability to complete study procedures|1|||
146338112|NCT00875420|527745173|FG003|Overall Study|Inability to complete study procedures|1|||
146338113|NCT00875420|527745174|FG004|Overall Study|Inability to complete study procedures|1|||
146338114|NCT00875420|527745170|FG000|Overall Study|Lost to Follow-up|1|||
146338115|NCT00875420|527745171|FG001|Overall Study|Lost to Follow-up|0|||
146338116|NCT00875420|527745172|FG002|Overall Study|Lost to Follow-up|0|||
146338117|NCT00875420|527745173|FG003|Overall Study|Lost to Follow-up|0|||
146338118|NCT00875420|527745174|FG004|Overall Study|Lost to Follow-up|0|||
146338119|NCT00875420|527745170|FG000|Overall Study|Personal reason|0|||
146338120|NCT00875420|527745171|FG001|Overall Study|Personal reason|0|||
146338121|NCT00875420|527745172|FG002|Overall Study|Personal reason|0|||
146338122|NCT00875420|527745173|FG003|Overall Study|Personal reason|0|||
146338123|NCT00875420|527745174|FG004|Overall Study|Personal reason|1|||
146338124|NCT00875420|527745170|FG000|Overall Study|Prohibited medication|0|||
146338125|NCT00875420|527745171|FG001|Overall Study|Prohibited medication|0|||
146338126|NCT00875420|527745172|FG002|Overall Study|Prohibited medication|0|||
146338127|NCT00875420|527745173|FG003|Overall Study|Prohibited medication|1|||
146338128|NCT00875420|527745174|FG004|Overall Study|Prohibited medication|0|||
146338129|NCT00875420|527745170|FG000|Overall Study|Sponsor decision|0|||
146338130|NCT00875420|527745171|FG001|Overall Study|Sponsor decision|1|||
146338131|NCT00875420|527745172|FG002|Overall Study|Sponsor decision|0|||
146338132|NCT00875420|527745173|FG003|Overall Study|Sponsor decision|0|||
146338133|NCT00875420|527745174|FG004|Overall Study|Sponsor decision|0|||
146338134|NCT00875420|527745170|FG000|Overall Study|Withdrawal by Subject|0|||
146338135|NCT00875420|527745171|FG001|Overall Study|Withdrawal by Subject|0|||
146338136|NCT00875420|527745172|FG002|Overall Study|Withdrawal by Subject|1|||
146338137|NCT00875420|527745173|FG003|Overall Study|Withdrawal by Subject|0|||
146338138|NCT00875420|527745174|FG004|Overall Study|Withdrawal by Subject|0|||
146338139|NCT00914628|527745175|FG000|Overall Study|Death|35|||
146338140|NCT00914628|527745176|FG001|Overall Study|Death|17|||
146338141|NCT00914628|527745175|FG000|Overall Study|Medical decision|4|||
146338142|NCT00914628|527745176|FG001|Overall Study|Medical decision|0|||
146338143|NCT00914628|527745175|FG000|Overall Study|Protocol Violation|1|||
146338144|NCT00914628|527745176|FG001|Overall Study|Protocol Violation|0|||
146338145|NCT00914628|527745175|FG000|Overall Study|Lack of Efficacy|1|||
146338146|NCT00914628|527745176|FG001|Overall Study|Lack of Efficacy|0|||
146338147|NCT00914628|527745175|FG000|Overall Study|non-randomized|1|||
146338148|NCT00914628|527745176|FG001|Overall Study|non-randomized|0|||
146338149|NCT00914628|527745175|FG000|Overall Study|Relapse|1|||
146338150|NCT00914628|527745176|FG001|Overall Study|Relapse|2|||
146338151|NCT00914628|527745175|FG000|Overall Study|Study terminated by Sponsor|14|||
146338152|NCT00914628|527745176|FG001|Overall Study|Study terminated by Sponsor|8|||
146338153|NCT00914628|527745175|FG000|Overall Study|Patients who did not receive a single dose|7|||
146338154|NCT00914628|527745176|FG001|Overall Study|Patients who did not receive a single dose|1|||
146338155|NCT03716726|527745177|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
146338156|NCT03716726|527745178|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
146338157|NCT03716726|527745177|FG000|12 Months Followup|Lost to Follow-up|10|||
146338158|NCT03716726|527745178|FG001|12 Months Followup|Lost to Follow-up|17|||
146338159|NCT02579603|527745179|FG000|Overall Study|Not treated|1|||
146338160|NCT02579603|527745180|FG001|Overall Study|Not treated|0|||
146338161|NCT02579603|527745179|FG000|Overall Study|Adverse Event|2|||
146338162|NCT02579603|527745180|FG001|Overall Study|Adverse Event|2|||
146338163|NCT02579603|527745179|FG000|Overall Study|Other than stated|1|||
146338164|NCT02579603|527745180|FG001|Overall Study|Other than stated|0|||
146338165|NCT00469079|527745181|FG000|Overall Study|Lack of Efficacy|3|||
146338166|NCT00469079|527745182|FG001|Overall Study|Lack of Efficacy|8|||
146338167|NCT00469079|527745183|FG002|Overall Study|Lack of Efficacy|5|||
146338168|NCT00469079|527745181|FG000|Overall Study|Adverse Event|1|||
146338169|NCT00469079|527745182|FG001|Overall Study|Adverse Event|3|||
146338170|NCT00469079|527745183|FG002|Overall Study|Adverse Event|2|||
146338171|NCT00469079|527745181|FG000|Overall Study|Lost to Follow-up|4|||
146338172|NCT00469079|527745182|FG001|Overall Study|Lost to Follow-up|8|||
146338173|NCT00469079|527745183|FG002|Overall Study|Lost to Follow-up|10|||
146338174|NCT00469079|527745181|FG000|Overall Study|Withdrawal by Subject|1|||
146338175|NCT00469079|527745182|FG001|Overall Study|Withdrawal by Subject|2|||
146338176|NCT00469079|527745183|FG002|Overall Study|Withdrawal by Subject|2|||
146338177|NCT00469079|527745181|FG000|Overall Study|Ineligible|0|||
146338178|NCT00469079|527745182|FG001|Overall Study|Ineligible|1|||
146338179|NCT00469079|527745183|FG002|Overall Study|Ineligible|0|||
146338180|NCT01006356|527745187|FG000|Overall Study|Adverse Event|6|||
146338181|NCT01006356|527745187|FG000|Overall Study|Physician Decision|1|||
146338182|NCT01006356|527745187|FG000|Overall Study|Paticipants did not cooperate|6|||
146338183|NCT01006356|527745187|FG000|Overall Study|Withdrawal by Subject|1|||
146338184|NCT01006356|527745187|FG000|Overall Study|Choice by participants|2|||
146338185|NCT01006356|527745187|FG000|Overall Study|Protocol Violation|3|||
146338186|NCT01006356|527745187|FG000|Overall Study|Other|23|||
146338187|NCT01756157|527745189|FG000|First Intervention Period|Withdrawal by Subject|1|||
146338188|NCT01756157|527745190|FG001|First Intervention Period|Withdrawal by Subject|0|||
146338189|NCT01756157|527745189|FG000|First Intervention Period|Lost to Follow-up|0|||
146338190|NCT01756157|527745190|FG001|First Intervention Period|Lost to Follow-up|2|||
146338191|NCT02799381|527745193|FG000|Overall Study|Withdrew consent|3|||
146338192|NCT02799381|527745194|FG001|Overall Study|Withdrew consent|2|||
146338193|NCT02799381|527745193|FG000|Overall Study|Adverse Event|0|||
146338194|NCT02799381|527745194|FG001|Overall Study|Adverse Event|1|||
146338195|NCT02799381|527745193|FG000|Overall Study|Participant did not take any study drug|1|||
146338196|NCT02799381|527745194|FG001|Overall Study|Participant did not take any study drug|0|||
146338197|NCT02698410|527745195|FG000|Overall Study|Adverse Event|2|||
146338198|NCT02698410|527745195|FG000|Overall Study|Withdrawal by Subject|1|||
146338199|NCT02698410|527745195|FG000|Overall Study|Other|1|||
146338200|NCT03952130|527745197|FG000|Overall Study|Adverse Event|0|||
146338201|NCT03952130|527745198|FG001|Overall Study|Adverse Event|1|||
146338202|NCT03952130|527745197|FG000|Overall Study|Lost to Follow-up|1|||
146338203|NCT03952130|527745198|FG001|Overall Study|Lost to Follow-up|0|||
146338204|NCT03952130|527745197|FG000|Overall Study|Withdrawal by Subject|1|||
146338205|NCT03952130|527745198|FG001|Overall Study|Withdrawal by Subject|5|||
146338206|NCT02638012|527745199|FG000|Overall Study|Lost to Follow-up|1|||
146338207|NCT02559505|527745205|FG000|Overall Study|Lost to Follow-up|23|||
146338208|NCT02559505|527745206|FG001|Overall Study|Lost to Follow-up|20|||
146338209|NCT02559505|527745205|FG000|Overall Study|Withdrawal by Subject|4|||
146338210|NCT02559505|527745206|FG001|Overall Study|Withdrawal by Subject|2|||
146338211|NCT01473004|527745207|FG000|Overall Study|Incomplete Lobar Treatment|1|||
146338212|NCT01473004|527745208|FG001|Overall Study|Incomplete Lobar Treatment|0|||
146338213|NCT05882890|527745209|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
146338214|NCT01584024|527745210|FG000|Overall Study|Lost to Follow-up|10|||
146338215|NCT01584024|527745210|FG000|Overall Study|Withdrawal by Subject|3|||
146338216|NCT04331899|527745213|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
146338217|NCT04331899|527745214|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
146338218|NCT02424539|527745217|FG000|Overall Study|Adverse Event|0|||
146338219|NCT02424539|527745218|FG001|Overall Study|Adverse Event|0|||
146338220|NCT02424539|527745219|FG002|Overall Study|Adverse Event|1|||
146338221|NCT02424539|527745217|FG000|Overall Study|Physician Decision|0|||
146338222|NCT02424539|527745218|FG001|Overall Study|Physician Decision|0|||
146338223|NCT02424539|527745219|FG002|Overall Study|Physician Decision|1|||
146338224|NCT02424539|527745217|FG000|Overall Study|Withdrawal by Subject|3|||
146338225|NCT02424539|527745218|FG001|Overall Study|Withdrawal by Subject|1|||
146338226|NCT02424539|527745219|FG002|Overall Study|Withdrawal by Subject|0|||
146338227|NCT02424539|527745217|FG000|Overall Study|Other: Reached stopping criteria|11|||
146338228|NCT02424539|527745218|FG001|Overall Study|Other: Reached stopping criteria|7|||
146338229|NCT02424539|527745219|FG002|Overall Study|Other: Reached stopping criteria|6|||
146338230|NCT00719810|527745220|FG000|Overall Study|Adverse Event|0|||
146338231|NCT00719810|527745221|FG001|Overall Study|Adverse Event|2|||
146338232|NCT00719810|527745222|FG002|Overall Study|Adverse Event|3|||
146338233|NCT00719810|527745220|FG000|Overall Study|Lost to Follow-up|2|||
146338234|NCT00719810|527745221|FG001|Overall Study|Lost to Follow-up|0|||
146338235|NCT00719810|527745222|FG002|Overall Study|Lost to Follow-up|3|||
146338236|NCT00719810|527745220|FG000|Overall Study|Physician Decision|0|||
146338237|NCT00719810|527745221|FG001|Overall Study|Physician Decision|1|||
146338238|NCT00719810|527745222|FG002|Overall Study|Physician Decision|0|||
146338239|NCT00719810|527745220|FG000|Overall Study|Withdrawal by Subject|1|||
146338240|NCT00719810|527745221|FG001|Overall Study|Withdrawal by Subject|1|||
146338241|NCT00719810|527745222|FG002|Overall Study|Withdrawal by Subject|2|||
146338242|NCT04893265|527745223|FG000|Overall Study|Withdrawal by Subject|2|||
146338243|NCT04893265|527745224|FG001|Overall Study|Withdrawal by Subject|5|||
146338244|NCT04893265|527745223|FG000|Overall Study|Lost to Follow-up|0|||
146338245|NCT04893265|527745224|FG001|Overall Study|Lost to Follow-up|4|||
146338246|NCT00893789|527745226|FG000|Overall Study|Withdrawal by Subject|3|||
146338247|NCT00893789|527745227|FG001|Overall Study|Withdrawal by Subject|1|||
146338248|NCT00893789|527745228|FG002|Overall Study|Withdrawal by Subject|3|||
146338249|NCT00893789|527745229|FG003|Overall Study|Withdrawal by Subject|1|||
146338250|NCT00893789|527745226|FG000|Overall Study|Noncompliance With Study Drug|1|||
146338251|NCT00893789|527745227|FG001|Overall Study|Noncompliance With Study Drug|0|||
146338252|NCT00893789|527745228|FG002|Overall Study|Noncompliance With Study Drug|1|||
146338253|NCT00893789|527745229|FG003|Overall Study|Noncompliance With Study Drug|2|||
146338254|NCT00893789|527745226|FG000|Overall Study|Noncompliance With Study Procedures|1|||
146338255|NCT00893789|527745227|FG001|Overall Study|Noncompliance With Study Procedures|0|||
146338256|NCT00893789|527745228|FG002|Overall Study|Noncompliance With Study Procedures|0|||
146338257|NCT00893789|527745229|FG003|Overall Study|Noncompliance With Study Procedures|0|||
146338258|NCT00893789|527745226|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
146338259|NCT00893789|527745227|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
146338260|NCT00893789|527745228|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
146338261|NCT00893789|527745229|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
146338262|NCT00893789|527745226|FG000|Overall Study|Adverse Event|0|||
146338263|NCT00893789|527745227|FG001|Overall Study|Adverse Event|2|||
146338264|NCT00893789|527745228|FG002|Overall Study|Adverse Event|1|||
146338265|NCT00893789|527745229|FG003|Overall Study|Adverse Event|5|||
146338266|NCT00893789|527745226|FG000|Overall Study|Protocol Violation|0|||
146338267|NCT00893789|527745227|FG001|Overall Study|Protocol Violation|1|||
146338268|NCT00893789|527745228|FG002|Overall Study|Protocol Violation|1|||
146338269|NCT00893789|527745229|FG003|Overall Study|Protocol Violation|4|||
146338270|NCT00893789|527745226|FG000|Overall Study|Lost to Follow-up|0|||
146338271|NCT00893789|527745227|FG001|Overall Study|Lost to Follow-up|0|||
146338272|NCT00893789|527745228|FG002|Overall Study|Lost to Follow-up|0|||
146338273|NCT00893789|527745229|FG003|Overall Study|Lost to Follow-up|1|||
146338274|NCT02024464|527745230|FG000|Overall Study|Discontinued|5|||
146338275|NCT02024464|527745231|FG001|Overall Study|Discontinued|4|||
146338276|NCT02024464|527745230|FG000|Overall Study|Missed Visits|1|||
146338277|NCT02024464|527745231|FG001|Overall Study|Missed Visits|0|||
146338278|NCT02024464|527745230|FG000|Overall Study|Lost to Follow-up|4|||
146338279|NCT02024464|527745231|FG001|Overall Study|Lost to Follow-up|7|||
146338280|NCT04419506|527745232|FG000|Overall Study|Adverse Event|0|||
146338281|NCT04419506|527745233|FG001|Overall Study|Adverse Event|10|||
146338282|NCT04419506|527745234|FG002|Overall Study|Adverse Event|0|||
146338283|NCT04419506|527745235|FG003|Overall Study|Adverse Event|3|||
146338284|NCT04419506|527745232|FG000|Overall Study|Withdrawal by Subject|0|||
146338285|NCT04419506|527745233|FG001|Overall Study|Withdrawal by Subject|0|||
146338286|NCT04419506|527745234|FG002|Overall Study|Withdrawal by Subject|0|||
146338287|NCT04419506|527745235|FG003|Overall Study|Withdrawal by Subject|1|||
146338288|NCT04419506|527745232|FG000|Overall Study|poor-compliance|0|||
146338289|NCT04419506|527745233|FG001|Overall Study|poor-compliance|0|||
146338290|NCT04419506|527745234|FG002|Overall Study|poor-compliance|0|||
146338291|NCT04419506|527745235|FG003|Overall Study|poor-compliance|1|||
146338292|NCT01845025|527745236|FG000|Overall Study|Adverse Event|6|||
146338293|NCT01845025|527745237|FG001|Overall Study|Adverse Event|3|||
146338294|NCT01845025|527745236|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146338295|NCT01845025|527745237|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146338296|NCT01845025|527745236|FG000|Overall Study|Withdrawal by Subject|48|||
146338297|NCT01845025|527745237|FG001|Overall Study|Withdrawal by Subject|44|||
146338298|NCT01845025|527745236|FG000|Overall Study|Lost to Follow-up|13|||
146338299|NCT01845025|527745237|FG001|Overall Study|Lost to Follow-up|13|||
146338300|NCT01845025|527745236|FG000|Overall Study|Administrative problems|8|||
146338301|NCT01845025|527745237|FG001|Overall Study|Administrative problems|8|||
146338302|NCT01845025|527745236|FG000|Overall Study|Death|2|||
146338303|NCT01845025|527745237|FG001|Overall Study|Death|0|||
146338304|NCT01845025|527745236|FG000|Overall Study|Protocol deviation|3|||
146338305|NCT01845025|527745237|FG001|Overall Study|Protocol deviation|6|||
146338306|NCT01845025|527745236|FG000|Overall Study|Missing|1|||
146338307|NCT01845025|527745237|FG001|Overall Study|Missing|1|||
146338308|NCT01973283|527745238|FG000|Overall Study|Lost to Follow-up|4|||
146338309|NCT00900796|527745239|FG000|Phase 1|Lacked sufficient information|4|||
146338310|NCT00900796|527745239|FG000|Phase 1|Missing information at Week 16|7|||
146338311|NCT00900796|527745239|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
146338312|NCT00900796|527745239|FG000|Phase 2|Lost to Follow-up|5|||
146338313|NCT02586805|527745240|FG000|Overall Study|Withdrawal by Subject|3|||
146338314|NCT02586805|527745241|FG001|Overall Study|Withdrawal by Subject|1|||
146338315|NCT02586805|527745242|FG002|Overall Study|Withdrawal by Subject|1|||
146338316|NCT02586805|527745243|FG003|Overall Study|Withdrawal by Subject|2|||
146338317|NCT02586805|527745240|FG000|Overall Study|Adverse Event|2|||
146338318|NCT02586805|527745241|FG001|Overall Study|Adverse Event|0|||
146338319|NCT02586805|527745242|FG002|Overall Study|Adverse Event|1|||
146338320|NCT02586805|527745243|FG003|Overall Study|Adverse Event|0|||
146338321|NCT02586805|527745240|FG000|Overall Study|Lost to Follow-up|0|||
146338322|NCT02586805|527745241|FG001|Overall Study|Lost to Follow-up|0|||
146338323|NCT02586805|527745242|FG002|Overall Study|Lost to Follow-up|1|||
146338324|NCT02586805|527745243|FG003|Overall Study|Lost to Follow-up|0|||
146338325|NCT02586805|527745240|FG000|Overall Study|Physician Decision|1|||
146338326|NCT02586805|527745241|FG001|Overall Study|Physician Decision|0|||
146338327|NCT02586805|527745242|FG002|Overall Study|Physician Decision|0|||
146338328|NCT02586805|527745243|FG003|Overall Study|Physician Decision|0|||
146338329|NCT01859403|527745244|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
146338330|NCT01859403|527745245|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
146338331|NCT01859403|527745244|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
146338332|NCT01859403|527745245|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
146338333|NCT01859403|527745244|FG000|Primary Endpoint Measure|Physician Decision|0|||
146338334|NCT01859403|527745245|FG001|Primary Endpoint Measure|Physician Decision|1|||
146338335|NCT01859403|527745244|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
146338336|NCT01859403|527745245|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
146338337|NCT00730236|527745255|FG000|Overall Study|Adverse Event|4|||
146338338|NCT00730236|527745255|FG000|Overall Study|Withdrawal by Subject|1|||
146338339|NCT00730236|527745255|FG000|Overall Study|Non-compliance|1|||
146338340|NCT03486314|527745257|FG000|Part A|Adverse Event|1|||
146338341|NCT03486314|527745258|FG001|Part A|Adverse Event|0|||
146338342|NCT03486314|527745259|FG002|Part A|Adverse Event|0|||
146338343|NCT03486314|527745257|FG000|Part A|Symptomatic Deterioration|2|||
146338344|NCT03486314|527745258|FG001|Part A|Symptomatic Deterioration|0|||
146338345|NCT03486314|527745259|FG002|Part A|Symptomatic Deterioration|0|||
146338346|NCT01985321|527745261|FG000|Overall Study|Protocol Violation|4|||
146338347|NCT01985321|527745262|FG001|Overall Study|Protocol Violation|3|||
146338348|NCT01985321|527745261|FG000|Overall Study|Withdrawal by Subject|1|||
146338349|NCT01985321|527745262|FG001|Overall Study|Withdrawal by Subject|0|||
146338350|NCT01985321|527745261|FG000|Overall Study|Lost to Follow-up|5|||
146338351|NCT01985321|527745262|FG001|Overall Study|Lost to Follow-up|2|||
146338352|NCT01985321|527745261|FG000|Overall Study|Subject treated wrong type of sore|1|||
146338353|NCT01985321|527745262|FG001|Overall Study|Subject treated wrong type of sore|0|||
146338354|NCT00482001|527745263|FG000|Overall Study|Protocol Violation|1|||
146338355|NCT00482001|527745264|FG001|Overall Study|Protocol Violation|1|||
146338356|NCT00542828|527745267|FG000|Overall Study|Physician Decision|1|||
146338357|NCT00542828|527745267|FG000|Overall Study|Need for Prohibited Treatment|3|||
146338358|NCT00542828|527745267|FG000|Overall Study|Study Prematurely Discontinued|7|||
146338359|NCT00542828|527745267|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
146338360|NCT03953118|527745268|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
146338361|NCT03953118|527745269|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
146338362|NCT04283461|527745270|FG000|Overall Study|Enrolled in separate trial|0|||
146338363|NCT04283461|527745271|FG001|Overall Study|Enrolled in separate trial|0|||
146338364|NCT04283461|527745272|FG002|Overall Study|Enrolled in separate trial|8|||
146338365|NCT04283461|527745273|FG003|Overall Study|Enrolled in separate trial|13|||
146338366|NCT04283461|527745274|FG004|Overall Study|Enrolled in separate trial|12|||
146338367|NCT04283461|527745275|FG005|Overall Study|Enrolled in separate trial|0|||
146338368|NCT04283461|527745276|FG006|Overall Study|Enrolled in separate trial|0|||
146338369|NCT04283461|527745277|FG007|Overall Study|Enrolled in separate trial|8|||
146338370|NCT04283461|527745278|FG008|Overall Study|Enrolled in separate trial|0|||
146338371|NCT04283461|527745279|FG009|Overall Study|Enrolled in separate trial|0|||
146338372|NCT04283461|527745280|FG010|Overall Study|Enrolled in separate trial|0|||
146338373|NCT04283461|527745281|FG011|Overall Study|Enrolled in separate trial|7|||
146338374|NCT04283461|527745282|FG012|Overall Study|Enrolled in separate trial|0|||
146338375|NCT05139030|527745286|FG000|Overall Study|Withdrawal by Subject|1|||
146338376|NCT05139030|527745287|FG001|Overall Study|Withdrawal by Subject|3|||
146338377|NCT05139030|527745286|FG000|Overall Study|Adverse Event|0|||
146338378|NCT05139030|527745287|FG001|Overall Study|Adverse Event|1|||
146338379|NCT05139030|527745286|FG000|Overall Study|Failure to meet continuation criteria|0|||
146338380|NCT05139030|527745287|FG001|Overall Study|Failure to meet continuation criteria|1|||
146338381|NCT03133767|527745291|FG000|Overall Study|Lost to Follow-up|38|||
146338382|NCT03133767|527745292|FG001|Overall Study|Lost to Follow-up|24|||
146338383|NCT03133767|527745291|FG000|Overall Study|Protocol Violation|0|||
146338384|NCT03133767|527745292|FG001|Overall Study|Protocol Violation|1|||
146338385|NCT04375878|527745298|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
146338386|NCT04375878|527745299|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
146338387|NCT04375878|527745300|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146338388|NCT04375878|527745301|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146338389|NCT04375878|527745302|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146338390|NCT04375878|527745303|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
146338391|NCT04375878|527745298|FG000|Crossover First and Second Interventions|Adverse Event|0|||
146338392|NCT04375878|527745299|FG001|Crossover First and Second Interventions|Adverse Event|0|||
146338393|NCT04375878|527745300|FG002|Crossover First and Second Interventions|Adverse Event|1|||
146338394|NCT04375878|527745301|FG003|Crossover First and Second Interventions|Adverse Event|0|||
146338395|NCT04375878|527745302|FG004|Crossover First and Second Interventions|Adverse Event|0|||
146338396|NCT04375878|527745303|FG005|Crossover First and Second Interventions|Adverse Event|0|||
146338397|NCT04375878|527745298|FG000|Extension Phase|Withdrawal by Subject|0|||
146338398|NCT04375878|527745299|FG001|Extension Phase|Withdrawal by Subject|0|||
146338399|NCT04375878|527745300|FG002|Extension Phase|Withdrawal by Subject|0|||
146338400|NCT04375878|527745301|FG003|Extension Phase|Withdrawal by Subject|0|||
146338401|NCT04375878|527745302|FG004|Extension Phase|Withdrawal by Subject|1|||
146338402|NCT04375878|527745303|FG005|Extension Phase|Withdrawal by Subject|0|||
146338403|NCT01259466|527745306|FG000|Overall Study|Withdrawal by Subject|1|||
146338404|NCT01259466|527745307|FG001|Overall Study|Withdrawal by Subject|9|||
146338405|NCT02296840|527745308|FG000|Overall Study|Adverse Event|1|||
146338406|NCT02296840|527745309|FG001|Overall Study|Adverse Event|1|||
146338407|NCT02296840|527745308|FG000|Overall Study|Protocol Violation|2|||
146169083|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
146338408|NCT02296840|527745309|FG001|Overall Study|Protocol Violation|1|||
146338409|NCT02296840|527745308|FG000|Overall Study|Lost to Follow-up|6|||
146338410|NCT02296840|527745309|FG001|Overall Study|Lost to Follow-up|17|||
146338411|NCT00814710|527745314|FG000|Overall Study|Adverse Event|1|||
146338412|NCT00814710|527745315|FG001|Overall Study|Adverse Event|0|||
146338413|NCT00814710|527745314|FG000|Overall Study|Lost to Follow-up|7|||
146338414|NCT00814710|527745315|FG001|Overall Study|Lost to Follow-up|3|||
146338415|NCT02117687|527745316|FG000|Overall Study|Lost to Follow-up|0|||
146338416|NCT02117687|527745317|FG001|Overall Study|Lost to Follow-up|1|||
146338417|NCT02117687|527745316|FG000|Overall Study|Adverse Event|0|||
146338418|NCT02117687|527745317|FG001|Overall Study|Adverse Event|2|||
146338419|NCT02117687|527745316|FG000|Overall Study|Other Reasons|1|||
146338420|NCT02117687|527745317|FG001|Overall Study|Other Reasons|1|||
146338421|NCT00618956|527745318|FG000|Overall Study|Adverse Event|10|||
146338422|NCT00618956|527745319|FG001|Overall Study|Adverse Event|34|||
146338423|NCT00618956|527745318|FG000|Overall Study|Lack of Efficacy|2|||
146338424|NCT00618956|527745319|FG001|Overall Study|Lack of Efficacy|1|||
146338425|NCT00618956|527745318|FG000|Overall Study|Withdrawal by Subject|5|||
146338426|NCT00618956|527745319|FG001|Overall Study|Withdrawal by Subject|7|||
146338427|NCT00618956|527745318|FG000|Overall Study|Lost to Follow-up|4|||
146338428|NCT00618956|527745319|FG001|Overall Study|Lost to Follow-up|5|||
146338429|NCT00618956|527745318|FG000|Overall Study|Protocol Violation|2|||
146338430|NCT00618956|527745319|FG001|Overall Study|Protocol Violation|2|||
146338431|NCT00618956|527745318|FG000|Overall Study|did not meet criteria, non-compliance|2|||
146338432|NCT00618956|527745319|FG001|Overall Study|did not meet criteria, non-compliance|1|||
146338433|NCT05405166|527747622|FG000|Overall Study|Death|49|||
146338434|NCT05405166|527747623|FG001|Overall Study|Death|50|||
146338435|NCT05405166|527747622|FG000|Overall Study|Withdrawal by Subject|10|||
146338436|NCT05405166|527747623|FG001|Overall Study|Withdrawal by Subject|3|||
146338437|NCT05405166|527747622|FG000|Overall Study|Ongoing at the time of PCD|209|||
146338438|NCT05405166|527747623|FG001|Overall Study|Ongoing at the time of PCD|210|||
146338439|NCT01386385|527747624|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
146338440|NCT01386385|527747625|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338441|NCT01386385|527747626|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338442|NCT01386385|527747627|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338443|NCT01386385|527747628|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338444|NCT01386385|527747629|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338445|NCT01386385|527747630|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338446|NCT01386385|527747631|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
146338447|NCT01386385|527747624|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
146338448|NCT01386385|527747625|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338449|NCT01386385|527747626|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338450|NCT01386385|527747627|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338451|NCT01386385|527747628|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338452|NCT01386385|527747629|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338453|NCT01386385|527747630|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338454|NCT01386385|527747631|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
146338455|NCT01386385|527747624|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338456|NCT01386385|527747625|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338457|NCT01386385|527747626|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
146338458|NCT01386385|527747627|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338459|NCT01386385|527747628|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338460|NCT01386385|527747629|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338461|NCT01386385|527747630|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338462|NCT01386385|527747631|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
146338463|NCT01386385|527747624|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338464|NCT01386385|527747625|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338465|NCT01386385|527747626|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338466|NCT01386385|527747627|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338467|NCT01386385|527747628|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
146338468|NCT01386385|527747629|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338469|NCT01386385|527747630|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338470|NCT01386385|527747631|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
146338471|NCT01386385|527747624|FG000|Phase II Concurrent CRT|Adverse Event|0|||
146338472|NCT01386385|527747625|FG001|Phase II Concurrent CRT|Adverse Event|0|||
146338473|NCT01386385|527747626|FG002|Phase II Concurrent CRT|Adverse Event|0|||
146338474|NCT01386385|527747627|FG003|Phase II Concurrent CRT|Adverse Event|0|||
146338475|NCT01386385|527747628|FG004|Phase II Concurrent CRT|Adverse Event|0|||
146338476|NCT01386385|527747629|FG005|Phase II Concurrent CRT|Adverse Event|0|||
146338477|NCT01386385|527747630|FG006|Phase II Concurrent CRT|Adverse Event|3|||
146338478|NCT01386385|527747631|FG007|Phase II Concurrent CRT|Adverse Event|3|||
146338479|NCT01386385|527747624|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338480|NCT01386385|527747625|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338481|NCT01386385|527747626|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338482|NCT01386385|527747627|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338483|NCT01386385|527747628|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338484|NCT01386385|527747629|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338485|NCT01386385|527747630|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
146338486|NCT01386385|527747631|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
146338487|NCT01386385|527747624|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
146338488|NCT01386385|527747625|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
146338489|NCT01386385|527747626|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
146338490|NCT01386385|527747627|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
146338491|NCT01386385|527747628|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
146338492|NCT01386385|527747629|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
146338493|NCT01386385|527747630|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
146338494|NCT01386385|527747631|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
146338495|NCT01386385|527747624|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338496|NCT01386385|527747625|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338497|NCT01386385|527747626|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338498|NCT01386385|527747627|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338499|NCT01386385|527747628|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338500|NCT01386385|527747629|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338501|NCT01386385|527747630|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
146338502|NCT01386385|527747631|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
146338503|NCT01386385|527747624|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338504|NCT01386385|527747625|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338505|NCT01386385|527747626|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338506|NCT01386385|527747627|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338507|NCT01386385|527747628|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338508|NCT01386385|527747629|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
146338509|NCT01386385|527747630|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
146338510|NCT01386385|527747631|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
146338511|NCT01084252|527747632|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338512|NCT01084252|527747633|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338513|NCT01084252|527747634|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338514|NCT01084252|527747635|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338515|NCT01084252|527747636|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338516|NCT01084252|527747637|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338517|NCT01084252|527747638|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338518|NCT01084252|527747639|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338519|NCT01084252|527747640|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338520|NCT01084252|527747641|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338521|NCT01084252|527747642|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338522|NCT01084252|527747643|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338523|NCT01084252|527747644|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
146338524|NCT01084252|527747645|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
146338525|NCT03395210|527747646|FG000|Overall Study|Other|0|||
146338526|NCT03395210|527747647|FG001|Overall Study|Other|0|||
146338527|NCT03395210|527747648|FG002|Overall Study|Other|0|||
146338528|NCT03395210|527747649|FG003|Overall Study|Other|0|||
146338529|NCT03395210|527747650|FG004|Overall Study|Other|1|||
146338530|NCT03395210|527747646|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
146338531|NCT03395210|527747647|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
146338532|NCT03395210|527747648|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
146338533|NCT03395210|527747649|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
146338534|NCT03395210|527747650|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
146338535|NCT03395210|527747646|FG000|Overall Study|Adverse Event|1|||
146338536|NCT03395210|527747647|FG001|Overall Study|Adverse Event|0|||
146338537|NCT03395210|527747648|FG002|Overall Study|Adverse Event|2|||
146338538|NCT03395210|527747649|FG003|Overall Study|Adverse Event|4|||
146338539|NCT03395210|527747650|FG004|Overall Study|Adverse Event|3|||
146338540|NCT03395210|527747646|FG000|Overall Study|Need of Rescue Medication|1|||
146338541|NCT03395210|527747647|FG001|Overall Study|Need of Rescue Medication|0|||
146338542|NCT03395210|527747648|FG002|Overall Study|Need of Rescue Medication|1|||
146338543|NCT03395210|527747649|FG003|Overall Study|Need of Rescue Medication|4|||
146338544|NCT03395210|527747650|FG004|Overall Study|Need of Rescue Medication|0|||
146338545|NCT03395210|527747646|FG000|Overall Study|Lack of Response|0|||
146338546|NCT03395210|527747647|FG001|Overall Study|Lack of Response|0|||
146338547|NCT03395210|527747648|FG002|Overall Study|Lack of Response|0|||
146338548|NCT03395210|527747649|FG003|Overall Study|Lack of Response|5|||
146338549|NCT03395210|527747650|FG004|Overall Study|Lack of Response|5|||
146338550|NCT03395210|527747646|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
146338551|NCT03395210|527747647|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146338552|NCT03395210|527747648|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146338553|NCT03395210|527747649|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
146338554|NCT03395210|527747650|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
146338555|NCT03395210|527747646|FG000|Overall Study|Participant Decision|1|||
146338556|NCT03395210|527747647|FG001|Overall Study|Participant Decision|1|||
146338557|NCT03395210|527747648|FG002|Overall Study|Participant Decision|0|||
146338558|NCT03395210|527747649|FG003|Overall Study|Participant Decision|4|||
146338559|NCT03395210|527747650|FG004|Overall Study|Participant Decision|0|||
146338560|NCT03395210|527747646|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
146338561|NCT03395210|527747647|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
146338562|NCT03395210|527747648|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
146338563|NCT03395210|527747649|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
146338564|NCT03395210|527747650|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
146338565|NCT04364854|527747651|FG000|Overall Study|Withdrawal by Subject|1|||
146338566|NCT04364854|527747652|FG001|Overall Study|Withdrawal by Subject|0|||
146338567|NCT04364854|527747653|FG002|Overall Study|Withdrawal by Subject|1|||
146338568|NCT04364854|527747654|FG003|Overall Study|Withdrawal by Subject|3|||
146338569|NCT04364854|527747651|FG000|Overall Study|Death|1|||
146338570|NCT04364854|527747652|FG001|Overall Study|Death|0|||
146338571|NCT04364854|527747653|FG002|Overall Study|Death|0|||
146338572|NCT04364854|527747654|FG003|Overall Study|Death|0|||
146338573|NCT04364854|527747651|FG000|Overall Study|Lost to Follow-up|0|||
146338574|NCT04364854|527747652|FG001|Overall Study|Lost to Follow-up|0|||
146338575|NCT04364854|527747653|FG002|Overall Study|Lost to Follow-up|0|||
146338576|NCT04364854|527747654|FG003|Overall Study|Lost to Follow-up|1|||
146338577|NCT01826214|527747658|FG000|Overall Study|Adverse Event|7|||
146338578|NCT01826214|527747659|FG001|Overall Study|Adverse Event|6|||
146338579|NCT01826214|527747658|FG000|Overall Study|Death|3|||
146338580|NCT01826214|527747659|FG001|Overall Study|Death|1|||
146338581|NCT01826214|527747658|FG000|Overall Study|Lost to Follow-up|1|||
146338582|NCT01826214|527747659|FG001|Overall Study|Lost to Follow-up|0|||
146338583|NCT01826214|527747658|FG000|Overall Study|Physician Decision|0|||
146338584|NCT01826214|527747659|FG001|Overall Study|Physician Decision|2|||
146338585|NCT01826214|527747658|FG000|Overall Study|Progressive disease|22|||
146338586|NCT01826214|527747659|FG001|Overall Study|Progressive disease|21|||
146338587|NCT01826214|527747658|FG000|Overall Study|Study terminated by Sponsor|0|||
146338588|NCT01826214|527747659|FG001|Overall Study|Study terminated by Sponsor|1|||
146338589|NCT01826214|527747658|FG000|Overall Study|Subject/guardian decision|2|||
146338590|NCT01826214|527747659|FG001|Overall Study|Subject/guardian decision|3|||
146338591|NCT00955110|527747660|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
146338592|NCT00955110|527747660|FG000|Treatment Phase|Adverse Event|2|||
146338593|NCT00955110|527747660|FG000|Treatment Phase|Administrative reasons|2|||
146338594|NCT00955110|527747660|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
146338595|NCT00955110|527747660|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
146338596|NCT02128490|527747661|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146338597|NCT02128490|527747662|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146338598|NCT02128490|527747663|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
146338599|NCT02128490|527747664|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
146338600|NCT02128490|527747665|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146338601|NCT02128490|527747661|FG000|Overall Study|Major Protocol Deviation|1|||
146338602|NCT02128490|527747662|FG001|Overall Study|Major Protocol Deviation|2|||
146338603|NCT02128490|527747663|FG002|Overall Study|Major Protocol Deviation|0|||
146338604|NCT02128490|527747664|FG003|Overall Study|Major Protocol Deviation|2|||
146338605|NCT02128490|527747665|FG004|Overall Study|Major Protocol Deviation|2|||
146338606|NCT02128490|527747661|FG000|Overall Study|Lost to Follow-up|0|||
146338607|NCT02128490|527747662|FG001|Overall Study|Lost to Follow-up|0|||
146338608|NCT02128490|527747663|FG002|Overall Study|Lost to Follow-up|1|||
146338609|NCT02128490|527747664|FG003|Overall Study|Lost to Follow-up|1|||
146338610|NCT02128490|527747665|FG004|Overall Study|Lost to Follow-up|1|||
146338611|NCT02128490|527747661|FG000|Overall Study|Voluntary Withdrawal|3|||
146338612|NCT02128490|527747662|FG001|Overall Study|Voluntary Withdrawal|3|||
146338613|NCT02128490|527747663|FG002|Overall Study|Voluntary Withdrawal|1|||
146338614|NCT02128490|527747664|FG003|Overall Study|Voluntary Withdrawal|1|||
146338615|NCT02128490|527747665|FG004|Overall Study|Voluntary Withdrawal|2|||
146338616|NCT02128490|527747661|FG000|Overall Study|Lack of Efficacy|0|||
146338617|NCT02128490|527747662|FG001|Overall Study|Lack of Efficacy|1|||
146338618|NCT02128490|527747663|FG002|Overall Study|Lack of Efficacy|0|||
146338619|NCT02128490|527747664|FG003|Overall Study|Lack of Efficacy|0|||
146338620|NCT02128490|527747665|FG004|Overall Study|Lack of Efficacy|0|||
146338621|NCT02128490|527747661|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146338622|NCT02128490|527747662|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146338623|NCT02128490|527747663|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146338624|NCT02128490|527747664|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
146338625|NCT02128490|527747665|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
146338626|NCT02128490|527747661|FG000|Overall Study|Other Miscellaneous Reasons|0|||
146338627|NCT02128490|527747662|FG001|Overall Study|Other Miscellaneous Reasons|0|||
146338628|NCT02128490|527747663|FG002|Overall Study|Other Miscellaneous Reasons|2|||
146338629|NCT02128490|527747664|FG003|Overall Study|Other Miscellaneous Reasons|1|||
146338630|NCT02128490|527747665|FG004|Overall Study|Other Miscellaneous Reasons|1|||
146338631|NCT02243176|527747666|FG000|Overall Study|Other reason|1|||
146338632|NCT02243176|527747667|FG001|Overall Study|Other reason|2|||
146338633|NCT02243176|527747666|FG000|Overall Study|protocol specified withdrawal critera|1|||
146338634|NCT02243176|527747667|FG001|Overall Study|protocol specified withdrawal critera|3|||
146338635|NCT02243176|527747666|FG000|Overall Study|Protocol Violation|2|||
146338636|NCT02243176|527747667|FG001|Overall Study|Protocol Violation|1|||
146338637|NCT02243176|527747666|FG000|Overall Study|Withdrawal by Subject|8|||
146338638|NCT02243176|527747667|FG001|Overall Study|Withdrawal by Subject|7|||
146338639|NCT02243176|527747666|FG000|Overall Study|Adverse Event|2|||
146338640|NCT02243176|527747667|FG001|Overall Study|Adverse Event|2|||
146338641|NCT02981472|527747673|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
146338642|NCT02981472|527747674|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
146338643|NCT02981472|527747673|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
146338644|NCT02981472|527747674|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
146338645|NCT02981472|527747673|FG000|Treatment Period|Adverse Event|6|||
146338646|NCT02981472|527747674|FG001|Treatment Period|Adverse Event|1|||
146338647|NCT02981472|527747673|FG000|Treatment Period|Participant withdrew consent|1|||
146338648|NCT02981472|527747674|FG001|Treatment Period|Participant withdrew consent|0|||
146338649|NCT02981472|527747673|FG000|Treatment Period|Lost to Follow-up|0|||
146338650|NCT02981472|527747674|FG001|Treatment Period|Lost to Follow-up|1|||
146338651|NCT03523585|527747677|FG000|Overall Study|Progressive Disease|174|||
146338652|NCT03523585|527747678|FG001|Overall Study|Progressive Disease|64|||
146338653|NCT03523585|527747679|FG002|Overall Study|Progressive Disease|77|||
146338654|NCT03523585|527747677|FG000|Overall Study|Adverse Event|74|||
146338655|NCT03523585|527747678|FG001|Overall Study|Adverse Event|5|||
146338656|NCT03523585|527747679|FG002|Overall Study|Adverse Event|9|||
146338657|NCT03523585|527747677|FG000|Overall Study|Withdrawal by Subject|30|||
146338658|NCT03523585|527747678|FG001|Overall Study|Withdrawal by Subject|11|||
146338659|NCT03523585|527747679|FG002|Overall Study|Withdrawal by Subject|6|||
146338660|NCT03523585|527747677|FG000|Overall Study|Clinical Progression|23|||
146338661|NCT03523585|527747678|FG001|Overall Study|Clinical Progression|5|||
146338662|NCT03523585|527747679|FG002|Overall Study|Clinical Progression|10|||
146338663|NCT03523585|527747677|FG000|Overall Study|Death|4|||
146338664|NCT03523585|527747678|FG001|Overall Study|Death|0|||
146338665|NCT03523585|527747679|FG002|Overall Study|Death|1|||
146338666|NCT03523585|527747677|FG000|Overall Study|Physician Decision|2|||
146338667|NCT03523585|527747678|FG001|Overall Study|Physician Decision|1|||
146338668|NCT03523585|527747679|FG002|Overall Study|Physician Decision|0|||
146338669|NCT03523585|527747677|FG000|Overall Study|Lost to Follow-up|1|||
146338670|NCT03523585|527747678|FG001|Overall Study|Lost to Follow-up|0|||
146338671|NCT03523585|527747679|FG002|Overall Study|Lost to Follow-up|0|||
146338672|NCT03523585|527747677|FG000|Overall Study|Miscellaneous|1|||
146338673|NCT03523585|527747678|FG001|Overall Study|Miscellaneous|0|||
146338674|NCT03523585|527747679|FG002|Overall Study|Miscellaneous|0|||
146338675|NCT03523585|527747677|FG000|Overall Study|Protocol Deviation|1|||
146338676|NCT03523585|527747678|FG001|Overall Study|Protocol Deviation|0|||
146338677|NCT03523585|527747679|FG002|Overall Study|Protocol Deviation|1|||
146169084|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
146169085|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
146169086|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
146169087|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
146169088|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
146169089|NCT00261495|527131130|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
146169090|NCT00261495|527131131|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
146169091|NCT03474107|527131132|FG000|Overall Study|Adverse Event|42|||
146169092|NCT03474107|527131133|FG001|Overall Study|Adverse Event|46|||
146169093|NCT03474107|527131132|FG000|Overall Study|Death|2|||
146169094|NCT03474107|527131133|FG001|Overall Study|Death|2|||
146169095|NCT03474107|527131132|FG000|Overall Study|Lost to Follow-up|0|||
146169096|NCT03474107|527131133|FG001|Overall Study|Lost to Follow-up|1|||
146169097|NCT03474107|527131132|FG000|Overall Study|Progressive Disease|177|||
146169098|NCT03474107|527131133|FG001|Overall Study|Progressive Disease|180|||
146169099|NCT03474107|527131132|FG000|Overall Study|Protocol Violation|1|||
146169100|NCT03474107|527131133|FG001|Overall Study|Protocol Violation|1|||
146169101|NCT03474107|527131132|FG000|Overall Study|Withdrawal by Subject|15|||
146169102|NCT03474107|527131133|FG001|Overall Study|Withdrawal by Subject|27|||
146169103|NCT03474107|527131132|FG000|Overall Study|Physician Decision|7|||
146169104|NCT03474107|527131133|FG001|Overall Study|Physician Decision|22|||
146169105|NCT03474107|527131132|FG000|Overall Study|Miscellaneous|1|||
146169106|NCT03474107|527131133|FG001|Overall Study|Miscellaneous|6|||
146338678|NCT03523585|527747677|FG000|Overall Study|Randomized But Not Treated|2|||
146169107|NCT01932697|527131134|FG000|Overall Study|Received a different amount of tx|1|||
146169108|NCT01932697|527131135|FG001|Overall Study|Received a different amount of tx|0|||
146169109|NCT01932697|527131134|FG000|Overall Study|Ineligible|1|||
146338679|NCT03523585|527747678|FG001|Overall Study|Randomized But Not Treated|4|||
146338680|NCT03523585|527747679|FG002|Overall Study|Randomized But Not Treated|3|||
146338681|NCT00613314|527747686|FG000|Overall Study|Adverse Event|5|||
146338682|NCT00613314|527747686|FG000|Overall Study|Protocol Violation|14|||
146338683|NCT00613314|527747686|FG000|Overall Study|Lost to Follow-up|46|||
146338684|NCT00613314|527747686|FG000|Overall Study|Other reason not defined above|90|||
146338685|NCT01062399|527747687|FG000|Overall Study|Protocol Violation|0|||
146338686|NCT01062399|527747688|FG001|Overall Study|Protocol Violation|1|||
146338687|NCT01062399|527747689|FG002|Overall Study|Protocol Violation|0|||
146338688|NCT01062399|527747690|FG003|Overall Study|Protocol Violation|6|||
146338689|NCT01062399|527747691|FG004|Overall Study|Protocol Violation|4|||
146338690|NCT05408858|527747712|FG000|Overall Study|no longer met eligibility criteria|1|||
146338691|NCT01021007|527747721|FG000|Overall Study|Lost to Follow-up|1|||
146338692|NCT01021007|527747722|FG001|Overall Study|Lost to Follow-up|1|||
146338693|NCT01021007|527747721|FG000|Overall Study|Adverse Event|1|||
146338694|NCT01021007|527747722|FG001|Overall Study|Adverse Event|3|||
146338695|NCT01126619|527747727|FG000|Overall Study|Not eligible for the study|2|||
146338696|NCT01126619|527747727|FG000|Overall Study|Investigator decision|4|||
146338697|NCT01126619|527747727|FG000|Overall Study|Serious adverse event|1|||
146338698|NCT01126619|527747727|FG000|Overall Study|Withdrawal by Subject|9|||
146338699|NCT01126619|527747727|FG000|Overall Study|Non-compliance|1|||
146338700|NCT00947154|527747728|FG000|Overall Study|Lost to Follow-up|1|||
146338701|NCT03293030|527747729|FG000|Overall Study|Withdrawal by Subject|3|||
146338702|NCT04899271|527747730|FG000|Overall Study|Lost to Follow-up|1|||
146338703|NCT04899271|527747731|FG001|Overall Study|Lost to Follow-up|0|||
146338704|NCT04899271|527747730|FG000|Overall Study|Subject request/consent withdrawal|2|||
146338705|NCT04899271|527747731|FG001|Overall Study|Subject request/consent withdrawal|0|||
146338706|NCT01829048|527747735|FG000|Overall Study|Withdrawal by Subject|0|||
146338707|NCT01829048|527747736|FG001|Overall Study|Withdrawal by Subject|0|||
146338708|NCT01829048|527747737|FG002|Overall Study|Withdrawal by Subject|0|||
146338709|NCT01829048|527747738|FG003|Overall Study|Withdrawal by Subject|2|||
146338710|NCT01829048|527747739|FG004|Overall Study|Withdrawal by Subject|0|||
146338711|NCT01121406|527747740|FG000|Overall Study|Progressive disease RECIST|44|||
146338712|NCT01121406|527747741|FG001|Overall Study|Progressive disease RECIST|28|||
146338713|NCT01121406|527747740|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
146338714|NCT01121406|527747741|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
146338715|NCT01121406|527747740|FG000|Overall Study|Other AE|3|||
146338716|NCT01121406|527747741|FG001|Overall Study|Other AE|10|||
146338717|NCT01121406|527747740|FG000|Overall Study|Non-compliant with protocol|0|||
146338718|NCT01121406|527747741|FG001|Overall Study|Non-compliant with protocol|2|||
146338719|NCT01121406|527747740|FG000|Overall Study|Lost to Follow-up|0|||
146338720|NCT01121406|527747741|FG001|Overall Study|Lost to Follow-up|1|||
146338721|NCT01121406|527747740|FG000|Overall Study|Refused continuation of study med.|1|||
146338722|NCT01121406|527747741|FG001|Overall Study|Refused continuation of study med.|2|||
146338723|NCT01121406|527747740|FG000|Overall Study|Reason other than specified above|2|||
146338724|NCT01121406|527747741|FG001|Overall Study|Reason other than specified above|6|||
146338725|NCT01121406|527747740|FG000|Overall Study|Not treated|1|||
146338726|NCT01121406|527747741|FG001|Overall Study|Not treated|0|||
146338727|NCT00892437|527747742|FG000|Randomized Phase|Randomized but not treated|6|||
146338728|NCT00892437|527747743|FG001|Randomized Phase|Randomized but not treated|0|||
146338729|NCT00892437|527747742|FG000|Randomized Phase|Adverse Event|2|||
146338730|NCT00892437|527747743|FG001|Randomized Phase|Adverse Event|2|||
146338731|NCT00892437|527747742|FG000|Randomized Phase|Lost to Follow-up|1|||
146338732|NCT00892437|527747743|FG001|Randomized Phase|Lost to Follow-up|3|||
146338733|NCT00892437|527747742|FG000|Randomized Phase|Investigator's Discretion|1|||
146338734|NCT00892437|527747743|FG001|Randomized Phase|Investigator's Discretion|0|||
146338735|NCT00892437|527747742|FG000|Randomized Phase|Withdrew Consent|1|||
146338736|NCT00892437|527747743|FG001|Randomized Phase|Withdrew Consent|0|||
146338737|NCT00892437|527747742|FG000|Open-Label Extension Phase|Adverse Event|4|||
146338738|NCT00892437|527747743|FG001|Open-Label Extension Phase|Adverse Event|2|||
146169110|NCT01932697|527131135|FG001|Overall Study|Ineligible|0|||
146169111|NCT01330316|527131136|FG000|Overall Study|Adverse Event|2|||
146169112|NCT01330316|527131137|FG001|Overall Study|Adverse Event|2|||
146169113|NCT01330316|527131136|FG000|Overall Study|Lack of Efficacy|0|||
146169114|NCT01330316|527131137|FG001|Overall Study|Lack of Efficacy|10|||
146169115|NCT01330316|527131136|FG000|Overall Study|Lost to Follow-up|0|||
146338739|NCT00892437|527747742|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
146338740|NCT00892437|527747743|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
146338741|NCT00892437|527747742|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
146169116|NCT01330316|527131137|FG001|Overall Study|Lost to Follow-up|1|||
146169117|NCT01330316|527131136|FG000|Overall Study|Withdrawal by Subject|0|||
146338742|NCT00892437|527747743|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
146338743|NCT00892437|527747742|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
146338744|NCT00892437|527747743|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146338745|NCT00892437|527747742|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
146338746|NCT00892437|527747743|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
146169118|NCT01330316|527131137|FG001|Overall Study|Withdrawal by Subject|1|||
146338747|NCT00504257|527747744|FG000|Overall Study|Withdrawal by Subject|2|||
146338748|NCT00504257|527747744|FG000|Overall Study|ineligible histology|2|||
146338749|NCT02750410|527747747|FG000|Double-Blind Treatment Period|Adverse Event|2|||
146338750|NCT02750410|527747748|FG001|Double-Blind Treatment Period|Adverse Event|2|||
146338751|NCT02750410|527747747|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146338752|NCT02750410|527747748|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146338753|NCT02750410|527747747|FG000|Open-Label Extension Period|Adverse Event|5|||
146338754|NCT02750410|527747748|FG001|Open-Label Extension Period|Adverse Event|3|||
146338755|NCT02750410|527747747|FG000|Open-Label Extension Period|Protocol Violation|0|||
146338756|NCT02750410|527747748|FG001|Open-Label Extension Period|Protocol Violation|1|||
146338757|NCT02750410|527747747|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
146338758|NCT02750410|527747748|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
146338759|NCT02504541|527747749|FG000|Overall Study|Adverse Event|4|||
146338760|NCT02504541|527747749|FG000|Overall Study|Withdrawal by Subject|4|||
146338761|NCT02504541|527747749|FG000|Overall Study|Lost to Follow-up|1|||
146338762|NCT02504541|527747749|FG000|Overall Study|Met Stopping Criteria|1|||
146338763|NCT02504541|527747749|FG000|Overall Study|Protocol Violation|2|||
146338764|NCT02504541|527747749|FG000|Overall Study|Termination by Sponsor|1|||
146338765|NCT02504541|527747749|FG000|Overall Study|Other|2|||
146338766|NCT02504541|527747749|FG000|Overall Study|Multiple|5|||
146338767|NCT02318602|527747753|FG000|Overall Study|Adverse Event|0|||
146338768|NCT02318602|527747754|FG001|Overall Study|Adverse Event|1|||
146338769|NCT02318602|527747755|FG002|Overall Study|Adverse Event|1|||
146338770|NCT02318602|527747753|FG000|Overall Study|Withdrawal by Subject|0|||
146338771|NCT02318602|527747754|FG001|Overall Study|Withdrawal by Subject|3|||
146338772|NCT02318602|527747755|FG002|Overall Study|Withdrawal by Subject|0|||
146338773|NCT02318602|527747753|FG000|Overall Study|Death|1|||
146338774|NCT02318602|527747754|FG001|Overall Study|Death|0|||
146338775|NCT02318602|527747755|FG002|Overall Study|Death|0|||
146338776|NCT02318602|527747753|FG000|Overall Study|Guardian decision to withdraw|0|||
146338777|NCT02318602|527747754|FG001|Overall Study|Guardian decision to withdraw|0|||
146338778|NCT02318602|527747755|FG002|Overall Study|Guardian decision to withdraw|1|||
146338779|NCT02580058|527747758|FG000|Overall Study|Adverse Event|16|||
146338780|NCT02580058|527747759|FG001|Overall Study|Adverse Event|30|||
146338781|NCT02580058|527747760|FG002|Overall Study|Adverse Event|20|||
146338782|NCT02580058|527747758|FG000|Overall Study|Death|4|||
146338783|NCT02580058|527747759|FG001|Overall Study|Death|4|||
146338784|NCT02580058|527747760|FG002|Overall Study|Death|5|||
146338785|NCT02580058|527747758|FG000|Overall Study|Physician Decision|1|||
146338786|NCT02580058|527747759|FG001|Overall Study|Physician Decision|3|||
146338787|NCT02580058|527747760|FG002|Overall Study|Physician Decision|11|||
146338788|NCT02580058|527747758|FG000|Overall Study|Other|5|||
146338789|NCT02580058|527747759|FG001|Overall Study|Other|1|||
146338790|NCT02580058|527747760|FG002|Overall Study|Other|3|||
146338791|NCT02580058|527747758|FG000|Overall Study|Withdrawal by Subject|4|||
146338792|NCT02580058|527747759|FG001|Overall Study|Withdrawal by Subject|7|||
146338793|NCT02580058|527747760|FG002|Overall Study|Withdrawal by Subject|31|||
146338794|NCT02580058|527747758|FG000|Overall Study|Global Deterioration of Health Status|19|||
146338795|NCT02580058|527747759|FG001|Overall Study|Global Deterioration of Health Status|18|||
146338796|NCT02580058|527747760|FG002|Overall Study|Global Deterioration of Health Status|24|||
146338797|NCT02580058|527747758|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
146338798|NCT02580058|527747759|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146338799|NCT02580058|527747760|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
146338800|NCT02580058|527747758|FG000|Overall Study|Progressive Disease|137|||
146338801|NCT02580058|527747759|FG001|Overall Study|Progressive Disease|125|||
146338802|NCT02580058|527747760|FG002|Overall Study|Progressive Disease|94|||
146338803|NCT02580058|527747758|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146338804|NCT02580058|527747759|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146338805|NCT02580058|527747760|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146338806|NCT01193335|527747761|FG000|After Infant Series|Lost to Follow-up|1|||
146338807|NCT01193335|527747762|FG001|After Infant Series|Lost to Follow-up|2|||
146338808|NCT01193335|527747761|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
146338809|NCT01193335|527747762|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
146338810|NCT01193335|527747761|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
146338811|NCT01193335|527747762|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
146338812|NCT01193335|527747761|FG000|1-Year Follow-up|Lost to Follow-up|4|||
146338813|NCT01193335|527747762|FG001|1-Year Follow-up|Lost to Follow-up|0|||
146338814|NCT01193335|527747761|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
146338815|NCT01193335|527747762|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
146338816|NCT01193335|527747761|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
146338817|NCT01193335|527747762|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
146338818|NCT01733329|527747763|FG000|Overall Study|Protocol Violation|1|||
146338819|NCT01733329|527747764|FG001|Overall Study|Protocol Violation|1|||
146338820|NCT01733329|527747763|FG000|Overall Study|Uterine artery injury|1|||
146169119|NCT01330316|527131136|FG000|Overall Study|other than above|0|||
146338821|NCT01733329|527747764|FG001|Overall Study|Uterine artery injury|0|||
146338822|NCT02388776|527747769|FG000|Overall Study|Death|1|||
146338823|NCT02388776|527747769|FG000|Overall Study|Lost to Follow-up|1|||
146338824|NCT00095303|527747774|FG000|Main Study|Lost to Follow-up|91|||
146338825|NCT00095303|527747775|FG001|Main Study|Lost to Follow-up|87|||
146338826|NCT00095303|527747774|FG000|Follow Up Study|Lost to Follow-up|59|||
146338827|NCT00095303|527747775|FG001|Follow Up Study|Lost to Follow-up|58|||
146338828|NCT01364467|527747778|FG000|Overall Study|Lost to Follow-up|1|||
146338829|NCT01364467|527747779|FG001|Overall Study|Lost to Follow-up|2|||
146338830|NCT03228186|527747780|FG000|Overall Study|Patient never started treatment|1|||
146338831|NCT01634243|527747783|FG000|Overall Study|Adverse Event|5|||
146338832|NCT01634243|527747784|FG001|Overall Study|Adverse Event|5|||
146338833|NCT01634243|527747783|FG000|Overall Study|Lack of Efficacy|1|||
146338834|NCT01634243|527747784|FG001|Overall Study|Lack of Efficacy|0|||
146338835|NCT05490771|527747785|FG000|Overall Study|Disease progression|18|||
146338836|NCT05490771|527747785|FG000|Overall Study|Adverse Event|3|||
146338837|NCT05490771|527747785|FG000|Overall Study|Other complicating disease|1|||
146338838|NCT05490771|527747785|FG000|Overall Study|Withdrawal by Subject|3|||
146338839|NCT05490771|527747785|FG000|Overall Study|Physician Decision|1|||
146338840|NCT05490771|527747785|FG000|Overall Study|Still on treatment|2|||
146338841|NCT05490771|527747785|FG000|Overall Study|Never start protocol therapy|5|||
146338842|NCT05490771|527747785|FG000|Overall Study|Ineligible|2|||
146338843|NCT04246047|527747786|FG000|Overall Study|Death|50|||
146338844|NCT04246047|527747787|FG001|Overall Study|Death|77|||
146338845|NCT04246047|527747786|FG000|Overall Study|Lost to Follow-up|1|||
146338846|NCT04246047|527747787|FG001|Overall Study|Lost to Follow-up|3|||
146338847|NCT04246047|527747786|FG000|Overall Study|Physician Decision|4|||
146338848|NCT04246047|527747787|FG001|Overall Study|Physician Decision|10|||
146338849|NCT04246047|527747786|FG000|Overall Study|Withdrawal by Subject|19|||
146338850|NCT04246047|527747787|FG001|Overall Study|Withdrawal by Subject|26|||
146338851|NCT04246047|527747786|FG000|Overall Study|Ongoing|169|||
146338852|NCT04246047|527747787|FG001|Overall Study|Ongoing|135|||
146338853|NCT02502864|527747790|FG000|Overall Study|Withdrawal by Subject|1|||
146338854|NCT00104871|527747796|FG000|Overall Study|Not evaluable|1|||
146338855|NCT00457639|527747800|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
146338856|NCT00457639|527747801|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
146338857|NCT00457639|527747800|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
146338858|NCT00457639|527747801|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
146338859|NCT00457639|527747800|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
146338860|NCT00457639|527747801|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
146338861|NCT01450540|527747802|FG000|Overall Study|Withdrawal by Subject|19|||
146338862|NCT01450540|527747803|FG001|Overall Study|Withdrawal by Subject|13|||
146338863|NCT01450540|527747802|FG000|Overall Study|protocol deviation|3|||
146338864|NCT01450540|527747803|FG001|Overall Study|protocol deviation|23|||
146338865|NCT00630032|527747810|FG000|Overall Study|Death|55|||
146338866|NCT00630032|527747811|FG001|Overall Study|Death|49|||
146338867|NCT00630032|527747810|FG000|Overall Study|Withdrawal by Subject|3|||
146338868|NCT00630032|527747811|FG001|Overall Study|Withdrawal by Subject|2|||
146338869|NCT00630032|527747810|FG000|Overall Study|Lost to Follow-up|18|||
146338870|NCT00630032|527747811|FG001|Overall Study|Lost to Follow-up|31|||
146338871|NCT00630032|527747810|FG000|Overall Study|Protocol Violation|1|||
146338872|NCT00630032|527747811|FG001|Overall Study|Protocol Violation|0|||
146338873|NCT00630032|527747810|FG000|Overall Study|Patient has moved|1|||
146338874|NCT00630032|527747811|FG001|Overall Study|Patient has moved|1|||
146338875|NCT00630032|527747810|FG000|Overall Study|Disease progression|1|||
146338876|NCT00630032|527747811|FG001|Overall Study|Disease progression|1|||
146338877|NCT00630032|527747810|FG000|Overall Study|End of monitoring in US centers|11|||
146338878|NCT00630032|527747811|FG001|Overall Study|End of monitoring in US centers|11|||
146338879|NCT03746080|527749317|FG000|Overall Study|In follow up|2|||
146338880|NCT03746080|527749317|FG000|Overall Study|Death|15|||
146338881|NCT03199911|527749321|FG000|Overall Study|Lost to Follow-up|5|||
146338882|NCT03199911|527749322|FG001|Overall Study|Lost to Follow-up|5|||
146338883|NCT03199911|527749321|FG000|Overall Study|Did not proceed with surgery|2|||
146338884|NCT03199911|527749322|FG001|Overall Study|Did not proceed with surgery|1|||
146338885|NCT04430348|527749327|FG000|Overall Study|Death|3|||
146338886|NCT04430348|527749328|FG001|Overall Study|Death|2|||
146338887|NCT04430348|527749329|FG002|Overall Study|Death|2|||
146338888|NCT04430348|527749330|FG003|Overall Study|Death|2|||
146338889|NCT04430348|527749331|FG004|Overall Study|Death|2|||
146338890|NCT04430348|527749332|FG005|Overall Study|Death|3|||
146338891|NCT04430348|527749327|FG000|Overall Study|Lost to Follow-up|0|||
146338892|NCT04430348|527749328|FG001|Overall Study|Lost to Follow-up|0|||
146338893|NCT04430348|527749329|FG002|Overall Study|Lost to Follow-up|0|||
146338894|NCT04430348|527749330|FG003|Overall Study|Lost to Follow-up|1|||
146338895|NCT04430348|527749331|FG004|Overall Study|Lost to Follow-up|0|||
146338896|NCT04430348|527749332|FG005|Overall Study|Lost to Follow-up|0|||
146338897|NCT04430348|527749327|FG000|Overall Study|Adverse Event|0|||
146338898|NCT04430348|527749328|FG001|Overall Study|Adverse Event|0|||
146338899|NCT04430348|527749329|FG002|Overall Study|Adverse Event|0|||
146338900|NCT04430348|527749330|FG003|Overall Study|Adverse Event|0|||
146338901|NCT04430348|527749331|FG004|Overall Study|Adverse Event|0|||
146338902|NCT04430348|527749332|FG005|Overall Study|Adverse Event|1|||
146338903|NCT04430348|527749327|FG000|Overall Study|Withdrawal by Subject|0|||
146338904|NCT04430348|527749328|FG001|Overall Study|Withdrawal by Subject|1|||
146338905|NCT04430348|527749329|FG002|Overall Study|Withdrawal by Subject|0|||
146338906|NCT04430348|527749330|FG003|Overall Study|Withdrawal by Subject|0|||
146338907|NCT04430348|527749331|FG004|Overall Study|Withdrawal by Subject|0|||
146338908|NCT04430348|527749332|FG005|Overall Study|Withdrawal by Subject|1|||
146338909|NCT04430348|527749327|FG000|Overall Study|Study Terminated by Sponsor|0|||
146338910|NCT04430348|527749328|FG001|Overall Study|Study Terminated by Sponsor|0|||
146338911|NCT04430348|527749329|FG002|Overall Study|Study Terminated by Sponsor|2|||
146338912|NCT04430348|527749330|FG003|Overall Study|Study Terminated by Sponsor|0|||
146338913|NCT04430348|527749331|FG004|Overall Study|Study Terminated by Sponsor|1|||
146338914|NCT04430348|527749332|FG005|Overall Study|Study Terminated by Sponsor|1|||
146338915|NCT02874794|527749335|FG000|Overall Study|Physician Decision|3|||
146338916|NCT02874794|527749336|FG001|Overall Study|Physician Decision|2|||
146338917|NCT02874794|527749335|FG000|Overall Study|Withdrawal by Subject|2|||
146338918|NCT02874794|527749336|FG001|Overall Study|Withdrawal by Subject|8|||
146338919|NCT02874794|527749335|FG000|Overall Study|Death|2|||
146338920|NCT02874794|527749336|FG001|Overall Study|Death|1|||
146338921|NCT04328623|527749337|FG000|Overall Study|Protocol Violation|0|||
146338922|NCT04328623|527749338|FG001|Overall Study|Protocol Violation|1|||
146338923|NCT03839524|527749340|FG000|Overall Study|Adverse Event|1|||
146338924|NCT05309668|527749344|FG000|Overall Study|Ongoing at data cut-off|14|||
146338925|NCT05309668|527749345|FG001|Overall Study|Ongoing at data cut-off|17|||
146338926|NCT05309668|527749346|FG002|Overall Study|Ongoing at data cut-off|4|||
146338927|NCT03715465|527749347|FG000|Overall Study|Withdrawal by Subject|1|||
146338928|NCT03715465|527749348|FG001|Overall Study|Withdrawal by Subject|2|||
146338929|NCT02465034|527749356|FG000|Overall Study|Withdrawal by Subject|1|||
146338930|NCT02465034|527749357|FG001|Overall Study|Withdrawal by Subject|1|||
146338931|NCT02465034|527749356|FG000|Overall Study|Screen fail|2|||
146338932|NCT02465034|527749357|FG001|Overall Study|Screen fail|0|||
146338933|NCT02465034|527749356|FG000|Overall Study|Could not be scheduled for study visit|0|||
146338934|NCT02465034|527749357|FG001|Overall Study|Could not be scheduled for study visit|5|||
146338935|NCT02401256|527749363|FG000|Overall Study|Adverse Event|5|||
146338936|NCT02401256|527749363|FG000|Overall Study|Withdrawal by Subject|12|||
146338937|NCT01451515|527749370|FG000|Overall Study|Death|0|||
146338938|NCT01451515|527749371|FG001|Overall Study|Death|1|||
146338939|NCT01451515|527749372|FG002|Overall Study|Death|0|||
146338940|NCT01451515|527749370|FG000|Overall Study|Withdrawal by Subject|0|||
146338941|NCT01451515|527749371|FG001|Overall Study|Withdrawal by Subject|1|||
146338942|NCT01451515|527749372|FG002|Overall Study|Withdrawal by Subject|0|||
146338943|NCT01451515|527749370|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
146338944|NCT01451515|527749371|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
146338945|NCT01451515|527749372|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
146338946|NCT01451515|527749370|FG000|Overall Study|Relapse (except CNS)|1|||
146338947|NCT01451515|527749371|FG001|Overall Study|Relapse (except CNS)|1|||
146338948|NCT01451515|527749372|FG002|Overall Study|Relapse (except CNS)|0|||
146338949|NCT02317510|527749374|FG000|Overall Study|Adverse Event|0|||
146338950|NCT02317510|527749375|FG001|Overall Study|Adverse Event|1|||
146338951|NCT03427073|527749376|FG000|Overall Study|Disease Progression|1|||
146338952|NCT03427073|527749377|FG001|Overall Study|Disease Progression|1|||
146338953|NCT03427073|527749378|FG002|Overall Study|Disease Progression|1|||
146338954|NCT03427073|527749379|FG003|Overall Study|Disease Progression|3|||
146338955|NCT03427073|527749380|FG004|Overall Study|Disease Progression|3|||
146338956|NCT03427073|527749381|FG005|Overall Study|Disease Progression|4|||
146338957|NCT03427073|527749382|FG006|Overall Study|Disease Progression|2|||
146338958|NCT03427073|527749383|FG007|Overall Study|Disease Progression|3|||
146338959|NCT03427073|527749376|FG000|Overall Study|Physician Decision|0|||
146338960|NCT03427073|527749377|FG001|Overall Study|Physician Decision|0|||
146338961|NCT03427073|527749378|FG002|Overall Study|Physician Decision|0|||
146338962|NCT03427073|527749379|FG003|Overall Study|Physician Decision|0|||
146338963|NCT03427073|527749380|FG004|Overall Study|Physician Decision|0|||
146338964|NCT03427073|527749381|FG005|Overall Study|Physician Decision|0|||
146338965|NCT03427073|527749382|FG006|Overall Study|Physician Decision|1|||
146338966|NCT03427073|527749383|FG007|Overall Study|Physician Decision|1|||
146338967|NCT04786210|527749387|FG000|Overall Study|Lost to Follow-up|2|||
146338968|NCT04786210|527749387|FG000|Overall Study|Withdrawal by Subject|4|||
146338969|NCT04334148|527749388|FG000|Overall Study|positive nasal swab at baseline|0|||
146338970|NCT04334148|527749389|FG001|Overall Study|positive nasal swab at baseline|1|||
146338971|NCT00498173|527749390|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
146338972|NCT00498173|527749391|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
146338973|NCT00498173|527749392|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
146338974|NCT00258154|527749393|FG000|Overall Study|Adverse Event|1|||
146338975|NCT00258154|527749394|FG001|Overall Study|Adverse Event|0|||
146338976|NCT00258154|527749393|FG000|Overall Study|Lost to Follow-up|0|||
146338977|NCT00258154|527749394|FG001|Overall Study|Lost to Follow-up|1|||
146338978|NCT00258154|527749393|FG000|Overall Study|Protocol Violation|2|||
146338979|NCT00258154|527749394|FG001|Overall Study|Protocol Violation|1|||
146338980|NCT00258154|527749393|FG000|Overall Study|Withdrawal by Subject|3|||
146338981|NCT00258154|527749394|FG001|Overall Study|Withdrawal by Subject|4|||
146338982|NCT00258154|527749393|FG000|Overall Study|Patient Moved|3|||
146338983|NCT00258154|527749394|FG001|Overall Study|Patient Moved|1|||
146338984|NCT03772327|527749395|FG000|Overall Study|Lost to Follow-up|3|||
146338985|NCT03772327|527749396|FG001|Overall Study|Lost to Follow-up|4|||
146338986|NCT03772327|527749395|FG000|Overall Study|Withdrawal by Subject|2|||
146338987|NCT03772327|527749396|FG001|Overall Study|Withdrawal by Subject|3|||
146338988|NCT04689828|527749397|FG000|Overall Study|Subject decision|5|||
146338989|NCT04689828|527749398|FG001|Overall Study|Subject decision|5|||
146338990|NCT04689828|527749397|FG000|Overall Study|Adverse Event|12|||
146338991|NCT04689828|527749398|FG001|Overall Study|Adverse Event|12|||
146338992|NCT04689828|527749397|FG000|Overall Study|Physician Decision|24|||
146338993|NCT04689828|527749398|FG001|Overall Study|Physician Decision|32|||
146338994|NCT04689828|527749397|FG000|Overall Study|Progressive disease|54|||
146338995|NCT04689828|527749398|FG001|Overall Study|Progressive disease|173|||
146338996|NCT04689828|527749397|FG000|Overall Study|Death|0|||
146338997|NCT04689828|527749398|FG001|Overall Study|Death|1|||
146338998|NCT04689828|527749397|FG000|Overall Study|Lost to Follow-up|1|||
146338999|NCT04689828|527749398|FG001|Overall Study|Lost to Follow-up|0|||
146339000|NCT04689828|527749397|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
146339001|NCT04689828|527749398|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
146339002|NCT04689828|527749397|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
146339003|NCT04689828|527749398|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
146339004|NCT04689828|527749397|FG000|Overall Study|Participants not treated|7|||
146339005|NCT04689828|527749398|FG001|Overall Study|Participants not treated|2|||
146339006|NCT02493751|527749399|FG000|Overall Study|Withdrawal by Subject|2|||
146339007|NCT02493751|527749400|FG001|Overall Study|Withdrawal by Subject|8|||
146339008|NCT02493751|527749399|FG000|Overall Study|Death|6|||
146339009|NCT02493751|527749400|FG001|Overall Study|Death|13|||
146339010|NCT02493751|527749399|FG000|Overall Study|Lost to Follow-up|2|||
146339011|NCT02493751|527749400|FG001|Overall Study|Lost to Follow-up|3|||
146339012|NCT02493751|527749399|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
146339013|NCT02493751|527749400|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
146339014|NCT01824602|527749402|FG000|Overall Study|Withdrawal by Subject|0|||
146339015|NCT01824602|527749403|FG001|Overall Study|Withdrawal by Subject|0|||
146339016|NCT01824602|527749404|FG002|Overall Study|Withdrawal by Subject|1|||
146339017|NCT01824602|527749405|FG003|Overall Study|Withdrawal by Subject|2|||
146339018|NCT01824602|527749402|FG000|Overall Study|Patient non-compliance|0|||
146339019|NCT01824602|527749403|FG001|Overall Study|Patient non-compliance|0|||
146339020|NCT01824602|527749404|FG002|Overall Study|Patient non-compliance|1|||
146339021|NCT01824602|527749405|FG003|Overall Study|Patient non-compliance|0|||
146339022|NCT01824602|527749402|FG000|Overall Study|Adverse Event|1|||
146339023|NCT01824602|527749403|FG001|Overall Study|Adverse Event|0|||
146339024|NCT01824602|527749404|FG002|Overall Study|Adverse Event|2|||
146339025|NCT01824602|527749405|FG003|Overall Study|Adverse Event|2|||
146339026|NCT01824602|527749402|FG000|Overall Study|Treatment failure|0|||
146339027|NCT01824602|527749403|FG001|Overall Study|Treatment failure|0|||
146339028|NCT01824602|527749404|FG002|Overall Study|Treatment failure|0|||
146339029|NCT01824602|527749405|FG003|Overall Study|Treatment failure|1|||
146339030|NCT00184054|527749406|FG000|Overall Study|Adverse Event|1|||
146339031|NCT02485717|527749411|FG000|Overall Study|Lost to Follow-up|6|||
146339032|NCT02485717|527749412|FG001|Overall Study|Lost to Follow-up|0|||
146339033|NCT02485717|527749413|FG002|Overall Study|Lost to Follow-up|0|||
146339034|NCT02485717|527749411|FG000|Overall Study|Withdrawal by Subject|0|||
146339035|NCT02485717|527749412|FG001|Overall Study|Withdrawal by Subject|0|||
146339036|NCT02485717|527749413|FG002|Overall Study|Withdrawal by Subject|1|||
146339037|NCT02485717|527749411|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
146339038|NCT02485717|527749412|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
146339039|NCT02485717|527749413|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
146339040|NCT02485717|527749411|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
146339041|NCT02485717|527749412|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
146339042|NCT02485717|527749413|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
146339043|NCT02192359|527749414|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146339044|NCT02192359|527749415|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146339045|NCT02192359|527749416|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
146339046|NCT02192359|527749417|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
146339047|NCT02192359|527749414|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
146396293|NCT00276458|527954548|FG000|Overall Study|Adverse Event|0|||
146339048|NCT02192359|527749415|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146339049|NCT02192359|527749416|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146339050|NCT02192359|527749417|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
146339051|NCT02192359|527749414|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146339052|NCT02192359|527749415|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146339053|NCT02192359|527749416|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
146339054|NCT02192359|527749417|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
146339055|NCT01687673|527749423|FG000|Overall Study|Physician Decision|1|||
146339056|NCT02234622|527749424|FG000|Overall Study|Withdrawal by Subject|16|||
146339057|NCT02234622|527749425|FG001|Overall Study|Withdrawal by Subject|22|||
146339058|NCT02234622|527749424|FG000|Overall Study|Lost to Follow-up|27|||
146339059|NCT02234622|527749425|FG001|Overall Study|Lost to Follow-up|14|||
146339060|NCT03598777|527749426|FG000|Overall Study|Study Terminated by Sponsor|3|||
146339061|NCT03598777|527749427|FG001|Overall Study|Study Terminated by Sponsor|0|||
146339062|NCT03598777|527749428|FG002|Overall Study|Study Terminated by Sponsor|0|||
146339063|NCT03598777|527749429|FG003|Overall Study|Study Terminated by Sponsor|0|||
146339064|NCT03598777|527749430|FG004|Overall Study|Study Terminated by Sponsor|15|||
146339065|NCT03598777|527749426|FG000|Overall Study|Withdrawal by Subject|1|||
146339066|NCT03598777|527749427|FG001|Overall Study|Withdrawal by Subject|1|||
146339067|NCT03598777|527749428|FG002|Overall Study|Withdrawal by Subject|0|||
146339068|NCT03598777|527749429|FG003|Overall Study|Withdrawal by Subject|0|||
146339069|NCT03598777|527749430|FG004|Overall Study|Withdrawal by Subject|0|||
146339070|NCT03598777|527749426|FG000|Overall Study|Adverse Event|1|||
146339071|NCT03598777|527749427|FG001|Overall Study|Adverse Event|0|||
146339072|NCT03598777|527749428|FG002|Overall Study|Adverse Event|0|||
146339073|NCT03598777|527749429|FG003|Overall Study|Adverse Event|0|||
146339074|NCT03598777|527749430|FG004|Overall Study|Adverse Event|0|||
146339075|NCT03598777|527749426|FG000|Overall Study|Lost to Follow-up|1|||
146339076|NCT03598777|527749427|FG001|Overall Study|Lost to Follow-up|0|||
146339077|NCT03598777|527749428|FG002|Overall Study|Lost to Follow-up|0|||
146339078|NCT03598777|527749429|FG003|Overall Study|Lost to Follow-up|0|||
146339079|NCT03598777|527749430|FG004|Overall Study|Lost to Follow-up|0|||
146339080|NCT02006576|527749431|FG000|Overall Study|Withdrawal by Subject|4|||
146339081|NCT02006576|527749432|FG001|Overall Study|Withdrawal by Subject|6|||
146339082|NCT02006576|527749433|FG002|Overall Study|Withdrawal by Subject|2|||
146339083|NCT02006576|527749431|FG000|Overall Study|Death|0|||
146339084|NCT02006576|527749432|FG001|Overall Study|Death|0|||
146339085|NCT02006576|527749433|FG002|Overall Study|Death|1|||
146339086|NCT02006576|527749431|FG000|Overall Study|Lost to Follow-up|1|||
146339087|NCT02006576|527749432|FG001|Overall Study|Lost to Follow-up|0|||
146339088|NCT02006576|527749433|FG002|Overall Study|Lost to Follow-up|1|||
146339089|NCT02006576|527749431|FG000|Overall Study|Screen Failure, too sick, other|13|||
146339090|NCT02006576|527749432|FG001|Overall Study|Screen Failure, too sick, other|1|||
146339091|NCT02006576|527749433|FG002|Overall Study|Screen Failure, too sick, other|13|||
146339092|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
146339093|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
146339094|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
146339095|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
146339096|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
146339097|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146339098|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146339099|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146339100|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
146339101|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
146339102|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146339103|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146339104|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146339105|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
146339106|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
146339107|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
146339108|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
146339109|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
146339110|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
146339111|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
146339112|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
146339113|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
146339114|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
146339115|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
146339116|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
146339117|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
145943282|NCT02326298|526300476|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146339118|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146339119|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146339120|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
146339121|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
146339122|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146339123|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
146339124|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146339125|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
146339126|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
146339127|NCT00785577|527749434|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146339128|NCT00785577|527749435|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
146339129|NCT00785577|527749436|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146339130|NCT00785577|527749437|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
146339131|NCT00785577|527749438|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
146339132|NCT00785577|527749434|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146339133|NCT00785577|527749435|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146339134|NCT00785577|527749436|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146339135|NCT00785577|527749437|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
146339136|NCT00785577|527749438|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
146339137|NCT00785577|527749434|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
146339138|NCT00785577|527749435|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
146339139|NCT00785577|527749436|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
146339140|NCT00785577|527749437|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
146339141|NCT00785577|527749438|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
146339142|NCT01650805|527749441|FG000|Overall Study|Withdrawal by Subject|1|||
146339143|NCT01650805|527749442|FG001|Overall Study|Withdrawal by Subject|0|||
146339144|NCT02452359|527749445|FG000|Overall Study|Adverse Event|1|||
146339145|NCT02452359|527749445|FG000|Overall Study|Lost to Follow-up|15|||
146339146|NCT02452359|527749445|FG000|Overall Study|Pregnancy|1|||
146339147|NCT02452359|527749445|FG000|Overall Study|Withdrawal by Subject|4|||
146339148|NCT01887210|527749446|FG000|Overall Study|Withdrawal by Subject|1|||
146339149|NCT01887210|527749447|FG001|Overall Study|Withdrawal by Subject|3|||
146339150|NCT01887210|527749446|FG000|Overall Study|Lost to Follow-up|0|||
146339151|NCT01887210|527749447|FG001|Overall Study|Lost to Follow-up|1|||
146339152|NCT02515669|527749452|FG000|228 Week Open-Label Phase|Other|0|||
146339153|NCT02515669|527749453|FG001|228 Week Open-Label Phase|Other|0|||
146339154|NCT02515669|527749454|FG002|228 Week Open-Label Phase|Other|1|||
146339155|NCT02515669|527749455|FG003|228 Week Open-Label Phase|Other|4|||
146339156|NCT02515669|527749452|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
146339157|NCT02515669|527749453|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
146339158|NCT02515669|527749454|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
146339159|NCT02515669|527749455|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
146339160|NCT02515669|527749452|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
146339161|NCT02515669|527749453|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
146339162|NCT02515669|527749454|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
146339163|NCT02515669|527749455|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
146339164|NCT02515669|527749452|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
146339165|NCT02515669|527749453|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
146339166|NCT02515669|527749454|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
146339167|NCT02515669|527749455|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
146339168|NCT02515669|527749452|FG000|228 Week Open-Label Phase|Missing|0|||
146339169|NCT02515669|527749453|FG001|228 Week Open-Label Phase|Missing|2|||
146339170|NCT02515669|527749454|FG002|228 Week Open-Label Phase|Missing|2|||
146339171|NCT02515669|527749455|FG003|228 Week Open-Label Phase|Missing|2|||
146339172|NCT02332915|527749458|FG000|Overall Study|Moved out of region|3|||
146339173|NCT02332915|527749459|FG001|Overall Study|Moved out of region|0|||
146339174|NCT02332915|527749458|FG000|Overall Study|Unrelated illness|1|||
146339175|NCT02332915|527749459|FG001|Overall Study|Unrelated illness|1|||
146339176|NCT02332915|527749458|FG000|Overall Study|Travel distance prohibitive|0|||
146339177|NCT02332915|527749459|FG001|Overall Study|Travel distance prohibitive|1|||
146339178|NCT02332915|527749458|FG000|Overall Study|did not meet inclusion criteria|2|||
146339179|NCT02332915|527749459|FG001|Overall Study|did not meet inclusion criteria|4|||
146339180|NCT01901328|527749463|FG000|Overall Study|Lost to Follow-up|1|||
146339181|NCT01901328|527749464|FG001|Overall Study|Lost to Follow-up|0|||
146339182|NCT01901328|527749463|FG000|Overall Study|Physician Decision|0|||
146339183|NCT01901328|527749464|FG001|Overall Study|Physician Decision|1|||
146339184|NCT01901328|527749463|FG000|Overall Study|Protocol Violation|1|||
146339185|NCT01901328|527749464|FG001|Overall Study|Protocol Violation|1|||
146339186|NCT01901328|527749463|FG000|Overall Study|Study Terminated by Sponsor|19|||
146339187|NCT01901328|527749464|FG001|Overall Study|Study Terminated by Sponsor|16|||
146339188|NCT01901328|527749463|FG000|Overall Study|Withdrawal by Subject|1|||
146169120|NCT01330316|527131137|FG001|Overall Study|other than above|1|||
146339189|NCT01901328|527749464|FG001|Overall Study|Withdrawal by Subject|2|||
146339190|NCT01901328|527749463|FG000|Overall Study|Lack of Efficacy|0|||
146339191|NCT01901328|527749464|FG001|Overall Study|Lack of Efficacy|1|||
146339192|NCT05847881|527749465|FG000|Overall Study|Principal Investigator Decision|8|||
146339193|NCT05847881|527749465|FG000|Overall Study|Withdrawal by Subject|2|||
146339194|NCT05781542|527751025|FG000|Overall Study|Lost to Follow-up|1|||
146339195|NCT05781542|527751026|FG001|Overall Study|Lost to Follow-up|0|||
146339196|NCT05781542|527751027|FG002|Overall Study|Lost to Follow-up|1|||
146339197|NCT05738486|527751030|FG000|Overall Study|Continuing Study|194|||
146339198|NCT05738486|527751031|FG001|Overall Study|Continuing Study|196|||
146339199|NCT05738486|527751032|FG002|Overall Study|Continuing Study|193|||
146339200|NCT05738486|527751033|FG003|Overall Study|Continuing Study|191|||
146339201|NCT05738486|527751030|FG000|Overall Study|Withdrawal by Subject|8|||
146339202|NCT05738486|527751031|FG001|Overall Study|Withdrawal by Subject|5|||
146339203|NCT05738486|527751032|FG002|Overall Study|Withdrawal by Subject|7|||
146339204|NCT05738486|527751033|FG003|Overall Study|Withdrawal by Subject|13|||
146339205|NCT05738486|527751030|FG000|Overall Study|Adverse Event|4|||
146339206|NCT05738486|527751031|FG001|Overall Study|Adverse Event|6|||
146339207|NCT05738486|527751032|FG002|Overall Study|Adverse Event|4|||
146339208|NCT05738486|527751033|FG003|Overall Study|Adverse Event|5|||
146339209|NCT05738486|527751030|FG000|Overall Study|Physician Decision|0|||
146339210|NCT05738486|527751031|FG001|Overall Study|Physician Decision|2|||
146339211|NCT05738486|527751032|FG002|Overall Study|Physician Decision|4|||
146339212|NCT05738486|527751033|FG003|Overall Study|Physician Decision|1|||
146339213|NCT05738486|527751030|FG000|Overall Study|Lost to Follow-up|1|||
146339214|NCT05738486|527751031|FG001|Overall Study|Lost to Follow-up|1|||
146339215|NCT05738486|527751032|FG002|Overall Study|Lost to Follow-up|2|||
146339216|NCT05738486|527751033|FG003|Overall Study|Lost to Follow-up|1|||
146339217|NCT05738486|527751030|FG000|Overall Study|Participant was Non-ambulatory|0|||
146339218|NCT05738486|527751031|FG001|Overall Study|Participant was Non-ambulatory|0|||
146339219|NCT05738486|527751032|FG002|Overall Study|Participant was Non-ambulatory|1|||
146339220|NCT05738486|527751033|FG003|Overall Study|Participant was Non-ambulatory|0|||
146339221|NCT05738486|527751030|FG000|Overall Study|Participant had Poor Venous Access|0|||
146339222|NCT05738486|527751031|FG001|Overall Study|Participant had Poor Venous Access|0|||
146339223|NCT05738486|527751032|FG002|Overall Study|Participant had Poor Venous Access|0|||
146339224|NCT05738486|527751033|FG003|Overall Study|Participant had Poor Venous Access|1|||
146339225|NCT05738486|527751030|FG000|Overall Study|Assigned Treatment by Mistake|0|||
146339226|NCT05738486|527751031|FG001|Overall Study|Assigned Treatment by Mistake|0|||
146339227|NCT05738486|527751032|FG002|Overall Study|Assigned Treatment by Mistake|0|||
146339228|NCT05738486|527751033|FG003|Overall Study|Assigned Treatment by Mistake|1|||
146339229|NCT05738486|527751030|FG000|Overall Study|Death|0|||
146339230|NCT05738486|527751031|FG001|Overall Study|Death|0|||
146339231|NCT05738486|527751032|FG002|Overall Study|Death|1|||
146339232|NCT05738486|527751033|FG003|Overall Study|Death|0|||
146339233|NCT05738486|527751030|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
146339234|NCT05738486|527751031|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146339235|NCT05738486|527751032|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146339236|NCT05738486|527751033|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
146339237|NCT01843374|527751034|FG000|Overall Study|Death|155|||
146339238|NCT01843374|527751035|FG001|Overall Study|Death|313|||
146339239|NCT01843374|527751034|FG000|Overall Study|Withdrawal by Subject|14|||
146339240|NCT01843374|527751035|FG001|Overall Study|Withdrawal by Subject|20|||
146339241|NCT01843374|527751034|FG000|Overall Study|Withdrawing due to Other reason|20|||
146339242|NCT01843374|527751035|FG001|Overall Study|Withdrawing due to Other reason|46|||
146339243|NCT03113500|527751036|FG000|Overall Study|Withdrawal by Subject|1|||
146339244|NCT02517515|527751039|FG000|Overall Study|Adverse Event|0|||
146339245|NCT02517515|527751040|FG001|Overall Study|Adverse Event|1|||
146339246|NCT02517515|527751039|FG000|Overall Study|Withdrew Consent|0|||
146339247|NCT02517515|527751040|FG001|Overall Study|Withdrew Consent|1|||
146339248|NCT02517515|527751039|FG000|Overall Study|Lost to Follow-up|1|||
146339249|NCT02517515|527751040|FG001|Overall Study|Lost to Follow-up|0|||
146339250|NCT02517515|527751039|FG000|Overall Study|Other|1|||
146339251|NCT02517515|527751040|FG001|Overall Study|Other|0|||
146339252|NCT06400238|527751043|FG000|Overall Study|Started Protocol Therapy|2|||
146339253|NCT06400238|527751043|FG000|Overall Study|Adverse Event|1|||
146339254|NCT06400238|527751043|FG000|Overall Study|Death|1|||
146339255|NCT06400238|527751043|FG000|Overall Study|Disease Progression|27|||
146339256|NCT06400238|527751043|FG000|Overall Study|Withdrawal by Subject|2|||
146339257|NCT06400238|527751043|FG000|Overall Study|Physician Decision|2|||
145943283|NCT02326298|526300477|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
146339258|NCT01981187|527751048|FG000|Overall Study|Participant/guardian decision|2|||
146339259|NCT01981187|527751048|FG000|Overall Study|Physician Decision|1|||
146339260|NCT01981187|527751048|FG000|Overall Study|Disease progression|2|||
146339261|NCT01981187|527751048|FG000|Overall Study|Adverse Event|7|||
146339262|NCT01362322|527751049|FG000|Overall Study|Withdrawal by Subject|3|||
146339263|NCT01362322|527751050|FG001|Overall Study|Withdrawal by Subject|1|||
146339264|NCT01362322|527751049|FG000|Overall Study|Lost to Follow-up|2|||
146339265|NCT01362322|527751050|FG001|Overall Study|Lost to Follow-up|6|||
146339266|NCT01009463|527751051|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
146339267|NCT01009463|527751052|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146339268|NCT01009463|527751053|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146339269|NCT01009463|527751054|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146339270|NCT01009463|527751055|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
146339271|NCT01009463|527751051|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
146339272|NCT01009463|527751052|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
146339273|NCT01009463|527751053|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
146339274|NCT01009463|527751054|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
146339275|NCT01009463|527751055|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
146339276|NCT01009463|527751051|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
146339277|NCT01009463|527751052|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146339278|NCT01009463|527751053|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146339279|NCT01009463|527751054|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146339280|NCT01009463|527751055|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
146339281|NCT01009463|527751051|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
146339282|NCT01009463|527751052|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
146339283|NCT01009463|527751053|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
146339284|NCT01009463|527751054|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
146339285|NCT01009463|527751055|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
146339286|NCT01009463|527751051|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
146339287|NCT01009463|527751052|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146339288|NCT01009463|527751053|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146339289|NCT01009463|527751054|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146339290|NCT01009463|527751055|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
146339291|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
146339292|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
146339293|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
146339294|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
146339295|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
146339296|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146339297|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
146339298|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
146339299|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
146339300|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
146339301|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146339302|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
146339303|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
146339304|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
146339305|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
146339306|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
146339307|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146339308|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146339309|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
146339310|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
146339311|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146339312|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
146339313|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
146339314|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
146339315|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
146339316|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146339317|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
146339318|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146339319|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
146339320|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
146339321|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146339322|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
146339323|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
146339324|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
146339325|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
146339326|NCT01009463|527751051|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
146339327|NCT01009463|527751052|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
146339328|NCT01009463|527751053|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
146339329|NCT01009463|527751054|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
146339330|NCT01009463|527751055|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
146339331|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
146339332|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
146339333|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
146339334|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
146339335|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
146339336|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
146339337|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
146339338|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
146339339|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
146339340|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
146339341|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
146339342|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
146339343|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
146339344|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
146339345|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
146339346|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
146339347|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
146339348|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
146339349|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Death|0|||
146339350|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Death|1|||
146339351|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Death|0|||
146339352|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
146339353|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
146339354|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
146339355|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
146339356|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
146339357|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
146339358|NCT00430781|527751056|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
146339359|NCT00430781|527751057|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
146339360|NCT00430781|527751058|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
146339361|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
146339362|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
146339363|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
146339364|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
146339365|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
146339366|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
146339367|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
146339368|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
146339369|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
146339370|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
146339371|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
146339372|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
146339373|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Other|0|||
146339374|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Other|1|||
146339375|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Other|0|||
146339376|NCT00430781|527751056|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
146339377|NCT00430781|527751057|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
146339378|NCT00430781|527751058|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
146339379|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
146339380|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
146339381|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
146339382|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
146339383|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
146339384|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
146339385|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
146339386|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
146339387|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
146339388|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
146339389|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
146339390|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
146339391|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
146339392|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
146339393|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
145943284|NCT02326298|526300464|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
146169121|NCT01337986|527131140|FG000|Overall Study|Adverse Event|2|||
146339394|NCT00430781|527751056|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
146339395|NCT00430781|527751057|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
146339396|NCT00430781|527751058|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
146339397|NCT04329949|527751060|FG000|Overall Study|Death|36|||
146339398|NCT04329949|527751060|FG000|Overall Study|Withdrawal by Subject|4|||
146339399|NCT04329949|527751060|FG000|Overall Study|Termination of study by sponsor|3|||
146339400|NCT00917384|527751063|FG000|Overall Study|Lost to Follow-up|4|||
146339401|NCT00917384|527751064|FG001|Overall Study|Lost to Follow-up|2|||
146339402|NCT00917384|527751063|FG000|Overall Study|Withdrawal by Subject|10|||
146339403|NCT00917384|527751064|FG001|Overall Study|Withdrawal by Subject|2|||
146339404|NCT03717922|527751065|FG000|Overall Study|Lost to Follow-up|2|||
146339405|NCT03717922|527751066|FG001|Overall Study|Lost to Follow-up|2|||
146339406|NCT01458340|527751071|FG000|Overall Study|Adverse Event|5|||
146339407|NCT01458340|527751072|FG001|Overall Study|Adverse Event|4|||
146339408|NCT01458340|527751073|FG002|Overall Study|Adverse Event|2|||
146339409|NCT01458340|527751071|FG000|Overall Study|Lost to Follow-up|3|||
146339410|NCT01458340|527751072|FG001|Overall Study|Lost to Follow-up|3|||
146339411|NCT01458340|527751073|FG002|Overall Study|Lost to Follow-up|10|||
146339412|NCT01458340|527751071|FG000|Overall Study|Miscellaneous|0|||
146339413|NCT01458340|527751072|FG001|Overall Study|Miscellaneous|1|||
146339414|NCT01458340|527751073|FG002|Overall Study|Miscellaneous|0|||
146339415|NCT01458340|527751071|FG000|Overall Study|Physician Decision|1|||
146339416|NCT01458340|527751072|FG001|Overall Study|Physician Decision|1|||
146339417|NCT01458340|527751073|FG002|Overall Study|Physician Decision|2|||
146339418|NCT01458340|527751071|FG000|Overall Study|Protocol Violation|6|||
146339419|NCT01458340|527751072|FG001|Overall Study|Protocol Violation|6|||
146339420|NCT01458340|527751073|FG002|Overall Study|Protocol Violation|5|||
146339421|NCT01458340|527751071|FG000|Overall Study|Withdrawal by Subject|12|||
146339422|NCT01458340|527751072|FG001|Overall Study|Withdrawal by Subject|6|||
146339423|NCT01458340|527751073|FG002|Overall Study|Withdrawal by Subject|4|||
146339424|NCT05218499|527751078|FG000|Overall Study|Not treated|1|||
146339425|NCT05218499|527751079|FG001|Overall Study|Not treated|1|||
146339426|NCT05218499|527751080|FG002|Overall Study|Not treated|8|||
146339427|NCT05218499|527751078|FG000|Overall Study|Death|2|||
146339428|NCT05218499|527751079|FG001|Overall Study|Death|0|||
146339429|NCT05218499|527751080|FG002|Overall Study|Death|0|||
146339430|NCT05218499|527751078|FG000|Overall Study|Other than listed|3|||
146339431|NCT05218499|527751079|FG001|Overall Study|Other than listed|7|||
146339432|NCT05218499|527751080|FG002|Overall Study|Other than listed|10|||
146339433|NCT05218499|527751078|FG000|Overall Study|Protocol deviation|5|||
146339434|NCT05218499|527751079|FG001|Overall Study|Protocol deviation|6|||
146339435|NCT05218499|527751080|FG002|Overall Study|Protocol deviation|4|||
146339436|NCT05218499|527751078|FG000|Overall Study|Technical problems|0|||
146339437|NCT05218499|527751079|FG001|Overall Study|Technical problems|1|||
146339438|NCT05218499|527751080|FG002|Overall Study|Technical problems|0|||
146339439|NCT05218499|527751078|FG000|Overall Study|Burden of trial procedures|0|||
146339440|NCT05218499|527751079|FG001|Overall Study|Burden of trial procedures|1|||
146339441|NCT05218499|527751080|FG002|Overall Study|Burden of trial procedures|2|||
146339442|NCT05218499|527751078|FG000|Overall Study|Clinical disease progression|6|||
146339443|NCT05218499|527751079|FG001|Overall Study|Clinical disease progression|6|||
146339444|NCT05218499|527751080|FG002|Overall Study|Clinical disease progression|11|||
146339445|NCT05218499|527751078|FG000|Overall Study|Objective disease progression|44|||
146339446|NCT05218499|527751079|FG001|Overall Study|Objective disease progression|61|||
146339447|NCT05218499|527751080|FG002|Overall Study|Objective disease progression|42|||
146339448|NCT05218499|527751078|FG000|Overall Study|Adverse Event|11|||
146339449|NCT05218499|527751079|FG001|Overall Study|Adverse Event|36|||
146339450|NCT05218499|527751080|FG002|Overall Study|Adverse Event|9|||
146339451|NCT05218499|527751078|FG000|Overall Study|On treatment at time of snapshot|18|||
146339452|NCT05218499|527751079|FG001|Overall Study|On treatment at time of snapshot|29|||
146339453|NCT05218499|527751080|FG002|Overall Study|On treatment at time of snapshot|0|||
146339454|NCT01575548|527751081|FG000|Overall Study|Adverse Event|15|||
146339455|NCT01575548|527751082|FG001|Overall Study|Adverse Event|2|||
146339456|NCT01575548|527751081|FG000|Overall Study|Disease progression|12|||
146339457|NCT01575548|527751082|FG001|Overall Study|Disease progression|25|||
146339458|NCT01575548|527751081|FG000|Overall Study|Death|1|||
146339459|NCT01575548|527751082|FG001|Overall Study|Death|0|||
146339460|NCT01575548|527751081|FG000|Overall Study|Other complicating disease|1|||
146339461|NCT01575548|527751082|FG001|Overall Study|Other complicating disease|0|||
146339462|NCT01575548|527751081|FG000|Overall Study|Withdrawal by Subject|7|||
146339463|NCT01575548|527751082|FG001|Overall Study|Withdrawal by Subject|3|||
146339464|NCT01575548|527751081|FG000|Overall Study|Noncompliance|1|||
146339465|NCT01575548|527751082|FG001|Overall Study|Noncompliance|0|||
146339466|NCT01575548|527751081|FG000|Overall Study|Anticipated surgery|0|||
146339467|NCT01575548|527751082|FG001|Overall Study|Anticipated surgery|1|||
146339468|NCT01575548|527751081|FG000|Overall Study|Never started protocol therapy|3|||
146339469|NCT01575548|527751082|FG001|Overall Study|Never started protocol therapy|2|||
146339470|NCT01702805|527751089|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
146339471|NCT01702805|527751090|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
146339472|NCT01702805|527751089|FG000|Overall Study|Incomplete Follow-up|18|||
146339473|NCT01702805|527751090|FG001|Overall Study|Incomplete Follow-up|15|||
146339474|NCT01702805|527751089|FG000|Overall Study|Vital Status Assessment Only|40|||
146339475|NCT01702805|527751090|FG001|Overall Study|Vital Status Assessment Only|39|||
146339476|NCT01702805|527751089|FG000|Overall Study|Lost to Follow-up|5|||
146339477|NCT01702805|527751090|FG001|Overall Study|Lost to Follow-up|5|||
146339478|NCT04876391|527751091|FG000|Overall Study|Withdrawal by Subject|1|||
146339479|NCT04876391|527751092|FG001|Overall Study|Withdrawal by Subject|10|||
146339480|NCT04876391|527751091|FG000|Overall Study|Lost to Follow-up|2|||
146339481|NCT04876391|527751092|FG001|Overall Study|Lost to Follow-up|4|||
146339482|NCT04876391|527751091|FG000|Overall Study|Lack of Efficacy|0|||
146339483|NCT04876391|527751092|FG001|Overall Study|Lack of Efficacy|2|||
146339484|NCT04876391|527751091|FG000|Overall Study|Adverse Event|3|||
146339485|NCT04876391|527751092|FG001|Overall Study|Adverse Event|1|||
146339486|NCT04876391|527751091|FG000|Overall Study|Patient non-compliance|0|||
146339487|NCT04876391|527751092|FG001|Overall Study|Patient non-compliance|1|||
146339488|NCT04876391|527751091|FG000|Overall Study|Personal reasons|0|||
146339489|NCT04876391|527751092|FG001|Overall Study|Personal reasons|1|||
146339490|NCT04876391|527751091|FG000|Overall Study|Withdrawn as per protocol|2|||
146339491|NCT04876391|527751092|FG001|Overall Study|Withdrawn as per protocol|2|||
146339492|NCT02286960|527751095|FG000|Overall Study|Lost to Follow-up|3|||
146339493|NCT02286960|527751096|FG001|Overall Study|Lost to Follow-up|3|||
146339494|NCT01238120|527751098|FG000|Overall Study|Withdrawal by Subject|4|||
146339495|NCT01238120|527751099|FG001|Overall Study|Withdrawal by Subject|1|||
146339496|NCT01238120|527751100|FG002|Overall Study|Withdrawal by Subject|2|||
146339497|NCT01238120|527751101|FG003|Overall Study|Withdrawal by Subject|5|||
146339498|NCT01238120|527751098|FG000|Overall Study|Lost to Follow-up|2|||
146339499|NCT01238120|527751099|FG001|Overall Study|Lost to Follow-up|0|||
146339500|NCT01238120|527751100|FG002|Overall Study|Lost to Follow-up|1|||
146339501|NCT01238120|527751101|FG003|Overall Study|Lost to Follow-up|1|||
146339502|NCT01238120|527751098|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
146339503|NCT01238120|527751099|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
146339504|NCT01238120|527751100|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
146339505|NCT01238120|527751101|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
146339506|NCT00881205|527751102|FG000|Overall Study|Adverse Event|8|||
146339507|NCT00881205|527751103|FG001|Overall Study|Adverse Event|3|||
146339508|NCT00881205|527751102|FG000|Overall Study|Withdrawal by Subject|1|||
146339509|NCT00881205|527751103|FG001|Overall Study|Withdrawal by Subject|2|||
146339510|NCT00881205|527751102|FG000|Overall Study|Lost to Follow-up|0|||
146339511|NCT00881205|527751103|FG001|Overall Study|Lost to Follow-up|1|||
146339512|NCT00881205|527751102|FG000|Overall Study|Administrative problems|1|||
146339513|NCT00881205|527751103|FG001|Overall Study|Administrative problems|1|||
146339514|NCT00881205|527751102|FG000|Overall Study|Condition no longer requires drug|1|||
146339515|NCT00881205|527751103|FG001|Overall Study|Condition no longer requires drug|0|||
146339516|NCT01486238|527751105|FG000|Overall Study|Death|0|||
146339517|NCT01486238|527751106|FG001|Overall Study|Death|2|||
146339518|NCT01486238|527751105|FG000|Overall Study|Withdrawal by Subject|2|||
146339519|NCT01486238|527751106|FG001|Overall Study|Withdrawal by Subject|1|||
146339520|NCT01486238|527751105|FG000|Overall Study|Lost to Follow-up|0|||
146339521|NCT01486238|527751106|FG001|Overall Study|Lost to Follow-up|3|||
146339522|NCT00693706|527751111|FG000|Overall Study|Protocol Violation|0|||
146339523|NCT00693706|527751112|FG001|Overall Study|Protocol Violation|1|||
146339524|NCT02498652|527751114|FG000|Overall Study|Protocol Violation|0|||
146339525|NCT02498652|527751115|FG001|Overall Study|Protocol Violation|1|||
146339526|NCT06129487|527751116|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
146339527|NCT06129487|527751117|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
146339528|NCT00847613|527751118|FG000|Overall Study|Ongoing at cut-off date|250|||
146339529|NCT00847613|527751119|FG001|Overall Study|Ongoing at cut-off date|265|||
146339530|NCT00847613|527751120|FG002|Overall Study|Ongoing at cut-off date|64|||
146339531|NCT00847613|527751121|FG003|Overall Study|Ongoing at cut-off date|64|||
146339532|NCT00847613|527751118|FG000|Overall Study|Death|1|||
146339533|NCT00847613|527751119|FG001|Overall Study|Death|1|||
146339534|NCT00847613|527751120|FG002|Overall Study|Death|0|||
146339535|NCT00847613|527751121|FG003|Overall Study|Death|0|||
146339536|NCT00847613|527751118|FG000|Overall Study|Adverse Event|36|||
146339537|NCT00847613|527751119|FG001|Overall Study|Adverse Event|26|||
146339538|NCT00847613|527751120|FG002|Overall Study|Adverse Event|5|||
146339539|NCT00847613|527751121|FG003|Overall Study|Adverse Event|6|||
146339540|NCT00847613|527751118|FG000|Overall Study|Lack of Efficacy|7|||
146339541|NCT00847613|527751119|FG001|Overall Study|Lack of Efficacy|3|||
146339542|NCT00847613|527751120|FG002|Overall Study|Lack of Efficacy|3|||
146339543|NCT00847613|527751121|FG003|Overall Study|Lack of Efficacy|1|||
146339544|NCT00847613|527751118|FG000|Overall Study|Study terminated by Sponsor|1|||
146339545|NCT00847613|527751119|FG001|Overall Study|Study terminated by Sponsor|0|||
146339546|NCT00847613|527751120|FG002|Overall Study|Study terminated by Sponsor|2|||
146339547|NCT00847613|527751121|FG003|Overall Study|Study terminated by Sponsor|1|||
146339548|NCT00847613|527751118|FG000|Overall Study|Lost to Follow-up|5|||
146339549|NCT00847613|527751119|FG001|Overall Study|Lost to Follow-up|0|||
146339550|NCT00847613|527751120|FG002|Overall Study|Lost to Follow-up|0|||
146339551|NCT00847613|527751121|FG003|Overall Study|Lost to Follow-up|3|||
146339552|NCT00847613|527751118|FG000|Overall Study|Protocol Violation|6|||
146339553|NCT00847613|527751119|FG001|Overall Study|Protocol Violation|6|||
146339554|NCT00847613|527751120|FG002|Overall Study|Protocol Violation|3|||
146339555|NCT00847613|527751121|FG003|Overall Study|Protocol Violation|1|||
146339556|NCT00847613|527751118|FG000|Overall Study|Pregnancy|1|||
146339557|NCT00847613|527751119|FG001|Overall Study|Pregnancy|1|||
146339558|NCT00847613|527751120|FG002|Overall Study|Pregnancy|0|||
146339559|NCT00847613|527751121|FG003|Overall Study|Pregnancy|0|||
146339560|NCT00847613|527751118|FG000|Overall Study|Site closure|1|||
146339561|NCT00847613|527751119|FG001|Overall Study|Site closure|0|||
146339562|NCT00847613|527751120|FG002|Overall Study|Site closure|0|||
146339563|NCT00847613|527751121|FG003|Overall Study|Site closure|1|||
146339564|NCT00847613|527751118|FG000|Overall Study|Withdrawal by Subject|8|||
146339565|NCT00847613|527751119|FG001|Overall Study|Withdrawal by Subject|11|||
146339566|NCT00847613|527751120|FG002|Overall Study|Withdrawal by Subject|2|||
146339567|NCT00847613|527751121|FG003|Overall Study|Withdrawal by Subject|2|||
146339568|NCT00847613|527751118|FG000|Overall Study|Participant moved|4|||
146339569|NCT00847613|527751119|FG001|Overall Study|Participant moved|1|||
146339570|NCT00847613|527751120|FG002|Overall Study|Participant moved|0|||
146339571|NCT00847613|527751121|FG003|Overall Study|Participant moved|0|||
146339572|NCT00847613|527751118|FG000|Overall Study|Sponsor request|0|||
146339573|NCT00847613|527751119|FG001|Overall Study|Sponsor request|1|||
146339574|NCT00847613|527751120|FG002|Overall Study|Sponsor request|0|||
146339575|NCT00847613|527751121|FG003|Overall Study|Sponsor request|0|||
146339576|NCT00847613|527751118|FG000|Overall Study|Randomized, but not treated|0|||
146339577|NCT00847613|527751119|FG001|Overall Study|Randomized, but not treated|3|||
146339578|NCT00847613|527751120|FG002|Overall Study|Randomized, but not treated|0|||
146339579|NCT00847613|527751121|FG003|Overall Study|Randomized, but not treated|0|||
146339580|NCT00847613|527751118|FG000|Overall Study|Other|1|||
146339581|NCT00847613|527751119|FG001|Overall Study|Other|1|||
146339582|NCT00847613|527751120|FG002|Overall Study|Other|2|||
146339583|NCT00847613|527751121|FG003|Overall Study|Other|0|||
146339584|NCT00754390|527751122|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
146339585|NCT00754390|527751122|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
146339586|NCT00754390|527751122|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
146339587|NCT00754390|527751122|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
146339588|NCT03256539|527751130|FG000|Overall Study|Withdrawal by Subject|0|||
146339589|NCT03256539|527751131|FG001|Overall Study|Withdrawal by Subject|3|||
146339590|NCT03256539|527751130|FG000|Overall Study|Unexpected closure of study components|8|||
146339591|NCT03256539|527751131|FG001|Overall Study|Unexpected closure of study components|4|||
146339592|NCT00828451|527751132|FG000|Overall Study|Death|2|||
146339593|NCT00828451|527751132|FG000|Overall Study|Lack of intravenous line|7|||
146339594|NCT00828451|527751132|FG000|Overall Study|Withdrawal by Subject|1|||
146339595|NCT00828451|527751132|FG000|Overall Study|Deterioration in clinical status|1|||
146339596|NCT02827877|527751133|FG000|Overall Study|Withdrawal by Subject|1|||
146339597|NCT05755438|527751134|FG000|12-week DBVC Period|Adverse Event|4|||
146339598|NCT05755438|527751135|FG001|12-week DBVC Period|Adverse Event|1|||
146339599|NCT05755438|527751134|FG000|12-week DBVC Period|Physician Decision|1|||
146339600|NCT05755438|527751135|FG001|12-week DBVC Period|Physician Decision|1|||
146339601|NCT05755438|527751134|FG000|12-week DBVC Period|Protocol Violation|4|||
146339602|NCT05755438|527751135|FG001|12-week DBVC Period|Protocol Violation|2|||
146339603|NCT05755438|527751134|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
146339604|NCT05755438|527751135|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
146339605|NCT05755438|527751134|FG000|12-week DBVC Period|Sponsor Decision|1|||
146339606|NCT05755438|527751135|FG001|12-week DBVC Period|Sponsor Decision|0|||
146339607|NCT05755438|527751134|FG000|40-week OLE Period|Adverse Event|0|||
146339608|NCT05755438|527751135|FG001|40-week OLE Period|Adverse Event|2|||
146339609|NCT05755438|527751134|FG000|40-week OLE Period|Lack of Efficacy|1|||
146339610|NCT05755438|527751135|FG001|40-week OLE Period|Lack of Efficacy|1|||
146339611|NCT05755438|527751134|FG000|40-week OLE Period|Lost to Follow-up|1|||
146339612|NCT05755438|527751135|FG001|40-week OLE Period|Lost to Follow-up|0|||
146339613|NCT05755438|527751134|FG000|40-week OLE Period|Physician Decision|1|||
146339614|NCT05755438|527751135|FG001|40-week OLE Period|Physician Decision|1|||
146169122|NCT01337986|527131141|FG001|Overall Study|Adverse Event|2|||
146339615|NCT05755438|527751134|FG000|40-week OLE Period|Protocol Violation|1|||
146339616|NCT05755438|527751135|FG001|40-week OLE Period|Protocol Violation|1|||
146339617|NCT05755438|527751134|FG000|40-week OLE Period|Withdrawal by Subject|6|||
146339618|NCT05755438|527751135|FG001|40-week OLE Period|Withdrawal by Subject|6|||
146339619|NCT05755438|527751134|FG000|40-week OLE Period|Sponsor Decision|3|||
146339620|NCT05755438|527751135|FG001|40-week OLE Period|Sponsor Decision|0|||
146339621|NCT05755438|527751134|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
146339622|NCT05755438|527751135|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
146339623|NCT05755438|527751134|FG000|40-week OLE Period|Ongoing|46|||
146339624|NCT05755438|527751135|FG001|40-week OLE Period|Ongoing|58|||
146339625|NCT03914300|527751137|FG000|Overall Study|Adverse Event|1|||
146339626|NCT05445843|527751143|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
146339627|NCT05445843|527751144|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
146339628|NCT05445843|527751143|FG000|Overall Study|Progressive disease|17|||
146339629|NCT05445843|527751144|FG001|Overall Study|Progressive disease|9|||
146339630|NCT05445843|527751143|FG000|Overall Study|Physician Decision|16|||
146339631|NCT05445843|527751144|FG001|Overall Study|Physician Decision|4|||
146339632|NCT05445843|527751143|FG000|Overall Study|Death|6|||
146339633|NCT05445843|527751144|FG001|Overall Study|Death|3|||
146339634|NCT05445843|527751143|FG000|Overall Study|Subject decision|6|||
146339635|NCT05445843|527751144|FG001|Overall Study|Subject decision|2|||
146339636|NCT05445843|527751143|FG000|Overall Study|Adverse Event|2|||
146339637|NCT05445843|527751144|FG001|Overall Study|Adverse Event|0|||
146339638|NCT03478683|527751146|FG000|Overall Study|Adverse Event|5|||
146339639|NCT03478683|527751147|FG001|Overall Study|Adverse Event|3|||
146339640|NCT03478683|527751146|FG000|Overall Study|Lost to Follow-up|0|||
146339641|NCT03478683|527751147|FG001|Overall Study|Lost to Follow-up|5|||
146339642|NCT03478683|527751146|FG000|Overall Study|Physician Decision|1|||
146339643|NCT03478683|527751147|FG001|Overall Study|Physician Decision|3|||
146339644|NCT03478683|527751146|FG000|Overall Study|Withdrawal by Subject|7|||
146339645|NCT03478683|527751147|FG001|Overall Study|Withdrawal by Subject|7|||
146339646|NCT00840463|527751150|FG000|Overall Study|Adverse Event|1|||
146339647|NCT00840463|527751151|FG001|Overall Study|Adverse Event|0|||
146339648|NCT03750838|527751156|FG000|Overall Study|Lost to Follow-up|10|||
146339649|NCT03750838|527751157|FG001|Overall Study|Lost to Follow-up|6|||
146339650|NCT03439345|527752518|FG000|Overall Study|Lost to Follow-up|0|||
146339651|NCT03439345|527752519|FG001|Overall Study|Lost to Follow-up|1|||
146339652|NCT03439345|527752518|FG000|Overall Study|Consent withdrawn|0|||
146339653|NCT03439345|527752519|FG001|Overall Study|Consent withdrawn|1|||
146339654|NCT03704051|527752522|FG000|Overall Study|Withdrawal by Subject|4|||
146339655|NCT03704051|527752523|FG001|Overall Study|Withdrawal by Subject|0|||
146339656|NCT02495077|527752524|FG000|Overall Study|Adverse Event|0|||
146339657|NCT02495077|527752525|FG001|Overall Study|Adverse Event|1|||
146339658|NCT02495077|527752526|FG002|Overall Study|Adverse Event|1|||
146339659|NCT02495077|527752527|FG003|Overall Study|Adverse Event|0|||
146339660|NCT02495077|527752524|FG000|Overall Study|Death|3|||
146339661|NCT02495077|527752525|FG001|Overall Study|Death|5|||
146339662|NCT02495077|527752526|FG002|Overall Study|Death|0|||
146339663|NCT02495077|527752527|FG003|Overall Study|Death|0|||
146339664|NCT02495077|527752524|FG000|Overall Study|Lost to Follow-up|6|||
146339665|NCT02495077|527752525|FG001|Overall Study|Lost to Follow-up|4|||
146339666|NCT02495077|527752526|FG002|Overall Study|Lost to Follow-up|0|||
146339667|NCT02495077|527752527|FG003|Overall Study|Lost to Follow-up|0|||
146339668|NCT02495077|527752524|FG000|Overall Study|Physician Decision|2|||
146339669|NCT02495077|527752525|FG001|Overall Study|Physician Decision|1|||
146339670|NCT02495077|527752526|FG002|Overall Study|Physician Decision|4|||
146339671|NCT02495077|527752527|FG003|Overall Study|Physician Decision|0|||
146339672|NCT02495077|527752524|FG000|Overall Study|Protocol Violation|0|||
146339673|NCT02495077|527752525|FG001|Overall Study|Protocol Violation|1|||
146339674|NCT02495077|527752526|FG002|Overall Study|Protocol Violation|0|||
146339675|NCT02495077|527752527|FG003|Overall Study|Protocol Violation|0|||
146339676|NCT02495077|527752524|FG000|Overall Study|Screen Failure|0|||
146339677|NCT02495077|527752525|FG001|Overall Study|Screen Failure|0|||
146339678|NCT02495077|527752526|FG002|Overall Study|Screen Failure|0|||
146339679|NCT02495077|527752527|FG003|Overall Study|Screen Failure|48|||
146339680|NCT02495077|527752524|FG000|Overall Study|Withdrawal by Subject|7|||
146339681|NCT02495077|527752525|FG001|Overall Study|Withdrawal by Subject|7|||
146339682|NCT02495077|527752526|FG002|Overall Study|Withdrawal by Subject|7|||
146339683|NCT02495077|527752527|FG003|Overall Study|Withdrawal by Subject|0|||
146339684|NCT02495077|527752524|FG000|Overall Study|Covid-19 research restrictions|1|||
146339685|NCT02495077|527752525|FG001|Overall Study|Covid-19 research restrictions|0|||
146339686|NCT02495077|527752526|FG002|Overall Study|Covid-19 research restrictions|0|||
146339687|NCT02495077|527752527|FG003|Overall Study|Covid-19 research restrictions|0|||
146339688|NCT02495077|527752524|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
146339689|NCT02495077|527752525|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
146339690|NCT02495077|527752526|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
146339691|NCT02495077|527752527|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
146169123|NCT01337986|527131140|FG000|Overall Study|Lost to Follow-up|1|||
146339692|NCT02495077|527752524|FG000|Overall Study|Incarcerated|0|||
146339693|NCT02495077|527752525|FG001|Overall Study|Incarcerated|1|||
146339694|NCT02495077|527752526|FG002|Overall Study|Incarcerated|0|||
146339695|NCT02495077|527752527|FG003|Overall Study|Incarcerated|0|||
146339696|NCT02495077|527752524|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
146339697|NCT02495077|527752525|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
146339698|NCT02495077|527752526|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
146339699|NCT02495077|527752527|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
146339700|NCT02495077|527752524|FG000|Overall Study|Timing of transplant and randomization|0|||
146396294|NCT00276458|527954549|FG001|Overall Study|Adverse Event|2|||
146339701|NCT02495077|527752525|FG001|Overall Study|Timing of transplant and randomization|0|||
146339702|NCT02495077|527752526|FG002|Overall Study|Timing of transplant and randomization|5|||
146339703|NCT02495077|527752527|FG003|Overall Study|Timing of transplant and randomization|0|||
146339704|NCT03230097|527752534|FG000|Overall Study|Adverse Event|2|||
146339705|NCT03230097|527752535|FG001|Overall Study|Adverse Event|1|||
146339706|NCT03230097|527752534|FG000|Overall Study|non-compliance|0|||
146339707|NCT03230097|527752535|FG001|Overall Study|non-compliance|1|||
146339708|NCT03230097|527752534|FG000|Overall Study|Lost to Follow-up|2|||
146339709|NCT03230097|527752535|FG001|Overall Study|Lost to Follow-up|4|||
146339710|NCT03230097|527752534|FG000|Overall Study|Withdrawal by Subject|7|||
146339711|NCT03230097|527752535|FG001|Overall Study|Withdrawal by Subject|3|||
146339712|NCT03230097|527752534|FG000|Overall Study|Trial termination|4|||
146339713|NCT03230097|527752535|FG001|Overall Study|Trial termination|5|||
146339714|NCT03230097|527752534|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
146339715|NCT03230097|527752535|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
146339716|NCT03230097|527752534|FG000|Overall Study|outcome event|0|||
146339717|NCT03230097|527752535|FG001|Overall Study|outcome event|1|||
146339718|NCT03056287|527752536|FG000|Overall Study|Withdrawal by Subject|0|||
146339719|NCT03056287|527752537|FG001|Overall Study|Withdrawal by Subject|1|||
146339720|NCT03056287|527752538|FG002|Overall Study|Withdrawal by Subject|0|||
146339721|NCT03056287|527752539|FG003|Overall Study|Withdrawal by Subject|0|||
146339722|NCT03056287|527752536|FG000|Overall Study|move out of area|0|||
146339723|NCT03056287|527752537|FG001|Overall Study|move out of area|0|||
146339724|NCT03056287|527752538|FG002|Overall Study|move out of area|1|||
146339725|NCT03056287|527752539|FG003|Overall Study|move out of area|1|||
146339726|NCT00845429|527752555|FG000|Overall Study|Protocol Violation|5|||
146339727|NCT00845429|527752556|FG001|Overall Study|Protocol Violation|4|||
146339728|NCT00845429|527752557|FG002|Overall Study|Protocol Violation|7|||
146339729|NCT00845429|527752555|FG000|Overall Study|Lost to Follow-up|7|||
146339730|NCT00845429|527752556|FG001|Overall Study|Lost to Follow-up|9|||
146339731|NCT00845429|527752557|FG002|Overall Study|Lost to Follow-up|10|||
146339732|NCT00845429|527752555|FG000|Overall Study|Withdrawal by Subject|2|||
146339733|NCT00845429|527752556|FG001|Overall Study|Withdrawal by Subject|2|||
146339734|NCT00845429|527752557|FG002|Overall Study|Withdrawal by Subject|2|||
146339735|NCT00845429|527752555|FG000|Overall Study|Serious adverse event|0|||
146339736|NCT00845429|527752556|FG001|Overall Study|Serious adverse event|0|||
146339737|NCT00845429|527752557|FG002|Overall Study|Serious adverse event|1|||
146339738|NCT01480180|527752563|FG000|Main Phase|Withdrawal criteria|12|||
146339739|NCT01480180|527752564|FG001|Main Phase|Withdrawal criteria|1|||
146339740|NCT01480180|527752565|FG002|Main Phase|Withdrawal criteria|0|||
146339741|NCT01480180|527752566|FG003|Main Phase|Withdrawal criteria|0|||
146339742|NCT01480180|527752567|FG004|Main Phase|Withdrawal criteria|0|||
146339743|NCT01480180|527752568|FG005|Main Phase|Withdrawal criteria|0|||
146339744|NCT01480180|527752563|FG000|Main Phase|Lack of Efficacy|1|||
146339745|NCT01480180|527752564|FG001|Main Phase|Lack of Efficacy|0|||
146339746|NCT01480180|527752565|FG002|Main Phase|Lack of Efficacy|0|||
146339747|NCT01480180|527752566|FG003|Main Phase|Lack of Efficacy|0|||
146339748|NCT01480180|527752567|FG004|Main Phase|Lack of Efficacy|0|||
146339749|NCT01480180|527752568|FG005|Main Phase|Lack of Efficacy|0|||
146339750|NCT01480180|527752563|FG000|Main Phase|Non-compliance|3|||
146339751|NCT01480180|527752564|FG001|Main Phase|Non-compliance|0|||
146339752|NCT01480180|527752565|FG002|Main Phase|Non-compliance|0|||
146169124|NCT01337986|527131141|FG001|Overall Study|Lost to Follow-up|0|||
146169125|NCT01337986|527131140|FG000|Overall Study|Protocol Violation|0|||
146169126|NCT01337986|527131141|FG001|Overall Study|Protocol Violation|3|||
146169127|NCT01520402|527131143|FG000|Overall Study|Withdrawal by Subject|2|||
146169128|NCT01520402|527131143|FG000|Overall Study|Physician Decision|3|||
146169129|NCT02798211|527131144|FG000|Period 1|Adverse Event|1|||
146169130|NCT02798211|527131145|FG001|Period 1|Adverse Event|1|||
146169131|NCT02798211|527131146|FG002|Period 1|Adverse Event|0|||
146169132|NCT02798211|527131147|FG003|Period 1|Adverse Event|0|||
146169133|NCT02798211|527131148|FG004|Period 1|Adverse Event|0|||
146169134|NCT02798211|527131149|FG005|Period 1|Adverse Event|0|||
146169135|NCT02798211|527131144|FG000|Period 1|Lost to Follow-up|2|||
146169136|NCT02798211|527131145|FG001|Period 1|Lost to Follow-up|1|||
146169137|NCT02798211|527131146|FG002|Period 1|Lost to Follow-up|0|||
146169138|NCT02798211|527131147|FG003|Period 1|Lost to Follow-up|0|||
146169139|NCT02798211|527131148|FG004|Period 1|Lost to Follow-up|0|||
146169140|NCT02798211|527131149|FG005|Period 1|Lost to Follow-up|0|||
146169141|NCT02798211|527131144|FG000|Period 1|Protocol Violation|0|||
146169142|NCT02798211|527131145|FG001|Period 1|Protocol Violation|0|||
146169143|NCT02798211|527131146|FG002|Period 1|Protocol Violation|2|||
146169144|NCT02798211|527131147|FG003|Period 1|Protocol Violation|0|||
146339753|NCT01480180|527752566|FG003|Main Phase|Non-compliance|0|||
146339754|NCT01480180|527752567|FG004|Main Phase|Non-compliance|0|||
146339755|NCT01480180|527752568|FG005|Main Phase|Non-compliance|0|||
146339756|NCT01480180|527752563|FG000|Main Phase|Unclassified|3|||
146339757|NCT01480180|527752564|FG001|Main Phase|Unclassified|0|||
146339758|NCT01480180|527752565|FG002|Main Phase|Unclassified|0|||
146339759|NCT01480180|527752566|FG003|Main Phase|Unclassified|0|||
146339760|NCT01480180|527752567|FG004|Main Phase|Unclassified|0|||
146339761|NCT01480180|527752568|FG005|Main Phase|Unclassified|0|||
146339762|NCT01480180|527752563|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
146339763|NCT01480180|527752564|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
146339764|NCT01480180|527752565|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
146339765|NCT01480180|527752566|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
146339766|NCT01480180|527752567|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
146169145|NCT02798211|527131148|FG004|Period 1|Protocol Violation|0|||
146169146|NCT02798211|527131149|FG005|Period 1|Protocol Violation|0|||
146169147|NCT02798211|527131144|FG000|Period 1|Withdrawal by Subject|1|||
146169148|NCT02798211|527131145|FG001|Period 1|Withdrawal by Subject|1|||
146169149|NCT02798211|527131146|FG002|Period 1|Withdrawal by Subject|0|||
146339767|NCT01480180|527752568|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
146339768|NCT01480180|527752563|FG000|Extension Phase, Part 1|Unclassified|0|||
146339769|NCT01480180|527752564|FG001|Extension Phase, Part 1|Unclassified|0|||
146339770|NCT01480180|527752565|FG002|Extension Phase, Part 1|Unclassified|1|||
146339771|NCT01480180|527752566|FG003|Extension Phase, Part 1|Unclassified|0|||
146339772|NCT01480180|527752567|FG004|Extension Phase, Part 1|Unclassified|0|||
146339773|NCT01480180|527752568|FG005|Extension Phase, Part 1|Unclassified|0|||
146339774|NCT01480180|527752563|FG000|Extension Phase, Part 1|Adverse Event|0|||
146339775|NCT01480180|527752564|FG001|Extension Phase, Part 1|Adverse Event|0|||
146339776|NCT01480180|527752565|FG002|Extension Phase, Part 1|Adverse Event|4|||
146339777|NCT01480180|527752566|FG003|Extension Phase, Part 1|Adverse Event|1|||
146339778|NCT01480180|527752567|FG004|Extension Phase, Part 1|Adverse Event|0|||
146339779|NCT01480180|527752568|FG005|Extension Phase, Part 1|Adverse Event|0|||
146339780|NCT01480180|527752563|FG000|Extension Phase, Part 1|Change of treatment|0|||
146339781|NCT01480180|527752564|FG001|Extension Phase, Part 1|Change of treatment|0|||
146339782|NCT01480180|527752565|FG002|Extension Phase, Part 1|Change of treatment|0|||
146339783|NCT01480180|527752566|FG003|Extension Phase, Part 1|Change of treatment|9|||
146339784|NCT01480180|527752567|FG004|Extension Phase, Part 1|Change of treatment|0|||
146339785|NCT01480180|527752568|FG005|Extension Phase, Part 1|Change of treatment|0|||
146339786|NCT01480180|527752563|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
146339787|NCT01480180|527752564|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
146339788|NCT01480180|527752565|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
146339789|NCT01480180|527752566|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
146339790|NCT01480180|527752567|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
146339791|NCT01480180|527752568|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
146339792|NCT01480180|527752563|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
146339793|NCT01480180|527752564|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
146339794|NCT01480180|527752565|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
146339795|NCT01480180|527752566|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
146339796|NCT01480180|527752567|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
146339797|NCT01480180|527752568|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
146339798|NCT01480180|527752563|FG000|Extension Phase, Part 2|Unclassified|0|||
146339799|NCT01480180|527752564|FG001|Extension Phase, Part 2|Unclassified|0|||
146339800|NCT01480180|527752565|FG002|Extension Phase, Part 2|Unclassified|3|||
146339801|NCT01480180|527752566|FG003|Extension Phase, Part 2|Unclassified|1|||
146339802|NCT01480180|527752567|FG004|Extension Phase, Part 2|Unclassified|1|||
146339803|NCT01480180|527752568|FG005|Extension Phase, Part 2|Unclassified|0|||
146339804|NCT01548638|527752571|FG000|Overall Study|Protocol Violation|3|||
146339805|NCT01548638|527752571|FG000|Overall Study|Withdrawal by Subject|1|||
146339806|NCT01919411|527752583|FG000|Overall Study|Lost to Follow-up|2|||
146339807|NCT01919411|527752584|FG001|Overall Study|Lost to Follow-up|4|||
146339808|NCT01919411|527752583|FG000|Overall Study|Physician Decision|1|||
146339809|NCT01919411|527752584|FG001|Overall Study|Physician Decision|0|||
146339810|NCT01919411|527752583|FG000|Overall Study|Protocol Violation|2|||
146339811|NCT01919411|527752584|FG001|Overall Study|Protocol Violation|1|||
146339812|NCT00144300|527752585|FG000|Overall Study|Adverse Event|18|||
146339813|NCT00144300|527752586|FG001|Overall Study|Adverse Event|16|||
146339814|NCT00144300|527752585|FG000|Overall Study|Protocol Violation|1|||
146339815|NCT00144300|527752586|FG001|Overall Study|Protocol Violation|3|||
146339816|NCT00144300|527752585|FG000|Overall Study|Lost to Follow-up|3|||
146339817|NCT00144300|527752586|FG001|Overall Study|Lost to Follow-up|0|||
146339818|NCT00144300|527752585|FG000|Overall Study|Withdrawal by Subject|6|||
146339819|NCT00144300|527752586|FG001|Overall Study|Withdrawal by Subject|6|||
146339820|NCT00144300|527752585|FG000|Overall Study|Other reason (not specified)|1|||
146339821|NCT00144300|527752586|FG001|Overall Study|Other reason (not specified)|3|||
146339822|NCT02426086|527752589|FG000|Overall Study|Death|33|||
146339823|NCT02426086|527752590|FG001|Overall Study|Death|36|||
146339824|NCT02426086|527752589|FG000|Overall Study|Lost to Follow-up|2|||
146339825|NCT02426086|527752590|FG001|Overall Study|Lost to Follow-up|0|||
146339826|NCT02426086|527752589|FG000|Overall Study|Study Terminated by Sponsor|5|||
146339827|NCT02426086|527752590|FG001|Overall Study|Study Terminated by Sponsor|14|||
146169150|NCT02798211|527131147|FG003|Period 1|Withdrawal by Subject|0|||
146169151|NCT02798211|527131148|FG004|Period 1|Withdrawal by Subject|0|||
146169152|NCT02798211|527131149|FG005|Period 1|Withdrawal by Subject|0|||
146169153|NCT02798211|527131144|FG000|Period 1|Death|0|||
146339828|NCT02426086|527752589|FG000|Overall Study|Withdrawal by Subject|8|||
146339829|NCT02426086|527752590|FG001|Overall Study|Withdrawal by Subject|9|||
146339830|NCT00524303|527752591|FG000|Overall Study|Lost to Follow-up|6|||
146339831|NCT00524303|527752592|FG001|Overall Study|Lost to Follow-up|0|||
146339832|NCT00524303|527752593|FG002|Overall Study|Lost to Follow-up|3|||
146339833|NCT00524303|527752591|FG000|Overall Study|Protocol Violation|0|||
146339834|NCT00524303|527752592|FG001|Overall Study|Protocol Violation|1|||
146339835|NCT00524303|527752593|FG002|Overall Study|Protocol Violation|1|||
146339836|NCT00524303|527752591|FG000|Overall Study|Withdrawal by Subject|3|||
146339837|NCT00524303|527752592|FG001|Overall Study|Withdrawal by Subject|0|||
146339838|NCT00524303|527752593|FG002|Overall Study|Withdrawal by Subject|4|||
146339839|NCT00524303|527752591|FG000|Overall Study|Death|0|||
146339840|NCT00524303|527752592|FG001|Overall Study|Death|2|||
146339841|NCT00524303|527752593|FG002|Overall Study|Death|3|||
146339842|NCT00524303|527752591|FG000|Overall Study|Adverse Event|1|||
146339843|NCT00524303|527752592|FG001|Overall Study|Adverse Event|2|||
146339844|NCT00524303|527752593|FG002|Overall Study|Adverse Event|3|||
146339845|NCT00524303|527752591|FG000|Overall Study|Did not Complete Study Dosing|1|||
146339846|NCT00524303|527752592|FG001|Overall Study|Did not Complete Study Dosing|0|||
146339847|NCT00524303|527752593|FG002|Overall Study|Did not Complete Study Dosing|0|||
146339848|NCT00524303|527752591|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
146339849|NCT00524303|527752592|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
146339850|NCT00524303|527752593|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
146339851|NCT00524303|527752591|FG000|Overall Study|Disease Progression|0|||
146339852|NCT00524303|527752592|FG001|Overall Study|Disease Progression|4|||
146339853|NCT00524303|527752593|FG002|Overall Study|Disease Progression|1|||
146339854|NCT00524303|527752591|FG000|Overall Study|Disease Recurrence|0|||
146339855|NCT00524303|527752592|FG001|Overall Study|Disease Recurrence|1|||
146339856|NCT00524303|527752593|FG002|Overall Study|Disease Recurrence|0|||
146339857|NCT00524303|527752591|FG000|Overall Study|Sponsor Request|0|||
146339858|NCT00524303|527752592|FG001|Overall Study|Sponsor Request|0|||
146339859|NCT00524303|527752593|FG002|Overall Study|Sponsor Request|1|||
146339860|NCT00524303|527752591|FG000|Overall Study|Physician Decision|0|||
146339861|NCT00524303|527752592|FG001|Overall Study|Physician Decision|0|||
146339862|NCT00524303|527752593|FG002|Overall Study|Physician Decision|1|||
146339863|NCT00524303|527752591|FG000|Overall Study|Completed 5 years|0|||
146339864|NCT00524303|527752592|FG001|Overall Study|Completed 5 years|0|||
146339865|NCT00524303|527752593|FG002|Overall Study|Completed 5 years|1|||
146339866|NCT04090164|527752598|FG000|Overall Study|incomplete data on file|245|||
146339867|NCT04090164|527752599|FG001|Overall Study|incomplete data on file|0|||
146339868|NCT03414359|527752603|FG000|Overall Study|Lack of Efficacy|1|||
146339869|NCT03414359|527752604|FG001|Overall Study|Lack of Efficacy|1|||
146339870|NCT03414359|527752603|FG000|Overall Study|Protocol Violation|0|||
146339871|NCT03414359|527752604|FG001|Overall Study|Protocol Violation|1|||
146339872|NCT01877655|527752605|FG000|Overall Study|Death|57|||
146339873|NCT01877655|527752606|FG001|Overall Study|Death|52|||
146339874|NCT01877655|527752605|FG000|Overall Study|Withdrawal by Subject|18|||
146339875|NCT01877655|527752606|FG001|Overall Study|Withdrawal by Subject|26|||
146339876|NCT01877655|527752605|FG000|Overall Study|Physician Decision|11|||
146339877|NCT01877655|527752606|FG001|Overall Study|Physician Decision|10|||
146339878|NCT01877655|527752605|FG000|Overall Study|Miscellaneous|4|||
146339879|NCT01877655|527752606|FG001|Overall Study|Miscellaneous|4|||
146339880|NCT01877655|527752605|FG000|Overall Study|Randomized but Never Received Drug|8|||
146339881|NCT01877655|527752606|FG001|Overall Study|Randomized but Never Received Drug|5|||
146339882|NCT00095121|527752609|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
146339883|NCT00095121|527752610|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
146339884|NCT00095121|527752609|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
146339885|NCT00095121|527752610|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
146339886|NCT04070378|527752613|FG000|Overall Study|Withdrawal by Subject|2|||
146339887|NCT04070378|527752613|FG000|Overall Study|Screen Failure|6|||
146339888|NCT04070378|527752613|FG000|Overall Study|Physician Decision|1|||
146339889|NCT04070378|527752613|FG000|Overall Study|Adverse Event|1|||
146339890|NCT02462889|527752615|FG000|Overall Study|Withdrawal by Subject|2|||
146339891|NCT02462889|527752616|FG001|Overall Study|Withdrawal by Subject|6|||
146339892|NCT02462889|527752615|FG000|Overall Study|Death|1|||
146339893|NCT02462889|527752616|FG001|Overall Study|Death|5|||
146339894|NCT03497689|527752622|FG000|Overall Study|Adverse Event|2|||
146339895|NCT03497689|527752622|FG000|Overall Study|Death|1|||
146339896|NCT03497689|527752622|FG000|Overall Study|Physician Decision|1|||
146339897|NCT03497689|527752622|FG000|Overall Study|Withdrawal by Subject|1|||
146339898|NCT03497689|527752622|FG000|Overall Study|Protocol Violation|2|||
146339899|NCT02032875|527752623|FG000|Treatment Period|Adverse Event|1|||
146339900|NCT02032875|527752624|FG001|Treatment Period|Adverse Event|0|||
146339901|NCT02032875|527752623|FG000|Treatment Period|Liver transplant, No extension needed|0|||
146339902|NCT02032875|527752624|FG001|Treatment Period|Liver transplant, No extension needed|1|||
146339903|NCT02032875|527752623|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
146339904|NCT02032875|527752624|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
146339905|NCT02032875|527752623|FG000|Follow-up Period|Death|0|||
146339906|NCT02032875|527752624|FG001|Follow-up Period|Death|1|||
146339907|NCT02032875|527752623|FG000|Follow-up Period|Virologic Relapse|3|||
146339908|NCT02032875|527752624|FG001|Follow-up Period|Virologic Relapse|10|||
146339909|NCT04636177|527752629|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
146339910|NCT04636177|527752630|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
146339911|NCT04636177|527752629|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
146339912|NCT04636177|527752630|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
146339913|NCT04636177|527752629|FG000|Single-arm portion|Withdrawal by Subject|1|||
146339914|NCT04636177|527752630|FG001|Single-arm portion|Withdrawal by Subject|0|||
146339915|NCT04636177|527752629|FG000|Single-arm portion|Adverse Event|1|||
146339916|NCT04636177|527752630|FG001|Single-arm portion|Adverse Event|0|||
146339917|NCT03191786|527752631|FG000|Overall Study|Death|236|||
146339918|NCT03191786|527752632|FG001|Overall Study|Death|127|||
146339919|NCT03191786|527752631|FG000|Overall Study|Lost to Follow-up|9|||
146339920|NCT03191786|527752632|FG001|Overall Study|Lost to Follow-up|3|||
146339921|NCT03191786|527752631|FG000|Overall Study|Physician Decision|1|||
146339922|NCT03191786|527752632|FG001|Overall Study|Physician Decision|0|||
146339923|NCT03191786|527752631|FG000|Overall Study|Moved to Post Trial Access Program|30|||
146339924|NCT03191786|527752632|FG001|Overall Study|Moved to Post Trial Access Program|5|||
146339925|NCT03191786|527752631|FG000|Overall Study|Withdrawal by Subject|26|||
146339926|NCT03191786|527752632|FG001|Overall Study|Withdrawal by Subject|16|||
146339927|NCT02277444|527752633|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
146339928|NCT02277444|527752633|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
146339929|NCT02277444|527752633|FG000|Treatment Period (Week 0-52)|Other|1|||
146339930|NCT02277444|527752633|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
146339931|NCT02277444|527752633|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
146339932|NCT02277444|527752633|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
146339933|NCT02277444|527752633|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
146339934|NCT02277444|527752633|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
146339935|NCT02277444|527752633|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
146339936|NCT05278104|527752634|FG000|Overall Study|Not treated|1|||
146339937|NCT05278104|527752635|FG001|Overall Study|Not treated|0|||
146339938|NCT05278104|527752634|FG000|Overall Study|Adverse Event|2|||
146339939|NCT05278104|527752635|FG001|Overall Study|Adverse Event|1|||
146339940|NCT05278104|527752634|FG000|Overall Study|Exclusion criteria not met|1|||
146339941|NCT05278104|527752635|FG001|Overall Study|Exclusion criteria not met|0|||
146339942|NCT02742649|527754332|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
146339943|NCT02742649|527754333|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146339944|NCT02742649|527754334|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146339945|NCT02742649|527754335|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146339946|NCT02742649|527754336|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
146339947|NCT02742649|527754332|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146339948|NCT02742649|527754333|FG001|Double-Blind Treatment Period|Adverse Event|1|||
146339949|NCT02742649|527754334|FG002|Double-Blind Treatment Period|Adverse Event|0|||
146339950|NCT02742649|527754335|FG003|Double-Blind Treatment Period|Adverse Event|0|||
146339951|NCT02742649|527754336|FG004|Double-Blind Treatment Period|Adverse Event|0|||
146339952|NCT02742649|527754332|FG000|Open-Label Period|Lost to Follow-up|0|||
146339953|NCT02742649|527754333|FG001|Open-Label Period|Lost to Follow-up|0|||
146339954|NCT02742649|527754334|FG002|Open-Label Period|Lost to Follow-up|0|||
146339955|NCT02742649|527754335|FG003|Open-Label Period|Lost to Follow-up|0|||
146339956|NCT02742649|527754336|FG004|Open-Label Period|Lost to Follow-up|1|||
146339957|NCT03167619|527754342|FG000|Overall Study|Death|11|||
146339958|NCT03167619|527754343|FG001|Overall Study|Death|8|||
146339959|NCT03167619|527754342|FG000|Overall Study|Withdrawal by Subject|1|||
146339960|NCT03167619|527754343|FG001|Overall Study|Withdrawal by Subject|2|||
146339961|NCT03167619|527754342|FG000|Overall Study|Physician Decision|0|||
146339962|NCT03167619|527754343|FG001|Overall Study|Physician Decision|1|||
146339963|NCT01943539|527754352|FG000|Overall Study|Non-compliance with at-home intervention|4|||
146339964|NCT01943539|527754353|FG001|Overall Study|Non-compliance with at-home intervention|0|||
146339965|NCT02333331|527754354|FG000|Overall Study|Adverse Event|1|||
146339966|NCT02333331|527754355|FG001|Overall Study|Adverse Event|0|||
146339967|NCT02333331|527754356|FG002|Overall Study|Adverse Event|4|||
146339968|NCT02333331|527754357|FG003|Overall Study|Adverse Event|1|||
146339969|NCT02333331|527754354|FG000|Overall Study|Death|0|||
146339970|NCT02333331|527754355|FG001|Overall Study|Death|0|||
146339971|NCT02333331|527754356|FG002|Overall Study|Death|2|||
146339972|NCT02333331|527754357|FG003|Overall Study|Death|0|||
146339973|NCT02333331|527754354|FG000|Overall Study|Lost to Follow-up|0|||
146339974|NCT02333331|527754355|FG001|Overall Study|Lost to Follow-up|0|||
146339975|NCT02333331|527754356|FG002|Overall Study|Lost to Follow-up|1|||
146339976|NCT02333331|527754357|FG003|Overall Study|Lost to Follow-up|0|||
146339977|NCT02333331|527754354|FG000|Overall Study|Physician Decision|0|||
146339978|NCT02333331|527754355|FG001|Overall Study|Physician Decision|1|||
146339979|NCT02333331|527754356|FG002|Overall Study|Physician Decision|0|||
146339980|NCT02333331|527754357|FG003|Overall Study|Physician Decision|0|||
146339981|NCT02333331|527754354|FG000|Overall Study|Protocol Deviation|0|||
146339982|NCT02333331|527754355|FG001|Overall Study|Protocol Deviation|3|||
146339983|NCT02333331|527754356|FG002|Overall Study|Protocol Deviation|2|||
146339984|NCT02333331|527754357|FG003|Overall Study|Protocol Deviation|1|||
146339985|NCT02333331|527754354|FG000|Overall Study|Patient/Guardian Decision|1|||
146339986|NCT02333331|527754355|FG001|Overall Study|Patient/Guardian Decision|2|||
146339987|NCT02333331|527754356|FG002|Overall Study|Patient/Guardian Decision|9|||
146339988|NCT02333331|527754357|FG003|Overall Study|Patient/Guardian Decision|1|||
146339989|NCT02158533|527754362|FG000|Stage 1|Adverse Event|6|||
146339990|NCT02158533|527754363|FG001|Stage 1|Adverse Event|4|||
146339991|NCT02158533|527754364|FG002|Stage 1|Adverse Event|7|||
146339992|NCT02158533|527754365|FG003|Stage 1|Adverse Event|0|||
146339993|NCT02158533|527754366|FG004|Stage 1|Adverse Event|0|||
146339994|NCT02158533|527754367|FG005|Stage 1|Adverse Event|0|||
146339995|NCT02158533|527754362|FG000|Stage 1|Withdrawal by Subject|3|||
146339996|NCT02158533|527754363|FG001|Stage 1|Withdrawal by Subject|2|||
146339997|NCT02158533|527754364|FG002|Stage 1|Withdrawal by Subject|1|||
146339998|NCT02158533|527754365|FG003|Stage 1|Withdrawal by Subject|0|||
146339999|NCT02158533|527754366|FG004|Stage 1|Withdrawal by Subject|0|||
146340000|NCT02158533|527754367|FG005|Stage 1|Withdrawal by Subject|0|||
146340001|NCT02158533|527754362|FG000|Stage 1|Lack of Efficacy|1|||
146340002|NCT02158533|527754363|FG001|Stage 1|Lack of Efficacy|0|||
146340003|NCT02158533|527754364|FG002|Stage 1|Lack of Efficacy|0|||
146340004|NCT02158533|527754365|FG003|Stage 1|Lack of Efficacy|0|||
146340005|NCT02158533|527754366|FG004|Stage 1|Lack of Efficacy|0|||
146340006|NCT02158533|527754367|FG005|Stage 1|Lack of Efficacy|0|||
146340007|NCT02158533|527754362|FG000|Stage 1|Lost to Follow-up|3|||
146340008|NCT02158533|527754363|FG001|Stage 1|Lost to Follow-up|1|||
146340009|NCT02158533|527754364|FG002|Stage 1|Lost to Follow-up|0|||
146340010|NCT02158533|527754365|FG003|Stage 1|Lost to Follow-up|0|||
146340011|NCT02158533|527754366|FG004|Stage 1|Lost to Follow-up|0|||
146340012|NCT02158533|527754367|FG005|Stage 1|Lost to Follow-up|0|||
146340013|NCT02158533|527754362|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
146340014|NCT02158533|527754363|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
146340015|NCT02158533|527754364|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
146340016|NCT02158533|527754365|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
146340017|NCT02158533|527754366|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
146340018|NCT02158533|527754367|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
146340019|NCT02158533|527754362|FG000|Stage 1|Non-compliance with study visits|1|||
146340020|NCT02158533|527754363|FG001|Stage 1|Non-compliance with study visits|0|||
146340021|NCT02158533|527754364|FG002|Stage 1|Non-compliance with study visits|0|||
146340022|NCT02158533|527754365|FG003|Stage 1|Non-compliance with study visits|0|||
146340023|NCT02158533|527754366|FG004|Stage 1|Non-compliance with study visits|0|||
146340024|NCT02158533|527754367|FG005|Stage 1|Non-compliance with study visits|0|||
146340025|NCT02158533|527754362|FG000|Stage 2|Adverse Event|0|||
146340026|NCT02158533|527754363|FG001|Stage 2|Adverse Event|0|||
146340027|NCT02158533|527754364|FG002|Stage 2|Adverse Event|0|||
146340028|NCT02158533|527754365|FG003|Stage 2|Adverse Event|0|||
146340029|NCT02158533|527754366|FG004|Stage 2|Adverse Event|0|||
146340030|NCT02158533|527754367|FG005|Stage 2|Adverse Event|1|||
146340031|NCT02158533|527754362|FG000|Stage 2|Lack of Efficacy|0|||
146340032|NCT02158533|527754363|FG001|Stage 2|Lack of Efficacy|0|||
146340033|NCT02158533|527754364|FG002|Stage 2|Lack of Efficacy|0|||
146340034|NCT02158533|527754365|FG003|Stage 2|Lack of Efficacy|0|||
146340035|NCT02158533|527754366|FG004|Stage 2|Lack of Efficacy|1|||
146340036|NCT02158533|527754367|FG005|Stage 2|Lack of Efficacy|0|||
146340037|NCT02158533|527754362|FG000|Stage 2|Lost to Follow-up|0|||
146340038|NCT02158533|527754363|FG001|Stage 2|Lost to Follow-up|0|||
146340039|NCT02158533|527754364|FG002|Stage 2|Lost to Follow-up|0|||
146340040|NCT02158533|527754365|FG003|Stage 2|Lost to Follow-up|1|||
146340041|NCT02158533|527754366|FG004|Stage 2|Lost to Follow-up|1|||
146340042|NCT02158533|527754367|FG005|Stage 2|Lost to Follow-up|2|||
146340043|NCT02158533|527754362|FG000|Stage 2|Withdrawal by Subject|0|||
146340044|NCT02158533|527754363|FG001|Stage 2|Withdrawal by Subject|0|||
146340045|NCT02158533|527754364|FG002|Stage 2|Withdrawal by Subject|0|||
146340046|NCT02158533|527754365|FG003|Stage 2|Withdrawal by Subject|0|||
146340047|NCT02158533|527754366|FG004|Stage 2|Withdrawal by Subject|1|||
146340048|NCT02158533|527754367|FG005|Stage 2|Withdrawal by Subject|2|||
146340049|NCT02158533|527754362|FG000|Stage 2|Physician Decision|0|||
146340050|NCT02158533|527754363|FG001|Stage 2|Physician Decision|0|||
146340051|NCT02158533|527754364|FG002|Stage 2|Physician Decision|0|||
146340052|NCT02158533|527754365|FG003|Stage 2|Physician Decision|0|||
146340053|NCT02158533|527754366|FG004|Stage 2|Physician Decision|1|||
146340054|NCT02158533|527754367|FG005|Stage 2|Physician Decision|0|||
146340055|NCT02158533|527754362|FG000|Stage 2|Pregnancy|0|||
146340056|NCT02158533|527754363|FG001|Stage 2|Pregnancy|0|||
146169154|NCT02798211|527131145|FG001|Period 1|Death|0|||
146340057|NCT02158533|527754364|FG002|Stage 2|Pregnancy|0|||
146340058|NCT02158533|527754365|FG003|Stage 2|Pregnancy|1|||
146340059|NCT02158533|527754366|FG004|Stage 2|Pregnancy|0|||
146340060|NCT02158533|527754367|FG005|Stage 2|Pregnancy|0|||
146340061|NCT02158533|527754362|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
146340062|NCT02158533|527754363|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
146340063|NCT02158533|527754364|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
146340064|NCT02158533|527754365|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
146340065|NCT02158533|527754366|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
146340066|NCT02158533|527754367|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
146340067|NCT02158533|527754362|FG000|Stage 2|Non-adherence with study visits|0|||
146340068|NCT02158533|527754363|FG001|Stage 2|Non-adherence with study visits|0|||
146340069|NCT02158533|527754364|FG002|Stage 2|Non-adherence with study visits|0|||
146340070|NCT02158533|527754365|FG003|Stage 2|Non-adherence with study visits|0|||
146340071|NCT02158533|527754366|FG004|Stage 2|Non-adherence with study visits|0|||
146340072|NCT02158533|527754367|FG005|Stage 2|Non-adherence with study visits|1|||
146340073|NCT02037919|527754374|FG000|Overall Study|Lost to Follow-up|30|||
146340074|NCT02037919|527754375|FG001|Overall Study|Lost to Follow-up|45|||
146340075|NCT00345605|527754376|FG000|Arm 1|Adverse Event|0|||
146340076|NCT00345605|527754377|FG001|Arm 1|Adverse Event|1|||
146340077|NCT00345605|527754376|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
146340078|NCT00345605|527754377|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
146340079|NCT01335971|527754378|FG000|Overall Study|Withdrawal by Subject|1|||
146340080|NCT01335971|527754379|FG001|Overall Study|Withdrawal by Subject|0|||
146340081|NCT01335971|527754380|FG002|Overall Study|Withdrawal by Subject|0|||
146340082|NCT01335971|527754378|FG000|Overall Study|Did not complete bronchoscopy|1|||
146340083|NCT01335971|527754379|FG001|Overall Study|Did not complete bronchoscopy|1|||
146340084|NCT01335971|527754380|FG002|Overall Study|Did not complete bronchoscopy|1|||
146340085|NCT00384956|527754381|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
146340086|NCT03180736|527754382|FG000|Overall Study|Adverse Event|3|||
146340087|NCT03180736|527754383|FG001|Overall Study|Adverse Event|4|||
146340088|NCT03180736|527754382|FG000|Overall Study|Death|10|||
146340089|NCT03180736|527754383|FG001|Overall Study|Death|7|||
146340090|NCT03180736|527754382|FG000|Overall Study|Withdrawal by Subject|5|||
146340091|NCT03180736|527754383|FG001|Overall Study|Withdrawal by Subject|12|||
146340092|NCT03180736|527754382|FG000|Overall Study|Lost to Follow-up|1|||
146340093|NCT03180736|527754383|FG001|Overall Study|Lost to Follow-up|0|||
146340094|NCT03180736|527754382|FG000|Overall Study|Lack of Efficacy|66|||
146340095|NCT03180736|527754383|FG001|Overall Study|Lack of Efficacy|87|||
146340096|NCT03180736|527754382|FG000|Overall Study|Physician Decision|4|||
146340097|NCT03180736|527754383|FG001|Overall Study|Physician Decision|7|||
146340098|NCT03180736|527754382|FG000|Overall Study|randomized but not treated|2|||
146340099|NCT03180736|527754383|FG001|Overall Study|randomized but not treated|3|||
146340100|NCT01389128|527754384|FG000|Overall Study|Fetal distress|1|||
146340101|NCT01389128|527754385|FG001|Overall Study|Fetal distress|0|||
146340102|NCT01389128|527754384|FG000|Overall Study|Cervix dilation stop|1|||
146340103|NCT01389128|527754385|FG001|Overall Study|Cervix dilation stop|2|||
146340104|NCT01389128|527754384|FG000|Overall Study|Rapid labor evolution|3|||
146340105|NCT01389128|527754385|FG001|Overall Study|Rapid labor evolution|2|||
146340106|NCT01389128|527754384|FG000|Overall Study|Intolerance to procedure|0|||
146340107|NCT01389128|527754385|FG001|Overall Study|Intolerance to procedure|2|||
146340108|NCT01059812|527754386|FG000|Overall Study|Adverse Event|9|||
146340109|NCT01059812|527754387|FG001|Overall Study|Adverse Event|5|||
146340110|NCT01059812|527754386|FG000|Overall Study|Lack of Efficacy|2|||
146340111|NCT01059812|527754387|FG001|Overall Study|Lack of Efficacy|2|||
146340112|NCT01059812|527754386|FG000|Overall Study|Protocol Violation|3|||
146340113|NCT01059812|527754387|FG001|Overall Study|Protocol Violation|1|||
146340114|NCT01059812|527754386|FG000|Overall Study|Withdrawal Criteria|9|||
146340115|NCT01059812|527754387|FG001|Overall Study|Withdrawal Criteria|4|||
146340116|NCT01059812|527754386|FG000|Overall Study|Unclassified|14|||
146340117|NCT01059812|527754387|FG001|Overall Study|Unclassified|4|||
146340118|NCT00174941|527754388|FG000|Overall Study|Adverse Event|1|||
146340119|NCT00174941|527754389|FG001|Overall Study|Adverse Event|10|||
146340120|NCT00174941|527754390|FG002|Overall Study|Adverse Event|2|||
146340121|NCT00174941|527754391|FG003|Overall Study|Adverse Event|13|||
146340122|NCT00174941|527754388|FG000|Overall Study|Protocol Violation|0|||
146340123|NCT00174941|527754389|FG001|Overall Study|Protocol Violation|1|||
146340124|NCT00174941|527754390|FG002|Overall Study|Protocol Violation|0|||
146340125|NCT00174941|527754391|FG003|Overall Study|Protocol Violation|1|||
146340126|NCT00174941|527754388|FG000|Overall Study|Lost to Follow-up|0|||
146340127|NCT00174941|527754389|FG001|Overall Study|Lost to Follow-up|3|||
146169155|NCT02798211|527131146|FG002|Period 1|Death|1|||
146340128|NCT00174941|527754390|FG002|Overall Study|Lost to Follow-up|2|||
146340129|NCT00174941|527754391|FG003|Overall Study|Lost to Follow-up|5|||
146340130|NCT00174941|527754388|FG000|Overall Study|Personal Reason(s)|0|||
146340131|NCT00174941|527754389|FG001|Overall Study|Personal Reason(s)|14|||
146340132|NCT00174941|527754390|FG002|Overall Study|Personal Reason(s)|8|||
146340133|NCT00174941|527754391|FG003|Overall Study|Personal Reason(s)|22|||
146340134|NCT00174941|527754388|FG000|Overall Study|Gout Flare|0|||
146340135|NCT00174941|527754389|FG001|Overall Study|Gout Flare|4|||
146340136|NCT00174941|527754390|FG002|Overall Study|Gout Flare|4|||
146340137|NCT00174941|527754391|FG003|Overall Study|Gout Flare|8|||
146340138|NCT00174941|527754388|FG000|Overall Study|Reason Not Specified|1|||
146340139|NCT00174941|527754389|FG001|Overall Study|Reason Not Specified|6|||
146340140|NCT00174941|527754390|FG002|Overall Study|Reason Not Specified|2|||
146340141|NCT00174941|527754391|FG003|Overall Study|Reason Not Specified|9|||
146340142|NCT03126227|527754392|FG000|Overall Study|Adverse Event|43|||
146340143|NCT03126227|527754393|FG001|Overall Study|Adverse Event|4|||
146340144|NCT03126227|527754392|FG000|Overall Study|Death|0|||
146340145|NCT03126227|527754393|FG001|Overall Study|Death|1|||
146340146|NCT03126227|527754392|FG000|Overall Study|Lost to Follow-up|0|||
146340147|NCT03126227|527754393|FG001|Overall Study|Lost to Follow-up|1|||
146340148|NCT03126227|527754392|FG000|Overall Study|Physician Decision|2|||
146340149|NCT03126227|527754393|FG001|Overall Study|Physician Decision|0|||
146340150|NCT03126227|527754392|FG000|Overall Study|Protocol Violation|1|||
146340151|NCT03126227|527754393|FG001|Overall Study|Protocol Violation|0|||
146340152|NCT03126227|527754392|FG000|Overall Study|Withdrawal by Subject|19|||
146340153|NCT03126227|527754393|FG001|Overall Study|Withdrawal by Subject|3|||
146340154|NCT03126227|527754392|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
146340155|NCT03126227|527754393|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
146340156|NCT03126227|527754392|FG000|Overall Study|Lack of dosing compliance|2|||
146340157|NCT03126227|527754393|FG001|Overall Study|Lack of dosing compliance|0|||
146340158|NCT03126227|527754392|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
146340159|NCT03126227|527754393|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
146340160|NCT03126227|527754392|FG000|Overall Study|Scheduling conflict|1|||
146340161|NCT03126227|527754393|FG001|Overall Study|Scheduling conflict|0|||
146340162|NCT00635102|527754404|FG000|Overall Study|Withdrawal by Subject|7|||
146340163|NCT00635102|527754405|FG001|Overall Study|Withdrawal by Subject|8|||
146340164|NCT00440401|527754407|FG000|Overall Study|Adverse Event|2|||
146340165|NCT00440401|527754408|FG001|Overall Study|Adverse Event|1|||
146340166|NCT00440401|527754407|FG000|Overall Study|Other|2|||
146340167|NCT00440401|527754408|FG001|Overall Study|Other|5|||
146340168|NCT01938625|527754409|FG000|Overall Study|Withdrawal by Subject|0|||
146340169|NCT01938625|527754410|FG001|Overall Study|Withdrawal by Subject|1|||
146340170|NCT01938625|527754409|FG000|Overall Study|Adverse Event|0|||
146340171|NCT01938625|527754410|FG001|Overall Study|Adverse Event|1|||
146340172|NCT01937312|527754411|FG000|Overall Study|Adverse Event|10|||
146340173|NCT01937312|527754412|FG001|Overall Study|Adverse Event|1|||
146340174|NCT01937312|527754411|FG000|Overall Study|Lack of Efficacy|0|||
146340175|NCT01937312|527754412|FG001|Overall Study|Lack of Efficacy|1|||
146340176|NCT01937312|527754411|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
146340177|NCT01937312|527754412|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
146340178|NCT05309083|527754413|FG000|Overall Study|Withdrawal by Subject|2|||
146340179|NCT00474253|527754414|FG000|Overall Study|Withdrew consent|2|||
146340180|NCT00474253|527754415|FG001|Overall Study|Withdrew consent|0|||
146340181|NCT00474253|527754414|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
146340182|NCT00474253|527754415|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
146340183|NCT00474253|527754414|FG000|Overall Study|Lost to Follow-up|1|||
146340184|NCT00474253|527754415|FG001|Overall Study|Lost to Follow-up|0|||
146340185|NCT00474253|527754414|FG000|Overall Study|Discharged prior to study completion|0|||
146340186|NCT00474253|527754415|FG001|Overall Study|Discharged prior to study completion|1|||
146340187|NCT01165229|527754416|FG000|Overall Study|Serious Adverse Event|456|||
146340188|NCT01165229|527754417|FG001|Overall Study|Serious Adverse Event|487|||
146340189|NCT01165229|527754416|FG000|Overall Study|Non-Serious Adverse Event|47|||
146340190|NCT01165229|527754417|FG001|Overall Study|Non-Serious Adverse Event|15|||
146340191|NCT01165229|527754416|FG000|Overall Study|Protocol Violation|6|||
146340192|NCT01165229|527754417|FG001|Overall Study|Protocol Violation|8|||
146340193|NCT01165229|527754416|FG000|Overall Study|Withdrawal by Subject|387|||
146340194|NCT01165229|527754417|FG001|Overall Study|Withdrawal by Subject|396|||
146340195|NCT01165229|527754416|FG000|Overall Study|Migrated/moved from study area|51|||
146340196|NCT01165229|527754417|FG001|Overall Study|Migrated/moved from study area|46|||
146340197|NCT01165229|527754416|FG000|Overall Study|Lost to Follow-up|123|||
146340198|NCT01165229|527754417|FG001|Overall Study|Lost to Follow-up|133|||
146340199|NCT01165229|527754416|FG000|Overall Study|Suspected HZ Episode|2|||
146340200|NCT01165229|527754417|FG001|Overall Study|Suspected HZ Episode|2|||
146340201|NCT01165229|527754416|FG000|Overall Study|No reason from the subject|108|||
146340202|NCT01165229|527754417|FG001|Overall Study|No reason from the subject|102|||
146340203|NCT01165229|527754416|FG000|Overall Study|Unknown completion status|0|||
146340204|NCT01165229|527754417|FG001|Overall Study|Unknown completion status|1|||
146340205|NCT00550238|527754421|FG000|Overall Study|Adverse Event|88|||
146340206|NCT00550238|527754421|FG000|Overall Study|Death|34|||
146340207|NCT00550238|527754421|FG000|Overall Study|Disease progression|46|||
146340208|NCT00550238|527754421|FG000|Overall Study|Withdrawal by Subject|167|||
146169156|NCT02798211|527131147|FG003|Period 1|Death|0|||
146169157|NCT02798211|527131148|FG004|Period 1|Death|0|||
146340209|NCT00550238|527754421|FG000|Overall Study|Physician Decision|31|||
146340210|NCT00550238|527754421|FG000|Overall Study|Patient noncompliance|25|||
146340211|NCT00550238|527754421|FG000|Overall Study|Lost to Follow-up|13|||
146169158|NCT02798211|527131149|FG005|Period 1|Death|0|||
146169159|NCT02798211|527131144|FG000|Period 1|Withdrawal of Informed Consent|2|||
146169160|NCT02798211|527131145|FG001|Period 1|Withdrawal of Informed Consent|7|||
146340212|NCT00550238|527754421|FG000|Overall Study|Sponsor decision|55|||
146340213|NCT03133481|527754422|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
146340214|NCT03133481|527754423|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
146340215|NCT01184989|527754428|FG000|Overall Study|Adverse Event|11|||
146340216|NCT01184989|527754428|FG000|Overall Study|Withdrawal by Subject|1|||
146340217|NCT01570491|527754429|FG000|Overall Study|Lost to Follow-up|3|||
146340218|NCT01570491|527754430|FG001|Overall Study|Lost to Follow-up|1|||
146340219|NCT01570491|527754429|FG000|Overall Study|treatment: not given or discontinued|2|||
146340220|NCT01570491|527754430|FG001|Overall Study|treatment: not given or discontinued|0|||
146340221|NCT05370157|527754433|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
146340222|NCT05370157|527754434|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
146340223|NCT05370157|527754433|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
146340224|NCT05370157|527754434|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
146340225|NCT01508676|527754435|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
146340226|NCT01508676|527754436|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
146340227|NCT01508676|527754435|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
146340228|NCT01508676|527754436|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
146340229|NCT01508676|527754435|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
146340230|NCT01508676|527754436|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
146340231|NCT01508676|527754435|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
146340232|NCT01508676|527754436|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
146340233|NCT01508676|527754435|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
146340234|NCT01508676|527754436|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
146340235|NCT03700892|527754437|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
146340236|NCT03700892|527754438|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
146340237|NCT03700892|527754439|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
146340238|NCT00849212|527754441|FG000|Overall Study|Lack of Efficacy|1|||
146340239|NCT00849212|527754441|FG000|Overall Study|Withdrawal by Subject|3|||
146340240|NCT00849212|527754441|FG000|Overall Study|Adverse Event|2|||
146340241|NCT00849212|527754441|FG000|Overall Study|Miscellaneous|1|||
146340242|NCT04407507|527754442|FG000|Overall Study|Withdrawal by Subject|0|||
146340243|NCT04407507|527754443|FG001|Overall Study|Withdrawal by Subject|1|||
146340244|NCT01499576|527754444|FG000|Overall Study|Physician Decision|12|||
146340245|NCT01499576|527754444|FG000|Overall Study|Withdrawal by Subject|9|||
146340246|NCT01254344|527754448|FG000|Overall Study|Adverse Event|2|||
146340247|NCT01254344|527754449|FG001|Overall Study|Adverse Event|5|||
146340248|NCT01254344|527754448|FG000|Overall Study|Physician Decision|7|||
146340249|NCT01254344|527754449|FG001|Overall Study|Physician Decision|4|||
146340250|NCT01254344|527754448|FG000|Overall Study|Protocol Violation|1|||
146340251|NCT01254344|527754449|FG001|Overall Study|Protocol Violation|4|||
146340252|NCT01254344|527754448|FG000|Overall Study|Withdrawal by Subject|3|||
146340253|NCT01254344|527754449|FG001|Overall Study|Withdrawal by Subject|6|||
146340254|NCT00587223|527754452|FG000|Overall Study|Adverse Event|1|||
146340255|NCT00195351|527754453|FG000|Overall Study|Lost to Follow-up|9|||
146340256|NCT00195351|527754454|FG001|Overall Study|Lost to Follow-up|9|||
146340257|NCT00195351|527754453|FG000|Overall Study|Withdrawal by Subject|6|||
146340258|NCT00195351|527754454|FG001|Overall Study|Withdrawal by Subject|3|||
146340259|NCT00195351|527754453|FG000|Overall Study|Protocol Deviation|3|||
146340260|NCT00195351|527754454|FG001|Overall Study|Protocol Deviation|2|||
146340261|NCT00195351|527754453|FG000|Overall Study|Death|3|||
146340262|NCT00195351|527754454|FG001|Overall Study|Death|1|||
146340263|NCT00195351|527754453|FG000|Overall Study|Lack of Efficacy|0|||
146340264|NCT00195351|527754454|FG001|Overall Study|Lack of Efficacy|1|||
146340265|NCT02111369|527754455|FG000|Overall Study|Lost to Follow-up|2|||
146340266|NCT02111369|527754455|FG000|Overall Study|Withdrawal by Subject|1|||
146340267|NCT04332419|527754459|FG000|Overall Study|Withdrawal by Subject|1|||
146340268|NCT00971321|527754460|FG000|Up to Month 7|Withdrawal by Subject|1|||
146340269|NCT00971321|527754461|FG001|Up to Month 7|Withdrawal by Subject|0|||
146340270|NCT00971321|527754460|FG000|Up to Month 7|Migrated/moved from study area|3|||
146340271|NCT00971321|527754461|FG001|Up to Month 7|Migrated/moved from study area|2|||
146340272|NCT00971321|527754460|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
146340273|NCT00971321|527754461|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
146340274|NCT00971321|527754460|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
146340275|NCT00971321|527754461|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
146340276|NCT00971321|527754460|FG000|Up to Month 11-12|Lost to Follow-up|1|||
146340277|NCT00971321|527754461|FG001|Up to Month 11-12|Lost to Follow-up|0|||
146340278|NCT00519623|527754462|FG000|Overall Study|Adverse Event|1|||
146340279|NCT04222725|527754463|FG000|Overall Study|Adverse Event|0|||
146340280|NCT04222725|527754464|FG001|Overall Study|Adverse Event|1|||
146340281|NCT04222725|527754465|FG002|Overall Study|Adverse Event|0|||
146340282|NCT04222725|527754466|FG003|Overall Study|Adverse Event|0|||
146340283|NCT03819140|527754467|FG000|Overall Study|Lost to Follow-up|1|||
146340284|NCT03819140|527754468|FG001|Overall Study|Lost to Follow-up|2|||
146340285|NCT03819140|527754467|FG000|Overall Study|Withdrawal by Subject|3|||
146340286|NCT03819140|527754468|FG001|Overall Study|Withdrawal by Subject|2|||
146340287|NCT03819140|527754467|FG000|Overall Study|Adverse Event|0|||
146340288|NCT03819140|527754468|FG001|Overall Study|Adverse Event|1|||
146340289|NCT03819140|527754467|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
146340290|NCT03819140|527754468|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
146340291|NCT03819140|527754467|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
146340292|NCT03819140|527754468|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
146340293|NCT00658333|527754469|FG000|Overall Study|Adverse Event|2|||
146340294|NCT00658333|527754470|FG001|Overall Study|Adverse Event|1|||
145943285|NCT02326298|526300465|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
145943286|NCT02326298|526300466|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943287|NCT02326298|526300467|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943288|NCT02326298|526300468|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943289|NCT02326298|526300469|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943290|NCT02326298|526300470|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943291|NCT02326298|526300471|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943292|NCT02326298|526300472|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943293|NCT02326298|526300473|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943294|NCT02326298|526300474|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943295|NCT02326298|526300475|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943296|NCT02326298|526300476|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943297|NCT02326298|526300477|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145943298|NCT02326298|526300464|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943299|NCT02326298|526300465|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943300|NCT02326298|526300466|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
145943301|NCT02326298|526300467|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943302|NCT02326298|526300468|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943303|NCT02326298|526300469|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943304|NCT02326298|526300470|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943305|NCT02326298|526300471|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943306|NCT02326298|526300472|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943307|NCT02326298|526300473|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943308|NCT02326298|526300474|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943309|NCT02326298|526300475|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943310|NCT02326298|526300476|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943311|NCT02326298|526300477|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145943312|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943313|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943314|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943315|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943316|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943317|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145943318|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
145943319|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145943320|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145943321|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145943322|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943323|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943324|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145943325|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
146169161|NCT02798211|527131146|FG002|Period 1|Withdrawal of Informed Consent|3|||
146340295|NCT03519178|527754471|FG000|PF-06873600 Treatment|Adverse Event|0|||
146340296|NCT03519178|527754472|FG001|PF-06873600 Treatment|Adverse Event|0|||
146340297|NCT03519178|527754473|FG002|PF-06873600 Treatment|Adverse Event|0|||
146340298|NCT03519178|527754474|FG003|PF-06873600 Treatment|Adverse Event|0|||
146340299|NCT03519178|527754475|FG004|PF-06873600 Treatment|Adverse Event|0|||
146340300|NCT03519178|527754476|FG005|PF-06873600 Treatment|Adverse Event|0|||
146340301|NCT03519178|527754477|FG006|PF-06873600 Treatment|Adverse Event|0|||
146340302|NCT03519178|527754478|FG007|PF-06873600 Treatment|Adverse Event|2|||
146340303|NCT03519178|527754479|FG008|PF-06873600 Treatment|Adverse Event|1|||
146340304|NCT03519178|527754480|FG009|PF-06873600 Treatment|Adverse Event|0|||
146340305|NCT03519178|527754481|FG010|PF-06873600 Treatment|Adverse Event|0|||
146340306|NCT03519178|527754482|FG011|PF-06873600 Treatment|Adverse Event|0|||
146340307|NCT03519178|527754483|FG012|PF-06873600 Treatment|Adverse Event|1|||
146340308|NCT03519178|527754484|FG013|PF-06873600 Treatment|Adverse Event|3|||
146340309|NCT03519178|527754485|FG014|PF-06873600 Treatment|Adverse Event|2|||
146340310|NCT03519178|527754471|FG000|PF-06873600 Treatment|Death|0|||
146340311|NCT03519178|527754472|FG001|PF-06873600 Treatment|Death|0|||
146340312|NCT03519178|527754473|FG002|PF-06873600 Treatment|Death|0|||
146340313|NCT03519178|527754474|FG003|PF-06873600 Treatment|Death|0|||
146340314|NCT03519178|527754475|FG004|PF-06873600 Treatment|Death|0|||
146340315|NCT03519178|527754476|FG005|PF-06873600 Treatment|Death|0|||
146340316|NCT03519178|527754477|FG006|PF-06873600 Treatment|Death|0|||
146340317|NCT03519178|527754478|FG007|PF-06873600 Treatment|Death|0|||
146340318|NCT03519178|527754479|FG008|PF-06873600 Treatment|Death|1|||
146340319|NCT03519178|527754480|FG009|PF-06873600 Treatment|Death|1|||
146340320|NCT03519178|527754481|FG010|PF-06873600 Treatment|Death|0|||
146340321|NCT03519178|527754482|FG011|PF-06873600 Treatment|Death|0|||
146340322|NCT03519178|527754483|FG012|PF-06873600 Treatment|Death|0|||
146340323|NCT03519178|527754484|FG013|PF-06873600 Treatment|Death|0|||
146340324|NCT03519178|527754485|FG014|PF-06873600 Treatment|Death|1|||
146340325|NCT03519178|527754471|FG000|PF-06873600 Treatment|Physician Decision|0|||
146340326|NCT03519178|527754472|FG001|PF-06873600 Treatment|Physician Decision|0|||
146340327|NCT03519178|527754473|FG002|PF-06873600 Treatment|Physician Decision|0|||
146340328|NCT03519178|527754474|FG003|PF-06873600 Treatment|Physician Decision|0|||
146340329|NCT03519178|527754475|FG004|PF-06873600 Treatment|Physician Decision|0|||
146340330|NCT03519178|527754476|FG005|PF-06873600 Treatment|Physician Decision|0|||
146340331|NCT03519178|527754477|FG006|PF-06873600 Treatment|Physician Decision|0|||
146340332|NCT03519178|527754478|FG007|PF-06873600 Treatment|Physician Decision|1|||
146340333|NCT03519178|527754479|FG008|PF-06873600 Treatment|Physician Decision|0|||
146340334|NCT03519178|527754480|FG009|PF-06873600 Treatment|Physician Decision|0|||
146340335|NCT03519178|527754481|FG010|PF-06873600 Treatment|Physician Decision|1|||
146340336|NCT03519178|527754482|FG011|PF-06873600 Treatment|Physician Decision|0|||
146340337|NCT03519178|527754483|FG012|PF-06873600 Treatment|Physician Decision|0|||
146340338|NCT03519178|527754484|FG013|PF-06873600 Treatment|Physician Decision|4|||
146340339|NCT03519178|527754485|FG014|PF-06873600 Treatment|Physician Decision|1|||
146340340|NCT03519178|527754471|FG000|PF-06873600 Treatment|Progressive disease|1|||
146340341|NCT03519178|527754472|FG001|PF-06873600 Treatment|Progressive disease|1|||
146340342|NCT03519178|527754473|FG002|PF-06873600 Treatment|Progressive disease|1|||
146340343|NCT03519178|527754474|FG003|PF-06873600 Treatment|Progressive disease|1|||
146340344|NCT03519178|527754475|FG004|PF-06873600 Treatment|Progressive disease|6|||
146340345|NCT03519178|527754476|FG005|PF-06873600 Treatment|Progressive disease|7|||
146340346|NCT03519178|527754477|FG006|PF-06873600 Treatment|Progressive disease|3|||
146340347|NCT03519178|527754478|FG007|PF-06873600 Treatment|Progressive disease|7|||
146340348|NCT03519178|527754479|FG008|PF-06873600 Treatment|Progressive disease|3|||
146340349|NCT03519178|527754480|FG009|PF-06873600 Treatment|Progressive disease|5|||
146340350|NCT03519178|527754481|FG010|PF-06873600 Treatment|Progressive disease|4|||
146340351|NCT03519178|527754482|FG011|PF-06873600 Treatment|Progressive disease|3|||
146340352|NCT03519178|527754483|FG012|PF-06873600 Treatment|Progressive disease|4|||
146340353|NCT03519178|527754484|FG013|PF-06873600 Treatment|Progressive disease|28|||
146340354|NCT03519178|527754485|FG014|PF-06873600 Treatment|Progressive disease|8|||
146340355|NCT03519178|527754471|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340356|NCT03519178|527754472|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340357|NCT03519178|527754473|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
146340358|NCT03519178|527754474|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340359|NCT03519178|527754475|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
146340360|NCT03519178|527754476|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340361|NCT03519178|527754477|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340362|NCT03519178|527754478|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
146340363|NCT03519178|527754479|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
146340364|NCT03519178|527754480|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
146340365|NCT03519178|527754481|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
146340366|NCT03519178|527754482|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
146340367|NCT03519178|527754483|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
146340368|NCT03519178|527754484|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
146340369|NCT03519178|527754485|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
146340370|NCT03519178|527754471|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
146340371|NCT03519178|527754472|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
146340372|NCT03519178|527754473|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
146340373|NCT03519178|527754474|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
146340374|NCT03519178|527754475|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
146340375|NCT03519178|527754476|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
146340376|NCT03519178|527754477|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
146340377|NCT03519178|527754478|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
146340378|NCT03519178|527754479|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
146340379|NCT03519178|527754480|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
146340380|NCT03519178|527754481|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
146340381|NCT03519178|527754482|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
146396295|NCT00276458|527954548|FG000|Overall Study|Lost to Follow-up|2|||
146340382|NCT03519178|527754483|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
146340383|NCT03519178|527754484|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
146340384|NCT03519178|527754485|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
146340385|NCT03519178|527754471|FG000|PF-06873600 Treatment|Refused further treatment|0|||
146340386|NCT03519178|527754472|FG001|PF-06873600 Treatment|Refused further treatment|1|||
146340387|NCT03519178|527754473|FG002|PF-06873600 Treatment|Refused further treatment|0|||
146340388|NCT03519178|527754474|FG003|PF-06873600 Treatment|Refused further treatment|0|||
146340389|NCT03519178|527754475|FG004|PF-06873600 Treatment|Refused further treatment|1|||
146340390|NCT03519178|527754476|FG005|PF-06873600 Treatment|Refused further treatment|0|||
146340391|NCT03519178|527754477|FG006|PF-06873600 Treatment|Refused further treatment|0|||
146340392|NCT03519178|527754478|FG007|PF-06873600 Treatment|Refused further treatment|0|||
146340393|NCT03519178|527754479|FG008|PF-06873600 Treatment|Refused further treatment|0|||
146340394|NCT03519178|527754480|FG009|PF-06873600 Treatment|Refused further treatment|0|||
146340395|NCT03519178|527754481|FG010|PF-06873600 Treatment|Refused further treatment|0|||
146340396|NCT03519178|527754482|FG011|PF-06873600 Treatment|Refused further treatment|0|||
146340397|NCT03519178|527754483|FG012|PF-06873600 Treatment|Refused further treatment|0|||
146340398|NCT03519178|527754484|FG013|PF-06873600 Treatment|Refused further treatment|0|||
146340399|NCT03519178|527754485|FG014|PF-06873600 Treatment|Refused further treatment|1|||
146340400|NCT03519178|527754471|FG000|PF-06873600 Treatment|Other|0|||
146340401|NCT03519178|527754472|FG001|PF-06873600 Treatment|Other|0|||
146340402|NCT03519178|527754473|FG002|PF-06873600 Treatment|Other|0|||
146340403|NCT03519178|527754474|FG003|PF-06873600 Treatment|Other|0|||
146340404|NCT03519178|527754475|FG004|PF-06873600 Treatment|Other|0|||
146340405|NCT03519178|527754476|FG005|PF-06873600 Treatment|Other|0|||
146340406|NCT03519178|527754477|FG006|PF-06873600 Treatment|Other|0|||
146340407|NCT03519178|527754478|FG007|PF-06873600 Treatment|Other|0|||
146340408|NCT03519178|527754479|FG008|PF-06873600 Treatment|Other|1|||
146340409|NCT03519178|527754480|FG009|PF-06873600 Treatment|Other|0|||
146340410|NCT03519178|527754481|FG010|PF-06873600 Treatment|Other|0|||
146340411|NCT03519178|527754482|FG011|PF-06873600 Treatment|Other|0|||
146340412|NCT03519178|527754483|FG012|PF-06873600 Treatment|Other|0|||
146340413|NCT03519178|527754484|FG013|PF-06873600 Treatment|Other|1|||
146340414|NCT03519178|527754485|FG014|PF-06873600 Treatment|Other|3|||
146340415|NCT03519178|527754471|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
146340416|NCT03519178|527754472|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
146340417|NCT03519178|527754473|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
146340418|NCT03519178|527754474|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
146340419|NCT03519178|527754475|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
146340420|NCT03519178|527754476|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
146340421|NCT03519178|527754477|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
146340422|NCT03519178|527754478|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
146340423|NCT03519178|527754479|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
146340424|NCT03519178|527754480|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
146340425|NCT03519178|527754481|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
146340426|NCT03519178|527754482|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
146340427|NCT03519178|527754483|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
146340428|NCT03519178|527754484|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
146340429|NCT03519178|527754485|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
146340430|NCT03519178|527754471|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340431|NCT03519178|527754472|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340432|NCT03519178|527754473|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340433|NCT03519178|527754474|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340434|NCT03519178|527754475|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340435|NCT03519178|527754476|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340436|NCT03519178|527754477|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340437|NCT03519178|527754478|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340438|NCT03519178|527754479|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340439|NCT03519178|527754480|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340440|NCT03519178|527754481|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340441|NCT03519178|527754482|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340442|NCT03519178|527754483|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
146340443|NCT03519178|527754484|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
146340444|NCT03519178|527754485|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
146340445|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Adverse Event|0|||
146340446|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Adverse Event|0|||
146340447|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Adverse Event|0|||
146340448|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Adverse Event|0|||
146340449|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Adverse Event|0|||
146340450|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Adverse Event|0|||
146340451|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Adverse Event|0|||
146340452|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Adverse Event|0|||
146340453|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Adverse Event|0|||
146340454|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Adverse Event|0|||
146340455|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Adverse Event|0|||
146340456|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Adverse Event|0|||
146340457|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Adverse Event|0|||
146340458|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Adverse Event|1|||
146340459|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Adverse Event|0|||
146340460|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Death|0|||
146340461|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Death|0|||
146340462|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Death|0|||
146340463|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Death|0|||
146340464|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Death|0|||
146340465|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Death|0|||
146340466|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Death|0|||
146340467|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Death|0|||
146340468|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Death|0|||
146340469|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Death|1|||
146340470|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Death|0|||
146340471|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Death|0|||
146340472|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Death|0|||
146340473|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Death|0|||
146340474|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Death|1|||
146340475|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340476|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340477|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340478|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340479|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340480|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340481|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340482|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340483|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340484|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340485|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340486|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340487|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340488|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
146340489|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
146340490|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Physician Decision|0|||
146340491|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Physician Decision|0|||
146340492|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Physician Decision|0|||
146340493|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Physician Decision|0|||
146340494|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Physician Decision|0|||
146340495|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Physician Decision|0|||
146340496|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Physician Decision|0|||
146340497|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Physician Decision|0|||
146340498|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Physician Decision|0|||
146340499|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Physician Decision|0|||
146340500|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Physician Decision|0|||
146340501|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Physician Decision|0|||
146340502|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Physician Decision|0|||
146340503|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Physician Decision|4|||
146340504|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Physician Decision|2|||
146340505|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Progressive disease|0|||
146340506|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Progressive disease|0|||
146340507|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Progressive disease|0|||
146340508|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Progressive disease|0|||
146340509|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Progressive disease|0|||
146340510|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Progressive disease|0|||
146340511|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Progressive disease|0|||
146340512|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Progressive disease|0|||
146340513|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Progressive disease|0|||
146340514|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Progressive disease|5|||
146340515|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Progressive disease|0|||
146340516|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Progressive disease|0|||
146340517|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Progressive disease|0|||
146340518|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Progressive disease|30|||
146340519|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Progressive disease|8|||
146340520|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340521|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340522|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340523|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340524|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340525|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340526|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340527|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340528|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340529|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340530|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340531|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340532|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
146340533|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
146340534|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
146340535|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340536|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340537|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340538|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340539|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340540|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340541|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340542|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340543|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340544|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
146340545|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340546|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340547|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
146340548|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
146340549|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
146340550|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340551|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340552|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340553|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340554|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340555|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340556|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340557|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340558|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340559|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
146340560|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340561|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340562|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340563|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
146340564|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
146340565|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
146340566|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
146340567|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
146340568|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
146340569|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
146340570|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
146340571|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
146340572|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
146340573|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
146340574|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
146340575|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
146340576|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
146340577|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
146340578|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
146340579|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
146340580|NCT03519178|527754471|FG000|Fulvestrant. Treatment|Other|0|||
146340581|NCT03519178|527754472|FG001|Fulvestrant. Treatment|Other|0|||
146340582|NCT03519178|527754473|FG002|Fulvestrant. Treatment|Other|0|||
146340583|NCT03519178|527754474|FG003|Fulvestrant. Treatment|Other|0|||
146340584|NCT03519178|527754475|FG004|Fulvestrant. Treatment|Other|0|||
146340585|NCT03519178|527754476|FG005|Fulvestrant. Treatment|Other|0|||
146340586|NCT03519178|527754477|FG006|Fulvestrant. Treatment|Other|0|||
146340587|NCT03519178|527754478|FG007|Fulvestrant. Treatment|Other|0|||
146340588|NCT03519178|527754479|FG008|Fulvestrant. Treatment|Other|0|||
146340589|NCT03519178|527754480|FG009|Fulvestrant. Treatment|Other|0|||
146340590|NCT03519178|527754481|FG010|Fulvestrant. Treatment|Other|0|||
146340591|NCT03519178|527754482|FG011|Fulvestrant. Treatment|Other|0|||
146340592|NCT03519178|527754483|FG012|Fulvestrant. Treatment|Other|0|||
146340593|NCT03519178|527754484|FG013|Fulvestrant. Treatment|Other|1|||
146340594|NCT03519178|527754485|FG014|Fulvestrant. Treatment|Other|3|||
146169162|NCT02798211|527131147|FG003|Period 1|Withdrawal of Informed Consent|0|||
146340595|NCT03519178|527754471|FG000|Letrozole Treatment|Physician Decision|0|||
146340596|NCT03519178|527754472|FG001|Letrozole Treatment|Physician Decision|0|||
146340597|NCT03519178|527754473|FG002|Letrozole Treatment|Physician Decision|0|||
146340598|NCT03519178|527754474|FG003|Letrozole Treatment|Physician Decision|0|||
146340599|NCT03519178|527754475|FG004|Letrozole Treatment|Physician Decision|0|||
146340600|NCT03519178|527754476|FG005|Letrozole Treatment|Physician Decision|0|||
146340601|NCT03519178|527754477|FG006|Letrozole Treatment|Physician Decision|0|||
146340602|NCT03519178|527754478|FG007|Letrozole Treatment|Physician Decision|0|||
146340603|NCT03519178|527754479|FG008|Letrozole Treatment|Physician Decision|0|||
146340604|NCT03519178|527754480|FG009|Letrozole Treatment|Physician Decision|0|||
146340605|NCT03519178|527754481|FG010|Letrozole Treatment|Physician Decision|1|||
146340606|NCT03519178|527754482|FG011|Letrozole Treatment|Physician Decision|0|||
146340607|NCT03519178|527754483|FG012|Letrozole Treatment|Physician Decision|0|||
146340608|NCT03519178|527754484|FG013|Letrozole Treatment|Physician Decision|0|||
146340609|NCT03519178|527754485|FG014|Letrozole Treatment|Physician Decision|0|||
146340610|NCT03519178|527754471|FG000|Letrozole Treatment|Progressive disease|0|||
146340611|NCT03519178|527754472|FG001|Letrozole Treatment|Progressive disease|0|||
146340612|NCT03519178|527754473|FG002|Letrozole Treatment|Progressive disease|0|||
146340613|NCT03519178|527754474|FG003|Letrozole Treatment|Progressive disease|0|||
146340614|NCT03519178|527754475|FG004|Letrozole Treatment|Progressive disease|0|||
146340615|NCT03519178|527754476|FG005|Letrozole Treatment|Progressive disease|0|||
146340616|NCT03519178|527754477|FG006|Letrozole Treatment|Progressive disease|0|||
146340617|NCT03519178|527754478|FG007|Letrozole Treatment|Progressive disease|0|||
146340618|NCT03519178|527754479|FG008|Letrozole Treatment|Progressive disease|0|||
146340619|NCT03519178|527754480|FG009|Letrozole Treatment|Progressive disease|0|||
146340620|NCT03519178|527754481|FG010|Letrozole Treatment|Progressive disease|4|||
146340621|NCT03519178|527754482|FG011|Letrozole Treatment|Progressive disease|0|||
146340622|NCT03519178|527754483|FG012|Letrozole Treatment|Progressive disease|0|||
146340623|NCT03519178|527754484|FG013|Letrozole Treatment|Progressive disease|0|||
146340624|NCT03519178|527754485|FG014|Letrozole Treatment|Progressive disease|0|||
146340625|NCT03519178|527754471|FG000|Letrozole Treatment|Global deterioration of health status|0|||
146340626|NCT03519178|527754472|FG001|Letrozole Treatment|Global deterioration of health status|0|||
146340627|NCT03519178|527754473|FG002|Letrozole Treatment|Global deterioration of health status|0|||
146340628|NCT03519178|527754474|FG003|Letrozole Treatment|Global deterioration of health status|0|||
146340629|NCT03519178|527754475|FG004|Letrozole Treatment|Global deterioration of health status|0|||
146340630|NCT03519178|527754476|FG005|Letrozole Treatment|Global deterioration of health status|0|||
146340631|NCT03519178|527754477|FG006|Letrozole Treatment|Global deterioration of health status|0|||
146340632|NCT03519178|527754478|FG007|Letrozole Treatment|Global deterioration of health status|0|||
146340633|NCT03519178|527754479|FG008|Letrozole Treatment|Global deterioration of health status|0|||
146340634|NCT03519178|527754480|FG009|Letrozole Treatment|Global deterioration of health status|0|||
146340635|NCT03519178|527754481|FG010|Letrozole Treatment|Global deterioration of health status|2|||
146340636|NCT03519178|527754482|FG011|Letrozole Treatment|Global deterioration of health status|0|||
146340637|NCT03519178|527754483|FG012|Letrozole Treatment|Global deterioration of health status|0|||
146340638|NCT03519178|527754484|FG013|Letrozole Treatment|Global deterioration of health status|0|||
146340639|NCT03519178|527754485|FG014|Letrozole Treatment|Global deterioration of health status|0|||
146340640|NCT03519178|527754471|FG000|Follow-Up|Death|0|||
146340641|NCT03519178|527754472|FG001|Follow-Up|Death|0|||
146340642|NCT03519178|527754473|FG002|Follow-Up|Death|0|||
146340643|NCT03519178|527754474|FG003|Follow-Up|Death|0|||
146340644|NCT03519178|527754475|FG004|Follow-Up|Death|0|||
146340645|NCT03519178|527754476|FG005|Follow-Up|Death|0|||
146340646|NCT03519178|527754477|FG006|Follow-Up|Death|0|||
146340647|NCT03519178|527754478|FG007|Follow-Up|Death|0|||
146340648|NCT03519178|527754479|FG008|Follow-Up|Death|3|||
146340649|NCT03519178|527754480|FG009|Follow-Up|Death|1|||
146340650|NCT03519178|527754481|FG010|Follow-Up|Death|0|||
146340651|NCT03519178|527754482|FG011|Follow-Up|Death|0|||
146340652|NCT03519178|527754483|FG012|Follow-Up|Death|2|||
146340653|NCT03519178|527754484|FG013|Follow-Up|Death|0|||
146340654|NCT03519178|527754485|FG014|Follow-Up|Death|0|||
146340655|NCT03519178|527754471|FG000|Follow-Up|Lost to Follow-up|0|||
146340656|NCT03519178|527754472|FG001|Follow-Up|Lost to Follow-up|0|||
146340657|NCT03519178|527754473|FG002|Follow-Up|Lost to Follow-up|0|||
146340658|NCT03519178|527754474|FG003|Follow-Up|Lost to Follow-up|0|||
146340659|NCT03519178|527754475|FG004|Follow-Up|Lost to Follow-up|0|||
146340660|NCT03519178|527754476|FG005|Follow-Up|Lost to Follow-up|3|||
146340661|NCT03519178|527754477|FG006|Follow-Up|Lost to Follow-up|1|||
146340662|NCT03519178|527754478|FG007|Follow-Up|Lost to Follow-up|4|||
146340663|NCT03519178|527754479|FG008|Follow-Up|Lost to Follow-up|1|||
146340664|NCT03519178|527754480|FG009|Follow-Up|Lost to Follow-up|0|||
146340665|NCT03519178|527754481|FG010|Follow-Up|Lost to Follow-up|0|||
146340666|NCT03519178|527754482|FG011|Follow-Up|Lost to Follow-up|0|||
146340667|NCT03519178|527754483|FG012|Follow-Up|Lost to Follow-up|0|||
146340668|NCT03519178|527754484|FG013|Follow-Up|Lost to Follow-up|0|||
146340669|NCT03519178|527754485|FG014|Follow-Up|Lost to Follow-up|0|||
146340670|NCT03519178|527754471|FG000|Follow-Up|Withdrawal by Subject|1|||
146340671|NCT03519178|527754472|FG001|Follow-Up|Withdrawal by Subject|2|||
146340672|NCT03519178|527754473|FG002|Follow-Up|Withdrawal by Subject|2|||
146340673|NCT03519178|527754474|FG003|Follow-Up|Withdrawal by Subject|3|||
146340674|NCT03519178|527754475|FG004|Follow-Up|Withdrawal by Subject|5|||
146340675|NCT03519178|527754476|FG005|Follow-Up|Withdrawal by Subject|1|||
146340676|NCT03519178|527754477|FG006|Follow-Up|Withdrawal by Subject|2|||
146340677|NCT03519178|527754478|FG007|Follow-Up|Withdrawal by Subject|6|||
146340678|NCT03519178|527754479|FG008|Follow-Up|Withdrawal by Subject|5|||
146340679|NCT03519178|527754480|FG009|Follow-Up|Withdrawal by Subject|2|||
146340680|NCT03519178|527754481|FG010|Follow-Up|Withdrawal by Subject|3|||
146340681|NCT03519178|527754482|FG011|Follow-Up|Withdrawal by Subject|5|||
146340682|NCT03519178|527754483|FG012|Follow-Up|Withdrawal by Subject|2|||
146340683|NCT03519178|527754484|FG013|Follow-Up|Withdrawal by Subject|0|||
146340684|NCT03519178|527754485|FG014|Follow-Up|Withdrawal by Subject|0|||
146340685|NCT03519178|527754471|FG000|Follow-Up|Other|0|||
146340686|NCT03519178|527754472|FG001|Follow-Up|Other|0|||
146340687|NCT03519178|527754473|FG002|Follow-Up|Other|0|||
146340688|NCT03519178|527754474|FG003|Follow-Up|Other|0|||
146340689|NCT03519178|527754475|FG004|Follow-Up|Other|0|||
146340690|NCT03519178|527754476|FG005|Follow-Up|Other|0|||
146340691|NCT03519178|527754477|FG006|Follow-Up|Other|0|||
146340692|NCT03519178|527754478|FG007|Follow-Up|Other|1|||
146340693|NCT03519178|527754479|FG008|Follow-Up|Other|0|||
146340694|NCT03519178|527754480|FG009|Follow-Up|Other|0|||
146340695|NCT03519178|527754481|FG010|Follow-Up|Other|0|||
146340696|NCT03519178|527754482|FG011|Follow-Up|Other|0|||
146340697|NCT03519178|527754483|FG012|Follow-Up|Other|0|||
146340698|NCT03519178|527754484|FG013|Follow-Up|Other|0|||
146340699|NCT03519178|527754485|FG014|Follow-Up|Other|0|||
146340700|NCT03519178|527754471|FG000|Long-term Follow-up|Death|0|||
146340701|NCT03519178|527754472|FG001|Long-term Follow-up|Death|0|||
146340702|NCT03519178|527754473|FG002|Long-term Follow-up|Death|0|||
146340703|NCT03519178|527754474|FG003|Long-term Follow-up|Death|0|||
146340704|NCT03519178|527754475|FG004|Long-term Follow-up|Death|0|||
146340705|NCT03519178|527754476|FG005|Long-term Follow-up|Death|0|||
146340706|NCT03519178|527754477|FG006|Long-term Follow-up|Death|0|||
146340707|NCT03519178|527754478|FG007|Long-term Follow-up|Death|0|||
146340708|NCT03519178|527754479|FG008|Long-term Follow-up|Death|0|||
146340709|NCT03519178|527754480|FG009|Long-term Follow-up|Death|0|||
146340710|NCT03519178|527754481|FG010|Long-term Follow-up|Death|0|||
146340711|NCT03519178|527754482|FG011|Long-term Follow-up|Death|0|||
146340712|NCT03519178|527754483|FG012|Long-term Follow-up|Death|0|||
146340713|NCT03519178|527754484|FG013|Long-term Follow-up|Death|4|||
146340714|NCT03519178|527754485|FG014|Long-term Follow-up|Death|4|||
146340715|NCT03519178|527754471|FG000|Long-term Follow-up|Lost to Follow-up|0|||
146340716|NCT03519178|527754472|FG001|Long-term Follow-up|Lost to Follow-up|0|||
146340717|NCT03519178|527754473|FG002|Long-term Follow-up|Lost to Follow-up|0|||
146340718|NCT03519178|527754474|FG003|Long-term Follow-up|Lost to Follow-up|0|||
146340719|NCT03519178|527754475|FG004|Long-term Follow-up|Lost to Follow-up|0|||
146340720|NCT03519178|527754476|FG005|Long-term Follow-up|Lost to Follow-up|0|||
146340721|NCT03519178|527754477|FG006|Long-term Follow-up|Lost to Follow-up|0|||
146340722|NCT03519178|527754478|FG007|Long-term Follow-up|Lost to Follow-up|0|||
146340723|NCT03519178|527754479|FG008|Long-term Follow-up|Lost to Follow-up|0|||
146340724|NCT03519178|527754480|FG009|Long-term Follow-up|Lost to Follow-up|0|||
146340725|NCT03519178|527754481|FG010|Long-term Follow-up|Lost to Follow-up|0|||
146340726|NCT03519178|527754482|FG011|Long-term Follow-up|Lost to Follow-up|0|||
146340727|NCT03519178|527754483|FG012|Long-term Follow-up|Lost to Follow-up|0|||
146340728|NCT03519178|527754484|FG013|Long-term Follow-up|Lost to Follow-up|1|||
146340729|NCT03519178|527754485|FG014|Long-term Follow-up|Lost to Follow-up|1|||
146340730|NCT03519178|527754471|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
146340731|NCT03519178|527754472|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
146340732|NCT03519178|527754473|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
146340733|NCT03519178|527754474|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
146340734|NCT03519178|527754475|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
146340735|NCT03519178|527754476|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
146340736|NCT03519178|527754477|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
146340737|NCT03519178|527754478|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
146340738|NCT03519178|527754479|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
146340739|NCT03519178|527754480|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
146169163|NCT02798211|527131148|FG004|Period 1|Withdrawal of Informed Consent|0|||
146340740|NCT03519178|527754481|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
146340741|NCT03519178|527754482|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
146340742|NCT03519178|527754483|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
146340743|NCT03519178|527754484|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
146340744|NCT03519178|527754485|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
146340745|NCT03519178|527754471|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
146340746|NCT03519178|527754472|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
146340747|NCT03519178|527754473|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
146340748|NCT03519178|527754474|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
146340749|NCT03519178|527754475|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
146340750|NCT03519178|527754476|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
146340751|NCT03519178|527754477|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
146340752|NCT03519178|527754478|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
146340753|NCT03519178|527754479|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
146340754|NCT03519178|527754480|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
146340755|NCT03519178|527754481|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
146340756|NCT03519178|527754482|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
146340757|NCT03519178|527754483|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
146340758|NCT03519178|527754484|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
146340759|NCT03519178|527754485|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
146340760|NCT03519178|527754471|FG000|Long-term Follow-up|Other|0|||
146340761|NCT03519178|527754472|FG001|Long-term Follow-up|Other|0|||
146340762|NCT03519178|527754473|FG002|Long-term Follow-up|Other|0|||
146340763|NCT03519178|527754474|FG003|Long-term Follow-up|Other|0|||
146340764|NCT03519178|527754475|FG004|Long-term Follow-up|Other|0|||
146340765|NCT03519178|527754476|FG005|Long-term Follow-up|Other|0|||
146340766|NCT03519178|527754477|FG006|Long-term Follow-up|Other|0|||
146340767|NCT03519178|527754478|FG007|Long-term Follow-up|Other|0|||
146340768|NCT03519178|527754479|FG008|Long-term Follow-up|Other|0|||
146340769|NCT03519178|527754480|FG009|Long-term Follow-up|Other|0|||
146340770|NCT03519178|527754481|FG010|Long-term Follow-up|Other|0|||
146340771|NCT03519178|527754482|FG011|Long-term Follow-up|Other|0|||
146340772|NCT03519178|527754483|FG012|Long-term Follow-up|Other|0|||
146340773|NCT03519178|527754484|FG013|Long-term Follow-up|Other|0|||
146340774|NCT03519178|527754485|FG014|Long-term Follow-up|Other|1|||
146340775|NCT03519178|527754471|FG000|Long-term Follow-up|Global deterioration of health status|0|||
146340776|NCT03519178|527754472|FG001|Long-term Follow-up|Global deterioration of health status|0|||
146340777|NCT03519178|527754473|FG002|Long-term Follow-up|Global deterioration of health status|0|||
146340778|NCT03519178|527754474|FG003|Long-term Follow-up|Global deterioration of health status|0|||
146340779|NCT03519178|527754475|FG004|Long-term Follow-up|Global deterioration of health status|0|||
146340780|NCT03519178|527754476|FG005|Long-term Follow-up|Global deterioration of health status|0|||
146340781|NCT03519178|527754477|FG006|Long-term Follow-up|Global deterioration of health status|0|||
146340782|NCT03519178|527754478|FG007|Long-term Follow-up|Global deterioration of health status|0|||
146340783|NCT03519178|527754479|FG008|Long-term Follow-up|Global deterioration of health status|0|||
146340784|NCT03519178|527754480|FG009|Long-term Follow-up|Global deterioration of health status|0|||
146340785|NCT03519178|527754481|FG010|Long-term Follow-up|Global deterioration of health status|0|||
146340786|NCT03519178|527754482|FG011|Long-term Follow-up|Global deterioration of health status|0|||
146340787|NCT03519178|527754483|FG012|Long-term Follow-up|Global deterioration of health status|0|||
146340788|NCT03519178|527754484|FG013|Long-term Follow-up|Global deterioration of health status|1|||
146340789|NCT03519178|527754485|FG014|Long-term Follow-up|Global deterioration of health status|0|||
146340790|NCT03249350|527754486|FG000|Overall Study|Participant did not initiate treatment|5|||
146340791|NCT03249350|527754487|FG001|Overall Study|Participant did not initiate treatment|8|||
146340792|NCT01591330|527754488|FG000|Period 1|Adverse Event|1|||
146340793|NCT01591330|527754489|FG001|Period 1|Adverse Event|0|||
146340794|NCT01591330|527754490|FG002|Period 1|Adverse Event|0|||
146340795|NCT01591330|527754491|FG003|Period 1|Adverse Event|0|||
146340796|NCT01591330|527754488|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
146340797|NCT01591330|527754489|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146340798|NCT01591330|527754490|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146340799|NCT01591330|527754491|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
146340800|NCT01591330|527754488|FG000|Period 2|Adverse Event|1|||
146340801|NCT01591330|527754489|FG001|Period 2|Adverse Event|0|||
146340802|NCT01591330|527754490|FG002|Period 2|Adverse Event|0|||
146340803|NCT01591330|527754491|FG003|Period 2|Adverse Event|0|||
146340804|NCT01450137|527754492|FG000|Up to Week 12|Adverse Event|2|||
146340805|NCT01450137|527754493|FG001|Up to Week 12|Adverse Event|1|||
146340806|NCT01450137|527754492|FG000|Up to Week 12|Withdrawal by Subject|0|||
146340807|NCT01450137|527754493|FG001|Up to Week 12|Withdrawal by Subject|2|||
146340808|NCT01450137|527754492|FG000|Week 12 to Study End|Death|0|||
146340809|NCT01450137|527754493|FG001|Week 12 to Study End|Death|1|||
146340810|NCT01450137|527754492|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
146340811|NCT01450137|527754493|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
146340812|NCT01348919|527756692|FG000|Overall Study|Adverse Event|3|||
146340813|NCT01348919|527756693|FG001|Overall Study|Adverse Event|1|||
146340814|NCT01348919|527756694|FG002|Overall Study|Adverse Event|0|||
146340815|NCT01348919|527756692|FG000|Overall Study|Withdrawal by Subject|0|||
146340816|NCT01348919|527756693|FG001|Overall Study|Withdrawal by Subject|1|||
146340817|NCT01348919|527756694|FG002|Overall Study|Withdrawal by Subject|0|||
146340818|NCT01348919|527756692|FG000|Overall Study|Disease progression|0|||
146340819|NCT01348919|527756693|FG001|Overall Study|Disease progression|1|||
146340820|NCT01348919|527756694|FG002|Overall Study|Disease progression|1|||
146340821|NCT02082184|527756695|FG000|Overall Study|Adverse Event|1|||
146340822|NCT02082184|527756696|FG001|Overall Study|Adverse Event|0|||
146340823|NCT02082184|527756695|FG000|Overall Study|Medical diagnosis|1|||
146340824|NCT02082184|527756696|FG001|Overall Study|Medical diagnosis|2|||
146340825|NCT02082184|527756695|FG000|Overall Study|Device associated symptoms|5|||
146340826|NCT02082184|527756696|FG001|Overall Study|Device associated symptoms|0|||
146340827|NCT02082184|527756695|FG000|Overall Study|Withdrawal by Subject|3|||
146340828|NCT02082184|527756696|FG001|Overall Study|Withdrawal by Subject|2|||
146340829|NCT02082184|527756695|FG000|Overall Study|Protocol Violation|0|||
146340830|NCT02082184|527756696|FG001|Overall Study|Protocol Violation|6|||
146340831|NCT02082184|527756695|FG000|Overall Study|Lost to Follow-up|0|||
146340832|NCT02082184|527756696|FG001|Overall Study|Lost to Follow-up|2|||
146340833|NCT02082184|527756695|FG000|Overall Study|Subject non-compliance|0|||
146340834|NCT02082184|527756696|FG001|Overall Study|Subject non-compliance|1|||
146340835|NCT00443560|527756697|FG000|Overall Study|No intrathecal dose|58|||
146340836|NCT00443560|527756698|FG001|Overall Study|No intrathecal dose|26|||
146340837|NCT00443560|527756697|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
146340838|NCT00443560|527756698|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
146340839|NCT02413255|527756703|FG000|Overall Study|Voluntary Withdrawal|0|||
146340840|NCT02413255|527756704|FG001|Overall Study|Voluntary Withdrawal|0|||
146340841|NCT02413255|527756705|FG002|Overall Study|Voluntary Withdrawal|0|||
146340842|NCT02413255|527756706|FG003|Overall Study|Voluntary Withdrawal|0|||
146340843|NCT02413255|527756707|FG004|Overall Study|Voluntary Withdrawal|0|||
146340844|NCT02413255|527756708|FG005|Overall Study|Voluntary Withdrawal|0|||
146340845|NCT02413255|527756709|FG006|Overall Study|Voluntary Withdrawal|0|||
146340846|NCT02413255|527756710|FG007|Overall Study|Voluntary Withdrawal|0|||
146340847|NCT02413255|527756711|FG008|Overall Study|Voluntary Withdrawal|0|||
146340848|NCT02413255|527756712|FG009|Overall Study|Voluntary Withdrawal|0|||
146340849|NCT02413255|527756713|FG010|Overall Study|Voluntary Withdrawal|0|||
146340850|NCT02413255|527756714|FG011|Overall Study|Voluntary Withdrawal|0|||
146340851|NCT02413255|527756715|FG012|Overall Study|Voluntary Withdrawal|0|||
146340852|NCT02413255|527756716|FG013|Overall Study|Voluntary Withdrawal|0|||
146340853|NCT02413255|527756717|FG014|Overall Study|Voluntary Withdrawal|1|||
146340854|NCT02413255|527756718|FG015|Overall Study|Voluntary Withdrawal|0|||
146340855|NCT02413255|527756719|FG016|Overall Study|Voluntary Withdrawal|0|||
146340856|NCT02413398|527756720|FG000|Overall Study|Lost to Follow-up|2|||
146340857|NCT02413398|527756721|FG001|Overall Study|Lost to Follow-up|4|||
146340858|NCT02413398|527756720|FG000|Overall Study|Withdrawal by Subject|1|||
146340859|NCT02413398|527756721|FG001|Overall Study|Withdrawal by Subject|1|||
146340860|NCT02413398|527756720|FG000|Overall Study|Other Eligibility criteria|1|||
146340861|NCT02413398|527756721|FG001|Overall Study|Other Eligibility criteria|2|||
146340862|NCT01494038|527756722|FG000|Overall Study|Protocol Violation|1|||
146340863|NCT01494038|527756723|FG001|Overall Study|Protocol Violation|1|||
146340864|NCT01494038|527756722|FG000|Overall Study|Lost to Follow-up|18|||
146340865|NCT01494038|527756723|FG001|Overall Study|Lost to Follow-up|20|||
146340866|NCT01494038|527756722|FG000|Overall Study|Withdrawal by Subject|44|||
146340867|NCT01494038|527756723|FG001|Overall Study|Withdrawal by Subject|34|||
146340868|NCT01494038|527756722|FG000|Overall Study|Not able to get to clinic|21|||
146340869|NCT01494038|527756723|FG001|Overall Study|Not able to get to clinic|15|||
146340870|NCT01494038|527756722|FG000|Overall Study|Not willing to adhere to reqs|2|||
146340871|NCT01494038|527756723|FG001|Overall Study|Not willing to adhere to reqs|9|||
146340872|NCT01494038|527756722|FG000|Overall Study|Death|2|||
146340873|NCT01494038|527756723|FG001|Overall Study|Death|4|||
146340874|NCT00537940|527756726|FG000|Overall Study|Adverse Event|20|||
146340875|NCT00537940|527756727|FG001|Overall Study|Adverse Event|19|||
146340876|NCT00537940|527756726|FG000|Overall Study|Lack of Efficacy|8|||
146340877|NCT00537940|527756727|FG001|Overall Study|Lack of Efficacy|16|||
146340878|NCT00537940|527756726|FG000|Overall Study|Lost to Follow-up|23|||
146340879|NCT00537940|527756727|FG001|Overall Study|Lost to Follow-up|29|||
146340880|NCT00537940|527756726|FG000|Overall Study|Withdrawal by Subject|113|||
146340881|NCT00537940|527756727|FG001|Overall Study|Withdrawal by Subject|95|||
146340882|NCT00537940|527756726|FG000|Overall Study|Protocol Violation|6|||
146340883|NCT00537940|527756727|FG001|Overall Study|Protocol Violation|4|||
146340884|NCT00537940|527756726|FG000|Overall Study|Pregnancy|1|||
146340885|NCT00537940|527756727|FG001|Overall Study|Pregnancy|1|||
146340886|NCT00537940|527756726|FG000|Overall Study|Study terminated by sponsor|2|||
146340887|NCT00537940|527756727|FG001|Overall Study|Study terminated by sponsor|3|||
146340888|NCT00537940|527756726|FG000|Overall Study|Other|10|||
146340889|NCT00537940|527756727|FG001|Overall Study|Other|12|||
146340890|NCT01978912|527756731|FG000|Overall Study|Adverse Event|0|||
146340891|NCT01978912|527756732|FG001|Overall Study|Adverse Event|1|||
146340892|NCT01978912|527756733|FG002|Overall Study|Adverse Event|0|||
146340893|NCT01978912|527756734|FG003|Overall Study|Adverse Event|0|||
146340894|NCT01978912|527756731|FG000|Overall Study|Lost to Follow-up|1|||
146340895|NCT01978912|527756732|FG001|Overall Study|Lost to Follow-up|1|||
146340896|NCT01978912|527756733|FG002|Overall Study|Lost to Follow-up|0|||
146340897|NCT01978912|527756734|FG003|Overall Study|Lost to Follow-up|1|||
146340898|NCT01978912|527756731|FG000|Overall Study|Withdrawal by Subject|1|||
146340899|NCT01978912|527756732|FG001|Overall Study|Withdrawal by Subject|0|||
146340900|NCT01978912|527756733|FG002|Overall Study|Withdrawal by Subject|2|||
146340901|NCT01978912|527756734|FG003|Overall Study|Withdrawal by Subject|2|||
146340902|NCT01978912|527756731|FG000|Overall Study|Lumbar Surgery|1|||
146340903|NCT01978912|527756732|FG001|Overall Study|Lumbar Surgery|0|||
146340904|NCT01978912|527756733|FG002|Overall Study|Lumbar Surgery|1|||
146340905|NCT01978912|527756734|FG003|Overall Study|Lumbar Surgery|0|||
146340906|NCT01978912|527756731|FG000|Overall Study|Intradiscal Steroid Injection|0|||
146340907|NCT01978912|527756732|FG001|Overall Study|Intradiscal Steroid Injection|1|||
146340908|NCT01978912|527756733|FG002|Overall Study|Intradiscal Steroid Injection|0|||
146396296|NCT00276458|527954549|FG001|Overall Study|Lost to Follow-up|2|||
146340909|NCT01978912|527756734|FG003|Overall Study|Intradiscal Steroid Injection|0|||
146340910|NCT00685178|527756739|FG000|Overall Study|Adverse Event|1|||
146340911|NCT00685178|527756740|FG001|Overall Study|Adverse Event|5|||
146340912|NCT00685178|527756741|FG002|Overall Study|Adverse Event|2|||
146340913|NCT00685178|527756742|FG003|Overall Study|Adverse Event|4|||
146340914|NCT00685178|527756739|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
146340915|NCT00685178|527756740|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
146340916|NCT00685178|527756741|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
146340917|NCT00685178|527756742|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
146340918|NCT00685178|527756739|FG000|Overall Study|voluntary study discharge|4|||
146340919|NCT00685178|527756740|FG001|Overall Study|voluntary study discharge|5|||
146340920|NCT00685178|527756741|FG002|Overall Study|voluntary study discharge|1|||
146340921|NCT00685178|527756742|FG003|Overall Study|voluntary study discharge|1|||
146340922|NCT00685178|527756739|FG000|Overall Study|incarcerated|1|||
146340923|NCT00685178|527756740|FG001|Overall Study|incarcerated|3|||
146340924|NCT00685178|527756741|FG002|Overall Study|incarcerated|7|||
146340925|NCT00685178|527756742|FG003|Overall Study|incarcerated|0|||
146340926|NCT00685178|527756739|FG000|Overall Study|administrative (disciplinary) discharge|0|||
146340927|NCT00685178|527756740|FG001|Overall Study|administrative (disciplinary) discharge|1|||
146340928|NCT00685178|527756741|FG002|Overall Study|administrative (disciplinary) discharge|0|||
146340929|NCT00685178|527756742|FG003|Overall Study|administrative (disciplinary) discharge|2|||
146340930|NCT00685178|527756739|FG000|Overall Study|Pregnancy|0|||
146340931|NCT00685178|527756740|FG001|Overall Study|Pregnancy|0|||
146340932|NCT00685178|527756741|FG002|Overall Study|Pregnancy|0|||
146340933|NCT00685178|527756742|FG003|Overall Study|Pregnancy|1|||
146340934|NCT00077623|527756748|FG000|Overall Study|Adverse Event|1|||
146340935|NCT00077623|527756749|FG001|Overall Study|Adverse Event|0|||
146340936|NCT00077623|527756750|FG002|Overall Study|Adverse Event|1|||
146340937|NCT00077623|527756748|FG000|Overall Study|Withdrawal by Subject|2|||
146340938|NCT00077623|527756749|FG001|Overall Study|Withdrawal by Subject|10|||
146340939|NCT00077623|527756750|FG002|Overall Study|Withdrawal by Subject|1|||
146340940|NCT00077623|527756748|FG000|Overall Study|Other-Non safety reason|18|||
146340941|NCT00077623|527756749|FG001|Overall Study|Other-Non safety reason|15|||
146340942|NCT00077623|527756750|FG002|Overall Study|Other-Non safety reason|19|||
146340943|NCT00077623|527756748|FG000|Overall Study|Insufficient therapeutic response|2|||
146340944|NCT00077623|527756749|FG001|Overall Study|Insufficient therapeutic response|0|||
146340945|NCT00077623|527756750|FG002|Overall Study|Insufficient therapeutic response|0|||
146340946|NCT00077623|527756748|FG000|Overall Study|Death|12|||
146340947|NCT00077623|527756749|FG001|Overall Study|Death|18|||
146340948|NCT00077623|527756750|FG002|Overall Study|Death|11|||
146340949|NCT00077623|527756748|FG000|Overall Study|Failure to return|1|||
146340950|NCT00077623|527756749|FG001|Overall Study|Failure to return|0|||
146340951|NCT00077623|527756750|FG002|Overall Study|Failure to return|0|||
146340952|NCT01334125|527756751|FG000|Overall Study|Lost to Follow-up|3|||
146340953|NCT01334125|527756752|FG001|Overall Study|Lost to Follow-up|3|||
146340954|NCT02138110|527756756|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
146340955|NCT02138110|527756756|FG000|Overall Scaffold Implantation|Death|3|||
146340956|NCT00882713|527756758|FG000|Overall Study|Adverse Event|2|||
146340957|NCT00882713|527756758|FG000|Overall Study|Death|3|||
146340958|NCT00882713|527756758|FG000|Overall Study|Administrative reasons|4|||
146340959|NCT00882713|527756758|FG000|Overall Study|refused treatment/withdrew consent|4|||
146340960|NCT00882713|527756758|FG000|Overall Study|Blood transfusion|2|||
146340961|NCT00882713|527756758|FG000|Overall Study|Insufficient therapeutic response|3|||
146340962|NCT00882713|527756758|FG000|Overall Study|Failure to return|2|||
146340963|NCT00882713|527756758|FG000|Overall Study|Other - Reasons|2|||
146340964|NCT00401973|527756761|FG000|Overall Study|Adverse Event|2|||
146340965|NCT00401973|527756762|FG001|Overall Study|Adverse Event|8|||
146340966|NCT00401973|527756763|FG002|Overall Study|Adverse Event|4|||
146340967|NCT00401973|527756761|FG000|Overall Study|Clinical Relapse|0|||
146340968|NCT00401973|527756762|FG001|Overall Study|Clinical Relapse|1|||
146340969|NCT00401973|527756763|FG002|Overall Study|Clinical Relapse|1|||
146340970|NCT00401973|527756761|FG000|Overall Study|Lack of Efficacy|0|||
146340971|NCT00401973|527756762|FG001|Overall Study|Lack of Efficacy|0|||
146340972|NCT00401973|527756763|FG002|Overall Study|Lack of Efficacy|3|||
146340973|NCT00401973|527756761|FG000|Overall Study|Lost to Follow-up|2|||
146169164|NCT02798211|527131149|FG005|Period 1|Withdrawal of Informed Consent|0|||
146169165|NCT02798211|527131144|FG000|Period 2|Withdrawal by Subject|2|||
146169166|NCT02798211|527131145|FG001|Period 2|Withdrawal by Subject|0|||
146340974|NCT00401973|527756762|FG001|Overall Study|Lost to Follow-up|2|||
146340975|NCT00401973|527756763|FG002|Overall Study|Lost to Follow-up|2|||
146340976|NCT00401973|527756761|FG000|Overall Study|Physician Decision|2|||
146340977|NCT00401973|527756762|FG001|Overall Study|Physician Decision|0|||
146340978|NCT00401973|527756763|FG002|Overall Study|Physician Decision|1|||
146340979|NCT00401973|527756761|FG000|Overall Study|Protocol Violation|1|||
146340980|NCT00401973|527756762|FG001|Overall Study|Protocol Violation|2|||
146340981|NCT00401973|527756763|FG002|Overall Study|Protocol Violation|3|||
146340982|NCT00401973|527756761|FG000|Overall Study|Sponsor Decision|0|||
146340983|NCT00401973|527756762|FG001|Overall Study|Sponsor Decision|1|||
146340984|NCT00401973|527756763|FG002|Overall Study|Sponsor Decision|0|||
146340985|NCT00401973|527756761|FG000|Overall Study|Withdrawal by Subject|4|||
146340986|NCT00401973|527756762|FG001|Overall Study|Withdrawal by Subject|12|||
146340987|NCT00401973|527756763|FG002|Overall Study|Withdrawal by Subject|9|||
146340988|NCT01408537|527756764|FG000|Overall Study|Withdrawal by Subject|2|||
146340989|NCT01408537|527756764|FG000|Overall Study|Protocol Violation|3|||
146340990|NCT01408537|527756764|FG000|Overall Study|Lost to Follow-up|3|||
146340991|NCT05523362|527756765|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
146340992|NCT05523362|527756765|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
146340993|NCT05523362|527756765|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
146340994|NCT05523362|527756765|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
146340995|NCT04075604|527756770|FG000|Overall Study|Adverse Event|0|||
146340996|NCT04075604|527756771|FG001|Overall Study|Adverse Event|0|||
146340997|NCT04075604|527756772|FG002|Overall Study|Adverse Event|3|||
146340998|NCT04075604|527756770|FG000|Overall Study|Participant request to discontinue study treatment|0|||
146340999|NCT04075604|527756771|FG001|Overall Study|Participant request to discontinue study treatment|0|||
146341000|NCT04075604|527756772|FG002|Overall Study|Participant request to discontinue study treatment|1|||
146341001|NCT04075604|527756770|FG000|Overall Study|Participant withdrew consent|0|||
146341002|NCT04075604|527756771|FG001|Overall Study|Participant withdrew consent|0|||
146341003|NCT04075604|527756772|FG002|Overall Study|Participant withdrew consent|1|||
146341004|NCT04075604|527756770|FG000|Overall Study|Other reasons|1|||
146341005|NCT04075604|527756771|FG001|Overall Study|Other reasons|0|||
146341006|NCT04075604|527756772|FG002|Overall Study|Other reasons|0|||
146341007|NCT04075604|527756770|FG000|Overall Study|Disease progression|0|||
146341008|NCT04075604|527756771|FG001|Overall Study|Disease progression|1|||
146341009|NCT04075604|527756772|FG002|Overall Study|Disease progression|0|||
146169167|NCT02798211|527131146|FG002|Period 2|Withdrawal by Subject|0|||
146169168|NCT02798211|527131147|FG003|Period 2|Withdrawal by Subject|0|||
146341010|NCT04075604|527756770|FG000|Overall Study|Study drug toxicity|0|||
146341011|NCT04075604|527756771|FG001|Overall Study|Study drug toxicity|5|||
146341012|NCT04075604|527756772|FG002|Overall Study|Study drug toxicity|1|||
146341013|NCT02760602|527756773|FG000|Overall Study|Withdrawal by Subject|1|||
146341014|NCT02760602|527756774|FG001|Overall Study|Withdrawal by Subject|0|||
146341015|NCT02760602|527756773|FG000|Overall Study|Terminated by sponsor|12|||
146341016|NCT02760602|527756774|FG001|Overall Study|Terminated by sponsor|13|||
146341017|NCT05299892|527756780|FG000|Overall Study|Withdrawal by Subject|2|||
146341018|NCT00149214|527756784|FG000|Overall Study|Adverse Event|12|||
146341019|NCT00149214|527756785|FG001|Overall Study|Adverse Event|9|||
146341020|NCT00149214|527756784|FG000|Overall Study|Withdrawal by Subject|4|||
146341021|NCT00149214|527756785|FG001|Overall Study|Withdrawal by Subject|1|||
146341022|NCT00149214|527756784|FG000|Overall Study|Physician Decision|3|||
146341023|NCT00149214|527756785|FG001|Overall Study|Physician Decision|3|||
146341024|NCT00149214|527756784|FG000|Overall Study|Sponsor Decision|0|||
146341025|NCT00149214|527756785|FG001|Overall Study|Sponsor Decision|1|||
146341026|NCT00149214|527756784|FG000|Overall Study|Progressive Disease|7|||
146341027|NCT00149214|527756785|FG001|Overall Study|Progressive Disease|3|||
146341028|NCT00756002|527756786|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
146341029|NCT00756002|527756787|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
146341030|NCT00756002|527756786|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146341031|NCT00756002|527756787|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146341032|NCT00756002|527756786|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146341033|NCT00756002|527756787|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
146341034|NCT00756002|527756786|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
146341035|NCT00756002|527756787|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
146341036|NCT00756002|527756786|FG000|Double-Blind Treatment Period|Other|2|||
146341037|NCT00756002|527756787|FG001|Double-Blind Treatment Period|Other|2|||
146341038|NCT04329923|527756791|FG000|Overall Study|Withdrawal by Subject|1|||
146341039|NCT04329923|527756792|FG001|Overall Study|Withdrawal by Subject|4|||
146341040|NCT04329923|527756793|FG002|Overall Study|Withdrawal by Subject|1|||
146341041|NCT04329923|527756794|FG003|Overall Study|Withdrawal by Subject|1|||
146169169|NCT02798211|527131148|FG004|Period 2|Withdrawal by Subject|2|||
146169170|NCT02798211|527131149|FG005|Period 2|Withdrawal by Subject|2|||
146341042|NCT04329923|527756795|FG004|Overall Study|Withdrawal by Subject|1|||
146341043|NCT04329923|527756796|FG005|Overall Study|Withdrawal by Subject|1|||
146341044|NCT04329923|527756791|FG000|Overall Study|early termination of study|0|||
146341045|NCT04329923|527756792|FG001|Overall Study|early termination of study|0|||
146341046|NCT04329923|527756793|FG002|Overall Study|early termination of study|0|||
146341047|NCT04329923|527756794|FG003|Overall Study|early termination of study|0|||
146341048|NCT04329923|527756795|FG004|Overall Study|early termination of study|1|||
146341049|NCT04329923|527756796|FG005|Overall Study|early termination of study|2|||
146341050|NCT04329923|527756791|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146341051|NCT04329923|527756792|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146341052|NCT04329923|527756793|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146341053|NCT04329923|527756794|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146396297|NCT00276458|527954548|FG000|Overall Study|Protocol Violation|4|||
146341054|NCT04329923|527756795|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
146341055|NCT04329923|527756796|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
146341056|NCT01260181|527756800|FG000|Overall Study|Decision of Investigator|1|||
146341057|NCT01588197|527756803|FG000|Overall Study|Lack of Efficacy|0|||
146341058|NCT01588197|527756804|FG001|Overall Study|Lack of Efficacy|1|||
146341059|NCT01588197|527756803|FG000|Overall Study|No MRI|1|||
146341060|NCT01588197|527756804|FG001|Overall Study|No MRI|0|||
146341061|NCT03351244|527756805|FG000|Overall Study|Adverse Event|7|||
146341062|NCT03351244|527756806|FG001|Overall Study|Adverse Event|11|||
146341063|NCT03351244|527756807|FG002|Overall Study|Adverse Event|12|||
146341064|NCT03351244|527756805|FG000|Overall Study|Investigator's decision|0|||
146341065|NCT03351244|527756806|FG001|Overall Study|Investigator's decision|0|||
146341066|NCT03351244|527756807|FG002|Overall Study|Investigator's decision|2|||
146341067|NCT03351244|527756805|FG000|Overall Study|System error|0|||
146341068|NCT03351244|527756806|FG001|Overall Study|System error|0|||
146341069|NCT03351244|527756807|FG002|Overall Study|System error|2|||
146341070|NCT03351244|527756805|FG000|Overall Study|COVID-19 restrictions|3|||
146341071|NCT03351244|527756806|FG001|Overall Study|COVID-19 restrictions|0|||
146341072|NCT03351244|527756807|FG002|Overall Study|COVID-19 restrictions|1|||
146341073|NCT03351244|527756805|FG000|Overall Study|Non-compliance|2|||
146341074|NCT03351244|527756806|FG001|Overall Study|Non-compliance|5|||
146341075|NCT03351244|527756807|FG002|Overall Study|Non-compliance|0|||
146341076|NCT03351244|527756805|FG000|Overall Study|Withdrawal by Subject|11|||
146341077|NCT03351244|527756806|FG001|Overall Study|Withdrawal by Subject|16|||
146341078|NCT03351244|527756807|FG002|Overall Study|Withdrawal by Subject|13|||
146341079|NCT03351244|527756805|FG000|Overall Study|Lost to Follow-up|2|||
146341080|NCT03351244|527756806|FG001|Overall Study|Lost to Follow-up|6|||
146341081|NCT03351244|527756807|FG002|Overall Study|Lost to Follow-up|4|||
146341082|NCT03351244|527756805|FG000|Overall Study|Protocol Violation|2|||
146341083|NCT03351244|527756806|FG001|Overall Study|Protocol Violation|2|||
146341084|NCT03351244|527756807|FG002|Overall Study|Protocol Violation|0|||
146341085|NCT01844076|527756810|FG000|Overall Study|Adverse Event|1|||
146341086|NCT01844076|527756811|FG001|Overall Study|Adverse Event|0|||
146341087|NCT01844076|527756812|FG002|Overall Study|Adverse Event|0|||
146341088|NCT01844076|527756813|FG003|Overall Study|Adverse Event|0|||
146341089|NCT01844076|527756810|FG000|Overall Study|Withdrawal by Subject|1|||
146341090|NCT01844076|527756811|FG001|Overall Study|Withdrawal by Subject|0|||
146341091|NCT01844076|527756812|FG002|Overall Study|Withdrawal by Subject|0|||
146341092|NCT01844076|527756813|FG003|Overall Study|Withdrawal by Subject|0|||
146341093|NCT01925703|527756823|FG000|Overall Study|Physician Decision|1|||
146341094|NCT01925703|527756823|FG000|Overall Study|Lost to Follow-up|2|||
146341095|NCT01925703|527756823|FG000|Overall Study|Discharge prior to full iron repletion|1|||
146341096|NCT02986373|527756824|FG000|Overall Study|Adverse Event|4|||
146341097|NCT02986373|527756824|FG000|Overall Study|Lost to Follow-up|1|||
146341098|NCT02986373|527756824|FG000|Overall Study|Withdrawal by Subject|10|||
146341099|NCT02986373|527756824|FG000|Overall Study|Other|24|||
146341100|NCT01607892|527756829|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
146341101|NCT01607892|527756830|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
146341102|NCT01607892|527756831|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
146341103|NCT01607892|527756832|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
146341104|NCT01607892|527756833|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
146341105|NCT01607892|527756829|FG000|Overall Study|Death|4|||
146341106|NCT01607892|527756830|FG001|Overall Study|Death|2|||
146341107|NCT01607892|527756831|FG002|Overall Study|Death|8|||
146341108|NCT01607892|527756832|FG003|Overall Study|Death|10|||
146341109|NCT01607892|527756833|FG004|Overall Study|Death|3|||
146341110|NCT01607892|527756829|FG000|Overall Study|Investigator discretion|2|||
146341111|NCT01607892|527756830|FG001|Overall Study|Investigator discretion|4|||
146341112|NCT01607892|527756831|FG002|Overall Study|Investigator discretion|4|||
146341113|NCT01607892|527756832|FG003|Overall Study|Investigator discretion|8|||
146341114|NCT01607892|527756833|FG004|Overall Study|Investigator discretion|0|||
146341115|NCT01607892|527756829|FG000|Overall Study|Other treatments became available|1|||
146341116|NCT01607892|527756830|FG001|Overall Study|Other treatments became available|1|||
146341117|NCT01607892|527756831|FG002|Overall Study|Other treatments became available|0|||
146341118|NCT01607892|527756832|FG003|Overall Study|Other treatments became available|0|||
146341119|NCT01607892|527756833|FG004|Overall Study|Other treatments became available|2|||
146341120|NCT01607892|527756829|FG000|Overall Study|Intercurrent illness|1|||
146341121|NCT01607892|527756830|FG001|Overall Study|Intercurrent illness|0|||
146169171|NCT02798211|527131144|FG000|Period 2|Adverse Event|5|||
146341122|NCT01607892|527756831|FG002|Overall Study|Intercurrent illness|0|||
146341123|NCT01607892|527756832|FG003|Overall Study|Intercurrent illness|3|||
146341124|NCT01607892|527756833|FG004|Overall Study|Intercurrent illness|0|||
146341125|NCT01607892|527756829|FG000|Overall Study|Non-Compliance with study procedures|0|||
146341126|NCT01607892|527756830|FG001|Overall Study|Non-Compliance with study procedures|0|||
146341127|NCT01607892|527756831|FG002|Overall Study|Non-Compliance with study procedures|1|||
146341128|NCT01607892|527756832|FG003|Overall Study|Non-Compliance with study procedures|0|||
146341129|NCT01607892|527756833|FG004|Overall Study|Non-Compliance with study procedures|0|||
146341130|NCT01607892|527756829|FG000|Overall Study|Consent withdrawn by participant|9|||
146341131|NCT01607892|527756830|FG001|Overall Study|Consent withdrawn by participant|4|||
146341132|NCT01607892|527756831|FG002|Overall Study|Consent withdrawn by participant|24|||
146341133|NCT01607892|527756832|FG003|Overall Study|Consent withdrawn by participant|14|||
146341134|NCT01607892|527756833|FG004|Overall Study|Consent withdrawn by participant|4|||
146341135|NCT01607892|527756829|FG000|Overall Study|Disease progression|38|||
146341136|NCT01607892|527756830|FG001|Overall Study|Disease progression|13|||
146341137|NCT01607892|527756831|FG002|Overall Study|Disease progression|37|||
146341138|NCT01607892|527756832|FG003|Overall Study|Disease progression|57|||
146341139|NCT01607892|527756833|FG004|Overall Study|Disease progression|9|||
146341140|NCT01607892|527756829|FG000|Overall Study|Incidence or severity of Adverse events|3|||
146341141|NCT01607892|527756830|FG001|Overall Study|Incidence or severity of Adverse events|3|||
146341142|NCT01607892|527756831|FG002|Overall Study|Incidence or severity of Adverse events|7|||
146341143|NCT01607892|527756832|FG003|Overall Study|Incidence or severity of Adverse events|2|||
146341144|NCT01607892|527756833|FG004|Overall Study|Incidence or severity of Adverse events|6|||
146341145|NCT02273973|527756836|FG000|Overall Study|Adverse Event|4|||
146341146|NCT02273973|527756837|FG001|Overall Study|Adverse Event|0|||
146341147|NCT02273973|527756836|FG000|Overall Study|Withdrawal by Subject|2|||
146341148|NCT02273973|527756837|FG001|Overall Study|Withdrawal by Subject|3|||
146341149|NCT02273973|527756836|FG000|Overall Study|Death|1|||
146341150|NCT02273973|527756837|FG001|Overall Study|Death|0|||
146341151|NCT02273973|527756836|FG000|Overall Study|Non-compliance|1|||
146341152|NCT02273973|527756837|FG001|Overall Study|Non-compliance|0|||
146341153|NCT02273973|527756836|FG000|Overall Study|Protocol Violation|1|||
146341154|NCT02273973|527756837|FG001|Overall Study|Protocol Violation|0|||
146341155|NCT02273973|527756836|FG000|Overall Study|Progression of disease|0|||
146341156|NCT02273973|527756837|FG001|Overall Study|Progression of disease|2|||
146341157|NCT02273973|527756836|FG000|Overall Study|Lost to Follow-up|0|||
146341158|NCT02273973|527756837|FG001|Overall Study|Lost to Follow-up|1|||
146341159|NCT02273973|527756836|FG000|Overall Study|Physician Decision|0|||
146341160|NCT02273973|527756837|FG001|Overall Study|Physician Decision|1|||
146341161|NCT02273973|527756836|FG000|Overall Study|Reason not specified|0|||
146341162|NCT02273973|527756837|FG001|Overall Study|Reason not specified|1|||
146341163|NCT03022422|527756839|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
146341164|NCT03022422|527756840|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
146341165|NCT03022422|527756841|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
146341166|NCT03022422|527756842|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
146341167|NCT03022422|527756843|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
146341168|NCT03022422|527756844|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
146341169|NCT01769404|527756845|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
146341170|NCT01769404|527756846|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
146341171|NCT01769404|527756845|FG000|Treatment Period 1|Withdrawal by Subject|3|||
146341172|NCT01769404|527756846|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146341173|NCT01769404|527756845|FG000|Treatment Period 1|Sponsor decision|1|||
146341174|NCT01769404|527756846|FG001|Treatment Period 1|Sponsor decision|0|||
146341175|NCT01769404|527756845|FG000|Treatment Period 2|Sponsor decision|7|||
146341176|NCT01769404|527756846|FG001|Treatment Period 2|Sponsor decision|0|||
146341177|NCT00538733|527756847|FG000|Overall Study|Adverse Event|8|||
146341178|NCT00538733|527756847|FG000|Overall Study|Death|1|||
146341179|NCT00538733|527756847|FG000|Overall Study|declined to participate|2|||
146341180|NCT00538733|527756847|FG000|Overall Study|still on therapy|1|||
146341181|NCT02032524|527756852|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
146341182|NCT02032524|527756853|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
146341183|NCT02032524|527756854|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
146341184|NCT02032524|527756855|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
146341185|NCT02032524|527756856|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
146341186|NCT02032524|527756857|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
146341187|NCT02032524|527756852|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146341188|NCT02032524|527756853|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146341189|NCT02032524|527756854|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146341190|NCT02032524|527756855|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
146341191|NCT02032524|527756856|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
146341192|NCT02032524|527756857|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
146341193|NCT02032524|527756852|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
146169172|NCT02798211|527131145|FG001|Period 2|Adverse Event|0|||
146169173|NCT02798211|527131146|FG002|Period 2|Adverse Event|0|||
146341194|NCT02032524|527756853|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
146341195|NCT02032524|527756854|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
146341196|NCT02032524|527756855|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
146341197|NCT02032524|527756856|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
146341198|NCT02032524|527756857|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
146341199|NCT02032524|527756852|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146341200|NCT02032524|527756853|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
146341201|NCT02032524|527756854|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146341202|NCT02032524|527756855|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146341203|NCT02032524|527756856|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
146341204|NCT02032524|527756857|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
146341205|NCT02032524|527756852|FG000|Period 2: LTS13769 Study|Other|0|||
146341206|NCT02032524|527756853|FG001|Period 2: LTS13769 Study|Other|0|||
146341207|NCT02032524|527756854|FG002|Period 2: LTS13769 Study|Other|0|||
146341208|NCT02032524|527756855|FG003|Period 2: LTS13769 Study|Other|0|||
146341209|NCT02032524|527756856|FG004|Period 2: LTS13769 Study|Other|0|||
146341210|NCT02032524|527756857|FG005|Period 2: LTS13769 Study|Other|1|||
146341211|NCT03567187|527756858|FG000|Overall Study|Lost to Follow-up|18|||
146341212|NCT03596645|527756861|FG000|Overall Study|Adverse Event|17|||
146341213|NCT03596645|527756862|FG001|Overall Study|Adverse Event|0|||
146341214|NCT03596645|527756861|FG000|Overall Study|Lack of Efficacy|8|||
146341215|NCT03596645|527756862|FG001|Overall Study|Lack of Efficacy|0|||
146341216|NCT03596645|527756861|FG000|Overall Study|Lost to Follow-up|1|||
146341217|NCT03596645|527756862|FG001|Overall Study|Lost to Follow-up|1|||
146341218|NCT03596645|527756861|FG000|Overall Study|Physician Decision|1|||
146341219|NCT03596645|527756862|FG001|Overall Study|Physician Decision|1|||
146341220|NCT03596645|527756861|FG000|Overall Study|Protocol Violation|1|||
146341221|NCT03596645|527756862|FG001|Overall Study|Protocol Violation|0|||
146341222|NCT03596645|527756861|FG000|Overall Study|Initiated Prohibited Medication|1|||
146341223|NCT03596645|527756862|FG001|Overall Study|Initiated Prohibited Medication|0|||
146341224|NCT03596645|527756861|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146341225|NCT03596645|527756862|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146341226|NCT03596645|527756861|FG000|Overall Study|No mucosal healing achieved|1|||
146341227|NCT03596645|527756862|FG001|Overall Study|No mucosal healing achieved|0|||
146341228|NCT03596645|527756861|FG000|Overall Study|Disease progression|1|||
146341229|NCT03596645|527756862|FG001|Overall Study|Disease progression|0|||
146341230|NCT03596645|527756861|FG000|Overall Study|Ongoing|37|||
146341231|NCT03596645|527756862|FG001|Overall Study|Ongoing|12|||
146341232|NCT03596645|527756861|FG000|Overall Study|Randomized but not treated|0|||
146341233|NCT03596645|527756862|FG001|Overall Study|Randomized but not treated|1|||
146341234|NCT04358458|527756863|FG000|Overall Study|Death|1|||
146341235|NCT04358458|527756864|FG001|Overall Study|Death|1|||
146341236|NCT04358458|527756865|FG002|Overall Study|Death|3|||
146341237|NCT04358458|527756866|FG003|Overall Study|Death|8|||
146341238|NCT04358458|527756867|FG004|Overall Study|Death|1|||
146341239|NCT04358458|527756868|FG005|Overall Study|Death|6|||
146341240|NCT04358458|527756869|FG006|Overall Study|Death|2|||
146341241|NCT04358458|527756870|FG007|Overall Study|Death|3|||
146341242|NCT04358458|527756863|FG000|Overall Study|Lost to Follow-up|0|||
146341243|NCT04358458|527756864|FG001|Overall Study|Lost to Follow-up|0|||
146341244|NCT04358458|527756865|FG002|Overall Study|Lost to Follow-up|0|||
146341245|NCT04358458|527756866|FG003|Overall Study|Lost to Follow-up|0|||
146341246|NCT04358458|527756867|FG004|Overall Study|Lost to Follow-up|0|||
146341247|NCT04358458|527756868|FG005|Overall Study|Lost to Follow-up|0|||
146341248|NCT04358458|527756869|FG006|Overall Study|Lost to Follow-up|0|||
146341249|NCT04358458|527756870|FG007|Overall Study|Lost to Follow-up|1|||
146341250|NCT04358458|527756863|FG000|Overall Study|Site is closing study participation|0|||
146341251|NCT04358458|527756864|FG001|Overall Study|Site is closing study participation|0|||
146341252|NCT04358458|527756865|FG002|Overall Study|Site is closing study participation|0|||
146341253|NCT04358458|527756866|FG003|Overall Study|Site is closing study participation|1|||
146341254|NCT04358458|527756867|FG004|Overall Study|Site is closing study participation|0|||
146341255|NCT04358458|527756868|FG005|Overall Study|Site is closing study participation|0|||
146341256|NCT04358458|527756869|FG006|Overall Study|Site is closing study participation|0|||
146341257|NCT04358458|527756870|FG007|Overall Study|Site is closing study participation|0|||
146341258|NCT04358458|527756863|FG000|Overall Study|Sponsor request|2|||
146341259|NCT04358458|527756864|FG001|Overall Study|Sponsor request|3|||
146341260|NCT04358458|527756865|FG002|Overall Study|Sponsor request|3|||
146341261|NCT04358458|527756866|FG003|Overall Study|Sponsor request|0|||
146341262|NCT04358458|527756867|FG004|Overall Study|Sponsor request|2|||
146341263|NCT04358458|527756868|FG005|Overall Study|Sponsor request|3|||
146341264|NCT04358458|527756869|FG006|Overall Study|Sponsor request|1|||
146169174|NCT02798211|527131147|FG003|Period 2|Adverse Event|0|||
146341265|NCT04358458|527756870|FG007|Overall Study|Sponsor request|1|||
146341266|NCT04358458|527756863|FG000|Overall Study|Withdrawal by Subject|0|||
146341267|NCT04358458|527756864|FG001|Overall Study|Withdrawal by Subject|0|||
146341268|NCT04358458|527756865|FG002|Overall Study|Withdrawal by Subject|1|||
146341269|NCT04358458|527756866|FG003|Overall Study|Withdrawal by Subject|1|||
146341270|NCT04358458|527756867|FG004|Overall Study|Withdrawal by Subject|0|||
146341271|NCT04358458|527756868|FG005|Overall Study|Withdrawal by Subject|1|||
146341272|NCT04358458|527756869|FG006|Overall Study|Withdrawal by Subject|0|||
146341273|NCT04358458|527756870|FG007|Overall Study|Withdrawal by Subject|1|||
146341274|NCT04513158|527756873|FG000|Overall Study|Screen Failure|1|||
146395692|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Adverse Event|6|||
146395693|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Adverse Event|6|||
146395694|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Death|14|||
146341275|NCT03334214|527758629|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
146341276|NCT03334214|527758630|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
146341277|NCT03334214|527758629|FG000|Overall Study|Withdrawal by Subject|0|||
146341278|NCT03334214|527758630|FG001|Overall Study|Withdrawal by Subject|1|||
146341279|NCT03334214|527758629|FG000|Overall Study|Other|1|||
146341280|NCT03334214|527758630|FG001|Overall Study|Other|0|||
146341281|NCT02088034|527758631|FG000|Overall Study|Lost to Follow-up|1|||
146341282|NCT02088034|527758632|FG001|Overall Study|Lost to Follow-up|1|||
146341283|NCT02088034|527758633|FG002|Overall Study|Lost to Follow-up|0|||
146341284|NCT02088034|527758631|FG000|Overall Study|Pregnancy|2|||
146341285|NCT02088034|527758632|FG001|Overall Study|Pregnancy|1|||
146341286|NCT02088034|527758633|FG002|Overall Study|Pregnancy|2|||
146341287|NCT00091793|527758634|FG000|Overall Study|Adverse Event|1|||
146341288|NCT00091793|527758635|FG001|Overall Study|Adverse Event|2|||
146341289|NCT00091793|527758634|FG000|Overall Study|Withdrawal by Subject|10|||
146341290|NCT00091793|527758635|FG001|Overall Study|Withdrawal by Subject|15|||
146341291|NCT00091793|527758634|FG000|Overall Study|Ineligibility determined|2|||
146341292|NCT00091793|527758635|FG001|Overall Study|Ineligibility determined|0|||
146341293|NCT00091793|527758634|FG000|Overall Study|Lost to Follow-up|7|||
146341294|NCT00091793|527758635|FG001|Overall Study|Lost to Follow-up|5|||
146341295|NCT00091793|527758634|FG000|Overall Study|Noncompliance|2|||
146341296|NCT00091793|527758635|FG001|Overall Study|Noncompliance|0|||
146341297|NCT00091793|527758634|FG000|Overall Study|Other|2|||
146341298|NCT00091793|527758635|FG001|Overall Study|Other|0|||
146341299|NCT00308620|527758636|FG000|Overall Study|Death|1|||
146341300|NCT00308620|527758637|FG001|Overall Study|Death|1|||
146341301|NCT00308620|527758638|FG002|Overall Study|Death|0|||
146341302|NCT00308620|527758636|FG000|Overall Study|Lost to Follow-up|0|||
146341303|NCT00308620|527758637|FG001|Overall Study|Lost to Follow-up|0|||
146341304|NCT00308620|527758638|FG002|Overall Study|Lost to Follow-up|1|||
146341305|NCT01025336|527758642|FG000|Overall Study|Protocol Violation|0|||
146341306|NCT01025336|527758643|FG001|Overall Study|Protocol Violation|0|||
146341307|NCT01025336|527758644|FG002|Overall Study|Protocol Violation|0|||
146341308|NCT01025336|527758645|FG003|Overall Study|Protocol Violation|2|||
146341309|NCT01025336|527758646|FG004|Overall Study|Protocol Violation|0|||
146341310|NCT03794986|527758647|FG000|Overall Study|0 Sessions Attended|34|||
146341311|NCT03794986|527758648|FG001|Overall Study|0 Sessions Attended|37|||
146341312|NCT03794986|527758647|FG000|Overall Study|Withdrawal by Subject|4|||
146341313|NCT03794986|527758648|FG001|Overall Study|Withdrawal by Subject|6|||
146341314|NCT03794986|527758647|FG000|Overall Study|Protocol Violation|1|||
146341315|NCT03794986|527758648|FG001|Overall Study|Protocol Violation|0|||
146341316|NCT03000452|527758649|FG000|Treatment Period|Death|1|||
146341317|NCT03000452|527758649|FG000|Treatment Period|Progressive Disease (PD)|14|||
146341318|NCT03000452|527758649|FG000|Treatment Period|Physician Decision|1|||
146341319|NCT03000452|527758649|FG000|Treatment Period|Miscellaneous|2|||
146341320|NCT03000452|527758649|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
146341321|NCT03000452|527758649|FG000|Follow-Up Period|Death|3|||
146341322|NCT03000452|527758649|FG000|Follow-Up Period|Withdrawal by Subject|3|||
146341323|NCT03043365|527758650|FG000|Weeks 0 to Week 8|Adverse Event|1|||
146341324|NCT03043365|527758651|FG001|Weeks 0 to Week 8|Adverse Event|3|||
146341325|NCT03043365|527758650|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
146341326|NCT03043365|527758651|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
146341327|NCT03043365|527758650|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
146341328|NCT03043365|527758651|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
146341329|NCT02723630|527758652|FG000|Intervention Period 1|Adverse Event|1|||
146341330|NCT02723630|527758653|FG001|Intervention Period 1|Adverse Event|0|||
146341331|NCT02723630|527758654|FG002|Intervention Period 1|Adverse Event|0|||
146341332|NCT02723630|527758655|FG003|Intervention Period 1|Adverse Event|0|||
146341333|NCT02723630|527758656|FG004|Intervention Period 1|Adverse Event|0|||
146341334|NCT02723630|527758657|FG005|Intervention Period 1|Adverse Event|0|||
146341335|NCT02723630|527758652|FG000|Intervention Period 3|consumption of restricted item|0|||
146341336|NCT02723630|527758653|FG001|Intervention Period 3|consumption of restricted item|1|||
146341337|NCT02723630|527758654|FG002|Intervention Period 3|consumption of restricted item|0|||
146341338|NCT02723630|527758655|FG003|Intervention Period 3|consumption of restricted item|0|||
146341339|NCT02723630|527758656|FG004|Intervention Period 3|consumption of restricted item|0|||
146341340|NCT02723630|527758657|FG005|Intervention Period 3|consumption of restricted item|0|||
146169175|NCT02798211|527131148|FG004|Period 2|Adverse Event|1|||
146341341|NCT00852930|527758658|FG000|Overall Study|Withdrawal by Subject|1|||
146341342|NCT00852930|527758659|FG001|Overall Study|Withdrawal by Subject|1|||
146341343|NCT00852930|527758660|FG002|Overall Study|Withdrawal by Subject|1|||
146341344|NCT00852930|527758658|FG000|Overall Study|Physician Decision|0|||
146341345|NCT00852930|527758659|FG001|Overall Study|Physician Decision|0|||
146341346|NCT00852930|527758660|FG002|Overall Study|Physician Decision|1|||
146341347|NCT00779038|527758661|FG000|Overall Study|Study Prematurely Terminated|13|||
146341348|NCT00537745|527758664|FG000|Overall Study|Did not meet eligibility criteria|2|||
146341349|NCT00537745|527758664|FG000|Overall Study|Withdrawal by Subject|2|||
146341350|NCT00537745|527758664|FG000|Overall Study|Subject unable to provide Interlock info|1|||
146341351|NCT05372315|527758665|FG000|Overall Study|Withdrawal by Subject|1|||
146341352|NCT05372315|527758666|FG001|Overall Study|Withdrawal by Subject|0|||
146341353|NCT01512368|527758667|FG000|Overall Study|Protocol Violation|3|||
146341354|NCT02532543|527758670|FG000|Overall Study|Lost to Follow-up|0|||
146341355|NCT02532543|527758671|FG001|Overall Study|Lost to Follow-up|0|||
146341356|NCT02532543|527758672|FG002|Overall Study|Lost to Follow-up|1|||
146341357|NCT02532543|527758673|FG003|Overall Study|Lost to Follow-up|0|||
146341358|NCT00650585|527758674|FG000|Overall Study|Lost to Follow-up|505|||
146341359|NCT00650585|527758675|FG001|Overall Study|Lost to Follow-up|482|||
146341360|NCT00650585|527758674|FG000|Overall Study|No parental consent|935|||
146341361|NCT00650585|527758675|FG001|Overall Study|No parental consent|866|||
146341362|NCT00650585|527758674|FG000|Overall Study|Excluded/ruled ineligible|357|||
146341363|NCT00650585|527758675|FG001|Overall Study|Excluded/ruled ineligible|129|||
146341364|NCT02640612|527758676|FG000|Overall Study|Adverse Event|6|||
146341365|NCT02640612|527758677|FG001|Overall Study|Adverse Event|7|||
146341366|NCT02640612|527758678|FG002|Overall Study|Adverse Event|2|||
146341367|NCT02640612|527758676|FG000|Overall Study|Death|1|||
146341368|NCT02640612|527758677|FG001|Overall Study|Death|0|||
146341369|NCT02640612|527758678|FG002|Overall Study|Death|0|||
146341370|NCT02640612|527758676|FG000|Overall Study|Withdrawal by Subject|10|||
146341371|NCT02640612|527758677|FG001|Overall Study|Withdrawal by Subject|3|||
146341372|NCT02640612|527758678|FG002|Overall Study|Withdrawal by Subject|3|||
146341373|NCT02640612|527758676|FG000|Overall Study|Lost to Follow-up|4|||
146341374|NCT02640612|527758677|FG001|Overall Study|Lost to Follow-up|1|||
146341375|NCT02640612|527758678|FG002|Overall Study|Lost to Follow-up|1|||
146341376|NCT02640612|527758676|FG000|Overall Study|Protocol Violation|0|||
146341377|NCT02640612|527758677|FG001|Overall Study|Protocol Violation|2|||
146341378|NCT02640612|527758678|FG002|Overall Study|Protocol Violation|0|||
146341379|NCT02640612|527758676|FG000|Overall Study|Lack of Efficacy|1|||
146341380|NCT02640612|527758677|FG001|Overall Study|Lack of Efficacy|1|||
146341381|NCT02640612|527758678|FG002|Overall Study|Lack of Efficacy|0|||
146341382|NCT00923091|527758689|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
146341383|NCT00923091|527758690|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
146341384|NCT00923091|527758691|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
146341385|NCT00923091|527758692|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
146341386|NCT00923091|527758693|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
146341387|NCT00923091|527758694|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
146341388|NCT00923091|527758695|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
146341389|NCT00923091|527758696|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
146341390|NCT00923091|527758697|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146341391|NCT00923091|527758698|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146341392|NCT00923091|527758699|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146341393|NCT00923091|527758700|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146341394|NCT00923091|527758701|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
146341395|NCT00923091|527758689|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
146341396|NCT00923091|527758690|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
146341397|NCT00923091|527758691|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146341398|NCT00923091|527758692|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
146341399|NCT00923091|527758693|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
146341400|NCT00923091|527758694|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
146341401|NCT00923091|527758695|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146341402|NCT00923091|527758696|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
146341403|NCT00923091|527758697|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146341404|NCT00923091|527758698|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146341405|NCT00923091|527758699|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146341406|NCT00923091|527758700|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146341407|NCT00923091|527758701|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
146341408|NCT00923091|527758689|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146341409|NCT00923091|527758690|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146341410|NCT00923091|527758691|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
146341411|NCT00923091|527758692|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
146341412|NCT00923091|527758693|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
146341413|NCT00923091|527758694|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
146341414|NCT00923091|527758695|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
146341415|NCT00923091|527758696|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
146341416|NCT00923091|527758697|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146341417|NCT00923091|527758698|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146341418|NCT00923091|527758699|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146341419|NCT00923091|527758700|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146341420|NCT00923091|527758701|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
146341421|NCT00923091|527758689|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341422|NCT00923091|527758690|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341423|NCT00923091|527758691|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341424|NCT00923091|527758692|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341425|NCT00923091|527758693|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145943326|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943327|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943328|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943329|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943330|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943331|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
145943332|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
145943333|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943334|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
145943335|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943336|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943337|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943338|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943339|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145943340|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943341|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943342|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943343|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943344|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943345|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
145943346|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943347|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943348|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943349|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943350|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943351|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943352|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943353|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145943354|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943355|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943356|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943357|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943358|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943359|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943360|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
145943361|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943362|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943363|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943364|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943365|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943366|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943367|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145943368|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943369|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943370|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943371|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943372|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943373|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943374|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943375|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
145943376|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943377|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943378|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943379|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145943380|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146341426|NCT00923091|527758694|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
146341427|NCT00923091|527758695|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341428|NCT00923091|527758696|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341429|NCT00923091|527758697|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341430|NCT00923091|527758698|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341431|NCT00923091|527758699|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341432|NCT00923091|527758700|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341433|NCT00923091|527758701|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
146341434|NCT00923091|527758689|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341435|NCT00923091|527758690|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146341436|NCT00923091|527758691|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341437|NCT00923091|527758692|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146341438|NCT00923091|527758693|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341439|NCT00923091|527758694|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
146341440|NCT00923091|527758695|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341441|NCT00923091|527758696|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341442|NCT00923091|527758697|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341443|NCT00923091|527758698|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341444|NCT00923091|527758699|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341445|NCT00923091|527758700|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341446|NCT00923091|527758701|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
146341447|NCT00923091|527758689|FG000|Period III (Single-Blind)|Adverse Event|5|||
146341448|NCT00923091|527758690|FG001|Period III (Single-Blind)|Adverse Event|0|||
146341449|NCT00923091|527758691|FG002|Period III (Single-Blind)|Adverse Event|0|||
146341450|NCT00923091|527758692|FG003|Period III (Single-Blind)|Adverse Event|0|||
146341451|NCT00923091|527758693|FG004|Period III (Single-Blind)|Adverse Event|0|||
146341452|NCT00923091|527758694|FG005|Period III (Single-Blind)|Adverse Event|0|||
146341453|NCT00923091|527758695|FG006|Period III (Single-Blind)|Adverse Event|0|||
146341454|NCT00923091|527758696|FG007|Period III (Single-Blind)|Adverse Event|0|||
146341455|NCT00923091|527758697|FG008|Period III (Single-Blind)|Adverse Event|0|||
146341456|NCT00923091|527758698|FG009|Period III (Single-Blind)|Adverse Event|0|||
146341457|NCT00923091|527758699|FG010|Period III (Single-Blind)|Adverse Event|0|||
146341458|NCT00923091|527758700|FG011|Period III (Single-Blind)|Adverse Event|0|||
146341459|NCT00923091|527758701|FG012|Period III (Single-Blind)|Adverse Event|0|||
146341460|NCT00923091|527758689|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
146341461|NCT00923091|527758690|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341462|NCT00923091|527758691|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341463|NCT00923091|527758692|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341464|NCT00923091|527758693|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341465|NCT00923091|527758694|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341466|NCT00923091|527758695|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341467|NCT00923091|527758696|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341468|NCT00923091|527758697|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341469|NCT00923091|527758698|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341470|NCT00923091|527758699|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341471|NCT00923091|527758700|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341472|NCT00923091|527758701|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
146341473|NCT00923091|527758689|FG000|Period III (Single-Blind)|Protocol Violation|3|||
146341474|NCT00923091|527758690|FG001|Period III (Single-Blind)|Protocol Violation|0|||
146341475|NCT00923091|527758691|FG002|Period III (Single-Blind)|Protocol Violation|0|||
146341476|NCT00923091|527758692|FG003|Period III (Single-Blind)|Protocol Violation|0|||
146341477|NCT00923091|527758693|FG004|Period III (Single-Blind)|Protocol Violation|0|||
146341478|NCT00923091|527758694|FG005|Period III (Single-Blind)|Protocol Violation|0|||
146341479|NCT00923091|527758695|FG006|Period III (Single-Blind)|Protocol Violation|0|||
146341480|NCT00923091|527758696|FG007|Period III (Single-Blind)|Protocol Violation|0|||
146341481|NCT00923091|527758697|FG008|Period III (Single-Blind)|Protocol Violation|0|||
146341482|NCT00923091|527758698|FG009|Period III (Single-Blind)|Protocol Violation|0|||
146341483|NCT00923091|527758699|FG010|Period III (Single-Blind)|Protocol Violation|0|||
146341484|NCT00923091|527758700|FG011|Period III (Single-Blind)|Protocol Violation|0|||
146341485|NCT00923091|527758701|FG012|Period III (Single-Blind)|Protocol Violation|0|||
146341486|NCT00923091|527758689|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
146341487|NCT00923091|527758690|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
146341488|NCT00923091|527758691|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
146341489|NCT00923091|527758692|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
146341490|NCT00923091|527758693|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
146169176|NCT02798211|527131149|FG005|Period 2|Adverse Event|0|||
146169177|NCT02798211|527131144|FG000|Period 2|Lack of Efficacy|1|||
146169178|NCT02798211|527131145|FG001|Period 2|Lack of Efficacy|0|||
146169179|NCT02798211|527131146|FG002|Period 2|Lack of Efficacy|0|||
146169180|NCT02798211|527131147|FG003|Period 2|Lack of Efficacy|1|||
146341491|NCT00923091|527758694|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
146341492|NCT00923091|527758695|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
146341493|NCT00923091|527758696|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
146341494|NCT00923091|527758697|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
146341495|NCT00923091|527758698|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
146341496|NCT00923091|527758699|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
146341497|NCT00923091|527758700|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
146341498|NCT00923091|527758701|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
146341499|NCT00923091|527758689|FG000|Period IV (Double-Blind)|Adverse Event|2|||
146341500|NCT00923091|527758690|FG001|Period IV (Double-Blind)|Adverse Event|0|||
146341501|NCT00923091|527758691|FG002|Period IV (Double-Blind)|Adverse Event|0|||
146341502|NCT00923091|527758692|FG003|Period IV (Double-Blind)|Adverse Event|0|||
146341503|NCT00923091|527758693|FG004|Period IV (Double-Blind)|Adverse Event|0|||
146341504|NCT00923091|527758694|FG005|Period IV (Double-Blind)|Adverse Event|0|||
146341505|NCT00923091|527758695|FG006|Period IV (Double-Blind)|Adverse Event|0|||
146341506|NCT00923091|527758696|FG007|Period IV (Double-Blind)|Adverse Event|0|||
146341507|NCT00923091|527758697|FG008|Period IV (Double-Blind)|Adverse Event|0|||
146341508|NCT00923091|527758698|FG009|Period IV (Double-Blind)|Adverse Event|0|||
146341509|NCT00923091|527758699|FG010|Period IV (Double-Blind)|Adverse Event|0|||
146341510|NCT00923091|527758700|FG011|Period IV (Double-Blind)|Adverse Event|0|||
146341511|NCT00923091|527758701|FG012|Period IV (Double-Blind)|Adverse Event|0|||
146341512|NCT00923091|527758689|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341513|NCT00923091|527758690|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
146341514|NCT00923091|527758691|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341515|NCT00923091|527758692|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341516|NCT00923091|527758693|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341517|NCT00923091|527758694|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341518|NCT00923091|527758695|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341519|NCT00923091|527758696|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341520|NCT00923091|527758697|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341521|NCT00923091|527758698|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341522|NCT00923091|527758699|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341523|NCT00923091|527758700|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341524|NCT00923091|527758701|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
146341525|NCT00923091|527758689|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
146341526|NCT00923091|527758690|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
146341527|NCT00923091|527758691|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
146341528|NCT00923091|527758692|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
146341529|NCT00923091|527758693|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
146341530|NCT00923091|527758694|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
146341531|NCT00923091|527758695|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
146341532|NCT00923091|527758696|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
146341533|NCT00923091|527758697|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
146341534|NCT00923091|527758698|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
146341535|NCT00923091|527758699|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
146341536|NCT00923091|527758700|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
146341537|NCT00923091|527758701|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
146341538|NCT00923091|527758689|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341539|NCT00923091|527758690|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341540|NCT00923091|527758691|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341541|NCT00923091|527758692|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341542|NCT00923091|527758693|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341543|NCT00923091|527758694|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341544|NCT00923091|527758695|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341545|NCT00923091|527758696|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341546|NCT00923091|527758697|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
146341547|NCT00923091|527758698|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341548|NCT00923091|527758699|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341549|NCT00923091|527758700|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
146341550|NCT00923091|527758701|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
146341551|NCT00923091|527758689|FG000|Period V (Double -Blind)|Protocol Violation|0|||
146341552|NCT00923091|527758690|FG001|Period V (Double -Blind)|Protocol Violation|0|||
146169181|NCT02798211|527131148|FG004|Period 2|Lack of Efficacy|0|||
146341553|NCT00923091|527758691|FG002|Period V (Double -Blind)|Protocol Violation|0|||
146169182|NCT02798211|527131149|FG005|Period 2|Lack of Efficacy|1|||
146169183|NCT02798211|527131144|FG000|Period 2|Lost to Follow-up|3|||
146169184|NCT02798211|527131145|FG001|Period 2|Lost to Follow-up|0|||
146341554|NCT00923091|527758692|FG003|Period V (Double -Blind)|Protocol Violation|0|||
146341555|NCT00923091|527758693|FG004|Period V (Double -Blind)|Protocol Violation|0|||
146341556|NCT00923091|527758694|FG005|Period V (Double -Blind)|Protocol Violation|0|||
146341557|NCT00923091|527758695|FG006|Period V (Double -Blind)|Protocol Violation|0|||
146341558|NCT00923091|527758696|FG007|Period V (Double -Blind)|Protocol Violation|0|||
146341559|NCT00923091|527758697|FG008|Period V (Double -Blind)|Protocol Violation|0|||
146341560|NCT00923091|527758698|FG009|Period V (Double -Blind)|Protocol Violation|0|||
146341561|NCT00923091|527758699|FG010|Period V (Double -Blind)|Protocol Violation|0|||
146341562|NCT00923091|527758700|FG011|Period V (Double -Blind)|Protocol Violation|0|||
146341563|NCT00923091|527758701|FG012|Period V (Double -Blind)|Protocol Violation|1|||
146341564|NCT00923091|527758689|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
146341565|NCT00923091|527758690|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
146341566|NCT00923091|527758691|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
146341567|NCT00923091|527758692|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
146341568|NCT00923091|527758693|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
146341569|NCT00923091|527758694|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
146341570|NCT00923091|527758695|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
146341571|NCT00923091|527758696|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
146341572|NCT00923091|527758697|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
146341573|NCT00923091|527758698|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
146341574|NCT00923091|527758699|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
146341575|NCT00923091|527758700|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
146341576|NCT00923091|527758701|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
146341577|NCT00923091|527758689|FG000|Period VI (Open-Label)|Adverse Event|17|||
146341578|NCT00923091|527758690|FG001|Period VI (Open-Label)|Adverse Event|0|||
146341579|NCT00923091|527758691|FG002|Period VI (Open-Label)|Adverse Event|4|||
146341580|NCT00923091|527758692|FG003|Period VI (Open-Label)|Adverse Event|1|||
146341581|NCT00923091|527758693|FG004|Period VI (Open-Label)|Adverse Event|1|||
146341582|NCT00923091|527758694|FG005|Period VI (Open-Label)|Adverse Event|0|||
146341583|NCT00923091|527758695|FG006|Period VI (Open-Label)|Adverse Event|0|||
146341584|NCT00923091|527758696|FG007|Period VI (Open-Label)|Adverse Event|0|||
146341585|NCT00923091|527758697|FG008|Period VI (Open-Label)|Adverse Event|0|||
146341586|NCT00923091|527758698|FG009|Period VI (Open-Label)|Adverse Event|0|||
146341587|NCT00923091|527758699|FG010|Period VI (Open-Label)|Adverse Event|0|||
146341588|NCT00923091|527758700|FG011|Period VI (Open-Label)|Adverse Event|0|||
146341589|NCT00923091|527758701|FG012|Period VI (Open-Label)|Adverse Event|0|||
146341590|NCT00923091|527758689|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
146341591|NCT00923091|527758690|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
146341592|NCT00923091|527758691|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
146341593|NCT00923091|527758692|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341594|NCT00923091|527758693|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
146341595|NCT00923091|527758694|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341596|NCT00923091|527758695|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341597|NCT00923091|527758696|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341598|NCT00923091|527758697|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341599|NCT00923091|527758698|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341600|NCT00923091|527758699|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341601|NCT00923091|527758700|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341602|NCT00923091|527758701|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
146341603|NCT00923091|527758689|FG000|Period VI (Open-Label)|Protocol Violation|6|||
146341604|NCT00923091|527758690|FG001|Period VI (Open-Label)|Protocol Violation|1|||
146341605|NCT00923091|527758691|FG002|Period VI (Open-Label)|Protocol Violation|3|||
146341606|NCT00923091|527758692|FG003|Period VI (Open-Label)|Protocol Violation|1|||
146341607|NCT00923091|527758693|FG004|Period VI (Open-Label)|Protocol Violation|4|||
146341608|NCT00923091|527758694|FG005|Period VI (Open-Label)|Protocol Violation|0|||
146341609|NCT00923091|527758695|FG006|Period VI (Open-Label)|Protocol Violation|0|||
146341610|NCT00923091|527758696|FG007|Period VI (Open-Label)|Protocol Violation|0|||
146341611|NCT00923091|527758697|FG008|Period VI (Open-Label)|Protocol Violation|0|||
146341612|NCT00923091|527758698|FG009|Period VI (Open-Label)|Protocol Violation|0|||
146341613|NCT00923091|527758699|FG010|Period VI (Open-Label)|Protocol Violation|0|||
146341614|NCT00923091|527758700|FG011|Period VI (Open-Label)|Protocol Violation|0|||
146341615|NCT00923091|527758701|FG012|Period VI (Open-Label)|Protocol Violation|0|||
146341616|NCT00923091|527758689|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
146341617|NCT00923091|527758690|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
146341618|NCT00923091|527758691|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
146341619|NCT00923091|527758692|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
146341620|NCT00923091|527758693|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
146341621|NCT00923091|527758694|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
146341622|NCT00923091|527758695|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
146341623|NCT00923091|527758696|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
146341624|NCT00923091|527758697|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
146341625|NCT00923091|527758698|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
146341626|NCT00923091|527758699|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
146341627|NCT00923091|527758700|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
146341628|NCT00923091|527758701|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
146341629|NCT00923091|527758689|FG000|Period VI (Open-Label)|Other Reason|0|||
146169185|NCT02798211|527131146|FG002|Period 2|Lost to Follow-up|0|||
146169186|NCT02798211|527131147|FG003|Period 2|Lost to Follow-up|0|||
146341630|NCT00923091|527758690|FG001|Period VI (Open-Label)|Other Reason|0|||
146341631|NCT00923091|527758691|FG002|Period VI (Open-Label)|Other Reason|0|||
146341632|NCT00923091|527758692|FG003|Period VI (Open-Label)|Other Reason|1|||
146341633|NCT00923091|527758693|FG004|Period VI (Open-Label)|Other Reason|1|||
146341634|NCT00923091|527758694|FG005|Period VI (Open-Label)|Other Reason|0|||
146341635|NCT00923091|527758695|FG006|Period VI (Open-Label)|Other Reason|0|||
146341636|NCT00923091|527758696|FG007|Period VI (Open-Label)|Other Reason|0|||
146341637|NCT00923091|527758697|FG008|Period VI (Open-Label)|Other Reason|0|||
146341638|NCT00923091|527758698|FG009|Period VI (Open-Label)|Other Reason|0|||
146341639|NCT00923091|527758699|FG010|Period VI (Open-Label)|Other Reason|0|||
146341640|NCT00923091|527758700|FG011|Period VI (Open-Label)|Other Reason|0|||
146341641|NCT00923091|527758701|FG012|Period VI (Open-Label)|Other Reason|0|||
146341642|NCT02460822|527758704|FG000|Overall Study|Withdrawal by Subject|1|||
146341643|NCT00467649|527758705|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
146341644|NCT00467649|527758706|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
146341645|NCT00467649|527758707|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
146341646|NCT00467649|527758708|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
146341647|NCT00467649|527758709|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
146341648|NCT00467649|527758710|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
146341649|NCT00467649|527758705|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
146341650|NCT00467649|527758706|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
146341651|NCT00467649|527758707|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
146341652|NCT00467649|527758708|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
146341653|NCT00467649|527758709|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
146341654|NCT00467649|527758710|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
146341655|NCT00467649|527758705|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
146341656|NCT00467649|527758706|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
146341657|NCT00467649|527758707|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146341658|NCT00467649|527758708|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146341659|NCT00467649|527758709|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146341660|NCT00467649|527758710|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
146341661|NCT00467649|527758705|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
146341662|NCT00467649|527758706|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
146341663|NCT00467649|527758707|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146341664|NCT00467649|527758708|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146341665|NCT00467649|527758709|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146341666|NCT00467649|527758710|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
146341667|NCT00467649|527758705|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146341668|NCT00467649|527758706|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146341669|NCT00467649|527758707|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146341670|NCT00467649|527758708|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
146341671|NCT00467649|527758709|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146341672|NCT00467649|527758710|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
146341673|NCT00467649|527758705|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146341674|NCT00467649|527758706|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146341675|NCT00467649|527758707|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146341676|NCT00467649|527758708|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
146341677|NCT00467649|527758709|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146341678|NCT00467649|527758710|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
146341679|NCT00467649|527758705|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146341680|NCT00467649|527758706|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146341681|NCT00467649|527758707|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146341682|NCT00467649|527758708|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146341683|NCT00467649|527758709|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
146341684|NCT00467649|527758710|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
146341685|NCT03240081|527758711|FG000|Overall Study|Withdrawal by Subject|0|||
146341686|NCT03240081|527758712|FG001|Overall Study|Withdrawal by Subject|2|||
146341687|NCT03240081|527758711|FG000|Overall Study|Lost to Follow-up|0|||
146341688|NCT03240081|527758712|FG001|Overall Study|Lost to Follow-up|1|||
146341689|NCT03114969|527758713|FG000|Overall Study|Lost to Follow-up|0|||
146341690|NCT03114969|527758714|FG001|Overall Study|Lost to Follow-up|0|||
146341691|NCT03114969|527758715|FG002|Overall Study|Lost to Follow-up|3|||
146341692|NCT03114969|527758716|FG003|Overall Study|Lost to Follow-up|2|||
146341693|NCT03114969|527758717|FG004|Overall Study|Lost to Follow-up|0|||
146341694|NCT03114969|527758718|FG005|Overall Study|Lost to Follow-up|0|||
146341695|NCT03114969|527758719|FG006|Overall Study|Lost to Follow-up|0|||
146341696|NCT03114969|527758720|FG007|Overall Study|Lost to Follow-up|0|||
146341697|NCT03114969|527758721|FG008|Overall Study|Lost to Follow-up|0|||
146341698|NCT03114969|527758713|FG000|Overall Study|Adverse Event|0|||
146169187|NCT02798211|527131148|FG004|Period 2|Lost to Follow-up|2|||
146341699|NCT03114969|527758714|FG001|Overall Study|Adverse Event|0|||
146341700|NCT03114969|527758715|FG002|Overall Study|Adverse Event|1|||
146341701|NCT03114969|527758716|FG003|Overall Study|Adverse Event|0|||
146341702|NCT03114969|527758717|FG004|Overall Study|Adverse Event|0|||
146341703|NCT03114969|527758718|FG005|Overall Study|Adverse Event|1|||
146341704|NCT03114969|527758719|FG006|Overall Study|Adverse Event|1|||
146341705|NCT03114969|527758720|FG007|Overall Study|Adverse Event|0|||
146341706|NCT03114969|527758721|FG008|Overall Study|Adverse Event|2|||
146341707|NCT04925570|527758726|FG000|Overall Study|Protocol Violation|24|||
146341708|NCT04925570|527758727|FG001|Overall Study|Protocol Violation|30|||
146341709|NCT04925570|527758726|FG000|Overall Study|Withdrawal by Subject|0|||
146341710|NCT04925570|527758727|FG001|Overall Study|Withdrawal by Subject|2|||
146341711|NCT05121103|527758730|FG000|Overall Study|Progressive disease|2|||
146341712|NCT05121103|527758731|FG001|Overall Study|Progressive disease|1|||
146341713|NCT05121103|527758732|FG002|Overall Study|Progressive disease|6|||
146341714|NCT05121103|527758730|FG000|Overall Study|Physician Decision|2|||
146341715|NCT05121103|527758731|FG001|Overall Study|Physician Decision|1|||
146341716|NCT05121103|527758732|FG002|Overall Study|Physician Decision|0|||
146341717|NCT05121103|527758730|FG000|Overall Study|Withdrawal by Subject|0|||
146341718|NCT05121103|527758731|FG001|Overall Study|Withdrawal by Subject|1|||
146341719|NCT05121103|527758732|FG002|Overall Study|Withdrawal by Subject|0|||
146341720|NCT03443024|527758734|FG000|Overall Study|Adverse Event|2|||
146341721|NCT03443024|527758735|FG001|Overall Study|Adverse Event|4|||
146341722|NCT03443024|527758736|FG002|Overall Study|Adverse Event|3|||
146341723|NCT03443024|527758737|FG003|Overall Study|Adverse Event|1|||
146341724|NCT03443024|527758734|FG000|Overall Study|Lost to Follow-up|9|||
146341725|NCT03443024|527758735|FG001|Overall Study|Lost to Follow-up|9|||
146341726|NCT03443024|527758736|FG002|Overall Study|Lost to Follow-up|7|||
146341727|NCT03443024|527758737|FG003|Overall Study|Lost to Follow-up|5|||
146341728|NCT03443024|527758734|FG000|Overall Study|Withdrawal by Subject|8|||
146341729|NCT03443024|527758735|FG001|Overall Study|Withdrawal by Subject|15|||
146341730|NCT03443024|527758736|FG002|Overall Study|Withdrawal by Subject|9|||
146341731|NCT03443024|527758737|FG003|Overall Study|Withdrawal by Subject|23|||
146341732|NCT03443024|527758734|FG000|Overall Study|Physician Decision|1|||
146341733|NCT03443024|527758735|FG001|Overall Study|Physician Decision|2|||
146341734|NCT03443024|527758736|FG002|Overall Study|Physician Decision|0|||
146341735|NCT03443024|527758737|FG003|Overall Study|Physician Decision|1|||
146341736|NCT03443024|527758734|FG000|Overall Study|Sponsor Decision|1|||
146341737|NCT03443024|527758735|FG001|Overall Study|Sponsor Decision|1|||
146341738|NCT03443024|527758736|FG002|Overall Study|Sponsor Decision|0|||
146341739|NCT03443024|527758737|FG003|Overall Study|Sponsor Decision|0|||
146341740|NCT03443024|527758734|FG000|Overall Study|Protocol Deviation|0|||
146341741|NCT03443024|527758735|FG001|Overall Study|Protocol Deviation|0|||
146341742|NCT03443024|527758736|FG002|Overall Study|Protocol Deviation|0|||
146341743|NCT03443024|527758737|FG003|Overall Study|Protocol Deviation|2|||
146341744|NCT00624338|527758739|FG000|Overall Study|Adverse Event|14|||
146341745|NCT00624338|527758740|FG001|Overall Study|Adverse Event|14|||
146341746|NCT00624338|527758741|FG002|Overall Study|Adverse Event|18|||
146341747|NCT00624338|527758739|FG000|Overall Study|Lost to Follow-up|1|||
146341748|NCT00624338|527758740|FG001|Overall Study|Lost to Follow-up|0|||
146341749|NCT00624338|527758741|FG002|Overall Study|Lost to Follow-up|0|||
146341750|NCT00624338|527758739|FG000|Overall Study|Lack of Efficacy|11|||
146341751|NCT00624338|527758740|FG001|Overall Study|Lack of Efficacy|3|||
146341752|NCT00624338|527758741|FG002|Overall Study|Lack of Efficacy|14|||
146341753|NCT00624338|527758739|FG000|Overall Study|Protocol Violation|3|||
146341754|NCT00624338|527758740|FG001|Overall Study|Protocol Violation|3|||
146341755|NCT00624338|527758741|FG002|Overall Study|Protocol Violation|2|||
146341756|NCT00624338|527758739|FG000|Overall Study|Death|0|||
146341757|NCT00624338|527758740|FG001|Overall Study|Death|2|||
146341758|NCT00624338|527758741|FG002|Overall Study|Death|0|||
146341759|NCT00624338|527758739|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
146341760|NCT00624338|527758740|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
146341761|NCT00624338|527758741|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
146341762|NCT00624338|527758739|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
146341763|NCT00624338|527758740|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
146341764|NCT00624338|527758741|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
146341765|NCT00624338|527758739|FG000|Overall Study|Other|15|||
146341766|NCT00624338|527758740|FG001|Overall Study|Other|5|||
146169188|NCT02798211|527131149|FG005|Period 2|Lost to Follow-up|0|||
146341767|NCT00624338|527758741|FG002|Overall Study|Other|9|||
146341768|NCT00624338|527758739|FG000|Overall Study|Randomized but not treated|2|||
146341769|NCT00624338|527758740|FG001|Overall Study|Randomized but not treated|1|||
146341770|NCT00624338|527758741|FG002|Overall Study|Randomized but not treated|3|||
146341771|NCT05593432|527758742|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
146341772|NCT05593432|527758743|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
146341773|NCT05593432|527758744|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
146341774|NCT05593432|527758745|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
146341775|NCT05593432|527758742|FG000|16-Week OLE Period|Lack of Efficacy|0|||
146341776|NCT05593432|527758743|FG001|16-Week OLE Period|Lack of Efficacy|0|||
146341777|NCT05593432|527758744|FG002|16-Week OLE Period|Lack of Efficacy|0|||
146341778|NCT05593432|527758745|FG003|16-Week OLE Period|Lack of Efficacy|1|||
146341779|NCT05593432|527758742|FG000|16-Week OLE Period|Lost to Follow-up|0|||
146341780|NCT05593432|527758743|FG001|16-Week OLE Period|Lost to Follow-up|0|||
146341781|NCT05593432|527758744|FG002|16-Week OLE Period|Lost to Follow-up|1|||
146341782|NCT05593432|527758745|FG003|16-Week OLE Period|Lost to Follow-up|2|||
146341783|NCT05593432|527758742|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
146341784|NCT05593432|527758743|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
146341785|NCT05593432|527758744|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
146341786|NCT05593432|527758745|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
146341787|NCT05897853|527758746|FG000|Overall Study|Lost to Follow-up|2|||
146341788|NCT05897853|527758747|FG001|Overall Study|Lost to Follow-up|0|||
146341789|NCT05897853|527758746|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
146341790|NCT05897853|527758747|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
146169189|NCT02798211|527131144|FG000|Period 2|Physician Decision|1|||
146169190|NCT02798211|527131145|FG001|Period 2|Physician Decision|0|||
146169191|NCT02798211|527131146|FG002|Period 2|Physician Decision|0|||
146169192|NCT02798211|527131147|FG003|Period 2|Physician Decision|1|||
146341791|NCT01476787|527758751|FG000|Treatment|Progression|64|||
146341792|NCT01476787|527758752|FG001|Treatment|Progression|71|||
146341793|NCT01476787|527758751|FG000|Treatment|Toxicity|44|||
146341794|NCT01476787|527758752|FG001|Treatment|Toxicity|16|||
146341795|NCT01476787|527758751|FG000|Treatment|Death|0|||
146341796|NCT01476787|527758752|FG001|Treatment|Death|1|||
146341797|NCT01476787|527758751|FG000|Treatment|Withdrawal by Subject|3|||
146341798|NCT01476787|527758752|FG001|Treatment|Withdrawal by Subject|14|||
146341799|NCT01476787|527758751|FG000|Treatment|Major protocol violation|1|||
146341800|NCT01476787|527758752|FG001|Treatment|Major protocol violation|6|||
146341801|NCT01476787|527758751|FG000|Treatment|Other reasons|10|||
146341802|NCT01476787|527758752|FG001|Treatment|Other reasons|22|||
146341803|NCT01476787|527758751|FG000|Treatment|Concurrent illness|12|||
146341804|NCT01476787|527758752|FG001|Treatment|Concurrent illness|9|||
146341805|NCT01476787|527758751|FG000|Treatment|Insufficient response|15|||
146341806|NCT01476787|527758752|FG001|Treatment|Insufficient response|3|||
146341807|NCT01476787|527758751|FG000|Treatment|Voluntary treatment discontinuation|8|||
146341808|NCT01476787|527758752|FG001|Treatment|Voluntary treatment discontinuation|4|||
146341809|NCT02782715|527758756|FG000|Overall Study|Withdrawal by Subject|1|||
146341810|NCT04458857|527758757|FG000|Overall Study|Adverse Event|0|||
146341811|NCT04458857|527758758|FG001|Overall Study|Adverse Event|1|||
146341812|NCT04458857|527758759|FG002|Overall Study|Adverse Event|0|||
146341813|NCT04458857|527758757|FG000|Overall Study|Withdrawal by Subject|2|||
146341814|NCT04458857|527758758|FG001|Overall Study|Withdrawal by Subject|0|||
146341815|NCT04458857|527758759|FG002|Overall Study|Withdrawal by Subject|0|||
146341816|NCT04458857|527758757|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146341817|NCT04458857|527758758|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146341818|NCT04458857|527758759|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146341819|NCT04458857|527758757|FG000|Overall Study|Non-compliance with study drug|0|||
146341820|NCT04458857|527758758|FG001|Overall Study|Non-compliance with study drug|1|||
146341821|NCT04458857|527758759|FG002|Overall Study|Non-compliance with study drug|0|||
146341822|NCT04458857|527758757|FG000|Overall Study|Lost to Follow-up|4|||
146341823|NCT04458857|527758758|FG001|Overall Study|Lost to Follow-up|1|||
146341824|NCT04458857|527758759|FG002|Overall Study|Lost to Follow-up|0|||
146341825|NCT04800315|527758768|FG000|Randomization|Did not receive study treatment|1|||
146341826|NCT04800315|527758769|FG001|Randomization|Did not receive study treatment|0|||
146341827|NCT04800315|527758770|FG002|Randomization|Did not receive study treatment|0|||
146341828|NCT04800315|527758771|FG003|Randomization|Did not receive study treatment|0|||
146341829|NCT04800315|527758768|FG000|Treatment Period|Adverse Event|4|||
146341830|NCT04800315|527758769|FG001|Treatment Period|Adverse Event|2|||
146341831|NCT04800315|527758770|FG002|Treatment Period|Adverse Event|1|||
146169193|NCT02798211|527131148|FG004|Period 2|Physician Decision|1|||
146169194|NCT02798211|527131149|FG005|Period 2|Physician Decision|0|||
146341832|NCT04800315|527758771|FG003|Treatment Period|Adverse Event|2|||
146341833|NCT04800315|527758768|FG000|Treatment Period|Lack of Efficacy|1|||
146341834|NCT04800315|527758769|FG001|Treatment Period|Lack of Efficacy|0|||
146341835|NCT04800315|527758770|FG002|Treatment Period|Lack of Efficacy|0|||
146341836|NCT04800315|527758771|FG003|Treatment Period|Lack of Efficacy|3|||
146341837|NCT04800315|527758768|FG000|Treatment Period|Lost to Follow-up|0|||
146341838|NCT04800315|527758769|FG001|Treatment Period|Lost to Follow-up|1|||
146341839|NCT04800315|527758770|FG002|Treatment Period|Lost to Follow-up|2|||
146341840|NCT04800315|527758771|FG003|Treatment Period|Lost to Follow-up|2|||
146169195|NCT02798211|527131144|FG000|Period 2|Pregnancy|0|||
146169196|NCT02798211|527131145|FG001|Period 2|Pregnancy|0|||
146169197|NCT02798211|527131146|FG002|Period 2|Pregnancy|0|||
146341841|NCT04800315|527758768|FG000|Treatment Period|Withdrawal by participant|0|||
146341842|NCT04800315|527758769|FG001|Treatment Period|Withdrawal by participant|0|||
146169198|NCT02798211|527131147|FG003|Period 2|Pregnancy|2|||
146341843|NCT04800315|527758770|FG002|Treatment Period|Withdrawal by participant|0|||
146341844|NCT04800315|527758771|FG003|Treatment Period|Withdrawal by participant|4|||
146341845|NCT04800315|527758768|FG000|Treatment Period|Other Reasons|0|||
146341846|NCT04800315|527758769|FG001|Treatment Period|Other Reasons|2|||
146341847|NCT04800315|527758770|FG002|Treatment Period|Other Reasons|0|||
146341848|NCT04800315|527758771|FG003|Treatment Period|Other Reasons|1|||
146341849|NCT00753922|527758772|FG000|Overall Study|Lost to Follow-up|155|||
146341850|NCT00753922|527758773|FG001|Overall Study|Lost to Follow-up|24|||
146341851|NCT00753922|527758774|FG002|Overall Study|Lost to Follow-up|28|||
146341852|NCT00753922|527758775|FG003|Overall Study|Lost to Follow-up|5|||
146341853|NCT00753922|527758772|FG000|Overall Study|Withdrawal by Subject|9|||
146341854|NCT00753922|527758773|FG001|Overall Study|Withdrawal by Subject|11|||
146341855|NCT00753922|527758774|FG002|Overall Study|Withdrawal by Subject|4|||
146341856|NCT00753922|527758775|FG003|Overall Study|Withdrawal by Subject|2|||
146341857|NCT00753922|527758772|FG000|Overall Study|Patient Non-compliance|55|||
146341858|NCT00753922|527758773|FG001|Overall Study|Patient Non-compliance|22|||
146341859|NCT00753922|527758774|FG002|Overall Study|Patient Non-compliance|14|||
146341860|NCT00753922|527758775|FG003|Overall Study|Patient Non-compliance|11|||
146341861|NCT00753922|527758772|FG000|Overall Study|Patients Not Completing Visit|11|||
146341862|NCT00753922|527758773|FG001|Overall Study|Patients Not Completing Visit|0|||
146341863|NCT00753922|527758774|FG002|Overall Study|Patients Not Completing Visit|1|||
146341864|NCT00753922|527758775|FG003|Overall Study|Patients Not Completing Visit|0|||
146341865|NCT00753922|527758772|FG000|Overall Study|Death|2|||
146341866|NCT00753922|527758773|FG001|Overall Study|Death|23|||
146341867|NCT00753922|527758774|FG002|Overall Study|Death|2|||
146341868|NCT00753922|527758775|FG003|Overall Study|Death|1|||
146341869|NCT00753922|527758772|FG000|Overall Study|Discontinuation Due to Explantation|14|||
146341870|NCT00753922|527758773|FG001|Overall Study|Discontinuation Due to Explantation|14|||
146341871|NCT00753922|527758774|FG002|Overall Study|Discontinuation Due to Explantation|14|||
146341872|NCT00753922|527758775|FG003|Overall Study|Discontinuation Due to Explantation|4|||
146341873|NCT01662999|527758776|FG000|Period 3|Withdrawal by Subject|0|||
146341874|NCT01662999|527758777|FG001|Period 3|Withdrawal by Subject|1|||
146341875|NCT01662999|527758778|FG002|Period 3|Withdrawal by Subject|0|||
146341876|NCT01662999|527758779|FG003|Period 3|Withdrawal by Subject|0|||
146341877|NCT01662999|527758780|FG004|Period 3|Withdrawal by Subject|0|||
146341878|NCT01662999|527758781|FG005|Period 3|Withdrawal by Subject|0|||
146341879|NCT00586690|527758790|FG000|Overall Study|Death|2|||
146341880|NCT00586690|527758791|FG001|Overall Study|Death|0|||
146341881|NCT00586690|527758790|FG000|Overall Study|Disease Progression|10|||
146341882|NCT00586690|527758791|FG001|Overall Study|Disease Progression|0|||
146341883|NCT00586690|527758790|FG000|Overall Study|Adverse Event|1|||
146341884|NCT00586690|527758791|FG001|Overall Study|Adverse Event|0|||
146341885|NCT00586690|527758790|FG000|Overall Study|Lack of Efficacy|2|||
146341886|NCT00586690|527758791|FG001|Overall Study|Lack of Efficacy|0|||
146341887|NCT00586690|527758790|FG000|Overall Study|Lab can't accommodate|1|||
146341888|NCT00586690|527758791|FG001|Overall Study|Lab can't accommodate|0|||
146341889|NCT01751646|527758792|FG000|Overall Study|Lost to Follow-up|5|||
146341890|NCT01751646|527758793|FG001|Overall Study|Lost to Follow-up|1|||
146341891|NCT01751646|527758792|FG000|Overall Study|Withdrawal by Subject|0|||
146341892|NCT01751646|527758793|FG001|Overall Study|Withdrawal by Subject|4|||
146341893|NCT01751646|527758792|FG000|Overall Study|Starting hormone therapy|1|||
146341894|NCT01751646|527758793|FG001|Overall Study|Starting hormone therapy|0|||
146341895|NCT01751646|527758792|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
146341896|NCT01751646|527758793|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
146341897|NCT01751646|527758792|FG000|Overall Study|Inadvertent enrollment|1|||
146341898|NCT01751646|527758793|FG001|Overall Study|Inadvertent enrollment|1|||
146341899|NCT01751646|527758792|FG000|Overall Study|Moved out of the area|1|||
146341900|NCT01751646|527758793|FG001|Overall Study|Moved out of the area|5|||
146341901|NCT01751646|527758792|FG000|Overall Study|Inability to attend required visits|0|||
146341902|NCT01751646|527758793|FG001|Overall Study|Inability to attend required visits|1|||
146341903|NCT01751646|527758792|FG000|Overall Study|Off study due to multiple obligations|0|||
146341904|NCT01751646|527758793|FG001|Overall Study|Off study due to multiple obligations|1|||
146341905|NCT01751646|527758792|FG000|Overall Study|Fails to comply with study requirements|0|||
146341906|NCT01751646|527758793|FG001|Overall Study|Fails to comply with study requirements|1|||
146341907|NCT01751646|527758792|FG000|Overall Study|Childcare issues|1|||
146169199|NCT02798211|527131148|FG004|Period 2|Pregnancy|0|||
146341908|NCT01751646|527758793|FG001|Overall Study|Childcare issues|1|||
146341909|NCT01151137|527758796|FG000|Overall Study|Death|15|||
146341910|NCT01151137|527758797|FG001|Overall Study|Death|27|||
146341911|NCT01151137|527758796|FG000|Overall Study|Lost to Follow-up|1|||
146341912|NCT01151137|527758797|FG001|Overall Study|Lost to Follow-up|1|||
146341913|NCT01933672|527758799|FG000|Metformin Run-in Period|Adverse Event|1|||
146341914|NCT01933672|527758800|FG001|Metformin Run-in Period|Adverse Event|0|||
146341915|NCT01933672|527758801|FG002|Metformin Run-in Period|Adverse Event|0|||
146341916|NCT01933672|527758802|FG003|Metformin Run-in Period|Adverse Event|0|||
146341917|NCT01933672|527758803|FG004|Metformin Run-in Period|Adverse Event|0|||
146341918|NCT01933672|527758804|FG005|Metformin Run-in Period|Adverse Event|0|||
146169200|NCT02798211|527131149|FG005|Period 2|Pregnancy|0|||
146341919|NCT01933672|527758805|FG006|Metformin Run-in Period|Adverse Event|0|||
146341920|NCT01933672|527758799|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
146341921|NCT01933672|527758800|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341922|NCT01933672|527758801|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341923|NCT01933672|527758802|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341924|NCT01933672|527758803|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341925|NCT01933672|527758804|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341926|NCT01933672|527758805|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
146341927|NCT01933672|527758799|FG000|Metformin Run-in Period|Other|5|||
146341928|NCT01933672|527758800|FG001|Metformin Run-in Period|Other|0|||
146341929|NCT01933672|527758801|FG002|Metformin Run-in Period|Other|0|||
146341930|NCT01933672|527758802|FG003|Metformin Run-in Period|Other|0|||
146341931|NCT01933672|527758803|FG004|Metformin Run-in Period|Other|0|||
146341932|NCT01933672|527758804|FG005|Metformin Run-in Period|Other|0|||
146341933|NCT01933672|527758805|FG006|Metformin Run-in Period|Other|0|||
146341934|NCT01933672|527758799|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341935|NCT01933672|527758800|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341936|NCT01933672|527758801|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341937|NCT01933672|527758802|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341938|NCT01933672|527758803|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
146341939|NCT01933672|527758804|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341940|NCT01933672|527758805|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341941|NCT01933672|527758799|FG000|First Intervention Period (12-16 Days)|Other|0|||
146341942|NCT01933672|527758800|FG001|First Intervention Period (12-16 Days)|Other|0|||
146341943|NCT01933672|527758801|FG002|First Intervention Period (12-16 Days)|Other|1|||
146341944|NCT01933672|527758802|FG003|First Intervention Period (12-16 Days)|Other|0|||
146341945|NCT01933672|527758803|FG004|First Intervention Period (12-16 Days)|Other|0|||
146341946|NCT01933672|527758804|FG005|First Intervention Period (12-16 Days)|Other|1|||
146341947|NCT01933672|527758805|FG006|First Intervention Period (12-16 Days)|Other|0|||
146341948|NCT01933672|527758799|FG000|Second Intervention Period (12-16 Days)|Other|0|||
146341949|NCT01933672|527758800|FG001|Second Intervention Period (12-16 Days)|Other|1|||
146341950|NCT01933672|527758801|FG002|Second Intervention Period (12-16 Days)|Other|1|||
146341951|NCT01933672|527758802|FG003|Second Intervention Period (12-16 Days)|Other|0|||
146341952|NCT01933672|527758803|FG004|Second Intervention Period (12-16 Days)|Other|0|||
146341953|NCT01933672|527758804|FG005|Second Intervention Period (12-16 Days)|Other|0|||
146341954|NCT01933672|527758805|FG006|Second Intervention Period (12-16 Days)|Other|0|||
146341955|NCT01933672|527758799|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341956|NCT01933672|527758800|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341957|NCT01933672|527758801|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341958|NCT01933672|527758802|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
146341959|NCT01933672|527758803|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341960|NCT01933672|527758804|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341961|NCT01933672|527758805|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
146341962|NCT01933672|527758799|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341963|NCT01933672|527758800|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
146341964|NCT01933672|527758801|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341965|NCT01933672|527758802|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341966|NCT01933672|527758803|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341967|NCT01933672|527758804|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341968|NCT01933672|527758805|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
146341969|NCT01282814|527758806|FG000|First Intervention|Emesis During Dosing Interval|0|||
146341970|NCT01282814|527758807|FG001|First Intervention|Emesis During Dosing Interval|3|||
146341971|NCT01282814|527758806|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
146341972|NCT01282814|527758807|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
146341973|NCT02403206|527758808|FG000|Overall Study|Lost to Follow-up|4|||
146341974|NCT02403206|527758809|FG001|Overall Study|Lost to Follow-up|3|||
146341975|NCT02403206|527758808|FG000|Overall Study|Physician Decision|2|||
146341976|NCT02403206|527758809|FG001|Overall Study|Physician Decision|0|||
146341977|NCT02403206|527758808|FG000|Overall Study|Withdrawal by Subject|3|||
146341978|NCT02403206|527758809|FG001|Overall Study|Withdrawal by Subject|3|||
146341979|NCT02403206|527758808|FG000|Overall Study|Reason not given|2|||
146341980|NCT02403206|527758809|FG001|Overall Study|Reason not given|4|||
146341981|NCT00957372|527758810|FG000|PART I|Lost to Follow-up|0|||
146341982|NCT00957372|527758811|FG001|PART I|Lost to Follow-up|0|||
146341983|NCT00957372|527758812|FG002|PART I|Lost to Follow-up|1|||
146169201|NCT02798211|527131144|FG000|Period 2|Technical problems|1|||
146341984|NCT00957372|527758813|FG003|PART I|Lost to Follow-up|0|||
146341985|NCT00957372|527758810|FG000|PART II|Withdrawal by Subject|0|||
146341986|NCT00957372|527758811|FG001|PART II|Withdrawal by Subject|0|||
146341987|NCT00957372|527758812|FG002|PART II|Withdrawal by Subject|0|||
146341988|NCT00957372|527758813|FG003|PART II|Withdrawal by Subject|8|||
146341989|NCT00957372|527758810|FG000|PART II|Physician Decision|0|||
146341990|NCT00957372|527758811|FG001|PART II|Physician Decision|0|||
146341991|NCT00957372|527758812|FG002|PART II|Physician Decision|0|||
146341992|NCT00957372|527758813|FG003|PART II|Physician Decision|1|||
146341993|NCT00957372|527758810|FG000|PART II|Pregnancy|0|||
146341994|NCT00957372|527758811|FG001|PART II|Pregnancy|0|||
146341995|NCT00957372|527758812|FG002|PART II|Pregnancy|0|||
146341996|NCT00957372|527758813|FG003|PART II|Pregnancy|1|||
146341997|NCT00957372|527758810|FG000|PART II|Not Know|0|||
146341998|NCT00957372|527758811|FG001|PART II|Not Know|0|||
146341999|NCT00957372|527758812|FG002|PART II|Not Know|0|||
146342000|NCT00957372|527758813|FG003|PART II|Not Know|20|||
146342001|NCT00957372|527758810|FG000|PART II|Adverse Event|0|||
146342002|NCT00957372|527758811|FG001|PART II|Adverse Event|0|||
146342003|NCT00957372|527758812|FG002|PART II|Adverse Event|0|||
146342004|NCT00957372|527758813|FG003|PART II|Adverse Event|10|||
146342005|NCT00957372|527758810|FG000|PART II|Patient non-compliance|0|||
146342006|NCT00957372|527758811|FG001|PART II|Patient non-compliance|0|||
146342007|NCT00957372|527758812|FG002|PART II|Patient non-compliance|0|||
146342008|NCT00957372|527758813|FG003|PART II|Patient non-compliance|4|||
146342009|NCT01444391|527758816|FG000|Overall Study|Death|1|||
146342010|NCT01676116|527758817|FG000|Overall Study|Withdrawal criteria|2|||
146342011|NCT01676116|527758818|FG001|Overall Study|Withdrawal criteria|14|||
146342012|NCT01676116|527758817|FG000|Overall Study|Adverse Event|1|||
146342013|NCT01676116|527758818|FG001|Overall Study|Adverse Event|2|||
146342014|NCT01676116|527758817|FG000|Overall Study|Unclassified|4|||
146342015|NCT01676116|527758818|FG001|Overall Study|Unclassified|10|||
146342016|NCT01676116|527758817|FG000|Overall Study|Protocol Violation|9|||
146342017|NCT01676116|527758818|FG001|Overall Study|Protocol Violation|3|||
146342018|NCT01287117|527758819|FG000|Overall Study|Adverse Event|2|||
146342019|NCT01287117|527758820|FG001|Overall Study|Adverse Event|1|||
146342020|NCT01287117|527758821|FG002|Overall Study|Adverse Event|1|||
146342021|NCT01287117|527758822|FG003|Overall Study|Adverse Event|1|||
146342022|NCT01287117|527758819|FG000|Overall Study|Lost to Follow-up|1|||
146342023|NCT01287117|527758820|FG001|Overall Study|Lost to Follow-up|1|||
146342024|NCT01287117|527758821|FG002|Overall Study|Lost to Follow-up|0|||
146342025|NCT01287117|527758822|FG003|Overall Study|Lost to Follow-up|0|||
146342026|NCT01287117|527758819|FG000|Overall Study|Physician Decision|0|||
146342027|NCT01287117|527758820|FG001|Overall Study|Physician Decision|1|||
146342028|NCT01287117|527758821|FG002|Overall Study|Physician Decision|1|||
146342029|NCT01287117|527758822|FG003|Overall Study|Physician Decision|1|||
146342030|NCT01287117|527758819|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
146342031|NCT01287117|527758820|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
146342032|NCT01287117|527758821|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
146342033|NCT01287117|527758822|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
146342034|NCT01287117|527758819|FG000|Overall Study|Disease Progression|10|||
146342035|NCT01287117|527758820|FG001|Overall Study|Disease Progression|5|||
146342036|NCT01287117|527758821|FG002|Overall Study|Disease Progression|6|||
146342037|NCT01287117|527758822|FG003|Overall Study|Disease Progression|5|||
146342038|NCT05635838|527760301|FG000|16-Week DBVC Period|Adverse Event|2|||
146342039|NCT05635838|527760302|FG001|16-Week DBVC Period|Adverse Event|0|||
146342040|NCT05635838|527760303|FG002|16-Week DBVC Period|Adverse Event|0|||
146342041|NCT05635838|527760304|FG003|16-Week DBVC Period|Adverse Event|0|||
146342042|NCT05635838|527760301|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
146342043|NCT05635838|527760302|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
146342044|NCT05635838|527760303|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
146342045|NCT05635838|527760304|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
146342046|NCT05635838|527760301|FG000|16-Week DBVC Period|Physician Decision|0|||
146342047|NCT05635838|527760302|FG001|16-Week DBVC Period|Physician Decision|1|||
146342048|NCT05635838|527760303|FG002|16-Week DBVC Period|Physician Decision|0|||
146342049|NCT05635838|527760304|FG003|16-Week DBVC Period|Physician Decision|0|||
146342050|NCT05635838|527760301|FG000|16-Week DBVC Period|Protocol Violation|1|||
146342051|NCT05635838|527760302|FG001|16-Week DBVC Period|Protocol Violation|0|||
146169202|NCT02798211|527131145|FG001|Period 2|Technical problems|0|||
146169203|NCT02798211|527131146|FG002|Period 2|Technical problems|0|||
146169204|NCT02798211|527131147|FG003|Period 2|Technical problems|1|||
146342052|NCT05635838|527760303|FG002|16-Week DBVC Period|Protocol Violation|0|||
146342053|NCT05635838|527760304|FG003|16-Week DBVC Period|Protocol Violation|0|||
146342054|NCT05635838|527760301|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
146342055|NCT05635838|527760302|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
146342056|NCT05635838|527760303|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
146342057|NCT05635838|527760304|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
146342058|NCT05635838|527760301|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
146342059|NCT05635838|527760302|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146342060|NCT05635838|527760303|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146342061|NCT05635838|527760304|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
146342062|NCT05635838|527760301|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
146169205|NCT02798211|527131148|FG004|Period 2|Technical problems|0|||
146169206|NCT02798211|527131149|FG005|Period 2|Technical problems|0|||
146342063|NCT05635838|527760302|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
146342064|NCT05635838|527760303|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
146342065|NCT05635838|527760304|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
146342066|NCT05635838|527760301|FG000|16-Week OLE Period|Adverse Event|0|||
146342067|NCT05635838|527760302|FG001|16-Week OLE Period|Adverse Event|0|||
146342068|NCT05635838|527760303|FG002|16-Week OLE Period|Adverse Event|0|||
146342069|NCT05635838|527760304|FG003|16-Week OLE Period|Adverse Event|2|||
146342070|NCT05635838|527760301|FG000|16-Week OLE Period|Lost to Follow-up|0|||
146342071|NCT05635838|527760302|FG001|16-Week OLE Period|Lost to Follow-up|0|||
146342072|NCT05635838|527760303|FG002|16-Week OLE Period|Lost to Follow-up|1|||
146342073|NCT05635838|527760304|FG003|16-Week OLE Period|Lost to Follow-up|3|||
146342074|NCT05635838|527760301|FG000|16-Week OLE Period|Physician Decision|0|||
146342075|NCT05635838|527760302|FG001|16-Week OLE Period|Physician Decision|0|||
146342076|NCT05635838|527760303|FG002|16-Week OLE Period|Physician Decision|0|||
146342077|NCT05635838|527760304|FG003|16-Week OLE Period|Physician Decision|1|||
146342078|NCT05635838|527760301|FG000|16-Week OLE Period|Protocol Violation|0|||
146342079|NCT05635838|527760302|FG001|16-Week OLE Period|Protocol Violation|0|||
146342080|NCT05635838|527760303|FG002|16-Week OLE Period|Protocol Violation|1|||
146342081|NCT05635838|527760304|FG003|16-Week OLE Period|Protocol Violation|1|||
146342082|NCT05635838|527760301|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
146342083|NCT05635838|527760302|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
146342084|NCT05635838|527760303|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
146342085|NCT05635838|527760304|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
146342086|NCT05635838|527760301|FG000|16-Week OLE Period|Pregnancy|0|||
146342087|NCT05635838|527760302|FG001|16-Week OLE Period|Pregnancy|0|||
146342088|NCT05635838|527760303|FG002|16-Week OLE Period|Pregnancy|1|||
146342089|NCT05635838|527760304|FG003|16-Week OLE Period|Pregnancy|0|||
146342090|NCT02031146|527760307|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146342091|NCT02031146|527760308|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146342092|NCT02031146|527760309|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
146342093|NCT02031146|527760310|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
146342094|NCT02031146|527760311|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
146342095|NCT02031146|527760312|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
146342096|NCT02031146|527760313|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
146342097|NCT05165394|527760314|FG000|Overall Study|Withdrawal by Subject|5|||
146342098|NCT05165394|527760315|FG001|Overall Study|Withdrawal by Subject|1|||
146342099|NCT05165394|527760314|FG000|Overall Study|Lost to Follow-up|1|||
146342100|NCT05165394|527760315|FG001|Overall Study|Lost to Follow-up|2|||
146342101|NCT05165394|527760314|FG000|Overall Study|Other Than Specified|0|||
146342102|NCT05165394|527760315|FG001|Overall Study|Other Than Specified|1|||
146342103|NCT00001259|527760318|FG000|Study 2|Adverse Event|0|||
146342104|NCT00001259|527760319|FG001|Study 2|Adverse Event|0|||
146342105|NCT00001259|527760320|FG002|Study 2|Adverse Event|0|||
146342106|NCT00001259|527760321|FG003|Study 2|Adverse Event|0|||
146342107|NCT00001259|527760322|FG004|Study 2|Adverse Event|2|||
146342108|NCT00001259|527760323|FG005|Study 2|Adverse Event|0|||
146342109|NCT00001259|527760324|FG006|Study 2|Adverse Event|0|||
146342110|NCT03705494|527760325|FG000|Overall Study|Lost to Follow-up|2|||
146342111|NCT03705494|527760326|FG001|Overall Study|Lost to Follow-up|1|||
146342112|NCT03705494|527760325|FG000|Overall Study|Withdrawal by Subject|5|||
146342113|NCT03705494|527760326|FG001|Overall Study|Withdrawal by Subject|2|||
146342114|NCT01582282|527760327|FG000|Overall Study|Adverse Event|1|||
146342115|NCT01582282|527760328|FG001|Overall Study|Adverse Event|1|||
146342116|NCT01582282|527760329|FG002|Overall Study|Adverse Event|0|||
146342117|NCT01582282|527760327|FG000|Overall Study|Lost to Follow-up|1|||
146342118|NCT01582282|527760328|FG001|Overall Study|Lost to Follow-up|0|||
146342119|NCT01582282|527760329|FG002|Overall Study|Lost to Follow-up|0|||
146342120|NCT01582282|527760327|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
146342121|NCT01582282|527760328|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
146342122|NCT01582282|527760329|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
146342123|NCT02629393|527760331|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
146342124|NCT02629393|527760331|FG000|Overall Study|Physician Decision|1|||
146342125|NCT03937986|527760332|FG000|Overall Study|COVID-19 Pandemic|1|||
146342126|NCT01853228|527760333|FG000|Phase 1|Lack of Efficacy|8|||
146342127|NCT01853228|527760334|FG001|Phase 1|Lack of Efficacy|0|||
146342128|NCT01853228|527760333|FG000|Phase 1|Other|1|||
146342129|NCT01853228|527760334|FG001|Phase 1|Other|0|||
146342130|NCT01853228|527760333|FG000|Phase 2|Physician Decision|0|||
146342131|NCT01853228|527760334|FG001|Phase 2|Physician Decision|1|||
146342132|NCT01853228|527760333|FG000|Phase 2|Proceed To Transplant|0|||
146342133|NCT01853228|527760334|FG001|Phase 2|Proceed To Transplant|3|||
146342134|NCT01853228|527760333|FG000|Phase 2|Lack of Efficacy|0|||
146342135|NCT01853228|527760334|FG001|Phase 2|Lack of Efficacy|4|||
146342136|NCT02839746|527760335|FG000|Overall Study|Not met selection criteria|12|||
146342137|NCT02089737|527760336|FG000|Overall Study|Survey form not completed|5|||
146342138|NCT02089737|527760336|FG000|Overall Study|Not treated|1|||
146342139|NCT01300286|527760337|FG000|Overall Study|did not get dosed|1|||
146342140|NCT02767570|527760338|FG000|Overall Study|Lost to Follow-up|3|||
146342141|NCT02767570|527760339|FG001|Overall Study|Lost to Follow-up|0|||
146342142|NCT02767570|527760338|FG000|Overall Study|COVID shutdown|2|||
146342143|NCT02767570|527760339|FG001|Overall Study|COVID shutdown|5|||
146342144|NCT02767570|527760338|FG000|Overall Study|Increased pain|2|||
146342145|NCT02767570|527760339|FG001|Overall Study|Increased pain|0|||
146342146|NCT02767570|527760338|FG000|Overall Study|Withdrawal by Subject|1|||
146342147|NCT02767570|527760339|FG001|Overall Study|Withdrawal by Subject|3|||
146342148|NCT02767570|527760338|FG000|Overall Study|Unrelated medical issue|1|||
146342149|NCT02767570|527760339|FG001|Overall Study|Unrelated medical issue|1|||
146342150|NCT02767570|527760338|FG000|Overall Study|Received intra-articular injection|0|||
146342151|NCT02767570|527760339|FG001|Overall Study|Received intra-articular injection|1|||
146342152|NCT04426630|527760340|FG000|Overall Study|Death|4|||
146342153|NCT04426630|527760340|FG000|Overall Study|Lost to Follow-up|2|||
146342154|NCT01123889|527760341|FG000|Overall Study|Lost to Follow-up|3|||
146342155|NCT01123889|527760342|FG001|Overall Study|Lost to Follow-up|1|||
146342156|NCT02786537|527760343|FG000|As Randomized|Adverse Event|0|||
146342157|NCT02786537|527760344|FG001|As Randomized|Adverse Event|11|||
146342158|NCT02786537|527760345|FG002|As Randomized|Adverse Event|0|||
146342159|NCT02786537|527760346|FG003|As Randomized|Adverse Event|4|||
146342160|NCT02786537|527760347|FG004|As Randomized|Adverse Event|6|||
146342161|NCT02786537|527760348|FG005|As Randomized|Adverse Event|2|||
146342162|NCT02786537|527760343|FG000|As Randomized|Lack of Efficacy|0|||
146342163|NCT02786537|527760344|FG001|As Randomized|Lack of Efficacy|0|||
146342164|NCT02786537|527760345|FG002|As Randomized|Lack of Efficacy|0|||
146342165|NCT02786537|527760346|FG003|As Randomized|Lack of Efficacy|1|||
146342166|NCT02786537|527760347|FG004|As Randomized|Lack of Efficacy|0|||
146342167|NCT02786537|527760348|FG005|As Randomized|Lack of Efficacy|0|||
146342168|NCT02786537|527760343|FG000|As Randomized|Withdrawal by Subject|1|||
146342169|NCT02786537|527760344|FG001|As Randomized|Withdrawal by Subject|2|||
146342170|NCT02786537|527760345|FG002|As Randomized|Withdrawal by Subject|0|||
146342171|NCT02786537|527760346|FG003|As Randomized|Withdrawal by Subject|1|||
146342172|NCT02786537|527760347|FG004|As Randomized|Withdrawal by Subject|1|||
146342173|NCT02786537|527760348|FG005|As Randomized|Withdrawal by Subject|0|||
146342174|NCT02786537|527760343|FG000|As Randomized|Death|0|||
146342175|NCT02786537|527760344|FG001|As Randomized|Death|2|||
146342176|NCT02786537|527760345|FG002|As Randomized|Death|0|||
146342177|NCT02786537|527760346|FG003|As Randomized|Death|3|||
146342178|NCT02786537|527760347|FG004|As Randomized|Death|1|||
146342179|NCT02786537|527760348|FG005|As Randomized|Death|0|||
146342180|NCT02786537|527760343|FG000|As Randomized|Non-compliance with study drug|1|||
146342181|NCT02786537|527760344|FG001|As Randomized|Non-compliance with study drug|11|||
146342182|NCT02786537|527760345|FG002|As Randomized|Non-compliance with study drug|0|||
146342183|NCT02786537|527760346|FG003|As Randomized|Non-compliance with study drug|1|||
146342184|NCT02786537|527760347|FG004|As Randomized|Non-compliance with study drug|0|||
146342185|NCT02786537|527760348|FG005|As Randomized|Non-compliance with study drug|1|||
146342186|NCT02786537|527760343|FG000|As Randomized|Lost to treatment follow-up|4|||
146342187|NCT02786537|527760344|FG001|As Randomized|Lost to treatment follow-up|32|||
146342188|NCT02786537|527760345|FG002|As Randomized|Lost to treatment follow-up|0|||
146342189|NCT02786537|527760346|FG003|As Randomized|Lost to treatment follow-up|24|||
146342190|NCT02786537|527760347|FG004|As Randomized|Lost to treatment follow-up|4|||
146342191|NCT02786537|527760348|FG005|As Randomized|Lost to treatment follow-up|4|||
146342192|NCT02786537|527760343|FG000|As Randomized|Incarceration|0|||
146342193|NCT02786537|527760344|FG001|As Randomized|Incarceration|1|||
146342194|NCT02786537|527760345|FG002|As Randomized|Incarceration|0|||
146342195|NCT02786537|527760346|FG003|As Randomized|Incarceration|0|||
146342196|NCT02786537|527760347|FG004|As Randomized|Incarceration|0|||
146342197|NCT02786537|527760348|FG005|As Randomized|Incarceration|0|||
146342198|NCT02786537|527760343|FG000|As Randomized|Opiate Dependency Relapse|0|||
146342199|NCT02786537|527760344|FG001|As Randomized|Opiate Dependency Relapse|1|||
146342200|NCT02786537|527760345|FG002|As Randomized|Opiate Dependency Relapse|0|||
146342201|NCT02786537|527760346|FG003|As Randomized|Opiate Dependency Relapse|0|||
146342202|NCT02786537|527760347|FG004|As Randomized|Opiate Dependency Relapse|0|||
146342203|NCT02786537|527760348|FG005|As Randomized|Opiate Dependency Relapse|0|||
146342204|NCT02786537|527760343|FG000|As Randomized|HCV drugs stolen from pt|0|||
146342205|NCT02786537|527760344|FG001|As Randomized|HCV drugs stolen from pt|1|||
146342206|NCT02786537|527760345|FG002|As Randomized|HCV drugs stolen from pt|0|||
146342207|NCT02786537|527760346|FG003|As Randomized|HCV drugs stolen from pt|0|||
146342208|NCT02786537|527760347|FG004|As Randomized|HCV drugs stolen from pt|0|||
146342209|NCT02786537|527760348|FG005|As Randomized|HCV drugs stolen from pt|0|||
146342210|NCT02786537|527760343|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
146342211|NCT02786537|527760344|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
146342212|NCT02786537|527760345|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
146342213|NCT02786537|527760346|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
146342214|NCT02786537|527760347|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
146342215|NCT02786537|527760348|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
146342216|NCT02786537|527760343|FG000|As Randomized|Subject lost insurance|0|||
146342217|NCT02786537|527760344|FG001|As Randomized|Subject lost insurance|0|||
146342218|NCT02786537|527760345|FG002|As Randomized|Subject lost insurance|0|||
146342219|NCT02786537|527760346|FG003|As Randomized|Subject lost insurance|1|||
146342220|NCT02786537|527760347|FG004|As Randomized|Subject lost insurance|0|||
146342221|NCT02786537|527760348|FG005|As Randomized|Subject lost insurance|0|||
146342222|NCT02786537|527760343|FG000|As Treated|Adverse Event|0|||
146342223|NCT02786537|527760344|FG001|As Treated|Adverse Event|11|||
146342224|NCT02786537|527760345|FG002|As Treated|Adverse Event|0|||
146342225|NCT02786537|527760346|FG003|As Treated|Adverse Event|4|||
146342226|NCT02786537|527760347|FG004|As Treated|Adverse Event|6|||
146342227|NCT02786537|527760348|FG005|As Treated|Adverse Event|2|||
146342228|NCT02786537|527760343|FG000|As Treated|Death|0|||
146342229|NCT02786537|527760344|FG001|As Treated|Death|2|||
146342230|NCT02786537|527760345|FG002|As Treated|Death|0|||
146342231|NCT02786537|527760346|FG003|As Treated|Death|3|||
146342232|NCT02786537|527760347|FG004|As Treated|Death|1|||
146342233|NCT02786537|527760348|FG005|As Treated|Death|0|||
146342234|NCT02786537|527760343|FG000|As Treated|Lack of Efficacy|0|||
146342235|NCT02786537|527760344|FG001|As Treated|Lack of Efficacy|0|||
146342236|NCT02786537|527760345|FG002|As Treated|Lack of Efficacy|0|||
146342237|NCT02786537|527760346|FG003|As Treated|Lack of Efficacy|1|||
146342238|NCT02786537|527760347|FG004|As Treated|Lack of Efficacy|0|||
146342239|NCT02786537|527760348|FG005|As Treated|Lack of Efficacy|0|||
146342240|NCT02786537|527760343|FG000|As Treated|Lost to Follow-up|4|||
146342241|NCT02786537|527760344|FG001|As Treated|Lost to Follow-up|32|||
146342242|NCT02786537|527760345|FG002|As Treated|Lost to Follow-up|0|||
146342243|NCT02786537|527760346|FG003|As Treated|Lost to Follow-up|25|||
146342244|NCT02786537|527760347|FG004|As Treated|Lost to Follow-up|4|||
146342245|NCT02786537|527760348|FG005|As Treated|Lost to Follow-up|4|||
146342246|NCT02786537|527760343|FG000|As Treated|Non-compliance with study drug|1|||
146342247|NCT02786537|527760344|FG001|As Treated|Non-compliance with study drug|11|||
146342248|NCT02786537|527760345|FG002|As Treated|Non-compliance with study drug|0|||
146342249|NCT02786537|527760346|FG003|As Treated|Non-compliance with study drug|1|||
146342250|NCT02786537|527760347|FG004|As Treated|Non-compliance with study drug|0|||
146342251|NCT02786537|527760348|FG005|As Treated|Non-compliance with study drug|1|||
146342252|NCT02786537|527760343|FG000|As Treated|Lost insurance|0|||
146342253|NCT02786537|527760344|FG001|As Treated|Lost insurance|0|||
146342254|NCT02786537|527760345|FG002|As Treated|Lost insurance|0|||
146342255|NCT02786537|527760346|FG003|As Treated|Lost insurance|1|||
146342256|NCT02786537|527760347|FG004|As Treated|Lost insurance|0|||
146342257|NCT02786537|527760348|FG005|As Treated|Lost insurance|0|||
146342258|NCT02786537|527760343|FG000|As Treated|Withdrawal by Subject|1|||
146342259|NCT02786537|527760344|FG001|As Treated|Withdrawal by Subject|2|||
146342260|NCT02786537|527760345|FG002|As Treated|Withdrawal by Subject|0|||
146169207|NCT02798211|527131144|FG000|Period 2|Withdrawal of Informed Consent|1|||
146169208|NCT02798211|527131145|FG001|Period 2|Withdrawal of Informed Consent|0|||
146169209|NCT02798211|527131146|FG002|Period 2|Withdrawal of Informed Consent|0|||
146169210|NCT02798211|527131147|FG003|Period 2|Withdrawal of Informed Consent|2|||
146169211|NCT02798211|527131148|FG004|Period 2|Withdrawal of Informed Consent|2|||
146169212|NCT02798211|527131149|FG005|Period 2|Withdrawal of Informed Consent|3|||
146169213|NCT01498822|527131151|FG000|Overall Study|Protocol Violation|8|||
146169214|NCT01498822|527131152|FG001|Overall Study|Protocol Violation|4|||
146169215|NCT01498822|527131151|FG000|Overall Study|Other Reason|5|||
146169216|NCT01498822|527131152|FG001|Overall Study|Other Reason|2|||
146169217|NCT01498822|527131151|FG000|Overall Study|Lack of Efficacy|7|||
146169218|NCT01498822|527131152|FG001|Overall Study|Lack of Efficacy|2|||
146169219|NCT01498822|527131151|FG000|Overall Study|AE, non-serious non-fatal|8|||
146169220|NCT01498822|527131152|FG001|Overall Study|AE, non-serious non-fatal|17|||
146169221|NCT01498822|527131151|FG000|Overall Study|SAE, non-fatal|2|||
146169222|NCT01498822|527131152|FG001|Overall Study|SAE, non-fatal|2|||
146169223|NCT01498822|527131151|FG000|Overall Study|Adverse Event, serious fatal|1|||
146169224|NCT01498822|527131152|FG001|Overall Study|Adverse Event, serious fatal|1|||
146169225|NCT01498822|527131151|FG000|Overall Study|Withdrawal by Subject|15|||
146169226|NCT01498822|527131152|FG001|Overall Study|Withdrawal by Subject|25|||
146169227|NCT01498822|527131151|FG000|Overall Study|Lost to Follow-up|8|||
146169228|NCT01498822|527131152|FG001|Overall Study|Lost to Follow-up|3|||
146169229|NCT01862796|527131153|FG000|Overall Study|Prohibited medications|0|||
146169230|NCT01862796|527131154|FG001|Overall Study|Prohibited medications|0|||
146169231|NCT01862796|527131155|FG002|Overall Study|Prohibited medications|1|||
146169232|NCT01375205|527131156|FG000|Overall Study|Lost to Follow-up|15|||
146169233|NCT01375205|527131157|FG001|Overall Study|Lost to Follow-up|12|||
146169234|NCT01375205|527131156|FG000|Overall Study|Withdrawal by Subject|6|||
146169235|NCT01375205|527131157|FG001|Overall Study|Withdrawal by Subject|1|||
146169236|NCT01148862|527131158|FG000|Second Intervention|Withdrawal by Subject|0|||
146342261|NCT02786537|527760346|FG003|As Treated|Withdrawal by Subject|0|||
146342262|NCT02786537|527760347|FG004|As Treated|Withdrawal by Subject|1|||
146342263|NCT02786537|527760348|FG005|As Treated|Withdrawal by Subject|0|||
146342264|NCT02786537|527760343|FG000|As Treated|Incarceration|0|||
146342265|NCT02786537|527760344|FG001|As Treated|Incarceration|1|||
146342266|NCT02786537|527760345|FG002|As Treated|Incarceration|0|||
146342267|NCT02786537|527760346|FG003|As Treated|Incarceration|0|||
146342268|NCT02786537|527760347|FG004|As Treated|Incarceration|0|||
146342269|NCT02786537|527760348|FG005|As Treated|Incarceration|0|||
146342270|NCT02786537|527760343|FG000|As Treated|Opiate dependency relapse|0|||
146342271|NCT02786537|527760344|FG001|As Treated|Opiate dependency relapse|1|||
146342272|NCT02786537|527760345|FG002|As Treated|Opiate dependency relapse|0|||
146342273|NCT02786537|527760346|FG003|As Treated|Opiate dependency relapse|0|||
146342274|NCT02786537|527760347|FG004|As Treated|Opiate dependency relapse|0|||
146342275|NCT02786537|527760348|FG005|As Treated|Opiate dependency relapse|0|||
146342276|NCT02786537|527760343|FG000|As Treated|Drugs stolen from patient|0|||
146342277|NCT02786537|527760344|FG001|As Treated|Drugs stolen from patient|1|||
146342278|NCT02786537|527760345|FG002|As Treated|Drugs stolen from patient|0|||
146342279|NCT02786537|527760346|FG003|As Treated|Drugs stolen from patient|0|||
146342280|NCT02786537|527760347|FG004|As Treated|Drugs stolen from patient|0|||
146342281|NCT02786537|527760348|FG005|As Treated|Drugs stolen from patient|0|||
146342282|NCT02786537|527760343|FG000|As Treated|Advised to stop tx after loss of meds|0|||
146342283|NCT02786537|527760344|FG001|As Treated|Advised to stop tx after loss of meds|1|||
146342284|NCT02786537|527760345|FG002|As Treated|Advised to stop tx after loss of meds|0|||
146342285|NCT02786537|527760346|FG003|As Treated|Advised to stop tx after loss of meds|0|||
146342286|NCT02786537|527760347|FG004|As Treated|Advised to stop tx after loss of meds|0|||
146342287|NCT02786537|527760348|FG005|As Treated|Advised to stop tx after loss of meds|0|||
146342288|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
146342289|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
146342290|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
146342291|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
146342292|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
146342293|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
146342294|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146342295|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
146342296|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
146342297|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
146342298|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
146342299|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
146342300|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
146342301|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
146342302|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
146342303|NCT01330381|527760349|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146342304|NCT01330381|527760350|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
146342305|NCT01330381|527760351|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
146342306|NCT01330381|527760349|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
146342307|NCT01330381|527760350|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
146342308|NCT01330381|527760351|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
146342309|NCT01330381|527760349|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
146342310|NCT01330381|527760350|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
146342311|NCT01330381|527760351|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
146342312|NCT01330381|527760349|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
146342313|NCT01330381|527760350|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
146342314|NCT01330381|527760351|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
146342315|NCT01330381|527760349|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
146342316|NCT01330381|527760350|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
146342317|NCT01330381|527760351|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
146342318|NCT01272180|527760352|FG000|Overall Study|Adverse Event|0|||
146342319|NCT01272180|527760353|FG001|Overall Study|Adverse Event|0|||
146342320|NCT01272180|527760354|FG002|Overall Study|Adverse Event|1|||
146342321|NCT01272180|527760355|FG003|Overall Study|Adverse Event|0|||
146342322|NCT01272180|527760352|FG000|Overall Study|Withdrawal by Subject|2|||
146342323|NCT01272180|527760353|FG001|Overall Study|Withdrawal by Subject|6|||
146342324|NCT01272180|527760354|FG002|Overall Study|Withdrawal by Subject|3|||
146342325|NCT01272180|527760355|FG003|Overall Study|Withdrawal by Subject|2|||
146342326|NCT01272180|527760352|FG000|Overall Study|Lost to Follow-up|15|||
146342327|NCT01272180|527760353|FG001|Overall Study|Lost to Follow-up|14|||
146342328|NCT01272180|527760354|FG002|Overall Study|Lost to Follow-up|8|||
146342329|NCT01272180|527760355|FG003|Overall Study|Lost to Follow-up|10|||
146342330|NCT01272180|527760352|FG000|Overall Study|Inappropriate enrollment|0|||
146342331|NCT01272180|527760353|FG001|Overall Study|Inappropriate enrollment|0|||
146342332|NCT01272180|527760354|FG002|Overall Study|Inappropriate enrollment|1|||
146342333|NCT01272180|527760355|FG003|Overall Study|Inappropriate enrollment|1|||
146342334|NCT01272180|527760352|FG000|Overall Study|Protocol Violation|0|||
146342335|NCT01272180|527760353|FG001|Overall Study|Protocol Violation|1|||
146342336|NCT01272180|527760354|FG002|Overall Study|Protocol Violation|0|||
146342337|NCT01272180|527760355|FG003|Overall Study|Protocol Violation|1|||
146342338|NCT00637728|527760360|FG000|Double-blind Phase|Adverse Event|1|||
146342339|NCT00637728|527760361|FG001|Double-blind Phase|Adverse Event|0|||
146342340|NCT00637728|527760362|FG002|Double-blind Phase|Adverse Event|0|||
146342341|NCT00637728|527760360|FG000|Double-blind Phase|Non-compliance|2|||
146342342|NCT00637728|527760361|FG001|Double-blind Phase|Non-compliance|0|||
146342343|NCT00637728|527760362|FG002|Double-blind Phase|Non-compliance|0|||
146342344|NCT00637728|527760360|FG000|Double-blind Phase|Study Discontinued|1|||
146342345|NCT00637728|527760361|FG001|Double-blind Phase|Study Discontinued|1|||
146342346|NCT00637728|527760362|FG002|Double-blind Phase|Study Discontinued|0|||
146342347|NCT01050062|527760363|FG000|Overall Study|Adverse Event|75|||
146342348|NCT01050062|527760364|FG001|Overall Study|Adverse Event|22|||
146342349|NCT01050062|527760363|FG000|Overall Study|Lost to Follow-up|83|||
146342350|NCT01050062|527760364|FG001|Overall Study|Lost to Follow-up|35|||
146342351|NCT01050062|527760363|FG000|Overall Study|Lack of Efficacy|22|||
146342352|NCT01050062|527760364|FG001|Overall Study|Lack of Efficacy|35|||
146342353|NCT01050062|527760363|FG000|Overall Study|Physician Decision|74|||
146342354|NCT01050062|527760364|FG001|Overall Study|Physician Decision|9|||
146342355|NCT01050062|527760363|FG000|Overall Study|Others|17|||
146342356|NCT01050062|527760364|FG001|Overall Study|Others|11|||
146342357|NCT01873950|527760367|FG000|Period 5|Withdrawal by Subject|0|||
146342358|NCT01873950|527760368|FG001|Period 5|Withdrawal by Subject|0|||
146342359|NCT01873950|527760369|FG002|Period 5|Withdrawal by Subject|0|||
146342360|NCT01873950|527760370|FG003|Period 5|Withdrawal by Subject|1|||
146342361|NCT01873950|527760371|FG004|Period 5|Withdrawal by Subject|0|||
146342362|NCT03894540|527760372|FG000|Overall Study|Adverse Event|0|||
146342363|NCT03894540|527760373|FG001|Overall Study|Adverse Event|0|||
146342364|NCT03894540|527760374|FG002|Overall Study|Adverse Event|0|||
146342365|NCT03894540|527760375|FG003|Overall Study|Adverse Event|0|||
146342366|NCT03894540|527760376|FG004|Overall Study|Adverse Event|1|||
146342367|NCT03894540|527760377|FG005|Overall Study|Adverse Event|0|||
146342368|NCT03894540|527760372|FG000|Overall Study|Withdrawal by Subject|0|||
146342369|NCT03894540|527760373|FG001|Overall Study|Withdrawal by Subject|0|||
146342370|NCT03894540|527760374|FG002|Overall Study|Withdrawal by Subject|0|||
146342371|NCT03894540|527760375|FG003|Overall Study|Withdrawal by Subject|0|||
146342372|NCT03894540|527760376|FG004|Overall Study|Withdrawal by Subject|1|||
146342373|NCT03894540|527760377|FG005|Overall Study|Withdrawal by Subject|0|||
146342374|NCT03894540|527760372|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
146342375|NCT03894540|527760373|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
146342376|NCT03894540|527760374|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
146342377|NCT03894540|527760375|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
146342378|NCT03894540|527760376|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
146342379|NCT03894540|527760377|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
146342380|NCT03894540|527760372|FG000|Overall Study|Progressive Disease Clinical|1|||
146342381|NCT03894540|527760373|FG001|Overall Study|Progressive Disease Clinical|1|||
146342382|NCT03894540|527760374|FG002|Overall Study|Progressive Disease Clinical|0|||
146342383|NCT03894540|527760375|FG003|Overall Study|Progressive Disease Clinical|1|||
146342384|NCT03894540|527760376|FG004|Overall Study|Progressive Disease Clinical|5|||
146342385|NCT03894540|527760377|FG005|Overall Study|Progressive Disease Clinical|1|||
146342386|NCT03894540|527760372|FG000|Overall Study|Study termination by sponsor|0|||
146342387|NCT03894540|527760373|FG001|Overall Study|Study termination by sponsor|0|||
146342388|NCT03894540|527760374|FG002|Overall Study|Study termination by sponsor|0|||
146342389|NCT03894540|527760375|FG003|Overall Study|Study termination by sponsor|0|||
146342390|NCT03894540|527760376|FG004|Overall Study|Study termination by sponsor|2|||
146342391|NCT03894540|527760377|FG005|Overall Study|Study termination by sponsor|0|||
146342392|NCT00593112|527760378|FG000|Overall Study|Scan Anxiety|3|||
146342393|NCT00593112|527760379|FG001|Overall Study|Scan Anxiety|0|||
146342394|NCT00593112|527760378|FG000|Overall Study|Abnormal Scan|1|||
146342395|NCT00593112|527760379|FG001|Overall Study|Abnormal Scan|0|||
146342396|NCT00593112|527760378|FG000|Overall Study|Unreadable Scan|1|||
146342397|NCT00593112|527760379|FG001|Overall Study|Unreadable Scan|0|||
146342398|NCT00593112|527760378|FG000|Overall Study|Withdrawal by Subject|5|||
146342399|NCT00593112|527760379|FG001|Overall Study|Withdrawal by Subject|0|||
146342400|NCT03455543|527760380|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
146342401|NCT03455543|527760381|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
146342402|NCT03455543|527760382|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
146342403|NCT03455543|527760380|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
146342404|NCT03455543|527760381|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
146342405|NCT03455543|527760382|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
146342406|NCT03455543|527760380|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
146342407|NCT03455543|527760381|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
146342408|NCT03455543|527760382|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
146342409|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
146342410|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
146395695|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Death|11|||
146342411|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
146342412|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
146342413|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
146342414|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
146342415|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
146342416|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
146342417|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
146342418|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
146342419|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
146342420|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
146342421|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
146342422|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
146342423|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
146342424|NCT03455543|527760380|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
146342425|NCT03455543|527760381|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
146342426|NCT03455543|527760382|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
146342427|NCT01221233|527760385|FG000|Overall Study|Withdrawal by Subject|3|||
146342428|NCT01221233|527760386|FG001|Overall Study|Withdrawal by Subject|1|||
146342429|NCT00546819|527760387|FG000|Overall Study|Adverse Event|2|||
146342430|NCT00546819|527760388|FG001|Overall Study|Adverse Event|3|||
146342431|NCT00546819|527760387|FG000|Overall Study|Lost to Follow-up|2|||
146342432|NCT00546819|527760388|FG001|Overall Study|Lost to Follow-up|1|||
146342433|NCT00546819|527760387|FG000|Overall Study|Withdrawal by Subject|4|||
146342434|NCT00546819|527760388|FG001|Overall Study|Withdrawal by Subject|2|||
146342435|NCT02111811|527760393|FG000|Treatment Phase|Lost to Follow-up|22|||
146342436|NCT02111811|527760394|FG001|Treatment Phase|Lost to Follow-up|18|||
146342437|NCT02111811|527760393|FG000|Treatment Phase|Death|2|||
146342438|NCT02111811|527760394|FG001|Treatment Phase|Death|0|||
146342439|NCT02111811|527760393|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
146342440|NCT02111811|527760394|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
146342441|NCT02111811|527760393|FG000|Follow up Period (Aim 2)|Death|2|||
146342442|NCT02111811|527760394|FG001|Follow up Period (Aim 2)|Death|0|||
146342443|NCT01359982|527760397|FG000|Overall Study|Adverse Event|2|||
146342444|NCT01359982|527760398|FG001|Overall Study|Adverse Event|0|||
146342445|NCT01359982|527760399|FG002|Overall Study|Adverse Event|0|||
146342446|NCT01359982|527760400|FG003|Overall Study|Adverse Event|1|||
146342447|NCT01359982|527760401|FG004|Overall Study|Adverse Event|0|||
146342448|NCT01359982|527760402|FG005|Overall Study|Adverse Event|0|||
146342449|NCT01359982|527760397|FG000|Overall Study|Death|1|||
146342450|NCT01359982|527760398|FG001|Overall Study|Death|0|||
146342451|NCT01359982|527760399|FG002|Overall Study|Death|0|||
146342452|NCT01359982|527760400|FG003|Overall Study|Death|0|||
146342453|NCT01359982|527760401|FG004|Overall Study|Death|0|||
146342454|NCT01359982|527760402|FG005|Overall Study|Death|0|||
146342455|NCT00196937|527760404|FG000|Overall Study|Serious Adverse Event|1|||
146342456|NCT00196937|527760405|FG001|Overall Study|Serious Adverse Event|0|||
146342457|NCT00196937|527760406|FG002|Overall Study|Serious Adverse Event|0|||
146342458|NCT00196937|527760404|FG000|Overall Study|Non-serious adverse event|1|||
146342459|NCT00196937|527760405|FG001|Overall Study|Non-serious adverse event|1|||
146342460|NCT00196937|527760406|FG002|Overall Study|Non-serious adverse event|1|||
146342461|NCT00196937|527760404|FG000|Overall Study|Withdrawal by Subject|0|||
146342462|NCT00196937|527760405|FG001|Overall Study|Withdrawal by Subject|0|||
146342463|NCT00196937|527760406|FG002|Overall Study|Withdrawal by Subject|2|||
146342464|NCT00196937|527760404|FG000|Overall Study|Lost to Follow-up|4|||
146342465|NCT00196937|527760405|FG001|Overall Study|Lost to Follow-up|3|||
146342466|NCT00196937|527760406|FG002|Overall Study|Lost to Follow-up|3|||
146342467|NCT00196937|527760404|FG000|Overall Study|Other|3|||
146342468|NCT00196937|527760405|FG001|Overall Study|Other|1|||
146342469|NCT00196937|527760406|FG002|Overall Study|Other|1|||
146342470|NCT03368404|527760412|FG000|Overall Study|Adverse Event|2|||
146342471|NCT03368404|527760413|FG001|Overall Study|Adverse Event|1|||
146342472|NCT03368404|527760412|FG000|Overall Study|Withdrawal by Subject|1|||
146342473|NCT03368404|527760413|FG001|Overall Study|Withdrawal by Subject|1|||
146342474|NCT02983292|527760414|FG000|Overall Study|Participant unwell & cannot travel|2|||
146342475|NCT02983292|527760414|FG000|Overall Study|Lost to Follow-up|3|||
146342476|NCT02983292|527760414|FG000|Overall Study|Participant withdrew consent|2|||
146342477|NCT02983292|527760414|FG000|Overall Study|Revision|7|||
146342478|NCT02983292|527760414|FG000|Overall Study|Death|1|||
146342479|NCT02983292|527760414|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
146342480|NCT02983292|527760414|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
146342481|NCT02983292|527760414|FG000|Overall Study|Participant relocation|1|||
146342482|NCT02190591|527760415|FG000|Overall Study|Withdrawal by Subject|1|||
146342483|NCT02190591|527760416|FG001|Overall Study|Withdrawal by Subject|8|||
146342484|NCT02190591|527760415|FG000|Overall Study|Protocol Violation|1|||
146342485|NCT02190591|527760416|FG001|Overall Study|Protocol Violation|0|||
146342486|NCT02190591|527760415|FG000|Overall Study|did not use peanut ball as instructed|0|||
146342487|NCT02190591|527760416|FG001|Overall Study|did not use peanut ball as instructed|2|||
146342488|NCT02190591|527760415|FG000|Overall Study|face presentation so she was ineligible|0|||
146342489|NCT02190591|527760416|FG001|Overall Study|face presentation so she was ineligible|1|||
146342490|NCT00072189|527760417|FG000|Overall Study|Withdrawal by Subject|1|||
146342491|NCT02973815|527760418|FG000|Post Intervention|Death|1|||
146342492|NCT02973815|527760419|FG001|Post Intervention|Death|0|||
146342493|NCT02973815|527760418|FG000|Post Intervention|Lost to Follow-up|7|||
146342494|NCT02973815|527760419|FG001|Post Intervention|Lost to Follow-up|24|||
146342495|NCT02973815|527760418|FG000|Follow-up|Lost to Follow-up|2|||
146342496|NCT02973815|527760419|FG001|Follow-up|Lost to Follow-up|0|||
146342497|NCT04542291|527760420|FG000|Overall Study|Adverse Event|1|||
146342498|NCT04542291|527760420|FG000|Overall Study|Physician Decision|2|||
146342499|NCT04579393|527760426|FG000|Overall Study|Withdrawal by Subject|2|||
146342500|NCT04579393|527760427|FG001|Overall Study|Withdrawal by Subject|2|||
146342501|NCT04579393|527760426|FG000|Overall Study|Death|1|||
146342502|NCT04579393|527760427|FG001|Overall Study|Death|3|||
146342503|NCT01739595|527760429|FG000|Overall Study|Adverse Event|3|||
146342504|NCT01739595|527760430|FG001|Overall Study|Adverse Event|0|||
146342505|NCT01739595|527760431|FG002|Overall Study|Adverse Event|0|||
146342506|NCT01739595|527760429|FG000|Overall Study|Lost to Follow-up|2|||
146342507|NCT01739595|527760430|FG001|Overall Study|Lost to Follow-up|0|||
146342508|NCT01739595|527760431|FG002|Overall Study|Lost to Follow-up|0|||
146342509|NCT01739595|527760429|FG000|Overall Study|Withdrawal by Subject|2|||
146342510|NCT01739595|527760430|FG001|Overall Study|Withdrawal by Subject|1|||
146342511|NCT01739595|527760431|FG002|Overall Study|Withdrawal by Subject|2|||
146342512|NCT01739595|527760429|FG000|Overall Study|Eligibility issue|3|||
146342513|NCT01739595|527760430|FG001|Overall Study|Eligibility issue|0|||
146342514|NCT01739595|527760431|FG002|Overall Study|Eligibility issue|0|||
146342515|NCT01739595|527760429|FG000|Overall Study|Protocol Violation|1|||
146342516|NCT01739595|527760430|FG001|Overall Study|Protocol Violation|0|||
146342517|NCT01739595|527760431|FG002|Overall Study|Protocol Violation|0|||
146342518|NCT01739595|527760429|FG000|Overall Study|Lab assessment|1|||
146342519|NCT01739595|527760430|FG001|Overall Study|Lab assessment|0|||
146342520|NCT01739595|527760431|FG002|Overall Study|Lab assessment|0|||
146342521|NCT01739595|527760429|FG000|Overall Study|Drug discrepancy|1|||
146342522|NCT01739595|527760430|FG001|Overall Study|Drug discrepancy|0|||
146342523|NCT01739595|527760431|FG002|Overall Study|Drug discrepancy|0|||
146342524|NCT01524289|527760432|FG000|Overall Study|Lost to Follow-up|0|||
146342525|NCT01524289|527760433|FG001|Overall Study|Lost to Follow-up|1|||
146342526|NCT01524289|527760432|FG000|Overall Study|Physician Decision|1|||
146342527|NCT01524289|527760433|FG001|Overall Study|Physician Decision|0|||
146342528|NCT01524289|527760432|FG000|Overall Study|Protocol Violation|5|||
146342529|NCT01524289|527760433|FG001|Overall Study|Protocol Violation|1|||
146342530|NCT01524289|527760432|FG000|Overall Study|Withdrawal by Subject|11|||
146342531|NCT01524289|527760433|FG001|Overall Study|Withdrawal by Subject|7|||
146342532|NCT01524289|527760432|FG000|Overall Study|Adverse Event|12|||
146342533|NCT01524289|527760433|FG001|Overall Study|Adverse Event|5|||
146342534|NCT01524289|527760432|FG000|Overall Study|Did not take study medication|1|||
146342535|NCT01524289|527760433|FG001|Overall Study|Did not take study medication|0|||
146342536|NCT02104180|527760434|FG000|Overall Study|Protocol Violation|1|||
146342537|NCT02104180|527760435|FG001|Overall Study|Protocol Violation|0|||
146342538|NCT02704429|527760438|FG000|Part A: 24 Weeks|Adverse Event|3|||
146342539|NCT02704429|527760439|FG001|Part A: 24 Weeks|Adverse Event|0|||
146342540|NCT02704429|527760438|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
146342541|NCT02704429|527760439|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
146342542|NCT00104104|527760440|FG000|Overall Study|Adverse Event|8|||
146342543|NCT00104104|527760441|FG001|Overall Study|Adverse Event|8|||
146342544|NCT00104104|527760440|FG000|Overall Study|Abnormal laboratory value(s)|20|||
146342545|NCT00104104|527760441|FG001|Overall Study|Abnormal laboratory value(s)|14|||
146342546|NCT00104104|527760440|FG000|Overall Study|Lack of Efficacy|0|||
146342547|NCT00104104|527760441|FG001|Overall Study|Lack of Efficacy|3|||
146342548|NCT00104104|527760440|FG000|Overall Study|Condition no longer requires study drug|7|||
146342549|NCT00104104|527760441|FG001|Overall Study|Condition no longer requires study drug|4|||
146342550|NCT00104104|527760440|FG000|Overall Study|Protocol Violation|5|||
146342551|NCT00104104|527760441|FG001|Overall Study|Protocol Violation|2|||
146342552|NCT00104104|527760440|FG000|Overall Study|Withdrawal by Subject|11|||
146342553|NCT00104104|527760441|FG001|Overall Study|Withdrawal by Subject|15|||
146342554|NCT00104104|527760440|FG000|Overall Study|Lost to Follow-up|3|||
146342555|NCT00104104|527760441|FG001|Overall Study|Lost to Follow-up|7|||
146342556|NCT00104104|527760440|FG000|Overall Study|Administrative problems|12|||
146342557|NCT00104104|527760441|FG001|Overall Study|Administrative problems|13|||
146342558|NCT00104104|527760440|FG000|Overall Study|Death|9|||
146342559|NCT00104104|527760441|FG001|Overall Study|Death|6|||
146342560|NCT01821677|527760447|FG000|Overall Study|Adverse Event|4|||
146342561|NCT01821677|527760448|FG001|Overall Study|Adverse Event|6|||
146342562|NCT01821677|527760449|FG002|Overall Study|Adverse Event|5|||
146342563|NCT01821677|527760447|FG000|Overall Study|Physician Decision|1|||
146342564|NCT01821677|527760448|FG001|Overall Study|Physician Decision|4|||
146342565|NCT01821677|527760449|FG002|Overall Study|Physician Decision|1|||
146342566|NCT01821677|527760447|FG000|Overall Study|Non-compliance|0|||
146342567|NCT01821677|527760448|FG001|Overall Study|Non-compliance|1|||
146342568|NCT01821677|527760449|FG002|Overall Study|Non-compliance|2|||
146342569|NCT01821677|527760447|FG000|Overall Study|Lost to Follow-up|2|||
146342570|NCT01821677|527760448|FG001|Overall Study|Lost to Follow-up|1|||
146342571|NCT01821677|527760449|FG002|Overall Study|Lost to Follow-up|3|||
146342572|NCT01821677|527760447|FG000|Overall Study|Protocol Violation|0|||
146342573|NCT01821677|527760448|FG001|Overall Study|Protocol Violation|0|||
146342574|NCT01821677|527760449|FG002|Overall Study|Protocol Violation|2|||
146342575|NCT01821677|527760447|FG000|Overall Study|Withdrawal by Subject|7|||
146342576|NCT01821677|527760448|FG001|Overall Study|Withdrawal by Subject|3|||
146342577|NCT01821677|527760449|FG002|Overall Study|Withdrawal by Subject|2|||
146342578|NCT01821677|527760447|FG000|Overall Study|Other|9|||
146342579|NCT01821677|527760448|FG001|Overall Study|Other|0|||
146342580|NCT01821677|527760449|FG002|Overall Study|Other|0|||
146342581|NCT02209597|527760458|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
146342582|NCT02209597|527760458|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
146342583|NCT02209597|527760458|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
146342584|NCT02209597|527760458|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
146342585|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Adverse Event|37|||
146342586|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Adverse Event|0|||
146342587|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Adverse Event|0|||
146342588|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Adverse Event|0|||
146342589|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Death|2|||
146342590|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Death|0|||
146342591|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Death|0|||
146342592|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Death|0|||
146342593|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
146342594|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
146342595|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
146342596|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
146342597|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
146342598|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
146342599|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
146342600|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
146342601|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
146342602|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
146342603|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
146342604|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
146342605|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
146342606|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146342607|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146342608|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
146342609|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Physician Decision|4|||
146342610|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Physician Decision|0|||
146169237|NCT01148862|527131159|FG001|Second Intervention|Withdrawal by Subject|2|||
146169238|NCT03815019|527131160|FG000|Overall Study|Withdrawal by Subject|6|||
146169239|NCT03815019|527131161|FG001|Overall Study|Withdrawal by Subject|8|||
146169240|NCT05398796|527131162|FG000|Overall Study|Participant moved from the area|0|||
146169241|NCT05398796|527131163|FG001|Overall Study|Participant moved from the area|1|||
146169242|NCT05398796|527131164|FG002|Overall Study|Participant moved from the area|0|||
146169243|NCT05398796|527131165|FG003|Overall Study|Participant moved from the area|0|||
146169244|NCT04270747|527131167|FG000|Through Week 16|Adverse Event|1|||
146169245|NCT04270747|527131168|FG001|Through Week 16|Adverse Event|2|||
146169246|NCT04270747|527131169|FG002|Through Week 16|Adverse Event|0|||
146169247|NCT04270747|527131167|FG000|Through Week 16|Death|0|||
146169248|NCT04270747|527131168|FG001|Through Week 16|Death|2|||
146342611|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Physician Decision|0|||
146342612|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Physician Decision|0|||
146342613|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Pregnancy|1|||
146342614|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Pregnancy|0|||
146342615|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Pregnancy|0|||
146342616|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Pregnancy|0|||
146342617|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
146169249|NCT04270747|527131169|FG002|Through Week 16|Death|0|||
146169250|NCT04270747|527131167|FG000|Through Week 16|Consent Withdrawn|3|||
146169251|NCT04270747|527131168|FG001|Through Week 16|Consent Withdrawn|3|||
146169252|NCT04270747|527131169|FG002|Through Week 16|Consent Withdrawn|0|||
146169253|NCT04270747|527131167|FG000|Through Week 16|Physician Decision|1|||
146342618|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
146342619|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
146342620|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
146342621|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
146342622|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
146342623|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
146342624|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
146342625|NCT01855789|527760460|FG000|1) Baseline up to Week 24|Other|4|||
146342626|NCT01855789|527760461|FG001|1) Baseline up to Week 24|Other|0|||
146342627|NCT01855789|527760462|FG002|1) Baseline up to Week 24|Other|0|||
146342628|NCT01855789|527760463|FG003|1) Baseline up to Week 24|Other|0|||
146342629|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
146342630|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
146342631|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
146342632|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
146342633|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146342634|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146342635|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
146342636|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
146342637|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
146342638|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
146342639|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
146342640|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
146342641|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
146342642|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
146342643|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
146342644|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
146342645|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
146342646|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
146342647|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
146342648|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
146342649|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
146342650|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
146342651|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
146342652|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
146342653|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
146342654|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
146342655|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
146342656|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
146342657|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
146342658|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
146342659|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
146342660|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
146342661|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
146342662|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
146342663|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
146342664|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
146342665|NCT01855789|527760460|FG000|2) Week 24 up to End of Study|Other|0|||
146342666|NCT01855789|527760461|FG001|2) Week 24 up to End of Study|Other|0|||
146342667|NCT01855789|527760462|FG002|2) Week 24 up to End of Study|Other|0|||
146342668|NCT01855789|527760463|FG003|2) Week 24 up to End of Study|Other|1|||
146342669|NCT01863758|527760464|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
146342670|NCT01863758|527760464|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
146342671|NCT02606877|527760465|FG000|Overall Study|Adverse Event|3|||
146342672|NCT02606877|527760466|FG001|Overall Study|Adverse Event|0|||
146342673|NCT02606877|527760465|FG000|Overall Study|Non-compliance with protocol|0|||
146342674|NCT02606877|527760466|FG001|Overall Study|Non-compliance with protocol|1|||
146342675|NCT02606877|527760465|FG000|Overall Study|Other than listed above|1|||
146342676|NCT02606877|527760466|FG001|Overall Study|Other than listed above|0|||
146342677|NCT04952389|527760469|FG000|Overall Study|Withdrawal by Subject|8|||
146342678|NCT04952389|527760470|FG001|Overall Study|Withdrawal by Subject|4|||
146342679|NCT00778999|527760471|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
146342680|NCT00778999|527760472|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
146342681|NCT00778999|527760471|FG000|Overall Study|Did not receive recFSH|14|||
146342682|NCT00778999|527760472|FG001|Overall Study|Did not receive recFSH|20|||
146342683|NCT01306058|527761778|FG000|Overall Study|Death|1|||
146342684|NCT01306058|527761778|FG000|Overall Study|Enrolled but did not get treatment|1|||
146342685|NCT00224107|527761779|FG000|Overall Study|Adverse Event|20|||
146342686|NCT00224107|527761780|FG001|Overall Study|Adverse Event|6|||
146342687|NCT00224107|527761779|FG000|Overall Study|Protocol Violation|2|||
146342688|NCT00224107|527761780|FG001|Overall Study|Protocol Violation|3|||
146342689|NCT00224107|527761779|FG000|Overall Study|Withdrawal by Subject|1|||
146342690|NCT00224107|527761780|FG001|Overall Study|Withdrawal by Subject|4|||
146342691|NCT00224107|527761779|FG000|Overall Study|Lack of Efficacy|2|||
146342692|NCT00224107|527761780|FG001|Overall Study|Lack of Efficacy|0|||
146342693|NCT00224107|527761779|FG000|Overall Study|Lost to Follow-up|4|||
146342694|NCT00224107|527761780|FG001|Overall Study|Lost to Follow-up|0|||
146342695|NCT00224107|527761779|FG000|Overall Study|Physician Decision|1|||
146342696|NCT00224107|527761780|FG001|Overall Study|Physician Decision|0|||
146342697|NCT00224107|527761779|FG000|Overall Study|Other|1|||
146342698|NCT00224107|527761780|FG001|Overall Study|Other|1|||
146342699|NCT03842709|527761781|FG000|Overall Study|Withdrawal by Subject|3|||
146342700|NCT03842709|527761782|FG001|Overall Study|Withdrawal by Subject|3|||
146342701|NCT03842709|527761781|FG000|Overall Study|Lost to Follow-up|1|||
146342702|NCT03842709|527761782|FG001|Overall Study|Lost to Follow-up|0|||
146342703|NCT00984659|527761783|FG000|2-week Run-in Period|Adverse Event|8|||
146342704|NCT00984659|527761784|FG001|2-week Run-in Period|Adverse Event|0|||
146342705|NCT00984659|527761785|FG002|2-week Run-in Period|Adverse Event|0|||
146342706|NCT00984659|527761786|FG003|2-week Run-in Period|Adverse Event|0|||
146342707|NCT00984659|527761783|FG000|2-week Run-in Period|Protocol Violation|5|||
146342708|NCT00984659|527761784|FG001|2-week Run-in Period|Protocol Violation|0|||
146342709|NCT00984659|527761785|FG002|2-week Run-in Period|Protocol Violation|0|||
146342710|NCT00984659|527761786|FG003|2-week Run-in Period|Protocol Violation|0|||
146342711|NCT00984659|527761783|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
146342712|NCT00984659|527761784|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
146342713|NCT00984659|527761785|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
146342714|NCT00984659|527761786|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
146342715|NCT00984659|527761783|FG000|2-week Run-in Period|Lost to Follow-up|3|||
146342716|NCT00984659|527761784|FG001|2-week Run-in Period|Lost to Follow-up|0|||
146342717|NCT00984659|527761785|FG002|2-week Run-in Period|Lost to Follow-up|0|||
146342718|NCT00984659|527761786|FG003|2-week Run-in Period|Lost to Follow-up|0|||
146342719|NCT00984659|527761783|FG000|2-week Run-in Period|Physician Decision|10|||
146342720|NCT00984659|527761784|FG001|2-week Run-in Period|Physician Decision|0|||
146342721|NCT00984659|527761785|FG002|2-week Run-in Period|Physician Decision|0|||
146342722|NCT00984659|527761786|FG003|2-week Run-in Period|Physician Decision|0|||
146342723|NCT00984659|527761783|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
146342724|NCT00984659|527761784|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
146342725|NCT00984659|527761785|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
146342726|NCT00984659|527761786|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
146342727|NCT00984659|527761783|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
146342728|NCT00984659|527761784|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146342729|NCT00984659|527761785|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146342730|NCT00984659|527761786|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
146342731|NCT00984659|527761783|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
146342732|NCT00984659|527761784|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
146342733|NCT00984659|527761785|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
146342734|NCT00984659|527761786|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
146342735|NCT00984659|527761783|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
146342736|NCT00984659|527761784|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
146342737|NCT00984659|527761785|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
146342738|NCT00984659|527761786|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
146342739|NCT00984659|527761783|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
146342740|NCT00984659|527761784|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
146342741|NCT00984659|527761785|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
146342742|NCT00984659|527761786|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
146342743|NCT00984659|527761783|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146342744|NCT00984659|527761784|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146342745|NCT00984659|527761785|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
146342746|NCT00984659|527761786|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
146342747|NCT00984659|527761783|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146342748|NCT00984659|527761784|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
146342749|NCT00984659|527761785|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
146342750|NCT00984659|527761786|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
146342751|NCT02424149|527761788|FG000|Overall Study|surgery cancelled|2|||
146342752|NCT02424149|527761789|FG001|Overall Study|surgery cancelled|0|||
146342753|NCT02424149|527761788|FG000|Overall Study|Withdrawal by Subject|0|||
146342754|NCT02424149|527761789|FG001|Overall Study|Withdrawal by Subject|1|||
146342755|NCT01357239|527761794|FG000|Stratum: All Patients|Adverse Event|0|||
146342756|NCT01357239|527761795|FG001|Stratum: All Patients|Adverse Event|0|||
146342757|NCT01357239|527761796|FG002|Stratum: All Patients|Adverse Event|1|||
146342758|NCT01357239|527761797|FG003|Stratum: All Patients|Adverse Event|1|||
146342759|NCT01357239|527761794|FG000|Stratum: All Patients|Subject withdrew consent|0|||
146342760|NCT01357239|527761795|FG001|Stratum: All Patients|Subject withdrew consent|0|||
146342761|NCT01357239|527761796|FG002|Stratum: All Patients|Subject withdrew consent|1|||
146342762|NCT01357239|527761797|FG003|Stratum: All Patients|Subject withdrew consent|1|||
146342763|NCT01357239|527761794|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
146342764|NCT01357239|527761795|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
146342765|NCT01357239|527761796|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
146342766|NCT01357239|527761797|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
146342767|NCT01357239|527761794|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
146342768|NCT01357239|527761795|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
146342769|NCT01357239|527761796|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
146342770|NCT01357239|527761797|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
146342771|NCT01357239|527761794|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
146342772|NCT01357239|527761795|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
146342773|NCT01357239|527761796|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
146342774|NCT01357239|527761797|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
146342775|NCT03472534|527761803|FG000|Overall Study|Withdrawal by Subject|9|||
146342776|NCT03472534|527761803|FG000|Overall Study|Adverse Event|2|||
146342777|NCT02614794|527761804|FG000|Overall Study|Death|258|||
146342778|NCT02614794|527761805|FG001|Overall Study|Death|151|||
146342779|NCT02614794|527761804|FG000|Overall Study|Study closure by Sponsor|119|||
146342780|NCT02614794|527761805|FG001|Overall Study|Study closure by Sponsor|45|||
146342781|NCT02614794|527761804|FG000|Overall Study|Withdrawal by Subject|24|||
146342782|NCT02614794|527761805|FG001|Overall Study|Withdrawal by Subject|5|||
146342783|NCT02614794|527761804|FG000|Overall Study|Lost to Follow-up|7|||
146342784|NCT02614794|527761805|FG001|Overall Study|Lost to Follow-up|0|||
146342785|NCT02614794|527761804|FG000|Overall Study|Physician Decision|1|||
146342786|NCT02614794|527761805|FG001|Overall Study|Physician Decision|1|||
146342787|NCT02614794|527761804|FG000|Overall Study|Hospital closure|1|||
146342788|NCT02614794|527761805|FG001|Overall Study|Hospital closure|0|||
146342789|NCT01319929|527761810|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
146342790|NCT01319929|527761811|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
146342791|NCT01319929|527761810|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
146342792|NCT01319929|527761811|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
146342793|NCT01319929|527761810|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
146342794|NCT01319929|527761811|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
146342795|NCT01319929|527761810|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
146342796|NCT01319929|527761811|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
146342797|NCT01319929|527761810|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
146342798|NCT01319929|527761811|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
146342799|NCT03237845|527761812|FG000|Overall Study|Adverse Event|0|||
146342800|NCT03237845|527761813|FG001|Overall Study|Adverse Event|1|||
146342801|NCT03237845|527761812|FG000|Overall Study|Lost to Follow-up|13|||
146342802|NCT03237845|527761813|FG001|Overall Study|Lost to Follow-up|10|||
146342803|NCT03237845|527761812|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
146342804|NCT03237845|527761813|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
146342805|NCT03237845|527761812|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
146342806|NCT03237845|527761813|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
146342807|NCT03237845|527761812|FG000|Overall Study|Physician Decision|1|||
146342808|NCT03237845|527761813|FG001|Overall Study|Physician Decision|2|||
146342809|NCT03237845|527761812|FG000|Overall Study|Pregnancy|1|||
146342810|NCT03237845|527761813|FG001|Overall Study|Pregnancy|0|||
146342811|NCT03237845|527761812|FG000|Overall Study|Protocol Deviation|0|||
146342812|NCT03237845|527761813|FG001|Overall Study|Protocol Deviation|1|||
146342813|NCT03237845|527761812|FG000|Overall Study|Technical Problems|8|||
146342814|NCT03237845|527761813|FG001|Overall Study|Technical Problems|1|||
146342815|NCT03237845|527761812|FG000|Overall Study|Withdrawal by Subject|3|||
146342816|NCT03237845|527761813|FG001|Overall Study|Withdrawal by Subject|3|||
146342817|NCT03237845|527761812|FG000|Overall Study|Other Reasons|4|||
146342818|NCT03237845|527761813|FG001|Overall Study|Other Reasons|0|||
146342819|NCT03865407|527761815|FG000|Overall Study|Adverse Event|1|||
146342820|NCT03865407|527761816|FG001|Overall Study|Adverse Event|0|||
146342821|NCT03865407|527761815|FG000|Overall Study|Withdrawal by Subject|1|||
146342822|NCT03865407|527761816|FG001|Overall Study|Withdrawal by Subject|0|||
146342823|NCT03865407|527761815|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
146342824|NCT03865407|527761816|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
146342825|NCT01645280|527761818|FG000|Overall Study|Death|0|||
146342826|NCT01645280|527761819|FG001|Overall Study|Death|1|||
146342827|NCT01645280|527761820|FG002|Overall Study|Death|0|||
146342828|NCT01645280|527761821|FG003|Overall Study|Death|0|||
146342829|NCT01645280|527761822|FG004|Overall Study|Death|0|||
146342830|NCT01645280|527761818|FG000|Overall Study|Withdrawal by Subject|4|||
146342831|NCT01645280|527761819|FG001|Overall Study|Withdrawal by Subject|0|||
146342832|NCT01645280|527761820|FG002|Overall Study|Withdrawal by Subject|2|||
146342833|NCT01645280|527761821|FG003|Overall Study|Withdrawal by Subject|4|||
146342834|NCT01645280|527761822|FG004|Overall Study|Withdrawal by Subject|5|||
146342835|NCT01645280|527761818|FG000|Overall Study|Lost to Follow-up|0|||
146342836|NCT01645280|527761819|FG001|Overall Study|Lost to Follow-up|0|||
146342837|NCT01645280|527761820|FG002|Overall Study|Lost to Follow-up|0|||
146342838|NCT01645280|527761821|FG003|Overall Study|Lost to Follow-up|2|||
146342839|NCT01645280|527761822|FG004|Overall Study|Lost to Follow-up|1|||
146342840|NCT01645280|527761818|FG000|Overall Study|Other|1|||
146342841|NCT01645280|527761819|FG001|Overall Study|Other|1|||
146342842|NCT01645280|527761820|FG002|Overall Study|Other|2|||
146342843|NCT01645280|527761821|FG003|Overall Study|Other|0|||
146342844|NCT01645280|527761822|FG004|Overall Study|Other|0|||
146342845|NCT01645280|527761818|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
146342846|NCT01645280|527761819|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
146342847|NCT01645280|527761820|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
146342848|NCT01645280|527761821|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
146342849|NCT01645280|527761822|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
146342850|NCT00234104|527761827|FG000|Overall Study|Adverse Event|4|||
146342851|NCT00234104|527761828|FG001|Overall Study|Adverse Event|0|||
146342852|NCT00234104|527761829|FG002|Overall Study|Adverse Event|3|||
146342853|NCT00234104|527761830|FG003|Overall Study|Adverse Event|5|||
146342854|NCT00234104|527761827|FG000|Overall Study|Protocol Violation|0|||
146342855|NCT00234104|527761828|FG001|Overall Study|Protocol Violation|0|||
146342856|NCT00234104|527761829|FG002|Overall Study|Protocol Violation|0|||
146342857|NCT00234104|527761830|FG003|Overall Study|Protocol Violation|1|||
146342858|NCT00234104|527761827|FG000|Overall Study|Physician Decision|0|||
146342859|NCT00234104|527761828|FG001|Overall Study|Physician Decision|1|||
146342860|NCT00234104|527761829|FG002|Overall Study|Physician Decision|2|||
146342861|NCT00234104|527761830|FG003|Overall Study|Physician Decision|2|||
146342862|NCT04045613|527761833|FG000|Overall Study|Adverse Event|2|||
146342863|NCT04045613|527761834|FG001|Overall Study|Adverse Event|2|||
146342864|NCT04045613|527761835|FG002|Overall Study|Adverse Event|1|||
146342865|NCT04045613|527761836|FG003|Overall Study|Adverse Event|1|||
146342866|NCT04045613|527761837|FG004|Overall Study|Adverse Event|0|||
146342867|NCT04045613|527761838|FG005|Overall Study|Adverse Event|0|||
146342868|NCT04045613|527761839|FG006|Overall Study|Adverse Event|1|||
146342869|NCT04045613|527761833|FG000|Overall Study|Withdrawal by Subject|0|||
146342870|NCT04045613|527761834|FG001|Overall Study|Withdrawal by Subject|5|||
146342871|NCT04045613|527761835|FG002|Overall Study|Withdrawal by Subject|0|||
146342872|NCT04045613|527761836|FG003|Overall Study|Withdrawal by Subject|0|||
146342873|NCT04045613|527761837|FG004|Overall Study|Withdrawal by Subject|0|||
146342874|NCT04045613|527761838|FG005|Overall Study|Withdrawal by Subject|1|||
146342875|NCT04045613|527761839|FG006|Overall Study|Withdrawal by Subject|0|||
146342876|NCT04045613|527761833|FG000|Overall Study|Physician Decision|2|||
146342877|NCT04045613|527761834|FG001|Overall Study|Physician Decision|0|||
146342878|NCT04045613|527761835|FG002|Overall Study|Physician Decision|0|||
146342879|NCT04045613|527761836|FG003|Overall Study|Physician Decision|0|||
146342880|NCT04045613|527761837|FG004|Overall Study|Physician Decision|1|||
146342881|NCT04045613|527761838|FG005|Overall Study|Physician Decision|0|||
146342882|NCT04045613|527761839|FG006|Overall Study|Physician Decision|0|||
146342883|NCT04045613|527761833|FG000|Overall Study|Death|3|||
146342884|NCT04045613|527761834|FG001|Overall Study|Death|0|||
146342885|NCT04045613|527761835|FG002|Overall Study|Death|0|||
146342886|NCT04045613|527761836|FG003|Overall Study|Death|0|||
146342887|NCT04045613|527761837|FG004|Overall Study|Death|0|||
146342888|NCT04045613|527761838|FG005|Overall Study|Death|0|||
146342889|NCT04045613|527761839|FG006|Overall Study|Death|1|||
146342890|NCT04045613|527761833|FG000|Overall Study|Other reasons|0|||
146342891|NCT04045613|527761834|FG001|Overall Study|Other reasons|1|||
146342892|NCT04045613|527761835|FG002|Overall Study|Other reasons|0|||
146342893|NCT04045613|527761836|FG003|Overall Study|Other reasons|0|||
146342894|NCT04045613|527761837|FG004|Overall Study|Other reasons|0|||
146342895|NCT04045613|527761838|FG005|Overall Study|Other reasons|0|||
146342896|NCT04045613|527761839|FG006|Overall Study|Other reasons|1|||
146342897|NCT04045613|527761833|FG000|Overall Study|Progressive disease: Clinical progression|1|||
146342898|NCT04045613|527761834|FG001|Overall Study|Progressive disease: Clinical progression|0|||
146342899|NCT04045613|527761835|FG002|Overall Study|Progressive disease: Clinical progression|3|||
146342900|NCT04045613|527761836|FG003|Overall Study|Progressive disease: Clinical progression|1|||
146342901|NCT04045613|527761837|FG004|Overall Study|Progressive disease: Clinical progression|1|||
146342902|NCT04045613|527761838|FG005|Overall Study|Progressive disease: Clinical progression|3|||
146342903|NCT04045613|527761839|FG006|Overall Study|Progressive disease: Clinical progression|3|||
146342904|NCT04045613|527761833|FG000|Overall Study|Progressive disease: Radiological progression|24|||
146342905|NCT04045613|527761834|FG001|Overall Study|Progressive disease: Radiological progression|6|||
146342906|NCT04045613|527761835|FG002|Overall Study|Progressive disease: Radiological progression|8|||
146342907|NCT04045613|527761836|FG003|Overall Study|Progressive disease: Radiological progression|0|||
146342908|NCT04045613|527761837|FG004|Overall Study|Progressive disease: Radiological progression|6|||
146342909|NCT04045613|527761838|FG005|Overall Study|Progressive disease: Radiological progression|6|||
146342910|NCT04045613|527761839|FG006|Overall Study|Progressive disease: Radiological progression|11|||
146342911|NCT01633060|527761846|FG000|Randomization Phase|Protocol deviation|1|||
146342912|NCT01633060|527761847|FG001|Randomization Phase|Protocol deviation|2|||
146342913|NCT01633060|527761846|FG000|Randomization Phase|Technical problem|0|||
146342914|NCT01633060|527761847|FG001|Randomization Phase|Technical problem|1|||
146342915|NCT01633060|527761846|FG000|Treatment Phase|Adverse Event|24|||
146342916|NCT01633060|527761847|FG001|Treatment Phase|Adverse Event|3|||
146342917|NCT01633060|527761846|FG000|Treatment Phase|Lost to Follow-up|1|||
146342918|NCT01633060|527761847|FG001|Treatment Phase|Lost to Follow-up|0|||
146342919|NCT01633060|527761846|FG000|Treatment Phase|Physician Decision|16|||
146342920|NCT01633060|527761847|FG001|Treatment Phase|Physician Decision|7|||
146342921|NCT01633060|527761846|FG000|Treatment Phase|Progressive Disease|210|||
146342922|NCT01633060|527761847|FG001|Treatment Phase|Progressive Disease|120|||
146342923|NCT01633060|527761846|FG000|Treatment Phase|Protocol Deviation|1|||
146342924|NCT01633060|527761847|FG001|Treatment Phase|Protocol Deviation|0|||
146342925|NCT01633060|527761846|FG000|Treatment Phase|Study Terminated by sponsor|7|||
146342926|NCT01633060|527761847|FG001|Treatment Phase|Study Terminated by sponsor|3|||
146342927|NCT01633060|527761846|FG000|Treatment Phase|Subject/guardian decision|25|||
146342928|NCT01633060|527761847|FG001|Treatment Phase|Subject/guardian decision|4|||
146342929|NCT01633060|527761846|FG000|Treatment Phase|Death|4|||
146342930|NCT01633060|527761847|FG001|Treatment Phase|Death|3|||
146342931|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
146342932|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
146342933|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
146342934|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
146342935|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
146342936|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
146342937|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
146342938|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
146342939|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146342940|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
146342941|NCT01633060|527761846|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
146342942|NCT01633060|527761847|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
146342943|NCT03633331|527761855|FG000|Overall Study|Withdrawal by Subject|1|||
146342944|NCT01009294|527761856|FG000|Overall Study|Study discontinued by Sponsor|6|||
146342945|NCT01856673|527761857|FG000|Overall Study|Withdrawal by Subject|44|||
146342946|NCT01856673|527761858|FG001|Overall Study|Withdrawal by Subject|50|||
146342947|NCT01856673|527761859|FG002|Overall Study|Withdrawal by Subject|33|||
146342948|NCT01856673|527761857|FG000|Overall Study|Lost to Follow-up|31|||
146342949|NCT01856673|527761858|FG001|Overall Study|Lost to Follow-up|34|||
146342950|NCT01856673|527761859|FG002|Overall Study|Lost to Follow-up|0|||
146342951|NCT01856673|527761857|FG000|Overall Study|Unknown reasons|9|||
146342952|NCT01856673|527761858|FG001|Overall Study|Unknown reasons|0|||
146342953|NCT01856673|527761859|FG002|Overall Study|Unknown reasons|0|||
146342954|NCT01856673|527761857|FG000|Overall Study|Psychologist decision|1|||
146342955|NCT01856673|527761858|FG001|Overall Study|Psychologist decision|0|||
146342956|NCT01856673|527761859|FG002|Overall Study|Psychologist decision|0|||
146342957|NCT01856673|527761857|FG000|Overall Study|Paperwork errors|8|||
146342958|NCT01856673|527761858|FG001|Overall Study|Paperwork errors|0|||
146342959|NCT01856673|527761859|FG002|Overall Study|Paperwork errors|0|||
146342960|NCT01856673|527761857|FG000|Overall Study|Death|1|||
146342961|NCT01856673|527761858|FG001|Overall Study|Death|1|||
146342962|NCT01856673|527761859|FG002|Overall Study|Death|0|||
146342963|NCT01856673|527761857|FG000|Overall Study|Protocol Violation|1|||
146342964|NCT01856673|527761858|FG001|Overall Study|Protocol Violation|0|||
146342965|NCT01856673|527761859|FG002|Overall Study|Protocol Violation|1|||
146342966|NCT00883753|527761860|FG000|Overall Study|Adverse Event|37|||
146342967|NCT00883753|527761860|FG000|Overall Study|Death|2|||
146342968|NCT00883753|527761860|FG000|Overall Study|Insufficient therapeutic response|16|||
146342969|NCT00883753|527761860|FG000|Overall Study|Lost to Follow-up|4|||
146342970|NCT00883753|527761860|FG000|Overall Study|Violation of selection criteria at entry|7|||
146342971|NCT00883753|527761860|FG000|Overall Study|Protocol Violation|2|||
146342972|NCT00883753|527761860|FG000|Overall Study|Refused treatment|4|||
146342973|NCT00883753|527761860|FG000|Overall Study|Withdrew consent|10|||
146342974|NCT00883753|527761860|FG000|Overall Study|Investigator's decision|17|||
146342975|NCT00883753|527761860|FG000|Overall Study|Administrative/Other|8|||
146342976|NCT02859415|527761861|FG000|Overall Study|Physician Decision|1|||
146342977|NCT02859415|527761862|FG001|Overall Study|Physician Decision|0|||
146342978|NCT02859415|527761861|FG000|Overall Study|Off treatment due to cardiac event|0|||
146342979|NCT02859415|527761862|FG001|Overall Study|Off treatment due to cardiac event|1|||
146342980|NCT02168946|527761865|FG000|Overall Study|Adverse Event|8|||
146342981|NCT02168946|527761866|FG001|Overall Study|Adverse Event|5|||
146342982|NCT02168946|527761865|FG000|Overall Study|Lost to Follow-up|3|||
146342983|NCT02168946|527761866|FG001|Overall Study|Lost to Follow-up|0|||
146342984|NCT02168946|527761865|FG000|Overall Study|Subject unable to come back for visits|1|||
146342985|NCT02168946|527761866|FG001|Overall Study|Subject unable to come back for visits|0|||
146342986|NCT01743027|527761872|FG000|Overall Study|Adverse Event|2|||
146342987|NCT01743027|527761873|FG001|Overall Study|Adverse Event|0|||
146342988|NCT01743027|527761874|FG002|Overall Study|Adverse Event|0|||
146342989|NCT01743027|527761875|FG003|Overall Study|Adverse Event|0|||
146342990|NCT01743027|527761872|FG000|Overall Study|Lost to Follow-up|0|||
146342991|NCT01743027|527761873|FG001|Overall Study|Lost to Follow-up|0|||
146342992|NCT01743027|527761874|FG002|Overall Study|Lost to Follow-up|2|||
146342993|NCT01743027|527761875|FG003|Overall Study|Lost to Follow-up|0|||
146342994|NCT01743027|527761872|FG000|Overall Study|Progressive Disease|1|||
146342995|NCT01743027|527761873|FG001|Overall Study|Progressive Disease|4|||
146342996|NCT01743027|527761874|FG002|Overall Study|Progressive Disease|3|||
146342997|NCT01743027|527761875|FG003|Overall Study|Progressive Disease|0|||
146342998|NCT01743027|527761872|FG000|Overall Study|Protocol Violation|1|||
146342999|NCT01743027|527761873|FG001|Overall Study|Protocol Violation|1|||
146343000|NCT01743027|527761874|FG002|Overall Study|Protocol Violation|1|||
146343001|NCT01743027|527761875|FG003|Overall Study|Protocol Violation|0|||
146343002|NCT01743027|527761872|FG000|Overall Study|Withdrawal by Subject|1|||
146343003|NCT01743027|527761873|FG001|Overall Study|Withdrawal by Subject|0|||
146343004|NCT01743027|527761874|FG002|Overall Study|Withdrawal by Subject|3|||
146343005|NCT01743027|527761875|FG003|Overall Study|Withdrawal by Subject|1|||
146343006|NCT00450866|527761876|FG000|Overall Study|Adverse Event|0|||
146343007|NCT00450866|527761877|FG001|Overall Study|Adverse Event|1|||
146343008|NCT00450866|527761876|FG000|Overall Study|Withdrawal by Subject|5|||
146343009|NCT00450866|527761877|FG001|Overall Study|Withdrawal by Subject|2|||
146343010|NCT00450866|527761876|FG000|Overall Study|Death|1|||
146343011|NCT00450866|527761877|FG001|Overall Study|Death|0|||
146343012|NCT00450866|527761876|FG000|Overall Study|Physician Decision|1|||
146343013|NCT00450866|527761877|FG001|Overall Study|Physician Decision|0|||
146343014|NCT01926886|527761881|FG000|Overall Study|Administrative/other|1|||
146343015|NCT01926886|527761882|FG001|Overall Study|Administrative/other|0|||
146343016|NCT01926886|527761881|FG000|Overall Study|Adverse event/intercurrent illness|4|||
146343017|NCT01926886|527761882|FG001|Overall Study|Adverse event/intercurrent illness|0|||
146343018|NCT01926886|527761881|FG000|Overall Study|Disease progression/recurrence|4|||
146343019|NCT01926886|527761882|FG001|Overall Study|Disease progression/recurrence|0|||
146343020|NCT01926886|527761881|FG000|Overall Study|Withdrawal by Subject|15|||
146343021|NCT01926886|527761882|FG001|Overall Study|Withdrawal by Subject|0|||
146343022|NCT01926886|527761881|FG000|Overall Study|Failure to return|3|||
146343023|NCT01926886|527761882|FG001|Overall Study|Failure to return|0|||
146343024|NCT01926886|527761881|FG000|Overall Study|Recurrence of disease|1|||
146343025|NCT01926886|527761882|FG001|Overall Study|Recurrence of disease|0|||
146343026|NCT01926886|527761881|FG000|Overall Study|Progression of disease|2|||
146343027|NCT01926886|527761882|FG001|Overall Study|Progression of disease|0|||
146343028|NCT01926886|527761881|FG000|Overall Study|Death|1|||
146343029|NCT01926886|527761882|FG001|Overall Study|Death|0|||
146343030|NCT01926886|527761881|FG000|Overall Study|Did not cooperate|1|||
146343031|NCT01926886|527761882|FG001|Overall Study|Did not cooperate|0|||
146343032|NCT02609399|527761886|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
146343033|NCT02609399|527761887|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
146343034|NCT02609399|527761886|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
146343035|NCT02609399|527761887|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
146343036|NCT02609399|527761886|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
146343037|NCT02609399|527761887|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
146343038|NCT00995371|527761890|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
146343039|NCT00995371|527761891|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
146343040|NCT04725682|527761892|FG000|Overall Study|Withdrawal by Subject|7|||
146343041|NCT04725682|527761893|FG001|Overall Study|Withdrawal by Subject|5|||
146343042|NCT04725682|527761892|FG000|Overall Study|Failed to comply with the requirements|2|||
146343043|NCT04725682|527761893|FG001|Overall Study|Failed to comply with the requirements|1|||
146343044|NCT04725682|527761892|FG000|Overall Study|Adverse Event|1|||
146343045|NCT04725682|527761893|FG001|Overall Study|Adverse Event|1|||
146343046|NCT04725682|527761892|FG000|Overall Study|Death|0|||
146343047|NCT04725682|527761893|FG001|Overall Study|Death|1|||
146343048|NCT00964795|527761894|FG000|Overall Study|Withdrawal by Subject|79|||
146343049|NCT00964795|527761894|FG000|Overall Study|Adverse Event|12|||
146343050|NCT00964795|527761894|FG000|Overall Study|Death|14|||
146343051|NCT00964795|527761894|FG000|Overall Study|Lost to Follow-up|7|||
146343052|NCT00964795|527761894|FG000|Overall Study|Termination of Study by Sponsor|169|||
146343053|NCT00964795|527761894|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
146343054|NCT00964795|527761894|FG000|Overall Study|Other|23|||
146343055|NCT02453841|527761898|FG000|Overall Study|Protocol Violation|1|||
146343056|NCT02453841|527761898|FG000|Overall Study|Unable to obtain blood samples|2|||
146343057|NCT00857246|527761899|FG000|Induction Regimen|Adverse Event|1|||
146343058|NCT00857246|527761899|FG000|Induction Regimen|disease-related complications|1|||
146343059|NCT00857246|527761899|FG000|Induction Regimen|Withdrawal by Subject|1|||
146169254|NCT04270747|527131168|FG001|Through Week 16|Physician Decision|1|||
146343060|NCT00857246|527761899|FG000|Surgery (Curative)|disease progression|6|||
146343061|NCT00857246|527761899|FG000|ChemoRT|Withdrawal by Subject|1|||
146343062|NCT00857246|527761899|FG000|ChemoRT|Adverse Event|2|||
146343063|NCT03851510|527761900|FG000|Overall Study|Screen Fail|1|||
146343064|NCT03851510|527761900|FG000|Overall Study|Adverse Event|1|||
146343065|NCT03851510|527761900|FG000|Overall Study|Withdrawal by Subject|1|||
146343066|NCT02613572|527761901|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
146343067|NCT02613572|527761902|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
146343068|NCT02613572|527761903|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
146343069|NCT02613572|527761901|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
146343070|NCT02613572|527761902|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
146343071|NCT02613572|527761903|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
146343072|NCT00970294|527761908|FG000|Overall Study|Physician Decision|4|||
146343073|NCT00970294|527761908|FG000|Overall Study|Withdrawal by Subject|1|||
146343074|NCT01333189|527761911|FG000|Overall Study|Time constraints|1|||
146343075|NCT01333189|527761912|FG001|Overall Study|Time constraints|0|||
146343076|NCT01333189|527761911|FG000|Overall Study|Adverse Event|1|||
146343077|NCT01333189|527761912|FG001|Overall Study|Adverse Event|0|||
146343078|NCT01333189|527761911|FG000|Overall Study|Transportation difficulties|0|||
146343079|NCT01333189|527761912|FG001|Overall Study|Transportation difficulties|1|||
146343080|NCT01333189|527761911|FG000|Overall Study|Moved from region|0|||
146343081|NCT01333189|527761912|FG001|Overall Study|Moved from region|1|||
146343082|NCT00393458|527761913|FG000|Overall Study|Adverse Event|35|||
146343083|NCT00393458|527761914|FG001|Overall Study|Adverse Event|24|||
146343084|NCT00393458|527761915|FG002|Overall Study|Adverse Event|40|||
146343085|NCT00393458|527761916|FG003|Overall Study|Adverse Event|35|||
146343086|NCT00393458|527761913|FG000|Overall Study|Subject withdrew consent|27|||
146343087|NCT00393458|527761914|FG001|Overall Study|Subject withdrew consent|40|||
146343088|NCT00393458|527761915|FG002|Overall Study|Subject withdrew consent|33|||
146343089|NCT00393458|527761916|FG003|Overall Study|Subject withdrew consent|50|||
146343090|NCT00393458|527761913|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
146343091|NCT00393458|527761914|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
146343092|NCT00393458|527761915|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
146343093|NCT00393458|527761916|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
146343094|NCT00393458|527761913|FG000|Overall Study|Protocol deviation|11|||
146343095|NCT00393458|527761914|FG001|Overall Study|Protocol deviation|11|||
146343096|NCT00393458|527761915|FG002|Overall Study|Protocol deviation|11|||
146343097|NCT00393458|527761916|FG003|Overall Study|Protocol deviation|10|||
146343098|NCT00393458|527761913|FG000|Overall Study|Administrative problems|7|||
146343099|NCT00393458|527761914|FG001|Overall Study|Administrative problems|8|||
146343100|NCT00393458|527761915|FG002|Overall Study|Administrative problems|5|||
146343101|NCT00393458|527761916|FG003|Overall Study|Administrative problems|2|||
146343102|NCT00393458|527761913|FG000|Overall Study|Lost to Follow-up|5|||
146343103|NCT00393458|527761914|FG001|Overall Study|Lost to Follow-up|6|||
146343104|NCT00393458|527761915|FG002|Overall Study|Lost to Follow-up|5|||
146343105|NCT00393458|527761916|FG003|Overall Study|Lost to Follow-up|3|||
146343106|NCT00393458|527761913|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146343107|NCT00393458|527761914|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146343108|NCT00393458|527761915|FG002|Overall Study|Abnormal laboratory value(s)|0|||
146343109|NCT00393458|527761916|FG003|Overall Study|Abnormal laboratory value(s)|0|||
146343110|NCT00393458|527761913|FG000|Overall Study|Death|1|||
146343111|NCT00393458|527761914|FG001|Overall Study|Death|1|||
146343112|NCT00393458|527761915|FG002|Overall Study|Death|5|||
146343113|NCT00393458|527761916|FG003|Overall Study|Death|5|||
146343114|NCT00393458|527761913|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146343115|NCT00393458|527761914|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146343116|NCT00393458|527761915|FG002|Overall Study|Abnormal test procedure result(s)|1|||
146343117|NCT00393458|527761916|FG003|Overall Study|Abnormal test procedure result(s)|2|||
146343118|NCT00393458|527761913|FG000|Overall Study|Subject no longer requires study drug|0|||
146343119|NCT00393458|527761914|FG001|Overall Study|Subject no longer requires study drug|1|||
146343120|NCT00393458|527761915|FG002|Overall Study|Subject no longer requires study drug|0|||
146343121|NCT00393458|527761916|FG003|Overall Study|Subject no longer requires study drug|0|||
146343122|NCT01326962|527761924|FG000|Overall Study|Adverse Event|1|||
146343123|NCT01326962|527761924|FG000|Overall Study|Withdrawal by Subject|1|||
146343124|NCT01326962|527761924|FG000|Overall Study|Lost to Follow-up|3|||
146343125|NCT01326962|527761924|FG000|Overall Study|Other|2|||
146343126|NCT00793585|527761925|FG000|Overall Study|Adverse Event|1|||
146343127|NCT00793585|527761926|FG001|Overall Study|Adverse Event|1|||
146343128|NCT00793585|527761925|FG000|Overall Study|Protocol Violation|1|||
146343129|NCT00793585|527761926|FG001|Overall Study|Protocol Violation|2|||
146343130|NCT00744055|527763148|FG000|Overall Study|Withdrawal by Subject|6|||
146343131|NCT00744055|527763149|FG001|Overall Study|Withdrawal by Subject|9|||
146343132|NCT00744055|527763148|FG000|Overall Study|Lack of Efficacy|0|||
146343133|NCT00744055|527763149|FG001|Overall Study|Lack of Efficacy|1|||
146343134|NCT00744055|527763148|FG000|Overall Study|Physician Decision|0|||
146343135|NCT00744055|527763149|FG001|Overall Study|Physician Decision|2|||
146343136|NCT00744055|527763148|FG000|Overall Study|Protocol Violation|1|||
146343137|NCT00744055|527763149|FG001|Overall Study|Protocol Violation|1|||
146343138|NCT00744055|527763148|FG000|Overall Study|Lost to Follow-up|0|||
146343139|NCT00744055|527763149|FG001|Overall Study|Lost to Follow-up|1|||
146056245|NCT03535974|526721151|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
146343140|NCT03635190|527763150|FG000|Overall Study|Lost to Follow-up|4|||
146343141|NCT03635190|527763150|FG000|Overall Study|Death|3|||
146343142|NCT03635190|527763150|FG000|Overall Study|Withdrawal by Subject|1|||
146343143|NCT03635190|527763150|FG000|Overall Study|Patient moved and did not return for follow up|1|||
146343144|NCT03846947|527763155|FG000|Overall Study|technical issues with imaging sequence|2|||
146343145|NCT03216265|527763156|FG000|Overall Study|Adverse Event|2|||
146343146|NCT03216265|527763157|FG001|Overall Study|Adverse Event|0|||
146343147|NCT03216265|527763158|FG002|Overall Study|Adverse Event|2|||
146343148|NCT03216265|527763156|FG000|Overall Study|Lost to Follow-up|0|||
146343149|NCT03216265|527763157|FG001|Overall Study|Lost to Follow-up|1|||
146343150|NCT03216265|527763158|FG002|Overall Study|Lost to Follow-up|0|||
146343151|NCT03216265|527763156|FG000|Overall Study|Withdrawal by Subject|0|||
146343152|NCT03216265|527763157|FG001|Overall Study|Withdrawal by Subject|0|||
146343153|NCT03216265|527763158|FG002|Overall Study|Withdrawal by Subject|1|||
146343154|NCT01539837|527763159|FG000|Overall Study|reduce neutrophil level|0|||
146343155|NCT01539837|527763160|FG001|Overall Study|reduce neutrophil level|1|||
146343156|NCT01539837|527763161|FG002|Overall Study|reduce neutrophil level|1|||
146343157|NCT01539837|527763159|FG000|Overall Study|bad compliance|0|||
146343158|NCT01539837|527763160|FG001|Overall Study|bad compliance|0|||
146343159|NCT01539837|527763161|FG002|Overall Study|bad compliance|1|||
146343160|NCT00849693|527763162|FG000|Acute Treatment Phase|Adverse Event|12|||
146343161|NCT00849693|527763163|FG001|Acute Treatment Phase|Adverse Event|7|||
146343162|NCT00849693|527763164|FG002|Acute Treatment Phase|Adverse Event|6|||
146343163|NCT00849693|527763165|FG003|Acute Treatment Phase|Adverse Event|4|||
146343164|NCT00849693|527763162|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
146343165|NCT00849693|527763163|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
146343166|NCT00849693|527763164|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
146343167|NCT00849693|527763165|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
146343168|NCT00849693|527763162|FG000|Acute Treatment Phase|Protocol Violation|1|||
146343169|NCT00849693|527763163|FG001|Acute Treatment Phase|Protocol Violation|5|||
146343170|NCT00849693|527763164|FG002|Acute Treatment Phase|Protocol Violation|2|||
146343171|NCT00849693|527763165|FG003|Acute Treatment Phase|Protocol Violation|6|||
146343172|NCT00849693|527763162|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
146343173|NCT00849693|527763163|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
146343174|NCT00849693|527763164|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
146343175|NCT00849693|527763165|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
146343176|NCT00849693|527763162|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
146343177|NCT00849693|527763163|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
146343178|NCT00849693|527763164|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
146343179|NCT00849693|527763165|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
146343180|NCT00849693|527763162|FG000|Acute Treatment Phase|Physician Decision|2|||
146343181|NCT00849693|527763163|FG001|Acute Treatment Phase|Physician Decision|1|||
146343182|NCT00849693|527763164|FG002|Acute Treatment Phase|Physician Decision|2|||
146343183|NCT00849693|527763165|FG003|Acute Treatment Phase|Physician Decision|1|||
146343184|NCT00849693|527763162|FG000|Acute Treatment Phase|Sponsor decision|0|||
146343185|NCT00849693|527763163|FG001|Acute Treatment Phase|Sponsor decision|0|||
146343186|NCT00849693|527763164|FG002|Acute Treatment Phase|Sponsor decision|1|||
146343187|NCT00849693|527763165|FG003|Acute Treatment Phase|Sponsor decision|0|||
146343188|NCT00849693|527763162|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
146343189|NCT00849693|527763163|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
146343190|NCT00849693|527763164|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
146343191|NCT00849693|527763165|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
146343192|NCT00849693|527763162|FG000|Extension Phase|Adverse Event|4|||
146343193|NCT00849693|527763163|FG001|Extension Phase|Adverse Event|6|||
146343194|NCT00849693|527763164|FG002|Extension Phase|Adverse Event|3|||
146343195|NCT00849693|527763165|FG003|Extension Phase|Adverse Event|7|||
146343196|NCT00849693|527763162|FG000|Extension Phase|Lost to Follow-up|7|||
146343197|NCT00849693|527763163|FG001|Extension Phase|Lost to Follow-up|5|||
146343198|NCT00849693|527763164|FG002|Extension Phase|Lost to Follow-up|6|||
146343199|NCT00849693|527763165|FG003|Extension Phase|Lost to Follow-up|6|||
146343200|NCT00849693|527763162|FG000|Extension Phase|Protocol Violation|0|||
146343201|NCT00849693|527763163|FG001|Extension Phase|Protocol Violation|3|||
146343202|NCT00849693|527763164|FG002|Extension Phase|Protocol Violation|2|||
146343203|NCT00849693|527763165|FG003|Extension Phase|Protocol Violation|3|||
146343204|NCT00849693|527763162|FG000|Extension Phase|Withdrawal by Subject|6|||
146169255|NCT04270747|527131169|FG002|Through Week 16|Physician Decision|0|||
146343205|NCT00849693|527763163|FG001|Extension Phase|Withdrawal by Subject|9|||
146343206|NCT00849693|527763164|FG002|Extension Phase|Withdrawal by Subject|10|||
146169256|NCT04270747|527131167|FG000|Through Week 16|Lost to Follow-up|2|||
146169257|NCT04270747|527131168|FG001|Through Week 16|Lost to Follow-up|0|||
146343207|NCT00849693|527763165|FG003|Extension Phase|Withdrawal by Subject|15|||
146343208|NCT00849693|527763162|FG000|Extension Phase|Parent or caregiver decision|9|||
146343209|NCT00849693|527763163|FG001|Extension Phase|Parent or caregiver decision|4|||
146343210|NCT00849693|527763164|FG002|Extension Phase|Parent or caregiver decision|10|||
146343211|NCT00849693|527763165|FG003|Extension Phase|Parent or caregiver decision|5|||
146343212|NCT00849693|527763162|FG000|Extension Phase|Physician Decision|1|||
146343213|NCT00849693|527763163|FG001|Extension Phase|Physician Decision|1|||
146343214|NCT00849693|527763164|FG002|Extension Phase|Physician Decision|2|||
146343215|NCT00849693|527763165|FG003|Extension Phase|Physician Decision|0|||
146343216|NCT00849693|527763162|FG000|Extension Phase|Sponsor decision|1|||
146343217|NCT00849693|527763163|FG001|Extension Phase|Sponsor decision|0|||
146343218|NCT00849693|527763164|FG002|Extension Phase|Sponsor decision|0|||
146343219|NCT00849693|527763165|FG003|Extension Phase|Sponsor decision|1|||
146343220|NCT00849693|527763162|FG000|Extension Phase|Lack of Efficacy|2|||
146343221|NCT00849693|527763163|FG001|Extension Phase|Lack of Efficacy|2|||
146343222|NCT00849693|527763164|FG002|Extension Phase|Lack of Efficacy|2|||
146343223|NCT00849693|527763165|FG003|Extension Phase|Lack of Efficacy|1|||
146343224|NCT02046564|527763166|FG000|Overall Study|Adverse Event|6|||
146343225|NCT02046564|527763167|FG001|Overall Study|Adverse Event|3|||
146343226|NCT02046564|527763166|FG000|Overall Study|Physician Decision|0|||
146343227|NCT02046564|527763167|FG001|Overall Study|Physician Decision|1|||
146343228|NCT02046564|527763166|FG000|Overall Study|Protocol Violation|3|||
146343229|NCT02046564|527763167|FG001|Overall Study|Protocol Violation|1|||
146343230|NCT02046564|527763166|FG000|Overall Study|Withdrawal by Subject|4|||
146343231|NCT02046564|527763167|FG001|Overall Study|Withdrawal by Subject|10|||
146343232|NCT02046564|527763166|FG000|Overall Study|Subject met withdrawal criteria|2|||
146343233|NCT02046564|527763167|FG001|Overall Study|Subject met withdrawal criteria|5|||
146343234|NCT01295905|527763168|FG000|Overall Study|Did not meet inclusion criteria|1|||
146343235|NCT01295905|527763169|FG001|Overall Study|Did not meet inclusion criteria|0|||
146343236|NCT01295905|527763168|FG000|Overall Study|Met exclusion criteria|1|||
146343237|NCT01295905|527763169|FG001|Overall Study|Met exclusion criteria|0|||
146343238|NCT00537823|527763172|FG000|Overall Study|Adverse Event|2|||
146343239|NCT00537823|527763173|FG001|Overall Study|Adverse Event|0|||
146343240|NCT02873221|527763174|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
146343241|NCT02873221|527763175|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
146343242|NCT02873221|527763176|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
146343243|NCT02873221|527763174|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
146343244|NCT02873221|527763175|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
146343245|NCT02873221|527763176|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
146343246|NCT02873221|527763174|FG000|Treatment Period|Protocol Violation|2|||
146343247|NCT02873221|527763175|FG001|Treatment Period|Protocol Violation|5|||
146343248|NCT02873221|527763176|FG002|Treatment Period|Protocol Violation|8|||
146343249|NCT02873221|527763174|FG000|Treatment Period|Pregnancy|4|||
146343250|NCT02873221|527763175|FG001|Treatment Period|Pregnancy|6|||
146343251|NCT02873221|527763176|FG002|Treatment Period|Pregnancy|3|||
146343252|NCT02873221|527763174|FG000|Treatment Period|Lack of Qualifying Event|0|||
146343253|NCT02873221|527763175|FG001|Treatment Period|Lack of Qualifying Event|3|||
146343254|NCT02873221|527763176|FG002|Treatment Period|Lack of Qualifying Event|1|||
146343255|NCT02873221|527763174|FG000|Treatment Period|Withdrawal of Consent|52|||
146343256|NCT02873221|527763175|FG001|Treatment Period|Withdrawal of Consent|51|||
146343257|NCT02873221|527763176|FG002|Treatment Period|Withdrawal of Consent|41|||
146343258|NCT02873221|527763174|FG000|Treatment Period|Lack of Efficacy|0|||
146343259|NCT02873221|527763175|FG001|Treatment Period|Lack of Efficacy|17|||
146343260|NCT02873221|527763176|FG002|Treatment Period|Lack of Efficacy|12|||
146343261|NCT02873221|527763174|FG000|Treatment Period|Adverse Event|4|||
146343262|NCT02873221|527763175|FG001|Treatment Period|Adverse Event|9|||
146343263|NCT02873221|527763176|FG002|Treatment Period|Adverse Event|11|||
146343264|NCT02873221|527763174|FG000|Treatment Period|Lost to Follow-up|26|||
146343265|NCT02873221|527763175|FG001|Treatment Period|Lost to Follow-up|30|||
146343266|NCT02873221|527763176|FG002|Treatment Period|Lost to Follow-up|26|||
146343267|NCT02873221|527763174|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146343268|NCT02873221|527763175|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
146343269|NCT02873221|527763176|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
146343270|NCT02873221|527763174|FG000|Safety Follow-up Period|Protocol Violation|0|||
146343271|NCT02873221|527763175|FG001|Safety Follow-up Period|Protocol Violation|0|||
146343272|NCT02873221|527763176|FG002|Safety Follow-up Period|Protocol Violation|1|||
146343273|NCT02873221|527763174|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
146343274|NCT02873221|527763175|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
146343275|NCT02873221|527763176|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
146343276|NCT02873221|527763174|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
146343277|NCT02873221|527763175|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
146343278|NCT02873221|527763176|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
146343279|NCT02717546|527763177|FG000|Overall Study|Lost to Follow-up|12|||
146343280|NCT03396471|527763183|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
146169258|NCT04270747|527131169|FG002|Through Week 16|Lost to Follow-up|0|||
146343281|NCT03396471|527763183|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
146343282|NCT03396471|527763183|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
146343283|NCT03396471|527763183|FG000|Study Treatment - Up to 22 Months|Death|2|||
146343284|NCT03396471|527763183|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
146343285|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|Death|9|||
146343286|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
146343287|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
146343288|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|study terminated|1|||
146343289|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
146343290|NCT03396471|527763183|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
146343291|NCT03849560|527763184|FG000|Overall Study|Withdrawal by Subject|1|||
146343292|NCT03849560|527763185|FG001|Overall Study|Withdrawal by Subject|0|||
146343293|NCT03849560|527763186|FG002|Overall Study|Withdrawal by Subject|0|||
146343294|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Adverse Event|12|||
146343295|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Adverse Event|3|||
146343296|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Adverse Event|4|||
146343297|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Adverse Event|2|||
146343298|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
146343299|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
146343300|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
146343301|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
146343302|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
146343303|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
146343304|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
146343305|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
146343306|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
146343307|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
146343308|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
146343309|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
146343310|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
146343311|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
146343312|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
146343313|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
146343314|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
146343315|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
146343316|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
146343317|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
146343318|NCT02436239|527763189|FG000|Open-Lable Treatment Period|Other Reason|1|||
146343319|NCT02436239|527763190|FG001|Open-Lable Treatment Period|Other Reason|1|||
146343320|NCT02436239|527763191|FG002|Open-Lable Treatment Period|Other Reason|0|||
146343321|NCT02436239|527763192|FG003|Open-Lable Treatment Period|Other Reason|0|||
146343322|NCT02436239|527763189|FG000|Down-Taper Period|Withdrawal by Subject|4|||
146343323|NCT02436239|527763190|FG001|Down-Taper Period|Withdrawal by Subject|4|||
146343324|NCT02436239|527763191|FG002|Down-Taper Period|Withdrawal by Subject|1|||
146343325|NCT02436239|527763192|FG003|Down-Taper Period|Withdrawal by Subject|2|||
146343326|NCT00138151|527763193|FG000|Overall Study|Withdrawal by Subject|3|||
146343327|NCT00138151|527763193|FG000|Overall Study|Physician Decision|1|||
146343328|NCT02675517|527763196|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
146343329|NCT02675517|527763196|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
146343330|NCT01716169|527763200|FG000|Overall Study|Adverse Event|1|||
146343331|NCT01716169|527763200|FG000|Overall Study|Lost to Follow-up|1|||
146343332|NCT01716169|527763200|FG000|Overall Study|Withdrawal by Subject|1|||
146343333|NCT01716169|527763200|FG000|Overall Study|inconsistent dressing application|1|||
146343334|NCT00301067|527763203|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
146343335|NCT00301067|527763204|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
146343336|NCT00301067|527763205|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
146343337|NCT00301067|527763206|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
146343338|NCT00301067|527763203|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
146343339|NCT00301067|527763204|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146343340|NCT00301067|527763205|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
146343341|NCT00301067|527763206|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
146343342|NCT00301067|527763203|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
146343343|NCT00301067|527763204|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
146343344|NCT00301067|527763205|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
146343345|NCT00301067|527763206|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
146343346|NCT00301067|527763203|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
146343347|NCT00301067|527763204|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
146343348|NCT00301067|527763205|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
146343349|NCT00301067|527763206|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
146343350|NCT00301067|527763203|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
146343351|NCT00301067|527763204|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
146343352|NCT00301067|527763205|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
146343353|NCT00301067|527763206|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
146343354|NCT00301067|527763203|FG000|Follow up Until Death|Alive at last data cut point|1|||
146343355|NCT00301067|527763204|FG001|Follow up Until Death|Alive at last data cut point|0|||
146343356|NCT00301067|527763205|FG002|Follow up Until Death|Alive at last data cut point|0|||
146343357|NCT00301067|527763206|FG003|Follow up Until Death|Alive at last data cut point|1|||
146343358|NCT00149825|527763207|FG000|Overall Study|Intolerance to medication side effects|1|||
146343359|NCT00149825|527763208|FG001|Overall Study|Intolerance to medication side effects|2|||
146343360|NCT00149825|527763207|FG000|Overall Study|Time commitments|2|||
146343361|NCT00149825|527763208|FG001|Overall Study|Time commitments|1|||
146343362|NCT00149825|527763207|FG000|Overall Study|Not liking insomnia therapy|1|||
146343363|NCT00149825|527763208|FG001|Overall Study|Not liking insomnia therapy|0|||
146343364|NCT00149825|527763207|FG000|Overall Study|Other|1|||
146343365|NCT00149825|527763208|FG001|Overall Study|Other|0|||
146343366|NCT00069121|527763209|FG000|Overall Study|Death|286|||
146343367|NCT00069121|527763210|FG001|Overall Study|Death|242|||
146343368|NCT00069121|527763209|FG000|Overall Study|Withdrawal by Subject|18|||
146343369|NCT00069121|527763210|FG001|Overall Study|Withdrawal by Subject|20|||
146343370|NCT00069121|527763209|FG000|Overall Study|Lost to Follow-up|63|||
146343371|NCT00069121|527763210|FG001|Overall Study|Lost to Follow-up|63|||
146343372|NCT00942708|527763211|FG000|Overall Study|Withdrawal by Subject|1|||
146343373|NCT00306891|527763212|FG000|Part A|Withdrawal by Subject|1|||
146343374|NCT00306891|527763213|FG001|Part A|Withdrawal by Subject|1|||
146343375|NCT00306891|527763214|FG002|Part A|Withdrawal by Subject|0|||
146343376|NCT00306891|527763215|FG003|Part A|Withdrawal by Subject|0|||
146343377|NCT00306891|527763212|FG000|Part A|Condition under investigation worsened|2|||
146343378|NCT00306891|527763213|FG001|Part A|Condition under investigation worsened|2|||
146343379|NCT00306891|527763214|FG002|Part A|Condition under investigation worsened|0|||
146343380|NCT00306891|527763215|FG003|Part A|Condition under investigation worsened|0|||
146343381|NCT00306891|527763212|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146343382|NCT00306891|527763213|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
146343383|NCT00306891|527763214|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146343384|NCT00306891|527763215|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
146343385|NCT00306891|527763212|FG000|Part A|Partial bowel obstruction|1|||
146343386|NCT00306891|527763213|FG001|Part A|Partial bowel obstruction|0|||
146343387|NCT00306891|527763214|FG002|Part A|Partial bowel obstruction|0|||
146343388|NCT00306891|527763215|FG003|Part A|Partial bowel obstruction|0|||
146343389|NCT00306891|527763212|FG000|Part A|Reaccumul. of ascites following drainage|0|||
146343390|NCT00306891|527763213|FG001|Part A|Reaccumul. of ascites following drainage|1|||
146343391|NCT00306891|527763214|FG002|Part A|Reaccumul. of ascites following drainage|0|||
146343392|NCT00306891|527763215|FG003|Part A|Reaccumul. of ascites following drainage|0|||
146343393|NCT00306891|527763212|FG000|Part A|Suspicion of second malignancy|0|||
146343394|NCT00306891|527763213|FG001|Part A|Suspicion of second malignancy|1|||
146343395|NCT00306891|527763214|FG002|Part A|Suspicion of second malignancy|0|||
146343396|NCT00306891|527763215|FG003|Part A|Suspicion of second malignancy|0|||
146343397|NCT00306891|527763212|FG000|Part A|QTC interval outwith elig. criteria|1|||
146343398|NCT00306891|527763213|FG001|Part A|QTC interval outwith elig. criteria|0|||
146343399|NCT00306891|527763214|FG002|Part A|QTC interval outwith elig. criteria|0|||
146343400|NCT00306891|527763215|FG003|Part A|QTC interval outwith elig. criteria|0|||
146343401|NCT00306891|527763212|FG000|Part B|Death|0|||
146343402|NCT00306891|527763213|FG001|Part B|Death|0|||
146343403|NCT00306891|527763214|FG002|Part B|Death|1|||
146343404|NCT00306891|527763215|FG003|Part B|Death|2|||
146343405|NCT00306891|527763212|FG000|Part B|Adverse Event|0|||
146343406|NCT00306891|527763213|FG001|Part B|Adverse Event|0|||
146343407|NCT00306891|527763214|FG002|Part B|Adverse Event|5|||
146343408|NCT00306891|527763215|FG003|Part B|Adverse Event|5|||
146343409|NCT00306891|527763212|FG000|Part B|Withdrawal by Subject|0|||
146343410|NCT00306891|527763213|FG001|Part B|Withdrawal by Subject|0|||
146343411|NCT00306891|527763214|FG002|Part B|Withdrawal by Subject|3|||
146343412|NCT00306891|527763215|FG003|Part B|Withdrawal by Subject|1|||
146343413|NCT00306891|527763212|FG000|Part B|Condition under investigation worsened|0|||
146343414|NCT00306891|527763213|FG001|Part B|Condition under investigation worsened|0|||
146343415|NCT00306891|527763214|FG002|Part B|Condition under investigation worsened|2|||
146343416|NCT00306891|527763215|FG003|Part B|Condition under investigation worsened|8|||
146343417|NCT00306891|527763212|FG000|Part B|Development of study specific disc crit.|0|||
146343418|NCT00306891|527763213|FG001|Part B|Development of study specific disc crit.|0|||
146343419|NCT00306891|527763214|FG002|Part B|Development of study specific disc crit.|0|||
146343420|NCT00306891|527763215|FG003|Part B|Development of study specific disc crit.|1|||
146343421|NCT00673673|527763216|FG000|Overall Study|Progressive disease|27|||
146343422|NCT00673673|527763216|FG000|Overall Study|Adverse Event|4|||
146343423|NCT00673673|527763216|FG000|Overall Study|Withdrawal by Subject|3|||
146343424|NCT00673673|527763216|FG000|Overall Study|Investigators' discretion|2|||
146343425|NCT00231478|527763221|FG000|Overall Study|Protocol Violation|3|||
146343426|NCT00231478|527763222|FG001|Overall Study|Protocol Violation|2|||
146343427|NCT00231478|527763221|FG000|Overall Study|Refused Treatment|1|||
146343428|NCT00231478|527763222|FG001|Overall Study|Refused Treatment|1|||
146343429|NCT00231478|527763221|FG000|Overall Study|Withdrawal by Subject|1|||
146343430|NCT00231478|527763222|FG001|Overall Study|Withdrawal by Subject|0|||
146343431|NCT00231478|527763221|FG000|Overall Study|Adverse Event|0|||
146343432|NCT00231478|527763222|FG001|Overall Study|Adverse Event|1|||
146343433|NCT00231478|527763221|FG000|Overall Study|Administrative|3|||
146343434|NCT00231478|527763222|FG001|Overall Study|Administrative|2|||
146343435|NCT04538950|527763223|FG000|Overall Study|Pulmonary Issues|2|||
146343436|NCT04538950|527763223|FG000|Overall Study|illness|2|||
146343437|NCT01707147|527763224|FG000|Overall Study|Administered Trajenta prior to contract|5|||
146343438|NCT01707147|527763224|FG000|Overall Study|Patients who have not taken Trajenta|1|||
146343439|NCT01707147|527763224|FG000|Overall Study|Follow-up failure|17|||
146343440|NCT01707147|527763224|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
146343441|NCT02489630|527763227|FG000|Overall Study|Oversedation|1|||
146343442|NCT02489630|527763228|FG001|Overall Study|Oversedation|1|||
146343443|NCT02489630|527763227|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
146343444|NCT02489630|527763228|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
146343445|NCT02053246|527763230|FG000|Overall Study|Withdrawal by Subject|3|||
146343446|NCT02053246|527763230|FG000|Overall Study|Physician Decision|1|||
146343447|NCT01056523|527763231|FG000|Overall Study|Death|1|||
146343448|NCT01056523|527763232|FG001|Overall Study|Death|0|||
146343449|NCT01056523|527763233|FG002|Overall Study|Death|2|||
146169259|NCT04270747|527131167|FG000|Through Week 16|Protocol Violation|1|||
146169260|NCT04270747|527131168|FG001|Through Week 16|Protocol Violation|2|||
146169261|NCT04270747|527131169|FG002|Through Week 16|Protocol Violation|0|||
146169262|NCT04270747|527131167|FG000|Through Week 16|Protocol Specified Criteria|6|||
146169263|NCT04270747|527131168|FG001|Through Week 16|Protocol Specified Criteria|7|||
146169264|NCT04270747|527131169|FG002|Through Week 16|Protocol Specified Criteria|0|||
146169265|NCT04270747|527131167|FG000|Through Week 16|Miscellaneous|1|||
146169266|NCT04270747|527131168|FG001|Through Week 16|Miscellaneous|1|||
146169267|NCT04270747|527131169|FG002|Through Week 16|Miscellaneous|0|||
146169268|NCT04270747|527131167|FG000|Post Week 16|Adverse Event|7|||
146169269|NCT04270747|527131168|FG001|Post Week 16|Adverse Event|5|||
146169270|NCT04270747|527131169|FG002|Post Week 16|Adverse Event|1|||
146169271|NCT04270747|527131167|FG000|Post Week 16|Death|2|||
146169272|NCT04270747|527131168|FG001|Post Week 16|Death|0|||
146169273|NCT04270747|527131169|FG002|Post Week 16|Death|2|||
146169274|NCT04270747|527131167|FG000|Post Week 16|Consent Withdrawn|4|||
146169275|NCT04270747|527131168|FG001|Post Week 16|Consent Withdrawn|3|||
146169276|NCT04270747|527131169|FG002|Post Week 16|Consent Withdrawn|6|||
146169277|NCT04270747|527131167|FG000|Post Week 16|Physician Decision|3|||
146169278|NCT04270747|527131168|FG001|Post Week 16|Physician Decision|1|||
146169279|NCT04270747|527131169|FG002|Post Week 16|Physician Decision|1|||
146169280|NCT04270747|527131167|FG000|Post Week 16|Lost to Follow-up|2|||
146169281|NCT04270747|527131168|FG001|Post Week 16|Lost to Follow-up|1|||
146169282|NCT04270747|527131169|FG002|Post Week 16|Lost to Follow-up|0|||
146169283|NCT04270747|527131167|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
146169284|NCT04270747|527131168|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
146169285|NCT04270747|527131169|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
146169286|NCT04270747|527131167|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
146169287|NCT04270747|527131168|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
146343450|NCT01056523|527763234|FG003|Overall Study|Death|3|||
146343451|NCT01056523|527763235|FG004|Overall Study|Death|0|||
146343452|NCT01056523|527763236|FG005|Overall Study|Death|0|||
146343453|NCT01056523|527763237|FG006|Overall Study|Death|1|||
146343454|NCT03429556|527763238|FG000|Overall Study|Lost to Follow-up|0|||
146343455|NCT03429556|527763239|FG001|Overall Study|Lost to Follow-up|1|||
146343456|NCT03429556|527763240|FG002|Overall Study|Lost to Follow-up|0|||
146343457|NCT03429556|527763241|FG003|Overall Study|Lost to Follow-up|0|||
146343458|NCT00035815|527763242|FG000|Overall Study|Withdrawal by Subject|17|||
146343459|NCT00035815|527763243|FG001|Overall Study|Withdrawal by Subject|11|||
146343460|NCT02369510|527763246|FG000|Overall Study|Spilled Medication|1|||
146343461|NCT02369510|527763247|FG001|Overall Study|Spilled Medication|2|||
146343462|NCT02369510|527763248|FG002|Overall Study|Spilled Medication|1|||
146343463|NCT02369510|527763246|FG000|Overall Study|Epidural Activation|1|||
146343464|NCT02369510|527763247|FG001|Overall Study|Epidural Activation|1|||
146343465|NCT02369510|527763248|FG002|Overall Study|Epidural Activation|5|||
146343466|NCT04285723|527763255|FG000|Overall Study|Subject decision|1|||
146343467|NCT04285723|527763256|FG001|Overall Study|Subject decision|2|||
146343468|NCT04285723|527763255|FG000|Overall Study|Physician Decision|1|||
146343469|NCT04285723|527763256|FG001|Overall Study|Physician Decision|0|||
146343470|NCT04285723|527763255|FG000|Overall Study|No efficiency|1|||
146343471|NCT04285723|527763256|FG001|Overall Study|No efficiency|0|||
146343472|NCT03067311|527763257|FG000|Overall Study|Lost to Follow-up|1|||
146343473|NCT03067311|527763258|FG001|Overall Study|Lost to Follow-up|1|||
146343474|NCT03067311|527763257|FG000|Overall Study|Moved away|1|||
146343475|NCT03067311|527763258|FG001|Overall Study|Moved away|1|||
146169288|NCT04270747|527131169|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
146169289|NCT04270747|527131167|FG000|Post Week 16|Miscellaneous|1|||
146169290|NCT04270747|527131168|FG001|Post Week 16|Miscellaneous|0|||
146343476|NCT02903511|527763259|FG000|Overall Study|Withdrawal by Subject|1|||
146343477|NCT02903511|527763260|FG001|Overall Study|Withdrawal by Subject|0|||
146343478|NCT02903511|527763259|FG000|Overall Study|Lost to Follow-up|3|||
146343479|NCT02903511|527763260|FG001|Overall Study|Lost to Follow-up|2|||
146343480|NCT00907738|527763261|FG000|Overall Study|Adverse Event|2|||
146343481|NCT00907738|527763262|FG001|Overall Study|Adverse Event|0|||
146343482|NCT00907738|527763263|FG002|Overall Study|Adverse Event|1|||
146343483|NCT00907738|527763264|FG003|Overall Study|Adverse Event|0|||
146343484|NCT00907738|527763265|FG004|Overall Study|Adverse Event|0|||
146343485|NCT00907738|527763261|FG000|Overall Study|not specified or withdrew consent|3|||
146343486|NCT00907738|527763262|FG001|Overall Study|not specified or withdrew consent|0|||
146343487|NCT00907738|527763263|FG002|Overall Study|not specified or withdrew consent|0|||
146343488|NCT00907738|527763264|FG003|Overall Study|not specified or withdrew consent|0|||
146343489|NCT00907738|527763265|FG004|Overall Study|not specified or withdrew consent|0|||
146343490|NCT00907738|527763261|FG000|Overall Study|Disease progression|8|||
146343491|NCT00907738|527763262|FG001|Overall Study|Disease progression|1|||
146343492|NCT00907738|527763263|FG002|Overall Study|Disease progression|6|||
146343493|NCT00907738|527763264|FG003|Overall Study|Disease progression|4|||
146343494|NCT00907738|527763265|FG004|Overall Study|Disease progression|2|||
146343495|NCT05363293|527763266|FG000|Overall Study|Withdrawal by Subject|1|||
146343496|NCT05363293|527763267|FG001|Overall Study|Withdrawal by Subject|0|||
146343497|NCT05363293|527763268|FG002|Overall Study|Withdrawal by Subject|0|||
146343498|NCT05363293|527763269|FG003|Overall Study|Withdrawal by Subject|0|||
146343499|NCT05363293|527763270|FG004|Overall Study|Withdrawal by Subject|0|||
146343500|NCT05363293|527763271|FG005|Overall Study|Withdrawal by Subject|0|||
146343501|NCT05363293|527763272|FG006|Overall Study|Withdrawal by Subject|0|||
146343502|NCT05363293|527763273|FG007|Overall Study|Withdrawal by Subject|0|||
146343503|NCT05363293|527763274|FG008|Overall Study|Withdrawal by Subject|0|||
146343504|NCT05363293|527763275|FG009|Overall Study|Withdrawal by Subject|0|||
146343505|NCT01089725|527763279|FG000|Overall Study|Adverse Event|1|||
146343506|NCT01089725|527763280|FG001|Overall Study|Adverse Event|1|||
146343507|NCT01089725|527763281|FG002|Overall Study|Adverse Event|0|||
146343508|NCT01089725|527763282|FG003|Overall Study|Adverse Event|0|||
146343509|NCT01089725|527763283|FG004|Overall Study|Adverse Event|2|||
146343510|NCT01089725|527763279|FG000|Overall Study|Lack of Efficacy|4|||
146343511|NCT01089725|527763280|FG001|Overall Study|Lack of Efficacy|3|||
146343512|NCT01089725|527763281|FG002|Overall Study|Lack of Efficacy|1|||
146343513|NCT01089725|527763282|FG003|Overall Study|Lack of Efficacy|0|||
146343514|NCT01089725|527763283|FG004|Overall Study|Lack of Efficacy|4|||
146343515|NCT01089725|527763279|FG000|Overall Study|Lost to Follow-up|2|||
146343516|NCT01089725|527763280|FG001|Overall Study|Lost to Follow-up|2|||
146343517|NCT01089725|527763281|FG002|Overall Study|Lost to Follow-up|0|||
146343518|NCT01089725|527763282|FG003|Overall Study|Lost to Follow-up|3|||
146343519|NCT01089725|527763283|FG004|Overall Study|Lost to Follow-up|0|||
146343520|NCT01089725|527763279|FG000|Overall Study|Protocol Violation|0|||
146343521|NCT01089725|527763280|FG001|Overall Study|Protocol Violation|0|||
146343522|NCT01089725|527763281|FG002|Overall Study|Protocol Violation|1|||
146343523|NCT01089725|527763282|FG003|Overall Study|Protocol Violation|1|||
146343524|NCT01089725|527763283|FG004|Overall Study|Protocol Violation|0|||
146343525|NCT01089725|527763279|FG000|Overall Study|Withdrawal by Subject|5|||
146343526|NCT01089725|527763280|FG001|Overall Study|Withdrawal by Subject|5|||
146343527|NCT01089725|527763281|FG002|Overall Study|Withdrawal by Subject|4|||
146343528|NCT01089725|527763282|FG003|Overall Study|Withdrawal by Subject|5|||
146343529|NCT01089725|527763283|FG004|Overall Study|Withdrawal by Subject|4|||
146343530|NCT01089725|527763279|FG000|Overall Study|Study Terminated by Sponsor|51|||
146343531|NCT01089725|527763280|FG001|Overall Study|Study Terminated by Sponsor|56|||
146343532|NCT01089725|527763281|FG002|Overall Study|Study Terminated by Sponsor|53|||
146343533|NCT01089725|527763282|FG003|Overall Study|Study Terminated by Sponsor|68|||
146343534|NCT01089725|527763283|FG004|Overall Study|Study Terminated by Sponsor|68|||
146343535|NCT01089725|527763279|FG000|Overall Study|Randomized, but not treated|0|||
146343536|NCT01089725|527763280|FG001|Overall Study|Randomized, but not treated|1|||
146343537|NCT01089725|527763281|FG002|Overall Study|Randomized, but not treated|2|||
146343538|NCT01089725|527763282|FG003|Overall Study|Randomized, but not treated|1|||
146343539|NCT01089725|527763283|FG004|Overall Study|Randomized, but not treated|2|||
146343540|NCT01089725|527763279|FG000|Overall Study|Other|3|||
146343541|NCT01089725|527763280|FG001|Overall Study|Other|0|||
146343542|NCT01089725|527763281|FG002|Overall Study|Other|0|||
146343543|NCT01089725|527763282|FG003|Overall Study|Other|1|||
146343544|NCT01089725|527763283|FG004|Overall Study|Other|0|||
146343545|NCT01486316|527764959|FG000|Overall Study|Device explanted with/without re-implant|3|||
146343546|NCT01486316|527764960|FG001|Overall Study|Device explanted with/without re-implant|2|||
146343547|NCT01486316|527764961|FG002|Overall Study|Device explanted with/without re-implant|0|||
146343548|NCT01486316|527764962|FG003|Overall Study|Device explanted with/without re-implant|2|||
146343549|NCT01486316|527764959|FG000|Overall Study|Not meeting eligibility criteria|0|||
146343550|NCT01486316|527764960|FG001|Overall Study|Not meeting eligibility criteria|0|||
146343551|NCT01486316|527764961|FG002|Overall Study|Not meeting eligibility criteria|1|||
146343552|NCT01486316|527764962|FG003|Overall Study|Not meeting eligibility criteria|0|||
146343553|NCT01486316|527764959|FG000|Overall Study|Withdrawal by Subject|1|||
146343554|NCT01486316|527764960|FG001|Overall Study|Withdrawal by Subject|0|||
146343555|NCT01486316|527764961|FG002|Overall Study|Withdrawal by Subject|3|||
146343556|NCT01486316|527764962|FG003|Overall Study|Withdrawal by Subject|0|||
146343557|NCT01486316|527764959|FG000|Overall Study|Physician Decision|0|||
146343558|NCT01486316|527764960|FG001|Overall Study|Physician Decision|0|||
146343559|NCT01486316|527764961|FG002|Overall Study|Physician Decision|1|||
146343560|NCT01486316|527764962|FG003|Overall Study|Physician Decision|0|||
146343561|NCT01486316|527764959|FG000|Overall Study|Death|0|||
146343562|NCT01486316|527764960|FG001|Overall Study|Death|1|||
146343563|NCT01486316|527764961|FG002|Overall Study|Death|0|||
146343564|NCT01486316|527764962|FG003|Overall Study|Death|0|||
146343565|NCT00375934|527764972|FG000|Overall Study|Adverse Event|1|||
146343566|NCT00375934|527764973|FG001|Overall Study|Adverse Event|1|||
146343567|NCT00375934|527764972|FG000|Overall Study|Withdrawal by Subject|2|||
146343568|NCT00375934|527764973|FG001|Overall Study|Withdrawal by Subject|2|||
146343569|NCT00375934|527764972|FG000|Overall Study|Lack of Efficacy|0|||
146343570|NCT00375934|527764973|FG001|Overall Study|Lack of Efficacy|2|||
146343571|NCT00375934|527764972|FG000|Overall Study|Physician Decision|0|||
146343572|NCT00375934|527764973|FG001|Overall Study|Physician Decision|1|||
146343573|NCT03191396|527764974|FG000|Overall Study|Lost to Follow-up|0|||
146343574|NCT03191396|527764975|FG001|Overall Study|Lost to Follow-up|3|||
146343575|NCT03191396|527764974|FG000|Overall Study|Withdrawal by Subject|3|||
146343576|NCT03191396|527764975|FG001|Overall Study|Withdrawal by Subject|2|||
146343577|NCT02452970|527764976|FG000|Overall Study|Adverse Event|1|||
146343578|NCT01266148|527764977|FG000|Overall Study|Adverse Event|2|||
146343579|NCT01266148|527764978|FG001|Overall Study|Adverse Event|0|||
146343580|NCT01266148|527764977|FG000|Overall Study|Ongoing rejection|1|||
146343581|NCT01266148|527764978|FG001|Overall Study|Ongoing rejection|0|||
146343582|NCT01266148|527764977|FG000|Overall Study|2 2R rejections|1|||
146343583|NCT01266148|527764978|FG001|Overall Study|2 2R rejections|0|||
146343584|NCT01266148|527764977|FG000|Overall Study|Death|2|||
146343585|NCT01266148|527764978|FG001|Overall Study|Death|3|||
146343586|NCT01266148|527764977|FG000|Overall Study|missing mGFR value + AE|1|||
146343587|NCT01266148|527764978|FG001|Overall Study|missing mGFR value + AE|0|||
146343588|NCT01269125|527764987|FG000|Overall Study|Adverse Event|3|||
146343589|NCT01269125|527764988|FG001|Overall Study|Adverse Event|5|||
146343590|NCT01269125|527764989|FG002|Overall Study|Adverse Event|0|||
146343591|NCT01269125|527764987|FG000|Overall Study|Lost to Follow-up|4|||
146343592|NCT01269125|527764988|FG001|Overall Study|Lost to Follow-up|0|||
146343593|NCT01269125|527764989|FG002|Overall Study|Lost to Follow-up|0|||
146343594|NCT01518699|527764991|FG000|Period 2|Protocol Violation|1|||
146343595|NCT01518699|527764992|FG001|Period 2|Protocol Violation|1|||
146343596|NCT01518699|527764993|FG002|Period 2|Protocol Violation|0|||
146343597|NCT01518699|527764994|FG003|Period 2|Protocol Violation|0|||
146343598|NCT01518699|527764995|FG004|Period 2|Protocol Violation|0|||
146343599|NCT01518699|527764996|FG005|Period 2|Protocol Violation|0|||
146343600|NCT01518699|527764991|FG000|Period 2|Lost to Follow-up|0|||
146343601|NCT01518699|527764992|FG001|Period 2|Lost to Follow-up|1|||
146343602|NCT01518699|527764993|FG002|Period 2|Lost to Follow-up|0|||
146343603|NCT01518699|527764994|FG003|Period 2|Lost to Follow-up|0|||
146343604|NCT01518699|527764995|FG004|Period 2|Lost to Follow-up|0|||
146343605|NCT01518699|527764996|FG005|Period 2|Lost to Follow-up|0|||
146343606|NCT01518699|527764991|FG000|Period 2|Adverse Event|1|||
146343607|NCT01518699|527764992|FG001|Period 2|Adverse Event|0|||
146343608|NCT01518699|527764993|FG002|Period 2|Adverse Event|0|||
146343609|NCT01518699|527764994|FG003|Period 2|Adverse Event|0|||
146343610|NCT01518699|527764995|FG004|Period 2|Adverse Event|0|||
146343611|NCT01518699|527764996|FG005|Period 2|Adverse Event|0|||
146343612|NCT01040832|527764997|FG000|Overall Study|Adverse Event|4|||
146343613|NCT01040832|527764998|FG001|Overall Study|Adverse Event|5|||
146343614|NCT01040832|527764997|FG000|Overall Study|Death|4|||
146343615|NCT01040832|527764998|FG001|Overall Study|Death|6|||
146343616|NCT01040832|527764997|FG000|Overall Study|Withdrawal by Subject|2|||
146343617|NCT01040832|527764998|FG001|Overall Study|Withdrawal by Subject|3|||
146343618|NCT01040832|527764997|FG000|Overall Study|Progressive disease|32|||
146343619|NCT01040832|527764998|FG001|Overall Study|Progressive disease|17|||
146343620|NCT01040832|527764997|FG000|Overall Study|Symptomatic deterioration|2|||
146343621|NCT01040832|527764998|FG001|Overall Study|Symptomatic deterioration|5|||
146343622|NCT01040832|527764997|FG000|Overall Study|Other|2|||
146343623|NCT01040832|527764998|FG001|Overall Study|Other|1|||
146343624|NCT03692910|527765001|FG000|Overall Study|Lost to Follow-up|4|||
146343625|NCT03692910|527765002|FG001|Overall Study|Lost to Follow-up|0|||
146343626|NCT03692910|527765003|FG002|Overall Study|Lost to Follow-up|0|||
146343627|NCT03692910|527765001|FG000|Overall Study|Withdrawal by Subject|2|||
146343628|NCT03692910|527765002|FG001|Overall Study|Withdrawal by Subject|0|||
146343629|NCT03692910|527765003|FG002|Overall Study|Withdrawal by Subject|0|||
146343630|NCT00417612|527765004|FG000|Overall Study|Errant diagnosis|0|||
146343631|NCT00417612|527765005|FG001|Overall Study|Errant diagnosis|1|||
146343632|NCT00417612|527765004|FG000|Overall Study|Adverse Event|2|||
146343633|NCT00417612|527765005|FG001|Overall Study|Adverse Event|0|||
146343634|NCT00417612|527765004|FG000|Overall Study|Protocol Violation|0|||
146343635|NCT00417612|527765005|FG001|Overall Study|Protocol Violation|2|||
146343636|NCT00417612|527765004|FG000|Overall Study|Lost to Follow-up|1|||
146343637|NCT00417612|527765005|FG001|Overall Study|Lost to Follow-up|0|||
146343638|NCT00486226|527765006|FG000|Overall Study|Death|3|||
146343639|NCT00486226|527765006|FG000|Overall Study|Adverse Event|1|||
146343640|NCT00486226|527765006|FG000|Overall Study|Withdrawal by Subject|1|||
146343641|NCT00486226|527765006|FG000|Overall Study|Lost to Follow-up|8|||
146343642|NCT01712438|527765007|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
146343643|NCT01712438|527765007|FG000|Overall Study|Ongoing ITI treatment|6|||
146343644|NCT01712438|527765007|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
146343645|NCT01712438|527765007|FG000|Overall Study|Prematurely Discontinued|25|||
146343646|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
146343647|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
146343648|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
146343649|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
146343650|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
146343651|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
146343652|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
146343653|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
146343654|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
146343655|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
146343656|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
146343657|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
146343658|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
146343659|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
146343660|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
146343661|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
146343662|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
146343663|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
146343664|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
146343665|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
146343666|NCT01259492|527765008|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
146343667|NCT01259492|527765009|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
146343668|NCT01259492|527765010|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
146343669|NCT01259492|527765011|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
146343670|NCT01259492|527765008|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
146343671|NCT01259492|527765009|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
146343672|NCT01259492|527765010|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
146343673|NCT01259492|527765011|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
146343674|NCT01259492|527765008|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
146343675|NCT01259492|527765009|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
146343676|NCT01259492|527765010|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
146343677|NCT01259492|527765011|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
146343678|NCT01259492|527765008|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
146343679|NCT01259492|527765009|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
146343680|NCT01259492|527765010|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
146343681|NCT01259492|527765011|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
146343682|NCT01259492|527765008|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146343683|NCT01259492|527765009|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146343684|NCT01259492|527765010|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
146343685|NCT01259492|527765011|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
146343686|NCT01259492|527765008|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
146343687|NCT01259492|527765009|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
146343688|NCT01259492|527765010|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
146343689|NCT01259492|527765011|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
146343690|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
146343691|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
146343692|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
146343693|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
146343694|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146343695|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146343696|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
146343697|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
146343698|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146343699|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146343700|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
146343701|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
146343702|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
146343703|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
146343704|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
146343705|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
146343706|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
146343707|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146343708|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146343709|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
146343710|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
146343711|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
146343712|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
146343713|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
146343714|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
146343715|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
146343716|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
146343717|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
146343718|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146343719|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146343720|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
146343721|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
146343722|NCT01259492|527765008|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
146343723|NCT01259492|527765009|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
146343724|NCT01259492|527765010|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
146343725|NCT01259492|527765011|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
146343726|NCT01981122|527765012|FG000|Overall Study|Withdrawal by Subject|0|||
146343727|NCT01981122|527765013|FG001|Overall Study|Withdrawal by Subject|2|||
146343728|NCT01981122|527765012|FG000|Overall Study|Protocol Violation|0|||
146343729|NCT01981122|527765013|FG001|Overall Study|Protocol Violation|1|||
146343730|NCT01981122|527765012|FG000|Overall Study|Lost to Follow-up|0|||
146343731|NCT01981122|527765013|FG001|Overall Study|Lost to Follow-up|1|||
146343732|NCT01981122|527765012|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
146343733|NCT01981122|527765013|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
146343734|NCT01981122|527765012|FG000|Overall Study|Death|14|||
146343735|NCT01981122|527765013|FG001|Overall Study|Death|15|||
146343736|NCT00521339|527765016|FG000|Treatment Phase|Adverse Event|2|||
146343737|NCT00521339|527765017|FG001|Treatment Phase|Adverse Event|0|||
146343738|NCT00521339|527765018|FG002|Treatment Phase|Adverse Event|0|||
146343739|NCT00521339|527765016|FG000|Treatment Phase|Intolerability to study drug|2|||
146343740|NCT00521339|527765017|FG001|Treatment Phase|Intolerability to study drug|0|||
146343741|NCT00521339|527765018|FG002|Treatment Phase|Intolerability to study drug|0|||
146343742|NCT00521339|527765016|FG000|Treatment Phase|Lack of Efficacy|3|||
146343743|NCT00521339|527765017|FG001|Treatment Phase|Lack of Efficacy|0|||
146343744|NCT00521339|527765018|FG002|Treatment Phase|Lack of Efficacy|0|||
146343745|NCT00521339|527765016|FG000|Treatment Phase|Withdrawal by Subject|3|||
146343746|NCT00521339|527765017|FG001|Treatment Phase|Withdrawal by Subject|0|||
146343747|NCT00521339|527765018|FG002|Treatment Phase|Withdrawal by Subject|0|||
146343748|NCT00521339|527765016|FG000|Treatment Phase|Lost to Follow-up|1|||
146343749|NCT00521339|527765017|FG001|Treatment Phase|Lost to Follow-up|0|||
146343750|NCT00521339|527765018|FG002|Treatment Phase|Lost to Follow-up|0|||
146343751|NCT00521339|527765016|FG000|Treatment Phase|Protocol Violation|1|||
146343752|NCT00521339|527765017|FG001|Treatment Phase|Protocol Violation|0|||
146343753|NCT00521339|527765018|FG002|Treatment Phase|Protocol Violation|0|||
146343754|NCT00521339|527765016|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
146343755|NCT00521339|527765017|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
146343756|NCT00521339|527765018|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
146343757|NCT00521339|527765016|FG000|Treatment Extension Phase|Death|0|||
146343758|NCT00521339|527765017|FG001|Treatment Extension Phase|Death|0|||
146343759|NCT00521339|527765018|FG002|Treatment Extension Phase|Death|1|||
146343760|NCT02940886|527765019|FG000|Overall Study|Adverse Event|7|||
146343761|NCT02940886|527765020|FG001|Overall Study|Adverse Event|3|||
146343762|NCT02940886|527765019|FG000|Overall Study|Protocol Violation|0|||
146343763|NCT02940886|527765020|FG001|Overall Study|Protocol Violation|2|||
146343764|NCT02940886|527765019|FG000|Overall Study|Withdrawal by Subject|28|||
146343765|NCT02940886|527765020|FG001|Overall Study|Withdrawal by Subject|20|||
146343766|NCT02940886|527765019|FG000|Overall Study|Death|1|||
146343767|NCT02940886|527765020|FG001|Overall Study|Death|0|||
146343768|NCT02940886|527765019|FG000|Overall Study|Lack of Efficacy|1|||
146343769|NCT02940886|527765020|FG001|Overall Study|Lack of Efficacy|0|||
146343770|NCT02940886|527765019|FG000|Overall Study|Lost to Follow-up|49|||
146343771|NCT02940886|527765020|FG001|Overall Study|Lost to Follow-up|21|||
146343772|NCT02940886|527765019|FG000|Overall Study|Physician Decision|9|||
146343773|NCT02940886|527765020|FG001|Overall Study|Physician Decision|4|||
146343774|NCT02940886|527765019|FG000|Overall Study|Sponsor decision|0|||
146343775|NCT02940886|527765020|FG001|Overall Study|Sponsor decision|1|||
146343776|NCT02940886|527765019|FG000|Overall Study|No treatment|7|||
146343777|NCT02940886|527765020|FG001|Overall Study|No treatment|2|||
146169291|NCT04270747|527131169|FG002|Post Week 16|Miscellaneous|1|||
146343778|NCT02940886|527765019|FG000|Overall Study|Enrolment error|0|||
146343779|NCT02940886|527765020|FG001|Overall Study|Enrolment error|1|||
146343780|NCT00634543|527765024|FG000|Overall Study|Other|1|||
146343781|NCT00634543|527765025|FG001|Overall Study|Other|2|||
146343782|NCT00634543|527765024|FG000|Overall Study|Protocol Violation|3|||
146343783|NCT00634543|527765025|FG001|Overall Study|Protocol Violation|3|||
146343784|NCT00634543|527765024|FG000|Overall Study|Adverse Event|11|||
146343785|NCT00634543|527765025|FG001|Overall Study|Adverse Event|11|||
146343786|NCT00634543|527765024|FG000|Overall Study|Withdrawal by Subject|4|||
146343787|NCT00634543|527765025|FG001|Overall Study|Withdrawal by Subject|4|||
146343788|NCT00634543|527765024|FG000|Overall Study|Lost to Follow-up|0|||
146343789|NCT00634543|527765025|FG001|Overall Study|Lost to Follow-up|1|||
146343790|NCT03515538|527765026|FG000|Overall Study|Lack of Efficacy|2|||
146343791|NCT03515538|527765027|FG001|Overall Study|Lack of Efficacy|0|||
146343792|NCT03515538|527765028|FG002|Overall Study|Lack of Efficacy|2|||
146343793|NCT03515538|527765029|FG003|Overall Study|Lack of Efficacy|0|||
146343794|NCT03515538|527765026|FG000|Overall Study|Death|0|||
146343795|NCT03515538|527765027|FG001|Overall Study|Death|0|||
146343796|NCT03515538|527765028|FG002|Overall Study|Death|1|||
146343797|NCT03515538|527765029|FG003|Overall Study|Death|0|||
146343798|NCT03515538|527765026|FG000|Overall Study|Protocol Violation|0|||
146343799|NCT03515538|527765027|FG001|Overall Study|Protocol Violation|0|||
146343800|NCT03515538|527765028|FG002|Overall Study|Protocol Violation|0|||
146343801|NCT03515538|527765029|FG003|Overall Study|Protocol Violation|1|||
146343802|NCT03515538|527765026|FG000|Overall Study|Screen failure (baseline dropout)|0|||
146343803|NCT03515538|527765027|FG001|Overall Study|Screen failure (baseline dropout)|1|||
146343804|NCT03515538|527765028|FG002|Overall Study|Screen failure (baseline dropout)|0|||
146343805|NCT03515538|527765029|FG003|Overall Study|Screen failure (baseline dropout)|0|||
146343806|NCT03515538|527765026|FG000|Overall Study|Withdrawal by Subject|2|||
146343807|NCT03515538|527765027|FG001|Overall Study|Withdrawal by Subject|2|||
146343808|NCT03515538|527765028|FG002|Overall Study|Withdrawal by Subject|1|||
146343809|NCT03515538|527765029|FG003|Overall Study|Withdrawal by Subject|3|||
146343810|NCT03515538|527765026|FG000|Overall Study|Physician Decision|1|||
146343811|NCT03515538|527765027|FG001|Overall Study|Physician Decision|0|||
146343812|NCT03515538|527765028|FG002|Overall Study|Physician Decision|0|||
146343813|NCT03515538|527765029|FG003|Overall Study|Physician Decision|1|||
146343814|NCT01650779|527765038|FG000|Overall Study|Withdrawal by Subject|1|||
146343815|NCT02397655|527765045|FG000|Overall Study|data not completed|1301|||
146343816|NCT01736683|527765046|FG000|Overall Study|Disease Relapse|0|||
146343817|NCT01736683|527765047|FG001|Overall Study|Disease Relapse|0|||
146343818|NCT01736683|527765048|FG002|Overall Study|Disease Relapse|2|||
146343819|NCT01736683|527765049|FG003|Overall Study|Disease Relapse|1|||
146343820|NCT01736683|527765050|FG004|Overall Study|Disease Relapse|0|||
146343821|NCT01736683|527765046|FG000|Overall Study|Adverse Event|0|||
146343822|NCT01736683|527765047|FG001|Overall Study|Adverse Event|2|||
146343823|NCT01736683|527765048|FG002|Overall Study|Adverse Event|2|||
146343824|NCT01736683|527765049|FG003|Overall Study|Adverse Event|3|||
146343825|NCT01736683|527765050|FG004|Overall Study|Adverse Event|2|||
146343826|NCT01736683|527765046|FG000|Overall Study|Withdrawal by Subject|0|||
146343827|NCT01736683|527765047|FG001|Overall Study|Withdrawal by Subject|0|||
146343828|NCT01736683|527765048|FG002|Overall Study|Withdrawal by Subject|3|||
146343829|NCT01736683|527765049|FG003|Overall Study|Withdrawal by Subject|1|||
146343830|NCT01736683|527765050|FG004|Overall Study|Withdrawal by Subject|1|||
146343831|NCT01736683|527765046|FG000|Overall Study|Lack of Therapeutic Effect|7|||
146343832|NCT01736683|527765047|FG001|Overall Study|Lack of Therapeutic Effect|4|||
146343833|NCT01736683|527765048|FG002|Overall Study|Lack of Therapeutic Effect|13|||
146343834|NCT01736683|527765049|FG003|Overall Study|Lack of Therapeutic Effect|20|||
146343835|NCT01736683|527765050|FG004|Overall Study|Lack of Therapeutic Effect|1|||
146343836|NCT01736683|527765046|FG000|Overall Study|Progressive Disease|0|||
146343837|NCT01736683|527765047|FG001|Overall Study|Progressive Disease|0|||
146343838|NCT01736683|527765048|FG002|Overall Study|Progressive Disease|0|||
146343839|NCT01736683|527765049|FG003|Overall Study|Progressive Disease|1|||
146343840|NCT01736683|527765050|FG004|Overall Study|Progressive Disease|0|||
146343841|NCT01736683|527765046|FG000|Overall Study|Other|0|||
146343842|NCT01736683|527765047|FG001|Overall Study|Other|0|||
146343843|NCT01736683|527765048|FG002|Overall Study|Other|1|||
146343844|NCT01736683|527765049|FG003|Overall Study|Other|9|||
146343845|NCT01736683|527765050|FG004|Overall Study|Other|1|||
146343846|NCT00098345|527765052|FG000|Overall Study|Adverse Event|7|||
146343847|NCT00098345|527765052|FG000|Overall Study|Withdrawal by Subject|2|||
146343848|NCT00098345|527765052|FG000|Overall Study|progression|4|||
146343849|NCT01183858|527765053|FG000|Overall Study|Death not related to Progressive Disease|5|||
146343850|NCT01183858|527765054|FG001|Overall Study|Death not related to Progressive Disease|6|||
146343851|NCT01183858|527765053|FG000|Overall Study|Adverse Event|14|||
146343852|NCT01183858|527765054|FG001|Overall Study|Adverse Event|11|||
146343853|NCT01183858|527765053|FG000|Overall Study|Investigator's Decision|0|||
146343854|NCT01183858|527765054|FG001|Overall Study|Investigator's Decision|3|||
146343855|NCT01183858|527765053|FG000|Overall Study|Insufficient Therapeutic Response|2|||
146343856|NCT01183858|527765054|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146343857|NCT01183858|527765053|FG000|Overall Study|Refused Treatment|1|||
146343858|NCT01183858|527765054|FG001|Overall Study|Refused Treatment|4|||
146343859|NCT01183858|527765053|FG000|Overall Study|Withdrew Consent|4|||
146343860|NCT01183858|527765054|FG001|Overall Study|Withdrew Consent|4|||
146343861|NCT01183858|527765053|FG000|Overall Study|Discontinued Smoking|3|||
146343862|NCT01183858|527765054|FG001|Overall Study|Discontinued Smoking|1|||
146343863|NCT01183858|527765053|FG000|Overall Study|Protocol Violation|1|||
146343864|NCT01183858|527765054|FG001|Overall Study|Protocol Violation|0|||
146343865|NCT01183858|527765053|FG000|Overall Study|Administrative/Other|6|||
146343866|NCT01183858|527765054|FG001|Overall Study|Administrative/Other|6|||
146343867|NCT01183858|527765053|FG000|Overall Study|Progressive Disease|112|||
146343868|NCT01183858|527765054|FG001|Overall Study|Progressive Disease|115|||
146343869|NCT01183858|527765053|FG000|Overall Study|Death related to Progressive Disease|4|||
146343870|NCT01183858|527765054|FG001|Overall Study|Death related to Progressive Disease|5|||
146343871|NCT01183858|527765053|FG000|Overall Study|Lost to Follow-up|1|||
146343872|NCT01183858|527765054|FG001|Overall Study|Lost to Follow-up|1|||
146343873|NCT03707977|527765059|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
146343874|NCT03707977|527765060|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
146343875|NCT03707977|527765061|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
146343876|NCT03707977|527765059|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
146343877|NCT03707977|527765060|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
146343878|NCT03707977|527765061|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
146343879|NCT00641147|527765062|FG000|Completed 4 Months.|Physician Decision|1|||
146343880|NCT00641147|527765063|FG001|Completed 4 Months.|Physician Decision|0|||
146343881|NCT00641147|527765062|FG000|Completed 4 Months.|Adverse Event|1|||
146343882|NCT00641147|527765063|FG001|Completed 4 Months.|Adverse Event|0|||
146343883|NCT00641147|527765062|FG000|Completed 8 Months.|Physician Decision|2|||
146343884|NCT00641147|527765063|FG001|Completed 8 Months.|Physician Decision|1|||
146343885|NCT00641147|527765062|FG000|Completed 8 Months.|non compliance|1|||
146343886|NCT00641147|527765063|FG001|Completed 8 Months.|non compliance|0|||
146343887|NCT00641147|527765062|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
146343888|NCT00641147|527765063|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
146343889|NCT00641147|527765062|FG000|Completed 12 Months.|Physician Decision|1|||
146343890|NCT00641147|527765063|FG001|Completed 12 Months.|Physician Decision|1|||
146343891|NCT00641147|527765062|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
146343892|NCT00641147|527765063|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
146343893|NCT00641147|527765062|FG000|Completed 16 Months.|Physician Decision|1|||
146343894|NCT00641147|527765063|FG001|Completed 16 Months.|Physician Decision|0|||
146343895|NCT00641147|527765062|FG000|Completed 16 Months.|Lost to Follow-up|1|||
146343896|NCT00641147|527765063|FG001|Completed 16 Months.|Lost to Follow-up|0|||
146343897|NCT00791128|527765064|FG000|Overall Study|Adverse Event|4|||
146343898|NCT00791128|527765064|FG000|Overall Study|Device migration|2|||
146343899|NCT00791128|527765064|FG000|Overall Study|non-compliance by subject|2|||
146343900|NCT00791128|527765064|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
146343901|NCT01629667|527765065|FG000|Overall Study|Lost to Follow-up|0|||
146343902|NCT01629667|527765066|FG001|Overall Study|Lost to Follow-up|1|||
146343903|NCT01629667|527765067|FG002|Overall Study|Lost to Follow-up|1|||
146343904|NCT01629667|527765065|FG000|Overall Study|Withdrawal by Subject|31|||
146343905|NCT01629667|527765066|FG001|Overall Study|Withdrawal by Subject|20|||
146343906|NCT01629667|527765067|FG002|Overall Study|Withdrawal by Subject|28|||
146343907|NCT01629667|527765065|FG000|Overall Study|Death|1|||
146343908|NCT01629667|527765066|FG001|Overall Study|Death|5|||
146343909|NCT01629667|527765067|FG002|Overall Study|Death|3|||
146343910|NCT01629667|527765065|FG000|Overall Study|Randomized, not treated|2|||
146343911|NCT01629667|527765066|FG001|Overall Study|Randomized, not treated|1|||
146343912|NCT01629667|527765067|FG002|Overall Study|Randomized, not treated|0|||
146343913|NCT01629667|527765065|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
146343914|NCT01629667|527765066|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
146343915|NCT01629667|527765067|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
146343916|NCT01629667|527765065|FG000|Overall Study|Requiring lung transplant|2|||
146343917|NCT01629667|527765066|FG001|Overall Study|Requiring lung transplant|1|||
146343918|NCT01629667|527765067|FG002|Overall Study|Requiring lung transplant|3|||
146343919|NCT01629667|527765065|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
146343920|NCT01629667|527765066|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
146343921|NCT01629667|527765067|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
146343922|NCT01629667|527765065|FG000|Overall Study|Started other medicine|1|||
146343923|NCT01629667|527765066|FG001|Overall Study|Started other medicine|0|||
146343924|NCT01629667|527765067|FG002|Overall Study|Started other medicine|1|||
146343925|NCT01629667|527765065|FG000|Overall Study|Site error in safety follow-up|0|||
146343926|NCT01629667|527765066|FG001|Overall Study|Site error in safety follow-up|0|||
146343927|NCT01629667|527765067|FG002|Overall Study|Site error in safety follow-up|1|||
146343928|NCT01629667|527765065|FG000|Overall Study|Enrolled in another clinical study|0|||
146343929|NCT01629667|527765066|FG001|Overall Study|Enrolled in another clinical study|1|||
146343930|NCT01629667|527765067|FG002|Overall Study|Enrolled in another clinical study|0|||
146343931|NCT01629667|527765065|FG000|Overall Study|Code break|1|||
146343932|NCT01629667|527765066|FG001|Overall Study|Code break|0|||
146343933|NCT01629667|527765067|FG002|Overall Study|Code break|0|||
146343934|NCT00670111|527765072|FG000|Enrollment to One Month|Testing Failure|0|||
146343935|NCT00670111|527765073|FG001|Enrollment to One Month|Testing Failure|0|||
146343936|NCT00670111|527765074|FG002|Enrollment to One Month|Testing Failure|13|||
146343937|NCT00670111|527765072|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
146343938|NCT00670111|527765073|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
146343939|NCT00670111|527765074|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
146343940|NCT00670111|527765072|FG000|Enrollment to One Month|Physician Decision|1|||
146343941|NCT00670111|527765073|FG001|Enrollment to One Month|Physician Decision|0|||
146343942|NCT00670111|527765074|FG002|Enrollment to One Month|Physician Decision|0|||
146343943|NCT00844883|527765075|FG000|Overall Study|Bridged to liver transplant|3|||
146343944|NCT00844883|527765075|FG000|Overall Study|Bridged to resection|1|||
146343945|NCT02623361|527765076|FG000|Overall Study|Protocol Violation|0|||
146343946|NCT02623361|527765077|FG001|Overall Study|Protocol Violation|1|||
146343947|NCT02623361|527765076|FG000|Overall Study|Withdrawal by Subject|0|||
146343948|NCT02623361|527765077|FG001|Overall Study|Withdrawal by Subject|1|||
146343949|NCT02441803|527765080|FG000|Overall Study|Physician Decision|0|||
146343950|NCT02441803|527765081|FG001|Overall Study|Physician Decision|2|||
146343951|NCT02441803|527765082|FG002|Overall Study|Physician Decision|2|||
146343952|NCT03065530|527765085|FG000|Overall Study|Lack of Efficacy|1|||
146343953|NCT03065530|527765086|FG001|Overall Study|Lack of Efficacy|1|||
146343954|NCT03065530|527765087|FG002|Overall Study|Lack of Efficacy|0|||
146343955|NCT03065530|527765088|FG003|Overall Study|Lack of Efficacy|1|||
146343956|NCT03065530|527765085|FG000|Overall Study|Protocol Violation|1|||
146343957|NCT03065530|527765086|FG001|Overall Study|Protocol Violation|0|||
146343958|NCT03065530|527765087|FG002|Overall Study|Protocol Violation|1|||
146343959|NCT03065530|527765088|FG003|Overall Study|Protocol Violation|1|||
146343960|NCT01325493|527765091|FG000|Overall Study|Protocol Violation|0|||
146343961|NCT01325493|527765092|FG001|Overall Study|Protocol Violation|1|||
146343962|NCT01325493|527765091|FG000|Overall Study|loss of neuromonitoring signals|0|||
146343963|NCT01325493|527765092|FG001|Overall Study|loss of neuromonitoring signals|2|||
146343964|NCT01325493|527765091|FG000|Overall Study|Allergy|1|||
146343965|NCT01325493|527765092|FG001|Overall Study|Allergy|0|||
146343966|NCT00328198|527765097|FG000|Treatment|Adverse Event|21|||
146343967|NCT00328198|527765097|FG000|Treatment|Death|1|||
146343968|NCT00328198|527765097|FG000|Treatment|Physician Decision|5|||
146343969|NCT00328198|527765097|FG000|Treatment|Withdrawal by Subject|5|||
146343970|NCT00328198|527765097|FG000|Treatment|Evidence of disease progression|2|||
146343971|NCT00328198|527765097|FG000|Treatment|Non-compliance|1|||
146343972|NCT00328198|527765097|FG000|Treatment|Confirmed complete response, MRD -|3|||
146343973|NCT00328198|527765097|FG000|Follow-up|Lost to Follow-up|4|||
146343974|NCT00328198|527765097|FG000|Follow-up|Death|31|||
146343975|NCT01720667|527765101|FG000|Overall Study|Adverse Event|1|||
146343976|NCT01720667|527765102|FG001|Overall Study|Adverse Event|1|||
146343977|NCT01720667|527765101|FG000|Overall Study|Withdrawal by Subject|3|||
146343978|NCT01720667|527765102|FG001|Overall Study|Withdrawal by Subject|0|||
146343979|NCT02117050|527765105|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
146343980|NCT02052960|527765107|FG000|Overall Study|Adverse Event|19|||
146343981|NCT02052960|527765108|FG001|Overall Study|Adverse Event|17|||
146343982|NCT02052960|527765107|FG000|Overall Study|Protocol Violation|4|||
146343983|NCT02052960|527765108|FG001|Overall Study|Protocol Violation|3|||
146343984|NCT02052960|527765107|FG000|Overall Study|Withdrawal by Subject|6|||
146343985|NCT02052960|527765108|FG001|Overall Study|Withdrawal by Subject|11|||
146343986|NCT02052960|527765107|FG000|Overall Study|Other|25|||
146343987|NCT02052960|527765108|FG001|Overall Study|Other|15|||
146343988|NCT03233048|527765111|FG000|Overall Study|Withdrawal by Subject|1|||
146343989|NCT00491530|527765112|FG000|Overall Study|Adverse Event|6|||
146343990|NCT00491530|527765113|FG001|Overall Study|Adverse Event|1|||
146343991|NCT00491530|527765114|FG002|Overall Study|Adverse Event|2|||
146343992|NCT00491530|527765112|FG000|Overall Study|Withdrawal by Subject|3|||
146343993|NCT00491530|527765113|FG001|Overall Study|Withdrawal by Subject|0|||
146343994|NCT00491530|527765114|FG002|Overall Study|Withdrawal by Subject|0|||
146169292|NCT05960097|527131170|FG000|Overall Study|Lost to Follow-up|3|||
146343995|NCT00491530|527765112|FG000|Overall Study|Lost to Follow-up|3|||
146343996|NCT00491530|527765113|FG001|Overall Study|Lost to Follow-up|2|||
146343997|NCT00491530|527765114|FG002|Overall Study|Lost to Follow-up|2|||
146343998|NCT00491530|527765112|FG000|Overall Study|Lack of Efficacy|0|||
146343999|NCT00491530|527765113|FG001|Overall Study|Lack of Efficacy|1|||
146344000|NCT00491530|527765114|FG002|Overall Study|Lack of Efficacy|0|||
146344001|NCT00491530|527765112|FG000|Overall Study|Investigator Discretion|0|||
146344002|NCT00491530|527765113|FG001|Overall Study|Investigator Discretion|1|||
146344003|NCT00491530|527765114|FG002|Overall Study|Investigator Discretion|0|||
146344004|NCT00491530|527765112|FG000|Overall Study|Patient Request|0|||
146344005|NCT00491530|527765113|FG001|Overall Study|Patient Request|1|||
146344006|NCT00491530|527765114|FG002|Overall Study|Patient Request|0|||
146344007|NCT00491530|527765112|FG000|Overall Study|Use of Prohibited Medication|0|||
146344008|NCT00491530|527765113|FG001|Overall Study|Use of Prohibited Medication|0|||
146344009|NCT00491530|527765114|FG002|Overall Study|Use of Prohibited Medication|1|||
146344010|NCT01396525|527765115|FG000|Overall Study|Withdrawal by Subject|8|||
146344011|NCT01396525|527765115|FG000|Overall Study|Death|14|||
146344012|NCT01396525|527765115|FG000|Overall Study|Lost to Follow-up|4|||
146344013|NCT00949650|527765116|FG000|Overall Study|Progressive disease|188|||
146344014|NCT00949650|527765117|FG001|Overall Study|Progressive disease|19|||
146344015|NCT00949650|527765116|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
146344016|NCT00949650|527765117|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
146344017|NCT00949650|527765116|FG000|Overall Study|Other Adverse Event (AE)|28|||
146344018|NCT00949650|527765117|FG001|Overall Study|Other Adverse Event (AE)|17|||
146344019|NCT00949650|527765116|FG000|Overall Study|Protocol Violation|1|||
146344020|NCT00949650|527765117|FG001|Overall Study|Protocol Violation|4|||
146344021|NCT00949650|527765116|FG000|Overall Study|Refusal to continue medication|7|||
146344022|NCT00949650|527765117|FG001|Overall Study|Refusal to continue medication|11|||
146344023|NCT00949650|527765116|FG000|Overall Study|Not treated|1|||
146344024|NCT00949650|527765117|FG001|Overall Study|Not treated|4|||
146344025|NCT00949650|527765116|FG000|Overall Study|Other not specified above|5|||
146344026|NCT00949650|527765117|FG001|Overall Study|Other not specified above|0|||
146344027|NCT03671369|527765119|FG000|Overall Study|Other|1|||
146344028|NCT03671369|527765119|FG000|Overall Study|Withdrawal by Subject|289|||
146344029|NCT03671369|527765119|FG000|Overall Study|Not willing to be vaccinated|1|||
146344030|NCT02612077|527765121|FG000|Overall Study|Adverse Event|3|||
146344031|NCT02612077|527765121|FG000|Overall Study|Withdrawal by Subject|9|||
146344032|NCT02612077|527765121|FG000|Overall Study|Protocol Violation|28|||
146344033|NCT02612077|527765121|FG000|Overall Study|Lost to Follow-up|20|||
146344034|NCT02612077|527765121|FG000|Overall Study|Death|377|||
146344035|NCT02612077|527765121|FG000|Overall Study|Moved or Changed Medical Team|23|||
146344036|NCT02612077|527765121|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
146344037|NCT02612077|527765121|FG000|Overall Study|Disease Progression|3|||
146344038|NCT02612077|527765121|FG000|Overall Study|Unknown reason|2|||
146344039|NCT01971476|527765122|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
146344040|NCT01971476|527765123|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
146344041|NCT01971476|527765124|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
146344042|NCT01971476|527765122|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
146344043|NCT01971476|527765123|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
146344044|NCT01971476|527765124|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
146344045|NCT01971476|527765122|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
146344046|NCT01971476|527765123|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
146344047|NCT01971476|527765124|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
146344048|NCT02498821|527765125|FG000|Overall Study|Screen failure|3|||
146344049|NCT02498821|527765126|FG001|Overall Study|Screen failure|5|||
146344050|NCT05243550|527767275|FG000|Overall Study|Ongoing in the Study|171|||
146344051|NCT05243550|527767275|FG000|Overall Study|Withdrawal by Subject|10|||
146344052|NCT05243550|527767275|FG000|Overall Study|Lost to Follow-up|7|||
146344053|NCT05243550|527767275|FG000|Overall Study|Adverse Event|3|||
146344054|NCT05243550|527767275|FG000|Overall Study|Noncompliance|1|||
146344055|NCT05243550|527767275|FG000|Overall Study|Physician Decision|1|||
146344056|NCT05243550|527767275|FG000|Overall Study|Other Reason|4|||
146344057|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
146344058|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
146344059|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
146344060|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
146344061|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
146344062|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146344063|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146344064|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
146344065|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
146344066|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
146344067|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
146344068|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
146344069|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146344070|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146344071|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
146344072|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
146344073|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
146344074|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146344075|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
146344076|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
146169293|NCT05960097|527131171|FG001|Overall Study|Lost to Follow-up|1|||
146344077|NCT01894516|527767276|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146344078|NCT01894516|527767277|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
146344079|NCT01894516|527767278|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
146344080|NCT01894516|527767279|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
146344081|NCT01894516|527767276|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
146344082|NCT01894516|527767277|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
146344083|NCT01894516|527767278|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
146344084|NCT01894516|527767279|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
146344085|NCT01894516|527767276|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146344086|NCT01894516|527767277|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146344087|NCT01894516|527767278|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
146344088|NCT01894516|527767279|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
146344089|NCT00893113|527767282|FG000|Overall Study|Lost to Follow-up|4|||
146344090|NCT00893113|527767283|FG001|Overall Study|Lost to Follow-up|8|||
146344091|NCT00893113|527767282|FG000|Overall Study|Early Termination|1|||
146344092|NCT00893113|527767283|FG001|Overall Study|Early Termination|1|||
146344093|NCT00893113|527767282|FG000|Overall Study|Withdrew Consent|8|||
146344094|NCT00893113|527767283|FG001|Overall Study|Withdrew Consent|7|||
146344095|NCT03270085|527767286|FG000|Overall Study|Withdrawal by Subject|1|||
146344096|NCT03270085|527767287|FG001|Overall Study|Withdrawal by Subject|0|||
146344097|NCT02114203|527767288|FG000|Overall Study|Adverse Event|0|||
146344098|NCT02114203|527767289|FG001|Overall Study|Adverse Event|1|||
146344099|NCT02114203|527767290|FG002|Overall Study|Adverse Event|0|||
146344100|NCT02114203|527767288|FG000|Overall Study|Withdrawal by Subject|0|||
146344101|NCT02114203|527767289|FG001|Overall Study|Withdrawal by Subject|1|||
146344102|NCT02114203|527767290|FG002|Overall Study|Withdrawal by Subject|0|||
146344103|NCT00151411|527767295|FG000|Overall Study|Lost to Follow-up|15|||
146344104|NCT00151411|527767296|FG001|Overall Study|Lost to Follow-up|19|||
146344105|NCT00151411|527767295|FG000|Overall Study|Withdrawal by Subject|12|||
146344106|NCT00151411|527767296|FG001|Overall Study|Withdrawal by Subject|20|||
146344107|NCT00151411|527767295|FG000|Overall Study|Adverse Event|6|||
146344108|NCT00151411|527767296|FG001|Overall Study|Adverse Event|0|||
146344109|NCT00151411|527767295|FG000|Overall Study|Pregnancy|0|||
146344110|NCT00151411|527767296|FG001|Overall Study|Pregnancy|4|||
146344111|NCT01283581|527767297|FG000|Overall Study|Lost to Follow-up|8|||
146344112|NCT01283581|527767298|FG001|Overall Study|Lost to Follow-up|6|||
146344113|NCT01283581|527767299|FG002|Overall Study|Lost to Follow-up|8|||
146344114|NCT01283581|527767297|FG000|Overall Study|Withdrawal by Subject|2|||
146344115|NCT01283581|527767298|FG001|Overall Study|Withdrawal by Subject|5|||
146344116|NCT01283581|527767299|FG002|Overall Study|Withdrawal by Subject|2|||
146344117|NCT01283581|527767297|FG000|Overall Study|Adverse Event|1|||
146344118|NCT01283581|527767298|FG001|Overall Study|Adverse Event|1|||
146344119|NCT01283581|527767299|FG002|Overall Study|Adverse Event|4|||
146344120|NCT01283581|527767297|FG000|Overall Study|Physician Decision|0|||
146344121|NCT01283581|527767298|FG001|Overall Study|Physician Decision|1|||
146344122|NCT01283581|527767299|FG002|Overall Study|Physician Decision|2|||
146344123|NCT01283581|527767297|FG000|Overall Study|Protocol Violation|0|||
146344124|NCT01283581|527767298|FG001|Overall Study|Protocol Violation|1|||
146344125|NCT01283581|527767299|FG002|Overall Study|Protocol Violation|2|||
146344126|NCT01283581|527767297|FG000|Overall Study|Noncompliance|1|||
146344127|NCT01283581|527767298|FG001|Overall Study|Noncompliance|0|||
146344128|NCT01283581|527767299|FG002|Overall Study|Noncompliance|0|||
146344129|NCT01283581|527767297|FG000|Overall Study|Investigator unblinded|0|||
146344130|NCT01283581|527767298|FG001|Overall Study|Investigator unblinded|0|||
146344131|NCT01283581|527767299|FG002|Overall Study|Investigator unblinded|1|||
146344132|NCT01283581|527767297|FG000|Overall Study|"Early termination"|0|||
146344133|NCT01283581|527767298|FG001|Overall Study|"Early termination"|0|||
146344134|NCT01283581|527767299|FG002|Overall Study|"Early termination"|1|||
146169294|NCT05960097|527131172|FG002|Overall Study|Lost to Follow-up|1|||
146344170|NCT03060577|527767312|FG000|Overall Study|Withdrawal by Subject|25|||
146344171|NCT03060577|527767313|FG001|Overall Study|Withdrawal by Subject|5|||
146344172|NCT03060577|527767312|FG000|Overall Study|Physician Decision|4|||
146344173|NCT03060577|527767313|FG001|Overall Study|Physician Decision|3|||
146344174|NCT03060577|527767312|FG000|Overall Study|Lost to Follow-up|3|||
146344175|NCT03060577|527767313|FG001|Overall Study|Lost to Follow-up|0|||
146344176|NCT03060577|527767312|FG000|Overall Study|Death|7|||
146344177|NCT03060577|527767313|FG001|Overall Study|Death|1|||
146344178|NCT03060577|527767312|FG000|Overall Study|Adverse Event|9|||
146344179|NCT03060577|527767313|FG001|Overall Study|Adverse Event|1|||
146344180|NCT03060577|527767312|FG000|Overall Study|Inclusion/Exclusion|1|||
146344181|NCT03060577|527767313|FG001|Overall Study|Inclusion/Exclusion|0|||
146344182|NCT03060577|527767312|FG000|Overall Study|Other|8|||
146344183|NCT03060577|527767313|FG001|Overall Study|Other|2|||
146344184|NCT02584634|527767315|FG000|Overall Study|Adverse Event|3|||
146344185|NCT02584634|527767316|FG001|Overall Study|Adverse Event|5|||
146344186|NCT02584634|527767315|FG000|Overall Study|Death|0|||
146344187|NCT02584634|527767316|FG001|Overall Study|Death|1|||
146344188|NCT02584634|527767315|FG000|Overall Study|Lost to Follow-up|0|||
146344189|NCT02584634|527767316|FG001|Overall Study|Lost to Follow-up|1|||
146344190|NCT02584634|527767315|FG000|Overall Study|Physician Decision|1|||
146344191|NCT02584634|527767316|FG001|Overall Study|Physician Decision|2|||
146344192|NCT02584634|527767315|FG000|Overall Study|Progressive disease|7|||
146344193|NCT02584634|527767316|FG001|Overall Study|Progressive disease|15|||
146344194|NCT02584634|527767315|FG000|Overall Study|Withdrawal by Subject|1|||
146344195|NCT02584634|527767316|FG001|Overall Study|Withdrawal by Subject|1|||
146344196|NCT02584634|527767315|FG000|Overall Study|Other|0|||
146344197|NCT02584634|527767316|FG001|Overall Study|Other|6|||
146344198|NCT00474630|527767317|FG000|Overall Study|Adverse Event|98|||
146344199|NCT00474630|527767318|FG001|Overall Study|Adverse Event|26|||
146344200|NCT00474630|527767317|FG000|Overall Study|Lost to Follow-up|22|||
146344201|NCT00474630|527767318|FG001|Overall Study|Lost to Follow-up|15|||
146344202|NCT00474630|527767317|FG000|Overall Study|Withdrawal by Subject|21|||
146344203|NCT00474630|527767318|FG001|Overall Study|Withdrawal by Subject|15|||
146344204|NCT00474630|527767317|FG000|Overall Study|Protocol Violation|3|||
146344205|NCT00474630|527767318|FG001|Overall Study|Protocol Violation|4|||
146344206|NCT00474630|527767317|FG000|Overall Study|Lack of Efficacy|5|||
146344207|NCT00474630|527767318|FG001|Overall Study|Lack of Efficacy|6|||
146344208|NCT00474630|527767317|FG000|Overall Study|Drug noncompliance, other|11|||
146344209|NCT00474630|527767318|FG001|Overall Study|Drug noncompliance, other|4|||
146344210|NCT00915005|527767319|FG000|Overall Study|Withdrawal by Subject|4|||
146344211|NCT00915005|527767320|FG001|Overall Study|Withdrawal by Subject|4|||
146344212|NCT00915005|527767319|FG000|Overall Study|Patient preferred protons therapy|6|||
146344213|NCT00915005|527767320|FG001|Overall Study|Patient preferred protons therapy|0|||
146344214|NCT00915005|527767319|FG000|Overall Study|Insurance denial|3|||
146344215|NCT00915005|527767320|FG001|Overall Study|Insurance denial|15|||
146344216|NCT03069690|527767323|FG000|Pregnancy Intervention|Pregnancy loss|9|||
146344217|NCT03069690|527767324|FG001|Pregnancy Intervention|Pregnancy loss|4|||
146344218|NCT03069690|527767325|FG002|Pregnancy Intervention|Pregnancy loss|0|||
146344219|NCT03069690|527767326|FG003|Pregnancy Intervention|Pregnancy loss|0|||
146344220|NCT03069690|527767327|FG004|Pregnancy Intervention|Pregnancy loss|0|||
146344221|NCT03069690|527767328|FG005|Pregnancy Intervention|Pregnancy loss|0|||
146344222|NCT03069690|527767323|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
146344223|NCT03069690|527767324|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
146396298|NCT00276458|527954549|FG001|Overall Study|Protocol Violation|3|||
146344224|NCT03069690|527767325|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
146344225|NCT03069690|527767326|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
146344226|NCT03069690|527767327|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
146344227|NCT03069690|527767328|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
146344228|NCT03069690|527767323|FG000|Postpartum Intervention|Lost to Follow-up|0|||
146344229|NCT03069690|527767324|FG001|Postpartum Intervention|Lost to Follow-up|0|||
146344230|NCT03069690|527767325|FG002|Postpartum Intervention|Lost to Follow-up|5|||
146344231|NCT03069690|527767326|FG003|Postpartum Intervention|Lost to Follow-up|5|||
146344232|NCT03069690|527767327|FG004|Postpartum Intervention|Lost to Follow-up|2|||
146344233|NCT03069690|527767328|FG005|Postpartum Intervention|Lost to Follow-up|4|||
146344234|NCT02564120|527767329|FG000|Overall Study|Did not return release forms|160|||
146344235|NCT02564120|527767329|FG000|Overall Study|Death|58|||
146344236|NCT02564120|527767329|FG000|Overall Study|Withdrawal by Subject|204|||
146344237|NCT02564120|527767329|FG000|Overall Study|Other medical condition|24|||
146344238|NCT01966731|527767332|FG000|Overall Study|Death|2|||
146344239|NCT01966731|527767332|FG000|Overall Study|Lost to Follow-up|1|||
146344240|NCT01966731|527767332|FG000|Overall Study|Physician Decision|2|||
146344241|NCT01966731|527767332|FG000|Overall Study|Follow up is not complete|600|||
146344242|NCT01966731|527767332|FG000|Overall Study|Screening Failure|29|||
146344243|NCT01966731|527767332|FG000|Overall Study|Found to be ineligible|1|||
146344244|NCT01380093|527767333|FG000|Naloxone Challenge Phase|Screen failures|21|||
146344245|NCT01380093|527767334|FG001|Naloxone Challenge Phase|Screen failures|0|||
146344246|NCT01380093|527767335|FG002|Naloxone Challenge Phase|Screen failures|0|||
146344247|NCT01380093|527767336|FG003|Naloxone Challenge Phase|Screen failures|0|||
146344248|NCT01380093|527767337|FG004|Naloxone Challenge Phase|Screen failures|0|||
146344249|NCT01380093|527767338|FG005|Naloxone Challenge Phase|Screen failures|0|||
146344250|NCT01380093|527767339|FG006|Naloxone Challenge Phase|Screen failures|0|||
146344251|NCT01380093|527767340|FG007|Naloxone Challenge Phase|Screen failures|0|||
146344252|NCT01380093|527767341|FG008|Naloxone Challenge Phase|Screen failures|0|||
146344253|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344254|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
146344255|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344256|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344257|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344258|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344259|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344260|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344261|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
146344262|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344263|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
146344264|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
146344265|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344266|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344267|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344268|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344269|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344270|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
146344271|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344272|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
146344273|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344274|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344275|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344276|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344277|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344278|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344279|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
146344280|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344281|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
146344282|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
146344283|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344284|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344285|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344286|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344287|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344288|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
146344289|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344290|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
146344291|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
145943381|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
146344292|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344293|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344294|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344295|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344296|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344297|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
146344298|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344299|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344300|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
146344301|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344302|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344303|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344304|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344305|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344306|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
146344307|NCT01380093|527767333|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344308|NCT01380093|527767334|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344309|NCT01380093|527767335|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
146344310|NCT01380093|527767336|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344311|NCT01380093|527767337|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344312|NCT01380093|527767338|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344313|NCT01380093|527767339|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344314|NCT01380093|527767340|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344315|NCT01380093|527767341|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
146344316|NCT01380093|527767333|FG000|Treatment Phase: Second Intervention|Other|0|||
146344317|NCT01380093|527767334|FG001|Treatment Phase: Second Intervention|Other|0|||
146344318|NCT01380093|527767335|FG002|Treatment Phase: Second Intervention|Other|0|||
146344319|NCT01380093|527767336|FG003|Treatment Phase: Second Intervention|Other|1|||
146344320|NCT01380093|527767337|FG004|Treatment Phase: Second Intervention|Other|0|||
146344321|NCT01380093|527767338|FG005|Treatment Phase: Second Intervention|Other|0|||
146344322|NCT01380093|527767339|FG006|Treatment Phase: Second Intervention|Other|0|||
146344323|NCT01380093|527767340|FG007|Treatment Phase: Second Intervention|Other|0|||
146344324|NCT01380093|527767341|FG008|Treatment Phase: Second Intervention|Other|0|||
146344325|NCT01380093|527767333|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
146344326|NCT01380093|527767334|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
146344327|NCT01380093|527767335|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
146344328|NCT01380093|527767336|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
146344329|NCT01380093|527767337|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
146344330|NCT01380093|527767338|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
146344331|NCT01380093|527767339|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
146344332|NCT01380093|527767340|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
146344333|NCT01380093|527767341|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
146344334|NCT01380093|527767333|FG000|Treatment Phase: Third Intervention|Other|0|||
146344335|NCT01380093|527767334|FG001|Treatment Phase: Third Intervention|Other|0|||
146344336|NCT01380093|527767335|FG002|Treatment Phase: Third Intervention|Other|0|||
146344337|NCT01380093|527767336|FG003|Treatment Phase: Third Intervention|Other|0|||
146344338|NCT01380093|527767337|FG004|Treatment Phase: Third Intervention|Other|0|||
146344339|NCT01380093|527767338|FG005|Treatment Phase: Third Intervention|Other|0|||
146344340|NCT01380093|527767339|FG006|Treatment Phase: Third Intervention|Other|0|||
146344341|NCT01380093|527767340|FG007|Treatment Phase: Third Intervention|Other|0|||
146344342|NCT01380093|527767341|FG008|Treatment Phase: Third Intervention|Other|1|||
146344343|NCT03952650|527767342|FG000|Overall Study|TRAVEL|0|||
146344344|NCT03952650|527767343|FG001|Overall Study|TRAVEL|4|||
146344345|NCT03952650|527767344|FG002|Overall Study|TRAVEL|0|||
146344346|NCT03952650|527767345|FG003|Overall Study|TRAVEL|4|||
146344347|NCT03952650|527767346|FG004|Overall Study|TRAVEL|0|||
146344348|NCT03952650|527767347|FG005|Overall Study|TRAVEL|3|||
146169295|NCT05960097|527131173|FG003|Overall Study|Lost to Follow-up|2|||
146169296|NCT05960097|527131174|FG004|Overall Study|Lost to Follow-up|1|||
146169297|NCT05960097|527131175|FG005|Overall Study|Lost to Follow-up|1|||
146169298|NCT05960097|527131176|FG006|Overall Study|Lost to Follow-up|2|||
146169299|NCT05960097|527131177|FG007|Overall Study|Lost to Follow-up|3|||
146169300|NCT05960097|527131170|FG000|Overall Study|Physician Decision|0|||
146344349|NCT03952650|527767348|FG006|Overall Study|TRAVEL|2|||
146344350|NCT03952650|527767342|FG000|Overall Study|Withdrawal by Subject|0|||
146344351|NCT03952650|527767343|FG001|Overall Study|Withdrawal by Subject|2|||
146344352|NCT03952650|527767344|FG002|Overall Study|Withdrawal by Subject|0|||
146344353|NCT03952650|527767345|FG003|Overall Study|Withdrawal by Subject|3|||
146344354|NCT03952650|527767346|FG004|Overall Study|Withdrawal by Subject|0|||
146344355|NCT03952650|527767347|FG005|Overall Study|Withdrawal by Subject|1|||
146169301|NCT05960097|527131171|FG001|Overall Study|Physician Decision|0|||
146169302|NCT05960097|527131172|FG002|Overall Study|Physician Decision|0|||
146344356|NCT03952650|527767348|FG006|Overall Study|Withdrawal by Subject|1|||
146344357|NCT03952650|527767342|FG000|Overall Study|Lost to Follow-up|0|||
146344358|NCT03952650|527767343|FG001|Overall Study|Lost to Follow-up|1|||
146344359|NCT03952650|527767344|FG002|Overall Study|Lost to Follow-up|0|||
146344360|NCT03952650|527767345|FG003|Overall Study|Lost to Follow-up|0|||
146344361|NCT03952650|527767346|FG004|Overall Study|Lost to Follow-up|0|||
146344362|NCT03952650|527767347|FG005|Overall Study|Lost to Follow-up|1|||
146344363|NCT03952650|527767348|FG006|Overall Study|Lost to Follow-up|1|||
146344364|NCT03952650|527767342|FG000|Overall Study|Received wrong vaccine and travelled|0|||
146344365|NCT03952650|527767343|FG001|Overall Study|Received wrong vaccine and travelled|0|||
146344366|NCT03952650|527767344|FG002|Overall Study|Received wrong vaccine and travelled|0|||
146344367|NCT03952650|527767345|FG003|Overall Study|Received wrong vaccine and travelled|0|||
146344368|NCT03952650|527767346|FG004|Overall Study|Received wrong vaccine and travelled|0|||
146344369|NCT03952650|527767347|FG005|Overall Study|Received wrong vaccine and travelled|1|||
146344370|NCT03952650|527767348|FG006|Overall Study|Received wrong vaccine and travelled|0|||
146344371|NCT03952650|527767342|FG000|Overall Study|Unable to make study visit|0|||
146344372|NCT03952650|527767343|FG001|Overall Study|Unable to make study visit|0|||
146344373|NCT03952650|527767344|FG002|Overall Study|Unable to make study visit|0|||
146344374|NCT03952650|527767345|FG003|Overall Study|Unable to make study visit|0|||
146344375|NCT03952650|527767346|FG004|Overall Study|Unable to make study visit|0|||
146344376|NCT03952650|527767347|FG005|Overall Study|Unable to make study visit|1|||
146344377|NCT03952650|527767348|FG006|Overall Study|Unable to make study visit|0|||
146344378|NCT00592683|527767349|FG000|Overall Study|Found ineligible|0|||
146344379|NCT00592683|527767350|FG001|Overall Study|Found ineligible|1|||
146344380|NCT00592683|527767349|FG000|Overall Study|Withdrawal by Subject|1|||
146344381|NCT00592683|527767350|FG001|Overall Study|Withdrawal by Subject|0|||
146344382|NCT00592683|527767349|FG000|Overall Study|Adverse Event|0|||
146344383|NCT00592683|527767350|FG001|Overall Study|Adverse Event|2|||
146344384|NCT00592683|527767349|FG000|Overall Study|Protocol Violation|1|||
146344385|NCT00592683|527767350|FG001|Overall Study|Protocol Violation|0|||
146344386|NCT00592683|527767349|FG000|Overall Study|Study drug expired|1|||
146344387|NCT00592683|527767350|FG001|Overall Study|Study drug expired|0|||
146344388|NCT00592683|527767349|FG000|Overall Study|Other|1|||
146344389|NCT00592683|527767350|FG001|Overall Study|Other|0|||
146344390|NCT00592683|527767349|FG000|Overall Study|Lost to Follow-up|0|||
146344391|NCT00592683|527767350|FG001|Overall Study|Lost to Follow-up|1|||
146344392|NCT00201201|527767351|FG000|Overall Study|Death|0|||
146344393|NCT00201201|527767352|FG001|Overall Study|Death|2|||
146344394|NCT00201201|527767351|FG000|Overall Study|Withdrawal by Subject|5|||
146344395|NCT00201201|527767352|FG001|Overall Study|Withdrawal by Subject|5|||
146344396|NCT00545818|527767356|FG000|Overall Study|Protocol Violation|1|||
146344397|NCT00545818|527767357|FG001|Overall Study|Protocol Violation|0|||
146344398|NCT00545818|527767356|FG000|Overall Study|Adverse Event|1|||
146344399|NCT00545818|527767357|FG001|Overall Study|Adverse Event|1|||
146344400|NCT00545818|527767356|FG000|Overall Study|Lost to Follow-up|1|||
146344401|NCT00545818|527767357|FG001|Overall Study|Lost to Follow-up|6|||
146344402|NCT00609609|527767358|FG000|Overall Study|Withdrawal by Subject|2|||
146344403|NCT00609609|527767359|FG001|Overall Study|Withdrawal by Subject|0|||
146344404|NCT00609609|527767358|FG000|Overall Study|Progression|4|||
146344405|NCT00609609|527767359|FG001|Overall Study|Progression|2|||
146344406|NCT03988751|527767362|FG000|Overall Study|Withdrawal by Subject|1|||
146344407|NCT03988751|527767363|FG001|Overall Study|Withdrawal by Subject|0|||
146344408|NCT03988751|527767362|FG000|Overall Study|Protocol Violation|0|||
146344409|NCT03988751|527767363|FG001|Overall Study|Protocol Violation|1|||
146344410|NCT01753518|527767365|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
146344411|NCT01753518|527767366|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
146344412|NCT01753518|527767365|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
146344413|NCT01753518|527767366|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
146344414|NCT01753518|527767365|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
146344415|NCT01753518|527767366|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
146344416|NCT01753518|527767365|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
146344417|NCT01753518|527767366|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
146344418|NCT00940342|527767367|FG000|Overall Study|Adverse Event|0|||
146344419|NCT00940342|527767368|FG001|Overall Study|Adverse Event|2|||
146344420|NCT00940342|527767369|FG002|Overall Study|Adverse Event|1|||
146344421|NCT00553787|527767370|FG000|Overall Study|Adverse Event|34|||
146344422|NCT00553787|527767371|FG001|Overall Study|Adverse Event|21|||
146344423|NCT00553787|527767372|FG002|Overall Study|Adverse Event|67|||
146169303|NCT05960097|527131173|FG003|Overall Study|Physician Decision|0|||
146169304|NCT05960097|527131174|FG004|Overall Study|Physician Decision|0|||
146169305|NCT05960097|527131175|FG005|Overall Study|Physician Decision|0|||
146344424|NCT00553787|527767370|FG000|Overall Study|Lost to Follow-up|132|||
146344425|NCT00553787|527767371|FG001|Overall Study|Lost to Follow-up|44|||
146344426|NCT00553787|527767372|FG002|Overall Study|Lost to Follow-up|78|||
146344427|NCT00553787|527767370|FG000|Overall Study|Withdrawal by Subject|151|||
146344428|NCT00553787|527767371|FG001|Overall Study|Withdrawal by Subject|40|||
146344429|NCT00553787|527767372|FG002|Overall Study|Withdrawal by Subject|83|||
146344430|NCT00553787|527767370|FG000|Overall Study|Lack of Efficacy|31|||
146344431|NCT00553787|527767371|FG001|Overall Study|Lack of Efficacy|1|||
146344432|NCT00553787|527767372|FG002|Overall Study|Lack of Efficacy|3|||
146344433|NCT00553787|527767370|FG000|Overall Study|Pregnancy|0|||
146344434|NCT00553787|527767371|FG001|Overall Study|Pregnancy|1|||
146344435|NCT00553787|527767372|FG002|Overall Study|Pregnancy|2|||
146344436|NCT00553787|527767370|FG000|Overall Study|non compliance|4|||
146344437|NCT00553787|527767371|FG001|Overall Study|non compliance|0|||
146344438|NCT00553787|527767372|FG002|Overall Study|non compliance|11|||
146344439|NCT00553787|527767370|FG000|Overall Study|Requirement for restricted medication|8|||
146344440|NCT00553787|527767371|FG001|Overall Study|Requirement for restricted medication|7|||
146344441|NCT00553787|527767372|FG002|Overall Study|Requirement for restricted medication|5|||
146344442|NCT00553787|527767370|FG000|Overall Study|Other|18|||
146344443|NCT00553787|527767371|FG001|Overall Study|Other|10|||
146344444|NCT00553787|527767372|FG002|Overall Study|Other|13|||
146344445|NCT01088412|527767373|FG000|Overall Study|Adverse Event|38|||
146344446|NCT01088412|527767374|FG001|Overall Study|Adverse Event|0|||
146344447|NCT01088412|527767375|FG002|Overall Study|Adverse Event|0|||
146344448|NCT01088412|527767373|FG000|Overall Study|Death|42|||
146344449|NCT01088412|527767374|FG001|Overall Study|Death|6|||
146344450|NCT01088412|527767375|FG002|Overall Study|Death|0|||
146344451|NCT01088412|527767373|FG000|Overall Study|Other Reason per Case Report Form|2089|||
146344452|NCT01088412|527767374|FG001|Overall Study|Other Reason per Case Report Form|103|||
146344453|NCT01088412|527767375|FG002|Overall Study|Other Reason per Case Report Form|9|||
146344454|NCT01088412|527767373|FG000|Overall Study|Withdrawal by Subject|1761|||
146344455|NCT01088412|527767374|FG001|Overall Study|Withdrawal by Subject|25|||
146344456|NCT01088412|527767375|FG002|Overall Study|Withdrawal by Subject|1|||
146344457|NCT01088412|527767373|FG000|Overall Study|Received Another GH Product|79|||
146344458|NCT01088412|527767374|FG001|Overall Study|Received Another GH Product|0|||
146344459|NCT01088412|527767375|FG002|Overall Study|Received Another GH Product|0|||
146344460|NCT01088412|527767373|FG000|Overall Study|Participant Moved|601|||
146344461|NCT01088412|527767374|FG001|Overall Study|Participant Moved|21|||
146344462|NCT01088412|527767375|FG002|Overall Study|Participant Moved|2|||
146344463|NCT01088412|527767373|FG000|Overall Study|Physician Decision|1041|||
146344464|NCT01088412|527767374|FG001|Overall Study|Physician Decision|8|||
146344465|NCT01088412|527767375|FG002|Overall Study|Physician Decision|4|||
146344466|NCT01088412|527767373|FG000|Overall Study|Sponsor Decision|4467|||
146344467|NCT01088412|527767374|FG001|Overall Study|Sponsor Decision|79|||
146344468|NCT01088412|527767375|FG002|Overall Study|Sponsor Decision|23|||
146344469|NCT01088412|527767373|FG000|Overall Study|Third Party Required to Change Brand|487|||
146344470|NCT01088412|527767374|FG001|Overall Study|Third Party Required to Change Brand|0|||
146344471|NCT01088412|527767375|FG002|Overall Study|Third Party Required to Change Brand|0|||
146344472|NCT01088412|527767373|FG000|Overall Study|Lost to Follow-up|3052|||
146344473|NCT01088412|527767374|FG001|Overall Study|Lost to Follow-up|130|||
146344474|NCT01088412|527767375|FG002|Overall Study|Lost to Follow-up|11|||
146344475|NCT01088412|527767373|FG000|Overall Study|Study Summary Not Completed|4360|||
146344476|NCT01088412|527767374|FG001|Overall Study|Study Summary Not Completed|64|||
146344477|NCT01088412|527767375|FG002|Overall Study|Study Summary Not Completed|22|||
146344478|NCT00793104|527767376|FG000|Overall Study|Lost to Follow-up|1|||
146344479|NCT03494725|527767379|FG000|Overall Study|Withdrawal by Subject|0|||
146344480|NCT03494725|527767380|FG001|Overall Study|Withdrawal by Subject|2|||
146344481|NCT03494725|527767379|FG000|Overall Study|Antibiotic use|1|||
146344482|NCT03494725|527767380|FG001|Overall Study|Antibiotic use|0|||
146344483|NCT02619253|527767381|FG000|Overall Study|Adverse Event|0|||
146344484|NCT02619253|527767382|FG001|Overall Study|Adverse Event|0|||
146344485|NCT02619253|527767383|FG002|Overall Study|Adverse Event|1|||
146344486|NCT02619253|527767384|FG003|Overall Study|Adverse Event|1|||
146344487|NCT02619253|527767385|FG004|Overall Study|Adverse Event|3|||
146344488|NCT02619253|527767381|FG000|Overall Study|Alternative Therapy|0|||
146344489|NCT02619253|527767382|FG001|Overall Study|Alternative Therapy|0|||
146344490|NCT02619253|527767383|FG002|Overall Study|Alternative Therapy|1|||
146344491|NCT02619253|527767384|FG003|Overall Study|Alternative Therapy|0|||
146344492|NCT02619253|527767385|FG004|Overall Study|Alternative Therapy|0|||
146344493|NCT02619253|527767381|FG000|Overall Study|Death|0|||
146344494|NCT02619253|527767382|FG001|Overall Study|Death|0|||
146344495|NCT02619253|527767383|FG002|Overall Study|Death|0|||
146344496|NCT02619253|527767384|FG003|Overall Study|Death|1|||
146344497|NCT02619253|527767385|FG004|Overall Study|Death|0|||
146169306|NCT05960097|527131176|FG006|Overall Study|Physician Decision|1|||
146344498|NCT02619253|527767381|FG000|Overall Study|Disease Progression|4|||
146344499|NCT02619253|527767382|FG001|Overall Study|Disease Progression|2|||
146344500|NCT02619253|527767383|FG002|Overall Study|Disease Progression|8|||
146344501|NCT02619253|527767384|FG003|Overall Study|Disease Progression|9|||
146344502|NCT02619253|527767385|FG004|Overall Study|Disease Progression|10|||
146344503|NCT02619253|527767381|FG000|Overall Study|Needed a disqualifying therapy|0|||
146344504|NCT02619253|527767382|FG001|Overall Study|Needed a disqualifying therapy|0|||
146344505|NCT02619253|527767383|FG002|Overall Study|Needed a disqualifying therapy|1|||
146344506|NCT02619253|527767384|FG003|Overall Study|Needed a disqualifying therapy|0|||
146344507|NCT02619253|527767385|FG004|Overall Study|Needed a disqualifying therapy|0|||
146344508|NCT02619253|527767381|FG000|Overall Study|Transferred to hospice|0|||
146344509|NCT02619253|527767382|FG001|Overall Study|Transferred to hospice|0|||
146344510|NCT02619253|527767383|FG002|Overall Study|Transferred to hospice|1|||
146344511|NCT02619253|527767384|FG003|Overall Study|Transferred to hospice|0|||
146344512|NCT02619253|527767385|FG004|Overall Study|Transferred to hospice|0|||
146344513|NCT02619253|527767381|FG000|Overall Study|Physician Decision|0|||
146344514|NCT02619253|527767382|FG001|Overall Study|Physician Decision|1|||
146344515|NCT02619253|527767383|FG002|Overall Study|Physician Decision|2|||
146344516|NCT02619253|527767384|FG003|Overall Study|Physician Decision|3|||
146344517|NCT02619253|527767385|FG004|Overall Study|Physician Decision|0|||
146344518|NCT02619253|527767381|FG000|Overall Study|Withdrawal by Subject|0|||
146344519|NCT02619253|527767382|FG001|Overall Study|Withdrawal by Subject|1|||
146344520|NCT02619253|527767383|FG002|Overall Study|Withdrawal by Subject|0|||
146344521|NCT02619253|527767384|FG003|Overall Study|Withdrawal by Subject|0|||
146344522|NCT02619253|527767385|FG004|Overall Study|Withdrawal by Subject|2|||
146344523|NCT00514449|527767386|FG000|Overall Study|Withdrawal by Subject|1|||
146344524|NCT00514449|527767387|FG001|Overall Study|Withdrawal by Subject|2|||
146344525|NCT00514449|527767386|FG000|Overall Study|Protocol Violation|1|||
146344526|NCT00514449|527767387|FG001|Overall Study|Protocol Violation|2|||
146344527|NCT00514449|527767386|FG000|Overall Study|Lost to Follow-up|1|||
146344528|NCT00514449|527767387|FG001|Overall Study|Lost to Follow-up|0|||
146344529|NCT01457339|527767400|FG000|Period 3 (100 mg)|Adverse Event|0|||
146344530|NCT01457339|527767401|FG001|Period 3 (100 mg)|Adverse Event|1|||
146344531|NCT01457339|527767400|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
146344532|NCT01457339|527767401|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
146344533|NCT01457339|527767400|FG000|Period 6 (250 mg)|Family Emergency|1|||
146344534|NCT01457339|527767401|FG001|Period 6 (250 mg)|Family Emergency|0|||
146344535|NCT01457339|527767400|FG000|Period 6 (250 mg)|Personal appointment|0|||
146344536|NCT01457339|527767401|FG001|Period 6 (250 mg)|Personal appointment|1|||
146344537|NCT01164501|527767404|FG000|Overall Study|Not treated|2|||
146344538|NCT01164501|527767405|FG001|Overall Study|Not treated|0|||
146344539|NCT01164501|527767406|FG002|Overall Study|Not treated|1|||
146344540|NCT01164501|527767404|FG000|Overall Study|Adverse Event|18|||
146344541|NCT01164501|527767405|FG001|Overall Study|Adverse Event|4|||
146344542|NCT01164501|527767406|FG002|Overall Study|Adverse Event|21|||
146344543|NCT01164501|527767404|FG000|Overall Study|Lack of Efficacy|0|||
146344544|NCT01164501|527767405|FG001|Overall Study|Lack of Efficacy|0|||
146344545|NCT01164501|527767406|FG002|Overall Study|Lack of Efficacy|1|||
146344546|NCT01164501|527767404|FG000|Overall Study|Non compliant with protocol|1|||
146344547|NCT01164501|527767405|FG001|Overall Study|Non compliant with protocol|1|||
146344548|NCT01164501|527767406|FG002|Overall Study|Non compliant with protocol|4|||
146344549|NCT01164501|527767404|FG000|Overall Study|Lost to Follow-up|3|||
146344550|NCT01164501|527767405|FG001|Overall Study|Lost to Follow-up|0|||
146344551|NCT01164501|527767406|FG002|Overall Study|Lost to Follow-up|3|||
146344552|NCT01164501|527767404|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
146344553|NCT01164501|527767405|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
146344554|NCT01164501|527767406|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
146344555|NCT01164501|527767404|FG000|Overall Study|Other reason not defined above|9|||
146344556|NCT01164501|527767405|FG001|Overall Study|Other reason not defined above|1|||
146344557|NCT01164501|527767406|FG002|Overall Study|Other reason not defined above|4|||
146344558|NCT01096667|527767408|FG000|Overall Study|Lost to Follow-up|1|||
146344559|NCT01096667|527767409|FG001|Overall Study|Lost to Follow-up|1|||
146344560|NCT01096667|527767410|FG002|Overall Study|Lost to Follow-up|1|||
146344561|NCT01096667|527767411|FG003|Overall Study|Lost to Follow-up|0|||
146344562|NCT01096667|527767412|FG004|Overall Study|Lost to Follow-up|0|||
146344563|NCT01096667|527767408|FG000|Overall Study|Withdrawal by Subject|1|||
146344564|NCT01096667|527767409|FG001|Overall Study|Withdrawal by Subject|0|||
146344565|NCT01096667|527767410|FG002|Overall Study|Withdrawal by Subject|0|||
146344566|NCT01096667|527767411|FG003|Overall Study|Withdrawal by Subject|1|||
146344567|NCT01096667|527767412|FG004|Overall Study|Withdrawal by Subject|0|||
146344568|NCT01096667|527767408|FG000|Overall Study|Reason not available|0|||
146344569|NCT01096667|527767409|FG001|Overall Study|Reason not available|1|||
146344570|NCT01096667|527767410|FG002|Overall Study|Reason not available|1|||
146344571|NCT01096667|527767411|FG003|Overall Study|Reason not available|1|||
146344572|NCT01096667|527767412|FG004|Overall Study|Reason not available|0|||
146344573|NCT01096667|527767408|FG000|Overall Study|Protocol Violation|0|||
146344574|NCT01096667|527767409|FG001|Overall Study|Protocol Violation|0|||
146344575|NCT01096667|527767410|FG002|Overall Study|Protocol Violation|0|||
146344576|NCT01096667|527767411|FG003|Overall Study|Protocol Violation|1|||
146344577|NCT01096667|527767412|FG004|Overall Study|Protocol Violation|0|||
146344578|NCT01096667|527767408|FG000|Overall Study|Not treated|1|||
146344579|NCT01096667|527767409|FG001|Overall Study|Not treated|0|||
146344580|NCT01096667|527767410|FG002|Overall Study|Not treated|0|||
146344581|NCT01096667|527767411|FG003|Overall Study|Not treated|0|||
146344582|NCT01096667|527767412|FG004|Overall Study|Not treated|0|||
146344583|NCT00206518|527767419|FG000|Overall Study|Lack of Efficacy|6|||
146344584|NCT00206518|527767420|FG001|Overall Study|Lack of Efficacy|4|||
146344585|NCT00206518|527767419|FG000|Overall Study|Adverse Event|2|||
146344586|NCT00206518|527767420|FG001|Overall Study|Adverse Event|1|||
146344587|NCT00206518|527767419|FG000|Overall Study|Physician Decision|1|||
146344588|NCT00206518|527767420|FG001|Overall Study|Physician Decision|0|||
146344589|NCT00206518|527767419|FG000|Overall Study|Protocol Violation|1|||
146344590|NCT00206518|527767420|FG001|Overall Study|Protocol Violation|1|||
146344591|NCT02335450|527767421|FG000|Overall Study|Pregnancy|1|||
146344592|NCT00847561|527767424|FG000|Overall Study|Withdrawal by Subject|4|||
146344593|NCT00847561|527767425|FG001|Overall Study|Withdrawal by Subject|3|||
146344594|NCT00847561|527767424|FG000|Overall Study|Unable to schedule|9|||
146344595|NCT00847561|527767425|FG001|Overall Study|Unable to schedule|1|||
146344596|NCT00377299|527767426|FG000|Overall Study|Lost to Follow-up|14|||
146344597|NCT00377299|527767427|FG001|Overall Study|Lost to Follow-up|19|||
146344598|NCT00377299|527767426|FG000|Overall Study|Adverse Event|0|||
146344599|NCT00377299|527767427|FG001|Overall Study|Adverse Event|1|||
146344600|NCT00377299|527767426|FG000|Overall Study|Withdrawal by Subject|5|||
146344601|NCT00377299|527767427|FG001|Overall Study|Withdrawal by Subject|4|||
146344602|NCT02050048|527767430|FG000|Overall Study|Lost to Follow-up|0|||
146344603|NCT02050048|527767431|FG001|Overall Study|Lost to Follow-up|1|||
146344604|NCT02050048|527767430|FG000|Overall Study|Death|1|||
146344605|NCT02050048|527767431|FG001|Overall Study|Death|0|||
146344606|NCT02050048|527767430|FG000|Overall Study|Ineligible after ERCP|4|||
146344607|NCT02050048|527767431|FG001|Overall Study|Ineligible after ERCP|1|||
146344608|NCT01507246|527767435|FG000|Overall Study|Required different surgical procedures|2|||
146344609|NCT01507246|527767436|FG001|Overall Study|Required different surgical procedures|1|||
146344610|NCT02975349|527767437|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146344611|NCT02975349|527767438|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146344612|NCT02975349|527767439|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146344613|NCT02975349|527767440|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146344614|NCT02975349|527767441|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146344615|NCT02975349|527767442|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146344616|NCT02975349|527767443|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146344617|NCT02975349|527767437|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146344618|NCT02975349|527767438|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344619|NCT02975349|527767439|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344620|NCT02975349|527767440|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344621|NCT02975349|527767441|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344622|NCT02975349|527767442|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344623|NCT02975349|527767443|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146344624|NCT02975349|527767437|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
146344625|NCT02975349|527767438|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
146344626|NCT02975349|527767439|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
146344627|NCT02975349|527767440|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146344628|NCT02975349|527767441|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146344629|NCT02975349|527767442|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
146344630|NCT02975349|527767443|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
146344631|NCT02975349|527767437|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146344632|NCT02975349|527767438|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146344633|NCT02975349|527767439|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146344634|NCT02975349|527767440|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146344635|NCT02975349|527767441|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
146344636|NCT02975349|527767442|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
146344637|NCT02975349|527767443|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
146344638|NCT02975349|527767437|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146344639|NCT02975349|527767438|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
146344640|NCT02975349|527767439|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146344641|NCT02975349|527767440|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
146344642|NCT02975349|527767441|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
146344643|NCT02975349|527767442|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
146344644|NCT02975349|527767443|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
146344645|NCT02975349|527767437|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344646|NCT02975349|527767438|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344647|NCT02975349|527767439|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344648|NCT02975349|527767440|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
146344649|NCT02975349|527767441|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344650|NCT02975349|527767442|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344651|NCT02975349|527767443|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
146344652|NCT02975349|527767437|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344653|NCT02975349|527767438|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
146344654|NCT02975349|527767439|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344655|NCT02975349|527767440|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344656|NCT02975349|527767441|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344657|NCT02975349|527767442|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344658|NCT02975349|527767443|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
146344659|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
146344660|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
146344661|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
146344662|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146344663|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146344664|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
146344665|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
146344666|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344667|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344668|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344669|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344670|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
146344671|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344672|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
146344673|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146344674|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146344675|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146344676|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146344677|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
146344678|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
146344679|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
146344680|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
146344681|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
146169307|NCT05960097|527131177|FG007|Overall Study|Physician Decision|0|||
146169308|NCT05960097|527131170|FG000|Overall Study|Withdrawal by Subject|1|||
146169309|NCT05960097|527131171|FG001|Overall Study|Withdrawal by Subject|0|||
146344682|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
146344683|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
146344684|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
146344685|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
146344686|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
146344687|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146344688|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146344689|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
146344690|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146344691|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146344692|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
146344693|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
146344694|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146344695|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146344696|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
146344697|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146344698|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146344699|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
146344700|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
146344701|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
146344702|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
146344703|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
146344704|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
146344705|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
146344706|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
146344707|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
146344708|NCT02975349|527767437|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
146344709|NCT02975349|527767438|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
146344710|NCT02975349|527767439|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
146344711|NCT02975349|527767440|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
146344712|NCT02975349|527767441|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
146344713|NCT02975349|527767442|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
146344714|NCT02975349|527767443|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
146344715|NCT02531035|527768970|FG000|Overall Study|Death|0|||
146344716|NCT02531035|527768971|FG001|Overall Study|Death|1|||
146344717|NCT02531035|527768970|FG000|Overall Study|Protocol Violation|1|||
146169310|NCT05960097|527131172|FG002|Overall Study|Withdrawal by Subject|0|||
146344718|NCT02531035|527768971|FG001|Overall Study|Protocol Violation|1|||
146344719|NCT02531035|527768970|FG000|Overall Study|Noncompliance with study drug|8|||
146344720|NCT02531035|527768971|FG001|Overall Study|Noncompliance with study drug|3|||
146344721|NCT02531035|527768970|FG000|Overall Study|Physician Decision|1|||
146344722|NCT02531035|527768971|FG001|Overall Study|Physician Decision|0|||
146344723|NCT02531035|527768970|FG000|Overall Study|Adverse Event|16|||
146344724|NCT02531035|527768971|FG001|Overall Study|Adverse Event|45|||
146344725|NCT02531035|527768970|FG000|Overall Study|Other|3|||
146344726|NCT02531035|527768971|FG001|Overall Study|Other|2|||
146344727|NCT02531035|527768970|FG000|Overall Study|Withdrawal by Subject|42|||
146344728|NCT02531035|527768971|FG001|Overall Study|Withdrawal by Subject|32|||
146344729|NCT02531035|527768970|FG000|Overall Study|Lost to Follow-up|8|||
146344730|NCT02531035|527768971|FG001|Overall Study|Lost to Follow-up|10|||
146344731|NCT02531035|527768970|FG000|Overall Study|Randomized, not treated|2|||
146344732|NCT02531035|527768971|FG001|Overall Study|Randomized, not treated|1|||
146344733|NCT01543490|527768975|FG000|Overall Study|Adverse Event|4|||
146344734|NCT01543490|527768976|FG001|Overall Study|Adverse Event|0|||
146344735|NCT01543490|527768975|FG000|Overall Study|Physician Decision|1|||
146344736|NCT01543490|527768976|FG001|Overall Study|Physician Decision|0|||
146344737|NCT01543490|527768975|FG000|Overall Study|Lack of Efficacy|3|||
146344738|NCT01543490|527768976|FG001|Overall Study|Lack of Efficacy|3|||
146344739|NCT01543490|527768975|FG000|Overall Study|Lost to Follow-up|5|||
146344740|NCT01543490|527768976|FG001|Overall Study|Lost to Follow-up|0|||
146344741|NCT01543490|527768975|FG000|Overall Study|Withdrawal by Subject|2|||
146344742|NCT01543490|527768976|FG001|Overall Study|Withdrawal by Subject|0|||
146344743|NCT01543490|527768975|FG000|Overall Study|Other-Various Administrative Reasons|1|||
146344744|NCT01543490|527768976|FG001|Overall Study|Other-Various Administrative Reasons|2|||
146344745|NCT04168645|527768981|FG000|Overall Study|Lost to Follow-up|23|||
146344746|NCT04168645|527768982|FG001|Overall Study|Lost to Follow-up|28|||
146344747|NCT04168645|527768983|FG002|Overall Study|Lost to Follow-up|15|||
146344748|NCT04168645|527768984|FG003|Overall Study|Lost to Follow-up|12|||
146344749|NCT04168645|527768981|FG000|Overall Study|Death|1|||
146344750|NCT04168645|527768982|FG001|Overall Study|Death|1|||
146344751|NCT04168645|527768983|FG002|Overall Study|Death|0|||
146344752|NCT04168645|527768984|FG003|Overall Study|Death|0|||
146344753|NCT04168645|527768981|FG000|Overall Study|Withdrawal by Subject|5|||
146344754|NCT04168645|527768982|FG001|Overall Study|Withdrawal by Subject|2|||
146344755|NCT04168645|527768983|FG002|Overall Study|Withdrawal by Subject|2|||
146344756|NCT04168645|527768984|FG003|Overall Study|Withdrawal by Subject|2|||
146344757|NCT04168645|527768981|FG000|Overall Study|Administrative Withdrawal|3|||
146344758|NCT04168645|527768982|FG001|Overall Study|Administrative Withdrawal|1|||
146344759|NCT04168645|527768983|FG002|Overall Study|Administrative Withdrawal|1|||
146344760|NCT04168645|527768984|FG003|Overall Study|Administrative Withdrawal|3|||
146344761|NCT02400346|527768985|FG000|Overall Study|Adverse Event|24|||
146344762|NCT02400346|527768985|FG000|Overall Study|Lack of Efficacy|9|||
146344763|NCT02400346|527768985|FG000|Overall Study|Non-compliance with IMP|1|||
146344764|NCT02400346|527768985|FG000|Overall Study|Withdrawal by Subject|7|||
146344765|NCT02400346|527768985|FG000|Overall Study|Administrative or other reason(s)|2|||
146344766|NCT02400346|527768985|FG000|Overall Study|Lost to Follow-up|1|||
146344767|NCT00500149|527768986|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
146344768|NCT00500149|527768987|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
146344769|NCT00500149|527768986|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
146344770|NCT00500149|527768987|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
146344771|NCT00500149|527768986|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
146344772|NCT00500149|527768987|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
146344773|NCT00500149|527768986|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
146344774|NCT00500149|527768987|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
146344775|NCT00500149|527768986|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
146344776|NCT00500149|527768987|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
146344777|NCT00500149|527768986|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
146344778|NCT00500149|527768987|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
146344779|NCT00500149|527768986|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
146344780|NCT00500149|527768987|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
146344781|NCT01058369|527768988|FG000|Overall Study|Adverse Event|1|||
146344782|NCT01058369|527768988|FG000|Overall Study|Early termination study|1|||
146344783|NCT00089843|527768989|FG000|Overall Study|Withdrawal by Subject|1|||
146344784|NCT00089843|527768990|FG001|Overall Study|Withdrawal by Subject|4|||
146344785|NCT00089843|527768991|FG002|Overall Study|Withdrawal by Subject|5|||
146344786|NCT00089843|527768992|FG003|Overall Study|Withdrawal by Subject|6|||
146344787|NCT00089843|527768989|FG000|Overall Study|Physician Decision|1|||
146344788|NCT00089843|527768990|FG001|Overall Study|Physician Decision|0|||
146344789|NCT00089843|527768991|FG002|Overall Study|Physician Decision|0|||
146344790|NCT00089843|527768992|FG003|Overall Study|Physician Decision|1|||
146344791|NCT01157169|527768993|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
146344792|NCT01157169|527768994|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
146344793|NCT01157169|527768993|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
146344794|NCT01157169|527768994|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
146344795|NCT00663858|527768995|FG000|Overall Study|Adverse Event|9|||
146344796|NCT00663858|527768996|FG001|Overall Study|Adverse Event|1|||
146344797|NCT00663858|527768997|FG002|Overall Study|Adverse Event|6|||
146344798|NCT00663858|527768995|FG000|Overall Study|Lack of Efficacy|5|||
146344799|NCT00663858|527768996|FG001|Overall Study|Lack of Efficacy|1|||
146344800|NCT00663858|527768997|FG002|Overall Study|Lack of Efficacy|3|||
146344801|NCT00663858|527768995|FG000|Overall Study|Withdrawal by Subject|7|||
146344802|NCT00663858|527768996|FG001|Overall Study|Withdrawal by Subject|3|||
146344803|NCT00663858|527768997|FG002|Overall Study|Withdrawal by Subject|3|||
146344804|NCT00663858|527768995|FG000|Overall Study|Protocol Violation|5|||
146344805|NCT00663858|527768996|FG001|Overall Study|Protocol Violation|3|||
146344806|NCT00663858|527768997|FG002|Overall Study|Protocol Violation|4|||
146344807|NCT00663858|527768995|FG000|Overall Study|Other|8|||
146344808|NCT00663858|527768996|FG001|Overall Study|Other|2|||
146344809|NCT00663858|527768997|FG002|Overall Study|Other|4|||
146344810|NCT01277289|527769001|FG000|Overall Study|fragile vein|1|||
146344811|NCT01277289|527769002|FG001|Overall Study|fragile vein|0|||
146344812|NCT01277289|527769001|FG000|Overall Study|Physician Decision|1|||
146344813|NCT01277289|527769002|FG001|Overall Study|Physician Decision|0|||
146344814|NCT01277289|527769001|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
146344815|NCT01277289|527769002|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
146344816|NCT01277289|527769001|FG000|Overall Study|Protocol Violation|1|||
146344817|NCT01277289|527769002|FG001|Overall Study|Protocol Violation|1|||
146344818|NCT01277289|527769001|FG000|Overall Study|Adverse Event|2|||
146344819|NCT01277289|527769002|FG001|Overall Study|Adverse Event|1|||
146344820|NCT01277289|527769001|FG000|Overall Study|consent withdrawn|1|||
146344821|NCT01277289|527769002|FG001|Overall Study|consent withdrawn|1|||
146344822|NCT01277289|527769001|FG000|Overall Study|premature closure of the study|4|||
146344823|NCT01277289|527769002|FG001|Overall Study|premature closure of the study|2|||
146344824|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
146344825|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
146344826|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
146344827|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
146344828|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
146344829|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
146344830|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
146344831|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
146344832|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
146344833|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
146344834|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
146344835|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
146344836|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
146344837|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
146344838|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
146344839|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
146344840|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
146344841|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
146344842|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
146344843|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
146344844|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
146344845|NCT00092547|527769003|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
146344846|NCT00092547|527769004|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
146344847|NCT00092547|527769005|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
146344848|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
146169311|NCT05960097|527131173|FG003|Overall Study|Withdrawal by Subject|1|||
146169312|NCT05960097|527131174|FG004|Overall Study|Withdrawal by Subject|1|||
146169313|NCT05960097|527131175|FG005|Overall Study|Withdrawal by Subject|0|||
146169314|NCT05960097|527131176|FG006|Overall Study|Withdrawal by Subject|0|||
146169315|NCT05960097|527131177|FG007|Overall Study|Withdrawal by Subject|0|||
146169316|NCT05960097|527131170|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169317|NCT05960097|527131171|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169318|NCT05960097|527131172|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
146169319|NCT05960097|527131173|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169320|NCT05960097|527131174|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169321|NCT05960097|527131175|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146344849|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
146344850|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
146169322|NCT05960097|527131176|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169323|NCT05960097|527131177|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
146169324|NCT01784068|527131178|FG000|NTCS Phase|Adverse Event|5|||
146169325|NCT01784068|527131179|FG001|NTCS Phase|Adverse Event|0|||
146169326|NCT01784068|527131178|FG000|NTCS Phase|Physician Decision|2|||
146169327|NCT01784068|527131179|FG001|NTCS Phase|Physician Decision|0|||
146169328|NCT01784068|527131178|FG000|NTCS Phase|Patient/guardian decision|3|||
146169329|NCT01784068|527131179|FG001|NTCS Phase|Patient/guardian decision|0|||
146169330|NCT01784068|527131178|FG000|NTCS Phase|Death|2|||
146169331|NCT01784068|527131179|FG001|NTCS Phase|Death|0|||
146169332|NCT01784068|527131178|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
146169333|NCT01784068|527131179|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
146169334|NCT01784068|527131178|FG000|TFR Phase|Physician Decision|0|||
146169335|NCT01784068|527131179|FG001|TFR Phase|Physician Decision|1|||
146169336|NCT01784068|527131178|FG000|TFR Phase|Patient/guardian decision|0|||
146169337|NCT01784068|527131179|FG001|TFR Phase|Patient/guardian decision|3|||
146169338|NCT01784068|527131178|FG000|TFR Phase|Death|0|||
146169339|NCT01784068|527131179|FG001|TFR Phase|Death|1|||
146169340|NCT01784068|527131178|FG000|TFR Phase|Lack of Efficacy|0|||
146169341|NCT01784068|527131179|FG001|TFR Phase|Lack of Efficacy|88|||
146169342|NCT03759834|527131180|FG000|Overall Study|Withdrawal by Subject|1|||
146169343|NCT00633464|527131191|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
146169344|NCT00633464|527131192|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
146169345|NCT00633464|527131191|FG000|Overall Study|Never Treated (Randomized in error)|0|||
146169346|NCT00633464|527131192|FG001|Overall Study|Never Treated (Randomized in error)|1|||
146169347|NCT02612064|527131193|FG000|Overall Study|Withdrawal by Subject|1|||
146169348|NCT02612064|527131194|FG001|Overall Study|Withdrawal by Subject|1|||
146169349|NCT02612064|527131193|FG000|Overall Study|Other|0|||
146169350|NCT02612064|527131194|FG001|Overall Study|Other|2|||
146169351|NCT03764072|527131199|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146169352|NCT03764072|527131200|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146169353|NCT03764072|527131201|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
146169354|NCT03764072|527131202|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146169355|NCT03764072|527131203|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146169356|NCT03764072|527131204|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
146169357|NCT03764072|527131199|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
146169358|NCT03764072|527131200|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
146169359|NCT03764072|527131201|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
146169360|NCT03764072|527131202|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
146169361|NCT03764072|527131203|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
146169362|NCT03764072|527131204|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
146169363|NCT03764072|527131199|FG000|Overall Study|Lost to Follow-up|0|||
146169364|NCT03764072|527131200|FG001|Overall Study|Lost to Follow-up|0|||
146169365|NCT03764072|527131201|FG002|Overall Study|Lost to Follow-up|0|||
146344851|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
146344852|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
146344853|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
146344854|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
146344855|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
146344856|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
146344857|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
146344858|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
146344859|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
146344860|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
146344861|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
146344862|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
146344863|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
146344864|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
146344865|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
146344866|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
146344867|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
146344868|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
146344869|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
146344870|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
146344871|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
146344872|NCT00092547|527769003|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
146344873|NCT00092547|527769004|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
146344874|NCT00092547|527769005|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
146344875|NCT00092547|527769003|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
146344876|NCT00092547|527769004|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
146344877|NCT00092547|527769005|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
146344878|NCT00092547|527769003|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
146344879|NCT00092547|527769004|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
146344880|NCT00092547|527769005|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
146344881|NCT00092547|527769003|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
146344882|NCT00092547|527769004|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
146344883|NCT00092547|527769005|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
146344884|NCT00092547|527769003|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
146344885|NCT00092547|527769004|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
146344886|NCT00092547|527769005|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
146344887|NCT01371838|527769007|FG000|Overall Study|Withdrawal by Subject|27|||
146344888|NCT01371838|527769008|FG001|Overall Study|Withdrawal by Subject|33|||
146344889|NCT01371838|527769007|FG000|Overall Study|Lost to Follow-up|10|||
146344890|NCT01371838|527769008|FG001|Overall Study|Lost to Follow-up|20|||
146344891|NCT01371838|527769007|FG000|Overall Study|Death|3|||
146344892|NCT01371838|527769008|FG001|Overall Study|Death|4|||
146344893|NCT01371838|527769007|FG000|Overall Study|Protocol Violation|3|||
146344894|NCT01371838|527769008|FG001|Overall Study|Protocol Violation|0|||
146344895|NCT01371838|527769007|FG000|Overall Study|Investigator Decision|3|||
146344896|NCT01371838|527769008|FG001|Overall Study|Investigator Decision|8|||
146344897|NCT01371838|527769007|FG000|Overall Study|Last follow-up visit not conducted|2|||
146344898|NCT01371838|527769008|FG001|Overall Study|Last follow-up visit not conducted|0|||
146344899|NCT01371838|527769007|FG000|Overall Study|Lack of therapeutic response|0|||
146344900|NCT01371838|527769008|FG001|Overall Study|Lack of therapeutic response|1|||
146344901|NCT01371838|527769007|FG000|Overall Study|Surgery|1|||
146344902|NCT01371838|527769008|FG001|Overall Study|Surgery|0|||
146344903|NCT00641043|527769013|FG000|Overall Study|Adverse Event|6|||
146344904|NCT00641043|527769014|FG001|Overall Study|Adverse Event|4|||
146344905|NCT00641043|527769013|FG000|Overall Study|Protocol Violation|2|||
146344906|NCT00641043|527769014|FG001|Overall Study|Protocol Violation|3|||
146344907|NCT00641043|527769013|FG000|Overall Study|Lost to Follow-up|3|||
146344908|NCT00641043|527769014|FG001|Overall Study|Lost to Follow-up|2|||
146344909|NCT00641043|527769013|FG000|Overall Study|Withdrawal by Subject|4|||
146344910|NCT00641043|527769014|FG001|Overall Study|Withdrawal by Subject|4|||
146344911|NCT00641043|527769013|FG000|Overall Study|Other incl. lack of efficacy|4|||
146344912|NCT00641043|527769014|FG001|Overall Study|Other incl. lack of efficacy|2|||
146344913|NCT03088605|527769015|FG000|Overall Study|Withdrawal by Subject|1|||
146344914|NCT03088605|527769016|FG001|Overall Study|Withdrawal by Subject|0|||
146344915|NCT02225223|527769018|FG000|Overall Study|Death|10|||
146344916|NCT02225223|527769019|FG001|Overall Study|Death|1|||
146344917|NCT02225223|527769018|FG000|Overall Study|Lost to Follow-up|5|||
146344918|NCT02225223|527769019|FG001|Overall Study|Lost to Follow-up|0|||
146344919|NCT02225223|527769018|FG000|Overall Study|Other|1|||
146344920|NCT02225223|527769019|FG001|Overall Study|Other|2|||
146344921|NCT02225223|527769018|FG000|Overall Study|Physician Decision|1|||
146344922|NCT02225223|527769019|FG001|Overall Study|Physician Decision|0|||
146344923|NCT02225223|527769018|FG000|Overall Study|Withdrawal by Subject|2|||
146344924|NCT02225223|527769019|FG001|Overall Study|Withdrawal by Subject|2|||
146344925|NCT03567291|527769020|FG000|Period I|Adverse Event|14|||
146344926|NCT03567291|527769021|FG001|Period I|Adverse Event|0|||
146344927|NCT03567291|527769022|FG002|Period I|Adverse Event|0|||
146344928|NCT03567291|527769023|FG003|Period I|Adverse Event|0|||
146344929|NCT03567291|527769020|FG000|Period I|Protocol Violation|1|||
146344930|NCT03567291|527769021|FG001|Period I|Protocol Violation|0|||
146344931|NCT03567291|527769022|FG002|Period I|Protocol Violation|0|||
146344932|NCT03567291|527769023|FG003|Period I|Protocol Violation|0|||
146344933|NCT03567291|527769020|FG000|Period I|Withdrawal by Subject|23|||
146344934|NCT03567291|527769021|FG001|Period I|Withdrawal by Subject|0|||
146344935|NCT03567291|527769022|FG002|Period I|Withdrawal by Subject|0|||
146344936|NCT03567291|527769023|FG003|Period I|Withdrawal by Subject|0|||
146344937|NCT03567291|527769020|FG000|Period I|Lost to Follow-up|2|||
146344938|NCT03567291|527769021|FG001|Period I|Lost to Follow-up|0|||
146169366|NCT03764072|527131202|FG003|Overall Study|Lost to Follow-up|0|||
146169367|NCT03764072|527131203|FG004|Overall Study|Lost to Follow-up|1|||
146169368|NCT03764072|527131204|FG005|Overall Study|Lost to Follow-up|0|||
146344939|NCT03567291|527769022|FG002|Period I|Lost to Follow-up|0|||
146344940|NCT03567291|527769023|FG003|Period I|Lost to Follow-up|0|||
146344941|NCT03567291|527769020|FG000|Period I|Terminated by sponsor|44|||
146344942|NCT03567291|527769021|FG001|Period I|Terminated by sponsor|0|||
146344943|NCT03567291|527769022|FG002|Period I|Terminated by sponsor|0|||
146344944|NCT03567291|527769023|FG003|Period I|Terminated by sponsor|0|||
146344945|NCT03567291|527769020|FG000|Period I|Missing or unknown|7|||
146344946|NCT03567291|527769021|FG001|Period I|Missing or unknown|0|||
146344947|NCT03567291|527769022|FG002|Period I|Missing or unknown|0|||
146344948|NCT03567291|527769023|FG003|Period I|Missing or unknown|0|||
146344949|NCT03567291|527769020|FG000|Period II|Adverse Event|0|||
146344950|NCT03567291|527769021|FG001|Period II|Adverse Event|1|||
146344951|NCT03567291|527769022|FG002|Period II|Adverse Event|0|||
146344952|NCT03567291|527769023|FG003|Period II|Adverse Event|0|||
146344953|NCT03567291|527769020|FG000|Period II|Missing or unknown|0|||
146344954|NCT03567291|527769021|FG001|Period II|Missing or unknown|2|||
146344955|NCT03567291|527769022|FG002|Period II|Missing or unknown|1|||
146344956|NCT03567291|527769023|FG003|Period II|Missing or unknown|0|||
146344957|NCT03567291|527769020|FG000|Period III|Adverse Event|0|||
146344958|NCT03567291|527769021|FG001|Period III|Adverse Event|0|||
146344959|NCT03567291|527769022|FG002|Period III|Adverse Event|0|||
146344960|NCT03567291|527769023|FG003|Period III|Adverse Event|4|||
146344961|NCT03567291|527769020|FG000|Period III|Withdrawal by Subject|0|||
146344962|NCT03567291|527769021|FG001|Period III|Withdrawal by Subject|0|||
146344963|NCT03567291|527769022|FG002|Period III|Withdrawal by Subject|0|||
146344964|NCT03567291|527769023|FG003|Period III|Withdrawal by Subject|4|||
146344965|NCT03567291|527769020|FG000|Period III|Lost to Follow-up|0|||
146344966|NCT03567291|527769021|FG001|Period III|Lost to Follow-up|0|||
146344967|NCT03567291|527769022|FG002|Period III|Lost to Follow-up|0|||
146344968|NCT03567291|527769023|FG003|Period III|Lost to Follow-up|1|||
146344969|NCT03567291|527769020|FG000|Period III|Terminated by sponsor|0|||
146344970|NCT03567291|527769021|FG001|Period III|Terminated by sponsor|0|||
146344971|NCT03567291|527769022|FG002|Period III|Terminated by sponsor|0|||
146344972|NCT03567291|527769023|FG003|Period III|Terminated by sponsor|68|||
146344973|NCT03567291|527769020|FG000|Period III|Missing or unknown|0|||
146344974|NCT03567291|527769021|FG001|Period III|Missing or unknown|0|||
146344975|NCT03567291|527769022|FG002|Period III|Missing or unknown|0|||
146344976|NCT03567291|527769023|FG003|Period III|Missing or unknown|8|||
146344977|NCT01103349|527769024|FG000|Overall Study|Adverse Event|8|||
146344978|NCT01103349|527769025|FG001|Overall Study|Adverse Event|5|||
146344979|NCT01103349|527769026|FG002|Overall Study|Adverse Event|3|||
146344980|NCT01103349|527769024|FG000|Overall Study|Consent withdrawn|1|||
146344981|NCT01103349|527769025|FG001|Overall Study|Consent withdrawn|0|||
146344982|NCT01103349|527769026|FG002|Overall Study|Consent withdrawn|0|||
146344983|NCT01103349|527769024|FG000|Overall Study|Incorrectly included in the trial|1|||
146344984|NCT01103349|527769025|FG001|Overall Study|Incorrectly included in the trial|0|||
146344985|NCT01103349|527769026|FG002|Overall Study|Incorrectly included in the trial|0|||
146344986|NCT01103349|527769024|FG000|Overall Study|Withdrawal by Subject|1|||
146344987|NCT01103349|527769025|FG001|Overall Study|Withdrawal by Subject|1|||
146344988|NCT01103349|527769026|FG002|Overall Study|Withdrawal by Subject|0|||
146344989|NCT01103349|527769024|FG000|Overall Study|did not want to take trial medication|0|||
146344990|NCT01103349|527769025|FG001|Overall Study|did not want to take trial medication|1|||
146344991|NCT01103349|527769026|FG002|Overall Study|did not want to take trial medication|0|||
146344992|NCT01103349|527769024|FG000|Overall Study|forgot to take medication|0|||
146344993|NCT01103349|527769025|FG001|Overall Study|forgot to take medication|0|||
146344994|NCT01103349|527769026|FG002|Overall Study|forgot to take medication|1|||
146344995|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
146344996|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146344997|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146344998|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
146344999|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
146345000|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146345001|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146345002|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
146345003|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
146345004|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146345005|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146345006|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
146345007|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
146345008|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146345009|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146345010|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
146345011|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
146345012|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146345013|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146345014|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
146345015|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
146345016|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146345017|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146345018|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
146345019|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
146345020|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146345021|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146345022|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
146345023|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
146345024|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146345025|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146345026|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
146345027|NCT00958568|527769028|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
146345028|NCT00958568|527769029|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146345029|NCT00958568|527769030|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146345030|NCT00958568|527769031|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
146345031|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146345032|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
146345033|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146345034|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
146345035|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146345036|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
146345037|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146345038|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
146345039|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146345040|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
146345041|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146345042|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
146345043|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146345044|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
146345045|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146345046|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
146345047|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146345048|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
146345049|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146345050|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
146345051|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146345052|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
146345053|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146345054|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
146345055|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146345056|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
146345057|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146345058|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
146345059|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146345060|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
146345061|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146345062|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
146345063|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146345064|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
146345065|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146345066|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
146345067|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146345068|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
146345069|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146345070|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
146345071|NCT00958568|527769028|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146345072|NCT00958568|527769029|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
146345073|NCT00958568|527769030|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146345074|NCT00958568|527769031|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
146345075|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
146345076|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
146345077|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
146345078|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
146345079|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
146345080|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
146345081|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
146345082|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
146345083|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
146345084|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
146345085|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
146345086|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
146345087|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
146345088|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
146345089|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
146345090|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
146345091|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
146345092|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
146345093|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
146345094|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
146345095|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
146345096|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
146345097|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
146345098|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
146345099|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
146345100|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
146345101|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
146345102|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
146345103|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146345104|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146345105|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
146345106|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
146345107|NCT00958568|527769028|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146345108|NCT00958568|527769029|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146345109|NCT00958568|527769030|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
146345110|NCT00958568|527769031|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
146345111|NCT00283712|527769032|FG000|Overall Study|Death|0|||
146345112|NCT00283712|527769033|FG001|Overall Study|Death|1|||
146345113|NCT02747043|527769040|FG000|Overall Study|Other|1|||
146345114|NCT02747043|527769041|FG001|Overall Study|Other|1|||
146345115|NCT02747043|527769040|FG000|Overall Study|Adverse Event|3|||
146345116|NCT02747043|527769041|FG001|Overall Study|Adverse Event|1|||
146345117|NCT02747043|527769040|FG000|Overall Study|Withdrawal by Subject|1|||
146345118|NCT02747043|527769041|FG001|Overall Study|Withdrawal by Subject|1|||
146345119|NCT02747043|527769040|FG000|Overall Study|Physician Decision|1|||
146345120|NCT02747043|527769041|FG001|Overall Study|Physician Decision|1|||
146345121|NCT02747043|527769040|FG000|Overall Study|Protocol Violation|0|||
146345122|NCT02747043|527769041|FG001|Overall Study|Protocol Violation|1|||
146345123|NCT02747043|527769040|FG000|Overall Study|Disease progression|4|||
146345124|NCT02747043|527769041|FG001|Overall Study|Disease progression|0|||
146345125|NCT00553059|527769046|FG000|Overall Study|Deemed ineligible|1|||
146345126|NCT00553059|527769047|FG001|Overall Study|Deemed ineligible|1|||
146345127|NCT00553059|527769046|FG000|Overall Study|Drug supply not available|0|||
146345128|NCT00553059|527769047|FG001|Overall Study|Drug supply not available|1|||
146345129|NCT00891657|527769051|FG000|Overall Study|Withdrawal by Subject|1|||
146345130|NCT00891657|527769052|FG001|Overall Study|Withdrawal by Subject|1|||
146345131|NCT00909090|527769053|FG000|Overall Study|Lost to Follow-up|17|||
146345132|NCT00909090|527769054|FG001|Overall Study|Lost to Follow-up|17|||
146345133|NCT01749735|527769056|FG000|Overall Study|Withdrawal by Subject|1|||
146345134|NCT01749735|527769057|FG001|Overall Study|Withdrawal by Subject|0|||
146345135|NCT02926573|527769058|FG000|Overall Study|Nausea|1|||
146345136|NCT02926573|527769059|FG001|Overall Study|Nausea|0|||
146345137|NCT02926573|527769058|FG000|Overall Study|Remain intubated|2|||
146345138|NCT02926573|527769059|FG001|Overall Study|Remain intubated|2|||
146345139|NCT02926573|527769058|FG000|Overall Study|Change in surgery plan|3|||
146345140|NCT02926573|527769059|FG001|Overall Study|Change in surgery plan|1|||
146345141|NCT02926573|527769058|FG000|Overall Study|Change to outpatient status|5|||
146345142|NCT02926573|527769059|FG001|Overall Study|Change to outpatient status|1|||
146345143|NCT02926573|527769058|FG000|Overall Study|Withdrawal by Subject|0|||
146345144|NCT02926573|527769059|FG001|Overall Study|Withdrawal by Subject|2|||
146345145|NCT02926573|527769058|FG000|Overall Study|Return to operating room|0|||
146345146|NCT02926573|527769059|FG001|Overall Study|Return to operating room|2|||
146345147|NCT02926573|527769058|FG000|Overall Study|Delirium|0|||
146345148|NCT02926573|527769059|FG001|Overall Study|Delirium|1|||
146345149|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
146345150|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
146345151|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
146345152|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
146345153|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146345154|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
146345155|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
146345156|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
146345157|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
146345158|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146345159|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
146345160|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146345161|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
146345162|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
146345163|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
146345164|NCT00611455|527769062|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
146345165|NCT00611455|527769063|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
146345166|NCT00611455|527769064|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
146345167|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146345168|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
146345169|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
146345170|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146345171|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
146345172|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
146345173|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146345174|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
146345175|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
146345176|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146345177|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
146345178|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
146345179|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146345180|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
146345181|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
146345182|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
146345183|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
146345184|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
146345185|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146345186|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
146345187|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
146345188|NCT00611455|527769062|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146345189|NCT00611455|527769063|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
146345190|NCT00611455|527769064|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
146345191|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
146345192|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
146345193|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
146345194|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
146345195|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
146345196|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
146345197|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
146345198|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
146345199|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
146345200|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
146345201|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
146345202|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
146345203|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
146345204|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
146345205|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
146345206|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
146345207|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
146345208|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
146345209|NCT00611455|527769062|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
146345210|NCT00611455|527769063|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
146345211|NCT00611455|527769064|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
146345212|NCT04601272|527769067|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
146345213|NCT04601272|527769068|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
146345214|NCT04601272|527769069|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
146345215|NCT00414440|527769070|FG000|Core Period|Withdrawal by Subject|70|||
146345216|NCT00414440|527769071|FG001|Core Period|Withdrawal by Subject|32|||
146345217|NCT00414440|527769070|FG000|Extension Period|Lost to Follow-up|44|||
146345218|NCT00414440|527769071|FG001|Extension Period|Lost to Follow-up|52|||
146396299|NCT02940392|527954550|FG000|Overall Study|Lost to Follow-up|3|||
146169369|NCT00982930|527131205|FG000|Overall Study|Adverse Event|1|||
146169370|NCT00982930|527131205|FG000|Overall Study|Withdrawal by Subject|1|||
146169371|NCT00982930|527131205|FG000|Overall Study|Administrative Problems|2|||
146345219|NCT00414440|527769070|FG000|Extension Period|Did not consent to continue follow up|61|||
146345220|NCT00414440|527769071|FG001|Extension Period|Did not consent to continue follow up|54|||
146345221|NCT00414440|527769070|FG000|Extension Period|Other|1|||
146345222|NCT00414440|527769071|FG001|Extension Period|Other|1|||
146345223|NCT00414440|527769070|FG000|Extension Period|Administrative|16|||
146345224|NCT00414440|527769071|FG001|Extension Period|Administrative|16|||
146345225|NCT00414440|527769070|FG000|Extension Period|Death|1|||
146345226|NCT00414440|527769071|FG001|Extension Period|Death|2|||
146345227|NCT00414440|527769070|FG000|Extension Period|Withdrawal by Subject|9|||
146345228|NCT00414440|527769071|FG001|Extension Period|Withdrawal by Subject|7|||
146345229|NCT00414440|527769070|FG000|Extension Period|Not included in follow up period|18|||
146345230|NCT00414440|527769071|FG001|Extension Period|Not included in follow up period|8|||
146345231|NCT04382651|527769072|FG000|Overall Study|Death|26|||
146345232|NCT04382651|527769073|FG001|Overall Study|Death|23|||
146345233|NCT04382651|527769072|FG000|Overall Study|Lost to Follow-up|3|||
146345234|NCT04382651|527769073|FG001|Overall Study|Lost to Follow-up|4|||
146345235|NCT04382651|527769072|FG000|Overall Study|Withdrawal by Subject|2|||
146345236|NCT04382651|527769073|FG001|Overall Study|Withdrawal by Subject|0|||
146345237|NCT04382651|527769072|FG000|Overall Study|Physician Decision|0|||
146345238|NCT04382651|527769073|FG001|Overall Study|Physician Decision|1|||
146345239|NCT02732912|527769074|FG000|Overall Study|Discharged before night|2|||
146345240|NCT02732912|527769075|FG001|Overall Study|Discharged before night|6|||
146345241|NCT02732912|527769074|FG000|Overall Study|Incomplete completion of questionnaire|2|||
146345242|NCT02732912|527769075|FG001|Overall Study|Incomplete completion of questionnaire|3|||
146345243|NCT02732912|527769074|FG000|Overall Study|No outcome; discharged or refused|6|||
146345244|NCT02732912|527769075|FG001|Overall Study|No outcome; discharged or refused|9|||
146345245|NCT01507545|527769076|FG000|Overall Study|Withdrawal by Subject|6|||
146345246|NCT01507545|527769077|FG001|Overall Study|Withdrawal by Subject|2|||
146345247|NCT01507545|527769076|FG000|Overall Study|Lost to Follow-up|1|||
146345248|NCT01507545|527769077|FG001|Overall Study|Lost to Follow-up|0|||
146345249|NCT01507545|527769076|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
146345250|NCT01507545|527769077|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
146345251|NCT01507545|527769076|FG000|Overall Study|Progressive disease|60|||
146345252|NCT01507545|527769077|FG001|Overall Study|Progressive disease|27|||
146345253|NCT01507545|527769076|FG000|Overall Study|Other|6|||
146345254|NCT01507545|527769077|FG001|Overall Study|Other|4|||
146345255|NCT01873742|527769078|FG000|Overall Study|Lost to Follow-up|68|||
146345256|NCT01873742|527769079|FG001|Overall Study|Lost to Follow-up|76|||
146345257|NCT00790296|527769080|FG000|Overall Study|Did not meet study eligibility criteria|1|||
146345258|NCT00790296|527769081|FG001|Overall Study|Did not meet study eligibility criteria|1|||
146345259|NCT00790296|527769080|FG000|Overall Study|Adverse Event|0|||
146345260|NCT00790296|527769081|FG001|Overall Study|Adverse Event|1|||
146345261|NCT00853905|527769084|FG000|Overall Study|Lost to Follow-up|1|||
146345262|NCT00853905|527769085|FG001|Overall Study|Lost to Follow-up|3|||
146345263|NCT00853905|527769084|FG000|Overall Study|Withdrawal by Subject|0|||
146345264|NCT00853905|527769085|FG001|Overall Study|Withdrawal by Subject|1|||
146345265|NCT00853905|527769084|FG000|Overall Study|never had surgery|1|||
146345266|NCT00853905|527769085|FG001|Overall Study|never had surgery|0|||
146345267|NCT00408681|527769099|FG000|Overall Study|Lack of Efficacy|2|||
146345268|NCT00408681|527769099|FG000|Overall Study|Adverse Event|7|||
146345269|NCT00447421|527769100|FG000|Overall Study|Lack of Efficacy|1|||
146345270|NCT00447421|527769100|FG000|Overall Study|Adverse Event|3|||
146345271|NCT00447421|527769100|FG000|Overall Study|Sponsor Decision|2|||
146345272|NCT01787591|527769101|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146345273|NCT01787591|527769102|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146345274|NCT01787591|527769103|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
146345275|NCT01787591|527769104|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
146345276|NCT02725177|527769107|FG000|Overall Study|Physician Decision|4|||
146345277|NCT02725177|527769107|FG000|Overall Study|Adverse Event|1|||
146345278|NCT00638846|527769108|FG000|Overall Study|Adverse Event|0|||
146345279|NCT00638846|527769109|FG001|Overall Study|Adverse Event|1|||
146345280|NCT00638846|527769108|FG000|Overall Study|Lost to Follow-up|3|||
146345281|NCT00638846|527769109|FG001|Overall Study|Lost to Follow-up|2|||
146345282|NCT00638846|527769108|FG000|Overall Study|lens issue|1|||
146345283|NCT00638846|527769109|FG001|Overall Study|lens issue|3|||
146345284|NCT04799782|527769114|FG000|Washout|Physician Decision|2|||
146345285|NCT04799782|527769115|FG001|Washout|Physician Decision|0|||
146345286|NCT04799782|527769114|FG000|Washout|Withdrawal by Subject|0|||
146345287|NCT04799782|527769115|FG001|Washout|Withdrawal by Subject|2|||
146345288|NCT04799782|527769114|FG000|Washout|Lost to Follow-up|0|||
146345289|NCT04799782|527769115|FG001|Washout|Lost to Follow-up|1|||
146345290|NCT01589094|527769122|FG000|Overall Study|Did not receive treatment|2|||
146345291|NCT00969618|527769131|FG000|Overall Study|Adverse Event|29|||
146345292|NCT00969618|527769131|FG000|Overall Study|Entry Criteria Not Met|3|||
146345293|NCT00969618|527769131|FG000|Overall Study|Lack of Efficacy|2|||
146345294|NCT00969618|527769131|FG000|Overall Study|Lost to Follow-up|7|||
146345295|NCT00969618|527769131|FG000|Overall Study|Physician Decision|1|||
146345296|NCT00969618|527769131|FG000|Overall Study|Protocol Violation|9|||
146345297|NCT00969618|527769131|FG000|Overall Study|Withdrawal by Subject|27|||
146345298|NCT05094154|527770691|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
146345299|NCT05094154|527770692|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
146345300|NCT05094154|527770691|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
146345301|NCT05094154|527770692|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
146345302|NCT02100657|527770693|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
146345303|NCT02100657|527770694|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
146345304|NCT02100657|527770695|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
146345305|NCT02100657|527770693|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
146345306|NCT02100657|527770694|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
146345307|NCT02100657|527770695|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
146345308|NCT02100657|527770693|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
146345309|NCT02100657|527770694|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
146345310|NCT02100657|527770695|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
146345311|NCT02100657|527770693|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
146345312|NCT02100657|527770694|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
146345313|NCT02100657|527770695|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
146345314|NCT02100657|527770693|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
146345315|NCT02100657|527770694|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
146345316|NCT02100657|527770695|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
146345317|NCT02100657|527770693|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
146345318|NCT02100657|527770694|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
146345319|NCT02100657|527770695|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
146345320|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
146345321|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
146345322|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
146345323|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Death|0|||
146345324|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Death|0|||
146345325|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Death|1|||
146345326|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
146345327|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
146345328|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
146345329|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
146345330|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
146345331|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
146345332|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
146345333|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
146345334|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
146345335|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
146345336|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
146345337|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
146345338|NCT02100657|527770693|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
146345339|NCT02100657|527770694|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
146345340|NCT02100657|527770695|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
146345341|NCT03825042|527770697|FG000|Overall Study|Adverse Event|1|||
146345342|NCT03825042|527770698|FG001|Overall Study|Adverse Event|0|||
146345343|NCT03825042|527770697|FG000|Overall Study|Withdrawal by Subject|1|||
146345344|NCT03825042|527770698|FG001|Overall Study|Withdrawal by Subject|0|||
146345345|NCT01158534|527770699|FG000|Overall Study|Withdrawal by Subject|1|||
146345346|NCT01158534|527770699|FG000|Overall Study|Death|1|||
146345347|NCT01158534|527770699|FG000|Overall Study|Other|1|||
146345348|NCT04003155|527770700|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
146345349|NCT04003155|527770701|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
146345350|NCT04003155|527770702|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
146345351|NCT04003155|527770703|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
146345352|NCT04003155|527770704|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
146345353|NCT04003155|527770700|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
146345354|NCT04003155|527770701|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
146345355|NCT04003155|527770702|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146345356|NCT04003155|527770703|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146345357|NCT04003155|527770704|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
146345358|NCT04003155|527770700|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
146345359|NCT04003155|527770701|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
146345360|NCT04003155|527770702|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
146345361|NCT04003155|527770703|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
146345362|NCT04003155|527770704|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
146345363|NCT04003155|527770700|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
146345364|NCT04003155|527770701|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
146169372|NCT07018999|527131208|FG000|Overall Study|Protocol Violation|0|||
146345365|NCT04003155|527770702|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
146345366|NCT04003155|527770703|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
146345367|NCT04003155|527770704|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
146345368|NCT04003155|527770700|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
146345369|NCT04003155|527770701|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
146345370|NCT04003155|527770702|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
146345371|NCT04003155|527770703|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
146345372|NCT04003155|527770704|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
146345373|NCT04003155|527770700|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
146345374|NCT04003155|527770701|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
146345375|NCT04003155|527770702|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
146345376|NCT04003155|527770703|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
146345377|NCT04003155|527770704|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
146345378|NCT04003155|527770700|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
146345379|NCT04003155|527770701|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146345380|NCT04003155|527770702|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
146345381|NCT04003155|527770703|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146345382|NCT04003155|527770704|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
146345383|NCT04003155|527770700|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
146345384|NCT04003155|527770701|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
146345385|NCT04003155|527770702|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
146345386|NCT04003155|527770703|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
146345387|NCT04003155|527770704|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
146345388|NCT04003155|527770700|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
146345389|NCT04003155|527770701|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
146345390|NCT04003155|527770702|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
146345391|NCT04003155|527770703|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
146345392|NCT04003155|527770704|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
146345393|NCT03042611|527770705|FG000|Core Phase|Withdrawal by Subject|13|||
146345394|NCT03042611|527770706|FG001|Core Phase|Withdrawal by Subject|4|||
146345395|NCT03042611|527770707|FG002|Core Phase|Withdrawal by Subject|0|||
146345396|NCT03042611|527770708|FG003|Core Phase|Withdrawal by Subject|0|||
146345397|NCT03042611|527770705|FG000|Core Phase|Death|232|||
146345398|NCT03042611|527770706|FG001|Core Phase|Death|110|||
146345399|NCT03042611|527770707|FG002|Core Phase|Death|0|||
146345400|NCT03042611|527770708|FG003|Core Phase|Death|0|||
146345401|NCT03042611|527770705|FG000|Core Phase|Lost to Follow-up|4|||
146345402|NCT03042611|527770706|FG001|Core Phase|Lost to Follow-up|7|||
146345403|NCT03042611|527770707|FG002|Core Phase|Lost to Follow-up|0|||
146345404|NCT03042611|527770708|FG003|Core Phase|Lost to Follow-up|0|||
146345405|NCT03042611|527770705|FG000|Core Phase|Physician Decision|7|||
146345406|NCT03042611|527770706|FG001|Core Phase|Physician Decision|2|||
146345407|NCT03042611|527770707|FG002|Core Phase|Physician Decision|0|||
146345408|NCT03042611|527770708|FG003|Core Phase|Physician Decision|0|||
146345409|NCT03042611|527770705|FG000|Core Phase|Study Closed|0|||
146345410|NCT03042611|527770706|FG001|Core Phase|Study Closed|1|||
146345411|NCT03042611|527770707|FG002|Core Phase|Study Closed|0|||
146345412|NCT03042611|527770708|FG003|Core Phase|Study Closed|0|||
146345413|NCT03042611|527770705|FG000|Extension Phase|Death|0|||
146345414|NCT03042611|527770706|FG001|Extension Phase|Death|0|||
146345415|NCT03042611|527770707|FG002|Extension Phase|Death|34|||
146345416|NCT03042611|527770708|FG003|Extension Phase|Death|16|||
146345417|NCT03042611|527770705|FG000|Extension Phase|Lost to Follow-up|0|||
146345418|NCT03042611|527770706|FG001|Extension Phase|Lost to Follow-up|0|||
146345419|NCT03042611|527770707|FG002|Extension Phase|Lost to Follow-up|1|||
146345420|NCT03042611|527770708|FG003|Extension Phase|Lost to Follow-up|1|||
146345421|NCT03042611|527770705|FG000|Extension Phase|Study Closed|0|||
146345422|NCT03042611|527770706|FG001|Extension Phase|Study Closed|0|||
146345423|NCT03042611|527770707|FG002|Extension Phase|Study Closed|17|||
146345424|NCT03042611|527770708|FG003|Extension Phase|Study Closed|11|||
146345425|NCT01666444|527770712|FG000|Overall Study|Did not initiate treatment|2|||
146345426|NCT01666444|527770713|FG001|Overall Study|Did not initiate treatment|1|||
146345427|NCT00950690|527770714|FG000|Overall Study|Death|4|||
146345428|NCT00950690|527770714|FG000|Overall Study|Adverse Event|15|||
146345429|NCT00950690|527770714|FG000|Overall Study|Lack of Efficacy|22|||
146345430|NCT00950690|527770714|FG000|Overall Study|Lost to Follow-up|40|||
146345431|NCT00950690|527770714|FG000|Overall Study|Other|163|||
146345432|NCT00084682|527770719|FG000|Overall Study|Withdrawal by Subject|1|||
146345433|NCT01013883|527770725|FG000|Overall Study|Lost to Follow-up|2|||
146345434|NCT01013883|527770726|FG001|Overall Study|Lost to Follow-up|2|||
146345435|NCT03666143|527770731|FG000|Overall Study|Death|158|||
146345436|NCT03666143|527770731|FG000|Overall Study|Sponsor Decision|31|||
146345437|NCT03666143|527770731|FG000|Overall Study|Withdrawal by Subject|11|||
146345438|NCT03666143|527770731|FG000|Overall Study|Lost to Follow-up|5|||
146345439|NCT03666143|527770731|FG000|Overall Study|Physician Decision|1|||
146345440|NCT03666143|527770731|FG000|Overall Study|Rolled into extension study|9|||
146345441|NCT03666143|527770731|FG000|Overall Study|Progressive Disease|1|||
146345442|NCT00907478|527770736|FG000|Overall Study|Ineligibility determined|0|||
146345443|NCT00907478|527770737|FG001|Overall Study|Ineligibility determined|0|||
146345444|NCT00907478|527770738|FG002|Overall Study|Ineligibility determined|1|||
146345445|NCT00907478|527770736|FG000|Overall Study|Noncompliance|0|||
146345446|NCT00907478|527770737|FG001|Overall Study|Noncompliance|0|||
146345447|NCT00907478|527770738|FG002|Overall Study|Noncompliance|1|||
146345448|NCT00907478|527770736|FG000|Overall Study|Adverse Event|3|||
146345449|NCT00907478|527770737|FG001|Overall Study|Adverse Event|1|||
146345450|NCT00907478|527770738|FG002|Overall Study|Adverse Event|2|||
146345451|NCT00907478|527770736|FG000|Overall Study|Withdrawal by Subject|8|||
146345452|NCT00907478|527770737|FG001|Overall Study|Withdrawal by Subject|9|||
146345453|NCT00907478|527770738|FG002|Overall Study|Withdrawal by Subject|6|||
146345454|NCT00907478|527770736|FG000|Overall Study|Requirement for alternative therapy|1|||
146345455|NCT00907478|527770737|FG001|Overall Study|Requirement for alternative therapy|2|||
146345456|NCT00907478|527770738|FG002|Overall Study|Requirement for alternative therapy|3|||
146345457|NCT00907478|527770736|FG000|Overall Study|Physician Decision|2|||
146345458|NCT00907478|527770737|FG001|Overall Study|Physician Decision|0|||
146345459|NCT00907478|527770738|FG002|Overall Study|Physician Decision|3|||
146345460|NCT00907478|527770736|FG000|Overall Study|Death|4|||
146345461|NCT00907478|527770737|FG001|Overall Study|Death|2|||
146345462|NCT00907478|527770738|FG002|Overall Study|Death|1|||
146345463|NCT00907478|527770736|FG000|Overall Study|Protocol-specified criteria|5|||
146345464|NCT00907478|527770737|FG001|Overall Study|Protocol-specified criteria|2|||
146345465|NCT00907478|527770738|FG002|Overall Study|Protocol-specified criteria|3|||
146345466|NCT00907478|527770736|FG000|Overall Study|Pregnancy|0|||
146345467|NCT00907478|527770737|FG001|Overall Study|Pregnancy|1|||
146345468|NCT00907478|527770738|FG002|Overall Study|Pregnancy|1|||
146345469|NCT00907478|527770736|FG000|Overall Study|Lost to Follow-up|1|||
146345470|NCT00907478|527770737|FG001|Overall Study|Lost to Follow-up|0|||
146345471|NCT00907478|527770738|FG002|Overall Study|Lost to Follow-up|0|||
146345472|NCT00907478|527770736|FG000|Overall Study|Other|3|||
146345473|NCT00907478|527770737|FG001|Overall Study|Other|0|||
146345474|NCT00907478|527770738|FG002|Overall Study|Other|1|||
146345475|NCT03648476|527770741|FG000|Overall Study|Withdrawal by Subject|2|||
146345476|NCT03648476|527770742|FG001|Overall Study|Withdrawal by Subject|1|||
146345477|NCT02546856|527770744|FG000|4 Months Evaluation|Death|2|||
146345478|NCT02546856|527770745|FG001|4 Months Evaluation|Death|3|||
146345479|NCT02546856|527770744|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
146345480|NCT02546856|527770745|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
146345481|NCT02546856|527770744|FG000|4 Months Evaluation|Lost to Follow-up|3|||
146345482|NCT02546856|527770745|FG001|4 Months Evaluation|Lost to Follow-up|3|||
146345483|NCT02546856|527770744|FG000|4 Months Evaluation|Physician Decision|3|||
146345484|NCT02546856|527770745|FG001|4 Months Evaluation|Physician Decision|0|||
146345485|NCT02546856|527770744|FG000|4 Months Evaluation|Working or living abroad|5|||
146345486|NCT02546856|527770745|FG001|4 Months Evaluation|Working or living abroad|1|||
146345487|NCT02546856|527770744|FG000|4 Months Evaluation|reasons not due to titration|4|||
146345488|NCT02546856|527770745|FG001|4 Months Evaluation|reasons not due to titration|1|||
146345489|NCT02546856|527770744|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
146345490|NCT02546856|527770745|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
146345491|NCT02546856|527770744|FG000|6 Months Evaluation|Death|1|||
146345492|NCT02546856|527770745|FG001|6 Months Evaluation|Death|1|||
146345493|NCT02546856|527770744|FG000|6 Months Evaluation|Lost to Follow-up|1|||
146345494|NCT02546856|527770745|FG001|6 Months Evaluation|Lost to Follow-up|1|||
146345495|NCT02546856|527770744|FG000|6 Months Evaluation|Working or living abroad|6|||
146345496|NCT02546856|527770745|FG001|6 Months Evaluation|Working or living abroad|4|||
146345497|NCT02546856|527770744|FG000|6 Months Evaluation|reasons not due to titration|0|||
146345498|NCT02546856|527770745|FG001|6 Months Evaluation|reasons not due to titration|1|||
146345499|NCT00130208|527770747|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
146345500|NCT00130208|527770748|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
146345501|NCT00130208|527770747|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
146345502|NCT00130208|527770748|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
146345503|NCT00130208|527770747|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
146345504|NCT00130208|527770748|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
146345505|NCT00130208|527770747|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
146345506|NCT00130208|527770748|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
146345507|NCT00130208|527770747|FG000|Maintenance Period (26 Weeks)|Other|1|||
146345508|NCT00130208|527770748|FG001|Maintenance Period (26 Weeks)|Other|1|||
146345509|NCT00130208|527770747|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
146345510|NCT00130208|527770748|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
146345511|NCT00130208|527770747|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
146345512|NCT00130208|527770748|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
146345513|NCT00130208|527770747|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
146345514|NCT00130208|527770748|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
146345515|NCT00130208|527770747|FG000|Washout Period (8 Weeks)|Other|1|||
146345516|NCT00130208|527770748|FG001|Washout Period (8 Weeks)|Other|1|||
146169373|NCT07018999|527131209|FG001|Overall Study|Protocol Violation|1|||
146345517|NCT04655586|527770751|FG000|Overall Study|Physician Decision|1|||
146345518|NCT04655586|527770752|FG001|Overall Study|Physician Decision|3|||
146345519|NCT04655586|527770753|FG002|Overall Study|Physician Decision|4|||
146345520|NCT04655586|527770751|FG000|Overall Study|Withdrawal by Subject|1|||
146345521|NCT04655586|527770752|FG001|Overall Study|Withdrawal by Subject|3|||
146345522|NCT04655586|527770753|FG002|Overall Study|Withdrawal by Subject|1|||
146345523|NCT03268746|527770760|FG000|Overall Study|Withdrawal by Subject|1|||
146345524|NCT04734873|527770761|FG000|Overall Study|Lost to Follow-up|1|||
146345525|NCT04734873|527770762|FG001|Overall Study|Lost to Follow-up|3|||
146345526|NCT04734873|527770763|FG002|Overall Study|Lost to Follow-up|2|||
146345527|NCT04734873|527770761|FG000|Overall Study|Randomized but not dosed|1|||
146345528|NCT04734873|527770762|FG001|Overall Study|Randomized but not dosed|0|||
146345529|NCT04734873|527770763|FG002|Overall Study|Randomized but not dosed|1|||
146345530|NCT02927171|527770765|FG000|Overall Study|Lost to Follow-up|0|||
146345531|NCT02927171|527770766|FG001|Overall Study|Lost to Follow-up|1|||
146345532|NCT02240628|527770767|FG000|Overall Study|Physician Decision|6|||
146345533|NCT02240628|527770768|FG001|Overall Study|Physician Decision|5|||
146345534|NCT04530825|527770771|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
146345535|NCT04530825|527770772|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
146345536|NCT04530825|527770773|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
146345537|NCT04530825|527770774|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
146345538|NCT04530825|527770771|FG000|Overall Study|Did not complete follow-up|3|||
146345539|NCT04530825|527770772|FG001|Overall Study|Did not complete follow-up|0|||
146345540|NCT04530825|527770773|FG002|Overall Study|Did not complete follow-up|0|||
146345541|NCT04530825|527770774|FG003|Overall Study|Did not complete follow-up|0|||
146345542|NCT04101422|527770776|FG000|Overall Study|Ineligible|1|||
146345543|NCT04101422|527770777|FG001|Overall Study|Ineligible|0|||
146345544|NCT04101422|527770778|FG002|Overall Study|Ineligible|9|||
146345545|NCT04101422|527770779|FG003|Overall Study|Ineligible|0|||
146345546|NCT04101422|527770776|FG000|Overall Study|Withdrawal by Subject|0|||
146345547|NCT04101422|527770777|FG001|Overall Study|Withdrawal by Subject|0|||
146345548|NCT04101422|527770778|FG002|Overall Study|Withdrawal by Subject|1|||
146345549|NCT04101422|527770779|FG003|Overall Study|Withdrawal by Subject|0|||
146345550|NCT04101422|527770776|FG000|Overall Study|Not attending to the stimuli|0|||
146345551|NCT04101422|527770777|FG001|Overall Study|Not attending to the stimuli|0|||
146345552|NCT04101422|527770778|FG002|Overall Study|Not attending to the stimuli|4|||
146345553|NCT04101422|527770779|FG003|Overall Study|Not attending to the stimuli|0|||
146345554|NCT04101422|527770776|FG000|Overall Study|Did not download app|0|||
146345555|NCT04101422|527770777|FG001|Overall Study|Did not download app|0|||
146345556|NCT04101422|527770778|FG002|Overall Study|Did not download app|0|||
146345557|NCT04101422|527770779|FG003|Overall Study|Did not download app|17|||
146345558|NCT04101422|527770776|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146345559|NCT04101422|527770777|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146345560|NCT04101422|527770778|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
146345561|NCT04101422|527770779|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
146345562|NCT00552305|527770780|FG000|Overall Study|Adverse Event|43|||
146345563|NCT00552305|527770780|FG000|Overall Study|Lack of Efficacy|120|||
146345564|NCT00552305|527770780|FG000|Overall Study|Lost to Follow-up|4|||
146345565|NCT00552305|527770780|FG000|Overall Study|Protocol Violation|3|||
146345566|NCT00552305|527770780|FG000|Overall Study|Withdrawal by Subject|44|||
146345567|NCT00552305|527770780|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
146345568|NCT00552305|527770780|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
146345569|NCT00552305|527770780|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
146345570|NCT00552305|527770780|FG000|Overall Study|Unsatisfactory compliance|11|||
146345571|NCT00552305|527770780|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
146345572|NCT00552305|527770780|FG000|Overall Study|AE/Other: prohibited drug required|1|||
146345573|NCT00552305|527770780|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
146345574|NCT00552305|527770780|FG000|Overall Study|Other: Site closed|4|||
146345575|NCT00552305|527770780|FG000|Overall Study|Other: Personal problems|1|||
146345576|NCT00552305|527770780|FG000|Overall Study|Other: Unable to attend visits|1|||
146345577|NCT00552305|527770780|FG000|Overall Study|Other: Subject underwent surgery|4|||
146345578|NCT00552305|527770780|FG000|Overall Study|Other: Subject became pregnant|1|||
146345579|NCT00552305|527770780|FG000|Overall Study|Other: Health problems, not drug related|1|||
146345580|NCT00552305|527770780|FG000|Overall Study|Other: Subject moved from area|2|||
146345581|NCT00552305|527770780|FG000|Overall Study|Other: Subject incarcerated|1|||
146345582|NCT00552305|527770780|FG000|Overall Study|Other: Subject went to rehab|1|||
146345583|NCT00718861|527770783|FG000|Overall Study|Withdrawal by Subject|15|||
146345584|NCT00718861|527770784|FG001|Overall Study|Withdrawal by Subject|10|||
146345585|NCT00718861|527770783|FG000|Overall Study|Adverse Event|2|||
146345586|NCT00718861|527770784|FG001|Overall Study|Adverse Event|1|||
146345587|NCT00718861|527770783|FG000|Overall Study|Lost to Follow-up|2|||
146345588|NCT00718861|527770784|FG001|Overall Study|Lost to Follow-up|1|||
146345589|NCT00718861|527770783|FG000|Overall Study|Administrative Problems|1|||
146345590|NCT00718861|527770784|FG001|Overall Study|Administrative Problems|1|||
146345591|NCT00718861|527770783|FG000|Overall Study|Death|1|||
146345592|NCT00718861|527770784|FG001|Overall Study|Death|5|||
146345593|NCT04983901|527770789|FG000|Overall Study|Death|1|||
146345594|NCT04983901|527770790|FG001|Overall Study|Death|4|||
146345595|NCT04983901|527770789|FG000|Overall Study|Lost to Follow-up|3|||
146345596|NCT04983901|527770790|FG001|Overall Study|Lost to Follow-up|0|||
146345597|NCT04983901|527770789|FG000|Overall Study|Protocol Violation|1|||
146345598|NCT04983901|527770790|FG001|Overall Study|Protocol Violation|0|||
146345599|NCT04983901|527770789|FG000|Overall Study|Withdrawal by Subject|1|||
146345600|NCT04983901|527770790|FG001|Overall Study|Withdrawal by Subject|2|||
146345601|NCT01174784|527770791|FG000|Overall Study|Screen fails|4|||
146345602|NCT01671488|527770792|FG000|Overall Study|Withdrawal by Subject|1|||
146345603|NCT01214434|527770795|FG000|Overall Study|Withdrawal by Subject|1|||
146345604|NCT01214434|527770796|FG001|Overall Study|Withdrawal by Subject|0|||
146345605|NCT01214434|527770795|FG000|Overall Study|Lost to Follow-up|2|||
146345606|NCT01214434|527770796|FG001|Overall Study|Lost to Follow-up|2|||
146345607|NCT01214434|527770795|FG000|Overall Study|Site error|1|||
146345608|NCT01214434|527770796|FG001|Overall Study|Site error|0|||
146345609|NCT01651052|527770797|FG000|Overall Study|Death|21|||
146345610|NCT01651052|527770797|FG000|Overall Study|Explant|1|||
146345611|NCT01651052|527770797|FG000|Overall Study|Withdrawal by Subject|1|||
146345612|NCT01651052|527770797|FG000|Overall Study|Lost to Follow-up|3|||
146345613|NCT03503773|527770798|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
146345614|NCT03503773|527770799|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
146345615|NCT03503773|527770798|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
146345616|NCT03503773|527770799|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
146345617|NCT03503773|527770798|FG000|Overall Study|Not completing the primary ABPM|3|||
146345618|NCT03503773|527770799|FG001|Overall Study|Not completing the primary ABPM|1|||
146345619|NCT03503773|527770798|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146345620|NCT03503773|527770799|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146345621|NCT00425438|527770803|FG000|Overall Study|Termination by Sponsor|25|||
146345622|NCT00425438|527770804|FG001|Overall Study|Termination by Sponsor|27|||
146345623|NCT02285010|527770807|FG000|Overall Study|not abdominal hysterectomy|2|||
146345624|NCT02285010|527770808|FG001|Overall Study|not abdominal hysterectomy|0|||
146345625|NCT02285010|527770807|FG000|Overall Study|Not spinal anesthesia|3|||
146345626|NCT02285010|527770808|FG001|Overall Study|Not spinal anesthesia|1|||
146345627|NCT02902809|527770809|FG000|Overall Study|Discontinuation of asthma program|28|||
146345628|NCT00532259|527770810|FG000|Overall Study|Withdrawal by Subject|2|||
146345629|NCT00532259|527770810|FG000|Overall Study|Adverse Event|1|||
146345630|NCT00532259|527770810|FG000|Overall Study|Death|1|||
146345631|NCT00532259|527770810|FG000|Overall Study|Lack of Efficacy|21|||
146345632|NCT00532259|527770810|FG000|Overall Study|Lost to Follow-up|3|||
146345633|NCT00532259|527770810|FG000|Overall Study|Physician Decision|3|||
146345634|NCT00532259|527770810|FG000|Overall Study|Protocol Violation|1|||
146345635|NCT04983940|527770811|FG000|Overall Study|Lost to Follow-up|14|||
146345636|NCT04983940|527770811|FG000|Overall Study|Lack of Efficacy|2|||
146345637|NCT04156646|527770815|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
146345638|NCT04156646|527770816|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
146345639|NCT01208181|527770819|FG000|Part 1|Withdrawal by Subject|11|||
146345640|NCT01208181|527770820|FG001|Part 1|Withdrawal by Subject|10|||
146345641|NCT01208181|527770821|FG002|Part 1|Withdrawal by Subject|0|||
146345642|NCT01208181|527770822|FG003|Part 1|Withdrawal by Subject|0|||
146345643|NCT01208181|527770823|FG004|Part 1|Withdrawal by Subject|0|||
146345644|NCT01208181|527770819|FG000|Part 1|Technical problem|5|||
146345645|NCT01208181|527770820|FG001|Part 1|Technical problem|0|||
146345646|NCT01208181|527770821|FG002|Part 1|Technical problem|0|||
146345647|NCT01208181|527770822|FG003|Part 1|Technical problem|0|||
146345648|NCT01208181|527770823|FG004|Part 1|Technical problem|0|||
146345649|NCT01208181|527770819|FG000|Part 1|Protocol Violation|10|||
146345650|NCT01208181|527770820|FG001|Part 1|Protocol Violation|5|||
146345651|NCT01208181|527770821|FG002|Part 1|Protocol Violation|0|||
146345652|NCT01208181|527770822|FG003|Part 1|Protocol Violation|0|||
146345653|NCT01208181|527770823|FG004|Part 1|Protocol Violation|0|||
146345654|NCT01208181|527770819|FG000|Part 1|Physician Decision|4|||
146345655|NCT01208181|527770820|FG001|Part 1|Physician Decision|0|||
146345656|NCT01208181|527770821|FG002|Part 1|Physician Decision|0|||
146345657|NCT01208181|527770822|FG003|Part 1|Physician Decision|0|||
146345658|NCT01208181|527770823|FG004|Part 1|Physician Decision|0|||
146345659|NCT01208181|527770819|FG000|Part 1|Non-compliance with study drug|1|||
146345660|NCT01208181|527770820|FG001|Part 1|Non-compliance with study drug|1|||
146345661|NCT01208181|527770821|FG002|Part 1|Non-compliance with study drug|0|||
146345662|NCT01208181|527770822|FG003|Part 1|Non-compliance with study drug|0|||
146345663|NCT01208181|527770823|FG004|Part 1|Non-compliance with study drug|0|||
146345664|NCT01208181|527770819|FG000|Part 1|Lost to Follow-up|5|||
146345665|NCT01208181|527770820|FG001|Part 1|Lost to Follow-up|3|||
146345666|NCT01208181|527770821|FG002|Part 1|Lost to Follow-up|0|||
146345667|NCT01208181|527770822|FG003|Part 1|Lost to Follow-up|0|||
146345668|NCT01208181|527770823|FG004|Part 1|Lost to Follow-up|1|||
146345669|NCT01208181|527770819|FG000|Part 1|Lack of Efficacy|37|||
146345670|NCT01208181|527770820|FG001|Part 1|Lack of Efficacy|12|||
146345671|NCT01208181|527770821|FG002|Part 1|Lack of Efficacy|0|||
146345672|NCT01208181|527770822|FG003|Part 1|Lack of Efficacy|0|||
146345673|NCT01208181|527770823|FG004|Part 1|Lack of Efficacy|17|||
146345674|NCT01208181|527770819|FG000|Part 1|Adverse Event|26|||
146345675|NCT01208181|527770820|FG001|Part 1|Adverse Event|24|||
146345676|NCT01208181|527770821|FG002|Part 1|Adverse Event|0|||
146345677|NCT01208181|527770822|FG003|Part 1|Adverse Event|0|||
146345678|NCT01208181|527770823|FG004|Part 1|Adverse Event|4|||
146345679|NCT01208181|527770819|FG000|Part 2|Adverse Event|0|||
146345680|NCT01208181|527770820|FG001|Part 2|Adverse Event|0|||
146345681|NCT01208181|527770821|FG002|Part 2|Adverse Event|6|||
146345682|NCT01208181|527770822|FG003|Part 2|Adverse Event|7|||
146345683|NCT01208181|527770823|FG004|Part 2|Adverse Event|0|||
146345684|NCT01208181|527770819|FG000|Part 2|Withdrawal by Subject|0|||
146345685|NCT01208181|527770820|FG001|Part 2|Withdrawal by Subject|0|||
146345686|NCT01208181|527770821|FG002|Part 2|Withdrawal by Subject|1|||
146345687|NCT01208181|527770822|FG003|Part 2|Withdrawal by Subject|1|||
146345688|NCT01208181|527770823|FG004|Part 2|Withdrawal by Subject|0|||
146345689|NCT01208181|527770819|FG000|Part 2|Protocol Violation|0|||
146345690|NCT01208181|527770820|FG001|Part 2|Protocol Violation|0|||
146345691|NCT01208181|527770821|FG002|Part 2|Protocol Violation|1|||
146345692|NCT01208181|527770822|FG003|Part 2|Protocol Violation|0|||
146345693|NCT01208181|527770823|FG004|Part 2|Protocol Violation|0|||
146345694|NCT01208181|527770819|FG000|Part 2|Physician Decision|0|||
146345695|NCT01208181|527770820|FG001|Part 2|Physician Decision|0|||
146345696|NCT01208181|527770821|FG002|Part 2|Physician Decision|1|||
146345697|NCT01208181|527770822|FG003|Part 2|Physician Decision|2|||
146345698|NCT01208181|527770823|FG004|Part 2|Physician Decision|0|||
146345699|NCT01208181|527770819|FG000|Part 2|Non-compliance with study drug|0|||
146345700|NCT01208181|527770820|FG001|Part 2|Non-compliance with study drug|0|||
146345701|NCT01208181|527770821|FG002|Part 2|Non-compliance with study drug|1|||
146345702|NCT01208181|527770822|FG003|Part 2|Non-compliance with study drug|1|||
146345703|NCT01208181|527770823|FG004|Part 2|Non-compliance with study drug|0|||
146345704|NCT01208181|527770819|FG000|Part 2|Lost to Follow-up|0|||
146345705|NCT01208181|527770820|FG001|Part 2|Lost to Follow-up|0|||
146345706|NCT01208181|527770821|FG002|Part 2|Lost to Follow-up|1|||
146345707|NCT01208181|527770822|FG003|Part 2|Lost to Follow-up|2|||
146345708|NCT01208181|527770823|FG004|Part 2|Lost to Follow-up|0|||
146345709|NCT01208181|527770819|FG000|Part 2|Lack of Efficacy|0|||
146345710|NCT01208181|527770820|FG001|Part 2|Lack of Efficacy|0|||
146345711|NCT01208181|527770821|FG002|Part 2|Lack of Efficacy|5|||
146345712|NCT01208181|527770822|FG003|Part 2|Lack of Efficacy|7|||
146345713|NCT01208181|527770823|FG004|Part 2|Lack of Efficacy|0|||
146345714|NCT05258058|527770826|FG000|Overall Study|Withdrawal by Subject|2|||
146345715|NCT00465738|527770833|FG000|Overall Study|Lost to Follow-up|2|||
146345716|NCT00465738|527770834|FG001|Overall Study|Lost to Follow-up|0|||
146345717|NCT00465738|527770833|FG000|Overall Study|Adverse Event|0|||
146345718|NCT00465738|527770834|FG001|Overall Study|Adverse Event|1|||
146345719|NCT00465738|527770833|FG000|Overall Study|Withdrawal by Subject|2|||
146345720|NCT00465738|527770834|FG001|Overall Study|Withdrawal by Subject|0|||
146345721|NCT00465738|527770833|FG000|Overall Study|Other|2|||
146345722|NCT00465738|527770834|FG001|Overall Study|Other|5|||
146345723|NCT02707757|527770835|FG000|Overall Study|Protocol Violation|3|||
146345724|NCT02707757|527770836|FG001|Overall Study|Protocol Violation|2|||
146345725|NCT02707757|527770835|FG000|Overall Study|Withdrawal by Subject|2|||
146345726|NCT02707757|527770836|FG001|Overall Study|Withdrawal by Subject|0|||
146345727|NCT02707757|527770835|FG000|Overall Study|Death|0|||
146345728|NCT02707757|527770836|FG001|Overall Study|Death|1|||
146345729|NCT02707757|527770835|FG000|Overall Study|Adverse Event|6|||
146345730|NCT02707757|527770836|FG001|Overall Study|Adverse Event|4|||
146345731|NCT02707757|527770835|FG000|Overall Study|Renal transplant/elective operation|1|||
146345732|NCT02707757|527770836|FG001|Overall Study|Renal transplant/elective operation|5|||
146345733|NCT00734929|527770837|FG000|Overall Study|Lost to Follow-up|1|||
146345734|NCT00734929|527770838|FG001|Overall Study|Lost to Follow-up|2|||
146345735|NCT00734929|527770837|FG000|Overall Study|No intervention/ screen fail|5|||
146345736|NCT00734929|527770838|FG001|Overall Study|No intervention/ screen fail|3|||
146345737|NCT01318902|527770839|FG000|Overall Study|Symptomatic Deterioration|0|||
146345738|NCT01318902|527770840|FG001|Overall Study|Symptomatic Deterioration|1|||
146345739|NCT01318902|527770841|FG002|Overall Study|Symptomatic Deterioration|1|||
146345740|NCT01318902|527770842|FG003|Overall Study|Symptomatic Deterioration|2|||
146345741|NCT01318902|527770839|FG000|Overall Study|Withdrawal by Patient|0|||
146345742|NCT01318902|527770840|FG001|Overall Study|Withdrawal by Patient|1|||
146345743|NCT01318902|527770841|FG002|Overall Study|Withdrawal by Patient|0|||
146345744|NCT01318902|527770842|FG003|Overall Study|Withdrawal by Patient|3|||
146345745|NCT01318902|527770839|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
146345746|NCT01318902|527770840|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
146345747|NCT01318902|527770841|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
146345748|NCT01318902|527770842|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
146345749|NCT01318902|527770839|FG000|Overall Study|Adverse Event|0|||
146345750|NCT01318902|527770840|FG001|Overall Study|Adverse Event|1|||
146345751|NCT01318902|527770841|FG002|Overall Study|Adverse Event|0|||
146345752|NCT01318902|527770842|FG003|Overall Study|Adverse Event|0|||
146345753|NCT01318902|527770839|FG000|Overall Study|Terminated by Sponsor|0|||
146345754|NCT01318902|527770840|FG001|Overall Study|Terminated by Sponsor|0|||
146345755|NCT01318902|527770841|FG002|Overall Study|Terminated by Sponsor|1|||
146345756|NCT01318902|527770842|FG003|Overall Study|Terminated by Sponsor|0|||
146345757|NCT04275310|527772422|FG000|Overall Study|Non-randomized due to running out of funding|4|||
146345758|NCT04275310|527772423|FG001|Overall Study|Non-randomized due to running out of funding|0|||
146345759|NCT01936649|527772431|FG000|Overall Study|Withdrawal by Subject|4|||
146345760|NCT01936649|527772431|FG000|Overall Study|Physician Decision|2|||
146345761|NCT01936649|527772431|FG000|Overall Study|Protocol Violation|2|||
146345762|NCT01936649|527772431|FG000|Overall Study|Other than specified above|5|||
146345763|NCT03554005|527772432|FG000|Overall Study|Not in participant's best interest|0|||
146345764|NCT03554005|527772433|FG001|Overall Study|Not in participant's best interest|0|||
146345765|NCT03554005|527772434|FG002|Overall Study|Not in participant's best interest|0|||
146345766|NCT03554005|527772435|FG003|Overall Study|Not in participant's best interest|0|||
146345767|NCT03554005|527772436|FG004|Overall Study|Not in participant's best interest|0|||
146345768|NCT03554005|527772437|FG005|Overall Study|Not in participant's best interest|1|||
146345769|NCT03554005|527772432|FG000|Overall Study|Disease Progression|1|||
146345770|NCT03554005|527772433|FG001|Overall Study|Disease Progression|1|||
146345771|NCT03554005|527772434|FG002|Overall Study|Disease Progression|1|||
146345772|NCT03554005|527772435|FG003|Overall Study|Disease Progression|1|||
146345773|NCT03554005|527772436|FG004|Overall Study|Disease Progression|5|||
146345774|NCT03554005|527772437|FG005|Overall Study|Disease Progression|6|||
146345775|NCT03554005|527772432|FG000|Overall Study|Adverse Event|0|||
146345776|NCT03554005|527772433|FG001|Overall Study|Adverse Event|0|||
146345777|NCT03554005|527772434|FG002|Overall Study|Adverse Event|0|||
146345778|NCT03554005|527772435|FG003|Overall Study|Adverse Event|0|||
146345779|NCT03554005|527772436|FG004|Overall Study|Adverse Event|0|||
146345780|NCT03554005|527772437|FG005|Overall Study|Adverse Event|3|||
146345781|NCT03554005|527772432|FG000|Overall Study|Physician Decision|0|||
146345782|NCT03554005|527772433|FG001|Overall Study|Physician Decision|0|||
146345783|NCT03554005|527772434|FG002|Overall Study|Physician Decision|0|||
146345784|NCT03554005|527772435|FG003|Overall Study|Physician Decision|0|||
146345785|NCT03554005|527772436|FG004|Overall Study|Physician Decision|1|||
146345786|NCT03554005|527772437|FG005|Overall Study|Physician Decision|0|||
146345787|NCT03554005|527772432|FG000|Overall Study|Other|0|||
146345788|NCT03554005|527772433|FG001|Overall Study|Other|0|||
146345789|NCT03554005|527772434|FG002|Overall Study|Other|0|||
146345790|NCT03554005|527772435|FG003|Overall Study|Other|0|||
146345791|NCT03554005|527772436|FG004|Overall Study|Other|0|||
146345792|NCT03554005|527772437|FG005|Overall Study|Other|1|||
146345793|NCT00631488|527772438|FG000|Overall Study|Adverse Event|1|||
146345794|NCT00631488|527772439|FG001|Overall Study|Adverse Event|0|||
146345795|NCT00631488|527772440|FG002|Overall Study|Adverse Event|0|||
146345796|NCT00631488|527772438|FG000|Overall Study|Lost to Follow-up|2|||
146345797|NCT00631488|527772439|FG001|Overall Study|Lost to Follow-up|2|||
146345798|NCT00631488|527772440|FG002|Overall Study|Lost to Follow-up|0|||
146345799|NCT00631488|527772438|FG000|Overall Study|Physician Decision|1|||
146345800|NCT00631488|527772439|FG001|Overall Study|Physician Decision|0|||
146345801|NCT00631488|527772440|FG002|Overall Study|Physician Decision|1|||
146345802|NCT00631488|527772438|FG000|Overall Study|Protocol Violation|0|||
146345803|NCT00631488|527772439|FG001|Overall Study|Protocol Violation|0|||
146345804|NCT00631488|527772440|FG002|Overall Study|Protocol Violation|1|||
146345805|NCT02639182|527772441|FG000|Overall Study|Disease Progression|50|||
146345806|NCT02639182|527772442|FG001|Overall Study|Disease Progression|49|||
146345807|NCT02639182|527772441|FG000|Overall Study|Adverse Event|7|||
146345808|NCT02639182|527772442|FG001|Overall Study|Adverse Event|5|||
146345809|NCT02639182|527772441|FG000|Overall Study|Physician Decision|3|||
146345810|NCT02639182|527772442|FG001|Overall Study|Physician Decision|3|||
146345811|NCT02639182|527772441|FG000|Overall Study|Withdrew Consent|5|||
146345812|NCT02639182|527772442|FG001|Overall Study|Withdrew Consent|4|||
146345813|NCT02639182|527772441|FG000|Overall Study|Lost to Follow-up|0|||
146345814|NCT02639182|527772442|FG001|Overall Study|Lost to Follow-up|1|||
146345815|NCT02639182|527772441|FG000|Overall Study|Study Closure|1|||
146169374|NCT07018999|527131208|FG000|Overall Study|Incomplete data entry|4|||
146169375|NCT07018999|527131209|FG001|Overall Study|Incomplete data entry|7|||
146345816|NCT02639182|527772442|FG001|Overall Study|Study Closure|2|||
146345817|NCT02639182|527772441|FG000|Overall Study|Sponsor Ended Study|0|||
146345818|NCT02639182|527772442|FG001|Overall Study|Sponsor Ended Study|1|||
146345819|NCT02639182|527772441|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
146345820|NCT02639182|527772442|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
146345821|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
146345822|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
146345823|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
146345824|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146345825|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146345826|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146396300|NCT02940392|527954550|FG000|Overall Study|Retreatment|3|||
146345827|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146345828|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
146345829|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
146345830|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
146345831|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
146345832|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146345833|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146345834|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146345835|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146345836|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
146345837|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
146345838|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
146345839|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
146345840|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146345841|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146345842|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146345843|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146345844|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
146345845|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146345846|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
146345847|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345848|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345849|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345850|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345851|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345852|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
146345853|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
146345854|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
146345855|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
146345856|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146345857|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146345858|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146345859|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146345860|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
146345861|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
146345862|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
146345863|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345864|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345865|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345866|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345867|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345868|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
146345869|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
146345870|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
146345871|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345872|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345873|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345874|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345875|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345876|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
146345877|NCT01097616|527772443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345878|NCT01097616|527772444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345879|NCT01097616|527772445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
146345880|NCT01097616|527772446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345881|NCT01097616|527772447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345882|NCT01097616|527772448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345883|NCT01097616|527772449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345884|NCT01097616|527772450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
146345885|NCT01097616|527772443|FG000|Optional DB EXT Phase|Adverse Event|0|||
146345886|NCT01097616|527772444|FG001|Optional DB EXT Phase|Adverse Event|7|||
146345887|NCT01097616|527772445|FG002|Optional DB EXT Phase|Adverse Event|2|||
146345888|NCT01097616|527772446|FG003|Optional DB EXT Phase|Adverse Event|0|||
146345889|NCT01097616|527772447|FG004|Optional DB EXT Phase|Adverse Event|0|||
146169376|NCT03444376|527131210|FG000|Part A|Disease relapse or Progression|1|||
146169377|NCT03444376|527131210|FG000|Part A|Withdrawal by Subject|2|||
146345890|NCT01097616|527772448|FG005|Optional DB EXT Phase|Adverse Event|0|||
146345891|NCT01097616|527772449|FG006|Optional DB EXT Phase|Adverse Event|0|||
146345892|NCT01097616|527772450|FG007|Optional DB EXT Phase|Adverse Event|0|||
146345893|NCT01097616|527772443|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
146345894|NCT01097616|527772444|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
146345895|NCT01097616|527772445|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
146345896|NCT01097616|527772446|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
146345897|NCT01097616|527772447|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
146345898|NCT01097616|527772448|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
146345899|NCT01097616|527772449|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
146345900|NCT01097616|527772450|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
146345901|NCT01097616|527772443|FG000|Optional DB EXT Phase|Protocol Violation|0|||
146345902|NCT01097616|527772444|FG001|Optional DB EXT Phase|Protocol Violation|2|||
146345903|NCT01097616|527772445|FG002|Optional DB EXT Phase|Protocol Violation|3|||
146345904|NCT01097616|527772446|FG003|Optional DB EXT Phase|Protocol Violation|0|||
146345905|NCT01097616|527772447|FG004|Optional DB EXT Phase|Protocol Violation|0|||
146345906|NCT01097616|527772448|FG005|Optional DB EXT Phase|Protocol Violation|0|||
146345907|NCT01097616|527772449|FG006|Optional DB EXT Phase|Protocol Violation|0|||
146345908|NCT01097616|527772450|FG007|Optional DB EXT Phase|Protocol Violation|0|||
146345909|NCT01097616|527772443|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
146345910|NCT01097616|527772444|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
146345911|NCT01097616|527772445|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
146345912|NCT01097616|527772446|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
146345913|NCT01097616|527772447|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
146345914|NCT01097616|527772448|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
146345915|NCT01097616|527772449|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
146345916|NCT01097616|527772450|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
146345917|NCT01097616|527772443|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
146345918|NCT01097616|527772444|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
146345919|NCT01097616|527772445|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
146345920|NCT01097616|527772446|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
146345921|NCT01097616|527772447|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
146345922|NCT01097616|527772448|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
146345923|NCT01097616|527772449|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
146345924|NCT01097616|527772450|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
146345925|NCT01097616|527772443|FG000|Optional DB EXT Phase|Physician Decision|1|||
146345926|NCT01097616|527772444|FG001|Optional DB EXT Phase|Physician Decision|0|||
146345927|NCT01097616|527772445|FG002|Optional DB EXT Phase|Physician Decision|0|||
146345928|NCT01097616|527772446|FG003|Optional DB EXT Phase|Physician Decision|0|||
146345929|NCT01097616|527772447|FG004|Optional DB EXT Phase|Physician Decision|0|||
146345930|NCT01097616|527772448|FG005|Optional DB EXT Phase|Physician Decision|0|||
146345931|NCT01097616|527772449|FG006|Optional DB EXT Phase|Physician Decision|0|||
146345932|NCT01097616|527772450|FG007|Optional DB EXT Phase|Physician Decision|0|||
146345933|NCT01097616|527772443|FG000|DB RO Phase|Adverse Event|0|||
146345934|NCT01097616|527772444|FG001|DB RO Phase|Adverse Event|0|||
146345935|NCT01097616|527772445|FG002|DB RO Phase|Adverse Event|0|||
146345936|NCT01097616|527772446|FG003|DB RO Phase|Adverse Event|0|||
146345937|NCT01097616|527772447|FG004|DB RO Phase|Adverse Event|0|||
146345938|NCT01097616|527772448|FG005|DB RO Phase|Adverse Event|0|||
146345939|NCT01097616|527772449|FG006|DB RO Phase|Adverse Event|1|||
146345940|NCT01097616|527772450|FG007|DB RO Phase|Adverse Event|0|||
146345941|NCT01097616|527772443|FG000|DB RO Phase|Withdrawal by Subject|0|||
146345942|NCT01097616|527772444|FG001|DB RO Phase|Withdrawal by Subject|0|||
146345943|NCT01097616|527772445|FG002|DB RO Phase|Withdrawal by Subject|0|||
146345944|NCT01097616|527772446|FG003|DB RO Phase|Withdrawal by Subject|0|||
146345945|NCT01097616|527772447|FG004|DB RO Phase|Withdrawal by Subject|0|||
146345946|NCT01097616|527772448|FG005|DB RO Phase|Withdrawal by Subject|1|||
146345947|NCT01097616|527772449|FG006|DB RO Phase|Withdrawal by Subject|0|||
146345948|NCT01097616|527772450|FG007|DB RO Phase|Withdrawal by Subject|0|||
146345949|NCT01097616|527772443|FG000|DB RO Phase|Lost to Follow-up|0|||
146345950|NCT01097616|527772444|FG001|DB RO Phase|Lost to Follow-up|0|||
146345951|NCT01097616|527772445|FG002|DB RO Phase|Lost to Follow-up|0|||
146345952|NCT01097616|527772446|FG003|DB RO Phase|Lost to Follow-up|1|||
146345953|NCT01097616|527772447|FG004|DB RO Phase|Lost to Follow-up|1|||
146345954|NCT01097616|527772448|FG005|DB RO Phase|Lost to Follow-up|0|||
146345955|NCT01097616|527772449|FG006|DB RO Phase|Lost to Follow-up|0|||
146345956|NCT01097616|527772450|FG007|DB RO Phase|Lost to Follow-up|1|||
146345957|NCT01097616|527772443|FG000|DB RO Phase|Not Treated in RO|0|||
146345958|NCT01097616|527772444|FG001|DB RO Phase|Not Treated in RO|0|||
146345959|NCT01097616|527772445|FG002|DB RO Phase|Not Treated in RO|0|||
146345960|NCT01097616|527772446|FG003|DB RO Phase|Not Treated in RO|0|||
146345961|NCT01097616|527772447|FG004|DB RO Phase|Not Treated in RO|0|||
146345962|NCT01097616|527772448|FG005|DB RO Phase|Not Treated in RO|1|||
146345963|NCT01097616|527772449|FG006|DB RO Phase|Not Treated in RO|0|||
146345964|NCT01097616|527772450|FG007|DB RO Phase|Not Treated in RO|0|||
146345965|NCT00589472|527772452|FG000|Overall Study|Adverse Event|1|||
146345966|NCT00117338|527772453|FG000|Overall Study|Adverse Event|0|||
146345967|NCT00117338|527772454|FG001|Overall Study|Adverse Event|1|||
146345968|NCT00117338|527772453|FG000|Overall Study|Protocol Violation|3|||
146345969|NCT00117338|527772454|FG001|Overall Study|Protocol Violation|2|||
146345970|NCT00117338|527772453|FG000|Overall Study|Withdrawal by Subject|1|||
146345971|NCT00117338|527772454|FG001|Overall Study|Withdrawal by Subject|0|||
146345972|NCT00117338|527772453|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
146345973|NCT00117338|527772454|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
146345974|NCT00117338|527772453|FG000|Overall Study|Lack of Efficacy|0|||
146345975|NCT00117338|527772454|FG001|Overall Study|Lack of Efficacy|1|||
146345976|NCT00546351|527772455|FG000|Overall Study|Adverse Event|76|||
146345977|NCT00546351|527772455|FG000|Overall Study|Lack of Efficacy|15|||
146345978|NCT00546351|527772455|FG000|Overall Study|Withdrawal by Subject|109|||
146345979|NCT00546351|527772455|FG000|Overall Study|Lost to Follow-up|9|||
146345980|NCT00546351|527772455|FG000|Overall Study|Protocol Deviation|1|||
146345981|NCT00546351|527772455|FG000|Overall Study|Unsatisfactory compliance|9|||
146345982|NCT00546351|527772455|FG000|Overall Study|Other reasons for premature termination|17|||
146345983|NCT01342640|527772456|FG000|Overall Study|Adverse Event|3|||
146345984|NCT01342640|527772456|FG000|Overall Study|Protocol Violation|16|||
146345985|NCT01342640|527772456|FG000|Overall Study|Lost to Follow-up|21|||
146345986|NCT01342640|527772456|FG000|Overall Study|Other|1|||
146345987|NCT00479466|527772458|FG000|Overall Study|Adverse Event|5|||
146345988|NCT00479466|527772459|FG001|Overall Study|Adverse Event|1|||
146345989|NCT00479466|527772460|FG002|Overall Study|Adverse Event|0|||
146345990|NCT00479466|527772461|FG003|Overall Study|Adverse Event|1|||
146345991|NCT00479466|527772462|FG004|Overall Study|Adverse Event|2|||
146345992|NCT00479466|527772463|FG005|Overall Study|Adverse Event|0|||
146345993|NCT00479466|527772458|FG000|Overall Study|Hyperglycemia|0|||
146345994|NCT00479466|527772459|FG001|Overall Study|Hyperglycemia|0|||
146345995|NCT00479466|527772460|FG002|Overall Study|Hyperglycemia|0|||
146345996|NCT00479466|527772461|FG003|Overall Study|Hyperglycemia|0|||
146345997|NCT00479466|527772462|FG004|Overall Study|Hyperglycemia|0|||
146345998|NCT00479466|527772463|FG005|Overall Study|Hyperglycemia|1|||
146345999|NCT00479466|527772458|FG000|Overall Study|Lack of Efficacy|2|||
146346000|NCT00479466|527772459|FG001|Overall Study|Lack of Efficacy|0|||
146346001|NCT00479466|527772460|FG002|Overall Study|Lack of Efficacy|1|||
146346002|NCT00479466|527772461|FG003|Overall Study|Lack of Efficacy|0|||
146346003|NCT00479466|527772462|FG004|Overall Study|Lack of Efficacy|0|||
146346004|NCT00479466|527772463|FG005|Overall Study|Lack of Efficacy|0|||
146346005|NCT00479466|527772458|FG000|Overall Study|Lost to Follow-up|0|||
146346006|NCT00479466|527772459|FG001|Overall Study|Lost to Follow-up|1|||
146346007|NCT00479466|527772460|FG002|Overall Study|Lost to Follow-up|1|||
146346008|NCT00479466|527772461|FG003|Overall Study|Lost to Follow-up|0|||
146346009|NCT00479466|527772462|FG004|Overall Study|Lost to Follow-up|2|||
146346010|NCT00479466|527772463|FG005|Overall Study|Lost to Follow-up|2|||
146346011|NCT00479466|527772458|FG000|Overall Study|Physician Decision|2|||
146346012|NCT00479466|527772459|FG001|Overall Study|Physician Decision|1|||
146346013|NCT00479466|527772460|FG002|Overall Study|Physician Decision|1|||
146346014|NCT00479466|527772461|FG003|Overall Study|Physician Decision|0|||
146346015|NCT00479466|527772462|FG004|Overall Study|Physician Decision|0|||
146346016|NCT00479466|527772463|FG005|Overall Study|Physician Decision|0|||
146346017|NCT00479466|527772458|FG000|Overall Study|Pregnancy|0|||
146346018|NCT00479466|527772459|FG001|Overall Study|Pregnancy|0|||
146346019|NCT00479466|527772460|FG002|Overall Study|Pregnancy|0|||
146346020|NCT00479466|527772461|FG003|Overall Study|Pregnancy|0|||
146346021|NCT00479466|527772462|FG004|Overall Study|Pregnancy|1|||
146346022|NCT00479466|527772463|FG005|Overall Study|Pregnancy|0|||
146346023|NCT00479466|527772458|FG000|Overall Study|Protocol Violation|1|||
146346024|NCT00479466|527772459|FG001|Overall Study|Protocol Violation|0|||
146346025|NCT00479466|527772460|FG002|Overall Study|Protocol Violation|0|||
146346026|NCT00479466|527772461|FG003|Overall Study|Protocol Violation|0|||
146346027|NCT00479466|527772462|FG004|Overall Study|Protocol Violation|0|||
146346028|NCT00479466|527772463|FG005|Overall Study|Protocol Violation|0|||
146346029|NCT00479466|527772458|FG000|Overall Study|Withdrawal by Subject|3|||
146346030|NCT00479466|527772459|FG001|Overall Study|Withdrawal by Subject|5|||
146346031|NCT00479466|527772460|FG002|Overall Study|Withdrawal by Subject|0|||
146346032|NCT00479466|527772461|FG003|Overall Study|Withdrawal by Subject|2|||
146346033|NCT00479466|527772462|FG004|Overall Study|Withdrawal by Subject|3|||
146346034|NCT00479466|527772463|FG005|Overall Study|Withdrawal by Subject|1|||
146346035|NCT00850499|527772469|FG000|Overall Study|Adverse Event|3|||
146346036|NCT00850499|527772470|FG001|Overall Study|Adverse Event|1|||
146346037|NCT00850499|527772469|FG000|Overall Study|Lack of Efficacy|0|||
146346038|NCT00850499|527772470|FG001|Overall Study|Lack of Efficacy|1|||
146346039|NCT04498910|527772474|FG000|Overall Study|Lost to Follow-up|0|||
146346040|NCT04498910|527772475|FG001|Overall Study|Lost to Follow-up|1|||
146346041|NCT04498910|527772474|FG000|Overall Study|Withdrawal by Subject|2|||
146346042|NCT04498910|527772475|FG001|Overall Study|Withdrawal by Subject|1|||
146346043|NCT04498910|527772474|FG000|Overall Study|Adverse Event|1|||
146346044|NCT04498910|527772475|FG001|Overall Study|Adverse Event|0|||
146346045|NCT02345434|527772478|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
146346046|NCT02345434|527772479|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
146346047|NCT01703819|527772480|FG000|Overall Study|Adverse Event|0|||
146346048|NCT01703819|527772481|FG001|Overall Study|Adverse Event|1|||
146346049|NCT01703819|527772480|FG000|Overall Study|Withdrawal by Subject|0|||
146346050|NCT01703819|527772481|FG001|Overall Study|Withdrawal by Subject|1|||
146346051|NCT01302041|527772488|FG000|Overall Study|Death|5|||
146346052|NCT01302041|527772488|FG000|Overall Study|Withdrawal by Subject|4|||
146346053|NCT01302041|527772488|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
146346054|NCT01302041|527772488|FG000|Overall Study|Other-Miscellaneous Reason|2|||
146346055|NCT02064439|527772489|FG000|Overall Study|Adverse Event|51|||
146346056|NCT02064439|527772490|FG001|Overall Study|Adverse Event|47|||
146346057|NCT02064439|527772491|FG002|Overall Study|Adverse Event|46|||
146346058|NCT02064439|527772489|FG000|Overall Study|Death|0|||
146346059|NCT02064439|527772490|FG001|Overall Study|Death|2|||
146346060|NCT02064439|527772491|FG002|Overall Study|Death|3|||
146346061|NCT02064439|527772489|FG000|Overall Study|Withdrawal by Subject|29|||
146346062|NCT02064439|527772490|FG001|Overall Study|Withdrawal by Subject|18|||
146346063|NCT02064439|527772491|FG002|Overall Study|Withdrawal by Subject|26|||
146346064|NCT02064439|527772489|FG000|Overall Study|Protocol Violation|3|||
146346065|NCT02064439|527772490|FG001|Overall Study|Protocol Violation|5|||
146346066|NCT02064439|527772491|FG002|Overall Study|Protocol Violation|3|||
146346067|NCT02064439|527772489|FG000|Overall Study|Lost to Follow-up|1|||
146346068|NCT02064439|527772490|FG001|Overall Study|Lost to Follow-up|3|||
146346069|NCT02064439|527772491|FG002|Overall Study|Lost to Follow-up|4|||
146346070|NCT02064439|527772489|FG000|Overall Study|Non-compliance with study medication|21|||
146346071|NCT02064439|527772490|FG001|Overall Study|Non-compliance with study medication|19|||
146346072|NCT02064439|527772491|FG002|Overall Study|Non-compliance with study medication|23|||
146346073|NCT02064439|527772489|FG000|Overall Study|Physician Decision|0|||
146346074|NCT02064439|527772490|FG001|Overall Study|Physician Decision|1|||
146346075|NCT02064439|527772491|FG002|Overall Study|Physician Decision|1|||
146346076|NCT02064439|527772489|FG000|Overall Study|Logistical difficulties|6|||
146346077|NCT02064439|527772490|FG001|Overall Study|Logistical difficulties|5|||
146346078|NCT02064439|527772491|FG002|Overall Study|Logistical difficulties|2|||
146346079|NCT02064439|527772489|FG000|Overall Study|Efficacy outcome reached|18|||
146346080|NCT02064439|527772490|FG001|Overall Study|Efficacy outcome reached|16|||
146346081|NCT02064439|527772491|FG002|Overall Study|Efficacy outcome reached|57|||
146346082|NCT02064439|527772489|FG000|Overall Study|Safety outcome reached|12|||
146346083|NCT02064439|527772490|FG001|Overall Study|Safety outcome reached|20|||
146346084|NCT02064439|527772491|FG002|Overall Study|Safety outcome reached|10|||
146346085|NCT02064439|527772489|FG000|Overall Study|Other|2|||
146346086|NCT02064439|527772490|FG001|Overall Study|Other|2|||
146346087|NCT02064439|527772491|FG002|Overall Study|Other|7|||
146346088|NCT03350750|527772492|FG000|Overall Study|Death|1|||
146346089|NCT03350750|527772493|FG001|Overall Study|Death|1|||
146346090|NCT02433288|527772494|FG000|Overall Study|Severe non-compliance to protocol|13|||
146346091|NCT02433288|527772495|FG001|Overall Study|Severe non-compliance to protocol|7|||
146346092|NCT02433288|527772494|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
146346093|NCT02433288|527772495|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
146346094|NCT02433288|527772494|FG000|Overall Study|Withdrawal by Subject|101|||
146346095|NCT02433288|527772495|FG001|Overall Study|Withdrawal by Subject|99|||
146346096|NCT02433288|527772494|FG000|Overall Study|Lost to Follow-up|2|||
146346097|NCT02433288|527772495|FG001|Overall Study|Lost to Follow-up|14|||
146346098|NCT02433288|527772494|FG000|Overall Study|Death|0|||
146346099|NCT02433288|527772495|FG001|Overall Study|Death|3|||
146346100|NCT00858702|527772496|FG000|Overall Study|Lack of Efficacy|1|||
146346101|NCT00858702|527772497|FG001|Overall Study|Lack of Efficacy|0|||
146346102|NCT00858702|527772496|FG000|Overall Study|Protocol Violation|1|||
146346103|NCT00858702|527772497|FG001|Overall Study|Protocol Violation|1|||
146346104|NCT00858702|527772496|FG000|Overall Study|Other|2|||
146346105|NCT00858702|527772497|FG001|Overall Study|Other|1|||
146346106|NCT00858702|527772496|FG000|Overall Study|Withdrawal by Subject|1|||
146346107|NCT00858702|527772497|FG001|Overall Study|Withdrawal by Subject|0|||
146346108|NCT01849250|527772500|FG000|Overall Study|Withdrawal by Subject|1|||
146346109|NCT01849250|527772501|FG001|Overall Study|Withdrawal by Subject|0|||
146346110|NCT01849250|527772500|FG000|Overall Study|Not Evaluable|5|||
146346111|NCT01849250|527772501|FG001|Overall Study|Not Evaluable|3|||
146346112|NCT01849250|527772500|FG000|Overall Study|Screen Failure|1|||
146346113|NCT01849250|527772501|FG001|Overall Study|Screen Failure|0|||
146346114|NCT00367640|527772502|FG000|Overall Study|Adverse Event|3|||
146346115|NCT00367640|527772503|FG001|Overall Study|Adverse Event|6|||
146346116|NCT00367640|527772504|FG002|Overall Study|Adverse Event|8|||
146346117|NCT00367640|527772505|FG003|Overall Study|Adverse Event|0|||
146346118|NCT00367640|527772502|FG000|Overall Study|Withdrawal by Subject|8|||
146346119|NCT00367640|527772503|FG001|Overall Study|Withdrawal by Subject|11|||
146346120|NCT00367640|527772504|FG002|Overall Study|Withdrawal by Subject|8|||
146346121|NCT00367640|527772505|FG003|Overall Study|Withdrawal by Subject|6|||
146346122|NCT00367640|527772502|FG000|Overall Study|Any other reason not above-mentioned|7|||
146346123|NCT00367640|527772503|FG001|Overall Study|Any other reason not above-mentioned|5|||
146346124|NCT00367640|527772504|FG002|Overall Study|Any other reason not above-mentioned|3|||
146346125|NCT00367640|527772505|FG003|Overall Study|Any other reason not above-mentioned|4|||
146346126|NCT04504032|527772511|FG000|Overall Study|Adverse Event|1|||
146346127|NCT04504032|527772512|FG001|Overall Study|Adverse Event|2|||
146346128|NCT04504032|527772511|FG000|Overall Study|Lost to Follow-up|6|||
146346129|NCT04504032|527772512|FG001|Overall Study|Lost to Follow-up|9|||
146346130|NCT04504032|527772511|FG000|Overall Study|Protocol Violation|2|||
146346131|NCT04504032|527772512|FG001|Overall Study|Protocol Violation|0|||
146346132|NCT04504032|527772511|FG000|Overall Study|Study terminated by sponsor|1|||
146346133|NCT04504032|527772512|FG001|Overall Study|Study terminated by sponsor|2|||
146346134|NCT04504032|527772511|FG000|Overall Study|Withdrawal by Subject|9|||
146346135|NCT04504032|527772512|FG001|Overall Study|Withdrawal by Subject|11|||
146346136|NCT04504032|527772511|FG000|Overall Study|Disease progression prior to dosing|15|||
146346137|NCT04504032|527772512|FG001|Overall Study|Disease progression prior to dosing|3|||
146346138|NCT04504032|527772511|FG000|Overall Study|Drug supply issues|1|||
146346139|NCT04504032|527772512|FG001|Overall Study|Drug supply issues|1|||
146346140|NCT04504032|527772511|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
146346141|NCT04504032|527772512|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
146346142|NCT00771030|527772513|FG000|Overall Study|Adverse Event|0|||
146346143|NCT00771030|527772514|FG001|Overall Study|Adverse Event|1|||
146346144|NCT00771030|527772515|FG002|Overall Study|Adverse Event|0|||
146346145|NCT00771030|527772516|FG003|Overall Study|Adverse Event|0|||
146346146|NCT00771030|527772517|FG004|Overall Study|Adverse Event|0|||
146346147|NCT00771030|527772518|FG005|Overall Study|Adverse Event|0|||
146346148|NCT00771030|527772519|FG006|Overall Study|Adverse Event|0|||
146346149|NCT01839188|527772520|FG000|Overall Study|Withdrawal by Subject|1|||
146346150|NCT02805907|527772521|FG000|Overall Study|Lost to Follow-up|3|||
146346151|NCT02805907|527772522|FG001|Overall Study|Lost to Follow-up|3|||
146346152|NCT01022853|527772533|FG000|Overall Study|Progressive disease|2|||
146346153|NCT01022853|527772534|FG001|Overall Study|Progressive disease|3|||
146346154|NCT01022853|527772535|FG002|Overall Study|Progressive disease|11|||
146346155|NCT01022853|527772536|FG003|Overall Study|Progressive disease|7|||
146346156|NCT01022853|527772537|FG004|Overall Study|Progressive disease|1|||
146346157|NCT01022853|527772533|FG000|Overall Study|Dose-limiting toxicity|0|||
146346158|NCT01022853|527772534|FG001|Overall Study|Dose-limiting toxicity|0|||
146346159|NCT01022853|527772535|FG002|Overall Study|Dose-limiting toxicity|0|||
146346160|NCT01022853|527772536|FG003|Overall Study|Dose-limiting toxicity|0|||
146346161|NCT01022853|527772537|FG004|Overall Study|Dose-limiting toxicity|1|||
146346162|NCT01022853|527772533|FG000|Overall Study|Withdrawal by Subject|0|||
146346163|NCT01022853|527772534|FG001|Overall Study|Withdrawal by Subject|1|||
146346164|NCT01022853|527772535|FG002|Overall Study|Withdrawal by Subject|1|||
146346165|NCT01022853|527772536|FG003|Overall Study|Withdrawal by Subject|1|||
146346166|NCT01022853|527772537|FG004|Overall Study|Withdrawal by Subject|0|||
146346167|NCT01022853|527772533|FG000|Overall Study|Other not stated above|1|||
146346168|NCT01022853|527772534|FG001|Overall Study|Other not stated above|0|||
146346169|NCT01022853|527772535|FG002|Overall Study|Other not stated above|1|||
146346170|NCT01022853|527772536|FG003|Overall Study|Other not stated above|0|||
146346171|NCT01022853|527772537|FG004|Overall Study|Other not stated above|0|||
146346172|NCT02416908|527772538|FG000|Dose Escalation Phase|Adverse Event|0|||
146346173|NCT02416908|527772539|FG001|Dose Escalation Phase|Adverse Event|0|||
146346174|NCT02416908|527772540|FG002|Dose Escalation Phase|Adverse Event|3|||
146346175|NCT02416908|527772541|FG003|Dose Escalation Phase|Adverse Event|0|||
146346176|NCT02416908|527772538|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146346177|NCT02416908|527772539|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146346178|NCT02416908|527772540|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
146346179|NCT02416908|527772541|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146346180|NCT02075255|527772543|FG000|Overall Study|Study specific withdrawal criteria|0|||
146346181|NCT02075255|527772544|FG001|Overall Study|Study specific withdrawal criteria|1|||
146346182|NCT02075255|527772545|FG002|Overall Study|Study specific withdrawal criteria|1|||
146346183|NCT02075255|527772543|FG000|Overall Study|Withdrawal by Subject|4|||
146346184|NCT02075255|527772544|FG001|Overall Study|Withdrawal by Subject|1|||
146346185|NCT02075255|527772545|FG002|Overall Study|Withdrawal by Subject|0|||
146346186|NCT02075255|527772543|FG000|Overall Study|Lost to Follow-up|0|||
146346187|NCT02075255|527772544|FG001|Overall Study|Lost to Follow-up|0|||
146346188|NCT02075255|527772545|FG002|Overall Study|Lost to Follow-up|1|||
146346189|NCT02075255|527772543|FG000|Overall Study|Adverse Event|0|||
145943382|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146346190|NCT02075255|527772544|FG001|Overall Study|Adverse Event|0|||
146346191|NCT02075255|527772545|FG002|Overall Study|Adverse Event|1|||
146346192|NCT02075255|527772543|FG000|Overall Study|Death|0|||
146346193|NCT02075255|527772544|FG001|Overall Study|Death|2|||
146346194|NCT02075255|527772545|FG002|Overall Study|Death|0|||
146346195|NCT03792750|527772546|FG000|Overall Study|Death|3|||
146346196|NCT01478347|527772548|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
146346197|NCT01478347|527772548|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
146346198|NCT01478347|527772548|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
146346199|NCT01645930|527772549|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
146346200|NCT01645930|527772549|FG000|Overall Study|Progressive Disease|12|||
146346201|NCT01645930|527772549|FG000|Overall Study|Adverse Event|4|||
146346202|NCT01645930|527772549|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
146346203|NCT01645930|527772549|FG000|Overall Study|Withdrawal by Participant|2|||
146346204|NCT01645930|527772549|FG000|Overall Study|Reason not Defined|1|||
146346205|NCT01748760|527772550|FG000|Overall Study|Withdrawal by Subject|1|||
146346206|NCT01748760|527772551|FG001|Overall Study|Withdrawal by Subject|1|||
146346207|NCT01748760|527772550|FG000|Overall Study|Lost to Follow-up|5|||
146346208|NCT01748760|527772551|FG001|Overall Study|Lost to Follow-up|1|||
146346209|NCT03245814|527772552|FG000|Overall Study|Lost to Follow-up|5|||
146346210|NCT03245814|527772553|FG001|Overall Study|Lost to Follow-up|8|||
146346211|NCT03245814|527772552|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
146346212|NCT03245814|527772553|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
146346213|NCT02263365|527772557|FG000|Overall Study|Physician Decision|22|||
146346214|NCT02263365|527772558|FG001|Overall Study|Physician Decision|18|||
146346215|NCT00510692|527772559|FG000|Overall Study|Adverse Event|1|||
146346216|NCT00510692|527772560|FG001|Overall Study|Adverse Event|3|||
146346217|NCT00510692|527772559|FG000|Overall Study|Withdrawal by Subject|1|||
146346218|NCT00510692|527772560|FG001|Overall Study|Withdrawal by Subject|0|||
146346219|NCT00945191|527772561|FG000|Overall Study|Did not achieve a complete response|18|||
146346220|NCT00945191|527772561|FG000|Overall Study|Participant relocated to another state|1|||
146346221|NCT00945191|527772561|FG000|Overall Study|Disease progression|3|||
146346222|NCT00945191|527772561|FG000|Overall Study|Serious adverse event or adverse event|1|||
146346223|NCT00945191|527772561|FG000|Overall Study|Investigator's discretion|1|||
146346224|NCT01845077|527772564|FG000|Washout Period|Lost to Follow-up|0|||
146346225|NCT01845077|527772565|FG001|Washout Period|Lost to Follow-up|1|||
146346226|NCT01845077|527772566|FG002|Washout Period|Lost to Follow-up|0|||
146346227|NCT01845077|527772567|FG003|Washout Period|Lost to Follow-up|1|||
146346228|NCT01845077|527772568|FG004|Washout Period|Lost to Follow-up|0|||
146346229|NCT01845077|527772569|FG005|Washout Period|Lost to Follow-up|1|||
146346230|NCT01845077|527772564|FG000|Washout Period|Adverse Event|1|||
146346231|NCT01845077|527772565|FG001|Washout Period|Adverse Event|0|||
146346232|NCT01845077|527772566|FG002|Washout Period|Adverse Event|0|||
146346233|NCT01845077|527772567|FG003|Washout Period|Adverse Event|0|||
146346234|NCT01845077|527772568|FG004|Washout Period|Adverse Event|0|||
146346235|NCT01845077|527772569|FG005|Washout Period|Adverse Event|0|||
146346236|NCT01845077|527772564|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
146346237|NCT01845077|527772565|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
146346238|NCT01845077|527772566|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
146346239|NCT01845077|527772567|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
146346240|NCT01845077|527772568|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
146346241|NCT01845077|527772569|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
146346242|NCT01845077|527772564|FG000|Washout Period|Protocol Violation|0|||
146346243|NCT01845077|527772565|FG001|Washout Period|Protocol Violation|0|||
146346244|NCT01845077|527772566|FG002|Washout Period|Protocol Violation|0|||
146346245|NCT01845077|527772567|FG003|Washout Period|Protocol Violation|1|||
146346246|NCT01845077|527772568|FG004|Washout Period|Protocol Violation|1|||
146346247|NCT01845077|527772569|FG005|Washout Period|Protocol Violation|0|||
146346248|NCT00394914|527772572|FG000|Treatment Period|Adverse Event|0|||
146346249|NCT00394914|527772573|FG001|Treatment Period|Adverse Event|3|||
146346250|NCT00394914|527772574|FG002|Treatment Period|Adverse Event|1|||
146346251|NCT00394914|527772572|FG000|Treatment Period|Lost to Follow-up|0|||
146346252|NCT00394914|527772573|FG001|Treatment Period|Lost to Follow-up|1|||
146346253|NCT00394914|527772574|FG002|Treatment Period|Lost to Follow-up|0|||
146346254|NCT00394914|527772572|FG000|Treatment Period|Withdrawal by Subject|0|||
146346255|NCT00394914|527772573|FG001|Treatment Period|Withdrawal by Subject|2|||
146346256|NCT00394914|527772574|FG002|Treatment Period|Withdrawal by Subject|2|||
146346257|NCT00394914|527772572|FG000|Treatment Period|Noncompliance with protocol|0|||
146346258|NCT00394914|527772573|FG001|Treatment Period|Noncompliance with protocol|3|||
146346259|NCT00394914|527772574|FG002|Treatment Period|Noncompliance with protocol|2|||
146346260|NCT00394914|527772572|FG000|Treatment Period|Did not meet protocol eligibility|0|||
146346261|NCT00394914|527772573|FG001|Treatment Period|Did not meet protocol eligibility|1|||
146169378|NCT03444376|527131210|FG000|Part A|Adverse Event|1|||
146169379|NCT03444376|527131210|FG000|Part B|Disease relapse or Progression|18|||
146346262|NCT00394914|527772574|FG002|Treatment Period|Did not meet protocol eligibility|1|||
146346263|NCT00312377|527772578|FG000|Overall Study|Death|403|||
146346264|NCT00312377|527772579|FG001|Overall Study|Death|418|||
146346265|NCT00312377|527772578|FG000|Overall Study|Withdrawal by Subject|23|||
146346266|NCT00312377|527772579|FG001|Overall Study|Withdrawal by Subject|30|||
146346267|NCT00312377|527772578|FG000|Overall Study|Lost to Follow-up|9|||
146346268|NCT00312377|527772579|FG001|Overall Study|Lost to Follow-up|12|||
145943383|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146346269|NCT00312377|527772578|FG000|Overall Study|Non-compliance|0|||
146346270|NCT00312377|527772579|FG001|Overall Study|Non-compliance|2|||
146346271|NCT00312377|527772578|FG000|Overall Study|Randomised but never received treatment|6|||
146346272|NCT00312377|527772579|FG001|Overall Study|Randomised but never received treatment|6|||
146346273|NCT00312377|527772578|FG000|Overall Study|Discontinue treatment survival follow up|202|||
146346274|NCT00312377|527772579|FG001|Overall Study|Discontinue treatment survival follow up|200|||
146346275|NCT00312377|527772578|FG000|Overall Study|Site ended participation in study|1|||
146346276|NCT00312377|527772579|FG001|Overall Study|Site ended participation in study|0|||
146346277|NCT00872898|527772580|FG000|Part Two - Double Blind|Adverse Event|4|||
146346278|NCT00872898|527772581|FG001|Part Two - Double Blind|Adverse Event|3|||
146346279|NCT00872898|527772580|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
146346280|NCT00872898|527772581|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
146346281|NCT00872898|527772580|FG000|Part Two - Double Blind|Protocol Violation|1|||
146346282|NCT00872898|527772581|FG001|Part Two - Double Blind|Protocol Violation|0|||
146346283|NCT00872898|527772580|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
146346284|NCT00872898|527772581|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
146346285|NCT00872898|527772580|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
146346286|NCT00872898|527772581|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
146346287|NCT00872898|527772580|FG000|Part Two - Double Blind|Other reasons|2|||
146346288|NCT00872898|527772581|FG001|Part Two - Double Blind|Other reasons|0|||
146346289|NCT01004146|527772583|FG000|Overall Study|Withdrawal by Subject|4|||
146346290|NCT01004146|527772584|FG001|Overall Study|Withdrawal by Subject|5|||
146346291|NCT03290300|527772591|FG000|Overall Study|Lost to Follow-up|3|||
146346292|NCT01001494|527772592|FG000|Overall Study|Adverse Event|8|||
146346293|NCT01001494|527772593|FG001|Overall Study|Adverse Event|4|||
146346294|NCT01001494|527772594|FG002|Overall Study|Adverse Event|6|||
146346295|NCT01001494|527772592|FG000|Overall Study|Protocol Violation|0|||
146346296|NCT01001494|527772593|FG001|Overall Study|Protocol Violation|1|||
146346297|NCT01001494|527772594|FG002|Overall Study|Protocol Violation|1|||
146346298|NCT01001494|527772592|FG000|Overall Study|Lost to Follow-up|2|||
146346299|NCT01001494|527772593|FG001|Overall Study|Lost to Follow-up|0|||
146346300|NCT01001494|527772594|FG002|Overall Study|Lost to Follow-up|1|||
146346301|NCT01001494|527772592|FG000|Overall Study|Withdrawal by Subject|9|||
146346302|NCT01001494|527772593|FG001|Overall Study|Withdrawal by Subject|7|||
146346303|NCT01001494|527772594|FG002|Overall Study|Withdrawal by Subject|17|||
146346304|NCT01001494|527772592|FG000|Overall Study|COPD exacerbation|3|||
146346305|NCT01001494|527772593|FG001|Overall Study|COPD exacerbation|4|||
146346306|NCT01001494|527772594|FG002|Overall Study|COPD exacerbation|5|||
146346307|NCT01001494|527772592|FG000|Overall Study|Lack of Efficacy|2|||
146346308|NCT01001494|527772593|FG001|Overall Study|Lack of Efficacy|0|||
146346309|NCT01001494|527772594|FG002|Overall Study|Lack of Efficacy|8|||
146346310|NCT01001494|527772592|FG000|Overall Study|Other|0|||
146346311|NCT01001494|527772593|FG001|Overall Study|Other|1|||
146346312|NCT01001494|527772594|FG002|Overall Study|Other|3|||
146346313|NCT02179398|527772595|FG000|Overall Study|Lack of obligatory data|3|||
146346314|NCT02179398|527772596|FG001|Overall Study|Lack of obligatory data|3|||
146346315|NCT02179398|527772595|FG000|Overall Study|Lost to Follow-up|0|||
146346316|NCT02179398|527772596|FG001|Overall Study|Lost to Follow-up|1|||
146346317|NCT02519231|527772598|FG000|Overall Study|Lost to Follow-up|2|||
146346318|NCT02519231|527772599|FG001|Overall Study|Lost to Follow-up|5|||
146346319|NCT02519231|527772598|FG000|Overall Study|Withdrawal by Subject|0|||
146346320|NCT02519231|527772599|FG001|Overall Study|Withdrawal by Subject|1|||
146346321|NCT00815308|527772600|FG000|Overall Study|Adverse Event|4|||
146346322|NCT00815308|527772600|FG000|Overall Study|Withdrawal by Subject|0|||
146346323|NCT00815308|527772600|FG000|Overall Study|Protocol Violation|6|||
146346324|NCT02699515|527774387|FG000|Overall Study|Death|3|||
146346325|NCT02699515|527774388|FG001|Overall Study|Death|3|||
146346326|NCT02699515|527774389|FG002|Overall Study|Death|3|||
146346327|NCT02699515|527774390|FG003|Overall Study|Death|23|||
146346328|NCT02699515|527774391|FG004|Overall Study|Death|22|||
146346329|NCT02699515|527774392|FG005|Overall Study|Death|23|||
146346330|NCT02699515|527774393|FG006|Overall Study|Death|3|||
146346331|NCT02699515|527774394|FG007|Overall Study|Death|5|||
146346332|NCT02699515|527774387|FG000|Overall Study|Withdrawal by Subject|0|||
146346333|NCT02699515|527774388|FG001|Overall Study|Withdrawal by Subject|0|||
146346334|NCT02699515|527774389|FG002|Overall Study|Withdrawal by Subject|3|||
146346335|NCT02699515|527774390|FG003|Overall Study|Withdrawal by Subject|1|||
146346336|NCT02699515|527774391|FG004|Overall Study|Withdrawal by Subject|5|||
146346337|NCT02699515|527774392|FG005|Overall Study|Withdrawal by Subject|3|||
146346338|NCT02699515|527774393|FG006|Overall Study|Withdrawal by Subject|0|||
146346339|NCT02699515|527774394|FG007|Overall Study|Withdrawal by Subject|1|||
146346340|NCT02699515|527774387|FG000|Overall Study|Other|1|||
146346341|NCT02699515|527774388|FG001|Overall Study|Other|0|||
146169380|NCT03444376|527131210|FG000|Part B|Withdrawal by Subject|2|||
146169381|NCT03444376|527131210|FG000|Part B|Adverse Event|2|||
146346342|NCT02699515|527774389|FG002|Overall Study|Other|1|||
146346343|NCT02699515|527774390|FG003|Overall Study|Other|6|||
146346344|NCT02699515|527774391|FG004|Overall Study|Other|4|||
146346345|NCT02699515|527774392|FG005|Overall Study|Other|3|||
146346346|NCT02699515|527774393|FG006|Overall Study|Other|0|||
146346347|NCT02699515|527774394|FG007|Overall Study|Other|0|||
146346348|NCT01240811|527774395|FG000|Overall Study|Physician Decision|0|||
146346349|NCT01240811|527774396|FG001|Overall Study|Physician Decision|1|||
146346350|NCT01240811|527774397|FG002|Overall Study|Physician Decision|0|||
146346351|NCT01240811|527774395|FG000|Overall Study|Withdrawal by Subject|0|||
146346352|NCT01240811|527774396|FG001|Overall Study|Withdrawal by Subject|0|||
146346353|NCT01240811|527774397|FG002|Overall Study|Withdrawal by Subject|1|||
146346354|NCT01988012|527774417|FG000|Overall Study|Adverse Event|5|||
146346355|NCT01988012|527774417|FG000|Overall Study|Insufficient Therapeutic Response|3|||
146346356|NCT01988012|527774417|FG000|Overall Study|Patient Withdrawal of Consent|4|||
146346357|NCT01988012|527774417|FG000|Overall Study|Lost to Follow-up|1|||
146346358|NCT01988012|527774417|FG000|Overall Study|Physician Decision|1|||
146346359|NCT01988012|527774417|FG000|Overall Study|Protocol Violation|1|||
146346360|NCT01228071|527774420|FG000|Overall Study|Protocol Violation|1|||
146346361|NCT01228071|527774420|FG000|Overall Study|Withdrawal by Subject|1|||
146346362|NCT03314519|527774421|FG000|Overall Study|Protocol Violation|3|||
146346363|NCT03314519|527774422|FG001|Overall Study|Protocol Violation|2|||
146346364|NCT01912872|527774423|FG000|Overall Study|Lost to Follow-up|2|||
146346365|NCT01912872|527774424|FG001|Overall Study|Lost to Follow-up|3|||
146346366|NCT01912872|527774425|FG002|Overall Study|Lost to Follow-up|5|||
146346367|NCT01912872|527774426|FG003|Overall Study|Lost to Follow-up|5|||
146346368|NCT01912872|527774423|FG000|Overall Study|Other unspecified|3|||
146346369|NCT01912872|527774424|FG001|Overall Study|Other unspecified|1|||
146346370|NCT01912872|527774425|FG002|Overall Study|Other unspecified|3|||
146346371|NCT01912872|527774426|FG003|Overall Study|Other unspecified|0|||
146346372|NCT01912872|527774423|FG000|Overall Study|Informed consent withdrawn|0|||
146346373|NCT01912872|527774424|FG001|Overall Study|Informed consent withdrawn|0|||
146346374|NCT01912872|527774425|FG002|Overall Study|Informed consent withdrawn|1|||
146346375|NCT01912872|527774426|FG003|Overall Study|Informed consent withdrawn|1|||
146346376|NCT01912872|527774423|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
146346377|NCT01912872|527774424|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
146346378|NCT01912872|527774425|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
146346379|NCT01912872|527774426|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
146346380|NCT01912872|527774423|FG000|Overall Study|Protocol Violation|0|||
146346381|NCT01912872|527774424|FG001|Overall Study|Protocol Violation|0|||
146346382|NCT01912872|527774425|FG002|Overall Study|Protocol Violation|1|||
146346383|NCT01912872|527774426|FG003|Overall Study|Protocol Violation|0|||
146346384|NCT01912872|527774423|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
146346385|NCT01912872|527774424|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146346386|NCT01912872|527774425|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146346387|NCT01912872|527774426|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
146346388|NCT01912872|527774423|FG000|Overall Study|Withdrawal of study medication|0|||
146346389|NCT01912872|527774424|FG001|Overall Study|Withdrawal of study medication|0|||
146346390|NCT01912872|527774425|FG002|Overall Study|Withdrawal of study medication|0|||
146346391|NCT01912872|527774426|FG003|Overall Study|Withdrawal of study medication|2|||
146346392|NCT01912872|527774423|FG000|Overall Study|Missing|0|||
146346393|NCT01912872|527774424|FG001|Overall Study|Missing|0|||
146346394|NCT01912872|527774425|FG002|Overall Study|Missing|0|||
146346395|NCT01912872|527774426|FG003|Overall Study|Missing|1|||
146346396|NCT01713036|527774429|FG000|Overall Study|Death|1|||
146346397|NCT00592358|527774430|FG000|Overall Study|Withdrawal by Subject|2|||
146346398|NCT00592358|527774430|FG000|Overall Study|Adverse Event|1|||
146346399|NCT00592358|527774430|FG000|Overall Study|Lack of Efficacy|2|||
146346400|NCT00592358|527774430|FG000|Overall Study|Inability to swallow pills|1|||
146346401|NCT01166659|527774431|FG000|Overall Study|Subject Decision|8|||
146346402|NCT01166659|527774431|FG000|Overall Study|Investigator Decision|2|||
146346403|NCT01166659|527774431|FG000|Overall Study|Death|1|||
146346404|NCT01166659|527774431|FG000|Overall Study|Lost to Follow-up|1|||
146346405|NCT01166659|527774431|FG000|Overall Study|Study Closed at Site|1|||
146346406|NCT04760314|527774434|FG000|Induction Period|Withdrawal by Subject|0|||
146346407|NCT04760314|527774435|FG001|Induction Period|Withdrawal by Subject|1|||
146346408|NCT04760314|527774436|FG002|Induction Period|Withdrawal by Subject|1|||
146346409|NCT04760314|527774437|FG003|Induction Period|Withdrawal by Subject|0|||
146346410|NCT04760314|527774438|FG004|Induction Period|Withdrawal by Subject|0|||
146346411|NCT04760314|527774439|FG005|Induction Period|Withdrawal by Subject|0|||
146346412|NCT04760314|527774440|FG006|Induction Period|Withdrawal by Subject|0|||
146346413|NCT04760314|527774441|FG007|Induction Period|Withdrawal by Subject|0|||
146346414|NCT04760314|527774442|FG008|Induction Period|Withdrawal by Subject|0|||
146346415|NCT04760314|527774443|FG009|Induction Period|Withdrawal by Subject|0|||
146346416|NCT04760314|527774444|FG010|Induction Period|Withdrawal by Subject|0|||
146346417|NCT04760314|527774434|FG000|Induction Period|Adverse Event|0|||
146346418|NCT04760314|527774435|FG001|Induction Period|Adverse Event|0|||
146346419|NCT04760314|527774436|FG002|Induction Period|Adverse Event|2|||
146346420|NCT04760314|527774437|FG003|Induction Period|Adverse Event|0|||
146346421|NCT04760314|527774438|FG004|Induction Period|Adverse Event|0|||
146346422|NCT04760314|527774439|FG005|Induction Period|Adverse Event|0|||
146346423|NCT04760314|527774440|FG006|Induction Period|Adverse Event|0|||
146346424|NCT04760314|527774441|FG007|Induction Period|Adverse Event|0|||
146346425|NCT04760314|527774442|FG008|Induction Period|Adverse Event|0|||
146346426|NCT04760314|527774443|FG009|Induction Period|Adverse Event|0|||
146346427|NCT04760314|527774444|FG010|Induction Period|Adverse Event|0|||
146346428|NCT04760314|527774434|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346429|NCT04760314|527774435|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346430|NCT04760314|527774436|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346431|NCT04760314|527774437|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
146346432|NCT04760314|527774438|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
146346433|NCT04760314|527774439|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
146346434|NCT04760314|527774440|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
146346435|NCT04760314|527774441|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346436|NCT04760314|527774442|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346437|NCT04760314|527774443|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346438|NCT04760314|527774444|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
146346439|NCT04760314|527774434|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346440|NCT04760314|527774435|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346441|NCT04760314|527774436|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346442|NCT04760314|527774437|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
146346443|NCT04760314|527774438|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346444|NCT04760314|527774439|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
146346445|NCT04760314|527774440|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
146346446|NCT04760314|527774441|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346447|NCT04760314|527774442|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346448|NCT04760314|527774443|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346449|NCT04760314|527774444|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
146346450|NCT04760314|527774434|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346451|NCT04760314|527774435|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346452|NCT04760314|527774436|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346453|NCT04760314|527774437|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346454|NCT04760314|527774438|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
146346455|NCT04760314|527774439|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346456|NCT04760314|527774440|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346457|NCT04760314|527774441|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346458|NCT04760314|527774442|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346459|NCT04760314|527774443|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346460|NCT04760314|527774444|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
146346461|NCT04760314|527774434|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
146346462|NCT04760314|527774435|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
146346463|NCT04760314|527774436|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
146346464|NCT04760314|527774437|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
146346465|NCT04760314|527774438|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
146346466|NCT04760314|527774439|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
146346467|NCT04760314|527774440|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
146346468|NCT04760314|527774441|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
146346469|NCT04760314|527774442|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
146346470|NCT04760314|527774443|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
146346471|NCT04760314|527774444|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
146346472|NCT04760314|527774434|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346473|NCT04760314|527774435|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346474|NCT04760314|527774436|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346475|NCT04760314|527774437|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346476|NCT04760314|527774438|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346477|NCT04760314|527774439|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346478|NCT04760314|527774440|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346479|NCT04760314|527774441|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146346480|NCT04760314|527774442|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
146346481|NCT04760314|527774443|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146346482|NCT04760314|527774444|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
146346483|NCT04760314|527774434|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346484|NCT04760314|527774435|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346485|NCT04760314|527774436|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346486|NCT04760314|527774437|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346487|NCT04760314|527774438|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346488|NCT04760314|527774439|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346489|NCT04760314|527774440|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346490|NCT04760314|527774441|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
146346491|NCT04760314|527774442|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
146346492|NCT04760314|527774443|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
146346493|NCT04760314|527774444|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
146346494|NCT04760314|527774434|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346495|NCT04760314|527774435|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346496|NCT04760314|527774436|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346497|NCT04760314|527774437|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346498|NCT04760314|527774438|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346499|NCT04760314|527774439|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346500|NCT04760314|527774440|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346501|NCT04760314|527774441|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
146346502|NCT04760314|527774442|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346503|NCT04760314|527774443|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346504|NCT04760314|527774444|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
146346505|NCT04760314|527774434|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346506|NCT04760314|527774435|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346507|NCT04760314|527774436|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346508|NCT04760314|527774437|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346509|NCT04760314|527774438|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346510|NCT04760314|527774439|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346511|NCT04760314|527774440|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346512|NCT04760314|527774441|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346513|NCT04760314|527774442|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
146346514|NCT04760314|527774443|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
146346515|NCT04760314|527774444|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
146346516|NCT03238248|527774447|FG000|Overall Study|Death|5|||
146346517|NCT03238248|527774447|FG000|Overall Study|Withdrawal by Subject|7|||
146346518|NCT03238248|527774447|FG000|Overall Study|Participant proceeding to transplant|10|||
146346519|NCT03238248|527774447|FG000|Overall Study|Lack of Efficacy|4|||
146346520|NCT03238248|527774447|FG000|Overall Study|Physician Decision|3|||
146346521|NCT03238248|527774447|FG000|Overall Study|Transitioning to another study|1|||
146346522|NCT03238248|527774447|FG000|Overall Study|No longer benefiting|1|||
146346523|NCT03238248|527774447|FG000|Overall Study|Other complicating disease|1|||
146346524|NCT03238248|527774447|FG000|Overall Study|Adverse Event|5|||
146346525|NCT03238248|527774447|FG000|Overall Study|Disease progression|26|||
146346526|NCT03238248|527774447|FG000|Overall Study|N/A participant is still on treatment|1|||
146346527|NCT03238248|527774447|FG000|Overall Study|Decline in condition|1|||
146346528|NCT03238248|527774447|FG000|Overall Study|Alternative therapy|2|||
146346529|NCT02241512|527774454|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
146346530|NCT02241512|527774455|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
146346531|NCT02345161|527774458|FG000|Overall Study|Withdrawal by Subject|25|||
146346532|NCT02345161|527774459|FG001|Overall Study|Withdrawal by Subject|33|||
146346533|NCT02345161|527774458|FG000|Overall Study|Adverse Event|16|||
146346534|NCT02345161|527774459|FG001|Overall Study|Adverse Event|19|||
146346535|NCT02345161|527774458|FG000|Overall Study|Physician Decision|4|||
146346536|NCT02345161|527774459|FG001|Overall Study|Physician Decision|4|||
146346537|NCT02345161|527774458|FG000|Overall Study|Lost to Follow-up|0|||
146346538|NCT02345161|527774459|FG001|Overall Study|Lost to Follow-up|1|||
146346539|NCT00090285|527774460|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
146346540|NCT00090285|527774461|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
146346541|NCT00090285|527774462|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146346542|NCT00090285|527774463|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146346543|NCT00090285|527774464|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146346544|NCT00090285|527774465|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
146346545|NCT00090285|527774460|FG000|Base Study Vaccination Period|Adverse Event|2|||
146346546|NCT00090285|527774461|FG001|Base Study Vaccination Period|Adverse Event|4|||
146346547|NCT00090285|527774462|FG002|Base Study Vaccination Period|Adverse Event|0|||
146346548|NCT00090285|527774463|FG003|Base Study Vaccination Period|Adverse Event|0|||
146346549|NCT00090285|527774464|FG004|Base Study Vaccination Period|Adverse Event|0|||
146346550|NCT00090285|527774465|FG005|Base Study Vaccination Period|Adverse Event|0|||
146346551|NCT00090285|527774460|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
146346552|NCT00090285|527774461|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
146346553|NCT00090285|527774462|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
146346554|NCT00090285|527774463|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
146346555|NCT00090285|527774464|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
146346556|NCT00090285|527774465|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
146346557|NCT00090285|527774460|FG000|Base Study Vaccination Period|Protocol Violation|2|||
146346558|NCT00090285|527774461|FG001|Base Study Vaccination Period|Protocol Violation|3|||
146346559|NCT00090285|527774462|FG002|Base Study Vaccination Period|Protocol Violation|0|||
146346560|NCT00090285|527774463|FG003|Base Study Vaccination Period|Protocol Violation|0|||
146346561|NCT00090285|527774464|FG004|Base Study Vaccination Period|Protocol Violation|0|||
146346562|NCT00090285|527774465|FG005|Base Study Vaccination Period|Protocol Violation|0|||
146346563|NCT00090285|527774460|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
146346564|NCT00090285|527774461|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
146396301|NCT02940392|527954550|FG000|Overall Study|Death|2|||
146346565|NCT00090285|527774462|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
146346566|NCT00090285|527774463|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
146346567|NCT00090285|527774464|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
146346568|NCT00090285|527774465|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
146346569|NCT00090285|527774460|FG000|Base Study Vaccination Period|Uncooperative|2|||
146346570|NCT00090285|527774461|FG001|Base Study Vaccination Period|Uncooperative|2|||
146346571|NCT00090285|527774462|FG002|Base Study Vaccination Period|Uncooperative|0|||
146346572|NCT00090285|527774463|FG003|Base Study Vaccination Period|Uncooperative|0|||
146346573|NCT00090285|527774464|FG004|Base Study Vaccination Period|Uncooperative|0|||
146346574|NCT00090285|527774465|FG005|Base Study Vaccination Period|Uncooperative|0|||
146346575|NCT00090285|527774460|FG000|Base Study Vaccination Period|Moved|20|||
146346576|NCT00090285|527774461|FG001|Base Study Vaccination Period|Moved|21|||
146346577|NCT00090285|527774462|FG002|Base Study Vaccination Period|Moved|0|||
146346578|NCT00090285|527774463|FG003|Base Study Vaccination Period|Moved|0|||
146346579|NCT00090285|527774464|FG004|Base Study Vaccination Period|Moved|0|||
146346580|NCT00090285|527774465|FG005|Base Study Vaccination Period|Moved|0|||
146346581|NCT00090285|527774460|FG000|Base Study Vaccination Period|Site Terminated|1|||
146346582|NCT00090285|527774461|FG001|Base Study Vaccination Period|Site Terminated|0|||
146346583|NCT00090285|527774462|FG002|Base Study Vaccination Period|Site Terminated|0|||
146346584|NCT00090285|527774463|FG003|Base Study Vaccination Period|Site Terminated|0|||
146346585|NCT00090285|527774464|FG004|Base Study Vaccination Period|Site Terminated|0|||
146346586|NCT00090285|527774465|FG005|Base Study Vaccination Period|Site Terminated|0|||
146346587|NCT00090285|527774460|FG000|Base Study Vaccination Period|Other|2|||
146346588|NCT00090285|527774461|FG001|Base Study Vaccination Period|Other|2|||
146346589|NCT00090285|527774462|FG002|Base Study Vaccination Period|Other|0|||
146346590|NCT00090285|527774463|FG003|Base Study Vaccination Period|Other|0|||
146346591|NCT00090285|527774464|FG004|Base Study Vaccination Period|Other|0|||
146346592|NCT00090285|527774465|FG005|Base Study Vaccination Period|Other|0|||
146346593|NCT00090285|527774460|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
146346594|NCT00090285|527774461|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
146346595|NCT00090285|527774462|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
146346596|NCT00090285|527774463|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
146346597|NCT00090285|527774464|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
146346598|NCT00090285|527774465|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
146346599|NCT00090285|527774460|FG000|Base Study Vaccination Period|HIV positive|1|||
146346600|NCT00090285|527774461|FG001|Base Study Vaccination Period|HIV positive|1|||
146346601|NCT00090285|527774462|FG002|Base Study Vaccination Period|HIV positive|0|||
146346602|NCT00090285|527774463|FG003|Base Study Vaccination Period|HIV positive|0|||
146346603|NCT00090285|527774464|FG004|Base Study Vaccination Period|HIV positive|0|||
146346604|NCT00090285|527774465|FG005|Base Study Vaccination Period|HIV positive|0|||
146346605|NCT00090285|527774460|FG000|Base Study Follow-up Period|Adverse Event|3|||
146346606|NCT00090285|527774461|FG001|Base Study Follow-up Period|Adverse Event|10|||
146346607|NCT00090285|527774462|FG002|Base Study Follow-up Period|Adverse Event|0|||
146346608|NCT00090285|527774463|FG003|Base Study Follow-up Period|Adverse Event|0|||
146346609|NCT00090285|527774464|FG004|Base Study Follow-up Period|Adverse Event|0|||
146346610|NCT00090285|527774465|FG005|Base Study Follow-up Period|Adverse Event|0|||
146346611|NCT00090285|527774460|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
146346612|NCT00090285|527774461|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
146346613|NCT00090285|527774462|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
146346614|NCT00090285|527774463|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
146346615|NCT00090285|527774464|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
146346616|NCT00090285|527774465|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
146346617|NCT00090285|527774460|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
146346618|NCT00090285|527774461|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
146346619|NCT00090285|527774462|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
146346620|NCT00090285|527774463|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
146346621|NCT00090285|527774464|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
146346622|NCT00090285|527774465|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
146346623|NCT00090285|527774460|FG000|Base Study Follow-up Period|Moved|41|||
146346624|NCT00090285|527774461|FG001|Base Study Follow-up Period|Moved|36|||
146346625|NCT00090285|527774462|FG002|Base Study Follow-up Period|Moved|0|||
146346626|NCT00090285|527774463|FG003|Base Study Follow-up Period|Moved|0|||
146346627|NCT00090285|527774464|FG004|Base Study Follow-up Period|Moved|0|||
146346628|NCT00090285|527774465|FG005|Base Study Follow-up Period|Moved|0|||
146346629|NCT00090285|527774460|FG000|Base Study Follow-up Period|Other|2|||
146346630|NCT00090285|527774461|FG001|Base Study Follow-up Period|Other|0|||
146346631|NCT00090285|527774462|FG002|Base Study Follow-up Period|Other|0|||
146346632|NCT00090285|527774463|FG003|Base Study Follow-up Period|Other|0|||
146346633|NCT00090285|527774464|FG004|Base Study Follow-up Period|Other|0|||
146346634|NCT00090285|527774465|FG005|Base Study Follow-up Period|Other|0|||
146346635|NCT00090285|527774460|FG000|Base Study Follow-up Period|Protocol Violation|1|||
146169382|NCT03444376|527131210|FG000|Part B|Physician Decision|1|||
146346636|NCT00090285|527774461|FG001|Base Study Follow-up Period|Protocol Violation|0|||
146346637|NCT00090285|527774462|FG002|Base Study Follow-up Period|Protocol Violation|0|||
146346638|NCT00090285|527774463|FG003|Base Study Follow-up Period|Protocol Violation|0|||
146346639|NCT00090285|527774464|FG004|Base Study Follow-up Period|Protocol Violation|0|||
146346640|NCT00090285|527774465|FG005|Base Study Follow-up Period|Protocol Violation|0|||
146346641|NCT00090285|527774460|FG000|Base Study Follow-up Period|Uncooperative|3|||
146346642|NCT00090285|527774461|FG001|Base Study Follow-up Period|Uncooperative|4|||
146346643|NCT00090285|527774462|FG002|Base Study Follow-up Period|Uncooperative|0|||
146346644|NCT00090285|527774463|FG003|Base Study Follow-up Period|Uncooperative|0|||
146346645|NCT00090285|527774464|FG004|Base Study Follow-up Period|Uncooperative|0|||
146346646|NCT00090285|527774465|FG005|Base Study Follow-up Period|Uncooperative|0|||
146346647|NCT00090285|527774460|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
146346648|NCT00090285|527774461|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
146346649|NCT00090285|527774462|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
146346650|NCT00090285|527774463|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
146346651|NCT00090285|527774464|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
146346652|NCT00090285|527774465|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
146346653|NCT00090285|527774460|FG000|Extension 1|Adverse Event|0|||
146346654|NCT00090285|527774461|FG001|Extension 1|Adverse Event|0|||
146346655|NCT00090285|527774462|FG002|Extension 1|Adverse Event|2|||
146346656|NCT00090285|527774463|FG003|Extension 1|Adverse Event|0|||
146346657|NCT00090285|527774464|FG004|Extension 1|Adverse Event|0|||
146346658|NCT00090285|527774465|FG005|Extension 1|Adverse Event|0|||
146346659|NCT00090285|527774460|FG000|Extension 1|Lost to Follow-up|0|||
146346660|NCT00090285|527774461|FG001|Extension 1|Lost to Follow-up|0|||
146346661|NCT00090285|527774462|FG002|Extension 1|Lost to Follow-up|35|||
146346662|NCT00090285|527774463|FG003|Extension 1|Lost to Follow-up|0|||
146346663|NCT00090285|527774464|FG004|Extension 1|Lost to Follow-up|0|||
146346664|NCT00090285|527774465|FG005|Extension 1|Lost to Follow-up|0|||
146346665|NCT00090285|527774460|FG000|Extension 1|Withdrawal by Subject|0|||
146346666|NCT00090285|527774461|FG001|Extension 1|Withdrawal by Subject|0|||
146346667|NCT00090285|527774462|FG002|Extension 1|Withdrawal by Subject|13|||
146346668|NCT00090285|527774463|FG003|Extension 1|Withdrawal by Subject|1|||
146346669|NCT00090285|527774464|FG004|Extension 1|Withdrawal by Subject|0|||
146346670|NCT00090285|527774465|FG005|Extension 1|Withdrawal by Subject|0|||
146346671|NCT00090285|527774460|FG000|Extension 1|Other|0|||
146346672|NCT00090285|527774461|FG001|Extension 1|Other|0|||
146346673|NCT00090285|527774462|FG002|Extension 1|Other|4|||
146346674|NCT00090285|527774463|FG003|Extension 1|Other|0|||
146346675|NCT00090285|527774464|FG004|Extension 1|Other|0|||
146346676|NCT00090285|527774465|FG005|Extension 1|Other|0|||
146346677|NCT00090285|527774460|FG000|Extension 1|Moved|0|||
146346678|NCT00090285|527774461|FG001|Extension 1|Moved|0|||
146346679|NCT00090285|527774462|FG002|Extension 1|Moved|3|||
146346680|NCT00090285|527774463|FG003|Extension 1|Moved|0|||
146346681|NCT00090285|527774464|FG004|Extension 1|Moved|0|||
146346682|NCT00090285|527774465|FG005|Extension 1|Moved|0|||
146346683|NCT00090285|527774460|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
146346684|NCT00090285|527774461|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
146346685|NCT00090285|527774462|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
146346686|NCT00090285|527774463|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
146346687|NCT00090285|527774464|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
146346688|NCT00090285|527774465|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
146346689|NCT00090285|527774460|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146346690|NCT00090285|527774461|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146346691|NCT00090285|527774462|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146346692|NCT00090285|527774463|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
146346693|NCT00090285|527774464|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
146346694|NCT00090285|527774465|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
146346695|NCT00090285|527774460|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146346696|NCT00090285|527774461|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146346697|NCT00090285|527774462|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146346698|NCT00090285|527774463|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
146346699|NCT00090285|527774464|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
146346700|NCT00090285|527774465|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
146346701|NCT00090285|527774460|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
146169383|NCT03444376|527131210|FG000|Part C|Disease relapse or Progression|43|||
146169384|NCT03444376|527131210|FG000|Part C|Withdrawal by Subject|5|||
146346702|NCT00090285|527774461|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
146346703|NCT00090285|527774462|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
146346704|NCT00090285|527774463|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
146346705|NCT00090285|527774464|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
146346706|NCT00090285|527774465|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
146346707|NCT01372878|527774471|FG000|Overall Study|Withdrawal by Subject|63|||
146346708|NCT01372878|527774471|FG000|Overall Study|Protocol Violation|17|||
146346709|NCT01372878|527774471|FG000|Overall Study|incomplete study procedure|104|||
146346710|NCT02616029|527774472|FG000|Overall Study|Adverse Event|1|||
146346711|NCT02616029|527774473|FG001|Overall Study|Adverse Event|0|||
146346712|NCT02616029|527774472|FG000|Overall Study|Death|0|||
146346713|NCT02616029|527774473|FG001|Overall Study|Death|1|||
146346714|NCT02616029|527774472|FG000|Overall Study|Protocol Violation|1|||
146346715|NCT02616029|527774473|FG001|Overall Study|Protocol Violation|0|||
146346716|NCT02616029|527774472|FG000|Overall Study|Withdrew Consent|1|||
146346717|NCT02616029|527774473|FG001|Overall Study|Withdrew Consent|0|||
146346718|NCT02616029|527774472|FG000|Overall Study|Enrolled and Never Treated|1|||
146346719|NCT02616029|527774473|FG001|Overall Study|Enrolled and Never Treated|1|||
146346720|NCT02385123|527774474|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
146346721|NCT02234583|527774475|FG000|Overall Study|Adverse Event|172|||
146346722|NCT02234583|527774476|FG001|Overall Study|Adverse Event|156|||
146346723|NCT02234583|527774475|FG000|Overall Study|Withdrawal by Subject|109|||
146346724|NCT02234583|527774476|FG001|Overall Study|Withdrawal by Subject|157|||
146346725|NCT02234583|527774475|FG000|Overall Study|Lost to Follow-up|0|||
146346726|NCT02234583|527774476|FG001|Overall Study|Lost to Follow-up|1|||
146346727|NCT02234583|527774475|FG000|Overall Study|Lack of Efficacy|58|||
146346728|NCT02234583|527774476|FG001|Overall Study|Lack of Efficacy|103|||
146346729|NCT02234583|527774475|FG000|Overall Study|Protocol Violation|35|||
146346730|NCT02234583|527774476|FG001|Overall Study|Protocol Violation|42|||
146346731|NCT02234583|527774475|FG000|Overall Study|Other|39|||
146346732|NCT02234583|527774476|FG001|Overall Study|Other|97|||
146346733|NCT01327339|527774484|FG000|Overall Study|Protocol Violation|8|||
146346734|NCT00700752|527774485|FG000|First Intervention|Withdrawal by Subject|0|||
146346735|NCT00700752|527774486|FG001|First Intervention|Withdrawal by Subject|2|||
146346736|NCT00784784|527774487|FG000|Overall Study|Withdrawal by Subject|2|||
146346737|NCT00784784|527774488|FG001|Overall Study|Withdrawal by Subject|2|||
146346738|NCT02792777|527774490|FG000|Overall Study|Withdrawal by Subject|2|||
146346739|NCT02792777|527774491|FG001|Overall Study|Withdrawal by Subject|0|||
146346740|NCT02792777|527774490|FG000|Overall Study|Recording malfunction|2|||
146346741|NCT02792777|527774491|FG001|Overall Study|Recording malfunction|0|||
146346742|NCT02792777|527774490|FG000|Overall Study|Later determined to be ineligible|2|||
146346743|NCT02792777|527774491|FG001|Overall Study|Later determined to be ineligible|0|||
146346744|NCT02792777|527774490|FG000|Overall Study|Participant interviewed twice|1|||
146346745|NCT02792777|527774491|FG001|Overall Study|Participant interviewed twice|0|||
146346746|NCT02795156|527774492|FG000|Overall Study|Progressive Disease|22|||
146346747|NCT02795156|527774493|FG001|Overall Study|Progressive Disease|7|||
146346748|NCT02795156|527774494|FG002|Overall Study|Progressive Disease|34|||
146346749|NCT02795156|527774495|FG003|Overall Study|Progressive Disease|7|||
146346750|NCT02795156|527774492|FG000|Overall Study|Adverse Event|13|||
146346751|NCT02795156|527774493|FG001|Overall Study|Adverse Event|2|||
146346752|NCT02795156|527774494|FG002|Overall Study|Adverse Event|3|||
146346753|NCT02795156|527774495|FG003|Overall Study|Adverse Event|2|||
146346754|NCT02795156|527774492|FG000|Overall Study|Death|1|||
146346755|NCT02795156|527774493|FG001|Overall Study|Death|1|||
146346756|NCT02795156|527774494|FG002|Overall Study|Death|1|||
146346757|NCT02795156|527774495|FG003|Overall Study|Death|0|||
146346758|NCT02795156|527774492|FG000|Overall Study|Physician Decision|1|||
146346759|NCT02795156|527774493|FG001|Overall Study|Physician Decision|0|||
146346760|NCT02795156|527774494|FG002|Overall Study|Physician Decision|1|||
146346761|NCT02795156|527774495|FG003|Overall Study|Physician Decision|0|||
146346762|NCT02795156|527774492|FG000|Overall Study|Withdrawal by Subject|2|||
146346763|NCT02795156|527774493|FG001|Overall Study|Withdrawal by Subject|0|||
146346764|NCT02795156|527774494|FG002|Overall Study|Withdrawal by Subject|3|||
146346765|NCT02795156|527774495|FG003|Overall Study|Withdrawal by Subject|0|||
146346766|NCT03176966|527774500|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
146346767|NCT03176966|527774501|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
146346768|NCT03176966|527774500|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
146346769|NCT03176966|527774501|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
146346770|NCT03176966|527774500|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
146346771|NCT03176966|527774501|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
146346772|NCT03176966|527774500|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
146346773|NCT03176966|527774501|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
146346774|NCT03176966|527774500|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
146346775|NCT03176966|527774501|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
146346776|NCT03176966|527774500|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
145943384|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146346777|NCT03176966|527774501|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
146346778|NCT03176966|527774500|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
146346779|NCT03176966|527774501|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
146346780|NCT01520922|527774505|FG000|Treatment Phase|Physician Decision|2|||
146346781|NCT01520922|527774506|FG001|Treatment Phase|Physician Decision|1|||
146346782|NCT01520922|527774505|FG000|Treatment Phase|Progression|0|||
146346783|NCT01520922|527774506|FG001|Treatment Phase|Progression|2|||
146346784|NCT01520922|527774505|FG000|Treatment Phase|Adverse Event|3|||
146346785|NCT01520922|527774506|FG001|Treatment Phase|Adverse Event|5|||
146346786|NCT01520922|527774505|FG000|Follow up|Lost to Follow-up|0|||
146346787|NCT01520922|527774506|FG001|Follow up|Lost to Follow-up|1|||
146346788|NCT01520922|527774505|FG000|Survival Follow-up|Withdrawal by Subject|1|||
146346789|NCT01520922|527774506|FG001|Survival Follow-up|Withdrawal by Subject|0|||
146346790|NCT01696877|527774509|FG000|Overall Study|Adverse Event|0|||
146346791|NCT01696877|527774510|FG001|Overall Study|Adverse Event|1|||
146346792|NCT00515463|527774511|FG000|Overall Study|Physician Decision|4|||
146346793|NCT00515463|527774512|FG001|Overall Study|Physician Decision|2|||
146346794|NCT00515463|527774511|FG000|Overall Study|Adverse Event|1|||
146346795|NCT00515463|527774512|FG001|Overall Study|Adverse Event|2|||
146346796|NCT00515463|527774511|FG000|Overall Study|Withdrawal by Subject|3|||
146346797|NCT00515463|527774512|FG001|Overall Study|Withdrawal by Subject|4|||
146346798|NCT00515463|527774511|FG000|Overall Study|Lost to Follow-up|6|||
146346799|NCT00515463|527774512|FG001|Overall Study|Lost to Follow-up|5|||
146346800|NCT00515463|527774511|FG000|Overall Study|Other|0|||
146346801|NCT00515463|527774512|FG001|Overall Study|Other|1|||
146346802|NCT00916721|527774513|FG000|Overall Study|Lost to Follow-up|0|||
146346803|NCT00916721|527774514|FG001|Overall Study|Lost to Follow-up|1|||
146346804|NCT00916721|527774513|FG000|Overall Study|Adverse Event|6|||
146346805|NCT00916721|527774514|FG001|Overall Study|Adverse Event|3|||
146346806|NCT00916721|527774513|FG000|Overall Study|Withdrawal by Subject|2|||
146346807|NCT00916721|527774514|FG001|Overall Study|Withdrawal by Subject|2|||
146346808|NCT00916721|527774513|FG000|Overall Study|Protocol Violation|2|||
146346809|NCT00916721|527774514|FG001|Overall Study|Protocol Violation|4|||
146346810|NCT01903434|527774518|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
146346811|NCT01903434|527774519|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
146346812|NCT01903434|527774518|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
146346813|NCT01903434|527774519|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
146346814|NCT01469052|527774522|FG000|Overall Study|Adverse Event|2|||
146346815|NCT01469052|527774523|FG001|Overall Study|Adverse Event|3|||
146346816|NCT01469052|527774524|FG002|Overall Study|Adverse Event|0|||
146346817|NCT01469052|527774525|FG003|Overall Study|Adverse Event|2|||
146346818|NCT01469052|527774526|FG004|Overall Study|Adverse Event|0|||
146346819|NCT01469052|527774527|FG005|Overall Study|Adverse Event|1|||
146346820|NCT01469052|527774522|FG000|Overall Study|Progressive disease|3|||
146346821|NCT01469052|527774523|FG001|Overall Study|Progressive disease|0|||
146346822|NCT01469052|527774524|FG002|Overall Study|Progressive disease|5|||
146346823|NCT01469052|527774525|FG003|Overall Study|Progressive disease|3|||
146346824|NCT01469052|527774526|FG004|Overall Study|Progressive disease|7|||
146346825|NCT01469052|527774527|FG005|Overall Study|Progressive disease|2|||
146346826|NCT01469052|527774522|FG000|Overall Study|Lack of Efficacy|0|||
146346827|NCT01469052|527774523|FG001|Overall Study|Lack of Efficacy|0|||
146346828|NCT01469052|527774524|FG002|Overall Study|Lack of Efficacy|0|||
146346829|NCT01469052|527774525|FG003|Overall Study|Lack of Efficacy|0|||
146346830|NCT01469052|527774526|FG004|Overall Study|Lack of Efficacy|0|||
146346831|NCT01469052|527774527|FG005|Overall Study|Lack of Efficacy|2|||
146346832|NCT01469052|527774522|FG000|Overall Study|Moved to rollover protocol|1|||
146346833|NCT01469052|527774523|FG001|Overall Study|Moved to rollover protocol|0|||
146346834|NCT01469052|527774524|FG002|Overall Study|Moved to rollover protocol|1|||
146346835|NCT01469052|527774525|FG003|Overall Study|Moved to rollover protocol|0|||
146346836|NCT01469052|527774526|FG004|Overall Study|Moved to rollover protocol|0|||
146346837|NCT01469052|527774527|FG005|Overall Study|Moved to rollover protocol|1|||
146346838|NCT01469052|527774522|FG000|Overall Study|Other|0|||
146346839|NCT01469052|527774523|FG001|Overall Study|Other|1|||
146346840|NCT01469052|527774524|FG002|Overall Study|Other|0|||
146346841|NCT01469052|527774525|FG003|Overall Study|Other|0|||
146346842|NCT01469052|527774526|FG004|Overall Study|Other|1|||
146346843|NCT01469052|527774527|FG005|Overall Study|Other|0|||
146346844|NCT02749370|527774529|FG000|Overall Study|Withdrawal by Subject|11|||
146346845|NCT02749370|527774529|FG000|Overall Study|Lost to Follow-up|3|||
146346846|NCT01519427|527774533|FG000|Overall Study|disease progression|2|||
146346847|NCT03894904|527774534|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
146346848|NCT03894904|527774535|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
146346849|NCT03894904|527774534|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
146346850|NCT03894904|527774535|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
146346851|NCT02190435|527774539|FG000|Overall Study|First 12 patients were lead-ins|12|||
146346852|NCT02190435|527774540|FG001|Overall Study|First 12 patients were lead-ins|0|||
146346853|NCT02190435|527774539|FG000|Overall Study|3 consented screen fails|3|||
146346854|NCT02190435|527774540|FG001|Overall Study|3 consented screen fails|0|||
146346855|NCT02260193|527774545|FG000|Overall Study|Lack of Efficacy|0|||
146346856|NCT02260193|527774546|FG001|Overall Study|Lack of Efficacy|1|||
146346857|NCT02260193|527774547|FG002|Overall Study|Lack of Efficacy|6|||
146346858|NCT02260193|527774545|FG000|Overall Study|Adverse Event|3|||
146346859|NCT02260193|527774546|FG001|Overall Study|Adverse Event|4|||
146346860|NCT02260193|527774547|FG002|Overall Study|Adverse Event|1|||
146346861|NCT02260193|527774545|FG000|Overall Study|Protocol Violation|0|||
146346862|NCT02260193|527774546|FG001|Overall Study|Protocol Violation|4|||
146346863|NCT02260193|527774547|FG002|Overall Study|Protocol Violation|0|||
146346864|NCT02260193|527774545|FG000|Overall Study|Withdrawal by Subject|3|||
146346865|NCT02260193|527774546|FG001|Overall Study|Withdrawal by Subject|0|||
146346866|NCT02260193|527774547|FG002|Overall Study|Withdrawal by Subject|2|||
146346867|NCT02260193|527774545|FG000|Overall Study|Kidney Transplantation|0|||
146346868|NCT02260193|527774546|FG001|Overall Study|Kidney Transplantation|0|||
146346869|NCT02260193|527774547|FG002|Overall Study|Kidney Transplantation|1|||
146346870|NCT00336492|527774548|FG000|Overall Study|Adverse Event|4|||
146346871|NCT00336492|527774549|FG001|Overall Study|Adverse Event|3|||
146346872|NCT00336492|527774550|FG002|Overall Study|Adverse Event|6|||
146346873|NCT00336492|527774548|FG000|Overall Study|Lack of Efficacy|6|||
146346874|NCT00336492|527774549|FG001|Overall Study|Lack of Efficacy|1|||
146346875|NCT00336492|527774550|FG002|Overall Study|Lack of Efficacy|4|||
146346876|NCT00336492|527774548|FG000|Overall Study|Other|5|||
146346877|NCT00336492|527774549|FG001|Overall Study|Other|0|||
146346878|NCT00336492|527774550|FG002|Overall Study|Other|1|||
146346879|NCT01781026|527774551|FG000|Overall Study|Lack of Efficacy|2|||
146346880|NCT02269319|527774552|FG000|Overall Study|Lost to Follow-up|4|||
146346881|NCT02269319|527774553|FG001|Overall Study|Lost to Follow-up|3|||
146346882|NCT02269319|527774552|FG000|Overall Study|Adverse Event|0|||
146346883|NCT02269319|527774553|FG001|Overall Study|Adverse Event|1|||
146346884|NCT02269319|527774552|FG000|Overall Study|Instructions not followed|1|||
146346885|NCT02269319|527774553|FG001|Overall Study|Instructions not followed|0|||
146346886|NCT03575468|527774556|FG000|Overall Study|Withdrawal by Subject|3|||
146346887|NCT03575468|527774557|FG001|Overall Study|Withdrawal by Subject|0|||
146346888|NCT03575468|527774556|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
146346889|NCT03575468|527774557|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
146346890|NCT03575468|527774556|FG000|Overall Study|Lost to Follow-up|13|||
146346891|NCT03575468|527774557|FG001|Overall Study|Lost to Follow-up|17|||
146346892|NCT00404768|527774558|FG000|Part A and B|Withdrawn due to labor progression|1|||
146346893|NCT00404768|527774559|FG001|Part A and B|Withdrawn due to labor progression|0|||
146346894|NCT00404768|527774560|FG002|Part A and B|Withdrawn due to labor progression|0|||
146346895|NCT00404768|527774561|FG003|Part A and B|Withdrawn due to labor progression|0|||
146346896|NCT00404768|527774558|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
146346897|NCT00404768|527774559|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
146346898|NCT00404768|527774560|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
146346899|NCT00404768|527774561|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
146346900|NCT00404768|527774558|FG000|Part C|Adverse Event|0|||
146346901|NCT00404768|527774559|FG001|Part C|Adverse Event|0|||
146346902|NCT00404768|527774560|FG002|Part C|Adverse Event|0|||
146346903|NCT00404768|527774561|FG003|Part C|Adverse Event|3|||
146346904|NCT00404768|527774558|FG000|Part C|Lost to Follow-up|0|||
146346905|NCT00404768|527774559|FG001|Part C|Lost to Follow-up|0|||
146346906|NCT00404768|527774560|FG002|Part C|Lost to Follow-up|3|||
146346907|NCT00404768|527774561|FG003|Part C|Lost to Follow-up|1|||
146346908|NCT00404768|527774558|FG000|Part C|Withdrawal by Subject|0|||
146346909|NCT00404768|527774559|FG001|Part C|Withdrawal by Subject|0|||
146346910|NCT00404768|527774560|FG002|Part C|Withdrawal by Subject|2|||
146346911|NCT00404768|527774561|FG003|Part C|Withdrawal by Subject|1|||
146346912|NCT00404768|527774558|FG000|Part C|Early withdrawal from study medication|0|||
146346913|NCT00404768|527774559|FG001|Part C|Early withdrawal from study medication|0|||
146346914|NCT00404768|527774560|FG002|Part C|Early withdrawal from study medication|1|||
146346915|NCT00404768|527774561|FG003|Part C|Early withdrawal from study medication|0|||
146346916|NCT00404768|527774558|FG000|Part C|Participant did not respond to therapy|0|||
146346917|NCT00404768|527774559|FG001|Part C|Participant did not respond to therapy|0|||
146346918|NCT00404768|527774560|FG002|Part C|Participant did not respond to therapy|1|||
146346919|NCT00404768|527774561|FG003|Part C|Participant did not respond to therapy|1|||
146346920|NCT00404768|527774558|FG000|Part C|Physician withdrew the study medication|0|||
146346921|NCT00404768|527774559|FG001|Part C|Physician withdrew the study medication|0|||
146346922|NCT00404768|527774560|FG002|Part C|Physician withdrew the study medication|1|||
146346923|NCT00404768|527774561|FG003|Part C|Physician withdrew the study medication|0|||
146346924|NCT00404768|527774558|FG000|Part C|Participant delivered baby|0|||
146346925|NCT00404768|527774559|FG001|Part C|Participant delivered baby|0|||
146346926|NCT00404768|527774560|FG002|Part C|Participant delivered baby|0|||
146346927|NCT00404768|527774561|FG003|Part C|Participant delivered baby|1|||
146346928|NCT00404768|527774558|FG000|Part C|Unsatisfactory uterine response to IP|0|||
146346929|NCT00404768|527774559|FG001|Part C|Unsatisfactory uterine response to IP|0|||
146346930|NCT00404768|527774560|FG002|Part C|Unsatisfactory uterine response to IP|0|||
146346931|NCT00404768|527774561|FG003|Part C|Unsatisfactory uterine response to IP|1|||
146346932|NCT00404768|527774558|FG000|Part C|Active labor|0|||
146346933|NCT00404768|527774559|FG001|Part C|Active labor|0|||
146346934|NCT00404768|527774560|FG002|Part C|Active labor|0|||
146346935|NCT00404768|527774561|FG003|Part C|Active labor|1|||
146346936|NCT00404768|527774558|FG000|Part C|Lack of Efficacy|0|||
146346937|NCT00404768|527774559|FG001|Part C|Lack of Efficacy|0|||
146346938|NCT00404768|527774560|FG002|Part C|Lack of Efficacy|0|||
146346939|NCT00404768|527774561|FG003|Part C|Lack of Efficacy|2|||
146346940|NCT00404768|527774558|FG000|Part C|Treatment failure|0|||
146346941|NCT00404768|527774559|FG001|Part C|Treatment failure|0|||
146346942|NCT00404768|527774560|FG002|Part C|Treatment failure|0|||
146346943|NCT00404768|527774561|FG003|Part C|Treatment failure|1|||
146346944|NCT00404768|527774558|FG000|Part C|Investigator discretion|0|||
146346945|NCT00404768|527774559|FG001|Part C|Investigator discretion|0|||
146346946|NCT00404768|527774560|FG002|Part C|Investigator discretion|0|||
146346947|NCT00404768|527774561|FG003|Part C|Investigator discretion|1|||
146346948|NCT00404768|527774558|FG000|Part C|Researcher suspended study medication|0|||
146346949|NCT00404768|527774559|FG001|Part C|Researcher suspended study medication|0|||
146346950|NCT00404768|527774560|FG002|Part C|Researcher suspended study medication|0|||
146346951|NCT00404768|527774561|FG003|Part C|Researcher suspended study medication|1|||
146346952|NCT04773041|527774564|FG000|Overall Study|Unable to data match|1|||
146346953|NCT04773041|527774565|FG001|Overall Study|Unable to data match|0|||
146346954|NCT04773041|527774566|FG002|Overall Study|Unable to data match|0|||
146346955|NCT05270694|527776114|FG000|Overall Study|Death|1|||
146346956|NCT05270694|527776114|FG000|Overall Study|Medical issues impacted ability to participate|2|||
146346957|NCT05270694|527776114|FG000|Overall Study|Lost to Follow-up|3|||
146346958|NCT05270694|527776114|FG000|Overall Study|Withdrawal by Subject|3|||
146346959|NCT00128206|527776121|FG000|Overall Study|Lost to Follow-up|137|||
146346960|NCT00128206|527776122|FG001|Overall Study|Lost to Follow-up|118|||
146346961|NCT00128206|527776121|FG000|Overall Study|Adverse Event|0|||
146346962|NCT00128206|527776122|FG001|Overall Study|Adverse Event|2|||
146346963|NCT03032068|527776125|FG000|Overall Study|Adverse Event|1|||
146346964|NCT01597622|527776126|FG000|Overall Study|Adverse Event|7|||
146346965|NCT01597622|527776126|FG000|Overall Study|Lack of Efficacy|3|||
146346966|NCT01597622|527776126|FG000|Overall Study|Protocol Violation|1|||
146346967|NCT01597622|527776126|FG000|Overall Study|Lost to Follow-up|1|||
146346968|NCT01597622|527776126|FG000|Overall Study|Investigator Discretion|5|||
146346969|NCT01597622|527776126|FG000|Overall Study|Withdrawal by Subject|20|||
146346970|NCT01597622|527776126|FG000|Overall Study|Death|1|||
146346971|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
146346972|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
146346973|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
146346974|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
146346975|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Death|8|||
146346976|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Death|3|||
146346977|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
146346978|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
146346979|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
146346980|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
146346981|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
146346982|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
146346983|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
146346984|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
146346985|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
146346986|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
146346987|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
146346988|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
146346989|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
146346990|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
146346991|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
146346992|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
146346993|NCT00494871|527776127|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
146346994|NCT00494871|527776128|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
146346995|NCT00494871|527776127|FG000|Follow-up (FU) Period|Adverse Event|1|||
146346996|NCT00494871|527776128|FG001|Follow-up (FU) Period|Adverse Event|1|||
146346997|NCT00494871|527776127|FG000|Follow-up (FU) Period|Death|13|||
146346998|NCT00494871|527776128|FG001|Follow-up (FU) Period|Death|12|||
146346999|NCT00494871|527776127|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
146347000|NCT00494871|527776128|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
146347001|NCT00494871|527776127|FG000|Follow-up (FU) Period|Physician Decision|0|||
146347002|NCT00494871|527776128|FG001|Follow-up (FU) Period|Physician Decision|1|||
146347003|NCT00494871|527776127|FG000|Follow-up (FU) Period|Protocol Violation|1|||
146347004|NCT00494871|527776128|FG001|Follow-up (FU) Period|Protocol Violation|0|||
146347005|NCT00494871|527776127|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
146347006|NCT00494871|527776128|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
146169385|NCT03444376|527131210|FG000|Part C|Adverse Event|2|||
146169386|NCT03444376|527131210|FG000|Part C|Physician Decision|2|||
146347007|NCT00494871|527776127|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
146347008|NCT00494871|527776128|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
146169387|NCT03444376|527131210|FG000|Part C|Death|1|||
146347009|NCT04543955|527776129|FG000|Overall Study|Company cancelled study|1|||
146347010|NCT04543955|527776130|FG001|Overall Study|Company cancelled study|0|||
146347011|NCT03918642|527776131|FG000|Overall Study|Lost to Follow-up|12|||
146347012|NCT03918642|527776132|FG001|Overall Study|Lost to Follow-up|10|||
146347013|NCT00972244|527776138|FG000|Overall Study|Incorrect Enrolment|1|||
146347014|NCT00972244|527776139|FG001|Overall Study|Incorrect Enrolment|0|||
146347015|NCT00972244|527776140|FG002|Overall Study|Incorrect Enrolment|0|||
146347016|NCT00972244|527776141|FG003|Overall Study|Incorrect Enrolment|0|||
146347017|NCT00972244|527776142|FG004|Overall Study|Incorrect Enrolment|0|||
146347018|NCT00972244|527776138|FG000|Overall Study|Adverse Event|0|||
146347019|NCT00972244|527776139|FG001|Overall Study|Adverse Event|1|||
146347020|NCT00972244|527776140|FG002|Overall Study|Adverse Event|1|||
146347021|NCT00972244|527776141|FG003|Overall Study|Adverse Event|0|||
146347022|NCT00972244|527776142|FG004|Overall Study|Adverse Event|0|||
146347023|NCT00972244|527776138|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
146347024|NCT00972244|527776139|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
146347025|NCT00972244|527776140|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
146347026|NCT00972244|527776141|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
146347027|NCT00972244|527776142|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
146347028|NCT00972244|527776138|FG000|Overall Study|Withdrawal by Subject|1|||
146347029|NCT00972244|527776139|FG001|Overall Study|Withdrawal by Subject|2|||
146347030|NCT00972244|527776140|FG002|Overall Study|Withdrawal by Subject|1|||
146347031|NCT00972244|527776141|FG003|Overall Study|Withdrawal by Subject|0|||
146347032|NCT00972244|527776142|FG004|Overall Study|Withdrawal by Subject|1|||
146347033|NCT00972244|527776138|FG000|Overall Study|Safety|0|||
146347034|NCT00972244|527776139|FG001|Overall Study|Safety|0|||
146347035|NCT00972244|527776140|FG002|Overall Study|Safety|0|||
146347036|NCT00972244|527776141|FG003|Overall Study|Safety|0|||
146347037|NCT00972244|527776142|FG004|Overall Study|Safety|1|||
146347038|NCT00972244|527776138|FG000|Overall Study|Death|1|||
146347039|NCT00972244|527776139|FG001|Overall Study|Death|0|||
146347040|NCT00972244|527776140|FG002|Overall Study|Death|0|||
146347041|NCT00972244|527776141|FG003|Overall Study|Death|0|||
146347042|NCT00972244|527776142|FG004|Overall Study|Death|0|||
146347043|NCT00972244|527776138|FG000|Overall Study|Various|0|||
146347044|NCT00972244|527776139|FG001|Overall Study|Various|0|||
146347045|NCT00972244|527776140|FG002|Overall Study|Various|0|||
146347046|NCT00972244|527776141|FG003|Overall Study|Various|0|||
146347047|NCT00972244|527776142|FG004|Overall Study|Various|2|||
146347048|NCT02855411|527776145|FG000|Overall Study|Study terminated by sponsor|21|||
146347049|NCT02855411|527776145|FG000|Overall Study|Does not meet entrance criteria|14|||
146347050|NCT00907881|527776146|FG000|Overall Study|Lost to Follow-up|59|||
146347051|NCT00907881|527776146|FG000|Overall Study|Noncompliance|5|||
146347052|NCT00907881|527776146|FG000|Overall Study|Withdrawal by Subject|5|||
146347053|NCT00907881|527776146|FG000|Overall Study|Protocol Violation|1|||
146347054|NCT00907881|527776146|FG000|Overall Study|Missing discontinuation information|15|||
146347055|NCT04230486|527776156|FG000|Overall Study|Screen Failure|1|||
146347056|NCT03215264|527776157|FG000|Dose Level 2|Adverse Event|0|||
146347057|NCT03215264|527776158|FG001|Dose Level 2|Adverse Event|1|||
146347058|NCT03215264|527776159|FG002|Dose Level 2|Adverse Event|0|||
146347059|NCT03215264|527776157|FG000|Dose Level 3|Withdrawal by Subject|0|||
146347060|NCT03215264|527776158|FG001|Dose Level 3|Withdrawal by Subject|0|||
146347061|NCT03215264|527776159|FG002|Dose Level 3|Withdrawal by Subject|1|||
146347062|NCT02145156|527776161|FG000|Overall Study|No match to vaccination records|60|||
146347063|NCT02145156|527776162|FG001|Overall Study|No match to vaccination records|52|||
146347064|NCT02145156|527776163|FG002|Overall Study|No match to vaccination records|41|||
146347065|NCT01264965|527776164|FG000|Overall Study|Withdrawal by Subject|10|||
146347066|NCT02795767|527776167|FG000|Overall Study|Received Commercial Emicizumab|1|||
146347067|NCT02795767|527776168|FG001|Overall Study|Received Commercial Emicizumab|0|||
146347068|NCT02795767|527776169|FG002|Overall Study|Received Commercial Emicizumab|0|||
146347069|NCT03964415|527776174|FG000|Overall Study|Sponsor's decision|1563|||
146347070|NCT03964415|527776175|FG001|Overall Study|Sponsor's decision|1528|||
146347071|NCT03964415|527776174|FG000|Overall Study|Lost to Follow-up|139|||
146347072|NCT03964415|527776175|FG001|Overall Study|Lost to Follow-up|146|||
146347073|NCT03964415|527776174|FG000|Overall Study|Withdrawal by Subject|68|||
146347074|NCT03964415|527776175|FG001|Overall Study|Withdrawal by Subject|72|||
146347075|NCT03964415|527776174|FG000|Overall Study|Physician Decision|34|||
146347076|NCT03964415|527776175|FG001|Overall Study|Physician Decision|48|||
146347077|NCT03964415|527776174|FG000|Overall Study|Adverse Event|3|||
146347078|NCT03964415|527776175|FG001|Overall Study|Adverse Event|0|||
146347079|NCT03964415|527776174|FG000|Overall Study|Death|4|||
146347080|NCT03964415|527776175|FG001|Overall Study|Death|6|||
146347081|NCT03964415|527776174|FG000|Overall Study|Protocol Violation|1|||
146347082|NCT03964415|527776175|FG001|Overall Study|Protocol Violation|4|||
146347083|NCT03964415|527776174|FG000|Overall Study|Other|35|||
146347084|NCT03964415|527776175|FG001|Overall Study|Other|38|||
146347085|NCT03964415|527776174|FG000|Overall Study|Randomized but not treated|6|||
146347086|NCT03964415|527776175|FG001|Overall Study|Randomized but not treated|7|||
146347087|NCT01302769|527776176|FG000|Overall Study|Lost to Follow-up|1|||
146347088|NCT01302769|527776177|FG001|Overall Study|Lost to Follow-up|1|||
146347089|NCT01426386|527776186|FG000|Overall Study|Adverse Event|0|||
146347090|NCT01426386|527776187|FG001|Overall Study|Adverse Event|1|||
146347091|NCT01426386|527776188|FG002|Overall Study|Adverse Event|0|||
146347092|NCT01426386|527776189|FG003|Overall Study|Adverse Event|0|||
146347093|NCT01426386|527776190|FG004|Overall Study|Adverse Event|0|||
146347094|NCT01426386|527776191|FG005|Overall Study|Adverse Event|0|||
146347095|NCT01426386|527776186|FG000|Overall Study|Did not attend scheduled visit|1|||
146347096|NCT01426386|527776187|FG001|Overall Study|Did not attend scheduled visit|4|||
146347097|NCT01426386|527776188|FG002|Overall Study|Did not attend scheduled visit|0|||
146347098|NCT01426386|527776189|FG003|Overall Study|Did not attend scheduled visit|0|||
146347099|NCT01426386|527776190|FG004|Overall Study|Did not attend scheduled visit|2|||
146347100|NCT01426386|527776191|FG005|Overall Study|Did not attend scheduled visit|1|||
146347101|NCT01426386|527776186|FG000|Overall Study|Poor response|2|||
146347102|NCT01426386|527776187|FG001|Overall Study|Poor response|1|||
146347103|NCT01426386|527776188|FG002|Overall Study|Poor response|2|||
146347104|NCT01426386|527776189|FG003|Overall Study|Poor response|0|||
146347105|NCT01426386|527776190|FG004|Overall Study|Poor response|1|||
146347106|NCT01426386|527776191|FG005|Overall Study|Poor response|0|||
146347107|NCT01426386|527776186|FG000|Overall Study|Personal reasons|0|||
146347108|NCT01426386|527776187|FG001|Overall Study|Personal reasons|0|||
146347109|NCT01426386|527776188|FG002|Overall Study|Personal reasons|0|||
146347110|NCT01426386|527776189|FG003|Overall Study|Personal reasons|0|||
146347111|NCT01426386|527776190|FG004|Overall Study|Personal reasons|1|||
146347112|NCT01426386|527776191|FG005|Overall Study|Personal reasons|0|||
146347113|NCT03694522|527776193|FG000|Overall Study|Withdrawal by Subject|8|||
146347114|NCT03694522|527776194|FG001|Overall Study|Withdrawal by Subject|10|||
146347115|NCT03694522|527776193|FG000|Overall Study|Physician Decision|53|||
146347116|NCT03694522|527776194|FG001|Overall Study|Physician Decision|54|||
146347117|NCT03694522|527776193|FG000|Overall Study|Other|1|||
146347118|NCT03694522|527776194|FG001|Overall Study|Other|1|||
146347119|NCT03694522|527776193|FG000|Overall Study|Lost to Follow-up|0|||
146347120|NCT03694522|527776194|FG001|Overall Study|Lost to Follow-up|1|||
146347121|NCT02760407|527776195|FG000|Overall Study|Death|2|||
146347122|NCT02760407|527776196|FG001|Overall Study|Death|3|||
146347123|NCT02760407|527776197|FG002|Overall Study|Death|1|||
146347124|NCT02760407|527776198|FG003|Overall Study|Death|1|||
146347125|NCT02760407|527776195|FG000|Overall Study|Lost to Follow-up|1|||
146347126|NCT02760407|527776196|FG001|Overall Study|Lost to Follow-up|7|||
146347127|NCT02760407|527776197|FG002|Overall Study|Lost to Follow-up|4|||
146347128|NCT02760407|527776198|FG003|Overall Study|Lost to Follow-up|6|||
146347129|NCT02760407|527776195|FG000|Overall Study|Withdrawal by Subject|25|||
146347130|NCT02760407|527776196|FG001|Overall Study|Withdrawal by Subject|31|||
146347131|NCT02760407|527776197|FG002|Overall Study|Withdrawal by Subject|37|||
146347132|NCT02760407|527776198|FG003|Overall Study|Withdrawal by Subject|25|||
146347133|NCT02760407|527776195|FG000|Overall Study|Violation of Eligibility criteria|0|||
146347134|NCT02760407|527776196|FG001|Overall Study|Violation of Eligibility criteria|0|||
146347135|NCT02760407|527776197|FG002|Overall Study|Violation of Eligibility criteria|1|||
146347136|NCT02760407|527776198|FG003|Overall Study|Violation of Eligibility criteria|1|||
146347137|NCT02760407|527776195|FG000|Overall Study|Personal reasons|0|||
146347138|NCT02760407|527776196|FG001|Overall Study|Personal reasons|0|||
146347139|NCT02760407|527776197|FG002|Overall Study|Personal reasons|0|||
146347140|NCT02760407|527776198|FG003|Overall Study|Personal reasons|1|||
146347141|NCT02760407|527776195|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
146347142|NCT02760407|527776196|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146347143|NCT02760407|527776197|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146347144|NCT02760407|527776198|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
146347145|NCT02760407|527776195|FG000|Overall Study|Use of prohibited Medication|0|||
146347146|NCT02760407|527776196|FG001|Overall Study|Use of prohibited Medication|0|||
146347147|NCT02760407|527776197|FG002|Overall Study|Use of prohibited Medication|1|||
146347148|NCT02760407|527776198|FG003|Overall Study|Use of prohibited Medication|0|||
146347149|NCT02760407|527776195|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146347150|NCT02760407|527776196|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146347151|NCT02760407|527776197|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
146347152|NCT02760407|527776198|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
146347153|NCT02760407|527776195|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
146347154|NCT02760407|527776196|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146347155|NCT02760407|527776197|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146347156|NCT02760407|527776198|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
146347157|NCT02760407|527776195|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
146347158|NCT02760407|527776196|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
146347159|NCT02760407|527776197|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
146347160|NCT02760407|527776198|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
146347161|NCT02760407|527776195|FG000|Overall Study|Inadequately Enrolled|0|||
146347162|NCT02760407|527776196|FG001|Overall Study|Inadequately Enrolled|0|||
146347163|NCT02760407|527776197|FG002|Overall Study|Inadequately Enrolled|0|||
146347164|NCT02760407|527776198|FG003|Overall Study|Inadequately Enrolled|1|||
146347165|NCT02760407|527776195|FG000|Overall Study|Withdrawal By PI's Decision|0|||
146347166|NCT02760407|527776196|FG001|Overall Study|Withdrawal By PI's Decision|1|||
146347167|NCT02760407|527776197|FG002|Overall Study|Withdrawal By PI's Decision|0|||
146347168|NCT02760407|527776198|FG003|Overall Study|Withdrawal By PI's Decision|0|||
146347169|NCT02760407|527776195|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
146347170|NCT02760407|527776196|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
146347171|NCT02760407|527776197|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
146347172|NCT02760407|527776198|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
146347173|NCT02760407|527776195|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146347174|NCT02760407|527776196|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146347175|NCT02760407|527776197|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
146347176|NCT02760407|527776198|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
146347177|NCT02760407|527776195|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
146347178|NCT02760407|527776196|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146347179|NCT02760407|527776197|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146347180|NCT02760407|527776198|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
146347181|NCT02760407|527776195|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
146347182|NCT02760407|527776196|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
146347183|NCT02760407|527776197|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
146347184|NCT02760407|527776198|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
146347185|NCT02760407|527776195|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
146347186|NCT02760407|527776196|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146347187|NCT02760407|527776197|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146347188|NCT02760407|527776198|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
146347189|NCT02760407|527776195|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
146347190|NCT02760407|527776196|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146347191|NCT02760407|527776197|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146347192|NCT02760407|527776198|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
146347193|NCT02760407|527776195|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
146347194|NCT02760407|527776196|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
146347195|NCT02760407|527776197|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
146347196|NCT02760407|527776198|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
146347197|NCT02760407|527776195|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
146347198|NCT02760407|527776196|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146347199|NCT02760407|527776197|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146347200|NCT02760407|527776198|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
146347201|NCT02760407|527776195|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
146347202|NCT02760407|527776196|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
146347203|NCT02760407|527776197|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
146347204|NCT02760407|527776198|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
146347205|NCT02522377|527776199|FG000|Overall Study|Withdrawal by Subject|1|||
146347206|NCT02522377|527776200|FG001|Overall Study|Withdrawal by Subject|0|||
146347207|NCT02522377|527776199|FG000|Overall Study|Remission Achieved|3|||
146347208|NCT02522377|527776200|FG001|Overall Study|Remission Achieved|0|||
146347209|NCT01158950|527776201|FG000|1st Intervention (1 Day)|Physician Decision|1|||
146347210|NCT01158950|527776202|FG001|1st Intervention (1 Day)|Physician Decision|2|||
146347211|NCT02116972|527776205|FG000|Overall Study|Adverse Event|4|||
146347212|NCT02116972|527776206|FG001|Overall Study|Adverse Event|4|||
146347213|NCT02116972|527776207|FG002|Overall Study|Adverse Event|1|||
146347214|NCT02116972|527776205|FG000|Overall Study|Withdrawal by Subject|1|||
146347215|NCT02116972|527776206|FG001|Overall Study|Withdrawal by Subject|1|||
146347216|NCT02116972|527776207|FG002|Overall Study|Withdrawal by Subject|5|||
146347217|NCT02116972|527776205|FG000|Overall Study|Protocol Violation|1|||
146347218|NCT02116972|527776206|FG001|Overall Study|Protocol Violation|0|||
146347219|NCT02116972|527776207|FG002|Overall Study|Protocol Violation|1|||
146347220|NCT02116972|527776205|FG000|Overall Study|Lost to Follow-up|4|||
146347221|NCT02116972|527776206|FG001|Overall Study|Lost to Follow-up|3|||
146347222|NCT02116972|527776207|FG002|Overall Study|Lost to Follow-up|1|||
146347223|NCT02116972|527776205|FG000|Overall Study|Lack of Efficacy|6|||
146347224|NCT02116972|527776206|FG001|Overall Study|Lack of Efficacy|6|||
146347225|NCT02116972|527776207|FG002|Overall Study|Lack of Efficacy|5|||
146347226|NCT02116972|527776205|FG000|Overall Study|scheduling conflicts and relocation|3|||
146347227|NCT02116972|527776206|FG001|Overall Study|scheduling conflicts and relocation|3|||
146347228|NCT02116972|527776207|FG002|Overall Study|scheduling conflicts and relocation|6|||
146347229|NCT01797432|527776208|FG000|Overall Study|Lost to Follow-up|1|||
146347230|NCT01797432|527776208|FG000|Overall Study|Adverse Event|1|||
146347231|NCT01797432|527776208|FG000|Overall Study|Withdrawal by Subject|1|||
146347232|NCT01797432|527776208|FG000|Overall Study|lived too far from study site|1|||
146347233|NCT01137435|527776209|FG000|Overall Study|Lost to Follow-up|24|||
146347234|NCT01137435|527776209|FG000|Overall Study|Off label usage|4|||
146347235|NCT01416610|527776217|FG000|Overall Study|Adverse Event|4|||
146347236|NCT01416610|527776217|FG000|Overall Study|Adverse Event -Patient decision|3|||
146347237|NCT01416610|527776217|FG000|Overall Study|Lack of Efficacy|4|||
146347238|NCT01416610|527776217|FG000|Overall Study|No reason given|5|||
146347239|NCT01416610|527776217|FG000|Overall Study|Withdrawal by Subject|13|||
146347240|NCT01416610|527776217|FG000|Overall Study|Lost to Follow-up|7|||
146347241|NCT01416610|527776217|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
146347242|NCT02961764|527776218|FG000|Overall Study|Protocol Violation|0|||
146347243|NCT02961764|527776219|FG001|Overall Study|Protocol Violation|1|||
146347244|NCT02961764|527776218|FG000|Overall Study|Death|2|||
146347245|NCT02961764|527776219|FG001|Overall Study|Death|0|||
146347246|NCT02961764|527776218|FG000|Overall Study|Lost to Follow-up|35|||
146347247|NCT02961764|527776219|FG001|Overall Study|Lost to Follow-up|24|||
146347248|NCT02961764|527776218|FG000|Overall Study|Withdrawal by Subject|2|||
146347249|NCT02961764|527776219|FG001|Overall Study|Withdrawal by Subject|0|||
146347250|NCT03461289|527776220|FG000|Overall Study|Death|1|||
146347251|NCT02698423|527776221|FG000|Overall Study|Lost to Follow-up|19|||
146347252|NCT02698423|527776222|FG001|Overall Study|Lost to Follow-up|24|||
146347253|NCT00530712|527776223|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
146347254|NCT00530712|527776223|FG000|30 Day Follow-up Visit|Missed Visit|5|||
146347255|NCT00530712|527776223|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
146347256|NCT00530712|527776223|FG000|6 Month Follow-up Visit|Missed Visit|3|||
146347257|NCT00530712|527776223|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
146347258|NCT00530712|527776223|FG000|6 Month Follow-up Visit|Death|2|||
146347259|NCT00530712|527776223|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
146347260|NCT00530712|527776223|FG000|12 Month Follow-up Visit|Missed Visit|3|||
146347261|NCT00530712|527776223|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
146347262|NCT00530712|527776223|FG000|12 Month Follow-up Visit|Death|9|||
146347263|NCT00839098|527776224|FG000|Overall Study|Withdrawal by Subject|2|||
146347264|NCT00839098|527776225|FG001|Overall Study|Withdrawal by Subject|1|||
146347265|NCT00839098|527776226|FG002|Overall Study|Withdrawal by Subject|7|||
146347266|NCT02399475|527776227|FG000|Overall Study|Physician Decision|1|||
146347267|NCT02399475|527776228|FG001|Overall Study|Physician Decision|0|||
146347268|NCT00935220|527776229|FG000|Overall Study|Adverse Event|1|||
146347269|NCT00935220|527776229|FG000|Overall Study|Other reason (not specified)|1|||
146347270|NCT01415440|527776232|FG000|Overall Study|Lost to Follow-up|0|||
146347271|NCT01415440|527776233|FG001|Overall Study|Lost to Follow-up|1|||
146347272|NCT01415440|527776234|FG002|Overall Study|Lost to Follow-up|2|||
146347273|NCT01415440|527776232|FG000|Overall Study|Physician Decision|3|||
146347274|NCT01415440|527776233|FG001|Overall Study|Physician Decision|0|||
146347275|NCT01415440|527776234|FG002|Overall Study|Physician Decision|0|||
146347276|NCT01415440|527776232|FG000|Overall Study|Withdrawal by Subject|1|||
146347277|NCT01415440|527776233|FG001|Overall Study|Withdrawal by Subject|0|||
146347278|NCT01415440|527776234|FG002|Overall Study|Withdrawal by Subject|0|||
146347279|NCT00633139|527776235|FG000|Overall Study|Non compliance|0|||
146347280|NCT00633139|527776236|FG001|Overall Study|Non compliance|0|||
146347281|NCT00633139|527776237|FG002|Overall Study|Non compliance|1|||
146347282|NCT00633139|527776235|FG000|Overall Study|Withdrawal by Subject|0|||
146347283|NCT00633139|527776236|FG001|Overall Study|Withdrawal by Subject|1|||
146347284|NCT00633139|527776237|FG002|Overall Study|Withdrawal by Subject|0|||
146347285|NCT02160977|527776238|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
146347286|NCT02160977|527776239|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
146347287|NCT02160977|527776238|FG000|Three Months After Surgery|Lost to Follow-up|0|||
146347288|NCT02160977|527776239|FG001|Three Months After Surgery|Lost to Follow-up|2|||
146347289|NCT02160977|527776238|FG000|Six Months After Surgery|Lost to Follow-up|2|||
146347290|NCT02160977|527776239|FG001|Six Months After Surgery|Lost to Follow-up|1|||
146169388|NCT01392300|527132800|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
146169389|NCT01392300|527132801|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
146347291|NCT03132805|527777465|FG000|Overall Study|Lost to Follow-up|142|||
146347292|NCT03132805|527777466|FG001|Overall Study|Lost to Follow-up|141|||
146347293|NCT03132805|527777467|FG002|Overall Study|Lost to Follow-up|113|||
146347294|NCT03009539|527777468|FG000|Overall Study|Lost to Follow-up|132|||
146347295|NCT03009539|527777469|FG001|Overall Study|Lost to Follow-up|113|||
146347296|NCT03009539|527777470|FG002|Overall Study|Lost to Follow-up|132|||
146347297|NCT03009539|527777471|FG003|Overall Study|Lost to Follow-up|113|||
146347298|NCT03151148|527777472|FG000|Overall Study|Lost to Follow-up|1|||
146347299|NCT03151148|527777473|FG001|Overall Study|Lost to Follow-up|0|||
146347300|NCT03151148|527777472|FG000|Overall Study|Withdrawal by Subject|1|||
146347301|NCT03151148|527777473|FG001|Overall Study|Withdrawal by Subject|0|||
146347302|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
146347303|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
146347304|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
146347305|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
146347306|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
146347307|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
146347308|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
146347309|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
146347310|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
146347311|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
146347312|NCT00710034|527777474|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
146347313|NCT00710034|527777475|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
146347314|NCT00710034|527777474|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
146347315|NCT00710034|527777475|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
146347316|NCT00710034|527777474|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
146347317|NCT00710034|527777475|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
146347318|NCT00710034|527777474|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
146347319|NCT00710034|527777475|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
146347320|NCT00710034|527777474|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
146347321|NCT00710034|527777475|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
146347322|NCT00710034|527777474|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
146347323|NCT00710034|527777475|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
146347324|NCT01614769|527777476|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
146347325|NCT01614769|527777477|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
146347326|NCT01614769|527777478|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
146347327|NCT01614769|527777479|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
146347328|NCT01614769|527777480|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
146347329|NCT01614769|527777481|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
146347330|NCT01614769|527777476|FG000|Period 1|Protocol Violation|0|||
146347331|NCT01614769|527777477|FG001|Period 1|Protocol Violation|0|||
146347332|NCT01614769|527777478|FG002|Period 1|Protocol Violation|0|||
146347333|NCT01614769|527777479|FG003|Period 1|Protocol Violation|1|||
146347334|NCT01614769|527777480|FG004|Period 1|Protocol Violation|0|||
146347335|NCT01614769|527777481|FG005|Period 1|Protocol Violation|0|||
146347336|NCT01614769|527777476|FG000|Period 1|Withdrawal by Subject|1|||
146347337|NCT01614769|527777477|FG001|Period 1|Withdrawal by Subject|0|||
146347338|NCT01614769|527777478|FG002|Period 1|Withdrawal by Subject|0|||
146347339|NCT01614769|527777479|FG003|Period 1|Withdrawal by Subject|0|||
146347340|NCT01614769|527777480|FG004|Period 1|Withdrawal by Subject|0|||
146347341|NCT01614769|527777481|FG005|Period 1|Withdrawal by Subject|0|||
146347342|NCT01614769|527777476|FG000|Period 3|Withdrawal by Subject|0|||
146347343|NCT01614769|527777477|FG001|Period 3|Withdrawal by Subject|0|||
146347344|NCT01614769|527777478|FG002|Period 3|Withdrawal by Subject|1|||
146347345|NCT01614769|527777479|FG003|Period 3|Withdrawal by Subject|0|||
146347346|NCT01614769|527777480|FG004|Period 3|Withdrawal by Subject|0|||
146347347|NCT01614769|527777481|FG005|Period 3|Withdrawal by Subject|0|||
146347348|NCT01958671|527777486|FG000|Overall Study|Adverse Event|1|||
146347349|NCT01958671|527777487|FG001|Overall Study|Adverse Event|1|||
146347350|NCT01958671|527777488|FG002|Overall Study|Adverse Event|5|||
146347351|NCT01958671|527777486|FG000|Overall Study|Death|1|||
146347352|NCT01958671|527777487|FG001|Overall Study|Death|0|||
146347353|NCT01958671|527777488|FG002|Overall Study|Death|0|||
146347354|NCT01958671|527777486|FG000|Overall Study|Excluded medication|0|||
146347355|NCT01958671|527777487|FG001|Overall Study|Excluded medication|0|||
146347356|NCT01958671|527777488|FG002|Overall Study|Excluded medication|1|||
146347357|NCT01958671|527777486|FG000|Overall Study|Hyperglycemia|0|||
146347358|NCT01958671|527777487|FG001|Overall Study|Hyperglycemia|0|||
146347359|NCT01958671|527777488|FG002|Overall Study|Hyperglycemia|2|||
146347360|NCT01958671|527777486|FG000|Overall Study|Lost to Follow-up|7|||
146347361|NCT01958671|527777487|FG001|Overall Study|Lost to Follow-up|11|||
146347362|NCT01958671|527777488|FG002|Overall Study|Lost to Follow-up|7|||
146347363|NCT01958671|527777486|FG000|Overall Study|Non-compliance with study drug|1|||
146347364|NCT01958671|527777487|FG001|Overall Study|Non-compliance with study drug|1|||
146347365|NCT01958671|527777488|FG002|Overall Study|Non-compliance with study drug|1|||
146347366|NCT01958671|527777486|FG000|Overall Study|Pregnancy|0|||
146347367|NCT01958671|527777487|FG001|Overall Study|Pregnancy|0|||
146347368|NCT01958671|527777488|FG002|Overall Study|Pregnancy|1|||
146347369|NCT01958671|527777486|FG000|Overall Study|Protocol Violation|0|||
146347370|NCT01958671|527777487|FG001|Overall Study|Protocol Violation|1|||
146347371|NCT01958671|527777488|FG002|Overall Study|Protocol Violation|0|||
146347372|NCT01958671|527777486|FG000|Overall Study|Study site terminated by sponsor|1|||
146347373|NCT01958671|527777487|FG001|Overall Study|Study site terminated by sponsor|0|||
146347374|NCT01958671|527777488|FG002|Overall Study|Study site terminated by sponsor|1|||
146347375|NCT01958671|527777486|FG000|Overall Study|Participant moved|0|||
146347376|NCT01958671|527777487|FG001|Overall Study|Participant moved|0|||
146347377|NCT01958671|527777488|FG002|Overall Study|Participant moved|1|||
146347378|NCT01958671|527777486|FG000|Overall Study|Withdrawal by Subject|8|||
146347379|NCT01958671|527777487|FG001|Overall Study|Withdrawal by Subject|10|||
146347380|NCT01958671|527777488|FG002|Overall Study|Withdrawal by Subject|13|||
146347381|NCT01070303|527777489|FG000|Overall Study|Adverse Event|39|||
146347382|NCT01070303|527777489|FG000|Overall Study|Withdrawal by Subject|20|||
146347383|NCT01070303|527777489|FG000|Overall Study|Lost to Follow-up|9|||
146347384|NCT01070303|527777489|FG000|Overall Study|Protocol Violation|0|||
146347385|NCT01070303|527777489|FG000|Overall Study|Lack of Efficacy|2|||
146347386|NCT01070303|527777489|FG000|Overall Study|Administrative Reason|1|||
146347387|NCT01070303|527777489|FG000|Overall Study|Other|18|||
146347388|NCT01849848|527777490|FG000|Overall Study|Physician Decision|1|||
146347389|NCT01849848|527777490|FG000|Overall Study|Progression of the primary disease|3|||
146347390|NCT00859898|527777492|FG000|Overall Study|Lack of Efficacy|0|||
146347391|NCT00859898|527777493|FG001|Overall Study|Lack of Efficacy|1|||
146347392|NCT00859898|527777494|FG002|Overall Study|Lack of Efficacy|1|||
146347393|NCT00859898|527777492|FG000|Overall Study|Adverse Event|4|||
146347394|NCT00859898|527777493|FG001|Overall Study|Adverse Event|9|||
146347395|NCT00859898|527777494|FG002|Overall Study|Adverse Event|8|||
146347396|NCT00859898|527777492|FG000|Overall Study|Withdrawal by Subject|11|||
146347397|NCT00859898|527777493|FG001|Overall Study|Withdrawal by Subject|8|||
146347398|NCT00859898|527777494|FG002|Overall Study|Withdrawal by Subject|11|||
146347399|NCT00859898|527777492|FG000|Overall Study|Death|0|||
146347400|NCT00859898|527777493|FG001|Overall Study|Death|0|||
146347401|NCT00859898|527777494|FG002|Overall Study|Death|1|||
146347402|NCT00859898|527777492|FG000|Overall Study|Lost to Follow-up|10|||
146347403|NCT00859898|527777493|FG001|Overall Study|Lost to Follow-up|11|||
146347404|NCT00859898|527777494|FG002|Overall Study|Lost to Follow-up|5|||
146347405|NCT00859898|527777492|FG000|Overall Study|poor/non-compliance|2|||
146347406|NCT00859898|527777493|FG001|Overall Study|poor/non-compliance|0|||
146347407|NCT00859898|527777494|FG002|Overall Study|poor/non-compliance|0|||
146347408|NCT00859898|527777492|FG000|Overall Study|No longer meets criteria|0|||
146347409|NCT00859898|527777493|FG001|Overall Study|No longer meets criteria|1|||
146347410|NCT00859898|527777494|FG002|Overall Study|No longer meets criteria|0|||
146347411|NCT00859898|527777492|FG000|Overall Study|non-specified|1|||
146347412|NCT00859898|527777493|FG001|Overall Study|non-specified|1|||
146347413|NCT00859898|527777494|FG002|Overall Study|non-specified|1|||
146347414|NCT02417233|527777497|FG000|Overall Study|Death|4|||
146347415|NCT02417233|527777498|FG001|Overall Study|Death|10|||
146347416|NCT02417233|527777499|FG002|Overall Study|Death|14|||
146347417|NCT02417233|527777497|FG000|Overall Study|Lost to Follow-up|27|||
146347418|NCT02417233|527777498|FG001|Overall Study|Lost to Follow-up|39|||
146347419|NCT02417233|527777499|FG002|Overall Study|Lost to Follow-up|34|||
146347420|NCT02417233|527777497|FG000|Overall Study|Protocol Violation|2|||
146347421|NCT02417233|527777498|FG001|Overall Study|Protocol Violation|0|||
146347422|NCT02417233|527777499|FG002|Overall Study|Protocol Violation|2|||
146347423|NCT02417233|527777497|FG000|Overall Study|Withdrawal by Subject|2|||
146347424|NCT02417233|527777498|FG001|Overall Study|Withdrawal by Subject|1|||
146347425|NCT02417233|527777499|FG002|Overall Study|Withdrawal by Subject|8|||
146347426|NCT02417233|527777497|FG000|Overall Study|Relocation out of study area|1|||
146347427|NCT02417233|527777498|FG001|Overall Study|Relocation out of study area|0|||
146347428|NCT02417233|527777499|FG002|Overall Study|Relocation out of study area|1|||
146347429|NCT02417233|527777497|FG000|Overall Study|Mentally unstable|0|||
146347430|NCT02417233|527777498|FG001|Overall Study|Mentally unstable|1|||
146347431|NCT02417233|527777499|FG002|Overall Study|Mentally unstable|0|||
146347432|NCT00532883|527777500|FG000|Overall Study|Adverse Event|1|||
146347433|NCT00532883|527777501|FG001|Overall Study|Adverse Event|0|||
146347434|NCT00532883|527777502|FG002|Overall Study|Adverse Event|0|||
146169390|NCT01392300|527132802|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
146347435|NCT00532883|527777503|FG003|Overall Study|Adverse Event|1|||
146347436|NCT00532883|527777500|FG000|Overall Study|Lost to Follow-up|1|||
146347437|NCT00532883|527777501|FG001|Overall Study|Lost to Follow-up|1|||
146347438|NCT00532883|527777502|FG002|Overall Study|Lost to Follow-up|1|||
146347439|NCT00532883|527777503|FG003|Overall Study|Lost to Follow-up|0|||
146347440|NCT00532883|527777500|FG000|Overall Study|Withdrawal by Subject|0|||
146347441|NCT00532883|527777501|FG001|Overall Study|Withdrawal by Subject|1|||
146347442|NCT00532883|527777502|FG002|Overall Study|Withdrawal by Subject|1|||
146347443|NCT00532883|527777503|FG003|Overall Study|Withdrawal by Subject|0|||
146347444|NCT00532883|527777500|FG000|Overall Study|Subject was Nonadherent|0|||
146347445|NCT00532883|527777501|FG001|Overall Study|Subject was Nonadherent|1|||
146347446|NCT00532883|527777502|FG002|Overall Study|Subject was Nonadherent|1|||
146347447|NCT00532883|527777503|FG003|Overall Study|Subject was Nonadherent|0|||
146347448|NCT00532883|527777500|FG000|Overall Study|Early Study Termination|4|||
146347449|NCT00532883|527777501|FG001|Overall Study|Early Study Termination|4|||
146347450|NCT00532883|527777502|FG002|Overall Study|Early Study Termination|1|||
146347451|NCT00532883|527777503|FG003|Overall Study|Early Study Termination|4|||
146347452|NCT03799718|527777504|FG000|Overall Study|Adverse Event|2|||
146347453|NCT02202031|527777505|FG000|Overall Study|Lost to Follow-up|1|||
146347454|NCT02202031|527777506|FG001|Overall Study|Lost to Follow-up|0|||
146347455|NCT02202031|527777505|FG000|Overall Study|Too Busy|1|||
146347456|NCT02202031|527777506|FG001|Overall Study|Too Busy|3|||
146347457|NCT02202031|527777505|FG000|Overall Study|Illness/Medical Reason|0|||
146347458|NCT02202031|527777506|FG001|Overall Study|Illness/Medical Reason|2|||
146347459|NCT02202031|527777505|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
146347460|NCT02202031|527777506|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
146347461|NCT02184143|527777507|FG000|Overall Study|Withdrawal by Subject|4|||
146347462|NCT02184143|527777508|FG001|Overall Study|Withdrawal by Subject|4|||
146347463|NCT02184143|527777507|FG000|Overall Study|Lost to Follow-up|5|||
146347464|NCT02184143|527777508|FG001|Overall Study|Lost to Follow-up|3|||
146347465|NCT02184143|527777507|FG000|Overall Study|Death|1|||
146347466|NCT02184143|527777508|FG001|Overall Study|Death|0|||
146347467|NCT00321984|527777509|FG000|Overall Study|Adverse Event|9|||
146347468|NCT00321984|527777510|FG001|Overall Study|Adverse Event|6|||
146347469|NCT00321984|527777511|FG002|Overall Study|Adverse Event|8|||
146347470|NCT00321984|527777509|FG000|Overall Study|Protocol Violation|0|||
146347471|NCT00321984|527777510|FG001|Overall Study|Protocol Violation|1|||
146347472|NCT00321984|527777511|FG002|Overall Study|Protocol Violation|1|||
146347473|NCT00321984|527777509|FG000|Overall Study|Lost to Follow-up|2|||
146347474|NCT00321984|527777510|FG001|Overall Study|Lost to Follow-up|4|||
146347475|NCT00321984|527777511|FG002|Overall Study|Lost to Follow-up|2|||
146347476|NCT00321984|527777509|FG000|Overall Study|Withdrawal by Subject|8|||
146347477|NCT00321984|527777510|FG001|Overall Study|Withdrawal by Subject|6|||
146347478|NCT00321984|527777511|FG002|Overall Study|Withdrawal by Subject|5|||
146347479|NCT00321984|527777509|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
146347480|NCT00321984|527777510|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
146347481|NCT00321984|527777511|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
146347482|NCT00321984|527777509|FG000|Overall Study|Lack of Efficacy|3|||
146347483|NCT00321984|527777510|FG001|Overall Study|Lack of Efficacy|1|||
146347484|NCT00321984|527777511|FG002|Overall Study|Lack of Efficacy|3|||
146347485|NCT00321984|527777509|FG000|Overall Study|Noncompliant|0|||
146347486|NCT00321984|527777510|FG001|Overall Study|Noncompliant|0|||
146347487|NCT00321984|527777511|FG002|Overall Study|Noncompliant|2|||
146347488|NCT00321984|527777509|FG000|Overall Study|Pregnancy|0|||
146347489|NCT00321984|527777510|FG001|Overall Study|Pregnancy|1|||
146347490|NCT00321984|527777511|FG002|Overall Study|Pregnancy|0|||
146347491|NCT00321984|527777509|FG000|Overall Study|Per Subject Request|1|||
146347492|NCT00321984|527777510|FG001|Overall Study|Per Subject Request|0|||
146347493|NCT00321984|527777511|FG002|Overall Study|Per Subject Request|0|||
146347494|NCT00321984|527777509|FG000|Overall Study|Per Investigator Request|1|||
146347495|NCT00321984|527777510|FG001|Overall Study|Per Investigator Request|0|||
146347496|NCT00321984|527777511|FG002|Overall Study|Per Investigator Request|0|||
146347497|NCT00321984|527777509|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
146347498|NCT00321984|527777510|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
146347499|NCT00321984|527777511|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
146347500|NCT05232097|527777512|FG000|Overall Study|Physician Decision|1|||
146347501|NCT01172288|527777513|FG000|Overall Study|Adverse Event|1|||
146347502|NCT01172288|527777514|FG001|Overall Study|Adverse Event|0|||
146347503|NCT01172288|527777513|FG000|Overall Study|Protocol Violation|0|||
146347504|NCT01172288|527777514|FG001|Overall Study|Protocol Violation|1|||
146347505|NCT00871858|527777517|FG000|Overall Study|Protocol Violation|3|||
146347506|NCT00871858|527777518|FG001|Overall Study|Protocol Violation|4|||
146347507|NCT00871858|527777517|FG000|Overall Study|Adverse Event|1|||
146347508|NCT00871858|527777518|FG001|Overall Study|Adverse Event|1|||
146347509|NCT00871858|527777517|FG000|Overall Study|Withdrawal by Subject|1|||
146347510|NCT00871858|527777518|FG001|Overall Study|Withdrawal by Subject|1|||
146347511|NCT00871858|527777517|FG000|Overall Study|Lost to Follow-up|0|||
146347512|NCT00871858|527777518|FG001|Overall Study|Lost to Follow-up|1|||
146347513|NCT01188798|527777519|FG000|Overall Study|Death|0|||
146347514|NCT01188798|527777520|FG001|Overall Study|Death|1|||
146347515|NCT01188798|527777519|FG000|Overall Study|Required additional transplant|1|||
146347516|NCT01188798|527777520|FG001|Overall Study|Required additional transplant|1|||
146347517|NCT01188798|527777519|FG000|Overall Study|Protocol closure|1|||
146347518|NCT01188798|527777520|FG001|Overall Study|Protocol closure|1|||
146347519|NCT01097330|527777521|FG000|Overall Study|Study terminated early|7|||
146347520|NCT01097330|527777522|FG001|Overall Study|Study terminated early|5|||
146347521|NCT00863928|527777528|FG000|Overall Study|Protocol Violation|26|||
146347522|NCT00863928|527777529|FG001|Overall Study|Protocol Violation|0|||
146347523|NCT00863928|527777528|FG000|Overall Study|Withdrawal by Subject|3|||
146347524|NCT00863928|527777529|FG001|Overall Study|Withdrawal by Subject|0|||
146347525|NCT00863928|527777528|FG000|Overall Study|surgery cancellation|4|||
146347526|NCT00863928|527777529|FG001|Overall Study|surgery cancellation|0|||
146347527|NCT00863928|527777528|FG000|Overall Study|medication allergy|3|||
146347528|NCT00863928|527777529|FG001|Overall Study|medication allergy|0|||
146347529|NCT02124798|527777530|FG000|Overall Study|Adverse Event|3|||
146347530|NCT02124798|527777530|FG000|Overall Study|Lost to Follow-up|1|||
146347531|NCT00487279|527777535|FG000|Overall Study|Death|1|||
146347532|NCT00487279|527777536|FG001|Overall Study|Death|0|||
146347533|NCT00487279|527777535|FG000|Overall Study|Withdrawal by Subject|0|||
146347534|NCT00487279|527777536|FG001|Overall Study|Withdrawal by Subject|2|||
146347535|NCT02746679|527777537|FG000|Overall Study|Lost to Follow-up|4|||
146347536|NCT02746679|527777538|FG001|Overall Study|Lost to Follow-up|6|||
146347537|NCT00501852|527777539|FG000|Overall Study|Adverse Event|3|||
146347538|NCT00501852|527777539|FG000|Overall Study|Withdrawal by Subject|2|||
146347539|NCT01171521|527777542|FG000|Overall Study|Lost to Follow-up|5|||
146347540|NCT01171521|527777542|FG000|Overall Study|screen failure|1|||
146347541|NCT01927562|527777543|FG000|Overall Study|Lost to Follow-up|30|||
146347542|NCT01927562|527777543|FG000|Overall Study|Withdrawal by Subject|3|||
146347543|NCT01927562|527777543|FG000|Overall Study|Physician Decision|5|||
146347544|NCT00492921|527777544|FG000|Overall Study|Death|1|||
146347545|NCT00492921|527777545|FG001|Overall Study|Death|0|||
146347546|NCT00492921|527777546|FG002|Overall Study|Death|1|||
146347547|NCT00652093|527777547|FG000|Overall Study|Withdrawal by Subject|0|||
146347548|NCT00652093|527777548|FG001|Overall Study|Withdrawal by Subject|0|||
146347549|NCT00652093|527777549|FG002|Overall Study|Withdrawal by Subject|1|||
146347550|NCT00652093|527777550|FG003|Overall Study|Withdrawal by Subject|0|||
146347551|NCT00652093|527777551|FG004|Overall Study|Withdrawal by Subject|1|||
146347552|NCT00652093|527777552|FG005|Overall Study|Withdrawal by Subject|0|||
146347553|NCT00652093|527777547|FG000|Overall Study|Physician Decision|0|||
146347554|NCT00652093|527777548|FG001|Overall Study|Physician Decision|0|||
146347555|NCT00652093|527777549|FG002|Overall Study|Physician Decision|0|||
146347556|NCT00652093|527777550|FG003|Overall Study|Physician Decision|0|||
146347557|NCT00652093|527777551|FG004|Overall Study|Physician Decision|1|||
146347558|NCT00652093|527777552|FG005|Overall Study|Physician Decision|0|||
146347559|NCT01422304|527777553|FG000|Overall Study|Adverse Event|0|||
146347560|NCT01422304|527777554|FG001|Overall Study|Adverse Event|1|||
146347561|NCT01422304|527777553|FG000|Overall Study|Lost to Follow-up|14|||
146347562|NCT01422304|527777554|FG001|Overall Study|Lost to Follow-up|20|||
146347563|NCT01422304|527777553|FG000|Overall Study|Never Entered Follow-up|2|||
146347564|NCT01422304|527777554|FG001|Overall Study|Never Entered Follow-up|1|||
146347565|NCT01422304|527777553|FG000|Overall Study|Protocol Violation|1|||
146347566|NCT01422304|527777554|FG001|Overall Study|Protocol Violation|0|||
146347567|NCT01422304|527777553|FG000|Overall Study|Withdrawal by Subject|4|||
146347568|NCT01422304|527777554|FG001|Overall Study|Withdrawal by Subject|2|||
146347569|NCT01422304|527777553|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
146347570|NCT01422304|527777554|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
146347571|NCT01422304|527777553|FG000|Overall Study|Not Treated|3|||
146347572|NCT01422304|527777554|FG001|Overall Study|Not Treated|11|||
146347573|NCT00469014|527777557|FG000|Initial Phase Randomization|Disease Progression|0|||
146347574|NCT00469014|527777558|FG001|Initial Phase Randomization|Disease Progression|1|||
146347575|NCT00469014|527777559|FG002|Initial Phase Randomization|Disease Progression|1|||
146347576|NCT00469014|527777560|FG003|Initial Phase Randomization|Disease Progression|0|||
146347577|NCT00469014|527777557|FG000|Initial Phase Randomization|No Response|1|||
146347578|NCT00469014|527777558|FG001|Initial Phase Randomization|No Response|0|||
146347579|NCT00469014|527777559|FG002|Initial Phase Randomization|No Response|0|||
146347580|NCT00469014|527777560|FG003|Initial Phase Randomization|No Response|1|||
146347581|NCT00469014|527777557|FG000|Adaptive Randomization|Not Evaluable|1|||
146347582|NCT00469014|527777558|FG001|Adaptive Randomization|Not Evaluable|0|||
146347583|NCT00469014|527777559|FG002|Adaptive Randomization|Not Evaluable|0|||
146347584|NCT00469014|527777560|FG003|Adaptive Randomization|Not Evaluable|1|||
146347585|NCT00469014|527777557|FG000|Adaptive Randomization|No Response|0|||
146347586|NCT00469014|527777558|FG001|Adaptive Randomization|No Response|1|||
146347587|NCT00469014|527777559|FG002|Adaptive Randomization|No Response|0|||
146347588|NCT00469014|527777560|FG003|Adaptive Randomization|No Response|0|||
146347589|NCT00469014|527777557|FG000|Adaptive Randomization|Death|0|||
146347590|NCT00469014|527777558|FG001|Adaptive Randomization|Death|0|||
146347591|NCT00469014|527777559|FG002|Adaptive Randomization|Death|1|||
146347592|NCT00469014|527777560|FG003|Adaptive Randomization|Death|0|||
146347593|NCT00866294|527777566|FG000|Overall Study|Adverse Event|12|||
146347594|NCT00866294|527777567|FG001|Overall Study|Adverse Event|13|||
146347595|NCT00866294|527777568|FG002|Overall Study|Adverse Event|9|||
146347596|NCT00866294|527777566|FG000|Overall Study|Lack of Efficacy|7|||
146347597|NCT00866294|527777567|FG001|Overall Study|Lack of Efficacy|1|||
146347598|NCT00866294|527777568|FG002|Overall Study|Lack of Efficacy|0|||
146347599|NCT00866294|527777566|FG000|Overall Study|Protocol Violation|2|||
146347600|NCT00866294|527777567|FG001|Overall Study|Protocol Violation|0|||
146347601|NCT00866294|527777568|FG002|Overall Study|Protocol Violation|0|||
146347602|NCT00866294|527777566|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
146347603|NCT00866294|527777567|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146347604|NCT00866294|527777568|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
146347605|NCT00866294|527777566|FG000|Overall Study|Lost to Follow-up|1|||
146347606|NCT00866294|527777567|FG001|Overall Study|Lost to Follow-up|3|||
146347607|NCT00866294|527777568|FG002|Overall Study|Lost to Follow-up|0|||
146347608|NCT00866294|527777566|FG000|Overall Study|Physician Decision|6|||
146347609|NCT00866294|527777567|FG001|Overall Study|Physician Decision|2|||
146347610|NCT00866294|527777568|FG002|Overall Study|Physician Decision|1|||
146347611|NCT01632878|527777569|FG000|Screening|Physician Decision|268|||
146347612|NCT01632878|527777569|FG000|Treatment|Lost to Follow-up|41|||
146347613|NCT01632878|527777569|FG000|Treatment|Withdrawal by Subject|36|||
146347614|NCT01632878|527777569|FG000|Treatment|Physician Decision|34|||
146347615|NCT01632878|527777569|FG000|Treatment|missing information|4|||
146347616|NCT01632878|527777569|FG000|Treatment|no information on study completion|43|||
146347617|NCT02119104|527777570|FG000|Overall Study|Protocol Violation|16|||
146347618|NCT00081289|527777574|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
146347619|NCT00081289|527777575|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
146347620|NCT00081289|527777574|FG000|Overall Study|Ineligible / no protocol treatment|3|||
146347621|NCT00081289|527777575|FG001|Overall Study|Ineligible / no protocol treatment|4|||
146347622|NCT02508701|527777578|FG000|Overall Study|Lost to Follow-up|9|||
146347623|NCT02508701|527777579|FG001|Overall Study|Lost to Follow-up|5|||
146347624|NCT02508701|527777580|FG002|Overall Study|Lost to Follow-up|5|||
146347625|NCT02508701|527777581|FG003|Overall Study|Lost to Follow-up|3|||
146347626|NCT03117049|527777586|FG000|Overall Study|Continued the follow-up period|109|||
146347627|NCT03117049|527777587|FG001|Overall Study|Continued the follow-up period|129|||
146347628|NCT03117049|527777586|FG000|Overall Study|Died|82|||
146347629|NCT03117049|527777587|FG001|Overall Study|Died|93|||
146347630|NCT03117049|527777586|FG000|Overall Study|Consent withdrawal|7|||
146347631|NCT03117049|527777587|FG001|Overall Study|Consent withdrawal|6|||
146347632|NCT03117049|527777586|FG000|Overall Study|Missing contact|3|||
146347633|NCT03117049|527777587|FG001|Overall Study|Missing contact|3|||
146347634|NCT03103750|527777592|FG000|Overall Study|Adverse Event|1|||
146347635|NCT03103750|527777593|FG001|Overall Study|Adverse Event|0|||
146347636|NCT03103750|527777592|FG000|Overall Study|Lost to Follow-up|1|||
146347637|NCT03103750|527777593|FG001|Overall Study|Lost to Follow-up|0|||
146347638|NCT03103750|527777592|FG000|Overall Study|PET Equipment Related|2|||
146347639|NCT03103750|527777593|FG001|Overall Study|PET Equipment Related|2|||
146347640|NCT01522651|527777594|FG000|Overall Study|Adverse Event|3|||
146347641|NCT01522651|527777595|FG001|Overall Study|Adverse Event|4|||
146347642|NCT01522651|527777596|FG002|Overall Study|Adverse Event|4|||
146347643|NCT01522651|527777597|FG003|Overall Study|Adverse Event|5|||
146347644|NCT01522651|527777598|FG004|Overall Study|Adverse Event|4|||
146347645|NCT01522651|527777594|FG000|Overall Study|Cardioversion|1|||
146347646|NCT01522651|527777595|FG001|Overall Study|Cardioversion|0|||
146347647|NCT01522651|527777596|FG002|Overall Study|Cardioversion|0|||
146347648|NCT01522651|527777597|FG003|Overall Study|Cardioversion|0|||
146347649|NCT01522651|527777598|FG004|Overall Study|Cardioversion|0|||
146347650|NCT01522651|527777594|FG000|Overall Study|Device Malfunction|0|||
146347651|NCT01522651|527777595|FG001|Overall Study|Device Malfunction|1|||
146347652|NCT01522651|527777596|FG002|Overall Study|Device Malfunction|0|||
146347653|NCT01522651|527777597|FG003|Overall Study|Device Malfunction|0|||
146347654|NCT01522651|527777598|FG004|Overall Study|Device Malfunction|0|||
146347655|NCT01522651|527777594|FG000|Overall Study|Investigator's Discretion|0|||
146347656|NCT01522651|527777595|FG001|Overall Study|Investigator's Discretion|1|||
146347657|NCT01522651|527777596|FG002|Overall Study|Investigator's Discretion|0|||
146347658|NCT01522651|527777597|FG003|Overall Study|Investigator's Discretion|0|||
146347659|NCT01522651|527777598|FG004|Overall Study|Investigator's Discretion|0|||
146347660|NCT01522651|527777594|FG000|Overall Study|Protocol Violation|3|||
146347661|NCT01522651|527777595|FG001|Overall Study|Protocol Violation|0|||
146347662|NCT01522651|527777596|FG002|Overall Study|Protocol Violation|0|||
146347663|NCT01522651|527777597|FG003|Overall Study|Protocol Violation|0|||
146347664|NCT01522651|527777598|FG004|Overall Study|Protocol Violation|0|||
146347665|NCT01522651|527777594|FG000|Overall Study|Reason Not Specified|0|||
146347666|NCT01522651|527777595|FG001|Overall Study|Reason Not Specified|0|||
146169391|NCT01392300|527132800|FG000|Main Period (MP)|Withdrawal by Subject|5|||
146169392|NCT01392300|527132801|FG001|Main Period (MP)|Withdrawal by Subject|1|||
146169393|NCT01392300|527132802|FG002|Main Period (MP)|Withdrawal by Subject|0|||
146347667|NCT01522651|527777596|FG002|Overall Study|Reason Not Specified|0|||
146347668|NCT01522651|527777597|FG003|Overall Study|Reason Not Specified|1|||
146347669|NCT01522651|527777598|FG004|Overall Study|Reason Not Specified|0|||
146347670|NCT01522651|527777594|FG000|Overall Study|Participant Non-Compliance|1|||
146347671|NCT01522651|527777595|FG001|Overall Study|Participant Non-Compliance|0|||
146347672|NCT01522651|527777596|FG002|Overall Study|Participant Non-Compliance|0|||
146347673|NCT01522651|527777597|FG003|Overall Study|Participant Non-Compliance|0|||
146169394|NCT01392300|527132800|FG000|Main Period (MP)|Lost to Follow-up|3|||
146347674|NCT01522651|527777598|FG004|Overall Study|Participant Non-Compliance|0|||
146347675|NCT01522651|527777594|FG000|Overall Study|Withdrew Consent|1|||
146347676|NCT01522651|527777595|FG001|Overall Study|Withdrew Consent|1|||
146347677|NCT01522651|527777596|FG002|Overall Study|Withdrew Consent|0|||
146347678|NCT01522651|527777597|FG003|Overall Study|Withdrew Consent|1|||
146347679|NCT01522651|527777598|FG004|Overall Study|Withdrew Consent|1|||
146347680|NCT01522651|527777594|FG000|Overall Study|Randomized but Never Treated|0|||
146347681|NCT01522651|527777595|FG001|Overall Study|Randomized but Never Treated|1|||
146347682|NCT01522651|527777596|FG002|Overall Study|Randomized but Never Treated|0|||
146347683|NCT01522651|527777597|FG003|Overall Study|Randomized but Never Treated|1|||
146347684|NCT01522651|527777598|FG004|Overall Study|Randomized but Never Treated|1|||
146347685|NCT02658656|527777599|FG000|Screening|Failed eligibility criteria|0|||
146347686|NCT02658656|527777600|FG001|Screening|Failed eligibility criteria|0|||
146347687|NCT02658656|527777601|FG002|Screening|Failed eligibility criteria|263|||
146347688|NCT02658656|527777599|FG000|Randomization|Withdrawal by Subject|8|||
146347689|NCT02658656|527777600|FG001|Randomization|Withdrawal by Subject|7|||
146347690|NCT02658656|527777601|FG002|Randomization|Withdrawal by Subject|0|||
146347691|NCT02658656|527777599|FG000|Randomization|Lost to Follow-up|1|||
146347692|NCT02658656|527777600|FG001|Randomization|Lost to Follow-up|3|||
146347693|NCT02658656|527777601|FG002|Randomization|Lost to Follow-up|0|||
146347694|NCT02658656|527777599|FG000|Randomization|Adverse Event|4|||
146347695|NCT02658656|527777600|FG001|Randomization|Adverse Event|0|||
146347696|NCT02658656|527777601|FG002|Randomization|Adverse Event|0|||
146347697|NCT02658656|527777599|FG000|Randomization|Administrative Termination|3|||
146347698|NCT02658656|527777600|FG001|Randomization|Administrative Termination|1|||
146347699|NCT02658656|527777601|FG002|Randomization|Administrative Termination|0|||
146347700|NCT02658656|527777599|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
146347701|NCT02658656|527777600|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
146347702|NCT02658656|527777601|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
146347703|NCT02658656|527777599|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
146347704|NCT02658656|527777600|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
146347705|NCT02658656|527777601|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
146347706|NCT02658656|527777599|FG000|Randomization|Not eligible for Randomization|1|||
146347707|NCT02658656|527777600|FG001|Randomization|Not eligible for Randomization|0|||
146347708|NCT02658656|527777601|FG002|Randomization|Not eligible for Randomization|0|||
146347709|NCT02658656|527777599|FG000|Randomization|Protocol Violation|1|||
146347710|NCT02658656|527777600|FG001|Randomization|Protocol Violation|0|||
146347711|NCT02658656|527777601|FG002|Randomization|Protocol Violation|0|||
146347712|NCT01118143|527777602|FG000|Overall Study|Withdrawal by Subject|2|||
146347713|NCT01118143|527777603|FG001|Overall Study|Withdrawal by Subject|5|||
146347714|NCT02112448|527777604|FG000|Overall Study|lab values precluding use of ketorolac|2|||
146347715|NCT02112448|527777605|FG001|Overall Study|lab values precluding use of ketorolac|2|||
146347716|NCT02112448|527777604|FG000|Overall Study|Protocol Violation|1|||
146347717|NCT02112448|527777605|FG001|Overall Study|Protocol Violation|2|||
146347718|NCT02112448|527777604|FG000|Overall Study|Physician Decision|4|||
146347719|NCT02112448|527777605|FG001|Overall Study|Physician Decision|6|||
146347720|NCT02112448|527777604|FG000|Overall Study|required heparin so could not use ketoro|1|||
146347721|NCT02112448|527777605|FG001|Overall Study|required heparin so could not use ketoro|0|||
146347722|NCT02115815|527779283|FG000|Overall Study|Withdrawal by Subject|2|||
146347723|NCT02115815|527779284|FG001|Overall Study|Withdrawal by Subject|0|||
146347724|NCT02115815|527779285|FG002|Overall Study|Withdrawal by Subject|0|||
146347725|NCT02115815|527779286|FG003|Overall Study|Withdrawal by Subject|0|||
146347726|NCT02115815|527779287|FG004|Overall Study|Withdrawal by Subject|0|||
146347727|NCT02115815|527779288|FG005|Overall Study|Withdrawal by Subject|0|||
146347728|NCT02115815|527779289|FG006|Overall Study|Withdrawal by Subject|0|||
146347729|NCT02115815|527779283|FG000|Overall Study|Not enough drug to dose participant|0|||
146347730|NCT02115815|527779284|FG001|Overall Study|Not enough drug to dose participant|0|||
146347731|NCT02115815|527779285|FG002|Overall Study|Not enough drug to dose participant|0|||
146347732|NCT02115815|527779286|FG003|Overall Study|Not enough drug to dose participant|0|||
146347733|NCT02115815|527779287|FG004|Overall Study|Not enough drug to dose participant|0|||
146347734|NCT02115815|527779288|FG005|Overall Study|Not enough drug to dose participant|1|||
146347735|NCT02115815|527779289|FG006|Overall Study|Not enough drug to dose participant|0|||
146347736|NCT02115815|527779283|FG000|Overall Study|Missed appointment, randomized in error|0|||
146347737|NCT02115815|527779284|FG001|Overall Study|Missed appointment, randomized in error|0|||
146347738|NCT02115815|527779285|FG002|Overall Study|Missed appointment, randomized in error|0|||
146347739|NCT02115815|527779286|FG003|Overall Study|Missed appointment, randomized in error|0|||
146347740|NCT02115815|527779287|FG004|Overall Study|Missed appointment, randomized in error|0|||
146347741|NCT02115815|527779288|FG005|Overall Study|Missed appointment, randomized in error|1|||
146347742|NCT02115815|527779289|FG006|Overall Study|Missed appointment, randomized in error|0|||
146347743|NCT01989546|527779290|FG000|Overall Study|Clinical Progression|1|||
146347744|NCT01989546|527779290|FG000|Overall Study|Disease progression on study|8|||
146347745|NCT04439838|527779293|FG000|Overall Study|Withdrawal by Subject|0|||
146347746|NCT04439838|527779294|FG001|Overall Study|Withdrawal by Subject|0|||
146347747|NCT04439838|527779295|FG002|Overall Study|Withdrawal by Subject|0|||
146347748|NCT04439838|527779296|FG003|Overall Study|Withdrawal by Subject|0|||
146347749|NCT04439838|527779297|FG004|Overall Study|Withdrawal by Subject|0|||
146347750|NCT04439838|527779298|FG005|Overall Study|Withdrawal by Subject|0|||
145943385|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146169395|NCT01392300|527132801|FG001|Main Period (MP)|Lost to Follow-up|3|||
146347751|NCT04439838|527779299|FG006|Overall Study|Withdrawal by Subject|0|||
146347752|NCT04439838|527779300|FG007|Overall Study|Withdrawal by Subject|0|||
146347753|NCT04439838|527779301|FG008|Overall Study|Withdrawal by Subject|1|||
146347754|NCT02778867|527779302|FG000|Phase 1|Withdrawal by Subject|2|||
146347755|NCT02778867|527779303|FG001|Phase 1|Withdrawal by Subject|3|||
146347756|NCT02778867|527779304|FG002|Phase 1|Withdrawal by Subject|0|||
146347757|NCT02778867|527779305|FG003|Phase 1|Withdrawal by Subject|0|||
146347758|NCT02778867|527779302|FG000|Phase 2|Withdrawal by Subject|0|||
146347759|NCT02778867|527779303|FG001|Phase 2|Withdrawal by Subject|0|||
146347760|NCT02778867|527779304|FG002|Phase 2|Withdrawal by Subject|1|||
146347761|NCT02778867|527779305|FG003|Phase 2|Withdrawal by Subject|0|||
146347762|NCT02778867|527779302|FG000|Phase 2|Physician Decision|0|||
146347763|NCT02778867|527779303|FG001|Phase 2|Physician Decision|0|||
146347764|NCT02778867|527779304|FG002|Phase 2|Physician Decision|0|||
146347765|NCT02778867|527779305|FG003|Phase 2|Physician Decision|1|||
146347766|NCT02778867|527779302|FG000|Phase 2|Adverse Event|0|||
146347767|NCT02778867|527779303|FG001|Phase 2|Adverse Event|0|||
146347768|NCT02778867|527779304|FG002|Phase 2|Adverse Event|0|||
146347769|NCT02778867|527779305|FG003|Phase 2|Adverse Event|1|||
146347770|NCT00960440|527779307|FG000|Overall Study|Death|0|||
146347771|NCT00960440|527779308|FG001|Overall Study|Death|0|||
146347772|NCT00960440|527779309|FG002|Overall Study|Death|0|||
146347773|NCT00960440|527779310|FG003|Overall Study|Death|1|||
146347774|NCT00960440|527779307|FG000|Overall Study|Adverse Event|12|||
146347775|NCT00960440|527779308|FG001|Overall Study|Adverse Event|12|||
146347776|NCT00960440|527779309|FG002|Overall Study|Adverse Event|4|||
146347777|NCT00960440|527779310|FG003|Overall Study|Adverse Event|4|||
146347778|NCT00960440|527779307|FG000|Overall Study|Lack of Efficacy|2|||
146347779|NCT00960440|527779308|FG001|Overall Study|Lack of Efficacy|5|||
146347780|NCT00960440|527779309|FG002|Overall Study|Lack of Efficacy|3|||
146347781|NCT00960440|527779310|FG003|Overall Study|Lack of Efficacy|8|||
146347782|NCT00960440|527779307|FG000|Overall Study|Protocol Violation|2|||
146347783|NCT00960440|527779308|FG001|Overall Study|Protocol Violation|8|||
146347784|NCT00960440|527779309|FG002|Overall Study|Protocol Violation|3|||
146347785|NCT00960440|527779310|FG003|Overall Study|Protocol Violation|4|||
146347786|NCT00960440|527779307|FG000|Overall Study|Withdrawal by Subject|9|||
146347787|NCT00960440|527779308|FG001|Overall Study|Withdrawal by Subject|5|||
146347788|NCT00960440|527779309|FG002|Overall Study|Withdrawal by Subject|2|||
146347789|NCT00960440|527779310|FG003|Overall Study|Withdrawal by Subject|1|||
146347790|NCT00960440|527779307|FG000|Overall Study|Other|1|||
146347791|NCT00960440|527779308|FG001|Overall Study|Other|1|||
146347792|NCT00960440|527779309|FG002|Overall Study|Other|1|||
146347793|NCT00960440|527779310|FG003|Overall Study|Other|0|||
146347794|NCT03504774|527779311|FG000|Overall Study|Adverse Event|2|||
146347795|NCT03504774|527779312|FG001|Overall Study|Adverse Event|0|||
146347796|NCT03504774|527779311|FG000|Overall Study|Lost to Follow-up|0|||
146347797|NCT03504774|527779312|FG001|Overall Study|Lost to Follow-up|1|||
146347798|NCT03504774|527779311|FG000|Overall Study|Protocol Violation|11|||
146347799|NCT03504774|527779312|FG001|Overall Study|Protocol Violation|3|||
146347800|NCT03504774|527779311|FG000|Overall Study|failed wk 52 DBPCFC|1|||
146347801|NCT03504774|527779312|FG001|Overall Study|failed wk 52 DBPCFC|0|||
146347802|NCT01781429|527779313|FG000|Overall Study|Death|0|||
146347803|NCT01781429|527779314|FG001|Overall Study|Death|0|||
146347804|NCT01781429|527779315|FG002|Overall Study|Death|0|||
146347805|NCT01781429|527779316|FG003|Overall Study|Death|0|||
146347806|NCT01781429|527779317|FG004|Overall Study|Death|0|||
146347807|NCT01781429|527779318|FG005|Overall Study|Death|0|||
146347808|NCT01781429|527779319|FG006|Overall Study|Death|0|||
146347809|NCT01781429|527779320|FG007|Overall Study|Death|0|||
146347810|NCT01781429|527779321|FG008|Overall Study|Death|0|||
146347811|NCT01781429|527779322|FG009|Overall Study|Death|1|||
146347812|NCT01781429|527779323|FG010|Overall Study|Death|0|||
146347813|NCT01781429|527779324|FG011|Overall Study|Death|0|||
146347814|NCT01781429|527779325|FG012|Overall Study|Death|1|||
146347815|NCT01781429|527779326|FG013|Overall Study|Death|0|||
146347816|NCT01781429|527779327|FG014|Overall Study|Death|1|||
146169396|NCT01392300|527132802|FG002|Main Period (MP)|Lost to Follow-up|0|||
146347817|NCT01781429|527779328|FG015|Overall Study|Death|0|||
146347818|NCT01781429|527779313|FG000|Overall Study|Withdrawal by Subject|0|||
146347819|NCT01781429|527779314|FG001|Overall Study|Withdrawal by Subject|0|||
146347820|NCT01781429|527779315|FG002|Overall Study|Withdrawal by Subject|0|||
146347821|NCT01781429|527779316|FG003|Overall Study|Withdrawal by Subject|0|||
146347822|NCT01781429|527779317|FG004|Overall Study|Withdrawal by Subject|0|||
146347823|NCT01781429|527779318|FG005|Overall Study|Withdrawal by Subject|0|||
146347824|NCT01781429|527779319|FG006|Overall Study|Withdrawal by Subject|0|||
146347825|NCT01781429|527779320|FG007|Overall Study|Withdrawal by Subject|0|||
146347826|NCT01781429|527779321|FG008|Overall Study|Withdrawal by Subject|1|||
146347827|NCT01781429|527779322|FG009|Overall Study|Withdrawal by Subject|3|||
146347828|NCT01781429|527779323|FG010|Overall Study|Withdrawal by Subject|1|||
146347829|NCT01781429|527779324|FG011|Overall Study|Withdrawal by Subject|1|||
146347830|NCT01781429|527779325|FG012|Overall Study|Withdrawal by Subject|5|||
146347831|NCT01781429|527779326|FG013|Overall Study|Withdrawal by Subject|2|||
146347832|NCT01781429|527779327|FG014|Overall Study|Withdrawal by Subject|3|||
146347833|NCT01781429|527779328|FG015|Overall Study|Withdrawal by Subject|0|||
146347834|NCT01781429|527779313|FG000|Overall Study|Disease Progression|1|||
146347835|NCT01781429|527779314|FG001|Overall Study|Disease Progression|0|||
146347836|NCT01781429|527779315|FG002|Overall Study|Disease Progression|1|||
146347837|NCT01781429|527779316|FG003|Overall Study|Disease Progression|1|||
146347838|NCT01781429|527779317|FG004|Overall Study|Disease Progression|1|||
146347839|NCT01781429|527779318|FG005|Overall Study|Disease Progression|4|||
146347840|NCT01781429|527779319|FG006|Overall Study|Disease Progression|7|||
146347841|NCT01781429|527779320|FG007|Overall Study|Disease Progression|4|||
146347842|NCT01781429|527779321|FG008|Overall Study|Disease Progression|6|||
146347843|NCT01781429|527779322|FG009|Overall Study|Disease Progression|15|||
146347844|NCT01781429|527779323|FG010|Overall Study|Disease Progression|15|||
146347845|NCT01781429|527779324|FG011|Overall Study|Disease Progression|15|||
146347846|NCT01781429|527779325|FG012|Overall Study|Disease Progression|15|||
146347847|NCT01781429|527779326|FG013|Overall Study|Disease Progression|4|||
146347848|NCT01781429|527779327|FG014|Overall Study|Disease Progression|11|||
146347849|NCT01781429|527779328|FG015|Overall Study|Disease Progression|0|||
146347850|NCT01781429|527779313|FG000|Overall Study|Unacceptable Toxicity|0|||
146347851|NCT01781429|527779314|FG001|Overall Study|Unacceptable Toxicity|0|||
146347852|NCT01781429|527779315|FG002|Overall Study|Unacceptable Toxicity|0|||
146347853|NCT01781429|527779316|FG003|Overall Study|Unacceptable Toxicity|0|||
146347854|NCT01781429|527779317|FG004|Overall Study|Unacceptable Toxicity|0|||
146347855|NCT01781429|527779318|FG005|Overall Study|Unacceptable Toxicity|0|||
146347856|NCT01781429|527779319|FG006|Overall Study|Unacceptable Toxicity|0|||
146347857|NCT01781429|527779320|FG007|Overall Study|Unacceptable Toxicity|0|||
146347858|NCT01781429|527779321|FG008|Overall Study|Unacceptable Toxicity|0|||
146347859|NCT01781429|527779322|FG009|Overall Study|Unacceptable Toxicity|0|||
146347860|NCT01781429|527779323|FG010|Overall Study|Unacceptable Toxicity|0|||
146347861|NCT01781429|527779324|FG011|Overall Study|Unacceptable Toxicity|2|||
146347862|NCT01781429|527779325|FG012|Overall Study|Unacceptable Toxicity|0|||
146347863|NCT01781429|527779326|FG013|Overall Study|Unacceptable Toxicity|0|||
146347864|NCT01781429|527779327|FG014|Overall Study|Unacceptable Toxicity|0|||
146347865|NCT01781429|527779328|FG015|Overall Study|Unacceptable Toxicity|0|||
146347866|NCT01781429|527779313|FG000|Overall Study|Patient Condition Changed|0|||
146347867|NCT01781429|527779314|FG001|Overall Study|Patient Condition Changed|0|||
146347868|NCT01781429|527779315|FG002|Overall Study|Patient Condition Changed|0|||
146347869|NCT01781429|527779316|FG003|Overall Study|Patient Condition Changed|0|||
146347870|NCT01781429|527779317|FG004|Overall Study|Patient Condition Changed|0|||
146347871|NCT01781429|527779318|FG005|Overall Study|Patient Condition Changed|0|||
146347872|NCT01781429|527779319|FG006|Overall Study|Patient Condition Changed|0|||
146347873|NCT01781429|527779320|FG007|Overall Study|Patient Condition Changed|0|||
146347874|NCT01781429|527779321|FG008|Overall Study|Patient Condition Changed|0|||
146347875|NCT01781429|527779322|FG009|Overall Study|Patient Condition Changed|4|||
146347876|NCT01781429|527779323|FG010|Overall Study|Patient Condition Changed|0|||
146347877|NCT01781429|527779324|FG011|Overall Study|Patient Condition Changed|1|||
146347878|NCT01781429|527779325|FG012|Overall Study|Patient Condition Changed|0|||
146347879|NCT01781429|527779326|FG013|Overall Study|Patient Condition Changed|1|||
146347880|NCT01781429|527779327|FG014|Overall Study|Patient Condition Changed|0|||
146347881|NCT01781429|527779328|FG015|Overall Study|Patient Condition Changed|0|||
146347882|NCT01781429|527779313|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
146347883|NCT01781429|527779314|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
146347884|NCT01781429|527779315|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
146347885|NCT01781429|527779316|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
146347886|NCT01781429|527779317|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
146347887|NCT01781429|527779318|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
146347888|NCT01781429|527779319|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
146347889|NCT01781429|527779320|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
146347890|NCT01781429|527779321|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
146347891|NCT01781429|527779322|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
146347892|NCT01781429|527779323|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
146347893|NCT01781429|527779324|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
146347894|NCT01781429|527779325|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
146347895|NCT01781429|527779326|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
146347896|NCT01781429|527779327|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
146347897|NCT01781429|527779328|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
146347898|NCT01781429|527779313|FG000|Overall Study|Enrolled, but not treated|0|||
146347899|NCT01781429|527779314|FG001|Overall Study|Enrolled, but not treated|0|||
146347900|NCT01781429|527779315|FG002|Overall Study|Enrolled, but not treated|0|||
146347901|NCT01781429|527779316|FG003|Overall Study|Enrolled, but not treated|0|||
146347902|NCT01781429|527779317|FG004|Overall Study|Enrolled, but not treated|0|||
146347903|NCT01781429|527779318|FG005|Overall Study|Enrolled, but not treated|0|||
146347904|NCT01781429|527779319|FG006|Overall Study|Enrolled, but not treated|0|||
146347905|NCT01781429|527779320|FG007|Overall Study|Enrolled, but not treated|0|||
146347906|NCT01781429|527779321|FG008|Overall Study|Enrolled, but not treated|0|||
146347907|NCT01781429|527779322|FG009|Overall Study|Enrolled, but not treated|0|||
146347908|NCT01781429|527779323|FG010|Overall Study|Enrolled, but not treated|1|||
146347909|NCT01781429|527779324|FG011|Overall Study|Enrolled, but not treated|0|||
146347910|NCT01781429|527779325|FG012|Overall Study|Enrolled, but not treated|0|||
146347911|NCT01781429|527779326|FG013|Overall Study|Enrolled, but not treated|0|||
146347912|NCT01781429|527779327|FG014|Overall Study|Enrolled, but not treated|0|||
146347913|NCT01781429|527779328|FG015|Overall Study|Enrolled, but not treated|0|||
146347914|NCT01312428|527779331|FG000|Overall Study|Study Termination|3|||
146347915|NCT01312428|527779332|FG001|Overall Study|Study Termination|4|||
146347916|NCT02214186|527779339|FG000|Overall Study|Lost to Follow-up|1|||
146347917|NCT02214186|527779340|FG001|Overall Study|Lost to Follow-up|1|||
146347918|NCT02214186|527779339|FG000|Overall Study|Protocol Violation|1|||
146347919|NCT02214186|527779340|FG001|Overall Study|Protocol Violation|1|||
146347920|NCT01525849|527779341|FG000|Overall Study|Lost to Follow-up|3|||
146347921|NCT01525849|527779342|FG001|Overall Study|Lost to Follow-up|2|||
146347922|NCT01525849|527779341|FG000|Overall Study|Withdrawal by Subject|1|||
146347923|NCT01525849|527779342|FG001|Overall Study|Withdrawal by Subject|9|||
146347924|NCT01525849|527779341|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
146347925|NCT01525849|527779342|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
146347926|NCT01525849|527779341|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
146347927|NCT01525849|527779342|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
146347928|NCT01469013|527779343|FG000|Part A (Treatment Period)|Adverse Event|1|||
146347929|NCT01469013|527779344|FG001|Part A (Treatment Period)|Adverse Event|0|||
146347930|NCT01469013|527779345|FG002|Part A (Treatment Period)|Adverse Event|0|||
146347931|NCT01469013|527779346|FG003|Part A (Treatment Period)|Adverse Event|0|||
146347932|NCT01469013|527779347|FG004|Part A (Treatment Period)|Adverse Event|1|||
146347933|NCT01469013|527779348|FG005|Part A (Treatment Period)|Adverse Event|0|||
146347934|NCT01469013|527779349|FG006|Part A (Treatment Period)|Adverse Event|0|||
146347935|NCT01469013|527779350|FG007|Part A (Treatment Period)|Adverse Event|0|||
146347936|NCT01469013|527779351|FG008|Part A (Treatment Period)|Adverse Event|0|||
146347937|NCT01469013|527779352|FG009|Part A (Treatment Period)|Adverse Event|0|||
146347938|NCT01469013|527779353|FG010|Part A (Treatment Period)|Adverse Event|0|||
146347939|NCT01469013|527779354|FG011|Part A (Treatment Period)|Adverse Event|0|||
146347940|NCT01469013|527779355|FG012|Part A (Treatment Period)|Adverse Event|0|||
146347941|NCT01469013|527779343|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347942|NCT01469013|527779344|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347943|NCT01469013|527779345|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
146347944|NCT01469013|527779346|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347945|NCT01469013|527779347|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347946|NCT01469013|527779348|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347947|NCT01469013|527779349|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347948|NCT01469013|527779350|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347949|NCT01469013|527779351|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347950|NCT01469013|527779352|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347951|NCT01469013|527779353|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347952|NCT01469013|527779354|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347953|NCT01469013|527779355|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
146347954|NCT01469013|527779343|FG000|Part B (Extension Period)|Adverse Event|0|||
146347955|NCT01469013|527779344|FG001|Part B (Extension Period)|Adverse Event|0|||
146347956|NCT01469013|527779345|FG002|Part B (Extension Period)|Adverse Event|0|||
146347957|NCT01469013|527779346|FG003|Part B (Extension Period)|Adverse Event|0|||
146347958|NCT01469013|527779347|FG004|Part B (Extension Period)|Adverse Event|0|||
146347959|NCT01469013|527779348|FG005|Part B (Extension Period)|Adverse Event|2|||
146347960|NCT01469013|527779349|FG006|Part B (Extension Period)|Adverse Event|5|||
146347961|NCT01469013|527779350|FG007|Part B (Extension Period)|Adverse Event|5|||
146347962|NCT01469013|527779351|FG008|Part B (Extension Period)|Adverse Event|3|||
146347963|NCT01469013|527779352|FG009|Part B (Extension Period)|Adverse Event|3|||
146347964|NCT01469013|527779353|FG010|Part B (Extension Period)|Adverse Event|1|||
146347965|NCT01469013|527779354|FG011|Part B (Extension Period)|Adverse Event|6|||
146347966|NCT01469013|527779355|FG012|Part B (Extension Period)|Adverse Event|3|||
146347967|NCT01469013|527779343|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
146347968|NCT01469013|527779344|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
146347969|NCT01469013|527779345|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
146347970|NCT01469013|527779346|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
146347971|NCT01469013|527779347|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
146347972|NCT01469013|527779348|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
146347973|NCT01469013|527779349|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
146347974|NCT01469013|527779350|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
146347975|NCT01469013|527779351|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
146347976|NCT01469013|527779352|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
146347977|NCT01469013|527779353|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
146347978|NCT01469013|527779354|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
146347979|NCT01469013|527779355|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
146347980|NCT00339183|527779356|FG000|Overall Study|Adverse Event|5|||
146347981|NCT00339183|527779357|FG001|Overall Study|Adverse Event|3|||
146347982|NCT00339183|527779356|FG000|Overall Study|Withdrawal by Subject|16|||
146347983|NCT00339183|527779357|FG001|Overall Study|Withdrawal by Subject|19|||
146347984|NCT00339183|527779356|FG000|Overall Study|Physician Decision|2|||
146347985|NCT00339183|527779357|FG001|Overall Study|Physician Decision|4|||
146347986|NCT00339183|527779356|FG000|Overall Study|Lost to Follow-up|17|||
146347987|NCT00339183|527779357|FG001|Overall Study|Lost to Follow-up|17|||
146347988|NCT00339183|527779356|FG000|Overall Study|Protocol-specified criteria|12|||
146347989|NCT00339183|527779357|FG001|Overall Study|Protocol-specified criteria|8|||
146347990|NCT00339183|527779356|FG000|Overall Study|Missing reason|3|||
146347991|NCT00339183|527779357|FG001|Overall Study|Missing reason|1|||
146347992|NCT00339183|527779356|FG000|Overall Study|Other|46|||
146347993|NCT00339183|527779357|FG001|Overall Study|Other|40|||
146347994|NCT00339183|527779356|FG000|Overall Study|Ongoing|20|||
146347995|NCT00339183|527779357|FG001|Overall Study|Ongoing|13|||
146347996|NCT00446446|527779360|FG000|Overall Study|Death|10|||
146347997|NCT00446446|527779360|FG000|Overall Study|Withdrawal by Subject|6|||
146347998|NCT00446446|527779360|FG000|Overall Study|Other|4|||
146347999|NCT00446446|527779360|FG000|Overall Study|Disease Progession|2|||
146348000|NCT00446446|527779360|FG000|Overall Study|Adverse Event|1|||
146348001|NCT00446446|527779360|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
146348002|NCT00611130|527779365|FG000|Overall Study|Lost to Follow-up|25|||
146348003|NCT00611130|527779366|FG001|Overall Study|Lost to Follow-up|29|||
146348004|NCT00611130|527779365|FG000|Overall Study|Protocol noncompliance|7|||
146348005|NCT00611130|527779366|FG001|Overall Study|Protocol noncompliance|6|||
146348006|NCT00611130|527779365|FG000|Overall Study|Withdrawal by Subject|6|||
146348007|NCT00611130|527779366|FG001|Overall Study|Withdrawal by Subject|5|||
146348008|NCT00611130|527779365|FG000|Overall Study|Other|5|||
146348009|NCT00611130|527779366|FG001|Overall Study|Other|4|||
146348010|NCT00611130|527779365|FG000|Overall Study|Incarceration|3|||
146348011|NCT00611130|527779366|FG001|Overall Study|Incarceration|2|||
146348012|NCT00611130|527779365|FG000|Overall Study|Administrative|1|||
146348013|NCT00611130|527779366|FG001|Overall Study|Administrative|1|||
146348014|NCT00611130|527779365|FG000|Overall Study|Adverse Event|1|||
146348015|NCT00611130|527779366|FG001|Overall Study|Adverse Event|0|||
146348016|NCT00611130|527779365|FG000|Overall Study|Death|1|||
146348017|NCT00611130|527779366|FG001|Overall Study|Death|0|||
146348018|NCT03662334|527779368|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
146348019|NCT03662334|527779369|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
146348020|NCT01024465|527779378|FG000|Overall Study|Adverse Event|2|||
146348021|NCT01024465|527779378|FG000|Overall Study|Physician Decision|1|||
146348022|NCT01734993|527779379|FG000|Overall Study|Adverse Event|1|||
146348023|NCT01734993|527779379|FG000|Overall Study|Lack of Efficacy|1|||
146348024|NCT03078608|527779380|FG000|Overall Study|Death|1|||
146348025|NCT03078608|527779381|FG001|Overall Study|Death|2|||
146348026|NCT03078608|527779382|FG002|Overall Study|Death|0|||
146348027|NCT03078608|527779383|FG003|Overall Study|Death|0|||
146348028|NCT03078608|527779380|FG000|Overall Study|Withdrawal by Subject|8|||
146348029|NCT03078608|527779381|FG001|Overall Study|Withdrawal by Subject|1|||
146348030|NCT03078608|527779382|FG002|Overall Study|Withdrawal by Subject|0|||
146348031|NCT03078608|527779383|FG003|Overall Study|Withdrawal by Subject|0|||
146348032|NCT03078608|527779380|FG000|Overall Study|Lost to Follow-up|5|||
146348033|NCT03078608|527779381|FG001|Overall Study|Lost to Follow-up|8|||
146348034|NCT03078608|527779382|FG002|Overall Study|Lost to Follow-up|4|||
146348035|NCT03078608|527779383|FG003|Overall Study|Lost to Follow-up|1|||
146348036|NCT03303339|527779384|FG000|Overall Study|Death|2|||
146348037|NCT03303339|527779385|FG001|Overall Study|Death|2|||
146348038|NCT03303339|527779386|FG002|Overall Study|Death|2|||
146348039|NCT03303339|527779387|FG003|Overall Study|Death|1|||
146348040|NCT03303339|527779388|FG004|Overall Study|Death|4|||
146348041|NCT03303339|527779389|FG005|Overall Study|Death|2|||
146348042|NCT03303339|527779390|FG006|Overall Study|Death|2|||
146169397|NCT01392300|527132800|FG000|Main Period (MP)|Non-compliance|1|||
146169398|NCT01392300|527132801|FG001|Main Period (MP)|Non-compliance|0|||
146169399|NCT01392300|527132802|FG002|Main Period (MP)|Non-compliance|0|||
146348043|NCT03303339|527779391|FG007|Overall Study|Death|2|||
146348044|NCT03303339|527779392|FG008|Overall Study|Death|3|||
146348045|NCT03303339|527779393|FG009|Overall Study|Death|3|||
146348046|NCT03303339|527779394|FG010|Overall Study|Death|4|||
146348047|NCT03303339|527779395|FG011|Overall Study|Death|24|||
146348048|NCT03303339|527779384|FG000|Overall Study|Study Terminated by Sponsor|0|||
146348049|NCT03303339|527779385|FG001|Overall Study|Study Terminated by Sponsor|0|||
146348050|NCT03303339|527779386|FG002|Overall Study|Study Terminated by Sponsor|0|||
146348051|NCT03303339|527779387|FG003|Overall Study|Study Terminated by Sponsor|0|||
146348052|NCT03303339|527779388|FG004|Overall Study|Study Terminated by Sponsor|0|||
146348053|NCT03303339|527779389|FG005|Overall Study|Study Terminated by Sponsor|0|||
146348054|NCT03303339|527779390|FG006|Overall Study|Study Terminated by Sponsor|0|||
146348055|NCT03303339|527779391|FG007|Overall Study|Study Terminated by Sponsor|0|||
146348056|NCT03303339|527779392|FG008|Overall Study|Study Terminated by Sponsor|1|||
146348057|NCT03303339|527779393|FG009|Overall Study|Study Terminated by Sponsor|0|||
146348058|NCT03303339|527779394|FG010|Overall Study|Study Terminated by Sponsor|1|||
146348059|NCT03303339|527779395|FG011|Overall Study|Study Terminated by Sponsor|1|||
146348060|NCT03303339|527779384|FG000|Overall Study|Withdrawal by Subject|1|||
146348061|NCT03303339|527779385|FG001|Overall Study|Withdrawal by Subject|0|||
146169400|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
146169401|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
146169402|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
146169403|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
146169404|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
146169405|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
146169406|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
146169407|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
146169408|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
146169409|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Death|0|||
146169410|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Death|0|||
146169411|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Death|4|||
146169412|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
146169413|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
146169414|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
146169415|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
146169416|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
146169417|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
146169418|NCT01392300|527132800|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
146348062|NCT03303339|527779386|FG002|Overall Study|Withdrawal by Subject|0|||
146169419|NCT01392300|527132801|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
146348063|NCT03303339|527779387|FG003|Overall Study|Withdrawal by Subject|0|||
146348064|NCT03303339|527779388|FG004|Overall Study|Withdrawal by Subject|0|||
146348065|NCT03303339|527779389|FG005|Overall Study|Withdrawal by Subject|1|||
146348066|NCT03303339|527779390|FG006|Overall Study|Withdrawal by Subject|1|||
146348067|NCT03303339|527779391|FG007|Overall Study|Withdrawal by Subject|0|||
146348068|NCT03303339|527779392|FG008|Overall Study|Withdrawal by Subject|0|||
146348069|NCT03303339|527779393|FG009|Overall Study|Withdrawal by Subject|0|||
146348070|NCT03303339|527779394|FG010|Overall Study|Withdrawal by Subject|0|||
146348071|NCT03303339|527779395|FG011|Overall Study|Withdrawal by Subject|2|||
146348072|NCT03303339|527779384|FG000|Overall Study|Physician Decision|0|||
146348073|NCT03303339|527779385|FG001|Overall Study|Physician Decision|0|||
146348074|NCT03303339|527779386|FG002|Overall Study|Physician Decision|0|||
146348075|NCT03303339|527779387|FG003|Overall Study|Physician Decision|0|||
146348076|NCT03303339|527779388|FG004|Overall Study|Physician Decision|1|||
146348077|NCT03303339|527779389|FG005|Overall Study|Physician Decision|0|||
146348078|NCT03303339|527779390|FG006|Overall Study|Physician Decision|0|||
146348079|NCT03303339|527779391|FG007|Overall Study|Physician Decision|0|||
146348080|NCT03303339|527779392|FG008|Overall Study|Physician Decision|0|||
146348081|NCT03303339|527779393|FG009|Overall Study|Physician Decision|0|||
146348082|NCT03303339|527779394|FG010|Overall Study|Physician Decision|0|||
146348083|NCT03303339|527779395|FG011|Overall Study|Physician Decision|0|||
146348084|NCT03303339|527779384|FG000|Overall Study|Safety/Non-compliance|0|||
146348085|NCT03303339|527779385|FG001|Overall Study|Safety/Non-compliance|0|||
146348086|NCT03303339|527779386|FG002|Overall Study|Safety/Non-compliance|0|||
146348087|NCT03303339|527779387|FG003|Overall Study|Safety/Non-compliance|0|||
146348088|NCT03303339|527779388|FG004|Overall Study|Safety/Non-compliance|0|||
146348089|NCT03303339|527779389|FG005|Overall Study|Safety/Non-compliance|0|||
146348090|NCT03303339|527779390|FG006|Overall Study|Safety/Non-compliance|0|||
146348091|NCT03303339|527779391|FG007|Overall Study|Safety/Non-compliance|0|||
146348092|NCT03303339|527779392|FG008|Overall Study|Safety/Non-compliance|0|||
146348093|NCT03303339|527779393|FG009|Overall Study|Safety/Non-compliance|0|||
146348094|NCT03303339|527779394|FG010|Overall Study|Safety/Non-compliance|0|||
146348095|NCT03303339|527779395|FG011|Overall Study|Safety/Non-compliance|1|||
146348096|NCT01400971|527779398|FG000|Overall Study|Death|82|||
146348097|NCT01400971|527779398|FG000|Overall Study|Lost to Follow-up|196|||
146169420|NCT01392300|527132802|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
146169421|NCT05056870|527132807|FG000|Period 1|Site COVID-19 Related|3|||
146169422|NCT05056870|527132808|FG001|Period 1|Site COVID-19 Related|3|||
146169423|NCT05056870|527132807|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
146169424|NCT05056870|527132808|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
146348098|NCT01400971|527779398|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
146348099|NCT01400971|527779398|FG000|Overall Study|Physician Decision|57|||
146348100|NCT01400971|527779398|FG000|Overall Study|Withdrawal by Subject|158|||
146348101|NCT01400971|527779398|FG000|Overall Study|Other|422|||
146348102|NCT01879618|527779399|FG000|Overall Study|Does not meet entrance criteria|1|||
146348103|NCT01879618|527779399|FG000|Overall Study|Withdrawal by Subject|1|||
146348104|NCT01879618|527779399|FG000|Overall Study|Surgery;changed schedule; not available|8|||
146348105|NCT01879618|527779399|FG000|Overall Study|Protocol Violation|6|||
146348106|NCT01879618|527779399|FG000|Overall Study|Adverse Event|5|||
146348109|NCT00864227|527779402|FG000|Overall Study|Withdrawal by Subject|1|||
146348110|NCT00864227|527779402|FG000|Overall Study|Disease Relapse/Progression|3|||
146348111|NCT03241173|527779403|FG000|Overall Study|Death|3|||
146348112|NCT03241173|527779404|FG001|Overall Study|Death|2|||
146348113|NCT03241173|527779405|FG002|Overall Study|Death|4|||
146348114|NCT03241173|527779406|FG003|Overall Study|Death|4|||
146348115|NCT03241173|527779407|FG004|Overall Study|Death|2|||
146348116|NCT03241173|527779408|FG005|Overall Study|Death|2|||
146348117|NCT03241173|527779409|FG006|Overall Study|Death|3|||
146348118|NCT03241173|527779410|FG007|Overall Study|Death|1|||
146348119|NCT03241173|527779411|FG008|Overall Study|Death|0|||
146348120|NCT03241173|527779412|FG009|Overall Study|Death|5|||
146348121|NCT03241173|527779413|FG010|Overall Study|Death|4|||
146348122|NCT03241173|527779414|FG011|Overall Study|Death|3|||
146348123|NCT03241173|527779415|FG012|Overall Study|Death|0|||
146348124|NCT03241173|527779416|FG013|Overall Study|Death|0|||
146348125|NCT03241173|527779417|FG014|Overall Study|Death|0|||
146348126|NCT03241173|527779403|FG000|Overall Study|Withdrawal by Subject|0|||
146348127|NCT03241173|527779404|FG001|Overall Study|Withdrawal by Subject|0|||
146348128|NCT03241173|527779405|FG002|Overall Study|Withdrawal by Subject|1|||
146348129|NCT03241173|527779406|FG003|Overall Study|Withdrawal by Subject|0|||
146348130|NCT03241173|527779407|FG004|Overall Study|Withdrawal by Subject|0|||
146348131|NCT03241173|527779408|FG005|Overall Study|Withdrawal by Subject|1|||
146348132|NCT03241173|527779409|FG006|Overall Study|Withdrawal by Subject|0|||
146348133|NCT03241173|527779410|FG007|Overall Study|Withdrawal by Subject|0|||
146348134|NCT03241173|527779411|FG008|Overall Study|Withdrawal by Subject|0|||
146348135|NCT03241173|527779412|FG009|Overall Study|Withdrawal by Subject|0|||
146348136|NCT03241173|527779413|FG010|Overall Study|Withdrawal by Subject|0|||
146348137|NCT03241173|527779414|FG011|Overall Study|Withdrawal by Subject|0|||
146348138|NCT03241173|527779415|FG012|Overall Study|Withdrawal by Subject|0|||
146348139|NCT03241173|527779416|FG013|Overall Study|Withdrawal by Subject|0|||
146348140|NCT03241173|527779417|FG014|Overall Study|Withdrawal by Subject|0|||
146348141|NCT03241173|527779403|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146348142|NCT03241173|527779404|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146348143|NCT03241173|527779405|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348144|NCT03241173|527779406|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146348145|NCT03241173|527779407|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146348146|NCT03241173|527779408|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146348147|NCT03241173|527779409|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
146348148|NCT03241173|527779410|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146348149|NCT03241173|527779411|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348150|NCT03241173|527779412|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348151|NCT03241173|527779413|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
146348152|NCT03241173|527779414|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
146348153|NCT03241173|527779415|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348154|NCT03241173|527779416|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348155|NCT03241173|527779417|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
146348156|NCT03241173|527779403|FG000|Overall Study|Lost to Follow-up|0|||
146348157|NCT03241173|527779404|FG001|Overall Study|Lost to Follow-up|0|||
146348158|NCT03241173|527779405|FG002|Overall Study|Lost to Follow-up|0|||
146348159|NCT03241173|527779406|FG003|Overall Study|Lost to Follow-up|0|||
146348160|NCT03241173|527779407|FG004|Overall Study|Lost to Follow-up|1|||
146348161|NCT03241173|527779408|FG005|Overall Study|Lost to Follow-up|0|||
146348162|NCT03241173|527779409|FG006|Overall Study|Lost to Follow-up|0|||
146348163|NCT03241173|527779410|FG007|Overall Study|Lost to Follow-up|0|||
146348164|NCT03241173|527779411|FG008|Overall Study|Lost to Follow-up|0|||
146348165|NCT03241173|527779412|FG009|Overall Study|Lost to Follow-up|1|||
146169425|NCT05056870|527132807|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
146169426|NCT05056870|527132808|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
146169427|NCT05056870|527132807|FG000|Period 2|COVID-19 Related|1|||
146169428|NCT05056870|527132808|FG001|Period 2|COVID-19 Related|0|||
146348166|NCT03241173|527779413|FG010|Overall Study|Lost to Follow-up|0|||
146348167|NCT03241173|527779414|FG011|Overall Study|Lost to Follow-up|0|||
146348168|NCT03241173|527779415|FG012|Overall Study|Lost to Follow-up|0|||
146348169|NCT03241173|527779416|FG013|Overall Study|Lost to Follow-up|0|||
146348170|NCT03241173|527779417|FG014|Overall Study|Lost to Follow-up|0|||
146348171|NCT03634072|527779418|FG000|Overall Study|Early termination of overall study|1|||
146348172|NCT03634072|527779419|FG001|Overall Study|Early termination of overall study|0|||
146348173|NCT01765764|527779420|FG000|Treatment Period|Adverse Event|1|||
146348174|NCT01765764|527779421|FG001|Treatment Period|Adverse Event|2|||
146348175|NCT01765764|527779422|FG002|Treatment Period|Adverse Event|1|||
146348176|NCT01765764|527779420|FG000|Treatment Period|Lost to Follow-up|0|||
146348177|NCT01765764|527779421|FG001|Treatment Period|Lost to Follow-up|3|||
146348178|NCT01765764|527779422|FG002|Treatment Period|Lost to Follow-up|2|||
146348179|NCT01765764|527779420|FG000|Treatment Period|Personal Reasons|1|||
146348180|NCT01765764|527779421|FG001|Treatment Period|Personal Reasons|2|||
146348181|NCT01765764|527779422|FG002|Treatment Period|Personal Reasons|1|||
146348182|NCT01765764|527779420|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
146348183|NCT01765764|527779421|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
146348184|NCT01765764|527779422|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
146348185|NCT01558089|527779425|FG000|Overall Study|Adverse Event|1|||
146348186|NCT01558089|527779425|FG000|Overall Study|Lack of Efficacy|1|||
146348187|NCT01558089|527779425|FG000|Overall Study|Lost to Follow-up|5|||
146348188|NCT01558089|527779425|FG000|Overall Study|Withdrawal by Subject|6|||
146348189|NCT02144220|527779426|FG000|Overall Study|technology incompatibility|9|||
146348190|NCT02144220|527779426|FG000|Overall Study|Lack of Efficacy|4|||
146348191|NCT02144220|527779426|FG000|Overall Study|Physician Decision|3|||
146348192|NCT02144220|527779426|FG000|Overall Study|Withdrawal by Subject|2|||
146348193|NCT02144220|527779426|FG000|Overall Study|Protocol Violation|1|||
146348194|NCT01952015|527779429|FG000|Induction|Protocol Violation|1|||
146348195|NCT01952015|527779429|FG000|Maintenance|Adverse Event|2|||
146348196|NCT01952015|527779429|FG000|Treatment Period 3|Physician Decision|9|||
146348197|NCT03184701|527779431|FG000|Overall Study|Death|3|||
146348198|NCT03184701|527779431|FG000|Overall Study|Physician Decision|3|||
146348199|NCT03184701|527779431|FG000|Overall Study|Withdrawal by Subject|6|||
146348200|NCT03184701|527779431|FG000|Overall Study|Lost to Follow-up|5|||
146348201|NCT03242759|527779434|FG000|Overall Study|Adverse Event|5|||
146348202|NCT03242759|527779435|FG001|Overall Study|Adverse Event|1|||
146348203|NCT03242759|527779434|FG000|Overall Study|Withdrawal by Subject|4|||
146348204|NCT03242759|527779435|FG001|Overall Study|Withdrawal by Subject|3|||
146348205|NCT03242759|527779434|FG000|Overall Study|Lost to Follow-up|3|||
146348206|NCT03242759|527779435|FG001|Overall Study|Lost to Follow-up|1|||
146348207|NCT03242759|527779434|FG000|Overall Study|Administrative problems|1|||
146348208|NCT03242759|527779435|FG001|Overall Study|Administrative problems|1|||
146348209|NCT03242759|527779434|FG000|Overall Study|Death|22|||
146348210|NCT03242759|527779435|FG001|Overall Study|Death|0|||
146348211|NCT03242759|527779434|FG000|Overall Study|Change visit schedule|0|||
146348212|NCT03242759|527779435|FG001|Overall Study|Change visit schedule|1|||
146348213|NCT00651118|527779440|FG000|Overall Study|Adverse Event|4|||
146348214|NCT00651118|527779441|FG001|Overall Study|Adverse Event|0|||
146348215|NCT00651118|527779442|FG002|Overall Study|Adverse Event|1|||
146348216|NCT00651118|527779443|FG003|Overall Study|Adverse Event|1|||
146348217|NCT00651118|527779440|FG000|Overall Study|Protocol Violation|2|||
146348218|NCT00651118|527779441|FG001|Overall Study|Protocol Violation|2|||
146348219|NCT00651118|527779442|FG002|Overall Study|Protocol Violation|6|||
146348220|NCT00651118|527779443|FG003|Overall Study|Protocol Violation|2|||
146348221|NCT00651118|527779440|FG000|Overall Study|Lost to Follow-up|2|||
146348222|NCT00651118|527779441|FG001|Overall Study|Lost to Follow-up|0|||
146348223|NCT00651118|527779442|FG002|Overall Study|Lost to Follow-up|1|||
146348224|NCT00651118|527779443|FG003|Overall Study|Lost to Follow-up|2|||
146348225|NCT00651118|527779440|FG000|Overall Study|administrative|1|||
146348226|NCT00651118|527779441|FG001|Overall Study|administrative|4|||
146348227|NCT00651118|527779442|FG002|Overall Study|administrative|2|||
146348228|NCT00651118|527779443|FG003|Overall Study|administrative|1|||
146348229|NCT00651118|527779440|FG000|Overall Study|Withdrawal by Subject|0|||
146348230|NCT00651118|527779441|FG001|Overall Study|Withdrawal by Subject|1|||
146348231|NCT00651118|527779442|FG002|Overall Study|Withdrawal by Subject|1|||
146348232|NCT00651118|527779443|FG003|Overall Study|Withdrawal by Subject|1|||
146348233|NCT00798967|527779446|FG000|Overall Study|Adverse Event|2|||
146348234|NCT00798967|527779447|FG001|Overall Study|Adverse Event|3|||
146348235|NCT00798967|527779446|FG000|Overall Study|Withdrawal by Subject|0|||
146348236|NCT00798967|527779447|FG001|Overall Study|Withdrawal by Subject|1|||
146348237|NCT00798967|527779446|FG000|Overall Study|Physician Decision|1|||
146348238|NCT00798967|527779447|FG001|Overall Study|Physician Decision|0|||
146348239|NCT00798967|527779446|FG000|Overall Study|Randomized in error by site|1|||
146348240|NCT00798967|527779447|FG001|Overall Study|Randomized in error by site|0|||
146348241|NCT00227877|527779450|FG000|Pre-visit Assessment|Technical difficulties|7|||
146348242|NCT00227877|527779451|FG001|Pre-visit Assessment|Technical difficulties|3|||
146348243|NCT00227877|527779452|FG002|Pre-visit Assessment|Technical difficulties|0|||
146348244|NCT00227877|527779453|FG003|Pre-visit Assessment|Technical difficulties|0|||
146348245|NCT00227877|527779450|FG000|Post-visit Checklist|Lost to Follow-up|24|||
146348246|NCT00227877|527779451|FG001|Post-visit Checklist|Lost to Follow-up|13|||
146348247|NCT00227877|527779452|FG002|Post-visit Checklist|Lost to Follow-up|1|||
146348248|NCT00227877|527779453|FG003|Post-visit Checklist|Lost to Follow-up|0|||
146348249|NCT00227877|527779450|FG000|3-months Follow-up|Completed late|135|||
146348250|NCT00227877|527779451|FG001|3-months Follow-up|Completed late|128|||
146348251|NCT00227877|527779452|FG002|3-months Follow-up|Completed late|34|||
146348252|NCT00227877|527779453|FG003|3-months Follow-up|Completed late|8|||
146348253|NCT00227877|527779450|FG000|3-months Follow-up|Lost to Follow-up|178|||
146348254|NCT00227877|527779451|FG001|3-months Follow-up|Lost to Follow-up|139|||
146348255|NCT00227877|527779452|FG002|3-months Follow-up|Lost to Follow-up|18|||
146348256|NCT00227877|527779453|FG003|3-months Follow-up|Lost to Follow-up|13|||
146348257|NCT00227877|527779450|FG000|12-months Follow-up|Completed late|78|||
146348258|NCT00227877|527779451|FG001|12-months Follow-up|Completed late|74|||
146348259|NCT00227877|527779452|FG002|12-months Follow-up|Completed late|1|||
146348260|NCT00227877|527779453|FG003|12-months Follow-up|Completed late|0|||
146348261|NCT00227877|527779450|FG000|12-months Follow-up|Lost to Follow-up|232|||
146348262|NCT00227877|527779451|FG001|12-months Follow-up|Lost to Follow-up|189|||
146348263|NCT00227877|527779452|FG002|12-months Follow-up|Lost to Follow-up|30|||
146348264|NCT00227877|527779453|FG003|12-months Follow-up|Lost to Follow-up|26|||
146348265|NCT03090737|527779454|FG000|Overall Study|Other reasons|1|||
146348266|NCT03090737|527779454|FG000|Overall Study|Completed treatment as per protocol|17|||
146348267|NCT03090737|527779454|FG000|Overall Study|Maximum clinical benefit|2|||
146348268|NCT03090737|527779454|FG000|Overall Study|Adverse event unrelated to study drug|7|||
146348269|NCT03090737|527779454|FG000|Overall Study|Study drug toxicity|4|||
146348270|NCT03090737|527779454|FG000|Overall Study|Disease progression|98|||
146348271|NCT03141307|527779455|FG000|In-Hospital|Withdrawal by Subject|0|||
146348272|NCT03141307|527779456|FG001|In-Hospital|Withdrawal by Subject|2|||
146348273|NCT03141307|527779455|FG000|In-Hospital|Protocol Violation|4|||
146348274|NCT03141307|527779456|FG001|In-Hospital|Protocol Violation|0|||
146348275|NCT03141307|527779455|FG000|Follow-Up|Lost to Follow-up|97|||
146348276|NCT03141307|527779456|FG001|Follow-Up|Lost to Follow-up|54|||
146348277|NCT01663740|527779459|FG000|Overall Study|Lost to Follow-up|1|||
146348278|NCT01663740|527779460|FG001|Overall Study|Lost to Follow-up|4|||
146348279|NCT01663740|527779459|FG000|Overall Study|Other|9|||
146348280|NCT01663740|527779460|FG001|Overall Study|Other|2|||
146348281|NCT01663740|527779459|FG000|Overall Study|Inclusion/Exclusion not met|1|||
146348282|NCT01663740|527779460|FG001|Overall Study|Inclusion/Exclusion not met|0|||
146348283|NCT01663740|527779459|FG000|Overall Study|Death|0|||
146348284|NCT01663740|527779460|FG001|Overall Study|Death|1|||
146348285|NCT01663740|527779459|FG000|Overall Study|Withdrawal by Subject|2|||
146348286|NCT01663740|527779460|FG001|Overall Study|Withdrawal by Subject|1|||
146348287|NCT01663740|527779459|FG000|Overall Study|No end of study status|3|||
146348288|NCT01663740|527779460|FG001|Overall Study|No end of study status|0|||
146348289|NCT02522481|527779461|FG000|Overall Study|discontinued|1|||
146348290|NCT02522481|527779461|FG000|Overall Study|Not dosed|2|||
146348291|NCT03123939|527779464|FG000|Overall Study|Lack of Efficacy|6|||
146348292|NCT03123939|527779464|FG000|Overall Study|Death|5|||
146348293|NCT03123939|527779464|FG000|Overall Study|Physician Decision|2|||
146348294|NCT03123939|527779464|FG000|Overall Study|Subject/guardian decision|2|||
146348295|NCT03123939|527779464|FG000|Overall Study|Lost to Follow-up|1|||
146348296|NCT03123939|527779464|FG000|Overall Study|New therapy for study indication|1|||
146348297|NCT03123939|527779464|FG000|Overall Study|Protocol deviation|1|||
146348298|NCT03123939|527779464|FG000|Overall Study|Progressive disease|18|||
146348299|NCT03123939|527779464|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
146348300|NCT03123939|527779464|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
146348301|NCT04267562|527781071|FG000|Assessed for Eligibility|Screen Failure|64|||
146348302|NCT04267562|527781071|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
146348303|NCT04267562|527781071|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
146348304|NCT04267562|527781071|FG000|Assessed for Eligibility|Site closure|6|||
146348305|NCT04267562|527781071|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
146348306|NCT04267562|527781071|FG000|Assessed for Eligibility|Physician Decision|1|||
146348307|NCT04267562|527781071|FG000|Month 24|Elective hysterectomy|1|||
146348308|NCT04267562|527781071|FG000|Month 24|Lost to Follow-up|1|||
146348309|NCT04267562|527781071|FG000|Month 36|Elective hysterectomy|2|||
146348310|NCT04267562|527781071|FG000|Month 36|Lost to Follow-up|3|||
146348311|NCT00408421|527781073|FG000|Treatment Initial Randomization|Adverse Event|5|||
146348312|NCT00408421|527781074|FG001|Treatment Initial Randomization|Adverse Event|9|||
146348313|NCT00408421|527781075|FG002|Treatment Initial Randomization|Adverse Event|0|||
146348314|NCT00408421|527781073|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
146348315|NCT00408421|527781074|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
146348316|NCT00408421|527781075|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
146348317|NCT00408421|527781073|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
146348318|NCT00408421|527781074|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
146348319|NCT00408421|527781075|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
146348320|NCT00408421|527781073|FG000|Treatment Initial Randomization|Physician Decision|1|||
146348321|NCT00408421|527781074|FG001|Treatment Initial Randomization|Physician Decision|0|||
146348322|NCT00408421|527781075|FG002|Treatment Initial Randomization|Physician Decision|0|||
146348323|NCT00408421|527781073|FG000|Treatment Initial Randomization|Protocol Violation|0|||
146348324|NCT00408421|527781074|FG001|Treatment Initial Randomization|Protocol Violation|1|||
146348325|NCT00408421|527781075|FG002|Treatment Initial Randomization|Protocol Violation|0|||
146348326|NCT00408421|527781073|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
146348327|NCT00408421|527781074|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
146348328|NCT00408421|527781075|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
146348329|NCT00408421|527781073|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
146348330|NCT00408421|527781074|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
146348331|NCT00408421|527781075|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
146348332|NCT00408421|527781073|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
146348333|NCT00408421|527781074|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
146348334|NCT00408421|527781075|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
146348335|NCT00408421|527781073|FG000|Treatment Re-Randomization|Adverse Event|2|||
146348336|NCT00408421|527781074|FG001|Treatment Re-Randomization|Adverse Event|2|||
146348337|NCT00408421|527781075|FG002|Treatment Re-Randomization|Adverse Event|4|||
146348338|NCT00408421|527781073|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
146348339|NCT00408421|527781074|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
146348340|NCT00408421|527781075|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
146348341|NCT00408421|527781073|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
146348342|NCT00408421|527781074|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
146348343|NCT00408421|527781075|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
146348344|NCT00408421|527781073|FG000|Treatment Re-Randomization|Physician Decision|1|||
146348345|NCT00408421|527781074|FG001|Treatment Re-Randomization|Physician Decision|3|||
146348346|NCT00408421|527781075|FG002|Treatment Re-Randomization|Physician Decision|0|||
146348347|NCT00408421|527781073|FG000|Treatment Re-Randomization|Protocol Violation|1|||
146348348|NCT00408421|527781074|FG001|Treatment Re-Randomization|Protocol Violation|1|||
146348349|NCT00408421|527781075|FG002|Treatment Re-Randomization|Protocol Violation|0|||
146348350|NCT00408421|527781073|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
146348351|NCT00408421|527781074|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
146348352|NCT00408421|527781075|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
146348353|NCT01254604|527781084|FG000|Overall Study|Lost to Follow-up|1|||
146348354|NCT01254604|527781085|FG001|Overall Study|Lost to Follow-up|1|||
146348355|NCT01254604|527781084|FG000|Overall Study|Protocol Violation|2|||
146348356|NCT01254604|527781085|FG001|Overall Study|Protocol Violation|2|||
146348357|NCT01254604|527781084|FG000|Overall Study|Withdrawal by Subject|2|||
146348358|NCT01254604|527781085|FG001|Overall Study|Withdrawal by Subject|4|||
146348359|NCT01254604|527781084|FG000|Overall Study|Adverse Event|3|||
146348360|NCT01254604|527781085|FG001|Overall Study|Adverse Event|2|||
146348361|NCT01703286|527781091|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
146348362|NCT01703286|527781092|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
146348363|NCT01703286|527781093|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
146348364|NCT01703286|527781094|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
146348365|NCT01703286|527781095|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
146348366|NCT01703286|527781096|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
146348367|NCT01703286|527781091|FG000|Period 2 Including Washout|Adverse Event|0|||
146348368|NCT01703286|527781092|FG001|Period 2 Including Washout|Adverse Event|0|||
146348369|NCT01703286|527781093|FG002|Period 2 Including Washout|Adverse Event|0|||
146348370|NCT01703286|527781094|FG003|Period 2 Including Washout|Adverse Event|1|||
146348371|NCT01703286|527781095|FG004|Period 2 Including Washout|Adverse Event|0|||
146348372|NCT01703286|527781096|FG005|Period 2 Including Washout|Adverse Event|0|||
146348373|NCT02421120|527781097|FG000|Overall Study|Adverse Event|1|||
146348374|NCT00931892|527781098|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
146348375|NCT00931892|527781099|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
146348376|NCT01876732|527781100|FG000|Overall Study|MMA was not over 800mg/dL|75|||
146348377|NCT02207530|527781101|FG000|Overall Study|Worsening condition under investigation|78|||
146348378|NCT02207530|527781101|FG000|Overall Study|Patient decision to stop study treatment|5|||
146348379|NCT02207530|527781101|FG000|Overall Study|Adverse Event|8|||
146348380|NCT00305006|527781102|FG000|Overall Study|Withdrawal by Subject|1|||
146348381|NCT00305006|527781103|FG001|Overall Study|Withdrawal by Subject|0|||
146348382|NCT00305006|527781102|FG000|Overall Study|Failure to complete pretest|0|||
146348383|NCT00305006|527781103|FG001|Overall Study|Failure to complete pretest|1|||
146348384|NCT01996319|527781104|FG000|Overall Study|Protocol Violation|1|||
146348385|NCT01996319|527781105|FG001|Overall Study|Protocol Violation|0|||
146348386|NCT01996319|527781104|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
146348387|NCT01996319|527781105|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
146348388|NCT01996319|527781104|FG000|Overall Study|Adverse Event|2|||
146348389|NCT01996319|527781105|FG001|Overall Study|Adverse Event|2|||
146169429|NCT05056870|527132807|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
146169430|NCT05056870|527132808|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
146169431|NCT00742079|527132809|FG000|Overall Study|Lost to Follow-up|0|||
146348390|NCT06094296|527781106|FG000|Overall Study|Progressive Disease|1|||
146169432|NCT00742079|527132810|FG001|Overall Study|Lost to Follow-up|1|||
146348391|NCT06094296|527781107|FG001|Overall Study|Progressive Disease|0|||
146348392|NCT06094296|527781108|FG002|Overall Study|Progressive Disease|0|||
146348393|NCT06094296|527781109|FG003|Overall Study|Progressive Disease|0|||
146348394|NCT00986258|527781110|FG000|Observation Period|Not eligible to be dosed|11|||
146348395|NCT00986258|527781110|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
146348396|NCT00986258|527781110|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
146348397|NCT00986258|527781110|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
146348398|NCT00986258|527781110|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
146348399|NCT00986258|527781110|FG000|Titration and Optimal Dose Period|Other|1|||
146348400|NCT00986258|527781110|FG000|Maintenance Period|Adverse Event|5|||
146348401|NCT00986258|527781110|FG000|Maintenance Period|Lack of Efficacy|2|||
146348402|NCT00986258|527781110|FG000|Maintenance Period|Withdrawal by Subject|2|||
146348403|NCT03332667|527781111|FG000|Overall Study|Adverse Event|0|||
146348404|NCT03332667|527781112|FG001|Overall Study|Adverse Event|0|||
146348405|NCT03332667|527781113|FG002|Overall Study|Adverse Event|2|||
146348406|NCT03332667|527781114|FG003|Overall Study|Adverse Event|1|||
146348407|NCT03332667|527781111|FG000|Overall Study|Withdrawal by Subject|2|||
146348408|NCT03332667|527781112|FG001|Overall Study|Withdrawal by Subject|1|||
146348409|NCT03332667|527781113|FG002|Overall Study|Withdrawal by Subject|5|||
146348410|NCT03332667|527781114|FG003|Overall Study|Withdrawal by Subject|1|||
146348411|NCT03332667|527781111|FG000|Overall Study|Disease Progression or Relapse|2|||
146348412|NCT03332667|527781112|FG001|Overall Study|Disease Progression or Relapse|1|||
146348413|NCT03332667|527781113|FG002|Overall Study|Disease Progression or Relapse|3|||
146348414|NCT03332667|527781114|FG003|Overall Study|Disease Progression or Relapse|0|||
146348415|NCT03332667|527781111|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146348416|NCT03332667|527781112|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146348417|NCT03332667|527781113|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
146348418|NCT03332667|527781114|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
146348419|NCT03332667|527781111|FG000|Overall Study|No Treatment Received|0|||
146348420|NCT03332667|527781112|FG001|Overall Study|No Treatment Received|0|||
146348421|NCT03332667|527781113|FG002|Overall Study|No Treatment Received|1|||
146348422|NCT03332667|527781114|FG003|Overall Study|No Treatment Received|0|||
146348423|NCT04964063|527781115|FG000|Overall Study|Adverse Event|4|||
146348424|NCT04964063|527781115|FG000|Overall Study|Lost to Follow-up|47|||
146348425|NCT04964063|527781115|FG000|Overall Study|Withdrawal by Subject|5|||
146348426|NCT04964063|527781115|FG000|Overall Study|Baseline Tasks Expired|41|||
146348427|NCT04964063|527781115|FG000|Overall Study|Participant withdrawn in error|1|||
146348428|NCT01035606|527781118|FG000|Overall Study|change in health, job demands,family|3|||
146348429|NCT01035606|527781119|FG001|Overall Study|change in health, job demands,family|3|||
146348430|NCT01035606|527781120|FG002|Overall Study|change in health, job demands,family|4|||
146348431|NCT01809262|527781121|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348432|NCT01809262|527781122|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348433|NCT01809262|527781123|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348434|NCT01809262|527781124|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348435|NCT01809262|527781125|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
146348436|NCT01809262|527781126|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348437|NCT01809262|527781127|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348438|NCT01809262|527781128|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348439|NCT01809262|527781129|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348440|NCT01809262|527781130|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
146348441|NCT01809262|527781121|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348442|NCT01809262|527781122|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
146348443|NCT01809262|527781123|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348444|NCT01809262|527781124|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348445|NCT01809262|527781125|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348446|NCT01809262|527781126|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348447|NCT01809262|527781127|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348448|NCT01809262|527781128|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348449|NCT01809262|527781129|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348450|NCT01809262|527781130|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
146348451|NCT01505491|527781131|FG000|Overall Study|Other reason not listed|1|||
146348452|NCT01505491|527781132|FG001|Overall Study|Other reason not listed|0|||
146348453|NCT01505491|527781133|FG002|Overall Study|Other reason not listed|0|||
146348454|NCT01505491|527781131|FG000|Overall Study|Withdrawal by Subject|1|||
146348455|NCT01505491|527781132|FG001|Overall Study|Withdrawal by Subject|1|||
146348456|NCT01505491|527781133|FG002|Overall Study|Withdrawal by Subject|4|||
146348457|NCT01505491|527781131|FG000|Overall Study|Lost to Follow-up|0|||
146348458|NCT01505491|527781132|FG001|Overall Study|Lost to Follow-up|0|||
146169433|NCT03124199|527132813|FG000|Overall Study|Lost to Follow-up|4|||
146348459|NCT01505491|527781133|FG002|Overall Study|Lost to Follow-up|1|||
146169434|NCT03086018|527132814|FG000|Final Testing for End of Trial|Adverse Event|1|||
146348460|NCT01740440|527781136|FG000|Overall Study|Lost to Follow-up|3|||
146348461|NCT01063751|527781138|FG000|Overall Study|Censored from analyses|42|||
146348462|NCT01063751|527781138|FG000|Overall Study|Withdrawal by Subject|34|||
146348463|NCT01063751|527781138|FG000|Overall Study|Lost to Follow-up|30|||
146348464|NCT01063751|527781138|FG000|Overall Study|Death|13|||
146348465|NCT01063751|527781138|FG000|Overall Study|Sponsored Terminated Study|60|||
146395696|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
146348466|NCT01063751|527781138|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
146348467|NCT01063751|527781138|FG000|Overall Study|Investigator site closed|10|||
146348468|NCT01063751|527781138|FG000|Overall Study|Revision|6|||
146348469|NCT01063751|527781138|FG000|Overall Study|Physician Decision|4|||
146348470|NCT03408873|527781144|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
146348471|NCT03408873|527781144|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
146348472|NCT03408873|527781144|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
146348473|NCT03408873|527781144|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
146348474|NCT03408873|527781144|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
146348475|NCT03408873|527781144|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
146348476|NCT00406315|527781150|FG000|Overall Study|Death|1|||
146348477|NCT00406315|527781150|FG000|Overall Study|Adverse Event|39|||
146348478|NCT00406315|527781150|FG000|Overall Study|Laboratory Abnormality|4|||
146348479|NCT00406315|527781150|FG000|Overall Study|Lack of Efficacy|13|||
146348480|NCT00406315|527781150|FG000|Overall Study|Other|33|||
146348481|NCT00406315|527781150|FG000|Overall Study|Lost to Follow-up|21|||
146348482|NCT00406315|527781150|FG000|Overall Study|Withdrawal by Subject|30|||
146348483|NCT01797783|527781152|FG000|Overall Study|Adverse Event|1|||
146348484|NCT01797783|527781153|FG001|Overall Study|Adverse Event|1|||
146348485|NCT01797783|527781152|FG000|Overall Study|Withdrawal by Subject|1|||
146348486|NCT01797783|527781153|FG001|Overall Study|Withdrawal by Subject|0|||
146348487|NCT00793819|527781156|FG000|Overall Study|Adverse Event|8|||
146348488|NCT00793819|527781157|FG001|Overall Study|Adverse Event|4|||
146348489|NCT00793819|527781156|FG000|Overall Study|Lack of Efficacy|1|||
146348490|NCT00793819|527781157|FG001|Overall Study|Lack of Efficacy|1|||
146348491|NCT00793819|527781156|FG000|Overall Study|Withdrawal by Subject|4|||
146348492|NCT00793819|527781157|FG001|Overall Study|Withdrawal by Subject|3|||
146348493|NCT00793819|527781156|FG000|Overall Study|Lost to Follow-up|1|||
146348494|NCT00793819|527781157|FG001|Overall Study|Lost to Follow-up|1|||
146348495|NCT00723840|527781163|FG000|Overall Study|Lost to Follow-up|2|||
146348496|NCT00723840|527781163|FG000|Overall Study|Failure to return|18|||
146348497|NCT00723840|527781163|FG000|Overall Study|Withdrawal by Subject|55|||
146348498|NCT00723840|527781163|FG000|Overall Study|Serious Adverse Events|3|||
146348499|NCT00723840|527781163|FG000|Overall Study|Other Medical Event|2|||
146348500|NCT00723840|527781163|FG000|Overall Study|Unspecified reason|2|||
146348501|NCT01161524|527781175|FG000|Core Study (23 Weeks)|Adverse Event|3|||
146348502|NCT01161524|527781176|FG001|Core Study (23 Weeks)|Adverse Event|0|||
146348503|NCT01161524|527781177|FG002|Core Study (23 Weeks)|Adverse Event|0|||
146348504|NCT01161524|527781175|FG000|Core Study (23 Weeks)|Other|1|||
146348505|NCT01161524|527781176|FG001|Core Study (23 Weeks)|Other|0|||
146348506|NCT01161524|527781177|FG002|Core Study (23 Weeks)|Other|0|||
146348507|NCT01161524|527781175|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
146348508|NCT01161524|527781176|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
146348509|NCT01161524|527781177|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
146348510|NCT01161524|527781175|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
146348511|NCT01161524|527781176|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
146348512|NCT01161524|527781177|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
146348513|NCT01161524|527781175|FG000|Core Study (23 Weeks)|Subject Choice|3|||
146348514|NCT01161524|527781176|FG001|Core Study (23 Weeks)|Subject Choice|2|||
146348515|NCT01161524|527781177|FG002|Core Study (23 Weeks)|Subject Choice|0|||
146348516|NCT01161524|527781175|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
146348517|NCT01161524|527781176|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
146348518|NCT01161524|527781177|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
146348519|NCT01161524|527781175|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
146348520|NCT01161524|527781176|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
146348521|NCT01161524|527781177|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
146348522|NCT01161524|527781175|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
146348523|NCT01161524|527781176|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
146348524|NCT01161524|527781177|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
146348525|NCT01161524|527781175|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
146348526|NCT01161524|527781176|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
146348527|NCT01161524|527781177|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
146348528|NCT01161524|527781175|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
146348529|NCT01161524|527781176|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
146348530|NCT01161524|527781177|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
146348531|NCT00642616|527781178|FG000|Overall Study|Adverse Event|2|||
146348532|NCT00642616|527781179|FG001|Overall Study|Adverse Event|0|||
146348533|NCT00642616|527781180|FG002|Overall Study|Adverse Event|1|||
146348534|NCT00642616|527781181|FG003|Overall Study|Adverse Event|0|||
146348535|NCT00642616|527781178|FG000|Overall Study|Study Terminated by Sponsor|7|||
146348536|NCT00642616|527781179|FG001|Overall Study|Study Terminated by Sponsor|6|||
146348537|NCT00642616|527781180|FG002|Overall Study|Study Terminated by Sponsor|4|||
146348538|NCT00642616|527781181|FG003|Overall Study|Study Terminated by Sponsor|5|||
146348539|NCT00642616|527781178|FG000|Overall Study|Withdrawal by Subject|0|||
146348540|NCT00642616|527781179|FG001|Overall Study|Withdrawal by Subject|1|||
146348541|NCT00642616|527781180|FG002|Overall Study|Withdrawal by Subject|1|||
146348542|NCT00642616|527781181|FG003|Overall Study|Withdrawal by Subject|1|||
146348543|NCT00642616|527781178|FG000|Overall Study|Protocol Violation|0|||
146348544|NCT00642616|527781179|FG001|Overall Study|Protocol Violation|0|||
146348545|NCT00642616|527781180|FG002|Overall Study|Protocol Violation|2|||
146348546|NCT00642616|527781181|FG003|Overall Study|Protocol Violation|0|||
146348547|NCT00642616|527781178|FG000|Overall Study|Physician Decision|0|||
146348548|NCT00642616|527781179|FG001|Overall Study|Physician Decision|0|||
146348549|NCT00642616|527781180|FG002|Overall Study|Physician Decision|1|||
146348550|NCT00642616|527781181|FG003|Overall Study|Physician Decision|1|||
146348551|NCT00399802|527781182|FG000|Overall Study|Adverse Event|0|||
146348552|NCT00399802|527781183|FG001|Overall Study|Adverse Event|2|||
146348553|NCT00399802|527781182|FG000|Overall Study|Participant discontinued by mistake|0|||
146348554|NCT00399802|527781183|FG001|Overall Study|Participant discontinued by mistake|1|||
146348555|NCT00542815|527781188|FG000|Overall Study|Adverse Event|19|||
146348556|NCT00542815|527781189|FG001|Overall Study|Adverse Event|6|||
146348557|NCT00542815|527781190|FG002|Overall Study|Adverse Event|9|||
146348558|NCT00542815|527781188|FG000|Overall Study|Death|10|||
146348559|NCT00542815|527781189|FG001|Overall Study|Death|7|||
146348560|NCT00542815|527781190|FG002|Overall Study|Death|3|||
146348561|NCT00542815|527781188|FG000|Overall Study|Lack of Efficacy|9|||
146348562|NCT00542815|527781189|FG001|Overall Study|Lack of Efficacy|2|||
146348563|NCT00542815|527781190|FG002|Overall Study|Lack of Efficacy|0|||
146348564|NCT00542815|527781188|FG000|Overall Study|Physician Decision|2|||
146348565|NCT00542815|527781189|FG001|Overall Study|Physician Decision|1|||
146348566|NCT00542815|527781190|FG002|Overall Study|Physician Decision|0|||
146348567|NCT00542815|527781188|FG000|Overall Study|Protocol Violation|1|||
146348568|NCT00542815|527781189|FG001|Overall Study|Protocol Violation|1|||
146348569|NCT00542815|527781190|FG002|Overall Study|Protocol Violation|2|||
146348570|NCT00542815|527781188|FG000|Overall Study|Withdrawal by Subject|41|||
146348571|NCT00542815|527781189|FG001|Overall Study|Withdrawal by Subject|5|||
146348572|NCT00542815|527781190|FG002|Overall Study|Withdrawal by Subject|8|||
146348573|NCT00542815|527781188|FG000|Overall Study|Other reasons|24|||
146348574|NCT00542815|527781189|FG001|Overall Study|Other reasons|10|||
146348575|NCT00542815|527781190|FG002|Overall Study|Other reasons|10|||
146348576|NCT01041573|527781193|FG000|Overall Study|Withdrawal by Subject|2|||
146348577|NCT01041573|527781194|FG001|Overall Study|Withdrawal by Subject|5|||
146348578|NCT01041573|527781195|FG002|Overall Study|Withdrawal by Subject|2|||
146348579|NCT01041573|527781196|FG003|Overall Study|Withdrawal by Subject|0|||
146348580|NCT01041573|527781193|FG000|Overall Study|Death|1|||
146348581|NCT01041573|527781194|FG001|Overall Study|Death|0|||
146348582|NCT01041573|527781195|FG002|Overall Study|Death|0|||
146348583|NCT01041573|527781196|FG003|Overall Study|Death|0|||
146348584|NCT01041573|527781193|FG000|Overall Study|Lost to Follow-up|0|||
146348585|NCT01041573|527781194|FG001|Overall Study|Lost to Follow-up|1|||
146348586|NCT01041573|527781195|FG002|Overall Study|Lost to Follow-up|2|||
146348587|NCT01041573|527781196|FG003|Overall Study|Lost to Follow-up|1|||
146348588|NCT01041573|527781193|FG000|Overall Study|Adverse Event|0|||
146348589|NCT01041573|527781194|FG001|Overall Study|Adverse Event|2|||
146348590|NCT01041573|527781195|FG002|Overall Study|Adverse Event|0|||
146348591|NCT01041573|527781196|FG003|Overall Study|Adverse Event|0|||
146348592|NCT01041573|527781193|FG000|Overall Study|relocation|1|||
146348593|NCT01041573|527781194|FG001|Overall Study|relocation|4|||
146348594|NCT01041573|527781195|FG002|Overall Study|relocation|3|||
146348595|NCT01041573|527781196|FG003|Overall Study|relocation|1|||
146348596|NCT01041573|527781193|FG000|Overall Study|further blood extraction|0|||
146348597|NCT01041573|527781194|FG001|Overall Study|further blood extraction|1|||
146348598|NCT01041573|527781195|FG002|Overall Study|further blood extraction|0|||
146348599|NCT01041573|527781196|FG003|Overall Study|further blood extraction|0|||
146348600|NCT01041573|527781193|FG000|Overall Study|positive to anti-HCV|1|||
146348601|NCT01041573|527781194|FG001|Overall Study|positive to anti-HCV|0|||
146348602|NCT01041573|527781195|FG002|Overall Study|positive to anti-HCV|0|||
146348603|NCT01041573|527781196|FG003|Overall Study|positive to anti-HCV|0|||
146169435|NCT03086018|527132814|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
146169436|NCT01782872|527132815|FG000|Overall Study|Protocol Violation|0|||
146348604|NCT02955186|527781197|FG000|Overall Study|Withdrawal by Subject|6|||
146348605|NCT02955186|527781198|FG001|Overall Study|Withdrawal by Subject|2|||
146348606|NCT02955186|527781197|FG000|Overall Study|Protocol Violation|1|||
146348607|NCT02955186|527781198|FG001|Overall Study|Protocol Violation|0|||
146169437|NCT01782872|527132816|FG001|Overall Study|Protocol Violation|0|||
146348608|NCT01618656|527781201|FG000|Overall Study|Withdrawal by Subject|7|||
146348609|NCT01618656|527781202|FG001|Overall Study|Withdrawal by Subject|3|||
146348610|NCT01618656|527781201|FG000|Overall Study|Physician Decision|1|||
146348611|NCT01618656|527781202|FG001|Overall Study|Physician Decision|1|||
146348612|NCT01276847|527781203|FG000|Overall Study|Withdrawal by Subject|1|||
146348613|NCT01276847|527781204|FG001|Overall Study|Withdrawal by Subject|0|||
146348614|NCT01276847|527781205|FG002|Overall Study|Withdrawal by Subject|0|||
146348615|NCT01899144|527781206|FG000|Treatment Period 2|Other|1|||
146348616|NCT01899144|527781206|FG000|Treatment Period 3|Other|2|||
146348617|NCT01899144|527781206|FG000|Treatment Period 5|Other|1|||
146348618|NCT00751881|527781209|FG000|Core Treatment Period|Not treated|1|||
146348619|NCT00751881|527781210|FG001|Core Treatment Period|Not treated|1|||
146348620|NCT00751881|527781211|FG002|Core Treatment Period|Not treated|2|||
146348621|NCT00751881|527781209|FG000|Core Treatment Period|Adverse Event|26|||
146348622|NCT00751881|527781210|FG001|Core Treatment Period|Adverse Event|54|||
146348623|NCT00751881|527781211|FG002|Core Treatment Period|Adverse Event|58|||
146348624|NCT00751881|527781209|FG000|Core Treatment Period|Lack of Efficacy|37|||
146348625|NCT00751881|527781210|FG001|Core Treatment Period|Lack of Efficacy|30|||
146348626|NCT00751881|527781211|FG002|Core Treatment Period|Lack of Efficacy|20|||
146348627|NCT00751881|527781209|FG000|Core Treatment Period|Poor compliance to protocol|15|||
146348628|NCT00751881|527781210|FG001|Core Treatment Period|Poor compliance to protocol|3|||
146348629|NCT00751881|527781211|FG002|Core Treatment Period|Poor compliance to protocol|4|||
146348630|NCT00751881|527781209|FG000|Core Treatment Period|Lost to Follow-up|6|||
146348631|NCT00751881|527781210|FG001|Core Treatment Period|Lost to Follow-up|4|||
146348632|NCT00751881|527781211|FG002|Core Treatment Period|Lost to Follow-up|3|||
146348633|NCT00751881|527781209|FG000|Core Treatment Period|Other: protocol deviation|3|||
146348634|NCT00751881|527781210|FG001|Core Treatment Period|Other: protocol deviation|3|||
146348635|NCT00751881|527781211|FG002|Core Treatment Period|Other: protocol deviation|7|||
146348636|NCT00751881|527781209|FG000|Core Treatment Period|Other: wish to parent|5|||
146348637|NCT00751881|527781210|FG001|Core Treatment Period|Other: wish to parent|7|||
146348638|NCT00751881|527781211|FG002|Core Treatment Period|Other: wish to parent|4|||
146348639|NCT00751881|527781209|FG000|Core Treatment Period|Other: personal/family constraints|6|||
146348640|NCT00751881|527781210|FG001|Core Treatment Period|Other: personal/family constraints|7|||
146348641|NCT00751881|527781211|FG002|Core Treatment Period|Other: personal/family constraints|10|||
146348642|NCT00751881|527781209|FG000|Core Treatment Period|Other: MS treatment change|6|||
146348643|NCT00751881|527781210|FG001|Core Treatment Period|Other: MS treatment change|4|||
146348644|NCT00751881|527781211|FG002|Core Treatment Period|Other: MS treatment change|4|||
146348645|NCT00751881|527781209|FG000|Core Treatment Period|Other: tolerability complaints|2|||
146348646|NCT00751881|527781210|FG001|Core Treatment Period|Other: tolerability complaints|0|||
146348647|NCT00751881|527781211|FG002|Core Treatment Period|Other: tolerability complaints|0|||
146348648|NCT00751881|527781209|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
146348649|NCT00751881|527781210|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
146348650|NCT00751881|527781211|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
146348651|NCT00751881|527781209|FG000|Extension Study Period|Adverse Event|18|||
146348652|NCT00751881|527781210|FG001|Extension Study Period|Adverse Event|20|||
146348653|NCT00751881|527781211|FG002|Extension Study Period|Adverse Event|21|||
146348654|NCT00751881|527781209|FG000|Extension Study Period|Lack of Efficacy|14|||
146348655|NCT00751881|527781210|FG001|Extension Study Period|Lack of Efficacy|10|||
146348656|NCT00751881|527781211|FG002|Extension Study Period|Lack of Efficacy|20|||
146348657|NCT00751881|527781209|FG000|Extension Study Period|Lost to Follow-up|4|||
146348658|NCT00751881|527781210|FG001|Extension Study Period|Lost to Follow-up|9|||
146348659|NCT00751881|527781211|FG002|Extension Study Period|Lost to Follow-up|6|||
146348660|NCT00751881|527781209|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
146348661|NCT00751881|527781210|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
146348662|NCT00751881|527781211|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
146348663|NCT00751881|527781209|FG000|Extension Study Period|Other than specified above|26|||
146348664|NCT00751881|527781210|FG001|Extension Study Period|Other than specified above|30|||
146348665|NCT00751881|527781211|FG002|Extension Study Period|Other than specified above|18|||
146348666|NCT04770155|527781212|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348667|NCT04770155|527781213|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348668|NCT04770155|527781214|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348669|NCT04770155|527781215|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348670|NCT04770155|527781216|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348671|NCT04770155|527781217|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348672|NCT04770155|527781218|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348673|NCT04770155|527781219|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
146348674|NCT02021812|527781220|FG000|Overall Study|Death|8|||
146348675|NCT02021812|527781220|FG000|Overall Study|Withdrawal by Subject|3|||
146348676|NCT02021812|527781220|FG000|Overall Study|Lost to Follow-up|2|||
146348677|NCT02021812|527781220|FG000|Overall Study|Refuse to return, COVD 19|2|||
146348678|NCT00564629|527781221|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
146348679|NCT00564629|527781222|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
146348680|NCT01597193|527781225|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
146348681|NCT01597193|527781226|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
146169438|NCT01782872|527132817|FG002|Overall Study|Protocol Violation|0|||
146169439|NCT01782872|527132818|FG003|Overall Study|Protocol Violation|1|||
146348682|NCT01597193|527781227|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146348683|NCT01597193|527781228|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146348684|NCT01597193|527781229|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146348685|NCT01597193|527781230|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146348686|NCT01597193|527781231|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
146348687|NCT01597193|527781225|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146348688|NCT01597193|527781226|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146348689|NCT01597193|527781227|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146348690|NCT01597193|527781228|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
146348691|NCT01597193|527781229|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
146348692|NCT01597193|527781230|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
146348693|NCT01597193|527781231|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
146348694|NCT01597193|527781225|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
146348695|NCT01597193|527781226|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
146348696|NCT01597193|527781227|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
146348697|NCT01597193|527781228|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
146348698|NCT01597193|527781229|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
146348699|NCT01597193|527781230|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
146348700|NCT01597193|527781231|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
146348701|NCT01597193|527781225|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348702|NCT01597193|527781226|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348703|NCT01597193|527781227|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348704|NCT01597193|527781228|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348705|NCT01597193|527781229|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348706|NCT01597193|527781230|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
146348707|NCT01597193|527781231|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
146348708|NCT01597193|527781225|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146348709|NCT01597193|527781226|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146348710|NCT01597193|527781227|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146348711|NCT01597193|527781228|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
146348712|NCT01597193|527781229|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146348713|NCT01597193|527781230|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
146348714|NCT01597193|527781231|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
146348715|NCT00064662|527781232|FG000|Overall Study|Death|1|||
146348716|NCT00064662|527781233|FG001|Overall Study|Death|1|||
146348717|NCT00064662|527781232|FG000|Overall Study|Lost to Follow-up|57|||
146348718|NCT00064662|527781233|FG001|Overall Study|Lost to Follow-up|44|||
146348719|NCT00064662|527781232|FG000|Overall Study|Withdrawal by Subject|14|||
146348720|NCT00064662|527781233|FG001|Overall Study|Withdrawal by Subject|14|||
146348721|NCT00064662|527781232|FG000|Overall Study|Administratively withdrawn|2|||
146348722|NCT00064662|527781233|FG001|Overall Study|Administratively withdrawn|2|||
146348723|NCT00365976|527781236|FG000|Overall Study|Withdrawal by Subject|1|||
146348724|NCT00365976|527781237|FG001|Overall Study|Withdrawal by Subject|5|||
146348725|NCT01000064|527781238|FG000|Overall Study|Withdrawal by Subject|1|||
146348726|NCT01000064|527781239|FG001|Overall Study|Withdrawal by Subject|1|||
146348727|NCT02518620|527781240|FG000|Overall Study|Adverse Event|23|||
146348728|NCT02518620|527781241|FG001|Overall Study|Adverse Event|11|||
146348729|NCT02518620|527781240|FG000|Overall Study|Lack of Efficacy|2|||
146348730|NCT02518620|527781241|FG001|Overall Study|Lack of Efficacy|0|||
146348731|NCT02518620|527781240|FG000|Overall Study|Non-Compliance with Study Drug|1|||
146348732|NCT02518620|527781241|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146348733|NCT02518620|527781240|FG000|Overall Study|Physician Decision|1|||
146348734|NCT02518620|527781241|FG001|Overall Study|Physician Decision|1|||
146348735|NCT02518620|527781240|FG000|Overall Study|Sponsor's Decision|0|||
146348736|NCT02518620|527781241|FG001|Overall Study|Sponsor's Decision|3|||
146348737|NCT02518620|527781240|FG000|Overall Study|Lost to Follow-up|1|||
146348738|NCT02518620|527781241|FG001|Overall Study|Lost to Follow-up|1|||
146348739|NCT02518620|527781240|FG000|Overall Study|Withdrawal by Subject|17|||
146348740|NCT02518620|527781241|FG001|Overall Study|Withdrawal by Subject|9|||
146348741|NCT02518620|527781240|FG000|Overall Study|Death|1|||
146348742|NCT02518620|527781241|FG001|Overall Study|Death|0|||
146348743|NCT02518620|527781240|FG000|Overall Study|Pregnancy Wish|3|||
146348744|NCT02518620|527781241|FG001|Overall Study|Pregnancy Wish|0|||
146348745|NCT02518620|527781240|FG000|Overall Study|Pregnancy|1|||
146348746|NCT02518620|527781241|FG001|Overall Study|Pregnancy|0|||
146348747|NCT02518620|527781240|FG000|Overall Study|Relocation|2|||
146348748|NCT02518620|527781241|FG001|Overall Study|Relocation|1|||
146348749|NCT01937130|527782805|FG000|Overall Study|Withdrawal by Subject|0|||
146348750|NCT01937130|527782806|FG001|Overall Study|Withdrawal by Subject|0|||
146348751|NCT01937130|527782807|FG002|Overall Study|Withdrawal by Subject|0|||
146348752|NCT01937130|527782808|FG003|Overall Study|Withdrawal by Subject|1|||
146348753|NCT01937130|527782805|FG000|Overall Study|Adverse Event|0|||
146348754|NCT01937130|527782806|FG001|Overall Study|Adverse Event|1|||
146348755|NCT01937130|527782807|FG002|Overall Study|Adverse Event|0|||
146348756|NCT01937130|527782808|FG003|Overall Study|Adverse Event|1|||
146348757|NCT01937130|527782805|FG000|Overall Study|Death|1|||
146348758|NCT01937130|527782806|FG001|Overall Study|Death|1|||
146348759|NCT01937130|527782807|FG002|Overall Study|Death|1|||
146348760|NCT01937130|527782808|FG003|Overall Study|Death|0|||
146348761|NCT01937130|527782805|FG000|Overall Study|Lost to Follow-up|2|||
146348762|NCT01937130|527782806|FG001|Overall Study|Lost to Follow-up|0|||
146348763|NCT01937130|527782807|FG002|Overall Study|Lost to Follow-up|2|||
146348764|NCT01937130|527782808|FG003|Overall Study|Lost to Follow-up|0|||
146348765|NCT01937130|527782805|FG000|Overall Study|Physician Decision|0|||
146348766|NCT01937130|527782806|FG001|Overall Study|Physician Decision|1|||
146348767|NCT01937130|527782807|FG002|Overall Study|Physician Decision|0|||
146348768|NCT01937130|527782808|FG003|Overall Study|Physician Decision|0|||
146348769|NCT01937130|527782805|FG000|Overall Study|Patients unable to swallow|0|||
146348770|NCT01937130|527782806|FG001|Overall Study|Patients unable to swallow|1|||
146348771|NCT01937130|527782807|FG002|Overall Study|Patients unable to swallow|0|||
146348772|NCT01937130|527782808|FG003|Overall Study|Patients unable to swallow|0|||
146348773|NCT01937130|527782805|FG000|Overall Study|Patient lost to FU due to death|2|||
146348774|NCT01937130|527782806|FG001|Overall Study|Patient lost to FU due to death|0|||
146348775|NCT01937130|527782807|FG002|Overall Study|Patient lost to FU due to death|0|||
146348776|NCT01937130|527782808|FG003|Overall Study|Patient lost to FU due to death|0|||
146348777|NCT01850563|527782809|FG000|Overall Study|Not eligible|3|||
146348778|NCT01850563|527782810|FG001|Overall Study|Not eligible|0|||
146348779|NCT01431144|527782811|FG000|Overall Study|Implant mobility and removal|2|||
146348780|NCT01431144|527782812|FG001|Overall Study|Implant mobility and removal|0|||
146348781|NCT02322892|527782813|FG000|Overall Study|Surgery cancelled|1|||
146348782|NCT02322892|527782814|FG001|Overall Study|Surgery cancelled|2|||
146348783|NCT02322892|527782813|FG000|Overall Study|Met exclusion criteria|0|||
146348784|NCT02322892|527782814|FG001|Overall Study|Met exclusion criteria|1|||
146348785|NCT02322892|527782813|FG000|Overall Study|Protocol Violation|1|||
146348786|NCT02322892|527782814|FG001|Overall Study|Protocol Violation|0|||
146348787|NCT02125331|527782815|FG000|Overall Study|Protocol Violation|1|||
146348788|NCT02125331|527782816|FG001|Overall Study|Protocol Violation|0|||
146348789|NCT02125331|527782815|FG000|Overall Study|technical problem|2|||
146348790|NCT02125331|527782816|FG001|Overall Study|technical problem|0|||
146348791|NCT02125331|527782815|FG000|Overall Study|screen failure|2|||
146348792|NCT02125331|527782816|FG001|Overall Study|screen failure|0|||
146348793|NCT02601001|527782817|FG000|Dosing Period 2|Adverse Event|0|||
146348794|NCT02601001|527782818|FG001|Dosing Period 2|Adverse Event|0|||
146348795|NCT02601001|527782819|FG002|Dosing Period 2|Adverse Event|0|||
146348796|NCT02601001|527782820|FG003|Dosing Period 2|Adverse Event|0|||
146348797|NCT02601001|527782821|FG004|Dosing Period 2|Adverse Event|0|||
146348798|NCT02601001|527782822|FG005|Dosing Period 2|Adverse Event|0|||
146348799|NCT02601001|527782823|FG006|Dosing Period 2|Adverse Event|1|||
146348800|NCT01115569|527782826|FG000|Conversion/Titration Phase|Adverse Event|59|||
146348801|NCT01115569|527782827|FG001|Conversion/Titration Phase|Adverse Event|0|||
146348802|NCT01115569|527782826|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
146348803|NCT01115569|527782827|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
146348804|NCT01115569|527782826|FG000|Conversion/Titration Phase|Physician Decision|5|||
146348805|NCT01115569|527782827|FG001|Conversion/Titration Phase|Physician Decision|0|||
146348806|NCT01115569|527782826|FG000|Conversion/Titration Phase|Protocol Violation|68|||
146348807|NCT01115569|527782827|FG001|Conversion/Titration Phase|Protocol Violation|0|||
146348808|NCT01115569|527782826|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
146348809|NCT01115569|527782827|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
146348810|NCT01115569|527782826|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
146348811|NCT01115569|527782827|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
146348812|NCT01115569|527782826|FG000|Maintenance Phase|Adverse Event|0|||
146348813|NCT01115569|527782827|FG001|Maintenance Phase|Adverse Event|43|||
146348814|NCT01115569|527782826|FG000|Maintenance Phase|Lost to Follow-up|0|||
146348815|NCT01115569|527782827|FG001|Maintenance Phase|Lost to Follow-up|8|||
146348816|NCT01115569|527782826|FG000|Maintenance Phase|Physician Decision|0|||
146348817|NCT01115569|527782827|FG001|Maintenance Phase|Physician Decision|3|||
146348818|NCT01115569|527782826|FG000|Maintenance Phase|Protocol Violation|0|||
146169440|NCT01782872|527132815|FG000|Overall Study|Withdrawal by Subject|0|||
146348819|NCT01115569|527782827|FG001|Maintenance Phase|Protocol Violation|9|||
146348820|NCT01115569|527782826|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146348821|NCT01115569|527782827|FG001|Maintenance Phase|Withdrawal by Subject|27|||
146169441|NCT01782872|527132816|FG001|Overall Study|Withdrawal by Subject|1|||
146169442|NCT01782872|527132817|FG002|Overall Study|Withdrawal by Subject|0|||
146348822|NCT01115569|527782826|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
146348823|NCT01115569|527782827|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
146348824|NCT01115569|527782826|FG000|Maintenance Phase|Administrative|0|||
146348825|NCT01115569|527782827|FG001|Maintenance Phase|Administrative|1|||
146348826|NCT03074162|527782830|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146348827|NCT03074162|527782831|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146169443|NCT01782872|527132818|FG003|Overall Study|Withdrawal by Subject|0|||
146348828|NCT03074162|527782832|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
146348829|NCT03074162|527782833|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146348830|NCT03074162|527782834|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146348831|NCT03074162|527782835|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
146348832|NCT03074162|527782830|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146348833|NCT03074162|527782831|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146348834|NCT03074162|527782832|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
146348835|NCT03074162|527782833|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146348836|NCT03074162|527782834|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
146348837|NCT03074162|527782835|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
146348838|NCT03074162|527782830|FG000|Period 3|Withdrawal by Subject|1|||
146348839|NCT03074162|527782831|FG001|Period 3|Withdrawal by Subject|0|||
146348840|NCT03074162|527782832|FG002|Period 3|Withdrawal by Subject|0|||
146348841|NCT03074162|527782833|FG003|Period 3|Withdrawal by Subject|0|||
146348842|NCT03074162|527782834|FG004|Period 3|Withdrawal by Subject|1|||
146348843|NCT03074162|527782835|FG005|Period 3|Withdrawal by Subject|0|||
146348844|NCT02948777|527782836|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
146348845|NCT03242928|527782837|FG000|Overall Study|Adverse Event|2|||
146348846|NCT03242928|527782838|FG001|Overall Study|Adverse Event|1|||
146348847|NCT03242928|527782837|FG000|Overall Study|Lost to Follow-up|2|||
146348848|NCT03242928|527782838|FG001|Overall Study|Lost to Follow-up|0|||
146348849|NCT03242928|527782837|FG000|Overall Study|Physician Decision|0|||
146348850|NCT03242928|527782838|FG001|Overall Study|Physician Decision|1|||
146348851|NCT03242928|527782837|FG000|Overall Study|Withdrawal by Subject|5|||
146348852|NCT03242928|527782838|FG001|Overall Study|Withdrawal by Subject|3|||
146348853|NCT00625365|527782842|FG000|Overall Study|Withdrawal by Subject|1|||
146348854|NCT00625365|527782842|FG000|Overall Study|No IV access|5|||
146348855|NCT00625365|527782842|FG000|Overall Study|VSD|1|||
146348856|NCT01120093|527782850|FG000|Treatment Period 1|Adverse Event|0|||
146348857|NCT01120093|527782851|FG001|Treatment Period 1|Adverse Event|0|||
146348858|NCT01120093|527782852|FG002|Treatment Period 1|Adverse Event|1|||
146348859|NCT01120093|527782853|FG003|Treatment Period 1|Adverse Event|0|||
146348860|NCT01120093|527782854|FG004|Treatment Period 1|Adverse Event|1|||
146348861|NCT01120093|527782850|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146348862|NCT01120093|527782851|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146348863|NCT01120093|527782852|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146348864|NCT01120093|527782853|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146348865|NCT01120093|527782854|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146348866|NCT01120093|527782850|FG000|Treatment Period 2|Adverse Event|0|||
146348867|NCT01120093|527782851|FG001|Treatment Period 2|Adverse Event|0|||
146348868|NCT01120093|527782852|FG002|Treatment Period 2|Adverse Event|0|||
146348869|NCT01120093|527782853|FG003|Treatment Period 2|Adverse Event|1|||
146348870|NCT01120093|527782854|FG004|Treatment Period 2|Adverse Event|0|||
146348871|NCT01120093|527782850|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146348872|NCT01120093|527782851|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146348873|NCT01120093|527782852|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146348874|NCT01120093|527782853|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146348875|NCT01120093|527782854|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146348876|NCT01120093|527782850|FG000|Treatment Period 3|Lack of Efficacy|0|||
146348877|NCT01120093|527782851|FG001|Treatment Period 3|Lack of Efficacy|0|||
146348878|NCT01120093|527782852|FG002|Treatment Period 3|Lack of Efficacy|0|||
146348879|NCT01120093|527782853|FG003|Treatment Period 3|Lack of Efficacy|1|||
146348880|NCT01120093|527782854|FG004|Treatment Period 3|Lack of Efficacy|0|||
146348881|NCT01120093|527782850|FG000|Treatment Period 3|Adverse Event|0|||
146348882|NCT01120093|527782851|FG001|Treatment Period 3|Adverse Event|0|||
146348883|NCT01120093|527782852|FG002|Treatment Period 3|Adverse Event|0|||
146348884|NCT01120093|527782853|FG003|Treatment Period 3|Adverse Event|0|||
146348885|NCT01120093|527782854|FG004|Treatment Period 3|Adverse Event|1|||
146348886|NCT01120093|527782850|FG000|Treatment Period 3|Withdrawal by Subject|0|||
146348887|NCT01120093|527782851|FG001|Treatment Period 3|Withdrawal by Subject|0|||
146348888|NCT01120093|527782852|FG002|Treatment Period 3|Withdrawal by Subject|1|||
146348889|NCT01120093|527782853|FG003|Treatment Period 3|Withdrawal by Subject|0|||
146348890|NCT01120093|527782854|FG004|Treatment Period 3|Withdrawal by Subject|0|||
146348891|NCT01120093|527782850|FG000|Treatment Period 4|Adverse Event|1|||
146348892|NCT01120093|527782851|FG001|Treatment Period 4|Adverse Event|0|||
146348893|NCT01120093|527782852|FG002|Treatment Period 4|Adverse Event|0|||
146348894|NCT01120093|527782853|FG003|Treatment Period 4|Adverse Event|0|||
146348895|NCT01120093|527782854|FG004|Treatment Period 4|Adverse Event|0|||
146348896|NCT01120093|527782850|FG000|Treatment Period 5|Adverse Event|0|||
146348897|NCT01120093|527782851|FG001|Treatment Period 5|Adverse Event|1|||
146348898|NCT01120093|527782852|FG002|Treatment Period 5|Adverse Event|0|||
146348899|NCT01120093|527782853|FG003|Treatment Period 5|Adverse Event|1|||
146348900|NCT01120093|527782854|FG004|Treatment Period 5|Adverse Event|0|||
146348901|NCT03649321|527782855|FG000|Overall Study|Withdrawal by Subject|1|||
146348902|NCT03649321|527782856|FG001|Overall Study|Withdrawal by Subject|0|||
145943386|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146348903|NCT03649321|527782855|FG000|Overall Study|Death|1|||
146348904|NCT03649321|527782856|FG001|Overall Study|Death|0|||
146348905|NCT00431847|527782862|FG000|Overall Study|completion of less than two study visits|6|||
146348906|NCT00431847|527782863|FG001|Overall Study|completion of less than two study visits|3|||
146348907|NCT00431847|527782864|FG002|Overall Study|completion of less than two study visits|4|||
146348908|NCT00431847|527782865|FG003|Overall Study|completion of less than two study visits|14|||
146348909|NCT00431847|527782866|FG004|Overall Study|completion of less than two study visits|0|||
146348910|NCT00431847|527782862|FG000|Overall Study|Protocol Violation|0|||
146348911|NCT00431847|527782863|FG001|Overall Study|Protocol Violation|0|||
146348912|NCT00431847|527782864|FG002|Overall Study|Protocol Violation|0|||
146348913|NCT00431847|527782865|FG003|Overall Study|Protocol Violation|0|||
146348914|NCT00431847|527782866|FG004|Overall Study|Protocol Violation|1|||
146348915|NCT02142894|527782867|FG000|Overall Study|Protocol Violation|8|||
146348916|NCT02853331|527782869|FG000|Overall Study|Death|59|||
146348917|NCT02853331|527782870|FG001|Overall Study|Death|95|||
146348918|NCT02853331|527782869|FG000|Overall Study|Withdrawal by Subject|5|||
146348919|NCT02853331|527782870|FG001|Overall Study|Withdrawal by Subject|9|||
146348920|NCT02853331|527782869|FG000|Overall Study|Ongoing in study|368|||
146348921|NCT02853331|527782870|FG001|Overall Study|Ongoing in study|325|||
146348922|NCT01455428|527782871|FG000|Overall Study|Protocol Violation|2|||
146348923|NCT01455428|527782872|FG001|Overall Study|Protocol Violation|1|||
146348924|NCT01455428|527782871|FG000|Overall Study|Adverse Event|6|||
146348925|NCT01455428|527782872|FG001|Overall Study|Adverse Event|2|||
146348926|NCT01455428|527782871|FG000|Overall Study|Lost to Follow-up|1|||
146348927|NCT01455428|527782872|FG001|Overall Study|Lost to Follow-up|1|||
146348928|NCT01455428|527782871|FG000|Overall Study|Withdrawal by Subject|2|||
146348929|NCT01455428|527782872|FG001|Overall Study|Withdrawal by Subject|5|||
146348930|NCT01455428|527782871|FG000|Overall Study|Did not meet entrance criteria|0|||
146348931|NCT01455428|527782872|FG001|Overall Study|Did not meet entrance criteria|2|||
146348932|NCT01455428|527782871|FG000|Overall Study|Insufficient clinical response|0|||
146348933|NCT01455428|527782872|FG001|Overall Study|Insufficient clinical response|2|||
146348934|NCT01455428|527782871|FG000|Overall Study|Did not receive treatment|1|||
146348935|NCT01455428|527782872|FG001|Overall Study|Did not receive treatment|1|||
146348936|NCT01455428|527782871|FG000|Overall Study|Other|2|||
146348937|NCT01455428|527782872|FG001|Overall Study|Other|4|||
146348938|NCT02062151|527782875|FG000|Overall Study|screen failure|1|||
146348939|NCT00257192|527782876|FG000|Overall Study|Adverse Event|21|||
146348940|NCT00257192|527782877|FG001|Overall Study|Adverse Event|10|||
146348941|NCT00257192|527782876|FG000|Overall Study|Laboratory abnormality|1|||
146348942|NCT00257192|527782877|FG001|Overall Study|Laboratory abnormality|1|||
146348943|NCT00257192|527782876|FG000|Overall Study|Lost to Follow-up|3|||
146348944|NCT00257192|527782877|FG001|Overall Study|Lost to Follow-up|3|||
146348945|NCT00257192|527782876|FG000|Overall Study|Insufficient clinical response|18|||
146348946|NCT00257192|527782877|FG001|Overall Study|Insufficient clinical response|18|||
146348947|NCT00257192|527782876|FG000|Overall Study|Withdrawal by Subject|14|||
146348948|NCT00257192|527782877|FG001|Overall Study|Withdrawal by Subject|2|||
146348949|NCT00257192|527782876|FG000|Overall Study|Randomized but not treated|0|||
146348950|NCT00257192|527782877|FG001|Overall Study|Randomized but not treated|1|||
146348951|NCT00257192|527782876|FG000|Overall Study|Study terminated by sponsor|1|||
146348952|NCT00257192|527782877|FG001|Overall Study|Study terminated by sponsor|0|||
146348953|NCT00257192|527782876|FG000|Overall Study|Miscellaneous|0|||
146348954|NCT00257192|527782877|FG001|Overall Study|Miscellaneous|4|||
146348955|NCT00570739|527782878|FG000|Overall Study|Adverse Event|8|||
146348956|NCT00570739|527782879|FG001|Overall Study|Adverse Event|6|||
146348957|NCT00570739|527782880|FG002|Overall Study|Adverse Event|2|||
146348958|NCT00570739|527782881|FG003|Overall Study|Adverse Event|2|||
146348959|NCT00570739|527782878|FG000|Overall Study|Lost to Follow-up|4|||
146348960|NCT00570739|527782879|FG001|Overall Study|Lost to Follow-up|5|||
146348961|NCT00570739|527782880|FG002|Overall Study|Lost to Follow-up|4|||
146348962|NCT00570739|527782881|FG003|Overall Study|Lost to Follow-up|1|||
146348963|NCT00570739|527782878|FG000|Overall Study|Physician Decision|1|||
146348964|NCT00570739|527782879|FG001|Overall Study|Physician Decision|1|||
146348965|NCT00570739|527782880|FG002|Overall Study|Physician Decision|0|||
146348966|NCT00570739|527782881|FG003|Overall Study|Physician Decision|0|||
146348967|NCT00570739|527782878|FG000|Overall Study|Withdrawal by Subject|7|||
146348968|NCT00570739|527782879|FG001|Overall Study|Withdrawal by Subject|7|||
146348969|NCT00570739|527782880|FG002|Overall Study|Withdrawal by Subject|3|||
146348970|NCT00570739|527782881|FG003|Overall Study|Withdrawal by Subject|5|||
146348971|NCT00570739|527782878|FG000|Overall Study|Required restricted medication|0|||
146348972|NCT00570739|527782879|FG001|Overall Study|Required restricted medication|0|||
146348973|NCT00570739|527782880|FG002|Overall Study|Required restricted medication|1|||
146348974|NCT00570739|527782881|FG003|Overall Study|Required restricted medication|0|||
146348975|NCT00570739|527782878|FG000|Overall Study|Met discontinuation criteria|1|||
146348976|NCT00570739|527782879|FG001|Overall Study|Met discontinuation criteria|0|||
146348977|NCT00570739|527782880|FG002|Overall Study|Met discontinuation criteria|1|||
146348978|NCT00570739|527782881|FG003|Overall Study|Met discontinuation criteria|1|||
146348979|NCT00570739|527782878|FG000|Overall Study|Other|0|||
146348980|NCT00570739|527782879|FG001|Overall Study|Other|2|||
146348981|NCT00570739|527782880|FG002|Overall Study|Other|5|||
146348982|NCT00570739|527782881|FG003|Overall Study|Other|3|||
146348983|NCT02086565|527782883|FG000|Overall Study|Lost to Follow-up|9|||
146348984|NCT02086565|527782884|FG001|Overall Study|Lost to Follow-up|7|||
146348985|NCT02086565|527782883|FG000|Overall Study|Withdrawal by Subject|2|||
146348986|NCT02086565|527782884|FG001|Overall Study|Withdrawal by Subject|1|||
146348987|NCT02086565|527782883|FG000|Overall Study|Death|3|||
146348988|NCT02086565|527782884|FG001|Overall Study|Death|2|||
146348989|NCT02086565|527782883|FG000|Overall Study|withdrawn by research team|2|||
146348990|NCT02086565|527782884|FG001|Overall Study|withdrawn by research team|2|||
146348991|NCT00751101|527782885|FG000|Overall Study|Withdrawal by Subject|1|||
146348992|NCT00751101|527782886|FG001|Overall Study|Withdrawal by Subject|0|||
146348993|NCT00751101|527782885|FG000|Overall Study|No HFS / Never Started Patch/|0|||
146348994|NCT00751101|527782886|FG001|Overall Study|No HFS / Never Started Patch/|4|||
146348995|NCT00751101|527782885|FG000|Overall Study|Never began capecitabine|1|||
146348996|NCT00751101|527782886|FG001|Overall Study|Never began capecitabine|0|||
146348997|NCT00751101|527782885|FG000|Overall Study|Physician Decision|0|||
146348998|NCT00751101|527782886|FG001|Overall Study|Physician Decision|1|||
146348999|NCT00739297|527782887|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
146349000|NCT00739297|527782888|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
146349001|NCT00739297|527782889|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
146349002|NCT00739297|527782890|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
146349003|NCT00739297|527782891|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
146349004|NCT00739297|527782892|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
146349005|NCT00739297|527782893|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
146349006|NCT00739297|527782887|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146349007|NCT00739297|527782888|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146349008|NCT00739297|527782889|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146349009|NCT00739297|527782890|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146349010|NCT00739297|527782891|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
146349011|NCT00739297|527782892|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
146349012|NCT00739297|527782893|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
146349013|NCT01921270|527782896|FG000|Overall Study|Withdrawal by Subject|1|||
146349014|NCT00844428|527782897|FG000|Screening Period|Screen Failure|3|||
146349015|NCT00844428|527782897|FG000|Extension Treatment Period|Death|1|||
146349016|NCT00844428|527782897|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
146349017|NCT00789477|527782898|FG000|Overall Study|Withdrawal by Subject|2|||
146349018|NCT00789477|527782899|FG001|Overall Study|Withdrawal by Subject|1|||
146349019|NCT00789477|527782900|FG002|Overall Study|Withdrawal by Subject|3|||
146349020|NCT00789477|527782901|FG003|Overall Study|Withdrawal by Subject|2|||
146349021|NCT00789477|527782902|FG004|Overall Study|Withdrawal by Subject|3|||
146349022|NCT00789477|527782898|FG000|Overall Study|Protocol Violation|1|||
146349023|NCT00789477|527782899|FG001|Overall Study|Protocol Violation|0|||
146349024|NCT00789477|527782900|FG002|Overall Study|Protocol Violation|0|||
146349025|NCT00789477|527782901|FG003|Overall Study|Protocol Violation|1|||
146349026|NCT00789477|527782902|FG004|Overall Study|Protocol Violation|0|||
146349027|NCT00789477|527782898|FG000|Overall Study|Adverse Event|3|||
146349028|NCT00789477|527782899|FG001|Overall Study|Adverse Event|3|||
146349029|NCT00789477|527782900|FG002|Overall Study|Adverse Event|1|||
146349030|NCT00789477|527782901|FG003|Overall Study|Adverse Event|0|||
146349031|NCT00789477|527782902|FG004|Overall Study|Adverse Event|0|||
146349032|NCT00789477|527782898|FG000|Overall Study|Death|1|||
146349033|NCT00789477|527782899|FG001|Overall Study|Death|1|||
146349034|NCT00789477|527782900|FG002|Overall Study|Death|2|||
146349035|NCT00789477|527782901|FG003|Overall Study|Death|2|||
146349036|NCT00789477|527782902|FG004|Overall Study|Death|0|||
146349037|NCT00789477|527782898|FG000|Overall Study|Lost to Follow-up|0|||
146349038|NCT00789477|527782899|FG001|Overall Study|Lost to Follow-up|1|||
146349039|NCT00789477|527782900|FG002|Overall Study|Lost to Follow-up|4|||
146349040|NCT00789477|527782901|FG003|Overall Study|Lost to Follow-up|2|||
146349041|NCT00789477|527782902|FG004|Overall Study|Lost to Follow-up|4|||
146349042|NCT00789477|527782898|FG000|Overall Study|Lack of Efficacy|2|||
146349043|NCT00789477|527782899|FG001|Overall Study|Lack of Efficacy|0|||
146349044|NCT00789477|527782900|FG002|Overall Study|Lack of Efficacy|0|||
146349045|NCT00789477|527782901|FG003|Overall Study|Lack of Efficacy|0|||
146349046|NCT00789477|527782902|FG004|Overall Study|Lack of Efficacy|0|||
146349047|NCT00789477|527782898|FG000|Overall Study|Other|2|||
146349048|NCT00789477|527782899|FG001|Overall Study|Other|0|||
146349049|NCT00789477|527782900|FG002|Overall Study|Other|1|||
146349050|NCT00789477|527782901|FG003|Overall Study|Other|3|||
146349051|NCT00789477|527782902|FG004|Overall Study|Other|0|||
146349052|NCT00455858|527782903|FG000|Overall Study|Lost to Follow-up|2|||
146349053|NCT00455858|527782903|FG000|Overall Study|Protocol Violation|1|||
146349054|NCT00455858|527782903|FG000|Overall Study|Lack of Efficacy|1|||
146349055|NCT00455858|527782903|FG000|Overall Study|Well controlled FPG without insulin|1|||
146349056|NCT00455858|527782903|FG000|Overall Study|Withdrawal|1|||
146349057|NCT02137772|527782904|FG000|Overall Study|Adverse Event|6|||
146349058|NCT02137772|527782905|FG001|Overall Study|Adverse Event|3|||
146349059|NCT02137772|527782904|FG000|Overall Study|Death|71|||
146349060|NCT02137772|527782905|FG001|Overall Study|Death|44|||
146349061|NCT02137772|527782904|FG000|Overall Study|Lost to Follow-up|8|||
146349062|NCT02137772|527782905|FG001|Overall Study|Lost to Follow-up|4|||
146349063|NCT02137772|527782904|FG000|Overall Study|Physician Decision|15|||
146349064|NCT02137772|527782905|FG001|Overall Study|Physician Decision|5|||
146349065|NCT02137772|527782904|FG000|Overall Study|Withdrawal by Subject|28|||
146349066|NCT02137772|527782905|FG001|Overall Study|Withdrawal by Subject|17|||
146349067|NCT02137772|527782904|FG000|Overall Study|Non-compliance with study drug|1|||
146349068|NCT02137772|527782905|FG001|Overall Study|Non-compliance with study drug|0|||
146349069|NCT02137772|527782904|FG000|Overall Study|Not treated|3|||
146349070|NCT02137772|527782905|FG001|Overall Study|Not treated|2|||
146349071|NCT02092389|527782906|FG000|Overall Study|Adverse Event|1|||
146349072|NCT02092389|527782906|FG000|Overall Study|Other|5|||
146349073|NCT01242020|527782907|FG000|Overall Study|Withdrawal by Subject|2|||
146349074|NCT01242020|527782908|FG001|Overall Study|Withdrawal by Subject|0|||
146349075|NCT01242020|527782907|FG000|Overall Study|Failed screening|1|||
146349076|NCT01242020|527782908|FG001|Overall Study|Failed screening|0|||
146349077|NCT01844700|527782909|FG000|Overall Study|Lack of Efficacy|1|||
146349078|NCT01844700|527782910|FG001|Overall Study|Lack of Efficacy|0|||
146349079|NCT01844700|527782909|FG000|Overall Study|refused medication switch|1|||
146349080|NCT01844700|527782910|FG001|Overall Study|refused medication switch|0|||
146349081|NCT01844700|527782909|FG000|Overall Study|Withdrawal by Subject|1|||
146349082|NCT01844700|527782910|FG001|Overall Study|Withdrawal by Subject|0|||
146349083|NCT01844700|527782909|FG000|Overall Study|stopped taking meds|0|||
146349084|NCT01844700|527782910|FG001|Overall Study|stopped taking meds|1|||
146349085|NCT02680847|527782911|FG000|Overall Study|Other|2|||
146349086|NCT02680847|527782912|FG001|Overall Study|Other|0|||
146349087|NCT02680847|527782913|FG002|Overall Study|Other|0|||
146349088|NCT02680847|527782911|FG000|Overall Study|No longer met eligibility criteria|2|||
146349089|NCT02680847|527782912|FG001|Overall Study|No longer met eligibility criteria|2|||
146349090|NCT02680847|527782913|FG002|Overall Study|No longer met eligibility criteria|0|||
146349091|NCT02680847|527782911|FG000|Overall Study|Unwilling to participate in study|1|||
146349092|NCT02680847|527782912|FG001|Overall Study|Unwilling to participate in study|1|||
146349093|NCT02680847|527782913|FG002|Overall Study|Unwilling to participate in study|0|||
146349094|NCT02680847|527782911|FG000|Overall Study|Lack of Efficacy|0|||
146349095|NCT02680847|527782912|FG001|Overall Study|Lack of Efficacy|0|||
146349096|NCT02680847|527782913|FG002|Overall Study|Lack of Efficacy|2|||
146349097|NCT02680847|527782911|FG000|Overall Study|Adverse Event|0|||
146349098|NCT02680847|527782912|FG001|Overall Study|Adverse Event|0|||
146349099|NCT02680847|527782913|FG002|Overall Study|Adverse Event|1|||
146349100|NCT02375698|527782914|FG000|Overall Study|Withdrawal by Subject|0|||
146349101|NCT02375698|527782915|FG001|Overall Study|Withdrawal by Subject|2|||
146349102|NCT02375698|527782914|FG000|Overall Study|Physician Decision|2|||
146349103|NCT02375698|527782915|FG001|Overall Study|Physician Decision|0|||
146349104|NCT00772967|527782916|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
146349105|NCT00772967|527782917|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
146349106|NCT00772967|527782918|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
146349107|NCT00772967|527782919|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
146349108|NCT00772967|527782920|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
146349109|NCT00772967|527782921|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
146349110|NCT00772967|527782916|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146349111|NCT00772967|527782917|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
146349112|NCT00772967|527782918|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146349113|NCT00772967|527782919|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146349114|NCT00772967|527782920|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146349115|NCT00772967|527782921|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
146349116|NCT00772967|527782916|FG000|Crossover Treatment 3|Adverse Event|0|||
146349117|NCT00772967|527782917|FG001|Crossover Treatment 3|Adverse Event|0|||
146349118|NCT00772967|527782918|FG002|Crossover Treatment 3|Adverse Event|0|||
146349119|NCT00772967|527782919|FG003|Crossover Treatment 3|Adverse Event|0|||
146349120|NCT00772967|527782920|FG004|Crossover Treatment 3|Adverse Event|1|||
146349121|NCT00772967|527782921|FG005|Crossover Treatment 3|Adverse Event|0|||
146349122|NCT01595646|527782922|FG000|Overall Study|Withdrawal by Subject|1|||
146349123|NCT01595646|527782923|FG001|Overall Study|Withdrawal by Subject|0|||
146349124|NCT01595646|527782924|FG002|Overall Study|Withdrawal by Subject|0|||
146349125|NCT04172831|527782926|FG000|Overall Study|Adverse Event|21|||
146349126|NCT04172831|527782927|FG001|Overall Study|Adverse Event|9|||
146349127|NCT04172831|527782926|FG000|Overall Study|Lack of Efficacy|2|||
146349128|NCT04172831|527782927|FG001|Overall Study|Lack of Efficacy|8|||
146349129|NCT04172831|527782926|FG000|Overall Study|Physician Decision|0|||
146349130|NCT04172831|527782927|FG001|Overall Study|Physician Decision|1|||
146349131|NCT04172831|527782926|FG000|Overall Study|Withdrawal by Subject|12|||
146349132|NCT04172831|527782927|FG001|Overall Study|Withdrawal by Subject|11|||
146349133|NCT04172831|527782926|FG000|Overall Study|Lost to Follow-up|4|||
146349134|NCT04172831|527782927|FG001|Overall Study|Lost to Follow-up|9|||
146349135|NCT04172831|527782926|FG000|Overall Study|COVID-19 related crisis|3|||
146349136|NCT04172831|527782927|FG001|Overall Study|COVID-19 related crisis|3|||
146349137|NCT04172831|527782926|FG000|Overall Study|Subject non-compliance|1|||
146349138|NCT04172831|527782927|FG001|Overall Study|Subject non-compliance|1|||
146349139|NCT04172831|527782926|FG000|Overall Study|Family emergency|1|||
146349140|NCT04172831|527782927|FG001|Overall Study|Family emergency|0|||
146349141|NCT01651260|527782931|FG000|Overall Study|unable to apply product|3|||
146349142|NCT02239094|527782932|FG000|Overall Study|Withdrawal by Subject|1|||
146349143|NCT02239094|527782932|FG000|Overall Study|Remitted before started|1|||
146349144|NCT03648996|527782935|FG000|Overall Study|Withdrawal by Subject|0|||
146349145|NCT03648996|527782936|FG001|Overall Study|Withdrawal by Subject|2|||
146349146|NCT03648996|527782937|FG002|Overall Study|Withdrawal by Subject|2|||
146349147|NCT03648996|527782935|FG000|Overall Study|Physician Decision|2|||
146349148|NCT03648996|527782936|FG001|Overall Study|Physician Decision|0|||
146349149|NCT03648996|527782937|FG002|Overall Study|Physician Decision|0|||
146349150|NCT01963117|527782945|FG000|Overall Study|Death|1|||
146349151|NCT01780389|527782946|FG000|Overall Study|Adverse Event|1|||
146349152|NCT01095250|527782947|FG000|Overall Study|administrative reasons|8|||
146349153|NCT01095250|527782948|FG001|Overall Study|administrative reasons|10|||
146349154|NCT01095250|527782949|FG002|Overall Study|administrative reasons|7|||
146349155|NCT01095250|527782950|FG003|Overall Study|administrative reasons|5|||
146349156|NCT01095250|527782947|FG000|Overall Study|Withdrawal by Subject|0|||
146349157|NCT01095250|527782948|FG001|Overall Study|Withdrawal by Subject|0|||
146349158|NCT01095250|527782949|FG002|Overall Study|Withdrawal by Subject|1|||
146349159|NCT01095250|527782950|FG003|Overall Study|Withdrawal by Subject|0|||
146349160|NCT01605396|527782955|FG000|Overall Study|Adverse Event|5|||
146349161|NCT01605396|527782956|FG001|Overall Study|Adverse Event|3|||
146349162|NCT01605396|527782955|FG000|Overall Study|Lost to Follow-up|1|||
146349163|NCT01605396|527782956|FG001|Overall Study|Lost to Follow-up|0|||
146349164|NCT01605396|527782955|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146349165|NCT01605396|527782956|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146349166|NCT01605396|527782955|FG000|Overall Study|Physician Decision|2|||
146349167|NCT01605396|527782956|FG001|Overall Study|Physician Decision|2|||
146349168|NCT01605396|527782955|FG000|Overall Study|Progressive Disease|23|||
146349169|NCT01605396|527782956|FG001|Overall Study|Progressive Disease|27|||
146349170|NCT01605396|527782955|FG000|Overall Study|Withdrawal by Subject|4|||
146349171|NCT01605396|527782956|FG001|Overall Study|Withdrawal by Subject|2|||
146349172|NCT01605396|527782955|FG000|Overall Study|Transfer Off Study|4|||
146349173|NCT01605396|527782956|FG001|Overall Study|Transfer Off Study|5|||
146349174|NCT04598165|527782958|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
146349175|NCT04598165|527782959|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
146349176|NCT04598165|527782958|FG000|Completed 6-week Follow-up|Death|2|||
146349177|NCT04598165|527782959|FG001|Completed 6-week Follow-up|Death|1|||
146349178|NCT04598165|527782958|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
146349179|NCT04598165|527782959|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
146349180|NCT04598165|527782958|FG000|Completed 6-week Follow-up|Ineligible|4|||
146349181|NCT04598165|527782959|FG001|Completed 6-week Follow-up|Ineligible|3|||
146349182|NCT04598165|527782958|FG000|Completed 6-week Follow-up|Partner refusal|0|||
146349183|NCT04598165|527782959|FG001|Completed 6-week Follow-up|Partner refusal|1|||
146349184|NCT04598165|527782958|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
146349185|NCT04598165|527782959|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
146349186|NCT01323673|527782960|FG000|Overall Study|Adverse Event|0|||
146349187|NCT01323673|527782961|FG001|Overall Study|Adverse Event|1|||
146349188|NCT01323673|527782960|FG000|Overall Study|Lost to Follow-up|0|||
146349189|NCT01323673|527782961|FG001|Overall Study|Lost to Follow-up|1|||
146349190|NCT01323673|527782960|FG000|Overall Study|Protocol Violation|1|||
146349191|NCT01323673|527782961|FG001|Overall Study|Protocol Violation|0|||
146349192|NCT01323673|527782960|FG000|Overall Study|Withdrawal by Subject|2|||
146349193|NCT01323673|527782961|FG001|Overall Study|Withdrawal by Subject|3|||
146349194|NCT04430582|527782962|FG000|Overall Study|Found to meet exclusionary criteria|1|||
146349195|NCT04430582|527782963|FG001|Overall Study|Found to meet exclusionary criteria|0|||
146349196|NCT04430582|527782962|FG000|Overall Study|Withdrawal by Subject|0|||
146349197|NCT04430582|527782963|FG001|Overall Study|Withdrawal by Subject|1|||
146349198|NCT03607682|527782964|FG000|Overall Study|Withdrawal by Subject|1|||
146349199|NCT03607682|527782964|FG000|Overall Study|Disease progression|1|||
146349200|NCT03625986|527785077|FG000|Randomization Period|Lost to Follow-up|7|||
146349201|NCT03625986|527785078|FG001|Randomization Period|Lost to Follow-up|12|||
146349202|NCT03625986|527785077|FG000|Randomization Period|Withdrawal by Subject|10|||
146349203|NCT03625986|527785078|FG001|Randomization Period|Withdrawal by Subject|6|||
146349204|NCT04359823|527785079|FG000|Overall Study|Lost to Follow-up|0|||
146169444|NCT01892345|527132819|FG000|Overall Study|Adverse Event|0|||
146349205|NCT04359823|527785080|FG001|Overall Study|Lost to Follow-up|1|||
146349206|NCT04359823|527785079|FG000|Overall Study|Withdrawal by Subject|0|||
146349207|NCT04359823|527785080|FG001|Overall Study|Withdrawal by Subject|1|||
146395697|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
146349208|NCT04191967|527785081|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
146349209|NCT04191967|527785081|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
146349210|NCT02078713|527785082|FG000|Overall Study|Lost to Follow-up|49|||
146349211|NCT02078713|527785083|FG001|Overall Study|Lost to Follow-up|55|||
146349212|NCT02078713|527785084|FG002|Overall Study|Lost to Follow-up|0|||
146349213|NCT02078713|527785085|FG003|Overall Study|Lost to Follow-up|0|||
146349214|NCT02078713|527785082|FG000|Overall Study|Pregnant at baseline|3|||
146349215|NCT02078713|527785083|FG001|Overall Study|Pregnant at baseline|5|||
146349216|NCT02078713|527785084|FG002|Overall Study|Pregnant at baseline|0|||
146349217|NCT02078713|527785085|FG003|Overall Study|Pregnant at baseline|0|||
146349218|NCT02078713|527785082|FG000|Overall Study|Enrolled twice|0|||
146349219|NCT02078713|527785083|FG001|Overall Study|Enrolled twice|1|||
146349220|NCT02078713|527785084|FG002|Overall Study|Enrolled twice|0|||
146349221|NCT02078713|527785085|FG003|Overall Study|Enrolled twice|0|||
146349222|NCT00696657|527785086|FG000|Overall Study|Protocol Violation|0|||
146349223|NCT00696657|527785087|FG001|Overall Study|Protocol Violation|0|||
146349224|NCT00696657|527785088|FG002|Overall Study|Protocol Violation|0|||
146349225|NCT00696657|527785089|FG003|Overall Study|Protocol Violation|0|||
146349226|NCT00696657|527785090|FG004|Overall Study|Protocol Violation|0|||
146349227|NCT00696657|527785091|FG005|Overall Study|Protocol Violation|1|||
146349228|NCT00696657|527785092|FG006|Overall Study|Protocol Violation|0|||
146349229|NCT00696657|527785093|FG007|Overall Study|Protocol Violation|0|||
146349230|NCT00696657|527785094|FG008|Overall Study|Protocol Violation|1|||
146349231|NCT00696657|527785086|FG000|Overall Study|Lack of Efficacy|0|||
146349232|NCT00696657|527785087|FG001|Overall Study|Lack of Efficacy|1|||
146349233|NCT00696657|527785088|FG002|Overall Study|Lack of Efficacy|0|||
146349234|NCT00696657|527785089|FG003|Overall Study|Lack of Efficacy|0|||
146349235|NCT00696657|527785090|FG004|Overall Study|Lack of Efficacy|0|||
146349236|NCT00696657|527785091|FG005|Overall Study|Lack of Efficacy|0|||
146349237|NCT00696657|527785092|FG006|Overall Study|Lack of Efficacy|0|||
146349238|NCT00696657|527785093|FG007|Overall Study|Lack of Efficacy|0|||
146349239|NCT00696657|527785094|FG008|Overall Study|Lack of Efficacy|0|||
146349240|NCT00696657|527785086|FG000|Overall Study|Withdrawal criteria|1|||
146349241|NCT00696657|527785087|FG001|Overall Study|Withdrawal criteria|3|||
146349242|NCT00696657|527785088|FG002|Overall Study|Withdrawal criteria|2|||
146349243|NCT00696657|527785089|FG003|Overall Study|Withdrawal criteria|2|||
146349244|NCT00696657|527785090|FG004|Overall Study|Withdrawal criteria|0|||
146349245|NCT00696657|527785091|FG005|Overall Study|Withdrawal criteria|0|||
146349246|NCT00696657|527785092|FG006|Overall Study|Withdrawal criteria|1|||
146349247|NCT00696657|527785093|FG007|Overall Study|Withdrawal criteria|1|||
146349248|NCT00696657|527785094|FG008|Overall Study|Withdrawal criteria|2|||
146349249|NCT00696657|527785086|FG000|Overall Study|Unclassified|0|||
146349250|NCT00696657|527785087|FG001|Overall Study|Unclassified|1|||
146349251|NCT00696657|527785088|FG002|Overall Study|Unclassified|3|||
146349252|NCT00696657|527785089|FG003|Overall Study|Unclassified|2|||
146349253|NCT00696657|527785090|FG004|Overall Study|Unclassified|4|||
146349254|NCT00696657|527785091|FG005|Overall Study|Unclassified|2|||
146349255|NCT00696657|527785092|FG006|Overall Study|Unclassified|0|||
146349256|NCT00696657|527785093|FG007|Overall Study|Unclassified|0|||
146349257|NCT00696657|527785094|FG008|Overall Study|Unclassified|1|||
146349258|NCT00696657|527785086|FG000|Overall Study|Adverse Event|0|||
146349259|NCT00696657|527785087|FG001|Overall Study|Adverse Event|0|||
146349260|NCT00696657|527785088|FG002|Overall Study|Adverse Event|3|||
146349261|NCT00696657|527785089|FG003|Overall Study|Adverse Event|7|||
146349262|NCT00696657|527785090|FG004|Overall Study|Adverse Event|6|||
146349263|NCT00696657|527785091|FG005|Overall Study|Adverse Event|9|||
146349264|NCT00696657|527785092|FG006|Overall Study|Adverse Event|14|||
146349265|NCT00696657|527785093|FG007|Overall Study|Adverse Event|2|||
146349266|NCT00696657|527785094|FG008|Overall Study|Adverse Event|5|||
146349267|NCT01790438|527785095|FG000|Overall Study|Adverse Event|3|||
146349268|NCT01790438|527785096|FG001|Overall Study|Adverse Event|2|||
146349269|NCT01790438|527785095|FG000|Overall Study|Death|4|||
146349270|NCT01790438|527785096|FG001|Overall Study|Death|0|||
146349271|NCT01790438|527785095|FG000|Overall Study|Lost to Follow-up|5|||
146349272|NCT01790438|527785096|FG001|Overall Study|Lost to Follow-up|2|||
146349273|NCT01790438|527785095|FG000|Overall Study|Withdrawal by Subject|13|||
146349274|NCT01790438|527785096|FG001|Overall Study|Withdrawal by Subject|2|||
146349275|NCT01790438|527785095|FG000|Overall Study|Physician Decision|3|||
146349276|NCT01790438|527785096|FG001|Overall Study|Physician Decision|1|||
146349277|NCT01790438|527785095|FG000|Overall Study|Sponsor Decision|0|||
146349278|NCT01790438|527785096|FG001|Overall Study|Sponsor Decision|3|||
146349279|NCT01790438|527785095|FG000|Overall Study|Protocol Required Discontinuation|7|||
146349280|NCT01790438|527785096|FG001|Overall Study|Protocol Required Discontinuation|1|||
146349281|NCT02433210|527785100|FG000|Overall Study|Physician Decision|1|||
146349282|NCT02433210|527785101|FG001|Overall Study|Physician Decision|0|||
146349283|NCT02433210|527785102|FG002|Overall Study|Physician Decision|0|||
146349284|NCT03123354|527785103|FG000|Overall Study|Physician Decision|6|||
146349285|NCT04494633|527785106|FG000|Overall Study|Lost to Follow-up|5|||
146349286|NCT04494633|527785107|FG001|Overall Study|Lost to Follow-up|3|||
146349287|NCT04494633|527785106|FG000|Overall Study|Protocol Violation|1|||
146349288|NCT04494633|527785107|FG001|Overall Study|Protocol Violation|1|||
146349289|NCT04907539|527785108|FG000|Overall Study|Consent withdrawn|1|||
146349290|NCT04907539|527785109|FG001|Overall Study|Consent withdrawn|0|||
146349291|NCT04907539|527785108|FG000|Overall Study|Death|14|||
146349292|NCT04907539|527785109|FG001|Overall Study|Death|3|||
146349293|NCT01881620|527785112|FG000|Overall Study|Protocol Violation|4|||
146349294|NCT01808118|527785115|FG000|Period 1|Adverse Event|15|||
146349295|NCT01808118|527785116|FG001|Period 1|Adverse Event|0|||
146349296|NCT01808118|527785117|FG002|Period 1|Adverse Event|0|||
146349297|NCT01808118|527785115|FG000|Period 1|Withdrew consent|24|||
146349298|NCT01808118|527785116|FG001|Period 1|Withdrew consent|0|||
146349299|NCT01808118|527785117|FG002|Period 1|Withdrew consent|0|||
146349300|NCT01808118|527785115|FG000|Period 1|Lost to Follow-up|9|||
146349301|NCT01808118|527785116|FG001|Period 1|Lost to Follow-up|0|||
146349302|NCT01808118|527785117|FG002|Period 1|Lost to Follow-up|0|||
146349303|NCT01808118|527785115|FG000|Period 1|Did not meet criteria for remission|303|||
146349304|NCT01808118|527785116|FG001|Period 1|Did not meet criteria for remission|0|||
146349305|NCT01808118|527785117|FG002|Period 1|Did not meet criteria for remission|0|||
146349306|NCT01808118|527785115|FG000|Period 1|Enrolled in error|7|||
146349307|NCT01808118|527785116|FG001|Period 1|Enrolled in error|0|||
146349308|NCT01808118|527785117|FG002|Period 1|Enrolled in error|0|||
146349309|NCT01808118|527785115|FG000|Period 1|Did not meet inclusion criteria|3|||
146349310|NCT01808118|527785116|FG001|Period 1|Did not meet inclusion criteria|0|||
146349311|NCT01808118|527785117|FG002|Period 1|Did not meet inclusion criteria|0|||
146349312|NCT01808118|527785115|FG000|Period 1|Non-conformance with inclusion criteria|3|||
146349313|NCT01808118|527785116|FG001|Period 1|Non-conformance with inclusion criteria|0|||
146349314|NCT01808118|527785117|FG002|Period 1|Non-conformance with inclusion criteria|0|||
146349315|NCT01808118|527785115|FG000|Period 1|Investigator decision: site closure|2|||
146349316|NCT01808118|527785116|FG001|Period 1|Investigator decision: site closure|0|||
146349317|NCT01808118|527785117|FG002|Period 1|Investigator decision: site closure|0|||
146349318|NCT01808118|527785115|FG000|Period 1|Non-compliance per sponsor|1|||
146349319|NCT01808118|527785116|FG001|Period 1|Non-compliance per sponsor|0|||
146349320|NCT01808118|527785117|FG002|Period 1|Non-compliance per sponsor|0|||
146349321|NCT01808118|527785115|FG000|Period 1|Lack of Efficacy|1|||
146349322|NCT01808118|527785116|FG001|Period 1|Lack of Efficacy|0|||
146349323|NCT01808118|527785117|FG002|Period 1|Lack of Efficacy|0|||
146349324|NCT01808118|527785115|FG000|Period 2|Adverse Event|0|||
146349325|NCT01808118|527785116|FG001|Period 2|Adverse Event|4|||
146349326|NCT01808118|527785117|FG002|Period 2|Adverse Event|0|||
146349327|NCT01808118|527785115|FG000|Period 2|Withdrew consent|0|||
146349328|NCT01808118|527785116|FG001|Period 2|Withdrew consent|7|||
146349329|NCT01808118|527785117|FG002|Period 2|Withdrew consent|6|||
146349330|NCT01808118|527785115|FG000|Period 2|Lost to Follow-up|0|||
146349331|NCT01808118|527785116|FG001|Period 2|Lost to Follow-up|0|||
146349332|NCT01808118|527785117|FG002|Period 2|Lost to Follow-up|2|||
146349333|NCT01808118|527785115|FG000|Period 2|Investigator no longer conducting trials|0|||
146349334|NCT01808118|527785116|FG001|Period 2|Investigator no longer conducting trials|1|||
146349335|NCT01808118|527785117|FG002|Period 2|Investigator no longer conducting trials|0|||
146349336|NCT01808118|527785115|FG000|Period 2|Switched to other therapy|0|||
146349337|NCT01808118|527785116|FG001|Period 2|Switched to other therapy|1|||
146349338|NCT01808118|527785117|FG002|Period 2|Switched to other therapy|0|||
146349339|NCT00414310|527785118|FG000|Overall Study|Not treated|1|||
146349340|NCT00414310|527785119|FG001|Overall Study|Not treated|0|||
146349341|NCT01993329|527785123|FG000|Period 2|Adverse Event|0|||
146349342|NCT01993329|527785124|FG001|Period 2|Adverse Event|0|||
146349343|NCT01993329|527785125|FG002|Period 2|Adverse Event|0|||
146349344|NCT01993329|527785126|FG003|Period 2|Adverse Event|0|||
146349345|NCT01993329|527785127|FG004|Period 2|Adverse Event|0|||
146349346|NCT01993329|527785128|FG005|Period 2|Adverse Event|1|||
146349347|NCT01993329|527785123|FG000|Wash-out|Personal reasons|0|||
146349348|NCT01993329|527785124|FG001|Wash-out|Personal reasons|1|||
146349349|NCT01993329|527785125|FG002|Wash-out|Personal reasons|0|||
146349350|NCT01993329|527785126|FG003|Wash-out|Personal reasons|0|||
146349351|NCT01993329|527785127|FG004|Wash-out|Personal reasons|0|||
146349352|NCT01993329|527785128|FG005|Wash-out|Personal reasons|0|||
146349353|NCT05070429|527785129|FG000|Overall Study|Death|0|||
146349354|NCT05070429|527785130|FG001|Overall Study|Death|4|||
146349355|NCT05070429|527785129|FG000|Overall Study|Withdrawal by Subject|2|||
146349356|NCT05070429|527785130|FG001|Overall Study|Withdrawal by Subject|1|||
146349357|NCT05070429|527785129|FG000|Overall Study|Other|15|||
146349358|NCT05070429|527785130|FG001|Overall Study|Other|5|||
146349359|NCT02311478|527785131|FG000|Overall Study|Withdrawal by Subject|1|||
146349360|NCT02311478|527785131|FG000|Overall Study|Lost to Follow-up|5|||
146349361|NCT02311478|527785131|FG000|Overall Study|Failed IUD Insertion|1|||
146349362|NCT03276936|527785132|FG000|Overall Study|Adverse Event|4|||
146349363|NCT03276936|527785133|FG001|Overall Study|Adverse Event|2|||
146349364|NCT03276936|527785132|FG000|Overall Study|Lost to Follow-up|16|||
146349365|NCT03276936|527785133|FG001|Overall Study|Lost to Follow-up|13|||
146349366|NCT03276936|527785132|FG000|Overall Study|Withdrawal by Subject|30|||
146349367|NCT03276936|527785133|FG001|Overall Study|Withdrawal by Subject|20|||
146349368|NCT03276936|527785132|FG000|Overall Study|Not mentioned|6|||
146349369|NCT03276936|527785133|FG001|Overall Study|Not mentioned|3|||
146349370|NCT03041116|527785134|FG000|Double-blind|Death|0|||
146349371|NCT03041116|527785135|FG001|Double-blind|Death|2|||
146349372|NCT03041116|527785134|FG000|Double-blind|Withdrawal by Subject|0|||
146349373|NCT03041116|527785135|FG001|Double-blind|Withdrawal by Subject|4|||
146349374|NCT03041116|527785134|FG000|Open-label|Death|1|||
146349375|NCT03041116|527785135|FG001|Open-label|Death|0|||
146349376|NCT03041116|527785134|FG000|Open-label|Termination of the study by Sponsor|39|||
146349377|NCT03041116|527785135|FG001|Open-label|Termination of the study by Sponsor|37|||
146349378|NCT03041116|527785134|FG000|Open-label|Withdrawal by Subject|1|||
146349379|NCT03041116|527785135|FG001|Open-label|Withdrawal by Subject|0|||
146349380|NCT00943319|527785136|FG000|Overall Study|Death|1|||
146349381|NCT02043301|527785137|FG000|Overall Study|Discontinued|0|||
146349382|NCT02043301|527785138|FG001|Overall Study|Discontinued|1|||
146349383|NCT02043301|527785139|FG002|Overall Study|Discontinued|0|||
146349384|NCT01798134|527785140|FG000|Overall Study|Lost to Follow-up|1|||
146349385|NCT01798134|527785140|FG000|Overall Study|Withdrawal by Subject|3|||
146349386|NCT01798134|527785140|FG000|Overall Study|Death|2|||
146349387|NCT01798134|527785140|FG000|Overall Study|Adverse Event|3|||
146349388|NCT01798134|527785140|FG000|Overall Study|Physician Decision|3|||
146349389|NCT01798134|527785140|FG000|Overall Study|Liver transplant/surgery|4|||
146349390|NCT02023164|527785141|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
146349391|NCT02023164|527785142|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
146349392|NCT02436577|527785143|FG000|Overall Study|Protocol Deviation|0|||
146349393|NCT02436577|527785144|FG001|Overall Study|Protocol Deviation|1|||
146349394|NCT02436577|527785145|FG002|Overall Study|Protocol Deviation|0|||
146349395|NCT02436577|527785146|FG003|Overall Study|Protocol Deviation|0|||
146349396|NCT02436577|527785147|FG004|Overall Study|Protocol Deviation|0|||
146349397|NCT02436577|527785148|FG005|Overall Study|Protocol Deviation|0|||
146349398|NCT03650452|527785149|FG000|Overall Study|Physician Decision|1|||
146349399|NCT03650452|527785150|FG001|Overall Study|Physician Decision|0|||
146349400|NCT03650452|527785149|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
146349401|NCT03650452|527785150|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
146349402|NCT03650452|527785149|FG000|Overall Study|Adverse Event|3|||
146349403|NCT03650452|527785150|FG001|Overall Study|Adverse Event|4|||
146349404|NCT03650452|527785149|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
146349405|NCT03650452|527785150|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
146349406|NCT02531373|527785164|FG000|Overall Study|Lack of Efficacy|0|||
146349407|NCT02531373|527785165|FG001|Overall Study|Lack of Efficacy|0|||
146349408|NCT02531373|527785166|FG002|Overall Study|Lack of Efficacy|0|||
146349409|NCT02531373|527785167|FG003|Overall Study|Lack of Efficacy|0|||
146349410|NCT02531373|527785168|FG004|Overall Study|Lack of Efficacy|3|||
146349411|NCT02531373|527785169|FG005|Overall Study|Lack of Efficacy|2|||
146349412|NCT02531373|527785170|FG006|Overall Study|Lack of Efficacy|4|||
146349413|NCT02531373|527785171|FG007|Overall Study|Lack of Efficacy|8|||
146349414|NCT02531373|527785172|FG008|Overall Study|Lack of Efficacy|5|||
146349415|NCT02531373|527785164|FG000|Overall Study|Lost to Follow-up|0|||
146349416|NCT02531373|527785165|FG001|Overall Study|Lost to Follow-up|0|||
146349417|NCT02531373|527785166|FG002|Overall Study|Lost to Follow-up|0|||
146349418|NCT02531373|527785167|FG003|Overall Study|Lost to Follow-up|0|||
146349419|NCT02531373|527785168|FG004|Overall Study|Lost to Follow-up|0|||
146349420|NCT02531373|527785169|FG005|Overall Study|Lost to Follow-up|2|||
146349421|NCT02531373|527785170|FG006|Overall Study|Lost to Follow-up|2|||
146349422|NCT02531373|527785171|FG007|Overall Study|Lost to Follow-up|0|||
146349423|NCT02531373|527785172|FG008|Overall Study|Lost to Follow-up|0|||
146349424|NCT02531373|527785164|FG000|Overall Study|Physician Decision|0|||
146349425|NCT02531373|527785165|FG001|Overall Study|Physician Decision|0|||
146349426|NCT02531373|527785166|FG002|Overall Study|Physician Decision|0|||
146349427|NCT02531373|527785167|FG003|Overall Study|Physician Decision|0|||
146349428|NCT02531373|527785168|FG004|Overall Study|Physician Decision|2|||
146349429|NCT02531373|527785169|FG005|Overall Study|Physician Decision|1|||
146349430|NCT02531373|527785170|FG006|Overall Study|Physician Decision|0|||
146349431|NCT02531373|527785171|FG007|Overall Study|Physician Decision|0|||
146349432|NCT02531373|527785172|FG008|Overall Study|Physician Decision|0|||
146349433|NCT02531373|527785164|FG000|Overall Study|Protocol Violation|0|||
146349434|NCT02531373|527785165|FG001|Overall Study|Protocol Violation|0|||
146349435|NCT02531373|527785166|FG002|Overall Study|Protocol Violation|0|||
146349436|NCT02531373|527785167|FG003|Overall Study|Protocol Violation|0|||
146349437|NCT02531373|527785168|FG004|Overall Study|Protocol Violation|0|||
146349438|NCT02531373|527785169|FG005|Overall Study|Protocol Violation|1|||
146349439|NCT02531373|527785170|FG006|Overall Study|Protocol Violation|1|||
146349440|NCT02531373|527785171|FG007|Overall Study|Protocol Violation|0|||
146349441|NCT02531373|527785172|FG008|Overall Study|Protocol Violation|1|||
146349442|NCT02531373|527785164|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146349443|NCT02531373|527785165|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146349444|NCT02531373|527785166|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146349445|NCT02531373|527785167|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146349446|NCT02531373|527785168|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146169445|NCT01892345|527132820|FG001|Overall Study|Adverse Event|2|||
146169446|NCT01892345|527132819|FG000|Overall Study|Death|1|||
146169447|NCT01892345|527132820|FG001|Overall Study|Death|0|||
146169448|NCT01892345|527132819|FG000|Overall Study|Lost to Follow-up|3|||
146169449|NCT01892345|527132820|FG001|Overall Study|Lost to Follow-up|0|||
146169450|NCT01892345|527132819|FG000|Overall Study|Withdrawal by Subject|12|||
146349447|NCT02531373|527785169|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
146349448|NCT02531373|527785170|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
146349449|NCT02531373|527785171|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
146349450|NCT02531373|527785172|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
146349451|NCT02531373|527785164|FG000|Overall Study|Withdrawal by Subject|0|||
146349452|NCT02531373|527785165|FG001|Overall Study|Withdrawal by Subject|0|||
146349453|NCT02531373|527785166|FG002|Overall Study|Withdrawal by Subject|0|||
146349454|NCT02531373|527785167|FG003|Overall Study|Withdrawal by Subject|0|||
146349455|NCT02531373|527785168|FG004|Overall Study|Withdrawal by Subject|3|||
146349456|NCT02531373|527785169|FG005|Overall Study|Withdrawal by Subject|0|||
146349457|NCT02531373|527785170|FG006|Overall Study|Withdrawal by Subject|0|||
146349458|NCT02531373|527785171|FG007|Overall Study|Withdrawal by Subject|0|||
146349459|NCT02531373|527785172|FG008|Overall Study|Withdrawal by Subject|0|||
146349460|NCT00623467|527785175|FG000|Overall Study|Lost to Follow-up|1|||
146349461|NCT00623467|527785175|FG000|Overall Study|Protocol Violation|4|||
146349462|NCT00623467|527785175|FG000|Overall Study|Withdrawal by Subject|2|||
146349463|NCT02834403|527785184|FG000|Overall Study|Physician Decision|2|||
146349464|NCT02834403|527785185|FG001|Overall Study|Physician Decision|1|||
146349465|NCT02834403|527785186|FG002|Overall Study|Physician Decision|2|||
146349466|NCT02834403|527785187|FG003|Overall Study|Physician Decision|1|||
146349467|NCT02834403|527785188|FG004|Overall Study|Physician Decision|1|||
146349468|NCT02834403|527785189|FG005|Overall Study|Physician Decision|2|||
146349469|NCT02834403|527785190|FG006|Overall Study|Physician Decision|12|||
146349470|NCT02834403|527785184|FG000|Overall Study|Adverse Event|0|||
146349471|NCT02834403|527785185|FG001|Overall Study|Adverse Event|0|||
146349472|NCT02834403|527785186|FG002|Overall Study|Adverse Event|0|||
146349473|NCT02834403|527785187|FG003|Overall Study|Adverse Event|0|||
146349474|NCT02834403|527785188|FG004|Overall Study|Adverse Event|1|||
146349475|NCT02834403|527785189|FG005|Overall Study|Adverse Event|1|||
146349476|NCT02834403|527785190|FG006|Overall Study|Adverse Event|3|||
146349477|NCT02834403|527785184|FG000|Overall Study|Withdrawal by Subject|0|||
146349478|NCT02834403|527785185|FG001|Overall Study|Withdrawal by Subject|1|||
146169451|NCT01892345|527132820|FG001|Overall Study|Withdrawal by Subject|1|||
146169452|NCT03505476|527132821|FG000|Overall Study|Physician Decision|18|||
146169453|NCT03505476|527132821|FG000|Overall Study|Device Malfunctioned|101|||
146169454|NCT03505476|527132821|FG000|Overall Study|Data Corrupt|6|||
146169455|NCT03505476|527132821|FG000|Overall Study|Device application insufficiant|3|||
146169456|NCT04026165|527132822|FG000|Run-in Placebo Period|Enrollment Error|13|||
146169457|NCT04026165|527132823|FG001|Run-in Placebo Period|Enrollment Error|0|||
146169458|NCT04026165|527132824|FG002|Run-in Placebo Period|Enrollment Error|0|||
146169459|NCT04026165|527132825|FG003|Run-in Placebo Period|Enrollment Error|0|||
146169460|NCT04026165|527132822|FG000|Run-in Placebo Period|Run-in Failure|4|||
146169461|NCT04026165|527132823|FG001|Run-in Placebo Period|Run-in Failure|0|||
146169462|NCT04026165|527132824|FG002|Run-in Placebo Period|Run-in Failure|0|||
146169463|NCT04026165|527132825|FG003|Run-in Placebo Period|Run-in Failure|0|||
146169464|NCT04026165|527132822|FG000|Run-in Placebo Period|Protocol Violation|2|||
146169465|NCT04026165|527132823|FG001|Run-in Placebo Period|Protocol Violation|0|||
146169466|NCT04026165|527132824|FG002|Run-in Placebo Period|Protocol Violation|0|||
146169467|NCT04026165|527132825|FG003|Run-in Placebo Period|Protocol Violation|0|||
146169468|NCT04026165|527132822|FG000|Run-in Placebo Period|Withdrew Consent|2|||
146169469|NCT04026165|527132823|FG001|Run-in Placebo Period|Withdrew Consent|0|||
146169470|NCT04026165|527132824|FG002|Run-in Placebo Period|Withdrew Consent|0|||
146169471|NCT04026165|527132825|FG003|Run-in Placebo Period|Withdrew Consent|0|||
146349479|NCT02834403|527785186|FG002|Overall Study|Withdrawal by Subject|0|||
146349480|NCT02834403|527785187|FG003|Overall Study|Withdrawal by Subject|0|||
146349481|NCT02834403|527785188|FG004|Overall Study|Withdrawal by Subject|1|||
146349482|NCT02834403|527785189|FG005|Overall Study|Withdrawal by Subject|0|||
146349483|NCT02834403|527785190|FG006|Overall Study|Withdrawal by Subject|0|||
146349484|NCT02834403|527785184|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
146349485|NCT02834403|527785185|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
146349486|NCT02834403|527785186|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
146349487|NCT02834403|527785187|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
146349488|NCT02834403|527785188|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
146169472|NCT04026165|527132822|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
146169473|NCT04026165|527132823|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146169474|NCT04026165|527132824|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146169475|NCT04026165|527132825|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
146169476|NCT04026165|527132822|FG000|Run-in SEL Period|Run-in Failure|0|||
146169477|NCT04026165|527132823|FG001|Run-in SEL Period|Run-in Failure|26|||
146349489|NCT02834403|527785189|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
146349490|NCT02834403|527785190|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
146349491|NCT00273858|527785197|FG000|Overall Study|Not completed 24 month observation time|334|||
146349492|NCT00273858|527785197|FG000|Overall Study|Lost to Follow-up|101|||
146349493|NCT00273858|527785197|FG000|Overall Study|Withdrawal by Subject|21|||
146349494|NCT00273858|527785197|FG000|Overall Study|Adverse Event|81|||
146349495|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
146349496|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
146349497|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
146349498|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
146349499|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
146349500|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
146349501|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
146349502|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
146349503|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
146349504|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
146349505|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
146349506|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
146349507|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
146349508|NCT02232516|527785202|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
146349509|NCT02232516|527785202|FG000|Survival Follow-up|Death|15|||
146349510|NCT02232516|527785202|FG000|Survival Follow-up|Withdrawal by Subject|3|||
146349511|NCT02232516|527785202|FG000|Survival Follow-up|Lost to Follow-up|1|||
146349512|NCT02232516|527785202|FG000|Survival Follow-up|Still in follow-up|5|||
146349513|NCT05058664|527785203|FG000|Overall Study|No follow-up data provided|4|||
146349514|NCT05058664|527785204|FG001|Overall Study|No follow-up data provided|0|||
146349515|NCT05058664|527785205|FG002|Overall Study|No follow-up data provided|2|||
146349516|NCT05058664|527785203|FG000|Overall Study|Withdrawal by Subject|0|||
146349517|NCT05058664|527785204|FG001|Overall Study|Withdrawal by Subject|0|||
146349518|NCT05058664|527785205|FG002|Overall Study|Withdrawal by Subject|1|||
146349519|NCT02606045|527785206|FG000|Overall Study|Study closed before treament could begin|1|||
146349520|NCT02606045|527785207|FG001|Overall Study|Study closed before treament could begin|2|||
146349521|NCT01671085|527785208|FG000|Overall Study|Withdrawal by Subject|1|||
146349522|NCT01671085|527785209|FG001|Overall Study|Withdrawal by Subject|0|||
146349523|NCT00637273|527785210|FG000|Overall Study|Adverse Event|11|||
146349524|NCT00637273|527785211|FG001|Overall Study|Adverse Event|5|||
146349525|NCT00637273|527785212|FG002|Overall Study|Adverse Event|7|||
146349526|NCT00637273|527785210|FG000|Overall Study|Lost to Follow-up|8|||
146349527|NCT00637273|527785211|FG001|Overall Study|Lost to Follow-up|9|||
146349528|NCT00637273|527785212|FG002|Overall Study|Lost to Follow-up|13|||
146349529|NCT00637273|527785210|FG000|Overall Study|Protocol Violation|2|||
146349530|NCT00637273|527785211|FG001|Overall Study|Protocol Violation|4|||
146349531|NCT00637273|527785212|FG002|Overall Study|Protocol Violation|1|||
146349532|NCT00637273|527785210|FG000|Overall Study|Withdrawal of Consent|18|||
146349533|NCT00637273|527785211|FG001|Overall Study|Withdrawal of Consent|6|||
146349534|NCT00637273|527785212|FG002|Overall Study|Withdrawal of Consent|18|||
146349535|NCT00637273|527785210|FG000|Overall Study|Investigator Decision|1|||
146349536|NCT00637273|527785211|FG001|Overall Study|Investigator Decision|3|||
146349537|NCT00637273|527785212|FG002|Overall Study|Investigator Decision|1|||
146349538|NCT00637273|527785210|FG000|Overall Study|Administrative|2|||
146349539|NCT00637273|527785211|FG001|Overall Study|Administrative|0|||
146349540|NCT00637273|527785212|FG002|Overall Study|Administrative|0|||
146349541|NCT00637273|527785210|FG000|Overall Study|Loss of Glucose Control|1|||
146349542|NCT00637273|527785211|FG001|Overall Study|Loss of Glucose Control|1|||
146349543|NCT00637273|527785212|FG002|Overall Study|Loss of Glucose Control|1|||
146349544|NCT00231062|527785216|FG000|Overall Study|Physician Decision|6|||
146349545|NCT00590681|527785217|FG000|Overall Study|Withdrawal by Subject|7|||
146349546|NCT00590681|527785217|FG000|Overall Study|Adverse Event|8|||
146349547|NCT00590681|527785217|FG000|Overall Study|Death|3|||
146349548|NCT00590681|527785217|FG000|Overall Study|Lost to Follow-up|1|||
146349549|NCT00590681|527785217|FG000|Overall Study|disease progression|1|||
146349550|NCT02229864|527785218|FG000|Overall Study|Death|2|||
146349551|NCT02229864|527785218|FG000|Overall Study|Lost to Follow-up|1|||
146349552|NCT01345786|527785221|FG000|Overall Study|Adverse Event|0|||
146349553|NCT01345786|527785222|FG001|Overall Study|Adverse Event|1|||
146349554|NCT01345786|527785223|FG002|Overall Study|Adverse Event|3|||
146169478|NCT04026165|527132824|FG002|Run-in SEL Period|Run-in Failure|0|||
146349555|NCT01345786|527785224|FG003|Overall Study|Adverse Event|1|||
146349556|NCT01345786|527785221|FG000|Overall Study|Subject withdrew consent|2|||
146349557|NCT01345786|527785222|FG001|Overall Study|Subject withdrew consent|2|||
146349558|NCT01345786|527785223|FG002|Overall Study|Subject withdrew consent|1|||
146349559|NCT01345786|527785224|FG003|Overall Study|Subject withdrew consent|0|||
146349560|NCT01345786|527785221|FG000|Overall Study|Noncompliance with protocol|1|||
146349561|NCT01345786|527785222|FG001|Overall Study|Noncompliance with protocol|0|||
146349562|NCT01345786|527785223|FG002|Overall Study|Noncompliance with protocol|1|||
146349563|NCT01345786|527785224|FG003|Overall Study|Noncompliance with protocol|0|||
146349564|NCT01345786|527785221|FG000|Overall Study|Administrative|3|||
146349565|NCT01345786|527785222|FG001|Overall Study|Administrative|5|||
146349566|NCT01345786|527785223|FG002|Overall Study|Administrative|0|||
146349567|NCT01345786|527785224|FG003|Overall Study|Administrative|0|||
146349568|NCT01345786|527785221|FG000|Overall Study|Lost to Follow-up|0|||
146349569|NCT01345786|527785222|FG001|Overall Study|Lost to Follow-up|0|||
146349570|NCT01345786|527785223|FG002|Overall Study|Lost to Follow-up|0|||
146349571|NCT01345786|527785224|FG003|Overall Study|Lost to Follow-up|2|||
146349572|NCT03844633|527785227|FG000|1 Week FU|Lost to Follow-up|0|||
146349573|NCT03844633|527785228|FG001|1 Week FU|Lost to Follow-up|1|||
146349574|NCT03844633|527785229|FG002|1 Week FU|Lost to Follow-up|4|||
146349575|NCT03844633|527785227|FG000|12-month Follow-up|Lost to Follow-up|7|||
146349576|NCT03844633|527785228|FG001|12-month Follow-up|Lost to Follow-up|5|||
146349577|NCT03844633|527785229|FG002|12-month Follow-up|Lost to Follow-up|8|||
146349578|NCT02588248|527785232|FG000|Overall Study|Physician Decision|4|||
146349579|NCT02588248|527785233|FG001|Overall Study|Physician Decision|3|||
146349580|NCT04229446|527785236|FG000|Overall Study|Death|12|||
146349581|NCT04229446|527785237|FG001|Overall Study|Death|10|||
146349582|NCT04229446|527785236|FG000|Overall Study|Lost to Follow-up|5|||
146349583|NCT04229446|527785237|FG001|Overall Study|Lost to Follow-up|8|||
146349584|NCT00705224|527785238|FG000|Overall Study|Adverse Event|1|||
146349585|NCT00705224|527785238|FG000|Overall Study|Lack of Efficacy|2|||
146349586|NCT00705224|527785238|FG000|Overall Study|Withdrawal by Subject|3|||
146349587|NCT00705224|527785238|FG000|Overall Study|Lost to Follow-up|5|||
146349588|NCT03596177|527785240|FG000|Single Blind Period|Withdrawal by Subject|1|||
146349589|NCT03596177|527785241|FG001|Single Blind Period|Withdrawal by Subject|1|||
146349590|NCT03596177|527785240|FG000|Single Blind Period|Other|1|||
146349591|NCT03596177|527785241|FG001|Single Blind Period|Other|0|||
146349592|NCT03596177|527785240|FG000|Double Blind Period|Withdrawal by Subject|0|||
146349593|NCT03596177|527785241|FG001|Double Blind Period|Withdrawal by Subject|1|||
146349594|NCT03596177|527785240|FG000|Double Blind Period|Other|0|||
146349595|NCT03596177|527785241|FG001|Double Blind Period|Other|4|||
146349596|NCT03596177|527785240|FG000|Double Blind Period|Death during safety follow-up|0|||
146349597|NCT03596177|527785241|FG001|Double Blind Period|Death during safety follow-up|1|||
146349598|NCT02566525|527785242|FG000|Overall Study|Protocol Violation|3|||
146349599|NCT02566525|527785243|FG001|Overall Study|Protocol Violation|5|||
146349600|NCT00337467|527785246|FG000|Overall Study|Adverse Event|3|||
146349601|NCT00337467|527785246|FG000|Overall Study|Subject Withdrew Consent|2|||
146349602|NCT00337467|527785246|FG000|Overall Study|Pregnancy|1|||
146349603|NCT00337467|527785246|FG000|Overall Study|Lost to Follow-up|2|||
146349604|NCT00337467|527785246|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
146349605|NCT03141086|527785247|FG000|Overall Study|Study Terminated By Sponsor|1|||
146349606|NCT03141086|527785248|FG001|Overall Study|Study Terminated By Sponsor|1|||
146349607|NCT03141086|527785247|FG000|Overall Study|Withdrawal by Subject|0|||
146349608|NCT03141086|527785248|FG001|Overall Study|Withdrawal by Subject|1|||
146349609|NCT03141086|527785247|FG000|Overall Study|Protocol Violation|0|||
146349610|NCT03141086|527785248|FG001|Overall Study|Protocol Violation|1|||
146349611|NCT03141086|527785247|FG000|Overall Study|Adverse Event|0|||
146349612|NCT03141086|527785248|FG001|Overall Study|Adverse Event|2|||
146349613|NCT04083222|527785250|FG000|Overall Study|Voluntary Withdrawal|0|||
146349614|NCT04083222|527785251|FG001|Overall Study|Voluntary Withdrawal|1|||
146349615|NCT04083222|527785250|FG000|Overall Study|Reason not Specified|0|||
146349616|NCT04083222|527785251|FG001|Overall Study|Reason not Specified|1|||
146349617|NCT04400318|527787352|FG000|Overall Study|Adverse Event|1|||
146349618|NCT04400318|527787353|FG001|Overall Study|Adverse Event|0|||
146349619|NCT04400318|527787352|FG000|Overall Study|Withdrawal by Subject|1|||
146349620|NCT04400318|527787353|FG001|Overall Study|Withdrawal by Subject|1|||
146349621|NCT04400318|527787352|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
146349622|NCT04400318|527787353|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
146349623|NCT00165646|527787358|FG000|Overall Study|Adverse Event|1|||
146349624|NCT00165646|527787359|FG001|Overall Study|Adverse Event|1|||
146349625|NCT00165646|527787360|FG002|Overall Study|Adverse Event|1|||
146349626|NCT00165646|527787358|FG000|Overall Study|Lack of Efficacy|1|||
146349627|NCT00165646|527787359|FG001|Overall Study|Lack of Efficacy|2|||
146349628|NCT00165646|527787360|FG002|Overall Study|Lack of Efficacy|0|||
146349629|NCT00165646|527787358|FG000|Overall Study|Withdrawal by Subject|0|||
146349630|NCT00165646|527787359|FG001|Overall Study|Withdrawal by Subject|2|||
146349631|NCT00165646|527787360|FG002|Overall Study|Withdrawal by Subject|1|||
146349632|NCT00165646|527787358|FG000|Overall Study|Physician Decision|2|||
146349633|NCT00165646|527787359|FG001|Overall Study|Physician Decision|0|||
146349634|NCT00165646|527787360|FG002|Overall Study|Physician Decision|2|||
146349635|NCT00165646|527787358|FG000|Overall Study|Protocol Violation|1|||
146349636|NCT00165646|527787359|FG001|Overall Study|Protocol Violation|0|||
146349637|NCT00165646|527787360|FG002|Overall Study|Protocol Violation|0|||
146349638|NCT04657016|527787361|FG000|Overall Study|Adverse Event|2|||
146349639|NCT04657016|527787362|FG001|Overall Study|Adverse Event|4|||
146349640|NCT04657016|527787361|FG000|Overall Study|Death|1|||
146349641|NCT04657016|527787362|FG001|Overall Study|Death|1|||
146349642|NCT04657016|527787361|FG000|Overall Study|Lost to Follow-up|24|||
146349643|NCT04657016|527787362|FG001|Overall Study|Lost to Follow-up|12|||
146349644|NCT04657016|527787361|FG000|Overall Study|Physician Decision|1|||
146349645|NCT04657016|527787362|FG001|Overall Study|Physician Decision|2|||
146349646|NCT04657016|527787361|FG000|Overall Study|Pregnancy|2|||
146349647|NCT04657016|527787362|FG001|Overall Study|Pregnancy|2|||
146349648|NCT04657016|527787361|FG000|Overall Study|Protocol Deviation|1|||
146349649|NCT04657016|527787362|FG001|Overall Study|Protocol Deviation|0|||
146349650|NCT04657016|527787361|FG000|Overall Study|Withdrawal by Subject|28|||
146349651|NCT04657016|527787362|FG001|Overall Study|Withdrawal by Subject|14|||
146349652|NCT04657016|527787361|FG000|Overall Study|Other - as reported by the investigator|6|||
146349653|NCT04657016|527787362|FG001|Overall Study|Other - as reported by the investigator|0|||
146349654|NCT00701727|527787363|FG000|First Treatment Period|Adverse Event|0|||
146349655|NCT00701727|527787364|FG001|First Treatment Period|Adverse Event|0|||
146349656|NCT00701727|527787363|FG000|First Treatment Period|Withdrawal by Subject|1|||
146349657|NCT00701727|527787364|FG001|First Treatment Period|Withdrawal by Subject|0|||
146349658|NCT00701727|527787363|FG000|First Treatment Period|sponsor decision|0|||
146349659|NCT00701727|527787364|FG001|First Treatment Period|sponsor decision|1|||
146349660|NCT00701727|527787363|FG000|First Treatment Period|Lost to Follow-up|0|||
146349661|NCT00701727|527787364|FG001|First Treatment Period|Lost to Follow-up|1|||
146349662|NCT00701727|527787363|FG000|Second Treatment Period|Withdrawal by Subject|2|||
146349663|NCT00701727|527787364|FG001|Second Treatment Period|Withdrawal by Subject|0|||
146349664|NCT01104558|527787367|FG000|Overall Study|Protocol Violation|6|||
146349665|NCT01104558|527787367|FG000|Overall Study|Missing of primary efficacy assessment|10|||
146349666|NCT01104558|527787367|FG000|Overall Study|Missing of genetic analysis results|1|||
146349667|NCT00523341|527787371|FG000|Overall Study|Withdrawal by Subject|399|||
146349668|NCT00523341|527787372|FG001|Overall Study|Withdrawal by Subject|427|||
146349669|NCT00523341|527787371|FG000|Overall Study|Other|181|||
146349670|NCT00523341|527787372|FG001|Overall Study|Other|198|||
146349671|NCT00523341|527787371|FG000|Overall Study|Adverse Event|122|||
146349672|NCT00523341|527787372|FG001|Overall Study|Adverse Event|155|||
146349673|NCT00523341|527787371|FG000|Overall Study|Death|101|||
146349674|NCT00523341|527787372|FG001|Overall Study|Death|110|||
146349675|NCT00523341|527787371|FG000|Overall Study|Lost to Follow-up|73|||
146349676|NCT00523341|527787372|FG001|Overall Study|Lost to Follow-up|61|||
146349677|NCT00523341|527787371|FG000|Overall Study|Non-compliance|20|||
146349678|NCT00523341|527787372|FG001|Overall Study|Non-compliance|13|||
146349679|NCT00523341|527787371|FG000|Overall Study|Physician Decision|14|||
146349680|NCT00523341|527787372|FG001|Overall Study|Physician Decision|13|||
146349681|NCT00523341|527787371|FG000|Overall Study|Requirement for Alternative Therapy|4|||
146349682|NCT00523341|527787372|FG001|Overall Study|Requirement for Alternative Therapy|14|||
146349683|NCT00523341|527787371|FG000|Overall Study|Protocol Deviation|6|||
146349684|NCT00523341|527787372|FG001|Overall Study|Protocol Deviation|5|||
146349685|NCT00523341|527787371|FG000|Overall Study|Ineligibility Determined|3|||
146349686|NCT00523341|527787372|FG001|Overall Study|Ineligibility Determined|4|||
146349687|NCT00523341|527787371|FG000|Overall Study|Disease Progression|1|||
146349688|NCT00523341|527787372|FG001|Overall Study|Disease Progression|0|||
146349689|NCT00912015|527787375|FG000|Overall Study|Lack of Efficacy|1|||
146349690|NCT00912015|527787376|FG001|Overall Study|Lack of Efficacy|0|||
146349691|NCT00912015|527787377|FG002|Overall Study|Lack of Efficacy|0|||
146349692|NCT00912015|527787378|FG003|Overall Study|Lack of Efficacy|0|||
146349693|NCT00912015|527787375|FG000|Overall Study|Withdrawal by Subject|8|||
146349694|NCT00912015|527787376|FG001|Overall Study|Withdrawal by Subject|8|||
146349695|NCT00912015|527787377|FG002|Overall Study|Withdrawal by Subject|3|||
146349696|NCT00912015|527787378|FG003|Overall Study|Withdrawal by Subject|0|||
146349697|NCT00912015|527787375|FG000|Overall Study|Protocol Violation|1|||
146349698|NCT00912015|527787376|FG001|Overall Study|Protocol Violation|0|||
146349699|NCT00912015|527787377|FG002|Overall Study|Protocol Violation|0|||
146349700|NCT00912015|527787378|FG003|Overall Study|Protocol Violation|1|||
146349701|NCT00912015|527787375|FG000|Overall Study|Adverse Event|6|||
146169479|NCT04026165|527132825|FG003|Run-in SEL Period|Run-in Failure|0|||
146169480|NCT04026165|527132822|FG000|Run-in SEL Period|Withdrew Consent|0|||
146349702|NCT00912015|527787376|FG001|Overall Study|Adverse Event|0|||
146349703|NCT00912015|527787377|FG002|Overall Study|Adverse Event|0|||
146349704|NCT00912015|527787378|FG003|Overall Study|Adverse Event|1|||
146349705|NCT05137041|527787379|FG000|Overall Study|Lost to Follow-up|1|||
146349706|NCT05137041|527787380|FG001|Overall Study|Lost to Follow-up|1|||
146349707|NCT05137041|527787379|FG000|Overall Study|Withdrawal by Subject|0|||
146349708|NCT05137041|527787380|FG001|Overall Study|Withdrawal by Subject|2|||
146349709|NCT05137041|527787379|FG000|Overall Study|Reason not Specified|0|||
146349710|NCT05137041|527787380|FG001|Overall Study|Reason not Specified|1|||
146349711|NCT02090114|527787381|FG000|Overall Study|Withdrawal by Subject|3|||
146349712|NCT02090114|527787382|FG001|Overall Study|Withdrawal by Subject|6|||
146349713|NCT02090114|527787383|FG002|Overall Study|Withdrawal by Subject|2|||
146349714|NCT02090114|527787384|FG003|Overall Study|Withdrawal by Subject|1|||
146349715|NCT02090114|527787381|FG000|Overall Study|Physician Decision|5|||
146349716|NCT02090114|527787382|FG001|Overall Study|Physician Decision|0|||
146349717|NCT02090114|527787383|FG002|Overall Study|Physician Decision|1|||
146349718|NCT02090114|527787384|FG003|Overall Study|Physician Decision|1|||
146349719|NCT02090114|527787381|FG000|Overall Study|Adverse Event|1|||
146349720|NCT02090114|527787382|FG001|Overall Study|Adverse Event|2|||
146349721|NCT02090114|527787383|FG002|Overall Study|Adverse Event|2|||
146349722|NCT02090114|527787384|FG003|Overall Study|Adverse Event|0|||
146349723|NCT02090114|527787381|FG000|Overall Study|Progressive Disease|20|||
146349724|NCT02090114|527787382|FG001|Overall Study|Progressive Disease|21|||
146349725|NCT02090114|527787383|FG002|Overall Study|Progressive Disease|23|||
146349726|NCT02090114|527787384|FG003|Overall Study|Progressive Disease|6|||
146349727|NCT02090114|527787381|FG000|Overall Study|Death|1|||
146349728|NCT02090114|527787382|FG001|Overall Study|Death|0|||
146349729|NCT02090114|527787383|FG002|Overall Study|Death|1|||
146349730|NCT02090114|527787384|FG003|Overall Study|Death|0|||
146349731|NCT01356602|527787385|FG000|Overall Study|Protocol Deviation|0|||
146349732|NCT01356602|527787386|FG001|Overall Study|Protocol Deviation|1|||
146349733|NCT01356602|527787387|FG002|Overall Study|Protocol Deviation|1|||
146349734|NCT01356602|527787385|FG000|Overall Study|Administrative Problems|1|||
146349735|NCT01356602|527787386|FG001|Overall Study|Administrative Problems|4|||
146349736|NCT01356602|527787387|FG002|Overall Study|Administrative Problems|5|||
146349737|NCT01356602|527787385|FG000|Overall Study|Lost to Follow-up|4|||
146349738|NCT01356602|527787386|FG001|Overall Study|Lost to Follow-up|5|||
146349739|NCT01356602|527787387|FG002|Overall Study|Lost to Follow-up|6|||
146349740|NCT01356602|527787385|FG000|Overall Study|Withdrawal by Subject|4|||
146349741|NCT01356602|527787386|FG001|Overall Study|Withdrawal by Subject|3|||
146349742|NCT01356602|527787387|FG002|Overall Study|Withdrawal by Subject|7|||
146349743|NCT01356602|527787385|FG000|Overall Study|Lack of Efficacy|0|||
146349744|NCT01356602|527787386|FG001|Overall Study|Lack of Efficacy|1|||
146349745|NCT01356602|527787387|FG002|Overall Study|Lack of Efficacy|4|||
146349746|NCT01356602|527787385|FG000|Overall Study|Adverse Event|0|||
146349747|NCT01356602|527787386|FG001|Overall Study|Adverse Event|1|||
146349748|NCT01356602|527787387|FG002|Overall Study|Adverse Event|1|||
146349749|NCT00392171|527787388|FG000|Overall Study|Did not meet inclusion criteria|4|||
146349750|NCT00392171|527787388|FG000|Overall Study|Disease progression|101|||
146349751|NCT01605071|527787389|FG000|Overall Study|Withdrawal by Subject|3|||
146349752|NCT01605071|527787390|FG001|Overall Study|Withdrawal by Subject|2|||
146349753|NCT03470922|527787392|FG000|Overall Study|Death|107|||
146349754|NCT03470922|527787393|FG001|Overall Study|Death|118|||
146349755|NCT03470922|527787392|FG000|Overall Study|Lost to Follow-up|5|||
146349756|NCT03470922|527787393|FG001|Overall Study|Lost to Follow-up|5|||
146349757|NCT03470922|527787392|FG000|Overall Study|Participant Withdrew Consent|4|||
146349758|NCT03470922|527787393|FG001|Overall Study|Participant Withdrew Consent|9|||
146349759|NCT03470922|527787392|FG000|Overall Study|Other reasons|1|||
146349760|NCT03470922|527787393|FG001|Overall Study|Other reasons|0|||
146349761|NCT03470922|527787392|FG000|Overall Study|Not reported|1|||
146349762|NCT03470922|527787393|FG001|Overall Study|Not reported|0|||
146349763|NCT01931462|527787394|FG000|Overall Study|Withdrawal by Subject|1|||
146349764|NCT02819310|527787395|FG000|Overall Study|Withdrawal by Subject|37|||
146349765|NCT02819310|527787395|FG000|Overall Study|Lost to Follow-up|16|||
146349766|NCT02819310|527787395|FG000|Overall Study|Adverse Event|13|||
146349767|NCT02819310|527787395|FG000|Overall Study|Lack of Efficacy|5|||
146349768|NCT02819310|527787395|FG000|Overall Study|Physician Decision|8|||
146349769|NCT02819310|527787395|FG000|Overall Study|Protocol Violation|30|||
146349770|NCT01793051|527787400|FG000|Overall Study|Withdrawal by Subject|6|||
146349771|NCT01793051|527787401|FG001|Overall Study|Withdrawal by Subject|4|||
146349772|NCT01793051|527787400|FG000|Overall Study|Adverse Event|0|||
146349773|NCT01793051|527787401|FG001|Overall Study|Adverse Event|2|||
146349774|NCT01793051|527787400|FG000|Overall Study|Too ill to continue|1|||
146349775|NCT01793051|527787401|FG001|Overall Study|Too ill to continue|0|||
146349776|NCT01793051|527787400|FG000|Overall Study|Switched chemo|1|||
146349777|NCT01793051|527787401|FG001|Overall Study|Switched chemo|1|||
146349778|NCT01793051|527787400|FG000|Overall Study|Lack of compliance|1|||
146349779|NCT01793051|527787401|FG001|Overall Study|Lack of compliance|0|||
146349780|NCT01793051|527787400|FG000|Overall Study|Requested to be removed from the study|1|||
146349781|NCT01793051|527787401|FG001|Overall Study|Requested to be removed from the study|1|||
146349782|NCT00059215|527787403|FG000|Overall Study|Adverse Event|5|||
146349783|NCT00059215|527787404|FG001|Overall Study|Adverse Event|5|||
146349784|NCT00059215|527787405|FG002|Overall Study|Adverse Event|9|||
146349785|NCT00059215|527787406|FG003|Overall Study|Adverse Event|9|||
146349786|NCT00059215|527787403|FG000|Overall Study|Death|0|||
146349787|NCT00059215|527787404|FG001|Overall Study|Death|0|||
146349788|NCT00059215|527787405|FG002|Overall Study|Death|3|||
146349789|NCT00059215|527787406|FG003|Overall Study|Death|0|||
146349790|NCT00059215|527787403|FG000|Overall Study|Lost to Follow-up|1|||
146349791|NCT00059215|527787404|FG001|Overall Study|Lost to Follow-up|2|||
146349792|NCT00059215|527787405|FG002|Overall Study|Lost to Follow-up|0|||
146349793|NCT00059215|527787406|FG003|Overall Study|Lost to Follow-up|0|||
146349794|NCT00059215|527787403|FG000|Overall Study|Withdrawal by Subject|4|||
146349795|NCT00059215|527787404|FG001|Overall Study|Withdrawal by Subject|4|||
146349796|NCT00059215|527787405|FG002|Overall Study|Withdrawal by Subject|1|||
146349797|NCT00059215|527787406|FG003|Overall Study|Withdrawal by Subject|3|||
146349798|NCT00059215|527787403|FG000|Overall Study|Protocol Violation|1|||
146349799|NCT00059215|527787404|FG001|Overall Study|Protocol Violation|0|||
146349800|NCT00059215|527787405|FG002|Overall Study|Protocol Violation|1|||
146349801|NCT00059215|527787406|FG003|Overall Study|Protocol Violation|0|||
146349802|NCT00059215|527787403|FG000|Overall Study|Protocol entry criteria not met|1|||
146349803|NCT00059215|527787404|FG001|Overall Study|Protocol entry criteria not met|1|||
146349804|NCT00059215|527787405|FG002|Overall Study|Protocol entry criteria not met|0|||
146349805|NCT00059215|527787406|FG003|Overall Study|Protocol entry criteria not met|2|||
146349806|NCT00059215|527787403|FG000|Overall Study|Physician Decision|1|||
146349807|NCT00059215|527787404|FG001|Overall Study|Physician Decision|2|||
146349808|NCT00059215|527787405|FG002|Overall Study|Physician Decision|1|||
146349809|NCT00059215|527787406|FG003|Overall Study|Physician Decision|1|||
146349810|NCT03097328|527787409|FG000|Overall Study|Still on Therapy|2|||
146349811|NCT03097328|527787409|FG000|Overall Study|Progressive Disease|29|||
146349812|NCT03097328|527787409|FG000|Overall Study|Adverse Event|4|||
146349813|NCT03097328|527787409|FG000|Overall Study|Withdrawal by Subject|1|||
146349814|NCT03097328|527787409|FG000|Overall Study|Physician Decision|1|||
146349815|NCT03097328|527787409|FG000|Overall Study|Patient Decision|1|||
146349816|NCT03097328|527787409|FG000|Overall Study|Ineligible for Study Drug|1|||
146349817|NCT02653976|527787410|FG000|Overall Study|Withdrawal by Subject|5|||
146349818|NCT02653976|527787410|FG000|Overall Study|Death|4|||
146349819|NCT03703375|527787411|FG000|Randomization Period|Withdrawal by Subject|0|||
146349820|NCT03703375|527787412|FG001|Randomization Period|Withdrawal by Subject|0|||
146349821|NCT03703375|527787413|FG002|Randomization Period|Withdrawal by Subject|0|||
146349822|NCT03703375|527787414|FG003|Randomization Period|Withdrawal by Subject|1|||
146349823|NCT03703375|527787411|FG000|Randomization Period|Completed safety run-in treatment|7|||
146349824|NCT03703375|527787412|FG001|Randomization Period|Completed safety run-in treatment|0|||
146349825|NCT03703375|527787413|FG002|Randomization Period|Completed safety run-in treatment|0|||
146349826|NCT03703375|527787414|FG003|Randomization Period|Completed safety run-in treatment|0|||
146349827|NCT03703375|527787411|FG000|Treatment Period|Other Reasons|0|||
146349828|NCT03703375|527787412|FG001|Treatment Period|Other Reasons|1|||
146349829|NCT03703375|527787413|FG002|Treatment Period|Other Reasons|0|||
146349830|NCT03703375|527787414|FG003|Treatment Period|Other Reasons|3|||
146349831|NCT03703375|527787411|FG000|Treatment Period|Consent Withdrawal|0|||
146349832|NCT03703375|527787412|FG001|Treatment Period|Consent Withdrawal|0|||
146349833|NCT03703375|527787413|FG002|Treatment Period|Consent Withdrawal|0|||
146349834|NCT03703375|527787414|FG003|Treatment Period|Consent Withdrawal|1|||
146349835|NCT03703375|527787411|FG000|Treatment Period|Death|1|||
146349836|NCT03703375|527787412|FG001|Treatment Period|Death|0|||
146349837|NCT03703375|527787413|FG002|Treatment Period|Death|1|||
146349838|NCT03703375|527787414|FG003|Treatment Period|Death|2|||
146349839|NCT03703375|527787411|FG000|Treatment Period|Toxicity of Study Treatment|2|||
146349840|NCT03703375|527787412|FG001|Treatment Period|Toxicity of Study Treatment|0|||
146349841|NCT03703375|527787413|FG002|Treatment Period|Toxicity of Study Treatment|4|||
146349842|NCT03703375|527787414|FG003|Treatment Period|Toxicity of Study Treatment|1|||
146349843|NCT03703375|527787411|FG000|Treatment Period|Progression|32|||
146349844|NCT03703375|527787412|FG001|Treatment Period|Progression|1|||
146349845|NCT03703375|527787413|FG002|Treatment Period|Progression|7|||
146349846|NCT03703375|527787414|FG003|Treatment Period|Progression|11|||
146349847|NCT03703375|527787411|FG000|Treatment Period|Completed treatment|7|||
146349848|NCT03703375|527787412|FG001|Treatment Period|Completed treatment|2|||
146349849|NCT03703375|527787413|FG002|Treatment Period|Completed treatment|0|||
146349850|NCT03703375|527787414|FG003|Treatment Period|Completed treatment|0|||
146349851|NCT01675011|527787415|FG000|Overall Study|Trial terminated by Sponsor|3|||
146349852|NCT01675011|527787416|FG001|Overall Study|Trial terminated by Sponsor|1|||
146349853|NCT00615290|527787417|FG000|Overall Study|Adverse Event|2|||
146349854|NCT00615290|527787417|FG000|Overall Study|Lost to Follow-up|3|||
146349855|NCT00615290|527787417|FG000|Overall Study|Withdrawal by Subject|1|||
146349856|NCT00615290|527787417|FG000|Overall Study|Other|2|||
146349857|NCT02849990|527787418|FG000|Overall Study|Adverse Event|1|||
146349858|NCT02849990|527787418|FG000|Overall Study|Withdrawal by Subject|1|||
146349859|NCT02678741|527787419|FG000|Overall Study|Death|4|||
146349860|NCT02678741|527787419|FG000|Overall Study|Withdrawal by Subject|1|||
146349861|NCT02678741|527787419|FG000|Overall Study|ineligible|3|||
146349862|NCT02678741|527787419|FG000|Overall Study|Not RECIST Measurable|2|||
146349863|NCT02678741|527787419|FG000|Overall Study|Lack of Efficacy|10|||
146349864|NCT01795898|527787420|FG000|Overall Study|Adverse Event|27|||
146349865|NCT01795898|527787420|FG000|Overall Study|Lost to Follow-up|20|||
146349866|NCT01795898|527787420|FG000|Overall Study|Withdrawal of consent|6|||
146349867|NCT01795898|527787420|FG000|Overall Study|Diagnosed with metastasis|1|||
146349868|NCT01795898|527787420|FG000|Overall Study|No pain|1|||
146349869|NCT01795898|527787420|FG000|Overall Study|Death|1|||
146349870|NCT01795898|527787420|FG000|Overall Study|Withdrew consent & had adverse events|3|||
146349871|NCT01795898|527787420|FG000|Overall Study|Physician Decision|1|||
146349872|NCT01984346|527787422|FG000|Overall Study|Physician Decision|4|||
146349873|NCT01984346|527787423|FG001|Overall Study|Physician Decision|2|||
146349874|NCT01984346|527787422|FG000|Overall Study|Withdrawal by Subject|2|||
146349875|NCT01984346|527787423|FG001|Overall Study|Withdrawal by Subject|2|||
146349876|NCT01984346|527787422|FG000|Overall Study|Enrollment Closed|8|||
146349877|NCT01984346|527787423|FG001|Overall Study|Enrollment Closed|1|||
146349878|NCT01984346|527787422|FG000|Overall Study|Insurance Coverage|1|||
146349879|NCT01984346|527787423|FG001|Overall Study|Insurance Coverage|0|||
146349880|NCT01984346|527787422|FG000|Overall Study|Intra-operative Exclusion|2|||
146349881|NCT01984346|527787423|FG001|Overall Study|Intra-operative Exclusion|0|||
146349882|NCT00536731|527787424|FG000|Overall Study|Adverse Event|3|||
146349883|NCT00536731|527787425|FG001|Overall Study|Adverse Event|2|||
146349884|NCT00536731|527787426|FG002|Overall Study|Adverse Event|3|||
146349885|NCT00536731|527787424|FG000|Overall Study|Withdrawal by Subject|0|||
146349886|NCT00536731|527787425|FG001|Overall Study|Withdrawal by Subject|2|||
146349887|NCT00536731|527787426|FG002|Overall Study|Withdrawal by Subject|0|||
146349888|NCT00536731|527787424|FG000|Overall Study|Intake of prohibited conc. medication|0|||
146349889|NCT00536731|527787425|FG001|Overall Study|Intake of prohibited conc. medication|0|||
146349890|NCT00536731|527787426|FG002|Overall Study|Intake of prohibited conc. medication|1|||
146349891|NCT00536731|527787424|FG000|Overall Study|Safety reasons|0|||
146349892|NCT00536731|527787425|FG001|Overall Study|Safety reasons|0|||
146349893|NCT00536731|527787426|FG002|Overall Study|Safety reasons|1|||
146349894|NCT00536731|527787424|FG000|Overall Study|Other|1|||
146349895|NCT00536731|527787425|FG001|Overall Study|Other|1|||
146349896|NCT00536731|527787426|FG002|Overall Study|Other|0|||
146349897|NCT00372190|527787427|FG000|Overall Study|Lost to Follow-up|3|||
146349898|NCT00372190|527787428|FG001|Overall Study|Lost to Follow-up|1|||
146349899|NCT01623531|527787429|FG000|Overall Study|Death|1|||
146349900|NCT01623531|527787430|FG001|Overall Study|Death|0|||
146349901|NCT01623531|527787429|FG000|Overall Study|Protocol Violation|2|||
146349902|NCT01623531|527787430|FG001|Overall Study|Protocol Violation|1|||
146349903|NCT01623531|527787429|FG000|Overall Study|Missing data at primary outcome time poi|1|||
146349904|NCT01623531|527787430|FG001|Overall Study|Missing data at primary outcome time poi|1|||
146349905|NCT04184622|527787432|FG000|Primary Treatment Period|Adverse Event|6|||
146349906|NCT04184622|527787433|FG001|Primary Treatment Period|Adverse Event|4|||
146349907|NCT04184622|527787434|FG002|Primary Treatment Period|Adverse Event|8|||
146349908|NCT04184622|527787435|FG003|Primary Treatment Period|Adverse Event|6|||
146349909|NCT04184622|527787432|FG000|Primary Treatment Period|Death|4|||
146349910|NCT04184622|527787433|FG001|Primary Treatment Period|Death|4|||
146349911|NCT04184622|527787434|FG002|Primary Treatment Period|Death|2|||
146349912|NCT04184622|527787435|FG003|Primary Treatment Period|Death|1|||
146349913|NCT04184622|527787432|FG000|Primary Treatment Period|Lost to Follow-up|41|||
146349914|NCT04184622|527787433|FG001|Primary Treatment Period|Lost to Follow-up|17|||
146349915|NCT04184622|527787434|FG002|Primary Treatment Period|Lost to Follow-up|15|||
146349916|NCT04184622|527787435|FG003|Primary Treatment Period|Lost to Follow-up|13|||
146349917|NCT04184622|527787432|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
146349918|NCT04184622|527787433|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
146349919|NCT04184622|527787434|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
146349920|NCT04184622|527787435|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
146349921|NCT04184622|527787432|FG000|Primary Treatment Period|Physician Decision|0|||
146349922|NCT04184622|527787433|FG001|Primary Treatment Period|Physician Decision|0|||
146349923|NCT04184622|527787434|FG002|Primary Treatment Period|Physician Decision|3|||
146349924|NCT04184622|527787435|FG003|Primary Treatment Period|Physician Decision|1|||
146349925|NCT04184622|527787432|FG000|Primary Treatment Period|Pregnancy|4|||
146349926|NCT04184622|527787433|FG001|Primary Treatment Period|Pregnancy|3|||
146349927|NCT04184622|527787434|FG002|Primary Treatment Period|Pregnancy|4|||
146349928|NCT04184622|527787435|FG003|Primary Treatment Period|Pregnancy|1|||
146349929|NCT04184622|527787432|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
146349930|NCT04184622|527787433|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
146349931|NCT04184622|527787434|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
146349932|NCT04184622|527787435|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
146349933|NCT04184622|527787432|FG000|Additional Treatment Period|Adverse Event|1|||
146349934|NCT04184622|527787433|FG001|Additional Treatment Period|Adverse Event|2|||
146169481|NCT04026165|527132823|FG001|Run-in SEL Period|Withdrew Consent|10|||
146169482|NCT04026165|527132824|FG002|Run-in SEL Period|Withdrew Consent|0|||
146169483|NCT04026165|527132825|FG003|Run-in SEL Period|Withdrew Consent|0|||
146169484|NCT04026165|527132822|FG000|Run-in SEL Period|Enrollment Error|0|||
146349935|NCT04184622|527787434|FG002|Additional Treatment Period|Adverse Event|1|||
146349936|NCT04184622|527787435|FG003|Additional Treatment Period|Adverse Event|0|||
146349937|NCT04184622|527787432|FG000|Additional Treatment Period|Death|0|||
146349938|NCT04184622|527787433|FG001|Additional Treatment Period|Death|0|||
146349939|NCT04184622|527787434|FG002|Additional Treatment Period|Death|1|||
146349940|NCT04184622|527787435|FG003|Additional Treatment Period|Death|1|||
146349941|NCT04184622|527787432|FG000|Additional Treatment Period|Lost to Follow-up|6|||
146349942|NCT04184622|527787433|FG001|Additional Treatment Period|Lost to Follow-up|4|||
146349943|NCT04184622|527787434|FG002|Additional Treatment Period|Lost to Follow-up|8|||
146349944|NCT04184622|527787435|FG003|Additional Treatment Period|Lost to Follow-up|6|||
146396302|NCT02219477|527954551|FG000|Overall Study|Adverse Event|0|||
146349945|NCT04184622|527787432|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
146349946|NCT04184622|527787433|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
146349947|NCT04184622|527787434|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
146349948|NCT04184622|527787435|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
146349949|NCT04184622|527787432|FG000|Additional Treatment Period|Physician Decision|0|||
146349950|NCT04184622|527787433|FG001|Additional Treatment Period|Physician Decision|0|||
146349951|NCT04184622|527787434|FG002|Additional Treatment Period|Physician Decision|1|||
146349952|NCT04184622|527787435|FG003|Additional Treatment Period|Physician Decision|0|||
146349953|NCT04184622|527787432|FG000|Additional Treatment Period|Pregnancy|0|||
146349954|NCT04184622|527787433|FG001|Additional Treatment Period|Pregnancy|0|||
146349955|NCT04184622|527787434|FG002|Additional Treatment Period|Pregnancy|0|||
146349956|NCT04184622|527787435|FG003|Additional Treatment Period|Pregnancy|1|||
146349957|NCT04184622|527787432|FG000|Additional Treatment Period|Protocol deviation|0|||
146349958|NCT04184622|527787433|FG001|Additional Treatment Period|Protocol deviation|0|||
146349959|NCT04184622|527787434|FG002|Additional Treatment Period|Protocol deviation|1|||
146349960|NCT04184622|527787435|FG003|Additional Treatment Period|Protocol deviation|0|||
146349961|NCT04184622|527787432|FG000|Additional Treatment Period|Site closed|1|||
146349962|NCT04184622|527787433|FG001|Additional Treatment Period|Site closed|0|||
146349963|NCT04184622|527787434|FG002|Additional Treatment Period|Site closed|1|||
146349964|NCT04184622|527787435|FG003|Additional Treatment Period|Site closed|0|||
146349965|NCT04184622|527787432|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
146349966|NCT04184622|527787433|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
146349967|NCT04184622|527787434|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
146349968|NCT04184622|527787435|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
146349969|NCT04184622|527787432|FG000|Safety Follow-up Period|Adverse Event|6|||
146349970|NCT04184622|527787433|FG001|Safety Follow-up Period|Adverse Event|8|||
146349971|NCT04184622|527787434|FG002|Safety Follow-up Period|Adverse Event|9|||
146349972|NCT04184622|527787435|FG003|Safety Follow-up Period|Adverse Event|16|||
146349973|NCT04184622|527787432|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
146349974|NCT04184622|527787433|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
146349975|NCT04184622|527787434|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
146349976|NCT04184622|527787435|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
146349977|NCT04184622|527787432|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
146349978|NCT04184622|527787433|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
146349979|NCT04184622|527787434|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
146349980|NCT04184622|527787435|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
146349981|NCT04184622|527787432|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
146349982|NCT04184622|527787433|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
146349983|NCT04184622|527787434|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
146349984|NCT04184622|527787435|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
146349985|NCT04184622|527787432|FG000|Safety Follow-up Period|Physician Decision|1|||
146349986|NCT04184622|527787433|FG001|Safety Follow-up Period|Physician Decision|0|||
146349987|NCT04184622|527787434|FG002|Safety Follow-up Period|Physician Decision|0|||
146349988|NCT04184622|527787435|FG003|Safety Follow-up Period|Physician Decision|1|||
146349989|NCT04184622|527787432|FG000|Safety Follow-up Period|Pregnancy|1|||
146349990|NCT04184622|527787433|FG001|Safety Follow-up Period|Pregnancy|3|||
146349991|NCT04184622|527787434|FG002|Safety Follow-up Period|Pregnancy|0|||
146349992|NCT04184622|527787435|FG003|Safety Follow-up Period|Pregnancy|6|||
146349993|NCT04184622|527787432|FG000|Safety Follow-up Period|Protocol deviation|1|||
146349994|NCT04184622|527787433|FG001|Safety Follow-up Period|Protocol deviation|0|||
146349995|NCT04184622|527787434|FG002|Safety Follow-up Period|Protocol deviation|0|||
146349996|NCT04184622|527787435|FG003|Safety Follow-up Period|Protocol deviation|0|||
146349997|NCT04184622|527787432|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
146349998|NCT04184622|527787433|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
146349999|NCT04184622|527787434|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
146350000|NCT04184622|527787435|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
146350001|NCT02795988|527787436|FG000|Phase 1b|Withdrawal by Subject|0|||
146350002|NCT02795988|527787437|FG001|Phase 1b|Withdrawal by Subject|1|||
146350003|NCT02795988|527787438|FG002|Phase 1b|Withdrawal by Subject|0|||
146350004|NCT02795988|527787439|FG003|Phase 1b|Withdrawal by Subject|0|||
146350005|NCT02795988|527787440|FG004|Phase 1b|Withdrawal by Subject|0|||
146350006|NCT02795988|527787441|FG005|Phase 1b|Withdrawal by Subject|0|||
146350007|NCT02795988|527787442|FG006|Phase 1b|Withdrawal by Subject|0|||
146350008|NCT02795988|527787436|FG000|Phase 1b|Death|1|||
146350009|NCT02795988|527787437|FG001|Phase 1b|Death|2|||
146350010|NCT02795988|527787438|FG002|Phase 1b|Death|1|||
146350011|NCT02795988|527787439|FG003|Phase 1b|Death|0|||
146350012|NCT02795988|527787440|FG004|Phase 1b|Death|0|||
146350013|NCT02795988|527787441|FG005|Phase 1b|Death|0|||
146350014|NCT02795988|527787442|FG006|Phase 1b|Death|0|||
146350015|NCT02795988|527787436|FG000|Phase 1b|Physician Decision|0|||
146350016|NCT02795988|527787437|FG001|Phase 1b|Physician Decision|0|||
146350017|NCT02795988|527787438|FG002|Phase 1b|Physician Decision|1|||
146350018|NCT02795988|527787439|FG003|Phase 1b|Physician Decision|0|||
146350019|NCT02795988|527787440|FG004|Phase 1b|Physician Decision|0|||
146350020|NCT02795988|527787441|FG005|Phase 1b|Physician Decision|0|||
146350021|NCT02795988|527787442|FG006|Phase 1b|Physician Decision|0|||
146350022|NCT02795988|527787436|FG000|Phase 1b|Progressive Disease|2|||
146350023|NCT02795988|527787437|FG001|Phase 1b|Progressive Disease|2|||
146350024|NCT02795988|527787438|FG002|Phase 1b|Progressive Disease|0|||
146350025|NCT02795988|527787439|FG003|Phase 1b|Progressive Disease|0|||
146350026|NCT02795988|527787440|FG004|Phase 1b|Progressive Disease|0|||
146350027|NCT02795988|527787441|FG005|Phase 1b|Progressive Disease|0|||
146350028|NCT02795988|527787442|FG006|Phase 1b|Progressive Disease|0|||
146350029|NCT02795988|527787436|FG000|Phase 2|Withdrawal by Subject|0|||
146350030|NCT02795988|527787437|FG001|Phase 2|Withdrawal by Subject|0|||
146350031|NCT02795988|527787438|FG002|Phase 2|Withdrawal by Subject|0|||
146350032|NCT02795988|527787439|FG003|Phase 2|Withdrawal by Subject|1|||
146350033|NCT02795988|527787440|FG004|Phase 2|Withdrawal by Subject|0|||
146350034|NCT02795988|527787441|FG005|Phase 2|Withdrawal by Subject|0|||
146350035|NCT02795988|527787442|FG006|Phase 2|Withdrawal by Subject|0|||
146350036|NCT02795988|527787436|FG000|Phase 2|Death|0|||
146350037|NCT02795988|527787437|FG001|Phase 2|Death|0|||
146350038|NCT02795988|527787438|FG002|Phase 2|Death|0|||
146350039|NCT02795988|527787439|FG003|Phase 2|Death|17|||
146350040|NCT02795988|527787440|FG004|Phase 2|Death|17|||
146350041|NCT02795988|527787441|FG005|Phase 2|Death|0|||
146350042|NCT02795988|527787442|FG006|Phase 2|Death|0|||
146350043|NCT02795988|527787436|FG000|Phase 2|Other|0|||
146350044|NCT02795988|527787437|FG001|Phase 2|Other|0|||
146350045|NCT02795988|527787438|FG002|Phase 2|Other|0|||
146350046|NCT02795988|527787439|FG003|Phase 2|Other|1|||
146350047|NCT02795988|527787440|FG004|Phase 2|Other|0|||
146350048|NCT02795988|527787441|FG005|Phase 2|Other|0|||
146350049|NCT02795988|527787442|FG006|Phase 2|Other|0|||
146350050|NCT02795988|527787436|FG000|Phase 2 Extension|Death|0|||
146350051|NCT02795988|527787437|FG001|Phase 2 Extension|Death|0|||
146350052|NCT02795988|527787438|FG002|Phase 2 Extension|Death|0|||
146350053|NCT02795988|527787439|FG003|Phase 2 Extension|Death|0|||
146350054|NCT02795988|527787440|FG004|Phase 2 Extension|Death|0|||
146350055|NCT02795988|527787441|FG005|Phase 2 Extension|Death|5|||
146350056|NCT02795988|527787442|FG006|Phase 2 Extension|Death|6|||
146350057|NCT02795988|527787436|FG000|Phase 2 Extension|Other reasons|0|||
146350058|NCT02795988|527787437|FG001|Phase 2 Extension|Other reasons|0|||
146350059|NCT02795988|527787438|FG002|Phase 2 Extension|Other reasons|0|||
146350060|NCT02795988|527787439|FG003|Phase 2 Extension|Other reasons|0|||
146350061|NCT02795988|527787440|FG004|Phase 2 Extension|Other reasons|0|||
146350062|NCT02795988|527787441|FG005|Phase 2 Extension|Other reasons|2|||
146350063|NCT02795988|527787442|FG006|Phase 2 Extension|Other reasons|1|||
146350064|NCT02341014|527787443|FG000|Overall Study|Adverse Event|0|||
146350065|NCT02341014|527787444|FG001|Overall Study|Adverse Event|1|||
146350066|NCT02341014|527787445|FG002|Overall Study|Adverse Event|0|||
146350067|NCT02341014|527787446|FG003|Overall Study|Adverse Event|0|||
146350068|NCT02341014|527787447|FG004|Overall Study|Adverse Event|2|||
146350069|NCT04705597|527787448|FG000|Overall Study|Death|16|||
146350070|NCT04705597|527787449|FG001|Overall Study|Death|9|||
146350071|NCT04705597|527787448|FG000|Overall Study|Lost to Follow-up|1|||
146350072|NCT04705597|527787449|FG001|Overall Study|Lost to Follow-up|0|||
146350073|NCT04705597|527787448|FG000|Overall Study|Withdrawal by Subject|1|||
146350074|NCT04705597|527787449|FG001|Overall Study|Withdrawal by Subject|2|||
146350075|NCT00390780|527787453|FG000|Overall Study|Not completed|10|||
146350076|NCT00390780|527787454|FG001|Overall Study|Not completed|4|||
146350077|NCT00390780|527787453|FG000|Overall Study|Protocol Violation|6|||
146350078|NCT00390780|527787454|FG001|Overall Study|Protocol Violation|4|||
146350079|NCT00390780|527787453|FG000|Overall Study|Lost to Follow-up|3|||
146350080|NCT00390780|527787454|FG001|Overall Study|Lost to Follow-up|6|||
146350081|NCT00390780|527787453|FG000|Overall Study|Adverse Event|2|||
146350082|NCT00390780|527787454|FG001|Overall Study|Adverse Event|3|||
146350083|NCT00390780|527787453|FG000|Overall Study|Death|1|||
146350084|NCT00390780|527787454|FG001|Overall Study|Death|3|||
146350085|NCT00390780|527787453|FG000|Overall Study|Withdrawal by Subject|1|||
146350086|NCT00390780|527787454|FG001|Overall Study|Withdrawal by Subject|2|||
146350087|NCT00390780|527787453|FG000|Overall Study|Inclusion criteria not satisfied|0|||
146350088|NCT00390780|527787454|FG001|Overall Study|Inclusion criteria not satisfied|2|||
146350089|NCT00390780|527787453|FG000|Overall Study|Lost to follow up and other reasons|0|||
146350090|NCT00390780|527787454|FG001|Overall Study|Lost to follow up and other reasons|1|||
146350091|NCT00390780|527787453|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
146350092|NCT00390780|527787454|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
146350093|NCT00390780|527787453|FG000|Overall Study|SAE, death|0|||
146350094|NCT00390780|527787454|FG001|Overall Study|SAE, death|1|||
146350095|NCT01070550|527787456|FG000|Overall Study|Adverse Event|43|||
146350096|NCT01070550|527787457|FG001|Overall Study|Adverse Event|1|||
146350097|NCT01070550|527787458|FG002|Overall Study|Adverse Event|3|||
146350098|NCT01070550|527787459|FG003|Overall Study|Adverse Event|0|||
146350099|NCT01070550|527787460|FG004|Overall Study|Adverse Event|0|||
146350100|NCT01070550|527787461|FG005|Overall Study|Adverse Event|0|||
146350101|NCT01070550|527787456|FG000|Overall Study|Death|20|||
146350102|NCT01070550|527787457|FG001|Overall Study|Death|4|||
146350103|NCT01070550|527787458|FG002|Overall Study|Death|3|||
146350104|NCT01070550|527787459|FG003|Overall Study|Death|0|||
146350105|NCT01070550|527787460|FG004|Overall Study|Death|0|||
146350106|NCT01070550|527787461|FG005|Overall Study|Death|0|||
146350107|NCT01070550|527787456|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
146350108|NCT01070550|527787457|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146350109|NCT01070550|527787458|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
146350110|NCT01070550|527787459|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146350111|NCT01070550|527787460|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146350112|NCT01070550|527787461|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
146350113|NCT01070550|527787456|FG000|Overall Study|Early termination|3|||
146350114|NCT01070550|527787457|FG001|Overall Study|Early termination|0|||
146350115|NCT01070550|527787458|FG002|Overall Study|Early termination|0|||
146350116|NCT01070550|527787459|FG003|Overall Study|Early termination|0|||
146350117|NCT01070550|527787460|FG004|Overall Study|Early termination|0|||
146350118|NCT01070550|527787461|FG005|Overall Study|Early termination|0|||
146350119|NCT01070550|527787456|FG000|Overall Study|Failed to return|450|||
146350120|NCT01070550|527787457|FG001|Overall Study|Failed to return|33|||
146350121|NCT01070550|527787458|FG002|Overall Study|Failed to return|144|||
146350122|NCT01070550|527787459|FG003|Overall Study|Failed to return|40|||
146350123|NCT01070550|527787460|FG004|Overall Study|Failed to return|1|||
146350124|NCT01070550|527787461|FG005|Overall Study|Failed to return|2|||
146350125|NCT01070550|527787456|FG000|Overall Study|Incomplete treatment|2|||
146350126|NCT01070550|527787457|FG001|Overall Study|Incomplete treatment|0|||
146350127|NCT01070550|527787458|FG002|Overall Study|Incomplete treatment|0|||
146350128|NCT01070550|527787459|FG003|Overall Study|Incomplete treatment|0|||
146350129|NCT01070550|527787460|FG004|Overall Study|Incomplete treatment|0|||
146350130|NCT01070550|527787461|FG005|Overall Study|Incomplete treatment|0|||
146350131|NCT01070550|527787456|FG000|Overall Study|Lab test not done|22|||
146350132|NCT01070550|527787457|FG001|Overall Study|Lab test not done|3|||
146350133|NCT01070550|527787458|FG002|Overall Study|Lab test not done|4|||
146350134|NCT01070550|527787459|FG003|Overall Study|Lab test not done|1|||
146350135|NCT01070550|527787460|FG004|Overall Study|Lab test not done|0|||
146350136|NCT01070550|527787461|FG005|Overall Study|Lab test not done|1|||
146350137|NCT01070550|527787456|FG000|Overall Study|Lack of Efficacy|65|||
146350138|NCT01070550|527787457|FG001|Overall Study|Lack of Efficacy|1|||
146350139|NCT01070550|527787458|FG002|Overall Study|Lack of Efficacy|5|||
146350140|NCT01070550|527787459|FG003|Overall Study|Lack of Efficacy|5|||
146350141|NCT01070550|527787460|FG004|Overall Study|Lack of Efficacy|0|||
146350142|NCT01070550|527787461|FG005|Overall Study|Lack of Efficacy|1|||
146350143|NCT01070550|527787456|FG000|Overall Study|Miscellaneous|12|||
146350144|NCT01070550|527787457|FG001|Overall Study|Miscellaneous|2|||
146350145|NCT01070550|527787458|FG002|Overall Study|Miscellaneous|3|||
146350146|NCT01070550|527787459|FG003|Overall Study|Miscellaneous|1|||
146350147|NCT01070550|527787460|FG004|Overall Study|Miscellaneous|0|||
146350148|NCT01070550|527787461|FG005|Overall Study|Miscellaneous|0|||
146350149|NCT01070550|527787456|FG000|Overall Study|New treatment started|3|||
146350150|NCT01070550|527787457|FG001|Overall Study|New treatment started|1|||
146350151|NCT01070550|527787458|FG002|Overall Study|New treatment started|0|||
146350152|NCT01070550|527787459|FG003|Overall Study|New treatment started|2|||
146350153|NCT01070550|527787460|FG004|Overall Study|New treatment started|0|||
146350154|NCT01070550|527787461|FG005|Overall Study|New treatment started|0|||
146350155|NCT01070550|527787456|FG000|Overall Study|Non-responders|493|||
146350156|NCT01070550|527787457|FG001|Overall Study|Non-responders|4|||
146350157|NCT01070550|527787458|FG002|Overall Study|Non-responders|21|||
146350158|NCT01070550|527787459|FG003|Overall Study|Non-responders|20|||
146350159|NCT01070550|527787460|FG004|Overall Study|Non-responders|0|||
146350160|NCT01070550|527787461|FG005|Overall Study|Non-responders|2|||
146350161|NCT01070550|527787456|FG000|Overall Study|Not categorized|33|||
146350162|NCT01070550|527787457|FG001|Overall Study|Not categorized|2|||
146350163|NCT01070550|527787458|FG002|Overall Study|Not categorized|6|||
146350164|NCT01070550|527787459|FG003|Overall Study|Not categorized|1|||
146350165|NCT01070550|527787460|FG004|Overall Study|Not categorized|0|||
146350166|NCT01070550|527787461|FG005|Overall Study|Not categorized|1|||
146350167|NCT01070550|527787456|FG000|Overall Study|Protocol Violation|15|||
146350168|NCT01070550|527787457|FG001|Overall Study|Protocol Violation|1|||
146350169|NCT01070550|527787458|FG002|Overall Study|Protocol Violation|1|||
146350170|NCT01070550|527787459|FG003|Overall Study|Protocol Violation|1|||
146350171|NCT01070550|527787460|FG004|Overall Study|Protocol Violation|0|||
146350172|NCT01070550|527787461|FG005|Overall Study|Protocol Violation|0|||
146350173|NCT01070550|527787456|FG000|Overall Study|Relapse|44|||
146350174|NCT01070550|527787457|FG001|Overall Study|Relapse|5|||
146350175|NCT01070550|527787458|FG002|Overall Study|Relapse|14|||
146350176|NCT01070550|527787459|FG003|Overall Study|Relapse|4|||
146350177|NCT01070550|527787460|FG004|Overall Study|Relapse|0|||
146350178|NCT01070550|527787461|FG005|Overall Study|Relapse|0|||
146350179|NCT01070550|527787456|FG000|Overall Study|Result not available|3|||
146350180|NCT01070550|527787457|FG001|Overall Study|Result not available|1|||
146350181|NCT01070550|527787458|FG002|Overall Study|Result not available|3|||
146350182|NCT01070550|527787459|FG003|Overall Study|Result not available|0|||
146350183|NCT01070550|527787460|FG004|Overall Study|Result not available|0|||
146350184|NCT01070550|527787461|FG005|Overall Study|Result not available|0|||
146350185|NCT01070550|527787456|FG000|Overall Study|Screen failure|1|||
146350186|NCT01070550|527787457|FG001|Overall Study|Screen failure|0|||
146350187|NCT01070550|527787458|FG002|Overall Study|Screen failure|0|||
146350188|NCT01070550|527787459|FG003|Overall Study|Screen failure|0|||
146350189|NCT01070550|527787460|FG004|Overall Study|Screen failure|0|||
146350190|NCT01070550|527787461|FG005|Overall Study|Screen failure|0|||
146350191|NCT01070550|527787456|FG000|Overall Study|Sponsor decision|1|||
146350192|NCT01070550|527787457|FG001|Overall Study|Sponsor decision|0|||
146350193|NCT01070550|527787458|FG002|Overall Study|Sponsor decision|0|||
146350194|NCT01070550|527787459|FG003|Overall Study|Sponsor decision|0|||
146350195|NCT01070550|527787460|FG004|Overall Study|Sponsor decision|0|||
146350196|NCT01070550|527787461|FG005|Overall Study|Sponsor decision|0|||
146350197|NCT01070550|527787456|FG000|Overall Study|Treatment duration shortened|1|||
146350198|NCT01070550|527787457|FG001|Overall Study|Treatment duration shortened|0|||
146350199|NCT01070550|527787458|FG002|Overall Study|Treatment duration shortened|0|||
146350200|NCT01070550|527787459|FG003|Overall Study|Treatment duration shortened|0|||
146350201|NCT01070550|527787460|FG004|Overall Study|Treatment duration shortened|0|||
146350202|NCT01070550|527787461|FG005|Overall Study|Treatment duration shortened|0|||
146350203|NCT01070550|527787456|FG000|Overall Study|Treatment interrupted|7|||
146350204|NCT01070550|527787457|FG001|Overall Study|Treatment interrupted|0|||
146350205|NCT01070550|527787458|FG002|Overall Study|Treatment interrupted|1|||
146350206|NCT01070550|527787459|FG003|Overall Study|Treatment interrupted|1|||
146350207|NCT01070550|527787460|FG004|Overall Study|Treatment interrupted|0|||
146350208|NCT01070550|527787461|FG005|Overall Study|Treatment interrupted|0|||
146350209|NCT01070550|527787456|FG000|Overall Study|Treatment not started|14|||
146350210|NCT01070550|527787457|FG001|Overall Study|Treatment not started|2|||
146350211|NCT01070550|527787458|FG002|Overall Study|Treatment not started|4|||
146350212|NCT01070550|527787459|FG003|Overall Study|Treatment not started|0|||
146350213|NCT01070550|527787460|FG004|Overall Study|Treatment not started|0|||
146350214|NCT01070550|527787461|FG005|Overall Study|Treatment not started|0|||
146350215|NCT01070550|527787456|FG000|Overall Study|Treatment restarted|0|||
146350216|NCT01070550|527787457|FG001|Overall Study|Treatment restarted|1|||
146350217|NCT01070550|527787458|FG002|Overall Study|Treatment restarted|0|||
146350218|NCT01070550|527787459|FG003|Overall Study|Treatment restarted|0|||
146350219|NCT01070550|527787460|FG004|Overall Study|Treatment restarted|0|||
146350220|NCT01070550|527787461|FG005|Overall Study|Treatment restarted|0|||
146350221|NCT01070550|527787456|FG000|Overall Study|Treatment stopped|3|||
146350222|NCT01070550|527787457|FG001|Overall Study|Treatment stopped|0|||
146350223|NCT01070550|527787458|FG002|Overall Study|Treatment stopped|0|||
146350224|NCT01070550|527787459|FG003|Overall Study|Treatment stopped|0|||
146350225|NCT01070550|527787460|FG004|Overall Study|Treatment stopped|0|||
146350226|NCT01070550|527787461|FG005|Overall Study|Treatment stopped|0|||
146350227|NCT01070550|527787456|FG000|Overall Study|Treatment unavailable|1|||
146350228|NCT01070550|527787457|FG001|Overall Study|Treatment unavailable|0|||
146350229|NCT01070550|527787458|FG002|Overall Study|Treatment unavailable|0|||
146350230|NCT01070550|527787459|FG003|Overall Study|Treatment unavailable|0|||
146169485|NCT04026165|527132823|FG001|Run-in SEL Period|Enrollment Error|4|||
146169486|NCT04026165|527132824|FG002|Run-in SEL Period|Enrollment Error|0|||
146169487|NCT04026165|527132825|FG003|Run-in SEL Period|Enrollment Error|0|||
146169488|NCT04026165|527132822|FG000|Run-in SEL Period|Protocol Violation|0|||
146169489|NCT04026165|527132823|FG001|Run-in SEL Period|Protocol Violation|3|||
146169490|NCT04026165|527132824|FG002|Run-in SEL Period|Protocol Violation|0|||
146350231|NCT01070550|527787460|FG004|Overall Study|Treatment unavailable|0|||
146350232|NCT01070550|527787461|FG005|Overall Study|Treatment unavailable|0|||
146350233|NCT01070550|527787456|FG000|Overall Study|Treatment was stopped early|7|||
146350234|NCT01070550|527787457|FG001|Overall Study|Treatment was stopped early|0|||
146350235|NCT01070550|527787458|FG002|Overall Study|Treatment was stopped early|0|||
146350236|NCT01070550|527787459|FG003|Overall Study|Treatment was stopped early|0|||
146350237|NCT01070550|527787460|FG004|Overall Study|Treatment was stopped early|0|||
146350238|NCT01070550|527787461|FG005|Overall Study|Treatment was stopped early|0|||
146350239|NCT01070550|527787456|FG000|Overall Study|Other|5|||
146350240|NCT01070550|527787457|FG001|Overall Study|Other|0|||
146350241|NCT01070550|527787458|FG002|Overall Study|Other|0|||
146350242|NCT01070550|527787459|FG003|Overall Study|Other|1|||
146350243|NCT01070550|527787460|FG004|Overall Study|Other|0|||
146350244|NCT01070550|527787461|FG005|Overall Study|Other|0|||
146350245|NCT01070550|527787456|FG000|Overall Study|Withdrawal by Subject|35|||
146350246|NCT01070550|527787457|FG001|Overall Study|Withdrawal by Subject|0|||
146350247|NCT01070550|527787458|FG002|Overall Study|Withdrawal by Subject|3|||
146350248|NCT01070550|527787459|FG003|Overall Study|Withdrawal by Subject|0|||
146350249|NCT01070550|527787460|FG004|Overall Study|Withdrawal by Subject|0|||
146350250|NCT01070550|527787461|FG005|Overall Study|Withdrawal by Subject|0|||
146169491|NCT04026165|527132825|FG003|Run-in SEL Period|Protocol Violation|0|||
146350251|NCT01585961|527787463|FG000|Overall Study|Death|6|||
146350252|NCT01585961|527787463|FG000|Overall Study|Physician Decision|1|||
146350253|NCT01585961|527787463|FG000|Overall Study|Decision to use non-study catheter|1|||
146350254|NCT01585961|527787463|FG000|Overall Study|Withdrawal by Subject|1|||
146350255|NCT01585961|527787463|FG000|Overall Study|Lost to Follow-up|23|||
146350256|NCT01585961|527787463|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
146350257|NCT01258348|527787464|FG000|Overall Study|Adverse Event|1|||
146350258|NCT01258348|527787465|FG001|Overall Study|Adverse Event|1|||
146350259|NCT01258348|527787466|FG002|Overall Study|Adverse Event|3|||
146350260|NCT01258348|527787467|FG003|Overall Study|Adverse Event|2|||
146350261|NCT01258348|527787468|FG004|Overall Study|Adverse Event|4|||
146350262|NCT01258348|527787464|FG000|Overall Study|Progressive Disease|0|||
146350263|NCT01258348|527787465|FG001|Overall Study|Progressive Disease|3|||
146350264|NCT01258348|527787466|FG002|Overall Study|Progressive Disease|0|||
146350265|NCT01258348|527787467|FG003|Overall Study|Progressive Disease|2|||
146350266|NCT01258348|527787468|FG004|Overall Study|Progressive Disease|2|||
146350267|NCT01258348|527787464|FG000|Overall Study|Physician Decision|0|||
146350268|NCT01258348|527787465|FG001|Overall Study|Physician Decision|0|||
146350269|NCT01258348|527787466|FG002|Overall Study|Physician Decision|0|||
146350270|NCT01258348|527787467|FG003|Overall Study|Physician Decision|2|||
146350271|NCT01258348|527787468|FG004|Overall Study|Physician Decision|0|||
146350272|NCT01258348|527787464|FG000|Overall Study|Withdrawal by Subject|0|||
146350273|NCT01258348|527787465|FG001|Overall Study|Withdrawal by Subject|1|||
146350274|NCT01258348|527787466|FG002|Overall Study|Withdrawal by Subject|0|||
146350275|NCT01258348|527787467|FG003|Overall Study|Withdrawal by Subject|0|||
146350276|NCT01258348|527787468|FG004|Overall Study|Withdrawal by Subject|0|||
146350277|NCT00109733|527787472|FG000|Overall Study|Protocol Violation|0|||
146350278|NCT00109733|527787473|FG001|Overall Study|Protocol Violation|1|||
146350279|NCT00109733|527787472|FG000|Overall Study|Stopped taking study drug|1|||
146350280|NCT00109733|527787473|FG001|Overall Study|Stopped taking study drug|1|||
146350281|NCT00109733|527787472|FG000|Overall Study|Non-compliant|0|||
146350282|NCT00109733|527787473|FG001|Overall Study|Non-compliant|1|||
146350283|NCT00109733|527787472|FG000|Overall Study|Could not commit time for study|1|||
146350284|NCT00109733|527787473|FG001|Overall Study|Could not commit time for study|1|||
146350285|NCT01702363|527787484|FG000|Overall Study|Adverse Event|14|||
146350286|NCT01702363|527787484|FG000|Overall Study|Lack of Efficacy|4|||
146350287|NCT01702363|527787484|FG000|Overall Study|Withdrawal by Subject|2|||
146350288|NCT00069576|527787487|FG000|Original Trial|Lost to Follow-up|25|||
146350289|NCT00069576|527787488|FG001|Original Trial|Lost to Follow-up|33|||
146350290|NCT00069576|527787487|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
146350291|NCT00069576|527787488|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
146350292|NCT00002663|527787489|FG000|Overall Study|Death|4|||
146350293|NCT00002663|527787490|FG001|Overall Study|Death|1|||
146350294|NCT00002663|527787491|FG002|Overall Study|Death|1|||
146350295|NCT00002663|527787492|FG003|Overall Study|Death|0|||
146350296|NCT00002663|527787493|FG004|Overall Study|Death|0|||
146350297|NCT00002663|527787494|FG005|Overall Study|Death|13|||
146350298|NCT00002663|527787495|FG006|Overall Study|Death|0|||
146350299|NCT00002663|527787496|FG007|Overall Study|Death|1|||
146350300|NCT00002663|527787497|FG008|Overall Study|Death|1|||
146350301|NCT00002663|527787498|FG009|Overall Study|Death|1|||
146350302|NCT00002663|527787489|FG000|Overall Study|Lost to Follow-up|3|||
146350303|NCT00002663|527787490|FG001|Overall Study|Lost to Follow-up|0|||
146350304|NCT00002663|527787491|FG002|Overall Study|Lost to Follow-up|0|||
146350305|NCT00002663|527787492|FG003|Overall Study|Lost to Follow-up|1|||
146350306|NCT00002663|527787493|FG004|Overall Study|Lost to Follow-up|0|||
146350307|NCT00002663|527787494|FG005|Overall Study|Lost to Follow-up|1|||
146350308|NCT00002663|527787495|FG006|Overall Study|Lost to Follow-up|0|||
146350309|NCT00002663|527787496|FG007|Overall Study|Lost to Follow-up|0|||
146350310|NCT00002663|527787497|FG008|Overall Study|Lost to Follow-up|0|||
146350311|NCT00002663|527787498|FG009|Overall Study|Lost to Follow-up|0|||
146350312|NCT00002663|527787489|FG000|Overall Study|Other|0|||
146350313|NCT00002663|527787490|FG001|Overall Study|Other|1|||
146350314|NCT00002663|527787491|FG002|Overall Study|Other|0|||
146350315|NCT00002663|527787492|FG003|Overall Study|Other|0|||
146350316|NCT00002663|527787493|FG004|Overall Study|Other|0|||
146350317|NCT00002663|527787494|FG005|Overall Study|Other|1|||
146350318|NCT00002663|527787495|FG006|Overall Study|Other|1|||
146350319|NCT00002663|527787496|FG007|Overall Study|Other|0|||
146350320|NCT00002663|527787497|FG008|Overall Study|Other|0|||
146350321|NCT00002663|527787498|FG009|Overall Study|Other|0|||
146350322|NCT00002663|527787489|FG000|Overall Study|Physician Decision|0|||
146350323|NCT00002663|527787490|FG001|Overall Study|Physician Decision|0|||
146350324|NCT00002663|527787491|FG002|Overall Study|Physician Decision|0|||
146350325|NCT00002663|527787492|FG003|Overall Study|Physician Decision|0|||
146350326|NCT00002663|527787493|FG004|Overall Study|Physician Decision|1|||
146350327|NCT00002663|527787494|FG005|Overall Study|Physician Decision|0|||
146350328|NCT00002663|527787495|FG006|Overall Study|Physician Decision|0|||
146350329|NCT00002663|527787496|FG007|Overall Study|Physician Decision|0|||
146350330|NCT00002663|527787497|FG008|Overall Study|Physician Decision|1|||
146350331|NCT00002663|527787498|FG009|Overall Study|Physician Decision|1|||
146350332|NCT00002663|527787489|FG000|Overall Study|Adverse Event|0|||
146350333|NCT00002663|527787490|FG001|Overall Study|Adverse Event|0|||
146350334|NCT00002663|527787491|FG002|Overall Study|Adverse Event|0|||
146350335|NCT00002663|527787492|FG003|Overall Study|Adverse Event|1|||
146350336|NCT00002663|527787493|FG004|Overall Study|Adverse Event|0|||
146350337|NCT00002663|527787494|FG005|Overall Study|Adverse Event|0|||
146350338|NCT00002663|527787495|FG006|Overall Study|Adverse Event|0|||
146350339|NCT00002663|527787496|FG007|Overall Study|Adverse Event|1|||
146350340|NCT00002663|527787497|FG008|Overall Study|Adverse Event|0|||
146350341|NCT00002663|527787498|FG009|Overall Study|Adverse Event|0|||
146350342|NCT00905307|527787500|FG000|Overall Study|Switched to Open Label Rescue|7|||
146350343|NCT00905307|527787501|FG001|Overall Study|Switched to Open Label Rescue|17|||
146350344|NCT00905307|527787502|FG002|Overall Study|Switched to Open Label Rescue|11|||
146350345|NCT00905307|527787503|FG003|Overall Study|Switched to Open Label Rescue|11|||
146350346|NCT00905307|527787504|FG004|Overall Study|Switched to Open Label Rescue|4|||
146350347|NCT00905307|527787505|FG005|Overall Study|Switched to Open Label Rescue|15|||
146350348|NCT00905307|527787500|FG000|Overall Study|Lost to Follow-up|0|||
146350349|NCT00905307|527787501|FG001|Overall Study|Lost to Follow-up|0|||
146350350|NCT00905307|527787502|FG002|Overall Study|Lost to Follow-up|0|||
146350351|NCT00905307|527787503|FG003|Overall Study|Lost to Follow-up|0|||
146350352|NCT00905307|527787504|FG004|Overall Study|Lost to Follow-up|1|||
146350353|NCT00905307|527787505|FG005|Overall Study|Lost to Follow-up|1|||
146350354|NCT00905307|527787500|FG000|Overall Study|Adverse Event|3|||
146350355|NCT00905307|527787501|FG001|Overall Study|Adverse Event|4|||
146350356|NCT00905307|527787502|FG002|Overall Study|Adverse Event|5|||
146350357|NCT00905307|527787503|FG003|Overall Study|Adverse Event|11|||
146350358|NCT00905307|527787504|FG004|Overall Study|Adverse Event|3|||
146350359|NCT00905307|527787505|FG005|Overall Study|Adverse Event|5|||
146350360|NCT00905307|527787500|FG000|Overall Study|Withdrawal by Subject|5|||
146350361|NCT00905307|527787501|FG001|Overall Study|Withdrawal by Subject|13|||
146350362|NCT00905307|527787502|FG002|Overall Study|Withdrawal by Subject|15|||
146350363|NCT00905307|527787503|FG003|Overall Study|Withdrawal by Subject|11|||
146350364|NCT00905307|527787504|FG004|Overall Study|Withdrawal by Subject|4|||
146350365|NCT00905307|527787505|FG005|Overall Study|Withdrawal by Subject|13|||
146350366|NCT00905307|527787500|FG000|Overall Study|Protocol Violation|1|||
146350367|NCT00905307|527787501|FG001|Overall Study|Protocol Violation|0|||
146350368|NCT00905307|527787502|FG002|Overall Study|Protocol Violation|1|||
146350369|NCT00905307|527787503|FG003|Overall Study|Protocol Violation|0|||
146350370|NCT00905307|527787504|FG004|Overall Study|Protocol Violation|0|||
146350371|NCT00905307|527787505|FG005|Overall Study|Protocol Violation|0|||
146350372|NCT00905307|527787500|FG000|Overall Study|Lack of Efficacy|6|||
146350373|NCT00905307|527787501|FG001|Overall Study|Lack of Efficacy|3|||
146350374|NCT00905307|527787502|FG002|Overall Study|Lack of Efficacy|5|||
146350375|NCT00905307|527787503|FG003|Overall Study|Lack of Efficacy|4|||
146350376|NCT00905307|527787504|FG004|Overall Study|Lack of Efficacy|4|||
146350377|NCT00905307|527787505|FG005|Overall Study|Lack of Efficacy|8|||
146350378|NCT03838367|527787506|FG000|Overall Study|Early termination of study|3|||
146350379|NCT03838367|527787507|FG001|Overall Study|Early termination of study|4|||
146350380|NCT03838367|527787508|FG002|Overall Study|Early termination of study|3|||
146350381|NCT03838367|527787509|FG003|Overall Study|Early termination of study|0|||
146350382|NCT03406104|527787510|FG000|Overall Study|Lost to Follow-up|2|||
146350383|NCT03406104|527787510|FG000|Overall Study|Withdrawal by Subject|2|||
146350384|NCT03406104|527787510|FG000|Overall Study|due to Covid patient did not want to travel|1|||
146350385|NCT03406104|527787510|FG000|Overall Study|Death|2|||
146350386|NCT00525148|527787513|FG000|Overall Study|Other Adverse Event|3|||
146350387|NCT00525148|527787514|FG001|Overall Study|Other Adverse Event|5|||
146350388|NCT00525148|527787515|FG002|Overall Study|Other Adverse Event|1|||
146350389|NCT00525148|527787516|FG003|Overall Study|Other Adverse Event|8|||
146350390|NCT00525148|527787513|FG000|Overall Study|Progressive disease|18|||
146350391|NCT00525148|527787514|FG001|Overall Study|Progressive disease|30|||
146350392|NCT00525148|527787515|FG002|Overall Study|Progressive disease|6|||
146350393|NCT00525148|527787516|FG003|Overall Study|Progressive disease|49|||
146350394|NCT00525148|527787513|FG000|Overall Study|Refused continuation of study medication|0|||
146350395|NCT00525148|527787514|FG001|Overall Study|Refused continuation of study medication|2|||
146350396|NCT00525148|527787515|FG002|Overall Study|Refused continuation of study medication|0|||
146350397|NCT00525148|527787516|FG003|Overall Study|Refused continuation of study medication|1|||
146350398|NCT00525148|527787513|FG000|Overall Study|Other than stated|2|||
146350399|NCT00525148|527787514|FG001|Overall Study|Other than stated|1|||
146350400|NCT00525148|527787515|FG002|Overall Study|Other than stated|0|||
146350401|NCT00525148|527787516|FG003|Overall Study|Other than stated|3|||
146350402|NCT03015610|527787517|FG000|Overall Study|Lost to Follow-up|1|||
146350403|NCT03015610|527787518|FG001|Overall Study|Lost to Follow-up|5|||
146350404|NCT01603641|527787519|FG000|Overall Study|Did not Receive Treatment|3|||
146350405|NCT01603641|527787519|FG000|Overall Study|Adverse Event|1|||
146350406|NCT01603641|527787519|FG000|Overall Study|Lack of Efficacy|1|||
146350407|NCT01603641|527787519|FG000|Overall Study|Lost to Follow-up|6|||
146350408|NCT01603641|527787519|FG000|Overall Study|Personal Reasons|18|||
146350409|NCT01603641|527787519|FG000|Overall Study|Other Miscellaneous Reasons|6|||
146350410|NCT05100199|527787526|FG000|Overall Study|Lost to Follow-up|5|||
146350411|NCT05100199|527787527|FG001|Overall Study|Lost to Follow-up|8|||
146350412|NCT05100199|527787528|FG002|Overall Study|Lost to Follow-up|3|||
146350413|NCT05100199|527787529|FG003|Overall Study|Lost to Follow-up|6|||
146350414|NCT05100199|527787526|FG000|Overall Study|Withdrawal by Subject|3|||
146350415|NCT05100199|527787527|FG001|Overall Study|Withdrawal by Subject|3|||
146350416|NCT05100199|527787528|FG002|Overall Study|Withdrawal by Subject|9|||
146350417|NCT05100199|527787529|FG003|Overall Study|Withdrawal by Subject|7|||
146350418|NCT05100199|527787526|FG000|Overall Study|Other|0|||
146350419|NCT05100199|527787527|FG001|Overall Study|Other|0|||
146350420|NCT05100199|527787528|FG002|Overall Study|Other|1|||
146350421|NCT05100199|527787529|FG003|Overall Study|Other|1|||
146350422|NCT01905397|527787532|FG000|Overall Study|Death|0|||
146350423|NCT01905397|527787533|FG001|Overall Study|Death|1|||
146350424|NCT01905397|527787532|FG000|Overall Study|Withdrawal by Subject|2|||
146350425|NCT01905397|527787533|FG001|Overall Study|Withdrawal by Subject|0|||
146350426|NCT01905397|527787532|FG000|Overall Study|Surgery canceled/aborted|9|||
146350427|NCT01905397|527787533|FG001|Overall Study|Surgery canceled/aborted|5|||
146350428|NCT01905397|527787532|FG000|Overall Study|Incision < 7 cm|2|||
146350429|NCT01905397|527787533|FG001|Overall Study|Incision < 7 cm|0|||
146350430|NCT01905397|527787532|FG000|Overall Study|Wrong treatment|1|||
146350431|NCT01905397|527787533|FG001|Overall Study|Wrong treatment|1|||
146350432|NCT01905397|527787532|FG000|Overall Study|Device not applied|3|||
146350433|NCT01905397|527787533|FG001|Overall Study|Device not applied|0|||
146350434|NCT01905397|527787532|FG000|Overall Study|Dressing not applied in operating room|1|||
146350435|NCT01905397|527787533|FG001|Overall Study|Dressing not applied in operating room|0|||
146350436|NCT01905397|527787532|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
146350437|NCT01905397|527787533|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
146350438|NCT01259297|527787537|FG000|Double Blind Randomized Period|Death|1|||
146350439|NCT01259297|527787538|FG001|Double Blind Randomized Period|Death|1|||
146350440|NCT01259297|527787539|FG002|Double Blind Randomized Period|Death|1|||
146350441|NCT01259297|527787540|FG003|Double Blind Randomized Period|Death|2|||
146350442|NCT01259297|527787541|FG004|Double Blind Randomized Period|Death|1|||
146350443|NCT01259297|527787542|FG005|Double Blind Randomized Period|Death|5|||
146350444|NCT01259297|527787543|FG006|Double Blind Randomized Period|Death|2|||
146350445|NCT01259297|527787544|FG007|Double Blind Randomized Period|Death|1|||
146350446|NCT01259297|527787537|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146350447|NCT01259297|527787538|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146350448|NCT01259297|527787539|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
146350449|NCT01259297|527787540|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
146350450|NCT01259297|527787541|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
146350451|NCT01259297|527787542|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146350452|NCT01259297|527787543|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146350453|NCT01259297|527787544|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
146350454|NCT01259297|527787537|FG000|Double Blind Randomized Period|Other reasons|0|||
146350455|NCT01259297|527787538|FG001|Double Blind Randomized Period|Other reasons|1|||
146350456|NCT01259297|527787539|FG002|Double Blind Randomized Period|Other reasons|0|||
146350457|NCT01259297|527787540|FG003|Double Blind Randomized Period|Other reasons|0|||
146350458|NCT01259297|527787541|FG004|Double Blind Randomized Period|Other reasons|1|||
146350459|NCT01259297|527787542|FG005|Double Blind Randomized Period|Other reasons|2|||
146350460|NCT01259297|527787543|FG006|Double Blind Randomized Period|Other reasons|3|||
146350461|NCT01259297|527787544|FG007|Double Blind Randomized Period|Other reasons|1|||
146350462|NCT01096550|527787547|FG000|Overall Study|discontinued site|10|||
146350463|NCT01096550|527787548|FG001|Overall Study|discontinued site|11|||
146350464|NCT01096550|527787547|FG000|Overall Study|non-regular treatment track at clinic|1|||
146350465|NCT01096550|527787548|FG001|Overall Study|non-regular treatment track at clinic|1|||
146350466|NCT01096550|527787547|FG000|Overall Study|clinic readmission|1|||
146350467|NCT01096550|527787548|FG001|Overall Study|clinic readmission|1|||
146350468|NCT01096550|527787547|FG000|Overall Study|Withdrawal by Subject|0|||
146350469|NCT01096550|527787548|FG001|Overall Study|Withdrawal by Subject|1|||
146350470|NCT01096550|527787547|FG000|Overall Study|non-African American participant|13|||
146350471|NCT01096550|527787548|FG001|Overall Study|non-African American participant|6|||
146350472|NCT01096550|527787547|FG000|Overall Study|Lost to Follow-up|12|||
146169492|NCT04026165|527132822|FG000|Run-in SEL Period|Investigator's Discretion|0|||
146350473|NCT01096550|527787548|FG001|Overall Study|Lost to Follow-up|9|||
146350474|NCT00783705|527787553|FG000|Overall Study|Adverse Event|2|||
146350475|NCT00783705|527787554|FG001|Overall Study|Adverse Event|0|||
146350476|NCT00783705|527787553|FG000|Overall Study|Withdrawal by Subject|3|||
146350477|NCT00783705|527787554|FG001|Overall Study|Withdrawal by Subject|2|||
146350478|NCT00783705|527787553|FG000|Overall Study|Lost to Follow-up|1|||
146350479|NCT00783705|527787554|FG001|Overall Study|Lost to Follow-up|3|||
146350480|NCT01770353|527787555|FG000|Overall Study|Progressive disease|2|||
146350481|NCT01770353|527787556|FG001|Overall Study|Progressive disease|1|||
146350482|NCT01770353|527787555|FG000|Overall Study|Adverse Event|0|||
146350483|NCT01770353|527787556|FG001|Overall Study|Adverse Event|1|||
146350484|NCT01770353|527787555|FG000|Overall Study|Protocol Violation|1|||
146350485|NCT01770353|527787556|FG001|Overall Study|Protocol Violation|0|||
146350486|NCT01770353|527787555|FG000|Overall Study|Physician Decision|0|||
146350487|NCT01770353|527787556|FG001|Overall Study|Physician Decision|3|||
146350488|NCT01770353|527787555|FG000|Overall Study|Clinical deterioration|3|||
146350489|NCT01770353|527787556|FG001|Overall Study|Clinical deterioration|6|||
146350490|NCT01770353|527787555|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
146350491|NCT01770353|527787556|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
146350492|NCT00376688|527787557|FG000|Overall Study|Adverse Event|3|||
146350493|NCT00376688|527787557|FG000|Overall Study|Death|1|||
146350494|NCT02574312|527787558|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
146350495|NCT02574312|527787559|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
146350496|NCT05128162|527787560|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
146350497|NCT05128162|527787560|FG000|Overall Study|Physician Decision|1|||
146350498|NCT02410902|527789008|FG000|Overall Study|Adverse Event|2|||
146350499|NCT02410902|527789009|FG001|Overall Study|Adverse Event|3|||
146350500|NCT02410902|527789008|FG000|Overall Study|Lost to Follow-up|4|||
146350501|NCT02410902|527789009|FG001|Overall Study|Lost to Follow-up|1|||
146350502|NCT02410902|527789008|FG000|Overall Study|Protocol Violation|1|||
146350503|NCT02410902|527789009|FG001|Overall Study|Protocol Violation|4|||
146350504|NCT02410902|527789008|FG000|Overall Study|Withdrawal by Subject|6|||
146350505|NCT02410902|527789009|FG001|Overall Study|Withdrawal by Subject|8|||
146350506|NCT02410902|527789008|FG000|Overall Study|Non-Compliance|8|||
146350507|NCT02410902|527789009|FG001|Overall Study|Non-Compliance|2|||
146350508|NCT00953043|527789010|FG000|Overall Study|Withdrawal by Subject|4|||
146350509|NCT00953043|527789011|FG001|Overall Study|Withdrawal by Subject|0|||
146350510|NCT00953043|527789010|FG000|Overall Study|Physician Decision|0|||
146350511|NCT00953043|527789011|FG001|Overall Study|Physician Decision|2|||
146350512|NCT00747617|527789013|FG000|Overall Study|Lost to Follow-up|3|||
146350513|NCT00747617|527789014|FG001|Overall Study|Lost to Follow-up|1|||
146350514|NCT01746732|527789015|FG000|Lead-In Period|Withdrawal by Subject|1|||
146350515|NCT01746732|527789016|FG001|Lead-In Period|Withdrawal by Subject|0|||
146350516|NCT01746732|527789017|FG002|Lead-In Period|Withdrawal by Subject|0|||
146350517|NCT01746732|527789015|FG000|Period 1|Physician Decision|0|||
146350518|NCT01746732|527789016|FG001|Period 1|Physician Decision|1|||
146350519|NCT01746732|527789017|FG002|Period 1|Physician Decision|0|||
146350520|NCT01746732|527789015|FG000|Period 2|Withdrawal by Subject|0|||
146350521|NCT01746732|527789016|FG001|Period 2|Withdrawal by Subject|0|||
146350522|NCT01746732|527789017|FG002|Period 2|Withdrawal by Subject|2|||
146350523|NCT01746732|527789015|FG000|Period 2|Adverse Event|0|||
146350524|NCT01746732|527789016|FG001|Period 2|Adverse Event|0|||
146350525|NCT01746732|527789017|FG002|Period 2|Adverse Event|1|||
146350526|NCT01746732|527789015|FG000|Period 2|Lost to Follow-up|0|||
146350527|NCT01746732|527789016|FG001|Period 2|Lost to Follow-up|0|||
146350528|NCT01746732|527789017|FG002|Period 2|Lost to Follow-up|1|||
146350529|NCT02279524|527789018|FG000|Overall Study|Withdrawal by Subject|3|||
146350530|NCT02279524|527789019|FG001|Overall Study|Withdrawal by Subject|6|||
146350531|NCT02279524|527789020|FG002|Overall Study|Withdrawal by Subject|3|||
146350532|NCT02279524|527789018|FG000|Overall Study|Adverse Event|4|||
146350533|NCT02279524|527789019|FG001|Overall Study|Adverse Event|3|||
146350534|NCT02279524|527789020|FG002|Overall Study|Adverse Event|2|||
146350535|NCT02279524|527789018|FG000|Overall Study|Lost to Follow-up|1|||
146350536|NCT02279524|527789019|FG001|Overall Study|Lost to Follow-up|1|||
146350537|NCT02279524|527789020|FG002|Overall Study|Lost to Follow-up|0|||
146350538|NCT02279524|527789018|FG000|Overall Study|Disallowed medication|1|||
146350539|NCT02279524|527789019|FG001|Overall Study|Disallowed medication|1|||
146350540|NCT02279524|527789020|FG002|Overall Study|Disallowed medication|2|||
146350541|NCT02279524|527789018|FG000|Overall Study|Bariatric surgery|1|||
146350542|NCT02279524|527789019|FG001|Overall Study|Bariatric surgery|0|||
146350543|NCT02279524|527789020|FG002|Overall Study|Bariatric surgery|0|||
146350544|NCT03509207|527789021|FG000|Overall Study|Death|2|||
146350545|NCT02817555|527789022|FG000|Overall Study|Death|1|||
146350546|NCT02817555|527789023|FG001|Overall Study|Death|3|||
146350547|NCT02817555|527789022|FG000|Overall Study|moved away|1|||
146350548|NCT02817555|527789023|FG001|Overall Study|moved away|0|||
146350549|NCT02817555|527789022|FG000|Overall Study|transplant|1|||
146350550|NCT02817555|527789023|FG001|Overall Study|transplant|1|||
146350551|NCT02817555|527789022|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
146350552|NCT02817555|527789023|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
146350553|NCT01043185|527789024|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
146350554|NCT01043185|527789025|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
146350555|NCT01043185|527789026|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
146350556|NCT01043185|527789027|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
146350557|NCT01043185|527789028|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
146350558|NCT01043185|527789029|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
146350559|NCT01043185|527789030|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
146350560|NCT01043185|527789031|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
146396303|NCT02219477|527954552|FG001|Overall Study|Adverse Event|1|||
146350561|NCT01043185|527789032|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
146350562|NCT01043185|527789033|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
146350563|NCT00137436|527789034|FG000|Overall Study|Adverse Event|13|||
146350564|NCT00137436|527789034|FG000|Overall Study|Death|2|||
146350565|NCT00137436|527789034|FG000|Overall Study|Lack of Efficacy|17|||
146350566|NCT00137436|527789034|FG000|Overall Study|Withdrawal by Subject|6|||
146350567|NCT00137436|527789034|FG000|Overall Study|Other|5|||
146350568|NCT01432262|527789035|FG000|Overall Study|Withdrawal by Subject|2|||
146350569|NCT01432262|527789036|FG001|Overall Study|Withdrawal by Subject|1|||
146350570|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
146350571|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
146350572|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146350573|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146350574|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146350575|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146350576|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
146350577|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146350578|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
146350579|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146350580|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146350581|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
146350582|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146350583|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
146350584|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
146350585|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
146350586|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
146350587|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
146350588|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146350589|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146350590|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
146350591|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Other|0|||
146350592|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Other|1|||
146350593|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Other|0|||
146350594|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Other|0|||
146350595|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Other|0|||
146350596|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Other|0|||
146350597|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Other|0|||
146350598|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
146350599|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
146350600|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
146350601|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
146350602|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
146350603|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
146350604|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
146350605|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
146350606|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
146350607|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146350608|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
146350609|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
146350610|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146350611|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
146350612|NCT00365716|527789037|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
146350613|NCT00365716|527789038|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
146350614|NCT00365716|527789039|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
146350615|NCT00365716|527789040|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
146350616|NCT00365716|527789041|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
146350617|NCT00365716|527789042|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
146350618|NCT00365716|527789043|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
146350619|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
146350620|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146350621|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146350622|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
146350623|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
146350624|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146350625|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
146350626|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
146350627|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
146350628|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
146350629|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
146350630|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
146350631|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
146350632|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
146350633|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
146350634|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
146350635|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
146350636|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
146350637|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146350638|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146350639|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
146350640|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
146350641|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146350642|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146350643|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146350644|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
146350645|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146350646|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
146350647|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146350648|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
146350649|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
146350650|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146350651|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146350652|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146350653|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
146350654|NCT00365716|527789037|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
146350655|NCT00365716|527789038|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
146350656|NCT00365716|527789039|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
146350657|NCT00365716|527789040|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
146350658|NCT00365716|527789041|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
146350659|NCT00365716|527789042|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
146350660|NCT00365716|527789043|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
146350661|NCT00365716|527789037|FG000|Extension 1|Lost to Follow-up|0|||
146350662|NCT00365716|527789038|FG001|Extension 1|Lost to Follow-up|0|||
146350663|NCT00365716|527789039|FG002|Extension 1|Lost to Follow-up|0|||
146350664|NCT00365716|527789040|FG003|Extension 1|Lost to Follow-up|0|||
146350665|NCT00365716|527789041|FG004|Extension 1|Lost to Follow-up|0|||
146350666|NCT00365716|527789042|FG005|Extension 1|Lost to Follow-up|1|||
146350667|NCT00365716|527789043|FG006|Extension 1|Lost to Follow-up|0|||
146350668|NCT00365716|527789037|FG000|Extension 1|Other|0|||
146350669|NCT00365716|527789038|FG001|Extension 1|Other|0|||
146350670|NCT00365716|527789039|FG002|Extension 1|Other|0|||
146350671|NCT00365716|527789040|FG003|Extension 1|Other|0|||
146350672|NCT00365716|527789041|FG004|Extension 1|Other|0|||
146350673|NCT00365716|527789042|FG005|Extension 1|Other|9|||
146350674|NCT00365716|527789043|FG006|Extension 1|Other|0|||
146350675|NCT00365716|527789037|FG000|Extension 1|Moved|0|||
146350676|NCT00365716|527789038|FG001|Extension 1|Moved|0|||
146350677|NCT00365716|527789039|FG002|Extension 1|Moved|0|||
146350678|NCT00365716|527789040|FG003|Extension 1|Moved|0|||
146350679|NCT00365716|527789041|FG004|Extension 1|Moved|0|||
146350680|NCT00365716|527789042|FG005|Extension 1|Moved|4|||
146350681|NCT00365716|527789043|FG006|Extension 1|Moved|0|||
146350682|NCT00365716|527789037|FG000|Extension 1|Withdrawal by Subject|0|||
146350683|NCT00365716|527789038|FG001|Extension 1|Withdrawal by Subject|0|||
146350684|NCT00365716|527789039|FG002|Extension 1|Withdrawal by Subject|0|||
146350685|NCT00365716|527789040|FG003|Extension 1|Withdrawal by Subject|0|||
146350686|NCT00365716|527789041|FG004|Extension 1|Withdrawal by Subject|0|||
146350687|NCT00365716|527789042|FG005|Extension 1|Withdrawal by Subject|3|||
146350688|NCT00365716|527789043|FG006|Extension 1|Withdrawal by Subject|0|||
146350689|NCT00365716|527789037|FG000|Extension 1|Pregnancy|0|||
146350690|NCT00365716|527789038|FG001|Extension 1|Pregnancy|0|||
146350691|NCT00365716|527789039|FG002|Extension 1|Pregnancy|0|||
146350692|NCT00365716|527789040|FG003|Extension 1|Pregnancy|0|||
146350693|NCT00365716|527789041|FG004|Extension 1|Pregnancy|0|||
146350694|NCT00365716|527789042|FG005|Extension 1|Pregnancy|4|||
146350695|NCT00365716|527789043|FG006|Extension 1|Pregnancy|0|||
146350696|NCT00365716|527789037|FG000|Extension 1|Protocol Violation|0|||
146350697|NCT00365716|527789038|FG001|Extension 1|Protocol Violation|0|||
146350698|NCT00365716|527789039|FG002|Extension 1|Protocol Violation|0|||
146350699|NCT00365716|527789040|FG003|Extension 1|Protocol Violation|0|||
146350700|NCT00365716|527789041|FG004|Extension 1|Protocol Violation|0|||
146169493|NCT04026165|527132823|FG001|Run-in SEL Period|Investigator's Discretion|2|||
146350701|NCT00365716|527789042|FG005|Extension 1|Protocol Violation|1|||
146350702|NCT00365716|527789043|FG006|Extension 1|Protocol Violation|0|||
146350703|NCT00365716|527789037|FG000|Extension 2|Lost to Follow-up|0|||
146350704|NCT00365716|527789038|FG001|Extension 2|Lost to Follow-up|0|||
146350705|NCT00365716|527789039|FG002|Extension 2|Lost to Follow-up|0|||
146350706|NCT00365716|527789040|FG003|Extension 2|Lost to Follow-up|0|||
146350707|NCT00365716|527789041|FG004|Extension 2|Lost to Follow-up|0|||
146350708|NCT00365716|527789042|FG005|Extension 2|Lost to Follow-up|0|||
146350709|NCT00365716|527789043|FG006|Extension 2|Lost to Follow-up|2|||
146350710|NCT00365716|527789037|FG000|Extension 2|Other|0|||
146350711|NCT00365716|527789038|FG001|Extension 2|Other|0|||
146350712|NCT00365716|527789039|FG002|Extension 2|Other|0|||
146350713|NCT00365716|527789040|FG003|Extension 2|Other|0|||
146350714|NCT00365716|527789041|FG004|Extension 2|Other|0|||
146350715|NCT00365716|527789042|FG005|Extension 2|Other|0|||
146350716|NCT00365716|527789043|FG006|Extension 2|Other|3|||
146350717|NCT00365716|527789037|FG000|Extension 2|Withdrawal by Subject|0|||
146350718|NCT00365716|527789038|FG001|Extension 2|Withdrawal by Subject|0|||
146350719|NCT00365716|527789039|FG002|Extension 2|Withdrawal by Subject|0|||
146350720|NCT00365716|527789040|FG003|Extension 2|Withdrawal by Subject|0|||
146350721|NCT00365716|527789041|FG004|Extension 2|Withdrawal by Subject|0|||
146350722|NCT00365716|527789042|FG005|Extension 2|Withdrawal by Subject|0|||
146350723|NCT00365716|527789043|FG006|Extension 2|Withdrawal by Subject|5|||
146350724|NCT01106534|527789047|FG000|Overall Study|Withdrawal by Subject|18|||
146350725|NCT01106534|527789047|FG000|Overall Study|Lost to Follow-up|2|||
146350726|NCT01106534|527789047|FG000|Overall Study|Death|16|||
146350727|NCT01106534|527789047|FG000|Overall Study|Physician Decision|1|||
146350728|NCT02985450|527789055|FG000|Overall Study|Lost to Follow-up|7|||
146350729|NCT05590793|527789056|FG000|Overall Study|Withdrawal by Subject|6|||
146350730|NCT05590793|527789056|FG000|Overall Study|Physician Decision|1|||
146350731|NCT04060667|527789057|FG000|Overall Study|Lost to Follow-up|75|||
146350732|NCT04060667|527789058|FG001|Overall Study|Lost to Follow-up|10|||
146350733|NCT04488822|527789059|FG000|Overall Study|Adverse Event|8|||
146350734|NCT04488822|527789059|FG000|Overall Study|Withdrawal by Subject|1|||
146350735|NCT00114972|527789065|FG000|Overall Study|Withdrawal by Subject|40|||
146350736|NCT00114972|527789066|FG001|Overall Study|Withdrawal by Subject|7|||
146350737|NCT00114972|527789065|FG000|Overall Study|Lost to Follow-up|8|||
146350738|NCT00114972|527789066|FG001|Overall Study|Lost to Follow-up|5|||
146350739|NCT02890329|527789067|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146350740|NCT02890329|527789068|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
146350741|NCT02890329|527789069|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146350742|NCT02890329|527789070|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146350743|NCT02890329|527789071|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146350744|NCT02890329|527789072|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
146350745|NCT02890329|527789067|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
146350746|NCT02890329|527789068|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
146350747|NCT02890329|527789069|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146350748|NCT02890329|527789070|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146350749|NCT02890329|527789071|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146350750|NCT02890329|527789072|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
146350751|NCT02890329|527789067|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146350752|NCT02890329|527789068|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146350753|NCT02890329|527789069|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146350754|NCT02890329|527789070|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
146350755|NCT02890329|527789071|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146350756|NCT02890329|527789072|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
146350757|NCT02890329|527789067|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146350758|NCT02890329|527789068|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146350759|NCT02890329|527789069|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
146350760|NCT02890329|527789070|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146350761|NCT02890329|527789071|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146350762|NCT02890329|527789072|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
146350763|NCT02691247|527789076|FG000|Overall Study|Withdrawal by Subject|1|||
146350764|NCT02691247|527789077|FG001|Overall Study|Withdrawal by Subject|2|||
146350765|NCT02691247|527789078|FG002|Overall Study|Withdrawal by Subject|2|||
146350766|NCT02691247|527789076|FG000|Overall Study|Lost to Follow-up|2|||
146350767|NCT02691247|527789077|FG001|Overall Study|Lost to Follow-up|0|||
146350768|NCT02691247|527789078|FG002|Overall Study|Lost to Follow-up|1|||
146350769|NCT02552355|527789079|FG000|Overall Study|Adverse Event|0|||
146350770|NCT02552355|527789080|FG001|Overall Study|Adverse Event|2|||
146350771|NCT02552355|527789081|FG002|Overall Study|Adverse Event|2|||
146350772|NCT02552355|527789082|FG003|Overall Study|Adverse Event|0|||
146350773|NCT02552355|527789079|FG000|Overall Study|Withdrawal by Subject|0|||
146350774|NCT02552355|527789080|FG001|Overall Study|Withdrawal by Subject|0|||
146350775|NCT02552355|527789081|FG002|Overall Study|Withdrawal by Subject|0|||
145943387|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146169494|NCT04026165|527132824|FG002|Run-in SEL Period|Investigator's Discretion|0|||
146350776|NCT02552355|527789082|FG003|Overall Study|Withdrawal by Subject|1|||
146350777|NCT01519245|527789083|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
146350778|NCT01519245|527789084|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
146350779|NCT00803244|527789087|FG000|Overall Study|Adverse Event|1|||
146350780|NCT00803244|527789088|FG001|Overall Study|Adverse Event|2|||
146350781|NCT00803244|527789087|FG000|Overall Study|Withdrawal by Subject|2|||
146350782|NCT00803244|527789088|FG001|Overall Study|Withdrawal by Subject|3|||
146350783|NCT00803244|527789087|FG000|Overall Study|Any other reason not above-mentioned|4|||
146350784|NCT00803244|527789088|FG001|Overall Study|Any other reason not above-mentioned|10|||
146350785|NCT03321929|527789089|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
146350786|NCT00616239|527789091|FG000|Overall Study|Withdrawal by Subject|2|||
146350787|NCT01052012|527789092|FG000|Overall Study|Not treated|2|||
146350788|NCT01052012|527789093|FG001|Overall Study|Not treated|5|||
146350789|NCT01052012|527789094|FG002|Overall Study|Not treated|0|||
146350790|NCT01052012|527789095|FG003|Overall Study|Not treated|0|||
146350791|NCT01052012|527789096|FG004|Overall Study|Not treated|11|||
146350792|NCT01052012|527789097|FG005|Overall Study|Not treated|8|||
146350793|NCT01052012|527789092|FG000|Overall Study|Adverse Event|1|||
146350794|NCT01052012|527789093|FG001|Overall Study|Adverse Event|0|||
146350795|NCT01052012|527789094|FG002|Overall Study|Adverse Event|0|||
146350796|NCT01052012|527789095|FG003|Overall Study|Adverse Event|1|||
146350797|NCT01052012|527789096|FG004|Overall Study|Adverse Event|0|||
146350798|NCT01052012|527789097|FG005|Overall Study|Adverse Event|0|||
146350799|NCT01052012|527789092|FG000|Overall Study|Lost to Follow-up|0|||
146350800|NCT01052012|527789093|FG001|Overall Study|Lost to Follow-up|0|||
146350801|NCT01052012|527789094|FG002|Overall Study|Lost to Follow-up|0|||
146350802|NCT01052012|527789095|FG003|Overall Study|Lost to Follow-up|0|||
146350803|NCT01052012|527789096|FG004|Overall Study|Lost to Follow-up|1|||
146350804|NCT01052012|527789097|FG005|Overall Study|Lost to Follow-up|0|||
146350805|NCT01052012|527789092|FG000|Overall Study|Withdrawal by Subject|1|||
146350806|NCT01052012|527789093|FG001|Overall Study|Withdrawal by Subject|1|||
146350807|NCT01052012|527789094|FG002|Overall Study|Withdrawal by Subject|0|||
146350808|NCT01052012|527789095|FG003|Overall Study|Withdrawal by Subject|0|||
146350809|NCT01052012|527789096|FG004|Overall Study|Withdrawal by Subject|3|||
146350810|NCT01052012|527789097|FG005|Overall Study|Withdrawal by Subject|1|||
146350811|NCT01052012|527789092|FG000|Overall Study|Physician Decision|0|||
146350812|NCT01052012|527789093|FG001|Overall Study|Physician Decision|0|||
146350813|NCT01052012|527789094|FG002|Overall Study|Physician Decision|0|||
146350814|NCT01052012|527789095|FG003|Overall Study|Physician Decision|0|||
146350815|NCT01052012|527789096|FG004|Overall Study|Physician Decision|0|||
146350816|NCT01052012|527789097|FG005|Overall Study|Physician Decision|1|||
146350817|NCT01052012|527789092|FG000|Overall Study|Other|0|||
146350818|NCT01052012|527789093|FG001|Overall Study|Other|0|||
146350819|NCT01052012|527789094|FG002|Overall Study|Other|0|||
146350820|NCT01052012|527789095|FG003|Overall Study|Other|0|||
146350821|NCT01052012|527789096|FG004|Overall Study|Other|1|||
146350822|NCT01052012|527789097|FG005|Overall Study|Other|0|||
146350823|NCT02873715|527789098|FG000|Overall Study|Lost to Follow-up|84|||
146350824|NCT02873715|527789099|FG001|Overall Study|Lost to Follow-up|94|||
146350825|NCT02873715|527789098|FG000|Overall Study|Withdrawal by Subject|7|||
146350826|NCT02873715|527789099|FG001|Overall Study|Withdrawal by Subject|26|||
146350827|NCT00443430|527789102|FG000|Overall Study|Lack of Efficacy|3|||
146350828|NCT00443430|527789103|FG001|Overall Study|Lack of Efficacy|3|||
146350829|NCT00443430|527789102|FG000|Overall Study|Adverse Event|1|||
146350830|NCT00443430|527789103|FG001|Overall Study|Adverse Event|1|||
146350831|NCT00592501|527789104|FG000|Overall Study|Withdrawal by Subject|1|||
146350832|NCT00592501|527789104|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
146350833|NCT00053846|527789105|FG000|Overall Study|Changed mind|8|||
146350834|NCT00053846|527789106|FG001|Overall Study|Changed mind|13|||
146350835|NCT00053846|527789105|FG000|Overall Study|Became too ill|8|||
146350836|NCT00053846|527789106|FG001|Overall Study|Became too ill|7|||
146350837|NCT00053846|527789105|FG000|Overall Study|Expired|5|||
146350838|NCT00053846|527789106|FG001|Overall Study|Expired|0|||
146350839|NCT00053846|527789105|FG000|Overall Study|Became ineligible|3|||
146350840|NCT00053846|527789106|FG001|Overall Study|Became ineligible|1|||
146350841|NCT00053846|527789105|FG000|Overall Study|Did not return data|1|||
146350842|NCT00053846|527789106|FG001|Overall Study|Did not return data|2|||
146350843|NCT00053846|527789105|FG000|Overall Study|Quit due to side effects|1|||
146350844|NCT00053846|527789106|FG001|Overall Study|Quit due to side effects|3|||
146350845|NCT00053846|527789105|FG000|Overall Study|Pills too large|0|||
146350846|NCT00053846|527789106|FG001|Overall Study|Pills too large|1|||
146350847|NCT00933335|527789108|FG000|Overall Study|Lost to Follow-up|1|||
146350848|NCT00933335|527789109|FG001|Overall Study|Lost to Follow-up|3|||
146350849|NCT00933335|527789108|FG000|Overall Study|Withdrawal by Subject|0|||
146350850|NCT00933335|527789109|FG001|Overall Study|Withdrawal by Subject|1|||
146350851|NCT00933335|527789108|FG000|Overall Study|Progressive Disease|0|||
146350852|NCT00933335|527789109|FG001|Overall Study|Progressive Disease|11|||
146350853|NCT00933335|527789108|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
146396304|NCT02219477|527954553|FG002|Overall Study|Adverse Event|1|||
146350854|NCT00933335|527789109|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
146350855|NCT00933335|527789108|FG000|Overall Study|Co-morbid Illness|1|||
146350856|NCT00933335|527789109|FG001|Overall Study|Co-morbid Illness|0|||
146350857|NCT03880227|527789110|FG000|First Visit|Withdrawal by Subject|1|||
146350858|NCT03880227|527789111|FG001|First Visit|Withdrawal by Subject|0|||
146350859|NCT03880227|527789112|FG002|First Visit|Withdrawal by Subject|0|||
146350860|NCT03880227|527789113|FG003|First Visit|Withdrawal by Subject|0|||
146350861|NCT03880227|527789110|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
146350862|NCT03880227|527789111|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
146350863|NCT03880227|527789112|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
146350864|NCT03880227|527789113|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
146350865|NCT03880227|527789110|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146350866|NCT03880227|527789111|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146350867|NCT03880227|527789112|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
146350868|NCT03880227|527789113|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
146350869|NCT03880227|527789110|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146350870|NCT03880227|527789111|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146350871|NCT03880227|527789112|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
146350872|NCT03880227|527789113|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
146350873|NCT00504166|527789114|FG000|Overall Study|Adverse Event|1|||
146350874|NCT00504166|527789115|FG001|Overall Study|Adverse Event|4|||
146350875|NCT00504166|527789114|FG000|Overall Study|Withdrawal by Subject|3|||
146350876|NCT00504166|527789115|FG001|Overall Study|Withdrawal by Subject|6|||
146350877|NCT00504166|527789114|FG000|Overall Study|Physician Decision|1|||
146350878|NCT00504166|527789115|FG001|Overall Study|Physician Decision|1|||
146350879|NCT00504166|527789114|FG000|Overall Study|Lost to Follow-up|1|||
146350880|NCT00504166|527789115|FG001|Overall Study|Lost to Follow-up|3|||
146350881|NCT02650284|527789116|FG000|Overall Study|Lost to Follow-up|3|||
146350882|NCT02650284|527789117|FG001|Overall Study|Lost to Follow-up|3|||
146350883|NCT02650284|527789116|FG000|Overall Study|Consent incorrectly taken|0|||
146350884|NCT02650284|527789117|FG001|Overall Study|Consent incorrectly taken|1|||
146350885|NCT04590937|527789118|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
146350886|NCT02084134|527789126|FG000|Overall Study|Protocol Violation|4|||
146350887|NCT02084134|527789127|FG001|Overall Study|Protocol Violation|2|||
146350888|NCT02084134|527789126|FG000|Overall Study|Death|0|||
146350889|NCT02084134|527789127|FG001|Overall Study|Death|1|||
146350890|NCT02807454|527789128|FG000|Overall Study|Adverse Event|1|||
146350891|NCT02807454|527789129|FG001|Overall Study|Adverse Event|0|||
146350892|NCT02807454|527789128|FG000|Overall Study|Withdrawal by Subject|0|||
146350893|NCT02807454|527789129|FG001|Overall Study|Withdrawal by Subject|1|||
146350894|NCT02807454|527789128|FG000|Overall Study|Progressive Disease|30|||
146350895|NCT02807454|527789129|FG001|Overall Study|Progressive Disease|3|||
146350896|NCT02807454|527789128|FG000|Overall Study|Other Reasons|1|||
146350897|NCT02807454|527789129|FG001|Overall Study|Other Reasons|1|||
146350898|NCT05468086|527789130|FG000|Overall Study|Withdrawal by Subject|3|||
146350899|NCT05468086|527789130|FG000|Overall Study|Subject was found ineligible after consent|1|||
146350900|NCT01165203|527789131|FG000|Active Phase|Serious Adverse Event|1|||
146350901|NCT01165203|527789132|FG001|Active Phase|Serious Adverse Event|0|||
146350902|NCT01165203|527789131|FG000|Active Phase|Withdrawal by Subject|2|||
146350903|NCT01165203|527789132|FG001|Active Phase|Withdrawal by Subject|1|||
146350904|NCT01165203|527789131|FG000|Active Phase|Migrated/moved from study area|0|||
146350905|NCT01165203|527789132|FG001|Active Phase|Migrated/moved from study area|1|||
146350906|NCT01165203|527789131|FG000|Active Phase|Lost to Follow-up|2|||
146350907|NCT01165203|527789132|FG001|Active Phase|Lost to Follow-up|0|||
146350908|NCT01165203|527789131|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
146350909|NCT01165203|527789132|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
146350910|NCT01165203|527789131|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
146350911|NCT01165203|527789132|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
146350912|NCT01165203|527789131|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
146350913|NCT01165203|527789132|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
146350914|NCT01165203|527789131|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
146350915|NCT01165203|527789132|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
146350916|NCT01165203|527789131|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
146350917|NCT01165203|527789132|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
146350918|NCT01070784|527789133|FG000|Overall Study|Withdrawal by Subject|6|||
146350919|NCT01070784|527789134|FG001|Overall Study|Withdrawal by Subject|9|||
146350920|NCT01070784|527789133|FG000|Overall Study|Adverse Event|14|||
146350921|NCT01070784|527789134|FG001|Overall Study|Adverse Event|9|||
146350922|NCT02815397|527789136|FG000|Overall Study|Physician Decision|2|||
146169495|NCT04026165|527132825|FG003|Run-in SEL Period|Investigator's Discretion|0|||
146350923|NCT00085540|527789137|FG000|Overall Study|Withdrawal by Subject|0|||
146350924|NCT00085540|527789138|FG001|Overall Study|Withdrawal by Subject|1|||
146350925|NCT00085540|527789137|FG000|Overall Study|Protocol Violation|0|||
146350926|NCT00085540|527789138|FG001|Overall Study|Protocol Violation|1|||
146350927|NCT01518192|527789139|FG000|Overall Study|Lost to Follow-up|29|||
146350928|NCT01518192|527789140|FG001|Overall Study|Lost to Follow-up|26|||
146350929|NCT01518192|527789141|FG002|Overall Study|Lost to Follow-up|35|||
146350930|NCT00426751|527789142|FG000|Overall Study|Adverse Event|8|||
146350931|NCT00426751|527789143|FG001|Overall Study|Adverse Event|1|||
146350932|NCT00426751|527789142|FG000|Overall Study|Lost to Follow-up|7|||
146350933|NCT00426751|527789143|FG001|Overall Study|Lost to Follow-up|6|||
146350934|NCT00426751|527789142|FG000|Overall Study|Consent Withdrawn|0|||
146350935|NCT00426751|527789143|FG001|Overall Study|Consent Withdrawn|1|||
146350936|NCT00426751|527789142|FG000|Overall Study|Other Reasons|7|||
146350937|NCT00426751|527789143|FG001|Overall Study|Other Reasons|12|||
146350938|NCT01200511|527789144|FG000|Overall Study|Lost to Follow-up|3|||
146350939|NCT01200511|527789144|FG000|Overall Study|Withdrawal by Subject|1|||
146350940|NCT01200511|527789144|FG000|Overall Study|Adverse Event|1|||
146350941|NCT03288779|527789149|FG000|Overall Study|Withdrawal by Subject|3|||
146350942|NCT01355068|527789153|FG000|First Intervention Period|Adverse Event|0|||
146350943|NCT01355068|527789154|FG001|First Intervention Period|Adverse Event|1|||
146350944|NCT01355068|527789153|FG000|First Intervention Period|Withdrawal by Subject|0|||
146350945|NCT01355068|527789154|FG001|First Intervention Period|Withdrawal by Subject|1|||
146350946|NCT00524745|527789155|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
146350947|NCT00524745|527789156|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
146350948|NCT00524745|527789157|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
146350949|NCT00524745|527789158|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
146350950|NCT02504892|527789159|FG000|Overall Study|Adverse event-pneumonitis|2|||
146350951|NCT00237796|527789160|FG000|Overall Study|Baseline and one other ILSS required|10|||
146350952|NCT00237796|527789161|FG001|Overall Study|Baseline and one other ILSS required|5|||
146350953|NCT00370149|527789162|FG000|Overall Study|Physician Decision|16|||
146350954|NCT00370149|527789163|FG001|Overall Study|Physician Decision|16|||
146350955|NCT00370149|527789162|FG000|Overall Study|Protocol Violation|1|||
146350956|NCT00370149|527789163|FG001|Overall Study|Protocol Violation|0|||
146350957|NCT00370149|527789162|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
146350958|NCT00370149|527789163|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
146350959|NCT00370149|527789162|FG000|Overall Study|Pre-existing infection|0|||
146350960|NCT00370149|527789163|FG001|Overall Study|Pre-existing infection|1|||
146350961|NCT00370149|527789162|FG000|Overall Study|Antibiotic coated dressing placed|0|||
146350962|NCT00370149|527789163|FG001|Overall Study|Antibiotic coated dressing placed|1|||
146350963|NCT04920084|527790283|FG000|Overall Study|Adverse Event|1|||
146350964|NCT04920084|527790283|FG000|Overall Study|Lost to Follow-up|2|||
146350965|NCT04920084|527790283|FG000|Overall Study|Withdrawal by Subject|2|||
146350966|NCT00620321|527790284|FG000|Overall Study|Adverse Event|1|||
146350967|NCT00620321|527790285|FG001|Overall Study|Adverse Event|1|||
146350968|NCT00620321|527790284|FG000|Overall Study|Death|1|||
146350969|NCT00620321|527790285|FG001|Overall Study|Death|1|||
146350970|NCT00620321|527790284|FG000|Overall Study|Physician Decision|0|||
146350971|NCT00620321|527790285|FG001|Overall Study|Physician Decision|7|||
146350972|NCT00620321|527790284|FG000|Overall Study|Progressive Disease|5|||
146350973|NCT00620321|527790285|FG001|Overall Study|Progressive Disease|5|||
146350974|NCT00620321|527790284|FG000|Overall Study|Sponsor Decision|0|||
146350975|NCT00620321|527790285|FG001|Overall Study|Sponsor Decision|1|||
146350976|NCT00620321|527790284|FG000|Overall Study|Withdrawal by Subject|1|||
146350977|NCT00620321|527790285|FG001|Overall Study|Withdrawal by Subject|1|||
146350978|NCT01755195|527790286|FG000|Overall Study|Participant noncompliance|2|||
146350979|NCT01755195|527790286|FG000|Overall Study|Switched to alternative treatment|4|||
146350980|NCT01755195|527790286|FG000|Overall Study|Withdrawal by Subject|1|||
146350981|NCT01755195|527790286|FG000|Overall Study|Participant refused to start treatment|1|||
146350982|NCT01755195|527790286|FG000|Overall Study|Participant has been consented for another trial|1|||
146350983|NCT01755195|527790286|FG000|Overall Study|Refused further treatment|3|||
146350984|NCT01755195|527790286|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
146350985|NCT02340819|527790287|FG000|Overall Study|Adverse Event|1|||
146350986|NCT02340819|527790287|FG000|Overall Study|Withdrawal by Subject|2|||
146350987|NCT02340819|527790287|FG000|Overall Study|Discontinued with other reason|1|||
146350988|NCT00051558|527790288|FG000|Overall Study|Adverse Event|30|||
146350989|NCT00051558|527790289|FG001|Overall Study|Adverse Event|18|||
146350990|NCT00051558|527790288|FG000|Overall Study|Withdrawal by Subject|29|||
146350991|NCT00051558|527790289|FG001|Overall Study|Withdrawal by Subject|42|||
146350992|NCT00051558|527790288|FG000|Overall Study|Death|9|||
146350993|NCT00051558|527790289|FG001|Overall Study|Death|15|||
146350994|NCT00051558|527790288|FG000|Overall Study|Lost to Follow-up|4|||
146350995|NCT00051558|527790289|FG001|Overall Study|Lost to Follow-up|13|||
146350996|NCT00051558|527790288|FG000|Overall Study|Protocol Violation|3|||
146350997|NCT00051558|527790289|FG001|Overall Study|Protocol Violation|4|||
146350998|NCT00051558|527790288|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
146350999|NCT00051558|527790289|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
146351000|NCT00051558|527790288|FG000|Overall Study|Sponsor Decision|6|||
146351001|NCT00051558|527790289|FG001|Overall Study|Sponsor Decision|1|||
146169496|NCT04026165|527132822|FG000|Run-in SEL Period|Death|0|||
146351002|NCT00051558|527790288|FG000|Overall Study|Other|2|||
146351003|NCT00051558|527790289|FG001|Overall Study|Other|1|||
146351004|NCT00051558|527790288|FG000|Overall Study|Significant Lab Value|2|||
146351005|NCT00051558|527790289|FG001|Overall Study|Significant Lab Value|0|||
146351006|NCT00051558|527790288|FG000|Overall Study|Physician Decision|5|||
146351007|NCT00051558|527790289|FG001|Overall Study|Physician Decision|0|||
146351008|NCT01701583|527790293|FG000|Overall Study|Withdrawal by Subject|2|||
146351009|NCT01701583|527790294|FG001|Overall Study|Withdrawal by Subject|0|||
146351010|NCT01441440|527790295|FG000|Overall Study|Death|1|||
146351011|NCT01441440|527790296|FG001|Overall Study|Death|0|||
146351012|NCT01441440|527790297|FG002|Overall Study|Death|1|||
146351013|NCT01441440|527790295|FG000|Overall Study|Adverse Event|2|||
146351014|NCT01441440|527790296|FG001|Overall Study|Adverse Event|9|||
146351015|NCT01441440|527790297|FG002|Overall Study|Adverse Event|9|||
146351016|NCT01441440|527790295|FG000|Overall Study|Lost to Follow-up|0|||
146351017|NCT01441440|527790296|FG001|Overall Study|Lost to Follow-up|2|||
146351018|NCT01441440|527790297|FG002|Overall Study|Lost to Follow-up|1|||
146351019|NCT01441440|527790295|FG000|Overall Study|Withdrawal by Subject|11|||
146351020|NCT01441440|527790296|FG001|Overall Study|Withdrawal by Subject|9|||
146351021|NCT01441440|527790297|FG002|Overall Study|Withdrawal by Subject|9|||
146351022|NCT01441440|527790295|FG000|Overall Study|Pregnancy|1|||
146351023|NCT01441440|527790296|FG001|Overall Study|Pregnancy|0|||
146351024|NCT01441440|527790297|FG002|Overall Study|Pregnancy|0|||
146351025|NCT01441440|527790295|FG000|Overall Study|Lack of Efficacy|1|||
146351026|NCT01441440|527790296|FG001|Overall Study|Lack of Efficacy|0|||
146351027|NCT01441440|527790297|FG002|Overall Study|Lack of Efficacy|1|||
146351028|NCT01441440|527790295|FG000|Overall Study|Moving|0|||
146351029|NCT01441440|527790296|FG001|Overall Study|Moving|1|||
146351030|NCT01441440|527790297|FG002|Overall Study|Moving|1|||
146351031|NCT01441440|527790295|FG000|Overall Study|Work-related matter|0|||
146351032|NCT01441440|527790296|FG001|Overall Study|Work-related matter|1|||
146351033|NCT01441440|527790297|FG002|Overall Study|Work-related matter|0|||
146351034|NCT01441440|527790295|FG000|Overall Study|Difficllty in keeping the schedule|1|||
146351035|NCT01441440|527790296|FG001|Overall Study|Difficllty in keeping the schedule|1|||
146351036|NCT01441440|527790297|FG002|Overall Study|Difficllty in keeping the schedule|0|||
146351037|NCT01345123|527790298|FG000|Overall Study|participants no longer with health plan|79|||
146351038|NCT01345123|527790299|FG001|Overall Study|participants no longer with health plan|85|||
146351039|NCT01345123|527790300|FG002|Overall Study|participants no longer with health plan|88|||
146351040|NCT00883558|527790301|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
146351041|NCT00883558|527790302|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
146351042|NCT00883558|527790303|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
146351043|NCT00883558|527790301|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
146351044|NCT00883558|527790302|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
146351045|NCT00883558|527790303|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
146351046|NCT00883558|527790301|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
146351047|NCT00883558|527790302|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
146351048|NCT00883558|527790303|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
146351049|NCT00883558|527790301|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
146351050|NCT00883558|527790302|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
146351051|NCT00883558|527790303|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
146351052|NCT00883558|527790301|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
146351053|NCT00883558|527790302|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
146351054|NCT00883558|527790303|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
146351055|NCT00366548|527790305|FG000|Infant Series|Adverse Event|1|||
146351056|NCT00366548|527790306|FG001|Infant Series|Adverse Event|3|||
146351057|NCT00366548|527790305|FG000|Infant Series|Protocol Violation|0|||
146351058|NCT00366548|527790306|FG001|Infant Series|Protocol Violation|1|||
146351059|NCT00366548|527790305|FG000|Infant Series|Withdrawal by Subject|3|||
146351060|NCT00366548|527790306|FG001|Infant Series|Withdrawal by Subject|1|||
146351061|NCT00366548|527790305|FG000|After Infant Series|Withdrawal by Subject|3|||
146351062|NCT00366548|527790306|FG001|After Infant Series|Withdrawal by Subject|1|||
146351063|NCT00366548|527790305|FG000|After Infant Series|Adverse Event|2|||
146351064|NCT00366548|527790306|FG001|After Infant Series|Adverse Event|0|||
146351065|NCT00366548|527790305|FG000|After Infant Series|Lost to Follow-up|1|||
146351066|NCT00366548|527790306|FG001|After Infant Series|Lost to Follow-up|0|||
146351067|NCT01252134|527790307|FG000|Period 1, 8 Hours|Personal Reasons|0|||
146351068|NCT01252134|527790308|FG001|Period 1, 8 Hours|Personal Reasons|1|||
146351069|NCT01252134|527790309|FG002|Period 1, 8 Hours|Personal Reasons|1|||
146351070|NCT01252134|527790310|FG003|Period 1, 8 Hours|Personal Reasons|0|||
146351071|NCT01252134|527790311|FG004|Period 1, 8 Hours|Personal Reasons|0|||
146351072|NCT01252134|527790312|FG005|Period 1, 8 Hours|Personal Reasons|0|||
146351073|NCT02273050|527790314|FG000|Overall Study|Adverse Event|4|||
146351074|NCT02273050|527790315|FG001|Overall Study|Adverse Event|3|||
146169497|NCT04026165|527132823|FG001|Run-in SEL Period|Death|1|||
146351075|NCT02273050|527790316|FG002|Overall Study|Adverse Event|3|||
146351076|NCT02273050|527790314|FG000|Overall Study|Death|0|||
146351077|NCT02273050|527790315|FG001|Overall Study|Death|0|||
146351078|NCT02273050|527790316|FG002|Overall Study|Death|1|||
146351079|NCT02273050|527790314|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
146351080|NCT02273050|527790315|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
146351081|NCT02273050|527790316|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
146351082|NCT02273050|527790314|FG000|Overall Study|Lack of Efficacy|0|||
146351083|NCT02273050|527790315|FG001|Overall Study|Lack of Efficacy|1|||
146351084|NCT02273050|527790316|FG002|Overall Study|Lack of Efficacy|1|||
146351085|NCT02273050|527790314|FG000|Overall Study|Withdrawal by Subject|17|||
146351086|NCT02273050|527790315|FG001|Overall Study|Withdrawal by Subject|14|||
146351087|NCT02273050|527790316|FG002|Overall Study|Withdrawal by Subject|16|||
146351088|NCT02273050|527790314|FG000|Overall Study|Lost to Follow-up|0|||
146351089|NCT02273050|527790315|FG001|Overall Study|Lost to Follow-up|2|||
146351090|NCT02273050|527790316|FG002|Overall Study|Lost to Follow-up|3|||
146351091|NCT02273050|527790314|FG000|Overall Study|Protocol Violation|3|||
146351092|NCT02273050|527790315|FG001|Overall Study|Protocol Violation|1|||
146351093|NCT02273050|527790316|FG002|Overall Study|Protocol Violation|4|||
146351094|NCT00903032|527790317|FG000|Overall Study|Withdrawal by Subject|5|||
146351095|NCT00903032|527790318|FG001|Overall Study|Withdrawal by Subject|3|||
146351096|NCT00903032|527790317|FG000|Overall Study|Lost to Follow-up|2|||
146351097|NCT00903032|527790318|FG001|Overall Study|Lost to Follow-up|2|||
146351098|NCT03539458|527790320|FG000|Overall Study|Death|1|||
146351099|NCT00718419|527790321|FG000|Overall Study|Adverse Event|2|||
146351100|NCT00718419|527790322|FG001|Overall Study|Adverse Event|1|||
146351101|NCT00718419|527790321|FG000|Overall Study|Physician Decision|1|||
146351102|NCT00718419|527790322|FG001|Overall Study|Physician Decision|6|||
146351103|NCT00718419|527790321|FG000|Overall Study|Sponsor decision|0|||
146351104|NCT00718419|527790322|FG001|Overall Study|Sponsor decision|1|||
146351105|NCT00718419|527790321|FG000|Overall Study|Withdrawal by Subject|0|||
146351106|NCT00718419|527790322|FG001|Overall Study|Withdrawal by Subject|5|||
146351107|NCT00718419|527790321|FG000|Overall Study|Progressive Disease|7|||
146351108|NCT00718419|527790322|FG001|Overall Study|Progressive Disease|25|||
146351109|NCT00718419|527790321|FG000|Overall Study|Death Due to Progressive Disease|2|||
146351110|NCT00718419|527790322|FG001|Overall Study|Death Due to Progressive Disease|0|||
146351111|NCT00718419|527790321|FG000|Overall Study|Death Due to Study Drug Related|0|||
146351112|NCT00718419|527790322|FG001|Overall Study|Death Due to Study Drug Related|1|||
146351113|NCT00718419|527790321|FG000|Overall Study|Death Due to Adverse Events|1|||
146351114|NCT00718419|527790322|FG001|Overall Study|Death Due to Adverse Events|0|||
146351115|NCT01675531|527790323|FG000|Overall Study|Adverse Event|9|||
146351116|NCT01675531|527790323|FG000|Overall Study|Withdrawal by Subject|7|||
146351117|NCT01675531|527790323|FG000|Overall Study|Lack of Efficacy|1|||
146351118|NCT01675531|527790323|FG000|Overall Study|Protocol Violation|8|||
146351119|NCT00972478|527790334|FG000|Overall Study|Adverse Event|3|||
146351120|NCT00972478|527790335|FG001|Overall Study|Adverse Event|16|||
146351121|NCT00972478|527790334|FG000|Overall Study|Withdrawal by Subject|1|||
146351122|NCT00972478|527790335|FG001|Overall Study|Withdrawal by Subject|8|||
146351123|NCT00972478|527790334|FG000|Overall Study|Progression/Relapse|0|||
146351124|NCT00972478|527790335|FG001|Overall Study|Progression/Relapse|2|||
146351125|NCT00972478|527790334|FG000|Overall Study|Death|0|||
146351126|NCT00972478|527790335|FG001|Overall Study|Death|2|||
146351127|NCT00972478|527790334|FG000|Overall Study|Not protocol specified|1|||
146351128|NCT00972478|527790335|FG001|Overall Study|Not protocol specified|1|||
146351129|NCT00972478|527790334|FG000|Overall Study|Ineligible|1|||
146351130|NCT00972478|527790335|FG001|Overall Study|Ineligible|7|||
146351131|NCT00972478|527790334|FG000|Overall Study|Not start protocol treatment|1|||
146351132|NCT00972478|527790335|FG001|Overall Study|Not start protocol treatment|2|||
146351133|NCT02561000|527790336|FG000|Overall Study|Withdrawal by Subject|2|||
146351134|NCT02561000|527790337|FG001|Overall Study|Withdrawal by Subject|3|||
146351135|NCT02561000|527790338|FG002|Overall Study|Withdrawal by Subject|0|||
146351136|NCT02561000|527790336|FG000|Overall Study|Adverse Event|0|||
146351137|NCT02561000|527790337|FG001|Overall Study|Adverse Event|1|||
146351138|NCT02561000|527790338|FG002|Overall Study|Adverse Event|0|||
146351139|NCT03952468|527790339|FG000|Overall Study|Death|0|||
146169498|NCT04026165|527132824|FG002|Run-in SEL Period|Death|0|||
146351140|NCT03952468|527790340|FG001|Overall Study|Death|1|||
146351141|NCT03952468|527790339|FG000|Overall Study|Adverse Event|0|||
146169499|NCT04026165|527132825|FG003|Run-in SEL Period|Death|0|||
146351142|NCT03952468|527790340|FG001|Overall Study|Adverse Event|1|||
146351143|NCT03952468|527790339|FG000|Overall Study|Physician Decision|1|||
146351144|NCT03952468|527790340|FG001|Overall Study|Physician Decision|0|||
146351145|NCT03952468|527790339|FG000|Overall Study|Lost to Follow-up|3|||
146351146|NCT03952468|527790340|FG001|Overall Study|Lost to Follow-up|4|||
146351147|NCT03952468|527790339|FG000|Overall Study|Withdrawal by Subject|2|||
146351148|NCT03952468|527790340|FG001|Overall Study|Withdrawal by Subject|1|||
146351149|NCT01234402|527790341|FG000|Overall Study|Lost to Follow-up|0|||
146351150|NCT01234402|527790342|FG001|Overall Study|Lost to Follow-up|1|||
146169500|NCT04026165|527132822|FG000|Randomized Period|Withdrew Consent|0|||
146351151|NCT01234402|527790343|FG002|Overall Study|Lost to Follow-up|3|||
146351152|NCT01234402|527790341|FG000|Overall Study|Withdrawal by Subject|1|||
146351153|NCT01234402|527790342|FG001|Overall Study|Withdrawal by Subject|3|||
146351154|NCT01234402|527790343|FG002|Overall Study|Withdrawal by Subject|4|||
146351155|NCT01234402|527790341|FG000|Overall Study|Never treated: Death|0|||
146351156|NCT01234402|527790342|FG001|Overall Study|Never treated: Death|0|||
146351157|NCT01234402|527790343|FG002|Overall Study|Never treated: Death|1|||
146351158|NCT01234402|527790341|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
146351159|NCT01234402|527790342|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
146351160|NCT01234402|527790343|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
146351161|NCT01234402|527790341|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
146351162|NCT01234402|527790342|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
146351163|NCT01234402|527790343|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
146351164|NCT02280291|527790344|FG000|Overall Study|Lost to Follow-up|2|||
146351165|NCT02280291|527790345|FG001|Overall Study|Lost to Follow-up|1|||
146351166|NCT02280291|527790346|FG002|Overall Study|Lost to Follow-up|3|||
146351167|NCT02280291|527790347|FG003|Overall Study|Lost to Follow-up|8|||
146351168|NCT02280291|527790344|FG000|Overall Study|Protocol Violation|1|||
146351169|NCT02280291|527790345|FG001|Overall Study|Protocol Violation|0|||
146351170|NCT02280291|527790346|FG002|Overall Study|Protocol Violation|0|||
146351171|NCT02280291|527790347|FG003|Overall Study|Protocol Violation|0|||
146351172|NCT02280291|527790344|FG000|Overall Study|Other|1|||
146351173|NCT02280291|527790345|FG001|Overall Study|Other|1|||
146351174|NCT02280291|527790346|FG002|Overall Study|Other|0|||
146351175|NCT02280291|527790347|FG003|Overall Study|Other|0|||
146351176|NCT00506077|527790348|FG000|Treatment Period 1|Adverse Event|2|||
146351177|NCT00506077|527790349|FG001|Treatment Period 1|Adverse Event|1|||
146351178|NCT00506077|527790348|FG000|Treatment Period 1|Lost to Follow-up|0|||
146351179|NCT00506077|527790349|FG001|Treatment Period 1|Lost to Follow-up|2|||
146351180|NCT00506077|527790348|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146351181|NCT00506077|527790349|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146351182|NCT00506077|527790348|FG000|Treatment Period 2|Adverse Event|0|||
146351183|NCT00506077|527790349|FG001|Treatment Period 2|Adverse Event|1|||
146351184|NCT00506077|527790348|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146351185|NCT00506077|527790349|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146351186|NCT00316303|527790351|FG000|Overall Study|Lost to Follow-up|11|||
146351187|NCT00316303|527790352|FG001|Overall Study|Lost to Follow-up|16|||
146351188|NCT01293032|527790355|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146351189|NCT01293032|527790356|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146351190|NCT01293032|527790357|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
146351191|NCT01293032|527790358|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
146351192|NCT01293032|527790355|FG000|Treatment|Adverse Event|0|||
146351193|NCT01293032|527790356|FG001|Treatment|Adverse Event|0|||
146351194|NCT01293032|527790357|FG002|Treatment|Adverse Event|1|||
146351195|NCT01293032|527790358|FG003|Treatment|Adverse Event|1|||
146351196|NCT01293032|527790355|FG000|Treatment|Withdrawal by Subject|2|||
146351197|NCT01293032|527790356|FG001|Treatment|Withdrawal by Subject|4|||
146351198|NCT01293032|527790357|FG002|Treatment|Withdrawal by Subject|0|||
146351199|NCT01293032|527790358|FG003|Treatment|Withdrawal by Subject|0|||
146351200|NCT01293032|527790355|FG000|Treatment|Disease Progression, relapse|0|||
146351201|NCT01293032|527790356|FG001|Treatment|Disease Progression, relapse|1|||
146351202|NCT01293032|527790357|FG002|Treatment|Disease Progression, relapse|0|||
146351203|NCT01293032|527790358|FG003|Treatment|Disease Progression, relapse|0|||
146351204|NCT01757704|527790361|FG000|Overall Study|Protocol Violation|1|||
146351205|NCT01757704|527790362|FG001|Overall Study|Protocol Violation|3|||
146351206|NCT02749721|527790365|FG000|Screening|Withdrawal by Subject|1|||
146351207|NCT02749721|527790365|FG000|Screening|Lost to Follow-up|2|||
146351208|NCT02749721|527790365|FG000|Screening|Protocol Violation|3|||
146351209|NCT02749721|527790365|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
146351210|NCT02749721|527790365|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
146351211|NCT01929044|527790370|FG000|Overall Study|Adverse Event|1|||
146351212|NCT01929044|527790371|FG001|Overall Study|Adverse Event|0|||
146351213|NCT01929044|527790370|FG000|Overall Study|Protocol Violation|9|||
146351214|NCT01929044|527790371|FG001|Overall Study|Protocol Violation|14|||
146351215|NCT01929044|527790370|FG000|Overall Study|Not Treated|1|||
145943388|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
146169501|NCT04026165|527132823|FG001|Randomized Period|Withdrew Consent|0|||
146351216|NCT01929044|527790371|FG001|Overall Study|Not Treated|3|||
146351217|NCT01555463|527790374|FG000|Treatment|Adverse Event|6|||
146351218|NCT01555463|527790375|FG001|Treatment|Adverse Event|12|||
146351219|NCT01555463|527790374|FG000|Treatment|Withdrawal by Subject|24|||
146351220|NCT01555463|527790375|FG001|Treatment|Withdrawal by Subject|36|||
146351221|NCT01555463|527790374|FG000|Treatment|Lost to Follow-up|28|||
146351222|NCT01555463|527790375|FG001|Treatment|Lost to Follow-up|23|||
146351223|NCT01555463|527790374|FG000|Treatment|Protocol Violation|4|||
146351224|NCT01555463|527790375|FG001|Treatment|Protocol Violation|5|||
146351225|NCT01555463|527790374|FG000|Treatment|Other reason|2|||
146351226|NCT01555463|527790375|FG001|Treatment|Other reason|3|||
146351227|NCT01555463|527790374|FG000|Follow up|Adverse Event|2|||
146351228|NCT01555463|527790375|FG001|Follow up|Adverse Event|5|||
146351229|NCT01555463|527790374|FG000|Follow up|Death|0|||
146351230|NCT01555463|527790375|FG001|Follow up|Death|1|||
146351231|NCT01555463|527790374|FG000|Follow up|Withdrawal by Subject|22|||
146351232|NCT01555463|527790375|FG001|Follow up|Withdrawal by Subject|22|||
146351233|NCT01555463|527790374|FG000|Follow up|Lost to Follow-up|9|||
146351234|NCT01555463|527790375|FG001|Follow up|Lost to Follow-up|10|||
146351235|NCT01555463|527790374|FG000|Follow up|Protocol Violation|2|||
146351236|NCT01555463|527790375|FG001|Follow up|Protocol Violation|4|||
146351237|NCT01555463|527790374|FG000|Follow up|Other reason|3|||
146351238|NCT01555463|527790375|FG001|Follow up|Other reason|3|||
146351239|NCT04333433|527790376|FG000|Overall Study|Withdrawal by Subject|6|||
146351240|NCT04333433|527790377|FG001|Overall Study|Withdrawal by Subject|3|||
146351241|NCT04333433|527790376|FG000|Overall Study|Death|3|||
146351242|NCT04333433|527790377|FG001|Overall Study|Death|0|||
146351243|NCT04333433|527790376|FG000|Overall Study|Lost to Follow-up|6|||
146351244|NCT04333433|527790377|FG001|Overall Study|Lost to Follow-up|1|||
146351245|NCT04333433|527790376|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
146351246|NCT04333433|527790377|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
146351247|NCT02026271|527790378|FG000|Overall Study|Adverse Event|2|||
146351248|NCT02026271|527790379|FG001|Overall Study|Adverse Event|3|||
146351249|NCT02026271|527790380|FG002|Overall Study|Adverse Event|2|||
146351250|NCT02026271|527790381|FG003|Overall Study|Adverse Event|3|||
146351251|NCT02026271|527790382|FG004|Overall Study|Adverse Event|0|||
146351252|NCT02026271|527790378|FG000|Overall Study|Withdrawal by Subject|0|||
146351253|NCT02026271|527790379|FG001|Overall Study|Withdrawal by Subject|0|||
146351254|NCT02026271|527790380|FG002|Overall Study|Withdrawal by Subject|0|||
146351255|NCT02026271|527790381|FG003|Overall Study|Withdrawal by Subject|0|||
146351256|NCT02026271|527790382|FG004|Overall Study|Withdrawal by Subject|1|||
146351257|NCT02275026|527790385|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
146351258|NCT02275026|527790385|FG000|Overall Study|Withdrawal by Subject|4|||
146351259|NCT02275026|527790385|FG000|Overall Study|Ineligible due to medical history|13|||
146351260|NCT02275026|527790385|FG000|Overall Study|MRI malfunction precluded testing|1|||
146351261|NCT02275026|527790385|FG000|Overall Study|Ineligible after MRI findings|1|||
146351262|NCT02275026|527790385|FG000|Overall Study|Lost to Follow-up|2|||
146351263|NCT02275026|527790385|FG000|Overall Study|Scanner failure|1|||
146351264|NCT00374907|527790386|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
146351265|NCT00374907|527790387|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
146351266|NCT00374907|527790386|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
146351267|NCT00374907|527790387|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
146351268|NCT00374907|527790386|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
146351269|NCT00374907|527790387|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
146351270|NCT00374907|527790386|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
146351271|NCT00374907|527790387|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
146351272|NCT00374907|527790386|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
146351273|NCT00374907|527790387|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
146351274|NCT01108809|527790388|FG000|Overall Study|Adverse Event|3|||
146351275|NCT01108809|527790388|FG000|Overall Study|Lost to Follow-up|1|||
146351276|NCT00001262|527790393|FG000|Overall Study|Death|10|||
146351277|NCT00001262|527790394|FG001|Overall Study|Death|11|||
146351278|NCT00001262|527790395|FG002|Overall Study|Death|0|||
146351279|NCT00001262|527790393|FG000|Overall Study|Withdrawal by Subject|0|||
146351280|NCT00001262|527790394|FG001|Overall Study|Withdrawal by Subject|3|||
146351281|NCT00001262|527790395|FG002|Overall Study|Withdrawal by Subject|0|||
146351282|NCT01413178|527790399|FG000|Overall Study|Toxicity|1|||
146351283|NCT01413178|527790400|FG001|Overall Study|Toxicity|0|||
146351284|NCT01413178|527790399|FG000|Overall Study|Ineligible|0|||
146351285|NCT01413178|527790400|FG001|Overall Study|Ineligible|2|||
146351286|NCT00576693|527790401|FG000|Overall Study|Lost to Follow-up|7|||
146351287|NCT00576693|527790402|FG001|Overall Study|Lost to Follow-up|11|||
146351288|NCT00576693|527790401|FG000|Overall Study|Withdrawal by Subject|3|||
146351289|NCT00576693|527790402|FG001|Overall Study|Withdrawal by Subject|13|||
146351290|NCT00540449|527790403|FG000|Overall Study|Adverse Event|12|||
146351291|NCT00540449|527790404|FG001|Overall Study|Adverse Event|32|||
146351292|NCT00540449|527790403|FG000|Overall Study|Sponsor's Decision|1|||
146351293|NCT00540449|527790404|FG001|Overall Study|Sponsor's Decision|1|||
146351294|NCT00540449|527790403|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
146351295|NCT00540449|527790404|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
146351296|NCT00540449|527790403|FG000|Overall Study|Lost to Follow-up|19|||
146351297|NCT00540449|527790404|FG001|Overall Study|Lost to Follow-up|17|||
146351298|NCT00540449|527790403|FG000|Overall Study|Subject Non-Compliant|7|||
146351299|NCT00540449|527790404|FG001|Overall Study|Subject Non-Compliant|5|||
146351300|NCT00540449|527790403|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
146351301|NCT00540449|527790404|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
146351302|NCT00540449|527790403|FG000|Overall Study|Withdrawal by Subject|10|||
146351303|NCT00540449|527790404|FG001|Overall Study|Withdrawal by Subject|10|||
146351304|NCT00540449|527790403|FG000|Overall Study|Other|1|||
146351305|NCT00540449|527790404|FG001|Overall Study|Other|4|||
146351306|NCT03643432|527790405|FG000|Overall Study|Lost to Follow-up|1|||
146351307|NCT03643432|527790406|FG001|Overall Study|Lost to Follow-up|0|||
146351308|NCT03283163|527790407|FG000|Overall Study|Lost to Follow-up|1|||
146351309|NCT03283163|527790407|FG000|Overall Study|other life commitments|6|||
146351310|NCT03283163|527790407|FG000|Overall Study|COVID-19 institution wide halting|1|||
146351311|NCT03283163|527790407|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
146351312|NCT03283163|527790407|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
146351313|NCT04238663|527790408|FG000|Overall Study|Lost to Follow-up|0|||
146351314|NCT04238663|527790409|FG001|Overall Study|Lost to Follow-up|1|||
146351315|NCT04238663|527790410|FG002|Overall Study|Lost to Follow-up|0|||
146351316|NCT00968253|527790411|FG000|Overall Study|Death|0|||
146351317|NCT00968253|527790412|FG001|Overall Study|Death|0|||
146351318|NCT00968253|527790413|FG002|Overall Study|Death|2|||
146351319|NCT00968253|527790411|FG000|Overall Study|Withdrawal by Subject|0|||
146351320|NCT00968253|527790412|FG001|Overall Study|Withdrawal by Subject|0|||
146351321|NCT00968253|527790413|FG002|Overall Study|Withdrawal by Subject|1|||
146351322|NCT00968253|527790411|FG000|Overall Study|Disease Progression|0|||
146351323|NCT00968253|527790412|FG001|Overall Study|Disease Progression|3|||
146351324|NCT00968253|527790413|FG002|Overall Study|Disease Progression|3|||
146351325|NCT00968253|527790411|FG000|Overall Study|Adverse Event|0|||
146351326|NCT00968253|527790412|FG001|Overall Study|Adverse Event|0|||
146351327|NCT00968253|527790413|FG002|Overall Study|Adverse Event|1|||
146351328|NCT03987620|527790416|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
146351329|NCT03987620|527790417|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
146351330|NCT03987620|527790416|FG000|Overall Study|Adverse Event|3|||
146351331|NCT03987620|527790417|FG001|Overall Study|Adverse Event|0|||
146351332|NCT03987620|527790416|FG000|Overall Study|Lost to Follow-up|1|||
146351333|NCT03987620|527790417|FG001|Overall Study|Lost to Follow-up|2|||
146351334|NCT03987620|527790416|FG000|Overall Study|Physician Decision|0|||
146351335|NCT03987620|527790417|FG001|Overall Study|Physician Decision|1|||
146351336|NCT03987620|527790416|FG000|Overall Study|Pregnancy|1|||
146351337|NCT03987620|527790417|FG001|Overall Study|Pregnancy|0|||
146351338|NCT03987620|527790416|FG000|Overall Study|Withdrawal by Subject|7|||
146351339|NCT03987620|527790417|FG001|Overall Study|Withdrawal by Subject|1|||
146351340|NCT03987620|527790416|FG000|Overall Study|Other|2|||
146351341|NCT03987620|527790417|FG001|Overall Study|Other|5|||
146351342|NCT02149836|527790418|FG000|Overall Study|Withdrawal by Subject|1|||
146351343|NCT05306873|527791733|FG000|Stage 2|Study stopped|1|||
146351344|NCT05306873|527791734|FG001|Stage 2|Study stopped|1|||
146351345|NCT05306873|527791735|FG002|Stage 2|Study stopped|0|||
146351346|NCT05306873|527791736|FG003|Stage 2|Study stopped|0|||
146351347|NCT05306873|527791733|FG000|Stage 2|Stage 2 Treatment Failure|2|||
146351348|NCT05306873|527791734|FG001|Stage 2|Stage 2 Treatment Failure|3|||
146351349|NCT05306873|527791735|FG002|Stage 2|Stage 2 Treatment Failure|0|||
146351350|NCT05306873|527791736|FG003|Stage 2|Stage 2 Treatment Failure|0|||
146351351|NCT05306873|527791733|FG000|Stage 2|Logistical issues due to participant moving|1|||
146351352|NCT05306873|527791734|FG001|Stage 2|Logistical issues due to participant moving|0|||
146169502|NCT04026165|527132824|FG002|Randomized Period|Withdrew Consent|5|||
146169503|NCT04026165|527132825|FG003|Randomized Period|Withdrew Consent|8|||
146169504|NCT04026165|527132822|FG000|Randomized Period|Death|0|||
146169505|NCT04026165|527132823|FG001|Randomized Period|Death|0|||
146169506|NCT04026165|527132824|FG002|Randomized Period|Death|5|||
146169507|NCT04026165|527132825|FG003|Randomized Period|Death|7|||
146169508|NCT04026165|527132822|FG000|Randomized Period|Investigator's Discretion|0|||
146169509|NCT04026165|527132823|FG001|Randomized Period|Investigator's Discretion|0|||
146169510|NCT04026165|527132824|FG002|Randomized Period|Investigator's Discretion|2|||
146169511|NCT04026165|527132825|FG003|Randomized Period|Investigator's Discretion|2|||
146169512|NCT04026165|527132822|FG000|Randomized Period|Lost to Follow-up|0|||
146169513|NCT04026165|527132823|FG001|Randomized Period|Lost to Follow-up|0|||
146169514|NCT04026165|527132824|FG002|Randomized Period|Lost to Follow-up|2|||
146169515|NCT04026165|527132825|FG003|Randomized Period|Lost to Follow-up|2|||
146169516|NCT01059630|527132826|FG000|Overall Study|Death|100|||
146169517|NCT01059630|527132827|FG001|Overall Study|Death|84|||
146351353|NCT05306873|527791735|FG002|Stage 2|Logistical issues due to participant moving|0|||
146169518|NCT01059630|527132826|FG000|Overall Study|Lost to Follow-up|4|||
146169519|NCT01059630|527132827|FG001|Overall Study|Lost to Follow-up|1|||
146169520|NCT01059630|527132826|FG000|Overall Study|Physician Decision|2|||
146169521|NCT01059630|527132827|FG001|Overall Study|Physician Decision|4|||
146351354|NCT05306873|527791736|FG003|Stage 2|Logistical issues due to participant moving|0|||
146351355|NCT05306873|527791733|FG000|Stage 3|Stage 3 Treatment Failure|0|||
146351356|NCT05306873|527791734|FG001|Stage 3|Stage 3 Treatment Failure|0|||
146351357|NCT05306873|527791735|FG002|Stage 3|Stage 3 Treatment Failure|0|||
146351358|NCT05306873|527791736|FG003|Stage 3|Stage 3 Treatment Failure|1|||
146351359|NCT05306873|527791733|FG000|Stage 3|Study Stopped|0|||
146351360|NCT05306873|527791734|FG001|Stage 3|Study Stopped|0|||
146351361|NCT05306873|527791735|FG002|Stage 3|Study Stopped|1|||
146169522|NCT01059630|527132826|FG000|Overall Study|Withdrawal by Subject|21|||
146169523|NCT01059630|527132827|FG001|Overall Study|Withdrawal by Subject|14|||
146169524|NCT03170375|527132828|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
146351362|NCT05306873|527791736|FG003|Stage 3|Study Stopped|0|||
146351363|NCT00074412|527791737|FG000|Overall Study|Death|30|||
146351364|NCT00074412|527791738|FG001|Overall Study|Death|26|||
146351365|NCT00074412|527791737|FG000|Overall Study|Lost to Follow-up|52|||
146351366|NCT00074412|527791738|FG001|Overall Study|Lost to Follow-up|58|||
146351367|NCT02361762|527791739|FG000|Overall Study|Withdrawal by Subject|0|||
146351368|NCT02361762|527791740|FG001|Overall Study|Withdrawal by Subject|1|||
146351369|NCT02361762|527791739|FG000|Overall Study|Lost to Follow-up|0|||
146351370|NCT02361762|527791740|FG001|Overall Study|Lost to Follow-up|1|||
146351371|NCT00028002|527791743|FG000|Overall Study|Withdrawal by Subject|3|||
146351372|NCT00028002|527791743|FG000|Overall Study|Ineligible|8|||
146351373|NCT02163993|527791747|FG000|Treatment Period|Adverse Event|0|||
146351374|NCT02163993|527791748|FG001|Treatment Period|Adverse Event|1|||
146351375|NCT02163993|527791749|FG002|Treatment Period|Adverse Event|0|||
146351376|NCT02163993|527791750|FG003|Treatment Period|Adverse Event|0|||
146351377|NCT02163993|527791751|FG004|Treatment Period|Adverse Event|1|||
146351378|NCT02163993|527791747|FG000|Treatment Period|Lost to Follow-up|2|||
146351379|NCT02163993|527791748|FG001|Treatment Period|Lost to Follow-up|3|||
146351380|NCT02163993|527791749|FG002|Treatment Period|Lost to Follow-up|1|||
146351381|NCT02163993|527791750|FG003|Treatment Period|Lost to Follow-up|3|||
146351382|NCT02163993|527791751|FG004|Treatment Period|Lost to Follow-up|1|||
146351383|NCT02163993|527791747|FG000|Treatment Period|Physician Decision|1|||
146351384|NCT02163993|527791748|FG001|Treatment Period|Physician Decision|0|||
146351385|NCT02163993|527791749|FG002|Treatment Period|Physician Decision|0|||
146351386|NCT02163993|527791750|FG003|Treatment Period|Physician Decision|0|||
146351387|NCT02163993|527791751|FG004|Treatment Period|Physician Decision|0|||
146351388|NCT02163993|527791747|FG000|Treatment Period|Protocol Violation|2|||
146351389|NCT02163993|527791748|FG001|Treatment Period|Protocol Violation|1|||
146351390|NCT02163993|527791749|FG002|Treatment Period|Protocol Violation|0|||
146351391|NCT02163993|527791750|FG003|Treatment Period|Protocol Violation|1|||
146351392|NCT02163993|527791751|FG004|Treatment Period|Protocol Violation|2|||
146351393|NCT02163993|527791747|FG000|Treatment Period|Withdrawal by Subject|6|||
146351394|NCT02163993|527791748|FG001|Treatment Period|Withdrawal by Subject|4|||
146351395|NCT02163993|527791749|FG002|Treatment Period|Withdrawal by Subject|1|||
146351396|NCT02163993|527791750|FG003|Treatment Period|Withdrawal by Subject|4|||
146351397|NCT02163993|527791751|FG004|Treatment Period|Withdrawal by Subject|1|||
146351398|NCT02163993|527791747|FG000|Treatment Period|Not treated|1|||
146351399|NCT02163993|527791748|FG001|Treatment Period|Not treated|0|||
146351400|NCT02163993|527791749|FG002|Treatment Period|Not treated|0|||
146351401|NCT02163993|527791750|FG003|Treatment Period|Not treated|1|||
146351402|NCT02163993|527791751|FG004|Treatment Period|Not treated|2|||
146351403|NCT02163993|527791747|FG000|Post-treatment Period|Adverse Event|0|||
146351404|NCT02163993|527791748|FG001|Post-treatment Period|Adverse Event|0|||
146351405|NCT02163993|527791749|FG002|Post-treatment Period|Adverse Event|1|||
146351406|NCT02163993|527791750|FG003|Post-treatment Period|Adverse Event|0|||
146351407|NCT02163993|527791751|FG004|Post-treatment Period|Adverse Event|0|||
146351408|NCT02163993|527791747|FG000|Post-treatment Period|Lost to Follow-up|2|||
146351409|NCT02163993|527791748|FG001|Post-treatment Period|Lost to Follow-up|2|||
146351410|NCT02163993|527791749|FG002|Post-treatment Period|Lost to Follow-up|3|||
146351411|NCT02163993|527791750|FG003|Post-treatment Period|Lost to Follow-up|1|||
146351412|NCT02163993|527791751|FG004|Post-treatment Period|Lost to Follow-up|0|||
146351413|NCT02163993|527791747|FG000|Post-treatment Period|Protocol Violation|0|||
146351414|NCT02163993|527791748|FG001|Post-treatment Period|Protocol Violation|0|||
146351415|NCT02163993|527791749|FG002|Post-treatment Period|Protocol Violation|0|||
146351416|NCT02163993|527791750|FG003|Post-treatment Period|Protocol Violation|0|||
146351417|NCT02163993|527791751|FG004|Post-treatment Period|Protocol Violation|1|||
146351418|NCT02163993|527791747|FG000|Post-treatment Period|Withdrawal by Subject|2|||
146351419|NCT02163993|527791748|FG001|Post-treatment Period|Withdrawal by Subject|4|||
146351420|NCT02163993|527791749|FG002|Post-treatment Period|Withdrawal by Subject|0|||
146351421|NCT02163993|527791750|FG003|Post-treatment Period|Withdrawal by Subject|1|||
146351422|NCT02163993|527791751|FG004|Post-treatment Period|Withdrawal by Subject|2|||
146169525|NCT03170375|527132829|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
146169526|NCT03170375|527132830|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
146351423|NCT04467164|527791752|FG000|Washout (1 Week)|Lost to Follow-up|2|||
146351424|NCT04467164|527791753|FG001|Washout (1 Week)|Lost to Follow-up|0|||
146351425|NCT02750813|527791754|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
146351426|NCT02750813|527791755|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
146351427|NCT02750813|527791754|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
146351428|NCT02750813|527791755|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
146351429|NCT02273752|527791756|FG000|Overall Study|Trial was terminated early|2|||
146351430|NCT02042404|527791759|FG000|Overall Study|Death|1|||
146351431|NCT02042404|527791760|FG001|Overall Study|Death|0|||
146351432|NCT02042404|527791759|FG000|Overall Study|Unrelated Adverse Event|3|||
146351433|NCT02042404|527791760|FG001|Overall Study|Unrelated Adverse Event|0|||
146351434|NCT02042404|527791759|FG000|Overall Study|Inability to meet time requirements|1|||
146351435|NCT02042404|527791760|FG001|Overall Study|Inability to meet time requirements|0|||
146351436|NCT03100942|527791761|FG000|Randomized Treatment Period|Withdrew Consent|4|||
146351437|NCT03100942|527791762|FG001|Randomized Treatment Period|Withdrew Consent|5|||
146351438|NCT03100942|527791763|FG002|Randomized Treatment Period|Withdrew Consent|3|||
146351439|NCT03100942|527791764|FG003|Randomized Treatment Period|Withdrew Consent|3|||
146351440|NCT03100942|527791765|FG004|Randomized Treatment Period|Withdrew Consent|0|||
146351441|NCT03100942|527791766|FG005|Randomized Treatment Period|Withdrew Consent|0|||
146351442|NCT03100942|527791767|FG006|Randomized Treatment Period|Withdrew Consent|0|||
146351443|NCT03100942|527791761|FG000|Randomized Treatment Period|Adverse Event|5|||
146351444|NCT03100942|527791762|FG001|Randomized Treatment Period|Adverse Event|2|||
146351445|NCT03100942|527791763|FG002|Randomized Treatment Period|Adverse Event|1|||
146351446|NCT03100942|527791764|FG003|Randomized Treatment Period|Adverse Event|0|||
146351447|NCT03100942|527791765|FG004|Randomized Treatment Period|Adverse Event|0|||
146351448|NCT03100942|527791766|FG005|Randomized Treatment Period|Adverse Event|0|||
146351449|NCT03100942|527791767|FG006|Randomized Treatment Period|Adverse Event|0|||
146351450|NCT03100942|527791761|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
146351451|NCT03100942|527791762|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
146351452|NCT03100942|527791763|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
146351453|NCT03100942|527791764|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
146351454|NCT03100942|527791765|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
146351455|NCT03100942|527791766|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
146351456|NCT03100942|527791767|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
146351457|NCT03100942|527791761|FG000|Randomized Treatment Period|Protocol Violation|0|||
146351458|NCT03100942|527791762|FG001|Randomized Treatment Period|Protocol Violation|1|||
146351459|NCT03100942|527791763|FG002|Randomized Treatment Period|Protocol Violation|1|||
146351460|NCT03100942|527791764|FG003|Randomized Treatment Period|Protocol Violation|1|||
146351461|NCT03100942|527791765|FG004|Randomized Treatment Period|Protocol Violation|0|||
146351462|NCT03100942|527791766|FG005|Randomized Treatment Period|Protocol Violation|0|||
146351463|NCT03100942|527791767|FG006|Randomized Treatment Period|Protocol Violation|0|||
146351464|NCT03100942|527791761|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
146351465|NCT03100942|527791762|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
146351466|NCT03100942|527791763|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
146351467|NCT03100942|527791764|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
146351468|NCT03100942|527791765|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
146351469|NCT03100942|527791766|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
146351470|NCT03100942|527791767|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
146351471|NCT03100942|527791761|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
146351472|NCT03100942|527791762|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146351473|NCT03100942|527791763|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146351474|NCT03100942|527791764|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
146351475|NCT03100942|527791765|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146351476|NCT03100942|527791766|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146351477|NCT03100942|527791767|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
146351478|NCT03100942|527791761|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351479|NCT03100942|527791762|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351480|NCT03100942|527791763|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351481|NCT03100942|527791764|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351482|NCT03100942|527791765|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351483|NCT03100942|527791766|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
146351484|NCT03100942|527791767|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
146351485|NCT01429792|527791768|FG000|Overall Study|Other Reasons|67|||
146351486|NCT01429792|527791768|FG000|Overall Study|Unknown Disposition|94|||
146351487|NCT01429792|527791768|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
146351488|NCT01429792|527791768|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
146351489|NCT01429792|527791768|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
146351490|NCT01429792|527791768|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
146351491|NCT01429792|527791768|FG000|Overall Study|Withdrawal by Subject|70|||
146351492|NCT01429792|527791768|FG000|Overall Study|Lost to Follow-up|88|||
146351493|NCT00726323|527791769|FG000|Overall Study|Withdrawal by Subject|3|||
146351494|NCT00726323|527791770|FG001|Overall Study|Withdrawal by Subject|1|||
146351495|NCT00726323|527791769|FG000|Overall Study|Physician Decision|1|||
146351496|NCT00726323|527791770|FG001|Overall Study|Physician Decision|0|||
146351497|NCT00726323|527791769|FG000|Overall Study|Progressive disease|23|||
146351498|NCT00726323|527791770|FG001|Overall Study|Progressive disease|16|||
146351499|NCT00726323|527791769|FG000|Overall Study|Clinical progression|0|||
146351500|NCT00726323|527791770|FG001|Overall Study|Clinical progression|3|||
146351501|NCT00726323|527791769|FG000|Overall Study|Adverse Event|9|||
146351502|NCT00726323|527791770|FG001|Overall Study|Adverse Event|9|||
146351503|NCT00726323|527791769|FG000|Overall Study|Death|1|||
146351504|NCT00726323|527791770|FG001|Overall Study|Death|0|||
146351505|NCT00726323|527791769|FG000|Overall Study|Participant wished to discontinue|0|||
146351506|NCT00726323|527791770|FG001|Overall Study|Participant wished to discontinue|1|||
146351507|NCT00726323|527791769|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
146351508|NCT00726323|527791770|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
146351509|NCT01005719|527791774|FG000|Period 1|Adverse Event|0|||
146351510|NCT01005719|527791775|FG001|Period 1|Adverse Event|0|||
146351511|NCT01005719|527791776|FG002|Period 1|Adverse Event|0|||
146351512|NCT01005719|527791777|FG003|Period 1|Adverse Event|1|||
146351513|NCT01005719|527791778|FG004|Period 1|Adverse Event|0|||
146351514|NCT01005719|527791779|FG005|Period 1|Adverse Event|0|||
146351515|NCT01005719|527791774|FG000|Period 1|Delay in completing study procedures|0|||
146351516|NCT01005719|527791775|FG001|Period 1|Delay in completing study procedures|0|||
146351517|NCT01005719|527791776|FG002|Period 1|Delay in completing study procedures|0|||
146351518|NCT01005719|527791777|FG003|Period 1|Delay in completing study procedures|0|||
146351519|NCT01005719|527791778|FG004|Period 1|Delay in completing study procedures|0|||
146351520|NCT01005719|527791779|FG005|Period 1|Delay in completing study procedures|1|||
146351521|NCT01005719|527791774|FG000|Period 2|Adverse Event|0|||
146351522|NCT01005719|527791775|FG001|Period 2|Adverse Event|0|||
146351523|NCT01005719|527791776|FG002|Period 2|Adverse Event|0|||
146351524|NCT01005719|527791777|FG003|Period 2|Adverse Event|0|||
146351525|NCT01005719|527791778|FG004|Period 2|Adverse Event|1|||
146351526|NCT01005719|527791779|FG005|Period 2|Adverse Event|1|||
146351527|NCT02918266|527791780|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
146351528|NCT02918266|527791781|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351529|NCT02918266|527791782|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351530|NCT02918266|527791783|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351531|NCT02918266|527791784|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351532|NCT02918266|527791785|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351533|NCT02918266|527791786|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
146351534|NCT02918266|527791787|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351535|NCT02918266|527791788|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
146351536|NCT02918266|527791789|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351537|NCT02918266|527791790|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
146351538|NCT02499146|527791791|FG000|Overall Study|Lost to Follow-up|1|||
146351539|NCT02499146|527791791|FG000|Overall Study|Withdrawal by Subject|1|||
146351540|NCT02499146|527791791|FG000|Overall Study|Other|2|||
146351541|NCT02499146|527791791|FG000|Overall Study|Ongoing at date of cut-off|9|||
146351542|NCT02499146|527791791|FG000|Overall Study|Began other treatment/therapy|13|||
146351543|NCT03161678|527791792|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146351544|NCT03161678|527791793|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146351545|NCT03161678|527791794|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146351546|NCT03161678|527791795|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
146351547|NCT03161678|527791796|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
146351548|NCT03161678|527791797|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
146351549|NCT03161678|527791792|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
146351550|NCT03161678|527791793|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
146351551|NCT03161678|527791794|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
146351552|NCT03161678|527791795|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
146351553|NCT03161678|527791796|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
146351554|NCT03161678|527791797|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
146351555|NCT03161678|527791792|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
146351556|NCT03161678|527791793|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
146351557|NCT03161678|527791794|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
146351558|NCT03161678|527791795|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
146351559|NCT03161678|527791796|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
146351560|NCT03161678|527791797|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
146351561|NCT03161678|527791792|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146351562|NCT03161678|527791793|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146351563|NCT03161678|527791794|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146351564|NCT03161678|527791795|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
146351565|NCT03161678|527791796|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146351566|NCT03161678|527791797|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
146351567|NCT00752609|527791798|FG000|Overall Study|Adverse Event|2|||
146351568|NCT00752609|527791799|FG001|Overall Study|Adverse Event|2|||
146169527|NCT03170375|527132828|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
146351569|NCT00752609|527791798|FG000|Overall Study|Withdrawal by Subject|3|||
146351570|NCT00752609|527791799|FG001|Overall Study|Withdrawal by Subject|0|||
146351571|NCT00752609|527791798|FG000|Overall Study|Physician Decision|1|||
146351572|NCT00752609|527791799|FG001|Overall Study|Physician Decision|0|||
146351573|NCT00752609|527791798|FG000|Overall Study|Death|1|||
146169528|NCT03170375|527132829|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
146351574|NCT00752609|527791799|FG001|Overall Study|Death|0|||
146351575|NCT00752609|527791798|FG000|Overall Study|Met exclusion criteria|1|||
146351576|NCT00752609|527791799|FG001|Overall Study|Met exclusion criteria|0|||
146351577|NCT00752609|527791798|FG000|Overall Study|Received Aranesp in error|1|||
146351578|NCT00752609|527791799|FG001|Overall Study|Received Aranesp in error|0|||
146351579|NCT05114590|527791800|FG000|Overall Study|Adverse Event|1|||
146351580|NCT05114590|527791800|FG000|Overall Study|Investigator decision|1|||
146351581|NCT05114590|527791800|FG000|Overall Study|Lost to Follow-up|5|||
146351582|NCT05114590|527791800|FG000|Overall Study|Withdrawal by Subject|5|||
146351583|NCT05114590|527791800|FG000|Overall Study|Other|2|||
146351584|NCT00358917|527791801|FG000|Overall Study|Adverse Event|14|||
146351585|NCT00358917|527791802|FG001|Overall Study|Adverse Event|21|||
146351586|NCT00358917|527791801|FG000|Overall Study|Withdrawal by Subject|5|||
146351587|NCT00358917|527791802|FG001|Overall Study|Withdrawal by Subject|7|||
146351588|NCT00358917|527791801|FG000|Overall Study|Lost to Follow-up|20|||
146351589|NCT00358917|527791802|FG001|Overall Study|Lost to Follow-up|17|||
146351590|NCT00358917|527791801|FG000|Overall Study|Noncompliance|12|||
146351591|NCT00358917|527791802|FG001|Overall Study|Noncompliance|11|||
146351592|NCT00358917|527791801|FG000|Overall Study|Death|2|||
146351593|NCT00358917|527791802|FG001|Overall Study|Death|3|||
146351594|NCT00358917|527791801|FG000|Overall Study|Virologic failure|11|||
146351595|NCT00358917|527791802|FG001|Overall Study|Virologic failure|8|||
146351596|NCT00358917|527791801|FG000|Overall Study|Unable to Continue Participation|2|||
146351597|NCT00358917|527791802|FG001|Overall Study|Unable to Continue Participation|2|||
146351598|NCT02582749|527791810|FG000|Overall Study|Study terminated by funder|5|||
146351599|NCT02582749|527791811|FG001|Overall Study|Study terminated by funder|10|||
146351600|NCT02582749|527791810|FG000|Overall Study|Withdrawal by Subject|0|||
146351601|NCT02582749|527791811|FG001|Overall Study|Withdrawal by Subject|1|||
146351602|NCT02213198|527791812|FG000|Baseline|No show for intake|7|||
146351603|NCT02213198|527791813|FG001|Baseline|No show for intake|9|||
146351604|NCT02213198|527791812|FG000|Baseline|Withdrawal by Subject|34|||
146351605|NCT02213198|527791813|FG001|Baseline|Withdrawal by Subject|11|||
146351606|NCT02213198|527791812|FG000|Baseline|transferred out of clinic|7|||
146351607|NCT02213198|527791813|FG001|Baseline|transferred out of clinic|9|||
146351608|NCT02213198|527791812|FG000|Baseline|Lost to Follow-up|40|||
146351609|NCT02213198|527791813|FG001|Baseline|Lost to Follow-up|21|||
146351610|NCT02213198|527791812|FG000|Baseline|incarcerated,violent|0|||
146351611|NCT02213198|527791813|FG001|Baseline|incarcerated,violent|1|||
146351612|NCT02213198|527791812|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
146351613|NCT02213198|527791813|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
146351614|NCT02213198|527791812|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
146351615|NCT02213198|527791813|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
146351616|NCT02213198|527791812|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
146351617|NCT02213198|527791813|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
146351618|NCT02213198|527791812|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
146351619|NCT02213198|527791813|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
146351620|NCT02213198|527791812|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
146351621|NCT02213198|527791813|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
146351622|NCT02213198|527791812|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
146351623|NCT02213198|527791813|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
146351624|NCT02379923|527791814|FG000|Overall Study|Death|5|||
146351625|NCT00601523|527791815|FG000|Overall Study|Adverse Event|42|||
146351626|NCT00601523|527791816|FG001|Overall Study|Adverse Event|14|||
146351627|NCT00601523|527791815|FG000|Overall Study|Lack of Efficacy|3|||
146351628|NCT00601523|527791816|FG001|Overall Study|Lack of Efficacy|0|||
146351629|NCT00601523|527791815|FG000|Overall Study|Protocol Violation|5|||
146351630|NCT00601523|527791816|FG001|Overall Study|Protocol Violation|1|||
146351631|NCT00601523|527791815|FG000|Overall Study|Lost to Follow-up|0|||
146351632|NCT00601523|527791816|FG001|Overall Study|Lost to Follow-up|1|||
146351633|NCT00601523|527791815|FG000|Overall Study|Withdrawal by Subject|18|||
146351634|NCT00601523|527791816|FG001|Overall Study|Withdrawal by Subject|9|||
146351635|NCT00601523|527791815|FG000|Overall Study|Other|9|||
146351636|NCT00601523|527791816|FG001|Overall Study|Other|1|||
146351637|NCT00804193|527791817|FG000|Overall Study|Lack of baseline fungus|32|||
146351638|NCT00804193|527791818|FG001|Overall Study|Lack of baseline fungus|31|||
146351639|NCT00804193|527791819|FG002|Overall Study|Lack of baseline fungus|19|||
146351640|NCT00804193|527791817|FG000|Overall Study|Adverse Event|0|||
146351641|NCT00804193|527791818|FG001|Overall Study|Adverse Event|0|||
146351642|NCT00804193|527791819|FG002|Overall Study|Adverse Event|2|||
146351643|NCT00804193|527791817|FG000|Overall Study|Lack of Efficacy|1|||
146351644|NCT00804193|527791818|FG001|Overall Study|Lack of Efficacy|1|||
146351645|NCT00804193|527791819|FG002|Overall Study|Lack of Efficacy|3|||
146351646|NCT00804193|527791817|FG000|Overall Study|Protocol Violation|0|||
146351647|NCT00804193|527791818|FG001|Overall Study|Protocol Violation|8|||
146351648|NCT00804193|527791819|FG002|Overall Study|Protocol Violation|2|||
146351649|NCT00804193|527791817|FG000|Overall Study|Lost to Follow-up|3|||
146351650|NCT00804193|527791818|FG001|Overall Study|Lost to Follow-up|3|||
146351651|NCT00804193|527791819|FG002|Overall Study|Lost to Follow-up|4|||
146351652|NCT00804193|527791817|FG000|Overall Study|Withdrawal by Subject|3|||
146351653|NCT00804193|527791818|FG001|Overall Study|Withdrawal by Subject|1|||
146351654|NCT00804193|527791819|FG002|Overall Study|Withdrawal by Subject|2|||
146351655|NCT04072146|527791822|FG000|Overall Study|Adverse Event|0|||
146351656|NCT04072146|527791823|FG001|Overall Study|Adverse Event|1|||
146351657|NCT01617434|527791824|FG000|Overall Study|Adverse Event|12|||
146351658|NCT01617434|527791825|FG001|Overall Study|Adverse Event|3|||
146351659|NCT01617434|527791824|FG000|Overall Study|Protocol Violation|8|||
146351660|NCT01617434|527791825|FG001|Overall Study|Protocol Violation|7|||
146351661|NCT01617434|527791824|FG000|Overall Study|Withdrawal Criteria|12|||
146351662|NCT01617434|527791825|FG001|Overall Study|Withdrawal Criteria|37|||
146351663|NCT01617434|527791824|FG000|Overall Study|Unclassified|3|||
146351664|NCT01617434|527791825|FG001|Overall Study|Unclassified|4|||
146351665|NCT01193348|527791826|FG000|Screening Period|Screen Failure|5|||
146351666|NCT01193348|527791826|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
146351667|NCT01193348|527791826|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
146351668|NCT01193348|527791826|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
146351669|NCT01193348|527791826|FG000|Extension Treatment Period|Physician Decision|1|||
146351670|NCT01193348|527791826|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
146351671|NCT01721408|527791827|FG000|Overall Study|Adverse Event|6|||
146351672|NCT01721408|527791828|FG001|Overall Study|Adverse Event|1|||
146351673|NCT01721408|527791827|FG000|Overall Study|Death|1|||
146351674|NCT01721408|527791828|FG001|Overall Study|Death|0|||
146351675|NCT01721408|527791827|FG000|Overall Study|Insufficient clinical response|15|||
146351676|NCT01721408|527791828|FG001|Overall Study|Insufficient clinical response|6|||
146351677|NCT01721408|527791827|FG000|Overall Study|No longer willing to participate study|9|||
146351678|NCT01721408|527791828|FG001|Overall Study|No longer willing to participate study|10|||
146351679|NCT01721408|527791827|FG000|Overall Study|Protocol Violation|0|||
146351680|NCT01721408|527791828|FG001|Overall Study|Protocol Violation|2|||
146351681|NCT01721408|527791827|FG000|Overall Study|Other|3|||
146351682|NCT01721408|527791828|FG001|Overall Study|Other|3|||
146351683|NCT01721408|527791827|FG000|Overall Study|Lost to Follow-up|1|||
146351684|NCT01721408|527791828|FG001|Overall Study|Lost to Follow-up|2|||
146351685|NCT01721408|527791827|FG000|Overall Study|Does not meet entrance criteria|1|||
146351686|NCT01721408|527791828|FG001|Overall Study|Does not meet entrance criteria|0|||
146351687|NCT02928406|527791829|FG000|Overall Study|Death|780|||
146351688|NCT02928406|527791829|FG000|Overall Study|Progressive disease|3|||
146351689|NCT02928406|527791829|FG000|Overall Study|Lost to Follow-up|49|||
146351690|NCT02928406|527791829|FG000|Overall Study|Non-compliance|2|||
146351691|NCT02928406|527791829|FG000|Overall Study|Withdrawal by Subject|40|||
146351692|NCT02928406|527791829|FG000|Overall Study|Study terminated by sponsor|57|||
146351693|NCT02928406|527791829|FG000|Overall Study|Physician Decision|1|||
146351694|NCT02928406|527791829|FG000|Overall Study|Various reasons|72|||
146351695|NCT01745393|527791831|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
146351696|NCT01745393|527791832|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
146351697|NCT01745393|527791831|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
146351698|NCT01745393|527791832|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
146351699|NCT01745393|527791831|FG000|12-month Follow-up|Lost to Follow-up|6|||
146351700|NCT01745393|527791832|FG001|12-month Follow-up|Lost to Follow-up|5|||
146351701|NCT00786838|527791833|FG000|Overall Study|Physician Decision|4|||
146351702|NCT00786838|527791833|FG000|Overall Study|Death|4|||
146351703|NCT00786838|527791833|FG000|Overall Study|Adverse Event|6|||
146351704|NCT00786838|527791833|FG000|Overall Study|Progressive disease|31|||
146351705|NCT00786838|527791833|FG000|Overall Study|Withdrawal by Subject|4|||
146351706|NCT02488759|527791835|FG000|Overall Study|Disease progression|73|||
146351707|NCT02488759|527791836|FG001|Overall Study|Disease progression|111|||
146351708|NCT02488759|527791837|FG002|Overall Study|Disease progression|62|||
146351709|NCT02488759|527791838|FG003|Overall Study|Disease progression|7|||
146351710|NCT02488759|527791839|FG004|Overall Study|Disease progression|4|||
146351711|NCT02488759|527791840|FG005|Overall Study|Disease progression|2|||
146351712|NCT02488759|527791835|FG000|Overall Study|Study drug toxicity|11|||
146351713|NCT02488759|527791836|FG001|Overall Study|Study drug toxicity|33|||
146351714|NCT02488759|527791837|FG002|Overall Study|Study drug toxicity|31|||
146351715|NCT02488759|527791838|FG003|Overall Study|Study drug toxicity|0|||
146351716|NCT02488759|527791839|FG004|Overall Study|Study drug toxicity|0|||
146351717|NCT02488759|527791840|FG005|Overall Study|Study drug toxicity|2|||
146351718|NCT02488759|527791835|FG000|Overall Study|Adverse event unrelated to study drug|9|||
146351719|NCT02488759|527791836|FG001|Overall Study|Adverse event unrelated to study drug|11|||
146351720|NCT02488759|527791837|FG002|Overall Study|Adverse event unrelated to study drug|7|||
146351721|NCT02488759|527791838|FG003|Overall Study|Adverse event unrelated to study drug|0|||
146351722|NCT02488759|527791839|FG004|Overall Study|Adverse event unrelated to study drug|1|||
146351723|NCT02488759|527791840|FG005|Overall Study|Adverse event unrelated to study drug|0|||
146351724|NCT02488759|527791835|FG000|Overall Study|Participant request to discontinue study treatment|6|||
146351725|NCT02488759|527791836|FG001|Overall Study|Participant request to discontinue study treatment|8|||
146351726|NCT02488759|527791837|FG002|Overall Study|Participant request to discontinue study treatment|4|||
146351727|NCT02488759|527791838|FG003|Overall Study|Participant request to discontinue study treatment|0|||
146351728|NCT02488759|527791839|FG004|Overall Study|Participant request to discontinue study treatment|0|||
146351729|NCT02488759|527791840|FG005|Overall Study|Participant request to discontinue study treatment|0|||
146351730|NCT02488759|527791835|FG000|Overall Study|Withdrawal by Subject|4|||
146351731|NCT02488759|527791836|FG001|Overall Study|Withdrawal by Subject|0|||
146351732|NCT02488759|527791837|FG002|Overall Study|Withdrawal by Subject|3|||
146351733|NCT02488759|527791838|FG003|Overall Study|Withdrawal by Subject|0|||
146351734|NCT02488759|527791839|FG004|Overall Study|Withdrawal by Subject|0|||
146351735|NCT02488759|527791840|FG005|Overall Study|Withdrawal by Subject|2|||
146351736|NCT02488759|527791835|FG000|Overall Study|Lost to Follow-up|0|||
146351737|NCT02488759|527791836|FG001|Overall Study|Lost to Follow-up|0|||
146351738|NCT02488759|527791837|FG002|Overall Study|Lost to Follow-up|2|||
146351739|NCT02488759|527791838|FG003|Overall Study|Lost to Follow-up|0|||
146351740|NCT02488759|527791839|FG004|Overall Study|Lost to Follow-up|0|||
146351741|NCT02488759|527791840|FG005|Overall Study|Lost to Follow-up|0|||
146351742|NCT02488759|527791835|FG000|Overall Study|Maximum clinical benefit|3|||
146351743|NCT02488759|527791836|FG001|Overall Study|Maximum clinical benefit|0|||
146351744|NCT02488759|527791837|FG002|Overall Study|Maximum clinical benefit|1|||
146351745|NCT02488759|527791838|FG003|Overall Study|Maximum clinical benefit|0|||
146351746|NCT02488759|527791839|FG004|Overall Study|Maximum clinical benefit|0|||
146351747|NCT02488759|527791840|FG005|Overall Study|Maximum clinical benefit|0|||
146351748|NCT02488759|527791835|FG000|Overall Study|Other reasons|7|||
146351749|NCT02488759|527791836|FG001|Overall Study|Other reasons|32|||
146351750|NCT02488759|527791837|FG002|Overall Study|Other reasons|23|||
146351751|NCT02488759|527791838|FG003|Overall Study|Other reasons|1|||
146351752|NCT02488759|527791839|FG004|Overall Study|Other reasons|1|||
146351753|NCT02488759|527791840|FG005|Overall Study|Other reasons|1|||
146351754|NCT03860844|527791841|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
146351755|NCT03860844|527791842|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
146351756|NCT03860844|527791843|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
146351757|NCT03860844|527791841|FG000|Overall Study|Progressive disease|5|||
146351758|NCT03860844|527791842|FG001|Overall Study|Progressive disease|3|||
146351759|NCT03860844|527791843|FG002|Overall Study|Progressive disease|4|||
146351760|NCT03860844|527791841|FG000|Overall Study|Other, Not related to COVID-19|0|||
146351761|NCT03860844|527791842|FG001|Overall Study|Other, Not related to COVID-19|1|||
146351762|NCT03860844|527791843|FG002|Overall Study|Other, Not related to COVID-19|0|||
146351763|NCT01678807|527791851|FG000|Overall Study|Adverse Event|4|||
146351764|NCT01678807|527791852|FG001|Overall Study|Adverse Event|4|||
146351765|NCT01678807|527791853|FG002|Overall Study|Adverse Event|0|||
146351766|NCT01678807|527791851|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
146351767|NCT01678807|527791852|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
146351768|NCT01678807|527791853|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
146351769|NCT02429427|527791854|FG000|Overall Study|Adverse Event|220|||
146351770|NCT02429427|527791855|FG001|Overall Study|Adverse Event|92|||
146351771|NCT02429427|527791854|FG000|Overall Study|Protocol Violation|10|||
146351772|NCT02429427|527791855|FG001|Overall Study|Protocol Violation|6|||
146351773|NCT02429427|527791854|FG000|Overall Study|Lost to Follow-up|15|||
146351774|NCT02429427|527791855|FG001|Overall Study|Lost to Follow-up|6|||
146351775|NCT02429427|527791854|FG000|Overall Study|Withdrawal by Subject|64|||
146351776|NCT02429427|527791855|FG001|Overall Study|Withdrawal by Subject|34|||
146351777|NCT02429427|527791854|FG000|Overall Study|Other|62|||
146351778|NCT02429427|527791855|FG001|Overall Study|Other|41|||
146351779|NCT02626819|527793523|FG000|Overall Study|Lost to Follow-up|3|||
146351780|NCT02626819|527793524|FG001|Overall Study|Lost to Follow-up|2|||
146351781|NCT02626819|527793523|FG000|Overall Study|Withdrawal by Subject|1|||
146351782|NCT02626819|527793524|FG001|Overall Study|Withdrawal by Subject|0|||
146351783|NCT02626819|527793523|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
146351784|NCT02626819|527793524|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
146351785|NCT03488472|527793525|FG000|Overall Study|disease progression additional mets|1|||
146351786|NCT01617681|527793526|FG000|Period 1 Double Blind|Adverse Event|2|||
146351787|NCT01617681|527793527|FG001|Period 1 Double Blind|Adverse Event|0|||
146351788|NCT01617681|527793528|FG002|Period 1 Double Blind|Adverse Event|0|||
146351789|NCT01617681|527793529|FG003|Period 1 Double Blind|Adverse Event|2|||
146351790|NCT01617681|527793530|FG004|Period 1 Double Blind|Adverse Event|0|||
146351791|NCT01617681|527793526|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
146351792|NCT01617681|527793527|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
146351793|NCT01617681|527793528|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
146351794|NCT01617681|527793529|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
146351795|NCT01617681|527793530|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
146351796|NCT01617681|527793526|FG000|Period 2 Open Label|Adverse Event|0|||
146351797|NCT01617681|527793527|FG001|Period 2 Open Label|Adverse Event|0|||
146351798|NCT01617681|527793528|FG002|Period 2 Open Label|Adverse Event|0|||
146351799|NCT01617681|527793529|FG003|Period 2 Open Label|Adverse Event|0|||
146351800|NCT01617681|527793530|FG004|Period 2 Open Label|Adverse Event|3|||
146351801|NCT01617681|527793526|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
146351802|NCT01617681|527793527|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
146351803|NCT01617681|527793528|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
146351804|NCT01617681|527793529|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
146351805|NCT01617681|527793530|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
146351806|NCT04426825|527793533|FG000|Overall Study|Death|17|||
146351807|NCT04426825|527793533|FG000|Overall Study|Lost to Follow-up|1|||
146351808|NCT04426825|527793533|FG000|Overall Study|Study terminated by sponsor|5|||
146351809|NCT01597557|527793534|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
146351810|NCT01597557|527793535|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
146351811|NCT01263691|527793536|FG000|Overall Study|Lost to Follow-up|1|||
146351812|NCT01263691|527793537|FG001|Overall Study|Lost to Follow-up|0|||
146351813|NCT01263691|527793538|FG002|Overall Study|Lost to Follow-up|1|||
146351814|NCT01263691|527793539|FG003|Overall Study|Lost to Follow-up|1|||
146351815|NCT01263691|527793540|FG004|Overall Study|Lost to Follow-up|0|||
146351816|NCT01263691|527793541|FG005|Overall Study|Lost to Follow-up|0|||
146351817|NCT01263691|527793536|FG000|Overall Study|Withdrawal by Subject|1|||
146351818|NCT01263691|527793537|FG001|Overall Study|Withdrawal by Subject|0|||
146351819|NCT01263691|527793538|FG002|Overall Study|Withdrawal by Subject|0|||
146351820|NCT01263691|527793539|FG003|Overall Study|Withdrawal by Subject|0|||
146351821|NCT01263691|527793540|FG004|Overall Study|Withdrawal by Subject|0|||
146351822|NCT01263691|527793541|FG005|Overall Study|Withdrawal by Subject|0|||
146351823|NCT01263691|527793536|FG000|Overall Study|Adverse Event|1|||
146351824|NCT01263691|527793537|FG001|Overall Study|Adverse Event|0|||
146351825|NCT01263691|527793538|FG002|Overall Study|Adverse Event|0|||
146351826|NCT01263691|527793539|FG003|Overall Study|Adverse Event|0|||
146351827|NCT01263691|527793540|FG004|Overall Study|Adverse Event|0|||
146351828|NCT01263691|527793541|FG005|Overall Study|Adverse Event|0|||
146351829|NCT00879814|527793544|FG000|Overall Study|Adverse Event|0|||
146351830|NCT00879814|527793545|FG001|Overall Study|Adverse Event|1|||
146351831|NCT00879814|527793546|FG002|Overall Study|Adverse Event|0|||
146351832|NCT00879814|527793547|FG003|Overall Study|Adverse Event|0|||
146351833|NCT00879814|527793544|FG000|Overall Study|Lost to Follow-up|1|||
146351834|NCT00879814|527793545|FG001|Overall Study|Lost to Follow-up|0|||
146351835|NCT00879814|527793546|FG002|Overall Study|Lost to Follow-up|0|||
146351836|NCT00879814|527793547|FG003|Overall Study|Lost to Follow-up|2|||
146351837|NCT00879814|527793544|FG000|Overall Study|Participant Failed to Return|0|||
146351838|NCT00879814|527793545|FG001|Overall Study|Participant Failed to Return|0|||
146351839|NCT00879814|527793546|FG002|Overall Study|Participant Failed to Return|0|||
146351840|NCT00879814|527793547|FG003|Overall Study|Participant Failed to Return|1|||
146351841|NCT00879814|527793544|FG000|Overall Study|Withdrawal by Subject|3|||
146351842|NCT00879814|527793545|FG001|Overall Study|Withdrawal by Subject|1|||
146351843|NCT00879814|527793546|FG002|Overall Study|Withdrawal by Subject|1|||
146351844|NCT00879814|527793547|FG003|Overall Study|Withdrawal by Subject|2|||
146351845|NCT00879814|527793544|FG000|Overall Study|Physician Decision|0|||
146351846|NCT00879814|527793545|FG001|Overall Study|Physician Decision|0|||
146351847|NCT00879814|527793546|FG002|Overall Study|Physician Decision|1|||
146351848|NCT00879814|527793547|FG003|Overall Study|Physician Decision|0|||
146351849|NCT00879814|527793544|FG000|Overall Study|Other|0|||
146351850|NCT00879814|527793545|FG001|Overall Study|Other|0|||
146351851|NCT00879814|527793546|FG002|Overall Study|Other|1|||
146351852|NCT00879814|527793547|FG003|Overall Study|Other|0|||
146351853|NCT00630812|527793558|FG000|Randomisation to First Dose|Adverse Event|1|||
146351854|NCT00630812|527793559|FG001|Randomisation to First Dose|Adverse Event|1|||
146351855|NCT00630812|527793558|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
146351856|NCT00630812|527793559|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
146351857|NCT00630812|527793558|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
146351858|NCT00630812|527793559|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
146351859|NCT00630812|527793558|FG000|Randomisation to First Dose|Protocol Violation|4|||
146351860|NCT00630812|527793559|FG001|Randomisation to First Dose|Protocol Violation|1|||
146351861|NCT00630812|527793558|FG000|Double Blind Treatment Period|Adverse Event|13|||
146351862|NCT00630812|527793559|FG001|Double Blind Treatment Period|Adverse Event|5|||
146351863|NCT00630812|527793558|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
146351864|NCT00630812|527793559|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146351865|NCT00630812|527793558|FG000|Double Blind Treatment Period|Physician Decision|2|||
146351866|NCT00630812|527793559|FG001|Double Blind Treatment Period|Physician Decision|1|||
146351867|NCT00630812|527793558|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146351868|NCT00630812|527793559|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146351869|NCT00630812|527793558|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
146351870|NCT00630812|527793559|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
146351871|NCT00630812|527793558|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
146351872|NCT00630812|527793559|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
146351873|NCT00630812|527793558|FG000|Double Blind Treatment Period|Non-compliance|0|||
146351874|NCT00630812|527793559|FG001|Double Blind Treatment Period|Non-compliance|1|||
145943389|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145943390|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146351875|NCT03430245|527793562|FG000|Overall Study|Withdrawal by Subject|6|||
146351876|NCT03430245|527793562|FG000|Overall Study|Lost to Follow-up|1|||
146351877|NCT05628181|527793563|FG000|Overall Study|Death|2|||
146351878|NCT05628181|527793564|FG001|Overall Study|Death|4|||
146351879|NCT05628181|527793565|FG002|Overall Study|Death|0|||
146351880|NCT04102098|527793566|FG000|Main Study Period|Ongoing in study|302|||
146351881|NCT04102098|527793567|FG001|Main Study Period|Ongoing in study|291|||
146351882|NCT04102098|527793566|FG000|Main Study Period|Death|20|||
146351883|NCT04102098|527793567|FG001|Main Study Period|Death|27|||
146351884|NCT04102098|527793566|FG000|Main Study Period|Lost to Follow-up|1|||
146351885|NCT04102098|527793567|FG001|Main Study Period|Lost to Follow-up|1|||
146351886|NCT04102098|527793566|FG000|Main Study Period|Physician Decision|0|||
146351887|NCT04102098|527793567|FG001|Main Study Period|Physician Decision|1|||
146351888|NCT04102098|527793566|FG000|Main Study Period|Withdrawal by Subject|11|||
146351889|NCT04102098|527793567|FG001|Main Study Period|Withdrawal by Subject|14|||
146351890|NCT04102098|527793566|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
146351891|NCT04102098|527793567|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
146351892|NCT04102098|527793566|FG000|Crossover: AS Who Crossed Over|Death|11|||
146351893|NCT04102098|527793567|FG001|Crossover: AS Who Crossed Over|Death|0|||
146351894|NCT04102098|527793566|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
146351895|NCT04102098|527793567|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
146351896|NCT04742907|527793574|FG000|Overall Study|Adverse Event|1|||
146351897|NCT04742907|527793575|FG001|Overall Study|Adverse Event|0|||
146351898|NCT04742907|527793576|FG002|Overall Study|Adverse Event|1|||
146351899|NCT04742907|527793574|FG000|Overall Study|Lost to Follow-up|3|||
146351900|NCT04742907|527793575|FG001|Overall Study|Lost to Follow-up|3|||
146351901|NCT04742907|527793576|FG002|Overall Study|Lost to Follow-up|2|||
146351902|NCT04742907|527793574|FG000|Overall Study|Physician Decision|0|||
146351903|NCT04742907|527793575|FG001|Overall Study|Physician Decision|1|||
146351904|NCT04742907|527793576|FG002|Overall Study|Physician Decision|0|||
146351905|NCT04742907|527793574|FG000|Overall Study|Protocol Violation|1|||
146351906|NCT04742907|527793575|FG001|Overall Study|Protocol Violation|1|||
146351907|NCT04742907|527793576|FG002|Overall Study|Protocol Violation|1|||
146351908|NCT04742907|527793574|FG000|Overall Study|Withdrawal by Subject|5|||
146351909|NCT04742907|527793575|FG001|Overall Study|Withdrawal by Subject|6|||
146351910|NCT04742907|527793576|FG002|Overall Study|Withdrawal by Subject|4|||
146351911|NCT04742907|527793574|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
146351912|NCT04742907|527793575|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
146351913|NCT04742907|527793576|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
146351914|NCT04742907|527793574|FG000|Overall Study|Did Not Receive the Study Drug|2|||
146351915|NCT04742907|527793575|FG001|Overall Study|Did Not Receive the Study Drug|4|||
146351916|NCT04742907|527793576|FG002|Overall Study|Did Not Receive the Study Drug|4|||
146351917|NCT01428063|527793578|FG000|Overall Study|Lack of Efficacy|8|||
146351918|NCT01428063|527793579|FG001|Overall Study|Lack of Efficacy|4|||
146351919|NCT01428063|527793580|FG002|Overall Study|Lack of Efficacy|1|||
146351920|NCT01428063|527793578|FG000|Overall Study|Adverse Event|2|||
146351921|NCT01428063|527793579|FG001|Overall Study|Adverse Event|3|||
146351922|NCT01428063|527793580|FG002|Overall Study|Adverse Event|0|||
146351923|NCT01428063|527793578|FG000|Overall Study|Lost to Follow-up|0|||
146351924|NCT01428063|527793579|FG001|Overall Study|Lost to Follow-up|2|||
146351925|NCT01428063|527793580|FG002|Overall Study|Lost to Follow-up|0|||
146351926|NCT01428063|527793578|FG000|Overall Study|No longer meets study criteria|0|||
146351927|NCT01428063|527793579|FG001|Overall Study|No longer meets study criteria|1|||
146351928|NCT01428063|527793580|FG002|Overall Study|No longer meets study criteria|0|||
146351929|NCT05761444|527793581|FG000|Overall Study|Protocol Violation|2|||
146351930|NCT05761444|527793582|FG001|Overall Study|Protocol Violation|1|||
146351931|NCT05761444|527793581|FG000|Overall Study|Adverse Event|2|||
146351932|NCT05761444|527793582|FG001|Overall Study|Adverse Event|2|||
146351933|NCT05761444|527793581|FG000|Overall Study|Withdrawal by Subject|3|||
146351934|NCT05761444|527793582|FG001|Overall Study|Withdrawal by Subject|2|||
146351935|NCT05761444|527793581|FG000|Overall Study|Other|1|||
146351936|NCT05761444|527793582|FG001|Overall Study|Other|0|||
146351937|NCT03508622|527793583|FG000|Overall Study|Protocol Violation|1|||
146351938|NCT03508622|527793584|FG001|Overall Study|Protocol Violation|0|||
146351939|NCT03508622|527793583|FG000|Overall Study|Withdrawal by Subject|1|||
146351940|NCT03508622|527793584|FG001|Overall Study|Withdrawal by Subject|0|||
146351941|NCT03508622|527793583|FG000|Overall Study|Lost to Follow-up|16|||
146351942|NCT03508622|527793584|FG001|Overall Study|Lost to Follow-up|0|||
146351943|NCT03508622|527793583|FG000|Overall Study|Incomplete data|0|||
146351944|NCT03508622|527793584|FG001|Overall Study|Incomplete data|24|||
146351945|NCT00850759|527793586|FG000|Overall Study|Lost to Follow-up|7|||
146351946|NCT00850759|527793587|FG001|Overall Study|Lost to Follow-up|5|||
146351947|NCT00850759|527793588|FG002|Overall Study|Lost to Follow-up|5|||
146351948|NCT00850759|527793589|FG003|Overall Study|Lost to Follow-up|3|||
146351949|NCT03196505|527793590|FG000|Overall Study|Physician Decision|26|||
146351950|NCT03196505|527793591|FG001|Overall Study|Physician Decision|26|||
146351951|NCT02389816|527793592|FG000|Overall Study|Randomized but Not Treated|1|||
146351952|NCT02389816|527793593|FG001|Overall Study|Randomized but Not Treated|0|||
146351953|NCT02389816|527793594|FG002|Overall Study|Randomized but Not Treated|0|||
146351954|NCT02389816|527793592|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
146351955|NCT02389816|527793593|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
146351956|NCT02389816|527793594|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
146351957|NCT02389816|527793592|FG000|Overall Study|Major Protocol Deviation|1|||
146351958|NCT02389816|527793593|FG001|Overall Study|Major Protocol Deviation|0|||
146351959|NCT02389816|527793594|FG002|Overall Study|Major Protocol Deviation|0|||
146351960|NCT02389816|527793592|FG000|Overall Study|Lost to Follow-up|1|||
146351961|NCT02389816|527793593|FG001|Overall Study|Lost to Follow-up|0|||
146351962|NCT02389816|527793594|FG002|Overall Study|Lost to Follow-up|0|||
146351963|NCT02389816|527793592|FG000|Overall Study|Withdrawal of Consent|6|||
146351964|NCT02389816|527793593|FG001|Overall Study|Withdrawal of Consent|4|||
146351965|NCT02389816|527793594|FG002|Overall Study|Withdrawal of Consent|4|||
146351966|NCT02389816|527793592|FG000|Overall Study|Lack of Efficacy|1|||
146351967|NCT02389816|527793593|FG001|Overall Study|Lack of Efficacy|0|||
146351968|NCT02389816|527793594|FG002|Overall Study|Lack of Efficacy|0|||
146351969|NCT02389816|527793592|FG000|Overall Study|Non Compliance with Study Drug|1|||
146351970|NCT02389816|527793593|FG001|Overall Study|Non Compliance with Study Drug|1|||
146351971|NCT02389816|527793594|FG002|Overall Study|Non Compliance with Study Drug|1|||
146351972|NCT02389816|527793592|FG000|Overall Study|Reason not Specified|0|||
146351973|NCT02389816|527793593|FG001|Overall Study|Reason not Specified|2|||
146351974|NCT02389816|527793594|FG002|Overall Study|Reason not Specified|0|||
146351975|NCT01259856|527793601|FG000|Overall Study|Adverse Event|12|||
146351976|NCT01259856|527793602|FG001|Overall Study|Adverse Event|9|||
146351977|NCT01259856|527793601|FG000|Overall Study|Death|0|||
146351978|NCT01259856|527793602|FG001|Overall Study|Death|1|||
146351979|NCT01259856|527793601|FG000|Overall Study|Lack of Efficacy|3|||
146351980|NCT01259856|527793602|FG001|Overall Study|Lack of Efficacy|1|||
146351981|NCT01259856|527793601|FG000|Overall Study|Lost to Follow-up|1|||
146351982|NCT01259856|527793602|FG001|Overall Study|Lost to Follow-up|1|||
146351983|NCT01259856|527793601|FG000|Overall Study|Physician Decision|2|||
146351984|NCT01259856|527793602|FG001|Overall Study|Physician Decision|1|||
146351985|NCT01259856|527793601|FG000|Overall Study|Withdrawal by Subject|9|||
146351986|NCT01259856|527793602|FG001|Overall Study|Withdrawal by Subject|10|||
146351987|NCT01259856|527793601|FG000|Overall Study|Treatment never started|0|||
146351988|NCT01259856|527793602|FG001|Overall Study|Treatment never started|6|||
146351989|NCT01259856|527793601|FG000|Overall Study|Study closure by sponsor|40|||
146351990|NCT01259856|527793602|FG001|Overall Study|Study closure by sponsor|41|||
146351991|NCT01259856|527793601|FG000|Overall Study|Patient developed other disease|0|||
146351992|NCT01259856|527793602|FG001|Overall Study|Patient developed other disease|1|||
146351993|NCT01259856|527793601|FG000|Overall Study|Transfer to another study|0|||
146351994|NCT01259856|527793602|FG001|Overall Study|Transfer to another study|1|||
146351995|NCT01259856|527793601|FG000|Overall Study|Unknown/missing|2|||
146351996|NCT01259856|527793602|FG001|Overall Study|Unknown/missing|2|||
146351997|NCT00788775|527793603|FG000|Overall Study|Progressive Disease|8|||
146351998|NCT00788775|527793604|FG001|Overall Study|Progressive Disease|6|||
146351999|NCT00788775|527793603|FG000|Overall Study|Withdrawal by Subject|0|||
146352000|NCT00788775|527793604|FG001|Overall Study|Withdrawal by Subject|2|||
146352001|NCT00788775|527793603|FG000|Overall Study|Patient Non-Compliance|1|||
146352002|NCT00788775|527793604|FG001|Overall Study|Patient Non-Compliance|0|||
146352003|NCT00788775|527793603|FG000|Overall Study|Patient's measurable disease resected.|1|||
146352004|NCT00788775|527793604|FG001|Overall Study|Patient's measurable disease resected.|0|||
146352005|NCT00578864|527793605|FG000|Overall Study|Death|1|||
146352006|NCT00578864|527793606|FG001|Overall Study|Death|0|||
146352007|NCT01217190|527793610|FG000|Second Dosing|Withdrawal by Subject|0|||
146352008|NCT01217190|527793611|FG001|Second Dosing|Withdrawal by Subject|2|||
146352009|NCT01594476|527793612|FG000|Overall Study|Protocol Violation|1|||
146352010|NCT01594476|527793613|FG001|Overall Study|Protocol Violation|3|||
146352011|NCT03116399|527793614|FG000|Overall Study|Death|8|||
146352012|NCT03116399|527793615|FG001|Overall Study|Death|3|||
146352013|NCT03116399|527793614|FG000|Overall Study|Lost to Follow-up|7|||
146352014|NCT03116399|527793615|FG001|Overall Study|Lost to Follow-up|11|||
146352015|NCT03116399|527793614|FG000|Overall Study|Investigator Decision|1|||
146352016|NCT03116399|527793615|FG001|Overall Study|Investigator Decision|1|||
146352017|NCT03116399|527793614|FG000|Overall Study|Withdrawal by Subject|24|||
146352018|NCT03116399|527793615|FG001|Overall Study|Withdrawal by Subject|9|||
146352019|NCT00938327|527793618|FG000|Overall Study|Adverse Event|2|||
146352020|NCT00938327|527793618|FG000|Overall Study|Protocol Violation|1|||
146352021|NCT00938327|527793618|FG000|Overall Study|Withdrawal by Subject|4|||
146352022|NCT00938327|527793618|FG000|Overall Study|Lost to Follow-up|37|||
146352023|NCT00938327|527793618|FG000|Overall Study|2nd dose received outside of the study|7|||
146352024|NCT00938327|527793618|FG000|Overall Study|Vaccine not received as out of stock|9|||
146352025|NCT01425190|527793619|FG000|Overall Study|Full dose not consumed.|1|||
146352026|NCT01425190|527793620|FG001|Overall Study|Full dose not consumed.|0|||
146352027|NCT01425190|527793621|FG002|Overall Study|Full dose not consumed.|0|||
146352028|NCT01035255|527793623|FG000|Overall Study|Death|724|||
146352029|NCT01035255|527793624|FG001|Overall Study|Death|844|||
146352030|NCT01035255|527793623|FG000|Overall Study|Lost to Follow-up|2|||
146352031|NCT01035255|527793624|FG001|Overall Study|Lost to Follow-up|5|||
146352032|NCT01035255|527793623|FG000|Overall Study|patient's request|15|||
146352033|NCT01035255|527793624|FG001|Overall Study|patient's request|13|||
146352034|NCT00195260|527793627|FG000|Part 1: Dose Escalation|Adverse Event|0|||
146352035|NCT00195260|527793628|FG001|Part 1: Dose Escalation|Adverse Event|1|||
146352036|NCT00195260|527793629|FG002|Part 1: Dose Escalation|Adverse Event|0|||
146352037|NCT00195260|527793630|FG003|Part 1: Dose Escalation|Adverse Event|1|||
146352038|NCT00195260|527793631|FG004|Part 1: Dose Escalation|Adverse Event|1|||
146352039|NCT00195260|527793632|FG005|Part 1: Dose Escalation|Adverse Event|0|||
146352040|NCT00195260|527793633|FG006|Part 1: Dose Escalation|Adverse Event|3|||
146352041|NCT00195260|527793634|FG007|Part 1: Dose Escalation|Adverse Event|0|||
146352042|NCT00195260|527793635|FG008|Part 1: Dose Escalation|Adverse Event|0|||
146352043|NCT00195260|527793636|FG009|Part 1: Dose Escalation|Adverse Event|0|||
146352044|NCT00195260|527793637|FG010|Part 1: Dose Escalation|Adverse Event|0|||
146352045|NCT00195260|527793627|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352046|NCT00195260|527793628|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352047|NCT00195260|527793629|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352048|NCT00195260|527793630|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352049|NCT00195260|527793631|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
146352050|NCT00195260|527793632|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352051|NCT00195260|527793633|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352052|NCT00195260|527793634|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
146352053|NCT00195260|527793635|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352054|NCT00195260|527793636|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352055|NCT00195260|527793637|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
146352056|NCT00195260|527793627|FG000|Part 1: Dose Escalation|Death|0|||
146352057|NCT00195260|527793628|FG001|Part 1: Dose Escalation|Death|0|||
146352058|NCT00195260|527793629|FG002|Part 1: Dose Escalation|Death|0|||
146352059|NCT00195260|527793630|FG003|Part 1: Dose Escalation|Death|0|||
146352060|NCT00195260|527793631|FG004|Part 1: Dose Escalation|Death|0|||
146352061|NCT00195260|527793632|FG005|Part 1: Dose Escalation|Death|0|||
146352062|NCT00195260|527793633|FG006|Part 1: Dose Escalation|Death|0|||
146352063|NCT00195260|527793634|FG007|Part 1: Dose Escalation|Death|1|||
146352064|NCT00195260|527793635|FG008|Part 1: Dose Escalation|Death|0|||
146352065|NCT00195260|527793636|FG009|Part 1: Dose Escalation|Death|0|||
146352066|NCT00195260|527793637|FG010|Part 1: Dose Escalation|Death|0|||
146352067|NCT00195260|527793627|FG000|Part 1: Dose Escalation|Disease Progression|3|||
146352068|NCT00195260|527793628|FG001|Part 1: Dose Escalation|Disease Progression|2|||
146352069|NCT00195260|527793629|FG002|Part 1: Dose Escalation|Disease Progression|5|||
146352070|NCT00195260|527793630|FG003|Part 1: Dose Escalation|Disease Progression|6|||
146352071|NCT00195260|527793631|FG004|Part 1: Dose Escalation|Disease Progression|4|||
146352072|NCT00195260|527793632|FG005|Part 1: Dose Escalation|Disease Progression|6|||
146352073|NCT00195260|527793633|FG006|Part 1: Dose Escalation|Disease Progression|7|||
146352074|NCT00195260|527793634|FG007|Part 1: Dose Escalation|Disease Progression|4|||
146352075|NCT00195260|527793635|FG008|Part 1: Dose Escalation|Disease Progression|0|||
146352076|NCT00195260|527793636|FG009|Part 1: Dose Escalation|Disease Progression|0|||
146352077|NCT00195260|527793637|FG010|Part 1: Dose Escalation|Disease Progression|0|||
146352078|NCT00195260|527793627|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146352079|NCT00195260|527793628|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146352080|NCT00195260|527793629|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146352081|NCT00195260|527793630|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352082|NCT00195260|527793631|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352083|NCT00195260|527793632|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
146352084|NCT00195260|527793633|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352085|NCT00195260|527793634|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352086|NCT00195260|527793635|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352087|NCT00195260|527793636|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352088|NCT00195260|527793637|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
146352089|NCT00195260|527793627|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146352090|NCT00195260|527793628|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146352091|NCT00195260|527793629|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146169529|NCT03170375|527132830|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
146169530|NCT00441701|527132831|FG000|Overall Study|Adverse Event|3|||
146352092|NCT00195260|527793630|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146352093|NCT00195260|527793631|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146169531|NCT00441701|527132832|FG001|Overall Study|Adverse Event|2|||
146352094|NCT00195260|527793632|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146352095|NCT00195260|527793633|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146169532|NCT00441701|527132833|FG002|Overall Study|Adverse Event|1|||
146352096|NCT00195260|527793634|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
146352097|NCT00195260|527793635|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
146352098|NCT00195260|527793636|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
146352099|NCT00195260|527793637|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
146352100|NCT00195260|527793627|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352101|NCT00195260|527793628|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352102|NCT00195260|527793629|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352103|NCT00195260|527793630|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352104|NCT00195260|527793631|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352105|NCT00195260|527793632|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352106|NCT00195260|527793633|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352107|NCT00195260|527793634|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
146352108|NCT00195260|527793635|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
146352109|NCT00195260|527793636|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
146352110|NCT00195260|527793637|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
146352111|NCT00195260|527793627|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352112|NCT00195260|527793628|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352113|NCT00195260|527793629|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352114|NCT00195260|527793630|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352115|NCT00195260|527793631|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352116|NCT00195260|527793632|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352117|NCT00195260|527793633|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352118|NCT00195260|527793634|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
146352119|NCT00195260|527793635|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
146352120|NCT00195260|527793636|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
146352121|NCT00195260|527793637|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
146352122|NCT00195260|527793627|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352123|NCT00195260|527793628|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352124|NCT00195260|527793629|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352125|NCT00195260|527793630|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352126|NCT00195260|527793631|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352127|NCT00195260|527793632|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352128|NCT00195260|527793633|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352129|NCT00195260|527793634|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
146352130|NCT00195260|527793635|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
146352131|NCT00195260|527793636|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
146352132|NCT00195260|527793637|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
146352133|NCT01379534|527793638|FG000|Treatment Phase|Withdrawal by Subject|2|||
146352134|NCT01379534|527793639|FG001|Treatment Phase|Withdrawal by Subject|2|||
146352135|NCT01379534|527793638|FG000|Treatment Phase|Progressive disease|13|||
146352136|NCT01379534|527793639|FG001|Treatment Phase|Progressive disease|22|||
146352137|NCT01379534|527793638|FG000|Treatment Phase|Adverse Event|7|||
146352138|NCT01379534|527793639|FG001|Treatment Phase|Adverse Event|7|||
146352139|NCT01379534|527793638|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
146352140|NCT01379534|527793639|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
146352141|NCT01379534|527793638|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
146352142|NCT01379534|527793639|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
146352143|NCT01379534|527793638|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
146352144|NCT01379534|527793639|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
146352145|NCT01379534|527793638|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
146352146|NCT01379534|527793639|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
146352147|NCT03007953|527793642|FG000|Overall Study|Withdrawal by Subject|5|||
146352148|NCT03007953|527793643|FG001|Overall Study|Withdrawal by Subject|2|||
146352149|NCT03007953|527793642|FG000|Overall Study|Death|5|||
146352150|NCT03007953|527793643|FG001|Overall Study|Death|7|||
146352151|NCT03007953|527793642|FG000|Overall Study|Lost to Follow-up|3|||
146352152|NCT03007953|527793643|FG001|Overall Study|Lost to Follow-up|2|||
146352153|NCT03007953|527793642|FG000|Overall Study|Enrolled in Hospice|3|||
146352154|NCT03007953|527793643|FG001|Overall Study|Enrolled in Hospice|2|||
146352155|NCT02538666|527793647|FG000|Pre-Treatment|Disease progression|1|||
146352156|NCT02538666|527793648|FG001|Pre-Treatment|Disease progression|0|||
146352157|NCT02538666|527793649|FG002|Pre-Treatment|Disease progression|0|||
146352158|NCT02538666|527793647|FG000|Pre-Treatment|no longer meets study criteria|1|||
146352159|NCT02538666|527793648|FG001|Pre-Treatment|no longer meets study criteria|0|||
146352160|NCT02538666|527793649|FG002|Pre-Treatment|no longer meets study criteria|0|||
146352161|NCT02538666|527793647|FG000|Pre-Treatment|Withdrew Consent|0|||
146352162|NCT02538666|527793648|FG001|Pre-Treatment|Withdrew Consent|1|||
146352163|NCT02538666|527793649|FG002|Pre-Treatment|Withdrew Consent|1|||
146352164|NCT02538666|527793647|FG000|Treatment|Disease progression|270|||
146169533|NCT00441701|527132834|FG003|Overall Study|Adverse Event|0|||
146352165|NCT02538666|527793648|FG001|Treatment|Disease progression|227|||
146352166|NCT02538666|527793649|FG002|Treatment|Disease progression|165|||
146352167|NCT02538666|527793647|FG000|Treatment|Study drug toxicity|1|||
146352168|NCT02538666|527793648|FG001|Treatment|Study drug toxicity|29|||
146352169|NCT02538666|527793649|FG002|Treatment|Study drug toxicity|92|||
146352170|NCT02538666|527793647|FG000|Treatment|Death|0|||
146352171|NCT02538666|527793648|FG001|Treatment|Death|2|||
146352172|NCT02538666|527793649|FG002|Treatment|Death|3|||
146352173|NCT02538666|527793647|FG000|Treatment|Adverse event unrelated to study drug|8|||
146352174|NCT02538666|527793648|FG001|Treatment|Adverse event unrelated to study drug|10|||
146352175|NCT02538666|527793649|FG002|Treatment|Adverse event unrelated to study drug|15|||
146352176|NCT02538666|527793647|FG000|Treatment|Participant request to discontinue study treatment|3|||
146352177|NCT02538666|527793648|FG001|Treatment|Participant request to discontinue study treatment|6|||
146352178|NCT02538666|527793649|FG002|Treatment|Participant request to discontinue study treatment|11|||
146352179|NCT02538666|527793647|FG000|Treatment|Participant withdrew consent|2|||
146352180|NCT02538666|527793648|FG001|Treatment|Participant withdrew consent|5|||
146352181|NCT02538666|527793649|FG002|Treatment|Participant withdrew consent|3|||
146352182|NCT02538666|527793647|FG000|Treatment|Lost to Follow-up|0|||
146352183|NCT02538666|527793648|FG001|Treatment|Lost to Follow-up|1|||
146352184|NCT02538666|527793649|FG002|Treatment|Lost to Follow-up|1|||
146352185|NCT02538666|527793647|FG000|Treatment|Maximum clinical benefit|4|||
146352186|NCT02538666|527793648|FG001|Treatment|Maximum clinical benefit|3|||
146352187|NCT02538666|527793649|FG002|Treatment|Maximum clinical benefit|4|||
146352188|NCT02538666|527793647|FG000|Treatment|Poor/non-compliance|0|||
146352189|NCT02538666|527793648|FG001|Treatment|Poor/non-compliance|1|||
146352190|NCT02538666|527793649|FG002|Treatment|Poor/non-compliance|0|||
146352191|NCT02538666|527793647|FG000|Treatment|Participant no longer meets study criteria|0|||
146352192|NCT02538666|527793648|FG001|Treatment|Participant no longer meets study criteria|2|||
146352193|NCT02538666|527793649|FG002|Treatment|Participant no longer meets study criteria|0|||
146352194|NCT02538666|527793647|FG000|Treatment|Administrative reason by sponsor|0|||
146352195|NCT02538666|527793648|FG001|Treatment|Administrative reason by sponsor|0|||
146352196|NCT02538666|527793649|FG002|Treatment|Administrative reason by sponsor|1|||
146352197|NCT02538666|527793647|FG000|Treatment|Other reasons|8|||
146352198|NCT02538666|527793648|FG001|Treatment|Other reasons|15|||
146352199|NCT02538666|527793649|FG002|Treatment|Other reasons|5|||
146352200|NCT02538666|527793647|FG000|Treatment|Not reported|2|||
146352201|NCT02538666|527793648|FG001|Treatment|Not reported|2|||
146352202|NCT02538666|527793649|FG002|Treatment|Not reported|2|||
146352203|NCT00829166|527793650|FG000|Overall Study|Death|305|||
146352204|NCT00829166|527793651|FG001|Overall Study|Death|333|||
146352205|NCT00829166|527793650|FG000|Overall Study|Lost to Follow-up|5|||
146352206|NCT00829166|527793651|FG001|Overall Study|Lost to Follow-up|4|||
146352207|NCT00829166|527793650|FG000|Overall Study|Physician's Decision|4|||
146352208|NCT00829166|527793651|FG001|Overall Study|Physician's Decision|3|||
146352209|NCT00829166|527793650|FG000|Overall Study|Subject's Decision|41|||
146352210|NCT00829166|527793651|FG001|Overall Study|Subject's Decision|55|||
146352211|NCT00829166|527793650|FG000|Overall Study|Sponsor's Decision|137|||
146352212|NCT00829166|527793651|FG001|Overall Study|Sponsor's Decision|98|||
146352213|NCT00829166|527793650|FG000|Overall Study|Reason Not Specified|3|||
146352214|NCT00829166|527793651|FG001|Overall Study|Reason Not Specified|3|||
146352215|NCT01635933|527793652|FG000|Overall Study|Adverse Event|1|||
146352216|NCT01635933|527793653|FG001|Overall Study|Adverse Event|0|||
146352217|NCT01635933|527793652|FG000|Overall Study|Lost to Follow-up|0|||
146352218|NCT01635933|527793653|FG001|Overall Study|Lost to Follow-up|5|||
146352219|NCT01635933|527793652|FG000|Overall Study|Subject decision|1|||
146352220|NCT01635933|527793653|FG001|Overall Study|Subject decision|1|||
146352221|NCT01635933|527793652|FG000|Overall Study|Noncompliance|0|||
146352222|NCT01635933|527793653|FG001|Overall Study|Noncompliance|1|||
146352223|NCT01635933|527793652|FG000|Overall Study|No longer had transportation|0|||
146352224|NCT01635933|527793653|FG001|Overall Study|No longer had transportation|1|||
146352225|NCT01544595|527793656|FG000|Status at Week 68|Adverse Event|3|||
146352226|NCT01544595|527793657|FG001|Status at Week 68|Adverse Event|2|||
146352227|NCT01544595|527793658|FG002|Status at Week 68|Adverse Event|1|||
146352228|NCT01544595|527793659|FG003|Status at Week 68|Adverse Event|0|||
146352229|NCT01544595|527793660|FG004|Status at Week 68|Adverse Event|0|||
146352230|NCT01544595|527793661|FG005|Status at Week 68|Adverse Event|0|||
146352231|NCT01544595|527793656|FG000|Status at Week 68|Lack of Efficacy|1|||
146352232|NCT01544595|527793657|FG001|Status at Week 68|Lack of Efficacy|0|||
146352233|NCT01544595|527793658|FG002|Status at Week 68|Lack of Efficacy|0|||
146352234|NCT01544595|527793659|FG003|Status at Week 68|Lack of Efficacy|0|||
146352235|NCT01544595|527793660|FG004|Status at Week 68|Lack of Efficacy|0|||
146352236|NCT01544595|527793661|FG005|Status at Week 68|Lack of Efficacy|0|||
146352237|NCT01544595|527793656|FG000|Status at Week 68|Lost to Follow-up|1|||
146352238|NCT01544595|527793657|FG001|Status at Week 68|Lost to Follow-up|1|||
146352239|NCT01544595|527793658|FG002|Status at Week 68|Lost to Follow-up|0|||
146352240|NCT01544595|527793659|FG003|Status at Week 68|Lost to Follow-up|0|||
146352241|NCT01544595|527793660|FG004|Status at Week 68|Lost to Follow-up|0|||
146352242|NCT01544595|527793661|FG005|Status at Week 68|Lost to Follow-up|0|||
146352243|NCT01544595|527793656|FG000|Status at Week 68|Non-compliance with study treatment|1|||
146352244|NCT01544595|527793657|FG001|Status at Week 68|Non-compliance with study treatment|0|||
146352245|NCT01544595|527793658|FG002|Status at Week 68|Non-compliance with study treatment|0|||
146352246|NCT01544595|527793659|FG003|Status at Week 68|Non-compliance with study treatment|1|||
146352247|NCT01544595|527793660|FG004|Status at Week 68|Non-compliance with study treatment|0|||
146352248|NCT01544595|527793661|FG005|Status at Week 68|Non-compliance with study treatment|0|||
146352249|NCT01544595|527793656|FG000|Status at Week 68|Protocol Violation|2|||
146352250|NCT01544595|527793657|FG001|Status at Week 68|Protocol Violation|0|||
146352251|NCT01544595|527793658|FG002|Status at Week 68|Protocol Violation|1|||
146352252|NCT01544595|527793659|FG003|Status at Week 68|Protocol Violation|1|||
146352253|NCT01544595|527793660|FG004|Status at Week 68|Protocol Violation|0|||
146352254|NCT01544595|527793661|FG005|Status at Week 68|Protocol Violation|0|||
146352255|NCT01544595|527793656|FG000|Status at Week 68|Technical problems|1|||
146352256|NCT01544595|527793657|FG001|Status at Week 68|Technical problems|0|||
146352257|NCT01544595|527793658|FG002|Status at Week 68|Technical problems|0|||
146352258|NCT01544595|527793659|FG003|Status at Week 68|Technical problems|1|||
146352259|NCT01544595|527793660|FG004|Status at Week 68|Technical problems|0|||
146352260|NCT01544595|527793661|FG005|Status at Week 68|Technical problems|0|||
146352261|NCT01544595|527793656|FG000|Status at Week 68|Withdrawal by Subject|0|||
146352262|NCT01544595|527793657|FG001|Status at Week 68|Withdrawal by Subject|1|||
146352263|NCT01544595|527793658|FG002|Status at Week 68|Withdrawal by Subject|1|||
146352264|NCT01544595|527793659|FG003|Status at Week 68|Withdrawal by Subject|2|||
146352265|NCT01544595|527793660|FG004|Status at Week 68|Withdrawal by Subject|0|||
146352266|NCT01544595|527793661|FG005|Status at Week 68|Withdrawal by Subject|0|||
146352267|NCT01544595|527793656|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
146352268|NCT01544595|527793657|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
146352269|NCT01544595|527793658|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
146352270|NCT01544595|527793659|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
146352271|NCT01544595|527793660|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
146352272|NCT01544595|527793661|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
146352273|NCT01544595|527793656|FG000|Status at Week 156|Withdrawal by Subject|9|||
146352274|NCT01544595|527793657|FG001|Status at Week 156|Withdrawal by Subject|10|||
146352275|NCT01544595|527793658|FG002|Status at Week 156|Withdrawal by Subject|4|||
146352276|NCT01544595|527793659|FG003|Status at Week 156|Withdrawal by Subject|9|||
146352277|NCT01544595|527793660|FG004|Status at Week 156|Withdrawal by Subject|20|||
146352278|NCT01544595|527793661|FG005|Status at Week 156|Withdrawal by Subject|6|||
146352279|NCT01544595|527793656|FG000|Status at Week 156|Adverse Event|9|||
146352280|NCT01544595|527793657|FG001|Status at Week 156|Adverse Event|11|||
146352281|NCT01544595|527793658|FG002|Status at Week 156|Adverse Event|1|||
146352282|NCT01544595|527793659|FG003|Status at Week 156|Adverse Event|3|||
146352283|NCT01544595|527793660|FG004|Status at Week 156|Adverse Event|4|||
146352284|NCT01544595|527793661|FG005|Status at Week 156|Adverse Event|2|||
146352285|NCT01544595|527793656|FG000|Status at Week 156|Lost to Follow-up|4|||
146352286|NCT01544595|527793657|FG001|Status at Week 156|Lost to Follow-up|4|||
146352287|NCT01544595|527793658|FG002|Status at Week 156|Lost to Follow-up|0|||
146352288|NCT01544595|527793659|FG003|Status at Week 156|Lost to Follow-up|1|||
146352289|NCT01544595|527793660|FG004|Status at Week 156|Lost to Follow-up|4|||
146352290|NCT01544595|527793661|FG005|Status at Week 156|Lost to Follow-up|1|||
146352291|NCT01544595|527793656|FG000|Status at Week 156|Non-compliance with study treatement|0|||
146352292|NCT01544595|527793657|FG001|Status at Week 156|Non-compliance with study treatement|1|||
146352293|NCT01544595|527793658|FG002|Status at Week 156|Non-compliance with study treatement|0|||
146352294|NCT01544595|527793659|FG003|Status at Week 156|Non-compliance with study treatement|1|||
146352295|NCT01544595|527793660|FG004|Status at Week 156|Non-compliance with study treatement|0|||
146352296|NCT01544595|527793661|FG005|Status at Week 156|Non-compliance with study treatement|1|||
146352297|NCT01544595|527793656|FG000|Status at Week 156|Physician Decision|0|||
146352298|NCT01544595|527793657|FG001|Status at Week 156|Physician Decision|3|||
146352299|NCT01544595|527793658|FG002|Status at Week 156|Physician Decision|1|||
146352300|NCT01544595|527793659|FG003|Status at Week 156|Physician Decision|0|||
146352301|NCT01544595|527793660|FG004|Status at Week 156|Physician Decision|0|||
146352302|NCT01544595|527793661|FG005|Status at Week 156|Physician Decision|0|||
146352303|NCT01544595|527793656|FG000|Status at Week 156|Pregnancy|2|||
146352304|NCT01544595|527793657|FG001|Status at Week 156|Pregnancy|3|||
146352305|NCT01544595|527793658|FG002|Status at Week 156|Pregnancy|0|||
146352306|NCT01544595|527793659|FG003|Status at Week 156|Pregnancy|0|||
146352307|NCT01544595|527793660|FG004|Status at Week 156|Pregnancy|0|||
146352308|NCT01544595|527793661|FG005|Status at Week 156|Pregnancy|0|||
146352309|NCT01544595|527793656|FG000|Status at Week 156|Protocol Violation|3|||
146352310|NCT01544595|527793657|FG001|Status at Week 156|Protocol Violation|1|||
146352311|NCT01544595|527793658|FG002|Status at Week 156|Protocol Violation|2|||
146352312|NCT01544595|527793659|FG003|Status at Week 156|Protocol Violation|2|||
146352313|NCT01544595|527793660|FG004|Status at Week 156|Protocol Violation|0|||
146352314|NCT01544595|527793661|FG005|Status at Week 156|Protocol Violation|0|||
146352315|NCT01544595|527793656|FG000|Status at Week 156|Technical problems|3|||
146169534|NCT00441701|527132835|FG004|Overall Study|Adverse Event|2|||
146352316|NCT01544595|527793657|FG001|Status at Week 156|Technical problems|1|||
146352317|NCT01544595|527793658|FG002|Status at Week 156|Technical problems|0|||
146352318|NCT01544595|527793659|FG003|Status at Week 156|Technical problems|1|||
146352319|NCT01544595|527793660|FG004|Status at Week 156|Technical problems|0|||
146352320|NCT01544595|527793661|FG005|Status at Week 156|Technical problems|0|||
146352321|NCT01544595|527793656|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
146352322|NCT01544595|527793657|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
146352323|NCT01544595|527793658|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
146352324|NCT01544595|527793659|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
146352325|NCT01544595|527793660|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
146352326|NCT01544595|527793661|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
146352327|NCT01544595|527793656|FG000|Status at Week 156|Lack of Efficacy|1|||
146352328|NCT01544595|527793657|FG001|Status at Week 156|Lack of Efficacy|0|||
146352329|NCT01544595|527793658|FG002|Status at Week 156|Lack of Efficacy|1|||
146352330|NCT01544595|527793659|FG003|Status at Week 156|Lack of Efficacy|4|||
146352331|NCT01544595|527793660|FG004|Status at Week 156|Lack of Efficacy|10|||
146352332|NCT01544595|527793661|FG005|Status at Week 156|Lack of Efficacy|5|||
146352333|NCT00878072|527793662|FG000|Overall Study|Withdrew consent|2|||
146352334|NCT03382899|527793668|FG000|Overall Study|Ineligibility Determined|0|||
146352335|NCT03382899|527793669|FG001|Overall Study|Ineligibility Determined|1|||
146352336|NCT03382899|527793668|FG000|Overall Study|Lost to Follow-up|0|||
146352337|NCT03382899|527793669|FG001|Overall Study|Lost to Follow-up|1|||
146352338|NCT03382899|527793668|FG000|Overall Study|Sponsor's decision|31|||
146352339|NCT03382899|527793669|FG001|Overall Study|Sponsor's decision|28|||
146352340|NCT03382899|527793668|FG000|Overall Study|Withdrawal by Subject|0|||
146352341|NCT03382899|527793669|FG001|Overall Study|Withdrawal by Subject|5|||
146352342|NCT00872170|527793670|FG000|Overall Study|Adverse Event|1|||
146352343|NCT00872170|527793671|FG001|Overall Study|Adverse Event|0|||
146352344|NCT01987986|527793672|FG000|Overall Study|Lost to Follow-up|1|||
146352345|NCT01987986|527793673|FG001|Overall Study|Lost to Follow-up|0|||
146352346|NCT01987986|527793674|FG002|Overall Study|Lost to Follow-up|0|||
146352347|NCT01987986|527793675|FG003|Overall Study|Lost to Follow-up|0|||
146352348|NCT01987986|527793672|FG000|Overall Study|Adverse Event|1|||
146352349|NCT01987986|527793673|FG001|Overall Study|Adverse Event|0|||
146352350|NCT01987986|527793674|FG002|Overall Study|Adverse Event|2|||
146352351|NCT01987986|527793675|FG003|Overall Study|Adverse Event|0|||
146352352|NCT05281523|527793676|FG000|Overall Study|Adverse Event|1|||
146352353|NCT05281523|527793677|FG001|Overall Study|Adverse Event|1|||
146352354|NCT05281523|527793676|FG000|Overall Study|Physician Decision|1|||
146352355|NCT05281523|527793677|FG001|Overall Study|Physician Decision|1|||
146352356|NCT05281523|527793676|FG000|Overall Study|Withdrawal by Subject|5|||
146352357|NCT05281523|527793677|FG001|Overall Study|Withdrawal by Subject|15|||
146352358|NCT05281523|527793676|FG000|Overall Study|GCP violations|3|||
146352359|NCT05281523|527793677|FG001|Overall Study|GCP violations|4|||
146352360|NCT00719732|527793678|FG000|Overall Study|Lost to Follow-up|20|||
146352361|NCT00719732|527793678|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
146352362|NCT00719732|527793678|FG000|Overall Study|Illness not associated with device|1|||
146352363|NCT04038255|527795166|FG000|Overall Study|Lost to Follow-up|0|||
146352364|NCT04038255|527795167|FG001|Overall Study|Lost to Follow-up|9|||
146352365|NCT04038255|527795168|FG002|Overall Study|Lost to Follow-up|5|||
146352366|NCT04038255|527795166|FG000|Overall Study|Withdrawal by Subject|0|||
146352367|NCT04038255|527795167|FG001|Overall Study|Withdrawal by Subject|0|||
146352368|NCT04038255|527795168|FG002|Overall Study|Withdrawal by Subject|1|||
146352369|NCT04491877|527795169|FG000|Overall Study|Protocol Deviation|1|||
146352370|NCT04491877|527795170|FG001|Overall Study|Protocol Deviation|0|||
146352371|NCT04491877|527795171|FG002|Overall Study|Protocol Deviation|2|||
146352372|NCT04491877|527795172|FG003|Overall Study|Protocol Deviation|0|||
146352373|NCT04491877|527795173|FG004|Overall Study|Protocol Deviation|0|||
146352374|NCT04491877|527795174|FG005|Overall Study|Protocol Deviation|0|||
146352375|NCT04491877|527795175|FG006|Overall Study|Protocol Deviation|1|||
146352376|NCT04491877|527795176|FG007|Overall Study|Protocol Deviation|1|||
146352377|NCT04491877|527795177|FG008|Overall Study|Protocol Deviation|0|||
146352378|NCT04491877|527795169|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
146352379|NCT04491877|527795170|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146352380|NCT04491877|527795171|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146352381|NCT04491877|527795172|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
146352382|NCT04491877|527795173|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146352383|NCT04491877|527795174|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
145943391|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146352384|NCT04491877|527795175|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
146352385|NCT04491877|527795176|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
146352386|NCT04491877|527795177|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
146352387|NCT04491877|527795169|FG000|Overall Study|Lost to Follow-up|0|||
146352388|NCT04491877|527795170|FG001|Overall Study|Lost to Follow-up|2|||
146352389|NCT04491877|527795171|FG002|Overall Study|Lost to Follow-up|0|||
146352390|NCT04491877|527795172|FG003|Overall Study|Lost to Follow-up|0|||
146352391|NCT04491877|527795173|FG004|Overall Study|Lost to Follow-up|0|||
146352392|NCT04491877|527795174|FG005|Overall Study|Lost to Follow-up|0|||
146352393|NCT04491877|527795175|FG006|Overall Study|Lost to Follow-up|2|||
146352394|NCT04491877|527795176|FG007|Overall Study|Lost to Follow-up|1|||
146352395|NCT04491877|527795177|FG008|Overall Study|Lost to Follow-up|1|||
146352396|NCT01096446|527795183|FG000|Overall Study|Death|1|||
146352397|NCT01096446|527795184|FG001|Overall Study|Death|0|||
146352398|NCT01096446|527795183|FG000|Overall Study|Protocol Violation|2|||
146352399|NCT01096446|527795184|FG001|Overall Study|Protocol Violation|0|||
146352400|NCT00418834|527795187|FG000|Overall Study|Adverse Event|16|||
146352401|NCT00418834|527795188|FG001|Overall Study|Adverse Event|9|||
146352402|NCT00418834|527795187|FG000|Overall Study|Lost to Follow-up|0|||
146352403|NCT00418834|527795188|FG001|Overall Study|Lost to Follow-up|1|||
146352404|NCT00418834|527795187|FG000|Overall Study|Protocol Violation|4|||
146352405|NCT00418834|527795188|FG001|Overall Study|Protocol Violation|3|||
146352406|NCT00418834|527795187|FG000|Overall Study|Withdrawal by Subject|3|||
146352407|NCT00418834|527795188|FG001|Overall Study|Withdrawal by Subject|7|||
146352408|NCT01953328|527795189|FG000|Overall Study|Withdrawal by Subject|0|||
146352409|NCT01953328|527795190|FG001|Overall Study|Withdrawal by Subject|0|||
146352410|NCT01953328|527795191|FG002|Overall Study|Withdrawal by Subject|0|||
146352411|NCT01953328|527795192|FG003|Overall Study|Withdrawal by Subject|0|||
146352412|NCT01953328|527795193|FG004|Overall Study|Withdrawal by Subject|1|||
146352413|NCT01953328|527795194|FG005|Overall Study|Withdrawal by Subject|0|||
146352414|NCT01953328|527795195|FG006|Overall Study|Withdrawal by Subject|0|||
146352415|NCT01953328|527795196|FG007|Overall Study|Withdrawal by Subject|0|||
146352416|NCT01953328|527795189|FG000|Overall Study|Lost to Follow-up|0|||
146352417|NCT01953328|527795190|FG001|Overall Study|Lost to Follow-up|0|||
146352418|NCT01953328|527795191|FG002|Overall Study|Lost to Follow-up|0|||
146352419|NCT01953328|527795192|FG003|Overall Study|Lost to Follow-up|0|||
146352420|NCT01953328|527795193|FG004|Overall Study|Lost to Follow-up|1|||
146352421|NCT01953328|527795194|FG005|Overall Study|Lost to Follow-up|0|||
146352422|NCT01953328|527795195|FG006|Overall Study|Lost to Follow-up|0|||
146352423|NCT01953328|527795196|FG007|Overall Study|Lost to Follow-up|0|||
146352424|NCT05113953|527795202|FG000|Overall Study|Adverse Event|5|||
146352425|NCT05113953|527795203|FG001|Overall Study|Adverse Event|0|||
146352426|NCT05113953|527795204|FG002|Overall Study|Adverse Event|3|||
146352427|NCT05113953|527795202|FG000|Overall Study|Lost to Follow-up|3|||
146352428|NCT05113953|527795203|FG001|Overall Study|Lost to Follow-up|4|||
146352429|NCT05113953|527795204|FG002|Overall Study|Lost to Follow-up|2|||
146352430|NCT05113953|527795202|FG000|Overall Study|Non-compliance with Study Drug|1|||
146352431|NCT05113953|527795203|FG001|Overall Study|Non-compliance with Study Drug|0|||
146352432|NCT05113953|527795204|FG002|Overall Study|Non-compliance with Study Drug|0|||
146352433|NCT05113953|527795202|FG000|Overall Study|Withdrawal by Subject|2|||
146352434|NCT05113953|527795203|FG001|Overall Study|Withdrawal by Subject|6|||
146352435|NCT05113953|527795204|FG002|Overall Study|Withdrawal by Subject|4|||
146352436|NCT05113953|527795202|FG000|Overall Study|Reason not Specified|2|||
146352437|NCT05113953|527795203|FG001|Overall Study|Reason not Specified|0|||
146352438|NCT05113953|527795204|FG002|Overall Study|Reason not Specified|0|||
146352439|NCT00502307|527795205|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
146352440|NCT00502307|527795206|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
146352441|NCT00502307|527795207|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
146352442|NCT00502307|527795205|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
146352443|NCT00502307|527795206|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
146352444|NCT00502307|527795207|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
146352445|NCT00502307|527795205|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
146352446|NCT00502307|527795206|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
146352447|NCT00502307|527795207|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
146352448|NCT00502307|527795205|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
146352449|NCT00502307|527795206|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
146352450|NCT00502307|527795207|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
146169535|NCT00441701|527132836|FG005|Overall Study|Adverse Event|2|||
146169536|NCT00441701|527132837|FG006|Overall Study|Adverse Event|0|||
146169537|NCT00441701|527132838|FG007|Overall Study|Adverse Event|0|||
146169538|NCT00441701|527132839|FG008|Overall Study|Adverse Event|0|||
146352451|NCT00502307|527795205|FG000|Maintenance Period|Progressive disease|80|||
146352452|NCT00502307|527795206|FG001|Maintenance Period|Progressive disease|0|||
146352453|NCT00502307|527795207|FG002|Maintenance Period|Progressive disease|0|||
146352454|NCT00502307|527795205|FG000|Maintenance Period|Discontinued due to other reasons|68|||
146352455|NCT00502307|527795206|FG001|Maintenance Period|Discontinued due to other reasons|0|||
146352456|NCT00502307|527795207|FG002|Maintenance Period|Discontinued due to other reasons|0|||
146352457|NCT00748553|527795208|FG000|Overall Study|Adverse Event|0|||
146352458|NCT00748553|527795209|FG001|Overall Study|Adverse Event|1|||
146352459|NCT00748553|527795208|FG000|Overall Study|disease progression|2|||
146352460|NCT00748553|527795209|FG001|Overall Study|disease progression|0|||
146352461|NCT00748553|527795208|FG000|Overall Study|noncompliance|1|||
146352462|NCT00748553|527795209|FG001|Overall Study|noncompliance|0|||
146169539|NCT00441701|527132840|FG009|Overall Study|Adverse Event|0|||
146169540|NCT00441701|527132831|FG000|Overall Study|Lack of Efficacy|2|||
146169541|NCT00441701|527132832|FG001|Overall Study|Lack of Efficacy|0|||
146169542|NCT00441701|527132833|FG002|Overall Study|Lack of Efficacy|2|||
146352463|NCT01998581|527795213|FG000|Overall Study|Refused repeat treatment|20|||
146352464|NCT01998581|527795214|FG001|Overall Study|Refused repeat treatment|4|||
146352465|NCT01998581|527795213|FG000|Overall Study|Protocol Violation|1|||
146352466|NCT01998581|527795214|FG001|Overall Study|Protocol Violation|0|||
146352467|NCT01998581|527795213|FG000|Overall Study|Withdrawal by Subject|8|||
146352468|NCT01998581|527795214|FG001|Overall Study|Withdrawal by Subject|1|||
146352469|NCT01998581|527795213|FG000|Overall Study|Lost to Follow-up|12|||
146352470|NCT01998581|527795214|FG001|Overall Study|Lost to Follow-up|4|||
146352471|NCT01998581|527795213|FG000|Overall Study|Adverse Event|1|||
146352472|NCT01998581|527795214|FG001|Overall Study|Adverse Event|1|||
146352473|NCT01998581|527795213|FG000|Overall Study|Other reasons|3|||
146352474|NCT01998581|527795214|FG001|Overall Study|Other reasons|2|||
146352475|NCT01998581|527795213|FG000|Overall Study|Randomized but withdrew before treatment|1|||
146352476|NCT01998581|527795214|FG001|Overall Study|Randomized but withdrew before treatment|0|||
146352477|NCT01251276|527795215|FG000|Overall Study|Protocol Violation|1|||
146352478|NCT01251276|527795216|FG001|Overall Study|Protocol Violation|0|||
146352479|NCT01251276|527795215|FG000|Overall Study|Lost to Follow-up|0|||
146352480|NCT01251276|527795216|FG001|Overall Study|Lost to Follow-up|1|||
146352481|NCT02245568|527795220|FG000|Overall Study|Study terminated by Sponsor|346|||
146352482|NCT02245568|527795220|FG000|Overall Study|Adverse Event|144|||
146352483|NCT02245568|527795220|FG000|Overall Study|Lack of Efficacy|98|||
146352484|NCT02245568|527795220|FG000|Overall Study|Withdrawal by Caregiver|85|||
146352485|NCT02245568|527795220|FG000|Overall Study|Withdrawal by Subject|77|||
146352486|NCT02245568|527795220|FG000|Overall Study|Withdrawal by Legal Representative|31|||
146352487|NCT02245568|527795220|FG000|Overall Study|Missing (Site closure)|16|||
146352488|NCT02245568|527795220|FG000|Overall Study|Physician Decision|14|||
146352489|NCT02245568|527795220|FG000|Overall Study|Non-compliance with study drug|11|||
146352490|NCT02245568|527795220|FG000|Overall Study|Death|9|||
146352491|NCT02245568|527795220|FG000|Overall Study|Blue staining|6|||
146352492|NCT02245568|527795220|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
146352493|NCT02245568|527795220|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
146352494|NCT02245568|527795220|FG000|Overall Study|Lost to Follow-up|5|||
146352495|NCT04346628|527795228|FG000|Overall Study|Lost to Follow-up|4|||
146352496|NCT04346628|527795229|FG001|Overall Study|Lost to Follow-up|4|||
146352497|NCT04346628|527795228|FG000|Overall Study|Withdrew (had personal reasons)|2|||
146352498|NCT04346628|527795229|FG001|Overall Study|Withdrew (had personal reasons)|5|||
146352499|NCT04346628|527795228|FG000|Overall Study|Withdrew (medication intolerant)|0|||
146352500|NCT04346628|527795229|FG001|Overall Study|Withdrew (medication intolerant)|3|||
146352501|NCT04346628|527795228|FG000|Overall Study|Withdrew (declined intervention)|0|||
146352502|NCT04346628|527795229|FG001|Overall Study|Withdrew (declined intervention)|1|||
146352503|NCT01763905|527795230|FG000|Overall Study|Withdrawal by Subject|1|||
146352504|NCT01763905|527795231|FG001|Overall Study|Withdrawal by Subject|1|||
146352505|NCT01763905|527795232|FG002|Overall Study|Withdrawal by Subject|0|||
146352506|NCT01763905|527795233|FG003|Overall Study|Withdrawal by Subject|1|||
146352507|NCT01763905|527795230|FG000|Overall Study|Decision by sponsor|5|||
146352508|NCT01763905|527795231|FG001|Overall Study|Decision by sponsor|0|||
146352509|NCT01763905|527795232|FG002|Overall Study|Decision by sponsor|8|||
146352510|NCT01763905|527795233|FG003|Overall Study|Decision by sponsor|0|||
146352511|NCT01763905|527795230|FG000|Overall Study|Lost to Follow-up|0|||
146352512|NCT01763905|527795231|FG001|Overall Study|Lost to Follow-up|0|||
146352513|NCT01763905|527795232|FG002|Overall Study|Lost to Follow-up|1|||
146352514|NCT01763905|527795233|FG003|Overall Study|Lost to Follow-up|0|||
146352515|NCT03165721|527795243|FG000|Overall Study|Refused further treatment|3|||
146352516|NCT03165721|527795244|FG001|Overall Study|Refused further treatment|0|||
146352517|NCT03165721|527795245|FG002|Overall Study|Refused further treatment|0|||
146352518|NCT03165721|527795243|FG000|Overall Study|Physician Decision|1|||
146352519|NCT03165721|527795244|FG001|Overall Study|Physician Decision|0|||
146352520|NCT03165721|527795245|FG002|Overall Study|Physician Decision|0|||
146169543|NCT00441701|527132834|FG003|Overall Study|Lack of Efficacy|2|||
146169544|NCT00441701|527132835|FG004|Overall Study|Lack of Efficacy|0|||
146352521|NCT01863849|527795246|FG000|Overall Study|Lost to Follow-up|1|||
146352522|NCT01863849|527795247|FG001|Overall Study|Lost to Follow-up|0|||
146169545|NCT00441701|527132836|FG005|Overall Study|Lack of Efficacy|1|||
146169546|NCT00441701|527132837|FG006|Overall Study|Lack of Efficacy|0|||
146352523|NCT01457118|527795248|FG000|Overall Study|Adverse Event|1|||
146352524|NCT01457118|527795249|FG001|Overall Study|Adverse Event|0|||
146352525|NCT01457118|527795250|FG002|Overall Study|Adverse Event|0|||
146352526|NCT01457118|527795251|FG003|Overall Study|Adverse Event|1|||
146352527|NCT01457118|527795248|FG000|Overall Study|Clinical Progression|0|||
146352528|NCT01457118|527795249|FG001|Overall Study|Clinical Progression|1|||
146352529|NCT01457118|527795250|FG002|Overall Study|Clinical Progression|0|||
146352530|NCT01457118|527795251|FG003|Overall Study|Clinical Progression|1|||
146352531|NCT01457118|527795248|FG000|Overall Study|Physician Decision|2|||
146352532|NCT01457118|527795249|FG001|Overall Study|Physician Decision|0|||
146352533|NCT01457118|527795250|FG002|Overall Study|Physician Decision|0|||
146352534|NCT01457118|527795251|FG003|Overall Study|Physician Decision|0|||
146352535|NCT01457118|527795248|FG000|Overall Study|Progressive Disease by RECIST|12|||
146352536|NCT01457118|527795249|FG001|Overall Study|Progressive Disease by RECIST|3|||
146352537|NCT01457118|527795250|FG002|Overall Study|Progressive Disease by RECIST|1|||
146352538|NCT01457118|527795251|FG003|Overall Study|Progressive Disease by RECIST|0|||
146352539|NCT01457118|527795248|FG000|Overall Study|Withdrawal by Subject|5|||
146352540|NCT01457118|527795249|FG001|Overall Study|Withdrawal by Subject|0|||
146352541|NCT01457118|527795250|FG002|Overall Study|Withdrawal by Subject|0|||
146352542|NCT01457118|527795251|FG003|Overall Study|Withdrawal by Subject|0|||
146169547|NCT00441701|527132838|FG007|Overall Study|Lack of Efficacy|0|||
146169548|NCT00441701|527132839|FG008|Overall Study|Lack of Efficacy|0|||
146169549|NCT00441701|527132840|FG009|Overall Study|Lack of Efficacy|0|||
146169550|NCT00441701|527132831|FG000|Overall Study|Withdrawal by Subject|0|||
146169551|NCT00441701|527132832|FG001|Overall Study|Withdrawal by Subject|2|||
146169552|NCT00441701|527132833|FG002|Overall Study|Withdrawal by Subject|1|||
146169553|NCT00441701|527132834|FG003|Overall Study|Withdrawal by Subject|1|||
146169554|NCT00441701|527132835|FG004|Overall Study|Withdrawal by Subject|0|||
146169555|NCT00441701|527132836|FG005|Overall Study|Withdrawal by Subject|0|||
146169556|NCT00441701|527132837|FG006|Overall Study|Withdrawal by Subject|0|||
146169557|NCT00441701|527132838|FG007|Overall Study|Withdrawal by Subject|0|||
146169558|NCT00441701|527132839|FG008|Overall Study|Withdrawal by Subject|0|||
146169559|NCT00441701|527132840|FG009|Overall Study|Withdrawal by Subject|0|||
146169560|NCT00621543|527132844|FG000|Overall Study|Lost to Follow-up|23|||
146169561|NCT01287611|527132849|FG000|Overall Study|Lost to Follow-up|29|||
146169562|NCT01287611|527132850|FG001|Overall Study|Lost to Follow-up|16|||
146169563|NCT01287611|527132849|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
146169564|NCT01287611|527132850|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
146169565|NCT00763958|527132851|FG000|Overall Study|did not meet final criteria|4|||
146169566|NCT00763958|527132852|FG001|Overall Study|did not meet final criteria|4|||
146169567|NCT00763958|527132851|FG000|Overall Study|Lost to Follow-up|10|||
146169568|NCT00763958|527132852|FG001|Overall Study|Lost to Follow-up|2|||
146169569|NCT00763958|527132851|FG000|Overall Study|Believed they were receiving placebo|0|||
146169570|NCT00763958|527132852|FG001|Overall Study|Believed they were receiving placebo|5|||
146169571|NCT02192970|527132853|FG000|Overall Study|Lost to Follow-up|6|||
146169572|NCT02192970|527132854|FG001|Overall Study|Lost to Follow-up|0|||
146169573|NCT03299686|527132856|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
146169574|NCT03299686|527132857|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
146169575|NCT03299686|527132856|FG000|Treatment Epoch|Physician Decision|1|||
146169576|NCT03299686|527132857|FG001|Treatment Epoch|Physician Decision|0|||
146169577|NCT03299686|527132856|FG000|Treatment Epoch|Adverse Event|8|||
146169578|NCT03299686|527132857|FG001|Treatment Epoch|Adverse Event|4|||
146352543|NCT02324842|527795252|FG000|Overall Study|Lost to Follow-up|1|||
146352544|NCT02324842|527795253|FG001|Overall Study|Lost to Follow-up|1|||
146352545|NCT02324842|527795254|FG002|Overall Study|Lost to Follow-up|2|||
146352546|NCT02750800|527795258|FG000|Overall Study|Adverse Event|18|||
146352547|NCT02750800|527795258|FG000|Overall Study|Lost to Follow-up|12|||
146352548|NCT02750800|527795258|FG000|Overall Study|Investigator decision|53|||
146352549|NCT02750800|527795258|FG000|Overall Study|Patient request|12|||
146352550|NCT02750800|527795258|FG000|Overall Study|Other, not specified|3|||
146352551|NCT03456713|527795261|FG000|Overall Study|Lost to Follow-up|1|||
146352552|NCT03456713|527795262|FG001|Overall Study|Lost to Follow-up|0|||
146352553|NCT03456713|527795263|FG002|Overall Study|Lost to Follow-up|0|||
146352554|NCT03456713|527795264|FG003|Overall Study|Lost to Follow-up|0|||
146352555|NCT01202227|527795270|FG000|Overall Study|Adverse Event|16|||
146352556|NCT01202227|527795270|FG000|Overall Study|Withdrawal by Subject|2|||
146352557|NCT01202227|527795270|FG000|Overall Study|Lack of Efficacy|1|||
146352558|NCT00643487|527795271|FG000|Overall Study|Technical difficulty|3|||
146352559|NCT06150573|527795272|FG000|Overall Study|Did not meet study criteria|1|||
146352560|NCT06150573|527795273|FG001|Overall Study|Did not meet study criteria|0|||
146352561|NCT06150573|527795272|FG000|Overall Study|Adverse Event|1|||
146352562|NCT06150573|527795273|FG001|Overall Study|Adverse Event|0|||
146352563|NCT06150573|527795272|FG000|Overall Study|Lost to Follow-up|0|||
146352564|NCT06150573|527795273|FG001|Overall Study|Lost to Follow-up|1|||
146169579|NCT03299686|527132856|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
146169580|NCT03299686|527132857|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
146169581|NCT02709005|527132858|FG000|Overall Study|Lost to Follow-up|1|||
146352565|NCT06150573|527795272|FG000|Overall Study|Protocol Violation|0|||
146352566|NCT06150573|527795273|FG001|Overall Study|Protocol Violation|1|||
146352567|NCT06150573|527795272|FG000|Overall Study|Withdrawal by Subject|2|||
146352568|NCT06150573|527795273|FG001|Overall Study|Withdrawal by Subject|0|||
146352569|NCT02284906|527795274|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146352570|NCT02284906|527795275|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
146169582|NCT02709005|527132859|FG001|Overall Study|Lost to Follow-up|1|||
146169583|NCT02709005|527132858|FG000|Overall Study|Withdrawal by Subject|3|||
146352571|NCT02284906|527795276|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146352572|NCT02284906|527795274|FG000|Overall Study|Major Protocol Deviation|0|||
146352573|NCT02284906|527795275|FG001|Overall Study|Major Protocol Deviation|1|||
146352574|NCT02284906|527795276|FG002|Overall Study|Major Protocol Deviation|0|||
146352575|NCT02284906|527795274|FG000|Overall Study|Voluntary Withdrawal|2|||
146352576|NCT02284906|527795275|FG001|Overall Study|Voluntary Withdrawal|4|||
146352577|NCT02284906|527795276|FG002|Overall Study|Voluntary Withdrawal|5|||
146352578|NCT02284906|527795274|FG000|Overall Study|Study Termination|0|||
146352579|NCT02284906|527795275|FG001|Overall Study|Study Termination|11|||
146352580|NCT02284906|527795276|FG002|Overall Study|Study Termination|14|||
146352581|NCT02284906|527795274|FG000|Overall Study|Reason not Specified|1|||
146352582|NCT02284906|527795275|FG001|Overall Study|Reason not Specified|1|||
146352583|NCT02284906|527795276|FG002|Overall Study|Reason not Specified|0|||
146352584|NCT01753076|527795277|FG000|Overall Study|Adverse Event|17|||
146352585|NCT01753076|527795278|FG001|Overall Study|Adverse Event|18|||
146352586|NCT01753076|527795277|FG000|Overall Study|Lack of Efficacy|3|||
146352587|NCT01753076|527795278|FG001|Overall Study|Lack of Efficacy|1|||
146352588|NCT01753076|527795277|FG000|Overall Study|Lost to Follow-up|2|||
146352589|NCT01753076|527795278|FG001|Overall Study|Lost to Follow-up|1|||
146352590|NCT01753076|527795277|FG000|Overall Study|Physician Decision|4|||
146352591|NCT01753076|527795278|FG001|Overall Study|Physician Decision|2|||
146352592|NCT01753076|527795277|FG000|Overall Study|Withdrawal by Subject|14|||
146352593|NCT01753076|527795278|FG001|Overall Study|Withdrawal by Subject|24|||
146352594|NCT01753076|527795277|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
146352595|NCT01753076|527795278|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
146352596|NCT02575079|527795279|FG000|Overall Study|Death|3|||
146352597|NCT02575079|527795280|FG001|Overall Study|Death|0|||
146352598|NCT02575079|527795279|FG000|Overall Study|Withdrawal by Subject|3|||
146352599|NCT02575079|527795280|FG001|Overall Study|Withdrawal by Subject|0|||
146352600|NCT03259334|527795281|FG000|Overall Study|Adverse Event|3|||
146352601|NCT03259334|527795282|FG001|Overall Study|Adverse Event|8|||
146352602|NCT03259334|527795283|FG002|Overall Study|Adverse Event|5|||
146352603|NCT03259334|527795281|FG000|Overall Study|Withdrawal by Subject|4|||
146352604|NCT03259334|527795282|FG001|Overall Study|Withdrawal by Subject|2|||
146352605|NCT03259334|527795283|FG002|Overall Study|Withdrawal by Subject|4|||
146352606|NCT03259334|527795281|FG000|Overall Study|Physician Decision|1|||
146352607|NCT03259334|527795282|FG001|Overall Study|Physician Decision|0|||
146352608|NCT03259334|527795283|FG002|Overall Study|Physician Decision|0|||
146352609|NCT03259334|527795281|FG000|Overall Study|Lost to Follow-up|0|||
146352610|NCT03259334|527795282|FG001|Overall Study|Lost to Follow-up|2|||
146352611|NCT03259334|527795283|FG002|Overall Study|Lost to Follow-up|1|||
146352612|NCT03259334|527795281|FG000|Overall Study|Protocol Deviation|0|||
146352613|NCT03259334|527795282|FG001|Overall Study|Protocol Deviation|3|||
146352614|NCT03259334|527795283|FG002|Overall Study|Protocol Deviation|2|||
146352615|NCT03259334|527795281|FG000|Overall Study|Lack of Efficacy|2|||
146352616|NCT03259334|527795282|FG001|Overall Study|Lack of Efficacy|0|||
146352617|NCT03259334|527795283|FG002|Overall Study|Lack of Efficacy|1|||
146352618|NCT03259334|527795281|FG000|Overall Study|Randomized but never treated|0|||
146352619|NCT03259334|527795282|FG001|Overall Study|Randomized but never treated|2|||
146352620|NCT03259334|527795283|FG002|Overall Study|Randomized but never treated|0|||
146352621|NCT01187901|527795286|FG000|Overall Study|Protocol Violation|1|||
146352622|NCT01187901|527795287|FG001|Overall Study|Protocol Violation|0|||
146352623|NCT01187901|527795286|FG000|Overall Study|Lost to Follow-up|1|||
146352624|NCT01187901|527795287|FG001|Overall Study|Lost to Follow-up|2|||
146352625|NCT01187901|527795286|FG000|Overall Study|Unrelated Health Reasons|1|||
146352626|NCT01187901|527795287|FG001|Overall Study|Unrelated Health Reasons|2|||
146352627|NCT01187901|527795286|FG000|Overall Study|Suspected Allergic Reaction|1|||
146352628|NCT01187901|527795287|FG001|Overall Study|Suspected Allergic Reaction|1|||
146352629|NCT01187901|527795286|FG000|Overall Study|Adverse Event|3|||
146352630|NCT01187901|527795287|FG001|Overall Study|Adverse Event|0|||
146169584|NCT02709005|527132859|FG001|Overall Study|Withdrawal by Subject|0|||
146169585|NCT00499863|527132865|FG000|Overall Study|Lack of Efficacy|21|||
146169586|NCT00499863|527132866|FG001|Overall Study|Lack of Efficacy|27|||
146352631|NCT01187901|527795286|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
146352632|NCT01187901|527795287|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
146352633|NCT01187901|527795286|FG000|Overall Study|Pregnancy|0|||
146352634|NCT01187901|527795287|FG001|Overall Study|Pregnancy|2|||
146352635|NCT04160468|527795288|FG000|Overall Study|Lost to Follow-up|19|||
146352636|NCT04160468|527795289|FG001|Overall Study|Lost to Follow-up|4|||
146352637|NCT04160468|527795288|FG000|Overall Study|Randomized but not dosed|6|||
146352638|NCT04160468|527795289|FG001|Overall Study|Randomized but not dosed|0|||
146352639|NCT04160468|527795288|FG000|Overall Study|Withdrawal by Subject|4|||
146352640|NCT04160468|527795289|FG001|Overall Study|Withdrawal by Subject|1|||
146352641|NCT04160468|527795288|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
146352642|NCT04160468|527795289|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
146352643|NCT04160468|527795288|FG000|Overall Study|Participant incarcerated|1|||
146352644|NCT04160468|527795289|FG001|Overall Study|Participant incarcerated|0|||
146352645|NCT01402284|527795290|FG000|Overall Study|Withdrawal consent|2|||
146352646|NCT01402284|527795290|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
146352647|NCT01402284|527795290|FG000|Overall Study|Physician Decision|1|||
146352648|NCT01402284|527795290|FG000|Overall Study|Disease progression on study|10|||
146352649|NCT00540436|527795291|FG000|First 12-Week Treatment Period|Adverse Event|1|||
146352650|NCT00540436|527795291|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
146352651|NCT00540436|527795291|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
146352652|NCT00540436|527795291|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
146352653|NCT00905021|527795296|FG000|Overall Study|Adverse Event|2|||
146352654|NCT05183867|527796644|FG000|Overall Study|Withdrawal by Subject|3|||
146352655|NCT05183867|527796645|FG001|Overall Study|Withdrawal by Subject|2|||
146352656|NCT05183867|527796646|FG002|Overall Study|Withdrawal by Subject|0|||
146352657|NCT00492856|527796647|FG000|Induction|Adverse Event|2|||
146352658|NCT00492856|527796648|FG001|Induction|Adverse Event|0|||
146352659|NCT00492856|527796649|FG002|Induction|Adverse Event|0|||
146352660|NCT00492856|527796650|FG003|Induction|Adverse Event|0|||
146352661|NCT00492856|527796647|FG000|Induction|Withdrawal by Subject|1|||
146352662|NCT00492856|527796648|FG001|Induction|Withdrawal by Subject|0|||
146352663|NCT00492856|527796649|FG002|Induction|Withdrawal by Subject|0|||
146352664|NCT00492856|527796650|FG003|Induction|Withdrawal by Subject|0|||
146352665|NCT00492856|527796647|FG000|Induction|Death|3|||
146352666|NCT00492856|527796648|FG001|Induction|Death|0|||
146352667|NCT00492856|527796649|FG002|Induction|Death|0|||
146352668|NCT00492856|527796650|FG003|Induction|Death|0|||
146352669|NCT00492856|527796647|FG000|Consolidation|Adverse Event|6|||
146352670|NCT00492856|527796648|FG001|Consolidation|Adverse Event|0|||
146352671|NCT00492856|527796649|FG002|Consolidation|Adverse Event|0|||
146352672|NCT00492856|527796650|FG003|Consolidation|Adverse Event|0|||
146352673|NCT00492856|527796647|FG000|Consolidation|Not protocol specified|2|||
146352674|NCT00492856|527796648|FG001|Consolidation|Not protocol specified|0|||
146352675|NCT00492856|527796649|FG002|Consolidation|Not protocol specified|0|||
146352676|NCT00492856|527796650|FG003|Consolidation|Not protocol specified|0|||
146352677|NCT00492856|527796647|FG000|Consolidation|Lost to Follow-up|1|||
146352678|NCT00492856|527796648|FG001|Consolidation|Lost to Follow-up|0|||
146352679|NCT00492856|527796649|FG002|Consolidation|Lost to Follow-up|0|||
146352680|NCT00492856|527796650|FG003|Consolidation|Lost to Follow-up|0|||
146352681|NCT00492856|527796647|FG000|Post-consolidation|Adverse Event|0|||
146352682|NCT00492856|527796648|FG001|Post-consolidation|Adverse Event|4|||
146352683|NCT00492856|527796649|FG002|Post-consolidation|Adverse Event|0|||
146352684|NCT00492856|527796650|FG003|Post-consolidation|Adverse Event|1|||
146352685|NCT00492856|527796647|FG000|Post-consolidation|Withdrawal by Subject|0|||
146352686|NCT00492856|527796648|FG001|Post-consolidation|Withdrawal by Subject|4|||
146352687|NCT00492856|527796649|FG002|Post-consolidation|Withdrawal by Subject|0|||
146352688|NCT00492856|527796650|FG003|Post-consolidation|Withdrawal by Subject|0|||
146352689|NCT00492856|527796647|FG000|Post-consolidation|Death|0|||
146352690|NCT00492856|527796648|FG001|Post-consolidation|Death|1|||
146352691|NCT00492856|527796649|FG002|Post-consolidation|Death|0|||
146352692|NCT00492856|527796650|FG003|Post-consolidation|Death|0|||
146352693|NCT00492856|527796647|FG000|Post-consolidation|Not protocol specified|0|||
146352694|NCT00492856|527796648|FG001|Post-consolidation|Not protocol specified|1|||
146352695|NCT00492856|527796649|FG002|Post-consolidation|Not protocol specified|0|||
146352696|NCT00492856|527796650|FG003|Post-consolidation|Not protocol specified|0|||
146352697|NCT00492856|527796647|FG000|Post-consolidation|Lost to Follow-up|0|||
146352698|NCT00492856|527796648|FG001|Post-consolidation|Lost to Follow-up|2|||
146352699|NCT00492856|527796649|FG002|Post-consolidation|Lost to Follow-up|0|||
146352700|NCT00492856|527796650|FG003|Post-consolidation|Lost to Follow-up|0|||
146352701|NCT00492856|527796647|FG000|Post-consolidation|Observation Arm|0|||
146352702|NCT00492856|527796648|FG001|Post-consolidation|Observation Arm|0|||
146352703|NCT00492856|527796649|FG002|Post-consolidation|Observation Arm|27|||
146352704|NCT00492856|527796650|FG003|Post-consolidation|Observation Arm|0|||
146352705|NCT02326467|527796655|FG000|Overall Study|Withdrawal by Subject|1|||
146352706|NCT00441441|527796656|FG000|Overall Study|Adverse Event|2|||
146352707|NCT00441441|527796657|FG001|Overall Study|Adverse Event|1|||
146169587|NCT00499863|527132865|FG000|Overall Study|Protocol Violation|12|||
146169588|NCT00499863|527132866|FG001|Overall Study|Protocol Violation|7|||
146169589|NCT00499863|527132865|FG000|Overall Study|Withdrawal by Subject|6|||
146352708|NCT00441441|527796656|FG000|Overall Study|Protocol Violation|4|||
146352709|NCT00441441|527796657|FG001|Overall Study|Protocol Violation|6|||
146352710|NCT00441441|527796656|FG000|Overall Study|Exacerbation of asthma|1|||
146352711|NCT00441441|527796657|FG001|Overall Study|Exacerbation of asthma|2|||
146352712|NCT00441441|527796656|FG000|Overall Study|Withdrawal by Subject|1|||
146352713|NCT00441441|527796657|FG001|Overall Study|Withdrawal by Subject|2|||
146352714|NCT00441441|527796656|FG000|Overall Study|Other|3|||
146352715|NCT00441441|527796657|FG001|Overall Study|Other|3|||
146352716|NCT01051986|527796658|FG000|Overall Study|Death|1|||
146352717|NCT01051986|527796659|FG001|Overall Study|Death|0|||
146352718|NCT01051986|527796658|FG000|Overall Study|Withdrawal by Subject|2|||
146352719|NCT01051986|527796659|FG001|Overall Study|Withdrawal by Subject|1|||
146352720|NCT01051986|527796658|FG000|Overall Study|Protocol Violation|2|||
146352721|NCT01051986|527796659|FG001|Overall Study|Protocol Violation|3|||
146352722|NCT01725152|527796661|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
146352723|NCT01725152|527796662|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
146352724|NCT01725152|527796661|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
146352725|NCT01725152|527796662|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
146352726|NCT01725152|527796661|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
146352727|NCT01725152|527796662|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
146352728|NCT01725152|527796661|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
146352729|NCT01725152|527796662|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
146352730|NCT02044159|527796663|FG000|Overall Study|Consent declined (deferred consent)|2|||
146352731|NCT02044159|527796664|FG001|Overall Study|Consent declined (deferred consent)|4|||
146352732|NCT02044159|527796663|FG000|Overall Study|No longer eligible, drug not given|1|||
146352733|NCT02044159|527796664|FG001|Overall Study|No longer eligible, drug not given|0|||
146352734|NCT02044159|527796663|FG000|Overall Study|Nurse declined to give study drug|1|||
146352735|NCT02044159|527796664|FG001|Overall Study|Nurse declined to give study drug|0|||
146352736|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
146352737|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146352738|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146352739|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146352740|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
146352741|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
146352742|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146352743|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146352744|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146352745|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
146352746|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
146352747|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146352748|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146352749|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146352750|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
146352751|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
146352752|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146352753|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146352754|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146352755|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
146352756|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
146352757|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146352758|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146352759|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146352760|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
146352761|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
146352762|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146352763|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146352764|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146352765|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
146352766|NCT01111539|527796665|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
146352767|NCT01111539|527796666|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146352768|NCT01111539|527796667|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146352769|NCT01111539|527796668|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146352770|NCT01111539|527796669|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
146352771|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146352772|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146352773|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
146352774|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
146352775|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
146352776|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146352777|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146352778|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
146352779|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
146352780|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
146352781|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
146352782|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
146352783|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
146352784|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146352785|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
146352786|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146352787|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146352788|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146352789|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
146352790|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
146352791|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146352792|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146352793|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146352794|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
146352795|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
146352796|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146352797|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146352798|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146352799|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
146352800|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
146352801|NCT01111539|527796665|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146352802|NCT01111539|527796666|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146352803|NCT01111539|527796667|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146352804|NCT01111539|527796668|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
146352805|NCT01111539|527796669|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
146352806|NCT03628417|527796670|FG000|Overall Study|Death|1|||
146352807|NCT03628417|527796671|FG001|Overall Study|Death|1|||
146352808|NCT05619172|527796675|FG000|Safety Cohort 1|Death|7|||
146352809|NCT05619172|527796676|FG001|Safety Cohort 1|Death|0|||
146352810|NCT05619172|527796675|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
146352811|NCT05619172|527796676|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
146352812|NCT05619172|527796675|FG000|Safety Cohort 2|Death|0|||
146352813|NCT05619172|527796676|FG001|Safety Cohort 2|Death|1|||
146352814|NCT05619172|527796675|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
146352815|NCT05619172|527796676|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
146352816|NCT00450372|527796678|FG000|Overall Study|Physician Decision|1|||
146352817|NCT00769704|527796679|FG000|Overall Study|Lost to Follow-up|3|||
146352818|NCT00769704|527796680|FG001|Overall Study|Lost to Follow-up|2|||
146352819|NCT00769704|527796679|FG000|Overall Study|Death|95|||
146352820|NCT00769704|527796680|FG001|Overall Study|Death|190|||
146352821|NCT00769704|527796679|FG000|Overall Study|Withdrawal by Subject|12|||
146352822|NCT00769704|527796680|FG001|Overall Study|Withdrawal by Subject|5|||
146352823|NCT00769704|527796679|FG000|Overall Study|Other|1|||
146352824|NCT00769704|527796680|FG001|Overall Study|Other|2|||
146352825|NCT05131451|527796681|FG000|Overall Study|Protocol Violation|1|||
146352826|NCT05131451|527796682|FG001|Overall Study|Protocol Violation|0|||
146352827|NCT01856595|527796688|FG000|Overall Study|Withdrawal by Subject|0|||
146352828|NCT01856595|527796689|FG001|Overall Study|Withdrawal by Subject|1|||
146352829|NCT01856595|527796690|FG002|Overall Study|Withdrawal by Subject|0|||
146352830|NCT01856595|527796691|FG003|Overall Study|Withdrawal by Subject|0|||
146352831|NCT01856595|527796692|FG004|Overall Study|Withdrawal by Subject|0|||
146352832|NCT01856595|527796693|FG005|Overall Study|Withdrawal by Subject|0|||
146352833|NCT01856595|527796694|FG006|Overall Study|Withdrawal by Subject|1|||
146352834|NCT01856595|527796695|FG007|Overall Study|Withdrawal by Subject|0|||
146352835|NCT01856595|527796696|FG008|Overall Study|Withdrawal by Subject|0|||
146352836|NCT01087528|527796701|FG000|Overall Study|Withdrawal by Subject|1|||
146352837|NCT01087528|527796701|FG000|Overall Study|Incomplete CE procedure|6|||
146352838|NCT05692154|527796704|FG000|Overall Study|Adverse Event|0|||
146352839|NCT05692154|527796705|FG001|Overall Study|Adverse Event|1|||
146352840|NCT03609359|527796708|FG000|Overall Study|Progression of primary disease (PD)|25|||
146352841|NCT03609359|527796708|FG000|Overall Study|Patient's refusal|1|||
146352842|NCT03609359|527796708|FG000|Overall Study|Physician Decision|1|||
146352843|NCT03609359|527796708|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
146352844|NCT01912729|527796710|FG000|Overall Study|Withdrawal by Subject|0|||
146352845|NCT01912729|527796711|FG001|Overall Study|Withdrawal by Subject|1|||
146352846|NCT04285346|527796719|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
146352847|NCT04285346|527796720|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
146352848|NCT04285346|527796719|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
146352849|NCT04285346|527796720|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
146352850|NCT04285346|527796719|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
146352851|NCT04285346|527796720|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
146352852|NCT01975272|527796721|FG000|Overall Study|Excluded after protocol amendment|1|||
146352853|NCT01975272|527796722|FG001|Overall Study|Excluded after protocol amendment|1|||
146352854|NCT01975272|527796723|FG002|Overall Study|Excluded after protocol amendment|2|||
146352855|NCT00850460|527796725|FG000|Overall Study|Lost to Follow-up|4|||
146352856|NCT00850460|527796726|FG001|Overall Study|Lost to Follow-up|4|||
146352857|NCT05372575|527796729|FG000|Overall Study|Protocol Violation|7|||
146352858|NCT05372575|527796730|FG001|Overall Study|Protocol Violation|16|||
146352859|NCT03196297|527796731|FG000|Main Period|Withdrawal by Subject|4|||
146352860|NCT03196297|527796731|FG000|Extension Period|Withdrawal by Subject|1|||
146352861|NCT03196297|527796731|FG000|Extension Period|Lack of Efficacy|2|||
146352862|NCT03510663|527796732|FG000|Overall Study|Withdrawal by Subject|0|||
146352863|NCT03510663|527796733|FG001|Overall Study|Withdrawal by Subject|1|||
146352864|NCT03510663|527796734|FG002|Overall Study|Withdrawal by Subject|0|||
146352865|NCT03510663|527796735|FG003|Overall Study|Withdrawal by Subject|0|||
146352866|NCT03510663|527796736|FG004|Overall Study|Withdrawal by Subject|0|||
146352867|NCT03510663|527796737|FG005|Overall Study|Withdrawal by Subject|0|||
146352868|NCT03510663|527796738|FG006|Overall Study|Withdrawal by Subject|0|||
146352869|NCT03510663|527796739|FG007|Overall Study|Withdrawal by Subject|0|||
146352870|NCT04370028|527796746|FG000|Overall Study|Withdrawal by Subject|695|||
146352871|NCT04370028|527796746|FG000|Overall Study|Protocol Violation|9|||
146352872|NCT04370028|527796746|FG000|Overall Study|Adverse Event|3|||
146352873|NCT04743635|527796749|FG000|Overall Study|Lost to Follow-up|2|||
146352874|NCT04743635|527796750|FG001|Overall Study|Lost to Follow-up|0|||
146352875|NCT01954121|527796751|FG000|Overall Study|Lack of Efficacy|94|||
146352876|NCT01954121|527796752|FG001|Overall Study|Lack of Efficacy|41|||
146352877|NCT01954121|527796751|FG000|Overall Study|Protocol Violation|0|||
146352878|NCT01954121|527796752|FG001|Overall Study|Protocol Violation|2|||
146352879|NCT01954121|527796751|FG000|Overall Study|Lost to Follow-up|5|||
146352880|NCT01954121|527796752|FG001|Overall Study|Lost to Follow-up|6|||
146352881|NCT01954121|527796751|FG000|Overall Study|Withdrawal by Subject|18|||
146352882|NCT01954121|527796752|FG001|Overall Study|Withdrawal by Subject|12|||
146352883|NCT01954121|527796751|FG000|Overall Study|Pregnancy|1|||
146352884|NCT01954121|527796752|FG001|Overall Study|Pregnancy|1|||
146352885|NCT01954121|527796751|FG000|Overall Study|AE, serious fatal|1|||
146352886|NCT01954121|527796752|FG001|Overall Study|AE, serious fatal|0|||
146352887|NCT01954121|527796751|FG000|Overall Study|AE, non-serious non-fatal|5|||
146352888|NCT01954121|527796752|FG001|Overall Study|AE, non-serious non-fatal|22|||
146352889|NCT01954121|527796751|FG000|Overall Study|SAE, non-fatal|1|||
146352890|NCT01954121|527796752|FG001|Overall Study|SAE, non-fatal|4|||
146352891|NCT01954121|527796751|FG000|Overall Study|Non-compliant with study procedures|1|||
146352892|NCT01954121|527796752|FG001|Overall Study|Non-compliant with study procedures|0|||
146352893|NCT01954121|527796751|FG000|Overall Study|Non-compliant patient|1|||
146352894|NCT01954121|527796752|FG001|Overall Study|Non-compliant patient|1|||
146352895|NCT01954121|527796751|FG000|Overall Study|Subject did not follow instructions|0|||
146352896|NCT01954121|527796752|FG001|Overall Study|Subject did not follow instructions|2|||
146352897|NCT01465178|527796755|FG000|Overall Study|Withdrawal by Subject|1|||
146352898|NCT01465178|527796756|FG001|Overall Study|Withdrawal by Subject|0|||
146352899|NCT04937816|527796763|FG000|Overall Study|Study drug stopped, reason missing|5|||
146352900|NCT04937816|527796764|FG001|Overall Study|Study drug stopped, reason missing|3|||
146352901|NCT04937816|527796765|FG002|Overall Study|Study drug stopped, reason missing|4|||
146352902|NCT04937816|527796766|FG003|Overall Study|Study drug stopped, reason missing|6|||
146352903|NCT04937816|527796767|FG004|Overall Study|Study drug stopped, reason missing|1|||
146352904|NCT04937816|527796768|FG005|Overall Study|Study drug stopped, reason missing|0|||
146352905|NCT04937816|527796769|FG006|Overall Study|Study drug stopped, reason missing|0|||
146352906|NCT04937816|527796763|FG000|Overall Study|Other than stated below|173|||
146352907|NCT04937816|527796764|FG001|Overall Study|Other than stated below|143|||
146352908|NCT04937816|527796765|FG002|Overall Study|Other than stated below|125|||
146352909|NCT04937816|527796766|FG003|Overall Study|Other than stated below|44|||
146352910|NCT04937816|527796767|FG004|Overall Study|Other than stated below|45|||
146352911|NCT04937816|527796768|FG005|Overall Study|Other than stated below|28|||
146352912|NCT04937816|527796769|FG006|Overall Study|Other than stated below|31|||
146352913|NCT04937816|527796763|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
146352914|NCT04937816|527796764|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
146352915|NCT04937816|527796765|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
146352916|NCT04937816|527796766|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
146352917|NCT04937816|527796767|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
146352918|NCT04937816|527796768|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
146352919|NCT04937816|527796769|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
146352920|NCT04937816|527796763|FG000|Overall Study|Lost to Follow-up|15|||
146352921|NCT04937816|527796764|FG001|Overall Study|Lost to Follow-up|9|||
146352922|NCT04937816|527796765|FG002|Overall Study|Lost to Follow-up|6|||
146352923|NCT04937816|527796766|FG003|Overall Study|Lost to Follow-up|6|||
146352924|NCT04937816|527796767|FG004|Overall Study|Lost to Follow-up|16|||
146352925|NCT04937816|527796768|FG005|Overall Study|Lost to Follow-up|11|||
146352926|NCT04937816|527796769|FG006|Overall Study|Lost to Follow-up|17|||
146352927|NCT04937816|527796763|FG000|Overall Study|Protocol Violation|15|||
146352928|NCT04937816|527796764|FG001|Overall Study|Protocol Violation|15|||
146352929|NCT04937816|527796765|FG002|Overall Study|Protocol Violation|12|||
146352930|NCT04937816|527796766|FG003|Overall Study|Protocol Violation|30|||
146352931|NCT04937816|527796767|FG004|Overall Study|Protocol Violation|24|||
146352932|NCT04937816|527796768|FG005|Overall Study|Protocol Violation|5|||
146352933|NCT04937816|527796769|FG006|Overall Study|Protocol Violation|5|||
146352934|NCT04937816|527796763|FG000|Overall Study|Adverse Event|303|||
146352935|NCT04937816|527796764|FG001|Overall Study|Adverse Event|267|||
146352936|NCT04937816|527796765|FG002|Overall Study|Adverse Event|273|||
146352937|NCT04937816|527796766|FG003|Overall Study|Adverse Event|553|||
146352938|NCT04937816|527796767|FG004|Overall Study|Adverse Event|575|||
146352939|NCT04937816|527796768|FG005|Overall Study|Adverse Event|343|||
146352940|NCT04937816|527796769|FG006|Overall Study|Adverse Event|337|||
146352941|NCT04937816|527796763|FG000|Overall Study|Not treated|4|||
146352942|NCT04937816|527796764|FG001|Overall Study|Not treated|2|||
146352943|NCT04937816|527796765|FG002|Overall Study|Not treated|2|||
146352944|NCT04937816|527796766|FG003|Overall Study|Not treated|2|||
146352945|NCT04937816|527796767|FG004|Overall Study|Not treated|1|||
146352946|NCT04937816|527796768|FG005|Overall Study|Not treated|4|||
146352947|NCT04937816|527796769|FG006|Overall Study|Not treated|0|||
146352948|NCT01064648|527796770|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
146352949|NCT01064648|527796771|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
146352950|NCT01064648|527796772|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
146352951|NCT01064648|527796773|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
146352952|NCT01064648|527796770|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
146352953|NCT01064648|527796771|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146352954|NCT01064648|527796772|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146352955|NCT01064648|527796773|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
146352956|NCT01064648|527796770|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146352957|NCT01064648|527796771|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
146352958|NCT01064648|527796772|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146352959|NCT01064648|527796773|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
146352960|NCT01064648|527796770|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146352961|NCT01064648|527796771|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
146352962|NCT01064648|527796772|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146352963|NCT01064648|527796773|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
146352964|NCT01064648|527796770|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
146352965|NCT01064648|527796771|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
146352966|NCT01064648|527796772|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
146352967|NCT01064648|527796773|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
146352968|NCT01064648|527796770|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146352969|NCT01064648|527796771|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
146352970|NCT01064648|527796772|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146352971|NCT01064648|527796773|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
146352972|NCT01064648|527796770|FG000|Phase II|Adverse Event|0|||
146352973|NCT01064648|527796771|FG001|Phase II|Adverse Event|0|||
146352974|NCT01064648|527796772|FG002|Phase II|Adverse Event|15|||
146352975|NCT01064648|527796773|FG003|Phase II|Adverse Event|8|||
146352976|NCT01064648|527796770|FG000|Phase II|Death|0|||
146352977|NCT01064648|527796771|FG001|Phase II|Death|0|||
146352978|NCT01064648|527796772|FG002|Phase II|Death|4|||
146352979|NCT01064648|527796773|FG003|Phase II|Death|5|||
146352980|NCT01064648|527796770|FG000|Phase II|Withdrawal by Subject|0|||
146352981|NCT01064648|527796771|FG001|Phase II|Withdrawal by Subject|0|||
146352982|NCT01064648|527796772|FG002|Phase II|Withdrawal by Subject|2|||
146352983|NCT01064648|527796773|FG003|Phase II|Withdrawal by Subject|5|||
146352984|NCT01064648|527796770|FG000|Phase II|Progression|0|||
146352985|NCT01064648|527796771|FG001|Phase II|Progression|0|||
146352986|NCT01064648|527796772|FG002|Phase II|Progression|21|||
146352987|NCT01064648|527796773|FG003|Phase II|Progression|27|||
146352988|NCT01064648|527796770|FG000|Phase II|Non-protocol specified|0|||
146352989|NCT01064648|527796771|FG001|Phase II|Non-protocol specified|0|||
146352990|NCT01064648|527796772|FG002|Phase II|Non-protocol specified|5|||
146352991|NCT01064648|527796773|FG003|Phase II|Non-protocol specified|3|||
146352992|NCT01064648|527796770|FG000|Phase II|Under Review|0|||
146352993|NCT01064648|527796771|FG001|Phase II|Under Review|0|||
146352994|NCT01064648|527796772|FG002|Phase II|Under Review|2|||
146352995|NCT01064648|527796773|FG003|Phase II|Under Review|0|||
146352996|NCT05513391|527796774|FG000|Overall Study|Adverse Event|1|||
146352997|NCT05513391|527796775|FG001|Overall Study|Adverse Event|0|||
146352998|NCT05513391|527796774|FG000|Overall Study|Protocol Deviation|0|||
146352999|NCT05513391|527796775|FG001|Overall Study|Protocol Deviation|1|||
146353000|NCT05513391|527796774|FG000|Overall Study|Withdrawal by Subject|3|||
146353001|NCT05513391|527796775|FG001|Overall Study|Withdrawal by Subject|1|||
146353002|NCT05513391|527796774|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
146353003|NCT05513391|527796775|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
146353004|NCT05513391|527796774|FG000|Overall Study|Lost to Follow-up|0|||
146353005|NCT05513391|527796775|FG001|Overall Study|Lost to Follow-up|2|||
146353006|NCT00436215|527796776|FG000|Overall Study|Refused further treatment|3|||
146353007|NCT00436215|527796776|FG000|Overall Study|Small bowel obstruction|1|||
146353008|NCT00309777|527796777|FG000|Overall Study|Adverse Event|13|||
146353009|NCT00309777|527796778|FG001|Overall Study|Adverse Event|2|||
146353010|NCT00309777|527796779|FG002|Overall Study|Adverse Event|8|||
146353011|NCT00309777|527796780|FG003|Overall Study|Adverse Event|1|||
146353012|NCT00309777|527796777|FG000|Overall Study|Protocol Violation|4|||
146353013|NCT00309777|527796778|FG001|Overall Study|Protocol Violation|1|||
146353014|NCT00309777|527796779|FG002|Overall Study|Protocol Violation|3|||
146353015|NCT00309777|527796780|FG003|Overall Study|Protocol Violation|1|||
146353016|NCT00309777|527796777|FG000|Overall Study|Withdrawal by Subject|6|||
146353017|NCT00309777|527796778|FG001|Overall Study|Withdrawal by Subject|5|||
146353018|NCT00309777|527796779|FG002|Overall Study|Withdrawal by Subject|7|||
146353019|NCT00309777|527796780|FG003|Overall Study|Withdrawal by Subject|2|||
146353020|NCT00309777|527796777|FG000|Overall Study|Lost to Follow-up|0|||
146353021|NCT00309777|527796778|FG001|Overall Study|Lost to Follow-up|0|||
146353022|NCT00309777|527796779|FG002|Overall Study|Lost to Follow-up|1|||
146353023|NCT00309777|527796780|FG003|Overall Study|Lost to Follow-up|0|||
146353024|NCT00309777|527796777|FG000|Overall Study|Death|0|||
146353025|NCT00309777|527796778|FG001|Overall Study|Death|1|||
146353026|NCT00309777|527796779|FG002|Overall Study|Death|0|||
146353027|NCT00309777|527796780|FG003|Overall Study|Death|0|||
146353028|NCT05513053|527796781|FG000|Overall Study|Lost to Follow-up|9|||
146353029|NCT05513053|527796782|FG001|Overall Study|Lost to Follow-up|11|||
146353030|NCT05513053|527796781|FG000|Overall Study|Withdrawal by parent/guardian|2|||
146353031|NCT05513053|527796782|FG001|Overall Study|Withdrawal by parent/guardian|0|||
146353032|NCT05513053|527796781|FG000|Overall Study|Withdrawal by Subject|2|||
146353033|NCT05513053|527796782|FG001|Overall Study|Withdrawal by Subject|9|||
146353034|NCT05513053|527796781|FG000|Overall Study|Protocol Violation|6|||
146353035|NCT05513053|527796782|FG001|Overall Study|Protocol Violation|3|||
146353036|NCT05513053|527796781|FG000|Overall Study|Adverse Event|0|||
146353037|NCT05513053|527796782|FG001|Overall Study|Adverse Event|2|||
146353038|NCT01520324|527798790|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
146353039|NCT01328249|527798791|FG000|Overall Study|Adverse Event|3|||
146353040|NCT01328249|527798792|FG001|Overall Study|Adverse Event|0|||
146353041|NCT01328249|527798791|FG000|Overall Study|Disease progression|1|||
146353042|NCT01328249|527798792|FG001|Overall Study|Disease progression|0|||
146353043|NCT01328249|527798791|FG000|Overall Study|Withdrawal by Subject|1|||
146353044|NCT01328249|527798792|FG001|Overall Study|Withdrawal by Subject|1|||
146353045|NCT01328249|527798791|FG000|Overall Study|Moved before end of treatment visit|1|||
146353046|NCT01328249|527798792|FG001|Overall Study|Moved before end of treatment visit|0|||
146353047|NCT01328249|527798791|FG000|Overall Study|Subject choice|1|||
146353048|NCT01328249|527798792|FG001|Overall Study|Subject choice|1|||
146353049|NCT01328249|527798791|FG000|Overall Study|Protocol Violation|0|||
146353050|NCT01328249|527798792|FG001|Overall Study|Protocol Violation|1|||
146353051|NCT00948818|527798793|FG000|Overall Study|Adverse Event|10|||
146353052|NCT00948818|527798794|FG001|Overall Study|Adverse Event|32|||
146353053|NCT00948818|527798793|FG000|Overall Study|Protocol Violation|9|||
146353054|NCT00948818|527798794|FG001|Overall Study|Protocol Violation|10|||
146353055|NCT00948818|527798793|FG000|Overall Study|Withdrawal by Subject|25|||
146353056|NCT00948818|527798794|FG001|Overall Study|Withdrawal by Subject|25|||
146353057|NCT00948818|527798793|FG000|Overall Study|Lost to Follow-up|10|||
146353058|NCT00948818|527798794|FG001|Overall Study|Lost to Follow-up|17|||
146353059|NCT00948818|527798793|FG000|Overall Study|Lack of Efficacy|4|||
146353060|NCT00948818|527798794|FG001|Overall Study|Lack of Efficacy|5|||
146353061|NCT00948818|527798793|FG000|Overall Study|Other Reason|4|||
146353062|NCT00948818|527798794|FG001|Overall Study|Other Reason|5|||
146353063|NCT02330549|527798795|FG000|Overall Study|Adverse Event|1|||
146353064|NCT02330549|527798796|FG001|Overall Study|Adverse Event|0|||
146353065|NCT02330549|527798795|FG000|Overall Study|Subject withdrew consent|2|||
146353066|NCT02330549|527798796|FG001|Overall Study|Subject withdrew consent|1|||
146353067|NCT02330549|527798795|FG000|Overall Study|Failure to meet randomization criteria|1|||
146353068|NCT02330549|527798796|FG001|Overall Study|Failure to meet randomization criteria|0|||
146353069|NCT00745368|527798797|FG000|Overall Study|Unable to provide sample|3|||
146353070|NCT02364947|527798800|FG000|Overall Study|Withdrawal by Subject|10|||
146353071|NCT02364947|527798801|FG001|Overall Study|Withdrawal by Subject|8|||
146353072|NCT02364947|527798802|FG002|Overall Study|Withdrawal by Subject|9|||
146353073|NCT02364947|527798800|FG000|Overall Study|Adverse Event|45|||
146353074|NCT02364947|527798801|FG001|Overall Study|Adverse Event|33|||
146353075|NCT02364947|527798802|FG002|Overall Study|Adverse Event|11|||
146353076|NCT02364947|527798800|FG000|Overall Study|Protocol Violation|1|||
146353077|NCT02364947|527798801|FG001|Overall Study|Protocol Violation|1|||
146353078|NCT02364947|527798802|FG002|Overall Study|Protocol Violation|1|||
146353079|NCT02364947|527798800|FG000|Overall Study|Physician Decision|3|||
146353080|NCT02364947|527798801|FG001|Overall Study|Physician Decision|2|||
146353081|NCT02364947|527798802|FG002|Overall Study|Physician Decision|5|||
146353082|NCT02364947|527798800|FG000|Overall Study|Death|0|||
146353083|NCT02364947|527798801|FG001|Overall Study|Death|1|||
146353084|NCT02364947|527798802|FG002|Overall Study|Death|0|||
146353085|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
146169590|NCT00499863|527132866|FG001|Overall Study|Withdrawal by Subject|4|||
146169591|NCT00499863|527132865|FG000|Overall Study|Adverse Event|8|||
146353086|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
146353087|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
146353088|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
146353089|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
146353090|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
146353091|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
146353092|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146353093|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
146353094|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
146353095|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
146353096|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146353097|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
146353098|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
146353099|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
146353100|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
146353101|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
146353102|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
146353103|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
146353104|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
146353105|NCT00423085|527798803|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
146353106|NCT00423085|527798804|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146353107|NCT00423085|527798805|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146353108|NCT00423085|527798806|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
146353109|NCT00423085|527798803|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
146353110|NCT00423085|527798804|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
146353111|NCT00423085|527798805|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
146353112|NCT00423085|527798806|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
146353113|NCT00423085|527798803|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146353114|NCT00423085|527798804|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146353115|NCT00423085|527798805|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
146353116|NCT00423085|527798806|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
146353117|NCT00423085|527798803|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146353118|NCT00423085|527798804|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146353119|NCT00423085|527798805|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
146353120|NCT00423085|527798806|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
146353121|NCT00423085|527798803|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146353122|NCT00423085|527798804|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146353123|NCT00423085|527798805|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
146353124|NCT00423085|527798806|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
146353125|NCT00423085|527798803|FG000|52-Week Open-Label Extension Phase|Death|0|||
146353126|NCT00423085|527798804|FG001|52-Week Open-Label Extension Phase|Death|0|||
146353127|NCT00423085|527798805|FG002|52-Week Open-Label Extension Phase|Death|0|||
146353128|NCT00423085|527798806|FG003|52-Week Open-Label Extension Phase|Death|2|||
146353129|NCT00853489|527798807|FG000|Overall Study|Lost to Follow-up|5|||
146353130|NCT00853489|527798808|FG001|Overall Study|Lost to Follow-up|2|||
146353131|NCT05525975|527798809|FG000|Overall Study|Surgery cancellation|4|||
146353132|NCT05525975|527798810|FG001|Overall Study|Surgery cancellation|5|||
146353133|NCT05525975|527798809|FG000|Overall Study|didn't fill prescription|1|||
146353134|NCT05525975|527798810|FG001|Overall Study|didn't fill prescription|0|||
146353135|NCT05525975|527798809|FG000|Overall Study|Withdrawal by Subject|0|||
146353136|NCT05525975|527798810|FG001|Overall Study|Withdrawal by Subject|3|||
146353137|NCT03580382|527798811|FG000|Overall Study|Early Termination of Study|0|||
146353138|NCT03580382|527798812|FG001|Overall Study|Early Termination of Study|3|||
146353139|NCT02808312|527798813|FG000|Overall Study|Enrolled but Never Treated|0|||
146353140|NCT02808312|527798814|FG001|Overall Study|Enrolled but Never Treated|0|||
146353141|NCT02808312|527798815|FG002|Overall Study|Enrolled but Never Treated|1|||
146353142|NCT02808312|527798816|FG003|Overall Study|Enrolled but Never Treated|0|||
146353143|NCT02808312|527798817|FG004|Overall Study|Enrolled but Never Treated|0|||
146353144|NCT04263142|527798818|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146353145|NCT04263142|527798819|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146353146|NCT04263142|527798820|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146353147|NCT04263142|527798821|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
146353148|NCT04263142|527798822|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
146353149|NCT04263142|527798818|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146353150|NCT04263142|527798819|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146353151|NCT04263142|527798820|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146353152|NCT04263142|527798821|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
146353153|NCT04263142|527798822|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
146353154|NCT00520676|527798826|FG000|Overall Study|Death|84|||
146353155|NCT00520676|527798827|FG001|Overall Study|Death|81|||
146353156|NCT00520676|527798826|FG000|Overall Study|Lost to Follow-up|6|||
146169592|NCT00499863|527132866|FG001|Overall Study|Adverse Event|2|||
146169593|NCT00499863|527132865|FG000|Overall Study|Sponsor decision|2|||
146353157|NCT00520676|527798827|FG001|Overall Study|Lost to Follow-up|10|||
146353158|NCT00520676|527798826|FG000|Overall Study|Physician Decision|4|||
146353159|NCT00520676|527798827|FG001|Overall Study|Physician Decision|1|||
146353160|NCT00520676|527798826|FG000|Overall Study|Withdrawal by Subject|7|||
146353161|NCT00520676|527798827|FG001|Overall Study|Withdrawal by Subject|11|||
146353162|NCT03439748|527798828|FG000|Overall Study|Withdrawal by Subject|11|||
146353163|NCT03439748|527798829|FG001|Overall Study|Withdrawal by Subject|17|||
146353164|NCT03298412|527798832|FG000|Run-in Period|Other, Not Specified|1|||
146353165|NCT03298412|527798832|FG000|Run-in Period|Disease Progression|1|||
146353166|NCT03298412|527798832|FG000|Run-in Period|Ineligibility Determined|1|||
146353167|NCT03298412|527798832|FG000|Run-in Period|Decision by Sponsor|6|||
146353168|NCT04402008|527798835|FG000|Overall Study|Adverse Event|0|||
146353169|NCT04402008|527798836|FG001|Overall Study|Adverse Event|0|||
146353170|NCT04402008|527798837|FG002|Overall Study|Adverse Event|0|||
146353171|NCT04402008|527798838|FG003|Overall Study|Adverse Event|1|||
146353172|NCT04402008|527798839|FG004|Overall Study|Adverse Event|0|||
146353173|NCT04402008|527798840|FG005|Overall Study|Adverse Event|0|||
146353174|NCT04402008|527798841|FG006|Overall Study|Adverse Event|0|||
146353175|NCT04402008|527798835|FG000|Overall Study|Disease Progression|3|||
146353176|NCT04402008|527798836|FG001|Overall Study|Disease Progression|2|||
146353177|NCT04402008|527798837|FG002|Overall Study|Disease Progression|3|||
146353178|NCT04402008|527798838|FG003|Overall Study|Disease Progression|3|||
146353179|NCT04402008|527798839|FG004|Overall Study|Disease Progression|4|||
146353180|NCT04402008|527798840|FG005|Overall Study|Disease Progression|3|||
146353181|NCT04402008|527798841|FG006|Overall Study|Disease Progression|10|||
146353182|NCT04402008|527798835|FG000|Overall Study|Withdrawal by Subject|0|||
146353183|NCT04402008|527798836|FG001|Overall Study|Withdrawal by Subject|1|||
146353184|NCT04402008|527798837|FG002|Overall Study|Withdrawal by Subject|0|||
146353185|NCT04402008|527798838|FG003|Overall Study|Withdrawal by Subject|0|||
146353186|NCT04402008|527798839|FG004|Overall Study|Withdrawal by Subject|1|||
146353187|NCT04402008|527798840|FG005|Overall Study|Withdrawal by Subject|0|||
146353188|NCT04402008|527798841|FG006|Overall Study|Withdrawal by Subject|0|||
146353189|NCT04402008|527798835|FG000|Overall Study|Sponsor Decision|0|||
146353190|NCT04402008|527798836|FG001|Overall Study|Sponsor Decision|0|||
146353191|NCT04402008|527798837|FG002|Overall Study|Sponsor Decision|0|||
146353192|NCT04402008|527798838|FG003|Overall Study|Sponsor Decision|0|||
146353193|NCT04402008|527798839|FG004|Overall Study|Sponsor Decision|0|||
146353194|NCT04402008|527798840|FG005|Overall Study|Sponsor Decision|0|||
146353195|NCT04402008|527798841|FG006|Overall Study|Sponsor Decision|3|||
146353196|NCT04402008|527798835|FG000|Overall Study|Death|0|||
146353197|NCT04402008|527798836|FG001|Overall Study|Death|0|||
146353198|NCT04402008|527798837|FG002|Overall Study|Death|0|||
146353199|NCT04402008|527798838|FG003|Overall Study|Death|0|||
146353200|NCT04402008|527798839|FG004|Overall Study|Death|1|||
146353201|NCT04402008|527798840|FG005|Overall Study|Death|0|||
146353202|NCT04402008|527798841|FG006|Overall Study|Death|2|||
146353203|NCT04402008|527798835|FG000|Overall Study|Other|0|||
146353204|NCT04402008|527798836|FG001|Overall Study|Other|0|||
146353205|NCT04402008|527798837|FG002|Overall Study|Other|0|||
146353206|NCT04402008|527798838|FG003|Overall Study|Other|0|||
146353207|NCT04402008|527798839|FG004|Overall Study|Other|0|||
146353208|NCT04402008|527798840|FG005|Overall Study|Other|0|||
146353209|NCT04402008|527798841|FG006|Overall Study|Other|5|||
146353210|NCT01894477|527798844|FG000|Overall Study|Protocol Violation|0|||
146353211|NCT01894477|527798845|FG001|Overall Study|Protocol Violation|1|||
146353212|NCT01894477|527798844|FG000|Overall Study|protocol changed due SC changed to cord|0|||
146353213|NCT01894477|527798845|FG001|Overall Study|protocol changed due SC changed to cord|1|||
146353214|NCT01028651|527798847|FG000|Overall Study|Death|2|||
146353215|NCT01028651|527798847|FG000|Overall Study|Adverse Event|1|||
146353216|NCT01533935|527798848|FG000|Overall Study|Adverse Event|5|||
146353217|NCT01533935|527798849|FG001|Overall Study|Adverse Event|7|||
146353218|NCT01533935|527798850|FG002|Overall Study|Adverse Event|1|||
146353219|NCT01533935|527798851|FG003|Overall Study|Adverse Event|5|||
146353220|NCT01533935|527798852|FG004|Overall Study|Adverse Event|3|||
146353221|NCT01533935|527798848|FG000|Overall Study|Protocol Violation|0|||
146353222|NCT01533935|527798849|FG001|Overall Study|Protocol Violation|2|||
146353223|NCT01533935|527798850|FG002|Overall Study|Protocol Violation|0|||
146353224|NCT01533935|527798851|FG003|Overall Study|Protocol Violation|0|||
146353225|NCT01533935|527798852|FG004|Overall Study|Protocol Violation|0|||
146353226|NCT01533935|527798848|FG000|Overall Study|Lost to Follow-up|0|||
146353227|NCT01533935|527798849|FG001|Overall Study|Lost to Follow-up|0|||
146353228|NCT01533935|527798850|FG002|Overall Study|Lost to Follow-up|1|||
146353229|NCT01533935|527798851|FG003|Overall Study|Lost to Follow-up|0|||
146353230|NCT01533935|527798852|FG004|Overall Study|Lost to Follow-up|0|||
146353231|NCT01533935|527798848|FG000|Overall Study|Withdrawal by Subject|0|||
146353232|NCT01533935|527798849|FG001|Overall Study|Withdrawal by Subject|4|||
146353233|NCT01533935|527798850|FG002|Overall Study|Withdrawal by Subject|5|||
146353234|NCT01533935|527798851|FG003|Overall Study|Withdrawal by Subject|2|||
146353235|NCT01533935|527798852|FG004|Overall Study|Withdrawal by Subject|4|||
146353236|NCT01533935|527798848|FG000|Overall Study|Other reason not defined above|1|||
146353237|NCT01533935|527798849|FG001|Overall Study|Other reason not defined above|0|||
146353238|NCT01533935|527798850|FG002|Overall Study|Other reason not defined above|1|||
146353239|NCT01533935|527798851|FG003|Overall Study|Other reason not defined above|0|||
146353240|NCT01533935|527798852|FG004|Overall Study|Other reason not defined above|1|||
146353241|NCT05631548|527798853|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
146353242|NCT05631548|527798854|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
146353243|NCT04075266|527798857|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
146353244|NCT04075266|527798858|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
146353245|NCT04075266|527798857|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
146353246|NCT04075266|527798858|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
146353247|NCT05132569|527798859|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
146353248|NCT05132569|527798860|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
146353249|NCT05132569|527798859|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
146353250|NCT05132569|527798860|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
146353251|NCT05132569|527798859|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
146353252|NCT05132569|527798860|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
146353253|NCT01554956|527798861|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
146353254|NCT01554956|527798862|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
146353255|NCT01554956|527798863|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
146353256|NCT01554956|527798861|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
146353257|NCT01554956|527798862|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
146353258|NCT01554956|527798863|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
146353259|NCT01554956|527798861|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
146353260|NCT01554956|527798862|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
146353261|NCT01554956|527798863|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
146353262|NCT03656926|527798864|FG000|Overall Study|Adverse Event|5|||
146353263|NCT03656926|527798865|FG001|Overall Study|Adverse Event|4|||
146353264|NCT03656926|527798864|FG000|Overall Study|Withdrawal by Subject|7|||
146353265|NCT03656926|527798865|FG001|Overall Study|Withdrawal by Subject|2|||
146353266|NCT03656926|527798864|FG000|Overall Study|Screen fail after randomization|1|||
146353267|NCT03656926|527798865|FG001|Overall Study|Screen fail after randomization|0|||
146353268|NCT03656926|527798864|FG000|Overall Study|PI decision due to patient condition|1|||
146353269|NCT03656926|527798865|FG001|Overall Study|PI decision due to patient condition|0|||
146353270|NCT03656926|527798864|FG000|Overall Study|Patient unresponsiveness|1|||
146353271|NCT03656926|527798865|FG001|Overall Study|Patient unresponsiveness|0|||
146353272|NCT00069095|527798866|FG000|Primary Treatment Phase|Ongoing|0|||
146353273|NCT00069095|527798867|FG001|Primary Treatment Phase|Ongoing|0|||
146353274|NCT00069095|527798868|FG002|Primary Treatment Phase|Ongoing|5|||
146353275|NCT00069095|527798869|FG003|Primary Treatment Phase|Ongoing|7|||
146353276|NCT00069095|527798870|FG004|Primary Treatment Phase|Ongoing|7|||
146353277|NCT00069095|527798871|FG005|Primary Treatment Phase|Ongoing|4|||
146353278|NCT00069095|527798866|FG000|Primary Treatment Phase|Admin/Other|29|||
146353279|NCT00069095|527798867|FG001|Primary Treatment Phase|Admin/Other|38|||
146353280|NCT00069095|527798868|FG002|Primary Treatment Phase|Admin/Other|31|||
146353281|NCT00069095|527798869|FG003|Primary Treatment Phase|Admin/Other|45|||
146353282|NCT00069095|527798870|FG004|Primary Treatment Phase|Admin/Other|48|||
146353283|NCT00069095|527798871|FG005|Primary Treatment Phase|Admin/Other|42|||
146353284|NCT00069095|527798866|FG000|Primary Treatment Phase|Adverse Event|99|||
146353285|NCT00069095|527798867|FG001|Primary Treatment Phase|Adverse Event|92|||
146353286|NCT00069095|527798868|FG002|Primary Treatment Phase|Adverse Event|71|||
146353287|NCT00069095|527798869|FG003|Primary Treatment Phase|Adverse Event|72|||
146353288|NCT00069095|527798870|FG004|Primary Treatment Phase|Adverse Event|109|||
146353289|NCT00069095|527798871|FG005|Primary Treatment Phase|Adverse Event|101|||
146353290|NCT00069095|527798866|FG000|Primary Treatment Phase|Death|14|||
146353291|NCT00069095|527798867|FG001|Primary Treatment Phase|Death|8|||
146353292|NCT00069095|527798868|FG002|Primary Treatment Phase|Death|2|||
146353293|NCT00069095|527798869|FG003|Primary Treatment Phase|Death|5|||
146353294|NCT00069095|527798870|FG004|Primary Treatment Phase|Death|8|||
146353295|NCT00069095|527798871|FG005|Primary Treatment Phase|Death|8|||
146353296|NCT00069095|527798866|FG000|Primary Treatment Phase|Failure to return|5|||
146353297|NCT00069095|527798867|FG001|Primary Treatment Phase|Failure to return|5|||
146353298|NCT00069095|527798868|FG002|Primary Treatment Phase|Failure to return|0|||
146353299|NCT00069095|527798869|FG003|Primary Treatment Phase|Failure to return|0|||
146353300|NCT00069095|527798870|FG004|Primary Treatment Phase|Failure to return|0|||
146353301|NCT00069095|527798871|FG005|Primary Treatment Phase|Failure to return|2|||
146353302|NCT00069095|527798866|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
146353303|NCT00069095|527798867|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
146353304|NCT00069095|527798868|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
146353305|NCT00069095|527798869|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
145943392|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146353306|NCT00069095|527798870|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
146353307|NCT00069095|527798871|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
146353308|NCT00069095|527798866|FG000|Primary Treatment Phase|Refused treatment|15|||
146353309|NCT00069095|527798867|FG001|Primary Treatment Phase|Refused treatment|26|||
146353310|NCT00069095|527798868|FG002|Primary Treatment Phase|Refused treatment|17|||
146353311|NCT00069095|527798869|FG003|Primary Treatment Phase|Refused treatment|31|||
146353312|NCT00069095|527798870|FG004|Primary Treatment Phase|Refused treatment|24|||
146353313|NCT00069095|527798871|FG005|Primary Treatment Phase|Refused treatment|27|||
146353314|NCT00069095|527798866|FG000|Primary Treatment Phase|Withdrew|2|||
146353315|NCT00069095|527798867|FG001|Primary Treatment Phase|Withdrew|3|||
146353316|NCT00069095|527798868|FG002|Primary Treatment Phase|Withdrew|8|||
146353317|NCT00069095|527798869|FG003|Primary Treatment Phase|Withdrew|2|||
146353318|NCT00069095|527798870|FG004|Primary Treatment Phase|Withdrew|4|||
146353319|NCT00069095|527798871|FG005|Primary Treatment Phase|Withdrew|9|||
146353320|NCT00069095|527798866|FG000|Primary Treatment Phase|Other Violation|0|||
146353321|NCT00069095|527798867|FG001|Primary Treatment Phase|Other Violation|1|||
146353322|NCT00069095|527798868|FG002|Primary Treatment Phase|Other Violation|1|||
146353323|NCT00069095|527798869|FG003|Primary Treatment Phase|Other Violation|1|||
146353324|NCT00069095|527798870|FG004|Primary Treatment Phase|Other Violation|0|||
146353325|NCT00069095|527798871|FG005|Primary Treatment Phase|Other Violation|1|||
146353326|NCT00069095|527798866|FG000|Primary Treatment Phase|Violation criteria|0|||
146353327|NCT00069095|527798867|FG001|Primary Treatment Phase|Violation criteria|2|||
146353328|NCT00069095|527798868|FG002|Primary Treatment Phase|Violation criteria|4|||
146353329|NCT00069095|527798869|FG003|Primary Treatment Phase|Violation criteria|3|||
146353330|NCT00069095|527798870|FG004|Primary Treatment Phase|Violation criteria|1|||
146353331|NCT00069095|527798871|FG005|Primary Treatment Phase|Violation criteria|5|||
146353332|NCT00069095|527798866|FG000|Post-study Treatment Phase|Missing reason|1|||
146353333|NCT00069095|527798867|FG001|Post-study Treatment Phase|Missing reason|3|||
146353334|NCT00069095|527798868|FG002|Post-study Treatment Phase|Missing reason|12|||
146353335|NCT00069095|527798869|FG003|Post-study Treatment Phase|Missing reason|8|||
146353336|NCT00069095|527798870|FG004|Post-study Treatment Phase|Missing reason|18|||
146353337|NCT00069095|527798871|FG005|Post-study Treatment Phase|Missing reason|17|||
146353338|NCT00069095|527798866|FG000|Post-study Treatment Phase|Adverse Event|2|||
146353339|NCT00069095|527798867|FG001|Post-study Treatment Phase|Adverse Event|3|||
146353340|NCT00069095|527798868|FG002|Post-study Treatment Phase|Adverse Event|1|||
146353341|NCT00069095|527798869|FG003|Post-study Treatment Phase|Adverse Event|0|||
146353342|NCT00069095|527798870|FG004|Post-study Treatment Phase|Adverse Event|5|||
146353343|NCT00069095|527798871|FG005|Post-study Treatment Phase|Adverse Event|1|||
146353344|NCT00069095|527798866|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
146353345|NCT00069095|527798867|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
146353346|NCT00069095|527798868|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
146353347|NCT00069095|527798869|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
146353348|NCT00069095|527798870|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
146353349|NCT00069095|527798871|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
146353350|NCT00069095|527798866|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
146353351|NCT00069095|527798867|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
146353352|NCT00069095|527798868|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
146353353|NCT00069095|527798869|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
146353354|NCT00069095|527798870|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
146353355|NCT00069095|527798871|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
146353356|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
146353357|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146353358|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146353359|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146353360|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
146353361|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
146353362|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant had complete response|1|||
146353363|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant had complete response|1|||
146353364|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant had complete response|0|||
146353365|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant had complete response|0|||
146353366|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant had complete response|0|||
146353367|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant had complete response|0|||
146353368|NCT00069095|527798866|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146353369|NCT00069095|527798867|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
146353370|NCT00069095|527798868|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146353371|NCT00069095|527798869|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146353372|NCT00069095|527798870|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146353373|NCT00069095|527798871|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
146353374|NCT00069095|527798866|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146353375|NCT00069095|527798867|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146353376|NCT00069095|527798868|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146353377|NCT00069095|527798869|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146353378|NCT00069095|527798870|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
146353379|NCT00069095|527798871|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
146353380|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
146353381|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
146353382|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
146353383|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
146353384|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
146353385|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
146353386|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
146353387|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
146353388|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
146353389|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
146353390|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
146353391|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
146353392|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146353393|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146353394|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146353395|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
146353396|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146353397|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
146353398|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
146353399|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
146353400|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
146353401|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
146353402|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
146353403|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
146353404|NCT00069095|527798866|FG000|Post-study Treatment Phase|Surgery|0|||
146353405|NCT00069095|527798867|FG001|Post-study Treatment Phase|Surgery|0|||
146353406|NCT00069095|527798868|FG002|Post-study Treatment Phase|Surgery|0|||
146353407|NCT00069095|527798869|FG003|Post-study Treatment Phase|Surgery|1|||
146353408|NCT00069095|527798870|FG004|Post-study Treatment Phase|Surgery|1|||
146353409|NCT00069095|527798871|FG005|Post-study Treatment Phase|Surgery|0|||
146353410|NCT00069095|527798866|FG000|Post-study Treatment Phase|Death|0|||
146353411|NCT00069095|527798867|FG001|Post-study Treatment Phase|Death|0|||
146353412|NCT00069095|527798868|FG002|Post-study Treatment Phase|Death|0|||
146353413|NCT00069095|527798869|FG003|Post-study Treatment Phase|Death|0|||
146353414|NCT00069095|527798870|FG004|Post-study Treatment Phase|Death|1|||
146353415|NCT00069095|527798871|FG005|Post-study Treatment Phase|Death|0|||
146353416|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
146353417|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
146353418|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
146353419|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
146353420|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
146353421|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
146353422|NCT00069095|527798866|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146353423|NCT00069095|527798867|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146353424|NCT00069095|527798868|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146353425|NCT00069095|527798869|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146353426|NCT00069095|527798870|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
146353427|NCT00069095|527798871|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
146353428|NCT00069095|527798866|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146353429|NCT00069095|527798867|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146353430|NCT00069095|527798868|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146353431|NCT00069095|527798869|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146353432|NCT00069095|527798870|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
146353433|NCT00069095|527798871|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
146353434|NCT00069095|527798866|FG000|Post-study Treatment Phase|Investigator decision|0|||
146353435|NCT00069095|527798867|FG001|Post-study Treatment Phase|Investigator decision|0|||
146353436|NCT00069095|527798868|FG002|Post-study Treatment Phase|Investigator decision|0|||
146353437|NCT00069095|527798869|FG003|Post-study Treatment Phase|Investigator decision|0|||
146169594|NCT00499863|527132866|FG001|Overall Study|Sponsor decision|2|||
146353438|NCT00069095|527798870|FG004|Post-study Treatment Phase|Investigator decision|0|||
146353439|NCT00069095|527798871|FG005|Post-study Treatment Phase|Investigator decision|1|||
146353440|NCT00069095|527798866|FG000|Follow-up Phase|Death|174|||
146353441|NCT00069095|527798867|FG001|Follow-up Phase|Death|206|||
146353442|NCT00069095|527798868|FG002|Follow-up Phase|Death|120|||
146353443|NCT00069095|527798869|FG003|Follow-up Phase|Death|112|||
146353444|NCT00069095|527798870|FG004|Follow-up Phase|Death|92|||
146353445|NCT00069095|527798871|FG005|Follow-up Phase|Death|101|||
146353446|NCT00913978|527798872|FG000|Overall Study|Surgeon choice|1|||
146353447|NCT00913978|527798873|FG001|Overall Study|Surgeon choice|3|||
146353448|NCT05610176|527798877|FG000|Overall Study|Death|6|||
146353449|NCT00210158|527798878|FG000|Overall Study|Protocol Violation|0|||
146353450|NCT00210158|527798879|FG001|Overall Study|Protocol Violation|2|||
146353451|NCT04716933|527798880|FG000|Overall Study|Sponsor Decision|36|||
146353452|NCT04716933|527798881|FG001|Overall Study|Sponsor Decision|33|||
146353453|NCT04716933|527798880|FG000|Overall Study|Death|65|||
146353454|NCT04716933|527798881|FG001|Overall Study|Death|67|||
146353455|NCT01327651|527798882|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
146353456|NCT01327651|527798883|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
146353457|NCT01327651|527798884|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
146353458|NCT01327651|527798885|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
146353459|NCT01327651|527798886|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
146353460|NCT01327651|527798887|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
146353461|NCT01327651|527798888|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
146353462|NCT01327651|527798889|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
146353463|NCT01327651|527798890|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
146353464|NCT01327651|527798882|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
146353465|NCT01327651|527798883|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353466|NCT01327651|527798884|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353467|NCT01327651|527798885|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353468|NCT01327651|527798886|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353469|NCT01327651|527798887|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353470|NCT01327651|527798888|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353471|NCT01327651|527798889|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353472|NCT01327651|527798890|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
146353473|NCT01327651|527798882|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
146353474|NCT01327651|527798883|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
146353475|NCT01327651|527798884|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
146353476|NCT01327651|527798885|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
146353477|NCT01327651|527798886|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
146353478|NCT01327651|527798887|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
146353479|NCT01327651|527798888|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
146353480|NCT01327651|527798889|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
146353481|NCT01327651|527798890|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
146353482|NCT01327651|527798882|FG000|Post Study Follow-up|Lost to Follow-up|0|||
146353483|NCT01327651|527798883|FG001|Post Study Follow-up|Lost to Follow-up|1|||
146353484|NCT01327651|527798884|FG002|Post Study Follow-up|Lost to Follow-up|1|||
146353485|NCT01327651|527798885|FG003|Post Study Follow-up|Lost to Follow-up|0|||
146353486|NCT01327651|527798886|FG004|Post Study Follow-up|Lost to Follow-up|0|||
146353487|NCT01327651|527798887|FG005|Post Study Follow-up|Lost to Follow-up|0|||
146353488|NCT01327651|527798888|FG006|Post Study Follow-up|Lost to Follow-up|4|||
146353489|NCT01327651|527798889|FG007|Post Study Follow-up|Lost to Follow-up|1|||
146353490|NCT01327651|527798890|FG008|Post Study Follow-up|Lost to Follow-up|2|||
146353491|NCT03249792|527798895|FG000|Arms 1, 2, and 4|Death|1|||
146353492|NCT03249792|527798896|FG001|Arms 1, 2, and 4|Death|1|||
146353493|NCT03249792|527798897|FG002|Arms 1, 2, and 4|Death|0|||
146353494|NCT03249792|527798898|FG003|Arms 1, 2, and 4|Death|2|||
146353495|NCT03249792|527798899|FG004|Arms 1, 2, and 4|Death|3|||
146353496|NCT03249792|527798900|FG005|Arms 1, 2, and 4|Death|2|||
146353497|NCT03249792|527798901|FG006|Arms 1, 2, and 4|Death|2|||
146353498|NCT03249792|527798902|FG007|Arms 1, 2, and 4|Death|4|||
146353499|NCT03249792|527798903|FG008|Arms 1, 2, and 4|Death|2|||
146353500|NCT03249792|527798904|FG009|Arms 1, 2, and 4|Death|1|||
146353501|NCT03249792|527798905|FG010|Arms 1, 2, and 4|Death|7|||
146353502|NCT03249792|527798906|FG011|Arms 1, 2, and 4|Death|7|||
146353503|NCT03249792|527798907|FG012|Arms 1, 2, and 4|Death|12|||
146353504|NCT03249792|527798908|FG013|Arms 1, 2, and 4|Death|7|||
146353505|NCT03249792|527798909|FG014|Arms 1, 2, and 4|Death|0|||
146353506|NCT03249792|527798910|FG015|Arms 1, 2, and 4|Death|4|||
146353507|NCT03249792|527798911|FG016|Arms 1, 2, and 4|Death|4|||
146353508|NCT03249792|527798912|FG017|Arms 1, 2, and 4|Death|12|||
146353509|NCT03249792|527798913|FG018|Arms 1, 2, and 4|Death|6|||
146353510|NCT03249792|527798914|FG019|Arms 1, 2, and 4|Death|4|||
146353511|NCT03249792|527798915|FG020|Arms 1, 2, and 4|Death|2|||
146353512|NCT03249792|527798916|FG021|Arms 1, 2, and 4|Death|3|||
146353513|NCT03249792|527798917|FG022|Arms 1, 2, and 4|Death|1|||
146353514|NCT03249792|527798918|FG023|Arms 1, 2, and 4|Death|1|||
146353515|NCT03249792|527798919|FG024|Arms 1, 2, and 4|Death|4|||
146353516|NCT03249792|527798920|FG025|Arms 1, 2, and 4|Death|0|||
146353517|NCT03249792|527798921|FG026|Arms 1, 2, and 4|Death|0|||
146353518|NCT03249792|527798922|FG027|Arms 1, 2, and 4|Death|0|||
146353519|NCT03249792|527798923|FG028|Arms 1, 2, and 4|Death|0|||
146353520|NCT03249792|527798924|FG029|Arms 1, 2, and 4|Death|0|||
146353521|NCT03249792|527798925|FG030|Arms 1, 2, and 4|Death|0|||
146353522|NCT03249792|527798926|FG031|Arms 1, 2, and 4|Death|0|||
146353523|NCT03249792|527798927|FG032|Arms 1, 2, and 4|Death|0|||
146353524|NCT03249792|527798895|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353525|NCT03249792|527798896|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353526|NCT03249792|527798897|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353527|NCT03249792|527798898|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353528|NCT03249792|527798899|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353529|NCT03249792|527798900|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353530|NCT03249792|527798901|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
146353531|NCT03249792|527798902|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353532|NCT03249792|527798903|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
146353533|NCT03249792|527798904|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353534|NCT03249792|527798905|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
146353535|NCT03249792|527798906|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146353536|NCT03249792|527798907|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
146353537|NCT03249792|527798908|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146353538|NCT03249792|527798909|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353539|NCT03249792|527798910|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353540|NCT03249792|527798911|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
146353541|NCT03249792|527798912|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353542|NCT03249792|527798913|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353543|NCT03249792|527798914|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353544|NCT03249792|527798915|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353545|NCT03249792|527798916|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353546|NCT03249792|527798917|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353547|NCT03249792|527798918|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
146353548|NCT03249792|527798919|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353549|NCT03249792|527798920|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353550|NCT03249792|527798921|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353551|NCT03249792|527798922|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353552|NCT03249792|527798923|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353553|NCT03249792|527798924|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353554|NCT03249792|527798925|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353555|NCT03249792|527798926|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353556|NCT03249792|527798927|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
146353557|NCT03249792|527798895|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
146353558|NCT03249792|527798896|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
146353559|NCT03249792|527798897|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
146353560|NCT03249792|527798898|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
146353561|NCT03249792|527798899|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
146353562|NCT03249792|527798900|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
146353563|NCT03249792|527798901|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
146353564|NCT03249792|527798902|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
146353565|NCT03249792|527798903|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
146353566|NCT03249792|527798904|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
146353567|NCT03249792|527798905|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
146353568|NCT03249792|527798906|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
146353569|NCT03249792|527798907|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
146353570|NCT03249792|527798908|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
146353571|NCT03249792|527798909|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
146353572|NCT03249792|527798910|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
146353573|NCT03249792|527798911|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
146353574|NCT03249792|527798912|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
146353575|NCT03249792|527798913|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
146353576|NCT03249792|527798914|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
146353577|NCT03249792|527798915|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
146353578|NCT03249792|527798916|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
146353579|NCT03249792|527798917|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
146353580|NCT03249792|527798918|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
146353581|NCT03249792|527798919|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
146353582|NCT03249792|527798920|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
146353583|NCT03249792|527798921|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
146353584|NCT03249792|527798922|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
146353585|NCT03249792|527798923|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
146353586|NCT03249792|527798924|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
146353587|NCT03249792|527798925|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
146353588|NCT03249792|527798926|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
146353589|NCT03249792|527798927|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
146353590|NCT03249792|527798895|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353591|NCT03249792|527798896|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353592|NCT03249792|527798897|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353593|NCT03249792|527798898|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353594|NCT03249792|527798899|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353595|NCT03249792|527798900|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353596|NCT03249792|527798901|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353597|NCT03249792|527798902|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353598|NCT03249792|527798903|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
146353599|NCT03249792|527798904|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353600|NCT03249792|527798905|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353601|NCT03249792|527798906|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353602|NCT03249792|527798907|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353603|NCT03249792|527798908|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353604|NCT03249792|527798909|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353605|NCT03249792|527798910|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353606|NCT03249792|527798911|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
146353607|NCT03249792|527798912|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
146353608|NCT03249792|527798913|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353609|NCT03249792|527798914|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
146353610|NCT03249792|527798915|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353611|NCT03249792|527798916|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353612|NCT03249792|527798917|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353613|NCT03249792|527798918|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353614|NCT03249792|527798919|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353615|NCT03249792|527798920|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353616|NCT03249792|527798921|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353617|NCT03249792|527798922|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353618|NCT03249792|527798923|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353619|NCT03249792|527798924|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353620|NCT03249792|527798925|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353621|NCT03249792|527798926|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353622|NCT03249792|527798927|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
146353623|NCT03249792|527798895|FG000|Switch Over Period|Withdrawal by Subject|0|||
146353624|NCT03249792|527798896|FG001|Switch Over Period|Withdrawal by Subject|0|||
146353625|NCT03249792|527798897|FG002|Switch Over Period|Withdrawal by Subject|0|||
146353626|NCT03249792|527798898|FG003|Switch Over Period|Withdrawal by Subject|0|||
146353627|NCT03249792|527798899|FG004|Switch Over Period|Withdrawal by Subject|0|||
146353628|NCT03249792|527798900|FG005|Switch Over Period|Withdrawal by Subject|0|||
146353629|NCT03249792|527798901|FG006|Switch Over Period|Withdrawal by Subject|0|||
146353630|NCT03249792|527798902|FG007|Switch Over Period|Withdrawal by Subject|0|||
146353631|NCT03249792|527798903|FG008|Switch Over Period|Withdrawal by Subject|0|||
146353632|NCT03249792|527798904|FG009|Switch Over Period|Withdrawal by Subject|0|||
146353633|NCT03249792|527798905|FG010|Switch Over Period|Withdrawal by Subject|0|||
146353634|NCT03249792|527798906|FG011|Switch Over Period|Withdrawal by Subject|0|||
146353635|NCT03249792|527798907|FG012|Switch Over Period|Withdrawal by Subject|0|||
146353636|NCT03249792|527798908|FG013|Switch Over Period|Withdrawal by Subject|0|||
146353637|NCT03249792|527798909|FG014|Switch Over Period|Withdrawal by Subject|0|||
146353638|NCT03249792|527798910|FG015|Switch Over Period|Withdrawal by Subject|0|||
146353639|NCT03249792|527798911|FG016|Switch Over Period|Withdrawal by Subject|0|||
146353640|NCT03249792|527798912|FG017|Switch Over Period|Withdrawal by Subject|0|||
146353641|NCT03249792|527798913|FG018|Switch Over Period|Withdrawal by Subject|0|||
146353642|NCT03249792|527798914|FG019|Switch Over Period|Withdrawal by Subject|0|||
146353643|NCT03249792|527798915|FG020|Switch Over Period|Withdrawal by Subject|0|||
146353644|NCT03249792|527798916|FG021|Switch Over Period|Withdrawal by Subject|0|||
146353645|NCT03249792|527798917|FG022|Switch Over Period|Withdrawal by Subject|0|||
146353646|NCT03249792|527798918|FG023|Switch Over Period|Withdrawal by Subject|0|||
146353647|NCT03249792|527798919|FG024|Switch Over Period|Withdrawal by Subject|0|||
146353648|NCT03249792|527798920|FG025|Switch Over Period|Withdrawal by Subject|0|||
146353649|NCT03249792|527798921|FG026|Switch Over Period|Withdrawal by Subject|0|||
146353650|NCT03249792|527798922|FG027|Switch Over Period|Withdrawal by Subject|0|||
146353651|NCT03249792|527798923|FG028|Switch Over Period|Withdrawal by Subject|0|||
146353652|NCT03249792|527798924|FG029|Switch Over Period|Withdrawal by Subject|0|||
146353653|NCT03249792|527798925|FG030|Switch Over Period|Withdrawal by Subject|0|||
146353654|NCT03249792|527798926|FG031|Switch Over Period|Withdrawal by Subject|1|||
146353655|NCT03249792|527798927|FG032|Switch Over Period|Withdrawal by Subject|0|||
146353656|NCT03249792|527798895|FG000|Switch Over Period|Progressive Disease|0|||
146353657|NCT03249792|527798896|FG001|Switch Over Period|Progressive Disease|0|||
146353658|NCT03249792|527798897|FG002|Switch Over Period|Progressive Disease|0|||
146353659|NCT03249792|527798898|FG003|Switch Over Period|Progressive Disease|0|||
146353660|NCT03249792|527798899|FG004|Switch Over Period|Progressive Disease|0|||
146353661|NCT03249792|527798900|FG005|Switch Over Period|Progressive Disease|0|||
145943393|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146169595|NCT00499863|527132865|FG000|Overall Study|Lost to Follow-up|1|||
146353662|NCT03249792|527798901|FG006|Switch Over Period|Progressive Disease|0|||
146353663|NCT03249792|527798902|FG007|Switch Over Period|Progressive Disease|0|||
146353664|NCT03249792|527798903|FG008|Switch Over Period|Progressive Disease|0|||
146353665|NCT03249792|527798904|FG009|Switch Over Period|Progressive Disease|0|||
146353666|NCT03249792|527798905|FG010|Switch Over Period|Progressive Disease|0|||
146353667|NCT03249792|527798906|FG011|Switch Over Period|Progressive Disease|0|||
146353668|NCT03249792|527798907|FG012|Switch Over Period|Progressive Disease|0|||
146353669|NCT03249792|527798908|FG013|Switch Over Period|Progressive Disease|0|||
146353670|NCT03249792|527798909|FG014|Switch Over Period|Progressive Disease|0|||
146353671|NCT03249792|527798910|FG015|Switch Over Period|Progressive Disease|0|||
146353672|NCT03249792|527798911|FG016|Switch Over Period|Progressive Disease|0|||
146353673|NCT03249792|527798912|FG017|Switch Over Period|Progressive Disease|0|||
146353674|NCT03249792|527798913|FG018|Switch Over Period|Progressive Disease|0|||
146353675|NCT03249792|527798914|FG019|Switch Over Period|Progressive Disease|0|||
146353676|NCT03249792|527798915|FG020|Switch Over Period|Progressive Disease|0|||
146353677|NCT03249792|527798916|FG021|Switch Over Period|Progressive Disease|0|||
146353678|NCT03249792|527798917|FG022|Switch Over Period|Progressive Disease|0|||
146353679|NCT03249792|527798918|FG023|Switch Over Period|Progressive Disease|0|||
146353680|NCT03249792|527798919|FG024|Switch Over Period|Progressive Disease|0|||
146353681|NCT03249792|527798920|FG025|Switch Over Period|Progressive Disease|0|||
146353682|NCT03249792|527798921|FG026|Switch Over Period|Progressive Disease|1|||
146353683|NCT03249792|527798922|FG027|Switch Over Period|Progressive Disease|0|||
146353684|NCT03249792|527798923|FG028|Switch Over Period|Progressive Disease|1|||
146353685|NCT03249792|527798924|FG029|Switch Over Period|Progressive Disease|2|||
146353686|NCT03249792|527798925|FG030|Switch Over Period|Progressive Disease|1|||
146353687|NCT03249792|527798926|FG031|Switch Over Period|Progressive Disease|0|||
146353688|NCT03249792|527798927|FG032|Switch Over Period|Progressive Disease|1|||
146353689|NCT03249792|527798895|FG000|Switch Over Period|Adverse Event|0|||
146353690|NCT03249792|527798896|FG001|Switch Over Period|Adverse Event|0|||
146353691|NCT03249792|527798897|FG002|Switch Over Period|Adverse Event|0|||
146353692|NCT03249792|527798898|FG003|Switch Over Period|Adverse Event|0|||
146353693|NCT03249792|527798899|FG004|Switch Over Period|Adverse Event|0|||
146353694|NCT03249792|527798900|FG005|Switch Over Period|Adverse Event|0|||
146353695|NCT03249792|527798901|FG006|Switch Over Period|Adverse Event|0|||
146353696|NCT03249792|527798902|FG007|Switch Over Period|Adverse Event|0|||
146353697|NCT03249792|527798903|FG008|Switch Over Period|Adverse Event|0|||
146353698|NCT03249792|527798904|FG009|Switch Over Period|Adverse Event|0|||
146353699|NCT03249792|527798905|FG010|Switch Over Period|Adverse Event|0|||
146353700|NCT03249792|527798906|FG011|Switch Over Period|Adverse Event|0|||
146353701|NCT03249792|527798907|FG012|Switch Over Period|Adverse Event|0|||
146353702|NCT03249792|527798908|FG013|Switch Over Period|Adverse Event|0|||
146353703|NCT03249792|527798909|FG014|Switch Over Period|Adverse Event|0|||
146353704|NCT03249792|527798910|FG015|Switch Over Period|Adverse Event|0|||
146353705|NCT03249792|527798911|FG016|Switch Over Period|Adverse Event|0|||
146353706|NCT03249792|527798912|FG017|Switch Over Period|Adverse Event|0|||
146353707|NCT03249792|527798913|FG018|Switch Over Period|Adverse Event|0|||
146353708|NCT03249792|527798914|FG019|Switch Over Period|Adverse Event|0|||
146353709|NCT03249792|527798915|FG020|Switch Over Period|Adverse Event|0|||
146353710|NCT03249792|527798916|FG021|Switch Over Period|Adverse Event|0|||
146353711|NCT03249792|527798917|FG022|Switch Over Period|Adverse Event|0|||
146353712|NCT03249792|527798918|FG023|Switch Over Period|Adverse Event|0|||
146353713|NCT03249792|527798919|FG024|Switch Over Period|Adverse Event|0|||
146353714|NCT03249792|527798920|FG025|Switch Over Period|Adverse Event|1|||
146353715|NCT03249792|527798921|FG026|Switch Over Period|Adverse Event|0|||
146353716|NCT03249792|527798922|FG027|Switch Over Period|Adverse Event|1|||
146353717|NCT03249792|527798923|FG028|Switch Over Period|Adverse Event|0|||
146353718|NCT03249792|527798924|FG029|Switch Over Period|Adverse Event|0|||
146353719|NCT03249792|527798925|FG030|Switch Over Period|Adverse Event|0|||
146353720|NCT03249792|527798926|FG031|Switch Over Period|Adverse Event|0|||
146353721|NCT03249792|527798927|FG032|Switch Over Period|Adverse Event|0|||
146353722|NCT01727713|527798935|FG000|Overall Study|Lost to Follow-up|5|||
146353723|NCT01727713|527798935|FG000|Overall Study|Adverse Event|10|||
146353724|NCT01727713|527798935|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
146353725|NCT01727713|527798935|FG000|Overall Study|Withdrawal by Subject|13|||
146353726|NCT01727713|527798935|FG000|Overall Study|Protocol Deviation|2|||
146353727|NCT00532948|527798936|FG000|Overall Study|Protocol Violation|1|||
146353728|NCT00532948|527798937|FG001|Overall Study|Protocol Violation|0|||
146353729|NCT00532948|527798938|FG002|Overall Study|Protocol Violation|0|||
146353730|NCT00532948|527798936|FG000|Overall Study|Death|3|||
146353731|NCT00532948|527798937|FG001|Overall Study|Death|3|||
146353732|NCT00532948|527798938|FG002|Overall Study|Death|4|||
146353733|NCT00532948|527798936|FG000|Overall Study|Violation of selection criteria at entry|0|||
146353734|NCT00532948|527798937|FG001|Overall Study|Violation of selection criteria at entry|1|||
146353735|NCT00532948|527798938|FG002|Overall Study|Violation of selection criteria at entry|0|||
146353736|NCT00532948|527798936|FG000|Overall Study|Failure to return|0|||
146353737|NCT00532948|527798937|FG001|Overall Study|Failure to return|1|||
146353738|NCT00532948|527798938|FG002|Overall Study|Failure to return|0|||
146353739|NCT01253044|527798943|FG000|Overall Study|Lost to Follow-up|38|||
146353740|NCT01253044|527798944|FG001|Overall Study|Lost to Follow-up|29|||
146353741|NCT03885726|527798945|FG000|Overall Study|Staffing issues/lost interest|1|||
146353742|NCT03885726|527798945|FG000|Overall Study|Early discharge from hospital|3|||
146353743|NCT02868216|527798948|FG000|Overall Study|Death|0|||
146353744|NCT02868216|527798949|FG001|Overall Study|Death|1|||
146353745|NCT02868216|527798948|FG000|Overall Study|coronary artery bypass|1|||
146353746|NCT02868216|527798949|FG001|Overall Study|coronary artery bypass|0|||
146353747|NCT02868216|527798948|FG000|Overall Study|Withdrawal by Subject|7|||
146353748|NCT02868216|527798949|FG001|Overall Study|Withdrawal by Subject|5|||
146353749|NCT00987623|527798950|FG000|Overall Study|Lost to Follow-up|2|||
146353750|NCT00987623|527798951|FG001|Overall Study|Lost to Follow-up|1|||
146353751|NCT00987623|527798950|FG000|Overall Study|Time/job conflict|2|||
146353752|NCT00987623|527798951|FG001|Overall Study|Time/job conflict|0|||
146353753|NCT00987623|527798950|FG000|Overall Study|Discomfort|1|||
146353754|NCT00987623|527798951|FG001|Overall Study|Discomfort|0|||
146353755|NCT00987623|527798950|FG000|Overall Study|Biomicroscopy|0|||
146353756|NCT00987623|527798951|FG001|Overall Study|Biomicroscopy|1|||
146353757|NCT00987623|527798950|FG000|Overall Study|Influenza|0|||
146353758|NCT00987623|527798951|FG001|Overall Study|Influenza|1|||
146353759|NCT02702193|527798954|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
146353760|NCT02702193|527798955|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
146353761|NCT02702193|527798954|FG000|4 Month Follow up|Withdrawal by Subject|1|||
146353762|NCT02702193|527798955|FG001|4 Month Follow up|Withdrawal by Subject|0|||
146353763|NCT02702193|527798954|FG000|4 Month Follow up|Lost to Follow-up|17|||
146353764|NCT02702193|527798955|FG001|4 Month Follow up|Lost to Follow-up|18|||
146353765|NCT02702193|527798954|FG000|8 Month Follow up|Withdrawal by Subject|1|||
146353766|NCT02702193|527798955|FG001|8 Month Follow up|Withdrawal by Subject|0|||
146353767|NCT02702193|527798954|FG000|8 Month Follow up|Lost to Follow-up|14|||
146353768|NCT02702193|527798955|FG001|8 Month Follow up|Lost to Follow-up|18|||
146353769|NCT02702193|527798954|FG000|12 Month Follow up|Withdrawal by Subject|1|||
146353770|NCT02702193|527798955|FG001|12 Month Follow up|Withdrawal by Subject|0|||
146353771|NCT02702193|527798954|FG000|12 Month Follow up|Lost to Follow-up|16|||
146353772|NCT02702193|527798955|FG001|12 Month Follow up|Lost to Follow-up|18|||
146353773|NCT01201798|527798956|FG000|Overall Study|Adverse Event|2|||
146353774|NCT01201798|527798957|FG001|Overall Study|Adverse Event|0|||
146353775|NCT01201798|527798956|FG000|Overall Study|Lost to Follow-up|3|||
146353776|NCT01201798|527798957|FG001|Overall Study|Lost to Follow-up|5|||
146353777|NCT01201798|527798956|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
146353778|NCT01201798|527798957|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
146353779|NCT01201798|527798956|FG000|Overall Study|Noncompliance|1|||
146353780|NCT01201798|527798957|FG001|Overall Study|Noncompliance|0|||
146353781|NCT01201798|527798956|FG000|Overall Study|Protocol Violation|1|||
146353782|NCT01201798|527798957|FG001|Overall Study|Protocol Violation|1|||
146353783|NCT01201798|527798956|FG000|Overall Study|Treatment Failure|1|||
146353784|NCT01201798|527798957|FG001|Overall Study|Treatment Failure|8|||
146353785|NCT00610935|527798970|FG000|Overall Study|Lost to Follow-up|0|||
146353786|NCT00610935|527798971|FG001|Overall Study|Lost to Follow-up|1|||
146353787|NCT00610935|527798970|FG000|Overall Study|Withdrawal by Subject|0|||
146353788|NCT00610935|527798971|FG001|Overall Study|Withdrawal by Subject|2|||
146353789|NCT00610935|527798970|FG000|Overall Study|Sponsor Discontinuation|1|||
146353790|NCT00610935|527798971|FG001|Overall Study|Sponsor Discontinuation|0|||
146353791|NCT00988559|527798972|FG000|Overall Study|Withdrawal by Subject|1|||
146353792|NCT00988559|527798973|FG001|Overall Study|Withdrawal by Subject|1|||
146353793|NCT00988559|527798974|FG002|Overall Study|Withdrawal by Subject|0|||
146353794|NCT00988559|527798975|FG003|Overall Study|Withdrawal by Subject|1|||
146353795|NCT00988559|527798972|FG000|Overall Study|Pregnancy|0|||
146353796|NCT00988559|527798973|FG001|Overall Study|Pregnancy|1|||
146353797|NCT00988559|527798974|FG002|Overall Study|Pregnancy|1|||
146353798|NCT00988559|527798975|FG003|Overall Study|Pregnancy|0|||
146353799|NCT00988559|527798972|FG000|Overall Study|Lost to Follow-up|0|||
146353800|NCT00988559|527798973|FG001|Overall Study|Lost to Follow-up|0|||
146353801|NCT00988559|527798974|FG002|Overall Study|Lost to Follow-up|1|||
146353802|NCT00988559|527798975|FG003|Overall Study|Lost to Follow-up|0|||
146353803|NCT02224846|527798976|FG000|Period 1 (Month 3)|Adverse Event|2|||
146353804|NCT02224846|527798977|FG001|Period 1 (Month 3)|Adverse Event|1|||
146353805|NCT02224846|527798976|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
146353806|NCT02224846|527798977|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
146353807|NCT02224846|527798976|FG000|Period 1 (Month 3)|Protocol Violation|4|||
146353808|NCT02224846|527798977|FG001|Period 1 (Month 3)|Protocol Violation|8|||
146353809|NCT02224846|527798976|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
146353810|NCT02224846|527798977|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
146353811|NCT02224846|527798976|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
146353812|NCT02224846|527798977|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
146353813|NCT02224846|527798976|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
146353814|NCT02224846|527798977|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
146353815|NCT02224846|527798976|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
146353816|NCT02224846|527798977|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
146353817|NCT02224846|527798976|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
146353818|NCT02224846|527798977|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
146353819|NCT02224846|527798976|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
146353820|NCT02224846|527798977|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
146353821|NCT02224846|527798976|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
146353822|NCT02224846|527798977|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
146353823|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
146353824|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
146353825|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
146353826|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
146353827|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
146353828|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
146353829|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
146353830|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
146353831|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
146353832|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
146353833|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
146353834|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
146353835|NCT02224846|527798976|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
146353836|NCT02224846|527798977|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
146353837|NCT03050359|527800604|FG000|Overall Study|Randomized But Not Treated|2|||
146353838|NCT03050359|527800605|FG001|Overall Study|Randomized But Not Treated|0|||
146353839|NCT03050359|527800604|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
146353840|NCT03050359|527800605|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
146353841|NCT03050359|527800604|FG000|Overall Study|Significant Protocol Deviation|2|||
146353842|NCT03050359|527800605|FG001|Overall Study|Significant Protocol Deviation|3|||
146353843|NCT03050359|527800604|FG000|Overall Study|Lost to Follow-up|2|||
146353844|NCT03050359|527800605|FG001|Overall Study|Lost to Follow-up|1|||
146353845|NCT03050359|527800604|FG000|Overall Study|Voluntary Withdrawal|4|||
146353846|NCT03050359|527800605|FG001|Overall Study|Voluntary Withdrawal|6|||
146353847|NCT03050359|527800604|FG000|Overall Study|Pregnancy|1|||
146353848|NCT03050359|527800605|FG001|Overall Study|Pregnancy|0|||
146353849|NCT03050359|527800604|FG000|Overall Study|Reason Not Specified|1|||
146353850|NCT03050359|527800605|FG001|Overall Study|Reason Not Specified|0|||
146353851|NCT02614287|527800608|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
146353852|NCT02614287|527800609|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
146353853|NCT02614287|527800608|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
146353854|NCT02614287|527800609|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
146353855|NCT02614287|527800608|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
146353856|NCT02614287|527800609|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
146353857|NCT02614287|527800608|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
146353858|NCT02614287|527800609|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
146353859|NCT02614287|527800608|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
146353860|NCT02614287|527800609|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
146353861|NCT02614287|527800608|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
146353862|NCT02614287|527800609|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
146353863|NCT02614287|527800608|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
146353864|NCT02614287|527800609|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
146353865|NCT02614287|527800608|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
146353866|NCT02614287|527800609|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
146353867|NCT01575197|527800611|FG000|Overall Study|Migration out of study area|1|||
146353868|NCT01575197|527800612|FG001|Overall Study|Migration out of study area|5|||
146353869|NCT01575197|527800613|FG002|Overall Study|Migration out of study area|4|||
146353870|NCT01575197|527800611|FG000|Overall Study|SAE|0|||
146353871|NCT01575197|527800612|FG001|Overall Study|SAE|1|||
146353872|NCT01575197|527800613|FG002|Overall Study|SAE|0|||
146353873|NCT01575197|527800611|FG000|Overall Study|Lost to Follow-up|0|||
146353874|NCT01575197|527800612|FG001|Overall Study|Lost to Follow-up|1|||
146353875|NCT01575197|527800613|FG002|Overall Study|Lost to Follow-up|0|||
146353876|NCT01575197|527800611|FG000|Overall Study|Withdrawal by Subject|0|||
146353877|NCT01575197|527800612|FG001|Overall Study|Withdrawal by Subject|1|||
146353878|NCT01575197|527800613|FG002|Overall Study|Withdrawal by Subject|1|||
146353879|NCT01575197|527800611|FG000|Overall Study|Protocol Violation|2|||
146353880|NCT01575197|527800612|FG001|Overall Study|Protocol Violation|1|||
146353881|NCT01575197|527800613|FG002|Overall Study|Protocol Violation|1|||
146353882|NCT00833248|527800617|FG000|Overall Study|Adverse Event|3|||
146353883|NCT00833248|527800618|FG001|Overall Study|Adverse Event|0|||
146353884|NCT00833248|527800617|FG000|Overall Study|Protocol Violation|1|||
146353885|NCT00833248|527800618|FG001|Overall Study|Protocol Violation|2|||
146353886|NCT00833248|527800617|FG000|Overall Study|Withdrawal by Subject|0|||
146353887|NCT00833248|527800618|FG001|Overall Study|Withdrawal by Subject|1|||
146353888|NCT01826422|527800621|FG000|Overall Study|Withdrawal by Subject|1|||
146353889|NCT01826422|527800622|FG001|Overall Study|Withdrawal by Subject|3|||
146353890|NCT04009096|527800623|FG000|Overall Study|Withdrawal by Subject|0|||
146353891|NCT04009096|527800624|FG001|Overall Study|Withdrawal by Subject|7|||
146353892|NCT04009096|527800625|FG002|Overall Study|Withdrawal by Subject|0|||
146353893|NCT04009096|527800623|FG000|Overall Study|Physician Decision|0|||
146169596|NCT00499863|527132866|FG001|Overall Study|Lost to Follow-up|1|||
146353894|NCT04009096|527800624|FG001|Overall Study|Physician Decision|1|||
146353895|NCT04009096|527800625|FG002|Overall Study|Physician Decision|0|||
146353896|NCT05151471|527800626|FG000|Overall Study|Adverse Event|21|||
146353897|NCT05151471|527800627|FG001|Overall Study|Adverse Event|16|||
146353898|NCT05151471|527800626|FG000|Overall Study|Death|1|||
146353899|NCT05151471|527800627|FG001|Overall Study|Death|0|||
146353900|NCT05151471|527800626|FG000|Overall Study|Lost to Follow-up|0|||
146353901|NCT05151471|527800627|FG001|Overall Study|Lost to Follow-up|1|||
146353902|NCT05151471|527800626|FG000|Overall Study|Withdrawal by Subject|7|||
146353903|NCT05151471|527800627|FG001|Overall Study|Withdrawal by Subject|9|||
146353904|NCT05151471|527800626|FG000|Overall Study|Study terminated by sponsor|49|||
146353905|NCT05151471|527800627|FG001|Overall Study|Study terminated by sponsor|47|||
146353906|NCT05151471|527800626|FG000|Overall Study|Other|2|||
146353907|NCT05151471|527800627|FG001|Overall Study|Other|1|||
146353908|NCT03010423|527800628|FG000|Overall Study|Study termination|8|||
146353909|NCT03484923|527800631|FG000|Overall Study|Adverse Event|3|||
146353910|NCT03484923|527800632|FG001|Overall Study|Adverse Event|3|||
146353911|NCT03484923|527800633|FG002|Overall Study|Adverse Event|5|||
146353912|NCT03484923|527800634|FG003|Overall Study|Adverse Event|11|||
146353913|NCT03484923|527800635|FG004|Overall Study|Adverse Event|1|||
146353914|NCT03484923|527800631|FG000|Overall Study|Death|2|||
146353915|NCT03484923|527800632|FG001|Overall Study|Death|2|||
146353916|NCT03484923|527800633|FG002|Overall Study|Death|3|||
146353917|NCT03484923|527800634|FG003|Overall Study|Death|0|||
146353918|NCT03484923|527800635|FG004|Overall Study|Death|1|||
146353919|NCT03484923|527800631|FG000|Overall Study|Physician Decision|6|||
146353920|NCT03484923|527800632|FG001|Overall Study|Physician Decision|7|||
146353921|NCT03484923|527800633|FG002|Overall Study|Physician Decision|6|||
146353922|NCT03484923|527800634|FG003|Overall Study|Physician Decision|3|||
146353923|NCT03484923|527800635|FG004|Overall Study|Physician Decision|2|||
146353924|NCT03484923|527800631|FG000|Overall Study|Progressive disease|33|||
146353925|NCT03484923|527800632|FG001|Overall Study|Progressive disease|28|||
146353926|NCT03484923|527800633|FG002|Overall Study|Progressive disease|26|||
146353927|NCT03484923|527800634|FG003|Overall Study|Progressive disease|30|||
146353928|NCT03484923|527800635|FG004|Overall Study|Progressive disease|16|||
146353929|NCT03484923|527800631|FG000|Overall Study|Subject Decision|1|||
146353930|NCT03484923|527800632|FG001|Overall Study|Subject Decision|3|||
146353931|NCT03484923|527800633|FG002|Overall Study|Subject Decision|3|||
146353932|NCT03484923|527800634|FG003|Overall Study|Subject Decision|0|||
146353933|NCT03484923|527800635|FG004|Overall Study|Subject Decision|1|||
146353934|NCT00115349|527800638|FG000|Overall Study|Study closed due to low enrollment.|11|||
146353935|NCT00115349|527800639|FG001|Overall Study|Study closed due to low enrollment.|9|||
146353936|NCT02935634|527800640|FG000|Randomization|Participant withdrew consent|0|||
146353937|NCT02935634|527800641|FG001|Randomization|Participant withdrew consent|1|||
146353938|NCT02935634|527800642|FG002|Randomization|Participant withdrew consent|0|||
146353939|NCT02935634|527800643|FG003|Randomization|Participant withdrew consent|0|||
146353940|NCT02935634|527800644|FG004|Randomization|Participant withdrew consent|0|||
146353941|NCT02935634|527800645|FG005|Randomization|Participant withdrew consent|0|||
146353942|NCT02935634|527800640|FG000|Randomization|Death|2|||
146353943|NCT02935634|527800641|FG001|Randomization|Death|1|||
146353944|NCT02935634|527800642|FG002|Randomization|Death|1|||
146353945|NCT02935634|527800643|FG003|Randomization|Death|0|||
146353946|NCT02935634|527800644|FG004|Randomization|Death|0|||
146353947|NCT02935634|527800645|FG005|Randomization|Death|0|||
146353948|NCT02935634|527800640|FG000|Randomization|Other reasons|0|||
146353949|NCT02935634|527800641|FG001|Randomization|Other reasons|2|||
146353950|NCT02935634|527800642|FG002|Randomization|Other reasons|2|||
146353951|NCT02935634|527800643|FG003|Randomization|Other reasons|0|||
146353952|NCT02935634|527800644|FG004|Randomization|Other reasons|0|||
146353953|NCT02935634|527800645|FG005|Randomization|Other reasons|0|||
146353954|NCT02935634|527800640|FG000|Treatment: Track 1|Disease progression|15|||
146353955|NCT02935634|527800641|FG001|Treatment: Track 1|Disease progression|17|||
146353956|NCT02935634|527800642|FG002|Treatment: Track 1|Disease progression|28|||
146353957|NCT02935634|527800643|FG003|Treatment: Track 1|Disease progression|4|||
146353958|NCT02935634|527800644|FG004|Treatment: Track 1|Disease progression|6|||
146353959|NCT02935634|527800645|FG005|Treatment: Track 1|Disease progression|2|||
146353960|NCT02935634|527800640|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
146353961|NCT02935634|527800641|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
146353962|NCT02935634|527800642|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
146353963|NCT02935634|527800643|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
146353964|NCT02935634|527800644|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
146353965|NCT02935634|527800645|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
146353966|NCT02935634|527800640|FG000|Treatment: Track 1|Lost to Follow-up|1|||
146353967|NCT02935634|527800641|FG001|Treatment: Track 1|Lost to Follow-up|0|||
146353968|NCT02935634|527800642|FG002|Treatment: Track 1|Lost to Follow-up|0|||
146353969|NCT02935634|527800643|FG003|Treatment: Track 1|Lost to Follow-up|0|||
146353970|NCT02935634|527800644|FG004|Treatment: Track 1|Lost to Follow-up|0|||
146353971|NCT02935634|527800645|FG005|Treatment: Track 1|Lost to Follow-up|0|||
146353972|NCT02935634|527800640|FG000|Treatment: Track 1|Study drug toxicity|2|||
146353973|NCT02935634|527800641|FG001|Treatment: Track 1|Study drug toxicity|1|||
146353974|NCT02935634|527800642|FG002|Treatment: Track 1|Study drug toxicity|3|||
146353975|NCT02935634|527800643|FG003|Treatment: Track 1|Study drug toxicity|0|||
146353976|NCT02935634|527800644|FG004|Treatment: Track 1|Study drug toxicity|0|||
146353977|NCT02935634|527800645|FG005|Treatment: Track 1|Study drug toxicity|1|||
146353978|NCT02935634|527800640|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
146353979|NCT02935634|527800641|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
146353980|NCT02935634|527800642|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
146353981|NCT02935634|527800643|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
146353982|NCT02935634|527800644|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
146353983|NCT02935634|527800645|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
146353984|NCT02935634|527800640|FG000|Treatment: Track 1|Participant withdrew consent|2|||
146353985|NCT02935634|527800641|FG001|Treatment: Track 1|Participant withdrew consent|0|||
146353986|NCT02935634|527800642|FG002|Treatment: Track 1|Participant withdrew consent|1|||
146353987|NCT02935634|527800643|FG003|Treatment: Track 1|Participant withdrew consent|0|||
146353988|NCT02935634|527800644|FG004|Treatment: Track 1|Participant withdrew consent|1|||
146353989|NCT02935634|527800645|FG005|Treatment: Track 1|Participant withdrew consent|0|||
146353990|NCT02935634|527800640|FG000|Treatment: Track 1|Other reasons|0|||
146353991|NCT02935634|527800641|FG001|Treatment: Track 1|Other reasons|0|||
146353992|NCT02935634|527800642|FG002|Treatment: Track 1|Other reasons|2|||
146353993|NCT02935634|527800643|FG003|Treatment: Track 1|Other reasons|0|||
146353994|NCT02935634|527800644|FG004|Treatment: Track 1|Other reasons|0|||
146353995|NCT02935634|527800645|FG005|Treatment: Track 1|Other reasons|0|||
146353996|NCT02935634|527800640|FG000|Treatment: Track 2|Disease progression|13|||
146353997|NCT02935634|527800641|FG001|Treatment: Track 2|Disease progression|26|||
146353998|NCT02935634|527800642|FG002|Treatment: Track 2|Disease progression|20|||
146353999|NCT02935634|527800643|FG003|Treatment: Track 2|Disease progression|5|||
146354000|NCT02935634|527800644|FG004|Treatment: Track 2|Disease progression|1|||
146354001|NCT02935634|527800645|FG005|Treatment: Track 2|Disease progression|4|||
146354002|NCT02935634|527800640|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
146354003|NCT02935634|527800641|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
146354004|NCT02935634|527800642|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146354005|NCT02935634|527800643|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146354006|NCT02935634|527800644|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146354007|NCT02935634|527800645|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
146354008|NCT02935634|527800640|FG000|Treatment: Track 2|Study drug toxicity|7|||
146354009|NCT02935634|527800641|FG001|Treatment: Track 2|Study drug toxicity|3|||
146354010|NCT02935634|527800642|FG002|Treatment: Track 2|Study drug toxicity|0|||
146354011|NCT02935634|527800643|FG003|Treatment: Track 2|Study drug toxicity|0|||
146354012|NCT02935634|527800644|FG004|Treatment: Track 2|Study drug toxicity|0|||
146354013|NCT02935634|527800645|FG005|Treatment: Track 2|Study drug toxicity|0|||
146354014|NCT02935634|527800640|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
146354015|NCT02935634|527800641|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
146354016|NCT02935634|527800642|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
146354017|NCT02935634|527800643|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
146354018|NCT02935634|527800644|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
146354019|NCT02935634|527800645|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
146354020|NCT02935634|527800640|FG000|Treatment: Track 2|Participant withdrew consent|0|||
146354021|NCT02935634|527800641|FG001|Treatment: Track 2|Participant withdrew consent|1|||
146354022|NCT02935634|527800642|FG002|Treatment: Track 2|Participant withdrew consent|1|||
146354023|NCT02935634|527800643|FG003|Treatment: Track 2|Participant withdrew consent|0|||
146354024|NCT02935634|527800644|FG004|Treatment: Track 2|Participant withdrew consent|1|||
146354025|NCT02935634|527800645|FG005|Treatment: Track 2|Participant withdrew consent|0|||
146354026|NCT00995345|527800646|FG000|Overall Study|Withdrawal by Subject|4|||
146354027|NCT00995345|527800647|FG001|Overall Study|Withdrawal by Subject|2|||
146354028|NCT00995345|527800648|FG002|Overall Study|Withdrawal by Subject|1|||
146354029|NCT00995345|527800649|FG003|Overall Study|Withdrawal by Subject|3|||
146354030|NCT00995345|527800650|FG004|Overall Study|Withdrawal by Subject|1|||
146354031|NCT00995345|527800646|FG000|Overall Study|Adverse Event|3|||
146354032|NCT00995345|527800647|FG001|Overall Study|Adverse Event|1|||
146354033|NCT00995345|527800648|FG002|Overall Study|Adverse Event|2|||
146354034|NCT00995345|527800649|FG003|Overall Study|Adverse Event|0|||
146354035|NCT00995345|527800650|FG004|Overall Study|Adverse Event|1|||
146354036|NCT00995345|527800646|FG000|Overall Study|Lost to Follow-up|2|||
146354037|NCT00995345|527800647|FG001|Overall Study|Lost to Follow-up|2|||
146354038|NCT00995345|527800648|FG002|Overall Study|Lost to Follow-up|2|||
146354039|NCT00995345|527800649|FG003|Overall Study|Lost to Follow-up|1|||
146354040|NCT00995345|527800650|FG004|Overall Study|Lost to Follow-up|0|||
146354041|NCT00995345|527800646|FG000|Overall Study|all other reasons combined|2|||
146354042|NCT00995345|527800647|FG001|Overall Study|all other reasons combined|2|||
146354043|NCT00995345|527800648|FG002|Overall Study|all other reasons combined|2|||
146354044|NCT00995345|527800649|FG003|Overall Study|all other reasons combined|1|||
146354045|NCT00995345|527800650|FG004|Overall Study|all other reasons combined|3|||
146354046|NCT02651194|527800651|FG000|Overall Study|Lost to Follow-up|3|||
146354047|NCT02651194|527800651|FG000|Overall Study|Other|2|||
146354048|NCT01842308|527800652|FG000|Overall Study|Withdrawal by Subject|0|||
146354049|NCT01842308|527800653|FG001|Overall Study|Withdrawal by Subject|0|||
146354050|NCT01842308|527800654|FG002|Overall Study|Withdrawal by Subject|0|||
146354051|NCT01842308|527800655|FG003|Overall Study|Withdrawal by Subject|0|||
146354052|NCT01842308|527800656|FG004|Overall Study|Withdrawal by Subject|1|||
146354053|NCT02399813|527800670|FG000|Overall Study|Progressive Disease-Radiographic|2|||
146354054|NCT02399813|527800670|FG000|Overall Study|Death|20|||
146354055|NCT02399813|527800670|FG000|Overall Study|Withdrawal by Subject|3|||
146354056|NCT02399813|527800670|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
146354057|NCT02399813|527800670|FG000|Overall Study|Lost to Follow-up|2|||
146354058|NCT02399813|527800670|FG000|Overall Study|Other than specified|5|||
146354059|NCT03280550|527800671|FG000|Overall Study|Withdrawal by Subject|2|||
146354060|NCT03280550|527800672|FG001|Overall Study|Withdrawal by Subject|2|||
146354061|NCT03280550|527800671|FG000|Overall Study|Physician Decision|0|||
146354062|NCT03280550|527800672|FG001|Overall Study|Physician Decision|1|||
146354063|NCT03345836|527800677|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
146354064|NCT03345836|527800678|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
146354065|NCT03345836|527800679|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
146354066|NCT03345836|527800680|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146354067|NCT03345836|527800681|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146354068|NCT03345836|527800682|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
146354069|NCT03345836|527800677|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
146354070|NCT03345836|527800678|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
146354071|NCT03345836|527800679|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
146354072|NCT03345836|527800680|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146354073|NCT03345836|527800681|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146354074|NCT03345836|527800682|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
146354075|NCT03345836|527800677|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146354076|NCT03345836|527800678|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
146354077|NCT03345836|527800679|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146354078|NCT03345836|527800680|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146354079|NCT03345836|527800681|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146354080|NCT03345836|527800682|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
146354081|NCT03345836|527800677|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
146354082|NCT03345836|527800678|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
146354083|NCT03345836|527800679|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146354084|NCT03345836|527800680|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146354085|NCT03345836|527800681|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146354086|NCT03345836|527800682|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
146354087|NCT03345836|527800677|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
146354088|NCT03345836|527800678|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
146354089|NCT03345836|527800679|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
146354090|NCT03345836|527800680|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146354091|NCT03345836|527800681|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146354092|NCT03345836|527800682|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
146354093|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146354094|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146354095|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146354096|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
146354097|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
146354098|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
146354099|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146354100|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146354101|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146354102|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
146354103|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
146354104|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
146354105|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146354106|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146354107|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146354108|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146354109|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
146354110|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
146354111|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146354112|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146354113|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
146354114|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
146354115|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
146354116|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
146354117|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146354118|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146354119|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146354120|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146354121|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
146354122|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
146354123|NCT03345836|527800677|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146354124|NCT03345836|527800678|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146354125|NCT03345836|527800679|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
146354126|NCT03345836|527800680|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146354127|NCT03345836|527800681|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146354128|NCT03345836|527800682|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
146354129|NCT00320385|527800685|FG000|Overall Study|Lost to Follow-up|7|||
146354130|NCT00320385|527800686|FG001|Overall Study|Lost to Follow-up|10|||
146354131|NCT00320385|527800685|FG000|Overall Study|Withdrawal by Subject|6|||
146354132|NCT00320385|527800686|FG001|Overall Study|Withdrawal by Subject|7|||
146354133|NCT00320385|527800685|FG000|Overall Study|Sponsor Terminated Study|2|||
146354134|NCT00320385|527800686|FG001|Overall Study|Sponsor Terminated Study|1|||
146354135|NCT00320385|527800685|FG000|Overall Study|Investigator Decision|0|||
146354136|NCT00320385|527800686|FG001|Overall Study|Investigator Decision|1|||
146354137|NCT00320385|527800685|FG000|Overall Study|Death|1|||
146354138|NCT00320385|527800686|FG001|Overall Study|Death|2|||
146354139|NCT00320385|527800685|FG000|Overall Study|Serious Adverse Event|1|||
146354140|NCT00320385|527800686|FG001|Overall Study|Serious Adverse Event|0|||
146354141|NCT00320385|527800685|FG000|Overall Study|Withdrew Consent|1|||
146354142|NCT00320385|527800686|FG001|Overall Study|Withdrew Consent|0|||
146354143|NCT00320385|527800685|FG000|Overall Study|Adverse Event|0|||
146354144|NCT00320385|527800686|FG001|Overall Study|Adverse Event|1|||
146354145|NCT00748540|527800692|FG000|Overall Study|Physician Decision|1|||
146354146|NCT02775864|527800693|FG000|Overall Study|Data ended end of 2010|1764|||
146354147|NCT02775864|527800694|FG001|Overall Study|Data ended end of 2010|2880|||
146354148|NCT02775864|527800695|FG002|Overall Study|Data ended end of 2010|1140|||
146354149|NCT02775864|527800696|FG003|Overall Study|Data ended end of 2010|1194|||
146354150|NCT02775864|527800693|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
146354151|NCT02775864|527800694|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
146354152|NCT02775864|527800695|FG002|Overall Study|Medicaid eligibility discontinued|720|||
146354153|NCT02775864|527800696|FG003|Overall Study|Medicaid eligibility discontinued|890|||
146354154|NCT02028338|527800698|FG000|Overall Study|Withdrawal by Subject|3|||
146354155|NCT02028338|527800699|FG001|Overall Study|Withdrawal by Subject|1|||
146354156|NCT02028338|527800698|FG000|Overall Study|Unable to contact participant|1|||
146354157|NCT02028338|527800699|FG001|Overall Study|Unable to contact participant|0|||
146354158|NCT01842620|527800702|FG000|Period 1|Withdrawal by Subject|1|||
146354159|NCT01842620|527800703|FG001|Period 1|Withdrawal by Subject|0|||
146354160|NCT00256867|527800704|FG000|Overall Study|Adverse Event|0|||
146354161|NCT00256867|527800705|FG001|Overall Study|Adverse Event|1|||
146354162|NCT00256867|527800706|FG002|Overall Study|Adverse Event|1|||
146354163|NCT00256867|527800707|FG003|Overall Study|Adverse Event|1|||
146354164|NCT00256867|527800708|FG004|Overall Study|Adverse Event|2|||
146354165|NCT00256867|527800709|FG005|Overall Study|Adverse Event|2|||
146354166|NCT00256867|527800710|FG006|Overall Study|Adverse Event|1|||
146354167|NCT00256867|527800711|FG007|Overall Study|Adverse Event|4|||
146354168|NCT00256867|527800704|FG000|Overall Study|Lost to Follow-up|2|||
146354169|NCT00256867|527800705|FG001|Overall Study|Lost to Follow-up|2|||
146354170|NCT00256867|527800706|FG002|Overall Study|Lost to Follow-up|2|||
146354171|NCT00256867|527800707|FG003|Overall Study|Lost to Follow-up|3|||
146354172|NCT00256867|527800708|FG004|Overall Study|Lost to Follow-up|2|||
146354173|NCT00256867|527800709|FG005|Overall Study|Lost to Follow-up|0|||
146354174|NCT00256867|527800710|FG006|Overall Study|Lost to Follow-up|1|||
146354175|NCT00256867|527800711|FG007|Overall Study|Lost to Follow-up|2|||
146354176|NCT00256867|527800704|FG000|Overall Study|Protocol Violation|0|||
146354177|NCT00256867|527800705|FG001|Overall Study|Protocol Violation|0|||
146354178|NCT00256867|527800706|FG002|Overall Study|Protocol Violation|0|||
146354179|NCT00256867|527800707|FG003|Overall Study|Protocol Violation|1|||
146354180|NCT00256867|527800708|FG004|Overall Study|Protocol Violation|0|||
146354181|NCT00256867|527800709|FG005|Overall Study|Protocol Violation|1|||
146354182|NCT00256867|527800710|FG006|Overall Study|Protocol Violation|0|||
146354183|NCT00256867|527800711|FG007|Overall Study|Protocol Violation|1|||
146354184|NCT00256867|527800704|FG000|Overall Study|Withdrawal by Subject|0|||
146354185|NCT00256867|527800705|FG001|Overall Study|Withdrawal by Subject|0|||
146354186|NCT00256867|527800706|FG002|Overall Study|Withdrawal by Subject|1|||
146354187|NCT00256867|527800707|FG003|Overall Study|Withdrawal by Subject|1|||
146354188|NCT00256867|527800708|FG004|Overall Study|Withdrawal by Subject|2|||
146354189|NCT00256867|527800709|FG005|Overall Study|Withdrawal by Subject|2|||
146354190|NCT00256867|527800710|FG006|Overall Study|Withdrawal by Subject|3|||
146354191|NCT00256867|527800711|FG007|Overall Study|Withdrawal by Subject|2|||
146354192|NCT00256867|527800704|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354193|NCT00256867|527800705|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
146354194|NCT00256867|527800706|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354195|NCT00256867|527800707|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354196|NCT00256867|527800708|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354197|NCT00256867|527800709|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354198|NCT00256867|527800710|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354199|NCT00256867|527800711|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
146354200|NCT00256867|527800704|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354201|NCT00256867|527800705|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354202|NCT00256867|527800706|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354203|NCT00256867|527800707|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354204|NCT00256867|527800708|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354205|NCT00256867|527800709|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354206|NCT00256867|527800710|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
146354207|NCT00256867|527800711|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
146354208|NCT00256867|527800704|FG000|Overall Study|Investigator's Decision|0|||
146354209|NCT00256867|527800705|FG001|Overall Study|Investigator's Decision|0|||
146354210|NCT00256867|527800706|FG002|Overall Study|Investigator's Decision|0|||
146354211|NCT00256867|527800707|FG003|Overall Study|Investigator's Decision|0|||
146354212|NCT00256867|527800708|FG004|Overall Study|Investigator's Decision|1|||
146354213|NCT00256867|527800709|FG005|Overall Study|Investigator's Decision|0|||
146354214|NCT00256867|527800710|FG006|Overall Study|Investigator's Decision|0|||
146354215|NCT00256867|527800711|FG007|Overall Study|Investigator's Decision|0|||
146354216|NCT00256867|527800704|FG000|Overall Study|Non-compliance with study medication|0|||
146354217|NCT00256867|527800705|FG001|Overall Study|Non-compliance with study medication|0|||
146354218|NCT00256867|527800706|FG002|Overall Study|Non-compliance with study medication|0|||
146354219|NCT00256867|527800707|FG003|Overall Study|Non-compliance with study medication|0|||
146354220|NCT00256867|527800708|FG004|Overall Study|Non-compliance with study medication|0|||
146354221|NCT00256867|527800709|FG005|Overall Study|Non-compliance with study medication|0|||
146354222|NCT00256867|527800710|FG006|Overall Study|Non-compliance with study medication|0|||
146354223|NCT00256867|527800711|FG007|Overall Study|Non-compliance with study medication|1|||
146354224|NCT00256867|527800704|FG000|Overall Study|Participant travelled Overseas|0|||
146354225|NCT00256867|527800705|FG001|Overall Study|Participant travelled Overseas|1|||
146354226|NCT00256867|527800706|FG002|Overall Study|Participant travelled Overseas|0|||
146354227|NCT00256867|527800707|FG003|Overall Study|Participant travelled Overseas|0|||
146354228|NCT00256867|527800708|FG004|Overall Study|Participant travelled Overseas|0|||
146354229|NCT00256867|527800709|FG005|Overall Study|Participant travelled Overseas|0|||
146354230|NCT00256867|527800710|FG006|Overall Study|Participant travelled Overseas|0|||
146354231|NCT00256867|527800711|FG007|Overall Study|Participant travelled Overseas|0|||
146354232|NCT00256867|527800704|FG000|Overall Study|Participant out of assessment window|0|||
146354233|NCT00256867|527800705|FG001|Overall Study|Participant out of assessment window|0|||
146354234|NCT00256867|527800706|FG002|Overall Study|Participant out of assessment window|1|||
146354235|NCT00256867|527800707|FG003|Overall Study|Participant out of assessment window|0|||
146354236|NCT00256867|527800708|FG004|Overall Study|Participant out of assessment window|0|||
146354237|NCT00256867|527800709|FG005|Overall Study|Participant out of assessment window|0|||
146354238|NCT00256867|527800710|FG006|Overall Study|Participant out of assessment window|0|||
146354239|NCT00256867|527800711|FG007|Overall Study|Participant out of assessment window|0|||
146354240|NCT00256867|527800704|FG000|Overall Study|Withdrawal by participant|0|||
146354241|NCT00256867|527800705|FG001|Overall Study|Withdrawal by participant|0|||
146354242|NCT00256867|527800706|FG002|Overall Study|Withdrawal by participant|0|||
146354243|NCT00256867|527800707|FG003|Overall Study|Withdrawal by participant|0|||
146354244|NCT00256867|527800708|FG004|Overall Study|Withdrawal by participant|0|||
146354245|NCT00256867|527800709|FG005|Overall Study|Withdrawal by participant|1|||
146354246|NCT00256867|527800710|FG006|Overall Study|Withdrawal by participant|0|||
146354247|NCT00256867|527800711|FG007|Overall Study|Withdrawal by participant|0|||
146354248|NCT01930799|527800712|FG000|Overall Study|Withdrawal by Subject|3|||
146354249|NCT01930799|527800712|FG000|Overall Study|Lost to Follow-up|5|||
146354250|NCT00875017|527800715|FG000|First Intervention|Withdrawal by Subject|1|||
146354251|NCT00875017|527800716|FG001|First Intervention|Withdrawal by Subject|0|||
146169597|NCT00691132|527132867|FG000|Overall Study|Adverse Event|2|||
146169598|NCT00691132|527132868|FG001|Overall Study|Adverse Event|3|||
146354252|NCT00875017|527800717|FG002|First Intervention|Withdrawal by Subject|1|||
146354253|NCT00875017|527800718|FG003|First Intervention|Withdrawal by Subject|0|||
146354254|NCT00875017|527800719|FG004|First Intervention|Withdrawal by Subject|0|||
146354255|NCT00875017|527800720|FG005|First Intervention|Withdrawal by Subject|0|||
146354256|NCT00875017|527800715|FG000|First Intervention|Adverse Event|0|||
146354257|NCT00875017|527800716|FG001|First Intervention|Adverse Event|0|||
146354258|NCT00875017|527800717|FG002|First Intervention|Adverse Event|0|||
146354259|NCT00875017|527800718|FG003|First Intervention|Adverse Event|1|||
146354260|NCT00875017|527800719|FG004|First Intervention|Adverse Event|0|||
146354261|NCT00875017|527800720|FG005|First Intervention|Adverse Event|0|||
146354262|NCT00875017|527800715|FG000|First Intervention|Problems collecting rectal effluent|1|||
146354263|NCT00875017|527800716|FG001|First Intervention|Problems collecting rectal effluent|0|||
146354264|NCT00875017|527800717|FG002|First Intervention|Problems collecting rectal effluent|0|||
146354265|NCT00875017|527800718|FG003|First Intervention|Problems collecting rectal effluent|0|||
146354266|NCT00875017|527800719|FG004|First Intervention|Problems collecting rectal effluent|0|||
146354267|NCT00875017|527800720|FG005|First Intervention|Problems collecting rectal effluent|0|||
146354268|NCT00875017|527800715|FG000|First Intervention|Intolerance to nasogastric tube|0|||
146354269|NCT00875017|527800716|FG001|First Intervention|Intolerance to nasogastric tube|0|||
146354270|NCT00875017|527800717|FG002|First Intervention|Intolerance to nasogastric tube|0|||
146354271|NCT00875017|527800718|FG003|First Intervention|Intolerance to nasogastric tube|0|||
146354272|NCT00875017|527800719|FG004|First Intervention|Intolerance to nasogastric tube|1|||
146354273|NCT00875017|527800720|FG005|First Intervention|Intolerance to nasogastric tube|0|||
146354274|NCT00875017|527800715|FG000|Washout|Problem collecting rectal effluent|0|||
146354275|NCT00875017|527800716|FG001|Washout|Problem collecting rectal effluent|0|||
146354276|NCT00875017|527800717|FG002|Washout|Problem collecting rectal effluent|1|||
146354277|NCT00875017|527800718|FG003|Washout|Problem collecting rectal effluent|0|||
146354278|NCT00875017|527800719|FG004|Washout|Problem collecting rectal effluent|0|||
146354279|NCT00875017|527800720|FG005|Washout|Problem collecting rectal effluent|0|||
146354280|NCT00875017|527800715|FG000|Second Intervention|Adverse Event|0|||
146354281|NCT00875017|527800716|FG001|Second Intervention|Adverse Event|0|||
146354282|NCT00875017|527800717|FG002|Second Intervention|Adverse Event|0|||
146354283|NCT00875017|527800718|FG003|Second Intervention|Adverse Event|1|||
146354284|NCT00875017|527800719|FG004|Second Intervention|Adverse Event|0|||
146354285|NCT00875017|527800720|FG005|Second Intervention|Adverse Event|0|||
146354286|NCT00875017|527800715|FG000|Washout|Problems collecting rectal effluent|0|||
146354287|NCT00875017|527800716|FG001|Washout|Problems collecting rectal effluent|1|||
146354288|NCT00875017|527800717|FG002|Washout|Problems collecting rectal effluent|0|||
146354289|NCT00875017|527800718|FG003|Washout|Problems collecting rectal effluent|0|||
146354290|NCT00875017|527800719|FG004|Washout|Problems collecting rectal effluent|0|||
146354291|NCT00875017|527800720|FG005|Washout|Problems collecting rectal effluent|0|||
146354292|NCT00875017|527800715|FG000|Third Intervention|Adverse Event|0|||
146354293|NCT00875017|527800716|FG001|Third Intervention|Adverse Event|1|||
146354294|NCT00875017|527800717|FG002|Third Intervention|Adverse Event|1|||
146354295|NCT00875017|527800718|FG003|Third Intervention|Adverse Event|0|||
146354296|NCT00875017|527800719|FG004|Third Intervention|Adverse Event|0|||
146354297|NCT00875017|527800720|FG005|Third Intervention|Adverse Event|0|||
146354298|NCT00875017|527800715|FG000|Washout|Withdrawal by Subject|0|||
146354299|NCT00875017|527800716|FG001|Washout|Withdrawal by Subject|0|||
146354300|NCT00875017|527800717|FG002|Washout|Withdrawal by Subject|0|||
146354301|NCT00875017|527800718|FG003|Washout|Withdrawal by Subject|0|||
146354302|NCT00875017|527800719|FG004|Washout|Withdrawal by Subject|1|||
146354303|NCT00875017|527800720|FG005|Washout|Withdrawal by Subject|0|||
146354304|NCT00875017|527800715|FG000|Fourth Intervention|Inability to comply with fasting|0|||
146354305|NCT00875017|527800716|FG001|Fourth Intervention|Inability to comply with fasting|0|||
146354306|NCT00875017|527800717|FG002|Fourth Intervention|Inability to comply with fasting|0|||
146354307|NCT00875017|527800718|FG003|Fourth Intervention|Inability to comply with fasting|0|||
146354308|NCT00875017|527800719|FG004|Fourth Intervention|Inability to comply with fasting|0|||
146354309|NCT00875017|527800720|FG005|Fourth Intervention|Inability to comply with fasting|1|||
146354310|NCT03342469|527800721|FG000|Overall Study|Withdrawal by Subject|0|||
146354311|NCT03342469|527800722|FG001|Overall Study|Withdrawal by Subject|1|||
146354312|NCT03342469|527800723|FG002|Overall Study|Withdrawal by Subject|0|||
146354313|NCT03342469|527800724|FG003|Overall Study|Withdrawal by Subject|0|||
146354314|NCT02689219|527800725|FG000|Overall Study|Death|1|||
146354315|NCT02689219|527800726|FG001|Overall Study|Death|1|||
146354316|NCT02689219|527800725|FG000|Overall Study|Disease Progression|10|||
146354317|NCT02689219|527800726|FG001|Overall Study|Disease Progression|6|||
146354318|NCT01477892|527800727|FG000|Overall Study|Withdrawal by Subject|0|||
146354319|NCT01477892|527800728|FG001|Overall Study|Withdrawal by Subject|2|||
146354320|NCT01921257|527800729|FG000|Overall Study|Adverse Event|1|||
146354321|NCT01921257|527800729|FG000|Overall Study|Protocol Violation|1|||
146354322|NCT01921257|527800729|FG000|Overall Study|Withdrawal by Subject|1|||
146354323|NCT05515601|527800731|FG000|Overall Study|Withdrawal by Subject|1|||
146354324|NCT05515601|527800732|FG001|Overall Study|Withdrawal by Subject|3|||
146354325|NCT05515601|527800733|FG002|Overall Study|Withdrawal by Subject|2|||
146354326|NCT05515601|527800734|FG003|Overall Study|Withdrawal by Subject|1|||
146354327|NCT05515601|527800735|FG004|Overall Study|Withdrawal by Subject|1|||
146354328|NCT05515601|527800736|FG005|Overall Study|Withdrawal by Subject|1|||
146354329|NCT05515601|527800731|FG000|Overall Study|Lost to Follow-up|0|||
146354330|NCT05515601|527800732|FG001|Overall Study|Lost to Follow-up|0|||
146354331|NCT05515601|527800733|FG002|Overall Study|Lost to Follow-up|0|||
146354332|NCT05515601|527800734|FG003|Overall Study|Lost to Follow-up|0|||
146354333|NCT05515601|527800735|FG004|Overall Study|Lost to Follow-up|1|||
146354334|NCT05515601|527800736|FG005|Overall Study|Lost to Follow-up|0|||
146354335|NCT01689207|527800737|FG000|Overall Study|Adverse Event|0|||
146354336|NCT01689207|527800738|FG001|Overall Study|Adverse Event|1|||
146354337|NCT01689207|527800739|FG002|Overall Study|Adverse Event|0|||
146354338|NCT01689207|527800740|FG003|Overall Study|Adverse Event|0|||
146354339|NCT01689207|527800741|FG004|Overall Study|Adverse Event|2|||
146354340|NCT01689207|527800742|FG005|Overall Study|Adverse Event|1|||
146354341|NCT01689207|527800743|FG006|Overall Study|Adverse Event|0|||
146354342|NCT01689207|527800744|FG007|Overall Study|Adverse Event|0|||
146354343|NCT01689207|527800745|FG008|Overall Study|Adverse Event|1|||
146354344|NCT01689207|527800746|FG009|Overall Study|Adverse Event|0|||
146354345|NCT01689207|527800747|FG010|Overall Study|Adverse Event|0|||
146354346|NCT01912768|527800748|FG000|Overall Study|Adverse Event|2|||
146354347|NCT01912768|527800749|FG001|Overall Study|Adverse Event|0|||
146354348|NCT01912768|527800748|FG000|Overall Study|Lost to Follow-up|2|||
146354349|NCT01912768|527800749|FG001|Overall Study|Lost to Follow-up|1|||
146354350|NCT01912768|527800748|FG000|Overall Study|Withdrawal by Subject|5|||
146354351|NCT01912768|527800749|FG001|Overall Study|Withdrawal by Subject|3|||
146354352|NCT01912768|527800748|FG000|Overall Study|Randomized in error|1|||
146354353|NCT01912768|527800749|FG001|Overall Study|Randomized in error|0|||
146354354|NCT02426658|527800750|FG000|Overall Study|Withdrawal by Subject|1|||
146354355|NCT02426658|527800750|FG000|Overall Study|Patient expired before treatment|2|||
146354356|NCT00524316|527800753|FG000|Overall Study|Withdrawal by Subject|2|||
146354357|NCT00524316|527800753|FG000|Overall Study|Adverse Event|7|||
146354358|NCT00524316|527800753|FG000|Overall Study|Disease Progression|7|||
146354359|NCT01199263|527800754|FG000|Overall Study|Ineligible|0|||
146354360|NCT01199263|527800755|FG001|Overall Study|Ineligible|2|||
146354361|NCT01199263|527800754|FG000|Overall Study|Never Treated|6|||
146354362|NCT01199263|527800755|FG001|Overall Study|Never Treated|0|||
146354363|NCT00488033|527800756|FG000|Overall Study|Withdrawal by Subject|1|||
146354364|NCT00488033|527800757|FG001|Overall Study|Withdrawal by Subject|0|||
146354365|NCT01515306|527800758|FG000|Overall Study|Adverse Event|3|||
146354366|NCT01515306|527800759|FG001|Overall Study|Adverse Event|2|||
146354367|NCT01515306|527800758|FG000|Overall Study|Progressive Disease|19|||
146354368|NCT01515306|527800759|FG001|Overall Study|Progressive Disease|9|||
146354369|NCT01515306|527800758|FG000|Overall Study|Withdrawal by Subject|1|||
146354370|NCT01515306|527800759|FG001|Overall Study|Withdrawal by Subject|2|||
146354371|NCT01515306|527800758|FG000|Overall Study|Physician Decision|1|||
146354372|NCT01515306|527800759|FG001|Overall Study|Physician Decision|1|||
146354373|NCT03591146|527800763|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146354374|NCT03591146|527800764|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146354375|NCT03591146|527800765|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146354376|NCT03591146|527800766|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
146354377|NCT03591146|527800767|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
146354378|NCT03591146|527800763|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146354379|NCT03591146|527800764|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
146354380|NCT03591146|527800765|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146354381|NCT03591146|527800766|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146354382|NCT03591146|527800767|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
146354383|NCT03591146|527800763|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146354384|NCT03591146|527800764|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146354385|NCT03591146|527800765|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146354386|NCT03591146|527800766|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
146354387|NCT03591146|527800767|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
146354388|NCT03591146|527800763|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146354389|NCT03591146|527800764|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146354390|NCT03591146|527800765|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
146354391|NCT03591146|527800766|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
146354392|NCT03591146|527800767|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
146354393|NCT04737031|527800770|FG000|Overall Study|Patients who did not have a treatment visit|0|||
146354394|NCT04737031|527800771|FG001|Overall Study|Patients who did not have a treatment visit|31|||
146354395|NCT04737031|527800772|FG002|Overall Study|Patients who did not have a treatment visit|93|||
146354396|NCT04737031|527800773|FG003|Overall Study|Patients who did not have a treatment visit|227|||
146354397|NCT01204658|527800774|FG000|Primary Phase|Adverse Event|0|||
146354398|NCT01204658|527800775|FG001|Primary Phase|Adverse Event|0|||
146354399|NCT01204658|527800776|FG002|Primary Phase|Adverse Event|1|||
146354400|NCT01204658|527800777|FG003|Primary Phase|Adverse Event|0|||
146354401|NCT03364335|527801865|FG000|Overall Study|Adverse Event|3|||
146354402|NCT03364335|527801866|FG001|Overall Study|Adverse Event|4|||
146354403|NCT03364335|527801867|FG002|Overall Study|Adverse Event|1|||
146354404|NCT03364335|527801868|FG003|Overall Study|Adverse Event|2|||
146354405|NCT03364335|527801869|FG004|Overall Study|Adverse Event|0|||
146354406|NCT03364335|527801865|FG000|Overall Study|Lost to Follow-up|7|||
146354407|NCT03364335|527801866|FG001|Overall Study|Lost to Follow-up|7|||
146354408|NCT03364335|527801867|FG002|Overall Study|Lost to Follow-up|10|||
146354409|NCT03364335|527801868|FG003|Overall Study|Lost to Follow-up|11|||
146354410|NCT03364335|527801869|FG004|Overall Study|Lost to Follow-up|11|||
146354411|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
146354412|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
146354413|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
146354414|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146354415|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146354416|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146354417|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146354418|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
146354419|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
146354420|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
146354421|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
146354422|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146354423|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146354424|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146354425|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146354426|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
146354427|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
146354428|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354429|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354430|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354431|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354432|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354433|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354434|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
146354435|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
146354436|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354437|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354438|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354439|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354440|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354441|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354442|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
146354443|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146354444|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146354445|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
146354446|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146354447|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146354448|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146354449|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146354450|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
146354451|NCT03725202|527801870|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354452|NCT03725202|527801871|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354453|NCT03725202|527801872|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
146354454|NCT03725202|527801873|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354455|NCT03725202|527801874|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354456|NCT03725202|527801875|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354457|NCT03725202|527801876|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354458|NCT03725202|527801877|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
146354459|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146354460|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146354461|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
146354462|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
146354463|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
146354464|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
146354465|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
146354466|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
146169599|NCT00691132|527132867|FG000|Overall Study|Withdrawal by Subject|10|||
146354467|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146354468|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146354469|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
146354470|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
146354471|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
146354472|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
146354473|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
146354474|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
146354475|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146354476|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146354477|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146354478|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
146354479|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146354480|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
146354481|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
146354482|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
146354483|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354484|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354485|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354486|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354487|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354488|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354489|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
146354490|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
146354491|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354492|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354493|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354494|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354495|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354496|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
146354497|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354498|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
146354499|NCT03725202|527801870|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146354500|NCT03725202|527801871|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146354501|NCT03725202|527801872|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146354502|NCT03725202|527801873|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
146354503|NCT03725202|527801874|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146354504|NCT03725202|527801875|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
146354505|NCT03725202|527801876|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
146354506|NCT03725202|527801877|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
146354507|NCT00262080|527801884|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
146354508|NCT00262080|527801885|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
146354509|NCT00262080|527801886|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
146354510|NCT00262080|527801884|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
146354511|NCT00262080|527801885|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
146354512|NCT00262080|527801886|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
146354513|NCT00262080|527801884|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
146354514|NCT00262080|527801885|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
146354515|NCT00262080|527801886|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
146354516|NCT00262080|527801884|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
146354517|NCT00262080|527801885|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
146354518|NCT00262080|527801886|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
146354519|NCT00262080|527801884|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
146354520|NCT00262080|527801885|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
146354521|NCT00262080|527801886|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
146354522|NCT00262080|527801884|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
146354523|NCT00262080|527801885|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
146354524|NCT00262080|527801886|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
146354525|NCT01030458|527801891|FG000|Overall Study|Lost to Follow-up|9|||
146354526|NCT01030458|527801892|FG001|Overall Study|Lost to Follow-up|10|||
146354527|NCT01030458|527801891|FG000|Overall Study|Withdrawal by Subject|2|||
146354528|NCT01030458|527801892|FG001|Overall Study|Withdrawal by Subject|3|||
146354529|NCT01030458|527801891|FG000|Overall Study|Logistical reasons|9|||
146354530|NCT01030458|527801892|FG001|Overall Study|Logistical reasons|5|||
146354531|NCT01030458|527801891|FG000|Overall Study|Moved or changed job|6|||
146354532|NCT01030458|527801892|FG001|Overall Study|Moved or changed job|13|||
146354533|NCT01030458|527801891|FG000|Overall Study|Side effect of medication|1|||
146354534|NCT01030458|527801892|FG001|Overall Study|Side effect of medication|1|||
146354535|NCT02420223|527801893|FG000|Overall Study|Adverse Event|1|||
146354536|NCT02420223|527801894|FG001|Overall Study|Adverse Event|0|||
146354537|NCT02420223|527801893|FG000|Overall Study|Physician Decision|0|||
146354538|NCT02420223|527801894|FG001|Overall Study|Physician Decision|2|||
146354539|NCT01361009|527801895|FG000|Overall Study|Protocol Violation|116|||
146354540|NCT02345252|527801899|FG000|Double-Blind Phase|Adverse Event|2|||
146354541|NCT02345252|527801900|FG001|Double-Blind Phase|Adverse Event|3|||
146354542|NCT02345252|527801899|FG000|Double-Blind Phase|Death|1|||
146354543|NCT02345252|527801900|FG001|Double-Blind Phase|Death|2|||
146354544|NCT02345252|527801899|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146354545|NCT02345252|527801900|FG001|Double-Blind Phase|Lack of Efficacy|0|||
146354546|NCT02345252|527801899|FG000|Double-Blind Phase|Investigator's Discretion|4|||
146354547|NCT02345252|527801900|FG001|Double-Blind Phase|Investigator's Discretion|6|||
146354548|NCT02345252|527801899|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
146354549|NCT02345252|527801900|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
146354550|NCT02345252|527801899|FG000|Double-Blind Phase|Protocol Violation|2|||
146354551|NCT02345252|527801900|FG001|Double-Blind Phase|Protocol Violation|1|||
146354552|NCT02345252|527801899|FG000|Double-Blind Phase|Withdrew Consent|21|||
146354553|NCT02345252|527801900|FG001|Double-Blind Phase|Withdrew Consent|23|||
146354554|NCT02345252|527801899|FG000|Double-Blind Phase|Lost to Follow-up|8|||
146354555|NCT02345252|527801900|FG001|Double-Blind Phase|Lost to Follow-up|10|||
146354556|NCT02345252|527801899|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
146354557|NCT02345252|527801900|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
146354558|NCT00471536|527801905|FG000|Overall Study|Withdrawal by Subject|1|||
146354559|NCT01980706|527801908|FG000|Overall Study|Withdrawal by Subject|9|||
146354560|NCT01980706|527801909|FG001|Overall Study|Withdrawal by Subject|6|||
146354561|NCT01980706|527801910|FG002|Overall Study|Withdrawal by Subject|2|||
146354562|NCT01980706|527801908|FG000|Overall Study|Adverse Event|1|||
146354563|NCT01980706|527801909|FG001|Overall Study|Adverse Event|2|||
146354564|NCT01980706|527801910|FG002|Overall Study|Adverse Event|5|||
146354565|NCT01980706|527801908|FG000|Overall Study|Lost to Follow-up|3|||
146354566|NCT01980706|527801909|FG001|Overall Study|Lost to Follow-up|4|||
146354567|NCT01980706|527801910|FG002|Overall Study|Lost to Follow-up|3|||
146354568|NCT01980706|527801908|FG000|Overall Study|miscellaneous|4|||
146354569|NCT01980706|527801909|FG001|Overall Study|miscellaneous|5|||
146354570|NCT01980706|527801910|FG002|Overall Study|miscellaneous|3|||
146354571|NCT02546674|527801911|FG000|Overall Study|Adverse Event|19|||
146354572|NCT02546674|527801911|FG000|Overall Study|Death|1|||
146354573|NCT02546674|527801911|FG000|Overall Study|Lost to Follow-up|1|||
146354574|NCT02546674|527801911|FG000|Overall Study|Physician Decision|13|||
146354575|NCT02546674|527801911|FG000|Overall Study|Pregnancy|1|||
146354576|NCT02546674|527801911|FG000|Overall Study|Progressive Disease|2|||
146354577|NCT02546674|527801911|FG000|Overall Study|Protocol Deviation|2|||
146354578|NCT02546674|527801911|FG000|Overall Study|Subject/Guardian Decision|6|||
146354579|NCT02546674|527801911|FG000|Overall Study|Withdrawal of Informed Consent|3|||
146354580|NCT01864018|527801912|FG000|Overall Study|Ineligible|3|||
146354581|NCT01864018|527801913|FG001|Overall Study|Ineligible|1|||
146354582|NCT03521687|527801915|FG000|Overall Study|Adverse Event|4|||
146354583|NCT03521687|527801915|FG000|Overall Study|Physician Decision|1|||
146354584|NCT00830037|527801921|FG000|Overall Study|Withdrawal by Subject|2|||
146354585|NCT00830037|527801922|FG001|Overall Study|Withdrawal by Subject|3|||
146354586|NCT00830037|527801921|FG000|Overall Study|Lost to Follow-up|1|||
146354587|NCT00830037|527801922|FG001|Overall Study|Lost to Follow-up|2|||
146354588|NCT00830037|527801921|FG000|Overall Study|Active when terminated by DSMB|15|||
146354589|NCT00830037|527801922|FG001|Overall Study|Active when terminated by DSMB|14|||
146354590|NCT00740779|527801923|FG000|Overall Study|Adverse Event|4|||
146354591|NCT00740779|527801924|FG001|Overall Study|Adverse Event|6|||
146354592|NCT00740779|527801925|FG002|Overall Study|Adverse Event|3|||
146354593|NCT00740779|527801923|FG000|Overall Study|Protocol Violation|1|||
146354594|NCT00740779|527801924|FG001|Overall Study|Protocol Violation|1|||
146354595|NCT00740779|527801925|FG002|Overall Study|Protocol Violation|1|||
146354596|NCT00740779|527801923|FG000|Overall Study|Lack of Efficacy|0|||
146354597|NCT00740779|527801924|FG001|Overall Study|Lack of Efficacy|0|||
146354598|NCT00740779|527801925|FG002|Overall Study|Lack of Efficacy|2|||
146354599|NCT00740779|527801923|FG000|Overall Study|Withdrawal by Subject|2|||
146354600|NCT00740779|527801924|FG001|Overall Study|Withdrawal by Subject|4|||
146354601|NCT00740779|527801925|FG002|Overall Study|Withdrawal by Subject|2|||
146354602|NCT00740779|527801923|FG000|Overall Study|Lost to Follow-up|2|||
146354603|NCT00740779|527801924|FG001|Overall Study|Lost to Follow-up|3|||
146354604|NCT00740779|527801925|FG002|Overall Study|Lost to Follow-up|5|||
146354605|NCT00222729|527801926|FG000|Overall Study|Adverse Event|3|||
146354606|NCT01915849|527801929|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
146354607|NCT01915849|527801930|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146354608|NCT01915849|527801931|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146354609|NCT01915849|527801932|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
146354610|NCT01915849|527801929|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
146354611|NCT01915849|527801930|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145943394|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146354612|NCT01915849|527801931|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146354613|NCT01915849|527801932|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
146354614|NCT01798706|527801933|FG000|Overall Study|Adverse Event|15|||
146354615|NCT01798706|527801934|FG001|Overall Study|Adverse Event|10|||
146354616|NCT01798706|527801933|FG000|Overall Study|Lack of Efficacy|0|||
146354617|NCT01798706|527801934|FG001|Overall Study|Lack of Efficacy|2|||
146354618|NCT01798706|527801933|FG000|Overall Study|Poor compliance to protocol|1|||
146354619|NCT01798706|527801934|FG001|Overall Study|Poor compliance to protocol|0|||
146354620|NCT01798706|527801933|FG000|Overall Study|Other than specified above|5|||
146354621|NCT01798706|527801934|FG001|Overall Study|Other than specified above|9|||
146354622|NCT00496873|527801935|FG000|Overall Study|Ineligible|2|||
146354623|NCT00496873|527801935|FG000|Overall Study|Death|2|||
146354624|NCT00496873|527801935|FG000|Overall Study|Withdrawal by Subject|3|||
146354625|NCT03552549|527801937|FG000|Overall Study|Disease progression|25|||
146354626|NCT03552549|527801938|FG001|Overall Study|Disease progression|17|||
146354627|NCT03552549|527801937|FG000|Overall Study|Adverse event in first 12 months|12|||
146354628|NCT03552549|527801938|FG001|Overall Study|Adverse event in first 12 months|8|||
146354629|NCT03552549|527801937|FG000|Overall Study|Withdrawal by Subject|7|||
146354630|NCT03552549|527801938|FG001|Overall Study|Withdrawal by Subject|7|||
146354631|NCT03552549|527801937|FG000|Overall Study|Unknown (no reason provided)|4|||
146354632|NCT03552549|527801938|FG001|Overall Study|Unknown (no reason provided)|2|||
146354633|NCT03552549|527801937|FG000|Overall Study|Not in participant's best interest|2|||
146354634|NCT03552549|527801938|FG001|Overall Study|Not in participant's best interest|1|||
146354635|NCT03552549|527801937|FG000|Overall Study|Did not complete study treatment|2|||
146354636|NCT03552549|527801938|FG001|Overall Study|Did not complete study treatment|3|||
146354637|NCT03552549|527801937|FG000|Overall Study|Did not meet eligibility criteria|1|||
146354638|NCT03552549|527801938|FG001|Overall Study|Did not meet eligibility criteria|0|||
146354639|NCT03552549|527801937|FG000|Overall Study|Administrative|0|||
146354640|NCT03552549|527801938|FG001|Overall Study|Administrative|14|||
146354641|NCT02761993|527801945|FG000|Overall Study|Adverse Event|0|||
146354642|NCT02761993|527801946|FG001|Overall Study|Adverse Event|2|||
146354643|NCT02761993|527801947|FG002|Overall Study|Adverse Event|0|||
146354644|NCT02761993|527801945|FG000|Overall Study|Lost to Follow-up|1|||
146354645|NCT02761993|527801946|FG001|Overall Study|Lost to Follow-up|3|||
146354646|NCT02761993|527801947|FG002|Overall Study|Lost to Follow-up|2|||
146354647|NCT02761993|527801945|FG000|Overall Study|Withdrawal by Subject|1|||
146354648|NCT02761993|527801946|FG001|Overall Study|Withdrawal by Subject|1|||
146354649|NCT02761993|527801947|FG002|Overall Study|Withdrawal by Subject|2|||
146354650|NCT00777491|527801955|FG000|Overall Study|Protocol Violation|0|||
146354651|NCT00777491|527801956|FG001|Overall Study|Protocol Violation|2|||
146354652|NCT00777491|527801955|FG000|Overall Study|Did not receive any protocol treatment|2|||
146354653|NCT00777491|527801956|FG001|Overall Study|Did not receive any protocol treatment|0|||
146354654|NCT00364845|527801957|FG000|Overall Study|Adverse Event|1|||
146354655|NCT00364845|527801958|FG001|Overall Study|Adverse Event|0|||
146354656|NCT00364845|527801957|FG000|Overall Study|Withdrawal by Subject|2|||
146354657|NCT00364845|527801958|FG001|Overall Study|Withdrawal by Subject|1|||
146354658|NCT00364845|527801957|FG000|Overall Study|Physician Decision|8|||
146354659|NCT00364845|527801958|FG001|Overall Study|Physician Decision|8|||
146354660|NCT00364845|527801957|FG000|Overall Study|Lost to Follow-up|0|||
146354661|NCT00364845|527801958|FG001|Overall Study|Lost to Follow-up|1|||
146354662|NCT00364845|527801957|FG000|Overall Study|Death|0|||
146354663|NCT00364845|527801958|FG001|Overall Study|Death|1|||
146354664|NCT03255291|527801959|FG000|Overall Study|Determined to be ineligible|10|||
146354665|NCT03255291|527801960|FG001|Overall Study|Determined to be ineligible|12|||
146354666|NCT03255291|527801961|FG002|Overall Study|Determined to be ineligible|6|||
146354667|NCT03255291|527801962|FG003|Overall Study|Determined to be ineligible|6|||
146354668|NCT03255291|527801963|FG004|Overall Study|Determined to be ineligible|5|||
146354669|NCT03255291|527801964|FG005|Overall Study|Determined to be ineligible|10|||
146354670|NCT03255291|527801959|FG000|Overall Study|Baseline data collection issues|3|||
146354671|NCT03255291|527801960|FG001|Overall Study|Baseline data collection issues|0|||
146354672|NCT03255291|527801961|FG002|Overall Study|Baseline data collection issues|0|||
146354673|NCT03255291|527801962|FG003|Overall Study|Baseline data collection issues|0|||
146354674|NCT03255291|527801963|FG004|Overall Study|Baseline data collection issues|2|||
146354675|NCT03255291|527801964|FG005|Overall Study|Baseline data collection issues|0|||
146354676|NCT00634244|527801965|FG000|Overall Study|Never started treatment|0|||
146354677|NCT00634244|527801966|FG001|Overall Study|Never started treatment|1|||
146354678|NCT00634244|527801967|FG002|Overall Study|Never started treatment|0|||
146354679|NCT00634244|527801965|FG000|Overall Study|Death|1|||
146354680|NCT00634244|527801966|FG001|Overall Study|Death|6|||
146354681|NCT00634244|527801967|FG002|Overall Study|Death|0|||
146354682|NCT00634244|527801965|FG000|Overall Study|Adverse Event|0|||
146354683|NCT00634244|527801966|FG001|Overall Study|Adverse Event|2|||
146354684|NCT00634244|527801967|FG002|Overall Study|Adverse Event|0|||
146354685|NCT00634244|527801965|FG000|Overall Study|Withdrawal by Subject|0|||
146354686|NCT00634244|527801966|FG001|Overall Study|Withdrawal by Subject|1|||
146354687|NCT00634244|527801967|FG002|Overall Study|Withdrawal by Subject|0|||
146354688|NCT00634244|527801965|FG000|Overall Study|Physician Decision|0|||
146354689|NCT00634244|527801966|FG001|Overall Study|Physician Decision|1|||
146354690|NCT00634244|527801967|FG002|Overall Study|Physician Decision|0|||
146354691|NCT00634244|527801965|FG000|Overall Study|Disease progression/relapse|0|||
146354692|NCT00634244|527801966|FG001|Overall Study|Disease progression/relapse|1|||
146354693|NCT00634244|527801967|FG002|Overall Study|Disease progression/relapse|0|||
146354694|NCT00634244|527801965|FG000|Overall Study|Other complicating disease|0|||
146354695|NCT00634244|527801966|FG001|Overall Study|Other complicating disease|1|||
146354696|NCT00634244|527801967|FG002|Overall Study|Other complicating disease|0|||
146354697|NCT04369430|527801975|FG000|Overall Study|Adverse Event|2|||
146354698|NCT04369430|527801976|FG001|Overall Study|Adverse Event|3|||
146354699|NCT04369430|527801975|FG000|Overall Study|Death|1|||
146354700|NCT04369430|527801976|FG001|Overall Study|Death|0|||
146354701|NCT04369430|527801975|FG000|Overall Study|Withdrawal by Subject|4|||
146354702|NCT04369430|527801976|FG001|Overall Study|Withdrawal by Subject|3|||
146354703|NCT04369430|527801975|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
146354704|NCT04369430|527801976|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
146354705|NCT04369430|527801975|FG000|Overall Study|Lost to Follow-up|0|||
146354706|NCT04369430|527801976|FG001|Overall Study|Lost to Follow-up|1|||
146354707|NCT00444626|527801977|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
146354708|NCT00444626|527801977|FG000|Initial Treatment Period|Adverse Event|1|||
146354709|NCT00444626|527801977|FG000|Initial Treatment Period|Lost to Follow-up|9|||
146354710|NCT00008138|527801978|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
146354711|NCT00008138|527801978|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
146354712|NCT00008138|527801978|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
146354713|NCT00008138|527801978|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
146354714|NCT00008138|527801978|FG000|Interval Debulking|Withdrawal by Subject|2|||
146354715|NCT00008138|527801978|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
146354716|NCT00008138|527801978|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
146354717|NCT00008138|527801978|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
146354718|NCT03453151|527801979|FG000|Overall Study|Withdrawal by Subject|1|||
146354719|NCT03453151|527801979|FG000|Overall Study|Physician Decision|3|||
146354720|NCT04973228|527801983|FG000|Overall Study|Adverse Event|2|||
146354721|NCT04973228|527801984|FG001|Overall Study|Adverse Event|3|||
146354722|NCT04973228|527801983|FG000|Overall Study|Lack of Efficacy|1|||
146354723|NCT04973228|527801984|FG001|Overall Study|Lack of Efficacy|3|||
146354724|NCT04973228|527801983|FG000|Overall Study|Lost to Follow-up|12|||
146354725|NCT04973228|527801984|FG001|Overall Study|Lost to Follow-up|4|||
146354726|NCT04973228|527801983|FG000|Overall Study|Withdrawal by Subject|11|||
146354727|NCT04973228|527801984|FG001|Overall Study|Withdrawal by Subject|4|||
146354728|NCT04973228|527801983|FG000|Overall Study|Did not tolerate application|1|||
146354729|NCT04973228|527801984|FG001|Overall Study|Did not tolerate application|0|||
146354730|NCT04973228|527801983|FG000|Overall Study|Wanted to early terminate and use own product|0|||
146354731|NCT04973228|527801984|FG001|Overall Study|Wanted to early terminate and use own product|1|||
146354732|NCT04973228|527801983|FG000|Overall Study|Missed visits due to new work schedule|1|||
146354733|NCT04973228|527801984|FG001|Overall Study|Missed visits due to new work schedule|0|||
146354734|NCT00091390|527801997|FG000|Overall Study|Protocol Violation|1|||
146354735|NCT00091390|527801997|FG000|Overall Study|No protocol treatment|3|||
146354736|NCT00406640|527801998|FG000|Acute Phase|Adverse Event|18|||
146354737|NCT00406640|527801999|FG001|Acute Phase|Adverse Event|13|||
146354738|NCT00406640|527801998|FG000|Acute Phase|Failed to Return|5|||
146354739|NCT00406640|527801999|FG001|Acute Phase|Failed to Return|1|||
146354740|NCT00406640|527801998|FG000|Acute Phase|Physician Decision|0|||
146354741|NCT00406640|527801999|FG001|Acute Phase|Physician Decision|1|||
146354742|NCT00406640|527801998|FG000|Acute Phase|Lost to Follow-up|7|||
146354743|NCT00406640|527801999|FG001|Acute Phase|Lost to Follow-up|4|||
146354744|NCT00406640|527801998|FG000|Acute Phase|Protocol deviation|4|||
146354745|NCT00406640|527801999|FG001|Acute Phase|Protocol deviation|10|||
146354746|NCT00406640|527801998|FG000|Acute Phase|Protocol Violation|3|||
146354747|NCT00406640|527801999|FG001|Acute Phase|Protocol Violation|2|||
146354748|NCT00406640|527801998|FG000|Acute Phase|Withdrawal by Subject|11|||
146354749|NCT00406640|527801999|FG001|Acute Phase|Withdrawal by Subject|9|||
146354750|NCT00406640|527801998|FG000|Acute Phase|Lack of Efficacy|3|||
146354751|NCT00406640|527801999|FG001|Acute Phase|Lack of Efficacy|3|||
146354752|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
146354753|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
146354754|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Death|1|||
146354755|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Death|0|||
146354756|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
146354757|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
146354758|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
146354759|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
146354760|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
146354761|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
146354762|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|non-compliance|7|||
146354763|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|non-compliance|5|||
146354764|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
146354765|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
146354766|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
146354767|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
146354768|NCT00406640|527801998|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
146354769|NCT00406640|527801999|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
146354770|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
146354771|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
146354772|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
146354773|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
146354774|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
146354775|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
146354776|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
146354777|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
146354778|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
146354779|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
146354780|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
146354781|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
146354782|NCT00406640|527801998|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
146354783|NCT00406640|527801999|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
146354784|NCT03229759|527802000|FG000|Overall Study|Screen Failure|30|||
146354785|NCT02020031|527803598|FG000|Overall Study|Physician Decision|1|||
146354786|NCT02020031|527803599|FG001|Overall Study|Physician Decision|1|||
146354787|NCT00683475|527803602|FG000|Overall Study|Withdrawal by Subject|1|||
146354788|NCT00683475|527803603|FG001|Overall Study|Withdrawal by Subject|0|||
146354789|NCT00683475|527803602|FG000|Overall Study|Never Treated: Adverse Event|2|||
146354790|NCT00683475|527803603|FG001|Overall Study|Never Treated: Adverse Event|3|||
146354791|NCT00683475|527803602|FG000|Overall Study|Never Treated: Progressive Disease|1|||
146354792|NCT00683475|527803603|FG001|Overall Study|Never Treated: Progressive Disease|0|||
146354793|NCT02669862|527803604|FG000|Overall Study|Lost to Follow-up|0|||
146354794|NCT02669862|527803605|FG001|Overall Study|Lost to Follow-up|2|||
146354795|NCT02669862|527803606|FG002|Overall Study|Lost to Follow-up|1|||
146354796|NCT02669862|527803604|FG000|Overall Study|Withdrawal by Subject|2|||
146354797|NCT02669862|527803605|FG001|Overall Study|Withdrawal by Subject|2|||
146354798|NCT02669862|527803606|FG002|Overall Study|Withdrawal by Subject|3|||
146354799|NCT02669862|527803604|FG000|Overall Study|moved|0|||
146354800|NCT02669862|527803605|FG001|Overall Study|moved|1|||
146354801|NCT02669862|527803606|FG002|Overall Study|moved|0|||
146354802|NCT02669862|527803604|FG000|Overall Study|Protocol Violation|0|||
146354803|NCT02669862|527803605|FG001|Overall Study|Protocol Violation|0|||
146354804|NCT02669862|527803606|FG002|Overall Study|Protocol Violation|1|||
146354805|NCT02429258|527803607|FG000|Overall Study|Withdrawal by Subject|2|||
146354806|NCT02429258|527803608|FG001|Overall Study|Withdrawal by Subject|0|||
146354807|NCT02429258|527803607|FG000|Overall Study|Protocol Violation|0|||
146354808|NCT02429258|527803608|FG001|Overall Study|Protocol Violation|1|||
146354809|NCT01694420|527803609|FG000|Overall Study|Lost to Follow-up|3|||
146354810|NCT03987919|527803611|FG000|Overall Study|Adverse Event|1|||
146354811|NCT03987919|527803612|FG001|Overall Study|Adverse Event|4|||
146354812|NCT03987919|527803613|FG002|Overall Study|Adverse Event|1|||
146354813|NCT03987919|527803614|FG003|Overall Study|Adverse Event|3|||
146354814|NCT03987919|527803611|FG000|Overall Study|Death|4|||
146354815|NCT03987919|527803612|FG001|Overall Study|Death|4|||
146354816|NCT03987919|527803613|FG002|Overall Study|Death|4|||
146354817|NCT03987919|527803614|FG003|Overall Study|Death|1|||
146354818|NCT03987919|527803611|FG000|Overall Study|Lost to Follow-up|5|||
146354819|NCT03987919|527803612|FG001|Overall Study|Lost to Follow-up|6|||
146354820|NCT03987919|527803613|FG002|Overall Study|Lost to Follow-up|8|||
146354821|NCT03987919|527803614|FG003|Overall Study|Lost to Follow-up|12|||
146354822|NCT03987919|527803611|FG000|Overall Study|Physician Decision|0|||
146354823|NCT03987919|527803612|FG001|Overall Study|Physician Decision|2|||
146354824|NCT03987919|527803613|FG002|Overall Study|Physician Decision|0|||
146354825|NCT03987919|527803614|FG003|Overall Study|Physician Decision|4|||
146354826|NCT03987919|527803611|FG000|Overall Study|Pregnancy|1|||
146354827|NCT03987919|527803612|FG001|Overall Study|Pregnancy|0|||
146354828|NCT03987919|527803613|FG002|Overall Study|Pregnancy|1|||
146354829|NCT03987919|527803614|FG003|Overall Study|Pregnancy|1|||
146354830|NCT03987919|527803611|FG000|Overall Study|Protocol Violation|0|||
146354831|NCT03987919|527803612|FG001|Overall Study|Protocol Violation|1|||
146354832|NCT03987919|527803613|FG002|Overall Study|Protocol Violation|0|||
146354833|NCT03987919|527803614|FG003|Overall Study|Protocol Violation|0|||
146354834|NCT03987919|527803611|FG000|Overall Study|Site terminated by Sponsor|0|||
146354835|NCT03987919|527803612|FG001|Overall Study|Site terminated by Sponsor|0|||
146354836|NCT03987919|527803613|FG002|Overall Study|Site terminated by Sponsor|0|||
146354837|NCT03987919|527803614|FG003|Overall Study|Site terminated by Sponsor|1|||
146354838|NCT03987919|527803611|FG000|Overall Study|Withdrawal by Subject|7|||
146354839|NCT03987919|527803612|FG001|Overall Study|Withdrawal by Subject|7|||
146354840|NCT03987919|527803613|FG002|Overall Study|Withdrawal by Subject|8|||
146354841|NCT03987919|527803614|FG003|Overall Study|Withdrawal by Subject|4|||
146354842|NCT03987919|527803611|FG000|Overall Study|Other - as reported by the investigator|1|||
146354843|NCT03987919|527803612|FG001|Overall Study|Other - as reported by the investigator|3|||
146354844|NCT03987919|527803613|FG002|Overall Study|Other - as reported by the investigator|2|||
146354845|NCT03987919|527803614|FG003|Overall Study|Other - as reported by the investigator|0|||
146354846|NCT00434512|527803618|FG000|Overall Study|Migrated/moved from study area|0|||
146354847|NCT00434512|527803619|FG001|Overall Study|Migrated/moved from study area|0|||
146354848|NCT00434512|527803620|FG002|Overall Study|Migrated/moved from study area|0|||
146354849|NCT00434512|527803621|FG003|Overall Study|Migrated/moved from study area|1|||
146354850|NCT00434512|527803622|FG004|Overall Study|Migrated/moved from study area|1|||
146354851|NCT00434512|527803623|FG005|Overall Study|Migrated/moved from study area|1|||
146354852|NCT00434512|527803618|FG000|Overall Study|Other|0|||
146354853|NCT00434512|527803619|FG001|Overall Study|Other|1|||
146354854|NCT00434512|527803620|FG002|Overall Study|Other|0|||
146354855|NCT00434512|527803621|FG003|Overall Study|Other|0|||
146354856|NCT00434512|527803622|FG004|Overall Study|Other|0|||
146354857|NCT00434512|527803623|FG005|Overall Study|Other|0|||
146354858|NCT03303092|527803624|FG000|Overall Study|Adverse Event|1|||
146354859|NCT03303092|527803625|FG001|Overall Study|Adverse Event|0|||
146354860|NCT03303092|527803626|FG002|Overall Study|Adverse Event|1|||
146354861|NCT03303092|527803624|FG000|Overall Study|Protocol Violation|1|||
146354862|NCT03303092|527803625|FG001|Overall Study|Protocol Violation|5|||
146354863|NCT03303092|527803626|FG002|Overall Study|Protocol Violation|1|||
146354864|NCT03303092|527803624|FG000|Overall Study|Withdrawal by Subject|1|||
146354865|NCT03303092|527803625|FG001|Overall Study|Withdrawal by Subject|1|||
146354866|NCT03303092|527803626|FG002|Overall Study|Withdrawal by Subject|3|||
146354867|NCT05142332|527803632|FG000|Overall Study|Withdrawal by Subject|0|||
146354868|NCT05142332|527803633|FG001|Overall Study|Withdrawal by Subject|1|||
146354869|NCT05142332|527803634|FG002|Overall Study|Withdrawal by Subject|2|||
146354870|NCT05142332|527803635|FG003|Overall Study|Withdrawal by Subject|0|||
146354871|NCT05142332|527803636|FG004|Overall Study|Withdrawal by Subject|0|||
146354872|NCT05142332|527803637|FG005|Overall Study|Withdrawal by Subject|2|||
146354873|NCT05142332|527803638|FG006|Overall Study|Withdrawal by Subject|6|||
146354874|NCT05142332|527803632|FG000|Overall Study|Left ED|3|||
146354875|NCT05142332|527803633|FG001|Overall Study|Left ED|0|||
146354876|NCT05142332|527803634|FG002|Overall Study|Left ED|4|||
146354877|NCT05142332|527803635|FG003|Overall Study|Left ED|6|||
146354878|NCT05142332|527803636|FG004|Overall Study|Left ED|1|||
146354879|NCT05142332|527803637|FG005|Overall Study|Left ED|2|||
146354880|NCT05142332|527803638|FG006|Overall Study|Left ED|6|||
146354881|NCT05142332|527803632|FG000|Overall Study|Physician Decision|0|||
146354882|NCT05142332|527803633|FG001|Overall Study|Physician Decision|0|||
146354883|NCT05142332|527803634|FG002|Overall Study|Physician Decision|2|||
146354884|NCT05142332|527803635|FG003|Overall Study|Physician Decision|1|||
146354885|NCT05142332|527803636|FG004|Overall Study|Physician Decision|0|||
146354886|NCT05142332|527803637|FG005|Overall Study|Physician Decision|0|||
146354887|NCT05142332|527803638|FG006|Overall Study|Physician Decision|3|||
146354888|NCT05142332|527803632|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
146354889|NCT05142332|527803633|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146354890|NCT05142332|527803634|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
146354891|NCT05142332|527803635|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
146354892|NCT05142332|527803636|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146354893|NCT05142332|527803637|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
146354894|NCT05142332|527803638|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
146354895|NCT00411788|527803643|FG000|Overall Study|Protocol Violation|1|||
146354896|NCT00411788|527803643|FG000|Overall Study|Adverse Event|1|||
146354897|NCT00390416|527803645|FG000|Overall Study|Withdrawal by Subject|1|||
146354898|NCT00390416|527803645|FG000|Overall Study|Not treated|3|||
146354899|NCT01592409|527803646|FG000|Overall Study|Withdrawal by Subject|0|||
146354900|NCT01592409|527803647|FG001|Overall Study|Withdrawal by Subject|1|||
146354901|NCT01219959|527803648|FG000|Overall Study|Adverse Event|6|||
146354902|NCT01219959|527803649|FG001|Overall Study|Adverse Event|14|||
146354903|NCT01219959|527803648|FG000|Overall Study|Physician Decision|0|||
146354904|NCT01219959|527803649|FG001|Overall Study|Physician Decision|4|||
146354905|NCT01219959|527803648|FG000|Overall Study|Withdrawal by Subject|0|||
146354906|NCT01219959|527803649|FG001|Overall Study|Withdrawal by Subject|2|||
146169600|NCT00691132|527132868|FG001|Overall Study|Withdrawal by Subject|10|||
146354907|NCT01219959|527803648|FG000|Overall Study|Renal Transplantation|0|||
146354908|NCT01219959|527803649|FG001|Overall Study|Renal Transplantation|3|||
146354909|NCT01219959|527803648|FG000|Overall Study|Other|1|||
146354910|NCT01219959|527803649|FG001|Overall Study|Other|0|||
146354911|NCT01728584|527803650|FG000|Overall Study|Adverse Event|1|||
146354912|NCT01728584|527803651|FG001|Overall Study|Adverse Event|0|||
146354913|NCT01728584|527803652|FG002|Overall Study|Adverse Event|0|||
146354914|NCT01728584|527803653|FG003|Overall Study|Adverse Event|0|||
146354915|NCT01728584|527803650|FG000|Overall Study|Physician Decision|4|||
146354916|NCT01728584|527803651|FG001|Overall Study|Physician Decision|0|||
146354917|NCT01728584|527803652|FG002|Overall Study|Physician Decision|1|||
146354918|NCT01728584|527803653|FG003|Overall Study|Physician Decision|0|||
146354919|NCT01728584|527803650|FG000|Overall Study|Withdrawal by Subject|1|||
146354920|NCT01728584|527803651|FG001|Overall Study|Withdrawal by Subject|0|||
146354921|NCT01728584|527803652|FG002|Overall Study|Withdrawal by Subject|0|||
146354922|NCT01728584|527803653|FG003|Overall Study|Withdrawal by Subject|0|||
146354923|NCT01728584|527803650|FG000|Overall Study|Screen failure|1|||
146354924|NCT01728584|527803651|FG001|Overall Study|Screen failure|0|||
146354925|NCT01728584|527803652|FG002|Overall Study|Screen failure|0|||
146354926|NCT01728584|527803653|FG003|Overall Study|Screen failure|0|||
146354927|NCT01728584|527803650|FG000|Overall Study|Other reason (not specified)|1|||
146354928|NCT01728584|527803651|FG001|Overall Study|Other reason (not specified)|0|||
146354929|NCT01728584|527803652|FG002|Overall Study|Other reason (not specified)|0|||
146354930|NCT01728584|527803653|FG003|Overall Study|Other reason (not specified)|1|||
146354931|NCT01409031|527803657|FG000|Overall Study|transferred to other hosp|1|||
146354932|NCT01409031|527803658|FG001|Overall Study|transferred to other hosp|0|||
146354933|NCT02232087|527803661|FG000|Overall Study|Withdrawal by Subject|2|||
146354934|NCT02232087|527803662|FG001|Overall Study|Withdrawal by Subject|0|||
146354935|NCT02232087|527803663|FG002|Overall Study|Withdrawal by Subject|0|||
146354936|NCT02232087|527803664|FG003|Overall Study|Withdrawal by Subject|0|||
146354937|NCT02232087|527803665|FG004|Overall Study|Withdrawal by Subject|0|||
146354938|NCT02232087|527803666|FG005|Overall Study|Withdrawal by Subject|1|||
146354939|NCT02232087|527803661|FG000|Overall Study|poor inhalation technique|0|||
146354940|NCT02232087|527803662|FG001|Overall Study|poor inhalation technique|1|||
146354941|NCT02232087|527803663|FG002|Overall Study|poor inhalation technique|0|||
146354942|NCT02232087|527803664|FG003|Overall Study|poor inhalation technique|0|||
146354943|NCT02232087|527803665|FG004|Overall Study|poor inhalation technique|0|||
146354944|NCT02232087|527803666|FG005|Overall Study|poor inhalation technique|2|||
146354945|NCT02232087|527803661|FG000|Overall Study|protocol stop criteria|0|||
146354946|NCT02232087|527803662|FG001|Overall Study|protocol stop criteria|1|||
146354947|NCT02232087|527803663|FG002|Overall Study|protocol stop criteria|0|||
146354948|NCT02232087|527803664|FG003|Overall Study|protocol stop criteria|1|||
146354949|NCT02232087|527803665|FG004|Overall Study|protocol stop criteria|0|||
146354950|NCT02232087|527803666|FG005|Overall Study|protocol stop criteria|0|||
146354951|NCT02232087|527803661|FG000|Overall Study|Adverse Event|0|||
146354952|NCT02232087|527803662|FG001|Overall Study|Adverse Event|0|||
146354953|NCT02232087|527803663|FG002|Overall Study|Adverse Event|0|||
146354954|NCT02232087|527803664|FG003|Overall Study|Adverse Event|0|||
146354955|NCT02232087|527803665|FG004|Overall Study|Adverse Event|1|||
146354956|NCT02232087|527803666|FG005|Overall Study|Adverse Event|0|||
146354957|NCT04056455|527803667|FG000|Overall Study|Adverse Event|1|||
146354958|NCT04056455|527803668|FG001|Overall Study|Adverse Event|0|||
146354959|NCT02512068|527803669|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
146354960|NCT02512068|527803670|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
146354961|NCT02512068|527803669|FG000|Overall Study|Major Protocol Deviation|1|||
146354962|NCT02512068|527803670|FG001|Overall Study|Major Protocol Deviation|0|||
146354963|NCT02512068|527803669|FG000|Overall Study|Voluntary Withdrawal|0|||
146354964|NCT02512068|527803670|FG001|Overall Study|Voluntary Withdrawal|1|||
146354965|NCT02512068|527803669|FG000|Overall Study|Lack of Efficacy|0|||
146354966|NCT02512068|527803670|FG001|Overall Study|Lack of Efficacy|1|||
146354967|NCT02512068|527803669|FG000|Overall Study|Reason Not Specified|3|||
146354968|NCT02512068|527803670|FG001|Overall Study|Reason Not Specified|5|||
146354969|NCT04891770|527803674|FG000|Overall Study|Withdrew consent|1|||
146354970|NCT04891770|527803675|FG001|Overall Study|Withdrew consent|3|||
146354971|NCT04891770|527803676|FG002|Overall Study|Withdrew consent|0|||
146354972|NCT04891770|527803674|FG000|Overall Study|Enrolled but never treated|0|||
146354973|NCT04891770|527803675|FG001|Overall Study|Enrolled but never treated|0|||
146354974|NCT04891770|527803676|FG002|Overall Study|Enrolled but never treated|1|||
146354975|NCT04891770|527803674|FG000|Overall Study|Investigator's discretion|0|||
146354976|NCT04891770|527803675|FG001|Overall Study|Investigator's discretion|1|||
146354977|NCT04891770|527803676|FG002|Overall Study|Investigator's discretion|0|||
146354978|NCT05122650|527803677|FG000|Overall Study|Adverse Event|4|||
146354979|NCT05122650|527803678|FG001|Overall Study|Adverse Event|16|||
146354980|NCT05122650|527803679|FG002|Overall Study|Adverse Event|11|||
146354981|NCT05122650|527803680|FG003|Overall Study|Adverse Event|12|||
146354982|NCT05122650|527803677|FG000|Overall Study|Lack of Efficacy|0|||
146169601|NCT00860067|527132871|FG000|Overall Study|Lost to Follow-up|46|||
146354983|NCT05122650|527803678|FG001|Overall Study|Lack of Efficacy|1|||
146354984|NCT05122650|527803679|FG002|Overall Study|Lack of Efficacy|1|||
146354985|NCT05122650|527803680|FG003|Overall Study|Lack of Efficacy|2|||
146354986|NCT05122650|527803677|FG000|Overall Study|Lost to Follow-up|1|||
146354987|NCT05122650|527803678|FG001|Overall Study|Lost to Follow-up|1|||
146354988|NCT05122650|527803679|FG002|Overall Study|Lost to Follow-up|3|||
146354989|NCT05122650|527803680|FG003|Overall Study|Lost to Follow-up|0|||
146354990|NCT05122650|527803677|FG000|Overall Study|Non-compliance with study intervention|0|||
146354991|NCT05122650|527803678|FG001|Overall Study|Non-compliance with study intervention|0|||
146354992|NCT05122650|527803679|FG002|Overall Study|Non-compliance with study intervention|0|||
146354993|NCT05122650|527803680|FG003|Overall Study|Non-compliance with study intervention|2|||
146354994|NCT05122650|527803677|FG000|Overall Study|Protocol Violation|0|||
146354995|NCT05122650|527803678|FG001|Overall Study|Protocol Violation|1|||
146354996|NCT05122650|527803679|FG002|Overall Study|Protocol Violation|0|||
146354997|NCT05122650|527803680|FG003|Overall Study|Protocol Violation|1|||
146354998|NCT05122650|527803677|FG000|Overall Study|Randomized by mistake|0|||
146354999|NCT05122650|527803678|FG001|Overall Study|Randomized by mistake|0|||
146355000|NCT05122650|527803679|FG002|Overall Study|Randomized by mistake|3|||
146355001|NCT05122650|527803680|FG003|Overall Study|Randomized by mistake|2|||
146355002|NCT05122650|527803677|FG000|Overall Study|Sponsor request|0|||
146355003|NCT05122650|527803678|FG001|Overall Study|Sponsor request|1|||
146355004|NCT05122650|527803679|FG002|Overall Study|Sponsor request|1|||
146355005|NCT05122650|527803680|FG003|Overall Study|Sponsor request|2|||
146355006|NCT05122650|527803677|FG000|Overall Study|Withdrawal by Subject|3|||
146355007|NCT05122650|527803678|FG001|Overall Study|Withdrawal by Subject|7|||
146355008|NCT05122650|527803679|FG002|Overall Study|Withdrawal by Subject|4|||
146355009|NCT05122650|527803680|FG003|Overall Study|Withdrawal by Subject|8|||
146355010|NCT05122650|527803677|FG000|Overall Study|Other|5|||
146355011|NCT05122650|527803678|FG001|Overall Study|Other|0|||
146355012|NCT05122650|527803679|FG002|Overall Study|Other|0|||
146355013|NCT05122650|527803680|FG003|Overall Study|Other|0|||
146355014|NCT01401010|527803684|FG000|Overall Study|Could not interpret assay results|1|||
146355015|NCT01401010|527803685|FG001|Overall Study|Could not interpret assay results|0|||
146355016|NCT01952834|527803686|FG000|Overall Study|Adverse Event|1|||
146355017|NCT04360187|527803694|FG000|Double-Blind Treatment|Adverse Event|9|||
146355018|NCT04360187|527803695|FG001|Double-Blind Treatment|Adverse Event|11|||
146355019|NCT04360187|527803694|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
146355020|NCT04360187|527803695|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
146355021|NCT04360187|527803694|FG000|Double-Blind Treatment|Physician Decision|1|||
146355022|NCT04360187|527803695|FG001|Double-Blind Treatment|Physician Decision|0|||
146355023|NCT04360187|527803694|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
146355024|NCT04360187|527803695|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
146355025|NCT04360187|527803694|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
146355026|NCT04360187|527803695|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
146355027|NCT04360187|527803694|FG000|Follow-Up|Lost to Follow-up|1|||
146355028|NCT04360187|527803695|FG001|Follow-Up|Lost to Follow-up|0|||
146355029|NCT02203838|527803696|FG000|Overall Study|Lack of Efficacy|7|||
146355030|NCT02203838|527803697|FG001|Overall Study|Lack of Efficacy|0|||
146355031|NCT02203838|527803698|FG002|Overall Study|Lack of Efficacy|1|||
146355032|NCT02203838|527803699|FG003|Overall Study|Lack of Efficacy|1|||
146355033|NCT02203838|527803696|FG000|Overall Study|Adverse Event|46|||
146355034|NCT02203838|527803697|FG001|Overall Study|Adverse Event|6|||
146355035|NCT02203838|527803698|FG002|Overall Study|Adverse Event|3|||
146355036|NCT02203838|527803699|FG003|Overall Study|Adverse Event|2|||
146355037|NCT02203838|527803696|FG000|Overall Study|Lost to Follow-up|39|||
146355038|NCT02203838|527803697|FG001|Overall Study|Lost to Follow-up|3|||
146355039|NCT02203838|527803698|FG002|Overall Study|Lost to Follow-up|2|||
146355040|NCT02203838|527803699|FG003|Overall Study|Lost to Follow-up|1|||
146355041|NCT02203838|527803696|FG000|Overall Study|Protocol Violation|7|||
146355042|NCT02203838|527803697|FG001|Overall Study|Protocol Violation|3|||
146355043|NCT02203838|527803698|FG002|Overall Study|Protocol Violation|0|||
146355044|NCT02203838|527803699|FG003|Overall Study|Protocol Violation|0|||
146355045|NCT02203838|527803696|FG000|Overall Study|Withdrawal by Subject|83|||
146355046|NCT02203838|527803697|FG001|Overall Study|Withdrawal by Subject|10|||
146355047|NCT02203838|527803698|FG002|Overall Study|Withdrawal by Subject|8|||
146355048|NCT02203838|527803699|FG003|Overall Study|Withdrawal by Subject|11|||
146355049|NCT02203838|527803696|FG000|Overall Study|Physician Decision|27|||
146355050|NCT02203838|527803697|FG001|Overall Study|Physician Decision|0|||
146355051|NCT02203838|527803698|FG002|Overall Study|Physician Decision|2|||
146355052|NCT02203838|527803699|FG003|Overall Study|Physician Decision|3|||
146355053|NCT02203838|527803696|FG000|Overall Study|Other|1|||
146355054|NCT02203838|527803697|FG001|Overall Study|Other|0|||
146355055|NCT02203838|527803698|FG002|Overall Study|Other|0|||
146355056|NCT02203838|527803699|FG003|Overall Study|Other|0|||
146355057|NCT05091060|527803700|FG000|Overall Study|Lost to Follow-up|1|||
146355058|NCT01318083|527803701|FG000|Overall Study|Adverse Event|4|||
146355059|NCT01318083|527803702|FG001|Overall Study|Adverse Event|1|||
146355060|NCT01318083|527803703|FG002|Overall Study|Adverse Event|2|||
146355061|NCT01318083|527803701|FG000|Overall Study|Withdrawal by Subject|1|||
146355062|NCT01318083|527803702|FG001|Overall Study|Withdrawal by Subject|0|||
146355063|NCT01318083|527803703|FG002|Overall Study|Withdrawal by Subject|2|||
146355064|NCT01318083|527803701|FG000|Overall Study|Lack of Efficacy|0|||
146355065|NCT01318083|527803702|FG001|Overall Study|Lack of Efficacy|0|||
146355066|NCT01318083|527803703|FG002|Overall Study|Lack of Efficacy|1|||
146355067|NCT01318083|527803701|FG000|Overall Study|Treatment Complications|1|||
146355068|NCT01318083|527803702|FG001|Overall Study|Treatment Complications|0|||
146355069|NCT01318083|527803703|FG002|Overall Study|Treatment Complications|0|||
146355070|NCT01318083|527803701|FG000|Overall Study|Lack of Study Medication Compliance|0|||
146355071|NCT01318083|527803702|FG001|Overall Study|Lack of Study Medication Compliance|1|||
146355072|NCT01318083|527803703|FG002|Overall Study|Lack of Study Medication Compliance|0|||
146355073|NCT05896761|527803704|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
146355074|NCT05896761|527803705|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
146355075|NCT05896761|527803704|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
146355076|NCT05896761|527803705|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
146355077|NCT02065869|527803707|FG000|Overall Study|Death|7|||
146355078|NCT02065869|527803707|FG000|Overall Study|Disease relapse|16|||
146355079|NCT02065869|527803707|FG000|Overall Study|Lost to Follow-up|4|||
146355080|NCT02065869|527803707|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
146355081|NCT02065869|527803707|FG000|Overall Study|Withdrawal by Subject|1|||
146355082|NCT02739594|527803708|FG000|Overall Study|Undesired Event|3|||
146355083|NCT02739594|527803709|FG001|Overall Study|Undesired Event|4|||
146355084|NCT02739594|527803708|FG000|Overall Study|Violation of Eligibility Criteria|1|||
146355085|NCT02739594|527803709|FG001|Overall Study|Violation of Eligibility Criteria|2|||
146355086|NCT02739594|527803708|FG000|Overall Study|Protocol Violation|5|||
146355087|NCT02739594|527803709|FG001|Overall Study|Protocol Violation|6|||
146355088|NCT02739594|527803708|FG000|Overall Study|Death|4|||
146355089|NCT02739594|527803709|FG001|Overall Study|Death|2|||
146355090|NCT02739594|527803708|FG000|Overall Study|Renal Insufficiency|4|||
146355091|NCT02739594|527803709|FG001|Overall Study|Renal Insufficiency|6|||
146355092|NCT02739594|527803708|FG000|Overall Study|Administrative Reasons|1|||
146355093|NCT02739594|527803709|FG001|Overall Study|Administrative Reasons|3|||
146355094|NCT02739594|527803708|FG000|Overall Study|Withdrawal by Subject|1|||
146355095|NCT02739594|527803709|FG001|Overall Study|Withdrawal by Subject|1|||
146355096|NCT02739594|527803708|FG000|Overall Study|Lost to Follow-up|0|||
146355097|NCT02739594|527803709|FG001|Overall Study|Lost to Follow-up|1|||
146355098|NCT02739594|527803708|FG000|Overall Study|Elevated Serum Creatinine|0|||
146355099|NCT02739594|527803709|FG001|Overall Study|Elevated Serum Creatinine|1|||
146355100|NCT02739594|527803708|FG000|Overall Study|Other|6|||
146355101|NCT02739594|527803709|FG001|Overall Study|Other|2|||
146355102|NCT00527111|527803712|FG000|Overall Study|Adverse Event|14|||
146355103|NCT00527111|527803713|FG001|Overall Study|Adverse Event|13|||
146355104|NCT00527111|527803712|FG000|Overall Study|Death|0|||
146355105|NCT00527111|527803713|FG001|Overall Study|Death|1|||
146355106|NCT00527111|527803712|FG000|Overall Study|Investigator Request|2|||
146355107|NCT00527111|527803713|FG001|Overall Study|Investigator Request|1|||
146355108|NCT00527111|527803712|FG000|Overall Study|Patient Request|2|||
146355109|NCT00527111|527803713|FG001|Overall Study|Patient Request|5|||
146355110|NCT00527111|527803712|FG000|Overall Study|Other|2|||
146355111|NCT00527111|527803713|FG001|Overall Study|Other|2|||
146355112|NCT03827473|527803716|FG000|Overall Study|Withdrawal by Subject|1|||
146355113|NCT03827473|527803717|FG001|Overall Study|Withdrawal by Subject|0|||
146355114|NCT00952289|527803718|FG000|All Participants|Death|9|||
146355115|NCT00952289|527803719|FG001|All Participants|Death|9|||
146355116|NCT00952289|527803718|FG000|All Participants|Adverse Event|8|||
146355117|NCT00952289|527803719|FG001|All Participants|Adverse Event|8|||
146355118|NCT00952289|527803718|FG000|All Participants|Disease progression|3|||
146355119|NCT00952289|527803719|FG001|All Participants|Disease progression|12|||
146355120|NCT00952289|527803718|FG000|All Participants|Withdrawal by Subject|1|||
146355121|NCT00952289|527803719|FG001|All Participants|Withdrawal by Subject|10|||
146355122|NCT00952289|527803718|FG000|All Participants|Data lost during site relocation|0|||
146355123|NCT00952289|527803719|FG001|All Participants|Data lost during site relocation|1|||
146355124|NCT00952289|527803718|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
146355125|NCT00952289|527803719|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
146355126|NCT00952289|527803718|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
146355127|NCT00952289|527803719|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
146355128|NCT00952289|527803718|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
146355129|NCT00952289|527803719|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
146355130|NCT00952289|527803718|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
146355131|NCT00952289|527803719|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
146355132|NCT00952289|527803718|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
146355133|NCT00952289|527803719|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
146355134|NCT00142519|527803728|FG000|Overall Study|Not Treated|7|||
146355135|NCT00142519|527803729|FG001|Overall Study|Not Treated|9|||
146355136|NCT00142519|527803728|FG000|Overall Study|Protocol Violation|1|||
146355137|NCT00142519|527803729|FG001|Overall Study|Protocol Violation|0|||
146169602|NCT00860067|527132872|FG001|Overall Study|Lost to Follow-up|9|||
146355138|NCT00142519|527803728|FG000|Overall Study|Withdrawal by Subject|10|||
146355139|NCT00142519|527803729|FG001|Overall Study|Withdrawal by Subject|7|||
146355140|NCT04594239|527803732|FG000|Overall Study|Withdrawal by Subject|3|||
146355141|NCT04594239|527803733|FG001|Overall Study|Withdrawal by Subject|4|||
146355142|NCT04594239|527803734|FG002|Overall Study|Withdrawal by Subject|2|||
146355143|NCT04594239|527803735|FG003|Overall Study|Withdrawal by Subject|4|||
146355144|NCT04594239|527803732|FG000|Overall Study|Lost to Follow-up|8|||
146355145|NCT04594239|527803733|FG001|Overall Study|Lost to Follow-up|5|||
146355146|NCT04594239|527803734|FG002|Overall Study|Lost to Follow-up|4|||
146355147|NCT04594239|527803735|FG003|Overall Study|Lost to Follow-up|6|||
146355148|NCT04594239|527803732|FG000|Overall Study|Subject relocated|0|||
146355149|NCT04594239|527803733|FG001|Overall Study|Subject relocated|0|||
146355150|NCT04594239|527803734|FG002|Overall Study|Subject relocated|0|||
146355151|NCT04594239|527803735|FG003|Overall Study|Subject relocated|1|||
146355152|NCT02678780|527803736|FG000|Overall Study|Adverse Event|11|||
146355153|NCT02678780|527803737|FG001|Overall Study|Adverse Event|14|||
146355154|NCT02678780|527803736|FG000|Overall Study|Withdrawal by Subject|2|||
146355155|NCT02678780|527803737|FG001|Overall Study|Withdrawal by Subject|1|||
146355156|NCT02678780|527803736|FG000|Overall Study|Sponsor discontinuation|7|||
146355157|NCT02678780|527803737|FG001|Overall Study|Sponsor discontinuation|4|||
146355158|NCT02678780|527803736|FG000|Overall Study|Death|1|||
146355159|NCT02678780|527803737|FG001|Overall Study|Death|1|||
146355160|NCT02678780|527803736|FG000|Overall Study|Other|6|||
146355161|NCT02678780|527803737|FG001|Overall Study|Other|8|||
146355162|NCT02294318|527805908|FG000|Overall Study|Worsening of drinking|3|||
146355163|NCT02294318|527805909|FG001|Overall Study|Worsening of drinking|0|||
146355164|NCT02294318|527805908|FG000|Overall Study|Not exposed to intervention|0|||
146355165|NCT02294318|527805909|FG001|Overall Study|Not exposed to intervention|2|||
146355166|NCT00762372|527805912|FG000|Overall Study|Adverse Event|1|||
146355167|NCT00762372|527805913|FG001|Overall Study|Adverse Event|0|||
146355168|NCT00762372|527805914|FG002|Overall Study|Adverse Event|0|||
146355169|NCT02670915|527805915|FG000|Overall Study|Withdrawal by Subject|0|||
146355170|NCT02670915|527805916|FG001|Overall Study|Withdrawal by Subject|1|||
146355171|NCT02670915|527805917|FG002|Overall Study|Withdrawal by Subject|4|||
146355172|NCT02670915|527805915|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146355173|NCT02670915|527805916|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146355174|NCT02670915|527805917|FG002|Overall Study|Withdrawal by parent/guardian|1|||
146355175|NCT02670915|527805915|FG000|Overall Study|Unclassified|0|||
146355176|NCT02670915|527805916|FG001|Overall Study|Unclassified|3|||
146355177|NCT02670915|527805917|FG002|Overall Study|Unclassified|0|||
146355178|NCT00818207|527805918|FG000|Overall Study|Adverse Event|6|||
146355179|NCT00818207|527805919|FG001|Overall Study|Adverse Event|0|||
146355180|NCT00818207|527805918|FG000|Overall Study|Lost to Follow-up|160|||
146355181|NCT00818207|527805919|FG001|Overall Study|Lost to Follow-up|146|||
146355182|NCT00818207|527805918|FG000|Overall Study|Multiple reasons|11|||
146355183|NCT00818207|527805919|FG001|Overall Study|Multiple reasons|12|||
146355184|NCT00818207|527805918|FG000|Overall Study|Withdrawal by Subject|42|||
146355185|NCT00818207|527805919|FG001|Overall Study|Withdrawal by Subject|104|||
146355186|NCT00818207|527805918|FG000|Overall Study|Death|3|||
146355187|NCT00818207|527805919|FG001|Overall Study|Death|5|||
146355188|NCT02616185|527805920|FG000|Overall Study|Death|0|||
146355189|NCT02616185|527805921|FG001|Overall Study|Death|0|||
146355190|NCT02616185|527805922|FG002|Overall Study|Death|0|||
146355191|NCT02616185|527805923|FG003|Overall Study|Death|1|||
146355192|NCT02616185|527805924|FG004|Overall Study|Death|2|||
146355193|NCT02616185|527805925|FG005|Overall Study|Death|0|||
146355194|NCT02616185|527805926|FG006|Overall Study|Death|0|||
146355195|NCT02616185|527805927|FG007|Overall Study|Death|2|||
146355196|NCT02616185|527805928|FG008|Overall Study|Death|1|||
146355197|NCT02616185|527805920|FG000|Overall Study|Study terminated by sponsor|0|||
146355198|NCT02616185|527805921|FG001|Overall Study|Study terminated by sponsor|0|||
146355199|NCT02616185|527805922|FG002|Overall Study|Study terminated by sponsor|1|||
146355200|NCT02616185|527805923|FG003|Overall Study|Study terminated by sponsor|0|||
146355201|NCT02616185|527805924|FG004|Overall Study|Study terminated by sponsor|0|||
146355202|NCT02616185|527805925|FG005|Overall Study|Study terminated by sponsor|0|||
146355203|NCT02616185|527805926|FG006|Overall Study|Study terminated by sponsor|5|||
146355204|NCT02616185|527805927|FG007|Overall Study|Study terminated by sponsor|2|||
146355205|NCT02616185|527805928|FG008|Overall Study|Study terminated by sponsor|0|||
146355206|NCT02616185|527805920|FG000|Overall Study|Participant refused further follow-up|1|||
146355207|NCT02616185|527805921|FG001|Overall Study|Participant refused further follow-up|1|||
146355208|NCT02616185|527805922|FG002|Overall Study|Participant refused further follow-up|2|||
146355209|NCT02616185|527805923|FG003|Overall Study|Participant refused further follow-up|3|||
146355210|NCT02616185|527805924|FG004|Overall Study|Participant refused further follow-up|4|||
146355211|NCT02616185|527805925|FG005|Overall Study|Participant refused further follow-up|0|||
146355212|NCT02616185|527805926|FG006|Overall Study|Participant refused further follow-up|3|||
146355213|NCT02616185|527805927|FG007|Overall Study|Participant refused further follow-up|4|||
146355214|NCT02616185|527805928|FG008|Overall Study|Participant refused further follow-up|3|||
146355215|NCT02616185|527805920|FG000|Overall Study|Not reported|0|||
146355216|NCT02616185|527805921|FG001|Overall Study|Not reported|0|||
146355217|NCT02616185|527805922|FG002|Overall Study|Not reported|0|||
146355218|NCT02616185|527805923|FG003|Overall Study|Not reported|1|||
146355219|NCT02616185|527805924|FG004|Overall Study|Not reported|3|||
146355220|NCT02616185|527805925|FG005|Overall Study|Not reported|1|||
146355221|NCT02616185|527805926|FG006|Overall Study|Not reported|0|||
146355222|NCT02616185|527805927|FG007|Overall Study|Not reported|5|||
146355223|NCT02616185|527805928|FG008|Overall Study|Not reported|2|||
146355224|NCT03621943|527805929|FG000|First Randomized Intervention|Lost to Follow-up|51|||
146355225|NCT03621943|527805930|FG001|First Randomized Intervention|Lost to Follow-up|54|||
146355226|NCT03621943|527805929|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
146355227|NCT03621943|527805930|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
146355228|NCT03621943|527805929|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
146355229|NCT03621943|527805930|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
146355230|NCT03621943|527805929|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
146355231|NCT03621943|527805930|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
146355232|NCT01346371|527805931|FG000|Overall Study|Lost to Follow-up|2|||
146355233|NCT01346371|527805932|FG001|Overall Study|Lost to Follow-up|0|||
146355234|NCT00495495|527805933|FG000|Overall Study|Protocol Violation|99|||
146355235|NCT02702518|527805934|FG000|Overall Study|Lost to Follow-up|3|||
146355236|NCT02702518|527805935|FG001|Overall Study|Lost to Follow-up|4|||
146355237|NCT01670656|527805936|FG000|Overall Study|Non-compliance with study drug|0|||
146355238|NCT01670656|527805937|FG001|Overall Study|Non-compliance with study drug|0|||
146355239|NCT01670656|527805938|FG002|Overall Study|Non-compliance with study drug|3|||
146355240|NCT01670656|527805939|FG003|Overall Study|Non-compliance with study drug|0|||
146355241|NCT01670656|527805940|FG004|Overall Study|Non-compliance with study drug|1|||
146355242|NCT01670656|527805936|FG000|Overall Study|Pregnancy|0|||
146355243|NCT01670656|527805937|FG001|Overall Study|Pregnancy|0|||
146355244|NCT01670656|527805938|FG002|Overall Study|Pregnancy|0|||
146355245|NCT01670656|527805939|FG003|Overall Study|Pregnancy|0|||
146355246|NCT01670656|527805940|FG004|Overall Study|Pregnancy|1|||
146355247|NCT01670656|527805936|FG000|Overall Study|Withdrawal by Subject|1|||
146355248|NCT01670656|527805937|FG001|Overall Study|Withdrawal by Subject|1|||
146355249|NCT01670656|527805938|FG002|Overall Study|Withdrawal by Subject|0|||
146355250|NCT01670656|527805939|FG003|Overall Study|Withdrawal by Subject|0|||
146355251|NCT01670656|527805940|FG004|Overall Study|Withdrawal by Subject|0|||
146355252|NCT01670656|527805936|FG000|Overall Study|Non-compliance with protocol|0|||
146355253|NCT01670656|527805937|FG001|Overall Study|Non-compliance with protocol|3|||
146355254|NCT01670656|527805938|FG002|Overall Study|Non-compliance with protocol|1|||
146355255|NCT01670656|527805939|FG003|Overall Study|Non-compliance with protocol|1|||
146355256|NCT01670656|527805940|FG004|Overall Study|Non-compliance with protocol|2|||
146355257|NCT01670656|527805936|FG000|Overall Study|Adverse Event|2|||
146355258|NCT01670656|527805937|FG001|Overall Study|Adverse Event|2|||
146355259|NCT01670656|527805938|FG002|Overall Study|Adverse Event|2|||
146355260|NCT01670656|527805939|FG003|Overall Study|Adverse Event|3|||
146355261|NCT01670656|527805940|FG004|Overall Study|Adverse Event|3|||
146355262|NCT01670656|527805936|FG000|Overall Study|Subject withdrew consent|0|||
146355263|NCT01670656|527805937|FG001|Overall Study|Subject withdrew consent|1|||
146355264|NCT01670656|527805938|FG002|Overall Study|Subject withdrew consent|2|||
146355265|NCT01670656|527805939|FG003|Overall Study|Subject withdrew consent|1|||
146355266|NCT01670656|527805940|FG004|Overall Study|Subject withdrew consent|1|||
146355267|NCT01670656|527805936|FG000|Overall Study|Lost to Follow-up|0|||
146355268|NCT01670656|527805937|FG001|Overall Study|Lost to Follow-up|0|||
146355269|NCT01670656|527805938|FG002|Overall Study|Lost to Follow-up|0|||
146355270|NCT01670656|527805939|FG003|Overall Study|Lost to Follow-up|0|||
146355271|NCT01670656|527805940|FG004|Overall Study|Lost to Follow-up|3|||
146355272|NCT01670656|527805936|FG000|Overall Study|Subject moved|0|||
146355273|NCT01670656|527805937|FG001|Overall Study|Subject moved|0|||
146355274|NCT01670656|527805938|FG002|Overall Study|Subject moved|0|||
146355275|NCT01670656|527805939|FG003|Overall Study|Subject moved|1|||
146355276|NCT01670656|527805940|FG004|Overall Study|Subject moved|0|||
146355277|NCT03331666|527805941|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
146355278|NCT03331666|527805942|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
146355279|NCT00111475|527805943|FG000|Overall Study|Lost to Follow-up|0|||
146355280|NCT00111475|527805944|FG001|Overall Study|Lost to Follow-up|0|||
146355281|NCT00111475|527805945|FG002|Overall Study|Lost to Follow-up|0|||
146355282|NCT00111475|527805946|FG003|Overall Study|Lost to Follow-up|0|||
146355283|NCT00111475|527805947|FG004|Overall Study|Lost to Follow-up|0|||
146355284|NCT00111475|527805948|FG005|Overall Study|Lost to Follow-up|1|||
146355285|NCT00111475|527805949|FG006|Overall Study|Lost to Follow-up|0|||
146355286|NCT00111475|527805950|FG007|Overall Study|Lost to Follow-up|0|||
146355287|NCT00111475|527805951|FG008|Overall Study|Lost to Follow-up|0|||
146355288|NCT00111475|527805952|FG009|Overall Study|Lost to Follow-up|0|||
146355289|NCT01026389|527805957|FG000|Overall Study|Withdrawal by Subject|1|||
146355290|NCT01026389|527805958|FG001|Overall Study|Withdrawal by Subject|3|||
146355291|NCT01026389|527805957|FG000|Overall Study|change of treatment, patient moved|4|||
146355292|NCT01026389|527805958|FG001|Overall Study|change of treatment, patient moved|2|||
146355293|NCT01995136|527805959|FG000|Overall Study|Change in residence|1|||
146355294|NCT03544268|527805960|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
146355295|NCT03544268|527805961|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
146355296|NCT01830543|527805965|FG000|Overall Study|Subject Decision|19|||
146355297|NCT01830543|527805966|FG001|Overall Study|Subject Decision|21|||
146355298|NCT01830543|527805967|FG002|Overall Study|Subject Decision|57|||
146355299|NCT01830543|527805965|FG000|Overall Study|Adverse Event|91|||
146355300|NCT01830543|527805966|FG001|Overall Study|Adverse Event|77|||
146355301|NCT01830543|527805967|FG002|Overall Study|Adverse Event|76|||
146355302|NCT01830543|527805965|FG000|Overall Study|Death|20|||
146355303|NCT01830543|527805966|FG001|Overall Study|Death|22|||
146355304|NCT01830543|527805967|FG002|Overall Study|Death|22|||
146355305|NCT01830543|527805965|FG000|Overall Study|Protocol Violation|3|||
146355306|NCT01830543|527805966|FG001|Overall Study|Protocol Violation|7|||
146355307|NCT01830543|527805967|FG002|Overall Study|Protocol Violation|7|||
146355308|NCT01830543|527805965|FG000|Overall Study|Physician Decision|11|||
146355309|NCT01830543|527805966|FG001|Overall Study|Physician Decision|5|||
146355310|NCT01830543|527805967|FG002|Overall Study|Physician Decision|12|||
146355311|NCT01830543|527805965|FG000|Overall Study|Withdrawal by consent|3|||
146355312|NCT01830543|527805966|FG001|Overall Study|Withdrawal by consent|3|||
146355313|NCT01830543|527805967|FG002|Overall Study|Withdrawal by consent|3|||
146355314|NCT01830543|527805965|FG000|Overall Study|Other|12|||
146355315|NCT01830543|527805966|FG001|Overall Study|Other|17|||
146355316|NCT01830543|527805967|FG002|Overall Study|Other|37|||
146355317|NCT02695524|527805972|FG000|Overall Study|Lost to Follow-up|3|||
146355318|NCT02695524|527805973|FG001|Overall Study|Lost to Follow-up|2|||
146355319|NCT02695524|527805972|FG000|Overall Study|Death|0|||
146355320|NCT02695524|527805973|FG001|Overall Study|Death|1|||
146355321|NCT04281030|527805985|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
146355322|NCT04281030|527805986|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
146355323|NCT04281030|527805985|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
146355324|NCT04281030|527805986|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
146355325|NCT01395368|527805987|FG000|Overall Study|Physician Decision|14|||
146355326|NCT01395368|527805987|FG000|Overall Study|Withdrawal by Subject|2|||
146355327|NCT01718509|527805990|FG000|Overall Study|Lost to Follow-up|18|||
146355328|NCT01718509|527805991|FG001|Overall Study|Lost to Follow-up|15|||
146355329|NCT01718509|527805990|FG000|Overall Study|Withdrawal by Subject|7|||
146355330|NCT01718509|527805991|FG001|Overall Study|Withdrawal by Subject|13|||
146355331|NCT01718509|527805990|FG000|Overall Study|Adverse Event|5|||
146355332|NCT01718509|527805991|FG001|Overall Study|Adverse Event|7|||
146355333|NCT01718509|527805990|FG000|Overall Study|Other|13|||
146355334|NCT01718509|527805991|FG001|Overall Study|Other|11|||
146355335|NCT01718509|527805990|FG000|Overall Study|Protocol Violation|4|||
146355336|NCT01718509|527805991|FG001|Overall Study|Protocol Violation|2|||
146355337|NCT01718509|527805990|FG000|Overall Study|Lack of Efficacy|1|||
146355338|NCT01718509|527805991|FG001|Overall Study|Lack of Efficacy|0|||
146355339|NCT05906732|527805992|FG000|Overall Study|Withdrawal by Subject|1|||
146355340|NCT05906732|527805993|FG001|Overall Study|Withdrawal by Subject|0|||
146355341|NCT05906732|527805994|FG002|Overall Study|Withdrawal by Subject|0|||
146355342|NCT05906732|527805995|FG003|Overall Study|Withdrawal by Subject|0|||
146355343|NCT05906732|527805992|FG000|Overall Study|Physician Decision|2|||
146355344|NCT05906732|527805993|FG001|Overall Study|Physician Decision|4|||
146355345|NCT05906732|527805994|FG002|Overall Study|Physician Decision|0|||
146355346|NCT05906732|527805995|FG003|Overall Study|Physician Decision|0|||
146355347|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146355348|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146355349|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146355350|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
146355351|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
146355352|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
146355353|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355354|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
146355355|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
146355356|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146355357|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
146355358|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
146355359|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
146355360|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
146355361|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355362|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355363|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355364|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355365|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145943395|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
146355366|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355367|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355368|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355369|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
146355370|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146355371|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146355372|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146355373|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146355374|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146355375|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146355376|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
146355377|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146355378|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
146355379|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355380|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355381|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146355382|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
146355383|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
146355384|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355385|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355386|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355387|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355388|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355389|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355390|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355391|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355392|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
146355393|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355394|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355395|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355396|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355397|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355398|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355399|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355400|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355401|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355402|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355403|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355404|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355405|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355406|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
146355407|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355408|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355409|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355410|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355411|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355412|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355413|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355414|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355415|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
146355416|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
146355417|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
146355418|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
146355419|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
146355420|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
146355421|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
146355422|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
146355423|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
146355424|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
146355425|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
146355426|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
146355427|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
146355428|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
146355429|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
146355430|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
146355431|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
146355432|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
146355433|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
146355434|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
146355435|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
146355436|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
146355437|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
146355438|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
146355439|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355440|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355441|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355442|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355443|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355444|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355445|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355446|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355447|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
146355448|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355449|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355450|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355451|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355452|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
146355453|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355454|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355455|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355456|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355457|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355458|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355459|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355460|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355461|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
146355462|NCT02052778|527805996|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355463|NCT02052778|527805997|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355464|NCT02052778|527805998|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355465|NCT02052778|527805999|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355466|NCT02052778|527806000|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355467|NCT02052778|527806001|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
146355468|NCT02052778|527806002|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355469|NCT02052778|527806003|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355470|NCT02052778|527806004|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355471|NCT02052778|527806005|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355472|NCT02052778|527806006|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355473|NCT02052778|527806007|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355474|NCT02052778|527806008|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
146355475|NCT02052778|527806009|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355476|NCT02052778|527806010|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355477|NCT02052778|527806011|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355478|NCT02052778|527806012|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355479|NCT02052778|527806013|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355480|NCT02052778|527806014|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355481|NCT02052778|527806015|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355482|NCT02052778|527806016|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355483|NCT02052778|527806017|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355484|NCT02052778|527806018|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
146355485|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355486|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355487|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355488|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355489|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355490|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355491|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355492|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355493|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355494|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355495|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355496|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355497|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355498|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355499|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
146355500|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
146355501|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
146355502|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
146355503|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
146355504|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
146355505|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
146355506|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
146355507|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
146355508|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355509|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355510|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355511|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355512|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355513|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355514|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355515|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355516|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355517|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355518|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355519|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355520|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355521|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355522|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
146355523|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
146355524|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355525|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
146355526|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
146355527|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
146355528|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
146355529|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
146355530|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
146355531|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355532|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355533|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355534|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355535|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355536|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355537|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355538|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355539|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355540|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355541|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355542|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355543|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355544|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355545|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
146355546|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
146355547|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
146355548|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355549|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
146355550|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
146355551|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355552|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355553|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
146355554|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355555|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355556|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355557|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355558|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355559|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355560|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355561|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355562|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355563|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355564|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355565|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355566|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355567|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355568|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
146355569|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
146355570|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355571|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355572|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355573|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355574|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355575|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355576|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
146355577|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355578|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355579|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355580|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355581|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355582|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355583|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355584|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355585|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355586|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355587|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355588|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355589|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355590|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355591|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
146355592|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
146355593|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355594|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355595|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355596|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
146355597|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355598|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355599|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
146355600|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
146355601|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
146355602|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
146355603|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
146355604|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
146355605|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
146355606|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
146355607|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
146355608|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
146355609|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
146355610|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
146355611|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
146355612|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
146355613|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
146355614|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
146355615|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
146355616|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
146355617|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
146355618|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
146355619|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
146355620|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
146355621|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
146355622|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
146355623|NCT02052778|527805996|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355624|NCT02052778|527805997|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355625|NCT02052778|527805998|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355626|NCT02052778|527805999|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355627|NCT02052778|527806000|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355628|NCT02052778|527806001|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355629|NCT02052778|527806002|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355630|NCT02052778|527806003|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355631|NCT02052778|527806004|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355632|NCT02052778|527806005|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355633|NCT02052778|527806006|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355634|NCT02052778|527806007|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355635|NCT02052778|527806008|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355636|NCT02052778|527806009|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355637|NCT02052778|527806010|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146355638|NCT02052778|527806011|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146355639|NCT02052778|527806012|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146355640|NCT02052778|527806013|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355641|NCT02052778|527806014|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
146355642|NCT02052778|527806015|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355643|NCT02052778|527806016|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355644|NCT02052778|527806017|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355645|NCT02052778|527806018|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
146355646|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355647|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355648|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355649|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355650|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355651|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355652|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355653|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355654|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355655|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355656|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355657|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355658|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355659|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355660|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355661|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355662|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355663|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355664|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355665|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355666|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355667|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
146355668|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
146355669|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355670|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355671|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355672|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355673|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355674|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355675|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355676|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355677|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355678|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355679|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355680|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355681|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355682|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355683|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355684|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355685|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355686|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355687|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355688|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355689|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355690|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
146355691|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
146355692|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355693|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355694|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355695|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355696|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355697|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355698|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355699|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355700|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355701|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355702|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355703|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355704|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355705|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355706|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355707|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355708|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355709|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355710|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355711|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355712|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355713|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
146355714|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
146355715|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355716|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355717|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355718|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355719|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355720|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355721|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355722|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355723|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355724|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355725|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355726|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355727|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355728|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355729|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355730|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355731|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355732|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355733|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355734|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355735|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355736|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
146355737|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
146355738|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355739|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355740|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355741|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146169603|NCT00860067|527132873|FG002|Overall Study|Lost to Follow-up|9|||
146355742|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355743|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355744|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355745|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355746|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355747|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355748|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355749|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355750|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355751|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355752|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355753|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355754|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355755|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355756|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355757|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355758|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355759|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
146355760|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
146355761|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
146355762|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
146355763|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
146355764|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
146355765|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
146355766|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
146355767|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
146355768|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
146355769|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
146355770|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
146355771|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
146355772|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
146355773|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
146355774|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
146355775|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
146355776|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
146355777|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
146355778|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
146355779|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
146355780|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
146355781|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
146355782|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
146355783|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
146355784|NCT02052778|527805996|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355785|NCT02052778|527805997|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355786|NCT02052778|527805998|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355787|NCT02052778|527805999|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355788|NCT02052778|527806000|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355789|NCT02052778|527806001|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355790|NCT02052778|527806002|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355791|NCT02052778|527806003|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355792|NCT02052778|527806004|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355793|NCT02052778|527806005|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355794|NCT02052778|527806006|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355795|NCT02052778|527806007|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355796|NCT02052778|527806008|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355797|NCT02052778|527806009|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355798|NCT02052778|527806010|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355799|NCT02052778|527806011|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355800|NCT02052778|527806012|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355801|NCT02052778|527806013|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355802|NCT02052778|527806014|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355803|NCT02052778|527806015|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355804|NCT02052778|527806016|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355805|NCT02052778|527806017|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
146355806|NCT02052778|527806018|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
146355807|NCT01994226|527806025|FG000|Overall Study|Protocol Violation|13|||
146355808|NCT01994226|527806026|FG001|Overall Study|Protocol Violation|10|||
146355809|NCT01994226|527806025|FG000|Overall Study|Early Cessation of treatment|6|||
146355810|NCT01994226|527806026|FG001|Overall Study|Early Cessation of treatment|11|||
146355811|NCT01094730|527806029|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
145943396|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146355812|NCT01094730|527806030|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
146355813|NCT01094730|527806029|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
146355814|NCT01094730|527806030|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
146355815|NCT01094730|527806029|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
146355816|NCT01094730|527806030|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
146355817|NCT01094730|527806029|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
146355818|NCT01094730|527806030|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
146355819|NCT01094730|527806029|FG000|Period 2 (14 Days)|Protocol Violation|2|||
146355820|NCT01094730|527806030|FG001|Period 2 (14 Days)|Protocol Violation|0|||
146355821|NCT01094730|527806029|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
146355822|NCT01094730|527806030|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
146355823|NCT01094730|527806029|FG000|Period 2 (14 Days)|Adverse Event|0|||
146355824|NCT01094730|527806030|FG001|Period 2 (14 Days)|Adverse Event|1|||
146355825|NCT01094730|527806029|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
146355826|NCT01094730|527806030|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
146355827|NCT04171037|527806031|FG000|Overall Study|Lost to Follow-up|1|||
146355828|NCT04171037|527806032|FG001|Overall Study|Lost to Follow-up|0|||
146355829|NCT04171037|527806031|FG000|Overall Study|Physician Decision|3|||
146355830|NCT04171037|527806032|FG001|Overall Study|Physician Decision|3|||
146355831|NCT01958125|527806033|FG000|Overall Study|Missing diary data|2|||
146355832|NCT01958125|527806034|FG001|Overall Study|Missing diary data|6|||
146355833|NCT01958125|527806033|FG000|Overall Study|No headache attacks|0|||
146355834|NCT01958125|527806034|FG001|Overall Study|No headache attacks|2|||
146355835|NCT04096326|527806035|FG000|Overall Study|Withdrawal by Subject|0|||
146355836|NCT04096326|527806036|FG001|Overall Study|Withdrawal by Subject|0|||
146355837|NCT04096326|527806037|FG002|Overall Study|Withdrawal by Subject|0|||
146355838|NCT04096326|527806038|FG003|Overall Study|Withdrawal by Subject|0|||
146355839|NCT04096326|527806039|FG004|Overall Study|Withdrawal by Subject|0|||
146355840|NCT04096326|527806040|FG005|Overall Study|Withdrawal by Subject|0|||
146355841|NCT04096326|527806041|FG006|Overall Study|Withdrawal by Subject|1|||
146355842|NCT04096326|527806042|FG007|Overall Study|Withdrawal by Subject|0|||
146355843|NCT04096326|527806043|FG008|Overall Study|Withdrawal by Subject|0|||
146355844|NCT04096326|527806044|FG009|Overall Study|Withdrawal by Subject|0|||
146355845|NCT04096326|527806035|FG000|Overall Study|Lost to Follow-up|0|||
146355846|NCT04096326|527806036|FG001|Overall Study|Lost to Follow-up|1|||
146355847|NCT04096326|527806037|FG002|Overall Study|Lost to Follow-up|0|||
146355848|NCT04096326|527806038|FG003|Overall Study|Lost to Follow-up|0|||
146355849|NCT04096326|527806039|FG004|Overall Study|Lost to Follow-up|0|||
146355850|NCT04096326|527806040|FG005|Overall Study|Lost to Follow-up|0|||
146355851|NCT04096326|527806041|FG006|Overall Study|Lost to Follow-up|0|||
146355852|NCT04096326|527806042|FG007|Overall Study|Lost to Follow-up|0|||
146355853|NCT04096326|527806043|FG008|Overall Study|Lost to Follow-up|0|||
146355854|NCT04096326|527806044|FG009|Overall Study|Lost to Follow-up|0|||
146355855|NCT04096326|527806035|FG000|Overall Study|COVID-19-related reasons|0|||
146355856|NCT04096326|527806036|FG001|Overall Study|COVID-19-related reasons|0|||
146355857|NCT04096326|527806037|FG002|Overall Study|COVID-19-related reasons|0|||
146355858|NCT04096326|527806038|FG003|Overall Study|COVID-19-related reasons|0|||
146355859|NCT04096326|527806039|FG004|Overall Study|COVID-19-related reasons|1|||
146355860|NCT04096326|527806040|FG005|Overall Study|COVID-19-related reasons|5|||
146355861|NCT04096326|527806041|FG006|Overall Study|COVID-19-related reasons|0|||
146355862|NCT04096326|527806042|FG007|Overall Study|COVID-19-related reasons|0|||
146355863|NCT04096326|527806043|FG008|Overall Study|COVID-19-related reasons|0|||
146355864|NCT04096326|527806044|FG009|Overall Study|COVID-19-related reasons|0|||
146355865|NCT01100307|527806045|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
146355866|NCT01100307|527806046|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
146355867|NCT01100307|527806045|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
146355868|NCT01100307|527806046|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
146355869|NCT01100307|527806045|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
146355870|NCT01100307|527806046|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
146355871|NCT01100307|527806045|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
146355872|NCT01100307|527806046|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
146355873|NCT01100307|527806045|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
146355874|NCT01100307|527806046|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
146355875|NCT01100307|527806045|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
146355876|NCT01100307|527806046|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
146355877|NCT02509598|527806047|FG000|Overall Study|Withdrawal by Subject|1|||
146355878|NCT02993224|527806048|FG000|Core Phase - Period 1|Adverse Event|4|||
146355879|NCT02993224|527806048|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
146355880|NCT02993224|527806048|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
146355881|NCT02993224|527806048|FG000|Core Phase- Period 2|Adverse Event|1|||
146355882|NCT02993224|527806048|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
146355883|NCT02993224|527806048|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
146355884|NCT02993224|527806048|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
146355885|NCT02993224|527806048|FG000|Extension Phase|Adverse Event|3|||
146355886|NCT02993224|527806048|FG000|Extension Phase|Withdrawal by Subject|3|||
146355887|NCT02993224|527806048|FG000|Extension Phase|Lost to Follow-up|2|||
146355888|NCT02993224|527806048|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
146355889|NCT01423617|527806052|FG000|Overall Study|Lost to Follow-up|0|||
146355890|NCT01423617|527806053|FG001|Overall Study|Lost to Follow-up|1|||
146355891|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
146355892|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
146355893|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
146355894|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
146355895|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
146355896|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
146355897|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
146355898|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
146355899|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
146355900|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
146355901|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
146355902|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
146355903|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
146355904|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
146355905|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
146355906|NCT03855137|527806056|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
146355907|NCT03855137|527806057|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
146355908|NCT03855137|527806058|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
146355909|NCT03855137|527806056|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
146355910|NCT03855137|527806057|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
146355911|NCT03855137|527806058|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
146355912|NCT03855137|527806056|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
146355913|NCT03855137|527806057|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
146355914|NCT03855137|527806058|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
146355915|NCT03855137|527806056|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
146355916|NCT03855137|527806057|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
146355917|NCT03855137|527806058|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
146355918|NCT03855137|527806056|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
146355919|NCT03855137|527806057|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
146355920|NCT03855137|527806058|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
146355921|NCT02435277|527806059|FG000|Overall Study|Adverse Event|1|||
146355922|NCT02435277|527806060|FG001|Overall Study|Adverse Event|1|||
146355923|NCT02435277|527806061|FG002|Overall Study|Adverse Event|0|||
146355924|NCT02435277|527806062|FG003|Overall Study|Adverse Event|0|||
146355925|NCT02435277|527806059|FG000|Overall Study|Withdrawal by Subject|1|||
146355926|NCT02435277|527806060|FG001|Overall Study|Withdrawal by Subject|0|||
146355927|NCT02435277|527806061|FG002|Overall Study|Withdrawal by Subject|0|||
146355928|NCT02435277|527806062|FG003|Overall Study|Withdrawal by Subject|0|||
146355929|NCT01067508|527806063|FG000|Overall Study|Physician Decision|0|||
146355930|NCT01067508|527806064|FG001|Overall Study|Physician Decision|1|||
146355931|NCT01067508|527806063|FG000|Overall Study|Withdrawal by Subject|0|||
146355932|NCT01067508|527806064|FG001|Overall Study|Withdrawal by Subject|1|||
146355933|NCT04715230|527806065|FG000|Overall Study|Withdrawal by Subject|1|||
146355934|NCT04715230|527806066|FG001|Overall Study|Withdrawal by Subject|0|||
146355935|NCT04715230|527806067|FG002|Overall Study|Withdrawal by Subject|0|||
146355936|NCT04715230|527806065|FG000|Overall Study|Lost to Follow-up|0|||
146355937|NCT04715230|527806066|FG001|Overall Study|Lost to Follow-up|5|||
146355938|NCT04715230|527806067|FG002|Overall Study|Lost to Follow-up|1|||
146355939|NCT01468909|527806071|FG000|Overall Study|Never Treated|2|||
146355940|NCT01468909|527806072|FG001|Overall Study|Never Treated|2|||
146355941|NCT02635737|527806077|FG000|Overall Study|Protocol Violation|1|||
146355942|NCT01511419|527806078|FG000|Dose 2|Physician Decision|1|||
146355943|NCT01511419|527806079|FG001|Dose 2|Physician Decision|0|||
146355944|NCT00937768|527806080|FG000|Overall Study|Refused Further Treatment|3|||
146355945|NCT00937768|527806081|FG001|Overall Study|Refused Further Treatment|2|||
146355946|NCT00937768|527806080|FG000|Overall Study|Disease Progression|1|||
146355947|NCT00937768|527806081|FG001|Overall Study|Disease Progression|1|||
146355948|NCT00937768|527806080|FG000|Overall Study|Alternate Treatment|0|||
146355949|NCT00937768|527806081|FG001|Overall Study|Alternate Treatment|1|||
146355950|NCT00937768|527806080|FG000|Overall Study|No Further Funding|4|||
146355951|NCT00937768|527806081|FG001|Overall Study|No Further Funding|4|||
146355952|NCT02065622|527806082|FG000|Induction Study|Adverse Event|13|||
146355953|NCT02065622|527806083|FG001|Induction Study|Adverse Event|19|||
146355954|NCT02065622|527806084|FG002|Induction Study|Adverse Event|0|||
146355955|NCT02065622|527806085|FG003|Induction Study|Adverse Event|0|||
146355956|NCT02065622|527806086|FG004|Induction Study|Adverse Event|0|||
146355957|NCT02065622|527806082|FG000|Induction Study|Withdrawal by Subject|3|||
146355958|NCT02065622|527806083|FG001|Induction Study|Withdrawal by Subject|5|||
146355959|NCT02065622|527806084|FG002|Induction Study|Withdrawal by Subject|0|||
146355960|NCT02065622|527806085|FG003|Induction Study|Withdrawal by Subject|0|||
146355961|NCT02065622|527806086|FG004|Induction Study|Withdrawal by Subject|0|||
146355962|NCT02065622|527806082|FG000|Induction Study|Lost to Follow-up|1|||
146355963|NCT02065622|527806083|FG001|Induction Study|Lost to Follow-up|0|||
146355964|NCT02065622|527806084|FG002|Induction Study|Lost to Follow-up|0|||
146355965|NCT02065622|527806085|FG003|Induction Study|Lost to Follow-up|0|||
146355966|NCT02065622|527806086|FG004|Induction Study|Lost to Follow-up|0|||
146355967|NCT02065622|527806082|FG000|Induction Study|Lack of Efficacy|22|||
146355968|NCT02065622|527806083|FG001|Induction Study|Lack of Efficacy|27|||
146355969|NCT02065622|527806084|FG002|Induction Study|Lack of Efficacy|0|||
146355970|NCT02065622|527806085|FG003|Induction Study|Lack of Efficacy|0|||
146355971|NCT02065622|527806086|FG004|Induction Study|Lack of Efficacy|0|||
146355972|NCT02065622|527806082|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
146355973|NCT02065622|527806083|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
146355974|NCT02065622|527806084|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146355975|NCT02065622|527806085|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146355976|NCT02065622|527806086|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
146355977|NCT02065622|527806082|FG000|Induction Study|Subject Noncompliance|1|||
146355978|NCT02065622|527806083|FG001|Induction Study|Subject Noncompliance|1|||
146355979|NCT02065622|527806084|FG002|Induction Study|Subject Noncompliance|0|||
146355980|NCT02065622|527806085|FG003|Induction Study|Subject Noncompliance|0|||
146355981|NCT02065622|527806086|FG004|Induction Study|Subject Noncompliance|0|||
146355982|NCT02065622|527806082|FG000|Induction Study|Other, Not Specified|3|||
146355983|NCT02065622|527806083|FG001|Induction Study|Other, Not Specified|2|||
146355984|NCT02065622|527806084|FG002|Induction Study|Other, Not Specified|0|||
146355985|NCT02065622|527806085|FG003|Induction Study|Other, Not Specified|0|||
146355986|NCT02065622|527806086|FG004|Induction Study|Other, Not Specified|0|||
146355987|NCT02065622|527806082|FG000|Maintenance Study|Adverse Event|0|||
146355988|NCT02065622|527806083|FG001|Maintenance Study|Adverse Event|0|||
146355989|NCT02065622|527806084|FG002|Maintenance Study|Adverse Event|25|||
146355990|NCT02065622|527806085|FG003|Maintenance Study|Adverse Event|22|||
146355991|NCT02065622|527806086|FG004|Maintenance Study|Adverse Event|11|||
146355992|NCT02065622|527806082|FG000|Maintenance Study|Withdrawal by Subject|0|||
146355993|NCT02065622|527806083|FG001|Maintenance Study|Withdrawal by Subject|0|||
146355994|NCT02065622|527806084|FG002|Maintenance Study|Withdrawal by Subject|11|||
146355995|NCT02065622|527806085|FG003|Maintenance Study|Withdrawal by Subject|5|||
146355996|NCT02065622|527806086|FG004|Maintenance Study|Withdrawal by Subject|7|||
146355997|NCT02065622|527806082|FG000|Maintenance Study|Lost to Follow-up|0|||
146355998|NCT02065622|527806083|FG001|Maintenance Study|Lost to Follow-up|0|||
146355999|NCT02065622|527806084|FG002|Maintenance Study|Lost to Follow-up|4|||
146356000|NCT02065622|527806085|FG003|Maintenance Study|Lost to Follow-up|1|||
146356001|NCT02065622|527806086|FG004|Maintenance Study|Lost to Follow-up|1|||
146356002|NCT02065622|527806082|FG000|Maintenance Study|Lack of Efficacy|0|||
146356003|NCT02065622|527806083|FG001|Maintenance Study|Lack of Efficacy|0|||
146356004|NCT02065622|527806084|FG002|Maintenance Study|Lack of Efficacy|70|||
146356005|NCT02065622|527806085|FG003|Maintenance Study|Lack of Efficacy|55|||
146356006|NCT02065622|527806086|FG004|Maintenance Study|Lack of Efficacy|19|||
146356007|NCT02065622|527806082|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
146356008|NCT02065622|527806083|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
146356009|NCT02065622|527806084|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
146356010|NCT02065622|527806085|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
146356011|NCT02065622|527806086|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
146356012|NCT02065622|527806082|FG000|Maintenance Study|Subject Non-Compliance|0|||
146356013|NCT02065622|527806083|FG001|Maintenance Study|Subject Non-Compliance|0|||
146356014|NCT02065622|527806084|FG002|Maintenance Study|Subject Non-Compliance|1|||
146356015|NCT02065622|527806085|FG003|Maintenance Study|Subject Non-Compliance|3|||
146356016|NCT02065622|527806086|FG004|Maintenance Study|Subject Non-Compliance|2|||
146356017|NCT02065622|527806082|FG000|Maintenance Study|Other, Not Specified|0|||
146356018|NCT02065622|527806083|FG001|Maintenance Study|Other, Not Specified|0|||
146356019|NCT02065622|527806084|FG002|Maintenance Study|Other, Not Specified|6|||
146356020|NCT02065622|527806085|FG003|Maintenance Study|Other, Not Specified|14|||
146356021|NCT02065622|527806086|FG004|Maintenance Study|Other, Not Specified|2|||
146356022|NCT02065622|527806082|FG000|Maintenance Study|Unknown Reason|0|||
146356023|NCT02065622|527806083|FG001|Maintenance Study|Unknown Reason|0|||
146356024|NCT02065622|527806084|FG002|Maintenance Study|Unknown Reason|0|||
146356025|NCT02065622|527806085|FG003|Maintenance Study|Unknown Reason|1|||
146356026|NCT02065622|527806086|FG004|Maintenance Study|Unknown Reason|0|||
146356027|NCT01687413|527806101|FG000|Overall Study|Withdrawal by Subject|0|||
146356028|NCT01687413|527806102|FG001|Overall Study|Withdrawal by Subject|2|||
146356029|NCT01687413|527806101|FG000|Overall Study|Not eligible|0|||
146356030|NCT01687413|527806102|FG001|Overall Study|Not eligible|2|||
146356031|NCT01687413|527806101|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
145943397|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146356032|NCT01687413|527806102|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
146356033|NCT00488618|527806108|FG000|Overall Study|Adverse Event|13|||
146356034|NCT00488618|527806109|FG001|Overall Study|Adverse Event|17|||
146356035|NCT00488618|527806108|FG000|Overall Study|Insufficient Therapeutic Response|18|||
146356036|NCT00488618|527806109|FG001|Overall Study|Insufficient Therapeutic Response|11|||
146356037|NCT00488618|527806108|FG000|Overall Study|Protocol Violation|0|||
146356038|NCT00488618|527806109|FG001|Overall Study|Protocol Violation|2|||
146356039|NCT00488618|527806108|FG000|Overall Study|Withdrawal of Consent|15|||
146356040|NCT00488618|527806109|FG001|Overall Study|Withdrawal of Consent|13|||
146356041|NCT00488618|527806108|FG000|Overall Study|Lost to Follow-up|1|||
146356042|NCT00488618|527806109|FG001|Overall Study|Lost to Follow-up|0|||
146356043|NCT00992446|527806110|FG000|Overall Study|Disease Progression|1|||
146356044|NCT00992446|527806110|FG000|Overall Study|Withdrawal by Subject|2|||
146356045|NCT00992446|527806110|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
146356046|NCT00755846|527808001|FG000|Overall Study|Adverse Event|0|||
146356047|NCT00755846|527808002|FG001|Overall Study|Adverse Event|0|||
146356048|NCT00755846|527808003|FG002|Overall Study|Adverse Event|0|||
146356049|NCT00755846|527808004|FG003|Overall Study|Adverse Event|1|||
146356050|NCT00755846|527808005|FG004|Overall Study|Adverse Event|3|||
146356051|NCT00755846|527808006|FG005|Overall Study|Adverse Event|2|||
146356052|NCT00755846|527808001|FG000|Overall Study|Protocol Violation|1|||
146356053|NCT00755846|527808002|FG001|Overall Study|Protocol Violation|1|||
146356054|NCT00755846|527808003|FG002|Overall Study|Protocol Violation|1|||
146356055|NCT00755846|527808004|FG003|Overall Study|Protocol Violation|1|||
146356056|NCT00755846|527808005|FG004|Overall Study|Protocol Violation|1|||
146356057|NCT00755846|527808006|FG005|Overall Study|Protocol Violation|1|||
146356058|NCT00755846|527808001|FG000|Overall Study|Lost to Follow-up|0|||
146356059|NCT00755846|527808002|FG001|Overall Study|Lost to Follow-up|2|||
146356060|NCT00755846|527808003|FG002|Overall Study|Lost to Follow-up|1|||
146356061|NCT00755846|527808004|FG003|Overall Study|Lost to Follow-up|0|||
146356062|NCT00755846|527808005|FG004|Overall Study|Lost to Follow-up|4|||
146356063|NCT00755846|527808006|FG005|Overall Study|Lost to Follow-up|2|||
146356064|NCT00755846|527808001|FG000|Overall Study|Withdrawal by Subject|2|||
146356065|NCT00755846|527808002|FG001|Overall Study|Withdrawal by Subject|3|||
146356066|NCT00755846|527808003|FG002|Overall Study|Withdrawal by Subject|5|||
146356067|NCT00755846|527808004|FG003|Overall Study|Withdrawal by Subject|2|||
146356068|NCT00755846|527808005|FG004|Overall Study|Withdrawal by Subject|0|||
146356069|NCT00755846|527808006|FG005|Overall Study|Withdrawal by Subject|1|||
146356070|NCT00755846|527808001|FG000|Overall Study|Hyperglycemic Rescue|21|||
146356071|NCT00755846|527808002|FG001|Overall Study|Hyperglycemic Rescue|7|||
146356072|NCT00755846|527808003|FG002|Overall Study|Hyperglycemic Rescue|5|||
146356073|NCT00755846|527808004|FG003|Overall Study|Hyperglycemic Rescue|8|||
146356074|NCT00755846|527808005|FG004|Overall Study|Hyperglycemic Rescue|8|||
146356075|NCT00755846|527808006|FG005|Overall Study|Hyperglycemic Rescue|7|||
146356076|NCT00755846|527808001|FG000|Overall Study|Physician Decision|1|||
146356077|NCT00755846|527808002|FG001|Overall Study|Physician Decision|3|||
146356078|NCT00755846|527808003|FG002|Overall Study|Physician Decision|0|||
146356079|NCT00755846|527808004|FG003|Overall Study|Physician Decision|1|||
146356080|NCT00755846|527808005|FG004|Overall Study|Physician Decision|0|||
146356081|NCT00755846|527808006|FG005|Overall Study|Physician Decision|1|||
146356082|NCT00755846|527808001|FG000|Overall Study|Administrative Error|0|||
146356083|NCT00755846|527808002|FG001|Overall Study|Administrative Error|1|||
146356084|NCT00755846|527808003|FG002|Overall Study|Administrative Error|0|||
146356085|NCT00755846|527808004|FG003|Overall Study|Administrative Error|0|||
146356086|NCT00755846|527808005|FG004|Overall Study|Administrative Error|0|||
146356087|NCT00755846|527808006|FG005|Overall Study|Administrative Error|0|||
146356088|NCT00755846|527808001|FG000|Overall Study|Participant Non-compliance|0|||
146356089|NCT00755846|527808002|FG001|Overall Study|Participant Non-compliance|0|||
146356090|NCT00755846|527808003|FG002|Overall Study|Participant Non-compliance|0|||
146356091|NCT00755846|527808004|FG003|Overall Study|Participant Non-compliance|0|||
146356092|NCT00755846|527808005|FG004|Overall Study|Participant Non-compliance|1|||
146356093|NCT00755846|527808006|FG005|Overall Study|Participant Non-compliance|0|||
146356094|NCT00786032|527808015|FG000|Overall Study|Death|4|||
146356095|NCT00786032|527808015|FG000|Overall Study|Withdrawal by Subject|14|||
146356096|NCT00786032|527808015|FG000|Overall Study|Did not complete in the timeframe|6|||
146356097|NCT02922634|527808016|FG000|Overall Study|Withdrawal by Subject|5|||
146356098|NCT02922634|527808016|FG000|Overall Study|Did not have their surgery|5|||
146356099|NCT01194804|527808017|FG000|Overall Study|Withdrawal by Subject|1|||
146356100|NCT02494778|527808018|FG000|Overall Study|Death|3|||
146356101|NCT02494778|527808018|FG000|Overall Study|Other|173|||
146356102|NCT02494778|527808018|FG000|Overall Study|Lack of Efficacy|4|||
146356103|NCT02494778|527808018|FG000|Overall Study|Adverse Event|18|||
146356104|NCT02494778|527808018|FG000|Overall Study|Withdrawal by Subject|20|||
146356105|NCT02494778|527808018|FG000|Overall Study|Lost to Follow-up|2|||
146356106|NCT02494778|527808018|FG000|Overall Study|Noncompliant with study drug admin.|1|||
146356107|NCT01303380|527808019|FG000|Overall Study|Lack of compliance to study procedures|1|||
146356108|NCT02174861|527808020|FG000|Overall Study|Decision by sponsor|8|||
146356109|NCT02174861|527808020|FG000|Overall Study|Withdrawal by Subject|124|||
146356110|NCT02174861|527808020|FG000|Overall Study|Lost to Follow-up|26|||
146356111|NCT01215734|527808021|FG000|Overall Study|Death|0|||
146356112|NCT01215734|527808022|FG001|Overall Study|Death|1|||
146356113|NCT00315705|527808023|FG000|Phase 1|Refused further treatment|1|||
146356114|NCT00315705|527808023|FG000|Phase 1|Failure to achieve response|8|||
146356115|NCT00315705|527808023|FG000|Phase 1|Disease relapse|4|||
146356116|NCT00315705|527808023|FG000|Phase 1|Scheduled for transplant|9|||
146356117|NCT00315705|527808023|FG000|Phase 1|Death|3|||
146356118|NCT00315705|527808023|FG000|Phase 2|Physician Decision|4|||
146356119|NCT00315705|527808023|FG000|Phase 2|Adverse Event|1|||
146356120|NCT00315705|527808023|FG000|Phase 2|Failure to achieve response|3|||
146356121|NCT00315705|527808023|FG000|Phase 2|Disease relapse|1|||
146356122|NCT00315705|527808023|FG000|Phase 2|Scheduled for transplant|8|||
146356123|NCT00315705|527808023|FG000|Phase 2|Other|1|||
146356124|NCT00315705|527808023|FG000|Phase 2|Death|7|||
146356125|NCT01716533|527808027|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
146356126|NCT01716533|527808028|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
146356127|NCT01716533|527808029|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
146356128|NCT01716533|527808030|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
146356129|NCT01716533|527808027|FG000|Overall Study|Withdrawal by Subject|0|||
146356130|NCT01716533|527808028|FG001|Overall Study|Withdrawal by Subject|0|||
146356131|NCT01716533|527808029|FG002|Overall Study|Withdrawal by Subject|0|||
146356132|NCT01716533|527808030|FG003|Overall Study|Withdrawal by Subject|5|||
146356133|NCT01716533|527808027|FG000|Overall Study|Death|0|||
146356134|NCT01716533|527808028|FG001|Overall Study|Death|0|||
146356135|NCT01716533|527808029|FG002|Overall Study|Death|0|||
146356136|NCT01716533|527808030|FG003|Overall Study|Death|2|||
146356137|NCT01716533|527808027|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
146356138|NCT01716533|527808028|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
146356139|NCT01716533|527808029|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
146356140|NCT01716533|527808030|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
146356141|NCT00165841|527808037|FG000|Overall Study|Adverse Event|2|||
146356142|NCT00165841|527808038|FG001|Overall Study|Adverse Event|3|||
146356143|NCT00165841|527808037|FG000|Overall Study|Lack of Efficacy|6|||
146356144|NCT00165841|527808038|FG001|Overall Study|Lack of Efficacy|33|||
146356145|NCT00165841|527808037|FG000|Overall Study|Lost to Follow-up|4|||
146356146|NCT00165841|527808038|FG001|Overall Study|Lost to Follow-up|4|||
146356147|NCT00165841|527808037|FG000|Overall Study|Withdrawal by Subject|7|||
146356148|NCT00165841|527808038|FG001|Overall Study|Withdrawal by Subject|8|||
146356149|NCT00165841|527808037|FG000|Overall Study|Physician Decision|1|||
146356150|NCT00165841|527808038|FG001|Overall Study|Physician Decision|0|||
146356151|NCT00165841|527808037|FG000|Overall Study|Protocol Violation|6|||
146356152|NCT00165841|527808038|FG001|Overall Study|Protocol Violation|8|||
146356153|NCT00165841|527808037|FG000|Overall Study|Other|3|||
146356154|NCT00165841|527808038|FG001|Overall Study|Other|5|||
146356155|NCT00165841|527808037|FG000|Overall Study|Medication Noncompliance|1|||
146356156|NCT00165841|527808038|FG001|Overall Study|Medication Noncompliance|1|||
146356157|NCT01626352|527808041|FG000|Overall Study|Disease Progression|3|||
146356158|NCT01626352|527808041|FG000|Overall Study|Intercurrent Illness|2|||
146356159|NCT01626352|527808041|FG000|Overall Study|Death|2|||
146356160|NCT01626352|527808041|FG000|Overall Study|Withdrawal by Subject|1|||
146356161|NCT01626352|527808041|FG000|Overall Study|Non-Compliance|1|||
146356162|NCT01626352|527808041|FG000|Overall Study|Never Treated|1|||
146356163|NCT02681055|527808042|FG000|Weeks 5-12|Adverse Event|1|||
146356164|NCT03446651|527808045|FG000|Overall Study|Lost to Follow-up|4|||
146356165|NCT03446651|527808046|FG001|Overall Study|Lost to Follow-up|0|||
146356166|NCT03446651|527808045|FG000|Overall Study|Open Label Participants|5|||
146356167|NCT03446651|527808046|FG001|Overall Study|Open Label Participants|0|||
146356168|NCT00798655|527808047|FG000|Overall Study|Did not receive at least one dose of pan|2|||
146356169|NCT00343291|527808048|FG000|Overall Study|Adverse Event|13|||
146356170|NCT00343291|527808049|FG001|Overall Study|Adverse Event|13|||
146356171|NCT00343291|527808048|FG000|Overall Study|Death|3|||
146356172|NCT00343291|527808049|FG001|Overall Study|Death|2|||
146356173|NCT00343291|527808048|FG000|Overall Study|Progressive disease|33|||
146356174|NCT00343291|527808049|FG001|Overall Study|Progressive disease|34|||
146356175|NCT00343291|527808048|FG000|Overall Study|Withdrawal by Subject|0|||
146356176|NCT00343291|527808049|FG001|Overall Study|Withdrawal by Subject|2|||
146356177|NCT00343291|527808048|FG000|Overall Study|Other|8|||
146356178|NCT00343291|527808049|FG001|Overall Study|Other|5|||
146356179|NCT03712345|527808050|FG000|Overall Study|Failure to meet randomization criteria|0|||
146356180|NCT03712345|527808051|FG001|Overall Study|Failure to meet randomization criteria|0|||
146356181|NCT03712345|527808052|FG002|Overall Study|Failure to meet randomization criteria|1|||
146356182|NCT00960934|527808055|FG000|Overall Study|Adverse Event|2|||
146356183|NCT00960934|527808056|FG001|Overall Study|Adverse Event|3|||
146356184|NCT00960934|527808057|FG002|Overall Study|Adverse Event|3|||
146356185|NCT00960934|527808058|FG003|Overall Study|Adverse Event|2|||
146356186|NCT00960934|527808059|FG004|Overall Study|Adverse Event|4|||
146356187|NCT00960934|527808060|FG005|Overall Study|Adverse Event|3|||
146356188|NCT00960934|527808055|FG000|Overall Study|Lack of Efficacy|1|||
146356189|NCT00960934|527808056|FG001|Overall Study|Lack of Efficacy|0|||
146356190|NCT00960934|527808057|FG002|Overall Study|Lack of Efficacy|0|||
146356191|NCT00960934|527808058|FG003|Overall Study|Lack of Efficacy|0|||
146356192|NCT00960934|527808059|FG004|Overall Study|Lack of Efficacy|0|||
146356193|NCT00960934|527808060|FG005|Overall Study|Lack of Efficacy|0|||
146356194|NCT00960934|527808055|FG000|Overall Study|Lost to Follow-up|0|||
146356195|NCT00960934|527808056|FG001|Overall Study|Lost to Follow-up|1|||
146356196|NCT00960934|527808057|FG002|Overall Study|Lost to Follow-up|0|||
146356197|NCT00960934|527808058|FG003|Overall Study|Lost to Follow-up|0|||
146356198|NCT00960934|527808059|FG004|Overall Study|Lost to Follow-up|0|||
146356199|NCT00960934|527808060|FG005|Overall Study|Lost to Follow-up|0|||
146356200|NCT00960934|527808055|FG000|Overall Study|Other|2|||
146356201|NCT00960934|527808056|FG001|Overall Study|Other|1|||
146356202|NCT00960934|527808057|FG002|Overall Study|Other|5|||
146356203|NCT00960934|527808058|FG003|Overall Study|Other|4|||
146356204|NCT00960934|527808059|FG004|Overall Study|Other|2|||
146356205|NCT00960934|527808060|FG005|Overall Study|Other|2|||
146356206|NCT00960934|527808055|FG000|Overall Study|Physician Decision|0|||
146356207|NCT00960934|527808056|FG001|Overall Study|Physician Decision|1|||
146356208|NCT00960934|527808057|FG002|Overall Study|Physician Decision|0|||
146356209|NCT00960934|527808058|FG003|Overall Study|Physician Decision|0|||
146356210|NCT00960934|527808059|FG004|Overall Study|Physician Decision|0|||
146356211|NCT00960934|527808060|FG005|Overall Study|Physician Decision|0|||
146356212|NCT00960934|527808055|FG000|Overall Study|Progressive Disease|1|||
146356213|NCT00960934|527808056|FG001|Overall Study|Progressive Disease|1|||
146356214|NCT00960934|527808057|FG002|Overall Study|Progressive Disease|0|||
146356215|NCT00960934|527808058|FG003|Overall Study|Progressive Disease|0|||
146356216|NCT00960934|527808059|FG004|Overall Study|Progressive Disease|1|||
146356217|NCT00960934|527808060|FG005|Overall Study|Progressive Disease|1|||
146356218|NCT00960934|527808055|FG000|Overall Study|Protocol Violation|3|||
146356219|NCT00960934|527808056|FG001|Overall Study|Protocol Violation|4|||
146356220|NCT00960934|527808057|FG002|Overall Study|Protocol Violation|0|||
146356221|NCT00960934|527808058|FG003|Overall Study|Protocol Violation|3|||
146356222|NCT00960934|527808059|FG004|Overall Study|Protocol Violation|3|||
146356223|NCT00960934|527808060|FG005|Overall Study|Protocol Violation|2|||
146356224|NCT00960934|527808055|FG000|Overall Study|Withdrawal by Subject|5|||
146356225|NCT00960934|527808056|FG001|Overall Study|Withdrawal by Subject|6|||
146356226|NCT00960934|527808057|FG002|Overall Study|Withdrawal by Subject|4|||
146356227|NCT00960934|527808058|FG003|Overall Study|Withdrawal by Subject|5|||
146356228|NCT00960934|527808059|FG004|Overall Study|Withdrawal by Subject|5|||
146356229|NCT00960934|527808060|FG005|Overall Study|Withdrawal by Subject|7|||
146356230|NCT00960934|527808055|FG000|Overall Study|Study Terminated by Sponsor|50|||
146356231|NCT00960934|527808056|FG001|Overall Study|Study Terminated by Sponsor|46|||
146356232|NCT00960934|527808057|FG002|Overall Study|Study Terminated by Sponsor|52|||
146356233|NCT00960934|527808058|FG003|Overall Study|Study Terminated by Sponsor|50|||
146356234|NCT00960934|527808059|FG004|Overall Study|Study Terminated by Sponsor|49|||
146356235|NCT00960934|527808060|FG005|Overall Study|Study Terminated by Sponsor|49|||
146356236|NCT01071096|527808063|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
146356237|NCT01071096|527808064|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
146356238|NCT00288860|527808067|FG000|Overall Study|Did not complete intake|4|||
146356239|NCT00288860|527808068|FG001|Overall Study|Did not complete intake|8|||
146356240|NCT00288860|527808067|FG000|Overall Study|Death|4|||
146356241|NCT00288860|527808068|FG001|Overall Study|Death|3|||
146356242|NCT00288860|527808067|FG000|Overall Study|Withdrawal by Subject|20|||
146356243|NCT00288860|527808068|FG001|Overall Study|Withdrawal by Subject|15|||
146356244|NCT00288860|527808067|FG000|Overall Study|Lost to Follow-up|74|||
146356245|NCT00288860|527808068|FG001|Overall Study|Lost to Follow-up|71|||
146356246|NCT02179515|527808071|FG000|Overall Study|switched to alternative treatment|0|||
146356247|NCT02179515|527808072|FG001|Overall Study|switched to alternative treatment|1|||
146356248|NCT02179515|527808073|FG002|Overall Study|switched to alternative treatment|1|||
146356249|NCT02179515|527808071|FG000|Overall Study|Death|0|||
146356250|NCT02179515|527808072|FG001|Overall Study|Death|1|||
146356251|NCT02179515|527808073|FG002|Overall Study|Death|1|||
146356252|NCT02179515|527808071|FG000|Overall Study|refused further treatment|0|||
146356253|NCT02179515|527808072|FG001|Overall Study|refused further treatment|3|||
146356254|NCT02179515|527808073|FG002|Overall Study|refused further treatment|4|||
146356255|NCT02179515|527808071|FG000|Overall Study|Disease progression on study|2|||
146356256|NCT02179515|527808072|FG001|Overall Study|Disease progression on study|11|||
146356257|NCT02179515|527808073|FG002|Overall Study|Disease progression on study|8|||
146356258|NCT00782418|527808074|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
146356259|NCT00782418|527808075|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356260|NCT00782418|527808076|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356261|NCT00782418|527808077|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356262|NCT00782418|527808078|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356263|NCT00782418|527808079|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356264|NCT00782418|527808080|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
146356265|NCT00782418|527808074|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146356266|NCT00782418|527808075|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146356267|NCT00782418|527808076|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146356268|NCT00782418|527808077|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146356269|NCT00782418|527808078|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146356270|NCT00782418|527808079|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
146356271|NCT00782418|527808080|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
146356272|NCT02116660|527808081|FG000|Overall Study|Deteriorating renal function|0|||
146356273|NCT02116660|527808082|FG001|Overall Study|Deteriorating renal function|1|||
146356274|NCT02116660|527808081|FG000|Overall Study|Adverse Event|1|||
146356275|NCT02116660|527808082|FG001|Overall Study|Adverse Event|1|||
146356276|NCT02116660|527808081|FG000|Overall Study|Withdrawal by Subject|0|||
146356277|NCT02116660|527808082|FG001|Overall Study|Withdrawal by Subject|2|||
146356278|NCT02116660|527808081|FG000|Overall Study|Organization reason|1|||
146356279|NCT02116660|527808082|FG001|Overall Study|Organization reason|0|||
146356280|NCT02561299|527808083|FG000|Overall Study|Death|2|||
146356281|NCT02561299|527808084|FG001|Overall Study|Death|4|||
146356282|NCT02561299|527808083|FG000|Overall Study|Lost to Follow-up|1|||
146356283|NCT02561299|527808084|FG001|Overall Study|Lost to Follow-up|0|||
146356284|NCT02561299|527808083|FG000|Overall Study|Withdrawal by Subject|2|||
146356285|NCT02561299|527808084|FG001|Overall Study|Withdrawal by Subject|2|||
146356286|NCT01911845|527808087|FG000|Overall Study|Adverse Event|2|||
146356287|NCT01911845|527808087|FG000|Overall Study|Lost to Follow-up|1|||
146356288|NCT01911845|527808087|FG000|Overall Study|Other (not specified)|3|||
146356289|NCT02488551|527808093|FG000|Overall Study|Lost to Follow-up|4|||
146356290|NCT02488551|527808094|FG001|Overall Study|Lost to Follow-up|7|||
146356291|NCT02488551|527808095|FG002|Overall Study|Lost to Follow-up|0|||
146356292|NCT02488551|527808096|FG003|Overall Study|Lost to Follow-up|0|||
146356293|NCT02488551|527808093|FG000|Overall Study|Military Deployment|1|||
146356294|NCT02488551|527808094|FG001|Overall Study|Military Deployment|1|||
146356295|NCT02488551|527808095|FG002|Overall Study|Military Deployment|0|||
146356296|NCT02488551|527808096|FG003|Overall Study|Military Deployment|0|||
146356297|NCT01860534|527808103|FG000|ROP #1|Needed treatment for ROP|0|||
146356298|NCT01860534|527808104|FG001|ROP #1|Needed treatment for ROP|1|||
146356299|NCT01860534|527808103|FG000|ROP #2|discharged prior to ROP #2|1|||
146356300|NCT01860534|527808104|FG001|ROP #2|discharged prior to ROP #2|0|||
146356301|NCT01188564|527808105|FG000|Double-blind Phase|randomized not treated|1|||
146356302|NCT01188564|527808106|FG001|Double-blind Phase|randomized not treated|0|||
146356303|NCT01934894|527808107|FG000|Overall Study|Adverse Event|1|||
146356304|NCT01934894|527808108|FG001|Overall Study|Adverse Event|2|||
146356305|NCT01934894|527808107|FG000|Overall Study|Death|2|||
146356306|NCT01934894|527808108|FG001|Overall Study|Death|0|||
146356307|NCT01934894|527808107|FG000|Overall Study|Withdrawal by Subject|0|||
146356308|NCT01934894|527808108|FG001|Overall Study|Withdrawal by Subject|1|||
146356309|NCT01934894|527808107|FG000|Overall Study|Progressive Disease|3|||
146356310|NCT01934894|527808108|FG001|Overall Study|Progressive Disease|2|||
146356311|NCT02864940|527808109|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
146356312|NCT02864940|527808110|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
146356313|NCT04804033|527808112|FG000|Period 1: DBT Phase|Adverse Event|1|||
146356314|NCT04804033|527808113|FG001|Period 1: DBT Phase|Adverse Event|5|||
146356315|NCT04804033|527808114|FG002|Period 1: DBT Phase|Adverse Event|3|||
146356316|NCT04804033|527808115|FG003|Period 1: DBT Phase|Adverse Event|4|||
146356317|NCT04804033|527808112|FG000|Period 1: DBT Phase|Death|1|||
146356318|NCT04804033|527808113|FG001|Period 1: DBT Phase|Death|0|||
146356319|NCT04804033|527808114|FG002|Period 1: DBT Phase|Death|0|||
146356320|NCT04804033|527808115|FG003|Period 1: DBT Phase|Death|0|||
146356321|NCT04804033|527808112|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
146356322|NCT04804033|527808113|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
146356323|NCT04804033|527808114|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
146356324|NCT04804033|527808115|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
146356325|NCT04804033|527808112|FG000|Period 1: DBT Phase|Non-compliance|1|||
146356326|NCT04804033|527808113|FG001|Period 1: DBT Phase|Non-compliance|0|||
146356327|NCT04804033|527808114|FG002|Period 1: DBT Phase|Non-compliance|1|||
146356328|NCT04804033|527808115|FG003|Period 1: DBT Phase|Non-compliance|2|||
146356329|NCT04804033|527808112|FG000|Period 1: DBT Phase|Other|0|||
146356330|NCT04804033|527808113|FG001|Period 1: DBT Phase|Other|1|||
146356331|NCT04804033|527808114|FG002|Period 1: DBT Phase|Other|0|||
146356332|NCT04804033|527808115|FG003|Period 1: DBT Phase|Other|0|||
146356333|NCT04804033|527808112|FG000|Period 1: DBT Phase|Pregnancy|2|||
146356334|NCT04804033|527808113|FG001|Period 1: DBT Phase|Pregnancy|0|||
146356335|NCT04804033|527808114|FG002|Period 1: DBT Phase|Pregnancy|0|||
146356336|NCT04804033|527808115|FG003|Period 1: DBT Phase|Pregnancy|0|||
146356337|NCT04804033|527808112|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
146356338|NCT04804033|527808113|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
146356339|NCT04804033|527808114|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
146356340|NCT04804033|527808115|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
146356341|NCT04804033|527808112|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
146356342|NCT04804033|527808113|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
146356343|NCT04804033|527808114|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
146356344|NCT04804033|527808115|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
146356345|NCT04804033|527808112|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
146356346|NCT04804033|527808113|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
146356347|NCT04804033|527808114|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
146356348|NCT04804033|527808115|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
146356349|NCT04804033|527808112|FG000|Period 2: OLE Phase|Adverse Event|3|||
146356350|NCT04804033|527808113|FG001|Period 2: OLE Phase|Adverse Event|4|||
146356351|NCT04804033|527808114|FG002|Period 2: OLE Phase|Adverse Event|2|||
146356352|NCT04804033|527808115|FG003|Period 2: OLE Phase|Adverse Event|0|||
146356353|NCT04804033|527808112|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
146356354|NCT04804033|527808113|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
146356355|NCT04804033|527808114|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
146356356|NCT04804033|527808115|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
146356357|NCT04804033|527808112|FG000|Period 2: OLE Phase|Non-compliance|2|||
146356358|NCT04804033|527808113|FG001|Period 2: OLE Phase|Non-compliance|2|||
146356359|NCT04804033|527808114|FG002|Period 2: OLE Phase|Non-compliance|0|||
146356360|NCT04804033|527808115|FG003|Period 2: OLE Phase|Non-compliance|1|||
146356361|NCT04804033|527808112|FG000|Period 2: OLE Phase|Other|0|||
146356362|NCT04804033|527808113|FG001|Period 2: OLE Phase|Other|2|||
146356363|NCT04804033|527808114|FG002|Period 2: OLE Phase|Other|0|||
146356364|NCT04804033|527808115|FG003|Period 2: OLE Phase|Other|0|||
146356365|NCT04804033|527808112|FG000|Period 2: OLE Phase|Physician Decision|1|||
146356366|NCT04804033|527808113|FG001|Period 2: OLE Phase|Physician Decision|1|||
146356367|NCT04804033|527808114|FG002|Period 2: OLE Phase|Physician Decision|0|||
146356368|NCT04804033|527808115|FG003|Period 2: OLE Phase|Physician Decision|0|||
146356369|NCT04804033|527808112|FG000|Period 2: OLE Phase|Pregnancy|0|||
146356370|NCT04804033|527808113|FG001|Period 2: OLE Phase|Pregnancy|0|||
146356371|NCT04804033|527808114|FG002|Period 2: OLE Phase|Pregnancy|2|||
146356372|NCT04804033|527808115|FG003|Period 2: OLE Phase|Pregnancy|0|||
146356373|NCT04804033|527808112|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
146356374|NCT04804033|527808113|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
146356375|NCT04804033|527808114|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
146356376|NCT04804033|527808115|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
146356377|NCT04804033|527808112|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
146356378|NCT04804033|527808113|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
146356379|NCT04804033|527808114|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
146356380|NCT04804033|527808115|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
146356381|NCT04804033|527808112|FG000|Period 2: OLE Phase|Not reported|0|||
146356382|NCT04804033|527808113|FG001|Period 2: OLE Phase|Not reported|2|||
146356383|NCT04804033|527808114|FG002|Period 2: OLE Phase|Not reported|0|||
146356384|NCT04804033|527808115|FG003|Period 2: OLE Phase|Not reported|0|||
146356385|NCT04804033|527808112|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
146356386|NCT04804033|527808113|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
146356387|NCT04804033|527808114|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
146356388|NCT04804033|527808115|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
146356389|NCT04804033|527808112|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
146356390|NCT04804033|527808113|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
146356391|NCT04804033|527808114|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
146356392|NCT04804033|527808115|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
146356393|NCT04804033|527808112|FG000|Period 3: Follow-up Phase|Other|0|||
146356394|NCT04804033|527808113|FG001|Period 3: Follow-up Phase|Other|1|||
146356395|NCT04804033|527808114|FG002|Period 3: Follow-up Phase|Other|2|||
146356396|NCT04804033|527808115|FG003|Period 3: Follow-up Phase|Other|1|||
146356397|NCT04804033|527808112|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
146356398|NCT04804033|527808113|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
146356399|NCT04804033|527808114|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
146356400|NCT04804033|527808115|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
146356401|NCT04804033|527808112|FG000|Period 3: Follow-up Phase|Not reported|18|||
146356402|NCT04804033|527808113|FG001|Period 3: Follow-up Phase|Not reported|15|||
146356403|NCT04804033|527808114|FG002|Period 3: Follow-up Phase|Not reported|1|||
146356404|NCT04804033|527808115|FG003|Period 3: Follow-up Phase|Not reported|4|||
146356405|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
146356406|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
146356407|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
146356408|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
146356409|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
146356410|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
146356411|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
146356412|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
146169604|NCT00860067|527132871|FG000|Overall Study|Withdrawal by Subject|4|||
146356413|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
146356414|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
146356415|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
146356416|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
146356417|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
146356418|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
146356419|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
146356420|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
146356421|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
146356422|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
146356423|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
146356424|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
146356425|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
146356426|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146356427|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
146356428|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
146356429|NCT01106625|527808126|FG000|Core Period: Baseline to Week 26|Other|8|||
146356430|NCT01106625|527808127|FG001|Core Period: Baseline to Week 26|Other|7|||
146356431|NCT01106625|527808128|FG002|Core Period: Baseline to Week 26|Other|4|||
146356432|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146356433|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
146356434|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
146356435|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
146356436|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
146356437|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
146356438|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
146356439|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
146356440|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
146356441|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146356442|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
146356443|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
146356444|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
146356445|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146356446|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
146356447|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
146356448|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
146356449|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
146356450|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
146356451|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
146356452|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
146356453|NCT01106625|527808126|FG000|Extension Period: Week 26 to Week 52|Other|5|||
146356454|NCT01106625|527808127|FG001|Extension Period: Week 26 to Week 52|Other|5|||
146356455|NCT01106625|527808128|FG002|Extension Period: Week 26 to Week 52|Other|4|||
146356456|NCT02496585|527808129|FG000|Overall Study|Death|3|||
146356457|NCT02496585|527808130|FG001|Overall Study|Death|0|||
146356458|NCT02496585|527808129|FG000|Overall Study|Lost to Follow-up|2|||
146356459|NCT02496585|527808130|FG001|Overall Study|Lost to Follow-up|0|||
146356460|NCT02496585|527808129|FG000|Overall Study|Withdrawal by Subject|1|||
146356461|NCT02496585|527808130|FG001|Overall Study|Withdrawal by Subject|2|||
146356462|NCT02496585|527808129|FG000|Overall Study|Progression of Malignancy|4|||
146356463|NCT02496585|527808130|FG001|Overall Study|Progression of Malignancy|1|||
146356464|NCT00997321|527808131|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
146356465|NCT00997321|527808132|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
146356466|NCT01276457|527808135|FG000|Core Study|Adverse Event|6|||
146356467|NCT01276457|527808136|FG001|Core Study|Adverse Event|3|||
146356468|NCT01276457|527808135|FG000|Core Study|Lost to Follow-up|1|||
146356469|NCT01276457|527808136|FG001|Core Study|Lost to Follow-up|2|||
146356470|NCT01276457|527808135|FG000|Core Study|Administrative problems|1|||
146356471|NCT01276457|527808136|FG001|Core Study|Administrative problems|1|||
146356472|NCT01276457|527808135|FG000|Core Study|Death|2|||
146356473|NCT01276457|527808136|FG001|Core Study|Death|2|||
146356474|NCT01276457|527808135|FG000|Core Study|Lack of Efficacy|3|||
146356475|NCT01276457|527808136|FG001|Core Study|Lack of Efficacy|12|||
146356476|NCT01276457|527808135|FG000|Extension Study|Lost to Follow-up|3|||
146356477|NCT01276457|527808136|FG001|Extension Study|Lost to Follow-up|0|||
146356478|NCT01276457|527808135|FG000|Extension Study|Death|0|||
146356479|NCT01276457|527808136|FG001|Extension Study|Death|1|||
146356480|NCT01276457|527808135|FG000|Extension Study|Lack of Efficacy|3|||
146356481|NCT01276457|527808136|FG001|Extension Study|Lack of Efficacy|1|||
146356482|NCT04436822|527808138|FG000|Overall Study|Physician Decision|2|||
146356483|NCT04436822|527808139|FG001|Overall Study|Physician Decision|0|||
146356484|NCT04436822|527808138|FG000|Overall Study|Sponsor request|1|||
146356485|NCT04436822|527808139|FG001|Overall Study|Sponsor request|0|||
146356486|NCT04436822|527808138|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146356487|NCT04436822|527808139|FG001|Overall Study|Withdrawal by parent/guardian|3|||
146356488|NCT04436822|527808138|FG000|Overall Study|Unsuccessful procedure|0|||
146356489|NCT04436822|527808139|FG001|Overall Study|Unsuccessful procedure|1|||
146356490|NCT04436822|527808138|FG000|Overall Study|Withdrawal due to Covid-19|8|||
146356491|NCT04436822|527808139|FG001|Overall Study|Withdrawal due to Covid-19|1|||
146356492|NCT04436822|527808138|FG000|Overall Study|Withdrawal by Subject|1|||
146356493|NCT04436822|527808139|FG001|Overall Study|Withdrawal by Subject|0|||
146356494|NCT04436822|527808138|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
146356495|NCT04436822|527808139|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
146356496|NCT05118386|527808140|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146356497|NCT05118386|527808141|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146356498|NCT05118386|527808142|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146356499|NCT05118386|527808143|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
146356500|NCT05118386|527808144|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146356501|NCT05118386|527808145|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
146356502|NCT05118386|527808140|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146356503|NCT05118386|527808141|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146356504|NCT05118386|527808142|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146356505|NCT05118386|527808143|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146356506|NCT05118386|527808144|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
146356507|NCT05118386|527808145|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
146356508|NCT00369668|527808146|FG000|Overall Study|Lack of Efficacy|4|||
146356509|NCT00369668|527808147|FG001|Overall Study|Lack of Efficacy|5|||
146356510|NCT00369668|527808148|FG002|Overall Study|Lack of Efficacy|7|||
146356511|NCT00303108|527808149|FG000|Overall Study|Adverse Event|5|||
146356512|NCT00303108|527808150|FG001|Overall Study|Adverse Event|6|||
146356513|NCT00303108|527808151|FG002|Overall Study|Adverse Event|7|||
146356514|NCT00303108|527808149|FG000|Overall Study|Patient Request|4|||
146356515|NCT00303108|527808150|FG001|Overall Study|Patient Request|2|||
146356516|NCT00303108|527808151|FG002|Overall Study|Patient Request|8|||
146356517|NCT00303108|527808149|FG000|Overall Study|Failed Entry|1|||
146356518|NCT00303108|527808150|FG001|Overall Study|Failed Entry|0|||
146356519|NCT00303108|527808151|FG002|Overall Study|Failed Entry|1|||
146356520|NCT00303108|527808149|FG000|Overall Study|ineligible|2|||
146356521|NCT00303108|527808150|FG001|Overall Study|ineligible|1|||
146356522|NCT00303108|527808151|FG002|Overall Study|ineligible|0|||
146356523|NCT00894413|527808154|FG000|Overall Study|Physician Decision|0|||
146356524|NCT00894413|527808155|FG001|Overall Study|Physician Decision|2|||
146356525|NCT00894413|527808154|FG000|Overall Study|Adverse Event|0|||
146356526|NCT00894413|527808155|FG001|Overall Study|Adverse Event|2|||
146356527|NCT00894413|527808154|FG000|Overall Study|Withdrawal by Subject|0|||
146356528|NCT00894413|527808155|FG001|Overall Study|Withdrawal by Subject|4|||
146356529|NCT00471445|527808159|FG000|Overall Study|Withdrawal by Subject|1|||
146356530|NCT00471445|527808160|FG001|Overall Study|Withdrawal by Subject|1|||
146356531|NCT00471445|527808159|FG000|Overall Study|Ineligible|1|||
146356532|NCT00471445|527808160|FG001|Overall Study|Ineligible|0|||
146356533|NCT00471445|527808159|FG000|Overall Study|Protocol Violation|0|||
146356534|NCT00471445|527808160|FG001|Overall Study|Protocol Violation|1|||
146356535|NCT02427477|527808161|FG000|Period 1|Adverse Event|1|||
146356536|NCT02427477|527808162|FG001|Period 1|Adverse Event|0|||
146356537|NCT01552928|527808163|FG000|Period 3|Adverse Event|0|||
146356538|NCT01552928|527808164|FG001|Period 3|Adverse Event|0|||
146356539|NCT01552928|527808165|FG002|Period 3|Adverse Event|1|||
146356540|NCT01552928|527808166|FG003|Period 3|Adverse Event|0|||
146356541|NCT01767194|527808167|FG000|Overall Study|Adverse Event|1|||
146356542|NCT01767194|527808168|FG001|Overall Study|Adverse Event|1|||
146356543|NCT01767194|527808167|FG000|Overall Study|Death|0|||
146356544|NCT01767194|527808168|FG001|Overall Study|Death|1|||
146356545|NCT01767194|527808167|FG000|Overall Study|Lack of Efficacy|12|||
146356546|NCT01767194|527808168|FG001|Overall Study|Lack of Efficacy|11|||
146356547|NCT01767194|527808167|FG000|Overall Study|Physician Decision|2|||
146356548|NCT01767194|527808168|FG001|Overall Study|Physician Decision|23|||
146356549|NCT01767194|527808167|FG000|Overall Study|Withdrawal by Subject|0|||
146356550|NCT01767194|527808168|FG001|Overall Study|Withdrawal by Subject|1|||
146356551|NCT01767194|527808167|FG000|Overall Study|Ineligible|1|||
146356552|NCT01767194|527808168|FG001|Overall Study|Ineligible|1|||
146356553|NCT01767194|527808167|FG000|Overall Study|Refusal by patient/parent|2|||
146356554|NCT01767194|527808168|FG001|Overall Study|Refusal by patient/parent|4|||
146356555|NCT01767194|527808167|FG000|Overall Study|Criteria not met on time for next cycle|0|||
146356556|NCT01767194|527808168|FG001|Overall Study|Criteria not met on time for next cycle|1|||
146356557|NCT02723604|527810028|FG000|Overall Study|ineligible|1|||
146356558|NCT02723604|527810028|FG000|Overall Study|never received treatment|1|||
146356559|NCT00311181|527810031|FG000|Overall Study|Final DFTs were not obtained|96|||
146356560|NCT00506948|527810037|FG000|Overall Study|Death|4|||
146356561|NCT00506948|527810037|FG000|Overall Study|Adverse Event|5|||
146356562|NCT00506948|527810037|FG000|Overall Study|Physician Decision|1|||
146356563|NCT02395653|527810038|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
146356564|NCT02395653|527810038|FG000|Overall Study|Consent Withdrawn at Screening|1|||
146356565|NCT02395653|527810038|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
146356566|NCT02395653|527810038|FG000|Overall Study|Investigator Decision at Screening|1|||
146356567|NCT02395653|527810038|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
146356568|NCT02395653|527810038|FG000|Overall Study|Withdrawal by Subject|1|||
146356569|NCT02395653|527810038|FG000|Overall Study|Lost to Follow-up|1|||
146356570|NCT00789958|527810041|FG000|Overall Study|Adverse Event|3|||
146356571|NCT00789958|527810041|FG000|Overall Study|Withdrawal by Subject|4|||
146356572|NCT00789958|527810041|FG000|Overall Study|Progression|3|||
146356573|NCT00789958|527810041|FG000|Overall Study|not protocol specified|1|||
146356574|NCT00789958|527810041|FG000|Overall Study|Not eligible/not analyzable|26|||
146356575|NCT00296725|527810044|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
146356576|NCT00296725|527810044|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
146356577|NCT00296725|527810044|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
146356578|NCT00254293|527810045|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146356579|NCT00254293|527810046|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
146356580|NCT00254293|527810047|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146356581|NCT00254293|527810048|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
146356582|NCT00254293|527810049|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146356583|NCT00254293|527810050|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146356584|NCT00254293|527810051|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
146356585|NCT00254293|527810045|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356586|NCT00254293|527810046|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356587|NCT00254293|527810047|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
146356588|NCT00254293|527810048|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356589|NCT00254293|527810049|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356590|NCT00254293|527810050|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356591|NCT00254293|527810051|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
146356592|NCT00254293|527810045|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356593|NCT00254293|527810046|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356594|NCT00254293|527810047|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
146356595|NCT00254293|527810048|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356596|NCT00254293|527810049|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356597|NCT00254293|527810050|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356598|NCT00254293|527810051|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
146356599|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Death|0|||
146356600|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Death|0|||
146356601|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Death|1|||
146356602|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Death|0|||
146356603|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Death|0|||
146356604|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Death|0|||
146356605|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Death|0|||
146356606|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
146356607|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146356608|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
146356609|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146356610|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
146356611|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146356612|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
146356613|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
146356614|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146356615|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
146356616|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146356617|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
146356618|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146356619|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
146356620|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356621|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356622|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
146356623|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356624|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356625|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356626|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
146356627|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356628|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356629|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
146356630|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356631|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356632|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356633|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
146356634|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356635|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356636|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
146356637|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356638|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356639|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356640|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
146356641|NCT00254293|527810045|FG000|LTE Open Label Variable SC Dosing|Other|0|||
146356642|NCT00254293|527810046|FG001|LTE Open Label Variable SC Dosing|Other|0|||
146356643|NCT00254293|527810047|FG002|LTE Open Label Variable SC Dosing|Other|2|||
146356644|NCT00254293|527810048|FG003|LTE Open Label Variable SC Dosing|Other|0|||
146356645|NCT00254293|527810049|FG004|LTE Open Label Variable SC Dosing|Other|0|||
146356646|NCT00254293|527810050|FG005|LTE Open Label Variable SC Dosing|Other|0|||
146356647|NCT00254293|527810051|FG006|LTE Open Label Variable SC Dosing|Other|0|||
146356648|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Death|0|||
146356649|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Death|0|||
146356650|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Death|0|||
146356651|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Death|0|||
146356652|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Death|0|||
146356653|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Death|0|||
146356654|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Death|3|||
146356655|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356656|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356657|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356658|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356659|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356660|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
146356661|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
146356662|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356663|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356664|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356665|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356666|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356667|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
146356668|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
146356669|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356670|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356671|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356672|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356673|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356674|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
146356675|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
146356676|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356677|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356678|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356679|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356680|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356681|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
146356682|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
146356683|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356684|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356685|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356686|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356687|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356688|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
146356689|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
146356690|NCT00254293|527810045|FG000|LTE Open Label Fixed Dosing|Other|0|||
146356691|NCT00254293|527810046|FG001|LTE Open Label Fixed Dosing|Other|0|||
146356692|NCT00254293|527810047|FG002|LTE Open Label Fixed Dosing|Other|0|||
146169605|NCT00860067|527132872|FG001|Overall Study|Withdrawal by Subject|0|||
146356693|NCT00254293|527810048|FG003|LTE Open Label Fixed Dosing|Other|0|||
146356694|NCT00254293|527810049|FG004|LTE Open Label Fixed Dosing|Other|0|||
146356695|NCT00254293|527810050|FG005|LTE Open Label Fixed Dosing|Other|0|||
146356696|NCT00254293|527810051|FG006|LTE Open Label Fixed Dosing|Other|1|||
146356697|NCT01000727|527810057|FG000|Overall Study|Lost to Follow-up|41|||
146356698|NCT01000727|527810058|FG001|Overall Study|Lost to Follow-up|43|||
146356699|NCT01000727|527810057|FG000|Overall Study|Withdrawal by Subject|111|||
146356700|NCT01000727|527810058|FG001|Overall Study|Withdrawal by Subject|109|||
146356701|NCT01000727|527810057|FG000|Overall Study|Study closed/terminated|23|||
146356702|NCT01000727|527810058|FG001|Overall Study|Study closed/terminated|24|||
146356703|NCT03137121|527810059|FG000|Overall Study|Withdrawal by Subject|0|||
146356704|NCT03137121|527810060|FG001|Overall Study|Withdrawal by Subject|1|||
146356705|NCT03196193|527810063|FG000|Overall Study|Adverse Event|1|||
146356706|NCT03196193|527810064|FG001|Overall Study|Adverse Event|0|||
146356707|NCT03196193|527810063|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
146356708|NCT03196193|527810064|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
146356709|NCT02709083|527810065|FG000|Overall Study|Original PI left institution|7|||
146356710|NCT04410198|527810070|FG000|Overall Study|Death|10|||
146356711|NCT04410198|527810070|FG000|Overall Study|Withdrawal by Subject|7|||
146356712|NCT04410198|527810070|FG000|Overall Study|Transferred/Relocation|4|||
146356713|NCT04410198|527810070|FG000|Overall Study|Kidney Transplant|9|||
146356714|NCT04410198|527810070|FG000|Overall Study|Adverse Event|4|||
146356715|NCT04410198|527810070|FG000|Overall Study|Physician Decision|2|||
146356716|NCT04410198|527810070|FG000|Overall Study|Other than specified|1|||
146356717|NCT02006667|527810071|FG000|Overall Study|Adverse Event|3|||
146356718|NCT02006667|527810071|FG000|Overall Study|Death|2|||
146356719|NCT02006667|527810071|FG000|Overall Study|Withdrawal by Subject|1|||
146356720|NCT02939937|527810072|FG000|Overall Study|Adverse Event|5|||
146356721|NCT02939937|527810073|FG001|Overall Study|Adverse Event|0|||
146356722|NCT02939937|527810072|FG000|Overall Study|Lost to Follow-up|1|||
146356723|NCT02939937|527810073|FG001|Overall Study|Lost to Follow-up|3|||
146356724|NCT00839423|527810081|FG000|Overall Study|Adverse Event|4|||
146356725|NCT00839423|527810082|FG001|Overall Study|Adverse Event|3|||
146356726|NCT00839423|527810083|FG002|Overall Study|Adverse Event|7|||
146356727|NCT00839423|527810084|FG003|Overall Study|Adverse Event|16|||
146356728|NCT00839423|527810081|FG000|Overall Study|Lack of Efficacy|6|||
146356729|NCT00839423|527810082|FG001|Overall Study|Lack of Efficacy|6|||
146356730|NCT00839423|527810083|FG002|Overall Study|Lack of Efficacy|3|||
146356731|NCT00839423|527810084|FG003|Overall Study|Lack of Efficacy|2|||
146356732|NCT00839423|527810081|FG000|Overall Study|Non-compliance|0|||
146356733|NCT00839423|527810082|FG001|Overall Study|Non-compliance|0|||
146356734|NCT00839423|527810083|FG002|Overall Study|Non-compliance|0|||
146356735|NCT00839423|527810084|FG003|Overall Study|Non-compliance|1|||
146356736|NCT00839423|527810081|FG000|Overall Study|Protocol Violation|0|||
146356737|NCT00839423|527810082|FG001|Overall Study|Protocol Violation|1|||
146356738|NCT00839423|527810083|FG002|Overall Study|Protocol Violation|2|||
146356739|NCT00839423|527810084|FG003|Overall Study|Protocol Violation|0|||
146356740|NCT00839423|527810081|FG000|Overall Study|Withdrawal of consent|4|||
146356741|NCT00839423|527810082|FG001|Overall Study|Withdrawal of consent|0|||
146356742|NCT00839423|527810083|FG002|Overall Study|Withdrawal of consent|4|||
146356743|NCT00839423|527810084|FG003|Overall Study|Withdrawal of consent|1|||
146356744|NCT00839423|527810081|FG000|Overall Study|Lost to Follow-up|1|||
146356745|NCT00839423|527810082|FG001|Overall Study|Lost to Follow-up|0|||
146356746|NCT00839423|527810083|FG002|Overall Study|Lost to Follow-up|1|||
146356747|NCT00839423|527810084|FG003|Overall Study|Lost to Follow-up|0|||
146356748|NCT00839423|527810081|FG000|Overall Study|Administrative or other reasons|3|||
146356749|NCT00839423|527810082|FG001|Overall Study|Administrative or other reasons|0|||
146356750|NCT00839423|527810083|FG002|Overall Study|Administrative or other reasons|1|||
146356751|NCT00839423|527810084|FG003|Overall Study|Administrative or other reasons|0|||
146356752|NCT02585999|527810085|FG000|Overall Study|Lost to Follow-up|1|||
146356753|NCT02585999|527810085|FG000|Overall Study|Protocol Violation|1|||
146356754|NCT01332019|527810086|FG000|Overall Study|Was Not Dosed|1|||
146356755|NCT01332019|527810087|FG001|Overall Study|Was Not Dosed|0|||
146356756|NCT01332019|527810086|FG000|Overall Study|Other|16|||
146356757|NCT01332019|527810087|FG001|Overall Study|Other|18|||
146356758|NCT01332019|527810086|FG000|Overall Study|Death|2|||
146356759|NCT01332019|527810087|FG001|Overall Study|Death|1|||
146356760|NCT01332019|527810086|FG000|Overall Study|Physician Decision|4|||
146356761|NCT01332019|527810087|FG001|Overall Study|Physician Decision|3|||
146356762|NCT01332019|527810086|FG000|Overall Study|Withdrawal by Subject|73|||
146356763|NCT01332019|527810087|FG001|Overall Study|Withdrawal by Subject|71|||
146356764|NCT01332019|527810086|FG000|Overall Study|Lost to Follow-up|4|||
146356765|NCT01332019|527810087|FG001|Overall Study|Lost to Follow-up|7|||
146356766|NCT01332019|527810086|FG000|Overall Study|Adverse Event|13|||
146356767|NCT01332019|527810087|FG001|Overall Study|Adverse Event|22|||
145943398|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146356768|NCT01369849|527810088|FG000|Overall Study|Ineligible prior to treatment|0|||
146356769|NCT01369849|527810089|FG001|Overall Study|Ineligible prior to treatment|0|||
146356770|NCT01369849|527810090|FG002|Overall Study|Ineligible prior to treatment|1|||
146356771|NCT01369849|527810088|FG000|Overall Study|Ineligible after receiving treatment|0|||
146356772|NCT01369849|527810089|FG001|Overall Study|Ineligible after receiving treatment|1|||
146356773|NCT01369849|527810090|FG002|Overall Study|Ineligible after receiving treatment|0|||
146356774|NCT00871377|527810091|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146356775|NCT00871377|527810092|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146356776|NCT00871377|527810093|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
146356777|NCT00871377|527810094|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146356778|NCT00871377|527810095|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146356779|NCT00871377|527810096|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
146356780|NCT00871377|527810091|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146356781|NCT00871377|527810092|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146356782|NCT00871377|527810093|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146356783|NCT00871377|527810094|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146356784|NCT00871377|527810095|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
146356785|NCT00871377|527810096|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
146356786|NCT00871377|527810091|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
146356787|NCT00871377|527810092|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356788|NCT00871377|527810093|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356789|NCT00871377|527810094|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356790|NCT00871377|527810095|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356791|NCT00871377|527810096|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356792|NCT00871377|527810091|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356793|NCT00871377|527810092|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356794|NCT00871377|527810093|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356795|NCT00871377|527810094|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356796|NCT00871377|527810095|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
146356797|NCT00871377|527810096|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
146356798|NCT00871377|527810091|FG000|Third Intervention (10 Weeks)|Death|0|||
146356799|NCT00871377|527810092|FG001|Third Intervention (10 Weeks)|Death|0|||
146356800|NCT00871377|527810093|FG002|Third Intervention (10 Weeks)|Death|0|||
146356801|NCT00871377|527810094|FG003|Third Intervention (10 Weeks)|Death|1|||
146356802|NCT00871377|527810095|FG004|Third Intervention (10 Weeks)|Death|0|||
146356803|NCT00871377|527810096|FG005|Third Intervention (10 Weeks)|Death|0|||
146356804|NCT00120289|527810097|FG000|Overall Study|Death|96|||
146356805|NCT00120289|527810098|FG001|Overall Study|Death|82|||
146356806|NCT00120289|527810097|FG000|Overall Study|Lost to Follow-up|11|||
146356807|NCT00120289|527810098|FG001|Overall Study|Lost to Follow-up|14|||
146356808|NCT00120289|527810097|FG000|Overall Study|Withdrawal by Subject|14|||
146356809|NCT00120289|527810098|FG001|Overall Study|Withdrawal by Subject|13|||
146356810|NCT00882999|527810100|FG000|Overall Study|Adverse Event|0|||
146356811|NCT00882999|527810101|FG001|Overall Study|Adverse Event|0|||
146356812|NCT00882999|527810102|FG002|Overall Study|Adverse Event|0|||
146356813|NCT00882999|527810103|FG003|Overall Study|Adverse Event|0|||
146356814|NCT00882999|527810104|FG004|Overall Study|Adverse Event|1|||
146356815|NCT00882999|527810105|FG005|Overall Study|Adverse Event|0|||
146356816|NCT00882999|527810106|FG006|Overall Study|Adverse Event|0|||
146356817|NCT00882999|527810100|FG000|Overall Study|Death|0|||
146356818|NCT00882999|527810101|FG001|Overall Study|Death|1|||
146356819|NCT00882999|527810102|FG002|Overall Study|Death|0|||
146356820|NCT00882999|527810103|FG003|Overall Study|Death|0|||
146356821|NCT00882999|527810104|FG004|Overall Study|Death|0|||
146356822|NCT00882999|527810105|FG005|Overall Study|Death|0|||
146356823|NCT00882999|527810106|FG006|Overall Study|Death|0|||
146356824|NCT00882999|527810100|FG000|Overall Study|Withdrawal by Subject|7|||
146356825|NCT00882999|527810101|FG001|Overall Study|Withdrawal by Subject|6|||
146356826|NCT00882999|527810102|FG002|Overall Study|Withdrawal by Subject|3|||
146356827|NCT00882999|527810103|FG003|Overall Study|Withdrawal by Subject|3|||
146356828|NCT00882999|527810104|FG004|Overall Study|Withdrawal by Subject|6|||
146356829|NCT00882999|527810105|FG005|Overall Study|Withdrawal by Subject|5|||
146356830|NCT00882999|527810106|FG006|Overall Study|Withdrawal by Subject|5|||
146356831|NCT00882999|527810100|FG000|Overall Study|Lost to Follow-up|0|||
146356832|NCT00882999|527810101|FG001|Overall Study|Lost to Follow-up|1|||
146356833|NCT00882999|527810102|FG002|Overall Study|Lost to Follow-up|1|||
146356834|NCT00882999|527810103|FG003|Overall Study|Lost to Follow-up|2|||
146356835|NCT00882999|527810104|FG004|Overall Study|Lost to Follow-up|1|||
146356836|NCT00882999|527810105|FG005|Overall Study|Lost to Follow-up|1|||
146356837|NCT00882999|527810106|FG006|Overall Study|Lost to Follow-up|2|||
146356838|NCT00882999|527810100|FG000|Overall Study|Physician Decision|1|||
146356839|NCT00882999|527810101|FG001|Overall Study|Physician Decision|0|||
146356840|NCT00882999|527810102|FG002|Overall Study|Physician Decision|0|||
146356841|NCT00882999|527810103|FG003|Overall Study|Physician Decision|0|||
146356842|NCT00882999|527810104|FG004|Overall Study|Physician Decision|0|||
146356843|NCT00882999|527810105|FG005|Overall Study|Physician Decision|1|||
146356844|NCT00882999|527810106|FG006|Overall Study|Physician Decision|1|||
146356845|NCT01757405|527810107|FG000|Overall Study|Lost to Follow-up|1|||
146356846|NCT01757405|527810108|FG001|Overall Study|Lost to Follow-up|1|||
145943399|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146356847|NCT01757405|527810107|FG000|Overall Study|Withdrawal by Subject|0|||
146356848|NCT01757405|527810108|FG001|Overall Study|Withdrawal by Subject|1|||
146356849|NCT00238303|527810109|FG000|Overall Study|Withdrawal by Subject|11|||
146356850|NCT00238303|527810110|FG001|Overall Study|Withdrawal by Subject|1|||
146356851|NCT00238303|527810111|FG002|Overall Study|Withdrawal by Subject|2|||
146356852|NCT00238303|527810109|FG000|Overall Study|Death|1|||
146356853|NCT00238303|527810110|FG001|Overall Study|Death|0|||
146356854|NCT00238303|527810111|FG002|Overall Study|Death|1|||
146356855|NCT00238303|527810109|FG000|Overall Study|Other Medical Problems|2|||
146356856|NCT00238303|527810110|FG001|Overall Study|Other Medical Problems|0|||
146356857|NCT00238303|527810111|FG002|Overall Study|Other Medical Problems|2|||
146356858|NCT00238303|527810109|FG000|Overall Study|Poor tolerance of study treatment|1|||
146356859|NCT00238303|527810110|FG001|Overall Study|Poor tolerance of study treatment|0|||
146356860|NCT00238303|527810111|FG002|Overall Study|Poor tolerance of study treatment|1|||
146356861|NCT00238303|527810109|FG000|Overall Study|Adverse Event|0|||
146356862|NCT00238303|527810110|FG001|Overall Study|Adverse Event|1|||
146356863|NCT00238303|527810111|FG002|Overall Study|Adverse Event|3|||
146356864|NCT00937560|527810112|FG000|Initial Treatment|Death|6|||
146356865|NCT00937560|527810112|FG000|Initial Treatment|Withdraw consent|3|||
146356866|NCT00937560|527810112|FG000|Initial Treatment|Adverse Event|1|||
146356867|NCT00937560|527810112|FG000|Initial Treatment|Lost to Follow-up|1|||
146356868|NCT00937560|527810112|FG000|Initial Treatment|No end of study page|10|||
146356869|NCT00937560|527810112|FG000|Maintenance Treatment|Death|12|||
146356870|NCT00937560|527810112|FG000|Maintenance Treatment|Withdraw consent|5|||
146356871|NCT00937560|527810112|FG000|Maintenance Treatment|According to protocol|1|||
146356872|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
146356873|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
146356874|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
146356875|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
146356876|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
146356877|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
146356878|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
146356879|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
146356880|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
146356881|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
146356882|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
146356883|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
146356884|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
146356885|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
146356886|NCT00848549|527810113|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
146356887|NCT00848549|527810114|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
146356888|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
146356889|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
146356890|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
146356891|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
146356892|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
146356893|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
146356894|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
146356895|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
146356896|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
146356897|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
146356898|NCT00848549|527810113|FG000|E2090-E044-314 (Extension Study)|Other|5|||
146356899|NCT00848549|527810114|FG001|E2090-E044-314 (Extension Study)|Other|6|||
146356900|NCT01248130|527810115|FG000|Overall Study|Protocol Violation|1|||
146356901|NCT01248130|527810116|FG001|Overall Study|Protocol Violation|0|||
146356902|NCT01248130|527810115|FG000|Overall Study|Ineligible|1|||
146169606|NCT00860067|527132873|FG002|Overall Study|Withdrawal by Subject|0|||
146169607|NCT00860067|527132871|FG000|Overall Study|Pregnancy|1|||
146169608|NCT00860067|527132872|FG001|Overall Study|Pregnancy|0|||
146169609|NCT00860067|527132873|FG002|Overall Study|Pregnancy|0|||
146169610|NCT01282801|527132874|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
146356903|NCT01248130|527810116|FG001|Overall Study|Ineligible|0|||
146356904|NCT04507867|527810122|FG000|Overall Study|Death|7|||
146356905|NCT04507867|527810123|FG001|Overall Study|Death|1|||
146356906|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
146169611|NCT01282801|527132875|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
146356907|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356908|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356909|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356910|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356911|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146169612|NCT01060553|527132876|FG000|Overall Study|Lost to Follow-up|3|||
146356912|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356913|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356914|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146356915|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
146356916|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356917|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356918|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356919|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356920|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356921|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356922|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356923|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146356924|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
146356925|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356926|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356927|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356928|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356929|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356930|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356931|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356932|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146356933|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
146356934|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356935|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356936|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356937|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356938|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356939|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356940|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356941|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
146356942|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
146356943|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356944|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356945|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356946|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356947|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356948|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356949|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356950|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146356951|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
146356952|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356953|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356954|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356955|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356956|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356957|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356958|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356959|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146356960|NCT02175771|527810128|FG000|Run-In Period (Pre-assignment)|Other|8|||
146356961|NCT02175771|527810129|FG001|Run-In Period (Pre-assignment)|Other|0|||
146356962|NCT02175771|527810130|FG002|Run-In Period (Pre-assignment)|Other|0|||
146356963|NCT02175771|527810131|FG003|Run-In Period (Pre-assignment)|Other|0|||
146356964|NCT02175771|527810132|FG004|Run-In Period (Pre-assignment)|Other|0|||
146356965|NCT02175771|527810133|FG005|Run-In Period (Pre-assignment)|Other|0|||
146356966|NCT02175771|527810134|FG006|Run-In Period (Pre-assignment)|Other|0|||
146356967|NCT02175771|527810135|FG007|Run-In Period (Pre-assignment)|Other|0|||
146356968|NCT02175771|527810136|FG008|Run-In Period (Pre-assignment)|Other|0|||
146356969|NCT02175771|527810128|FG000|Treatment Period|Adverse Event|0|||
146356970|NCT02175771|527810129|FG001|Treatment Period|Adverse Event|2|||
146356971|NCT02175771|527810130|FG002|Treatment Period|Adverse Event|1|||
146356972|NCT02175771|527810131|FG003|Treatment Period|Adverse Event|1|||
146356973|NCT02175771|527810132|FG004|Treatment Period|Adverse Event|1|||
146356974|NCT02175771|527810133|FG005|Treatment Period|Adverse Event|3|||
146356975|NCT02175771|527810134|FG006|Treatment Period|Adverse Event|2|||
146356976|NCT02175771|527810135|FG007|Treatment Period|Adverse Event|0|||
146356977|NCT02175771|527810136|FG008|Treatment Period|Adverse Event|1|||
146356978|NCT02175771|527810128|FG000|Treatment Period|Withdrawal by Subject|0|||
146356979|NCT02175771|527810129|FG001|Treatment Period|Withdrawal by Subject|9|||
146356980|NCT02175771|527810130|FG002|Treatment Period|Withdrawal by Subject|3|||
146356981|NCT02175771|527810131|FG003|Treatment Period|Withdrawal by Subject|6|||
146356982|NCT02175771|527810132|FG004|Treatment Period|Withdrawal by Subject|2|||
146169613|NCT01060553|527132877|FG001|Overall Study|Lost to Follow-up|5|||
146356983|NCT02175771|527810133|FG005|Treatment Period|Withdrawal by Subject|4|||
146356984|NCT02175771|527810134|FG006|Treatment Period|Withdrawal by Subject|2|||
146356985|NCT02175771|527810135|FG007|Treatment Period|Withdrawal by Subject|9|||
146356986|NCT02175771|527810136|FG008|Treatment Period|Withdrawal by Subject|2|||
146356987|NCT02175771|527810128|FG000|Treatment Period|Noncompliance|0|||
146356988|NCT02175771|527810129|FG001|Treatment Period|Noncompliance|1|||
146356989|NCT02175771|527810130|FG002|Treatment Period|Noncompliance|2|||
146356990|NCT02175771|527810131|FG003|Treatment Period|Noncompliance|0|||
146356991|NCT02175771|527810132|FG004|Treatment Period|Noncompliance|0|||
146356992|NCT02175771|527810133|FG005|Treatment Period|Noncompliance|0|||
146356993|NCT02175771|527810134|FG006|Treatment Period|Noncompliance|0|||
146356994|NCT02175771|527810135|FG007|Treatment Period|Noncompliance|0|||
146356995|NCT02175771|527810136|FG008|Treatment Period|Noncompliance|1|||
146356996|NCT02175771|527810128|FG000|Treatment Period|Protocol Violation|0|||
146356997|NCT02175771|527810129|FG001|Treatment Period|Protocol Violation|0|||
146356998|NCT02175771|527810130|FG002|Treatment Period|Protocol Violation|0|||
146356999|NCT02175771|527810131|FG003|Treatment Period|Protocol Violation|0|||
146357000|NCT02175771|527810132|FG004|Treatment Period|Protocol Violation|0|||
146357001|NCT02175771|527810133|FG005|Treatment Period|Protocol Violation|0|||
146357002|NCT02175771|527810134|FG006|Treatment Period|Protocol Violation|0|||
146357003|NCT02175771|527810135|FG007|Treatment Period|Protocol Violation|1|||
146357004|NCT02175771|527810136|FG008|Treatment Period|Protocol Violation|0|||
146357005|NCT02175771|527810128|FG000|Treatment Period|Disease progression|0|||
146357006|NCT02175771|527810129|FG001|Treatment Period|Disease progression|0|||
146357007|NCT02175771|527810130|FG002|Treatment Period|Disease progression|0|||
146357008|NCT02175771|527810131|FG003|Treatment Period|Disease progression|0|||
146357009|NCT02175771|527810132|FG004|Treatment Period|Disease progression|0|||
146357010|NCT02175771|527810133|FG005|Treatment Period|Disease progression|0|||
146357011|NCT02175771|527810134|FG006|Treatment Period|Disease progression|0|||
146357012|NCT02175771|527810135|FG007|Treatment Period|Disease progression|2|||
146357013|NCT02175771|527810136|FG008|Treatment Period|Disease progression|0|||
146357014|NCT02175771|527810128|FG000|Treatment Period|Lost to Follow-up|0|||
146357015|NCT02175771|527810129|FG001|Treatment Period|Lost to Follow-up|3|||
146357016|NCT02175771|527810130|FG002|Treatment Period|Lost to Follow-up|1|||
146357017|NCT02175771|527810131|FG003|Treatment Period|Lost to Follow-up|3|||
146357018|NCT02175771|527810132|FG004|Treatment Period|Lost to Follow-up|1|||
146357019|NCT02175771|527810133|FG005|Treatment Period|Lost to Follow-up|2|||
146357020|NCT02175771|527810134|FG006|Treatment Period|Lost to Follow-up|1|||
146357021|NCT02175771|527810135|FG007|Treatment Period|Lost to Follow-up|2|||
146357022|NCT02175771|527810136|FG008|Treatment Period|Lost to Follow-up|2|||
146357023|NCT02175771|527810128|FG000|Treatment Period|Lack of Efficacy|0|||
146357024|NCT02175771|527810129|FG001|Treatment Period|Lack of Efficacy|0|||
146357025|NCT02175771|527810130|FG002|Treatment Period|Lack of Efficacy|0|||
146357026|NCT02175771|527810131|FG003|Treatment Period|Lack of Efficacy|0|||
146357027|NCT02175771|527810132|FG004|Treatment Period|Lack of Efficacy|0|||
146357028|NCT02175771|527810133|FG005|Treatment Period|Lack of Efficacy|1|||
146357029|NCT02175771|527810134|FG006|Treatment Period|Lack of Efficacy|0|||
146357030|NCT02175771|527810135|FG007|Treatment Period|Lack of Efficacy|1|||
146357031|NCT02175771|527810136|FG008|Treatment Period|Lack of Efficacy|0|||
146357032|NCT02175771|527810128|FG000|Treatment Period|Other|0|||
146357033|NCT02175771|527810129|FG001|Treatment Period|Other|1|||
146357034|NCT02175771|527810130|FG002|Treatment Period|Other|0|||
146357035|NCT02175771|527810131|FG003|Treatment Period|Other|3|||
146357036|NCT02175771|527810132|FG004|Treatment Period|Other|1|||
146357037|NCT02175771|527810133|FG005|Treatment Period|Other|0|||
146357038|NCT02175771|527810134|FG006|Treatment Period|Other|0|||
146357039|NCT02175771|527810135|FG007|Treatment Period|Other|2|||
146357040|NCT02175771|527810136|FG008|Treatment Period|Other|0|||
146357041|NCT03364673|527810137|FG000|Overall Study|Withdrawal by Subject|2|||
146357042|NCT03364673|527810137|FG000|Overall Study|Injury unrelated to study|3|||
146357043|NCT02207556|527810138|FG000|Overall Study|Physician Decision|1|||
146357044|NCT02207556|527810139|FG001|Overall Study|Physician Decision|0|||
146357045|NCT02207556|527810138|FG000|Overall Study|Withdrawal by Subject|1|||
146357046|NCT02207556|527810139|FG001|Overall Study|Withdrawal by Subject|0|||
146357047|NCT02207556|527810138|FG000|Overall Study|Death|0|||
146357048|NCT02207556|527810139|FG001|Overall Study|Death|5|||
146357049|NCT03558555|527810140|FG000|Overall Study|Lost to Follow-up|2|||
146357050|NCT03558555|527810141|FG001|Overall Study|Lost to Follow-up|1|||
146357051|NCT00194025|527810142|FG000|Overall Study|Adverse Event|1|||
146357052|NCT00194025|527810142|FG000|Overall Study|non-adherence with study medication|4|||
146357053|NCT00617409|527810143|FG000|Overall Study|Withdrawal by Subject|4|||
146357054|NCT00617409|527810144|FG001|Overall Study|Withdrawal by Subject|1|||
146357055|NCT00617409|527810145|FG002|Overall Study|Withdrawal by Subject|2|||
146357056|NCT00617409|527810143|FG000|Overall Study|Adverse Event|0|||
146357057|NCT00617409|527810144|FG001|Overall Study|Adverse Event|2|||
146357058|NCT00617409|527810145|FG002|Overall Study|Adverse Event|3|||
146357059|NCT00617409|527810143|FG000|Overall Study|Disease Progression|8|||
146357060|NCT00617409|527810144|FG001|Overall Study|Disease Progression|8|||
146357061|NCT00617409|527810145|FG002|Overall Study|Disease Progression|18|||
146357062|NCT00617409|527810143|FG000|Overall Study|Death|3|||
146357063|NCT00617409|527810144|FG001|Overall Study|Death|5|||
146357064|NCT00617409|527810145|FG002|Overall Study|Death|4|||
146357065|NCT00617409|527810143|FG000|Overall Study|Alternative Therapy|1|||
146357066|NCT00617409|527810144|FG001|Overall Study|Alternative Therapy|2|||
146357067|NCT00617409|527810145|FG002|Overall Study|Alternative Therapy|0|||
146357068|NCT00668200|527810151|FG000|Overall Study|Withdrawal by Subject|2|||
146357069|NCT00668200|527810151|FG000|Overall Study|Lost to Follow-up|1|||
146357070|NCT01496430|527810152|FG000|Overall Study|Adverse Event|0|||
146357071|NCT01496430|527810153|FG001|Overall Study|Adverse Event|0|||
146357072|NCT01496430|527810154|FG002|Overall Study|Adverse Event|1|||
146357073|NCT01496430|527810152|FG000|Overall Study|Major Protocol Deviation|0|||
146357074|NCT01496430|527810153|FG001|Overall Study|Major Protocol Deviation|0|||
146357075|NCT01496430|527810154|FG002|Overall Study|Major Protocol Deviation|1|||
146357076|NCT01496430|527810152|FG000|Overall Study|Lost to Follow-up|2|||
146357077|NCT01496430|527810153|FG001|Overall Study|Lost to Follow-up|3|||
146357078|NCT01496430|527810154|FG002|Overall Study|Lost to Follow-up|1|||
146357079|NCT01496430|527810152|FG000|Overall Study|Voluntary Withdrawal|2|||
146357080|NCT01496430|527810153|FG001|Overall Study|Voluntary Withdrawal|1|||
146357081|NCT01496430|527810154|FG002|Overall Study|Voluntary Withdrawal|6|||
146357082|NCT01496430|527810152|FG000|Overall Study|Principal Investigator Discretion|0|||
146357083|NCT01496430|527810153|FG001|Overall Study|Principal Investigator Discretion|1|||
146357084|NCT01496430|527810154|FG002|Overall Study|Principal Investigator Discretion|1|||
146357085|NCT01496430|527810152|FG000|Overall Study|Other|2|||
146357086|NCT01496430|527810153|FG001|Overall Study|Other|0|||
146357087|NCT01496430|527810154|FG002|Overall Study|Other|0|||
146357088|NCT01151579|527810157|FG000|Overall Study|Physician Decision|3|||
146357089|NCT01151579|527810158|FG001|Overall Study|Physician Decision|1|||
146357090|NCT01151579|527810157|FG000|Overall Study|Withdrawal by Subject|3|||
146357091|NCT01151579|527810158|FG001|Overall Study|Withdrawal by Subject|2|||
146357092|NCT01151579|527810157|FG000|Overall Study|Not meet inclusion criteria|6|||
146357093|NCT01151579|527810158|FG001|Overall Study|Not meet inclusion criteria|4|||
146357094|NCT01153763|527810163|FG000|Overall Study|Study Closed|16|||
146357095|NCT01153763|527810163|FG000|Overall Study|Lost to Follow-up|1|||
146357096|NCT01153763|527810163|FG000|Overall Study|Physician Decision|2|||
146357097|NCT01153763|527810163|FG000|Overall Study|Withdrawal by Subject|2|||
146357098|NCT01474746|527810166|FG000|Overall Study|Lost to Follow-up|1|||
146357099|NCT01474746|527810167|FG001|Overall Study|Lost to Follow-up|1|||
146357100|NCT01474746|527810166|FG000|Overall Study|Withdrawal by Subject|2|||
146357101|NCT01474746|527810167|FG001|Overall Study|Withdrawal by Subject|1|||
146357102|NCT01606761|527810171|FG000|Prior to Week 24|Lost to Follow-up|0|||
146357103|NCT01606761|527810172|FG001|Prior to Week 24|Lost to Follow-up|3|||
146357104|NCT01606761|527810173|FG002|Prior to Week 24|Lost to Follow-up|2|||
146357105|NCT01606761|527810174|FG003|Prior to Week 24|Lost to Follow-up|0|||
146357106|NCT01606761|527810175|FG004|Prior to Week 24|Lost to Follow-up|0|||
146357107|NCT01606761|527810171|FG000|Prior to Week 24|Withdrawal by Subject|12|||
146357108|NCT01606761|527810172|FG001|Prior to Week 24|Withdrawal by Subject|10|||
146357109|NCT01606761|527810173|FG002|Prior to Week 24|Withdrawal by Subject|9|||
146357110|NCT01606761|527810174|FG003|Prior to Week 24|Withdrawal by Subject|0|||
146357111|NCT01606761|527810175|FG004|Prior to Week 24|Withdrawal by Subject|0|||
146357112|NCT01606761|527810171|FG000|Prior to Week 24|Adverse Event|11|||
146357113|NCT01606761|527810172|FG001|Prior to Week 24|Adverse Event|18|||
146357114|NCT01606761|527810173|FG002|Prior to Week 24|Adverse Event|22|||
146357115|NCT01606761|527810174|FG003|Prior to Week 24|Adverse Event|0|||
146357116|NCT01606761|527810175|FG004|Prior to Week 24|Adverse Event|0|||
146357117|NCT01606761|527810171|FG000|Prior to Week 24|Lack of Efficacy|15|||
146357118|NCT01606761|527810172|FG001|Prior to Week 24|Lack of Efficacy|14|||
146357119|NCT01606761|527810173|FG002|Prior to Week 24|Lack of Efficacy|8|||
146357120|NCT01606761|527810174|FG003|Prior to Week 24|Lack of Efficacy|0|||
146357121|NCT01606761|527810175|FG004|Prior to Week 24|Lack of Efficacy|0|||
146357122|NCT01606761|527810171|FG000|Prior to Week 24|Physician Decision|0|||
146357123|NCT01606761|527810172|FG001|Prior to Week 24|Physician Decision|3|||
146357124|NCT01606761|527810173|FG002|Prior to Week 24|Physician Decision|1|||
146357125|NCT01606761|527810174|FG003|Prior to Week 24|Physician Decision|0|||
146357126|NCT01606761|527810175|FG004|Prior to Week 24|Physician Decision|0|||
146357127|NCT01606761|527810171|FG000|Prior to Week 24|Other|4|||
146357128|NCT01606761|527810172|FG001|Prior to Week 24|Other|7|||
146357129|NCT01606761|527810173|FG002|Prior to Week 24|Other|5|||
146357130|NCT01606761|527810174|FG003|Prior to Week 24|Other|0|||
146357131|NCT01606761|527810175|FG004|Prior to Week 24|Other|0|||
146357132|NCT01606761|527810171|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
146357133|NCT01606761|527810172|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
146357134|NCT01606761|527810173|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
146357135|NCT01606761|527810174|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
146357136|NCT01606761|527810175|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
146357137|NCT01606761|527810171|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
146357138|NCT01606761|527810172|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
146357139|NCT01606761|527810173|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
146357140|NCT01606761|527810174|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
146357141|NCT01606761|527810175|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
146357142|NCT01606761|527810171|FG000|Week 24 to Week 52|Adverse Event|0|||
146357143|NCT01606761|527810172|FG001|Week 24 to Week 52|Adverse Event|11|||
146357144|NCT01606761|527810173|FG002|Week 24 to Week 52|Adverse Event|14|||
146357145|NCT01606761|527810174|FG003|Week 24 to Week 52|Adverse Event|3|||
146357146|NCT01606761|527810175|FG004|Week 24 to Week 52|Adverse Event|15|||
146357147|NCT01606761|527810171|FG000|Week 24 to Week 52|Death|0|||
146357148|NCT01606761|527810172|FG001|Week 24 to Week 52|Death|0|||
146357149|NCT01606761|527810173|FG002|Week 24 to Week 52|Death|2|||
146357150|NCT01606761|527810174|FG003|Week 24 to Week 52|Death|1|||
146357151|NCT01606761|527810175|FG004|Week 24 to Week 52|Death|0|||
146357152|NCT01606761|527810171|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
146357153|NCT01606761|527810172|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
146357154|NCT01606761|527810173|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
146357155|NCT01606761|527810174|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
146357156|NCT01606761|527810175|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
146357157|NCT01606761|527810171|FG000|Week 24 to Week 52|Physician Decision|0|||
146357158|NCT01606761|527810172|FG001|Week 24 to Week 52|Physician Decision|1|||
146357159|NCT01606761|527810173|FG002|Week 24 to Week 52|Physician Decision|1|||
146357160|NCT01606761|527810174|FG003|Week 24 to Week 52|Physician Decision|0|||
146357161|NCT01606761|527810175|FG004|Week 24 to Week 52|Physician Decision|0|||
146357162|NCT01606761|527810171|FG000|Week 24 to Week 52|Other|0|||
146357163|NCT01606761|527810172|FG001|Week 24 to Week 52|Other|1|||
146357164|NCT01606761|527810173|FG002|Week 24 to Week 52|Other|5|||
146357165|NCT01606761|527810174|FG003|Week 24 to Week 52|Other|2|||
146357166|NCT01606761|527810175|FG004|Week 24 to Week 52|Other|2|||
146357167|NCT01606761|527810171|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
146357168|NCT01606761|527810172|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
146357169|NCT01606761|527810173|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
146357170|NCT01606761|527810174|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
146357171|NCT01606761|527810175|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
146357172|NCT01606761|527810171|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
146357173|NCT01606761|527810172|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
146357174|NCT01606761|527810173|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
146357175|NCT01606761|527810174|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
146357176|NCT01606761|527810175|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
146357177|NCT01606761|527810171|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
146357178|NCT01606761|527810172|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
146357179|NCT01606761|527810173|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
146357180|NCT01606761|527810174|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
146357181|NCT01606761|527810175|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
146357182|NCT01606761|527810171|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
146357183|NCT01606761|527810172|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
146357184|NCT01606761|527810173|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
146357185|NCT01606761|527810174|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
146357186|NCT01606761|527810175|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
146357187|NCT05086289|527810176|FG000|Overall Study|Adverse Event|4|||
146357188|NCT05086289|527810177|FG001|Overall Study|Adverse Event|2|||
146357189|NCT05086289|527810176|FG000|Overall Study|Lost to Follow-up|2|||
146357190|NCT05086289|527810177|FG001|Overall Study|Lost to Follow-up|0|||
146357191|NCT05086289|527810176|FG000|Overall Study|Non-compliance with study drug|2|||
146357192|NCT05086289|527810177|FG001|Overall Study|Non-compliance with study drug|1|||
146357193|NCT05086289|527810176|FG000|Overall Study|Physician Decision|2|||
146357194|NCT05086289|527810177|FG001|Overall Study|Physician Decision|0|||
146357195|NCT05086289|527810176|FG000|Overall Study|Withdrawal by Subject|5|||
146357196|NCT05086289|527810177|FG001|Overall Study|Withdrawal by Subject|2|||
146357197|NCT04544709|527810178|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
146357198|NCT03238235|527810179|FG000|Overall Study|Adverse Event|2|||
146357199|NCT03238235|527810180|FG001|Overall Study|Adverse Event|0|||
146357200|NCT03238235|527810179|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
146357201|NCT03238235|527810180|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
146357202|NCT01814800|527810181|FG000|Overall Study|Adverse Event|2|||
146357203|NCT01814800|527810181|FG000|Overall Study|Pregnancy|1|||
146357204|NCT01814800|527810181|FG000|Overall Study|Sponsor decision|1|||
146357205|NCT01814800|527810181|FG000|Overall Study|Subject relocation|1|||
146357206|NCT03807739|527810182|FG000|Overall Study|Adverse Event|1|||
146357207|NCT03807739|527810183|FG001|Overall Study|Adverse Event|0|||
146357208|NCT03807739|527810184|FG002|Overall Study|Adverse Event|0|||
146357209|NCT03807739|527810185|FG003|Overall Study|Adverse Event|0|||
146357210|NCT03807739|527810182|FG000|Overall Study|Withdrawal by Subject|1|||
146357211|NCT03807739|527810183|FG001|Overall Study|Withdrawal by Subject|0|||
146357212|NCT03807739|527810184|FG002|Overall Study|Withdrawal by Subject|0|||
146357213|NCT03807739|527810185|FG003|Overall Study|Withdrawal by Subject|0|||
146357214|NCT02371759|527810186|FG000|Overall Study|Protocol Violation|3|||
146357215|NCT02371759|527810187|FG001|Overall Study|Protocol Violation|1|||
146357216|NCT02371759|527810188|FG002|Overall Study|Protocol Violation|1|||
146357217|NCT02371759|527810189|FG003|Overall Study|Protocol Violation|0|||
146357218|NCT02371759|527810190|FG004|Overall Study|Protocol Violation|3|||
146357219|NCT02371759|527810191|FG005|Overall Study|Protocol Violation|1|||
146357220|NCT02371759|527810192|FG006|Overall Study|Protocol Violation|0|||
146357221|NCT02371759|527810193|FG007|Overall Study|Protocol Violation|3|||
146357222|NCT02371759|527810186|FG000|Overall Study|Withdrawal by Subject|0|||
146357223|NCT02371759|527810187|FG001|Overall Study|Withdrawal by Subject|0|||
146357224|NCT02371759|527810188|FG002|Overall Study|Withdrawal by Subject|0|||
146357225|NCT02371759|527810189|FG003|Overall Study|Withdrawal by Subject|0|||
146357226|NCT02371759|527810190|FG004|Overall Study|Withdrawal by Subject|0|||
146357227|NCT02371759|527810191|FG005|Overall Study|Withdrawal by Subject|0|||
146357228|NCT02371759|527810192|FG006|Overall Study|Withdrawal by Subject|0|||
146357229|NCT02371759|527810193|FG007|Overall Study|Withdrawal by Subject|1|||
146357230|NCT03201198|527810207|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
146357231|NCT03201198|527810208|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
146357232|NCT03201198|527810207|FG000|Overall Study|Withdrawal by Subject|2|||
146357233|NCT03201198|527810208|FG001|Overall Study|Withdrawal by Subject|3|||
146357234|NCT03213626|527810209|FG000|Overall Study|Adverse Event|1|||
146357235|NCT03213626|527810209|FG000|Overall Study|Progressive Disease|6|||
146357236|NCT00352755|527812306|FG000|Overall Study|Physician Decision|1|||
146357237|NCT00352755|527812306|FG000|Overall Study|Adverse Event|1|||
146357238|NCT02622724|527812307|FG000|Overall Study|Death|51|||
146357239|NCT02622724|527812308|FG001|Overall Study|Death|53|||
146357240|NCT02622724|527812307|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
146357241|NCT02622724|527812308|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
146357242|NCT02622724|527812307|FG000|Overall Study|Early termination of study|38|||
146357243|NCT02622724|527812308|FG001|Overall Study|Early termination of study|43|||
146357244|NCT00487084|527812309|FG000|Overall Study|Did not receive intervention|4|||
146357245|NCT00487084|527812310|FG001|Overall Study|Did not receive intervention|3|||
146357246|NCT00487084|527812311|FG002|Overall Study|Did not receive intervention|5|||
146357247|NCT01697267|527812312|FG000|Overall Study|Death|3|||
146357248|NCT01697267|527812313|FG001|Overall Study|Death|1|||
146357249|NCT01697267|527812312|FG000|Overall Study|Withdrawal by Subject|5|||
146357250|NCT01697267|527812313|FG001|Overall Study|Withdrawal by Subject|5|||
146357251|NCT01697267|527812312|FG000|Overall Study|Adverse Event|2|||
146357252|NCT01697267|527812313|FG001|Overall Study|Adverse Event|1|||
146357253|NCT01697267|527812312|FG000|Overall Study|Lost to Follow-up|2|||
146357254|NCT01697267|527812313|FG001|Overall Study|Lost to Follow-up|4|||
146357255|NCT01697267|527812312|FG000|Overall Study|Physician Decision|2|||
146357256|NCT01697267|527812313|FG001|Overall Study|Physician Decision|4|||
146357257|NCT05254613|527812323|FG000|Overall Study|Lost to Follow-up|0|||
146357258|NCT05254613|527812324|FG001|Overall Study|Lost to Follow-up|0|||
146357259|NCT05254613|527812325|FG002|Overall Study|Lost to Follow-up|1|||
146357260|NCT02338492|527812326|FG000|Overall Study|Death|32|||
146357261|NCT02338492|527812326|FG000|Overall Study|Adverse Event|3|||
146357262|NCT02338492|527812326|FG000|Overall Study|Lost to Follow-up|4|||
146357263|NCT02338492|527812326|FG000|Overall Study|Reason not captured above|6|||
146357264|NCT00756886|527812330|FG000|Overall Study|Lost to Follow-up|1|||
146357265|NCT00756886|527812331|FG001|Overall Study|Lost to Follow-up|0|||
146357266|NCT00756886|527812330|FG000|Overall Study|Adverse Event|0|||
146357267|NCT00756886|527812331|FG001|Overall Study|Adverse Event|3|||
146357268|NCT00756886|527812330|FG000|Overall Study|Lack of Efficacy|1|||
146357269|NCT00756886|527812331|FG001|Overall Study|Lack of Efficacy|0|||
146357270|NCT00756886|527812330|FG000|Overall Study|Ineligible|9|||
146357271|NCT00756886|527812331|FG001|Overall Study|Ineligible|4|||
146357272|NCT00174785|527812332|FG000|Overall Study|Adverse Event|293|||
146357273|NCT00174785|527812333|FG001|Overall Study|Adverse Event|191|||
146357274|NCT00174785|527812332|FG000|Overall Study|Protocol Violation|14|||
146357275|NCT00174785|527812333|FG001|Overall Study|Protocol Violation|14|||
146357276|NCT00174785|527812332|FG000|Overall Study|Withdrawal by Subject|173|||
146357277|NCT00174785|527812333|FG001|Overall Study|Withdrawal by Subject|175|||
146169614|NCT01060553|527132876|FG000|Overall Study|Withdrawal by Subject|5|||
146169615|NCT01060553|527132877|FG001|Overall Study|Withdrawal by Subject|5|||
146169616|NCT01060553|527132876|FG000|Overall Study|Lack of Efficacy|1|||
146357278|NCT00174785|527812332|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
146357279|NCT00174785|527812333|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
146357280|NCT00174785|527812332|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
146357281|NCT00174785|527812333|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
146357282|NCT00174785|527812332|FG000|Overall Study|Other prohibited medication|5|||
146357283|NCT00174785|527812333|FG001|Overall Study|Other prohibited medication|3|||
146357284|NCT00174785|527812332|FG000|Overall Study|Family request|6|||
146357285|NCT00174785|527812333|FG001|Overall Study|Family request|8|||
146357286|NCT00174785|527812332|FG000|Overall Study|Not pre-specified/Not coded|56|||
146357287|NCT00174785|527812333|FG001|Overall Study|Not pre-specified/Not coded|70|||
146357288|NCT00310388|527812335|FG000|Primary Reporting Phase|Adverse Event|101|||
146357289|NCT00310388|527812336|FG001|Primary Reporting Phase|Adverse Event|0|||
146357290|NCT00310388|527812335|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
146357291|NCT00310388|527812336|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
146357292|NCT00310388|527812335|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
146357293|NCT00310388|527812336|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
146357294|NCT00310388|527812335|FG000|Primary Reporting Phase|Protocol Violation|10|||
146357295|NCT00310388|527812336|FG001|Primary Reporting Phase|Protocol Violation|0|||
146357296|NCT00310388|527812335|FG000|Primary Reporting Phase|Pregnancy|3|||
146357297|NCT00310388|527812336|FG001|Primary Reporting Phase|Pregnancy|0|||
146357298|NCT00310388|527812335|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
146357299|NCT00310388|527812336|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
146357300|NCT00310388|527812335|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
146357301|NCT00310388|527812336|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
146357302|NCT00310388|527812335|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
146357303|NCT00310388|527812336|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
146357304|NCT00310388|527812335|FG000|Primary Reporting Phase|Physician Decision|2|||
146357305|NCT00310388|527812336|FG001|Primary Reporting Phase|Physician Decision|0|||
146357306|NCT00310388|527812335|FG000|Primary Reporting Phase|Request of the sponsor|19|||
146357307|NCT00310388|527812336|FG001|Primary Reporting Phase|Request of the sponsor|0|||
146357308|NCT00310388|527812335|FG000|Primary Reporting Phase|Failed to return|8|||
146357309|NCT00310388|527812336|FG001|Primary Reporting Phase|Failed to return|0|||
146357310|NCT00310388|527812335|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
146357311|NCT00310388|527812336|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
146357312|NCT00310388|527812335|FG000|Primary Reporting Phase|Participant request|2|||
146357313|NCT00310388|527812336|FG001|Primary Reporting Phase|Participant request|0|||
146357314|NCT00310388|527812335|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
146357315|NCT00310388|527812336|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
146357316|NCT00310388|527812335|FG000|Primary Reporting Phase|Discontinuation of study|1|||
146357317|NCT00310388|527812336|FG001|Primary Reporting Phase|Discontinuation of study|0|||
146357318|NCT00310388|527812335|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
146357319|NCT00310388|527812336|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
146357320|NCT00310388|527812335|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
146357321|NCT00310388|527812336|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
146357322|NCT00310388|527812335|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
146357323|NCT00310388|527812336|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
146357324|NCT00310388|527812335|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
146357325|NCT00310388|527812336|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
146357326|NCT00310388|527812335|FG000|Primary Reporting Phase|Participant passed away|1|||
146357327|NCT00310388|527812336|FG001|Primary Reporting Phase|Participant passed away|0|||
146357328|NCT00310388|527812335|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
146357329|NCT00310388|527812336|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
146357330|NCT00310388|527812335|FG000|Primary Reporting Phase|Missing|1|||
146357331|NCT00310388|527812336|FG001|Primary Reporting Phase|Missing|0|||
146357332|NCT00310388|527812335|FG000|Primary Reporting Phase|Other|1|||
146357333|NCT00310388|527812336|FG001|Primary Reporting Phase|Other|0|||
146357334|NCT00310388|527812335|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
146357335|NCT00310388|527812336|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
146357336|NCT00310388|527812335|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
146357337|NCT00310388|527812336|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
146357338|NCT00310388|527812335|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
146357339|NCT00310388|527812336|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
146357340|NCT00310388|527812335|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
146357341|NCT00310388|527812336|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
146357342|NCT02387372|527812343|FG000|Overall Study|Not Treated|1|||
146357343|NCT02387372|527812344|FG001|Overall Study|Not Treated|0|||
146357344|NCT00082758|527812346|FG000|Overall Study|Adverse Event|0|||
146357345|NCT00082758|527812347|FG001|Overall Study|Adverse Event|2|||
146357346|NCT00082758|527812348|FG002|Overall Study|Adverse Event|0|||
146357347|NCT00082758|527812346|FG000|Overall Study|Lack of Efficacy|12|||
146357348|NCT00082758|527812347|FG001|Overall Study|Lack of Efficacy|13|||
146357349|NCT00082758|527812348|FG002|Overall Study|Lack of Efficacy|0|||
146357350|NCT00082758|527812346|FG000|Overall Study|Physician Decision|0|||
146357351|NCT00082758|527812347|FG001|Overall Study|Physician Decision|1|||
146357352|NCT00082758|527812348|FG002|Overall Study|Physician Decision|0|||
146357353|NCT00082758|527812346|FG000|Overall Study|Withdrawal by Subject|3|||
146357354|NCT00082758|527812347|FG001|Overall Study|Withdrawal by Subject|0|||
146357355|NCT00082758|527812348|FG002|Overall Study|Withdrawal by Subject|0|||
146357356|NCT00082758|527812346|FG000|Overall Study|Protocol Violation|0|||
146357357|NCT00082758|527812347|FG001|Overall Study|Protocol Violation|1|||
146357358|NCT00082758|527812348|FG002|Overall Study|Protocol Violation|0|||
146357359|NCT00501046|527812352|FG000|Overall Study|Adverse Event|21|||
146357360|NCT00501046|527812353|FG001|Overall Study|Adverse Event|25|||
146357361|NCT00501046|527812352|FG000|Overall Study|Death|23|||
146357362|NCT00501046|527812353|FG001|Overall Study|Death|30|||
146357363|NCT00501046|527812352|FG000|Overall Study|Lost to Follow-up|14|||
146357364|NCT00501046|527812353|FG001|Overall Study|Lost to Follow-up|13|||
146357365|NCT00501046|527812352|FG000|Overall Study|Physician Decision|7|||
146357366|NCT00501046|527812353|FG001|Overall Study|Physician Decision|2|||
146357367|NCT00501046|527812352|FG000|Overall Study|Pregnancy|0|||
146357368|NCT00501046|527812353|FG001|Overall Study|Pregnancy|3|||
146357369|NCT00501046|527812352|FG000|Overall Study|Protocol Violation|2|||
146357370|NCT00501046|527812353|FG001|Overall Study|Protocol Violation|1|||
146357371|NCT00501046|527812352|FG000|Overall Study|Withdrawal by Subject|84|||
146357372|NCT00501046|527812353|FG001|Overall Study|Withdrawal by Subject|83|||
146357373|NCT00501046|527812352|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
146357374|NCT00501046|527812353|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
146357375|NCT01576016|527812354|FG000|Lead Safety|Death|132|||
146357376|NCT01576016|527812355|FG001|Lead Safety|Death|0|||
146357377|NCT01576016|527812354|FG000|Lead Safety|Withdrawal by Subject|81|||
146357378|NCT01576016|527812355|FG001|Lead Safety|Withdrawal by Subject|0|||
146357379|NCT01576016|527812354|FG000|Lead Safety|System Explanted without Replacement|24|||
146357380|NCT01576016|527812355|FG001|Lead Safety|System Explanted without Replacement|0|||
146357381|NCT01576016|527812354|FG000|Lead Safety|Physician Decision|14|||
146357382|NCT01576016|527812355|FG001|Lead Safety|Physician Decision|0|||
146357383|NCT01576016|527812354|FG000|Lead Safety|Lost to Follow-up|13|||
146357384|NCT01576016|527812355|FG001|Lead Safety|Lost to Follow-up|0|||
146357385|NCT01576016|527812354|FG000|Lead Safety|Unsuccessful implant|2|||
146357386|NCT01576016|527812355|FG001|Lead Safety|Unsuccessful implant|0|||
146357387|NCT01576016|527812354|FG000|Lead Safety|Sponsor request|1|||
146357388|NCT01576016|527812355|FG001|Lead Safety|Sponsor request|0|||
146357389|NCT01576016|527812354|FG000|Lead Safety|Device replaced with CRT-D|1|||
146357390|NCT01576016|527812355|FG001|Lead Safety|Device replaced with CRT-D|0|||
146357391|NCT01576016|527812354|FG000|Lead Safety|Patient on Palliative Care|1|||
146357392|NCT01576016|527812355|FG001|Lead Safety|Patient on Palliative Care|0|||
146357393|NCT01576016|527812354|FG000|Lead Safety|Patient noncompliance|1|||
146357394|NCT01576016|527812355|FG001|Lead Safety|Patient noncompliance|0|||
146357395|NCT01576016|527812354|FG000|Lead Safety|Too far from study site|1|||
146357396|NCT01576016|527812355|FG001|Lead Safety|Too far from study site|0|||
146357397|NCT01576016|527812354|FG000|Lead Safety|System deactivated|1|||
146357398|NCT01576016|527812355|FG001|Lead Safety|System deactivated|0|||
146357399|NCT01576016|527812354|FG000|Lead Safety|Patient no longer followed by study PI|1|||
146357400|NCT01576016|527812355|FG001|Lead Safety|Patient no longer followed by study PI|0|||
146357401|NCT01576016|527812354|FG000|MRI Safety|Withdrawal by Subject|0|||
146357402|NCT01576016|527812355|FG001|MRI Safety|Withdrawal by Subject|10|||
146357403|NCT01576016|527812354|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
146357404|NCT01576016|527812355|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
146357405|NCT01576016|527812354|FG000|MRI Safety|Has not yet completed MRI scan|0|||
146357406|NCT01576016|527812355|FG001|MRI Safety|Has not yet completed MRI scan|56|||
146357407|NCT01576016|527812354|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
146357408|NCT01576016|527812355|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
146357409|NCT02208024|527812357|FG000|Overall Study|Withdrawal by Subject|1|||
146357410|NCT00779324|527812358|FG000|Overall Study|Lost to Follow-up|2|||
146357411|NCT00779324|527812359|FG001|Overall Study|Lost to Follow-up|1|||
146357412|NCT00779324|527812358|FG000|Overall Study|Withdrawal by Subject|4|||
146357413|NCT00779324|527812359|FG001|Overall Study|Withdrawal by Subject|2|||
146357414|NCT00779324|527812358|FG000|Overall Study|Missed visit|1|||
146357415|NCT00779324|527812359|FG001|Overall Study|Missed visit|1|||
146357416|NCT00543569|527812360|FG000|Overall Study|Death|2|||
146357417|NCT00543569|527812361|FG001|Overall Study|Death|2|||
146357418|NCT00543569|527812362|FG002|Overall Study|Death|3|||
146357419|NCT00543569|527812363|FG003|Overall Study|Death|1|||
146357420|NCT00543569|527812360|FG000|Overall Study|Lost to Follow-up|0|||
146357421|NCT00543569|527812361|FG001|Overall Study|Lost to Follow-up|0|||
146357422|NCT00543569|527812362|FG002|Overall Study|Lost to Follow-up|1|||
146169617|NCT01060553|527132877|FG001|Overall Study|Lack of Efficacy|0|||
146357423|NCT00543569|527812363|FG003|Overall Study|Lost to Follow-up|1|||
146357424|NCT00543569|527812360|FG000|Overall Study|Miscellaneous Reasons|7|||
146357425|NCT00543569|527812361|FG001|Overall Study|Miscellaneous Reasons|3|||
146357426|NCT00543569|527812362|FG002|Overall Study|Miscellaneous Reasons|11|||
146357427|NCT00543569|527812363|FG003|Overall Study|Miscellaneous Reasons|4|||
146357428|NCT00543569|527812360|FG000|Overall Study|Randomized but never received study drug|3|||
146357429|NCT00543569|527812361|FG001|Overall Study|Randomized but never received study drug|3|||
146357430|NCT00543569|527812362|FG002|Overall Study|Randomized but never received study drug|5|||
146357431|NCT00543569|527812363|FG003|Overall Study|Randomized but never received study drug|3|||
146357432|NCT00862849|527812364|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146357433|NCT00862849|527812365|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
146357434|NCT00862849|527812366|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146357435|NCT00862849|527812367|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146357436|NCT00862849|527812368|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146357437|NCT00862849|527812369|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
146357438|NCT00862849|527812364|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146357439|NCT00862849|527812365|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
146357440|NCT00862849|527812366|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146357441|NCT00862849|527812367|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146357442|NCT00862849|527812368|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146357443|NCT00862849|527812369|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
146357444|NCT00718666|527812370|FG000|Booster Phase Year 5|No active participation request|0|||
146357445|NCT00718666|527812371|FG001|Booster Phase Year 5|No active participation request|0|||
146357446|NCT00718666|527812372|FG002|Booster Phase Year 5|No active participation request|1|||
146357447|NCT00718666|527812370|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
146357448|NCT00718666|527812371|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
146357449|NCT00718666|527812372|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
146357450|NCT00718666|527812370|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
146357451|NCT00718666|527812371|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
146357452|NCT00718666|527812372|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
146357453|NCT00718666|527812370|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
146357454|NCT00718666|527812371|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
146357455|NCT00718666|527812372|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
146357456|NCT02196038|527812375|FG000|Overall Study|Death|16|||
146357457|NCT02196038|527812376|FG001|Overall Study|Death|21|||
146357458|NCT02196038|527812375|FG000|Overall Study|Withdrawal by Subject|0|||
146357459|NCT02196038|527812376|FG001|Overall Study|Withdrawal by Subject|1|||
146357460|NCT02196038|527812375|FG000|Overall Study|Lost to Follow-up|1|||
146357461|NCT02196038|527812376|FG001|Overall Study|Lost to Follow-up|0|||
146357462|NCT01952730|527812383|FG000|Overall Study|FDA shut down core lab used by study|1|||
146357463|NCT00608530|527812384|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
146357464|NCT00608530|527812385|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
146357465|NCT00608530|527812386|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
146357466|NCT00608530|527812387|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
146357467|NCT00608530|527812384|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
146357468|NCT00608530|527812385|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
146357469|NCT00608530|527812386|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
146357470|NCT00608530|527812387|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
146357471|NCT00608530|527812384|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
146357472|NCT00608530|527812385|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
146357473|NCT00608530|527812386|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
146357474|NCT00608530|527812387|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
146357475|NCT00608530|527812384|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146357476|NCT00608530|527812385|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146357477|NCT00608530|527812386|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
146357478|NCT00608530|527812387|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
146357479|NCT00608530|527812384|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
146357480|NCT00608530|527812385|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
146357481|NCT00608530|527812386|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
146357482|NCT00608530|527812387|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
146357483|NCT00608530|527812384|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146357484|NCT00608530|527812385|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146357485|NCT00608530|527812386|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
146357486|NCT00608530|527812387|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
146357487|NCT01098461|527812388|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
146357488|NCT01098461|527812389|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
146357489|NCT01098461|527812390|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
146357490|NCT01098461|527812391|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
146357491|NCT01098461|527812388|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
146357492|NCT01098461|527812389|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
146357493|NCT01098461|527812390|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
146357494|NCT01098461|527812391|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
146357495|NCT01098461|527812388|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
146357496|NCT01098461|527812389|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
146357497|NCT01098461|527812390|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
146357498|NCT01098461|527812391|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
146357499|NCT01098461|527812388|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146357500|NCT01098461|527812389|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
146357501|NCT01098461|527812390|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146357502|NCT01098461|527812391|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
146357503|NCT01098461|527812388|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146357504|NCT01098461|527812389|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
146357505|NCT01098461|527812390|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146357506|NCT01098461|527812391|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
146357507|NCT01098461|527812388|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146357508|NCT01098461|527812389|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
146357509|NCT01098461|527812390|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146357510|NCT01098461|527812391|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
146357511|NCT01098461|527812388|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
146357512|NCT01098461|527812389|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
146357513|NCT01098461|527812390|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
146357514|NCT01098461|527812391|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
146357515|NCT01514188|527812392|FG000|Overall Study|Adverse Event|3|||
146357516|NCT01514188|527812393|FG001|Overall Study|Adverse Event|5|||
146357517|NCT01514188|527812392|FG000|Overall Study|Withdrawal by Subject|2|||
146357518|NCT01514188|527812393|FG001|Overall Study|Withdrawal by Subject|4|||
146357519|NCT01514188|527812392|FG000|Overall Study|Protocol Violation|2|||
146357520|NCT01514188|527812393|FG001|Overall Study|Protocol Violation|4|||
146357521|NCT01514188|527812392|FG000|Overall Study|Physician Decision|0|||
146357522|NCT01514188|527812393|FG001|Overall Study|Physician Decision|2|||
146357523|NCT01514188|527812392|FG000|Overall Study|Disease Progression|13|||
146357524|NCT01514188|527812393|FG001|Overall Study|Disease Progression|14|||
146357525|NCT01514188|527812392|FG000|Overall Study|Death|1|||
146357526|NCT01514188|527812393|FG001|Overall Study|Death|3|||
146357527|NCT01514188|527812392|FG000|Overall Study|Other|2|||
146357528|NCT01514188|527812393|FG001|Overall Study|Other|1|||
146357529|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
146357530|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
146357531|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Death|2|||
146357532|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Death|1|||
146357533|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
146357534|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
146357535|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
146357536|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
146357537|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
146357538|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
146357539|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
146357540|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
146357541|NCT03633227|527812398|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
146357542|NCT03633227|527812399|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
146357543|NCT03633227|527812398|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
146357544|NCT03633227|527812399|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
146357545|NCT03633227|527812398|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
146357546|NCT03633227|527812399|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
146357547|NCT03633227|527812398|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
146357548|NCT03633227|527812399|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
146357549|NCT03633227|527812398|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
146357550|NCT03633227|527812399|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
146357551|NCT03633227|527812398|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
146357552|NCT03633227|527812399|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
146357553|NCT01766336|527812405|FG000|Overall Study|Adverse Event|11|||
146357554|NCT01766336|527812406|FG001|Overall Study|Adverse Event|8|||
146357555|NCT01766336|527812405|FG000|Overall Study|Death|4|||
146357556|NCT01766336|527812406|FG001|Overall Study|Death|3|||
146357557|NCT01766336|527812405|FG000|Overall Study|Lost to Follow-up|1|||
146357558|NCT01766336|527812406|FG001|Overall Study|Lost to Follow-up|3|||
146357559|NCT01766336|527812405|FG000|Overall Study|Physician Decision|4|||
146357560|NCT01766336|527812406|FG001|Overall Study|Physician Decision|2|||
146357561|NCT01766336|527812405|FG000|Overall Study|Protocol Violation|0|||
146357562|NCT01766336|527812406|FG001|Overall Study|Protocol Violation|1|||
146357563|NCT01766336|527812405|FG000|Overall Study|Sponsor Decision|52|||
146357564|NCT01766336|527812406|FG001|Overall Study|Sponsor Decision|43|||
146357565|NCT01766336|527812405|FG000|Overall Study|Withdrawal by Subject|18|||
146357566|NCT01766336|527812406|FG001|Overall Study|Withdrawal by Subject|15|||
146357567|NCT02605447|527812408|FG000|Overall Study|Death|66|||
146357568|NCT02605447|527812408|FG000|Overall Study|Physician Decision|1|||
146357569|NCT02605447|527812408|FG000|Overall Study|Lost to Follow-up|24|||
146357570|NCT02605447|527812408|FG000|Overall Study|Withdrawal by Subject|10|||
146357571|NCT02605447|527812408|FG000|Overall Study|Not disclosed|1|||
146357572|NCT01479374|527812409|FG000|Overall Study|Adverse Event|2|||
146357573|NCT01479374|527812410|FG001|Overall Study|Adverse Event|1|||
146357574|NCT01479374|527812411|FG002|Overall Study|Adverse Event|0|||
146357575|NCT01479374|527812409|FG000|Overall Study|Lost to Follow-up|1|||
146357576|NCT01479374|527812410|FG001|Overall Study|Lost to Follow-up|2|||
146357577|NCT01479374|527812411|FG002|Overall Study|Lost to Follow-up|0|||
146357578|NCT01479374|527812409|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
146357579|NCT01479374|527812410|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
146357580|NCT01479374|527812411|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
146357581|NCT01479374|527812409|FG000|Overall Study|Other|0|||
146357582|NCT01479374|527812410|FG001|Overall Study|Other|4|||
146357583|NCT01479374|527812411|FG002|Overall Study|Other|5|||
146357584|NCT02045212|527812413|FG000|Overall Study|Adverse Event|0|||
146357585|NCT02045212|527812414|FG001|Overall Study|Adverse Event|1|||
146357586|NCT02045212|527812413|FG000|Overall Study|Withdrawal by Subject|1|||
146357587|NCT02045212|527812414|FG001|Overall Study|Withdrawal by Subject|0|||
146357588|NCT02045212|527812413|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
146357589|NCT02045212|527812414|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
146357590|NCT03135028|527812420|FG000|Overall Study|Death|6|||
146357591|NCT03135028|527812420|FG000|Overall Study|Study Terminated by Sponsor|2|||
146357592|NCT03135028|527812420|FG000|Overall Study|Withdrew Consent|1|||
146357593|NCT03375112|527812423|FG000|Overall Study|Withdrawal by Subject|3|||
146357594|NCT03375112|527812424|FG001|Overall Study|Withdrawal by Subject|0|||
146357595|NCT00243230|527812426|FG000|Double-Blind Period|Adverse Event|0|||
146357596|NCT00243230|527812427|FG001|Double-Blind Period|Adverse Event|2|||
146357597|NCT00243230|527812428|FG002|Double-Blind Period|Adverse Event|2|||
146357598|NCT00243230|527812429|FG003|Double-Blind Period|Adverse Event|0|||
146357599|NCT00243230|527812426|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146357600|NCT00243230|527812427|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146357601|NCT00243230|527812428|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146357602|NCT00243230|527812429|FG003|Double-Blind Period|Withdrawal by Subject|0|||
146357603|NCT00243230|527812426|FG000|Double-Blind Period|Protocol Violation|0|||
146357604|NCT00243230|527812427|FG001|Double-Blind Period|Protocol Violation|0|||
146357605|NCT00243230|527812428|FG002|Double-Blind Period|Protocol Violation|1|||
146357606|NCT00243230|527812429|FG003|Double-Blind Period|Protocol Violation|0|||
146357607|NCT00243230|527812426|FG000|Double-Blind Period|Randomized but Not Treated|0|||
146357608|NCT00243230|527812427|FG001|Double-Blind Period|Randomized but Not Treated|0|||
146357609|NCT00243230|527812428|FG002|Double-Blind Period|Randomized but Not Treated|2|||
146357610|NCT00243230|527812429|FG003|Double-Blind Period|Randomized but Not Treated|0|||
146357611|NCT00243230|527812426|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
146357612|NCT00243230|527812427|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
146357613|NCT00243230|527812428|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
146357614|NCT00243230|527812429|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
146357615|NCT00243230|527812426|FG000|Open Label Period|Adverse Event|0|||
146357616|NCT00243230|527812427|FG001|Open Label Period|Adverse Event|0|||
146357617|NCT00243230|527812428|FG002|Open Label Period|Adverse Event|0|||
146357618|NCT00243230|527812429|FG003|Open Label Period|Adverse Event|2|||
146357619|NCT00243230|527812426|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
146357620|NCT00243230|527812427|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
146357621|NCT00243230|527812428|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
146357622|NCT00243230|527812429|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
146357623|NCT00243230|527812426|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146357624|NCT00243230|527812427|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146357625|NCT00243230|527812428|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
146357626|NCT00243230|527812429|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
146357627|NCT00243230|527812426|FG000|Open Label Period|Lost to Follow-up|0|||
146357628|NCT00243230|527812427|FG001|Open Label Period|Lost to Follow-up|0|||
146357629|NCT00243230|527812428|FG002|Open Label Period|Lost to Follow-up|0|||
146357630|NCT00243230|527812429|FG003|Open Label Period|Lost to Follow-up|2|||
146357631|NCT00243230|527812426|FG000|Open Label Period|Withdrawal by Subject|0|||
146357632|NCT00243230|527812427|FG001|Open Label Period|Withdrawal by Subject|0|||
146357633|NCT00243230|527812428|FG002|Open Label Period|Withdrawal by Subject|0|||
146357634|NCT00243230|527812429|FG003|Open Label Period|Withdrawal by Subject|2|||
146357635|NCT00243230|527812426|FG000|Open Label Period|Protocol Violation|0|||
146357636|NCT00243230|527812427|FG001|Open Label Period|Protocol Violation|0|||
146357637|NCT00243230|527812428|FG002|Open Label Period|Protocol Violation|0|||
146357638|NCT00243230|527812429|FG003|Open Label Period|Protocol Violation|2|||
146357639|NCT00243230|527812426|FG000|Open Label Period|Administrative Reason|0|||
146357640|NCT00243230|527812427|FG001|Open Label Period|Administrative Reason|0|||
146357641|NCT00243230|527812428|FG002|Open Label Period|Administrative Reason|0|||
146357642|NCT00243230|527812429|FG003|Open Label Period|Administrative Reason|63|||
146357643|NCT03599141|527812432|FG000|Overall Study|Lost to Follow-up|3|||
146357644|NCT03599141|527812433|FG001|Overall Study|Lost to Follow-up|1|||
146357645|NCT03136185|527812434|FG000|Overall Study|Adverse Event|0|||
146357646|NCT03136185|527812435|FG001|Overall Study|Adverse Event|1|||
146357647|NCT03136185|527812436|FG002|Overall Study|Adverse Event|3|||
146357648|NCT03136185|527812437|FG003|Overall Study|Adverse Event|1|||
146357649|NCT03136185|527812438|FG004|Overall Study|Adverse Event|2|||
146357650|NCT03136185|527812439|FG005|Overall Study|Adverse Event|2|||
146357651|NCT03136185|527812440|FG006|Overall Study|Adverse Event|5|||
146357652|NCT03136185|527812441|FG007|Overall Study|Adverse Event|1|||
146357653|NCT03136185|527812442|FG008|Overall Study|Adverse Event|1|||
146357654|NCT03136185|527812434|FG000|Overall Study|Death|0|||
146357655|NCT03136185|527812435|FG001|Overall Study|Death|0|||
146357656|NCT03136185|527812436|FG002|Overall Study|Death|0|||
146357657|NCT03136185|527812437|FG003|Overall Study|Death|1|||
146357658|NCT03136185|527812438|FG004|Overall Study|Death|1|||
146357659|NCT03136185|527812439|FG005|Overall Study|Death|0|||
146357660|NCT03136185|527812440|FG006|Overall Study|Death|1|||
146357661|NCT03136185|527812441|FG007|Overall Study|Death|0|||
146357662|NCT03136185|527812442|FG008|Overall Study|Death|0|||
146357663|NCT03136185|527812434|FG000|Overall Study|Physician Decision|3|||
146357664|NCT03136185|527812435|FG001|Overall Study|Physician Decision|1|||
146357665|NCT03136185|527812436|FG002|Overall Study|Physician Decision|1|||
146357666|NCT03136185|527812437|FG003|Overall Study|Physician Decision|2|||
146357667|NCT03136185|527812438|FG004|Overall Study|Physician Decision|1|||
146357668|NCT03136185|527812439|FG005|Overall Study|Physician Decision|2|||
146357669|NCT03136185|527812440|FG006|Overall Study|Physician Decision|1|||
146357670|NCT03136185|527812441|FG007|Overall Study|Physician Decision|0|||
146357671|NCT03136185|527812442|FG008|Overall Study|Physician Decision|1|||
146357672|NCT03136185|527812434|FG000|Overall Study|Protocol Defined Disease Progression|0|||
146357673|NCT03136185|527812435|FG001|Overall Study|Protocol Defined Disease Progression|0|||
146357674|NCT03136185|527812436|FG002|Overall Study|Protocol Defined Disease Progression|1|||
146357675|NCT03136185|527812437|FG003|Overall Study|Protocol Defined Disease Progression|0|||
146357676|NCT03136185|527812438|FG004|Overall Study|Protocol Defined Disease Progression|0|||
146357677|NCT03136185|527812439|FG005|Overall Study|Protocol Defined Disease Progression|1|||
146357678|NCT03136185|527812440|FG006|Overall Study|Protocol Defined Disease Progression|0|||
146357679|NCT03136185|527812441|FG007|Overall Study|Protocol Defined Disease Progression|1|||
146357680|NCT03136185|527812442|FG008|Overall Study|Protocol Defined Disease Progression|1|||
146357681|NCT03136185|527812434|FG000|Overall Study|Withdrawal by Subject|1|||
146357682|NCT03136185|527812435|FG001|Overall Study|Withdrawal by Subject|0|||
146357683|NCT03136185|527812436|FG002|Overall Study|Withdrawal by Subject|1|||
146357684|NCT03136185|527812437|FG003|Overall Study|Withdrawal by Subject|1|||
146357685|NCT03136185|527812438|FG004|Overall Study|Withdrawal by Subject|1|||
146357686|NCT03136185|527812439|FG005|Overall Study|Withdrawal by Subject|1|||
146357687|NCT03136185|527812440|FG006|Overall Study|Withdrawal by Subject|2|||
146357688|NCT03136185|527812441|FG007|Overall Study|Withdrawal by Subject|3|||
146357689|NCT03136185|527812442|FG008|Overall Study|Withdrawal by Subject|3|||
146357690|NCT03136185|527812434|FG000|Overall Study|Not Reported|4|||
146357691|NCT03136185|527812435|FG001|Overall Study|Not Reported|1|||
146357692|NCT03136185|527812436|FG002|Overall Study|Not Reported|0|||
146357693|NCT03136185|527812437|FG003|Overall Study|Not Reported|1|||
146357694|NCT03136185|527812438|FG004|Overall Study|Not Reported|0|||
146357695|NCT03136185|527812439|FG005|Overall Study|Not Reported|2|||
146357696|NCT03136185|527812440|FG006|Overall Study|Not Reported|1|||
146357697|NCT03136185|527812441|FG007|Overall Study|Not Reported|1|||
146357698|NCT03136185|527812442|FG008|Overall Study|Not Reported|0|||
146357699|NCT02998554|527812446|FG000|Overall Study|Adverse Event|8|||
146357700|NCT02998554|527812447|FG001|Overall Study|Adverse Event|3|||
146357701|NCT02998554|527812446|FG000|Overall Study|Protocol deviation|1|||
146357702|NCT02998554|527812447|FG001|Overall Study|Protocol deviation|0|||
146357703|NCT02998554|527812446|FG000|Overall Study|Withdrawal by Subject|2|||
146357704|NCT02998554|527812447|FG001|Overall Study|Withdrawal by Subject|6|||
146357705|NCT02998554|527812446|FG000|Overall Study|Lost to Follow-up|0|||
146357706|NCT02998554|527812447|FG001|Overall Study|Lost to Follow-up|1|||
146357707|NCT02998554|527812446|FG000|Overall Study|Lack of Efficacy|0|||
146357708|NCT02998554|527812447|FG001|Overall Study|Lack of Efficacy|1|||
146357709|NCT02112994|527812450|FG000|Overall Study|Progressive Disease|0|||
146357710|NCT02112994|527812451|FG001|Overall Study|Progressive Disease|0|||
146357711|NCT02112994|527812452|FG002|Overall Study|Progressive Disease|1|||
146357712|NCT02112994|527812450|FG000|Overall Study|Pregnancy|0|||
146357713|NCT02112994|527812451|FG001|Overall Study|Pregnancy|1|||
146357714|NCT02112994|527812452|FG002|Overall Study|Pregnancy|1|||
146357715|NCT02112994|527812450|FG000|Overall Study|Liver Transplant|0|||
146357716|NCT02112994|527812451|FG001|Overall Study|Liver Transplant|1|||
146357717|NCT02112994|527812452|FG002|Overall Study|Liver Transplant|0|||
146357718|NCT02112994|527812450|FG000|Overall Study|Withdrawal by Subject|0|||
146357719|NCT02112994|527812451|FG001|Overall Study|Withdrawal by Subject|0|||
146357720|NCT02112994|527812452|FG002|Overall Study|Withdrawal by Subject|1|||
146357721|NCT03675737|527812456|FG000|Overall Study|Death|593|||
146357722|NCT03675737|527812457|FG001|Overall Study|Death|660|||
146357723|NCT03675737|527812456|FG000|Overall Study|Lost to Follow-up|1|||
146357724|NCT03675737|527812457|FG001|Overall Study|Lost to Follow-up|5|||
146357725|NCT03675737|527812456|FG000|Overall Study|Physician Decision|1|||
146357726|NCT03675737|527812457|FG001|Overall Study|Physician Decision|0|||
146357727|NCT03675737|527812456|FG000|Overall Study|Withdrawal by Subject|14|||
146357728|NCT03675737|527812457|FG001|Overall Study|Withdrawal by Subject|12|||
146357729|NCT03675737|527812456|FG000|Overall Study|Ongoing in Study|181|||
146357730|NCT03675737|527812457|FG001|Overall Study|Ongoing in Study|112|||
146357731|NCT02349789|527813476|FG000|Overall Study|Withdrawal by Subject|2|||
146357732|NCT02625324|527813479|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
146357733|NCT02625324|527813479|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
146357734|NCT02625324|527813479|FG000|6-Month Follow-up Subject Accountability|Death|5|||
146357735|NCT02625324|527813479|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
146357736|NCT02625324|527813479|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
146357737|NCT02625324|527813479|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
146357738|NCT02625324|527813479|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
146357739|NCT02625324|527813479|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
146357740|NCT02625324|527813479|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
146357741|NCT02625324|527813479|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
146357742|NCT02625324|527813479|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
146357743|NCT02625324|527813479|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
146357744|NCT02625324|527813479|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
146357745|NCT02625324|527813479|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
146357746|NCT02625324|527813479|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
146357747|NCT02625324|527813479|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
146357748|NCT02625324|527813479|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
146357749|NCT02457182|527813480|FG000|Overall Study|Lost to Follow-up|1|||
146357750|NCT02457182|527813481|FG001|Overall Study|Lost to Follow-up|0|||
146357751|NCT02397694|527813482|FG000|Double-Blinded Phase|Adverse Event|1|||
146357752|NCT02397694|527813483|FG001|Double-Blinded Phase|Adverse Event|0|||
146357753|NCT02397694|527813482|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
146357754|NCT02397694|527813483|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
146357755|NCT02397694|527813482|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
146357756|NCT02397694|527813483|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
146357757|NCT02397694|527813482|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
146357758|NCT02397694|527813483|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
146357759|NCT02397694|527813482|FG000|Open Label Extension Phase|Protocol Violation|1|||
146357760|NCT02397694|527813483|FG001|Open Label Extension Phase|Protocol Violation|0|||
146357761|NCT02397694|527813482|FG000|Open Label Extension Phase|Withdrew Consent|3|||
146357762|NCT02397694|527813483|FG001|Open Label Extension Phase|Withdrew Consent|1|||
146357763|NCT02397694|527813482|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
146357764|NCT02397694|527813483|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
146357765|NCT01116687|527813484|FG000|Overall Study|Withdrawal by Subject|4|||
146357766|NCT00424528|527813485|FG000|Overall Study|Adverse Event|2|||
146357767|NCT00424528|527813486|FG001|Overall Study|Adverse Event|1|||
146357768|NCT00424528|527813487|FG002|Overall Study|Adverse Event|2|||
146357769|NCT00424528|527813485|FG000|Overall Study|Protocol Violation|1|||
146357770|NCT00424528|527813486|FG001|Overall Study|Protocol Violation|1|||
146357771|NCT00424528|527813487|FG002|Overall Study|Protocol Violation|0|||
146357772|NCT00424528|527813485|FG000|Overall Study|Lost to Follow-up|0|||
146357773|NCT00424528|527813486|FG001|Overall Study|Lost to Follow-up|1|||
146357774|NCT00424528|527813487|FG002|Overall Study|Lost to Follow-up|0|||
146357775|NCT00424528|527813485|FG000|Overall Study|noncompliance with study requirements|2|||
146357776|NCT00424528|527813486|FG001|Overall Study|noncompliance with study requirements|1|||
146357777|NCT00424528|527813487|FG002|Overall Study|noncompliance with study requirements|2|||
146357778|NCT02115113|527813488|FG000|Participants in Run-in Period|Death|0|||
146357779|NCT02115113|527813489|FG001|Participants in Run-in Period|Death|0|||
146357780|NCT02115113|527813490|FG002|Participants in Run-in Period|Death|1|||
146357781|NCT02115113|527813488|FG000|Participants in Run-in Period|Administrative problems|0|||
146357782|NCT02115113|527813489|FG001|Participants in Run-in Period|Administrative problems|0|||
146357783|NCT02115113|527813490|FG002|Participants in Run-in Period|Administrative problems|1|||
146357784|NCT02115113|527813488|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
146357785|NCT02115113|527813489|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
146357786|NCT02115113|527813490|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
146357787|NCT02115113|527813488|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
146357788|NCT02115113|527813489|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
146357789|NCT02115113|527813490|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
146357790|NCT02115113|527813488|FG000|Participants Randomized|Lost to Follow-up|1|||
146357791|NCT02115113|527813489|FG001|Participants Randomized|Lost to Follow-up|0|||
146357792|NCT02115113|527813490|FG002|Participants Randomized|Lost to Follow-up|0|||
146357793|NCT02115113|527813488|FG000|Participants Randomized|Death|1|||
146357794|NCT02115113|527813489|FG001|Participants Randomized|Death|0|||
146357795|NCT02115113|527813490|FG002|Participants Randomized|Death|0|||
146357796|NCT00789191|527813492|FG000|Overall Study|Adverse Event|2|||
146357797|NCT00789191|527813493|FG001|Overall Study|Adverse Event|4|||
146357798|NCT00789191|527813492|FG000|Overall Study|Lack of Efficacy|0|||
146357799|NCT00789191|527813493|FG001|Overall Study|Lack of Efficacy|5|||
146357800|NCT00789191|527813492|FG000|Overall Study|Protocol Violation|5|||
146357801|NCT00789191|527813493|FG001|Overall Study|Protocol Violation|3|||
146357802|NCT00789191|527813492|FG000|Overall Study|Withdrawal Criteria|2|||
146357803|NCT00789191|527813493|FG001|Overall Study|Withdrawal Criteria|4|||
146357804|NCT00789191|527813492|FG000|Overall Study|Unclassified|5|||
146357805|NCT00789191|527813493|FG001|Overall Study|Unclassified|3|||
146357806|NCT03497429|527813495|FG000|Overall Study|Progressive disease|3|||
146357807|NCT03497429|527813496|FG001|Overall Study|Progressive disease|4|||
146357808|NCT03497429|527813495|FG000|Overall Study|Adverse Event|0|||
146357809|NCT03497429|527813496|FG001|Overall Study|Adverse Event|2|||
146357810|NCT01009983|527813497|FG000|Overall Study|necessary scans not completed|1|||
146357811|NCT00967226|527813501|FG000|Overall Study|Adverse Event|0|||
146357812|NCT00967226|527813502|FG001|Overall Study|Adverse Event|5|||
146357813|NCT00967226|527813501|FG000|Overall Study|Protocol Violation|2|||
146357814|NCT00967226|527813502|FG001|Overall Study|Protocol Violation|0|||
146357815|NCT00967226|527813501|FG000|Overall Study|Physician Decision|0|||
146357816|NCT00967226|527813502|FG001|Overall Study|Physician Decision|1|||
146357817|NCT00836277|527813503|FG000|Overall Study|Not evaluable for response|6|||
146357818|NCT00280150|527813504|FG000|Overall Study|Adverse Event|0|||
146357819|NCT00280150|527813505|FG001|Overall Study|Adverse Event|1|||
146357820|NCT00280150|527813506|FG002|Overall Study|Adverse Event|2|||
146357821|NCT00280150|527813507|FG003|Overall Study|Adverse Event|3|||
146357822|NCT00280150|527813504|FG000|Overall Study|Lack of Efficacy|0|||
146357823|NCT00280150|527813505|FG001|Overall Study|Lack of Efficacy|0|||
146357824|NCT00280150|527813506|FG002|Overall Study|Lack of Efficacy|0|||
146357825|NCT00280150|527813507|FG003|Overall Study|Lack of Efficacy|3|||
146357826|NCT00280150|527813504|FG000|Overall Study|Physician Decision|0|||
146357827|NCT00280150|527813505|FG001|Overall Study|Physician Decision|0|||
146357828|NCT00280150|527813506|FG002|Overall Study|Physician Decision|0|||
146357829|NCT00280150|527813507|FG003|Overall Study|Physician Decision|1|||
146357830|NCT00280150|527813504|FG000|Overall Study|Protocol Violation|0|||
146357831|NCT00280150|527813505|FG001|Overall Study|Protocol Violation|0|||
146357832|NCT00280150|527813506|FG002|Overall Study|Protocol Violation|0|||
146357833|NCT00280150|527813507|FG003|Overall Study|Protocol Violation|1|||
146357834|NCT00280150|527813504|FG000|Overall Study|Withdrawal by Subject|0|||
146357835|NCT00280150|527813505|FG001|Overall Study|Withdrawal by Subject|0|||
146357836|NCT00280150|527813506|FG002|Overall Study|Withdrawal by Subject|0|||
146357837|NCT00280150|527813507|FG003|Overall Study|Withdrawal by Subject|1|||
146357838|NCT00280150|527813504|FG000|Overall Study|Did not get consolidation therapy|3|||
146357839|NCT00280150|527813505|FG001|Overall Study|Did not get consolidation therapy|0|||
146357840|NCT00280150|527813506|FG002|Overall Study|Did not get consolidation therapy|3|||
146357841|NCT00280150|527813507|FG003|Overall Study|Did not get consolidation therapy|0|||
146357842|NCT00280150|527813504|FG000|Overall Study|Declining Performance Status|0|||
146357843|NCT00280150|527813505|FG001|Overall Study|Declining Performance Status|0|||
146357844|NCT00280150|527813506|FG002|Overall Study|Declining Performance Status|0|||
146357845|NCT00280150|527813507|FG003|Overall Study|Declining Performance Status|1|||
146357846|NCT00111917|527813509|FG000|Overall Study|Withdrawal by Subject|1|||
146357847|NCT00111917|527813510|FG001|Overall Study|Withdrawal by Subject|1|||
146357848|NCT02504268|527813522|FG000|Overall Study|Adverse Event|18|||
146357849|NCT02504268|527813523|FG001|Overall Study|Adverse Event|8|||
146357850|NCT02504268|527813524|FG002|Overall Study|Adverse Event|14|||
146357851|NCT02504268|527813525|FG003|Overall Study|Adverse Event|0|||
146357852|NCT02504268|527813526|FG004|Overall Study|Adverse Event|0|||
146357853|NCT02504268|527813527|FG005|Overall Study|Adverse Event|0|||
146357854|NCT02504268|527813528|FG006|Overall Study|Adverse Event|0|||
146357855|NCT02504268|527813529|FG007|Overall Study|Adverse Event|0|||
146357856|NCT02504268|527813530|FG008|Overall Study|Adverse Event|0|||
146357857|NCT02504268|527813522|FG000|Overall Study|Withdrawal of Consent|11|||
146357858|NCT02504268|527813523|FG001|Overall Study|Withdrawal of Consent|10|||
146357859|NCT02504268|527813524|FG002|Overall Study|Withdrawal of Consent|3|||
146357860|NCT02504268|527813525|FG003|Overall Study|Withdrawal of Consent|0|||
146357861|NCT02504268|527813526|FG004|Overall Study|Withdrawal of Consent|0|||
146357862|NCT02504268|527813527|FG005|Overall Study|Withdrawal of Consent|0|||
146357863|NCT02504268|527813528|FG006|Overall Study|Withdrawal of Consent|0|||
146357864|NCT02504268|527813529|FG007|Overall Study|Withdrawal of Consent|0|||
146357865|NCT02504268|527813530|FG008|Overall Study|Withdrawal of Consent|0|||
146357866|NCT02504268|527813522|FG000|Overall Study|Pregnancy|2|||
146357867|NCT02504268|527813523|FG001|Overall Study|Pregnancy|0|||
146357868|NCT02504268|527813524|FG002|Overall Study|Pregnancy|0|||
146357869|NCT02504268|527813525|FG003|Overall Study|Pregnancy|0|||
146357870|NCT02504268|527813526|FG004|Overall Study|Pregnancy|0|||
146357871|NCT02504268|527813527|FG005|Overall Study|Pregnancy|0|||
146357872|NCT02504268|527813528|FG006|Overall Study|Pregnancy|0|||
146357873|NCT02504268|527813529|FG007|Overall Study|Pregnancy|0|||
146357874|NCT02504268|527813530|FG008|Overall Study|Pregnancy|0|||
146357875|NCT02504268|527813522|FG000|Overall Study|Lost to Follow-up|3|||
146357876|NCT02504268|527813523|FG001|Overall Study|Lost to Follow-up|6|||
146357877|NCT02504268|527813524|FG002|Overall Study|Lost to Follow-up|4|||
146357878|NCT02504268|527813525|FG003|Overall Study|Lost to Follow-up|0|||
146357879|NCT02504268|527813526|FG004|Overall Study|Lost to Follow-up|0|||
146357880|NCT02504268|527813527|FG005|Overall Study|Lost to Follow-up|0|||
146357881|NCT02504268|527813528|FG006|Overall Study|Lost to Follow-up|0|||
146357882|NCT02504268|527813529|FG007|Overall Study|Lost to Follow-up|0|||
146357883|NCT02504268|527813530|FG008|Overall Study|Lost to Follow-up|0|||
146357884|NCT02504268|527813522|FG000|Overall Study|Death|1|||
146357885|NCT02504268|527813523|FG001|Overall Study|Death|1|||
146357886|NCT02504268|527813524|FG002|Overall Study|Death|0|||
146357887|NCT02504268|527813525|FG003|Overall Study|Death|0|||
146357888|NCT02504268|527813526|FG004|Overall Study|Death|0|||
146357889|NCT02504268|527813527|FG005|Overall Study|Death|0|||
146357890|NCT02504268|527813528|FG006|Overall Study|Death|0|||
146357891|NCT02504268|527813529|FG007|Overall Study|Death|0|||
146357892|NCT02504268|527813530|FG008|Overall Study|Death|0|||
146357893|NCT02504268|527813522|FG000|Overall Study|Subject Request to Discontinue|11|||
146357894|NCT02504268|527813523|FG001|Overall Study|Subject Request to Discontinue|3|||
146357895|NCT02504268|527813524|FG002|Overall Study|Subject Request to Discontinue|6|||
146357896|NCT02504268|527813525|FG003|Overall Study|Subject Request to Discontinue|0|||
146357897|NCT02504268|527813526|FG004|Overall Study|Subject Request to Discontinue|0|||
146357898|NCT02504268|527813527|FG005|Overall Study|Subject Request to Discontinue|0|||
146357899|NCT02504268|527813528|FG006|Overall Study|Subject Request to Discontinue|0|||
146357900|NCT02504268|527813529|FG007|Overall Study|Subject Request to Discontinue|0|||
146357901|NCT02504268|527813530|FG008|Overall Study|Subject Request to Discontinue|0|||
146357902|NCT02504268|527813522|FG000|Overall Study|No Longer Meets Study Criteria|2|||
146357903|NCT02504268|527813523|FG001|Overall Study|No Longer Meets Study Criteria|3|||
146357904|NCT02504268|527813524|FG002|Overall Study|No Longer Meets Study Criteria|0|||
146357905|NCT02504268|527813525|FG003|Overall Study|No Longer Meets Study Criteria|0|||
146357906|NCT02504268|527813526|FG004|Overall Study|No Longer Meets Study Criteria|0|||
146357907|NCT02504268|527813527|FG005|Overall Study|No Longer Meets Study Criteria|0|||
146357908|NCT02504268|527813528|FG006|Overall Study|No Longer Meets Study Criteria|0|||
146357909|NCT02504268|527813529|FG007|Overall Study|No Longer Meets Study Criteria|0|||
146357910|NCT02504268|527813530|FG008|Overall Study|No Longer Meets Study Criteria|0|||
146357911|NCT02504268|527813522|FG000|Overall Study|Lack of Efficacy|11|||
146357912|NCT02504268|527813523|FG001|Overall Study|Lack of Efficacy|35|||
146357913|NCT02504268|527813524|FG002|Overall Study|Lack of Efficacy|9|||
146357914|NCT02504268|527813525|FG003|Overall Study|Lack of Efficacy|0|||
146357915|NCT02504268|527813526|FG004|Overall Study|Lack of Efficacy|0|||
146357916|NCT02504268|527813527|FG005|Overall Study|Lack of Efficacy|0|||
146357917|NCT02504268|527813528|FG006|Overall Study|Lack of Efficacy|0|||
146357918|NCT02504268|527813529|FG007|Overall Study|Lack of Efficacy|0|||
146357919|NCT02504268|527813530|FG008|Overall Study|Lack of Efficacy|0|||
146357920|NCT02504268|527813522|FG000|Overall Study|Poor/Non-Compliance|3|||
146357921|NCT02504268|527813523|FG001|Overall Study|Poor/Non-Compliance|2|||
146357922|NCT02504268|527813524|FG002|Overall Study|Poor/Non-Compliance|3|||
146357923|NCT02504268|527813525|FG003|Overall Study|Poor/Non-Compliance|0|||
146357924|NCT02504268|527813526|FG004|Overall Study|Poor/Non-Compliance|0|||
146357925|NCT02504268|527813527|FG005|Overall Study|Poor/Non-Compliance|0|||
146357926|NCT02504268|527813528|FG006|Overall Study|Poor/Non-Compliance|0|||
146357927|NCT02504268|527813529|FG007|Overall Study|Poor/Non-Compliance|0|||
146357928|NCT02504268|527813530|FG008|Overall Study|Poor/Non-Compliance|0|||
146357929|NCT02504268|527813522|FG000|Overall Study|Not Disclosed|1|||
146357930|NCT02504268|527813523|FG001|Overall Study|Not Disclosed|0|||
146357931|NCT02504268|527813524|FG002|Overall Study|Not Disclosed|2|||
146357932|NCT02504268|527813525|FG003|Overall Study|Not Disclosed|0|||
146357933|NCT02504268|527813526|FG004|Overall Study|Not Disclosed|0|||
146357934|NCT02504268|527813527|FG005|Overall Study|Not Disclosed|0|||
146357935|NCT02504268|527813528|FG006|Overall Study|Not Disclosed|0|||
146357936|NCT02504268|527813529|FG007|Overall Study|Not Disclosed|0|||
146357937|NCT02504268|527813530|FG008|Overall Study|Not Disclosed|0|||
146357938|NCT03025217|527813531|FG000|Overall Study|Pregnancy|1|||
146357939|NCT03025217|527813531|FG000|Overall Study|Lost to Follow-up|1|||
146357940|NCT03025217|527813531|FG000|Overall Study|Not eligible, poor English|2|||
146357941|NCT02124707|527813538|FG000|Overall Study|Adverse Event|5|||
146357942|NCT02124707|527813538|FG000|Overall Study|Physician Decision|1|||
146357943|NCT02124707|527813538|FG000|Overall Study|Death|1|||
146357944|NCT00781599|527813539|FG000|Overall Study|Lost to Follow-up|7|||
146357945|NCT00781599|527813540|FG001|Overall Study|Lost to Follow-up|4|||
146169618|NCT04707196|527132879|FG000|Overall Study|Withdrawal by Subject|9|||
146357946|NCT01088438|527813541|FG000|Overall Study|Withdrawal by Subject|11|||
146357947|NCT01088438|527813542|FG001|Overall Study|Withdrawal by Subject|6|||
146357948|NCT01088438|527813541|FG000|Overall Study|Lost to Follow-up|18|||
146357949|NCT01088438|527813542|FG001|Overall Study|Lost to Follow-up|30|||
146357950|NCT01363713|527813543|FG000|Overall Study|Adverse Event|1|||
146357951|NCT01363713|527813543|FG000|Overall Study|Protocol Violation|3|||
146357952|NCT01363713|527813543|FG000|Overall Study|Withdrawal by Subject|2|||
146357953|NCT01199055|527813546|FG000|Overall Study|Death|0|||
146357954|NCT01199055|527813547|FG001|Overall Study|Death|1|||
146357955|NCT01199055|527813548|FG002|Overall Study|Death|0|||
146357956|NCT01199055|527813546|FG000|Overall Study|Physician Decision|0|||
146357957|NCT01199055|527813547|FG001|Overall Study|Physician Decision|1|||
146357958|NCT01199055|527813548|FG002|Overall Study|Physician Decision|1|||
146357959|NCT01199055|527813546|FG000|Overall Study|Progressive disease|2|||
146357960|NCT01199055|527813547|FG001|Overall Study|Progressive disease|1|||
146357961|NCT01199055|527813548|FG002|Overall Study|Progressive disease|2|||
146357962|NCT01199055|527813546|FG000|Overall Study|Withdrawal by Subject|0|||
146357963|NCT01199055|527813547|FG001|Overall Study|Withdrawal by Subject|0|||
146357964|NCT01199055|527813548|FG002|Overall Study|Withdrawal by Subject|1|||
146357965|NCT00511342|527813549|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
146357966|NCT00511342|527813550|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
146357967|NCT00511342|527813549|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
146357968|NCT00511342|527813550|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
146357969|NCT00511342|527813549|FG000|Overall Study|Pregnancy|0|||
146357970|NCT00511342|527813550|FG001|Overall Study|Pregnancy|1|||
146357971|NCT00511342|527813549|FG000|Overall Study|Pregnancy wish|0|||
146357972|NCT00511342|527813550|FG001|Overall Study|Pregnancy wish|1|||
146357973|NCT00511342|527813549|FG000|Overall Study|Lost to Follow-up|1|||
146357974|NCT00511342|527813550|FG001|Overall Study|Lost to Follow-up|5|||
146357975|NCT00511342|527813549|FG000|Overall Study|Other Reason|2|||
146357976|NCT00511342|527813550|FG001|Overall Study|Other Reason|2|||
146357977|NCT02432040|527813551|FG000|Overall Study|Lack of Efficacy|3|||
146357978|NCT02432040|527813552|FG001|Overall Study|Lack of Efficacy|0|||
146357979|NCT02432040|527813551|FG000|Overall Study|Lost to Follow-up|4|||
146357980|NCT02432040|527813552|FG001|Overall Study|Lost to Follow-up|5|||
146357981|NCT02432040|527813551|FG000|Overall Study|Physician Decision|1|||
146357982|NCT02432040|527813552|FG001|Overall Study|Physician Decision|1|||
146357983|NCT03198754|527813554|FG000|Overall Study|Withdrawal by Subject|5|||
146357984|NCT03198754|527813555|FG001|Overall Study|Withdrawal by Subject|4|||
146357985|NCT03198754|527813554|FG000|Overall Study|Lost to Follow-up|4|||
146357986|NCT03198754|527813555|FG001|Overall Study|Lost to Follow-up|3|||
146357987|NCT03198754|527813554|FG000|Overall Study|Ineligible|2|||
146357988|NCT03198754|527813555|FG001|Overall Study|Ineligible|1|||
146357989|NCT02108951|527813564|FG000|Overall Study|Lost to Follow-up|1|||
146357990|NCT02108951|527813564|FG000|Overall Study|Patient's/guardian's decision|1|||
146357991|NCT02108951|527813564|FG000|Overall Study|Study Terminated by Sponsor|14|||
146357992|NCT00421343|527813565|FG000|Overall Study|Death|1|||
146357993|NCT00421343|527813565|FG000|Overall Study|Withdrawal by Subject|2|||
146357994|NCT00421343|527813565|FG000|Overall Study|Lost to Follow-up|3|||
146357995|NCT03471767|527813573|FG000|Overall Study|Withdrawal by Subject|3|||
146357996|NCT03471767|527813574|FG001|Overall Study|Withdrawal by Subject|1|||
146357997|NCT03471767|527813573|FG000|Overall Study|Adverse Event|1|||
146357998|NCT03471767|527813574|FG001|Overall Study|Adverse Event|0|||
146357999|NCT03471767|527813573|FG000|Overall Study|Lost to Follow-up|1|||
146358000|NCT03471767|527813574|FG001|Overall Study|Lost to Follow-up|0|||
146358001|NCT03471767|527813573|FG000|Overall Study|PI Withdrawal|1|||
146358002|NCT03471767|527813574|FG001|Overall Study|PI Withdrawal|3|||
146358003|NCT05373706|527813576|FG000|Overall Study|Lost to Follow-up|2|||
146358004|NCT05373706|527813577|FG001|Overall Study|Lost to Follow-up|2|||
146358005|NCT00515008|527813578|FG000|Overall Study|Lost to Follow-up|1|||
146358006|NCT00515008|527813579|FG001|Overall Study|Lost to Follow-up|0|||
146358007|NCT00515008|527813578|FG000|Overall Study|Declined|0|||
146358008|NCT00515008|527813579|FG001|Overall Study|Declined|3|||
146358009|NCT00515008|527813578|FG000|Overall Study|Left the Boston Area|1|||
146358010|NCT00515008|527813579|FG001|Overall Study|Left the Boston Area|1|||
146358011|NCT00515008|527813578|FG000|Overall Study|Scheduling conflict|1|||
146358012|NCT00515008|527813579|FG001|Overall Study|Scheduling conflict|0|||
146358013|NCT03126539|527813587|FG000|Overall Study|Lost to Follow-up|1|||
146358014|NCT03126539|527813588|FG001|Overall Study|Lost to Follow-up|1|||
146358015|NCT03126539|527813589|FG002|Overall Study|Lost to Follow-up|1|||
146358016|NCT03126539|527813590|FG003|Overall Study|Lost to Follow-up|0|||
146358017|NCT03126539|527813591|FG004|Overall Study|Lost to Follow-up|0|||
146358018|NCT02596711|527813594|FG000|Overall Study|Lost to Follow-up|1|||
146169619|NCT04707196|527132880|FG001|Overall Study|Withdrawal by Subject|6|||
146358019|NCT02596711|527813595|FG001|Overall Study|Lost to Follow-up|2|||
146358020|NCT02596711|527813596|FG002|Overall Study|Lost to Follow-up|3|||
146358021|NCT01005732|527813597|FG000|Overall Study|Lost to Follow-up|10|||
146358022|NCT01005732|527813597|FG000|Overall Study|Death|1|||
146358023|NCT00632463|527813598|FG000|Overall Study|Adverse Event|0|||
146358024|NCT00632463|527813599|FG001|Overall Study|Adverse Event|1|||
146358025|NCT00632463|527813600|FG002|Overall Study|Adverse Event|0|||
146358026|NCT01683071|527813607|FG000|Part 1|Lack of Efficacy|1|||
146358027|NCT01683071|527813608|FG001|Part 1|Lack of Efficacy|0|||
146358028|NCT01683071|527813609|FG002|Part 1|Lack of Efficacy|0|||
146358029|NCT01683071|527813610|FG003|Part 1|Lack of Efficacy|3|||
146358030|NCT01683071|527813611|FG004|Part 1|Lack of Efficacy|0|||
146358031|NCT01683071|527813612|FG005|Part 1|Lack of Efficacy|0|||
146358032|NCT01683071|527813607|FG000|Part 1|Withdrawal by Subject|1|||
146358033|NCT01683071|527813608|FG001|Part 1|Withdrawal by Subject|2|||
146358034|NCT01683071|527813609|FG002|Part 1|Withdrawal by Subject|2|||
146358035|NCT01683071|527813610|FG003|Part 1|Withdrawal by Subject|1|||
146358036|NCT01683071|527813611|FG004|Part 1|Withdrawal by Subject|0|||
146358037|NCT01683071|527813612|FG005|Part 1|Withdrawal by Subject|0|||
146358038|NCT01683071|527813607|FG000|Part 1|Surgery Cancelled|1|||
146358039|NCT01683071|527813608|FG001|Part 1|Surgery Cancelled|0|||
146358040|NCT01683071|527813609|FG002|Part 1|Surgery Cancelled|0|||
146358041|NCT01683071|527813610|FG003|Part 1|Surgery Cancelled|0|||
146358042|NCT01683071|527813611|FG004|Part 1|Surgery Cancelled|0|||
146358043|NCT01683071|527813612|FG005|Part 1|Surgery Cancelled|0|||
146358044|NCT01683071|527813607|FG000|Part 1|Did not receive study drug|1|||
146358045|NCT01683071|527813608|FG001|Part 1|Did not receive study drug|0|||
146358046|NCT01683071|527813609|FG002|Part 1|Did not receive study drug|0|||
146358047|NCT01683071|527813610|FG003|Part 1|Did not receive study drug|1|||
146358048|NCT01683071|527813611|FG004|Part 1|Did not receive study drug|0|||
146358049|NCT01683071|527813612|FG005|Part 1|Did not receive study drug|0|||
146358050|NCT01683071|527813607|FG000|Part 1|Early termination; met exclusion criteria|0|||
146358051|NCT01683071|527813608|FG001|Part 1|Early termination; met exclusion criteria|2|||
146358052|NCT01683071|527813609|FG002|Part 1|Early termination; met exclusion criteria|1|||
146358053|NCT01683071|527813610|FG003|Part 1|Early termination; met exclusion criteria|0|||
146358054|NCT01683071|527813611|FG004|Part 1|Early termination; met exclusion criteria|0|||
146358055|NCT01683071|527813612|FG005|Part 1|Early termination; met exclusion criteria|0|||
146358056|NCT01683071|527813607|FG000|Part 2|Lack of Efficacy|0|||
146358057|NCT01683071|527813608|FG001|Part 2|Lack of Efficacy|0|||
146358058|NCT01683071|527813609|FG002|Part 2|Lack of Efficacy|0|||
146358059|NCT01683071|527813610|FG003|Part 2|Lack of Efficacy|0|||
146358060|NCT01683071|527813611|FG004|Part 2|Lack of Efficacy|3|||
146358061|NCT01683071|527813612|FG005|Part 2|Lack of Efficacy|4|||
146358062|NCT01683071|527813607|FG000|Part 2|Lost to Follow-up|0|||
146358063|NCT01683071|527813608|FG001|Part 2|Lost to Follow-up|0|||
146358064|NCT01683071|527813609|FG002|Part 2|Lost to Follow-up|0|||
146358065|NCT01683071|527813610|FG003|Part 2|Lost to Follow-up|0|||
146358066|NCT01683071|527813611|FG004|Part 2|Lost to Follow-up|2|||
146358067|NCT01683071|527813612|FG005|Part 2|Lost to Follow-up|0|||
146358068|NCT01683071|527813607|FG000|Part 2|Withdrawal by Subject|0|||
146358069|NCT01683071|527813608|FG001|Part 2|Withdrawal by Subject|0|||
146358070|NCT01683071|527813609|FG002|Part 2|Withdrawal by Subject|0|||
146358071|NCT01683071|527813610|FG003|Part 2|Withdrawal by Subject|0|||
146358072|NCT01683071|527813611|FG004|Part 2|Withdrawal by Subject|3|||
146358073|NCT01683071|527813612|FG005|Part 2|Withdrawal by Subject|3|||
146358074|NCT01683071|527813607|FG000|Part 2|Surgery cancelled|0|||
146358075|NCT01683071|527813608|FG001|Part 2|Surgery cancelled|0|||
146358076|NCT01683071|527813609|FG002|Part 2|Surgery cancelled|0|||
146358077|NCT01683071|527813610|FG003|Part 2|Surgery cancelled|0|||
146358078|NCT01683071|527813611|FG004|Part 2|Surgery cancelled|4|||
146358079|NCT01683071|527813612|FG005|Part 2|Surgery cancelled|2|||
146358080|NCT01683071|527813607|FG000|Part 2|Did not receive study drug|0|||
146358081|NCT01683071|527813608|FG001|Part 2|Did not receive study drug|0|||
146358082|NCT01683071|527813609|FG002|Part 2|Did not receive study drug|0|||
146358083|NCT01683071|527813610|FG003|Part 2|Did not receive study drug|0|||
146358084|NCT01683071|527813611|FG004|Part 2|Did not receive study drug|2|||
146358085|NCT01683071|527813612|FG005|Part 2|Did not receive study drug|1|||
146358086|NCT01683071|527813607|FG000|Part 2|Met exclusion criterion|0|||
146358087|NCT01683071|527813608|FG001|Part 2|Met exclusion criterion|0|||
146358088|NCT01683071|527813609|FG002|Part 2|Met exclusion criterion|0|||
146358089|NCT01683071|527813610|FG003|Part 2|Met exclusion criterion|0|||
146358090|NCT01683071|527813611|FG004|Part 2|Met exclusion criterion|1|||
146358091|NCT01683071|527813612|FG005|Part 2|Met exclusion criterion|1|||
146358092|NCT01683071|527813607|FG000|Part 2|Protocol deviation|0|||
146358093|NCT01683071|527813608|FG001|Part 2|Protocol deviation|0|||
146358094|NCT01683071|527813609|FG002|Part 2|Protocol deviation|0|||
146358095|NCT01683071|527813610|FG003|Part 2|Protocol deviation|0|||
146358096|NCT01683071|527813611|FG004|Part 2|Protocol deviation|1|||
146358097|NCT01683071|527813612|FG005|Part 2|Protocol deviation|2|||
146358098|NCT01683071|527813607|FG000|Part 2|Withdrawal by investigator decision|0|||
146358099|NCT01683071|527813608|FG001|Part 2|Withdrawal by investigator decision|0|||
146358100|NCT01683071|527813609|FG002|Part 2|Withdrawal by investigator decision|0|||
146358101|NCT01683071|527813610|FG003|Part 2|Withdrawal by investigator decision|0|||
146358102|NCT01683071|527813611|FG004|Part 2|Withdrawal by investigator decision|1|||
146358103|NCT01683071|527813612|FG005|Part 2|Withdrawal by investigator decision|2|||
146358104|NCT01454401|527813613|FG000|Overall Study|Death|1|||
146358105|NCT01454401|527813613|FG000|Overall Study|hospitalised|1|||
146358106|NCT01454401|527813613|FG000|Overall Study|osteomyelitis|2|||
146358107|NCT01454401|527813613|FG000|Overall Study|non-adherence|1|||
146358108|NCT00605722|527815093|FG000|Overall Study|Adverse Event|6|||
146358109|NCT00605722|527815093|FG000|Overall Study|Insufficient therapeutic response|44|||
146358110|NCT00605722|527815093|FG000|Overall Study|Failure to return|1|||
146358111|NCT00356863|527815099|FG000|Overall Study|Death|16|||
146358112|NCT00356863|527815100|FG001|Overall Study|Death|32|||
146358113|NCT00356863|527815099|FG000|Overall Study|Lost to Follow-up|76|||
146358114|NCT00356863|527815100|FG001|Overall Study|Lost to Follow-up|43|||
146358115|NCT00333619|527815103|FG000|Overall Study|Death|12|||
146358116|NCT00333619|527815104|FG001|Overall Study|Death|6|||
146358117|NCT00333619|527815103|FG000|Overall Study|Withdrawal by Subject|6|||
146358118|NCT00333619|527815104|FG001|Overall Study|Withdrawal by Subject|1|||
146358119|NCT00333619|527815103|FG000|Overall Study|Lost to Follow-up|3|||
146358120|NCT00333619|527815104|FG001|Overall Study|Lost to Follow-up|3|||
146358121|NCT02871401|527815113|FG000|Overall Study|Adverse Event|1|||
146358122|NCT02871401|527815114|FG001|Overall Study|Adverse Event|0|||
146358123|NCT01120379|527815115|FG000|One Year Timepoint|Withdrawal by Subject|41|||
146358124|NCT01120379|527815115|FG000|One Year Timepoint|Lost to Follow-up|115|||
146358125|NCT01120379|527815115|FG000|One Year Timepoint|Death|108|||
146358126|NCT01120379|527815115|FG000|One Year Timepoint|Physician Decision|9|||
146358127|NCT01120379|527815115|FG000|One Year Timepoint|Any other reason for early termination|5|||
146358128|NCT01120379|527815115|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
146358129|NCT01120379|527815115|FG000|Two Year Timepoint|Lost to Follow-up|87|||
146358130|NCT01120379|527815115|FG000|Two Year Timepoint|Death|123|||
146358131|NCT01120379|527815115|FG000|Two Year Timepoint|Physician Decision|12|||
146358132|NCT01120379|527815115|FG000|Two Year Timepoint|Any other reason for early termination|4|||
146358133|NCT01120379|527815115|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
146358134|NCT01120379|527815115|FG000|Three Year Timepoint|Lost to Follow-up|43|||
146358135|NCT01120379|527815115|FG000|Three Year Timepoint|Death|120|||
146358136|NCT01120379|527815115|FG000|Three Year Timepoint|Physician Decision|9|||
146358137|NCT01120379|527815115|FG000|Three Year Timepoint|Any other reason for early termination|17|||
146358138|NCT01120379|527815115|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
146358139|NCT01120379|527815115|FG000|Four Year Timepoint|Lost to Follow-up|10|||
146358140|NCT01120379|527815115|FG000|Four Year Timepoint|Death|131|||
146358141|NCT01120379|527815115|FG000|Four Year Timepoint|Physician Decision|5|||
146358142|NCT01120379|527815115|FG000|Four Year Timepoint|Any other reason for early termination|217|||
146358143|NCT04031404|527815116|FG000|Baseline|Lost to Follow-up|0|||
146358144|NCT04031404|527815117|FG001|Baseline|Lost to Follow-up|1|||
146358145|NCT04031404|527815116|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
146358146|NCT04031404|527815117|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
146358147|NCT04031404|527815116|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
146358148|NCT04031404|527815117|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
146358149|NCT04031404|527815116|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
146358150|NCT04031404|527815117|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
146358151|NCT04031404|527815116|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
146358152|NCT04031404|527815117|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
146358153|NCT00568958|527815120|FG000|Allocation|Withdrawal by Subject|7|||
146358154|NCT00568958|527815121|FG001|Allocation|Withdrawal by Subject|3|||
146358155|NCT00568958|527815120|FG000|Allocation|Physician Decision|2|||
146358156|NCT00568958|527815121|FG001|Allocation|Physician Decision|0|||
146358157|NCT00568958|527815120|FG000|Follow-Up|Withdrawal by Subject|6|||
146358158|NCT00568958|527815121|FG001|Follow-Up|Withdrawal by Subject|6|||
146358159|NCT00568958|527815120|FG000|Follow-Up|Physician Decision|1|||
146358160|NCT00568958|527815121|FG001|Follow-Up|Physician Decision|1|||
146358161|NCT00568958|527815120|FG000|Follow-Up|Family Emergency|1|||
146358162|NCT00568958|527815121|FG001|Follow-Up|Family Emergency|0|||
146358163|NCT00568958|527815120|FG000|Follow-Up|Adverse Event|1|||
146358164|NCT00568958|527815121|FG001|Follow-Up|Adverse Event|0|||
146358165|NCT03583372|527815122|FG000|Overall Study|Withdrawal by Subject|6|||
146358166|NCT03583372|527815123|FG001|Overall Study|Withdrawal by Subject|11|||
146358167|NCT03583372|527815124|FG002|Overall Study|Withdrawal by Subject|7|||
146358168|NCT03583372|527815125|FG003|Overall Study|Withdrawal by Subject|8|||
146358169|NCT03583372|527815122|FG000|Overall Study|Lost to Follow-up|4|||
146358170|NCT03583372|527815123|FG001|Overall Study|Lost to Follow-up|6|||
146358171|NCT03583372|527815124|FG002|Overall Study|Lost to Follow-up|3|||
146358172|NCT03583372|527815125|FG003|Overall Study|Lost to Follow-up|2|||
146358173|NCT03583372|527815122|FG000|Overall Study|Adverse Event|1|||
146358174|NCT03583372|527815123|FG001|Overall Study|Adverse Event|3|||
146358175|NCT03583372|527815124|FG002|Overall Study|Adverse Event|4|||
146358176|NCT03583372|527815125|FG003|Overall Study|Adverse Event|4|||
146358177|NCT03583372|527815122|FG000|Overall Study|Physician Decision|0|||
146358178|NCT03583372|527815123|FG001|Overall Study|Physician Decision|1|||
146358179|NCT03583372|527815124|FG002|Overall Study|Physician Decision|1|||
146358180|NCT03583372|527815125|FG003|Overall Study|Physician Decision|1|||
146358181|NCT03583372|527815122|FG000|Overall Study|Lack of Efficacy|0|||
146358182|NCT03583372|527815123|FG001|Overall Study|Lack of Efficacy|1|||
146358183|NCT03583372|527815124|FG002|Overall Study|Lack of Efficacy|0|||
146358184|NCT03583372|527815125|FG003|Overall Study|Lack of Efficacy|1|||
146358185|NCT03583372|527815122|FG000|Overall Study|Death|1|||
146358186|NCT03583372|527815123|FG001|Overall Study|Death|0|||
146358187|NCT03583372|527815124|FG002|Overall Study|Death|0|||
146358188|NCT03583372|527815125|FG003|Overall Study|Death|0|||
146358189|NCT03583372|527815122|FG000|Overall Study|Protocol Violation|0|||
146358190|NCT03583372|527815123|FG001|Overall Study|Protocol Violation|1|||
146358191|NCT03583372|527815124|FG002|Overall Study|Protocol Violation|0|||
146358192|NCT03583372|527815125|FG003|Overall Study|Protocol Violation|0|||
146358193|NCT03583372|527815122|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
146358194|NCT03583372|527815123|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
146358195|NCT03583372|527815124|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
146358196|NCT03583372|527815125|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
146358197|NCT03583372|527815122|FG000|Overall Study|Did Not Receive Study Drug|0|||
146358198|NCT03583372|527815123|FG001|Overall Study|Did Not Receive Study Drug|1|||
146358199|NCT03583372|527815124|FG002|Overall Study|Did Not Receive Study Drug|0|||
146169620|NCT04707196|527132879|FG000|Overall Study|Lost to Follow-up|1|||
146169621|NCT04707196|527132880|FG001|Overall Study|Lost to Follow-up|0|||
146169622|NCT04707196|527132879|FG000|Overall Study|Protocol Violation|4|||
146169623|NCT04707196|527132880|FG001|Overall Study|Protocol Violation|1|||
146169624|NCT04707196|527132879|FG000|Overall Study|Adverse Event|2|||
146169625|NCT04707196|527132880|FG001|Overall Study|Adverse Event|2|||
146169626|NCT04707196|527132879|FG000|Overall Study|Death|3|||
146169627|NCT04707196|527132880|FG001|Overall Study|Death|1|||
146169628|NCT04707196|527132879|FG000|Overall Study|Non-compliance with study drug|1|||
146169629|NCT04707196|527132880|FG001|Overall Study|Non-compliance with study drug|0|||
146358200|NCT03583372|527815125|FG003|Overall Study|Did Not Receive Study Drug|0|||
146358201|NCT03583372|527815122|FG000|Overall Study|Captured as Other in the Database|1|||
146358202|NCT03583372|527815123|FG001|Overall Study|Captured as Other in the Database|2|||
146358203|NCT03583372|527815124|FG002|Overall Study|Captured as Other in the Database|4|||
146358204|NCT03583372|527815125|FG003|Overall Study|Captured as Other in the Database|1|||
146358205|NCT02796391|527815126|FG000|Overall Study|Lost to Follow-up|2|||
146358206|NCT02796391|527815127|FG001|Overall Study|Lost to Follow-up|2|||
146358207|NCT02796391|527815128|FG002|Overall Study|Lost to Follow-up|13|||
146358208|NCT02796391|527815129|FG003|Overall Study|Lost to Follow-up|8|||
146358209|NCT02796391|527815130|FG004|Overall Study|Lost to Follow-up|14|||
146358210|NCT02796391|527815131|FG005|Overall Study|Lost to Follow-up|13|||
146358211|NCT02796391|527815126|FG000|Overall Study|COVID|0|||
146358212|NCT02796391|527815127|FG001|Overall Study|COVID|0|||
146358213|NCT02796391|527815128|FG002|Overall Study|COVID|5|||
146358214|NCT02796391|527815129|FG003|Overall Study|COVID|5|||
146358215|NCT02796391|527815130|FG004|Overall Study|COVID|2|||
146358216|NCT02796391|527815131|FG005|Overall Study|COVID|4|||
146358217|NCT02796391|527815126|FG000|Overall Study|Participant did not like study cigarettes|0|||
146358218|NCT02796391|527815127|FG001|Overall Study|Participant did not like study cigarettes|0|||
146358219|NCT02796391|527815128|FG002|Overall Study|Participant did not like study cigarettes|3|||
146358220|NCT02796391|527815129|FG003|Overall Study|Participant did not like study cigarettes|0|||
146358221|NCT02796391|527815130|FG004|Overall Study|Participant did not like study cigarettes|0|||
146358222|NCT02796391|527815131|FG005|Overall Study|Participant did not like study cigarettes|0|||
146358223|NCT02796391|527815126|FG000|Overall Study|Withdrawal by Subject|1|||
146358224|NCT02796391|527815127|FG001|Overall Study|Withdrawal by Subject|1|||
146358225|NCT02796391|527815128|FG002|Overall Study|Withdrawal by Subject|4|||
146358226|NCT02796391|527815129|FG003|Overall Study|Withdrawal by Subject|3|||
146358227|NCT02796391|527815130|FG004|Overall Study|Withdrawal by Subject|4|||
146358228|NCT02796391|527815131|FG005|Overall Study|Withdrawal by Subject|3|||
146358229|NCT02796391|527815126|FG000|Overall Study|Adverse Event|0|||
146358230|NCT02796391|527815127|FG001|Overall Study|Adverse Event|0|||
146358231|NCT02796391|527815128|FG002|Overall Study|Adverse Event|0|||
146358232|NCT02796391|527815129|FG003|Overall Study|Adverse Event|1|||
146358233|NCT02796391|527815130|FG004|Overall Study|Adverse Event|0|||
146358234|NCT02796391|527815131|FG005|Overall Study|Adverse Event|0|||
146358235|NCT02796391|527815126|FG000|Overall Study|Protocol Violation|0|||
146358236|NCT02796391|527815127|FG001|Overall Study|Protocol Violation|0|||
146358237|NCT02796391|527815128|FG002|Overall Study|Protocol Violation|0|||
146358238|NCT02796391|527815129|FG003|Overall Study|Protocol Violation|1|||
146358239|NCT02796391|527815130|FG004|Overall Study|Protocol Violation|0|||
146358240|NCT02796391|527815131|FG005|Overall Study|Protocol Violation|0|||
146358241|NCT00377611|527815132|FG000|Overall Study|Adverse Event|2|||
146358242|NCT00377611|527815133|FG001|Overall Study|Adverse Event|9|||
146358243|NCT00377611|527815132|FG000|Overall Study|Protocol Violation|2|||
146358244|NCT00377611|527815133|FG001|Overall Study|Protocol Violation|0|||
146358245|NCT00377611|527815132|FG000|Overall Study|Withdrawal by Subject|0|||
146358246|NCT00377611|527815133|FG001|Overall Study|Withdrawal by Subject|5|||
146358247|NCT00377611|527815132|FG000|Overall Study|Lost to Follow-up|18|||
146358248|NCT00377611|527815133|FG001|Overall Study|Lost to Follow-up|16|||
146358249|NCT00377611|527815132|FG000|Overall Study|Other|0|||
146358250|NCT00377611|527815133|FG001|Overall Study|Other|3|||
146358251|NCT00831441|527815134|FG000|Randomized|Death|82|||
146358252|NCT00831441|527815135|FG001|Randomized|Death|81|||
146358253|NCT00831441|527815134|FG000|Randomized|Adverse Event|248|||
146358254|NCT00831441|527815135|FG001|Randomized|Adverse Event|321|||
146358255|NCT00831441|527815134|FG000|Randomized|Emergency procedure|2|||
146358256|NCT00831441|527815135|FG001|Randomized|Emergency procedure|2|||
146358257|NCT00831441|527815134|FG000|Randomized|Elective procedure|26|||
146358258|NCT00831441|527815135|FG001|Randomized|Elective procedure|25|||
146358259|NCT00831441|527815134|FG000|Randomized|Physician Decision|26|||
146358260|NCT00831441|527815135|FG001|Randomized|Physician Decision|35|||
146358261|NCT00831441|527815134|FG000|Randomized|No longer met criteria|13|||
146169630|NCT04707196|527132879|FG000|Overall Study|Progressive disease|9|||
146358262|NCT00831441|527815135|FG001|Randomized|No longer met criteria|19|||
146358263|NCT00831441|527815134|FG000|Randomized|Withdrawal by Subject|178|||
146358264|NCT00831441|527815135|FG001|Randomized|Withdrawal by Subject|212|||
146358265|NCT00831441|527815134|FG000|Randomized|Lost to Follow-up|26|||
146358266|NCT00831441|527815135|FG001|Randomized|Lost to Follow-up|35|||
146358267|NCT00831441|527815134|FG000|Randomized|Administrative reason by sponsor|2780|||
146358268|NCT00831441|527815135|FG001|Randomized|Administrative reason by sponsor|2671|||
146358269|NCT00831441|527815134|FG000|Randomized|poor/non-compliance|30|||
146358270|NCT00831441|527815135|FG001|Randomized|poor/non-compliance|38|||
146358271|NCT00831441|527815134|FG000|Randomized|non-specified|276|||
146358272|NCT00831441|527815135|FG001|Randomized|non-specified|266|||
146358273|NCT00831441|527815134|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
146358274|NCT00831441|527815135|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
146358275|NCT00831441|527815134|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
146358276|NCT00831441|527815135|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
146358277|NCT00831441|527815134|FG000|Follow Up (30 Days)|Death|63|||
146358278|NCT00831441|527815135|FG001|Follow Up (30 Days)|Death|86|||
146358279|NCT00831441|527815134|FG000|Follow Up (30 Days)|non-specified|16|||
146358280|NCT00831441|527815135|FG001|Follow Up (30 Days)|non-specified|26|||
146358281|NCT00831441|527815134|FG000|Follow Up (30 Days)|missing end of study status|0|||
146358282|NCT00831441|527815135|FG001|Follow Up (30 Days)|missing end of study status|1|||
146358283|NCT05674344|527815136|FG000|Overall Study|Screen Fail|21|||
146358284|NCT05674344|527815136|FG000|Overall Study|Incomplete study procedures|3|||
146358285|NCT04831515|527815137|FG000|First Intervention|Adverse Event|0|||
146358286|NCT04831515|527815138|FG001|First Intervention|Adverse Event|1|||
146358287|NCT01640925|527815139|FG000|Overall Study|Withdrawal by Subject|1|||
146358288|NCT01640925|527815140|FG001|Overall Study|Withdrawal by Subject|0|||
146358289|NCT01640925|527815139|FG000|Overall Study|Previously enrolled in this trial|13|||
146358290|NCT01640925|527815140|FG001|Overall Study|Previously enrolled in this trial|11|||
146358291|NCT02156492|527815141|FG000|Period 1|No Reason Given|0|||
146358292|NCT02156492|527815142|FG001|Period 1|No Reason Given|1|||
146358293|NCT02156492|527815143|FG002|Period 1|No Reason Given|0|||
146358294|NCT02156492|527815141|FG000|Period 3|Adverse Event|0|||
146358295|NCT02156492|527815142|FG001|Period 3|Adverse Event|1|||
146358296|NCT02156492|527815143|FG002|Period 3|Adverse Event|0|||
146358297|NCT00485589|527815159|FG000|Overall Study|Death|2|||
146358298|NCT00485589|527815160|FG001|Overall Study|Death|2|||
146358299|NCT00485589|527815161|FG002|Overall Study|Death|0|||
146358300|NCT00485589|527815159|FG000|Overall Study|Failure to return|6|||
146358301|NCT00485589|527815160|FG001|Overall Study|Failure to return|5|||
146358302|NCT00485589|527815161|FG002|Overall Study|Failure to return|1|||
146358303|NCT00485589|527815159|FG000|Overall Study|Protocol Violation|1|||
146358304|NCT00485589|527815160|FG001|Overall Study|Protocol Violation|0|||
146358305|NCT00485589|527815161|FG002|Overall Study|Protocol Violation|0|||
146358306|NCT00485589|527815159|FG000|Overall Study|Violation of selection criteria at entry|0|||
146358307|NCT00485589|527815160|FG001|Overall Study|Violation of selection criteria at entry|3|||
146358308|NCT00485589|527815161|FG002|Overall Study|Violation of selection criteria at entry|1|||
146358309|NCT00485589|527815159|FG000|Overall Study|Administrative/Other|1|||
146358310|NCT00485589|527815160|FG001|Overall Study|Administrative/Other|2|||
146358311|NCT00485589|527815161|FG002|Overall Study|Administrative/Other|1|||
146358312|NCT00485589|527815159|FG000|Overall Study|Insufficient therapeutic response|10|||
146358313|NCT00485589|527815160|FG001|Overall Study|Insufficient therapeutic response|3|||
146358314|NCT00485589|527815161|FG002|Overall Study|Insufficient therapeutic response|1|||
146358315|NCT00485589|527815159|FG000|Overall Study|Refused treatment/did not cooperate|1|||
146358316|NCT00485589|527815160|FG001|Overall Study|Refused treatment/did not cooperate|0|||
146358317|NCT00485589|527815161|FG002|Overall Study|Refused treatment/did not cooperate|2|||
146358318|NCT00485589|527815159|FG000|Overall Study|Withdrawal by Subject|3|||
146358319|NCT00485589|527815160|FG001|Overall Study|Withdrawal by Subject|2|||
146358320|NCT00485589|527815161|FG002|Overall Study|Withdrawal by Subject|2|||
146358321|NCT00485589|527815159|FG000|Overall Study|Adverse Event|3|||
146358322|NCT00485589|527815160|FG001|Overall Study|Adverse Event|3|||
146358323|NCT00485589|527815161|FG002|Overall Study|Adverse Event|10|||
146358324|NCT04348656|527815162|FG000|Overall Study|Withdrawal by Subject|2|||
146358325|NCT04348656|527815163|FG001|Overall Study|Withdrawal by Subject|0|||
146358326|NCT04348656|527815162|FG000|Overall Study|Lost to Follow-up|11|||
146358327|NCT04348656|527815163|FG001|Overall Study|Lost to Follow-up|6|||
146358328|NCT01944969|527815164|FG000|Overall Study|Adverse Event|1|||
146358329|NCT01944969|527815164|FG000|Overall Study|Lack of Efficacy|1|||
146358330|NCT01944969|527815164|FG000|Overall Study|Non-compliance with IMP|1|||
146358331|NCT01944969|527815164|FG000|Overall Study|Administrative or other reasons|23|||
146358332|NCT03072719|527815165|FG000|Overall Study|Adverse Event|1|||
146358333|NCT03072719|527815166|FG001|Overall Study|Adverse Event|1|||
146358334|NCT01104584|527815167|FG000|Overall Study|Study drug never administered|21|||
146358335|NCT01104584|527815167|FG000|Overall Study|Study prematurely discontinued|2|||
146358336|NCT04017442|527815168|FG000|Overall Study|Withdrawal by Subject|0|||
146358337|NCT04017442|527815169|FG001|Overall Study|Withdrawal by Subject|3|||
146358338|NCT04017442|527815168|FG000|Overall Study|Lost to Follow-up|21|||
146358339|NCT04017442|527815169|FG001|Overall Study|Lost to Follow-up|19|||
146358340|NCT02586233|527815170|FG000|Overall Study|Randomized but did not receive treatment|0|||
146358341|NCT02586233|527815171|FG001|Overall Study|Randomized but did not receive treatment|1|||
146358342|NCT02586233|527815172|FG002|Overall Study|Randomized but did not receive treatment|0|||
146358343|NCT02586233|527815173|FG003|Overall Study|Randomized but did not receive treatment|0|||
146358344|NCT02586233|527815174|FG004|Overall Study|Randomized but did not receive treatment|0|||
146358345|NCT02586233|527815175|FG005|Overall Study|Randomized but did not receive treatment|2|||
146358346|NCT02586233|527815176|FG006|Overall Study|Randomized but did not receive treatment|2|||
146358347|NCT02586233|527815170|FG000|Overall Study|Death|0|||
146358348|NCT02586233|527815171|FG001|Overall Study|Death|1|||
146358349|NCT02586233|527815172|FG002|Overall Study|Death|0|||
146358350|NCT02586233|527815173|FG003|Overall Study|Death|0|||
146358351|NCT02586233|527815174|FG004|Overall Study|Death|2|||
146358352|NCT02586233|527815175|FG005|Overall Study|Death|0|||
146358353|NCT02586233|527815176|FG006|Overall Study|Death|0|||
146358354|NCT03421964|527815179|FG000|Overall Study|Lost to Follow-up|11|||
146358355|NCT03421964|527815180|FG001|Overall Study|Lost to Follow-up|21|||
146358356|NCT03421964|527815179|FG000|Overall Study|Withdrawal by Subject|9|||
146358357|NCT03421964|527815180|FG001|Overall Study|Withdrawal by Subject|3|||
146358358|NCT03421964|527815179|FG000|Overall Study|Incarcerated|1|||
146358359|NCT03421964|527815180|FG001|Overall Study|Incarcerated|0|||
146358360|NCT03421964|527815179|FG000|Overall Study|Inpt Treatment Facility|1|||
146358361|NCT03421964|527815180|FG001|Overall Study|Inpt Treatment Facility|1|||
146358362|NCT03421964|527815179|FG000|Overall Study|Virtual Platform Issues|1|||
146358363|NCT03421964|527815180|FG001|Overall Study|Virtual Platform Issues|1|||
146358364|NCT02938585|527815181|FG000|Overall Study|Withdrawal by parent or guardian|0|||
146358365|NCT02938585|527815182|FG001|Overall Study|Withdrawal by parent or guardian|1|||
146358366|NCT02938585|527815183|FG002|Overall Study|Withdrawal by parent or guardian|0|||
146358367|NCT02938585|527815184|FG003|Overall Study|Withdrawal by parent or guardian|0|||
146358368|NCT02938585|527815181|FG000|Overall Study|Withdrawal by Subject|0|||
146358369|NCT02938585|527815182|FG001|Overall Study|Withdrawal by Subject|0|||
146358370|NCT02938585|527815183|FG002|Overall Study|Withdrawal by Subject|0|||
146358371|NCT02938585|527815184|FG003|Overall Study|Withdrawal by Subject|5|||
146358372|NCT02106455|527815185|FG000|Overall Study|Case Report Form Uncollected|6|||
146358373|NCT02106455|527815185|FG000|Overall Study|Protocol Deviation|2|||
146358374|NCT01260467|527815186|FG000|Overall Study|Withdrawal by Subject|2|||
146358375|NCT00436566|527815189|FG000|Overall Study|Withdrawal by Subject|2|||
146358376|NCT00436566|527815189|FG000|Overall Study|Protocol Violation|1|||
146358377|NCT03888391|527815192|FG000|Overall Study|Lost to Follow-up|15|||
146358378|NCT01954251|527815193|FG000|Overall Study|Adverse Event|5|||
146358379|NCT01954251|527815194|FG001|Overall Study|Adverse Event|7|||
146358380|NCT01954251|527815193|FG000|Overall Study|Lost to Follow-up|6|||
146358381|NCT01954251|527815194|FG001|Overall Study|Lost to Follow-up|6|||
146358382|NCT01954251|527815193|FG000|Overall Study|Withdrawal by Subject|2|||
146358383|NCT01954251|527815194|FG001|Overall Study|Withdrawal by Subject|6|||
146358384|NCT00502320|527815195|FG000|Overall Study|Lost to Follow-up|1|||
146358385|NCT00502320|527815196|FG001|Overall Study|Lost to Follow-up|1|||
146358386|NCT00502320|527815195|FG000|Overall Study|Withdrew Consent|1|||
146358387|NCT00502320|527815196|FG001|Overall Study|Withdrew Consent|0|||
146358388|NCT00502320|527815195|FG000|Overall Study|No longer met criteria|1|||
146358389|NCT00502320|527815196|FG001|Overall Study|No longer met criteria|0|||
146358390|NCT00502320|527815195|FG000|Overall Study|Screen Failure|0|||
146358391|NCT00502320|527815196|FG001|Overall Study|Screen Failure|1|||
146358392|NCT00502320|527815195|FG000|Overall Study|Adverse Event|3|||
146358393|NCT00502320|527815196|FG001|Overall Study|Adverse Event|5|||
146358394|NCT00678587|527815208|FG000|Overall Study|Adverse Event|3|||
146358395|NCT00678587|527815209|FG001|Overall Study|Adverse Event|3|||
146358396|NCT00678587|527815208|FG000|Overall Study|Lack of Efficacy|1|||
146358397|NCT00678587|527815209|FG001|Overall Study|Lack of Efficacy|0|||
146358398|NCT00678587|527815208|FG000|Overall Study|Protocol Violation|2|||
146358399|NCT00678587|527815209|FG001|Overall Study|Protocol Violation|1|||
146358400|NCT00678587|527815208|FG000|Overall Study|Study Closed/Terminated|1|||
146358401|NCT00678587|527815209|FG001|Overall Study|Study Closed/Terminated|0|||
146358402|NCT00678587|527815208|FG000|Overall Study|Lost to Follow-up|3|||
146358403|NCT00678587|527815209|FG001|Overall Study|Lost to Follow-up|5|||
146358404|NCT00678587|527815208|FG000|Overall Study|Investigator Discretion|2|||
146358405|NCT00678587|527815209|FG001|Overall Study|Investigator Discretion|6|||
146358406|NCT00678587|527815208|FG000|Overall Study|Withdrew Consent|8|||
146358407|NCT00678587|527815209|FG001|Overall Study|Withdrew Consent|3|||
146358408|NCT00077610|527815210|FG000|Overall Study|Adverse Event|9|||
146358409|NCT00077610|527815211|FG001|Overall Study|Adverse Event|7|||
146358410|NCT00077610|527815212|FG002|Overall Study|Adverse Event|1|||
146358411|NCT00077610|527815210|FG000|Overall Study|Lost to Follow-up|0|||
146358412|NCT00077610|527815211|FG001|Overall Study|Lost to Follow-up|1|||
146358413|NCT00077610|527815212|FG002|Overall Study|Lost to Follow-up|2|||
146358414|NCT00077610|527815210|FG000|Overall Study|Withdrawal by Subject|4|||
146358415|NCT00077610|527815211|FG001|Overall Study|Withdrawal by Subject|10|||
146358416|NCT00077610|527815212|FG002|Overall Study|Withdrawal by Subject|6|||
146358417|NCT00077610|527815210|FG000|Overall Study|Death|17|||
146358418|NCT00077610|527815211|FG001|Overall Study|Death|13|||
146358419|NCT00077610|527815212|FG002|Overall Study|Death|13|||
146358420|NCT00077610|527815210|FG000|Overall Study|Renal transplant|12|||
146358421|NCT00077610|527815211|FG001|Overall Study|Renal transplant|15|||
146358422|NCT00077610|527815212|FG002|Overall Study|Renal transplant|11|||
146358423|NCT00077610|527815210|FG000|Overall Study|Withdrew from dialysis care|5|||
146358424|NCT00077610|527815211|FG001|Overall Study|Withdrew from dialysis care|0|||
146358425|NCT00077610|527815212|FG002|Overall Study|Withdrew from dialysis care|3|||
146358426|NCT00077610|527815210|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146358427|NCT00077610|527815211|FG001|Overall Study|Insufficient Therapeutic Response|0|||
146358428|NCT00077610|527815212|FG002|Overall Study|Insufficient Therapeutic Response|0|||
146358429|NCT00077610|527815210|FG000|Overall Study|Multiple blood transfusions|0|||
146358430|NCT00077610|527815211|FG001|Overall Study|Multiple blood transfusions|0|||
146358431|NCT00077610|527815212|FG002|Overall Study|Multiple blood transfusions|1|||
146358432|NCT00077610|527815210|FG000|Overall Study|Principal Investigator's decision|1|||
146358433|NCT00077610|527815211|FG001|Overall Study|Principal Investigator's decision|0|||
146358434|NCT00077610|527815212|FG002|Overall Study|Principal Investigator's decision|1|||
146358435|NCT00077610|527815210|FG000|Overall Study|Worsening of health condition|1|||
146358436|NCT00077610|527815211|FG001|Overall Study|Worsening of health condition|1|||
146358437|NCT00077610|527815212|FG002|Overall Study|Worsening of health condition|0|||
146358438|NCT00077610|527815210|FG000|Overall Study|Given Epogen in hospital|1|||
146358439|NCT00077610|527815211|FG001|Overall Study|Given Epogen in hospital|0|||
146358440|NCT00077610|527815212|FG002|Overall Study|Given Epogen in hospital|0|||
146358441|NCT00077610|527815210|FG000|Overall Study|Transferred to other unit|0|||
146358442|NCT00077610|527815211|FG001|Overall Study|Transferred to other unit|0|||
146358443|NCT00077610|527815212|FG002|Overall Study|Transferred to other unit|1|||
146358444|NCT00077610|527815210|FG000|Overall Study|Transferred to nursing home|0|||
146358445|NCT00077610|527815211|FG001|Overall Study|Transferred to nursing home|0|||
146358446|NCT00077610|527815212|FG002|Overall Study|Transferred to nursing home|1|||
146358447|NCT00077610|527815210|FG000|Overall Study|Transfer to satellite unit|1|||
146358448|NCT00077610|527815211|FG001|Overall Study|Transfer to satellite unit|0|||
146358449|NCT00077610|527815212|FG002|Overall Study|Transfer to satellite unit|0|||
146358450|NCT00077610|527815210|FG000|Overall Study|Transfer to other center for surgery|1|||
146358451|NCT00077610|527815211|FG001|Overall Study|Transfer to other center for surgery|0|||
146358452|NCT00077610|527815212|FG002|Overall Study|Transfer to other center for surgery|0|||
146358453|NCT00077610|527815210|FG000|Overall Study|Change in dialysis modality|1|||
146358454|NCT00077610|527815211|FG001|Overall Study|Change in dialysis modality|0|||
146358455|NCT00077610|527815212|FG002|Overall Study|Change in dialysis modality|0|||
146358456|NCT00077610|527815210|FG000|Overall Study|Relocation|0|||
146358457|NCT00077610|527815211|FG001|Overall Study|Relocation|8|||
146358458|NCT00077610|527815212|FG002|Overall Study|Relocation|5|||
146358459|NCT00077610|527815210|FG000|Overall Study|Financial issues|0|||
146358460|NCT00077610|527815211|FG001|Overall Study|Financial issues|1|||
146358461|NCT00077610|527815212|FG002|Overall Study|Financial issues|0|||
146358462|NCT00077610|527815210|FG000|Overall Study|Sponsors decision to withdraw|0|||
146358463|NCT00077610|527815211|FG001|Overall Study|Sponsors decision to withdraw|0|||
146358464|NCT00077610|527815212|FG002|Overall Study|Sponsors decision to withdraw|1|||
146358465|NCT00305253|527815215|FG000|Overall Study|Withdrawal by Subject|0|||
146358466|NCT00305253|527815216|FG001|Overall Study|Withdrawal by Subject|1|||
146358467|NCT01019486|527815218|FG000|Overall Study|Withdrawal by Subject|1|||
146358468|NCT01019486|527815219|FG001|Overall Study|Withdrawal by Subject|1|||
146358469|NCT01019486|527815220|FG002|Overall Study|Withdrawal by Subject|1|||
146358470|NCT03442829|527815221|FG000|Overall Study|Scheduling clash|3|||
146358471|NCT03442829|527815222|FG001|Overall Study|Scheduling clash|1|||
146358472|NCT03442829|527815221|FG000|Overall Study|Illness unrelated to study|1|||
146358473|NCT03442829|527815222|FG001|Overall Study|Illness unrelated to study|1|||
146358474|NCT01996748|527815223|FG000|Overall Study|Personal reason|1|||
146358475|NCT01996748|527815224|FG001|Overall Study|Personal reason|0|||
146358476|NCT01996748|527815223|FG000|Overall Study|Physician Decision|2|||
146358477|NCT01996748|527815224|FG001|Overall Study|Physician Decision|0|||
146358478|NCT01996748|527815223|FG000|Overall Study|Adverse Event|1|||
146358479|NCT01996748|527815224|FG001|Overall Study|Adverse Event|4|||
146358480|NCT01996748|527815223|FG000|Overall Study|Withdrawal by Subject|0|||
146358481|NCT01996748|527815224|FG001|Overall Study|Withdrawal by Subject|1|||
146358482|NCT01996748|527815223|FG000|Overall Study|Lost to Follow-up|4|||
146358483|NCT01996748|527815224|FG001|Overall Study|Lost to Follow-up|1|||
146358484|NCT02402218|527815227|FG000|Overall Study|Did not pickup study medication|12|||
146358485|NCT02402218|527815228|FG001|Overall Study|Did not pickup study medication|9|||
146358486|NCT02402218|527815229|FG002|Overall Study|Did not pickup study medication|13|||
146358487|NCT02402218|527815227|FG000|Overall Study|Lack of Efficacy|0|||
146358488|NCT02402218|527815228|FG001|Overall Study|Lack of Efficacy|1|||
146358489|NCT02402218|527815229|FG002|Overall Study|Lack of Efficacy|1|||
146358490|NCT02402218|527815227|FG000|Overall Study|Death|1|||
146358491|NCT02402218|527815228|FG001|Overall Study|Death|0|||
146358492|NCT02402218|527815229|FG002|Overall Study|Death|0|||
146358493|NCT02402218|527815227|FG000|Overall Study|Reinfection|0|||
146358494|NCT02402218|527815228|FG001|Overall Study|Reinfection|0|||
146358495|NCT02402218|527815229|FG002|Overall Study|Reinfection|1|||
146358496|NCT02402218|527815227|FG000|Overall Study|Adverse Event|0|||
146358497|NCT02402218|527815228|FG001|Overall Study|Adverse Event|2|||
146358498|NCT02402218|527815229|FG002|Overall Study|Adverse Event|1|||
146358499|NCT02402218|527815227|FG000|Overall Study|Withdrawal by Subject|1|||
146358500|NCT02402218|527815228|FG001|Overall Study|Withdrawal by Subject|1|||
146358501|NCT02402218|527815229|FG002|Overall Study|Withdrawal by Subject|1|||
146358502|NCT03011840|527815230|FG000|Overall Study|Not received PIL in post PIL phase|0|||
146358503|NCT03011840|527815231|FG001|Overall Study|Not received PIL in post PIL phase|21|||
146358504|NCT03738566|527815232|FG000|Initial Study Phase|Withdrawal by Subject|1|||
146358505|NCT03738566|527815233|FG001|Initial Study Phase|Withdrawal by Subject|1|||
146358506|NCT03738566|527815234|FG002|Initial Study Phase|Withdrawal by Subject|2|||
146358507|NCT03738566|527815235|FG003|Initial Study Phase|Withdrawal by Subject|0|||
146358508|NCT03738566|527815232|FG000|Initial Study Phase|Death|0|||
146358509|NCT03738566|527815233|FG001|Initial Study Phase|Death|1|||
146358510|NCT03738566|527815234|FG002|Initial Study Phase|Death|0|||
146358511|NCT03738566|527815235|FG003|Initial Study Phase|Death|0|||
146358512|NCT03738566|527815232|FG000|Initial Study Phase|Treatment failure|5|||
146358513|NCT03738566|527815233|FG001|Initial Study Phase|Treatment failure|0|||
146358514|NCT03738566|527815234|FG002|Initial Study Phase|Treatment failure|0|||
146358515|NCT03738566|527815235|FG003|Initial Study Phase|Treatment failure|0|||
146358516|NCT03738566|527815232|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146358517|NCT03738566|527815233|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146358518|NCT03738566|527815234|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
146358519|NCT03738566|527815235|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
146358520|NCT00946530|527815236|FG000|Overall Study|Withdrawal by Subject|0|||
146358521|NCT00946530|527815237|FG001|Overall Study|Withdrawal by Subject|3|||
146358522|NCT00946530|527815238|FG002|Overall Study|Withdrawal by Subject|0|||
146358523|NCT00946530|527815239|FG003|Overall Study|Withdrawal by Subject|3|||
146358524|NCT00946530|527815236|FG000|Overall Study|Physician Decision|1|||
146358525|NCT00946530|527815237|FG001|Overall Study|Physician Decision|1|||
146358526|NCT00946530|527815238|FG002|Overall Study|Physician Decision|1|||
146358527|NCT00946530|527815239|FG003|Overall Study|Physician Decision|1|||
146358528|NCT03105700|527815240|FG000|Overall Study|screen fail|3|||
146358529|NCT03105700|527815240|FG000|Overall Study|Lost to Follow-up|4|||
146358530|NCT02768194|527815241|FG000|Period 1|Adverse Event|0|||
146358531|NCT02768194|527815242|FG001|Period 1|Adverse Event|0|||
146358532|NCT02768194|527815243|FG002|Period 1|Adverse Event|0|||
146358533|NCT02768194|527815244|FG003|Period 1|Adverse Event|1|||
146358534|NCT02768194|527815245|FG004|Period 1|Adverse Event|0|||
146358535|NCT02768194|527815246|FG005|Period 1|Adverse Event|0|||
146358536|NCT02768194|527815241|FG000|Period 2|Other (Reason not specified)|1|||
146358537|NCT02768194|527815242|FG001|Period 2|Other (Reason not specified)|0|||
146358538|NCT02768194|527815243|FG002|Period 2|Other (Reason not specified)|0|||
146358539|NCT02768194|527815244|FG003|Period 2|Other (Reason not specified)|0|||
146358540|NCT02768194|527815245|FG004|Period 2|Other (Reason not specified)|0|||
146358541|NCT02768194|527815246|FG005|Period 2|Other (Reason not specified)|0|||
146358542|NCT02768194|527815241|FG000|Period 3|Other (Reason not specified)|0|||
146358543|NCT02768194|527815242|FG001|Period 3|Other (Reason not specified)|1|||
146358544|NCT02768194|527815243|FG002|Period 3|Other (Reason not specified)|0|||
146358545|NCT02768194|527815244|FG003|Period 3|Other (Reason not specified)|0|||
146358546|NCT02768194|527815245|FG004|Period 3|Other (Reason not specified)|0|||
146358547|NCT02768194|527815246|FG005|Period 3|Other (Reason not specified)|0|||
146358548|NCT01982773|527815247|FG000|Overall Study|Withdrawal by Subject|1|||
146358549|NCT01982773|527815248|FG001|Overall Study|Withdrawal by Subject|3|||
146358550|NCT01982773|527815247|FG000|Overall Study|Lost to Follow-up|7|||
146358551|NCT01982773|527815248|FG001|Overall Study|Lost to Follow-up|1|||
146358552|NCT01029886|527815249|FG000|Overall Study|Adverse Event|12|||
146358553|NCT01029886|527815250|FG001|Overall Study|Adverse Event|25|||
146358554|NCT01029886|527815249|FG000|Overall Study|Lost to Follow-up|1|||
146358555|NCT01029886|527815250|FG001|Overall Study|Lost to Follow-up|0|||
146358556|NCT01029886|527815249|FG000|Overall Study|Physician Decision|2|||
146358557|NCT01029886|527815250|FG001|Overall Study|Physician Decision|6|||
146358558|NCT01029886|527815249|FG000|Overall Study|Protocol Violation|17|||
146358559|NCT01029886|527815250|FG001|Overall Study|Protocol Violation|5|||
146358560|NCT01029886|527815249|FG000|Overall Study|Withdrawal by Subject|8|||
146358561|NCT01029886|527815250|FG001|Overall Study|Withdrawal by Subject|18|||
146358562|NCT01029886|527815249|FG000|Overall Study|Entry Criteria Not Met|13|||
146358563|NCT01029886|527815250|FG001|Overall Study|Entry Criteria Not Met|5|||
146358564|NCT01029886|527815249|FG000|Overall Study|Sponsor Decision|1|||
146358565|NCT01029886|527815250|FG001|Overall Study|Sponsor Decision|0|||
146358566|NCT01029886|527815249|FG000|Overall Study|Loss Glucose Control|7|||
146358567|NCT01029886|527815250|FG001|Overall Study|Loss Glucose Control|1|||
146358568|NCT01778127|527815253|FG000|Overall Study|Lost to Follow-up|5|||
146358569|NCT01778127|527815254|FG001|Overall Study|Lost to Follow-up|1|||
146358570|NCT01778127|527815255|FG002|Overall Study|Lost to Follow-up|2|||
146358571|NCT01778127|527815253|FG000|Overall Study|Withdrawal by Subject|3|||
146358572|NCT01778127|527815254|FG001|Overall Study|Withdrawal by Subject|1|||
146358573|NCT01778127|527815255|FG002|Overall Study|Withdrawal by Subject|4|||
146358574|NCT00751114|527815260|FG000|Overall Study|Adverse Event|2|||
146358575|NCT00751114|527815261|FG001|Overall Study|Adverse Event|4|||
146358576|NCT00751114|527815260|FG000|Overall Study|Protocol Violation|8|||
146358577|NCT00751114|527815261|FG001|Overall Study|Protocol Violation|9|||
146358578|NCT00751114|527815260|FG000|Overall Study|Withdrawal by Subject|9|||
146358579|NCT00751114|527815261|FG001|Overall Study|Withdrawal by Subject|4|||
146358580|NCT00751114|527815260|FG000|Overall Study|Lost to Follow-up|4|||
146358581|NCT00751114|527815261|FG001|Overall Study|Lost to Follow-up|7|||
146358582|NCT00751114|527815260|FG000|Overall Study|Lack of Efficacy|0|||
146358583|NCT00751114|527815261|FG001|Overall Study|Lack of Efficacy|7|||
146358584|NCT00751114|527815260|FG000|Overall Study|Not Treated|13|||
146358585|NCT00751114|527815261|FG001|Overall Study|Not Treated|1|||
146358586|NCT00751114|527815260|FG000|Overall Study|Out of country for 2 months|1|||
146358587|NCT00751114|527815261|FG001|Overall Study|Out of country for 2 months|0|||
146358588|NCT00751114|527815260|FG000|Overall Study|Move to another city|1|||
146358589|NCT00751114|527815261|FG001|Overall Study|Move to another city|0|||
146358590|NCT03095521|527815262|FG000|Overall Study|Withdrawal by Subject|0|||
146358591|NCT03095521|527815263|FG001|Overall Study|Withdrawal by Subject|1|||
146358592|NCT03095521|527815262|FG000|Overall Study|Lost to Follow-up|0|||
146358593|NCT03095521|527815263|FG001|Overall Study|Lost to Follow-up|1|||
146358594|NCT01536119|527815264|FG000|Overall Study|Lost to Follow-up|17|||
146358595|NCT01536119|527815265|FG001|Overall Study|Lost to Follow-up|14|||
146358596|NCT03521193|527815266|FG000|Overall Study|Withdrawal by Subject|8|||
146358597|NCT03521193|527815267|FG001|Overall Study|Withdrawal by Subject|0|||
146358598|NCT03521193|527815266|FG000|Overall Study|non compliant to ASA treatment|8|||
146358599|NCT03521193|527815267|FG001|Overall Study|non compliant to ASA treatment|0|||
146358600|NCT01810042|527815268|FG000|Overall Study|Lost to Follow-up|10|||
146358601|NCT01354353|527817663|FG000|Overall Study|Adverse Event|1|||
146358602|NCT01354353|527817664|FG001|Overall Study|Adverse Event|0|||
146358603|NCT01354353|527817665|FG002|Overall Study|Adverse Event|0|||
146358604|NCT01354353|527817666|FG003|Overall Study|Adverse Event|4|||
146358605|NCT01354353|527817667|FG004|Overall Study|Adverse Event|0|||
146358606|NCT01354353|527817668|FG005|Overall Study|Adverse Event|5|||
146358607|NCT01354353|527817663|FG000|Overall Study|Entry Criteria Not Met|0|||
146358608|NCT01354353|527817664|FG001|Overall Study|Entry Criteria Not Met|0|||
146358609|NCT01354353|527817665|FG002|Overall Study|Entry Criteria Not Met|0|||
146358610|NCT01354353|527817666|FG003|Overall Study|Entry Criteria Not Met|1|||
146358611|NCT01354353|527817667|FG004|Overall Study|Entry Criteria Not Met|1|||
146358612|NCT01354353|527817668|FG005|Overall Study|Entry Criteria Not Met|0|||
146358613|NCT01354353|527817663|FG000|Overall Study|Physician Decision|0|||
146358614|NCT01354353|527817664|FG001|Overall Study|Physician Decision|1|||
146358615|NCT01354353|527817665|FG002|Overall Study|Physician Decision|1|||
146358616|NCT01354353|527817666|FG003|Overall Study|Physician Decision|0|||
146358617|NCT01354353|527817667|FG004|Overall Study|Physician Decision|0|||
146358618|NCT01354353|527817668|FG005|Overall Study|Physician Decision|0|||
146358619|NCT01354353|527817663|FG000|Overall Study|Withdrawal by Subject|2|||
146358620|NCT01354353|527817664|FG001|Overall Study|Withdrawal by Subject|0|||
146358621|NCT01354353|527817665|FG002|Overall Study|Withdrawal by Subject|1|||
146169631|NCT04707196|527132880|FG001|Overall Study|Progressive disease|10|||
146169632|NCT01462162|527132881|FG000|Overall Study|Adverse Event|5|||
146169633|NCT01462162|527132881|FG000|Overall Study|Lack of Efficacy|4|||
146169634|NCT01462162|527132881|FG000|Overall Study|Abnormal laboratory parameters|1|||
146169635|NCT01462162|527132881|FG000|Overall Study|Other|2|||
146169636|NCT04404478|527132882|FG000|Overall Study|Withdrawal by Subject|1|||
146169637|NCT04404478|527132883|FG001|Overall Study|Withdrawal by Subject|3|||
146169638|NCT03333928|527132884|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
146169639|NCT03333928|527132885|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
146169640|NCT03333928|527132886|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
146169641|NCT03333928|527132884|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
146169642|NCT03333928|527132885|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
146169643|NCT03333928|527132886|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
146169644|NCT03333928|527132884|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
146169645|NCT03333928|527132885|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
146358622|NCT01354353|527817666|FG003|Overall Study|Withdrawal by Subject|0|||
146358623|NCT01354353|527817667|FG004|Overall Study|Withdrawal by Subject|0|||
146358624|NCT01354353|527817668|FG005|Overall Study|Withdrawal by Subject|1|||
146358625|NCT00848250|527817669|FG000|Overall Study|surgery was completed without cardiopulm|0|||
146358626|NCT00848250|527817670|FG001|Overall Study|surgery was completed without cardiopulm|1|||
146358627|NCT00213980|527817678|FG000|Overall Study|Withdrawal by Subject|3|||
146358628|NCT00213980|527817679|FG001|Overall Study|Withdrawal by Subject|1|||
146358629|NCT00213980|527817678|FG000|Overall Study|Adverse Event|1|||
146358630|NCT00213980|527817679|FG001|Overall Study|Adverse Event|1|||
146358631|NCT00213980|527817678|FG000|Overall Study|Disease progression|0|||
146358632|NCT00213980|527817679|FG001|Overall Study|Disease progression|2|||
146358633|NCT00213980|527817678|FG000|Overall Study|Developed ovarian cancer|1|||
146358634|NCT00213980|527817679|FG001|Overall Study|Developed ovarian cancer|0|||
146358635|NCT00213980|527817678|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
146358636|NCT00213980|527817679|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
146358637|NCT03607838|527817680|FG000|Overall Study|Lack of Efficacy|14|||
146358638|NCT03607838|527817681|FG001|Overall Study|Lack of Efficacy|20|||
146358639|NCT03607838|527817680|FG000|Overall Study|Withdrawal by Subject|13|||
146358640|NCT03607838|527817681|FG001|Overall Study|Withdrawal by Subject|8|||
146358641|NCT03607838|527817680|FG000|Overall Study|Lost to Follow-up|6|||
146358642|NCT03607838|527817681|FG001|Overall Study|Lost to Follow-up|11|||
146358643|NCT03607838|527817680|FG000|Overall Study|Adverse Event|2|||
146358644|NCT03607838|527817681|FG001|Overall Study|Adverse Event|2|||
146358645|NCT03607838|527817680|FG000|Overall Study|Physician Decision|2|||
146358646|NCT03607838|527817681|FG001|Overall Study|Physician Decision|0|||
146358647|NCT03607838|527817680|FG000|Overall Study|Failure to meet randomization criteria|1|||
146358648|NCT03607838|527817681|FG001|Overall Study|Failure to meet randomization criteria|2|||
146358649|NCT03607838|527817680|FG000|Overall Study|Pregnancy|1|||
146358650|NCT03607838|527817681|FG001|Overall Study|Pregnancy|0|||
146358651|NCT03607838|527817680|FG000|Overall Study|Protocol Violation|1|||
146358652|NCT03607838|527817681|FG001|Overall Study|Protocol Violation|0|||
146358653|NCT03607838|527817680|FG000|Overall Study|Due to work|1|||
146358654|NCT03607838|527817681|FG001|Overall Study|Due to work|0|||
146358655|NCT03607838|527817680|FG000|Overall Study|Litigation|0|||
146358656|NCT03607838|527817681|FG001|Overall Study|Litigation|1|||
146358657|NCT03607838|527817680|FG000|Overall Study|Temperature excursion for study drug|0|||
146358658|NCT03607838|527817681|FG001|Overall Study|Temperature excursion for study drug|1|||
146358659|NCT03607838|527817680|FG000|Overall Study|Change of mind|0|||
146358660|NCT03607838|527817681|FG001|Overall Study|Change of mind|1|||
146358661|NCT00423735|527817682|FG000|Overall Study|Ineligible / No protocol treatment|8|||
146358662|NCT00423735|527817683|FG001|Overall Study|Ineligible / No protocol treatment|6|||
146358663|NCT00423735|527817684|FG002|Overall Study|Ineligible / No protocol treatment|0|||
146358664|NCT03654755|527817685|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
146358665|NCT03654755|527817686|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
146358666|NCT03654755|527817687|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
146358667|NCT03654755|527817685|FG000|Overall Study|Withdrawal by Subject|2|||
146358668|NCT03654755|527817686|FG001|Overall Study|Withdrawal by Subject|4|||
146358669|NCT03654755|527817687|FG002|Overall Study|Withdrawal by Subject|8|||
146358670|NCT03654755|527817685|FG000|Overall Study|Lost to Follow-up|1|||
146358671|NCT03654755|527817686|FG001|Overall Study|Lost to Follow-up|3|||
146358672|NCT03654755|527817687|FG002|Overall Study|Lost to Follow-up|7|||
146358673|NCT03654755|527817685|FG000|Overall Study|Physician Decision|0|||
146358674|NCT03654755|527817686|FG001|Overall Study|Physician Decision|1|||
146358675|NCT03654755|527817687|FG002|Overall Study|Physician Decision|0|||
146358676|NCT03654755|527817685|FG000|Overall Study|Adverse Event|0|||
146358677|NCT03654755|527817686|FG001|Overall Study|Adverse Event|0|||
146358678|NCT03654755|527817687|FG002|Overall Study|Adverse Event|4|||
146358679|NCT03654755|527817685|FG000|Overall Study|Lack of Efficacy|0|||
146358680|NCT03654755|527817686|FG001|Overall Study|Lack of Efficacy|0|||
146358681|NCT03654755|527817687|FG002|Overall Study|Lack of Efficacy|1|||
146358682|NCT03806179|527817692|FG000|Overall Study|Progressive disease|0|||
146358683|NCT03806179|527817693|FG001|Overall Study|Progressive disease|2|||
146358684|NCT01357915|527817697|FG000|Overall Study|Lost to Follow-up|3|||
146358685|NCT01357915|527817698|FG001|Overall Study|Lost to Follow-up|0|||
146358686|NCT02662985|527817699|FG000|Treatment Period 1|Adverse Event|0|||
146358687|NCT02662985|527817700|FG001|Treatment Period 1|Adverse Event|2|||
146358688|NCT02662985|527817699|FG000|Treatment Period 1|Protocol Violation|0|||
146358689|NCT02662985|527817700|FG001|Treatment Period 1|Protocol Violation|1|||
146358690|NCT02662985|527817699|FG000|Treatment Period 1|Physician Decision|1|||
146358691|NCT02662985|527817700|FG001|Treatment Period 1|Physician Decision|0|||
146358692|NCT02662985|527817699|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146358693|NCT02662985|527817700|FG001|Treatment Period 1|Withdrawal by Subject|1|||
146358694|NCT02662985|527817699|FG000|Treatment Period 2|Lack of Efficacy|0|||
146358695|NCT02662985|527817700|FG001|Treatment Period 2|Lack of Efficacy|1|||
146358696|NCT02662985|527817699|FG000|Treatment Period 2|Lost to Follow-up|1|||
146358697|NCT02662985|527817700|FG001|Treatment Period 2|Lost to Follow-up|0|||
146358698|NCT02662985|527817699|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
146358699|NCT02662985|527817700|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
146358700|NCT02662985|527817699|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
146358701|NCT02662985|527817700|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
146358702|NCT02662985|527817699|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
146358703|NCT02662985|527817700|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
146358704|NCT02662985|527817699|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
146358705|NCT02662985|527817700|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
146358706|NCT02662985|527817699|FG000|Treatment Period 3 (Extension Period)|Death|0|||
146358707|NCT02662985|527817700|FG001|Treatment Period 3 (Extension Period)|Death|1|||
146358708|NCT01486784|527817701|FG000|Overall Study|Withdrawal by Subject|0|||
146358709|NCT01486784|527817702|FG001|Overall Study|Withdrawal by Subject|0|||
146358710|NCT01486784|527817703|FG002|Overall Study|Withdrawal by Subject|1|||
146358711|NCT01486784|527817704|FG003|Overall Study|Withdrawal by Subject|0|||
146358712|NCT01486784|527817705|FG004|Overall Study|Withdrawal by Subject|1|||
146358713|NCT01486784|527817706|FG005|Overall Study|Withdrawal by Subject|2|||
146358714|NCT01486784|527817701|FG000|Overall Study|Subject did not meet entry criteria|0|||
146358715|NCT01486784|527817702|FG001|Overall Study|Subject did not meet entry criteria|0|||
146358716|NCT01486784|527817703|FG002|Overall Study|Subject did not meet entry criteria|0|||
146358717|NCT01486784|527817704|FG003|Overall Study|Subject did not meet entry criteria|0|||
146358718|NCT01486784|527817705|FG004|Overall Study|Subject did not meet entry criteria|1|||
146358719|NCT01486784|527817706|FG005|Overall Study|Subject did not meet entry criteria|0|||
146358720|NCT01486784|527817701|FG000|Overall Study|Death|0|||
146358721|NCT01486784|527817702|FG001|Overall Study|Death|0|||
146358722|NCT01486784|527817703|FG002|Overall Study|Death|0|||
146358723|NCT01486784|527817704|FG003|Overall Study|Death|0|||
146358724|NCT01486784|527817705|FG004|Overall Study|Death|0|||
146358725|NCT01486784|527817706|FG005|Overall Study|Death|1|||
146358726|NCT02841787|527817707|FG000|Overall Study|Lost to Follow-up|1|||
146358727|NCT02841787|527817708|FG001|Overall Study|Lost to Follow-up|0|||
146358728|NCT02841787|527817709|FG002|Overall Study|Lost to Follow-up|0|||
146358729|NCT02841787|527817707|FG000|Overall Study|Symptoms dropped below threshold|1|||
146358730|NCT02841787|527817708|FG001|Overall Study|Symptoms dropped below threshold|0|||
146358731|NCT02841787|527817709|FG002|Overall Study|Symptoms dropped below threshold|0|||
146358732|NCT02841787|527817707|FG000|Overall Study|Withdrawal by Subject|1|||
146358733|NCT02841787|527817708|FG001|Overall Study|Withdrawal by Subject|4|||
146358734|NCT02841787|527817709|FG002|Overall Study|Withdrawal by Subject|0|||
146358735|NCT03491553|527817710|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
146358736|NCT03491553|527817711|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
146358737|NCT03491553|527817712|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
146358738|NCT03491553|527817713|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
146358739|NCT03491553|527817714|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
146358740|NCT03491553|527817715|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
146358741|NCT03491553|527817710|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
146358742|NCT03491553|527817711|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
146358743|NCT03491553|527817712|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
146358744|NCT03491553|527817713|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
146358745|NCT03491553|527817714|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
146358746|NCT03491553|527817715|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
146358747|NCT03029650|527817718|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
146358748|NCT03029650|527817719|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
146358749|NCT03029650|527817718|FG000|Washout (1 Week)|Physician Decision|0|||
146358750|NCT03029650|527817719|FG001|Washout (1 Week)|Physician Decision|1|||
146358751|NCT01875367|527817720|FG000|Overall Study|Not complete at least 2 questionaries|4|||
146358752|NCT01875367|527817721|FG001|Overall Study|Not complete at least 2 questionaries|2|||
146358753|NCT01875367|527817720|FG000|Overall Study|Not receive study treatment|1|||
146358754|NCT01875367|527817721|FG001|Overall Study|Not receive study treatment|0|||
146358755|NCT02237157|527817722|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
146358756|NCT02237157|527817723|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146358757|NCT02237157|527817724|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146358758|NCT02237157|527817725|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
146358759|NCT02237157|527817722|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
146358760|NCT02237157|527817723|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146358761|NCT02237157|527817724|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146358762|NCT02237157|527817725|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
146358763|NCT03628508|527817726|FG000|Overall Study|Lost to Follow-up|1|||
146358764|NCT02951988|527817727|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
146358765|NCT02951988|527817728|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146358766|NCT02951988|527817729|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146358767|NCT02951988|527817730|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
146358768|NCT02951988|527817727|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
146358769|NCT02951988|527817728|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
146358770|NCT02951988|527817729|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
146358771|NCT02951988|527817730|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
146358772|NCT02951988|527817727|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
146358773|NCT02951988|527817728|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146358774|NCT02951988|527817729|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146358775|NCT02951988|527817730|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
146358776|NCT02951988|527817727|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
146358777|NCT02951988|527817728|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
146358778|NCT02951988|527817729|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
146358779|NCT02951988|527817730|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
146358780|NCT02951988|527817727|FG000|Open-Label Treatment Period|Protocol Violation|22|||
146358781|NCT02951988|527817728|FG001|Open-Label Treatment Period|Protocol Violation|0|||
146358782|NCT02951988|527817729|FG002|Open-Label Treatment Period|Protocol Violation|0|||
146358783|NCT02951988|527817730|FG003|Open-Label Treatment Period|Protocol Violation|0|||
146358784|NCT02951988|527817727|FG000|Open-Label Treatment Period|Pregnancy|2|||
146358785|NCT02951988|527817728|FG001|Open-Label Treatment Period|Pregnancy|0|||
146358786|NCT02951988|527817729|FG002|Open-Label Treatment Period|Pregnancy|0|||
146358787|NCT02951988|527817730|FG003|Open-Label Treatment Period|Pregnancy|0|||
146358788|NCT02951988|527817727|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
146358789|NCT02951988|527817728|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
146358790|NCT02951988|527817729|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
146358791|NCT02951988|527817730|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
146358792|NCT02951988|527817727|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
146358793|NCT02951988|527817728|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
146358794|NCT02951988|527817729|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
146358795|NCT02951988|527817730|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
146358796|NCT02951988|527817727|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
146358797|NCT02951988|527817728|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
146358798|NCT02951988|527817729|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
146358799|NCT02951988|527817730|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
146358800|NCT02951988|527817727|FG000|Open-Label Treatment Period|Adverse Event|45|||
146358801|NCT02951988|527817728|FG001|Open-Label Treatment Period|Adverse Event|0|||
146358802|NCT02951988|527817729|FG002|Open-Label Treatment Period|Adverse Event|0|||
146358803|NCT02951988|527817730|FG003|Open-Label Treatment Period|Adverse Event|0|||
146358804|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
146358805|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
146358806|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
146358807|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
146358808|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
146358809|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
146358810|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
146358811|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
146358812|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
146358813|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
146358814|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
146358815|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
146358816|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
146358817|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
146358818|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
146358819|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
146358820|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Pregnancy|0|||
146358821|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Pregnancy|1|||
146358822|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Pregnancy|1|||
146358823|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Pregnancy|0|||
146358824|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146358825|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
146358826|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
146358827|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
146358828|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146358829|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
146358830|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
146358831|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
146358832|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Adverse Event|0|||
146358833|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Adverse Event|8|||
146358834|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Adverse Event|3|||
146358835|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Adverse Event|6|||
146358836|NCT02951988|527817727|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
146358837|NCT02951988|527817728|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
146358838|NCT02951988|527817729|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
146358839|NCT02951988|527817730|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
146358840|NCT05836818|527817731|FG000|Overall Study|Physician Decision|1|||
146358841|NCT05836818|527817732|FG001|Overall Study|Physician Decision|1|||
146358842|NCT05836818|527817733|FG002|Overall Study|Physician Decision|0|||
146358843|NCT05836818|527817731|FG000|Overall Study|Withdrawal by Subject|0|||
146358844|NCT05836818|527817732|FG001|Overall Study|Withdrawal by Subject|0|||
146358845|NCT05836818|527817733|FG002|Overall Study|Withdrawal by Subject|1|||
146358846|NCT05836818|527817731|FG000|Overall Study|Later found to be previously vaccinated|0|||
146358847|NCT05836818|527817732|FG001|Overall Study|Later found to be previously vaccinated|1|||
146358848|NCT05836818|527817733|FG002|Overall Study|Later found to be previously vaccinated|3|||
146358849|NCT05836818|527817731|FG000|Overall Study|Pregnancy|0|||
146358850|NCT05836818|527817732|FG001|Overall Study|Pregnancy|1|||
146358851|NCT05836818|527817733|FG002|Overall Study|Pregnancy|0|||
146358852|NCT05836818|527817731|FG000|Overall Study|Allergic to vaccines|0|||
146358853|NCT05836818|527817732|FG001|Overall Study|Allergic to vaccines|1|||
146358854|NCT05836818|527817733|FG002|Overall Study|Allergic to vaccines|0|||
146358855|NCT01165021|527817734|FG000|Overall Study|Death|1|||
146358856|NCT02491073|527817735|FG000|Overall Study|screen failure|1|||
146358857|NCT02491073|527817736|FG001|Overall Study|screen failure|0|||
146358858|NCT01419665|527817737|FG000|Combination Treatment|Adverse Event|7|||
146358859|NCT01419665|527817738|FG001|Combination Treatment|Adverse Event|10|||
146358860|NCT01419665|527817737|FG000|Combination Treatment|Physician Decision|5|||
146358861|NCT01419665|527817738|FG001|Combination Treatment|Physician Decision|8|||
146358862|NCT01419665|527817737|FG000|Combination Treatment|Protocol Violation|6|||
146358863|NCT01419665|527817738|FG001|Combination Treatment|Protocol Violation|2|||
146358864|NCT01419665|527817737|FG000|Combination Treatment|disease progression|10|||
146358865|NCT01419665|527817738|FG001|Combination Treatment|disease progression|9|||
146358866|NCT01419665|527817737|FG000|Combination Treatment|Death|5|||
146358867|NCT01419665|527817738|FG001|Combination Treatment|Death|7|||
146358868|NCT01419665|527817737|FG000|Combination Treatment|administrative problems|0|||
146358869|NCT01419665|527817738|FG001|Combination Treatment|administrative problems|1|||
146358870|NCT01419665|527817737|FG000|Combination Treatment|Withdrawal by Subject|5|||
146358871|NCT01419665|527817738|FG001|Combination Treatment|Withdrawal by Subject|4|||
146358872|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
146358873|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
146358874|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
146358875|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
146358876|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
146358877|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
146358878|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
146358879|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
146358880|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
146358881|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
146358882|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
146358883|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
146358884|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Death|1|||
146358885|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Death|2|||
146358886|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
146358887|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
146358888|NCT01419665|527817737|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
146358889|NCT01419665|527817738|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
146358890|NCT01419665|527817737|FG000|Open Label Phase|Death|1|||
146358891|NCT01419665|527817738|FG001|Open Label Phase|Death|0|||
146358892|NCT01419665|527817737|FG000|Open Label Phase|disease progression|0|||
146358893|NCT01419665|527817738|FG001|Open Label Phase|disease progression|1|||
146358894|NCT03977727|527817739|FG000|Second Treatment|Lost to Follow-up|0|||
146358895|NCT03977727|527817740|FG001|Second Treatment|Lost to Follow-up|3|||
146358896|NCT01655823|527817742|FG000|Overall Study|Lost to Follow-up|0|||
146358897|NCT01655823|527817743|FG001|Overall Study|Lost to Follow-up|1|||
146358898|NCT01655823|527817744|FG002|Overall Study|Lost to Follow-up|0|||
146358899|NCT01655823|527817745|FG003|Overall Study|Lost to Follow-up|0|||
146358900|NCT01655823|527817746|FG004|Overall Study|Lost to Follow-up|1|||
146358901|NCT01655823|527817742|FG000|Overall Study|Withdrawal by Subject|0|||
146358902|NCT01655823|527817743|FG001|Overall Study|Withdrawal by Subject|1|||
146358903|NCT01655823|527817744|FG002|Overall Study|Withdrawal by Subject|0|||
146358904|NCT01655823|527817745|FG003|Overall Study|Withdrawal by Subject|1|||
146358905|NCT01655823|527817746|FG004|Overall Study|Withdrawal by Subject|0|||
146358906|NCT01627067|527817749|FG000|Overall Study|Screen Failure|1|||
146358907|NCT03352414|527817753|FG000|Overall Study|Ineligible by operative criteria|12|||
146358908|NCT03352414|527817754|FG001|Overall Study|Ineligible by operative criteria|10|||
146358909|NCT02632110|527817755|FG000|Overall Study|Withdrawal by Subject|1|||
146358910|NCT02632110|527817756|FG001|Overall Study|Withdrawal by Subject|1|||
146358911|NCT02632110|527817757|FG002|Overall Study|Withdrawal by Subject|0|||
146358912|NCT02632110|527817758|FG003|Overall Study|Withdrawal by Subject|0|||
146358913|NCT02632110|527817759|FG004|Overall Study|Withdrawal by Subject|1|||
146358914|NCT02632110|527817760|FG005|Overall Study|Withdrawal by Subject|1|||
146358915|NCT02632110|527817761|FG006|Overall Study|Withdrawal by Subject|3|||
146358916|NCT02632110|527817762|FG007|Overall Study|Withdrawal by Subject|3|||
146358917|NCT02632110|527817763|FG008|Overall Study|Withdrawal by Subject|1|||
146358918|NCT02632110|527817764|FG009|Overall Study|Withdrawal by Subject|1|||
146358919|NCT00516269|527817765|FG000|Overall Study|Adverse Event|2|||
146358920|NCT00516269|527817766|FG001|Overall Study|Adverse Event|1|||
146358921|NCT00516269|527817765|FG000|Overall Study|Lost to Follow-up|0|||
146358922|NCT00516269|527817766|FG001|Overall Study|Lost to Follow-up|1|||
146358923|NCT00516269|527817765|FG000|Overall Study|Protocol Violation|0|||
146358924|NCT00516269|527817766|FG001|Overall Study|Protocol Violation|1|||
146358925|NCT00926796|527817767|FG000|Overall Study|Did not receive randomized treatment|4|||
146358926|NCT00926796|527817768|FG001|Overall Study|Did not receive randomized treatment|7|||
146358927|NCT00926796|527817767|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
146358928|NCT00926796|527817768|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
146358929|NCT00926796|527817767|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
146358930|NCT00926796|527817768|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
146358931|NCT00926796|527817767|FG000|Overall Study|Adverse Event|7|||
146358932|NCT00926796|527817768|FG001|Overall Study|Adverse Event|14|||
146358933|NCT00926796|527817767|FG000|Overall Study|Lost to Follow-up|22|||
146358934|NCT00926796|527817768|FG001|Overall Study|Lost to Follow-up|13|||
146358935|NCT00926796|527817767|FG000|Overall Study|Protocol Violation|15|||
146358936|NCT00926796|527817768|FG001|Overall Study|Protocol Violation|11|||
146358937|NCT00926796|527817767|FG000|Overall Study|Withdrawal by Subject|1|||
146358938|NCT00926796|527817768|FG001|Overall Study|Withdrawal by Subject|0|||
146358939|NCT01341652|527817769|FG000|Overall Study|Incorrect Random Assignment|0|||
146358940|NCT01341652|527817770|FG001|Overall Study|Incorrect Random Assignment|1|||
146358941|NCT01341652|527817769|FG000|Overall Study|ineligible; presence metastatic disease|0|||
146358942|NCT01341652|527817770|FG001|Overall Study|ineligible; presence metastatic disease|1|||
146358943|NCT00586924|527817775|FG000|Overall Study|Adverse event/serious adverse event|0|||
146358944|NCT00586924|527817776|FG001|Overall Study|Adverse event/serious adverse event|0|||
146358945|NCT00586924|527817777|FG002|Overall Study|Adverse event/serious adverse event|0|||
146358946|NCT00586924|527817778|FG003|Overall Study|Adverse event/serious adverse event|1|||
146358947|NCT00586924|527817779|FG004|Overall Study|Adverse event/serious adverse event|0|||
146358948|NCT00586924|527817780|FG005|Overall Study|Adverse event/serious adverse event|2|||
146358949|NCT00586924|527817775|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
146358950|NCT00586924|527817776|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
146358951|NCT00586924|527817777|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
146358952|NCT00586924|527817778|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
146358953|NCT00586924|527817779|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
146358954|NCT00586924|527817780|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
146358955|NCT00586924|527817775|FG000|Overall Study|Disease progression|0|||
146358956|NCT00586924|527817776|FG001|Overall Study|Disease progression|0|||
146358957|NCT00586924|527817777|FG002|Overall Study|Disease progression|0|||
146358958|NCT00586924|527817778|FG003|Overall Study|Disease progression|1|||
146358959|NCT00586924|527817779|FG004|Overall Study|Disease progression|1|||
146358960|NCT00586924|527817780|FG005|Overall Study|Disease progression|0|||
146358961|NCT00586924|527817775|FG000|Overall Study|Development of neutralizing antibodies|2|||
146358962|NCT00586924|527817776|FG001|Overall Study|Development of neutralizing antibodies|2|||
146358963|NCT00586924|527817777|FG002|Overall Study|Development of neutralizing antibodies|2|||
146358964|NCT00586924|527817778|FG003|Overall Study|Development of neutralizing antibodies|0|||
146358965|NCT00586924|527817779|FG004|Overall Study|Development of neutralizing antibodies|0|||
146358966|NCT00586924|527817780|FG005|Overall Study|Development of neutralizing antibodies|22|||
146358967|NCT00586924|527817775|FG000|Overall Study|Complete response|0|||
146358968|NCT00586924|527817776|FG001|Overall Study|Complete response|1|||
146358969|NCT00586924|527817777|FG002|Overall Study|Complete response|0|||
146358970|NCT00586924|527817778|FG003|Overall Study|Complete response|0|||
146358971|NCT00586924|527817779|FG004|Overall Study|Complete response|2|||
146358972|NCT00586924|527817780|FG005|Overall Study|Complete response|2|||
146358973|NCT00586924|527817775|FG000|Overall Study|Other|1|||
146358974|NCT00586924|527817776|FG001|Overall Study|Other|0|||
146358975|NCT00586924|527817777|FG002|Overall Study|Other|1|||
146358976|NCT00586924|527817778|FG003|Overall Study|Other|1|||
146358977|NCT00586924|527817779|FG004|Overall Study|Other|1|||
146358978|NCT00586924|527817780|FG005|Overall Study|Other|6|||
146358979|NCT04570657|527817783|FG000|Overall Study|Adverse Event|0|||
146358980|NCT04570657|527817784|FG001|Overall Study|Adverse Event|0|||
146358981|NCT04570657|527817785|FG002|Overall Study|Adverse Event|1|||
146358982|NCT04570657|527817783|FG000|Overall Study|Lost to Follow-up|0|||
146358983|NCT04570657|527817784|FG001|Overall Study|Lost to Follow-up|0|||
146358984|NCT04570657|527817785|FG002|Overall Study|Lost to Follow-up|1|||
146358985|NCT04570657|527817783|FG000|Overall Study|Physician Decision|0|||
146358986|NCT04570657|527817784|FG001|Overall Study|Physician Decision|1|||
146358987|NCT04570657|527817785|FG002|Overall Study|Physician Decision|0|||
146358988|NCT04570657|527817783|FG000|Overall Study|Withdrawal by Subject|1|||
146358989|NCT04570657|527817784|FG001|Overall Study|Withdrawal by Subject|2|||
146358990|NCT04570657|527817785|FG002|Overall Study|Withdrawal by Subject|2|||
146358991|NCT01079962|527817786|FG000|Overall Study|Adverse Event|2|||
146358992|NCT01079962|527817787|FG001|Overall Study|Adverse Event|2|||
146358993|NCT01079962|527817786|FG000|Overall Study|Withdrawal by Subject|5|||
145943400|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146358994|NCT01079962|527817787|FG001|Overall Study|Withdrawal by Subject|7|||
146358995|NCT01079962|527817786|FG000|Overall Study|Protocol Violation|2|||
146358996|NCT01079962|527817787|FG001|Overall Study|Protocol Violation|2|||
146358997|NCT01079962|527817786|FG000|Overall Study|No blood pressure (BP) control|3|||
146358998|NCT01079962|527817787|FG001|Overall Study|No blood pressure (BP) control|0|||
146358999|NCT01079962|527817786|FG000|Overall Study|Inclusion/exclusion criteria|1|||
146359000|NCT01079962|527817787|FG001|Overall Study|Inclusion/exclusion criteria|3|||
146359001|NCT01079962|527817786|FG000|Overall Study|Participant not returning for next visit|1|||
146359002|NCT01079962|527817787|FG001|Overall Study|Participant not returning for next visit|0|||
146359003|NCT01079962|527817786|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
146359004|NCT01079962|527817787|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
146359005|NCT01331239|527817788|FG000|Part II: Core Study|Adverse Event|0|||
146359006|NCT01331239|527817789|FG001|Part II: Core Study|Adverse Event|3|||
146359007|NCT01331239|527817790|FG002|Part II: Core Study|Adverse Event|0|||
146359008|NCT01331239|527817788|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
146359009|NCT01331239|527817789|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
146359010|NCT01331239|527817790|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
146359011|NCT01331239|527817788|FG000|Part II: Core Study|Withdrawal by Subject|0|||
146359012|NCT01331239|527817789|FG001|Part II: Core Study|Withdrawal by Subject|2|||
146359013|NCT01331239|527817790|FG002|Part II: Core Study|Withdrawal by Subject|0|||
146359014|NCT01331239|527817788|FG000|Part II: Core Study|Administrative problems|0|||
146359015|NCT01331239|527817789|FG001|Part II: Core Study|Administrative problems|1|||
146359016|NCT01331239|527817790|FG002|Part II: Core Study|Administrative problems|0|||
146359017|NCT01072539|527817791|FG000|Overall Study|Treated prior to the Site Initiation|1|||
146359018|NCT01072539|527817791|FG000|Overall Study|Protocol Violation|2|||
146359019|NCT01008995|527817793|FG000|Controlled Period|Adverse Event|1|||
146359020|NCT01008995|527817794|FG001|Controlled Period|Adverse Event|2|||
146359021|NCT01008995|527817795|FG002|Controlled Period|Adverse Event|0|||
146359022|NCT01008995|527817796|FG003|Controlled Period|Adverse Event|0|||
146359023|NCT01008995|527817793|FG000|Controlled Period|Other|2|||
146359024|NCT01008995|527817794|FG001|Controlled Period|Other|1|||
146359025|NCT01008995|527817795|FG002|Controlled Period|Other|0|||
146359026|NCT01008995|527817796|FG003|Controlled Period|Other|0|||
146359027|NCT01008995|527817793|FG000|After Controlled Period|Adverse Event|0|||
146359028|NCT01008995|527817794|FG001|After Controlled Period|Adverse Event|0|||
146359029|NCT01008995|527817795|FG002|After Controlled Period|Adverse Event|1|||
146359030|NCT01008995|527817796|FG003|After Controlled Period|Adverse Event|1|||
146359031|NCT01008995|527817793|FG000|After Controlled Period|Other|0|||
146359032|NCT01008995|527817794|FG001|After Controlled Period|Other|0|||
146359033|NCT01008995|527817795|FG002|After Controlled Period|Other|1|||
146359034|NCT01008995|527817796|FG003|After Controlled Period|Other|0|||
146359035|NCT00115804|527817797|FG000|Overall Study|Adverse Event|2|||
146359036|NCT00621855|527817800|FG000|Overall Study|Adverse Event|32|||
146359037|NCT00621855|527817801|FG001|Overall Study|Adverse Event|31|||
146359038|NCT00621855|527817802|FG002|Overall Study|Adverse Event|48|||
146359039|NCT00621855|527817803|FG003|Overall Study|Adverse Event|34|||
146359040|NCT00621855|527817804|FG004|Overall Study|Adverse Event|31|||
146359041|NCT00621855|527817800|FG000|Overall Study|Lost to Follow-up|0|||
146359042|NCT00621855|527817801|FG001|Overall Study|Lost to Follow-up|1|||
146359043|NCT00621855|527817802|FG002|Overall Study|Lost to Follow-up|3|||
146359044|NCT00621855|527817803|FG003|Overall Study|Lost to Follow-up|4|||
146359045|NCT00621855|527817804|FG004|Overall Study|Lost to Follow-up|1|||
146359046|NCT00621855|527817800|FG000|Overall Study|Protocol Violation|16|||
146359047|NCT00621855|527817801|FG001|Overall Study|Protocol Violation|8|||
146359048|NCT00621855|527817802|FG002|Overall Study|Protocol Violation|6|||
146359049|NCT00621855|527817803|FG003|Overall Study|Protocol Violation|7|||
146359050|NCT00621855|527817804|FG004|Overall Study|Protocol Violation|8|||
146359051|NCT00621855|527817800|FG000|Overall Study|Withdrawal by Subject|16|||
146359052|NCT00621855|527817801|FG001|Overall Study|Withdrawal by Subject|11|||
146359053|NCT00621855|527817802|FG002|Overall Study|Withdrawal by Subject|13|||
146359054|NCT00621855|527817803|FG003|Overall Study|Withdrawal by Subject|13|||
146359055|NCT00621855|527817804|FG004|Overall Study|Withdrawal by Subject|9|||
146359056|NCT00621855|527817800|FG000|Overall Study|Other|9|||
146359057|NCT00621855|527817801|FG001|Overall Study|Other|7|||
146359058|NCT00621855|527817802|FG002|Overall Study|Other|6|||
146359059|NCT00621855|527817803|FG003|Overall Study|Other|5|||
146359060|NCT00621855|527817804|FG004|Overall Study|Other|4|||
146359061|NCT00621855|527817800|FG000|Overall Study|Patients did not receive study drug|3|||
146359062|NCT00621855|527817801|FG001|Overall Study|Patients did not receive study drug|3|||
146359063|NCT00621855|527817802|FG002|Overall Study|Patients did not receive study drug|5|||
146359064|NCT00621855|527817803|FG003|Overall Study|Patients did not receive study drug|4|||
146359065|NCT00621855|527817804|FG004|Overall Study|Patients did not receive study drug|2|||
146359066|NCT03731364|527817805|FG000|Overall Study|Adverse Event|0|||
146359067|NCT03731364|527817806|FG001|Overall Study|Adverse Event|0|||
146359068|NCT03731364|527817807|FG002|Overall Study|Adverse Event|1|||
146359069|NCT03731364|527817808|FG003|Overall Study|Adverse Event|2|||
146359070|NCT03731364|527817809|FG004|Overall Study|Adverse Event|1|||
146359071|NCT02953782|527817810|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
146359072|NCT02953782|527817811|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
146359073|NCT02953782|527817812|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
146359074|NCT02953782|527817813|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
146359075|NCT02953782|527817814|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
146359076|NCT02953782|527817815|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146359077|NCT02953782|527817816|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146359078|NCT02953782|527817817|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
146359079|NCT02953782|527817810|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
146359080|NCT02953782|527817811|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146359081|NCT02953782|527817812|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
146359082|NCT02953782|527817813|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146359083|NCT02953782|527817814|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
146359084|NCT02953782|527817815|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146359085|NCT02953782|527817816|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146359086|NCT02953782|527817817|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
146359087|NCT02953782|527817810|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146359088|NCT02953782|527817811|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146359089|NCT02953782|527817812|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146359090|NCT02953782|527817813|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146359091|NCT02953782|527817814|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
146359092|NCT02953782|527817815|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146359093|NCT02953782|527817816|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146359094|NCT02953782|527817817|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
146359095|NCT02953782|527817810|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359096|NCT02953782|527817811|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359097|NCT02953782|527817812|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
146359098|NCT02953782|527817813|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
146359099|NCT02953782|527817814|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359100|NCT02953782|527817815|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359101|NCT02953782|527817816|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359102|NCT02953782|527817817|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
146359103|NCT02953782|527817810|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146359104|NCT02953782|527817811|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146359105|NCT02953782|527817812|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146359106|NCT02953782|527817813|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146359107|NCT02953782|527817814|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
146359108|NCT02953782|527817815|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
146359109|NCT02953782|527817816|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
146359110|NCT02953782|527817817|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
146359111|NCT02953782|527817810|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146359112|NCT02953782|527817811|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146359113|NCT02953782|527817812|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146359114|NCT02953782|527817813|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146359115|NCT02953782|527817814|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
146359116|NCT02953782|527817815|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
146359117|NCT02953782|527817816|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
146359118|NCT02953782|527817817|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
146359119|NCT02953782|527817810|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146359120|NCT02953782|527817811|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146359121|NCT02953782|527817812|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146359122|NCT02953782|527817813|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146359123|NCT02953782|527817814|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
146359124|NCT02953782|527817815|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
146359125|NCT02953782|527817816|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
146359126|NCT02953782|527817817|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
146359127|NCT02953782|527817810|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359128|NCT02953782|527817811|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359129|NCT02953782|527817812|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359130|NCT02953782|527817813|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359131|NCT02953782|527817814|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359132|NCT02953782|527817815|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359133|NCT02953782|527817816|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
146359134|NCT02953782|527817817|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
146359135|NCT01934192|527817820|FG000|Overall Study|Protocol Violation|0|||
146359136|NCT01934192|527817821|FG001|Overall Study|Protocol Violation|0|||
146359137|NCT01934192|527817822|FG002|Overall Study|Protocol Violation|0|||
146359138|NCT01934192|527817823|FG003|Overall Study|Protocol Violation|1|||
146359139|NCT01934192|527817820|FG000|Overall Study|Other: reached stopping criteria|6|||
146359140|NCT01934192|527817821|FG001|Overall Study|Other: reached stopping criteria|5|||
146359141|NCT01934192|527817822|FG002|Overall Study|Other: reached stopping criteria|1|||
146359142|NCT01934192|527817823|FG003|Overall Study|Other: reached stopping criteria|0|||
146359143|NCT01934192|527817820|FG000|Overall Study|Physician Decision|3|||
146359144|NCT01934192|527817821|FG001|Overall Study|Physician Decision|2|||
146359145|NCT01934192|527817822|FG002|Overall Study|Physician Decision|0|||
146359146|NCT01934192|527817823|FG003|Overall Study|Physician Decision|0|||
146359147|NCT01737840|527817824|FG000|Overall Study|Diagnosed with an other pathology|2|||
146359148|NCT01737840|527817825|FG001|Overall Study|Diagnosed with an other pathology|2|||
146359149|NCT02357849|527817828|FG000|Overall Study|Withdrawal by Subject|2|||
146359150|NCT02357849|527817829|FG001|Overall Study|Withdrawal by Subject|3|||
146359151|NCT00403559|527817832|FG000|Overall Study|Adverse Event|0|||
146359152|NCT00403559|527817833|FG001|Overall Study|Adverse Event|1|||
146359153|NCT00403559|527817832|FG000|Overall Study|Lost to Follow-up|3|||
146359154|NCT00403559|527817833|FG001|Overall Study|Lost to Follow-up|3|||
146359155|NCT00403559|527817832|FG000|Overall Study|Withdrawal by Subject|1|||
146359156|NCT00403559|527817833|FG001|Overall Study|Withdrawal by Subject|0|||
146359157|NCT04105244|527817834|FG000|Overall Study|Withdrawal by Subject|10|||
146359158|NCT04105244|527817835|FG001|Overall Study|Withdrawal by Subject|12|||
146359159|NCT04105244|527817834|FG000|Overall Study|Lost to Follow-up|20|||
146359160|NCT04105244|527817835|FG001|Overall Study|Lost to Follow-up|15|||
146359161|NCT04105244|527817834|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
146359162|NCT04105244|527817835|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
146359163|NCT04105244|527817834|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
146359164|NCT04105244|527817835|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
146359165|NCT04633473|527817836|FG000|Overall Study|Withdrawal by Subject|6|||
146359166|NCT04387136|527817837|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
146359167|NCT04387136|527817838|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
146359168|NCT03294681|527817841|FG000|Overall Study|Withdrawal by Subject|1|||
146359169|NCT03089216|527817842|FG000|Overall Study|Adverse Event|0|||
146359170|NCT03089216|527817843|FG001|Overall Study|Adverse Event|0|||
146359171|NCT03089216|527817844|FG002|Overall Study|Adverse Event|0|||
146359172|NCT03089216|527817845|FG003|Overall Study|Adverse Event|1|||
146359173|NCT01348425|527817848|FG000|Overall Study|Imaging was not taken.|1|||
146359174|NCT01348425|527817849|FG001|Overall Study|Imaging was not taken.|1|||
146359175|NCT02720016|527817853|FG000|Overall Study|Separation of couple|6|||
146359176|NCT02720016|527817854|FG001|Overall Study|Separation of couple|8|||
146359177|NCT02720016|527817855|FG002|Overall Study|Separation of couple|2|||
146359178|NCT02720016|527817853|FG000|Overall Study|Withdrawal by Subject|6|||
146359179|NCT02720016|527817854|FG001|Overall Study|Withdrawal by Subject|6|||
146359180|NCT02720016|527817855|FG002|Overall Study|Withdrawal by Subject|4|||
146359181|NCT02720016|527817853|FG000|Overall Study|Scheduling issues|2|||
146359182|NCT02720016|527817854|FG001|Overall Study|Scheduling issues|4|||
146359183|NCT02720016|527817855|FG002|Overall Study|Scheduling issues|7|||
146359184|NCT02720016|527817853|FG000|Overall Study|Childcare|2|||
146359185|NCT02720016|527817854|FG001|Overall Study|Childcare|0|||
146359186|NCT02720016|527817855|FG002|Overall Study|Childcare|2|||
146359187|NCT02720016|527817853|FG000|Overall Study|Withdrawal by PI|2|||
146359188|NCT02720016|527817854|FG001|Overall Study|Withdrawal by PI|2|||
146359189|NCT02720016|527817855|FG002|Overall Study|Withdrawal by PI|0|||
146359190|NCT02720016|527817853|FG000|Overall Study|Moved away|2|||
146359191|NCT02720016|527817854|FG001|Overall Study|Moved away|0|||
146359192|NCT02720016|527817855|FG002|Overall Study|Moved away|0|||
146359193|NCT02720016|527817853|FG000|Overall Study|Not Primary Health Concern|0|||
146359194|NCT02720016|527817854|FG001|Overall Study|Not Primary Health Concern|0|||
146359195|NCT02720016|527817855|FG002|Overall Study|Not Primary Health Concern|2|||
146359196|NCT02720016|527817853|FG000|Overall Study|Transportation issues|0|||
146359197|NCT02720016|527817854|FG001|Overall Study|Transportation issues|0|||
146359198|NCT02720016|527817855|FG002|Overall Study|Transportation issues|1|||
146359199|NCT02720016|527817853|FG000|Overall Study|Other|0|||
146359200|NCT02720016|527817854|FG001|Overall Study|Other|0|||
146359201|NCT02720016|527817855|FG002|Overall Study|Other|2|||
146359202|NCT05319080|527817856|FG000|Overall Study|Withdrawal by Subject|2|||
146169646|NCT03333928|527132886|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
146359203|NCT05319080|527817856|FG000|Overall Study|Physician Decision|4|||
146359204|NCT02358369|527817857|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
146359205|NCT02358369|527817858|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146359206|NCT02358369|527817859|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146359207|NCT02358369|527817860|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146359208|NCT02358369|527817861|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
146359209|NCT02358369|527817857|FG000|Treatment Period A/B|Adverse Event|0|||
146359210|NCT02358369|527817858|FG001|Treatment Period A/B|Adverse Event|0|||
146359211|NCT02358369|527817859|FG002|Treatment Period A/B|Adverse Event|1|||
146359212|NCT02358369|527817860|FG003|Treatment Period A/B|Adverse Event|2|||
146359213|NCT02358369|527817861|FG004|Treatment Period A/B|Adverse Event|0|||
146359214|NCT02358369|527817857|FG000|Treatment Period A/B|Death|0|||
146359215|NCT02358369|527817858|FG001|Treatment Period A/B|Death|0|||
146359216|NCT02358369|527817859|FG002|Treatment Period A/B|Death|1|||
146359217|NCT02358369|527817860|FG003|Treatment Period A/B|Death|0|||
146359218|NCT02358369|527817861|FG004|Treatment Period A/B|Death|0|||
146359219|NCT02358369|527817857|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
146359220|NCT02358369|527817858|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
146359221|NCT02358369|527817859|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
146359222|NCT02358369|527817860|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
146359223|NCT02358369|527817861|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
146359224|NCT02358369|527817857|FG000|Treatment Period C|Adverse Event|0|||
146359225|NCT02358369|527817858|FG001|Treatment Period C|Adverse Event|0|||
146359226|NCT02358369|527817859|FG002|Treatment Period C|Adverse Event|0|||
146359227|NCT02358369|527817860|FG003|Treatment Period C|Adverse Event|0|||
146359228|NCT02358369|527817861|FG004|Treatment Period C|Adverse Event|7|||
146359229|NCT00448916|527817862|FG000|Overall Study|Adverse Event|2|||
146359230|NCT00448916|527817863|FG001|Overall Study|Adverse Event|2|||
146359231|NCT00448916|527817864|FG002|Overall Study|Adverse Event|3|||
146359232|NCT00448916|527817865|FG003|Overall Study|Adverse Event|2|||
146359233|NCT00448916|527817862|FG000|Overall Study|Lack of Efficacy|1|||
146359234|NCT00448916|527817863|FG001|Overall Study|Lack of Efficacy|0|||
146359235|NCT00448916|527817864|FG002|Overall Study|Lack of Efficacy|2|||
146359236|NCT00448916|527817865|FG003|Overall Study|Lack of Efficacy|1|||
146359237|NCT00448916|527817862|FG000|Overall Study|Withdrawal by Subject|3|||
146359238|NCT00448916|527817863|FG001|Overall Study|Withdrawal by Subject|3|||
146359239|NCT00448916|527817864|FG002|Overall Study|Withdrawal by Subject|1|||
146359240|NCT00448916|527817865|FG003|Overall Study|Withdrawal by Subject|1|||
146359241|NCT00448916|527817862|FG000|Overall Study|Other|1|||
146359242|NCT00448916|527817863|FG001|Overall Study|Other|0|||
146359243|NCT00448916|527817864|FG002|Overall Study|Other|0|||
146359244|NCT00448916|527817865|FG003|Overall Study|Other|0|||
146359245|NCT00448916|527817862|FG000|Overall Study|Lost to Follow-up|0|||
146359246|NCT00448916|527817863|FG001|Overall Study|Lost to Follow-up|1|||
146359247|NCT00448916|527817864|FG002|Overall Study|Lost to Follow-up|0|||
146359248|NCT00448916|527817865|FG003|Overall Study|Lost to Follow-up|1|||
146359249|NCT00448916|527817862|FG000|Overall Study|Protocol Violation|0|||
146359250|NCT00448916|527817863|FG001|Overall Study|Protocol Violation|0|||
146359251|NCT00448916|527817864|FG002|Overall Study|Protocol Violation|0|||
146359252|NCT00448916|527817865|FG003|Overall Study|Protocol Violation|1|||
146359253|NCT03655717|527817866|FG000|Overall Study|Withdrawal by Subject|4|||
146359254|NCT03655717|527817867|FG001|Overall Study|Withdrawal by Subject|8|||
146359255|NCT03655717|527817868|FG002|Overall Study|Withdrawal by Subject|1|||
146359256|NCT03655717|527817869|FG003|Overall Study|Withdrawal by Subject|0|||
146359257|NCT03655717|527817870|FG004|Overall Study|Withdrawal by Subject|0|||
146359258|NCT03655717|527817871|FG005|Overall Study|Withdrawal by Subject|1|||
146359259|NCT03655717|527817872|FG006|Overall Study|Withdrawal by Subject|3|||
146359260|NCT03655717|527817873|FG007|Overall Study|Withdrawal by Subject|1|||
146359261|NCT03655717|527817874|FG008|Overall Study|Withdrawal by Subject|2|||
146359262|NCT03655717|527817875|FG009|Overall Study|Withdrawal by Subject|0|||
146359263|NCT03655717|527817876|FG010|Overall Study|Withdrawal by Subject|0|||
146359264|NCT03655717|527817877|FG011|Overall Study|Withdrawal by Subject|1|||
146359265|NCT03655717|527817878|FG012|Overall Study|Withdrawal by Subject|0|||
146169647|NCT03333928|527132884|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
146169648|NCT03333928|527132885|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
146359266|NCT03655717|527817879|FG013|Overall Study|Withdrawal by Subject|3|||
146359267|NCT03655717|527817880|FG014|Overall Study|Withdrawal by Subject|0|||
146359268|NCT03655717|527817881|FG015|Overall Study|Withdrawal by Subject|1|||
146359269|NCT03655717|527817882|FG016|Overall Study|Withdrawal by Subject|0|||
146359270|NCT03655717|527817883|FG017|Overall Study|Withdrawal by Subject|0|||
146359271|NCT03655717|527817884|FG018|Overall Study|Withdrawal by Subject|1|||
146359272|NCT03655717|527817885|FG019|Overall Study|Withdrawal by Subject|0|||
146359273|NCT03655717|527817886|FG020|Overall Study|Withdrawal by Subject|0|||
146359274|NCT03655717|527817887|FG021|Overall Study|Withdrawal by Subject|1|||
146359275|NCT03655717|527817888|FG022|Overall Study|Withdrawal by Subject|2|||
146359276|NCT03655717|527817889|FG023|Overall Study|Withdrawal by Subject|1|||
146359277|NCT03655717|527817890|FG024|Overall Study|Withdrawal by Subject|1|||
146359278|NCT03655717|527817891|FG025|Overall Study|Withdrawal by Subject|0|||
146359279|NCT03655717|527817866|FG000|Overall Study|Physician Decision|3|||
146359280|NCT03655717|527817867|FG001|Overall Study|Physician Decision|3|||
146359281|NCT03655717|527817868|FG002|Overall Study|Physician Decision|0|||
146359282|NCT03655717|527817869|FG003|Overall Study|Physician Decision|0|||
146359283|NCT03655717|527817870|FG004|Overall Study|Physician Decision|0|||
146359284|NCT03655717|527817871|FG005|Overall Study|Physician Decision|0|||
146359285|NCT03655717|527817872|FG006|Overall Study|Physician Decision|0|||
146359286|NCT03655717|527817873|FG007|Overall Study|Physician Decision|0|||
146359287|NCT03655717|527817874|FG008|Overall Study|Physician Decision|0|||
146359288|NCT03655717|527817875|FG009|Overall Study|Physician Decision|1|||
146359289|NCT03655717|527817876|FG010|Overall Study|Physician Decision|0|||
146359290|NCT03655717|527817877|FG011|Overall Study|Physician Decision|0|||
146359291|NCT03655717|527817878|FG012|Overall Study|Physician Decision|0|||
146359292|NCT03655717|527817879|FG013|Overall Study|Physician Decision|0|||
146359293|NCT03655717|527817880|FG014|Overall Study|Physician Decision|0|||
146359294|NCT03655717|527817881|FG015|Overall Study|Physician Decision|0|||
146359295|NCT03655717|527817882|FG016|Overall Study|Physician Decision|0|||
146359296|NCT03655717|527817883|FG017|Overall Study|Physician Decision|0|||
146359297|NCT03655717|527817884|FG018|Overall Study|Physician Decision|0|||
146359298|NCT03655717|527817885|FG019|Overall Study|Physician Decision|1|||
146359299|NCT03655717|527817886|FG020|Overall Study|Physician Decision|0|||
146359300|NCT03655717|527817887|FG021|Overall Study|Physician Decision|0|||
146359301|NCT03655717|527817888|FG022|Overall Study|Physician Decision|0|||
146359302|NCT03655717|527817889|FG023|Overall Study|Physician Decision|1|||
146359303|NCT03655717|527817890|FG024|Overall Study|Physician Decision|0|||
146359304|NCT03655717|527817891|FG025|Overall Study|Physician Decision|0|||
146359305|NCT03655717|527817866|FG000|Overall Study|Lost to Follow-up|3|||
146359306|NCT03655717|527817867|FG001|Overall Study|Lost to Follow-up|1|||
146359307|NCT03655717|527817868|FG002|Overall Study|Lost to Follow-up|0|||
146359308|NCT03655717|527817869|FG003|Overall Study|Lost to Follow-up|1|||
146359309|NCT03655717|527817870|FG004|Overall Study|Lost to Follow-up|0|||
146359310|NCT03655717|527817871|FG005|Overall Study|Lost to Follow-up|1|||
146359311|NCT03655717|527817872|FG006|Overall Study|Lost to Follow-up|0|||
146359312|NCT03655717|527817873|FG007|Overall Study|Lost to Follow-up|0|||
146359313|NCT03655717|527817874|FG008|Overall Study|Lost to Follow-up|0|||
146359314|NCT03655717|527817875|FG009|Overall Study|Lost to Follow-up|0|||
146359315|NCT03655717|527817876|FG010|Overall Study|Lost to Follow-up|0|||
146359316|NCT03655717|527817877|FG011|Overall Study|Lost to Follow-up|1|||
146359317|NCT03655717|527817878|FG012|Overall Study|Lost to Follow-up|0|||
146359318|NCT03655717|527817879|FG013|Overall Study|Lost to Follow-up|0|||
146359319|NCT03655717|527817880|FG014|Overall Study|Lost to Follow-up|0|||
146359320|NCT03655717|527817881|FG015|Overall Study|Lost to Follow-up|0|||
146359321|NCT03655717|527817882|FG016|Overall Study|Lost to Follow-up|0|||
146359322|NCT03655717|527817883|FG017|Overall Study|Lost to Follow-up|0|||
146359323|NCT03655717|527817884|FG018|Overall Study|Lost to Follow-up|0|||
146359324|NCT03655717|527817885|FG019|Overall Study|Lost to Follow-up|0|||
146359325|NCT03655717|527817886|FG020|Overall Study|Lost to Follow-up|0|||
146359326|NCT03655717|527817887|FG021|Overall Study|Lost to Follow-up|0|||
146359327|NCT03655717|527817888|FG022|Overall Study|Lost to Follow-up|0|||
146359328|NCT03655717|527817889|FG023|Overall Study|Lost to Follow-up|0|||
146359329|NCT03655717|527817890|FG024|Overall Study|Lost to Follow-up|0|||
146359330|NCT03655717|527817891|FG025|Overall Study|Lost to Follow-up|0|||
146359331|NCT00369967|527820039|FG000|Overall Study|Lost to Follow-up|23|||
146359332|NCT00369967|527820040|FG001|Overall Study|Lost to Follow-up|12|||
146359333|NCT03162055|527820050|FG000|Overall Study|Adverse Event|6|||
146359334|NCT03162055|527820051|FG001|Overall Study|Adverse Event|5|||
146359335|NCT03162055|527820050|FG000|Overall Study|Death|3|||
146359336|NCT03162055|527820051|FG001|Overall Study|Death|3|||
146359337|NCT03162055|527820050|FG000|Overall Study|Lost to Follow-up|0|||
146359338|NCT03162055|527820051|FG001|Overall Study|Lost to Follow-up|1|||
146359339|NCT03162055|527820050|FG000|Overall Study|Study-specific withdrawal criteria|22|||
146359340|NCT03162055|527820051|FG001|Overall Study|Study-specific withdrawal criteria|14|||
146359341|NCT03162055|527820050|FG000|Overall Study|Withdrawal by Subject|17|||
146359342|NCT03162055|527820051|FG001|Overall Study|Withdrawal by Subject|2|||
146359343|NCT03162055|527820050|FG000|Overall Study|Did not receive treatment|2|||
146359344|NCT03162055|527820051|FG001|Overall Study|Did not receive treatment|0|||
146359345|NCT03162055|527820050|FG000|Overall Study|Incorrect randomization|4|||
146359346|NCT03162055|527820051|FG001|Overall Study|Incorrect randomization|3|||
146359347|NCT03162055|527820050|FG000|Overall Study|Other|8|||
146359348|NCT03162055|527820051|FG001|Overall Study|Other|15|||
146359349|NCT01993615|527820052|FG000|Overall Study|Death|1|||
146359350|NCT01993615|527820053|FG001|Overall Study|Death|0|||
146359351|NCT02282982|527820059|FG000|Overall Study|Lost to Follow-up|15|||
146359352|NCT02282982|527820059|FG000|Overall Study|Withdrew consent|2|||
146359353|NCT02282982|527820059|FG000|Overall Study|Death|4|||
146359354|NCT02282982|527820059|FG000|Overall Study|Lack of product|156|||
146359355|NCT02282982|527820059|FG000|Overall Study|Palivizumab is ended|11|||
146359356|NCT02282982|527820059|FG000|Overall Study|Other, not specified|18|||
146359357|NCT02924688|527820062|FG000|Overall Study|Adverse Event|9|||
146359358|NCT02924688|527820063|FG001|Overall Study|Adverse Event|3|||
146359359|NCT02924688|527820064|FG002|Overall Study|Adverse Event|2|||
146359360|NCT02924688|527820065|FG003|Overall Study|Adverse Event|2|||
146359361|NCT02924688|527820066|FG004|Overall Study|Adverse Event|3|||
146359362|NCT02924688|527820067|FG005|Overall Study|Adverse Event|2|||
146359363|NCT02924688|527820062|FG000|Overall Study|Lack of Efficacy|2|||
146359364|NCT02924688|527820063|FG001|Overall Study|Lack of Efficacy|3|||
146359365|NCT02924688|527820064|FG002|Overall Study|Lack of Efficacy|4|||
146359366|NCT02924688|527820065|FG003|Overall Study|Lack of Efficacy|2|||
146359367|NCT02924688|527820066|FG004|Overall Study|Lack of Efficacy|1|||
146359368|NCT02924688|527820067|FG005|Overall Study|Lack of Efficacy|1|||
146359369|NCT02924688|527820062|FG000|Overall Study|Protocol Violation|3|||
146359370|NCT02924688|527820063|FG001|Overall Study|Protocol Violation|7|||
146359371|NCT02924688|527820064|FG002|Overall Study|Protocol Violation|5|||
146359372|NCT02924688|527820065|FG003|Overall Study|Protocol Violation|6|||
146359373|NCT02924688|527820066|FG004|Overall Study|Protocol Violation|2|||
146359374|NCT02924688|527820067|FG005|Overall Study|Protocol Violation|2|||
146359375|NCT02924688|527820062|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
146359376|NCT02924688|527820063|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
146359377|NCT02924688|527820064|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
146359378|NCT02924688|527820065|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
146359379|NCT02924688|527820066|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
146359380|NCT02924688|527820067|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
146359381|NCT02924688|527820062|FG000|Overall Study|Lost to Follow-up|2|||
146359382|NCT02924688|527820063|FG001|Overall Study|Lost to Follow-up|4|||
146359383|NCT02924688|527820064|FG002|Overall Study|Lost to Follow-up|2|||
146359384|NCT02924688|527820065|FG003|Overall Study|Lost to Follow-up|4|||
146359385|NCT02924688|527820066|FG004|Overall Study|Lost to Follow-up|2|||
146359386|NCT02924688|527820067|FG005|Overall Study|Lost to Follow-up|4|||
146359387|NCT02924688|527820062|FG000|Overall Study|Physician Decision|2|||
146359388|NCT02924688|527820063|FG001|Overall Study|Physician Decision|1|||
146359389|NCT02924688|527820064|FG002|Overall Study|Physician Decision|0|||
146359390|NCT02924688|527820065|FG003|Overall Study|Physician Decision|1|||
146359391|NCT02924688|527820066|FG004|Overall Study|Physician Decision|1|||
146359392|NCT02924688|527820067|FG005|Overall Study|Physician Decision|1|||
146359393|NCT02924688|527820062|FG000|Overall Study|Withdrawal by Subject|14|||
146359394|NCT02924688|527820063|FG001|Overall Study|Withdrawal by Subject|13|||
146359395|NCT02924688|527820064|FG002|Overall Study|Withdrawal by Subject|9|||
146359396|NCT02924688|527820065|FG003|Overall Study|Withdrawal by Subject|12|||
146359397|NCT02924688|527820066|FG004|Overall Study|Withdrawal by Subject|13|||
146359398|NCT02924688|527820067|FG005|Overall Study|Withdrawal by Subject|14|||
146359399|NCT02370498|527820073|FG000|Overall Study|Adverse Event|10|||
146359400|NCT02370498|527820074|FG001|Overall Study|Adverse Event|8|||
146359401|NCT02370498|527820073|FG000|Overall Study|Death|263|||
146359402|NCT02370498|527820074|FG001|Overall Study|Death|265|||
146359403|NCT02370498|527820073|FG000|Overall Study|Protocol Violation|1|||
146359404|NCT02370498|527820074|FG001|Overall Study|Protocol Violation|2|||
146359405|NCT02370498|527820073|FG000|Overall Study|Withdrawal by Subject|7|||
146359406|NCT02370498|527820074|FG001|Overall Study|Withdrawal by Subject|12|||
146359407|NCT02370498|527820073|FG000|Overall Study|Sponsor's decision|15|||
146359408|NCT02370498|527820074|FG001|Overall Study|Sponsor's decision|9|||
146359409|NCT03225716|527820078|FG000|Overall Study|Withdrawal by Subject|2|||
146359410|NCT03225716|527820079|FG001|Overall Study|Withdrawal by Subject|2|||
146359411|NCT03225716|527820080|FG002|Overall Study|Withdrawal by Subject|0|||
146359412|NCT03225716|527820078|FG000|Overall Study|Lack of Efficacy|1|||
146359413|NCT03225716|527820079|FG001|Overall Study|Lack of Efficacy|0|||
146359414|NCT03225716|527820080|FG002|Overall Study|Lack of Efficacy|0|||
146359415|NCT03225716|527820078|FG000|Overall Study|Adverse Event|2|||
146359416|NCT03225716|527820079|FG001|Overall Study|Adverse Event|0|||
146359417|NCT03225716|527820080|FG002|Overall Study|Adverse Event|1|||
146359418|NCT03225716|527820078|FG000|Overall Study|Study early termination by Sponsor|0|||
146359419|NCT03225716|527820079|FG001|Overall Study|Study early termination by Sponsor|0|||
146359420|NCT03225716|527820080|FG002|Overall Study|Study early termination by Sponsor|2|||
146359421|NCT01205451|527820091|FG000|Overall Study|Lost to Follow-up|1|||
146359422|NCT01205451|527820092|FG001|Overall Study|Lost to Follow-up|1|||
146359423|NCT01205451|527820091|FG000|Overall Study|Withdrawal by Subject|5|||
146359424|NCT01205451|527820092|FG001|Overall Study|Withdrawal by Subject|9|||
146359425|NCT00229203|527820096|FG000|Overall Study|Progressive disease|18|||
146359426|NCT00229203|527820097|FG001|Overall Study|Progressive disease|9|||
146359427|NCT00229203|527820096|FG000|Overall Study|Toxicity|6|||
146359428|NCT00229203|527820097|FG001|Overall Study|Toxicity|1|||
146359429|NCT00229203|527820096|FG000|Overall Study|Death|4|||
146359430|NCT00229203|527820097|FG001|Overall Study|Death|2|||
146359431|NCT00229203|527820096|FG000|Overall Study|Other|3|||
146359432|NCT00229203|527820097|FG001|Overall Study|Other|3|||
146359433|NCT00229203|527820096|FG000|Overall Study|Withdrawal by Subject|1|||
146359434|NCT00229203|527820097|FG001|Overall Study|Withdrawal by Subject|4|||
146359435|NCT03457103|527820098|FG000|Overall Study|illness/hospitalization|4|||
146359436|NCT03457103|527820099|FG001|Overall Study|illness/hospitalization|2|||
146359437|NCT03457103|527820098|FG000|Overall Study|Lost to Follow-up|2|||
146359438|NCT03457103|527820099|FG001|Overall Study|Lost to Follow-up|1|||
146359439|NCT03457103|527820098|FG000|Overall Study|Withdrawal by Subject|1|||
146359440|NCT03457103|527820099|FG001|Overall Study|Withdrawal by Subject|2|||
146359441|NCT03457103|527820098|FG000|Overall Study|financial/ insurance issues|1|||
146359442|NCT03457103|527820099|FG001|Overall Study|financial/ insurance issues|1|||
146359443|NCT02411201|527820100|FG000|Overall Study|Adverse Event|2|||
146359444|NCT02411201|527820100|FG000|Overall Study|Withdrawal by Subject|2|||
146359445|NCT02411201|527820100|FG000|Overall Study|Age group completed|2|||
146359446|NCT00798694|527820101|FG000|Overall Study|Lost to Follow-up|1|||
146359447|NCT00798694|527820102|FG001|Overall Study|Lost to Follow-up|1|||
146359448|NCT00798694|527820101|FG000|Overall Study|Physician Decision|1|||
146359449|NCT00798694|527820102|FG001|Overall Study|Physician Decision|0|||
146359450|NCT01774344|527820104|FG000|Overall Study|Withdrawal by Subject|3|||
146359451|NCT01774344|527820105|FG001|Overall Study|Withdrawal by Subject|10|||
146359452|NCT01774344|527820104|FG000|Overall Study|Protocol Violation|0|||
146359453|NCT01774344|527820105|FG001|Overall Study|Protocol Violation|1|||
146359454|NCT01774344|527820104|FG000|Overall Study|Lost to Follow-up|4|||
146359455|NCT01774344|527820105|FG001|Overall Study|Lost to Follow-up|10|||
146359456|NCT01774344|527820104|FG000|Overall Study|End of survival follow-up not available|2|||
146359457|NCT01774344|527820105|FG001|Overall Study|End of survival follow-up not available|2|||
146359458|NCT01774344|527820104|FG000|Overall Study|Data collection finished|4|||
146359459|NCT01774344|527820105|FG001|Overall Study|Data collection finished|14|||
146359460|NCT01774344|527820104|FG000|Overall Study|Other|0|||
146359461|NCT01774344|527820105|FG001|Overall Study|Other|1|||
146359462|NCT01774344|527820104|FG000|Overall Study|Did not enter Survival Follow up|49|||
146359463|NCT01774344|527820105|FG001|Overall Study|Did not enter Survival Follow up|83|||
146359464|NCT03364608|527820114|FG000|Overall Study|Withdrawal by Subject|4|||
146359465|NCT03364608|527820114|FG000|Overall Study|Protocol Violation|2|||
146359466|NCT03364608|527820114|FG000|Overall Study|Lost to Follow-up|2|||
146359467|NCT03004469|527820117|FG000|Overall Study|Adverse Event|6|||
146359468|NCT03004469|527820118|FG001|Overall Study|Adverse Event|4|||
146359469|NCT03004469|527820119|FG002|Overall Study|Adverse Event|6|||
146359470|NCT03004469|527820117|FG000|Overall Study|Lack of Efficacy|1|||
146359471|NCT03004469|527820118|FG001|Overall Study|Lack of Efficacy|0|||
146359472|NCT03004469|527820119|FG002|Overall Study|Lack of Efficacy|1|||
146359473|NCT03004469|527820117|FG000|Overall Study|Lost to Follow-up|23|||
146359474|NCT03004469|527820118|FG001|Overall Study|Lost to Follow-up|14|||
146359475|NCT03004469|527820119|FG002|Overall Study|Lost to Follow-up|6|||
146359476|NCT03004469|527820117|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146359477|NCT03004469|527820118|FG001|Overall Study|Non-Compliance with Study Drug|0|||
146359478|NCT03004469|527820119|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146359479|NCT03004469|527820117|FG000|Overall Study|Protocol Violation|0|||
146359480|NCT03004469|527820118|FG001|Overall Study|Protocol Violation|0|||
146359481|NCT03004469|527820119|FG002|Overall Study|Protocol Violation|1|||
146359482|NCT03004469|527820117|FG000|Overall Study|Withdrawal by Subject|29|||
146359483|NCT03004469|527820118|FG001|Overall Study|Withdrawal by Subject|27|||
146359484|NCT03004469|527820119|FG002|Overall Study|Withdrawal by Subject|10|||
146359485|NCT03004469|527820117|FG000|Overall Study|Other unspecified reason|0|||
146359486|NCT03004469|527820118|FG001|Overall Study|Other unspecified reason|4|||
146359487|NCT03004469|527820119|FG002|Overall Study|Other unspecified reason|1|||
146359488|NCT01163253|527820120|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
146359489|NCT01163253|527820121|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
146359490|NCT01163253|527820120|FG000|Overall Study|Study Terminated by Sponsor|978|||
146359491|NCT01163253|527820121|FG001|Overall Study|Study Terminated by Sponsor|349|||
146359492|NCT01163253|527820120|FG000|Overall Study|Protocol Violation|43|||
146359493|NCT01163253|527820121|FG001|Overall Study|Protocol Violation|12|||
146359494|NCT01163253|527820120|FG000|Overall Study|Withdrawal by Subject|199|||
146359495|NCT01163253|527820121|FG001|Overall Study|Withdrawal by Subject|50|||
146359496|NCT01163253|527820120|FG000|Overall Study|Medication Error|1|||
146359497|NCT01163253|527820121|FG001|Overall Study|Medication Error|0|||
146359498|NCT01163253|527820120|FG000|Overall Study|Lost to Follow-up|125|||
146359499|NCT01163253|527820121|FG001|Overall Study|Lost to Follow-up|23|||
146359500|NCT01163253|527820120|FG000|Overall Study|Insufficient Clinical Response|423|||
146359501|NCT01163253|527820121|FG001|Overall Study|Insufficient Clinical Response|29|||
146359502|NCT01163253|527820120|FG000|Overall Study|Adverse Event|300|||
146359503|NCT01163253|527820121|FG001|Overall Study|Adverse Event|78|||
146359504|NCT01163253|527820120|FG000|Overall Study|Death|17|||
146359505|NCT01163253|527820121|FG001|Overall Study|Death|5|||
146359506|NCT01163253|527820120|FG000|Overall Study|Ongoing|13|||
146359507|NCT01163253|527820121|FG001|Overall Study|Ongoing|4|||
146359508|NCT01163253|527820120|FG000|Overall Study|Other Unspecified|170|||
146359509|NCT01163253|527820121|FG001|Overall Study|Other Unspecified|34|||
146359510|NCT02492997|527820122|FG000|Overall Study|Withdrawal by Subject|1|||
146359511|NCT02492997|527820123|FG001|Overall Study|Withdrawal by Subject|0|||
146359512|NCT02492997|527820122|FG000|Overall Study|Gained Weight|1|||
146359513|NCT02492997|527820123|FG001|Overall Study|Gained Weight|0|||
146359514|NCT02492997|527820122|FG000|Overall Study|Lost to Follow-up|0|||
146359515|NCT02492997|527820123|FG001|Overall Study|Lost to Follow-up|1|||
146359516|NCT01089582|527820126|FG000|Overall Study|Death|2|||
146359517|NCT01089582|527820126|FG000|Overall Study|Adverse Event|15|||
146359518|NCT01089582|527820126|FG000|Overall Study|Lost to Follow-up|8|||
146359519|NCT01089582|527820126|FG000|Overall Study|Other|4|||
146359520|NCT01089582|527820126|FG000|Overall Study|Withdrawal by Subject|1|||
146359521|NCT04863014|527820127|FG000|Overall Study|Lost to Follow-up|3|||
146359522|NCT04863014|527820128|FG001|Overall Study|Lost to Follow-up|2|||
146359523|NCT04863014|527820127|FG000|Overall Study|Subject Decision|0|||
146359524|NCT04863014|527820128|FG001|Overall Study|Subject Decision|4|||
146359525|NCT00417976|527820129|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
146359526|NCT00417976|527820129|FG000|Overall Study|Treatment -related toxicity|2|||
146359527|NCT01968954|527820132|FG000|Overall Study|Adverse Event|6|||
146359528|NCT01968954|527820133|FG001|Overall Study|Adverse Event|3|||
146359529|NCT01968954|527820132|FG000|Overall Study|Death|1|||
146359530|NCT01968954|527820133|FG001|Overall Study|Death|2|||
146359531|NCT01968954|527820132|FG000|Overall Study|Lost to Follow-up|6|||
146359532|NCT01968954|527820133|FG001|Overall Study|Lost to Follow-up|4|||
146359533|NCT01968954|527820132|FG000|Overall Study|Withdrawal by Subject|20|||
146359534|NCT01968954|527820133|FG001|Overall Study|Withdrawal by Subject|23|||
146359535|NCT01968954|527820132|FG000|Overall Study|Other|7|||
146359536|NCT01968954|527820133|FG001|Overall Study|Other|8|||
146359537|NCT01968954|527820132|FG000|Overall Study|Protocol Violation|0|||
146359538|NCT01968954|527820133|FG001|Overall Study|Protocol Violation|1|||
146359539|NCT01968954|527820132|FG000|Overall Study|Did not met inclusion criteria|0|||
146359540|NCT01968954|527820133|FG001|Overall Study|Did not met inclusion criteria|2|||
146359541|NCT00064350|527820134|FG000|Induction Treatment|Disease Progression|5|||
146359542|NCT00064350|527820135|FG001|Induction Treatment|Disease Progression|1|||
146359543|NCT00064350|527820136|FG002|Induction Treatment|Disease Progression|110|||
146359544|NCT00064350|527820134|FG000|Induction Treatment|Adverse Event|0|||
146359545|NCT00064350|527820135|FG001|Induction Treatment|Adverse Event|2|||
146359546|NCT00064350|527820136|FG002|Induction Treatment|Adverse Event|49|||
146359547|NCT00064350|527820134|FG000|Induction Treatment|Death|0|||
146359548|NCT00064350|527820135|FG001|Induction Treatment|Death|0|||
146359549|NCT00064350|527820136|FG002|Induction Treatment|Death|9|||
146359550|NCT00064350|527820134|FG000|Induction Treatment|Withdrawal by Subject|0|||
146359551|NCT00064350|527820135|FG001|Induction Treatment|Withdrawal by Subject|0|||
146359552|NCT00064350|527820136|FG002|Induction Treatment|Withdrawal by Subject|21|||
146359553|NCT00064350|527820134|FG000|Induction Treatment|Ineligible or never started treatment|3|||
146359554|NCT00064350|527820135|FG001|Induction Treatment|Ineligible or never started treatment|6|||
146359555|NCT00064350|527820136|FG002|Induction Treatment|Ineligible or never started treatment|34|||
146359556|NCT00064350|527820134|FG000|Induction Treatment|Other|0|||
146359557|NCT00064350|527820135|FG001|Induction Treatment|Other|0|||
146359558|NCT00064350|527820136|FG002|Induction Treatment|Other|13|||
146359559|NCT00064350|527820134|FG000|Randomization|Adverse Event|8|||
146359560|NCT00064350|527820135|FG001|Randomization|Adverse Event|3|||
146359561|NCT00064350|527820136|FG002|Randomization|Adverse Event|0|||
146359562|NCT00064350|527820134|FG000|Randomization|Death|3|||
146359563|NCT00064350|527820135|FG001|Randomization|Death|0|||
146359564|NCT00064350|527820136|FG002|Randomization|Death|0|||
146359565|NCT00064350|527820134|FG000|Randomization|Withdrawal by Subject|1|||
146359566|NCT00064350|527820135|FG001|Randomization|Withdrawal by Subject|0|||
146359567|NCT00064350|527820136|FG002|Randomization|Withdrawal by Subject|0|||
146359568|NCT00064350|527820134|FG000|Randomization|Ineligible or never started treatment|9|||
146359569|NCT00064350|527820135|FG001|Randomization|Ineligible or never started treatment|15|||
146359570|NCT00064350|527820136|FG002|Randomization|Ineligible or never started treatment|0|||
146359571|NCT00064350|527820134|FG000|Randomization|Other|5|||
146359572|NCT00064350|527820135|FG001|Randomization|Other|0|||
146359573|NCT00064350|527820136|FG002|Randomization|Other|0|||
146359574|NCT00064350|527820134|FG000|Cross-Over|Adverse Event|0|||
146359575|NCT00064350|527820135|FG001|Cross-Over|Adverse Event|1|||
146359576|NCT00064350|527820136|FG002|Cross-Over|Adverse Event|0|||
146359577|NCT00064350|527820134|FG000|Cross-Over|Death|1|||
146359578|NCT00064350|527820135|FG001|Cross-Over|Death|3|||
146359579|NCT00064350|527820136|FG002|Cross-Over|Death|0|||
146359580|NCT00064350|527820134|FG000|Cross-Over|Withdrawal by Subject|2|||
146359581|NCT00064350|527820135|FG001|Cross-Over|Withdrawal by Subject|2|||
146359582|NCT00064350|527820136|FG002|Cross-Over|Withdrawal by Subject|0|||
146359583|NCT00064350|527820134|FG000|Cross-Over|Ineligible or never started treatment|3|||
146169649|NCT03333928|527132886|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
146169650|NCT03333928|527132884|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
146169651|NCT03333928|527132885|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
146169652|NCT03333928|527132886|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
146169653|NCT03333928|527132884|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
146169654|NCT03333928|527132885|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
146169655|NCT03333928|527132886|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
146169656|NCT03333928|527132884|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
146169657|NCT03333928|527132885|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
146359584|NCT00064350|527820135|FG001|Cross-Over|Ineligible or never started treatment|6|||
146359585|NCT00064350|527820136|FG002|Cross-Over|Ineligible or never started treatment|0|||
146359586|NCT00064350|527820134|FG000|Cross-Over|Other|0|||
146359587|NCT00064350|527820135|FG001|Cross-Over|Other|2|||
146359588|NCT00064350|527820136|FG002|Cross-Over|Other|0|||
146359589|NCT03600714|527820137|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
146359590|NCT01935336|527820140|FG000|Overall Study|Adverse Event|1|||
146359591|NCT01935336|527820141|FG001|Overall Study|Adverse Event|0|||
146359592|NCT01935336|527820142|FG002|Overall Study|Adverse Event|0|||
146359593|NCT01935336|527820143|FG003|Overall Study|Adverse Event|0|||
146359594|NCT01935336|527820140|FG000|Overall Study|Progressive disease|5|||
146359595|NCT01935336|527820141|FG001|Overall Study|Progressive disease|3|||
146359596|NCT01935336|527820142|FG002|Overall Study|Progressive disease|47|||
146359597|NCT01935336|527820143|FG003|Overall Study|Progressive disease|66|||
146359598|NCT00592553|527820144|FG000|Overall Study|Protocol Noncompliance|1|||
146359599|NCT00592553|527820145|FG001|Overall Study|Protocol Noncompliance|0|||
146359600|NCT00592553|527820146|FG002|Overall Study|Protocol Noncompliance|0|||
146359601|NCT01752842|527820147|FG000|Overall Study|Adverse Event|3|||
146359602|NCT01752842|527820148|FG001|Overall Study|Adverse Event|0|||
146359603|NCT01752842|527820147|FG000|Overall Study|Withdrawal by Subject|0|||
146359604|NCT01752842|527820148|FG001|Overall Study|Withdrawal by Subject|2|||
146359605|NCT03707158|527820149|FG000|Midtreatment|Lost to Follow-up|16|||
146359606|NCT03707158|527820150|FG001|Midtreatment|Lost to Follow-up|7|||
146359607|NCT03707158|527820149|FG000|Midtreatment|Withdrawal by Subject|28|||
146359608|NCT03707158|527820150|FG001|Midtreatment|Withdrawal by Subject|19|||
146359609|NCT03707158|527820149|FG000|Posttreatment|Lost to Follow-up|0|||
146359610|NCT03707158|527820150|FG001|Posttreatment|Lost to Follow-up|5|||
146359611|NCT03707158|527820149|FG000|Follow-up|Lost to Follow-up|19|||
146359612|NCT03707158|527820150|FG001|Follow-up|Lost to Follow-up|18|||
146359613|NCT03707158|527820149|FG000|Follow-up|Withdrawal by Subject|13|||
146359614|NCT03707158|527820150|FG001|Follow-up|Withdrawal by Subject|6|||
146359615|NCT01208038|527820154|FG000|Overall Study|Withdrawal by Subject|1|||
146359616|NCT03260205|527820157|FG000|Overall Study|Adverse Event|2|||
146359617|NCT03260205|527820158|FG001|Overall Study|Adverse Event|0|||
146359618|NCT03260205|527820159|FG002|Overall Study|Adverse Event|2|||
146359619|NCT03260205|527820160|FG003|Overall Study|Adverse Event|2|||
146359620|NCT03260205|527820161|FG004|Overall Study|Adverse Event|4|||
146359621|NCT03260205|527820157|FG000|Overall Study|Lost to Follow-up|2|||
146359622|NCT03260205|527820158|FG001|Overall Study|Lost to Follow-up|2|||
146359623|NCT03260205|527820159|FG002|Overall Study|Lost to Follow-up|1|||
146359624|NCT03260205|527820160|FG003|Overall Study|Lost to Follow-up|1|||
146359625|NCT03260205|527820161|FG004|Overall Study|Lost to Follow-up|5|||
146359626|NCT03260205|527820157|FG000|Overall Study|Protocol Violation|0|||
146359627|NCT03260205|527820158|FG001|Overall Study|Protocol Violation|0|||
146359628|NCT03260205|527820159|FG002|Overall Study|Protocol Violation|2|||
146359629|NCT03260205|527820160|FG003|Overall Study|Protocol Violation|0|||
146359630|NCT03260205|527820161|FG004|Overall Study|Protocol Violation|1|||
146359631|NCT03260205|527820157|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
146359632|NCT03260205|527820158|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
146359633|NCT03260205|527820159|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
146359634|NCT03260205|527820160|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
146359635|NCT03260205|527820161|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
146359636|NCT03260205|527820157|FG000|Overall Study|Other: Unspecified|0|||
146359637|NCT03260205|527820158|FG001|Overall Study|Other: Unspecified|0|||
146359638|NCT03260205|527820159|FG002|Overall Study|Other: Unspecified|3|||
146359639|NCT03260205|527820160|FG003|Overall Study|Other: Unspecified|1|||
146359640|NCT03260205|527820161|FG004|Overall Study|Other: Unspecified|1|||
146359641|NCT03260205|527820157|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
146359642|NCT03260205|527820158|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
146359643|NCT03260205|527820159|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
146359644|NCT03260205|527820160|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
146359645|NCT03260205|527820161|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
146359646|NCT01968187|527820162|FG000|Overall Study|Adverse Event|0|||
146359647|NCT01968187|527820163|FG001|Overall Study|Adverse Event|1|||
146359648|NCT01968187|527820162|FG000|Overall Study|Randomized but not treated|1|||
146359649|NCT01968187|527820163|FG001|Overall Study|Randomized but not treated|0|||
146359650|NCT01877382|527820164|FG000|Dose Escalation|Progressive disease|2|||
146359651|NCT01877382|527820165|FG001|Dose Escalation|Progressive disease|0|||
146359652|NCT01877382|527820166|FG002|Dose Escalation|Progressive disease|1|||
146359653|NCT01877382|527820167|FG003|Dose Escalation|Progressive disease|6|||
146359654|NCT01877382|527820168|FG004|Dose Escalation|Progressive disease|1|||
146359655|NCT01877382|527820169|FG005|Dose Escalation|Progressive disease|0|||
146359656|NCT01877382|527820170|FG006|Dose Escalation|Progressive disease|3|||
146359657|NCT01877382|527820171|FG007|Dose Escalation|Progressive disease|10|||
146359658|NCT01877382|527820172|FG008|Dose Escalation|Progressive disease|4|||
146359659|NCT01877382|527820173|FG009|Dose Escalation|Progressive disease|2|||
146359660|NCT01877382|527820174|FG010|Dose Escalation|Progressive disease|3|||
146359661|NCT01877382|527820175|FG011|Dose Escalation|Progressive disease|3|||
146359662|NCT01877382|527820176|FG012|Dose Escalation|Progressive disease|13|||
146359663|NCT01877382|527820177|FG013|Dose Escalation|Progressive disease|1|||
146359664|NCT01877382|527820178|FG014|Dose Escalation|Progressive disease|0|||
146359665|NCT01877382|527820164|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146359666|NCT01877382|527820165|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359667|NCT01877382|527820166|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359668|NCT01877382|527820167|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146359669|NCT01877382|527820168|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359670|NCT01877382|527820169|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359671|NCT01877382|527820170|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146359672|NCT01877382|527820171|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359673|NCT01877382|527820172|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359674|NCT01877382|527820173|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359675|NCT01877382|527820174|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359676|NCT01877382|527820175|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359677|NCT01877382|527820176|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359678|NCT01877382|527820177|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359679|NCT01877382|527820178|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359680|NCT01877382|527820164|FG000|Dose Escalation|Clinical progression|0|||
146359681|NCT01877382|527820165|FG001|Dose Escalation|Clinical progression|1|||
146359682|NCT01877382|527820166|FG002|Dose Escalation|Clinical progression|0|||
146359683|NCT01877382|527820167|FG003|Dose Escalation|Clinical progression|2|||
146359684|NCT01877382|527820168|FG004|Dose Escalation|Clinical progression|0|||
146359685|NCT01877382|527820169|FG005|Dose Escalation|Clinical progression|0|||
146359686|NCT01877382|527820170|FG006|Dose Escalation|Clinical progression|1|||
146359687|NCT01877382|527820171|FG007|Dose Escalation|Clinical progression|0|||
146359688|NCT01877382|527820172|FG008|Dose Escalation|Clinical progression|0|||
146359689|NCT01877382|527820173|FG009|Dose Escalation|Clinical progression|1|||
146359690|NCT01877382|527820174|FG010|Dose Escalation|Clinical progression|0|||
146359691|NCT01877382|527820175|FG011|Dose Escalation|Clinical progression|0|||
146359692|NCT01877382|527820176|FG012|Dose Escalation|Clinical progression|2|||
146359693|NCT01877382|527820177|FG013|Dose Escalation|Clinical progression|1|||
146359694|NCT01877382|527820178|FG014|Dose Escalation|Clinical progression|0|||
146359695|NCT01877382|527820164|FG000|Dose Escalation|Adverse Event|0|||
146359696|NCT01877382|527820165|FG001|Dose Escalation|Adverse Event|0|||
146359697|NCT01877382|527820166|FG002|Dose Escalation|Adverse Event|0|||
146359698|NCT01877382|527820167|FG003|Dose Escalation|Adverse Event|4|||
146359699|NCT01877382|527820168|FG004|Dose Escalation|Adverse Event|1|||
146359700|NCT01877382|527820169|FG005|Dose Escalation|Adverse Event|2|||
146359701|NCT01877382|527820170|FG006|Dose Escalation|Adverse Event|1|||
146359702|NCT01877382|527820171|FG007|Dose Escalation|Adverse Event|2|||
146359703|NCT01877382|527820172|FG008|Dose Escalation|Adverse Event|0|||
146359704|NCT01877382|527820173|FG009|Dose Escalation|Adverse Event|0|||
146359705|NCT01877382|527820174|FG010|Dose Escalation|Adverse Event|0|||
146359706|NCT01877382|527820175|FG011|Dose Escalation|Adverse Event|0|||
146359707|NCT01877382|527820176|FG012|Dose Escalation|Adverse Event|1|||
146359708|NCT01877382|527820177|FG013|Dose Escalation|Adverse Event|0|||
146359709|NCT01877382|527820178|FG014|Dose Escalation|Adverse Event|0|||
146359710|NCT01877382|527820164|FG000|Dose Escalation|Withdrawal by Subject|0|||
146359711|NCT01877382|527820165|FG001|Dose Escalation|Withdrawal by Subject|0|||
146359712|NCT01877382|527820166|FG002|Dose Escalation|Withdrawal by Subject|0|||
146359713|NCT01877382|527820167|FG003|Dose Escalation|Withdrawal by Subject|0|||
146359714|NCT01877382|527820168|FG004|Dose Escalation|Withdrawal by Subject|0|||
146359715|NCT01877382|527820169|FG005|Dose Escalation|Withdrawal by Subject|3|||
146359716|NCT01877382|527820170|FG006|Dose Escalation|Withdrawal by Subject|2|||
146359717|NCT01877382|527820171|FG007|Dose Escalation|Withdrawal by Subject|1|||
146359718|NCT01877382|527820172|FG008|Dose Escalation|Withdrawal by Subject|1|||
146359719|NCT01877382|527820173|FG009|Dose Escalation|Withdrawal by Subject|0|||
146359720|NCT01877382|527820174|FG010|Dose Escalation|Withdrawal by Subject|0|||
146359721|NCT01877382|527820175|FG011|Dose Escalation|Withdrawal by Subject|0|||
146359722|NCT01877382|527820176|FG012|Dose Escalation|Withdrawal by Subject|0|||
146359723|NCT01877382|527820177|FG013|Dose Escalation|Withdrawal by Subject|0|||
146359724|NCT01877382|527820178|FG014|Dose Escalation|Withdrawal by Subject|0|||
146359725|NCT01877382|527820164|FG000|Dose Escalation|Protocol Violation|0|||
146359726|NCT01877382|527820165|FG001|Dose Escalation|Protocol Violation|0|||
146359727|NCT01877382|527820166|FG002|Dose Escalation|Protocol Violation|0|||
146359728|NCT01877382|527820167|FG003|Dose Escalation|Protocol Violation|0|||
146169658|NCT03333928|527132886|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
146359729|NCT01877382|527820168|FG004|Dose Escalation|Protocol Violation|0|||
146359730|NCT01877382|527820169|FG005|Dose Escalation|Protocol Violation|0|||
146169659|NCT03333928|527132884|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
146169660|NCT03333928|527132885|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
146359731|NCT01877382|527820170|FG006|Dose Escalation|Protocol Violation|1|||
146359732|NCT01877382|527820171|FG007|Dose Escalation|Protocol Violation|0|||
146359733|NCT01877382|527820172|FG008|Dose Escalation|Protocol Violation|0|||
146359734|NCT01877382|527820173|FG009|Dose Escalation|Protocol Violation|0|||
146359735|NCT01877382|527820174|FG010|Dose Escalation|Protocol Violation|0|||
146359736|NCT01877382|527820175|FG011|Dose Escalation|Protocol Violation|0|||
146359737|NCT01877382|527820176|FG012|Dose Escalation|Protocol Violation|0|||
146359738|NCT01877382|527820177|FG013|Dose Escalation|Protocol Violation|0|||
146359739|NCT01877382|527820178|FG014|Dose Escalation|Protocol Violation|0|||
146359740|NCT01877382|527820164|FG000|Dose Escalation|Study terminated by sponsor|0|||
146359741|NCT01877382|527820165|FG001|Dose Escalation|Study terminated by sponsor|0|||
146359742|NCT01877382|527820166|FG002|Dose Escalation|Study terminated by sponsor|0|||
146359743|NCT01877382|527820167|FG003|Dose Escalation|Study terminated by sponsor|0|||
146359744|NCT01877382|527820168|FG004|Dose Escalation|Study terminated by sponsor|0|||
146359745|NCT01877382|527820169|FG005|Dose Escalation|Study terminated by sponsor|0|||
146359746|NCT01877382|527820170|FG006|Dose Escalation|Study terminated by sponsor|0|||
146359747|NCT01877382|527820171|FG007|Dose Escalation|Study terminated by sponsor|1|||
146359748|NCT01877382|527820172|FG008|Dose Escalation|Study terminated by sponsor|1|||
146359749|NCT01877382|527820173|FG009|Dose Escalation|Study terminated by sponsor|0|||
146359750|NCT01877382|527820174|FG010|Dose Escalation|Study terminated by sponsor|0|||
146359751|NCT01877382|527820175|FG011|Dose Escalation|Study terminated by sponsor|0|||
146359752|NCT01877382|527820176|FG012|Dose Escalation|Study terminated by sponsor|3|||
146359753|NCT01877382|527820177|FG013|Dose Escalation|Study terminated by sponsor|0|||
146359754|NCT01877382|527820178|FG014|Dose Escalation|Study terminated by sponsor|0|||
146359755|NCT01877382|527820164|FG000|Dose Escalation|Death|0|||
146359756|NCT01877382|527820165|FG001|Dose Escalation|Death|0|||
146359757|NCT01877382|527820166|FG002|Dose Escalation|Death|0|||
146359758|NCT01877382|527820167|FG003|Dose Escalation|Death|0|||
146359759|NCT01877382|527820168|FG004|Dose Escalation|Death|0|||
146359760|NCT01877382|527820169|FG005|Dose Escalation|Death|0|||
146359761|NCT01877382|527820170|FG006|Dose Escalation|Death|0|||
146359762|NCT01877382|527820171|FG007|Dose Escalation|Death|1|||
146359763|NCT01877382|527820172|FG008|Dose Escalation|Death|0|||
146359764|NCT01877382|527820173|FG009|Dose Escalation|Death|0|||
146359765|NCT01877382|527820174|FG010|Dose Escalation|Death|0|||
146359766|NCT01877382|527820175|FG011|Dose Escalation|Death|0|||
146359767|NCT01877382|527820176|FG012|Dose Escalation|Death|1|||
146359768|NCT01877382|527820177|FG013|Dose Escalation|Death|1|||
146359769|NCT01877382|527820178|FG014|Dose Escalation|Death|0|||
146359770|NCT01877382|527820164|FG000|Dose Expansion|Progressive disease|0|||
146359771|NCT01877382|527820165|FG001|Dose Expansion|Progressive disease|0|||
146359772|NCT01877382|527820166|FG002|Dose Expansion|Progressive disease|0|||
146359773|NCT01877382|527820167|FG003|Dose Expansion|Progressive disease|0|||
146359774|NCT01877382|527820168|FG004|Dose Expansion|Progressive disease|0|||
146359775|NCT01877382|527820169|FG005|Dose Expansion|Progressive disease|0|||
146359776|NCT01877382|527820170|FG006|Dose Expansion|Progressive disease|0|||
146359777|NCT01877382|527820171|FG007|Dose Expansion|Progressive disease|0|||
146359778|NCT01877382|527820172|FG008|Dose Expansion|Progressive disease|0|||
146359779|NCT01877382|527820173|FG009|Dose Expansion|Progressive disease|0|||
146359780|NCT01877382|527820174|FG010|Dose Expansion|Progressive disease|0|||
146359781|NCT01877382|527820175|FG011|Dose Expansion|Progressive disease|0|||
146359782|NCT01877382|527820176|FG012|Dose Expansion|Progressive disease|0|||
146359783|NCT01877382|527820177|FG013|Dose Expansion|Progressive disease|0|||
146359784|NCT01877382|527820178|FG014|Dose Expansion|Progressive disease|11|||
146359785|NCT01877382|527820164|FG000|Dose Expansion|Clinical progression|0|||
146359786|NCT01877382|527820165|FG001|Dose Expansion|Clinical progression|0|||
146359787|NCT01877382|527820166|FG002|Dose Expansion|Clinical progression|0|||
146359788|NCT01877382|527820167|FG003|Dose Expansion|Clinical progression|0|||
146359789|NCT01877382|527820168|FG004|Dose Expansion|Clinical progression|0|||
146359790|NCT01877382|527820169|FG005|Dose Expansion|Clinical progression|0|||
146359791|NCT01877382|527820170|FG006|Dose Expansion|Clinical progression|0|||
146359792|NCT01877382|527820171|FG007|Dose Expansion|Clinical progression|0|||
146359793|NCT01877382|527820172|FG008|Dose Expansion|Clinical progression|0|||
146359794|NCT01877382|527820173|FG009|Dose Expansion|Clinical progression|0|||
146359795|NCT01877382|527820174|FG010|Dose Expansion|Clinical progression|0|||
146359796|NCT01877382|527820175|FG011|Dose Expansion|Clinical progression|0|||
146359797|NCT01877382|527820176|FG012|Dose Expansion|Clinical progression|0|||
146359798|NCT01877382|527820177|FG013|Dose Expansion|Clinical progression|0|||
146359799|NCT01877382|527820178|FG014|Dose Expansion|Clinical progression|6|||
146359800|NCT01877382|527820164|FG000|Dose Expansion|Adverse Event|0|||
146359801|NCT01877382|527820165|FG001|Dose Expansion|Adverse Event|0|||
146359802|NCT01877382|527820166|FG002|Dose Expansion|Adverse Event|0|||
146359803|NCT01877382|527820167|FG003|Dose Expansion|Adverse Event|0|||
146359804|NCT01877382|527820168|FG004|Dose Expansion|Adverse Event|0|||
146359805|NCT01877382|527820169|FG005|Dose Expansion|Adverse Event|0|||
146359806|NCT01877382|527820170|FG006|Dose Expansion|Adverse Event|0|||
146359807|NCT01877382|527820171|FG007|Dose Expansion|Adverse Event|0|||
146359808|NCT01877382|527820172|FG008|Dose Expansion|Adverse Event|0|||
146359809|NCT01877382|527820173|FG009|Dose Expansion|Adverse Event|0|||
146359810|NCT01877382|527820174|FG010|Dose Expansion|Adverse Event|0|||
146359811|NCT01877382|527820175|FG011|Dose Expansion|Adverse Event|0|||
146359812|NCT01877382|527820176|FG012|Dose Expansion|Adverse Event|0|||
146359813|NCT01877382|527820177|FG013|Dose Expansion|Adverse Event|0|||
146359814|NCT01877382|527820178|FG014|Dose Expansion|Adverse Event|1|||
146359815|NCT01877382|527820164|FG000|Dose Expansion|Death|0|||
146359816|NCT01877382|527820165|FG001|Dose Expansion|Death|0|||
146359817|NCT01877382|527820166|FG002|Dose Expansion|Death|0|||
146359818|NCT01877382|527820167|FG003|Dose Expansion|Death|0|||
146359819|NCT01877382|527820168|FG004|Dose Expansion|Death|0|||
146359820|NCT01877382|527820169|FG005|Dose Expansion|Death|0|||
146359821|NCT01877382|527820170|FG006|Dose Expansion|Death|0|||
146359822|NCT01877382|527820171|FG007|Dose Expansion|Death|0|||
146359823|NCT01877382|527820172|FG008|Dose Expansion|Death|0|||
146359824|NCT01877382|527820173|FG009|Dose Expansion|Death|0|||
146359825|NCT01877382|527820174|FG010|Dose Expansion|Death|0|||
146359826|NCT01877382|527820175|FG011|Dose Expansion|Death|0|||
146359827|NCT01877382|527820176|FG012|Dose Expansion|Death|0|||
146359828|NCT01877382|527820177|FG013|Dose Expansion|Death|0|||
146359829|NCT01877382|527820178|FG014|Dose Expansion|Death|1|||
146359830|NCT01877382|527820164|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359831|NCT01877382|527820165|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359832|NCT01877382|527820166|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359833|NCT01877382|527820167|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359834|NCT01877382|527820168|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359835|NCT01877382|527820169|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359836|NCT01877382|527820170|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359837|NCT01877382|527820171|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359838|NCT01877382|527820172|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359839|NCT01877382|527820173|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359840|NCT01877382|527820174|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359841|NCT01877382|527820175|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359842|NCT01877382|527820176|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359843|NCT01877382|527820177|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
146359844|NCT01877382|527820178|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
146359845|NCT00430521|527820181|FG000|Overall Study|Adverse Event|0|||
146359846|NCT00430521|527820182|FG001|Overall Study|Adverse Event|0|||
146359847|NCT00430521|527820183|FG002|Overall Study|Adverse Event|0|||
146359848|NCT00430521|527820184|FG003|Overall Study|Adverse Event|0|||
146359849|NCT00430521|527820185|FG004|Overall Study|Adverse Event|0|||
146359850|NCT00430521|527820186|FG005|Overall Study|Adverse Event|2|||
146359851|NCT00430521|527820187|FG006|Overall Study|Adverse Event|1|||
146359852|NCT00430521|527820188|FG007|Overall Study|Adverse Event|0|||
146359853|NCT00430521|527820181|FG000|Overall Study|Lost to Follow-up|7|||
146359854|NCT00430521|527820182|FG001|Overall Study|Lost to Follow-up|8|||
146359855|NCT00430521|527820183|FG002|Overall Study|Lost to Follow-up|3|||
146359856|NCT00430521|527820184|FG003|Overall Study|Lost to Follow-up|5|||
146359857|NCT00430521|527820185|FG004|Overall Study|Lost to Follow-up|5|||
146359858|NCT00430521|527820186|FG005|Overall Study|Lost to Follow-up|2|||
146359859|NCT00430521|527820187|FG006|Overall Study|Lost to Follow-up|8|||
146359860|NCT00430521|527820188|FG007|Overall Study|Lost to Follow-up|10|||
146359861|NCT00430521|527820181|FG000|Overall Study|Pregnancy|0|||
146359862|NCT00430521|527820182|FG001|Overall Study|Pregnancy|0|||
146359863|NCT00430521|527820183|FG002|Overall Study|Pregnancy|0|||
146359864|NCT00430521|527820184|FG003|Overall Study|Pregnancy|0|||
146359865|NCT00430521|527820185|FG004|Overall Study|Pregnancy|0|||
146359866|NCT00430521|527820186|FG005|Overall Study|Pregnancy|0|||
146359867|NCT00430521|527820187|FG006|Overall Study|Pregnancy|1|||
146359868|NCT00430521|527820188|FG007|Overall Study|Pregnancy|0|||
146359869|NCT00430521|527820181|FG000|Overall Study|Vaccine Expired|0|||
146359870|NCT00430521|527820182|FG001|Overall Study|Vaccine Expired|0|||
146169661|NCT03333928|527132886|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
146169662|NCT05687032|527132897|FG000|Treatment Phase|Adverse Event|13|||
146169663|NCT05687032|527132897|FG000|Treatment Phase|Death|1|||
146359871|NCT00430521|527820183|FG002|Overall Study|Vaccine Expired|0|||
146359872|NCT00430521|527820184|FG003|Overall Study|Vaccine Expired|0|||
146359873|NCT00430521|527820185|FG004|Overall Study|Vaccine Expired|0|||
146359874|NCT00430521|527820186|FG005|Overall Study|Vaccine Expired|1|||
146359875|NCT00430521|527820187|FG006|Overall Study|Vaccine Expired|0|||
146359876|NCT00430521|527820188|FG007|Overall Study|Vaccine Expired|0|||
146359877|NCT00430521|527820181|FG000|Overall Study|Protocol Violation|1|||
146359878|NCT00430521|527820182|FG001|Overall Study|Protocol Violation|0|||
146359879|NCT00430521|527820183|FG002|Overall Study|Protocol Violation|0|||
146359880|NCT00430521|527820184|FG003|Overall Study|Protocol Violation|0|||
146359881|NCT00430521|527820185|FG004|Overall Study|Protocol Violation|0|||
146359882|NCT00430521|527820186|FG005|Overall Study|Protocol Violation|0|||
146359883|NCT00430521|527820187|FG006|Overall Study|Protocol Violation|0|||
146359884|NCT00430521|527820188|FG007|Overall Study|Protocol Violation|0|||
146359885|NCT00430521|527820181|FG000|Overall Study|Withdrawal by Subject|3|||
146359886|NCT00430521|527820182|FG001|Overall Study|Withdrawal by Subject|1|||
146359887|NCT00430521|527820183|FG002|Overall Study|Withdrawal by Subject|0|||
146359888|NCT00430521|527820184|FG003|Overall Study|Withdrawal by Subject|3|||
146359889|NCT00430521|527820185|FG004|Overall Study|Withdrawal by Subject|0|||
146359890|NCT00430521|527820186|FG005|Overall Study|Withdrawal by Subject|0|||
146359891|NCT00430521|527820187|FG006|Overall Study|Withdrawal by Subject|0|||
146359892|NCT00430521|527820188|FG007|Overall Study|Withdrawal by Subject|2|||
146359893|NCT05108805|527820191|FG000|Overall Study|T-cell expansion was not successful.|5|||
146359894|NCT04092816|527821974|FG000|Overall Study|Lost to Follow-up|1|||
146359895|NCT04092816|527821975|FG001|Overall Study|Lost to Follow-up|2|||
146359896|NCT03073213|527821979|FG000|Multiple Dose Period|Protocol Violation|0|||
146359897|NCT03073213|527821980|FG001|Multiple Dose Period|Protocol Violation|0|||
146359898|NCT03073213|527821981|FG002|Multiple Dose Period|Protocol Violation|1|||
146359899|NCT02690207|527821982|FG000|Overall Study|Lost to Follow-up|48|||
146359900|NCT02690207|527821982|FG000|Overall Study|Withdrawal by Subject|46|||
146359901|NCT02690207|527821982|FG000|Overall Study|Protocol Violation|2|||
146359902|NCT02690207|527821982|FG000|Overall Study|Serious adverse event|110|||
146359903|NCT02690207|527821982|FG000|Overall Study|Non-serious Adverse Event|18|||
146359904|NCT02690207|527821982|FG000|Overall Study|Migrated/moved from study area|5|||
146359905|NCT02690207|527821982|FG000|Overall Study|Suspected HZ Episode|1|||
146359906|NCT02690207|527821982|FG000|Overall Study|Other reasons for withdrawal|23|||
146359907|NCT01617655|527821986|FG000|Overall Study|Adverse Event|2|||
146359908|NCT01617655|527821987|FG001|Overall Study|Adverse Event|3|||
146359909|NCT01617655|527821986|FG000|Overall Study|Poor compliance to protocol|1|||
146359910|NCT01617655|527821987|FG001|Overall Study|Poor compliance to protocol|4|||
146359911|NCT01617655|527821986|FG000|Overall Study|Participants moved|0|||
146359912|NCT01617655|527821987|FG001|Overall Study|Participants moved|4|||
146359913|NCT01617655|527821986|FG000|Overall Study|Consent withdrawn by participant|1|||
146359914|NCT01617655|527821987|FG001|Overall Study|Consent withdrawn by participant|1|||
146359915|NCT01617655|527821986|FG000|Overall Study|Last visit outside protocol visit window|1|||
146359916|NCT01617655|527821987|FG001|Overall Study|Last visit outside protocol visit window|10|||
146359917|NCT01617655|527821986|FG000|Overall Study|Site closure|3|||
146359918|NCT01617655|527821987|FG001|Overall Study|Site closure|5|||
146359919|NCT01617655|527821986|FG000|Overall Study|Other than specified above|1|||
146359920|NCT01617655|527821987|FG001|Overall Study|Other than specified above|2|||
146359921|NCT01397552|527821988|FG000|Overall Study|Adverse Event|1|||
146359922|NCT01397552|527821989|FG001|Overall Study|Adverse Event|0|||
146359923|NCT01397552|527821988|FG000|Overall Study|Withdrawal by Subject|2|||
146359924|NCT01397552|527821989|FG001|Overall Study|Withdrawal by Subject|1|||
146359925|NCT00579501|527821993|FG000|Overall Study|Death|1|||
146359926|NCT00579501|527821993|FG000|Overall Study|End of neoadjuvant therapy|25|||
146359927|NCT00579501|527821993|FG000|Overall Study|toxicity|1|||
146359928|NCT00579501|527821993|FG000|Overall Study|Secondary lesion|1|||
146359929|NCT00579501|527821993|FG000|Overall Study|Radiation therapy before surgery|1|||
146359930|NCT00190983|527821994|FG000|Overall Study|Inevaluable (never treated)|2|||
146359931|NCT02287402|527821995|FG000|Treatment Period|Adverse Event|17|||
146359932|NCT02287402|527821995|FG000|Treatment Period|Voluntary Withdrawal|10|||
146359933|NCT02287402|527821995|FG000|Follow-up|Lost to Follow-up|1|||
146359934|NCT02287402|527821995|FG000|Follow-up|Voluntary Withdrawal|2|||
146359935|NCT04069156|527821996|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
146359936|NCT04069156|527821997|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
146359937|NCT04069156|527821996|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
146359938|NCT04069156|527821997|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
146359939|NCT04069156|527821996|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
146359940|NCT04069156|527821997|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
146359941|NCT04069156|527821996|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
146359942|NCT04069156|527821997|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
146359943|NCT04247815|527821998|FG000|Overall Study|Adverse Event|1|||
146359944|NCT04247815|527821999|FG001|Overall Study|Adverse Event|0|||
146359945|NCT04247815|527821998|FG000|Overall Study|Withdrawal by Subject|1|||
146169664|NCT05687032|527132897|FG000|Treatment Phase|Physician Decision|3|||
146169665|NCT05687032|527132897|FG000|Treatment Phase|Progressive disease|9|||
146359946|NCT04247815|527821999|FG001|Overall Study|Withdrawal by Subject|0|||
146359947|NCT04247815|527821998|FG000|Overall Study|Protocol Violation|0|||
146359948|NCT04247815|527821999|FG001|Overall Study|Protocol Violation|1|||
146359949|NCT02394808|527822000|FG000|Period 1|Unsatisfactory lens fitting|0|||
146359950|NCT02394808|527822001|FG001|Period 1|Unsatisfactory lens fitting|1|||
146359951|NCT02394808|527822000|FG000|Period 2|Lost to Follow-up|1|||
146359952|NCT02394808|527822001|FG001|Period 2|Lost to Follow-up|0|||
146359953|NCT00209170|527822002|FG000|Overall Study|Adverse Event|0|||
146359954|NCT00209170|527822003|FG001|Overall Study|Adverse Event|1|||
146359955|NCT00209170|527822002|FG000|Overall Study|Withdrawal by Subject|2|||
146359956|NCT00209170|527822003|FG001|Overall Study|Withdrawal by Subject|1|||
146359957|NCT00209170|527822002|FG000|Overall Study|Lack of Efficacy|0|||
146359958|NCT00209170|527822003|FG001|Overall Study|Lack of Efficacy|1|||
146359959|NCT02130427|527822004|FG000|Overall Study|Imaging results not interpretable|30|||
146359960|NCT02108600|527822009|FG000|Overall Study|Withdrawal by Subject|2|||
146359961|NCT02108600|527822010|FG001|Overall Study|Withdrawal by Subject|0|||
146359962|NCT02108600|527822009|FG000|Overall Study|Lost to Follow-up|1|||
146359963|NCT02108600|527822010|FG001|Overall Study|Lost to Follow-up|1|||
146359964|NCT01295580|527822012|FG000|Overall Study|Protocol Violation|4|||
146359965|NCT01295580|527822013|FG001|Overall Study|Protocol Violation|2|||
146359966|NCT01295580|527822012|FG000|Overall Study|Withdrawal by Subject|1|||
146359967|NCT01295580|527822013|FG001|Overall Study|Withdrawal by Subject|4|||
146359968|NCT01295580|527822012|FG000|Overall Study|Adverse Event|2|||
146359969|NCT01295580|527822013|FG001|Overall Study|Adverse Event|1|||
146359970|NCT01295580|527822012|FG000|Overall Study|Lost to Follow-up|1|||
146359971|NCT01295580|527822013|FG001|Overall Study|Lost to Follow-up|0|||
146359972|NCT01295580|527822012|FG000|Overall Study|Lack of Efficacy|1|||
146359973|NCT01295580|527822013|FG001|Overall Study|Lack of Efficacy|0|||
146359974|NCT01295580|527822012|FG000|Overall Study|Other: inconvenience|1|||
146359975|NCT01295580|527822013|FG001|Overall Study|Other: inconvenience|0|||
146359976|NCT01295580|527822012|FG000|Overall Study|Other: family objection|0|||
146359977|NCT01295580|527822013|FG001|Overall Study|Other: family objection|1|||
146359978|NCT04032171|527822014|FG000|Overall Study|Study Termination|1|||
146359979|NCT04032171|527822015|FG001|Overall Study|Study Termination|0|||
146359980|NCT00992784|527822016|FG000|Overall Study|Adverse Event|2|||
146359981|NCT00992784|527822017|FG001|Overall Study|Adverse Event|1|||
146359982|NCT00992784|527822018|FG002|Overall Study|Adverse Event|0|||
146359983|NCT00992784|527822016|FG000|Overall Study|Withdrawal by Subject|1|||
146359984|NCT00992784|527822017|FG001|Overall Study|Withdrawal by Subject|1|||
146359985|NCT00992784|527822018|FG002|Overall Study|Withdrawal by Subject|1|||
146359986|NCT00089479|527822027|FG000|Overall Study|Death|108|||
146359987|NCT00089479|527822028|FG001|Overall Study|Death|75|||
146359988|NCT00089479|527822027|FG000|Overall Study|Withdrawal by Subject|86|||
146359989|NCT00089479|527822028|FG001|Overall Study|Withdrawal by Subject|107|||
146359990|NCT00089479|527822027|FG000|Overall Study|Lost to Follow-up|137|||
146359991|NCT00089479|527822028|FG001|Overall Study|Lost to Follow-up|107|||
146359992|NCT03943953|527822029|FG000|Trial of ITG 1|Lost to Follow-up|19|||
146359993|NCT03943953|527822030|FG001|Trial of ITG 1|Lost to Follow-up|1|||
146359994|NCT03943953|527822029|FG000|Trial of ITG 2|Lost to Follow-up|8|||
146359995|NCT03943953|527822030|FG001|Trial of ITG 2|Lost to Follow-up|0|||
146359996|NCT03943953|527822029|FG000|Trial of ITG 3|Lost to Follow-up|2|||
146359997|NCT03943953|527822030|FG001|Trial of ITG 3|Lost to Follow-up|0|||
146169666|NCT05687032|527132897|FG000|Treatment Phase|Withdrawal by Subject|5|||
146169667|NCT05687032|527132897|FG000|Follow-Up Phase|Death|16|||
146169668|NCT05687032|527132897|FG000|Follow-Up Phase|Ongoing|26|||
146169669|NCT01674621|527132898|FG000|Overall Study|Adverse Event|3|||
146169670|NCT01674621|527132899|FG001|Overall Study|Adverse Event|2|||
146169671|NCT01674621|527132900|FG002|Overall Study|Adverse Event|5|||
146169672|NCT01674621|527132901|FG003|Overall Study|Adverse Event|5|||
146169673|NCT01674621|527132902|FG004|Overall Study|Adverse Event|1|||
146169674|NCT01674621|527132898|FG000|Overall Study|Inability to Complete Study Procedures|0|||
146169675|NCT01674621|527132899|FG001|Overall Study|Inability to Complete Study Procedures|0|||
146169676|NCT01674621|527132900|FG002|Overall Study|Inability to Complete Study Procedures|0|||
146169677|NCT01674621|527132901|FG003|Overall Study|Inability to Complete Study Procedures|0|||
146169678|NCT01674621|527132902|FG004|Overall Study|Inability to Complete Study Procedures|2|||
146169679|NCT01674621|527132898|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146169680|NCT01674621|527132899|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146169681|NCT01674621|527132900|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146359998|NCT03943953|527822029|FG000|Trial of ITG 4|Lost to Follow-up|2|||
146359999|NCT03943953|527822030|FG001|Trial of ITG 4|Lost to Follow-up|0|||
146360000|NCT00289185|527822033|FG000|Overall Study|Withdrawal by Subject|4|||
146360001|NCT00289185|527822034|FG001|Overall Study|Withdrawal by Subject|8|||
146360002|NCT00289185|527822033|FG000|Overall Study|Lost to Follow-up|23|||
146360003|NCT00289185|527822034|FG001|Overall Study|Lost to Follow-up|17|||
146360004|NCT00289185|527822033|FG000|Overall Study|Death|1|||
146169682|NCT01674621|527132901|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
146169683|NCT01674621|527132902|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
146169684|NCT01674621|527132898|FG000|Overall Study|Withdrawal by Subject|2|||
146360005|NCT00289185|527822034|FG001|Overall Study|Death|1|||
146360006|NCT01742078|527822035|FG000|Overall Study|Withdrawal by Subject|0|||
146360007|NCT01742078|527822036|FG001|Overall Study|Withdrawal by Subject|0|||
146360008|NCT01742078|527822037|FG002|Overall Study|Withdrawal by Subject|0|||
146360009|NCT01742078|527822038|FG003|Overall Study|Withdrawal by Subject|1|||
146360010|NCT01742078|527822039|FG004|Overall Study|Withdrawal by Subject|0|||
146360011|NCT01742078|527822040|FG005|Overall Study|Withdrawal by Subject|0|||
146360012|NCT01742078|527822041|FG006|Overall Study|Withdrawal by Subject|0|||
146360013|NCT01742078|527822042|FG007|Overall Study|Withdrawal by Subject|0|||
146360014|NCT01742078|527822043|FG008|Overall Study|Withdrawal by Subject|0|||
146360015|NCT01124448|527822048|FG000|Overall Study|Lost to Follow-up|0|||
146360016|NCT01124448|527822049|FG001|Overall Study|Lost to Follow-up|3|||
146360017|NCT01124448|527822048|FG000|Overall Study|Protocol Violation|2|||
146360018|NCT01124448|527822049|FG001|Overall Study|Protocol Violation|0|||
146360019|NCT03247413|527822053|FG000|Overall Study|Lost to Follow-up|28|||
146360020|NCT00642746|527822054|FG000|Overall Study|Patient unevaluable|1|||
146360021|NCT00642746|527822055|FG001|Overall Study|Patient unevaluable|0|||
146360022|NCT00424294|527822056|FG000|Overall Study|Adverse Event|4|||
146360023|NCT00424294|527822057|FG001|Overall Study|Adverse Event|10|||
146360024|NCT00424294|527822056|FG000|Overall Study|Lack of Efficacy|2|||
146360025|NCT00424294|527822057|FG001|Overall Study|Lack of Efficacy|1|||
146360026|NCT00424294|527822056|FG000|Overall Study|Withdrawal by Subject|1|||
146360027|NCT00424294|527822057|FG001|Overall Study|Withdrawal by Subject|2|||
146360028|NCT00424294|527822056|FG000|Overall Study|Other|0|||
146360029|NCT00424294|527822057|FG001|Overall Study|Other|2|||
146360030|NCT00424294|527822056|FG000|Overall Study|Randomized but not Treated|1|||
146360031|NCT00424294|527822057|FG001|Overall Study|Randomized but not Treated|0|||
146360032|NCT03337152|527822060|FG000|Overall Study|Physician Decision|1|||
146360033|NCT03337152|527822061|FG001|Overall Study|Physician Decision|0|||
146360034|NCT03337152|527822060|FG000|Overall Study|Lost to Follow-up|1|||
146360035|NCT03337152|527822061|FG001|Overall Study|Lost to Follow-up|3|||
146360036|NCT03337152|527822060|FG000|Overall Study|Adverse Event|3|||
146360037|NCT03337152|527822061|FG001|Overall Study|Adverse Event|1|||
146360038|NCT03337152|527822060|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
146360039|NCT03337152|527822061|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
146360040|NCT00976950|527822062|FG000|Overall Study|Adverse Event|3|||
146360041|NCT00976950|527822062|FG000|Overall Study|Events with no relationship to Aptivus|3|||
146360042|NCT02932332|527822072|FG000|Overall Study|Withdrawal by Subject|1|||
146360043|NCT02932332|527822073|FG001|Overall Study|Withdrawal by Subject|1|||
146360044|NCT02932332|527822074|FG002|Overall Study|Withdrawal by Subject|0|||
146360045|NCT02932332|527822075|FG003|Overall Study|Withdrawal by Subject|1|||
146360046|NCT02932332|527822072|FG000|Overall Study|Chest pain|0|||
146360047|NCT02932332|527822073|FG001|Overall Study|Chest pain|0|||
146360048|NCT02932332|527822074|FG002|Overall Study|Chest pain|0|||
146360049|NCT02932332|527822075|FG003|Overall Study|Chest pain|1|||
146360050|NCT02932332|527822072|FG000|Overall Study|Not Dyspneic cough|1|||
146360051|NCT02932332|527822073|FG001|Overall Study|Not Dyspneic cough|2|||
146360052|NCT02932332|527822074|FG002|Overall Study|Not Dyspneic cough|1|||
146360053|NCT02932332|527822075|FG003|Overall Study|Not Dyspneic cough|0|||
146360054|NCT01021852|527822076|FG000|Treatment Period 1|Adverse Event|3|||
146360055|NCT01021852|527822077|FG001|Treatment Period 1|Adverse Event|1|||
146360056|NCT01021852|527822078|FG002|Treatment Period 1|Adverse Event|1|||
146360057|NCT01021852|527822079|FG003|Treatment Period 1|Adverse Event|0|||
146360058|NCT01021852|527822080|FG004|Treatment Period 1|Adverse Event|2|||
146360059|NCT01021852|527822081|FG005|Treatment Period 1|Adverse Event|2|||
146360060|NCT01021852|527822082|FG006|Treatment Period 1|Adverse Event|0|||
146360061|NCT01021852|527822083|FG007|Treatment Period 1|Adverse Event|0|||
146360062|NCT01021852|527822076|FG000|Treatment Period 1|Pregnancy|0|||
146360063|NCT01021852|527822077|FG001|Treatment Period 1|Pregnancy|0|||
146360064|NCT01021852|527822078|FG002|Treatment Period 1|Pregnancy|1|||
146360065|NCT01021852|527822079|FG003|Treatment Period 1|Pregnancy|0|||
146360066|NCT01021852|527822080|FG004|Treatment Period 1|Pregnancy|0|||
146360067|NCT01021852|527822081|FG005|Treatment Period 1|Pregnancy|0|||
146360068|NCT01021852|527822082|FG006|Treatment Period 1|Pregnancy|0|||
146360069|NCT01021852|527822083|FG007|Treatment Period 1|Pregnancy|0|||
146360070|NCT01021852|527822076|FG000|Treatment Period 1|Withdrawal by Subject|0|||
146360071|NCT01021852|527822077|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146360072|NCT01021852|527822078|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146360073|NCT01021852|527822079|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146360074|NCT01021852|527822080|FG004|Treatment Period 1|Withdrawal by Subject|1|||
146360075|NCT01021852|527822081|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146360076|NCT01021852|527822082|FG006|Treatment Period 1|Withdrawal by Subject|0|||
146360077|NCT01021852|527822083|FG007|Treatment Period 1|Withdrawal by Subject|1|||
146360078|NCT01021852|527822076|FG000|Treatment Period 1|Not Treated|0|||
146360079|NCT01021852|527822077|FG001|Treatment Period 1|Not Treated|0|||
146360080|NCT01021852|527822078|FG002|Treatment Period 1|Not Treated|0|||
146360081|NCT01021852|527822079|FG003|Treatment Period 1|Not Treated|2|||
146360082|NCT01021852|527822080|FG004|Treatment Period 1|Not Treated|0|||
146360083|NCT01021852|527822081|FG005|Treatment Period 1|Not Treated|0|||
146360084|NCT01021852|527822082|FG006|Treatment Period 1|Not Treated|0|||
146360085|NCT01021852|527822083|FG007|Treatment Period 1|Not Treated|0|||
146360086|NCT01021852|527822076|FG000|Washout Period-Placebo|Adverse Event|0|||
146360087|NCT01021852|527822077|FG001|Washout Period-Placebo|Adverse Event|0|||
146360088|NCT01021852|527822078|FG002|Washout Period-Placebo|Adverse Event|0|||
146360089|NCT01021852|527822079|FG003|Washout Period-Placebo|Adverse Event|1|||
146360090|NCT01021852|527822080|FG004|Washout Period-Placebo|Adverse Event|0|||
146360091|NCT01021852|527822081|FG005|Washout Period-Placebo|Adverse Event|1|||
146360092|NCT01021852|527822082|FG006|Washout Period-Placebo|Adverse Event|0|||
146360093|NCT01021852|527822083|FG007|Washout Period-Placebo|Adverse Event|0|||
146360094|NCT01021852|527822076|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
146360095|NCT01021852|527822077|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
146360096|NCT01021852|527822078|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
146360097|NCT01021852|527822079|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
146360098|NCT01021852|527822080|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
146360099|NCT01021852|527822081|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
146360100|NCT01021852|527822082|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
146360101|NCT01021852|527822083|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
146360102|NCT01021852|527822076|FG000|Washout Period-Placebo|Protocol Violation|0|||
146360103|NCT01021852|527822077|FG001|Washout Period-Placebo|Protocol Violation|0|||
146360104|NCT01021852|527822078|FG002|Washout Period-Placebo|Protocol Violation|0|||
146360105|NCT01021852|527822079|FG003|Washout Period-Placebo|Protocol Violation|0|||
146360106|NCT01021852|527822080|FG004|Washout Period-Placebo|Protocol Violation|0|||
146360107|NCT01021852|527822081|FG005|Washout Period-Placebo|Protocol Violation|0|||
146360108|NCT01021852|527822082|FG006|Washout Period-Placebo|Protocol Violation|1|||
146360109|NCT01021852|527822083|FG007|Washout Period-Placebo|Protocol Violation|0|||
146360110|NCT01021852|527822076|FG000|Washout Period-No Drug|Adverse Event|1|||
146360111|NCT01021852|527822077|FG001|Washout Period-No Drug|Adverse Event|0|||
146360112|NCT01021852|527822078|FG002|Washout Period-No Drug|Adverse Event|0|||
146360113|NCT01021852|527822079|FG003|Washout Period-No Drug|Adverse Event|0|||
146360114|NCT01021852|527822080|FG004|Washout Period-No Drug|Adverse Event|0|||
146360115|NCT01021852|527822081|FG005|Washout Period-No Drug|Adverse Event|1|||
146360116|NCT01021852|527822082|FG006|Washout Period-No Drug|Adverse Event|0|||
146360117|NCT01021852|527822083|FG007|Washout Period-No Drug|Adverse Event|0|||
146360118|NCT01021852|527822076|FG000|Treatment Period 2|Adverse Event|0|||
146360119|NCT01021852|527822077|FG001|Treatment Period 2|Adverse Event|1|||
146360120|NCT01021852|527822078|FG002|Treatment Period 2|Adverse Event|0|||
146360121|NCT01021852|527822079|FG003|Treatment Period 2|Adverse Event|0|||
146360122|NCT01021852|527822080|FG004|Treatment Period 2|Adverse Event|1|||
146360123|NCT01021852|527822081|FG005|Treatment Period 2|Adverse Event|0|||
146360124|NCT01021852|527822082|FG006|Treatment Period 2|Adverse Event|1|||
146360125|NCT01021852|527822083|FG007|Treatment Period 2|Adverse Event|0|||
146360126|NCT01021852|527822076|FG000|Treatment Period 2|Lack of Efficacy|0|||
146360127|NCT01021852|527822077|FG001|Treatment Period 2|Lack of Efficacy|0|||
146360128|NCT01021852|527822078|FG002|Treatment Period 2|Lack of Efficacy|0|||
146360129|NCT01021852|527822079|FG003|Treatment Period 2|Lack of Efficacy|0|||
146360130|NCT01021852|527822080|FG004|Treatment Period 2|Lack of Efficacy|0|||
146360131|NCT01021852|527822081|FG005|Treatment Period 2|Lack of Efficacy|1|||
146360132|NCT01021852|527822082|FG006|Treatment Period 2|Lack of Efficacy|0|||
146360133|NCT01021852|527822083|FG007|Treatment Period 2|Lack of Efficacy|0|||
146360134|NCT01021852|527822076|FG000|Treatment Period 2|Physician Decision|0|||
146360135|NCT01021852|527822077|FG001|Treatment Period 2|Physician Decision|0|||
146360136|NCT01021852|527822078|FG002|Treatment Period 2|Physician Decision|1|||
146360137|NCT01021852|527822079|FG003|Treatment Period 2|Physician Decision|0|||
146360138|NCT01021852|527822080|FG004|Treatment Period 2|Physician Decision|0|||
146360139|NCT01021852|527822081|FG005|Treatment Period 2|Physician Decision|0|||
146360140|NCT01021852|527822082|FG006|Treatment Period 2|Physician Decision|0|||
146360141|NCT01021852|527822083|FG007|Treatment Period 2|Physician Decision|0|||
146360142|NCT01021852|527822076|FG000|Treatment Period 2|Protocol Violation|0|||
146360143|NCT01021852|527822077|FG001|Treatment Period 2|Protocol Violation|0|||
146360144|NCT01021852|527822078|FG002|Treatment Period 2|Protocol Violation|0|||
146360145|NCT01021852|527822079|FG003|Treatment Period 2|Protocol Violation|0|||
146360146|NCT01021852|527822080|FG004|Treatment Period 2|Protocol Violation|1|||
146360147|NCT01021852|527822081|FG005|Treatment Period 2|Protocol Violation|0|||
146360148|NCT01021852|527822082|FG006|Treatment Period 2|Protocol Violation|1|||
146360149|NCT01021852|527822083|FG007|Treatment Period 2|Protocol Violation|0|||
146360150|NCT01021852|527822076|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146360151|NCT01021852|527822077|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146360152|NCT01021852|527822078|FG002|Treatment Period 2|Withdrawal by Subject|0|||
146360153|NCT01021852|527822079|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146360154|NCT01021852|527822080|FG004|Treatment Period 2|Withdrawal by Subject|0|||
146360155|NCT01021852|527822081|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146360156|NCT01021852|527822082|FG006|Treatment Period 2|Withdrawal by Subject|1|||
146360157|NCT01021852|527822083|FG007|Treatment Period 2|Withdrawal by Subject|2|||
146360158|NCT02493426|527822084|FG000|Overall Study|Withdrawal by Subject|0|||
146360159|NCT02493426|527822085|FG001|Overall Study|Withdrawal by Subject|1|||
146360160|NCT01069523|527822086|FG000|Overall Study|Withdrawal by Subject|4|||
146360161|NCT01069523|527822087|FG001|Overall Study|Withdrawal by Subject|7|||
146360162|NCT01025817|527822091|FG000|Completed Study Medication|Adverse Event|66|||
146360163|NCT01025817|527822092|FG001|Completed Study Medication|Adverse Event|39|||
146360164|NCT01025817|527822091|FG000|Completed Study Medication|Protocol Deviation|9|||
146360165|NCT01025817|527822092|FG001|Completed Study Medication|Protocol Deviation|8|||
146360166|NCT01025817|527822091|FG000|Completed Study Medication|Withdrawal by Subject|8|||
146360167|NCT01025817|527822092|FG001|Completed Study Medication|Withdrawal by Subject|9|||
146360168|NCT01025817|527822091|FG000|Completed Study Medication|Administrative problems|7|||
146360169|NCT01025817|527822092|FG001|Completed Study Medication|Administrative problems|5|||
146360170|NCT01025817|527822091|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
146360171|NCT01025817|527822092|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
146360172|NCT01025817|527822091|FG000|Completed Study Medication|Abnormal test procedure|4|||
146360173|NCT01025817|527822092|FG001|Completed Study Medication|Abnormal test procedure|0|||
146360174|NCT01025817|527822091|FG000|Completed Study Medication|Graft loss|2|||
146360175|NCT01025817|527822092|FG001|Completed Study Medication|Graft loss|5|||
146360176|NCT01025817|527822091|FG000|Completed Study Medication|Death|2|||
146360177|NCT01025817|527822092|FG001|Completed Study Medication|Death|2|||
146360178|NCT01025817|527822091|FG000|Completed Study Medication|Abnormal lab values|0|||
146360179|NCT01025817|527822092|FG001|Completed Study Medication|Abnormal lab values|2|||
146360180|NCT01025817|527822091|FG000|Completed Study Medication|Subject no longer required study drug|0|||
146360181|NCT01025817|527822092|FG001|Completed Study Medication|Subject no longer required study drug|1|||
146360182|NCT01025817|527822091|FG000|Completed Study Medication|Lost to Follow-up|0|||
146360183|NCT01025817|527822092|FG001|Completed Study Medication|Lost to Follow-up|1|||
146360184|NCT01025817|527822091|FG000|Completed Study|Withdrawal by Subject|8|||
146360185|NCT01025817|527822092|FG001|Completed Study|Withdrawal by Subject|16|||
146360186|NCT01025817|527822091|FG000|Completed Study|Death|6|||
146360187|NCT01025817|527822092|FG001|Completed Study|Death|5|||
146360188|NCT01025817|527822091|FG000|Completed Study|Missing|2|||
146360189|NCT01025817|527822092|FG001|Completed Study|Missing|0|||
146360190|NCT01025817|527822091|FG000|Completed Study|Lost to Follow-up|0|||
146360191|NCT01025817|527822092|FG001|Completed Study|Lost to Follow-up|1|||
146360192|NCT04533815|527822096|FG000|Overall Study|Adverse Event|2|||
146360193|NCT04533815|527822096|FG000|Overall Study|Site withdrew|5|||
146360194|NCT00488592|527822099|FG000|Overall Study|Withdrawal by Subject|1|||
146360195|NCT00488592|527822099|FG000|Overall Study|Disease progression|1|||
146360196|NCT00488592|527822099|FG000|Overall Study|Enrolled but not treated|1|||
146360197|NCT00441103|527822100|FG000|Overall Study|Adverse Event|2|||
146360198|NCT00441103|527822101|FG001|Overall Study|Adverse Event|1|||
146360199|NCT00441103|527822100|FG000|Overall Study|Death|1|||
146360200|NCT00441103|527822101|FG001|Overall Study|Death|0|||
146360201|NCT00441103|527822100|FG000|Overall Study|Disease Progression|2|||
146360202|NCT00441103|527822101|FG001|Overall Study|Disease Progression|0|||
146360203|NCT00441103|527822100|FG000|Overall Study|Lost to Follow-up|1|||
146360204|NCT00441103|527822101|FG001|Overall Study|Lost to Follow-up|0|||
146360205|NCT00441103|527822100|FG000|Overall Study|Protocol Violation|1|||
146360206|NCT00441103|527822101|FG001|Overall Study|Protocol Violation|0|||
146360207|NCT00441103|527822100|FG000|Overall Study|Participant unable to use Rebiject II|1|||
146360208|NCT00441103|527822101|FG001|Overall Study|Participant unable to use Rebiject II|0|||
146360209|NCT00441103|527822100|FG000|Overall Study|Participant refused MRI|1|||
146360210|NCT00441103|527822101|FG001|Overall Study|Participant refused MRI|0|||
146360211|NCT00441103|527822100|FG000|Overall Study|Inclusion criteria absent|1|||
146360212|NCT00441103|527822101|FG001|Overall Study|Inclusion criteria absent|0|||
146360213|NCT00441103|527822100|FG000|Overall Study|Non-compliant|0|||
146360214|NCT00441103|527822101|FG001|Overall Study|Non-compliant|1|||
146360215|NCT00441103|527822100|FG000|Overall Study|Participant decided to withdraw|1|||
146360216|NCT00441103|527822101|FG001|Overall Study|Participant decided to withdraw|0|||
146360217|NCT00441103|527822100|FG000|Overall Study|Participant's reason|0|||
146360218|NCT00441103|527822101|FG001|Overall Study|Participant's reason|1|||
146360219|NCT00441103|527822100|FG000|Overall Study|Participant decided to stop|0|||
146360220|NCT00441103|527822101|FG001|Overall Study|Participant decided to stop|1|||
146360221|NCT00807846|527822102|FG000|Overall Study|Adverse Event|5|||
146360222|NCT00807846|527822103|FG001|Overall Study|Adverse Event|0|||
146169685|NCT01674621|527132899|FG001|Overall Study|Withdrawal by Subject|5|||
146169686|NCT01674621|527132900|FG002|Overall Study|Withdrawal by Subject|2|||
146169687|NCT01674621|527132901|FG003|Overall Study|Withdrawal by Subject|0|||
146169688|NCT01674621|527132902|FG004|Overall Study|Withdrawal by Subject|1|||
146169689|NCT01674621|527132898|FG000|Overall Study|Other than specified|0|||
146169690|NCT01674621|527132899|FG001|Overall Study|Other than specified|1|||
146169691|NCT01674621|527132900|FG002|Overall Study|Other than specified|0|||
146169692|NCT01674621|527132901|FG003|Overall Study|Other than specified|0|||
146360223|NCT00807846|527822102|FG000|Overall Study|Lack of Efficacy|2|||
146360224|NCT00807846|527822103|FG001|Overall Study|Lack of Efficacy|0|||
146360225|NCT00807846|527822102|FG000|Overall Study|Protocol Violation|2|||
146360226|NCT00807846|527822103|FG001|Overall Study|Protocol Violation|1|||
146360227|NCT00807846|527822102|FG000|Overall Study|Withdrawal by Subject|2|||
146360228|NCT00807846|527822103|FG001|Overall Study|Withdrawal by Subject|1|||
146360229|NCT00807846|527822102|FG000|Overall Study|Other|1|||
146360230|NCT00807846|527822103|FG001|Overall Study|Other|2|||
146360231|NCT01081873|527822104|FG000|Overall Study|Death|86|||
146360232|NCT01081873|527822104|FG000|Overall Study|Withdrawal by Subject|10|||
146360233|NCT01081873|527822104|FG000|Overall Study|Lost to Follow-up|142|||
146360234|NCT01081873|527822104|FG000|Overall Study|Progression of prostate cancer|13|||
146360235|NCT01081873|527822104|FG000|Overall Study|Other|47|||
146360236|NCT04799405|527822106|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
146360237|NCT00603980|527822107|FG000|Study Qualification|Protocol Violation|3|||
146360238|NCT00603980|527822107|FG000|Study Qualification|Inconsistent data reporting|13|||
146360239|NCT00603980|527822107|FG000|Main Study|14th subject completed trial|1|||
146360240|NCT01029002|527822108|FG000|Overall Study|Lost to Follow-up|2|||
146360241|NCT01029002|527822109|FG001|Overall Study|Lost to Follow-up|4|||
146360242|NCT02683525|527822110|FG000|Overall Study|Lost to Follow-up|1|||
146360243|NCT02683525|527822110|FG000|Overall Study|Physician Decision|1|||
146360244|NCT02683525|527822110|FG000|Overall Study|Disease Progression|6|||
146360245|NCT02618928|527822117|FG000|Overall Study|Failure to Return|28|||
146360246|NCT02618928|527822117|FG000|Overall Study|Insufficient Virological Response|1|||
146360247|NCT02618928|527822117|FG000|Overall Study|Withdrawal by Subject|2|||
146360248|NCT02618928|527822117|FG000|Overall Study|Death|3|||
146360249|NCT02618928|527822117|FG000|Overall Study|Other|11|||
146360250|NCT02618928|527822117|FG000|Overall Study|Missing|6|||
146360251|NCT02618928|527822117|FG000|Overall Study|Treatment Never Started|7|||
146360252|NCT01096849|527822122|FG000|Overall Study|Consent Withdrawn|1|||
146360253|NCT01096849|527822123|FG001|Overall Study|Consent Withdrawn|4|||
146360254|NCT01096849|527822124|FG002|Overall Study|Consent Withdrawn|2|||
146360255|NCT01096849|527822122|FG000|Overall Study|Lack of Efficacy|0|||
146360256|NCT01096849|527822123|FG001|Overall Study|Lack of Efficacy|2|||
146360257|NCT01096849|527822124|FG002|Overall Study|Lack of Efficacy|0|||
146360258|NCT01096849|527822122|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
146360259|NCT01096849|527822123|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
146360260|NCT01096849|527822124|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
146360261|NCT01096849|527822122|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
146360262|NCT01096849|527822123|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
146360263|NCT01096849|527822124|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
146360264|NCT01096849|527822122|FG000|Overall Study|Administrative Reasons|0|||
146360265|NCT01096849|527822123|FG001|Overall Study|Administrative Reasons|1|||
146360266|NCT01096849|527822124|FG002|Overall Study|Administrative Reasons|2|||
146360267|NCT01096849|527822122|FG000|Overall Study|Lost to Follow-up|1|||
146360268|NCT01096849|527822123|FG001|Overall Study|Lost to Follow-up|3|||
146360269|NCT01096849|527822124|FG002|Overall Study|Lost to Follow-up|1|||
146360270|NCT04167306|527822126|FG000|Overall Study|Lost to Follow-up|2|||
146360271|NCT04167306|527822127|FG001|Overall Study|Lost to Follow-up|2|||
146360272|NCT04167306|527822128|FG002|Overall Study|Lost to Follow-up|5|||
146360273|NCT04167306|527822129|FG003|Overall Study|Lost to Follow-up|5|||
146360274|NCT04167306|527822126|FG000|Overall Study|Adverse Event|13|||
146360275|NCT04167306|527822127|FG001|Overall Study|Adverse Event|14|||
146360276|NCT04167306|527822128|FG002|Overall Study|Adverse Event|5|||
146360277|NCT04167306|527822129|FG003|Overall Study|Adverse Event|4|||
146360278|NCT04167306|527822126|FG000|Overall Study|Withdrawal by Subject|4|||
146360279|NCT04167306|527822127|FG001|Overall Study|Withdrawal by Subject|6|||
146360280|NCT04167306|527822128|FG002|Overall Study|Withdrawal by Subject|8|||
146360281|NCT04167306|527822129|FG003|Overall Study|Withdrawal by Subject|3|||
146360282|NCT04167306|527822126|FG000|Overall Study|covid|1|||
146360283|NCT04167306|527822127|FG001|Overall Study|covid|1|||
146360284|NCT04167306|527822128|FG002|Overall Study|covid|2|||
146360285|NCT04167306|527822129|FG003|Overall Study|covid|1|||
146360286|NCT04167306|527822126|FG000|Overall Study|concomitant medication|0|||
146360287|NCT04167306|527822127|FG001|Overall Study|concomitant medication|0|||
146360288|NCT04167306|527822128|FG002|Overall Study|concomitant medication|0|||
146360289|NCT04167306|527822129|FG003|Overall Study|concomitant medication|1|||
146360290|NCT04167306|527822126|FG000|Overall Study|Alcohol treatment|0|||
146360291|NCT04167306|527822127|FG001|Overall Study|Alcohol treatment|4|||
146360292|NCT04167306|527822128|FG002|Overall Study|Alcohol treatment|3|||
146360293|NCT04167306|527822129|FG003|Overall Study|Alcohol treatment|2|||
146360294|NCT04167306|527822126|FG000|Overall Study|non-compliance|0|||
146360295|NCT04167306|527822127|FG001|Overall Study|non-compliance|0|||
146360296|NCT04167306|527822128|FG002|Overall Study|non-compliance|1|||
146360297|NCT04167306|527822129|FG003|Overall Study|non-compliance|0|||
146360298|NCT04167306|527822126|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
146360299|NCT04167306|527822127|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
146360300|NCT04167306|527822128|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
146360301|NCT04167306|527822129|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
146360302|NCT04146467|527822134|FG000|Overall Study|Adverse Event|0|||
146360303|NCT04146467|527822135|FG001|Overall Study|Adverse Event|1|||
146360304|NCT04146467|527822134|FG000|Overall Study|Lost to Follow-up|0|||
146360305|NCT04146467|527822135|FG001|Overall Study|Lost to Follow-up|2|||
146360306|NCT01189435|527822138|FG000|Overall Study|Withdrawal by Subject|1|||
146360307|NCT01189435|527822138|FG000|Overall Study|Physician Decision|1|||
146360308|NCT01253421|527822139|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
146360309|NCT01253421|527822140|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
146360310|NCT01253421|527822141|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
146360311|NCT01253421|527822142|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
146360312|NCT01253421|527822143|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
146360313|NCT01253421|527822139|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
146360314|NCT01253421|527822140|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
146360315|NCT01253421|527822141|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
146360316|NCT01253421|527822142|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
146360317|NCT01253421|527822143|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
146360318|NCT01253421|527822139|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
146360319|NCT01253421|527822140|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
146360320|NCT01253421|527822141|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
146360321|NCT01253421|527822142|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
146360322|NCT01253421|527822143|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
146360323|NCT01253421|527822139|FG000|Assessment and Scheduling|Physician Decision|1|||
146360324|NCT01253421|527822140|FG001|Assessment and Scheduling|Physician Decision|0|||
146360325|NCT01253421|527822141|FG002|Assessment and Scheduling|Physician Decision|0|||
146360326|NCT01253421|527822142|FG003|Assessment and Scheduling|Physician Decision|0|||
146360327|NCT01253421|527822143|FG004|Assessment and Scheduling|Physician Decision|0|||
146360328|NCT01253421|527822139|FG000|Drug+Scanning Visit|Physician Decision|0|||
146360329|NCT01253421|527822140|FG001|Drug+Scanning Visit|Physician Decision|0|||
146360330|NCT01253421|527822141|FG002|Drug+Scanning Visit|Physician Decision|0|||
146360331|NCT01253421|527822142|FG003|Drug+Scanning Visit|Physician Decision|0|||
146360332|NCT01253421|527822143|FG004|Drug+Scanning Visit|Physician Decision|1|||
146360333|NCT02198651|527823721|FG000|Lead-in Period|Withdrew consent|13|||
146360334|NCT02198651|527823722|FG001|Lead-in Period|Withdrew consent|0|||
146360335|NCT02198651|527823723|FG002|Lead-in Period|Withdrew consent|0|||
146360336|NCT02198651|527823724|FG003|Lead-in Period|Withdrew consent|0|||
146360337|NCT02198651|527823725|FG004|Lead-in Period|Withdrew consent|0|||
146360338|NCT02198651|527823721|FG000|Lead-in Period|Adverse Event|2|||
146360339|NCT02198651|527823722|FG001|Lead-in Period|Adverse Event|0|||
146360340|NCT02198651|527823723|FG002|Lead-in Period|Adverse Event|0|||
146360341|NCT02198651|527823724|FG003|Lead-in Period|Adverse Event|0|||
146360342|NCT02198651|527823725|FG004|Lead-in Period|Adverse Event|0|||
146360343|NCT02198651|527823721|FG000|Lead-in Period|Other, not specified|22|||
146360344|NCT02198651|527823722|FG001|Lead-in Period|Other, not specified|0|||
146360345|NCT02198651|527823723|FG002|Lead-in Period|Other, not specified|0|||
146360346|NCT02198651|527823724|FG003|Lead-in Period|Other, not specified|0|||
146360347|NCT02198651|527823725|FG004|Lead-in Period|Other, not specified|0|||
146360348|NCT02198651|527823721|FG000|Double-blind Period|Withdrew consent|0|||
146360349|NCT02198651|527823722|FG001|Double-blind Period|Withdrew consent|4|||
146360350|NCT02198651|527823723|FG002|Double-blind Period|Withdrew consent|0|||
146360351|NCT02198651|527823724|FG003|Double-blind Period|Withdrew consent|0|||
146360352|NCT02198651|527823725|FG004|Double-blind Period|Withdrew consent|0|||
146360353|NCT02198651|527823721|FG000|Double-blind Period|Adverse Event|0|||
146360354|NCT02198651|527823722|FG001|Double-blind Period|Adverse Event|1|||
146360355|NCT02198651|527823723|FG002|Double-blind Period|Adverse Event|0|||
146360356|NCT02198651|527823724|FG003|Double-blind Period|Adverse Event|0|||
146360357|NCT02198651|527823725|FG004|Double-blind Period|Adverse Event|0|||
146360358|NCT02198651|527823721|FG000|Double-blind Period|Other, not specified|0|||
146360359|NCT02198651|527823722|FG001|Double-blind Period|Other, not specified|4|||
146360360|NCT02198651|527823723|FG002|Double-blind Period|Other, not specified|1|||
146360361|NCT02198651|527823724|FG003|Double-blind Period|Other, not specified|0|||
146360362|NCT02198651|527823725|FG004|Double-blind Period|Other, not specified|0|||
146360363|NCT02198651|527823721|FG000|Open-label Rescue Period|Withdrew consent|0|||
146360364|NCT02198651|527823722|FG001|Open-label Rescue Period|Withdrew consent|0|||
146360365|NCT02198651|527823723|FG002|Open-label Rescue Period|Withdrew consent|0|||
146360366|NCT02198651|527823724|FG003|Open-label Rescue Period|Withdrew consent|2|||
146360367|NCT02198651|527823725|FG004|Open-label Rescue Period|Withdrew consent|0|||
146360368|NCT02198651|527823721|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146360369|NCT02198651|527823722|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146360370|NCT02198651|527823723|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146360371|NCT02198651|527823724|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
146360372|NCT02198651|527823725|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
146360373|NCT01146951|527823726|FG000|Overall Study|Adverse Event|4|||
146360374|NCT01146951|527823727|FG001|Overall Study|Adverse Event|1|||
146360375|NCT01747811|527823728|FG000|Overall Study|Lack of Efficacy|2|||
146360376|NCT01747811|527823729|FG001|Overall Study|Lack of Efficacy|4|||
146169693|NCT01674621|527132902|FG004|Overall Study|Other than specified|2|||
146360377|NCT01175213|527823734|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
146360378|NCT01175213|527823735|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
146360379|NCT01175213|527823734|FG000|IGSC, 10%/rHuPH20|Death|1|||
146360380|NCT01175213|527823735|FG001|IGSC, 10%/rHuPH20|Death|0|||
146360381|NCT01175213|527823734|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
146360382|NCT01175213|527823735|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
146360383|NCT01175213|527823734|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
146360384|NCT01175213|527823735|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
146360385|NCT01175213|527823734|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
146360386|NCT01175213|527823735|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
146360387|NCT01175213|527823734|FG000|Safety Follow-up|Adverse Event|1|||
146360388|NCT01175213|527823735|FG001|Safety Follow-up|Adverse Event|0|||
146360389|NCT03057951|527823737|FG000|Overall Study|Adverse Event|553|||
146360390|NCT03057951|527823738|FG001|Overall Study|Adverse Event|575|||
146360391|NCT03057951|527823737|FG000|Overall Study|Protocol Violation|30|||
146360392|NCT03057951|527823738|FG001|Overall Study|Protocol Violation|24|||
146360393|NCT03057951|527823737|FG000|Overall Study|Lost to Follow-up|6|||
146360394|NCT03057951|527823738|FG001|Overall Study|Lost to Follow-up|16|||
146360395|NCT03057951|527823737|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
146360396|NCT03057951|527823738|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
146360397|NCT03057951|527823737|FG000|Overall Study|Study drug stopped, reason missing|6|||
146360398|NCT03057951|527823738|FG001|Overall Study|Study drug stopped, reason missing|1|||
146360399|NCT03057951|527823737|FG000|Overall Study|Medical advice|6|||
146360400|NCT03057951|527823738|FG001|Overall Study|Medical advice|2|||
146360401|NCT03057951|527823737|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
146360402|NCT03057951|527823738|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
146360403|NCT03057951|527823737|FG000|Overall Study|Investigator decision|2|||
146360404|NCT03057951|527823738|FG001|Overall Study|Investigator decision|0|||
146360405|NCT03057951|527823737|FG000|Overall Study|Patient decision|5|||
146360406|NCT03057951|527823738|FG001|Overall Study|Patient decision|2|||
146360407|NCT03057951|527823737|FG000|Overall Study|Not attending study visits|3|||
146360408|NCT03057951|527823738|FG001|Overall Study|Not attending study visits|0|||
146360409|NCT03057951|527823737|FG000|Overall Study|Patient moved away|3|||
146360410|NCT03057951|527823738|FG001|Overall Study|Patient moved away|4|||
146360411|NCT03057951|527823737|FG000|Overall Study|Other reason than stated above|23|||
146360412|NCT03057951|527823738|FG001|Overall Study|Other reason than stated above|29|||
146360413|NCT03057951|527823737|FG000|Overall Study|Not treated|2|||
146360414|NCT03057951|527823738|FG001|Overall Study|Not treated|1|||
146360415|NCT02064205|527823739|FG000|Overall Study|Withdrawal by Subject|1|||
146360416|NCT02700919|527823740|FG000|Overall Study|Physician Decision|1|||
146360417|NCT02700919|527823741|FG001|Overall Study|Physician Decision|0|||
146360418|NCT02700919|527823742|FG002|Overall Study|Physician Decision|0|||
146360419|NCT02700919|527823740|FG000|Overall Study|Protocol Violation|1|||
146360420|NCT02700919|527823741|FG001|Overall Study|Protocol Violation|0|||
146360421|NCT02700919|527823742|FG002|Overall Study|Protocol Violation|0|||
146360422|NCT02700919|527823740|FG000|Overall Study|Adverse Event|1|||
146360423|NCT02700919|527823741|FG001|Overall Study|Adverse Event|3|||
146360424|NCT02700919|527823742|FG002|Overall Study|Adverse Event|1|||
146360425|NCT02700919|527823740|FG000|Overall Study|Withdrawal by Subject|5|||
146360426|NCT02700919|527823741|FG001|Overall Study|Withdrawal by Subject|8|||
146360427|NCT02700919|527823742|FG002|Overall Study|Withdrawal by Subject|2|||
146360428|NCT02700919|527823740|FG000|Overall Study|Lost to Follow-up|2|||
146360429|NCT02700919|527823741|FG001|Overall Study|Lost to Follow-up|0|||
146360430|NCT02700919|527823742|FG002|Overall Study|Lost to Follow-up|0|||
146360431|NCT02700919|527823740|FG000|Overall Study|Other|2|||
146360432|NCT02700919|527823741|FG001|Overall Study|Other|1|||
146360433|NCT02700919|527823742|FG002|Overall Study|Other|1|||
146360434|NCT01194869|527823743|FG000|Overall Study|Disease Progression|2|||
146360435|NCT01194869|527823743|FG000|Overall Study|Toxicity|2|||
146360436|NCT00547378|527823744|FG000|Randomized Cohort|Withdrawal by Subject|7|||
146360437|NCT00547378|527823745|FG001|Randomized Cohort|Withdrawal by Subject|5|||
146360438|NCT00547378|527823746|FG002|Randomized Cohort|Withdrawal by Subject|0|||
146360439|NCT00547378|527823744|FG000|Randomized Cohort|Death|0|||
146360440|NCT00547378|527823745|FG001|Randomized Cohort|Death|1|||
146169694|NCT03056534|527132905|FG000|Overall Study|Participant withdrew consent|8|||
146169695|NCT03056534|527132905|FG000|Overall Study|Participant not able to return|6|||
146169696|NCT03056534|527132905|FG000|Overall Study|Lost to Follow-up|37|||
146169697|NCT03056534|527132905|FG000|Overall Study|Investigator judgment|1|||
146169698|NCT03056534|527132905|FG000|Overall Study|Death|4|||
146169699|NCT03056534|527132905|FG000|Overall Study|Adverse Event|1|||
146169700|NCT03056534|527132905|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
146169701|NCT02675465|527132906|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
146360441|NCT00547378|527823746|FG002|Randomized Cohort|Death|0|||
146360442|NCT00547378|527823744|FG000|Randomized Cohort|Lost to Follow-up|1|||
146360443|NCT00547378|527823745|FG001|Randomized Cohort|Lost to Follow-up|0|||
146360444|NCT00547378|527823746|FG002|Randomized Cohort|Lost to Follow-up|0|||
146360445|NCT00547378|527823744|FG000|Randomized Cohort|Adverse Event|1|||
146360446|NCT00547378|527823745|FG001|Randomized Cohort|Adverse Event|0|||
146360447|NCT00547378|527823746|FG002|Randomized Cohort|Adverse Event|0|||
146360448|NCT00547378|527823744|FG000|Randomized Cohort|Other reasons|2|||
146360449|NCT00547378|527823745|FG001|Randomized Cohort|Other reasons|0|||
146360450|NCT00547378|527823746|FG002|Randomized Cohort|Other reasons|0|||
146360451|NCT00547378|527823744|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
146360452|NCT00547378|527823745|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
146360453|NCT00547378|527823746|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
146360454|NCT00547378|527823744|FG000|All Implanted Cohort|Adverse Event|4|||
146360455|NCT00547378|527823745|FG001|All Implanted Cohort|Adverse Event|10|||
146360456|NCT00547378|527823746|FG002|All Implanted Cohort|Adverse Event|17|||
146360457|NCT00547378|527823744|FG000|All Implanted Cohort|Lost to Follow-up|0|||
146360458|NCT00547378|527823745|FG001|All Implanted Cohort|Lost to Follow-up|1|||
146360459|NCT00547378|527823746|FG002|All Implanted Cohort|Lost to Follow-up|14|||
146360460|NCT00547378|527823744|FG000|All Implanted Cohort|Death|3|||
146360461|NCT00547378|527823745|FG001|All Implanted Cohort|Death|1|||
146360462|NCT00547378|527823746|FG002|All Implanted Cohort|Death|4|||
146360463|NCT00547378|527823744|FG000|All Implanted Cohort|Physician Decision|0|||
146360464|NCT00547378|527823745|FG001|All Implanted Cohort|Physician Decision|2|||
146360465|NCT00547378|527823746|FG002|All Implanted Cohort|Physician Decision|6|||
146360466|NCT00547378|527823744|FG000|All Implanted Cohort|Site closure|2|||
146360467|NCT00547378|527823745|FG001|All Implanted Cohort|Site closure|0|||
146360468|NCT00547378|527823746|FG002|All Implanted Cohort|Site closure|1|||
146360469|NCT00547378|527823744|FG000|All Implanted Cohort|Other reasons|1|||
146360470|NCT00547378|527823745|FG001|All Implanted Cohort|Other reasons|0|||
146360471|NCT00547378|527823746|FG002|All Implanted Cohort|Other reasons|1|||
146360472|NCT00414960|527823747|FG000|Overall Study|Adverse Event|4|||
146360473|NCT00414960|527823748|FG001|Overall Study|Adverse Event|0|||
146360474|NCT00414960|527823747|FG000|Overall Study|Withdrawal by Subject|3|||
146360475|NCT00414960|527823748|FG001|Overall Study|Withdrawal by Subject|0|||
146360476|NCT00414960|527823747|FG000|Overall Study|Physician Decision|0|||
146360477|NCT00414960|527823748|FG001|Overall Study|Physician Decision|1|||
146360478|NCT01449682|527823750|FG000|Overall Study|Death|0|||
146360479|NCT01449682|527823751|FG001|Overall Study|Death|1|||
146360480|NCT01449682|527823750|FG000|Overall Study|Adverse Event|1|||
146360481|NCT01449682|527823751|FG001|Overall Study|Adverse Event|0|||
146360482|NCT00264849|527823757|FG000|Overall Study|Adverse Event|7|||
146360483|NCT00264849|527823758|FG001|Overall Study|Adverse Event|2|||
146360484|NCT00264849|527823757|FG000|Overall Study|Withdrawal by Subject|7|||
146360485|NCT00264849|527823758|FG001|Overall Study|Withdrawal by Subject|11|||
146360486|NCT00264849|527823757|FG000|Overall Study|Protocol Violation|5|||
146360487|NCT00264849|527823758|FG001|Overall Study|Protocol Violation|3|||
146360488|NCT00264849|527823757|FG000|Overall Study|Lack of Efficacy|1|||
146360489|NCT00264849|527823758|FG001|Overall Study|Lack of Efficacy|6|||
146360490|NCT00264849|527823757|FG000|Overall Study|Lost to Follow-up|0|||
146360491|NCT00264849|527823758|FG001|Overall Study|Lost to Follow-up|2|||
146360492|NCT00264849|527823757|FG000|Overall Study|Death|0|||
146360493|NCT00264849|527823758|FG001|Overall Study|Death|1|||
146360494|NCT00264849|527823757|FG000|Overall Study|Administrative Problems|2|||
146360495|NCT00264849|527823758|FG001|Overall Study|Administrative Problems|0|||
146360496|NCT00099359|527823759|FG000|Overall Study|Death|11|||
146360497|NCT00099359|527823760|FG001|Overall Study|Death|15|||
146360498|NCT00099359|527823761|FG002|Overall Study|Death|17|||
146360499|NCT00099359|527823759|FG000|Overall Study|Withdrawal by Subject|19|||
146360500|NCT00099359|527823760|FG001|Overall Study|Withdrawal by Subject|19|||
146360501|NCT00099359|527823761|FG002|Overall Study|Withdrawal by Subject|23|||
146360502|NCT00099359|527823759|FG000|Overall Study|Lost to Follow-up|15|||
146360503|NCT00099359|527823760|FG001|Overall Study|Lost to Follow-up|24|||
146360504|NCT00099359|527823761|FG002|Overall Study|Lost to Follow-up|24|||
146360505|NCT00099359|527823759|FG000|Overall Study|moved out of area|9|||
146360506|NCT00099359|527823760|FG001|Overall Study|moved out of area|7|||
146360507|NCT00099359|527823761|FG002|Overall Study|moved out of area|4|||
146360508|NCT00717366|527823762|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
146360509|NCT00717366|527823763|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
146360510|NCT00717366|527823762|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
146360511|NCT00717366|527823763|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
146360512|NCT00717366|527823762|FG000|Core Study Period (20 Weeks)|Death|0|||
146360513|NCT00717366|527823763|FG001|Core Study Period (20 Weeks)|Death|1|||
146360514|NCT00717366|527823762|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
146360515|NCT00717366|527823763|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
146360516|NCT00717366|527823762|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
146169702|NCT02675465|527132907|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
146360517|NCT00717366|527823763|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
146360518|NCT00717366|527823762|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
146360519|NCT00717366|527823763|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
146360520|NCT00717366|527823762|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
146360521|NCT00717366|527823763|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
146360522|NCT02104804|527823764|FG000|Overall Study|Did not take study medication|0|||
146360523|NCT02104804|527823765|FG001|Overall Study|Did not take study medication|1|||
146360524|NCT02104804|527823764|FG000|Overall Study|Study specific discontinuation criteria|6|||
146360525|NCT02104804|527823765|FG001|Overall Study|Study specific discontinuation criteria|1|||
146360526|NCT02104804|527823764|FG000|Overall Study|Other listed|2|||
146360527|NCT02104804|527823765|FG001|Overall Study|Other listed|1|||
146360528|NCT02104804|527823764|FG000|Overall Study|Protocol Violation|0|||
146360529|NCT02104804|527823765|FG001|Overall Study|Protocol Violation|1|||
146360530|NCT02104804|527823764|FG000|Overall Study|Adverse Event|4|||
146360531|NCT02104804|527823765|FG001|Overall Study|Adverse Event|3|||
146360532|NCT02104804|527823764|FG000|Overall Study|Withdrawal by Subject|4|||
146360533|NCT02104804|527823765|FG001|Overall Study|Withdrawal by Subject|12|||
146360534|NCT04501679|527823766|FG000|Overall Study|Pregnancy|0|||
146360535|NCT04501679|527823767|FG001|Overall Study|Pregnancy|1|||
146360536|NCT04501679|527823766|FG000|Overall Study|Adverse Event|4|||
146360537|NCT04501679|527823767|FG001|Overall Study|Adverse Event|2|||
146360538|NCT04501679|527823766|FG000|Overall Study|Withdrawal by Subject|2|||
146360539|NCT04501679|527823767|FG001|Overall Study|Withdrawal by Subject|0|||
146360540|NCT04501679|527823766|FG000|Overall Study|Physician Decision|1|||
146360541|NCT04501679|527823767|FG001|Overall Study|Physician Decision|0|||
146360542|NCT04501679|527823766|FG000|Overall Study|Lost to Follow-up|2|||
146360543|NCT04501679|527823767|FG001|Overall Study|Lost to Follow-up|0|||
146360544|NCT02121756|527823772|FG000|Overall Study|Adverse Event|3|||
146360545|NCT02121756|527823773|FG001|Overall Study|Adverse Event|0|||
146360546|NCT02121756|527823772|FG000|Overall Study|Protocol Violation|1|||
146360547|NCT02121756|527823773|FG001|Overall Study|Protocol Violation|1|||
146360548|NCT02121756|527823772|FG000|Overall Study|Physician Decision|2|||
146360549|NCT02121756|527823773|FG001|Overall Study|Physician Decision|1|||
146360550|NCT03259490|527823779|FG000|Period 1|Withdrawal by Subject|0|||
146360551|NCT03259490|527823780|FG001|Period 1|Withdrawal by Subject|1|||
146360552|NCT03259490|527823779|FG000|Period 2|Protocol Violation|1|||
146360553|NCT03259490|527823780|FG001|Period 2|Protocol Violation|0|||
146360554|NCT00434122|527823781|FG000|Overall Study|Non-compliance with protocol|0|||
146360555|NCT00434122|527823782|FG001|Overall Study|Non-compliance with protocol|1|||
146360556|NCT00434122|527823781|FG000|Overall Study|loss of subject contact|1|||
146360557|NCT00434122|527823782|FG001|Overall Study|loss of subject contact|1|||
146360558|NCT00434122|527823781|FG000|Overall Study|Personal reasons|1|||
146360559|NCT00434122|527823782|FG001|Overall Study|Personal reasons|1|||
146360560|NCT00434122|527823781|FG000|Overall Study|Large follicle size|2|||
146360561|NCT00434122|527823782|FG001|Overall Study|Large follicle size|2|||
146360562|NCT00434122|527823781|FG000|Overall Study|Low follicular response.|1|||
146360563|NCT00434122|527823782|FG001|Overall Study|Low follicular response.|2|||
146360564|NCT00434122|527823781|FG000|Overall Study|Travelling of subject.|1|||
146360565|NCT00434122|527823782|FG001|Overall Study|Travelling of subject.|0|||
146360566|NCT00255086|527823784|FG000|Overall Study|Adverse Event|1|||
146360567|NCT00255086|527823785|FG001|Overall Study|Adverse Event|1|||
146360568|NCT00255086|527823784|FG000|Overall Study|Protocol Violation|1|||
146360569|NCT00255086|527823785|FG001|Overall Study|Protocol Violation|1|||
146360570|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
146360571|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146360572|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
146360573|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
146360574|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146360575|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
146360576|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146360577|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
146360578|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
146360579|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
146360580|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146360581|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
146360582|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146360583|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146360584|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
146360585|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146360586|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146360587|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
146360588|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146360589|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146360590|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
146360591|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
146360592|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146360593|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
146360594|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
146360595|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
146169703|NCT02675465|527132908|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
146360596|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
146360597|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
146360598|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
146360599|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
146360600|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146360601|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146360602|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146360603|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
146360604|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146360605|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
146360606|NCT01963208|527823786|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146360607|NCT01963208|527823787|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146360608|NCT01963208|527823788|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146360609|NCT01963208|527823789|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
146360610|NCT01963208|527823790|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146360611|NCT01963208|527823791|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
146360612|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146360613|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146360614|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146360615|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
146360616|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
146360617|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
146360618|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146360619|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146360620|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146360621|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
146360622|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
146360623|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
146360624|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146360625|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146360626|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146360627|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146360628|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
146360629|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
146360630|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146360631|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146360632|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146360633|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146360634|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
146360635|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
146360636|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
146360637|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
146360638|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
146360639|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
146360640|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
146360641|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
146360642|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146360643|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146360644|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146360645|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
146360646|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
146360647|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
146360648|NCT01963208|527823786|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
146360649|NCT01963208|527823787|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
146360650|NCT01963208|527823788|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
146360651|NCT01963208|527823789|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
146360652|NCT01963208|527823790|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
146360653|NCT01963208|527823791|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
146360654|NCT04191577|527823794|FG000|Overall Study|Withdrawal by Subject|2|||
146360655|NCT04191577|527823795|FG001|Overall Study|Withdrawal by Subject|2|||
146360656|NCT04191577|527823796|FG002|Overall Study|Withdrawal by Subject|1|||
146360657|NCT04191577|527823794|FG000|Overall Study|Physician Decision|1|||
146360658|NCT04191577|527823795|FG001|Overall Study|Physician Decision|1|||
146360659|NCT04191577|527823796|FG002|Overall Study|Physician Decision|0|||
146360660|NCT04191577|527823794|FG000|Overall Study|Adverse Event|0|||
146360661|NCT04191577|527823795|FG001|Overall Study|Adverse Event|0|||
146360662|NCT04191577|527823796|FG002|Overall Study|Adverse Event|1|||
146360663|NCT04191577|527823794|FG000|Overall Study|Death|0|||
146360664|NCT04191577|527823795|FG001|Overall Study|Death|0|||
146360665|NCT04191577|527823796|FG002|Overall Study|Death|1|||
146360666|NCT02365584|527823797|FG000|Overall Study|Adverse Event|2|||
146360667|NCT02365584|527823798|FG001|Overall Study|Adverse Event|2|||
146360668|NCT02365584|527823797|FG000|Overall Study|Withdrawal by Subject|1|||
146360669|NCT02365584|527823798|FG001|Overall Study|Withdrawal by Subject|0|||
146360670|NCT02365584|527823797|FG000|Overall Study|Disease Progression|9|||
146169704|NCT02675465|527132909|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
146360671|NCT02365584|527823798|FG001|Overall Study|Disease Progression|12|||
146360672|NCT01185249|527823799|FG000|Overall Study|Patients discharged or change in status|42|||
146360673|NCT01973452|527823800|FG000|Overall Study|Lack of Efficacy|0|||
146360674|NCT01973452|527823801|FG001|Overall Study|Lack of Efficacy|1|||
146360675|NCT01973452|527823800|FG000|Overall Study|Lost to Follow-up|1|||
146360676|NCT01973452|527823801|FG001|Overall Study|Lost to Follow-up|0|||
146360677|NCT01973452|527823800|FG000|Overall Study|Withdrawal by Subject|10|||
146360678|NCT01973452|527823801|FG001|Overall Study|Withdrawal by Subject|9|||
146360679|NCT01973452|527823800|FG000|Overall Study|Ineligible|1|||
146360680|NCT01973452|527823801|FG001|Overall Study|Ineligible|1|||
146360681|NCT01973452|527823800|FG000|Overall Study|Surgery canceled by participant|5|||
146360682|NCT01973452|527823801|FG001|Overall Study|Surgery canceled by participant|3|||
146360683|NCT05294211|527823805|FG000|Overall Study|Withdrawal by Subject|3|||
146360684|NCT05294211|527823805|FG000|Overall Study|Physician Decision|2|||
146360685|NCT05294211|527823805|FG000|Overall Study|Progressed to active labor|1|||
146360686|NCT05294211|527823805|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
146360687|NCT05294211|527823805|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
146360688|NCT00406783|527823806|FG000|Overall Study|Adverse Event|4|||
146360689|NCT00406783|527823807|FG001|Overall Study|Adverse Event|4|||
146360690|NCT00406783|527823806|FG000|Overall Study|Treatment Failure|2|||
146360691|NCT00406783|527823807|FG001|Overall Study|Treatment Failure|3|||
146360692|NCT00406783|527823806|FG000|Overall Study|Lost to Follow-up|3|||
146360693|NCT00406783|527823807|FG001|Overall Study|Lost to Follow-up|0|||
146360694|NCT00406783|527823806|FG000|Overall Study|Withdrawal by Subject|1|||
146360695|NCT00406783|527823807|FG001|Overall Study|Withdrawal by Subject|4|||
146360696|NCT00406783|527823806|FG000|Overall Study|Protocol Violation|4|||
146360697|NCT00406783|527823807|FG001|Overall Study|Protocol Violation|4|||
146360698|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
146360699|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
146360700|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
146360701|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
146360702|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
146360703|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
146360704|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
146360705|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
146360706|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
146360707|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
146360708|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
146360709|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
146360710|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
146360711|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
146360712|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
146360713|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
146360714|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Missing|3|||
146360715|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Missing|1|||
146360716|NCT00838916|527823808|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
146360717|NCT00838916|527823809|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
146360718|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
146360719|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
146360720|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
146360721|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
146360722|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
146360723|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
146360724|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
146360725|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
146360726|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
146360727|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
146360728|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
146360729|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
146360730|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
146360731|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
146360732|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
146360733|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
146360734|NCT00838916|527823808|FG000|Follow-up Period (8 Weeks)|Missing|3|||
146360735|NCT00838916|527823809|FG001|Follow-up Period (8 Weeks)|Missing|0|||
146360736|NCT01842607|527823810|FG000|Overall Study|Adverse Event|11|||
146360737|NCT01842607|527823810|FG000|Overall Study|Lack of Efficacy|19|||
146360738|NCT01842607|527823810|FG000|Overall Study|Protocol Violation|8|||
146169705|NCT02675465|527132910|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
146360739|NCT01842607|527823810|FG000|Overall Study|Protocol defined stopping criteria|2|||
146360740|NCT01842607|527823810|FG000|Overall Study|Lost to Follow-up|3|||
146360741|NCT01842607|527823810|FG000|Overall Study|Physician Decision|9|||
146360742|NCT01842607|527823810|FG000|Overall Study|Withdrawal by Subject|14|||
146360743|NCT00012012|527823811|FG000|Overall Study|Protocol Violation|1|||
146360744|NCT00012012|527823812|FG001|Overall Study|Protocol Violation|1|||
146360745|NCT00012012|527823811|FG000|Overall Study|Withdrawal by Subject|0|||
146360746|NCT00012012|527823812|FG001|Overall Study|Withdrawal by Subject|2|||
146360747|NCT02159469|527823813|FG000|Overall Study|Missing Completion status|1|||
146360748|NCT02159469|527823813|FG000|Overall Study|Adverse Event|5|||
146360749|NCT02159469|527823813|FG000|Overall Study|Non-compliance|2|||
146360750|NCT02159469|527823813|FG000|Overall Study|Withdrawal by Subject|9|||
146360751|NCT02159469|527823813|FG000|Overall Study|Lost to Follow-up|1|||
146360752|NCT02159469|527823813|FG000|Overall Study|Sponsor's request|2|||
146360753|NCT02159469|527823813|FG000|Overall Study|Met Stopping Criteria|3|||
146360754|NCT02159469|527823813|FG000|Overall Study|Other|1|||
146360755|NCT02159469|527823813|FG000|Overall Study|Multiple|29|||
146360756|NCT02034474|527823814|FG000|Overall Study|Adverse Event|3|||
146360757|NCT02034474|527823815|FG001|Overall Study|Adverse Event|2|||
146360758|NCT02034474|527823814|FG000|Overall Study|Withdrawal by Subject|1|||
146360759|NCT02034474|527823815|FG001|Overall Study|Withdrawal by Subject|2|||
146360760|NCT01391819|527823821|FG000|Overall Study|Withdrawal by Subject|56|||
146360761|NCT01391819|527823821|FG000|Overall Study|Migrated/moved from study area|82|||
146360762|NCT01391819|527823821|FG000|Overall Study|Lost to Follow-up|252|||
146360763|NCT01391819|527823821|FG000|Overall Study|Death|3|||
146360764|NCT01391819|527823821|FG000|Overall Study|Other|9|||
146360765|NCT03629041|527823822|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146360766|NCT03629041|527823823|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
146360767|NCT03629041|527823824|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146360768|NCT03629041|527823825|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
146360769|NCT01927419|527823827|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
146360770|NCT01927419|527823828|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
146360771|NCT01927419|527823827|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
146360772|NCT01927419|527823828|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
146360773|NCT01927419|527823827|FG000|Treatment Period|Disease progression|17|||
146360774|NCT01927419|527823828|FG001|Treatment Period|Disease progression|20|||
146360775|NCT01927419|527823827|FG000|Treatment Period|Study drug toxicity|48|||
146360776|NCT01927419|527823828|FG001|Treatment Period|Study drug toxicity|10|||
146360777|NCT01927419|527823827|FG000|Treatment Period|Death|0|||
146360778|NCT01927419|527823828|FG001|Treatment Period|Death|1|||
146360779|NCT01927419|527823827|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
146360780|NCT01927419|527823828|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
146360781|NCT01927419|527823827|FG000|Treatment Period|Participant request to discontinue|12|||
146360782|NCT01927419|527823828|FG001|Treatment Period|Participant request to discontinue|4|||
146360783|NCT01927419|527823827|FG000|Treatment Period|Withdrawal by Subject|1|||
146360784|NCT01927419|527823828|FG001|Treatment Period|Withdrawal by Subject|1|||
146360785|NCT01927419|527823827|FG000|Treatment Period|Maximum Clinical Benefit|6|||
146360786|NCT01927419|527823828|FG001|Treatment Period|Maximum Clinical Benefit|2|||
146360787|NCT01927419|527823827|FG000|Treatment Period|Other reasons|3|||
146360788|NCT01927419|527823828|FG001|Treatment Period|Other reasons|4|||
146360789|NCT01927419|527823827|FG000|Treatment Period|Not Reported|1|||
146360790|NCT01927419|527823828|FG001|Treatment Period|Not Reported|1|||
146360791|NCT03488251|527823829|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
146360792|NCT03488251|527823830|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146360793|NCT03488251|527823831|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146360794|NCT03488251|527823832|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
146360795|NCT03488251|527823829|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
146360796|NCT03488251|527823830|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146360797|NCT03488251|527823831|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146360798|NCT03488251|527823832|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
146360799|NCT03488251|527823829|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
146360800|NCT03488251|527823830|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146360801|NCT03488251|527823831|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146360802|NCT03488251|527823832|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
146360803|NCT03488251|527823829|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
146360804|NCT03488251|527823830|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146360805|NCT03488251|527823831|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146360806|NCT03488251|527823832|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
146360807|NCT03488251|527823829|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
146360808|NCT03488251|527823830|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146360809|NCT03488251|527823831|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146360810|NCT03488251|527823832|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
146360811|NCT00115765|527823835|FG000|Overall Study|Withdrawal by Subject|22|||
146360812|NCT00115765|527823836|FG001|Overall Study|Withdrawal by Subject|53|||
146360813|NCT00115765|527823837|FG002|Overall Study|Withdrawal by Subject|76|||
146360814|NCT00115765|527823838|FG003|Overall Study|Withdrawal by Subject|15|||
146360815|NCT00115765|527823835|FG000|Overall Study|Physician Decision|4|||
146360816|NCT00115765|527823836|FG001|Overall Study|Physician Decision|15|||
146360817|NCT00115765|527823837|FG002|Overall Study|Physician Decision|18|||
146360818|NCT00115765|527823838|FG003|Overall Study|Physician Decision|13|||
146360819|NCT00115765|527823835|FG000|Overall Study|Lost to Follow-up|3|||
146360820|NCT00115765|527823836|FG001|Overall Study|Lost to Follow-up|20|||
146360821|NCT00115765|527823837|FG002|Overall Study|Lost to Follow-up|18|||
146360822|NCT00115765|527823838|FG003|Overall Study|Lost to Follow-up|1|||
146360823|NCT00115765|527823835|FG000|Overall Study|Other|6|||
146360824|NCT00115765|527823836|FG001|Overall Study|Other|12|||
146360825|NCT00115765|527823837|FG002|Overall Study|Other|9|||
146360826|NCT00115765|527823838|FG003|Overall Study|Other|2|||
146360827|NCT00995670|527823839|FG000|Overall Study|Failed arterial cannulation|1|||
146360828|NCT00995670|527823840|FG001|Overall Study|Failed arterial cannulation|0|||
146360829|NCT00995670|527823841|FG002|Overall Study|Failed arterial cannulation|3|||
146360830|NCT00675103|527823842|FG000|Overall Study|Lack of Efficacy|2|||
146360831|NCT00675103|527823842|FG000|Overall Study|Adverse Event|1|||
146360832|NCT02164513|527823845|FG000|Overall Study|Adverse Event|162|||
146360833|NCT02164513|527823846|FG001|Overall Study|Adverse Event|180|||
146360834|NCT02164513|527823847|FG002|Overall Study|Adverse Event|111|||
146360835|NCT02164513|527823845|FG000|Overall Study|Other: Study Closed or terminated|5|||
146360836|NCT02164513|527823846|FG001|Overall Study|Other: Study Closed or terminated|2|||
146360837|NCT02164513|527823847|FG002|Overall Study|Other: Study Closed or terminated|4|||
146360838|NCT02164513|527823845|FG000|Overall Study|Lost to Follow-up|30|||
146360839|NCT02164513|527823846|FG001|Overall Study|Lost to Follow-up|36|||
146360840|NCT02164513|527823847|FG002|Overall Study|Lost to Follow-up|22|||
146360841|NCT02164513|527823845|FG000|Overall Study|Physician Decision|47|||
146360842|NCT02164513|527823846|FG001|Overall Study|Physician Decision|57|||
146360843|NCT02164513|527823847|FG002|Overall Study|Physician Decision|28|||
146360844|NCT02164513|527823845|FG000|Overall Study|Withdrawal by Subject|192|||
146360845|NCT02164513|527823846|FG001|Overall Study|Withdrawal by Subject|261|||
146360846|NCT02164513|527823847|FG002|Overall Study|Withdrawal by Subject|130|||
146360847|NCT02164513|527823845|FG000|Overall Study|Other: Reason not provided by site|1|||
146360848|NCT02164513|527823846|FG001|Overall Study|Other: Reason not provided by site|0|||
146360849|NCT02164513|527823847|FG002|Overall Study|Other: Reason not provided by site|0|||
146360850|NCT02773238|527823849|FG000|Overall Study|Lack of Efficacy|4|||
146360851|NCT04095286|527823850|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360852|NCT04095286|527823851|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
146360853|NCT04095286|527823852|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360854|NCT04095286|527823853|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360855|NCT04095286|527823854|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360856|NCT04095286|527823855|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360857|NCT04095286|527823850|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
146360858|NCT04095286|527823851|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146360859|NCT04095286|527823852|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146360860|NCT04095286|527823853|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146360861|NCT04095286|527823854|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146360862|NCT04095286|527823855|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
146360863|NCT04095286|527823850|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146360864|NCT04095286|527823851|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146360865|NCT04095286|527823852|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
146360866|NCT04095286|527823853|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146360867|NCT04095286|527823854|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146360868|NCT04095286|527823855|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
146360869|NCT04095286|527823850|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360870|NCT04095286|527823851|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360871|NCT04095286|527823852|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
146360872|NCT04095286|527823853|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360873|NCT04095286|527823854|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360874|NCT04095286|527823855|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
146360875|NCT04095286|527823850|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146360876|NCT04095286|527823851|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146360877|NCT04095286|527823852|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146169706|NCT02675465|527132911|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
146169707|NCT02675465|527132906|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146360878|NCT04095286|527823853|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146360879|NCT04095286|527823854|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
146360880|NCT04095286|527823855|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
146360881|NCT00479557|527823856|FG000|Overall Study|Death|0|||
146360882|NCT00479557|527823857|FG001|Overall Study|Death|0|||
146360883|NCT00479557|527823858|FG002|Overall Study|Death|0|||
146360884|NCT00479557|527823859|FG003|Overall Study|Death|0|||
146360885|NCT00479557|527823860|FG004|Overall Study|Death|0|||
146360886|NCT00479557|527823861|FG005|Overall Study|Death|1|||
146360887|NCT00479557|527823862|FG006|Overall Study|Death|0|||
146360888|NCT00479557|527823856|FG000|Overall Study|Lack of Efficacy|1|||
146360889|NCT00479557|527823857|FG001|Overall Study|Lack of Efficacy|0|||
146360890|NCT00479557|527823858|FG002|Overall Study|Lack of Efficacy|0|||
146360891|NCT00479557|527823859|FG003|Overall Study|Lack of Efficacy|0|||
146360892|NCT00479557|527823860|FG004|Overall Study|Lack of Efficacy|0|||
146360893|NCT00479557|527823861|FG005|Overall Study|Lack of Efficacy|0|||
146360894|NCT00479557|527823862|FG006|Overall Study|Lack of Efficacy|0|||
146360895|NCT00479557|527823856|FG000|Overall Study|Lost to Follow-up|0|||
146360896|NCT00479557|527823857|FG001|Overall Study|Lost to Follow-up|2|||
146360897|NCT00479557|527823858|FG002|Overall Study|Lost to Follow-up|0|||
146360898|NCT00479557|527823859|FG003|Overall Study|Lost to Follow-up|2|||
146360899|NCT00479557|527823860|FG004|Overall Study|Lost to Follow-up|0|||
146360900|NCT00479557|527823861|FG005|Overall Study|Lost to Follow-up|0|||
146360901|NCT00479557|527823862|FG006|Overall Study|Lost to Follow-up|0|||
146360902|NCT00479557|527823856|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146360903|NCT00479557|527823857|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146360904|NCT00479557|527823858|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
146360905|NCT00479557|527823859|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
146360906|NCT00479557|527823860|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146360907|NCT00479557|527823861|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
146360908|NCT00479557|527823862|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
146360909|NCT00479557|527823856|FG000|Overall Study|AE not related to Study Drug|1|||
146360910|NCT00479557|527823857|FG001|Overall Study|AE not related to Study Drug|3|||
146360911|NCT00479557|527823858|FG002|Overall Study|AE not related to Study Drug|0|||
146360912|NCT00479557|527823859|FG003|Overall Study|AE not related to Study Drug|0|||
146360913|NCT00479557|527823860|FG004|Overall Study|AE not related to Study Drug|2|||
146360914|NCT00479557|527823861|FG005|Overall Study|AE not related to Study Drug|2|||
146360915|NCT00479557|527823862|FG006|Overall Study|AE not related to Study Drug|1|||
146360916|NCT00479557|527823856|FG000|Overall Study|Caregiver Request|2|||
146360917|NCT00479557|527823857|FG001|Overall Study|Caregiver Request|2|||
146360918|NCT00479557|527823858|FG002|Overall Study|Caregiver Request|2|||
146360919|NCT00479557|527823859|FG003|Overall Study|Caregiver Request|0|||
146360920|NCT00479557|527823860|FG004|Overall Study|Caregiver Request|1|||
146360921|NCT00479557|527823861|FG005|Overall Study|Caregiver Request|2|||
146360922|NCT00479557|527823862|FG006|Overall Study|Caregiver Request|0|||
146360923|NCT00479557|527823856|FG000|Overall Study|Investigator Request|0|||
146360924|NCT00479557|527823857|FG001|Overall Study|Investigator Request|0|||
146360925|NCT00479557|527823858|FG002|Overall Study|Investigator Request|1|||
146360926|NCT00479557|527823859|FG003|Overall Study|Investigator Request|0|||
146360927|NCT00479557|527823860|FG004|Overall Study|Investigator Request|0|||
146360928|NCT00479557|527823861|FG005|Overall Study|Investigator Request|0|||
146360929|NCT00479557|527823862|FG006|Overall Study|Investigator Request|0|||
146360930|NCT00479557|527823856|FG000|Overall Study|Subject Request|3|||
146360931|NCT00479557|527823857|FG001|Overall Study|Subject Request|0|||
146360932|NCT00479557|527823858|FG002|Overall Study|Subject Request|1|||
146360933|NCT00479557|527823859|FG003|Overall Study|Subject Request|1|||
146360934|NCT00479557|527823860|FG004|Overall Study|Subject Request|1|||
146360935|NCT00479557|527823861|FG005|Overall Study|Subject Request|4|||
146360936|NCT00479557|527823862|FG006|Overall Study|Subject Request|1|||
146360937|NCT00479557|527823856|FG000|Overall Study|Other|2|||
146360938|NCT00479557|527823857|FG001|Overall Study|Other|3|||
146360939|NCT00479557|527823858|FG002|Overall Study|Other|1|||
146360940|NCT00479557|527823859|FG003|Overall Study|Other|0|||
146360941|NCT00479557|527823860|FG004|Overall Study|Other|0|||
146360942|NCT00479557|527823861|FG005|Overall Study|Other|3|||
146360943|NCT00479557|527823862|FG006|Overall Study|Other|0|||
146360944|NCT02509494|527823865|FG000|Overall Study|Lost to Follow-up|8|||
146360945|NCT02509494|527823866|FG001|Overall Study|Lost to Follow-up|47|||
146360946|NCT02509494|527823867|FG002|Overall Study|Lost to Follow-up|19|||
146360947|NCT02509494|527823868|FG003|Overall Study|Lost to Follow-up|6|||
146360948|NCT02509494|527823869|FG004|Overall Study|Lost to Follow-up|3|||
146360949|NCT02509494|527823870|FG005|Overall Study|Lost to Follow-up|3|||
146360950|NCT02509494|527823871|FG006|Overall Study|Lost to Follow-up|1|||
146360951|NCT02509494|527823872|FG007|Overall Study|Lost to Follow-up|3|||
146360952|NCT02509494|527823873|FG008|Overall Study|Lost to Follow-up|1|||
146360953|NCT02509494|527823865|FG000|Overall Study|Physician Decision|2|||
146360954|NCT02509494|527823866|FG001|Overall Study|Physician Decision|1|||
146360955|NCT02509494|527823867|FG002|Overall Study|Physician Decision|0|||
146360956|NCT02509494|527823868|FG003|Overall Study|Physician Decision|0|||
146360957|NCT02509494|527823869|FG004|Overall Study|Physician Decision|0|||
146360958|NCT02509494|527823870|FG005|Overall Study|Physician Decision|0|||
146360959|NCT02509494|527823871|FG006|Overall Study|Physician Decision|0|||
146360960|NCT02509494|527823872|FG007|Overall Study|Physician Decision|0|||
146360961|NCT02509494|527823873|FG008|Overall Study|Physician Decision|0|||
146360962|NCT02509494|527823865|FG000|Overall Study|Withdrawal by Subject|4|||
146360963|NCT02509494|527823866|FG001|Overall Study|Withdrawal by Subject|17|||
146360964|NCT02509494|527823867|FG002|Overall Study|Withdrawal by Subject|7|||
146360965|NCT02509494|527823868|FG003|Overall Study|Withdrawal by Subject|5|||
146360966|NCT02509494|527823869|FG004|Overall Study|Withdrawal by Subject|0|||
146360967|NCT02509494|527823870|FG005|Overall Study|Withdrawal by Subject|6|||
146360968|NCT02509494|527823871|FG006|Overall Study|Withdrawal by Subject|1|||
146360969|NCT02509494|527823872|FG007|Overall Study|Withdrawal by Subject|2|||
146360970|NCT02509494|527823873|FG008|Overall Study|Withdrawal by Subject|1|||
146360971|NCT02509494|527823865|FG000|Overall Study|Death|0|||
146360972|NCT02509494|527823866|FG001|Overall Study|Death|1|||
146360973|NCT02509494|527823867|FG002|Overall Study|Death|0|||
146360974|NCT02509494|527823868|FG003|Overall Study|Death|0|||
146360975|NCT02509494|527823869|FG004|Overall Study|Death|1|||
146360976|NCT02509494|527823870|FG005|Overall Study|Death|0|||
146360977|NCT02509494|527823871|FG006|Overall Study|Death|0|||
146360978|NCT02509494|527823872|FG007|Overall Study|Death|1|||
146360979|NCT02509494|527823873|FG008|Overall Study|Death|0|||
146360980|NCT02509494|527823865|FG000|Overall Study|Other|0|||
146360981|NCT02509494|527823866|FG001|Overall Study|Other|4|||
146360982|NCT02509494|527823867|FG002|Overall Study|Other|5|||
146360983|NCT02509494|527823868|FG003|Overall Study|Other|0|||
146360984|NCT02509494|527823869|FG004|Overall Study|Other|0|||
146360985|NCT02509494|527823870|FG005|Overall Study|Other|0|||
146360986|NCT02509494|527823871|FG006|Overall Study|Other|0|||
146360987|NCT02509494|527823872|FG007|Overall Study|Other|0|||
146360988|NCT02509494|527823873|FG008|Overall Study|Other|0|||
146360989|NCT02509494|527823865|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146360990|NCT02509494|527823866|FG001|Overall Study|Non-Compliance With Study Drug|11|||
146360991|NCT02509494|527823867|FG002|Overall Study|Non-Compliance With Study Drug|7|||
146360992|NCT02509494|527823868|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146360993|NCT02509494|527823869|FG004|Overall Study|Non-Compliance With Study Drug|1|||
146360994|NCT02509494|527823870|FG005|Overall Study|Non-Compliance With Study Drug|2|||
146360995|NCT02509494|527823871|FG006|Overall Study|Non-Compliance With Study Drug|1|||
146360996|NCT02509494|527823872|FG007|Overall Study|Non-Compliance With Study Drug|1|||
146360997|NCT02509494|527823873|FG008|Overall Study|Non-Compliance With Study Drug|0|||
146360998|NCT01511107|527823874|FG000|Overall Study|Ineligible|3|||
146360999|NCT01511107|527823875|FG001|Overall Study|Ineligible|2|||
146361000|NCT01511107|527823874|FG000|Overall Study|Lost to Follow-up|10|||
146361001|NCT01511107|527823875|FG001|Overall Study|Lost to Follow-up|19|||
146361002|NCT01511107|527823874|FG000|Overall Study|Withdrawal by Subject|9|||
146361003|NCT01511107|527823875|FG001|Overall Study|Withdrawal by Subject|20|||
146361004|NCT04752189|527823876|FG000|Overall Study|Withdrawal by Subject|0|||
146361005|NCT04752189|527823877|FG001|Overall Study|Withdrawal by Subject|150|||
146361006|NCT04752189|527823876|FG000|Overall Study|Lost to Follow-up|261|||
146361007|NCT04752189|527823877|FG001|Overall Study|Lost to Follow-up|126|||
146361008|NCT00975195|527823878|FG000|Overall Study|Adverse Event|108|||
146361009|NCT00975195|527823879|FG001|Overall Study|Adverse Event|101|||
146361010|NCT00975195|527823878|FG000|Overall Study|Lack of Efficacy|6|||
146361011|NCT00975195|527823879|FG001|Overall Study|Lack of Efficacy|6|||
146361012|NCT00975195|527823878|FG000|Overall Study|Protocol Violation|27|||
146361013|NCT00975195|527823879|FG001|Overall Study|Protocol Violation|23|||
146361014|NCT00975195|527823878|FG000|Overall Study|Lost to Follow-up|9|||
146361015|NCT00975195|527823879|FG001|Overall Study|Lost to Follow-up|7|||
146361016|NCT00975195|527823878|FG000|Overall Study|Withdrawal by Subject|48|||
146361017|NCT00975195|527823879|FG001|Overall Study|Withdrawal by Subject|61|||
146361018|NCT00975195|527823878|FG000|Overall Study|Other reason not defined above|29|||
146361019|NCT00975195|527823879|FG001|Overall Study|Other reason not defined above|33|||
146361020|NCT00975195|527823878|FG000|Overall Study|Not treated|1|||
146361021|NCT00975195|527823879|FG001|Overall Study|Not treated|2|||
146361022|NCT03422133|527823884|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
146361023|NCT03422133|527823885|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
146361024|NCT03003403|527823886|FG000|Overall Study|Ineligible|8|||
146361025|NCT03003403|527823887|FG001|Overall Study|Ineligible|7|||
146361026|NCT03003403|527823886|FG000|Overall Study|Withdrawal by Subject|3|||
146361027|NCT03003403|527823887|FG001|Overall Study|Withdrawal by Subject|1|||
146361028|NCT01274338|527825182|FG000|Overall Study|Lack of Efficacy|72|||
146361029|NCT01274338|527825183|FG001|Overall Study|Lack of Efficacy|108|||
146361030|NCT01274338|527825184|FG002|Overall Study|Lack of Efficacy|116|||
146361031|NCT01274338|527825185|FG003|Overall Study|Lack of Efficacy|0|||
146361032|NCT01274338|527825186|FG004|Overall Study|Lack of Efficacy|0|||
146361033|NCT01274338|527825187|FG005|Overall Study|Lack of Efficacy|0|||
146361034|NCT01274338|527825182|FG000|Overall Study|Adverse Event|272|||
146361035|NCT01274338|527825183|FG001|Overall Study|Adverse Event|105|||
146361036|NCT01274338|527825184|FG002|Overall Study|Adverse Event|180|||
146361037|NCT01274338|527825185|FG003|Overall Study|Adverse Event|1|||
146361038|NCT01274338|527825186|FG004|Overall Study|Adverse Event|0|||
146361039|NCT01274338|527825187|FG005|Overall Study|Adverse Event|0|||
146361040|NCT01274338|527825182|FG000|Overall Study|Death|8|||
146361041|NCT01274338|527825183|FG001|Overall Study|Death|1|||
146361042|NCT01274338|527825184|FG002|Overall Study|Death|0|||
146361043|NCT01274338|527825185|FG003|Overall Study|Death|0|||
146361044|NCT01274338|527825186|FG004|Overall Study|Death|0|||
146361045|NCT01274338|527825187|FG005|Overall Study|Death|0|||
146361046|NCT01274338|527825182|FG000|Overall Study|Withdrawal by Subject|27|||
146361047|NCT01274338|527825183|FG001|Overall Study|Withdrawal by Subject|99|||
146361048|NCT01274338|527825184|FG002|Overall Study|Withdrawal by Subject|17|||
146361049|NCT01274338|527825185|FG003|Overall Study|Withdrawal by Subject|0|||
146361050|NCT01274338|527825186|FG004|Overall Study|Withdrawal by Subject|0|||
146361051|NCT01274338|527825187|FG005|Overall Study|Withdrawal by Subject|0|||
146361052|NCT01274338|527825182|FG000|Overall Study|Did not start treatment|8|||
146361053|NCT01274338|527825183|FG001|Overall Study|Did not start treatment|116|||
146361054|NCT01274338|527825184|FG002|Overall Study|Did not start treatment|7|||
146361055|NCT01274338|527825185|FG003|Overall Study|Did not start treatment|0|||
146361056|NCT01274338|527825186|FG004|Overall Study|Did not start treatment|0|||
146361057|NCT01274338|527825187|FG005|Overall Study|Did not start treatment|0|||
146361058|NCT01274338|527825182|FG000|Overall Study|Alternative therapy|0|||
146361059|NCT01274338|527825183|FG001|Overall Study|Alternative therapy|1|||
146361060|NCT01274338|527825184|FG002|Overall Study|Alternative therapy|0|||
146361061|NCT01274338|527825185|FG003|Overall Study|Alternative therapy|0|||
146361062|NCT01274338|527825186|FG004|Overall Study|Alternative therapy|0|||
146361063|NCT01274338|527825187|FG005|Overall Study|Alternative therapy|0|||
146361064|NCT01274338|527825182|FG000|Overall Study|Other complicating diseases|0|||
146361065|NCT01274338|527825183|FG001|Overall Study|Other complicating diseases|3|||
146361066|NCT01274338|527825184|FG002|Overall Study|Other complicating diseases|1|||
146361067|NCT01274338|527825185|FG003|Overall Study|Other complicating diseases|0|||
146361068|NCT01274338|527825186|FG004|Overall Study|Other complicating diseases|0|||
146361069|NCT01274338|527825187|FG005|Overall Study|Other complicating diseases|0|||
146361070|NCT01274338|527825182|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
146361071|NCT01274338|527825183|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
146361072|NCT01274338|527825184|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
146361073|NCT01274338|527825185|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
146361074|NCT01274338|527825186|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
146361075|NCT01274338|527825187|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
146361076|NCT01274338|527825182|FG000|Overall Study|Pregnancy|0|||
146361077|NCT01274338|527825183|FG001|Overall Study|Pregnancy|0|||
146361078|NCT01274338|527825184|FG002|Overall Study|Pregnancy|1|||
146361079|NCT01274338|527825185|FG003|Overall Study|Pregnancy|0|||
146361080|NCT01274338|527825186|FG004|Overall Study|Pregnancy|0|||
146361081|NCT01274338|527825187|FG005|Overall Study|Pregnancy|0|||
146361082|NCT01274338|527825182|FG000|Overall Study|Reason not reported|12|||
146361083|NCT01274338|527825183|FG001|Overall Study|Reason not reported|21|||
146361084|NCT01274338|527825184|FG002|Overall Study|Reason not reported|3|||
146361085|NCT01274338|527825185|FG003|Overall Study|Reason not reported|0|||
146361086|NCT01274338|527825186|FG004|Overall Study|Reason not reported|1|||
146361087|NCT01274338|527825187|FG005|Overall Study|Reason not reported|0|||
146361088|NCT05084053|527825188|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
146361089|NCT05084053|527825189|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146361090|NCT05084053|527825190|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146361091|NCT05084053|527825191|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
146361092|NCT05084053|527825188|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
146361093|NCT05084053|527825189|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
146361094|NCT05084053|527825190|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
146361095|NCT05084053|527825191|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
146361096|NCT05084053|527825188|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
146361097|NCT05084053|527825189|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
146361098|NCT05084053|527825190|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
146361099|NCT05084053|527825191|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
146361100|NCT02180724|527825192|FG000|Overall Study|Death|26|||
146361101|NCT02180724|527825193|FG001|Overall Study|Death|1|||
146361102|NCT02180724|527825192|FG000|Overall Study|Lost to Follow-up|3|||
146361103|NCT02180724|527825193|FG001|Overall Study|Lost to Follow-up|1|||
146361104|NCT02180724|527825192|FG000|Overall Study|Withdrawal by Subject|4|||
146361105|NCT02180724|527825193|FG001|Overall Study|Withdrawal by Subject|2|||
146361106|NCT02180724|527825192|FG000|Overall Study|PI Decision|5|||
146361107|NCT02180724|527825193|FG001|Overall Study|PI Decision|2|||
146361108|NCT02180724|527825192|FG000|Overall Study|Study terminated by sponsor|54|||
146361109|NCT02180724|527825193|FG001|Overall Study|Study terminated by sponsor|8|||
146361110|NCT01927744|527825194|FG000|Overall Study|Death|2|||
146361111|NCT01927744|527825195|FG001|Overall Study|Death|9|||
146361112|NCT05195359|527825199|FG000|Overall Study|Lost to Follow-up|124|||
146361113|NCT05195359|527825200|FG001|Overall Study|Lost to Follow-up|34|||
146361114|NCT05458011|527825206|FG000|DB Period (12 Weeks)|Adverse Event|2|||
146361115|NCT05458011|527825207|FG001|DB Period (12 Weeks)|Adverse Event|1|||
146361116|NCT05458011|527825208|FG002|DB Period (12 Weeks)|Adverse Event|1|||
146361117|NCT05458011|527825206|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
146361118|NCT05458011|527825207|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
146361119|NCT05458011|527825208|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
146361120|NCT05458011|527825206|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
146361121|NCT05458011|527825207|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
146361122|NCT05458011|527825208|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
146361123|NCT05458011|527825206|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
146361124|NCT05458011|527825207|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
146361125|NCT05458011|527825208|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
146361126|NCT05458011|527825206|FG000|OL Period (12 Weeks)|Adverse Event|1|||
146361127|NCT05458011|527825207|FG001|OL Period (12 Weeks)|Adverse Event|2|||
146361128|NCT05458011|527825208|FG002|OL Period (12 Weeks)|Adverse Event|1|||
146361129|NCT05458011|527825206|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
146361130|NCT05458011|527825207|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
146361131|NCT05458011|527825208|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
146361132|NCT03569449|527825211|FG000|Overall Study|Lost to Follow-up|0|||
146361133|NCT03569449|527825212|FG001|Overall Study|Lost to Follow-up|1|||
146361134|NCT03569449|527825213|FG002|Overall Study|Lost to Follow-up|0|||
146361135|NCT03569449|527825214|FG003|Overall Study|Lost to Follow-up|2|||
146361136|NCT03569449|527825215|FG004|Overall Study|Lost to Follow-up|0|||
146361137|NCT03569449|527825216|FG005|Overall Study|Lost to Follow-up|0|||
146361138|NCT03569449|527825217|FG006|Overall Study|Lost to Follow-up|0|||
146361139|NCT03569449|527825218|FG007|Overall Study|Lost to Follow-up|0|||
146361140|NCT03569449|527825219|FG008|Overall Study|Lost to Follow-up|0|||
146361141|NCT03569449|527825220|FG009|Overall Study|Lost to Follow-up|0|||
146361142|NCT03569449|527825221|FG010|Overall Study|Lost to Follow-up|0|||
146361143|NCT03569449|527825222|FG011|Overall Study|Lost to Follow-up|0|||
146361144|NCT03569449|527825223|FG012|Overall Study|Lost to Follow-up|0|||
146361145|NCT03569449|527825224|FG013|Overall Study|Lost to Follow-up|0|||
146361146|NCT03569449|527825225|FG014|Overall Study|Lost to Follow-up|1|||
146361147|NCT03569449|527825226|FG015|Overall Study|Lost to Follow-up|0|||
146361148|NCT03569449|527825211|FG000|Overall Study|Withdrawal by Subject|0|||
146361149|NCT03569449|527825212|FG001|Overall Study|Withdrawal by Subject|1|||
146361150|NCT03569449|527825213|FG002|Overall Study|Withdrawal by Subject|0|||
146361151|NCT03569449|527825214|FG003|Overall Study|Withdrawal by Subject|0|||
146361152|NCT03569449|527825215|FG004|Overall Study|Withdrawal by Subject|1|||
146361153|NCT03569449|527825216|FG005|Overall Study|Withdrawal by Subject|0|||
146361154|NCT03569449|527825217|FG006|Overall Study|Withdrawal by Subject|0|||
146361155|NCT03569449|527825218|FG007|Overall Study|Withdrawal by Subject|0|||
146361156|NCT03569449|527825219|FG008|Overall Study|Withdrawal by Subject|0|||
146361157|NCT03569449|527825220|FG009|Overall Study|Withdrawal by Subject|0|||
146361158|NCT03569449|527825221|FG010|Overall Study|Withdrawal by Subject|0|||
146361159|NCT03569449|527825222|FG011|Overall Study|Withdrawal by Subject|0|||
146361160|NCT03569449|527825223|FG012|Overall Study|Withdrawal by Subject|0|||
146361161|NCT03569449|527825224|FG013|Overall Study|Withdrawal by Subject|0|||
146361162|NCT03569449|527825225|FG014|Overall Study|Withdrawal by Subject|0|||
146361163|NCT03569449|527825226|FG015|Overall Study|Withdrawal by Subject|0|||
146361164|NCT05279898|527825229|FG000|Overall Study|Withdrawal by Subject|1|||
146361165|NCT05279898|527825230|FG001|Overall Study|Withdrawal by Subject|0|||
146361166|NCT05279898|527825229|FG000|Overall Study|Physician Decision|1|||
146361167|NCT05279898|527825230|FG001|Overall Study|Physician Decision|1|||
146361168|NCT05136170|527825231|FG000|Overall Study|Withdrawal by Subject|2|||
146361169|NCT05136170|527825232|FG001|Overall Study|Withdrawal by Subject|2|||
146361170|NCT05136170|527825231|FG000|Overall Study|Can no longer make office visits|1|||
146361171|NCT05136170|527825232|FG001|Overall Study|Can no longer make office visits|0|||
146361172|NCT04393038|527825233|FG000|Overall Study|Adverse Event|11|||
146361173|NCT04393038|527825234|FG001|Overall Study|Adverse Event|2|||
146361174|NCT04393038|527825233|FG000|Overall Study|Protocol Violation|1|||
146361175|NCT04393038|527825234|FG001|Overall Study|Protocol Violation|0|||
146361176|NCT04393038|527825233|FG000|Overall Study|Death|6|||
146361177|NCT04393038|527825234|FG001|Overall Study|Death|4|||
146361178|NCT04393038|527825233|FG000|Overall Study|Withdrawal by Subject|24|||
146361179|NCT04393038|527825234|FG001|Overall Study|Withdrawal by Subject|8|||
146361180|NCT04393038|527825233|FG000|Overall Study|Lost to Follow-up|5|||
146361181|NCT04393038|527825234|FG001|Overall Study|Lost to Follow-up|4|||
146361182|NCT04393038|527825233|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
146169708|NCT02675465|527132907|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146361183|NCT04393038|527825234|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
146361184|NCT04393038|527825233|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
146361185|NCT04393038|527825234|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
146361186|NCT05168813|527825235|FG000|Part A (Open-label)|Lost to Follow-up|21|||
146361187|NCT05168813|527825236|FG001|Part A (Open-label)|Lost to Follow-up|39|||
146361188|NCT05168813|527825237|FG002|Part A (Open-label)|Lost to Follow-up|8|||
146361189|NCT05168813|527825238|FG003|Part A (Open-label)|Lost to Follow-up|26|||
146361190|NCT05168813|527825239|FG004|Part A (Open-label)|Lost to Follow-up|0|||
146361191|NCT05168813|527825240|FG005|Part A (Open-label)|Lost to Follow-up|0|||
146361192|NCT05168813|527825235|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
146361193|NCT05168813|527825236|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
146361194|NCT05168813|527825237|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
146361195|NCT05168813|527825238|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
146361196|NCT05168813|527825239|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
146361197|NCT05168813|527825240|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
146361198|NCT05168813|527825235|FG000|Part A (Open-label)|Death|23|||
146361199|NCT05168813|527825236|FG001|Part A (Open-label)|Death|28|||
146361200|NCT05168813|527825237|FG002|Part A (Open-label)|Death|1|||
146361201|NCT05168813|527825238|FG003|Part A (Open-label)|Death|9|||
146361202|NCT05168813|527825239|FG004|Part A (Open-label)|Death|0|||
146361203|NCT05168813|527825240|FG005|Part A (Open-label)|Death|0|||
146361204|NCT05168813|527825235|FG000|Part A (Open-label)|Physician Decision|0|||
146361205|NCT05168813|527825236|FG001|Part A (Open-label)|Physician Decision|1|||
146361206|NCT05168813|527825237|FG002|Part A (Open-label)|Physician Decision|0|||
146361207|NCT05168813|527825238|FG003|Part A (Open-label)|Physician Decision|2|||
146361208|NCT05168813|527825239|FG004|Part A (Open-label)|Physician Decision|0|||
146361209|NCT05168813|527825240|FG005|Part A (Open-label)|Physician Decision|0|||
146361210|NCT05168813|527825235|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
146361211|NCT05168813|527825236|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
146361212|NCT05168813|527825237|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146361213|NCT05168813|527825238|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
146361214|NCT05168813|527825239|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146361215|NCT05168813|527825240|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
146361216|NCT05168813|527825235|FG000|Part A (Open-label)|Protocol Violation|0|||
146361217|NCT05168813|527825236|FG001|Part A (Open-label)|Protocol Violation|1|||
146361218|NCT05168813|527825237|FG002|Part A (Open-label)|Protocol Violation|0|||
146361219|NCT05168813|527825238|FG003|Part A (Open-label)|Protocol Violation|0|||
146361220|NCT05168813|527825239|FG004|Part A (Open-label)|Protocol Violation|0|||
146361221|NCT05168813|527825240|FG005|Part A (Open-label)|Protocol Violation|0|||
146361222|NCT05168813|527825235|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
146361223|NCT05168813|527825236|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
146361224|NCT05168813|527825237|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
146361225|NCT05168813|527825238|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
146361226|NCT05168813|527825239|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
146361227|NCT05168813|527825240|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
146361228|NCT05168813|527825235|FG000|Part A (Open-label)|Other|0|||
146361229|NCT05168813|527825236|FG001|Part A (Open-label)|Other|1|||
146361230|NCT05168813|527825237|FG002|Part A (Open-label)|Other|0|||
146361231|NCT05168813|527825238|FG003|Part A (Open-label)|Other|0|||
146361232|NCT05168813|527825239|FG004|Part A (Open-label)|Other|0|||
146361233|NCT05168813|527825240|FG005|Part A (Open-label)|Other|0|||
146361234|NCT05168813|527825235|FG000|Part B (Blinded)|Lost to Follow-up|0|||
146361235|NCT05168813|527825236|FG001|Part B (Blinded)|Lost to Follow-up|0|||
146361236|NCT05168813|527825237|FG002|Part B (Blinded)|Lost to Follow-up|0|||
146361237|NCT05168813|527825238|FG003|Part B (Blinded)|Lost to Follow-up|0|||
146361238|NCT05168813|527825239|FG004|Part B (Blinded)|Lost to Follow-up|219|||
146361239|NCT05168813|527825240|FG005|Part B (Blinded)|Lost to Follow-up|88|||
146361240|NCT05168813|527825235|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
146361241|NCT05168813|527825236|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
146361242|NCT05168813|527825237|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
146361243|NCT05168813|527825238|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
146361244|NCT05168813|527825239|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
146361245|NCT05168813|527825240|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
146361246|NCT05168813|527825235|FG000|Part B (Blinded)|Death|0|||
146361247|NCT05168813|527825236|FG001|Part B (Blinded)|Death|0|||
146361248|NCT05168813|527825237|FG002|Part B (Blinded)|Death|0|||
146361249|NCT05168813|527825238|FG003|Part B (Blinded)|Death|0|||
146361250|NCT05168813|527825239|FG004|Part B (Blinded)|Death|63|||
146361251|NCT05168813|527825240|FG005|Part B (Blinded)|Death|19|||
146361252|NCT05168813|527825235|FG000|Part B (Blinded)|Physician Decision|0|||
146361253|NCT05168813|527825236|FG001|Part B (Blinded)|Physician Decision|0|||
146361254|NCT05168813|527825237|FG002|Part B (Blinded)|Physician Decision|0|||
146361255|NCT05168813|527825238|FG003|Part B (Blinded)|Physician Decision|0|||
146361256|NCT05168813|527825239|FG004|Part B (Blinded)|Physician Decision|6|||
146361257|NCT05168813|527825240|FG005|Part B (Blinded)|Physician Decision|1|||
146361258|NCT05168813|527825235|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146361259|NCT05168813|527825236|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146169709|NCT02675465|527132908|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
146361260|NCT05168813|527825237|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146361261|NCT05168813|527825238|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
146361262|NCT05168813|527825239|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
146361263|NCT05168813|527825240|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
146361264|NCT05168813|527825235|FG000|Part B (Blinded)|Pregnancy|0|||
146361265|NCT05168813|527825236|FG001|Part B (Blinded)|Pregnancy|0|||
146361266|NCT05168813|527825237|FG002|Part B (Blinded)|Pregnancy|0|||
146361267|NCT05168813|527825238|FG003|Part B (Blinded)|Pregnancy|0|||
146361268|NCT05168813|527825239|FG004|Part B (Blinded)|Pregnancy|1|||
146361269|NCT05168813|527825240|FG005|Part B (Blinded)|Pregnancy|0|||
146361270|NCT05168813|527825235|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
146361271|NCT05168813|527825236|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
146361272|NCT05168813|527825237|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
146361273|NCT05168813|527825238|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
146361274|NCT05168813|527825239|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
146361275|NCT05168813|527825240|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
146361276|NCT05168813|527825235|FG000|Part B (Blinded)|Other|0|||
146361277|NCT05168813|527825236|FG001|Part B (Blinded)|Other|0|||
146361278|NCT05168813|527825237|FG002|Part B (Blinded)|Other|0|||
146361279|NCT05168813|527825238|FG003|Part B (Blinded)|Other|0|||
146361280|NCT05168813|527825239|FG004|Part B (Blinded)|Other|41|||
146361281|NCT05168813|527825240|FG005|Part B (Blinded)|Other|27|||
146361282|NCT02680587|527825244|FG000|Overall Study|Withdrawal by Subject|1|||
146361283|NCT02680587|527825245|FG001|Overall Study|Withdrawal by Subject|0|||
146361284|NCT00571688|527825252|FG000|Overall Study|Lost to Follow-up|3|||
146361285|NCT00571688|527825253|FG001|Overall Study|Lost to Follow-up|6|||
146361286|NCT00571688|527825252|FG000|Overall Study|subject did not tolerate Consta|1|||
146361287|NCT00571688|527825253|FG001|Overall Study|subject did not tolerate Consta|0|||
146361288|NCT00571688|527825252|FG000|Overall Study|subject moved out of the area|1|||
146361289|NCT00571688|527825253|FG001|Overall Study|subject moved out of the area|0|||
146361290|NCT01708941|527825254|FG000|Overall Study|Adverse Event|4|||
146361291|NCT01708941|527825255|FG001|Overall Study|Adverse Event|6|||
146361292|NCT01708941|527825256|FG002|Overall Study|Adverse Event|1|||
146361293|NCT01708941|527825257|FG003|Overall Study|Adverse Event|0|||
146361294|NCT01708941|527825254|FG000|Overall Study|Death|1|||
146361295|NCT01708941|527825255|FG001|Overall Study|Death|1|||
146361296|NCT01708941|527825256|FG002|Overall Study|Death|2|||
146361297|NCT01708941|527825257|FG003|Overall Study|Death|14|||
146361298|NCT01708941|527825254|FG000|Overall Study|Withdrawal by Subject|1|||
146361299|NCT01708941|527825255|FG001|Overall Study|Withdrawal by Subject|0|||
146361300|NCT01708941|527825256|FG002|Overall Study|Withdrawal by Subject|3|||
146361301|NCT01708941|527825257|FG003|Overall Study|Withdrawal by Subject|4|||
146361302|NCT01708941|527825254|FG000|Overall Study|Disease progression|9|||
146361303|NCT01708941|527825255|FG001|Overall Study|Disease progression|10|||
146361304|NCT01708941|527825256|FG002|Overall Study|Disease progression|8|||
146361305|NCT01708941|527825257|FG003|Overall Study|Disease progression|0|||
146361306|NCT01708941|527825254|FG000|Overall Study|Alternative therapy|0|||
146361307|NCT01708941|527825255|FG001|Overall Study|Alternative therapy|0|||
146361308|NCT01708941|527825256|FG002|Overall Study|Alternative therapy|2|||
146361309|NCT01708941|527825257|FG003|Overall Study|Alternative therapy|0|||
146361310|NCT01708941|527825254|FG000|Overall Study|Ineligible and never started treatment|1|||
146361311|NCT01708941|527825255|FG001|Overall Study|Ineligible and never started treatment|0|||
146361312|NCT01708941|527825256|FG002|Overall Study|Ineligible and never started treatment|1|||
146361313|NCT01708941|527825257|FG003|Overall Study|Ineligible and never started treatment|0|||
146361314|NCT01708941|527825254|FG000|Overall Study|Never started treatment|2|||
146361315|NCT01708941|527825255|FG001|Overall Study|Never started treatment|1|||
146361316|NCT01708941|527825256|FG002|Overall Study|Never started treatment|0|||
146361317|NCT01708941|527825257|FG003|Overall Study|Never started treatment|0|||
146361318|NCT01708941|527825254|FG000|Overall Study|Ineligible|0|||
146361319|NCT01708941|527825255|FG001|Overall Study|Ineligible|0|||
146361320|NCT01708941|527825256|FG002|Overall Study|Ineligible|2|||
146361321|NCT01708941|527825257|FG003|Overall Study|Ineligible|0|||
146361322|NCT02226146|527825258|FG000|Overall Study|Received rescue therapy|1|||
146361323|NCT02226146|527825258|FG000|Overall Study|Withdrawal by Subject|2|||
146361324|NCT05464836|527825259|FG000|Overall Study|Progression of Disease|1|||
146361325|NCT05464836|527825259|FG000|Overall Study|Physician Decision|1|||
146361326|NCT01522976|527825260|FG000|Overall Study|Ineligible|4|||
146361327|NCT01522976|527825261|FG001|Overall Study|Ineligible|0|||
146361328|NCT01522976|527825262|FG002|Overall Study|Ineligible|1|||
146361329|NCT01522976|527825260|FG000|Overall Study|Death|7|||
146361330|NCT01522976|527825261|FG001|Overall Study|Death|6|||
146361331|NCT01522976|527825262|FG002|Overall Study|Death|2|||
146361332|NCT01522976|527825260|FG000|Overall Study|Still on treatment|9|||
146361333|NCT01522976|527825261|FG001|Overall Study|Still on treatment|9|||
146361334|NCT01522976|527825262|FG002|Overall Study|Still on treatment|6|||
146361335|NCT01522976|527825260|FG000|Overall Study|Disease progression|28|||
146361336|NCT01522976|527825261|FG001|Overall Study|Disease progression|30|||
146361337|NCT01522976|527825262|FG002|Overall Study|Disease progression|25|||
146361338|NCT01522976|527825260|FG000|Overall Study|Adverse Event|17|||
146361339|NCT01522976|527825261|FG001|Overall Study|Adverse Event|7|||
146361340|NCT01522976|527825262|FG002|Overall Study|Adverse Event|18|||
146361341|NCT01522976|527825260|FG000|Overall Study|Refusal unrelated to adverse event|10|||
146361342|NCT01522976|527825261|FG001|Overall Study|Refusal unrelated to adverse event|13|||
146361343|NCT01522976|527825262|FG002|Overall Study|Refusal unrelated to adverse event|14|||
146361344|NCT01522976|527825260|FG000|Overall Study|Not protocol specified|22|||
146361345|NCT01522976|527825261|FG001|Overall Study|Not protocol specified|27|||
146361346|NCT01522976|527825262|FG002|Overall Study|Not protocol specified|27|||
146361347|NCT02883049|527825263|FG000|Induction|Adverse Event|52|||
146361348|NCT02883049|527825264|FG001|Induction|Adverse Event|2|||
146361349|NCT02883049|527825265|FG002|Induction|Adverse Event|0|||
146361350|NCT02883049|527825266|FG003|Induction|Adverse Event|0|||
146361351|NCT02883049|527825267|FG004|Induction|Adverse Event|0|||
146361352|NCT02883049|527825268|FG005|Induction|Adverse Event|0|||
146361353|NCT02883049|527825269|FG006|Induction|Adverse Event|0|||
146361354|NCT02883049|527825270|FG007|Induction|Adverse Event|0|||
146361355|NCT02883049|527825271|FG008|Induction|Adverse Event|0|||
146361356|NCT02883049|527825272|FG009|Induction|Adverse Event|0|||
146361357|NCT02883049|527825273|FG010|Induction|Adverse Event|0|||
146361358|NCT02883049|527825274|FG011|Induction|Adverse Event|0|||
146361359|NCT02883049|527825275|FG012|Induction|Adverse Event|0|||
146361360|NCT02883049|527825276|FG013|Induction|Adverse Event|0|||
146361361|NCT02883049|527825277|FG014|Induction|Adverse Event|0|||
146361362|NCT02883049|527825278|FG015|Induction|Adverse Event|0|||
146361363|NCT02883049|527825263|FG000|Induction|Death|76|||
146361364|NCT02883049|527825264|FG001|Induction|Death|8|||
146361365|NCT02883049|527825265|FG002|Induction|Death|0|||
146361366|NCT02883049|527825266|FG003|Induction|Death|0|||
146361367|NCT02883049|527825267|FG004|Induction|Death|0|||
146361368|NCT02883049|527825268|FG005|Induction|Death|0|||
146361369|NCT02883049|527825269|FG006|Induction|Death|0|||
146361370|NCT02883049|527825270|FG007|Induction|Death|0|||
146361371|NCT02883049|527825271|FG008|Induction|Death|0|||
146361372|NCT02883049|527825272|FG009|Induction|Death|0|||
146361373|NCT02883049|527825273|FG010|Induction|Death|0|||
146361374|NCT02883049|527825274|FG011|Induction|Death|0|||
146361375|NCT02883049|527825275|FG012|Induction|Death|0|||
146361376|NCT02883049|527825276|FG013|Induction|Death|0|||
146361377|NCT02883049|527825277|FG014|Induction|Death|0|||
146361378|NCT02883049|527825278|FG015|Induction|Death|0|||
146361379|NCT02883049|527825263|FG000|Induction|Lost to Follow-up|2|||
146361380|NCT02883049|527825264|FG001|Induction|Lost to Follow-up|0|||
146361381|NCT02883049|527825265|FG002|Induction|Lost to Follow-up|0|||
146361382|NCT02883049|527825266|FG003|Induction|Lost to Follow-up|0|||
146361383|NCT02883049|527825267|FG004|Induction|Lost to Follow-up|0|||
146361384|NCT02883049|527825268|FG005|Induction|Lost to Follow-up|0|||
146361385|NCT02883049|527825269|FG006|Induction|Lost to Follow-up|0|||
146361386|NCT02883049|527825270|FG007|Induction|Lost to Follow-up|0|||
146361387|NCT02883049|527825271|FG008|Induction|Lost to Follow-up|0|||
146361388|NCT02883049|527825272|FG009|Induction|Lost to Follow-up|0|||
146361389|NCT02883049|527825273|FG010|Induction|Lost to Follow-up|0|||
146361390|NCT02883049|527825274|FG011|Induction|Lost to Follow-up|0|||
146361391|NCT02883049|527825275|FG012|Induction|Lost to Follow-up|0|||
146361392|NCT02883049|527825276|FG013|Induction|Lost to Follow-up|0|||
146361393|NCT02883049|527825277|FG014|Induction|Lost to Follow-up|0|||
146361394|NCT02883049|527825278|FG015|Induction|Lost to Follow-up|0|||
146361395|NCT02883049|527825263|FG000|Induction|Physician Decision|1407|||
146361396|NCT02883049|527825264|FG001|Induction|Physician Decision|8|||
146361397|NCT02883049|527825265|FG002|Induction|Physician Decision|0|||
146361398|NCT02883049|527825266|FG003|Induction|Physician Decision|0|||
146361399|NCT02883049|527825267|FG004|Induction|Physician Decision|0|||
146361400|NCT02883049|527825268|FG005|Induction|Physician Decision|0|||
146361401|NCT02883049|527825269|FG006|Induction|Physician Decision|0|||
146361402|NCT02883049|527825270|FG007|Induction|Physician Decision|0|||
146361403|NCT02883049|527825271|FG008|Induction|Physician Decision|0|||
146361404|NCT02883049|527825272|FG009|Induction|Physician Decision|0|||
146361405|NCT02883049|527825273|FG010|Induction|Physician Decision|0|||
146361406|NCT02883049|527825274|FG011|Induction|Physician Decision|0|||
146361407|NCT02883049|527825275|FG012|Induction|Physician Decision|0|||
146361408|NCT02883049|527825276|FG013|Induction|Physician Decision|0|||
146361409|NCT02883049|527825277|FG014|Induction|Physician Decision|0|||
146361410|NCT02883049|527825278|FG015|Induction|Physician Decision|0|||
146361411|NCT02883049|527825263|FG000|Induction|Protocol Violation|6|||
146361412|NCT02883049|527825264|FG001|Induction|Protocol Violation|0|||
146361413|NCT02883049|527825265|FG002|Induction|Protocol Violation|0|||
146361414|NCT02883049|527825266|FG003|Induction|Protocol Violation|0|||
146361415|NCT02883049|527825267|FG004|Induction|Protocol Violation|0|||
146361416|NCT02883049|527825268|FG005|Induction|Protocol Violation|0|||
146361417|NCT02883049|527825269|FG006|Induction|Protocol Violation|0|||
146361418|NCT02883049|527825270|FG007|Induction|Protocol Violation|0|||
146361419|NCT02883049|527825271|FG008|Induction|Protocol Violation|0|||
146361420|NCT02883049|527825272|FG009|Induction|Protocol Violation|0|||
146361421|NCT02883049|527825273|FG010|Induction|Protocol Violation|0|||
146361422|NCT02883049|527825274|FG011|Induction|Protocol Violation|0|||
146361423|NCT02883049|527825275|FG012|Induction|Protocol Violation|0|||
146361424|NCT02883049|527825276|FG013|Induction|Protocol Violation|0|||
146361425|NCT02883049|527825277|FG014|Induction|Protocol Violation|0|||
146361426|NCT02883049|527825278|FG015|Induction|Protocol Violation|0|||
146361427|NCT02883049|527825263|FG000|Induction|Withdrawal by Subject|6|||
146361428|NCT02883049|527825264|FG001|Induction|Withdrawal by Subject|0|||
146361429|NCT02883049|527825265|FG002|Induction|Withdrawal by Subject|0|||
146361430|NCT02883049|527825266|FG003|Induction|Withdrawal by Subject|0|||
146361431|NCT02883049|527825267|FG004|Induction|Withdrawal by Subject|0|||
146361432|NCT02883049|527825268|FG005|Induction|Withdrawal by Subject|0|||
146361433|NCT02883049|527825269|FG006|Induction|Withdrawal by Subject|0|||
146361434|NCT02883049|527825270|FG007|Induction|Withdrawal by Subject|0|||
146361435|NCT02883049|527825271|FG008|Induction|Withdrawal by Subject|0|||
146361436|NCT02883049|527825272|FG009|Induction|Withdrawal by Subject|0|||
146361437|NCT02883049|527825273|FG010|Induction|Withdrawal by Subject|0|||
146361438|NCT02883049|527825274|FG011|Induction|Withdrawal by Subject|0|||
146361439|NCT02883049|527825275|FG012|Induction|Withdrawal by Subject|0|||
146361440|NCT02883049|527825276|FG013|Induction|Withdrawal by Subject|0|||
146361441|NCT02883049|527825277|FG014|Induction|Withdrawal by Subject|0|||
146361442|NCT02883049|527825278|FG015|Induction|Withdrawal by Subject|0|||
146361443|NCT02883049|527825263|FG000|Induction|Ineligible|35|||
146361444|NCT02883049|527825264|FG001|Induction|Ineligible|1|||
146361445|NCT02883049|527825265|FG002|Induction|Ineligible|0|||
146361446|NCT02883049|527825266|FG003|Induction|Ineligible|0|||
146361447|NCT02883049|527825267|FG004|Induction|Ineligible|0|||
146361448|NCT02883049|527825268|FG005|Induction|Ineligible|0|||
146361449|NCT02883049|527825269|FG006|Induction|Ineligible|0|||
146361450|NCT02883049|527825270|FG007|Induction|Ineligible|0|||
146361451|NCT02883049|527825271|FG008|Induction|Ineligible|0|||
146361452|NCT02883049|527825272|FG009|Induction|Ineligible|0|||
146361453|NCT02883049|527825273|FG010|Induction|Ineligible|0|||
146361454|NCT02883049|527825274|FG011|Induction|Ineligible|0|||
146361455|NCT02883049|527825275|FG012|Induction|Ineligible|0|||
146361456|NCT02883049|527825276|FG013|Induction|Ineligible|0|||
146361457|NCT02883049|527825277|FG014|Induction|Ineligible|0|||
146361458|NCT02883049|527825278|FG015|Induction|Ineligible|0|||
146361459|NCT02883049|527825263|FG000|Induction|Refusal of further protocol therapy|466|||
146361460|NCT02883049|527825264|FG001|Induction|Refusal of further protocol therapy|2|||
146361461|NCT02883049|527825265|FG002|Induction|Refusal of further protocol therapy|0|||
146361462|NCT02883049|527825266|FG003|Induction|Refusal of further protocol therapy|0|||
146361463|NCT02883049|527825267|FG004|Induction|Refusal of further protocol therapy|0|||
146361464|NCT02883049|527825268|FG005|Induction|Refusal of further protocol therapy|0|||
146361465|NCT02883049|527825269|FG006|Induction|Refusal of further protocol therapy|0|||
146361466|NCT02883049|527825270|FG007|Induction|Refusal of further protocol therapy|0|||
146361467|NCT02883049|527825271|FG008|Induction|Refusal of further protocol therapy|0|||
146361468|NCT02883049|527825272|FG009|Induction|Refusal of further protocol therapy|0|||
146361469|NCT02883049|527825273|FG010|Induction|Refusal of further protocol therapy|0|||
146361470|NCT02883049|527825274|FG011|Induction|Refusal of further protocol therapy|0|||
146361471|NCT02883049|527825275|FG012|Induction|Refusal of further protocol therapy|0|||
146361472|NCT02883049|527825276|FG013|Induction|Refusal of further protocol therapy|0|||
146361473|NCT02883049|527825277|FG014|Induction|Refusal of further protocol therapy|0|||
146361474|NCT02883049|527825278|FG015|Induction|Refusal of further protocol therapy|0|||
146361475|NCT02883049|527825263|FG000|Induction|Identified as Ph+ patients|279|||
146361476|NCT02883049|527825264|FG001|Induction|Identified as Ph+ patients|1|||
146361477|NCT02883049|527825265|FG002|Induction|Identified as Ph+ patients|0|||
146361478|NCT02883049|527825266|FG003|Induction|Identified as Ph+ patients|0|||
146361479|NCT02883049|527825267|FG004|Induction|Identified as Ph+ patients|0|||
146361480|NCT02883049|527825268|FG005|Induction|Identified as Ph+ patients|0|||
146361481|NCT02883049|527825269|FG006|Induction|Identified as Ph+ patients|0|||
146361482|NCT02883049|527825270|FG007|Induction|Identified as Ph+ patients|0|||
146361483|NCT02883049|527825271|FG008|Induction|Identified as Ph+ patients|0|||
146361484|NCT02883049|527825272|FG009|Induction|Identified as Ph+ patients|0|||
146361485|NCT02883049|527825273|FG010|Induction|Identified as Ph+ patients|0|||
146361486|NCT02883049|527825274|FG011|Induction|Identified as Ph+ patients|0|||
146361487|NCT02883049|527825275|FG012|Induction|Identified as Ph+ patients|0|||
146361488|NCT02883049|527825276|FG013|Induction|Identified as Ph+ patients|0|||
146361489|NCT02883049|527825277|FG014|Induction|Identified as Ph+ patients|0|||
146361490|NCT02883049|527825278|FG015|Induction|Identified as Ph+ patients|0|||
146361491|NCT02883049|527825263|FG000|Induction|M3 Marrow at Day29|8|||
146361492|NCT02883049|527825264|FG001|Induction|M3 Marrow at Day29|1|||
146361493|NCT02883049|527825265|FG002|Induction|M3 Marrow at Day29|0|||
146361494|NCT02883049|527825266|FG003|Induction|M3 Marrow at Day29|0|||
146361495|NCT02883049|527825267|FG004|Induction|M3 Marrow at Day29|0|||
146361496|NCT02883049|527825268|FG005|Induction|M3 Marrow at Day29|0|||
146361497|NCT02883049|527825269|FG006|Induction|M3 Marrow at Day29|0|||
146361498|NCT02883049|527825270|FG007|Induction|M3 Marrow at Day29|0|||
146361499|NCT02883049|527825271|FG008|Induction|M3 Marrow at Day29|0|||
146361500|NCT02883049|527825272|FG009|Induction|M3 Marrow at Day29|0|||
146361501|NCT02883049|527825273|FG010|Induction|M3 Marrow at Day29|0|||
146361502|NCT02883049|527825274|FG011|Induction|M3 Marrow at Day29|0|||
146361503|NCT02883049|527825275|FG012|Induction|M3 Marrow at Day29|0|||
146361504|NCT02883049|527825276|FG013|Induction|M3 Marrow at Day29|0|||
146361505|NCT02883049|527825277|FG014|Induction|M3 Marrow at Day29|0|||
146361506|NCT02883049|527825278|FG015|Induction|M3 Marrow at Day29|0|||
146361507|NCT02883049|527825263|FG000|Induction|Inevaluable|33|||
146361508|NCT02883049|527825264|FG001|Induction|Inevaluable|1|||
146361509|NCT02883049|527825265|FG002|Induction|Inevaluable|0|||
146361510|NCT02883049|527825266|FG003|Induction|Inevaluable|0|||
146361511|NCT02883049|527825267|FG004|Induction|Inevaluable|0|||
146361512|NCT02883049|527825268|FG005|Induction|Inevaluable|0|||
146361513|NCT02883049|527825269|FG006|Induction|Inevaluable|0|||
146361514|NCT02883049|527825270|FG007|Induction|Inevaluable|0|||
146361515|NCT02883049|527825271|FG008|Induction|Inevaluable|0|||
146361516|NCT02883049|527825272|FG009|Induction|Inevaluable|0|||
146361517|NCT02883049|527825273|FG010|Induction|Inevaluable|0|||
146361518|NCT02883049|527825274|FG011|Induction|Inevaluable|0|||
146361519|NCT02883049|527825275|FG012|Induction|Inevaluable|0|||
146361520|NCT02883049|527825276|FG013|Induction|Inevaluable|0|||
146361521|NCT02883049|527825277|FG014|Induction|Inevaluable|0|||
146361522|NCT02883049|527825278|FG015|Induction|Inevaluable|0|||
146361523|NCT02883049|527825263|FG000|Induction|Identified as VHR at end of Induction|244|||
146361524|NCT02883049|527825264|FG001|Induction|Identified as VHR at end of Induction|0|||
146361525|NCT02883049|527825265|FG002|Induction|Identified as VHR at end of Induction|0|||
146361526|NCT02883049|527825266|FG003|Induction|Identified as VHR at end of Induction|0|||
146361527|NCT02883049|527825267|FG004|Induction|Identified as VHR at end of Induction|0|||
146361528|NCT02883049|527825268|FG005|Induction|Identified as VHR at end of Induction|0|||
146361529|NCT02883049|527825269|FG006|Induction|Identified as VHR at end of Induction|0|||
146361530|NCT02883049|527825270|FG007|Induction|Identified as VHR at end of Induction|0|||
146361531|NCT02883049|527825271|FG008|Induction|Identified as VHR at end of Induction|0|||
146361532|NCT02883049|527825272|FG009|Induction|Identified as VHR at end of Induction|0|||
146361533|NCT02883049|527825273|FG010|Induction|Identified as VHR at end of Induction|0|||
146361534|NCT02883049|527825274|FG011|Induction|Identified as VHR at end of Induction|0|||
146361535|NCT02883049|527825275|FG012|Induction|Identified as VHR at end of Induction|0|||
146361536|NCT02883049|527825276|FG013|Induction|Identified as VHR at end of Induction|0|||
146361537|NCT02883049|527825277|FG014|Induction|Identified as VHR at end of Induction|0|||
146361538|NCT02883049|527825278|FG015|Induction|Identified as VHR at end of Induction|0|||
146361539|NCT02883049|527825263|FG000|Induction|Moved to another non-COG institution|3|||
146361540|NCT02883049|527825264|FG001|Induction|Moved to another non-COG institution|0|||
146361541|NCT02883049|527825265|FG002|Induction|Moved to another non-COG institution|0|||
146361542|NCT02883049|527825266|FG003|Induction|Moved to another non-COG institution|0|||
146361543|NCT02883049|527825267|FG004|Induction|Moved to another non-COG institution|0|||
146361544|NCT02883049|527825268|FG005|Induction|Moved to another non-COG institution|0|||
146361545|NCT02883049|527825269|FG006|Induction|Moved to another non-COG institution|0|||
146361546|NCT02883049|527825270|FG007|Induction|Moved to another non-COG institution|0|||
146361547|NCT02883049|527825271|FG008|Induction|Moved to another non-COG institution|0|||
146361548|NCT02883049|527825272|FG009|Induction|Moved to another non-COG institution|0|||
146361549|NCT02883049|527825273|FG010|Induction|Moved to another non-COG institution|0|||
146361550|NCT02883049|527825274|FG011|Induction|Moved to another non-COG institution|0|||
146361551|NCT02883049|527825275|FG012|Induction|Moved to another non-COG institution|0|||
146361552|NCT02883049|527825276|FG013|Induction|Moved to another non-COG institution|0|||
146361553|NCT02883049|527825277|FG014|Induction|Moved to another non-COG institution|0|||
146361554|NCT02883049|527825278|FG015|Induction|Moved to another non-COG institution|0|||
146361555|NCT02883049|527825263|FG000|Induction|Randomization closed|41|||
146361556|NCT02883049|527825264|FG001|Induction|Randomization closed|0|||
146361557|NCT02883049|527825265|FG002|Induction|Randomization closed|0|||
146361558|NCT02883049|527825266|FG003|Induction|Randomization closed|0|||
146361559|NCT02883049|527825267|FG004|Induction|Randomization closed|0|||
146361560|NCT02883049|527825268|FG005|Induction|Randomization closed|0|||
146361561|NCT02883049|527825269|FG006|Induction|Randomization closed|0|||
146361562|NCT02883049|527825270|FG007|Induction|Randomization closed|0|||
146361563|NCT02883049|527825271|FG008|Induction|Randomization closed|0|||
146361564|NCT02883049|527825272|FG009|Induction|Randomization closed|0|||
146361565|NCT02883049|527825273|FG010|Induction|Randomization closed|0|||
146361566|NCT02883049|527825274|FG011|Induction|Randomization closed|0|||
146361567|NCT02883049|527825275|FG012|Induction|Randomization closed|0|||
146361568|NCT02883049|527825276|FG013|Induction|Randomization closed|0|||
146361569|NCT02883049|527825277|FG014|Induction|Randomization closed|0|||
146361570|NCT02883049|527825278|FG015|Induction|Randomization closed|0|||
146361571|NCT02883049|527825263|FG000|Induction|MRD negative|36|||
146361572|NCT02883049|527825264|FG001|Induction|MRD negative|0|||
146361573|NCT02883049|527825265|FG002|Induction|MRD negative|0|||
146361574|NCT02883049|527825266|FG003|Induction|MRD negative|0|||
146361575|NCT02883049|527825267|FG004|Induction|MRD negative|0|||
146361576|NCT02883049|527825268|FG005|Induction|MRD negative|0|||
146361577|NCT02883049|527825269|FG006|Induction|MRD negative|0|||
146361578|NCT02883049|527825270|FG007|Induction|MRD negative|0|||
146361579|NCT02883049|527825271|FG008|Induction|MRD negative|0|||
146361580|NCT02883049|527825272|FG009|Induction|MRD negative|0|||
146361581|NCT02883049|527825273|FG010|Induction|MRD negative|0|||
146361582|NCT02883049|527825274|FG011|Induction|MRD negative|0|||
146361583|NCT02883049|527825275|FG012|Induction|MRD negative|0|||
146361584|NCT02883049|527825276|FG013|Induction|MRD negative|0|||
146361585|NCT02883049|527825277|FG014|Induction|MRD negative|0|||
146361586|NCT02883049|527825278|FG015|Induction|MRD negative|0|||
146361587|NCT02883049|527825263|FG000|Induction|Identified as HR patients|165|||
146361588|NCT02883049|527825264|FG001|Induction|Identified as HR patients|0|||
146361589|NCT02883049|527825265|FG002|Induction|Identified as HR patients|0|||
146361590|NCT02883049|527825266|FG003|Induction|Identified as HR patients|0|||
146361591|NCT02883049|527825267|FG004|Induction|Identified as HR patients|0|||
146361592|NCT02883049|527825268|FG005|Induction|Identified as HR patients|0|||
146361593|NCT02883049|527825269|FG006|Induction|Identified as HR patients|0|||
146361594|NCT02883049|527825270|FG007|Induction|Identified as HR patients|0|||
146361595|NCT02883049|527825271|FG008|Induction|Identified as HR patients|0|||
146361596|NCT02883049|527825272|FG009|Induction|Identified as HR patients|0|||
146361597|NCT02883049|527825273|FG010|Induction|Identified as HR patients|0|||
146361598|NCT02883049|527825274|FG011|Induction|Identified as HR patients|0|||
146361599|NCT02883049|527825275|FG012|Induction|Identified as HR patients|0|||
146361600|NCT02883049|527825276|FG013|Induction|Identified as HR patients|0|||
146361601|NCT02883049|527825277|FG014|Induction|Identified as HR patients|0|||
146361602|NCT02883049|527825278|FG015|Induction|Identified as HR patients|0|||
146361603|NCT02883049|527825263|FG000|Induction|Developed SMN|0|||
146361604|NCT02883049|527825264|FG001|Induction|Developed SMN|1|||
146361605|NCT02883049|527825265|FG002|Induction|Developed SMN|0|||
146361606|NCT02883049|527825266|FG003|Induction|Developed SMN|0|||
146361607|NCT02883049|527825267|FG004|Induction|Developed SMN|0|||
146361608|NCT02883049|527825268|FG005|Induction|Developed SMN|0|||
146361609|NCT02883049|527825269|FG006|Induction|Developed SMN|0|||
146361610|NCT02883049|527825270|FG007|Induction|Developed SMN|0|||
146361611|NCT02883049|527825271|FG008|Induction|Developed SMN|0|||
146361612|NCT02883049|527825272|FG009|Induction|Developed SMN|0|||
146361613|NCT02883049|527825273|FG010|Induction|Developed SMN|0|||
146361614|NCT02883049|527825274|FG011|Induction|Developed SMN|0|||
146361615|NCT02883049|527825275|FG012|Induction|Developed SMN|0|||
146361616|NCT02883049|527825276|FG013|Induction|Developed SMN|0|||
146361617|NCT02883049|527825277|FG014|Induction|Developed SMN|0|||
146361618|NCT02883049|527825278|FG015|Induction|Developed SMN|0|||
146361619|NCT02883049|527825263|FG000|Induction|Enrolled onto another COG study|72|||
146361620|NCT02883049|527825264|FG001|Induction|Enrolled onto another COG study|0|||
146361621|NCT02883049|527825265|FG002|Induction|Enrolled onto another COG study|0|||
146361622|NCT02883049|527825266|FG003|Induction|Enrolled onto another COG study|0|||
146361623|NCT02883049|527825267|FG004|Induction|Enrolled onto another COG study|0|||
146361624|NCT02883049|527825268|FG005|Induction|Enrolled onto another COG study|0|||
146361625|NCT02883049|527825269|FG006|Induction|Enrolled onto another COG study|0|||
146361626|NCT02883049|527825270|FG007|Induction|Enrolled onto another COG study|0|||
146361627|NCT02883049|527825271|FG008|Induction|Enrolled onto another COG study|0|||
146361628|NCT02883049|527825272|FG009|Induction|Enrolled onto another COG study|0|||
146361629|NCT02883049|527825273|FG010|Induction|Enrolled onto another COG study|0|||
146361630|NCT02883049|527825274|FG011|Induction|Enrolled onto another COG study|0|||
146361631|NCT02883049|527825275|FG012|Induction|Enrolled onto another COG study|0|||
146361632|NCT02883049|527825276|FG013|Induction|Enrolled onto another COG study|0|||
146361633|NCT02883049|527825277|FG014|Induction|Enrolled onto another COG study|0|||
146361634|NCT02883049|527825278|FG015|Induction|Enrolled onto another COG study|0|||
146361635|NCT02883049|527825263|FG000|Induction|Incomplete induction data|17|||
146361636|NCT02883049|527825264|FG001|Induction|Incomplete induction data|0|||
146361637|NCT02883049|527825265|FG002|Induction|Incomplete induction data|0|||
146361638|NCT02883049|527825266|FG003|Induction|Incomplete induction data|0|||
146361639|NCT02883049|527825267|FG004|Induction|Incomplete induction data|0|||
146361640|NCT02883049|527825268|FG005|Induction|Incomplete induction data|0|||
146361641|NCT02883049|527825269|FG006|Induction|Incomplete induction data|0|||
146361642|NCT02883049|527825270|FG007|Induction|Incomplete induction data|0|||
146361643|NCT02883049|527825271|FG008|Induction|Incomplete induction data|0|||
146361644|NCT02883049|527825272|FG009|Induction|Incomplete induction data|0|||
146361645|NCT02883049|527825273|FG010|Induction|Incomplete induction data|0|||
146361646|NCT02883049|527825274|FG011|Induction|Incomplete induction data|0|||
146361647|NCT02883049|527825275|FG012|Induction|Incomplete induction data|0|||
146361648|NCT02883049|527825276|FG013|Induction|Incomplete induction data|0|||
146361649|NCT02883049|527825277|FG014|Induction|Incomplete induction data|0|||
146361650|NCT02883049|527825278|FG015|Induction|Incomplete induction data|0|||
146361651|NCT02883049|527825263|FG000|Post Induction|Adverse Event|0|||
146361652|NCT02883049|527825264|FG001|Post Induction|Adverse Event|0|||
146361653|NCT02883049|527825265|FG002|Post Induction|Adverse Event|0|||
146361654|NCT02883049|527825266|FG003|Post Induction|Adverse Event|7|||
146361655|NCT02883049|527825267|FG004|Post Induction|Adverse Event|8|||
146361656|NCT02883049|527825268|FG005|Post Induction|Adverse Event|3|||
146361657|NCT02883049|527825269|FG006|Post Induction|Adverse Event|4|||
146361658|NCT02883049|527825270|FG007|Post Induction|Adverse Event|5|||
146361659|NCT02883049|527825271|FG008|Post Induction|Adverse Event|6|||
146361660|NCT02883049|527825272|FG009|Post Induction|Adverse Event|7|||
146361661|NCT02883049|527825273|FG010|Post Induction|Adverse Event|2|||
146361662|NCT02883049|527825274|FG011|Post Induction|Adverse Event|2|||
146361663|NCT02883049|527825275|FG012|Post Induction|Adverse Event|0|||
146361664|NCT02883049|527825276|FG013|Post Induction|Adverse Event|0|||
146361665|NCT02883049|527825277|FG014|Post Induction|Adverse Event|5|||
146361666|NCT02883049|527825278|FG015|Post Induction|Adverse Event|2|||
146361667|NCT02883049|527825263|FG000|Post Induction|Death|0|||
146361668|NCT02883049|527825264|FG001|Post Induction|Death|0|||
146361669|NCT02883049|527825265|FG002|Post Induction|Death|0|||
146361670|NCT02883049|527825266|FG003|Post Induction|Death|9|||
146361671|NCT02883049|527825267|FG004|Post Induction|Death|9|||
146361672|NCT02883049|527825268|FG005|Post Induction|Death|0|||
146361673|NCT02883049|527825269|FG006|Post Induction|Death|1|||
146361674|NCT02883049|527825270|FG007|Post Induction|Death|6|||
146361675|NCT02883049|527825271|FG008|Post Induction|Death|5|||
146361676|NCT02883049|527825272|FG009|Post Induction|Death|3|||
146361677|NCT02883049|527825273|FG010|Post Induction|Death|1|||
146361678|NCT02883049|527825274|FG011|Post Induction|Death|0|||
146361679|NCT02883049|527825275|FG012|Post Induction|Death|1|||
146361680|NCT02883049|527825276|FG013|Post Induction|Death|1|||
146361681|NCT02883049|527825277|FG014|Post Induction|Death|10|||
146361682|NCT02883049|527825278|FG015|Post Induction|Death|2|||
146361683|NCT02883049|527825263|FG000|Post Induction|Lost to Follow-up|0|||
146361684|NCT02883049|527825264|FG001|Post Induction|Lost to Follow-up|0|||
146361685|NCT02883049|527825265|FG002|Post Induction|Lost to Follow-up|0|||
146361686|NCT02883049|527825266|FG003|Post Induction|Lost to Follow-up|0|||
146361687|NCT02883049|527825267|FG004|Post Induction|Lost to Follow-up|1|||
146361688|NCT02883049|527825268|FG005|Post Induction|Lost to Follow-up|1|||
146361689|NCT02883049|527825269|FG006|Post Induction|Lost to Follow-up|0|||
146361690|NCT02883049|527825270|FG007|Post Induction|Lost to Follow-up|0|||
146361691|NCT02883049|527825271|FG008|Post Induction|Lost to Follow-up|3|||
146361692|NCT02883049|527825272|FG009|Post Induction|Lost to Follow-up|0|||
146361693|NCT02883049|527825273|FG010|Post Induction|Lost to Follow-up|1|||
146361694|NCT02883049|527825274|FG011|Post Induction|Lost to Follow-up|0|||
146361695|NCT02883049|527825275|FG012|Post Induction|Lost to Follow-up|0|||
146361696|NCT02883049|527825276|FG013|Post Induction|Lost to Follow-up|0|||
146361697|NCT02883049|527825277|FG014|Post Induction|Lost to Follow-up|0|||
146361698|NCT02883049|527825278|FG015|Post Induction|Lost to Follow-up|0|||
146361699|NCT02883049|527825263|FG000|Post Induction|Physician Decision|0|||
146361700|NCT02883049|527825264|FG001|Post Induction|Physician Decision|0|||
146361701|NCT02883049|527825265|FG002|Post Induction|Physician Decision|0|||
146361702|NCT02883049|527825266|FG003|Post Induction|Physician Decision|27|||
146361703|NCT02883049|527825267|FG004|Post Induction|Physician Decision|27|||
146361704|NCT02883049|527825268|FG005|Post Induction|Physician Decision|23|||
146361705|NCT02883049|527825269|FG006|Post Induction|Physician Decision|30|||
146361706|NCT02883049|527825270|FG007|Post Induction|Physician Decision|56|||
146361707|NCT02883049|527825271|FG008|Post Induction|Physician Decision|85|||
146361708|NCT02883049|527825272|FG009|Post Induction|Physician Decision|12|||
146361709|NCT02883049|527825273|FG010|Post Induction|Physician Decision|5|||
146361710|NCT02883049|527825274|FG011|Post Induction|Physician Decision|14|||
146361711|NCT02883049|527825275|FG012|Post Induction|Physician Decision|1|||
146361712|NCT02883049|527825276|FG013|Post Induction|Physician Decision|11|||
146361713|NCT02883049|527825277|FG014|Post Induction|Physician Decision|19|||
146361714|NCT02883049|527825278|FG015|Post Induction|Physician Decision|5|||
146361715|NCT02883049|527825263|FG000|Post Induction|Protocol Violation|0|||
146361716|NCT02883049|527825264|FG001|Post Induction|Protocol Violation|0|||
146361717|NCT02883049|527825265|FG002|Post Induction|Protocol Violation|0|||
146361718|NCT02883049|527825266|FG003|Post Induction|Protocol Violation|0|||
146361719|NCT02883049|527825267|FG004|Post Induction|Protocol Violation|0|||
146361720|NCT02883049|527825268|FG005|Post Induction|Protocol Violation|0|||
146361721|NCT02883049|527825269|FG006|Post Induction|Protocol Violation|0|||
146361722|NCT02883049|527825270|FG007|Post Induction|Protocol Violation|1|||
146361723|NCT02883049|527825271|FG008|Post Induction|Protocol Violation|0|||
146361724|NCT02883049|527825272|FG009|Post Induction|Protocol Violation|0|||
146361725|NCT02883049|527825273|FG010|Post Induction|Protocol Violation|0|||
146361726|NCT02883049|527825274|FG011|Post Induction|Protocol Violation|0|||
146361727|NCT02883049|527825275|FG012|Post Induction|Protocol Violation|0|||
146361728|NCT02883049|527825276|FG013|Post Induction|Protocol Violation|0|||
145943401|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146361729|NCT02883049|527825277|FG014|Post Induction|Protocol Violation|0|||
146361730|NCT02883049|527825278|FG015|Post Induction|Protocol Violation|0|||
146361731|NCT02883049|527825263|FG000|Post Induction|Withdrawal by Subject|0|||
146361732|NCT02883049|527825264|FG001|Post Induction|Withdrawal by Subject|0|||
146361733|NCT02883049|527825265|FG002|Post Induction|Withdrawal by Subject|0|||
146361734|NCT02883049|527825266|FG003|Post Induction|Withdrawal by Subject|5|||
146361735|NCT02883049|527825267|FG004|Post Induction|Withdrawal by Subject|2|||
145943402|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
146361736|NCT02883049|527825268|FG005|Post Induction|Withdrawal by Subject|1|||
146361737|NCT02883049|527825269|FG006|Post Induction|Withdrawal by Subject|0|||
146361738|NCT02883049|527825270|FG007|Post Induction|Withdrawal by Subject|0|||
146361739|NCT02883049|527825271|FG008|Post Induction|Withdrawal by Subject|2|||
146361740|NCT02883049|527825272|FG009|Post Induction|Withdrawal by Subject|0|||
146361741|NCT02883049|527825273|FG010|Post Induction|Withdrawal by Subject|1|||
146361742|NCT02883049|527825274|FG011|Post Induction|Withdrawal by Subject|1|||
146361743|NCT02883049|527825275|FG012|Post Induction|Withdrawal by Subject|0|||
146361744|NCT02883049|527825276|FG013|Post Induction|Withdrawal by Subject|0|||
146361745|NCT02883049|527825277|FG014|Post Induction|Withdrawal by Subject|1|||
146169710|NCT02675465|527132909|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146169711|NCT02675465|527132910|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146169712|NCT02675465|527132911|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
146169713|NCT02675465|527132906|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
146361746|NCT02883049|527825278|FG015|Post Induction|Withdrawal by Subject|0|||
146361747|NCT02883049|527825263|FG000|Post Induction|Ineligible|0|||
146361748|NCT02883049|527825264|FG001|Post Induction|Ineligible|0|||
146361749|NCT02883049|527825265|FG002|Post Induction|Ineligible|2|||
146361750|NCT02883049|527825266|FG003|Post Induction|Ineligible|0|||
146361751|NCT02883049|527825267|FG004|Post Induction|Ineligible|0|||
146361752|NCT02883049|527825268|FG005|Post Induction|Ineligible|0|||
146361753|NCT02883049|527825269|FG006|Post Induction|Ineligible|1|||
146361754|NCT02883049|527825270|FG007|Post Induction|Ineligible|0|||
146361755|NCT02883049|527825271|FG008|Post Induction|Ineligible|0|||
146361756|NCT02883049|527825272|FG009|Post Induction|Ineligible|0|||
146361757|NCT02883049|527825273|FG010|Post Induction|Ineligible|1|||
146361758|NCT02883049|527825274|FG011|Post Induction|Ineligible|0|||
146361759|NCT02883049|527825275|FG012|Post Induction|Ineligible|0|||
146361760|NCT02883049|527825276|FG013|Post Induction|Ineligible|0|||
146361761|NCT02883049|527825277|FG014|Post Induction|Ineligible|0|||
146361762|NCT02883049|527825278|FG015|Post Induction|Ineligible|1|||
146361763|NCT02883049|527825263|FG000|Post Induction|Refusal of further protocol therapy|0|||
146361764|NCT02883049|527825264|FG001|Post Induction|Refusal of further protocol therapy|0|||
146361765|NCT02883049|527825265|FG002|Post Induction|Refusal of further protocol therapy|0|||
146361766|NCT02883049|527825266|FG003|Post Induction|Refusal of further protocol therapy|11|||
146361767|NCT02883049|527825267|FG004|Post Induction|Refusal of further protocol therapy|15|||
146361768|NCT02883049|527825268|FG005|Post Induction|Refusal of further protocol therapy|9|||
146361769|NCT02883049|527825269|FG006|Post Induction|Refusal of further protocol therapy|13|||
146361770|NCT02883049|527825270|FG007|Post Induction|Refusal of further protocol therapy|5|||
146361771|NCT02883049|527825271|FG008|Post Induction|Refusal of further protocol therapy|21|||
146361772|NCT02883049|527825272|FG009|Post Induction|Refusal of further protocol therapy|7|||
146361773|NCT02883049|527825273|FG010|Post Induction|Refusal of further protocol therapy|0|||
146361774|NCT02883049|527825274|FG011|Post Induction|Refusal of further protocol therapy|7|||
146361775|NCT02883049|527825275|FG012|Post Induction|Refusal of further protocol therapy|3|||
146361776|NCT02883049|527825276|FG013|Post Induction|Refusal of further protocol therapy|0|||
146361777|NCT02883049|527825277|FG014|Post Induction|Refusal of further protocol therapy|4|||
146361778|NCT02883049|527825278|FG015|Post Induction|Refusal of further protocol therapy|1|||
146361779|NCT02883049|527825263|FG000|Post Induction|Inevaluable|0|||
146361780|NCT02883049|527825264|FG001|Post Induction|Inevaluable|0|||
146361781|NCT02883049|527825265|FG002|Post Induction|Inevaluable|0|||
146361782|NCT02883049|527825266|FG003|Post Induction|Inevaluable|1|||
146361783|NCT02883049|527825267|FG004|Post Induction|Inevaluable|1|||
146361784|NCT02883049|527825268|FG005|Post Induction|Inevaluable|2|||
146361785|NCT02883049|527825269|FG006|Post Induction|Inevaluable|7|||
146361786|NCT02883049|527825270|FG007|Post Induction|Inevaluable|6|||
146361787|NCT02883049|527825271|FG008|Post Induction|Inevaluable|4|||
146361788|NCT02883049|527825272|FG009|Post Induction|Inevaluable|4|||
146361789|NCT02883049|527825273|FG010|Post Induction|Inevaluable|1|||
146361790|NCT02883049|527825274|FG011|Post Induction|Inevaluable|1|||
146169714|NCT02675465|527132907|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
146169715|NCT02675465|527132908|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
146361791|NCT02883049|527825275|FG012|Post Induction|Inevaluable|2|||
146361792|NCT02883049|527825276|FG013|Post Induction|Inevaluable|0|||
146361793|NCT02883049|527825277|FG014|Post Induction|Inevaluable|0|||
146361794|NCT02883049|527825278|FG015|Post Induction|Inevaluable|1|||
146361795|NCT02883049|527825263|FG000|Post Induction|Moved to another non-COG institution|0|||
146361796|NCT02883049|527825264|FG001|Post Induction|Moved to another non-COG institution|0|||
146361797|NCT02883049|527825265|FG002|Post Induction|Moved to another non-COG institution|0|||
146361798|NCT02883049|527825266|FG003|Post Induction|Moved to another non-COG institution|0|||
146361799|NCT02883049|527825267|FG004|Post Induction|Moved to another non-COG institution|0|||
146361800|NCT02883049|527825268|FG005|Post Induction|Moved to another non-COG institution|0|||
146361801|NCT02883049|527825269|FG006|Post Induction|Moved to another non-COG institution|0|||
146361802|NCT02883049|527825270|FG007|Post Induction|Moved to another non-COG institution|2|||
146361803|NCT02883049|527825271|FG008|Post Induction|Moved to another non-COG institution|2|||
146361804|NCT02883049|527825272|FG009|Post Induction|Moved to another non-COG institution|0|||
146361805|NCT02883049|527825273|FG010|Post Induction|Moved to another non-COG institution|0|||
146361806|NCT02883049|527825274|FG011|Post Induction|Moved to another non-COG institution|1|||
146361807|NCT02883049|527825275|FG012|Post Induction|Moved to another non-COG institution|0|||
146361808|NCT02883049|527825276|FG013|Post Induction|Moved to another non-COG institution|0|||
146361809|NCT02883049|527825277|FG014|Post Induction|Moved to another non-COG institution|0|||
146361810|NCT02883049|527825278|FG015|Post Induction|Moved to another non-COG institution|0|||
146361811|NCT02883049|527825263|FG000|Post Induction|Randomization closed|0|||
146361812|NCT02883049|527825264|FG001|Post Induction|Randomization closed|0|||
146361813|NCT02883049|527825265|FG002|Post Induction|Randomization closed|0|||
146361814|NCT02883049|527825266|FG003|Post Induction|Randomization closed|0|||
146361815|NCT02883049|527825267|FG004|Post Induction|Randomization closed|0|||
146361816|NCT02883049|527825268|FG005|Post Induction|Randomization closed|0|||
146361817|NCT02883049|527825269|FG006|Post Induction|Randomization closed|0|||
146361818|NCT02883049|527825270|FG007|Post Induction|Randomization closed|20|||
146361819|NCT02883049|527825271|FG008|Post Induction|Randomization closed|0|||
146361820|NCT02883049|527825272|FG009|Post Induction|Randomization closed|0|||
146361821|NCT02883049|527825273|FG010|Post Induction|Randomization closed|0|||
146361822|NCT02883049|527825274|FG011|Post Induction|Randomization closed|0|||
146361823|NCT02883049|527825275|FG012|Post Induction|Randomization closed|0|||
146361824|NCT02883049|527825276|FG013|Post Induction|Randomization closed|0|||
146361825|NCT02883049|527825277|FG014|Post Induction|Randomization closed|0|||
146361826|NCT02883049|527825278|FG015|Post Induction|Randomization closed|0|||
146361827|NCT02883049|527825263|FG000|Post Induction|MRD negative|0|||
146361828|NCT02883049|527825264|FG001|Post Induction|MRD negative|0|||
146361829|NCT02883049|527825265|FG002|Post Induction|MRD negative|0|||
146361830|NCT02883049|527825266|FG003|Post Induction|MRD negative|0|||
146361831|NCT02883049|527825267|FG004|Post Induction|MRD negative|0|||
146361832|NCT02883049|527825268|FG005|Post Induction|MRD negative|0|||
146361833|NCT02883049|527825269|FG006|Post Induction|MRD negative|0|||
146361834|NCT02883049|527825270|FG007|Post Induction|MRD negative|11|||
146361835|NCT02883049|527825271|FG008|Post Induction|MRD negative|0|||
146361836|NCT02883049|527825272|FG009|Post Induction|MRD negative|0|||
146361837|NCT02883049|527825273|FG010|Post Induction|MRD negative|0|||
146361838|NCT02883049|527825274|FG011|Post Induction|MRD negative|0|||
146361839|NCT02883049|527825275|FG012|Post Induction|MRD negative|0|||
146361840|NCT02883049|527825276|FG013|Post Induction|MRD negative|0|||
146361841|NCT02883049|527825277|FG014|Post Induction|MRD negative|0|||
146361842|NCT02883049|527825278|FG015|Post Induction|MRD negative|0|||
146361843|NCT02883049|527825263|FG000|Post Induction|Developed SMN|0|||
146361844|NCT02883049|527825264|FG001|Post Induction|Developed SMN|0|||
146361845|NCT02883049|527825265|FG002|Post Induction|Developed SMN|0|||
146361846|NCT02883049|527825266|FG003|Post Induction|Developed SMN|0|||
146361847|NCT02883049|527825267|FG004|Post Induction|Developed SMN|1|||
146361848|NCT02883049|527825268|FG005|Post Induction|Developed SMN|0|||
146361849|NCT02883049|527825269|FG006|Post Induction|Developed SMN|1|||
146361850|NCT02883049|527825270|FG007|Post Induction|Developed SMN|0|||
146361851|NCT02883049|527825271|FG008|Post Induction|Developed SMN|0|||
146361852|NCT02883049|527825272|FG009|Post Induction|Developed SMN|0|||
146361853|NCT02883049|527825273|FG010|Post Induction|Developed SMN|1|||
146361854|NCT02883049|527825274|FG011|Post Induction|Developed SMN|1|||
146361855|NCT02883049|527825275|FG012|Post Induction|Developed SMN|0|||
146361856|NCT02883049|527825276|FG013|Post Induction|Developed SMN|0|||
146361857|NCT02883049|527825277|FG014|Post Induction|Developed SMN|1|||
146361858|NCT02883049|527825278|FG015|Post Induction|Developed SMN|0|||
146361859|NCT02883049|527825263|FG000|Post Induction|Enrolled onto another COG study|0|||
146361860|NCT02883049|527825264|FG001|Post Induction|Enrolled onto another COG study|0|||
146361861|NCT02883049|527825265|FG002|Post Induction|Enrolled onto another COG study|0|||
146361862|NCT02883049|527825266|FG003|Post Induction|Enrolled onto another COG study|1|||
146361863|NCT02883049|527825267|FG004|Post Induction|Enrolled onto another COG study|1|||
146361864|NCT02883049|527825268|FG005|Post Induction|Enrolled onto another COG study|0|||
146361865|NCT02883049|527825269|FG006|Post Induction|Enrolled onto another COG study|0|||
146361866|NCT02883049|527825270|FG007|Post Induction|Enrolled onto another COG study|4|||
146361867|NCT02883049|527825271|FG008|Post Induction|Enrolled onto another COG study|0|||
146361868|NCT02883049|527825272|FG009|Post Induction|Enrolled onto another COG study|0|||
146361869|NCT02883049|527825273|FG010|Post Induction|Enrolled onto another COG study|0|||
146361870|NCT02883049|527825274|FG011|Post Induction|Enrolled onto another COG study|2|||
146361871|NCT02883049|527825275|FG012|Post Induction|Enrolled onto another COG study|0|||
146361872|NCT02883049|527825276|FG013|Post Induction|Enrolled onto another COG study|1|||
146361873|NCT02883049|527825277|FG014|Post Induction|Enrolled onto another COG study|0|||
146361874|NCT02883049|527825278|FG015|Post Induction|Enrolled onto another COG study|0|||
146361875|NCT02883049|527825263|FG000|Post Induction|Recurrent leukemia|0|||
146361876|NCT02883049|527825264|FG001|Post Induction|Recurrent leukemia|0|||
146361877|NCT02883049|527825265|FG002|Post Induction|Recurrent leukemia|0|||
146361878|NCT02883049|527825266|FG003|Post Induction|Recurrent leukemia|17|||
146361879|NCT02883049|527825267|FG004|Post Induction|Recurrent leukemia|12|||
146361880|NCT02883049|527825268|FG005|Post Induction|Recurrent leukemia|4|||
146361881|NCT02883049|527825269|FG006|Post Induction|Recurrent leukemia|1|||
146361882|NCT02883049|527825270|FG007|Post Induction|Recurrent leukemia|13|||
146361883|NCT02883049|527825271|FG008|Post Induction|Recurrent leukemia|27|||
146361884|NCT02883049|527825272|FG009|Post Induction|Recurrent leukemia|5|||
146361885|NCT02883049|527825273|FG010|Post Induction|Recurrent leukemia|3|||
146361886|NCT02883049|527825274|FG011|Post Induction|Recurrent leukemia|12|||
146361887|NCT02883049|527825275|FG012|Post Induction|Recurrent leukemia|1|||
146361888|NCT02883049|527825276|FG013|Post Induction|Recurrent leukemia|1|||
146361889|NCT02883049|527825277|FG014|Post Induction|Recurrent leukemia|9|||
146361890|NCT02883049|527825278|FG015|Post Induction|Recurrent leukemia|3|||
146361891|NCT02883049|527825263|FG000|Post Induction|Induction Failure|0|||
146361892|NCT02883049|527825264|FG001|Post Induction|Induction Failure|0|||
146361893|NCT02883049|527825265|FG002|Post Induction|Induction Failure|0|||
146361894|NCT02883049|527825266|FG003|Post Induction|Induction Failure|0|||
146361895|NCT02883049|527825267|FG004|Post Induction|Induction Failure|0|||
146361896|NCT02883049|527825268|FG005|Post Induction|Induction Failure|0|||
146361897|NCT02883049|527825269|FG006|Post Induction|Induction Failure|0|||
146361898|NCT02883049|527825270|FG007|Post Induction|Induction Failure|2|||
146361899|NCT02883049|527825271|FG008|Post Induction|Induction Failure|2|||
146361900|NCT02883049|527825272|FG009|Post Induction|Induction Failure|0|||
146361901|NCT02883049|527825273|FG010|Post Induction|Induction Failure|0|||
146361902|NCT02883049|527825274|FG011|Post Induction|Induction Failure|0|||
146361903|NCT02883049|527825275|FG012|Post Induction|Induction Failure|0|||
146361904|NCT02883049|527825276|FG013|Post Induction|Induction Failure|2|||
146361905|NCT02883049|527825277|FG014|Post Induction|Induction Failure|0|||
146361906|NCT02883049|527825278|FG015|Post Induction|Induction Failure|0|||
146361907|NCT01048853|527825279|FG000|Overall Study|Death|1|||
146361908|NCT01048853|527825280|FG001|Overall Study|Death|0|||
146361909|NCT01048853|527825281|FG002|Overall Study|Death|0|||
146361910|NCT01048853|527825279|FG000|Overall Study|Lost to Follow-up|1|||
146361911|NCT01048853|527825280|FG001|Overall Study|Lost to Follow-up|4|||
146361912|NCT01048853|527825281|FG002|Overall Study|Lost to Follow-up|0|||
146361913|NCT06964165|527825288|FG000|Overall Study|Death|4|||
146361914|NCT06964165|527825289|FG001|Overall Study|Death|4|||
146361915|NCT06964165|527825288|FG000|Overall Study|Physician Decision|1|||
146361916|NCT06964165|527825289|FG001|Overall Study|Physician Decision|1|||
146361917|NCT06964165|527825288|FG000|Overall Study|Withdrawal by Subject|0|||
146361918|NCT06964165|527825289|FG001|Overall Study|Withdrawal by Subject|2|||
146361919|NCT06964165|527825288|FG000|Overall Study|Study terminated by sponsor|12|||
146361920|NCT06964165|527825289|FG001|Overall Study|Study terminated by sponsor|10|||
146361921|NCT06964165|527825288|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
146361922|NCT06964165|527825289|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
146361923|NCT06964165|527825288|FG000|Overall Study|Participant removed due to non-compliance|0|||
146361924|NCT06964165|527825289|FG001|Overall Study|Participant removed due to non-compliance|1|||
146361925|NCT06245044|527825290|FG000|No MI help|Technical issues|18|||
146361926|NCT05600309|527825298|FG000|Overall Study|Death|41|||
146361927|NCT05600309|527825299|FG001|Overall Study|Death|38|||
146361928|NCT05600309|527825298|FG000|Overall Study|Sponsor Decision|9|||
146361929|NCT05600309|527825299|FG001|Overall Study|Sponsor Decision|6|||
146361930|NCT06087328|527825300|FG000|28-Day Treatment|Lost to Follow-up|7|||
146361931|NCT06087328|527825301|FG001|28-Day Treatment|Lost to Follow-up|3|||
146361932|NCT06087328|527825302|FG002|28-Day Treatment|Lost to Follow-up|4|||
146361933|NCT06087328|527825300|FG000|1-month Follow-up|Lost to Follow-up|0|||
146361934|NCT06087328|527825301|FG001|1-month Follow-up|Lost to Follow-up|1|||
146361935|NCT06087328|527825302|FG002|1-month Follow-up|Lost to Follow-up|1|||
146361936|NCT05822830|527825303|FG000|Overall Study|Adverse Event|6|||
146361937|NCT05822830|527825304|FG001|Overall Study|Adverse Event|6|||
146361938|NCT05822830|527825303|FG000|Overall Study|Assigned Treatment by Mistake|5|||
146361939|NCT05822830|527825304|FG001|Overall Study|Assigned Treatment by Mistake|3|||
146361940|NCT05822830|527825303|FG000|Overall Study|Lost to Follow-up|16|||
146361941|NCT05822830|527825304|FG001|Overall Study|Lost to Follow-up|18|||
146361942|NCT05822830|527825303|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146169716|NCT02675465|527132909|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
146361943|NCT05822830|527825304|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146361944|NCT05822830|527825303|FG000|Overall Study|Participant was Out of the Country|0|||
146361945|NCT05822830|527825304|FG001|Overall Study|Participant was Out of the Country|1|||
146169717|NCT02675465|527132910|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
146169718|NCT02675465|527132911|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
146361946|NCT05822830|527825303|FG000|Overall Study|Pregnancy|1|||
146361947|NCT05822830|527825304|FG001|Overall Study|Pregnancy|2|||
146361948|NCT05822830|527825303|FG000|Overall Study|Withdrawal by Subject|27|||
146361949|NCT05822830|527825304|FG001|Overall Study|Withdrawal by Subject|26|||
146361950|NCT00118482|527825305|FG000|Overall Study|Lost to Follow-up|7|||
146361951|NCT00118482|527825306|FG001|Overall Study|Lost to Follow-up|7|||
146361952|NCT00118482|527825305|FG000|Overall Study|Withdrawal by Subject|23|||
146361953|NCT00118482|527825306|FG001|Overall Study|Withdrawal by Subject|22|||
146361954|NCT00125190|527825307|FG000|Overall Study|Subject/Parent Decision|7|||
146361955|NCT00125190|527825307|FG000|Overall Study|Non-compliance|2|||
146361956|NCT00125190|527825307|FG000|Overall Study|Adverse Event|1|||
146361957|NCT00125190|527825307|FG000|Overall Study|Other|1|||
146361958|NCT00125190|527825307|FG000|Overall Study|Lost to Follow-up|4|||
146361959|NCT01586156|527825308|FG000|Overall Study|Pregnancy|0|||
146361960|NCT01586156|527825309|FG001|Overall Study|Pregnancy|1|||
146361961|NCT01586156|527825310|FG002|Overall Study|Pregnancy|0|||
146361962|NCT01244191|527825312|FG000|Overall Study|Progressive disease|295|||
146361963|NCT01244191|527825313|FG001|Overall Study|Progressive disease|350|||
146361964|NCT01244191|527825312|FG000|Overall Study|Clinical disease progression|54|||
146361965|NCT01244191|527825313|FG001|Overall Study|Clinical disease progression|36|||
146361966|NCT01244191|527825312|FG000|Overall Study|Adverse Event|65|||
146361967|NCT01244191|527825313|FG001|Overall Study|Adverse Event|48|||
146361968|NCT01244191|527825312|FG000|Overall Study|Death|22|||
146361969|NCT01244191|527825313|FG001|Overall Study|Death|29|||
146361970|NCT01244191|527825312|FG000|Overall Study|Lost to Follow-up|0|||
146361971|NCT01244191|527825313|FG001|Overall Study|Lost to Follow-up|2|||
146361972|NCT01244191|527825312|FG000|Overall Study|Protocol Violation|1|||
146361973|NCT01244191|527825313|FG001|Overall Study|Protocol Violation|2|||
146361974|NCT01244191|527825312|FG000|Overall Study|Withdrawal by Subject|31|||
146361975|NCT01244191|527825313|FG001|Overall Study|Withdrawal by Subject|23|||
146361976|NCT01244191|527825312|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
146361977|NCT01244191|527825313|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
146361978|NCT05301322|527825314|FG000|Overall Study|Adverse Event|7|||
146361979|NCT05301322|527825315|FG001|Overall Study|Adverse Event|3|||
146361980|NCT05301322|527825314|FG000|Overall Study|Death|0|||
146361981|NCT05301322|527825315|FG001|Overall Study|Death|1|||
146361982|NCT05301322|527825314|FG000|Overall Study|Lost to Follow-up|2|||
146361983|NCT05301322|527825315|FG001|Overall Study|Lost to Follow-up|1|||
146361984|NCT05301322|527825314|FG000|Overall Study|Protocol Violation|3|||
146361985|NCT05301322|527825315|FG001|Overall Study|Protocol Violation|1|||
146361986|NCT05301322|527825314|FG000|Overall Study|Withdrawal by Subject|3|||
146361987|NCT05301322|527825315|FG001|Overall Study|Withdrawal by Subject|0|||
146361988|NCT05301322|527825314|FG000|Overall Study|Other|4|||
146361989|NCT05301322|527825315|FG001|Overall Study|Other|0|||
146361990|NCT00808249|527825316|FG000|Overall Study|Adverse Event|4|||
146361991|NCT00808249|527825317|FG001|Overall Study|Adverse Event|7|||
146361992|NCT00808249|527825318|FG002|Overall Study|Adverse Event|10|||
146361993|NCT00808249|527825319|FG003|Overall Study|Adverse Event|6|||
146361994|NCT00808249|527825316|FG000|Overall Study|Lost to Follow-up|2|||
146361995|NCT00808249|527825317|FG001|Overall Study|Lost to Follow-up|3|||
146361996|NCT00808249|527825318|FG002|Overall Study|Lost to Follow-up|3|||
146361997|NCT00808249|527825319|FG003|Overall Study|Lost to Follow-up|5|||
146361998|NCT00808249|527825316|FG000|Overall Study|Withdrawal by Subject|4|||
146361999|NCT00808249|527825317|FG001|Overall Study|Withdrawal by Subject|0|||
146362000|NCT00808249|527825318|FG002|Overall Study|Withdrawal by Subject|2|||
146362001|NCT00808249|527825319|FG003|Overall Study|Withdrawal by Subject|4|||
146362002|NCT00808249|527825316|FG000|Overall Study|Protocol Violation|3|||
146362003|NCT00808249|527825317|FG001|Overall Study|Protocol Violation|3|||
146362004|NCT00808249|527825318|FG002|Overall Study|Protocol Violation|3|||
146362005|NCT00808249|527825319|FG003|Overall Study|Protocol Violation|0|||
146362006|NCT00808249|527825316|FG000|Overall Study|Lack of Efficacy|1|||
146362007|NCT00808249|527825317|FG001|Overall Study|Lack of Efficacy|1|||
146362008|NCT00808249|527825318|FG002|Overall Study|Lack of Efficacy|0|||
146362009|NCT00808249|527825319|FG003|Overall Study|Lack of Efficacy|0|||
146362010|NCT00808249|527825316|FG000|Overall Study|study specific discontinuation criteria|1|||
146362011|NCT00808249|527825317|FG001|Overall Study|study specific discontinuation criteria|0|||
146362012|NCT00808249|527825318|FG002|Overall Study|study specific discontinuation criteria|1|||
146362013|NCT00808249|527825319|FG003|Overall Study|study specific discontinuation criteria|0|||
146362014|NCT00808249|527825316|FG000|Overall Study|All other reasons|2|||
146362015|NCT00808249|527825317|FG001|Overall Study|All other reasons|1|||
146169719|NCT02675465|527132906|FG000|Stage 4: Long Term Extension|Death|0|||
146169720|NCT02675465|527132907|FG001|Stage 4: Long Term Extension|Death|0|||
146362016|NCT00808249|527825318|FG002|Overall Study|All other reasons|3|||
146362017|NCT00808249|527825319|FG003|Overall Study|All other reasons|1|||
146362018|NCT03829332|527825320|FG000|Overall Study|Death|225|||
146362019|NCT03829332|527825321|FG001|Overall Study|Death|230|||
146362020|NCT03829332|527825320|FG000|Overall Study|Lost to Follow-up|1|||
146362021|NCT03829332|527825321|FG001|Overall Study|Lost to Follow-up|3|||
146362022|NCT03829332|527825320|FG000|Overall Study|Physician Decision|1|||
146362023|NCT03829332|527825321|FG001|Overall Study|Physician Decision|0|||
146362024|NCT03829332|527825320|FG000|Overall Study|Sponsor Decision|71|||
146362025|NCT03829332|527825321|FG001|Overall Study|Sponsor Decision|72|||
146362026|NCT03829332|527825320|FG000|Overall Study|Withdrawal by Subject|11|||
146362027|NCT03829332|527825321|FG001|Overall Study|Withdrawal by Subject|9|||
146362028|NCT04999969|527825958|FG000|Overall Study|Death|76|||
146362029|NCT04999969|527825958|FG000|Overall Study|Progressive Disease|1|||
146362030|NCT04999969|527825958|FG000|Overall Study|Withdrawal by Subject|8|||
146362031|NCT03779334|527825963|FG000|Overall Study|Withdrawal by Subject|3|||
146362032|NCT03779334|527825964|FG001|Overall Study|Withdrawal by Subject|0|||
146362033|NCT03779334|527825965|FG002|Overall Study|Withdrawal by Subject|0|||
146362034|NCT03779334|527825963|FG000|Overall Study|Ongoing in Study|5|||
146362035|NCT03779334|527825964|FG001|Overall Study|Ongoing in Study|13|||
146362036|NCT03779334|527825965|FG002|Overall Study|Ongoing in Study|5|||
146362037|NCT04735393|527825966|FG000|Overall Study|Lost to Follow-up|46|||
146362038|NCT04735393|527825967|FG001|Overall Study|Lost to Follow-up|24|||
146362039|NCT04735393|527825966|FG000|Overall Study|Physician Decision|2|||
146362040|NCT04735393|527825967|FG001|Overall Study|Physician Decision|1|||
146362041|NCT04735393|527825966|FG000|Overall Study|Not Detailed|1|||
146362042|NCT04735393|527825967|FG001|Overall Study|Not Detailed|2|||
146362043|NCT04735393|527825966|FG000|Overall Study|Withdrawal by Subject|71|||
146362044|NCT04735393|527825967|FG001|Overall Study|Withdrawal by Subject|28|||
146362045|NCT04735393|527825966|FG000|Overall Study|Adverse Event|56|||
146362046|NCT04735393|527825967|FG001|Overall Study|Adverse Event|7|||
146362047|NCT04735393|527825966|FG000|Overall Study|Protocol Violation|6|||
146362048|NCT04735393|527825967|FG001|Overall Study|Protocol Violation|1|||
146362049|NCT04735393|527825966|FG000|Overall Study|Trial terminated by Sponsor|49|||
146362050|NCT04735393|527825967|FG001|Overall Study|Trial terminated by Sponsor|29|||
146362051|NCT03224104|527825968|FG000|Overall Study|Lack of Efficacy|2|||
146362052|NCT03224104|527825969|FG001|Overall Study|Lack of Efficacy|6|||
146362053|NCT03224104|527825970|FG002|Overall Study|Lack of Efficacy|3|||
146362054|NCT03224104|527825971|FG003|Overall Study|Lack of Efficacy|4|||
146362055|NCT03224104|527825972|FG004|Overall Study|Lack of Efficacy|42|||
146362056|NCT03224104|527825968|FG000|Overall Study|Withdrawal by Subject|0|||
146362057|NCT03224104|527825969|FG001|Overall Study|Withdrawal by Subject|2|||
146362058|NCT03224104|527825970|FG002|Overall Study|Withdrawal by Subject|0|||
146362059|NCT03224104|527825971|FG003|Overall Study|Withdrawal by Subject|1|||
146362060|NCT03224104|527825972|FG004|Overall Study|Withdrawal by Subject|3|||
146362061|NCT03224104|527825968|FG000|Overall Study|Death|0|||
146362062|NCT03224104|527825969|FG001|Overall Study|Death|1|||
146362063|NCT03224104|527825970|FG002|Overall Study|Death|0|||
146362064|NCT03224104|527825971|FG003|Overall Study|Death|0|||
146362065|NCT03224104|527825972|FG004|Overall Study|Death|0|||
146362066|NCT03224104|527825968|FG000|Overall Study|Adverse Event|1|||
146362067|NCT03224104|527825969|FG001|Overall Study|Adverse Event|0|||
146362068|NCT03224104|527825970|FG002|Overall Study|Adverse Event|0|||
146362069|NCT03224104|527825971|FG003|Overall Study|Adverse Event|1|||
146362070|NCT03224104|527825972|FG004|Overall Study|Adverse Event|3|||
146362071|NCT03224104|527825968|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
146362072|NCT03224104|527825969|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
146362073|NCT03224104|527825970|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
146362074|NCT03224104|527825971|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
146362075|NCT03224104|527825972|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
146362076|NCT03224104|527825968|FG000|Overall Study|Treatment ongoing|0|||
146362077|NCT03224104|527825969|FG001|Overall Study|Treatment ongoing|0|||
146362078|NCT03224104|527825970|FG002|Overall Study|Treatment ongoing|0|||
146362079|NCT03224104|527825971|FG003|Overall Study|Treatment ongoing|0|||
146362080|NCT03224104|527825972|FG004|Overall Study|Treatment ongoing|1|||
146362081|NCT05025787|527825973|FG000|Overall Study|Lack of Efficacy|0|||
146362082|NCT05025787|527825974|FG001|Overall Study|Lack of Efficacy|1|||
146362083|NCT05025787|527825973|FG000|Overall Study|Adverse Event|2|||
146362084|NCT05025787|527825974|FG001|Overall Study|Adverse Event|4|||
146362085|NCT05025787|527825973|FG000|Overall Study|Non compliance|0|||
146362086|NCT05025787|527825974|FG001|Overall Study|Non compliance|1|||
146362087|NCT05025787|527825973|FG000|Overall Study|Protocol Violation|3|||
146362088|NCT05025787|527825974|FG001|Overall Study|Protocol Violation|1|||
146362089|NCT05025787|527825973|FG000|Overall Study|Stopping criteria met|1|||
146362090|NCT05025787|527825974|FG001|Overall Study|Stopping criteria met|1|||
146362091|NCT05025787|527825973|FG000|Overall Study|Withdrawal by Subject|3|||
146362092|NCT05025787|527825974|FG001|Overall Study|Withdrawal by Subject|1|||
146362093|NCT03201965|527825978|FG000|Overall Study|Death|5|||
146169721|NCT02675465|527132908|FG002|Stage 4: Long Term Extension|Death|0|||
146362094|NCT03201965|527825979|FG001|Overall Study|Death|65|||
146362095|NCT03201965|527825980|FG002|Overall Study|Death|47|||
146362096|NCT03201965|527825978|FG000|Overall Study|Lost to Follow-up|0|||
146169722|NCT02675465|527132909|FG003|Stage 4: Long Term Extension|Death|1|||
146362097|NCT03201965|527825979|FG001|Overall Study|Lost to Follow-up|6|||
146362098|NCT03201965|527825980|FG002|Overall Study|Lost to Follow-up|0|||
146362099|NCT03201965|527825978|FG000|Overall Study|Withdrawal by Subject|3|||
146362100|NCT03201965|527825979|FG001|Overall Study|Withdrawal by Subject|23|||
146362101|NCT03201965|527825980|FG002|Overall Study|Withdrawal by Subject|8|||
146362102|NCT03201965|527825978|FG000|Overall Study|Sponsor's Decision|20|||
146362103|NCT03201965|527825979|FG001|Overall Study|Sponsor's Decision|99|||
146362104|NCT03201965|527825980|FG002|Overall Study|Sponsor's Decision|140|||
146362105|NCT03368664|527825981|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
146362106|NCT03368664|527825981|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
146362107|NCT03368664|527825981|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
146362108|NCT03368664|527825981|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
146362109|NCT03589326|527825989|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
146362110|NCT03589326|527825990|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
146362111|NCT03589326|527825989|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
146362112|NCT03589326|527825990|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
146362113|NCT03589326|527825989|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
146362114|NCT03589326|527825990|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
146362115|NCT03589326|527825989|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
146362116|NCT03589326|527825990|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
146362117|NCT03589326|527825989|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
146362118|NCT03589326|527825990|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
146362119|NCT05441592|527825991|FG000|Overall Study|Lost to Follow-up|1|||
146362120|NCT05441592|527825992|FG001|Overall Study|Lost to Follow-up|5|||
146362121|NCT01371981|527825993|FG000|Overall Study|Adverse Event|12|||
146362122|NCT01371981|527825994|FG001|Overall Study|Adverse Event|17|||
146362123|NCT01371981|527825995|FG002|Overall Study|Adverse Event|0|||
146362124|NCT01371981|527825996|FG003|Overall Study|Adverse Event|4|||
146362125|NCT01371981|527825997|FG004|Overall Study|Adverse Event|1|||
146362126|NCT01371981|527825998|FG005|Overall Study|Adverse Event|0|||
146362127|NCT01371981|527825993|FG000|Overall Study|Death|22|||
146362128|NCT01371981|527825994|FG001|Overall Study|Death|16|||
146362129|NCT01371981|527825995|FG002|Overall Study|Death|0|||
146362130|NCT01371981|527825996|FG003|Overall Study|Death|0|||
146362131|NCT01371981|527825997|FG004|Overall Study|Death|2|||
146362132|NCT01371981|527825998|FG005|Overall Study|Death|2|||
146362133|NCT01371981|527825993|FG000|Overall Study|Lack of Efficacy|69|||
146362134|NCT01371981|527825994|FG001|Overall Study|Lack of Efficacy|61|||
146362135|NCT01371981|527825995|FG002|Overall Study|Lack of Efficacy|4|||
146362136|NCT01371981|527825996|FG003|Overall Study|Lack of Efficacy|8|||
146362137|NCT01371981|527825997|FG004|Overall Study|Lack of Efficacy|5|||
146362138|NCT01371981|527825998|FG005|Overall Study|Lack of Efficacy|0|||
146362139|NCT01371981|527825993|FG000|Overall Study|Physician Decision|48|||
146362140|NCT01371981|527825994|FG001|Overall Study|Physician Decision|63|||
146362141|NCT01371981|527825995|FG002|Overall Study|Physician Decision|1|||
146362142|NCT01371981|527825996|FG003|Overall Study|Physician Decision|7|||
146362143|NCT01371981|527825997|FG004|Overall Study|Physician Decision|14|||
146362144|NCT01371981|527825998|FG005|Overall Study|Physician Decision|3|||
146362145|NCT01371981|527825993|FG000|Overall Study|Withdrawal by Subject|12|||
146362146|NCT01371981|527825994|FG001|Overall Study|Withdrawal by Subject|19|||
146362147|NCT01371981|527825995|FG002|Overall Study|Withdrawal by Subject|1|||
146362148|NCT01371981|527825996|FG003|Overall Study|Withdrawal by Subject|2|||
146362149|NCT01371981|527825997|FG004|Overall Study|Withdrawal by Subject|10|||
146362150|NCT01371981|527825998|FG005|Overall Study|Withdrawal by Subject|3|||
146362151|NCT01371981|527825993|FG000|Overall Study|Ineligible|19|||
146362152|NCT01371981|527825994|FG001|Overall Study|Ineligible|13|||
146362153|NCT01371981|527825995|FG002|Overall Study|Ineligible|0|||
146362154|NCT01371981|527825996|FG003|Overall Study|Ineligible|0|||
146362155|NCT01371981|527825997|FG004|Overall Study|Ineligible|0|||
146362156|NCT01371981|527825998|FG005|Overall Study|Ineligible|4|||
146362157|NCT01371981|527825993|FG000|Overall Study|Did not start treatment|2|||
146362158|NCT01371981|527825994|FG001|Overall Study|Did not start treatment|3|||
146362159|NCT01371981|527825995|FG002|Overall Study|Did not start treatment|0|||
146362160|NCT01371981|527825996|FG003|Overall Study|Did not start treatment|0|||
146362161|NCT01371981|527825997|FG004|Overall Study|Did not start treatment|0|||
146362162|NCT01371981|527825998|FG005|Overall Study|Did not start treatment|2|||
146362163|NCT05584202|527825999|FG000|Overall Study|Withdrawal of Consent|3|||
146362164|NCT05584202|527826000|FG001|Overall Study|Withdrawal of Consent|2|||
146169723|NCT02675465|527132910|FG004|Stage 4: Long Term Extension|Death|0|||
146169724|NCT02675465|527132911|FG005|Stage 4: Long Term Extension|Death|0|||
146169725|NCT05031078|527132912|FG000|Overall Study|Withdrawal by Subject|0|||
146169726|NCT05031078|527132913|FG001|Overall Study|Withdrawal by Subject|1|||
146362165|NCT05584202|527825999|FG000|Overall Study|Lost to Follow-up|2|||
146362166|NCT05584202|527826000|FG001|Overall Study|Lost to Follow-up|1|||
146362167|NCT05584202|527825999|FG000|Overall Study|Death|0|||
146362168|NCT05584202|527826000|FG001|Overall Study|Death|1|||
146362169|NCT05757427|527826001|FG000|Overall Study|Adverse Event|1|||
146362170|NCT05757427|527826001|FG000|Overall Study|Device deficiency|1|||
146362171|NCT05757427|527826001|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
146362172|NCT05757427|527826001|FG000|Overall Study|MWBI scan of only 1 breast|3|||
146362173|NCT05757427|527826001|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
146362174|NCT03423979|527826002|FG000|Overall Study|Death|5|||
146362175|NCT03423979|527826002|FG000|Overall Study|Adverse Event|4|||
146362176|NCT03423979|527826002|FG000|Overall Study|Withdrawal by Subject|3|||
146362177|NCT03423979|527826002|FG000|Overall Study|Lost to Follow-up|16|||
146362178|NCT04971785|527826003|FG000|Overall Study|Withdrew Consent|5|||
146362179|NCT04971785|527826004|FG001|Overall Study|Withdrew Consent|5|||
146362180|NCT04971785|527826005|FG002|Overall Study|Withdrew Consent|17|||
146362181|NCT04971785|527826006|FG003|Overall Study|Withdrew Consent|7|||
146362182|NCT04971785|527826003|FG000|Overall Study|Adverse Event|7|||
146362183|NCT04971785|527826004|FG001|Overall Study|Adverse Event|8|||
146362184|NCT04971785|527826005|FG002|Overall Study|Adverse Event|6|||
146362185|NCT04971785|527826006|FG003|Overall Study|Adverse Event|3|||
146362186|NCT04971785|527826003|FG000|Overall Study|Lost to Follow-up|2|||
146362187|NCT04971785|527826004|FG001|Overall Study|Lost to Follow-up|1|||
146362188|NCT04971785|527826005|FG002|Overall Study|Lost to Follow-up|6|||
146362189|NCT04971785|527826006|FG003|Overall Study|Lost to Follow-up|7|||
146362190|NCT04971785|527826003|FG000|Overall Study|Protocol Violation|3|||
146362191|NCT04971785|527826004|FG001|Overall Study|Protocol Violation|1|||
146362192|NCT04971785|527826005|FG002|Overall Study|Protocol Violation|1|||
146362193|NCT04971785|527826006|FG003|Overall Study|Protocol Violation|2|||
146362194|NCT04971785|527826003|FG000|Overall Study|Investigator's Discretion|3|||
146362195|NCT04971785|527826004|FG001|Overall Study|Investigator's Discretion|1|||
146362196|NCT04971785|527826005|FG002|Overall Study|Investigator's Discretion|1|||
146362197|NCT04971785|527826006|FG003|Overall Study|Investigator's Discretion|0|||
146362198|NCT04971785|527826003|FG000|Overall Study|Randomized but Never Treated|1|||
146362199|NCT04971785|527826004|FG001|Overall Study|Randomized but Never Treated|2|||
146362200|NCT04971785|527826005|FG002|Overall Study|Randomized but Never Treated|0|||
146362201|NCT04971785|527826006|FG003|Overall Study|Randomized but Never Treated|1|||
146362202|NCT04971785|527826003|FG000|Overall Study|Death|0|||
146362203|NCT04971785|527826004|FG001|Overall Study|Death|1|||
146362204|NCT04971785|527826005|FG002|Overall Study|Death|1|||
146362205|NCT04971785|527826006|FG003|Overall Study|Death|0|||
146362206|NCT04971785|527826003|FG000|Overall Study|Site Terminated by Sponsor|1|||
146362207|NCT04971785|527826004|FG001|Overall Study|Site Terminated by Sponsor|1|||
146362208|NCT04971785|527826005|FG002|Overall Study|Site Terminated by Sponsor|0|||
146362209|NCT04971785|527826006|FG003|Overall Study|Site Terminated by Sponsor|0|||
146362210|NCT01251861|527826007|FG000|Overall Study|Disease progression|6|||
146362211|NCT01251861|527826008|FG001|Overall Study|Disease progression|6|||
146362212|NCT01251861|527826007|FG000|Overall Study|Adverse Event|2|||
146362213|NCT01251861|527826008|FG001|Overall Study|Adverse Event|17|||
146362214|NCT01251861|527826007|FG000|Overall Study|Withdrawal by Subject|2|||
146362215|NCT01251861|527826008|FG001|Overall Study|Withdrawal by Subject|2|||
146362216|NCT01251861|527826007|FG000|Overall Study|Alternative therapy|1|||
146362217|NCT01251861|527826008|FG001|Overall Study|Alternative therapy|0|||
146362218|NCT01251861|527826007|FG000|Overall Study|Other complicating disease|0|||
146362219|NCT01251861|527826008|FG001|Overall Study|Other complicating disease|1|||
146362220|NCT01251861|527826007|FG000|Overall Study|Physician Decision|1|||
146362221|NCT01251861|527826008|FG001|Overall Study|Physician Decision|0|||
146362222|NCT01251861|527826007|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
146362223|NCT01251861|527826008|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
146362224|NCT01251861|527826007|FG000|Overall Study|Other|1|||
146362225|NCT01251861|527826008|FG001|Overall Study|Other|0|||
146362226|NCT01251861|527826007|FG000|Overall Study|Never started therapy|4|||
146362227|NCT01251861|527826008|FG001|Overall Study|Never started therapy|1|||
146362228|NCT01251861|527826007|FG000|Overall Study|Potential interaction of drugs|0|||
146362229|NCT01251861|527826008|FG001|Overall Study|Potential interaction of drugs|1|||
146362230|NCT05371912|527826009|FG000|Overall Study|Lost to Follow-up|3|||
146362231|NCT05371912|527826010|FG001|Overall Study|Lost to Follow-up|2|||
146362232|NCT02598661|527826011|FG000|Overall Study|Death|27|||
146362233|NCT02598661|527826012|FG001|Overall Study|Death|34|||
146362234|NCT02598661|527826013|FG002|Overall Study|Death|14|||
146362235|NCT02598661|527826014|FG003|Overall Study|Death|1|||
146362236|NCT02598661|527826015|FG004|Overall Study|Death|0|||
146362237|NCT02598661|527826011|FG000|Overall Study|Lost to Follow-up|2|||
146362238|NCT02598661|527826012|FG001|Overall Study|Lost to Follow-up|3|||
146362239|NCT02598661|527826013|FG002|Overall Study|Lost to Follow-up|2|||
146362240|NCT02598661|527826014|FG003|Overall Study|Lost to Follow-up|0|||
146362241|NCT02598661|527826015|FG004|Overall Study|Lost to Follow-up|0|||
146362242|NCT02598661|527826011|FG000|Overall Study|Withdrawal by Subject|13|||
146362243|NCT02598661|527826012|FG001|Overall Study|Withdrawal by Subject|24|||
146362244|NCT02598661|527826013|FG002|Overall Study|Withdrawal by Subject|14|||
146362245|NCT02598661|527826014|FG003|Overall Study|Withdrawal by Subject|1|||
146362246|NCT02598661|527826015|FG004|Overall Study|Withdrawal by Subject|1|||
146362247|NCT02598661|527826011|FG000|Overall Study|Adverse Event|0|||
146362248|NCT02598661|527826012|FG001|Overall Study|Adverse Event|0|||
146362249|NCT02598661|527826013|FG002|Overall Study|Adverse Event|1|||
146362250|NCT02598661|527826014|FG003|Overall Study|Adverse Event|0|||
146362251|NCT02598661|527826015|FG004|Overall Study|Adverse Event|0|||
146362252|NCT02598661|527826011|FG000|Overall Study|Randomized, Never Treated|0|||
146362253|NCT02598661|527826012|FG001|Overall Study|Randomized, Never Treated|0|||
146362254|NCT02598661|527826013|FG002|Overall Study|Randomized, Never Treated|0|||
146362255|NCT02598661|527826014|FG003|Overall Study|Randomized, Never Treated|0|||
146362256|NCT02598661|527826015|FG004|Overall Study|Randomized, Never Treated|1|||
146362257|NCT02499575|527827873|FG000|Overall Study|Protocol Violation|0|||
146362258|NCT02499575|527827874|FG001|Overall Study|Protocol Violation|1|||
146362259|NCT03297216|527827881|FG000|Overall Study|Death|0|||
146362260|NCT03297216|527827882|FG001|Overall Study|Death|1|||
146362261|NCT03297216|527827881|FG000|Overall Study|Miscarriage|0|||
146362262|NCT03297216|527827882|FG001|Overall Study|Miscarriage|2|||
146362263|NCT03297216|527827881|FG000|Overall Study|Lost to Follow-up|3|||
146362264|NCT03297216|527827882|FG001|Overall Study|Lost to Follow-up|2|||
146362265|NCT00781963|527827883|FG000|Overall Study|Death|3|||
146362266|NCT00781963|527827884|FG001|Overall Study|Death|0|||
146362267|NCT00781963|527827883|FG000|Overall Study|Lost to Follow-up|2|||
146362268|NCT00781963|527827884|FG001|Overall Study|Lost to Follow-up|1|||
146362269|NCT00781963|527827883|FG000|Overall Study|Withdrawal by Subject|3|||
146362270|NCT00781963|527827884|FG001|Overall Study|Withdrawal by Subject|1|||
146362271|NCT00781963|527827883|FG000|Overall Study|Refused follow-up|9|||
146362272|NCT00781963|527827884|FG001|Overall Study|Refused follow-up|0|||
146362273|NCT03434418|527827885|FG000|Overall Study|Disease Progression|11|||
146362274|NCT03434418|527827885|FG000|Overall Study|Adverse Event|2|||
146362275|NCT03434418|527827885|FG000|Overall Study|Physician Decision|1|||
146362276|NCT03434418|527827885|FG000|Overall Study|Decline in Performance Status (PS)|1|||
146362277|NCT00696436|527827886|FG000|Overall Study|Adverse Event|7|||
146362278|NCT00696436|527827887|FG001|Overall Study|Adverse Event|9|||
146362279|NCT00696436|527827888|FG002|Overall Study|Adverse Event|8|||
146362280|NCT00696436|527827889|FG003|Overall Study|Adverse Event|6|||
146362281|NCT00696436|527827890|FG004|Overall Study|Adverse Event|4|||
146362282|NCT00696436|527827886|FG000|Overall Study|Protocol Violation|3|||
146362283|NCT00696436|527827887|FG001|Overall Study|Protocol Violation|2|||
146362284|NCT00696436|527827888|FG002|Overall Study|Protocol Violation|2|||
146362285|NCT00696436|527827889|FG003|Overall Study|Protocol Violation|0|||
146362286|NCT00696436|527827890|FG004|Overall Study|Protocol Violation|1|||
146362287|NCT00696436|527827886|FG000|Overall Study|Lost to Follow-up|1|||
146362288|NCT00696436|527827887|FG001|Overall Study|Lost to Follow-up|6|||
146362289|NCT00696436|527827888|FG002|Overall Study|Lost to Follow-up|2|||
146362290|NCT00696436|527827889|FG003|Overall Study|Lost to Follow-up|4|||
146362291|NCT00696436|527827890|FG004|Overall Study|Lost to Follow-up|3|||
146362292|NCT00696436|527827886|FG000|Overall Study|Withdrawal by Subject|4|||
146362293|NCT00696436|527827887|FG001|Overall Study|Withdrawal by Subject|11|||
146362294|NCT00696436|527827888|FG002|Overall Study|Withdrawal by Subject|5|||
146362295|NCT00696436|527827889|FG003|Overall Study|Withdrawal by Subject|7|||
146362296|NCT00696436|527827890|FG004|Overall Study|Withdrawal by Subject|1|||
146362297|NCT00696436|527827886|FG000|Overall Study|Lack of Efficacy|3|||
146362298|NCT00696436|527827887|FG001|Overall Study|Lack of Efficacy|1|||
146362299|NCT00696436|527827888|FG002|Overall Study|Lack of Efficacy|5|||
146362300|NCT00696436|527827889|FG003|Overall Study|Lack of Efficacy|2|||
146362301|NCT00696436|527827890|FG004|Overall Study|Lack of Efficacy|4|||
146362302|NCT00696436|527827886|FG000|Overall Study|Participant Unavailability|2|||
146362303|NCT00696436|527827887|FG001|Overall Study|Participant Unavailability|0|||
146362304|NCT00696436|527827888|FG002|Overall Study|Participant Unavailability|2|||
146362305|NCT00696436|527827889|FG003|Overall Study|Participant Unavailability|1|||
146362306|NCT00696436|527827890|FG004|Overall Study|Participant Unavailability|0|||
146362307|NCT00696436|527827886|FG000|Overall Study|Administrative Error|2|||
146362308|NCT00696436|527827887|FG001|Overall Study|Administrative Error|0|||
146362309|NCT00696436|527827888|FG002|Overall Study|Administrative Error|2|||
146362310|NCT00696436|527827889|FG003|Overall Study|Administrative Error|0|||
146362311|NCT00696436|527827890|FG004|Overall Study|Administrative Error|0|||
146362312|NCT00696436|527827886|FG000|Overall Study|Participant Non-compliance|0|||
146362313|NCT00696436|527827887|FG001|Overall Study|Participant Non-compliance|0|||
146362314|NCT00696436|527827888|FG002|Overall Study|Participant Non-compliance|1|||
146362315|NCT00696436|527827889|FG003|Overall Study|Participant Non-compliance|2|||
146362316|NCT00696436|527827890|FG004|Overall Study|Participant Non-compliance|0|||
146362317|NCT00696436|527827886|FG000|Overall Study|Administrative Decision|1|||
146362318|NCT00696436|527827887|FG001|Overall Study|Administrative Decision|0|||
146362319|NCT00696436|527827888|FG002|Overall Study|Administrative Decision|0|||
146169727|NCT05031078|527132914|FG002|Overall Study|Withdrawal by Subject|0|||
146169728|NCT00728962|527132918|FG000|Implant Placement Surgery|Adverse Event|8|||
146169729|NCT00728962|527132918|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
146362320|NCT00696436|527827889|FG003|Overall Study|Administrative Decision|0|||
146362321|NCT00696436|527827890|FG004|Overall Study|Administrative Decision|0|||
146362322|NCT00696436|527827886|FG000|Overall Study|Missing|0|||
146362323|NCT00696436|527827887|FG001|Overall Study|Missing|1|||
146362324|NCT00696436|527827888|FG002|Overall Study|Missing|1|||
146362325|NCT00696436|527827889|FG003|Overall Study|Missing|0|||
146362326|NCT00696436|527827890|FG004|Overall Study|Missing|0|||
146362327|NCT03039738|527827893|FG000|Overall Study|Incomplete data sets|54|||
146362328|NCT03039738|527827894|FG001|Overall Study|Incomplete data sets|0|||
146362329|NCT00912340|527827897|FG000|Overall Study|Adverse Event|2|||
146362330|NCT00912340|527827898|FG001|Overall Study|Adverse Event|4|||
146362331|NCT00912340|527827899|FG002|Overall Study|Adverse Event|0|||
146362332|NCT00912340|527827897|FG000|Overall Study|Protocol revised to remove arm|0|||
146362333|NCT00912340|527827898|FG001|Overall Study|Protocol revised to remove arm|0|||
146362334|NCT00912340|527827899|FG002|Overall Study|Protocol revised to remove arm|4|||
146362335|NCT01517412|527827900|FG000|Overall Study|Adverse Event|10|||
146362336|NCT01517412|527827901|FG001|Overall Study|Adverse Event|11|||
146362337|NCT01517412|527827900|FG000|Overall Study|Lack of Efficacy|10|||
146362338|NCT01517412|527827901|FG001|Overall Study|Lack of Efficacy|5|||
146362339|NCT01517412|527827900|FG000|Overall Study|Poor compliance to protocol|8|||
146362340|NCT01517412|527827901|FG001|Overall Study|Poor compliance to protocol|3|||
146362341|NCT01517412|527827900|FG000|Overall Study|Other than specified above|8|||
146362342|NCT01517412|527827901|FG001|Overall Study|Other than specified above|5|||
146362343|NCT02062463|527827902|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
146362344|NCT02062463|527827903|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
146362345|NCT02062463|527827904|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
146362346|NCT02062463|527827905|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
146362347|NCT02062463|527827902|FG000|Stage 2|Adverse Event|0|||
146362348|NCT02062463|527827903|FG001|Stage 2|Adverse Event|0|||
146362349|NCT02062463|527827904|FG002|Stage 2|Adverse Event|12|||
146362350|NCT02062463|527827905|FG003|Stage 2|Adverse Event|20|||
146362351|NCT02062463|527827902|FG000|Stage 2|Lack of Efficacy|0|||
146362352|NCT02062463|527827903|FG001|Stage 2|Lack of Efficacy|0|||
146362353|NCT02062463|527827904|FG002|Stage 2|Lack of Efficacy|3|||
146362354|NCT02062463|527827905|FG003|Stage 2|Lack of Efficacy|4|||
146362355|NCT02062463|527827902|FG000|Stage 2|Lost to Follow-up|0|||
146362356|NCT02062463|527827903|FG001|Stage 2|Lost to Follow-up|0|||
146362357|NCT02062463|527827904|FG002|Stage 2|Lost to Follow-up|20|||
146362358|NCT02062463|527827905|FG003|Stage 2|Lost to Follow-up|20|||
146362359|NCT02062463|527827902|FG000|Stage 2|Non-Compliance|0|||
146362360|NCT02062463|527827903|FG001|Stage 2|Non-Compliance|0|||
146362361|NCT02062463|527827904|FG002|Stage 2|Non-Compliance|0|||
146362362|NCT02062463|527827905|FG003|Stage 2|Non-Compliance|1|||
146362363|NCT02062463|527827902|FG000|Stage 2|Other than specified|0|||
146362364|NCT02062463|527827903|FG001|Stage 2|Other than specified|0|||
146362365|NCT02062463|527827904|FG002|Stage 2|Other than specified|3|||
146362366|NCT02062463|527827905|FG003|Stage 2|Other than specified|1|||
146362367|NCT02062463|527827902|FG000|Stage 2|Withdrawal by Subject|0|||
146362368|NCT02062463|527827903|FG001|Stage 2|Withdrawal by Subject|0|||
146362369|NCT02062463|527827904|FG002|Stage 2|Withdrawal by Subject|15|||
146362370|NCT02062463|527827905|FG003|Stage 2|Withdrawal by Subject|10|||
146362371|NCT01830816|527827921|FG000|Overall Study|Progressive Disease|12|||
146362372|NCT01830816|527827922|FG001|Overall Study|Progressive Disease|7|||
146362373|NCT01830816|527827923|FG002|Overall Study|Progressive Disease|7|||
146362374|NCT01830816|527827921|FG000|Overall Study|Adverse Event|3|||
146362375|NCT01830816|527827922|FG001|Overall Study|Adverse Event|4|||
146362376|NCT01830816|527827923|FG002|Overall Study|Adverse Event|0|||
146362377|NCT01830816|527827921|FG000|Overall Study|Study Terminated by Sponsor|1|||
146362378|NCT01830816|527827922|FG001|Overall Study|Study Terminated by Sponsor|1|||
146362379|NCT01830816|527827923|FG002|Overall Study|Study Terminated by Sponsor|0|||
146362380|NCT01830816|527827921|FG000|Overall Study|Withdrawal by Subject|1|||
146362381|NCT01830816|527827922|FG001|Overall Study|Withdrawal by Subject|1|||
146362382|NCT01830816|527827923|FG002|Overall Study|Withdrawal by Subject|0|||
146362383|NCT01830816|527827921|FG000|Overall Study|Lost to Follow-up|0|||
146362384|NCT01830816|527827922|FG001|Overall Study|Lost to Follow-up|1|||
146362385|NCT01830816|527827923|FG002|Overall Study|Lost to Follow-up|0|||
146362386|NCT01830816|527827921|FG000|Overall Study|Symptomatic Deterioration|1|||
146362387|NCT01830816|527827922|FG001|Overall Study|Symptomatic Deterioration|0|||
146362388|NCT01830816|527827923|FG002|Overall Study|Symptomatic Deterioration|0|||
146362389|NCT01830816|527827921|FG000|Overall Study|Reason not Specified|2|||
146362390|NCT01830816|527827922|FG001|Overall Study|Reason not Specified|0|||
146362391|NCT01830816|527827923|FG002|Overall Study|Reason not Specified|0|||
146362392|NCT04124692|527827924|FG000|Overall Study|Medical reason|0|||
146362393|NCT04124692|527827925|FG001|Overall Study|Medical reason|1|||
146169730|NCT00728962|527132918|FG000|Implant Placement Surgery|Protocol Violation|1|||
146169731|NCT00728962|527132918|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
146169732|NCT00728962|527132918|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
146169733|NCT04954586|527132919|FG000|Overall Study|Withdrawal by Subject|5|||
146169734|NCT02063828|527132920|FG000|Overall Study|Withdrawal by Subject|4|||
146169735|NCT02063828|527132921|FG001|Overall Study|Withdrawal by Subject|6|||
146169736|NCT02063828|527132922|FG002|Overall Study|Withdrawal by Subject|3|||
146169737|NCT02063828|527132920|FG000|Overall Study|Death|0|||
146169738|NCT02063828|527132921|FG001|Overall Study|Death|0|||
146169739|NCT02063828|527132922|FG002|Overall Study|Death|1|||
146169740|NCT00532155|527132923|FG000|Overall Study|Adverse Event|66|||
146169741|NCT00532155|527132924|FG001|Overall Study|Adverse Event|123|||
146169742|NCT00532155|527132923|FG000|Overall Study|Lack of Efficacy|332|||
146362394|NCT04124692|527827924|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
146362395|NCT04124692|527827925|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
146362396|NCT04124692|527827924|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
146362397|NCT04124692|527827925|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
146362398|NCT04124692|527827924|FG000|Overall Study|Lost to Follow-up|2|||
146362399|NCT04124692|527827925|FG001|Overall Study|Lost to Follow-up|4|||
146362400|NCT04124692|527827924|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
146362401|NCT04124692|527827925|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
146362402|NCT02716194|527827926|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
146362403|NCT02716194|527827927|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
146362404|NCT02716194|527827928|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
146362405|NCT00363051|527827932|FG000|Overall Study|Adminstrative problems|1|||
146362406|NCT00363051|527827933|FG001|Overall Study|Adminstrative problems|1|||
146362407|NCT00363051|527827932|FG000|Overall Study|Adverse Event|21|||
146362408|NCT00363051|527827933|FG001|Overall Study|Adverse Event|12|||
146362409|NCT00363051|527827932|FG000|Overall Study|New Cancer Therapy|2|||
146362410|NCT00363051|527827933|FG001|Overall Study|New Cancer Therapy|1|||
146362411|NCT00363051|527827932|FG000|Overall Study|Withdrawal by Subject|11|||
146362412|NCT00363051|527827933|FG001|Overall Study|Withdrawal by Subject|3|||
146362413|NCT00363051|527827932|FG000|Overall Study|Lost to Follow-up|0|||
146362414|NCT00363051|527827933|FG001|Overall Study|Lost to Follow-up|1|||
146362415|NCT00363051|527827932|FG000|Overall Study|Protocol Violation|0|||
146362416|NCT00363051|527827933|FG001|Overall Study|Protocol Violation|2|||
146362417|NCT00363051|527827932|FG000|Overall Study|Death|3|||
146362418|NCT00363051|527827933|FG001|Overall Study|Death|2|||
146362419|NCT00205699|527827936|FG000|Overall Study|Lost to Follow-up|1|||
146362420|NCT00205699|527827937|FG001|Overall Study|Lost to Follow-up|3|||
146362421|NCT00205699|527827938|FG002|Overall Study|Lost to Follow-up|5|||
146362422|NCT00205699|527827936|FG000|Overall Study|Adverse Event|1|||
146362423|NCT00205699|527827937|FG001|Overall Study|Adverse Event|0|||
146362424|NCT00205699|527827938|FG002|Overall Study|Adverse Event|0|||
146362425|NCT00205699|527827936|FG000|Overall Study|Withdrawal by Subject|1|||
146362426|NCT00205699|527827937|FG001|Overall Study|Withdrawal by Subject|2|||
146362427|NCT00205699|527827938|FG002|Overall Study|Withdrawal by Subject|1|||
146362428|NCT00205699|527827936|FG000|Overall Study|Lack of Efficacy|0|||
146169743|NCT00532155|527132924|FG001|Overall Study|Lack of Efficacy|255|||
146169744|NCT00532155|527132923|FG000|Overall Study|Protocol Violation|1|||
146169745|NCT00532155|527132924|FG001|Overall Study|Protocol Violation|3|||
146169746|NCT00532155|527132923|FG000|Overall Study|Lost to Follow-up|2|||
146169747|NCT00532155|527132924|FG001|Overall Study|Lost to Follow-up|0|||
146169748|NCT00532155|527132923|FG000|Overall Study|Physician Decision|16|||
146169749|NCT00532155|527132924|FG001|Overall Study|Physician Decision|15|||
146169750|NCT00532155|527132923|FG000|Overall Study|Withdrawal by Subject|23|||
146169751|NCT00532155|527132924|FG001|Overall Study|Withdrawal by Subject|44|||
146169752|NCT00532155|527132923|FG000|Overall Study|Consent withdrawn|5|||
146169753|NCT00532155|527132924|FG001|Overall Study|Consent withdrawn|7|||
146169754|NCT00532155|527132923|FG000|Overall Study|Moved|1|||
146169755|NCT00532155|527132924|FG001|Overall Study|Moved|0|||
146169756|NCT00532155|527132923|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
146169757|NCT00532155|527132924|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
146169758|NCT00532155|527132923|FG000|Overall Study|Occurence of a second cancer|0|||
146169759|NCT00532155|527132924|FG001|Overall Study|Occurence of a second cancer|1|||
146169760|NCT00532155|527132923|FG000|Overall Study|Occurence of a secondary cancer|0|||
146169761|NCT00532155|527132924|FG001|Overall Study|Occurence of a secondary cancer|1|||
146169762|NCT00532155|527132923|FG000|Overall Study|Promotor ended study|1|||
146169763|NCT00532155|527132924|FG001|Overall Study|Promotor ended study|0|||
146169764|NCT00532155|527132923|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
146169765|NCT00532155|527132924|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
146169766|NCT00532155|527132923|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
146169767|NCT00532155|527132924|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
146169768|NCT00532155|527132923|FG000|Overall Study|Study stopped|1|||
146169769|NCT00532155|527132924|FG001|Overall Study|Study stopped|0|||
146169770|NCT00532155|527132923|FG000|Overall Study|Study terminated by sponsor|1|||
146169771|NCT00532155|527132924|FG001|Overall Study|Study terminated by sponsor|0|||
146169772|NCT00532155|527132923|FG000|Overall Study|Study termination stop further treatment|4|||
146169773|NCT00532155|527132924|FG001|Overall Study|Study termination stop further treatment|0|||
146169774|NCT00532155|527132923|FG000|Overall Study|Did not receive study medication|2|||
146169775|NCT00532155|527132924|FG001|Overall Study|Did not receive study medication|6|||
146169776|NCT03483038|527132925|FG000|Overall Study|Subjects still in follow-up|18|||
146169777|NCT02134925|527132926|FG000|Overall Study|Withdrawal by Subject|1|||
146169778|NCT02134925|527132927|FG001|Overall Study|Withdrawal by Subject|0|||
146169779|NCT02134925|527132926|FG000|Overall Study|Cancel|1|||
146169780|NCT02134925|527132927|FG001|Overall Study|Cancel|6|||
146169781|NCT04987762|527132928|FG000|Overall Study|Study was Terminated by Sponsor|103|||
146169782|NCT01064297|527132929|FG000|Overall Study|Lost to Follow-up|791|||
146169783|NCT01064297|527132930|FG001|Overall Study|Lost to Follow-up|48|||
146169784|NCT01064297|527132931|FG002|Overall Study|Lost to Follow-up|133|||
146169785|NCT04027348|527132934|FG000|Overall Study|Adverse Event|2|||
146362429|NCT00205699|527827937|FG001|Overall Study|Lack of Efficacy|1|||
146362430|NCT00205699|527827938|FG002|Overall Study|Lack of Efficacy|0|||
146362431|NCT00830115|527827942|FG000|Overall Study|Adverse Event|2|||
146362432|NCT00830115|527827942|FG000|Overall Study|Improvement/recovery|1|||
146362433|NCT01925612|527827953|FG000|Overall Study|Progressive Disease|1|||
146362434|NCT01925612|527827954|FG001|Overall Study|Progressive Disease|1|||
146362435|NCT01925612|527827955|FG002|Overall Study|Progressive Disease|1|||
146362436|NCT01925612|527827956|FG003|Overall Study|Progressive Disease|0|||
146362437|NCT01925612|527827957|FG004|Overall Study|Progressive Disease|0|||
146362438|NCT01925612|527827953|FG000|Overall Study|Adverse Event|3|||
146362439|NCT01925612|527827954|FG001|Overall Study|Adverse Event|3|||
146362440|NCT01925612|527827955|FG002|Overall Study|Adverse Event|0|||
146362441|NCT01925612|527827956|FG003|Overall Study|Adverse Event|1|||
146362442|NCT01925612|527827957|FG004|Overall Study|Adverse Event|2|||
146362443|NCT01754922|527827958|FG000|Overall Study|Adverse Event|0|||
146362444|NCT01754922|527827959|FG001|Overall Study|Adverse Event|1|||
146362445|NCT01207388|527827960|FG000|Overall Study|Death|67|||
146362446|NCT01207388|527827960|FG000|Overall Study|Withdrawal by Subject|1|||
146362447|NCT01885078|527827961|FG000|Treatment Period|Adverse Event|52|||
146362448|NCT01885078|527827962|FG001|Treatment Period|Adverse Event|136|||
146362449|NCT01885078|527827963|FG002|Treatment Period|Adverse Event|30|||
146362450|NCT01885078|527827964|FG003|Treatment Period|Adverse Event|73|||
146362451|NCT01885078|527827965|FG004|Treatment Period|Adverse Event|17|||
146362452|NCT01885078|527827966|FG005|Treatment Period|Adverse Event|72|||
146362453|NCT01885078|527827967|FG006|Treatment Period|Adverse Event|24|||
146362454|NCT01885078|527827968|FG007|Treatment Period|Adverse Event|5|||
146362455|NCT01885078|527827969|FG008|Treatment Period|Adverse Event|0|||
146362456|NCT01885078|527827970|FG009|Treatment Period|Adverse Event|0|||
146362457|NCT01885078|527827961|FG000|Treatment Period|Death|13|||
146362458|NCT01885078|527827962|FG001|Treatment Period|Death|33|||
146362459|NCT01885078|527827963|FG002|Treatment Period|Death|5|||
146362460|NCT01885078|527827964|FG003|Treatment Period|Death|9|||
146362461|NCT01885078|527827965|FG004|Treatment Period|Death|2|||
146362462|NCT01885078|527827966|FG005|Treatment Period|Death|10|||
146362463|NCT01885078|527827967|FG006|Treatment Period|Death|3|||
146362464|NCT01885078|527827968|FG007|Treatment Period|Death|2|||
146362465|NCT01885078|527827969|FG008|Treatment Period|Death|0|||
146362466|NCT01885078|527827970|FG009|Treatment Period|Death|0|||
146362467|NCT01885078|527827961|FG000|Treatment Period|Lack of Efficacy|12|||
146362468|NCT01885078|527827962|FG001|Treatment Period|Lack of Efficacy|33|||
146362469|NCT01885078|527827963|FG002|Treatment Period|Lack of Efficacy|10|||
146362470|NCT01885078|527827964|FG003|Treatment Period|Lack of Efficacy|23|||
146362471|NCT01885078|527827965|FG004|Treatment Period|Lack of Efficacy|24|||
146362472|NCT01885078|527827966|FG005|Treatment Period|Lack of Efficacy|58|||
146362473|NCT01885078|527827967|FG006|Treatment Period|Lack of Efficacy|9|||
146362474|NCT01885078|527827968|FG007|Treatment Period|Lack of Efficacy|5|||
146362475|NCT01885078|527827969|FG008|Treatment Period|Lack of Efficacy|0|||
146362476|NCT01885078|527827970|FG009|Treatment Period|Lack of Efficacy|0|||
146362477|NCT01885078|527827961|FG000|Treatment Period|Lost to Follow-up|16|||
146362478|NCT01885078|527827962|FG001|Treatment Period|Lost to Follow-up|19|||
146362479|NCT01885078|527827963|FG002|Treatment Period|Lost to Follow-up|7|||
146362480|NCT01885078|527827964|FG003|Treatment Period|Lost to Follow-up|9|||
146362481|NCT01885078|527827965|FG004|Treatment Period|Lost to Follow-up|2|||
146362482|NCT01885078|527827966|FG005|Treatment Period|Lost to Follow-up|8|||
146362483|NCT01885078|527827967|FG006|Treatment Period|Lost to Follow-up|2|||
146362484|NCT01885078|527827968|FG007|Treatment Period|Lost to Follow-up|0|||
146362485|NCT01885078|527827969|FG008|Treatment Period|Lost to Follow-up|0|||
146362486|NCT01885078|527827970|FG009|Treatment Period|Lost to Follow-up|0|||
146362487|NCT01885078|527827961|FG000|Treatment Period|Physician Decision|19|||
146362488|NCT01885078|527827962|FG001|Treatment Period|Physician Decision|21|||
146362489|NCT01885078|527827963|FG002|Treatment Period|Physician Decision|5|||
146362490|NCT01885078|527827964|FG003|Treatment Period|Physician Decision|12|||
146362491|NCT01885078|527827965|FG004|Treatment Period|Physician Decision|9|||
146362492|NCT01885078|527827966|FG005|Treatment Period|Physician Decision|24|||
146362493|NCT01885078|527827967|FG006|Treatment Period|Physician Decision|4|||
146362494|NCT01885078|527827968|FG007|Treatment Period|Physician Decision|3|||
146362495|NCT01885078|527827969|FG008|Treatment Period|Physician Decision|0|||
146362496|NCT01885078|527827970|FG009|Treatment Period|Physician Decision|0|||
146362497|NCT01885078|527827961|FG000|Treatment Period|Protocol Violation|3|||
146362498|NCT01885078|527827962|FG001|Treatment Period|Protocol Violation|5|||
146362499|NCT01885078|527827963|FG002|Treatment Period|Protocol Violation|0|||
146362500|NCT01885078|527827964|FG003|Treatment Period|Protocol Violation|3|||
146362501|NCT01885078|527827965|FG004|Treatment Period|Protocol Violation|1|||
146362502|NCT01885078|527827966|FG005|Treatment Period|Protocol Violation|6|||
146362503|NCT01885078|527827967|FG006|Treatment Period|Protocol Violation|0|||
146362504|NCT01885078|527827968|FG007|Treatment Period|Protocol Violation|0|||
146362505|NCT01885078|527827969|FG008|Treatment Period|Protocol Violation|0|||
146362506|NCT01885078|527827970|FG009|Treatment Period|Protocol Violation|0|||
146362507|NCT01885078|527827961|FG000|Treatment Period|Sponsor Decision|245|||
146362508|NCT01885078|527827962|FG001|Treatment Period|Sponsor Decision|648|||
146362509|NCT01885078|527827963|FG002|Treatment Period|Sponsor Decision|49|||
146362510|NCT01885078|527827964|FG003|Treatment Period|Sponsor Decision|90|||
146362511|NCT01885078|527827965|FG004|Treatment Period|Sponsor Decision|20|||
146362512|NCT01885078|527827966|FG005|Treatment Period|Sponsor Decision|38|||
146362513|NCT01885078|527827967|FG006|Treatment Period|Sponsor Decision|162|||
146362514|NCT01885078|527827968|FG007|Treatment Period|Sponsor Decision|3|||
146362515|NCT01885078|527827969|FG008|Treatment Period|Sponsor Decision|0|||
146362516|NCT01885078|527827970|FG009|Treatment Period|Sponsor Decision|0|||
146362517|NCT01885078|527827961|FG000|Treatment Period|Withdrawal by Subject|72|||
146362518|NCT01885078|527827962|FG001|Treatment Period|Withdrawal by Subject|132|||
146362519|NCT01885078|527827963|FG002|Treatment Period|Withdrawal by Subject|25|||
146362520|NCT01885078|527827964|FG003|Treatment Period|Withdrawal by Subject|63|||
146362521|NCT01885078|527827965|FG004|Treatment Period|Withdrawal by Subject|15|||
146362522|NCT01885078|527827966|FG005|Treatment Period|Withdrawal by Subject|34|||
146362523|NCT01885078|527827967|FG006|Treatment Period|Withdrawal by Subject|17|||
146362524|NCT01885078|527827968|FG007|Treatment Period|Withdrawal by Subject|10|||
146362525|NCT01885078|527827969|FG008|Treatment Period|Withdrawal by Subject|0|||
146362526|NCT01885078|527827970|FG009|Treatment Period|Withdrawal by Subject|0|||
146362527|NCT01885078|527827961|FG000|Treatment Period|Other|0|||
146362528|NCT01885078|527827962|FG001|Treatment Period|Other|0|||
146362529|NCT01885078|527827963|FG002|Treatment Period|Other|0|||
146362530|NCT01885078|527827964|FG003|Treatment Period|Other|1|||
146362531|NCT01885078|527827965|FG004|Treatment Period|Other|0|||
146362532|NCT01885078|527827966|FG005|Treatment Period|Other|0|||
146362533|NCT01885078|527827967|FG006|Treatment Period|Other|0|||
146362534|NCT01885078|527827968|FG007|Treatment Period|Other|0|||
146362535|NCT01885078|527827969|FG008|Treatment Period|Other|0|||
146362536|NCT01885078|527827970|FG009|Treatment Period|Other|0|||
146362537|NCT01885078|527827961|FG000|Step-down Period|Sponsor Decision|0|||
146362538|NCT01885078|527827962|FG001|Step-down Period|Sponsor Decision|0|||
146362539|NCT01885078|527827963|FG002|Step-down Period|Sponsor Decision|0|||
146362540|NCT01885078|527827964|FG003|Step-down Period|Sponsor Decision|0|||
146362541|NCT01885078|527827965|FG004|Step-down Period|Sponsor Decision|0|||
146362542|NCT01885078|527827966|FG005|Step-down Period|Sponsor Decision|0|||
146362543|NCT01885078|527827967|FG006|Step-down Period|Sponsor Decision|0|||
146362544|NCT01885078|527827968|FG007|Step-down Period|Sponsor Decision|0|||
146362545|NCT01885078|527827969|FG008|Step-down Period|Sponsor Decision|1|||
146362546|NCT01885078|527827970|FG009|Step-down Period|Sponsor Decision|1|||
146362547|NCT01885078|527827961|FG000|Step-down Period|Adverse Event|0|||
146362548|NCT01885078|527827962|FG001|Step-down Period|Adverse Event|0|||
146362549|NCT01885078|527827963|FG002|Step-down Period|Adverse Event|0|||
146362550|NCT01885078|527827964|FG003|Step-down Period|Adverse Event|0|||
146362551|NCT01885078|527827965|FG004|Step-down Period|Adverse Event|0|||
146362552|NCT01885078|527827966|FG005|Step-down Period|Adverse Event|0|||
146362553|NCT01885078|527827967|FG006|Step-down Period|Adverse Event|0|||
146362554|NCT01885078|527827968|FG007|Step-down Period|Adverse Event|0|||
146362555|NCT01885078|527827969|FG008|Step-down Period|Adverse Event|29|||
146362556|NCT01885078|527827970|FG009|Step-down Period|Adverse Event|38|||
146362557|NCT01885078|527827961|FG000|Step-down Period|Withdrawal by Subject|0|||
146362558|NCT01885078|527827962|FG001|Step-down Period|Withdrawal by Subject|0|||
146362559|NCT01885078|527827963|FG002|Step-down Period|Withdrawal by Subject|0|||
146362560|NCT01885078|527827964|FG003|Step-down Period|Withdrawal by Subject|0|||
146362561|NCT01885078|527827965|FG004|Step-down Period|Withdrawal by Subject|0|||
146362562|NCT01885078|527827966|FG005|Step-down Period|Withdrawal by Subject|0|||
146362563|NCT01885078|527827967|FG006|Step-down Period|Withdrawal by Subject|0|||
146362564|NCT01885078|527827968|FG007|Step-down Period|Withdrawal by Subject|0|||
146362565|NCT01885078|527827969|FG008|Step-down Period|Withdrawal by Subject|25|||
146362566|NCT01885078|527827970|FG009|Step-down Period|Withdrawal by Subject|15|||
146362567|NCT01885078|527827961|FG000|Step-down Period|Physician Decision|0|||
146362568|NCT01885078|527827962|FG001|Step-down Period|Physician Decision|0|||
146362569|NCT01885078|527827963|FG002|Step-down Period|Physician Decision|0|||
146362570|NCT01885078|527827964|FG003|Step-down Period|Physician Decision|0|||
146362571|NCT01885078|527827965|FG004|Step-down Period|Physician Decision|0|||
146362572|NCT01885078|527827966|FG005|Step-down Period|Physician Decision|0|||
146362573|NCT01885078|527827967|FG006|Step-down Period|Physician Decision|0|||
146362574|NCT01885078|527827968|FG007|Step-down Period|Physician Decision|0|||
146362575|NCT01885078|527827969|FG008|Step-down Period|Physician Decision|7|||
146362576|NCT01885078|527827970|FG009|Step-down Period|Physician Decision|2|||
146362577|NCT01885078|527827961|FG000|Step-down Period|Death|0|||
146362578|NCT01885078|527827962|FG001|Step-down Period|Death|0|||
146362579|NCT01885078|527827963|FG002|Step-down Period|Death|0|||
146362580|NCT01885078|527827964|FG003|Step-down Period|Death|0|||
146362581|NCT01885078|527827965|FG004|Step-down Period|Death|0|||
146362582|NCT01885078|527827966|FG005|Step-down Period|Death|0|||
146362583|NCT01885078|527827967|FG006|Step-down Period|Death|0|||
146362584|NCT01885078|527827968|FG007|Step-down Period|Death|0|||
146362585|NCT01885078|527827969|FG008|Step-down Period|Death|4|||
146362586|NCT01885078|527827970|FG009|Step-down Period|Death|3|||
146362587|NCT01885078|527827961|FG000|Step-down Period|Lost to Follow-up|0|||
146362588|NCT01885078|527827962|FG001|Step-down Period|Lost to Follow-up|0|||
146362589|NCT01885078|527827963|FG002|Step-down Period|Lost to Follow-up|0|||
146362590|NCT01885078|527827964|FG003|Step-down Period|Lost to Follow-up|0|||
146362591|NCT01885078|527827965|FG004|Step-down Period|Lost to Follow-up|0|||
146362592|NCT01885078|527827966|FG005|Step-down Period|Lost to Follow-up|0|||
146362593|NCT01885078|527827967|FG006|Step-down Period|Lost to Follow-up|0|||
146362594|NCT01885078|527827968|FG007|Step-down Period|Lost to Follow-up|0|||
146362595|NCT01885078|527827969|FG008|Step-down Period|Lost to Follow-up|1|||
146362596|NCT01885078|527827970|FG009|Step-down Period|Lost to Follow-up|1|||
146362597|NCT01885078|527827961|FG000|Step-down Period|Lack of Efficacy|0|||
146362598|NCT01885078|527827962|FG001|Step-down Period|Lack of Efficacy|0|||
146362599|NCT01885078|527827963|FG002|Step-down Period|Lack of Efficacy|0|||
146362600|NCT01885078|527827964|FG003|Step-down Period|Lack of Efficacy|0|||
146362601|NCT01885078|527827965|FG004|Step-down Period|Lack of Efficacy|0|||
146362602|NCT01885078|527827966|FG005|Step-down Period|Lack of Efficacy|0|||
146362603|NCT01885078|527827967|FG006|Step-down Period|Lack of Efficacy|0|||
146362604|NCT01885078|527827968|FG007|Step-down Period|Lack of Efficacy|0|||
146362605|NCT01885078|527827969|FG008|Step-down Period|Lack of Efficacy|1|||
146362606|NCT01885078|527827970|FG009|Step-down Period|Lack of Efficacy|0|||
146362607|NCT01885078|527827961|FG000|Step-down Period|Protocol Violation|0|||
146362608|NCT01885078|527827962|FG001|Step-down Period|Protocol Violation|0|||
146362609|NCT01885078|527827963|FG002|Step-down Period|Protocol Violation|0|||
146362610|NCT01885078|527827964|FG003|Step-down Period|Protocol Violation|0|||
146362611|NCT01885078|527827965|FG004|Step-down Period|Protocol Violation|0|||
146362612|NCT01885078|527827966|FG005|Step-down Period|Protocol Violation|0|||
146362613|NCT01885078|527827967|FG006|Step-down Period|Protocol Violation|0|||
146362614|NCT01885078|527827968|FG007|Step-down Period|Protocol Violation|0|||
146362615|NCT01885078|527827969|FG008|Step-down Period|Protocol Violation|1|||
146362616|NCT01885078|527827970|FG009|Step-down Period|Protocol Violation|1|||
146362617|NCT02899377|527827974|FG000|Overall Study|Adverse Event|1|||
146362618|NCT02899377|527827975|FG001|Overall Study|Adverse Event|0|||
146362619|NCT01231607|527827976|FG000|Overall Study|Adverse Event|0|||
146362620|NCT01231607|527827977|FG001|Overall Study|Adverse Event|8|||
146362621|NCT01231607|527827978|FG002|Overall Study|Adverse Event|4|||
146362622|NCT01231607|527827979|FG003|Overall Study|Adverse Event|4|||
146362623|NCT01231607|527827980|FG004|Overall Study|Adverse Event|5|||
146362624|NCT01231607|527827976|FG000|Overall Study|Lost to Follow-up|13|||
146362625|NCT01231607|527827977|FG001|Overall Study|Lost to Follow-up|11|||
146362626|NCT01231607|527827978|FG002|Overall Study|Lost to Follow-up|10|||
146362627|NCT01231607|527827979|FG003|Overall Study|Lost to Follow-up|10|||
146362628|NCT01231607|527827980|FG004|Overall Study|Lost to Follow-up|4|||
146362629|NCT01231607|527827976|FG000|Overall Study|Physician Decision|4|||
146362630|NCT01231607|527827977|FG001|Overall Study|Physician Decision|4|||
146362631|NCT01231607|527827978|FG002|Overall Study|Physician Decision|3|||
146362632|NCT01231607|527827979|FG003|Overall Study|Physician Decision|5|||
146362633|NCT01231607|527827980|FG004|Overall Study|Physician Decision|4|||
146362634|NCT01231607|527827976|FG000|Overall Study|Protocol Violation|3|||
146362635|NCT01231607|527827977|FG001|Overall Study|Protocol Violation|2|||
146362636|NCT01231607|527827978|FG002|Overall Study|Protocol Violation|0|||
146362637|NCT01231607|527827979|FG003|Overall Study|Protocol Violation|2|||
146362638|NCT01231607|527827980|FG004|Overall Study|Protocol Violation|2|||
146362639|NCT01231607|527827976|FG000|Overall Study|Withdrawal by Subject|9|||
146362640|NCT01231607|527827977|FG001|Overall Study|Withdrawal by Subject|9|||
146362641|NCT01231607|527827978|FG002|Overall Study|Withdrawal by Subject|14|||
146362642|NCT01231607|527827979|FG003|Overall Study|Withdrawal by Subject|17|||
146362643|NCT01231607|527827980|FG004|Overall Study|Withdrawal by Subject|9|||
146362644|NCT01677507|527827981|FG000|Initial Assignment|Adverse Event|0|||
146362645|NCT01677507|527827982|FG001|Initial Assignment|Adverse Event|1|||
146362646|NCT01677507|527827981|FG000|Initial Assignment|Protocol Violation|0|||
146362647|NCT01677507|527827982|FG001|Initial Assignment|Protocol Violation|1|||
146362648|NCT01677507|527827981|FG000|Second Assigment|Withdrawal by Subject|2|||
146362649|NCT01677507|527827982|FG001|Second Assigment|Withdrawal by Subject|2|||
146362650|NCT01677507|527827981|FG000|Second Assigment|Adverse Event|1|||
146362651|NCT01677507|527827982|FG001|Second Assigment|Adverse Event|3|||
146362652|NCT04321252|527827983|FG000|Overall Study|Withdrawal by Subject|0|||
146362653|NCT04321252|527827984|FG001|Overall Study|Withdrawal by Subject|0|||
146362654|NCT04321252|527827985|FG002|Overall Study|Withdrawal by Subject|0|||
146362655|NCT04321252|527827986|FG003|Overall Study|Withdrawal by Subject|0|||
146362656|NCT04321252|527827987|FG004|Overall Study|Withdrawal by Subject|0|||
146362657|NCT04321252|527827988|FG005|Overall Study|Withdrawal by Subject|1|||
146362658|NCT04321252|527827989|FG006|Overall Study|Withdrawal by Subject|0|||
146362659|NCT04321252|527827990|FG007|Overall Study|Withdrawal by Subject|0|||
146362660|NCT04321252|527827991|FG008|Overall Study|Withdrawal by Subject|0|||
146362661|NCT00259740|527827994|FG000|Overall Study|Physician Decision|1|||
146362662|NCT00259740|527827995|FG001|Overall Study|Physician Decision|1|||
146362663|NCT00259740|527827994|FG000|Overall Study|Adverse Event|0|||
146362664|NCT00259740|527827995|FG001|Overall Study|Adverse Event|2|||
146362665|NCT00259740|527827994|FG000|Overall Study|Withdrawal by Subject|2|||
146362666|NCT00259740|527827995|FG001|Overall Study|Withdrawal by Subject|6|||
146362667|NCT00259740|527827994|FG000|Overall Study|Death|1|||
146362668|NCT00259740|527827995|FG001|Overall Study|Death|1|||
146362669|NCT00259740|527827994|FG000|Overall Study|Disease progression|19|||
146362670|NCT00259740|527827995|FG001|Overall Study|Disease progression|36|||
146362671|NCT00259740|527827994|FG000|Overall Study|Ongoing|17|||
146362672|NCT00259740|527827995|FG001|Overall Study|Ongoing|3|||
146362673|NCT00259740|527827994|FG000|Overall Study|Other|3|||
146362674|NCT00259740|527827995|FG001|Overall Study|Other|0|||
146362675|NCT00259740|527827994|FG000|Overall Study|Requirement for alternative therapy|0|||
146362676|NCT00259740|527827995|FG001|Overall Study|Requirement for alternative therapy|4|||
146362677|NCT01844830|527827997|FG000|Overall Study|Withdrawal by Subject|1|||
146362678|NCT01844830|527827998|FG001|Overall Study|Withdrawal by Subject|0|||
146362679|NCT03150095|527828010|FG000|Overall Study|Death|0|||
146362680|NCT03150095|527828011|FG001|Overall Study|Death|1|||
146362681|NCT03150095|527828010|FG000|Overall Study|Lost to Follow-up|1|||
146362682|NCT03150095|527828011|FG001|Overall Study|Lost to Follow-up|1|||
146362683|NCT03150095|527828010|FG000|Overall Study|Withdrawal by Subject|4|||
146362684|NCT03150095|527828011|FG001|Overall Study|Withdrawal by Subject|0|||
146362685|NCT03150095|527828010|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
146362686|NCT03150095|527828011|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
146362687|NCT01153893|527828015|FG000|Overall Study|Adverse Event|1|||
146362688|NCT01153893|527828016|FG001|Overall Study|Adverse Event|0|||
146362689|NCT01551758|527828021|FG000|Overall Study|Adverse Event|29|||
146362690|NCT01551758|527828022|FG001|Overall Study|Adverse Event|43|||
146362691|NCT01551758|527828021|FG000|Overall Study|Lack of Efficacy|0|||
146362692|NCT01551758|527828022|FG001|Overall Study|Lack of Efficacy|1|||
146362693|NCT01551758|527828021|FG000|Overall Study|Protocol Violation|5|||
146362694|NCT01551758|527828022|FG001|Overall Study|Protocol Violation|6|||
146362695|NCT01551758|527828021|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
146362696|NCT01551758|527828022|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
146362697|NCT01551758|527828021|FG000|Overall Study|Lost to Follow-up|29|||
146362698|NCT01551758|527828022|FG001|Overall Study|Lost to Follow-up|25|||
146362699|NCT01551758|527828021|FG000|Overall Study|Physician Decision|9|||
146362700|NCT01551758|527828022|FG001|Overall Study|Physician Decision|3|||
146362701|NCT01551758|527828021|FG000|Overall Study|Withdrawal by Subject|14|||
146362702|NCT01551758|527828022|FG001|Overall Study|Withdrawal by Subject|17|||
146362703|NCT02128763|527828023|FG000|Overall Study|Death|1|||
146362704|NCT02128763|527828024|FG001|Overall Study|Death|0|||
146362705|NCT02128763|527828023|FG000|Overall Study|Lost to Follow-up|19|||
146362706|NCT02128763|527828024|FG001|Overall Study|Lost to Follow-up|16|||
146362707|NCT03666858|527828025|FG000|Cohort 1|Adverse Event|1|||
146362708|NCT03666858|527828026|FG001|Cohort 1|Adverse Event|0|||
146362709|NCT03666858|527828025|FG000|Cohort 2|Adverse Event|0|||
146362710|NCT03666858|527828026|FG001|Cohort 2|Adverse Event|1|||
146362711|NCT00121992|527828027|FG000|Overall Study|Treatment not received|2|||
146362712|NCT00121992|527828028|FG001|Overall Study|Treatment not received|11|||
146362713|NCT01608724|527828029|FG000|Overall Study|Withdrawal by Subject|131|||
146362714|NCT01608724|527828029|FG000|Overall Study|Lost to Follow-up|41|||
146362715|NCT01608724|527828029|FG000|Overall Study|Study-specific discontinuation criteria|32|||
146362716|NCT01608724|527828029|FG000|Overall Study|Adverse Event|29|||
146362717|NCT01608724|527828029|FG000|Overall Study|Protocol Violation|6|||
146362718|NCT01608724|527828029|FG000|Overall Study|bood sugar too high, etc.|3|||
146362719|NCT01608724|527828029|FG000|Overall Study|Safety reasons|1|||
146362720|NCT00363246|527828030|FG000|Overall Study|Death|40|||
146362721|NCT00363246|527828030|FG000|Overall Study|Withdrawal by Subject|19|||
146362722|NCT00363246|527828030|FG000|Overall Study|Lost to Follow-up|14|||
146362723|NCT00363246|527828030|FG000|Overall Study|Bad health|6|||
146362724|NCT00363246|527828030|FG000|Overall Study|Stopped using wheelchair|11|||
146362725|NCT00363246|527828030|FG000|Overall Study|Subject expressed security concerns|2|||
146362726|NCT00363246|527828030|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
146362727|NCT01255306|527830237|FG000|Overall Study|Physician Decision|1|||
146362728|NCT01255306|527830238|FG001|Overall Study|Physician Decision|1|||
146362729|NCT01179347|527830239|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
146362730|NCT01179347|527830240|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
146362731|NCT01179347|527830239|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
146362732|NCT01179347|527830240|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
146362733|NCT01179347|527830239|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
146362734|NCT01179347|527830240|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
146362735|NCT01179347|527830239|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
146362736|NCT01179347|527830240|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
146362737|NCT01179347|527830239|FG000|Double-blind Period (12 Weeks)|Other|2|||
146362738|NCT01179347|527830240|FG001|Double-blind Period (12 Weeks)|Other|4|||
146362739|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
146362740|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
146362741|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
146362742|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
146362743|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
146362744|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
146362745|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
146362746|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
146362747|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
146362748|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
146362749|NCT01179347|527830239|FG000|Open-label Period (12 Weeks)|Other|7|||
146362750|NCT01179347|527830240|FG001|Open-label Period (12 Weeks)|Other|4|||
146362751|NCT01337167|527830241|FG000|Infant Series|Adverse Event|1|||
146362752|NCT01337167|527830242|FG001|Infant Series|Adverse Event|1|||
146362753|NCT01337167|527830241|FG000|Infant Series|Death|1|||
146362754|NCT01337167|527830242|FG001|Infant Series|Death|1|||
146362755|NCT01337167|527830241|FG000|Infant Series|Lost to Follow-up|13|||
146362756|NCT01337167|527830242|FG001|Infant Series|Lost to Follow-up|7|||
146362757|NCT01337167|527830241|FG000|Infant Series|Non-compliance with study drug|2|||
146362758|NCT01337167|527830242|FG001|Infant Series|Non-compliance with study drug|1|||
146362759|NCT01337167|527830241|FG000|Infant Series|Physician Decision|3|||
146362760|NCT01337167|527830242|FG001|Infant Series|Physician Decision|1|||
146362761|NCT01337167|527830241|FG000|Infant Series|Protocol Violation|22|||
146362762|NCT01337167|527830242|FG001|Infant Series|Protocol Violation|9|||
146362763|NCT01337167|527830241|FG000|Infant Series|Withdrawal by Subject|15|||
146362764|NCT01337167|527830242|FG001|Infant Series|Withdrawal by Subject|4|||
146362765|NCT01337167|527830241|FG000|Infant Series|Randomized but not vaccinated|5|||
146362766|NCT01337167|527830242|FG001|Infant Series|Randomized but not vaccinated|3|||
146362767|NCT01337167|527830241|FG000|Interim Period|Lost to Follow-up|51|||
146362768|NCT01337167|527830242|FG001|Interim Period|Lost to Follow-up|23|||
146362769|NCT01337167|527830241|FG000|Interim Period|Non-compliance with study drug|1|||
146362770|NCT01337167|527830242|FG001|Interim Period|Non-compliance with study drug|0|||
146362771|NCT01337167|527830241|FG000|Interim Period|Physician Decision|6|||
146362772|NCT01337167|527830242|FG001|Interim Period|Physician Decision|3|||
146362773|NCT01337167|527830241|FG000|Interim Period|Protocol Violation|5|||
146362774|NCT01337167|527830242|FG001|Interim Period|Protocol Violation|3|||
146362775|NCT01337167|527830241|FG000|Interim Period|Withdrawal by Subject|18|||
146362776|NCT01337167|527830242|FG001|Interim Period|Withdrawal by Subject|10|||
146362777|NCT01337167|527830241|FG000|Interim Period|Other protocol criterion not met|0|||
146362778|NCT01337167|527830242|FG001|Interim Period|Other protocol criterion not met|1|||
146362779|NCT01337167|527830241|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
146362780|NCT01337167|527830242|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
146362781|NCT01337167|527830241|FG000|Toddler Vaccinations|Protocol Violation|0|||
146362782|NCT01337167|527830242|FG001|Toddler Vaccinations|Protocol Violation|1|||
146362783|NCT01337167|527830241|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
146362784|NCT01337167|527830242|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
146362785|NCT03363919|527830245|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
146362786|NCT03363919|527830246|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
146362787|NCT03363919|527830245|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
146362788|NCT03363919|527830246|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
146362789|NCT01646398|527830247|FG000|Overall Study|Withdrawal by Subject|1|||
146362790|NCT01646398|527830248|FG001|Overall Study|Withdrawal by Subject|0|||
146362791|NCT01827319|527830249|FG000|Overall Study|Lost to Follow-up|3|||
146362792|NCT00571519|527830250|FG000|Overall Study|Subject withdrew consent|0|||
146362793|NCT00571519|527830251|FG001|Overall Study|Subject withdrew consent|1|||
146362794|NCT00571519|527830252|FG002|Overall Study|Subject withdrew consent|0|||
146362795|NCT00571519|527830253|FG003|Overall Study|Subject withdrew consent|2|||
146362796|NCT00571519|527830254|FG004|Overall Study|Subject withdrew consent|1|||
146362797|NCT00571519|527830255|FG005|Overall Study|Subject withdrew consent|1|||
146362798|NCT00571519|527830256|FG006|Overall Study|Subject withdrew consent|2|||
146362799|NCT00571519|527830250|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146362800|NCT00571519|527830251|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146362801|NCT00571519|527830252|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146362802|NCT00571519|527830253|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
146362803|NCT00571519|527830254|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146362804|NCT00571519|527830255|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146362805|NCT00571519|527830256|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
146362806|NCT00571519|527830250|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362807|NCT00571519|527830251|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
146362808|NCT00571519|527830252|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362809|NCT00571519|527830253|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362810|NCT00571519|527830254|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362811|NCT00571519|527830255|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362812|NCT00571519|527830256|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
146362813|NCT00571519|527830250|FG000|Overall Study|Termination of study by Sponsor|2|||
146362814|NCT00571519|527830251|FG001|Overall Study|Termination of study by Sponsor|7|||
146362815|NCT00571519|527830252|FG002|Overall Study|Termination of study by Sponsor|10|||
146362816|NCT00571519|527830253|FG003|Overall Study|Termination of study by Sponsor|24|||
146362817|NCT00571519|527830254|FG004|Overall Study|Termination of study by Sponsor|8|||
146362818|NCT00571519|527830255|FG005|Overall Study|Termination of study by Sponsor|9|||
146362819|NCT00571519|527830256|FG006|Overall Study|Termination of study by Sponsor|22|||
146362820|NCT00571519|527830250|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362821|NCT00571519|527830251|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362822|NCT00571519|527830252|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
146362823|NCT00571519|527830253|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362824|NCT00571519|527830254|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362825|NCT00571519|527830255|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362826|NCT00571519|527830256|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
146362827|NCT03947255|527830258|FG000|Overall Study|Study Closure by Sponsor|2|||
146362828|NCT03947255|527830259|FG001|Overall Study|Study Closure by Sponsor|2|||
146362829|NCT03947255|527830258|FG000|Overall Study|Withdrawal by Subject|2|||
146362830|NCT03947255|527830259|FG001|Overall Study|Withdrawal by Subject|2|||
146362831|NCT03947255|527830258|FG000|Overall Study|Lost to Follow-up|2|||
146362832|NCT03947255|527830259|FG001|Overall Study|Lost to Follow-up|0|||
146362833|NCT03947255|527830258|FG000|Overall Study|Death|0|||
146362834|NCT03947255|527830259|FG001|Overall Study|Death|2|||
146362835|NCT00574119|527830260|FG000|Overall Study|Adverse Event|1|||
146362836|NCT00574119|527830260|FG000|Overall Study|Protocol Violation|1|||
146362837|NCT00574119|527830260|FG000|Overall Study|Withdrawal by Subject|1|||
146362838|NCT00574119|527830260|FG000|Overall Study|Physician Decision|1|||
146362839|NCT04656418|527830266|FG000|Overall Study|Withdrawal by Subject|1|||
146362840|NCT04656418|527830267|FG001|Overall Study|Withdrawal by Subject|3|||
146362841|NCT02586077|527830268|FG000|Overall Study|Withdrawal by Subject|1|||
146362842|NCT02586077|527830268|FG000|Overall Study|Physician Decision|4|||
146362843|NCT02586077|527830268|FG000|Overall Study|Lost to Follow-up|3|||
146362844|NCT01245764|527830269|FG000|Study Phase A|Other|3|||
146362845|NCT01245764|527830270|FG001|Study Phase A|Other|2|||
146362846|NCT01245764|527830271|FG002|Study Phase A|Other|3|||
146362847|NCT01245764|527830272|FG003|Study Phase A|Other|1|||
146362848|NCT01245764|527830269|FG000|Study Phase A|Protocol Violation|6|||
146362849|NCT01245764|527830270|FG001|Study Phase A|Protocol Violation|3|||
146362850|NCT01245764|527830271|FG002|Study Phase A|Protocol Violation|2|||
146362851|NCT01245764|527830272|FG003|Study Phase A|Protocol Violation|2|||
146362852|NCT01245764|527830269|FG000|Study Phase A|Lost to Follow-up|0|||
146362853|NCT01245764|527830270|FG001|Study Phase A|Lost to Follow-up|0|||
146362854|NCT01245764|527830271|FG002|Study Phase A|Lost to Follow-up|5|||
146362855|NCT01245764|527830272|FG003|Study Phase A|Lost to Follow-up|0|||
146362856|NCT00003476|527830273|FG000|Overall Study|Not evaluable|1|||
146362857|NCT02475850|527830274|FG000|Overall Study|Death|155|||
146362858|NCT02475850|527830275|FG001|Overall Study|Death|141|||
146362859|NCT02475850|527830274|FG000|Overall Study|Lost to Follow-up|217|||
146362860|NCT02475850|527830275|FG001|Overall Study|Lost to Follow-up|188|||
146362861|NCT02475850|527830274|FG000|Overall Study|Withdrawal by Subject|221|||
146362862|NCT02475850|527830275|FG001|Overall Study|Withdrawal by Subject|155|||
146362863|NCT01610076|527830280|FG000|Overall Study|Technical issue with video|0|||
146362864|NCT01610076|527830281|FG001|Overall Study|Technical issue with video|1|||
146362865|NCT01610076|527830280|FG000|Overall Study|Lost to Follow-up|3|||
146362866|NCT01610076|527830281|FG001|Overall Study|Lost to Follow-up|4|||
146362867|NCT01895452|527830285|FG000|Overall Study|Adverse Event|1|||
146362868|NCT01895452|527830286|FG001|Overall Study|Adverse Event|4|||
146362869|NCT01895452|527830285|FG000|Overall Study|Lost to Follow-up|1|||
146362870|NCT01895452|527830286|FG001|Overall Study|Lost to Follow-up|5|||
146362871|NCT01895452|527830285|FG000|Overall Study|Pregnancy|0|||
146362872|NCT01895452|527830286|FG001|Overall Study|Pregnancy|1|||
146362873|NCT01895452|527830285|FG000|Overall Study|Withdrawal by Subject|2|||
146362874|NCT01895452|527830286|FG001|Overall Study|Withdrawal by Subject|14|||
146362875|NCT01895452|527830285|FG000|Overall Study|Underlying disease|0|||
146362876|NCT01895452|527830286|FG001|Overall Study|Underlying disease|3|||
146362877|NCT01895452|527830285|FG000|Overall Study|Noncompliance with study drug|0|||
146362878|NCT01895452|527830286|FG001|Overall Study|Noncompliance with study drug|1|||
146362879|NCT01653158|527830287|FG000|Overall Study|Death|0|||
146362880|NCT01653158|527830288|FG001|Overall Study|Death|0|||
146362881|NCT01653158|527830289|FG002|Overall Study|Death|0|||
146362882|NCT01653158|527830290|FG003|Overall Study|Death|1|||
146362883|NCT01653158|527830291|FG004|Overall Study|Death|0|||
146362884|NCT01653158|527830292|FG005|Overall Study|Death|0|||
146362885|NCT01653158|527830293|FG006|Overall Study|Death|0|||
146362886|NCT01653158|527830294|FG007|Overall Study|Death|2|||
146362887|NCT01653158|527830287|FG000|Overall Study|Adverse Event|0|||
146362888|NCT01653158|527830288|FG001|Overall Study|Adverse Event|0|||
146362889|NCT01653158|527830289|FG002|Overall Study|Adverse Event|0|||
146362890|NCT01653158|527830290|FG003|Overall Study|Adverse Event|1|||
146362891|NCT01653158|527830291|FG004|Overall Study|Adverse Event|0|||
146362892|NCT01653158|527830292|FG005|Overall Study|Adverse Event|0|||
146362893|NCT01653158|527830293|FG006|Overall Study|Adverse Event|0|||
146362894|NCT01653158|527830294|FG007|Overall Study|Adverse Event|3|||
146362895|NCT01653158|527830287|FG000|Overall Study|Other|0|||
146362896|NCT01653158|527830288|FG001|Overall Study|Other|0|||
146362897|NCT01653158|527830289|FG002|Overall Study|Other|0|||
146362898|NCT01653158|527830290|FG003|Overall Study|Other|0|||
146362899|NCT01653158|527830291|FG004|Overall Study|Other|0|||
146362900|NCT01653158|527830292|FG005|Overall Study|Other|0|||
146362901|NCT01653158|527830293|FG006|Overall Study|Other|0|||
146362902|NCT01653158|527830294|FG007|Overall Study|Other|1|||
146362903|NCT01653158|527830287|FG000|Overall Study|Progressive disease|0|||
146362904|NCT01653158|527830288|FG001|Overall Study|Progressive disease|0|||
146362905|NCT01653158|527830289|FG002|Overall Study|Progressive disease|0|||
146362906|NCT01653158|527830290|FG003|Overall Study|Progressive disease|0|||
146362907|NCT01653158|527830291|FG004|Overall Study|Progressive disease|1|||
146362908|NCT01653158|527830292|FG005|Overall Study|Progressive disease|1|||
146362909|NCT01653158|527830293|FG006|Overall Study|Progressive disease|2|||
146362910|NCT01653158|527830294|FG007|Overall Study|Progressive disease|9|||
146362911|NCT01653158|527830287|FG000|Overall Study|Withdrawal by Subject|1|||
146362912|NCT01653158|527830288|FG001|Overall Study|Withdrawal by Subject|0|||
146362913|NCT01653158|527830289|FG002|Overall Study|Withdrawal by Subject|0|||
146362914|NCT01653158|527830290|FG003|Overall Study|Withdrawal by Subject|0|||
146362915|NCT01653158|527830291|FG004|Overall Study|Withdrawal by Subject|0|||
146362916|NCT01653158|527830292|FG005|Overall Study|Withdrawal by Subject|0|||
146362917|NCT01653158|527830293|FG006|Overall Study|Withdrawal by Subject|0|||
146362918|NCT01653158|527830294|FG007|Overall Study|Withdrawal by Subject|0|||
146362919|NCT00980343|527830295|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
146362920|NCT00980343|527830296|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
146362921|NCT01840228|527830309|FG000|Overall Study|Lost to Follow-up|1|||
146362922|NCT01840228|527830310|FG001|Overall Study|Lost to Follow-up|1|||
146362923|NCT01103778|527830315|FG000|Overall Study|Lost to Follow-up|1|||
146362924|NCT01103778|527830315|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
146362925|NCT01103778|527830315|FG000|Overall Study|Screen failure|1|||
146362926|NCT01658579|527830316|FG000|Treatment Period A|Other|0|||
146362927|NCT01658579|527830317|FG001|Treatment Period A|Other|0|||
146362928|NCT01658579|527830318|FG002|Treatment Period A|Other|1|||
146362929|NCT01658579|527830319|FG003|Treatment Period A|Other|1|||
146362930|NCT01658579|527830316|FG000|Treatment Period A|Adverse Event|1|||
146362931|NCT01658579|527830317|FG001|Treatment Period A|Adverse Event|0|||
146362932|NCT01658579|527830318|FG002|Treatment Period A|Adverse Event|0|||
146362933|NCT01658579|527830319|FG003|Treatment Period A|Adverse Event|0|||
146362934|NCT01658579|527830316|FG000|Treatment Period B|Other|0|||
146362935|NCT01658579|527830317|FG001|Treatment Period B|Other|0|||
146362936|NCT01658579|527830318|FG002|Treatment Period B|Other|0|||
146362937|NCT01658579|527830319|FG003|Treatment Period B|Other|1|||
146362938|NCT04580394|527830320|FG000|First Intervention|Incorrectly Randomized|1|||
146362939|NCT04580394|527830320|FG000|First Intervention|Physician Decision|1|||
146362940|NCT04580394|527830320|FG000|First Intervention|Lost to Follow-up|1|||
146362941|NCT04580394|527830320|FG000|Washout (One Week)|Withdrawal by Subject|1|||
146362942|NCT04580394|527830320|FG000|Washout (One Week)|Adverse Event|1|||
146362943|NCT04580394|527830320|FG000|Washout (One Week)|Withdrawal by Subject|2|||
146362944|NCT04580394|527830320|FG000|Third Intervention|Adverse Event|1|||
146362945|NCT04580394|527830320|FG000|Third Intervention|Withdrawal by Subject|1|||
146362946|NCT04580394|527830320|FG000|Washout (One Week)|Withdrawal by Subject|2|||
146362947|NCT01464788|527830321|FG000|Overall Study|Lost to Follow-up|0|||
146362948|NCT01464788|527830322|FG001|Overall Study|Lost to Follow-up|1|||
146362949|NCT01464788|527830323|FG002|Overall Study|Lost to Follow-up|0|||
146362950|NCT01464788|527830321|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
146362951|NCT01464788|527830322|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
146362952|NCT01464788|527830323|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
146362953|NCT04397718|527830326|FG000|Overall Study|Death|7|||
146362954|NCT04397718|527830327|FG001|Overall Study|Death|11|||
146362955|NCT04397718|527830326|FG000|Overall Study|Lost to Follow-up|0|||
146362956|NCT04397718|527830327|FG001|Overall Study|Lost to Follow-up|4|||
146362957|NCT00973921|527830328|FG000|Overall Study|IVUS results were not available|9|||
146362958|NCT01354431|527830341|FG000|Pre-Treatment Period|Not reported|1|||
146362959|NCT01354431|527830342|FG001|Pre-Treatment Period|Not reported|0|||
146362960|NCT01354431|527830343|FG002|Pre-Treatment Period|Not reported|0|||
146362961|NCT01354431|527830341|FG000|Treatment Period|Disease Progression|50|||
146362962|NCT01354431|527830342|FG001|Treatment Period|Disease Progression|40|||
146362963|NCT01354431|527830343|FG002|Treatment Period|Disease Progression|44|||
146362964|NCT01354431|527830341|FG000|Treatment Period|Study Drug Toxicity|5|||
146362965|NCT01354431|527830342|FG001|Treatment Period|Study Drug Toxicity|8|||
146362966|NCT01354431|527830343|FG002|Treatment Period|Study Drug Toxicity|4|||
146362967|NCT01354431|527830341|FG000|Treatment Period|Death|0|||
146362968|NCT01354431|527830342|FG001|Treatment Period|Death|1|||
146362969|NCT01354431|527830343|FG002|Treatment Period|Death|0|||
146362970|NCT01354431|527830341|FG000|Treatment Period|AE unrelated to study drug|1|||
146362971|NCT01354431|527830342|FG001|Treatment Period|AE unrelated to study drug|2|||
146362972|NCT01354431|527830343|FG002|Treatment Period|AE unrelated to study drug|5|||
146362973|NCT01354431|527830341|FG000|Treatment Period|Participant request to discontinue|2|||
146362974|NCT01354431|527830342|FG001|Treatment Period|Participant request to discontinue|2|||
146362975|NCT01354431|527830343|FG002|Treatment Period|Participant request to discontinue|1|||
146362976|NCT01354431|527830341|FG000|Treatment Period|Participant withdrew consent|0|||
146362977|NCT01354431|527830342|FG001|Treatment Period|Participant withdrew consent|1|||
146362978|NCT01354431|527830343|FG002|Treatment Period|Participant withdrew consent|0|||
146362979|NCT01354431|527830341|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
146362980|NCT01354431|527830342|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
146362981|NCT01354431|527830343|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
146362982|NCT03691610|527830344|FG000|Overall Study|Adverse Event|0|||
146362983|NCT03691610|527830345|FG001|Overall Study|Adverse Event|1|||
146362984|NCT03691610|527830346|FG002|Overall Study|Adverse Event|0|||
146362985|NCT03691610|527830347|FG003|Overall Study|Adverse Event|0|||
146362986|NCT03691610|527830344|FG000|Overall Study|Protocol Deviation|15|||
146362987|NCT03691610|527830345|FG001|Overall Study|Protocol Deviation|8|||
146362988|NCT03691610|527830346|FG002|Overall Study|Protocol Deviation|1|||
146362989|NCT03691610|527830347|FG003|Overall Study|Protocol Deviation|2|||
146362990|NCT03691610|527830344|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
146362991|NCT03691610|527830345|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
146362992|NCT03691610|527830346|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
146362993|NCT03691610|527830347|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
146362994|NCT03691610|527830344|FG000|Overall Study|Lost to Follow-up|20|||
146362995|NCT03691610|527830345|FG001|Overall Study|Lost to Follow-up|11|||
146362996|NCT03691610|527830346|FG002|Overall Study|Lost to Follow-up|5|||
146362997|NCT03691610|527830347|FG003|Overall Study|Lost to Follow-up|2|||
146362998|NCT00916370|527830350|FG000|Overall Study|Death|3|||
146362999|NCT00916370|527830351|FG001|Overall Study|Death|1|||
146363000|NCT00916370|527830350|FG000|Overall Study|Withdrawal by Subject|2|||
146363001|NCT00916370|527830351|FG001|Overall Study|Withdrawal by Subject|0|||
146363002|NCT00916370|527830350|FG000|Overall Study|Physician Decision|0|||
146363003|NCT00916370|527830351|FG001|Overall Study|Physician Decision|1|||
146363004|NCT02921919|527830352|FG000|Overall Study|Other|5|||
146363005|NCT02921919|527830353|FG001|Overall Study|Other|6|||
146363006|NCT02921919|527830352|FG000|Overall Study|Lost to Follow-up|0|||
146363007|NCT02921919|527830353|FG001|Overall Study|Lost to Follow-up|1|||
146363008|NCT02921919|527830352|FG000|Overall Study|Withdrawal by Subject|5|||
146363009|NCT02921919|527830353|FG001|Overall Study|Withdrawal by Subject|1|||
146363010|NCT02921919|527830352|FG000|Overall Study|Disease Progression|47|||
146363011|NCT02921919|527830353|FG001|Overall Study|Disease Progression|38|||
146363012|NCT02921919|527830352|FG000|Overall Study|Physician Decision|3|||
146363013|NCT02921919|527830353|FG001|Overall Study|Physician Decision|2|||
146363014|NCT02921919|527830352|FG000|Overall Study|Adverse Event|6|||
146363015|NCT02921919|527830353|FG001|Overall Study|Adverse Event|4|||
146363016|NCT00980980|527830354|FG000|Overall Study|Withdrawal by Hospital|0|||
146363017|NCT00980980|527830355|FG001|Overall Study|Withdrawal by Hospital|1|||
146363018|NCT00980980|527830356|FG002|Overall Study|Withdrawal by Hospital|0|||
146363019|NCT02756650|527830358|FG000|Overall Study|Physician Decision|1|||
146363020|NCT02756650|527830358|FG000|Overall Study|Adverse Event|1|||
146363021|NCT01553916|527830359|FG000|Overall Study|Withdrawal by Subject|2|||
146363022|NCT01553916|527830359|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
146363023|NCT04348591|527830365|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
146363024|NCT04348591|527830366|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
146363025|NCT04348591|527830365|FG000|Imaging Session (120 Min)|Physician Decision|0|||
146363026|NCT04348591|527830366|FG001|Imaging Session (120 Min)|Physician Decision|1|||
146363027|NCT04348591|527830365|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
146363028|NCT04348591|527830366|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
146363029|NCT03722784|527830369|FG000|Overall Study|Withdrawal by Subject|1|||
146363030|NCT03722784|527830370|FG001|Overall Study|Withdrawal by Subject|0|||
146363031|NCT03722784|527830369|FG000|Overall Study|Physician Decision|1|||
146363032|NCT03722784|527830370|FG001|Overall Study|Physician Decision|1|||
146363033|NCT03722784|527830369|FG000|Overall Study|Protocol Violation|0|||
146363034|NCT03722784|527830370|FG001|Overall Study|Protocol Violation|1|||
146363035|NCT00910429|527830373|FG000|Overall Study|Death|18|||
146363036|NCT00910429|527830374|FG001|Overall Study|Death|12|||
146363037|NCT00910429|527830373|FG000|Overall Study|Withdrawal by Subject|3|||
146363038|NCT00910429|527830374|FG001|Overall Study|Withdrawal by Subject|2|||
146363039|NCT00910429|527830373|FG000|Overall Study|Protocol Violation|1|||
146363040|NCT00910429|527830374|FG001|Overall Study|Protocol Violation|0|||
146363041|NCT00910429|527830373|FG000|Overall Study|Lost to Follow-up|2|||
146363042|NCT00910429|527830374|FG001|Overall Study|Lost to Follow-up|1|||
146363043|NCT00910429|527830373|FG000|Overall Study|Adverse Event|10|||
146363044|NCT00910429|527830374|FG001|Overall Study|Adverse Event|5|||
146363045|NCT00910429|527830373|FG000|Overall Study|Drug non-compliance|1|||
146363046|NCT00910429|527830374|FG001|Overall Study|Drug non-compliance|0|||
146363047|NCT00910429|527830373|FG000|Overall Study|Lack of Efficacy|4|||
146363048|NCT00910429|527830374|FG001|Overall Study|Lack of Efficacy|1|||
146363049|NCT01317615|527830375|FG000|Overall Study|Disease progression|25|||
146363050|NCT01317615|527830375|FG000|Overall Study|New cancer therapy|5|||
146363051|NCT01317615|527830375|FG000|Overall Study|Death|6|||
146363052|NCT01317615|527830375|FG000|Overall Study|Withdrawal by Subject|5|||
146363053|NCT01317615|527830375|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146363054|NCT01317615|527830375|FG000|Overall Study|Adverse Event|7|||
146363055|NCT04465396|527830378|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
146363056|NCT04465396|527830379|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
146363057|NCT04465396|527830380|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
146363058|NCT04465396|527830381|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
146363059|NCT00438399|527830382|FG000|Overall Study|Lost to Follow-up|2|||
146363060|NCT00438399|527830383|FG001|Overall Study|Lost to Follow-up|2|||
146363061|NCT00438399|527830384|FG002|Overall Study|Lost to Follow-up|1|||
146363062|NCT00438399|527830385|FG003|Overall Study|Lost to Follow-up|1|||
146363063|NCT00438399|527830386|FG004|Overall Study|Lost to Follow-up|1|||
146363064|NCT00438399|527830387|FG005|Overall Study|Lost to Follow-up|1|||
146363065|NCT00438399|527830382|FG000|Overall Study|Adverse Event|0|||
146363066|NCT00438399|527830383|FG001|Overall Study|Adverse Event|0|||
146363067|NCT00438399|527830384|FG002|Overall Study|Adverse Event|1|||
146363068|NCT00438399|527830385|FG003|Overall Study|Adverse Event|1|||
146363069|NCT00438399|527830386|FG004|Overall Study|Adverse Event|0|||
146363070|NCT00438399|527830387|FG005|Overall Study|Adverse Event|1|||
146363071|NCT00438399|527830382|FG000|Overall Study|Withdrawal by Subject|5|||
146363072|NCT00438399|527830383|FG001|Overall Study|Withdrawal by Subject|6|||
146363073|NCT00438399|527830384|FG002|Overall Study|Withdrawal by Subject|3|||
146363074|NCT00438399|527830385|FG003|Overall Study|Withdrawal by Subject|2|||
146363075|NCT00438399|527830386|FG004|Overall Study|Withdrawal by Subject|2|||
146363076|NCT00438399|527830387|FG005|Overall Study|Withdrawal by Subject|2|||
146363077|NCT00438399|527830382|FG000|Overall Study|Protocol Violation|0|||
146363078|NCT00438399|527830383|FG001|Overall Study|Protocol Violation|0|||
146363079|NCT00438399|527830384|FG002|Overall Study|Protocol Violation|1|||
146363080|NCT00438399|527830385|FG003|Overall Study|Protocol Violation|0|||
146363081|NCT00438399|527830386|FG004|Overall Study|Protocol Violation|0|||
146363082|NCT00438399|527830387|FG005|Overall Study|Protocol Violation|1|||
146363083|NCT00438399|527830382|FG000|Overall Study|Subje stopped study|0|||
146363084|NCT00438399|527830383|FG001|Overall Study|Subje stopped study|0|||
146363085|NCT00438399|527830384|FG002|Overall Study|Subje stopped study|1|||
146363086|NCT00438399|527830385|FG003|Overall Study|Subje stopped study|0|||
146363087|NCT00438399|527830386|FG004|Overall Study|Subje stopped study|0|||
146363088|NCT00438399|527830387|FG005|Overall Study|Subje stopped study|0|||
146363089|NCT00438399|527830382|FG000|Overall Study|Pregnancy|0|||
146363090|NCT00438399|527830383|FG001|Overall Study|Pregnancy|0|||
146363091|NCT00438399|527830384|FG002|Overall Study|Pregnancy|0|||
146363092|NCT00438399|527830385|FG003|Overall Study|Pregnancy|0|||
146363093|NCT00438399|527830386|FG004|Overall Study|Pregnancy|0|||
146363094|NCT00438399|527830387|FG005|Overall Study|Pregnancy|1|||
146363095|NCT00438399|527830382|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
146363096|NCT00438399|527830383|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
146363097|NCT00438399|527830384|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
146363098|NCT00438399|527830385|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
146363099|NCT00438399|527830386|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
146363100|NCT00438399|527830387|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
146363101|NCT01364233|527830388|FG000|Overall Study|Lost to Follow-up|1|||
146363102|NCT03730194|527830392|FG000|First Stage Treatment|Withdrawal by Subject|1|||
146363103|NCT03730194|527830393|FG001|First Stage Treatment|Withdrawal by Subject|1|||
146363104|NCT03730194|527830394|FG002|First Stage Treatment|Withdrawal by Subject|0|||
146363105|NCT03730194|527830395|FG003|First Stage Treatment|Withdrawal by Subject|0|||
146363106|NCT03730194|527830396|FG004|First Stage Treatment|Withdrawal by Subject|0|||
146363107|NCT03730194|527830397|FG005|First Stage Treatment|Withdrawal by Subject|0|||
146363108|NCT03730194|527830392|FG000|First Stage Treatment|Protocol Violation|3|||
146363109|NCT03730194|527830393|FG001|First Stage Treatment|Protocol Violation|3|||
146363110|NCT03730194|527830394|FG002|First Stage Treatment|Protocol Violation|0|||
146363111|NCT03730194|527830395|FG003|First Stage Treatment|Protocol Violation|0|||
146363112|NCT03730194|527830396|FG004|First Stage Treatment|Protocol Violation|0|||
146363113|NCT03730194|527830397|FG005|First Stage Treatment|Protocol Violation|0|||
146363114|NCT01766817|527830400|FG000|Overall Study|Drug-related adverse event|1|||
146363115|NCT01766817|527830401|FG001|Overall Study|Drug-related adverse event|2|||
146363116|NCT01766817|527830402|FG002|Overall Study|Drug-related adverse event|1|||
146363117|NCT01766817|527830400|FG000|Overall Study|Drug-unrelated adverse event|3|||
146363118|NCT01766817|527830401|FG001|Overall Study|Drug-unrelated adverse event|3|||
146363119|NCT01766817|527830402|FG002|Overall Study|Drug-unrelated adverse event|3|||
146363120|NCT01766817|527830400|FG000|Overall Study|Death|1|||
146363121|NCT01766817|527830401|FG001|Overall Study|Death|1|||
146363122|NCT01766817|527830402|FG002|Overall Study|Death|0|||
146363123|NCT01766817|527830400|FG000|Overall Study|Unable to take study drug|0|||
146363124|NCT01766817|527830401|FG001|Overall Study|Unable to take study drug|1|||
146363125|NCT01766817|527830402|FG002|Overall Study|Unable to take study drug|0|||
146363126|NCT01766817|527830400|FG000|Overall Study|Withdrawal by Subject|2|||
146363127|NCT01766817|527830401|FG001|Overall Study|Withdrawal by Subject|0|||
146363128|NCT01766817|527830402|FG002|Overall Study|Withdrawal by Subject|3|||
146363129|NCT01766817|527830400|FG000|Overall Study|Subject non-compliance|0|||
146363130|NCT01766817|527830401|FG001|Overall Study|Subject non-compliance|1|||
146363131|NCT01766817|527830402|FG002|Overall Study|Subject non-compliance|2|||
146363132|NCT01766817|527830400|FG000|Overall Study|Physician Decision|3|||
146363133|NCT01766817|527830401|FG001|Overall Study|Physician Decision|3|||
146363134|NCT01766817|527830402|FG002|Overall Study|Physician Decision|4|||
146363135|NCT01766817|527830400|FG000|Overall Study|Other|1|||
146363136|NCT01766817|527830401|FG001|Overall Study|Other|0|||
146363137|NCT01766817|527830402|FG002|Overall Study|Other|0|||
146363138|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
146363139|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
146363140|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
146363141|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
146363142|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
146363143|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
146363144|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146363145|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
146363146|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
146363147|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
146363148|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146363149|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
146363150|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
146363151|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
146363152|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
146363153|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
146363154|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
146363155|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
146363156|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
146363157|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
146363158|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
146363159|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
146363160|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
146363161|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
146363162|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
146363163|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
146363164|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
146363165|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
146363166|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
146363167|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
146363168|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
146363169|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
146363170|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
146363171|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
146363172|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
146363173|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
146363174|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
146363175|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
146363176|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
146363177|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
146363178|NCT00383721|527830407|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
146363179|NCT00383721|527830408|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
146363180|NCT00383721|527830409|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
146363181|NCT00383721|527830410|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
146363182|NCT00383721|527830411|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
146363183|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
146363184|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
146363185|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
146363186|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
146363187|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
146363188|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146363189|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
146363190|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
146363191|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
146363192|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
146363193|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
146363194|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146363195|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146363196|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
146363197|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
146363198|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
146363199|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
146363200|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
146363201|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
146363202|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
146363203|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146363204|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146363205|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146363206|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
146363207|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
146363208|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
146363209|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146363210|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
146363211|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
146363212|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
146363213|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146363214|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146363215|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146363216|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
146363217|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
146363218|NCT00383721|527830407|FG000|26-Week Treatment Safety Extension|Administrative|1|||
146363219|NCT00383721|527830408|FG001|26-Week Treatment Safety Extension|Administrative|2|||
146363220|NCT00383721|527830409|FG002|26-Week Treatment Safety Extension|Administrative|3|||
146363221|NCT00383721|527830410|FG003|26-Week Treatment Safety Extension|Administrative|1|||
146363222|NCT00383721|527830411|FG004|26-Week Treatment Safety Extension|Administrative|0|||
146363223|NCT03833817|527832340|FG000|Overall Study|Withdrawal by Subject|3|||
146363224|NCT03833817|527832341|FG001|Overall Study|Withdrawal by Subject|3|||
146363225|NCT03833817|527832340|FG000|Overall Study|Lost to Follow-up|3|||
146363226|NCT03833817|527832341|FG001|Overall Study|Lost to Follow-up|3|||
146363227|NCT00884221|527832346|FG000|Overall Study|Withdrawal by Subject|0|||
146363228|NCT00884221|527832347|FG001|Overall Study|Withdrawal by Subject|3|||
146363229|NCT00884221|527832346|FG000|Overall Study|Adverse Event|6|||
146363230|NCT00884221|527832347|FG001|Overall Study|Adverse Event|3|||
146363231|NCT00884221|527832346|FG000|Overall Study|Protocol Violation|16|||
146363232|NCT00884221|527832347|FG001|Overall Study|Protocol Violation|13|||
146363233|NCT00884221|527832346|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
146363234|NCT00884221|527832347|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
146363235|NCT02126670|527832352|FG000|Overall Study|Withdrawal by Subject|1|||
146363236|NCT02126670|527832353|FG001|Overall Study|Withdrawal by Subject|0|||
146363237|NCT02126670|527832354|FG002|Overall Study|Withdrawal by Subject|0|||
146363238|NCT02126670|527832355|FG003|Overall Study|Withdrawal by Subject|1|||
146363239|NCT00600028|527832356|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
146363240|NCT00600028|527832357|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
146363241|NCT00600028|527832356|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
146363242|NCT00600028|527832357|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
146363243|NCT00600028|527832356|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
146363244|NCT00600028|527832357|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
146363245|NCT03172481|527832358|FG000|Double-blind|Withdrawal by Subject|1|||
146363246|NCT03172481|527832359|FG001|Double-blind|Withdrawal by Subject|0|||
146363247|NCT01107405|527832364|FG000|Overall Study|Adverse Event|1|||
146363248|NCT01107405|527832365|FG001|Overall Study|Adverse Event|1|||
146363249|NCT01107405|527832366|FG002|Overall Study|Adverse Event|0|||
146363250|NCT01107405|527832367|FG003|Overall Study|Adverse Event|0|||
146363251|NCT01107405|527832368|FG004|Overall Study|Adverse Event|2|||
146363252|NCT01107405|527832364|FG000|Overall Study|Withdrawal by Subject|1|||
146363253|NCT01107405|527832365|FG001|Overall Study|Withdrawal by Subject|0|||
146363254|NCT01107405|527832366|FG002|Overall Study|Withdrawal by Subject|1|||
146363255|NCT01107405|527832367|FG003|Overall Study|Withdrawal by Subject|2|||
146363256|NCT01107405|527832368|FG004|Overall Study|Withdrawal by Subject|1|||
146363257|NCT01107405|527832364|FG000|Overall Study|Protocol Violation|0|||
146363258|NCT01107405|527832365|FG001|Overall Study|Protocol Violation|0|||
146363259|NCT01107405|527832366|FG002|Overall Study|Protocol Violation|1|||
146363260|NCT01107405|527832367|FG003|Overall Study|Protocol Violation|1|||
146363261|NCT01107405|527832368|FG004|Overall Study|Protocol Violation|0|||
146363262|NCT03495453|527832369|FG000|Overall Study|Withdrawal by Subject|0|||
146363263|NCT03495453|527832370|FG001|Overall Study|Withdrawal by Subject|1|||
146363264|NCT00085917|527832371|FG000|Overall Study|Adverse Event|4|||
146363265|NCT00085917|527832372|FG001|Overall Study|Adverse Event|3|||
146363266|NCT01360762|527832375|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
146363267|NCT01360762|527832375|FG000|Main Study Period (12-month Treatment)|Death|5|||
146363268|NCT01360762|527832375|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
146363269|NCT01360762|527832375|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
146363270|NCT01360762|527832375|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
146363271|NCT01360762|527832375|FG000|Whole Study Period|Lost to Follow-up|10|||
146363272|NCT01360762|527832375|FG000|Whole Study Period|Death|7|||
146363273|NCT01360762|527832375|FG000|Whole Study Period|Patient relapsed|18|||
146363274|NCT01360762|527832375|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
146363275|NCT00865189|527832376|FG000|Overall Study|Other|1|||
146363276|NCT00865189|527832377|FG001|Overall Study|Other|2|||
146363277|NCT00865189|527832376|FG000|Overall Study|Death|4|||
146363278|NCT00865189|527832377|FG001|Overall Study|Death|11|||
146363279|NCT00865189|527832376|FG000|Overall Study|Lost to Follow-up|6|||
146363280|NCT00865189|527832377|FG001|Overall Study|Lost to Follow-up|6|||
146363281|NCT00865189|527832376|FG000|Overall Study|Withdrawal by Subject|1|||
146363282|NCT00865189|527832377|FG001|Overall Study|Withdrawal by Subject|0|||
146363283|NCT05590767|527832382|FG000|Overall Study|Protocol Violation|1|||
146363284|NCT05590767|527832382|FG000|Overall Study|surgery canceled|1|||
146363285|NCT05590767|527832382|FG000|Overall Study|interscalene brachial block not performed|1|||
146363286|NCT00084929|527832384|FG000|Overall Study|ineligible - medical contraindication|1|||
146363287|NCT00084929|527832384|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
146363288|NCT00084929|527832384|FG000|Overall Study|Ineligible - Medical history|6|||
146363289|NCT00084929|527832384|FG000|Overall Study|Withdrawal by Subject|10|||
146363290|NCT00084929|527832384|FG000|Overall Study|Missing/incomplete CTC exam|9|||
146363291|NCT00084929|527832384|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
146363292|NCT00844649|527832385|FG000|Overall Study|Progressive Disease|196|||
146363293|NCT00844649|527832386|FG001|Overall Study|Progressive Disease|245|||
146363294|NCT00844649|527832385|FG000|Overall Study|Adverse Event|128|||
146363295|NCT00844649|527832386|FG001|Overall Study|Adverse Event|73|||
146363296|NCT00844649|527832385|FG000|Overall Study|Physician Decision|25|||
146363297|NCT00844649|527832386|FG001|Overall Study|Physician Decision|18|||
146363298|NCT00844649|527832385|FG000|Overall Study|Protocol Violation|10|||
146363299|NCT00844649|527832386|FG001|Overall Study|Protocol Violation|6|||
146363300|NCT00844649|527832385|FG000|Overall Study|Withdrawal by Subject|28|||
146363301|NCT00844649|527832386|FG001|Overall Study|Withdrawal by Subject|39|||
146363302|NCT00844649|527832385|FG000|Overall Study|Other|7|||
146363303|NCT00844649|527832386|FG001|Overall Study|Other|10|||
146363304|NCT00844649|527832385|FG000|Overall Study|Withdrew prior to starting treatment|11|||
146363305|NCT00844649|527832386|FG001|Overall Study|Withdrew prior to starting treatment|27|||
146363306|NCT00091026|527832389|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
146363307|NCT00091026|527832390|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
146363308|NCT00091026|527832389|FG000|Overall Study|Patient withdrew and never received trea|0|||
146363309|NCT00091026|527832390|FG001|Overall Study|Patient withdrew and never received trea|2|||
146363310|NCT00091026|527832389|FG000|Overall Study|Unknown-never received treatment|0|||
146363311|NCT00091026|527832390|FG001|Overall Study|Unknown-never received treatment|1|||
146363312|NCT00065442|527832393|FG000|Overall Study|Lost to Follow-up|1|||
146363313|NCT00065442|527832394|FG001|Overall Study|Lost to Follow-up|1|||
146363314|NCT00065442|527832393|FG000|Overall Study|Death|121|||
146363315|NCT00065442|527832394|FG001|Overall Study|Death|210|||
146363316|NCT00065442|527832393|FG000|Overall Study|Withdrawal by Subject|3|||
146363317|NCT00065442|527832394|FG001|Overall Study|Withdrawal by Subject|9|||
146363318|NCT01797965|527832395|FG000|Overall Study|Adverse Event|104|||
146363319|NCT01797965|527832396|FG001|Overall Study|Adverse Event|129|||
146363320|NCT01797965|527832397|FG002|Overall Study|Adverse Event|4|||
146363321|NCT01797965|527832398|FG003|Overall Study|Adverse Event|21|||
146363322|NCT01797965|527832395|FG000|Overall Study|Lost to Follow-up|9|||
146363323|NCT01797965|527832396|FG001|Overall Study|Lost to Follow-up|8|||
146363324|NCT01797965|527832397|FG002|Overall Study|Lost to Follow-up|1|||
146363325|NCT01797965|527832398|FG003|Overall Study|Lost to Follow-up|2|||
146363326|NCT01797965|527832395|FG000|Overall Study|Consent withdrawn|130|||
146363327|NCT01797965|527832396|FG001|Overall Study|Consent withdrawn|117|||
146363328|NCT01797965|527832397|FG002|Overall Study|Consent withdrawn|3|||
146363329|NCT01797965|527832398|FG003|Overall Study|Consent withdrawn|35|||
146363330|NCT01797965|527832395|FG000|Overall Study|Investigator decision|21|||
146363331|NCT01797965|527832396|FG001|Overall Study|Investigator decision|15|||
146363332|NCT01797965|527832397|FG002|Overall Study|Investigator decision|0|||
146363333|NCT01797965|527832398|FG003|Overall Study|Investigator decision|0|||
146363334|NCT01797965|527832395|FG000|Overall Study|Death|2|||
146363335|NCT01797965|527832396|FG001|Overall Study|Death|4|||
146363336|NCT01797965|527832397|FG002|Overall Study|Death|0|||
146363337|NCT01797965|527832398|FG003|Overall Study|Death|0|||
146363338|NCT01797965|527832395|FG000|Overall Study|Disease progression, defined by protocol|3|||
146363339|NCT01797965|527832396|FG001|Overall Study|Disease progression, defined by protocol|1|||
146363340|NCT01797965|527832397|FG002|Overall Study|Disease progression, defined by protocol|0|||
146363341|NCT01797965|527832398|FG003|Overall Study|Disease progression, defined by protocol|0|||
146363342|NCT01797965|527832395|FG000|Overall Study|Reason Not Specified|280|||
146363343|NCT01797965|527832396|FG001|Overall Study|Reason Not Specified|295|||
146363344|NCT01797965|527832397|FG002|Overall Study|Reason Not Specified|0|||
146363345|NCT01797965|527832398|FG003|Overall Study|Reason Not Specified|15|||
146363346|NCT00304915|527832399|FG000|Overall Study|Lost to Follow-up|11|||
146363347|NCT00304915|527832400|FG001|Overall Study|Lost to Follow-up|11|||
146363348|NCT00304915|527832399|FG000|Overall Study|Death|4|||
146363349|NCT00304915|527832400|FG001|Overall Study|Death|5|||
146363350|NCT00304915|527832399|FG000|Overall Study|Withdrawal by Subject|3|||
146363351|NCT00304915|527832400|FG001|Overall Study|Withdrawal by Subject|0|||
146363352|NCT00712322|527832401|FG000|Overall Study|Protocol deviation|0|||
146363353|NCT00712322|527832402|FG001|Overall Study|Protocol deviation|1|||
146363354|NCT00712322|527832403|FG002|Overall Study|Protocol deviation|0|||
146363355|NCT02670330|527832406|FG000|Overall Study|Protocol Deviation|1|||
146363356|NCT02670330|527832407|FG001|Overall Study|Protocol Deviation|0|||
146363357|NCT02670330|527832406|FG000|Overall Study|Study Terminated By Sponsor|36|||
146363358|NCT02670330|527832407|FG001|Overall Study|Study Terminated By Sponsor|43|||
146363359|NCT02670330|527832406|FG000|Overall Study|Adverse Event|1|||
146363360|NCT02670330|527832407|FG001|Overall Study|Adverse Event|3|||
146363361|NCT02670330|527832406|FG000|Overall Study|Withdrawal by Subject|34|||
146363362|NCT02670330|527832407|FG001|Overall Study|Withdrawal by Subject|29|||
146363363|NCT02670330|527832406|FG000|Overall Study|Lost to Follow-up|3|||
146363364|NCT02670330|527832407|FG001|Overall Study|Lost to Follow-up|2|||
146363365|NCT04404010|527832408|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
146363366|NCT04404010|527832409|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
146363367|NCT02120157|527832410|FG000|Overall Study|Death|8|||
146363368|NCT04685499|527832414|FG000|Overall Study|Study Terminated Early|1|||
146363369|NCT00634114|527832415|FG000|Overall Study|Adverse Event|6|||
146363370|NCT00634114|527832416|FG001|Overall Study|Adverse Event|8|||
146363371|NCT00634114|527832417|FG002|Overall Study|Adverse Event|3|||
146363372|NCT00634114|527832415|FG000|Overall Study|Withdrawal by Subject|9|||
146363373|NCT00634114|527832416|FG001|Overall Study|Withdrawal by Subject|6|||
146363374|NCT00634114|527832417|FG002|Overall Study|Withdrawal by Subject|11|||
146363375|NCT00634114|527832415|FG000|Overall Study|Lost to Follow-up|0|||
146363376|NCT00634114|527832416|FG001|Overall Study|Lost to Follow-up|0|||
146363377|NCT00634114|527832417|FG002|Overall Study|Lost to Follow-up|1|||
146363378|NCT00634114|527832415|FG000|Overall Study|Protocol Violation|3|||
146363379|NCT00634114|527832416|FG001|Overall Study|Protocol Violation|3|||
146363380|NCT00634114|527832417|FG002|Overall Study|Protocol Violation|1|||
146363381|NCT00634114|527832415|FG000|Overall Study|Pregnancy|1|||
146363382|NCT00634114|527832416|FG001|Overall Study|Pregnancy|0|||
146363383|NCT00634114|527832417|FG002|Overall Study|Pregnancy|0|||
146363384|NCT00634114|527832415|FG000|Overall Study|Incorrect enrolment|0|||
146363385|NCT00634114|527832416|FG001|Overall Study|Incorrect enrolment|1|||
146363386|NCT00634114|527832417|FG002|Overall Study|Incorrect enrolment|0|||
146363387|NCT00634114|527832415|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
146363388|NCT00634114|527832416|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
146363389|NCT00634114|527832417|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
146363390|NCT00634114|527832415|FG000|Overall Study|Difficult to continue|3|||
146363391|NCT00634114|527832416|FG001|Overall Study|Difficult to continue|1|||
146363392|NCT00634114|527832417|FG002|Overall Study|Difficult to continue|1|||
146363393|NCT00634114|527832415|FG000|Overall Study|Other reason|1|||
146363394|NCT00634114|527832416|FG001|Overall Study|Other reason|1|||
146363395|NCT00634114|527832417|FG002|Overall Study|Other reason|1|||
146363396|NCT02802878|527832418|FG000|Overall Study|Withdrawal by Subject|3|||
146363397|NCT02802878|527832419|FG001|Overall Study|Withdrawal by Subject|3|||
146363398|NCT02802878|527832418|FG000|Overall Study|Protocol Violation|1|||
146363399|NCT02802878|527832419|FG001|Overall Study|Protocol Violation|0|||
146363400|NCT01599754|527832420|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
146363401|NCT01599754|527832421|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
146363402|NCT01599754|527832420|FG000|Overall Study|Participant noncompliance|4|||
146363403|NCT01599754|527832421|FG001|Overall Study|Participant noncompliance|4|||
146363404|NCT01599754|527832420|FG000|Overall Study|Lost to Follow-up|13|||
146363405|NCT01599754|527832421|FG001|Overall Study|Lost to Follow-up|6|||
146363406|NCT01599754|527832420|FG000|Overall Study|Death|31|||
146363407|NCT01599754|527832421|FG001|Overall Study|Death|33|||
146363408|NCT01599754|527832420|FG000|Overall Study|Adverse Event|3|||
146363409|NCT01599754|527832421|FG001|Overall Study|Adverse Event|2|||
146363410|NCT01599754|527832420|FG000|Overall Study|Investigator decision|1|||
146363411|NCT01599754|527832421|FG001|Overall Study|Investigator decision|3|||
146363412|NCT01599754|527832420|FG000|Overall Study|Withdrawal by Subject|24|||
146363413|NCT01599754|527832421|FG001|Overall Study|Withdrawal by Subject|25|||
146363414|NCT01599754|527832420|FG000|Overall Study|Study terminated by sponsor|282|||
146363415|NCT01599754|527832421|FG001|Overall Study|Study terminated by sponsor|285|||
146363416|NCT00702052|527832422|FG000|Overall Study|Adverse Event|23|||
146363417|NCT00702052|527832422|FG000|Overall Study|Disease Progression|30|||
146363418|NCT00702052|527832422|FG000|Overall Study|Withdrawal by Subject|5|||
146363419|NCT01577160|527832423|FG000|Overall Study|Adverse Event|9|||
146363420|NCT01577160|527832423|FG000|Overall Study|Lack of Efficacy|15|||
146363421|NCT01577160|527832423|FG000|Overall Study|Lost to Follow-up|40|||
146363422|NCT01577160|527832423|FG000|Overall Study|Withdrawal by Subject|18|||
146363423|NCT01577160|527832423|FG000|Overall Study|Subject Uncooperative|7|||
146363424|NCT01577160|527832423|FG000|Overall Study|Other|9|||
146363425|NCT00101192|527832424|FG000|Overall Study|Ineligible|6|||
146363426|NCT00101192|527832424|FG000|Overall Study|Inevaluable|1|||
146363427|NCT03670641|527832425|FG000|Overall Study|Lost to Follow-up|3|||
146363428|NCT00242580|527832427|FG000|Overall Study|Adverse Event|3|||
146363429|NCT00242580|527832428|FG001|Overall Study|Adverse Event|0|||
146363430|NCT00242580|527832429|FG002|Overall Study|Adverse Event|2|||
146363431|NCT00242580|527832427|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146363432|NCT00242580|527832428|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
146363433|NCT00242580|527832429|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
146363434|NCT00242580|527832427|FG000|Overall Study|Protocol Violation|0|||
146363435|NCT00242580|527832428|FG001|Overall Study|Protocol Violation|0|||
146363436|NCT00242580|527832429|FG002|Overall Study|Protocol Violation|1|||
146363437|NCT00242580|527832427|FG000|Overall Study|Subject withdrew consent|2|||
146363438|NCT00242580|527832428|FG001|Overall Study|Subject withdrew consent|2|||
146363439|NCT00242580|527832429|FG002|Overall Study|Subject withdrew consent|5|||
146363440|NCT00242580|527832427|FG000|Overall Study|Lost to Follow-up|0|||
146363441|NCT00242580|527832428|FG001|Overall Study|Lost to Follow-up|3|||
146363442|NCT00242580|527832429|FG002|Overall Study|Lost to Follow-up|0|||
146363443|NCT00242580|527832427|FG000|Overall Study|Death|1|||
146363444|NCT00242580|527832428|FG001|Overall Study|Death|2|||
146363445|NCT00242580|527832429|FG002|Overall Study|Death|1|||
146363446|NCT01232894|527832430|FG000|Overall Study|Lost to Follow-up|0|||
146363447|NCT01232894|527832431|FG001|Overall Study|Lost to Follow-up|1|||
146363448|NCT01232894|527832430|FG000|Overall Study|Death|1|||
146363449|NCT01232894|527832431|FG001|Overall Study|Death|0|||
146363450|NCT01232894|527832430|FG000|Overall Study|Protocol Violation|1|||
146363451|NCT01232894|527832431|FG001|Overall Study|Protocol Violation|1|||
146363452|NCT01232894|527832430|FG000|Overall Study|Withdrawal by Subject|8|||
146363453|NCT01232894|527832431|FG001|Overall Study|Withdrawal by Subject|5|||
146363454|NCT01232894|527832430|FG000|Overall Study|Physician Decision|2|||
146363455|NCT01232894|527832431|FG001|Overall Study|Physician Decision|1|||
146363456|NCT03970395|527832436|FG000|Overall Study|Withdrawal by Subject|3|||
146363457|NCT03970395|527832437|FG001|Overall Study|Withdrawal by Subject|4|||
146363458|NCT03970395|527832436|FG000|Overall Study|Lost to Follow-up|4|||
146363459|NCT03970395|527832437|FG001|Overall Study|Lost to Follow-up|8|||
146363460|NCT00929734|527832438|FG000|Overall Study|Lost to Follow-up|2|||
146363461|NCT00929734|527832439|FG001|Overall Study|Lost to Follow-up|1|||
146363462|NCT00929734|527832438|FG000|Overall Study|Withdrawal by Subject|0|||
146363463|NCT00929734|527832439|FG001|Overall Study|Withdrawal by Subject|2|||
146363464|NCT00645567|527832440|FG000|Overall Study|Adverse Event|1|||
146363465|NCT02648724|527832441|FG000|Overall Study|Withdrawal by Subject|0|||
146363466|NCT02648724|527832442|FG001|Overall Study|Withdrawal by Subject|1|||
146363467|NCT02648724|527832443|FG002|Overall Study|Withdrawal by Subject|1|||
146363468|NCT02648724|527832444|FG003|Overall Study|Withdrawal by Subject|0|||
146363469|NCT02648724|527832445|FG004|Overall Study|Withdrawal by Subject|1|||
146363470|NCT02648724|527832446|FG005|Overall Study|Withdrawal by Subject|0|||
146363471|NCT02648724|527832447|FG006|Overall Study|Withdrawal by Subject|0|||
146363472|NCT02648724|527832441|FG000|Overall Study|Progressive disease|2|||
146363473|NCT02648724|527832442|FG001|Overall Study|Progressive disease|2|||
146363474|NCT02648724|527832443|FG002|Overall Study|Progressive disease|2|||
146363475|NCT02648724|527832444|FG003|Overall Study|Progressive disease|3|||
146363476|NCT02648724|527832445|FG004|Overall Study|Progressive disease|22|||
146363477|NCT02648724|527832446|FG005|Overall Study|Progressive disease|7|||
146363478|NCT02648724|527832447|FG006|Overall Study|Progressive disease|8|||
146363479|NCT02648724|527832441|FG000|Overall Study|Other reason (unknown)|1|||
146363480|NCT02648724|527832442|FG001|Overall Study|Other reason (unknown)|0|||
146363481|NCT02648724|527832443|FG002|Overall Study|Other reason (unknown)|0|||
146363482|NCT02648724|527832444|FG003|Overall Study|Other reason (unknown)|0|||
146363483|NCT02648724|527832445|FG004|Overall Study|Other reason (unknown)|0|||
146363484|NCT02648724|527832446|FG005|Overall Study|Other reason (unknown)|0|||
146363485|NCT02648724|527832447|FG006|Overall Study|Other reason (unknown)|0|||
146363486|NCT02648724|527832441|FG000|Overall Study|Protocol Violation|0|||
146363487|NCT02648724|527832442|FG001|Overall Study|Protocol Violation|0|||
146363488|NCT02648724|527832443|FG002|Overall Study|Protocol Violation|0|||
146363489|NCT02648724|527832444|FG003|Overall Study|Protocol Violation|0|||
146363490|NCT02648724|527832445|FG004|Overall Study|Protocol Violation|1|||
146363491|NCT02648724|527832446|FG005|Overall Study|Protocol Violation|0|||
146363492|NCT02648724|527832447|FG006|Overall Study|Protocol Violation|0|||
146363493|NCT02648724|527832441|FG000|Overall Study|Death|0|||
146363494|NCT02648724|527832442|FG001|Overall Study|Death|0|||
146363495|NCT02648724|527832443|FG002|Overall Study|Death|0|||
146363496|NCT02648724|527832444|FG003|Overall Study|Death|0|||
146363497|NCT02648724|527832445|FG004|Overall Study|Death|0|||
146363498|NCT02648724|527832446|FG005|Overall Study|Death|0|||
146363499|NCT02648724|527832447|FG006|Overall Study|Death|3|||
146363500|NCT02648724|527832441|FG000|Overall Study|Physician Decision|0|||
146363501|NCT02648724|527832442|FG001|Overall Study|Physician Decision|0|||
146363502|NCT02648724|527832443|FG002|Overall Study|Physician Decision|0|||
146363503|NCT02648724|527832444|FG003|Overall Study|Physician Decision|0|||
146363504|NCT02648724|527832445|FG004|Overall Study|Physician Decision|1|||
146363505|NCT02648724|527832446|FG005|Overall Study|Physician Decision|0|||
146363506|NCT02648724|527832447|FG006|Overall Study|Physician Decision|1|||
146363507|NCT02648724|527832441|FG000|Overall Study|Transferred to named patient program|0|||
146363508|NCT02648724|527832442|FG001|Overall Study|Transferred to named patient program|0|||
146363509|NCT02648724|527832443|FG002|Overall Study|Transferred to named patient program|0|||
146363510|NCT02648724|527832444|FG003|Overall Study|Transferred to named patient program|0|||
146363511|NCT02648724|527832445|FG004|Overall Study|Transferred to named patient program|0|||
146363512|NCT02648724|527832446|FG005|Overall Study|Transferred to named patient program|1|||
146363513|NCT02648724|527832447|FG006|Overall Study|Transferred to named patient program|0|||
146363514|NCT00302718|527832448|FG000|Overall Study|Participant left the hospital|1|||
146363515|NCT00302718|527832449|FG001|Overall Study|Participant left the hospital|0|||
146363516|NCT00302718|527832450|FG002|Overall Study|Participant left the hospital|0|||
146363517|NCT00302718|527832451|FG003|Overall Study|Participant left the hospital|1|||
146363518|NCT00302718|527832448|FG000|Overall Study|Withdrawal by Subject|0|||
146363519|NCT00302718|527832449|FG001|Overall Study|Withdrawal by Subject|1|||
146363520|NCT00302718|527832450|FG002|Overall Study|Withdrawal by Subject|0|||
146363521|NCT00302718|527832451|FG003|Overall Study|Withdrawal by Subject|0|||
146363522|NCT00302718|527832448|FG000|Overall Study|Participant left primary care setting|0|||
146363523|NCT00302718|527832449|FG001|Overall Study|Participant left primary care setting|0|||
146363524|NCT00302718|527832450|FG002|Overall Study|Participant left primary care setting|2|||
146363525|NCT00302718|527832451|FG003|Overall Study|Participant left primary care setting|1|||
146363526|NCT00819585|527832452|FG000|Core Study|Adverse Event|2|||
146363527|NCT00819585|527832453|FG001|Core Study|Adverse Event|1|||
146363528|NCT00819585|527832454|FG002|Core Study|Adverse Event|1|||
146363529|NCT00819585|527832455|FG003|Core Study|Adverse Event|4|||
146363530|NCT00819585|527832456|FG004|Core Study|Adverse Event|1|||
146363531|NCT00819585|527832457|FG005|Core Study|Adverse Event|0|||
146363532|NCT00819585|527832458|FG006|Core Study|Adverse Event|2|||
146363533|NCT00819585|527832459|FG007|Core Study|Adverse Event|0|||
146363534|NCT00819585|527832460|FG008|Core Study|Adverse Event|0|||
146363535|NCT00819585|527832461|FG009|Core Study|Adverse Event|0|||
146363536|NCT00819585|527832462|FG010|Core Study|Adverse Event|0|||
146363537|NCT00819585|527832452|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
146363538|NCT00819585|527832453|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
146363539|NCT00819585|527832454|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
146363540|NCT00819585|527832455|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
146363541|NCT00819585|527832456|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
146363542|NCT00819585|527832457|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
146363543|NCT00819585|527832458|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
146363544|NCT00819585|527832459|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
146363545|NCT00819585|527832460|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
146363546|NCT00819585|527832461|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
146363547|NCT00819585|527832462|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
146363548|NCT00819585|527832452|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363549|NCT00819585|527832453|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
146363550|NCT00819585|527832454|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363551|NCT00819585|527832455|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363552|NCT00819585|527832456|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363553|NCT00819585|527832457|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363554|NCT00819585|527832458|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
146363555|NCT00819585|527832459|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363556|NCT00819585|527832460|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363557|NCT00819585|527832461|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363558|NCT00819585|527832462|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
146363559|NCT00819585|527832452|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
146363560|NCT00819585|527832453|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
146363561|NCT00819585|527832454|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
146363562|NCT00819585|527832455|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
146363563|NCT00819585|527832456|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
146363564|NCT00819585|527832457|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
146363565|NCT00819585|527832458|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
146363566|NCT00819585|527832459|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
146169786|NCT02158884|527132935|FG000|Baseline Assessment|Missed performance assessment|3|||
146363567|NCT00819585|527832460|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
146363568|NCT00819585|527832461|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
146363569|NCT00819585|527832462|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
146363570|NCT00819585|527832452|FG000|Core Study|Subject Withdrew Consent|0|||
146363571|NCT00819585|527832453|FG001|Core Study|Subject Withdrew Consent|3|||
146363572|NCT00819585|527832454|FG002|Core Study|Subject Withdrew Consent|2|||
146363573|NCT00819585|527832455|FG003|Core Study|Subject Withdrew Consent|1|||
146363574|NCT00819585|527832456|FG004|Core Study|Subject Withdrew Consent|0|||
146363575|NCT00819585|527832457|FG005|Core Study|Subject Withdrew Consent|0|||
146363576|NCT00819585|527832458|FG006|Core Study|Subject Withdrew Consent|3|||
146363577|NCT00819585|527832459|FG007|Core Study|Subject Withdrew Consent|0|||
146363578|NCT00819585|527832460|FG008|Core Study|Subject Withdrew Consent|0|||
146363579|NCT00819585|527832461|FG009|Core Study|Subject Withdrew Consent|0|||
146363580|NCT00819585|527832462|FG010|Core Study|Subject Withdrew Consent|0|||
146363581|NCT00819585|527832452|FG000|Core Study|Lost to Follow-up|2|||
146363582|NCT00819585|527832453|FG001|Core Study|Lost to Follow-up|1|||
146363583|NCT00819585|527832454|FG002|Core Study|Lost to Follow-up|2|||
146363584|NCT00819585|527832455|FG003|Core Study|Lost to Follow-up|0|||
146363585|NCT00819585|527832456|FG004|Core Study|Lost to Follow-up|1|||
146363586|NCT00819585|527832457|FG005|Core Study|Lost to Follow-up|1|||
146363587|NCT00819585|527832458|FG006|Core Study|Lost to Follow-up|1|||
146363588|NCT00819585|527832459|FG007|Core Study|Lost to Follow-up|0|||
146363589|NCT00819585|527832460|FG008|Core Study|Lost to Follow-up|0|||
146363590|NCT00819585|527832461|FG009|Core Study|Lost to Follow-up|0|||
146363591|NCT00819585|527832462|FG010|Core Study|Lost to Follow-up|0|||
146363592|NCT00819585|527832452|FG000|Core Study|Administrative Problems|0|||
146363593|NCT00819585|527832453|FG001|Core Study|Administrative Problems|0|||
146363594|NCT00819585|527832454|FG002|Core Study|Administrative Problems|0|||
146363595|NCT00819585|527832455|FG003|Core Study|Administrative Problems|0|||
146363596|NCT00819585|527832456|FG004|Core Study|Administrative Problems|0|||
146363597|NCT00819585|527832457|FG005|Core Study|Administrative Problems|0|||
146363598|NCT00819585|527832458|FG006|Core Study|Administrative Problems|2|||
146363599|NCT00819585|527832459|FG007|Core Study|Administrative Problems|0|||
146363600|NCT00819585|527832460|FG008|Core Study|Administrative Problems|0|||
146363601|NCT00819585|527832461|FG009|Core Study|Administrative Problems|0|||
146363602|NCT00819585|527832462|FG010|Core Study|Administrative Problems|0|||
146363603|NCT00819585|527832452|FG000|Core Study|Death|0|||
146363604|NCT00819585|527832453|FG001|Core Study|Death|0|||
146363605|NCT00819585|527832454|FG002|Core Study|Death|0|||
146363606|NCT00819585|527832455|FG003|Core Study|Death|0|||
146363607|NCT00819585|527832456|FG004|Core Study|Death|0|||
146363608|NCT00819585|527832457|FG005|Core Study|Death|0|||
146363609|NCT00819585|527832458|FG006|Core Study|Death|1|||
146363610|NCT00819585|527832459|FG007|Core Study|Death|0|||
146363611|NCT00819585|527832460|FG008|Core Study|Death|0|||
146363612|NCT00819585|527832461|FG009|Core Study|Death|0|||
146363613|NCT00819585|527832462|FG010|Core Study|Death|0|||
146363614|NCT00819585|527832452|FG000|Core Study|Protocol Violation|0|||
146363615|NCT00819585|527832453|FG001|Core Study|Protocol Violation|0|||
146363616|NCT00819585|527832454|FG002|Core Study|Protocol Violation|1|||
146363617|NCT00819585|527832455|FG003|Core Study|Protocol Violation|0|||
146363618|NCT00819585|527832456|FG004|Core Study|Protocol Violation|0|||
146363619|NCT00819585|527832457|FG005|Core Study|Protocol Violation|1|||
146363620|NCT00819585|527832458|FG006|Core Study|Protocol Violation|3|||
146363621|NCT00819585|527832459|FG007|Core Study|Protocol Violation|0|||
146363622|NCT00819585|527832460|FG008|Core Study|Protocol Violation|0|||
146363623|NCT00819585|527832461|FG009|Core Study|Protocol Violation|0|||
146363624|NCT00819585|527832462|FG010|Core Study|Protocol Violation|0|||
146363625|NCT00819585|527832452|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
146363626|NCT00819585|527832453|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
146363627|NCT00819585|527832454|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
146363628|NCT00819585|527832455|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
146363629|NCT00819585|527832456|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
146363630|NCT00819585|527832457|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
146363631|NCT00819585|527832458|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
146363632|NCT00819585|527832459|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
146363633|NCT00819585|527832460|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
146363634|NCT00819585|527832461|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
146363635|NCT00819585|527832462|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
146363636|NCT00819585|527832452|FG000|Extension Study|Subject Withdrew Consent|0|||
146169787|NCT02158884|527132935|FG000|Baseline Assessment|Missed SMFA|1|||
146169788|NCT02158884|527132935|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
146169789|NCT02158884|527132935|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
146363637|NCT00819585|527832453|FG001|Extension Study|Subject Withdrew Consent|0|||
146363638|NCT00819585|527832454|FG002|Extension Study|Subject Withdrew Consent|0|||
146363639|NCT00819585|527832455|FG003|Extension Study|Subject Withdrew Consent|0|||
146363640|NCT00819585|527832456|FG004|Extension Study|Subject Withdrew Consent|0|||
146363641|NCT00819585|527832457|FG005|Extension Study|Subject Withdrew Consent|0|||
146363642|NCT00819585|527832458|FG006|Extension Study|Subject Withdrew Consent|0|||
146363643|NCT00819585|527832459|FG007|Extension Study|Subject Withdrew Consent|0|||
146363644|NCT00819585|527832460|FG008|Extension Study|Subject Withdrew Consent|3|||
146363645|NCT00819585|527832461|FG009|Extension Study|Subject Withdrew Consent|0|||
146363646|NCT00819585|527832462|FG010|Extension Study|Subject Withdrew Consent|1|||
146363647|NCT00819585|527832452|FG000|Extension Study|Lost to Follow-up|0|||
146363648|NCT00819585|527832453|FG001|Extension Study|Lost to Follow-up|0|||
146363649|NCT00819585|527832454|FG002|Extension Study|Lost to Follow-up|0|||
146363650|NCT00819585|527832455|FG003|Extension Study|Lost to Follow-up|0|||
146363651|NCT00819585|527832456|FG004|Extension Study|Lost to Follow-up|0|||
146363652|NCT00819585|527832457|FG005|Extension Study|Lost to Follow-up|0|||
146363653|NCT00819585|527832458|FG006|Extension Study|Lost to Follow-up|0|||
146363654|NCT00819585|527832459|FG007|Extension Study|Lost to Follow-up|0|||
146363655|NCT00819585|527832460|FG008|Extension Study|Lost to Follow-up|2|||
146363656|NCT00819585|527832461|FG009|Extension Study|Lost to Follow-up|1|||
146363657|NCT00819585|527832462|FG010|Extension Study|Lost to Follow-up|1|||
146363658|NCT00819585|527832452|FG000|Extension Study|Death|0|||
146363659|NCT00819585|527832453|FG001|Extension Study|Death|0|||
146363660|NCT00819585|527832454|FG002|Extension Study|Death|0|||
146363661|NCT00819585|527832455|FG003|Extension Study|Death|0|||
146363662|NCT00819585|527832456|FG004|Extension Study|Death|0|||
146363663|NCT00819585|527832457|FG005|Extension Study|Death|0|||
146363664|NCT00819585|527832458|FG006|Extension Study|Death|0|||
146363665|NCT00819585|527832459|FG007|Extension Study|Death|0|||
146363666|NCT00819585|527832460|FG008|Extension Study|Death|2|||
146363667|NCT00819585|527832461|FG009|Extension Study|Death|0|||
146363668|NCT00819585|527832462|FG010|Extension Study|Death|0|||
146363669|NCT00349752|527832463|FG000|Overall Study|Adverse Event|8|||
146363670|NCT00349752|527832464|FG001|Overall Study|Adverse Event|12|||
146363671|NCT00349752|527832463|FG000|Overall Study|Lack of Efficacy|37|||
146363672|NCT00349752|527832464|FG001|Overall Study|Lack of Efficacy|42|||
146363673|NCT00349752|527832463|FG000|Overall Study|Lost to Follow-up|4|||
146363674|NCT00349752|527832464|FG001|Overall Study|Lost to Follow-up|2|||
146363675|NCT00349752|527832463|FG000|Overall Study|Personal reasons|6|||
146363676|NCT00349752|527832464|FG001|Overall Study|Personal reasons|5|||
146363677|NCT00349752|527832463|FG000|Overall Study|Other: Required exclusionary medication|0|||
146363678|NCT00349752|527832464|FG001|Overall Study|Other: Required exclusionary medication|1|||
146363679|NCT00349752|527832463|FG000|Overall Study|Other: Non compliance|0|||
146363680|NCT00349752|527832464|FG001|Overall Study|Other: Non compliance|1|||
146363681|NCT00349752|527832463|FG000|Overall Study|Other: Patient stopped steroids|0|||
146363682|NCT00349752|527832464|FG001|Overall Study|Other: Patient stopped steroids|1|||
146363683|NCT00349752|527832463|FG000|Overall Study|Other: Patient's steroid use|1|||
146363684|NCT00349752|527832464|FG001|Overall Study|Other: Patient's steroid use|0|||
146363685|NCT00349752|527832463|FG000|Overall Study|Other: Ineligible|1|||
146363686|NCT00349752|527832464|FG001|Overall Study|Other: Ineligible|0|||
146363687|NCT00349752|527832463|FG000|Overall Study|Other: Inadvertently unblinded|1|||
146363688|NCT00349752|527832464|FG001|Overall Study|Other: Inadvertently unblinded|0|||
146363689|NCT00349752|527832463|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
146363690|NCT00349752|527832464|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
146363691|NCT00738374|527832465|FG000|Induction Treatment Phase|Adverse Event|14|||
146363692|NCT00738374|527832466|FG001|Induction Treatment Phase|Adverse Event|0|||
146363693|NCT00738374|527832467|FG002|Induction Treatment Phase|Adverse Event|0|||
146363694|NCT00738374|527832468|FG003|Induction Treatment Phase|Adverse Event|0|||
146363695|NCT00738374|527832465|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
146363696|NCT00738374|527832466|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146363697|NCT00738374|527832467|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146363698|NCT00738374|527832468|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
146363699|NCT00738374|527832465|FG000|Induction Treatment Phase|Physician Decision|2|||
146363700|NCT00738374|527832466|FG001|Induction Treatment Phase|Physician Decision|0|||
146363701|NCT00738374|527832467|FG002|Induction Treatment Phase|Physician Decision|0|||
146363702|NCT00738374|527832468|FG003|Induction Treatment Phase|Physician Decision|0|||
146363703|NCT00738374|527832465|FG000|Induction Treatment Phase|Protocol Violation|2|||
146363704|NCT00738374|527832466|FG001|Induction Treatment Phase|Protocol Violation|0|||
146363705|NCT00738374|527832467|FG002|Induction Treatment Phase|Protocol Violation|0|||
146363706|NCT00738374|527832468|FG003|Induction Treatment Phase|Protocol Violation|0|||
146363707|NCT00738374|527832465|FG000|Induction Treatment Phase|Non-compliance|1|||
146363708|NCT00738374|527832466|FG001|Induction Treatment Phase|Non-compliance|0|||
146363709|NCT00738374|527832467|FG002|Induction Treatment Phase|Non-compliance|0|||
146363710|NCT00738374|527832468|FG003|Induction Treatment Phase|Non-compliance|0|||
146363711|NCT00738374|527832465|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
146363712|NCT00738374|527832466|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
146363713|NCT00738374|527832467|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
146363714|NCT00738374|527832468|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
146363715|NCT00738374|527832465|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
146363716|NCT00738374|527832466|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
146363717|NCT00738374|527832467|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
146363718|NCT00738374|527832468|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
146363719|NCT00738374|527832465|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
146363720|NCT00738374|527832466|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
146363721|NCT00738374|527832467|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
146363722|NCT00738374|527832468|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
146363723|NCT00738374|527832465|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146363724|NCT00738374|527832466|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146363725|NCT00738374|527832467|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
146363726|NCT00738374|527832468|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
146363727|NCT00738374|527832465|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146363728|NCT00738374|527832466|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
146363729|NCT00738374|527832467|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146363730|NCT00738374|527832468|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
146363731|NCT00738374|527832465|FG000|Maintenance Treatment/Observation Phase|Other|0|||
146363732|NCT00738374|527832466|FG001|Maintenance Treatment/Observation Phase|Other|1|||
146363733|NCT00738374|527832467|FG002|Maintenance Treatment/Observation Phase|Other|0|||
146363734|NCT00738374|527832468|FG003|Maintenance Treatment/Observation Phase|Other|0|||
146363735|NCT00632541|527832469|FG000|Overall Study|Adverse Event|7|||
146363736|NCT03334396|527832470|FG000|Overall Study|Adverse Event|1|||
146363737|NCT03334396|527832471|FG001|Overall Study|Adverse Event|0|||
146363738|NCT03334396|527832472|FG002|Overall Study|Adverse Event|1|||
146363739|NCT03334396|527832473|FG003|Overall Study|Adverse Event|0|||
146363740|NCT03334396|527832474|FG004|Overall Study|Adverse Event|0|||
146363741|NCT03334396|527832475|FG005|Overall Study|Adverse Event|0|||
146363742|NCT03334396|527832476|FG006|Overall Study|Adverse Event|0|||
146363743|NCT03334396|527832477|FG007|Overall Study|Adverse Event|0|||
146363744|NCT03334396|527832470|FG000|Overall Study|Lack of Efficacy|10|||
146363745|NCT03334396|527832471|FG001|Overall Study|Lack of Efficacy|4|||
146363746|NCT03334396|527832472|FG002|Overall Study|Lack of Efficacy|1|||
146363747|NCT03334396|527832473|FG003|Overall Study|Lack of Efficacy|3|||
146363748|NCT03334396|527832474|FG004|Overall Study|Lack of Efficacy|1|||
146363749|NCT03334396|527832475|FG005|Overall Study|Lack of Efficacy|0|||
146363750|NCT03334396|527832476|FG006|Overall Study|Lack of Efficacy|0|||
146363751|NCT03334396|527832477|FG007|Overall Study|Lack of Efficacy|1|||
146363752|NCT03334396|527832470|FG000|Overall Study|Lost to Follow-up|0|||
146363753|NCT03334396|527832471|FG001|Overall Study|Lost to Follow-up|0|||
146363754|NCT03334396|527832472|FG002|Overall Study|Lost to Follow-up|1|||
146363755|NCT03334396|527832473|FG003|Overall Study|Lost to Follow-up|0|||
146363756|NCT03334396|527832474|FG004|Overall Study|Lost to Follow-up|0|||
146363757|NCT03334396|527832475|FG005|Overall Study|Lost to Follow-up|0|||
146363758|NCT03334396|527832476|FG006|Overall Study|Lost to Follow-up|1|||
146363759|NCT03334396|527832477|FG007|Overall Study|Lost to Follow-up|0|||
146363760|NCT03334396|527832470|FG000|Overall Study|Physician Decision|1|||
146363761|NCT03334396|527832471|FG001|Overall Study|Physician Decision|0|||
146363762|NCT03334396|527832472|FG002|Overall Study|Physician Decision|0|||
146363763|NCT03334396|527832473|FG003|Overall Study|Physician Decision|0|||
146363764|NCT03334396|527832474|FG004|Overall Study|Physician Decision|0|||
146363765|NCT03334396|527832475|FG005|Overall Study|Physician Decision|0|||
146363766|NCT03334396|527832476|FG006|Overall Study|Physician Decision|0|||
146363767|NCT03334396|527832477|FG007|Overall Study|Physician Decision|0|||
146363768|NCT03334396|527832470|FG000|Overall Study|Withdrawal by Subject|10|||
146363769|NCT03334396|527832471|FG001|Overall Study|Withdrawal by Subject|5|||
146363770|NCT03334396|527832472|FG002|Overall Study|Withdrawal by Subject|7|||
146363771|NCT03334396|527832473|FG003|Overall Study|Withdrawal by Subject|2|||
146363772|NCT03334396|527832474|FG004|Overall Study|Withdrawal by Subject|2|||
146363773|NCT03334396|527832475|FG005|Overall Study|Withdrawal by Subject|1|||
146363774|NCT03334396|527832476|FG006|Overall Study|Withdrawal by Subject|2|||
146363775|NCT03334396|527832477|FG007|Overall Study|Withdrawal by Subject|0|||
146363776|NCT03334396|527832470|FG000|Overall Study|Pregnancy|0|||
146363777|NCT03334396|527832471|FG001|Overall Study|Pregnancy|1|||
146363778|NCT03334396|527832472|FG002|Overall Study|Pregnancy|0|||
146363779|NCT03334396|527832473|FG003|Overall Study|Pregnancy|0|||
146363780|NCT03334396|527832474|FG004|Overall Study|Pregnancy|0|||
146363781|NCT03334396|527832475|FG005|Overall Study|Pregnancy|0|||
146363782|NCT03334396|527832476|FG006|Overall Study|Pregnancy|0|||
146363783|NCT03334396|527832477|FG007|Overall Study|Pregnancy|0|||
146363784|NCT03334396|527832470|FG000|Overall Study|Ineligible|0|||
146363785|NCT03334396|527832471|FG001|Overall Study|Ineligible|1|||
146363786|NCT03334396|527832472|FG002|Overall Study|Ineligible|0|||
146363787|NCT03334396|527832473|FG003|Overall Study|Ineligible|0|||
146363788|NCT03334396|527832474|FG004|Overall Study|Ineligible|0|||
146363789|NCT03334396|527832475|FG005|Overall Study|Ineligible|0|||
146363790|NCT03334396|527832476|FG006|Overall Study|Ineligible|0|||
146363791|NCT03334396|527832477|FG007|Overall Study|Ineligible|0|||
146363792|NCT03334396|527832470|FG000|Overall Study|Started New Job|1|||
146363793|NCT03334396|527832471|FG001|Overall Study|Started New Job|0|||
146363794|NCT03334396|527832472|FG002|Overall Study|Started New Job|0|||
146363795|NCT03334396|527832473|FG003|Overall Study|Started New Job|0|||
146363796|NCT03334396|527832474|FG004|Overall Study|Started New Job|0|||
146363797|NCT03334396|527832475|FG005|Overall Study|Started New Job|0|||
146363798|NCT03334396|527832476|FG006|Overall Study|Started New Job|0|||
146363799|NCT03334396|527832477|FG007|Overall Study|Started New Job|0|||
146363800|NCT02927873|527832481|FG000|Overall Study|Lost to Follow-up|0|||
146363801|NCT02927873|527832482|FG001|Overall Study|Lost to Follow-up|1|||
146363802|NCT02927873|527832483|FG002|Overall Study|Lost to Follow-up|0|||
146363803|NCT02927873|527832484|FG003|Overall Study|Lost to Follow-up|0|||
146363804|NCT02927873|527832485|FG004|Overall Study|Lost to Follow-up|0|||
146363805|NCT02927873|527832486|FG005|Overall Study|Lost to Follow-up|0|||
146363806|NCT02927873|527832481|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146363807|NCT02927873|527832482|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
146363808|NCT02927873|527832483|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146363809|NCT02927873|527832484|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146363810|NCT02927873|527832485|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146363811|NCT02927873|527832486|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
146363812|NCT02927873|527832481|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363813|NCT02927873|527832482|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363814|NCT02927873|527832483|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363815|NCT02927873|527832484|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363816|NCT02927873|527832485|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363817|NCT02927873|527832486|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146363818|NCT02927873|527832481|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146363819|NCT02927873|527832482|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
146363820|NCT02927873|527832483|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146363821|NCT02927873|527832484|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146363822|NCT02927873|527832485|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146363823|NCT02927873|527832486|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
146363824|NCT02927873|527832481|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
146363825|NCT02927873|527832482|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146363826|NCT02927873|527832483|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146363827|NCT02927873|527832484|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146363828|NCT02927873|527832485|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146363829|NCT02927873|527832486|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
146363830|NCT02927873|527832481|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
146363831|NCT02927873|527832482|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146363832|NCT02927873|527832483|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146363833|NCT02927873|527832484|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146363834|NCT02927873|527832485|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146363835|NCT02927873|527832486|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
146363836|NCT03814590|527832487|FG000|Overall Study|Adverse Event|0|||
146363837|NCT03814590|527832488|FG001|Overall Study|Adverse Event|0|||
146363838|NCT03814590|527832489|FG002|Overall Study|Adverse Event|0|||
146363839|NCT03814590|527832490|FG003|Overall Study|Adverse Event|0|||
146363840|NCT03814590|527832491|FG004|Overall Study|Adverse Event|0|||
146363841|NCT03814590|527832492|FG005|Overall Study|Adverse Event|1|||
146363842|NCT03814590|527832493|FG006|Overall Study|Adverse Event|1|||
146363843|NCT03814590|527832494|FG007|Overall Study|Adverse Event|1|||
146363844|NCT03814590|527832495|FG008|Overall Study|Adverse Event|0|||
146363845|NCT03814590|527832496|FG009|Overall Study|Adverse Event|0|||
146363846|NCT03814590|527832497|FG010|Overall Study|Adverse Event|1|||
146363847|NCT03814590|527832498|FG011|Overall Study|Adverse Event|0|||
146363848|NCT03814590|527832499|FG012|Overall Study|Adverse Event|3|||
146363849|NCT03814590|527832500|FG013|Overall Study|Adverse Event|0|||
146363850|NCT03814590|527832487|FG000|Overall Study|Lost to Follow-up|0|||
146363851|NCT03814590|527832488|FG001|Overall Study|Lost to Follow-up|2|||
146363852|NCT03814590|527832489|FG002|Overall Study|Lost to Follow-up|1|||
146363853|NCT03814590|527832490|FG003|Overall Study|Lost to Follow-up|0|||
146363854|NCT03814590|527832491|FG004|Overall Study|Lost to Follow-up|1|||
146363855|NCT03814590|527832492|FG005|Overall Study|Lost to Follow-up|1|||
146363856|NCT03814590|527832493|FG006|Overall Study|Lost to Follow-up|1|||
146363857|NCT03814590|527832494|FG007|Overall Study|Lost to Follow-up|1|||
146363858|NCT03814590|527832495|FG008|Overall Study|Lost to Follow-up|0|||
146363859|NCT03814590|527832496|FG009|Overall Study|Lost to Follow-up|0|||
146363860|NCT03814590|527832497|FG010|Overall Study|Lost to Follow-up|1|||
146363861|NCT03814590|527832498|FG011|Overall Study|Lost to Follow-up|0|||
146363862|NCT03814590|527832499|FG012|Overall Study|Lost to Follow-up|0|||
146363863|NCT03814590|527832500|FG013|Overall Study|Lost to Follow-up|1|||
146363864|NCT03814590|527832487|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363865|NCT03814590|527832488|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363866|NCT03814590|527832489|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363867|NCT03814590|527832490|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363868|NCT03814590|527832491|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363869|NCT03814590|527832492|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363870|NCT03814590|527832493|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363871|NCT03814590|527832494|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363872|NCT03814590|527832495|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363873|NCT03814590|527832496|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
146363874|NCT03814590|527832497|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363875|NCT03814590|527832498|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363876|NCT03814590|527832499|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363877|NCT03814590|527832500|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
146363878|NCT03814590|527832487|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363879|NCT03814590|527832488|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363880|NCT03814590|527832489|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363881|NCT03814590|527832490|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363882|NCT03814590|527832491|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363883|NCT03814590|527832492|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
146363884|NCT03814590|527832493|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146363885|NCT03814590|527832494|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
146363886|NCT03814590|527832495|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363887|NCT03814590|527832496|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
146363888|NCT03814590|527832497|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146363889|NCT03814590|527832498|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
146363890|NCT03814590|527832499|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
146363891|NCT03814590|527832500|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
146363892|NCT03814590|527832487|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363893|NCT03814590|527832488|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363894|NCT03814590|527832489|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363895|NCT03814590|527832490|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363896|NCT03814590|527832491|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363897|NCT03814590|527832492|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363898|NCT03814590|527832493|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363899|NCT03814590|527832494|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146363900|NCT03814590|527832495|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363901|NCT03814590|527832496|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
146363902|NCT03814590|527832497|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363903|NCT03814590|527832498|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363904|NCT03814590|527832499|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363905|NCT03814590|527832500|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
146363906|NCT03814590|527832487|FG000|Overall Study|UNKNOWN REASON|0|||
146363907|NCT03814590|527832488|FG001|Overall Study|UNKNOWN REASON|0|||
146363908|NCT03814590|527832489|FG002|Overall Study|UNKNOWN REASON|0|||
146363909|NCT03814590|527832490|FG003|Overall Study|UNKNOWN REASON|0|||
146363910|NCT03814590|527832491|FG004|Overall Study|UNKNOWN REASON|0|||
146363911|NCT03814590|527832492|FG005|Overall Study|UNKNOWN REASON|0|||
146363912|NCT03814590|527832493|FG006|Overall Study|UNKNOWN REASON|0|||
146363913|NCT03814590|527832494|FG007|Overall Study|UNKNOWN REASON|1|||
146363914|NCT03814590|527832495|FG008|Overall Study|UNKNOWN REASON|0|||
146363915|NCT03814590|527832496|FG009|Overall Study|UNKNOWN REASON|0|||
146363916|NCT03814590|527832497|FG010|Overall Study|UNKNOWN REASON|0|||
146363917|NCT03814590|527832498|FG011|Overall Study|UNKNOWN REASON|0|||
146363918|NCT03814590|527832499|FG012|Overall Study|UNKNOWN REASON|0|||
146363919|NCT03814590|527832500|FG013|Overall Study|UNKNOWN REASON|0|||
146363920|NCT03519516|527832501|FG000|Overall Study|Adverse Event|0|||
146363921|NCT03519516|527832502|FG001|Overall Study|Adverse Event|1|||
146363922|NCT02379390|527832503|FG000|Overall Study|Adverse Event|1|||
146363923|NCT02379390|527832504|FG001|Overall Study|Adverse Event|1|||
146363924|NCT02379390|527832503|FG000|Overall Study|Investigator's decision|1|||
146363925|NCT02379390|527832504|FG001|Overall Study|Investigator's decision|0|||
146363926|NCT02379390|527832503|FG000|Overall Study|Study Termination|0|||
146363927|NCT02379390|527832504|FG001|Overall Study|Study Termination|1|||
146363928|NCT03245723|527832513|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
146363929|NCT03245723|527832514|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
146363930|NCT03245723|527832513|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
146363931|NCT03245723|527832514|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
146363932|NCT03245723|527832513|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
146363933|NCT03245723|527832514|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
146363934|NCT03245723|527832513|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
146363935|NCT03245723|527832514|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
146363936|NCT00077376|527832515|FG000|Overall Study|Adverse Event|8|||
146363937|NCT00077376|527832515|FG000|Overall Study|Withdrawal by Subject|2|||
146363938|NCT00077376|527832515|FG000|Overall Study|Death|1|||
146363939|NCT00077376|527832515|FG000|Overall Study|Physician Decision|1|||
146363940|NCT00077376|527832515|FG000|Overall Study|Alternative therapy|5|||
146363941|NCT00077376|527832515|FG000|Overall Study|Complicating disease|1|||
146363942|NCT00077376|527832515|FG000|Overall Study|Still on treatment|1|||
146363943|NCT00077376|527832515|FG000|Overall Study|Symptomatic deterioration|1|||
146363944|NCT00077376|527832515|FG000|Overall Study|Surgery|1|||
146363945|NCT00077376|527832515|FG000|Overall Study|Insurance ran out|1|||
146363946|NCT03784027|527832516|FG000|Period 1|Withdrawal by Subject|0|||
146363947|NCT03784027|527832517|FG001|Period 1|Withdrawal by Subject|1|||
146363948|NCT01975246|527833947|FG000|Overall Study|Adverse Event|2|||
146363949|NCT01975246|527833948|FG001|Overall Study|Adverse Event|1|||
146363950|NCT01975246|527833947|FG000|Overall Study|Lack of Efficacy|1|||
146363951|NCT01975246|527833948|FG001|Overall Study|Lack of Efficacy|0|||
146363952|NCT01975246|527833947|FG000|Overall Study|Protocol Violation|1|||
146363953|NCT01975246|527833948|FG001|Overall Study|Protocol Violation|0|||
146363954|NCT01975246|527833947|FG000|Overall Study|Other than stated|0|||
146363955|NCT01975246|527833948|FG001|Overall Study|Other than stated|1|||
146363956|NCT00255034|527833949|FG000|Overall Study|Withdrawal by Subject|15|||
146363957|NCT00255034|527833950|FG001|Overall Study|Withdrawal by Subject|38|||
146363958|NCT01263093|527833951|FG000|Washout|Physician Decision|1|||
146363959|NCT01263093|527833952|FG001|Washout|Physician Decision|0|||
146363960|NCT01263093|527833951|FG000|Period 2|Adverse Event|1|||
146363961|NCT01263093|527833952|FG001|Period 2|Adverse Event|0|||
146363962|NCT00424346|527833953|FG000|Core Study|Adverse Event|5|||
146363963|NCT00424346|527833954|FG001|Core Study|Adverse Event|3|||
146363964|NCT00424346|527833955|FG002|Core Study|Adverse Event|1|||
146363965|NCT00424346|527833956|FG003|Core Study|Adverse Event|1|||
146363966|NCT00424346|527833953|FG000|Core Study|Abnormal Laboratory Values|0|||
146363967|NCT00424346|527833954|FG001|Core Study|Abnormal Laboratory Values|1|||
146363968|NCT00424346|527833955|FG002|Core Study|Abnormal Laboratory Values|0|||
146363969|NCT00424346|527833956|FG003|Core Study|Abnormal Laboratory Values|0|||
146363970|NCT00424346|527833953|FG000|Core Study|Lack of Efficacy|1|||
146363971|NCT00424346|527833954|FG001|Core Study|Lack of Efficacy|3|||
146363972|NCT00424346|527833955|FG002|Core Study|Lack of Efficacy|0|||
146363973|NCT00424346|527833956|FG003|Core Study|Lack of Efficacy|4|||
146363974|NCT00424346|527833953|FG000|Core Study|Withdrawal by Subject|1|||
146363975|NCT00424346|527833954|FG001|Core Study|Withdrawal by Subject|0|||
146363976|NCT00424346|527833955|FG002|Core Study|Withdrawal by Subject|0|||
146363977|NCT00424346|527833956|FG003|Core Study|Withdrawal by Subject|2|||
146363978|NCT00424346|527833953|FG000|Core Study|Lost to Follow-up|1|||
146363979|NCT00424346|527833954|FG001|Core Study|Lost to Follow-up|1|||
146363980|NCT00424346|527833955|FG002|Core Study|Lost to Follow-up|0|||
146363981|NCT00424346|527833956|FG003|Core Study|Lost to Follow-up|0|||
146363982|NCT00424346|527833953|FG000|Core Study|Administrative Problems|1|||
146363983|NCT00424346|527833954|FG001|Core Study|Administrative Problems|0|||
146363984|NCT00424346|527833955|FG002|Core Study|Administrative Problems|1|||
146363985|NCT00424346|527833956|FG003|Core Study|Administrative Problems|0|||
146363986|NCT00424346|527833953|FG000|Core Study|Protocol Violation|0|||
146363987|NCT00424346|527833954|FG001|Core Study|Protocol Violation|0|||
146363988|NCT00424346|527833955|FG002|Core Study|Protocol Violation|2|||
146363989|NCT00424346|527833956|FG003|Core Study|Protocol Violation|0|||
146363990|NCT00424346|527833953|FG000|Extension Phase|Adverse Event|0|||
146363991|NCT00424346|527833954|FG001|Extension Phase|Adverse Event|9|||
146363992|NCT00424346|527833955|FG002|Extension Phase|Adverse Event|5|||
146363993|NCT00424346|527833956|FG003|Extension Phase|Adverse Event|4|||
146363994|NCT00424346|527833953|FG000|Extension Phase|Lack of Efficacy|0|||
146363995|NCT00424346|527833954|FG001|Extension Phase|Lack of Efficacy|16|||
146363996|NCT00424346|527833955|FG002|Extension Phase|Lack of Efficacy|14|||
146363997|NCT00424346|527833956|FG003|Extension Phase|Lack of Efficacy|11|||
146363998|NCT00424346|527833953|FG000|Extension Phase|Withdrawal by Subject|0|||
146363999|NCT00424346|527833954|FG001|Extension Phase|Withdrawal by Subject|5|||
146364000|NCT00424346|527833955|FG002|Extension Phase|Withdrawal by Subject|3|||
146364001|NCT00424346|527833956|FG003|Extension Phase|Withdrawal by Subject|4|||
146364002|NCT00424346|527833953|FG000|Extension Phase|Lost to Follow-up|0|||
146364003|NCT00424346|527833954|FG001|Extension Phase|Lost to Follow-up|2|||
146364004|NCT00424346|527833955|FG002|Extension Phase|Lost to Follow-up|0|||
146364005|NCT00424346|527833956|FG003|Extension Phase|Lost to Follow-up|0|||
146364006|NCT00424346|527833953|FG000|Extension Phase|Administrative Problems|0|||
146364007|NCT00424346|527833954|FG001|Extension Phase|Administrative Problems|69|||
146364008|NCT00424346|527833955|FG002|Extension Phase|Administrative Problems|32|||
146364009|NCT00424346|527833956|FG003|Extension Phase|Administrative Problems|35|||
146364010|NCT00424346|527833953|FG000|Extension Phase|Death|0|||
146364011|NCT00424346|527833954|FG001|Extension Phase|Death|0|||
146364012|NCT00424346|527833955|FG002|Extension Phase|Death|0|||
146364013|NCT00424346|527833956|FG003|Extension Phase|Death|1|||
146364014|NCT00424346|527833953|FG000|Extension Phase|Protocol Violation|0|||
146364015|NCT00424346|527833954|FG001|Extension Phase|Protocol Violation|1|||
146364016|NCT00424346|527833955|FG002|Extension Phase|Protocol Violation|1|||
146364017|NCT00424346|527833956|FG003|Extension Phase|Protocol Violation|0|||
146364018|NCT03287245|527833957|FG000|Overall Study|Study terminated by sponsor|3|||
146364019|NCT03287245|527833958|FG001|Overall Study|Study terminated by sponsor|0|||
146364020|NCT03287245|527833959|FG002|Overall Study|Study terminated by sponsor|3|||
146364021|NCT03287245|527833960|FG003|Overall Study|Study terminated by sponsor|1|||
146364022|NCT03287245|527833957|FG000|Overall Study|Adverse Event|1|||
146364023|NCT03287245|527833958|FG001|Overall Study|Adverse Event|0|||
146364024|NCT03287245|527833959|FG002|Overall Study|Adverse Event|0|||
146364025|NCT03287245|527833960|FG003|Overall Study|Adverse Event|0|||
146364026|NCT03287245|527833957|FG000|Overall Study|Withdrawal by Subject|8|||
146364027|NCT03287245|527833958|FG001|Overall Study|Withdrawal by Subject|3|||
146364028|NCT03287245|527833959|FG002|Overall Study|Withdrawal by Subject|3|||
146364029|NCT03287245|527833960|FG003|Overall Study|Withdrawal by Subject|0|||
146364030|NCT03287245|527833957|FG000|Overall Study|Physician Decision|3|||
146364031|NCT03287245|527833958|FG001|Overall Study|Physician Decision|2|||
146364032|NCT03287245|527833959|FG002|Overall Study|Physician Decision|0|||
146364033|NCT03287245|527833960|FG003|Overall Study|Physician Decision|0|||
146364034|NCT02701192|527833961|FG000|Overall Study|Protocol Violation|2|||
146364035|NCT02701192|527833961|FG000|Overall Study|Lost to Follow-up|4|||
146364036|NCT02862548|527833962|FG000|Randomized Phase (Up to Week 48)|Death|0|||
146364037|NCT02862548|527833963|FG001|Randomized Phase (Up to Week 48)|Death|1|||
146364038|NCT02862548|527833962|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
146364039|NCT02862548|527833963|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
146364040|NCT02862548|527833962|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
146364041|NCT02862548|527833963|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
146364042|NCT02862548|527833962|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
146364043|NCT02862548|527833963|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
146364044|NCT00880763|527833964|FG000|Extension Period (Part 2)|Adverse Event|0|||
146364045|NCT00880763|527833965|FG001|Extension Period (Part 2)|Adverse Event|0|||
146364046|NCT00880763|527833966|FG002|Extension Period (Part 2)|Adverse Event|1|||
146364047|NCT00880763|527833967|FG003|Extension Period (Part 2)|Adverse Event|1|||
146364048|NCT00880763|527833964|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
146364049|NCT00880763|527833965|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
146364050|NCT00880763|527833966|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
146364051|NCT00880763|527833967|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
146364052|NCT00880763|527833964|FG000|Extension Period (Part 2)|Physician Decision|0|||
146364053|NCT00880763|527833965|FG001|Extension Period (Part 2)|Physician Decision|1|||
146364054|NCT00880763|527833966|FG002|Extension Period (Part 2)|Physician Decision|1|||
146364055|NCT00880763|527833967|FG003|Extension Period (Part 2)|Physician Decision|0|||
146364056|NCT00880763|527833964|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
146364057|NCT00880763|527833965|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
146364058|NCT00880763|527833966|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
146364059|NCT00880763|527833967|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
146364060|NCT02667457|527833969|FG000|Overall Study|Withdrawal by Subject|1|||
146364061|NCT02667457|527833970|FG001|Overall Study|Withdrawal by Subject|0|||
146364062|NCT02667457|527833969|FG000|Overall Study|Other Reason|0|||
146364063|NCT02667457|527833970|FG001|Overall Study|Other Reason|2|||
146364064|NCT00603733|527833973|FG000|Active Phase ITT|Adverse Event|8|||
146169790|NCT02158884|527132935|FG000|6 Month Assessment|Missed SMFA|20|||
146169791|NCT02158884|527132935|FG000|12 Month Assessment|Missed SMFA|17|||
146364065|NCT00603733|527833974|FG001|Active Phase ITT|Adverse Event|7|||
146364066|NCT00603733|527833973|FG000|Active Phase ITT|Withdrawal by Subject|0|||
146364067|NCT00603733|527833974|FG001|Active Phase ITT|Withdrawal by Subject|3|||
146364068|NCT00603733|527833973|FG000|Active Phase ITT|Lost to Follow-up|0|||
146364069|NCT00603733|527833974|FG001|Active Phase ITT|Lost to Follow-up|1|||
146364070|NCT00603733|527833973|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
146364071|NCT00603733|527833974|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
146364072|NCT00603733|527833973|FG000|Active Phase ITT|Lack of Efficacy|1|||
146364073|NCT00603733|527833974|FG001|Active Phase ITT|Lack of Efficacy|2|||
146364074|NCT00603733|527833973|FG000|Active Phase ITT|Subject moved, site closed|1|||
146364075|NCT00603733|527833974|FG001|Active Phase ITT|Subject moved, site closed|1|||
146364076|NCT00603733|527833973|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
146364077|NCT00603733|527833974|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
146364078|NCT00603733|527833973|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
146364079|NCT00603733|527833974|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
146364080|NCT00603733|527833973|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
146364081|NCT00603733|527833974|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
146364082|NCT00603733|527833973|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
146364083|NCT00603733|527833974|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
146364084|NCT00603733|527833973|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
146364085|NCT00603733|527833974|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
146364086|NCT00603733|527833973|FG000|Maintenance Phase ITT|Adverse Event|3|||
146364087|NCT00603733|527833974|FG001|Maintenance Phase ITT|Adverse Event|6|||
146364088|NCT00603733|527833973|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
146364089|NCT00603733|527833974|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
146364090|NCT00603733|527833973|FG000|Maintenance Phase ITT|Protocol Violation|1|||
146364091|NCT00603733|527833974|FG001|Maintenance Phase ITT|Protocol Violation|1|||
146364092|NCT00603733|527833973|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
146364093|NCT00603733|527833974|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
146364094|NCT00603733|527833973|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
146364095|NCT00603733|527833974|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
146364096|NCT00603733|527833973|FG000|Maintenance Phase ITT|Physician Decision|0|||
146364097|NCT00603733|527833974|FG001|Maintenance Phase ITT|Physician Decision|1|||
146364098|NCT00603733|527833973|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
146364099|NCT00603733|527833974|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
146364100|NCT01253187|527833985|FG000|Period 2|Withdrawal by Subject|0|||
146364101|NCT01253187|527833986|FG001|Period 2|Withdrawal by Subject|0|||
146364102|NCT01253187|527833987|FG002|Period 2|Withdrawal by Subject|0|||
146364103|NCT01253187|527833988|FG003|Period 2|Withdrawal by Subject|0|||
146364104|NCT01253187|527833989|FG004|Period 2|Withdrawal by Subject|1|||
146364105|NCT01253187|527833990|FG005|Period 2|Withdrawal by Subject|0|||
146364106|NCT01253187|527833985|FG000|Period 3|Pregnancy|1|||
146364107|NCT01253187|527833986|FG001|Period 3|Pregnancy|0|||
146364108|NCT01253187|527833987|FG002|Period 3|Pregnancy|0|||
146364109|NCT01253187|527833988|FG003|Period 3|Pregnancy|0|||
146364110|NCT01253187|527833989|FG004|Period 3|Pregnancy|0|||
146364111|NCT01253187|527833990|FG005|Period 3|Pregnancy|0|||
146364112|NCT01253187|527833985|FG000|Period 3|difficulty with blood sampling|0|||
146364113|NCT01253187|527833986|FG001|Period 3|difficulty with blood sampling|1|||
146364114|NCT01253187|527833987|FG002|Period 3|difficulty with blood sampling|0|||
146364115|NCT01253187|527833988|FG003|Period 3|difficulty with blood sampling|0|||
146364116|NCT01253187|527833989|FG004|Period 3|difficulty with blood sampling|0|||
146364117|NCT01253187|527833990|FG005|Period 3|difficulty with blood sampling|0|||
146364118|NCT01253187|527833985|FG000|Period 3|non-compliance|0|||
146364119|NCT01253187|527833986|FG001|Period 3|non-compliance|0|||
146364120|NCT01253187|527833987|FG002|Period 3|non-compliance|0|||
146364121|NCT01253187|527833988|FG003|Period 3|non-compliance|0|||
146364122|NCT01253187|527833989|FG004|Period 3|non-compliance|1|||
146364123|NCT01253187|527833990|FG005|Period 3|non-compliance|0|||
146364124|NCT01293006|527833992|FG000|Period 2|Lost to Follow-up|1|||
146364125|NCT01293006|527833993|FG001|Period 2|Lost to Follow-up|0|||
146364126|NCT01293006|527833994|FG002|Period 2|Lost to Follow-up|0|||
146364127|NCT01293006|527833995|FG003|Period 2|Lost to Follow-up|0|||
146364128|NCT01494987|527833996|FG000|Overall Study|Adverse Event|6|||
146364129|NCT01494987|527833997|FG001|Overall Study|Adverse Event|5|||
146364130|NCT01494987|527833996|FG000|Overall Study|Hyperglycemia|6|||
146364131|NCT01494987|527833997|FG001|Overall Study|Hyperglycemia|4|||
146364132|NCT01494987|527833996|FG000|Overall Study|Investigator's Discretion|1|||
146364133|NCT01494987|527833997|FG001|Overall Study|Investigator's Discretion|2|||
146364134|NCT01494987|527833996|FG000|Overall Study|Lost to Follow-up|1|||
146364135|NCT01494987|527833997|FG001|Overall Study|Lost to Follow-up|1|||
146364136|NCT01494987|527833996|FG000|Overall Study|Protocol Violation|3|||
146364137|NCT01494987|527833997|FG001|Overall Study|Protocol Violation|3|||
146364138|NCT01494987|527833996|FG000|Overall Study|Subject Non-Compliance|9|||
146364139|NCT01494987|527833997|FG001|Overall Study|Subject Non-Compliance|10|||
146364140|NCT01494987|527833996|FG000|Overall Study|Subject Withdrew Consent|2|||
146364141|NCT01494987|527833997|FG001|Overall Study|Subject Withdrew Consent|3|||
146364142|NCT02254551|527833998|FG000|Dose Escalation|Physician Decision|1|||
146364143|NCT02254551|527833998|FG000|Dose Escalation|Dose-limiting toxicity|2|||
146364144|NCT01061736|527833999|FG000|Overall Study|Dose regimen not selected|0|||
146364145|NCT01061736|527834000|FG001|Overall Study|Dose regimen not selected|0|||
146364146|NCT01061736|527834001|FG002|Overall Study|Dose regimen not selected|0|||
146364147|NCT01061736|527834002|FG003|Overall Study|Dose regimen not selected|0|||
146364148|NCT01061736|527834003|FG004|Overall Study|Dose regimen not selected|0|||
146364149|NCT01061736|527834004|FG005|Overall Study|Dose regimen not selected|0|||
146364150|NCT01061736|527834005|FG006|Overall Study|Dose regimen not selected|79|||
146364151|NCT01061736|527834006|FG007|Overall Study|Dose regimen not selected|0|||
146364152|NCT01061736|527834007|FG008|Overall Study|Dose regimen not selected|0|||
146364153|NCT01061736|527834008|FG009|Overall Study|Dose regimen not selected|0|||
146364154|NCT01061736|527833999|FG000|Overall Study|Adverse Event|13|||
146364155|NCT01061736|527834000|FG001|Overall Study|Adverse Event|1|||
146364156|NCT01061736|527834001|FG002|Overall Study|Adverse Event|3|||
146364157|NCT01061736|527834002|FG003|Overall Study|Adverse Event|2|||
146364158|NCT01061736|527834003|FG004|Overall Study|Adverse Event|4|||
146364159|NCT01061736|527834004|FG005|Overall Study|Adverse Event|1|||
146364160|NCT01061736|527834005|FG006|Overall Study|Adverse Event|4|||
146364161|NCT01061736|527834006|FG007|Overall Study|Adverse Event|63|||
146364162|NCT01061736|527834007|FG008|Overall Study|Adverse Event|67|||
146364163|NCT01061736|527834008|FG009|Overall Study|Adverse Event|34|||
146364164|NCT01061736|527833999|FG000|Overall Study|Lack of Efficacy|0|||
146364165|NCT01061736|527834000|FG001|Overall Study|Lack of Efficacy|2|||
146364166|NCT01061736|527834001|FG002|Overall Study|Lack of Efficacy|1|||
146364167|NCT01061736|527834002|FG003|Overall Study|Lack of Efficacy|1|||
146364168|NCT01061736|527834003|FG004|Overall Study|Lack of Efficacy|1|||
146364169|NCT01061736|527834004|FG005|Overall Study|Lack of Efficacy|2|||
146364170|NCT01061736|527834005|FG006|Overall Study|Lack of Efficacy|1|||
146364171|NCT01061736|527834006|FG007|Overall Study|Lack of Efficacy|9|||
146364172|NCT01061736|527834007|FG008|Overall Study|Lack of Efficacy|9|||
146364173|NCT01061736|527834008|FG009|Overall Study|Lack of Efficacy|10|||
146364174|NCT01061736|527833999|FG000|Overall Study|Poor compliance to protocol|0|||
146364175|NCT01061736|527834000|FG001|Overall Study|Poor compliance to protocol|0|||
146364176|NCT01061736|527834001|FG002|Overall Study|Poor compliance to protocol|0|||
146364177|NCT01061736|527834002|FG003|Overall Study|Poor compliance to protocol|0|||
146364178|NCT01061736|527834003|FG004|Overall Study|Poor compliance to protocol|0|||
146364179|NCT01061736|527834004|FG005|Overall Study|Poor compliance to protocol|0|||
146364180|NCT01061736|527834005|FG006|Overall Study|Poor compliance to protocol|0|||
146364181|NCT01061736|527834006|FG007|Overall Study|Poor compliance to protocol|2|||
146364182|NCT01061736|527834007|FG008|Overall Study|Poor compliance to protocol|5|||
146364183|NCT01061736|527834008|FG009|Overall Study|Poor compliance to protocol|9|||
146364184|NCT01061736|527833999|FG000|Overall Study|Not treated|0|||
146364185|NCT01061736|527834000|FG001|Overall Study|Not treated|0|||
146364186|NCT01061736|527834001|FG002|Overall Study|Not treated|0|||
146364187|NCT01061736|527834002|FG003|Overall Study|Not treated|0|||
146364188|NCT01061736|527834003|FG004|Overall Study|Not treated|1|||
146364189|NCT01061736|527834004|FG005|Overall Study|Not treated|0|||
146364190|NCT01061736|527834005|FG006|Overall Study|Not treated|0|||
146364191|NCT01061736|527834006|FG007|Overall Study|Not treated|2|||
146364192|NCT01061736|527834007|FG008|Overall Study|Not treated|1|||
146364193|NCT01061736|527834008|FG009|Overall Study|Not treated|0|||
146364194|NCT01061736|527833999|FG000|Overall Study|Other than specified above|0|||
146364195|NCT01061736|527834000|FG001|Overall Study|Other than specified above|1|||
146364196|NCT01061736|527834001|FG002|Overall Study|Other than specified above|2|||
146364197|NCT01061736|527834002|FG003|Overall Study|Other than specified above|0|||
146364198|NCT01061736|527834003|FG004|Overall Study|Other than specified above|1|||
146364199|NCT01061736|527834004|FG005|Overall Study|Other than specified above|0|||
146364200|NCT01061736|527834005|FG006|Overall Study|Other than specified above|0|||
146364201|NCT01061736|527834006|FG007|Overall Study|Other than specified above|18|||
146364202|NCT01061736|527834007|FG008|Overall Study|Other than specified above|15|||
146364203|NCT01061736|527834008|FG009|Overall Study|Other than specified above|21|||
146364204|NCT01093755|527834010|FG000|Overall Study|Withdrawal by Subject|3|||
146364205|NCT01093755|527834011|FG001|Overall Study|Withdrawal by Subject|4|||
146364206|NCT04019795|527834012|FG000|Overall Study|Withdrawal by Subject|1|||
146364207|NCT04019795|527834013|FG001|Overall Study|Withdrawal by Subject|2|||
146364208|NCT04019795|527834014|FG002|Overall Study|Withdrawal by Subject|2|||
146364209|NCT04019795|527834015|FG003|Overall Study|Withdrawal by Subject|1|||
146364210|NCT04019795|527834012|FG000|Overall Study|Lost to Follow-up|0|||
146364211|NCT04019795|527834013|FG001|Overall Study|Lost to Follow-up|1|||
146364212|NCT04019795|527834014|FG002|Overall Study|Lost to Follow-up|1|||
146364213|NCT04019795|527834015|FG003|Overall Study|Lost to Follow-up|2|||
146364214|NCT04019795|527834012|FG000|Overall Study|Treatment non-compliance|3|||
146364215|NCT04019795|527834013|FG001|Overall Study|Treatment non-compliance|1|||
146364216|NCT04019795|527834014|FG002|Overall Study|Treatment non-compliance|2|||
146364217|NCT04019795|527834015|FG003|Overall Study|Treatment non-compliance|0|||
146364218|NCT04019795|527834012|FG000|Overall Study|Physician Decision|0|||
146364219|NCT04019795|527834013|FG001|Overall Study|Physician Decision|0|||
146364220|NCT04019795|527834014|FG002|Overall Study|Physician Decision|1|||
146364221|NCT04019795|527834015|FG003|Overall Study|Physician Decision|0|||
146364222|NCT04019795|527834012|FG000|Overall Study|Adverse Event|1|||
146364223|NCT04019795|527834013|FG001|Overall Study|Adverse Event|0|||
146364224|NCT04019795|527834014|FG002|Overall Study|Adverse Event|0|||
146364225|NCT04019795|527834015|FG003|Overall Study|Adverse Event|0|||
146364226|NCT00098020|527834021|FG000|Overall Study|Adverse Event|2|||
146364227|NCT00098020|527834021|FG000|Overall Study|Lost to Follow-up|1|||
146364228|NCT00098020|527834021|FG000|Overall Study|elevated liver enzymes|1|||
146364229|NCT00098020|527834021|FG000|Overall Study|Low urine PCR|1|||
146364230|NCT00098020|527834021|FG000|Overall Study|Low epidermal growth factor receptor|1|||
146364231|NCT00712933|527834024|FG000|Overall Study|Adverse Event|69|||
146364232|NCT00712933|527834024|FG000|Overall Study|Lack of Efficacy|6|||
146364233|NCT00712933|527834024|FG000|Overall Study|Lost to Follow-up|22|||
146364234|NCT00712933|527834024|FG000|Overall Study|Non-compliance with study drug|13|||
146364235|NCT00712933|527834024|FG000|Overall Study|Other Pregnancy|37|||
146364236|NCT00712933|527834024|FG000|Overall Study|Sponsor decision|14|||
146364237|NCT00712933|527834024|FG000|Overall Study|Withdrew consent|4|||
146364238|NCT00712933|527834024|FG000|Overall Study|Hip replacement surgery|1|||
146364239|NCT00712933|527834024|FG000|Overall Study|Involved in Clinical research|3|||
146364240|NCT00712933|527834024|FG000|Overall Study|Participant hospitalized|1|||
146364241|NCT00712933|527834024|FG000|Overall Study|Participant travelled overseas|2|||
146364242|NCT00712933|527834024|FG000|Overall Study|Death of patient|1|||
146364243|NCT00712933|527834024|FG000|Overall Study|Other Physician decision|1|||
146364244|NCT00712933|527834024|FG000|Overall Study|Not committed to contraception|1|||
146364245|NCT00712933|527834024|FG000|Overall Study|Participant received medication|1|||
146364246|NCT00712933|527834024|FG000|Overall Study|Physician Decision|36|||
146364247|NCT00712933|527834024|FG000|Overall Study|Protocol Violation|4|||
146364248|NCT00712933|527834024|FG000|Overall Study|Withdrawal by Subject|151|||
146364249|NCT02022033|527834028|FG000|Overall Study|Physician Decision|1|||
146364250|NCT01429077|527834029|FG000|Overall Study|Lost to Follow-up|0|||
146364251|NCT01429077|527834030|FG001|Overall Study|Lost to Follow-up|3|||
146364252|NCT01413542|527834032|FG000|Overall Study|Physician Decision|1|||
146364253|NCT01413542|527834033|FG001|Overall Study|Physician Decision|0|||
146364254|NCT01413542|527834034|FG002|Overall Study|Physician Decision|3|||
146364255|NCT01413542|527834035|FG003|Overall Study|Physician Decision|0|||
146364256|NCT01413542|527834032|FG000|Overall Study|Adverse Event|0|||
146364257|NCT01413542|527834033|FG001|Overall Study|Adverse Event|0|||
146364258|NCT01413542|527834034|FG002|Overall Study|Adverse Event|0|||
146364259|NCT01413542|527834035|FG003|Overall Study|Adverse Event|1|||
146364260|NCT03084718|527834036|FG000|Overall Study|Withdrawal by Subject|4|||
146364261|NCT03084718|527834037|FG001|Overall Study|Withdrawal by Subject|3|||
146364262|NCT03084718|527834038|FG002|Overall Study|Withdrawal by Subject|4|||
146364263|NCT03084718|527834039|FG003|Overall Study|Withdrawal by Subject|0|||
146364264|NCT03084718|527834040|FG004|Overall Study|Withdrawal by Subject|0|||
146364265|NCT03084718|527834036|FG000|Overall Study|Physician Decision|1|||
146364266|NCT03084718|527834037|FG001|Overall Study|Physician Decision|0|||
146364267|NCT03084718|527834038|FG002|Overall Study|Physician Decision|0|||
146364268|NCT03084718|527834039|FG003|Overall Study|Physician Decision|0|||
146364269|NCT03084718|527834040|FG004|Overall Study|Physician Decision|0|||
146364270|NCT03084718|527834036|FG000|Overall Study|Adverse Event|3|||
146364271|NCT03084718|527834037|FG001|Overall Study|Adverse Event|5|||
146364272|NCT03084718|527834038|FG002|Overall Study|Adverse Event|5|||
146364273|NCT03084718|527834039|FG003|Overall Study|Adverse Event|8|||
146364274|NCT03084718|527834040|FG004|Overall Study|Adverse Event|2|||
146364275|NCT03084718|527834036|FG000|Overall Study|Lack of Efficacy|2|||
146364276|NCT03084718|527834037|FG001|Overall Study|Lack of Efficacy|0|||
146364277|NCT03084718|527834038|FG002|Overall Study|Lack of Efficacy|1|||
146364278|NCT03084718|527834039|FG003|Overall Study|Lack of Efficacy|4|||
146364279|NCT03084718|527834040|FG004|Overall Study|Lack of Efficacy|0|||
146364280|NCT03084718|527834036|FG000|Overall Study|Lost to Follow-up|0|||
146364281|NCT03084718|527834037|FG001|Overall Study|Lost to Follow-up|1|||
146364282|NCT03084718|527834038|FG002|Overall Study|Lost to Follow-up|0|||
146364283|NCT03084718|527834039|FG003|Overall Study|Lost to Follow-up|0|||
146364284|NCT03084718|527834040|FG004|Overall Study|Lost to Follow-up|2|||
146364285|NCT03084718|527834036|FG000|Overall Study|Protocol Violation|0|||
146364286|NCT03084718|527834037|FG001|Overall Study|Protocol Violation|0|||
146364287|NCT03084718|527834038|FG002|Overall Study|Protocol Violation|1|||
146364288|NCT03084718|527834039|FG003|Overall Study|Protocol Violation|0|||
146364289|NCT03084718|527834040|FG004|Overall Study|Protocol Violation|0|||
146364290|NCT03084718|527834036|FG000|Overall Study|Death|0|||
146364291|NCT03084718|527834037|FG001|Overall Study|Death|1|||
146364292|NCT03084718|527834038|FG002|Overall Study|Death|0|||
146364293|NCT03084718|527834039|FG003|Overall Study|Death|0|||
146364294|NCT03084718|527834040|FG004|Overall Study|Death|0|||
146364295|NCT03084718|527834036|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
146364296|NCT03084718|527834037|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
146364297|NCT03084718|527834038|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
146364298|NCT03084718|527834039|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
146364299|NCT03084718|527834040|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
146364300|NCT03341923|527834041|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
146364301|NCT03341923|527834042|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
146364302|NCT02806947|527834043|FG000|Overall Study|Withdrawal by Subject|5|||
146364303|NCT02806947|527834044|FG001|Overall Study|Withdrawal by Subject|1|||
146364304|NCT03986190|527834045|FG000|Overall Study|Withdrawal by Subject|12|||
146364305|NCT03986190|527834046|FG001|Overall Study|Withdrawal by Subject|0|||
146364306|NCT04511819|527834047|FG000|Overall Study|Non-compliance with study drug|5|||
146364307|NCT04511819|527834048|FG001|Overall Study|Non-compliance with study drug|1|||
146364308|NCT04511819|527834047|FG000|Overall Study|Withdrawal by Subject|0|||
146364309|NCT04511819|527834048|FG001|Overall Study|Withdrawal by Subject|3|||
146364310|NCT04511819|527834047|FG000|Overall Study|Adverse Event|0|||
146364311|NCT04511819|527834048|FG001|Overall Study|Adverse Event|1|||
146364312|NCT04511819|527834047|FG000|Overall Study|Protocol deviation|1|||
146364313|NCT04511819|527834048|FG001|Overall Study|Protocol deviation|0|||
146364314|NCT02767856|527834059|FG000|Overall Study|Lost to Follow-up|9|||
146364315|NCT02767856|527834060|FG001|Overall Study|Lost to Follow-up|1|||
146364316|NCT02767856|527834059|FG000|Overall Study|Withdrawal by Subject|2|||
146364317|NCT02767856|527834060|FG001|Overall Study|Withdrawal by Subject|1|||
146364318|NCT01594333|527834061|FG000|Overall Study|Death|96|||
146364319|NCT01594333|527834062|FG001|Overall Study|Death|83|||
146364320|NCT01594333|527834061|FG000|Overall Study|Lost to Follow-up|5|||
146364321|NCT01594333|527834062|FG001|Overall Study|Lost to Follow-up|5|||
146364322|NCT01594333|527834061|FG000|Overall Study|Withdrawal by Subject|60|||
146364323|NCT01594333|527834062|FG001|Overall Study|Withdrawal by Subject|63|||
146364324|NCT03176277|527834063|FG000|Part A Dose Escalation Study|Adverse Event|1|||
146364325|NCT03176277|527834064|FG001|Part A Dose Escalation Study|Adverse Event|0|||
146364326|NCT03176277|527834065|FG002|Part A Dose Escalation Study|Adverse Event|1|||
146364327|NCT03176277|527834066|FG003|Part A Dose Escalation Study|Adverse Event|0|||
146364328|NCT03176277|527834063|FG000|Part A Dose Escalation Study|Physician Decision|1|||
146364329|NCT03176277|527834064|FG001|Part A Dose Escalation Study|Physician Decision|1|||
146364330|NCT03176277|527834065|FG002|Part A Dose Escalation Study|Physician Decision|2|||
146364331|NCT03176277|527834066|FG003|Part A Dose Escalation Study|Physician Decision|0|||
146364332|NCT03176277|527834063|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
146364333|NCT03176277|527834064|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
146364334|NCT03176277|527834065|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
146364335|NCT03176277|527834066|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
146364336|NCT03176277|527834063|FG000|Part A Dose Escalation Study|Progressive disease|3|||
146364337|NCT03176277|527834064|FG001|Part A Dose Escalation Study|Progressive disease|1|||
146364338|NCT03176277|527834065|FG002|Part A Dose Escalation Study|Progressive disease|3|||
146364339|NCT03176277|527834066|FG003|Part A Dose Escalation Study|Progressive disease|0|||
146364340|NCT03282357|527834068|FG000|Overall Study|Lost to Follow-up|3|||
146364341|NCT03282357|527834068|FG000|Overall Study|Withdrawal by Subject|4|||
146364342|NCT03282357|527834068|FG000|Overall Study|Adverse Event|1|||
146364343|NCT03282357|527834068|FG000|Overall Study|Other|9|||
146364344|NCT03550131|527834069|FG000|Overall Study|Lost to Follow-up|16|||
146364345|NCT03550131|527834070|FG001|Overall Study|Lost to Follow-up|24|||
146364346|NCT03550131|527834069|FG000|Overall Study|Withdrawal by Subject|36|||
146364347|NCT03550131|527834070|FG001|Overall Study|Withdrawal by Subject|28|||
146364348|NCT03550131|527834069|FG000|Overall Study|Illness of dyad member|10|||
146364349|NCT03550131|527834070|FG001|Overall Study|Illness of dyad member|2|||
146364350|NCT03550131|527834069|FG000|Overall Study|Death of person with dementia|4|||
146364351|NCT03550131|527834070|FG001|Overall Study|Death of person with dementia|8|||
146364352|NCT01318512|527834071|FG000|Maintenance Period (6 Months)|Death|2|||
146364353|NCT01318512|527834071|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
146364354|NCT01822691|527834076|FG000|Overall Study|Withdrawal by Subject|2|||
146364355|NCT00622869|527834077|FG000|Overall Study|Subject Withdrew Consent|13|||
146364356|NCT00622869|527834078|FG001|Overall Study|Subject Withdrew Consent|17|||
146364357|NCT00622869|527834079|FG002|Overall Study|Subject Withdrew Consent|11|||
146364358|NCT00622869|527834077|FG000|Overall Study|Administrative Problems|11|||
146364359|NCT00622869|527834078|FG001|Overall Study|Administrative Problems|17|||
146364360|NCT00622869|527834079|FG002|Overall Study|Administrative Problems|13|||
146364361|NCT00622869|527834077|FG000|Overall Study|Death|12|||
146364362|NCT00622869|527834078|FG001|Overall Study|Death|15|||
146364363|NCT00622869|527834079|FG002|Overall Study|Death|10|||
146364364|NCT00622869|527834077|FG000|Overall Study|Lost to Follow-up|2|||
146364365|NCT00622869|527834078|FG001|Overall Study|Lost to Follow-up|4|||
146364366|NCT00622869|527834079|FG002|Overall Study|Lost to Follow-up|2|||
146364367|NCT00622869|527834077|FG000|Overall Study|Graft Loss|5|||
146364368|NCT00622869|527834078|FG001|Overall Study|Graft Loss|3|||
146364369|NCT00622869|527834079|FG002|Overall Study|Graft Loss|2|||
146364370|NCT00622869|527834077|FG000|Overall Study|Missing|0|||
146364371|NCT00622869|527834078|FG001|Overall Study|Missing|1|||
146364372|NCT00622869|527834079|FG002|Overall Study|Missing|1|||
146364373|NCT04664855|527834080|FG000|Overall Study|Withdrawal by Subject|0|||
146364374|NCT04664855|527834081|FG001|Overall Study|Withdrawal by Subject|2|||
146364375|NCT03076190|527834083|FG000|Overall Study|Lost to Follow-up|9|||
146364376|NCT03076190|527834084|FG001|Overall Study|Lost to Follow-up|34|||
146364377|NCT03076190|527834083|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
146364378|NCT03076190|527834084|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
146364379|NCT01283997|527835353|FG000|Overall Study|Physician Decision|8|||
146364380|NCT01283997|527835354|FG001|Overall Study|Physician Decision|10|||
146364381|NCT01283997|527835353|FG000|Overall Study|Withdrawal by Subject|3|||
146364382|NCT01283997|527835354|FG001|Overall Study|Withdrawal by Subject|2|||
146364383|NCT01283997|527835353|FG000|Overall Study|Physically unable to continue|0|||
146364384|NCT01283997|527835354|FG001|Overall Study|Physically unable to continue|1|||
146364385|NCT01283997|527835353|FG000|Overall Study|Progressive disease|1|||
146364386|NCT01283997|527835354|FG001|Overall Study|Progressive disease|0|||
146364387|NCT01283997|527835353|FG000|Overall Study|Other|4|||
146364388|NCT01283997|527835354|FG001|Overall Study|Other|4|||
146364389|NCT02658968|527835355|FG000|Received Rituximab|Adverse Event|0|||
146364390|NCT02658968|527835356|FG001|Received Rituximab|Adverse Event|0|||
146364391|NCT02658968|527835357|FG002|Received Rituximab|Adverse Event|0|||
146364392|NCT02658968|527835358|FG003|Received Rituximab|Adverse Event|0|||
146364393|NCT02658968|527835359|FG004|Received Rituximab|Adverse Event|1|||
146364394|NCT02658968|527835355|FG000|Received Rituximab|Progressive disease|0|||
146364395|NCT02658968|527835356|FG001|Received Rituximab|Progressive disease|0|||
146364396|NCT02658968|527835357|FG002|Received Rituximab|Progressive disease|0|||
146364397|NCT02658968|527835358|FG003|Received Rituximab|Progressive disease|0|||
146364398|NCT02658968|527835359|FG004|Received Rituximab|Progressive disease|1|||
146364399|NCT02658968|527835355|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
146364400|NCT02658968|527835356|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
146364401|NCT02658968|527835357|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
146364402|NCT02658968|527835358|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
146364403|NCT02658968|527835359|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
146364404|NCT02658968|527835355|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
146364405|NCT02658968|527835356|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
146364406|NCT02658968|527835357|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
146364407|NCT02658968|527835358|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
146364408|NCT02658968|527835359|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
146364409|NCT02658968|527835355|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146364410|NCT02658968|527835356|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
146364411|NCT02658968|527835357|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146364412|NCT02658968|527835358|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
146364413|NCT02658968|527835359|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
146364414|NCT02658968|527835355|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146364415|NCT02658968|527835356|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
146364416|NCT02658968|527835357|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146364417|NCT02658968|527835358|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146364418|NCT02658968|527835359|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
146364419|NCT02658968|527835355|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
146364420|NCT02658968|527835356|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
146364421|NCT02658968|527835357|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
146364422|NCT02658968|527835358|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
146364423|NCT02658968|527835359|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
146364424|NCT03097614|527835363|FG000|Overall Study|Adverse Event|3|||
146364425|NCT00436982|527835364|FG000|Overall Study|Withdrawal by Subject|3|||
146364426|NCT00436982|527835365|FG001|Overall Study|Withdrawal by Subject|1|||
146364427|NCT00436982|527835364|FG000|Overall Study|Did not receive allocated intervention|0|||
146364428|NCT00436982|527835365|FG001|Overall Study|Did not receive allocated intervention|1|||
146364429|NCT00436982|527835364|FG000|Overall Study|no RSA data|1|||
146364430|NCT00436982|527835365|FG001|Overall Study|no RSA data|2|||
146364431|NCT00953225|527835369|FG000|Overall Study|Withdrawal by Subject|2|||
146364432|NCT00953225|527835370|FG001|Overall Study|Withdrawal by Subject|0|||
146364433|NCT04058158|527835373|FG000|Period 1|Death|1|||
146364434|NCT04058158|527835374|FG001|Period 1|Death|0|||
146364435|NCT04058158|527835373|FG000|Period 1|Adverse Event|1|||
146364436|NCT04058158|527835374|FG001|Period 1|Adverse Event|1|||
146364437|NCT04058158|527835373|FG000|Period 1|Pregnancy|0|||
146364438|NCT04058158|527835374|FG001|Period 1|Pregnancy|1|||
146364439|NCT02215616|527835375|FG000|Overall Study|Sponsor requested to stop study drug|0|||
146364440|NCT02215616|527835376|FG001|Overall Study|Sponsor requested to stop study drug|0|||
146364441|NCT02215616|527835377|FG002|Overall Study|Sponsor requested to stop study drug|1|||
146364442|NCT02215616|527835378|FG003|Overall Study|Sponsor requested to stop study drug|4|||
146364443|NCT02215616|527835375|FG000|Overall Study|Death|1|||
146364444|NCT02215616|527835376|FG001|Overall Study|Death|0|||
146364445|NCT02215616|527835377|FG002|Overall Study|Death|0|||
146364446|NCT02215616|527835378|FG003|Overall Study|Death|0|||
146364447|NCT02215616|527835375|FG000|Overall Study|Adverse Event|7|||
146364448|NCT02215616|527835376|FG001|Overall Study|Adverse Event|4|||
146364449|NCT02215616|527835377|FG002|Overall Study|Adverse Event|9|||
146364450|NCT02215616|527835378|FG003|Overall Study|Adverse Event|2|||
146364451|NCT02215616|527835375|FG000|Overall Study|Withdrawal by Subject|1|||
146364452|NCT02215616|527835376|FG001|Overall Study|Withdrawal by Subject|8|||
146364453|NCT02215616|527835377|FG002|Overall Study|Withdrawal by Subject|2|||
146364454|NCT02215616|527835378|FG003|Overall Study|Withdrawal by Subject|5|||
146364455|NCT02215616|527835375|FG000|Overall Study|Non-compliance|0|||
146364456|NCT02215616|527835376|FG001|Overall Study|Non-compliance|2|||
146364457|NCT02215616|527835377|FG002|Overall Study|Non-compliance|1|||
146364458|NCT02215616|527835378|FG003|Overall Study|Non-compliance|0|||
146364459|NCT02215616|527835375|FG000|Overall Study|Protocol Violation|0|||
146364460|NCT02215616|527835376|FG001|Overall Study|Protocol Violation|2|||
146364461|NCT02215616|527835377|FG002|Overall Study|Protocol Violation|0|||
146364462|NCT02215616|527835378|FG003|Overall Study|Protocol Violation|0|||
146364463|NCT02215616|527835375|FG000|Overall Study|Lost to Follow-up|1|||
146364464|NCT02215616|527835376|FG001|Overall Study|Lost to Follow-up|1|||
146364465|NCT02215616|527835377|FG002|Overall Study|Lost to Follow-up|0|||
146364466|NCT02215616|527835378|FG003|Overall Study|Lost to Follow-up|1|||
146364467|NCT02215616|527835375|FG000|Overall Study|Other than specified|1|||
146364468|NCT02215616|527835376|FG001|Overall Study|Other than specified|0|||
146364469|NCT02215616|527835377|FG002|Overall Study|Other than specified|1|||
146364470|NCT02215616|527835378|FG003|Overall Study|Other than specified|1|||
146364471|NCT01634113|527835379|FG000|Overall Study|Not treated|0|||
146364472|NCT01634113|527835380|FG001|Overall Study|Not treated|0|||
146364473|NCT01634113|527835381|FG002|Overall Study|Not treated|1|||
146364474|NCT01352845|527835384|FG000|Overall Study|Lost to Follow-up|313|||
146364475|NCT01352845|527835385|FG001|Overall Study|Lost to Follow-up|92|||
146364476|NCT01352845|527835384|FG000|Overall Study|No Longer Willing to Participate|205|||
146364477|NCT01352845|527835385|FG001|Overall Study|No Longer Willing to Participate|58|||
146364478|NCT01352845|527835384|FG000|Overall Study|Withdrawal by Subject|48|||
146364479|NCT01352845|527835385|FG001|Overall Study|Withdrawal by Subject|16|||
146364480|NCT01352845|527835384|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
146364481|NCT01352845|527835385|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
146364482|NCT01352845|527835384|FG000|Overall Study|Pregnancy|27|||
146364483|NCT01352845|527835385|FG001|Overall Study|Pregnancy|7|||
146364484|NCT01352845|527835384|FG000|Overall Study|Adverse Event|22|||
146364485|NCT01352845|527835385|FG001|Overall Study|Adverse Event|6|||
146364486|NCT01352845|527835384|FG000|Overall Study|Other|17|||
146364487|NCT01352845|527835385|FG001|Overall Study|Other|7|||
146364488|NCT01352845|527835384|FG000|Overall Study|Protocol Violation|12|||
146364489|NCT01352845|527835385|FG001|Overall Study|Protocol Violation|6|||
146364490|NCT01352845|527835384|FG000|Overall Study|Death|3|||
146364491|NCT01352845|527835385|FG001|Overall Study|Death|0|||
146364492|NCT01956240|527835386|FG000|Overall Study|Lost to Follow-up|6|||
146364493|NCT01956240|527835387|FG001|Overall Study|Lost to Follow-up|20|||
146364494|NCT01956240|527835386|FG000|Overall Study|Adverse Event|17|||
146364495|NCT01956240|527835387|FG001|Overall Study|Adverse Event|4|||
146364496|NCT02759562|527835391|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
146364497|NCT02759562|527835392|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
146364498|NCT02759562|527835391|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
146364499|NCT02759562|527835392|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
146364500|NCT02293993|527835393|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
146364501|NCT02293993|527835394|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
146364502|NCT02293993|527835395|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
146364503|NCT02293993|527835396|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
146364504|NCT02293993|527835393|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
146364505|NCT02293993|527835394|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
146364506|NCT02293993|527835395|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
146364507|NCT02293993|527835396|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
146364508|NCT02293993|527835393|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146364509|NCT02293993|527835394|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146364510|NCT02293993|527835395|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
146364511|NCT02293993|527835396|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
146364512|NCT02293993|527835393|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
146364513|NCT02293993|527835394|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
146364514|NCT02293993|527835395|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
146364515|NCT02293993|527835396|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
146364516|NCT02293993|527835393|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146364517|NCT02293993|527835394|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
146364518|NCT02293993|527835395|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146364519|NCT02293993|527835396|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
146364520|NCT01957709|527835397|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
146364521|NCT03587584|527835398|FG000|Overall Study|SOC deviations|4|||
146364522|NCT03587584|527835399|FG001|Overall Study|SOC deviations|6|||
146364523|NCT03587584|527835398|FG000|Overall Study|Incomplete data|0|||
146364524|NCT03587584|527835399|FG001|Overall Study|Incomplete data|3|||
146364525|NCT03115112|527835407|FG000|Overall Study|Adverse Event|5|||
146364526|NCT03115112|527835408|FG001|Overall Study|Adverse Event|1|||
146364527|NCT03115112|527835407|FG000|Overall Study|Withdrawal by Subject|4|||
146364528|NCT03115112|527835408|FG001|Overall Study|Withdrawal by Subject|2|||
146364529|NCT03115112|527835407|FG000|Overall Study|Lost to Follow-up|0|||
146364530|NCT03115112|527835408|FG001|Overall Study|Lost to Follow-up|1|||
146364531|NCT03115112|527835407|FG000|Overall Study|Death|1|||
146364532|NCT03115112|527835408|FG001|Overall Study|Death|0|||
146364533|NCT03115112|527835407|FG000|Overall Study|Pregnancy|1|||
146364534|NCT03115112|527835408|FG001|Overall Study|Pregnancy|0|||
146364535|NCT03115112|527835407|FG000|Overall Study|Site closure|1|||
146364536|NCT03115112|527835408|FG001|Overall Study|Site closure|1|||
146364537|NCT01170702|527835413|FG000|Overall Study|Exclusion criteria met after consent|1|||
146364538|NCT01170702|527835414|FG001|Overall Study|Exclusion criteria met after consent|2|||
146364539|NCT01170702|527835415|FG002|Overall Study|Exclusion criteria met after consent|0|||
146364540|NCT01170702|527835416|FG003|Overall Study|Exclusion criteria met after consent|2|||
146364541|NCT01453998|527835417|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
146364542|NCT01453998|527835418|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
146364543|NCT01453998|527835419|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
146364544|NCT01879319|527835422|FG000|Overall Study|Withdrawal by Subject|1|||
146364545|NCT01879319|527835423|FG001|Overall Study|Withdrawal by Subject|0|||
146364546|NCT01879319|527835422|FG000|Overall Study|Lost to Follow-up|1|||
146364547|NCT01879319|527835423|FG001|Overall Study|Lost to Follow-up|5|||
146364548|NCT00589979|527835425|FG000|Run-In Period|Adverse Event|5|||
146364549|NCT00589979|527835426|FG001|Run-In Period|Adverse Event|0|||
146364550|NCT00589979|527835427|FG002|Run-In Period|Adverse Event|0|||
146364551|NCT00589979|527835425|FG000|Run-In Period|Protocol Violation|3|||
146364552|NCT00589979|527835426|FG001|Run-In Period|Protocol Violation|0|||
146364553|NCT00589979|527835427|FG002|Run-In Period|Protocol Violation|0|||
146364554|NCT00589979|527835425|FG000|Run-In Period|Did not qualify for randomization|54|||
146364555|NCT00589979|527835426|FG001|Run-In Period|Did not qualify for randomization|0|||
146364556|NCT00589979|527835427|FG002|Run-In Period|Did not qualify for randomization|0|||
146364557|NCT00589979|527835425|FG000|Run-In Period|Withdrawal by Subject|10|||
146364558|NCT00589979|527835426|FG001|Run-In Period|Withdrawal by Subject|0|||
146364559|NCT00589979|527835427|FG002|Run-In Period|Withdrawal by Subject|0|||
146364560|NCT00589979|527835425|FG000|Run-In Period|Informed Consent Withdrawn|4|||
146364561|NCT00589979|527835426|FG001|Run-In Period|Informed Consent Withdrawn|0|||
146364562|NCT00589979|527835427|FG002|Run-In Period|Informed Consent Withdrawn|0|||
146364563|NCT00589979|527835425|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
146364564|NCT00589979|527835426|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
146364565|NCT00589979|527835427|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
146364566|NCT00589979|527835425|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
146364567|NCT00589979|527835426|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
146364568|NCT00589979|527835427|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
146364569|NCT00589979|527835425|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
146364570|NCT00589979|527835426|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
146364571|NCT00589979|527835427|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
146364572|NCT00589979|527835425|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
146364573|NCT00589979|527835426|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
146364574|NCT00589979|527835427|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
146364575|NCT00589979|527835425|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
146364576|NCT00589979|527835426|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
146364577|NCT00589979|527835427|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
146364578|NCT00589979|527835425|FG000|Double-Blind Treatment Period 2|Other|0|||
146364579|NCT00589979|527835426|FG001|Double-Blind Treatment Period 2|Other|0|||
146364580|NCT00589979|527835427|FG002|Double-Blind Treatment Period 2|Other|1|||
146364581|NCT00589979|527835425|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
146364582|NCT00589979|527835426|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
146364583|NCT00589979|527835427|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
146364584|NCT00589979|527835425|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
146364585|NCT00589979|527835426|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
146364586|NCT00589979|527835427|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
146364587|NCT01397448|527835438|FG000|Overall Study|Adverse Event|4|||
146364588|NCT01397448|527835439|FG001|Overall Study|Adverse Event|4|||
146364589|NCT01397448|527835440|FG002|Overall Study|Adverse Event|6|||
146364590|NCT01397448|527835438|FG000|Overall Study|Withdrawal by Subject|4|||
146364591|NCT01397448|527835439|FG001|Overall Study|Withdrawal by Subject|4|||
146364592|NCT01397448|527835440|FG002|Overall Study|Withdrawal by Subject|3|||
146364593|NCT01397448|527835438|FG000|Overall Study|Lack of Efficacy|2|||
146364594|NCT01397448|527835439|FG001|Overall Study|Lack of Efficacy|0|||
146364595|NCT01397448|527835440|FG002|Overall Study|Lack of Efficacy|5|||
146364596|NCT01397448|527835438|FG000|Overall Study|Other|8|||
146364597|NCT01397448|527835439|FG001|Overall Study|Other|7|||
146364598|NCT01397448|527835440|FG002|Overall Study|Other|4|||
146364599|NCT02180217|527835447|FG000|Overall Study|Adverse Event|3|||
146364600|NCT02180217|527835448|FG001|Overall Study|Adverse Event|2|||
146364601|NCT02180217|527835449|FG002|Overall Study|Adverse Event|22|||
146364602|NCT02180217|527835447|FG000|Overall Study|Death|1|||
146364603|NCT02180217|527835448|FG001|Overall Study|Death|1|||
146364604|NCT02180217|527835449|FG002|Overall Study|Death|0|||
146364605|NCT02180217|527835447|FG000|Overall Study|Withdrawal by Subject|1|||
146364606|NCT02180217|527835448|FG001|Overall Study|Withdrawal by Subject|1|||
146364607|NCT02180217|527835449|FG002|Overall Study|Withdrawal by Subject|4|||
146364608|NCT02180217|527835447|FG000|Overall Study|Subject/Guardian decision|5|||
146364609|NCT02180217|527835448|FG001|Overall Study|Subject/Guardian decision|3|||
146364610|NCT02180217|527835449|FG002|Overall Study|Subject/Guardian decision|6|||
146364611|NCT02180217|527835447|FG000|Overall Study|Physician Decision|1|||
146364612|NCT02180217|527835448|FG001|Overall Study|Physician Decision|1|||
146364613|NCT02180217|527835449|FG002|Overall Study|Physician Decision|6|||
146364614|NCT02180217|527835447|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146364615|NCT02180217|527835448|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146364616|NCT02180217|527835449|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
146364617|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
146364618|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
146364619|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
146364620|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
146364621|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
146364622|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
146364623|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Death|1|||
146364624|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Death|3|||
146364625|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
146364626|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
146169792|NCT00316173|527132940|FG000|Run-in Phase|Adverse Event|1|||
146364627|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
146364628|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
146364629|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
146364630|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
146364631|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
146364632|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
146364633|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
146364634|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
146364635|NCT02553317|527835450|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
146364636|NCT02553317|527835451|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
146364637|NCT03483116|527835453|FG000|Overall Study|Adverse Event|0|||
146364638|NCT03483116|527835454|FG001|Overall Study|Adverse Event|1|||
146169793|NCT00316173|527132941|FG001|Run-in Phase|Adverse Event|0|||
146169794|NCT00316173|527132940|FG000|Run-in Phase|Protocol Violation|1|||
146169795|NCT00316173|527132941|FG001|Run-in Phase|Protocol Violation|0|||
146169796|NCT00316173|527132940|FG000|Run-in Phase|Study Follow-up Stopped|5|||
146169797|NCT00316173|527132941|FG001|Run-in Phase|Study Follow-up Stopped|0|||
146169798|NCT00316173|527132940|FG000|Treatment Phase|Adverse Event|0|||
146169799|NCT00316173|527132941|FG001|Treatment Phase|Adverse Event|1|||
146169800|NCT00316173|527132940|FG000|Treatment Phase|Lack of Efficacy|0|||
146169801|NCT00316173|527132941|FG001|Treatment Phase|Lack of Efficacy|3|||
146169802|NCT00316173|527132940|FG000|Treatment Phase|Lost to Follow-up|0|||
146169803|NCT00316173|527132941|FG001|Treatment Phase|Lost to Follow-up|3|||
146169804|NCT00316173|527132940|FG000|Treatment Phase|Withdrawal by Subject|0|||
146169805|NCT00316173|527132941|FG001|Treatment Phase|Withdrawal by Subject|1|||
146169806|NCT00316173|527132940|FG000|Treatment Phase|Study Follow-up Stopped|0|||
146364639|NCT03483116|527835455|FG002|Overall Study|Adverse Event|0|||
146364640|NCT03483116|527835456|FG003|Overall Study|Adverse Event|1|||
146364641|NCT03483116|527835453|FG000|Overall Study|Protocol Violation|1|||
146364642|NCT03483116|527835454|FG001|Overall Study|Protocol Violation|0|||
146364643|NCT03483116|527835455|FG002|Overall Study|Protocol Violation|0|||
146364644|NCT03483116|527835456|FG003|Overall Study|Protocol Violation|7|||
146364645|NCT03483116|527835453|FG000|Overall Study|Lost to Follow-up|9|||
146364646|NCT03483116|527835454|FG001|Overall Study|Lost to Follow-up|4|||
146364647|NCT03483116|527835455|FG002|Overall Study|Lost to Follow-up|9|||
146364648|NCT03483116|527835456|FG003|Overall Study|Lost to Follow-up|5|||
146364649|NCT03483116|527835453|FG000|Overall Study|Death|1|||
146364650|NCT03483116|527835454|FG001|Overall Study|Death|0|||
146364651|NCT03483116|527835455|FG002|Overall Study|Death|2|||
146364652|NCT03483116|527835456|FG003|Overall Study|Death|1|||
146364653|NCT03483116|527835453|FG000|Overall Study|Withdrawal by Subject|14|||
146364654|NCT03483116|527835454|FG001|Overall Study|Withdrawal by Subject|16|||
146364655|NCT03483116|527835455|FG002|Overall Study|Withdrawal by Subject|14|||
146364656|NCT03483116|527835456|FG003|Overall Study|Withdrawal by Subject|16|||
146364657|NCT03483116|527835453|FG000|Overall Study|Unknown other reason|3|||
146364658|NCT03483116|527835454|FG001|Overall Study|Unknown other reason|2|||
146364659|NCT03483116|527835455|FG002|Overall Study|Unknown other reason|1|||
146364660|NCT03483116|527835456|FG003|Overall Study|Unknown other reason|1|||
146364661|NCT00239837|527835460|FG000|Overall Study|Lost to Follow-up|3|||
146364662|NCT00239837|527835461|FG001|Overall Study|Lost to Follow-up|7|||
146364663|NCT01838590|527835462|FG000|Overall Study|Lack of Efficacy|12|||
146364664|NCT01838590|527835463|FG001|Overall Study|Lack of Efficacy|4|||
146364665|NCT01838590|527835462|FG000|Overall Study|Lost to Follow-up|0|||
146364666|NCT01838590|527835463|FG001|Overall Study|Lost to Follow-up|1|||
145943403|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
146169807|NCT00316173|527132941|FG001|Treatment Phase|Study Follow-up Stopped|34|||
146169808|NCT04108000|527132946|FG000|Overall Study|Death of patient|1|||
146364667|NCT00536978|527835464|FG000|Overall Study|Not eligible for Adback Infusion|22|||
146364668|NCT00393913|527835467|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
146364669|NCT00393913|527835467|FG000|Initial Assessment|Withdrawal by Subject|16|||
146364670|NCT00393913|527835467|FG000|CPAP|Withdrawal by Subject|3|||
146364671|NCT00393913|527835467|FG000|CPAP|Physician Decision|1|||
146364672|NCT00393913|527835467|FG000|CPAP|TEchnical problem with CPAP|3|||
146364673|NCT01518244|527835468|FG000|Overall Study|Adverse Event|3|||
146364674|NCT00870818|527835469|FG000|Overall Study|Lost to Follow-up|3|||
146364675|NCT00870818|527835470|FG001|Overall Study|Lost to Follow-up|2|||
146364676|NCT00870818|527835471|FG002|Overall Study|Lost to Follow-up|1|||
146364677|NCT00870818|527835472|FG003|Overall Study|Lost to Follow-up|0|||
146364678|NCT00870818|527835473|FG004|Overall Study|Lost to Follow-up|0|||
146364679|NCT00870818|527835469|FG000|Overall Study|Withdrawal by Subject|0|||
146364680|NCT00870818|527835470|FG001|Overall Study|Withdrawal by Subject|0|||
146364681|NCT00870818|527835471|FG002|Overall Study|Withdrawal by Subject|1|||
146364682|NCT00870818|527835472|FG003|Overall Study|Withdrawal by Subject|2|||
146364683|NCT00870818|527835473|FG004|Overall Study|Withdrawal by Subject|0|||
146364684|NCT00870818|527835469|FG000|Overall Study|Terminated by sponsor|29|||
146364685|NCT00870818|527835470|FG001|Overall Study|Terminated by sponsor|70|||
146364686|NCT00870818|527835471|FG002|Overall Study|Terminated by sponsor|36|||
146364687|NCT00870818|527835472|FG003|Overall Study|Terminated by sponsor|36|||
146364688|NCT00870818|527835473|FG004|Overall Study|Terminated by sponsor|38|||
146364689|NCT00870818|527835469|FG000|Overall Study|Other|0|||
146364690|NCT00870818|527835470|FG001|Overall Study|Other|1|||
146364691|NCT00870818|527835471|FG002|Overall Study|Other|0|||
146364692|NCT00870818|527835472|FG003|Overall Study|Other|0|||
146364693|NCT00870818|527835473|FG004|Overall Study|Other|0|||
146364694|NCT04900038|527835474|FG000|Overall Study|Adverse Event|1|||
146364695|NCT04900038|527835475|FG001|Overall Study|Adverse Event|0|||
146364696|NCT04900038|527835476|FG002|Overall Study|Adverse Event|1|||
146364697|NCT04900038|527835477|FG003|Overall Study|Adverse Event|1|||
146364698|NCT04900038|527835474|FG000|Overall Study|Withdrawal by Subject|0|||
146364699|NCT04900038|527835475|FG001|Overall Study|Withdrawal by Subject|1|||
146364700|NCT04900038|527835476|FG002|Overall Study|Withdrawal by Subject|0|||
146364701|NCT04900038|527835477|FG003|Overall Study|Withdrawal by Subject|0|||
146364702|NCT04900038|527835474|FG000|Overall Study|Study terminated by sponsor|18|||
146364703|NCT04900038|527835475|FG001|Overall Study|Study terminated by sponsor|15|||
146364704|NCT04900038|527835476|FG002|Overall Study|Study terminated by sponsor|17|||
146364705|NCT04900038|527835477|FG003|Overall Study|Study terminated by sponsor|14|||
146364706|NCT04900038|527835474|FG000|Overall Study|Protocol Deviation|1|||
146364707|NCT04900038|527835475|FG001|Overall Study|Protocol Deviation|1|||
146364708|NCT04900038|527835476|FG002|Overall Study|Protocol Deviation|0|||
146364709|NCT04900038|527835477|FG003|Overall Study|Protocol Deviation|0|||
146364710|NCT04900038|527835474|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
146364711|NCT04900038|527835475|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
146364712|NCT04900038|527835476|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
146364713|NCT04900038|527835477|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
146364714|NCT04900038|527835474|FG000|Overall Study|Lost to Follow-up|0|||
146364715|NCT04900038|527835475|FG001|Overall Study|Lost to Follow-up|0|||
146364716|NCT04900038|527835476|FG002|Overall Study|Lost to Follow-up|0|||
146364717|NCT04900038|527835477|FG003|Overall Study|Lost to Follow-up|1|||
146364718|NCT04093258|527835481|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
146364719|NCT04093258|527835482|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
146364720|NCT00986427|527835483|FG000|Overall Study|Lost to Follow-up|2|||
146364721|NCT00986427|527835484|FG001|Overall Study|Lost to Follow-up|0|||
146364722|NCT00986427|527835483|FG000|Overall Study|Lack of Efficacy|1|||
146364723|NCT00986427|527835484|FG001|Overall Study|Lack of Efficacy|0|||
146364724|NCT00986427|527835483|FG000|Overall Study|Withdrawal by Subject|1|||
146364725|NCT00986427|527835484|FG001|Overall Study|Withdrawal by Subject|0|||
146364726|NCT01512108|527837280|FG000|Overall Study|Adverse Event|9|||
146364727|NCT01512108|527837281|FG001|Overall Study|Adverse Event|4|||
146364728|NCT01512108|527837280|FG000|Overall Study|Protocol Violation|1|||
146364729|NCT01512108|527837281|FG001|Overall Study|Protocol Violation|2|||
146364730|NCT01512108|527837280|FG000|Overall Study|Withdrawal Criteria|1|||
146364731|NCT01512108|527837281|FG001|Overall Study|Withdrawal Criteria|0|||
146364732|NCT01512108|527837280|FG000|Overall Study|Unclassified|11|||
146364733|NCT01512108|527837281|FG001|Overall Study|Unclassified|3|||
146364734|NCT02017899|527837282|FG000|Overall Study|Withdrawal by Subject|0|||
146364735|NCT02017899|527837283|FG001|Overall Study|Withdrawal by Subject|0|||
146364736|NCT02017899|527837284|FG002|Overall Study|Withdrawal by Subject|0|||
146364737|NCT02017899|527837285|FG003|Overall Study|Withdrawal by Subject|1|||
146364738|NCT02017899|527837286|FG004|Overall Study|Withdrawal by Subject|1|||
146364739|NCT02017899|527837287|FG005|Overall Study|Withdrawal by Subject|0|||
146364740|NCT02843178|527837290|FG000|Overall Study|Lost to Follow-up|8|||
146364741|NCT02843178|527837291|FG001|Overall Study|Lost to Follow-up|8|||
146364742|NCT02843178|527837292|FG002|Overall Study|Lost to Follow-up|6|||
146364743|NCT02843178|527837293|FG003|Overall Study|Lost to Follow-up|3|||
146364744|NCT02843178|527837290|FG000|Overall Study|Withdrawal by Subject|0|||
146364745|NCT02843178|527837291|FG001|Overall Study|Withdrawal by Subject|0|||
146364746|NCT02843178|527837292|FG002|Overall Study|Withdrawal by Subject|1|||
146364747|NCT02843178|527837293|FG003|Overall Study|Withdrawal by Subject|1|||
146364748|NCT02109744|527837295|FG000|Overall Study|Death|1|||
146364749|NCT02109744|527837296|FG001|Overall Study|Death|1|||
146364750|NCT02109744|527837295|FG000|Overall Study|no marrow exam|1|||
146364751|NCT02109744|527837296|FG001|Overall Study|no marrow exam|0|||
146364752|NCT04095442|527837299|FG000|Overall Study|Lost to Follow-up|0|||
146364753|NCT04095442|527837300|FG001|Overall Study|Lost to Follow-up|1|||
146364754|NCT04095442|527837299|FG000|Overall Study|Screen failure|1|||
146364755|NCT04095442|527837300|FG001|Overall Study|Screen failure|0|||
146364756|NCT01677624|527837305|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
146364757|NCT02420795|527837308|FG000|Overall Study|Withdrawal by Subject|1|||
146364758|NCT02420795|527837309|FG001|Overall Study|Withdrawal by Subject|0|||
146364759|NCT02420795|527837310|FG002|Overall Study|Withdrawal by Subject|0|||
146364760|NCT02420795|527837308|FG000|Overall Study|Adverse Event|1|||
146364761|NCT02420795|527837309|FG001|Overall Study|Adverse Event|0|||
146364762|NCT02420795|527837310|FG002|Overall Study|Adverse Event|0|||
146364763|NCT02420795|527837308|FG000|Overall Study|Progressive disease|2|||
146364764|NCT02420795|527837309|FG001|Overall Study|Progressive disease|2|||
146364765|NCT02420795|527837310|FG002|Overall Study|Progressive disease|4|||
146364766|NCT02420795|527837308|FG000|Overall Study|Death|0|||
146364767|NCT02420795|527837309|FG001|Overall Study|Death|0|||
146364768|NCT02420795|527837310|FG002|Overall Study|Death|1|||
146364769|NCT00949910|527837311|FG000|Overall Study|Progressive Disease|3750|||
146364770|NCT00949910|527837311|FG000|Overall Study|Symptomatic Deterioration|1088|||
146364771|NCT00949910|527837311|FG000|Overall Study|Lost to Follow-up|100|||
146364772|NCT00949910|527837311|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
146364773|NCT00949910|527837311|FG000|Overall Study|Participant Refusal|390|||
146364774|NCT00949910|527837311|FG000|Overall Study|Death Due to Malignant Disease|456|||
146364775|NCT00949910|527837311|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
146364776|NCT00949910|527837311|FG000|Overall Study|Death Due to Adverse Event|115|||
146364777|NCT00949910|527837311|FG000|Overall Study|Death Due to Toxicity|3|||
146364778|NCT00949910|527837311|FG000|Overall Study|Death from Unknown Cause|5|||
146364779|NCT00949910|527837311|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
146364780|NCT00949910|527837311|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
146364781|NCT00949910|527837311|FG000|Overall Study|Switched to Commercial Treatment|4|||
146364782|NCT00949910|527837311|FG000|Overall Study|Violation of Eligibility|23|||
146364783|NCT00949910|527837311|FG000|Overall Study|Logistical Reasons|13|||
146364784|NCT00949910|527837311|FG000|Overall Study|Non-Compliance|10|||
146364785|NCT00949910|527837311|FG000|Overall Study|Prolonged Dosing Interruption|4|||
146364786|NCT00949910|527837311|FG000|Overall Study|Adverse Event|83|||
146364787|NCT00949910|527837311|FG000|Overall Study|Serious Adverse Event|6|||
146364788|NCT00949910|527837311|FG000|Overall Study|Physician/Participant Decision|7|||
146364789|NCT00949910|527837311|FG000|Overall Study|Other|4|||
146364790|NCT00949910|527837311|FG000|Overall Study|No Data|9|||
146364791|NCT04847141|527837312|FG000|Overall Study|Adverse Event|1|||
146364792|NCT04847141|527837313|FG001|Overall Study|Adverse Event|0|||
146364793|NCT04847141|527837314|FG002|Overall Study|Adverse Event|1|||
146364794|NCT04847141|527837312|FG000|Overall Study|Withdrawal by Subject|2|||
146364795|NCT04847141|527837313|FG001|Overall Study|Withdrawal by Subject|4|||
146364796|NCT04847141|527837314|FG002|Overall Study|Withdrawal by Subject|3|||
146364797|NCT04847141|527837312|FG000|Overall Study|Lost to Follow-up|7|||
146364798|NCT04847141|527837313|FG001|Overall Study|Lost to Follow-up|5|||
146364799|NCT04847141|527837314|FG002|Overall Study|Lost to Follow-up|7|||
146364800|NCT04847141|527837312|FG000|Overall Study|Reason not Specified|0|||
146364801|NCT04847141|527837313|FG001|Overall Study|Reason not Specified|1|||
146364802|NCT04847141|527837314|FG002|Overall Study|Reason not Specified|0|||
146364803|NCT00324740|527837315|FG000|Overall Study|Withdrawal by Subject|1|||
146364804|NCT00324740|527837316|FG001|Overall Study|Withdrawal by Subject|0|||
146364805|NCT00324740|527837317|FG002|Overall Study|Withdrawal by Subject|1|||
146364806|NCT00520299|527837320|FG000|Overall Study|Withdrawal by Subject|0|||
146364807|NCT00520299|527837321|FG001|Overall Study|Withdrawal by Subject|0|||
146364808|NCT00520299|527837322|FG002|Overall Study|Withdrawal by Subject|2|||
146169809|NCT04108000|527132947|FG001|Overall Study|Death of patient|0|||
146169810|NCT04108000|527132948|FG002|Overall Study|Death of patient|1|||
146364809|NCT00520299|527837320|FG000|Overall Study|Progressive disease|0|||
146364810|NCT00520299|527837321|FG001|Overall Study|Progressive disease|3|||
146364811|NCT00520299|527837322|FG002|Overall Study|Progressive disease|4|||
146364812|NCT00387348|527837323|FG000|Overall Study|Death|1|||
146364813|NCT00387348|527837324|FG001|Overall Study|Death|1|||
146364814|NCT00387348|527837325|FG002|Overall Study|Death|0|||
146364815|NCT00387348|527837323|FG000|Overall Study|Physician Decision|1|||
146364816|NCT00387348|527837324|FG001|Overall Study|Physician Decision|0|||
146364817|NCT00387348|527837325|FG002|Overall Study|Physician Decision|1|||
146364818|NCT00387348|527837323|FG000|Overall Study|Withdrawal by Subject|0|||
146364819|NCT00387348|527837324|FG001|Overall Study|Withdrawal by Subject|2|||
146364820|NCT00387348|527837325|FG002|Overall Study|Withdrawal by Subject|2|||
146364821|NCT00387348|527837323|FG000|Overall Study|Adverse Event|1|||
146364822|NCT00387348|527837324|FG001|Overall Study|Adverse Event|0|||
146364823|NCT00387348|527837325|FG002|Overall Study|Adverse Event|1|||
146364824|NCT00505752|527837326|FG000|Overall Study|Adverse Event|1|||
146364825|NCT00505752|527837327|FG001|Overall Study|Adverse Event|0|||
146364826|NCT00505752|527837328|FG002|Overall Study|Adverse Event|1|||
146364827|NCT00505752|527837329|FG003|Overall Study|Adverse Event|0|||
146364828|NCT00505752|527837326|FG000|Overall Study|Lost to Follow-up|1|||
146364829|NCT00505752|527837327|FG001|Overall Study|Lost to Follow-up|0|||
146364830|NCT00505752|527837328|FG002|Overall Study|Lost to Follow-up|0|||
146364831|NCT00505752|527837329|FG003|Overall Study|Lost to Follow-up|0|||
146364832|NCT00505752|527837326|FG000|Overall Study|Lack of ovarian response|1|||
146364833|NCT00505752|527837327|FG001|Overall Study|Lack of ovarian response|3|||
146364834|NCT00505752|527837328|FG002|Overall Study|Lack of ovarian response|0|||
146364835|NCT00505752|527837329|FG003|Overall Study|Lack of ovarian response|0|||
146364836|NCT00505752|527837326|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146364837|NCT00505752|527837327|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146364838|NCT00505752|527837328|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146364839|NCT00505752|527837329|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
146364840|NCT00505752|527837326|FG000|Overall Study|No oocytes retrieved|0|||
146364841|NCT00505752|527837327|FG001|Overall Study|No oocytes retrieved|2|||
146364842|NCT00505752|527837328|FG002|Overall Study|No oocytes retrieved|0|||
146364843|NCT00505752|527837329|FG003|Overall Study|No oocytes retrieved|1|||
146364844|NCT00505752|527837326|FG000|Overall Study|No Fertilization|1|||
146364845|NCT00505752|527837327|FG001|Overall Study|No Fertilization|1|||
146364846|NCT00505752|527837328|FG002|Overall Study|No Fertilization|2|||
146364847|NCT00505752|527837329|FG003|Overall Study|No Fertilization|1|||
146364848|NCT00505752|527837326|FG000|Overall Study|All embryos/blastocysts discarded|0|||
146364849|NCT00505752|527837327|FG001|Overall Study|All embryos/blastocysts discarded|0|||
146364850|NCT00505752|527837328|FG002|Overall Study|All embryos/blastocysts discarded|1|||
146364851|NCT00505752|527837329|FG003|Overall Study|All embryos/blastocysts discarded|1|||
146364852|NCT00505752|527837326|FG000|Overall Study|Other|1|||
146364853|NCT00505752|527837327|FG001|Overall Study|Other|2|||
146364854|NCT00505752|527837328|FG002|Overall Study|Other|1|||
146364855|NCT00505752|527837329|FG003|Overall Study|Other|2|||
146364856|NCT04624672|527837330|FG000|Overall Study|Early Study Closure|2|||
146364857|NCT04624672|527837331|FG001|Overall Study|Early Study Closure|1|||
146364858|NCT03250377|527837337|FG000|Overall Study|Adverse Event|2|||
146364859|NCT03250377|527837338|FG001|Overall Study|Adverse Event|4|||
146364860|NCT03250377|527837339|FG002|Overall Study|Adverse Event|0|||
146364861|NCT03250377|527837340|FG003|Overall Study|Adverse Event|4|||
146364862|NCT03250377|527837337|FG000|Overall Study|Lack of Efficacy|5|||
146364863|NCT03250377|527837338|FG001|Overall Study|Lack of Efficacy|14|||
146364864|NCT03250377|527837339|FG002|Overall Study|Lack of Efficacy|1|||
146364865|NCT03250377|527837340|FG003|Overall Study|Lack of Efficacy|3|||
146364866|NCT03250377|527837337|FG000|Overall Study|Protocol Violation|0|||
146364867|NCT03250377|527837338|FG001|Overall Study|Protocol Violation|2|||
146364868|NCT03250377|527837339|FG002|Overall Study|Protocol Violation|0|||
146364869|NCT03250377|527837340|FG003|Overall Study|Protocol Violation|1|||
146364870|NCT03250377|527837337|FG000|Overall Study|Lost to Follow-up|0|||
146364871|NCT03250377|527837338|FG001|Overall Study|Lost to Follow-up|1|||
146364872|NCT03250377|527837339|FG002|Overall Study|Lost to Follow-up|0|||
146364873|NCT03250377|527837340|FG003|Overall Study|Lost to Follow-up|0|||
146364874|NCT03250377|527837337|FG000|Overall Study|Withdrawal by Subject|7|||
146364875|NCT03250377|527837338|FG001|Overall Study|Withdrawal by Subject|7|||
146364876|NCT03250377|527837339|FG002|Overall Study|Withdrawal by Subject|0|||
146364877|NCT03250377|527837340|FG003|Overall Study|Withdrawal by Subject|4|||
146364878|NCT03250377|527837337|FG000|Overall Study|Investigator's Judgment|1|||
146364879|NCT03250377|527837338|FG001|Overall Study|Investigator's Judgment|0|||
146364880|NCT03250377|527837339|FG002|Overall Study|Investigator's Judgment|0|||
146364881|NCT03250377|527837340|FG003|Overall Study|Investigator's Judgment|0|||
146364882|NCT03250377|527837337|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
146364883|NCT03250377|527837338|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
146364884|NCT03250377|527837339|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
146364885|NCT03250377|527837340|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
146364886|NCT03250377|527837337|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
146364887|NCT03250377|527837338|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
146364888|NCT03250377|527837339|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
146364889|NCT03250377|527837340|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
146364890|NCT03250377|527837337|FG000|Overall Study|Epilepsy Surgery|0|||
146364891|NCT03250377|527837338|FG001|Overall Study|Epilepsy Surgery|1|||
146169811|NCT04108000|527132949|FG003|Overall Study|Death of patient|0|||
146364892|NCT03250377|527837339|FG002|Overall Study|Epilepsy Surgery|2|||
146364893|NCT03250377|527837340|FG003|Overall Study|Epilepsy Surgery|0|||
146364894|NCT03250377|527837337|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146364895|NCT03250377|527837338|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
146364896|NCT03250377|527837339|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146364897|NCT03250377|527837340|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
146364898|NCT03250377|527837337|FG000|Overall Study|Request From The Sponsor|0|||
146364899|NCT03250377|527837338|FG001|Overall Study|Request From The Sponsor|1|||
146364900|NCT03250377|527837339|FG002|Overall Study|Request From The Sponsor|0|||
146364901|NCT03250377|527837340|FG003|Overall Study|Request From The Sponsor|0|||
146364902|NCT03250377|527837337|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
146364903|NCT03250377|527837338|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
146364904|NCT03250377|527837339|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
146364905|NCT03250377|527837340|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
146364906|NCT03250377|527837337|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
146364907|NCT03250377|527837338|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
146364908|NCT03250377|527837339|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
146364909|NCT03250377|527837340|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
146364910|NCT03250377|527837337|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
146364911|NCT03250377|527837338|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
146364912|NCT03250377|527837339|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
146364913|NCT03250377|527837340|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
146364914|NCT03250377|527837337|FG000|Overall Study|Pregnancy Event|0|||
146364915|NCT03250377|527837338|FG001|Overall Study|Pregnancy Event|1|||
146364916|NCT03250377|527837339|FG002|Overall Study|Pregnancy Event|0|||
146364917|NCT03250377|527837340|FG003|Overall Study|Pregnancy Event|0|||
146364918|NCT03250377|527837337|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146364919|NCT03250377|527837338|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
146364920|NCT03250377|527837339|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146364921|NCT03250377|527837340|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
146364922|NCT03250377|527837337|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146364923|NCT03250377|527837338|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
146364924|NCT03250377|527837339|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146364925|NCT03250377|527837340|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
146364926|NCT03250377|527837337|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146364927|NCT03250377|527837338|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
146364928|NCT03250377|527837339|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146364929|NCT03250377|527837340|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
146364930|NCT03250377|527837337|FG000|Overall Study|Patient requested to change hospital|0|||
146364931|NCT03250377|527837338|FG001|Overall Study|Patient requested to change hospital|0|||
146364932|NCT03250377|527837339|FG002|Overall Study|Patient requested to change hospital|0|||
146364933|NCT03250377|527837340|FG003|Overall Study|Patient requested to change hospital|1|||
146364934|NCT03250377|527837337|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
146364935|NCT03250377|527837338|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
146364936|NCT03250377|527837339|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
146364937|NCT03250377|527837340|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
146364938|NCT02168803|527837342|FG000|Overall Study|Lost to Follow-up|1|||
146364939|NCT02168803|527837343|FG001|Overall Study|Lost to Follow-up|0|||
146364940|NCT02168803|527837344|FG002|Overall Study|Lost to Follow-up|1|||
146364941|NCT02168803|527837342|FG000|Overall Study|Withdrawal by Subject|1|||
146364942|NCT02168803|527837343|FG001|Overall Study|Withdrawal by Subject|1|||
146364943|NCT02168803|527837344|FG002|Overall Study|Withdrawal by Subject|2|||
146364944|NCT02168803|527837342|FG000|Overall Study|Physician Decision|0|||
146364945|NCT02168803|527837343|FG001|Overall Study|Physician Decision|1|||
146364946|NCT02168803|527837344|FG002|Overall Study|Physician Decision|0|||
146364947|NCT02168803|527837342|FG000|Overall Study|Adverse Event|0|||
146364948|NCT02168803|527837343|FG001|Overall Study|Adverse Event|1|||
146364949|NCT02168803|527837344|FG002|Overall Study|Adverse Event|1|||
146364950|NCT02168803|527837342|FG000|Overall Study|Death|0|||
146364951|NCT02168803|527837343|FG001|Overall Study|Death|0|||
146364952|NCT02168803|527837344|FG002|Overall Study|Death|1|||
146364953|NCT02168803|527837342|FG000|Overall Study|Sponsor Decision|0|||
146364954|NCT02168803|527837343|FG001|Overall Study|Sponsor Decision|0|||
146364955|NCT02168803|527837344|FG002|Overall Study|Sponsor Decision|1|||
146364956|NCT01114373|527837345|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
146364957|NCT01114373|527837346|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
146364958|NCT01114373|527837345|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
146364959|NCT01114373|527837346|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
146364960|NCT01114373|527837345|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
146364961|NCT01114373|527837346|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
146364962|NCT01114373|527837345|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
146364963|NCT01114373|527837346|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
146364964|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146364965|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146364966|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
146364967|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
146364968|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146364969|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
146364970|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
146364971|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
146364972|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
146364973|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146364974|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146364975|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
146364976|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
146364977|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
146364978|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
146364979|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146364980|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146364981|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
146364982|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
146364983|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
146364984|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146364985|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146364986|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146364987|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
146364988|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
146364989|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
146364990|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146364991|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146364992|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146364993|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
146364994|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
146364995|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146364996|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146364997|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146364998|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146364999|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
146365000|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
146365001|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
146365002|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
146365003|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
146365004|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
146365005|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
146365006|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
146365007|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
146365008|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146365009|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146365010|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146365011|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
146365012|NCT03444870|527837347|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
146365013|NCT03444870|527837348|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146365014|NCT03444870|527837349|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146365015|NCT03444870|527837350|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146365016|NCT03444870|527837351|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146365017|NCT03444870|527837352|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
146365018|NCT03444870|527837347|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146365019|NCT03444870|527837348|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146365020|NCT03444870|527837349|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146365021|NCT03444870|527837350|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
146365022|NCT03444870|527837351|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
146365023|NCT03444870|527837352|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
146365024|NCT03444870|527837347|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
146365025|NCT03444870|527837348|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
146365026|NCT03444870|527837349|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
146365027|NCT03444870|527837350|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
146365028|NCT03444870|527837351|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
146365029|NCT03444870|527837352|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
146365030|NCT03444870|527837347|FG000|Open-Label Extension (OLE) Period|Death|0|||
146365031|NCT03444870|527837348|FG001|Open-Label Extension (OLE) Period|Death|0|||
146365032|NCT03444870|527837349|FG002|Open-Label Extension (OLE) Period|Death|0|||
146365033|NCT03444870|527837350|FG003|Open-Label Extension (OLE) Period|Death|0|||
146365034|NCT03444870|527837351|FG004|Open-Label Extension (OLE) Period|Death|1|||
146365035|NCT03444870|527837352|FG005|Open-Label Extension (OLE) Period|Death|0|||
146365036|NCT00868166|527837353|FG000|Overall Study|Death|58|||
146365037|NCT00868166|527837354|FG001|Overall Study|Death|65|||
146365038|NCT00868166|527837353|FG000|Overall Study|Withdrawal by Subject|33|||
146365039|NCT00868166|527837354|FG001|Overall Study|Withdrawal by Subject|25|||
146365040|NCT00868166|527837353|FG000|Overall Study|Protocol Violation|1|||
146365041|NCT00868166|527837354|FG001|Overall Study|Protocol Violation|0|||
146365042|NCT00868166|527837353|FG000|Overall Study|Lost to Follow-up|1|||
146365043|NCT00868166|527837354|FG001|Overall Study|Lost to Follow-up|3|||
146365044|NCT00868166|527837353|FG000|Overall Study|Adverse Event|9|||
146365045|NCT00868166|527837354|FG001|Overall Study|Adverse Event|10|||
146365046|NCT00868166|527837353|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
146365047|NCT00868166|527837354|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
146365048|NCT00868166|527837353|FG000|Overall Study|Non-compliance with IMP|1|||
146365049|NCT00868166|527837354|FG001|Overall Study|Non-compliance with IMP|1|||
146365050|NCT02310906|527837355|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146365051|NCT02310906|527837356|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146365052|NCT02310906|527837357|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
146365053|NCT02310906|527837358|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
146365054|NCT02310906|527837355|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
146365055|NCT02310906|527837356|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
146365056|NCT02310906|527837357|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
146365057|NCT02310906|527837358|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
146365058|NCT02310906|527837355|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146365059|NCT02310906|527837356|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146365060|NCT02310906|527837357|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
146365061|NCT02310906|527837358|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
146365062|NCT02310906|527837355|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146365063|NCT02310906|527837356|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146365064|NCT02310906|527837357|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
146365065|NCT02310906|527837358|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
146365066|NCT00433446|527837361|FG000|Overall Study|Adverse Event|4|||
146365067|NCT00433446|527837361|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
146365068|NCT00433446|527837361|FG000|Overall Study|Progression|44|||
146365069|NCT00433446|527837361|FG000|Overall Study|Other - Not Protocol specified|3|||
146365070|NCT00433446|527837361|FG000|Overall Study|Ineligible|9|||
146365071|NCT03819218|527837362|FG000|Overall Study|Protocol Violation|1|||
146365072|NCT01188538|527837363|FG000|Overall Study|Lost to Follow-up|0|||
146365073|NCT01188538|527837364|FG001|Overall Study|Lost to Follow-up|1|||
146365074|NCT02267278|527837365|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
146365075|NCT02267278|527837365|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
146365076|NCT02267278|527837365|FG000|Overall Study|Developed new cancer diagnoses|2|||
146365077|NCT02267278|527837365|FG000|Overall Study|prescribed prohibited medication|1|||
146365078|NCT02513771|527837366|FG000|Overall Study|Lost to Follow-up|1|||
146365079|NCT02513771|527837367|FG001|Overall Study|Lost to Follow-up|1|||
146365080|NCT02513771|527837366|FG000|Overall Study|Not being able to get to clinic|1|||
146365081|NCT02513771|527837367|FG001|Overall Study|Not being able to get to clinic|0|||
146365082|NCT01797445|527837368|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
146365083|NCT01797445|527837369|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
146365084|NCT01797445|527837368|FG000|Double-Blind Phase|Adverse Event|3|||
146365085|NCT01797445|527837369|FG001|Double-Blind Phase|Adverse Event|0|||
146365086|NCT01797445|527837368|FG000|Double-Blind Phase|Death|5|||
146365087|NCT01797445|527837369|FG001|Double-Blind Phase|Death|4|||
146365088|NCT01797445|527837368|FG000|Double-Blind Phase|Pregnancy|0|||
146365089|NCT01797445|527837369|FG001|Double-Blind Phase|Pregnancy|1|||
146365090|NCT01797445|527837368|FG000|Double-Blind Phase|Lack of Efficacy|1|||
146365091|NCT01797445|527837369|FG001|Double-Blind Phase|Lack of Efficacy|2|||
146365092|NCT01797445|527837368|FG000|Double-Blind Phase|Investigator's Discretion|15|||
146365093|NCT01797445|527837369|FG001|Double-Blind Phase|Investigator's Discretion|17|||
146365094|NCT01797445|527837368|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
146365095|NCT01797445|527837369|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
146365096|NCT01797445|527837368|FG000|Double-Blind Phase|Protocol Violation|0|||
146365097|NCT01797445|527837369|FG001|Double-Blind Phase|Protocol Violation|1|||
146365098|NCT01797445|527837368|FG000|Double-Blind Phase|Withdrew Consent|20|||
146365099|NCT01797445|527837369|FG001|Double-Blind Phase|Withdrew Consent|35|||
146365100|NCT01797445|527837368|FG000|Double-Blind Phase|Lost to Follow-up|34|||
146365101|NCT01797445|527837369|FG001|Double-Blind Phase|Lost to Follow-up|26|||
146365102|NCT01797445|527837368|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
146365103|NCT01797445|527837369|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
146365104|NCT01595438|527837370|FG000|Overall Study|Lost to Follow-up|20|||
146365105|NCT01595438|527837371|FG001|Overall Study|Lost to Follow-up|20|||
146365106|NCT01595438|527837370|FG000|Overall Study|Withdrawal by Subject|12|||
146365107|NCT01595438|527837371|FG001|Overall Study|Withdrawal by Subject|12|||
146365108|NCT01595438|527837370|FG000|Overall Study|Other Eligibility criteria|11|||
146365109|NCT01595438|527837371|FG001|Overall Study|Other Eligibility criteria|9|||
146365110|NCT00650091|527837373|FG000|Amended Study Design|Withdrawal by Subject|12|||
146365111|NCT00650091|527837374|FG001|Amended Study Design|Withdrawal by Subject|11|||
146365112|NCT00650091|527837375|FG002|Amended Study Design|Withdrawal by Subject|0|||
146365113|NCT00650091|527837373|FG000|Amended Study Design|Physician Decision|5|||
146365114|NCT00650091|527837374|FG001|Amended Study Design|Physician Decision|0|||
146365115|NCT00650091|527837375|FG002|Amended Study Design|Physician Decision|0|||
146365116|NCT00650091|527837373|FG000|Amended Study Design|Adverse Event|1|||
146365117|NCT00650091|527837374|FG001|Amended Study Design|Adverse Event|4|||
146365118|NCT00650091|527837375|FG002|Amended Study Design|Adverse Event|0|||
146365119|NCT00650091|527837373|FG000|Amended Study Design|Lung transplantation|4|||
146365120|NCT00650091|527837374|FG001|Amended Study Design|Lung transplantation|2|||
146365121|NCT00650091|527837375|FG002|Amended Study Design|Lung transplantation|0|||
146365122|NCT00650091|527837373|FG000|Amended Study Design|Other|1|||
146365123|NCT00650091|527837374|FG001|Amended Study Design|Other|3|||
146365124|NCT00650091|527837375|FG002|Amended Study Design|Other|0|||
146365125|NCT01204697|527837376|FG000|Overall Study|Death|26|||
146365126|NCT01204697|527837377|FG001|Overall Study|Death|27|||
146365127|NCT01204697|527837376|FG000|Overall Study|Lost to Follow-up|3|||
146365128|NCT01204697|527837377|FG001|Overall Study|Lost to Follow-up|4|||
146365129|NCT01204697|527837376|FG000|Overall Study|Withdrawal by Subject|2|||
146365130|NCT01204697|527837377|FG001|Overall Study|Withdrawal by Subject|4|||
146365131|NCT01204697|527837376|FG000|Overall Study|Randomized, but not treated|0|||
146365132|NCT01204697|527837377|FG001|Overall Study|Randomized, but not treated|1|||
146365133|NCT01280266|527837384|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
146365134|NCT01280266|527837385|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
146365135|NCT01280266|527837384|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
146365136|NCT01280266|527837385|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
146365137|NCT00469209|527837392|FG000|Overall Study|Adverse Event|1|||
146365138|NCT00469209|527837393|FG001|Overall Study|Adverse Event|0|||
146365139|NCT00469209|527837394|FG002|Overall Study|Adverse Event|1|||
146365140|NCT04268004|527837397|FG000|Overall Study|Excluded from analyses|0|||
146365141|NCT04268004|527837398|FG001|Overall Study|Excluded from analyses|1|||
146365142|NCT01082367|527837399|FG000|Double-blind Period|Administrative problems|0|||
146365143|NCT01082367|527837400|FG001|Double-blind Period|Administrative problems|1|||
146365144|NCT01082367|527837399|FG000|Double-blind Period|Lack of Efficacy|5|||
146365145|NCT01082367|527837400|FG001|Double-blind Period|Lack of Efficacy|11|||
146365146|NCT01082367|527837399|FG000|Double-blind Period|Adverse Event|0|||
146365147|NCT01082367|527837400|FG001|Double-blind Period|Adverse Event|1|||
146365148|NCT01082367|527837399|FG000|Follow-up (F-U) Period|Administrative problems|1|||
146365149|NCT01082367|527837400|FG001|Follow-up (F-U) Period|Administrative problems|0|||
146365150|NCT01082367|527837399|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
146365151|NCT01082367|527837400|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
146365152|NCT01082367|527837399|FG000|Follow-up (F-U) Period|Adverse Event|0|||
146365153|NCT01082367|527837400|FG001|Follow-up (F-U) Period|Adverse Event|1|||
146365154|NCT04724733|527837406|FG000|Overall Study|Lost to Follow-up|1|||
146365155|NCT04724733|527837407|FG001|Overall Study|Lost to Follow-up|1|||
146365156|NCT04724733|527837408|FG002|Overall Study|Lost to Follow-up|1|||
146365157|NCT03067129|527837409|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146365158|NCT03067129|527837410|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146365159|NCT03067129|527837411|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
146365160|NCT03067129|527837412|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
146365161|NCT03067129|527837409|FG000|Overall Study|Withdrawal by Subject|0|||
146365162|NCT03067129|527837410|FG001|Overall Study|Withdrawal by Subject|0|||
146365163|NCT03067129|527837411|FG002|Overall Study|Withdrawal by Subject|1|||
146365164|NCT03067129|527837412|FG003|Overall Study|Withdrawal by Subject|2|||
146365165|NCT03067129|527837409|FG000|Overall Study|Lost to Follow-up|5|||
146365166|NCT03067129|527837410|FG001|Overall Study|Lost to Follow-up|5|||
146365167|NCT03067129|527837411|FG002|Overall Study|Lost to Follow-up|4|||
146365168|NCT03067129|527837412|FG003|Overall Study|Lost to Follow-up|3|||
146365169|NCT03372603|527837413|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
146365170|NCT03372603|527837414|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
146365171|NCT03372603|527837413|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
146365172|NCT03372603|527837414|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
146365173|NCT04929613|527837415|FG000|Overall Study|Withdrawal by Subject|12|||
146365174|NCT00664209|527837421|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
146365175|NCT00664209|527837421|FG000|Study Treatment Period|Physician Decision|4|||
146365176|NCT00664209|527837421|FG000|Study Treatment Period|Withdrawal by Subject|2|||
146365177|NCT00418379|527837422|FG000|Year 1|Adverse Event|9|||
146365178|NCT00418379|527837423|FG001|Year 1|Adverse Event|15|||
146365179|NCT00418379|527837424|FG002|Year 1|Adverse Event|3|||
146365180|NCT00418379|527837422|FG000|Year 1|Withdrawal by Subject|7|||
146365181|NCT00418379|527837423|FG001|Year 1|Withdrawal by Subject|8|||
146365182|NCT00418379|527837424|FG002|Year 1|Withdrawal by Subject|5|||
146365183|NCT00418379|527837422|FG000|Year 1|Any other reason not above-mentioned|2|||
146365184|NCT00418379|527837423|FG001|Year 1|Any other reason not above-mentioned|5|||
146365185|NCT00418379|527837424|FG002|Year 1|Any other reason not above-mentioned|7|||
146365186|NCT00418379|527837422|FG000|Year 2|Adverse Event|5|||
146365187|NCT00418379|527837423|FG001|Year 2|Adverse Event|2|||
146365188|NCT00418379|527837424|FG002|Year 2|Adverse Event|1|||
146365189|NCT00418379|527837422|FG000|Year 2|Withdrawal by Subject|1|||
146365190|NCT00418379|527837423|FG001|Year 2|Withdrawal by Subject|1|||
146365191|NCT00418379|527837424|FG002|Year 2|Withdrawal by Subject|3|||
146365192|NCT00418379|527837422|FG000|Year 2|Any other reason not above-mentioned|2|||
146365193|NCT00418379|527837423|FG001|Year 2|Any other reason not above-mentioned|1|||
146365194|NCT00418379|527837424|FG002|Year 2|Any other reason not above-mentioned|6|||
146365195|NCT00418379|527837422|FG000|Year 3|Withdrawal by Subject|1|||
146365196|NCT00418379|527837423|FG001|Year 3|Withdrawal by Subject|1|||
146365197|NCT00418379|527837424|FG002|Year 3|Withdrawal by Subject|2|||
146365198|NCT00418379|527837422|FG000|Year 3|Any other reason not above-mentioned|2|||
146365199|NCT00418379|527837423|FG001|Year 3|Any other reason not above-mentioned|1|||
146365200|NCT00418379|527837424|FG002|Year 3|Any other reason not above-mentioned|1|||
146365201|NCT00418379|527837422|FG000|Year 4|Adverse Event|0|||
146365202|NCT00418379|527837423|FG001|Year 4|Adverse Event|1|||
146365203|NCT00418379|527837424|FG002|Year 4|Adverse Event|0|||
146365204|NCT00418379|527837422|FG000|Year 4|Withdrawal by Subject|2|||
146365205|NCT00418379|527837423|FG001|Year 4|Withdrawal by Subject|3|||
146365206|NCT00418379|527837424|FG002|Year 4|Withdrawal by Subject|2|||
146365207|NCT00418379|527837422|FG000|Year 4|Any other reason not above-mentioned|1|||
146365208|NCT00418379|527837423|FG001|Year 4|Any other reason not above-mentioned|1|||
146365209|NCT00418379|527837424|FG002|Year 4|Any other reason not above-mentioned|0|||
146365210|NCT00418379|527837422|FG000|Year 5|Adverse Event|0|||
146365211|NCT00418379|527837423|FG001|Year 5|Adverse Event|1|||
146365212|NCT00418379|527837424|FG002|Year 5|Adverse Event|0|||
146365213|NCT00418379|527837422|FG000|Year 5|Any other reason not above-mentioned|2|||
146365214|NCT00418379|527837423|FG001|Year 5|Any other reason not above-mentioned|4|||
146365215|NCT00418379|527837424|FG002|Year 5|Any other reason not above-mentioned|3|||
146365216|NCT00843843|527837425|FG000|Overall Study|Physician Decision|1|||
146365217|NCT00843843|527837426|FG001|Overall Study|Physician Decision|1|||
146365218|NCT00843843|527837425|FG000|Overall Study|Protocol Violation|1|||
146365219|NCT00843843|527837426|FG001|Overall Study|Protocol Violation|1|||
146365220|NCT01764256|527837427|FG000|Received All Vaccinations|Adverse Event|1|||
146365221|NCT01764256|527837428|FG001|Received All Vaccinations|Adverse Event|1|||
146365222|NCT01764256|527837429|FG002|Received All Vaccinations|Adverse Event|0|||
146365223|NCT01764256|527837430|FG003|Received All Vaccinations|Adverse Event|0|||
146365224|NCT01764256|527837427|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
146365225|NCT01764256|527837428|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
146365226|NCT01764256|527837429|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
146365227|NCT01764256|527837430|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
146365228|NCT01764256|527837427|FG000|Received All Vaccinations|Lost to Follow-up|1|||
146365229|NCT01764256|527837428|FG001|Received All Vaccinations|Lost to Follow-up|0|||
146365230|NCT01764256|527837429|FG002|Received All Vaccinations|Lost to Follow-up|0|||
146365231|NCT01764256|527837430|FG003|Received All Vaccinations|Lost to Follow-up|0|||
146365232|NCT01764256|527837427|FG000|Completed Study|Lost to Follow-up|0|||
146365233|NCT01764256|527837428|FG001|Completed Study|Lost to Follow-up|0|||
146365234|NCT01764256|527837429|FG002|Completed Study|Lost to Follow-up|0|||
146365235|NCT01764256|527837430|FG003|Completed Study|Lost to Follow-up|1|||
146365236|NCT02029638|527837431|FG000|Overall Study|Death|0|||
146365237|NCT02029638|527837432|FG001|Overall Study|Death|0|||
146365238|NCT02029638|527837433|FG002|Overall Study|Death|1|||
146365239|NCT02029638|527837431|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
146365240|NCT02029638|527837432|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
146365241|NCT02029638|527837433|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
146365242|NCT01153841|527837434|FG000|Overall Study|Adverse Event|1|||
146365243|NCT01153841|527837435|FG001|Overall Study|Adverse Event|0|||
146365244|NCT01153841|527837434|FG000|Overall Study|Withdrawal by Subject|1|||
146365245|NCT01153841|527837435|FG001|Overall Study|Withdrawal by Subject|0|||
146365246|NCT01153841|527837434|FG000|Overall Study|Protocol Violation|2|||
146365247|NCT01153841|527837435|FG001|Overall Study|Protocol Violation|0|||
146365248|NCT01153841|527837434|FG000|Overall Study|Lost to Follow-up|2|||
146365249|NCT01153841|527837435|FG001|Overall Study|Lost to Follow-up|0|||
146365250|NCT00830804|527837436|FG000|Overall Study|Lost to Follow-up|4|||
146365251|NCT00830804|527837436|FG000|Overall Study|Death|1|||
146365252|NCT00830804|527837436|FG000|Overall Study|Unable to get to clinic|7|||
146365253|NCT00830804|527837436|FG000|Overall Study|Consent withdrawn|2|||
146365254|NCT00830804|527837436|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
146365255|NCT03428997|527837437|FG000|Overall Study|Sponsor decision.|1|||
146365256|NCT03428997|527837437|FG000|Overall Study|Withdrawal by Subject|3|||
146365257|NCT03428997|527837437|FG000|Overall Study|Lost to Follow-up|4|||
146365258|NCT00510068|527837444|FG000|Double-blind Period|Disease progression|98|||
146365259|NCT00510068|527837445|FG001|Double-blind Period|Disease progression|169|||
146365260|NCT00510068|527837444|FG000|Double-blind Period|Final primary analysis|52|||
146365261|NCT00510068|527837445|FG001|Double-blind Period|Final primary analysis|18|||
146365262|NCT00510068|527837444|FG000|Double-blind Period|Adverse Event|37|||
146365263|NCT00510068|527837445|FG001|Double-blind Period|Adverse Event|7|||
146365264|NCT00510068|527837444|FG000|Double-blind Period|Withdrawal by Subject|8|||
146365265|NCT00510068|527837445|FG001|Double-blind Period|Withdrawal by Subject|6|||
146365266|NCT00510068|527837444|FG000|Double-blind Period|Death|4|||
146365267|NCT00510068|527837445|FG001|Double-blind Period|Death|3|||
146365268|NCT00510068|527837444|FG000|Double-blind Period|Abnormal test result (s)|1|||
146365269|NCT00510068|527837445|FG001|Double-blind Period|Abnormal test result (s)|0|||
146365270|NCT00510068|527837444|FG000|Double-blind Period|Lost to Follow-up|1|||
146365271|NCT00510068|527837445|FG001|Double-blind Period|Lost to Follow-up|0|||
146365272|NCT00510068|527837444|FG000|Double-blind Period|Protocol Violation|6|||
146365273|NCT00510068|527837445|FG001|Double-blind Period|Protocol Violation|0|||
146365274|NCT00510068|527837444|FG000|Open-label Period|Disease Progression|124|||
146365275|NCT00510068|527837445|FG001|Open-label Period|Disease Progression|0|||
146365276|NCT00510068|527837444|FG000|Open-label Period|Adverse Event|46|||
146365277|NCT00510068|527837445|FG001|Open-label Period|Adverse Event|0|||
146365278|NCT00510068|527837444|FG000|Open-label Period|Withdrawal by Subject|21|||
146365279|NCT00510068|527837445|FG001|Open-label Period|Withdrawal by Subject|0|||
146365280|NCT00510068|527837444|FG000|Open-label Period|Administrative problems|17|||
146365281|NCT00510068|527837445|FG001|Open-label Period|Administrative problems|0|||
146365282|NCT00510068|527837444|FG000|Open-label Period|Death|7|||
146365283|NCT00510068|527837445|FG001|Open-label Period|Death|0|||
146365284|NCT00510068|527837444|FG000|Open-label Period|New cancer therapy|7|||
146365285|NCT00510068|527837445|FG001|Open-label Period|New cancer therapy|0|||
146365286|NCT00510068|527837444|FG000|Open-label Period|Protocol Violation|2|||
146365287|NCT00510068|527837445|FG001|Open-label Period|Protocol Violation|0|||
146365288|NCT00510068|527837444|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
146365289|NCT00510068|527837445|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
146365290|NCT00776555|527837446|FG000|Overall Study|Study terminated|3|||
146365291|NCT00776555|527837447|FG001|Overall Study|Study terminated|0|||
146365292|NCT02475395|527837448|FG000|Overall Study|Protocol Violation|30|||
146365293|NCT02475395|527837449|FG001|Overall Study|Protocol Violation|3|||
146365294|NCT00567541|527837450|FG000|Overall Study|Adverse Event|0|||
146365295|NCT00567541|527837451|FG001|Overall Study|Adverse Event|1|||
146365296|NCT03337139|527837452|FG000|Phase I|Withdrawal by Subject|10|||
146365297|NCT03337139|527837453|FG001|Phase I|Withdrawal by Subject|0|||
146365298|NCT03288493|527837454|FG000|Overall Study|Withdrawal by Subject|4|||
146365299|NCT03288493|527837455|FG001|Overall Study|Withdrawal by Subject|0|||
146365300|NCT03288493|527837456|FG002|Overall Study|Withdrawal by Subject|0|||
146365301|NCT03288493|527837457|FG003|Overall Study|Withdrawal by Subject|0|||
146365302|NCT03288493|527837458|FG004|Overall Study|Withdrawal by Subject|0|||
146365303|NCT03288493|527837459|FG005|Overall Study|Withdrawal by Subject|2|||
146365304|NCT03288493|527837460|FG006|Overall Study|Withdrawal by Subject|0|||
146365305|NCT03288493|527837454|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
146365306|NCT03288493|527837455|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
146365307|NCT03288493|527837456|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
146365308|NCT03288493|527837457|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
146365309|NCT03288493|527837458|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
146365310|NCT03288493|527837459|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
146365311|NCT03288493|527837460|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
146365312|NCT03288493|527837454|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
146365313|NCT03288493|527837455|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146365314|NCT03288493|527837456|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146365315|NCT03288493|527837457|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
146365316|NCT03288493|527837458|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146365317|NCT03288493|527837459|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
146365318|NCT03288493|527837460|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
146365319|NCT03288493|527837454|FG000|Overall Study|Death|2|||
146365320|NCT03288493|527837455|FG001|Overall Study|Death|0|||
146365321|NCT03288493|527837456|FG002|Overall Study|Death|0|||
146365322|NCT03288493|527837457|FG003|Overall Study|Death|0|||
146365323|NCT03288493|527837458|FG004|Overall Study|Death|0|||
146365324|NCT03288493|527837459|FG005|Overall Study|Death|0|||
146365325|NCT03288493|527837460|FG006|Overall Study|Death|0|||
146365326|NCT03288493|527837454|FG000|Overall Study|other reason not listed above|2|||
146365327|NCT03288493|527837455|FG001|Overall Study|other reason not listed above|0|||
146365328|NCT03288493|527837456|FG002|Overall Study|other reason not listed above|0|||
146365329|NCT03288493|527837457|FG003|Overall Study|other reason not listed above|0|||
146365330|NCT03288493|527837458|FG004|Overall Study|other reason not listed above|0|||
146365331|NCT03288493|527837459|FG005|Overall Study|other reason not listed above|0|||
146365332|NCT03288493|527837460|FG006|Overall Study|other reason not listed above|0|||
146365333|NCT06025396|527839958|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
146365334|NCT06025396|527839959|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
146365335|NCT06025396|527839960|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
146365336|NCT06025396|527839961|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
146365337|NCT06025396|527839962|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
146365338|NCT06025396|527839958|FG000|Overall Study|Withdrawal by Subject|0|||
146365339|NCT06025396|527839959|FG001|Overall Study|Withdrawal by Subject|1|||
146365340|NCT06025396|527839960|FG002|Overall Study|Withdrawal by Subject|1|||
146365341|NCT06025396|527839961|FG003|Overall Study|Withdrawal by Subject|0|||
146365342|NCT06025396|527839962|FG004|Overall Study|Withdrawal by Subject|0|||
146365343|NCT06422377|527839967|FG000|Overall Study|Study Terminated by Sponsor|1|||
146365344|NCT00646113|527839968|FG000|Overall Study|Lost to Follow-up|5|||
146365345|NCT00646113|527839968|FG000|Overall Study|Adverse Event|3|||
146365346|NCT00804843|527839969|FG000|Overall Study|Protocol Violation|1|||
146365347|NCT00804843|527839970|FG001|Overall Study|Protocol Violation|0|||
146365348|NCT00804843|527839969|FG000|Overall Study|Adverse Event|8|||
146365349|NCT00804843|527839970|FG001|Overall Study|Adverse Event|5|||
146365350|NCT00804843|527839969|FG000|Overall Study|Withdrawal by Subject|1|||
146365351|NCT00804843|527839970|FG001|Overall Study|Withdrawal by Subject|2|||
146365352|NCT03287869|527839971|FG000|Overall Study|Adverse Event|14|||
146365353|NCT03287869|527839972|FG001|Overall Study|Adverse Event|12|||
146365354|NCT03287869|527839971|FG000|Overall Study|Lack of Efficacy|1|||
146365355|NCT03287869|527839972|FG001|Overall Study|Lack of Efficacy|0|||
146365356|NCT03287869|527839971|FG000|Overall Study|Lost to Follow-up|13|||
146365357|NCT03287869|527839972|FG001|Overall Study|Lost to Follow-up|19|||
146365358|NCT03287869|527839971|FG000|Overall Study|Non-Compliance With Study Drug|5|||
146365359|NCT03287869|527839972|FG001|Overall Study|Non-Compliance With Study Drug|9|||
146365360|NCT03287869|527839971|FG000|Overall Study|Progressive Disease|1|||
146365361|NCT03287869|527839972|FG001|Overall Study|Progressive Disease|0|||
146365362|NCT03287869|527839971|FG000|Overall Study|Protocol Deviation|2|||
146365363|NCT03287869|527839972|FG001|Overall Study|Protocol Deviation|1|||
146365364|NCT03287869|527839971|FG000|Overall Study|Withdrawal by Subject|36|||
146365365|NCT03287869|527839972|FG001|Overall Study|Withdrawal by Subject|43|||
146365366|NCT03287869|527839971|FG000|Overall Study|Early Closure of the Site|0|||
146365367|NCT03287869|527839972|FG001|Overall Study|Early Closure of the Site|1|||
146365368|NCT03287869|527839971|FG000|Overall Study|Physician Decision|5|||
146365369|NCT03287869|527839972|FG001|Overall Study|Physician Decision|5|||
146365370|NCT03287869|527839971|FG000|Overall Study|Reason not Specified|6|||
146365371|NCT03287869|527839972|FG001|Overall Study|Reason not Specified|3|||
146365372|NCT02455388|527839976|FG000|Overall Study|Protocol Violation|1|||
146365373|NCT02455388|527839977|FG001|Overall Study|Protocol Violation|0|||
146365374|NCT02455388|527839978|FG002|Overall Study|Protocol Violation|4|||
146365375|NCT02455388|527839976|FG000|Overall Study|Withdrawal by Subject|0|||
146365376|NCT02455388|527839977|FG001|Overall Study|Withdrawal by Subject|0|||
146365377|NCT02455388|527839978|FG002|Overall Study|Withdrawal by Subject|7|||
146365378|NCT00971425|527839982|FG000|Overall Study|Adverse Event|1|||
146365379|NCT00971425|527839983|FG001|Overall Study|Adverse Event|1|||
146365380|NCT00971425|527839982|FG000|Overall Study|Withdrawal by Subject|0|||
146365381|NCT00971425|527839983|FG001|Overall Study|Withdrawal by Subject|1|||
146365382|NCT02528253|527839986|FG000|Overall Study|Adverse Event|3|||
146365383|NCT02528253|527839987|FG001|Overall Study|Adverse Event|4|||
146365384|NCT02528253|527839988|FG002|Overall Study|Adverse Event|4|||
146365385|NCT02528253|527839989|FG003|Overall Study|Adverse Event|8|||
146365386|NCT02528253|527839990|FG004|Overall Study|Adverse Event|18|||
146365387|NCT02528253|527839986|FG000|Overall Study|Death|2|||
146365388|NCT02528253|527839987|FG001|Overall Study|Death|2|||
146365389|NCT02528253|527839988|FG002|Overall Study|Death|1|||
146365390|NCT02528253|527839989|FG003|Overall Study|Death|0|||
146365391|NCT02528253|527839990|FG004|Overall Study|Death|1|||
146365392|NCT02528253|527839986|FG000|Overall Study|Insufficient clinical response|7|||
146365393|NCT02528253|527839987|FG001|Overall Study|Insufficient clinical response|10|||
146365394|NCT02528253|527839988|FG002|Overall Study|Insufficient clinical response|13|||
146365395|NCT02528253|527839989|FG003|Overall Study|Insufficient clinical response|12|||
146365396|NCT02528253|527839990|FG004|Overall Study|Insufficient clinical response|16|||
146365397|NCT02528253|527839986|FG000|Overall Study|Lost to Follow-up|16|||
146365398|NCT02528253|527839987|FG001|Overall Study|Lost to Follow-up|9|||
146365399|NCT02528253|527839988|FG002|Overall Study|Lost to Follow-up|31|||
146365400|NCT02528253|527839989|FG003|Overall Study|Lost to Follow-up|16|||
146365401|NCT02528253|527839990|FG004|Overall Study|Lost to Follow-up|34|||
146365402|NCT02528253|527839986|FG000|Overall Study|Other|21|||
146365403|NCT02528253|527839987|FG001|Overall Study|Other|22|||
146365404|NCT02528253|527839988|FG002|Overall Study|Other|58|||
146365405|NCT02528253|527839989|FG003|Overall Study|Other|52|||
146365406|NCT02528253|527839990|FG004|Overall Study|Other|76|||
146365407|NCT02528253|527839986|FG000|Overall Study|Withdrawal by Subject|25|||
146365408|NCT02528253|527839987|FG001|Overall Study|Withdrawal by Subject|20|||
146365409|NCT02528253|527839988|FG002|Overall Study|Withdrawal by Subject|29|||
146365410|NCT02528253|527839989|FG003|Overall Study|Withdrawal by Subject|48|||
146365411|NCT02528253|527839990|FG004|Overall Study|Withdrawal by Subject|73|||
146365412|NCT02528253|527839986|FG000|Overall Study|Protocol Violation|1|||
146365413|NCT02528253|527839987|FG001|Overall Study|Protocol Violation|2|||
146365414|NCT02528253|527839988|FG002|Overall Study|Protocol Violation|4|||
146365415|NCT02528253|527839989|FG003|Overall Study|Protocol Violation|0|||
146365416|NCT02528253|527839990|FG004|Overall Study|Protocol Violation|4|||
146365417|NCT02528253|527839986|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
146365418|NCT02528253|527839987|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
146365419|NCT02528253|527839988|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
146365420|NCT02528253|527839989|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
146365421|NCT02528253|527839990|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
146365422|NCT01357980|527839991|FG000|Overall Study|Lack of Efficacy|0|||
146365423|NCT01357980|527839992|FG001|Overall Study|Lack of Efficacy|1|||
146365424|NCT01357980|527839993|FG002|Overall Study|Lack of Efficacy|0|||
146365425|NCT01357980|527839994|FG003|Overall Study|Lack of Efficacy|0|||
146365426|NCT01357980|527839991|FG000|Overall Study|Consent withdrawn|0|||
146365427|NCT01357980|527839992|FG001|Overall Study|Consent withdrawn|0|||
146365428|NCT01357980|527839993|FG002|Overall Study|Consent withdrawn|1|||
146365429|NCT01357980|527839994|FG003|Overall Study|Consent withdrawn|0|||
146365430|NCT00094835|527839997|FG000|Overall Study|Physician Decision|1|||
146365431|NCT00094835|527839998|FG001|Overall Study|Physician Decision|0|||
146365432|NCT00094835|527839999|FG002|Overall Study|Physician Decision|0|||
146365433|NCT00094835|527840000|FG003|Overall Study|Physician Decision|0|||
146365434|NCT00094835|527840001|FG004|Overall Study|Physician Decision|0|||
146365435|NCT00094835|527840002|FG005|Overall Study|Physician Decision|1|||
146365436|NCT00094835|527840003|FG006|Overall Study|Physician Decision|0|||
146365437|NCT00094835|527839997|FG000|Overall Study|Withdrawal by Subject|0|||
146365438|NCT00094835|527839998|FG001|Overall Study|Withdrawal by Subject|0|||
146365439|NCT00094835|527839999|FG002|Overall Study|Withdrawal by Subject|0|||
146365440|NCT00094835|527840000|FG003|Overall Study|Withdrawal by Subject|0|||
146365441|NCT00094835|527840001|FG004|Overall Study|Withdrawal by Subject|0|||
146365442|NCT00094835|527840002|FG005|Overall Study|Withdrawal by Subject|0|||
146365443|NCT00094835|527840003|FG006|Overall Study|Withdrawal by Subject|1|||
146365444|NCT00094835|527839997|FG000|Overall Study|Lost to Follow-up|0|||
146365445|NCT00094835|527839998|FG001|Overall Study|Lost to Follow-up|0|||
146365446|NCT00094835|527839999|FG002|Overall Study|Lost to Follow-up|0|||
146365447|NCT00094835|527840000|FG003|Overall Study|Lost to Follow-up|0|||
146365448|NCT00094835|527840001|FG004|Overall Study|Lost to Follow-up|1|||
146365449|NCT00094835|527840002|FG005|Overall Study|Lost to Follow-up|0|||
146365450|NCT00094835|527840003|FG006|Overall Study|Lost to Follow-up|0|||
146365451|NCT00094835|527839997|FG000|Overall Study|Death|1|||
146365452|NCT00094835|527839998|FG001|Overall Study|Death|0|||
146365453|NCT00094835|527839999|FG002|Overall Study|Death|0|||
146365454|NCT00094835|527840000|FG003|Overall Study|Death|0|||
146365455|NCT00094835|527840001|FG004|Overall Study|Death|1|||
146365456|NCT00094835|527840002|FG005|Overall Study|Death|0|||
146365457|NCT00094835|527840003|FG006|Overall Study|Death|0|||
146365458|NCT00094835|527839997|FG000|Overall Study|Non-compliance|1|||
146365459|NCT00094835|527839998|FG001|Overall Study|Non-compliance|2|||
146365460|NCT00094835|527839999|FG002|Overall Study|Non-compliance|2|||
146365461|NCT00094835|527840000|FG003|Overall Study|Non-compliance|0|||
146365462|NCT00094835|527840001|FG004|Overall Study|Non-compliance|2|||
146365463|NCT00094835|527840002|FG005|Overall Study|Non-compliance|2|||
146169812|NCT04108000|527132946|FG000|Overall Study|Withdrawal by Subject|2|||
146365464|NCT00094835|527840003|FG006|Overall Study|Non-compliance|1|||
146365465|NCT00094835|527839997|FG000|Overall Study|Other|1|||
146365466|NCT00094835|527839998|FG001|Overall Study|Other|1|||
146365467|NCT00094835|527839999|FG002|Overall Study|Other|1|||
146365468|NCT00094835|527840000|FG003|Overall Study|Other|1|||
146365469|NCT00094835|527840001|FG004|Overall Study|Other|0|||
146365470|NCT00094835|527840002|FG005|Overall Study|Other|0|||
146365471|NCT00094835|527840003|FG006|Overall Study|Other|0|||
146365472|NCT01149343|527840004|FG000|Overall Study|Withdrawal by Subject|1|||
146365473|NCT01149343|527840005|FG001|Overall Study|Withdrawal by Subject|1|||
146365474|NCT01149343|527840006|FG002|Overall Study|Withdrawal by Subject|1|||
146365475|NCT01149343|527840007|FG003|Overall Study|Withdrawal by Subject|5|||
146365476|NCT01149343|527840004|FG000|Overall Study|Death|10|||
146365477|NCT01149343|527840005|FG001|Overall Study|Death|13|||
146365478|NCT01149343|527840006|FG002|Overall Study|Death|18|||
146365479|NCT01149343|527840007|FG003|Overall Study|Death|18|||
146365480|NCT01149343|527840004|FG000|Overall Study|Lost to Follow-up|1|||
146365481|NCT01149343|527840005|FG001|Overall Study|Lost to Follow-up|0|||
146365482|NCT01149343|527840006|FG002|Overall Study|Lost to Follow-up|0|||
146365483|NCT01149343|527840007|FG003|Overall Study|Lost to Follow-up|1|||
146365484|NCT01149343|527840004|FG000|Overall Study|Other|8|||
146365485|NCT01149343|527840005|FG001|Overall Study|Other|10|||
146365486|NCT01149343|527840006|FG002|Overall Study|Other|2|||
146365487|NCT01149343|527840007|FG003|Overall Study|Other|14|||
146365488|NCT01149343|527840004|FG000|Overall Study|Sponsor study termination|0|||
146365489|NCT01149343|527840005|FG001|Overall Study|Sponsor study termination|0|||
146365490|NCT01149343|527840006|FG002|Overall Study|Sponsor study termination|0|||
146365491|NCT01149343|527840007|FG003|Overall Study|Sponsor study termination|2|||
146365492|NCT01149343|527840004|FG000|Overall Study|Recurrence / Progressive disease|0|||
146365493|NCT01149343|527840005|FG001|Overall Study|Recurrence / Progressive disease|0|||
146365494|NCT01149343|527840006|FG002|Overall Study|Recurrence / Progressive disease|1|||
146365495|NCT01149343|527840007|FG003|Overall Study|Recurrence / Progressive disease|0|||
146365496|NCT03472040|527840011|FG000|Overall Study|Physician Decision|0|||
146365497|NCT03472040|527840012|FG001|Overall Study|Physician Decision|3|||
146365498|NCT03472040|527840011|FG000|Overall Study|Withdrawal by Subject|10|||
146365499|NCT03472040|527840012|FG001|Overall Study|Withdrawal by Subject|23|||
146365500|NCT03472040|527840011|FG000|Overall Study|Perceived Lack of Efficacy|29|||
146365501|NCT03472040|527840012|FG001|Overall Study|Perceived Lack of Efficacy|30|||
146365502|NCT03472040|527840011|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
146365503|NCT03472040|527840012|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
146365504|NCT03472040|527840011|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
146365505|NCT03472040|527840012|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
146365506|NCT03472040|527840011|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
146365507|NCT03472040|527840012|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
146365508|NCT03472040|527840011|FG000|Overall Study|Subject Non-compliance|2|||
146365509|NCT03472040|527840012|FG001|Overall Study|Subject Non-compliance|5|||
146365510|NCT03472040|527840011|FG000|Overall Study|Discontinuation due to Rash|0|||
146365511|NCT03472040|527840012|FG001|Overall Study|Discontinuation due to Rash|1|||
146365512|NCT03472040|527840011|FG000|Overall Study|Subsequent Ineligibility|0|||
146365513|NCT03472040|527840012|FG001|Overall Study|Subsequent Ineligibility|2|||
146365514|NCT03472040|527840011|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
146365515|NCT03472040|527840012|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
146365516|NCT02769832|527840013|FG000|Overall Study|Death|30|||
146365517|NCT00225147|527840020|FG000|Open-label Phase|Lost to Follow-up|0|||
146365518|NCT00225147|527840021|FG001|Open-label Phase|Lost to Follow-up|0|||
146365519|NCT00225147|527840022|FG002|Open-label Phase|Lost to Follow-up|0|||
146365520|NCT00225147|527840023|FG003|Open-label Phase|Lost to Follow-up|4|||
146365521|NCT00225147|527840020|FG000|Open-label Phase|Withdrawal by Subject|0|||
146365522|NCT00225147|527840021|FG001|Open-label Phase|Withdrawal by Subject|0|||
146365523|NCT00225147|527840022|FG002|Open-label Phase|Withdrawal by Subject|0|||
146365524|NCT00225147|527840023|FG003|Open-label Phase|Withdrawal by Subject|6|||
146365525|NCT02685995|527840026|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
146365526|NCT02685995|527840027|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
146365527|NCT03625141|527840028|FG000|Overall Study|Adverse Event|0|||
146365528|NCT03625141|527840029|FG001|Overall Study|Adverse Event|2|||
146365529|NCT03625141|527840028|FG000|Overall Study|Study Terminated By Sponsor|1|||
146365530|NCT03625141|527840029|FG001|Overall Study|Study Terminated By Sponsor|13|||
146365531|NCT03625141|527840028|FG000|Overall Study|Withdrawal by Subject|3|||
146365532|NCT03625141|527840029|FG001|Overall Study|Withdrawal by Subject|0|||
146365533|NCT03625141|527840028|FG000|Overall Study|Withdrawal Of Consent|0|||
146365534|NCT03625141|527840029|FG001|Overall Study|Withdrawal Of Consent|1|||
146365535|NCT03625141|527840028|FG000|Overall Study|Death|11|||
146365536|NCT03625141|527840029|FG001|Overall Study|Death|47|||
146365537|NCT03625141|527840028|FG000|Overall Study|Progressive Disease|0|||
146365538|NCT03625141|527840029|FG001|Overall Study|Progressive Disease|2|||
146365539|NCT02034552|527840034|FG000|Overall Study|Never treated|3|||
146365540|NCT02034552|527840035|FG001|Overall Study|Never treated|2|||
146365541|NCT02034552|527840036|FG002|Overall Study|Never treated|0|||
146365542|NCT02034552|527840034|FG000|Overall Study|Radiological progression|3|||
146365543|NCT02034552|527840035|FG001|Overall Study|Radiological progression|5|||
146365544|NCT02034552|527840036|FG002|Overall Study|Radiological progression|4|||
146365545|NCT02034552|527840034|FG000|Overall Study|AE not assoc. with disease progression|1|||
146365546|NCT02034552|527840035|FG001|Overall Study|AE not assoc. with disease progression|4|||
146365547|NCT02034552|527840036|FG002|Overall Study|AE not assoc. with disease progression|2|||
146365548|NCT02034552|527840034|FG000|Overall Study|AE associated with disease progression|0|||
146365549|NCT02034552|527840035|FG001|Overall Study|AE associated with disease progression|1|||
146365550|NCT02034552|527840036|FG002|Overall Study|AE associated with disease progression|0|||
146365551|NCT02034552|527840034|FG000|Overall Study|Withdrawal by Subject|2|||
146365552|NCT02034552|527840035|FG001|Overall Study|Withdrawal by Subject|1|||
146365553|NCT02034552|527840036|FG002|Overall Study|Withdrawal by Subject|1|||
146365554|NCT02034552|527840034|FG000|Overall Study|Non-compliance with study drug|0|||
146365555|NCT02034552|527840035|FG001|Overall Study|Non-compliance with study drug|0|||
146365556|NCT02034552|527840036|FG002|Overall Study|Non-compliance with study drug|1|||
146365557|NCT02034552|527840034|FG000|Overall Study|Clinical progression|5|||
146365558|NCT02034552|527840035|FG001|Overall Study|Clinical progression|7|||
146365559|NCT02034552|527840036|FG002|Overall Study|Clinical progression|9|||
146365560|NCT02501902|527840040|FG000|Overall Study|Subject Refused Further Follow-up|0|||
146365561|NCT02501902|527840041|FG001|Overall Study|Subject Refused Further Follow-up|0|||
146365562|NCT02501902|527840042|FG002|Overall Study|Subject Refused Further Follow-up|0|||
146365563|NCT02501902|527840043|FG003|Overall Study|Subject Refused Further Follow-up|0|||
146365564|NCT02501902|527840044|FG004|Overall Study|Subject Refused Further Follow-up|0|||
146365565|NCT02501902|527840045|FG005|Overall Study|Subject Refused Further Follow-up|0|||
146365566|NCT02501902|527840046|FG006|Overall Study|Subject Refused Further Follow-up|0|||
146365567|NCT02501902|527840047|FG007|Overall Study|Subject Refused Further Follow-up|1|||
146365568|NCT02501902|527840040|FG000|Overall Study|Study Terminated by Sponsor|0|||
146365569|NCT02501902|527840041|FG001|Overall Study|Study Terminated by Sponsor|3|||
146365570|NCT02501902|527840042|FG002|Overall Study|Study Terminated by Sponsor|0|||
146365571|NCT02501902|527840043|FG003|Overall Study|Study Terminated by Sponsor|1|||
146365572|NCT02501902|527840044|FG004|Overall Study|Study Terminated by Sponsor|1|||
146365573|NCT02501902|527840045|FG005|Overall Study|Study Terminated by Sponsor|0|||
146365574|NCT02501902|527840046|FG006|Overall Study|Study Terminated by Sponsor|2|||
146365575|NCT02501902|527840047|FG007|Overall Study|Study Terminated by Sponsor|4|||
146365576|NCT02501902|527840040|FG000|Overall Study|Death|3|||
146365577|NCT02501902|527840041|FG001|Overall Study|Death|4|||
146365578|NCT02501902|527840042|FG002|Overall Study|Death|4|||
146365579|NCT02501902|527840043|FG003|Overall Study|Death|10|||
146365580|NCT02501902|527840044|FG004|Overall Study|Death|10|||
146365581|NCT02501902|527840045|FG005|Overall Study|Death|11|||
146365582|NCT02501902|527840046|FG006|Overall Study|Death|7|||
146365583|NCT02501902|527840047|FG007|Overall Study|Death|15|||
146365584|NCT01878097|527840050|FG000|Baseline|Surveys not fully completed|2497|||
146365585|NCT01878097|527840051|FG001|Baseline|Surveys not fully completed|1800|||
146365586|NCT01878097|527840050|FG000|Implementation Year 1|Surveys not fully completed|3202|||
146365587|NCT01878097|527840051|FG001|Implementation Year 1|Surveys not fully completed|2549|||
146365588|NCT01878097|527840050|FG000|Implementation Year 2|Surveys not fully completed|3281|||
146365589|NCT01878097|527840051|FG001|Implementation Year 2|Surveys not fully completed|2841|||
146365590|NCT01878097|527840050|FG000|Implementation Year 3|Surveys not fully completed|3494|||
146365591|NCT01878097|527840051|FG001|Implementation Year 3|Surveys not fully completed|2980|||
146365592|NCT01878097|527840050|FG000|Implementation Year 4|Surveys not fully completed|3604|||
146365593|NCT01878097|527840051|FG001|Implementation Year 4|Surveys not fully completed|3007|||
146365594|NCT00565058|527840054|FG000|Overall Study|Adverse Event|1|||
146365595|NCT00565058|527840055|FG001|Overall Study|Adverse Event|0|||
146365596|NCT00400712|527840056|FG000|Overall Study|Death|1|||
146365597|NCT00400712|527840057|FG001|Overall Study|Death|0|||
146365598|NCT00400712|527840056|FG000|Overall Study|Withdrawal by Subject|11|||
146365599|NCT00400712|527840057|FG001|Overall Study|Withdrawal by Subject|12|||
146365600|NCT00400712|527840056|FG000|Overall Study|Physician Decision|5|||
146365601|NCT00400712|527840057|FG001|Overall Study|Physician Decision|4|||
146365602|NCT00574496|527840062|FG000|Overall Study|Withdrawal by Subject|1|||
146365603|NCT01969799|527840063|FG000|Overall Study|Adverse Event|0|||
146365604|NCT01969799|527840064|FG001|Overall Study|Adverse Event|1|||
146365605|NCT01969799|527840063|FG000|Overall Study|Death|16|||
146365606|NCT01969799|527840064|FG001|Overall Study|Death|11|||
146365607|NCT01969799|527840063|FG000|Overall Study|Lost to Follow-up|0|||
146365608|NCT01969799|527840064|FG001|Overall Study|Lost to Follow-up|2|||
146365609|NCT01969799|527840063|FG000|Overall Study|Physician Decision|1|||
146365610|NCT01969799|527840064|FG001|Overall Study|Physician Decision|0|||
146365611|NCT01681576|527840065|FG000|Period 1|Adverse Event|1|||
146365612|NCT01681576|527840066|FG001|Period 1|Adverse Event|0|||
146365613|NCT01681576|527840065|FG000|Period 1|Protocol Deviation|1|||
146365614|NCT01681576|527840066|FG001|Period 1|Protocol Deviation|0|||
146365615|NCT01681576|527840065|FG000|Period 2|subject/guardian decision|3|||
146365616|NCT01681576|527840066|FG001|Period 2|subject/guardian decision|1|||
146365617|NCT01681576|527840065|FG000|Period 2|Non-compliance with study treatment|1|||
146365618|NCT01681576|527840066|FG001|Period 2|Non-compliance with study treatment|0|||
146365619|NCT02227108|527840068|FG000|Overall Study|Did not receive treatment|2|||
146365620|NCT02227108|527840068|FG000|Overall Study|Other|3|||
146365621|NCT02227108|527840068|FG000|Overall Study|Progressive disease|17|||
146365622|NCT02227108|527840068|FG000|Overall Study|Initiation of alternative therapy|2|||
146365623|NCT02227108|527840068|FG000|Overall Study|Investigator discretion|1|||
146365624|NCT02227108|527840068|FG000|Overall Study|Adverse Event|6|||
146365625|NCT02486952|527840069|FG000|Overall Study|Not Started Induction Therapy|3|||
146365626|NCT02486952|527840069|FG000|Overall Study|Adverse Event|1|||
146365627|NCT02486952|527840069|FG000|Overall Study|Death|15|||
146365628|NCT02486952|527840069|FG000|Overall Study|Lack of Efficacy|3|||
146365629|NCT02486952|527840069|FG000|Overall Study|Lost to Follow-up|26|||
146365630|NCT02486952|527840069|FG000|Overall Study|Other|2|||
146365631|NCT04111107|527840070|FG000|Overall Study|Withdrawal by Subject|6|||
146365632|NCT04111107|527840070|FG000|Overall Study|Declining Health|5|||
146365633|NCT00594204|527840071|FG000|Overall Study|Adverse Event|15|||
146365634|NCT00594204|527840072|FG001|Overall Study|Adverse Event|3|||
146365635|NCT00594204|527840071|FG000|Overall Study|Lost to Follow-up|9|||
146365636|NCT00594204|527840072|FG001|Overall Study|Lost to Follow-up|5|||
146365637|NCT00594204|527840071|FG000|Overall Study|Withdrawal by Subject|23|||
146365638|NCT00594204|527840072|FG001|Overall Study|Withdrawal by Subject|29|||
146365639|NCT00594204|527840071|FG000|Overall Study|Other|4|||
146365640|NCT00594204|527840072|FG001|Overall Study|Other|3|||
146365641|NCT00594204|527840071|FG000|Overall Study|Lack of Efficacy|3|||
146365642|NCT00594204|527840072|FG001|Overall Study|Lack of Efficacy|4|||
146365643|NCT00594204|527840071|FG000|Overall Study|Randomized but not treated|4|||
146365644|NCT00594204|527840072|FG001|Overall Study|Randomized but not treated|1|||
146365645|NCT01890512|527840075|FG000|Overall Study|Physician Decision|1|||
146365646|NCT01890512|527840075|FG000|Overall Study|Withdrawal by Subject|1|||
146365647|NCT01890512|527840075|FG000|Overall Study|Protocol Violation|1|||
146365648|NCT01529385|527840076|FG000|Overall Study|Lost to Follow-up|2|||
146365649|NCT01529385|527840077|FG001|Overall Study|Lost to Follow-up|1|||
146365650|NCT01401465|527840078|FG000|Treatment Period 1|Adverse Event|4|||
146365651|NCT01401465|527840079|FG001|Treatment Period 1|Adverse Event|1|||
146365652|NCT01401465|527840078|FG000|Treatment Period 1|Pregnancy|0|||
146365653|NCT01401465|527840079|FG001|Treatment Period 1|Pregnancy|1|||
146365654|NCT01401465|527840078|FG000|Treatment Period 1|Protocol Violation|5|||
146365655|NCT01401465|527840079|FG001|Treatment Period 1|Protocol Violation|0|||
146365656|NCT01401465|527840078|FG000|Treatment Period 1|Withdrawal by Subject|1|||
146365657|NCT01401465|527840079|FG001|Treatment Period 1|Withdrawal by Subject|4|||
146365658|NCT01401465|527840078|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
146365659|NCT01401465|527840079|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
146365660|NCT01401465|527840078|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
146365661|NCT01401465|527840079|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
146365662|NCT01401465|527840078|FG000|Treatment Period 1|Scheduling Difficulties|1|||
146365663|NCT01401465|527840079|FG001|Treatment Period 1|Scheduling Difficulties|1|||
146365664|NCT01401465|527840078|FG000|Treatment Period 2|Lost to Follow-up|0|||
146365665|NCT01401465|527840079|FG001|Treatment Period 2|Lost to Follow-up|1|||
146365666|NCT01401465|527840078|FG000|Treatment Period 2|Withdrawal by Subject|0|||
146365667|NCT01401465|527840079|FG001|Treatment Period 2|Withdrawal by Subject|1|||
146365668|NCT01115738|527840080|FG000|Overall Study|Death|1|||
146365669|NCT01115738|527840081|FG001|Overall Study|Death|0|||
146365670|NCT01115738|527840082|FG002|Overall Study|Death|0|||
146365671|NCT01115738|527840080|FG000|Overall Study|Lost to Follow-up|0|||
146365672|NCT01115738|527840081|FG001|Overall Study|Lost to Follow-up|0|||
146365673|NCT01115738|527840082|FG002|Overall Study|Lost to Follow-up|1|||
146365674|NCT01115738|527840080|FG000|Overall Study|Physician Decision|18|||
146365675|NCT01115738|527840081|FG001|Overall Study|Physician Decision|15|||
146365676|NCT01115738|527840082|FG002|Overall Study|Physician Decision|17|||
146365677|NCT01115738|527840080|FG000|Overall Study|Withdrawal by Subject|6|||
146365678|NCT01115738|527840081|FG001|Overall Study|Withdrawal by Subject|6|||
146365679|NCT01115738|527840082|FG002|Overall Study|Withdrawal by Subject|9|||
146365680|NCT00575094|527840090|FG000|Overall Study|Adverse Event|2|||
146365681|NCT00575094|527840090|FG000|Overall Study|Withdrawal by Subject|1|||
146365682|NCT00772382|527840092|FG000|Overall Study|Adverse Event|19|||
146365683|NCT00772382|527840092|FG000|Overall Study|Death|6|||
146365684|NCT00772382|527840092|FG000|Overall Study|Lack of Efficacy|4|||
146365685|NCT00772382|527840092|FG000|Overall Study|Physician Decision|5|||
146365686|NCT00772382|527840092|FG000|Overall Study|Protocol Violation|1|||
146365687|NCT00772382|527840092|FG000|Overall Study|Withdrawal by Subject|10|||
146365688|NCT00772382|527840092|FG000|Overall Study|Other Reasons|10|||
146365689|NCT00643604|527840093|FG000|Overall Study|Death|1|||
146365690|NCT02721251|527840096|FG000|Overall Study|Withdrawal by Subject|8|||
146365691|NCT02721251|527840097|FG001|Overall Study|Withdrawal by Subject|7|||
146365692|NCT02721251|527840098|FG002|Overall Study|Withdrawal by Subject|9|||
146365693|NCT02721251|527840096|FG000|Overall Study|poor adherence|2|||
146365694|NCT02721251|527840097|FG001|Overall Study|poor adherence|2|||
146365695|NCT02721251|527840098|FG002|Overall Study|poor adherence|2|||
146365696|NCT02921763|527840099|FG000|Overall Study|Adverse Event|4|||
146365697|NCT02921763|527840099|FG000|Overall Study|Lost to Follow-up|4|||
146365698|NCT02921763|527840099|FG000|Overall Study|Lack of Efficacy|3|||
146365699|NCT02921763|527840099|FG000|Overall Study|Protocol Violation|2|||
146365700|NCT02921763|527840099|FG000|Overall Study|Withdrawal by Subject|2|||
146365701|NCT02921763|527840099|FG000|Overall Study|Physician Decision|1|||
146365702|NCT02921763|527840099|FG000|Overall Study|No data obtained|2|||
146365703|NCT00862121|527840106|FG000|Overall Study|Adverse Event|1|||
146365704|NCT00862121|527840107|FG001|Overall Study|Adverse Event|2|||
146365705|NCT00862121|527840106|FG000|Overall Study|Lack of Efficacy|0|||
146365706|NCT00862121|527840107|FG001|Overall Study|Lack of Efficacy|3|||
146365707|NCT00862121|527840106|FG000|Overall Study|Protocol Violation|0|||
146365708|NCT00862121|527840107|FG001|Overall Study|Protocol Violation|1|||
146365709|NCT00862121|527840106|FG000|Overall Study|Exclusion criterion violation|0|||
146365710|NCT00862121|527840107|FG001|Overall Study|Exclusion criterion violation|1|||
146365711|NCT00862121|527840106|FG000|Overall Study|Incorrect randomisation|0|||
146365712|NCT00862121|527840107|FG001|Overall Study|Incorrect randomisation|1|||
146365713|NCT01582971|527840108|FG000|Overall Study|Death|2|||
146365714|NCT01582971|527840109|FG001|Overall Study|Death|1|||
146365715|NCT01582971|527840108|FG000|Overall Study|Lost to Follow-up|18|||
146365716|NCT01582971|527840109|FG001|Overall Study|Lost to Follow-up|21|||
146365717|NCT01582971|527840108|FG000|Overall Study|Withdrawal by Subject|4|||
146365718|NCT01582971|527840109|FG001|Overall Study|Withdrawal by Subject|2|||
146365719|NCT01582971|527840108|FG000|Overall Study|Other|15|||
146365720|NCT01582971|527840109|FG001|Overall Study|Other|13|||
146365721|NCT02007954|527840112|FG000|Overall Study|Received liver transplant|3|||
146365722|NCT02007954|527840112|FG000|Overall Study|Switch in treatment modality|2|||
146365723|NCT02007954|527840112|FG000|Overall Study|Disease progression and unrelated AE|1|||
146365724|NCT02007954|527840112|FG000|Overall Study|Death|1|||
146365725|NCT01054976|527840115|FG000|Overall Study|Adverse Event|16|||
146365726|NCT01054976|527840115|FG000|Overall Study|Uncooperative participations to study|7|||
146365727|NCT01054976|527840115|FG000|Overall Study|Withdrawal by Subject|4|||
146365728|NCT01054976|527840115|FG000|Overall Study|Other|8|||
146365729|NCT01195363|527840117|FG000|Overall Study|Lost to Follow-up|7|||
146365730|NCT01195363|527840118|FG001|Overall Study|Lost to Follow-up|4|||
146365731|NCT01195363|527840117|FG000|Overall Study|Adverse Event|3|||
146365732|NCT01195363|527840118|FG001|Overall Study|Adverse Event|1|||
146365733|NCT01195363|527840117|FG000|Overall Study|Lack of Efficacy|0|||
146365734|NCT01195363|527840118|FG001|Overall Study|Lack of Efficacy|4|||
146365735|NCT01195363|527840117|FG000|Overall Study|incarceration|1|||
146365736|NCT01195363|527840118|FG001|Overall Study|incarceration|0|||
146365737|NCT01763866|527840120|FG000|Overall Study|Withdrawal by Subject|2|||
146365738|NCT01763866|527840121|FG001|Overall Study|Withdrawal by Subject|1|||
146365739|NCT01763866|527840122|FG002|Overall Study|Withdrawal by Subject|4|||
146365740|NCT01763866|527840123|FG003|Overall Study|Withdrawal by Subject|0|||
146365741|NCT01763866|527840124|FG004|Overall Study|Withdrawal by Subject|0|||
146365742|NCT01763866|527840125|FG005|Overall Study|Withdrawal by Subject|3|||
146365743|NCT01763866|527840126|FG006|Overall Study|Withdrawal by Subject|4|||
146365744|NCT01763866|527840127|FG007|Overall Study|Withdrawal by Subject|0|||
146365745|NCT01763866|527840128|FG008|Overall Study|Withdrawal by Subject|1|||
146365746|NCT01763866|527840129|FG009|Overall Study|Withdrawal by Subject|1|||
146365747|NCT01763866|527840130|FG010|Overall Study|Withdrawal by Subject|2|||
146365748|NCT01763866|527840131|FG011|Overall Study|Withdrawal by Subject|2|||
146365749|NCT01763866|527840132|FG012|Overall Study|Withdrawal by Subject|2|||
146365750|NCT01763866|527840133|FG013|Overall Study|Withdrawal by Subject|0|||
146365751|NCT01763866|527840134|FG014|Overall Study|Withdrawal by Subject|6|||
146365752|NCT01763866|527840135|FG015|Overall Study|Withdrawal by Subject|3|||
146365753|NCT01763866|527840136|FG016|Overall Study|Withdrawal by Subject|0|||
146365754|NCT01763866|527840137|FG017|Overall Study|Withdrawal by Subject|1|||
146365755|NCT01763866|527840138|FG018|Overall Study|Withdrawal by Subject|1|||
146365756|NCT01763866|527840139|FG019|Overall Study|Withdrawal by Subject|1|||
146365757|NCT01763866|527840140|FG020|Overall Study|Withdrawal by Subject|2|||
146365758|NCT01763866|527840141|FG021|Overall Study|Withdrawal by Subject|1|||
146365759|NCT01763866|527840142|FG022|Overall Study|Withdrawal by Subject|2|||
146365760|NCT01763866|527840143|FG023|Overall Study|Withdrawal by Subject|1|||
146365761|NCT01763866|527840120|FG000|Overall Study|Decision by sponsor|0|||
146365762|NCT01763866|527840121|FG001|Overall Study|Decision by sponsor|0|||
146365763|NCT01763866|527840122|FG002|Overall Study|Decision by sponsor|1|||
146365764|NCT01763866|527840123|FG003|Overall Study|Decision by sponsor|0|||
146365765|NCT01763866|527840124|FG004|Overall Study|Decision by sponsor|2|||
146365766|NCT01763866|527840125|FG005|Overall Study|Decision by sponsor|0|||
146365767|NCT01763866|527840126|FG006|Overall Study|Decision by sponsor|2|||
146365768|NCT01763866|527840127|FG007|Overall Study|Decision by sponsor|0|||
146365769|NCT01763866|527840128|FG008|Overall Study|Decision by sponsor|2|||
146365770|NCT01763866|527840129|FG009|Overall Study|Decision by sponsor|0|||
146365771|NCT01763866|527840130|FG010|Overall Study|Decision by sponsor|6|||
146365772|NCT01763866|527840131|FG011|Overall Study|Decision by sponsor|0|||
146365773|NCT01763866|527840132|FG012|Overall Study|Decision by sponsor|1|||
146365774|NCT01763866|527840133|FG013|Overall Study|Decision by sponsor|0|||
146365775|NCT01763866|527840134|FG014|Overall Study|Decision by sponsor|5|||
146365776|NCT01763866|527840135|FG015|Overall Study|Decision by sponsor|0|||
146365777|NCT01763866|527840136|FG016|Overall Study|Decision by sponsor|0|||
146365778|NCT01763866|527840137|FG017|Overall Study|Decision by sponsor|0|||
146365779|NCT01763866|527840138|FG018|Overall Study|Decision by sponsor|4|||
146365780|NCT01763866|527840139|FG019|Overall Study|Decision by sponsor|0|||
146365781|NCT01763866|527840140|FG020|Overall Study|Decision by sponsor|2|||
146365782|NCT01763866|527840141|FG021|Overall Study|Decision by sponsor|0|||
146365783|NCT01763866|527840142|FG022|Overall Study|Decision by sponsor|1|||
146365784|NCT01763866|527840143|FG023|Overall Study|Decision by sponsor|0|||
146365785|NCT01763866|527840120|FG000|Overall Study|Lost to Follow-up|0|||
146365786|NCT01763866|527840121|FG001|Overall Study|Lost to Follow-up|0|||
146365787|NCT01763866|527840122|FG002|Overall Study|Lost to Follow-up|0|||
146365788|NCT01763866|527840123|FG003|Overall Study|Lost to Follow-up|0|||
146365789|NCT01763866|527840124|FG004|Overall Study|Lost to Follow-up|0|||
146365790|NCT01763866|527840125|FG005|Overall Study|Lost to Follow-up|0|||
146365791|NCT01763866|527840126|FG006|Overall Study|Lost to Follow-up|1|||
146365792|NCT01763866|527840127|FG007|Overall Study|Lost to Follow-up|0|||
146365793|NCT01763866|527840128|FG008|Overall Study|Lost to Follow-up|0|||
146365794|NCT01763866|527840129|FG009|Overall Study|Lost to Follow-up|0|||
146365795|NCT01763866|527840130|FG010|Overall Study|Lost to Follow-up|0|||
146365796|NCT01763866|527840131|FG011|Overall Study|Lost to Follow-up|0|||
146365797|NCT01763866|527840132|FG012|Overall Study|Lost to Follow-up|1|||
146365798|NCT01763866|527840133|FG013|Overall Study|Lost to Follow-up|0|||
146365799|NCT01763866|527840134|FG014|Overall Study|Lost to Follow-up|1|||
146365800|NCT01763866|527840135|FG015|Overall Study|Lost to Follow-up|0|||
146365801|NCT01763866|527840136|FG016|Overall Study|Lost to Follow-up|0|||
146365802|NCT01763866|527840137|FG017|Overall Study|Lost to Follow-up|0|||
146365803|NCT01763866|527840138|FG018|Overall Study|Lost to Follow-up|1|||
146365804|NCT01763866|527840139|FG019|Overall Study|Lost to Follow-up|1|||
146365805|NCT01763866|527840140|FG020|Overall Study|Lost to Follow-up|0|||
146365806|NCT01763866|527840141|FG021|Overall Study|Lost to Follow-up|0|||
146365807|NCT01763866|527840142|FG022|Overall Study|Lost to Follow-up|0|||
146365808|NCT01763866|527840143|FG023|Overall Study|Lost to Follow-up|1|||
146365809|NCT01763866|527840120|FG000|Overall Study|Death|0|||
146365810|NCT01763866|527840121|FG001|Overall Study|Death|0|||
146365811|NCT01763866|527840122|FG002|Overall Study|Death|0|||
146365812|NCT01763866|527840123|FG003|Overall Study|Death|0|||
146365813|NCT01763866|527840124|FG004|Overall Study|Death|0|||
146365814|NCT01763866|527840125|FG005|Overall Study|Death|0|||
146365815|NCT01763866|527840126|FG006|Overall Study|Death|0|||
146365816|NCT01763866|527840127|FG007|Overall Study|Death|0|||
146365817|NCT01763866|527840128|FG008|Overall Study|Death|0|||
146365818|NCT01763866|527840129|FG009|Overall Study|Death|0|||
146365819|NCT01763866|527840130|FG010|Overall Study|Death|0|||
146365820|NCT01763866|527840131|FG011|Overall Study|Death|0|||
146365821|NCT01763866|527840132|FG012|Overall Study|Death|0|||
146365822|NCT01763866|527840133|FG013|Overall Study|Death|0|||
146365823|NCT01763866|527840134|FG014|Overall Study|Death|0|||
146365824|NCT01763866|527840135|FG015|Overall Study|Death|0|||
146365825|NCT01763866|527840136|FG016|Overall Study|Death|1|||
146365826|NCT01763866|527840137|FG017|Overall Study|Death|0|||
146365827|NCT01763866|527840138|FG018|Overall Study|Death|0|||
146365828|NCT01763866|527840139|FG019|Overall Study|Death|0|||
146365829|NCT01763866|527840140|FG020|Overall Study|Death|0|||
146365830|NCT01763866|527840141|FG021|Overall Study|Death|0|||
146365831|NCT01763866|527840142|FG022|Overall Study|Death|0|||
146365832|NCT01763866|527840143|FG023|Overall Study|Death|0|||
146365833|NCT05691829|527841474|FG000|Overall Study|Physician Decision|2|||
146365834|NCT05691829|527841474|FG000|Overall Study|Eligibility criteria not met|3|||
146365835|NCT00453180|527841475|FG000|Overall Study|Lost to Follow-up|2|||
146365836|NCT00453180|527841476|FG001|Overall Study|Lost to Follow-up|1|||
146365837|NCT00453180|527841475|FG000|Overall Study|Adverse Event|1|||
146365838|NCT00453180|527841476|FG001|Overall Study|Adverse Event|2|||
146365839|NCT03326869|527841481|FG000|Overall Study|Study data has been lost to natural disa|1|||
146365840|NCT03326869|527841482|FG001|Overall Study|Study data has been lost to natural disa|1|||
146365841|NCT01002742|527841485|FG000|Overall Study|Determined to be ineligible|0|||
146365842|NCT01002742|527841486|FG001|Overall Study|Determined to be ineligible|1|||
146365843|NCT01824693|527841487|FG000|Overall Study|Death|0|||
146365844|NCT01824693|527841488|FG001|Overall Study|Death|1|||
146365845|NCT01824693|527841489|FG002|Overall Study|Death|0|||
146365846|NCT01824693|527841487|FG000|Overall Study|Physician Decision|1|||
146365847|NCT01824693|527841488|FG001|Overall Study|Physician Decision|1|||
146365848|NCT01824693|527841489|FG002|Overall Study|Physician Decision|1|||
146365849|NCT01824693|527841487|FG000|Overall Study|Withdrawal by Subject|0|||
146365850|NCT01824693|527841488|FG001|Overall Study|Withdrawal by Subject|0|||
146365851|NCT01824693|527841489|FG002|Overall Study|Withdrawal by Subject|1|||
146365852|NCT01824693|527841487|FG000|Overall Study|Progressive Disease|0|||
146365853|NCT01824693|527841488|FG001|Overall Study|Progressive Disease|5|||
146365854|NCT01824693|527841489|FG002|Overall Study|Progressive Disease|0|||
146365855|NCT01824693|527841487|FG000|Overall Study|Ineligible|0|||
146365856|NCT01824693|527841488|FG001|Overall Study|Ineligible|0|||
146365857|NCT01824693|527841489|FG002|Overall Study|Ineligible|3|||
146365858|NCT01824693|527841487|FG000|Overall Study|No Transplant Planned|0|||
146365859|NCT01824693|527841488|FG001|Overall Study|No Transplant Planned|0|||
146365860|NCT01824693|527841489|FG002|Overall Study|No Transplant Planned|10|||
146365861|NCT02150213|527841493|FG000|Overall Study|Lost to Follow-up|1|||
146365862|NCT02150213|527841493|FG000|Overall Study|Withdrawal by Subject|1|||
146365863|NCT01297309|527841494|FG000|Overall Study|Eligibility failure|2|||
146365864|NCT01297309|527841494|FG000|Overall Study|Screen failure|2|||
146365865|NCT01297309|527841494|FG000|Overall Study|Withdrawal by Subject|5|||
146365866|NCT01297309|527841494|FG000|Overall Study|Adverse Event|1|||
146365867|NCT01297309|527841494|FG000|Overall Study|Investigator Decision|2|||
146365868|NCT01297309|527841494|FG000|Overall Study|Death|1|||
146365869|NCT01297309|527841494|FG000|Overall Study|Participant not entering extensionperiod|1|||
146365870|NCT02678312|527841495|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
146365871|NCT02678312|527841496|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146365872|NCT02678312|527841497|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146365873|NCT02678312|527841498|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146365874|NCT02678312|527841499|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
146365875|NCT02678312|527841495|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
146365876|NCT02678312|527841496|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146365877|NCT02678312|527841497|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146365878|NCT02678312|527841498|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146365879|NCT02678312|527841499|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
146365880|NCT02678312|527841495|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
146365881|NCT02678312|527841496|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146365882|NCT02678312|527841497|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146365883|NCT02678312|527841498|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146365884|NCT02678312|527841499|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
146365885|NCT02678312|527841495|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
146365886|NCT02678312|527841496|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
146365887|NCT02678312|527841497|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
146365888|NCT02678312|527841498|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
146365889|NCT02678312|527841499|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
146365890|NCT02678312|527841495|FG000|Part 2 Double Blind Epoch|Death|0|||
146365891|NCT02678312|527841496|FG001|Part 2 Double Blind Epoch|Death|0|||
146365892|NCT02678312|527841497|FG002|Part 2 Double Blind Epoch|Death|0|||
146365893|NCT02678312|527841498|FG003|Part 2 Double Blind Epoch|Death|8|||
146365894|NCT02678312|527841499|FG004|Part 2 Double Blind Epoch|Death|12|||
146365895|NCT02678312|527841495|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
146365896|NCT02678312|527841496|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
146365897|NCT02678312|527841497|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
146365898|NCT02678312|527841498|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
146365899|NCT02678312|527841499|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
146365900|NCT02678312|527841495|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146365901|NCT02678312|527841496|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146365902|NCT02678312|527841497|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146365903|NCT02678312|527841498|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
146365904|NCT02678312|527841499|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
146365905|NCT02678312|527841495|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146365906|NCT02678312|527841496|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146365907|NCT02678312|527841497|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
146365908|NCT02678312|527841498|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
146365909|NCT02678312|527841499|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
146365910|NCT00656084|527841500|FG000|Overall Study|Adverse Event|4|||
146365911|NCT00656084|527841500|FG000|Overall Study|Withdrawal by Subject|1|||
146365912|NCT00656084|527841500|FG000|Overall Study|Patient Request|1|||
146365913|NCT00656084|527841500|FG000|Overall Study|Investigator Request|1|||
146365914|NCT00640146|527841502|FG000|Overall Study|Adverse Event|2|||
146365915|NCT00640146|527841503|FG001|Overall Study|Adverse Event|0|||
146365916|NCT00640146|527841502|FG000|Overall Study|Lost to Follow-up|0|||
146365917|NCT00640146|527841503|FG001|Overall Study|Lost to Follow-up|1|||
146365918|NCT00640146|527841502|FG000|Overall Study|Lack of Efficacy|0|||
146365919|NCT00640146|527841503|FG001|Overall Study|Lack of Efficacy|1|||
146365920|NCT00640146|527841502|FG000|Overall Study|Withdrawal by Subject|1|||
146365921|NCT00640146|527841503|FG001|Overall Study|Withdrawal by Subject|1|||
146365922|NCT00640146|527841502|FG000|Overall Study|Randomized but not treated|1|||
146365923|NCT00640146|527841503|FG001|Overall Study|Randomized but not treated|3|||
146365924|NCT03024255|527841504|FG000|Overall Study|Adverse Event|1|||
146365925|NCT03024255|527841505|FG001|Overall Study|Adverse Event|4|||
146365926|NCT03024255|527841506|FG002|Overall Study|Adverse Event|8|||
146365927|NCT03024255|527841507|FG003|Overall Study|Adverse Event|0|||
146365928|NCT03024255|527841504|FG000|Overall Study|Withdrawal by Subject|3|||
146365929|NCT03024255|527841505|FG001|Overall Study|Withdrawal by Subject|1|||
146365930|NCT03024255|527841506|FG002|Overall Study|Withdrawal by Subject|0|||
146365931|NCT03024255|527841507|FG003|Overall Study|Withdrawal by Subject|3|||
146365932|NCT03024255|527841504|FG000|Overall Study|Protocol Violation|0|||
146365933|NCT03024255|527841505|FG001|Overall Study|Protocol Violation|0|||
146365934|NCT03024255|527841506|FG002|Overall Study|Protocol Violation|2|||
146365935|NCT03024255|527841507|FG003|Overall Study|Protocol Violation|0|||
146365936|NCT03024255|527841504|FG000|Overall Study|Lost to Follow-up|1|||
146365937|NCT03024255|527841505|FG001|Overall Study|Lost to Follow-up|2|||
146365938|NCT03024255|527841506|FG002|Overall Study|Lost to Follow-up|1|||
146365939|NCT03024255|527841507|FG003|Overall Study|Lost to Follow-up|1|||
146365940|NCT03024255|527841504|FG000|Overall Study|Lack of Efficacy|1|||
146365941|NCT03024255|527841505|FG001|Overall Study|Lack of Efficacy|0|||
146365942|NCT03024255|527841506|FG002|Overall Study|Lack of Efficacy|0|||
146365943|NCT03024255|527841507|FG003|Overall Study|Lack of Efficacy|0|||
146365944|NCT03024255|527841504|FG000|Overall Study|Protocol Noncompliance|1|||
146365945|NCT03024255|527841505|FG001|Overall Study|Protocol Noncompliance|1|||
146365946|NCT03024255|527841506|FG002|Overall Study|Protocol Noncompliance|0|||
146365947|NCT03024255|527841507|FG003|Overall Study|Protocol Noncompliance|1|||
146365948|NCT01415908|527841508|FG000|Overall Study|Withdrawal by Subject|1|||
146365949|NCT01415908|527841509|FG001|Overall Study|Withdrawal by Subject|0|||
146365950|NCT02197897|527841512|FG000|Overall Study|not eligible|1|||
146365951|NCT00688545|527841513|FG000|Overall Study|Lost to Follow-up|1|||
146365952|NCT00688545|527841514|FG001|Overall Study|Lost to Follow-up|4|||
146365953|NCT00688545|527841513|FG000|Overall Study|Insurance/cost of drug|0|||
146365954|NCT00688545|527841514|FG001|Overall Study|Insurance/cost of drug|1|||
146365955|NCT00688545|527841513|FG000|Overall Study|Withdrawal by Subject|2|||
146365956|NCT00688545|527841514|FG001|Overall Study|Withdrawal by Subject|3|||
146365957|NCT00688545|527841513|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
146365958|NCT00688545|527841514|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
146365959|NCT04295356|527841515|FG000|Overall Study|Physician Decision|1|||
146365960|NCT04295356|527841516|FG001|Overall Study|Physician Decision|0|||
146365961|NCT04295356|527841515|FG000|Overall Study|Lost to Follow-up|0|||
146365962|NCT04295356|527841516|FG001|Overall Study|Lost to Follow-up|3|||
146365963|NCT04295356|527841515|FG000|Overall Study|Protocol Violation|0|||
146365964|NCT04295356|527841516|FG001|Overall Study|Protocol Violation|1|||
146365965|NCT04116073|527841523|FG000|Overall Study|Withdrawal by Subject|2|||
146365966|NCT04116073|527841523|FG000|Overall Study|failed to maintained eligibility|1|||
146365967|NCT03783442|527841528|FG000|Overall Study|Death|252|||
146365968|NCT03783442|527841529|FG001|Overall Study|Death|268|||
146365969|NCT03783442|527841528|FG000|Overall Study|Withdrawal by Subject|19|||
146365970|NCT03783442|527841529|FG001|Overall Study|Withdrawal by Subject|21|||
146365971|NCT03783442|527841528|FG000|Overall Study|Lost to Follow-up|7|||
146365972|NCT03783442|527841529|FG001|Overall Study|Lost to Follow-up|6|||
146365973|NCT03783442|527841528|FG000|Overall Study|Sponsor Ended Study|48|||
146365974|NCT03783442|527841529|FG001|Overall Study|Sponsor Ended Study|28|||
146365975|NCT01381718|527841530|FG000|Overall Study|Withdrawal by Subject|2|||
146365976|NCT01381718|527841531|FG001|Overall Study|Withdrawal by Subject|5|||
146365977|NCT01381718|527841530|FG000|Overall Study|Lost to Follow-up|3|||
146365978|NCT01381718|527841531|FG001|Overall Study|Lost to Follow-up|5|||
146365979|NCT01381718|527841530|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
146365980|NCT01381718|527841531|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
146365981|NCT02505542|527841532|FG000|Part A: Open-Label Period|Adverse Event|31|||
146365982|NCT02505542|527841533|FG001|Part A: Open-Label Period|Adverse Event|0|||
146365983|NCT02505542|527841534|FG002|Part A: Open-Label Period|Adverse Event|0|||
146365984|NCT02505542|527841535|FG003|Part A: Open-Label Period|Adverse Event|0|||
146365985|NCT02505542|527841532|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
146365986|NCT02505542|527841533|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
146365987|NCT02505542|527841534|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
146365988|NCT02505542|527841535|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
146365989|NCT02505542|527841532|FG000|Part A: Open-Label Period|Protocol Violation|1|||
146365990|NCT02505542|527841533|FG001|Part A: Open-Label Period|Protocol Violation|0|||
146365991|NCT02505542|527841534|FG002|Part A: Open-Label Period|Protocol Violation|0|||
146365992|NCT02505542|527841535|FG003|Part A: Open-Label Period|Protocol Violation|0|||
146365993|NCT02505542|527841532|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
146365994|NCT02505542|527841533|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
146365995|NCT02505542|527841534|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
146365996|NCT02505542|527841535|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
146365997|NCT02505542|527841532|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
146365998|NCT02505542|527841533|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
146365999|NCT02505542|527841534|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
146366000|NCT02505542|527841535|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
146366001|NCT02505542|527841532|FG000|Part A: Open-Label Period|New medical history available|1|||
146366002|NCT02505542|527841533|FG001|Part A: Open-Label Period|New medical history available|0|||
146366003|NCT02505542|527841534|FG002|Part A: Open-Label Period|New medical history available|0|||
146366004|NCT02505542|527841535|FG003|Part A: Open-Label Period|New medical history available|0|||
146366005|NCT02505542|527841532|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
146366006|NCT02505542|527841533|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146366007|NCT02505542|527841534|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146366008|NCT02505542|527841535|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
146366009|NCT02505542|527841532|FG000|Part A: Open-Label Period|Pregnancy|2|||
146366010|NCT02505542|527841533|FG001|Part A: Open-Label Period|Pregnancy|0|||
146366011|NCT02505542|527841534|FG002|Part A: Open-Label Period|Pregnancy|0|||
146366012|NCT02505542|527841535|FG003|Part A: Open-Label Period|Pregnancy|0|||
146366013|NCT02505542|527841532|FG000|Part A: Open-Label Period|Sponsor directive|1|||
146366014|NCT02505542|527841533|FG001|Part A: Open-Label Period|Sponsor directive|0|||
146366015|NCT02505542|527841534|FG002|Part A: Open-Label Period|Sponsor directive|0|||
146366016|NCT02505542|527841535|FG003|Part A: Open-Label Period|Sponsor directive|0|||
146366017|NCT02505542|527841532|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
146366018|NCT02505542|527841533|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
146366019|NCT02505542|527841534|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
146366020|NCT02505542|527841535|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
146366021|NCT02505542|527841532|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
146366022|NCT02505542|527841533|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146366023|NCT02505542|527841534|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146366024|NCT02505542|527841535|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
146366025|NCT02505542|527841532|FG000|Part A: Open-Label Period|Non-compliance|1|||
146366026|NCT02505542|527841533|FG001|Part A: Open-Label Period|Non-compliance|0|||
146366027|NCT02505542|527841534|FG002|Part A: Open-Label Period|Non-compliance|0|||
146366028|NCT02505542|527841535|FG003|Part A: Open-Label Period|Non-compliance|0|||
146366029|NCT02505542|527841532|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
146366030|NCT02505542|527841533|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146366031|NCT02505542|527841534|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146366032|NCT02505542|527841535|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
146366033|NCT02505542|527841532|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
146366034|NCT02505542|527841533|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146366035|NCT02505542|527841534|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146366036|NCT02505542|527841535|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
146366037|NCT02505542|527841532|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
146366038|NCT02505542|527841533|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146366039|NCT02505542|527841534|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146366040|NCT02505542|527841535|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
146366041|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Adverse Event|0|||
146366042|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Adverse Event|0|||
146366043|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Adverse Event|1|||
146366044|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Adverse Event|3|||
146366045|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
146366046|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
146366047|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
146366048|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
146366049|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
146366050|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
146366051|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
146366052|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
146366053|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
146366054|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
146366055|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
146366056|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
146366057|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
146366058|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
146366059|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
146366060|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
146366061|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
146366062|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
146366063|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
146366064|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
146366065|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
146366066|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
146366067|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
146366068|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
146366069|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Miscalculation|0|||
146366070|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Miscalculation|1|||
146366071|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Miscalculation|0|||
146366072|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Miscalculation|0|||
146366073|NCT02505542|527841532|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146366074|NCT02505542|527841533|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
146366075|NCT02505542|527841534|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146366076|NCT02505542|527841535|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
146366077|NCT00168064|527841537|FG000|Overall Study|Adverse Event|26|||
146366078|NCT00168064|527841538|FG001|Overall Study|Adverse Event|22|||
146366079|NCT00168064|527841537|FG000|Overall Study|Withdrawal by Subject|3|||
146366080|NCT00168064|527841538|FG001|Overall Study|Withdrawal by Subject|4|||
146169813|NCT04108000|527132947|FG001|Overall Study|Withdrawal by Subject|2|||
146366081|NCT00168064|527841537|FG000|Overall Study|Lack of Efficacy|4|||
146366082|NCT00168064|527841538|FG001|Overall Study|Lack of Efficacy|4|||
146366083|NCT00168064|527841537|FG000|Overall Study|Lost to Follow-up|4|||
146366084|NCT00168064|527841538|FG001|Overall Study|Lost to Follow-up|3|||
146366085|NCT00168064|527841537|FG000|Overall Study|Non-compliance|2|||
146366086|NCT00168064|527841538|FG001|Overall Study|Non-compliance|3|||
146366087|NCT00168064|527841537|FG000|Overall Study|Concurrent Illness|4|||
146366088|NCT00168064|527841538|FG001|Overall Study|Concurrent Illness|3|||
146366089|NCT00168064|527841537|FG000|Overall Study|Subject's Best interest|2|||
146366090|NCT00168064|527841538|FG001|Overall Study|Subject's Best interest|2|||
146366091|NCT00168064|527841537|FG000|Overall Study|Various|4|||
146366092|NCT00168064|527841538|FG001|Overall Study|Various|3|||
146366093|NCT05489081|527841542|FG000|Overall Study|student left classroom|0|||
146366094|NCT05489081|527841543|FG001|Overall Study|student left classroom|1|||
146366095|NCT05489081|527841542|FG000|Overall Study|teacher left school|0|||
146366096|NCT05489081|527841543|FG001|Overall Study|teacher left school|2|||
146366097|NCT01181102|527841544|FG000|Overall Study|Adverse Event|28|||
146366098|NCT01181102|527841545|FG001|Overall Study|Adverse Event|26|||
146366099|NCT01181102|527841544|FG000|Overall Study|Lack of Efficacy|3|||
146366100|NCT01181102|527841545|FG001|Overall Study|Lack of Efficacy|1|||
146366101|NCT01181102|527841544|FG000|Overall Study|Lost to Follow-up|2|||
146366102|NCT01181102|527841545|FG001|Overall Study|Lost to Follow-up|0|||
146366103|NCT01181102|527841544|FG000|Overall Study|Physician Decision|3|||
146366104|NCT01181102|527841545|FG001|Overall Study|Physician Decision|1|||
146366105|NCT01181102|527841544|FG000|Overall Study|Protocol Violation|5|||
146366106|NCT01181102|527841545|FG001|Overall Study|Protocol Violation|6|||
146366107|NCT01181102|527841544|FG000|Overall Study|Withdrawal by Subject|10|||
146366108|NCT01181102|527841545|FG001|Overall Study|Withdrawal by Subject|12|||
146366109|NCT01309841|527841548|FG000|Overall Study|Other|0|||
146366110|NCT01309841|527841549|FG001|Overall Study|Other|1|||
146366111|NCT01309841|527841550|FG002|Overall Study|Other|1|||
146366112|NCT01309841|527841548|FG000|Overall Study|Lost to Follow-up|7|||
146366113|NCT01309841|527841549|FG001|Overall Study|Lost to Follow-up|6|||
146366114|NCT01309841|527841550|FG002|Overall Study|Lost to Follow-up|4|||
146366115|NCT01309841|527841548|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
146366116|NCT01309841|527841549|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
146366117|NCT01309841|527841550|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
146366118|NCT01309841|527841548|FG000|Overall Study|Lack of Efficacy|0|||
146366119|NCT01309841|527841549|FG001|Overall Study|Lack of Efficacy|0|||
146366120|NCT01309841|527841550|FG002|Overall Study|Lack of Efficacy|2|||
146366121|NCT01309841|527841548|FG000|Overall Study|Adverse Event|9|||
146366122|NCT01309841|527841549|FG001|Overall Study|Adverse Event|22|||
146366123|NCT01309841|527841550|FG002|Overall Study|Adverse Event|11|||
146366124|NCT01309841|527841548|FG000|Overall Study|Death|1|||
146366125|NCT01309841|527841549|FG001|Overall Study|Death|0|||
146366126|NCT01309841|527841550|FG002|Overall Study|Death|0|||
146366127|NCT01309841|527841548|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146366128|NCT01309841|527841549|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146366129|NCT01309841|527841550|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
146366130|NCT01309841|527841548|FG000|Overall Study|Withdrawal by Subject|17|||
146366131|NCT01309841|527841549|FG001|Overall Study|Withdrawal by Subject|6|||
146366132|NCT01309841|527841550|FG002|Overall Study|Withdrawal by Subject|13|||
146366133|NCT01309841|527841548|FG000|Overall Study|Did Not Receive Treatment|2|||
146366134|NCT01309841|527841549|FG001|Overall Study|Did Not Receive Treatment|0|||
146366135|NCT01309841|527841550|FG002|Overall Study|Did Not Receive Treatment|1|||
146366136|NCT01309841|527841548|FG000|Overall Study|Severe non-compliance with protocol|0|||
146366137|NCT01309841|527841549|FG001|Overall Study|Severe non-compliance with protocol|5|||
146366138|NCT01309841|527841550|FG002|Overall Study|Severe non-compliance with protocol|2|||
146366139|NCT05127421|527841552|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
146366140|NCT05127421|527841553|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
146366141|NCT05127421|527841554|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
146366142|NCT05127421|527841555|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
146366143|NCT05127421|527841552|FG000|4-Week Double-Blind Period|Physician Decision|1|||
146366144|NCT05127421|527841553|FG001|4-Week Double-Blind Period|Physician Decision|0|||
146366145|NCT05127421|527841554|FG002|4-Week Double-Blind Period|Physician Decision|0|||
146366146|NCT05127421|527841555|FG003|4-Week Double-Blind Period|Physician Decision|0|||
146366147|NCT05127421|527841552|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
146366148|NCT05127421|527841553|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
146366149|NCT05127421|527841554|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
146366150|NCT05127421|527841555|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
146366151|NCT05127421|527841552|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146366152|NCT05127421|527841553|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
146366153|NCT05127421|527841554|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146366154|NCT05127421|527841555|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
146366155|NCT05127421|527841552|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146366156|NCT05127421|527841553|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
146366157|NCT05127421|527841554|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146366158|NCT05127421|527841555|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
146366159|NCT05127421|527841552|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
146366160|NCT05127421|527841553|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
146366161|NCT05127421|527841554|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
146366162|NCT05127421|527841555|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
146366163|NCT05127421|527841552|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
146366164|NCT05127421|527841553|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
146366165|NCT05127421|527841554|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
146366166|NCT05127421|527841555|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
146366167|NCT05127421|527841552|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146366168|NCT05127421|527841553|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146366169|NCT05127421|527841554|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
146366170|NCT05127421|527841555|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
146366171|NCT01441115|527841556|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
146366172|NCT00878215|527841560|FG000|Overall Study|Determined to be ineligible|0|||
146366173|NCT00878215|527841561|FG001|Overall Study|Determined to be ineligible|10|||
146366174|NCT00878215|527841562|FG002|Overall Study|Determined to be ineligible|0|||
146366175|NCT00878215|527841563|FG003|Overall Study|Determined to be ineligible|0|||
146366176|NCT01361919|527841564|FG000|Overall Study|technical issues|10|||
146366177|NCT01361919|527841565|FG001|Overall Study|technical issues|12|||
146366178|NCT01361919|527841566|FG002|Overall Study|technical issues|10|||
146366179|NCT00178464|527841569|FG000|Overall Study|Withdrawal by Subject|1|||
146366180|NCT00178464|527841569|FG000|Overall Study|Physician Decision|1|||
146366181|NCT02260648|527841570|FG000|Overall Study|Adverse Event|3|||
146366182|NCT02260648|527841571|FG001|Overall Study|Adverse Event|0|||
146366183|NCT02260648|527841572|FG002|Overall Study|Adverse Event|1|||
146366184|NCT02260648|527841570|FG000|Overall Study|Withdrawal by Subject|1|||
146366185|NCT02260648|527841571|FG001|Overall Study|Withdrawal by Subject|1|||
146366186|NCT02260648|527841572|FG002|Overall Study|Withdrawal by Subject|0|||
146366187|NCT02260648|527841570|FG000|Overall Study|Protocol Violation|1|||
146366188|NCT02260648|527841571|FG001|Overall Study|Protocol Violation|0|||
146366189|NCT02260648|527841572|FG002|Overall Study|Protocol Violation|0|||
146366190|NCT02260648|527841570|FG000|Overall Study|Discontinue Due to Study Termination|13|||
146366191|NCT02260648|527841571|FG001|Overall Study|Discontinue Due to Study Termination|12|||
146366192|NCT02260648|527841572|FG002|Overall Study|Discontinue Due to Study Termination|7|||
146366193|NCT03956225|527841573|FG000|Overall Study|Lack of Efficacy|1|||
146366194|NCT03956225|527841574|FG001|Overall Study|Lack of Efficacy|1|||
146366195|NCT03956225|527841573|FG000|Overall Study|Lost to Follow-up|0|||
146366196|NCT03956225|527841574|FG001|Overall Study|Lost to Follow-up|1|||
146366197|NCT03956225|527841573|FG000|Overall Study|Withdrawal by Subject|2|||
146366198|NCT03956225|527841574|FG001|Overall Study|Withdrawal by Subject|1|||
146366199|NCT03956225|527841573|FG000|Overall Study|Other Reasons|2|||
146366200|NCT03956225|527841574|FG001|Overall Study|Other Reasons|1|||
146366201|NCT00805545|527841575|FG000|Overall Study|Protocol Violation|3|||
146366202|NCT00805545|527841576|FG001|Overall Study|Protocol Violation|2|||
146366203|NCT00805545|527841575|FG000|Overall Study|Protocol Violation|3|||
146366204|NCT00805545|527841576|FG001|Overall Study|Protocol Violation|1|||
146366205|NCT02157506|527841581|FG000|Overall Study|Adverse Event|0|||
146366206|NCT02157506|527841582|FG001|Overall Study|Adverse Event|1|||
146366207|NCT02157506|527841583|FG002|Overall Study|Adverse Event|0|||
146366208|NCT02157506|527841584|FG003|Overall Study|Adverse Event|0|||
146366209|NCT02157506|527841585|FG004|Overall Study|Adverse Event|0|||
146366210|NCT02157506|527841581|FG000|Overall Study|Lost to Follow-up|0|||
146366211|NCT02157506|527841582|FG001|Overall Study|Lost to Follow-up|0|||
146366212|NCT02157506|527841583|FG002|Overall Study|Lost to Follow-up|1|||
146366213|NCT02157506|527841584|FG003|Overall Study|Lost to Follow-up|0|||
146366214|NCT02157506|527841585|FG004|Overall Study|Lost to Follow-up|0|||
146366215|NCT02702011|527841586|FG000|Overall Study|Withdrawal by Subject|0|||
146366216|NCT02702011|527841587|FG001|Overall Study|Withdrawal by Subject|1|||
146366217|NCT02702011|527841588|FG002|Overall Study|Withdrawal by Subject|0|||
146366218|NCT02702011|527841589|FG003|Overall Study|Withdrawal by Subject|0|||
146366219|NCT00171314|527841593|FG000|Overall Study|Adverse Event|44|||
146366220|NCT00171314|527841594|FG001|Overall Study|Adverse Event|41|||
146366221|NCT00171314|527841593|FG000|Overall Study|Lack of Efficacy|19|||
146366222|NCT00171314|527841594|FG001|Overall Study|Lack of Efficacy|14|||
146366223|NCT00171314|527841593|FG000|Overall Study|Withdrawal by Subject|9|||
146366224|NCT00171314|527841594|FG001|Overall Study|Withdrawal by Subject|6|||
146366225|NCT00171314|527841593|FG000|Overall Study|Abnormal Test Procedure Results|9|||
146366226|NCT00171314|527841594|FG001|Overall Study|Abnormal Test Procedure Results|3|||
146366227|NCT00171314|527841593|FG000|Overall Study|Protocol Violation|3|||
146366228|NCT00171314|527841594|FG001|Overall Study|Protocol Violation|7|||
146366229|NCT00171314|527841593|FG000|Overall Study|Administrative Problems|4|||
146366230|NCT00171314|527841594|FG001|Overall Study|Administrative Problems|3|||
146366231|NCT00171314|527841593|FG000|Overall Study|Lost to Follow-up|1|||
146366232|NCT00171314|527841594|FG001|Overall Study|Lost to Follow-up|3|||
146366233|NCT00171314|527841593|FG000|Overall Study|Death|2|||
146366234|NCT00171314|527841594|FG001|Overall Study|Death|1|||
146366235|NCT00377429|527841595|FG000|Overall Study|Withdrawal by Subject|5|||
146366236|NCT00377429|527841595|FG000|Overall Study|Adverse Event|8|||
146366237|NCT00377429|527841595|FG000|Overall Study|Physician Decision|1|||
146366238|NCT00377429|527841595|FG000|Overall Study|Patient non-compliance|1|||
146366239|NCT02939599|527841596|FG000|Overall Study|Adverse Event|1|||
146366240|NCT02939599|527841597|FG001|Overall Study|Adverse Event|0|||
146366241|NCT02939599|527841596|FG000|Overall Study|Study Terminated By Sponsor|2|||
146366242|NCT02939599|527841597|FG001|Overall Study|Study Terminated By Sponsor|2|||
146366243|NCT01669811|527841598|FG000|Overall Study|Investigator decision|0|||
146366244|NCT01669811|527841599|FG001|Overall Study|Investigator decision|1|||
146366245|NCT01669811|527841598|FG000|Overall Study|Withdrawal by Subject|1|||
146366246|NCT01669811|527841599|FG001|Overall Study|Withdrawal by Subject|2|||
146366247|NCT01669811|527841598|FG000|Overall Study|Adverse Event|2|||
146366248|NCT01669811|527841599|FG001|Overall Study|Adverse Event|6|||
146366249|NCT01669811|527841598|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
146366250|NCT01669811|527841599|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
146366251|NCT02559206|527841603|FG000|Overall Study|Adverse Event|0|||
146366252|NCT02559206|527841604|FG001|Overall Study|Adverse Event|4|||
146366253|NCT02559206|527841605|FG002|Overall Study|Adverse Event|1|||
146366254|NCT02559206|527841606|FG003|Overall Study|Adverse Event|5|||
146366255|NCT02559206|527841607|FG004|Overall Study|Adverse Event|3|||
146366256|NCT02559206|527841608|FG005|Overall Study|Adverse Event|0|||
146366257|NCT02559206|527841609|FG006|Overall Study|Adverse Event|1|||
146366258|NCT02559206|527841610|FG007|Overall Study|Adverse Event|0|||
146366259|NCT02559206|527841603|FG000|Overall Study|Protocol Violation|1|||
146366260|NCT02559206|527841604|FG001|Overall Study|Protocol Violation|0|||
146366261|NCT02559206|527841605|FG002|Overall Study|Protocol Violation|1|||
146366262|NCT02559206|527841606|FG003|Overall Study|Protocol Violation|0|||
146366263|NCT02559206|527841607|FG004|Overall Study|Protocol Violation|0|||
146366264|NCT02559206|527841608|FG005|Overall Study|Protocol Violation|2|||
146366265|NCT02559206|527841609|FG006|Overall Study|Protocol Violation|0|||
146366266|NCT02559206|527841610|FG007|Overall Study|Protocol Violation|0|||
146366267|NCT02559206|527841603|FG000|Overall Study|Withdrawal by Subject|3|||
146366268|NCT02559206|527841604|FG001|Overall Study|Withdrawal by Subject|3|||
146366269|NCT02559206|527841605|FG002|Overall Study|Withdrawal by Subject|1|||
146366270|NCT02559206|527841606|FG003|Overall Study|Withdrawal by Subject|3|||
146366271|NCT02559206|527841607|FG004|Overall Study|Withdrawal by Subject|5|||
146366272|NCT02559206|527841608|FG005|Overall Study|Withdrawal by Subject|4|||
146366273|NCT02559206|527841609|FG006|Overall Study|Withdrawal by Subject|1|||
146366274|NCT02559206|527841610|FG007|Overall Study|Withdrawal by Subject|2|||
146169814|NCT04108000|527132948|FG002|Overall Study|Withdrawal by Subject|0|||
146169815|NCT04108000|527132949|FG003|Overall Study|Withdrawal by Subject|0|||
146169816|NCT04108000|527132946|FG000|Overall Study|Death of surrogate partner|0|||
146169817|NCT04108000|527132947|FG001|Overall Study|Death of surrogate partner|1|||
146169818|NCT04108000|527132948|FG002|Overall Study|Death of surrogate partner|0|||
146169819|NCT04108000|527132949|FG003|Overall Study|Death of surrogate partner|1|||
146169820|NCT05559866|527132950|FG000|Overall Study|Withdrawal by Subject|1|||
146169821|NCT05559866|527132951|FG001|Overall Study|Withdrawal by Subject|0|||
146169822|NCT06027619|527132953|FG000|Overall Study|Adverse Event|0|||
146169823|NCT06027619|527132954|FG001|Overall Study|Adverse Event|0|||
146169824|NCT06027619|527132955|FG002|Overall Study|Adverse Event|1|||
146282353|NCT01879722|527546478|FG009|Overall Study|Voluntary Withdrawal|0|||
146282354|NCT01983254|527546479|FG000|Overall Study|Death|6|||
146282355|NCT01983254|527546480|FG001|Overall Study|Death|6|||
146282356|NCT01983254|527546479|FG000|Overall Study|Lost to Follow-up|17|||
146282357|NCT01983254|527546480|FG001|Overall Study|Lost to Follow-up|16|||
146282358|NCT01983254|527546479|FG000|Overall Study|too ill|11|||
146282359|NCT01983254|527546480|FG001|Overall Study|too ill|8|||
146282360|NCT00434213|527546483|FG000|Overall Study|Adverse Event|12|||
146282361|NCT00434213|527546483|FG000|Overall Study|Lack of Efficacy|9|||
146282362|NCT00434213|527546483|FG000|Overall Study|Lost to Follow-up|14|||
146282363|NCT00434213|527546483|FG000|Overall Study|Withdrawal by Subject|7|||
146366275|NCT02559206|527841603|FG000|Overall Study|Lost to Follow-up|3|||
146282364|NCT00434213|527546483|FG000|Overall Study|Protocol Violation|3|||
146282365|NCT00434213|527546483|FG000|Overall Study|Unable to comply with study visit window|2|||
146282366|NCT00434213|527546483|FG000|Overall Study|Application site reaction|1|||
146282367|NCT00434213|527546483|FG000|Overall Study|Non-compliant to study schedule|1|||
146282368|NCT00037830|527546484|FG000|Overall Study|Adverse Event|2|||
146282369|NCT00037830|527546485|FG001|Overall Study|Adverse Event|0|||
146282370|NCT00037830|527546486|FG002|Overall Study|Adverse Event|0|||
146282371|NCT00037830|527546484|FG000|Overall Study|Withdrawal by Subject|4|||
146366276|NCT02559206|527841604|FG001|Overall Study|Lost to Follow-up|5|||
146366277|NCT02559206|527841605|FG002|Overall Study|Lost to Follow-up|3|||
146366278|NCT02559206|527841606|FG003|Overall Study|Lost to Follow-up|3|||
146282372|NCT00037830|527546485|FG001|Overall Study|Withdrawal by Subject|5|||
146366279|NCT02559206|527841607|FG004|Overall Study|Lost to Follow-up|2|||
146366280|NCT02559206|527841608|FG005|Overall Study|Lost to Follow-up|5|||
146366281|NCT02559206|527841609|FG006|Overall Study|Lost to Follow-up|1|||
146366282|NCT02559206|527841610|FG007|Overall Study|Lost to Follow-up|4|||
146366283|NCT02559206|527841603|FG000|Overall Study|Lack of Efficacy|1|||
146366284|NCT02559206|527841604|FG001|Overall Study|Lack of Efficacy|0|||
146366285|NCT02559206|527841605|FG002|Overall Study|Lack of Efficacy|3|||
146366286|NCT02559206|527841606|FG003|Overall Study|Lack of Efficacy|2|||
146366287|NCT02559206|527841607|FG004|Overall Study|Lack of Efficacy|2|||
146366288|NCT02559206|527841608|FG005|Overall Study|Lack of Efficacy|3|||
146366289|NCT02559206|527841609|FG006|Overall Study|Lack of Efficacy|3|||
146366290|NCT02559206|527841610|FG007|Overall Study|Lack of Efficacy|3|||
146366291|NCT02559206|527841603|FG000|Overall Study|Other Not Specified|0|||
146366292|NCT02559206|527841604|FG001|Overall Study|Other Not Specified|0|||
146366293|NCT02559206|527841605|FG002|Overall Study|Other Not Specified|0|||
146366294|NCT02559206|527841606|FG003|Overall Study|Other Not Specified|1|||
146366295|NCT02559206|527841607|FG004|Overall Study|Other Not Specified|0|||
146366296|NCT02559206|527841608|FG005|Overall Study|Other Not Specified|0|||
146366297|NCT02559206|527841609|FG006|Overall Study|Other Not Specified|0|||
146366298|NCT02559206|527841610|FG007|Overall Study|Other Not Specified|0|||
146366299|NCT01871896|527841613|FG000|Overall Study|Lost to Follow-up|1|||
146366300|NCT03927911|527843127|FG000|Overall Study|problems with eDiary|0|||
146366301|NCT03927911|527843128|FG001|Overall Study|problems with eDiary|1|||
146366302|NCT03927911|527843129|FG002|Overall Study|problems with eDiary|0|||
146366303|NCT03927911|527843130|FG003|Overall Study|problems with eDiary|1|||
146366304|NCT03927911|527843131|FG004|Overall Study|problems with eDiary|0|||
146366305|NCT03927911|527843132|FG005|Overall Study|problems with eDiary|4|||
146366306|NCT03927911|527843127|FG000|Overall Study|Adverse Event|0|||
146366307|NCT03927911|527843128|FG001|Overall Study|Adverse Event|0|||
146366308|NCT03927911|527843129|FG002|Overall Study|Adverse Event|0|||
146366309|NCT03927911|527843130|FG003|Overall Study|Adverse Event|0|||
146366310|NCT03927911|527843131|FG004|Overall Study|Adverse Event|0|||
146366311|NCT03927911|527843132|FG005|Overall Study|Adverse Event|1|||
146366312|NCT03927911|527843127|FG000|Overall Study|not treated -study terminated by sponsor|0|||
146366313|NCT03927911|527843128|FG001|Overall Study|not treated -study terminated by sponsor|1|||
146366314|NCT03927911|527843129|FG002|Overall Study|not treated -study terminated by sponsor|0|||
146366315|NCT03927911|527843130|FG003|Overall Study|not treated -study terminated by sponsor|0|||
146366316|NCT03927911|527843131|FG004|Overall Study|not treated -study terminated by sponsor|0|||
146366317|NCT03927911|527843132|FG005|Overall Study|not treated -study terminated by sponsor|0|||
146366318|NCT03927911|527843127|FG000|Overall Study|Surgery cancelled|0|||
146366319|NCT03927911|527843128|FG001|Overall Study|Surgery cancelled|0|||
146366320|NCT03927911|527843129|FG002|Overall Study|Surgery cancelled|0|||
146366321|NCT03927911|527843130|FG003|Overall Study|Surgery cancelled|1|||
146366322|NCT03927911|527843131|FG004|Overall Study|Surgery cancelled|0|||
146366323|NCT03927911|527843132|FG005|Overall Study|Surgery cancelled|1|||
146366324|NCT03927911|527843127|FG000|Overall Study|Protocol Violation|0|||
146366325|NCT03927911|527843128|FG001|Overall Study|Protocol Violation|0|||
146366326|NCT03927911|527843129|FG002|Overall Study|Protocol Violation|0|||
146366327|NCT03927911|527843130|FG003|Overall Study|Protocol Violation|0|||
146366328|NCT03927911|527843131|FG004|Overall Study|Protocol Violation|0|||
146366329|NCT03927911|527843132|FG005|Overall Study|Protocol Violation|1|||
146366330|NCT00562640|527843133|FG000|Overall Study|Death|0|||
146366331|NCT00562640|527843134|FG001|Overall Study|Death|1|||
146366332|NCT00562640|527843135|FG002|Overall Study|Death|1|||
146366333|NCT00562640|527843136|FG003|Overall Study|Death|0|||
146366334|NCT05263921|527843137|FG000|Overall Study|Other: family emergency.|0|||
146366335|NCT05263921|527843138|FG001|Overall Study|Other: family emergency.|0|||
146366336|NCT05263921|527843139|FG002|Overall Study|Other: family emergency.|1|||
146366337|NCT05263921|527843140|FG003|Overall Study|Other: family emergency.|0|||
146366338|NCT01412151|527843141|FG000|Week 0 - 306 - Treatment Period|Death|1|||
146366339|NCT01412151|527843141|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
146366340|NCT01412151|527843141|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
146366341|NCT01412151|527843141|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
146366342|NCT03127852|527843142|FG000|Overall Study|Withdrawal by Subject|4|||
146366343|NCT03127852|527843143|FG001|Overall Study|Withdrawal by Subject|1|||
146366344|NCT03127852|527843142|FG000|Overall Study|Death|1|||
146366345|NCT03127852|527843143|FG001|Overall Study|Death|1|||
146366346|NCT02670928|527843144|FG000|Overall Study|Adverse Event|3|||
146366347|NCT02670928|527843145|FG001|Overall Study|Adverse Event|1|||
146366348|NCT02670928|527843144|FG000|Overall Study|Withdrawal by Subject|4|||
146366349|NCT02670928|527843145|FG001|Overall Study|Withdrawal by Subject|0|||
146366350|NCT02670928|527843144|FG000|Overall Study|Lost to Follow-up|1|||
146366351|NCT02670928|527843145|FG001|Overall Study|Lost to Follow-up|0|||
146366352|NCT02670928|527843144|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
146366353|NCT02670928|527843145|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
146366354|NCT02591238|527843146|FG000|Overall Study|Pregnancy|1|||
146366355|NCT02591238|527843147|FG001|Overall Study|Pregnancy|0|||
146366356|NCT02591238|527843148|FG002|Overall Study|Pregnancy|0|||
146366357|NCT02591238|527843149|FG003|Overall Study|Pregnancy|0|||
146366358|NCT02591238|527843146|FG000|Overall Study|Withdrawal by Subject|0|||
146366359|NCT02591238|527843147|FG001|Overall Study|Withdrawal by Subject|0|||
146366360|NCT02591238|527843148|FG002|Overall Study|Withdrawal by Subject|0|||
146366361|NCT02591238|527843149|FG003|Overall Study|Withdrawal by Subject|1|||
146366362|NCT02591238|527843146|FG000|Overall Study|influenza|0|||
146366363|NCT02591238|527843147|FG001|Overall Study|influenza|0|||
146366364|NCT02591238|527843148|FG002|Overall Study|influenza|0|||
146366365|NCT02591238|527843149|FG003|Overall Study|influenza|1|||
146366366|NCT02591238|527843146|FG000|Overall Study|personal circumstances|0|||
146366367|NCT02591238|527843147|FG001|Overall Study|personal circumstances|0|||
146366368|NCT02591238|527843148|FG002|Overall Study|personal circumstances|0|||
146366369|NCT02591238|527843149|FG003|Overall Study|personal circumstances|1|||
146366370|NCT02591238|527843146|FG000|Overall Study|personal circumstances|0|||
146366371|NCT02591238|527843147|FG001|Overall Study|personal circumstances|1|||
146366372|NCT02591238|527843148|FG002|Overall Study|personal circumstances|0|||
146366373|NCT02591238|527843149|FG003|Overall Study|personal circumstances|0|||
146366374|NCT00525785|527843153|FG000|Overall Study|Withdrawal by Subject|1|||
146366375|NCT00525785|527843153|FG000|Overall Study|Lack of Efficacy|1|||
146366376|NCT00525785|527843153|FG000|Overall Study|Physician Decision|1|||
146366377|NCT03628599|527843154|FG000|Overall Study|Adverse Event|0|||
146366378|NCT03628599|527843155|FG001|Overall Study|Adverse Event|1|||
146366379|NCT01624506|527843156|FG000|Overall Study|Lost to Follow-up|29|||
146366380|NCT01624506|527843157|FG001|Overall Study|Lost to Follow-up|15|||
146366381|NCT01624506|527843156|FG000|Overall Study|Withdrawal by Subject|9|||
146366382|NCT01624506|527843157|FG001|Overall Study|Withdrawal by Subject|2|||
146366383|NCT01624506|527843156|FG000|Overall Study|Death|1|||
146366384|NCT01624506|527843157|FG001|Overall Study|Death|0|||
146366385|NCT01624506|527843156|FG000|Overall Study|LINX explants|23|||
146366386|NCT01624506|527843157|FG001|Overall Study|LINX explants|0|||
146366387|NCT01624506|527843156|FG000|Overall Study|Adverse Event|3|||
146366388|NCT01624506|527843157|FG001|Overall Study|Adverse Event|0|||
146366389|NCT00132314|527843163|FG000|Overall Study|Lost to Follow-up|70|||
146366390|NCT00132314|527843164|FG001|Overall Study|Lost to Follow-up|62|||
146366391|NCT00132314|527843163|FG000|Overall Study|Lacked SSN|1|||
146366392|NCT00132314|527843164|FG001|Overall Study|Lacked SSN|3|||
146366393|NCT00132314|527843163|FG000|Overall Study|Refused intervention at baseline|2|||
146366394|NCT00132314|527843164|FG001|Overall Study|Refused intervention at baseline|7|||
146366395|NCT02966353|527843185|FG000|Overall Study|Withdrawal by Subject|7|||
146366396|NCT02966353|527843185|FG000|Overall Study|Adverse Event|4|||
146366397|NCT02966353|527843185|FG000|Overall Study|Death|4|||
146366398|NCT02966353|527843185|FG000|Overall Study|Physician Decision|3|||
146366399|NCT02966353|527843185|FG000|Overall Study|Progressive disease|2|||
146366400|NCT02966353|527843185|FG000|Overall Study|Protocol deviation|2|||
146366401|NCT00093470|527843191|FG000|Overall Study|Disease progression|39|||
146366402|NCT00093470|527843192|FG001|Overall Study|Disease progression|0|||
146366403|NCT00093470|527843191|FG000|Overall Study|Adverse Event|15|||
146366404|NCT00093470|527843192|FG001|Overall Study|Adverse Event|0|||
146366405|NCT00093470|527843191|FG000|Overall Study|Death|2|||
146366406|NCT00093470|527843192|FG001|Overall Study|Death|0|||
146366407|NCT00093470|527843191|FG000|Overall Study|Withdrawal by Subject|8|||
146366408|NCT00093470|527843192|FG001|Overall Study|Withdrawal by Subject|0|||
146366409|NCT00093470|527843191|FG000|Overall Study|Alternative therapy|2|||
146366410|NCT00093470|527843192|FG001|Overall Study|Alternative therapy|0|||
146366411|NCT00093470|527843191|FG000|Overall Study|Other complicating disease|3|||
146366412|NCT00093470|527843192|FG001|Overall Study|Other complicating disease|0|||
146366413|NCT00093470|527843191|FG000|Overall Study|Physician Decision|2|||
146366414|NCT00093470|527843192|FG001|Overall Study|Physician Decision|0|||
146366415|NCT00093470|527843191|FG000|Overall Study|Never started treatment|1|||
146366416|NCT00093470|527843192|FG001|Overall Study|Never started treatment|0|||
146366417|NCT00093470|527843191|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
146366418|NCT00093470|527843192|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
146366419|NCT02514772|527843193|FG000|Overall Study|Adverse Event|1|||
146366420|NCT02514772|527843194|FG001|Overall Study|Adverse Event|0|||
146366421|NCT02514772|527843193|FG000|Overall Study|Death|0|||
146366422|NCT02514772|527843194|FG001|Overall Study|Death|1|||
146366423|NCT02514772|527843193|FG000|Overall Study|Withdrawal by Subject|2|||
146366424|NCT02514772|527843194|FG001|Overall Study|Withdrawal by Subject|1|||
146366425|NCT00877006|527843195|FG000|Treatment Period|Death|2|||
146366426|NCT00877006|527843196|FG001|Treatment Period|Death|1|||
146366427|NCT00877006|527843195|FG000|Treatment Period|Adverse Event|10|||
146366428|NCT00877006|527843196|FG001|Treatment Period|Adverse Event|3|||
146366429|NCT00877006|527843195|FG000|Treatment Period|Withdrawal by Subject|2|||
146366430|NCT00877006|527843196|FG001|Treatment Period|Withdrawal by Subject|3|||
146366431|NCT00877006|527843195|FG000|Treatment Period|Protocol Violation|1|||
146366432|NCT00877006|527843196|FG001|Treatment Period|Protocol Violation|0|||
146366433|NCT00877006|527843195|FG000|Treatment Period|Lost to Follow-up|0|||
146366434|NCT00877006|527843196|FG001|Treatment Period|Lost to Follow-up|1|||
146366435|NCT00877006|527843195|FG000|Treatment Period|Disease Progression|1|||
146366436|NCT00877006|527843196|FG001|Treatment Period|Disease Progression|2|||
146366437|NCT00877006|527843195|FG000|Treatment Period|Started New Treatment Regimen|2|||
146366438|NCT00877006|527843196|FG001|Treatment Period|Started New Treatment Regimen|5|||
146366439|NCT00877006|527843195|FG000|Treatment Period|Other|4|||
146366440|NCT00877006|527843196|FG001|Treatment Period|Other|4|||
146366441|NCT00877006|527843195|FG000|Treatment Period|Randomized but Not Treated|3|||
146366442|NCT00877006|527843196|FG001|Treatment Period|Randomized but Not Treated|8|||
146366443|NCT00877006|527843195|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
146366444|NCT00877006|527843196|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
146366445|NCT00877006|527843195|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
146366446|NCT00877006|527843196|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
146366447|NCT00877006|527843195|FG000|Long-Term Follow-up Period|Death|26|||
146366448|NCT00877006|527843196|FG001|Long-Term Follow-up Period|Death|18|||
146366449|NCT00877006|527843195|FG000|Long-Term Follow-up Period|Other|7|||
146366450|NCT00877006|527843196|FG001|Long-Term Follow-up Period|Other|9|||
146366451|NCT00817206|527843197|FG000|Overall Study|Adverse Event|10|||
146366452|NCT00817206|527843198|FG001|Overall Study|Adverse Event|3|||
146366453|NCT00817206|527843197|FG000|Overall Study|Protocol Violation|0|||
146366454|NCT00817206|527843198|FG001|Overall Study|Protocol Violation|2|||
146366455|NCT00817206|527843197|FG000|Overall Study|Lost to Follow-up|0|||
146366456|NCT00817206|527843198|FG001|Overall Study|Lost to Follow-up|1|||
146366457|NCT00817206|527843197|FG000|Overall Study|Death|2|||
146366458|NCT00817206|527843198|FG001|Overall Study|Death|0|||
146366459|NCT00817206|527843197|FG000|Overall Study|Withdrawal by Subject|7|||
146366460|NCT00817206|527843198|FG001|Overall Study|Withdrawal by Subject|3|||
146366461|NCT00817206|527843197|FG000|Overall Study|Physician Decision|2|||
146366462|NCT00817206|527843198|FG001|Overall Study|Physician Decision|0|||
146366463|NCT00126581|527843199|FG000|Overall Study|Adverse Event|3|||
146366464|NCT00126581|527843200|FG001|Overall Study|Adverse Event|7|||
146366465|NCT00126581|527843199|FG000|Overall Study|Death|3|||
146366466|NCT00126581|527843200|FG001|Overall Study|Death|2|||
146366467|NCT00126581|527843199|FG000|Overall Study|Withdrawal by Subject|1|||
146366468|NCT00126581|527843200|FG001|Overall Study|Withdrawal by Subject|4|||
146366469|NCT00126581|527843199|FG000|Overall Study|Alternative therapy|3|||
146366470|NCT00126581|527843200|FG001|Overall Study|Alternative therapy|3|||
146366471|NCT00126581|527843199|FG000|Overall Study|Other illness/MD discretion|3|||
146366472|NCT00126581|527843200|FG001|Overall Study|Other illness/MD discretion|4|||
146366473|NCT03728140|527843202|FG000|Overall Study|Abnormal embryo transfer operation|10|||
146366474|NCT03728140|527843203|FG001|Overall Study|Abnormal embryo transfer operation|7|||
146366475|NCT01188096|527843204|FG000|Overall Study|progression of disease|4|||
146366476|NCT01188096|527843204|FG000|Overall Study|Withdrawal by Subject|2|||
146366477|NCT02384395|527843205|FG000|Overall Study|Physician Decision|4|||
146366478|NCT02384395|527843205|FG000|Overall Study|Withdrawal by Subject|3|||
146366479|NCT02384395|527843205|FG000|Overall Study|Lost to Follow-up|3|||
146366480|NCT03485222|527843206|FG000|Overall Study|Death|0|||
146366481|NCT03485222|527843207|FG001|Overall Study|Death|1|||
146366482|NCT03485222|527843206|FG000|Overall Study|Lost to Follow-up|2|||
146366483|NCT03485222|527843207|FG001|Overall Study|Lost to Follow-up|1|||
146366484|NCT03004976|527843212|FG000|Overall Study|Lost to Follow-up|7|||
146366485|NCT03004976|527843213|FG001|Overall Study|Lost to Follow-up|5|||
146366486|NCT03004976|527843212|FG000|Overall Study|Physician Decision|1|||
146366487|NCT03004976|527843213|FG001|Overall Study|Physician Decision|0|||
146366488|NCT03004976|527843212|FG000|Overall Study|Withdrawal by Subject|1|||
146366489|NCT03004976|527843213|FG001|Overall Study|Withdrawal by Subject|0|||
146366490|NCT03004976|527843212|FG000|Overall Study|Death|4|||
146366491|NCT03004976|527843213|FG001|Overall Study|Death|1|||
146366492|NCT01143714|527843214|FG000|Overall Study|Adverse Event|4|||
146366493|NCT01143714|527843215|FG001|Overall Study|Adverse Event|2|||
146366494|NCT01143714|527843214|FG000|Overall Study|Withdrawal by Subject|1|||
146366495|NCT01143714|527843215|FG001|Overall Study|Withdrawal by Subject|0|||
146366496|NCT01143714|527843214|FG000|Overall Study|Subject non-compliance|0|||
146366497|NCT01143714|527843215|FG001|Overall Study|Subject non-compliance|1|||
146366498|NCT01143714|527843214|FG000|Overall Study|wound closed = deemed healed|1|||
146366499|NCT01143714|527843215|FG001|Overall Study|wound closed = deemed healed|0|||
146366500|NCT01143714|527843214|FG000|Overall Study|wound size increased|1|||
146366501|NCT01143714|527843215|FG001|Overall Study|wound size increased|0|||
146366502|NCT01106391|527843216|FG000|Overall Study|Death|12|||
146366503|NCT01106391|527843216|FG000|Overall Study|Withdrawal by Subject|7|||
146366504|NCT00150345|527843217|FG000|Overall Study|Death|5|||
146366505|NCT00150345|527843218|FG001|Overall Study|Death|2|||
146366506|NCT00150345|527843217|FG000|Overall Study|Adverse Event|8|||
146366507|NCT00150345|527843218|FG001|Overall Study|Adverse Event|6|||
146366508|NCT00150345|527843217|FG000|Overall Study|Lack of Efficacy|5|||
146366509|NCT00150345|527843218|FG001|Overall Study|Lack of Efficacy|4|||
146366510|NCT00150345|527843217|FG000|Overall Study|Withdrawal by Subject|3|||
146366511|NCT00150345|527843218|FG001|Overall Study|Withdrawal by Subject|4|||
146366512|NCT00150345|527843217|FG000|Overall Study|Laboratory abnormality|1|||
146366513|NCT00150345|527843218|FG001|Overall Study|Laboratory abnormality|2|||
146366514|NCT00150345|527843217|FG000|Overall Study|Other|12|||
146366515|NCT00150345|527843218|FG001|Overall Study|Other|14|||
146395698|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
146282373|NCT00037830|527546486|FG002|Overall Study|Withdrawal by Subject|1|||
146282374|NCT00037830|527546484|FG000|Overall Study|Protocol Violation|2|||
146282375|NCT00037830|527546485|FG001|Overall Study|Protocol Violation|2|||
146282376|NCT00037830|527546486|FG002|Overall Study|Protocol Violation|0|||
146282377|NCT00037830|527546484|FG000|Overall Study|Unrelated Medical Problem|2|||
146282378|NCT00037830|527546485|FG001|Overall Study|Unrelated Medical Problem|0|||
146282379|NCT00037830|527546486|FG002|Overall Study|Unrelated Medical Problem|0|||
146282380|NCT01253304|527546487|FG000|Overall Study|Adverse Event|0|||
146282381|NCT01253304|527546488|FG001|Overall Study|Adverse Event|0|||
146282382|NCT01253304|527546489|FG002|Overall Study|Adverse Event|0|||
146282383|NCT01253304|527546490|FG003|Overall Study|Adverse Event|1|||
146282384|NCT01699503|527546491|FG000|Overall Study|Death|31|||
146282385|NCT01699503|527546492|FG001|Overall Study|Death|40|||
146282386|NCT01699503|527546491|FG000|Overall Study|Withdrawal by Subject|65|||
146282387|NCT01699503|527546492|FG001|Overall Study|Withdrawal by Subject|57|||
146282388|NCT01699503|527546491|FG000|Overall Study|Lost to Follow-up|121|||
146282389|NCT01699503|527546492|FG001|Overall Study|Lost to Follow-up|117|||
146282390|NCT01699503|527546491|FG000|Overall Study|Excluded due to quality|783|||
146282391|NCT01699503|527546492|FG001|Overall Study|Excluded due to quality|791|||
146282392|NCT02101385|527546495|FG000|Study Treatment|Disease Progression|9|||
146282393|NCT02101385|527546496|FG001|Study Treatment|Disease Progression|3|||
146282394|NCT02101385|527546495|FG000|Study Treatment|Alternative therapy|0|||
146282395|NCT02101385|527546496|FG001|Study Treatment|Alternative therapy|1|||
146282396|NCT02101385|527546495|FG000|Study Treatment|No treatment, per protocol criteria|0|||
146282397|NCT02101385|527546496|FG001|Study Treatment|No treatment, per protocol criteria|4|||
146282398|NCT02101385|527546495|FG000|Study Treatment|Patient Non compliance|0|||
146282399|NCT02101385|527546496|FG001|Study Treatment|Patient Non compliance|2|||
146282400|NCT02101385|527546495|FG000|Study Treatment|Withdrawal by Subject|5|||
146282401|NCT02101385|527546496|FG001|Study Treatment|Withdrawal by Subject|2|||
146282402|NCT02101385|527546495|FG000|Study Treatment|screen failure|1|||
146282403|NCT02101385|527546496|FG001|Study Treatment|screen failure|0|||
146282404|NCT02101385|527546495|FG000|Study Treatment|AE/Side Effects/Complications|8|||
146282405|NCT02101385|527546496|FG001|Study Treatment|AE/Side Effects/Complications|0|||
146282406|NCT02101385|527546495|FG000|Study Treatment|Lost to Follow-up|1|||
146282407|NCT02101385|527546496|FG001|Study Treatment|Lost to Follow-up|0|||
146282408|NCT02101385|527546495|FG000|Study Treatment|Disease Progression before treatment|1|||
146282409|NCT02101385|527546496|FG001|Study Treatment|Disease Progression before treatment|0|||
146282410|NCT02101385|527546495|FG000|Study Treatment|Death|1|||
146282411|NCT02101385|527546496|FG001|Study Treatment|Death|0|||
146282412|NCT02101385|527546495|FG000|Follow up|Lost to Follow-up|4|||
146282413|NCT02101385|527546496|FG001|Follow up|Lost to Follow-up|9|||
146282414|NCT02101385|527546495|FG000|Follow up|Refused to follow up|5|||
146282415|NCT02101385|527546496|FG001|Follow up|Refused to follow up|4|||
146282416|NCT02101385|527546495|FG000|Follow up|Death|21|||
146282417|NCT02101385|527546496|FG001|Follow up|Death|39|||
146282418|NCT02101385|527546495|FG000|Follow up|study completed|33|||
146282419|NCT02101385|527546496|FG001|Follow up|study completed|52|||
146282420|NCT02101385|527546495|FG000|Follow up|screen failure|2|||
146282421|NCT02101385|527546496|FG001|Follow up|screen failure|0|||
146282422|NCT02101385|527546495|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
146282423|NCT02101385|527546496|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
146282424|NCT02101385|527546495|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
146282425|NCT02101385|527546496|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
146282426|NCT02101385|527546495|FG000|Follow up|Withdrawal by Subject|2|||
146282427|NCT02101385|527546496|FG001|Follow up|Withdrawal by Subject|2|||
146282428|NCT02101385|527546495|FG000|Follow up|PI requested closure of site|0|||
146282429|NCT02101385|527546496|FG001|Follow up|PI requested closure of site|5|||
146282430|NCT02432196|527546497|FG000|Overall Study|Exit - did not receive study device|1|||
146282431|NCT02432196|527546497|FG000|Overall Study|Death|2|||
146282432|NCT02432196|527546497|FG000|Overall Study|Reoperation|3|||
146282433|NCT01905150|527546499|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
146282434|NCT01905150|527546500|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
146282435|NCT03738423|527546505|FG000|Overall Study|Withdrawal by Subject|9|||
146282436|NCT03738423|527546506|FG001|Overall Study|Withdrawal by Subject|12|||
146282437|NCT03738423|527546507|FG002|Overall Study|Withdrawal by Subject|9|||
146282438|NCT03738423|527546508|FG003|Overall Study|Withdrawal by Subject|12|||
146282439|NCT03738423|527546509|FG004|Overall Study|Withdrawal by Subject|10|||
146282440|NCT03738423|527546505|FG000|Overall Study|Lack of Efficacy|3|||
146282441|NCT03738423|527546506|FG001|Overall Study|Lack of Efficacy|1|||
146282442|NCT03738423|527546507|FG002|Overall Study|Lack of Efficacy|1|||
146282443|NCT03738423|527546508|FG003|Overall Study|Lack of Efficacy|1|||
146366516|NCT03939637|527843220|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
146366517|NCT03939637|527843221|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
146366518|NCT03939637|527843220|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
146366519|NCT03939637|527843221|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
146366520|NCT04325906|527843222|FG000|Overall Study|Withdrawal by Subject|2|||
146366521|NCT04325906|527843223|FG001|Overall Study|Withdrawal by Subject|0|||
146366522|NCT02016898|527843224|FG000|Overall Study|Death|1|||
146366523|NCT02016898|527843225|FG001|Overall Study|Death|1|||
146366524|NCT02016898|527843224|FG000|Overall Study|Lost to Follow-up|4|||
146366525|NCT02016898|527843225|FG001|Overall Study|Lost to Follow-up|4|||
146366526|NCT00992186|527843230|FG000|Overall Study|Withdrawal by Subject|2|||
146366527|NCT00992186|527843230|FG000|Overall Study|Protocol Violation|1|||
146366528|NCT00992186|527843230|FG000|Overall Study|Physician Decision|1|||
146366529|NCT00992186|527843230|FG000|Overall Study|Adverse Event|9|||
146366530|NCT00992186|527843230|FG000|Overall Study|Progressive Disease|30|||
146366531|NCT00992186|527843230|FG000|Overall Study|Refusal To Receive Study Agent|3|||
146366532|NCT00973622|527843233|FG000|Overall Study|did not attend MRI|14|||
146366533|NCT00973622|527843234|FG001|Overall Study|did not attend MRI|3|||
146366534|NCT00973622|527843233|FG000|Overall Study|did not pass MRI screen|6|||
146366535|NCT00973622|527843234|FG001|Overall Study|did not pass MRI screen|0|||
146366536|NCT00973622|527843233|FG000|Overall Study|did not complete rTMS sessions|11|||
146366537|NCT00973622|527843234|FG001|Overall Study|did not complete rTMS sessions|2|||
146366538|NCT03074149|527843239|FG000|Overall Study|Reason unknown|22|||
146366539|NCT03074149|527843240|FG001|Overall Study|Reason unknown|35|||
146366540|NCT03074149|527843239|FG000|Overall Study|Death|10|||
146366541|NCT03074149|527843240|FG001|Overall Study|Death|45|||
146366542|NCT00830960|527843241|FG000|Overall Study|Death|5|||
146366543|NCT00830960|527843242|FG001|Overall Study|Death|4|||
146366544|NCT00830960|527843243|FG002|Overall Study|Death|3|||
146366545|NCT00830960|527843244|FG003|Overall Study|Death|2|||
146366546|NCT00830960|527843245|FG004|Overall Study|Death|6|||
146366547|NCT00830960|527843246|FG005|Overall Study|Death|1|||
146366548|NCT00830960|527843241|FG000|Overall Study|Lost to Follow-up|1|||
146366549|NCT00830960|527843242|FG001|Overall Study|Lost to Follow-up|1|||
146366550|NCT00830960|527843243|FG002|Overall Study|Lost to Follow-up|1|||
146366551|NCT00830960|527843244|FG003|Overall Study|Lost to Follow-up|0|||
146366552|NCT00830960|527843245|FG004|Overall Study|Lost to Follow-up|0|||
146366553|NCT00830960|527843246|FG005|Overall Study|Lost to Follow-up|1|||
146366554|NCT00830960|527843241|FG000|Overall Study|Withdrawal by Subject|19|||
146366555|NCT00830960|527843242|FG001|Overall Study|Withdrawal by Subject|19|||
146366556|NCT00830960|527843243|FG002|Overall Study|Withdrawal by Subject|18|||
146366557|NCT00830960|527843244|FG003|Overall Study|Withdrawal by Subject|23|||
146366558|NCT00830960|527843245|FG004|Overall Study|Withdrawal by Subject|16|||
146366559|NCT00830960|527843246|FG005|Overall Study|Withdrawal by Subject|21|||
146366560|NCT00830960|527843241|FG000|Overall Study|Sponsor Decision|1|||
146366561|NCT00830960|527843242|FG001|Overall Study|Sponsor Decision|2|||
146366562|NCT00830960|527843243|FG002|Overall Study|Sponsor Decision|3|||
146366563|NCT00830960|527843244|FG003|Overall Study|Sponsor Decision|4|||
146366564|NCT00830960|527843245|FG004|Overall Study|Sponsor Decision|5|||
146366565|NCT00830960|527843246|FG005|Overall Study|Sponsor Decision|7|||
146366566|NCT00830960|527843241|FG000|Overall Study|No study drug received|7|||
146366567|NCT00830960|527843242|FG001|Overall Study|No study drug received|2|||
146366568|NCT00830960|527843243|FG002|Overall Study|No study drug received|4|||
146366569|NCT00830960|527843244|FG003|Overall Study|No study drug received|3|||
146366570|NCT00830960|527843245|FG004|Overall Study|No study drug received|5|||
146366571|NCT00830960|527843246|FG005|Overall Study|No study drug received|7|||
146366572|NCT02855450|527843251|FG000|Overall Study|Adverse Event|1|||
146366573|NCT02855450|527843252|FG001|Overall Study|Adverse Event|0|||
146366574|NCT02855450|527843251|FG000|Overall Study|Lost to Follow-up|4|||
146366575|NCT02855450|527843252|FG001|Overall Study|Lost to Follow-up|0|||
146366576|NCT05159362|527843253|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
146366577|NCT05159362|527843254|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
146366578|NCT05159362|527843255|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
146366579|NCT01324622|527843256|FG000|Overall Study|Lost to Follow-up|7|||
146366580|NCT01324622|527843257|FG001|Overall Study|Lost to Follow-up|7|||
146366581|NCT01324622|527843256|FG000|Overall Study|Death|1|||
146366582|NCT01324622|527843257|FG001|Overall Study|Death|0|||
146366583|NCT01324622|527843256|FG000|Overall Study|Lack of Efficacy|1|||
146366584|NCT01324622|527843257|FG001|Overall Study|Lack of Efficacy|0|||
146366585|NCT00618449|527843258|FG000|Overall Study|Lost to Follow-up|98|||
146366586|NCT00618449|527843259|FG001|Overall Study|Lost to Follow-up|110|||
146366587|NCT02219087|527843260|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
146366588|NCT02219087|527843261|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
146366589|NCT02815293|527843264|FG000|Overall Study|Study termination by sponsor|10|||
146366590|NCT02815293|527843265|FG001|Overall Study|Study termination by sponsor|7|||
146366591|NCT02815293|527843266|FG002|Overall Study|Study termination by sponsor|0|||
146366592|NCT02815293|527843264|FG000|Overall Study|Participants not randomized|0|||
146366593|NCT02815293|527843265|FG001|Overall Study|Participants not randomized|0|||
146366594|NCT02815293|527843266|FG002|Overall Study|Participants not randomized|18|||
146366595|NCT02815293|527843264|FG000|Overall Study|Adverse Event|0|||
146366596|NCT02815293|527843265|FG001|Overall Study|Adverse Event|1|||
146366597|NCT02815293|527843266|FG002|Overall Study|Adverse Event|0|||
146366598|NCT00006604|527843269|FG000|Overall Study|Met study objective - no further FU|1|||
146366599|NCT00006604|527843270|FG001|Overall Study|Met study objective - no further FU|0|||
146366600|NCT00006604|527843271|FG002|Overall Study|Met study objective - no further FU|0|||
146366601|NCT00006604|527843272|FG003|Overall Study|Met study objective - no further FU|0|||
146366602|NCT00006604|527843273|FG004|Overall Study|Met study objective - no further FU|0|||
146366603|NCT00006604|527843274|FG005|Overall Study|Met study objective - no further FU|0|||
146366604|NCT00006604|527843275|FG006|Overall Study|Met study objective - no further FU|0|||
146366605|NCT00006604|527843276|FG007|Overall Study|Met study objective - no further FU|0|||
146366606|NCT00006604|527843277|FG008|Overall Study|Met study objective - no further FU|0|||
146366607|NCT00006604|527843278|FG009|Overall Study|Met study objective - no further FU|0|||
146366608|NCT00006604|527843279|FG010|Overall Study|Met study objective - no further FU|0|||
146366609|NCT00006604|527843280|FG011|Overall Study|Met study objective - no further FU|0|||
146366610|NCT00006604|527843281|FG012|Overall Study|Met study objective - no further FU|0|||
146366611|NCT00006604|527843282|FG013|Overall Study|Met study objective - no further FU|0|||
146366612|NCT00006604|527843283|FG014|Overall Study|Met study objective - no further FU|1|||
146366613|NCT00006604|527843284|FG015|Overall Study|Met study objective - no further FU|1|||
146366614|NCT00006604|527843285|FG016|Overall Study|Met study objective - no further FU|0|||
146366615|NCT00006604|527843269|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
146366616|NCT00006604|527843270|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
146366617|NCT00006604|527843271|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
146366618|NCT00006604|527843272|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
146366619|NCT00006604|527843273|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
146366620|NCT00006604|527843274|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
146366621|NCT00006604|527843275|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
146366622|NCT00006604|527843276|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
146366623|NCT00006604|527843277|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
146366624|NCT00006604|527843278|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
146366625|NCT00006604|527843279|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
146366626|NCT00006604|527843280|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
146366627|NCT00006604|527843281|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
146366628|NCT00006604|527843282|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
146366629|NCT00006604|527843283|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
146366630|NCT00006604|527843284|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
146366631|NCT00006604|527843285|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
146366632|NCT00006604|527843269|FG000|Overall Study|Death|0|||
146366633|NCT00006604|527843270|FG001|Overall Study|Death|0|||
146366634|NCT00006604|527843271|FG002|Overall Study|Death|0|||
146366635|NCT00006604|527843272|FG003|Overall Study|Death|0|||
146366636|NCT00006604|527843273|FG004|Overall Study|Death|0|||
146366637|NCT00006604|527843274|FG005|Overall Study|Death|0|||
146366638|NCT00006604|527843275|FG006|Overall Study|Death|0|||
146366639|NCT00006604|527843276|FG007|Overall Study|Death|0|||
146366640|NCT00006604|527843277|FG008|Overall Study|Death|0|||
146366641|NCT00006604|527843278|FG009|Overall Study|Death|1|||
146366642|NCT00006604|527843279|FG010|Overall Study|Death|1|||
146366643|NCT00006604|527843280|FG011|Overall Study|Death|1|||
146366644|NCT00006604|527843281|FG012|Overall Study|Death|0|||
146366645|NCT00006604|527843282|FG013|Overall Study|Death|0|||
146366646|NCT00006604|527843283|FG014|Overall Study|Death|0|||
146366647|NCT00006604|527843284|FG015|Overall Study|Death|0|||
146366648|NCT00006604|527843285|FG016|Overall Study|Death|0|||
146366649|NCT00006604|527843269|FG000|Overall Study|Severe debilitation, unable to continue|0|||
146366650|NCT00006604|527843270|FG001|Overall Study|Severe debilitation, unable to continue|0|||
146366651|NCT00006604|527843271|FG002|Overall Study|Severe debilitation, unable to continue|0|||
146366652|NCT00006604|527843272|FG003|Overall Study|Severe debilitation, unable to continue|0|||
146366653|NCT00006604|527843273|FG004|Overall Study|Severe debilitation, unable to continue|0|||
146366654|NCT00006604|527843274|FG005|Overall Study|Severe debilitation, unable to continue|0|||
146366655|NCT00006604|527843275|FG006|Overall Study|Severe debilitation, unable to continue|3|||
146366656|NCT00006604|527843276|FG007|Overall Study|Severe debilitation, unable to continue|0|||
146366657|NCT00006604|527843277|FG008|Overall Study|Severe debilitation, unable to continue|0|||
146366658|NCT00006604|527843278|FG009|Overall Study|Severe debilitation, unable to continue|5|||
146366659|NCT00006604|527843279|FG010|Overall Study|Severe debilitation, unable to continue|0|||
146366660|NCT00006604|527843280|FG011|Overall Study|Severe debilitation, unable to continue|2|||
146366661|NCT00006604|527843281|FG012|Overall Study|Severe debilitation, unable to continue|1|||
146366662|NCT00006604|527843282|FG013|Overall Study|Severe debilitation, unable to continue|0|||
146366663|NCT00006604|527843283|FG014|Overall Study|Severe debilitation, unable to continue|2|||
146366664|NCT00006604|527843284|FG015|Overall Study|Severe debilitation, unable to continue|0|||
146366665|NCT00006604|527843285|FG016|Overall Study|Severe debilitation, unable to continue|0|||
146366666|NCT00006604|527843269|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
146366667|NCT00006604|527843270|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
146366668|NCT00006604|527843271|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
146366669|NCT00006604|527843272|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
146366670|NCT00006604|527843273|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
146366671|NCT00006604|527843274|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
146366672|NCT00006604|527843275|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
146366673|NCT00006604|527843276|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
146366674|NCT00006604|527843277|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
146366675|NCT00006604|527843278|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
146366676|NCT00006604|527843279|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
146366677|NCT00006604|527843280|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
146366678|NCT00006604|527843281|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
146366679|NCT00006604|527843282|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
146366680|NCT00006604|527843283|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
146366681|NCT00006604|527843284|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
146366682|NCT00006604|527843285|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
146366683|NCT00006604|527843269|FG000|Overall Study|Site closing|0|||
146366684|NCT00006604|527843270|FG001|Overall Study|Site closing|0|||
146366685|NCT00006604|527843271|FG002|Overall Study|Site closing|1|||
146366686|NCT00006604|527843272|FG003|Overall Study|Site closing|1|||
146366687|NCT00006604|527843273|FG004|Overall Study|Site closing|0|||
146366688|NCT00006604|527843274|FG005|Overall Study|Site closing|0|||
146366689|NCT00006604|527843275|FG006|Overall Study|Site closing|0|||
146366690|NCT00006604|527843276|FG007|Overall Study|Site closing|1|||
146366691|NCT00006604|527843277|FG008|Overall Study|Site closing|0|||
146366692|NCT00006604|527843278|FG009|Overall Study|Site closing|0|||
146366693|NCT00006604|527843279|FG010|Overall Study|Site closing|0|||
146366694|NCT00006604|527843280|FG011|Overall Study|Site closing|1|||
146366695|NCT00006604|527843281|FG012|Overall Study|Site closing|1|||
146366696|NCT00006604|527843282|FG013|Overall Study|Site closing|1|||
146366697|NCT00006604|527843283|FG014|Overall Study|Site closing|0|||
146366698|NCT00006604|527843284|FG015|Overall Study|Site closing|0|||
146366699|NCT00006604|527843285|FG016|Overall Study|Site closing|1|||
146366700|NCT00006604|527843269|FG000|Overall Study|Withdrawal by Subject|1|||
146366701|NCT00006604|527843270|FG001|Overall Study|Withdrawal by Subject|0|||
146366702|NCT00006604|527843271|FG002|Overall Study|Withdrawal by Subject|2|||
146366703|NCT00006604|527843272|FG003|Overall Study|Withdrawal by Subject|0|||
146366704|NCT00006604|527843273|FG004|Overall Study|Withdrawal by Subject|1|||
146366705|NCT00006604|527843274|FG005|Overall Study|Withdrawal by Subject|2|||
146366706|NCT00006604|527843275|FG006|Overall Study|Withdrawal by Subject|2|||
146366707|NCT00006604|527843276|FG007|Overall Study|Withdrawal by Subject|0|||
146366708|NCT00006604|527843277|FG008|Overall Study|Withdrawal by Subject|1|||
146366709|NCT00006604|527843278|FG009|Overall Study|Withdrawal by Subject|3|||
146366710|NCT00006604|527843279|FG010|Overall Study|Withdrawal by Subject|2|||
146366711|NCT00006604|527843280|FG011|Overall Study|Withdrawal by Subject|0|||
146366712|NCT00006604|527843281|FG012|Overall Study|Withdrawal by Subject|1|||
146366713|NCT00006604|527843282|FG013|Overall Study|Withdrawal by Subject|2|||
146366714|NCT00006604|527843283|FG014|Overall Study|Withdrawal by Subject|1|||
146366715|NCT00006604|527843284|FG015|Overall Study|Withdrawal by Subject|0|||
146366716|NCT00006604|527843285|FG016|Overall Study|Withdrawal by Subject|1|||
146366717|NCT00006604|527843269|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
146366718|NCT00006604|527843270|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
146366719|NCT00006604|527843271|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
146366720|NCT00006604|527843272|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
146366721|NCT00006604|527843273|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
146366722|NCT00006604|527843274|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
146366723|NCT00006604|527843275|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
146366724|NCT00006604|527843276|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
146366725|NCT00006604|527843277|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
146366726|NCT00006604|527843278|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
146366727|NCT00006604|527843279|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
146366728|NCT00006604|527843280|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
146366729|NCT00006604|527843281|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
146366730|NCT00006604|527843282|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
146366731|NCT00006604|527843283|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
146366732|NCT00006604|527843284|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
146366733|NCT00006604|527843285|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
146366734|NCT00006604|527843269|FG000|Overall Study|Lost to Follow-up|0|||
146366735|NCT00006604|527843270|FG001|Overall Study|Lost to Follow-up|0|||
146366736|NCT00006604|527843271|FG002|Overall Study|Lost to Follow-up|0|||
146366737|NCT00006604|527843272|FG003|Overall Study|Lost to Follow-up|0|||
146366738|NCT00006604|527843273|FG004|Overall Study|Lost to Follow-up|0|||
146366739|NCT00006604|527843274|FG005|Overall Study|Lost to Follow-up|0|||
146366740|NCT00006604|527843275|FG006|Overall Study|Lost to Follow-up|0|||
146366741|NCT00006604|527843276|FG007|Overall Study|Lost to Follow-up|1|||
146366742|NCT00006604|527843277|FG008|Overall Study|Lost to Follow-up|0|||
146366743|NCT00006604|527843278|FG009|Overall Study|Lost to Follow-up|2|||
146366744|NCT00006604|527843279|FG010|Overall Study|Lost to Follow-up|0|||
146366745|NCT00006604|527843280|FG011|Overall Study|Lost to Follow-up|0|||
146366746|NCT00006604|527843281|FG012|Overall Study|Lost to Follow-up|0|||
146366747|NCT00006604|527843282|FG013|Overall Study|Lost to Follow-up|0|||
146366748|NCT00006604|527843283|FG014|Overall Study|Lost to Follow-up|0|||
146366749|NCT00006604|527843284|FG015|Overall Study|Lost to Follow-up|1|||
146366750|NCT00006604|527843285|FG016|Overall Study|Lost to Follow-up|3|||
146366751|NCT00006604|527843269|FG000|Overall Study|Other Reason|0|||
146366752|NCT00006604|527843270|FG001|Overall Study|Other Reason|0|||
146366753|NCT00006604|527843271|FG002|Overall Study|Other Reason|0|||
146366754|NCT00006604|527843272|FG003|Overall Study|Other Reason|0|||
146366755|NCT00006604|527843273|FG004|Overall Study|Other Reason|0|||
146366756|NCT00006604|527843274|FG005|Overall Study|Other Reason|1|||
146366757|NCT00006604|527843275|FG006|Overall Study|Other Reason|0|||
146366758|NCT00006604|527843276|FG007|Overall Study|Other Reason|0|||
146366759|NCT00006604|527843277|FG008|Overall Study|Other Reason|0|||
146366760|NCT00006604|527843278|FG009|Overall Study|Other Reason|1|||
146366761|NCT00006604|527843279|FG010|Overall Study|Other Reason|0|||
146366762|NCT00006604|527843280|FG011|Overall Study|Other Reason|0|||
146366763|NCT00006604|527843281|FG012|Overall Study|Other Reason|0|||
146366764|NCT00006604|527843282|FG013|Overall Study|Other Reason|0|||
146366765|NCT00006604|527843283|FG014|Overall Study|Other Reason|0|||
146366766|NCT00006604|527843284|FG015|Overall Study|Other Reason|0|||
146366767|NCT00006604|527843285|FG016|Overall Study|Other Reason|0|||
146366768|NCT02431468|527843286|FG000|Overall Study|Adverse Event|2|||
146366769|NCT02431468|527843287|FG001|Overall Study|Adverse Event|4|||
146366770|NCT02431468|527843288|FG002|Overall Study|Adverse Event|5|||
146366771|NCT02431468|527843286|FG000|Overall Study|Withdrawal by Subject|4|||
146366772|NCT02431468|527843287|FG001|Overall Study|Withdrawal by Subject|12|||
146366773|NCT02431468|527843288|FG002|Overall Study|Withdrawal by Subject|2|||
146366774|NCT02431468|527843286|FG000|Overall Study|noncompliance, investigator termination,|2|||
146366775|NCT02431468|527843287|FG001|Overall Study|noncompliance, investigator termination,|2|||
146366776|NCT02431468|527843288|FG002|Overall Study|noncompliance, investigator termination,|2|||
146366777|NCT01056341|527843289|FG000|Overall Study|Treatment Intolerance|0|||
146366778|NCT01056341|527843290|FG001|Overall Study|Treatment Intolerance|2|||
146366779|NCT01056341|527843291|FG002|Overall Study|Treatment Intolerance|0|||
146366780|NCT01056341|527843292|FG003|Overall Study|Treatment Intolerance|2|||
146366781|NCT01056341|527843293|FG004|Overall Study|Treatment Intolerance|0|||
146366782|NCT01056341|527843289|FG000|Overall Study|Lack of Efficacy|32|||
146366783|NCT01056341|527843290|FG001|Overall Study|Lack of Efficacy|30|||
146366784|NCT01056341|527843291|FG002|Overall Study|Lack of Efficacy|7|||
146366785|NCT01056341|527843292|FG003|Overall Study|Lack of Efficacy|25|||
146366786|NCT01056341|527843293|FG004|Overall Study|Lack of Efficacy|9|||
146366787|NCT01056341|527843289|FG000|Overall Study|Other reasons|4|||
146366788|NCT01056341|527843290|FG001|Overall Study|Other reasons|4|||
146366789|NCT01056341|527843291|FG002|Overall Study|Other reasons|8|||
146366790|NCT01056341|527843292|FG003|Overall Study|Other reasons|9|||
146366791|NCT01056341|527843293|FG004|Overall Study|Other reasons|5|||
146366792|NCT01086150|527843294|FG000|Overall Study|Withdrawal by Subject|0|||
146366793|NCT01086150|527843295|FG001|Overall Study|Withdrawal by Subject|4|||
146366794|NCT01086150|527843296|FG002|Overall Study|Withdrawal by Subject|1|||
146366795|NCT01086150|527843294|FG000|Overall Study|Lost to Follow-up|0|||
146366796|NCT01086150|527843295|FG001|Overall Study|Lost to Follow-up|1|||
146366797|NCT01086150|527843296|FG002|Overall Study|Lost to Follow-up|0|||
146366798|NCT01086150|527843294|FG000|Overall Study|Screen Failure|0|||
146366799|NCT01086150|527843295|FG001|Overall Study|Screen Failure|1|||
146366800|NCT01086150|527843296|FG002|Overall Study|Screen Failure|0|||
146366801|NCT03543358|527843299|FG000|Overall Study|Death|1|||
146366802|NCT03543358|527843300|FG001|Overall Study|Death|0|||
146366803|NCT03543358|527843299|FG000|Overall Study|Disease Progression|1|||
146366804|NCT03543358|527843300|FG001|Overall Study|Disease Progression|0|||
146366805|NCT03543358|527843299|FG000|Overall Study|Parent Study Closure|1|||
146366806|NCT03543358|527843300|FG001|Overall Study|Parent Study Closure|0|||
146366807|NCT01578785|527843307|FG000|Overall Study|Withdrawal by Subject|0|||
146366808|NCT01578785|527843308|FG001|Overall Study|Withdrawal by Subject|1|||
146366809|NCT01578785|527843307|FG000|Overall Study|Study terminated by sponsor|59|||
146366810|NCT01578785|527843308|FG001|Overall Study|Study terminated by sponsor|118|||
146366811|NCT01164865|527843309|FG000|Overall Study|Lost to Follow-up|2|||
146366812|NCT01164865|527843310|FG001|Overall Study|Lost to Follow-up|1|||
146366813|NCT02394795|527843313|FG000|Overall Study|Adverse Event|92|||
146366814|NCT02394795|527843314|FG001|Overall Study|Adverse Event|70|||
146282444|NCT03738423|527546509|FG004|Overall Study|Lack of Efficacy|2|||
146282445|NCT03738423|527546505|FG000|Overall Study|Lost to Follow-up|1|||
146282446|NCT03738423|527546506|FG001|Overall Study|Lost to Follow-up|0|||
146282447|NCT03738423|527546507|FG002|Overall Study|Lost to Follow-up|1|||
146282448|NCT03738423|527546508|FG003|Overall Study|Lost to Follow-up|1|||
146282449|NCT03738423|527546509|FG004|Overall Study|Lost to Follow-up|0|||
146282450|NCT03738423|527546505|FG000|Overall Study|Protocol Violation|1|||
146282451|NCT03738423|527546506|FG001|Overall Study|Protocol Violation|0|||
146282452|NCT03738423|527546507|FG002|Overall Study|Protocol Violation|0|||
146282453|NCT03738423|527546508|FG003|Overall Study|Protocol Violation|0|||
146282454|NCT03738423|527546509|FG004|Overall Study|Protocol Violation|1|||
146282455|NCT03738423|527546505|FG000|Overall Study|Physician Decision|0|||
146282456|NCT03738423|527546506|FG001|Overall Study|Physician Decision|0|||
146282457|NCT03738423|527546507|FG002|Overall Study|Physician Decision|1|||
146282458|NCT03738423|527546508|FG003|Overall Study|Physician Decision|0|||
146282459|NCT03738423|527546509|FG004|Overall Study|Physician Decision|1|||
146282460|NCT03738423|527546505|FG000|Overall Study|Death|0|||
146282461|NCT03738423|527546506|FG001|Overall Study|Death|0|||
146282462|NCT03738423|527546507|FG002|Overall Study|Death|0|||
146282463|NCT03738423|527546508|FG003|Overall Study|Death|0|||
146282464|NCT03738423|527546509|FG004|Overall Study|Death|1|||
146282465|NCT03738423|527546505|FG000|Overall Study|Randomized but never treated|0|||
146282466|NCT03738423|527546506|FG001|Overall Study|Randomized but never treated|0|||
146282467|NCT03738423|527546507|FG002|Overall Study|Randomized but never treated|1|||
146282468|NCT03738423|527546508|FG003|Overall Study|Randomized but never treated|1|||
146282469|NCT03738423|527546509|FG004|Overall Study|Randomized but never treated|0|||
146282470|NCT02592876|527546516|FG000|Overall Study|Withdrawal by Subject|3|||
146282471|NCT02592876|527546517|FG001|Overall Study|Withdrawal by Subject|3|||
146282472|NCT02592876|527546516|FG000|Overall Study|Study Termination by Sponsor|32|||
146282473|NCT02592876|527546517|FG001|Overall Study|Study Termination by Sponsor|27|||
146282474|NCT02592876|527546516|FG000|Overall Study|Lost to Follow-up|0|||
146282475|NCT02592876|527546517|FG001|Overall Study|Lost to Follow-up|1|||
146282476|NCT02592876|527546516|FG000|Overall Study|Death|6|||
146282477|NCT02592876|527546517|FG001|Overall Study|Death|9|||
146282478|NCT00611975|527546520|FG000|Overall Study|Withdrawal by Subject|3|||
146282479|NCT00611975|527546521|FG001|Overall Study|Withdrawal by Subject|7|||
146282480|NCT00611975|527546520|FG000|Overall Study|Pregnancy|2|||
146282481|NCT00611975|527546521|FG001|Overall Study|Pregnancy|1|||
146282482|NCT03465904|527546522|FG000|Overall Study|Withdrawal by Subject|9|||
146282483|NCT03465904|527546523|FG001|Overall Study|Withdrawal by Subject|5|||
146282484|NCT03465904|527546522|FG000|Overall Study|Lost to Follow-up|11|||
146282485|NCT03465904|527546523|FG001|Overall Study|Lost to Follow-up|9|||
146282486|NCT03465904|527546522|FG000|Overall Study|Protocol Violation|20|||
146282487|NCT03465904|527546523|FG001|Overall Study|Protocol Violation|15|||
146282488|NCT04625413|527546524|FG000|Overall Study|Hospice|2|||
146282489|NCT04625413|527546524|FG000|Overall Study|Distress|1|||
146282490|NCT04625413|527546524|FG000|Overall Study|Not feeling well|1|||
146282491|NCT01305200|527546525|FG000|Overall Study|Physician Decision|4|||
146282492|NCT01305200|527546526|FG001|Overall Study|Physician Decision|6|||
146282493|NCT01305200|527546527|FG002|Overall Study|Physician Decision|1|||
146282494|NCT01305200|527546525|FG000|Overall Study|Withdrawal by Subject|24|||
146282495|NCT01305200|527546526|FG001|Overall Study|Withdrawal by Subject|21|||
146282496|NCT01305200|527546527|FG002|Overall Study|Withdrawal by Subject|1|||
146282497|NCT01305200|527546525|FG000|Overall Study|Ineligible|1|||
146282498|NCT01305200|527546526|FG001|Overall Study|Ineligible|2|||
146282499|NCT01305200|527546527|FG002|Overall Study|Ineligible|1|||
146282500|NCT01305200|527546525|FG000|Overall Study|Death|0|||
146282501|NCT01305200|527546526|FG001|Overall Study|Death|2|||
146282502|NCT01305200|527546527|FG002|Overall Study|Death|0|||
146282503|NCT03981861|527546528|FG000|Overall Study|Withdrawal by Subject|3|||
146282504|NCT05618912|527546529|FG000|Overall Study|Lost to Follow-up|14|||
146282505|NCT05618912|527546530|FG001|Overall Study|Lost to Follow-up|19|||
146282506|NCT00925353|527546531|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
146282507|NCT00055601|527548213|FG000|Overall Study|Protocol Violation|1|||
146282508|NCT00055601|527548214|FG001|Overall Study|Protocol Violation|1|||
146282509|NCT00055601|527548213|FG000|Overall Study|No protocol treatment received|1|||
146282510|NCT00055601|527548214|FG001|Overall Study|No protocol treatment received|1|||
146282511|NCT00275262|527548221|FG000|Overall Study|Adverse Event|2|||
146282512|NCT00275262|527548222|FG001|Overall Study|Adverse Event|0|||
146282513|NCT00275262|527548221|FG000|Overall Study|Disease progression|2|||
146282514|NCT00275262|527548222|FG001|Overall Study|Disease progression|5|||
146282515|NCT00275262|527548221|FG000|Overall Study|Lost to Follow-up|0|||
146282516|NCT00275262|527548222|FG001|Overall Study|Lost to Follow-up|2|||
146282517|NCT00275262|527548221|FG000|Overall Study|Protocol Violation|0|||
146282518|NCT00275262|527548222|FG001|Overall Study|Protocol Violation|2|||
146282519|NCT00275262|527548221|FG000|Overall Study|Death|1|||
146282520|NCT00275262|527548222|FG001|Overall Study|Death|0|||
146366815|NCT02394795|527843313|FG000|Overall Study|Lost to Follow-up|0|||
146366816|NCT02394795|527843314|FG001|Overall Study|Lost to Follow-up|1|||
146366817|NCT02394795|527843313|FG000|Overall Study|Withdrawal by Subject|17|||
146366818|NCT02394795|527843314|FG001|Overall Study|Withdrawal by Subject|26|||
146366819|NCT02394795|527843313|FG000|Overall Study|Lack of Efficacy|181|||
146366820|NCT02394795|527843314|FG001|Overall Study|Lack of Efficacy|211|||
146366821|NCT02394795|527843313|FG000|Overall Study|Death|4|||
146366822|NCT02394795|527843314|FG001|Overall Study|Death|5|||
146366823|NCT02394795|527843313|FG000|Overall Study|Physician Decision|109|||
146366824|NCT02394795|527843314|FG001|Overall Study|Physician Decision|93|||
146366825|NCT01432457|527845083|FG000|Overall Study|Adverse Event|7|||
146366826|NCT01432457|527845084|FG001|Overall Study|Adverse Event|10|||
146366827|NCT01432457|527845085|FG002|Overall Study|Adverse Event|16|||
146366828|NCT01432457|527845083|FG000|Overall Study|Lack of Efficacy|2|||
146366829|NCT01432457|527845084|FG001|Overall Study|Lack of Efficacy|1|||
146366830|NCT01432457|527845085|FG002|Overall Study|Lack of Efficacy|1|||
146366831|NCT01432457|527845083|FG000|Overall Study|Lost to Follow-up|11|||
146366832|NCT01432457|527845084|FG001|Overall Study|Lost to Follow-up|15|||
146366833|NCT01432457|527845085|FG002|Overall Study|Lost to Follow-up|20|||
146366834|NCT01432457|527845083|FG000|Overall Study|Protocol Violation|3|||
146366835|NCT01432457|527845084|FG001|Overall Study|Protocol Violation|2|||
146366836|NCT01432457|527845085|FG002|Overall Study|Protocol Violation|6|||
146366837|NCT01432457|527845083|FG000|Overall Study|Withdrawal by Subject|6|||
146366838|NCT01432457|527845084|FG001|Overall Study|Withdrawal by Subject|11|||
146366839|NCT01432457|527845085|FG002|Overall Study|Withdrawal by Subject|9|||
146366840|NCT01432457|527845083|FG000|Overall Study|Reasons not defined|2|||
146366841|NCT01432457|527845084|FG001|Overall Study|Reasons not defined|3|||
146366842|NCT01432457|527845085|FG002|Overall Study|Reasons not defined|4|||
146366843|NCT01432457|527845083|FG000|Overall Study|Did not take study drug|6|||
146366844|NCT01432457|527845084|FG001|Overall Study|Did not take study drug|6|||
146366845|NCT01432457|527845085|FG002|Overall Study|Did not take study drug|3|||
146366846|NCT05905601|527845087|FG000|Overall Study|Lost to Follow-up|1|||
146366847|NCT05905601|527845088|FG001|Overall Study|Lost to Follow-up|3|||
146366848|NCT03583606|527845089|FG000|Overall Study|Lost to Follow-up|0|||
146366849|NCT03583606|527845090|FG001|Overall Study|Lost to Follow-up|1|||
146366850|NCT03583606|527845091|FG002|Overall Study|Lost to Follow-up|0|||
146366851|NCT03583606|527845089|FG000|Overall Study|Ineligible at baseline|1|||
146366852|NCT03583606|527845090|FG001|Overall Study|Ineligible at baseline|0|||
146366853|NCT03583606|527845091|FG002|Overall Study|Ineligible at baseline|0|||
146366854|NCT01532570|527845096|FG000|Overall Study|Lack of Efficacy|1|||
146366855|NCT01532570|527845097|FG001|Overall Study|Lack of Efficacy|0|||
146366856|NCT01532570|527845098|FG002|Overall Study|Lack of Efficacy|0|||
146366857|NCT01532570|527845099|FG003|Overall Study|Lack of Efficacy|0|||
146366858|NCT01532570|527845096|FG000|Overall Study|Withdrawal by Subject|0|||
146366859|NCT01532570|527845097|FG001|Overall Study|Withdrawal by Subject|1|||
146366860|NCT01532570|527845098|FG002|Overall Study|Withdrawal by Subject|0|||
146366861|NCT01532570|527845099|FG003|Overall Study|Withdrawal by Subject|0|||
146366862|NCT05224076|527845105|FG000|Overall Study|Lost to Follow-up|24|||
146366863|NCT01807949|527845107|FG000|Overall Study|Adverse Event|1|||
146366864|NCT01807949|527845108|FG001|Overall Study|Adverse Event|2|||
146366865|NCT01807949|527845109|FG002|Overall Study|Adverse Event|2|||
146366866|NCT01807949|527845107|FG000|Overall Study|Withdrawal by Subject|1|||
146366867|NCT01807949|527845108|FG001|Overall Study|Withdrawal by Subject|2|||
146366868|NCT01807949|527845109|FG002|Overall Study|Withdrawal by Subject|2|||
146366869|NCT01807949|527845107|FG000|Overall Study|Non-Compliance|0|||
146366870|NCT01807949|527845108|FG001|Overall Study|Non-Compliance|0|||
146366871|NCT01807949|527845109|FG002|Overall Study|Non-Compliance|1|||
146366872|NCT01807949|527845107|FG000|Overall Study|Undefined|0|||
146366873|NCT01807949|527845108|FG001|Overall Study|Undefined|1|||
146366874|NCT01807949|527845109|FG002|Overall Study|Undefined|2|||
146366875|NCT01807949|527845107|FG000|Overall Study|Randomized But Not Treated|0|||
146366876|NCT01807949|527845108|FG001|Overall Study|Randomized But Not Treated|2|||
146366877|NCT01807949|527845109|FG002|Overall Study|Randomized But Not Treated|2|||
146366878|NCT04190186|527845110|FG000|Overall Study|ILR is no longer functioning|0|||
146366879|NCT04190186|527845111|FG001|Overall Study|ILR is no longer functioning|1|||
146366880|NCT04190186|527845110|FG000|Overall Study|Lost to Follow-up|0|||
146366881|NCT04190186|527845111|FG001|Overall Study|Lost to Follow-up|1|||
146366882|NCT04190186|527845110|FG000|Overall Study|Withdrawal by Subject|2|||
146366883|NCT04190186|527845111|FG001|Overall Study|Withdrawal by Subject|0|||
146366884|NCT04190186|527845110|FG000|Overall Study|Subject choice to explant|1|||
146366885|NCT04190186|527845111|FG001|Overall Study|Subject choice to explant|0|||
146366886|NCT04190186|527845110|FG000|Overall Study|Physician Decision|0|||
146366887|NCT04190186|527845111|FG001|Overall Study|Physician Decision|1|||
146366888|NCT04190186|527845110|FG000|Overall Study|Study was stopped|4|||
146366889|NCT04190186|527845111|FG001|Overall Study|Study was stopped|5|||
146366890|NCT01665768|527845112|FG000|Overall Study|Adverse Event|3|||
146366891|NCT01665768|527845112|FG000|Overall Study|Lack of Efficacy|19|||
146366892|NCT01665768|527845112|FG000|Overall Study|Withdrawal by Subject|1|||
146366893|NCT01803711|527845119|FG000|Overall Study|Adverse Event|1|||
146282521|NCT00275262|527548221|FG000|Overall Study|Started Chemotherapy|1|||
146282522|NCT00275262|527548222|FG001|Overall Study|Started Chemotherapy|0|||
146282523|NCT02217332|527548225|FG000|Overall Study|Adverse Event|3|||
146282524|NCT02217332|527548225|FG000|Overall Study|Dose interruption >1 month|1|||
146282525|NCT02217332|527548225|FG000|Overall Study|Protocol Violation (eligibility)|1|||
146282526|NCT02217332|527548225|FG000|Overall Study|Withdrawal by Subject|1|||
146282527|NCT02217332|527548225|FG000|Overall Study|Lost to Follow-up|1|||
146282528|NCT03573583|527548226|FG000|Overall Study|Lost to Follow-up|1|||
146282529|NCT03573583|527548227|FG001|Overall Study|Lost to Follow-up|0|||
146282530|NCT03573583|527548226|FG000|Overall Study|Withdrawal by Subject|1|||
146282531|NCT03573583|527548227|FG001|Overall Study|Withdrawal by Subject|1|||
146282532|NCT01658150|527548232|FG000|Overall Study|Withdrawal by Subject|1|||
146282533|NCT03602066|527548233|FG000|Overall Study|Withdrawal by Subject|2|||
146282534|NCT03602066|527548234|FG001|Overall Study|Withdrawal by Subject|0|||
146282535|NCT03602066|527548233|FG000|Overall Study|Physician Decision|1|||
146282536|NCT03602066|527548234|FG001|Overall Study|Physician Decision|0|||
146282537|NCT00006011|527548238|FG000|Overall Study|Disease progression|13|||
146282538|NCT00006011|527548239|FG001|Overall Study|Disease progression|6|||
146282539|NCT00006011|527548240|FG002|Overall Study|Disease progression|26|||
146282540|NCT00006011|527548238|FG000|Overall Study|Refused further treatment|15|||
146282541|NCT00006011|527548239|FG001|Overall Study|Refused further treatment|13|||
146282542|NCT00006011|527548240|FG002|Overall Study|Refused further treatment|26|||
146282543|NCT00006011|527548238|FG000|Overall Study|Adverse Event|15|||
146282544|NCT00006011|527548239|FG001|Overall Study|Adverse Event|39|||
146282545|NCT00006011|527548240|FG002|Overall Study|Adverse Event|5|||
146282546|NCT00006011|527548238|FG000|Overall Study|Death|0|||
146282547|NCT00006011|527548239|FG001|Overall Study|Death|1|||
146282548|NCT00006011|527548240|FG002|Overall Study|Death|2|||
146282549|NCT00006011|527548238|FG000|Overall Study|Other|4|||
146282550|NCT00006011|527548239|FG001|Overall Study|Other|2|||
146282551|NCT00006011|527548240|FG002|Overall Study|Other|5|||
146282552|NCT00006011|527548238|FG000|Overall Study|Ineligible|18|||
146282553|NCT00006011|527548239|FG001|Overall Study|Ineligible|16|||
146282554|NCT00006011|527548240|FG002|Overall Study|Ineligible|9|||
146282555|NCT01639560|527548243|FG000|Overall Study|Withdrawal by Subject|9|||
146282556|NCT01639560|527548244|FG001|Overall Study|Withdrawal by Subject|14|||
146282557|NCT01639560|527548243|FG000|Overall Study|Lack of Efficacy|1|||
146282558|NCT01639560|527548244|FG001|Overall Study|Lack of Efficacy|2|||
146282559|NCT01639560|527548243|FG000|Overall Study|Lost to Follow-up|9|||
146282560|NCT01639560|527548244|FG001|Overall Study|Lost to Follow-up|11|||
146282561|NCT01639560|527548243|FG000|Overall Study|Adverse Event|0|||
146282562|NCT01639560|527548244|FG001|Overall Study|Adverse Event|2|||
146282563|NCT00766363|527548251|FG000|Overall Study|Withdrawal by Subject|1|||
146282564|NCT00766363|527548252|FG001|Overall Study|Withdrawal by Subject|0|||
146282565|NCT00766363|527548253|FG002|Overall Study|Withdrawal by Subject|0|||
146282566|NCT00766363|527548254|FG003|Overall Study|Withdrawal by Subject|0|||
146282567|NCT00766363|527548251|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
146282568|NCT00766363|527548252|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
146282569|NCT00766363|527548253|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
146282570|NCT00766363|527548254|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
146282571|NCT03292432|527548257|FG000|Overall Study|Lost to Follow-up|11|||
146282572|NCT03292432|527548258|FG001|Overall Study|Lost to Follow-up|8|||
146282573|NCT03292432|527548257|FG000|Overall Study|Death|2|||
146282574|NCT03292432|527548258|FG001|Overall Study|Death|1|||
146282575|NCT03292432|527548257|FG000|Overall Study|Withdrawal by Subject|1|||
146282576|NCT03292432|527548258|FG001|Overall Study|Withdrawal by Subject|2|||
146282577|NCT03292432|527548257|FG000|Overall Study|Site closed before any data collected|1|||
146282578|NCT03292432|527548258|FG001|Overall Study|Site closed before any data collected|0|||
146282579|NCT00911937|527548259|FG000|Overall Study|Death|1|||
146282580|NCT00911937|527548260|FG001|Overall Study|Death|0|||
146282581|NCT00911937|527548259|FG000|Overall Study|Lost to Follow-up|8|||
146282582|NCT00911937|527548260|FG001|Overall Study|Lost to Follow-up|5|||
146282583|NCT00911937|527548259|FG000|Overall Study|Withdrawal by Subject|10|||
146282584|NCT00911937|527548260|FG001|Overall Study|Withdrawal by Subject|7|||
146282585|NCT00911937|527548259|FG000|Overall Study|Withdrawn due to pregnancy|1|||
146282586|NCT00911937|527548260|FG001|Overall Study|Withdrawn due to pregnancy|0|||
146282587|NCT00911937|527548259|FG000|Overall Study|Adverse Event|11|||
146282588|NCT00911937|527548260|FG001|Overall Study|Adverse Event|25|||
146282589|NCT00911937|527548259|FG000|Overall Study|Lack of Efficacy|11|||
146282590|NCT00911937|527548260|FG001|Overall Study|Lack of Efficacy|6|||
146282591|NCT00911937|527548259|FG000|Overall Study|Did not meet inclusion criteria|9|||
146282592|NCT00911937|527548260|FG001|Overall Study|Did not meet inclusion criteria|11|||
146282593|NCT00911937|527548259|FG000|Overall Study|Protocol Violation|14|||
146282594|NCT00911937|527548260|FG001|Overall Study|Protocol Violation|23|||
146282595|NCT00911937|527548259|FG000|Overall Study|Randomized but not treated|13|||
146366894|NCT01803711|527845120|FG001|Overall Study|Adverse Event|1|||
146366895|NCT00225212|527845121|FG000|Overall Study|Disease progression|2|||
146366896|NCT00225212|527845121|FG000|Overall Study|Death|1|||
146366897|NCT00225212|527845121|FG000|Overall Study|Adverse Event|2|||
146366898|NCT00225212|527845121|FG000|Overall Study|Intercurrent illness|1|||
146366899|NCT01376245|527845124|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
146366900|NCT01376245|527845125|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146366901|NCT01376245|527845126|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146366902|NCT01376245|527845127|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146366903|NCT01376245|527845128|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
146366904|NCT01376245|527845124|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
146366905|NCT01376245|527845125|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146366906|NCT01376245|527845126|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146366907|NCT01376245|527845127|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146366908|NCT01376245|527845128|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
146366909|NCT01376245|527845124|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
146366910|NCT01376245|527845125|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146366911|NCT01376245|527845126|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146366912|NCT01376245|527845127|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146366913|NCT01376245|527845128|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
146366914|NCT01376245|527845124|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
146366915|NCT01376245|527845125|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146366916|NCT01376245|527845126|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146366917|NCT01376245|527845127|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146366918|NCT01376245|527845128|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
146366919|NCT01376245|527845124|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
146366920|NCT01376245|527845125|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146366921|NCT01376245|527845126|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146366922|NCT01376245|527845127|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146366923|NCT01376245|527845128|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
146366924|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
146366925|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
146366926|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
146366927|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
146366928|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
146366929|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
146366930|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
146366931|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
146366932|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
146366933|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
146366934|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146366935|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146366936|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
146366937|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
146366938|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
146366939|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146366940|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
146366941|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
146366942|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
146366943|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
146366944|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146366945|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
146366946|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
146366947|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146366948|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
146366949|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
146366950|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
146366951|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
146366952|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
146366953|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
146366954|NCT01376245|527845124|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
146366955|NCT01376245|527845125|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
146366956|NCT01376245|527845126|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
146366957|NCT01376245|527845127|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
146366958|NCT01376245|527845128|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
146366959|NCT01335698|527845129|FG000|Treatment Stage 1|Lack of Efficacy|3|||
146366960|NCT01335698|527845130|FG001|Treatment Stage 1|Lack of Efficacy|1|||
146366961|NCT01335698|527845131|FG002|Treatment Stage 1|Lack of Efficacy|3|||
146366962|NCT01335698|527845132|FG003|Treatment Stage 1|Lack of Efficacy|3|||
146366963|NCT01335698|527845133|FG004|Treatment Stage 1|Lack of Efficacy|1|||
146366964|NCT01335698|527845129|FG000|Treatment Stage 1|Adverse Event|1|||
146366965|NCT01335698|527845130|FG001|Treatment Stage 1|Adverse Event|2|||
146366966|NCT01335698|527845131|FG002|Treatment Stage 1|Adverse Event|2|||
146366967|NCT01335698|527845132|FG003|Treatment Stage 1|Adverse Event|1|||
146366968|NCT01335698|527845133|FG004|Treatment Stage 1|Adverse Event|1|||
146366969|NCT01335698|527845129|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
146366970|NCT01335698|527845130|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
146366971|NCT01335698|527845131|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
146366972|NCT01335698|527845132|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
146366973|NCT01335698|527845133|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
146366974|NCT01335698|527845129|FG000|Treatment Stage 1|Lost to Follow-up|1|||
146366975|NCT01335698|527845130|FG001|Treatment Stage 1|Lost to Follow-up|1|||
146366976|NCT01335698|527845131|FG002|Treatment Stage 1|Lost to Follow-up|0|||
146366977|NCT01335698|527845132|FG003|Treatment Stage 1|Lost to Follow-up|0|||
146366978|NCT01335698|527845133|FG004|Treatment Stage 1|Lost to Follow-up|0|||
146366979|NCT01335698|527845129|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
146366980|NCT01335698|527845130|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
146366981|NCT01335698|527845131|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
146366982|NCT01335698|527845132|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
146366983|NCT01335698|527845133|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
146366984|NCT01335698|527845129|FG000|Treatment Stage 1|No longer meets study criteria|1|||
146366985|NCT01335698|527845130|FG001|Treatment Stage 1|No longer meets study criteria|1|||
146366986|NCT01335698|527845131|FG002|Treatment Stage 1|No longer meets study criteria|0|||
146366987|NCT01335698|527845132|FG003|Treatment Stage 1|No longer meets study criteria|1|||
146366988|NCT01335698|527845133|FG004|Treatment Stage 1|No longer meets study criteria|0|||
146366989|NCT01335698|527845129|FG000|Treatment Stage 1|Other|1|||
146366990|NCT01335698|527845130|FG001|Treatment Stage 1|Other|0|||
146366991|NCT01335698|527845131|FG002|Treatment Stage 1|Other|0|||
146366992|NCT01335698|527845132|FG003|Treatment Stage 1|Other|1|||
146366993|NCT01335698|527845133|FG004|Treatment Stage 1|Other|0|||
146366994|NCT01335698|527845129|FG000|Treatment Stage 2|Lack of Efficacy|2|||
146366995|NCT01335698|527845130|FG001|Treatment Stage 2|Lack of Efficacy|1|||
146366996|NCT01335698|527845131|FG002|Treatment Stage 2|Lack of Efficacy|3|||
146366997|NCT01335698|527845132|FG003|Treatment Stage 2|Lack of Efficacy|1|||
146366998|NCT01335698|527845133|FG004|Treatment Stage 2|Lack of Efficacy|0|||
146366999|NCT01335698|527845129|FG000|Treatment Stage 2|Adverse Event|2|||
146367000|NCT01335698|527845130|FG001|Treatment Stage 2|Adverse Event|0|||
146367001|NCT01335698|527845131|FG002|Treatment Stage 2|Adverse Event|0|||
146367002|NCT01335698|527845132|FG003|Treatment Stage 2|Adverse Event|3|||
146367003|NCT01335698|527845133|FG004|Treatment Stage 2|Adverse Event|0|||
146367004|NCT01335698|527845129|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
146367005|NCT01335698|527845130|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
146367006|NCT01335698|527845131|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
146367007|NCT01335698|527845132|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
146367008|NCT01335698|527845133|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
146367009|NCT01335698|527845129|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
146367010|NCT01335698|527845130|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
146367011|NCT01335698|527845131|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
146367012|NCT01335698|527845132|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
146367013|NCT01335698|527845133|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
146367014|NCT01335698|527845129|FG000|Treatment Stage 2|Lost to Follow-up|1|||
146367015|NCT01335698|527845130|FG001|Treatment Stage 2|Lost to Follow-up|0|||
146367016|NCT01335698|527845131|FG002|Treatment Stage 2|Lost to Follow-up|0|||
146367017|NCT01335698|527845132|FG003|Treatment Stage 2|Lost to Follow-up|0|||
146367018|NCT01335698|527845133|FG004|Treatment Stage 2|Lost to Follow-up|0|||
146367019|NCT01335698|527845129|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
146367020|NCT01335698|527845130|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
146367021|NCT01335698|527845131|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
146367022|NCT01335698|527845132|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
146367023|NCT01335698|527845133|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
146367024|NCT01335698|527845129|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
146367025|NCT01335698|527845130|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
146367026|NCT01335698|527845131|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
146367027|NCT01335698|527845132|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
146367028|NCT01335698|527845133|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
146367029|NCT01335698|527845129|FG000|Treatment Stage 2|Switched to another formulation|1|||
146367030|NCT01335698|527845130|FG001|Treatment Stage 2|Switched to another formulation|1|||
146367031|NCT01335698|527845131|FG002|Treatment Stage 2|Switched to another formulation|0|||
146367032|NCT01335698|527845132|FG003|Treatment Stage 2|Switched to another formulation|0|||
146367033|NCT01335698|527845133|FG004|Treatment Stage 2|Switched to another formulation|0|||
146367034|NCT01357889|527845134|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
146367035|NCT01357889|527845135|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
146367036|NCT01357889|527845134|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
146367037|NCT01357889|527845135|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
146367038|NCT01357889|527845134|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
146367039|NCT01357889|527845135|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
146367040|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
146367041|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
146367042|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
146367043|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
146367044|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
146367045|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
146367046|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
146367047|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
146367048|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
146367049|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
146367050|NCT01357889|527845134|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
146367051|NCT01357889|527845135|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
146367052|NCT01357889|527845134|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
146367053|NCT01357889|527845135|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
146367054|NCT01357889|527845134|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
146367055|NCT01357889|527845135|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
146367056|NCT01357889|527845134|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
146367057|NCT01357889|527845135|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
146367058|NCT01357889|527845134|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
146367059|NCT01357889|527845135|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
146367060|NCT01170221|527845136|FG000|Overall Study|Lost to Follow-up|22|||
146367061|NCT01170221|527845137|FG001|Overall Study|Lost to Follow-up|21|||
146367062|NCT01170221|527845136|FG000|Overall Study|Withdrawal by Subject|9|||
146367063|NCT01170221|527845137|FG001|Overall Study|Withdrawal by Subject|7|||
146367064|NCT01170221|527845136|FG000|Overall Study|Subject completed only screening and LFU|1|||
146367065|NCT01170221|527845137|FG001|Overall Study|Subject completed only screening and LFU|0|||
146367066|NCT01170221|527845136|FG000|Overall Study|Randomized but not treated|1|||
146367067|NCT01170221|527845137|FG001|Overall Study|Randomized but not treated|0|||
146367068|NCT02727660|527845139|FG000|Overall Study|Lack of Efficacy|40|||
146367069|NCT02727660|527845140|FG001|Overall Study|Lack of Efficacy|40|||
146367070|NCT02727660|527845141|FG002|Overall Study|Lack of Efficacy|70|||
146367071|NCT02727660|527845139|FG000|Overall Study|Adverse Event|28|||
146367072|NCT02727660|527845140|FG001|Overall Study|Adverse Event|21|||
146367073|NCT02727660|527845141|FG002|Overall Study|Adverse Event|32|||
146367074|NCT02727660|527845139|FG000|Overall Study|Withdrawal by Subject|26|||
146367075|NCT02727660|527845140|FG001|Overall Study|Withdrawal by Subject|25|||
146367076|NCT02727660|527845141|FG002|Overall Study|Withdrawal by Subject|30|||
146367077|NCT02727660|527845139|FG000|Overall Study|Physician Decision|3|||
146367078|NCT02727660|527845140|FG001|Overall Study|Physician Decision|8|||
146367079|NCT02727660|527845141|FG002|Overall Study|Physician Decision|14|||
146367080|NCT02727660|527845139|FG000|Overall Study|Lost to Follow-up|5|||
146367081|NCT02727660|527845140|FG001|Overall Study|Lost to Follow-up|9|||
146367082|NCT02727660|527845141|FG002|Overall Study|Lost to Follow-up|8|||
146367083|NCT02727660|527845139|FG000|Overall Study|Protocol Violation|7|||
146367084|NCT02727660|527845140|FG001|Overall Study|Protocol Violation|5|||
146367085|NCT02727660|527845141|FG002|Overall Study|Protocol Violation|5|||
146367086|NCT02727660|527845139|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
146367087|NCT02727660|527845140|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
146367088|NCT02727660|527845141|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
146367089|NCT02727660|527845139|FG000|Overall Study|Administrative Reasons|2|||
146367090|NCT02727660|527845140|FG001|Overall Study|Administrative Reasons|3|||
146367091|NCT02727660|527845141|FG002|Overall Study|Administrative Reasons|4|||
146367092|NCT00050960|527845142|FG000|Overall Study|Progressive Disease|137|||
146367093|NCT00050960|527845143|FG001|Overall Study|Progressive Disease|93|||
146367094|NCT00050960|527845142|FG000|Overall Study|Stable Disease|19|||
146367095|NCT00050960|527845143|FG001|Overall Study|Stable Disease|48|||
146367096|NCT00050960|527845142|FG000|Overall Study|Partial Response|14|||
146367097|NCT00050960|527845143|FG001|Overall Study|Partial Response|19|||
146367098|NCT00050960|527845142|FG000|Overall Study|Complete Response|0|||
146367099|NCT00050960|527845143|FG001|Overall Study|Complete Response|2|||
146367100|NCT00050960|527845142|FG000|Overall Study|Adverse Event|62|||
146367101|NCT00050960|527845143|FG001|Overall Study|Adverse Event|61|||
146367102|NCT00050960|527845142|FG000|Overall Study|Lost to Follow-up|0|||
146367103|NCT00050960|527845143|FG001|Overall Study|Lost to Follow-up|1|||
146367104|NCT00050960|527845142|FG000|Overall Study|Withdrawal by Subject|23|||
146367105|NCT00050960|527845143|FG001|Overall Study|Withdrawal by Subject|18|||
146367106|NCT00050960|527845142|FG000|Overall Study|Administrative|31|||
146367107|NCT00050960|527845143|FG001|Overall Study|Administrative|46|||
146367108|NCT00050960|527845142|FG000|Overall Study|Non-compliance|3|||
146367109|NCT00050960|527845143|FG001|Overall Study|Non-compliance|1|||
146367110|NCT00050960|527845142|FG000|Overall Study|Death|13|||
146367111|NCT00050960|527845143|FG001|Overall Study|Death|15|||
146367112|NCT02940626|527845148|FG000|Overall Study|Death|40|||
146367113|NCT02940626|527845149|FG001|Overall Study|Death|32|||
146367114|NCT02940626|527845148|FG000|Overall Study|Lost to Follow-up|5|||
146367115|NCT02940626|527845149|FG001|Overall Study|Lost to Follow-up|2|||
146367116|NCT02940626|527845148|FG000|Overall Study|Withdrawal by Subject|1|||
146367117|NCT02940626|527845149|FG001|Overall Study|Withdrawal by Subject|0|||
146367118|NCT02940626|527845148|FG000|Overall Study|Transfer to Hospice Care|1|||
146367119|NCT02940626|527845149|FG001|Overall Study|Transfer to Hospice Care|0|||
146367120|NCT02940626|527845148|FG000|Overall Study|Prohibited Concomitant Medication|0|||
146367121|NCT02940626|527845149|FG001|Overall Study|Prohibited Concomitant Medication|1|||
146367122|NCT01996904|527845150|FG000|Overall Study|Lost to Follow-up|38|||
146367123|NCT01996904|527845151|FG001|Overall Study|Lost to Follow-up|27|||
146367124|NCT00585923|527845152|FG000|Overall Study|Physician decided not to continue|31|||
146367125|NCT00585923|527845153|FG001|Overall Study|Physician decided not to continue|33|||
146367126|NCT00138424|527845156|FG000|Overall Study|Physician Decision|0|||
146367127|NCT00138424|527845157|FG001|Overall Study|Physician Decision|1|||
146367128|NCT00138424|527845158|FG002|Overall Study|Physician Decision|0|||
146367129|NCT00138424|527845159|FG003|Overall Study|Physician Decision|0|||
146367130|NCT04311177|527845160|FG000|Overall Study|Adverse Event|3|||
146367131|NCT04311177|527845161|FG001|Overall Study|Adverse Event|1|||
146367132|NCT04311177|527845160|FG000|Overall Study|Physician Decision|4|||
146282596|NCT00911937|527548260|FG001|Overall Study|Randomized but not treated|13|||
146282597|NCT00911937|527548259|FG000|Overall Study|Other|9|||
146282598|NCT00911937|527548260|FG001|Overall Study|Other|5|||
146282599|NCT03500159|527548271|FG000|Overall Study|Study Terminated|2|||
146282600|NCT03500159|527548272|FG001|Overall Study|Study Terminated|1|||
146282601|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
146282602|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
146282603|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
146282604|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
146282605|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
146282606|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
146282607|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
146282608|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
146282609|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
146282610|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
146282611|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
146282612|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
146282613|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
146282614|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
146282615|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
146282616|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
146282617|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
146282618|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
146282619|NCT03412747|527548277|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
146282620|NCT03412747|527548278|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
146282621|NCT03412747|527548279|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
146282622|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
146282623|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
146282624|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
146282625|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
146282626|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
146282627|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
146282628|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
146282629|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
146282630|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
146282631|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
146282632|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
146282633|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
146282634|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
146282635|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
146367133|NCT04311177|527845161|FG001|Overall Study|Physician Decision|3|||
146367134|NCT04311177|527845160|FG000|Overall Study|Withdrawal by Subject|1|||
146367135|NCT04311177|527845161|FG001|Overall Study|Withdrawal by Subject|0|||
146367136|NCT00413062|527845166|FG000|Overall Study|Adverse event/serious adverse event|289|||
146367137|NCT00413062|527845167|FG001|Overall Study|Adverse event/serious adverse event|56|||
146367138|NCT00413062|527845166|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
146367139|NCT00413062|527845167|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
146367140|NCT00413062|527845166|FG000|Overall Study|Withdrawal of informed consent|111|||
146367141|NCT00413062|527845167|FG001|Overall Study|Withdrawal of informed consent|36|||
146367142|NCT00413062|527845166|FG000|Overall Study|Pregnancy|15|||
146367143|NCT00413062|527845167|FG001|Overall Study|Pregnancy|5|||
146367144|NCT00413062|527845166|FG000|Overall Study|Pregnancy wish|17|||
146367145|NCT00413062|527845167|FG001|Overall Study|Pregnancy wish|6|||
146367146|NCT00413062|527845166|FG000|Overall Study|Lost to Follow-up|175|||
146367147|NCT00413062|527845167|FG001|Overall Study|Lost to Follow-up|73|||
146367148|NCT00413062|527845166|FG000|Overall Study|Other reason|70|||
146367149|NCT00413062|527845167|FG001|Overall Study|Other reason|34|||
146367150|NCT02176291|527845168|FG000|Overall Study|Death|1|||
146367151|NCT02176291|527845169|FG001|Overall Study|Death|0|||
146367152|NCT02176291|527845168|FG000|Overall Study|non compliance with protocol|2|||
146367153|NCT02176291|527845169|FG001|Overall Study|non compliance with protocol|0|||
146367154|NCT02176291|527845168|FG000|Overall Study|Withdrawal by Subject|2|||
146367155|NCT02176291|527845169|FG001|Overall Study|Withdrawal by Subject|0|||
146367156|NCT03589885|527845170|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
146367157|NCT03589885|527845171|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
146367158|NCT03589885|527845172|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
146367159|NCT03589885|527845173|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
146367160|NCT03589885|527845174|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
146367161|NCT03589885|527845170|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146367162|NCT03589885|527845171|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146367163|NCT03589885|527845172|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
146367164|NCT03589885|527845173|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146367165|NCT03589885|527845174|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
146367166|NCT03589885|527845170|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146367167|NCT03589885|527845171|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
146367168|NCT03589885|527845172|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146367169|NCT03589885|527845173|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146367170|NCT03589885|527845174|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
146367171|NCT03589885|527845170|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146367172|NCT03589885|527845171|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146367173|NCT03589885|527845172|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
146367174|NCT03589885|527845173|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146367175|NCT03589885|527845174|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
146367176|NCT03589885|527845170|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
146367177|NCT03589885|527845171|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
146367178|NCT03589885|527845172|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
146367179|NCT03589885|527845173|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
146367180|NCT03589885|527845174|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
146367181|NCT03589885|527845170|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
146367182|NCT03589885|527845171|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
146367183|NCT03589885|527845172|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
146367184|NCT03589885|527845173|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
146367185|NCT03589885|527845174|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
146367186|NCT03589885|527845170|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
146367187|NCT03589885|527845171|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
146367188|NCT03589885|527845172|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
146367189|NCT03589885|527845173|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
146367190|NCT03589885|527845174|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
146367191|NCT03589885|527845170|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146367192|NCT03589885|527845171|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
146367193|NCT03589885|527845172|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146367194|NCT03589885|527845173|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146367195|NCT03589885|527845174|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
146367196|NCT03448224|527845175|FG000|Overall Study|Provided same answer to every question|1|||
146367197|NCT03448224|527845176|FG001|Overall Study|Provided same answer to every question|0|||
146367198|NCT03103906|527845177|FG000|Overall Study|Adverse Event|2|||
146367199|NCT03103906|527845178|FG001|Overall Study|Adverse Event|3|||
146367200|NCT03103906|527845177|FG000|Overall Study|Other|2|||
146367201|NCT03103906|527845178|FG001|Overall Study|Other|0|||
146367202|NCT00764478|527845179|FG000|Overall Study|Adverse Event|1|||
146367203|NCT00764478|527845180|FG001|Overall Study|Adverse Event|1|||
146367204|NCT00764478|527845181|FG002|Overall Study|Adverse Event|1|||
146367205|NCT00764478|527845179|FG000|Overall Study|Withdrawal by Subject|7|||
146367206|NCT00764478|527845180|FG001|Overall Study|Withdrawal by Subject|12|||
146367207|NCT00764478|527845181|FG002|Overall Study|Withdrawal by Subject|1|||
146367208|NCT00764478|527845179|FG000|Overall Study|Lost to Follow-up|7|||
146367209|NCT00764478|527845180|FG001|Overall Study|Lost to Follow-up|8|||
146367210|NCT00764478|527845181|FG002|Overall Study|Lost to Follow-up|5|||
146367211|NCT00764478|527845179|FG000|Overall Study|Protocol Violation|0|||
146367212|NCT00764478|527845180|FG001|Overall Study|Protocol Violation|1|||
146367213|NCT00764478|527845181|FG002|Overall Study|Protocol Violation|1|||
146367214|NCT03571256|527845182|FG000|Overall Study|Adverse Event|3|||
146367215|NCT03571256|527845183|FG001|Overall Study|Adverse Event|0|||
146367216|NCT03571256|527845184|FG002|Overall Study|Adverse Event|1|||
146367217|NCT03571256|527845182|FG000|Overall Study|Withdrawal by Subject|3|||
146367218|NCT03571256|527845183|FG001|Overall Study|Withdrawal by Subject|1|||
146367219|NCT03571256|527845184|FG002|Overall Study|Withdrawal by Subject|1|||
146367220|NCT03571256|527845182|FG000|Overall Study|Other than specified|0|||
146367221|NCT03571256|527845183|FG001|Overall Study|Other than specified|1|||
146367222|NCT03571256|527845184|FG002|Overall Study|Other than specified|1|||
146367223|NCT03571256|527845182|FG000|Overall Study|Protocol Violation|0|||
146367224|NCT03571256|527845183|FG001|Overall Study|Protocol Violation|1|||
146367225|NCT03571256|527845184|FG002|Overall Study|Protocol Violation|1|||
146367226|NCT03498287|527845191|FG000|Overall Study|Withdrawal by Subject|3|||
146367227|NCT03498287|527845192|FG001|Overall Study|Withdrawal by Subject|0|||
146367228|NCT03498287|527845191|FG000|Overall Study|Protocol Violation|0|||
146367229|NCT03498287|527845192|FG001|Overall Study|Protocol Violation|4|||
146367230|NCT03498287|527845191|FG000|Overall Study|Adverse Event|0|||
146367231|NCT03498287|527845192|FG001|Overall Study|Adverse Event|1|||
146367232|NCT01714817|527845193|FG000|Year 1 Period|Lack of Efficacy|11|||
146367233|NCT01714817|527845194|FG001|Year 1 Period|Lack of Efficacy|9|||
146367234|NCT01714817|527845193|FG000|Year 1 Period|Adverse Event|20|||
146367235|NCT01714817|527845194|FG001|Year 1 Period|Adverse Event|17|||
146367236|NCT01714817|527845193|FG000|Year 1 Period|Withdrawal by Subject|6|||
146367237|NCT01714817|527845194|FG001|Year 1 Period|Withdrawal by Subject|7|||
146367238|NCT01714817|527845193|FG000|Year 1 Period|Death|1|||
146367239|NCT01714817|527845194|FG001|Year 1 Period|Death|1|||
146367240|NCT01714817|527845193|FG000|Year 1 Period|Lost to Follow-up|0|||
146367241|NCT01714817|527845194|FG001|Year 1 Period|Lost to Follow-up|2|||
146367242|NCT01714817|527845193|FG000|Year 1 Period|Poor / non-compliance|0|||
146367243|NCT01714817|527845194|FG001|Year 1 Period|Poor / non-compliance|1|||
146367244|NCT01714817|527845193|FG000|Year 1 Period|Pregnancy|2|||
146367245|NCT01714817|527845194|FG001|Year 1 Period|Pregnancy|0|||
146367246|NCT01714817|527845193|FG000|Year 1 Period|Participant no longer meets criteria|6|||
146367247|NCT01714817|527845194|FG001|Year 1 Period|Participant no longer meets criteria|2|||
146367248|NCT01714817|527845193|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
146367249|NCT01714817|527845194|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
146367250|NCT01714817|527845193|FG000|Year 1 Period|Change in Concomitant Medication|0|||
146367251|NCT01714817|527845194|FG001|Year 1 Period|Change in Concomitant Medication|1|||
146367252|NCT01714817|527845193|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
146367253|NCT01714817|527845194|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
146367254|NCT01714817|527845193|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
146367255|NCT01714817|527845194|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
146367256|NCT01714817|527845193|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
146367257|NCT01714817|527845194|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
146367258|NCT01714817|527845193|FG000|Year 2 Period|Lack of Efficacy|4|||
146367259|NCT01714817|527845194|FG001|Year 2 Period|Lack of Efficacy|12|||
146367260|NCT01714817|527845193|FG000|Year 2 Period|Adverse Event|7|||
146367261|NCT01714817|527845194|FG001|Year 2 Period|Adverse Event|6|||
146367262|NCT01714817|527845193|FG000|Year 2 Period|Participant request to stop treatment|4|||
146367263|NCT01714817|527845194|FG001|Year 2 Period|Participant request to stop treatment|4|||
146367264|NCT01714817|527845193|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
146367265|NCT01714817|527845194|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
146367266|NCT01714817|527845193|FG000|Year 2 Period|Participant withdrew consent|1|||
146367267|NCT01714817|527845194|FG001|Year 2 Period|Participant withdrew consent|5|||
146367268|NCT01714817|527845193|FG000|Year 2 Period|Participant no longer meets criteria|1|||
146367269|NCT01714817|527845194|FG001|Year 2 Period|Participant no longer meets criteria|4|||
146367270|NCT01714817|527845193|FG000|Year 2 Period|Lost to Follow-up|2|||
146367271|NCT01714817|527845194|FG001|Year 2 Period|Lost to Follow-up|0|||
146367272|NCT01714817|527845193|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
146367273|NCT01714817|527845194|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
146367274|NCT01714817|527845193|FG000|Year 2 Period|Pregnancy|1|||
146367275|NCT01714817|527845194|FG001|Year 2 Period|Pregnancy|1|||
146367276|NCT01714817|527845193|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
146367277|NCT01714817|527845194|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
146367278|NCT01714817|527845193|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
146367279|NCT01714817|527845194|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
146367280|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
146367281|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
146367282|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
146367283|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
146367284|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
146367285|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
146367286|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
146367287|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
146367288|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
146367289|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
146367290|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
146367291|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
146367292|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
146367293|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
146367294|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
146367295|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
146367296|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
146367297|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
146367298|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
146367299|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
146367300|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
146367301|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
146367302|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
146367303|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
146367304|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
146367305|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
146367306|NCT01714817|527845193|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
146367307|NCT01714817|527845194|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
146367308|NCT01740388|527845195|FG000|Overall Study|Withdrawal by Subject|1|||
146367309|NCT01740388|527845196|FG001|Overall Study|Withdrawal by Subject|2|||
146367310|NCT01740388|527845195|FG000|Overall Study|Lost to Follow-up|2|||
146367311|NCT01740388|527845196|FG001|Overall Study|Lost to Follow-up|0|||
146367312|NCT01740388|527845195|FG000|Overall Study|Physician Decision|2|||
146367313|NCT01740388|527845196|FG001|Overall Study|Physician Decision|6|||
146367314|NCT01740388|527845195|FG000|Overall Study|Subjects missing data, completed|41|||
146367315|NCT01740388|527845196|FG001|Overall Study|Subjects missing data, completed|36|||
146367316|NCT04142216|527845197|FG000|Overall Study|Hospitalization|0|||
146367317|NCT04142216|527845198|FG001|Overall Study|Hospitalization|2|||
146367318|NCT04142216|527845197|FG000|Overall Study|Death|3|||
146367319|NCT04142216|527845198|FG001|Overall Study|Death|1|||
146367320|NCT04142216|527845197|FG000|Overall Study|Referral to another hemodialysis unit|3|||
146367321|NCT04142216|527845198|FG001|Overall Study|Referral to another hemodialysis unit|2|||
146367322|NCT04142216|527845197|FG000|Overall Study|Use of clove|0|||
146367323|NCT04142216|527845198|FG001|Overall Study|Use of clove|1|||
146367324|NCT01641991|527845199|FG000|Overall Study|Physician Decision|0|||
146367325|NCT01641991|527845200|FG001|Overall Study|Physician Decision|1|||
146367326|NCT01641991|527845201|FG002|Overall Study|Physician Decision|7|||
146367327|NCT01641991|527845202|FG003|Overall Study|Physician Decision|5|||
146367328|NCT01641991|527845199|FG000|Overall Study|Withdrawal by Subject|4|||
146367329|NCT01641991|527845200|FG001|Overall Study|Withdrawal by Subject|2|||
146367330|NCT01641991|527845201|FG002|Overall Study|Withdrawal by Subject|1|||
146367331|NCT01641991|527845202|FG003|Overall Study|Withdrawal by Subject|5|||
146367332|NCT01641991|527845199|FG000|Overall Study|Adverse Event|2|||
146367333|NCT01641991|527845200|FG001|Overall Study|Adverse Event|1|||
146367334|NCT01641991|527845201|FG002|Overall Study|Adverse Event|2|||
146367335|NCT01641991|527845202|FG003|Overall Study|Adverse Event|1|||
146367336|NCT01641991|527845199|FG000|Overall Study|Lost to Follow-up|0|||
146367337|NCT01641991|527845200|FG001|Overall Study|Lost to Follow-up|2|||
146367338|NCT01641991|527845201|FG002|Overall Study|Lost to Follow-up|3|||
146367339|NCT01641991|527845202|FG003|Overall Study|Lost to Follow-up|1|||
146367340|NCT01641991|527845199|FG000|Overall Study|Protocol Violation|1|||
146367341|NCT01641991|527845200|FG001|Overall Study|Protocol Violation|1|||
146367342|NCT01641991|527845201|FG002|Overall Study|Protocol Violation|3|||
146367343|NCT01641991|527845202|FG003|Overall Study|Protocol Violation|0|||
146367344|NCT01641991|527845199|FG000|Overall Study|Pregnancy|0|||
146367345|NCT01641991|527845200|FG001|Overall Study|Pregnancy|0|||
146367346|NCT01641991|527845201|FG002|Overall Study|Pregnancy|1|||
146367347|NCT01641991|527845202|FG003|Overall Study|Pregnancy|0|||
146367348|NCT01641991|527845199|FG000|Overall Study|no longer eligible|2|||
146367349|NCT01641991|527845200|FG001|Overall Study|no longer eligible|1|||
146367350|NCT01641991|527845201|FG002|Overall Study|no longer eligible|0|||
146367351|NCT01641991|527845202|FG003|Overall Study|no longer eligible|4|||
146367352|NCT02555657|527845203|FG000|Overall Study|Death|274|||
146367353|NCT02555657|527845204|FG001|Overall Study|Death|262|||
146367354|NCT02555657|527845203|FG000|Overall Study|Physician Decision|0|||
146282636|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
146282637|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
146282638|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
146282639|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
146282640|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
146282641|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
146282642|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
146282643|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
146282644|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
146282645|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
146282646|NCT03412747|527548277|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
146282647|NCT03412747|527548278|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
146282648|NCT03412747|527548279|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
146282649|NCT03484273|527548280|FG000|Overall Study|Equipment Malfunction|1|||
146282650|NCT03484273|527548280|FG000|Overall Study|Data excluded from analysis|1|||
146282651|NCT01263665|527548281|FG000|Overall Study|Withdrew Consent|1|||
146282652|NCT01263665|527548281|FG000|Overall Study|Lost to Follow-up|3|||
146282653|NCT01263665|527548281|FG000|Overall Study|Death|2|||
146282654|NCT01263665|527548281|FG000|Overall Study|Amputation above the ankle|1|||
146282655|NCT01263665|527548281|FG000|Overall Study|Surgical Bypass|2|||
146282656|NCT00560066|527548286|FG000|Overall Study|Death|2|||
146282657|NCT00560066|527548287|FG001|Overall Study|Death|1|||
146282658|NCT00560066|527548286|FG000|Overall Study|Withdrawal by Subject|0|||
146282659|NCT00560066|527548287|FG001|Overall Study|Withdrawal by Subject|3|||
146282660|NCT00560066|527548286|FG000|Overall Study|Lost to Follow-up|4|||
146282661|NCT00560066|527548287|FG001|Overall Study|Lost to Follow-up|10|||
146282662|NCT00560066|527548286|FG000|Overall Study|Protocol Violation|0|||
146282663|NCT00560066|527548287|FG001|Overall Study|Protocol Violation|1|||
146282664|NCT00560066|527548286|FG000|Overall Study|Administrative reason|0|||
146282665|NCT00560066|527548287|FG001|Overall Study|Administrative reason|5|||
146282666|NCT00560066|527548286|FG000|Overall Study|Missing primary reason|0|||
146282667|NCT00560066|527548287|FG001|Overall Study|Missing primary reason|2|||
146282668|NCT02217475|527548300|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
146282669|NCT02217475|527548301|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
146282670|NCT02217475|527548302|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
146282671|NCT02217475|527548300|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
146282672|NCT02217475|527548301|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
146282673|NCT02217475|527548302|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
146282674|NCT02217475|527548300|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
146282675|NCT02217475|527548301|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
146282676|NCT02217475|527548302|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
146282677|NCT02217475|527548300|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
146282678|NCT02217475|527548301|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
146282679|NCT02217475|527548302|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
146282680|NCT02217475|527548300|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
146282681|NCT02217475|527548301|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
146282682|NCT02217475|527548302|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
146282683|NCT02217475|527548300|FG000|Discontinued After Period 1|Adverse Event|1|||
146282684|NCT02217475|527548301|FG001|Discontinued After Period 1|Adverse Event|2|||
146282685|NCT02217475|527548302|FG002|Discontinued After Period 1|Adverse Event|0|||
146282686|NCT02217475|527548300|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
146282687|NCT02217475|527548301|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
146282688|NCT02217475|527548302|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
146282689|NCT02217475|527548300|FG000|Discontinued After Period 1|Physician Decision|0|||
146282690|NCT02217475|527548301|FG001|Discontinued After Period 1|Physician Decision|0|||
146282691|NCT02217475|527548302|FG002|Discontinued After Period 1|Physician Decision|1|||
146282692|NCT02217475|527548300|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
146282693|NCT02217475|527548301|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
146282694|NCT02217475|527548302|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
146282695|NCT02217475|527548300|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
146282696|NCT02217475|527548301|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
146282697|NCT02217475|527548302|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
146282698|NCT02217475|527548300|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
146282699|NCT02217475|527548301|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
146282700|NCT02217475|527548302|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
146282701|NCT02217475|527548300|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
146282702|NCT02217475|527548301|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
146367355|NCT02555657|527845204|FG001|Overall Study|Physician Decision|1|||
146367356|NCT02555657|527845203|FG000|Overall Study|Sponsor Decision|27|||
146367357|NCT02555657|527845204|FG001|Overall Study|Sponsor Decision|15|||
146367358|NCT02555657|527845203|FG000|Overall Study|Withdrawal by Subject|11|||
146367359|NCT02555657|527845204|FG001|Overall Study|Withdrawal by Subject|32|||
146367360|NCT00599027|527845210|FG000|Overall Study|Withdrawal by Subject|1|||
146367361|NCT00599027|527845211|FG001|Overall Study|Withdrawal by Subject|1|||
146367362|NCT00599027|527845210|FG000|Overall Study|Adverse Event|0|||
146367363|NCT00599027|527845211|FG001|Overall Study|Adverse Event|1|||
146367364|NCT00599027|527845210|FG000|Overall Study|Treatment Failure|0|||
146367365|NCT00599027|527845211|FG001|Overall Study|Treatment Failure|1|||
146367366|NCT00475540|527845212|FG000|36 Months|Lost to Follow-up|4|||
146367367|NCT00475540|527845213|FG001|36 Months|Lost to Follow-up|4|||
146367368|NCT00475540|527845212|FG000|36 Months|Death|1|||
146367369|NCT00475540|527845213|FG001|36 Months|Death|2|||
146367370|NCT00475540|527845212|FG000|36 Months|Censored due to reoperation|3|||
146367371|NCT00475540|527845213|FG001|36 Months|Censored due to reoperation|0|||
146367372|NCT02133742|527845228|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
146367373|NCT02133742|527845228|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
146367374|NCT02133742|527845228|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
146367375|NCT02133742|527845228|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
146367376|NCT02133742|527845228|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
146367377|NCT03479216|527845229|FG000|Overall Study|Withdrawal by Subject|3|||
146367378|NCT03479216|527845230|FG001|Overall Study|Withdrawal by Subject|2|||
146367379|NCT03479216|527845229|FG000|Overall Study|Physician Decision|2|||
146367380|NCT03479216|527845230|FG001|Overall Study|Physician Decision|3|||
146367381|NCT02031432|527845231|FG000|Overall Study|Protocol Violation|1|||
146367382|NCT02031432|527845231|FG000|Overall Study|Lack of Efficacy|5|||
146367383|NCT02031432|527845231|FG000|Overall Study|Cancer Progression|2|||
146367384|NCT02031432|527845231|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
146367385|NCT02031432|527845231|FG000|Overall Study|Adverse Event|8|||
146367386|NCT02031432|527845231|FG000|Overall Study|Withdrawal by Subject|5|||
146367387|NCT02031432|527845231|FG000|Overall Study|Lost to Follow-up|1|||
146367388|NCT02031432|527845231|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
146367389|NCT02031432|527845231|FG000|Overall Study|Death|10|||
146367390|NCT02148211|527845232|FG000|Overall Study|Lost to Follow-up|352|||
146367391|NCT02726113|527845233|FG000|Total Enrollment|Physician Decision|0|||
146367392|NCT02726113|527845234|FG001|Total Enrollment|Physician Decision|1|||
146367393|NCT02726113|527845233|FG000|Total Enrollment|Protocol Violation|1|||
146367394|NCT02726113|527845234|FG001|Total Enrollment|Protocol Violation|0|||
146367395|NCT02726113|527845233|FG000|Total Enrollment|Withdrawal by Subject|2|||
146367396|NCT02726113|527845234|FG001|Total Enrollment|Withdrawal by Subject|1|||
146367397|NCT02726113|527845233|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
146367398|NCT02726113|527845234|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
146367399|NCT02726113|527845233|FG000|Genomic Analysis|Protocol Violation|1|||
146367400|NCT02726113|527845234|FG001|Genomic Analysis|Protocol Violation|0|||
146367401|NCT02726113|527845233|FG000|Genomic Analysis|Withdrawal by Subject|2|||
146367402|NCT02726113|527845234|FG001|Genomic Analysis|Withdrawal by Subject|1|||
146367403|NCT02726113|527845233|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
146367404|NCT02726113|527845234|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
146367405|NCT01617187|527845235|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146367406|NCT01617187|527845236|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146367407|NCT01617187|527845237|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
146367408|NCT01617187|527845238|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
146367409|NCT01617187|527845235|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146367410|NCT01617187|527845236|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146367411|NCT01617187|527845237|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
146367412|NCT01617187|527845238|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
146367413|NCT01617187|527845235|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
146367414|NCT01617187|527845236|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146367415|NCT01617187|527845237|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146367416|NCT01617187|527845238|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
146367417|NCT01617187|527845235|FG000|Treatment Through Study Completion|Adverse Event|1|||
146367418|NCT01617187|527845236|FG001|Treatment Through Study Completion|Adverse Event|1|||
146367419|NCT01617187|527845237|FG002|Treatment Through Study Completion|Adverse Event|0|||
146367420|NCT01617187|527845238|FG003|Treatment Through Study Completion|Adverse Event|1|||
146367421|NCT01617187|527845235|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
146367422|NCT01617187|527845236|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
146367423|NCT01617187|527845237|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
146367424|NCT01617187|527845238|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
146282703|NCT02217475|527548302|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
146282704|NCT02217475|527548300|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
146282705|NCT02217475|527548301|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
146282706|NCT02217475|527548302|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
146282707|NCT04738292|527548307|FG000|Overall Study|Death|1|||
146282708|NCT03001076|527548309|FG000|Overall Study|Withdrawal by patient|2|||
146282709|NCT03001076|527548310|FG001|Overall Study|Withdrawal by patient|0|||
146282710|NCT03001076|527548309|FG000|Overall Study|Other|1|||
146282711|NCT03001076|527548310|FG001|Overall Study|Other|0|||
146282712|NCT03001076|527548309|FG000|Overall Study|Adverse Event|3|||
146282713|NCT03001076|527548310|FG001|Overall Study|Adverse Event|3|||
146282714|NCT03001076|527548309|FG000|Overall Study|Sponsor decision|1|||
146282715|NCT03001076|527548310|FG001|Overall Study|Sponsor decision|0|||
146282716|NCT03001076|527548309|FG000|Overall Study|Lost to Follow-up|0|||
146282717|NCT03001076|527548310|FG001|Overall Study|Lost to Follow-up|2|||
146282718|NCT04602221|527548311|FG000|Overall Study|Discontinuation of trial treatment|0|||
146282719|NCT04602221|527548312|FG001|Overall Study|Discontinuation of trial treatment|0|||
146282720|NCT04602221|527548313|FG002|Overall Study|Discontinuation of trial treatment|1|||
146282721|NCT04602221|527548314|FG003|Overall Study|Discontinuation of trial treatment|0|||
146282722|NCT04602221|527548315|FG004|Overall Study|Discontinuation of trial treatment|0|||
146282723|NCT04602221|527548316|FG005|Overall Study|Discontinuation of trial treatment|0|||
146282724|NCT04602221|527548317|FG006|Overall Study|Discontinuation of trial treatment|0|||
146282725|NCT04602221|527548318|FG007|Overall Study|Discontinuation of trial treatment|0|||
146282726|NCT04602221|527548319|FG008|Overall Study|Discontinuation of trial treatment|0|||
146282727|NCT04602221|527548320|FG009|Overall Study|Discontinuation of trial treatment|0|||
146282728|NCT04602221|527548321|FG010|Overall Study|Discontinuation of trial treatment|0|||
146282729|NCT04602221|527548322|FG011|Overall Study|Discontinuation of trial treatment|0|||
146282730|NCT04602221|527548323|FG012|Overall Study|Discontinuation of trial treatment|0|||
146282731|NCT04602221|527548324|FG013|Overall Study|Discontinuation of trial treatment|0|||
146282732|NCT04602221|527548325|FG014|Overall Study|Discontinuation of trial treatment|0|||
146282733|NCT04602221|527548326|FG015|Overall Study|Discontinuation of trial treatment|0|||
146282734|NCT04602221|527548327|FG016|Overall Study|Discontinuation of trial treatment|0|||
146282735|NCT04602221|527548328|FG017|Overall Study|Discontinuation of trial treatment|0|||
146282736|NCT04602221|527548311|FG000|Overall Study|Other than listed|0|||
146282737|NCT04602221|527548312|FG001|Overall Study|Other than listed|0|||
146282738|NCT04602221|527548313|FG002|Overall Study|Other than listed|0|||
146282739|NCT04602221|527548314|FG003|Overall Study|Other than listed|0|||
146282740|NCT04602221|527548315|FG004|Overall Study|Other than listed|0|||
146282741|NCT04602221|527548316|FG005|Overall Study|Other than listed|0|||
146282742|NCT04602221|527548317|FG006|Overall Study|Other than listed|0|||
146282743|NCT04602221|527548318|FG007|Overall Study|Other than listed|0|||
146282744|NCT04602221|527548319|FG008|Overall Study|Other than listed|0|||
146282745|NCT04602221|527548320|FG009|Overall Study|Other than listed|0|||
146282746|NCT04602221|527548321|FG010|Overall Study|Other than listed|0|||
146282747|NCT04602221|527548322|FG011|Overall Study|Other than listed|0|||
146282748|NCT04602221|527548323|FG012|Overall Study|Other than listed|0|||
146282749|NCT04602221|527548324|FG013|Overall Study|Other than listed|0|||
146282750|NCT04602221|527548325|FG014|Overall Study|Other than listed|0|||
146282751|NCT04602221|527548326|FG015|Overall Study|Other than listed|1|||
146282752|NCT04602221|527548327|FG016|Overall Study|Other than listed|0|||
146282753|NCT04602221|527548328|FG017|Overall Study|Other than listed|1|||
146282754|NCT04602221|527548311|FG000|Overall Study|Withdrawal by Subject|0|||
146282755|NCT04602221|527548312|FG001|Overall Study|Withdrawal by Subject|0|||
146282756|NCT04602221|527548313|FG002|Overall Study|Withdrawal by Subject|0|||
146282757|NCT04602221|527548314|FG003|Overall Study|Withdrawal by Subject|0|||
146282758|NCT04602221|527548315|FG004|Overall Study|Withdrawal by Subject|0|||
146282759|NCT04602221|527548316|FG005|Overall Study|Withdrawal by Subject|0|||
146282760|NCT04602221|527548317|FG006|Overall Study|Withdrawal by Subject|0|||
146282761|NCT04602221|527548318|FG007|Overall Study|Withdrawal by Subject|0|||
146282762|NCT04602221|527548319|FG008|Overall Study|Withdrawal by Subject|0|||
146282763|NCT04602221|527548320|FG009|Overall Study|Withdrawal by Subject|0|||
146282764|NCT04602221|527548321|FG010|Overall Study|Withdrawal by Subject|0|||
146282765|NCT04602221|527548322|FG011|Overall Study|Withdrawal by Subject|0|||
146282766|NCT04602221|527548323|FG012|Overall Study|Withdrawal by Subject|1|||
146282767|NCT04602221|527548324|FG013|Overall Study|Withdrawal by Subject|0|||
146282768|NCT04602221|527548325|FG014|Overall Study|Withdrawal by Subject|0|||
146282769|NCT04602221|527548326|FG015|Overall Study|Withdrawal by Subject|0|||
146282770|NCT04602221|527548327|FG016|Overall Study|Withdrawal by Subject|0|||
146282771|NCT04602221|527548328|FG017|Overall Study|Withdrawal by Subject|0|||
146282772|NCT04602221|527548311|FG000|Overall Study|Lost to Follow-up|0|||
146282773|NCT04602221|527548312|FG001|Overall Study|Lost to Follow-up|0|||
146282774|NCT04602221|527548313|FG002|Overall Study|Lost to Follow-up|0|||
146282775|NCT04602221|527548314|FG003|Overall Study|Lost to Follow-up|0|||
146367425|NCT01617187|527845235|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
146367426|NCT01617187|527845236|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
146367427|NCT01617187|527845237|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
146367428|NCT01617187|527845238|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
146367429|NCT01617187|527845235|FG000|Treatment Through Study Completion|Protocol Violation|1|||
146367430|NCT01617187|527845236|FG001|Treatment Through Study Completion|Protocol Violation|0|||
146367431|NCT01617187|527845237|FG002|Treatment Through Study Completion|Protocol Violation|0|||
146367432|NCT01617187|527845238|FG003|Treatment Through Study Completion|Protocol Violation|1|||
146367433|NCT01265420|527845240|FG000|Overall Study|Lost to Follow-up|1|||
146367434|NCT02554253|527845244|FG000|Overall Study|ineligible after enrollment|1|||
146367435|NCT02554253|527845245|FG001|Overall Study|ineligible after enrollment|0|||
146367436|NCT02554253|527845244|FG000|Overall Study|converted to transcatheter procedure|0|||
146367437|NCT02554253|527845245|FG001|Overall Study|converted to transcatheter procedure|1|||
146367438|NCT02554253|527845244|FG000|Overall Study|received both drugs|0|||
146367439|NCT02554253|527845245|FG001|Overall Study|received both drugs|1|||
146367440|NCT01736254|527845249|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
146367441|NCT01736254|527845249|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
146367442|NCT01561560|527845250|FG000|First Two Weeks of Wear|Time/job conflict|0|||
146367443|NCT01561560|527845251|FG001|First Two Weeks of Wear|Time/job conflict|1|||
146367444|NCT01561560|527845250|FG000|First Two Weeks of Wear|Adverse Event|0|||
146367445|NCT01561560|527845251|FG001|First Two Weeks of Wear|Adverse Event|1|||
146367446|NCT01561560|527845250|FG000|Second Two Weeks of Wear|Adverse Event|0|||
146367447|NCT01561560|527845251|FG001|Second Two Weeks of Wear|Adverse Event|1|||
146367448|NCT03862131|527845252|FG000|Overall Study|Lost to Follow-up|1|||
146367449|NCT03862131|527845253|FG001|Overall Study|Lost to Follow-up|0|||
146367450|NCT03862131|527845254|FG002|Overall Study|Lost to Follow-up|1|||
146367451|NCT03862131|527845252|FG000|Overall Study|Determined to be ineligible|0|||
146367452|NCT03862131|527845253|FG001|Overall Study|Determined to be ineligible|0|||
146367453|NCT03862131|527845254|FG002|Overall Study|Determined to be ineligible|5|||
146367454|NCT03862131|527845252|FG000|Overall Study|Death|4|||
146367455|NCT03862131|527845253|FG001|Overall Study|Death|4|||
146367456|NCT03862131|527845254|FG002|Overall Study|Death|0|||
146367457|NCT03862131|527845252|FG000|Overall Study|Withdrawal by Subject|5|||
146367458|NCT03862131|527845253|FG001|Overall Study|Withdrawal by Subject|3|||
146367459|NCT03862131|527845254|FG002|Overall Study|Withdrawal by Subject|0|||
146367460|NCT03862131|527845252|FG000|Overall Study|Physician Decision|0|||
146367461|NCT03862131|527845253|FG001|Overall Study|Physician Decision|1|||
146367462|NCT03862131|527845254|FG002|Overall Study|Physician Decision|0|||
146367463|NCT00859573|527847016|FG000|Overall Study|Withdrawal by Subject|4|||
146367464|NCT00859573|527847017|FG001|Overall Study|Withdrawal by Subject|1|||
146367465|NCT00859573|527847016|FG000|Overall Study|Physician Decision|1|||
146367466|NCT00859573|527847017|FG001|Overall Study|Physician Decision|1|||
146367467|NCT03488238|527847018|FG000|Overall Study|Equipment malfunction|1|||
146367468|NCT03488238|527847018|FG000|Overall Study|Adverse Event|1|||
146367469|NCT01316939|527847019|FG000|Overall Study|Study closed/terminated|26|||
146367470|NCT01316939|527847020|FG001|Overall Study|Study closed/terminated|25|||
146367471|NCT01316939|527847021|FG002|Overall Study|Study closed/terminated|23|||
146367472|NCT01316939|527847019|FG000|Overall Study|Lack of Efficacy|24|||
146367473|NCT01316939|527847020|FG001|Overall Study|Lack of Efficacy|25|||
146367474|NCT01316939|527847021|FG002|Overall Study|Lack of Efficacy|25|||
146367475|NCT01316939|527847019|FG000|Overall Study|Adverse Event|9|||
146367476|NCT01316939|527847020|FG001|Overall Study|Adverse Event|12|||
146282776|NCT04602221|527548315|FG004|Overall Study|Lost to Follow-up|0|||
146282777|NCT04602221|527548316|FG005|Overall Study|Lost to Follow-up|1|||
146282778|NCT04602221|527548317|FG006|Overall Study|Lost to Follow-up|0|||
146282779|NCT04602221|527548318|FG007|Overall Study|Lost to Follow-up|0|||
146282780|NCT04602221|527548319|FG008|Overall Study|Lost to Follow-up|0|||
146282781|NCT04602221|527548320|FG009|Overall Study|Lost to Follow-up|0|||
146282782|NCT04602221|527548321|FG010|Overall Study|Lost to Follow-up|0|||
146282783|NCT04602221|527548322|FG011|Overall Study|Lost to Follow-up|0|||
146282784|NCT04602221|527548323|FG012|Overall Study|Lost to Follow-up|0|||
146282785|NCT04602221|527548324|FG013|Overall Study|Lost to Follow-up|0|||
146282786|NCT04602221|527548325|FG014|Overall Study|Lost to Follow-up|0|||
146282787|NCT04602221|527548326|FG015|Overall Study|Lost to Follow-up|0|||
146282788|NCT04602221|527548327|FG016|Overall Study|Lost to Follow-up|0|||
146282789|NCT04602221|527548328|FG017|Overall Study|Lost to Follow-up|0|||
146282790|NCT01056718|527548329|FG000|Overall Study|Withdrawal by Subject|2|||
146282791|NCT01056718|527548329|FG000|Overall Study|Ischemia on baseline stress test|1|||
146282792|NCT02270515|527548330|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
146282793|NCT02270515|527548330|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
146282794|NCT02270515|527548330|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
146282795|NCT02270515|527548330|FG000|Intervention Period 1: 0-6 Months|Death|7|||
146367477|NCT01316939|527847021|FG002|Overall Study|Adverse Event|11|||
146282796|NCT02270515|527548330|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
146367478|NCT01316939|527847019|FG000|Overall Study|Withdrawal by Subject|1|||
146367479|NCT01316939|527847020|FG001|Overall Study|Withdrawal by Subject|3|||
146367480|NCT01316939|527847021|FG002|Overall Study|Withdrawal by Subject|6|||
146367481|NCT01316939|527847019|FG000|Overall Study|Physician Decision|2|||
146367482|NCT01316939|527847020|FG001|Overall Study|Physician Decision|2|||
146367483|NCT01316939|527847021|FG002|Overall Study|Physician Decision|1|||
146367484|NCT01316939|527847019|FG000|Overall Study|Lost to Follow-up|0|||
146367485|NCT01316939|527847020|FG001|Overall Study|Lost to Follow-up|0|||
146367486|NCT01316939|527847021|FG002|Overall Study|Lost to Follow-up|2|||
146367487|NCT01316939|527847019|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
146367488|NCT01316939|527847020|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
146367489|NCT01316939|527847021|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
146367490|NCT01316939|527847019|FG000|Overall Study|Protocol Violation|0|||
146367491|NCT01316939|527847020|FG001|Overall Study|Protocol Violation|1|||
146367492|NCT01316939|527847021|FG002|Overall Study|Protocol Violation|0|||
146367493|NCT00793182|527847022|FG000|Overall Study|Adverse Event|0|||
146367494|NCT00793182|527847023|FG001|Overall Study|Adverse Event|1|||
146367495|NCT00851253|527847024|FG000|Overall Study|Disease Progression|1|||
146367496|NCT00851253|527847025|FG001|Overall Study|Disease Progression|0|||
146367497|NCT01779648|527847026|FG000|Overall Study|Protocol Violation|1|||
146367498|NCT01779648|527847027|FG001|Overall Study|Protocol Violation|0|||
146367499|NCT00367341|527847030|FG000|Overall Study|Physician Decision|1|||
146367500|NCT00367341|527847031|FG001|Overall Study|Physician Decision|0|||
146367501|NCT00367341|527847030|FG000|Overall Study|Protocol Violation|1|||
146367502|NCT00367341|527847031|FG001|Overall Study|Protocol Violation|0|||
146367503|NCT02119026|527847034|FG000|1st-line Treatment|Adverse Event|9|||
146367504|NCT02119026|527847035|FG001|1st-line Treatment|Adverse Event|14|||
146367505|NCT02119026|527847034|FG000|1st-line Treatment|Physician Decision|3|||
146367506|NCT02119026|527847035|FG001|1st-line Treatment|Physician Decision|8|||
146367507|NCT02119026|527847034|FG000|1st-line Treatment|Withdrawal by Subject|4|||
146367508|NCT02119026|527847035|FG001|1st-line Treatment|Withdrawal by Subject|10|||
146367509|NCT02119026|527847034|FG000|1st-line Treatment|Patient condition or compliance|6|||
146367510|NCT02119026|527847035|FG001|1st-line Treatment|Patient condition or compliance|4|||
146367511|NCT02119026|527847034|FG000|1st-line Treatment|Surgery of metastases|2|||
146367512|NCT02119026|527847035|FG001|1st-line Treatment|Surgery of metastases|1|||
146367513|NCT02119026|527847034|FG000|1st-line Treatment|Death|2|||
146367514|NCT02119026|527847035|FG001|1st-line Treatment|Death|1|||
146367515|NCT02119026|527847034|FG000|2nd-line Treatment|Lost to Follow-up|2|||
146367516|NCT02119026|527847035|FG001|2nd-line Treatment|Lost to Follow-up|0|||
146367517|NCT02119026|527847034|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
146367518|NCT02119026|527847035|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
146367519|NCT02119026|527847034|FG000|2nd-line Treatment|Adverse Event|4|||
146367520|NCT02119026|527847035|FG001|2nd-line Treatment|Adverse Event|1|||
146367521|NCT01373918|527847036|FG000|Overall Study|Physician Decision|0|||
146367522|NCT01373918|527847037|FG001|Overall Study|Physician Decision|1|||
146367523|NCT00340834|527847038|FG000|Core Phase of Study|Adverse Event|26|||
146367524|NCT00340834|527847039|FG001|Core Phase of Study|Adverse Event|9|||
146367525|NCT00340834|527847040|FG002|Core Phase of Study|Adverse Event|9|||
146367526|NCT00340834|527847041|FG003|Core Phase of Study|Adverse Event|0|||
146367527|NCT00340834|527847042|FG004|Core Phase of Study|Adverse Event|0|||
146367528|NCT00340834|527847038|FG000|Core Phase of Study|Withdrawal by Subject|11|||
146367529|NCT00340834|527847039|FG001|Core Phase of Study|Withdrawal by Subject|9|||
146367530|NCT00340834|527847040|FG002|Core Phase of Study|Withdrawal by Subject|16|||
146367531|NCT00340834|527847041|FG003|Core Phase of Study|Withdrawal by Subject|0|||
146367532|NCT00340834|527847042|FG004|Core Phase of Study|Withdrawal by Subject|0|||
146367533|NCT00340834|527847038|FG000|Core Phase of Study|Administrative Problems|6|||
146367534|NCT00340834|527847039|FG001|Core Phase of Study|Administrative Problems|2|||
146367535|NCT00340834|527847040|FG002|Core Phase of Study|Administrative Problems|7|||
146367536|NCT00340834|527847041|FG003|Core Phase of Study|Administrative Problems|0|||
146367537|NCT00340834|527847042|FG004|Core Phase of Study|Administrative Problems|0|||
146367538|NCT00340834|527847038|FG000|Core Phase of Study|Lack of Efficacy|3|||
146367539|NCT00340834|527847039|FG001|Core Phase of Study|Lack of Efficacy|3|||
146367540|NCT00340834|527847040|FG002|Core Phase of Study|Lack of Efficacy|7|||
146367541|NCT00340834|527847041|FG003|Core Phase of Study|Lack of Efficacy|0|||
146367542|NCT00340834|527847042|FG004|Core Phase of Study|Lack of Efficacy|0|||
146367543|NCT00340834|527847038|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
146367544|NCT00340834|527847039|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
146367545|NCT00340834|527847040|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
146367546|NCT00340834|527847041|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
146367547|NCT00340834|527847042|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
146367548|NCT00340834|527847038|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
146367549|NCT00340834|527847039|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
146367550|NCT00340834|527847040|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
146367551|NCT00340834|527847041|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
146367552|NCT00340834|527847042|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
146367553|NCT00340834|527847038|FG000|Core Phase of Study|Lost to Follow-up|1|||
146367554|NCT00340834|527847039|FG001|Core Phase of Study|Lost to Follow-up|1|||
146367555|NCT00340834|527847040|FG002|Core Phase of Study|Lost to Follow-up|4|||
146367556|NCT00340834|527847041|FG003|Core Phase of Study|Lost to Follow-up|0|||
146367557|NCT00340834|527847042|FG004|Core Phase of Study|Lost to Follow-up|0|||
146367558|NCT00340834|527847038|FG000|Core Phase of Study|Death|2|||
146367559|NCT00340834|527847039|FG001|Core Phase of Study|Death|0|||
146367560|NCT00340834|527847040|FG002|Core Phase of Study|Death|0|||
146367561|NCT00340834|527847041|FG003|Core Phase of Study|Death|0|||
146367562|NCT00340834|527847042|FG004|Core Phase of Study|Death|0|||
146367563|NCT00340834|527847038|FG000|Core Phase of Study|Protocol Violation|0|||
146367564|NCT00340834|527847039|FG001|Core Phase of Study|Protocol Violation|0|||
146367565|NCT00340834|527847040|FG002|Core Phase of Study|Protocol Violation|2|||
146367566|NCT00340834|527847041|FG003|Core Phase of Study|Protocol Violation|0|||
146367567|NCT00340834|527847042|FG004|Core Phase of Study|Protocol Violation|0|||
146367568|NCT00340834|527847038|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
146367569|NCT00340834|527847039|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
146367570|NCT00340834|527847040|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
146367571|NCT00340834|527847041|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
146367572|NCT00340834|527847042|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
146367573|NCT00340834|527847038|FG000|Extension Phase of Study|Subject withdrew consent|26|||
146367574|NCT00340834|527847039|FG001|Extension Phase of Study|Subject withdrew consent|31|||
146367575|NCT00340834|527847040|FG002|Extension Phase of Study|Subject withdrew consent|0|||
146367576|NCT00340834|527847041|FG003|Extension Phase of Study|Subject withdrew consent|12|||
146367577|NCT00340834|527847042|FG004|Extension Phase of Study|Subject withdrew consent|15|||
146367578|NCT00340834|527847038|FG000|Extension Phase of Study|Adverse Event|21|||
146367579|NCT00340834|527847039|FG001|Extension Phase of Study|Adverse Event|22|||
146367580|NCT00340834|527847040|FG002|Extension Phase of Study|Adverse Event|0|||
146367581|NCT00340834|527847041|FG003|Extension Phase of Study|Adverse Event|19|||
146367582|NCT00340834|527847042|FG004|Extension Phase of Study|Adverse Event|7|||
146367583|NCT00340834|527847038|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
146367584|NCT00340834|527847039|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
146367585|NCT00340834|527847040|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
146367586|NCT00340834|527847041|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
146367587|NCT00340834|527847042|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
146367588|NCT00340834|527847038|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
146367589|NCT00340834|527847039|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
146367590|NCT00340834|527847040|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
146367591|NCT00340834|527847041|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
146367592|NCT00340834|527847042|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
146367593|NCT00340834|527847038|FG000|Extension Phase of Study|Lost to Follow-up|1|||
146367594|NCT00340834|527847039|FG001|Extension Phase of Study|Lost to Follow-up|1|||
146367595|NCT00340834|527847040|FG002|Extension Phase of Study|Lost to Follow-up|0|||
146367596|NCT00340834|527847041|FG003|Extension Phase of Study|Lost to Follow-up|2|||
146367597|NCT00340834|527847042|FG004|Extension Phase of Study|Lost to Follow-up|3|||
146367598|NCT00340834|527847038|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
146367599|NCT00340834|527847039|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
146367600|NCT00340834|527847040|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
146367601|NCT00340834|527847041|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
146367602|NCT00340834|527847042|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
146367603|NCT00340834|527847038|FG000|Extension Phase of Study|Administrative problems|3|||
146367604|NCT00340834|527847039|FG001|Extension Phase of Study|Administrative problems|0|||
146367605|NCT00340834|527847040|FG002|Extension Phase of Study|Administrative problems|0|||
146367606|NCT00340834|527847041|FG003|Extension Phase of Study|Administrative problems|1|||
146367607|NCT00340834|527847042|FG004|Extension Phase of Study|Administrative problems|1|||
146367608|NCT00340834|527847038|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146367609|NCT00340834|527847039|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
146367610|NCT00340834|527847040|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146367611|NCT00340834|527847041|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
146367612|NCT00340834|527847042|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
146367613|NCT00340834|527847038|FG000|Extension Phase of Study|Protocol Violation|3|||
146367614|NCT00340834|527847039|FG001|Extension Phase of Study|Protocol Violation|0|||
146367615|NCT00340834|527847040|FG002|Extension Phase of Study|Protocol Violation|0|||
146367616|NCT00340834|527847041|FG003|Extension Phase of Study|Protocol Violation|0|||
146367617|NCT00340834|527847042|FG004|Extension Phase of Study|Protocol Violation|0|||
146367618|NCT00340834|527847038|FG000|Extension Phase of Study|Death|0|||
146367619|NCT00340834|527847039|FG001|Extension Phase of Study|Death|0|||
146367620|NCT00340834|527847040|FG002|Extension Phase of Study|Death|0|||
146367621|NCT00340834|527847041|FG003|Extension Phase of Study|Death|0|||
146367622|NCT00340834|527847042|FG004|Extension Phase of Study|Death|1|||
146367623|NCT00291499|527847043|FG000|Overall Study|Adverse Event|3|||
146367624|NCT00291499|527847044|FG001|Overall Study|Adverse Event|8|||
146367625|NCT00291499|527847043|FG000|Overall Study|Change to other therapy|2|||
146367626|NCT00291499|527847044|FG001|Overall Study|Change to other therapy|1|||
146367627|NCT00291499|527847043|FG000|Overall Study|Intercurrent illness|1|||
146367628|NCT00291499|527847044|FG001|Overall Study|Intercurrent illness|0|||
146282797|NCT02270515|527548330|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
146367629|NCT00291499|527847043|FG000|Overall Study|Protocol Violation|2|||
146367630|NCT00291499|527847044|FG001|Overall Study|Protocol Violation|2|||
146367631|NCT00291499|527847043|FG000|Overall Study|Other reasons|1|||
146367632|NCT00291499|527847044|FG001|Overall Study|Other reasons|4|||
146367633|NCT02786836|527847047|FG000|Overall Study|Death|1|||
146367634|NCT02786836|527847047|FG000|Overall Study|Lack of Efficacy|2|||
146367635|NCT02786836|527847047|FG000|Overall Study|Protocol Violation|3|||
146367636|NCT02786836|527847047|FG000|Overall Study|Withdrawal by Subject|3|||
146367637|NCT02786836|527847047|FG000|Overall Study|Liver Transplantation|2|||
146367638|NCT02786836|527847047|FG000|Overall Study|Device or Pharmacy Issues|3|||
146367639|NCT01387074|527847050|FG000|Overall Study|Lost to Follow-up|7|||
146367640|NCT01387074|527847050|FG000|Overall Study|Lack of Efficacy|1|||
146367641|NCT03892707|527847060|FG000|Overall Study|Screen failure|6|||
146367642|NCT03892707|527847061|FG001|Overall Study|Screen failure|0|||
146367643|NCT03892707|527847060|FG000|Overall Study|Pain resolution|0|||
146367644|NCT03892707|527847061|FG001|Overall Study|Pain resolution|4|||
146367645|NCT03892707|527847060|FG000|Overall Study|Withdrawal by Subject|0|||
146367646|NCT03892707|527847061|FG001|Overall Study|Withdrawal by Subject|1|||
146367647|NCT03892707|527847060|FG000|Overall Study|Other (long business trip)|0|||
146367648|NCT03892707|527847061|FG001|Overall Study|Other (long business trip)|1|||
146367649|NCT02151682|527847062|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146367650|NCT02151682|527847063|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
146367651|NCT02151682|527847064|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146367652|NCT02151682|527847065|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146367653|NCT02151682|527847066|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146367654|NCT02151682|527847067|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
146367655|NCT02151682|527847062|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146367656|NCT02151682|527847063|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
146367657|NCT02151682|527847064|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146367658|NCT02151682|527847065|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146367659|NCT02151682|527847066|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146367660|NCT02151682|527847067|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
146367661|NCT02151682|527847062|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146367662|NCT02151682|527847063|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
146367663|NCT02151682|527847064|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146367664|NCT02151682|527847065|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146367665|NCT02151682|527847066|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146367666|NCT02151682|527847067|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
146367667|NCT02151682|527847062|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
146367668|NCT02151682|527847063|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
146367669|NCT02151682|527847064|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146367670|NCT02151682|527847065|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146367671|NCT02151682|527847066|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146367672|NCT02151682|527847067|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
146367673|NCT02151682|527847062|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
146367674|NCT02151682|527847063|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146367675|NCT02151682|527847064|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146367676|NCT02151682|527847065|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146367677|NCT02151682|527847066|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146367678|NCT02151682|527847067|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
146367679|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146367680|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146367681|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
146367682|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146367683|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146367684|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
146282798|NCT02270515|527548330|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
146282799|NCT02270515|527548330|FG000|Intervention Period 2: 6-12 Months|Death|5|||
146282800|NCT02270515|527548330|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
146282801|NCT02270515|527548330|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
146282802|NCT02270515|527548330|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
146282803|NCT02270515|527548330|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
146282804|NCT02270515|527548330|FG000|Intervention Period 3: 12-18 Months|Death|3|||
146282805|NCT02270515|527548330|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
146367685|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
146367686|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
146367687|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
146367688|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
146367689|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
146367690|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
146367691|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146367692|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146367693|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
146367694|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
146367695|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146367696|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
146367697|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146367698|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146367699|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
146367700|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146367701|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146367702|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
146367703|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146367704|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146367705|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
146367706|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146367707|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146367708|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
146367709|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146367710|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146367711|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
146367712|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146367713|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146367714|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
146367715|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
146367716|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
146367717|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
146367718|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
146367719|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
146367720|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
146367721|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
146367722|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
146367723|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
146367724|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
146367725|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
146367726|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
146367727|NCT02151682|527847062|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146367728|NCT02151682|527847063|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146367729|NCT02151682|527847064|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
146367730|NCT02151682|527847065|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146367731|NCT02151682|527847066|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146367732|NCT02151682|527847067|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
146367733|NCT02151682|527847062|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146367734|NCT02151682|527847063|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146367735|NCT02151682|527847064|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146367736|NCT02151682|527847065|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146367737|NCT02151682|527847066|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
146367738|NCT02151682|527847067|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
146367739|NCT02151682|527847062|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146367740|NCT02151682|527847063|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146367741|NCT02151682|527847064|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146367742|NCT02151682|527847065|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146367743|NCT02151682|527847066|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
146367744|NCT02151682|527847067|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
146367745|NCT02151682|527847062|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146367746|NCT02151682|527847063|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146367747|NCT02151682|527847064|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146367748|NCT02151682|527847065|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146367749|NCT02151682|527847066|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
146367750|NCT02151682|527847067|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
146367751|NCT02151682|527847062|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146367752|NCT02151682|527847063|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146367753|NCT02151682|527847064|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146367754|NCT02151682|527847065|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146367755|NCT02151682|527847066|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
146367756|NCT02151682|527847067|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
146367757|NCT01522443|527847068|FG000|Overall Study|No longer receiving clinical benefit|36|||
146367758|NCT01522443|527847069|FG001|Overall Study|No longer receiving clinical benefit|28|||
146367759|NCT01522443|527847068|FG000|Overall Study|Adverse Event|10|||
146367760|NCT01522443|527847069|FG001|Overall Study|Adverse Event|15|||
146367761|NCT01522443|527847068|FG000|Overall Study|Withdrawal by Subject|5|||
146367762|NCT01522443|527847069|FG001|Overall Study|Withdrawal by Subject|8|||
146367763|NCT01522443|527847068|FG000|Overall Study|No study treatment given|1|||
146367764|NCT01522443|527847069|FG001|Overall Study|No study treatment given|1|||
146367765|NCT01522443|527847068|FG000|Overall Study|Other|1|||
146367766|NCT01522443|527847069|FG001|Overall Study|Other|3|||
146367767|NCT03260894|527847070|FG000|Overall Study|Death|6|||
146367768|NCT03260894|527847071|FG001|Overall Study|Death|8|||
146367769|NCT03260894|527847070|FG000|Overall Study|Withdrawal by Subject|4|||
146367770|NCT03260894|527847071|FG001|Overall Study|Withdrawal by Subject|11|||
146367771|NCT03260894|527847070|FG000|Overall Study|On-going at clinical cut off date|36|||
146367772|NCT03260894|527847071|FG001|Overall Study|On-going at clinical cut off date|31|||
146367773|NCT00290589|527847073|FG000|Overall Study|Lost to Follow-up|2|||
146367774|NCT00290589|527847074|FG001|Overall Study|Lost to Follow-up|2|||
146367775|NCT00555568|527847075|FG000|Overall Study|Lost to Follow-up|26|||
146367776|NCT00555568|527847076|FG001|Overall Study|Lost to Follow-up|16|||
146367777|NCT00555568|527847077|FG002|Overall Study|Lost to Follow-up|16|||
146367778|NCT00318565|527847078|FG000|Overall Study|Excluded per protocol|24|||
146367779|NCT00691093|527847079|FG000|Overall Study|Adverse Event|1|||
146367780|NCT00691093|527847079|FG000|Overall Study|Lost to Follow-up|1|||
146367781|NCT00691093|527847079|FG000|Overall Study|Lack of Efficacy|1|||
146367782|NCT00691093|527847079|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
146367783|NCT01588353|527847080|FG000|Step2|Withdrawal by Subject|0|||
146367784|NCT01588353|527847081|FG001|Step2|Withdrawal by Subject|1|||
146367785|NCT01588353|527847082|FG002|Step2|Withdrawal by Subject|0|||
146367786|NCT01588353|527847080|FG000|Step3|Adverse Event|0|||
146367787|NCT01588353|527847081|FG001|Step3|Adverse Event|0|||
146367788|NCT01588353|527847082|FG002|Step3|Adverse Event|2|||
146367789|NCT01896856|527847083|FG000|Overall Study|Transportation issues / Non-compliance|0|||
146367790|NCT01896856|527847084|FG001|Overall Study|Transportation issues / Non-compliance|0|||
146367791|NCT01896856|527847085|FG002|Overall Study|Transportation issues / Non-compliance|1|||
146367792|NCT01896856|527847086|FG003|Overall Study|Transportation issues / Non-compliance|0|||
146367793|NCT01896856|527847087|FG004|Overall Study|Transportation issues / Non-compliance|0|||
146367794|NCT01896856|527847088|FG005|Overall Study|Transportation issues / Non-compliance|0|||
146367795|NCT01409993|527847089|FG000|Overall Study|Adverse Event|4|||
146367796|NCT01409993|527847090|FG001|Overall Study|Adverse Event|4|||
146367797|NCT01409993|527847091|FG002|Overall Study|Adverse Event|3|||
146367798|NCT01409993|527847092|FG003|Overall Study|Adverse Event|1|||
146367799|NCT01409993|527847089|FG000|Overall Study|Withdrawal by Subject|0|||
146367800|NCT01409993|527847090|FG001|Overall Study|Withdrawal by Subject|0|||
146367801|NCT01409993|527847091|FG002|Overall Study|Withdrawal by Subject|0|||
146367802|NCT01409993|527847092|FG003|Overall Study|Withdrawal by Subject|4|||
146367803|NCT01409993|527847089|FG000|Overall Study|Lost to Follow-up|0|||
146367804|NCT01409993|527847090|FG001|Overall Study|Lost to Follow-up|1|||
146367805|NCT01409993|527847091|FG002|Overall Study|Lost to Follow-up|0|||
146367806|NCT01409993|527847092|FG003|Overall Study|Lost to Follow-up|0|||
146367807|NCT02677220|527847093|FG000|Overall Study|Adverse Event|1|||
146367808|NCT00965146|527847094|FG000|Overall Study|Death|7|||
146367809|NCT00965146|527847094|FG000|Overall Study|Lost to Follow-up|22|||
146367810|NCT00965146|527847094|FG000|Overall Study|Withdrawal by Subject|17|||
146367811|NCT00965146|527847094|FG000|Overall Study|Unable to return|1|||
146367812|NCT00965146|527847094|FG000|Overall Study|Unwilling to return|11|||
146367813|NCT00965146|527847094|FG000|Overall Study|Intercurrent illness|1|||
146367814|NCT00965146|527847094|FG000|Overall Study|Revision / Removal of Study Implant|6|||
146367815|NCT00965146|527847094|FG000|Overall Study|Overall Study Termination|145|||
146367816|NCT05067452|527847095|FG000|Overall Study|Lost to Follow-up|0|||
146367817|NCT05067452|527847096|FG001|Overall Study|Lost to Follow-up|4|||
146367818|NCT00067470|527847097|FG000|Overall Study|Withdrawal by Subject|0|||
146367819|NCT00067470|527847098|FG001|Overall Study|Withdrawal by Subject|1|||
146367820|NCT01135017|527847099|FG000|Overall Study|Adverse Event|3|||
146367821|NCT01135017|527847100|FG001|Overall Study|Adverse Event|8|||
146367822|NCT01135017|527847099|FG000|Overall Study|Other than above|3|||
146367823|NCT01135017|527847100|FG001|Overall Study|Other than above|4|||
146367824|NCT01148693|527847101|FG000|Overall Study|Attempts for cannulation were failed|13|||
146282806|NCT01139580|527548331|FG000|Overall Study|Adverse Event|5|||
146282807|NCT01139580|527548332|FG001|Overall Study|Adverse Event|4|||
146282808|NCT01139580|527548331|FG000|Overall Study|Lost to Follow-up|9|||
146282809|NCT01139580|527548332|FG001|Overall Study|Lost to Follow-up|1|||
146282810|NCT01139580|527548331|FG000|Overall Study|Lack of Efficacy|0|||
146282811|NCT01139580|527548332|FG001|Overall Study|Lack of Efficacy|2|||
146282812|NCT01139580|527548331|FG000|Overall Study|Withdrawal by Subject|6|||
146282813|NCT01139580|527548332|FG001|Overall Study|Withdrawal by Subject|9|||
146282814|NCT01139580|527548331|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
146282815|NCT01139580|527548332|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
146282816|NCT01139580|527548331|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
146282817|NCT01139580|527548332|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
146282818|NCT01139580|527548331|FG000|Overall Study|Misrandomized|1|||
146282819|NCT01139580|527548332|FG001|Overall Study|Misrandomized|0|||
146282820|NCT01139580|527548331|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
146282821|NCT01139580|527548332|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
146282822|NCT01139580|527548331|FG000|Overall Study|Participant Randomization in Error|0|||
146282823|NCT01139580|527548332|FG001|Overall Study|Participant Randomization in Error|1|||
146282824|NCT00633880|527548333|FG000|Open Label Titration|Lack of Efficacy|1|||
146282825|NCT00633880|527548334|FG001|Open Label Titration|Lack of Efficacy|0|||
146282826|NCT00633880|527548335|FG002|Open Label Titration|Lack of Efficacy|0|||
146282827|NCT00633880|527548333|FG000|Open Label Titration|Adverse Event|13|||
146282828|NCT00633880|527548334|FG001|Open Label Titration|Adverse Event|0|||
146282829|NCT00633880|527548335|FG002|Open Label Titration|Adverse Event|0|||
146282830|NCT00633880|527548333|FG000|Open Label Titration|Treatment Failure|55|||
146282831|NCT00633880|527548334|FG001|Open Label Titration|Treatment Failure|0|||
146282832|NCT00633880|527548335|FG002|Open Label Titration|Treatment Failure|0|||
146282833|NCT00633880|527548333|FG000|Open Label Titration|Protocol Violation|6|||
146282834|NCT00633880|527548334|FG001|Open Label Titration|Protocol Violation|0|||
146282835|NCT00633880|527548335|FG002|Open Label Titration|Protocol Violation|0|||
146282836|NCT00633880|527548333|FG000|Open Label Titration|Physician Decision|1|||
146282837|NCT00633880|527548334|FG001|Open Label Titration|Physician Decision|0|||
146282838|NCT00633880|527548335|FG002|Open Label Titration|Physician Decision|0|||
146282839|NCT00633880|527548333|FG000|Open Label Titration|Withdrawal by Subject|4|||
146282840|NCT00633880|527548334|FG001|Open Label Titration|Withdrawal by Subject|0|||
146282841|NCT00633880|527548335|FG002|Open Label Titration|Withdrawal by Subject|0|||
146282842|NCT00350103|527548336|FG000|Overall Study|Adverse Event|12|||
146282843|NCT00350103|527548337|FG001|Overall Study|Adverse Event|29|||
146282844|NCT00350103|527548338|FG002|Overall Study|Adverse Event|17|||
146282845|NCT00350103|527548336|FG000|Overall Study|Lack of Efficacy|5|||
146282846|NCT00350103|527548337|FG001|Overall Study|Lack of Efficacy|1|||
146282847|NCT00350103|527548338|FG002|Overall Study|Lack of Efficacy|3|||
146282848|NCT00350103|527548336|FG000|Overall Study|Withdrawal by Subject|6|||
146282849|NCT00350103|527548337|FG001|Overall Study|Withdrawal by Subject|6|||
146282850|NCT00350103|527548338|FG002|Overall Study|Withdrawal by Subject|8|||
146282851|NCT00350103|527548336|FG000|Overall Study|Protocol Violation|0|||
146282852|NCT00350103|527548337|FG001|Overall Study|Protocol Violation|0|||
146282853|NCT00350103|527548338|FG002|Overall Study|Protocol Violation|1|||
146282854|NCT00350103|527548336|FG000|Overall Study|Unsatisfactory Compliance|2|||
146282855|NCT00350103|527548337|FG001|Overall Study|Unsatisfactory Compliance|2|||
146282856|NCT00350103|527548338|FG002|Overall Study|Unsatisfactory Compliance|1|||
146282857|NCT00350103|527548336|FG000|Overall Study|Investigator´s decision|1|||
146282858|NCT00350103|527548337|FG001|Overall Study|Investigator´s decision|1|||
146282859|NCT00350103|527548338|FG002|Overall Study|Investigator´s decision|0|||
146282860|NCT00350103|527548336|FG000|Overall Study|Exclusion criteria met|0|||
146282861|NCT00350103|527548337|FG001|Overall Study|Exclusion criteria met|0|||
146282862|NCT00350103|527548338|FG002|Overall Study|Exclusion criteria met|1|||
146282863|NCT00350103|527548336|FG000|Overall Study|Patient relocated|0|||
146282864|NCT00350103|527548337|FG001|Overall Study|Patient relocated|0|||
146282865|NCT00350103|527548338|FG002|Overall Study|Patient relocated|1|||
146282866|NCT00350103|527548336|FG000|Overall Study|Need for prohibited medication|1|||
146282867|NCT00350103|527548337|FG001|Overall Study|Need for prohibited medication|0|||
146282868|NCT00350103|527548338|FG002|Overall Study|Need for prohibited medication|0|||
146282869|NCT00350103|527548336|FG000|Overall Study|Personal reasons|0|||
146282870|NCT00350103|527548337|FG001|Overall Study|Personal reasons|0|||
146282871|NCT00350103|527548338|FG002|Overall Study|Personal reasons|1|||
146282872|NCT00350103|527548336|FG000|Overall Study|Patient stopped feeling pain|1|||
146282873|NCT00350103|527548337|FG001|Overall Study|Patient stopped feeling pain|0|||
146282874|NCT00350103|527548338|FG002|Overall Study|Patient stopped feeling pain|0|||
146282875|NCT00350103|527548336|FG000|Overall Study|PR greater than 250ms|0|||
146282876|NCT00350103|527548337|FG001|Overall Study|PR greater than 250ms|0|||
146282877|NCT00350103|527548338|FG002|Overall Study|PR greater than 250ms|1|||
146282878|NCT00350103|527548336|FG000|Overall Study|Wrong calculation of QT interval|0|||
146367825|NCT01148693|527847102|FG001|Overall Study|Attempts for cannulation were failed|10|||
146367826|NCT01504971|527847104|FG000|Overall Study|Physician Decision|13|||
146367827|NCT00050622|527847105|FG000|Overall Study|Adverse Event|1|||
146367828|NCT00936117|527847108|FG000|Overall Study|Adverse Event|7|||
146367829|NCT00936117|527847108|FG000|Overall Study|Unable to continue oral medication|3|||
146367830|NCT04581863|527847109|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
146367831|NCT04581863|527847110|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
146367832|NCT02693691|527847111|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
146367833|NCT02693691|527847111|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
146367834|NCT02693691|527847111|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
146367835|NCT02693691|527847111|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
146367836|NCT02693691|527847111|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
146367837|NCT02693691|527847111|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
146367838|NCT02693691|527847111|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
146367839|NCT00764946|527847113|FG000|Overall Study|Lack of Efficacy|1|||
146367840|NCT00764946|527847114|FG001|Overall Study|Lack of Efficacy|0|||
146367841|NCT00764946|527847115|FG002|Overall Study|Lack of Efficacy|0|||
146367842|NCT00764946|527847113|FG000|Overall Study|Lost to Follow-up|3|||
146367843|NCT00764946|527847114|FG001|Overall Study|Lost to Follow-up|4|||
146367844|NCT00764946|527847115|FG002|Overall Study|Lost to Follow-up|0|||
146367845|NCT00764946|527847113|FG000|Overall Study|Physician Decision|2|||
146367846|NCT00764946|527847114|FG001|Overall Study|Physician Decision|4|||
146367847|NCT00764946|527847115|FG002|Overall Study|Physician Decision|0|||
146367848|NCT00764946|527847113|FG000|Overall Study|Adverse Event|3|||
146367849|NCT00764946|527847114|FG001|Overall Study|Adverse Event|2|||
146367850|NCT00764946|527847115|FG002|Overall Study|Adverse Event|1|||
146367851|NCT00764946|527847113|FG000|Overall Study|Withdrawal by Subject|3|||
146367852|NCT00764946|527847114|FG001|Overall Study|Withdrawal by Subject|6|||
146367853|NCT00764946|527847115|FG002|Overall Study|Withdrawal by Subject|2|||
146367854|NCT00764946|527847113|FG000|Overall Study|Never Treated|1|||
146367855|NCT00764946|527847114|FG001|Overall Study|Never Treated|1|||
146367856|NCT00764946|527847115|FG002|Overall Study|Never Treated|1|||
146367857|NCT01162304|527847116|FG000|Overall Study|Beck scale to high|11|||
146367858|NCT03454412|527847117|FG000|Baseline Assesment|Physician Decision|12|||
146367859|NCT01167582|527847118|FG000|Overall Study|Lost to Follow-up|0|||
146367860|NCT01167582|527847119|FG001|Overall Study|Lost to Follow-up|1|||
146367861|NCT01928485|527847120|FG000|Overall Study|Physician Decision|0|||
146367862|NCT01928485|527847121|FG001|Overall Study|Physician Decision|1|||
146367863|NCT00039741|527847122|FG000|Overall Study|Death|0|||
146367864|NCT00039741|527847123|FG001|Overall Study|Death|1|||
145943404|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943405|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943406|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943407|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943408|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943409|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145943410|NCT02326298|526300464|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943411|NCT02326298|526300465|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943412|NCT02326298|526300466|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943413|NCT02326298|526300467|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943414|NCT02326298|526300468|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943415|NCT02326298|526300469|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
145943416|NCT02326298|526300470|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943417|NCT02326298|526300471|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943418|NCT02326298|526300472|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943419|NCT02326298|526300473|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943420|NCT02326298|526300474|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943421|NCT02326298|526300475|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943422|NCT02326298|526300476|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145943423|NCT02326298|526300477|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
146367865|NCT00039741|527847124|FG002|Overall Study|Death|0|||
146367866|NCT00039741|527847125|FG003|Overall Study|Death|0|||
146367867|NCT00039741|527847122|FG000|Overall Study|Lost to Follow-up|3|||
146367868|NCT00039741|527847123|FG001|Overall Study|Lost to Follow-up|1|||
146367869|NCT00039741|527847124|FG002|Overall Study|Lost to Follow-up|5|||
146367870|NCT00039741|527847125|FG003|Overall Study|Lost to Follow-up|2|||
146367871|NCT00039741|527847122|FG000|Overall Study|Confounding medical condition|1|||
146367872|NCT00039741|527847123|FG001|Overall Study|Confounding medical condition|0|||
146367873|NCT00039741|527847124|FG002|Overall Study|Confounding medical condition|0|||
146367874|NCT00039741|527847125|FG003|Overall Study|Confounding medical condition|0|||
146367875|NCT00039741|527847122|FG000|Overall Study|Not able to get to clinic|5|||
146367876|NCT00039741|527847123|FG001|Overall Study|Not able to get to clinic|2|||
146367877|NCT00039741|527847124|FG002|Overall Study|Not able to get to clinic|0|||
146367878|NCT00039741|527847125|FG003|Overall Study|Not able to get to clinic|3|||
146367879|NCT00039741|527847122|FG000|Overall Study|Moved|3|||
146367880|NCT00039741|527847123|FG001|Overall Study|Moved|2|||
146367881|NCT00039741|527847124|FG002|Overall Study|Moved|3|||
146367882|NCT00039741|527847125|FG003|Overall Study|Moved|6|||
146367883|NCT00039741|527847122|FG000|Overall Study|Non-compliance with protocol|1|||
146367884|NCT00039741|527847123|FG001|Overall Study|Non-compliance with protocol|0|||
146367885|NCT00039741|527847124|FG002|Overall Study|Non-compliance with protocol|1|||
146367886|NCT00039741|527847125|FG003|Overall Study|Non-compliance with protocol|0|||
146367887|NCT00039741|527847122|FG000|Overall Study|Withdrew consent|0|||
146367888|NCT00039741|527847123|FG001|Overall Study|Withdrew consent|5|||
146367889|NCT00039741|527847124|FG002|Overall Study|Withdrew consent|0|||
146367890|NCT00039741|527847125|FG003|Overall Study|Withdrew consent|1|||
146367891|NCT00039741|527847122|FG000|Overall Study|Missed final visit|2|||
146367892|NCT00039741|527847123|FG001|Overall Study|Missed final visit|1|||
146367893|NCT00039741|527847124|FG002|Overall Study|Missed final visit|2|||
146367894|NCT00039741|527847125|FG003|Overall Study|Missed final visit|2|||
146367895|NCT00946881|527847126|FG000|First Treatment|Withdrawal by Subject|1|||
146367896|NCT00946881|527847126|FG000|First Treatment|Patient relocated to another state|1|||
146367897|NCT00946881|527847126|FG000|Retreatment|Withdrawal by Subject|1|||
146367898|NCT00293423|527847127|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
146367899|NCT00293423|527847128|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
146367900|NCT00293423|527847127|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
146367901|NCT00293423|527847128|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
146367902|NCT00293423|527847127|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
146367903|NCT00293423|527847128|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
146367904|NCT00293423|527847127|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
146367905|NCT00293423|527847128|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
146367906|NCT00293423|527847127|FG000|Surgical Resection|processing error during surgical resection|1|||
146367907|NCT00293423|527847128|FG001|Surgical Resection|processing error during surgical resection|0|||
146367908|NCT00293423|527847127|FG000|Surgical Resection|Withdrawal by Subject|4|||
146367909|NCT00293423|527847128|FG001|Surgical Resection|Withdrawal by Subject|0|||
146367910|NCT00293423|527847127|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
146367911|NCT00293423|527847128|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
146367912|NCT00964158|527847129|FG000|Overall Study|Lost to Follow-up|0|||
146367913|NCT00964158|527847130|FG001|Overall Study|Lost to Follow-up|1|||
146367914|NCT00964158|527847131|FG002|Overall Study|Lost to Follow-up|2|||
146367915|NCT00964158|527847129|FG000|Overall Study|Withdrawal by Subject|0|||
146367916|NCT00964158|527847130|FG001|Overall Study|Withdrawal by Subject|0|||
146367917|NCT00964158|527847131|FG002|Overall Study|Withdrawal by Subject|6|||
146367918|NCT00507416|527847132|FG000|Overall Study|Adverse Event|58|||
146367919|NCT00507416|527847133|FG001|Overall Study|Adverse Event|67|||
146367920|NCT00507416|527847134|FG002|Overall Study|Adverse Event|65|||
146367921|NCT00507416|527847132|FG000|Overall Study|Protocol Violation|1|||
146367922|NCT00507416|527847133|FG001|Overall Study|Protocol Violation|2|||
146367923|NCT00507416|527847134|FG002|Overall Study|Protocol Violation|0|||
146367924|NCT00507416|527847132|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
146367925|NCT00507416|527847133|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
146367926|NCT00507416|527847134|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
146367927|NCT00507416|527847132|FG000|Overall Study|Progressive Disease|20|||
146367928|NCT00507416|527847133|FG001|Overall Study|Progressive Disease|10|||
146367929|NCT00507416|527847134|FG002|Overall Study|Progressive Disease|13|||
146367930|NCT00507416|527847132|FG000|Overall Study|Patient declined further treatment|18|||
146367931|NCT00507416|527847133|FG001|Overall Study|Patient declined further treatment|14|||
146367932|NCT00507416|527847134|FG002|Overall Study|Patient declined further treatment|11|||
146367933|NCT00507416|527847132|FG000|Overall Study|Other|11|||
146367934|NCT00507416|527847133|FG001|Overall Study|Other|16|||
146367935|NCT00507416|527847134|FG002|Overall Study|Other|13|||
146367936|NCT00507416|527847132|FG000|Overall Study|Did not Receive Study Treatment|3|||
146367937|NCT00507416|527847133|FG001|Overall Study|Did not Receive Study Treatment|9|||
146367938|NCT00507416|527847134|FG002|Overall Study|Did not Receive Study Treatment|4|||
146367939|NCT01182337|527847135|FG000|Overall Study|Withdrawal by Subject|3|||
146367940|NCT01182337|527847136|FG001|Overall Study|Withdrawal by Subject|1|||
146367941|NCT01182337|527847135|FG000|Overall Study|Lost to Follow-up|0|||
146367942|NCT01182337|527847136|FG001|Overall Study|Lost to Follow-up|1|||
146367943|NCT01021813|527847137|FG000|DB Treatment Phase|Adverse Event|60|||
146367944|NCT01021813|527847138|FG001|DB Treatment Phase|Adverse Event|22|||
146367945|NCT01021813|527847139|FG002|DB Treatment Phase|Adverse Event|0|||
146367946|NCT01021813|527847140|FG003|DB Treatment Phase|Adverse Event|0|||
146367947|NCT01021813|527847141|FG004|DB Treatment Phase|Adverse Event|0|||
146367948|NCT01021813|527847137|FG000|DB Treatment Phase|Lack of Efficacy|44|||
146367949|NCT01021813|527847138|FG001|DB Treatment Phase|Lack of Efficacy|28|||
146367950|NCT01021813|527847139|FG002|DB Treatment Phase|Lack of Efficacy|0|||
146367951|NCT01021813|527847140|FG003|DB Treatment Phase|Lack of Efficacy|0|||
146367952|NCT01021813|527847141|FG004|DB Treatment Phase|Lack of Efficacy|0|||
146367953|NCT01021813|527847137|FG000|DB Treatment Phase|Lost to Follow-up|14|||
146367954|NCT01021813|527847138|FG001|DB Treatment Phase|Lost to Follow-up|12|||
146367955|NCT01021813|527847139|FG002|DB Treatment Phase|Lost to Follow-up|0|||
146367956|NCT01021813|527847140|FG003|DB Treatment Phase|Lost to Follow-up|0|||
146367957|NCT01021813|527847141|FG004|DB Treatment Phase|Lost to Follow-up|0|||
146367958|NCT01021813|527847137|FG000|DB Treatment Phase|Physician Decision|17|||
146282879|NCT00350103|527548337|FG001|Overall Study|Wrong calculation of QT interval|0|||
146282880|NCT00350103|527548338|FG002|Overall Study|Wrong calculation of QT interval|1|||
146282881|NCT00350103|527548336|FG000|Overall Study|Sponsor mistake|1|||
146282882|NCT00350103|527548337|FG001|Overall Study|Sponsor mistake|0|||
146282883|NCT00350103|527548338|FG002|Overall Study|Sponsor mistake|0|||
146282884|NCT00350103|527548336|FG000|Overall Study|Randomization mistake|0|||
146282885|NCT00350103|527548337|FG001|Overall Study|Randomization mistake|1|||
146282886|NCT00350103|527548338|FG002|Overall Study|Randomization mistake|1|||
146282887|NCT00350103|527548336|FG000|Overall Study|Sponsor´s decision|0|||
146282888|NCT00350103|527548337|FG001|Overall Study|Sponsor´s decision|1|||
146282889|NCT00350103|527548338|FG002|Overall Study|Sponsor´s decision|0|||
146282890|NCT00350103|527548336|FG000|Overall Study|Lost, Reason unknown|1|||
146282891|NCT00350103|527548337|FG001|Overall Study|Lost, Reason unknown|1|||
146282892|NCT00350103|527548338|FG002|Overall Study|Lost, Reason unknown|0|||
146282893|NCT02842151|527548339|FG000|Overall Study|Adverse Event|1|||
146282894|NCT02842151|527548339|FG000|Overall Study|Subject moved too far away|1|||
146282895|NCT02559895|527548340|FG000|Overall Study|Adverse Event|3|||
146282896|NCT02559895|527548341|FG001|Overall Study|Adverse Event|3|||
146282897|NCT02559895|527548342|FG002|Overall Study|Adverse Event|2|||
146282898|NCT02559895|527548343|FG003|Overall Study|Adverse Event|1|||
146282899|NCT02559895|527548340|FG000|Overall Study|Lack of Efficacy|2|||
146282900|NCT02559895|527548341|FG001|Overall Study|Lack of Efficacy|3|||
146282901|NCT02559895|527548342|FG002|Overall Study|Lack of Efficacy|2|||
146282902|NCT02559895|527548343|FG003|Overall Study|Lack of Efficacy|8|||
146282903|NCT02559895|527548340|FG000|Overall Study|Lost to Follow-up|22|||
146282904|NCT02559895|527548341|FG001|Overall Study|Lost to Follow-up|16|||
146282905|NCT02559895|527548342|FG002|Overall Study|Lost to Follow-up|12|||
146282906|NCT02559895|527548343|FG003|Overall Study|Lost to Follow-up|17|||
146282907|NCT02559895|527548340|FG000|Overall Study|Physician Decision|1|||
146282908|NCT02559895|527548341|FG001|Overall Study|Physician Decision|1|||
146282909|NCT02559895|527548342|FG002|Overall Study|Physician Decision|3|||
146282910|NCT02559895|527548343|FG003|Overall Study|Physician Decision|0|||
146282911|NCT02559895|527548340|FG000|Overall Study|Withdrawal by Subject|16|||
146282912|NCT02559895|527548341|FG001|Overall Study|Withdrawal by Subject|9|||
146282913|NCT02559895|527548342|FG002|Overall Study|Withdrawal by Subject|20|||
146282914|NCT02559895|527548343|FG003|Overall Study|Withdrawal by Subject|9|||
146282915|NCT02559895|527548340|FG000|Overall Study|Study Burden|10|||
146282916|NCT02559895|527548341|FG001|Overall Study|Study Burden|16|||
146282917|NCT02559895|527548342|FG002|Overall Study|Study Burden|12|||
146282918|NCT02559895|527548343|FG003|Overall Study|Study Burden|22|||
146282919|NCT02559895|527548340|FG000|Overall Study|Other|1|||
146282920|NCT02559895|527548341|FG001|Overall Study|Other|5|||
146282921|NCT02559895|527548342|FG002|Overall Study|Other|3|||
146282922|NCT02559895|527548343|FG003|Overall Study|Other|3|||
146282923|NCT00760474|527548347|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
146282924|NCT00760474|527548348|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
146282925|NCT00760474|527548347|FG000|Placebo Washout Period|Other|0|||
146282926|NCT00760474|527548348|FG001|Placebo Washout Period|Other|1|||
146282927|NCT00760474|527548347|FG000|Period 2 (P2)|Lost to Follow-up|1|||
146282928|NCT00760474|527548348|FG001|Period 2 (P2)|Lost to Follow-up|0|||
146282929|NCT00760474|527548347|FG000|Period 2 (P2)|Adverse Event|0|||
146282930|NCT00760474|527548348|FG001|Period 2 (P2)|Adverse Event|1|||
146282931|NCT00513305|527548349|FG000|Overall Study|Adverse Event|6|||
146282932|NCT00513305|527548350|FG001|Overall Study|Adverse Event|2|||
146282933|NCT00513305|527548349|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
146282934|NCT00513305|527548350|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
146282935|NCT00513305|527548349|FG000|Overall Study|Lack of Efficacy|8|||
146282936|NCT00513305|527548350|FG001|Overall Study|Lack of Efficacy|13|||
146282937|NCT00513305|527548349|FG000|Overall Study|Withdrawal by Subject|1|||
146282938|NCT00513305|527548350|FG001|Overall Study|Withdrawal by Subject|2|||
146282939|NCT00513305|527548349|FG000|Overall Study|Disease progression|8|||
146282940|NCT00513305|527548350|FG001|Overall Study|Disease progression|5|||
146282941|NCT00513305|527548349|FG000|Overall Study|Eligible for stem cell transplant|1|||
146282942|NCT00513305|527548350|FG001|Overall Study|Eligible for stem cell transplant|0|||
146282943|NCT00513305|527548349|FG000|Overall Study|Hematologic counts did not recover|1|||
146367959|NCT01021813|527847138|FG001|DB Treatment Phase|Physician Decision|8|||
146367960|NCT01021813|527847139|FG002|DB Treatment Phase|Physician Decision|0|||
146367961|NCT01021813|527847140|FG003|DB Treatment Phase|Physician Decision|0|||
146367962|NCT01021813|527847141|FG004|DB Treatment Phase|Physician Decision|0|||
146367963|NCT01021813|527847137|FG000|DB Treatment Phase|Pregnancy|1|||
146367964|NCT01021813|527847138|FG001|DB Treatment Phase|Pregnancy|0|||
146367965|NCT01021813|527847139|FG002|DB Treatment Phase|Pregnancy|0|||
146367966|NCT01021813|527847140|FG003|DB Treatment Phase|Pregnancy|0|||
146367967|NCT01021813|527847141|FG004|DB Treatment Phase|Pregnancy|0|||
146367968|NCT01021813|527847137|FG000|DB Treatment Phase|Protocol Violation|4|||
146367969|NCT01021813|527847138|FG001|DB Treatment Phase|Protocol Violation|3|||
146367970|NCT01021813|527847139|FG002|DB Treatment Phase|Protocol Violation|0|||
146367971|NCT01021813|527847140|FG003|DB Treatment Phase|Protocol Violation|0|||
146367972|NCT01021813|527847141|FG004|DB Treatment Phase|Protocol Violation|0|||
146367973|NCT01021813|527847137|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
146367974|NCT01021813|527847138|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
146367975|NCT01021813|527847139|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
146367976|NCT01021813|527847140|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
146367977|NCT01021813|527847141|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
146367978|NCT01021813|527847137|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
146367979|NCT01021813|527847138|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
146367980|NCT01021813|527847139|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
146367981|NCT01021813|527847140|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
146367982|NCT01021813|527847141|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
146367983|NCT01021813|527847137|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146367984|NCT01021813|527847138|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146367985|NCT01021813|527847139|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146367986|NCT01021813|527847140|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
146367987|NCT01021813|527847141|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
146367988|NCT01021813|527847137|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146367989|NCT01021813|527847138|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146367990|NCT01021813|527847139|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146367991|NCT01021813|527847140|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
146367992|NCT01021813|527847141|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
146367993|NCT01021813|527847137|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146367994|NCT01021813|527847138|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146367995|NCT01021813|527847139|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
146367996|NCT01021813|527847140|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146367997|NCT01021813|527847141|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
146367998|NCT01021813|527847137|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
146367999|NCT01021813|527847138|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
146368000|NCT01021813|527847139|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
146368001|NCT01021813|527847140|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
146368002|NCT01021813|527847141|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
146368003|NCT02270684|527847142|FG000|Overall Study|Lost to Follow-up|0|||
146368004|NCT02270684|527847143|FG001|Overall Study|Lost to Follow-up|3|||
146368005|NCT02270684|527847142|FG000|Overall Study|Study terminated|1|||
146368006|NCT02270684|527847143|FG001|Overall Study|Study terminated|0|||
146368007|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
146368008|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
146368009|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
146368010|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
146368011|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
146368012|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
146368013|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
146368014|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
146368015|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
146368016|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
146368017|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
146368018|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
146368019|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146368020|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
146368021|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146368022|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
146368023|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
146368024|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
146368025|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
146368026|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
146368027|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
146368028|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
146368029|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
146368030|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
146368031|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
146368032|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
146368033|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
146368034|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
146368035|NCT00476996|527847148|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
146368036|NCT00476996|527847149|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
146368037|NCT00476996|527847150|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
146368038|NCT00476996|527847151|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
146368039|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146368040|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146368041|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
146368042|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
146368043|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
146368044|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
146368045|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
146368046|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
146368047|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Death|0|||
146368048|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Death|0|||
146368049|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Death|0|||
146368050|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Death|7|||
146368051|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146368052|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146368053|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
146368054|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
146368055|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146368056|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146368057|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
146368058|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
146368059|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146368060|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146368061|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
146368062|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
146368063|NCT00476996|527847148|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
146368064|NCT00476996|527847149|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
146368065|NCT00476996|527847150|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
146368066|NCT00476996|527847151|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
146368067|NCT01769469|527847156|FG000|Overall Study|Consent Withdrawn|5|||
146368068|NCT01769469|527847156|FG000|Overall Study|Moved Out Of Area|3|||
146368069|NCT01769469|527847156|FG000|Overall Study|Lost to Follow-up|17|||
146368070|NCT01769469|527847156|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
146368071|NCT01769469|527847156|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
146368072|NCT02447458|527847162|FG000|Overall Study|Other|0|||
146282944|NCT00513305|527548350|FG001|Overall Study|Hematologic counts did not recover|0|||
146282945|NCT00513305|527548349|FG000|Overall Study|Physician Decision|1|||
146282946|NCT00513305|527548350|FG001|Overall Study|Physician Decision|0|||
146282947|NCT00513305|527548349|FG000|Overall Study|Persistent hypocellularity|0|||
146282948|NCT00513305|527548350|FG001|Overall Study|Persistent hypocellularity|1|||
146282949|NCT00513305|527548349|FG000|Overall Study|Sponsor Decision|0|||
146282950|NCT00513305|527548350|FG001|Overall Study|Sponsor Decision|2|||
146282951|NCT01262027|527548351|FG000|Overall Study|Adverse Event|1|||
146282952|NCT01262027|527548351|FG000|Overall Study|Withdrawal by Subject|3|||
146282953|NCT01262027|527548351|FG000|Overall Study|Protocol Violation|1|||
146282954|NCT03014479|527548352|FG000|Overall Study|Adverse Event|0|||
146282955|NCT03014479|527548353|FG001|Overall Study|Adverse Event|1|||
146282956|NCT03014479|527548352|FG000|Overall Study|Voluntary Withdrawal|0|||
146282957|NCT03014479|527548353|FG001|Overall Study|Voluntary Withdrawal|2|||
146282958|NCT03014479|527548352|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
146282959|NCT03014479|527548353|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
146282960|NCT01394978|527548356|FG000|Overall Study|Withdrawal by Subject|2|||
146282961|NCT01394978|527548357|FG001|Overall Study|Withdrawal by Subject|4|||
146282962|NCT01394978|527548356|FG000|Overall Study|Lost to Follow-up|13|||
146282963|NCT01394978|527548357|FG001|Overall Study|Lost to Follow-up|20|||
146282964|NCT01394978|527548356|FG000|Overall Study|Death|6|||
146282965|NCT01394978|527548357|FG001|Overall Study|Death|7|||
146282966|NCT02217501|527548358|FG000|Overall Study|Death|3|||
146282967|NCT02217501|527548359|FG001|Overall Study|Death|4|||
146282968|NCT02019667|527548360|FG000|First Intervention (6 Months)|Adverse Event|0|||
146282969|NCT02019667|527548361|FG001|First Intervention (6 Months)|Adverse Event|1|||
146368073|NCT02447458|527847163|FG001|Overall Study|Other|0|||
146368074|NCT02447458|527847164|FG002|Overall Study|Other|1|||
146368075|NCT02447458|527847165|FG003|Overall Study|Other|0|||
146368076|NCT02447458|527847166|FG004|Overall Study|Other|0|||
146368077|NCT02447458|527847167|FG005|Overall Study|Other|0|||
146368078|NCT01181778|527847170|FG000|Overall Study|Physician Decision|48|||
146368079|NCT02674685|527847171|FG000|Overall Study|Withdrawal by Subject|4|||
146368080|NCT03148756|527847172|FG000|Overall Study|Study Terminated|0|||
146368081|NCT03148756|527847173|FG001|Overall Study|Study Terminated|1|||
146368082|NCT05406440|527849199|FG000|Overall Study|Lost to Follow-up|0|||
146368083|NCT05406440|527849200|FG001|Overall Study|Lost to Follow-up|0|||
146368084|NCT05406440|527849201|FG002|Overall Study|Lost to Follow-up|0|||
146368085|NCT05406440|527849202|FG003|Overall Study|Lost to Follow-up|0|||
146368086|NCT05406440|527849203|FG004|Overall Study|Lost to Follow-up|2|||
146368087|NCT05406440|527849204|FG005|Overall Study|Lost to Follow-up|0|||
146368088|NCT05406440|527849205|FG006|Overall Study|Lost to Follow-up|0|||
146368089|NCT05406440|527849199|FG000|Overall Study|Physician Decision|0|||
146368090|NCT05406440|527849200|FG001|Overall Study|Physician Decision|0|||
146368091|NCT05406440|527849201|FG002|Overall Study|Physician Decision|0|||
146368092|NCT05406440|527849202|FG003|Overall Study|Physician Decision|0|||
146368093|NCT05406440|527849203|FG004|Overall Study|Physician Decision|1|||
146368094|NCT05406440|527849204|FG005|Overall Study|Physician Decision|0|||
146368095|NCT05406440|527849205|FG006|Overall Study|Physician Decision|0|||
146368096|NCT05406440|527849199|FG000|Overall Study|Withdrawal by Subject|0|||
146368097|NCT05406440|527849200|FG001|Overall Study|Withdrawal by Subject|0|||
146368098|NCT05406440|527849201|FG002|Overall Study|Withdrawal by Subject|0|||
146368099|NCT05406440|527849202|FG003|Overall Study|Withdrawal by Subject|0|||
146368100|NCT05406440|527849203|FG004|Overall Study|Withdrawal by Subject|0|||
146368101|NCT05406440|527849204|FG005|Overall Study|Withdrawal by Subject|2|||
146368102|NCT05406440|527849205|FG006|Overall Study|Withdrawal by Subject|0|||
146368103|NCT04507776|527849218|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
146368104|NCT01711541|527849221|FG000|Overall Study|Cancel prior to treatment|0|||
146368105|NCT01711541|527849222|FG001|Overall Study|Cancel prior to treatment|0|||
146368106|NCT01711541|527849223|FG002|Overall Study|Cancel prior to treatment|0|||
146368107|NCT01711541|527849224|FG003|Overall Study|Cancel prior to treatment|1|||
146368108|NCT01711541|527849225|FG004|Overall Study|Cancel prior to treatment|0|||
146368109|NCT01711541|527849221|FG000|Overall Study|Ineligible|0|||
146368110|NCT01711541|527849222|FG001|Overall Study|Ineligible|1|||
146368111|NCT01711541|527849223|FG002|Overall Study|Ineligible|0|||
146368112|NCT01711541|527849224|FG003|Overall Study|Ineligible|0|||
146368113|NCT01711541|527849225|FG004|Overall Study|Ineligible|0|||
146368114|NCT03943446|527849226|FG000|Overall Study|Lost to Follow-up|0|||
146368115|NCT03943446|527849227|FG001|Overall Study|Lost to Follow-up|0|||
146368116|NCT03943446|527849228|FG002|Overall Study|Lost to Follow-up|1|||
146368117|NCT03943446|527849226|FG000|Overall Study|Withdrawal by Subject|1|||
146368118|NCT03943446|527849227|FG001|Overall Study|Withdrawal by Subject|1|||
146368119|NCT03943446|527849228|FG002|Overall Study|Withdrawal by Subject|2|||
146368120|NCT03943446|527849226|FG000|Overall Study|Study Terminated by Sponsor|1|||
146368121|NCT03943446|527849227|FG001|Overall Study|Study Terminated by Sponsor|2|||
146368122|NCT03943446|527849228|FG002|Overall Study|Study Terminated by Sponsor|1|||
146368123|NCT03943446|527849226|FG000|Overall Study|Reason not Specified|5|||
146368124|NCT03943446|527849227|FG001|Overall Study|Reason not Specified|1|||
146368125|NCT03943446|527849228|FG002|Overall Study|Reason not Specified|3|||
146368126|NCT01281189|527849238|FG000|Overall Study|Adverse Event|7|||
146368127|NCT01281189|527849239|FG001|Overall Study|Adverse Event|9|||
146368128|NCT01281189|527849238|FG000|Overall Study|Lost to Follow-up|6|||
146368129|NCT01281189|527849239|FG001|Overall Study|Lost to Follow-up|4|||
146368130|NCT01281189|527849238|FG000|Overall Study|Withdrawal by Subject|21|||
146368131|NCT01281189|527849239|FG001|Overall Study|Withdrawal by Subject|24|||
146368132|NCT01281189|527849238|FG000|Overall Study|Physician Decision|2|||
146368133|NCT01281189|527849239|FG001|Overall Study|Physician Decision|3|||
146368134|NCT01281189|527849238|FG000|Overall Study|Death|103|||
146368135|NCT01281189|527849239|FG001|Overall Study|Death|91|||
146368136|NCT01281189|527849238|FG000|Overall Study|Other|8|||
146368137|NCT01281189|527849239|FG001|Overall Study|Other|12|||
146368138|NCT05355818|527849240|FG000|Overall Study|Adverse Event|1|||
146368139|NCT05355818|527849241|FG001|Overall Study|Adverse Event|1|||
146368140|NCT05355818|527849240|FG000|Overall Study|Lack of Efficacy|2|||
146368141|NCT05355818|527849241|FG001|Overall Study|Lack of Efficacy|1|||
146368142|NCT05355818|527849240|FG000|Overall Study|Lost to Follow-up|0|||
146368143|NCT05355818|527849241|FG001|Overall Study|Lost to Follow-up|1|||
146368144|NCT01136746|527849242|FG000|Overall Study|Lost to Follow-up|0|||
146368145|NCT01136746|527849243|FG001|Overall Study|Lost to Follow-up|2|||
146368146|NCT01136746|527849242|FG000|Overall Study|Protocol Violation|2|||
146368147|NCT01136746|527849243|FG001|Overall Study|Protocol Violation|1|||
146368148|NCT01136746|527849242|FG000|Overall Study|Death|1|||
146368149|NCT01136746|527849243|FG001|Overall Study|Death|0|||
146368150|NCT01175590|527849244|FG000|Overall Study|Lost to Follow-up|1|||
146368151|NCT01175590|527849245|FG001|Overall Study|Lost to Follow-up|0|||
146368152|NCT01175590|527849244|FG000|Overall Study|Withdrawal by Subject|0|||
146368153|NCT01175590|527849245|FG001|Overall Study|Withdrawal by Subject|2|||
146368154|NCT01175590|527849244|FG000|Overall Study|Adverse Event|4|||
146368155|NCT01175590|527849245|FG001|Overall Study|Adverse Event|0|||
146368156|NCT01175590|527849244|FG000|Overall Study|Physician Decision|1|||
146368157|NCT01175590|527849245|FG001|Overall Study|Physician Decision|4|||
146368158|NCT01175590|527849244|FG000|Overall Study|Lack of Efficacy|1|||
146368159|NCT01175590|527849245|FG001|Overall Study|Lack of Efficacy|1|||
146368160|NCT01175590|527849244|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
146368161|NCT01175590|527849245|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
146368162|NCT01175590|527849244|FG000|Overall Study|Treated not as randomized|3|||
146368163|NCT01175590|527849245|FG001|Overall Study|Treated not as randomized|2|||
146368164|NCT01175590|527849244|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
146368165|NCT01175590|527849245|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
146368166|NCT01175590|527849244|FG000|Overall Study|Protocol Violation|0|||
146368167|NCT01175590|527849245|FG001|Overall Study|Protocol Violation|1|||
146368168|NCT00092677|527849251|FG000|Overall Study|Lost to Follow-up|0|||
146368169|NCT00092677|527849252|FG001|Overall Study|Lost to Follow-up|2|||
146368170|NCT00092677|527849251|FG000|Overall Study|Adminstrative|5|||
146368171|NCT00092677|527849252|FG001|Overall Study|Adminstrative|9|||
146368172|NCT00010803|527849260|FG000|Overall Study|Withdrawal by Subject|97|||
146368173|NCT00010803|527849261|FG001|Overall Study|Withdrawal by Subject|98|||
146368174|NCT04671342|527849262|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
146368175|NCT04671342|527849262|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
146368176|NCT04671342|527849262|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
146368177|NCT04671342|527849262|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
146368178|NCT04671342|527849262|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
146368179|NCT04671342|527849262|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
146368180|NCT03351478|527849265|FG000|Overall Study|At the subject's own request|11|||
146368181|NCT03351478|527849266|FG001|Overall Study|At the subject's own request|12|||
146368182|NCT03351478|527849267|FG002|Overall Study|At the subject's own request|5|||
146368183|NCT03351478|527849265|FG000|Overall Study|Adverse Event|1|||
146368184|NCT03351478|527849266|FG001|Overall Study|Adverse Event|2|||
146368185|NCT03351478|527849267|FG002|Overall Study|Adverse Event|1|||
146368186|NCT03351478|527849265|FG000|Overall Study|Poor compliance to protocol|1|||
146368187|NCT03351478|527849266|FG001|Overall Study|Poor compliance to protocol|0|||
146368188|NCT03351478|527849267|FG002|Overall Study|Poor compliance to protocol|0|||
146368189|NCT03351478|527849265|FG000|Overall Study|Reason not Specified|1|||
146368190|NCT03351478|527849266|FG001|Overall Study|Reason not Specified|3|||
146368191|NCT03351478|527849267|FG002|Overall Study|Reason not Specified|0|||
146368192|NCT03351478|527849265|FG000|Overall Study|Lost to Follow-up|0|||
146368193|NCT03351478|527849266|FG001|Overall Study|Lost to Follow-up|0|||
146368194|NCT03351478|527849267|FG002|Overall Study|Lost to Follow-up|1|||
146368195|NCT03911869|527849268|FG000|Safety Lead-in Phase|Death|7|||
146368196|NCT03911869|527849269|FG001|Safety Lead-in Phase|Death|0|||
146368197|NCT03911869|527849270|FG002|Safety Lead-in Phase|Death|0|||
146368198|NCT03911869|527849268|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
146368199|NCT03911869|527849269|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
146368200|NCT03911869|527849270|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
146368201|NCT03911869|527849268|FG000|Safety Lead-in Phase|Other|1|||
146368202|NCT03911869|527849269|FG001|Safety Lead-in Phase|Other|0|||
146368203|NCT03911869|527849270|FG002|Safety Lead-in Phase|Other|0|||
146368204|NCT03911869|527849268|FG000|Phase 2|Death|0|||
146368205|NCT03911869|527849269|FG001|Phase 2|Death|3|||
146368206|NCT03911869|527849270|FG002|Phase 2|Death|0|||
146368207|NCT00985738|527849274|FG000|Overall Study|Study closed prematurely|8|||
146368208|NCT00985738|527849275|FG001|Overall Study|Study closed prematurely|8|||
146368209|NCT02141217|527849279|FG000|Overall Study|Adverse Event|1|||
146368210|NCT02141217|527849280|FG001|Overall Study|Adverse Event|2|||
146368211|NCT02141217|527849279|FG000|Overall Study|Protocol Violation|1|||
146368212|NCT02141217|527849280|FG001|Overall Study|Protocol Violation|4|||
146368213|NCT02141217|527849279|FG000|Overall Study|Withdrawal by Subject|6|||
146368214|NCT02141217|527849280|FG001|Overall Study|Withdrawal by Subject|0|||
146368215|NCT02141217|527849279|FG000|Overall Study|Lost to Follow-up|1|||
146368216|NCT02141217|527849280|FG001|Overall Study|Lost to Follow-up|1|||
146368217|NCT02141217|527849279|FG000|Overall Study|Physician Decision|1|||
146368218|NCT02141217|527849280|FG001|Overall Study|Physician Decision|0|||
146368219|NCT02141217|527849279|FG000|Overall Study|Surgical Intervention|1|||
146368220|NCT02141217|527849280|FG001|Overall Study|Surgical Intervention|1|||
146368221|NCT04603391|527849281|FG000|First Intervention (4 Days)|Adverse Event|1|||
146368222|NCT04603391|527849282|FG001|First Intervention (4 Days)|Adverse Event|0|||
146368223|NCT04603391|527849281|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
146368224|NCT04603391|527849282|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
146368225|NCT02759861|527849285|FG000|Overall Study|Death|1|||
146368226|NCT00618995|527849286|FG000|Period 1|Adverse Event|0|||
146368227|NCT00618995|527849287|FG001|Period 1|Adverse Event|0|||
146368228|NCT00618995|527849288|FG002|Period 1|Adverse Event|1|||
146368229|NCT00618995|527849289|FG003|Period 1|Adverse Event|0|||
146368230|NCT00618995|527849286|FG000|Period 1|Protocol Violation|0|||
146368231|NCT00618995|527849287|FG001|Period 1|Protocol Violation|1|||
146368232|NCT00618995|527849288|FG002|Period 1|Protocol Violation|1|||
146368233|NCT00618995|527849289|FG003|Period 1|Protocol Violation|0|||
146368234|NCT00618995|527849286|FG000|Period 2|Protocol Violation|0|||
146368235|NCT00618995|527849287|FG001|Period 2|Protocol Violation|0|||
146368236|NCT00618995|527849288|FG002|Period 2|Protocol Violation|1|||
146368237|NCT00618995|527849289|FG003|Period 2|Protocol Violation|0|||
146368238|NCT00618995|527849286|FG000|Period 4|Adverse Event|1|||
146368239|NCT00618995|527849287|FG001|Period 4|Adverse Event|0|||
146368240|NCT00618995|527849288|FG002|Period 4|Adverse Event|0|||
146368241|NCT00618995|527849289|FG003|Period 4|Adverse Event|0|||
146368242|NCT01306032|527849292|FG000|First Intervention|Adverse Event|1|||
146368243|NCT01306032|527849293|FG001|First Intervention|Adverse Event|0|||
146368244|NCT01306032|527849294|FG002|First Intervention|Adverse Event|1|||
146368245|NCT01306032|527849295|FG003|First Intervention|Adverse Event|0|||
146368246|NCT01306032|527849296|FG004|First Intervention|Adverse Event|0|||
146368247|NCT01306032|527849297|FG005|First Intervention|Adverse Event|1|||
146368248|NCT01306032|527849292|FG000|First Intervention|Withdrawal by Subject|0|||
146368249|NCT01306032|527849293|FG001|First Intervention|Withdrawal by Subject|2|||
146368250|NCT01306032|527849294|FG002|First Intervention|Withdrawal by Subject|0|||
146368251|NCT01306032|527849295|FG003|First Intervention|Withdrawal by Subject|1|||
146368252|NCT01306032|527849296|FG004|First Intervention|Withdrawal by Subject|0|||
146368253|NCT01306032|527849297|FG005|First Intervention|Withdrawal by Subject|0|||
146368254|NCT01306032|527849292|FG000|First Intervention|Death|0|||
146368255|NCT01306032|527849293|FG001|First Intervention|Death|0|||
146368256|NCT01306032|527849294|FG002|First Intervention|Death|1|||
146368257|NCT01306032|527849295|FG003|First Intervention|Death|0|||
146368258|NCT01306032|527849296|FG004|First Intervention|Death|0|||
146368259|NCT01306032|527849297|FG005|First Intervention|Death|0|||
146368260|NCT01306032|527849292|FG000|First Intervention|Ineligible|0|||
146368261|NCT01306032|527849293|FG001|First Intervention|Ineligible|0|||
146368262|NCT01306032|527849294|FG002|First Intervention|Ineligible|0|||
146368263|NCT01306032|527849295|FG003|First Intervention|Ineligible|0|||
146368264|NCT01306032|527849296|FG004|First Intervention|Ineligible|0|||
146368265|NCT01306032|527849297|FG005|First Intervention|Ineligible|1|||
146368266|NCT01306032|527849292|FG000|First Intervention|Progressive disease|0|||
146368267|NCT01306032|527849293|FG001|First Intervention|Progressive disease|0|||
146368268|NCT01306032|527849294|FG002|First Intervention|Progressive disease|0|||
146368269|NCT01306032|527849295|FG003|First Intervention|Progressive disease|0|||
146368270|NCT01306032|527849296|FG004|First Intervention|Progressive disease|2|||
146368271|NCT01306032|527849297|FG005|First Intervention|Progressive disease|0|||
146368272|NCT01306032|527849292|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
146368273|NCT01306032|527849293|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
146368274|NCT01306032|527849294|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
146368275|NCT01306032|527849295|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
146368276|NCT01306032|527849296|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
146368277|NCT01306032|527849297|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
146368278|NCT01306032|527849292|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
146368279|NCT01306032|527849293|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
146368280|NCT01306032|527849294|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
146368281|NCT01306032|527849295|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
146368282|NCT01306032|527849296|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
146368283|NCT01306032|527849297|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
146368284|NCT02988219|527849298|FG000|Overall Study|Lack of Efficacy|1|||
146368285|NCT02988219|527849299|FG001|Overall Study|Lack of Efficacy|1|||
146368286|NCT02988219|527849298|FG000|Overall Study|Withdrawal by Subject|0|||
146368287|NCT02988219|527849299|FG001|Overall Study|Withdrawal by Subject|2|||
146368288|NCT01213264|527849300|FG000|Overall Study|Adverse Event|1|||
146368289|NCT01213264|527849301|FG001|Overall Study|Adverse Event|0|||
146368290|NCT01213264|527849302|FG002|Overall Study|Adverse Event|0|||
146368291|NCT01213264|527849300|FG000|Overall Study|Lost to Follow-up|1|||
146368292|NCT01213264|527849301|FG001|Overall Study|Lost to Follow-up|2|||
146368293|NCT01213264|527849302|FG002|Overall Study|Lost to Follow-up|6|||
146368294|NCT02378883|527849304|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
146368295|NCT02378883|527849304|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
146368296|NCT02378883|527849304|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
146368297|NCT02378883|527849304|FG000|30 Day Follow-Up|Physician Decision|2|||
146368298|NCT02378883|527849304|FG000|30 Day Follow-Up|Missed Visit|2|||
146368299|NCT02378883|527849304|FG000|30 Day Follow-Up|Death|1|||
146368300|NCT02378883|527849304|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
146368301|NCT02378883|527849304|FG000|12 Months Follow-Up|Death|2|||
146368302|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
146368303|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
146368304|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
146368305|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
146368306|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
146368307|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
146368308|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
146368309|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
146368310|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
146368311|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
146368312|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
146368313|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
146368314|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
146368315|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
146368316|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
146368317|NCT03814005|527849308|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
146368318|NCT03814005|527849309|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
146368319|NCT03814005|527849310|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
146368320|NCT00810810|527849311|FG000|Overall Study|Withdrawal by Subject|0|||
146368321|NCT00810810|527849312|FG001|Overall Study|Withdrawal by Subject|8|||
146368322|NCT00810810|527849313|FG002|Overall Study|Withdrawal by Subject|10|||
146368323|NCT00810810|527849314|FG003|Overall Study|Withdrawal by Subject|8|||
146368324|NCT00810810|527849311|FG000|Overall Study|Physician Decision|0|||
146368325|NCT00810810|527849312|FG001|Overall Study|Physician Decision|3|||
146368326|NCT00810810|527849313|FG002|Overall Study|Physician Decision|1|||
146368327|NCT00810810|527849314|FG003|Overall Study|Physician Decision|5|||
146368328|NCT02563925|527849317|FG000|Overall Study|Withdrawal by Subject|2|||
146368329|NCT00282867|527849318|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
146368330|NCT00282867|527849319|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
146368331|NCT00282867|527849320|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
146368332|NCT01700985|527849321|FG000|Overall Study|Incarcerated|0|||
146368333|NCT01700985|527849322|FG001|Overall Study|Incarcerated|1|||
146368334|NCT00426556|527849324|FG000|Phase I - Core Phase|Disease Progression|0|||
146368335|NCT00426556|527849325|FG001|Phase I - Core Phase|Disease Progression|6|||
146368336|NCT00426556|527849326|FG002|Phase I - Core Phase|Disease Progression|2|||
146368337|NCT00426556|527849327|FG003|Phase I - Core Phase|Disease Progression|0|||
146368338|NCT00426556|527849324|FG000|Phase I - Core Phase|Adverse Event|1|||
146368339|NCT00426556|527849325|FG001|Phase I - Core Phase|Adverse Event|3|||
146368340|NCT00426556|527849326|FG002|Phase I - Core Phase|Adverse Event|1|||
146368341|NCT00426556|527849327|FG003|Phase I - Core Phase|Adverse Event|0|||
146368342|NCT00426556|527849324|FG000|Phase I - Core Phase|Death|0|||
146368343|NCT00426556|527849325|FG001|Phase I - Core Phase|Death|1|||
146368344|NCT00426556|527849326|FG002|Phase I - Core Phase|Death|0|||
146368345|NCT00426556|527849327|FG003|Phase I - Core Phase|Death|0|||
146368346|NCT00426556|527849324|FG000|Phase I - Extension Phase|Adverse Event|0|||
146368347|NCT00426556|527849325|FG001|Phase I - Extension Phase|Adverse Event|1|||
146368348|NCT00426556|527849326|FG002|Phase I - Extension Phase|Adverse Event|1|||
146368349|NCT00426556|527849327|FG003|Phase I - Extension Phase|Adverse Event|0|||
146368350|NCT00426556|527849324|FG000|Phase I - Extension Phase|Disease Progression|5|||
146368351|NCT00426556|527849325|FG001|Phase I - Extension Phase|Disease Progression|5|||
146368352|NCT00426556|527849326|FG002|Phase I - Extension Phase|Disease Progression|6|||
146368353|NCT00426556|527849327|FG003|Phase I - Extension Phase|Disease Progression|0|||
146368354|NCT00426556|527849324|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
146368355|NCT00426556|527849325|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
146368356|NCT00426556|527849326|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
146368357|NCT00426556|527849327|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
146368358|NCT00426556|527849324|FG000|Phase II - Core Phase|Disease Progression|0|||
146368359|NCT00426556|527849325|FG001|Phase II - Core Phase|Disease Progression|0|||
146368360|NCT00426556|527849326|FG002|Phase II - Core Phase|Disease Progression|0|||
146368361|NCT00426556|527849327|FG003|Phase II - Core Phase|Disease Progression|16|||
146368362|NCT00426556|527849324|FG000|Phase II - Core Phase|Adverse Event|0|||
146368363|NCT00426556|527849325|FG001|Phase II - Core Phase|Adverse Event|0|||
146368364|NCT00426556|527849326|FG002|Phase II - Core Phase|Adverse Event|0|||
146368365|NCT00426556|527849327|FG003|Phase II - Core Phase|Adverse Event|8|||
146368366|NCT00426556|527849324|FG000|Phase II - Extension Phase|Disease Progression|0|||
146368367|NCT00426556|527849325|FG001|Phase II - Extension Phase|Disease Progression|0|||
146368368|NCT00426556|527849326|FG002|Phase II - Extension Phase|Disease Progression|0|||
146368369|NCT00426556|527849327|FG003|Phase II - Extension Phase|Disease Progression|21|||
146368370|NCT00426556|527849324|FG000|Phase II - Extension Phase|Adverse Event|0|||
146368371|NCT00426556|527849325|FG001|Phase II - Extension Phase|Adverse Event|0|||
146368372|NCT00426556|527849326|FG002|Phase II - Extension Phase|Adverse Event|0|||
146368373|NCT00426556|527849327|FG003|Phase II - Extension Phase|Adverse Event|2|||
146368374|NCT01192204|527849330|FG000|Overall Study|could not keep recall appointments|1|||
146368375|NCT01192204|527849331|FG001|Overall Study|could not keep recall appointments|0|||
146368376|NCT03699631|527849334|FG000|Overall Study|Adverse Event|3|||
146368377|NCT01767519|527849335|FG000|Overall Study|Other Reasons|4|||
146368378|NCT01767519|527849336|FG001|Overall Study|Other Reasons|4|||
146368379|NCT01767519|527849337|FG002|Overall Study|Other Reasons|2|||
146368380|NCT01767519|527849335|FG000|Overall Study|Protocol Violation|0|||
146368381|NCT01767519|527849336|FG001|Overall Study|Protocol Violation|3|||
146368382|NCT01767519|527849337|FG002|Overall Study|Protocol Violation|0|||
146368383|NCT01767519|527849335|FG000|Overall Study|Personal Reasons|1|||
146368384|NCT01767519|527849336|FG001|Overall Study|Personal Reasons|0|||
146368385|NCT01767519|527849337|FG002|Overall Study|Personal Reasons|0|||
146368386|NCT01767519|527849335|FG000|Overall Study|Lost to Follow-up|3|||
146368387|NCT01767519|527849336|FG001|Overall Study|Lost to Follow-up|1|||
146368388|NCT01767519|527849337|FG002|Overall Study|Lost to Follow-up|2|||
146368389|NCT01767519|527849335|FG000|Overall Study|Lack of Efficacy|1|||
146368390|NCT01767519|527849336|FG001|Overall Study|Lack of Efficacy|0|||
146368391|NCT01767519|527849337|FG002|Overall Study|Lack of Efficacy|0|||
146368392|NCT01767519|527849335|FG000|Overall Study|Adverse Event|5|||
146368393|NCT01767519|527849336|FG001|Overall Study|Adverse Event|5|||
146368394|NCT01767519|527849337|FG002|Overall Study|Adverse Event|1|||
146368395|NCT03101514|527849340|FG000|Overall Study|Withdrawal by Subject|4|||
146368396|NCT03101514|527849340|FG000|Overall Study|Protocol Violation|2|||
146368397|NCT03101514|527849340|FG000|Overall Study|patient's information was incomplete|1|||
146368398|NCT02247401|527849341|FG000|Overall Study|Adverse Event|1|||
146368399|NCT02247401|527849342|FG001|Overall Study|Adverse Event|0|||
146368400|NCT02247401|527849343|FG002|Overall Study|Adverse Event|0|||
146368401|NCT02247401|527849341|FG000|Overall Study|Withdrawal by Subject|4|||
146368402|NCT02247401|527849342|FG001|Overall Study|Withdrawal by Subject|1|||
146368403|NCT02247401|527849343|FG002|Overall Study|Withdrawal by Subject|1|||
146368404|NCT02247401|527849341|FG000|Overall Study|Lost to Follow-up|1|||
146368405|NCT02247401|527849342|FG001|Overall Study|Lost to Follow-up|1|||
146368406|NCT02247401|527849343|FG002|Overall Study|Lost to Follow-up|1|||
146368407|NCT03695393|527849346|FG000|Overall Study|Death|3|||
146368408|NCT03695393|527849347|FG001|Overall Study|Death|1|||
146368409|NCT03695393|527849346|FG000|Overall Study|Lost to Follow-up|0|||
146368410|NCT03695393|527849347|FG001|Overall Study|Lost to Follow-up|1|||
146368411|NCT04169061|527849350|FG000|Overall Study|Adverse Event|2|||
146368412|NCT04169061|527849350|FG000|Overall Study|Death|1|||
146368413|NCT04169061|527849350|FG000|Overall Study|Withdrawal by Subject|1|||
146368414|NCT04169061|527849350|FG000|Overall Study|Protocol Violation|1|||
146368415|NCT04585451|527849351|FG000|Overall Study|Withdrawal by Subject|26|||
146368416|NCT04585451|527849352|FG001|Overall Study|Withdrawal by Subject|0|||
146368417|NCT00673894|527849353|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
146368418|NCT00673894|527849354|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
146368419|NCT00673894|527849353|FG000|First Intervention 4 Weeks|Adverse Event|1|||
146368420|NCT00673894|527849354|FG001|First Intervention 4 Weeks|Adverse Event|0|||
146368421|NCT00493974|527849355|FG000|Overall Study|Death|1|||
146368422|NCT00493974|527849356|FG001|Overall Study|Death|2|||
146368423|NCT00493974|527849355|FG000|Overall Study|Withdrawal by Subject|8|||
146282970|NCT02019667|527548360|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
146282971|NCT02019667|527548361|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
146282972|NCT02019667|527548360|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
146282973|NCT02019667|527548361|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
146282974|NCT05453201|527548362|FG000|Overall Study|Withdrawal by Subject|1|||
146282975|NCT01934790|527548363|FG000|Treatment|Adverse Event|3|||
146282976|NCT01934790|527548363|FG000|Treatment|Clinical progression|6|||
146282977|NCT01934790|527548363|FG000|Treatment|Radiological progression|4|||
146282978|NCT01934790|527548363|FG000|Treatment|Withdrawal by Subject|2|||
146282979|NCT01934790|527548363|FG000|Treatment|Study drug never administered|1|||
146282980|NCT01934790|527548363|FG000|Active Follow up|Death|20|||
146282981|NCT01934790|527548363|FG000|Active Follow up|Physician Decision|2|||
146282982|NCT01934790|527548363|FG000|Active Follow up|Progressive disease|1|||
146282983|NCT01934790|527548363|FG000|Active Follow up|Other reason|1|||
146282984|NCT03798691|527548364|FG000|Overall Study|Lost to Follow-up|2|||
146282985|NCT03798691|527548365|FG001|Overall Study|Lost to Follow-up|2|||
146282986|NCT01147536|527548371|FG000|Overall Study|Administrative study close|2|||
146282987|NCT01147536|527548371|FG000|Overall Study|Death|1|||
146282988|NCT03762200|527548372|FG000|Overall Study|Death|2|||
146282989|NCT05559476|527548377|FG000|Overall Study|Adverse Event|2|||
146282990|NCT05559476|527548378|FG001|Overall Study|Adverse Event|0|||
146282991|NCT05559476|527548377|FG000|Overall Study|Lost to Follow-up|13|||
146282992|NCT05559476|527548378|FG001|Overall Study|Lost to Follow-up|12|||
146282993|NCT05559476|527548377|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
146282994|NCT05559476|527548378|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
146282995|NCT05559476|527548377|FG000|Overall Study|Other|0|||
146282996|NCT05559476|527548378|FG001|Overall Study|Other|2|||
146282997|NCT05110690|527548379|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
146282998|NCT05110690|527548379|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
146282999|NCT05110690|527548379|FG000|Completion of Intervention|Lost to Follow-up|1|||
146283000|NCT05110690|527548379|FG000|Completion of Intervention|Death|1|||
146283001|NCT05110690|527548379|FG000|Completion of Intervention|Withdrawal by Subject|2|||
146368424|NCT00493974|527849356|FG001|Overall Study|Withdrawal by Subject|6|||
146368425|NCT00493974|527849355|FG000|Overall Study|Lost to Follow-up|4|||
146368426|NCT00493974|527849356|FG001|Overall Study|Lost to Follow-up|6|||
146368427|NCT02807363|527849357|FG000|Dosing Period|Adverse Event|0|||
146368428|NCT02807363|527849358|FG001|Dosing Period|Adverse Event|1|||
146368429|NCT02807363|527849359|FG002|Dosing Period|Adverse Event|0|||
146368430|NCT02807363|527849360|FG003|Dosing Period|Adverse Event|0|||
146368431|NCT02188719|527849361|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146368432|NCT02188719|527849362|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
146368433|NCT02188719|527849363|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146368434|NCT02188719|527849364|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
146368435|NCT00966693|527849365|FG000|Overall Study|Adverse Event|0|||
146368436|NCT00966693|527849366|FG001|Overall Study|Adverse Event|0|||
146368437|NCT00966693|527849367|FG002|Overall Study|Adverse Event|1|||
146368438|NCT00966693|527849368|FG003|Overall Study|Adverse Event|2|||
146368439|NCT00966693|527849365|FG000|Overall Study|Death|0|||
146368440|NCT00966693|527849366|FG001|Overall Study|Death|0|||
146368441|NCT00966693|527849367|FG002|Overall Study|Death|1|||
146368442|NCT00966693|527849368|FG003|Overall Study|Death|0|||
146368443|NCT00966693|527849365|FG000|Overall Study|Withdrawal by Subject|1|||
146368444|NCT00966693|527849366|FG001|Overall Study|Withdrawal by Subject|0|||
146368445|NCT00966693|527849367|FG002|Overall Study|Withdrawal by Subject|0|||
146368446|NCT00966693|527849368|FG003|Overall Study|Withdrawal by Subject|5|||
146368447|NCT00966693|527849365|FG000|Overall Study|Disease Progression|0|||
146368448|NCT00966693|527849366|FG001|Overall Study|Disease Progression|0|||
146368449|NCT00966693|527849367|FG002|Overall Study|Disease Progression|1|||
146368450|NCT00966693|527849368|FG003|Overall Study|Disease Progression|16|||
146368451|NCT00192036|527849369|FG000|Overall Study|Protocol Violation|3|||
146368452|NCT00192036|527849369|FG000|Overall Study|Adverse Event|6|||
146368453|NCT00192036|527849369|FG000|Overall Study|Patient/Physician Perception|1|||
146368454|NCT00192036|527849369|FG000|Overall Study|Objective Tumor Progression|4|||
146368455|NCT00192036|527849369|FG000|Overall Study|Clinical Disease Progression|1|||
146368456|NCT00192036|527849369|FG000|Overall Study|Death|1|||
146368457|NCT00192036|527849369|FG000|Overall Study|Unknown or Not Specified|5|||
146368458|NCT03371732|527849370|FG000|Overall Study|Withdrawal by Subject|9|||
146368459|NCT03371732|527849371|FG001|Overall Study|Withdrawal by Subject|3|||
146368460|NCT03371732|527849370|FG000|Overall Study|Refusal to continue|3|||
146368461|NCT03371732|527849371|FG001|Overall Study|Refusal to continue|4|||
146368462|NCT02581982|527849374|FG000|Overall Study|Lack of Efficacy|12|||
146368463|NCT02581982|527849374|FG000|Overall Study|Adverse Event|3|||
146368464|NCT02581982|527849374|FG000|Overall Study|Physician Decision|1|||
146368465|NCT00405821|527849375|FG000|Overall Study|Death|5|||
146368466|NCT00405821|527849376|FG001|Overall Study|Death|7|||
146368467|NCT00405821|527849375|FG000|Overall Study|Lost to Follow-up|7|||
146368468|NCT00405821|527849376|FG001|Overall Study|Lost to Follow-up|7|||
146368469|NCT00405821|527849375|FG000|Overall Study|Protocol Violation|1|||
146368470|NCT00405821|527849376|FG001|Overall Study|Protocol Violation|0|||
146368471|NCT00405821|527849375|FG000|Overall Study|initiated ART|9|||
146368472|NCT00405821|527849376|FG001|Overall Study|initiated ART|8|||
146368473|NCT01033487|527849378|FG000|Fourth Intervention Period|Adverse Event|0|||
146368474|NCT01033487|527849379|FG001|Fourth Intervention Period|Adverse Event|0|||
146368475|NCT01033487|527849380|FG002|Fourth Intervention Period|Adverse Event|0|||
146368476|NCT01033487|527849381|FG003|Fourth Intervention Period|Adverse Event|0|||
146368477|NCT01033487|527849382|FG004|Fourth Intervention Period|Adverse Event|0|||
146368478|NCT01033487|527849383|FG005|Fourth Intervention Period|Adverse Event|0|||
146368479|NCT01033487|527849384|FG006|Fourth Intervention Period|Adverse Event|0|||
146368480|NCT01033487|527849385|FG007|Fourth Intervention Period|Adverse Event|0|||
146368481|NCT01033487|527849386|FG008|Fourth Intervention Period|Adverse Event|1|||
146368482|NCT01033487|527849387|FG009|Fourth Intervention Period|Adverse Event|0|||
146368483|NCT03094832|527849392|FG000|Overall Study|Lost to Follow-up|0|||
146368484|NCT03094832|527849393|FG001|Overall Study|Lost to Follow-up|0|||
146368485|NCT03094832|527849394|FG002|Overall Study|Lost to Follow-up|0|||
146368486|NCT03094832|527849395|FG003|Overall Study|Lost to Follow-up|1|||
146368487|NCT03094832|527849396|FG004|Overall Study|Lost to Follow-up|1|||
146368488|NCT03094832|527849392|FG000|Overall Study|Death|1|||
146368489|NCT03094832|527849393|FG001|Overall Study|Death|0|||
146368490|NCT03094832|527849394|FG002|Overall Study|Death|0|||
146368491|NCT03094832|527849395|FG003|Overall Study|Death|0|||
146368492|NCT03094832|527849396|FG004|Overall Study|Death|0|||
146368493|NCT03094832|527849392|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
146368494|NCT03094832|527849393|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
146368495|NCT03094832|527849394|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
146368496|NCT03094832|527849395|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
146368497|NCT03094832|527849396|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
146368498|NCT03094832|527849392|FG000|Overall Study|Other|13|||
146368499|NCT03094832|527849393|FG001|Overall Study|Other|20|||
146368500|NCT03094832|527849394|FG002|Overall Study|Other|1|||
146368501|NCT03094832|527849395|FG003|Overall Study|Other|7|||
146368502|NCT03094832|527849396|FG004|Overall Study|Other|1|||
146368503|NCT00719862|527849404|FG000|Overall Study|Adverse Event|1|||
146368504|NCT00719862|527849405|FG001|Overall Study|Adverse Event|2|||
146368505|NCT00719862|527849404|FG000|Overall Study|Lack of Efficacy|3|||
146368506|NCT00719862|527849405|FG001|Overall Study|Lack of Efficacy|0|||
146368507|NCT00719862|527849404|FG000|Overall Study|Non-Compliance|1|||
146368508|NCT00719862|527849405|FG001|Overall Study|Non-Compliance|0|||
146368509|NCT00719862|527849404|FG000|Overall Study|Withdrawal by Subject|1|||
146368510|NCT00719862|527849405|FG001|Overall Study|Withdrawal by Subject|0|||
146368511|NCT00719862|527849404|FG000|Overall Study|Lost to Follow-up|0|||
146368512|NCT00719862|527849405|FG001|Overall Study|Lost to Follow-up|1|||
146368513|NCT00719862|527849404|FG000|Overall Study|Other|2|||
146368514|NCT00719862|527849405|FG001|Overall Study|Other|3|||
146368515|NCT01184846|527849406|FG000|Overall Study|Adverse Event|2|||
146368516|NCT01184846|527849406|FG000|Overall Study|Insufficient response|1|||
146368517|NCT01999946|527849407|FG000|Overall Study|Participant not released from jail|2|||
146368518|NCT01999946|527849408|FG001|Overall Study|Participant not released from jail|2|||
146368519|NCT01999946|527849409|FG002|Overall Study|Participant not released from jail|0|||
146368520|NCT01999946|527849407|FG000|Overall Study|Not included in primary outcome analysis|0|||
146368521|NCT01999946|527849408|FG001|Overall Study|Not included in primary outcome analysis|0|||
146368522|NCT01999946|527849409|FG002|Overall Study|Not included in primary outcome analysis|79|||
146368523|NCT01770145|527851346|FG000|Baseline|Adverse Event|20|||
146368524|NCT01770145|527851346|FG000|Baseline|Withdrawal by Subject|1|||
146368525|NCT01770145|527851346|FG000|Baseline|Lost to Follow-up|1|||
146368526|NCT01770145|527851346|FG000|Baseline|Unable to define optimal dose|4|||
146368527|NCT01770145|527851346|FG000|Treatment|Adverse Event|3|||
146368528|NCT01770145|527851346|FG000|Treatment|Withdrawal by Subject|1|||
146368529|NCT04268303|527851347|FG000|Overall Study|Lost to Follow-up|1|||
146368530|NCT04268303|527851348|FG001|Overall Study|Lost to Follow-up|1|||
146368531|NCT04268303|527851349|FG002|Overall Study|Lost to Follow-up|2|||
146368532|NCT04268303|527851347|FG000|Overall Study|Withdrawal by Subject|0|||
146368533|NCT04268303|527851348|FG001|Overall Study|Withdrawal by Subject|1|||
146368534|NCT04268303|527851349|FG002|Overall Study|Withdrawal by Subject|1|||
146368535|NCT04268303|527851347|FG000|Overall Study|Adverse Event|2|||
146368536|NCT04268303|527851348|FG001|Overall Study|Adverse Event|0|||
146368537|NCT04268303|527851349|FG002|Overall Study|Adverse Event|0|||
146368538|NCT00355134|527851350|FG000|Core Phase|Withdrawal by Subject|35|||
146368539|NCT00355134|527851351|FG001|Core Phase|Withdrawal by Subject|24|||
146368540|NCT00355134|527851352|FG002|Core Phase|Withdrawal by Subject|35|||
146368541|NCT00355134|527851353|FG003|Core Phase|Withdrawal by Subject|0|||
146368542|NCT00355134|527851354|FG004|Core Phase|Withdrawal by Subject|0|||
146368543|NCT00355134|527851350|FG000|Core Phase|Adverse Event|28|||
146368544|NCT00355134|527851351|FG001|Core Phase|Adverse Event|22|||
146368545|NCT00355134|527851352|FG002|Core Phase|Adverse Event|16|||
146368546|NCT00355134|527851353|FG003|Core Phase|Adverse Event|0|||
146368547|NCT00355134|527851354|FG004|Core Phase|Adverse Event|0|||
146368548|NCT00355134|527851350|FG000|Core Phase|Lost to Follow-up|17|||
146368549|NCT00355134|527851351|FG001|Core Phase|Lost to Follow-up|13|||
146368550|NCT00355134|527851352|FG002|Core Phase|Lost to Follow-up|21|||
146368551|NCT00355134|527851353|FG003|Core Phase|Lost to Follow-up|0|||
146368552|NCT00355134|527851354|FG004|Core Phase|Lost to Follow-up|0|||
146368553|NCT00355134|527851350|FG000|Core Phase|Abnormal laboratory value(s)|19|||
146368554|NCT00355134|527851351|FG001|Core Phase|Abnormal laboratory value(s)|14|||
146368555|NCT00355134|527851352|FG002|Core Phase|Abnormal laboratory value(s)|2|||
146368556|NCT00355134|527851353|FG003|Core Phase|Abnormal laboratory value(s)|0|||
146368557|NCT00355134|527851354|FG004|Core Phase|Abnormal laboratory value(s)|0|||
146368558|NCT00355134|527851350|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
146368559|NCT00355134|527851351|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
146368560|NCT00355134|527851352|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
146368561|NCT00355134|527851353|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
146368562|NCT00355134|527851354|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
146368563|NCT00355134|527851350|FG000|Core Phase|Administrative problems|5|||
146368564|NCT00355134|527851351|FG001|Core Phase|Administrative problems|3|||
146368565|NCT00355134|527851352|FG002|Core Phase|Administrative problems|5|||
146368566|NCT00355134|527851353|FG003|Core Phase|Administrative problems|0|||
146368567|NCT00355134|527851354|FG004|Core Phase|Administrative problems|0|||
146368568|NCT00355134|527851350|FG000|Core Phase|Protocol Violation|3|||
146368569|NCT00355134|527851351|FG001|Core Phase|Protocol Violation|2|||
146368570|NCT00355134|527851352|FG002|Core Phase|Protocol Violation|2|||
146368571|NCT00355134|527851353|FG003|Core Phase|Protocol Violation|0|||
146368572|NCT00355134|527851354|FG004|Core Phase|Protocol Violation|0|||
146368573|NCT00355134|527851350|FG000|Core Phase|Abnormal test procedure result(s)|1|||
146368574|NCT00355134|527851351|FG001|Core Phase|Abnormal test procedure result(s)|2|||
146368575|NCT00355134|527851352|FG002|Core Phase|Abnormal test procedure result(s)|1|||
146368576|NCT00355134|527851353|FG003|Core Phase|Abnormal test procedure result(s)|0|||
146368577|NCT00355134|527851354|FG004|Core Phase|Abnormal test procedure result(s)|0|||
146368578|NCT00355134|527851350|FG000|Core Phase|Condition no longer requires study drug|1|||
146368579|NCT00355134|527851351|FG001|Core Phase|Condition no longer requires study drug|0|||
146368580|NCT00355134|527851352|FG002|Core Phase|Condition no longer requires study drug|1|||
146368581|NCT00355134|527851353|FG003|Core Phase|Condition no longer requires study drug|0|||
146368582|NCT00355134|527851354|FG004|Core Phase|Condition no longer requires study drug|0|||
146368583|NCT00355134|527851350|FG000|Extension Phase|Withdrawal by Subject|7|||
146368584|NCT00355134|527851351|FG001|Extension Phase|Withdrawal by Subject|11|||
146368585|NCT00355134|527851352|FG002|Extension Phase|Withdrawal by Subject|0|||
146368586|NCT00355134|527851353|FG003|Extension Phase|Withdrawal by Subject|7|||
146368587|NCT00355134|527851354|FG004|Extension Phase|Withdrawal by Subject|5|||
146368588|NCT00355134|527851350|FG000|Extension Phase|Adverse Event|13|||
146368589|NCT00355134|527851351|FG001|Extension Phase|Adverse Event|9|||
146368590|NCT00355134|527851352|FG002|Extension Phase|Adverse Event|0|||
146368591|NCT00355134|527851353|FG003|Extension Phase|Adverse Event|3|||
146368592|NCT00355134|527851354|FG004|Extension Phase|Adverse Event|5|||
146368593|NCT00355134|527851350|FG000|Extension Phase|Lost to Follow-up|2|||
146368594|NCT00355134|527851351|FG001|Extension Phase|Lost to Follow-up|6|||
146368595|NCT00355134|527851352|FG002|Extension Phase|Lost to Follow-up|0|||
146368596|NCT00355134|527851353|FG003|Extension Phase|Lost to Follow-up|2|||
146368597|NCT00355134|527851354|FG004|Extension Phase|Lost to Follow-up|4|||
146368598|NCT00355134|527851350|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
146368599|NCT00355134|527851351|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
146368600|NCT00355134|527851352|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
146368601|NCT00355134|527851353|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
146368602|NCT00355134|527851354|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
146368603|NCT00355134|527851350|FG000|Extension Phase|Administrative problems|2|||
146368604|NCT00355134|527851351|FG001|Extension Phase|Administrative problems|4|||
146368605|NCT00355134|527851352|FG002|Extension Phase|Administrative problems|0|||
146368606|NCT00355134|527851353|FG003|Extension Phase|Administrative problems|1|||
146368607|NCT00355134|527851354|FG004|Extension Phase|Administrative problems|1|||
146368608|NCT00355134|527851350|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
146368609|NCT00355134|527851351|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
146368610|NCT00355134|527851352|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
146368611|NCT00355134|527851353|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
146368612|NCT00355134|527851354|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
146368613|NCT00355134|527851350|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
146368614|NCT00355134|527851351|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
146368615|NCT00355134|527851352|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
146368616|NCT00355134|527851353|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
146368617|NCT00355134|527851354|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
146368618|NCT00355134|527851350|FG000|Extension Phase|Protocol Violation|0|||
146368619|NCT00355134|527851351|FG001|Extension Phase|Protocol Violation|0|||
146368620|NCT00355134|527851352|FG002|Extension Phase|Protocol Violation|0|||
146368621|NCT00355134|527851353|FG003|Extension Phase|Protocol Violation|1|||
146368622|NCT00355134|527851354|FG004|Extension Phase|Protocol Violation|0|||
146368623|NCT03621189|527851359|FG000|Overall Study|Withdrawal by Subject|0|||
146368624|NCT03621189|527851360|FG001|Overall Study|Withdrawal by Subject|3|||
146368625|NCT03621189|527851359|FG000|Overall Study|Physician Decision|0|||
146368626|NCT03621189|527851360|FG001|Overall Study|Physician Decision|2|||
146368627|NCT01135394|527851361|FG000|Screening|Lost to Follow-up|2|||
146368628|NCT01135394|527851361|FG000|Screening|Withdrawal by Subject|10|||
146368629|NCT01135394|527851361|FG000|Screening|Screening failure|16|||
146368630|NCT01135394|527851361|FG000|Screening|Physician Decision|5|||
146368631|NCT01135394|527851361|FG000|Baseline Assessment|Withdrawal by Subject|9|||
146368632|NCT01135394|527851361|FG000|Baseline Assessment|Physician Decision|3|||
146368633|NCT01135394|527851361|FG000|Baseline Assessment|Lost to Follow-up|2|||
146368634|NCT01135394|527851361|FG000|Baseline Assessment|Adverse Event|1|||
146368635|NCT01135394|527851361|FG000|Study Treatment|Withdrawal by Subject|1|||
146368636|NCT01135394|527851361|FG000|Study Treatment|Physician Decision|1|||
146368637|NCT01135394|527851361|FG000|Study Treatment|Adverse Event|2|||
146368638|NCT04432376|527851362|FG000|Double-blind Treatment Period|Adverse Event|2|||
146368639|NCT04432376|527851363|FG001|Double-blind Treatment Period|Adverse Event|6|||
146368640|NCT04432376|527851364|FG002|Double-blind Treatment Period|Adverse Event|0|||
146368641|NCT04432376|527851362|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
146368642|NCT04432376|527851363|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
146368643|NCT04432376|527851364|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
146368644|NCT04432376|527851362|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146368645|NCT04432376|527851363|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146368646|NCT04432376|527851364|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146368647|NCT04432376|527851362|FG000|Double-blind Treatment Period|Protocol Violation|0|||
146368648|NCT04432376|527851363|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146368649|NCT04432376|527851364|FG002|Double-blind Treatment Period|Protocol Violation|0|||
146368650|NCT04432376|527851362|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
146368651|NCT04432376|527851363|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
146368652|NCT04432376|527851364|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
146368653|NCT02088541|527851365|FG000|Overall Study|Adverse Event|3|||
146368654|NCT02088541|527851366|FG001|Overall Study|Adverse Event|0|||
146368655|NCT02088541|527851367|FG002|Overall Study|Adverse Event|3|||
146368656|NCT02088541|527851368|FG003|Overall Study|Adverse Event|3|||
146368657|NCT02088541|527851369|FG004|Overall Study|Adverse Event|0|||
146368658|NCT02088541|527851365|FG000|Overall Study|Death|51|||
146368659|NCT02088541|527851366|FG001|Overall Study|Death|21|||
146368660|NCT02088541|527851367|FG002|Overall Study|Death|85|||
146368661|NCT02088541|527851368|FG003|Overall Study|Death|28|||
146368662|NCT02088541|527851369|FG004|Overall Study|Death|38|||
146368663|NCT02088541|527851365|FG000|Overall Study|Lost to Follow-up|2|||
146368664|NCT02088541|527851366|FG001|Overall Study|Lost to Follow-up|0|||
146368665|NCT02088541|527851367|FG002|Overall Study|Lost to Follow-up|1|||
146368666|NCT02088541|527851368|FG003|Overall Study|Lost to Follow-up|0|||
146368667|NCT02088541|527851369|FG004|Overall Study|Lost to Follow-up|0|||
146368668|NCT02088541|527851365|FG000|Overall Study|Physician Decision|2|||
146368669|NCT02088541|527851366|FG001|Overall Study|Physician Decision|1|||
146368670|NCT02088541|527851367|FG002|Overall Study|Physician Decision|2|||
146368671|NCT02088541|527851368|FG003|Overall Study|Physician Decision|0|||
146368672|NCT02088541|527851369|FG004|Overall Study|Physician Decision|2|||
146368673|NCT02088541|527851365|FG000|Overall Study|Disease progression|7|||
146368674|NCT02088541|527851366|FG001|Overall Study|Disease progression|1|||
146368675|NCT02088541|527851367|FG002|Overall Study|Disease progression|2|||
146368676|NCT02088541|527851368|FG003|Overall Study|Disease progression|3|||
146368677|NCT02088541|527851369|FG004|Overall Study|Disease progression|1|||
146368678|NCT02088541|527851365|FG000|Overall Study|Study terminated by sponsor|1|||
146368679|NCT02088541|527851366|FG001|Overall Study|Study terminated by sponsor|1|||
146368680|NCT02088541|527851367|FG002|Overall Study|Study terminated by sponsor|12|||
146368681|NCT02088541|527851368|FG003|Overall Study|Study terminated by sponsor|2|||
146368682|NCT02088541|527851369|FG004|Overall Study|Study terminated by sponsor|6|||
146368683|NCT02088541|527851365|FG000|Overall Study|Withdrawal by Subject|3|||
146368684|NCT02088541|527851366|FG001|Overall Study|Withdrawal by Subject|2|||
146368685|NCT02088541|527851367|FG002|Overall Study|Withdrawal by Subject|9|||
146368686|NCT02088541|527851368|FG003|Overall Study|Withdrawal by Subject|7|||
146368687|NCT02088541|527851369|FG004|Overall Study|Withdrawal by Subject|10|||
146368688|NCT02088541|527851365|FG000|Overall Study|Other|2|||
146368689|NCT02088541|527851366|FG001|Overall Study|Other|1|||
146368690|NCT02088541|527851367|FG002|Overall Study|Other|3|||
146368691|NCT02088541|527851368|FG003|Overall Study|Other|1|||
146368692|NCT02088541|527851369|FG004|Overall Study|Other|1|||
146368693|NCT05742841|527851370|FG000|Overall Study|Withdrawal by Subject|1|||
146368694|NCT05742841|527851370|FG000|Overall Study|Lost to Follow-up|1|||
146368695|NCT04134728|527851371|FG000|Overall Study|Adverse Event|3|||
146368696|NCT04134728|527851372|FG001|Overall Study|Adverse Event|2|||
146368697|NCT04134728|527851373|FG002|Overall Study|Adverse Event|9|||
146368698|NCT04134728|527851374|FG003|Overall Study|Adverse Event|0|||
146368699|NCT04134728|527851375|FG004|Overall Study|Adverse Event|0|||
146368700|NCT04134728|527851376|FG005|Overall Study|Adverse Event|0|||
146368701|NCT04134728|527851371|FG000|Overall Study|Lack of Efficacy|3|||
146368702|NCT04134728|527851372|FG001|Overall Study|Lack of Efficacy|3|||
146368703|NCT04134728|527851373|FG002|Overall Study|Lack of Efficacy|1|||
146368704|NCT04134728|527851374|FG003|Overall Study|Lack of Efficacy|2|||
146368705|NCT04134728|527851375|FG004|Overall Study|Lack of Efficacy|0|||
146368706|NCT04134728|527851376|FG005|Overall Study|Lack of Efficacy|0|||
146368707|NCT04134728|527851371|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
146368708|NCT04134728|527851372|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146368709|NCT04134728|527851373|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
146368710|NCT04134728|527851374|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146368711|NCT04134728|527851375|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146368712|NCT04134728|527851376|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
146368713|NCT04134728|527851371|FG000|Overall Study|Protocol Deviation|0|||
146368714|NCT04134728|527851372|FG001|Overall Study|Protocol Deviation|0|||
146368715|NCT04134728|527851373|FG002|Overall Study|Protocol Deviation|1|||
146368716|NCT04134728|527851374|FG003|Overall Study|Protocol Deviation|0|||
146368717|NCT04134728|527851375|FG004|Overall Study|Protocol Deviation|0|||
146368718|NCT04134728|527851376|FG005|Overall Study|Protocol Deviation|0|||
146368719|NCT04134728|527851371|FG000|Overall Study|Informed Consent Withdrawn|3|||
146368720|NCT04134728|527851372|FG001|Overall Study|Informed Consent Withdrawn|6|||
146368721|NCT04134728|527851373|FG002|Overall Study|Informed Consent Withdrawn|8|||
146368722|NCT04134728|527851374|FG003|Overall Study|Informed Consent Withdrawn|1|||
146368723|NCT04134728|527851375|FG004|Overall Study|Informed Consent Withdrawn|1|||
146368724|NCT04134728|527851376|FG005|Overall Study|Informed Consent Withdrawn|0|||
146368725|NCT04134728|527851371|FG000|Overall Study|Physician Decision|2|||
146368726|NCT04134728|527851372|FG001|Overall Study|Physician Decision|0|||
146368727|NCT04134728|527851373|FG002|Overall Study|Physician Decision|0|||
146368728|NCT04134728|527851374|FG003|Overall Study|Physician Decision|0|||
146368729|NCT04134728|527851375|FG004|Overall Study|Physician Decision|0|||
146368730|NCT04134728|527851376|FG005|Overall Study|Physician Decision|0|||
146368731|NCT04134728|527851371|FG000|Overall Study|Lost to Follow-up|1|||
146368732|NCT04134728|527851372|FG001|Overall Study|Lost to Follow-up|2|||
146368733|NCT04134728|527851373|FG002|Overall Study|Lost to Follow-up|1|||
146368734|NCT04134728|527851374|FG003|Overall Study|Lost to Follow-up|0|||
146368735|NCT04134728|527851375|FG004|Overall Study|Lost to Follow-up|0|||
146368736|NCT04134728|527851376|FG005|Overall Study|Lost to Follow-up|1|||
146368737|NCT04134728|527851371|FG000|Overall Study|Investigator Site Closed|0|||
146368738|NCT04134728|527851372|FG001|Overall Study|Investigator Site Closed|1|||
146368739|NCT04134728|527851373|FG002|Overall Study|Investigator Site Closed|1|||
146368740|NCT04134728|527851374|FG003|Overall Study|Investigator Site Closed|0|||
146368741|NCT04134728|527851375|FG004|Overall Study|Investigator Site Closed|0|||
146368742|NCT04134728|527851376|FG005|Overall Study|Investigator Site Closed|0|||
146368743|NCT03518034|527851382|FG000|Overall Study|Not Treated|5|||
146368744|NCT03518034|527851383|FG001|Overall Study|Not Treated|1|||
146368745|NCT03518034|527851382|FG000|Overall Study|Withdrawal by Subject|309|||
146368746|NCT03518034|527851383|FG001|Overall Study|Withdrawal by Subject|351|||
146368747|NCT03518034|527851382|FG000|Overall Study|Lost to Follow-up|446|||
146368748|NCT03518034|527851383|FG001|Overall Study|Lost to Follow-up|458|||
146368749|NCT03518034|527851382|FG000|Overall Study|Adverse Event|138|||
146368750|NCT03518034|527851383|FG001|Overall Study|Adverse Event|130|||
146368751|NCT03518034|527851382|FG000|Overall Study|Lack of Efficacy|11|||
146368752|NCT03518034|527851383|FG001|Overall Study|Lack of Efficacy|23|||
146368753|NCT03518034|527851382|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
146368754|NCT03518034|527851383|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
146368755|NCT03518034|527851382|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
146368756|NCT03518034|527851383|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
146368757|NCT03518034|527851382|FG000|Overall Study|Other, Not Specified|84|||
146368758|NCT03518034|527851383|FG001|Overall Study|Other, Not Specified|53|||
146368759|NCT03518034|527851382|FG000|Overall Study|Reason Missing|2|||
146368760|NCT03518034|527851383|FG001|Overall Study|Reason Missing|3|||
146368761|NCT01019252|527851384|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
146368762|NCT01019252|527851385|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
146368763|NCT01019252|527851384|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
146368764|NCT01019252|527851385|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
146368765|NCT01019252|527851384|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
146368766|NCT01019252|527851385|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
146368767|NCT01019252|527851384|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
146368768|NCT01019252|527851385|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
146368769|NCT02062398|527851386|FG000|Overall Study|Implant removal|1|||
146368770|NCT00415519|527851387|FG000|Overall Study|Adverse Event|1|||
146368771|NCT00415519|527851388|FG001|Overall Study|Adverse Event|0|||
146368772|NCT00415519|527851387|FG000|Overall Study|Withdrawal by Subject|2|||
146368773|NCT00415519|527851388|FG001|Overall Study|Withdrawal by Subject|0|||
146368774|NCT00415519|527851387|FG000|Overall Study|Patient's convenience|1|||
146368775|NCT00415519|527851388|FG001|Overall Study|Patient's convenience|0|||
146368776|NCT03657810|527851393|FG000|Overall Study|Adverse Event|0|||
146368777|NCT03657810|527851394|FG001|Overall Study|Adverse Event|1|||
146368778|NCT03657810|527851395|FG002|Overall Study|Adverse Event|0|||
146368779|NCT03657810|527851393|FG000|Overall Study|Lack of Efficacy|4|||
146368780|NCT03657810|527851394|FG001|Overall Study|Lack of Efficacy|1|||
146368781|NCT03657810|527851395|FG002|Overall Study|Lack of Efficacy|3|||
146368782|NCT03657810|527851393|FG000|Overall Study|Protocol Violation|1|||
146368783|NCT03657810|527851394|FG001|Overall Study|Protocol Violation|0|||
146368784|NCT03657810|527851395|FG002|Overall Study|Protocol Violation|0|||
146368785|NCT03657810|527851393|FG000|Overall Study|Lost to Follow-up|0|||
146368786|NCT03657810|527851394|FG001|Overall Study|Lost to Follow-up|1|||
146368787|NCT03657810|527851395|FG002|Overall Study|Lost to Follow-up|0|||
146368788|NCT03657810|527851393|FG000|Overall Study|Not provided|0|||
146368789|NCT03657810|527851394|FG001|Overall Study|Not provided|1|||
146368790|NCT03657810|527851395|FG002|Overall Study|Not provided|0|||
146368791|NCT03325556|527851396|FG000|Open-label Period|Lack of Response in OL period|70|||
146368792|NCT03325556|527851397|FG001|Open-label Period|Lack of Response in OL period|0|||
146368793|NCT03325556|527851398|FG002|Open-label Period|Lack of Response in OL period|0|||
146368794|NCT03325556|527851396|FG000|Open-label Period|Adverse Event|27|||
146368795|NCT03325556|527851397|FG001|Open-label Period|Adverse Event|0|||
146368796|NCT03325556|527851398|FG002|Open-label Period|Adverse Event|0|||
146368797|NCT03325556|527851396|FG000|Open-label Period|Death|1|||
146368798|NCT03325556|527851397|FG001|Open-label Period|Death|0|||
146368799|NCT03325556|527851398|FG002|Open-label Period|Death|0|||
146368800|NCT03325556|527851396|FG000|Open-label Period|Lost to Follow-up|1|||
146368801|NCT03325556|527851397|FG001|Open-label Period|Lost to Follow-up|0|||
146368802|NCT03325556|527851398|FG002|Open-label Period|Lost to Follow-up|0|||
146368803|NCT03325556|527851396|FG000|Open-label Period|Non-compliance with study drug|5|||
146368804|NCT03325556|527851397|FG001|Open-label Period|Non-compliance with study drug|0|||
146368805|NCT03325556|527851398|FG002|Open-label Period|Non-compliance with study drug|0|||
146368806|NCT03325556|527851396|FG000|Open-label Period|Use of prohibited medication|1|||
146368807|NCT03325556|527851397|FG001|Open-label Period|Use of prohibited medication|0|||
146368808|NCT03325556|527851398|FG002|Open-label Period|Use of prohibited medication|0|||
146368809|NCT03325556|527851396|FG000|Open-label Period|Protocol Violation|4|||
146368810|NCT03325556|527851397|FG001|Open-label Period|Protocol Violation|0|||
146368811|NCT03325556|527851398|FG002|Open-label Period|Protocol Violation|0|||
146368812|NCT03325556|527851396|FG000|Open-label Period|Withdrawal by Subject|17|||
146368813|NCT03325556|527851397|FG001|Open-label Period|Withdrawal by Subject|0|||
146368814|NCT03325556|527851398|FG002|Open-label Period|Withdrawal by Subject|0|||
146368815|NCT03325556|527851396|FG000|Open-label Period|Not otherwise specified|8|||
146368816|NCT03325556|527851397|FG001|Open-label Period|Not otherwise specified|0|||
146368817|NCT03325556|527851398|FG002|Open-label Period|Not otherwise specified|0|||
146368818|NCT03325556|527851396|FG000|Open-label Period|Administrative discont. at study termination|41|||
146368819|NCT03325556|527851397|FG001|Open-label Period|Administrative discont. at study termination|0|||
146368820|NCT03325556|527851398|FG002|Open-label Period|Administrative discont. at study termination|0|||
146368821|NCT03325556|527851396|FG000|Double-blind Period|Relapse|0|||
146368822|NCT03325556|527851397|FG001|Double-blind Period|Relapse|15|||
146368823|NCT03325556|527851398|FG002|Double-blind Period|Relapse|34|||
146368824|NCT03325556|527851396|FG000|Double-blind Period|Adverse Event|0|||
146368825|NCT03325556|527851397|FG001|Double-blind Period|Adverse Event|3|||
146368826|NCT03325556|527851398|FG002|Double-blind Period|Adverse Event|1|||
146368827|NCT03325556|527851396|FG000|Double-blind Period|Noncompliance with study drug|0|||
146368828|NCT03325556|527851397|FG001|Double-blind Period|Noncompliance with study drug|0|||
146368829|NCT03325556|527851398|FG002|Double-blind Period|Noncompliance with study drug|1|||
146368830|NCT03325556|527851396|FG000|Double-blind Period|Use of prohibited medication|0|||
146368831|NCT03325556|527851397|FG001|Double-blind Period|Use of prohibited medication|1|||
146368832|NCT03325556|527851398|FG002|Double-blind Period|Use of prohibited medication|0|||
146368833|NCT03325556|527851396|FG000|Double-blind Period|Physician Decision|0|||
146368834|NCT03325556|527851397|FG001|Double-blind Period|Physician Decision|0|||
146368835|NCT03325556|527851398|FG002|Double-blind Period|Physician Decision|1|||
146368836|NCT03325556|527851396|FG000|Double-blind Period|Withdrawal by Subject|0|||
146368837|NCT03325556|527851397|FG001|Double-blind Period|Withdrawal by Subject|6|||
146368838|NCT03325556|527851398|FG002|Double-blind Period|Withdrawal by Subject|4|||
146368839|NCT03325556|527851396|FG000|Double-blind Period|Not otherwise specified|0|||
146368840|NCT03325556|527851397|FG001|Double-blind Period|Not otherwise specified|1|||
146368841|NCT03325556|527851398|FG002|Double-blind Period|Not otherwise specified|5|||
146368842|NCT03325556|527851396|FG000|Double-blind Period|Administrative discont. at study termination|0|||
146368843|NCT03325556|527851397|FG001|Double-blind Period|Administrative discont. at study termination|35|||
146368844|NCT03325556|527851398|FG002|Double-blind Period|Administrative discont. at study termination|31|||
146368845|NCT01705587|527851399|FG000|Overall Study|Withdrawal by Subject|0|||
146368846|NCT01705587|527851400|FG001|Overall Study|Withdrawal by Subject|1|||
146368847|NCT02227849|527851401|FG000|Overall Study|Adverse Event|4|||
146368848|NCT02227849|527851401|FG000|Overall Study|Physician Decision|1|||
146368849|NCT02227849|527851401|FG000|Overall Study|Withdrawal by Subject|3|||
146368850|NCT00510484|527851402|FG000|Wash-out Period|Adverse Event|0|||
146368851|NCT00510484|527851403|FG001|Wash-out Period|Adverse Event|1|||
146368852|NCT01590212|527851404|FG000|Overall Study|Withdrawal by Subject|2|||
146368853|NCT01590212|527851405|FG001|Overall Study|Withdrawal by Subject|2|||
146368854|NCT01590212|527851406|FG002|Overall Study|Withdrawal by Subject|2|||
146368855|NCT01590212|527851404|FG000|Overall Study|Lost to Follow-up|1|||
146368856|NCT01590212|527851405|FG001|Overall Study|Lost to Follow-up|2|||
146368857|NCT01590212|527851406|FG002|Overall Study|Lost to Follow-up|3|||
146368858|NCT00762268|527851407|FG000|Overall Study|Withdrawal by Subject|3|||
146368859|NCT00762268|527851408|FG001|Overall Study|Withdrawal by Subject|3|||
146368860|NCT02533401|527851409|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
146368861|NCT02533401|527851409|FG000|Overall Study|Death|5|||
146368862|NCT02533401|527851409|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
146368863|NCT02533401|527851409|FG000|Overall Study|Lost to Follow-up|1|||
146368864|NCT02533401|527851409|FG000|Overall Study|Violation of Selection Criteria|1|||
146368865|NCT04897594|527851411|FG000|Overall Study|Lost to Follow-up|0|||
146368866|NCT04897594|527851412|FG001|Overall Study|Lost to Follow-up|1|||
146368867|NCT04897594|527851413|FG002|Overall Study|Lost to Follow-up|1|||
146368868|NCT04897594|527851411|FG000|Overall Study|Sponsor Decision|0|||
146368869|NCT04897594|527851412|FG001|Overall Study|Sponsor Decision|0|||
146368870|NCT04897594|527851413|FG002|Overall Study|Sponsor Decision|1|||
146368871|NCT04897594|527851411|FG000|Overall Study|Withdrawal by Subject|1|||
146368872|NCT04897594|527851412|FG001|Overall Study|Withdrawal by Subject|0|||
146368873|NCT04897594|527851413|FG002|Overall Study|Withdrawal by Subject|1|||
146368874|NCT00881361|527851418|FG000|Overall Study|Terminated prior to surgery|27|||
146368875|NCT00881361|527851419|FG001|Overall Study|Terminated prior to surgery|7|||
146368876|NCT00881361|527851420|FG002|Overall Study|Terminated prior to surgery|0|||
146368877|NCT00881361|527851418|FG000|Overall Study|Ineligible|17|||
146368878|NCT00881361|527851419|FG001|Overall Study|Ineligible|2|||
146368879|NCT00881361|527851420|FG002|Overall Study|Ineligible|2|||
146368880|NCT02137837|527851421|FG000|Overall Study|Adverse Event|0|||
146368881|NCT02137837|527851422|FG001|Overall Study|Adverse Event|2|||
146368882|NCT02137837|527851423|FG002|Overall Study|Adverse Event|1|||
146368883|NCT02137837|527851421|FG000|Overall Study|Refusal unrelated to adverse event|2|||
146368884|NCT02137837|527851422|FG001|Overall Study|Refusal unrelated to adverse event|2|||
146368885|NCT02137837|527851423|FG002|Overall Study|Refusal unrelated to adverse event|1|||
146368886|NCT02137837|527851421|FG000|Overall Study|Progression/relapse|9|||
146368887|NCT02137837|527851422|FG001|Overall Study|Progression/relapse|7|||
146368888|NCT02137837|527851423|FG002|Overall Study|Progression/relapse|7|||
146368889|NCT02137837|527851421|FG000|Overall Study|Not protocol specified|2|||
146368890|NCT02137837|527851422|FG001|Overall Study|Not protocol specified|1|||
146368891|NCT02137837|527851423|FG002|Overall Study|Not protocol specified|3|||
146368892|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
146368893|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
146368894|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
146368895|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
146368896|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
146368897|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146368898|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146368899|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146368900|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
146368901|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
146368902|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
146368903|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146368904|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146368905|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146368906|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
146368907|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
146368908|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146368909|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
146368910|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146368911|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
146368912|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146368913|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146368914|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
146368915|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
146368916|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
146368917|NCT01457924|527851426|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
146368918|NCT01457924|527851427|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
146368919|NCT01457924|527851428|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
146368920|NCT01457924|527851429|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
146368921|NCT01457924|527851430|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
146368922|NCT01457924|527851426|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
146368923|NCT01457924|527851427|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
146368924|NCT01457924|527851428|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
146368925|NCT01457924|527851429|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
146368926|NCT01457924|527851430|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
146368927|NCT01457924|527851426|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
146368928|NCT01457924|527851427|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
146368929|NCT01457924|527851428|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
146368930|NCT01457924|527851429|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
146368931|NCT01457924|527851430|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
146368932|NCT01457924|527851426|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146368933|NCT01457924|527851427|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146368934|NCT01457924|527851428|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146368935|NCT01457924|527851429|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
146368936|NCT01457924|527851430|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
146368937|NCT01457924|527851426|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
146368938|NCT01457924|527851427|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
146368939|NCT01457924|527851428|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
146368940|NCT01457924|527851429|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
146368941|NCT01457924|527851430|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
146368942|NCT01457924|527851426|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
146368943|NCT01457924|527851427|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146368944|NCT01457924|527851428|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
146368945|NCT01457924|527851429|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146368946|NCT01457924|527851430|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
146368947|NCT01457924|527851426|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
146368948|NCT01457924|527851427|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
146368949|NCT01457924|527851428|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
146368950|NCT01457924|527851429|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
146368951|NCT01457924|527851430|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
146368952|NCT01457924|527851426|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146368953|NCT01457924|527851427|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
146368954|NCT01457924|527851428|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146368955|NCT01457924|527851429|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
146368956|NCT01457924|527851430|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
146368957|NCT01329341|527851433|FG000|Overall Study|Withdrawal by Subject|44|||
146368958|NCT00448760|527851434|FG000|Overall Study|Death|3|||
146368959|NCT03017846|527851437|FG000|Overall Study|Lost to Follow-up|3|||
146368960|NCT03017846|527851437|FG000|Overall Study|Adverse Event|2|||
146368961|NCT00118911|527851439|FG000|Overall Study|Withdrawal by Subject|2|||
146368962|NCT00118911|527851440|FG001|Overall Study|Withdrawal by Subject|5|||
146368963|NCT05014542|527851441|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
146368964|NCT05014542|527851442|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
146368965|NCT05014542|527851441|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
146368966|NCT05014542|527851442|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
146368967|NCT05014542|527851441|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
146368968|NCT05014542|527851442|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
146368969|NCT05014542|527851441|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
146368970|NCT05014542|527851442|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
146368971|NCT01438307|527851443|FG000|Overall Study|Death|1|||
146368972|NCT01438307|527851444|FG001|Overall Study|Death|1|||
146368973|NCT01342952|527851446|FG000|Overall Study|Adverse Event|0|||
146368974|NCT01342952|527851447|FG001|Overall Study|Adverse Event|5|||
146368975|NCT01342952|527851448|FG002|Overall Study|Adverse Event|1|||
146368976|NCT01342952|527851449|FG003|Overall Study|Adverse Event|0|||
146368977|NCT01342952|527851446|FG000|Overall Study|Lost to Follow-up|0|||
146368978|NCT01342952|527851447|FG001|Overall Study|Lost to Follow-up|2|||
146368979|NCT01342952|527851448|FG002|Overall Study|Lost to Follow-up|0|||
146368980|NCT01342952|527851449|FG003|Overall Study|Lost to Follow-up|0|||
146368981|NCT01342952|527851446|FG000|Overall Study|Withdrawal by Subject|1|||
146368982|NCT01342952|527851447|FG001|Overall Study|Withdrawal by Subject|1|||
146368983|NCT01342952|527851448|FG002|Overall Study|Withdrawal by Subject|0|||
146368984|NCT01342952|527851449|FG003|Overall Study|Withdrawal by Subject|0|||
146368985|NCT01342952|527851446|FG000|Overall Study|Physician Decision|3|||
146368986|NCT01342952|527851447|FG001|Overall Study|Physician Decision|3|||
146368987|NCT01342952|527851448|FG002|Overall Study|Physician Decision|1|||
146368988|NCT01342952|527851449|FG003|Overall Study|Physician Decision|0|||
146368989|NCT03970824|527851453|FG000|Overall Study|Withdrawal by Subject|1|||
145943424|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
145943425|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
145943426|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
145943427|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
145943428|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
145943429|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
145943430|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
145943431|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
145943432|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
145943433|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
145943434|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
145943435|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
145943436|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
145943437|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
145943438|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943439|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943440|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943441|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943442|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943443|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943444|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943445|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943446|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943447|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943448|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943449|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
145943450|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
145943451|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145943452|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943453|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943454|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943455|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943456|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943457|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
146368990|NCT03970824|527851454|FG001|Overall Study|Withdrawal by Subject|1|||
146368991|NCT03970824|527851455|FG002|Overall Study|Withdrawal by Subject|3|||
146368992|NCT03970824|527851453|FG000|Overall Study|Lost to Follow-up|0|||
146368993|NCT03970824|527851454|FG001|Overall Study|Lost to Follow-up|2|||
146368994|NCT03970824|527851455|FG002|Overall Study|Lost to Follow-up|1|||
146368995|NCT03970824|527851453|FG000|Overall Study|Adverse Event|1|||
146368996|NCT03970824|527851454|FG001|Overall Study|Adverse Event|0|||
146368997|NCT03970824|527851455|FG002|Overall Study|Adverse Event|0|||
146368998|NCT00416312|527851456|FG000|Overall Study|tumors not visible on imaging|2|||
146368999|NCT00105560|527851459|FG000|Overall Study|Lost to Follow-up|1|||
146369000|NCT02146248|527851461|FG000|Overall Study|Withdrawal by Subject|2|||
146369001|NCT01315847|527851462|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
146369002|NCT01315847|527851463|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
146369003|NCT01315847|527851462|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
146369004|NCT01315847|527851463|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
146369005|NCT00862654|527851469|FG000|Overall Study|Lack of Efficacy|1|||
146369006|NCT00862654|527851470|FG001|Overall Study|Lack of Efficacy|0|||
146369007|NCT00862654|527851471|FG002|Overall Study|Lack of Efficacy|1|||
146369008|NCT00862654|527851472|FG003|Overall Study|Lack of Efficacy|0|||
146369009|NCT00862654|527851469|FG000|Overall Study|Lost to Follow-up|1|||
146369010|NCT00862654|527851470|FG001|Overall Study|Lost to Follow-up|2|||
146369011|NCT00862654|527851471|FG002|Overall Study|Lost to Follow-up|1|||
146369012|NCT00862654|527851472|FG003|Overall Study|Lost to Follow-up|3|||
146369013|NCT00862654|527851469|FG000|Overall Study|Adverse Event|0|||
146369014|NCT00862654|527851470|FG001|Overall Study|Adverse Event|1|||
146369015|NCT00862654|527851471|FG002|Overall Study|Adverse Event|1|||
146369016|NCT00862654|527851472|FG003|Overall Study|Adverse Event|0|||
146369017|NCT00862654|527851469|FG000|Overall Study|Pregnancy|1|||
146369018|NCT00862654|527851470|FG001|Overall Study|Pregnancy|1|||
146369019|NCT00862654|527851471|FG002|Overall Study|Pregnancy|0|||
146369020|NCT00862654|527851472|FG003|Overall Study|Pregnancy|0|||
146369021|NCT00862654|527851469|FG000|Overall Study|Withdrawal by Subject|2|||
146369022|NCT00862654|527851470|FG001|Overall Study|Withdrawal by Subject|2|||
146369023|NCT00862654|527851471|FG002|Overall Study|Withdrawal by Subject|2|||
146369024|NCT00862654|527851472|FG003|Overall Study|Withdrawal by Subject|3|||
146369025|NCT00862654|527851469|FG000|Overall Study|Subject mistake|0|||
146369026|NCT00862654|527851470|FG001|Overall Study|Subject mistake|1|||
146369027|NCT00862654|527851471|FG002|Overall Study|Subject mistake|0|||
146369028|NCT00862654|527851472|FG003|Overall Study|Subject mistake|0|||
146369029|NCT00862654|527851469|FG000|Overall Study|Familly constraint|0|||
146369030|NCT00862654|527851470|FG001|Overall Study|Familly constraint|1|||
146369031|NCT00862654|527851471|FG002|Overall Study|Familly constraint|0|||
146369032|NCT00862654|527851472|FG003|Overall Study|Familly constraint|0|||
146369033|NCT00862654|527851469|FG000|Overall Study|Never used study drugs|1|||
146369034|NCT00862654|527851470|FG001|Overall Study|Never used study drugs|0|||
146369035|NCT00862654|527851471|FG002|Overall Study|Never used study drugs|0|||
146369036|NCT00862654|527851472|FG003|Overall Study|Never used study drugs|0|||
146369037|NCT00862654|527851469|FG000|Overall Study|Included after end of inclusions|0|||
146369038|NCT00862654|527851470|FG001|Overall Study|Included after end of inclusions|0|||
146369039|NCT00862654|527851471|FG002|Overall Study|Included after end of inclusions|1|||
146369040|NCT00862654|527851472|FG003|Overall Study|Included after end of inclusions|0|||
146369041|NCT03954444|527851473|FG000|Overall Study|Withdrawal by Subject|5|||
146369042|NCT03954444|527851474|FG001|Overall Study|Withdrawal by Subject|5|||
146369043|NCT03954444|527851475|FG002|Overall Study|Withdrawal by Subject|5|||
146369044|NCT03954444|527851473|FG000|Overall Study|Adverse Event|1|||
146369045|NCT03954444|527851474|FG001|Overall Study|Adverse Event|3|||
146369046|NCT03954444|527851475|FG002|Overall Study|Adverse Event|2|||
146369047|NCT03954444|527851473|FG000|Overall Study|Protocol Violation|0|||
146369048|NCT03954444|527851474|FG001|Overall Study|Protocol Violation|3|||
146369049|NCT03954444|527851475|FG002|Overall Study|Protocol Violation|5|||
146369050|NCT03954444|527851473|FG000|Overall Study|Use of prohibited therapy|1|||
146369051|NCT03954444|527851474|FG001|Overall Study|Use of prohibited therapy|1|||
146369052|NCT03954444|527851475|FG002|Overall Study|Use of prohibited therapy|2|||
146369053|NCT03954444|527851473|FG000|Overall Study|Lost to Follow-up|1|||
146369054|NCT03954444|527851474|FG001|Overall Study|Lost to Follow-up|0|||
146369055|NCT03954444|527851475|FG002|Overall Study|Lost to Follow-up|1|||
146369056|NCT03954444|527851473|FG000|Overall Study|Non-compliant with study drug application|2|||
146369057|NCT03954444|527851474|FG001|Overall Study|Non-compliant with study drug application|2|||
146369058|NCT03954444|527851475|FG002|Overall Study|Non-compliant with study drug application|0|||
146369059|NCT03954444|527851473|FG000|Overall Study|Administrative reasons|0|||
146369060|NCT03954444|527851474|FG001|Overall Study|Administrative reasons|0|||
146369061|NCT03954444|527851475|FG002|Overall Study|Administrative reasons|1|||
146369062|NCT03954444|527851473|FG000|Overall Study|Miscellaneous|3|||
146369063|NCT03954444|527851474|FG001|Overall Study|Miscellaneous|2|||
146369064|NCT03954444|527851475|FG002|Overall Study|Miscellaneous|1|||
146369065|NCT02713789|527851477|FG000|Overall Study|Lost to Follow-up|0|||
146369066|NCT02713789|527851478|FG001|Overall Study|Lost to Follow-up|1|||
146369067|NCT02713789|527851479|FG002|Overall Study|Lost to Follow-up|1|||
146369068|NCT02661464|527851482|FG000|Overall Study|Lost to Follow-up|28|||
146369069|NCT02661464|527851483|FG001|Overall Study|Lost to Follow-up|0|||
146369070|NCT02661464|527851484|FG002|Overall Study|Lost to Follow-up|0|||
146369071|NCT02661464|527851485|FG003|Overall Study|Lost to Follow-up|0|||
146369072|NCT02661464|527851482|FG000|Overall Study|Withdrawal by Subject|3|||
146369073|NCT02661464|527851483|FG001|Overall Study|Withdrawal by Subject|1|||
146369074|NCT02661464|527851484|FG002|Overall Study|Withdrawal by Subject|0|||
146369075|NCT02661464|527851485|FG003|Overall Study|Withdrawal by Subject|0|||
146369076|NCT02661464|527851482|FG000|Overall Study|Participants terminated prematurely|288|||
146369077|NCT02661464|527851483|FG001|Overall Study|Participants terminated prematurely|52|||
146369078|NCT02661464|527851484|FG002|Overall Study|Participants terminated prematurely|1|||
146369079|NCT02661464|527851485|FG003|Overall Study|Participants terminated prematurely|1|||
146369080|NCT02661464|527851482|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
146369081|NCT02661464|527851483|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
146369082|NCT02661464|527851484|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
146369083|NCT02661464|527851485|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
146369084|NCT00903370|527851486|FG000|Overall Study|Death|13|||
146369085|NCT00903370|527851487|FG001|Overall Study|Death|10|||
146369086|NCT00903370|527851486|FG000|Overall Study|Withdrawal by Subject|9|||
146369087|NCT00903370|527851487|FG001|Overall Study|Withdrawal by Subject|6|||
146369088|NCT00903370|527851486|FG000|Overall Study|Lost to Follow-up|6|||
146369089|NCT00903370|527851487|FG001|Overall Study|Lost to Follow-up|8|||
146369090|NCT01293084|527851491|FG000|Overall Study|Physician Decision|3|||
146369091|NCT01293084|527851491|FG000|Overall Study|Withdrawal by Subject|2|||
146369092|NCT00719953|527851494|FG000|Overall Study|Adverse Event|4|||
146369093|NCT01626989|527851495|FG000|Screening Period|Screen Failure|15|||
146369094|NCT01626989|527851496|FG001|Screening Period|Screen Failure|0|||
146369095|NCT01626989|527851497|FG002|Screening Period|Screen Failure|0|||
146369096|NCT01626989|527851495|FG000|Screening Period|Withdrawal by Subject|2|||
146369097|NCT01626989|527851496|FG001|Screening Period|Withdrawal by Subject|0|||
146369098|NCT01626989|527851497|FG002|Screening Period|Withdrawal by Subject|0|||
146369099|NCT02947022|527851500|FG000|Overall Study|Study Stopped|1|||
146369100|NCT00379236|527853168|FG000|Double-blind|Adverse Event|11|||
146369101|NCT00379236|527853169|FG001|Double-blind|Adverse Event|6|||
146369102|NCT00379236|527853170|FG002|Double-blind|Adverse Event|0|||
146369103|NCT00379236|527853168|FG000|Double-blind|Protocol Violation|3|||
146369104|NCT00379236|527853169|FG001|Double-blind|Protocol Violation|3|||
146369105|NCT00379236|527853170|FG002|Double-blind|Protocol Violation|0|||
146369106|NCT00379236|527853168|FG000|Double-blind|Withdrawal by Subject|12|||
146369107|NCT00379236|527853169|FG001|Double-blind|Withdrawal by Subject|13|||
146369108|NCT00379236|527853170|FG002|Double-blind|Withdrawal by Subject|0|||
146369109|NCT00379236|527853168|FG000|Double-blind|Lost to Follow-up|4|||
146369110|NCT00379236|527853169|FG001|Double-blind|Lost to Follow-up|3|||
146369111|NCT00379236|527853170|FG002|Double-blind|Lost to Follow-up|0|||
146369112|NCT00379236|527853168|FG000|Double-blind|Use of exclusionary medication|1|||
146369113|NCT00379236|527853169|FG001|Double-blind|Use of exclusionary medication|2|||
146369114|NCT00379236|527853170|FG002|Double-blind|Use of exclusionary medication|0|||
146369115|NCT00379236|527853168|FG000|Double-blind|Other|3|||
146369116|NCT00379236|527853169|FG001|Double-blind|Other|7|||
146369117|NCT00379236|527853170|FG002|Double-blind|Other|0|||
146369118|NCT00379236|527853168|FG000|Double-blind|Data could not be retrieved|2|||
146369119|NCT00379236|527853169|FG001|Double-blind|Data could not be retrieved|2|||
146369120|NCT00379236|527853170|FG002|Double-blind|Data could not be retrieved|0|||
146369121|NCT00379236|527853168|FG000|Open-label Extension|Adverse Event|0|||
146369122|NCT00379236|527853169|FG001|Open-label Extension|Adverse Event|0|||
146369123|NCT00379236|527853170|FG002|Open-label Extension|Adverse Event|13|||
146369124|NCT00379236|527853168|FG000|Open-label Extension|Protocol Violation|0|||
146369125|NCT00379236|527853169|FG001|Open-label Extension|Protocol Violation|0|||
146369126|NCT00379236|527853170|FG002|Open-label Extension|Protocol Violation|7|||
146369127|NCT00379236|527853168|FG000|Open-label Extension|Withdrawal by Subject|0|||
146369128|NCT00379236|527853169|FG001|Open-label Extension|Withdrawal by Subject|0|||
146369129|NCT00379236|527853170|FG002|Open-label Extension|Withdrawal by Subject|13|||
146369130|NCT00379236|527853168|FG000|Open-label Extension|Lost to Follow-up|0|||
146369131|NCT00379236|527853169|FG001|Open-label Extension|Lost to Follow-up|0|||
146369132|NCT00379236|527853170|FG002|Open-label Extension|Lost to Follow-up|12|||
146369133|NCT00379236|527853168|FG000|Open-label Extension|Use of exclusionary medication|0|||
146369134|NCT00379236|527853169|FG001|Open-label Extension|Use of exclusionary medication|0|||
146369135|NCT00379236|527853170|FG002|Open-label Extension|Use of exclusionary medication|3|||
146369136|NCT00379236|527853168|FG000|Open-label Extension|Other|0|||
146369137|NCT00379236|527853169|FG001|Open-label Extension|Other|0|||
146369138|NCT00379236|527853170|FG002|Open-label Extension|Other|7|||
146369139|NCT00801892|527853171|FG000|Main Study Period|Withdrawal by Subject|0|||
146369140|NCT00801892|527853172|FG001|Main Study Period|Withdrawal by Subject|1|||
146369141|NCT00801892|527853171|FG000|Sham Crossover Period|Lost to Follow-up|0|||
146369142|NCT00801892|527853172|FG001|Sham Crossover Period|Lost to Follow-up|2|||
146369143|NCT00728936|527853173|FG000|Overall Study|Withdrawal by Subject|0|||
146369144|NCT00728936|527853174|FG001|Overall Study|Withdrawal by Subject|0|||
146369145|NCT00728936|527853175|FG002|Overall Study|Withdrawal by Subject|0|||
146369146|NCT00728936|527853176|FG003|Overall Study|Withdrawal by Subject|0|||
146369147|NCT00728936|527853177|FG004|Overall Study|Withdrawal by Subject|0|||
146369148|NCT00728936|527853178|FG005|Overall Study|Withdrawal by Subject|1|||
146369149|NCT00728936|527853179|FG006|Overall Study|Withdrawal by Subject|0|||
146369150|NCT00438464|527853180|FG000|Overall Study|Terminated Early|14|||
146369151|NCT00438464|527853181|FG001|Overall Study|Terminated Early|5|||
146369152|NCT00438464|527853180|FG000|Overall Study|Incomplete data submission|0|||
146369153|NCT00438464|527853181|FG001|Overall Study|Incomplete data submission|2|||
146369154|NCT02905825|527853182|FG000|Overall Study|Protocol Violation|11|||
146369155|NCT02905825|527853182|FG000|Overall Study|Device Malfunction|1|||
146369156|NCT01090102|527853184|FG000|First 12 Weeks|Withdrawal by Subject|1|||
146369157|NCT01090102|527853185|FG001|First 12 Weeks|Withdrawal by Subject|1|||
146369158|NCT01090102|527853184|FG000|First 12 Weeks|Adverse Event|2|||
146369159|NCT01090102|527853185|FG001|First 12 Weeks|Adverse Event|0|||
146369160|NCT01090102|527853184|FG000|First 12 Weeks|Death|1|||
146369161|NCT01090102|527853185|FG001|First 12 Weeks|Death|1|||
146369162|NCT01090102|527853184|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
146369163|NCT01090102|527853185|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
146369164|NCT01601704|527853186|FG000|Overall Study|Randomized but not dispensed study med|1|||
146369165|NCT01601704|527853187|FG001|Overall Study|Randomized but not dispensed study med|4|||
146369166|NCT02273037|527853189|FG000|Overall Study|Lost to Follow-up|1|||
146369167|NCT02273037|527853190|FG001|Overall Study|Lost to Follow-up|0|||
146369168|NCT02273037|527853189|FG000|Overall Study|Delivered before monitoring initiated|1|||
146369169|NCT02273037|527853190|FG001|Overall Study|Delivered before monitoring initiated|3|||
146369170|NCT02273037|527853189|FG000|Overall Study|Breech delivery|2|||
146369171|NCT02273037|527853190|FG001|Overall Study|Breech delivery|3|||
146369172|NCT02273037|527853189|FG000|Overall Study|Multiple delivery|2|||
146369173|NCT02273037|527853190|FG001|Overall Study|Multiple delivery|2|||
146369174|NCT02273037|527853189|FG000|Overall Study|Other complication|2|||
146369175|NCT02273037|527853190|FG001|Overall Study|Other complication|0|||
146369176|NCT01181141|527853197|FG000|Overall Study|Adverse Event|2|||
146369177|NCT01181141|527853198|FG001|Overall Study|Adverse Event|1|||
146369178|NCT01181141|527853197|FG000|Overall Study|Lack of Efficacy|1|||
146369179|NCT01181141|527853198|FG001|Overall Study|Lack of Efficacy|0|||
146369180|NCT01181141|527853197|FG000|Overall Study|Lost to Follow-up|1|||
146369181|NCT01181141|527853198|FG001|Overall Study|Lost to Follow-up|1|||
146369182|NCT01181141|527853197|FG000|Overall Study|Physician Decision|2|||
146369183|NCT01181141|527853198|FG001|Overall Study|Physician Decision|0|||
146369184|NCT01181141|527853197|FG000|Overall Study|Protocol Violation|3|||
146369185|NCT01181141|527853198|FG001|Overall Study|Protocol Violation|1|||
146369186|NCT01181141|527853197|FG000|Overall Study|Withdrawal by Subject|3|||
146369187|NCT01181141|527853198|FG001|Overall Study|Withdrawal by Subject|1|||
146369188|NCT05507580|527853199|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
146369189|NCT05507580|527853200|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
146369190|NCT05507580|527853201|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
146369191|NCT05507580|527853202|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
146369192|NCT05507580|527853203|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
146369193|NCT05507580|527853204|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
146369194|NCT05507580|527853199|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
146369195|NCT05507580|527853200|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
146369196|NCT05507580|527853201|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146369197|NCT05507580|527853202|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146369198|NCT05507580|527853203|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146369199|NCT05507580|527853204|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
146369200|NCT05507580|527853199|FG000|Double-Blind Treatment Period|Other, not specified|5|||
146369201|NCT05507580|527853200|FG001|Double-Blind Treatment Period|Other, not specified|4|||
146369202|NCT05507580|527853201|FG002|Double-Blind Treatment Period|Other, not specified|0|||
146369203|NCT05507580|527853202|FG003|Double-Blind Treatment Period|Other, not specified|0|||
146369204|NCT05507580|527853203|FG004|Double-Blind Treatment Period|Other, not specified|0|||
146369205|NCT05507580|527853204|FG005|Double-Blind Treatment Period|Other, not specified|0|||
146369206|NCT05507580|527853199|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
146369207|NCT05507580|527853200|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
146369208|NCT05507580|527853201|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
146369209|NCT05507580|527853202|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
146369210|NCT05507580|527853203|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
146369211|NCT05507580|527853204|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
146369212|NCT05507580|527853199|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146369213|NCT05507580|527853200|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146369214|NCT05507580|527853201|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
146369215|NCT05507580|527853202|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
146369216|NCT05507580|527853203|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
146369217|NCT05507580|527853204|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
146369218|NCT05507580|527853199|FG000|Single-Blind Treatment Period|Other, not specified|0|||
146369219|NCT05507580|527853200|FG001|Single-Blind Treatment Period|Other, not specified|0|||
146369220|NCT05507580|527853201|FG002|Single-Blind Treatment Period|Other, not specified|2|||
146369221|NCT05507580|527853202|FG003|Single-Blind Treatment Period|Other, not specified|7|||
146369222|NCT05507580|527853203|FG004|Single-Blind Treatment Period|Other, not specified|3|||
146369223|NCT05507580|527853204|FG005|Single-Blind Treatment Period|Other, not specified|5|||
146369224|NCT06000501|527853205|FG000|Overall Study|Screen failure|3|||
146369225|NCT06000501|527853205|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
146369226|NCT06000501|527853205|FG000|Overall Study|Physician Decision|4|||
146369227|NCT06000501|527853205|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
146369228|NCT06000501|527853205|FG000|Overall Study|Scheduling issues|2|||
146369229|NCT03496662|527853206|FG000|Overall Study|Adverse Event|0|||
146369230|NCT03496662|527853207|FG001|Overall Study|Adverse Event|0|||
146369231|NCT03496662|527853208|FG002|Overall Study|Adverse Event|4|||
146369232|NCT03496662|527853206|FG000|Overall Study|Withdrawal by Subject|1|||
146369233|NCT03496662|527853207|FG001|Overall Study|Withdrawal by Subject|0|||
146369234|NCT03496662|527853208|FG002|Overall Study|Withdrawal by Subject|2|||
146369235|NCT03496662|527853206|FG000|Overall Study|Death|0|||
146369236|NCT03496662|527853207|FG001|Overall Study|Death|0|||
146369237|NCT03496662|527853208|FG002|Overall Study|Death|2|||
146369238|NCT03496662|527853206|FG000|Overall Study|Noncompliance|0|||
146369239|NCT03496662|527853207|FG001|Overall Study|Noncompliance|0|||
146369240|NCT03496662|527853208|FG002|Overall Study|Noncompliance|1|||
146369241|NCT00493467|527853209|FG000|Overall Study|Death|1|||
146369242|NCT01074658|527853213|FG000|Overall Study|No implant attempted|19|||
146369243|NCT00432562|527853217|FG000|Overall Study|Death|3|||
146369244|NCT00432562|527853218|FG001|Overall Study|Death|0|||
146369245|NCT00425100|527853219|FG000|Overall Study|Adverse Event|36|||
146369246|NCT00425100|527853219|FG000|Overall Study|Lack of Efficacy|4|||
146369247|NCT00425100|527853219|FG000|Overall Study|Lost to Follow-up|2|||
146369248|NCT00425100|527853219|FG000|Overall Study|Protocol Violation|4|||
146369249|NCT00425100|527853219|FG000|Overall Study|Withdrawal by Subject|7|||
146369250|NCT02559713|527853222|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
146369251|NCT01374217|527853224|FG000|Overall Study|Lack of Efficacy|13|||
146369252|NCT01117012|527853229|FG000|Overall Study|Adverse Event|0|||
146369253|NCT01117012|527853230|FG001|Overall Study|Adverse Event|1|||
146369254|NCT01117012|527853229|FG000|Overall Study|Death|1|||
146369255|NCT01117012|527853230|FG001|Overall Study|Death|1|||
146369256|NCT01117012|527853229|FG000|Overall Study|Withdrawal by Subject|3|||
146369257|NCT01117012|527853230|FG001|Overall Study|Withdrawal by Subject|0|||
146369258|NCT01117012|527853229|FG000|Overall Study|Undefined|4|||
146369259|NCT01117012|527853230|FG001|Overall Study|Undefined|3|||
146369260|NCT05425719|527853238|FG000|Overall Study|Lost to Follow-up|4|||
146369261|NCT05425719|527853239|FG001|Overall Study|Lost to Follow-up|0|||
146369262|NCT05425719|527853238|FG000|Overall Study|Withdrew consent|1|||
146369263|NCT05425719|527853239|FG001|Overall Study|Withdrew consent|1|||
146369264|NCT04682353|527853240|FG000|Overall Study|Lost to Follow-up|0|||
146369265|NCT04682353|527853241|FG001|Overall Study|Lost to Follow-up|1|||
146369266|NCT04682353|527853242|FG002|Overall Study|Lost to Follow-up|0|||
146369267|NCT04682353|527853243|FG003|Overall Study|Lost to Follow-up|1|||
146369268|NCT04682353|527853240|FG000|Overall Study|Personal reasons|0|||
146369269|NCT04682353|527853241|FG001|Overall Study|Personal reasons|1|||
146369270|NCT04682353|527853242|FG002|Overall Study|Personal reasons|0|||
146369271|NCT04682353|527853243|FG003|Overall Study|Personal reasons|0|||
146369272|NCT00555906|527853244|FG000|Phase 1|Objective Progression or Relapse|3|||
146369273|NCT00555906|527853245|FG001|Phase 1|Objective Progression or Relapse|5|||
146369274|NCT00555906|527853246|FG002|Phase 1|Objective Progression or Relapse|3|||
146369275|NCT00555906|527853247|FG003|Phase 1|Objective Progression or Relapse|1|||
146369276|NCT00555906|527853248|FG004|Phase 1|Objective Progression or Relapse|0|||
146369277|NCT00555906|527853244|FG000|Phase 1|Global Deterioration of Health Status|0|||
146369278|NCT00555906|527853245|FG001|Phase 1|Global Deterioration of Health Status|1|||
146369279|NCT00555906|527853246|FG002|Phase 1|Global Deterioration of Health Status|1|||
146369280|NCT00555906|527853247|FG003|Phase 1|Global Deterioration of Health Status|1|||
146369281|NCT00555906|527853248|FG004|Phase 1|Global Deterioration of Health Status|0|||
146369282|NCT00555906|527853244|FG000|Phase 1|Adverse Event|0|||
146369283|NCT00555906|527853245|FG001|Phase 1|Adverse Event|0|||
146369284|NCT00555906|527853246|FG002|Phase 1|Adverse Event|3|||
146369285|NCT00555906|527853247|FG003|Phase 1|Adverse Event|2|||
146369286|NCT00555906|527853248|FG004|Phase 1|Adverse Event|0|||
146369287|NCT00555906|527853244|FG000|Phase 1|Withdrawal by Subject|0|||
146369288|NCT00555906|527853245|FG001|Phase 1|Withdrawal by Subject|0|||
146369289|NCT00555906|527853246|FG002|Phase 1|Withdrawal by Subject|0|||
146369290|NCT00555906|527853247|FG003|Phase 1|Withdrawal by Subject|1|||
146369291|NCT00555906|527853248|FG004|Phase 1|Withdrawal by Subject|0|||
146369292|NCT00555906|527853244|FG000|Phase 2|Adverse Event|0|||
146369293|NCT00555906|527853245|FG001|Phase 2|Adverse Event|0|||
146369294|NCT00555906|527853246|FG002|Phase 2|Adverse Event|0|||
146369295|NCT00555906|527853247|FG003|Phase 2|Adverse Event|0|||
146369296|NCT00555906|527853248|FG004|Phase 2|Adverse Event|4|||
146369297|NCT00555906|527853244|FG000|Phase 2|Global Deterioration of Health Status|0|||
146369298|NCT00555906|527853245|FG001|Phase 2|Global Deterioration of Health Status|0|||
146369299|NCT00555906|527853246|FG002|Phase 2|Global Deterioration of Health Status|0|||
146369300|NCT00555906|527853247|FG003|Phase 2|Global Deterioration of Health Status|0|||
146369301|NCT00555906|527853248|FG004|Phase 2|Global Deterioration of Health Status|2|||
146369302|NCT00555906|527853244|FG000|Phase 2|Objective Progression or Relapse|0|||
146369303|NCT00555906|527853245|FG001|Phase 2|Objective Progression or Relapse|0|||
146369304|NCT00555906|527853246|FG002|Phase 2|Objective Progression or Relapse|0|||
146369305|NCT00555906|527853247|FG003|Phase 2|Objective Progression or Relapse|0|||
146369306|NCT00555906|527853248|FG004|Phase 2|Objective Progression or Relapse|16|||
146369307|NCT00555906|527853244|FG000|Phase 2|Withdrawal by Subject|0|||
146369308|NCT00555906|527853245|FG001|Phase 2|Withdrawal by Subject|0|||
146369309|NCT00555906|527853246|FG002|Phase 2|Withdrawal by Subject|0|||
146369310|NCT00555906|527853247|FG003|Phase 2|Withdrawal by Subject|0|||
146369311|NCT00555906|527853248|FG004|Phase 2|Withdrawal by Subject|2|||
146369312|NCT00555906|527853244|FG000|Phase 2|Other|0|||
146369313|NCT00555906|527853245|FG001|Phase 2|Other|0|||
146369314|NCT00555906|527853246|FG002|Phase 2|Other|0|||
146369315|NCT00555906|527853247|FG003|Phase 2|Other|0|||
146369316|NCT00555906|527853248|FG004|Phase 2|Other|6|||
146369317|NCT00555906|527853244|FG000|Phase 2|Randomized but not Treated|0|||
146369318|NCT00555906|527853245|FG001|Phase 2|Randomized but not Treated|0|||
146369319|NCT00555906|527853246|FG002|Phase 2|Randomized but not Treated|0|||
146369320|NCT00555906|527853247|FG003|Phase 2|Randomized but not Treated|0|||
146369321|NCT00555906|527853248|FG004|Phase 2|Randomized but not Treated|2|||
146369322|NCT02193828|527853249|FG000|Overall Study|Withdrawal by Subject|0|||
146369323|NCT02193828|527853250|FG001|Overall Study|Withdrawal by Subject|0|||
146369324|NCT02193828|527853251|FG002|Overall Study|Withdrawal by Subject|1|||
146369325|NCT02193828|527853252|FG003|Overall Study|Withdrawal by Subject|1|||
146369326|NCT03219567|527853253|FG000|Overall Study|Withdrawal by Subject|0|||
146369327|NCT03219567|527853254|FG001|Overall Study|Withdrawal by Subject|1|||
146369328|NCT00889681|527853255|FG000|Overall Study|Not meeting qualification Criteria|2|||
146369329|NCT00889681|527853255|FG000|Overall Study|Insurance disapproval|1|||
146369330|NCT02849626|527853256|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
146369331|NCT02849626|527853257|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
146369332|NCT02849626|527853258|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
146369333|NCT02849626|527853259|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
146369334|NCT02849626|527853256|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
146369335|NCT02849626|527853257|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
146369336|NCT02849626|527853258|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
146369337|NCT02849626|527853259|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
146369338|NCT02849626|527853256|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
146369339|NCT02849626|527853257|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
146369340|NCT02849626|527853258|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
146369341|NCT02849626|527853259|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
146369342|NCT02849626|527853256|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
146369343|NCT02849626|527853257|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
146369344|NCT02849626|527853258|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
146369345|NCT02849626|527853259|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
146369346|NCT02849626|527853256|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
146369347|NCT02849626|527853257|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
146369348|NCT02849626|527853258|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
146369349|NCT02849626|527853259|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
146369350|NCT02849626|527853256|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
146369351|NCT02849626|527853257|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146369352|NCT02849626|527853258|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146369353|NCT02849626|527853259|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
146369354|NCT02849626|527853256|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
146369355|NCT02849626|527853257|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
146369356|NCT02849626|527853258|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
146369357|NCT02849626|527853259|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
146369358|NCT02849626|527853256|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
146369359|NCT02849626|527853257|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146369360|NCT02849626|527853258|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146369361|NCT02849626|527853259|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
146369362|NCT02849626|527853256|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146369363|NCT02849626|527853257|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146369364|NCT02849626|527853258|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
146369365|NCT02849626|527853259|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
146369366|NCT02849626|527853256|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146369367|NCT02849626|527853257|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146369368|NCT02849626|527853258|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
146369369|NCT02849626|527853259|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
146369370|NCT02849626|527853256|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
146369371|NCT02849626|527853257|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
146369372|NCT02849626|527853258|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
146369373|NCT02849626|527853259|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
146369374|NCT01185704|527853260|FG000|Overall Study|Randomized but not treated|3|||
146369375|NCT01185704|527853261|FG001|Overall Study|Randomized but not treated|3|||
146369376|NCT01185704|527853260|FG000|Overall Study|Lack of ovarian response|5|||
146369377|NCT01185704|527853261|FG001|Overall Study|Lack of ovarian response|1|||
146369378|NCT01185704|527853260|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
146369379|NCT01185704|527853261|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
146369380|NCT01185704|527853260|FG000|Overall Study|Ectopic pregnancy|0|||
146369381|NCT01185704|527853261|FG001|Overall Study|Ectopic pregnancy|1|||
146369382|NCT01313208|527853262|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
146369383|NCT01313208|527853263|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
146369384|NCT01313208|527853262|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
146369385|NCT01313208|527853263|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
146369386|NCT01313208|527853262|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
146369387|NCT01313208|527853263|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
146369388|NCT01313208|527853262|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
146369389|NCT01313208|527853263|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
146369390|NCT01313208|527853262|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
146369391|NCT01313208|527853263|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
146369392|NCT01313208|527853262|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
146369393|NCT01313208|527853263|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
146369394|NCT01313208|527853262|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
146369395|NCT01313208|527853263|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
146369396|NCT01313208|527853262|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
146369397|NCT01313208|527853263|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
146369398|NCT01313208|527853262|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
146369399|NCT01313208|527853263|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
146369400|NCT01957787|527853266|FG000|Overall Study|Death|18|||
146369401|NCT01957787|527853266|FG000|Overall Study|Lost to Follow-up|3|||
146369402|NCT01957787|527853266|FG000|Overall Study|Withdrawal by Subject|3|||
146369403|NCT01957787|527853266|FG000|Overall Study|Entered Hospice or Similar Program|2|||
146369404|NCT01957787|527853266|FG000|Overall Study|Index Tumor(s) Resected|2|||
146369405|NCT01957787|527853266|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
146369406|NCT01957787|527853266|FG000|Overall Study|Local therapy, not cryoablation|6|||
146369407|NCT04176445|527853267|FG000|Overall Study|Adverse Event|0|||
146369408|NCT04176445|527853268|FG001|Overall Study|Adverse Event|1|||
146369409|NCT04176445|527853267|FG000|Overall Study|change plans weaning after first intervention|0|||
146369410|NCT04176445|527853268|FG001|Overall Study|change plans weaning after first intervention|1|||
146369411|NCT00187889|527853269|FG000|Overall Study|Withdrawal by Subject|6|||
146369412|NCT00187889|527853270|FG001|Overall Study|Withdrawal by Subject|4|||
146369413|NCT04046341|527853272|FG000|Overall Study|Lost to Follow-up|2|||
146369414|NCT04046341|527853272|FG000|Overall Study|Withdrawal by Subject|1|||
146369415|NCT04377672|527853273|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
146369416|NCT00405652|527853277|FG000|Overall Study|Adverse Event|4|||
146369417|NCT05109702|527853278|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
146369418|NCT05109702|527853279|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
146369419|NCT05109702|527853280|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
146369420|NCT05109702|527853278|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
146369421|NCT05109702|527853279|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
146369422|NCT05109702|527853280|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
146369423|NCT05109702|527853278|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
146369424|NCT05109702|527853279|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
146369425|NCT05109702|527853280|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
146369426|NCT05109702|527853278|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
146369427|NCT05109702|527853279|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
146369428|NCT05109702|527853280|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
146369429|NCT05109702|527853278|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
146369430|NCT05109702|527853279|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
146369431|NCT05109702|527853280|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
146369432|NCT01392378|527853283|FG000|Infant Series|Adverse Event|0|||
146369433|NCT01392378|527853284|FG001|Infant Series|Adverse Event|0|||
146369434|NCT01392378|527853285|FG002|Infant Series|Adverse Event|0|||
146369435|NCT01392378|527853286|FG003|Infant Series|Adverse Event|1|||
146369436|NCT01392378|527853287|FG004|Infant Series|Adverse Event|0|||
146369437|NCT01392378|527853283|FG000|Infant Series|Lost to Follow-up|0|||
146369438|NCT01392378|527853284|FG001|Infant Series|Lost to Follow-up|0|||
146369439|NCT01392378|527853285|FG002|Infant Series|Lost to Follow-up|0|||
146369440|NCT01392378|527853286|FG003|Infant Series|Lost to Follow-up|1|||
146369441|NCT01392378|527853287|FG004|Infant Series|Lost to Follow-up|0|||
146369442|NCT01392378|527853283|FG000|Infant Series|Protocol Violation|0|||
146369443|NCT01392378|527853284|FG001|Infant Series|Protocol Violation|1|||
146369444|NCT01392378|527853285|FG002|Infant Series|Protocol Violation|0|||
146369445|NCT01392378|527853286|FG003|Infant Series|Protocol Violation|0|||
146369446|NCT01392378|527853287|FG004|Infant Series|Protocol Violation|0|||
146369447|NCT01392378|527853283|FG000|Infant Series|Withdrawal by Parent|4|||
146369448|NCT01392378|527853284|FG001|Infant Series|Withdrawal by Parent|1|||
146369449|NCT01392378|527853285|FG002|Infant Series|Withdrawal by Parent|0|||
146369450|NCT01392378|527853286|FG003|Infant Series|Withdrawal by Parent|0|||
146369451|NCT01392378|527853287|FG004|Infant Series|Withdrawal by Parent|0|||
146369452|NCT01392378|527853283|FG000|After Infant Series|Lost to Follow-up|0|||
146369453|NCT01392378|527853284|FG001|After Infant Series|Lost to Follow-up|0|||
146369454|NCT01392378|527853285|FG002|After Infant Series|Lost to Follow-up|1|||
146369455|NCT01392378|527853286|FG003|After Infant Series|Lost to Follow-up|0|||
146369456|NCT01392378|527853287|FG004|After Infant Series|Lost to Follow-up|0|||
146369457|NCT01392378|527853283|FG000|After Infant Series|Withdrawal by Parent|0|||
146369458|NCT01392378|527853284|FG001|After Infant Series|Withdrawal by Parent|1|||
146369459|NCT01392378|527853285|FG002|After Infant Series|Withdrawal by Parent|1|||
146369460|NCT01392378|527853286|FG003|After Infant Series|Withdrawal by Parent|0|||
146369461|NCT01392378|527853287|FG004|After Infant Series|Withdrawal by Parent|1|||
146369462|NCT01392378|527853283|FG000|Toddler Dose|Lost to Follow-up|0|||
146369463|NCT01392378|527853284|FG001|Toddler Dose|Lost to Follow-up|0|||
146369464|NCT01392378|527853285|FG002|Toddler Dose|Lost to Follow-up|0|||
146369465|NCT01392378|527853286|FG003|Toddler Dose|Lost to Follow-up|1|||
146369466|NCT01392378|527853287|FG004|Toddler Dose|Lost to Follow-up|0|||
146369467|NCT01392378|527853283|FG000|Toddler Dose|Withdrawal by Parent|0|||
146369468|NCT01392378|527853284|FG001|Toddler Dose|Withdrawal by Parent|1|||
146369469|NCT01392378|527853285|FG002|Toddler Dose|Withdrawal by Parent|0|||
146369470|NCT01392378|527853286|FG003|Toddler Dose|Withdrawal by Parent|1|||
146369471|NCT01392378|527853287|FG004|Toddler Dose|Withdrawal by Parent|1|||
146369472|NCT00788697|527853288|FG000|Overall Study|No study drug administered|12|||
146369473|NCT00788697|527853288|FG000|Overall Study|Training Patients|74|||
146369474|NCT00788697|527853288|FG000|Overall Study|no truth standard procedure available|5|||
146369475|NCT00788697|527853288|FG000|Overall Study|Technically inadequate truth standard|1|||
146369476|NCT00788697|527853288|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
146369477|NCT01998880|527853292|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
146369478|NCT01998880|527853293|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
146369479|NCT01998880|527853292|FG000|Overall Study|Disease Progression|1|||
145943458|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943459|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943460|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943461|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943462|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943463|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145943464|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145943465|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145943466|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943467|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943468|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943469|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943470|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943471|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943472|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943473|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943474|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943475|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943476|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943477|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943478|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145943479|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
145943480|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145943481|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145943482|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145943483|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146369480|NCT01998880|527853293|FG001|Overall Study|Disease Progression|8|||
145943484|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146369481|NCT01998880|527853292|FG000|Overall Study|Withdrew Consent|2|||
146369482|NCT01998880|527853293|FG001|Overall Study|Withdrew Consent|1|||
146369483|NCT01998880|527853292|FG000|Overall Study|Death|3|||
146369484|NCT01998880|527853293|FG001|Overall Study|Death|6|||
146369485|NCT01998880|527853292|FG000|Overall Study|Insufficient Therapeutic Response|1|||
146369486|NCT01998880|527853293|FG001|Overall Study|Insufficient Therapeutic Response|5|||
146369487|NCT01998880|527853292|FG000|Overall Study|Administrative/Other|1|||
146369488|NCT01998880|527853293|FG001|Overall Study|Administrative/Other|1|||
146369489|NCT01998880|527853292|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
146369490|NCT01998880|527853293|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
146369491|NCT01998880|527853292|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
146369492|NCT01998880|527853293|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
146369493|NCT01998880|527853292|FG000|Overall Study|Did Not Receive Treatment|3|||
146369494|NCT01998880|527853293|FG001|Overall Study|Did Not Receive Treatment|2|||
146369495|NCT00004732|527853294|FG000|Overall Study|Withdrawal by Subject|36|||
146369496|NCT00004732|527853295|FG001|Overall Study|Withdrawal by Subject|64|||
146369497|NCT00004732|527853294|FG000|Overall Study|Lost to Follow-up|33|||
146369498|NCT00004732|527853295|FG001|Overall Study|Lost to Follow-up|47|||
146369499|NCT01688635|527853296|FG000|Washout 1|Withdrawal by Subject|1|||
146369500|NCT01688635|527853297|FG001|Washout 1|Withdrawal by Subject|0|||
146369501|NCT01688635|527853296|FG000|Washout 1|Adverse Event|0|||
146369502|NCT01688635|527853297|FG001|Washout 1|Adverse Event|1|||
146369503|NCT01688635|527853296|FG000|Washout 1|Physician Decision|0|||
146369504|NCT01688635|527853297|FG001|Washout 1|Physician Decision|1|||
146369505|NCT01688635|527853296|FG000|Washout 2|Physician Decision|1|||
146369506|NCT01688635|527853297|FG001|Washout 2|Physician Decision|0|||
146369507|NCT01688635|527853296|FG000|Washout 2|Withdrawal by Subject|1|||
146369508|NCT01688635|527853297|FG001|Washout 2|Withdrawal by Subject|0|||
146369509|NCT01688635|527853296|FG000|Washout 2|Sponsor Decision|1|||
146369510|NCT01688635|527853297|FG001|Washout 2|Sponsor Decision|2|||
146369511|NCT01688635|527853296|FG000|Washout 3|Withdrawal by Subject|1|||
146369512|NCT01688635|527853297|FG001|Washout 3|Withdrawal by Subject|0|||
146369513|NCT00014911|527853298|FG000|Overall Study|Adverse Event|1|||
146369514|NCT00014911|527853298|FG000|Overall Study|Lost to Follow-up|1|||
146369515|NCT00014911|527853298|FG000|Overall Study|Withdrawal by Subject|6|||
146369516|NCT00014911|527853298|FG000|Overall Study|Unknown Reasons|2|||
146369517|NCT00014911|527853298|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
146369518|NCT01924299|527853299|FG000|Period 2|Withdrawal by Subject|1|||
146369519|NCT01924299|527853300|FG001|Period 2|Withdrawal by Subject|0|||
146369520|NCT01924299|527853299|FG000|Period 2|Adverse Event|0|||
146369521|NCT01924299|527853300|FG001|Period 2|Adverse Event|1|||
146369522|NCT00888615|527853302|FG000|Overall Study|No treatment|2|||
146369523|NCT00141037|527853303|FG000|Overall Study|Physician Decision|1|||
146369524|NCT00141037|527853304|FG001|Overall Study|Physician Decision|2|||
146369525|NCT00141037|527853303|FG000|Overall Study|Lost to Follow-up|3|||
146369526|NCT00141037|527853304|FG001|Overall Study|Lost to Follow-up|1|||
146369527|NCT00141037|527853303|FG000|Overall Study|Protocol Violation|0|||
146369528|NCT00141037|527853304|FG001|Overall Study|Protocol Violation|2|||
146369529|NCT00141037|527853303|FG000|Overall Study|Withdrawal by Subject|2|||
146369530|NCT00141037|527853304|FG001|Overall Study|Withdrawal by Subject|1|||
146369531|NCT00141037|527853303|FG000|Overall Study|Other|0|||
146369532|NCT00141037|527853304|FG001|Overall Study|Other|1|||
146369533|NCT00141037|527853303|FG000|Overall Study|Moved from area|1|||
146369534|NCT00141037|527853304|FG001|Overall Study|Moved from area|7|||
146369535|NCT00141037|527853303|FG000|Overall Study|Graft Failure|3|||
146369536|NCT00141037|527853304|FG001|Overall Study|Graft Failure|4|||
146369537|NCT00637377|527853305|FG000|Overall Study|Adverse Event|2|||
146369538|NCT00637377|527853306|FG001|Overall Study|Adverse Event|6|||
146369539|NCT00637377|527853307|FG002|Overall Study|Adverse Event|8|||
146369540|NCT00637377|527853308|FG003|Overall Study|Adverse Event|9|||
146369541|NCT00637377|527853305|FG000|Overall Study|Death|1|||
146369542|NCT00637377|527853306|FG001|Overall Study|Death|3|||
146369543|NCT00637377|527853307|FG002|Overall Study|Death|2|||
146369544|NCT00637377|527853308|FG003|Overall Study|Death|1|||
146369545|NCT00637377|527853305|FG000|Overall Study|Lack of Efficacy|0|||
146369546|NCT00637377|527853306|FG001|Overall Study|Lack of Efficacy|0|||
146369547|NCT00637377|527853307|FG002|Overall Study|Lack of Efficacy|1|||
146369548|NCT00637377|527853308|FG003|Overall Study|Lack of Efficacy|1|||
146369549|NCT00637377|527853305|FG000|Overall Study|Lost to Follow-up|4|||
146369550|NCT00637377|527853306|FG001|Overall Study|Lost to Follow-up|1|||
146369551|NCT00637377|527853307|FG002|Overall Study|Lost to Follow-up|2|||
146369552|NCT00637377|527853308|FG003|Overall Study|Lost to Follow-up|2|||
146369553|NCT00637377|527853305|FG000|Overall Study|Protocol Violation|2|||
146369554|NCT00637377|527853306|FG001|Overall Study|Protocol Violation|1|||
146369555|NCT00637377|527853307|FG002|Overall Study|Protocol Violation|1|||
146369556|NCT00637377|527853308|FG003|Overall Study|Protocol Violation|0|||
146369557|NCT00637377|527853305|FG000|Overall Study|Withdrawal by Subject|11|||
146369558|NCT00637377|527853306|FG001|Overall Study|Withdrawal by Subject|15|||
146369559|NCT00637377|527853307|FG002|Overall Study|Withdrawal by Subject|13|||
146369560|NCT00637377|527853308|FG003|Overall Study|Withdrawal by Subject|11|||
146369561|NCT00637377|527853305|FG000|Overall Study|Other (no further information available)|7|||
146369562|NCT00637377|527853306|FG001|Overall Study|Other (no further information available)|6|||
146369563|NCT00637377|527853307|FG002|Overall Study|Other (no further information available)|10|||
146369564|NCT00637377|527853308|FG003|Overall Study|Other (no further information available)|5|||
146369565|NCT04186663|527853311|FG000|Overall Study|Lost to Follow-up|1|||
146369566|NCT04186663|527853311|FG000|Overall Study|Unable to complete blood draw|3|||
146369567|NCT04021706|527855121|FG000|Overall Study|Adverse Event|2|||
146369568|NCT04021706|527855122|FG001|Overall Study|Adverse Event|0|||
146369569|NCT04021706|527855121|FG000|Overall Study|Withdrawal by Subject|1|||
146369570|NCT04021706|527855122|FG001|Overall Study|Withdrawal by Subject|2|||
146369571|NCT04021706|527855121|FG000|Overall Study|Physician Decision|1|||
146369572|NCT04021706|527855122|FG001|Overall Study|Physician Decision|0|||
146369573|NCT01375647|527855123|FG000|Overall Study|Lost to Follow-up|3|||
146369574|NCT01375647|527855124|FG001|Overall Study|Lost to Follow-up|3|||
146369575|NCT01375647|527855125|FG002|Overall Study|Lost to Follow-up|7|||
146369576|NCT01375647|527855126|FG003|Overall Study|Lost to Follow-up|10|||
146369577|NCT01375647|527855123|FG000|Overall Study|Death|1|||
146369578|NCT01375647|527855124|FG001|Overall Study|Death|2|||
146369579|NCT01375647|527855125|FG002|Overall Study|Death|1|||
146369580|NCT01375647|527855126|FG003|Overall Study|Death|0|||
146369581|NCT01375647|527855123|FG000|Overall Study|Withdrawal by Subject|17|||
146369582|NCT01375647|527855124|FG001|Overall Study|Withdrawal by Subject|20|||
146369583|NCT01375647|527855125|FG002|Overall Study|Withdrawal by Subject|26|||
146369584|NCT01375647|527855126|FG003|Overall Study|Withdrawal by Subject|14|||
146369585|NCT01375647|527855123|FG000|Overall Study|Physician Decision|1|||
146369586|NCT01375647|527855124|FG001|Overall Study|Physician Decision|0|||
146369587|NCT01375647|527855125|FG002|Overall Study|Physician Decision|0|||
146369588|NCT01375647|527855126|FG003|Overall Study|Physician Decision|0|||
146369589|NCT02332798|527855129|FG000|Overall Study|Unwilling to Participate in Study|0|||
146369590|NCT02332798|527855130|FG001|Overall Study|Unwilling to Participate in Study|1|||
146369591|NCT02332798|527855131|FG002|Overall Study|Unwilling to Participate in Study|1|||
146369592|NCT02332798|527855129|FG000|Overall Study|Positive Urine Drug Test|0|||
146369593|NCT02332798|527855130|FG001|Overall Study|Positive Urine Drug Test|1|||
146369594|NCT02332798|527855131|FG002|Overall Study|Positive Urine Drug Test|0|||
146369595|NCT02332798|527855129|FG000|Overall Study|Abnormal Laboratory Findings|1|||
146369596|NCT02332798|527855130|FG001|Overall Study|Abnormal Laboratory Findings|0|||
146369597|NCT02332798|527855131|FG002|Overall Study|Abnormal Laboratory Findings|0|||
146369598|NCT00595868|527855132|FG000|Overall Study|Lost to Follow-up|45|||
146369599|NCT00595868|527855133|FG001|Overall Study|Lost to Follow-up|50|||
146369600|NCT01102140|527855134|FG000|Overall Study|Lost to Follow-up|1|||
146369601|NCT01102140|527855135|FG001|Overall Study|Lost to Follow-up|0|||
146369602|NCT01102140|527855134|FG000|Overall Study|Investigator terminated study|2|||
146369603|NCT01102140|527855135|FG001|Overall Study|Investigator terminated study|2|||
146369604|NCT03788967|527855138|FG000|Overall Study|Lost to Follow-up|14|||
146369605|NCT03788967|527855139|FG001|Overall Study|Lost to Follow-up|10|||
146369606|NCT03788967|527855138|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
146369607|NCT03788967|527855139|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
146369608|NCT03788967|527855138|FG000|Overall Study|Participant Withdrawal of Consent|13|||
146369609|NCT03788967|527855139|FG001|Overall Study|Participant Withdrawal of Consent|5|||
146369610|NCT03788967|527855138|FG000|Overall Study|Adverse Event|1|||
146369611|NCT03788967|527855139|FG001|Overall Study|Adverse Event|1|||
146369612|NCT03788967|527855138|FG000|Overall Study|COVID-19|1|||
146369613|NCT03788967|527855139|FG001|Overall Study|COVID-19|2|||
146369614|NCT00462488|527855141|FG000|Overall Study|Protocol Violation|1|||
146369615|NCT00462488|527855142|FG001|Overall Study|Protocol Violation|0|||
146369616|NCT00462488|527855141|FG000|Overall Study|Lack of Efficacy|19|||
146369617|NCT00462488|527855142|FG001|Overall Study|Lack of Efficacy|17|||
146369618|NCT01742091|527855149|FG000|Overall Study|Adverse Event|0|||
146369619|NCT01742091|527855150|FG001|Overall Study|Adverse Event|0|||
146369620|NCT01742091|527855151|FG002|Overall Study|Adverse Event|0|||
146369621|NCT01742091|527855152|FG003|Overall Study|Adverse Event|0|||
146369622|NCT01742091|527855153|FG004|Overall Study|Adverse Event|1|||
146369623|NCT01742091|527855154|FG005|Overall Study|Adverse Event|0|||
146369624|NCT01742091|527855149|FG000|Overall Study|Physician Decision|0|||
146369625|NCT01742091|527855150|FG001|Overall Study|Physician Decision|0|||
146369626|NCT01742091|527855151|FG002|Overall Study|Physician Decision|0|||
146369627|NCT01742091|527855152|FG003|Overall Study|Physician Decision|0|||
146369628|NCT01742091|527855153|FG004|Overall Study|Physician Decision|0|||
146369629|NCT01742091|527855154|FG005|Overall Study|Physician Decision|1|||
146369630|NCT01742091|527855149|FG000|Overall Study|Withdrawal by Subject|0|||
146369631|NCT01742091|527855150|FG001|Overall Study|Withdrawal by Subject|0|||
146369632|NCT01742091|527855151|FG002|Overall Study|Withdrawal by Subject|0|||
146369633|NCT01742091|527855152|FG003|Overall Study|Withdrawal by Subject|1|||
146369634|NCT01742091|527855153|FG004|Overall Study|Withdrawal by Subject|0|||
146369635|NCT01742091|527855154|FG005|Overall Study|Withdrawal by Subject|0|||
146369636|NCT01742091|527855149|FG000|Overall Study|Lost to Follow-up|0|||
146369637|NCT01742091|527855150|FG001|Overall Study|Lost to Follow-up|0|||
146369638|NCT01742091|527855151|FG002|Overall Study|Lost to Follow-up|0|||
146369639|NCT01742091|527855152|FG003|Overall Study|Lost to Follow-up|0|||
146369640|NCT01742091|527855153|FG004|Overall Study|Lost to Follow-up|0|||
146369641|NCT01742091|527855154|FG005|Overall Study|Lost to Follow-up|1|||
146369642|NCT02848313|527855155|FG000|Overall Study|Adverse Event|1|||
146369643|NCT02848313|527855156|FG001|Overall Study|Adverse Event|2|||
146369644|NCT02848313|527855155|FG000|Overall Study|Lack of Efficacy|0|||
146369645|NCT02848313|527855156|FG001|Overall Study|Lack of Efficacy|1|||
146369646|NCT02848313|527855155|FG000|Overall Study|Withdrawal by Subject|1|||
146369647|NCT02848313|527855156|FG001|Overall Study|Withdrawal by Subject|1|||
146369648|NCT02848313|527855155|FG000|Overall Study|Lost to follow up|1|||
146369649|NCT02848313|527855156|FG001|Overall Study|Lost to follow up|0|||
146369650|NCT00212758|527855159|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
146369651|NCT00212758|527855160|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
146369652|NCT00212758|527855159|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
146369653|NCT00212758|527855160|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
146369654|NCT02574481|527855161|FG000|Overall Study|Withdrawal by Subject|29|||
146369655|NCT02574481|527855162|FG001|Overall Study|Withdrawal by Subject|15|||
146369656|NCT02574481|527855163|FG002|Overall Study|Withdrawal by Subject|4|||
146369657|NCT02574481|527855164|FG003|Overall Study|Withdrawal by Subject|1|||
146369658|NCT02574481|527855161|FG000|Overall Study|Adverse Event|5|||
146369659|NCT02574481|527855162|FG001|Overall Study|Adverse Event|1|||
146369660|NCT02574481|527855163|FG002|Overall Study|Adverse Event|1|||
146369661|NCT02574481|527855164|FG003|Overall Study|Adverse Event|0|||
146369662|NCT02574481|527855161|FG000|Overall Study|Visit Missed|15|||
146369663|NCT02574481|527855162|FG001|Overall Study|Visit Missed|7|||
146369664|NCT02574481|527855163|FG002|Overall Study|Visit Missed|5|||
146369665|NCT02574481|527855164|FG003|Overall Study|Visit Missed|0|||
146369666|NCT02574481|527855161|FG000|Overall Study|Other|7|||
146369667|NCT02574481|527855162|FG001|Overall Study|Other|2|||
146369668|NCT02574481|527855163|FG002|Overall Study|Other|0|||
146369669|NCT02574481|527855164|FG003|Overall Study|Other|0|||
146369670|NCT02574481|527855161|FG000|Overall Study|Death|48|||
146369671|NCT02574481|527855162|FG001|Overall Study|Death|26|||
146369672|NCT02574481|527855163|FG002|Overall Study|Death|12|||
146369673|NCT02574481|527855164|FG003|Overall Study|Death|4|||
146369674|NCT02574481|527855161|FG000|Overall Study|Physician Decision|5|||
146369675|NCT02574481|527855162|FG001|Overall Study|Physician Decision|2|||
146369676|NCT02574481|527855163|FG002|Overall Study|Physician Decision|0|||
146369677|NCT02574481|527855164|FG003|Overall Study|Physician Decision|0|||
146369678|NCT02574481|527855161|FG000|Overall Study|Lost to Follow-up|5|||
146369679|NCT02574481|527855162|FG001|Overall Study|Lost to Follow-up|1|||
146369680|NCT02574481|527855163|FG002|Overall Study|Lost to Follow-up|3|||
146369681|NCT02574481|527855164|FG003|Overall Study|Lost to Follow-up|0|||
146369682|NCT03510910|527855165|FG000|Overall Study|Incomplete Survey|2|||
146369683|NCT03510910|527855166|FG001|Overall Study|Incomplete Survey|3|||
146369684|NCT01105936|527855170|FG000|Period 1|Adverse Event|0|||
146369685|NCT01105936|527855171|FG001|Period 1|Adverse Event|0|||
146369686|NCT01105936|527855172|FG002|Period 1|Adverse Event|0|||
146369687|NCT01105936|527855173|FG003|Period 1|Adverse Event|1|||
146369688|NCT01105936|527855170|FG000|Period 2|Adverse Event|1|||
146369689|NCT01105936|527855171|FG001|Period 2|Adverse Event|0|||
146369690|NCT01105936|527855172|FG002|Period 2|Adverse Event|0|||
146369691|NCT01105936|527855173|FG003|Period 2|Adverse Event|0|||
146369692|NCT01105936|527855170|FG000|Period 3|Protocol Violation|0|||
146369693|NCT01105936|527855171|FG001|Period 3|Protocol Violation|2|||
146369694|NCT01105936|527855172|FG002|Period 3|Protocol Violation|0|||
146369695|NCT01105936|527855173|FG003|Period 3|Protocol Violation|0|||
146369696|NCT01673490|527855174|FG000|Overall Study|Lost to Follow-up|1|||
146369697|NCT01673490|527855174|FG000|Overall Study|Adverse Event|3|||
146369698|NCT01673490|527855174|FG000|Overall Study|Withdrawal by Subject|3|||
146369699|NCT03382262|527855177|FG000|Overall Study|Physician Decision|0|||
146369700|NCT03382262|527855178|FG001|Overall Study|Physician Decision|0|||
146369701|NCT03382262|527855179|FG002|Overall Study|Physician Decision|1|||
146369702|NCT03382262|527855180|FG003|Overall Study|Physician Decision|0|||
146369703|NCT03382262|527855177|FG000|Overall Study|Withdrawal by Subject|0|||
146369704|NCT03382262|527855178|FG001|Overall Study|Withdrawal by Subject|0|||
146369705|NCT03382262|527855179|FG002|Overall Study|Withdrawal by Subject|0|||
146369706|NCT03382262|527855180|FG003|Overall Study|Withdrawal by Subject|1|||
146369707|NCT02940860|527855181|FG000|Overall Study|Non-serious AE|1|||
146369708|NCT02940860|527855182|FG001|Overall Study|Non-serious AE|2|||
146369709|NCT02940860|527855181|FG000|Overall Study|Serious AE|7|||
146369710|NCT02940860|527855182|FG001|Overall Study|Serious AE|3|||
146369711|NCT02940860|527855181|FG000|Overall Study|Withdrawal by Subject|19|||
146369712|NCT02940860|527855182|FG001|Overall Study|Withdrawal by Subject|9|||
146369713|NCT02940860|527855181|FG000|Overall Study|Lost to Follow-up|13|||
146369714|NCT02940860|527855182|FG001|Overall Study|Lost to Follow-up|7|||
146369715|NCT02940860|527855181|FG000|Overall Study|Physician Decision|5|||
146369716|NCT02940860|527855182|FG001|Overall Study|Physician Decision|3|||
146369717|NCT02940860|527855181|FG000|Overall Study|Sponsor Decision|0|||
146369718|NCT02940860|527855182|FG001|Overall Study|Sponsor Decision|1|||
146369719|NCT02940860|527855181|FG000|Overall Study|Protocol Violation|0|||
146369720|NCT02940860|527855182|FG001|Overall Study|Protocol Violation|2|||
146369721|NCT02940860|527855181|FG000|Overall Study|Death|3|||
146369722|NCT02940860|527855182|FG001|Overall Study|Death|2|||
146369723|NCT02940860|527855181|FG000|Overall Study|Moved, poor venous access, transport|6|||
146369724|NCT02940860|527855182|FG001|Overall Study|Moved, poor venous access, transport|4|||
146369725|NCT02940860|527855181|FG000|Overall Study|Not treated|2|||
146369726|NCT02940860|527855182|FG001|Overall Study|Not treated|2|||
146369727|NCT04914819|527855184|FG000|Overall Study|Pregnancy|3|||
146369728|NCT04914819|527855185|FG001|Overall Study|Pregnancy|1|||
146369729|NCT04914819|527855184|FG000|Overall Study|Discontinued study|4|||
146369730|NCT04914819|527855185|FG001|Overall Study|Discontinued study|1|||
146369731|NCT04914819|527855184|FG000|Overall Study|Lost to Follow-up|7|||
146369732|NCT04914819|527855185|FG001|Overall Study|Lost to Follow-up|0|||
146369733|NCT02715804|527855186|FG000|Overall Study|Death|222|||
146369734|NCT02715804|527855187|FG001|Overall Study|Death|106|||
146369735|NCT02715804|527855186|FG000|Overall Study|Withdrawal by Subject|5|||
146369736|NCT02715804|527855187|FG001|Overall Study|Withdrawal by Subject|4|||
146369737|NCT02715804|527855186|FG000|Overall Study|Other than specified|2|||
146369738|NCT02715804|527855187|FG001|Overall Study|Other than specified|3|||
146369739|NCT01625611|527855190|FG000|Overall Study|No adlib drinks Lab 1|3|||
146369740|NCT01625611|527855191|FG001|Overall Study|No adlib drinks Lab 1|0|||
146369741|NCT01625611|527855190|FG000|Overall Study|Technical issues with PET|1|||
146369742|NCT01625611|527855191|FG001|Overall Study|Technical issues with PET|0|||
146369743|NCT01625611|527855190|FG000|Overall Study|Unable to complete study procedures|1|||
146369744|NCT01625611|527855191|FG001|Overall Study|Unable to complete study procedures|0|||
146369745|NCT01625611|527855190|FG000|Overall Study|Withdrawal by Subject|3|||
146369746|NCT01625611|527855191|FG001|Overall Study|Withdrawal by Subject|0|||
146369747|NCT00948194|527855192|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
146369748|NCT00948194|527855193|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
146369749|NCT00233324|527855194|FG000|Main Study|Death|68|||
146369750|NCT00233324|527855195|FG001|Main Study|Death|60|||
146369751|NCT00233324|527855196|FG002|Main Study|Death|62|||
146369752|NCT00233324|527855197|FG003|Main Study|Death|47|||
146369753|NCT00233324|527855194|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
146369754|NCT00233324|527855195|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
146369755|NCT00233324|527855196|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
146369756|NCT00233324|527855197|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
146369757|NCT00233324|527855194|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
146369758|NCT00233324|527855195|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
146369759|NCT00233324|527855196|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
146369760|NCT00233324|527855197|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
146369761|NCT00608881|527855200|FG000|Overall Study|Death|22|||
146369762|NCT00608881|527855201|FG001|Overall Study|Death|13|||
146369763|NCT00608881|527855200|FG000|Overall Study|Adverse Event|5|||
146369764|NCT00608881|527855201|FG001|Overall Study|Adverse Event|3|||
146369765|NCT00608881|527855200|FG000|Overall Study|Lost to Follow-up|28|||
146369766|NCT00608881|527855201|FG001|Overall Study|Lost to Follow-up|14|||
146369767|NCT00608881|527855200|FG000|Overall Study|Withdrawal by Subject|18|||
146369768|NCT00608881|527855201|FG001|Overall Study|Withdrawal by Subject|29|||
146369769|NCT00608881|527855200|FG000|Overall Study|Physician Decision|5|||
146369770|NCT00608881|527855201|FG001|Overall Study|Physician Decision|5|||
146369771|NCT00608881|527855200|FG000|Overall Study|Institutionalized|1|||
146369772|NCT00608881|527855201|FG001|Overall Study|Institutionalized|2|||
146369773|NCT04702984|527855204|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
146369774|NCT00270998|527855205|FG000|3 Month Follow-up|Adverse Event|1|||
146369775|NCT00270998|527855206|FG001|3 Month Follow-up|Adverse Event|0|||
146369776|NCT00270998|527855207|FG002|3 Month Follow-up|Adverse Event|0|||
146369777|NCT00270998|527855205|FG000|3 Month Follow-up|Lack of Efficacy|1|||
146369778|NCT00270998|527855206|FG001|3 Month Follow-up|Lack of Efficacy|2|||
146369779|NCT00270998|527855207|FG002|3 Month Follow-up|Lack of Efficacy|1|||
146369780|NCT00270998|527855205|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
146369781|NCT00270998|527855206|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
146369782|NCT00270998|527855207|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
146369783|NCT00270998|527855205|FG000|3 Month Follow-up|Pessary did not fit|12|||
146369784|NCT00270998|527855206|FG001|3 Month Follow-up|Pessary did not fit|0|||
146369785|NCT00270998|527855207|FG002|3 Month Follow-up|Pessary did not fit|0|||
146369786|NCT00270998|527855205|FG000|3 Month Follow-up|Personal/family health|1|||
146369787|NCT00270998|527855206|FG001|3 Month Follow-up|Personal/family health|1|||
146369788|NCT00270998|527855207|FG002|3 Month Follow-up|Personal/family health|0|||
146369789|NCT00270998|527855205|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
146369790|NCT00270998|527855206|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
146369791|NCT00270998|527855207|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
146369792|NCT00270998|527855205|FG000|12 Month Follow-up|Lack of Efficacy|5|||
146369793|NCT00270998|527855206|FG001|12 Month Follow-up|Lack of Efficacy|4|||
146369794|NCT00270998|527855207|FG002|12 Month Follow-up|Lack of Efficacy|3|||
146369795|NCT00270998|527855205|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
146369796|NCT00270998|527855206|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
146369797|NCT00270998|527855207|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
146369798|NCT00270998|527855205|FG000|12 Month Follow-up|Pessary did not fit|1|||
146369799|NCT00270998|527855206|FG001|12 Month Follow-up|Pessary did not fit|0|||
146369800|NCT00270998|527855207|FG002|12 Month Follow-up|Pessary did not fit|0|||
146369801|NCT00270998|527855205|FG000|12 Month Follow-up|Personal/family health|0|||
146369802|NCT00270998|527855206|FG001|12 Month Follow-up|Personal/family health|5|||
146369803|NCT00270998|527855207|FG002|12 Month Follow-up|Personal/family health|1|||
146369804|NCT00270998|527855205|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
146369805|NCT00270998|527855206|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
146369806|NCT00270998|527855207|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
146369807|NCT03395223|527855208|FG000|Overall Study|Lost to Follow-up|3|||
146369808|NCT03395223|527855208|FG000|Overall Study|Other|1|||
146369809|NCT01248364|527855212|FG000|Overall Study|Adverse Event|0|||
146369810|NCT01248364|527855213|FG001|Overall Study|Adverse Event|1|||
146369811|NCT01248364|527855214|FG002|Overall Study|Adverse Event|0|||
146369812|NCT01248364|527855215|FG003|Overall Study|Adverse Event|0|||
146369813|NCT03505749|527855217|FG000|Overall Study|Lost to Follow-up|7|||
146369814|NCT03505749|527855218|FG001|Overall Study|Lost to Follow-up|11|||
146369815|NCT03505749|527855217|FG000|Overall Study|Withdrawal by Subject|6|||
146369816|NCT03505749|527855218|FG001|Overall Study|Withdrawal by Subject|0|||
146369817|NCT03505749|527855217|FG000|Overall Study|Discharged from treatment|3|||
146369818|NCT03505749|527855218|FG001|Overall Study|Discharged from treatment|6|||
146369819|NCT01151540|527855219|FG000|Overall Study|Other|2|||
146369820|NCT01151540|527855219|FG000|Overall Study|Adverse event, non-fatal|4|||
146369821|NCT01151540|527855219|FG000|Overall Study|Withdrawal by Subject|7|||
146369822|NCT03846219|527855221|FG000|Overall Study|Withdrawal by Subject|3|||
146369823|NCT03846219|527855222|FG001|Overall Study|Withdrawal by Subject|2|||
146369824|NCT03846219|527855223|FG002|Overall Study|Withdrawal by Subject|2|||
146369825|NCT03846219|527855221|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
146369826|NCT03846219|527855222|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
146369827|NCT03846219|527855223|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
146369828|NCT03846219|527855221|FG000|Overall Study|Physician Decision|0|||
146369829|NCT03846219|527855222|FG001|Overall Study|Physician Decision|0|||
146369830|NCT03846219|527855223|FG002|Overall Study|Physician Decision|2|||
146369831|NCT02322411|527855226|FG000|Overall Study|Lost to Follow-up|4|||
146369832|NCT02322411|527855227|FG001|Overall Study|Lost to Follow-up|7|||
146369833|NCT02322411|527855226|FG000|Overall Study|Withdrawal by Subject|1|||
146369834|NCT02322411|527855227|FG001|Overall Study|Withdrawal by Subject|0|||
146369835|NCT02248857|527855229|FG000|3 Month|Withdrawal by Subject|9|||
146369836|NCT02248857|527855230|FG001|3 Month|Withdrawal by Subject|3|||
146369837|NCT02248857|527855231|FG002|3 Month|Withdrawal by Subject|4|||
146369838|NCT02248857|527855229|FG000|3 Month|Unable to reach for 3 month|35|||
146369839|NCT02248857|527855230|FG001|3 Month|Unable to reach for 3 month|29|||
146369840|NCT02248857|527855231|FG002|3 Month|Unable to reach for 3 month|26|||
146369841|NCT02248857|527855229|FG000|3 Month|Partially completed, unable to finish|2|||
146369842|NCT02248857|527855230|FG001|3 Month|Partially completed, unable to finish|2|||
146369843|NCT02248857|527855231|FG002|3 Month|Partially completed, unable to finish|1|||
146369844|NCT02248857|527855229|FG000|6 Month|Lost to Follow-up|27|||
146369845|NCT02248857|527855230|FG001|6 Month|Lost to Follow-up|26|||
146369846|NCT02248857|527855231|FG002|6 Month|Lost to Follow-up|15|||
146369847|NCT02248857|527855229|FG000|6 Month|Partially completed, unable to finish|0|||
146369848|NCT02248857|527855230|FG001|6 Month|Partially completed, unable to finish|1|||
146369849|NCT02248857|527855231|FG002|6 Month|Partially completed, unable to finish|0|||
146369850|NCT02248857|527855229|FG000|6 Month|Withdrawal by Subject|0|||
146369851|NCT02248857|527855230|FG001|6 Month|Withdrawal by Subject|2|||
146369852|NCT02248857|527855231|FG002|6 Month|Withdrawal by Subject|2|||
146369853|NCT02248857|527855229|FG000|6 Month|Death|1|||
146369854|NCT02248857|527855230|FG001|6 Month|Death|0|||
146369855|NCT02248857|527855231|FG002|6 Month|Death|0|||
146369856|NCT02261883|527855232|FG000|Overall Study|Death|3|||
146369857|NCT02261883|527855233|FG001|Overall Study|Death|2|||
146369858|NCT02261883|527855232|FG000|Overall Study|Physician Decision|1|||
146369859|NCT02261883|527855233|FG001|Overall Study|Physician Decision|0|||
146369860|NCT02261883|527855232|FG000|Overall Study|Protocol Violation|1|||
146369861|NCT02261883|527855233|FG001|Overall Study|Protocol Violation|0|||
146369862|NCT02261883|527855232|FG000|Overall Study|Withdrawal by Subject|0|||
146369863|NCT02261883|527855233|FG001|Overall Study|Withdrawal by Subject|1|||
146369864|NCT02261883|527855232|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
146369865|NCT02261883|527855233|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
146369866|NCT02671461|527855234|FG000|Treatment|Adverse Event|0|||
146369867|NCT02671461|527855235|FG001|Treatment|Adverse Event|0|||
146369868|NCT02671461|527855236|FG002|Treatment|Adverse Event|1|||
146369869|NCT02671461|527855234|FG000|Treatment|Administrative Reason by Sponsor|1|||
146369870|NCT02671461|527855235|FG001|Treatment|Administrative Reason by Sponsor|3|||
146369871|NCT02671461|527855236|FG002|Treatment|Administrative Reason by Sponsor|4|||
146369872|NCT02671461|527855234|FG000|Treatment|Randomized, not treated|1|||
146369873|NCT02671461|527855235|FG001|Treatment|Randomized, not treated|0|||
146369874|NCT02671461|527855236|FG002|Treatment|Randomized, not treated|0|||
146369875|NCT02671461|527855234|FG000|Follow-up|Withdrawal by Subject|1|||
146369876|NCT02671461|527855235|FG001|Follow-up|Withdrawal by Subject|0|||
146369877|NCT02671461|527855236|FG002|Follow-up|Withdrawal by Subject|0|||
146369878|NCT02671461|527855234|FG000|Follow-up|Lost to Follow-up|0|||
146369879|NCT02671461|527855235|FG001|Follow-up|Lost to Follow-up|0|||
146369880|NCT02671461|527855236|FG002|Follow-up|Lost to Follow-up|1|||
146369881|NCT02671461|527855234|FG000|Follow-up|Administrative Reason by Sponsor|0|||
146369882|NCT02671461|527855235|FG001|Follow-up|Administrative Reason by Sponsor|1|||
146369883|NCT02671461|527855236|FG002|Follow-up|Administrative Reason by Sponsor|0|||
146369884|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
146369885|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
146369886|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
146369887|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
146369888|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
146369889|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
146369890|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
146369891|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
146369892|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
146369893|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
146369894|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
146369895|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
146369896|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
146369897|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
146369898|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
146369899|NCT01412060|527855237|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
146369900|NCT01412060|527855238|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
146369901|NCT01412060|527855239|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
146369902|NCT01412060|527855237|FG000|Period Between RIP and SP|Adverse Event|4|||
146369903|NCT01412060|527855238|FG001|Period Between RIP and SP|Adverse Event|0|||
146369904|NCT01412060|527855239|FG002|Period Between RIP and SP|Adverse Event|0|||
146369905|NCT01412060|527855237|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
146369906|NCT01412060|527855238|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
146369907|NCT01412060|527855239|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
146369908|NCT01412060|527855237|FG000|Period Between RIP and SP|Protocol Violation|2|||
146369909|NCT01412060|527855238|FG001|Period Between RIP and SP|Protocol Violation|0|||
146369910|NCT01412060|527855239|FG002|Period Between RIP and SP|Protocol Violation|0|||
146369911|NCT01412060|527855237|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
146369912|NCT01412060|527855238|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
146369913|NCT01412060|527855239|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
146369914|NCT01412060|527855237|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
146369915|NCT01412060|527855238|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
146369916|NCT01412060|527855239|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
146369917|NCT01412060|527855237|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
146369918|NCT01412060|527855238|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
146369919|NCT01412060|527855239|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
146369920|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
146369921|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
146369922|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
146369923|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
146369924|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
146369925|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
146369926|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
146369927|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
146369928|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
146369929|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
146369930|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
146369931|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
146369932|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
146369933|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
146369934|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
146369935|NCT01412060|527855237|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
146369936|NCT01412060|527855238|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
146369937|NCT01412060|527855239|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
146369938|NCT01412060|527855237|FG000|Period Between SP and DBP|Protocol Violation|2|||
146369939|NCT01412060|527855238|FG001|Period Between SP and DBP|Protocol Violation|0|||
146369940|NCT01412060|527855239|FG002|Period Between SP and DBP|Protocol Violation|0|||
146369941|NCT01412060|527855237|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
146369942|NCT01412060|527855238|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
146369943|NCT01412060|527855239|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
146369944|NCT01412060|527855237|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
146369945|NCT01412060|527855238|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
146369946|NCT01412060|527855239|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
146369947|NCT01412060|527855237|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
146369948|NCT01412060|527855238|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
146369949|NCT01412060|527855239|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
146369950|NCT01412060|527855237|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
146369951|NCT01412060|527855238|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
146369952|NCT01412060|527855239|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
146369953|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
146369954|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
146369955|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
146369956|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
146369957|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
146369958|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
146369959|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
146369960|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
146369961|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
146369962|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
146369963|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
146369964|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
146369965|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
146369966|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
146369967|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
146369968|NCT01412060|527855237|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
146369969|NCT01412060|527855238|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
146369970|NCT01412060|527855239|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
146369971|NCT03549117|527855249|FG000|Overall Study|Withdrawal by Subject|1|||
146369972|NCT03549117|527855250|FG001|Overall Study|Withdrawal by Subject|0|||
146369973|NCT00367432|527855251|FG000|First Period (16 Weeks)|Adverse Event|6|||
146369974|NCT00367432|527855252|FG001|First Period (16 Weeks)|Adverse Event|0|||
146369975|NCT00367432|527855251|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
146369976|NCT00367432|527855252|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
146369977|NCT00367432|527855251|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
146369978|NCT00367432|527855252|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
146369979|NCT00367432|527855251|FG000|First Period (16 Weeks)|Other Reason|2|||
146369980|NCT00367432|527855252|FG001|First Period (16 Weeks)|Other Reason|0|||
146369981|NCT00367432|527855251|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
146369982|NCT00367432|527855252|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
146369983|NCT00367432|527855251|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
146369984|NCT00367432|527855252|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
146369985|NCT00367432|527855251|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
146369986|NCT00367432|527855252|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
146369987|NCT00367432|527855251|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
146369988|NCT00367432|527855252|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
146369989|NCT00367432|527855251|FG000|Second Period (up to 54 Months)|Other Reason|6|||
146369990|NCT00367432|527855252|FG001|Second Period (up to 54 Months)|Other Reason|2|||
146369991|NCT05567393|527855253|FG000|Overall Study|Voluntary Withdrawal|0|||
146369992|NCT05567393|527855254|FG001|Overall Study|Voluntary Withdrawal|0|||
146369993|NCT05567393|527855255|FG002|Overall Study|Voluntary Withdrawal|0|||
146369994|NCT05567393|527855256|FG003|Overall Study|Voluntary Withdrawal|0|||
146369995|NCT05567393|527855257|FG004|Overall Study|Voluntary Withdrawal|0|||
146369996|NCT05567393|527855258|FG005|Overall Study|Voluntary Withdrawal|0|||
146369997|NCT05567393|527855259|FG006|Overall Study|Voluntary Withdrawal|0|||
146369998|NCT05567393|527855260|FG007|Overall Study|Voluntary Withdrawal|0|||
146369999|NCT05567393|527855261|FG008|Overall Study|Voluntary Withdrawal|0|||
146370000|NCT05567393|527855262|FG009|Overall Study|Voluntary Withdrawal|0|||
146370001|NCT05567393|527855263|FG010|Overall Study|Voluntary Withdrawal|0|||
146370002|NCT05567393|527855264|FG011|Overall Study|Voluntary Withdrawal|0|||
146370003|NCT05567393|527855265|FG012|Overall Study|Voluntary Withdrawal|0|||
146370004|NCT05567393|527855266|FG013|Overall Study|Voluntary Withdrawal|1|||
146370005|NCT05567393|527855267|FG014|Overall Study|Voluntary Withdrawal|0|||
146370006|NCT05567393|527855268|FG015|Overall Study|Voluntary Withdrawal|0|||
146370007|NCT05567393|527855269|FG016|Overall Study|Voluntary Withdrawal|0|||
146370008|NCT05567393|527855270|FG017|Overall Study|Voluntary Withdrawal|0|||
146370009|NCT02177175|527855275|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
146370010|NCT02177175|527855276|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
146370011|NCT04199793|527855277|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
146370012|NCT04199793|527855278|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
146370013|NCT04199793|527855277|FG000|Overall Study|Withdrawal by Subject|1|||
146370014|NCT04199793|527855278|FG001|Overall Study|Withdrawal by Subject|1|||
146370015|NCT03820726|527855279|FG000|Overall Study|Other than listed|23|||
146370016|NCT03820726|527855279|FG000|Overall Study|Withdrawal by Subject|37|||
146370017|NCT03820726|527855279|FG000|Overall Study|Lost to Follow-up|3|||
146370018|NCT03820726|527855279|FG000|Overall Study|Protocol deviation|1|||
146370019|NCT03820726|527855279|FG000|Overall Study|Adverse Event|146|||
146370020|NCT03820726|527855279|FG000|Overall Study|Not treated|1|||
146370021|NCT01938001|527855287|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
146370022|NCT01938001|527855288|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
146370023|NCT01938001|527855287|FG000|Pre-Treatment|Death|1|||
146370024|NCT01938001|527855288|FG001|Pre-Treatment|Death|0|||
146370025|NCT01938001|527855287|FG000|Treatment|Death|2|||
146370026|NCT01938001|527855288|FG001|Treatment|Death|0|||
146370027|NCT01938001|527855287|FG000|Treatment|Adverse Event|14|||
146370028|NCT01938001|527855288|FG001|Treatment|Adverse Event|8|||
146370029|NCT01938001|527855287|FG000|Treatment|Progressive Disease|21|||
146370030|NCT01938001|527855288|FG001|Treatment|Progressive Disease|54|||
146370031|NCT01938001|527855287|FG000|Treatment|Withdrawal by Subject|13|||
146370032|NCT01938001|527855288|FG001|Treatment|Withdrawal by Subject|7|||
146370033|NCT01938001|527855287|FG000|Treatment|Other reasons|2|||
146370034|NCT01938001|527855288|FG001|Treatment|Other reasons|1|||
146370035|NCT02293902|527855292|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
146370036|NCT02293902|527855293|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
146370037|NCT02293902|527855294|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
146370038|NCT02293902|527855295|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
146370039|NCT02293902|527855296|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
146370040|NCT02293902|527855292|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
146370041|NCT02293902|527855293|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
146370042|NCT02293902|527855294|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
146370043|NCT02293902|527855295|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
146370044|NCT02293902|527855296|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
146370045|NCT02293902|527855292|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
146370046|NCT02293902|527855293|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146370047|NCT02293902|527855294|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146370048|NCT02293902|527855295|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146370049|NCT02293902|527855296|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
146370050|NCT02293902|527855292|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
146370051|NCT02293902|527855293|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
146370052|NCT02293902|527855294|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
146370053|NCT02293902|527855295|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
146370054|NCT02293902|527855296|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
146370055|NCT02293902|527855292|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146370056|NCT02293902|527855293|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
146370057|NCT02293902|527855294|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
146370058|NCT02293902|527855295|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146370059|NCT02293902|527855296|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
146395699|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
146395700|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
146395701|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
146395702|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Disease Progression|1|||
146395703|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Disease Progression|0|||
146395704|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
146395705|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
146395706|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
146395707|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
146395708|NCT04419558|527950897|FG000|DB Period (48 Weeks)|Participant Decision|4|||
146395709|NCT04419558|527950898|FG001|DB Period (48 Weeks)|Participant Decision|3|||
146395710|NCT04419558|527950897|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
146395711|NCT04419558|527950898|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
146395712|NCT04419558|527950897|FG000|OLE Period (48 Weeks)|Death|4|||
146395713|NCT04419558|527950898|FG001|OLE Period (48 Weeks)|Death|6|||
146395714|NCT04419558|527950897|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
146395715|NCT04419558|527950898|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
146395716|NCT04419558|527950897|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
146395717|NCT04419558|527950898|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
146395718|NCT00908375|527950899|FG000|Overall Study|Withdrawal by Subject|2|||
146395719|NCT00908375|527950900|FG001|Overall Study|Withdrawal by Subject|4|||
146395720|NCT00908375|527950899|FG000|Overall Study|Lost to Follow-up|8|||
146395721|NCT00908375|527950900|FG001|Overall Study|Lost to Follow-up|6|||
146370060|NCT03170258|527857358|FG000|Overall Study|Physician Decision|4|||
146370061|NCT03170258|527857359|FG001|Overall Study|Physician Decision|0|||
146370062|NCT03170258|527857358|FG000|Overall Study|Equipment issues|1|||
146370063|NCT03170258|527857359|FG001|Overall Study|Equipment issues|0|||
146370064|NCT03170258|527857358|FG000|Overall Study|Medication|1|||
146370065|NCT03170258|527857359|FG001|Overall Study|Medication|0|||
146370066|NCT03170258|527857358|FG000|Overall Study|Sleep issues|1|||
146370067|NCT03170258|527857359|FG001|Overall Study|Sleep issues|0|||
146370068|NCT01563107|527857360|FG000|Overall Study|Physician Decision|0|||
146370069|NCT01563107|527857361|FG001|Overall Study|Physician Decision|1|||
146370070|NCT01563107|527857362|FG002|Overall Study|Physician Decision|1|||
146370071|NCT01563107|527857363|FG003|Overall Study|Physician Decision|3|||
146370072|NCT01563107|527857360|FG000|Overall Study|Withdrawal by Subject|1|||
146370073|NCT01563107|527857361|FG001|Overall Study|Withdrawal by Subject|2|||
146370074|NCT01563107|527857362|FG002|Overall Study|Withdrawal by Subject|1|||
146370075|NCT01563107|527857363|FG003|Overall Study|Withdrawal by Subject|2|||
146370076|NCT02707601|527857364|FG000|Overall Study|Death|0|||
146370077|NCT02707601|527857365|FG001|Overall Study|Death|1|||
146370078|NCT02707601|527857364|FG000|Overall Study|Lack of Efficacy|0|||
146370079|NCT02707601|527857365|FG001|Overall Study|Lack of Efficacy|1|||
146370080|NCT02707601|527857364|FG000|Overall Study|Investigator's Discretion|1|||
146370081|NCT02707601|527857365|FG001|Overall Study|Investigator's Discretion|0|||
146370082|NCT02707601|527857364|FG000|Overall Study|Withdrew Consent|0|||
146370083|NCT02707601|527857365|FG001|Overall Study|Withdrew Consent|1|||
146370084|NCT02707601|527857364|FG000|Overall Study|Lost to Follow-up|1|||
146370085|NCT02707601|527857365|FG001|Overall Study|Lost to Follow-up|1|||
146370086|NCT02707601|527857364|FG000|Overall Study|Participants Randomized but Not Treated|2|||
146370087|NCT02707601|527857365|FG001|Overall Study|Participants Randomized but Not Treated|0|||
146370088|NCT03907969|527857367|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
146370089|NCT03907969|527857368|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
146370090|NCT03907969|527857369|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
146370091|NCT03907969|527857370|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
146370092|NCT03907969|527857371|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
146370093|NCT03907969|527857372|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
146370094|NCT03907969|527857373|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
146370095|NCT03907969|527857374|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
146370096|NCT03907969|527857375|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
146370097|NCT03907969|527857376|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
146370098|NCT03907969|527857377|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
146370099|NCT03907969|527857367|FG000|Monotherapy Part A|Progressive Disease|0|||
146370100|NCT03907969|527857368|FG001|Monotherapy Part A|Progressive Disease|1|||
146370101|NCT03907969|527857369|FG002|Monotherapy Part A|Progressive Disease|0|||
146370102|NCT03907969|527857370|FG003|Monotherapy Part A|Progressive Disease|0|||
146370103|NCT03907969|527857371|FG004|Monotherapy Part A|Progressive Disease|0|||
146370104|NCT03907969|527857372|FG005|Monotherapy Part A|Progressive Disease|1|||
146370105|NCT03907969|527857373|FG006|Monotherapy Part A|Progressive Disease|2|||
146370106|NCT03907969|527857374|FG007|Monotherapy Part A|Progressive Disease|0|||
146370107|NCT03907969|527857375|FG008|Monotherapy Part A|Progressive Disease|0|||
146370108|NCT03907969|527857376|FG009|Monotherapy Part A|Progressive Disease|0|||
146370109|NCT03907969|527857377|FG010|Monotherapy Part A|Progressive Disease|0|||
146370110|NCT03907969|527857367|FG000|Monotherapy Part A|Death|0|||
146370111|NCT03907969|527857368|FG001|Monotherapy Part A|Death|0|||
146370112|NCT03907969|527857369|FG002|Monotherapy Part A|Death|1|||
146370113|NCT03907969|527857370|FG003|Monotherapy Part A|Death|1|||
146370114|NCT03907969|527857371|FG004|Monotherapy Part A|Death|0|||
146370115|NCT03907969|527857372|FG005|Monotherapy Part A|Death|1|||
146370116|NCT03907969|527857373|FG006|Monotherapy Part A|Death|0|||
146370117|NCT03907969|527857374|FG007|Monotherapy Part A|Death|0|||
146370118|NCT03907969|527857375|FG008|Monotherapy Part A|Death|0|||
146370119|NCT03907969|527857376|FG009|Monotherapy Part A|Death|0|||
146370120|NCT03907969|527857377|FG010|Monotherapy Part A|Death|0|||
146370121|NCT03907969|527857367|FG000|Combination Therapy Part A|Adverse Event|0|||
146370122|NCT03907969|527857368|FG001|Combination Therapy Part A|Adverse Event|0|||
146370123|NCT03907969|527857369|FG002|Combination Therapy Part A|Adverse Event|0|||
146370124|NCT03907969|527857370|FG003|Combination Therapy Part A|Adverse Event|0|||
146370125|NCT03907969|527857371|FG004|Combination Therapy Part A|Adverse Event|0|||
146370126|NCT03907969|527857372|FG005|Combination Therapy Part A|Adverse Event|0|||
146370127|NCT03907969|527857373|FG006|Combination Therapy Part A|Adverse Event|0|||
146370128|NCT03907969|527857374|FG007|Combination Therapy Part A|Adverse Event|0|||
146370129|NCT03907969|527857375|FG008|Combination Therapy Part A|Adverse Event|0|||
146370130|NCT03907969|527857376|FG009|Combination Therapy Part A|Adverse Event|1|||
146370131|NCT03907969|527857377|FG010|Combination Therapy Part A|Adverse Event|1|||
146370132|NCT03907969|527857367|FG000|Combination Therapy Part A|Progressive disease|0|||
146370133|NCT03907969|527857368|FG001|Combination Therapy Part A|Progressive disease|0|||
146370134|NCT03907969|527857369|FG002|Combination Therapy Part A|Progressive disease|0|||
146370135|NCT03907969|527857370|FG003|Combination Therapy Part A|Progressive disease|0|||
146370136|NCT03907969|527857371|FG004|Combination Therapy Part A|Progressive disease|0|||
146370137|NCT03907969|527857372|FG005|Combination Therapy Part A|Progressive disease|0|||
146370138|NCT03907969|527857373|FG006|Combination Therapy Part A|Progressive disease|0|||
146370139|NCT03907969|527857374|FG007|Combination Therapy Part A|Progressive disease|1|||
146370140|NCT03907969|527857375|FG008|Combination Therapy Part A|Progressive disease|0|||
146370141|NCT03907969|527857376|FG009|Combination Therapy Part A|Progressive disease|2|||
146370142|NCT03907969|527857377|FG010|Combination Therapy Part A|Progressive disease|3|||
146370143|NCT03907969|527857367|FG000|Combination Therapy Part A|Death|0|||
146370144|NCT03907969|527857368|FG001|Combination Therapy Part A|Death|0|||
146370145|NCT03907969|527857369|FG002|Combination Therapy Part A|Death|0|||
146370146|NCT03907969|527857370|FG003|Combination Therapy Part A|Death|0|||
146370147|NCT03907969|527857371|FG004|Combination Therapy Part A|Death|0|||
146370148|NCT03907969|527857372|FG005|Combination Therapy Part A|Death|0|||
146370149|NCT03907969|527857373|FG006|Combination Therapy Part A|Death|0|||
146370150|NCT03907969|527857374|FG007|Combination Therapy Part A|Death|0|||
146370151|NCT03907969|527857375|FG008|Combination Therapy Part A|Death|1|||
146370152|NCT03907969|527857376|FG009|Combination Therapy Part A|Death|0|||
146370153|NCT03907969|527857377|FG010|Combination Therapy Part A|Death|1|||
146370154|NCT03907969|527857367|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
146370155|NCT03907969|527857368|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
146370156|NCT03907969|527857369|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
146370157|NCT03907969|527857370|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
146370158|NCT03907969|527857371|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
146370159|NCT03907969|527857372|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
146370160|NCT03907969|527857373|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
146370161|NCT03907969|527857374|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
146370162|NCT03907969|527857375|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
146370163|NCT03907969|527857376|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
146370164|NCT03907969|527857377|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
146370165|NCT03907969|527857367|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
146370166|NCT03907969|527857368|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
146370167|NCT03907969|527857369|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
146370168|NCT03907969|527857370|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
146370169|NCT03907969|527857371|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
146370170|NCT03907969|527857372|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
146370171|NCT03907969|527857373|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
146370172|NCT03907969|527857374|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
146370173|NCT03907969|527857375|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
146370174|NCT03907969|527857376|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
146370175|NCT03907969|527857377|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
146370176|NCT03907969|527857367|FG000|Combination Therapy Part A|Physician Decision|0|||
146370177|NCT03907969|527857368|FG001|Combination Therapy Part A|Physician Decision|0|||
146370178|NCT03907969|527857369|FG002|Combination Therapy Part A|Physician Decision|0|||
146370179|NCT03907969|527857370|FG003|Combination Therapy Part A|Physician Decision|0|||
146370180|NCT03907969|527857371|FG004|Combination Therapy Part A|Physician Decision|0|||
146370181|NCT03907969|527857372|FG005|Combination Therapy Part A|Physician Decision|0|||
146370182|NCT03907969|527857373|FG006|Combination Therapy Part A|Physician Decision|0|||
146370183|NCT03907969|527857374|FG007|Combination Therapy Part A|Physician Decision|1|||
146370184|NCT03907969|527857375|FG008|Combination Therapy Part A|Physician Decision|0|||
146370185|NCT03907969|527857376|FG009|Combination Therapy Part A|Physician Decision|0|||
146370186|NCT03907969|527857377|FG010|Combination Therapy Part A|Physician Decision|1|||
146370187|NCT00247273|527857388|FG000|Overall Study|Adverse Event|85|||
146370188|NCT00247273|527857389|FG001|Overall Study|Adverse Event|80|||
146370189|NCT00247273|527857388|FG000|Overall Study|Physician Decision|6|||
146370190|NCT00247273|527857389|FG001|Overall Study|Physician Decision|3|||
146370191|NCT00247273|527857388|FG000|Overall Study|Lost to Follow-up|7|||
146370192|NCT00247273|527857389|FG001|Overall Study|Lost to Follow-up|7|||
146370193|NCT00247273|527857388|FG000|Overall Study|Withdrawal by Subject|46|||
146370194|NCT00247273|527857389|FG001|Overall Study|Withdrawal by Subject|47|||
146370195|NCT00247273|527857388|FG000|Overall Study|Did not take any study drug|2|||
146370196|NCT00247273|527857389|FG001|Overall Study|Did not take any study drug|0|||
146370197|NCT04209530|527857390|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
146370198|NCT04209530|527857391|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
146370199|NCT04209530|527857390|FG000|Overall Study|Withdrawal by Subject|0|||
146370200|NCT04209530|527857391|FG001|Overall Study|Withdrawal by Subject|1|||
146370201|NCT03276572|527857392|FG000|Overall Study|In follow-up|0|||
146370202|NCT03276572|527857393|FG001|Overall Study|In follow-up|0|||
146370203|NCT03276572|527857394|FG002|Overall Study|In follow-up|0|||
146370204|NCT03276572|527857395|FG003|Overall Study|In follow-up|0|||
146370205|NCT03276572|527857396|FG004|Overall Study|In follow-up|0|||
146370206|NCT03276572|527857397|FG005|Overall Study|In follow-up|1|||
146370207|NCT03276572|527857398|FG006|Overall Study|In follow-up|1|||
146370208|NCT03276572|527857392|FG000|Overall Study|Lost to Follow-up|0|||
146370209|NCT03276572|527857393|FG001|Overall Study|Lost to Follow-up|0|||
146370210|NCT03276572|527857394|FG002|Overall Study|Lost to Follow-up|0|||
146370211|NCT03276572|527857395|FG003|Overall Study|Lost to Follow-up|0|||
146370212|NCT03276572|527857396|FG004|Overall Study|Lost to Follow-up|0|||
146370213|NCT03276572|527857397|FG005|Overall Study|Lost to Follow-up|0|||
146370214|NCT03276572|527857398|FG006|Overall Study|Lost to Follow-up|1|||
146370215|NCT00607919|527857411|FG000|Acute Phase|Adverse Event|9|||
146370216|NCT00607919|527857412|FG001|Acute Phase|Adverse Event|2|||
146370217|NCT00607919|527857411|FG000|Acute Phase|Entry Criteria Not Met|1|||
146370218|NCT00607919|527857412|FG001|Acute Phase|Entry Criteria Not Met|1|||
146370219|NCT00607919|527857411|FG000|Acute Phase|Lack of Efficacy|1|||
146370220|NCT00607919|527857412|FG001|Acute Phase|Lack of Efficacy|2|||
146370221|NCT00607919|527857411|FG000|Acute Phase|Lost to Follow-up|9|||
146370222|NCT00607919|527857412|FG001|Acute Phase|Lost to Follow-up|3|||
146370223|NCT00607919|527857411|FG000|Acute Phase|Parent/Caregiver Decision|6|||
146370224|NCT00607919|527857412|FG001|Acute Phase|Parent/Caregiver Decision|4|||
146370225|NCT00607919|527857411|FG000|Acute Phase|Protocol Violation|5|||
146370226|NCT00607919|527857412|FG001|Acute Phase|Protocol Violation|1|||
146370227|NCT00607919|527857411|FG000|Acute Phase|Withdrawal by Subject|3|||
146370228|NCT00607919|527857412|FG001|Acute Phase|Withdrawal by Subject|3|||
146370229|NCT00607919|527857411|FG000|Open-Label Phase|Adverse Event|1|||
146370230|NCT00607919|527857412|FG001|Open-Label Phase|Adverse Event|5|||
146370231|NCT00607919|527857411|FG000|Open-Label Phase|Lost to Follow-up|4|||
146370232|NCT00607919|527857412|FG001|Open-Label Phase|Lost to Follow-up|1|||
146370233|NCT00607919|527857411|FG000|Open-Label Phase|Protocol Violation|2|||
146370234|NCT00607919|527857412|FG001|Open-Label Phase|Protocol Violation|2|||
146370235|NCT00607919|527857411|FG000|Open-Label Phase|Withdrawal by Subject|2|||
146370236|NCT00607919|527857412|FG001|Open-Label Phase|Withdrawal by Subject|2|||
146370237|NCT00607919|527857411|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
146370238|NCT00607919|527857412|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
146370239|NCT01709708|527857413|FG000|Overall Study|Protocol Violation|1|||
146370240|NCT01709708|527857414|FG001|Overall Study|Protocol Violation|2|||
146370241|NCT01527110|527857417|FG000|Overall Study|Adverse Event|1|||
146370242|NCT00527072|527857418|FG000|Overall Study|Adverse Event|13|||
146370243|NCT00527072|527857418|FG000|Overall Study|Lack of Efficacy|11|||
146370244|NCT00527072|527857418|FG000|Overall Study|Lost to Follow-up|3|||
146370245|NCT00527072|527857418|FG000|Overall Study|Protocol Violation|2|||
146370246|NCT00527072|527857418|FG000|Overall Study|Withdrawal by Subject|7|||
146370247|NCT02007252|527857419|FG000|Overall Study|Administrative problems|3|||
146370248|NCT02007252|527857420|FG001|Overall Study|Administrative problems|7|||
146370249|NCT02007252|527857419|FG000|Overall Study|Abnormal laboratory value(s)|1|||
146370250|NCT02007252|527857420|FG001|Overall Study|Abnormal laboratory value(s)|0|||
146370251|NCT02007252|527857419|FG000|Overall Study|Adverse Event|7|||
146370252|NCT02007252|527857420|FG001|Overall Study|Adverse Event|4|||
146370253|NCT02657434|527857421|FG000|Overall Study|Study Terminated By Sponsor|64|||
146370254|NCT02657434|527857422|FG001|Overall Study|Study Terminated By Sponsor|82|||
146370255|NCT02657434|527857421|FG000|Overall Study|Death|189|||
146370256|NCT02657434|527857422|FG001|Overall Study|Death|190|||
146370257|NCT02657434|527857421|FG000|Overall Study|Lost to Follow-up|2|||
146370258|NCT02657434|527857422|FG001|Overall Study|Lost to Follow-up|2|||
146370259|NCT02657434|527857421|FG000|Overall Study|Randomization by Error|2|||
146370260|NCT02657434|527857422|FG001|Overall Study|Randomization by Error|0|||
146370261|NCT02657434|527857421|FG000|Overall Study|Withdrawal by Subject|28|||
146370262|NCT02657434|527857422|FG001|Overall Study|Withdrawal by Subject|17|||
146370263|NCT02657434|527857421|FG000|Overall Study|Protocol Violation|1|||
146370264|NCT02657434|527857422|FG001|Overall Study|Protocol Violation|0|||
146370265|NCT02657434|527857421|FG000|Overall Study|Physician Decision|0|||
146370266|NCT02657434|527857422|FG001|Overall Study|Physician Decision|1|||
146370267|NCT00511108|527857425|FG000|Overall Study|Adverse Event|2|||
146370268|NCT00511108|527857426|FG001|Overall Study|Adverse Event|0|||
146370269|NCT00511108|527857427|FG002|Overall Study|Adverse Event|1|||
146370270|NCT00511108|527857428|FG003|Overall Study|Adverse Event|2|||
146370271|NCT00511108|527857425|FG000|Overall Study|Lost to Follow-up|0|||
146370272|NCT00511108|527857426|FG001|Overall Study|Lost to Follow-up|2|||
146370273|NCT00511108|527857427|FG002|Overall Study|Lost to Follow-up|1|||
146370274|NCT00511108|527857428|FG003|Overall Study|Lost to Follow-up|0|||
146370275|NCT00511108|527857425|FG000|Overall Study|Physician Decision|0|||
146370276|NCT00511108|527857426|FG001|Overall Study|Physician Decision|0|||
146370277|NCT00511108|527857427|FG002|Overall Study|Physician Decision|0|||
146370278|NCT00511108|527857428|FG003|Overall Study|Physician Decision|1|||
146370279|NCT00511108|527857425|FG000|Overall Study|Withdrawal by Subject|4|||
146370280|NCT00511108|527857426|FG001|Overall Study|Withdrawal by Subject|0|||
146370281|NCT00511108|527857427|FG002|Overall Study|Withdrawal by Subject|3|||
146370282|NCT00511108|527857428|FG003|Overall Study|Withdrawal by Subject|2|||
146370283|NCT02147691|527857431|FG000|Overall Study|Withdrawal by Subject|2|||
146370284|NCT02147691|527857432|FG001|Overall Study|Withdrawal by Subject|0|||
146370285|NCT02147691|527857431|FG000|Overall Study|Adverse Event|2|||
146370286|NCT02147691|527857432|FG001|Overall Study|Adverse Event|0|||
146370287|NCT02147691|527857431|FG000|Overall Study|Lost to Follow-up|0|||
146370288|NCT02147691|527857432|FG001|Overall Study|Lost to Follow-up|1|||
146370289|NCT01392742|527857435|FG000|Overall Study|Premature study termination|42|||
146370290|NCT01392742|527857435|FG000|Overall Study|Failure to return|35|||
146370291|NCT01392742|527857435|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
146370292|NCT01392742|527857435|FG000|Overall Study|Lost to Follow-up|34|||
146370293|NCT01392742|527857435|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
146370294|NCT01392742|527857435|FG000|Overall Study|ITR and Protocol deviation|1|||
146370295|NCT01392742|527857435|FG000|Overall Study|Adverse event/intercurrent illness|17|||
146370296|NCT01392742|527857435|FG000|Overall Study|Protocol Violation|14|||
146370297|NCT01392742|527857435|FG000|Overall Study|Other|3|||
146370298|NCT01392742|527857435|FG000|Overall Study|Missing information|13|||
146370299|NCT01998958|527857436|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370300|NCT01998958|527857437|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
146370301|NCT01998958|527857438|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370302|NCT01998958|527857439|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370303|NCT01998958|527857440|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370304|NCT01998958|527857441|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370305|NCT01998958|527857442|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370306|NCT01998958|527857443|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370307|NCT01998958|527857444|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370308|NCT01998958|527857445|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370309|NCT01998958|527857446|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370310|NCT01998958|527857447|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370311|NCT01998958|527857448|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370312|NCT01998958|527857449|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370313|NCT01998958|527857450|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370314|NCT01998958|527857451|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370315|NCT01998958|527857452|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370316|NCT01998958|527857453|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370317|NCT01998958|527857454|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370318|NCT01998958|527857455|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370319|NCT01998958|527857456|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370320|NCT01998958|527857457|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370321|NCT01998958|527857458|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370322|NCT01998958|527857459|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370323|NCT01998958|527857460|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370324|NCT01998958|527857461|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370325|NCT01998958|527857462|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370326|NCT01998958|527857463|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370327|NCT01998958|527857464|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370328|NCT01998958|527857465|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370329|NCT01998958|527857466|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370330|NCT01998958|527857467|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
146370331|NCT01998958|527857436|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370332|NCT01998958|527857437|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
146370333|NCT01998958|527857438|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370334|NCT01998958|527857439|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370335|NCT01998958|527857440|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370336|NCT01998958|527857441|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370337|NCT01998958|527857442|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370338|NCT01998958|527857443|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370339|NCT01998958|527857444|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370340|NCT01998958|527857445|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370341|NCT01998958|527857446|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370342|NCT01998958|527857447|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370343|NCT01998958|527857448|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370344|NCT01998958|527857449|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370345|NCT01998958|527857450|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370346|NCT01998958|527857451|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370347|NCT01998958|527857452|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370348|NCT01998958|527857453|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370349|NCT01998958|527857454|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370350|NCT01998958|527857455|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370351|NCT01998958|527857456|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370352|NCT01998958|527857457|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370353|NCT01998958|527857458|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370354|NCT01998958|527857459|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370355|NCT01998958|527857460|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370356|NCT01998958|527857461|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370357|NCT01998958|527857462|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370358|NCT01998958|527857463|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370359|NCT01998958|527857464|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370360|NCT01998958|527857465|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370361|NCT01998958|527857466|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370362|NCT01998958|527857467|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
146370363|NCT01998958|527857436|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
146370364|NCT01998958|527857437|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
146370365|NCT01998958|527857438|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
146370366|NCT01998958|527857439|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
146370367|NCT01998958|527857440|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
146370368|NCT01998958|527857441|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
146370369|NCT01998958|527857442|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
146370370|NCT01998958|527857443|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
146370371|NCT01998958|527857444|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
146370372|NCT01998958|527857445|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
146370373|NCT01998958|527857446|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
146370374|NCT01998958|527857447|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
146370375|NCT01998958|527857448|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
146370376|NCT01998958|527857449|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
146370377|NCT01998958|527857450|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
146370378|NCT01998958|527857451|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
146370379|NCT01998958|527857452|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
146370380|NCT01998958|527857453|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
146370381|NCT01998958|527857454|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
146370382|NCT01998958|527857455|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
146370383|NCT01998958|527857456|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
146370384|NCT01998958|527857457|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
146370385|NCT01998958|527857458|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
146370386|NCT01998958|527857459|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
146370387|NCT01998958|527857460|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
146370388|NCT01998958|527857461|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
146370389|NCT01998958|527857462|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
146370390|NCT01998958|527857463|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
146370391|NCT01998958|527857464|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
146370392|NCT01998958|527857465|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
146370393|NCT01998958|527857466|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
146370394|NCT01998958|527857467|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
146370395|NCT01998958|527857436|FG000|Period 1 (Panel A and B)|Other|1|||
146370396|NCT01998958|527857437|FG001|Period 1 (Panel A and B)|Other|0|||
146370397|NCT01998958|527857438|FG002|Period 1 (Panel A and B)|Other|0|||
146370398|NCT01998958|527857439|FG003|Period 1 (Panel A and B)|Other|0|||
146370399|NCT01998958|527857440|FG004|Period 1 (Panel A and B)|Other|0|||
146370400|NCT01998958|527857441|FG005|Period 1 (Panel A and B)|Other|0|||
146370401|NCT01998958|527857442|FG006|Period 1 (Panel A and B)|Other|0|||
146370402|NCT01998958|527857443|FG007|Period 1 (Panel A and B)|Other|0|||
146370403|NCT01998958|527857444|FG008|Period 1 (Panel A and B)|Other|0|||
146370404|NCT01998958|527857445|FG009|Period 1 (Panel A and B)|Other|0|||
146370405|NCT01998958|527857446|FG010|Period 1 (Panel A and B)|Other|0|||
146370406|NCT01998958|527857447|FG011|Period 1 (Panel A and B)|Other|0|||
146370407|NCT01998958|527857448|FG012|Period 1 (Panel A and B)|Other|0|||
146370408|NCT01998958|527857449|FG013|Period 1 (Panel A and B)|Other|0|||
146370409|NCT01998958|527857450|FG014|Period 1 (Panel A and B)|Other|0|||
146370410|NCT01998958|527857451|FG015|Period 1 (Panel A and B)|Other|0|||
146370411|NCT01998958|527857452|FG016|Period 1 (Panel A and B)|Other|0|||
146370412|NCT01998958|527857453|FG017|Period 1 (Panel A and B)|Other|0|||
146370413|NCT01998958|527857454|FG018|Period 1 (Panel A and B)|Other|0|||
146370414|NCT01998958|527857455|FG019|Period 1 (Panel A and B)|Other|0|||
146370415|NCT01998958|527857456|FG020|Period 1 (Panel A and B)|Other|0|||
146370416|NCT01998958|527857457|FG021|Period 1 (Panel A and B)|Other|0|||
146370417|NCT01998958|527857458|FG022|Period 1 (Panel A and B)|Other|0|||
146370418|NCT01998958|527857459|FG023|Period 1 (Panel A and B)|Other|0|||
146370419|NCT01998958|527857460|FG024|Period 1 (Panel A and B)|Other|0|||
146370420|NCT01998958|527857461|FG025|Period 1 (Panel A and B)|Other|0|||
146370421|NCT01998958|527857462|FG026|Period 1 (Panel A and B)|Other|0|||
146370422|NCT01998958|527857463|FG027|Period 1 (Panel A and B)|Other|0|||
146370423|NCT01998958|527857464|FG028|Period 1 (Panel A and B)|Other|0|||
146370424|NCT01998958|527857465|FG029|Period 1 (Panel A and B)|Other|0|||
146370425|NCT01998958|527857466|FG030|Period 1 (Panel A and B)|Other|0|||
146370426|NCT01998958|527857467|FG031|Period 1 (Panel A and B)|Other|0|||
146370427|NCT01998958|527857436|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
146370428|NCT01998958|527857437|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
146370429|NCT01998958|527857438|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
146370430|NCT01998958|527857439|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
146370431|NCT01998958|527857440|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
146370432|NCT01998958|527857441|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
146370433|NCT01998958|527857442|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
146370434|NCT01998958|527857443|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
146370435|NCT01998958|527857444|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
146370436|NCT01998958|527857445|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
146370437|NCT01998958|527857446|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
146370438|NCT01998958|527857447|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
146370439|NCT01998958|527857448|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
146370440|NCT01998958|527857449|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
146370441|NCT01998958|527857450|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
146370442|NCT01998958|527857451|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
146370443|NCT01998958|527857452|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
146370444|NCT01998958|527857453|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
146370445|NCT01998958|527857454|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
146370446|NCT01998958|527857455|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
146370447|NCT01998958|527857456|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
146370448|NCT01998958|527857457|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
146370449|NCT01998958|527857458|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
146370450|NCT01998958|527857459|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
146370451|NCT01998958|527857460|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
146370452|NCT01998958|527857461|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
146370453|NCT01998958|527857462|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
146370454|NCT01998958|527857463|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
146370455|NCT01998958|527857464|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
146370456|NCT01998958|527857465|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
146370457|NCT01998958|527857466|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
146370458|NCT01998958|527857467|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
146370459|NCT01998958|527857436|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370460|NCT01998958|527857437|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370461|NCT01998958|527857438|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370462|NCT01998958|527857439|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370463|NCT01998958|527857440|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370464|NCT01998958|527857441|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370465|NCT01998958|527857442|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370466|NCT01998958|527857443|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370467|NCT01998958|527857444|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370468|NCT01998958|527857445|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370469|NCT01998958|527857446|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370470|NCT01998958|527857447|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370471|NCT01998958|527857448|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370472|NCT01998958|527857449|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370473|NCT01998958|527857450|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
146370474|NCT01998958|527857451|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370475|NCT01998958|527857452|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370476|NCT01998958|527857453|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370477|NCT01998958|527857454|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
146370478|NCT01998958|527857455|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370479|NCT01998958|527857456|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370480|NCT01998958|527857457|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370481|NCT01998958|527857458|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370482|NCT01998958|527857459|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370483|NCT01998958|527857460|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370484|NCT01998958|527857461|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370485|NCT01998958|527857462|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370486|NCT01998958|527857463|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370487|NCT01998958|527857464|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370488|NCT01998958|527857465|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370489|NCT01998958|527857466|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370490|NCT01998958|527857467|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
146370491|NCT01998958|527857436|FG000|Open Label Phase (Optional)|Adverse Event|0|||
146370492|NCT01998958|527857437|FG001|Open Label Phase (Optional)|Adverse Event|0|||
146370493|NCT01998958|527857438|FG002|Open Label Phase (Optional)|Adverse Event|0|||
146370494|NCT01998958|527857439|FG003|Open Label Phase (Optional)|Adverse Event|0|||
146370495|NCT01998958|527857440|FG004|Open Label Phase (Optional)|Adverse Event|0|||
146370496|NCT01998958|527857441|FG005|Open Label Phase (Optional)|Adverse Event|0|||
146370497|NCT01998958|527857442|FG006|Open Label Phase (Optional)|Adverse Event|0|||
146370498|NCT01998958|527857443|FG007|Open Label Phase (Optional)|Adverse Event|0|||
146370499|NCT01998958|527857444|FG008|Open Label Phase (Optional)|Adverse Event|0|||
146370500|NCT01998958|527857445|FG009|Open Label Phase (Optional)|Adverse Event|0|||
146370501|NCT01998958|527857446|FG010|Open Label Phase (Optional)|Adverse Event|0|||
146370502|NCT01998958|527857447|FG011|Open Label Phase (Optional)|Adverse Event|0|||
146370503|NCT01998958|527857448|FG012|Open Label Phase (Optional)|Adverse Event|0|||
146370504|NCT01998958|527857449|FG013|Open Label Phase (Optional)|Adverse Event|0|||
146370505|NCT01998958|527857450|FG014|Open Label Phase (Optional)|Adverse Event|0|||
146370506|NCT01998958|527857451|FG015|Open Label Phase (Optional)|Adverse Event|0|||
146370507|NCT01998958|527857452|FG016|Open Label Phase (Optional)|Adverse Event|0|||
146370508|NCT01998958|527857453|FG017|Open Label Phase (Optional)|Adverse Event|0|||
146370509|NCT01998958|527857454|FG018|Open Label Phase (Optional)|Adverse Event|0|||
146370510|NCT01998958|527857455|FG019|Open Label Phase (Optional)|Adverse Event|0|||
146370511|NCT01998958|527857456|FG020|Open Label Phase (Optional)|Adverse Event|0|||
146370512|NCT01998958|527857457|FG021|Open Label Phase (Optional)|Adverse Event|0|||
146370513|NCT01998958|527857458|FG022|Open Label Phase (Optional)|Adverse Event|0|||
146370514|NCT01998958|527857459|FG023|Open Label Phase (Optional)|Adverse Event|1|||
146370515|NCT01998958|527857460|FG024|Open Label Phase (Optional)|Adverse Event|0|||
146370516|NCT01998958|527857461|FG025|Open Label Phase (Optional)|Adverse Event|0|||
146370517|NCT01998958|527857462|FG026|Open Label Phase (Optional)|Adverse Event|0|||
146370518|NCT01998958|527857463|FG027|Open Label Phase (Optional)|Adverse Event|0|||
146370519|NCT01998958|527857464|FG028|Open Label Phase (Optional)|Adverse Event|0|||
146370520|NCT01998958|527857465|FG029|Open Label Phase (Optional)|Adverse Event|0|||
146370521|NCT01998958|527857466|FG030|Open Label Phase (Optional)|Adverse Event|0|||
146370522|NCT01998958|527857467|FG031|Open Label Phase (Optional)|Adverse Event|0|||
146370523|NCT01998958|527857436|FG000|Open Label Phase (Optional)|Other|0|||
146370524|NCT01998958|527857437|FG001|Open Label Phase (Optional)|Other|0|||
146370525|NCT01998958|527857438|FG002|Open Label Phase (Optional)|Other|0|||
146370526|NCT01998958|527857439|FG003|Open Label Phase (Optional)|Other|0|||
146370527|NCT01998958|527857440|FG004|Open Label Phase (Optional)|Other|0|||
146370528|NCT01998958|527857441|FG005|Open Label Phase (Optional)|Other|0|||
146370529|NCT01998958|527857442|FG006|Open Label Phase (Optional)|Other|0|||
146370530|NCT01998958|527857443|FG007|Open Label Phase (Optional)|Other|0|||
146370531|NCT01998958|527857444|FG008|Open Label Phase (Optional)|Other|0|||
146370532|NCT01998958|527857445|FG009|Open Label Phase (Optional)|Other|0|||
146370533|NCT01998958|527857446|FG010|Open Label Phase (Optional)|Other|0|||
146370534|NCT01998958|527857447|FG011|Open Label Phase (Optional)|Other|0|||
146370535|NCT01998958|527857448|FG012|Open Label Phase (Optional)|Other|0|||
146370536|NCT01998958|527857449|FG013|Open Label Phase (Optional)|Other|0|||
146370537|NCT01998958|527857450|FG014|Open Label Phase (Optional)|Other|0|||
146370538|NCT01998958|527857451|FG015|Open Label Phase (Optional)|Other|0|||
146370539|NCT01998958|527857452|FG016|Open Label Phase (Optional)|Other|0|||
146370540|NCT01998958|527857453|FG017|Open Label Phase (Optional)|Other|0|||
146370541|NCT01998958|527857454|FG018|Open Label Phase (Optional)|Other|0|||
146370542|NCT01998958|527857455|FG019|Open Label Phase (Optional)|Other|0|||
146370543|NCT01998958|527857456|FG020|Open Label Phase (Optional)|Other|0|||
146370544|NCT01998958|527857457|FG021|Open Label Phase (Optional)|Other|0|||
146370545|NCT01998958|527857458|FG022|Open Label Phase (Optional)|Other|5|||
146370546|NCT01998958|527857459|FG023|Open Label Phase (Optional)|Other|1|||
146370547|NCT01998958|527857460|FG024|Open Label Phase (Optional)|Other|0|||
146370548|NCT01998958|527857461|FG025|Open Label Phase (Optional)|Other|0|||
146370549|NCT01998958|527857462|FG026|Open Label Phase (Optional)|Other|0|||
146370550|NCT01998958|527857463|FG027|Open Label Phase (Optional)|Other|0|||
146370551|NCT01998958|527857464|FG028|Open Label Phase (Optional)|Other|0|||
146370552|NCT01998958|527857465|FG029|Open Label Phase (Optional)|Other|0|||
146370553|NCT01998958|527857466|FG030|Open Label Phase (Optional)|Other|0|||
146370554|NCT01998958|527857467|FG031|Open Label Phase (Optional)|Other|0|||
146370555|NCT01998958|527857436|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370556|NCT01998958|527857437|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370557|NCT01998958|527857438|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370558|NCT01998958|527857439|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370559|NCT01998958|527857440|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370560|NCT01998958|527857441|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370561|NCT01998958|527857442|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370562|NCT01998958|527857443|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370563|NCT01998958|527857444|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370564|NCT01998958|527857445|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370565|NCT01998958|527857446|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370566|NCT01998958|527857447|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370567|NCT01998958|527857448|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370568|NCT01998958|527857449|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370569|NCT01998958|527857450|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370570|NCT01998958|527857451|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370571|NCT01998958|527857452|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370572|NCT01998958|527857453|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370573|NCT01998958|527857454|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370574|NCT01998958|527857455|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370575|NCT01998958|527857456|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370576|NCT01998958|527857457|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370577|NCT01998958|527857458|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
146370578|NCT01998958|527857459|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370579|NCT01998958|527857460|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370580|NCT01998958|527857461|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370581|NCT01998958|527857462|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370582|NCT01998958|527857463|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370583|NCT01998958|527857464|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370584|NCT01998958|527857465|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370585|NCT01998958|527857466|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370586|NCT01998958|527857467|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
146370587|NCT01998958|527857436|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370588|NCT01998958|527857437|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370589|NCT01998958|527857438|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370590|NCT01998958|527857439|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370591|NCT01998958|527857440|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370592|NCT01998958|527857441|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370593|NCT01998958|527857442|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370594|NCT01998958|527857443|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370595|NCT01998958|527857444|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370596|NCT01998958|527857445|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370597|NCT01998958|527857446|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370598|NCT01998958|527857447|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370599|NCT01998958|527857448|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370600|NCT01998958|527857449|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370601|NCT01998958|527857450|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370602|NCT01998958|527857451|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370603|NCT01998958|527857452|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370604|NCT01998958|527857453|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370605|NCT01998958|527857454|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370606|NCT01998958|527857455|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370607|NCT01998958|527857456|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370608|NCT01998958|527857457|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
146370609|NCT01998958|527857458|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
146370610|NCT01998958|527857459|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370611|NCT01998958|527857460|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370612|NCT01998958|527857461|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370613|NCT01998958|527857462|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370614|NCT01998958|527857463|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370615|NCT01998958|527857464|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370616|NCT01998958|527857465|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370617|NCT01998958|527857466|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370618|NCT01998958|527857467|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
146370619|NCT01998958|527857436|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370620|NCT01998958|527857437|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370621|NCT01998958|527857438|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370622|NCT01998958|527857439|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370623|NCT01998958|527857440|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370624|NCT01998958|527857441|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370625|NCT01998958|527857442|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370626|NCT01998958|527857443|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370627|NCT01998958|527857444|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370628|NCT01998958|527857445|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370629|NCT01998958|527857446|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370630|NCT01998958|527857447|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370631|NCT01998958|527857448|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370632|NCT01998958|527857449|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370633|NCT01998958|527857450|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370634|NCT01998958|527857451|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370635|NCT01998958|527857452|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370636|NCT01998958|527857453|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370637|NCT01998958|527857454|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370638|NCT01998958|527857455|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370639|NCT01998958|527857456|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370640|NCT01998958|527857457|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
146370641|NCT01998958|527857458|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
146370642|NCT01998958|527857459|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
146370643|NCT01998958|527857460|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370644|NCT01998958|527857461|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370645|NCT01998958|527857462|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370646|NCT01998958|527857463|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370647|NCT01998958|527857464|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370648|NCT01998958|527857465|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370649|NCT01998958|527857466|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370650|NCT01998958|527857467|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
146370651|NCT02432703|527857468|FG000|Overall Study|Adverse Event|1|||
146370652|NCT02432703|527857469|FG001|Overall Study|Adverse Event|4|||
146370653|NCT02432703|527857468|FG000|Overall Study|Lack of Efficacy|1|||
146370654|NCT02432703|527857469|FG001|Overall Study|Lack of Efficacy|0|||
146370655|NCT02432703|527857468|FG000|Overall Study|Lost to Follow-up|5|||
146370656|NCT02432703|527857469|FG001|Overall Study|Lost to Follow-up|3|||
146370657|NCT02432703|527857468|FG000|Overall Study|Withdrawal by Subject|9|||
146370658|NCT02432703|527857469|FG001|Overall Study|Withdrawal by Subject|6|||
146370659|NCT02432703|527857468|FG000|Overall Study|Other|6|||
146370660|NCT02432703|527857469|FG001|Overall Study|Other|5|||
146370661|NCT00724815|527857472|FG000|Overall Study|Randomized, not treated|31|||
146370662|NCT00724815|527857473|FG001|Overall Study|Randomized, not treated|30|||
146370663|NCT00724815|527857472|FG000|Overall Study|Adverse Event|5|||
146370664|NCT00724815|527857473|FG001|Overall Study|Adverse Event|3|||
146370665|NCT00724815|527857472|FG000|Overall Study|Lost to Follow-up|4|||
146370666|NCT00724815|527857473|FG001|Overall Study|Lost to Follow-up|1|||
146370667|NCT00724815|527857472|FG000|Overall Study|Other Various|3|||
146370668|NCT00724815|527857473|FG001|Overall Study|Other Various|5|||
146370669|NCT01628393|527857474|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
146370670|NCT01628393|527857475|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146370671|NCT01628393|527857476|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146370672|NCT01628393|527857477|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146370673|NCT01628393|527857478|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
146370674|NCT01628393|527857474|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
146370675|NCT01628393|527857475|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
146370676|NCT01628393|527857476|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
146370677|NCT01628393|527857477|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
146370678|NCT01628393|527857478|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
146370679|NCT01628393|527857474|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
146370680|NCT01628393|527857475|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
146370681|NCT01628393|527857476|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
146370682|NCT01628393|527857477|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146370683|NCT01628393|527857478|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
146370684|NCT01628393|527857474|FG000|Blinded Active Extension Period|Adverse Event|0|||
146370685|NCT01628393|527857475|FG001|Blinded Active Extension Period|Adverse Event|1|||
146370686|NCT01628393|527857476|FG002|Blinded Active Extension Period|Adverse Event|0|||
146370687|NCT01628393|527857477|FG003|Blinded Active Extension Period|Adverse Event|2|||
146370688|NCT01628393|527857478|FG004|Blinded Active Extension Period|Adverse Event|2|||
146370689|NCT01628393|527857474|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
146370690|NCT01628393|527857475|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
146370691|NCT01628393|527857476|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
146370692|NCT01628393|527857477|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
146370693|NCT01628393|527857478|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
146370694|NCT01628393|527857474|FG000|Blinded Active Extension Period|Physician Decision|0|||
146370695|NCT01628393|527857475|FG001|Blinded Active Extension Period|Physician Decision|3|||
146370696|NCT01628393|527857476|FG002|Blinded Active Extension Period|Physician Decision|0|||
146370697|NCT01628393|527857477|FG003|Blinded Active Extension Period|Physician Decision|1|||
146370698|NCT01628393|527857478|FG004|Blinded Active Extension Period|Physician Decision|0|||
146370699|NCT01628393|527857474|FG000|Blinded Active Extension Period|Protocol Violation|0|||
146370700|NCT01628393|527857475|FG001|Blinded Active Extension Period|Protocol Violation|0|||
146370701|NCT01628393|527857476|FG002|Blinded Active Extension Period|Protocol Violation|2|||
146370702|NCT01628393|527857477|FG003|Blinded Active Extension Period|Protocol Violation|1|||
146370703|NCT01628393|527857478|FG004|Blinded Active Extension Period|Protocol Violation|0|||
146370704|NCT01628393|527857474|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
146370705|NCT01628393|527857475|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
146370706|NCT01628393|527857476|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
146370707|NCT01628393|527857477|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
146370708|NCT01628393|527857478|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
146370709|NCT00561340|527857479|FG000|Overall Study|refused to drink pediasure|6|||
146370710|NCT00561340|527857480|FG001|Overall Study|refused to drink pediasure|0|||
146370711|NCT01989754|527857481|FG000|Overall Study|Withdrawal by Subject|10|||
146370712|NCT01989754|527857482|FG001|Overall Study|Withdrawal by Subject|14|||
146370713|NCT01989754|527857481|FG000|Overall Study|Lost to Follow-up|28|||
146370714|NCT01989754|527857482|FG001|Overall Study|Lost to Follow-up|20|||
146370715|NCT01989754|527857481|FG000|Overall Study|Closed Site|1|||
146370716|NCT01989754|527857482|FG001|Overall Study|Closed Site|1|||
146370717|NCT01369225|527857485|FG000|Overall Study|Withdrawal by Subject|1|||
146370718|NCT01369225|527857486|FG001|Overall Study|Withdrawal by Subject|0|||
146370719|NCT01369225|527857487|FG002|Overall Study|Withdrawal by Subject|2|||
146370720|NCT01369225|527857488|FG003|Overall Study|Withdrawal by Subject|1|||
146370721|NCT01369225|527857489|FG004|Overall Study|Withdrawal by Subject|0|||
146370722|NCT01369225|527857490|FG005|Overall Study|Withdrawal by Subject|0|||
146370723|NCT01369225|527857485|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
146370724|NCT01369225|527857486|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
146370725|NCT01369225|527857487|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
146370726|NCT01369225|527857488|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
146370727|NCT01369225|527857489|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
146370728|NCT01369225|527857490|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
146370729|NCT01369225|527857485|FG000|Overall Study|Other|1|||
146370730|NCT01369225|527857486|FG001|Overall Study|Other|0|||
146370731|NCT01369225|527857487|FG002|Overall Study|Other|0|||
146370732|NCT01369225|527857488|FG003|Overall Study|Other|0|||
146370733|NCT01369225|527857489|FG004|Overall Study|Other|1|||
146370734|NCT01369225|527857490|FG005|Overall Study|Other|0|||
146370735|NCT01369225|527857485|FG000|Overall Study|Adverse Event|0|||
146370736|NCT01369225|527857486|FG001|Overall Study|Adverse Event|0|||
146370737|NCT01369225|527857487|FG002|Overall Study|Adverse Event|0|||
146370738|NCT01369225|527857488|FG003|Overall Study|Adverse Event|1|||
146370739|NCT01369225|527857489|FG004|Overall Study|Adverse Event|1|||
146370740|NCT01369225|527857490|FG005|Overall Study|Adverse Event|0|||
146370741|NCT00105183|527857494|FG000|Overall Study|Death|19|||
146370742|NCT00105183|527857495|FG001|Overall Study|Death|13|||
146370743|NCT00105183|527857496|FG002|Overall Study|Death|15|||
146370744|NCT00105183|527857494|FG000|Overall Study|Withdrawal by Subject|1|||
146370745|NCT00105183|527857495|FG001|Overall Study|Withdrawal by Subject|1|||
146370746|NCT00105183|527857496|FG002|Overall Study|Withdrawal by Subject|4|||
146370747|NCT00105183|527857494|FG000|Overall Study|Physician Decision|1|||
146370748|NCT00105183|527857495|FG001|Overall Study|Physician Decision|2|||
146370749|NCT00105183|527857496|FG002|Overall Study|Physician Decision|3|||
146370750|NCT00105183|527857494|FG000|Overall Study|Lost to Follow-up|0|||
146370751|NCT00105183|527857495|FG001|Overall Study|Lost to Follow-up|1|||
146370752|NCT00105183|527857496|FG002|Overall Study|Lost to Follow-up|1|||
146370753|NCT00105183|527857494|FG000|Overall Study|Other reason|1|||
146370754|NCT00105183|527857495|FG001|Overall Study|Other reason|2|||
146370755|NCT00105183|527857496|FG002|Overall Study|Other reason|0|||
146370756|NCT01467661|527857498|FG000|Overall Study|Adverse Event|16|||
146370757|NCT01467661|527857498|FG000|Overall Study|Withdrawal by Subject|1|||
146370758|NCT01467661|527857498|FG000|Overall Study|Lack of Efficacy|3|||
146370759|NCT01467661|527857498|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
146370760|NCT03037307|527857499|FG000|Period 1|Did Not Meet Study Criteria|0|||
146370761|NCT03037307|527857500|FG001|Period 1|Did Not Meet Study Criteria|0|||
146370762|NCT03037307|527857501|FG002|Period 1|Did Not Meet Study Criteria|0|||
146370763|NCT03037307|527857502|FG003|Period 1|Did Not Meet Study Criteria|1|||
146370764|NCT03037307|527857503|FG004|Period 1|Did Not Meet Study Criteria|0|||
146370765|NCT03037307|527857504|FG005|Period 1|Did Not Meet Study Criteria|0|||
146370766|NCT01855945|527857507|FG000|Overall Study|Adverse Event|0|||
146370767|NCT01855945|527857508|FG001|Overall Study|Adverse Event|0|||
146370768|NCT01855945|527857509|FG002|Overall Study|Adverse Event|0|||
146370769|NCT01855945|527857510|FG003|Overall Study|Adverse Event|0|||
146370770|NCT01855945|527857511|FG004|Overall Study|Adverse Event|0|||
146370771|NCT01855945|527857512|FG005|Overall Study|Adverse Event|0|||
146370772|NCT01855945|527857513|FG006|Overall Study|Adverse Event|1|||
146370773|NCT01855945|527857514|FG007|Overall Study|Adverse Event|0|||
146370774|NCT01855945|527857515|FG008|Overall Study|Adverse Event|0|||
146370775|NCT01855945|527857516|FG009|Overall Study|Adverse Event|0|||
146370776|NCT01855945|527857517|FG010|Overall Study|Adverse Event|0|||
146370777|NCT01855945|527857518|FG011|Overall Study|Adverse Event|0|||
146370778|NCT01855945|527857507|FG000|Overall Study|Death|0|||
146370779|NCT01855945|527857508|FG001|Overall Study|Death|0|||
146370780|NCT01855945|527857509|FG002|Overall Study|Death|0|||
146370781|NCT01855945|527857510|FG003|Overall Study|Death|0|||
146370782|NCT01855945|527857511|FG004|Overall Study|Death|0|||
146370783|NCT01855945|527857512|FG005|Overall Study|Death|0|||
146370784|NCT01855945|527857513|FG006|Overall Study|Death|2|||
146370785|NCT01855945|527857514|FG007|Overall Study|Death|0|||
146370786|NCT01855945|527857515|FG008|Overall Study|Death|0|||
146370787|NCT01855945|527857516|FG009|Overall Study|Death|0|||
146370788|NCT01855945|527857517|FG010|Overall Study|Death|0|||
146370789|NCT01855945|527857518|FG011|Overall Study|Death|0|||
146370790|NCT01855945|527857507|FG000|Overall Study|Lost to Follow-up|11|||
146370791|NCT01855945|527857508|FG001|Overall Study|Lost to Follow-up|10|||
146370792|NCT01855945|527857509|FG002|Overall Study|Lost to Follow-up|7|||
146370793|NCT01855945|527857510|FG003|Overall Study|Lost to Follow-up|3|||
146370794|NCT01855945|527857511|FG004|Overall Study|Lost to Follow-up|0|||
146370795|NCT01855945|527857512|FG005|Overall Study|Lost to Follow-up|3|||
146370796|NCT01855945|527857513|FG006|Overall Study|Lost to Follow-up|4|||
146370797|NCT01855945|527857514|FG007|Overall Study|Lost to Follow-up|7|||
146370798|NCT01855945|527857515|FG008|Overall Study|Lost to Follow-up|2|||
146370799|NCT01855945|527857516|FG009|Overall Study|Lost to Follow-up|0|||
146370800|NCT01855945|527857517|FG010|Overall Study|Lost to Follow-up|0|||
146370801|NCT01855945|527857518|FG011|Overall Study|Lost to Follow-up|2|||
146370802|NCT01855945|527857507|FG000|Overall Study|Other - Unclassified|1|||
146370803|NCT01855945|527857508|FG001|Overall Study|Other - Unclassified|1|||
146370804|NCT01855945|527857509|FG002|Overall Study|Other - Unclassified|1|||
146370805|NCT01855945|527857510|FG003|Overall Study|Other - Unclassified|0|||
146370806|NCT01855945|527857511|FG004|Overall Study|Other - Unclassified|0|||
146370807|NCT01855945|527857512|FG005|Overall Study|Other - Unclassified|0|||
146370808|NCT01855945|527857513|FG006|Overall Study|Other - Unclassified|2|||
146370809|NCT01855945|527857514|FG007|Overall Study|Other - Unclassified|1|||
146370810|NCT01855945|527857515|FG008|Overall Study|Other - Unclassified|0|||
146370811|NCT01855945|527857516|FG009|Overall Study|Other - Unclassified|0|||
146370812|NCT01855945|527857517|FG010|Overall Study|Other - Unclassified|1|||
146370813|NCT01855945|527857518|FG011|Overall Study|Other - Unclassified|0|||
146370814|NCT01855945|527857507|FG000|Overall Study|Withdrawal by Subject|4|||
146370815|NCT01855945|527857508|FG001|Overall Study|Withdrawal by Subject|0|||
146370816|NCT01855945|527857509|FG002|Overall Study|Withdrawal by Subject|4|||
146370817|NCT01855945|527857510|FG003|Overall Study|Withdrawal by Subject|1|||
146370818|NCT01855945|527857511|FG004|Overall Study|Withdrawal by Subject|1|||
146370819|NCT01855945|527857512|FG005|Overall Study|Withdrawal by Subject|0|||
146370820|NCT01855945|527857513|FG006|Overall Study|Withdrawal by Subject|1|||
146370821|NCT01855945|527857514|FG007|Overall Study|Withdrawal by Subject|0|||
146370822|NCT01855945|527857515|FG008|Overall Study|Withdrawal by Subject|0|||
146370823|NCT01855945|527857516|FG009|Overall Study|Withdrawal by Subject|2|||
146370824|NCT01855945|527857517|FG010|Overall Study|Withdrawal by Subject|4|||
146370825|NCT01855945|527857518|FG011|Overall Study|Withdrawal by Subject|1|||
146370826|NCT02156804|527857519|FG000|Overall Study|Withdrawal by Subject|1|||
146370827|NCT02260388|527857522|FG000|Overall Study|Lost to Follow-up|2|||
146370828|NCT02260388|527857523|FG001|Overall Study|Lost to Follow-up|8|||
146370829|NCT02260388|527857524|FG002|Overall Study|Lost to Follow-up|3|||
146370830|NCT02260388|527857525|FG003|Overall Study|Lost to Follow-up|4|||
146370831|NCT00389441|527857526|FG000|Overall Study|Adverse Event|7|||
146370832|NCT00389441|527857526|FG000|Overall Study|Death|4|||
146370833|NCT00389441|527857526|FG000|Overall Study|Lost to Follow-up|2|||
146370834|NCT00389441|527857526|FG000|Overall Study|Withdrawal by Subject|4|||
146370835|NCT00389441|527857526|FG000|Overall Study|Physician Decision|1|||
146370836|NCT00389441|527857526|FG000|Overall Study|Protocol Violation|1|||
146370837|NCT00389441|527857526|FG000|Overall Study|Global deterioration of health status|4|||
146370838|NCT00389441|527857526|FG000|Overall Study|Objective progression or relapse|26|||
146370839|NCT00389441|527857526|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
146370840|NCT00389441|527857526|FG000|Overall Study|Clinical progression|1|||
146370841|NCT00636441|527857527|FG000|Overall Study|Adverse Event|0|||
146370842|NCT00636441|527857528|FG001|Overall Study|Adverse Event|1|||
146370843|NCT00636441|527857529|FG002|Overall Study|Adverse Event|1|||
146370844|NCT00636441|527857530|FG003|Overall Study|Adverse Event|0|||
146370845|NCT00636441|527857531|FG004|Overall Study|Adverse Event|0|||
146370846|NCT00636441|527857532|FG005|Overall Study|Adverse Event|1|||
146370847|NCT00636441|527857533|FG006|Overall Study|Adverse Event|0|||
146370848|NCT00636441|527857527|FG000|Overall Study|Late, ineligible|0|||
146370849|NCT00636441|527857528|FG001|Overall Study|Late, ineligible|0|||
146370850|NCT00636441|527857529|FG002|Overall Study|Late, ineligible|0|||
146370851|NCT00636441|527857530|FG003|Overall Study|Late, ineligible|0|||
146370852|NCT00636441|527857531|FG004|Overall Study|Late, ineligible|0|||
146370853|NCT00636441|527857532|FG005|Overall Study|Late, ineligible|0|||
146370854|NCT00636441|527857533|FG006|Overall Study|Late, ineligible|1|||
146370855|NCT00636441|527857527|FG000|Overall Study|Screen Failure|0|||
146370856|NCT00636441|527857528|FG001|Overall Study|Screen Failure|0|||
146370857|NCT00636441|527857529|FG002|Overall Study|Screen Failure|0|||
146370858|NCT00636441|527857530|FG003|Overall Study|Screen Failure|0|||
146370859|NCT00636441|527857531|FG004|Overall Study|Screen Failure|0|||
146370860|NCT00636441|527857532|FG005|Overall Study|Screen Failure|0|||
146370861|NCT00636441|527857533|FG006|Overall Study|Screen Failure|17|||
146370862|NCT00305604|527857535|FG000|Overall Study|Adverse Event|6|||
146370863|NCT00305604|527857536|FG001|Overall Study|Adverse Event|3|||
146370864|NCT00305604|527857535|FG000|Overall Study|Lack of Efficacy|11|||
146370865|NCT00305604|527857536|FG001|Overall Study|Lack of Efficacy|18|||
146370866|NCT00305604|527857535|FG000|Overall Study|Lost to Follow-up|0|||
146370867|NCT00305604|527857536|FG001|Overall Study|Lost to Follow-up|4|||
146370868|NCT00305604|527857535|FG000|Overall Study|Protocol Violation|2|||
146370869|NCT00305604|527857536|FG001|Overall Study|Protocol Violation|1|||
146370870|NCT00305604|527857535|FG000|Overall Study|Withdrawal by Subject|12|||
146370871|NCT00305604|527857536|FG001|Overall Study|Withdrawal by Subject|21|||
146370872|NCT00305604|527857535|FG000|Overall Study|Patient moved|1|||
146370873|NCT00305604|527857536|FG001|Overall Study|Patient moved|0|||
146370874|NCT00753623|527857538|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
146370875|NCT00753623|527857539|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
146370876|NCT00753623|527857538|FG000|Phase I (14 Days)|Physician Decision|1|||
146370877|NCT00753623|527857539|FG001|Phase I (14 Days)|Physician Decision|2|||
146370878|NCT00753623|527857538|FG000|Phase I (14 Days)|Adverse Event|0|||
146370879|NCT00753623|527857539|FG001|Phase I (14 Days)|Adverse Event|1|||
146370880|NCT00753623|527857538|FG000|Washout (7 Days)|Physician Decision|1|||
146370881|NCT00753623|527857539|FG001|Washout (7 Days)|Physician Decision|0|||
146370882|NCT00753623|527857538|FG000|Phase II (14 Days)|Physician Decision|0|||
146370883|NCT00753623|527857539|FG001|Phase II (14 Days)|Physician Decision|1|||
146370884|NCT03332303|527857540|FG000|Overall Study|Participant did not dose|1|||
146370885|NCT03332303|527857541|FG001|Overall Study|Participant did not dose|2|||
146370886|NCT03332303|527857542|FG002|Overall Study|Participant did not dose|0|||
146370887|NCT03332303|527857540|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
146370888|NCT03332303|527857541|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
146370889|NCT03332303|527857542|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
146370890|NCT03332303|527857540|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
146370891|NCT03332303|527857541|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
146370892|NCT03332303|527857542|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
146370893|NCT03332303|527857540|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
146370894|NCT03332303|527857541|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
146370895|NCT03332303|527857542|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
146370896|NCT03332303|527857540|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
146370897|NCT03332303|527857541|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
146370898|NCT03332303|527857542|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
146370899|NCT03332303|527857540|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
146370900|NCT03332303|527857541|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
146370901|NCT03332303|527857542|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
146370902|NCT03332303|527857540|FG000|Overall Study|Participant had a significant protocol deviation|0|||
146370903|NCT03332303|527857541|FG001|Overall Study|Participant had a significant protocol deviation|1|||
146370904|NCT03332303|527857542|FG002|Overall Study|Participant had a significant protocol deviation|0|||
146370905|NCT03495817|527857544|FG000|26 Week Open Label|Adverse Event|3|||
146370906|NCT03495817|527857544|FG000|26 Week Open Label|Withdrawal by Subject|4|||
146370907|NCT03495817|527857544|FG000|26 Week Open Label|Lost to Follow-up|1|||
146370908|NCT03495817|527857544|FG000|26 Week Extension|Lost to Follow-up|2|||
146370909|NCT00326417|527857545|FG000|Overall Study|Withdrawal by Subject|0|||
146370910|NCT00326417|527857546|FG001|Overall Study|Withdrawal by Subject|0|||
146370911|NCT00326417|527857547|FG002|Overall Study|Withdrawal by Subject|1|||
146370912|NCT00326417|527857548|FG003|Overall Study|Withdrawal by Subject|0|||
146370913|NCT00326417|527857545|FG000|Overall Study|Arm Closed|7|||
146370914|NCT00326417|527857546|FG001|Overall Study|Arm Closed|0|||
146370915|NCT00326417|527857547|FG002|Overall Study|Arm Closed|0|||
146370916|NCT00326417|527857548|FG003|Overall Study|Arm Closed|3|||
146370917|NCT00326417|527857545|FG000|Overall Study|Death|7|||
146370918|NCT00326417|527857546|FG001|Overall Study|Death|0|||
146370919|NCT00326417|527857547|FG002|Overall Study|Death|0|||
146370920|NCT00326417|527857548|FG003|Overall Study|Death|0|||
146370921|NCT00844285|527857549|FG000|Overall Study|Other|0|||
146370922|NCT00844285|527857550|FG001|Overall Study|Other|1|||
146370923|NCT00844285|527857551|FG002|Overall Study|Other|0|||
146370924|NCT00844285|527857549|FG000|Overall Study|Other than specified|95|||
146370925|NCT00844285|527857550|FG001|Overall Study|Other than specified|129|||
146370926|NCT00844285|527857551|FG002|Overall Study|Other than specified|12|||
146370927|NCT00844285|527857549|FG000|Overall Study|Site closure|256|||
146370928|NCT00844285|527857550|FG001|Overall Study|Site closure|450|||
146370929|NCT00844285|527857551|FG002|Overall Study|Site closure|50|||
146370930|NCT00844285|527857549|FG000|Overall Study|Follow-up < 8 years|16|||
146370931|NCT00844285|527857550|FG001|Overall Study|Follow-up < 8 years|23|||
146370932|NCT00844285|527857551|FG002|Overall Study|Follow-up < 8 years|4|||
146370933|NCT00844285|527857549|FG000|Overall Study|Protocol Violation|26|||
146370934|NCT00844285|527857550|FG001|Overall Study|Protocol Violation|28|||
146370935|NCT00844285|527857551|FG002|Overall Study|Protocol Violation|54|||
146370936|NCT00844285|527857549|FG000|Overall Study|Death|22|||
146370937|NCT00844285|527857550|FG001|Overall Study|Death|21|||
146370938|NCT00844285|527857551|FG002|Overall Study|Death|8|||
146370939|NCT00844285|527857549|FG000|Overall Study|Withdrew Consent|344|||
146370940|NCT00844285|527857550|FG001|Overall Study|Withdrew Consent|466|||
146370941|NCT00844285|527857551|FG002|Overall Study|Withdrew Consent|70|||
146370942|NCT00844285|527857549|FG000|Overall Study|Lost to Follow-up|330|||
146370943|NCT00844285|527857550|FG001|Overall Study|Lost to Follow-up|486|||
146370944|NCT00844285|527857551|FG002|Overall Study|Lost to Follow-up|74|||
146370945|NCT01586806|527857552|FG000|Overall Study|Protocol Violation|0|||
146370946|NCT01586806|527857553|FG001|Overall Study|Protocol Violation|1|||
146370947|NCT01586806|527857554|FG002|Overall Study|Protocol Violation|0|||
146370948|NCT01586806|527857552|FG000|Overall Study|Withdrawal by Subject|1|||
146370949|NCT01586806|527857553|FG001|Overall Study|Withdrawal by Subject|0|||
146370950|NCT01586806|527857554|FG002|Overall Study|Withdrawal by Subject|0|||
146370951|NCT01586806|527857552|FG000|Overall Study|Lost to Follow-up|2|||
146370952|NCT01586806|527857553|FG001|Overall Study|Lost to Follow-up|3|||
146370953|NCT01586806|527857554|FG002|Overall Study|Lost to Follow-up|2|||
146370954|NCT00435994|527857556|FG000|Overall Study|Lost to Follow-up|7|||
146370955|NCT00435994|527857557|FG001|Overall Study|Lost to Follow-up|0|||
146370956|NCT00435994|527857558|FG002|Overall Study|Lost to Follow-up|0|||
146370957|NCT00345540|527857559|FG000|Overall Study|Withdrawal by Subject|1|||
146370958|NCT00628758|527857560|FG000|Overall Study|Adverse Event|2|||
146370959|NCT00628758|527857561|FG001|Overall Study|Adverse Event|3|||
146370960|NCT00628758|527857560|FG000|Overall Study|Withdrawal by Subject|6|||
146370961|NCT00628758|527857561|FG001|Overall Study|Withdrawal by Subject|3|||
146370962|NCT00628758|527857560|FG000|Overall Study|Death|1|||
146370963|NCT00628758|527857561|FG001|Overall Study|Death|0|||
146370964|NCT00628758|527857560|FG000|Overall Study|Protocol Violation|5|||
146370965|NCT00628758|527857561|FG001|Overall Study|Protocol Violation|1|||
146370966|NCT00628758|527857560|FG000|Overall Study|Lost to Follow-up|25|||
146370967|NCT00628758|527857561|FG001|Overall Study|Lost to Follow-up|31|||
146370968|NCT00628758|527857560|FG000|Overall Study|Pregnancy|2|||
146370969|NCT00628758|527857561|FG001|Overall Study|Pregnancy|2|||
146370970|NCT00628758|527857560|FG000|Overall Study|Investigator Moved|3|||
146370971|NCT00628758|527857561|FG001|Overall Study|Investigator Moved|0|||
146370972|NCT00628758|527857560|FG000|Overall Study|Treatment Failure|0|||
146370973|NCT00628758|527857561|FG001|Overall Study|Treatment Failure|2|||
146370974|NCT04179786|527857562|FG000|Overall Study|Withdrawal by Subject|8|||
146370975|NCT02983799|527857563|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
146370976|NCT02983799|527857564|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
146370977|NCT02983799|527857565|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
146370978|NCT02983799|527857566|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
146370979|NCT02983799|527857567|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
146370980|NCT02983799|527857563|FG000|Overall Study|Death|20|||
146370981|NCT02983799|527857564|FG001|Overall Study|Death|5|||
146370982|NCT02983799|527857565|FG002|Overall Study|Death|23|||
146370983|NCT02983799|527857566|FG003|Overall Study|Death|47|||
146370984|NCT02983799|527857567|FG004|Overall Study|Death|7|||
146370985|NCT02983799|527857563|FG000|Overall Study|Withdrawal by Subject|1|||
146370986|NCT02983799|527857564|FG001|Overall Study|Withdrawal by Subject|0|||
146370987|NCT02983799|527857565|FG002|Overall Study|Withdrawal by Subject|3|||
146370988|NCT02983799|527857566|FG003|Overall Study|Withdrawal by Subject|4|||
146370989|NCT02983799|527857567|FG004|Overall Study|Withdrawal by Subject|1|||
146370990|NCT02983799|527857563|FG000|Overall Study|Protocol Violation|0|||
146370991|NCT02983799|527857564|FG001|Overall Study|Protocol Violation|1|||
146370992|NCT02983799|527857565|FG002|Overall Study|Protocol Violation|0|||
146370993|NCT02983799|527857566|FG003|Overall Study|Protocol Violation|0|||
146370994|NCT02983799|527857567|FG004|Overall Study|Protocol Violation|1|||
146370995|NCT02983799|527857563|FG000|Overall Study|Lost to Follow-up|1|||
146370996|NCT02983799|527857564|FG001|Overall Study|Lost to Follow-up|0|||
146370997|NCT02983799|527857565|FG002|Overall Study|Lost to Follow-up|1|||
146370998|NCT02983799|527857566|FG003|Overall Study|Lost to Follow-up|0|||
146370999|NCT02983799|527857567|FG004|Overall Study|Lost to Follow-up|0|||
146371000|NCT03175562|527857574|FG000|Overall Study|Adverse Event|1|||
146371001|NCT03175562|527857574|FG000|Overall Study|Lost to Follow-up|3|||
146371002|NCT03175562|527857574|FG000|Overall Study|Withdrawal by Subject|7|||
146371003|NCT03175562|527857574|FG000|Overall Study|Other (Not Specified)|5|||
146371004|NCT01230749|527857575|FG000|Overall Study|Adverse Event|0|||
146371005|NCT01230749|527857576|FG001|Overall Study|Adverse Event|0|||
146371006|NCT01230749|527857577|FG002|Overall Study|Adverse Event|0|||
146371007|NCT01230749|527857578|FG003|Overall Study|Adverse Event|1|||
146371008|NCT01230749|527857575|FG000|Overall Study|Physician Decision|0|||
146371009|NCT01230749|527857576|FG001|Overall Study|Physician Decision|0|||
146371010|NCT01230749|527857577|FG002|Overall Study|Physician Decision|1|||
146371011|NCT01230749|527857578|FG003|Overall Study|Physician Decision|0|||
146371012|NCT01230749|527857575|FG000|Overall Study|Withdrawal by Subject|0|||
146371013|NCT01230749|527857576|FG001|Overall Study|Withdrawal by Subject|1|||
146371014|NCT01230749|527857577|FG002|Overall Study|Withdrawal by Subject|0|||
146371015|NCT01230749|527857578|FG003|Overall Study|Withdrawal by Subject|0|||
146371016|NCT01230749|527857575|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
146371017|NCT01230749|527857576|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146371018|NCT01230749|527857577|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146371019|NCT01230749|527857578|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
146371020|NCT00107172|527859796|FG000|Overall Study|Withdrawal by Subject|1|||
146371021|NCT00107172|527859797|FG001|Overall Study|Withdrawal by Subject|0|||
146371022|NCT00107172|527859796|FG000|Overall Study|Death|0|||
146371023|NCT00107172|527859797|FG001|Overall Study|Death|2|||
146371024|NCT00107172|527859796|FG000|Overall Study|Other Reason|4|||
146371025|NCT00107172|527859797|FG001|Overall Study|Other Reason|3|||
145943485|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146371026|NCT02688153|527859798|FG000|Overall Study|Death|7|||
146371027|NCT02688153|527859799|FG001|Overall Study|Death|5|||
146371028|NCT02688153|527859798|FG000|Overall Study|Withdrawal by Subject|4|||
146371029|NCT02688153|527859799|FG001|Overall Study|Withdrawal by Subject|2|||
146371030|NCT02688153|527859798|FG000|Overall Study|Valve Explant|1|||
146371031|NCT02688153|527859799|FG001|Overall Study|Valve Explant|0|||
146371032|NCT02688153|527859798|FG000|Overall Study|Conversion to Commercial Valve|3|||
146371033|NCT02688153|527859799|FG001|Overall Study|Conversion to Commercial Valve|0|||
146371034|NCT03750240|527859801|FG000|Overall Study|Technical Difficulties|2|||
146371035|NCT03706040|527859802|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
146371036|NCT03706040|527859803|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
146371037|NCT03706040|527859804|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
146371038|NCT03706040|527859805|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
146371039|NCT03706040|527859806|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
146371040|NCT03706040|527859807|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
146371041|NCT03706040|527859808|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
146371042|NCT03706040|527859802|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
146371043|NCT03706040|527859803|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
146371044|NCT03706040|527859804|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
146371045|NCT03706040|527859805|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146371046|NCT03706040|527859806|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146371047|NCT03706040|527859807|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146371048|NCT03706040|527859808|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
146371049|NCT03706040|527859802|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
146371050|NCT03706040|527859803|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
146371051|NCT03706040|527859804|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
146371052|NCT03706040|527859805|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146371053|NCT03706040|527859806|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146371054|NCT03706040|527859807|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146371055|NCT03706040|527859808|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
146371056|NCT03706040|527859802|FG000|Period A (Week 0 to Week 16)|Other|2|||
146371057|NCT03706040|527859803|FG001|Period A (Week 0 to Week 16)|Other|0|||
146371058|NCT03706040|527859804|FG002|Period A (Week 0 to Week 16)|Other|2|||
146371059|NCT03706040|527859805|FG003|Period A (Week 0 to Week 16)|Other|0|||
146371060|NCT03706040|527859806|FG004|Period A (Week 0 to Week 16)|Other|0|||
146371061|NCT03706040|527859807|FG005|Period A (Week 0 to Week 16)|Other|0|||
146371062|NCT03706040|527859808|FG006|Period A (Week 0 to Week 16)|Other|0|||
146371063|NCT03706040|527859802|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
146371064|NCT03706040|527859803|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
146371065|NCT03706040|527859804|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
146371066|NCT03706040|527859805|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
146371067|NCT03706040|527859806|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
146371068|NCT03706040|527859807|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
146371069|NCT03706040|527859808|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
146371070|NCT03706040|527859802|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146371071|NCT03706040|527859803|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146371072|NCT03706040|527859804|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
146371073|NCT03706040|527859805|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
146371074|NCT03706040|527859806|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
146371075|NCT03706040|527859807|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
146371076|NCT03706040|527859808|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
146371077|NCT03706040|527859802|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146371078|NCT03706040|527859803|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146371079|NCT03706040|527859804|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146371080|NCT03706040|527859805|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146371081|NCT03706040|527859806|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
146371082|NCT03706040|527859807|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
146371083|NCT03706040|527859808|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
146371084|NCT03706040|527859802|FG000|Period B (Week 16 to Week 52)|Other|0|||
146371085|NCT03706040|527859803|FG001|Period B (Week 16 to Week 52)|Other|0|||
146371086|NCT03706040|527859804|FG002|Period B (Week 16 to Week 52)|Other|0|||
146371087|NCT03706040|527859805|FG003|Period B (Week 16 to Week 52)|Other|4|||
146371088|NCT03706040|527859806|FG004|Period B (Week 16 to Week 52)|Other|5|||
146371089|NCT03706040|527859807|FG005|Period B (Week 16 to Week 52)|Other|23|||
146371090|NCT03706040|527859808|FG006|Period B (Week 16 to Week 52)|Other|17|||
146371091|NCT00927758|527859809|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146371092|NCT00927758|527859810|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146371093|NCT00927758|527859811|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146371094|NCT00927758|527859812|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
146371095|NCT00927758|527859813|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
146371096|NCT00927758|527859814|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
146371097|NCT00927758|527859809|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146371098|NCT00927758|527859810|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146371099|NCT00927758|527859811|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146371100|NCT00927758|527859812|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146371101|NCT00927758|527859813|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
146371102|NCT00927758|527859814|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
146371103|NCT00439725|527859816|FG000|Treatment Period|Withdrawal by Subject|22|||
146371104|NCT00439725|527859817|FG001|Treatment Period|Withdrawal by Subject|19|||
146371105|NCT00439725|527859816|FG000|Treatment Period|Study terminated by sponsor|156|||
146371106|NCT00439725|527859817|FG001|Treatment Period|Study terminated by sponsor|148|||
146371107|NCT00439725|527859816|FG000|Treatment Period|Site closed by investigator|1|||
146371108|NCT00439725|527859817|FG001|Treatment Period|Site closed by investigator|2|||
146371109|NCT00439725|527859816|FG000|Treatment Period|Adverse Event|39|||
146371110|NCT00439725|527859817|FG001|Treatment Period|Adverse Event|18|||
146371111|NCT00439725|527859816|FG000|Treatment Period|Physician Decision|1|||
146371112|NCT00439725|527859817|FG001|Treatment Period|Physician Decision|1|||
146371113|NCT00439725|527859816|FG000|Treatment Period|Protocol Violation|2|||
146371114|NCT00439725|527859817|FG001|Treatment Period|Protocol Violation|1|||
146371115|NCT00439725|527859816|FG000|Treatment Period|Clinical endpoint reached|6|||
146371116|NCT00439725|527859817|FG001|Treatment Period|Clinical endpoint reached|50|||
146371117|NCT00439725|527859816|FG000|Treatment Period|Technical problems|1|||
146371118|NCT00439725|527859817|FG001|Treatment Period|Technical problems|0|||
146371119|NCT00439725|527859816|FG000|Treatment Period|Lost to Follow-up|1|||
146371120|NCT00439725|527859817|FG001|Treatment Period|Lost to Follow-up|1|||
146371121|NCT00439725|527859816|FG000|Treatment Period|Participant convenience|1|||
146371122|NCT00439725|527859817|FG001|Treatment Period|Participant convenience|0|||
146371123|NCT00439725|527859816|FG000|Treatment Period|Protocol driven decision point|1|||
146371124|NCT00439725|527859817|FG001|Treatment Period|Protocol driven decision point|1|||
146371125|NCT00439725|527859816|FG000|Treatment Period|Death|1|||
146371126|NCT00439725|527859817|FG001|Treatment Period|Death|1|||
146371127|NCT00439725|527859816|FG000|Treatment Period|Participant did not receive treatment|4|||
146371128|NCT00439725|527859817|FG001|Treatment Period|Participant did not receive treatment|4|||
146371129|NCT00439725|527859816|FG000|Observational Period|Withdrawal by Subject|2|||
146371130|NCT00439725|527859817|FG001|Observational Period|Withdrawal by Subject|2|||
146371131|NCT00439725|527859816|FG000|Observational Period|Lost to Follow-up|0|||
146371132|NCT00439725|527859817|FG001|Observational Period|Lost to Follow-up|1|||
146371133|NCT00439725|527859816|FG000|Observational Period|Death|0|||
146371134|NCT00439725|527859817|FG001|Observational Period|Death|2|||
146371135|NCT00439725|527859816|FG000|Observational Period|Study termination by sponsor|1|||
146371136|NCT00439725|527859817|FG001|Observational Period|Study termination by sponsor|1|||
146371137|NCT00439725|527859816|FG000|Observational Period|Clinical endpoint reached|3|||
146371138|NCT00439725|527859817|FG001|Observational Period|Clinical endpoint reached|1|||
146371139|NCT00439725|527859816|FG000|Observational Period|Technical problems|1|||
146371140|NCT00439725|527859817|FG001|Observational Period|Technical problems|0|||
146371141|NCT00439725|527859816|FG000|Observational Period|Participant convenience|1|||
146371142|NCT00439725|527859817|FG001|Observational Period|Participant convenience|0|||
146371143|NCT03077243|527859818|FG000|Overall Study|Death|1|||
146371144|NCT03077243|527859819|FG001|Overall Study|Death|2|||
146371145|NCT03077243|527859820|FG002|Overall Study|Death|0|||
146371146|NCT03077243|527859821|FG003|Overall Study|Death|0|||
146371147|NCT03077243|527859818|FG000|Overall Study|Withdrawal by Subject|1|||
146371148|NCT03077243|527859819|FG001|Overall Study|Withdrawal by Subject|3|||
146371149|NCT03077243|527859820|FG002|Overall Study|Withdrawal by Subject|0|||
146371150|NCT03077243|527859821|FG003|Overall Study|Withdrawal by Subject|0|||
146371151|NCT03077243|527859818|FG000|Overall Study|Physician Decision|1|||
146371152|NCT03077243|527859819|FG001|Overall Study|Physician Decision|0|||
146371153|NCT03077243|527859820|FG002|Overall Study|Physician Decision|0|||
146371154|NCT03077243|527859821|FG003|Overall Study|Physician Decision|0|||
146371155|NCT03077243|527859818|FG000|Overall Study|Research at two study sites terminated early|0|||
146371156|NCT03077243|527859819|FG001|Overall Study|Research at two study sites terminated early|0|||
146371157|NCT03077243|527859820|FG002|Overall Study|Research at two study sites terminated early|0|||
146371158|NCT03077243|527859821|FG003|Overall Study|Research at two study sites terminated early|69|||
146371159|NCT01544478|527859823|FG000|Overall Study|Adverse Event|1|||
146371160|NCT01544478|527859823|FG000|Overall Study|Death|1|||
146371161|NCT01544478|527859823|FG000|Overall Study|Lost to Follow-up|48|||
146371162|NCT01544478|527859823|FG000|Overall Study|Physician Decision|15|||
146371163|NCT01544478|527859823|FG000|Overall Study|Pregnancy|1|||
146371164|NCT01544478|527859823|FG000|Overall Study|Withdrawal by Subject|52|||
146371165|NCT03984812|527859824|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371166|NCT03984812|527859825|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371167|NCT03984812|527859826|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
146371168|NCT03984812|527859827|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371169|NCT03984812|527859828|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371170|NCT03984812|527859829|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371171|NCT03984812|527859830|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371172|NCT03984812|527859831|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371173|NCT03984812|527859832|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371174|NCT03984812|527859833|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371175|NCT03984812|527859834|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
146371176|NCT04038385|527859835|FG000|Overall Study|Completed baseline assessment only|7|||
146371177|NCT04038385|527859836|FG001|Overall Study|Completed baseline assessment only|4|||
146371178|NCT04038385|527859835|FG000|Overall Study|Moved out of area|4|||
146371179|NCT04038385|527859836|FG001|Overall Study|Moved out of area|2|||
146371180|NCT04038385|527859835|FG000|Overall Study|Discontinued study involvement|6|||
146371181|NCT04038385|527859836|FG001|Overall Study|Discontinued study involvement|1|||
146371182|NCT00063986|527859837|FG000|Overall Study|Withdrawal by Subject|1|||
146371183|NCT00063986|527859837|FG000|Overall Study|Ineligible|1|||
146371184|NCT00063986|527859837|FG000|Overall Study|Intra-operatively ineligible|4|||
146371185|NCT02580240|527859838|FG000|Overall Study|Physician Decision|2|||
146371186|NCT02580240|527859839|FG001|Overall Study|Physician Decision|0|||
146371187|NCT02954952|527859840|FG000|Overall Study|Withdrawal by Subject|1|||
146371188|NCT02954952|527859841|FG001|Overall Study|Withdrawal by Subject|0|||
146371189|NCT02954952|527859842|FG002|Overall Study|Withdrawal by Subject|0|||
146371190|NCT02954952|527859840|FG000|Overall Study|No data collected|0|||
146371191|NCT02954952|527859841|FG001|Overall Study|No data collected|1|||
146371192|NCT02954952|527859842|FG002|Overall Study|No data collected|0|||
146371193|NCT00810043|527859849|FG000|Overall Study|Withdrawal by Subject|1|||
146371194|NCT00810043|527859850|FG001|Overall Study|Withdrawal by Subject|0|||
146371195|NCT00810043|527859851|FG002|Overall Study|Withdrawal by Subject|2|||
146371196|NCT00810043|527859849|FG000|Overall Study|Lost to Follow-up|1|||
146371197|NCT00810043|527859850|FG001|Overall Study|Lost to Follow-up|0|||
146371198|NCT00810043|527859851|FG002|Overall Study|Lost to Follow-up|0|||
146371199|NCT00810043|527859849|FG000|Overall Study|Physician Decision|0|||
146371200|NCT00810043|527859850|FG001|Overall Study|Physician Decision|0|||
146371201|NCT00810043|527859851|FG002|Overall Study|Physician Decision|2|||
146371202|NCT00810043|527859849|FG000|Overall Study|Death|2|||
146371203|NCT00810043|527859850|FG001|Overall Study|Death|0|||
146371204|NCT00810043|527859851|FG002|Overall Study|Death|0|||
146371205|NCT00810043|527859849|FG000|Overall Study|Unrelated medical problem|0|||
146371206|NCT00810043|527859850|FG001|Overall Study|Unrelated medical problem|1|||
146371207|NCT00810043|527859851|FG002|Overall Study|Unrelated medical problem|0|||
146371208|NCT00810043|527859849|FG000|Overall Study|Non-medical problem|0|||
146371209|NCT00810043|527859850|FG001|Overall Study|Non-medical problem|0|||
146371210|NCT00810043|527859851|FG002|Overall Study|Non-medical problem|1|||
146371211|NCT00810043|527859849|FG000|Overall Study|No longer met enrollment criteria|0|||
146371212|NCT00810043|527859850|FG001|Overall Study|No longer met enrollment criteria|0|||
146371213|NCT00810043|527859851|FG002|Overall Study|No longer met enrollment criteria|3|||
146371214|NCT02001688|527859852|FG000|Overall Study|Withdrawal by Subject|0|||
146371215|NCT02001688|527859853|FG001|Overall Study|Withdrawal by Subject|0|||
146371216|NCT02001688|527859854|FG002|Overall Study|Withdrawal by Subject|1|||
146371217|NCT02001688|527859852|FG000|Overall Study|Adverse Event|0|||
146371218|NCT02001688|527859853|FG001|Overall Study|Adverse Event|1|||
146371219|NCT02001688|527859854|FG002|Overall Study|Adverse Event|0|||
146371220|NCT00445341|527859858|FG000|Overall Study|refused further treatment|1|||
146371221|NCT00445341|527859858|FG000|Overall Study|taken off treatment too early|1|||
146371222|NCT03051217|527859861|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
146371223|NCT03051217|527859862|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146371224|NCT03051217|527859863|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
146371225|NCT03051217|527859864|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146371226|NCT03051217|527859865|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146371227|NCT03051217|527859866|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146371228|NCT03051217|527859867|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
146371229|NCT03051217|527859861|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371230|NCT03051217|527859862|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
146371231|NCT03051217|527859863|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371232|NCT03051217|527859864|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371233|NCT03051217|527859865|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371234|NCT03051217|527859866|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371235|NCT03051217|527859867|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
146371236|NCT03051217|527859861|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146371237|NCT03051217|527859862|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146371238|NCT03051217|527859863|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
146371239|NCT03051217|527859864|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146371240|NCT03051217|527859865|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146371241|NCT03051217|527859866|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146371242|NCT03051217|527859867|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
146371243|NCT03051217|527859861|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146371244|NCT03051217|527859862|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146371245|NCT03051217|527859863|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
146371246|NCT03051217|527859864|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146371247|NCT03051217|527859865|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
146371248|NCT03051217|527859866|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146371249|NCT03051217|527859867|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
146371250|NCT03051217|527859861|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371251|NCT03051217|527859862|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371252|NCT03051217|527859863|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371253|NCT03051217|527859864|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
145943486|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146371254|NCT03051217|527859865|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371255|NCT03051217|527859866|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371256|NCT03051217|527859867|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
146371257|NCT03051217|527859861|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371258|NCT03051217|527859862|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371259|NCT03051217|527859863|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371260|NCT03051217|527859864|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
146371261|NCT03051217|527859865|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371262|NCT03051217|527859866|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371263|NCT03051217|527859867|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
146371264|NCT03051217|527859861|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371265|NCT03051217|527859862|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371266|NCT03051217|527859863|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371267|NCT03051217|527859864|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371268|NCT03051217|527859865|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
146371269|NCT03051217|527859866|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371270|NCT03051217|527859867|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
146371271|NCT03051217|527859861|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371272|NCT03051217|527859862|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371273|NCT03051217|527859863|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371274|NCT03051217|527859864|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371275|NCT03051217|527859865|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371276|NCT03051217|527859866|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
146371277|NCT03051217|527859867|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
146371278|NCT00641706|527859868|FG000|Overall Study|Adverse Event|2|||
146371279|NCT00641706|527859869|FG001|Overall Study|Adverse Event|1|||
146371280|NCT00641706|527859868|FG000|Overall Study|Withdrawal by Subject|6|||
146371281|NCT00641706|527859869|FG001|Overall Study|Withdrawal by Subject|1|||
146371282|NCT00641706|527859868|FG000|Overall Study|Clinical Decline|1|||
146371283|NCT00641706|527859869|FG001|Overall Study|Clinical Decline|0|||
146371284|NCT00641706|527859868|FG000|Overall Study|Lead Investigator Decision|0|||
146371285|NCT00641706|527859869|FG001|Overall Study|Lead Investigator Decision|1|||
146371286|NCT01675141|527859870|FG000|Overall Study|Lenalidomide outside NIH|3|||
146371287|NCT01675141|527859870|FG000|Overall Study|Withdrawal by Subject|3|||
146371288|NCT01675141|527859870|FG000|Overall Study|Physician Decision|4|||
146371289|NCT01675141|527859870|FG000|Overall Study|No treatment, per protocol|1|||
146371290|NCT00109772|527859871|FG000|Double-blind Treatment|Adverse Event|14|||
146371291|NCT00109772|527859872|FG001|Double-blind Treatment|Adverse Event|5|||
146371292|NCT00109772|527859871|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146371293|NCT00109772|527859872|FG001|Double-blind Treatment|Lack of Efficacy|0|||
146371294|NCT00109772|527859871|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
146371295|NCT00109772|527859872|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
146371296|NCT00109772|527859871|FG000|Double-blind Treatment|Lost to Follow-up|2|||
146371297|NCT00109772|527859872|FG001|Double-blind Treatment|Lost to Follow-up|3|||
146371298|NCT00109772|527859871|FG000|Double-blind Treatment|Protocol Violation|0|||
146371299|NCT00109772|527859872|FG001|Double-blind Treatment|Protocol Violation|1|||
146371300|NCT00109772|527859871|FG000|Double-blind Treatment|Other|0|||
146371301|NCT00109772|527859872|FG001|Double-blind Treatment|Other|4|||
146371302|NCT00109772|527859871|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
146371303|NCT00109772|527859872|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
146371304|NCT00109772|527859871|FG000|Open-label Extension|Adverse Event|10|||
146371305|NCT00109772|527859872|FG001|Open-label Extension|Adverse Event|19|||
146371306|NCT00109772|527859871|FG000|Open-label Extension|Lack of Efficacy|19|||
146371307|NCT00109772|527859872|FG001|Open-label Extension|Lack of Efficacy|11|||
146371308|NCT00109772|527859871|FG000|Open-label Extension|Withdrawal by Subject|9|||
146371309|NCT00109772|527859872|FG001|Open-label Extension|Withdrawal by Subject|6|||
146371310|NCT00109772|527859871|FG000|Open-label Extension|Lost to Follow-up|1|||
146371311|NCT00109772|527859872|FG001|Open-label Extension|Lost to Follow-up|0|||
146371312|NCT00109772|527859871|FG000|Open-label Extension|Death|0|||
146371313|NCT00109772|527859872|FG001|Open-label Extension|Death|1|||
146371314|NCT00109772|527859871|FG000|Open-label Extension|Protocol Violation|2|||
146371315|NCT00109772|527859872|FG001|Open-label Extension|Protocol Violation|2|||
146371316|NCT00109772|527859871|FG000|Open-label Extension|Other|4|||
146371317|NCT00109772|527859872|FG001|Open-label Extension|Other|10|||
146371318|NCT05441540|527859875|FG000|Overall Study|Withdrawal by Subject|2|||
146371319|NCT00813917|527859876|FG000|Overall Study|Adverse Event|0|||
146371320|NCT00813917|527859877|FG001|Overall Study|Adverse Event|1|||
146371321|NCT00813917|527859876|FG000|Overall Study|Withdrawal by Subject|3|||
146371322|NCT00813917|527859877|FG001|Overall Study|Withdrawal by Subject|4|||
146371323|NCT00813917|527859876|FG000|Overall Study|Lost to Follow-up|3|||
146371324|NCT00813917|527859877|FG001|Overall Study|Lost to Follow-up|1|||
146371325|NCT01359046|527859878|FG000|Overall Study|Did not receive allocated intervention|6|||
146371326|NCT01359046|527859879|FG001|Overall Study|Did not receive allocated intervention|6|||
146371327|NCT01359046|527859878|FG000|Overall Study|Physician Decision|1|||
146371328|NCT01359046|527859879|FG001|Overall Study|Physician Decision|11|||
146371329|NCT04539262|527859885|FG000|Overall Study|Adverse Event|0|||
146371330|NCT04539262|527859886|FG001|Overall Study|Adverse Event|0|||
146371331|NCT04539262|527859887|FG002|Overall Study|Adverse Event|1|||
146371332|NCT04539262|527859888|FG003|Overall Study|Adverse Event|0|||
146371333|NCT04539262|527859889|FG004|Overall Study|Adverse Event|0|||
146371334|NCT04539262|527859890|FG005|Overall Study|Adverse Event|0|||
146371335|NCT04539262|527859891|FG006|Overall Study|Adverse Event|0|||
146371336|NCT04539262|527859892|FG007|Overall Study|Adverse Event|0|||
146371337|NCT04539262|527859885|FG000|Overall Study|Withdrew Consent|0|||
146371338|NCT04539262|527859886|FG001|Overall Study|Withdrew Consent|0|||
146371339|NCT04539262|527859887|FG002|Overall Study|Withdrew Consent|0|||
146371340|NCT04539262|527859888|FG003|Overall Study|Withdrew Consent|1|||
146371341|NCT04539262|527859889|FG004|Overall Study|Withdrew Consent|0|||
146371342|NCT04539262|527859890|FG005|Overall Study|Withdrew Consent|0|||
146371343|NCT04539262|527859891|FG006|Overall Study|Withdrew Consent|0|||
146371344|NCT04539262|527859892|FG007|Overall Study|Withdrew Consent|0|||
146371345|NCT04539262|527859885|FG000|Overall Study|Randomized, Not treated|0|||
146371346|NCT04539262|527859886|FG001|Overall Study|Randomized, Not treated|1|||
146371347|NCT04539262|527859887|FG002|Overall Study|Randomized, Not treated|0|||
146371348|NCT04539262|527859888|FG003|Overall Study|Randomized, Not treated|0|||
146371349|NCT04539262|527859889|FG004|Overall Study|Randomized, Not treated|0|||
146371350|NCT04539262|527859890|FG005|Overall Study|Randomized, Not treated|0|||
146371351|NCT04539262|527859891|FG006|Overall Study|Randomized, Not treated|1|||
146371352|NCT04539262|527859892|FG007|Overall Study|Randomized, Not treated|0|||
146371353|NCT03673956|527859895|FG000|Overall Study|Lost to Follow-up|1|||
146371354|NCT03673956|527859896|FG001|Overall Study|Lost to Follow-up|0|||
146371355|NCT03673956|527859897|FG002|Overall Study|Lost to Follow-up|0|||
146371356|NCT03673956|527859898|FG003|Overall Study|Lost to Follow-up|0|||
146371357|NCT03673956|527859895|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
146371358|NCT03673956|527859896|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146371359|NCT03673956|527859897|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146371360|NCT03673956|527859898|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
146371361|NCT00802867|527859901|FG000|Overall Study|Lost to Follow-up|6|||
146371362|NCT00802867|527859901|FG000|Overall Study|Protocol Violation|6|||
146371363|NCT00802867|527859901|FG000|Overall Study|Withdrawal by Subject|1|||
146371364|NCT04075396|527859904|FG000|Overall Study|Death|11|||
146371365|NCT04075396|527859905|FG001|Overall Study|Death|9|||
146371366|NCT04075396|527859904|FG000|Overall Study|Withdrawal by Subject|1|||
146371367|NCT04075396|527859905|FG001|Overall Study|Withdrawal by Subject|2|||
146371368|NCT04075396|527859904|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
146371369|NCT04075396|527859905|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
146371370|NCT04075396|527859904|FG000|Overall Study|Enrolled but not-treated|0|||
146371371|NCT04075396|527859905|FG001|Overall Study|Enrolled but not-treated|1|||
146371372|NCT01156532|527859906|FG000|Overall Study|Family Reasons|1|||
146371373|NCT01156532|527859906|FG000|Overall Study|Lost to Follow-up|1|||
146371374|NCT03228394|527859907|FG000|Overall Study|Lost to Follow-up|0|||
146371375|NCT03228394|527859908|FG001|Overall Study|Lost to Follow-up|0|||
146371376|NCT03228394|527859909|FG002|Overall Study|Lost to Follow-up|1|||
146371377|NCT03228394|527859910|FG003|Overall Study|Lost to Follow-up|1|||
146371378|NCT03228394|527859911|FG004|Overall Study|Lost to Follow-up|0|||
146371379|NCT03228394|527859912|FG005|Overall Study|Lost to Follow-up|0|||
146371380|NCT03228394|527859913|FG006|Overall Study|Lost to Follow-up|2|||
146371381|NCT03228394|527859914|FG007|Overall Study|Lost to Follow-up|0|||
146371382|NCT03228394|527859907|FG000|Overall Study|Withdrawal by Subject|0|||
146371383|NCT03228394|527859908|FG001|Overall Study|Withdrawal by Subject|0|||
146371384|NCT03228394|527859909|FG002|Overall Study|Withdrawal by Subject|1|||
146371385|NCT03228394|527859910|FG003|Overall Study|Withdrawal by Subject|0|||
146371386|NCT03228394|527859911|FG004|Overall Study|Withdrawal by Subject|0|||
146371387|NCT03228394|527859912|FG005|Overall Study|Withdrawal by Subject|0|||
146371388|NCT03228394|527859913|FG006|Overall Study|Withdrawal by Subject|1|||
146371389|NCT03228394|527859914|FG007|Overall Study|Withdrawal by Subject|3|||
146371390|NCT03228394|527859907|FG000|Overall Study|Protocol Violation|0|||
146371391|NCT03228394|527859908|FG001|Overall Study|Protocol Violation|0|||
146371392|NCT03228394|527859909|FG002|Overall Study|Protocol Violation|0|||
146371393|NCT03228394|527859910|FG003|Overall Study|Protocol Violation|1|||
146371394|NCT03228394|527859911|FG004|Overall Study|Protocol Violation|0|||
146371395|NCT03228394|527859912|FG005|Overall Study|Protocol Violation|0|||
146371396|NCT03228394|527859913|FG006|Overall Study|Protocol Violation|0|||
146371397|NCT03228394|527859914|FG007|Overall Study|Protocol Violation|0|||
146371398|NCT03228394|527859907|FG000|Overall Study|Physician Decision|0|||
146371399|NCT03228394|527859908|FG001|Overall Study|Physician Decision|0|||
146371400|NCT03228394|527859909|FG002|Overall Study|Physician Decision|0|||
146371401|NCT03228394|527859910|FG003|Overall Study|Physician Decision|0|||
146371402|NCT03228394|527859911|FG004|Overall Study|Physician Decision|0|||
146371403|NCT03228394|527859912|FG005|Overall Study|Physician Decision|0|||
146371404|NCT03228394|527859913|FG006|Overall Study|Physician Decision|1|||
146371405|NCT03228394|527859914|FG007|Overall Study|Physician Decision|0|||
146371406|NCT03228394|527859907|FG000|Overall Study|Noncompliance|0|||
146371407|NCT03228394|527859908|FG001|Overall Study|Noncompliance|0|||
146371408|NCT03228394|527859909|FG002|Overall Study|Noncompliance|0|||
146371409|NCT03228394|527859910|FG003|Overall Study|Noncompliance|0|||
146371410|NCT03228394|527859911|FG004|Overall Study|Noncompliance|0|||
146371411|NCT03228394|527859912|FG005|Overall Study|Noncompliance|0|||
146371412|NCT03228394|527859913|FG006|Overall Study|Noncompliance|1|||
146371413|NCT03228394|527859914|FG007|Overall Study|Noncompliance|0|||
146371414|NCT00294684|527859916|FG000|Overall Study|Lost to Follow-up|5|||
146371415|NCT00294684|527859917|FG001|Overall Study|Lost to Follow-up|8|||
146371416|NCT02443805|527859918|FG000|Overall Study|Adverse Event|100|||
146371417|NCT02443805|527859919|FG001|Overall Study|Adverse Event|18|||
146371418|NCT02443805|527859918|FG000|Overall Study|Withdrawal by Subject|73|||
146371419|NCT02443805|527859919|FG001|Overall Study|Withdrawal by Subject|74|||
146371420|NCT02443805|527859918|FG000|Overall Study|Lost to Follow-up|19|||
146371421|NCT02443805|527859919|FG001|Overall Study|Lost to Follow-up|14|||
146371422|NCT02443805|527859918|FG000|Overall Study|Pregnancy|6|||
146371423|NCT02443805|527859919|FG001|Overall Study|Pregnancy|5|||
146371424|NCT02443805|527859918|FG000|Overall Study|Protocol Violation|2|||
146371425|NCT02443805|527859919|FG001|Overall Study|Protocol Violation|4|||
146371426|NCT02443805|527859918|FG000|Overall Study|Lack of Efficacy|1|||
146371427|NCT02443805|527859919|FG001|Overall Study|Lack of Efficacy|1|||
146371428|NCT02443805|527859918|FG000|Overall Study|Non-compliance with study drug|6|||
146371429|NCT02443805|527859919|FG001|Overall Study|Non-compliance with study drug|4|||
146371430|NCT02443805|527859918|FG000|Overall Study|Withdrawal by parent/guardian|3|||
146371431|NCT02443805|527859919|FG001|Overall Study|Withdrawal by parent/guardian|5|||
146371432|NCT02443805|527859918|FG000|Overall Study|Any other reason not above-mentioned|3|||
146371433|NCT02443805|527859919|FG001|Overall Study|Any other reason not above-mentioned|2|||
146371434|NCT00968708|527859920|FG000|Overall Study|Adverse Event|169|||
146371435|NCT00968708|527859921|FG001|Overall Study|Adverse Event|150|||
146371436|NCT00968708|527859920|FG000|Overall Study|Major Protocol Deviation|0|||
146371437|NCT00968708|527859921|FG001|Overall Study|Major Protocol Deviation|1|||
146371438|NCT00968708|527859920|FG000|Overall Study|Lost to Follow-up|19|||
146371439|NCT00968708|527859921|FG001|Overall Study|Lost to Follow-up|11|||
146371440|NCT00968708|527859920|FG000|Overall Study|Voluntary Withdrawal|104|||
146371441|NCT00968708|527859921|FG001|Overall Study|Voluntary Withdrawal|101|||
146371442|NCT00968708|527859920|FG000|Overall Study|Investigator Discretion|0|||
146371443|NCT00968708|527859921|FG001|Overall Study|Investigator Discretion|1|||
146371444|NCT00968708|527859920|FG000|Overall Study|Other|26|||
146371445|NCT00968708|527859921|FG001|Overall Study|Other|34|||
146371446|NCT02708966|527859922|FG000|Overall Study|Lost to Follow-up|2|||
146371447|NCT02708966|527859923|FG001|Overall Study|Lost to Follow-up|2|||
146371448|NCT01851863|527859929|FG000|Overall Study|Did not receive study medication|2|||
146371449|NCT01851863|527859930|FG001|Overall Study|Did not receive study medication|5|||
146371450|NCT01851863|527859931|FG002|Overall Study|Did not receive study medication|3|||
146371451|NCT01851863|527859932|FG003|Overall Study|Did not receive study medication|0|||
146371452|NCT01851863|527859929|FG000|Overall Study|Lost to Follow-up|3|||
146371453|NCT01851863|527859930|FG001|Overall Study|Lost to Follow-up|4|||
146371454|NCT01851863|527859931|FG002|Overall Study|Lost to Follow-up|2|||
146371455|NCT01851863|527859932|FG003|Overall Study|Lost to Follow-up|3|||
146371456|NCT02076334|527859933|FG000|Overall Study|Protocol Violation|1|||
146371457|NCT02076334|527859934|FG001|Overall Study|Protocol Violation|0|||
146371458|NCT02076334|527859935|FG002|Overall Study|Protocol Violation|0|||
146371459|NCT02076334|527859936|FG003|Overall Study|Protocol Violation|0|||
146371460|NCT02076334|527859933|FG000|Overall Study|Lost to Follow-up|0|||
146371461|NCT02076334|527859934|FG001|Overall Study|Lost to Follow-up|1|||
146371462|NCT02076334|527859935|FG002|Overall Study|Lost to Follow-up|1|||
146371463|NCT02076334|527859936|FG003|Overall Study|Lost to Follow-up|0|||
146371464|NCT02076334|527859933|FG000|Overall Study|muscle soreness|0|||
146371465|NCT02076334|527859934|FG001|Overall Study|muscle soreness|0|||
146371466|NCT02076334|527859935|FG002|Overall Study|muscle soreness|0|||
146371467|NCT02076334|527859936|FG003|Overall Study|muscle soreness|1|||
146371468|NCT01611298|527859937|FG000|Overall Study|Relapsed|2|||
146371469|NCT02224638|527859940|FG000|Overall Study|Adverse Event|1|||
146371470|NCT02224638|527859941|FG001|Overall Study|Adverse Event|1|||
146371471|NCT01406652|527859942|FG000|Overall Study|Lost-to-follow-up|3|||
146371472|NCT01406652|527859943|FG001|Overall Study|Lost-to-follow-up|4|||
146371473|NCT01406652|527859942|FG000|Overall Study|Withdrawal by Subject|2|||
146371474|NCT01406652|527859943|FG001|Overall Study|Withdrawal by Subject|2|||
146371475|NCT01406652|527859942|FG000|Overall Study|Insufficient follow-up|5|||
146371476|NCT01406652|527859943|FG001|Overall Study|Insufficient follow-up|4|||
146371477|NCT01406652|527859942|FG000|Overall Study|Infection not sure|10|||
146371478|NCT01406652|527859943|FG001|Overall Study|Infection not sure|10|||
146371479|NCT00861380|527859944|FG000|Overall Study|Withdrawal Information not recorded|8427|||
146371480|NCT00861380|527859945|FG001|Overall Study|Withdrawal Information not recorded|9112|||
146371481|NCT00861380|527859946|FG002|Overall Study|Withdrawal Information not recorded|8872|||
146371482|NCT00861380|527859947|FG003|Overall Study|Withdrawal Information not recorded|3689|||
146371483|NCT00861380|527859948|FG004|Overall Study|Withdrawal Information not recorded|1812|||
146371484|NCT00861380|527859949|FG005|Overall Study|Withdrawal Information not recorded|6249|||
146371485|NCT00861380|527859950|FG006|Overall Study|Withdrawal Information not recorded|3020|||
146371486|NCT03310580|527859951|FG000|Overall Study|Adverse Event|0|||
146371487|NCT03310580|527859952|FG001|Overall Study|Adverse Event|1|||
146371488|NCT03310580|527859953|FG002|Overall Study|Adverse Event|0|||
146371489|NCT00376246|527859955|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
146371490|NCT00376246|527859956|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
146371491|NCT00376246|527859955|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
146371492|NCT00376246|527859956|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
146371493|NCT00376246|527859955|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
146371494|NCT00376246|527859956|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
146371495|NCT03205982|527859957|FG000|Overall Study|Lost to Follow-up|20|||
146371496|NCT03205982|527859958|FG001|Overall Study|Lost to Follow-up|19|||
146371497|NCT03205982|527859957|FG000|Overall Study|Withdrawal by Subject|4|||
146371498|NCT03205982|527859958|FG001|Overall Study|Withdrawal by Subject|3|||
146371499|NCT03205982|527859957|FG000|Overall Study|Withdrawal by PI|0|||
146371500|NCT03205982|527859958|FG001|Overall Study|Withdrawal by PI|1|||
146371501|NCT00994162|527859961|FG000|Overall Study|Withdrawal by Subject|1|||
146371502|NCT00994162|527859961|FG000|Overall Study|Lost to Follow-up|2|||
146371503|NCT00994162|527859961|FG000|Overall Study|Product Complaint|1|||
146371504|NCT00994162|527859961|FG000|Overall Study|Poor Compliance|5|||
146371505|NCT00994162|527859961|FG000|Overall Study|Lack of Response|3|||
146371506|NCT00994162|527859961|FG000|Overall Study|Discharged from Hospital|4|||
146371507|NCT00994162|527859961|FG000|Overall Study|Death|2|||
146371508|NCT00994162|527859961|FG000|Overall Study|Care Transferred to Another Physician|2|||
146371509|NCT00994162|527859961|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
146371510|NCT00994162|527859961|FG000|Overall Study|Physician Decision|2|||
146371511|NCT00994162|527859961|FG000|Overall Study|Surrounding Wound Erythematous|1|||
146371512|NCT00994162|527859961|FG000|Overall Study|Machine Losing Vaccum|1|||
146371513|NCT00994162|527859961|FG000|Overall Study|Patient Lived Too Far Away|1|||
146371514|NCT00994162|527859961|FG000|Overall Study|Above Knee Amputation|1|||
146371515|NCT00994162|527859961|FG000|Overall Study|Reason Not Reported By Site|1|||
146371516|NCT03136367|527859966|FG000|T1 Consultation|discontinued mistakenly included|2|||
146371517|NCT03136367|527859967|FG001|T1 Consultation|discontinued mistakenly included|6|||
146371518|NCT03136367|527859968|FG002|T1 Consultation|discontinued mistakenly included|1|||
146371519|NCT03136367|527859966|FG000|T1 Consultation|Discontinued other|0|||
146371520|NCT03136367|527859967|FG001|T1 Consultation|Discontinued other|1|||
146371521|NCT03136367|527859968|FG002|T1 Consultation|Discontinued other|0|||
146371522|NCT03136367|527859966|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
146371523|NCT03136367|527859967|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
146371524|NCT03136367|527859968|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
146371525|NCT03136367|527859966|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
146371526|NCT03136367|527859967|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
146371527|NCT03136367|527859968|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
146371528|NCT03136367|527859966|FG000|T2 Post-consultation|Discontinued other|0|||
146371529|NCT03136367|527859967|FG001|T2 Post-consultation|Discontinued other|2|||
146371530|NCT03136367|527859968|FG002|T2 Post-consultation|Discontinued other|6|||
146371531|NCT03136367|527859966|FG000|T2 Post-consultation|Discontinued transferred care|0|||
146371532|NCT03136367|527859967|FG001|T2 Post-consultation|Discontinued transferred care|0|||
146371533|NCT03136367|527859968|FG002|T2 Post-consultation|Discontinued transferred care|3|||
146371534|NCT03136367|527859966|FG000|T2 Post-consultation|Discontinued lost contact|0|||
146371535|NCT03136367|527859967|FG001|T2 Post-consultation|Discontinued lost contact|1|||
146371536|NCT03136367|527859968|FG002|T2 Post-consultation|Discontinued lost contact|0|||
146371537|NCT03136367|527859966|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
146371538|NCT03136367|527859967|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
146371539|NCT03136367|527859968|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
146371540|NCT03136367|527859966|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
146371541|NCT03136367|527859967|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
146371542|NCT03136367|527859968|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
146371543|NCT03136367|527859966|FG000|T3 1 Week After Surgery|other discontinued|2|||
146371544|NCT03136367|527859967|FG001|T3 1 Week After Surgery|other discontinued|4|||
146371545|NCT03136367|527859968|FG002|T3 1 Week After Surgery|other discontinued|3|||
146371546|NCT03136367|527859966|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
146371547|NCT03136367|527859967|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
146371548|NCT03136367|527859968|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
146371549|NCT03136367|527859966|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
146371550|NCT03136367|527859967|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
146371551|NCT03136367|527859968|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
146371552|NCT03136367|527859966|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
146371553|NCT03136367|527859967|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
146371554|NCT03136367|527859968|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
146371555|NCT03136367|527859966|FG000|T4 12 Weeks After Surgery|Death|0|||
146371556|NCT03136367|527859967|FG001|T4 12 Weeks After Surgery|Death|1|||
146371557|NCT03136367|527859968|FG002|T4 12 Weeks After Surgery|Death|3|||
146371558|NCT03136367|527859966|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
146371559|NCT03136367|527859967|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
146371560|NCT03136367|527859968|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
146371561|NCT03136367|527859966|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
146371562|NCT03136367|527859967|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
146371563|NCT03136367|527859968|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
146371564|NCT03136367|527859966|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
146371565|NCT03136367|527859967|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
146371566|NCT03136367|527859968|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
146371567|NCT03136367|527859966|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146371568|NCT03136367|527859967|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146371569|NCT03136367|527859968|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
146371570|NCT03136367|527859966|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
146371571|NCT03136367|527859967|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
146371572|NCT03136367|527859968|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
146371573|NCT03136367|527859966|FG000|T5 1 Year After Surgery|Death|0|||
146371574|NCT03136367|527859967|FG001|T5 1 Year After Surgery|Death|0|||
146371575|NCT03136367|527859968|FG002|T5 1 Year After Surgery|Death|1|||
146371576|NCT03136367|527859966|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
146371577|NCT03136367|527859967|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
146371578|NCT03136367|527859968|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
146371579|NCT03136367|527859966|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
146371580|NCT03136367|527859967|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
146371581|NCT03136367|527859968|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
146371582|NCT03136367|527859966|FG000|T5 1 Year After Surgery|study ended before due|31|||
146371583|NCT03136367|527859967|FG001|T5 1 Year After Surgery|study ended before due|103|||
146371584|NCT03136367|527859968|FG002|T5 1 Year After Surgery|study ended before due|110|||
146371585|NCT03136367|527859966|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
146371586|NCT03136367|527859967|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
146371587|NCT03136367|527859968|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
146371588|NCT03307629|527859972|FG000|Overall Study|Withdrawal by Subject|0|||
146371589|NCT03307629|527859973|FG001|Overall Study|Withdrawal by Subject|0|||
146371590|NCT03307629|527859974|FG002|Overall Study|Withdrawal by Subject|0|||
146371591|NCT03307629|527859975|FG003|Overall Study|Withdrawal by Subject|2|||
146371592|NCT03307629|527859972|FG000|Overall Study|Disease Progression|0|||
146371593|NCT03307629|527859973|FG001|Overall Study|Disease Progression|0|||
146371594|NCT03307629|527859974|FG002|Overall Study|Disease Progression|0|||
146371595|NCT03307629|527859975|FG003|Overall Study|Disease Progression|3|||
146371596|NCT03307629|527859972|FG000|Overall Study|Death|0|||
146371597|NCT03307629|527859973|FG001|Overall Study|Death|3|||
146371598|NCT03307629|527859974|FG002|Overall Study|Death|0|||
146371599|NCT03307629|527859975|FG003|Overall Study|Death|1|||
146371600|NCT02853032|527859976|FG000|Overall Study|Adverse Event|4|||
146371601|NCT02853032|527859977|FG001|Overall Study|Adverse Event|0|||
146371602|NCT02853032|527859976|FG000|Overall Study|Withdrawal by Subject|3|||
146371603|NCT02853032|527859977|FG001|Overall Study|Withdrawal by Subject|1|||
146371604|NCT02853032|527859976|FG000|Overall Study|Requested to withdraw from all treatment|2|||
146371605|NCT02853032|527859977|FG001|Overall Study|Requested to withdraw from all treatment|2|||
146371606|NCT02146833|527859978|FG000|Overall Study|Death|10|||
146371607|NCT02146833|527859978|FG000|Overall Study|No longer consented to study treatment|1|||
146371608|NCT03726333|527859979|FG000|Overall Study|Progressive Disease|0|||
146371609|NCT03726333|527859980|FG001|Overall Study|Progressive Disease|0|||
146371610|NCT03726333|527859981|FG002|Overall Study|Progressive Disease|1|||
146371611|NCT03726333|527859982|FG003|Overall Study|Progressive Disease|0|||
146371612|NCT03726333|527859983|FG004|Overall Study|Progressive Disease|0|||
146371613|NCT03366844|527861206|FG000|Overall Study|Physician Decision|1|||
146371614|NCT03366844|527861206|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
146371615|NCT02687711|527861209|FG000|Overall Study|Adverse Event|89|||
146371616|NCT02687711|527861209|FG000|Overall Study|Lack of Efficacy|70|||
146371617|NCT02687711|527861209|FG000|Overall Study|Lost to Follow-up|20|||
146371618|NCT02687711|527861209|FG000|Overall Study|Consent withdrawn|15|||
146371619|NCT02687711|527861209|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
146371620|NCT02687711|527861209|FG000|Overall Study|Too expensive|4|||
146371621|NCT02687711|527861209|FG000|Overall Study|Participant moved abroad|1|||
145943487|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146371622|NCT02687711|527861209|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
146371623|NCT02687711|527861209|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
146371624|NCT02687711|527861209|FG000|Overall Study|Disliked taste|1|||
146371625|NCT02687711|527861209|FG000|Overall Study|Low mood|1|||
146371626|NCT02687711|527861209|FG000|Overall Study|Side effects|1|||
146371627|NCT02687711|527861209|FG000|Overall Study|Change of Hospital|1|||
146371628|NCT02687711|527861209|FG000|Overall Study|Liver Encephalopathy|1|||
146371629|NCT02687711|527861209|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
146371630|NCT02687711|527861209|FG000|Overall Study|Withdrawn due to intake interruption|1|||
146371631|NCT02687711|527861209|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
146371632|NCT02687711|527861209|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
146371633|NCT02687711|527861209|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
146371634|NCT00191386|527861210|FG000|Overall Study|Adverse Event|16|||
146371635|NCT00191386|527861210|FG000|Overall Study|Lost to Follow-up|1|||
146371636|NCT00191386|527861210|FG000|Overall Study|Entry Criteria Exclusion|3|||
146371637|NCT00191386|527861210|FG000|Overall Study|Protocol Violation|18|||
146371638|NCT00191386|527861210|FG000|Overall Study|Withdrawal by Subject|96|||
146371639|NCT00191386|527861210|FG000|Overall Study|Physician Decision|11|||
146371640|NCT00191386|527861210|FG000|Overall Study|Lack of Efficacy|15|||
146371641|NCT02038790|527861211|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
146371642|NCT02038790|527861212|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
146371643|NCT02431793|527861213|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
146371644|NCT02431793|527861214|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
146371645|NCT02431793|527861215|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
146371646|NCT02431793|527861213|FG000|Overall Study|Withdrawal by Subject|7|||
146371647|NCT02431793|527861214|FG001|Overall Study|Withdrawal by Subject|5|||
146371648|NCT02431793|527861215|FG002|Overall Study|Withdrawal by Subject|5|||
146371649|NCT02431793|527861213|FG000|Overall Study|Lost to Follow-up|101|||
146371650|NCT02431793|527861214|FG001|Overall Study|Lost to Follow-up|122|||
146371651|NCT02431793|527861215|FG002|Overall Study|Lost to Follow-up|104|||
146371652|NCT01419015|527861216|FG000|Overall Study|Death|2|||
146371653|NCT02911519|527861217|FG000|Overall Study|Lost to Follow-up|2|||
146371654|NCT02911519|527861218|FG001|Overall Study|Lost to Follow-up|2|||
146371655|NCT02911519|527861217|FG000|Overall Study|Death|0|||
146371656|NCT02911519|527861218|FG001|Overall Study|Death|2|||
146371657|NCT00653328|527861219|FG000|Overall Study|Withdrawal by Subject|1|||
146371658|NCT00653328|527861219|FG000|Overall Study|Adverse Event|2|||
146371659|NCT00653328|527861219|FG000|Overall Study|Disease progression|10|||
146371660|NCT00653328|527861219|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
146371661|NCT01237223|527861220|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
146371662|NCT01237223|527861221|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146371663|NCT01237223|527861222|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146371664|NCT01237223|527861223|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146371665|NCT01237223|527861224|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146371666|NCT01237223|527861225|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
146371667|NCT01237223|527861220|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
146371668|NCT01237223|527861221|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146371669|NCT01237223|527861222|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146371670|NCT01237223|527861223|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146371671|NCT01237223|527861224|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146371672|NCT01237223|527861225|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
146371673|NCT01237223|527861220|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
146371674|NCT01237223|527861221|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146371675|NCT01237223|527861222|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146371676|NCT01237223|527861223|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146371677|NCT01237223|527861224|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146371678|NCT01237223|527861225|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
146371679|NCT01237223|527861220|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
146371680|NCT01237223|527861221|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146371681|NCT01237223|527861222|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146371682|NCT01237223|527861223|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146371683|NCT01237223|527861224|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146371684|NCT01237223|527861225|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
146371685|NCT01237223|527861220|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
146371686|NCT01237223|527861221|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146371687|NCT01237223|527861222|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146371688|NCT01237223|527861223|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146371689|NCT01237223|527861224|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146371690|NCT01237223|527861225|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
146371691|NCT01237223|527861220|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
146371692|NCT01237223|527861221|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
146371693|NCT01237223|527861222|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
146371694|NCT01237223|527861223|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
146371695|NCT01237223|527861224|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
146371696|NCT01237223|527861225|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
146371697|NCT01237223|527861220|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
146371698|NCT01237223|527861221|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
146371699|NCT01237223|527861222|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
146371700|NCT01237223|527861223|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
146371701|NCT01237223|527861224|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
146371702|NCT01237223|527861225|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
146371703|NCT01237223|527861220|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146371704|NCT01237223|527861221|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
146371705|NCT01237223|527861222|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
146371706|NCT01237223|527861223|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
146371707|NCT01237223|527861224|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146371708|NCT01237223|527861225|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
146371709|NCT01237223|527861220|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146371710|NCT01237223|527861221|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146371711|NCT01237223|527861222|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146371712|NCT01237223|527861223|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146371713|NCT01237223|527861224|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
146371714|NCT01237223|527861225|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
146371715|NCT01237223|527861220|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
146371716|NCT01237223|527861221|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146371717|NCT01237223|527861222|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146371718|NCT01237223|527861223|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
146371719|NCT01237223|527861224|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146371720|NCT01237223|527861225|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
146371721|NCT00792701|527861231|FG000|Overall Study|Adverse Event|0|||
146371722|NCT00792701|527861232|FG001|Overall Study|Adverse Event|22|||
146371723|NCT00792701|527861231|FG000|Overall Study|Ineligible|1|||
146371724|NCT00792701|527861232|FG001|Overall Study|Ineligible|3|||
146371725|NCT00792701|527861231|FG000|Overall Study|Withdrawal by Subject|1|||
146371726|NCT00792701|527861232|FG001|Overall Study|Withdrawal by Subject|19|||
146371727|NCT00792701|527861231|FG000|Overall Study|Not protocol specified|17|||
146371728|NCT00792701|527861232|FG001|Overall Study|Not protocol specified|0|||
146371729|NCT00064077|527861237|FG000|Overall Study|Improper prior treatment|1|||
146371730|NCT00064077|527861238|FG001|Overall Study|Improper prior treatment|0|||
146371731|NCT00064077|527861239|FG002|Overall Study|Improper prior treatment|0|||
146371732|NCT00064077|527861240|FG003|Overall Study|Improper prior treatment|0|||
146371733|NCT00064077|527861237|FG000|Overall Study|Poor risk|2|||
146371734|NCT00064077|527861238|FG001|Overall Study|Poor risk|0|||
146371735|NCT00064077|527861239|FG002|Overall Study|Poor risk|1|||
146371736|NCT00064077|527861240|FG003|Overall Study|Poor risk|1|||
146371737|NCT00064077|527861237|FG000|Overall Study|Pathology|10|||
146371738|NCT00064077|527861238|FG001|Overall Study|Pathology|7|||
146371739|NCT00064077|527861239|FG002|Overall Study|Pathology|3|||
146371740|NCT00064077|527861240|FG003|Overall Study|Pathology|4|||
146371741|NCT00064077|527861237|FG000|Overall Study|No surgery|0|||
146371742|NCT00064077|527861238|FG001|Overall Study|No surgery|0|||
146371743|NCT00064077|527861239|FG002|Overall Study|No surgery|1|||
146371744|NCT00064077|527861240|FG003|Overall Study|No surgery|0|||
146371745|NCT00064077|527861237|FG000|Overall Study|No tumor|0|||
146371746|NCT00064077|527861238|FG001|Overall Study|No tumor|0|||
146371747|NCT00064077|527861239|FG002|Overall Study|No tumor|1|||
146371748|NCT00064077|527861240|FG003|Overall Study|No tumor|0|||
146371749|NCT00064077|527861237|FG000|Overall Study|Other reasons|2|||
146371750|NCT00064077|527861238|FG001|Overall Study|Other reasons|2|||
146371751|NCT00064077|527861239|FG002|Overall Study|Other reasons|1|||
146371752|NCT00064077|527861240|FG003|Overall Study|Other reasons|2|||
146371753|NCT00615914|527861241|FG000|Overall Study|Adverse Event|274|||
146371754|NCT00615914|527861241|FG000|Overall Study|Death|20|||
146371755|NCT00615914|527861241|FG000|Overall Study|Lack of Efficacy|59|||
146371756|NCT00615914|527861241|FG000|Overall Study|Lost to Follow-up|187|||
146371757|NCT00615914|527861241|FG000|Overall Study|Withdrawal by Subject|16|||
146371758|NCT00615914|527861241|FG000|Overall Study|Physician Decision|4|||
145943488|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146371759|NCT00615914|527861241|FG000|Overall Study|No data was collected.|65|||
146371760|NCT00615914|527861241|FG000|Overall Study|No treatment|2|||
146371761|NCT00615914|527861241|FG000|Overall Study|Irregularly enrolled patients|10|||
146371762|NCT01809197|527861242|FG000|Overall Study|Lost to Follow-up|4|||
146371763|NCT01809197|527861243|FG001|Overall Study|Lost to Follow-up|2|||
146371764|NCT01809197|527861242|FG000|Overall Study|Adverse Event|2|||
146371765|NCT01809197|527861243|FG001|Overall Study|Adverse Event|3|||
146371766|NCT01809197|527861242|FG000|Overall Study|Failed slit lamp exam|1|||
146371767|NCT01809197|527861243|FG001|Overall Study|Failed slit lamp exam|0|||
146371768|NCT01809197|527861242|FG000|Overall Study|Non-Compliance|1|||
146371769|NCT01809197|527861243|FG001|Overall Study|Non-Compliance|1|||
146371770|NCT01809197|527861242|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
146371771|NCT01809197|527861243|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
146371772|NCT01809197|527861242|FG000|Overall Study|Withdrawal by Subject|1|||
146371773|NCT01809197|527861243|FG001|Overall Study|Withdrawal by Subject|1|||
146371774|NCT01809197|527861242|FG000|Overall Study|Product not available|0|||
146371775|NCT01809197|527861243|FG001|Overall Study|Product not available|1|||
146371776|NCT01112982|527861249|FG000|Overall Study|Withdrawal by Subject|1|||
146371777|NCT01112982|527861249|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
146371778|NCT03407170|527861252|FG000|Overall Study|Adverse Event|1|||
146371779|NCT00126672|527861255|FG000|Overall Study|Adverse Event|4|||
146371780|NCT00126672|527861255|FG000|Overall Study|Lost to Follow-up|4|||
146371781|NCT01001234|527861256|FG000|Overall Study|Withdrawal by Subject|2|||
146371782|NCT01001234|527861257|FG001|Overall Study|Withdrawal by Subject|0|||
146371783|NCT01001234|527861258|FG002|Overall Study|Withdrawal by Subject|3|||
146371784|NCT01001234|527861259|FG003|Overall Study|Withdrawal by Subject|0|||
146371785|NCT01001234|527861260|FG004|Overall Study|Withdrawal by Subject|0|||
146371786|NCT01001234|527861256|FG000|Overall Study|Protocol Violation|34|||
146371787|NCT01001234|527861257|FG001|Overall Study|Protocol Violation|3|||
146371788|NCT01001234|527861258|FG002|Overall Study|Protocol Violation|19|||
146371789|NCT01001234|527861259|FG003|Overall Study|Protocol Violation|18|||
146371790|NCT01001234|527861260|FG004|Overall Study|Protocol Violation|0|||
146371791|NCT01001234|527861256|FG000|Overall Study|Lost to Follow-up|0|||
146371792|NCT01001234|527861257|FG001|Overall Study|Lost to Follow-up|0|||
146371793|NCT01001234|527861258|FG002|Overall Study|Lost to Follow-up|1|||
146371794|NCT01001234|527861259|FG003|Overall Study|Lost to Follow-up|2|||
146371795|NCT01001234|527861260|FG004|Overall Study|Lost to Follow-up|0|||
146371796|NCT01001234|527861256|FG000|Overall Study|Physician Decision|1|||
146371797|NCT01001234|527861257|FG001|Overall Study|Physician Decision|0|||
146371798|NCT01001234|527861258|FG002|Overall Study|Physician Decision|0|||
146371799|NCT01001234|527861259|FG003|Overall Study|Physician Decision|0|||
146371800|NCT01001234|527861260|FG004|Overall Study|Physician Decision|0|||
146371801|NCT01001234|527861256|FG000|Overall Study|Not Treated: Adverse Event|1|||
146371802|NCT01001234|527861257|FG001|Overall Study|Not Treated: Adverse Event|0|||
146371803|NCT01001234|527861258|FG002|Overall Study|Not Treated: Adverse Event|0|||
146371804|NCT01001234|527861259|FG003|Overall Study|Not Treated: Adverse Event|0|||
146371805|NCT01001234|527861260|FG004|Overall Study|Not Treated: Adverse Event|0|||
146371806|NCT01001234|527861256|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
146371807|NCT01001234|527861257|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
146371808|NCT01001234|527861258|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
146371809|NCT01001234|527861259|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
146371810|NCT01001234|527861260|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
146371811|NCT01001234|527861256|FG000|Overall Study|Not Treated: Protocol Violation|3|||
146371812|NCT01001234|527861257|FG001|Overall Study|Not Treated: Protocol Violation|0|||
146371813|NCT01001234|527861258|FG002|Overall Study|Not Treated: Protocol Violation|0|||
146371814|NCT01001234|527861259|FG003|Overall Study|Not Treated: Protocol Violation|0|||
146371815|NCT01001234|527861260|FG004|Overall Study|Not Treated: Protocol Violation|0|||
146371816|NCT01001234|527861256|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
146371817|NCT01001234|527861257|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
146371818|NCT01001234|527861258|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
146371819|NCT01001234|527861259|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
146371820|NCT01001234|527861260|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
146371821|NCT01001234|527861256|FG000|Overall Study|Not Treated: Pregnancy|3|||
146371822|NCT01001234|527861257|FG001|Overall Study|Not Treated: Pregnancy|0|||
146371823|NCT01001234|527861258|FG002|Overall Study|Not Treated: Pregnancy|0|||
145943489|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146371824|NCT01001234|527861259|FG003|Overall Study|Not Treated: Pregnancy|0|||
146371825|NCT01001234|527861260|FG004|Overall Study|Not Treated: Pregnancy|0|||
146371826|NCT01001234|527861256|FG000|Overall Study|Not Treated: Physician Decision|37|||
146371827|NCT01001234|527861257|FG001|Overall Study|Not Treated: Physician Decision|4|||
146371828|NCT01001234|527861258|FG002|Overall Study|Not Treated: Physician Decision|0|||
146371829|NCT01001234|527861259|FG003|Overall Study|Not Treated: Physician Decision|0|||
146371830|NCT01001234|527861260|FG004|Overall Study|Not Treated: Physician Decision|0|||
146371831|NCT01001234|527861256|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
146395795|NCT01990339|527950943|FG000|Overall Study|Lost to Follow-up|861|||
146371832|NCT01001234|527861257|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
146371833|NCT01001234|527861258|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146371834|NCT01001234|527861259|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146371835|NCT01001234|527861260|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
146371836|NCT03379376|527861263|FG000|Overall Study|Lost to Follow-up|2|||
146371837|NCT03379376|527861263|FG000|Overall Study|Did not wish to complete follow up|1|||
146371838|NCT03379376|527861263|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
146371839|NCT03379376|527861263|FG000|Overall Study|Death|1|||
146371840|NCT01296698|527861266|FG000|Overall Study|Adverse Event|1|||
146371841|NCT01296698|527861267|FG001|Overall Study|Adverse Event|0|||
146371842|NCT01296698|527861266|FG000|Overall Study|Death|1|||
146371843|NCT01296698|527861267|FG001|Overall Study|Death|0|||
146371844|NCT01296698|527861266|FG000|Overall Study|Lost to Follow-up|19|||
146371845|NCT01296698|527861267|FG001|Overall Study|Lost to Follow-up|1|||
146371846|NCT01296698|527861266|FG000|Overall Study|Withdrawal by Subject|12|||
146371847|NCT01296698|527861267|FG001|Overall Study|Withdrawal by Subject|0|||
146371848|NCT01296698|527861266|FG000|Overall Study|Difficulty Contacting Subject|2|||
146371849|NCT01296698|527861267|FG001|Overall Study|Difficulty Contacting Subject|0|||
146371850|NCT01296698|527861266|FG000|Overall Study|Study Terminated by Sponsor|209|||
146371851|NCT01296698|527861267|FG001|Overall Study|Study Terminated by Sponsor|12|||
146371852|NCT03639987|527861270|FG000|Overall Study|Study terminated by sponsor|26|||
146371853|NCT03639987|527861271|FG001|Overall Study|Study terminated by sponsor|25|||
146371854|NCT03639987|527861270|FG000|Overall Study|Lost to Follow-up|0|||
146371855|NCT03639987|527861271|FG001|Overall Study|Lost to Follow-up|1|||
146371856|NCT04294095|527861283|FG000|Overall Study|Adverse Event|1|||
146371857|NCT04294095|527861284|FG001|Overall Study|Adverse Event|0|||
146371858|NCT01998399|527861292|FG000|Overall Study|Lost to Follow-up|1|||
146371859|NCT01998399|527861293|FG001|Overall Study|Lost to Follow-up|3|||
146371860|NCT01998399|527861292|FG000|Overall Study|Death|4|||
146371861|NCT01998399|527861293|FG001|Overall Study|Death|2|||
146371862|NCT01998399|527861292|FG000|Overall Study|Study stopped before dosing completed|3|||
146371863|NCT01998399|527861293|FG001|Overall Study|Study stopped before dosing completed|3|||
146371864|NCT01998399|527861292|FG000|Overall Study|Withdrawal by Subject|0|||
146371865|NCT01998399|527861293|FG001|Overall Study|Withdrawal by Subject|1|||
146371866|NCT01455415|527861302|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
146371867|NCT01455415|527861303|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
146371868|NCT01455415|527861302|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
146371869|NCT01455415|527861303|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
146371870|NCT01455415|527861302|FG000|Period 1|Drug Error not Associated to AE|0|||
146371871|NCT01455415|527861303|FG001|Period 1|Drug Error not Associated to AE|1|||
146371872|NCT01455415|527861302|FG000|Period 1|AE Not Related to Study Drug|2|||
146371873|NCT01455415|527861303|FG001|Period 1|AE Not Related to Study Drug|6|||
146371874|NCT01455415|527861302|FG000|Period 1|Withdrawal by Subject|4|||
146371875|NCT01455415|527861303|FG001|Period 1|Withdrawal by Subject|5|||
146371876|NCT01455415|527861302|FG000|Period 1|Unspecified Reason|1|||
146371877|NCT01455415|527861303|FG001|Period 1|Unspecified Reason|1|||
146371878|NCT01455415|527861302|FG000|Period 1|Protocol Violation|0|||
146371879|NCT01455415|527861303|FG001|Period 1|Protocol Violation|2|||
146371880|NCT01455415|527861302|FG000|Washout|AE Related to Study Drug|2|||
146371881|NCT01455415|527861303|FG001|Washout|AE Related to Study Drug|0|||
146371882|NCT01455415|527861302|FG000|Washout|Lost to Follow-up|1|||
146371883|NCT01455415|527861303|FG001|Washout|Lost to Follow-up|0|||
146371884|NCT01455415|527861302|FG000|Washout|Drug Error not Associated to AE|2|||
146371885|NCT01455415|527861303|FG001|Washout|Drug Error not Associated to AE|1|||
146371886|NCT01455415|527861302|FG000|Washout|AE Not Related to Study Drug|2|||
146371887|NCT01455415|527861303|FG001|Washout|AE Not Related to Study Drug|3|||
146371888|NCT01455415|527861302|FG000|Washout|Unspecified Reason|1|||
146371889|NCT01455415|527861303|FG001|Washout|Unspecified Reason|2|||
146371890|NCT01455415|527861302|FG000|Washout|Protocol Violation|0|||
146371891|NCT01455415|527861303|FG001|Washout|Protocol Violation|1|||
146371892|NCT01455415|527861302|FG000|Period 2|AE Related to Study Drug|1|||
146371893|NCT01455415|527861303|FG001|Period 2|AE Related to Study Drug|2|||
146371894|NCT01455415|527861302|FG000|Period 2|Lost to Follow-up|2|||
146371895|NCT01455415|527861303|FG001|Period 2|Lost to Follow-up|1|||
146371896|NCT01455415|527861302|FG000|Period 2|AE Not Related to Study Drug|2|||
146371897|NCT01455415|527861303|FG001|Period 2|AE Not Related to Study Drug|1|||
146371898|NCT01455415|527861302|FG000|Period 2|Lack of Efficacy|2|||
146371899|NCT01455415|527861303|FG001|Period 2|Lack of Efficacy|0|||
146371900|NCT01455415|527861302|FG000|Period 2|Withdrawal by Subject|2|||
146371901|NCT01455415|527861303|FG001|Period 2|Withdrawal by Subject|3|||
146371902|NCT01455415|527861302|FG000|Period 2|Unspecified Reason|2|||
146371903|NCT01455415|527861303|FG001|Period 2|Unspecified Reason|3|||
146371904|NCT01455415|527861302|FG000|Period 2|Protocol Violation|2|||
146371905|NCT01455415|527861303|FG001|Period 2|Protocol Violation|0|||
146371906|NCT01455415|527861302|FG000|Follow-up|AE Related to Study Drug|0|||
146371907|NCT01455415|527861303|FG001|Follow-up|AE Related to Study Drug|1|||
146371908|NCT01455415|527861302|FG000|Follow-up|Lack of Efficacy|0|||
146371909|NCT01455415|527861303|FG001|Follow-up|Lack of Efficacy|1|||
146371910|NCT01455415|527861302|FG000|Follow-up|Withdrawal by Subject|2|||
146371911|NCT01455415|527861303|FG001|Follow-up|Withdrawal by Subject|0|||
146371912|NCT01455415|527861302|FG000|Follow-up|Unspecified Reason|1|||
146371913|NCT01455415|527861303|FG001|Follow-up|Unspecified Reason|0|||
146371914|NCT01468701|527861310|FG000|Overall Study|Not eligible|91|||
146371915|NCT01468701|527861311|FG001|Overall Study|Not eligible|140|||
146371916|NCT01468701|527861312|FG002|Overall Study|Not eligible|29|||
146371917|NCT01468701|527861313|FG003|Overall Study|Not eligible|12|||
146371918|NCT01468701|527861314|FG004|Overall Study|Not eligible|22|||
146371919|NCT01468701|527861315|FG005|Overall Study|Not eligible|2|||
146371920|NCT01468701|527861316|FG006|Overall Study|Not eligible|39|||
146371921|NCT01468701|527861317|FG007|Overall Study|Not eligible|1|||
146371922|NCT01468701|527861318|FG008|Overall Study|Not eligible|40|||
146371923|NCT01468701|527861319|FG009|Overall Study|Not eligible|126|||
146371924|NCT01468701|527861320|FG010|Overall Study|Not eligible|39|||
146371925|NCT01468701|527861321|FG011|Overall Study|Not eligible|33|||
146371926|NCT01468701|527861322|FG012|Overall Study|Not eligible|1|||
146371927|NCT01468701|527861323|FG013|Overall Study|Not eligible|19|||
146371928|NCT01468701|527861324|FG014|Overall Study|Not eligible|1|||
146371929|NCT01468701|527861325|FG015|Overall Study|Not eligible|32|||
146371930|NCT01468701|527861326|FG016|Overall Study|Not eligible|0|||
146371931|NCT01468701|527861310|FG000|Overall Study|Lost to Follow-up|306|||
146371932|NCT01468701|527861311|FG001|Overall Study|Lost to Follow-up|0|||
146371933|NCT01468701|527861312|FG002|Overall Study|Lost to Follow-up|0|||
146371934|NCT01468701|527861313|FG003|Overall Study|Lost to Follow-up|0|||
146371935|NCT01468701|527861314|FG004|Overall Study|Lost to Follow-up|0|||
146371936|NCT01468701|527861315|FG005|Overall Study|Lost to Follow-up|0|||
146371937|NCT01468701|527861316|FG006|Overall Study|Lost to Follow-up|0|||
146371938|NCT01468701|527861317|FG007|Overall Study|Lost to Follow-up|0|||
146371939|NCT01468701|527861318|FG008|Overall Study|Lost to Follow-up|215|||
146371940|NCT01468701|527861319|FG009|Overall Study|Lost to Follow-up|309|||
146371941|NCT01468701|527861320|FG010|Overall Study|Lost to Follow-up|224|||
146371942|NCT01468701|527861321|FG011|Overall Study|Lost to Follow-up|212|||
146371943|NCT01468701|527861322|FG012|Overall Study|Lost to Follow-up|11|||
146371944|NCT01468701|527861323|FG013|Overall Study|Lost to Follow-up|164|||
146371945|NCT01468701|527861324|FG014|Overall Study|Lost to Follow-up|17|||
146371946|NCT01468701|527861325|FG015|Overall Study|Lost to Follow-up|127|||
146371947|NCT01468701|527861326|FG016|Overall Study|Lost to Follow-up|1|||
146371948|NCT01468701|527861310|FG000|Overall Study|Withdrawal by Subject|165|||
146371949|NCT01468701|527861311|FG001|Overall Study|Withdrawal by Subject|0|||
146371950|NCT01468701|527861312|FG002|Overall Study|Withdrawal by Subject|0|||
146371951|NCT01468701|527861313|FG003|Overall Study|Withdrawal by Subject|0|||
146371952|NCT01468701|527861314|FG004|Overall Study|Withdrawal by Subject|0|||
146371953|NCT01468701|527861315|FG005|Overall Study|Withdrawal by Subject|0|||
146371954|NCT01468701|527861316|FG006|Overall Study|Withdrawal by Subject|0|||
146371955|NCT01468701|527861317|FG007|Overall Study|Withdrawal by Subject|0|||
146371956|NCT01468701|527861318|FG008|Overall Study|Withdrawal by Subject|83|||
146371957|NCT01468701|527861319|FG009|Overall Study|Withdrawal by Subject|88|||
146371958|NCT01468701|527861320|FG010|Overall Study|Withdrawal by Subject|100|||
146371959|NCT01468701|527861321|FG011|Overall Study|Withdrawal by Subject|114|||
146371960|NCT01468701|527861322|FG012|Overall Study|Withdrawal by Subject|9|||
146371961|NCT01468701|527861323|FG013|Overall Study|Withdrawal by Subject|47|||
146371962|NCT01468701|527861324|FG014|Overall Study|Withdrawal by Subject|6|||
146371963|NCT01468701|527861325|FG015|Overall Study|Withdrawal by Subject|31|||
146371964|NCT01468701|527861326|FG016|Overall Study|Withdrawal by Subject|0|||
146371965|NCT01468701|527861310|FG000|Overall Study|Other reasons than listed|437|||
146371966|NCT01468701|527861311|FG001|Overall Study|Other reasons than listed|0|||
146371967|NCT01468701|527861312|FG002|Overall Study|Other reasons than listed|0|||
146371968|NCT01468701|527861313|FG003|Overall Study|Other reasons than listed|0|||
146371969|NCT01468701|527861314|FG004|Overall Study|Other reasons than listed|0|||
146371970|NCT01468701|527861315|FG005|Overall Study|Other reasons than listed|0|||
146371971|NCT01468701|527861316|FG006|Overall Study|Other reasons than listed|0|||
146371972|NCT01468701|527861317|FG007|Overall Study|Other reasons than listed|0|||
146371973|NCT01468701|527861318|FG008|Overall Study|Other reasons than listed|318|||
146371974|NCT01468701|527861319|FG009|Overall Study|Other reasons than listed|658|||
146371975|NCT01468701|527861320|FG010|Overall Study|Other reasons than listed|433|||
146371976|NCT01468701|527861321|FG011|Overall Study|Other reasons than listed|504|||
146371977|NCT01468701|527861322|FG012|Overall Study|Other reasons than listed|28|||
146371978|NCT01468701|527861323|FG013|Overall Study|Other reasons than listed|239|||
146371979|NCT01468701|527861324|FG014|Overall Study|Other reasons than listed|39|||
146371980|NCT01468701|527861325|FG015|Overall Study|Other reasons than listed|172|||
146371981|NCT01468701|527861326|FG016|Overall Study|Other reasons than listed|0|||
146371982|NCT01468701|527861310|FG000|Overall Study|No end of study case report form|0|||
146371983|NCT01468701|527861311|FG001|Overall Study|No end of study case report form|0|||
146371984|NCT01468701|527861312|FG002|Overall Study|No end of study case report form|0|||
146371985|NCT01468701|527861313|FG003|Overall Study|No end of study case report form|0|||
146371986|NCT01468701|527861314|FG004|Overall Study|No end of study case report form|0|||
146371987|NCT01468701|527861315|FG005|Overall Study|No end of study case report form|0|||
146371988|NCT01468701|527861316|FG006|Overall Study|No end of study case report form|0|||
146371989|NCT01468701|527861317|FG007|Overall Study|No end of study case report form|0|||
146371990|NCT01468701|527861318|FG008|Overall Study|No end of study case report form|4|||
146371991|NCT01468701|527861319|FG009|Overall Study|No end of study case report form|1|||
146371992|NCT01468701|527861320|FG010|Overall Study|No end of study case report form|2|||
146371993|NCT01468701|527861321|FG011|Overall Study|No end of study case report form|3|||
146371994|NCT01468701|527861322|FG012|Overall Study|No end of study case report form|0|||
146371995|NCT01468701|527861323|FG013|Overall Study|No end of study case report form|1|||
146371996|NCT01468701|527861324|FG014|Overall Study|No end of study case report form|0|||
146371997|NCT01468701|527861325|FG015|Overall Study|No end of study case report form|0|||
146371998|NCT01468701|527861326|FG016|Overall Study|No end of study case report form|0|||
146371999|NCT01468701|527861310|FG000|Overall Study|Not being followed up|0|||
146372000|NCT01468701|527861311|FG001|Overall Study|Not being followed up|4963|||
146372001|NCT01468701|527861312|FG002|Overall Study|Not being followed up|1755|||
146372002|NCT01468701|527861313|FG003|Overall Study|Not being followed up|703|||
146372003|NCT01468701|527861314|FG004|Overall Study|Not being followed up|1714|||
146372004|NCT01468701|527861315|FG005|Overall Study|Not being followed up|126|||
146372005|NCT01468701|527861316|FG006|Overall Study|Not being followed up|1170|||
146372006|NCT01468701|527861317|FG007|Overall Study|Not being followed up|4|||
146372007|NCT01468701|527861318|FG008|Overall Study|Not being followed up|0|||
146372008|NCT01468701|527861319|FG009|Overall Study|Not being followed up|0|||
146372009|NCT01468701|527861320|FG010|Overall Study|Not being followed up|0|||
146372010|NCT01468701|527861321|FG011|Overall Study|Not being followed up|0|||
146372011|NCT01468701|527861322|FG012|Overall Study|Not being followed up|0|||
146372012|NCT01468701|527861323|FG013|Overall Study|Not being followed up|0|||
146372013|NCT01468701|527861324|FG014|Overall Study|Not being followed up|0|||
146372014|NCT01468701|527861325|FG015|Overall Study|Not being followed up|0|||
146372015|NCT01468701|527861326|FG016|Overall Study|Not being followed up|0|||
146372016|NCT01822223|527861327|FG000|Overall Study|Death|0|||
146372017|NCT01822223|527861328|FG001|Overall Study|Death|1|||
146372018|NCT02679781|527861329|FG000|Overall Study|Lost to Follow-up|1|||
146372019|NCT02679781|527861330|FG001|Overall Study|Lost to Follow-up|2|||
146372020|NCT02679781|527861329|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
146372021|NCT02679781|527861330|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
146372022|NCT04209400|527861333|FG000|Overall Study|Withdrawal by Subject|0|||
146372023|NCT04209400|527861334|FG001|Overall Study|Withdrawal by Subject|1|||
146372024|NCT00631540|527861344|FG000|Overall Study|Withdrawal by Subject|5|||
146372025|NCT00631540|527861344|FG000|Overall Study|Death|4|||
146372026|NCT00631540|527861344|FG000|Overall Study|Lost to Follow-up|2|||
146372027|NCT00631540|527861344|FG000|Overall Study|Core Lab Data Unavailable|3|||
146372028|NCT00795509|527861345|FG000|Overall Study|Protocol Violation|31|||
146372029|NCT00970268|527861346|FG000|Overall Study|Withdrawal by Subject|12|||
146372030|NCT00970268|527861347|FG001|Overall Study|Withdrawal by Subject|19|||
146372031|NCT00970268|527861346|FG000|Overall Study|Adverse Event|15|||
146372032|NCT00970268|527861347|FG001|Overall Study|Adverse Event|12|||
146372033|NCT00970268|527861346|FG000|Overall Study|Lack of Efficacy|3|||
146372034|NCT00970268|527861347|FG001|Overall Study|Lack of Efficacy|6|||
146372035|NCT00970268|527861346|FG000|Overall Study|Protocol Violation|4|||
146372036|NCT00970268|527861347|FG001|Overall Study|Protocol Violation|7|||
146372037|NCT00970268|527861346|FG000|Overall Study|Other Reason|3|||
146372038|NCT00970268|527861347|FG001|Overall Study|Other Reason|1|||
146372039|NCT00970268|527861346|FG000|Overall Study|COPD Exacerbation|4|||
146372040|NCT00970268|527861347|FG001|Overall Study|COPD Exacerbation|2|||
146372041|NCT00970268|527861346|FG000|Overall Study|Lost to Follow-up|1|||
146372042|NCT00970268|527861347|FG001|Overall Study|Lost to Follow-up|2|||
146372043|NCT00970268|527861346|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
146372044|NCT00970268|527861347|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
146372045|NCT01079195|527861348|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
146372046|NCT01079195|527861348|FG000|Overall Study|No Documentation Available|437|||
146372047|NCT01079195|527861348|FG000|Overall Study|Adverse Event|157|||
146372048|NCT01079195|527861348|FG000|Overall Study|Reason Unknown|39|||
146372049|NCT01079195|527861348|FG000|Overall Study|Withdrawal by Subject|18|||
146372050|NCT01079195|527861348|FG000|Overall Study|Financial Reasons|15|||
145943490|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
146372051|NCT01079195|527861348|FG000|Overall Study|Lack of Effectiveness|12|||
146372052|NCT01079195|527861348|FG000|Overall Study|Physician Decision|4|||
146372053|NCT01079195|527861348|FG000|Overall Study|Improved Status of Participant|4|||
146372054|NCT01079195|527861348|FG000|Overall Study|No Follow-up Documentation Available|4|||
146372055|NCT01079195|527861348|FG000|Overall Study|Non-compliance|2|||
146372056|NCT02091921|527861354|FG000|Overall Study|Adverse Event|3|||
146372057|NCT02483078|527861355|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
146372058|NCT02483078|527861356|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
146372059|NCT02483078|527861355|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
146372060|NCT02483078|527861356|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
146372061|NCT02483078|527861355|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
146372062|NCT02483078|527861356|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
146372063|NCT02483078|527861355|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
146372064|NCT02483078|527861356|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
146372065|NCT02483078|527861355|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
146372066|NCT02483078|527861356|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
146372067|NCT02483078|527861355|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
146372068|NCT02483078|527861356|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
146372069|NCT04876599|527861361|FG000|Overall Study|Missed|2|||
146372070|NCT04876599|527861362|FG001|Overall Study|Missed|0|||
146372071|NCT04876599|527861361|FG000|Overall Study|Declined|2|||
146372072|NCT04876599|527861362|FG001|Overall Study|Declined|3|||
146372073|NCT03682055|527863796|FG000|Overall Study|Lack of Efficacy|1|||
146372074|NCT03682055|527863797|FG001|Overall Study|Lack of Efficacy|2|||
146372075|NCT03682055|527863798|FG002|Overall Study|Lack of Efficacy|1|||
146372076|NCT03682055|527863799|FG003|Overall Study|Lack of Efficacy|2|||
146372077|NCT03682055|527863800|FG004|Overall Study|Lack of Efficacy|1|||
146372078|NCT03682055|527863801|FG005|Overall Study|Lack of Efficacy|3|||
146372079|NCT03682055|527863796|FG000|Overall Study|Withdrawal by Subject|0|||
146372080|NCT03682055|527863797|FG001|Overall Study|Withdrawal by Subject|0|||
146372081|NCT03682055|527863798|FG002|Overall Study|Withdrawal by Subject|0|||
146372082|NCT03682055|527863799|FG003|Overall Study|Withdrawal by Subject|0|||
146372083|NCT03682055|527863800|FG004|Overall Study|Withdrawal by Subject|0|||
146372084|NCT03682055|527863801|FG005|Overall Study|Withdrawal by Subject|1|||
146372085|NCT03682055|527863796|FG000|Overall Study|Termination of Study by Sponsor|0|||
146372086|NCT03682055|527863797|FG001|Overall Study|Termination of Study by Sponsor|0|||
146372087|NCT03682055|527863798|FG002|Overall Study|Termination of Study by Sponsor|0|||
146372088|NCT03682055|527863799|FG003|Overall Study|Termination of Study by Sponsor|0|||
146372089|NCT03682055|527863800|FG004|Overall Study|Termination of Study by Sponsor|0|||
146372090|NCT03682055|527863801|FG005|Overall Study|Termination of Study by Sponsor|3|||
146372091|NCT01826448|527863802|FG000|Overall Study|Adverse Event|1|||
146372092|NCT01826448|527863803|FG001|Overall Study|Adverse Event|3|||
146372093|NCT01826448|527863802|FG000|Overall Study|Disease progression|2|||
146372094|NCT01826448|527863803|FG001|Overall Study|Disease progression|4|||
146372095|NCT01826448|527863802|FG000|Overall Study|Withdrawal by Subject|1|||
146372096|NCT01826448|527863803|FG001|Overall Study|Withdrawal by Subject|0|||
146372097|NCT01826448|527863802|FG000|Overall Study|Physician Decision|0|||
146372098|NCT01826448|527863803|FG001|Overall Study|Physician Decision|1|||
146372099|NCT01826448|527863802|FG000|Overall Study|2 active cancers|0|||
146372100|NCT01826448|527863803|FG001|Overall Study|2 active cancers|1|||
146372101|NCT00880100|527863804|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
146372102|NCT00880100|527863804|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
146372103|NCT00880100|527863804|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
146372104|NCT02971007|527863806|FG000|Overall Study|Adverse Event|1|||
146372105|NCT02971007|527863807|FG001|Overall Study|Adverse Event|0|||
146372106|NCT02971007|527863808|FG002|Overall Study|Adverse Event|0|||
146372107|NCT02971007|527863806|FG000|Overall Study|Lost to Follow-up|0|||
146372108|NCT02971007|527863807|FG001|Overall Study|Lost to Follow-up|1|||
146372109|NCT02971007|527863808|FG002|Overall Study|Lost to Follow-up|1|||
146372110|NCT02971007|527863806|FG000|Overall Study|Withdrawal by Subject|0|||
146372111|NCT02971007|527863807|FG001|Overall Study|Withdrawal by Subject|1|||
146372112|NCT02971007|527863808|FG002|Overall Study|Withdrawal by Subject|0|||
146372113|NCT02971007|527863806|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
146372114|NCT02971007|527863807|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
146372115|NCT02971007|527863808|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
146372116|NCT02971007|527863806|FG000|Overall Study|Patient discontinued study drug|0|||
146372117|NCT02971007|527863807|FG001|Overall Study|Patient discontinued study drug|1|||
146372118|NCT02971007|527863808|FG002|Overall Study|Patient discontinued study drug|0|||
146372119|NCT00425113|527863812|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
146372120|NCT00425113|527863813|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
146372121|NCT00425113|527863812|FG000|Overall Study|diagnosis of abdominal TB|0|||
146372122|NCT00425113|527863813|FG001|Overall Study|diagnosis of abdominal TB|1|||
146372123|NCT00425113|527863812|FG000|Overall Study|missing study drug more than 14 days|0|||
146372124|NCT00425113|527863813|FG001|Overall Study|missing study drug more than 14 days|1|||
146372125|NCT00425113|527863812|FG000|Overall Study|Withdrawal by Subject|1|||
146372126|NCT00425113|527863813|FG001|Overall Study|Withdrawal by Subject|0|||
146372127|NCT00879437|527863816|FG000|Overall Study|Protocol Violation|0|||
146372128|NCT00879437|527863817|FG001|Overall Study|Protocol Violation|1|||
146372129|NCT00879437|527863816|FG000|Overall Study|Death|1|||
146372130|NCT00879437|527863817|FG001|Overall Study|Death|0|||
146372131|NCT00268463|527863818|FG000|Overall Study|study terminated due to low accrual|10|||
146372132|NCT00268463|527863819|FG001|Overall Study|study terminated due to low accrual|12|||
146372133|NCT03000686|527863820|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146372134|NCT03000686|527863821|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
146372135|NCT03000686|527863822|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146372136|NCT03000686|527863823|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
146372137|NCT02920450|527863824|FG000|Overall Study|Death|1|||
146372138|NCT02920450|527863825|FG001|Overall Study|Death|0|||
146372139|NCT02920450|527863826|FG002|Overall Study|Death|0|||
146372140|NCT02920450|527863827|FG003|Overall Study|Death|0|||
146372141|NCT02920450|527863824|FG000|Overall Study|Withdrawal by Subject|1|||
146372142|NCT02920450|527863825|FG001|Overall Study|Withdrawal by Subject|0|||
146372143|NCT02920450|527863826|FG002|Overall Study|Withdrawal by Subject|0|||
146372144|NCT02920450|527863827|FG003|Overall Study|Withdrawal by Subject|0|||
146372145|NCT00770224|527863832|FG000|Step 1: Induction|Adverse Event|3|||
146372146|NCT00770224|527863833|FG001|Step 1: Induction|Adverse Event|0|||
146372147|NCT00770224|527863832|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
146372148|NCT00770224|527863833|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
146372149|NCT00770224|527863832|FG000|Step 1: Induction|Other reason not protocol specified|2|||
146372150|NCT00770224|527863833|FG001|Step 1: Induction|Other reason not protocol specified|0|||
146372151|NCT00770224|527863832|FG000|Step 1: Induction|Ineligible|2|||
146372152|NCT00770224|527863833|FG001|Step 1: Induction|Ineligible|0|||
146372153|NCT00770224|527863832|FG000|Step 1: Induction|No protocol treatment given|1|||
146372154|NCT00770224|527863833|FG001|Step 1: Induction|No protocol treatment given|0|||
146372155|NCT00770224|527863832|FG000|Step 2: Maintenance|Adverse Event|0|||
146372156|NCT00770224|527863833|FG001|Step 2: Maintenance|Adverse Event|10|||
146372157|NCT00770224|527863832|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
146372158|NCT00770224|527863833|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
146372159|NCT00770224|527863832|FG000|Step 2: Maintenance|Progression/relapse|0|||
146372160|NCT00770224|527863833|FG001|Step 2: Maintenance|Progression/relapse|1|||
146372161|NCT00770224|527863832|FG000|Step 2: Maintenance|Death|0|||
146372162|NCT00770224|527863833|FG001|Step 2: Maintenance|Death|2|||
146372163|NCT00770224|527863832|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
146372164|NCT00770224|527863833|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
146372165|NCT00770224|527863832|FG000|Step 2: Maintenance|Ineligible|0|||
146372166|NCT00770224|527863833|FG001|Step 2: Maintenance|Ineligible|2|||
146372167|NCT04737759|527863834|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
146372168|NCT04737759|527863835|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
146372169|NCT04737759|527863834|FG000|Overall Study|Death|2|||
146372170|NCT04737759|527863835|FG001|Overall Study|Death|0|||
146372171|NCT04737759|527863834|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
146372172|NCT04737759|527863835|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
146372173|NCT04737759|527863834|FG000|Overall Study|Lost to Follow-up|4|||
146372174|NCT04737759|527863835|FG001|Overall Study|Lost to Follow-up|12|||
146372175|NCT01484561|527863836|FG000|Overall Study|Lack of Efficacy|3|||
146372176|NCT01484561|527863837|FG001|Overall Study|Lack of Efficacy|1|||
146372177|NCT01484561|527863836|FG000|Overall Study|Lost to Follow-up|1|||
146372178|NCT01484561|527863837|FG001|Overall Study|Lost to Follow-up|0|||
146372179|NCT01484561|527863836|FG000|Overall Study|Withdrawal by Subject|3|||
146372180|NCT01484561|527863837|FG001|Overall Study|Withdrawal by Subject|0|||
146372181|NCT01484561|527863836|FG000|Overall Study|Other|1|||
146372182|NCT01484561|527863837|FG001|Overall Study|Other|1|||
146372183|NCT01484561|527863836|FG000|Overall Study|Adverse Event|1|||
146372184|NCT01484561|527863837|FG001|Overall Study|Adverse Event|4|||
146372185|NCT03371251|527863838|FG000|Overall Study|Withdrawal by Subject|1|||
146372186|NCT03371251|527863839|FG001|Overall Study|Withdrawal by Subject|0|||
146372187|NCT03371251|527863840|FG002|Overall Study|Withdrawal by Subject|1|||
146372188|NCT03371251|527863841|FG003|Overall Study|Withdrawal by Subject|0|||
146372189|NCT03371251|527863842|FG004|Overall Study|Withdrawal by Subject|2|||
146372190|NCT03371251|527863843|FG005|Overall Study|Withdrawal by Subject|2|||
146372191|NCT03371251|527863838|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
146372192|NCT03371251|527863839|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146372193|NCT03371251|527863840|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146372194|NCT03371251|527863841|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
146372195|NCT03371251|527863842|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
146372196|NCT03371251|527863843|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
146372197|NCT03371251|527863838|FG000|Overall Study|Adverse Event|0|||
146372198|NCT03371251|527863839|FG001|Overall Study|Adverse Event|0|||
146372199|NCT03371251|527863840|FG002|Overall Study|Adverse Event|0|||
146372200|NCT03371251|527863841|FG003|Overall Study|Adverse Event|0|||
146372201|NCT03371251|527863842|FG004|Overall Study|Adverse Event|1|||
146372202|NCT03371251|527863843|FG005|Overall Study|Adverse Event|0|||
146372203|NCT03371251|527863838|FG000|Overall Study|Decision by Sponsor|0|||
146372204|NCT03371251|527863839|FG001|Overall Study|Decision by Sponsor|0|||
146372205|NCT03371251|527863840|FG002|Overall Study|Decision by Sponsor|0|||
146372206|NCT03371251|527863841|FG003|Overall Study|Decision by Sponsor|0|||
146372207|NCT03371251|527863842|FG004|Overall Study|Decision by Sponsor|2|||
146372208|NCT03371251|527863843|FG005|Overall Study|Decision by Sponsor|0|||
146372209|NCT00291187|527863844|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
146372210|NCT00291187|527863845|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
146372211|NCT00291187|527863846|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
146372212|NCT00291187|527863847|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
146372213|NCT04362813|527863848|FG000|Overall Study|Death|12|||
146372214|NCT04362813|527863849|FG001|Overall Study|Death|16|||
146372215|NCT04362813|527863848|FG000|Overall Study|Withdrawal by Subject|3|||
146372216|NCT04362813|527863849|FG001|Overall Study|Withdrawal by Subject|1|||
146372217|NCT04362813|527863848|FG000|Overall Study|Protocol Violation|0|||
146372218|NCT04362813|527863849|FG001|Overall Study|Protocol Violation|3|||
146372219|NCT04362813|527863848|FG000|Overall Study|Lost to Follow-up|1|||
146372220|NCT04362813|527863849|FG001|Overall Study|Lost to Follow-up|1|||
146372221|NCT04362813|527863848|FG000|Overall Study|Enrolled but did not receive treatment|2|||
146372222|NCT04362813|527863849|FG001|Overall Study|Enrolled but did not receive treatment|4|||
146372223|NCT00961116|527863850|FG000|Washout Period of 7 Days|Adverse Event|1|||
146372224|NCT00961116|527863851|FG001|Washout Period of 7 Days|Adverse Event|1|||
146372225|NCT00961116|527863850|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
146372226|NCT00961116|527863851|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
146372227|NCT00961116|527863850|FG000|Washout Period of 7 Days|Protocol Violation|0|||
146372228|NCT00961116|527863851|FG001|Washout Period of 7 Days|Protocol Violation|1|||
146372229|NCT01981109|527863855|FG000|Overall Study|Death|36|||
146372230|NCT01981109|527863855|FG000|Overall Study|Withdrawal by Subject|40|||
146372231|NCT01981109|527863855|FG000|Overall Study|Lost to Follow-up|9|||
146372232|NCT01981109|527863855|FG000|Overall Study|No Discontinuation Documentation|37|||
146372233|NCT01981109|527863855|FG000|Overall Study|Study Termination|100|||
146372234|NCT01981109|527863855|FG000|Overall Study|No data available|2|||
146372235|NCT02023268|527863856|FG000|Overall Study|Lack of Efficacy|0|||
146372236|NCT02023268|527863857|FG001|Overall Study|Lack of Efficacy|1|||
146372237|NCT02023268|527863856|FG000|Overall Study|Adverse Event|0|||
146372238|NCT02023268|527863857|FG001|Overall Study|Adverse Event|2|||
146372239|NCT02023268|527863856|FG000|Overall Study|Withdrawal by Subject|0|||
146372240|NCT02023268|527863857|FG001|Overall Study|Withdrawal by Subject|1|||
146372241|NCT00615459|527863858|FG000|Period I|Adverse Event|2|||
146372242|NCT00615459|527863859|FG001|Period I|Adverse Event|0|||
146372243|NCT00615459|527863860|FG002|Period I|Adverse Event|1|||
146372244|NCT00615459|527863861|FG003|Period I|Adverse Event|0|||
146372245|NCT00615459|527863858|FG000|Period I|Subject withdrew consent|1|||
146372246|NCT00615459|527863859|FG001|Period I|Subject withdrew consent|0|||
146372247|NCT00615459|527863860|FG002|Period I|Subject withdrew consent|0|||
146372248|NCT00615459|527863861|FG003|Period I|Subject withdrew consent|1|||
146372249|NCT00615459|527863858|FG000|Period I|Abnormal test procedure results|1|||
146372250|NCT00615459|527863859|FG001|Period I|Abnormal test procedure results|1|||
146372251|NCT00615459|527863860|FG002|Period I|Abnormal test procedure results|1|||
146372252|NCT00615459|527863861|FG003|Period I|Abnormal test procedure results|0|||
146372253|NCT00615459|527863858|FG000|Period II|Adverse Event|1|||
146372254|NCT00615459|527863859|FG001|Period II|Adverse Event|0|||
146372255|NCT00615459|527863860|FG002|Period II|Adverse Event|0|||
146372256|NCT00615459|527863861|FG003|Period II|Adverse Event|0|||
146372257|NCT00615459|527863858|FG000|Period II|Lost to Follow-up|0|||
146372258|NCT00615459|527863859|FG001|Period II|Lost to Follow-up|0|||
146372259|NCT00615459|527863860|FG002|Period II|Lost to Follow-up|0|||
146372260|NCT00615459|527863861|FG003|Period II|Lost to Follow-up|1|||
146372261|NCT00615459|527863858|FG000|Period III|Adverse Event|0|||
146372262|NCT00615459|527863859|FG001|Period III|Adverse Event|1|||
146372263|NCT00615459|527863860|FG002|Period III|Adverse Event|0|||
146372264|NCT00615459|527863861|FG003|Period III|Adverse Event|0|||
146372265|NCT00615459|527863858|FG000|Period III|Administrative problems|0|||
146372266|NCT00615459|527863859|FG001|Period III|Administrative problems|1|||
146372267|NCT00615459|527863860|FG002|Period III|Administrative problems|1|||
146372268|NCT00615459|527863861|FG003|Period III|Administrative problems|0|||
146372269|NCT00615459|527863858|FG000|Period III|Unsatisfactory therapeutic effect|0|||
146372270|NCT00615459|527863859|FG001|Period III|Unsatisfactory therapeutic effect|1|||
146372271|NCT00615459|527863860|FG002|Period III|Unsatisfactory therapeutic effect|0|||
146372272|NCT00615459|527863861|FG003|Period III|Unsatisfactory therapeutic effect|0|||
146372273|NCT00918346|527863864|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
146372274|NCT00918346|527863865|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
146372275|NCT03238352|527863866|FG000|Overall Study|Lost to Follow-up|0|||
146372276|NCT03238352|527863867|FG001|Overall Study|Lost to Follow-up|2|||
146372277|NCT03238352|527863868|FG002|Overall Study|Lost to Follow-up|1|||
146372278|NCT03238352|527863866|FG000|Overall Study|Withdrawal by Subject|0|||
146372279|NCT03238352|527863867|FG001|Overall Study|Withdrawal by Subject|1|||
146372280|NCT03238352|527863868|FG002|Overall Study|Withdrawal by Subject|0|||
146372281|NCT00928512|527863869|FG000|Overall Study|Adverse Event|4|||
146372282|NCT00928512|527863870|FG001|Overall Study|Adverse Event|3|||
146372283|NCT00928512|527863871|FG002|Overall Study|Adverse Event|2|||
146372284|NCT00928512|527863872|FG003|Overall Study|Adverse Event|8|||
146372285|NCT00928512|527863873|FG004|Overall Study|Adverse Event|6|||
146372286|NCT00928512|527863869|FG000|Overall Study|Lack of Efficacy|2|||
146372287|NCT00928512|527863870|FG001|Overall Study|Lack of Efficacy|0|||
146372288|NCT00928512|527863871|FG002|Overall Study|Lack of Efficacy|4|||
146372289|NCT00928512|527863872|FG003|Overall Study|Lack of Efficacy|7|||
146372290|NCT00928512|527863873|FG004|Overall Study|Lack of Efficacy|3|||
146372291|NCT00928512|527863869|FG000|Overall Study|Protocol Violation|0|||
146372292|NCT00928512|527863870|FG001|Overall Study|Protocol Violation|1|||
146372293|NCT00928512|527863871|FG002|Overall Study|Protocol Violation|0|||
146372294|NCT00928512|527863872|FG003|Overall Study|Protocol Violation|1|||
146372295|NCT00928512|527863873|FG004|Overall Study|Protocol Violation|3|||
146372296|NCT00928512|527863869|FG000|Overall Study|Withdrawal by Subject|3|||
146372297|NCT00928512|527863870|FG001|Overall Study|Withdrawal by Subject|0|||
146372298|NCT00928512|527863871|FG002|Overall Study|Withdrawal by Subject|3|||
146372299|NCT00928512|527863872|FG003|Overall Study|Withdrawal by Subject|4|||
146372300|NCT00928512|527863873|FG004|Overall Study|Withdrawal by Subject|0|||
146372301|NCT00928512|527863869|FG000|Overall Study|Lost to Follow-up|1|||
146372302|NCT00928512|527863870|FG001|Overall Study|Lost to Follow-up|1|||
146372303|NCT00928512|527863871|FG002|Overall Study|Lost to Follow-up|2|||
146372304|NCT00928512|527863872|FG003|Overall Study|Lost to Follow-up|1|||
146372305|NCT00928512|527863873|FG004|Overall Study|Lost to Follow-up|3|||
146372306|NCT00928512|527863869|FG000|Overall Study|Administrative Problems|0|||
146372307|NCT00928512|527863870|FG001|Overall Study|Administrative Problems|1|||
146372308|NCT00928512|527863871|FG002|Overall Study|Administrative Problems|0|||
146372309|NCT00928512|527863872|FG003|Overall Study|Administrative Problems|0|||
146372310|NCT00928512|527863873|FG004|Overall Study|Administrative Problems|0|||
146372311|NCT00729326|527863878|FG000|Overall Study|Lost to Follow-up|2|||
146372312|NCT00729326|527863879|FG001|Overall Study|Lost to Follow-up|0|||
146372313|NCT00729326|527863878|FG000|Overall Study|Physician Decision|0|||
146372314|NCT00729326|527863879|FG001|Overall Study|Physician Decision|1|||
146372315|NCT00729326|527863878|FG000|Overall Study|Protocol Violation|3|||
146372316|NCT00729326|527863879|FG001|Overall Study|Protocol Violation|2|||
146372317|NCT00729326|527863878|FG000|Overall Study|Subject Decision|4|||
146372318|NCT00729326|527863879|FG001|Overall Study|Subject Decision|4|||
146372319|NCT00729326|527863878|FG000|Overall Study|Sponsor Decision|1|||
146372320|NCT00729326|527863879|FG001|Overall Study|Sponsor Decision|2|||
146372321|NCT01235728|527863882|FG000|Overall Study|Protocol Violation|0|||
146372322|NCT01235728|527863883|FG001|Overall Study|Protocol Violation|0|||
146372323|NCT01235728|527863884|FG002|Overall Study|Protocol Violation|0|||
146372324|NCT01235728|527863885|FG003|Overall Study|Protocol Violation|1|||
146372325|NCT01235728|527863886|FG004|Overall Study|Protocol Violation|0|||
146372326|NCT01235728|527863887|FG005|Overall Study|Protocol Violation|0|||
146372327|NCT01235728|527863888|FG006|Overall Study|Protocol Violation|0|||
146372328|NCT01235728|527863889|FG007|Overall Study|Protocol Violation|0|||
146372329|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
146372330|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
146372331|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
146372332|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146372333|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
146372334|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
146372335|NCT00996593|527863890|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
146372336|NCT00996593|527863890|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
146372337|NCT00996593|527863890|FG000|Long-Term Follow-Up|Site Closed|1|||
146372338|NCT01202760|527863891|FG000|Overall Study|Entry Criteria Not Met|0|||
146372339|NCT01202760|527863892|FG001|Overall Study|Entry Criteria Not Met|3|||
146372340|NCT01202760|527863893|FG002|Overall Study|Entry Criteria Not Met|1|||
146372341|NCT01202760|527863891|FG000|Overall Study|Adverse Event|11|||
146372342|NCT01202760|527863892|FG001|Overall Study|Adverse Event|9|||
146372343|NCT01202760|527863893|FG002|Overall Study|Adverse Event|10|||
146372344|NCT01202760|527863891|FG000|Overall Study|Death|2|||
146372345|NCT01202760|527863892|FG001|Overall Study|Death|1|||
146372346|NCT01202760|527863893|FG002|Overall Study|Death|0|||
146372347|NCT01202760|527863891|FG000|Overall Study|Lack of Efficacy|6|||
146372348|NCT01202760|527863892|FG001|Overall Study|Lack of Efficacy|8|||
146372349|NCT01202760|527863893|FG002|Overall Study|Lack of Efficacy|7|||
146372350|NCT01202760|527863891|FG000|Overall Study|Lost to Follow-up|0|||
146372351|NCT01202760|527863892|FG001|Overall Study|Lost to Follow-up|2|||
146372352|NCT01202760|527863893|FG002|Overall Study|Lost to Follow-up|1|||
146372353|NCT01202760|527863891|FG000|Overall Study|Parent / Caregiver Decision|0|||
146372354|NCT01202760|527863892|FG001|Overall Study|Parent / Caregiver Decision|1|||
146372355|NCT01202760|527863893|FG002|Overall Study|Parent / Caregiver Decision|0|||
146372356|NCT01202760|527863891|FG000|Overall Study|Withdrawal by Subject|17|||
146372357|NCT01202760|527863892|FG001|Overall Study|Withdrawal by Subject|18|||
146372358|NCT01202760|527863893|FG002|Overall Study|Withdrawal by Subject|14|||
146372359|NCT01202760|527863891|FG000|Overall Study|Physician Decision|0|||
146372360|NCT01202760|527863892|FG001|Overall Study|Physician Decision|1|||
146372361|NCT01202760|527863893|FG002|Overall Study|Physician Decision|0|||
146372362|NCT01202760|527863891|FG000|Overall Study|Protocol Violation|7|||
146372363|NCT01202760|527863892|FG001|Overall Study|Protocol Violation|5|||
146372364|NCT01202760|527863893|FG002|Overall Study|Protocol Violation|2|||
146372365|NCT01202760|527863891|FG000|Overall Study|Sponsor Decision|4|||
146372366|NCT01202760|527863892|FG001|Overall Study|Sponsor Decision|4|||
146372367|NCT01202760|527863893|FG002|Overall Study|Sponsor Decision|0|||
146372368|NCT00871572|527863894|FG000|Overall Study|Adverse Event|0|||
146372369|NCT00871572|527863895|FG001|Overall Study|Adverse Event|2|||
146372370|NCT00871572|527863896|FG002|Overall Study|Adverse Event|0|||
146372371|NCT00871572|527863897|FG003|Overall Study|Adverse Event|3|||
146372372|NCT00871572|527863894|FG000|Overall Study|Investigator Decision|0|||
146372373|NCT00871572|527863895|FG001|Overall Study|Investigator Decision|1|||
146372374|NCT00871572|527863896|FG002|Overall Study|Investigator Decision|0|||
146372375|NCT00871572|527863897|FG003|Overall Study|Investigator Decision|1|||
146372376|NCT00871572|527863894|FG000|Overall Study|Lost to Follow-up|0|||
146372377|NCT00871572|527863895|FG001|Overall Study|Lost to Follow-up|1|||
146372378|NCT00871572|527863896|FG002|Overall Study|Lost to Follow-up|0|||
146372379|NCT00871572|527863897|FG003|Overall Study|Lost to Follow-up|1|||
146372380|NCT00871572|527863894|FG000|Overall Study|Protocol Violation|0|||
146372381|NCT00871572|527863895|FG001|Overall Study|Protocol Violation|0|||
146372382|NCT00871572|527863896|FG002|Overall Study|Protocol Violation|1|||
146372383|NCT00871572|527863897|FG003|Overall Study|Protocol Violation|1|||
146372384|NCT00871572|527863894|FG000|Overall Study|Sponsor Decision|1|||
146372385|NCT00871572|527863895|FG001|Overall Study|Sponsor Decision|0|||
146372386|NCT00871572|527863896|FG002|Overall Study|Sponsor Decision|0|||
146372387|NCT00871572|527863897|FG003|Overall Study|Sponsor Decision|0|||
146372388|NCT00871572|527863894|FG000|Overall Study|Withdrawal by Subject|1|||
146372389|NCT00871572|527863895|FG001|Overall Study|Withdrawal by Subject|2|||
146372390|NCT00871572|527863896|FG002|Overall Study|Withdrawal by Subject|3|||
146372391|NCT00871572|527863897|FG003|Overall Study|Withdrawal by Subject|1|||
146372392|NCT01654523|527863898|FG000|Overall Study|Withdrawal by Subject|1|||
146372393|NCT04354155|527863901|FG000|Overall Study|Withdrawal by Subject|1|||
146372394|NCT04354155|527863901|FG000|Overall Study|Did not meet criteria for study intervention|1|||
146372395|NCT01686958|527863902|FG000|Overall Study|Withdrawal by Subject|1|||
146372396|NCT02810951|527863905|FG000|Overall Study|Adverse Event|1|||
146372397|NCT03199638|527863906|FG000|Overall Study|inability to drink glutamine during regularly|0|||
146372398|NCT03199638|527863907|FG001|Overall Study|inability to drink glutamine during regularly|2|||
146372399|NCT01575899|527863908|FG000|Overall Study|Lost to Follow-up|3|||
146372400|NCT01575899|527863909|FG001|Overall Study|Lost to Follow-up|4|||
146372401|NCT01575899|527863910|FG002|Overall Study|Lost to Follow-up|2|||
146372402|NCT01575899|527863908|FG000|Overall Study|Protocol Violation|2|||
146372403|NCT01575899|527863909|FG001|Overall Study|Protocol Violation|1|||
146372404|NCT01575899|527863910|FG002|Overall Study|Protocol Violation|0|||
146372405|NCT03097029|527863911|FG000|Overall Study|Withdrawal by Subject|1|||
146372406|NCT02807844|527863912|FG000|Overall Study|Physician Decision|0|||
146372407|NCT02807844|527863913|FG001|Overall Study|Physician Decision|0|||
146372408|NCT02807844|527863914|FG002|Overall Study|Physician Decision|0|||
146372409|NCT02807844|527863915|FG003|Overall Study|Physician Decision|0|||
146372410|NCT02807844|527863916|FG004|Overall Study|Physician Decision|0|||
146372411|NCT02807844|527863917|FG005|Overall Study|Physician Decision|0|||
146372412|NCT02807844|527863918|FG006|Overall Study|Physician Decision|3|||
146372413|NCT02807844|527863919|FG007|Overall Study|Physician Decision|0|||
146372414|NCT02807844|527863920|FG008|Overall Study|Physician Decision|1|||
146372415|NCT02807844|527863921|FG009|Overall Study|Physician Decision|2|||
146372416|NCT02807844|527863912|FG000|Overall Study|Death|0|||
146372417|NCT02807844|527863913|FG001|Overall Study|Death|0|||
146372418|NCT02807844|527863914|FG002|Overall Study|Death|2|||
146372419|NCT02807844|527863915|FG003|Overall Study|Death|4|||
146372420|NCT02807844|527863916|FG004|Overall Study|Death|1|||
146372421|NCT02807844|527863917|FG005|Overall Study|Death|2|||
146372422|NCT02807844|527863918|FG006|Overall Study|Death|1|||
146372423|NCT02807844|527863919|FG007|Overall Study|Death|2|||
146372424|NCT02807844|527863920|FG008|Overall Study|Death|0|||
146372425|NCT02807844|527863921|FG009|Overall Study|Death|1|||
146372426|NCT02807844|527863912|FG000|Overall Study|Withdrawal by Subject|0|||
146372427|NCT02807844|527863913|FG001|Overall Study|Withdrawal by Subject|0|||
146372428|NCT02807844|527863914|FG002|Overall Study|Withdrawal by Subject|2|||
146372429|NCT02807844|527863915|FG003|Overall Study|Withdrawal by Subject|1|||
146372430|NCT02807844|527863916|FG004|Overall Study|Withdrawal by Subject|1|||
146372431|NCT02807844|527863917|FG005|Overall Study|Withdrawal by Subject|0|||
146372432|NCT02807844|527863918|FG006|Overall Study|Withdrawal by Subject|1|||
146372433|NCT02807844|527863919|FG007|Overall Study|Withdrawal by Subject|0|||
146372434|NCT02807844|527863920|FG008|Overall Study|Withdrawal by Subject|0|||
146372435|NCT02807844|527863921|FG009|Overall Study|Withdrawal by Subject|0|||
146372436|NCT02807844|527863912|FG000|Overall Study|Progressive disease|5|||
146372437|NCT02807844|527863913|FG001|Overall Study|Progressive disease|12|||
146372438|NCT02807844|527863914|FG002|Overall Study|Progressive disease|8|||
146372439|NCT02807844|527863915|FG003|Overall Study|Progressive disease|8|||
146372440|NCT02807844|527863916|FG004|Overall Study|Progressive disease|3|||
146372441|NCT02807844|527863917|FG005|Overall Study|Progressive disease|8|||
146372442|NCT02807844|527863918|FG006|Overall Study|Progressive disease|14|||
146372443|NCT02807844|527863919|FG007|Overall Study|Progressive disease|17|||
146372444|NCT02807844|527863920|FG008|Overall Study|Progressive disease|19|||
146372445|NCT02807844|527863921|FG009|Overall Study|Progressive disease|15|||
146372446|NCT02807844|527863912|FG000|Overall Study|Adverse Event|1|||
146372447|NCT02807844|527863913|FG001|Overall Study|Adverse Event|0|||
146372448|NCT02807844|527863914|FG002|Overall Study|Adverse Event|0|||
146372449|NCT02807844|527863915|FG003|Overall Study|Adverse Event|0|||
146372450|NCT02807844|527863916|FG004|Overall Study|Adverse Event|1|||
146372451|NCT02807844|527863917|FG005|Overall Study|Adverse Event|1|||
146372452|NCT02807844|527863918|FG006|Overall Study|Adverse Event|1|||
146372453|NCT02807844|527863919|FG007|Overall Study|Adverse Event|1|||
146372454|NCT02807844|527863920|FG008|Overall Study|Adverse Event|1|||
146372455|NCT02807844|527863921|FG009|Overall Study|Adverse Event|2|||
146372456|NCT00709124|527863922|FG000|Overall Study|Death|3|||
146372457|NCT00709124|527863923|FG001|Overall Study|Death|1|||
146372458|NCT00709124|527863922|FG000|Overall Study|encephalopathy; can't do assessment|1|||
146372459|NCT00709124|527863923|FG001|Overall Study|encephalopathy; can't do assessment|0|||
146372460|NCT00373490|527863924|FG000|Overall Study|Adverse Event|0|||
146372461|NCT00373490|527863925|FG001|Overall Study|Adverse Event|1|||
146372462|NCT00373490|527863924|FG000|Overall Study|Lack of Efficacy|9|||
146372463|NCT00373490|527863925|FG001|Overall Study|Lack of Efficacy|4|||
146372464|NCT00373490|527863924|FG000|Overall Study|Withdrawal by Subject|0|||
146372465|NCT00373490|527863925|FG001|Overall Study|Withdrawal by Subject|1|||
146372466|NCT00108953|527863932|FG000|Follow-up|Death|18|||
146372467|NCT00108953|527863933|FG001|Follow-up|Death|26|||
146372468|NCT00108953|527863932|FG000|Follow-up|Lost to Follow-up|1|||
146372469|NCT00108953|527863933|FG001|Follow-up|Lost to Follow-up|1|||
146372470|NCT00108953|527863932|FG000|Follow-up|Study terminated by sponsor|10|||
146372471|NCT00108953|527863933|FG001|Follow-up|Study terminated by sponsor|6|||
146372472|NCT00753688|527863934|FG000|Overall Study|Death|102|||
146372473|NCT00753688|527863935|FG001|Overall Study|Death|203|||
146372474|NCT00753688|527863934|FG000|Overall Study|Missing|4|||
146372475|NCT00753688|527863935|FG001|Overall Study|Missing|9|||
146372476|NCT00753688|527863934|FG000|Overall Study|Participant Withdrew Consent|2|||
146372477|NCT00753688|527863935|FG001|Overall Study|Participant Withdrew Consent|2|||
146372478|NCT00753688|527863934|FG000|Overall Study|Ongoing - in Follow-up|15|||
146372479|NCT00753688|527863935|FG001|Overall Study|Ongoing - in Follow-up|31|||
146372480|NCT00753688|527863934|FG000|Overall Study|Adverse Event|0|||
146372481|NCT00753688|527863935|FG001|Overall Study|Adverse Event|1|||
146372482|NCT00587301|527863943|FG000|Overall Study|Screen Failure|9|||
146372483|NCT00587301|527863943|FG000|Overall Study|Lost to Follow-up|22|||
146372484|NCT00587301|527863943|FG000|Overall Study|Withdrawal by Subject|7|||
146372485|NCT00587301|527863943|FG000|Overall Study|Protocol Violation|7|||
146372486|NCT01496274|527863944|FG000|Overall Study|Protocol Violation|0|||
146372487|NCT01496274|527863945|FG001|Overall Study|Protocol Violation|1|||
146372488|NCT01496274|527863944|FG000|Overall Study|Adverse Event|1|||
146372489|NCT01496274|527863945|FG001|Overall Study|Adverse Event|1|||
146372490|NCT01496274|527863944|FG000|Overall Study|Withdrawal by Subject|2|||
146372491|NCT01496274|527863945|FG001|Overall Study|Withdrawal by Subject|0|||
146372492|NCT01496274|527863944|FG000|Overall Study|Lost to Follow-up|0|||
146372493|NCT01496274|527863945|FG001|Overall Study|Lost to Follow-up|3|||
146372494|NCT02758613|527863946|FG000|Treatment|Physician and Sponsor Decision|1|||
146372495|NCT02758613|527863947|FG001|Treatment|Physician and Sponsor Decision|0|||
146372496|NCT02758613|527863948|FG002|Treatment|Physician and Sponsor Decision|0|||
146372497|NCT02758613|527863949|FG003|Treatment|Physician and Sponsor Decision|0|||
146372498|NCT02758613|527863946|FG000|Treatment|Withdrawal by Subject|1|||
146372499|NCT02758613|527863947|FG001|Treatment|Withdrawal by Subject|0|||
146372500|NCT02758613|527863948|FG002|Treatment|Withdrawal by Subject|1|||
146372501|NCT02758613|527863949|FG003|Treatment|Withdrawal by Subject|0|||
146372502|NCT01400139|527863951|FG000|HYD Core Study|Adverse Event|210|||
146372503|NCT01400139|527863951|FG000|HYD Core Study|Lack of Efficacy|59|||
146372504|NCT01400139|527863951|FG000|HYD Core Study|Withdrawal by Subject|114|||
146372505|NCT01400139|527863951|FG000|HYD Core Study|Lost to Follow-up|39|||
146372506|NCT01400139|527863951|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
146372507|NCT01400139|527863951|FG000|HYD Core Study|Administrative|56|||
146372508|NCT01400139|527863951|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
146372509|NCT01400139|527863951|FG000|HYD Extension Period|Adverse Event|8|||
146372510|NCT01400139|527863951|FG000|HYD Extension Period|Withdrawal by Subject|5|||
146372511|NCT01400139|527863951|FG000|HYD Extension Period|Administrative|10|||
146372512|NCT00418717|527863953|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
146372513|NCT00418717|527863953|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
146372514|NCT00351819|527863955|FG000|Overall Study|Lost to Follow-up|4|||
146372515|NCT00351819|527863956|FG001|Overall Study|Lost to Follow-up|4|||
146372516|NCT00351819|527863955|FG000|Overall Study|Withdrawal by Subject|0|||
146372517|NCT00351819|527863956|FG001|Overall Study|Withdrawal by Subject|4|||
146372518|NCT00351819|527863955|FG000|Overall Study|Elevated PSA|1|||
146372519|NCT00351819|527863956|FG001|Overall Study|Elevated PSA|1|||
146372520|NCT00351819|527863955|FG000|Overall Study|Traumatic ankle fracture|1|||
146372521|NCT00351819|527863956|FG001|Overall Study|Traumatic ankle fracture|0|||
146372522|NCT00351819|527863955|FG000|Overall Study|Unprofessional behavior|1|||
146372523|NCT00351819|527863956|FG001|Overall Study|Unprofessional behavior|0|||
146372524|NCT00351819|527863955|FG000|Overall Study|Non-compliance|0|||
146372525|NCT00351819|527863956|FG001|Overall Study|Non-compliance|1|||
146372526|NCT00351819|527863955|FG000|Overall Study|Incarcerated|0|||
146372527|NCT00351819|527863956|FG001|Overall Study|Incarcerated|1|||
146372528|NCT00351819|527863955|FG000|Overall Study|Enrolled in another trial|0|||
146372529|NCT00351819|527863956|FG001|Overall Study|Enrolled in another trial|1|||
146372530|NCT00249795|527863959|FG000|Overall Study|Not treated|16|||
146372531|NCT00249795|527863960|FG001|Overall Study|Not treated|14|||
146372532|NCT00249795|527863959|FG000|Overall Study|Symptomatic hypotension|127|||
146372533|NCT00249795|527863960|FG001|Overall Study|Symptomatic hypotension|64|||
146372534|NCT00249795|527863959|FG000|Overall Study|Other Serious Adverse Event|84|||
146372535|NCT00249795|527863960|FG001|Overall Study|Other Serious Adverse Event|93|||
146372536|NCT00249795|527863959|FG000|Overall Study|Qualifying condition not present|26|||
146372537|NCT00249795|527863960|FG001|Overall Study|Qualifying condition not present|29|||
146372538|NCT00249795|527863959|FG000|Overall Study|Withdrawal by Subject|678|||
146372539|NCT00249795|527863960|FG001|Overall Study|Withdrawal by Subject|742|||
146372540|NCT00249795|527863959|FG000|Overall Study|Thromboembolic / outcome event|39|||
146372541|NCT00249795|527863960|FG001|Overall Study|Thromboembolic / outcome event|45|||
146372542|NCT00249795|527863959|FG000|Overall Study|Oral anticoagulant required|2|||
146372543|NCT00249795|527863960|FG001|Overall Study|Oral anticoagulant required|0|||
146372544|NCT00249795|527863959|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
146372545|NCT00249795|527863960|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
146372546|NCT00249795|527863959|FG000|Overall Study|Non-compliance|71|||
146372547|NCT00249795|527863960|FG001|Overall Study|Non-compliance|69|||
146372548|NCT00249795|527863959|FG000|Overall Study|Study drug intolerance|3|||
146372549|NCT00249795|527863960|FG001|Overall Study|Study drug intolerance|3|||
146372550|NCT00249795|527863959|FG000|Overall Study|Other adverse events (non-serious)|188|||
146372551|NCT00249795|527863960|FG001|Overall Study|Other adverse events (non-serious)|159|||
146372552|NCT00249795|527863959|FG000|Overall Study|Physician withdrew consent|71|||
146372553|NCT00249795|527863960|FG001|Overall Study|Physician withdrew consent|63|||
146372554|NCT00249795|527863959|FG000|Overall Study|Surgery / procedure|4|||
146372555|NCT00249795|527863960|FG001|Overall Study|Surgery / procedure|5|||
146372556|NCT00249795|527863959|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
146372557|NCT00249795|527863960|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
146372558|NCT00249795|527863959|FG000|Overall Study|Lightheadedness / dizziness|15|||
146372559|NCT00249795|527863960|FG001|Overall Study|Lightheadedness / dizziness|11|||
146372560|NCT00249795|527863959|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
146372561|NCT00249795|527863960|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
146372562|NCT00249795|527863959|FG000|Overall Study|Other contraindicated medication|1|||
146372563|NCT00249795|527863960|FG001|Overall Study|Other contraindicated medication|1|||
146372564|NCT00249795|527863959|FG000|Overall Study|Event related to cardiac condition|17|||
146372565|NCT00249795|527863960|FG001|Overall Study|Event related to cardiac condition|16|||
146372566|NCT00249795|527863959|FG000|Overall Study|Patient not wish to continue after May08|4|||
146372567|NCT00249795|527863960|FG001|Overall Study|Patient not wish to continue after May08|6|||
146372568|NCT00249795|527863959|FG000|Overall Study|Site not agree to continue after May08|1|||
146372569|NCT00249795|527863960|FG001|Overall Study|Site not agree to continue after May08|1|||
146372570|NCT00249795|527863959|FG000|Overall Study|Lost to Follow-up|0|||
146372571|NCT00249795|527863960|FG001|Overall Study|Lost to Follow-up|2|||
146372572|NCT00249795|527863959|FG000|Overall Study|Missing|0|||
146372573|NCT00249795|527863960|FG001|Overall Study|Missing|1|||
146372574|NCT00719537|527863961|FG000|Overall Study|Withdrawal by Subject|1|||
146372575|NCT00719537|527863962|FG001|Overall Study|Withdrawal by Subject|0|||
146372576|NCT00719537|527863961|FG000|Overall Study|Lost to Follow-up|0|||
146372577|NCT00719537|527863962|FG001|Overall Study|Lost to Follow-up|1|||
146372578|NCT01142193|527863963|FG000|Overall Study|Adverse Event|12|||
146372579|NCT01142193|527863964|FG001|Overall Study|Adverse Event|4|||
146372580|NCT01142193|527863963|FG000|Overall Study|Lack of Efficacy|2|||
146372581|NCT01142193|527863964|FG001|Overall Study|Lack of Efficacy|1|||
146372582|NCT01142193|527863963|FG000|Overall Study|Physician Decision|1|||
146372583|NCT01142193|527863964|FG001|Overall Study|Physician Decision|1|||
146372584|NCT01142193|527863963|FG000|Overall Study|Withdrawal by Subject|4|||
146372585|NCT01142193|527863964|FG001|Overall Study|Withdrawal by Subject|3|||
146372586|NCT01142193|527863963|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
146372587|NCT01142193|527863964|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
146372588|NCT01142193|527863963|FG000|Overall Study|Other|1|||
146372589|NCT01142193|527863964|FG001|Overall Study|Other|2|||
146372590|NCT03549429|527863967|FG000|Overall Study|Protocol Violation|5|||
146372591|NCT03549429|527863968|FG001|Overall Study|Protocol Violation|3|||
146372592|NCT01425749|527863969|FG000|Overall Study|progression of melanoma|0|||
146372593|NCT01425749|527863970|FG001|Overall Study|progression of melanoma|1|||
146372594|NCT02910219|527863971|FG000|Overall Study|Withdrawal by Subject|1|||
146372595|NCT02910219|527863972|FG001|Overall Study|Withdrawal by Subject|1|||
146372596|NCT00701441|527863973|FG000|Overall Study|failure in cpap compliance|0|||
146372597|NCT00701441|527863974|FG001|Overall Study|failure in cpap compliance|4|||
146372598|NCT02762708|527863976|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146372599|NCT02762708|527863977|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
146372600|NCT02762708|527863978|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146372601|NCT02762708|527863979|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
146372602|NCT01068717|527863981|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
146372603|NCT01068717|527863982|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146372604|NCT01068717|527863983|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146372605|NCT01068717|527863984|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
146372606|NCT05200455|527863987|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
146372607|NCT01602549|527863988|FG000|Overall Study|Protocol Violation|0|||
146372608|NCT01602549|527863989|FG001|Overall Study|Protocol Violation|1|||
146372609|NCT01602549|527863988|FG000|Overall Study|Withdrawal by Subject|1|||
146372610|NCT01602549|527863989|FG001|Overall Study|Withdrawal by Subject|0|||
146372611|NCT00807014|527863990|FG000|Overall Study|Participant Considered Disease Cured|13|||
146372612|NCT00807014|527863991|FG001|Overall Study|Participant Considered Disease Cured|2|||
146372613|NCT00807014|527863990|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
146372614|NCT00807014|527863991|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
146372615|NCT00807014|527863990|FG000|Overall Study|Protocol Violation|2|||
146372616|NCT00807014|527863991|FG001|Overall Study|Protocol Violation|8|||
146372617|NCT00807014|527863990|FG000|Overall Study|Adverse Event|0|||
146372618|NCT00807014|527863991|FG001|Overall Study|Adverse Event|2|||
146372619|NCT00807014|527863990|FG000|Overall Study|Lost to Follow-up|9|||
146372620|NCT00807014|527863991|FG001|Overall Study|Lost to Follow-up|7|||
146372621|NCT00807014|527863990|FG000|Overall Study|Recovery|1|||
146372622|NCT00807014|527863991|FG001|Overall Study|Recovery|0|||
146372623|NCT00807014|527863990|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
146372624|NCT00807014|527863991|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
146372625|NCT03700736|527863994|FG000|Overall Study|Pregnancy|1|||
146372626|NCT03700736|527863995|FG001|Overall Study|Pregnancy|1|||
146372627|NCT03700736|527863994|FG000|Overall Study|Withdrawal by Subject|2|||
146372628|NCT03700736|527863995|FG001|Overall Study|Withdrawal by Subject|6|||
146372629|NCT01410799|527863997|FG000|Overall Study|PI decision|13|||
146372630|NCT00446641|527866216|FG000|Overall Study|Withdrawal by Subject|8|||
146372631|NCT00446641|527866217|FG001|Overall Study|Withdrawal by Subject|3|||
146372632|NCT00446641|527866216|FG000|Overall Study|poor compliance|8|||
146372633|NCT00446641|527866217|FG001|Overall Study|poor compliance|6|||
146372634|NCT00446641|527866216|FG000|Overall Study|Lost to Follow-up|1|||
146372635|NCT00446641|527866217|FG001|Overall Study|Lost to Follow-up|1|||
146372636|NCT00402285|527866218|FG000|Overall Study|insufficient RNA quality|7|||
146372637|NCT00402285|527866219|FG001|Overall Study|insufficient RNA quality|6|||
146372638|NCT00402285|527866220|FG002|Overall Study|insufficient RNA quality|2|||
146372639|NCT00784459|527866223|FG000|Overall Study|Adverse Event|0|||
146372640|NCT00784459|527866224|FG001|Overall Study|Adverse Event|2|||
146372641|NCT02431702|527866225|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
146372642|NCT02431702|527866226|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372643|NCT02431702|527866227|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372644|NCT02431702|527866228|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372645|NCT02431702|527866229|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372646|NCT02431702|527866230|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372647|NCT02431702|527866231|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
146372648|NCT02431702|527866225|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
146372649|NCT02431702|527866226|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146372650|NCT02431702|527866227|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146372651|NCT02431702|527866228|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146372652|NCT02431702|527866229|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146372653|NCT02431702|527866230|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
146372654|NCT02431702|527866231|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
146372655|NCT02431702|527866225|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
146372656|NCT02431702|527866226|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146372657|NCT02431702|527866227|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146372658|NCT02431702|527866228|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146372659|NCT02431702|527866229|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146372660|NCT02431702|527866230|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
146372661|NCT02431702|527866231|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
146372662|NCT02431702|527866225|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
146372663|NCT02431702|527866226|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146372664|NCT02431702|527866227|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146372665|NCT02431702|527866228|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146372666|NCT02431702|527866229|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146372667|NCT02431702|527866230|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
146372668|NCT02431702|527866231|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
146395796|NCT01314261|527950944|FG000|Overall Study|Adverse Event|1|||
146372669|NCT02431702|527866225|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
146372670|NCT02431702|527866226|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372671|NCT02431702|527866227|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372672|NCT02431702|527866228|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372673|NCT02431702|527866229|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372674|NCT02431702|527866230|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372675|NCT02431702|527866231|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
146372676|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146372677|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
146372678|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
146372679|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146372680|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146372681|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146372682|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
146372683|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146372684|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
146372685|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
146372686|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146372687|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146372688|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146372689|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
146372690|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146372691|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
146372692|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
146372693|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146372694|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146372695|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146372696|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
146372697|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372698|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
146372699|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372700|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372701|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372702|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372703|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
146372704|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
146372705|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
146372706|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
146372707|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
146372708|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
146372709|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
146372710|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
146372711|NCT02431702|527866225|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372712|NCT02431702|527866226|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372713|NCT02431702|527866227|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
146372714|NCT02431702|527866228|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372715|NCT02431702|527866229|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372716|NCT02431702|527866230|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372717|NCT02431702|527866231|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
146372718|NCT02431702|527866225|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146372719|NCT02431702|527866226|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146372720|NCT02431702|527866227|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146372721|NCT02431702|527866228|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
146372722|NCT02431702|527866229|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
146372723|NCT02431702|527866230|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146372724|NCT02431702|527866231|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
146372725|NCT02431702|527866225|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146372726|NCT02431702|527866226|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146372727|NCT02431702|527866227|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146372728|NCT02431702|527866228|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
146372729|NCT02431702|527866229|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146372730|NCT02431702|527866230|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
146372731|NCT02431702|527866231|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
146372732|NCT02431702|527866225|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146372733|NCT02431702|527866226|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146372734|NCT02431702|527866227|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146372735|NCT02431702|527866228|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
146372736|NCT02431702|527866229|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
146372737|NCT02431702|527866230|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
146372738|NCT02431702|527866231|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
146372739|NCT02431702|527866225|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
146372740|NCT02431702|527866226|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
146372741|NCT02431702|527866227|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
146372742|NCT02431702|527866228|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
146372743|NCT02431702|527866229|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
146372744|NCT02431702|527866230|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
146372745|NCT02431702|527866231|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
146372746|NCT03551626|527866232|FG000|Overall Study|Adverse Event|88|||
146372747|NCT03551626|527866232|FG000|Overall Study|Disease relapse|18|||
146372748|NCT03551626|527866232|FG000|Overall Study|Withdrawal of informed consent|6|||
146372749|NCT03551626|527866232|FG000|Overall Study|Patient decision|5|||
146372750|NCT03551626|527866232|FG000|Overall Study|Physician Decision|4|||
146372751|NCT03551626|527866232|FG000|Overall Study|Lost to Follow-up|3|||
146372752|NCT03551626|527866232|FG000|Overall Study|Pregnancy|1|||
146372753|NCT03551626|527866232|FG000|Overall Study|Protocol deviation|1|||
146372754|NCT03551626|527866232|FG000|Overall Study|Technical problems|1|||
146372755|NCT01017549|527866235|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
146372756|NCT01017549|527866235|FG000|One-year Follow-up|Lost to Follow-up|2|||
146372757|NCT01017549|527866235|FG000|One-year Follow-up|Withdrawal by Subject|5|||
146372758|NCT01017549|527866235|FG000|5 Year Follow-up|Lost to Follow-up|9|||
146372759|NCT01017549|527866235|FG000|5 Year Follow-up|Mastectomy|3|||
146372760|NCT00443846|527866236|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
146372761|NCT00443846|527866237|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
146372762|NCT00443846|527866236|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
146372763|NCT00443846|527866237|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
146372764|NCT00443846|527866236|FG000|Overall Study|Adverse Event|0|||
146372765|NCT00443846|527866237|FG001|Overall Study|Adverse Event|1|||
146372766|NCT00443846|527866236|FG000|Overall Study|Personal reason|8|||
146372767|NCT00443846|527866237|FG001|Overall Study|Personal reason|3|||
146372768|NCT00443846|527866236|FG000|Overall Study|Lost to Follow-up|1|||
146372769|NCT00443846|527866237|FG001|Overall Study|Lost to Follow-up|2|||
146372770|NCT00391807|527866244|FG000|Overall Study|Did not receive study medication|23|||
146372771|NCT00391807|527866244|FG000|Overall Study|Adverse Event|177|||
146372772|NCT00391807|527866244|FG000|Overall Study|Pregnancy|25|||
146372773|NCT00391807|527866244|FG000|Overall Study|Lost to Follow-up|227|||
146372774|NCT00391807|527866244|FG000|Overall Study|Withdrawal by Subject|147|||
146372775|NCT00391807|527866244|FG000|Overall Study|Protocol Violation|20|||
146372776|NCT00391807|527866244|FG000|Overall Study|Various|96|||
146372777|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
146372778|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
146372779|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
146372780|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
146372781|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
146372782|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146372783|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
146372784|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146372785|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
146372786|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
146372787|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146372788|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146372789|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146372790|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
146372791|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
146372792|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
146372793|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
146372794|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
146372795|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
146372796|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
146372797|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
146372798|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146372799|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
146395797|NCT01314261|527950945|FG001|Overall Study|Adverse Event|0|||
146372800|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146372801|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
146372802|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Other|1|||
146372803|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Other|0|||
146372804|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Other|0|||
146372805|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Other|0|||
146372806|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Other|1|||
146372807|NCT02980692|527866247|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
146372808|NCT02980692|527866248|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
146372809|NCT02980692|527866249|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
146372810|NCT02980692|527866250|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
146372811|NCT02980692|527866251|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
146372812|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Adverse Event|0|||
146372813|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Adverse Event|0|||
146372814|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Adverse Event|0|||
146372815|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Adverse Event|1|||
146372816|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Adverse Event|1|||
146372817|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146372818|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
146372819|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
146372820|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146372821|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
146372822|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
146372823|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
146372824|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
146372825|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
146372826|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
146372827|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Pregnancy|0|||
146372828|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Pregnancy|0|||
146372829|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Pregnancy|1|||
146372830|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Pregnancy|1|||
146372831|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Pregnancy|0|||
146372832|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
146372833|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146372834|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
146372835|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146372836|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
146372837|NCT02980692|527866247|FG000|Double-blind Follow-up Period|Other|0|||
146372838|NCT02980692|527866248|FG001|Double-blind Follow-up Period|Other|0|||
146372839|NCT02980692|527866249|FG002|Double-blind Follow-up Period|Other|1|||
146372840|NCT02980692|527866250|FG003|Double-blind Follow-up Period|Other|1|||
146372841|NCT02980692|527866251|FG004|Double-blind Follow-up Period|Other|3|||
146372842|NCT03725293|527866255|FG000|Overall Study|Physician Decision|9|||
146372843|NCT03725293|527866256|FG001|Overall Study|Physician Decision|6|||
146372844|NCT03725293|527866255|FG000|Overall Study|alternative vascular access needs|1|||
146372845|NCT03725293|527866256|FG001|Overall Study|alternative vascular access needs|2|||
146372846|NCT03725293|527866255|FG000|Overall Study|venous anatomy screen failures|2|||
146372847|NCT03725293|527866256|FG001|Overall Study|venous anatomy screen failures|1|||
146372848|NCT02143141|527866257|FG000|Overall Study|pain scores at 24 hours not collected|1|||
146372849|NCT02143141|527866258|FG001|Overall Study|pain scores at 24 hours not collected|0|||
146372850|NCT04583969|527866259|FG000|Overall Study|Death|31|||
146372851|NCT04583969|527866260|FG001|Overall Study|Death|38|||
146372852|NCT04583969|527866259|FG000|Overall Study|Lost to Follow-up|16|||
146372853|NCT04583969|527866260|FG001|Overall Study|Lost to Follow-up|13|||
146372854|NCT04583969|527866259|FG000|Overall Study|Protocol Violation|1|||
146372855|NCT04583969|527866260|FG001|Overall Study|Protocol Violation|0|||
146372856|NCT04583969|527866259|FG000|Overall Study|Withdrawal by Subject|3|||
146372857|NCT04583969|527866260|FG001|Overall Study|Withdrawal by Subject|3|||
146372858|NCT04583969|527866259|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
146372859|NCT04583969|527866260|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
146372860|NCT04583969|527866259|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
146372861|NCT04583969|527866260|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
146372862|NCT04583969|527866259|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
146372863|NCT04583969|527866260|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
146372864|NCT04583969|527866259|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
146395798|NCT01314261|527950946|FG002|Overall Study|Adverse Event|0|||
145943491|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
146372865|NCT04583969|527866260|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
146372866|NCT04583969|527866259|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
146372867|NCT04583969|527866260|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
146372868|NCT03862495|527866263|FG000|Overall Study|Lost to Follow-up|37|||
146372869|NCT03862495|527866264|FG001|Overall Study|Lost to Follow-up|35|||
146372870|NCT04397796|527866265|FG000|Overall Study|Death|3|||
146372871|NCT04397796|527866266|FG001|Overall Study|Death|1|||
146372872|NCT01057862|527866267|FG000|Overall Study|Withdrawal by Subject|1|||
146372873|NCT01057862|527866268|FG001|Overall Study|Withdrawal by Subject|2|||
146372874|NCT03363165|527866271|FG000|3-month Follow-up|Death|0|||
146372875|NCT03363165|527866272|FG001|3-month Follow-up|Death|1|||
146372876|NCT03363165|527866271|FG000|6-month Follow-up|Death|0|||
146372877|NCT03363165|527866272|FG001|6-month Follow-up|Death|1|||
146372878|NCT03363165|527866271|FG000|6-month Follow-up|Withdrawal by Subject|1|||
146372879|NCT03363165|527866272|FG001|6-month Follow-up|Withdrawal by Subject|1|||
146372880|NCT03363165|527866271|FG000|12-month Follow-up|Death|1|||
146372881|NCT03363165|527866272|FG001|12-month Follow-up|Death|1|||
146372882|NCT03363165|527866271|FG000|12-month Follow-up|Withdrawal by Subject|1|||
146372883|NCT03363165|527866272|FG001|12-month Follow-up|Withdrawal by Subject|1|||
146372884|NCT02255760|527866273|FG000|Overall Study|Lost to Follow-up|0|||
146372885|NCT02255760|527866274|FG001|Overall Study|Lost to Follow-up|1|||
146372886|NCT02255760|527866275|FG002|Overall Study|Lost to Follow-up|0|||
146372887|NCT02255760|527866276|FG003|Overall Study|Lost to Follow-up|0|||
146372888|NCT02255760|527866277|FG004|Overall Study|Lost to Follow-up|0|||
146372889|NCT00618813|527866278|FG000|Overall Study|Lack of Efficacy|1|||
146372890|NCT00618813|527866278|FG000|Overall Study|Physician Decision|2|||
146372891|NCT00618813|527866278|FG000|Overall Study|Withdrawal by Subject|1|||
146372892|NCT00003838|527866279|FG000|Overall Study|Death|0|||
146372893|NCT00003838|527866280|FG001|Overall Study|Death|12|||
146372894|NCT00003838|527866281|FG002|Overall Study|Death|7|||
146372895|NCT00003838|527866279|FG000|Overall Study|Lost to Follow-up|0|||
146372896|NCT00003838|527866280|FG001|Overall Study|Lost to Follow-up|1|||
146372897|NCT00003838|527866281|FG002|Overall Study|Lost to Follow-up|1|||
146372898|NCT00003838|527866279|FG000|Overall Study|Disease Progression|0|||
146372899|NCT00003838|527866280|FG001|Overall Study|Disease Progression|12|||
146372900|NCT00003838|527866281|FG002|Overall Study|Disease Progression|0|||
146372901|NCT04153929|527866282|FG000|Overall Study|Other than listed|2|||
146372902|NCT04153929|527866283|FG001|Overall Study|Other than listed|2|||
146372903|NCT04153929|527866284|FG002|Overall Study|Other than listed|0|||
146372904|NCT04153929|527866285|FG003|Overall Study|Other than listed|1|||
146372905|NCT04153929|527866286|FG004|Overall Study|Other than listed|0|||
146372906|NCT04153929|527866287|FG005|Overall Study|Other than listed|2|||
146372907|NCT04153929|527866288|FG006|Overall Study|Other than listed|2|||
146372908|NCT04153929|527866289|FG007|Overall Study|Other than listed|1|||
146372909|NCT04153929|527866282|FG000|Overall Study|Lost to Follow-up|2|||
146372910|NCT04153929|527866283|FG001|Overall Study|Lost to Follow-up|1|||
146372911|NCT04153929|527866284|FG002|Overall Study|Lost to Follow-up|0|||
146372912|NCT04153929|527866285|FG003|Overall Study|Lost to Follow-up|1|||
146372913|NCT04153929|527866286|FG004|Overall Study|Lost to Follow-up|1|||
146372914|NCT04153929|527866287|FG005|Overall Study|Lost to Follow-up|0|||
146372915|NCT04153929|527866288|FG006|Overall Study|Lost to Follow-up|0|||
146372916|NCT04153929|527866289|FG007|Overall Study|Lost to Follow-up|0|||
146372917|NCT04153929|527866282|FG000|Overall Study|Withdrawal by Subject|3|||
146372918|NCT04153929|527866283|FG001|Overall Study|Withdrawal by Subject|1|||
146372919|NCT04153929|527866284|FG002|Overall Study|Withdrawal by Subject|0|||
146372920|NCT04153929|527866285|FG003|Overall Study|Withdrawal by Subject|3|||
146372921|NCT04153929|527866286|FG004|Overall Study|Withdrawal by Subject|1|||
146372922|NCT04153929|527866287|FG005|Overall Study|Withdrawal by Subject|0|||
146372923|NCT04153929|527866288|FG006|Overall Study|Withdrawal by Subject|1|||
146372924|NCT04153929|527866289|FG007|Overall Study|Withdrawal by Subject|0|||
146372925|NCT04153929|527866282|FG000|Overall Study|Protocol Violation|0|||
146372926|NCT04153929|527866283|FG001|Overall Study|Protocol Violation|0|||
146372927|NCT04153929|527866284|FG002|Overall Study|Protocol Violation|0|||
146372928|NCT04153929|527866285|FG003|Overall Study|Protocol Violation|0|||
146372929|NCT04153929|527866286|FG004|Overall Study|Protocol Violation|0|||
146372930|NCT04153929|527866287|FG005|Overall Study|Protocol Violation|0|||
146372931|NCT04153929|527866288|FG006|Overall Study|Protocol Violation|1|||
146372932|NCT04153929|527866289|FG007|Overall Study|Protocol Violation|2|||
146372933|NCT04153929|527866282|FG000|Overall Study|Adverse Event|3|||
146372934|NCT04153929|527866283|FG001|Overall Study|Adverse Event|5|||
146372935|NCT04153929|527866284|FG002|Overall Study|Adverse Event|5|||
146372936|NCT04153929|527866285|FG003|Overall Study|Adverse Event|11|||
146372937|NCT04153929|527866286|FG004|Overall Study|Adverse Event|15|||
146372938|NCT04153929|527866287|FG005|Overall Study|Adverse Event|4|||
146372939|NCT04153929|527866288|FG006|Overall Study|Adverse Event|8|||
146372940|NCT04153929|527866289|FG007|Overall Study|Adverse Event|2|||
146372941|NCT04153929|527866282|FG000|Overall Study|Not treated|1|||
146372942|NCT04153929|527866283|FG001|Overall Study|Not treated|0|||
146372943|NCT04153929|527866284|FG002|Overall Study|Not treated|0|||
146372944|NCT04153929|527866285|FG003|Overall Study|Not treated|0|||
146372945|NCT04153929|527866286|FG004|Overall Study|Not treated|0|||
146372946|NCT04153929|527866287|FG005|Overall Study|Not treated|0|||
146372947|NCT04153929|527866288|FG006|Overall Study|Not treated|1|||
146372948|NCT04153929|527866289|FG007|Overall Study|Not treated|0|||
146372949|NCT04083794|527866290|FG000|Overall Study|Lost to Follow-up|9|||
146372950|NCT01975675|527866291|FG000|Overall Study|Death|0|||
146372951|NCT01975675|527866292|FG001|Overall Study|Death|1|||
146372952|NCT01975675|527866293|FG002|Overall Study|Death|0|||
146372953|NCT01975675|527866294|FG003|Overall Study|Death|0|||
146372954|NCT00224003|527866295|FG000|Overall Study|Adverse Event|1|||
146372955|NCT00224003|527866295|FG000|Overall Study|Protocol Violation|2|||
146372956|NCT00224003|527866295|FG000|Overall Study|Withdrawal by Subject|1|||
146372957|NCT00224003|527866295|FG000|Overall Study|unk|3|||
146372958|NCT03803202|527866298|FG000|Overall Study|Other|0|||
146372959|NCT03803202|527866299|FG001|Overall Study|Other|1|||
146372960|NCT03803202|527866300|FG002|Overall Study|Other|0|||
146372961|NCT03803202|527866301|FG003|Overall Study|Other|0|||
146372962|NCT03803202|527866302|FG004|Overall Study|Other|0|||
146372963|NCT03803202|527866303|FG005|Overall Study|Other|0|||
146372964|NCT03803202|527866304|FG006|Overall Study|Other|0|||
146372965|NCT03803202|527866305|FG007|Overall Study|Other|0|||
146372966|NCT03803202|527866306|FG008|Overall Study|Other|0|||
146372967|NCT03803202|527866298|FG000|Overall Study|Death|0|||
146372968|NCT03803202|527866299|FG001|Overall Study|Death|0|||
146372969|NCT03803202|527866300|FG002|Overall Study|Death|0|||
146372970|NCT03803202|527866301|FG003|Overall Study|Death|0|||
146372971|NCT03803202|527866302|FG004|Overall Study|Death|0|||
146372972|NCT03803202|527866303|FG005|Overall Study|Death|1|||
146372973|NCT03803202|527866304|FG006|Overall Study|Death|0|||
146372974|NCT03803202|527866305|FG007|Overall Study|Death|0|||
146372975|NCT03803202|527866306|FG008|Overall Study|Death|0|||
146372976|NCT03803202|527866298|FG000|Overall Study|Withdrawal by Subject|0|||
146372977|NCT03803202|527866299|FG001|Overall Study|Withdrawal by Subject|0|||
146372978|NCT03803202|527866300|FG002|Overall Study|Withdrawal by Subject|1|||
146372979|NCT03803202|527866301|FG003|Overall Study|Withdrawal by Subject|0|||
146372980|NCT03803202|527866302|FG004|Overall Study|Withdrawal by Subject|0|||
146372981|NCT03803202|527866303|FG005|Overall Study|Withdrawal by Subject|0|||
146372982|NCT03803202|527866304|FG006|Overall Study|Withdrawal by Subject|0|||
146372983|NCT03803202|527866305|FG007|Overall Study|Withdrawal by Subject|1|||
146372984|NCT03803202|527866306|FG008|Overall Study|Withdrawal by Subject|0|||
146372985|NCT03803202|527866298|FG000|Overall Study|Lost to Follow-up|0|||
146372986|NCT03803202|527866299|FG001|Overall Study|Lost to Follow-up|0|||
146372987|NCT03803202|527866300|FG002|Overall Study|Lost to Follow-up|0|||
146372988|NCT03803202|527866301|FG003|Overall Study|Lost to Follow-up|1|||
146372989|NCT03803202|527866302|FG004|Overall Study|Lost to Follow-up|1|||
146372990|NCT03803202|527866303|FG005|Overall Study|Lost to Follow-up|0|||
146372991|NCT03803202|527866304|FG006|Overall Study|Lost to Follow-up|1|||
146372992|NCT03803202|527866305|FG007|Overall Study|Lost to Follow-up|0|||
146372993|NCT03803202|527866306|FG008|Overall Study|Lost to Follow-up|0|||
146372994|NCT01125293|527866307|FG000|Overall Study|Disease Progression|1|||
146372995|NCT01125293|527866308|FG001|Overall Study|Disease Progression|3|||
146372996|NCT01125293|527866309|FG002|Overall Study|Disease Progression|4|||
146372997|NCT01125293|527866310|FG003|Overall Study|Disease Progression|3|||
146372998|NCT01125293|527866311|FG004|Overall Study|Disease Progression|5|||
146372999|NCT01125293|527866312|FG005|Overall Study|Disease Progression|12|||
146373000|NCT01125293|527866307|FG000|Overall Study|Adverse Event|1|||
146373001|NCT01125293|527866308|FG001|Overall Study|Adverse Event|0|||
146373002|NCT01125293|527866309|FG002|Overall Study|Adverse Event|0|||
146373003|NCT01125293|527866310|FG003|Overall Study|Adverse Event|0|||
146373004|NCT01125293|527866311|FG004|Overall Study|Adverse Event|2|||
146373005|NCT01125293|527866312|FG005|Overall Study|Adverse Event|8|||
146373006|NCT01125293|527866307|FG000|Overall Study|Symptomatic Deterioration|1|||
146373007|NCT01125293|527866308|FG001|Overall Study|Symptomatic Deterioration|0|||
146373008|NCT01125293|527866309|FG002|Overall Study|Symptomatic Deterioration|0|||
146373009|NCT01125293|527866310|FG003|Overall Study|Symptomatic Deterioration|0|||
146373010|NCT01125293|527866311|FG004|Overall Study|Symptomatic Deterioration|0|||
146373011|NCT01125293|527866312|FG005|Overall Study|Symptomatic Deterioration|0|||
146373012|NCT01125293|527866307|FG000|Overall Study|Death|0|||
146373013|NCT01125293|527866308|FG001|Overall Study|Death|0|||
146373014|NCT01125293|527866309|FG002|Overall Study|Death|0|||
146373015|NCT01125293|527866310|FG003|Overall Study|Death|0|||
146373016|NCT01125293|527866311|FG004|Overall Study|Death|1|||
146373017|NCT01125293|527866312|FG005|Overall Study|Death|0|||
146373018|NCT01125293|527866307|FG000|Overall Study|Withdrawal by Subject|0|||
146373019|NCT01125293|527866308|FG001|Overall Study|Withdrawal by Subject|0|||
146373020|NCT01125293|527866309|FG002|Overall Study|Withdrawal by Subject|0|||
146373021|NCT01125293|527866310|FG003|Overall Study|Withdrawal by Subject|0|||
146373022|NCT01125293|527866311|FG004|Overall Study|Withdrawal by Subject|2|||
146373023|NCT01125293|527866312|FG005|Overall Study|Withdrawal by Subject|1|||
146373024|NCT01125293|527866307|FG000|Overall Study|Physician Decision|0|||
146373025|NCT01125293|527866308|FG001|Overall Study|Physician Decision|0|||
146373026|NCT01125293|527866309|FG002|Overall Study|Physician Decision|0|||
146373027|NCT01125293|527866310|FG003|Overall Study|Physician Decision|0|||
146373028|NCT01125293|527866311|FG004|Overall Study|Physician Decision|0|||
146373029|NCT01125293|527866312|FG005|Overall Study|Physician Decision|2|||
146373030|NCT00659126|527866317|FG000|Overall Study|Adverse Event|2|||
146373031|NCT00659126|527866318|FG001|Overall Study|Adverse Event|2|||
146373032|NCT00659126|527866317|FG000|Overall Study|Screen failure|1|||
146373033|NCT00659126|527866318|FG001|Overall Study|Screen failure|1|||
146373034|NCT00659126|527866317|FG000|Overall Study|Technical problems with MRI|0|||
146373035|NCT00659126|527866318|FG001|Overall Study|Technical problems with MRI|1|||
146373036|NCT00260429|527866319|FG000|Overall Study|failure to follow appointments|1|||
146373037|NCT00260429|527866320|FG001|Overall Study|failure to follow appointments|0|||
146373038|NCT00260429|527866319|FG000|Overall Study|scheduled hand surgery|1|||
146373039|NCT00260429|527866320|FG001|Overall Study|scheduled hand surgery|0|||
146373040|NCT02228564|527866321|FG000|Overall Study|Withdrawal by Subject|10|||
146373041|NCT02228564|527866321|FG000|Overall Study|Death|11|||
146373042|NCT02228564|527866321|FG000|Overall Study|Physician Decision|5|||
146373043|NCT02228564|527866321|FG000|Overall Study|Lost to Follow-up|17|||
146373044|NCT02228564|527866321|FG000|Overall Study|Other|6|||
146373045|NCT02633046|527866325|FG000|Overall Study|Adverse Event|8|||
146373046|NCT02633046|527866325|FG000|Overall Study|Physician Decision|7|||
146373047|NCT02633046|527866325|FG000|Overall Study|Withdrawal by Subject|8|||
146373048|NCT02633046|527866325|FG000|Overall Study|Increased proteinuria|2|||
146373049|NCT02633046|527866325|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
146373050|NCT02633046|527866325|FG000|Overall Study|Mutual decision patient and physician|1|||
146373051|NCT02142504|527866326|FG000|Overall Study|Protocol Violation|2|||
146373052|NCT02142504|527866327|FG001|Overall Study|Protocol Violation|1|||
146373053|NCT02142504|527866328|FG002|Overall Study|Protocol Violation|2|||
146373054|NCT02142504|527866326|FG000|Overall Study|Adverse Event|2|||
146373055|NCT02142504|527866327|FG001|Overall Study|Adverse Event|3|||
146373056|NCT02142504|527866328|FG002|Overall Study|Adverse Event|4|||
146373057|NCT02142504|527866326|FG000|Overall Study|Lost to Follow-up|12|||
146373058|NCT02142504|527866327|FG001|Overall Study|Lost to Follow-up|19|||
146373059|NCT02142504|527866328|FG002|Overall Study|Lost to Follow-up|17|||
146373060|NCT02142504|527866326|FG000|Overall Study|Withdrawal by Subject|7|||
146373061|NCT02142504|527866327|FG001|Overall Study|Withdrawal by Subject|9|||
146373062|NCT02142504|527866328|FG002|Overall Study|Withdrawal by Subject|11|||
146373063|NCT02142504|527866326|FG000|Overall Study|Pregnancy|4|||
146373064|NCT02142504|527866327|FG001|Overall Study|Pregnancy|4|||
146373065|NCT02142504|527866328|FG002|Overall Study|Pregnancy|2|||
146373066|NCT02142504|527866326|FG000|Overall Study|Physician Decision|0|||
146373067|NCT02142504|527866327|FG001|Overall Study|Physician Decision|1|||
146373068|NCT02142504|527866328|FG002|Overall Study|Physician Decision|3|||
146373069|NCT02142504|527866326|FG000|Overall Study|Reason Not Specified|4|||
146373070|NCT02142504|527866327|FG001|Overall Study|Reason Not Specified|5|||
146373071|NCT02142504|527866328|FG002|Overall Study|Reason Not Specified|4|||
146373072|NCT02925312|527866329|FG000|Overall Study|Lost to Follow-up|25|||
146373073|NCT02925312|527866330|FG001|Overall Study|Lost to Follow-up|0|||
146373074|NCT02925312|527866329|FG000|Overall Study|Adverse Event|2|||
146373075|NCT02925312|527866330|FG001|Overall Study|Adverse Event|0|||
146373076|NCT00617591|527866333|FG000|Overall Study|Withdrew consent during Induction|4|||
146373077|NCT00617591|527866333|FG000|Overall Study|Withdrew consent during Maintenance|6|||
146373078|NCT04114539|527866335|FG000|Overall Study|Adverse Event|14|||
146373079|NCT04114539|527866335|FG000|Overall Study|Lost to Follow-up|2|||
146373080|NCT04114539|527866335|FG000|Overall Study|Non-compliance with Protocol|2|||
146373081|NCT04114539|527866335|FG000|Overall Study|Non-compliance with Study Drug|1|||
146373082|NCT04114539|527866335|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
146373083|NCT04114539|527866335|FG000|Overall Study|Withdrew consent|10|||
146373084|NCT04114539|527866335|FG000|Overall Study|Others not specified|5|||
146373085|NCT04114539|527866335|FG000|Overall Study|Investigator Decision|2|||
146373086|NCT02096042|527866340|FG000|Overall Study|Disease Progression|1|||
146373087|NCT02096042|527866341|FG001|Overall Study|Disease Progression|0|||
146373088|NCT02096042|527866342|FG002|Overall Study|Disease Progression|0|||
146373089|NCT01225172|527866347|FG000|Overall Study|Subject decision to stop|1|||
146373090|NCT01225172|527866348|FG001|Overall Study|Subject decision to stop|0|||
146373091|NCT01225172|527866347|FG000|Overall Study|Subject request to discontinue treatment|3|||
146373092|NCT01225172|527866348|FG001|Overall Study|Subject request to discontinue treatment|1|||
146373093|NCT01225172|527866347|FG000|Overall Study|Subject no longer meets study criteria|1|||
146373094|NCT01225172|527866348|FG001|Overall Study|Subject no longer meets study criteria|0|||
146373095|NCT01225172|527866347|FG000|Overall Study|Withdrawal by Subject|1|||
146373096|NCT01225172|527866348|FG001|Overall Study|Withdrawal by Subject|0|||
146373097|NCT01203787|527866353|FG000|Overall Study|Death|12|||
146373098|NCT01203787|527866354|FG001|Overall Study|Death|10|||
146373099|NCT01203787|527866353|FG000|Overall Study|Withdrawal by Subject|6|||
146373100|NCT01203787|527866354|FG001|Overall Study|Withdrawal by Subject|2|||
146373101|NCT01203787|527866353|FG000|Overall Study|Lost to Follow-up|2|||
146373102|NCT01203787|527866354|FG001|Overall Study|Lost to Follow-up|0|||
146373103|NCT01203787|527866353|FG000|Overall Study|Adverse Event|11|||
146373104|NCT01203787|527866354|FG001|Overall Study|Adverse Event|15|||
146373105|NCT03693404|527866356|FG000|Overall Study|Withdrawal by Subject|1|||
146373106|NCT03693404|527866357|FG001|Overall Study|Withdrawal by Subject|0|||
146373107|NCT03693404|527866356|FG000|Overall Study|Lost to Follow-up|0|||
146373108|NCT03693404|527866357|FG001|Overall Study|Lost to Follow-up|5|||
146373109|NCT03693404|527866356|FG000|Overall Study|Excluded from Analysis|0|||
146373110|NCT03693404|527866357|FG001|Overall Study|Excluded from Analysis|1|||
146373111|NCT02079519|527866358|FG000|Overall Study|Disease Progression|9|||
146373112|NCT02079519|527866358|FG000|Overall Study|Adverse Event|1|||
146373113|NCT01576406|527866359|FG000|Overall Study|Lost to Follow-up|1|||
146373114|NCT01576406|527866360|FG001|Overall Study|Lost to Follow-up|2|||
146373115|NCT01576406|527866361|FG002|Overall Study|Lost to Follow-up|0|||
146373116|NCT01576406|527866362|FG003|Overall Study|Lost to Follow-up|0|||
146373117|NCT01576406|527866363|FG004|Overall Study|Lost to Follow-up|0|||
146373118|NCT01576406|527866364|FG005|Overall Study|Lost to Follow-up|0|||
146373119|NCT01576406|527866359|FG000|Overall Study|Death|3|||
146373120|NCT01576406|527866360|FG001|Overall Study|Death|4|||
146373121|NCT01576406|527866361|FG002|Overall Study|Death|8|||
146373122|NCT01576406|527866362|FG003|Overall Study|Death|5|||
146373123|NCT01576406|527866363|FG004|Overall Study|Death|7|||
146373124|NCT01576406|527866364|FG005|Overall Study|Death|9|||
146373125|NCT01576406|527866359|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146373126|NCT01576406|527866360|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146373127|NCT01576406|527866361|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
146373128|NCT01576406|527866362|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
146373129|NCT01576406|527866363|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146373130|NCT01576406|527866364|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
146373131|NCT01576406|527866359|FG000|Overall Study|Withdrawal the consent|2|||
146373132|NCT01576406|527866360|FG001|Overall Study|Withdrawal the consent|2|||
146373133|NCT01576406|527866361|FG002|Overall Study|Withdrawal the consent|5|||
146373134|NCT01576406|527866362|FG003|Overall Study|Withdrawal the consent|1|||
146373135|NCT01576406|527866363|FG004|Overall Study|Withdrawal the consent|1|||
146373136|NCT01576406|527866364|FG005|Overall Study|Withdrawal the consent|3|||
146373137|NCT01576406|527866359|FG000|Overall Study|Other|0|||
146373138|NCT01576406|527866360|FG001|Overall Study|Other|0|||
146373139|NCT01576406|527866361|FG002|Overall Study|Other|2|||
146373140|NCT01576406|527866362|FG003|Overall Study|Other|2|||
146373141|NCT01576406|527866363|FG004|Overall Study|Other|0|||
146373142|NCT01576406|527866364|FG005|Overall Study|Other|0|||
146373143|NCT00651313|527866365|FG000|Overall Study|Adverse Event|0|||
146373144|NCT00651313|527866366|FG001|Overall Study|Adverse Event|1|||
146373145|NCT00651313|527866365|FG000|Overall Study|Withdrawal by Subject|3|||
146373146|NCT00651313|527866366|FG001|Overall Study|Withdrawal by Subject|1|||
146373147|NCT00651313|527866365|FG000|Overall Study|Lost to Follow-up|1|||
146373148|NCT00651313|527866366|FG001|Overall Study|Lost to Follow-up|1|||
146373149|NCT00651313|527866365|FG000|Overall Study|Adminstrative Discontinuation|2|||
146373150|NCT00651313|527866366|FG001|Overall Study|Adminstrative Discontinuation|3|||
146373151|NCT00892957|527866368|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
146373152|NCT00892957|527866369|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
146373153|NCT00892957|527866368|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
146373154|NCT00892957|527866369|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
146373155|NCT00676208|527866383|FG000|Overall Study|Lost to Follow-up|0|||
146373156|NCT00676208|527866384|FG001|Overall Study|Lost to Follow-up|2|||
146373157|NCT00676208|527866383|FG000|Overall Study|Incomplete data|2|||
146373158|NCT00676208|527866384|FG001|Overall Study|Incomplete data|4|||
146373159|NCT00669032|527866385|FG000|Overall Study|Lost to Follow-up|6|||
146373160|NCT00669032|527866386|FG001|Overall Study|Lost to Follow-up|5|||
146373161|NCT00669032|527866385|FG000|Overall Study|Lack of Efficacy|8|||
146373162|NCT00669032|527866386|FG001|Overall Study|Lack of Efficacy|19|||
146373163|NCT00669032|527866385|FG000|Overall Study|Withdrawal by Subject|12|||
146373164|NCT00669032|527866386|FG001|Overall Study|Withdrawal by Subject|13|||
146373165|NCT00669032|527866385|FG000|Overall Study|Adverse Event|12|||
146373166|NCT00669032|527866386|FG001|Overall Study|Adverse Event|16|||
146373167|NCT00669032|527866385|FG000|Overall Study|Physician Decision|1|||
146373168|NCT00669032|527866386|FG001|Overall Study|Physician Decision|1|||
146373169|NCT00669032|527866385|FG000|Overall Study|No fulfilment of the selection criteria|5|||
146373170|NCT00669032|527866386|FG001|Overall Study|No fulfilment of the selection criteria|5|||
146373171|NCT01607073|527866387|FG000|Overall Study|Adverse Event|1|||
146373172|NCT00642018|527866388|FG000|Overall Study|Adverse Event|11|||
146373173|NCT00642018|527866389|FG001|Overall Study|Adverse Event|36|||
146373174|NCT00642018|527866388|FG000|Overall Study|Withdrawal by Subject|4|||
146373175|NCT00642018|527866389|FG001|Overall Study|Withdrawal by Subject|10|||
146373176|NCT00642018|527866388|FG000|Overall Study|Progressive Disease|13|||
146373177|NCT00642018|527866389|FG001|Overall Study|Progressive Disease|18|||
146373178|NCT00642018|527866388|FG000|Overall Study|Physician Decision|0|||
146373179|NCT00642018|527866389|FG001|Overall Study|Physician Decision|10|||
146373180|NCT00642018|527866388|FG000|Overall Study|Protocol Violation|0|||
146373181|NCT00642018|527866389|FG001|Overall Study|Protocol Violation|1|||
146373182|NCT00642018|527866388|FG000|Overall Study|Death|0|||
146373183|NCT00642018|527866389|FG001|Overall Study|Death|3|||
146373184|NCT00642018|527866388|FG000|Overall Study|Entry Criteria Not Met|0|||
146373185|NCT00642018|527866389|FG001|Overall Study|Entry Criteria Not Met|1|||
146373186|NCT04126031|527866390|FG000|Part A|Withdrawal by Subject|0|||
146373187|NCT04126031|527866391|FG001|Part A|Withdrawal by Subject|0|||
146373188|NCT04126031|527866392|FG002|Part A|Withdrawal by Subject|1|||
146373189|NCT04126031|527866393|FG003|Part A|Withdrawal by Subject|0|||
146373190|NCT04126031|527866394|FG004|Part A|Withdrawal by Subject|0|||
146373191|NCT04126031|527866395|FG005|Part A|Withdrawal by Subject|0|||
146373192|NCT04126031|527866390|FG000|Part A|Other|1|||
146373193|NCT04126031|527866391|FG001|Part A|Other|0|||
146373194|NCT04126031|527866392|FG002|Part A|Other|0|||
146373195|NCT04126031|527866393|FG003|Part A|Other|0|||
146373196|NCT04126031|527866394|FG004|Part A|Other|0|||
146373197|NCT04126031|527866395|FG005|Part A|Other|0|||
146373198|NCT04126031|527866390|FG000|Part B|Adverse Event|0|||
146373199|NCT04126031|527866391|FG001|Part B|Adverse Event|0|||
146373200|NCT04126031|527866392|FG002|Part B|Adverse Event|0|||
146373201|NCT04126031|527866393|FG003|Part B|Adverse Event|0|||
146373202|NCT04126031|527866394|FG004|Part B|Adverse Event|0|||
146373203|NCT04126031|527866395|FG005|Part B|Adverse Event|2|||
146373204|NCT04126031|527866390|FG000|Part B|Pre-existing hypertransaminasemia|0|||
146373205|NCT04126031|527866391|FG001|Part B|Pre-existing hypertransaminasemia|0|||
146373206|NCT04126031|527866392|FG002|Part B|Pre-existing hypertransaminasemia|0|||
146373207|NCT04126031|527866393|FG003|Part B|Pre-existing hypertransaminasemia|0|||
146373208|NCT04126031|527866394|FG004|Part B|Pre-existing hypertransaminasemia|1|||
146373209|NCT04126031|527866395|FG005|Part B|Pre-existing hypertransaminasemia|0|||
146373210|NCT01946412|527866396|FG000|Overall Study|Adverse Event|1|||
146373211|NCT01946412|527866396|FG000|Overall Study|Non-Compliance|1|||
146373212|NCT01946412|527866396|FG000|Overall Study|Continued with commercial Kalydeco|2|||
146373213|NCT01946412|527866396|FG000|Overall Study|Difficulty in swallowing|1|||
146373214|NCT00617656|527866397|FG000|Overall Study|Inclusion error|4|||
146373215|NCT00617656|527866398|FG001|Overall Study|Inclusion error|4|||
146373216|NCT00617656|527866399|FG002|Overall Study|Inclusion error|0|||
146373217|NCT00617656|527866400|FG003|Overall Study|Inclusion error|0|||
146373218|NCT00617656|527866397|FG000|Overall Study|Missing data|44|||
146373219|NCT00617656|527866398|FG001|Overall Study|Missing data|30|||
146373220|NCT00617656|527866399|FG002|Overall Study|Missing data|13|||
146373221|NCT00617656|527866400|FG003|Overall Study|Missing data|6|||
146373222|NCT00617656|527866397|FG000|Overall Study|Withdrawal by Subject|0|||
146373223|NCT00617656|527866398|FG001|Overall Study|Withdrawal by Subject|2|||
146373224|NCT00617656|527866399|FG002|Overall Study|Withdrawal by Subject|0|||
146373225|NCT00617656|527866400|FG003|Overall Study|Withdrawal by Subject|0|||
146373226|NCT01280812|527868284|FG000|Overall Study|Withdrawal by Subject|2|||
146373227|NCT01280812|527868285|FG001|Overall Study|Withdrawal by Subject|1|||
146373228|NCT01280812|527868286|FG002|Overall Study|Withdrawal by Subject|0|||
146373229|NCT01280812|527868284|FG000|Overall Study|Lost to Follow-up|1|||
146373230|NCT01280812|527868285|FG001|Overall Study|Lost to Follow-up|1|||
146373231|NCT01280812|527868286|FG002|Overall Study|Lost to Follow-up|1|||
146373232|NCT00959894|527868289|FG000|Overall Study|Lost to Follow-up|10|||
146373233|NCT00959894|527868289|FG000|Overall Study|Adverse Event|3|||
146373234|NCT00959894|527868289|FG000|Overall Study|Withdrawal by Subject|1|||
146373235|NCT00959894|527868289|FG000|Overall Study|Need for contraindicated medication|1|||
146373236|NCT00959894|527868289|FG000|Overall Study|Subject moved out of town|1|||
146373237|NCT00323310|527868290|FG000|Overall Study|Withdrawal by Subject|1|||
146373238|NCT00323310|527868290|FG000|Overall Study|a parent refused blood draw|1|||
146373239|NCT00323310|527868290|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
146373240|NCT03565991|527868292|FG000|Overall Study|Other|11|||
146373241|NCT03565991|527868293|FG001|Overall Study|Other|0|||
146373242|NCT03565991|527868292|FG000|Overall Study|Global deterioration of health status|14|||
146373243|NCT03565991|527868293|FG001|Overall Study|Global deterioration of health status|4|||
146373244|NCT03565991|527868292|FG000|Overall Study|Withdrawal by Subject|2|||
146373245|NCT03565991|527868293|FG001|Overall Study|Withdrawal by Subject|6|||
146373246|NCT03565991|527868292|FG000|Overall Study|Progressive disease|121|||
146373247|NCT03565991|527868293|FG001|Overall Study|Progressive disease|29|||
146373248|NCT03565991|527868292|FG000|Overall Study|Death|3|||
146373249|NCT03565991|527868293|FG001|Overall Study|Death|0|||
146373250|NCT03565991|527868292|FG000|Overall Study|Adverse Event|7|||
146373251|NCT03565991|527868293|FG001|Overall Study|Adverse Event|2|||
146373252|NCT00086385|527868296|FG000|Overall Study|Death|2|||
146373253|NCT00086385|527868297|FG001|Overall Study|Death|2|||
146373254|NCT00086385|527868298|FG002|Overall Study|Death|1|||
146373255|NCT00086385|527868299|FG003|Overall Study|Death|1|||
146373256|NCT03424044|527868304|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373257|NCT03424044|527868305|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373258|NCT03424044|527868306|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
146373259|NCT03424044|527868307|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373260|NCT03424044|527868308|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373261|NCT03424044|527868309|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373262|NCT03424044|527868310|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373263|NCT03424044|527868311|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373264|NCT03424044|527868312|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
146373265|NCT03424044|527868304|FG000|First Intervention (76 Hours)|Adverse Event|0|||
146373266|NCT03424044|527868305|FG001|First Intervention (76 Hours)|Adverse Event|0|||
146373267|NCT03424044|527868306|FG002|First Intervention (76 Hours)|Adverse Event|0|||
146373268|NCT03424044|527868307|FG003|First Intervention (76 Hours)|Adverse Event|0|||
146373269|NCT03424044|527868308|FG004|First Intervention (76 Hours)|Adverse Event|1|||
146373270|NCT03424044|527868309|FG005|First Intervention (76 Hours)|Adverse Event|0|||
146373271|NCT03424044|527868310|FG006|First Intervention (76 Hours)|Adverse Event|0|||
146373272|NCT03424044|527868311|FG007|First Intervention (76 Hours)|Adverse Event|0|||
146373273|NCT03424044|527868312|FG008|First Intervention (76 Hours)|Adverse Event|0|||
146373274|NCT03424044|527868304|FG000|First Intervention (76 Hours)|device issues|0|||
146373275|NCT03424044|527868305|FG001|First Intervention (76 Hours)|device issues|0|||
146373276|NCT03424044|527868306|FG002|First Intervention (76 Hours)|device issues|0|||
146373277|NCT03424044|527868307|FG003|First Intervention (76 Hours)|device issues|0|||
146373278|NCT03424044|527868308|FG004|First Intervention (76 Hours)|device issues|0|||
146373279|NCT03424044|527868309|FG005|First Intervention (76 Hours)|device issues|0|||
146373280|NCT03424044|527868310|FG006|First Intervention (76 Hours)|device issues|1|||
146373281|NCT03424044|527868311|FG007|First Intervention (76 Hours)|device issues|1|||
146373282|NCT03424044|527868312|FG008|First Intervention (76 Hours)|device issues|1|||
146373283|NCT03424044|527868304|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
146373284|NCT03424044|527868305|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
146373285|NCT03424044|527868306|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
146373286|NCT03424044|527868307|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
146373287|NCT03424044|527868308|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
146373288|NCT03424044|527868309|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
146373289|NCT03424044|527868310|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
146373290|NCT03424044|527868311|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
146373291|NCT03424044|527868312|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
146373292|NCT03424044|527868304|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373293|NCT03424044|527868305|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373294|NCT03424044|527868306|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373295|NCT03424044|527868307|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
146373296|NCT03424044|527868308|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373297|NCT03424044|527868309|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373298|NCT03424044|527868310|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373299|NCT03424044|527868311|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373300|NCT03424044|527868312|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
146373301|NCT01376388|527868314|FG000|Overall Study|Adverse Event|13|||
146373302|NCT01376388|527868314|FG000|Overall Study|Lack of Efficacy|2|||
146373303|NCT01376388|527868314|FG000|Overall Study|Withdrawal by Subject|3|||
146373304|NCT02471586|527868323|FG000|Overall Study|Lost to Follow-up|3|||
146373305|NCT02471586|527868324|FG001|Overall Study|Lost to Follow-up|8|||
146373306|NCT02471586|527868325|FG002|Overall Study|Lost to Follow-up|4|||
146373307|NCT02471586|527868323|FG000|Overall Study|Death|2|||
146373308|NCT02471586|527868324|FG001|Overall Study|Death|2|||
146373309|NCT02471586|527868325|FG002|Overall Study|Death|0|||
146373310|NCT03805971|527868336|FG000|Overall Study|Withdrawal by Subject|1|||
146373311|NCT03805971|527868336|FG000|Overall Study|Protocol Violation|2|||
146373312|NCT04839393|527868337|FG000|Overall Study|Adverse Event|0|||
146373313|NCT04839393|527868338|FG001|Overall Study|Adverse Event|0|||
146373314|NCT04839393|527868339|FG002|Overall Study|Adverse Event|2|||
146373315|NCT04839393|527868337|FG000|Overall Study|Withdrawal by participant|0|||
146373316|NCT04839393|527868338|FG001|Overall Study|Withdrawal by participant|0|||
146373317|NCT04839393|527868339|FG002|Overall Study|Withdrawal by participant|1|||
146373318|NCT00254163|527868340|FG000|Overall Study|Adverse Event|29|||
146373319|NCT00254163|527868341|FG001|Overall Study|Adverse Event|26|||
146373320|NCT00254163|527868340|FG000|Overall Study|Patient request/withdrew consent|6|||
146373321|NCT00254163|527868341|FG001|Overall Study|Patient request/withdrew consent|4|||
146373322|NCT00254163|527868340|FG000|Overall Study|Investigator request|1|||
146373323|NCT00254163|527868341|FG001|Overall Study|Investigator request|3|||
146373324|NCT00254163|527868340|FG000|Overall Study|Failed entry|1|||
146373325|NCT00254163|527868341|FG001|Overall Study|Failed entry|3|||
146373326|NCT00254163|527868340|FG000|Overall Study|Progressive disease|0|||
146373327|NCT00254163|527868341|FG001|Overall Study|Progressive disease|1|||
146373328|NCT00254163|527868340|FG000|Overall Study|Death|0|||
146373329|NCT00254163|527868341|FG001|Overall Study|Death|1|||
146373330|NCT00254163|527868340|FG000|Overall Study|Other|8|||
146373331|NCT00254163|527868341|FG001|Overall Study|Other|8|||
146373332|NCT01510028|527868347|FG000|Overall Study|Lack of Efficacy|1|||
146373333|NCT01510028|527868348|FG001|Overall Study|Lack of Efficacy|0|||
146373334|NCT01510028|527868349|FG002|Overall Study|Lack of Efficacy|0|||
146373335|NCT01510028|527868350|FG003|Overall Study|Lack of Efficacy|0|||
146373336|NCT00633893|527868351|FG000|Overall Study|Death|1|||
146373337|NCT00633893|527868352|FG001|Overall Study|Death|3|||
146373338|NCT00633893|527868353|FG002|Overall Study|Death|9|||
146373339|NCT00633893|527868351|FG000|Overall Study|Adverse Event|65|||
146373340|NCT00633893|527868352|FG001|Overall Study|Adverse Event|58|||
146373341|NCT00633893|527868353|FG002|Overall Study|Adverse Event|126|||
146373342|NCT00633893|527868351|FG000|Overall Study|Withdrawal by Subject|7|||
146373343|NCT00633893|527868352|FG001|Overall Study|Withdrawal by Subject|12|||
146373344|NCT00633893|527868353|FG002|Overall Study|Withdrawal by Subject|6|||
146373345|NCT00633893|527868351|FG000|Overall Study|Lost to Follow-up|2|||
146373346|NCT00633893|527868352|FG001|Overall Study|Lost to Follow-up|4|||
146373347|NCT00633893|527868353|FG002|Overall Study|Lost to Follow-up|8|||
146373348|NCT00633893|527868351|FG000|Overall Study|Poor/non-compliance|5|||
146373349|NCT00633893|527868352|FG001|Overall Study|Poor/non-compliance|12|||
146373350|NCT00633893|527868353|FG002|Overall Study|Poor/non-compliance|3|||
146373351|NCT00633893|527868351|FG000|Overall Study|Pregnancy|2|||
146373352|NCT00633893|527868352|FG001|Overall Study|Pregnancy|1|||
146373353|NCT00633893|527868353|FG002|Overall Study|Pregnancy|1|||
146373354|NCT00633893|527868351|FG000|Overall Study|Not meet/no longer meets criteria|4|||
146373355|NCT00633893|527868352|FG001|Overall Study|Not meet/no longer meets criteria|6|||
146373356|NCT00633893|527868353|FG002|Overall Study|Not meet/no longer meets criteria|4|||
146373357|NCT00633893|527868351|FG000|Overall Study|Other|28|||
146373358|NCT00633893|527868352|FG001|Overall Study|Other|33|||
146373359|NCT00633893|527868353|FG002|Overall Study|Other|31|||
146373360|NCT02741310|527868354|FG000|Overall Study|Sponsor Decision|2|||
146373361|NCT02741310|527868355|FG001|Overall Study|Sponsor Decision|2|||
146373362|NCT05091918|527868356|FG000|Overall Study|Adverse Event|1|||
146373363|NCT05091918|527868356|FG000|Overall Study|Withdrawal by Subject|81|||
146373364|NCT01100658|527868360|FG000|Overall Study|Withdrawal by Subject|1|||
146373365|NCT01784211|527868361|FG000|Part A (Days 1-15)|Adverse Event|1|||
146373366|NCT01784211|527868362|FG001|Part A (Days 1-15)|Adverse Event|1|||
146373367|NCT01784211|527868363|FG002|Part A (Days 1-15)|Adverse Event|0|||
146373368|NCT01784211|527868364|FG003|Part A (Days 1-15)|Adverse Event|0|||
146373369|NCT01784211|527868365|FG004|Part A (Days 1-15)|Adverse Event|0|||
146373370|NCT01784211|527868366|FG005|Part A (Days 1-15)|Adverse Event|0|||
146373371|NCT01784211|527868361|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
146373372|NCT01784211|527868362|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
146373373|NCT01784211|527868363|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
146373374|NCT01784211|527868364|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
146373375|NCT01784211|527868365|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
146373376|NCT01784211|527868366|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
146373377|NCT00239356|527868369|FG000|Overall Study|Lack of Efficacy|1|||
146373378|NCT00239356|527868370|FG001|Overall Study|Lack of Efficacy|0|||
146373379|NCT00239356|527868369|FG000|Overall Study|Adverse Event|6|||
146373380|NCT00239356|527868370|FG001|Overall Study|Adverse Event|0|||
146373381|NCT00239356|527868369|FG000|Overall Study|Withdrawal by Subject|15|||
146373382|NCT00239356|527868370|FG001|Overall Study|Withdrawal by Subject|6|||
146373383|NCT00239356|527868369|FG000|Overall Study|Lost to Follow-up|3|||
146373384|NCT00239356|527868370|FG001|Overall Study|Lost to Follow-up|0|||
146373385|NCT00239356|527868369|FG000|Overall Study|poor/non-compliance|2|||
146373386|NCT00239356|527868370|FG001|Overall Study|poor/non-compliance|0|||
146373387|NCT00239356|527868369|FG000|Overall Study|Pregnancy|1|||
146373388|NCT00239356|527868370|FG001|Overall Study|Pregnancy|0|||
146373389|NCT00239356|527868369|FG000|Overall Study|Administrative reason|0|||
146373390|NCT00239356|527868370|FG001|Overall Study|Administrative reason|1|||
146373391|NCT00239356|527868369|FG000|Overall Study|Drug available on market|11|||
146373392|NCT00239356|527868370|FG001|Overall Study|Drug available on market|2|||
146373393|NCT00369278|527868371|FG000|Overall Study|Adverse Event|14|||
146373394|NCT00369278|527868372|FG001|Overall Study|Adverse Event|11|||
146373395|NCT00369278|527868371|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
146373396|NCT00369278|527868372|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
146373397|NCT00369278|527868371|FG000|Overall Study|Protocol Violation|2|||
146373398|NCT00369278|527868372|FG001|Overall Study|Protocol Violation|1|||
146373399|NCT00369278|527868371|FG000|Overall Study|Withdrawal by Subject|2|||
146373400|NCT00369278|527868372|FG001|Overall Study|Withdrawal by Subject|2|||
146373401|NCT00369278|527868371|FG000|Overall Study|Lost to Follow-up|1|||
146373402|NCT00369278|527868372|FG001|Overall Study|Lost to Follow-up|0|||
146373403|NCT00369278|527868371|FG000|Overall Study|Graft loss|1|||
146373404|NCT00369278|527868372|FG001|Overall Study|Graft loss|2|||
146373405|NCT02044822|527868373|FG000|Overall Study|Study Terminated by Sponsor|77|||
146373406|NCT02044822|527868373|FG000|Overall Study|Investigator's Discretion|10|||
146373407|NCT02044822|527868373|FG000|Overall Study|Withdrew Consent|3|||
146373408|NCT02044822|527868373|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
146373409|NCT02044822|527868373|FG000|Overall Study|Lost to Follow-up|1|||
146373410|NCT03417505|527868376|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
146373411|NCT03417505|527868377|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
146373412|NCT02025530|527868378|FG000|Overall Study|No longer met elligibility criteria|5|||
146373413|NCT02025530|527868379|FG001|Overall Study|No longer met elligibility criteria|1|||
146373414|NCT01444898|527868391|FG000|Overall Study|Withdrawal by Subject|1|||
146373415|NCT03235726|527868392|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373416|NCT03235726|527868393|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373417|NCT03235726|527868394|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373418|NCT03235726|527868395|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373419|NCT03235726|527868396|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
146373420|NCT03235726|527868397|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373421|NCT03235726|527868398|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373422|NCT03235726|527868399|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373423|NCT03235726|527868400|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373424|NCT03235726|527868401|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
146373425|NCT03235726|527868392|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373426|NCT03235726|527868393|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373427|NCT03235726|527868394|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373428|NCT03235726|527868395|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373429|NCT03235726|527868396|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
146373430|NCT03235726|527868397|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373431|NCT03235726|527868398|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373432|NCT03235726|527868399|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373433|NCT03235726|527868400|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373434|NCT03235726|527868401|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
146373435|NCT01819506|527868402|FG000|Overall Study|Physician Decision|5|||
146373436|NCT01819506|527868403|FG001|Overall Study|Physician Decision|2|||
146373437|NCT01819506|527868402|FG000|Overall Study|Withdrawal by Subject|3|||
146373438|NCT01819506|527868403|FG001|Overall Study|Withdrawal by Subject|3|||
146373439|NCT00114218|527868414|FG000|Overall Study|Wrong Cell Type|2|||
146373440|NCT00114218|527868414|FG000|Overall Study|Wrong Primary|1|||
146373441|NCT00114218|527868414|FG000|Overall Study|Never Treated|1|||
146373442|NCT01505114|527868415|FG000|Overall Study|Withdrawal by Subject|5|||
146373443|NCT01505114|527868416|FG001|Overall Study|Withdrawal by Subject|4|||
146373444|NCT01505114|527868417|FG002|Overall Study|Withdrawal by Subject|4|||
146373445|NCT01505114|527868418|FG003|Overall Study|Withdrawal by Subject|7|||
146373446|NCT01505114|527868415|FG000|Overall Study|Death|1|||
146373447|NCT01505114|527868416|FG001|Overall Study|Death|0|||
146373448|NCT01505114|527868417|FG002|Overall Study|Death|0|||
146373449|NCT01505114|527868418|FG003|Overall Study|Death|1|||
146373450|NCT01505114|527868415|FG000|Overall Study|unable to adhere to visit schedule|3|||
146373451|NCT01505114|527868416|FG001|Overall Study|unable to adhere to visit schedule|2|||
146373452|NCT01505114|527868417|FG002|Overall Study|unable to adhere to visit schedule|3|||
146373453|NCT01505114|527868418|FG003|Overall Study|unable to adhere to visit schedule|3|||
146373454|NCT01505114|527868415|FG000|Overall Study|Lost to Follow-up|11|||
146373455|NCT01505114|527868416|FG001|Overall Study|Lost to Follow-up|5|||
146373456|NCT01505114|527868417|FG002|Overall Study|Lost to Follow-up|8|||
146373457|NCT01505114|527868418|FG003|Overall Study|Lost to Follow-up|7|||
146373458|NCT01505114|527868415|FG000|Overall Study|relocated|4|||
146373459|NCT01505114|527868416|FG001|Overall Study|relocated|2|||
146373460|NCT01505114|527868417|FG002|Overall Study|relocated|2|||
146373461|NCT01505114|527868418|FG003|Overall Study|relocated|3|||
146373462|NCT01505114|527868415|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
146373463|NCT01505114|527868416|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
146373464|NCT01505114|527868417|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
146373465|NCT01505114|527868418|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
146373466|NCT01505114|527868415|FG000|Overall Study|staff safety concerns|0|||
146373467|NCT01505114|527868416|FG001|Overall Study|staff safety concerns|0|||
146373468|NCT01505114|527868417|FG002|Overall Study|staff safety concerns|0|||
146373469|NCT01505114|527868418|FG003|Overall Study|staff safety concerns|1|||
146373470|NCT01505114|527868415|FG000|Overall Study|investigator decision|1|||
146373471|NCT01505114|527868416|FG001|Overall Study|investigator decision|0|||
146373472|NCT01505114|527868417|FG002|Overall Study|investigator decision|1|||
146373473|NCT01505114|527868418|FG003|Overall Study|investigator decision|0|||
146373474|NCT01040845|527868420|FG000|Overall Study|Withdrawal by Subject|1|||
146373475|NCT01040845|527868421|FG001|Overall Study|Withdrawal by Subject|1|||
146373476|NCT01040845|527868420|FG000|Overall Study|Physician Decision|1|||
146373477|NCT01040845|527868421|FG001|Overall Study|Physician Decision|0|||
146373478|NCT01963780|527868422|FG000|Overall Study|Death|7|||
146373479|NCT01000025|527868426|FG000|Overall Study|Adverse Event|43|||
146373480|NCT01000025|527868427|FG001|Overall Study|Adverse Event|2|||
146373481|NCT01000025|527868426|FG000|Overall Study|Withdrawal by Subject|13|||
146373482|NCT01000025|527868427|FG001|Overall Study|Withdrawal by Subject|8|||
146373483|NCT01000025|527868426|FG000|Overall Study|Death|23|||
146373484|NCT01000025|527868427|FG001|Overall Study|Death|13|||
145943492|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
146373485|NCT01000025|527868426|FG000|Overall Study|Lack of Efficacy|363|||
146373486|NCT01000025|527868427|FG001|Overall Study|Lack of Efficacy|208|||
146373487|NCT01000025|527868426|FG000|Overall Study|Intercurrent Illness|26|||
146373488|NCT01000025|527868427|FG001|Overall Study|Intercurrent Illness|7|||
146373489|NCT04423757|527868428|FG000|Overall Study|Adverse Event|2|||
146373490|NCT04423757|527868429|FG001|Overall Study|Adverse Event|0|||
146373491|NCT04423757|527868428|FG000|Overall Study|Not treated|1|||
146373492|NCT04423757|527868429|FG001|Overall Study|Not treated|1|||
146373493|NCT02738580|527868430|FG000|Overall Study|Adverse Event|1|||
146373494|NCT02738580|527868431|FG001|Overall Study|Adverse Event|0|||
146373495|NCT02738580|527868430|FG000|Overall Study|Lack of Efficacy|3|||
146373496|NCT02738580|527868431|FG001|Overall Study|Lack of Efficacy|2|||
146373497|NCT02738580|527868430|FG000|Overall Study|Withdrawal by Subject|0|||
146373498|NCT02738580|527868431|FG001|Overall Study|Withdrawal by Subject|1|||
146373499|NCT02738580|527868430|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
146373500|NCT02738580|527868431|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
146373501|NCT01250756|527868434|FG000|Infant Series|Withdrawal by Subject|4|||
146373502|NCT01250756|527868435|FG001|Infant Series|Withdrawal by Subject|5|||
146373503|NCT01250756|527868434|FG000|Infant Series|Randomized, Not Vaccinated|2|||
146373504|NCT01250756|527868435|FG001|Infant Series|Randomized, Not Vaccinated|2|||
146373505|NCT01250756|527868434|FG000|Infant Series|Other|22|||
146373506|NCT01250756|527868435|FG001|Infant Series|Other|0|||
146373507|NCT01250756|527868434|FG000|After Infant Series|Adverse Event|5|||
146373508|NCT01250756|527868435|FG001|After Infant Series|Adverse Event|2|||
146373509|NCT01250756|527868434|FG000|After Infant Series|Withdrawal by Subject|4|||
146373510|NCT01250756|527868435|FG001|After Infant Series|Withdrawal by Subject|1|||
146373511|NCT01250756|527868434|FG000|After Infant Series|Other|2|||
146373512|NCT01250756|527868435|FG001|After Infant Series|Other|1|||
146373513|NCT01250756|527868434|FG000|Toddler Dose|Adverse Event|0|||
146373514|NCT01250756|527868435|FG001|Toddler Dose|Adverse Event|1|||
146373515|NCT01250756|527868434|FG000|After Toddler Dose|Adverse Event|0|||
146373516|NCT01250756|527868435|FG001|After Toddler Dose|Adverse Event|1|||
146373517|NCT02999100|527868436|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
146373518|NCT02999100|527868437|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
146373519|NCT02999100|527868438|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
146373520|NCT02999100|527868439|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
146373521|NCT02999100|527868440|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
146373522|NCT02999100|527868441|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
146373523|NCT02999100|527868436|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146373524|NCT02999100|527868437|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146373525|NCT02999100|527868438|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146373526|NCT02999100|527868439|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146373527|NCT02999100|527868440|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
146373528|NCT02999100|527868441|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
146373529|NCT02999100|527868436|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146373530|NCT02999100|527868437|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146373531|NCT02999100|527868438|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
146373532|NCT02999100|527868439|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146373533|NCT02999100|527868440|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146373534|NCT02999100|527868441|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
146373535|NCT03595384|527868442|FG000|Overall Study|Other time commitments|8|||
146373536|NCT03595384|527868442|FG000|Overall Study|Changes to session time|7|||
146373537|NCT03595384|527868442|FG000|Overall Study|Relocation out of country|1|||
146373538|NCT00293241|527868443|FG000|Overall Study|Lost to Follow-up|9|||
146373539|NCT00293241|527868444|FG001|Overall Study|Lost to Follow-up|16|||
146373540|NCT00293241|527868443|FG000|Overall Study|Physician Decision|23|||
146373541|NCT00293241|527868444|FG001|Overall Study|Physician Decision|17|||
146373542|NCT00293241|527868443|FG000|Overall Study|Withdrawal by Subject|4|||
146373543|NCT00293241|527868444|FG001|Overall Study|Withdrawal by Subject|8|||
146373544|NCT01270958|527868446|FG000|Overall Study|Lost to Follow-up|2|||
146373545|NCT01270958|527868446|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
146373546|NCT04285853|527868447|FG000|Overall Study|Withdrawal by Subject|1|||
146373547|NCT04285853|527868448|FG001|Overall Study|Withdrawal by Subject|0|||
146373548|NCT04285853|527868447|FG000|Overall Study|Lost to Follow-up|9|||
146373549|NCT04285853|527868448|FG001|Overall Study|Lost to Follow-up|5|||
146373550|NCT01072448|527868449|FG000|Overall Study|Adverse Event|9|||
146373551|NCT01072448|527868450|FG001|Overall Study|Adverse Event|10|||
146373552|NCT01072448|527868449|FG000|Overall Study|Subject withdrew consent|4|||
146373553|NCT01072448|527868450|FG001|Overall Study|Subject withdrew consent|9|||
146373554|NCT01072448|527868449|FG000|Overall Study|Protocol deviation|3|||
146373555|NCT01072448|527868450|FG001|Overall Study|Protocol deviation|4|||
146373556|NCT01072448|527868449|FG000|Overall Study|Abnormal test procedure result(s)|1|||
146373557|NCT01072448|527868450|FG001|Overall Study|Abnormal test procedure result(s)|0|||
146373558|NCT01072448|527868449|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146373559|NCT01072448|527868450|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
146373560|NCT01072448|527868449|FG000|Overall Study|Lost to Follow-up|1|||
146373561|NCT01072448|527868450|FG001|Overall Study|Lost to Follow-up|1|||
146373562|NCT01072448|527868449|FG000|Overall Study|Abnormal laboratory value(s)|0|||
146373563|NCT01072448|527868450|FG001|Overall Study|Abnormal laboratory value(s)|1|||
146373564|NCT01072448|527868449|FG000|Overall Study|Death|0|||
146373565|NCT01072448|527868450|FG001|Overall Study|Death|2|||
146373566|NCT03404518|527868452|FG000|Overall Study|Lost to Follow-up|28|||
146373567|NCT03404518|527868453|FG001|Overall Study|Lost to Follow-up|30|||
146373568|NCT03404518|527868452|FG000|Overall Study|Protocol Violation|13|||
146373569|NCT03404518|527868453|FG001|Overall Study|Protocol Violation|6|||
146373570|NCT00131664|527868454|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
146373571|NCT00131664|527868455|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
146373572|NCT00131664|527868456|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
146373573|NCT00131664|527868457|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
146373574|NCT00131664|527868458|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
146373575|NCT00131664|527868459|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
146373576|NCT00131664|527868454|FG000|First Period (First 6 Months)|Death|0|||
146373577|NCT00131664|527868455|FG001|First Period (First 6 Months)|Death|1|||
146373578|NCT00131664|527868456|FG002|First Period (First 6 Months)|Death|0|||
146373579|NCT00131664|527868457|FG003|First Period (First 6 Months)|Death|0|||
146373580|NCT00131664|527868458|FG004|First Period (First 6 Months)|Death|0|||
146373581|NCT00131664|527868459|FG005|First Period (First 6 Months)|Death|0|||
146373582|NCT00131664|527868454|FG000|First Period (First 6 Months)|Protocol Violation|2|||
146373583|NCT00131664|527868455|FG001|First Period (First 6 Months)|Protocol Violation|2|||
146373584|NCT00131664|527868456|FG002|First Period (First 6 Months)|Protocol Violation|1|||
146373585|NCT00131664|527868457|FG003|First Period (First 6 Months)|Protocol Violation|0|||
146373586|NCT00131664|527868458|FG004|First Period (First 6 Months)|Protocol Violation|0|||
146373587|NCT00131664|527868459|FG005|First Period (First 6 Months)|Protocol Violation|0|||
146373588|NCT00131664|527868454|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
146373589|NCT00131664|527868455|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
146373590|NCT00131664|527868456|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
146373591|NCT00131664|527868457|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
146373592|NCT00131664|527868458|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
146373593|NCT00131664|527868459|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
146373594|NCT00131664|527868454|FG000|First Period (First 6 Months)|Adverse Event|9|||
146373595|NCT00131664|527868455|FG001|First Period (First 6 Months)|Adverse Event|4|||
146373596|NCT00131664|527868456|FG002|First Period (First 6 Months)|Adverse Event|5|||
146373597|NCT00131664|527868457|FG003|First Period (First 6 Months)|Adverse Event|0|||
146373598|NCT00131664|527868458|FG004|First Period (First 6 Months)|Adverse Event|0|||
146373599|NCT00131664|527868459|FG005|First Period (First 6 Months)|Adverse Event|0|||
146373600|NCT00131664|527868454|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
146373601|NCT00131664|527868455|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
146373602|NCT00131664|527868456|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146373603|NCT00131664|527868457|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146373604|NCT00131664|527868458|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146373605|NCT00131664|527868459|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
146373606|NCT00131664|527868454|FG000|First Period (First 6 Months)|Administrative reasons|2|||
146373607|NCT00131664|527868455|FG001|First Period (First 6 Months)|Administrative reasons|0|||
146373608|NCT00131664|527868456|FG002|First Period (First 6 Months)|Administrative reasons|5|||
146373609|NCT00131664|527868457|FG003|First Period (First 6 Months)|Administrative reasons|0|||
146373610|NCT00131664|527868458|FG004|First Period (First 6 Months)|Administrative reasons|0|||
146373611|NCT00131664|527868459|FG005|First Period (First 6 Months)|Administrative reasons|0|||
146373612|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
146373613|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
146373614|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
146373615|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
146373616|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
146373617|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
146373618|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
146373619|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
146373620|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
146373621|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
146373622|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
146373623|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
146373624|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
146373625|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146373626|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146373627|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146373628|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146373629|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
146373630|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
146373631|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
146373632|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
146373633|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
146373634|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
146373635|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
146373636|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146373637|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146373638|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146373639|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
146373640|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146373641|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
146373642|NCT00131664|527868454|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
146373643|NCT00131664|527868455|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
146373644|NCT00131664|527868456|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
146373645|NCT00131664|527868457|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
146373646|NCT00131664|527868458|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
146373647|NCT00131664|527868459|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
146373648|NCT02009930|527870250|FG000|Overall Study|withdrawn|5|||
146373649|NCT02959970|527870253|FG000|Overall Study|Adverse Event|1|||
146373650|NCT02959970|527870254|FG001|Overall Study|Adverse Event|0|||
146373651|NCT02959970|527870253|FG000|Overall Study|Withdrawal by Subject|0|||
146373652|NCT02959970|527870254|FG001|Overall Study|Withdrawal by Subject|2|||
146373653|NCT02959970|527870253|FG000|Overall Study|Lost to Follow-up|1|||
146373654|NCT02959970|527870254|FG001|Overall Study|Lost to Follow-up|5|||
146373655|NCT00666536|527870255|FG000|Overall Study|Adverse Event|9|||
146373656|NCT00666536|527870256|FG001|Overall Study|Adverse Event|19|||
146373657|NCT00666536|527870255|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
146373658|NCT00666536|527870256|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
146373659|NCT00666536|527870255|FG000|Overall Study|Protocol deviation(s)|8|||
146373660|NCT00666536|527870256|FG001|Overall Study|Protocol deviation(s)|6|||
146373661|NCT00666536|527870255|FG000|Overall Study|Withdrawal by Subject|10|||
146373662|NCT00666536|527870256|FG001|Overall Study|Withdrawal by Subject|9|||
146373663|NCT00666536|527870255|FG000|Overall Study|Lost to Follow-up|4|||
146373664|NCT00666536|527870256|FG001|Overall Study|Lost to Follow-up|3|||
146373665|NCT01495689|527870260|FG000|Overall Study|Death|0|||
146373666|NCT01495689|527870261|FG001|Overall Study|Death|1|||
146373667|NCT01495689|527870260|FG000|Overall Study|Withdrawal by Subject|3|||
146373668|NCT01495689|527870261|FG001|Overall Study|Withdrawal by Subject|0|||
146373669|NCT01495689|527870260|FG000|Overall Study|Lost to Follow-up|7|||
146373670|NCT01495689|527870261|FG001|Overall Study|Lost to Follow-up|6|||
146373671|NCT05516134|527870262|FG000|Overall Study|Lost to Follow-up|1|||
146373672|NCT05516134|527870263|FG001|Overall Study|Lost to Follow-up|0|||
146373673|NCT05516134|527870264|FG002|Overall Study|Lost to Follow-up|0|||
146373674|NCT00136357|527870277|FG000|Overall Study|Withdrawal by Subject|3|||
146373675|NCT00136357|527870278|FG001|Overall Study|Withdrawal by Subject|2|||
146373676|NCT01355497|527870279|FG000|Overall Study|Death|19|||
146373677|NCT01355497|527870280|FG001|Overall Study|Death|18|||
146373678|NCT01355497|527870279|FG000|Overall Study|Lost to Follow-up|3|||
146373679|NCT01355497|527870280|FG001|Overall Study|Lost to Follow-up|0|||
146373680|NCT01355497|527870279|FG000|Overall Study|Protocol Violation|0|||
146373681|NCT01355497|527870280|FG001|Overall Study|Protocol Violation|1|||
146373682|NCT01355497|527870279|FG000|Overall Study|other-not provided|9|||
146373683|NCT01355497|527870280|FG001|Overall Study|other-not provided|4|||
146373684|NCT01355497|527870279|FG000|Overall Study|Withdrawal by Subject|12|||
146373685|NCT01355497|527870280|FG001|Overall Study|Withdrawal by Subject|20|||
146373686|NCT01355497|527870279|FG000|Overall Study|noncompliance|1|||
146373687|NCT01355497|527870280|FG001|Overall Study|noncompliance|2|||
146373688|NCT01355497|527870279|FG000|Overall Study|progressive disease|11|||
146373689|NCT01355497|527870280|FG001|Overall Study|progressive disease|8|||
146373690|NCT01355497|527870279|FG000|Overall Study|Adverse Event|11|||
146373691|NCT01355497|527870280|FG001|Overall Study|Adverse Event|10|||
146373692|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
146373693|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
146373694|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
146373695|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
146373696|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
146373697|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
146373698|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
146373699|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
146373700|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
146373701|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
146373702|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
146373703|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
146373704|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
146373705|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
146373706|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
146373707|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
146373708|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
146373709|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
146373710|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
146373711|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
146373712|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
146373713|NCT01001572|527870282|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
146373714|NCT01001572|527870283|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
146373715|NCT01001572|527870284|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
146373716|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146373717|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
146373718|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
146373719|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146373720|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
146373721|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
146373722|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
146373723|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
146373724|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
146373725|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146373726|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
146373727|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
146373728|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
146373729|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
146373730|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
146373731|NCT01001572|527870282|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146373732|NCT01001572|527870283|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146373733|NCT01001572|527870284|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146373734|NCT01094808|527870285|FG000|Overall Study|Withdrawal by Subject|1|||
146373735|NCT01094808|527870286|FG001|Overall Study|Withdrawal by Subject|1|||
146373736|NCT01094808|527870287|FG002|Overall Study|Withdrawal by Subject|0|||
146373737|NCT00282568|527870296|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
146373738|NCT00282568|527870296|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
146373739|NCT00282568|527870296|FG000|Extended Treatment Period|Adverse Event|17|||
146373740|NCT00282568|527870296|FG000|Extended Treatment Period|Non-compliance|4|||
146373741|NCT00282568|527870296|FG000|Extended Treatment Period|Physician Decision|1|||
146373742|NCT00282568|527870296|FG000|Extended Treatment Period|Lost to Follow-up|2|||
146373743|NCT00990249|527870301|FG000|Overall Study|Disease Progression|8|||
146373744|NCT00990249|527870301|FG000|Overall Study|Non-Compliance|1|||
146373745|NCT00990249|527870301|FG000|Overall Study|Death|2|||
146373746|NCT00990249|527870301|FG000|Overall Study|Not treated|2|||
146373747|NCT02873208|527870304|FG000|Overall Study|Withdrawal by Subject|36|||
146373748|NCT02873208|527870304|FG000|Overall Study|Lost to Follow-up|22|||
146373749|NCT02873208|527870304|FG000|Overall Study|Adverse Event|15|||
146373750|NCT02873208|527870304|FG000|Overall Study|Non-compliance with study drug|12|||
146373751|NCT02873208|527870304|FG000|Overall Study|Protocol Violation|8|||
146373752|NCT02873208|527870304|FG000|Overall Study|Pregnancy|2|||
146373753|NCT02873208|527870304|FG000|Overall Study|Incarceration|1|||
146373754|NCT02873208|527870304|FG000|Overall Study|Lack of Efficacy|1|||
146373755|NCT02873208|527870304|FG000|Overall Study|Physician Decision|1|||
146373756|NCT00415584|527870305|FG000|Overall Study|Withdrawal by Subject|1|||
146373757|NCT01831804|527870306|FG000|Overall Study|Adverse Event|0|||
146373758|NCT01831804|527870307|FG001|Overall Study|Adverse Event|0|||
146373759|NCT01831804|527870308|FG002|Overall Study|Adverse Event|0|||
146373760|NCT01831804|527870309|FG003|Overall Study|Adverse Event|0|||
146373761|NCT01831804|527870310|FG004|Overall Study|Adverse Event|0|||
146373762|NCT01831804|527870311|FG005|Overall Study|Adverse Event|0|||
146373763|NCT01831804|527870312|FG006|Overall Study|Adverse Event|1|||
146373764|NCT01831804|527870313|FG007|Overall Study|Adverse Event|0|||
146373765|NCT01831804|527870314|FG008|Overall Study|Adverse Event|1|||
146373766|NCT01831804|527870306|FG000|Overall Study|Protocol Violation|0|||
146373767|NCT01831804|527870307|FG001|Overall Study|Protocol Violation|0|||
146373768|NCT01831804|527870308|FG002|Overall Study|Protocol Violation|2|||
146373769|NCT01831804|527870309|FG003|Overall Study|Protocol Violation|0|||
146373770|NCT01831804|527870310|FG004|Overall Study|Protocol Violation|0|||
146373771|NCT01831804|527870311|FG005|Overall Study|Protocol Violation|0|||
146373772|NCT01831804|527870312|FG006|Overall Study|Protocol Violation|0|||
146373773|NCT01831804|527870313|FG007|Overall Study|Protocol Violation|0|||
146373774|NCT01831804|527870314|FG008|Overall Study|Protocol Violation|0|||
146373775|NCT01831804|527870306|FG000|Overall Study|Protocol defined stopping criteria|1|||
146373776|NCT01831804|527870307|FG001|Overall Study|Protocol defined stopping criteria|1|||
146373777|NCT01831804|527870308|FG002|Overall Study|Protocol defined stopping criteria|3|||
146373778|NCT01831804|527870309|FG003|Overall Study|Protocol defined stopping criteria|0|||
146373779|NCT01831804|527870310|FG004|Overall Study|Protocol defined stopping criteria|1|||
146373780|NCT01831804|527870311|FG005|Overall Study|Protocol defined stopping criteria|0|||
146373781|NCT01831804|527870312|FG006|Overall Study|Protocol defined stopping criteria|0|||
146373782|NCT01831804|527870313|FG007|Overall Study|Protocol defined stopping criteria|0|||
146373783|NCT01831804|527870314|FG008|Overall Study|Protocol defined stopping criteria|0|||
146373784|NCT01831804|527870306|FG000|Overall Study|Lost to Follow-up|0|||
146373785|NCT01831804|527870307|FG001|Overall Study|Lost to Follow-up|0|||
146373786|NCT01831804|527870308|FG002|Overall Study|Lost to Follow-up|1|||
146373787|NCT01831804|527870309|FG003|Overall Study|Lost to Follow-up|0|||
146373788|NCT01831804|527870310|FG004|Overall Study|Lost to Follow-up|0|||
146373789|NCT01831804|527870311|FG005|Overall Study|Lost to Follow-up|0|||
146373790|NCT01831804|527870312|FG006|Overall Study|Lost to Follow-up|0|||
146373791|NCT01831804|527870313|FG007|Overall Study|Lost to Follow-up|0|||
146373792|NCT01831804|527870314|FG008|Overall Study|Lost to Follow-up|1|||
146373793|NCT01831804|527870306|FG000|Overall Study|Investigator discretion|0|||
146373794|NCT01831804|527870307|FG001|Overall Study|Investigator discretion|0|||
146373795|NCT01831804|527870308|FG002|Overall Study|Investigator discretion|0|||
146373796|NCT01831804|527870309|FG003|Overall Study|Investigator discretion|0|||
146373797|NCT01831804|527870310|FG004|Overall Study|Investigator discretion|1|||
146373798|NCT01831804|527870311|FG005|Overall Study|Investigator discretion|0|||
146373799|NCT01831804|527870312|FG006|Overall Study|Investigator discretion|0|||
146373800|NCT01831804|527870313|FG007|Overall Study|Investigator discretion|1|||
146373801|NCT01831804|527870314|FG008|Overall Study|Investigator discretion|0|||
146373802|NCT01831804|527870306|FG000|Overall Study|Withdrew Consent|0|||
146373803|NCT01831804|527870307|FG001|Overall Study|Withdrew Consent|1|||
146373804|NCT01831804|527870308|FG002|Overall Study|Withdrew Consent|0|||
146373805|NCT01831804|527870309|FG003|Overall Study|Withdrew Consent|0|||
146373806|NCT01831804|527870310|FG004|Overall Study|Withdrew Consent|0|||
146373807|NCT01831804|527870311|FG005|Overall Study|Withdrew Consent|0|||
146373808|NCT01831804|527870312|FG006|Overall Study|Withdrew Consent|0|||
146373809|NCT01831804|527870313|FG007|Overall Study|Withdrew Consent|2|||
146373810|NCT01831804|527870314|FG008|Overall Study|Withdrew Consent|0|||
146373811|NCT01061567|527870315|FG000|Overall Study|Adverse Event|32|||
146373812|NCT01061567|527870315|FG000|Overall Study|Death|2|||
146373813|NCT01061567|527870315|FG000|Overall Study|Lack of Efficacy|3|||
146373814|NCT01061567|527870315|FG000|Overall Study|Lost to Follow-up|24|||
146373815|NCT01061567|527870315|FG000|Overall Study|Protocol Violation|1|||
146373816|NCT01061567|527870315|FG000|Overall Study|Withdrawal by Subject|11|||
146373817|NCT01061567|527870315|FG000|Overall Study|Other reason than stated above|3|||
146373818|NCT00563368|527870316|FG000|Overall Study|Lost to Follow-up|14|||
146373819|NCT00563368|527870317|FG001|Overall Study|Lost to Follow-up|14|||
146373820|NCT00563368|527870318|FG002|Overall Study|Lost to Follow-up|12|||
146373821|NCT00563368|527870319|FG003|Overall Study|Lost to Follow-up|6|||
146373822|NCT00563368|527870320|FG004|Overall Study|Lost to Follow-up|9|||
146373823|NCT00563368|527870321|FG005|Overall Study|Lost to Follow-up|8|||
146373824|NCT00563368|527870322|FG006|Overall Study|Lost to Follow-up|9|||
146373825|NCT00563368|527870316|FG000|Overall Study|Adverse Event|3|||
146373826|NCT00563368|527870317|FG001|Overall Study|Adverse Event|4|||
146373827|NCT00563368|527870318|FG002|Overall Study|Adverse Event|5|||
146373828|NCT00563368|527870319|FG003|Overall Study|Adverse Event|9|||
146373829|NCT00563368|527870320|FG004|Overall Study|Adverse Event|6|||
146373830|NCT00563368|527870321|FG005|Overall Study|Adverse Event|10|||
146373831|NCT00563368|527870322|FG006|Overall Study|Adverse Event|17|||
146373832|NCT00563368|527870316|FG000|Overall Study|Withdrawal by Subject|11|||
146373833|NCT00563368|527870317|FG001|Overall Study|Withdrawal by Subject|6|||
146373834|NCT00563368|527870318|FG002|Overall Study|Withdrawal by Subject|5|||
146373835|NCT00563368|527870319|FG003|Overall Study|Withdrawal by Subject|7|||
146373836|NCT00563368|527870320|FG004|Overall Study|Withdrawal by Subject|8|||
146373837|NCT00563368|527870321|FG005|Overall Study|Withdrawal by Subject|5|||
146373838|NCT00563368|527870322|FG006|Overall Study|Withdrawal by Subject|4|||
146373839|NCT00563368|527870316|FG000|Overall Study|protocol non-compliance|1|||
146373840|NCT00563368|527870317|FG001|Overall Study|protocol non-compliance|1|||
146373841|NCT00563368|527870318|FG002|Overall Study|protocol non-compliance|2|||
146373842|NCT00563368|527870319|FG003|Overall Study|protocol non-compliance|1|||
146373843|NCT00563368|527870320|FG004|Overall Study|protocol non-compliance|0|||
146373844|NCT00563368|527870321|FG005|Overall Study|protocol non-compliance|1|||
146373845|NCT00563368|527870322|FG006|Overall Study|protocol non-compliance|3|||
146373846|NCT00563368|527870316|FG000|Overall Study|Pregnancy|1|||
146373847|NCT00563368|527870317|FG001|Overall Study|Pregnancy|0|||
146373848|NCT00563368|527870318|FG002|Overall Study|Pregnancy|1|||
146373849|NCT00563368|527870319|FG003|Overall Study|Pregnancy|2|||
146373850|NCT00563368|527870320|FG004|Overall Study|Pregnancy|1|||
146373851|NCT00563368|527870321|FG005|Overall Study|Pregnancy|2|||
146373852|NCT00563368|527870322|FG006|Overall Study|Pregnancy|0|||
146373853|NCT00563368|527870316|FG000|Overall Study|requirement for restricted medication|0|||
146373854|NCT00563368|527870317|FG001|Overall Study|requirement for restricted medication|0|||
146373855|NCT00563368|527870318|FG002|Overall Study|requirement for restricted medication|2|||
146373856|NCT00563368|527870319|FG003|Overall Study|requirement for restricted medication|0|||
146373857|NCT00563368|527870320|FG004|Overall Study|requirement for restricted medication|0|||
146373858|NCT00563368|527870321|FG005|Overall Study|requirement for restricted medication|0|||
146373859|NCT00563368|527870322|FG006|Overall Study|requirement for restricted medication|0|||
146373860|NCT00563368|527870316|FG000|Overall Study|Other|5|||
146373861|NCT00563368|527870317|FG001|Overall Study|Other|5|||
146373862|NCT00563368|527870318|FG002|Overall Study|Other|3|||
146373863|NCT00563368|527870319|FG003|Overall Study|Other|4|||
146373864|NCT00563368|527870320|FG004|Overall Study|Other|4|||
146373865|NCT00563368|527870321|FG005|Overall Study|Other|4|||
146373866|NCT00563368|527870322|FG006|Overall Study|Other|0|||
146373867|NCT02640755|527870323|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
146373868|NCT02640755|527870324|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
146373869|NCT02640755|527870323|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
146373870|NCT02640755|527870324|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
146373871|NCT02640755|527870323|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
146373872|NCT02640755|527870324|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
146373873|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
146373874|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
146373875|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
146373876|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
146373877|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
146373878|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
146373879|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
146373880|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
146373881|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
146373882|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
146373883|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
146373884|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
146373885|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
146373886|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
146373887|NCT03434041|527870325|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
146373888|NCT03434041|527870326|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
146373889|NCT03434041|527870325|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
146373890|NCT03434041|527870326|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
146373891|NCT03434041|527870325|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
146373892|NCT03434041|527870326|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
146373893|NCT03434041|527870325|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
146373894|NCT03434041|527870326|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
146373895|NCT02057068|527870329|FG000|Overall Study|Withdrawal by Subject|2|||
146373896|NCT02057068|527870330|FG001|Overall Study|Withdrawal by Subject|2|||
146373897|NCT02057068|527870329|FG000|Overall Study|Caregiver (CG) Health|0|||
146373898|NCT02057068|527870330|FG001|Overall Study|Caregiver (CG) Health|2|||
146373899|NCT02057068|527870329|FG000|Overall Study|Carepartner (CP) Health|4|||
146373900|NCT02057068|527870330|FG001|Overall Study|Carepartner (CP) Health|2|||
146373901|NCT02057068|527870329|FG000|Overall Study|Lost to Follow-up|2|||
146373902|NCT02057068|527870330|FG001|Overall Study|Lost to Follow-up|2|||
146373903|NCT03447821|527870331|FG000|Overall Study|Withdrawal by Subject|1|||
146373904|NCT03447821|527870332|FG001|Overall Study|Withdrawal by Subject|1|||
146373905|NCT03447821|527870333|FG002|Overall Study|Withdrawal by Subject|0|||
146373906|NCT03447821|527870331|FG000|Overall Study|Lost to Follow-up|0|||
146373907|NCT03447821|527870332|FG001|Overall Study|Lost to Follow-up|0|||
146373908|NCT03447821|527870333|FG002|Overall Study|Lost to Follow-up|1|||
146373909|NCT04685538|527870334|FG000|Overall Study|Adverse Event|0|||
146373910|NCT04685538|527870335|FG001|Overall Study|Adverse Event|1|||
146373911|NCT04685538|527870334|FG000|Overall Study|Lost to Follow-up|0|||
146373912|NCT04685538|527870335|FG001|Overall Study|Lost to Follow-up|2|||
146373913|NCT03168555|527870337|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
146373914|NCT03168555|527870337|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
146373915|NCT03168555|527870337|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
146373916|NCT03168555|527870337|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
146373917|NCT01732107|527870339|FG000|Overall Study|Adverse Event|2|||
146373918|NCT01732107|527870339|FG000|Overall Study|Disease Progression|8|||
146373919|NCT01732107|527870339|FG000|Overall Study|Physician Decision|1|||
146373920|NCT01732107|527870339|FG000|Overall Study|Withdrawal by Subject|2|||
146373921|NCT02959190|527870341|FG000|Open Label|Adverse Event|5|||
146373922|NCT02959190|527870342|FG001|Open Label|Adverse Event|7|||
146373923|NCT02959190|527870343|FG002|Open Label|Adverse Event|3|||
146373924|NCT02959190|527870344|FG003|Open Label|Adverse Event|4|||
146373925|NCT02959190|527870341|FG000|Open Label|Pregnancy|0|||
146373926|NCT02959190|527870342|FG001|Open Label|Pregnancy|1|||
146373927|NCT02959190|527870343|FG002|Open Label|Pregnancy|0|||
146373928|NCT02959190|527870344|FG003|Open Label|Pregnancy|0|||
146373929|NCT02959190|527870341|FG000|Open Label|Withdrawal by Subject|2|||
146373930|NCT02959190|527870342|FG001|Open Label|Withdrawal by Subject|8|||
146373931|NCT02959190|527870343|FG002|Open Label|Withdrawal by Subject|0|||
146373932|NCT02959190|527870344|FG003|Open Label|Withdrawal by Subject|0|||
146373933|NCT02959190|527870341|FG000|Open Label|Physician Decision|0|||
146373934|NCT02959190|527870342|FG001|Open Label|Physician Decision|0|||
146373935|NCT02959190|527870343|FG002|Open Label|Physician Decision|1|||
146373936|NCT02959190|527870344|FG003|Open Label|Physician Decision|0|||
146373937|NCT02959190|527870341|FG000|Open Label|Protocol Violation|0|||
146373938|NCT02959190|527870342|FG001|Open Label|Protocol Violation|0|||
146373939|NCT02959190|527870343|FG002|Open Label|Protocol Violation|0|||
146373940|NCT02959190|527870344|FG003|Open Label|Protocol Violation|2|||
146373941|NCT02959190|527870341|FG000|Post Treatment Follow Up|Adverse Event|1|||
146373942|NCT02959190|527870342|FG001|Post Treatment Follow Up|Adverse Event|1|||
146373943|NCT02959190|527870343|FG002|Post Treatment Follow Up|Adverse Event|0|||
146373944|NCT02959190|527870344|FG003|Post Treatment Follow Up|Adverse Event|0|||
146373945|NCT02959190|527870341|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
146373946|NCT02959190|527870342|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
146373947|NCT02959190|527870343|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
146373948|NCT02959190|527870344|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
146373949|NCT04445688|527870345|FG000|Washout (One Week)|Adverse Event|2|||
146373950|NCT04445688|527870345|FG000|Washout (One Week)|Withdrawal by Subject|1|||
146373951|NCT01235507|527870348|FG000|Overall Study|Adverse Event|1|||
146373952|NCT01235507|527870348|FG000|Overall Study|Withdrawal by Subject|1|||
146373953|NCT02017704|527870356|FG000|Overall Study|Withdrawal by Subject|2|||
146373954|NCT02017704|527870357|FG001|Overall Study|Withdrawal by Subject|0|||
146373955|NCT01749800|527870358|FG000|Overall Study|not meeting inclusion criteria|3|||
146373956|NCT01749800|527870359|FG001|Overall Study|not meeting inclusion criteria|0|||
146373957|NCT01749800|527870360|FG002|Overall Study|not meeting inclusion criteria|0|||
146373958|NCT01749800|527870358|FG000|Overall Study|Withdrawal by Subject|0|||
146373959|NCT01749800|527870359|FG001|Overall Study|Withdrawal by Subject|1|||
146373960|NCT01749800|527870360|FG002|Overall Study|Withdrawal by Subject|0|||
146373961|NCT01928082|527870363|FG000|Overall Study|Study terminated.|1|||
146373962|NCT01815580|527870364|FG000|Overall Study|Lost to Follow-up|4|||
146373963|NCT01815580|527870365|FG001|Overall Study|Lost to Follow-up|7|||
146373964|NCT01815580|527870364|FG000|Overall Study|Withdrawal by Subject|3|||
146373965|NCT01815580|527870365|FG001|Overall Study|Withdrawal by Subject|4|||
146373966|NCT01815580|527870364|FG000|Overall Study|Excluded from analysis|5|||
146373967|NCT01815580|527870365|FG001|Overall Study|Excluded from analysis|4|||
146373968|NCT00166517|527870369|FG000|Overall Study|Lost to Follow-up|1|||
146373969|NCT00166517|527870370|FG001|Overall Study|Lost to Follow-up|0|||
146373970|NCT00166517|527870369|FG000|Overall Study|Protocol Violation|4|||
146373971|NCT00166517|527870370|FG001|Overall Study|Protocol Violation|1|||
146373972|NCT00166517|527870369|FG000|Overall Study|Withdrawal by Subject|0|||
146373973|NCT00166517|527870370|FG001|Overall Study|Withdrawal by Subject|1|||
146373974|NCT03094611|527870374|FG000|Overall Study|Lack of Efficacy|1|||
146373975|NCT03094611|527870374|FG000|Overall Study|Stem Cell Transplant|1|||
146373976|NCT00842361|527870375|FG000|Overall Study|Protocol Violation|1|||
146373977|NCT00842361|527870376|FG001|Overall Study|Protocol Violation|0|||
146373978|NCT00842361|527870375|FG000|Overall Study|Unclassified|0|||
146373979|NCT00842361|527870376|FG001|Overall Study|Unclassified|2|||
146373980|NCT02186561|527870377|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
146373981|NCT02186561|527870377|FG000|Enrollment|Enrollment Cap Reached|5|||
146373982|NCT02186561|527870377|FG000|Enrollment|Insurance Denial|2|||
146373983|NCT02186561|527870377|FG000|Enrollment|Withdrawal by Subject|2|||
146373984|NCT02186561|527870377|FG000|Enrollment|Investigator Withdrew Consent|1|||
146373985|NCT02186561|527870377|FG000|30-Day Post Index Procedure Visit|Death|1|||
146373986|NCT02186561|527870377|FG000|1- Year Post Index Procedure Visit|Death|1|||
146373987|NCT02186561|527870377|FG000|1- Year Post Index Procedure Visit|Missed|1|||
146373988|NCT02460978|527870379|FG000|Overall Study|Adverse Event|17|||
146373989|NCT02460978|527870380|FG001|Overall Study|Adverse Event|11|||
146373990|NCT02460978|527870381|FG002|Overall Study|Adverse Event|11|||
146373991|NCT02460978|527870379|FG000|Overall Study|Withdrawal by Subject|5|||
146373992|NCT02460978|527870380|FG001|Overall Study|Withdrawal by Subject|5|||
146373993|NCT02460978|527870381|FG002|Overall Study|Withdrawal by Subject|14|||
146373994|NCT02460978|527870379|FG000|Overall Study|Lost to Follow-up|2|||
146373995|NCT02460978|527870380|FG001|Overall Study|Lost to Follow-up|3|||
146373996|NCT02460978|527870381|FG002|Overall Study|Lost to Follow-up|1|||
146373997|NCT02460978|527870379|FG000|Overall Study|Protocol Violation|1|||
146373998|NCT02460978|527870380|FG001|Overall Study|Protocol Violation|1|||
146373999|NCT02460978|527870381|FG002|Overall Study|Protocol Violation|1|||
146374000|NCT02460978|527870379|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
146374001|NCT02460978|527870380|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
146374002|NCT02460978|527870381|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
146374003|NCT02460978|527870379|FG000|Overall Study|Pregnancy|0|||
146374004|NCT02460978|527870380|FG001|Overall Study|Pregnancy|0|||
146374005|NCT02460978|527870381|FG002|Overall Study|Pregnancy|2|||
146374006|NCT00588523|527870385|FG000|Overall Study|Not treated|3|||
146374007|NCT01459068|527870388|FG000|Overall Study|Withdrawal by Subject|8|||
146374008|NCT01459068|527870389|FG001|Overall Study|Withdrawal by Subject|18|||
146374009|NCT01459068|527870388|FG000|Overall Study|Lost to Follow-up|31|||
146374010|NCT01459068|527870389|FG001|Overall Study|Lost to Follow-up|15|||
146374011|NCT01459068|527870388|FG000|Overall Study|Death|0|||
146374012|NCT01459068|527870389|FG001|Overall Study|Death|1|||
146374013|NCT02023112|527870392|FG000|Overall Study|Withdrawal by Subject|2|||
146374014|NCT02023112|527870393|FG001|Overall Study|Withdrawal by Subject|1|||
146374015|NCT01313078|527870394|FG000|Overall Study|Death|1|||
146374016|NCT01313078|527870394|FG000|Overall Study|Discontinued study drug|1|||
146374017|NCT01313078|527870394|FG000|Overall Study|Withdrawal by Subject|1|||
146374018|NCT03136484|527870395|FG000|Overall Study|Withdrawal by Subject|19|||
146374019|NCT03136484|527870396|FG001|Overall Study|Withdrawal by Subject|14|||
146374020|NCT03136484|527870395|FG000|Overall Study|Lost to Follow-up|7|||
146374021|NCT03136484|527870396|FG001|Overall Study|Lost to Follow-up|8|||
146374022|NCT03136484|527870395|FG000|Overall Study|Death|1|||
146374023|NCT03136484|527870396|FG001|Overall Study|Death|0|||
146374024|NCT01449955|527870399|FG000|Overall Study|Withdrawal by Subject|1|||
146374025|NCT01449955|527870400|FG001|Overall Study|Withdrawal by Subject|2|||
146374026|NCT01601470|527870401|FG000|Period 2 - LCZ696|Physician Decision|1|||
146374027|NCT01176240|527870404|FG000|Study 306A|Lack of Efficacy|2|||
146374028|NCT01176240|527870405|FG001|Study 306A|Lack of Efficacy|1|||
146374029|NCT01176240|527870404|FG000|Study 306A|Protocol Violation|0|||
146374030|NCT01176240|527870405|FG001|Study 306A|Protocol Violation|1|||
146374031|NCT01176240|527870404|FG000|Study 306A|Withdrawal by Subject|0|||
146374032|NCT01176240|527870405|FG001|Study 306A|Withdrawal by Subject|1|||
146374033|NCT01176240|527870404|FG000|Study 306A|Stop due to diverse problems|1|||
146374034|NCT01176240|527870405|FG001|Study 306A|Stop due to diverse problems|0|||
146374035|NCT01176240|527870404|FG000|Study 306B|Lack of Efficacy|5|||
146374036|NCT01176240|527870405|FG001|Study 306B|Lack of Efficacy|3|||
146374037|NCT01176240|527870404|FG000|Study 306B|Adverse Event|10|||
146374038|NCT01176240|527870405|FG001|Study 306B|Adverse Event|5|||
146374039|NCT01176240|527870404|FG000|Study 306B|Protocol Violation|2|||
146374040|NCT01176240|527870405|FG001|Study 306B|Protocol Violation|3|||
146374041|NCT01176240|527870404|FG000|Study 306B|Withdrawal by Subject|4|||
146374042|NCT01176240|527870405|FG001|Study 306B|Withdrawal by Subject|1|||
146374043|NCT01176240|527870404|FG000|Study 306B|Physician Decision|2|||
146374044|NCT01176240|527870405|FG001|Study 306B|Physician Decision|1|||
146374045|NCT01176240|527870404|FG000|Study 306B|Supine Hypertension|1|||
146374046|NCT01176240|527870405|FG001|Study 306B|Supine Hypertension|2|||
146374047|NCT01176240|527870404|FG000|Study 306B|Lost to Follow-up|0|||
146374048|NCT01176240|527870405|FG001|Study 306B|Lost to Follow-up|1|||
146374049|NCT01176240|527870404|FG000|Study 306B|withdrew prior to dosing|2|||
146374050|NCT01176240|527870405|FG001|Study 306B|withdrew prior to dosing|1|||
146374051|NCT03627494|527870408|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
146374052|NCT03627494|527870409|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374053|NCT03627494|527870410|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
146374054|NCT03627494|527870411|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374055|NCT03627494|527870412|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374056|NCT03627494|527870413|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374057|NCT03627494|527870414|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374058|NCT03627494|527870415|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374059|NCT03627494|527870416|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374060|NCT03627494|527870417|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374061|NCT03627494|527870418|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374062|NCT03627494|527870419|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
146374063|NCT03627494|527870408|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374064|NCT03627494|527870409|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374065|NCT03627494|527870410|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374066|NCT03627494|527870411|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374067|NCT03627494|527870412|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374068|NCT03627494|527870413|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374069|NCT03627494|527870414|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374070|NCT03627494|527870415|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374071|NCT03627494|527870416|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
146374072|NCT03627494|527870417|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374073|NCT03627494|527870418|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374074|NCT03627494|527870419|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
146374075|NCT03627494|527870408|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374076|NCT03627494|527870409|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374077|NCT03627494|527870410|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374078|NCT03627494|527870411|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374079|NCT03627494|527870412|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374080|NCT03627494|527870413|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374081|NCT03627494|527870414|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374082|NCT03627494|527870415|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374083|NCT03627494|527870416|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374084|NCT03627494|527870417|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
146374085|NCT03627494|527870418|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
146374086|NCT03627494|527870419|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
146374087|NCT02578992|527872346|FG000|Overall Study|equipment not available or malfunction|3|||
146374088|NCT02578992|527872347|FG001|Overall Study|equipment not available or malfunction|3|||
146374089|NCT00790218|527872348|FG000|Overall Study|Death|1|||
146374090|NCT00790218|527872349|FG001|Overall Study|Death|0|||
146374091|NCT00790218|527872350|FG002|Overall Study|Death|0|||
146374092|NCT02443155|527872351|FG000|Overall Study|Adverse Event|3|||
146374093|NCT02443155|527872352|FG001|Overall Study|Adverse Event|4|||
146374094|NCT02443155|527872353|FG002|Overall Study|Adverse Event|1|||
146374095|NCT02443155|527872354|FG003|Overall Study|Adverse Event|2|||
146374096|NCT02443155|527872351|FG000|Overall Study|Unclassified|0|||
146374097|NCT02443155|527872352|FG001|Overall Study|Unclassified|0|||
146374098|NCT02443155|527872353|FG002|Overall Study|Unclassified|2|||
146374099|NCT02443155|527872354|FG003|Overall Study|Unclassified|1|||
146374100|NCT02443155|527872351|FG000|Overall Study|Withdrawal by Subject|4|||
146374101|NCT02443155|527872352|FG001|Overall Study|Withdrawal by Subject|7|||
146374102|NCT02443155|527872353|FG002|Overall Study|Withdrawal by Subject|3|||
146374103|NCT02443155|527872354|FG003|Overall Study|Withdrawal by Subject|9|||
146374104|NCT02443155|527872351|FG000|Overall Study|Pregnancy|3|||
146374105|NCT02443155|527872352|FG001|Overall Study|Pregnancy|1|||
146374106|NCT02443155|527872353|FG002|Overall Study|Pregnancy|1|||
146374107|NCT02443155|527872354|FG003|Overall Study|Pregnancy|2|||
146374108|NCT02443155|527872351|FG000|Overall Study|Lost to Follow-up|1|||
146374109|NCT02443155|527872352|FG001|Overall Study|Lost to Follow-up|2|||
146374110|NCT02443155|527872353|FG002|Overall Study|Lost to Follow-up|0|||
146374111|NCT02443155|527872354|FG003|Overall Study|Lost to Follow-up|1|||
146374112|NCT02443155|527872351|FG000|Overall Study|Protocol Violation|1|||
146374113|NCT02443155|527872352|FG001|Overall Study|Protocol Violation|0|||
146374114|NCT02443155|527872353|FG002|Overall Study|Protocol Violation|1|||
146374115|NCT02443155|527872354|FG003|Overall Study|Protocol Violation|1|||
146374116|NCT02443155|527872351|FG000|Overall Study|Death|0|||
146374117|NCT02443155|527872352|FG001|Overall Study|Death|0|||
146374118|NCT02443155|527872353|FG002|Overall Study|Death|1|||
146374119|NCT02443155|527872354|FG003|Overall Study|Death|0|||
146374120|NCT00405275|527872360|FG000|Overall Study|Death|1|||
146374121|NCT00405275|527872361|FG001|Overall Study|Death|0|||
146374122|NCT00405275|527872360|FG000|Overall Study|Lost to Follow-up|5|||
146374123|NCT00405275|527872361|FG001|Overall Study|Lost to Follow-up|1|||
146374124|NCT00405275|527872360|FG000|Overall Study|Withdrawal by Subject|7|||
146374125|NCT00405275|527872361|FG001|Overall Study|Withdrawal by Subject|9|||
146374126|NCT00405275|527872360|FG000|Overall Study|Unwilling to continue|10|||
146374127|NCT00405275|527872361|FG001|Overall Study|Unwilling to continue|9|||
146374128|NCT01308853|527872364|FG000|Overall Study|Adverse Event|1|||
146374129|NCT01308853|527872364|FG000|Overall Study|Lost to Follow-up|2|||
146374130|NCT01308853|527872364|FG000|Overall Study|Insertion of permanent implants|1|||
146374131|NCT00693420|527872367|FG000|Overall Study|Adverse Event|4|||
146374132|NCT00693420|527872368|FG001|Overall Study|Adverse Event|4|||
146374133|NCT00693420|527872367|FG000|Overall Study|Lost to Follow-up|0|||
146374134|NCT00693420|527872368|FG001|Overall Study|Lost to Follow-up|3|||
146374135|NCT00693420|527872367|FG000|Overall Study|Withdrawal by Subject|1|||
146374136|NCT00693420|527872368|FG001|Overall Study|Withdrawal by Subject|0|||
146374137|NCT00693420|527872367|FG000|Overall Study|Protocol Violation|0|||
146374138|NCT00693420|527872368|FG001|Overall Study|Protocol Violation|2|||
146374139|NCT00693420|527872367|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
146374140|NCT00693420|527872368|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
146374141|NCT00693420|527872367|FG000|Overall Study|Personal Reasons|1|||
146374142|NCT00693420|527872368|FG001|Overall Study|Personal Reasons|4|||
146374143|NCT02853123|527872372|FG000|Treatment Period 1|Adverse Event|0|||
146374144|NCT02853123|527872373|FG001|Treatment Period 1|Adverse Event|3|||
146374145|NCT02853123|527872372|FG000|Washout Period|Worsening of COPD|0|||
146374146|NCT02853123|527872373|FG001|Washout Period|Worsening of COPD|3|||
146374147|NCT02853123|527872372|FG000|Washout Period|Adverse Event|1|||
146374148|NCT02853123|527872373|FG001|Washout Period|Adverse Event|0|||
146374149|NCT01473355|527872374|FG000|Overall Study|Protocol Violation|2|||
146374150|NCT01473355|527872374|FG000|Overall Study|Adverse Event|2|||
146374151|NCT01473355|527872374|FG000|Overall Study|Lost to Follow-up|2|||
146374152|NCT03250624|527872375|FG000|Overall Study|Lack of Efficacy|1|||
146374153|NCT03250624|527872376|FG001|Overall Study|Lack of Efficacy|4|||
146374154|NCT03250624|527872375|FG000|Overall Study|Adverse Event|0|||
146374155|NCT03250624|527872376|FG001|Overall Study|Adverse Event|1|||
146374156|NCT03250624|527872375|FG000|Overall Study|Other|1|||
146374157|NCT03250624|527872376|FG001|Overall Study|Other|2|||
146374158|NCT00106249|527872378|FG000|Overall Study|Lost to Follow-up|3|||
146374159|NCT00106249|527872379|FG001|Overall Study|Lost to Follow-up|2|||
146374160|NCT02809118|527872384|FG000|Overall Study|Withdrawal by Subject|0|||
146374161|NCT02809118|527872385|FG001|Overall Study|Withdrawal by Subject|1|||
146374162|NCT02809118|527872386|FG002|Overall Study|Withdrawal by Subject|1|||
146374163|NCT01235338|527872387|FG000|Overall Study|Adverse Event|3|||
146374164|NCT01235338|527872388|FG001|Overall Study|Adverse Event|2|||
146374165|NCT01235338|527872387|FG000|Overall Study|Protocol Violation|1|||
146374166|NCT01235338|527872388|FG001|Overall Study|Protocol Violation|1|||
146374167|NCT01235338|527872387|FG000|Overall Study|Withdrawal by Subject|5|||
146374168|NCT01235338|527872388|FG001|Overall Study|Withdrawal by Subject|0|||
146374169|NCT01235338|527872387|FG000|Overall Study|Exclusion criteria violations|1|||
146374170|NCT01235338|527872388|FG001|Overall Study|Exclusion criteria violations|1|||
146374171|NCT01235338|527872387|FG000|Overall Study|Positive drug screen|0|||
146374172|NCT01235338|527872388|FG001|Overall Study|Positive drug screen|1|||
146374173|NCT01235338|527872387|FG000|Overall Study|Prohibited meds|1|||
146374174|NCT01235338|527872388|FG001|Overall Study|Prohibited meds|0|||
146374175|NCT00948428|527872389|FG000|Overall Study|Withdrawal by Subject|6|||
146374176|NCT00948428|527872390|FG001|Overall Study|Withdrawal by Subject|12|||
146374177|NCT00948428|527872391|FG002|Overall Study|Withdrawal by Subject|7|||
146374178|NCT00948428|527872389|FG000|Overall Study|Adverse Event|6|||
146374179|NCT00948428|527872390|FG001|Overall Study|Adverse Event|3|||
146374180|NCT00948428|527872391|FG002|Overall Study|Adverse Event|0|||
146374181|NCT00948428|527872389|FG000|Overall Study|Lost to Follow-up|2|||
146374182|NCT00948428|527872390|FG001|Overall Study|Lost to Follow-up|1|||
146374183|NCT00948428|527872391|FG002|Overall Study|Lost to Follow-up|1|||
146374184|NCT00948428|527872389|FG000|Overall Study|Death|2|||
146374185|NCT00948428|527872390|FG001|Overall Study|Death|0|||
146374186|NCT00948428|527872391|FG002|Overall Study|Death|0|||
146374187|NCT00948428|527872389|FG000|Overall Study|Intercurrent Illness|1|||
146374188|NCT00948428|527872390|FG001|Overall Study|Intercurrent Illness|0|||
146374189|NCT00948428|527872391|FG002|Overall Study|Intercurrent Illness|0|||
146374190|NCT00948428|527872389|FG000|Overall Study|Non-compliance|1|||
146374191|NCT00948428|527872390|FG001|Overall Study|Non-compliance|2|||
146374192|NCT00948428|527872391|FG002|Overall Study|Non-compliance|0|||
146374193|NCT00509028|527872392|FG000|Overall Study|Adverse Event|2|||
146374194|NCT00509028|527872393|FG001|Overall Study|Adverse Event|0|||
146374195|NCT00509028|527872392|FG000|Overall Study|Withdrawal by Subject|4|||
146374196|NCT00509028|527872393|FG001|Overall Study|Withdrawal by Subject|3|||
146374197|NCT00509028|527872392|FG000|Overall Study|Lost to Follow-up|0|||
146374198|NCT00509028|527872393|FG001|Overall Study|Lost to Follow-up|1|||
146374199|NCT00509028|527872392|FG000|Overall Study|Protocol Violation|4|||
146374200|NCT00509028|527872393|FG001|Overall Study|Protocol Violation|2|||
146374201|NCT00509028|527872392|FG000|Overall Study|Non-compliance|2|||
146374202|NCT00509028|527872393|FG001|Overall Study|Non-compliance|1|||
146374203|NCT05283499|527872397|FG000|Overall Study|Did not receive intervention|1|||
146374204|NCT05283499|527872398|FG001|Overall Study|Did not receive intervention|2|||
146374205|NCT02408484|527872399|FG000|Overall Study|Withdrawal by Subject|3|||
146374206|NCT02408484|527872399|FG000|Overall Study|Not treated during study period|1|||
146374207|NCT02436915|527872400|FG000|Overall Study|Withdrawal by Subject|0|||
146374208|NCT02436915|527872401|FG001|Overall Study|Withdrawal by Subject|1|||
146374209|NCT01117181|527872403|FG000|Overall Study|Lost to Follow-up|1|||
146374210|NCT01117181|527872404|FG001|Overall Study|Lost to Follow-up|0|||
146374211|NCT01117181|527872403|FG000|Overall Study|Withdrawal by Subject|0|||
146374212|NCT01117181|527872404|FG001|Overall Study|Withdrawal by Subject|2|||
146374213|NCT01843205|527872408|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
146374214|NCT01843205|527872409|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
146374215|NCT00517413|527872410|FG000|Overall Study|Adverse Event|7|||
146374216|NCT00517413|527872410|FG000|Overall Study|Death|13|||
146374217|NCT00517413|527872410|FG000|Overall Study|Protocol Violation|15|||
146374218|NCT00517413|527872410|FG000|Overall Study|Withdrawal by Subject|2|||
146374219|NCT00517413|527872410|FG000|Overall Study|Failure to return|1|||
146374220|NCT00517413|527872410|FG000|Overall Study|Other-Reasons|23|||
146374221|NCT00606177|527872411|FG000|Overall Study|Adverse Event|9|||
146374222|NCT00606177|527872412|FG001|Overall Study|Adverse Event|5|||
146374223|NCT00606177|527872411|FG000|Overall Study|Lack of Efficacy|3|||
146374224|NCT00606177|527872412|FG001|Overall Study|Lack of Efficacy|7|||
146374225|NCT00606177|527872411|FG000|Overall Study|Physician Decision|1|||
146374226|NCT00606177|527872412|FG001|Overall Study|Physician Decision|0|||
146374227|NCT00606177|527872411|FG000|Overall Study|Protocol Violation|1|||
146374228|NCT00606177|527872412|FG001|Overall Study|Protocol Violation|4|||
146374229|NCT00606177|527872411|FG000|Overall Study|Withdrawal by Subject|5|||
146374230|NCT00606177|527872412|FG001|Overall Study|Withdrawal by Subject|6|||
146374231|NCT00606177|527872411|FG000|Overall Study|Progression to depressive phase|6|||
146374232|NCT00606177|527872412|FG001|Overall Study|Progression to depressive phase|1|||
146374233|NCT00606177|527872411|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
146374234|NCT00606177|527872412|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
146374235|NCT00606177|527872411|FG000|Overall Study|Change of residence or other commitments|1|||
146374236|NCT00606177|527872412|FG001|Overall Study|Change of residence or other commitments|1|||
146374237|NCT02603172|527872418|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374238|NCT02603172|527872419|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374239|NCT02603172|527872420|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
146374240|NCT02603172|527872421|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374241|NCT02603172|527872422|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374242|NCT02603172|527872423|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374243|NCT02603172|527872424|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374244|NCT02603172|527872425|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
146374245|NCT00441727|527872428|FG000|Overall Study|Protocol Violation|19|||
146374246|NCT00441727|527872429|FG001|Overall Study|Protocol Violation|28|||
146374247|NCT00441727|527872430|FG002|Overall Study|Protocol Violation|32|||
146374248|NCT00441727|527872428|FG000|Overall Study|Adverse Event|26|||
146374249|NCT00441727|527872429|FG001|Overall Study|Adverse Event|33|||
146374250|NCT00441727|527872430|FG002|Overall Study|Adverse Event|28|||
146374251|NCT00441727|527872428|FG000|Overall Study|Lack of Efficacy|7|||
146374252|NCT00441727|527872429|FG001|Overall Study|Lack of Efficacy|8|||
146374253|NCT00441727|527872430|FG002|Overall Study|Lack of Efficacy|48|||
146374254|NCT00441727|527872428|FG000|Overall Study|Withdrawal by Subject|40|||
146374255|NCT00441727|527872429|FG001|Overall Study|Withdrawal by Subject|34|||
146374256|NCT00441727|527872430|FG002|Overall Study|Withdrawal by Subject|47|||
146374257|NCT00441727|527872428|FG000|Overall Study|Lost to Follow-up|5|||
146374258|NCT00441727|527872429|FG001|Overall Study|Lost to Follow-up|6|||
146374259|NCT00441727|527872430|FG002|Overall Study|Lost to Follow-up|5|||
146374260|NCT00441727|527872428|FG000|Overall Study|Safety Reasons|3|||
146374261|NCT00441727|527872429|FG001|Overall Study|Safety Reasons|1|||
146374262|NCT00441727|527872430|FG002|Overall Study|Safety Reasons|3|||
146374263|NCT00441727|527872428|FG000|Overall Study|Various reason specified|6|||
146374264|NCT00441727|527872429|FG001|Overall Study|Various reason specified|8|||
146374265|NCT00441727|527872430|FG002|Overall Study|Various reason specified|5|||
146374266|NCT02133001|527872431|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
146374267|NCT02133001|527872432|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
146374268|NCT02133001|527872431|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
146374269|NCT02133001|527872432|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
146374270|NCT02133001|527872431|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
146374271|NCT02133001|527872432|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
146374272|NCT02133001|527872431|FG000|Double Blind (Day 1-25)|Other|2|||
146374273|NCT02133001|527872432|FG001|Double Blind (Day 1-25)|Other|2|||
146374274|NCT02133001|527872431|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
146374275|NCT02133001|527872432|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
146374276|NCT02133001|527872431|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
146374277|NCT02133001|527872432|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
146374278|NCT02133001|527872431|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
146374279|NCT02133001|527872432|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
146374280|NCT02133001|527872431|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
146374281|NCT02133001|527872432|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
146374282|NCT04211961|527872433|FG000|Overall Study|Death|0|||
146374283|NCT04211961|527872434|FG001|Overall Study|Death|1|||
146374284|NCT04211961|527872433|FG000|Overall Study|Lost to Follow-up|0|||
146374285|NCT04211961|527872434|FG001|Overall Study|Lost to Follow-up|1|||
146374286|NCT04211961|527872433|FG000|Overall Study|Withdrawal by Subject|0|||
146374287|NCT04211961|527872434|FG001|Overall Study|Withdrawal by Subject|1|||
146374288|NCT03210220|527872437|FG000|Overall Study|Physician Decision|1|||
146374289|NCT03210220|527872438|FG001|Overall Study|Physician Decision|0|||
146374290|NCT01548417|527872439|FG000|Overall Study|Withdrawal by Subject|0|||
146374291|NCT01548417|527872440|FG001|Overall Study|Withdrawal by Subject|2|||
146374292|NCT00865046|527872445|FG000|Overall Study|Lost to Follow-up|1|||
146374293|NCT00865046|527872446|FG001|Overall Study|Lost to Follow-up|4|||
146374294|NCT00865046|527872447|FG002|Overall Study|Lost to Follow-up|0|||
146374295|NCT00865046|527872445|FG000|Overall Study|Death|0|||
146374296|NCT00865046|527872446|FG001|Overall Study|Death|1|||
146374297|NCT00865046|527872447|FG002|Overall Study|Death|1|||
146374298|NCT00865046|527872445|FG000|Overall Study|Withdrawal by Subject|5|||
146374299|NCT00865046|527872446|FG001|Overall Study|Withdrawal by Subject|0|||
146374300|NCT00865046|527872447|FG002|Overall Study|Withdrawal by Subject|0|||
146374301|NCT01587274|527872451|FG000|Overall Study|Lost to Follow-up|4|||
146374302|NCT01587274|527872452|FG001|Overall Study|Lost to Follow-up|5|||
146374303|NCT01587274|527872453|FG002|Overall Study|Lost to Follow-up|3|||
146374304|NCT01421069|527872454|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
146374305|NCT01421069|527872454|FG000|Parent Study|Failed to return|3|||
146374306|NCT01421069|527872454|FG000|Parent Study|Withdrawal by Subject|1|||
146374307|NCT01421069|527872454|FG000|Parent Study|Lost to Follow-up|2|||
146374308|NCT01421069|527872454|FG000|Parent Study|Lack of Efficacy|1|||
146374309|NCT01421069|527872454|FG000|Overall Period for Extension Study|Other|2|||
146374310|NCT01421069|527872454|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
146374311|NCT01421069|527872454|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
146374312|NCT01421069|527872454|FG000|Overall Period for Extension Study|Pregnancy|1|||
146374313|NCT01421069|527872454|FG000|Overall Period for Extension Study|Adverse Event|1|||
146374314|NCT01421069|527872454|FG000|Overall Period for Extension Study|Protocol Violation|1|||
146374315|NCT01421069|527872454|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
146374316|NCT01421069|527872454|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
146374317|NCT01421069|527872454|FG000|Active Treatment Period|Other|1|||
146374318|NCT01421069|527872454|FG000|Active Treatment Period|No longer willing to participate in study|8|||
146374319|NCT01421069|527872454|FG000|Active Treatment Period|Insufficient clinical response|1|||
146374320|NCT01421069|527872454|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
146374321|NCT01421069|527872454|FG000|Active Treatment Period|Pregnancy|1|||
146374322|NCT01421069|527872454|FG000|Active Treatment Period|Adverse Event|1|||
146374323|NCT01421069|527872454|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
146374324|NCT01421069|527872454|FG000|Active Treatment Period|Enrolled in observational period|29|||
146374325|NCT01421069|527872454|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
146374326|NCT01421069|527872454|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
146374327|NCT01421069|527872454|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
146374328|NCT01421069|527872454|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
146374329|NCT01421069|527872454|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
146374330|NCT01421069|527872454|FG000|2b. Retreatment Period|Protocol Violation|1|||
146374331|NCT01421069|527872454|FG000|Observational Period|Other|1|||
146374332|NCT01421069|527872454|FG000|Observational Period|No longer willing to participate in study|4|||
146374333|NCT01421069|527872454|FG000|Observational Period|Lost to Follow-up|3|||
146374334|NCT01641081|527872455|FG000|Period 1|Sponsor request (potential unblinding)|0|||
146374335|NCT01641081|527872456|FG001|Period 1|Sponsor request (potential unblinding)|0|||
146374336|NCT01641081|527872457|FG002|Period 1|Sponsor request (potential unblinding)|0|||
146374337|NCT01641081|527872458|FG003|Period 1|Sponsor request (potential unblinding)|0|||
146374338|NCT01641081|527872459|FG004|Period 1|Sponsor request (potential unblinding)|0|||
146374339|NCT01641081|527872460|FG005|Period 1|Sponsor request (potential unblinding)|0|||
146374340|NCT01641081|527872461|FG006|Period 1|Sponsor request (potential unblinding)|1|||
146374341|NCT01641081|527872462|FG007|Period 1|Sponsor request (potential unblinding)|0|||
146374342|NCT01641081|527872463|FG008|Period 1|Sponsor request (potential unblinding)|0|||
146374343|NCT01641081|527872464|FG009|Period 1|Sponsor request (potential unblinding)|0|||
146374344|NCT01641081|527872455|FG000|Period 1|Protocol Violation|0|||
146374345|NCT01641081|527872456|FG001|Period 1|Protocol Violation|0|||
146374346|NCT01641081|527872457|FG002|Period 1|Protocol Violation|0|||
146374347|NCT01641081|527872458|FG003|Period 1|Protocol Violation|0|||
146374348|NCT01641081|527872459|FG004|Period 1|Protocol Violation|1|||
146374349|NCT01641081|527872460|FG005|Period 1|Protocol Violation|0|||
146374350|NCT01641081|527872461|FG006|Period 1|Protocol Violation|0|||
146374351|NCT01641081|527872462|FG007|Period 1|Protocol Violation|1|||
146374352|NCT01641081|527872463|FG008|Period 1|Protocol Violation|0|||
146374353|NCT01641081|527872464|FG009|Period 1|Protocol Violation|0|||
146374354|NCT01641081|527872455|FG000|Period 1|Adverse Event|1|||
146374355|NCT01641081|527872456|FG001|Period 1|Adverse Event|0|||
146374356|NCT01641081|527872457|FG002|Period 1|Adverse Event|0|||
146374357|NCT01641081|527872458|FG003|Period 1|Adverse Event|0|||
146374358|NCT01641081|527872459|FG004|Period 1|Adverse Event|0|||
146374359|NCT01641081|527872460|FG005|Period 1|Adverse Event|0|||
146374360|NCT01641081|527872461|FG006|Period 1|Adverse Event|0|||
146374361|NCT01641081|527872462|FG007|Period 1|Adverse Event|2|||
146374362|NCT01641081|527872463|FG008|Period 1|Adverse Event|0|||
146374363|NCT01641081|527872464|FG009|Period 1|Adverse Event|0|||
146374364|NCT01641081|527872455|FG000|Period 2|Adverse Event|0|||
146374365|NCT01641081|527872456|FG001|Period 2|Adverse Event|0|||
146374366|NCT01641081|527872457|FG002|Period 2|Adverse Event|0|||
146374367|NCT01641081|527872458|FG003|Period 2|Adverse Event|0|||
146374368|NCT01641081|527872459|FG004|Period 2|Adverse Event|0|||
146374369|NCT01641081|527872460|FG005|Period 2|Adverse Event|1|||
146374370|NCT01641081|527872461|FG006|Period 2|Adverse Event|0|||
146374371|NCT01641081|527872462|FG007|Period 2|Adverse Event|0|||
146374372|NCT01641081|527872463|FG008|Period 2|Adverse Event|0|||
146374373|NCT01641081|527872464|FG009|Period 2|Adverse Event|0|||
146374374|NCT01641081|527872455|FG000|Period 2|Withdrawal by Subject|0|||
146374375|NCT01641081|527872456|FG001|Period 2|Withdrawal by Subject|0|||
146374376|NCT01641081|527872457|FG002|Period 2|Withdrawal by Subject|0|||
146374377|NCT01641081|527872458|FG003|Period 2|Withdrawal by Subject|1|||
146374378|NCT01641081|527872459|FG004|Period 2|Withdrawal by Subject|0|||
146374379|NCT01641081|527872460|FG005|Period 2|Withdrawal by Subject|0|||
146374380|NCT01641081|527872461|FG006|Period 2|Withdrawal by Subject|2|||
146374381|NCT01641081|527872462|FG007|Period 2|Withdrawal by Subject|0|||
146374382|NCT01641081|527872463|FG008|Period 2|Withdrawal by Subject|0|||
146374383|NCT01641081|527872464|FG009|Period 2|Withdrawal by Subject|0|||
146374384|NCT01641081|527872455|FG000|Period 2|Protocol Violation|1|||
146374385|NCT01641081|527872456|FG001|Period 2|Protocol Violation|0|||
146374386|NCT01641081|527872457|FG002|Period 2|Protocol Violation|0|||
146374387|NCT01641081|527872458|FG003|Period 2|Protocol Violation|0|||
146374388|NCT01641081|527872459|FG004|Period 2|Protocol Violation|0|||
146374389|NCT01641081|527872460|FG005|Period 2|Protocol Violation|0|||
146374390|NCT01641081|527872461|FG006|Period 2|Protocol Violation|0|||
146374391|NCT01641081|527872462|FG007|Period 2|Protocol Violation|0|||
146374392|NCT01641081|527872463|FG008|Period 2|Protocol Violation|0|||
146374393|NCT01641081|527872464|FG009|Period 2|Protocol Violation|0|||
146374394|NCT01641081|527872455|FG000|Period 3|Adverse Event|0|||
146374395|NCT01641081|527872456|FG001|Period 3|Adverse Event|0|||
146374396|NCT01641081|527872457|FG002|Period 3|Adverse Event|1|||
146374397|NCT01641081|527872458|FG003|Period 3|Adverse Event|0|||
146374398|NCT01641081|527872459|FG004|Period 3|Adverse Event|0|||
146374399|NCT01641081|527872460|FG005|Period 3|Adverse Event|0|||
146374400|NCT01641081|527872461|FG006|Period 3|Adverse Event|0|||
146374401|NCT01641081|527872462|FG007|Period 3|Adverse Event|0|||
146374402|NCT01641081|527872463|FG008|Period 3|Adverse Event|0|||
146374403|NCT01641081|527872464|FG009|Period 3|Adverse Event|0|||
146374404|NCT01641081|527872455|FG000|Period 3|Withdrawal by Subject|0|||
146374405|NCT01641081|527872456|FG001|Period 3|Withdrawal by Subject|0|||
146374406|NCT01641081|527872457|FG002|Period 3|Withdrawal by Subject|0|||
146374407|NCT01641081|527872458|FG003|Period 3|Withdrawal by Subject|0|||
146374408|NCT01641081|527872459|FG004|Period 3|Withdrawal by Subject|0|||
146374409|NCT01641081|527872460|FG005|Period 3|Withdrawal by Subject|0|||
146374410|NCT01641081|527872461|FG006|Period 3|Withdrawal by Subject|0|||
146374411|NCT01641081|527872462|FG007|Period 3|Withdrawal by Subject|0|||
146374412|NCT01641081|527872463|FG008|Period 3|Withdrawal by Subject|1|||
146374413|NCT01641081|527872464|FG009|Period 3|Withdrawal by Subject|0|||
146374414|NCT01641081|527872455|FG000|Period 4|Adverse Event|0|||
146374415|NCT01641081|527872456|FG001|Period 4|Adverse Event|1|||
146374416|NCT01641081|527872457|FG002|Period 4|Adverse Event|0|||
146374417|NCT01641081|527872458|FG003|Period 4|Adverse Event|1|||
146374418|NCT01641081|527872459|FG004|Period 4|Adverse Event|0|||
146374419|NCT01641081|527872460|FG005|Period 4|Adverse Event|0|||
146374420|NCT01641081|527872461|FG006|Period 4|Adverse Event|0|||
146374421|NCT01641081|527872462|FG007|Period 4|Adverse Event|0|||
146374422|NCT01641081|527872463|FG008|Period 4|Adverse Event|0|||
146374423|NCT01641081|527872464|FG009|Period 4|Adverse Event|0|||
146374424|NCT01641081|527872455|FG000|Period 5|Adverse Event|0|||
146374425|NCT01641081|527872456|FG001|Period 5|Adverse Event|0|||
146374426|NCT01641081|527872457|FG002|Period 5|Adverse Event|2|||
146374427|NCT01641081|527872458|FG003|Period 5|Adverse Event|0|||
146374428|NCT01641081|527872459|FG004|Period 5|Adverse Event|0|||
146374429|NCT01641081|527872460|FG005|Period 5|Adverse Event|0|||
146374430|NCT01641081|527872461|FG006|Period 5|Adverse Event|0|||
146374431|NCT01641081|527872462|FG007|Period 5|Adverse Event|0|||
146374432|NCT01641081|527872463|FG008|Period 5|Adverse Event|0|||
146374433|NCT01641081|527872464|FG009|Period 5|Adverse Event|0|||
146374434|NCT03383614|527872466|FG000|Overall Study|Withdrawal by Subject|0|||
146374435|NCT03383614|527872467|FG001|Overall Study|Withdrawal by Subject|1|||
146374436|NCT03383614|527872468|FG002|Overall Study|Withdrawal by Subject|0|||
146374437|NCT03383614|527872469|FG003|Overall Study|Withdrawal by Subject|0|||
146374438|NCT00841672|527872470|FG000|Overall Study|Adverse Event|7|||
146374439|NCT00841672|527872471|FG001|Overall Study|Adverse Event|16|||
146374440|NCT00841672|527872470|FG000|Overall Study|Abnormal test procedure result(s)|0|||
146374441|NCT00841672|527872471|FG001|Overall Study|Abnormal test procedure result(s)|1|||
146374442|NCT00841672|527872470|FG000|Overall Study|Subject withdrew consent|2|||
146374443|NCT00841672|527872471|FG001|Overall Study|Subject withdrew consent|4|||
146374444|NCT00841672|527872470|FG000|Overall Study|Lost to Follow-up|1|||
146374445|NCT00841672|527872471|FG001|Overall Study|Lost to Follow-up|1|||
146374446|NCT00841672|527872470|FG000|Overall Study|Administrative problems|9|||
146374447|NCT00841672|527872471|FG001|Overall Study|Administrative problems|9|||
146374448|NCT00841672|527872470|FG000|Overall Study|Misrandomized|1|||
146374449|NCT00841672|527872471|FG001|Overall Study|Misrandomized|0|||
146374450|NCT00841672|527872470|FG000|Overall Study|Protocol Deviation|0|||
146374451|NCT00841672|527872471|FG001|Overall Study|Protocol Deviation|1|||
146374452|NCT00422669|527872472|FG000|Overall Study|The study was terminated early.|98|||
146374453|NCT00422669|527872473|FG001|Overall Study|The study was terminated early.|100|||
146374454|NCT00422669|527872474|FG002|Overall Study|The study was terminated early.|7|||
146374455|NCT02709109|527872475|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
146374456|NCT02709109|527872476|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
146374457|NCT02709109|527872477|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
146374458|NCT02709109|527872478|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
146374459|NCT02709109|527872475|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146374460|NCT02709109|527872476|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
146374461|NCT02709109|527872477|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146374462|NCT02709109|527872478|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
146374463|NCT02709109|527872475|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
146374464|NCT02709109|527872476|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146374465|NCT02709109|527872477|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146374466|NCT02709109|527872478|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
146374467|NCT02709109|527872475|FG000|Washout Period (28 Days)|Other|2|||
146374468|NCT02709109|527872476|FG001|Washout Period (28 Days)|Other|2|||
146374469|NCT02709109|527872477|FG002|Washout Period (28 Days)|Other|3|||
146374470|NCT02709109|527872478|FG003|Washout Period (28 Days)|Other|0|||
146374471|NCT02709109|527872475|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
146374472|NCT02709109|527872476|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
146374473|NCT02709109|527872477|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
146374474|NCT02709109|527872478|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
146374475|NCT02709109|527872475|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
146374476|NCT02709109|527872476|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
146374477|NCT02709109|527872477|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
146374478|NCT02709109|527872478|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
146374479|NCT02709109|527872475|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146374480|NCT02709109|527872476|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146374481|NCT02709109|527872477|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
146374482|NCT02709109|527872478|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
146374483|NCT02709109|527872475|FG000|Treatment Period 2 (28 Days)|Other|0|||
146374484|NCT02709109|527872476|FG001|Treatment Period 2 (28 Days)|Other|0|||
146374485|NCT02709109|527872477|FG002|Treatment Period 2 (28 Days)|Other|1|||
146374486|NCT02709109|527872478|FG003|Treatment Period 2 (28 Days)|Other|0|||
146374487|NCT01015820|527872480|FG000|Overall Study|Suboptimal measurements|1|||
146374488|NCT01015820|527872481|FG001|Overall Study|Suboptimal measurements|0|||
146374489|NCT02650895|527872487|FG000|Overall Study|Withdrawal by Subject|0|||
146374490|NCT02650895|527872488|FG001|Overall Study|Withdrawal by Subject|1|||
146374491|NCT02650895|527872489|FG002|Overall Study|Withdrawal by Subject|0|||
146374492|NCT02650895|527872490|FG003|Overall Study|Withdrawal by Subject|0|||
146374493|NCT02650895|527872491|FG004|Overall Study|Withdrawal by Subject|0|||
146374494|NCT02650895|527872492|FG005|Overall Study|Withdrawal by Subject|0|||
146374495|NCT03906136|527874975|FG000|Overall Study|Adverse Event|1|||
146374496|NCT03906136|527874976|FG001|Overall Study|Adverse Event|0|||
146374497|NCT03906136|527874975|FG000|Overall Study|Lost to Follow-up|7|||
146374498|NCT03906136|527874976|FG001|Overall Study|Lost to Follow-up|4|||
146374499|NCT03906136|527874975|FG000|Overall Study|Physician Decision|1|||
146374500|NCT03906136|527874976|FG001|Overall Study|Physician Decision|0|||
146374501|NCT03906136|527874975|FG000|Overall Study|Withdrawal by Subject|3|||
146374502|NCT03906136|527874976|FG001|Overall Study|Withdrawal by Subject|7|||
146374503|NCT02371980|527874985|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
146374504|NCT02371980|527874986|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
146374505|NCT02371980|527874987|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
146374506|NCT02371980|527874988|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
146374507|NCT02371980|527874989|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
146374508|NCT02371980|527874985|FG000|Open-label Period|Significant Protocol Deviation|19|||
146374509|NCT02371980|527874986|FG001|Open-label Period|Significant Protocol Deviation|0|||
146374510|NCT02371980|527874987|FG002|Open-label Period|Significant Protocol Deviation|0|||
146374511|NCT02371980|527874988|FG003|Open-label Period|Significant Protocol Deviation|0|||
146374512|NCT02371980|527874989|FG004|Open-label Period|Significant Protocol Deviation|0|||
146374513|NCT02371980|527874985|FG000|Open-label Period|Noncompliance with Study Drug|10|||
146374514|NCT02371980|527874986|FG001|Open-label Period|Noncompliance with Study Drug|0|||
146374515|NCT02371980|527874987|FG002|Open-label Period|Noncompliance with Study Drug|0|||
146374516|NCT02371980|527874988|FG003|Open-label Period|Noncompliance with Study Drug|0|||
146374517|NCT02371980|527874989|FG004|Open-label Period|Noncompliance with Study Drug|0|||
146374518|NCT02371980|527874985|FG000|Open-label Period|Lost to Follow-up|55|||
146374519|NCT02371980|527874986|FG001|Open-label Period|Lost to Follow-up|0|||
146374520|NCT02371980|527874987|FG002|Open-label Period|Lost to Follow-up|0|||
146374521|NCT02371980|527874988|FG003|Open-label Period|Lost to Follow-up|0|||
146374522|NCT02371980|527874989|FG004|Open-label Period|Lost to Follow-up|0|||
146374523|NCT02371980|527874985|FG000|Open-label Period|Voluntary Withdrawal|91|||
146374524|NCT02371980|527874986|FG001|Open-label Period|Voluntary Withdrawal|0|||
146374525|NCT02371980|527874987|FG002|Open-label Period|Voluntary Withdrawal|0|||
146374526|NCT02371980|527874988|FG003|Open-label Period|Voluntary Withdrawal|0|||
146374527|NCT02371980|527874989|FG004|Open-label Period|Voluntary Withdrawal|0|||
146374528|NCT02371980|527874985|FG000|Open-label Period|Pregnancy|1|||
146374529|NCT02371980|527874986|FG001|Open-label Period|Pregnancy|0|||
146374530|NCT02371980|527874987|FG002|Open-label Period|Pregnancy|0|||
146374531|NCT02371980|527874988|FG003|Open-label Period|Pregnancy|0|||
146374532|NCT02371980|527874989|FG004|Open-label Period|Pregnancy|0|||
146374533|NCT02371980|527874985|FG000|Open-label Period|Lack of Efficacy|116|||
146374534|NCT02371980|527874986|FG001|Open-label Period|Lack of Efficacy|0|||
146374535|NCT02371980|527874987|FG002|Open-label Period|Lack of Efficacy|0|||
146374536|NCT02371980|527874988|FG003|Open-label Period|Lack of Efficacy|0|||
146374537|NCT02371980|527874989|FG004|Open-label Period|Lack of Efficacy|0|||
146374538|NCT02371980|527874985|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
146374539|NCT02371980|527874986|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
146374540|NCT02371980|527874987|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
146374541|NCT02371980|527874988|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
146374542|NCT02371980|527874989|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
146374543|NCT02371980|527874985|FG000|Open-label Period|Reason not Specified|9|||
146374544|NCT02371980|527874986|FG001|Open-label Period|Reason not Specified|0|||
146374545|NCT02371980|527874987|FG002|Open-label Period|Reason not Specified|0|||
146374546|NCT02371980|527874988|FG003|Open-label Period|Reason not Specified|0|||
146374547|NCT02371980|527874989|FG004|Open-label Period|Reason not Specified|0|||
146374548|NCT02371980|527874985|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
146374549|NCT02371980|527874986|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
146374550|NCT02371980|527874987|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
146374551|NCT02371980|527874988|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
146374552|NCT02371980|527874989|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
146374553|NCT02371980|527874985|FG000|Double-blind Period|Significant Protocol Deviation|0|||
146374554|NCT02371980|527874986|FG001|Double-blind Period|Significant Protocol Deviation|2|||
146374555|NCT02371980|527874987|FG002|Double-blind Period|Significant Protocol Deviation|7|||
146374556|NCT02371980|527874988|FG003|Double-blind Period|Significant Protocol Deviation|3|||
146374557|NCT02371980|527874989|FG004|Double-blind Period|Significant Protocol Deviation|3|||
146374558|NCT02371980|527874985|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
146374559|NCT02371980|527874986|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
146374560|NCT02371980|527874987|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
146374561|NCT02371980|527874988|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
146374562|NCT02371980|527874989|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
146374563|NCT02371980|527874985|FG000|Double-blind Period|Lost to Follow-up|0|||
146374564|NCT02371980|527874986|FG001|Double-blind Period|Lost to Follow-up|8|||
146374565|NCT02371980|527874987|FG002|Double-blind Period|Lost to Follow-up|8|||
146374566|NCT02371980|527874988|FG003|Double-blind Period|Lost to Follow-up|6|||
146374567|NCT02371980|527874989|FG004|Double-blind Period|Lost to Follow-up|5|||
146374568|NCT02371980|527874985|FG000|Double-blind Period|Voluntary Withdrawal|0|||
146374569|NCT02371980|527874986|FG001|Double-blind Period|Voluntary Withdrawal|12|||
146374570|NCT02371980|527874987|FG002|Double-blind Period|Voluntary Withdrawal|8|||
146374571|NCT02371980|527874988|FG003|Double-blind Period|Voluntary Withdrawal|9|||
146374572|NCT02371980|527874989|FG004|Double-blind Period|Voluntary Withdrawal|11|||
146374573|NCT02371980|527874985|FG000|Double-blind Period|Relapse|0|||
146374574|NCT02371980|527874986|FG001|Double-blind Period|Relapse|50|||
146374575|NCT02371980|527874987|FG002|Double-blind Period|Relapse|25|||
146374576|NCT02371980|527874988|FG003|Double-blind Period|Relapse|25|||
146374577|NCT02371980|527874989|FG004|Double-blind Period|Relapse|26|||
146374578|NCT02371980|527874985|FG000|Double-blind Period|Reason not Specified|0|||
146374579|NCT02371980|527874986|FG001|Double-blind Period|Reason not Specified|3|||
146374580|NCT02371980|527874987|FG002|Double-blind Period|Reason not Specified|3|||
146374581|NCT02371980|527874988|FG003|Double-blind Period|Reason not Specified|2|||
146374582|NCT02371980|527874989|FG004|Double-blind Period|Reason not Specified|1|||
146374583|NCT02371980|527874985|FG000|Double-blind Period|Missing|0|||
146374584|NCT02371980|527874986|FG001|Double-blind Period|Missing|1|||
146374585|NCT02371980|527874987|FG002|Double-blind Period|Missing|0|||
146374586|NCT02371980|527874988|FG003|Double-blind Period|Missing|0|||
146374587|NCT02371980|527874989|FG004|Double-blind Period|Missing|0|||
146374588|NCT00922974|527874990|FG000|Phase II Component|Protocol Violation|2|||
146374589|NCT00922974|527874991|FG001|Phase II Component|Protocol Violation|0|||
146374590|NCT00922974|527874990|FG000|Phase II Component|Not evaluable for treatment review|5|||
146374591|NCT00922974|527874991|FG001|Phase II Component|Not evaluable for treatment review|0|||
146374592|NCT00922974|527874990|FG000|Phase III Component|Protocol Violation|8|||
146374593|NCT00922974|527874991|FG001|Phase III Component|Protocol Violation|6|||
146374594|NCT02944513|527874992|FG000|Overall Study|Withdrawal by Subject|4|||
146374595|NCT02944513|527874993|FG001|Overall Study|Withdrawal by Subject|1|||
146374596|NCT00937326|527874994|FG000|Overall Study|Adverse Event|0|||
146374597|NCT00937326|527874995|FG001|Overall Study|Adverse Event|3|||
146374598|NCT00937326|527874996|FG002|Overall Study|Adverse Event|1|||
146374599|NCT00937326|527874997|FG003|Overall Study|Adverse Event|1|||
146374600|NCT00937326|527874998|FG004|Overall Study|Adverse Event|2|||
146374601|NCT00937326|527874994|FG000|Overall Study|Death|0|||
146374602|NCT00937326|527874995|FG001|Overall Study|Death|0|||
146374603|NCT00937326|527874996|FG002|Overall Study|Death|1|||
146374604|NCT00937326|527874997|FG003|Overall Study|Death|0|||
146374605|NCT00937326|527874998|FG004|Overall Study|Death|0|||
146374606|NCT00937326|527874994|FG000|Overall Study|Withdrawal by Subject|3|||
146374607|NCT00937326|527874995|FG001|Overall Study|Withdrawal by Subject|4|||
146374608|NCT00937326|527874996|FG002|Overall Study|Withdrawal by Subject|1|||
146374609|NCT00937326|527874997|FG003|Overall Study|Withdrawal by Subject|4|||
146374610|NCT00937326|527874998|FG004|Overall Study|Withdrawal by Subject|3|||
146374611|NCT00937326|527874994|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146374612|NCT00937326|527874995|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146374613|NCT00937326|527874996|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
146374614|NCT00937326|527874997|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146374615|NCT00937326|527874998|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
146374616|NCT00731666|527875001|FG000|Overall Study|Adverse Event|2|||
146374617|NCT00731666|527875001|FG000|Overall Study|Lost to Follow-up|8|||
146374618|NCT00731666|527875001|FG000|Overall Study|Withdrawal by Subject|2|||
146374619|NCT00088595|527875002|FG000|Overall Study|Adverse Event|11|||
146374620|NCT00088595|527875002|FG000|Overall Study|Withdrawal by Subject|8|||
146374621|NCT00088595|527875002|FG000|Overall Study|Ongoing (After Core)|7|||
146374622|NCT00088595|527875002|FG000|Overall Study|New Cancer Therapy|2|||
146374623|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Death|3|||
146374624|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Death|0|||
146374625|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Death|0|||
146374626|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Death|0|||
146374627|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Death|0|||
146374628|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
146374629|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
146374630|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
146374631|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
146374632|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
146374633|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
146374634|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
146374635|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
146374636|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146374637|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
146374638|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Other|0|||
146374639|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Other|0|||
146374640|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Other|1|||
146374641|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Other|0|||
146374642|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Other|0|||
146374643|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
146374644|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
146374645|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
146374646|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
146374647|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
146374648|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
146374649|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
146374650|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
146374651|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
146374652|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
146374653|NCT01224106|527875013|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146374654|NCT01224106|527875014|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146374655|NCT01224106|527875015|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146374656|NCT01224106|527875016|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146374657|NCT01224106|527875017|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146374658|NCT01224106|527875013|FG000|Open-Label Extension (OLE) Phase|Death|0|||
146374659|NCT01224106|527875014|FG001|Open-Label Extension (OLE) Phase|Death|0|||
146374660|NCT01224106|527875015|FG002|Open-Label Extension (OLE) Phase|Death|0|||
146374661|NCT01224106|527875016|FG003|Open-Label Extension (OLE) Phase|Death|1|||
146374662|NCT01224106|527875017|FG004|Open-Label Extension (OLE) Phase|Death|3|||
146374663|NCT01224106|527875013|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146374664|NCT01224106|527875014|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146374665|NCT01224106|527875015|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
146374666|NCT01224106|527875016|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
146374667|NCT01224106|527875017|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
146374668|NCT01224106|527875013|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146374669|NCT01224106|527875014|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146374670|NCT01224106|527875015|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
146374671|NCT01224106|527875016|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
146374672|NCT01224106|527875017|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
146374673|NCT01224106|527875013|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146374674|NCT01224106|527875014|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146374675|NCT01224106|527875015|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
146374676|NCT01224106|527875016|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
146374677|NCT01224106|527875017|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
146374678|NCT01224106|527875013|FG000|Open-Label Extension (OLE) Phase|Other|0|||
146374679|NCT01224106|527875014|FG001|Open-Label Extension (OLE) Phase|Other|0|||
146374680|NCT01224106|527875015|FG002|Open-Label Extension (OLE) Phase|Other|0|||
146374681|NCT01224106|527875016|FG003|Open-Label Extension (OLE) Phase|Other|5|||
146374682|NCT01224106|527875017|FG004|Open-Label Extension (OLE) Phase|Other|3|||
146374683|NCT00420342|527875018|FG000|Overall Study|Lost to Follow-up|1|||
146374684|NCT00420342|527875019|FG001|Overall Study|Lost to Follow-up|0|||
146374685|NCT00420342|527875020|FG002|Overall Study|Lost to Follow-up|1|||
146374686|NCT00420342|527875018|FG000|Overall Study|Withdrawal by Subject|0|||
146374687|NCT00420342|527875019|FG001|Overall Study|Withdrawal by Subject|2|||
146374688|NCT00420342|527875020|FG002|Overall Study|Withdrawal by Subject|0|||
146374689|NCT00839436|527875021|FG000|Overall Study|Developed exclusionary condition|1|||
146374690|NCT00839436|527875022|FG001|Overall Study|Developed exclusionary condition|0|||
146374691|NCT00839436|527875023|FG002|Overall Study|Developed exclusionary condition|0|||
146374692|NCT00839436|527875021|FG000|Overall Study|Withdrawal by Subject|0|||
146374693|NCT00839436|527875022|FG001|Overall Study|Withdrawal by Subject|1|||
146374694|NCT00839436|527875023|FG002|Overall Study|Withdrawal by Subject|0|||
146374695|NCT00839436|527875021|FG000|Overall Study|Study drug no longer available|0|||
146374696|NCT00839436|527875022|FG001|Overall Study|Study drug no longer available|0|||
146374697|NCT00839436|527875023|FG002|Overall Study|Study drug no longer available|1|||
146374698|NCT05784129|527875024|FG000|Overall Study|Study terminated by sponsor|2|||
146374699|NCT05784129|527875025|FG001|Overall Study|Study terminated by sponsor|2|||
146374700|NCT02580591|527875027|FG000|Overall Study|Adverse Event|0|||
146374701|NCT02580591|527875028|FG001|Overall Study|Adverse Event|1|||
146374702|NCT02580591|527875029|FG002|Overall Study|Adverse Event|2|||
146374703|NCT02580591|527875030|FG003|Overall Study|Adverse Event|5|||
146374704|NCT02580591|527875027|FG000|Overall Study|Protocol Violation|3|||
146374705|NCT02580591|527875028|FG001|Overall Study|Protocol Violation|2|||
146374706|NCT02580591|527875029|FG002|Overall Study|Protocol Violation|1|||
146374707|NCT02580591|527875030|FG003|Overall Study|Protocol Violation|1|||
146374708|NCT02580591|527875027|FG000|Overall Study|Lost to Follow-up|5|||
146374709|NCT02580591|527875028|FG001|Overall Study|Lost to Follow-up|3|||
146374710|NCT02580591|527875029|FG002|Overall Study|Lost to Follow-up|3|||
146374711|NCT02580591|527875030|FG003|Overall Study|Lost to Follow-up|1|||
146374712|NCT02580591|527875027|FG000|Overall Study|Withdrawal by Subject|6|||
146374713|NCT02580591|527875028|FG001|Overall Study|Withdrawal by Subject|1|||
146374714|NCT02580591|527875029|FG002|Overall Study|Withdrawal by Subject|2|||
146374715|NCT02580591|527875030|FG003|Overall Study|Withdrawal by Subject|3|||
146374716|NCT02580591|527875027|FG000|Overall Study|Not treated|1|||
146374717|NCT02580591|527875028|FG001|Overall Study|Not treated|1|||
146374718|NCT02580591|527875029|FG002|Overall Study|Not treated|0|||
146374719|NCT02580591|527875030|FG003|Overall Study|Not treated|0|||
146374720|NCT02580591|527875027|FG000|Overall Study|Other than specified|3|||
146374721|NCT02580591|527875028|FG001|Overall Study|Other than specified|2|||
146374722|NCT02580591|527875029|FG002|Overall Study|Other than specified|5|||
146374723|NCT02580591|527875030|FG003|Overall Study|Other than specified|2|||
146374724|NCT01599806|527875034|FG000|Overall Study|Lost to Follow-up|20|||
146374725|NCT01599806|527875035|FG001|Overall Study|Lost to Follow-up|20|||
146374726|NCT01599806|527875034|FG000|Overall Study|Withdrawal by Subject|12|||
146374727|NCT01599806|527875035|FG001|Overall Study|Withdrawal by Subject|12|||
146374728|NCT01599806|527875034|FG000|Overall Study|Other Eligibility criteria|11|||
146374729|NCT01599806|527875035|FG001|Overall Study|Other Eligibility criteria|9|||
146374730|NCT03006926|527875039|FG000|Overall Study|Adverse Event|0|||
146374731|NCT03006926|527875040|FG001|Overall Study|Adverse Event|27|||
146374732|NCT03006926|527875039|FG000|Overall Study|Withdrawal by Subject|0|||
146374733|NCT03006926|527875040|FG001|Overall Study|Withdrawal by Subject|1|||
146374734|NCT03006926|527875039|FG000|Overall Study|Radiological Disease Progression|0|||
146374735|NCT03006926|527875040|FG001|Overall Study|Radiological Disease Progression|52|||
146374736|NCT03006926|527875039|FG000|Overall Study|Clinical Disease Progression|0|||
146374737|NCT03006926|527875040|FG001|Overall Study|Clinical Disease Progression|10|||
146374738|NCT03006926|527875039|FG000|Overall Study|Other|0|||
146374739|NCT03006926|527875040|FG001|Overall Study|Other|8|||
146374740|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
146374741|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
146374742|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146374743|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146374744|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
146374745|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146374746|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
146374747|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146374748|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146374749|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
146374750|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146374751|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
146374752|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146374753|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146374754|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
146374755|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
146374756|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
146374757|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146395799|NCT01314261|527950947|FG003|Overall Study|Adverse Event|0|||
146374758|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146374759|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
146374760|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
146374761|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
146374762|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146374763|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146374764|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
146374765|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
146374766|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
146374767|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146374768|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146374769|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
146374770|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
146374771|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
146374772|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146374773|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146374774|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
146374775|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
146374776|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
146374777|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146374778|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146374779|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
146374780|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
146374781|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
146374782|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146374783|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146374784|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
146374785|NCT03689972|527875041|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
146374786|NCT03689972|527875042|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
146374787|NCT03689972|527875043|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146374788|NCT03689972|527875044|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146374789|NCT03689972|527875045|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
146374790|NCT03689972|527875041|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146374791|NCT03689972|527875042|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146374792|NCT03689972|527875043|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
146374793|NCT03689972|527875044|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146374794|NCT03689972|527875045|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
146374795|NCT03689972|527875041|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146374796|NCT03689972|527875042|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146374797|NCT03689972|527875043|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
146374798|NCT03689972|527875044|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146374799|NCT03689972|527875045|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
146374800|NCT03689972|527875041|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146374801|NCT03689972|527875042|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146374802|NCT03689972|527875043|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
146374803|NCT03689972|527875044|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146374804|NCT03689972|527875045|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
146374805|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146374806|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146374807|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
146374808|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
146374809|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
146374810|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146374811|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146374812|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
146374813|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
146374814|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
146374815|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146374816|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146374817|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
146374818|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
146374819|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
146374820|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146374821|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
145943493|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
146374822|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146374823|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
146374824|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
146374825|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146374826|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146374827|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
146374828|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
146374829|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
146374830|NCT03689972|527875041|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146374831|NCT03689972|527875042|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146374832|NCT03689972|527875043|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146374833|NCT03689972|527875044|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
146374834|NCT03689972|527875045|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
146374835|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
146374836|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
146374837|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
146374838|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146374839|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146374840|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
146374841|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146374842|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
146374843|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146374844|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
146374845|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146374846|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146374847|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146374848|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
146374849|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146374850|NCT02417064|527875046|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
146374851|NCT02417064|527875047|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
146374852|NCT02417064|527875048|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
146374853|NCT02417064|527875046|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
146374854|NCT02417064|527875047|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
146374855|NCT02417064|527875048|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
146374856|NCT02417064|527875046|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
146374857|NCT02417064|527875047|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
146374858|NCT02417064|527875048|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
146374859|NCT02417064|527875046|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
146374860|NCT02417064|527875047|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
146374861|NCT02417064|527875048|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
146374862|NCT02417064|527875046|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
146374863|NCT02417064|527875047|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
146374864|NCT02417064|527875048|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
146374865|NCT02417064|527875046|FG000|Follow-up Phase (24 Weeks)|Other|2|||
146374866|NCT02417064|527875047|FG001|Follow-up Phase (24 Weeks)|Other|2|||
146374867|NCT02417064|527875048|FG002|Follow-up Phase (24 Weeks)|Other|3|||
146374868|NCT04882072|527875049|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
146374869|NCT04882072|527875050|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
146374870|NCT04882072|527875049|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
146374871|NCT04882072|527875050|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
146374872|NCT04882072|527875049|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
146374873|NCT04882072|527875050|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
146374874|NCT00732641|527875051|FG000|Overall Study|Relapse or Progressive Disease|65|||
146374875|NCT00732641|527875052|FG001|Overall Study|Relapse or Progressive Disease|101|||
146374876|NCT00732641|527875051|FG000|Overall Study|Serious Adverse Events|12|||
146374877|NCT00732641|527875052|FG001|Overall Study|Serious Adverse Events|3|||
146374878|NCT00732641|527875051|FG000|Overall Study|Physician Decision|6|||
146374879|NCT00732641|527875052|FG001|Overall Study|Physician Decision|0|||
146374880|NCT00732641|527875051|FG000|Overall Study|Withdrawal by Subject|4|||
146374881|NCT00732641|527875052|FG001|Overall Study|Withdrawal by Subject|2|||
146374882|NCT00732641|527875051|FG000|Overall Study|Unable to Complete|1|||
146374883|NCT00732641|527875052|FG001|Overall Study|Unable to Complete|1|||
146374884|NCT00732641|527875051|FG000|Overall Study|Other|18|||
146374885|NCT00732641|527875052|FG001|Overall Study|Other|5|||
146374886|NCT01192100|527875053|FG000|Overall Study|Withdrawal by Subject|0|||
146374887|NCT01192100|527875054|FG001|Overall Study|Withdrawal by Subject|0|||
146374888|NCT01192100|527875055|FG002|Overall Study|Withdrawal by Subject|0|||
146374889|NCT01192100|527875056|FG003|Overall Study|Withdrawal by Subject|0|||
146374890|NCT01192100|527875057|FG004|Overall Study|Withdrawal by Subject|1|||
146374891|NCT01192100|527875058|FG005|Overall Study|Withdrawal by Subject|0|||
146374892|NCT01192100|527875053|FG000|Overall Study|Protocol Violation|0|||
146374893|NCT01192100|527875054|FG001|Overall Study|Protocol Violation|0|||
146374894|NCT01192100|527875055|FG002|Overall Study|Protocol Violation|0|||
146374895|NCT01192100|527875056|FG003|Overall Study|Protocol Violation|1|||
146374896|NCT01192100|527875057|FG004|Overall Study|Protocol Violation|0|||
146374897|NCT01192100|527875058|FG005|Overall Study|Protocol Violation|0|||
146374898|NCT02475629|527875059|FG000|Overall Study|Adverse Event|1|||
146374899|NCT02475629|527875059|FG000|Overall Study|Death|4|||
146374900|NCT02475629|527875059|FG000|Overall Study|Physician Decision|1|||
146374901|NCT02475629|527875059|FG000|Overall Study|Withdrawal by Subject|1|||
146374902|NCT02475629|527875059|FG000|Overall Study|Lost to Follow-up|1|||
146374903|NCT02475629|527875059|FG000|Overall Study|Subject non-compliance|1|||
146374904|NCT01095666|527875063|FG000|Overall Study|Lack of Efficacy|0|||
146374905|NCT01095666|527875064|FG001|Overall Study|Lack of Efficacy|0|||
146374906|NCT01095666|527875065|FG002|Overall Study|Lack of Efficacy|1|||
146374907|NCT01095666|527875063|FG000|Overall Study|Adverse Event|2|||
146374908|NCT01095666|527875064|FG001|Overall Study|Adverse Event|1|||
146374909|NCT01095666|527875065|FG002|Overall Study|Adverse Event|3|||
146374910|NCT01095666|527875063|FG000|Overall Study|Lost to Follow-up|2|||
146374911|NCT01095666|527875064|FG001|Overall Study|Lost to Follow-up|2|||
146374912|NCT01095666|527875065|FG002|Overall Study|Lost to Follow-up|0|||
146374913|NCT01095666|527875063|FG000|Overall Study|Withdrawal by Subject|6|||
146374914|NCT01095666|527875064|FG001|Overall Study|Withdrawal by Subject|6|||
146374915|NCT01095666|527875065|FG002|Overall Study|Withdrawal by Subject|1|||
146374916|NCT01095666|527875063|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
146374917|NCT01095666|527875064|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
146374918|NCT01095666|527875065|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
146374919|NCT01451398|527875073|FG000|Overall Study|Adverse Event|7|||
146374920|NCT01451398|527875074|FG001|Overall Study|Adverse Event|9|||
146374921|NCT01451398|527875073|FG000|Overall Study|Protocol Violation|1|||
146374922|NCT01451398|527875074|FG001|Overall Study|Protocol Violation|2|||
146374923|NCT01451398|527875073|FG000|Overall Study|Physician Decision|1|||
146374924|NCT01451398|527875074|FG001|Overall Study|Physician Decision|1|||
146374925|NCT01451398|527875073|FG000|Overall Study|Withdrawal by Subject|10|||
146374926|NCT01451398|527875074|FG001|Overall Study|Withdrawal by Subject|14|||
146374927|NCT01451398|527875073|FG000|Overall Study|Lost to Follow-up|6|||
146374928|NCT01451398|527875074|FG001|Overall Study|Lost to Follow-up|4|||
146374929|NCT01451398|527875073|FG000|Overall Study|Non-compliance with study drug|1|||
146374930|NCT01451398|527875074|FG001|Overall Study|Non-compliance with study drug|3|||
146374931|NCT01451398|527875073|FG000|Overall Study|Non-compliance with protocol|1|||
146374932|NCT01451398|527875074|FG001|Overall Study|Non-compliance with protocol|1|||
146374933|NCT01451398|527875073|FG000|Overall Study|Moved out of country|0|||
146374934|NCT01451398|527875074|FG001|Overall Study|Moved out of country|1|||
146374935|NCT01451398|527875073|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
146374936|NCT01451398|527875074|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
146374937|NCT01451398|527875073|FG000|Overall Study|Lack of Efficacy|0|||
146374938|NCT01451398|527875074|FG001|Overall Study|Lack of Efficacy|1|||
146374939|NCT00741260|527875075|FG000|Overall Study|Disease Progression|3|||
146374940|NCT00741260|527875076|FG001|Overall Study|Disease Progression|5|||
146374941|NCT00741260|527875077|FG002|Overall Study|Disease Progression|3|||
146374942|NCT00741260|527875078|FG003|Overall Study|Disease Progression|3|||
146374943|NCT00741260|527875079|FG004|Overall Study|Disease Progression|5|||
146374944|NCT00741260|527875080|FG005|Overall Study|Disease Progression|37|||
146374945|NCT00741260|527875081|FG006|Overall Study|Disease Progression|4|||
146374946|NCT00741260|527875075|FG000|Overall Study|Death|0|||
146374947|NCT00741260|527875076|FG001|Overall Study|Death|1|||
146374948|NCT00741260|527875077|FG002|Overall Study|Death|0|||
146374949|NCT00741260|527875078|FG003|Overall Study|Death|1|||
146374950|NCT00741260|527875079|FG004|Overall Study|Death|2|||
146374951|NCT00741260|527875080|FG005|Overall Study|Death|2|||
146374952|NCT00741260|527875081|FG006|Overall Study|Death|1|||
146374953|NCT00741260|527875075|FG000|Overall Study|Withdrawal by Subject|0|||
146374954|NCT00741260|527875076|FG001|Overall Study|Withdrawal by Subject|0|||
146374955|NCT00741260|527875077|FG002|Overall Study|Withdrawal by Subject|0|||
145943494|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146374956|NCT00741260|527875078|FG003|Overall Study|Withdrawal by Subject|0|||
146374957|NCT00741260|527875079|FG004|Overall Study|Withdrawal by Subject|1|||
146374958|NCT00741260|527875080|FG005|Overall Study|Withdrawal by Subject|3|||
146374959|NCT00741260|527875081|FG006|Overall Study|Withdrawal by Subject|1|||
146374960|NCT00741260|527875075|FG000|Overall Study|Physician Decision|1|||
146374961|NCT00741260|527875076|FG001|Overall Study|Physician Decision|1|||
146374962|NCT00741260|527875077|FG002|Overall Study|Physician Decision|0|||
146374963|NCT00741260|527875078|FG003|Overall Study|Physician Decision|0|||
146374964|NCT00741260|527875079|FG004|Overall Study|Physician Decision|0|||
146374965|NCT00741260|527875080|FG005|Overall Study|Physician Decision|0|||
146374966|NCT00741260|527875081|FG006|Overall Study|Physician Decision|0|||
146374967|NCT00741260|527875075|FG000|Overall Study|Other|2|||
146374968|NCT00741260|527875076|FG001|Overall Study|Other|1|||
146374969|NCT00741260|527875077|FG002|Overall Study|Other|1|||
146374970|NCT00741260|527875078|FG003|Overall Study|Other|2|||
146374971|NCT00741260|527875079|FG004|Overall Study|Other|1|||
146374972|NCT00741260|527875080|FG005|Overall Study|Other|3|||
146374973|NCT00741260|527875081|FG006|Overall Study|Other|1|||
146374974|NCT02565615|527875082|FG000|Overall Study|Death|0|||
146374975|NCT02565615|527875083|FG001|Overall Study|Death|1|||
146374976|NCT02565615|527875084|FG002|Overall Study|Death|0|||
146374977|NCT02565615|527875085|FG003|Overall Study|Death|0|||
146374978|NCT02565615|527875086|FG004|Overall Study|Death|4|||
146374979|NCT02565615|527875082|FG000|Overall Study|Not willing to participate in study|2|||
146374980|NCT02565615|527875083|FG001|Overall Study|Not willing to participate in study|21|||
146374981|NCT02565615|527875084|FG002|Overall Study|Not willing to participate in study|0|||
146374982|NCT02565615|527875085|FG003|Overall Study|Not willing to participate in study|1|||
146374983|NCT02565615|527875086|FG004|Overall Study|Not willing to participate in study|169|||
146374984|NCT02565615|527875082|FG000|Overall Study|Lost to Follow-up|0|||
146374985|NCT02565615|527875083|FG001|Overall Study|Lost to Follow-up|4|||
146374986|NCT02565615|527875084|FG002|Overall Study|Lost to Follow-up|0|||
146374987|NCT02565615|527875085|FG003|Overall Study|Lost to Follow-up|1|||
146374988|NCT02565615|527875086|FG004|Overall Study|Lost to Follow-up|765|||
146374989|NCT02565615|527875082|FG000|Overall Study|Not meeting eligibility criteria|0|||
146374990|NCT02565615|527875083|FG001|Overall Study|Not meeting eligibility criteria|7|||
146374991|NCT02565615|527875084|FG002|Overall Study|Not meeting eligibility criteria|0|||
146374992|NCT02565615|527875085|FG003|Overall Study|Not meeting eligibility criteria|0|||
146374993|NCT02565615|527875086|FG004|Overall Study|Not meeting eligibility criteria|25|||
146374994|NCT02565615|527875082|FG000|Overall Study|Reason not defined|0|||
146374995|NCT02565615|527875083|FG001|Overall Study|Reason not defined|2|||
146374996|NCT02565615|527875084|FG002|Overall Study|Reason not defined|0|||
146374997|NCT02565615|527875085|FG003|Overall Study|Reason not defined|1|||
146374998|NCT02565615|527875086|FG004|Overall Study|Reason not defined|62|||
146374999|NCT02565615|527875082|FG000|Overall Study|Adverse Event|1|||
146375000|NCT02565615|527875083|FG001|Overall Study|Adverse Event|1|||
146375001|NCT02565615|527875084|FG002|Overall Study|Adverse Event|0|||
146375002|NCT02565615|527875085|FG003|Overall Study|Adverse Event|0|||
146375003|NCT02565615|527875086|FG004|Overall Study|Adverse Event|9|||
146375004|NCT02565615|527875082|FG000|Overall Study|Untreated|0|||
146375005|NCT02565615|527875083|FG001|Overall Study|Untreated|0|||
146375006|NCT02565615|527875084|FG002|Overall Study|Untreated|0|||
146375007|NCT02565615|527875085|FG003|Overall Study|Untreated|0|||
146375008|NCT02565615|527875086|FG004|Overall Study|Untreated|567|||
146375009|NCT00924729|527875094|FG000|Overall Study|insufficient volume for analysis|1|||
146375010|NCT00924729|527875095|FG001|Overall Study|insufficient volume for analysis|0|||
146375011|NCT00924729|527875094|FG000|Overall Study|Protocol Violation|1|||
146375012|NCT00924729|527875095|FG001|Overall Study|Protocol Violation|0|||
146375013|NCT03034057|527875100|FG000|Overall Study|Withdrawal by Subject|10|||
146375014|NCT03034057|527875100|FG000|Overall Study|Protocol Violation|1|||
146375015|NCT03034057|527875100|FG000|Overall Study|Not defined|2|||
146375016|NCT03034057|527875100|FG000|Overall Study|Lost to Follow-up|19|||
146375017|NCT03034057|527875100|FG000|Overall Study|Adverse Event|22|||
146375018|NCT03034057|527875100|FG000|Overall Study|Medication error without associated AE|1|||
146375019|NCT01814826|527875101|FG000|Overall Study|Other|3|||
146375020|NCT01814826|527875102|FG001|Overall Study|Other|5|||
146375021|NCT01814826|527875103|FG002|Overall Study|Other|0|||
146375022|NCT01814826|527875101|FG000|Overall Study|Death|29|||
146375023|NCT01814826|527875102|FG001|Overall Study|Death|24|||
146375024|NCT01814826|527875103|FG002|Overall Study|Death|3|||
146375025|NCT02917629|527875104|FG000|Overall Study|Withdrawal by Subject|0|||
146375026|NCT02917629|527875105|FG001|Overall Study|Withdrawal by Subject|1|||
146375027|NCT03339401|527875106|FG000|Overall Study|Death|2|||
146375028|NCT03339401|527875107|FG001|Overall Study|Death|1|||
146375029|NCT03339401|527875106|FG000|Overall Study|Withdrawal by Subject|2|||
146375030|NCT03339401|527875107|FG001|Overall Study|Withdrawal by Subject|0|||
146375031|NCT03339401|527875106|FG000|Overall Study|Study terminated|4|||
146375032|NCT03339401|527875107|FG001|Overall Study|Study terminated|3|||
146375033|NCT03339401|527875106|FG000|Overall Study|Investigator Decision|1|||
146375034|NCT03339401|527875107|FG001|Overall Study|Investigator Decision|0|||
146375035|NCT00718523|527875108|FG000|Overall Study|Withdrawal by Subject|5|||
146375036|NCT00718523|527875109|FG001|Overall Study|Withdrawal by Subject|7|||
146375037|NCT00718523|527875108|FG000|Overall Study|Death|13|||
146375038|NCT00718523|527875109|FG001|Overall Study|Death|17|||
146375039|NCT03271307|527875110|FG000|Overall Study|Lost to Follow-up|0|||
146375040|NCT03271307|527875111|FG001|Overall Study|Lost to Follow-up|0|||
146375041|NCT03271307|527875112|FG002|Overall Study|Lost to Follow-up|0|||
146375042|NCT03271307|527875113|FG003|Overall Study|Lost to Follow-up|28|||
146375043|NCT03271307|527875114|FG004|Overall Study|Lost to Follow-up|91|||
146375044|NCT01042938|527875115|FG000|Overall Study|Withdrawal by Subject|1|||
146375045|NCT01042938|527875116|FG001|Overall Study|Withdrawal by Subject|1|||
146375046|NCT01042938|527875115|FG000|Overall Study|Protocol Violation|1|||
146375047|NCT01042938|527875116|FG001|Overall Study|Protocol Violation|1|||
146375048|NCT01042938|527875115|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
146375049|NCT01042938|527875116|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
146375050|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
146375051|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
146375052|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
146375053|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
146375054|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
146375055|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146375056|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146375057|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146375058|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
146375059|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
146375060|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146375061|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146375062|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146375063|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
146375064|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
146375065|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146375066|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146375067|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146375068|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
146375069|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
146375070|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146375071|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146375072|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146375073|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
146375074|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
146375075|NCT00856986|527875117|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
146375076|NCT00856986|527875118|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
146375077|NCT00856986|527875119|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
146375078|NCT00856986|527875120|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
146375079|NCT00856986|527875121|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
146375080|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
146375081|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
146375082|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
146375083|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
146375084|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
146375085|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
146375086|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
146375087|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
146375088|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
146375089|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
146375090|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
146375091|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146375092|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
146375093|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146375094|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
146375095|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
146375096|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
146375097|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
146375098|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
146375099|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
146375100|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
146375101|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
146375102|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146375103|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146375104|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
146375105|NCT00856986|527875117|FG000|Main Period, Weeks 0-26|Unclassified|7|||
146375106|NCT00856986|527875118|FG001|Main Period, Weeks 0-26|Unclassified|6|||
146375107|NCT00856986|527875119|FG002|Main Period, Weeks 0-26|Unclassified|7|||
146375108|NCT00856986|527875120|FG003|Main Period, Weeks 0-26|Unclassified|0|||
146375109|NCT00856986|527875121|FG004|Main Period, Weeks 0-26|Unclassified|0|||
146375110|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
146375111|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
146375112|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
146375113|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
146375114|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
146375115|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
146375116|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
146375117|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
146375118|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
146375119|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
146375120|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
146375121|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146375122|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
146375123|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146375124|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
146375125|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146375126|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
146375127|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
146375128|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146375129|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
146375130|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
146375131|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
146375132|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
146375133|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
146375134|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
146375135|NCT00856986|527875117|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
146375136|NCT00856986|527875118|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
146375137|NCT00856986|527875119|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
146375138|NCT00856986|527875120|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
146375139|NCT00856986|527875121|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
146375140|NCT03032510|527875122|FG000|Overall Study|Adverse Event|5|||
146375141|NCT03032510|527875123|FG001|Overall Study|Adverse Event|2|||
146375142|NCT03032510|527875122|FG000|Overall Study|Lost to Follow-up|8|||
146375143|NCT03032510|527875123|FG001|Overall Study|Lost to Follow-up|7|||
146375144|NCT03032510|527875122|FG000|Overall Study|Withdrawal by Subject|8|||
146375145|NCT03032510|527875123|FG001|Overall Study|Withdrawal by Subject|7|||
146375146|NCT03032510|527875122|FG000|Overall Study|Subject noncompliance|4|||
146375147|NCT03032510|527875123|FG001|Overall Study|Subject noncompliance|2|||
146375148|NCT03032510|527875122|FG000|Overall Study|Physician Decision|2|||
146375149|NCT03032510|527875123|FG001|Overall Study|Physician Decision|0|||
146375150|NCT05041062|527875126|FG000|Overall Study|Adverse Event|2|||
146375151|NCT04018612|527875127|FG000|Overall Study|Withdrawal by Subject|1|||
146375152|NCT04018612|527875128|FG001|Overall Study|Withdrawal by Subject|0|||
146375153|NCT04018612|527875129|FG002|Overall Study|Withdrawal by Subject|1|||
146375154|NCT02671760|527875131|FG000|Overall Study|Lost to Follow-up|0|||
146375155|NCT02671760|527875132|FG001|Overall Study|Lost to Follow-up|1|||
146375156|NCT02671760|527875133|FG002|Overall Study|Lost to Follow-up|0|||
146375157|NCT02999191|527875134|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
146375158|NCT02999191|527875135|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
146375159|NCT02999191|527875136|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
146375160|NCT01802515|527875146|FG000|Overall Study|Withdrawal by Subject|3|||
146375161|NCT01802515|527875147|FG001|Overall Study|Withdrawal by Subject|0|||
146375162|NCT01802515|527875148|FG002|Overall Study|Withdrawal by Subject|0|||
146375163|NCT02566109|527875149|FG000|Overall Study|Withdrawal by Subject|1|||
146375164|NCT01906476|527875150|FG000|Overall Study|Lost to Follow-up|17|||
146375165|NCT01906476|527875151|FG001|Overall Study|Lost to Follow-up|16|||
146375166|NCT01041404|527875157|FG000|Overall Study|Adverse Event|45|||
146375167|NCT01041404|527875158|FG001|Overall Study|Adverse Event|35|||
146375168|NCT01041404|527875157|FG000|Overall Study|Lack of Efficacy|200|||
146375169|NCT01041404|527875158|FG001|Overall Study|Lack of Efficacy|210|||
146375170|NCT01041404|527875157|FG000|Overall Study|Violation of Selection Criteria|0|||
146375171|NCT01041404|527875158|FG001|Overall Study|Violation of Selection Criteria|1|||
146375172|NCT01041404|527875157|FG000|Overall Study|Protocol Violation|4|||
146375173|NCT01041404|527875158|FG001|Overall Study|Protocol Violation|0|||
146375174|NCT01041404|527875157|FG000|Overall Study|Withdrawal by Subject|29|||
146375175|NCT01041404|527875158|FG001|Overall Study|Withdrawal by Subject|23|||
146375176|NCT01041404|527875157|FG000|Overall Study|Failure to Return|1|||
146375177|NCT01041404|527875158|FG001|Overall Study|Failure to Return|2|||
146375178|NCT01041404|527875157|FG000|Overall Study|Other|11|||
146375179|NCT01041404|527875158|FG001|Overall Study|Other|23|||
146375180|NCT01993667|527875159|FG000|Overall Study|Insufficient data to analyze|16|||
146375181|NCT01993667|527875160|FG001|Overall Study|Insufficient data to analyze|16|||
146375182|NCT01993667|527875159|FG000|Overall Study|Insufficient altitude reached|3|||
146375183|NCT01993667|527875160|FG001|Overall Study|Insufficient altitude reached|1|||
146375184|NCT01993667|527875159|FG000|Overall Study|Lost to Follow-up|2|||
146375185|NCT01993667|527875160|FG001|Overall Study|Lost to Follow-up|2|||
146375186|NCT01931150|527875161|FG000|Overall Study|Withdrawal by Subject|1|||
146375187|NCT01931150|527875162|FG001|Overall Study|Withdrawal by Subject|2|||
146375188|NCT01685203|527875163|FG000|Overall Study|Lost to Follow-up|3|||
146375189|NCT01685203|527875164|FG001|Overall Study|Lost to Follow-up|3|||
146375190|NCT01685203|527875165|FG002|Overall Study|Lost to Follow-up|0|||
146375191|NCT01685203|527875166|FG003|Overall Study|Lost to Follow-up|1|||
146375192|NCT01685203|527875167|FG004|Overall Study|Lost to Follow-up|0|||
146375193|NCT01685203|527875168|FG005|Overall Study|Lost to Follow-up|0|||
146375194|NCT01685203|527875169|FG006|Overall Study|Lost to Follow-up|0|||
146375195|NCT01685203|527875163|FG000|Overall Study|Adverse Event|0|||
146375196|NCT01685203|527875164|FG001|Overall Study|Adverse Event|0|||
146375197|NCT01685203|527875165|FG002|Overall Study|Adverse Event|0|||
146375198|NCT01685203|527875166|FG003|Overall Study|Adverse Event|0|||
146375199|NCT01685203|527875167|FG004|Overall Study|Adverse Event|0|||
146375200|NCT01685203|527875168|FG005|Overall Study|Adverse Event|2|||
146375201|NCT01685203|527875169|FG006|Overall Study|Adverse Event|0|||
146375202|NCT01685203|527875163|FG000|Overall Study|Adverse event and withdrew consent|1|||
146375203|NCT01685203|527875164|FG001|Overall Study|Adverse event and withdrew consent|0|||
146375204|NCT01685203|527875165|FG002|Overall Study|Adverse event and withdrew consent|0|||
146375205|NCT01685203|527875166|FG003|Overall Study|Adverse event and withdrew consent|0|||
146375206|NCT01685203|527875167|FG004|Overall Study|Adverse event and withdrew consent|0|||
146375207|NCT01685203|527875168|FG005|Overall Study|Adverse event and withdrew consent|0|||
146375208|NCT01685203|527875169|FG006|Overall Study|Adverse event and withdrew consent|0|||
146375209|NCT01685203|527875163|FG000|Overall Study|Patient's decision|0|||
146375210|NCT01685203|527875164|FG001|Overall Study|Patient's decision|0|||
146375211|NCT01685203|527875165|FG002|Overall Study|Patient's decision|0|||
146375212|NCT01685203|527875166|FG003|Overall Study|Patient's decision|0|||
146375213|NCT01685203|527875167|FG004|Overall Study|Patient's decision|0|||
146375214|NCT01685203|527875168|FG005|Overall Study|Patient's decision|1|||
146375215|NCT01685203|527875169|FG006|Overall Study|Patient's decision|0|||
146375216|NCT00383708|527875170|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
146375217|NCT00383708|527875170|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
146375218|NCT00383708|527875170|FG000|Run-in Period|Protocol Violation|4|||
146375219|NCT00383708|527875170|FG000|Run-in Period|Adverse Event|2|||
146375220|NCT00383708|527875170|FG000|Run-in Period|Claustrophobia|1|||
146375221|NCT00383708|527875170|FG000|Co-administration Period|Adverse Event|5|||
146375222|NCT01750840|527875173|FG000|Overall Study|Lost to Follow-up|4|||
146375223|NCT01997281|527875174|FG000|Overall Study|Withdrawal by Subject|1|||
146375224|NCT01997281|527875175|FG001|Overall Study|Withdrawal by Subject|0|||
146375225|NCT03619837|527875176|FG000|Screening|received organs from HCV-negative donors|47|||
146375226|NCT03619837|527875176|FG000|Screening|died on the wait-list|2|||
146375227|NCT03619837|527875176|FG000|Screening|remained on the wait list|40|||
146375228|NCT03619837|527875176|FG000|Screening|didn't meet eligibility criteria|3|||
146375229|NCT03619837|527875176|FG000|Screening|withdrew consent|2|||
146375230|NCT03619837|527875176|FG000|Screening|never listed for HCV-viremic donor|1|||
146375231|NCT03619837|527875176|FG000|Screening|developed exclusion criteria|2|||
146375232|NCT03619837|527875176|FG000|Screening|excluded by the investigator due to non-compliance|1|||
146375233|NCT00981682|527875180|FG000|Overall Study|Adverse Event|48|||
146375234|NCT00981682|527875180|FG000|Overall Study|Withdrawal by Subject|52|||
146375235|NCT00981682|527875180|FG000|Overall Study|Lost to Follow-up|14|||
146375236|NCT00981682|527875180|FG000|Overall Study|Lack of Efficacy|13|||
146375237|NCT00981682|527875180|FG000|Overall Study|Protocol Violation|6|||
146375238|NCT00981682|527875180|FG000|Overall Study|administrative|9|||
146375239|NCT01696396|527876871|FG000|Overall Study|Withdrawal by Subject|19|||
146375240|NCT01696396|527876872|FG001|Overall Study|Withdrawal by Subject|5|||
146375241|NCT01696396|527876873|FG002|Overall Study|Withdrawal by Subject|19|||
146375242|NCT01696396|527876874|FG003|Overall Study|Withdrawal by Subject|11|||
146375243|NCT01696396|527876871|FG000|Overall Study|Decision by Sponsor|3|||
146375244|NCT01696396|527876872|FG001|Overall Study|Decision by Sponsor|1|||
146375245|NCT01696396|527876873|FG002|Overall Study|Decision by Sponsor|2|||
146375246|NCT01696396|527876874|FG003|Overall Study|Decision by Sponsor|2|||
146375247|NCT01696396|527876871|FG000|Overall Study|Lost to Follow-up|9|||
146375248|NCT01696396|527876872|FG001|Overall Study|Lost to Follow-up|1|||
146375249|NCT01696396|527876873|FG002|Overall Study|Lost to Follow-up|4|||
146375250|NCT01696396|527876874|FG003|Overall Study|Lost to Follow-up|1|||
146375251|NCT01696396|527876871|FG000|Overall Study|Death|0|||
146375252|NCT01696396|527876872|FG001|Overall Study|Death|0|||
146375253|NCT01696396|527876873|FG002|Overall Study|Death|1|||
146375254|NCT01696396|527876874|FG003|Overall Study|Death|0|||
146375255|NCT00608894|527876875|FG000|Overall Study|Withdrawal by Subject|0|||
146375256|NCT00608894|527876876|FG001|Overall Study|Withdrawal by Subject|2|||
146375257|NCT03654560|527876877|FG000|Overall Study|Death|3|||
146375258|NCT03654560|527876878|FG001|Overall Study|Death|1|||
146375259|NCT03654560|527876877|FG000|Overall Study|Lost to Follow-up|1|||
146375260|NCT03654560|527876878|FG001|Overall Study|Lost to Follow-up|0|||
146375261|NCT03938636|527876879|FG000|Overall Study|Protocol Violation|0|||
146375262|NCT03938636|527876880|FG001|Overall Study|Protocol Violation|1|||
146375263|NCT03938636|527876881|FG002|Overall Study|Protocol Violation|1|||
146375264|NCT03938636|527876879|FG000|Overall Study|Subject withdrew due to death in family|0|||
146375265|NCT03938636|527876880|FG001|Overall Study|Subject withdrew due to death in family|1|||
146375266|NCT03938636|527876881|FG002|Overall Study|Subject withdrew due to death in family|0|||
146375267|NCT03938636|527876879|FG000|Overall Study|Missed visit|0|||
146375268|NCT03938636|527876880|FG001|Overall Study|Missed visit|1|||
146375269|NCT03938636|527876881|FG002|Overall Study|Missed visit|0|||
146375270|NCT03938636|527876879|FG000|Overall Study|Adverse Event|0|||
146375271|NCT03938636|527876880|FG001|Overall Study|Adverse Event|0|||
146375272|NCT03938636|527876881|FG002|Overall Study|Adverse Event|1|||
146375273|NCT03938636|527876879|FG000|Overall Study|Lost to Follow-up|0|||
146375274|NCT03938636|527876880|FG001|Overall Study|Lost to Follow-up|0|||
146375275|NCT03938636|527876881|FG002|Overall Study|Lost to Follow-up|1|||
146375276|NCT01518309|527876882|FG000|Overall Study|Adverse Event|6|||
146375277|NCT01518309|527876882|FG000|Overall Study|Death|6|||
146375278|NCT01518309|527876882|FG000|Overall Study|Lack of Efficacy|7|||
146375279|NCT01518309|527876882|FG000|Overall Study|Withdrawal by Subject|6|||
146375280|NCT01518309|527876882|FG000|Overall Study|Physician Decision|3|||
146375281|NCT01518309|527876882|FG000|Overall Study|Sponsor Decision|2|||
146375282|NCT01518309|527876882|FG000|Overall Study|Not in Predefined Categories|9|||
146375283|NCT00863317|527876883|FG000|Overall Study|Lost to Follow-up|8|||
146375284|NCT00863317|527876884|FG001|Overall Study|Lost to Follow-up|9|||
146375285|NCT02579863|527876885|FG000|Overall Study|Final Disposition Unknown|2|||
146375286|NCT02579863|527876886|FG001|Overall Study|Final Disposition Unknown|1|||
146375287|NCT02579863|527876885|FG000|Overall Study|Adverse Event|18|||
146375288|NCT02579863|527876886|FG001|Overall Study|Adverse Event|11|||
146375289|NCT02579863|527876885|FG000|Overall Study|Death|31|||
146375290|NCT02579863|527876886|FG001|Overall Study|Death|29|||
146375291|NCT02579863|527876885|FG000|Overall Study|Lost to Follow-up|2|||
146375292|NCT02579863|527876886|FG001|Overall Study|Lost to Follow-up|1|||
146375293|NCT02579863|527876885|FG000|Overall Study|Physician Decision|1|||
146375294|NCT02579863|527876886|FG001|Overall Study|Physician Decision|2|||
146375295|NCT02579863|527876885|FG000|Overall Study|Screen Failure|0|||
146375296|NCT02579863|527876886|FG001|Overall Study|Screen Failure|2|||
146375297|NCT02579863|527876885|FG000|Overall Study|Study Terminated at Selected Sites|82|||
146375298|NCT02579863|527876886|FG001|Overall Study|Study Terminated at Selected Sites|88|||
146375299|NCT02579863|527876885|FG000|Overall Study|Withdrawal by Subject|20|||
146375300|NCT02579863|527876886|FG001|Overall Study|Withdrawal by Subject|20|||
146375301|NCT00216086|527876889|FG000|Overall Study|Protocol Violation|1|||
146375302|NCT00216086|527876889|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
146375303|NCT00216086|527876889|FG000|Overall Study|Social Reasons|2|||
146375304|NCT00038142|527876890|FG000|Overall Study|Ineligible|1|||
146375305|NCT00038142|527876891|FG001|Overall Study|Ineligible|0|||
146375306|NCT00038142|527876890|FG000|Overall Study|Progressive Disease|11|||
146375307|NCT00038142|527876891|FG001|Overall Study|Progressive Disease|7|||
146375308|NCT00038142|527876890|FG000|Overall Study|Death|1|||
146375309|NCT00038142|527876891|FG001|Overall Study|Death|0|||
146375310|NCT00038142|527876890|FG000|Overall Study|Adverse Event|1|||
146375311|NCT00038142|527876891|FG001|Overall Study|Adverse Event|0|||
146375312|NCT00038142|527876890|FG000|Overall Study|Unknown Reason|8|||
146375313|NCT00038142|527876891|FG001|Overall Study|Unknown Reason|0|||
146375314|NCT00809614|527876892|FG000|Overall Study|Lack of Efficacy|2|||
146375315|NCT00809614|527876893|FG001|Overall Study|Lack of Efficacy|3|||
146375316|NCT00809614|527876892|FG000|Overall Study|Withdrawal by Subject|1|||
146375317|NCT00809614|527876893|FG001|Overall Study|Withdrawal by Subject|1|||
146375318|NCT01080625|527876894|FG000|Overall Study|Physician Decision|0|||
146375319|NCT01080625|527876895|FG001|Overall Study|Physician Decision|2|||
146375320|NCT01080625|527876896|FG002|Overall Study|Physician Decision|1|||
146375321|NCT00446797|527876897|FG000|Overall Study|Lack of Efficacy|0|||
146375322|NCT00446797|527876898|FG001|Overall Study|Lack of Efficacy|2|||
146375323|NCT00446797|527876897|FG000|Overall Study|Lost to Follow-up|5|||
146375324|NCT00446797|527876898|FG001|Overall Study|Lost to Follow-up|3|||
146375325|NCT00446797|527876897|FG000|Overall Study|Withdrawal by Subject|2|||
146375326|NCT00446797|527876898|FG001|Overall Study|Withdrawal by Subject|2|||
146375327|NCT00446797|527876897|FG000|Overall Study|Protocol Violation|1|||
146375328|NCT00446797|527876898|FG001|Overall Study|Protocol Violation|3|||
146375329|NCT00446797|527876897|FG000|Overall Study|subject entered at another site|0|||
146375330|NCT00446797|527876898|FG001|Overall Study|subject entered at another site|1|||
146375331|NCT00446797|527876897|FG000|Overall Study|did not meet entrance criteria|0|||
146375332|NCT00446797|527876898|FG001|Overall Study|did not meet entrance criteria|1|||
146375333|NCT00364832|527876901|FG000|Core Period|Early Withdrawals|2|||
146375334|NCT00364832|527876902|FG001|Core Period|Early Withdrawals|2|||
146375335|NCT00364832|527876903|FG002|Core Period|Early Withdrawals|1|||
146375336|NCT00364832|527876904|FG003|Core Period|Early Withdrawals|1|||
146375337|NCT00364832|527876905|FG004|Core Period|Early Withdrawals|0|||
146375338|NCT00364832|527876906|FG005|Core Period|Early Withdrawals|0|||
146375339|NCT00364832|527876907|FG006|Core Period|Early Withdrawals|4|||
146375340|NCT00364832|527876908|FG007|Core Period|Early Withdrawals|1|||
146375341|NCT00364832|527876909|FG008|Core Period|Early Withdrawals|0|||
146375342|NCT00364832|527876910|FG009|Core Period|Early Withdrawals|0|||
146375343|NCT00364832|527876911|FG010|Core Period|Early Withdrawals|0|||
146375344|NCT00364832|527876912|FG011|Core Period|Early Withdrawals|0|||
146375345|NCT00364832|527876901|FG000|Extension Year 1|Early Withdrawals|0|||
146375346|NCT00364832|527876902|FG001|Extension Year 1|Early Withdrawals|0|||
146375347|NCT00364832|527876903|FG002|Extension Year 1|Early Withdrawals|0|||
146375348|NCT00364832|527876904|FG003|Extension Year 1|Early Withdrawals|0|||
146375349|NCT00364832|527876905|FG004|Extension Year 1|Early Withdrawals|0|||
146375350|NCT00364832|527876906|FG005|Extension Year 1|Early Withdrawals|0|||
146375351|NCT00364832|527876907|FG006|Extension Year 1|Early Withdrawals|0|||
146375352|NCT00364832|527876908|FG007|Extension Year 1|Early Withdrawals|0|||
146375353|NCT00364832|527876909|FG008|Extension Year 1|Early Withdrawals|0|||
146375354|NCT00364832|527876910|FG009|Extension Year 1|Early Withdrawals|4|||
146375355|NCT00364832|527876911|FG010|Extension Year 1|Early Withdrawals|2|||
146375356|NCT00364832|527876912|FG011|Extension Year 1|Early Withdrawals|10|||
146375357|NCT00364832|527876901|FG000|Extension Year 2|Early Withdrawals|0|||
146375358|NCT00364832|527876902|FG001|Extension Year 2|Early Withdrawals|0|||
146375359|NCT00364832|527876903|FG002|Extension Year 2|Early Withdrawals|0|||
146375360|NCT00364832|527876904|FG003|Extension Year 2|Early Withdrawals|0|||
146375361|NCT00364832|527876905|FG004|Extension Year 2|Early Withdrawals|0|||
146375362|NCT00364832|527876906|FG005|Extension Year 2|Early Withdrawals|0|||
146375363|NCT00364832|527876907|FG006|Extension Year 2|Early Withdrawals|0|||
146375364|NCT00364832|527876908|FG007|Extension Year 2|Early Withdrawals|0|||
146375365|NCT00364832|527876909|FG008|Extension Year 2|Early Withdrawals|0|||
146375366|NCT00364832|527876910|FG009|Extension Year 2|Early Withdrawals|5|||
146375367|NCT00364832|527876911|FG010|Extension Year 2|Early Withdrawals|5|||
146375368|NCT00364832|527876912|FG011|Extension Year 2|Early Withdrawals|3|||
146375369|NCT01440972|527876921|FG000|Overall Study|Withdrawal by Subject|3|||
146375370|NCT01440972|527876922|FG001|Overall Study|Withdrawal by Subject|2|||
146375371|NCT03933215|527876923|FG000|Overall Study|Other|6|||
146375372|NCT03933215|527876923|FG000|Overall Study|Sponsor decision|5|||
146375373|NCT03933215|527876923|FG000|Overall Study|Protocol Violation|5|||
146375374|NCT03933215|527876923|FG000|Overall Study|Withdrawal by Subject|6|||
146375375|NCT03933215|527876923|FG000|Overall Study|Lost to Follow-up|6|||
146375376|NCT03933215|527876923|FG000|Overall Study|Enrolled but not treated|38|||
146375377|NCT00407550|527876924|FG000|Overall Study|Adverse Event|0|||
146375378|NCT00407550|527876925|FG001|Overall Study|Adverse Event|1|||
146375379|NCT00407550|527876924|FG000|Overall Study|Withdrawal by Subject|0|||
146375380|NCT00407550|527876925|FG001|Overall Study|Withdrawal by Subject|2|||
146375381|NCT00407550|527876924|FG000|Overall Study|Death|1|||
146375382|NCT00407550|527876925|FG001|Overall Study|Death|0|||
146375383|NCT00407550|527876924|FG000|Overall Study|Insurance or Other medical condition|2|||
146375384|NCT00407550|527876925|FG001|Overall Study|Insurance or Other medical condition|1|||
146375385|NCT01266070|527876926|FG000|Overall Study|Adverse Event|3|||
146375386|NCT01266070|527876926|FG000|Overall Study|Protocol Violation|1|||
146375387|NCT01838213|527876927|FG000|Overall Study|Ineligible|166|||
146375388|NCT01838213|527876928|FG001|Overall Study|Ineligible|191|||
146375389|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
146375390|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
146375391|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
146375392|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
146375393|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
146375394|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146375395|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146375396|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146375397|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
146375398|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
146375399|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146375400|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146375401|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146375402|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
146375403|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
146375404|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
146375405|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
146375406|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146375407|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146375408|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
146375409|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146375410|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146375411|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146375412|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
146375413|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
146375414|NCT02918318|527876929|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
146375415|NCT02918318|527876930|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
146375416|NCT02918318|527876931|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
146375417|NCT02918318|527876932|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
146375418|NCT02918318|527876933|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
146375419|NCT02918318|527876929|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146375420|NCT02918318|527876930|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146375421|NCT02918318|527876931|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146375422|NCT02918318|527876932|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
146375423|NCT02918318|527876933|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
146375424|NCT02918318|527876929|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146375425|NCT02918318|527876930|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375426|NCT02918318|527876931|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146375427|NCT02918318|527876932|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
146375428|NCT02918318|527876933|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375429|NCT02918318|527876929|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
146375430|NCT02918318|527876930|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146375431|NCT02918318|527876931|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146375432|NCT02918318|527876932|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
146375433|NCT02918318|527876933|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
146375434|NCT02918318|527876929|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
146375435|NCT02918318|527876930|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
146375436|NCT02918318|527876931|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
146375437|NCT02918318|527876932|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
146375438|NCT02918318|527876933|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
146375439|NCT02918318|527876929|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146375440|NCT02918318|527876930|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146375441|NCT02918318|527876931|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146375442|NCT02918318|527876932|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
146375443|NCT02918318|527876933|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
146375444|NCT02918318|527876929|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375445|NCT02918318|527876930|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375446|NCT02918318|527876931|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375447|NCT02918318|527876932|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
146375448|NCT02918318|527876933|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
146375449|NCT03185819|527876934|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146375450|NCT03185819|527876935|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146375451|NCT03185819|527876936|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
146375452|NCT03185819|527876937|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
146375453|NCT03185819|527876934|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
146375454|NCT03185819|527876935|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
146375455|NCT03185819|527876936|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
146375456|NCT03185819|527876937|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
146375457|NCT03185819|527876934|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
146375458|NCT03185819|527876935|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146375459|NCT03185819|527876936|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146375460|NCT03185819|527876937|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
146375461|NCT03185819|527876934|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
146375462|NCT03185819|527876935|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
146375463|NCT03185819|527876936|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
146375464|NCT03185819|527876937|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
146375465|NCT03185819|527876934|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146375466|NCT03185819|527876935|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146375467|NCT03185819|527876936|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
146375468|NCT03185819|527876937|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
146375469|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
146375470|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
146375471|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
146375472|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
146375473|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
146375474|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
146375475|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
146375476|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
146375477|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146375478|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
146375479|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146375480|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
146375481|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
146375482|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146375483|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146375484|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
146375485|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
146395877|NCT00869362|527952397|FG000|Overall Study|Death|0|||
146375486|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
146375487|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
146375488|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
146375489|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
146375490|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
146375491|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
146375492|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
146375493|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
146375494|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
146375495|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
146375496|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
146375497|NCT03185819|527876934|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
146375498|NCT03185819|527876935|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146375499|NCT03185819|527876936|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146375500|NCT03185819|527876937|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
146375501|NCT03097133|527876938|FG000|Overall Study|Lost to Follow-up|3|||
146375502|NCT03097133|527876939|FG001|Overall Study|Lost to Follow-up|2|||
146375503|NCT03097133|527876938|FG000|Overall Study|Withdrawal by Subject|2|||
146375504|NCT03097133|527876939|FG001|Overall Study|Withdrawal by Subject|5|||
146375505|NCT03097133|527876938|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
146375506|NCT03097133|527876939|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
146375507|NCT03097133|527876938|FG000|Overall Study|Other|3|||
146375508|NCT03097133|527876939|FG001|Overall Study|Other|2|||
146375509|NCT03097133|527876938|FG000|Overall Study|Adverse Event|1|||
146375510|NCT03097133|527876939|FG001|Overall Study|Adverse Event|0|||
146375511|NCT02910089|527876942|FG000|Overall Study|Lost insurance eligibility|22|||
146375512|NCT02910089|527876943|FG001|Overall Study|Lost insurance eligibility|16|||
146375513|NCT02939976|527876944|FG000|Overall Study|Lost to Follow-up|7|||
146375514|NCT02939976|527876945|FG001|Overall Study|Lost to Follow-up|1|||
146375515|NCT02939976|527876946|FG002|Overall Study|Lost to Follow-up|1|||
146375516|NCT02939976|527876947|FG003|Overall Study|Lost to Follow-up|2|||
146375517|NCT02939976|527876944|FG000|Overall Study|Withdrawal by Subject|4|||
146375518|NCT02939976|527876945|FG001|Overall Study|Withdrawal by Subject|0|||
146375519|NCT02939976|527876946|FG002|Overall Study|Withdrawal by Subject|2|||
146375520|NCT02939976|527876947|FG003|Overall Study|Withdrawal by Subject|4|||
146375521|NCT02939976|527876944|FG000|Overall Study|Due to early study closure|4|||
146375522|NCT02939976|527876945|FG001|Overall Study|Due to early study closure|3|||
146375523|NCT02939976|527876946|FG002|Overall Study|Due to early study closure|2|||
146375524|NCT02939976|527876947|FG003|Overall Study|Due to early study closure|3|||
146375525|NCT04080752|527876948|FG000|Overall Study|Adverse Event|2|||
146375526|NCT04080752|527876949|FG001|Overall Study|Adverse Event|3|||
146375527|NCT04080752|527876948|FG000|Overall Study|Lack of Efficacy|1|||
146375528|NCT04080752|527876949|FG001|Overall Study|Lack of Efficacy|0|||
146375529|NCT04080752|527876948|FG000|Overall Study|Lost to Follow-up|1|||
146375530|NCT04080752|527876949|FG001|Overall Study|Lost to Follow-up|0|||
146375531|NCT04080752|527876948|FG000|Overall Study|Pregnancy|0|||
146375532|NCT04080752|527876949|FG001|Overall Study|Pregnancy|1|||
146375533|NCT04080752|527876948|FG000|Overall Study|Withdrawal by Subject|7|||
146375534|NCT04080752|527876949|FG001|Overall Study|Withdrawal by Subject|0|||
146375535|NCT04080752|527876948|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146375536|NCT04080752|527876949|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146375537|NCT04080752|527876948|FG000|Overall Study|Other|2|||
146375538|NCT04080752|527876949|FG001|Overall Study|Other|1|||
146375539|NCT01585168|527876950|FG000|Overall Study|Lost to Follow-up|3|||
146375540|NCT01585168|527876951|FG001|Overall Study|Lost to Follow-up|1|||
146375541|NCT01585168|527876952|FG002|Overall Study|Lost to Follow-up|1|||
146375542|NCT01585168|527876953|FG003|Overall Study|Lost to Follow-up|1|||
146375543|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
146375544|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
146375545|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
146375546|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
146375547|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
146375548|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
146375549|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
146375550|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
146375551|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
146375552|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
146375553|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
146375554|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
146375555|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146375556|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
146395878|NCT00869362|527952398|FG001|Overall Study|Death|2|||
146375557|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146375558|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
146375559|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
146375560|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
146375561|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
146375562|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
146375563|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
146375564|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
146375565|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
146375566|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
146375567|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Other|0|||
146375568|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Other|1|||
146375569|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Other|0|||
146375570|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Other|0|||
146375571|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
146375572|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
146375573|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
146375574|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
146375575|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
146375576|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
146375577|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
146375578|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
146375579|NCT01194414|527876954|FG000|24 Weeks Double Blind Period|Death|0|||
146375580|NCT01194414|527876955|FG001|24 Weeks Double Blind Period|Death|1|||
146375581|NCT01194414|527876956|FG002|24 Weeks Double Blind Period|Death|0|||
146375582|NCT01194414|527876957|FG003|24 Weeks Double Blind Period|Death|0|||
146375583|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
146375584|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
146375585|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
146375586|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
146375587|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
146375588|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
146375589|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
146375590|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
146375591|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
146375592|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
146375593|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
146375594|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
146375595|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
146375596|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
146375597|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
146375598|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
146375599|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
146375600|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
146375601|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
146375602|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
146375603|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
146375604|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
146375605|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
146375606|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
146375607|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Other|2|||
146375608|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Other|1|||
146375609|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Other|0|||
146375610|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Other|0|||
146375611|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
146375612|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
146375613|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
146375614|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
146375615|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
146375616|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
146375617|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
146375618|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
146375619|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
146375620|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
146375621|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
145943495|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146375622|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
146375623|NCT01194414|527876954|FG000|72 Weeks Open Label Extension|Death|1|||
146375624|NCT01194414|527876955|FG001|72 Weeks Open Label Extension|Death|2|||
146375625|NCT01194414|527876956|FG002|72 Weeks Open Label Extension|Death|0|||
146375626|NCT01194414|527876957|FG003|72 Weeks Open Label Extension|Death|2|||
146375627|NCT02977507|527876959|FG000|Overall Study|Protocol Deviation|1|||
146375628|NCT02977507|527876960|FG001|Overall Study|Protocol Deviation|0|||
146375629|NCT02977507|527876959|FG000|Overall Study|Lost to Follow-up|1|||
146375630|NCT02977507|527876960|FG001|Overall Study|Lost to Follow-up|0|||
146375631|NCT00481988|527876961|FG000|Overall Study|Withdrawal by Subject|1|||
146375632|NCT00481988|527876962|FG001|Overall Study|Withdrawal by Subject|1|||
146375633|NCT00654420|527876963|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
146375634|NCT00654420|527876964|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
146375635|NCT00654420|527876965|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
146375636|NCT00654420|527876966|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
146375637|NCT00654420|527876963|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
146375638|NCT00654420|527876964|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
146375639|NCT00654420|527876965|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
146375640|NCT00654420|527876966|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
146375641|NCT00654420|527876963|FG000|Phase II|Adverse Event|0|||
146375642|NCT00654420|527876964|FG001|Phase II|Adverse Event|0|||
146375643|NCT00654420|527876965|FG002|Phase II|Adverse Event|3|||
146375644|NCT00654420|527876966|FG003|Phase II|Adverse Event|3|||
146375645|NCT00654420|527876963|FG000|Phase II|Lost to Follow-up|0|||
146375646|NCT00654420|527876964|FG001|Phase II|Lost to Follow-up|0|||
146375647|NCT00654420|527876965|FG002|Phase II|Lost to Follow-up|0|||
146375648|NCT00654420|527876966|FG003|Phase II|Lost to Follow-up|1|||
146375649|NCT00654420|527876963|FG000|Phase II|Physician Decision|0|||
146375650|NCT00654420|527876964|FG001|Phase II|Physician Decision|0|||
146375651|NCT00654420|527876965|FG002|Phase II|Physician Decision|0|||
146375652|NCT00654420|527876966|FG003|Phase II|Physician Decision|4|||
146375653|NCT00654420|527876963|FG000|Phase II|Progressive Disease|0|||
146375654|NCT00654420|527876964|FG001|Phase II|Progressive Disease|0|||
146375655|NCT00654420|527876965|FG002|Phase II|Progressive Disease|29|||
146375656|NCT00654420|527876966|FG003|Phase II|Progressive Disease|29|||
146375657|NCT00654420|527876963|FG000|Phase II|Withdrawal by Subject|0|||
146375658|NCT00654420|527876964|FG001|Phase II|Withdrawal by Subject|0|||
146375659|NCT00654420|527876965|FG002|Phase II|Withdrawal by Subject|4|||
146375660|NCT00654420|527876966|FG003|Phase II|Withdrawal by Subject|1|||
146375661|NCT00654420|527876963|FG000|Phase II|Missing Disposition Record|0|||
146375662|NCT00654420|527876964|FG001|Phase II|Missing Disposition Record|0|||
146375663|NCT00654420|527876965|FG002|Phase II|Missing Disposition Record|1|||
146375664|NCT00654420|527876966|FG003|Phase II|Missing Disposition Record|0|||
146375665|NCT05563714|527876988|FG000|Overall Study|Death|2|||
146375666|NCT05563714|527876989|FG001|Overall Study|Death|2|||
146375667|NCT05563714|527876990|FG002|Overall Study|Death|0|||
146375668|NCT05563714|527876991|FG003|Overall Study|Death|0|||
146375669|NCT05563714|527876988|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
146375670|NCT05563714|527876989|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
146375671|NCT05563714|527876990|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
146375672|NCT05563714|527876991|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
146375673|NCT05563714|527876988|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
146375674|NCT05563714|527876989|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
146375675|NCT05563714|527876990|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
146375676|NCT05563714|527876991|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
146375677|NCT05563714|527876988|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146375678|NCT05563714|527876989|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
146375679|NCT05563714|527876990|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146375680|NCT05563714|527876991|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
146375681|NCT05563714|527876988|FG000|Overall Study|Lost to Follow-up|22|||
146375682|NCT05563714|527876989|FG001|Overall Study|Lost to Follow-up|19|||
146375683|NCT05563714|527876990|FG002|Overall Study|Lost to Follow-up|0|||
146375684|NCT05563714|527876991|FG003|Overall Study|Lost to Follow-up|0|||
146375685|NCT02427100|527876995|FG000|Overall Study|Lost to Follow-up|0|||
146375686|NCT02427100|527876996|FG001|Overall Study|Lost to Follow-up|2|||
146375687|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
146375688|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
146375689|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
146375690|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
146375691|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
146375692|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
146375693|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
146395879|NCT00869362|527952397|FG000|Overall Study|Lost to Follow-up|1|||
146375694|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
146375695|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375696|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375697|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375698|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375699|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375700|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
146375701|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
146375702|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
146375703|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
146375704|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
146375705|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
146375706|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
146375707|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
146375708|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
146375709|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375710|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375711|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375712|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375713|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375714|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
146375715|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
146375716|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375717|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375718|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375719|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375720|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375721|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
146375722|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
146375723|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375724|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375725|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375726|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375727|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375728|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
146375729|NCT02120352|527876999|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
146375730|NCT02120352|527877000|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
146375731|NCT02120352|527877001|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
146375732|NCT02120352|527877002|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
146375733|NCT02120352|527877003|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
146375734|NCT02120352|527877004|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
146375735|NCT02120352|527877005|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
146375736|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146375737|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
146375738|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
146375739|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
146375740|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146375741|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146375742|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
146375743|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146375744|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
146375745|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146375746|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
146375747|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146375748|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146375749|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
146375750|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146375751|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
146375752|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
146375753|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146375754|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146375755|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146375756|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
146375757|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146375758|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146375759|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
146375760|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
146375761|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146375762|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146375763|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
146375764|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375765|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375766|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375767|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
146375768|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375769|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375770|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
146375771|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146375772|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
146375773|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
146375774|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
146375775|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146375776|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146375777|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
146375778|NCT02120352|527876999|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375779|NCT02120352|527877000|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
146375780|NCT02120352|527877001|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375781|NCT02120352|527877002|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375782|NCT02120352|527877003|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375783|NCT02120352|527877004|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375784|NCT02120352|527877005|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
146375785|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146375786|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
146375787|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
146375788|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146375789|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
146375790|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
146375791|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
146375792|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375793|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375794|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375795|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375796|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
146375797|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375798|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
146375799|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146375800|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
146375801|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
146375802|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146375803|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
146375804|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146375805|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
146375806|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146375807|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
146375808|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
146375809|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146375810|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
146375811|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146375812|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
146375813|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146375814|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
146375815|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
146375816|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146375817|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
146375818|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146375819|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
146375820|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146375821|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
146375822|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
146375823|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145943496|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146375824|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146375825|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146375826|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
146375827|NCT02120352|527876999|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
146375828|NCT02120352|527877000|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
146375829|NCT02120352|527877001|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
146375830|NCT02120352|527877002|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
146375831|NCT02120352|527877003|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
146375832|NCT02120352|527877004|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
146375833|NCT02120352|527877005|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
146375834|NCT02120352|527876999|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375835|NCT02120352|527877000|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375836|NCT02120352|527877001|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375837|NCT02120352|527877002|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375838|NCT02120352|527877003|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375839|NCT02120352|527877004|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
146375840|NCT02120352|527877005|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
146375841|NCT01610206|527877006|FG000|Overall Study|Adverse Event|10|||
146375842|NCT01610206|527877007|FG001|Overall Study|Adverse Event|30|||
146375843|NCT00196196|527877010|FG000|Overall Study|Withdrawal by Subject|2|||
146375844|NCT00196196|527877010|FG000|Overall Study|Did not have required condition (hydroce|5|||
146375845|NCT00910728|527877011|FG000|Overall Study|Lack of Efficacy|2|||
146375846|NCT00910728|527877012|FG001|Overall Study|Lack of Efficacy|3|||
146375847|NCT00910728|527877013|FG002|Overall Study|Lack of Efficacy|1|||
146375848|NCT00910728|527877014|FG003|Overall Study|Lack of Efficacy|2|||
146375849|NCT00910728|527877015|FG004|Overall Study|Lack of Efficacy|1|||
146375850|NCT00910728|527877016|FG005|Overall Study|Lack of Efficacy|0|||
146375851|NCT00910728|527877017|FG006|Overall Study|Lack of Efficacy|2|||
146375852|NCT00910728|527877018|FG007|Overall Study|Lack of Efficacy|2|||
146375853|NCT00910728|527877019|FG008|Overall Study|Lack of Efficacy|2|||
146375854|NCT00910728|527877011|FG000|Overall Study|Withdrawal by Subject|0|||
146375855|NCT00910728|527877012|FG001|Overall Study|Withdrawal by Subject|0|||
146375856|NCT00910728|527877013|FG002|Overall Study|Withdrawal by Subject|0|||
146375857|NCT00910728|527877014|FG003|Overall Study|Withdrawal by Subject|0|||
146375858|NCT00910728|527877015|FG004|Overall Study|Withdrawal by Subject|3|||
146375859|NCT00910728|527877016|FG005|Overall Study|Withdrawal by Subject|1|||
146375860|NCT00910728|527877017|FG006|Overall Study|Withdrawal by Subject|2|||
146375861|NCT00910728|527877018|FG007|Overall Study|Withdrawal by Subject|0|||
146375862|NCT00910728|527877019|FG008|Overall Study|Withdrawal by Subject|0|||
146375863|NCT00910728|527877011|FG000|Overall Study|(not specified)|2|||
146375864|NCT00910728|527877012|FG001|Overall Study|(not specified)|0|||
146375865|NCT00910728|527877013|FG002|Overall Study|(not specified)|1|||
146375866|NCT00910728|527877014|FG003|Overall Study|(not specified)|0|||
146375867|NCT00910728|527877015|FG004|Overall Study|(not specified)|1|||
146375868|NCT00910728|527877016|FG005|Overall Study|(not specified)|0|||
146375869|NCT00910728|527877017|FG006|Overall Study|(not specified)|0|||
146375870|NCT00910728|527877018|FG007|Overall Study|(not specified)|0|||
146375871|NCT00910728|527877019|FG008|Overall Study|(not specified)|0|||
146375872|NCT00910728|527877011|FG000|Overall Study|Adverse Event|2|||
146375873|NCT00910728|527877012|FG001|Overall Study|Adverse Event|0|||
146375874|NCT00910728|527877013|FG002|Overall Study|Adverse Event|1|||
146375875|NCT00910728|527877014|FG003|Overall Study|Adverse Event|1|||
146375876|NCT00910728|527877015|FG004|Overall Study|Adverse Event|0|||
146375877|NCT00910728|527877016|FG005|Overall Study|Adverse Event|0|||
146375878|NCT00910728|527877017|FG006|Overall Study|Adverse Event|2|||
146375879|NCT00910728|527877018|FG007|Overall Study|Adverse Event|1|||
146375880|NCT00910728|527877019|FG008|Overall Study|Adverse Event|1|||
146375881|NCT03997760|527877020|FG000|Overall Study|Protocol Deviation|0|||
146375882|NCT03997760|527877021|FG001|Overall Study|Protocol Deviation|1|||
146375883|NCT03997760|527877022|FG002|Overall Study|Protocol Deviation|0|||
146375884|NCT03997760|527877023|FG003|Overall Study|Protocol Deviation|0|||
146375885|NCT01915095|527877024|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
146375886|NCT01915095|527877025|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
146375887|NCT01915095|527877026|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
146375888|NCT01915095|527877027|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
146375889|NCT01915095|527877028|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
146375890|NCT00361218|527877029|FG000|Overall Study|Lost to Follow-up|11|||
146375891|NCT00361218|527877029|FG000|Overall Study|Personal Reasons|7|||
146375892|NCT00361218|527877029|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
146375893|NCT04968353|527877032|FG000|Overall Study|Non-compliance|1|||
146375894|NCT04968353|527877033|FG001|Overall Study|Non-compliance|0|||
146375895|NCT04968353|527877034|FG002|Overall Study|Non-compliance|2|||
146375896|NCT04968353|527877035|FG003|Overall Study|Non-compliance|0|||
146375897|NCT02896192|527877036|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
146375898|NCT02896192|527877036|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
146375899|NCT02896192|527877036|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
146375900|NCT00318370|527877037|FG000|Period 1|Lack of Efficacy|5|||
146375901|NCT00318370|527877038|FG001|Period 1|Lack of Efficacy|0|||
146375902|NCT00318370|527877039|FG002|Period 1|Lack of Efficacy|0|||
146375903|NCT00318370|527877037|FG000|Period 1|Physician Decision|1|||
146375904|NCT00318370|527877038|FG001|Period 1|Physician Decision|0|||
146375905|NCT00318370|527877039|FG002|Period 1|Physician Decision|0|||
146375906|NCT00318370|527877037|FG000|Period 1|Withdrawal by Subject|1|||
146375907|NCT00318370|527877038|FG001|Period 1|Withdrawal by Subject|0|||
146375908|NCT00318370|527877039|FG002|Period 1|Withdrawal by Subject|0|||
146375909|NCT00318370|527877037|FG000|Period 2|Adverse Event|0|||
146375910|NCT00318370|527877038|FG001|Period 2|Adverse Event|3|||
146375911|NCT00318370|527877039|FG002|Period 2|Adverse Event|0|||
146375912|NCT00318370|527877037|FG000|Period 2|Lack of Efficacy|0|||
146375913|NCT00318370|527877038|FG001|Period 2|Lack of Efficacy|5|||
146375914|NCT00318370|527877039|FG002|Period 2|Lack of Efficacy|0|||
146375915|NCT00318370|527877037|FG000|Period 2|Physician Decision|0|||
146375916|NCT00318370|527877038|FG001|Period 2|Physician Decision|1|||
146375917|NCT00318370|527877039|FG002|Period 2|Physician Decision|0|||
146375918|NCT00318370|527877037|FG000|Period 2|Withdrawal by Subject|0|||
146375919|NCT00318370|527877038|FG001|Period 2|Withdrawal by Subject|1|||
146375920|NCT00318370|527877039|FG002|Period 2|Withdrawal by Subject|0|||
146375921|NCT00318370|527877037|FG000|Period 2|Other|0|||
146375922|NCT00318370|527877038|FG001|Period 2|Other|1|||
146375923|NCT00318370|527877039|FG002|Period 2|Other|0|||
146375924|NCT00318370|527877037|FG000|Period 3|Adverse Event|0|||
146375925|NCT00318370|527877038|FG001|Period 3|Adverse Event|0|||
146375926|NCT00318370|527877039|FG002|Period 3|Adverse Event|1|||
146375927|NCT00318370|527877037|FG000|Period 3|Lack of Efficacy|0|||
146375928|NCT00318370|527877038|FG001|Period 3|Lack of Efficacy|0|||
146375929|NCT00318370|527877039|FG002|Period 3|Lack of Efficacy|24|||
146375930|NCT00318370|527877037|FG000|Period 3|Death|0|||
146375931|NCT00318370|527877038|FG001|Period 3|Death|0|||
146375932|NCT00318370|527877039|FG002|Period 3|Death|1|||
146375933|NCT00318370|527877037|FG000|Period 3|Physician Decision|0|||
146375934|NCT00318370|527877038|FG001|Period 3|Physician Decision|0|||
146375935|NCT00318370|527877039|FG002|Period 3|Physician Decision|1|||
146375936|NCT00318370|527877037|FG000|Period 3|Withdrawal by Subject|0|||
146375937|NCT00318370|527877038|FG001|Period 3|Withdrawal by Subject|0|||
146375938|NCT00318370|527877039|FG002|Period 3|Withdrawal by Subject|3|||
146375939|NCT00318370|527877037|FG000|Period 3|Other|0|||
146375940|NCT00318370|527877038|FG001|Period 3|Other|0|||
146375941|NCT00318370|527877039|FG002|Period 3|Other|3|||
146375942|NCT00880607|527877045|FG000|Overall Study|Physician Decision|2|||
146375943|NCT00880607|527877046|FG001|Overall Study|Physician Decision|2|||
146375944|NCT00880607|527877045|FG000|Overall Study|Protocol Violation|2|||
146375945|NCT00880607|527877046|FG001|Overall Study|Protocol Violation|1|||
146375946|NCT00880607|527877045|FG000|Overall Study|surgery did not extend past L1 level|3|||
146375947|NCT00880607|527877046|FG001|Overall Study|surgery did not extend past L1 level|0|||
146375948|NCT02712008|527878718|FG000|Baseline (Day 1) up to Week 12|Death|3|||
146375949|NCT02712008|527878719|FG001|Baseline (Day 1) up to Week 12|Death|0|||
146375950|NCT02712008|527878720|FG002|Baseline (Day 1) up to Week 12|Death|0|||
146375951|NCT02712008|527878721|FG003|Baseline (Day 1) up to Week 12|Death|0|||
146375952|NCT02712008|527878722|FG004|Baseline (Day 1) up to Week 12|Death|0|||
146375953|NCT02712008|527878723|FG005|Baseline (Day 1) up to Week 12|Death|0|||
146375954|NCT02712008|527878724|FG006|Baseline (Day 1) up to Week 12|Death|0|||
146375955|NCT02712008|527878725|FG007|Baseline (Day 1) up to Week 12|Death|0|||
146375956|NCT02712008|527878718|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375957|NCT02712008|527878719|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
146375958|NCT02712008|527878720|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
146375959|NCT02712008|527878721|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375960|NCT02712008|527878722|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375961|NCT02712008|527878723|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375962|NCT02712008|527878724|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375963|NCT02712008|527878725|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
146375964|NCT02712008|527878718|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
146375965|NCT02712008|527878719|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375966|NCT02712008|527878720|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
146375967|NCT02712008|527878721|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375968|NCT02712008|527878722|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375969|NCT02712008|527878723|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375970|NCT02712008|527878724|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375971|NCT02712008|527878725|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
146375972|NCT02712008|527878718|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375973|NCT02712008|527878719|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375974|NCT02712008|527878720|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
146375975|NCT02712008|527878721|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146395880|NCT00869362|527952398|FG001|Overall Study|Lost to Follow-up|3|||
146375976|NCT02712008|527878722|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375977|NCT02712008|527878723|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375978|NCT02712008|527878724|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375979|NCT02712008|527878725|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
146375980|NCT02712008|527878718|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375981|NCT02712008|527878719|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
146375982|NCT02712008|527878720|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375983|NCT02712008|527878721|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375984|NCT02712008|527878722|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375985|NCT02712008|527878723|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375986|NCT02712008|527878724|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375987|NCT02712008|527878725|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
146375988|NCT02712008|527878718|FG000|From Week 12 up to Week 36|Adverse Event|0|||
146375989|NCT02712008|527878719|FG001|From Week 12 up to Week 36|Adverse Event|0|||
146375990|NCT02712008|527878720|FG002|From Week 12 up to Week 36|Adverse Event|0|||
146375991|NCT02712008|527878721|FG003|From Week 12 up to Week 36|Adverse Event|0|||
146375992|NCT02712008|527878722|FG004|From Week 12 up to Week 36|Adverse Event|1|||
146375993|NCT02712008|527878723|FG005|From Week 12 up to Week 36|Adverse Event|0|||
146375994|NCT02712008|527878724|FG006|From Week 12 up to Week 36|Adverse Event|0|||
146375995|NCT02712008|527878725|FG007|From Week 12 up to Week 36|Adverse Event|2|||
146375996|NCT02712008|527878718|FG000|From Week 12 up to Week 36|Death|1|||
146375997|NCT02712008|527878719|FG001|From Week 12 up to Week 36|Death|0|||
146375998|NCT02712008|527878720|FG002|From Week 12 up to Week 36|Death|0|||
146375999|NCT02712008|527878721|FG003|From Week 12 up to Week 36|Death|0|||
146376000|NCT02712008|527878722|FG004|From Week 12 up to Week 36|Death|0|||
146376001|NCT02712008|527878723|FG005|From Week 12 up to Week 36|Death|0|||
146376002|NCT02712008|527878724|FG006|From Week 12 up to Week 36|Death|1|||
146376003|NCT02712008|527878725|FG007|From Week 12 up to Week 36|Death|0|||
146376004|NCT02712008|527878718|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376005|NCT02712008|527878719|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376006|NCT02712008|527878720|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376007|NCT02712008|527878721|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
146376008|NCT02712008|527878722|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376009|NCT02712008|527878723|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376010|NCT02712008|527878724|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
146376011|NCT02712008|527878725|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
146376012|NCT02712008|527878718|FG000|From Week 12 up to Week 36|Physician Decision|0|||
146376013|NCT02712008|527878719|FG001|From Week 12 up to Week 36|Physician Decision|0|||
146376014|NCT02712008|527878720|FG002|From Week 12 up to Week 36|Physician Decision|0|||
146376015|NCT02712008|527878721|FG003|From Week 12 up to Week 36|Physician Decision|1|||
146376016|NCT02712008|527878722|FG004|From Week 12 up to Week 36|Physician Decision|1|||
146376017|NCT02712008|527878723|FG005|From Week 12 up to Week 36|Physician Decision|0|||
146376018|NCT02712008|527878724|FG006|From Week 12 up to Week 36|Physician Decision|0|||
146376019|NCT02712008|527878725|FG007|From Week 12 up to Week 36|Physician Decision|0|||
146376020|NCT02712008|527878718|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376021|NCT02712008|527878719|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376022|NCT02712008|527878720|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376023|NCT02712008|527878721|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376024|NCT02712008|527878722|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376025|NCT02712008|527878723|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
146376026|NCT02712008|527878724|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
146376027|NCT02712008|527878725|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
146376028|NCT01731990|527878726|FG000|Overall Study|Adverse Event|1|||
146376029|NCT01731990|527878727|FG001|Overall Study|Adverse Event|5|||
146376030|NCT01731990|527878726|FG000|Overall Study|Withdrawal by Subject|1|||
146376031|NCT01731990|527878727|FG001|Overall Study|Withdrawal by Subject|1|||
146376032|NCT01731990|527878726|FG000|Overall Study|Protocol deviation|1|||
146376033|NCT01731990|527878727|FG001|Overall Study|Protocol deviation|2|||
146376034|NCT01731990|527878726|FG000|Overall Study|Death|1|||
146376035|NCT01731990|527878727|FG001|Overall Study|Death|0|||
146376036|NCT01131078|527878736|FG000|Overall Study|Adverse Event|22|||
146376037|NCT01131078|527878737|FG001|Overall Study|Adverse Event|12|||
146376038|NCT01131078|527878738|FG002|Overall Study|Adverse Event|17|||
146376039|NCT01131078|527878736|FG000|Overall Study|Progressive Disease|58|||
146376040|NCT01131078|527878737|FG001|Overall Study|Progressive Disease|77|||
146376041|NCT01131078|527878738|FG002|Overall Study|Progressive Disease|71|||
146376042|NCT01131078|527878736|FG000|Overall Study|Protocol Violation|1|||
146376043|NCT01131078|527878737|FG001|Overall Study|Protocol Violation|0|||
146376044|NCT01131078|527878738|FG002|Overall Study|Protocol Violation|0|||
146376045|NCT01131078|527878736|FG000|Overall Study|Lost to Follow-up|1|||
146376046|NCT01131078|527878737|FG001|Overall Study|Lost to Follow-up|1|||
146376047|NCT01131078|527878738|FG002|Overall Study|Lost to Follow-up|1|||
146376048|NCT01131078|527878736|FG000|Overall Study|Withdrawal by Subject|2|||
146376049|NCT01131078|527878737|FG001|Overall Study|Withdrawal by Subject|4|||
146376050|NCT01131078|527878738|FG002|Overall Study|Withdrawal by Subject|3|||
146376051|NCT01131078|527878736|FG000|Overall Study|Non-compliance|3|||
146376052|NCT01131078|527878737|FG001|Overall Study|Non-compliance|0|||
146376053|NCT01131078|527878738|FG002|Overall Study|Non-compliance|0|||
146376054|NCT01131078|527878736|FG000|Overall Study|Physician Decision|10|||
146376055|NCT01131078|527878737|FG001|Overall Study|Physician Decision|6|||
146376056|NCT01131078|527878738|FG002|Overall Study|Physician Decision|8|||
146376057|NCT01131078|527878736|FG000|Overall Study|Death|4|||
146376058|NCT01131078|527878737|FG001|Overall Study|Death|0|||
146376059|NCT01131078|527878738|FG002|Overall Study|Death|2|||
146376060|NCT01131078|527878736|FG000|Overall Study|Other|0|||
146376061|NCT01131078|527878737|FG001|Overall Study|Other|1|||
146376062|NCT01131078|527878738|FG002|Overall Study|Other|0|||
146376063|NCT04315298|527878739|FG000|Overall Study|Withdrawal by Subject|0|||
146376064|NCT04315298|527878740|FG001|Overall Study|Withdrawal by Subject|0|||
146376065|NCT04315298|527878741|FG002|Overall Study|Withdrawal by Subject|0|||
146376066|NCT04315298|527878742|FG003|Overall Study|Withdrawal by Subject|2|||
146376067|NCT04315298|527878743|FG004|Overall Study|Withdrawal by Subject|2|||
146376068|NCT04315298|527878744|FG005|Overall Study|Withdrawal by Subject|2|||
146376069|NCT04315298|527878745|FG006|Overall Study|Withdrawal by Subject|0|||
146376070|NCT04315298|527878746|FG007|Overall Study|Withdrawal by Subject|1|||
146376071|NCT04315298|527878747|FG008|Overall Study|Withdrawal by Subject|1|||
146376072|NCT04315298|527878748|FG009|Overall Study|Withdrawal by Subject|1|||
146376073|NCT04315298|527878749|FG010|Overall Study|Withdrawal by Subject|0|||
146376074|NCT04315298|527878750|FG011|Overall Study|Withdrawal by Subject|0|||
146376075|NCT04315298|527878751|FG012|Overall Study|Withdrawal by Subject|0|||
146376076|NCT04315298|527878752|FG013|Overall Study|Withdrawal by Subject|0|||
146376077|NCT04315298|527878753|FG014|Overall Study|Withdrawal by Subject|0|||
146376078|NCT04315298|527878754|FG015|Overall Study|Withdrawal by Subject|0|||
146376079|NCT04315298|527878755|FG016|Overall Study|Withdrawal by Subject|0|||
146376080|NCT04315298|527878756|FG017|Overall Study|Withdrawal by Subject|0|||
146376081|NCT04315298|527878757|FG018|Overall Study|Withdrawal by Subject|0|||
146376082|NCT04315298|527878739|FG000|Overall Study|Physician Decision|0|||
146376083|NCT04315298|527878740|FG001|Overall Study|Physician Decision|0|||
146376084|NCT04315298|527878741|FG002|Overall Study|Physician Decision|0|||
146376085|NCT04315298|527878742|FG003|Overall Study|Physician Decision|0|||
146376086|NCT04315298|527878743|FG004|Overall Study|Physician Decision|1|||
146376087|NCT04315298|527878744|FG005|Overall Study|Physician Decision|0|||
146376088|NCT04315298|527878745|FG006|Overall Study|Physician Decision|0|||
146376089|NCT04315298|527878746|FG007|Overall Study|Physician Decision|0|||
146376090|NCT04315298|527878747|FG008|Overall Study|Physician Decision|0|||
146376091|NCT04315298|527878748|FG009|Overall Study|Physician Decision|0|||
146376092|NCT04315298|527878749|FG010|Overall Study|Physician Decision|0|||
146376093|NCT04315298|527878750|FG011|Overall Study|Physician Decision|0|||
146376094|NCT04315298|527878751|FG012|Overall Study|Physician Decision|0|||
146376095|NCT04315298|527878752|FG013|Overall Study|Physician Decision|0|||
146376096|NCT04315298|527878753|FG014|Overall Study|Physician Decision|0|||
146376097|NCT04315298|527878754|FG015|Overall Study|Physician Decision|0|||
146376098|NCT04315298|527878755|FG016|Overall Study|Physician Decision|0|||
146376099|NCT04315298|527878756|FG017|Overall Study|Physician Decision|0|||
146376100|NCT04315298|527878757|FG018|Overall Study|Physician Decision|0|||
146376101|NCT04315298|527878739|FG000|Overall Study|Lost to Follow-up|5|||
146376102|NCT04315298|527878740|FG001|Overall Study|Lost to Follow-up|10|||
146376103|NCT04315298|527878741|FG002|Overall Study|Lost to Follow-up|6|||
146376104|NCT04315298|527878742|FG003|Overall Study|Lost to Follow-up|8|||
146376105|NCT04315298|527878743|FG004|Overall Study|Lost to Follow-up|12|||
146376106|NCT04315298|527878744|FG005|Overall Study|Lost to Follow-up|13|||
146376107|NCT04315298|527878745|FG006|Overall Study|Lost to Follow-up|9|||
146376108|NCT04315298|527878746|FG007|Overall Study|Lost to Follow-up|16|||
146376109|NCT04315298|527878747|FG008|Overall Study|Lost to Follow-up|14|||
146376110|NCT04315298|527878748|FG009|Overall Study|Lost to Follow-up|0|||
146376111|NCT04315298|527878749|FG010|Overall Study|Lost to Follow-up|2|||
146376112|NCT04315298|527878750|FG011|Overall Study|Lost to Follow-up|1|||
146376113|NCT04315298|527878751|FG012|Overall Study|Lost to Follow-up|0|||
146376114|NCT04315298|527878752|FG013|Overall Study|Lost to Follow-up|0|||
146376115|NCT04315298|527878753|FG014|Overall Study|Lost to Follow-up|0|||
146376116|NCT04315298|527878754|FG015|Overall Study|Lost to Follow-up|2|||
146376117|NCT04315298|527878755|FG016|Overall Study|Lost to Follow-up|0|||
146376118|NCT04315298|527878756|FG017|Overall Study|Lost to Follow-up|0|||
146376119|NCT04315298|527878757|FG018|Overall Study|Lost to Follow-up|0|||
146376120|NCT04315298|527878739|FG000|Overall Study|Death|24|||
146376121|NCT04315298|527878740|FG001|Overall Study|Death|60|||
146376122|NCT04315298|527878741|FG002|Overall Study|Death|49|||
146376123|NCT04315298|527878742|FG003|Overall Study|Death|59|||
146376124|NCT04315298|527878743|FG004|Overall Study|Death|70|||
146376125|NCT04315298|527878744|FG005|Overall Study|Death|114|||
146376126|NCT04315298|527878745|FG006|Overall Study|Death|9|||
146376127|NCT04315298|527878746|FG007|Overall Study|Death|12|||
146376128|NCT04315298|527878747|FG008|Overall Study|Death|21|||
146376129|NCT04315298|527878748|FG009|Overall Study|Death|16|||
146376130|NCT04315298|527878749|FG010|Overall Study|Death|40|||
146376131|NCT04315298|527878750|FG011|Overall Study|Death|40|||
146376132|NCT04315298|527878751|FG012|Overall Study|Death|3|||
146376133|NCT04315298|527878752|FG013|Overall Study|Death|4|||
146376134|NCT04315298|527878753|FG014|Overall Study|Death|6|||
146376135|NCT04315298|527878754|FG015|Overall Study|Death|4|||
146376136|NCT04315298|527878755|FG016|Overall Study|Death|3|||
146376137|NCT04315298|527878756|FG017|Overall Study|Death|1|||
146376138|NCT04315298|527878757|FG018|Overall Study|Death|0|||
146376139|NCT01199198|527878758|FG000|Overall Study|Adverse Event|3|||
146376140|NCT01199198|527878759|FG001|Overall Study|Adverse Event|0|||
146376141|NCT01199198|527878758|FG000|Overall Study|Lost to Follow-up|1|||
146376142|NCT01199198|527878759|FG001|Overall Study|Lost to Follow-up|5|||
146376143|NCT01199198|527878758|FG000|Overall Study|Withdrawal by Subject|1|||
146376144|NCT01199198|527878759|FG001|Overall Study|Withdrawal by Subject|2|||
146376145|NCT01199198|527878758|FG000|Overall Study|ICU Transfer|1|||
146376146|NCT01199198|527878759|FG001|Overall Study|ICU Transfer|2|||
146376147|NCT01199198|527878758|FG000|Overall Study|Hospice-care transfer|1|||
146376148|NCT01199198|527878759|FG001|Overall Study|Hospice-care transfer|2|||
146376149|NCT00736385|527878760|FG000|Overall Study|Withdrawal by Subject|2|||
146376150|NCT00736385|527878761|FG001|Overall Study|Withdrawal by Subject|2|||
146376151|NCT00736385|527878760|FG000|Overall Study|Adverse Event|0|||
146376152|NCT00736385|527878761|FG001|Overall Study|Adverse Event|1|||
146376153|NCT01183104|527878762|FG000|Overall Study|Adverse Event|8|||
146376154|NCT01183104|527878763|FG001|Overall Study|Adverse Event|6|||
146376155|NCT01183104|527878762|FG000|Overall Study|Death|0|||
146376156|NCT01183104|527878763|FG001|Overall Study|Death|1|||
146376157|NCT01183104|527878762|FG000|Overall Study|Lost to Follow-up|14|||
146376158|NCT01183104|527878763|FG001|Overall Study|Lost to Follow-up|7|||
146376159|NCT01183104|527878762|FG000|Overall Study|Physician Decision|5|||
146376160|NCT01183104|527878763|FG001|Overall Study|Physician Decision|8|||
146376161|NCT01183104|527878762|FG000|Overall Study|Withdrawal by Subject|6|||
146376162|NCT01183104|527878763|FG001|Overall Study|Withdrawal by Subject|11|||
146376163|NCT01183104|527878762|FG000|Overall Study|Nonparticipation in Extension Study|39|||
146376164|NCT01183104|527878763|FG001|Overall Study|Nonparticipation in Extension Study|50|||
146376165|NCT01183104|527878762|FG000|Overall Study|Did not receive study drug|5|||
146376166|NCT01183104|527878763|FG001|Overall Study|Did not receive study drug|9|||
146376167|NCT03267511|527878764|FG000|Overall Study|Lost to Follow-up|0|||
146376168|NCT03267511|527878765|FG001|Overall Study|Lost to Follow-up|0|||
146376169|NCT03267511|527878766|FG002|Overall Study|Lost to Follow-up|0|||
146376170|NCT03267511|527878767|FG003|Overall Study|Lost to Follow-up|1|||
146376171|NCT01594749|527878768|FG000|Overall Study|Adverse Event|2|||
146376172|NCT01594749|527878769|FG001|Overall Study|Adverse Event|1|||
146376173|NCT01594749|527878768|FG000|Overall Study|Withdrawal by Subject|2|||
146376174|NCT01594749|527878769|FG001|Overall Study|Withdrawal by Subject|2|||
146376175|NCT01594749|527878768|FG000|Overall Study|Protocol Violation|2|||
146376176|NCT01594749|527878769|FG001|Overall Study|Protocol Violation|0|||
146376177|NCT01594749|527878768|FG000|Overall Study|Physician Decision|1|||
146376178|NCT01594749|527878769|FG001|Overall Study|Physician Decision|1|||
146376179|NCT01594749|527878768|FG000|Overall Study|Non-compliance with Protocol|0|||
146376180|NCT01594749|527878769|FG001|Overall Study|Non-compliance with Protocol|1|||
146376181|NCT01594749|527878768|FG000|Overall Study|Lost to Follow-up|1|||
146376182|NCT01594749|527878769|FG001|Overall Study|Lost to Follow-up|0|||
146376183|NCT01594749|527878768|FG000|Overall Study|Death|9|||
146376184|NCT01594749|527878769|FG001|Overall Study|Death|3|||
146376185|NCT01594749|527878768|FG000|Overall Study|Not Treated|4|||
146376186|NCT01594749|527878769|FG001|Overall Study|Not Treated|10|||
146376187|NCT01594749|527878768|FG000|Overall Study|Lost Source Documentation|1|||
146376188|NCT01594749|527878769|FG001|Overall Study|Lost Source Documentation|0|||
146376189|NCT00364351|527878770|FG000|Overall Study|Adverse Event|90|||
146376190|NCT00364351|527878771|FG001|Overall Study|Adverse Event|44|||
146376191|NCT00364351|527878770|FG000|Overall Study|Condition under investigation worsened|469|||
146376192|NCT00364351|527878771|FG001|Overall Study|Condition under investigation worsened|497|||
146376193|NCT00364351|527878770|FG000|Overall Study|Prohibited concomitant medication|0|||
146376194|NCT00364351|527878771|FG001|Overall Study|Prohibited concomitant medication|2|||
146376195|NCT00364351|527878770|FG000|Overall Study|Lost to Follow-up|1|||
146376196|NCT00364351|527878771|FG001|Overall Study|Lost to Follow-up|1|||
146376197|NCT00364351|527878770|FG000|Overall Study|Withdrawal by Subject|30|||
146376198|NCT00364351|527878771|FG001|Overall Study|Withdrawal by Subject|29|||
146376199|NCT00364351|527878770|FG000|Overall Study|Incorrect enrollment|1|||
146376200|NCT00364351|527878771|FG001|Overall Study|Incorrect enrollment|1|||
146376201|NCT00364351|527878770|FG000|Overall Study|Sponsor decision|1|||
146376202|NCT00364351|527878771|FG001|Overall Study|Sponsor decision|0|||
146376203|NCT00364351|527878770|FG000|Overall Study|Poor treatment compliance|0|||
146376204|NCT00364351|527878771|FG001|Overall Study|Poor treatment compliance|3|||
146376205|NCT00364351|527878770|FG000|Overall Study|Investigator error|0|||
146376206|NCT00364351|527878771|FG001|Overall Study|Investigator error|2|||
146376207|NCT00364351|527878770|FG000|Overall Study|Patient could not travel to site|0|||
146376208|NCT00364351|527878771|FG001|Overall Study|Patient could not travel to site|1|||
146376209|NCT00364351|527878770|FG000|Overall Study|Randomised treatment not started|0|||
146376210|NCT00364351|527878771|FG001|Overall Study|Randomised treatment not started|3|||
146376211|NCT00653068|527878772|FG000|Overall Study|Death|9|||
146376212|NCT00653068|527878772|FG000|Overall Study|Lack of Efficacy|34|||
146376213|NCT00653068|527878772|FG000|Overall Study|Physician Decision|4|||
146376214|NCT00653068|527878772|FG000|Overall Study|Withdrawal by Subject|1|||
146376215|NCT00653068|527878772|FG000|Overall Study|Ineligible|2|||
146376216|NCT02177786|527878773|FG000|Overall Study|Withdrew Consent|2|||
146376217|NCT02177786|527878774|FG001|Overall Study|Withdrew Consent|6|||
146376218|NCT02177786|527878775|FG002|Overall Study|Withdrew Consent|9|||
146376219|NCT02177786|527878776|FG003|Overall Study|Withdrew Consent|5|||
146376220|NCT02177786|527878773|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
146376221|NCT02177786|527878774|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
146376222|NCT02177786|527878775|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
146376223|NCT02177786|527878776|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
146376224|NCT02177786|527878773|FG000|Overall Study|Adverse Event|1|||
146376225|NCT02177786|527878774|FG001|Overall Study|Adverse Event|1|||
146376226|NCT02177786|527878775|FG002|Overall Study|Adverse Event|2|||
146376227|NCT02177786|527878776|FG003|Overall Study|Adverse Event|3|||
146376228|NCT02177786|527878773|FG000|Overall Study|Death|1|||
146376229|NCT02177786|527878774|FG001|Overall Study|Death|1|||
146376230|NCT02177786|527878775|FG002|Overall Study|Death|1|||
146376231|NCT02177786|527878776|FG003|Overall Study|Death|1|||
146376232|NCT02177786|527878773|FG000|Overall Study|Lost to Follow-up|0|||
146376233|NCT02177786|527878774|FG001|Overall Study|Lost to Follow-up|0|||
146376234|NCT02177786|527878775|FG002|Overall Study|Lost to Follow-up|2|||
146376235|NCT02177786|527878776|FG003|Overall Study|Lost to Follow-up|2|||
146376236|NCT02177786|527878773|FG000|Overall Study|Non-Compliance with Study Drug|0|||
146376237|NCT02177786|527878774|FG001|Overall Study|Non-Compliance with Study Drug|1|||
146376238|NCT02177786|527878775|FG002|Overall Study|Non-Compliance with Study Drug|0|||
146376239|NCT02177786|527878776|FG003|Overall Study|Non-Compliance with Study Drug|1|||
146376240|NCT02177786|527878773|FG000|Overall Study|Protocol Violation|0|||
146376241|NCT02177786|527878774|FG001|Overall Study|Protocol Violation|0|||
146376242|NCT02177786|527878775|FG002|Overall Study|Protocol Violation|2|||
146376243|NCT02177786|527878776|FG003|Overall Study|Protocol Violation|0|||
146376244|NCT02177786|527878773|FG000|Overall Study|Progressive Disease|0|||
146376245|NCT02177786|527878774|FG001|Overall Study|Progressive Disease|1|||
146376246|NCT02177786|527878775|FG002|Overall Study|Progressive Disease|0|||
146376247|NCT02177786|527878776|FG003|Overall Study|Progressive Disease|0|||
146376248|NCT02177786|527878773|FG000|Overall Study|Missing study completion status|0|||
146376249|NCT02177786|527878774|FG001|Overall Study|Missing study completion status|1|||
146376250|NCT02177786|527878775|FG002|Overall Study|Missing study completion status|0|||
146376251|NCT02177786|527878776|FG003|Overall Study|Missing study completion status|0|||
146376252|NCT01305941|527878777|FG000|Overall Study|Adverse Event|6|||
146376253|NCT01305941|527878777|FG000|Overall Study|Clinical decline|2|||
146376254|NCT01305941|527878777|FG000|Overall Study|Withdrawal by Subject|1|||
146376255|NCT01305941|527878777|FG000|Overall Study|Death|1|||
146376256|NCT03950440|527878778|FG000|Overall Study|Death|8|||
146376257|NCT03950440|527878779|FG001|Overall Study|Death|2|||
146376258|NCT03950440|527878780|FG002|Overall Study|Death|1|||
146376259|NCT02892734|527878781|FG000|Treatment on Study|Progressive Disease|2|||
146376260|NCT02892734|527878781|FG000|Follow up for 2 Years|Death|2|||
146376261|NCT02892734|527878781|FG000|Follow up for 2 Years|Study closed early|1|||
146376262|NCT02043509|527878782|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
146376263|NCT02043509|527878783|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
146376264|NCT02043509|527878782|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
146376265|NCT02043509|527878783|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
146376266|NCT02043509|527878782|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
146376267|NCT02043509|527878783|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
146376268|NCT02043509|527878782|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
146376269|NCT02043509|527878783|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
146376270|NCT00608244|527878788|FG000|Overall Study|Adverse Event|1|||
146376271|NCT00608244|527878788|FG000|Overall Study|Low trough levels|1|||
146376272|NCT01957215|527878793|FG000|Overall Study|Adverse Event|2|||
146376273|NCT01957215|527878794|FG001|Overall Study|Adverse Event|2|||
146376274|NCT01957215|527878793|FG000|Overall Study|Lost to Follow-up|3|||
146376275|NCT01957215|527878794|FG001|Overall Study|Lost to Follow-up|3|||
146376276|NCT01957215|527878793|FG000|Overall Study|Protocol Violation|1|||
146376277|NCT01957215|527878794|FG001|Overall Study|Protocol Violation|2|||
146376278|NCT01957215|527878793|FG000|Overall Study|Withdrawal by Subject|7|||
146376279|NCT01957215|527878794|FG001|Overall Study|Withdrawal by Subject|5|||
146376280|NCT03597503|527878802|FG000|Overall Study|Withdrawal by Subject|0|||
146376281|NCT03597503|527878803|FG001|Overall Study|Withdrawal by Subject|2|||
146376282|NCT03597503|527878802|FG000|Overall Study|Lost to Follow-up|1|||
146376283|NCT03597503|527878803|FG001|Overall Study|Lost to Follow-up|2|||
146376284|NCT03597503|527878802|FG000|Overall Study|Protocol Violation|1|||
146376285|NCT03597503|527878803|FG001|Overall Study|Protocol Violation|0|||
146376286|NCT00688623|527878808|FG000|Overall Study|Adverse Event|22|||
146376287|NCT00688623|527878808|FG000|Overall Study|abnormal lab value|1|||
146376288|NCT00688623|527878808|FG000|Overall Study|Withdrawal by Subject|4|||
146376289|NCT00688623|527878808|FG000|Overall Study|Death|3|||
146376290|NCT00688623|527878808|FG000|Overall Study|disease progression|23|||
146376291|NCT00688623|527878808|FG000|Overall Study|Protocol Violation|2|||
146376292|NCT02000219|527878809|FG000|14-Week Study Period|Physician Decision|1|||
146376293|NCT02000219|527878809|FG000|14-Week Study Period|Adverse Event|1|||
146376294|NCT02000219|527878809|FG000|14-Week Study Period|Underwent transplantation|1|||
146376295|NCT02000219|527878809|FG000|Continuation Period|Withdrawal by Subject|1|||
146376296|NCT02000219|527878809|FG000|Continuation Period|Had liver transplant|2|||
146376297|NCT02000219|527878809|FG000|Continuation Period|Non-compliance with study drug|2|||
146376298|NCT02667236|527878810|FG000|Overall Study|Adverse Event|1|||
146376299|NCT02667236|527878811|FG001|Overall Study|Adverse Event|1|||
146376300|NCT02667236|527878810|FG000|Overall Study|Withdrawal by Subject|2|||
146376301|NCT02667236|527878811|FG001|Overall Study|Withdrawal by Subject|0|||
146376302|NCT00634751|527878816|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
146376303|NCT00634751|527878817|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146376304|NCT00634751|527878818|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146376305|NCT00634751|527878819|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
146376306|NCT00634751|527878816|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146376307|NCT00634751|527878817|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
146376308|NCT00634751|527878818|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146376309|NCT00634751|527878819|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
146376310|NCT00634751|527878816|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
146376311|NCT00634751|527878817|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
146376312|NCT00634751|527878818|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
146376313|NCT00634751|527878819|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
146376314|NCT04402385|527878820|FG000|Overall Study|Withdrawal by Subject|4|||
146376315|NCT04402385|527878821|FG001|Overall Study|Withdrawal by Subject|4|||
146376316|NCT04402385|527878820|FG000|Overall Study|Lost to Follow-up|1|||
146376317|NCT04402385|527878821|FG001|Overall Study|Lost to Follow-up|1|||
146376318|NCT04402385|527878820|FG000|Overall Study|Physician Decision|0|||
146376319|NCT04402385|527878821|FG001|Overall Study|Physician Decision|1|||
146376320|NCT02473289|527878822|FG000|Overall Study|Adverse Event|2|||
146376321|NCT02473289|527878823|FG001|Overall Study|Adverse Event|3|||
146376322|NCT02473289|527878822|FG000|Overall Study|Lost to Follow-up|1|||
146376323|NCT02473289|527878823|FG001|Overall Study|Lost to Follow-up|1|||
146376324|NCT02473289|527878822|FG000|Overall Study|Protocol Violation|0|||
146376325|NCT02473289|527878823|FG001|Overall Study|Protocol Violation|1|||
146376326|NCT02473289|527878822|FG000|Overall Study|Withdrawal of consent|6|||
146376327|NCT02473289|527878823|FG001|Overall Study|Withdrawal of consent|7|||
146376328|NCT02473289|527878822|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
146376329|NCT02473289|527878823|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
146376330|NCT02473289|527878822|FG000|Overall Study|Other|2|||
146376331|NCT02473289|527878823|FG001|Overall Study|Other|0|||
146376332|NCT03745989|527878825|FG000|Overall Study|Death|3|||
146376333|NCT03745989|527878826|FG001|Overall Study|Death|7|||
146376334|NCT03745989|527878827|FG002|Overall Study|Death|4|||
146376335|NCT03745989|527878825|FG000|Overall Study|Lost to Follow-up|0|||
146376336|NCT03745989|527878826|FG001|Overall Study|Lost to Follow-up|2|||
146376337|NCT03745989|527878827|FG002|Overall Study|Lost to Follow-up|0|||
146376338|NCT03745989|527878825|FG000|Overall Study|Sponsor Decision|0|||
146376339|NCT03745989|527878826|FG001|Overall Study|Sponsor Decision|2|||
146376340|NCT03745989|527878827|FG002|Overall Study|Sponsor Decision|8|||
146376341|NCT03745989|527878825|FG000|Overall Study|Withdrawal by Subject|0|||
146376342|NCT03745989|527878826|FG001|Overall Study|Withdrawal by Subject|1|||
146376343|NCT03745989|527878827|FG002|Overall Study|Withdrawal by Subject|3|||
146376344|NCT00732238|527878832|FG000|Overall Study|Bacteremia|4|||
146376345|NCT00732238|527878833|FG001|Overall Study|Bacteremia|1|||
146376346|NCT00732238|527878832|FG000|Overall Study|Asymptomatic bacteriuria|1|||
146376347|NCT00732238|527878833|FG001|Overall Study|Asymptomatic bacteriuria|0|||
146376348|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
146376349|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146376350|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146376351|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
146376352|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
146376353|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146376354|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146376355|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
146376356|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
146376357|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146376358|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146376359|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
146376360|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
146376361|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146376362|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146376363|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
146376364|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
146376365|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146376366|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146376367|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
146376368|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
146376369|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146376370|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146376371|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
146376372|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
146376373|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146376374|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146376375|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
146376376|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
146376377|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146376378|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146376379|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
146376380|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
146376381|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146376382|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146376383|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
146376384|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
146376385|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146376386|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146376387|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
146376388|NCT03605836|527878834|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
146376389|NCT03605836|527878835|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146376390|NCT03605836|527878836|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146376391|NCT03605836|527878837|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
146376392|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
146376393|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
146376394|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
146376395|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
146376396|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
146376397|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
146376398|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
146376399|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
146376400|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
146376401|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
146376402|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
146376403|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
146376404|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
146376405|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
146376406|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
146376407|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
146376408|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
146376409|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
146376410|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
146376411|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
146376412|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146376413|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
146376414|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146376415|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
146376416|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
146376417|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
146376418|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
146376419|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
146376420|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
146376421|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
146376422|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
146376423|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
146376424|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
146376425|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
146376426|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
146376427|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
146376428|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
146376429|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
146376430|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
146376431|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
146376432|NCT03605836|527878834|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
146376433|NCT03605836|527878835|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
146376434|NCT03605836|527878836|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
146376435|NCT03605836|527878837|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
146376436|NCT01929707|527878842|FG000|Intervention Period 1|Lost to Follow-up|0|||
146376437|NCT01929707|527878843|FG001|Intervention Period 1|Lost to Follow-up|0|||
146376438|NCT01929707|527878844|FG002|Intervention Period 1|Lost to Follow-up|0|||
146376439|NCT01929707|527878845|FG003|Intervention Period 1|Lost to Follow-up|1|||
146376440|NCT01929707|527878846|FG004|Intervention Period 1|Lost to Follow-up|0|||
146376441|NCT01929707|527878847|FG005|Intervention Period 1|Lost to Follow-up|0|||
146376442|NCT01929707|527878848|FG006|Intervention Period 1|Lost to Follow-up|0|||
146376443|NCT01929707|527878849|FG007|Intervention Period 1|Lost to Follow-up|0|||
146376444|NCT01929707|527878842|FG000|Intervention Period 1|Withdrawal by Subject|0|||
146376445|NCT01929707|527878843|FG001|Intervention Period 1|Withdrawal by Subject|0|||
146376446|NCT01929707|527878844|FG002|Intervention Period 1|Withdrawal by Subject|0|||
146376447|NCT01929707|527878845|FG003|Intervention Period 1|Withdrawal by Subject|2|||
146376448|NCT01929707|527878846|FG004|Intervention Period 1|Withdrawal by Subject|0|||
146376449|NCT01929707|527878847|FG005|Intervention Period 1|Withdrawal by Subject|0|||
146376450|NCT01929707|527878848|FG006|Intervention Period 1|Withdrawal by Subject|0|||
146376451|NCT01929707|527878849|FG007|Intervention Period 1|Withdrawal by Subject|0|||
146376452|NCT01929707|527878842|FG000|Intervention Period 2|Withdrawal by Subject|0|||
146376453|NCT01929707|527878843|FG001|Intervention Period 2|Withdrawal by Subject|0|||
146376454|NCT01929707|527878844|FG002|Intervention Period 2|Withdrawal by Subject|0|||
146376455|NCT01929707|527878845|FG003|Intervention Period 2|Withdrawal by Subject|0|||
146376456|NCT01929707|527878846|FG004|Intervention Period 2|Withdrawal by Subject|0|||
146376457|NCT01929707|527878847|FG005|Intervention Period 2|Withdrawal by Subject|2|||
146376458|NCT01929707|527878848|FG006|Intervention Period 2|Withdrawal by Subject|0|||
146376459|NCT01929707|527878849|FG007|Intervention Period 2|Withdrawal by Subject|0|||
146376460|NCT00431496|527878856|FG000|Overall Study|Adverse Event|3|||
146376461|NCT00431496|527878856|FG000|Overall Study|Lost to Follow-up|1|||
146376462|NCT00431496|527878856|FG000|Overall Study|Withdrawal by Subject|2|||
146376463|NCT00431496|527878856|FG000|Overall Study|Protocol-specified criteria|5|||
146376464|NCT02343952|527878857|FG000|Study Treatment|Disease Progression|23|||
146376465|NCT02343952|527878857|FG000|Study Treatment|Death|3|||
146376466|NCT02343952|527878857|FG000|Study Treatment|Adverse Event|19|||
146376467|NCT02343952|527878857|FG000|Study Treatment|Withdrawal by Subject|7|||
146376468|NCT02343952|527878857|FG000|Study Treatment|other complicating Diseases|1|||
146376469|NCT02343952|527878857|FG000|Follow up|Withdrawal by Subject|3|||
146376470|NCT02343952|527878857|FG000|Follow up|Death|33|||
146376471|NCT02343952|527878857|FG000|Follow up|Patient does not meet eligibility for study.|1|||
146376472|NCT02343952|527878857|FG000|Follow up|Research department closed by the practice.|5|||
146376473|NCT02343952|527878857|FG000|Follow up|Patient went home to Russia|1|||
146376474|NCT02343952|527878857|FG000|Follow up|Disease Progression|1|||
146376475|NCT02343952|527878857|FG000|Follow up|study terminated|1|||
146376476|NCT02067533|527878858|FG000|Overall Study|Lost to Follow-up|4|||
146376477|NCT02067533|527878859|FG001|Overall Study|Lost to Follow-up|2|||
146376478|NCT00845845|527878860|FG000|Overall Study|Lost to Follow-up|0|||
146376479|NCT00845845|527878861|FG001|Overall Study|Lost to Follow-up|4|||
146376480|NCT00560794|527878862|FG000|Overall Study|Adverse Event|2|||
146376481|NCT00560794|527878862|FG000|Overall Study|Patient was not Compliant|1|||
146376482|NCT00560794|527878862|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
146376483|NCT00560794|527878862|FG000|Overall Study|Hematological Relapse|1|||
146376484|NCT00560794|527878862|FG000|Overall Study|Received Bone Marrow Transplant|6|||
146376485|NCT00368472|527878867|FG000|Overall Study|Adverse Event|22|||
146376486|NCT00368472|527878867|FG000|Overall Study|Medication non-compliance|4|||
146376487|NCT00368472|527878867|FG000|Overall Study|Protocol Violation|2|||
146376488|NCT00368472|527878867|FG000|Overall Study|Request of Investigator or Sponsor|3|||
146376489|NCT00368472|527878867|FG000|Overall Study|Withdrawal by Subject|40|||
146376490|NCT00368472|527878867|FG000|Overall Study|Diary non-compliance|1|||
146376491|NCT00368472|527878867|FG000|Overall Study|Other|32|||
146376492|NCT00368472|527878867|FG000|Overall Study|Missing Final Disposition Date|1|||
146376493|NCT02384993|527878871|FG000|Overall Study|Adverse Event|0|||
146376494|NCT02384993|527878872|FG001|Overall Study|Adverse Event|1|||
146376495|NCT04507360|527880393|FG000|Week 1|Lost to Follow-up|0|||
146376496|NCT04507360|527880394|FG001|Week 1|Lost to Follow-up|0|||
146376497|NCT04507360|527880395|FG002|Week 1|Lost to Follow-up|0|||
146056246|NCT03535974|526721152|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
146376498|NCT04507360|527880396|FG003|Week 1|Lost to Follow-up|0|||
146376499|NCT04507360|527880397|FG004|Week 1|Lost to Follow-up|0|||
146376500|NCT04507360|527880398|FG005|Week 1|Lost to Follow-up|0|||
146376501|NCT04507360|527880399|FG006|Week 1|Lost to Follow-up|0|||
146376502|NCT04507360|527880400|FG007|Week 1|Lost to Follow-up|0|||
146376503|NCT04507360|527880401|FG008|Week 1|Lost to Follow-up|72|||
146376504|NCT04507360|527880402|FG009|Week 1|Lost to Follow-up|22|||
146376505|NCT04507360|527880403|FG010|Week 1|Lost to Follow-up|10|||
146376506|NCT04507360|527880393|FG000|Week 2|Lost to Follow-up|0|||
146376507|NCT04507360|527880394|FG001|Week 2|Lost to Follow-up|0|||
146376508|NCT04507360|527880395|FG002|Week 2|Lost to Follow-up|0|||
146376509|NCT04507360|527880396|FG003|Week 2|Lost to Follow-up|0|||
146376510|NCT04507360|527880397|FG004|Week 2|Lost to Follow-up|0|||
146376511|NCT04507360|527880398|FG005|Week 2|Lost to Follow-up|0|||
146376512|NCT04507360|527880399|FG006|Week 2|Lost to Follow-up|0|||
146376513|NCT04507360|527880400|FG007|Week 2|Lost to Follow-up|0|||
146376514|NCT04507360|527880401|FG008|Week 2|Lost to Follow-up|121|||
146376515|NCT04507360|527880402|FG009|Week 2|Lost to Follow-up|85|||
146376516|NCT04507360|527880403|FG010|Week 2|Lost to Follow-up|82|||
146376517|NCT04507360|527880393|FG000|Week 3|Lost to Follow-up|0|||
146376518|NCT04507360|527880394|FG001|Week 3|Lost to Follow-up|0|||
146376519|NCT04507360|527880395|FG002|Week 3|Lost to Follow-up|0|||
146376520|NCT04507360|527880396|FG003|Week 3|Lost to Follow-up|0|||
146376521|NCT04507360|527880397|FG004|Week 3|Lost to Follow-up|0|||
146376522|NCT04507360|527880398|FG005|Week 3|Lost to Follow-up|0|||
146376523|NCT04507360|527880399|FG006|Week 3|Lost to Follow-up|0|||
146376524|NCT04507360|527880400|FG007|Week 3|Lost to Follow-up|0|||
146376525|NCT04507360|527880401|FG008|Week 3|Lost to Follow-up|123|||
146376526|NCT04507360|527880402|FG009|Week 3|Lost to Follow-up|92|||
146376527|NCT04507360|527880403|FG010|Week 3|Lost to Follow-up|84|||
146376528|NCT04507360|527880393|FG000|Week 4|Lost to Follow-up|0|||
146376529|NCT04507360|527880394|FG001|Week 4|Lost to Follow-up|0|||
146376530|NCT04507360|527880395|FG002|Week 4|Lost to Follow-up|0|||
146376531|NCT04507360|527880396|FG003|Week 4|Lost to Follow-up|0|||
146376532|NCT04507360|527880397|FG004|Week 4|Lost to Follow-up|0|||
146376533|NCT04507360|527880398|FG005|Week 4|Lost to Follow-up|0|||
146376534|NCT04507360|527880399|FG006|Week 4|Lost to Follow-up|0|||
146376535|NCT04507360|527880400|FG007|Week 4|Lost to Follow-up|0|||
146376536|NCT04507360|527880401|FG008|Week 4|Lost to Follow-up|131|||
146376537|NCT04507360|527880402|FG009|Week 4|Lost to Follow-up|115|||
146376538|NCT04507360|527880403|FG010|Week 4|Lost to Follow-up|102|||
146376539|NCT04507360|527880393|FG000|Week 5|Lost to Follow-up|0|||
146376540|NCT04507360|527880394|FG001|Week 5|Lost to Follow-up|0|||
146376541|NCT04507360|527880395|FG002|Week 5|Lost to Follow-up|0|||
146376542|NCT04507360|527880396|FG003|Week 5|Lost to Follow-up|0|||
146376543|NCT04507360|527880397|FG004|Week 5|Lost to Follow-up|0|||
146376544|NCT04507360|527880398|FG005|Week 5|Lost to Follow-up|0|||
146376545|NCT04507360|527880399|FG006|Week 5|Lost to Follow-up|0|||
146376546|NCT04507360|527880400|FG007|Week 5|Lost to Follow-up|0|||
146376547|NCT04507360|527880401|FG008|Week 5|Lost to Follow-up|103|||
146376548|NCT04507360|527880402|FG009|Week 5|Lost to Follow-up|135|||
146376549|NCT04507360|527880403|FG010|Week 5|Lost to Follow-up|143|||
146376550|NCT04507360|527880393|FG000|Week 8|Lost to Follow-up|0|||
146376551|NCT04507360|527880394|FG001|Week 8|Lost to Follow-up|0|||
146376552|NCT04507360|527880395|FG002|Week 8|Lost to Follow-up|0|||
146376553|NCT04507360|527880396|FG003|Week 8|Lost to Follow-up|0|||
146376554|NCT04507360|527880397|FG004|Week 8|Lost to Follow-up|0|||
146376555|NCT04507360|527880398|FG005|Week 8|Lost to Follow-up|0|||
146376556|NCT04507360|527880399|FG006|Week 8|Lost to Follow-up|0|||
146376557|NCT04507360|527880400|FG007|Week 8|Lost to Follow-up|0|||
146376558|NCT04507360|527880401|FG008|Week 8|Lost to Follow-up|139|||
146376559|NCT04507360|527880402|FG009|Week 8|Lost to Follow-up|145|||
146376560|NCT04507360|527880403|FG010|Week 8|Lost to Follow-up|152|||
146376561|NCT01004159|527880404|FG000|Overall Study|Adverse Event|2|||
146376562|NCT01004159|527880404|FG000|Overall Study|Disease Progression|18|||
146376563|NCT04483544|527880406|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
146376564|NCT04483544|527880406|FG000|Post-Treatment|Admitted to hospice|2|||
146376565|NCT04483544|527880406|FG000|Post-Treatment|Study terminated|3|||
146376566|NCT01977040|527880408|FG000|Overall Study|Vasa previa not confirmed|2|||
146376567|NCT01685060|527880409|FG000|Overall Study|Rollover patients|16|||
146376568|NCT01685060|527880409|FG000|Overall Study|Adverse Event|12|||
146376569|NCT01685060|527880409|FG000|Overall Study|Progressive disease|69|||
146376570|NCT01685060|527880409|FG000|Overall Study|Physician Decision|14|||
146376571|NCT01685060|527880409|FG000|Overall Study|Subject/guardian decision|20|||
146376572|NCT01685060|527880409|FG000|Overall Study|Lost to Follow-up|1|||
146376573|NCT01685060|527880409|FG000|Overall Study|Death|8|||
146376574|NCT00209092|527880414|FG000|Overall Study|Progression of disease|7|||
146376575|NCT00209092|527880415|FG001|Overall Study|Progression of disease|1|||
146376576|NCT00209092|527880414|FG000|Overall Study|Adverse Event|0|||
146376577|NCT00209092|527880415|FG001|Overall Study|Adverse Event|1|||
146376578|NCT00209092|527880414|FG000|Overall Study|Withdrawal by Subject|1|||
146376579|NCT00209092|527880415|FG001|Overall Study|Withdrawal by Subject|0|||
146376580|NCT01119963|527880419|FG000|Overall Study|Lost to Follow-up|1|||
146376581|NCT01119963|527880420|FG001|Overall Study|Lost to Follow-up|1|||
146376582|NCT04072575|527880432|FG000|Overall Study|Physician Decision|1|||
146376583|NCT04072575|527880432|FG000|Overall Study|Adverse Event|7|||
146376584|NCT04072575|527880432|FG000|Overall Study|Withdrawal by Subject|14|||
146376585|NCT04072575|527880432|FG000|Overall Study|Other|2|||
146376586|NCT02498392|527880433|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
146376587|NCT02498392|527880434|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
146376588|NCT02498392|527880433|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
146376589|NCT02498392|527880434|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
146376590|NCT02498392|527880433|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
146376591|NCT02498392|527880434|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
146376592|NCT02498392|527880433|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
146376593|NCT02498392|527880434|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
146376594|NCT02498392|527880433|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
146376595|NCT02498392|527880434|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
146376596|NCT02498392|527880433|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
146376597|NCT02498392|527880434|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
146376598|NCT02244619|527880435|FG000|Overall Study|Did not receive study intervention|8|||
146376599|NCT02244619|527880436|FG001|Overall Study|Did not receive study intervention|21|||
146376600|NCT01156363|527880437|FG000|Overall Study|Adverse Event|6|||
146376601|NCT01156363|527880437|FG000|Overall Study|Insufficient Therapeutic Response|5|||
146376602|NCT01156363|527880437|FG000|Overall Study|Failure to Return|1|||
146376603|NCT01156363|527880437|FG000|Overall Study|Refused Treatment|4|||
146376604|NCT01156363|527880437|FG000|Overall Study|Other|6|||
146376605|NCT03135262|527880438|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
146376606|NCT03135262|527880439|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146376607|NCT03135262|527880440|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146376608|NCT03135262|527880441|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146376609|NCT03135262|527880442|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
146376610|NCT03135262|527880438|FG000|Overall Study|Progression of disease|0|||
146376611|NCT03135262|527880439|FG001|Overall Study|Progression of disease|0|||
146376612|NCT03135262|527880440|FG002|Overall Study|Progression of disease|0|||
146376613|NCT03135262|527880441|FG003|Overall Study|Progression of disease|1|||
146376614|NCT03135262|527880442|FG004|Overall Study|Progression of disease|0|||
146376615|NCT03135262|527880438|FG000|Overall Study|Death|6|||
146376616|NCT03135262|527880439|FG001|Overall Study|Death|2|||
146376617|NCT03135262|527880440|FG002|Overall Study|Death|2|||
146376618|NCT03135262|527880441|FG003|Overall Study|Death|2|||
146376619|NCT03135262|527880442|FG004|Overall Study|Death|0|||
146376620|NCT03135262|527880438|FG000|Overall Study|Withdrawal by Subject|0|||
146376621|NCT03135262|527880439|FG001|Overall Study|Withdrawal by Subject|0|||
146376622|NCT03135262|527880440|FG002|Overall Study|Withdrawal by Subject|1|||
146376623|NCT03135262|527880441|FG003|Overall Study|Withdrawal by Subject|0|||
146376624|NCT03135262|527880442|FG004|Overall Study|Withdrawal by Subject|1|||
146376625|NCT03135262|527880438|FG000|Overall Study|Study terminated by sponsor|2|||
146376626|NCT03135262|527880439|FG001|Overall Study|Study terminated by sponsor|4|||
146376627|NCT03135262|527880440|FG002|Overall Study|Study terminated by sponsor|4|||
146376628|NCT03135262|527880441|FG003|Overall Study|Study terminated by sponsor|3|||
146376629|NCT03135262|527880442|FG004|Overall Study|Study terminated by sponsor|0|||
146376630|NCT03285490|527880443|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
146376631|NCT03285490|527880444|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
146376632|NCT03285490|527880443|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
146376633|NCT03285490|527880444|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
146376634|NCT02728206|527880445|FG000|Overall Study|Death|1|||
146376635|NCT00246376|527880451|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
146376636|NCT00246376|527880452|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
146376637|NCT00246376|527880453|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
146376638|NCT00246376|527880454|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
146376639|NCT00246376|527880455|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
146376640|NCT00246376|527880451|FG000|Overall Study|Adverse Event|2|||
146376641|NCT00246376|527880452|FG001|Overall Study|Adverse Event|3|||
146376642|NCT00246376|527880453|FG002|Overall Study|Adverse Event|1|||
146376643|NCT00246376|527880454|FG003|Overall Study|Adverse Event|3|||
146376644|NCT00246376|527880455|FG004|Overall Study|Adverse Event|1|||
146376645|NCT00246376|527880451|FG000|Overall Study|Lost to Follow-up|2|||
146376646|NCT00246376|527880452|FG001|Overall Study|Lost to Follow-up|11|||
146376647|NCT00246376|527880453|FG002|Overall Study|Lost to Follow-up|11|||
146376648|NCT00246376|527880454|FG003|Overall Study|Lost to Follow-up|16|||
146376649|NCT00246376|527880455|FG004|Overall Study|Lost to Follow-up|13|||
146376650|NCT01872897|527880456|FG000|Overall Study|Withdrawal by Subject|1|||
146376651|NCT01872897|527880457|FG001|Overall Study|Withdrawal by Subject|0|||
146376652|NCT01782885|527880466|FG000|Overall Study|Lost to Follow-up|4|||
146376653|NCT01782885|527880467|FG001|Overall Study|Lost to Follow-up|6|||
146376654|NCT00633360|527880470|FG000|Overall Study|Lost to Follow-up|1|||
146376655|NCT00633360|527880471|FG001|Overall Study|Lost to Follow-up|1|||
146376656|NCT00633360|527880470|FG000|Overall Study|Adverse Event|3|||
146376657|NCT00633360|527880471|FG001|Overall Study|Adverse Event|1|||
146376658|NCT00633360|527880470|FG000|Overall Study|Protocol Violation|0|||
146376659|NCT00633360|527880471|FG001|Overall Study|Protocol Violation|1|||
146376660|NCT01098032|527880472|FG000|Overall Study|Withdrawal by Subject|1|||
146376661|NCT01098032|527880473|FG001|Overall Study|Withdrawal by Subject|1|||
146376662|NCT00610207|527880475|FG000|Overall Study|Lost to Follow-up|3|||
146376663|NCT03236506|527880488|FG000|Overall Study|Death|1|||
146376664|NCT03236506|527880489|FG001|Overall Study|Death|1|||
146376665|NCT03236506|527880490|FG002|Overall Study|Death|1|||
146376666|NCT03236506|527880488|FG000|Overall Study|Withdrawal by Subject|3|||
146376667|NCT03236506|527880489|FG001|Overall Study|Withdrawal by Subject|3|||
146376668|NCT03236506|527880490|FG002|Overall Study|Withdrawal by Subject|4|||
146376669|NCT03236506|527880488|FG000|Overall Study|Did not initiate treatment|2|||
146376670|NCT03236506|527880489|FG001|Overall Study|Did not initiate treatment|1|||
146376671|NCT03236506|527880490|FG002|Overall Study|Did not initiate treatment|2|||
146376672|NCT01594411|527880499|FG000|Overall Study|Lost to Follow-up|2|||
146376673|NCT00437203|527880502|FG000|Overall Study|Death|0|||
146376674|NCT00437203|527880503|FG001|Overall Study|Death|0|||
146376675|NCT00437203|527880504|FG002|Overall Study|Death|1|||
146376676|NCT00437203|527880505|FG003|Overall Study|Death|0|||
146376677|NCT00437203|527880506|FG004|Overall Study|Death|0|||
146376678|NCT00437203|527880507|FG005|Overall Study|Death|0|||
146376679|NCT00437203|527880508|FG006|Overall Study|Death|0|||
146376680|NCT00437203|527880509|FG007|Overall Study|Death|1|||
146376681|NCT00437203|527880510|FG008|Overall Study|Death|0|||
146376682|NCT00437203|527880511|FG009|Overall Study|Death|1|||
146376683|NCT00437203|527880502|FG000|Overall Study|Adverse Event|1|||
146376684|NCT00437203|527880503|FG001|Overall Study|Adverse Event|1|||
146376685|NCT00437203|527880504|FG002|Overall Study|Adverse Event|0|||
146376686|NCT00437203|527880505|FG003|Overall Study|Adverse Event|0|||
146376687|NCT00437203|527880506|FG004|Overall Study|Adverse Event|0|||
146376688|NCT00437203|527880507|FG005|Overall Study|Adverse Event|0|||
146376689|NCT00437203|527880508|FG006|Overall Study|Adverse Event|0|||
146376690|NCT00437203|527880509|FG007|Overall Study|Adverse Event|1|||
146376691|NCT00437203|527880510|FG008|Overall Study|Adverse Event|0|||
146376692|NCT00437203|527880511|FG009|Overall Study|Adverse Event|1|||
146376693|NCT00437203|527880502|FG000|Overall Study|Study terminated by sponsor|0|||
146376694|NCT00437203|527880503|FG001|Overall Study|Study terminated by sponsor|0|||
146376695|NCT00437203|527880504|FG002|Overall Study|Study terminated by sponsor|0|||
146376696|NCT00437203|527880505|FG003|Overall Study|Study terminated by sponsor|0|||
146376697|NCT00437203|527880506|FG004|Overall Study|Study terminated by sponsor|0|||
146376698|NCT00437203|527880507|FG005|Overall Study|Study terminated by sponsor|0|||
146376699|NCT00437203|527880508|FG006|Overall Study|Study terminated by sponsor|0|||
146376700|NCT00437203|527880509|FG007|Overall Study|Study terminated by sponsor|0|||
146376701|NCT00437203|527880510|FG008|Overall Study|Study terminated by sponsor|1|||
146376702|NCT00437203|527880511|FG009|Overall Study|Study terminated by sponsor|0|||
146376703|NCT00437203|527880502|FG000|Overall Study|Objective progression or relapse|5|||
146376704|NCT00437203|527880503|FG001|Overall Study|Objective progression or relapse|6|||
146376705|NCT00437203|527880504|FG002|Overall Study|Objective progression or relapse|2|||
146376706|NCT00437203|527880505|FG003|Overall Study|Objective progression or relapse|3|||
146376707|NCT00437203|527880506|FG004|Overall Study|Objective progression or relapse|3|||
146376708|NCT00437203|527880507|FG005|Overall Study|Objective progression or relapse|3|||
146376709|NCT00437203|527880508|FG006|Overall Study|Objective progression or relapse|6|||
146376710|NCT00437203|527880509|FG007|Overall Study|Objective progression or relapse|1|||
146376711|NCT00437203|527880510|FG008|Overall Study|Objective progression or relapse|2|||
146376712|NCT00437203|527880511|FG009|Overall Study|Objective progression or relapse|2|||
146376713|NCT00437203|527880502|FG000|Overall Study|Other|0|||
146376714|NCT00437203|527880503|FG001|Overall Study|Other|1|||
146376715|NCT00437203|527880504|FG002|Overall Study|Other|0|||
146376716|NCT00437203|527880505|FG003|Overall Study|Other|0|||
146376717|NCT00437203|527880506|FG004|Overall Study|Other|0|||
146376718|NCT00437203|527880507|FG005|Overall Study|Other|0|||
146376719|NCT00437203|527880508|FG006|Overall Study|Other|1|||
146376720|NCT00437203|527880509|FG007|Overall Study|Other|0|||
146376721|NCT00437203|527880510|FG008|Overall Study|Other|0|||
146376722|NCT00437203|527880511|FG009|Overall Study|Other|0|||
146376723|NCT00565812|527880512|FG000|Overall Study|Death|2|||
146376724|NCT00565812|527880513|FG001|Overall Study|Death|1|||
146376725|NCT00565812|527880514|FG002|Overall Study|Death|3|||
146376726|NCT00565812|527880512|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
146376727|NCT00565812|527880513|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
146376728|NCT00565812|527880514|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
146376729|NCT00565812|527880512|FG000|Overall Study|Lost to Follow-up|10|||
146376730|NCT00565812|527880513|FG001|Overall Study|Lost to Follow-up|8|||
146376731|NCT00565812|527880514|FG002|Overall Study|Lost to Follow-up|8|||
146376732|NCT00565812|527880512|FG000|Overall Study|Withdrawal by Subject|58|||
146376733|NCT00565812|527880513|FG001|Overall Study|Withdrawal by Subject|47|||
146376734|NCT00565812|527880514|FG002|Overall Study|Withdrawal by Subject|48|||
146376735|NCT00565812|527880512|FG000|Overall Study|Work Schedule|5|||
146376736|NCT00565812|527880513|FG001|Overall Study|Work Schedule|3|||
146376737|NCT00565812|527880514|FG002|Overall Study|Work Schedule|1|||
146376738|NCT00565812|527880512|FG000|Overall Study|Protocol Violation|2|||
146376739|NCT00565812|527880513|FG001|Overall Study|Protocol Violation|6|||
146376740|NCT00565812|527880514|FG002|Overall Study|Protocol Violation|4|||
146376741|NCT00565812|527880512|FG000|Overall Study|Adverse Event|41|||
146376742|NCT00565812|527880513|FG001|Overall Study|Adverse Event|54|||
146376743|NCT00565812|527880514|FG002|Overall Study|Adverse Event|40|||
146376744|NCT00565812|527880512|FG000|Overall Study|Jury Duty|1|||
146376745|NCT00565812|527880513|FG001|Overall Study|Jury Duty|0|||
146376746|NCT00565812|527880514|FG002|Overall Study|Jury Duty|0|||
146376747|NCT00565812|527880512|FG000|Overall Study|Relocated Out of Area|5|||
146376748|NCT00565812|527880513|FG001|Overall Study|Relocated Out of Area|8|||
146376749|NCT00565812|527880514|FG002|Overall Study|Relocated Out of Area|9|||
146376750|NCT00565812|527880512|FG000|Overall Study|Sponsor Decision|1|||
146376751|NCT00565812|527880513|FG001|Overall Study|Sponsor Decision|5|||
146376752|NCT00565812|527880514|FG002|Overall Study|Sponsor Decision|1|||
146376753|NCT00565812|527880512|FG000|Overall Study|Domestic Reasons|7|||
146376754|NCT00565812|527880513|FG001|Overall Study|Domestic Reasons|1|||
146376755|NCT00565812|527880514|FG002|Overall Study|Domestic Reasons|3|||
146376756|NCT00565812|527880512|FG000|Overall Study|Research Site Closure|6|||
146376757|NCT00565812|527880513|FG001|Overall Study|Research Site Closure|1|||
146376758|NCT00565812|527880514|FG002|Overall Study|Research Site Closure|8|||
146376759|NCT00565812|527880512|FG000|Overall Study|Surgical Intervention|0|||
146376760|NCT00565812|527880513|FG001|Overall Study|Surgical Intervention|1|||
146376761|NCT00565812|527880514|FG002|Overall Study|Surgical Intervention|2|||
146376762|NCT00565812|527880512|FG000|Overall Study|Low Compliance|1|||
146376763|NCT00565812|527880513|FG001|Overall Study|Low Compliance|0|||
146376764|NCT00565812|527880514|FG002|Overall Study|Low Compliance|1|||
146376765|NCT00565812|527880512|FG000|Overall Study|Follow-up Visit Not Completed|2|||
146376766|NCT00565812|527880513|FG001|Overall Study|Follow-up Visit Not Completed|0|||
146376767|NCT00565812|527880514|FG002|Overall Study|Follow-up Visit Not Completed|1|||
146376768|NCT00565812|527880512|FG000|Overall Study|Physician Decision|2|||
146376769|NCT00565812|527880513|FG001|Overall Study|Physician Decision|0|||
146376770|NCT00565812|527880514|FG002|Overall Study|Physician Decision|0|||
146376771|NCT00479167|527880515|FG000|Overall Study|Withdrawal by Subject|1|||
146376772|NCT01570309|527880518|FG000|Overall Study|Withdrawal by Subject|3|||
146376773|NCT01570309|527880519|FG001|Overall Study|Withdrawal by Subject|3|||
146376774|NCT04857892|527880520|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
146376775|NCT04857892|527880521|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146376776|NCT04857892|527880522|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146376777|NCT04857892|527880523|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146376778|NCT04857892|527880524|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
146376779|NCT04857892|527880520|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
146376780|NCT04857892|527880521|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
146376781|NCT04857892|527880522|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
146376782|NCT04857892|527880523|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
146376783|NCT04857892|527880524|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
146376784|NCT04857892|527880520|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146376785|NCT04857892|527880521|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146376786|NCT04857892|527880522|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146376787|NCT04857892|527880523|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
146376788|NCT04857892|527880524|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
146376789|NCT04095793|527880525|FG000|Overall Study|Adverse Event|3|||
146376790|NCT04095793|527880525|FG000|Overall Study|Study Terminated by Sponsor|103|||
146376791|NCT04095793|527880525|FG000|Overall Study|Withdrawal by Subject|4|||
146376792|NCT00098865|527883056|FG000|Overall Study|Progressive Disease|6|||
146376793|NCT00098865|527883056|FG000|Overall Study|Adverse Event|2|||
146376794|NCT00098865|527883056|FG000|Overall Study|Alternative Therapy|1|||
146376795|NCT03050307|527883057|FG000|Overall Study|Adverse Event|4|||
146376796|NCT03050307|527883058|FG001|Overall Study|Adverse Event|2|||
146376797|NCT03050307|527883057|FG000|Overall Study|Significant Protocol Deviation|0|||
146376798|NCT03050307|527883058|FG001|Overall Study|Significant Protocol Deviation|1|||
146376799|NCT03050307|527883057|FG000|Overall Study|Lost to Follow-up|0|||
146376800|NCT03050307|527883058|FG001|Overall Study|Lost to Follow-up|1|||
146376801|NCT03050307|527883057|FG000|Overall Study|Voluntary Withdrawal|3|||
146376802|NCT03050307|527883058|FG001|Overall Study|Voluntary Withdrawal|4|||
146376803|NCT03050307|527883057|FG000|Overall Study|Reason not Specified|1|||
146376804|NCT03050307|527883058|FG001|Overall Study|Reason not Specified|1|||
146376805|NCT00439309|527883059|FG000|Follow-Up|Death|1|||
146376806|NCT00439309|527883060|FG001|Follow-Up|Death|0|||
146376807|NCT00439309|527883059|FG000|Follow-Up|Lost to Follow-up|2|||
146376808|NCT00439309|527883060|FG001|Follow-Up|Lost to Follow-up|0|||
146376809|NCT00439309|527883059|FG000|Follow-Up|Withdrawal by Subject|0|||
146376810|NCT00439309|527883060|FG001|Follow-Up|Withdrawal by Subject|1|||
146376811|NCT00439309|527883059|FG000|Follow-Up|Late response by subject|0|||
146376812|NCT00439309|527883060|FG001|Follow-Up|Late response by subject|1|||
146376813|NCT00430027|527883062|FG000|Overall Study|Study terminated|8|||
146376814|NCT02828644|527883063|FG000|Overall Study|Lost to Follow-up|23|||
146376815|NCT02828644|527883064|FG001|Overall Study|Lost to Follow-up|22|||
146376816|NCT02996110|527883065|FG000|Pre-Treatment|Other Reasons|0|||
146376817|NCT02996110|527883066|FG001|Pre-Treatment|Other Reasons|1|||
146376818|NCT02996110|527883067|FG002|Pre-Treatment|Other Reasons|0|||
146376819|NCT02996110|527883068|FG003|Pre-Treatment|Other Reasons|0|||
146376820|NCT02996110|527883069|FG004|Pre-Treatment|Other Reasons|1|||
146376821|NCT02996110|527883065|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
146376822|NCT02996110|527883066|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
146376823|NCT02996110|527883067|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
146376824|NCT02996110|527883068|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
146376825|NCT02996110|527883069|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
146376826|NCT02996110|527883065|FG000|Track 1|Disease Progression|15|||
146376827|NCT02996110|527883066|FG001|Track 1|Disease Progression|17|||
146376828|NCT02996110|527883067|FG002|Track 1|Disease Progression|0|||
146376829|NCT02996110|527883068|FG003|Track 1|Disease Progression|0|||
146376830|NCT02996110|527883069|FG004|Track 1|Disease Progression|0|||
146376831|NCT02996110|527883065|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
146376832|NCT02996110|527883066|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
146376833|NCT02996110|527883067|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
146376834|NCT02996110|527883068|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
146376835|NCT02996110|527883069|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
146376836|NCT02996110|527883065|FG000|Track 1|Study Drug Toxicity|5|||
146376837|NCT02996110|527883066|FG001|Track 1|Study Drug Toxicity|3|||
146376838|NCT02996110|527883067|FG002|Track 1|Study Drug Toxicity|0|||
146376839|NCT02996110|527883068|FG003|Track 1|Study Drug Toxicity|0|||
146376840|NCT02996110|527883069|FG004|Track 1|Study Drug Toxicity|0|||
146376841|NCT02996110|527883065|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
146376842|NCT02996110|527883066|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146376843|NCT02996110|527883067|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146376844|NCT02996110|527883068|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146376845|NCT02996110|527883069|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
146376846|NCT02996110|527883065|FG000|Track 1|Administrative Reason by Sponsor|0|||
146376847|NCT02996110|527883066|FG001|Track 1|Administrative Reason by Sponsor|1|||
146376848|NCT02996110|527883067|FG002|Track 1|Administrative Reason by Sponsor|0|||
146376849|NCT02996110|527883068|FG003|Track 1|Administrative Reason by Sponsor|0|||
146376850|NCT02996110|527883069|FG004|Track 1|Administrative Reason by Sponsor|0|||
146376851|NCT02996110|527883065|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
146376852|NCT02996110|527883066|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
146376853|NCT02996110|527883067|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
146376854|NCT02996110|527883068|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
146376855|NCT02996110|527883069|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
146376856|NCT02996110|527883065|FG000|Track 2|Disease Progression|33|||
146376857|NCT02996110|527883066|FG001|Track 2|Disease Progression|26|||
146376858|NCT02996110|527883067|FG002|Track 2|Disease Progression|19|||
146376859|NCT02996110|527883068|FG003|Track 2|Disease Progression|16|||
146376860|NCT02996110|527883069|FG004|Track 2|Disease Progression|15|||
146376861|NCT02996110|527883065|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
146376862|NCT02996110|527883066|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
146376863|NCT02996110|527883067|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
146376864|NCT02996110|527883068|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
146376865|NCT02996110|527883069|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
146376866|NCT02996110|527883065|FG000|Track 2|Death|0|||
146376867|NCT02996110|527883066|FG001|Track 2|Death|0|||
146376868|NCT02996110|527883067|FG002|Track 2|Death|1|||
146376869|NCT02996110|527883068|FG003|Track 2|Death|0|||
146376870|NCT02996110|527883069|FG004|Track 2|Death|1|||
146376871|NCT02996110|527883065|FG000|Track 2|Study Drug Toxicity|4|||
146376872|NCT02996110|527883066|FG001|Track 2|Study Drug Toxicity|1|||
146376873|NCT02996110|527883067|FG002|Track 2|Study Drug Toxicity|4|||
146376874|NCT02996110|527883068|FG003|Track 2|Study Drug Toxicity|1|||
146376875|NCT02996110|527883069|FG004|Track 2|Study Drug Toxicity|0|||
146376876|NCT02996110|527883065|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
146376877|NCT02996110|527883066|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
146376878|NCT02996110|527883067|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
146376879|NCT02996110|527883068|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
146376880|NCT02996110|527883069|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
146376881|NCT02996110|527883065|FG000|Track 2|Participant Withdrew Consent|1|||
146376882|NCT02996110|527883066|FG001|Track 2|Participant Withdrew Consent|2|||
146376883|NCT02996110|527883067|FG002|Track 2|Participant Withdrew Consent|3|||
146376884|NCT02996110|527883068|FG003|Track 2|Participant Withdrew Consent|1|||
146376885|NCT02996110|527883069|FG004|Track 2|Participant Withdrew Consent|1|||
146376886|NCT02996110|527883065|FG000|Track 2|Other Reasons|0|||
146376887|NCT02996110|527883066|FG001|Track 2|Other Reasons|0|||
146376888|NCT02996110|527883067|FG002|Track 2|Other Reasons|1|||
146376889|NCT02996110|527883068|FG003|Track 2|Other Reasons|0|||
146376890|NCT02996110|527883069|FG004|Track 2|Other Reasons|1|||
146376891|NCT00524043|527883070|FG000|Overall Study|Lack of Efficacy|15|||
146376892|NCT00524043|527883071|FG001|Overall Study|Lack of Efficacy|13|||
146376893|NCT00524043|527883072|FG002|Overall Study|Lack of Efficacy|14|||
146376894|NCT00524043|527883070|FG000|Overall Study|Withdrawal by Subject|5|||
146376895|NCT00524043|527883071|FG001|Overall Study|Withdrawal by Subject|7|||
146376896|NCT00524043|527883072|FG002|Overall Study|Withdrawal by Subject|7|||
146376897|NCT00524043|527883070|FG000|Overall Study|Adverse Event|5|||
146376898|NCT00524043|527883071|FG001|Overall Study|Adverse Event|2|||
146376899|NCT00524043|527883072|FG002|Overall Study|Adverse Event|7|||
146376900|NCT00524043|527883070|FG000|Overall Study|Lost to Follow-up|3|||
146376901|NCT00524043|527883071|FG001|Overall Study|Lost to Follow-up|5|||
146376902|NCT00524043|527883072|FG002|Overall Study|Lost to Follow-up|3|||
146376903|NCT00524043|527883070|FG000|Overall Study|Various (eg, incarceration)|2|||
146376904|NCT00524043|527883071|FG001|Overall Study|Various (eg, incarceration)|1|||
146376905|NCT00524043|527883072|FG002|Overall Study|Various (eg, incarceration)|0|||
146376906|NCT01536418|527883079|FG000|Overall Study|Protocol Violation|2|||
146376907|NCT01536418|527883080|FG001|Overall Study|Protocol Violation|3|||
146376908|NCT01536418|527883079|FG000|Overall Study|Physician Decision|1|||
146376909|NCT01536418|527883080|FG001|Overall Study|Physician Decision|3|||
146376910|NCT01536418|527883079|FG000|Overall Study|Study closed/terminated|41|||
146376911|NCT01536418|527883080|FG001|Overall Study|Study closed/terminated|37|||
146376912|NCT01536418|527883079|FG000|Overall Study|Lack of Efficacy|10|||
146376913|NCT01536418|527883080|FG001|Overall Study|Lack of Efficacy|16|||
146376914|NCT01536418|527883079|FG000|Overall Study|Adverse Event|9|||
146376915|NCT01536418|527883080|FG001|Overall Study|Adverse Event|4|||
146376916|NCT01536418|527883079|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
146376917|NCT01536418|527883080|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
146376918|NCT01536418|527883079|FG000|Overall Study|Withdrawal by Subject|5|||
146376919|NCT01536418|527883080|FG001|Overall Study|Withdrawal by Subject|3|||
146376920|NCT02658149|527883085|FG000|Overall Study|Physician Decision|1|||
146376921|NCT02658149|527883086|FG001|Overall Study|Physician Decision|0|||
146376922|NCT00711412|527883089|FG000|Induction Treatment|Death|2|||
146376923|NCT00711412|527883089|FG000|Induction Treatment|Adverse Event|1|||
146376924|NCT00711412|527883089|FG000|Induction Treatment|Other|1|||
146376925|NCT00711412|527883089|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
146376926|NCT00711412|527883089|FG000|Evaluated for Combination Treatment|Death|1|||
146376927|NCT00711412|527883089|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
146376928|NCT00711412|527883089|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
146376929|NCT00711412|527883089|FG000|Combination Treatment|Progressive Disease|1|||
146376930|NCT00711412|527883089|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
146376931|NCT00711412|527883089|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
146376932|NCT00711412|527883089|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
146376933|NCT00711412|527883089|FG000|Evaluation for Response and Surgery|Death|1|||
146376934|NCT00711412|527883089|FG000|Survival Follow up Until Death|Other|12|||
146376935|NCT04097028|527883094|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
146376936|NCT04097028|527883094|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
146376937|NCT04097028|527883094|FG000|Overall Study|Disease Progression prior to Surgery|2|||
146376938|NCT04097028|527883094|FG000|Overall Study|Adverse Event prior to Surgery|1|||
146376939|NCT03687827|527883095|FG000|Treatment Period 1|Death|0|||
146376940|NCT03687827|527883096|FG001|Treatment Period 1|Death|1|||
146376941|NCT03687827|527883095|FG000|Treatment Period 1|Lost to Follow-up|2|||
146376942|NCT03687827|527883096|FG001|Treatment Period 1|Lost to Follow-up|2|||
146376943|NCT03687827|527883095|FG000|Treatment Period 1|Physician Decision|5|||
146376944|NCT03687827|527883096|FG001|Treatment Period 1|Physician Decision|2|||
146376945|NCT03687827|527883095|FG000|Treatment Period 1|Withdrawal by Subject|7|||
146376946|NCT03687827|527883096|FG001|Treatment Period 1|Withdrawal by Subject|3|||
146376947|NCT03687827|527883095|FG000|Treatment Period 2|Physician Decision|4|||
146376948|NCT03687827|527883096|FG001|Treatment Period 2|Physician Decision|1|||
146376949|NCT03687827|527883095|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146376950|NCT03687827|527883096|FG001|Treatment Period 2|Withdrawal by Subject|2|||
146376951|NCT00735072|527883099|FG000|Overall Study|interrupted study med during ARV change|1|||
146376952|NCT00735072|527883100|FG001|Overall Study|interrupted study med during ARV change|0|||
146376953|NCT00735072|527883099|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
146376954|NCT00735072|527883100|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
146376955|NCT00911144|527883101|FG000|Overall Study|Withdrawal by Subject|16|||
146376956|NCT00911144|527883102|FG001|Overall Study|Withdrawal by Subject|5|||
146376957|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
146376958|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
146376959|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
146376960|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
146395881|NCT02646566|527952399|FG000|Overall Study|Lost to Follow-up|5|||
146376961|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
146376962|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
146376963|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
146376964|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
146376965|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
146376966|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
146376967|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
146376968|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
146376969|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
146376970|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
146376971|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
146376972|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
146376973|NCT01291511|527883103|FG000|Cross-Titration and Stabilization Phase|Death|1|||
146376974|NCT01291511|527883104|FG001|Cross-Titration and Stabilization Phase|Death|0|||
146376975|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
146376976|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
146376977|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
146376978|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
146376979|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
146376980|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
146376981|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
146376982|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
146376983|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
146376984|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
146376985|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
146376986|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
146376987|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
146376988|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
146376989|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
146376990|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
146376991|NCT01291511|527883103|FG000|Double-blind Relapse Prevention Phase|Death|1|||
146376992|NCT01291511|527883104|FG001|Double-blind Relapse Prevention Phase|Death|0|||
146376993|NCT00047008|527883107|FG000|Overall Study|Withdrawn consent|2|||
146376994|NCT00047008|527883108|FG001|Overall Study|Withdrawn consent|3|||
146376995|NCT00047008|527883107|FG000|Overall Study|Ineligible|9|||
146376996|NCT00047008|527883108|FG001|Overall Study|Ineligible|8|||
146376997|NCT00429572|527883109|FG000|Overall Study|Disease progression|1|||
146376998|NCT02773368|527883110|FG000|Overall Study|Lost to Follow-up|4|||
146376999|NCT02773368|527883111|FG001|Overall Study|Lost to Follow-up|1|||
146377000|NCT02773368|527883110|FG000|Overall Study|Withdrawal by Subject|5|||
146377001|NCT02773368|527883111|FG001|Overall Study|Withdrawal by Subject|1|||
146377002|NCT02773368|527883110|FG000|Overall Study|Unclassified|1|||
146377003|NCT02773368|527883111|FG001|Overall Study|Unclassified|1|||
146377004|NCT02773368|527883110|FG000|Overall Study|Missing|0|||
146377005|NCT02773368|527883111|FG001|Overall Study|Missing|1|||
146377006|NCT01929018|527883112|FG000|Overall Study|Lost to Follow-up|1|||
146377007|NCT01929018|527883113|FG001|Overall Study|Lost to Follow-up|0|||
146377008|NCT01929018|527883112|FG000|Overall Study|Hospitalization|0|||
146377009|NCT01929018|527883113|FG001|Overall Study|Hospitalization|1|||
146377010|NCT01366534|527883114|FG000|Overall Study|Lost to Follow-up|1|||
146377011|NCT01366534|527883115|FG001|Overall Study|Lost to Follow-up|0|||
146377012|NCT01366534|527883116|FG002|Overall Study|Lost to Follow-up|0|||
146377013|NCT01366534|527883114|FG000|Overall Study|Migrated|1|||
146377014|NCT01366534|527883115|FG001|Overall Study|Migrated|1|||
146377015|NCT01366534|527883116|FG002|Overall Study|Migrated|0|||
146377016|NCT01366534|527883114|FG000|Overall Study|Declined challenged|0|||
146377017|NCT01366534|527883115|FG001|Overall Study|Declined challenged|1|||
146377018|NCT01366534|527883116|FG002|Overall Study|Declined challenged|0|||
146377019|NCT01047436|527883120|FG000|Overall Study|Protocol Violation|1|||
146377020|NCT01047436|527883121|FG001|Overall Study|Protocol Violation|0|||
146377021|NCT01678313|527883125|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
146377022|NCT01678313|527883126|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
146377023|NCT01678313|527883125|FG000|Completed the 3-month Therapy|Physician Decision|3|||
146377024|NCT01678313|527883126|FG001|Completed the 3-month Therapy|Physician Decision|4|||
146377025|NCT01678313|527883125|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
146377026|NCT01678313|527883126|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
146377027|NCT01678313|527883125|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
146377028|NCT01678313|527883126|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
146377029|NCT02635867|527883128|FG000|Overall Study|Lost to Follow-up|4|||
146377030|NCT02635867|527883129|FG001|Overall Study|Lost to Follow-up|3|||
146377031|NCT02635867|527883130|FG002|Overall Study|Lost to Follow-up|3|||
146377032|NCT02635867|527883131|FG003|Overall Study|Lost to Follow-up|4|||
146377033|NCT02635867|527883132|FG004|Overall Study|Lost to Follow-up|1|||
146377034|NCT02565576|527883135|FG000|Overall Study|abnormal lab value|2|||
146377035|NCT02565576|527883136|FG001|Overall Study|abnormal lab value|0|||
146377036|NCT02565576|527883135|FG000|Overall Study|subject / guardian decision|1|||
146377037|NCT02565576|527883136|FG001|Overall Study|subject / guardian decision|3|||
146377038|NCT02565576|527883135|FG000|Overall Study|Lost to Follow-up|1|||
146377039|NCT02565576|527883136|FG001|Overall Study|Lost to Follow-up|0|||
146377040|NCT02565576|527883135|FG000|Overall Study|Death|0|||
146377041|NCT02565576|527883136|FG001|Overall Study|Death|2|||
146377042|NCT02565576|527883135|FG000|Overall Study|Adverse Event|1|||
146377043|NCT02565576|527883136|FG001|Overall Study|Adverse Event|0|||
146377044|NCT00939341|527883137|FG000|Overall Study|Adverse Event|15|||
146377045|NCT00939341|527883137|FG000|Overall Study|Pregnancy|1|||
146377046|NCT00939341|527883137|FG000|Overall Study|Lost to Follow-up|23|||
146377047|NCT00939341|527883137|FG000|Overall Study|Withdrawal by Subject|13|||
146377048|NCT00939341|527883137|FG000|Overall Study|Protocol Violation|6|||
146377049|NCT00939341|527883137|FG000|Overall Study|Incorrect enrolment|8|||
146377050|NCT01131130|527883140|FG000|Period 1 - Baseline|Pregnancy|1|||
146377051|NCT01131130|527883140|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
146377052|NCT02437162|527883145|FG000|Overall Study|Protocol Violation|0|||
146377053|NCT02437162|527883146|FG001|Overall Study|Protocol Violation|1|||
146377054|NCT02437162|527883147|FG002|Overall Study|Protocol Violation|0|||
146377055|NCT02437162|527883145|FG000|Overall Study|Randomized but not treated|0|||
146377056|NCT02437162|527883146|FG001|Overall Study|Randomized but not treated|0|||
146377057|NCT02437162|527883147|FG002|Overall Study|Randomized but not treated|1|||
146377058|NCT02437162|527883145|FG000|Overall Study|Study discontinued by Sponsor|93|||
146377059|NCT02437162|527883146|FG001|Overall Study|Study discontinued by Sponsor|98|||
146377060|NCT02437162|527883147|FG002|Overall Study|Study discontinued by Sponsor|97|||
146377061|NCT02437162|527883145|FG000|Overall Study|Withdrawal by Subject|13|||
146377062|NCT02437162|527883146|FG001|Overall Study|Withdrawal by Subject|7|||
146377063|NCT02437162|527883147|FG002|Overall Study|Withdrawal by Subject|9|||
146377064|NCT02437162|527883145|FG000|Overall Study|Adverse Event|0|||
146377065|NCT02437162|527883146|FG001|Overall Study|Adverse Event|1|||
146377066|NCT02437162|527883147|FG002|Overall Study|Adverse Event|0|||
146377067|NCT02437162|527883145|FG000|Overall Study|Lost to Follow-up|1|||
146377068|NCT02437162|527883146|FG001|Overall Study|Lost to Follow-up|0|||
146377069|NCT02437162|527883147|FG002|Overall Study|Lost to Follow-up|1|||
146377070|NCT02437162|527883145|FG000|Overall Study|Death|0|||
146377071|NCT02437162|527883146|FG001|Overall Study|Death|1|||
146377072|NCT02437162|527883147|FG002|Overall Study|Death|0|||
146377073|NCT02437162|527883145|FG000|Overall Study|Other|0|||
146377074|NCT02437162|527883146|FG001|Overall Study|Other|0|||
146377075|NCT02437162|527883147|FG002|Overall Study|Other|1|||
146377076|NCT03981744|527883148|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146377077|NCT03981744|527883149|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
146377078|NCT03981744|527883150|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146377079|NCT03981744|527883151|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
146377080|NCT03981744|527883148|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146377081|NCT03981744|527883149|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146377082|NCT03981744|527883150|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
146377083|NCT03981744|527883151|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
146377084|NCT03981744|527883148|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146377085|NCT03981744|527883149|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146377086|NCT03981744|527883150|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
146377087|NCT03981744|527883151|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
146377088|NCT02782104|527883152|FG000|Overall Study|Other|215|||
146377089|NCT02782104|527883152|FG000|Overall Study|Induction Day 28 Non Responder|9|||
146377090|NCT02782104|527883152|FG000|Overall Study|Non-Compliance with Study Drug|2|||
146377091|NCT02782104|527883152|FG000|Overall Study|Death|8|||
146377092|NCT02782104|527883152|FG000|Overall Study|Pregnancy|6|||
146377093|NCT02782104|527883152|FG000|Overall Study|Withdrawal by Subject|63|||
146377094|NCT02782104|527883152|FG000|Overall Study|Protocol Violation|7|||
146377095|NCT02782104|527883152|FG000|Overall Study|Lack of Efficacy|61|||
146377096|NCT02782104|527883152|FG000|Overall Study|Lost to Follow-up|23|||
146377097|NCT02782104|527883152|FG000|Overall Study|Adverse Event|74|||
146377098|NCT03464136|527883153|FG000|Overall Study|Lost to Follow-up|5|||
146377099|NCT03464136|527883154|FG001|Overall Study|Lost to Follow-up|8|||
146377100|NCT03464136|527883153|FG000|Overall Study|Withdrawal by Subject|16|||
146377101|NCT03464136|527883154|FG001|Overall Study|Withdrawal by Subject|13|||
146377102|NCT03464136|527883153|FG000|Overall Study|Death|1|||
146377103|NCT03464136|527883154|FG001|Overall Study|Death|0|||
146377104|NCT03464136|527883153|FG000|Overall Study|Other|8|||
146377105|NCT03464136|527883154|FG001|Overall Study|Other|4|||
146377106|NCT04338321|527883155|FG000|Overall Study|Adverse Event|4|||
146377107|NCT04338321|527883156|FG001|Overall Study|Adverse Event|10|||
146377108|NCT04338321|527883155|FG000|Overall Study|Death|1|||
146377109|NCT04338321|527883156|FG001|Overall Study|Death|1|||
146377110|NCT04338321|527883155|FG000|Overall Study|Lost to Follow-up|4|||
146377111|NCT04338321|527883156|FG001|Overall Study|Lost to Follow-up|9|||
146377112|NCT04338321|527883155|FG000|Overall Study|Withdrawal by Subject|45|||
146377113|NCT04338321|527883156|FG001|Overall Study|Withdrawal by Subject|69|||
146377114|NCT04338321|527883155|FG000|Overall Study|Physician Decision|5|||
146377115|NCT04338321|527883156|FG001|Overall Study|Physician Decision|9|||
146377116|NCT04338321|527883155|FG000|Overall Study|Other|3|||
146377117|NCT04338321|527883156|FG001|Overall Study|Other|10|||
146377118|NCT02438787|527883157|FG000|Overall Study|Adverse Event|1|||
146377119|NCT02438787|527883158|FG001|Overall Study|Adverse Event|0|||
146377120|NCT02438787|527883159|FG002|Overall Study|Adverse Event|2|||
146377121|NCT02438787|527883157|FG000|Overall Study|Lack of Efficacy|1|||
146377122|NCT02438787|527883158|FG001|Overall Study|Lack of Efficacy|2|||
146377123|NCT02438787|527883159|FG002|Overall Study|Lack of Efficacy|0|||
146377124|NCT02438787|527883157|FG000|Overall Study|Lost to Follow-up|0|||
146377125|NCT02438787|527883158|FG001|Overall Study|Lost to Follow-up|1|||
146377126|NCT02438787|527883159|FG002|Overall Study|Lost to Follow-up|0|||
146377127|NCT02438787|527883157|FG000|Overall Study|Protocol Violation|0|||
146377128|NCT02438787|527883158|FG001|Overall Study|Protocol Violation|0|||
146377129|NCT02438787|527883159|FG002|Overall Study|Protocol Violation|1|||
146377130|NCT02438787|527883157|FG000|Overall Study|Withdrawal by Subject|15|||
146377131|NCT02438787|527883158|FG001|Overall Study|Withdrawal by Subject|7|||
146377132|NCT02438787|527883159|FG002|Overall Study|Withdrawal by Subject|10|||
146377133|NCT02438787|527883157|FG000|Overall Study|Study discontinued by sponsor|64|||
146377134|NCT02438787|527883158|FG001|Overall Study|Study discontinued by sponsor|72|||
146377135|NCT02438787|527883159|FG002|Overall Study|Study discontinued by sponsor|69|||
146377136|NCT02438787|527883157|FG000|Overall Study|Other|0|||
146377137|NCT02438787|527883158|FG001|Overall Study|Other|1|||
146377138|NCT02438787|527883159|FG002|Overall Study|Other|0|||
146377139|NCT02438787|527883157|FG000|Overall Study|Site terminated by sponsor|0|||
146377140|NCT02438787|527883158|FG001|Overall Study|Site terminated by sponsor|0|||
146377141|NCT02438787|527883159|FG002|Overall Study|Site terminated by sponsor|1|||
146377142|NCT03412565|527883160|FG000|Overall Study|Lost to Follow-up|0|||
146377143|NCT03412565|527883161|FG001|Overall Study|Lost to Follow-up|0|||
146377144|NCT03412565|527883162|FG002|Overall Study|Lost to Follow-up|1|||
146377145|NCT03412565|527883163|FG003|Overall Study|Lost to Follow-up|0|||
146377146|NCT03412565|527883160|FG000|Overall Study|Physician Decision|0|||
146377147|NCT03412565|527883161|FG001|Overall Study|Physician Decision|0|||
146377148|NCT03412565|527883162|FG002|Overall Study|Physician Decision|0|||
146377149|NCT03412565|527883163|FG003|Overall Study|Physician Decision|1|||
146377150|NCT03412565|527883160|FG000|Overall Study|Withdrawal by Subject|0|||
146377151|NCT03412565|527883161|FG001|Overall Study|Withdrawal by Subject|4|||
146377152|NCT03412565|527883162|FG002|Overall Study|Withdrawal by Subject|5|||
146377153|NCT03412565|527883163|FG003|Overall Study|Withdrawal by Subject|5|||
146377154|NCT03412565|527883160|FG000|Overall Study|Death|1|||
146377155|NCT03412565|527883161|FG001|Overall Study|Death|3|||
146377156|NCT03412565|527883162|FG002|Overall Study|Death|4|||
146377157|NCT03412565|527883163|FG003|Overall Study|Death|5|||
146377158|NCT03412565|527883160|FG000|Overall Study|Data collection ended|0|||
146377159|NCT03412565|527883161|FG001|Overall Study|Data collection ended|41|||
146377160|NCT03412565|527883162|FG002|Overall Study|Data collection ended|41|||
146377161|NCT03412565|527883163|FG003|Overall Study|Data collection ended|40|||
146377162|NCT03375203|527883164|FG000|Overall Study|Protocol Violation|0|||
146377163|NCT03375203|527883165|FG001|Overall Study|Protocol Violation|0|||
146377164|NCT03375203|527883166|FG002|Overall Study|Protocol Violation|1|||
146377165|NCT03375203|527883167|FG003|Overall Study|Protocol Violation|0|||
146377166|NCT03375203|527883168|FG004|Overall Study|Protocol Violation|0|||
146377167|NCT03375203|527883164|FG000|Overall Study|Adverse Event|2|||
146377168|NCT03375203|527883165|FG001|Overall Study|Adverse Event|3|||
146377169|NCT03375203|527883166|FG002|Overall Study|Adverse Event|0|||
146377170|NCT03375203|527883167|FG003|Overall Study|Adverse Event|2|||
146377171|NCT03375203|527883168|FG004|Overall Study|Adverse Event|2|||
146377172|NCT03375203|527883164|FG000|Overall Study|Withdrawal by Subject|3|||
146377173|NCT03375203|527883165|FG001|Overall Study|Withdrawal by Subject|0|||
146377174|NCT03375203|527883166|FG002|Overall Study|Withdrawal by Subject|1|||
146377175|NCT03375203|527883167|FG003|Overall Study|Withdrawal by Subject|0|||
146377176|NCT03375203|527883168|FG004|Overall Study|Withdrawal by Subject|2|||
146377177|NCT03375203|527883164|FG000|Overall Study|Non-compliance with study drug|1|||
146377178|NCT03375203|527883165|FG001|Overall Study|Non-compliance with study drug|0|||
146377179|NCT03375203|527883166|FG002|Overall Study|Non-compliance with study drug|0|||
146377180|NCT03375203|527883167|FG003|Overall Study|Non-compliance with study drug|0|||
146377181|NCT03375203|527883168|FG004|Overall Study|Non-compliance with study drug|0|||
146377182|NCT03375203|527883164|FG000|Overall Study|Randomized, not treated.|0|||
146377183|NCT03375203|527883165|FG001|Overall Study|Randomized, not treated.|1|||
146377184|NCT03375203|527883166|FG002|Overall Study|Randomized, not treated.|0|||
146377185|NCT03375203|527883167|FG003|Overall Study|Randomized, not treated.|0|||
146377186|NCT03375203|527883168|FG004|Overall Study|Randomized, not treated.|0|||
146377187|NCT03107793|527883169|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
146377188|NCT03107793|527883170|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
146377189|NCT03107793|527883171|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
146377190|NCT03107793|527883172|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
146377191|NCT03107793|527883173|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
146377192|NCT03107793|527883169|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
146377193|NCT03107793|527883170|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
146377194|NCT03107793|527883171|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
146377195|NCT03107793|527883172|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
146377196|NCT03107793|527883173|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
146377197|NCT03107793|527883169|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
146377198|NCT03107793|527883170|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
146377199|NCT03107793|527883171|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
146377200|NCT03107793|527883172|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
146377201|NCT03107793|527883173|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
146377202|NCT03107793|527883169|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
146377203|NCT03107793|527883170|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146377204|NCT03107793|527883171|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146377205|NCT03107793|527883172|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146377206|NCT03107793|527883173|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
146377207|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146377208|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
146377209|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
146377210|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146377211|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
146377212|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146377213|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
146377214|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
146377215|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146377216|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
146377217|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146377218|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146377219|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
146377220|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146377221|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
146377222|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146377223|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
146377224|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
146377225|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146377226|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
146377227|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
146377228|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
146377229|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
146377230|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
146377231|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
146377232|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146377233|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
146377234|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
146377235|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146377236|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
146377237|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146377238|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
146377239|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146377240|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146377241|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
146377242|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146377243|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
146377244|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
146377245|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146377246|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
146377247|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146377248|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146377249|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
146377250|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146377251|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
146377252|NCT03107793|527883169|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146377253|NCT03107793|527883170|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
146395882|NCT02646566|527952400|FG001|Overall Study|Lost to Follow-up|4|||
146377254|NCT03107793|527883171|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
146377255|NCT03107793|527883172|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146377256|NCT03107793|527883173|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
146377257|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146377258|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146377259|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
146377260|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
146377261|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
146377262|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146377263|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146377264|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146377265|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
146377266|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
146377267|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146377268|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146377269|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
146377270|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
146377271|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
146377272|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Death|0|||
146377273|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Death|0|||
146377274|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Death|0|||
146377275|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Death|0|||
146377276|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Death|1|||
146377277|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146377278|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146377279|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146377280|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
146377281|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
146377282|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146377283|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146377284|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
146377285|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
146377286|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
146377287|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146377288|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146377289|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
146377290|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
146377291|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
146377292|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146377293|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146377294|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146377295|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
146377296|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
146377297|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146377298|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146377299|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146377300|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
146377301|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
146377302|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Other|0|||
146377303|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Other|0|||
146377304|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Other|0|||
146377305|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Other|1|||
146377306|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Other|3|||
146377307|NCT03107793|527883169|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146377308|NCT03107793|527883170|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146377309|NCT03107793|527883171|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
146377310|NCT03107793|527883172|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
146377311|NCT03107793|527883173|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
146377312|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
146377313|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
146377314|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
146377315|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
146377316|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
146377317|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
146377318|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
146377319|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
146377320|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
146377321|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
146377322|NCT02418585|527883185|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
146377323|NCT02418585|527883186|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
146377324|NCT02418585|527883185|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
146377325|NCT02418585|527883186|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
146377326|NCT02418585|527883185|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
146377327|NCT02418585|527883186|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
146377328|NCT02418585|527883185|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
146377329|NCT02418585|527883186|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
146377330|NCT02418585|527883185|FG000|Follow-up Phase (24 Weeks)|Other|3|||
146377331|NCT02418585|527883186|FG001|Follow-up Phase (24 Weeks)|Other|2|||
146377332|NCT02040857|527883187|FG000|Overall Study|Adverse Event|14|||
146377333|NCT02040857|527883187|FG000|Overall Study|Physician Decision|5|||
146377334|NCT02040857|527883187|FG000|Overall Study|Withdrawal by Subject|31|||
146377335|NCT02040857|527883187|FG000|Overall Study|patient non-compliance|3|||
146377336|NCT02040857|527883187|FG000|Overall Study|Lost to Follow-up|2|||
146377337|NCT02040857|527883187|FG000|Overall Study|recurrence|4|||
146377338|NCT02040857|527883187|FG000|Overall Study|ineligible|1|||
146377339|NCT04159701|527883188|FG000|Period 1: Treatment Period|Pregnancy|1|||
146377340|NCT04159701|527883189|FG001|Period 1: Treatment Period|Pregnancy|0|||
146377341|NCT04159701|527883188|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
146377342|NCT04159701|527883189|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
146377343|NCT04159701|527883188|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
146377344|NCT04159701|527883189|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
146377345|NCT04159701|527883188|FG000|Washout Period|site terminated by sponsor|0|||
146377346|NCT04159701|527883189|FG001|Washout Period|site terminated by sponsor|1|||
146377347|NCT04159701|527883188|FG000|Washout Period|study terminated by sponsor|10|||
146377348|NCT04159701|527883189|FG001|Washout Period|study terminated by sponsor|3|||
146377349|NCT04159701|527883188|FG000|Washout Period|Withdrawal by Subject|1|||
146377350|NCT04159701|527883189|FG001|Washout Period|Withdrawal by Subject|0|||
146377351|NCT04159701|527883188|FG000|Washout Period|Inadvertent Enrollment|1|||
146377352|NCT04159701|527883189|FG001|Washout Period|Inadvertent Enrollment|0|||
146377353|NCT04159701|527883188|FG000|Washout Period|Miscellaneous|1|||
146377354|NCT04159701|527883189|FG001|Washout Period|Miscellaneous|0|||
146377355|NCT04159701|527883188|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
146377356|NCT04159701|527883189|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
146377357|NCT04159701|527883188|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
146377358|NCT04159701|527883189|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
146377359|NCT04159701|527883188|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
146377360|NCT04159701|527883189|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
146377361|NCT04159701|527883188|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
146377362|NCT04159701|527883189|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
146377363|NCT04159701|527883188|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
146377364|NCT04159701|527883189|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
146377365|NCT01849562|527883194|FG000|Overall Study|Lost to Follow-up|1|||
146377366|NCT01849562|527883195|FG001|Overall Study|Lost to Follow-up|0|||
146377367|NCT01849562|527883196|FG002|Overall Study|Lost to Follow-up|0|||
146377368|NCT01849562|527883194|FG000|Overall Study|Non-compliance with Study Drug|1|||
146377369|NCT01849562|527883195|FG001|Overall Study|Non-compliance with Study Drug|0|||
146377370|NCT01849562|527883196|FG002|Overall Study|Non-compliance with Study Drug|0|||
146377371|NCT01024920|527883197|FG000|Overall Study|Progressive disease|47|||
146377372|NCT01024920|527883198|FG001|Overall Study|Progressive disease|25|||
146377373|NCT01024920|527883197|FG000|Overall Study|Adverse Event|8|||
146377374|NCT01024920|527883198|FG001|Overall Study|Adverse Event|4|||
146377375|NCT01024920|527883197|FG000|Overall Study|Lost to Follow-up|0|||
146377376|NCT01024920|527883198|FG001|Overall Study|Lost to Follow-up|1|||
146377377|NCT01024920|527883197|FG000|Overall Study|Patient refusal to continue|4|||
146377378|NCT01024920|527883198|FG001|Overall Study|Patient refusal to continue|0|||
146377379|NCT01024920|527883197|FG000|Overall Study|Other than listed|5|||
146377380|NCT01024920|527883198|FG001|Overall Study|Other than listed|1|||
146377381|NCT01024920|527883197|FG000|Overall Study|Not treated|3|||
146377382|NCT01024920|527883198|FG001|Overall Study|Not treated|0|||
146377383|NCT01024920|527883197|FG000|Overall Study|Protocol Violation|0|||
146377384|NCT01024920|527883198|FG001|Overall Study|Protocol Violation|1|||
146377385|NCT00329784|527883199|FG000|Overall Study|Lost to Follow-up|0|||
146377386|NCT00329784|527883200|FG001|Overall Study|Lost to Follow-up|1|||
146377387|NCT00329784|527883201|FG002|Overall Study|Lost to Follow-up|0|||
146377388|NCT00329784|527883202|FG003|Overall Study|Lost to Follow-up|0|||
146377389|NCT00329784|527883199|FG000|Overall Study|Withdrawal by Subject|4|||
146377390|NCT00329784|527883200|FG001|Overall Study|Withdrawal by Subject|2|||
146377391|NCT00329784|527883201|FG002|Overall Study|Withdrawal by Subject|0|||
146377392|NCT00329784|527883202|FG003|Overall Study|Withdrawal by Subject|0|||
146377393|NCT00329784|527883199|FG000|Overall Study|Other|1|||
146377394|NCT00329784|527883200|FG001|Overall Study|Other|2|||
146377395|NCT00329784|527883201|FG002|Overall Study|Other|0|||
146377396|NCT00329784|527883202|FG003|Overall Study|Other|0|||
146377397|NCT03152110|527883213|FG000|Overall Study|Withdrawal by Subject|3|||
146377398|NCT00552344|527883214|FG000|Overall Study|Lack of Efficacy|55|||
146377399|NCT00552344|527883214|FG000|Overall Study|Loss of efficacy|75|||
146377400|NCT00552344|527883214|FG000|Overall Study|Lost to Follow-up|8|||
146377401|NCT00552344|527883214|FG000|Overall Study|Withdrawal by Subject|48|||
146377402|NCT00552344|527883214|FG000|Overall Study|SAE, non-fatal|6|||
146377403|NCT00552344|527883214|FG000|Overall Study|AE, non-serious non-fatal|38|||
146377404|NCT00552344|527883214|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
146377405|NCT00552344|527883214|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
146377406|NCT00552344|527883214|FG000|Overall Study|Other Reason|22|||
146377407|NCT01634100|527883215|FG000|Overall Study|Withdrawal by Subject|1|||
146377408|NCT01634100|527883216|FG001|Overall Study|Withdrawal by Subject|0|||
146377409|NCT01634100|527883217|FG002|Overall Study|Withdrawal by Subject|1|||
146377410|NCT01634100|527883218|FG003|Overall Study|Withdrawal by Subject|0|||
146377411|NCT01634100|527883219|FG004|Overall Study|Withdrawal by Subject|0|||
146377412|NCT01634100|527883220|FG005|Overall Study|Withdrawal by Subject|0|||
146377413|NCT00471276|527883221|FG000|Overall Study|Death|2|||
146377414|NCT00471276|527883221|FG000|Overall Study|Adverse Event|16|||
146377415|NCT00471276|527883221|FG000|Overall Study|Protocol Violation|1|||
146377416|NCT00471276|527883221|FG000|Overall Study|Objective progression or relapse|54|||
146377417|NCT00471276|527883221|FG000|Overall Study|Global deterioration of health status|1|||
146377418|NCT00471276|527883221|FG000|Overall Study|Other|3|||
146377419|NCT00471276|527883221|FG000|Overall Study|Refused treatment|6|||
146377420|NCT00338806|527883222|FG000|Acute Phase|Withdrawal by Subject|0|||
146377421|NCT00338806|527883223|FG001|Acute Phase|Withdrawal by Subject|1|||
146377422|NCT00338806|527883222|FG000|Follow-up|Lost to Follow-up|1|||
146377423|NCT00338806|527883223|FG001|Follow-up|Lost to Follow-up|3|||
146377424|NCT00744991|527883224|FG000|Overall Study|Progressive Disease|11|||
146377425|NCT00744991|527883224|FG000|Overall Study|Withdrawal by Subject|8|||
146377426|NCT00744991|527883224|FG000|Overall Study|Physician Decision|3|||
146377427|NCT00744991|527883224|FG000|Overall Study|Adverse Event|2|||
146377428|NCT00744991|527883224|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
146377429|NCT01662986|527883225|FG000|Overall Study|Adverse Event|5|||
146377430|NCT01662986|527883226|FG001|Overall Study|Adverse Event|4|||
146377431|NCT01662986|527883225|FG000|Overall Study|Protocol Violation|2|||
146377432|NCT01662986|527883226|FG001|Overall Study|Protocol Violation|3|||
146377433|NCT01662986|527883225|FG000|Overall Study|Lost to Follow-up|5|||
146377434|NCT01662986|527883226|FG001|Overall Study|Lost to Follow-up|4|||
146377435|NCT01662986|527883225|FG000|Overall Study|Withdrawal by Subject|2|||
146377436|NCT01662986|527883226|FG001|Overall Study|Withdrawal by Subject|2|||
146377437|NCT01662986|527883225|FG000|Overall Study|Not Treated|1|||
146377438|NCT01662986|527883226|FG001|Overall Study|Not Treated|0|||
146377439|NCT01662986|527883225|FG000|Overall Study|Other than stated above|3|||
146377440|NCT01662986|527883226|FG001|Overall Study|Other than stated above|0|||
146377441|NCT01487863|527883227|FG000|Overall Study|Death|19|||
146377442|NCT01487863|527883228|FG001|Overall Study|Death|19|||
146377443|NCT01975376|527883229|FG000|Overall Study|Adverse Event|5|||
146377444|NCT01975376|527883230|FG001|Overall Study|Adverse Event|5|||
146377445|NCT01975376|527883229|FG000|Overall Study|Death|65|||
146377446|NCT01975376|527883230|FG001|Overall Study|Death|72|||
146377447|NCT01975376|527883229|FG000|Overall Study|Lost to Follow-up|70|||
146377448|NCT01975376|527883230|FG001|Overall Study|Lost to Follow-up|66|||
146377449|NCT01975376|527883229|FG000|Overall Study|Withdrew consent|68|||
146377450|NCT01975376|527883230|FG001|Overall Study|Withdrew consent|62|||
146377451|NCT01975376|527883229|FG000|Overall Study|Other|2|||
146377452|NCT01975376|527883230|FG001|Overall Study|Other|4|||
146377453|NCT01975376|527883229|FG000|Overall Study|Randomized, Not Treated|16|||
146377454|NCT01975376|527883230|FG001|Overall Study|Randomized, Not Treated|8|||
146377455|NCT04449276|527883231|FG000|Overall Study|Adverse Event|1|||
146377456|NCT04449276|527883232|FG001|Overall Study|Adverse Event|2|||
146377457|NCT04449276|527883233|FG002|Overall Study|Adverse Event|0|||
146377458|NCT04449276|527883234|FG003|Overall Study|Adverse Event|0|||
146377459|NCT04449276|527883235|FG004|Overall Study|Adverse Event|2|||
146377460|NCT04449276|527883236|FG005|Overall Study|Adverse Event|0|||
146377461|NCT04449276|527883237|FG006|Overall Study|Adverse Event|0|||
146377462|NCT04449276|527883238|FG007|Overall Study|Adverse Event|1|||
146377463|NCT04449276|527883231|FG000|Overall Study|Withdrawal by Subject|2|||
146377464|NCT04449276|527883232|FG001|Overall Study|Withdrawal by Subject|0|||
146377465|NCT04449276|527883233|FG002|Overall Study|Withdrawal by Subject|0|||
146377466|NCT04449276|527883234|FG003|Overall Study|Withdrawal by Subject|1|||
146377467|NCT04449276|527883235|FG004|Overall Study|Withdrawal by Subject|0|||
146377468|NCT04449276|527883236|FG005|Overall Study|Withdrawal by Subject|0|||
146377469|NCT04449276|527883237|FG006|Overall Study|Withdrawal by Subject|0|||
146377470|NCT04449276|527883238|FG007|Overall Study|Withdrawal by Subject|0|||
146377471|NCT04449276|527883231|FG000|Overall Study|Other|0|||
146377472|NCT04449276|527883232|FG001|Overall Study|Other|2|||
146377473|NCT04449276|527883233|FG002|Overall Study|Other|3|||
146377474|NCT04449276|527883234|FG003|Overall Study|Other|2|||
146377475|NCT04449276|527883235|FG004|Overall Study|Other|0|||
146377476|NCT04449276|527883236|FG005|Overall Study|Other|0|||
146377477|NCT04449276|527883237|FG006|Overall Study|Other|0|||
146377478|NCT04449276|527883238|FG007|Overall Study|Other|1|||
146377479|NCT01614795|527883239|FG000|Overall Study|Adverse Event|0|||
146377480|NCT01614795|527883240|FG001|Overall Study|Adverse Event|0|||
146377481|NCT01614795|527883241|FG002|Overall Study|Adverse Event|1|||
146377482|NCT01614795|527883242|FG003|Overall Study|Adverse Event|1|||
146377483|NCT01614795|527883239|FG000|Overall Study|Lack of Efficacy|10|||
146377484|NCT01614795|527883240|FG001|Overall Study|Lack of Efficacy|10|||
146377485|NCT01614795|527883241|FG002|Overall Study|Lack of Efficacy|9|||
146377486|NCT01614795|527883242|FG003|Overall Study|Lack of Efficacy|8|||
146377487|NCT01614795|527883239|FG000|Overall Study|Physician Decision|1|||
146377488|NCT01614795|527883240|FG001|Overall Study|Physician Decision|0|||
146377489|NCT01614795|527883241|FG002|Overall Study|Physician Decision|1|||
146377490|NCT01614795|527883242|FG003|Overall Study|Physician Decision|1|||
146377491|NCT01614795|527883239|FG000|Overall Study|Withdrawal by Subject|0|||
146377492|NCT01614795|527883240|FG001|Overall Study|Withdrawal by Subject|1|||
146377493|NCT01614795|527883241|FG002|Overall Study|Withdrawal by Subject|0|||
146377494|NCT01614795|527883242|FG003|Overall Study|Withdrawal by Subject|2|||
146377495|NCT01614795|527883239|FG000|Overall Study|Ineligible|0|||
146377496|NCT01614795|527883240|FG001|Overall Study|Ineligible|1|||
146377497|NCT01614795|527883241|FG002|Overall Study|Ineligible|0|||
146377498|NCT01614795|527883242|FG003|Overall Study|Ineligible|0|||
146377499|NCT00179517|527883248|FG000|Overall Study|Withdrawal by Subject|2|||
146377500|NCT00179517|527883249|FG001|Overall Study|Withdrawal by Subject|1|||
146377501|NCT00023712|527883250|FG000|Overall Study|Not platinum sensitive|1|||
146377502|NCT00023712|527883251|FG001|Overall Study|Not platinum sensitive|0|||
146377503|NCT00023712|527883250|FG000|Overall Study|Never treated|1|||
146377504|NCT00023712|527883251|FG001|Overall Study|Never treated|1|||
146377505|NCT00044213|527883253|FG000|Overall Study|Withdrawal by Subject|50|||
146377506|NCT00044213|527883254|FG001|Overall Study|Withdrawal by Subject|65|||
146377507|NCT00044213|527883255|FG002|Overall Study|Withdrawal by Subject|91|||
146377508|NCT00044213|527883256|FG003|Overall Study|Withdrawal by Subject|83|||
146377509|NCT00044213|527883253|FG000|Overall Study|Death|42|||
146377510|NCT00044213|527883254|FG001|Overall Study|Death|42|||
146377511|NCT00044213|527883255|FG002|Overall Study|Death|42|||
146377512|NCT00044213|527883256|FG003|Overall Study|Death|49|||
146377513|NCT00044213|527883253|FG000|Overall Study|Lost to Follow-up|8|||
146377514|NCT00044213|527883254|FG001|Overall Study|Lost to Follow-up|5|||
146377515|NCT00044213|527883255|FG002|Overall Study|Lost to Follow-up|5|||
146377516|NCT00044213|527883256|FG003|Overall Study|Lost to Follow-up|4|||
146377517|NCT00251589|527883263|FG000|Overall Study|Adverse Event|5|||
146377518|NCT00251589|527883264|FG001|Overall Study|Adverse Event|1|||
146377519|NCT00251589|527883265|FG002|Overall Study|Adverse Event|2|||
146377520|NCT00251589|527883266|FG003|Overall Study|Adverse Event|1|||
146377521|NCT00251589|527883263|FG000|Overall Study|Withdrawal by Subject|1|||
146377522|NCT00251589|527883264|FG001|Overall Study|Withdrawal by Subject|1|||
146377523|NCT00251589|527883265|FG002|Overall Study|Withdrawal by Subject|0|||
146377524|NCT00251589|527883266|FG003|Overall Study|Withdrawal by Subject|0|||
146377525|NCT00251589|527883263|FG000|Overall Study|Discontinued due to progressive disease|9|||
146377526|NCT00251589|527883264|FG001|Overall Study|Discontinued due to progressive disease|1|||
146377527|NCT00251589|527883265|FG002|Overall Study|Discontinued due to progressive disease|0|||
146377528|NCT00251589|527883266|FG003|Overall Study|Discontinued due to progressive disease|1|||
146377529|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Adverse Event|22|||
146377530|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Adverse Event|0|||
146377531|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
146377532|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
146377533|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
146377534|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
146377535|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
146377536|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
146377537|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
146377538|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
146377539|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
146377540|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
146377541|NCT02493868|527883267|FG000|Induction Phase: DE Participants|Other|8|||
146377542|NCT02493868|527883268|FG001|Induction Phase: DE Participants|Other|0|||
146377543|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
146377544|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
146377545|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
146377546|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
146377547|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
146377548|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
146377549|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
146377550|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
146377551|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
146377552|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
146377553|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
146377554|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
146377555|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
146377556|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
146377557|NCT02493868|527883267|FG000|Optimization Phase: DE+TE Participants|Other|10|||
146377558|NCT02493868|527883268|FG001|Optimization Phase: DE+TE Participants|Other|2|||
146377559|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
146377560|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
146377561|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
146377562|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
146377563|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
146377564|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
146377565|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
146377566|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
146377567|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
146377568|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
146377569|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
146377570|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
146377571|NCT02493868|527883267|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
146377572|NCT02493868|527883268|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
146377573|NCT02493868|527883267|FG000|Follow-up Phase|Lost to Follow-up|1|||
146377574|NCT02493868|527883268|FG001|Follow-up Phase|Lost to Follow-up|0|||
146377575|NCT02493868|527883267|FG000|Follow-up Phase|Withdrawal by Subject|3|||
146377576|NCT02493868|527883268|FG001|Follow-up Phase|Withdrawal by Subject|0|||
146377577|NCT02493868|527883267|FG000|Follow-up Phase|Investigator Decision|5|||
146377578|NCT02493868|527883268|FG001|Follow-up Phase|Investigator Decision|1|||
146377579|NCT02493868|527883267|FG000|Follow-up Phase|Other|2|||
146377580|NCT02493868|527883268|FG001|Follow-up Phase|Other|1|||
146377581|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
146377582|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
146377583|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
146377584|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
146377585|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
146377586|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
146377587|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
146377588|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
146377589|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
146377590|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
146377591|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
146377592|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
146377593|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
146377594|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Death|0|||
146377595|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Death|0|||
146377596|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Death|1|||
146377597|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Death|0|||
146377598|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Death|0|||
146377599|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Death|0|||
146377600|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Death|0|||
146377601|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Death|0|||
146377602|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Death|0|||
146377603|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Death|0|||
146377604|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Death|0|||
146377605|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Death|0|||
146377606|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Death|0|||
146377607|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
146377608|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
146377609|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
146377610|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377611|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377612|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377613|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377614|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377615|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377616|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377617|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377618|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377619|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
146377620|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377621|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377622|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
146377623|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377624|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377625|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377626|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377627|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377628|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377629|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377630|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377631|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377632|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
146377633|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
146377634|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
146377635|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
146377636|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
146377637|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
146377638|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
146377639|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
146377640|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
146377641|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
146377642|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
146377643|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
146377644|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
146377645|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
146377646|NCT02407236|527883269|FG000|Induction Study (8 Weeks)|Other|2|||
146377647|NCT02407236|527883270|FG001|Induction Study (8 Weeks)|Other|1|||
146377648|NCT02407236|527883271|FG002|Induction Study (8 Weeks)|Other|5|||
146377649|NCT02407236|527883272|FG003|Induction Study (8 Weeks)|Other|0|||
146377650|NCT02407236|527883273|FG004|Induction Study (8 Weeks)|Other|0|||
146377651|NCT02407236|527883274|FG005|Induction Study (8 Weeks)|Other|0|||
146377652|NCT02407236|527883275|FG006|Induction Study (8 Weeks)|Other|0|||
146377653|NCT02407236|527883276|FG007|Induction Study (8 Weeks)|Other|0|||
146377654|NCT02407236|527883277|FG008|Induction Study (8 Weeks)|Other|0|||
146377655|NCT02407236|527883278|FG009|Induction Study (8 Weeks)|Other|0|||
146377656|NCT02407236|527883279|FG010|Induction Study (8 Weeks)|Other|0|||
146377657|NCT02407236|527883280|FG011|Induction Study (8 Weeks)|Other|0|||
146377658|NCT02407236|527883281|FG012|Induction Study (8 Weeks)|Other|0|||
146377659|NCT02407236|527883269|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377660|NCT02407236|527883270|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377661|NCT02407236|527883271|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377662|NCT02407236|527883272|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
146377663|NCT02407236|527883273|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
146377664|NCT02407236|527883274|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
146377665|NCT02407236|527883275|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
146377666|NCT02407236|527883276|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
146377667|NCT02407236|527883277|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377668|NCT02407236|527883278|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377669|NCT02407236|527883279|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377670|NCT02407236|527883280|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377671|NCT02407236|527883281|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
146377672|NCT02407236|527883269|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377673|NCT02407236|527883270|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377674|NCT02407236|527883271|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377675|NCT02407236|527883272|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
146377676|NCT02407236|527883273|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
146377677|NCT02407236|527883274|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
146377678|NCT02407236|527883275|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
146377679|NCT02407236|527883276|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
146377680|NCT02407236|527883277|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377681|NCT02407236|527883278|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377682|NCT02407236|527883279|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377683|NCT02407236|527883280|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377684|NCT02407236|527883281|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
146377685|NCT02407236|527883269|FG000|Maintenance Study (44 Weeks)|Other|0|||
146377686|NCT02407236|527883270|FG001|Maintenance Study (44 Weeks)|Other|0|||
146377687|NCT02407236|527883271|FG002|Maintenance Study (44 Weeks)|Other|0|||
146377688|NCT02407236|527883272|FG003|Maintenance Study (44 Weeks)|Other|5|||
146377689|NCT02407236|527883273|FG004|Maintenance Study (44 Weeks)|Other|7|||
146377690|NCT02407236|527883274|FG005|Maintenance Study (44 Weeks)|Other|8|||
146377691|NCT02407236|527883275|FG006|Maintenance Study (44 Weeks)|Other|4|||
146377692|NCT02407236|527883276|FG007|Maintenance Study (44 Weeks)|Other|6|||
146377693|NCT02407236|527883277|FG008|Maintenance Study (44 Weeks)|Other|0|||
146377694|NCT02407236|527883278|FG009|Maintenance Study (44 Weeks)|Other|0|||
146377695|NCT02407236|527883279|FG010|Maintenance Study (44 Weeks)|Other|0|||
146377696|NCT02407236|527883280|FG011|Maintenance Study (44 Weeks)|Other|0|||
146377697|NCT02407236|527883281|FG012|Maintenance Study (44 Weeks)|Other|0|||
146377698|NCT02407236|527883269|FG000|Maintenance Study (44 Weeks)|Death|0|||
146377699|NCT02407236|527883270|FG001|Maintenance Study (44 Weeks)|Death|0|||
146377700|NCT02407236|527883271|FG002|Maintenance Study (44 Weeks)|Death|0|||
146377701|NCT02407236|527883272|FG003|Maintenance Study (44 Weeks)|Death|0|||
146377702|NCT02407236|527883273|FG004|Maintenance Study (44 Weeks)|Death|0|||
146377703|NCT02407236|527883274|FG005|Maintenance Study (44 Weeks)|Death|0|||
146377704|NCT02407236|527883275|FG006|Maintenance Study (44 Weeks)|Death|0|||
146377705|NCT02407236|527883276|FG007|Maintenance Study (44 Weeks)|Death|1|||
146377706|NCT02407236|527883277|FG008|Maintenance Study (44 Weeks)|Death|0|||
146377707|NCT02407236|527883278|FG009|Maintenance Study (44 Weeks)|Death|0|||
146377708|NCT02407236|527883279|FG010|Maintenance Study (44 Weeks)|Death|0|||
146377709|NCT02407236|527883280|FG011|Maintenance Study (44 Weeks)|Death|0|||
146377710|NCT02407236|527883281|FG012|Maintenance Study (44 Weeks)|Death|0|||
146377711|NCT02407236|527883269|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377712|NCT02407236|527883270|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377713|NCT02407236|527883271|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377714|NCT02407236|527883272|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377715|NCT02407236|527883273|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377716|NCT02407236|527883274|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377717|NCT02407236|527883275|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377718|NCT02407236|527883276|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
146377719|NCT02407236|527883277|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
146377720|NCT02407236|527883278|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
146377721|NCT02407236|527883279|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
146377722|NCT02407236|527883280|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
146377723|NCT02407236|527883281|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
146377724|NCT02407236|527883269|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377725|NCT02407236|527883270|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377726|NCT02407236|527883271|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377727|NCT02407236|527883272|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377728|NCT02407236|527883273|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377729|NCT02407236|527883274|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377730|NCT02407236|527883275|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377731|NCT02407236|527883276|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377732|NCT02407236|527883277|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377733|NCT02407236|527883278|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377734|NCT02407236|527883279|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
146377735|NCT02407236|527883280|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377736|NCT02407236|527883281|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
146377737|NCT02407236|527883269|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377738|NCT02407236|527883270|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377739|NCT02407236|527883271|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377740|NCT02407236|527883272|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377741|NCT02407236|527883273|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377742|NCT02407236|527883274|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377743|NCT02407236|527883275|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377744|NCT02407236|527883276|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
146377745|NCT02407236|527883277|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
146377746|NCT02407236|527883278|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
146377747|NCT02407236|527883279|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
146377748|NCT02407236|527883280|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
146377749|NCT02407236|527883281|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
146377750|NCT02407236|527883269|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
146377751|NCT02407236|527883270|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
146377752|NCT02407236|527883271|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
146377753|NCT02407236|527883272|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
146377754|NCT02407236|527883273|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
146377755|NCT02407236|527883274|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
146377756|NCT02407236|527883275|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
146377757|NCT02407236|527883276|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
146377758|NCT02407236|527883277|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
146377759|NCT02407236|527883278|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
146377760|NCT02407236|527883279|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
146377761|NCT02407236|527883280|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
146377762|NCT02407236|527883281|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
146377763|NCT01167153|527883282|FG000|Overall Study|Non-effective therapy|1|||
146377764|NCT01167153|527883283|FG001|Overall Study|Non-effective therapy|4|||
146377765|NCT01167153|527883282|FG000|Overall Study|AE including clinical laboratory AE|2|||
146377766|NCT01167153|527883283|FG001|Overall Study|AE including clinical laboratory AE|8|||
146377767|NCT01167153|527883282|FG000|Overall Study|Hypotension|1|||
146377768|NCT01167153|527883283|FG001|Overall Study|Hypotension|0|||
146377769|NCT01167153|527883282|FG000|Overall Study|Lost to Follow-up|7|||
146377770|NCT01167153|527883283|FG001|Overall Study|Lost to Follow-up|9|||
146377771|NCT01167153|527883282|FG000|Overall Study|Non-compliance to concomitant medication|0|||
146377772|NCT01167153|527883283|FG001|Overall Study|Non-compliance to concomitant medication|2|||
146377773|NCT01167153|527883282|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
146377774|NCT01167153|527883283|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
146377775|NCT01167153|527883282|FG000|Overall Study|Withdrawal consent|1|||
146377776|NCT01167153|527883283|FG001|Overall Study|Withdrawal consent|1|||
146377777|NCT01167153|527883282|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
146377778|NCT01167153|527883283|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
146377779|NCT00464620|527885401|FG000|Overall Study|Physician Decision|1|||
146377780|NCT00464620|527885402|FG001|Overall Study|Physician Decision|0|||
146377781|NCT00464620|527885403|FG002|Overall Study|Physician Decision|0|||
146377782|NCT00464620|527885401|FG000|Overall Study|Withdrawal by Subject|1|||
146377783|NCT00464620|527885402|FG001|Overall Study|Withdrawal by Subject|0|||
146377784|NCT00464620|527885403|FG002|Overall Study|Withdrawal by Subject|3|||
146377785|NCT00464620|527885401|FG000|Overall Study|Ineligible sarcoma subtype|0|||
146377786|NCT00464620|527885402|FG001|Overall Study|Ineligible sarcoma subtype|2|||
146377787|NCT00464620|527885403|FG002|Overall Study|Ineligible sarcoma subtype|2|||
146377788|NCT00464620|527885401|FG000|Overall Study|Use of prohibited concomitant medication|0|||
146377789|NCT00464620|527885402|FG001|Overall Study|Use of prohibited concomitant medication|0|||
146377790|NCT00464620|527885403|FG002|Overall Study|Use of prohibited concomitant medication|2|||
146377791|NCT01998906|527885404|FG000|Overall Study|Participants ongoing in follow-up|77|||
146377792|NCT01998906|527885405|FG001|Overall Study|Participants ongoing in follow-up|60|||
146377793|NCT01998906|527885406|FG002|Overall Study|Participants ongoing in follow-up|58|||
146377794|NCT01998906|527885404|FG000|Overall Study|Death|21|||
146377795|NCT01998906|527885405|FG001|Overall Study|Death|30|||
146377796|NCT01998906|527885406|FG002|Overall Study|Death|17|||
146377797|NCT01998906|527885404|FG000|Overall Study|Lack of Efficacy|10|||
146377798|NCT01998906|527885405|FG001|Overall Study|Lack of Efficacy|9|||
146377799|NCT01998906|527885406|FG002|Overall Study|Lack of Efficacy|8|||
146377800|NCT01998906|527885404|FG000|Overall Study|Failure to return|0|||
146377801|NCT01998906|527885405|FG001|Overall Study|Failure to return|2|||
146377802|NCT01998906|527885406|FG002|Overall Study|Failure to return|4|||
146377803|NCT01998906|527885404|FG000|Overall Study|Violation of Selection Criteria|0|||
146377804|NCT01998906|527885405|FG001|Overall Study|Violation of Selection Criteria|0|||
146377805|NCT01998906|527885406|FG002|Overall Study|Violation of Selection Criteria|1|||
146377806|NCT01998906|527885404|FG000|Overall Study|Withdrawal by Subject|1|||
146377807|NCT01998906|527885405|FG001|Overall Study|Withdrawal by Subject|4|||
146377808|NCT01998906|527885406|FG002|Overall Study|Withdrawal by Subject|3|||
146377809|NCT01998906|527885404|FG000|Overall Study|Administrative/Other|2|||
146377810|NCT01998906|527885405|FG001|Overall Study|Administrative/Other|1|||
146377811|NCT01998906|527885406|FG002|Overall Study|Administrative/Other|3|||
146377812|NCT01998906|527885404|FG000|Overall Study|Other|3|||
146377813|NCT01998906|527885405|FG001|Overall Study|Other|8|||
146377814|NCT01998906|527885406|FG002|Overall Study|Other|4|||
146377815|NCT01572844|527885407|FG000|Overall Study|Physician Decision|1|||
146377816|NCT01572844|527885408|FG001|Overall Study|Physician Decision|1|||
146377817|NCT04984876|527885413|FG000|Overall Study|Subject decision|2|||
146377818|NCT04984876|527885414|FG001|Overall Study|Subject decision|10|||
146377819|NCT04984876|527885415|FG002|Overall Study|Subject decision|3|||
146377820|NCT04984876|527885416|FG003|Overall Study|Subject decision|3|||
146377821|NCT04984876|527885417|FG004|Overall Study|Subject decision|3|||
146377822|NCT04984876|527885418|FG005|Overall Study|Subject decision|0|||
146377823|NCT04984876|527885413|FG000|Overall Study|Guardian decision|0|||
146377824|NCT04984876|527885414|FG001|Overall Study|Guardian decision|1|||
146377825|NCT04984876|527885415|FG002|Overall Study|Guardian decision|0|||
146377826|NCT04984876|527885416|FG003|Overall Study|Guardian decision|2|||
146377827|NCT04984876|527885417|FG004|Overall Study|Guardian decision|0|||
146377828|NCT04984876|527885418|FG005|Overall Study|Guardian decision|1|||
146377829|NCT04984876|527885413|FG000|Overall Study|Lost to Follow-up|0|||
146377830|NCT04984876|527885414|FG001|Overall Study|Lost to Follow-up|0|||
146377831|NCT04984876|527885415|FG002|Overall Study|Lost to Follow-up|1|||
146377832|NCT04984876|527885416|FG003|Overall Study|Lost to Follow-up|1|||
146377833|NCT04984876|527885417|FG004|Overall Study|Lost to Follow-up|0|||
146377834|NCT04984876|527885418|FG005|Overall Study|Lost to Follow-up|0|||
146377835|NCT04984876|527885413|FG000|Overall Study|Physician Decision|1|||
146377836|NCT04984876|527885414|FG001|Overall Study|Physician Decision|0|||
146377837|NCT04984876|527885415|FG002|Overall Study|Physician Decision|0|||
146377838|NCT04984876|527885416|FG003|Overall Study|Physician Decision|1|||
146377839|NCT04984876|527885417|FG004|Overall Study|Physician Decision|0|||
146377840|NCT04984876|527885418|FG005|Overall Study|Physician Decision|0|||
146377841|NCT04984876|527885413|FG000|Overall Study|Adverse Event|0|||
146377842|NCT04984876|527885414|FG001|Overall Study|Adverse Event|0|||
146377843|NCT04984876|527885415|FG002|Overall Study|Adverse Event|1|||
146377844|NCT04984876|527885416|FG003|Overall Study|Adverse Event|0|||
146377845|NCT04984876|527885417|FG004|Overall Study|Adverse Event|0|||
146377846|NCT04984876|527885418|FG005|Overall Study|Adverse Event|0|||
146377847|NCT02204410|527885419|FG000|Overall Study|Lost to Follow-up|5|||
146377848|NCT02204410|527885419|FG000|Overall Study|Physician Decision|2|||
146377849|NCT02204410|527885419|FG000|Overall Study|Protocol Violation|1|||
146377850|NCT02204410|527885419|FG000|Overall Study|Withdrawal by Subject|3|||
146377851|NCT01462045|527885424|FG000|Overall Study|Family matter|0|||
146377852|NCT01462045|527885425|FG001|Overall Study|Family matter|1|||
146377853|NCT01462045|527885426|FG002|Overall Study|Family matter|0|||
146377854|NCT06073054|527885435|FG000|Overall Study|Withdrawal by Subject|2|||
146377855|NCT03149029|527885436|FG000|Overall Study|Adverse Event|2|||
146377856|NCT03149029|527885437|FG001|Overall Study|Adverse Event|0|||
146377857|NCT00068822|527885438|FG000|First Randomized Intervention|Lost to Follow-up|1|||
146377858|NCT00068822|527885439|FG001|First Randomized Intervention|Lost to Follow-up|2|||
146377859|NCT00981292|527885440|FG000|Day 1|Protocol Violation|1|||
146377860|NCT00981292|527885441|FG001|Day 1|Protocol Violation|0|||
146377861|NCT00981292|527885442|FG002|Day 1|Protocol Violation|0|||
146377862|NCT00981292|527885443|FG003|Day 1|Protocol Violation|0|||
146377863|NCT00981292|527885444|FG004|Day 1|Protocol Violation|0|||
146377864|NCT00981292|527885445|FG005|Day 1|Protocol Violation|2|||
146377865|NCT00981292|527885440|FG000|Day 2|Protocol Violation|2|||
146377866|NCT00981292|527885441|FG001|Day 2|Protocol Violation|0|||
146377867|NCT00981292|527885442|FG002|Day 2|Protocol Violation|0|||
146377868|NCT00981292|527885443|FG003|Day 2|Protocol Violation|0|||
146377869|NCT00981292|527885444|FG004|Day 2|Protocol Violation|0|||
146377870|NCT00981292|527885445|FG005|Day 2|Protocol Violation|0|||
146377871|NCT00981292|527885440|FG000|Day 3|Protocol Violation|0|||
146377872|NCT00981292|527885441|FG001|Day 3|Protocol Violation|0|||
146377873|NCT00981292|527885442|FG002|Day 3|Protocol Violation|0|||
146377874|NCT00981292|527885443|FG003|Day 3|Protocol Violation|0|||
146377875|NCT00981292|527885444|FG004|Day 3|Protocol Violation|0|||
146377876|NCT00981292|527885445|FG005|Day 3|Protocol Violation|1|||
146377877|NCT00764322|527885446|FG000|Overall Study|Withdrawal by Subject|11|||
146377878|NCT00764322|527885446|FG000|Overall Study|No CYP2D6 genotyping|9|||
146377879|NCT03345342|527885447|FG000|Open-Label Phase|Adverse Event|30|||
146377880|NCT03345342|527885448|FG001|Open-Label Phase|Adverse Event|0|||
146377881|NCT03345342|527885449|FG002|Open-Label Phase|Adverse Event|0|||
146377882|NCT03345342|527885450|FG003|Open-Label Phase|Adverse Event|0|||
146377883|NCT03345342|527885451|FG004|Open-Label Phase|Adverse Event|0|||
146377884|NCT03345342|527885447|FG000|Open-Label Phase|Death|1|||
146377885|NCT03345342|527885448|FG001|Open-Label Phase|Death|0|||
146377886|NCT03345342|527885449|FG002|Open-Label Phase|Death|0|||
146377887|NCT03345342|527885450|FG003|Open-Label Phase|Death|0|||
146377888|NCT03345342|527885451|FG004|Open-Label Phase|Death|0|||
146377889|NCT03345342|527885447|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
146377890|NCT03345342|527885448|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
146377891|NCT03345342|527885449|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
146377892|NCT03345342|527885450|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
146377893|NCT03345342|527885451|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
146377894|NCT03345342|527885447|FG000|Open-Label Phase|Lack of Efficacy|6|||
146377895|NCT03345342|527885448|FG001|Open-Label Phase|Lack of Efficacy|0|||
146377896|NCT03345342|527885449|FG002|Open-Label Phase|Lack of Efficacy|0|||
146377897|NCT03345342|527885450|FG003|Open-Label Phase|Lack of Efficacy|0|||
146377898|NCT03345342|527885451|FG004|Open-Label Phase|Lack of Efficacy|0|||
146377899|NCT03345342|527885447|FG000|Open-Label Phase|Lost to Follow-up|9|||
146377900|NCT03345342|527885448|FG001|Open-Label Phase|Lost to Follow-up|0|||
146377901|NCT03345342|527885449|FG002|Open-Label Phase|Lost to Follow-up|0|||
146377902|NCT03345342|527885450|FG003|Open-Label Phase|Lost to Follow-up|0|||
146377903|NCT03345342|527885451|FG004|Open-Label Phase|Lost to Follow-up|0|||
146377904|NCT03345342|527885447|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
146377905|NCT03345342|527885448|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
146377906|NCT03345342|527885449|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
146377907|NCT03345342|527885450|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
146377908|NCT03345342|527885451|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
146377909|NCT03345342|527885447|FG000|Open-Label Phase|Physician Decision|4|||
146377910|NCT03345342|527885448|FG001|Open-Label Phase|Physician Decision|0|||
146377911|NCT03345342|527885449|FG002|Open-Label Phase|Physician Decision|0|||
146377912|NCT03345342|527885450|FG003|Open-Label Phase|Physician Decision|0|||
146377913|NCT03345342|527885451|FG004|Open-Label Phase|Physician Decision|0|||
146377914|NCT03345342|527885447|FG000|Open-Label Phase|Protocol Violation|8|||
146377915|NCT03345342|527885448|FG001|Open-Label Phase|Protocol Violation|0|||
146377916|NCT03345342|527885449|FG002|Open-Label Phase|Protocol Violation|0|||
146377917|NCT03345342|527885450|FG003|Open-Label Phase|Protocol Violation|0|||
146377918|NCT03345342|527885451|FG004|Open-Label Phase|Protocol Violation|0|||
146377919|NCT03345342|527885447|FG000|Open-Label Phase|Withdrawal by Subject|57|||
146377920|NCT03345342|527885448|FG001|Open-Label Phase|Withdrawal by Subject|0|||
146377921|NCT03345342|527885449|FG002|Open-Label Phase|Withdrawal by Subject|0|||
146377922|NCT03345342|527885450|FG003|Open-Label Phase|Withdrawal by Subject|0|||
146377923|NCT03345342|527885451|FG004|Open-Label Phase|Withdrawal by Subject|0|||
146377924|NCT03345342|527885447|FG000|Open-Label Phase|Other|15|||
146377925|NCT03345342|527885448|FG001|Open-Label Phase|Other|0|||
146377926|NCT03345342|527885449|FG002|Open-Label Phase|Other|0|||
146377927|NCT03345342|527885450|FG003|Open-Label Phase|Other|0|||
146377928|NCT03345342|527885451|FG004|Open-Label Phase|Other|0|||
146377929|NCT03345342|527885447|FG000|Double-Blind Phase|Adverse Event|0|||
146377930|NCT03345342|527885448|FG001|Double-Blind Phase|Adverse Event|1|||
146377931|NCT03345342|527885449|FG002|Double-Blind Phase|Adverse Event|6|||
146377932|NCT03345342|527885450|FG003|Double-Blind Phase|Adverse Event|0|||
146377933|NCT03345342|527885451|FG004|Double-Blind Phase|Adverse Event|0|||
146377934|NCT03345342|527885447|FG000|Double-Blind Phase|Death|0|||
146377935|NCT03345342|527885448|FG001|Double-Blind Phase|Death|2|||
146377936|NCT03345342|527885449|FG002|Double-Blind Phase|Death|1|||
146377937|NCT03345342|527885450|FG003|Double-Blind Phase|Death|0|||
146377938|NCT03345342|527885451|FG004|Double-Blind Phase|Death|0|||
146377939|NCT03345342|527885447|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
146377940|NCT03345342|527885448|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
146377941|NCT03345342|527885449|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
146377942|NCT03345342|527885450|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
146377943|NCT03345342|527885451|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
146377944|NCT03345342|527885447|FG000|Double-Blind Phase|Lost to Follow-up|0|||
146377945|NCT03345342|527885448|FG001|Double-Blind Phase|Lost to Follow-up|1|||
146377946|NCT03345342|527885449|FG002|Double-Blind Phase|Lost to Follow-up|7|||
146377947|NCT03345342|527885450|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146377948|NCT03345342|527885451|FG004|Double-Blind Phase|Lost to Follow-up|0|||
146377949|NCT03345342|527885447|FG000|Double-Blind Phase|Physician Decision|0|||
146377950|NCT03345342|527885448|FG001|Double-Blind Phase|Physician Decision|1|||
146377951|NCT03345342|527885449|FG002|Double-Blind Phase|Physician Decision|4|||
146377952|NCT03345342|527885450|FG003|Double-Blind Phase|Physician Decision|0|||
146377953|NCT03345342|527885451|FG004|Double-Blind Phase|Physician Decision|0|||
146377954|NCT03345342|527885447|FG000|Double-Blind Phase|Protocol Violation|0|||
146377955|NCT03345342|527885448|FG001|Double-Blind Phase|Protocol Violation|0|||
146377956|NCT03345342|527885449|FG002|Double-Blind Phase|Protocol Violation|1|||
146377957|NCT03345342|527885450|FG003|Double-Blind Phase|Protocol Violation|0|||
146377958|NCT03345342|527885451|FG004|Double-Blind Phase|Protocol Violation|0|||
146377959|NCT03345342|527885447|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
146377960|NCT03345342|527885448|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
146377961|NCT03345342|527885449|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
146377962|NCT03345342|527885450|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
146377963|NCT03345342|527885451|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
146377964|NCT03345342|527885447|FG000|Double-Blind Phase|Other|0|||
146377965|NCT03345342|527885448|FG001|Double-Blind Phase|Other|1|||
146377966|NCT03345342|527885449|FG002|Double-Blind Phase|Other|3|||
146377967|NCT03345342|527885450|FG003|Double-Blind Phase|Other|0|||
146377968|NCT03345342|527885451|FG004|Double-Blind Phase|Other|0|||
146377969|NCT03345342|527885447|FG000|Follow-Up Phase|Adverse Event|0|||
146377970|NCT03345342|527885448|FG001|Follow-Up Phase|Adverse Event|0|||
146377971|NCT03345342|527885449|FG002|Follow-Up Phase|Adverse Event|0|||
146377972|NCT03345342|527885450|FG003|Follow-Up Phase|Adverse Event|0|||
146377973|NCT03345342|527885451|FG004|Follow-Up Phase|Adverse Event|4|||
146377974|NCT03345342|527885447|FG000|Follow-Up Phase|Lost to Follow-up|0|||
146377975|NCT03345342|527885448|FG001|Follow-Up Phase|Lost to Follow-up|0|||
146377976|NCT03345342|527885449|FG002|Follow-Up Phase|Lost to Follow-up|0|||
146377977|NCT03345342|527885450|FG003|Follow-Up Phase|Lost to Follow-up|0|||
146377978|NCT03345342|527885451|FG004|Follow-Up Phase|Lost to Follow-up|6|||
146377979|NCT03345342|527885447|FG000|Follow-Up Phase|Physician Decision|0|||
146377980|NCT03345342|527885448|FG001|Follow-Up Phase|Physician Decision|0|||
146377981|NCT03345342|527885449|FG002|Follow-Up Phase|Physician Decision|0|||
146377982|NCT03345342|527885450|FG003|Follow-Up Phase|Physician Decision|0|||
146377983|NCT03345342|527885451|FG004|Follow-Up Phase|Physician Decision|5|||
146377984|NCT03345342|527885447|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
146377985|NCT03345342|527885448|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
146377986|NCT03345342|527885449|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
146377987|NCT03345342|527885450|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
146377988|NCT03345342|527885451|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
146377989|NCT03345342|527885447|FG000|Follow-Up Phase|Other|0|||
146377990|NCT03345342|527885448|FG001|Follow-Up Phase|Other|0|||
146377991|NCT03345342|527885449|FG002|Follow-Up Phase|Other|0|||
146377992|NCT03345342|527885450|FG003|Follow-Up Phase|Other|3|||
146377993|NCT03345342|527885451|FG004|Follow-Up Phase|Other|1|||
146395883|NCT02646566|527952401|FG002|Overall Study|Lost to Follow-up|5|||
146377994|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
146377995|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
146377996|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
146377997|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
146377998|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
146377999|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
146378000|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
146378001|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
146378002|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
146378003|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
146378004|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
146378005|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
146378006|NCT03321526|527885452|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
146378007|NCT03321526|527885453|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
146378008|NCT03321526|527885452|FG000|Follow-up Phase (2 Weeks)|Other|24|||
146378009|NCT03321526|527885453|FG001|Follow-up Phase (2 Weeks)|Other|24|||
146378010|NCT01989572|527885454|FG000|Overall Study|Lack of Efficacy|35|||
146378011|NCT01989572|527885455|FG001|Overall Study|Lack of Efficacy|48|||
146378012|NCT01989572|527885456|FG002|Overall Study|Lack of Efficacy|48|||
146378013|NCT01989572|527885457|FG003|Overall Study|Lack of Efficacy|43|||
146378014|NCT01989572|527885458|FG004|Overall Study|Lack of Efficacy|71|||
146378015|NCT01989572|527885459|FG005|Overall Study|Lack of Efficacy|79|||
146378016|NCT01989572|527885454|FG000|Overall Study|Adverse Event|2|||
146378017|NCT01989572|527885455|FG001|Overall Study|Adverse Event|1|||
146378018|NCT01989572|527885456|FG002|Overall Study|Adverse Event|3|||
146378019|NCT01989572|527885457|FG003|Overall Study|Adverse Event|0|||
146378020|NCT01989572|527885458|FG004|Overall Study|Adverse Event|3|||
146378021|NCT01989572|527885459|FG005|Overall Study|Adverse Event|0|||
146378022|NCT01989572|527885454|FG000|Overall Study|Death|0|||
146378023|NCT01989572|527885455|FG001|Overall Study|Death|0|||
146378024|NCT01989572|527885456|FG002|Overall Study|Death|0|||
146378025|NCT01989572|527885457|FG003|Overall Study|Death|0|||
146378026|NCT01989572|527885458|FG004|Overall Study|Death|1|||
146378027|NCT01989572|527885459|FG005|Overall Study|Death|0|||
146378028|NCT01989572|527885454|FG000|Overall Study|Withdrawal by Subject|4|||
146378029|NCT01989572|527885455|FG001|Overall Study|Withdrawal by Subject|1|||
146378030|NCT01989572|527885456|FG002|Overall Study|Withdrawal by Subject|5|||
146378031|NCT01989572|527885457|FG003|Overall Study|Withdrawal by Subject|1|||
146378032|NCT01989572|527885458|FG004|Overall Study|Withdrawal by Subject|12|||
146378033|NCT01989572|527885459|FG005|Overall Study|Withdrawal by Subject|4|||
146378034|NCT01989572|527885454|FG000|Overall Study|complicating disease|1|||
146378035|NCT01989572|527885455|FG001|Overall Study|complicating disease|1|||
146378036|NCT01989572|527885456|FG002|Overall Study|complicating disease|2|||
146378037|NCT01989572|527885457|FG003|Overall Study|complicating disease|0|||
146378038|NCT01989572|527885458|FG004|Overall Study|complicating disease|1|||
146378039|NCT01989572|527885459|FG005|Overall Study|complicating disease|0|||
146378040|NCT01989572|527885454|FG000|Overall Study|error|2|||
146378041|NCT01989572|527885455|FG001|Overall Study|error|1|||
146378042|NCT01989572|527885456|FG002|Overall Study|error|1|||
146378043|NCT01989572|527885457|FG003|Overall Study|error|1|||
146378044|NCT01989572|527885458|FG004|Overall Study|error|1|||
146378045|NCT01989572|527885459|FG005|Overall Study|error|1|||
146378046|NCT01989572|527885454|FG000|Overall Study|maximum dose reached|0|||
146378047|NCT01989572|527885455|FG001|Overall Study|maximum dose reached|1|||
146378048|NCT01989572|527885456|FG002|Overall Study|maximum dose reached|0|||
146378049|NCT01989572|527885457|FG003|Overall Study|maximum dose reached|0|||
146378050|NCT01989572|527885458|FG004|Overall Study|maximum dose reached|1|||
146378051|NCT01989572|527885459|FG005|Overall Study|maximum dose reached|0|||
146378052|NCT01989572|527885454|FG000|Overall Study|unknown/not specify|3|||
146378053|NCT01989572|527885455|FG001|Overall Study|unknown/not specify|4|||
146378054|NCT01989572|527885456|FG002|Overall Study|unknown/not specify|1|||
146378055|NCT01989572|527885457|FG003|Overall Study|unknown/not specify|3|||
146378056|NCT01989572|527885458|FG004|Overall Study|unknown/not specify|3|||
146378057|NCT01989572|527885459|FG005|Overall Study|unknown/not specify|5|||
146378058|NCT01989572|527885454|FG000|Overall Study|not start protocol therapy|5|||
146378059|NCT01989572|527885455|FG001|Overall Study|not start protocol therapy|1|||
146378060|NCT01989572|527885456|FG002|Overall Study|not start protocol therapy|2|||
146378061|NCT01989572|527885457|FG003|Overall Study|not start protocol therapy|3|||
146378062|NCT01989572|527885458|FG004|Overall Study|not start protocol therapy|4|||
146378063|NCT01989572|527885459|FG005|Overall Study|not start protocol therapy|18|||
146378064|NCT01989572|527885454|FG000|Overall Study|alternative therapy|3|||
146378065|NCT01989572|527885455|FG001|Overall Study|alternative therapy|0|||
146378066|NCT01989572|527885456|FG002|Overall Study|alternative therapy|0|||
146378067|NCT01989572|527885457|FG003|Overall Study|alternative therapy|0|||
146378068|NCT01989572|527885458|FG004|Overall Study|alternative therapy|1|||
146378069|NCT01989572|527885459|FG005|Overall Study|alternative therapy|3|||
146378070|NCT04599972|527885460|FG000|Overall Study|Withdrawal by Subject|6|||
146378071|NCT04599972|527885461|FG001|Overall Study|Withdrawal by Subject|1|||
146378072|NCT04599972|527885460|FG000|Overall Study|Adverse Event|1|||
146378073|NCT04599972|527885461|FG001|Overall Study|Adverse Event|1|||
146378074|NCT04599972|527885460|FG000|Overall Study|Lost to Follow-up|1|||
146378075|NCT04599972|527885461|FG001|Overall Study|Lost to Follow-up|6|||
146378076|NCT04599972|527885460|FG000|Overall Study|Protocol Violation|1|||
146378077|NCT04599972|527885461|FG001|Overall Study|Protocol Violation|0|||
146378078|NCT04599972|527885460|FG000|Overall Study|Other reason|1|||
146378079|NCT04599972|527885461|FG001|Overall Study|Other reason|0|||
146378080|NCT00638690|527885462|FG000|Overall Study|Death|655|||
146378081|NCT00638690|527885463|FG001|Overall Study|Death|335|||
146378082|NCT00638690|527885462|FG000|Overall Study|Withdrawal by Subject|22|||
146378083|NCT00638690|527885463|FG001|Overall Study|Withdrawal by Subject|5|||
146378084|NCT00638690|527885462|FG000|Overall Study|Lost to Follow-up|4|||
146378085|NCT00638690|527885463|FG001|Overall Study|Lost to Follow-up|2|||
146378086|NCT02348840|527885464|FG000|Overall Study|Withdrawal by Subject|2|||
146378087|NCT02348840|527885465|FG001|Overall Study|Withdrawal by Subject|1|||
146378088|NCT02348840|527885466|FG002|Overall Study|Withdrawal by Subject|0|||
146378089|NCT02348840|527885467|FG003|Overall Study|Withdrawal by Subject|0|||
146378090|NCT00373880|527885468|FG000|Overall Study|Physician Decision|3|||
146378091|NCT00373880|527885468|FG000|Overall Study|Arrested|1|||
146378092|NCT00373880|527885468|FG000|Overall Study|Protocol Violation|14|||
146378093|NCT01347073|527885470|FG000|Overall Study|Adverse Event|1|||
146378094|NCT01347073|527885470|FG000|Overall Study|Liver Transplant|1|||
146378095|NCT00621244|527885471|FG000|Overall Study|Withdrawal by Subject|7|||
146378096|NCT00621244|527885472|FG001|Overall Study|Withdrawal by Subject|3|||
146378097|NCT00621244|527885473|FG002|Overall Study|Withdrawal by Subject|3|||
146378098|NCT00621244|527885474|FG003|Overall Study|Withdrawal by Subject|3|||
146378099|NCT00621244|527885471|FG000|Overall Study|Disease progression|44|||
146378100|NCT00621244|527885472|FG001|Overall Study|Disease progression|20|||
146378101|NCT00621244|527885473|FG002|Overall Study|Disease progression|20|||
146378102|NCT00621244|527885474|FG003|Overall Study|Disease progression|15|||
146378103|NCT00621244|527885471|FG000|Overall Study|Death|3|||
146378104|NCT00621244|527885472|FG001|Overall Study|Death|3|||
146378105|NCT00621244|527885473|FG002|Overall Study|Death|1|||
146378106|NCT00621244|527885474|FG003|Overall Study|Death|1|||
146378107|NCT00621244|527885471|FG000|Overall Study|Adverse Event|27|||
146378108|NCT00621244|527885472|FG001|Overall Study|Adverse Event|7|||
146378109|NCT00621244|527885473|FG002|Overall Study|Adverse Event|9|||
146378110|NCT00621244|527885474|FG003|Overall Study|Adverse Event|2|||
146378111|NCT00621244|527885471|FG000|Overall Study|Administrative problems|5|||
146378112|NCT00621244|527885472|FG001|Overall Study|Administrative problems|1|||
146378113|NCT00621244|527885473|FG002|Overall Study|Administrative problems|0|||
146378114|NCT00621244|527885474|FG003|Overall Study|Administrative problems|2|||
146378115|NCT01466062|527885475|FG000|Overall Study|Adverse Event|1|||
146378116|NCT01466062|527885475|FG000|Overall Study|Withdrawal by Subject|1|||
146378117|NCT02865928|527885476|FG000|Overall Study|Withdrawal by Subject|1|||
146378118|NCT02865928|527885477|FG001|Overall Study|Withdrawal by Subject|0|||
146378119|NCT02865928|527885476|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
146378120|NCT02865928|527885477|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
146378121|NCT02865928|527885476|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
146378122|NCT02865928|527885477|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
146378123|NCT01925014|527885484|FG000|Overall Study|Inappropriate enrollment|4|||
146378124|NCT01925014|527885485|FG001|Overall Study|Inappropriate enrollment|6|||
146378125|NCT01925014|527885484|FG000|Overall Study|Withdrawal by Subject|5|||
146378126|NCT01925014|527885485|FG001|Overall Study|Withdrawal by Subject|13|||
146378127|NCT01690988|527885486|FG000|Overall Study|Withdrawal by Subject|2|||
146378128|NCT01690988|527885487|FG001|Overall Study|Withdrawal by Subject|2|||
146378129|NCT01690988|527885488|FG002|Overall Study|Withdrawal by Subject|3|||
146378130|NCT01690988|527885486|FG000|Overall Study|Physician Decision|0|||
146378131|NCT01690988|527885487|FG001|Overall Study|Physician Decision|0|||
146378132|NCT01690988|527885488|FG002|Overall Study|Physician Decision|1|||
146378133|NCT01690988|527885486|FG000|Overall Study|Operation Cancelled|1|||
146378134|NCT01690988|527885487|FG001|Overall Study|Operation Cancelled|1|||
146378135|NCT01690988|527885488|FG002|Overall Study|Operation Cancelled|0|||
146378136|NCT01690988|527885486|FG000|Overall Study|Determined ineligible|1|||
146378137|NCT01690988|527885487|FG001|Overall Study|Determined ineligible|0|||
146378138|NCT01690988|527885488|FG002|Overall Study|Determined ineligible|0|||
146378139|NCT01690988|527885486|FG000|Overall Study|Death|1|||
146378140|NCT01690988|527885487|FG001|Overall Study|Death|1|||
146378141|NCT01690988|527885488|FG002|Overall Study|Death|1|||
146378142|NCT01690988|527885486|FG000|Overall Study|Sedated|1|||
146378143|NCT01690988|527885487|FG001|Overall Study|Sedated|1|||
146378144|NCT01690988|527885488|FG002|Overall Study|Sedated|2|||
146378145|NCT03696576|527885491|FG000|Overall Study|Soreness of throat after therapy|1|||
146378146|NCT03696576|527885492|FG001|Overall Study|Soreness of throat after therapy|1|||
146378147|NCT03696576|527885491|FG000|Overall Study|Lost to Follow-up|2|||
146378148|NCT03696576|527885492|FG001|Overall Study|Lost to Follow-up|4|||
146378149|NCT00312728|527885493|FG000|Overall Study|Progressive disease|53|||
146378150|NCT00312728|527885493|FG000|Overall Study|Adverse Event|32|||
146378151|NCT00312728|527885493|FG000|Overall Study|Withdrawal by Subject|10|||
146378152|NCT00312728|527885493|FG000|Overall Study|Required non-protocol cancer treatment|2|||
146378153|NCT00312728|527885493|FG000|Overall Study|Protocol Violation|2|||
146378154|NCT00312728|527885493|FG000|Overall Study|Other|10|||
146378155|NCT00312728|527885493|FG000|Overall Study|Other|1|||
146378156|NCT01819194|527885506|FG000|Overall Study|Loss of study articles|2|||
146378157|NCT00045630|527885507|FG000|Overall Study|Adverse Event|1|||
146378158|NCT00045630|527885507|FG000|Overall Study|Refusal unrelated to adverse event|1|||
146378159|NCT00045630|527885507|FG000|Overall Study|Progression/relapse|1|||
146378160|NCT00045630|527885507|FG000|Overall Study|Death|1|||
146378161|NCT00045630|527885507|FG000|Overall Study|Ineligible|2|||
146378162|NCT00701103|527885508|FG000|Overall Study|Adverse Event|0|||
146378163|NCT00701103|527885509|FG001|Overall Study|Adverse Event|0|||
146378164|NCT00701103|527885510|FG002|Overall Study|Adverse Event|1|||
146378165|NCT00701103|527885511|FG003|Overall Study|Adverse Event|1|||
146378166|NCT00701103|527885512|FG004|Overall Study|Adverse Event|0|||
146378167|NCT00701103|527885513|FG005|Overall Study|Adverse Event|1|||
146378168|NCT00701103|527885514|FG006|Overall Study|Adverse Event|1|||
146378169|NCT00701103|527885515|FG007|Overall Study|Adverse Event|0|||
146378170|NCT00701103|527885516|FG008|Overall Study|Adverse Event|0|||
146378171|NCT00701103|527885517|FG009|Overall Study|Adverse Event|2|||
146378172|NCT00701103|527885518|FG010|Overall Study|Adverse Event|0|||
146378173|NCT00701103|527885508|FG000|Overall Study|Progressive Disease|5|||
146378174|NCT00701103|527885509|FG001|Overall Study|Progressive Disease|2|||
146378175|NCT00701103|527885510|FG002|Overall Study|Progressive Disease|6|||
146378176|NCT00701103|527885511|FG003|Overall Study|Progressive Disease|5|||
146378177|NCT00701103|527885512|FG004|Overall Study|Progressive Disease|6|||
146378178|NCT00701103|527885513|FG005|Overall Study|Progressive Disease|5|||
146378179|NCT00701103|527885514|FG006|Overall Study|Progressive Disease|7|||
146378180|NCT00701103|527885515|FG007|Overall Study|Progressive Disease|7|||
146378181|NCT00701103|527885516|FG008|Overall Study|Progressive Disease|8|||
146378182|NCT00701103|527885517|FG009|Overall Study|Progressive Disease|8|||
146378183|NCT00701103|527885518|FG010|Overall Study|Progressive Disease|11|||
146378184|NCT00701103|527885508|FG000|Overall Study|Withdrawal by Subject|0|||
146378185|NCT00701103|527885509|FG001|Overall Study|Withdrawal by Subject|1|||
146378186|NCT00701103|527885510|FG002|Overall Study|Withdrawal by Subject|1|||
146378187|NCT00701103|527885511|FG003|Overall Study|Withdrawal by Subject|0|||
146378188|NCT00701103|527885512|FG004|Overall Study|Withdrawal by Subject|0|||
146378189|NCT00701103|527885513|FG005|Overall Study|Withdrawal by Subject|0|||
146378190|NCT00701103|527885514|FG006|Overall Study|Withdrawal by Subject|0|||
146378191|NCT00701103|527885515|FG007|Overall Study|Withdrawal by Subject|0|||
146378192|NCT00701103|527885516|FG008|Overall Study|Withdrawal by Subject|0|||
146378193|NCT00701103|527885517|FG009|Overall Study|Withdrawal by Subject|0|||
146378194|NCT00701103|527885518|FG010|Overall Study|Withdrawal by Subject|0|||
146378195|NCT00701103|527885508|FG000|Overall Study|Other|0|||
146378196|NCT00701103|527885509|FG001|Overall Study|Other|0|||
146378197|NCT00701103|527885510|FG002|Overall Study|Other|0|||
146378198|NCT00701103|527885511|FG003|Overall Study|Other|0|||
146378199|NCT00701103|527885512|FG004|Overall Study|Other|0|||
146378200|NCT00701103|527885513|FG005|Overall Study|Other|0|||
146378201|NCT00701103|527885514|FG006|Overall Study|Other|0|||
146378202|NCT00701103|527885515|FG007|Overall Study|Other|0|||
146378203|NCT00701103|527885516|FG008|Overall Study|Other|1|||
146378204|NCT00701103|527885517|FG009|Overall Study|Other|1|||
146378205|NCT00701103|527885518|FG010|Overall Study|Other|0|||
146378206|NCT00614991|527885527|FG000|Overall Study|Adverse Event|3|||
146378207|NCT00614991|527885528|FG001|Overall Study|Adverse Event|3|||
146378208|NCT00614991|527885529|FG002|Overall Study|Adverse Event|0|||
146378209|NCT00614991|527885530|FG003|Overall Study|Adverse Event|0|||
146378210|NCT00614991|527885531|FG004|Overall Study|Adverse Event|1|||
146378211|NCT00614991|527885532|FG005|Overall Study|Adverse Event|0|||
146378212|NCT02623699|527885533|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378213|NCT02623699|527885534|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
146378214|NCT02623699|527885535|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378215|NCT02623699|527885536|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378216|NCT02623699|527885537|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378217|NCT02623699|527885538|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378218|NCT02623699|527885539|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378219|NCT02623699|527885540|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378220|NCT02623699|527885541|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378221|NCT02623699|527885542|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378222|NCT02623699|527885543|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378223|NCT02623699|527885544|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
146378224|NCT02623699|527885533|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378225|NCT02623699|527885534|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378226|NCT02623699|527885535|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378227|NCT02623699|527885536|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378228|NCT02623699|527885537|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378229|NCT02623699|527885538|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378230|NCT02623699|527885539|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
146378231|NCT02623699|527885540|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378232|NCT02623699|527885541|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378233|NCT02623699|527885542|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378234|NCT02623699|527885543|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378235|NCT02623699|527885544|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
146378236|NCT02623699|527885533|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378237|NCT02623699|527885534|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378238|NCT02623699|527885535|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378239|NCT02623699|527885536|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378240|NCT02623699|527885537|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378241|NCT02623699|527885538|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
146378242|NCT02623699|527885539|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378243|NCT02623699|527885540|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378244|NCT02623699|527885541|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378245|NCT02623699|527885542|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378246|NCT02623699|527885543|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378247|NCT02623699|527885544|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
146378248|NCT02623699|527885533|FG000|Part B (Up to 289 Days)|Death|0|||
146378249|NCT02623699|527885534|FG001|Part B (Up to 289 Days)|Death|0|||
146378250|NCT02623699|527885535|FG002|Part B (Up to 289 Days)|Death|0|||
146378251|NCT02623699|527885536|FG003|Part B (Up to 289 Days)|Death|0|||
146378252|NCT02623699|527885537|FG004|Part B (Up to 289 Days)|Death|0|||
146378253|NCT02623699|527885538|FG005|Part B (Up to 289 Days)|Death|1|||
146378254|NCT02623699|527885539|FG006|Part B (Up to 289 Days)|Death|1|||
146378255|NCT02623699|527885540|FG007|Part B (Up to 289 Days)|Death|0|||
146378256|NCT02623699|527885541|FG008|Part B (Up to 289 Days)|Death|1|||
146378257|NCT02623699|527885542|FG009|Part B (Up to 289 Days)|Death|0|||
146378258|NCT02623699|527885543|FG010|Part B (Up to 289 Days)|Death|0|||
146378259|NCT02623699|527885544|FG011|Part B (Up to 289 Days)|Death|0|||
146378260|NCT02623699|527885533|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
146378261|NCT02623699|527885534|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
146378262|NCT02623699|527885535|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
146378263|NCT02623699|527885536|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
146378264|NCT02623699|527885537|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
146378265|NCT02623699|527885538|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
146378266|NCT02623699|527885539|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
146378267|NCT02623699|527885540|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
146378268|NCT02623699|527885541|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
146378269|NCT02623699|527885542|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
146378270|NCT02623699|527885543|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
146378271|NCT02623699|527885544|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
146378272|NCT02623699|527885533|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378273|NCT02623699|527885534|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378274|NCT02623699|527885535|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378275|NCT02623699|527885536|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378276|NCT02623699|527885537|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378277|NCT02623699|527885538|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378278|NCT02623699|527885539|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378279|NCT02623699|527885540|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378280|NCT02623699|527885541|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378281|NCT02623699|527885542|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
146378282|NCT02623699|527885543|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
146378283|NCT02623699|527885544|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
146378284|NCT02623699|527885533|FG000|Part C (Up to 236 Days)|Death|0|||
146378285|NCT02623699|527885534|FG001|Part C (Up to 236 Days)|Death|0|||
146378286|NCT02623699|527885535|FG002|Part C (Up to 236 Days)|Death|0|||
146378287|NCT02623699|527885536|FG003|Part C (Up to 236 Days)|Death|0|||
146378288|NCT02623699|527885537|FG004|Part C (Up to 236 Days)|Death|0|||
146378289|NCT02623699|527885538|FG005|Part C (Up to 236 Days)|Death|0|||
146378290|NCT02623699|527885539|FG006|Part C (Up to 236 Days)|Death|0|||
146378291|NCT02623699|527885540|FG007|Part C (Up to 236 Days)|Death|0|||
146378292|NCT02623699|527885541|FG008|Part C (Up to 236 Days)|Death|0|||
146378293|NCT02623699|527885542|FG009|Part C (Up to 236 Days)|Death|0|||
146378294|NCT02623699|527885543|FG010|Part C (Up to 236 Days)|Death|0|||
146378295|NCT02623699|527885544|FG011|Part C (Up to 236 Days)|Death|1|||
146378296|NCT02623699|527885533|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
146056247|NCT03535974|526721153|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
146378297|NCT02623699|527885534|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
146378298|NCT02623699|527885535|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
146378299|NCT02623699|527885536|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
146378300|NCT02623699|527885537|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
146378301|NCT02623699|527885538|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
146378302|NCT02623699|527885539|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
146378303|NCT02623699|527885540|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
146378304|NCT02623699|527885541|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
146378305|NCT02623699|527885542|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
146378306|NCT02623699|527885543|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
146378307|NCT02623699|527885544|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
146378308|NCT00033371|527885545|FG000|Overall Study|Adverse Event|1|||
146378309|NCT00033371|527885546|FG001|Overall Study|Adverse Event|5|||
146378310|NCT00033371|527885545|FG000|Overall Study|Lost to Follow-up|2|||
146378311|NCT00033371|527885546|FG001|Overall Study|Lost to Follow-up|1|||
146378312|NCT00033371|527885545|FG000|Overall Study|Withdrawal by Subject|3|||
146378313|NCT00033371|527885546|FG001|Overall Study|Withdrawal by Subject|3|||
146378314|NCT00033371|527885545|FG000|Overall Study|Disease Progression|0|||
146378315|NCT00033371|527885546|FG001|Overall Study|Disease Progression|1|||
146378316|NCT00422240|527885547|FG000|Overall Study|Lack of Efficacy|1|||
146378317|NCT00422240|527885548|FG001|Overall Study|Lack of Efficacy|2|||
146378318|NCT00422240|527885549|FG002|Overall Study|Lack of Efficacy|0|||
146378319|NCT00422240|527885550|FG003|Overall Study|Lack of Efficacy|1|||
146378320|NCT00422240|527885547|FG000|Overall Study|Adverse Event|11|||
146378321|NCT00422240|527885548|FG001|Overall Study|Adverse Event|4|||
146378322|NCT00422240|527885549|FG002|Overall Study|Adverse Event|5|||
146378323|NCT00422240|527885550|FG003|Overall Study|Adverse Event|2|||
146378324|NCT00422240|527885547|FG000|Overall Study|Subject request|21|||
146378325|NCT00422240|527885548|FG001|Overall Study|Subject request|17|||
146378326|NCT00422240|527885549|FG002|Overall Study|Subject request|18|||
146378327|NCT00422240|527885550|FG003|Overall Study|Subject request|30|||
146378328|NCT00422240|527885547|FG000|Overall Study|Protocol Violation|0|||
146378329|NCT00422240|527885548|FG001|Overall Study|Protocol Violation|1|||
146378330|NCT00422240|527885549|FG002|Overall Study|Protocol Violation|0|||
146378331|NCT00422240|527885550|FG003|Overall Study|Protocol Violation|1|||
146378332|NCT00422240|527885547|FG000|Overall Study|Lost to Follow-up|31|||
146378333|NCT00422240|527885548|FG001|Overall Study|Lost to Follow-up|32|||
146378334|NCT00422240|527885549|FG002|Overall Study|Lost to Follow-up|19|||
146378335|NCT00422240|527885550|FG003|Overall Study|Lost to Follow-up|34|||
146378336|NCT00422240|527885547|FG000|Overall Study|Other|1|||
146378337|NCT00422240|527885548|FG001|Overall Study|Other|0|||
146378338|NCT00422240|527885549|FG002|Overall Study|Other|0|||
146378339|NCT00422240|527885550|FG003|Overall Study|Other|1|||
146378340|NCT00422240|527885547|FG000|Overall Study|Pregnancy|3|||
146378341|NCT00422240|527885548|FG001|Overall Study|Pregnancy|1|||
146378342|NCT00422240|527885549|FG002|Overall Study|Pregnancy|1|||
146378343|NCT00422240|527885550|FG003|Overall Study|Pregnancy|2|||
146378344|NCT00441012|527885551|FG000|Overall Study|Adverse Event|0|||
146378345|NCT00441012|527885552|FG001|Overall Study|Adverse Event|1|||
146378346|NCT00441012|527885551|FG000|Overall Study|Lost to Follow-up|3|||
146378347|NCT00441012|527885552|FG001|Overall Study|Lost to Follow-up|3|||
146378348|NCT00441012|527885551|FG000|Overall Study|Protocol Violation|10|||
146378349|NCT00441012|527885552|FG001|Overall Study|Protocol Violation|9|||
146378350|NCT00441012|527885551|FG000|Overall Study|Withdrawal by Subject|4|||
146378351|NCT00441012|527885552|FG001|Overall Study|Withdrawal by Subject|0|||
146378352|NCT00441012|527885551|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
146378353|NCT00441012|527885552|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
146378354|NCT02725268|527885553|FG000|Overall Study|Death|58|||
146378355|NCT02725268|527885554|FG001|Overall Study|Death|59|||
146378356|NCT02725268|527885555|FG002|Overall Study|Death|30|||
146378357|NCT02725268|527885556|FG003|Overall Study|Death|16|||
146378358|NCT02725268|527885553|FG000|Overall Study|Lost to Follow-up|4|||
146378359|NCT02725268|527885554|FG001|Overall Study|Lost to Follow-up|3|||
146378360|NCT02725268|527885555|FG002|Overall Study|Lost to Follow-up|0|||
146378361|NCT02725268|527885556|FG003|Overall Study|Lost to Follow-up|1|||
146378362|NCT02725268|527885553|FG000|Overall Study|Site Terminated by Sponsor|0|||
146378363|NCT02725268|527885554|FG001|Overall Study|Site Terminated by Sponsor|1|||
146378364|NCT02725268|527885555|FG002|Overall Study|Site Terminated by Sponsor|0|||
146378365|NCT02725268|527885556|FG003|Overall Study|Site Terminated by Sponsor|0|||
146378366|NCT02725268|527885553|FG000|Overall Study|Withdrawal by Subject|8|||
146378367|NCT02725268|527885554|FG001|Overall Study|Withdrawal by Subject|6|||
146378368|NCT02725268|527885555|FG002|Overall Study|Withdrawal by Subject|8|||
146378369|NCT02725268|527885556|FG003|Overall Study|Withdrawal by Subject|1|||
146378370|NCT02725268|527885553|FG000|Overall Study|Reason not Specified|2|||
146378371|NCT02725268|527885554|FG001|Overall Study|Reason not Specified|1|||
146378372|NCT02725268|527885555|FG002|Overall Study|Reason not Specified|0|||
146378373|NCT02725268|527885556|FG003|Overall Study|Reason not Specified|0|||
146378374|NCT02963766|527885562|FG000|Double-Blind Period|Adverse Event|1|||
146378375|NCT02963766|527885563|FG001|Double-Blind Period|Adverse Event|0|||
146378376|NCT02963766|527885564|FG002|Double-Blind Period|Adverse Event|1|||
146378377|NCT02963766|527885562|FG000|Double-Blind Period|Physician Decision|1|||
146378378|NCT02963766|527885563|FG001|Double-Blind Period|Physician Decision|0|||
146378379|NCT02963766|527885564|FG002|Double-Blind Period|Physician Decision|0|||
146378380|NCT02963766|527885562|FG000|Double-Blind Period|Withdrawal by Subject|1|||
146378381|NCT02963766|527885563|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146378382|NCT02963766|527885564|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146378383|NCT02963766|527885562|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
146378384|NCT02963766|527885563|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
146378385|NCT02963766|527885564|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
146378386|NCT02963766|527885562|FG000|Double-Blind Period|Protocol Violation|1|||
146378387|NCT02963766|527885563|FG001|Double-Blind Period|Protocol Violation|0|||
146378388|NCT02963766|527885564|FG002|Double-Blind Period|Protocol Violation|0|||
146378389|NCT02963766|527885562|FG000|Double-Blind Period|Lost to Follow-up|0|||
146378390|NCT02963766|527885563|FG001|Double-Blind Period|Lost to Follow-up|1|||
146378391|NCT02963766|527885564|FG002|Double-Blind Period|Lost to Follow-up|0|||
146378392|NCT02963766|527885562|FG000|Open Label Extension (OLE)|Physician Decision|1|||
146378393|NCT02963766|527885563|FG001|Open Label Extension (OLE)|Physician Decision|2|||
146378394|NCT02963766|527885564|FG002|Open Label Extension (OLE)|Physician Decision|2|||
146378395|NCT02963766|527885562|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
146378396|NCT02963766|527885563|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
146378397|NCT02963766|527885564|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
146378398|NCT00499460|527885567|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
146378399|NCT00499460|527885568|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
146378400|NCT00499460|527885567|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
146378401|NCT00499460|527885568|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
146378402|NCT00499460|527885567|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
146378403|NCT00499460|527885568|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
146378404|NCT03209362|527885569|FG000|Overall Study|Adverse Event|0|||
146378405|NCT03209362|527885570|FG001|Overall Study|Adverse Event|1|||
146378406|NCT03209362|527885569|FG000|Overall Study|Lost to Follow-up|0|||
146378407|NCT03209362|527885570|FG001|Overall Study|Lost to Follow-up|1|||
146378408|NCT03209362|527885569|FG000|Overall Study|Withdrawal by Subject|2|||
146378409|NCT03209362|527885570|FG001|Overall Study|Withdrawal by Subject|0|||
146378410|NCT03209362|527885569|FG000|Overall Study|Other|0|||
146378411|NCT03209362|527885570|FG001|Overall Study|Other|1|||
146378412|NCT01627782|527885577|FG000|Overall Study|Adverse Event|1|||
146378413|NCT01627782|527885578|FG001|Overall Study|Adverse Event|2|||
146378414|NCT01627782|527885579|FG002|Overall Study|Adverse Event|0|||
146378415|NCT01627782|527885580|FG003|Overall Study|Adverse Event|1|||
146378416|NCT01627782|527885577|FG000|Overall Study|Lack of Efficacy|11|||
146378417|NCT01627782|527885578|FG001|Overall Study|Lack of Efficacy|1|||
146378418|NCT01627782|527885579|FG002|Overall Study|Lack of Efficacy|15|||
146378419|NCT01627782|527885580|FG003|Overall Study|Lack of Efficacy|2|||
146378420|NCT01627782|527885577|FG000|Overall Study|Protocol Violation|1|||
146378421|NCT01627782|527885578|FG001|Overall Study|Protocol Violation|0|||
146378422|NCT01627782|527885579|FG002|Overall Study|Protocol Violation|0|||
146378423|NCT01627782|527885580|FG003|Overall Study|Protocol Violation|0|||
146378424|NCT01627782|527885577|FG000|Overall Study|Withdrawal by Subject|2|||
146378425|NCT01627782|527885578|FG001|Overall Study|Withdrawal by Subject|1|||
146378426|NCT01627782|527885579|FG002|Overall Study|Withdrawal by Subject|0|||
146378427|NCT01627782|527885580|FG003|Overall Study|Withdrawal by Subject|0|||
146378428|NCT01627782|527885577|FG000|Overall Study|Other|0|||
146378429|NCT01627782|527885578|FG001|Overall Study|Other|2|||
146378430|NCT01627782|527885579|FG002|Overall Study|Other|0|||
146378431|NCT01627782|527885580|FG003|Overall Study|Other|3|||
146378432|NCT01627782|527885577|FG000|Overall Study|Randomized But Not Treated|1|||
146378433|NCT01627782|527885578|FG001|Overall Study|Randomized But Not Treated|0|||
146378434|NCT01627782|527885579|FG002|Overall Study|Randomized But Not Treated|0|||
146378435|NCT01627782|527885580|FG003|Overall Study|Randomized But Not Treated|0|||
146378436|NCT00643448|527885581|FG000|Overall Study|Lack of Efficacy|2|||
146378437|NCT00643448|527885582|FG001|Overall Study|Lack of Efficacy|0|||
146378438|NCT00643448|527885583|FG002|Overall Study|Lack of Efficacy|4|||
146378439|NCT00643448|527885581|FG000|Overall Study|Adverse Event|2|||
146378440|NCT00643448|527885582|FG001|Overall Study|Adverse Event|2|||
146378441|NCT00643448|527885583|FG002|Overall Study|Adverse Event|2|||
146378442|NCT00643448|527885581|FG000|Overall Study|QTcF>550 ms|0|||
146378443|NCT00643448|527885582|FG001|Overall Study|QTcF>550 ms|3|||
146378444|NCT00643448|527885583|FG002|Overall Study|QTcF>550 ms|0|||
146378445|NCT02177812|527885587|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378446|NCT02177812|527885588|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378447|NCT02177812|527885589|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378448|NCT02177812|527885590|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378449|NCT02177812|527885591|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378450|NCT02177812|527885592|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
146378451|NCT02177812|527885593|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
146378452|NCT02177812|527885594|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
146378453|NCT02177812|527885595|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
146378454|NCT02177812|527885587|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378455|NCT02177812|527885588|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378456|NCT02177812|527885589|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378457|NCT02177812|527885590|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378458|NCT02177812|527885591|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378459|NCT02177812|527885592|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
146378460|NCT02177812|527885593|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
146378461|NCT02177812|527885594|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378462|NCT02177812|527885595|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
146378463|NCT02177812|527885587|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146378464|NCT02177812|527885588|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146378465|NCT02177812|527885589|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146378466|NCT02177812|527885590|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146378467|NCT02177812|527885591|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146378468|NCT02177812|527885592|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146378469|NCT02177812|527885593|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
146378470|NCT02177812|527885594|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
146378471|NCT02177812|527885595|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
146378472|NCT00089999|527885596|FG000|Overall Study|Adverse Event|4|||
146378473|NCT00089999|527885597|FG001|Overall Study|Adverse Event|7|||
146378474|NCT00089999|527885596|FG000|Overall Study|Withdrawal by Subject|0|||
146378475|NCT00089999|527885597|FG001|Overall Study|Withdrawal by Subject|4|||
146378476|NCT00089999|527885596|FG000|Overall Study|Lost to Follow-up|2|||
146378477|NCT00089999|527885597|FG001|Overall Study|Lost to Follow-up|1|||
146378478|NCT00089999|527885596|FG000|Overall Study|Radiological Progression of Cancer|52|||
146378479|NCT00089999|527885597|FG001|Overall Study|Radiological Progression of Cancer|44|||
146378480|NCT00089999|527885596|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
146378481|NCT00089999|527885597|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
146378482|NCT00089999|527885596|FG000|Overall Study|Death|3|||
146378483|NCT00089999|527885597|FG001|Overall Study|Death|3|||
146378484|NCT00089999|527885596|FG000|Overall Study|Poor General Condition|1|||
146378485|NCT00089999|527885597|FG001|Overall Study|Poor General Condition|0|||
146378486|NCT00089999|527885596|FG000|Overall Study|Clinical Progression|1|||
146378487|NCT00089999|527885597|FG001|Overall Study|Clinical Progression|2|||
146378488|NCT00089999|527885596|FG000|Overall Study|Physician Decision|2|||
146378489|NCT00089999|527885597|FG001|Overall Study|Physician Decision|2|||
146378490|NCT00089999|527885596|FG000|Overall Study|Patient Underwent Surgery|2|||
146378491|NCT00089999|527885597|FG001|Overall Study|Patient Underwent Surgery|0|||
146378492|NCT00089999|527885596|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
146378493|NCT00089999|527885597|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
146378494|NCT03039569|527885598|FG000|Overall Study|Lost to Follow-up|5|||
146378495|NCT03039569|527885599|FG001|Overall Study|Lost to Follow-up|4|||
146378496|NCT03695471|527887329|FG000|Overall Study|Cancellation|1|||
146378497|NCT02859558|527887330|FG000|Step 1|Not Eligible|0|||
146378498|NCT02859558|527887331|FG001|Step 1|Not Eligible|0|||
146378499|NCT02859558|527887332|FG002|Step 1|Not Eligible|0|||
146378500|NCT02859558|527887333|FG003|Step 1|Not Eligible|0|||
146378501|NCT02859558|527887334|FG004|Step 1|Not Eligible|3|||
146378502|NCT02859558|527887330|FG000|Step 1|Lost to Follow-up|1|||
146378503|NCT02859558|527887331|FG001|Step 1|Lost to Follow-up|3|||
146378504|NCT02859558|527887332|FG002|Step 1|Lost to Follow-up|3|||
146378505|NCT02859558|527887333|FG003|Step 1|Lost to Follow-up|0|||
146378506|NCT02859558|527887334|FG004|Step 1|Lost to Follow-up|0|||
146378507|NCT02859558|527887330|FG000|Step 1|Did Not Return to Clinic|2|||
146378508|NCT02859558|527887331|FG001|Step 1|Did Not Return to Clinic|3|||
146378509|NCT02859558|527887332|FG002|Step 1|Did Not Return to Clinic|4|||
146378510|NCT02859558|527887333|FG003|Step 1|Did Not Return to Clinic|0|||
146378511|NCT02859558|527887334|FG004|Step 1|Did Not Return to Clinic|0|||
146378512|NCT02859558|527887330|FG000|Step 1|Moved|0|||
146378513|NCT02859558|527887331|FG001|Step 1|Moved|1|||
146378514|NCT02859558|527887332|FG002|Step 1|Moved|1|||
146378515|NCT02859558|527887333|FG003|Step 1|Moved|0|||
146378516|NCT02859558|527887334|FG004|Step 1|Moved|0|||
146378517|NCT02859558|527887330|FG000|Step 1|Withdrawal By Participant|1|||
146378518|NCT02859558|527887331|FG001|Step 1|Withdrawal By Participant|2|||
146378519|NCT02859558|527887332|FG002|Step 1|Withdrawal By Participant|1|||
146378520|NCT02859558|527887333|FG003|Step 1|Withdrawal By Participant|0|||
146378521|NCT02859558|527887334|FG004|Step 1|Withdrawal By Participant|0|||
146378522|NCT02859558|527887330|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
146378523|NCT02859558|527887331|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146378524|NCT02859558|527887332|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146378525|NCT02859558|527887333|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146378526|NCT02859558|527887334|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
146378527|NCT02859558|527887330|FG000|Step 1|Incarceration|0|||
146378528|NCT02859558|527887331|FG001|Step 1|Incarceration|1|||
146378529|NCT02859558|527887332|FG002|Step 1|Incarceration|0|||
146378530|NCT02859558|527887333|FG003|Step 1|Incarceration|0|||
146378531|NCT02859558|527887334|FG004|Step 1|Incarceration|0|||
146056248|NCT04059549|526721154|FG000|Overall Study|Withdrawal by Subject|2|||
146056249|NCT04059549|526721155|FG001|Overall Study|Withdrawal by Subject|0|||
146378532|NCT02859558|527887330|FG000|Step 1|Non-Adherence to Study Drug|2|||
146378533|NCT02859558|527887331|FG001|Step 1|Non-Adherence to Study Drug|0|||
146378534|NCT02859558|527887332|FG002|Step 1|Non-Adherence to Study Drug|1|||
146378535|NCT02859558|527887333|FG003|Step 1|Non-Adherence to Study Drug|0|||
146378536|NCT02859558|527887334|FG004|Step 1|Non-Adherence to Study Drug|0|||
146378537|NCT02859558|527887330|FG000|Step 1|Non-Adherence to Study Requirements|3|||
146378538|NCT02859558|527887331|FG001|Step 1|Non-Adherence to Study Requirements|1|||
146378539|NCT02859558|527887332|FG002|Step 1|Non-Adherence to Study Requirements|0|||
146378540|NCT02859558|527887333|FG003|Step 1|Non-Adherence to Study Requirements|0|||
146378541|NCT02859558|527887334|FG004|Step 1|Non-Adherence to Study Requirements|0|||
146378542|NCT02859558|527887330|FG000|Step 1|Virologic Failure|2|||
146378543|NCT02859558|527887331|FG001|Step 1|Virologic Failure|1|||
146378544|NCT02859558|527887332|FG002|Step 1|Virologic Failure|1|||
146378545|NCT02859558|527887333|FG003|Step 1|Virologic Failure|0|||
146378546|NCT02859558|527887334|FG004|Step 1|Virologic Failure|0|||
146378547|NCT02859558|527887330|FG000|Step 2|Lost to Follow-up|3|||
146378548|NCT02859558|527887331|FG001|Step 2|Lost to Follow-up|3|||
146378549|NCT02859558|527887332|FG002|Step 2|Lost to Follow-up|1|||
146378550|NCT02859558|527887333|FG003|Step 2|Lost to Follow-up|0|||
146378551|NCT02859558|527887334|FG004|Step 2|Lost to Follow-up|0|||
146378552|NCT02859558|527887330|FG000|Step 2|Withdrawal by Subject|0|||
146378553|NCT02859558|527887331|FG001|Step 2|Withdrawal by Subject|1|||
146378554|NCT02859558|527887332|FG002|Step 2|Withdrawal by Subject|1|||
146378555|NCT02859558|527887333|FG003|Step 2|Withdrawal by Subject|0|||
146378556|NCT02859558|527887334|FG004|Step 2|Withdrawal by Subject|0|||
146378557|NCT02859558|527887330|FG000|Step 2|Unexpected Closure of Site|0|||
146378558|NCT02859558|527887331|FG001|Step 2|Unexpected Closure of Site|1|||
146378559|NCT02859558|527887332|FG002|Step 2|Unexpected Closure of Site|1|||
146378560|NCT02859558|527887333|FG003|Step 2|Unexpected Closure of Site|0|||
146378561|NCT02859558|527887334|FG004|Step 2|Unexpected Closure of Site|0|||
146378562|NCT02859558|527887330|FG000|Step 2|Death|1|||
146378563|NCT02859558|527887331|FG001|Step 2|Death|0|||
146378564|NCT02859558|527887332|FG002|Step 2|Death|0|||
146378565|NCT02859558|527887333|FG003|Step 2|Death|0|||
146378566|NCT02859558|527887334|FG004|Step 2|Death|0|||
146378567|NCT02859558|527887330|FG000|Step 2|Incarceration|0|||
146378568|NCT02859558|527887331|FG001|Step 2|Incarceration|0|||
146378569|NCT02859558|527887332|FG002|Step 2|Incarceration|1|||
146378570|NCT02859558|527887333|FG003|Step 2|Incarceration|0|||
146378571|NCT02859558|527887334|FG004|Step 2|Incarceration|0|||
146378572|NCT01938391|527887337|FG000|6 Month Follow up|Withdrawal by Subject|1|||
146378573|NCT01938391|527887337|FG000|12 Month Follow up|Physician Decision|1|||
146378574|NCT01938391|527887337|FG000|12 Month Follow up|Withdrawal by Subject|1|||
146378575|NCT01077193|527887338|FG000|Overall Study|Lost to Follow-up|1|||
146378576|NCT01077193|527887338|FG000|Overall Study|Withdrawal by Subject|2|||
146378577|NCT01077193|527887338|FG000|Overall Study|Lack of Efficacy|1|||
146378578|NCT01077193|527887338|FG000|Overall Study|Study Terminated by Sponsor|40|||
146378579|NCT02234050|527887350|FG000|Overall Study|Lack of Efficacy|38|||
146378580|NCT02234050|527887351|FG001|Overall Study|Lack of Efficacy|22|||
146378581|NCT02234050|527887350|FG000|Overall Study|Adverse Event|13|||
146378582|NCT02234050|527887351|FG001|Overall Study|Adverse Event|1|||
146378583|NCT02234050|527887350|FG000|Overall Study|Withdrawal by Subject|4|||
146378584|NCT02234050|527887351|FG001|Overall Study|Withdrawal by Subject|2|||
146378585|NCT02234050|527887350|FG000|Overall Study|Sponsor's decision|6|||
146378586|NCT02234050|527887351|FG001|Overall Study|Sponsor's decision|0|||
146378587|NCT01680991|527887352|FG000|Overall Study|Adverse Event|1|||
146378588|NCT01680991|527887353|FG001|Overall Study|Adverse Event|0|||
146378589|NCT01680991|527887354|FG002|Overall Study|Adverse Event|0|||
146378590|NCT01680991|527887352|FG000|Overall Study|Death|1|||
146378591|NCT01680991|527887353|FG001|Overall Study|Death|0|||
146378592|NCT01680991|527887354|FG002|Overall Study|Death|1|||
146378593|NCT01680991|527887352|FG000|Overall Study|Protocol Violation|0|||
146378594|NCT01680991|527887353|FG001|Overall Study|Protocol Violation|1|||
146378595|NCT01680991|527887354|FG002|Overall Study|Protocol Violation|0|||
146378596|NCT01680991|527887352|FG000|Overall Study|Withdrawal by Subject|5|||
146378597|NCT01680991|527887353|FG001|Overall Study|Withdrawal by Subject|1|||
146378598|NCT01680991|527887354|FG002|Overall Study|Withdrawal by Subject|0|||
146378599|NCT01680991|527887352|FG000|Overall Study|Progressive disease (PD)|0|||
146378600|NCT01680991|527887353|FG001|Overall Study|Progressive disease (PD)|10|||
146378601|NCT01680991|527887354|FG002|Overall Study|Progressive disease (PD)|0|||
146378602|NCT01680991|527887352|FG000|Overall Study|Physician Decision|0|||
146378603|NCT01680991|527887353|FG001|Overall Study|Physician Decision|7|||
146378604|NCT01680991|527887354|FG002|Overall Study|Physician Decision|2|||
146378605|NCT01680991|527887352|FG000|Overall Study|Bad physical condition|0|||
146378606|NCT01680991|527887353|FG001|Overall Study|Bad physical condition|0|||
146378607|NCT01680991|527887354|FG002|Overall Study|Bad physical condition|1|||
146378608|NCT01680991|527887352|FG000|Overall Study|PD confirmed in other hospital|1|||
146378609|NCT01680991|527887353|FG001|Overall Study|PD confirmed in other hospital|0|||
146378610|NCT01680991|527887354|FG002|Overall Study|PD confirmed in other hospital|0|||
146378611|NCT01408732|527887355|FG000|Overall Study|Withdrawal by Subject|2|||
146378612|NCT01408732|527887356|FG001|Overall Study|Withdrawal by Subject|2|||
146378613|NCT00424099|527887357|FG000|Overall Study|Adverse Event|0|||
146378614|NCT00424099|527887358|FG001|Overall Study|Adverse Event|1|||
146378615|NCT00424099|527887359|FG002|Overall Study|Adverse Event|1|||
146378616|NCT00424099|527887360|FG003|Overall Study|Adverse Event|0|||
146378617|NCT00424099|527887357|FG000|Overall Study|Death|0|||
146378618|NCT00424099|527887358|FG001|Overall Study|Death|1|||
146378619|NCT00424099|527887359|FG002|Overall Study|Death|0|||
146378620|NCT00424099|527887360|FG003|Overall Study|Death|0|||
146378621|NCT00424099|527887357|FG000|Overall Study|Illness|2|||
146378622|NCT00424099|527887358|FG001|Overall Study|Illness|0|||
146378623|NCT00424099|527887359|FG002|Overall Study|Illness|1|||
146378624|NCT00424099|527887360|FG003|Overall Study|Illness|4|||
146378625|NCT00424099|527887357|FG000|Overall Study|Lost to Follow-up|0|||
146378626|NCT00424099|527887358|FG001|Overall Study|Lost to Follow-up|0|||
146378627|NCT00424099|527887359|FG002|Overall Study|Lost to Follow-up|3|||
146378628|NCT00424099|527887360|FG003|Overall Study|Lost to Follow-up|0|||
146378629|NCT00424099|527887357|FG000|Overall Study|Hospitalized|1|||
146378630|NCT00424099|527887358|FG001|Overall Study|Hospitalized|2|||
146378631|NCT00424099|527887359|FG002|Overall Study|Hospitalized|1|||
146378632|NCT00424099|527887360|FG003|Overall Study|Hospitalized|3|||
146378633|NCT00424099|527887357|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
146378634|NCT00424099|527887358|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
146378635|NCT00424099|527887359|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
146378636|NCT00424099|527887360|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
146378637|NCT00424099|527887357|FG000|Overall Study|Withdrawal by Subject|1|||
146378638|NCT00424099|527887358|FG001|Overall Study|Withdrawal by Subject|9|||
146378639|NCT00424099|527887359|FG002|Overall Study|Withdrawal by Subject|4|||
146378640|NCT00424099|527887360|FG003|Overall Study|Withdrawal by Subject|6|||
146378641|NCT00424099|527887357|FG000|Overall Study|Physician Decision|0|||
146378642|NCT00424099|527887358|FG001|Overall Study|Physician Decision|0|||
146378643|NCT00424099|527887359|FG002|Overall Study|Physician Decision|1|||
146378644|NCT00424099|527887360|FG003|Overall Study|Physician Decision|0|||
146378645|NCT00424099|527887357|FG000|Overall Study|Missing|0|||
146378646|NCT00424099|527887358|FG001|Overall Study|Missing|0|||
146378647|NCT00424099|527887359|FG002|Overall Study|Missing|1|||
146378648|NCT00424099|527887360|FG003|Overall Study|Missing|0|||
146378649|NCT03377452|527887361|FG000|Overall Study|Refused assessment|0|||
146378650|NCT03377452|527887362|FG001|Overall Study|Refused assessment|2|||
146378651|NCT03377452|527887361|FG000|Overall Study|Lost to Follow-up|5|||
146378652|NCT03377452|527887362|FG001|Overall Study|Lost to Follow-up|4|||
146378653|NCT03277105|527887363|FG000|Overall Study|Death|129|||
146378654|NCT03277105|527887364|FG001|Overall Study|Death|124|||
146378655|NCT03277105|527887363|FG000|Overall Study|Lost to Follow-up|2|||
146378656|NCT03277105|527887364|FG001|Overall Study|Lost to Follow-up|4|||
146378657|NCT03277105|527887363|FG000|Overall Study|Withdrawal by Subject|10|||
146378658|NCT03277105|527887364|FG001|Overall Study|Withdrawal by Subject|10|||
146378659|NCT03277105|527887363|FG000|Overall Study|Other|118|||
146378660|NCT03277105|527887364|FG001|Overall Study|Other|125|||
146378661|NCT02280096|527887365|FG000|Overall Study|Pregnancy|1|||
146378662|NCT02280096|527887366|FG001|Overall Study|Pregnancy|0|||
146378663|NCT02280096|527887365|FG000|Overall Study|Functional neurological disorder|1|||
146378664|NCT02280096|527887366|FG001|Overall Study|Functional neurological disorder|0|||
146378665|NCT02280096|527887365|FG000|Overall Study|Lack of attachment|0|||
146378666|NCT02280096|527887366|FG001|Overall Study|Lack of attachment|1|||
146378667|NCT00285649|527887369|FG000|Overall Study|Lost to Follow-up|6|||
146378668|NCT00285649|527887370|FG001|Overall Study|Lost to Follow-up|4|||
146378669|NCT00285649|527887371|FG002|Overall Study|Lost to Follow-up|4|||
146378670|NCT00285649|527887369|FG000|Overall Study|Withdrawal by Subject|3|||
146378671|NCT00285649|527887370|FG001|Overall Study|Withdrawal by Subject|2|||
146378672|NCT00285649|527887371|FG002|Overall Study|Withdrawal by Subject|2|||
146378673|NCT02465489|527887372|FG000|Overall Study|Adverse Event|5|||
146378674|NCT00693693|527887373|FG000|Overall Study|Lost to Follow-up|1|||
146378675|NCT00693693|527887374|FG001|Overall Study|Lost to Follow-up|1|||
146378676|NCT00693693|527887375|FG002|Overall Study|Lost to Follow-up|2|||
146378677|NCT02972593|527887376|FG000|Overall Study|Lost to Follow-up|19|||
146378678|NCT02972593|527887377|FG001|Overall Study|Lost to Follow-up|15|||
146378679|NCT02972593|527887376|FG000|Overall Study|Protocol Violation|1|||
146378680|NCT02972593|527887377|FG001|Overall Study|Protocol Violation|0|||
146378681|NCT01764022|527887382|FG000|Overall Study|Death|3|||
146378682|NCT01764022|527887383|FG001|Overall Study|Death|5|||
146378683|NCT01764022|527887382|FG000|Overall Study|Withdrawal by Subject|2|||
146378684|NCT01764022|527887383|FG001|Overall Study|Withdrawal by Subject|6|||
146378685|NCT01764022|527887382|FG000|Overall Study|Lack of Efficacy|0|||
146378686|NCT01764022|527887383|FG001|Overall Study|Lack of Efficacy|1|||
146378687|NCT01764022|527887382|FG000|Overall Study|Physician Decision|0|||
146378688|NCT01764022|527887383|FG001|Overall Study|Physician Decision|2|||
146378689|NCT01764022|527887382|FG000|Overall Study|Lost to Follow-up|2|||
146378690|NCT01764022|527887383|FG001|Overall Study|Lost to Follow-up|0|||
146378691|NCT01764022|527887382|FG000|Overall Study|Protocol Violation|1|||
146378692|NCT01764022|527887383|FG001|Overall Study|Protocol Violation|0|||
146378693|NCT02203916|527887384|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
146378694|NCT02203916|527887385|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
146378695|NCT02203916|527887386|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
146378696|NCT02203916|527887384|FG000|Overall Study|Major Protocol Deviation|1|||
146378697|NCT02203916|527887385|FG001|Overall Study|Major Protocol Deviation|1|||
146378698|NCT02203916|527887386|FG002|Overall Study|Major Protocol Deviation|0|||
146378699|NCT02203916|527887384|FG000|Overall Study|Lost to Follow-up|0|||
146378700|NCT02203916|527887385|FG001|Overall Study|Lost to Follow-up|1|||
146378701|NCT02203916|527887386|FG002|Overall Study|Lost to Follow-up|0|||
146378702|NCT02203916|527887384|FG000|Overall Study|Voluntary Withdrawal|3|||
146378703|NCT02203916|527887385|FG001|Overall Study|Voluntary Withdrawal|3|||
146378704|NCT02203916|527887386|FG002|Overall Study|Voluntary Withdrawal|8|||
146378705|NCT02203916|527887384|FG000|Overall Study|Lack of Efficacy|3|||
146378706|NCT02203916|527887385|FG001|Overall Study|Lack of Efficacy|0|||
146378707|NCT02203916|527887386|FG002|Overall Study|Lack of Efficacy|0|||
146378708|NCT02203916|527887384|FG000|Overall Study|Reason Not Specified|0|||
146378709|NCT02203916|527887385|FG001|Overall Study|Reason Not Specified|2|||
146378710|NCT02203916|527887386|FG002|Overall Study|Reason Not Specified|1|||
146378711|NCT00414973|527887387|FG000|Overall Study|Withdrawal by Subject|14|||
146378712|NCT00414973|527887388|FG001|Overall Study|Withdrawal by Subject|4|||
146378713|NCT00414973|527887389|FG002|Overall Study|Withdrawal by Subject|1|||
146378714|NCT00414973|527887390|FG003|Overall Study|Withdrawal by Subject|0|||
146378715|NCT00414973|527887387|FG000|Overall Study|Adverse Event|10|||
146378716|NCT00414973|527887388|FG001|Overall Study|Adverse Event|0|||
146378717|NCT00414973|527887389|FG002|Overall Study|Adverse Event|1|||
146378718|NCT00414973|527887390|FG003|Overall Study|Adverse Event|0|||
146378719|NCT00414973|527887387|FG000|Overall Study|Protocol Violation|3|||
146378720|NCT00414973|527887388|FG001|Overall Study|Protocol Violation|4|||
146378721|NCT00414973|527887389|FG002|Overall Study|Protocol Violation|0|||
146378722|NCT00414973|527887390|FG003|Overall Study|Protocol Violation|0|||
146378723|NCT00414973|527887387|FG000|Overall Study|Lost to Follow-up|0|||
146378724|NCT00414973|527887388|FG001|Overall Study|Lost to Follow-up|2|||
146378725|NCT00414973|527887389|FG002|Overall Study|Lost to Follow-up|0|||
146378726|NCT00414973|527887390|FG003|Overall Study|Lost to Follow-up|0|||
146378727|NCT00414973|527887387|FG000|Overall Study|Sponsor Decision|1|||
146378728|NCT00414973|527887388|FG001|Overall Study|Sponsor Decision|0|||
146378729|NCT00414973|527887389|FG002|Overall Study|Sponsor Decision|0|||
146378730|NCT00414973|527887390|FG003|Overall Study|Sponsor Decision|0|||
146378731|NCT00414973|527887387|FG000|Overall Study|Death|0|||
146378732|NCT00414973|527887388|FG001|Overall Study|Death|0|||
146378733|NCT00414973|527887389|FG002|Overall Study|Death|1|||
146378734|NCT00414973|527887390|FG003|Overall Study|Death|0|||
146378735|NCT01512693|527887402|FG000|Overall Study|Withdrawal by Subject|0|||
146378736|NCT01512693|527887403|FG001|Overall Study|Withdrawal by Subject|1|||
146378737|NCT04731922|527887413|FG000|Overall Study|Adverse Event|0|||
146378738|NCT04731922|527887414|FG001|Overall Study|Adverse Event|0|||
146378739|NCT04731922|527887415|FG002|Overall Study|Adverse Event|0|||
146378740|NCT04731922|527887416|FG003|Overall Study|Adverse Event|0|||
146378741|NCT04731922|527887417|FG004|Overall Study|Adverse Event|0|||
146378742|NCT04731922|527887418|FG005|Overall Study|Adverse Event|0|||
146378743|NCT04731922|527887419|FG006|Overall Study|Adverse Event|0|||
146378744|NCT04731922|527887420|FG007|Overall Study|Adverse Event|0|||
146378745|NCT04731922|527887421|FG008|Overall Study|Adverse Event|0|||
146378746|NCT04731922|527887422|FG009|Overall Study|Adverse Event|0|||
146378747|NCT04731922|527887423|FG010|Overall Study|Adverse Event|1|||
146378748|NCT04731922|527887424|FG011|Overall Study|Adverse Event|0|||
146378749|NCT04731922|527887425|FG012|Overall Study|Adverse Event|0|||
146378750|NCT04731922|527887426|FG013|Overall Study|Adverse Event|0|||
146378751|NCT04731922|527887427|FG014|Overall Study|Adverse Event|0|||
146378752|NCT04731922|527887428|FG015|Overall Study|Adverse Event|0|||
146378753|NCT04731922|527887429|FG016|Overall Study|Adverse Event|0|||
146378754|NCT04731922|527887413|FG000|Overall Study|Lost to Follow-up|0|||
146378755|NCT04731922|527887414|FG001|Overall Study|Lost to Follow-up|0|||
146378756|NCT04731922|527887415|FG002|Overall Study|Lost to Follow-up|0|||
146378757|NCT04731922|527887416|FG003|Overall Study|Lost to Follow-up|1|||
146378758|NCT04731922|527887417|FG004|Overall Study|Lost to Follow-up|0|||
146378759|NCT04731922|527887418|FG005|Overall Study|Lost to Follow-up|1|||
146378760|NCT04731922|527887419|FG006|Overall Study|Lost to Follow-up|0|||
146378761|NCT04731922|527887420|FG007|Overall Study|Lost to Follow-up|0|||
146378762|NCT04731922|527887421|FG008|Overall Study|Lost to Follow-up|0|||
146378763|NCT04731922|527887422|FG009|Overall Study|Lost to Follow-up|0|||
146378764|NCT04731922|527887423|FG010|Overall Study|Lost to Follow-up|0|||
146378765|NCT04731922|527887424|FG011|Overall Study|Lost to Follow-up|0|||
146378766|NCT04731922|527887425|FG012|Overall Study|Lost to Follow-up|0|||
146378767|NCT04731922|527887426|FG013|Overall Study|Lost to Follow-up|0|||
146378768|NCT04731922|527887427|FG014|Overall Study|Lost to Follow-up|0|||
146378769|NCT04731922|527887428|FG015|Overall Study|Lost to Follow-up|0|||
146378770|NCT04731922|527887429|FG016|Overall Study|Lost to Follow-up|0|||
146378771|NCT04731922|527887413|FG000|Overall Study|Withdrawal by Subject|1|||
146378772|NCT04731922|527887414|FG001|Overall Study|Withdrawal by Subject|0|||
146378773|NCT04731922|527887415|FG002|Overall Study|Withdrawal by Subject|0|||
146378774|NCT04731922|527887416|FG003|Overall Study|Withdrawal by Subject|0|||
146378775|NCT04731922|527887417|FG004|Overall Study|Withdrawal by Subject|1|||
146378776|NCT04731922|527887418|FG005|Overall Study|Withdrawal by Subject|0|||
146378777|NCT04731922|527887419|FG006|Overall Study|Withdrawal by Subject|1|||
146378778|NCT04731922|527887420|FG007|Overall Study|Withdrawal by Subject|0|||
146378779|NCT04731922|527887421|FG008|Overall Study|Withdrawal by Subject|0|||
146378780|NCT04731922|527887422|FG009|Overall Study|Withdrawal by Subject|0|||
146378781|NCT04731922|527887423|FG010|Overall Study|Withdrawal by Subject|0|||
146378782|NCT04731922|527887424|FG011|Overall Study|Withdrawal by Subject|0|||
146378783|NCT04731922|527887425|FG012|Overall Study|Withdrawal by Subject|0|||
146378784|NCT04731922|527887426|FG013|Overall Study|Withdrawal by Subject|1|||
146378785|NCT04731922|527887427|FG014|Overall Study|Withdrawal by Subject|0|||
146378786|NCT04731922|527887428|FG015|Overall Study|Withdrawal by Subject|0|||
146378787|NCT04731922|527887429|FG016|Overall Study|Withdrawal by Subject|0|||
146378788|NCT04731922|527887413|FG000|Overall Study|Other|0|||
146378789|NCT04731922|527887414|FG001|Overall Study|Other|0|||
146378790|NCT04731922|527887415|FG002|Overall Study|Other|0|||
146378791|NCT04731922|527887416|FG003|Overall Study|Other|0|||
146378792|NCT04731922|527887417|FG004|Overall Study|Other|0|||
146378793|NCT04731922|527887418|FG005|Overall Study|Other|0|||
146378794|NCT04731922|527887419|FG006|Overall Study|Other|1|||
146378795|NCT04731922|527887420|FG007|Overall Study|Other|0|||
146378796|NCT04731922|527887421|FG008|Overall Study|Other|0|||
146378797|NCT04731922|527887422|FG009|Overall Study|Other|0|||
146378798|NCT04731922|527887423|FG010|Overall Study|Other|0|||
146378799|NCT04731922|527887424|FG011|Overall Study|Other|0|||
146378800|NCT04731922|527887425|FG012|Overall Study|Other|0|||
146378801|NCT04731922|527887426|FG013|Overall Study|Other|0|||
146378802|NCT04731922|527887427|FG014|Overall Study|Other|0|||
146378803|NCT04731922|527887428|FG015|Overall Study|Other|0|||
146378804|NCT04731922|527887429|FG016|Overall Study|Other|0|||
146378805|NCT00981747|527887435|FG000|Losartan|Withdrawal by Subject|1|||
146378806|NCT00981747|527887435|FG000|Losartan|Death|1|||
146378807|NCT00981747|527887435|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
146378808|NCT01448707|527887443|FG000|Overall Study|Adverse Event|3|||
146378809|NCT01448707|527887444|FG001|Overall Study|Adverse Event|1|||
146378810|NCT01448707|527887443|FG000|Overall Study|Lost to Follow-up|2|||
146378811|NCT01448707|527887444|FG001|Overall Study|Lost to Follow-up|6|||
146378812|NCT01448707|527887443|FG000|Overall Study|Withdrawal by Subject|6|||
146378813|NCT01448707|527887444|FG001|Overall Study|Withdrawal by Subject|7|||
146378814|NCT01448707|527887443|FG000|Overall Study|Other|7|||
146378815|NCT01448707|527887444|FG001|Overall Study|Other|4|||
146378816|NCT02033850|527887449|FG000|Overall Study|Death|1|||
146378817|NCT02033850|527887450|FG001|Overall Study|Death|0|||
146378818|NCT02033850|527887449|FG000|Overall Study|unrelated medical reason|1|||
146378819|NCT02033850|527887450|FG001|Overall Study|unrelated medical reason|1|||
146378820|NCT02820038|527887451|FG000|Overall Study|Lost to Follow-up|7|||
146378821|NCT02820038|527887452|FG001|Overall Study|Lost to Follow-up|11|||
146378822|NCT02820038|527887453|FG002|Overall Study|Lost to Follow-up|2|||
146378823|NCT02820038|527887454|FG003|Overall Study|Lost to Follow-up|9|||
146378824|NCT02820038|527887451|FG000|Overall Study|Withdrawal by Subject|3|||
146378825|NCT02820038|527887452|FG001|Overall Study|Withdrawal by Subject|14|||
146378826|NCT02820038|527887453|FG002|Overall Study|Withdrawal by Subject|3|||
146378827|NCT02820038|527887454|FG003|Overall Study|Withdrawal by Subject|13|||
146378828|NCT03215667|527887455|FG000|Overall Study|Physician Decision|4|||
146378829|NCT03934203|527887456|FG000|Overall Study|Adverse Event|0|||
146378830|NCT03934203|527887457|FG001|Overall Study|Adverse Event|0|||
146378831|NCT03934203|527887458|FG002|Overall Study|Adverse Event|1|||
146378832|NCT03934203|527887459|FG003|Overall Study|Adverse Event|0|||
146378833|NCT03934203|527887460|FG004|Overall Study|Adverse Event|1|||
146378834|NCT03934203|527887461|FG005|Overall Study|Adverse Event|0|||
146378835|NCT03934203|527887462|FG006|Overall Study|Adverse Event|2|||
146378836|NCT03934203|527887463|FG007|Overall Study|Adverse Event|0|||
146378837|NCT03934203|527887464|FG008|Overall Study|Adverse Event|0|||
146378838|NCT03934203|527887465|FG009|Overall Study|Adverse Event|0|||
146378839|NCT03934203|527887466|FG010|Overall Study|Adverse Event|0|||
146378840|NCT03934203|527887467|FG011|Overall Study|Adverse Event|0|||
146378841|NCT03934203|527887468|FG012|Overall Study|Adverse Event|0|||
146378842|NCT03934203|527887469|FG013|Overall Study|Adverse Event|1|||
146378843|NCT03934203|527887470|FG014|Overall Study|Adverse Event|0|||
146378844|NCT01810380|527887472|FG000|Overall Study|Randomised not treated|2|||
146378845|NCT01810380|527887473|FG001|Overall Study|Randomised not treated|1|||
146378846|NCT01810380|527887474|FG002|Overall Study|Randomised not treated|1|||
146378847|NCT01810380|527887472|FG000|Overall Study|Adverse Event|11|||
146378848|NCT01810380|527887473|FG001|Overall Study|Adverse Event|14|||
146378849|NCT01810380|527887474|FG002|Overall Study|Adverse Event|4|||
146378850|NCT01810380|527887472|FG000|Overall Study|Lack of Efficacy|24|||
146378851|NCT01810380|527887473|FG001|Overall Study|Lack of Efficacy|10|||
146378852|NCT01810380|527887474|FG002|Overall Study|Lack of Efficacy|11|||
146378853|NCT01810380|527887472|FG000|Overall Study|Protocol Violation|1|||
146378854|NCT01810380|527887473|FG001|Overall Study|Protocol Violation|0|||
146378855|NCT01810380|527887474|FG002|Overall Study|Protocol Violation|1|||
146378856|NCT01810380|527887472|FG000|Overall Study|Withdrawal by Subject|6|||
146378857|NCT01810380|527887473|FG001|Overall Study|Withdrawal by Subject|0|||
146378858|NCT01810380|527887474|FG002|Overall Study|Withdrawal by Subject|6|||
146378859|NCT01810380|527887472|FG000|Overall Study|Administrative or other reasons|11|||
146378860|NCT01810380|527887473|FG001|Overall Study|Administrative or other reasons|13|||
146378861|NCT01810380|527887474|FG002|Overall Study|Administrative or other reasons|9|||
146378862|NCT00441480|527887475|FG000|Overall Study|Protocol Violation|1|||
146378863|NCT00441480|527887476|FG001|Overall Study|Protocol Violation|1|||
146378864|NCT00441480|527887475|FG000|Overall Study|Withdrawal by Subject|2|||
146378865|NCT00441480|527887476|FG001|Overall Study|Withdrawal by Subject|3|||
146378866|NCT01390038|527887477|FG000|Overall Study|Death|1|||
146378867|NCT01390038|527887477|FG000|Overall Study|Lost to Follow-up|1|||
146378868|NCT01390038|527887477|FG000|Overall Study|Withdrawal by Subject|4|||
146378869|NCT01390038|527887477|FG000|Overall Study|Simpliciti System Removal|2|||
146378870|NCT01922739|527887478|FG000|Titration/Adjustment Period|Adverse Event|3|||
146378871|NCT01922739|527887478|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
146378872|NCT01922739|527887478|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
146378873|NCT01922739|527887478|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
146378874|NCT01922739|527887478|FG000|Open-label Treatment Period|Adverse Event|6|||
146378875|NCT01922739|527887478|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
146378876|NCT01922739|527887478|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
146378877|NCT01922739|527887478|FG000|Open-label Treatment Period|Protocol Violation|5|||
146378878|NCT01922739|527887478|FG000|Open-label Treatment Period|Pregnancy|1|||
146378879|NCT01922739|527887478|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
146378880|NCT01922739|527887478|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
146378881|NCT01922739|527887478|FG000|Open-label Treatment Period|Physician Decision|1|||
146378882|NCT01922739|527887478|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
146378883|NCT01927068|527887479|FG000|Overall Study|Death|37|||
146378884|NCT01927068|527887480|FG001|Overall Study|Death|3|||
146378885|NCT01927068|527887479|FG000|Overall Study|Withdrawal by Subject|50|||
146378886|NCT01927068|527887480|FG001|Overall Study|Withdrawal by Subject|3|||
146378887|NCT01927068|527887479|FG000|Overall Study|Lost to Follow-up|10|||
146378888|NCT01927068|527887480|FG001|Overall Study|Lost to Follow-up|2|||
146378889|NCT01927068|527887479|FG000|Overall Study|Physician Decision|9|||
146378890|NCT01927068|527887480|FG001|Overall Study|Physician Decision|0|||
146378891|NCT01927068|527887479|FG000|Overall Study|Missed last follow-up visit|2|||
146378892|NCT01927068|527887480|FG001|Overall Study|Missed last follow-up visit|0|||
146378893|NCT04489940|527887481|FG000|Overall Study|Other|2|||
146378894|NCT04489940|527887481|FG000|Overall Study|Withdrawal by Subject|2|||
146378895|NCT04489940|527887481|FG000|Overall Study|Death|5|||
146378896|NCT04489940|527887481|FG000|Overall Study|Lost to Follow-up|1|||
146378897|NCT01624467|527887482|FG000|Overall Study|Withdrawal by Subject|2|||
146378898|NCT01624467|527887482|FG000|Overall Study|Lost to Follow-up|1|||
146378899|NCT01624467|527887482|FG000|Overall Study|Adverse Event|7|||
146378900|NCT01624467|527887482|FG000|Overall Study|Progressive Disease|19|||
146378901|NCT01624467|527887482|FG000|Overall Study|Per Sponsor Requirement|1|||
146378902|NCT01624467|527887482|FG000|Overall Study|Subject Withdrew from Treatment|1|||
146378903|NCT04498468|527887483|FG000|Overall Study|Lost to Follow-up|3|||
146378904|NCT00262314|527887484|FG000|Overall Study|Changing physicians|38|||
146378905|NCT00262314|527887484|FG000|Overall Study|Death|12|||
146378906|NCT00262314|527887484|FG000|Overall Study|Patient's decision|92|||
146378907|NCT00262314|527887484|FG000|Overall Study|Other|95|||
146378908|NCT00262314|527887484|FG000|Overall Study|Lost to Follow-up|70|||
146378909|NCT00262314|527887484|FG000|Overall Study|Administrative withdrawal|30|||
146378910|NCT05104749|527887485|FG000|Overall Study|Lost to Follow-up|2|||
146378911|NCT05104749|527887486|FG001|Overall Study|Lost to Follow-up|3|||
146378912|NCT03964493|527887487|FG000|Overall Study|Withdrawal by Subject|4|||
146378913|NCT03964493|527887488|FG001|Overall Study|Withdrawal by Subject|1|||
146378914|NCT03964493|527887487|FG000|Overall Study|Lost to Follow-up|13|||
146378915|NCT03964493|527887488|FG001|Overall Study|Lost to Follow-up|4|||
146378916|NCT02224274|527887489|FG000|Overall Study|Death|1|||
146378917|NCT02224274|527887490|FG001|Overall Study|Death|0|||
146378918|NCT00887068|527887491|FG000|Overall Study|Withdrawal by Subject|2|||
146378919|NCT00887068|527887492|FG001|Overall Study|Withdrawal by Subject|0|||
146378920|NCT00887068|527887491|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
146378921|NCT00887068|527887492|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
146378922|NCT00814307|527887493|FG000|Overall Study|Randomized but not treated|1|||
146378923|NCT00814307|527887494|FG001|Overall Study|Randomized but not treated|0|||
146378924|NCT00814307|527887495|FG002|Overall Study|Randomized but not treated|0|||
146378925|NCT00814307|527887496|FG003|Overall Study|Randomized but not treated|0|||
146378926|NCT00814307|527887493|FG000|Overall Study|Adverse Event|3|||
146378927|NCT00814307|527887494|FG001|Overall Study|Adverse Event|9|||
146378928|NCT00814307|527887495|FG002|Overall Study|Adverse Event|3|||
146378929|NCT00814307|527887496|FG003|Overall Study|Adverse Event|2|||
146378930|NCT00814307|527887493|FG000|Overall Study|Lack of Efficacy|1|||
146378931|NCT00814307|527887494|FG001|Overall Study|Lack of Efficacy|1|||
146378932|NCT00814307|527887495|FG002|Overall Study|Lack of Efficacy|3|||
146378933|NCT00814307|527887496|FG003|Overall Study|Lack of Efficacy|4|||
146378934|NCT00814307|527887493|FG000|Overall Study|Other|1|||
146378935|NCT00814307|527887494|FG001|Overall Study|Other|2|||
146378936|NCT00814307|527887495|FG002|Overall Study|Other|0|||
146378937|NCT00814307|527887496|FG003|Overall Study|Other|1|||
146378938|NCT00814307|527887493|FG000|Overall Study|Protocol Violation|2|||
146378939|NCT00814307|527887494|FG001|Overall Study|Protocol Violation|8|||
146378940|NCT00814307|527887495|FG002|Overall Study|Protocol Violation|1|||
146378941|NCT00814307|527887496|FG003|Overall Study|Protocol Violation|1|||
146378942|NCT00814307|527887493|FG000|Overall Study|Withdrawal by Subject|4|||
146378943|NCT00814307|527887494|FG001|Overall Study|Withdrawal by Subject|6|||
146378944|NCT00814307|527887495|FG002|Overall Study|Withdrawal by Subject|0|||
146378945|NCT00814307|527887496|FG003|Overall Study|Withdrawal by Subject|2|||
146378946|NCT00814307|527887493|FG000|Overall Study|Death|0|||
146378947|NCT00814307|527887494|FG001|Overall Study|Death|1|||
146378948|NCT00814307|527887495|FG002|Overall Study|Death|0|||
146378949|NCT00814307|527887496|FG003|Overall Study|Death|0|||
146378950|NCT03073200|527887505|FG000|Double Blind Treatment Period|Protocol Violation|1|||
146378951|NCT03073200|527887506|FG001|Double Blind Treatment Period|Protocol Violation|0|||
146378952|NCT03073200|527887507|FG002|Double Blind Treatment Period|Protocol Violation|0|||
146378953|NCT03073200|527887508|FG003|Double Blind Treatment Period|Protocol Violation|0|||
146378954|NCT03073200|527887509|FG004|Double Blind Treatment Period|Protocol Violation|0|||
146378955|NCT03073200|527887510|FG005|Double Blind Treatment Period|Protocol Violation|0|||
146378956|NCT03073200|527887511|FG006|Double Blind Treatment Period|Protocol Violation|0|||
146378957|NCT03073200|527887512|FG007|Double Blind Treatment Period|Protocol Violation|0|||
146378958|NCT03073200|527887513|FG008|Double Blind Treatment Period|Protocol Violation|0|||
146378959|NCT03073200|527887514|FG009|Double Blind Treatment Period|Protocol Violation|0|||
146378960|NCT03073200|527887515|FG010|Double Blind Treatment Period|Protocol Violation|0|||
146378961|NCT03073200|527887516|FG011|Double Blind Treatment Period|Protocol Violation|0|||
146378962|NCT03073200|527887517|FG012|Double Blind Treatment Period|Protocol Violation|0|||
146378963|NCT03073200|527887518|FG013|Double Blind Treatment Period|Protocol Violation|0|||
146378964|NCT03073200|527887519|FG014|Double Blind Treatment Period|Protocol Violation|0|||
146378965|NCT03073200|527887505|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378966|NCT03073200|527887506|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
146378967|NCT03073200|527887507|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378968|NCT03073200|527887508|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378969|NCT03073200|527887509|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378970|NCT03073200|527887510|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378971|NCT03073200|527887511|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378972|NCT03073200|527887512|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378973|NCT03073200|527887513|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378974|NCT03073200|527887514|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378975|NCT03073200|527887515|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378976|NCT03073200|527887516|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378977|NCT03073200|527887517|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378978|NCT03073200|527887518|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378979|NCT03073200|527887519|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
146378980|NCT03073200|527887505|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
146378981|NCT03073200|527887506|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378982|NCT03073200|527887507|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378983|NCT03073200|527887508|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378984|NCT03073200|527887509|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378985|NCT03073200|527887510|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378986|NCT03073200|527887511|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378987|NCT03073200|527887512|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378988|NCT03073200|527887513|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378989|NCT03073200|527887514|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378990|NCT03073200|527887515|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378991|NCT03073200|527887516|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378992|NCT03073200|527887517|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378993|NCT03073200|527887518|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378994|NCT03073200|527887519|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
146378995|NCT03073200|527887505|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
146378996|NCT03073200|527887506|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
146378997|NCT03073200|527887507|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
146378998|NCT03073200|527887508|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
146378999|NCT03073200|527887509|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
146379000|NCT03073200|527887510|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379001|NCT03073200|527887511|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379002|NCT03073200|527887512|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379003|NCT03073200|527887513|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379004|NCT03073200|527887514|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379005|NCT03073200|527887515|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379006|NCT03073200|527887516|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379007|NCT03073200|527887517|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379008|NCT03073200|527887518|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379009|NCT03073200|527887519|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
146379010|NCT03073200|527887505|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
146379011|NCT03073200|527887506|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
146379012|NCT03073200|527887507|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
146379013|NCT03073200|527887508|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
146379014|NCT03073200|527887509|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
146379015|NCT03073200|527887510|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
146379016|NCT03073200|527887511|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
146379017|NCT03073200|527887512|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
146379018|NCT03073200|527887513|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
146379019|NCT03073200|527887514|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
146379020|NCT03073200|527887515|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
146379021|NCT03073200|527887516|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
146379022|NCT03073200|527887517|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
146379023|NCT03073200|527887518|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
146379024|NCT03073200|527887519|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
146379025|NCT03073200|527887505|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379026|NCT03073200|527887506|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379027|NCT03073200|527887507|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379028|NCT03073200|527887508|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379029|NCT03073200|527887509|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
146379030|NCT03073200|527887510|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379031|NCT03073200|527887511|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379032|NCT03073200|527887512|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379033|NCT03073200|527887513|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379034|NCT03073200|527887514|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379035|NCT03073200|527887515|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379036|NCT03073200|527887516|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379037|NCT03073200|527887517|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379038|NCT03073200|527887518|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379039|NCT03073200|527887519|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
146379040|NCT03073200|527887505|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379041|NCT03073200|527887506|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379042|NCT03073200|527887507|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379043|NCT03073200|527887508|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
146379044|NCT03073200|527887509|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
146379045|NCT03073200|527887510|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379046|NCT03073200|527887511|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379047|NCT03073200|527887512|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379048|NCT03073200|527887513|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379049|NCT03073200|527887514|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379050|NCT03073200|527887515|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379051|NCT03073200|527887516|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379052|NCT03073200|527887517|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379053|NCT03073200|527887518|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379054|NCT03073200|527887519|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
146379055|NCT03073200|527887505|FG000|Extension Period|Lost to Follow-up|0|||
146379056|NCT03073200|527887506|FG001|Extension Period|Lost to Follow-up|0|||
146379057|NCT03073200|527887507|FG002|Extension Period|Lost to Follow-up|0|||
146379058|NCT03073200|527887508|FG003|Extension Period|Lost to Follow-up|0|||
146379059|NCT03073200|527887509|FG004|Extension Period|Lost to Follow-up|0|||
146379060|NCT03073200|527887510|FG005|Extension Period|Lost to Follow-up|0|||
146379061|NCT03073200|527887511|FG006|Extension Period|Lost to Follow-up|1|||
146379062|NCT03073200|527887512|FG007|Extension Period|Lost to Follow-up|1|||
146379063|NCT03073200|527887513|FG008|Extension Period|Lost to Follow-up|0|||
146379064|NCT03073200|527887514|FG009|Extension Period|Lost to Follow-up|0|||
146379065|NCT03073200|527887515|FG010|Extension Period|Lost to Follow-up|0|||
146379066|NCT03073200|527887516|FG011|Extension Period|Lost to Follow-up|0|||
146379067|NCT03073200|527887517|FG012|Extension Period|Lost to Follow-up|0|||
146379068|NCT03073200|527887518|FG013|Extension Period|Lost to Follow-up|0|||
146379069|NCT03073200|527887519|FG014|Extension Period|Lost to Follow-up|0|||
146379070|NCT03073200|527887505|FG000|Extension Period|Sponsor Decision|0|||
146379071|NCT03073200|527887506|FG001|Extension Period|Sponsor Decision|0|||
146379072|NCT03073200|527887507|FG002|Extension Period|Sponsor Decision|0|||
146379073|NCT03073200|527887508|FG003|Extension Period|Sponsor Decision|0|||
146379074|NCT03073200|527887509|FG004|Extension Period|Sponsor Decision|0|||
146379075|NCT03073200|527887510|FG005|Extension Period|Sponsor Decision|0|||
146379076|NCT03073200|527887511|FG006|Extension Period|Sponsor Decision|0|||
146379077|NCT03073200|527887512|FG007|Extension Period|Sponsor Decision|0|||
146379078|NCT03073200|527887513|FG008|Extension Period|Sponsor Decision|1|||
146379079|NCT03073200|527887514|FG009|Extension Period|Sponsor Decision|0|||
146379080|NCT03073200|527887515|FG010|Extension Period|Sponsor Decision|0|||
146379081|NCT03073200|527887516|FG011|Extension Period|Sponsor Decision|0|||
146379082|NCT03073200|527887517|FG012|Extension Period|Sponsor Decision|0|||
146379083|NCT03073200|527887518|FG013|Extension Period|Sponsor Decision|0|||
146379084|NCT03073200|527887519|FG014|Extension Period|Sponsor Decision|0|||
146379085|NCT03073200|527887505|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
146379086|NCT03073200|527887506|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
146379087|NCT03073200|527887507|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
146379088|NCT03073200|527887508|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
146379089|NCT03073200|527887509|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
146379090|NCT03073200|527887510|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
146379091|NCT03073200|527887511|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
146379092|NCT03073200|527887512|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
146379093|NCT03073200|527887513|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
146379094|NCT03073200|527887514|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
146379095|NCT03073200|527887515|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
146379096|NCT03073200|527887516|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
146379097|NCT03073200|527887517|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
146379098|NCT03073200|527887518|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
146379099|NCT03073200|527887519|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
146379100|NCT03073200|527887505|FG000|Extension Period|Withdrawal by Subject|0|||
146379101|NCT03073200|527887506|FG001|Extension Period|Withdrawal by Subject|0|||
146379102|NCT03073200|527887507|FG002|Extension Period|Withdrawal by Subject|0|||
146379103|NCT03073200|527887508|FG003|Extension Period|Withdrawal by Subject|0|||
146379104|NCT03073200|527887509|FG004|Extension Period|Withdrawal by Subject|0|||
146379105|NCT03073200|527887510|FG005|Extension Period|Withdrawal by Subject|0|||
146379106|NCT03073200|527887511|FG006|Extension Period|Withdrawal by Subject|1|||
146379107|NCT03073200|527887512|FG007|Extension Period|Withdrawal by Subject|2|||
146379108|NCT03073200|527887513|FG008|Extension Period|Withdrawal by Subject|0|||
146379109|NCT03073200|527887514|FG009|Extension Period|Withdrawal by Subject|0|||
146379110|NCT03073200|527887515|FG010|Extension Period|Withdrawal by Subject|0|||
146379111|NCT03073200|527887516|FG011|Extension Period|Withdrawal by Subject|0|||
146379112|NCT03073200|527887517|FG012|Extension Period|Withdrawal by Subject|0|||
146379113|NCT03073200|527887518|FG013|Extension Period|Withdrawal by Subject|0|||
146379114|NCT03073200|527887519|FG014|Extension Period|Withdrawal by Subject|0|||
146379115|NCT03073200|527887505|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379116|NCT03073200|527887506|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379117|NCT03073200|527887507|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379118|NCT03073200|527887508|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379119|NCT03073200|527887509|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379120|NCT03073200|527887510|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379121|NCT03073200|527887511|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379122|NCT03073200|527887512|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379123|NCT03073200|527887513|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379124|NCT03073200|527887514|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379125|NCT03073200|527887515|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379126|NCT03073200|527887516|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
146379127|NCT03073200|527887517|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379128|NCT03073200|527887518|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379129|NCT03073200|527887519|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
146379130|NCT03073200|527887505|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379131|NCT03073200|527887506|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379132|NCT03073200|527887507|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379133|NCT03073200|527887508|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379134|NCT03073200|527887509|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379135|NCT03073200|527887510|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379136|NCT03073200|527887511|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379137|NCT03073200|527887512|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379138|NCT03073200|527887513|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379139|NCT03073200|527887514|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379140|NCT03073200|527887515|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379141|NCT03073200|527887516|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
146379142|NCT03073200|527887517|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379143|NCT03073200|527887518|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379144|NCT03073200|527887519|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
146379145|NCT03073200|527887505|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379146|NCT03073200|527887506|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379147|NCT03073200|527887507|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379148|NCT03073200|527887508|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379149|NCT03073200|527887509|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379150|NCT03073200|527887510|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379151|NCT03073200|527887511|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379152|NCT03073200|527887512|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379153|NCT03073200|527887513|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379154|NCT03073200|527887514|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379155|NCT03073200|527887515|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146379156|NCT03073200|527887516|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
146379157|NCT03073200|527887517|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379158|NCT03073200|527887518|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379159|NCT03073200|527887519|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
146379160|NCT03073200|527887505|FG000|Randomized Withdrawal Period|Adverse Event|0|||
146379161|NCT03073200|527887506|FG001|Randomized Withdrawal Period|Adverse Event|0|||
146379162|NCT03073200|527887507|FG002|Randomized Withdrawal Period|Adverse Event|0|||
146379163|NCT03073200|527887508|FG003|Randomized Withdrawal Period|Adverse Event|0|||
146379164|NCT03073200|527887509|FG004|Randomized Withdrawal Period|Adverse Event|0|||
146379165|NCT03073200|527887510|FG005|Randomized Withdrawal Period|Adverse Event|0|||
146379166|NCT03073200|527887511|FG006|Randomized Withdrawal Period|Adverse Event|0|||
146379167|NCT03073200|527887512|FG007|Randomized Withdrawal Period|Adverse Event|0|||
146379168|NCT03073200|527887513|FG008|Randomized Withdrawal Period|Adverse Event|0|||
146379169|NCT03073200|527887514|FG009|Randomized Withdrawal Period|Adverse Event|0|||
146379170|NCT03073200|527887515|FG010|Randomized Withdrawal Period|Adverse Event|1|||
146379171|NCT03073200|527887516|FG011|Randomized Withdrawal Period|Adverse Event|0|||
146379172|NCT03073200|527887517|FG012|Randomized Withdrawal Period|Adverse Event|0|||
146379173|NCT03073200|527887518|FG013|Randomized Withdrawal Period|Adverse Event|0|||
146379174|NCT03073200|527887519|FG014|Randomized Withdrawal Period|Adverse Event|0|||
146379175|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379176|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379177|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379178|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379179|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379180|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379181|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379182|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379183|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379184|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379185|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379186|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379187|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379188|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
146379189|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
146379190|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379191|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379192|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379193|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379194|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379195|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379196|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379197|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379198|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379199|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379200|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379201|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379202|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379203|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
146379204|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
146379205|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379206|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379207|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379208|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379209|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379210|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379211|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379212|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379213|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379214|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379215|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379216|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379217|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379218|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
146379219|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
146379220|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379221|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379222|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379223|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379224|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379225|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379226|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379227|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379228|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379229|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379230|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379231|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379232|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379233|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
146379234|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
146379235|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379236|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379237|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379238|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379239|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379240|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379241|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379242|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379243|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379244|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379245|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379246|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379247|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379248|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
146379249|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
146379250|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379251|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379252|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379253|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379254|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379255|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379256|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379257|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379258|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379259|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379260|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379261|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379262|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379263|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
146379264|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
146379265|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379266|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379267|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379268|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379269|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379270|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379271|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379272|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379273|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379274|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379275|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379276|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379277|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379278|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
146379279|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
146379280|NCT03073200|527887505|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379281|NCT03073200|527887506|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379282|NCT03073200|527887507|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379283|NCT03073200|527887508|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379284|NCT03073200|527887509|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379285|NCT03073200|527887510|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379286|NCT03073200|527887511|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379287|NCT03073200|527887512|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379288|NCT03073200|527887513|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379289|NCT03073200|527887514|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379290|NCT03073200|527887515|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379291|NCT03073200|527887516|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379292|NCT03073200|527887517|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379293|NCT03073200|527887518|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
146379294|NCT03073200|527887519|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
146379295|NCT00901394|527887520|FG000|Overall Study|Physician Decision|1|||
146379296|NCT00901394|527887521|FG001|Overall Study|Physician Decision|1|||
146379297|NCT00901394|527887522|FG002|Overall Study|Physician Decision|2|||
146379298|NCT02290340|527887524|FG000|Overall Study|Lost to Follow-up|0|||
146379299|NCT02290340|527887525|FG001|Overall Study|Lost to Follow-up|0|||
146379300|NCT02290340|527887526|FG002|Overall Study|Lost to Follow-up|0|||
146379301|NCT02290340|527887527|FG003|Overall Study|Lost to Follow-up|1|||
146379302|NCT02290340|527887524|FG000|Overall Study|Withdrawal by Subject|1|||
146379303|NCT02290340|527887525|FG001|Overall Study|Withdrawal by Subject|0|||
146379304|NCT02290340|527887526|FG002|Overall Study|Withdrawal by Subject|0|||
146379305|NCT02290340|527887527|FG003|Overall Study|Withdrawal by Subject|0|||
146379306|NCT02290340|527887524|FG000|Overall Study|Other|1|||
146379307|NCT02290340|527887525|FG001|Overall Study|Other|0|||
146379308|NCT02290340|527887526|FG002|Overall Study|Other|0|||
146379309|NCT02290340|527887527|FG003|Overall Study|Other|1|||
146379310|NCT02571972|527887530|FG000|Overall Study|Protocol Violation|2|||
146379311|NCT02571972|527887530|FG000|Overall Study|Withdrawal by Subject|2|||
146379312|NCT03039192|527887533|FG000|Overall Study|Lost to Follow-up|4|||
146379313|NCT03039192|527887534|FG001|Overall Study|Lost to Follow-up|4|||
146379314|NCT03039192|527887533|FG000|Overall Study|Adverse event, serious fatal|0|||
146379315|NCT03039192|527887534|FG001|Overall Study|Adverse event, serious fatal|1|||
146379316|NCT03039192|527887533|FG000|Overall Study|Adverse event, non-fatal|0|||
146379317|NCT03039192|527887534|FG001|Overall Study|Adverse event, non-fatal|2|||
146379318|NCT03039192|527887533|FG000|Overall Study|Withdrawal by Subject|6|||
146379319|NCT03039192|527887534|FG001|Overall Study|Withdrawal by Subject|9|||
146379320|NCT03039192|527887533|FG000|Overall Study|Discontinued from treatment phase|19|||
146379321|NCT03039192|527887534|FG001|Overall Study|Discontinued from treatment phase|12|||
146379322|NCT03039192|527887533|FG000|Overall Study|Other|3|||
146379323|NCT03039192|527887534|FG001|Overall Study|Other|2|||
146379324|NCT01432756|527889421|FG000|Overall Study|Lost to Follow-up|1|||
146379325|NCT01432756|527889422|FG001|Overall Study|Lost to Follow-up|0|||
146379326|NCT01432756|527889423|FG002|Overall Study|Lost to Follow-up|2|||
146379327|NCT01432756|527889424|FG003|Overall Study|Lost to Follow-up|1|||
146379328|NCT00777257|527889432|FG000|Overall Study|Adverse Event|3|||
146379329|NCT00777257|527889433|FG001|Overall Study|Adverse Event|1|||
146379330|NCT00777257|527889434|FG002|Overall Study|Adverse Event|0|||
146379331|NCT00777257|527889432|FG000|Overall Study|Lost to Follow-up|3|||
146379332|NCT00777257|527889433|FG001|Overall Study|Lost to Follow-up|3|||
146379333|NCT00777257|527889434|FG002|Overall Study|Lost to Follow-up|2|||
146379334|NCT00777257|527889432|FG000|Overall Study|Protocol Violation|2|||
146379335|NCT00777257|527889433|FG001|Overall Study|Protocol Violation|2|||
146379336|NCT00777257|527889434|FG002|Overall Study|Protocol Violation|2|||
146379337|NCT00777257|527889432|FG000|Overall Study|Withdrawal by Subject|3|||
146379338|NCT00777257|527889433|FG001|Overall Study|Withdrawal by Subject|6|||
146379339|NCT00777257|527889434|FG002|Overall Study|Withdrawal by Subject|5|||
146379340|NCT02973997|527889439|FG000|Overall Study|Withdrawal by Subject|4|||
146379341|NCT02973997|527889440|FG001|Overall Study|Withdrawal by Subject|0|||
146379342|NCT02973997|527889439|FG000|Overall Study|Adverse Event|4|||
146379343|NCT02973997|527889440|FG001|Overall Study|Adverse Event|1|||
146379344|NCT02973997|527889439|FG000|Overall Study|Disease Progression|11|||
146379345|NCT02973997|527889440|FG001|Overall Study|Disease Progression|20|||
146379346|NCT02973997|527889439|FG000|Overall Study|Alternative Therapy|3|||
146379347|NCT02973997|527889440|FG001|Overall Study|Alternative Therapy|0|||
146379348|NCT02973997|527889439|FG000|Overall Study|Other complicating disease|0|||
146379349|NCT02973997|527889440|FG001|Overall Study|Other complicating disease|1|||
146379350|NCT02973997|527889439|FG000|Overall Study|Death|0|||
146379351|NCT02973997|527889440|FG001|Overall Study|Death|1|||
146379352|NCT01431521|527889441|FG000|Overall Study|Withdrawal by Subject|0|||
146379353|NCT01431521|527889442|FG001|Overall Study|Withdrawal by Subject|0|||
146379354|NCT01431521|527889443|FG002|Overall Study|Withdrawal by Subject|1|||
146379355|NCT01431521|527889444|FG003|Overall Study|Withdrawal by Subject|0|||
146379356|NCT00444951|527889445|FG000|Overall Study|Lost to Follow-up|1|||
146379357|NCT00444951|527889446|FG001|Overall Study|Lost to Follow-up|1|||
146379358|NCT00444951|527889447|FG002|Overall Study|Lost to Follow-up|0|||
146379359|NCT00444951|527889445|FG000|Overall Study|Withdrawal by Subject|4|||
146379360|NCT00444951|527889446|FG001|Overall Study|Withdrawal by Subject|5|||
146379361|NCT00444951|527889447|FG002|Overall Study|Withdrawal by Subject|3|||
146379362|NCT00366444|527889449|FG000|Overall Study|Withdrawal by Subject|1|||
146379363|NCT00366444|527889450|FG001|Overall Study|Withdrawal by Subject|1|||
146379364|NCT00366444|527889449|FG000|Overall Study|Lack of Efficacy|0|||
146379365|NCT00366444|527889450|FG001|Overall Study|Lack of Efficacy|1|||
146379366|NCT02000622|527889451|FG000|Overall Study|Withdrawal by Subject|5|||
146379367|NCT02000622|527889452|FG001|Overall Study|Withdrawal by Subject|7|||
146379368|NCT02000622|527889451|FG000|Overall Study|Lost to Follow-up|4|||
146379369|NCT02000622|527889452|FG001|Overall Study|Lost to Follow-up|0|||
146379370|NCT02000622|527889451|FG000|Overall Study|Death|159|||
146379371|NCT02000622|527889452|FG001|Overall Study|Death|73|||
146379372|NCT02000622|527889451|FG000|Overall Study|Withdrawn due to site closure|1|||
146379373|NCT02000622|527889452|FG001|Overall Study|Withdrawn due to site closure|0|||
146379374|NCT01405027|527889453|FG000|Overall Study|Withdrawn consent|3|||
146379375|NCT01405027|527889454|FG001|Overall Study|Withdrawn consent|0|||
146379376|NCT01405027|527889453|FG000|Overall Study|Lost to Follow-up|16|||
146379377|NCT01405027|527889454|FG001|Overall Study|Lost to Follow-up|24|||
146379378|NCT01405027|527889453|FG000|Overall Study|Investigator judgement|0|||
146379379|NCT01405027|527889454|FG001|Overall Study|Investigator judgement|2|||
146379380|NCT01405027|527889453|FG000|Overall Study|Death|1|||
146379381|NCT01405027|527889454|FG001|Overall Study|Death|0|||
146379382|NCT01405027|527889453|FG000|Overall Study|Other or Unknown|12|||
146379383|NCT01405027|527889454|FG001|Overall Study|Other or Unknown|25|||
146379384|NCT06048809|527889467|FG000|Overall Study|Adverse Event|2|||
146379385|NCT06048809|527889468|FG001|Overall Study|Adverse Event|0|||
146379386|NCT06048809|527889467|FG000|Overall Study|Withdrawal by Subject|1|||
146379387|NCT06048809|527889468|FG001|Overall Study|Withdrawal by Subject|1|||
146379388|NCT04960202|527889470|FG000|Overall Study|Other|5|||
146379389|NCT04960202|527889471|FG001|Overall Study|Other|0|||
146379390|NCT04960202|527889470|FG000|Overall Study|Withdrawal by Subject|37|||
146379391|NCT04960202|527889471|FG001|Overall Study|Withdrawal by Subject|43|||
146379392|NCT04960202|527889470|FG000|Overall Study|Lost to Follow-up|20|||
146379393|NCT04960202|527889471|FG001|Overall Study|Lost to Follow-up|16|||
146379394|NCT04960202|527889470|FG000|Overall Study|Death|0|||
146379395|NCT04960202|527889471|FG001|Overall Study|Death|15|||
146379396|NCT02158728|527889472|FG000|Overall Study|no procedure according to CIP done|3|||
146379397|NCT02158728|527889472|FG000|Overall Study|no qualified dataset|24|||
146379398|NCT03558828|527889473|FG000|Overall Study|Lost to Follow-up|4|||
146379399|NCT03558828|527889474|FG001|Overall Study|Lost to Follow-up|3|||
146379400|NCT03558828|527889475|FG002|Overall Study|Lost to Follow-up|3|||
146379401|NCT03558828|527889476|FG003|Overall Study|Lost to Follow-up|5|||
146379402|NCT03558828|527889477|FG004|Overall Study|Lost to Follow-up|2|||
146379403|NCT03558828|527889478|FG005|Overall Study|Lost to Follow-up|3|||
146379404|NCT03558828|527889473|FG000|Overall Study|dropped before the intervention|1|||
146379405|NCT03558828|527889474|FG001|Overall Study|dropped before the intervention|1|||
146379406|NCT03558828|527889475|FG002|Overall Study|dropped before the intervention|0|||
146379407|NCT03558828|527889476|FG003|Overall Study|dropped before the intervention|0|||
146379408|NCT03558828|527889477|FG004|Overall Study|dropped before the intervention|0|||
146379409|NCT03558828|527889478|FG005|Overall Study|dropped before the intervention|0|||
146379410|NCT00673816|527889483|FG000|Overall Study|Adverse Event|1|||
146379411|NCT00673816|527889483|FG000|Overall Study|Withdrawal by Subject|1|||
146379412|NCT00589602|527889484|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
146379413|NCT01804842|527889485|FG000|Overall Study|Adverse Event|1|||
146379414|NCT01804842|527889486|FG001|Overall Study|Adverse Event|1|||
146379415|NCT01804842|527889487|FG002|Overall Study|Adverse Event|0|||
146379416|NCT01804842|527889485|FG000|Overall Study|Lost to Follow-up|1|||
146379417|NCT01804842|527889486|FG001|Overall Study|Lost to Follow-up|0|||
146379418|NCT01804842|527889487|FG002|Overall Study|Lost to Follow-up|0|||
146379419|NCT01804842|527889485|FG000|Overall Study|Non-Compliance|1|||
146379420|NCT01804842|527889486|FG001|Overall Study|Non-Compliance|1|||
146379421|NCT01804842|527889487|FG002|Overall Study|Non-Compliance|0|||
146379422|NCT01804842|527889485|FG000|Overall Study|Personal Reason|0|||
146379423|NCT01804842|527889486|FG001|Overall Study|Personal Reason|0|||
146379424|NCT01804842|527889487|FG002|Overall Study|Personal Reason|1|||
146379425|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
146379426|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
146379427|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
146379428|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
146379429|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
146379430|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
146379431|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
146379432|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
146379433|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
146379434|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
146379435|NCT03774875|527889488|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
146379436|NCT03774875|527889489|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
146379437|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
146379438|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
146379439|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
146379440|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
146379441|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
146379442|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
146379443|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
146379444|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
146379445|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
146379446|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
146379447|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
146379448|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
146379449|NCT03774875|527889488|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
146379450|NCT03774875|527889489|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
146379451|NCT02352090|527889490|FG000|Overall Study|general malaise|1|||
146379452|NCT02352090|527889491|FG001|Overall Study|general malaise|0|||
146379453|NCT02352090|527889492|FG002|Overall Study|general malaise|0|||
146379454|NCT02352090|527889490|FG000|Overall Study|non-specified mild side-effects|0|||
146379455|NCT02352090|527889491|FG001|Overall Study|non-specified mild side-effects|0|||
146379456|NCT02352090|527889492|FG002|Overall Study|non-specified mild side-effects|2|||
146379457|NCT00796003|527889495|FG000|Overall Study|Disease Progression|2|||
146379458|NCT00796003|527889496|FG001|Overall Study|Disease Progression|13|||
146379459|NCT00796003|527889495|FG000|Overall Study|Adverse Event|1|||
146379460|NCT00796003|527889496|FG001|Overall Study|Adverse Event|7|||
146379461|NCT00796003|527889495|FG000|Overall Study|Specified organ function not met|0|||
146379462|NCT00796003|527889496|FG001|Overall Study|Specified organ function not met|1|||
146379463|NCT00796003|527889495|FG000|Overall Study|Physician Decision|0|||
146379464|NCT00796003|527889496|FG001|Overall Study|Physician Decision|4|||
146379465|NCT00796003|527889495|FG000|Overall Study|Withdrawal by Subject|0|||
146379466|NCT00796003|527889496|FG001|Overall Study|Withdrawal by Subject|1|||
146379467|NCT00796003|527889495|FG000|Overall Study|Other|0|||
146379468|NCT00796003|527889496|FG001|Overall Study|Other|1|||
146379469|NCT00796003|527889495|FG000|Overall Study|Participants Not treated|0|||
146379470|NCT00796003|527889496|FG001|Overall Study|Participants Not treated|2|||
146379471|NCT05179057|527889497|FG000|Overall Study|Adverse Event|3|||
146379472|NCT05179057|527889498|FG001|Overall Study|Adverse Event|2|||
146379473|NCT05179057|527889497|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
146379474|NCT05179057|527889498|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
146379475|NCT05179057|527889497|FG000|Overall Study|Study terminated|13|||
146379476|NCT05179057|527889498|FG001|Overall Study|Study terminated|7|||
146379477|NCT05179057|527889497|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
146379478|NCT05179057|527889498|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
146379479|NCT05179057|527889497|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
146379480|NCT05179057|527889498|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
146379481|NCT04288089|527889504|FG000|Overall Study|Ongoing Treatment|2|||
146379482|NCT04288089|527889505|FG001|Overall Study|Ongoing Treatment|1|||
146379483|NCT04288089|527889506|FG002|Overall Study|Ongoing Treatment|1|||
146379484|NCT04288089|527889507|FG003|Overall Study|Ongoing Treatment|4|||
146379485|NCT00976963|527889512|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
146379486|NCT00976963|527889513|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
146379487|NCT00976963|527889512|FG000|Overall Study|administrative error|1|||
146379488|NCT00976963|527889513|FG001|Overall Study|administrative error|0|||
146379489|NCT00976963|527889512|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
146379490|NCT00976963|527889513|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
146379491|NCT03146403|527889514|FG000|Overall Study|Withdrawal by Subject|0|||
146379492|NCT03146403|527889515|FG001|Overall Study|Withdrawal by Subject|3|||
146379493|NCT03146403|527889514|FG000|Overall Study|Lost to Follow-up|2|||
146379494|NCT03146403|527889515|FG001|Overall Study|Lost to Follow-up|0|||
146379495|NCT02182999|527889517|FG000|Overall Study|Adverse Event|4|||
146379496|NCT02182999|527889518|FG001|Overall Study|Adverse Event|3|||
146379497|NCT02182999|527889517|FG000|Overall Study|Physician Decision|1|||
146379498|NCT02182999|527889518|FG001|Overall Study|Physician Decision|0|||
146379499|NCT02252588|527889520|FG000|Overall Study|Withdrawal by Subject|4|||
146379500|NCT02252588|527889521|FG001|Overall Study|Withdrawal by Subject|0|||
146379501|NCT03039790|527889523|FG000|Overall Study|Lost to Follow-up|2|||
146379502|NCT03039790|527889524|FG001|Overall Study|Lost to Follow-up|0|||
146379503|NCT03039790|527889525|FG002|Overall Study|Lost to Follow-up|1|||
146379504|NCT03039790|527889526|FG003|Overall Study|Lost to Follow-up|1|||
146379505|NCT03039790|527889527|FG004|Overall Study|Lost to Follow-up|0|||
146379506|NCT03039790|527889528|FG005|Overall Study|Lost to Follow-up|1|||
146379507|NCT03039790|527889529|FG006|Overall Study|Lost to Follow-up|1|||
146379508|NCT03039790|527889530|FG007|Overall Study|Lost to Follow-up|1|||
146379509|NCT03039790|527889531|FG008|Overall Study|Lost to Follow-up|0|||
146379510|NCT03039790|527889532|FG009|Overall Study|Lost to Follow-up|1|||
146379511|NCT03039790|527889533|FG010|Overall Study|Lost to Follow-up|1|||
146379512|NCT03039790|527889534|FG011|Overall Study|Lost to Follow-up|0|||
146379513|NCT03039790|527889535|FG012|Overall Study|Lost to Follow-up|1|||
146379514|NCT03039790|527889536|FG013|Overall Study|Lost to Follow-up|0|||
146379515|NCT03039790|527889537|FG014|Overall Study|Lost to Follow-up|3|||
146379516|NCT03039790|527889538|FG015|Overall Study|Lost to Follow-up|1|||
146379517|NCT03039790|527889539|FG016|Overall Study|Lost to Follow-up|2|||
146379518|NCT03039790|527889540|FG017|Overall Study|Lost to Follow-up|2|||
146379519|NCT03039790|527889541|FG018|Overall Study|Lost to Follow-up|1|||
146379520|NCT03039790|527889542|FG019|Overall Study|Lost to Follow-up|3|||
146379521|NCT03039790|527889523|FG000|Overall Study|Withdrawal of Consent|1|||
146379522|NCT03039790|527889524|FG001|Overall Study|Withdrawal of Consent|0|||
146379523|NCT03039790|527889525|FG002|Overall Study|Withdrawal of Consent|0|||
146379524|NCT03039790|527889526|FG003|Overall Study|Withdrawal of Consent|1|||
146379525|NCT03039790|527889527|FG004|Overall Study|Withdrawal of Consent|0|||
146379526|NCT03039790|527889528|FG005|Overall Study|Withdrawal of Consent|0|||
146379527|NCT03039790|527889529|FG006|Overall Study|Withdrawal of Consent|0|||
146379528|NCT03039790|527889530|FG007|Overall Study|Withdrawal of Consent|0|||
146379529|NCT03039790|527889531|FG008|Overall Study|Withdrawal of Consent|0|||
146379530|NCT03039790|527889532|FG009|Overall Study|Withdrawal of Consent|1|||
146379531|NCT03039790|527889533|FG010|Overall Study|Withdrawal of Consent|0|||
146379532|NCT03039790|527889534|FG011|Overall Study|Withdrawal of Consent|0|||
146379533|NCT03039790|527889535|FG012|Overall Study|Withdrawal of Consent|2|||
146379534|NCT03039790|527889536|FG013|Overall Study|Withdrawal of Consent|0|||
146379535|NCT03039790|527889537|FG014|Overall Study|Withdrawal of Consent|1|||
146379536|NCT03039790|527889538|FG015|Overall Study|Withdrawal of Consent|5|||
146379537|NCT03039790|527889539|FG016|Overall Study|Withdrawal of Consent|3|||
146379538|NCT03039790|527889540|FG017|Overall Study|Withdrawal of Consent|0|||
146379539|NCT03039790|527889541|FG018|Overall Study|Withdrawal of Consent|2|||
146379540|NCT03039790|527889542|FG019|Overall Study|Withdrawal of Consent|5|||
146379541|NCT03039790|527889523|FG000|Overall Study|Death|0|||
146379542|NCT03039790|527889524|FG001|Overall Study|Death|0|||
146379543|NCT03039790|527889525|FG002|Overall Study|Death|0|||
146379544|NCT03039790|527889526|FG003|Overall Study|Death|0|||
146379545|NCT03039790|527889527|FG004|Overall Study|Death|0|||
146379546|NCT03039790|527889528|FG005|Overall Study|Death|0|||
146379547|NCT03039790|527889529|FG006|Overall Study|Death|0|||
146379548|NCT03039790|527889530|FG007|Overall Study|Death|0|||
146379549|NCT03039790|527889531|FG008|Overall Study|Death|0|||
146379550|NCT03039790|527889532|FG009|Overall Study|Death|0|||
146379551|NCT03039790|527889533|FG010|Overall Study|Death|0|||
146379552|NCT03039790|527889534|FG011|Overall Study|Death|0|||
146379553|NCT03039790|527889535|FG012|Overall Study|Death|0|||
146379554|NCT03039790|527889536|FG013|Overall Study|Death|0|||
146379555|NCT03039790|527889537|FG014|Overall Study|Death|0|||
146379556|NCT03039790|527889538|FG015|Overall Study|Death|1|||
146379557|NCT03039790|527889539|FG016|Overall Study|Death|3|||
146379558|NCT03039790|527889540|FG017|Overall Study|Death|0|||
146379559|NCT03039790|527889541|FG018|Overall Study|Death|2|||
146379560|NCT03039790|527889542|FG019|Overall Study|Death|0|||
146379561|NCT03039790|527889523|FG000|Overall Study|Reason, not Specified|1|||
146379562|NCT03039790|527889524|FG001|Overall Study|Reason, not Specified|0|||
146379563|NCT03039790|527889525|FG002|Overall Study|Reason, not Specified|0|||
146379564|NCT03039790|527889526|FG003|Overall Study|Reason, not Specified|0|||
146379565|NCT03039790|527889527|FG004|Overall Study|Reason, not Specified|0|||
146379566|NCT03039790|527889528|FG005|Overall Study|Reason, not Specified|0|||
146379567|NCT03039790|527889529|FG006|Overall Study|Reason, not Specified|0|||
146379568|NCT03039790|527889530|FG007|Overall Study|Reason, not Specified|0|||
146379569|NCT03039790|527889531|FG008|Overall Study|Reason, not Specified|0|||
146379570|NCT03039790|527889532|FG009|Overall Study|Reason, not Specified|0|||
146379571|NCT03039790|527889533|FG010|Overall Study|Reason, not Specified|0|||
146379572|NCT03039790|527889534|FG011|Overall Study|Reason, not Specified|0|||
146379573|NCT03039790|527889535|FG012|Overall Study|Reason, not Specified|0|||
146379574|NCT03039790|527889536|FG013|Overall Study|Reason, not Specified|0|||
146379575|NCT03039790|527889537|FG014|Overall Study|Reason, not Specified|0|||
146379576|NCT03039790|527889538|FG015|Overall Study|Reason, not Specified|0|||
146379577|NCT03039790|527889539|FG016|Overall Study|Reason, not Specified|2|||
146379578|NCT03039790|527889540|FG017|Overall Study|Reason, not Specified|0|||
146379579|NCT03039790|527889541|FG018|Overall Study|Reason, not Specified|1|||
146379580|NCT03039790|527889542|FG019|Overall Study|Reason, not Specified|0|||
146379581|NCT00557323|527889543|FG000|Overall Study|Death|3|||
146379582|NCT00557323|527889543|FG000|Overall Study|Withdrawal by Subject|2|||
146379583|NCT00557323|527889543|FG000|Overall Study|Administrative change|2|||
146379584|NCT00498368|527889553|FG000|Overall Study|Withdrawal by Subject|3|||
146379585|NCT00498368|527889554|FG001|Overall Study|Withdrawal by Subject|2|||
146379586|NCT02266004|527889555|FG000|Overall Study|unrelated adverse event|1|||
146379587|NCT02266004|527889555|FG000|Overall Study|Physician Decision|1|||
146379588|NCT00537771|527889560|FG000|Overall Study|Withdrawal by Subject|6|||
146379589|NCT00537771|527889561|FG001|Overall Study|Withdrawal by Subject|23|||
146379590|NCT00537771|527889560|FG000|Overall Study|Adverse Event|8|||
146379591|NCT00537771|527889561|FG001|Overall Study|Adverse Event|15|||
146379592|NCT00537771|527889560|FG000|Overall Study|Lost to Follow-up|9|||
146379593|NCT00537771|527889561|FG001|Overall Study|Lost to Follow-up|15|||
146379594|NCT00537771|527889560|FG000|Overall Study|Protocol Violation|2|||
146379595|NCT00537771|527889561|FG001|Overall Study|Protocol Violation|6|||
146379596|NCT00537771|527889560|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
146379597|NCT00537771|527889561|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
146379598|NCT02736929|527889565|FG000|Main Study|Lost to Follow-up|7|||
146379599|NCT02736929|527889566|FG001|Main Study|Lost to Follow-up|1|||
146379600|NCT02736929|527889567|FG002|Main Study|Lost to Follow-up|0|||
146379601|NCT02736929|527889565|FG000|Main Study|Withdrawal by Subject|1|||
146379602|NCT02736929|527889566|FG001|Main Study|Withdrawal by Subject|1|||
146379603|NCT02736929|527889567|FG002|Main Study|Withdrawal by Subject|0|||
146379604|NCT02736929|527889565|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
146379605|NCT02736929|527889566|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
146379606|NCT02736929|527889567|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
146379607|NCT02148952|527889575|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
146379608|NCT02148952|527889576|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
146379609|NCT02148952|527889575|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
146379610|NCT02148952|527889576|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
146379611|NCT02148952|527889575|FG000|Follow-Up|Lost to Follow-up|219|||
146379612|NCT02148952|527889576|FG001|Follow-Up|Lost to Follow-up|231|||
146379613|NCT02148952|527889575|FG000|Follow-Up|Withdrawal by Subject|46|||
146379614|NCT02148952|527889576|FG001|Follow-Up|Withdrawal by Subject|48|||
146379615|NCT03748420|527889577|FG000|Overall Study|No 12 month medication adherence data available|0|||
146379616|NCT03748420|527889578|FG001|Overall Study|No 12 month medication adherence data available|1|||
146379617|NCT03748420|527889577|FG000|Overall Study|Death|24|||
146379618|NCT03748420|527889578|FG001|Overall Study|Death|28|||
146379619|NCT03748420|527889577|FG000|Overall Study|Lost to Follow-up|231|||
146379620|NCT03748420|527889578|FG001|Overall Study|Lost to Follow-up|230|||
146379621|NCT04007367|527889579|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
146379622|NCT04007367|527889580|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
146379623|NCT04007367|527889581|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
146379624|NCT04007367|527889579|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
146379625|NCT04007367|527889580|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
146379626|NCT04007367|527889581|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
146379627|NCT04007367|527889579|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
146379628|NCT04007367|527889580|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
146379629|NCT04007367|527889581|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
146379630|NCT04007367|527889579|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
146379631|NCT04007367|527889580|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
146379632|NCT04007367|527889581|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
146379633|NCT04007367|527889579|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
146379634|NCT04007367|527889580|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
146379635|NCT04007367|527889581|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
146379636|NCT04247828|527889585|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
146379637|NCT00623766|527889586|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
146379638|NCT00623766|527889587|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
146379639|NCT00623766|527889586|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
146379640|NCT00623766|527889587|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
146379641|NCT00623766|527889586|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
146379642|NCT00623766|527889587|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
146379643|NCT00623766|527889586|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
146379644|NCT00623766|527889587|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
146379645|NCT00623766|527889586|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
146379646|NCT00623766|527889587|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
146379647|NCT00893763|527889589|FG000|Overall Study|extubated|110|||
146379648|NCT00893763|527889590|FG001|Overall Study|extubated|110|||
146379649|NCT01437267|527889591|FG000|Overall Study|Withdrawal by Subject|0|||
146379650|NCT01437267|527889592|FG001|Overall Study|Withdrawal by Subject|0|||
146379651|NCT01437267|527889593|FG002|Overall Study|Withdrawal by Subject|0|||
146379652|NCT01437267|527889594|FG003|Overall Study|Withdrawal by Subject|1|||
146379653|NCT01437267|527889595|FG004|Overall Study|Withdrawal by Subject|0|||
146379654|NCT01437267|527889596|FG005|Overall Study|Withdrawal by Subject|0|||
146379655|NCT01437267|527889591|FG000|Overall Study|Protocol Violation|0|||
146379656|NCT01437267|527889592|FG001|Overall Study|Protocol Violation|1|||
146379657|NCT01437267|527889593|FG002|Overall Study|Protocol Violation|0|||
146379658|NCT01437267|527889594|FG003|Overall Study|Protocol Violation|0|||
146379659|NCT01437267|527889595|FG004|Overall Study|Protocol Violation|0|||
146379660|NCT01437267|527889596|FG005|Overall Study|Protocol Violation|0|||
146379661|NCT00608842|527889599|FG000|Overall Study|Participant's Request|0|||
146379662|NCT00608842|527889600|FG001|Overall Study|Participant's Request|1|||
146379663|NCT00608842|527889601|FG002|Overall Study|Participant's Request|2|||
146379664|NCT00608842|527889602|FG003|Overall Study|Participant's Request|1|||
146379665|NCT00608842|527889599|FG000|Overall Study|Lost to Follow-up|1|||
146379666|NCT00608842|527889600|FG001|Overall Study|Lost to Follow-up|0|||
146379667|NCT00608842|527889601|FG002|Overall Study|Lost to Follow-up|0|||
146379668|NCT00608842|527889602|FG003|Overall Study|Lost to Follow-up|0|||
146379669|NCT03799627|527889603|FG000|Overall Study|Adverse Event|1|||
146379670|NCT03799627|527889604|FG001|Overall Study|Adverse Event|2|||
146379671|NCT03799627|527889605|FG002|Overall Study|Adverse Event|0|||
146379672|NCT03799627|527889606|FG003|Overall Study|Adverse Event|0|||
146379673|NCT03799627|527889607|FG004|Overall Study|Adverse Event|2|||
146379674|NCT03799627|527889608|FG005|Overall Study|Adverse Event|5|||
146379675|NCT03799627|527889609|FG006|Overall Study|Adverse Event|0|||
146379676|NCT03799627|527889610|FG007|Overall Study|Adverse Event|2|||
146379677|NCT03799627|527889611|FG008|Overall Study|Adverse Event|0|||
146379678|NCT03799627|527889603|FG000|Overall Study|Physician Decision|2|||
146379679|NCT03799627|527889604|FG001|Overall Study|Physician Decision|2|||
146379680|NCT03799627|527889605|FG002|Overall Study|Physician Decision|0|||
146379681|NCT03799627|527889606|FG003|Overall Study|Physician Decision|0|||
146379682|NCT03799627|527889607|FG004|Overall Study|Physician Decision|2|||
146379683|NCT03799627|527889608|FG005|Overall Study|Physician Decision|2|||
146379684|NCT03799627|527889609|FG006|Overall Study|Physician Decision|0|||
146379685|NCT03799627|527889610|FG007|Overall Study|Physician Decision|0|||
146379686|NCT03799627|527889611|FG008|Overall Study|Physician Decision|0|||
146379687|NCT03799627|527889603|FG000|Overall Study|Withdrawal by Subject|1|||
146379688|NCT03799627|527889604|FG001|Overall Study|Withdrawal by Subject|1|||
146379689|NCT03799627|527889605|FG002|Overall Study|Withdrawal by Subject|0|||
146379690|NCT03799627|527889606|FG003|Overall Study|Withdrawal by Subject|2|||
146379691|NCT03799627|527889607|FG004|Overall Study|Withdrawal by Subject|0|||
146379692|NCT03799627|527889608|FG005|Overall Study|Withdrawal by Subject|3|||
146379693|NCT03799627|527889609|FG006|Overall Study|Withdrawal by Subject|0|||
146379694|NCT03799627|527889610|FG007|Overall Study|Withdrawal by Subject|0|||
146379695|NCT03799627|527889611|FG008|Overall Study|Withdrawal by Subject|0|||
146379696|NCT03799627|527889603|FG000|Overall Study|Lack of Efficacy|0|||
146379697|NCT03799627|527889604|FG001|Overall Study|Lack of Efficacy|0|||
146379698|NCT03799627|527889605|FG002|Overall Study|Lack of Efficacy|0|||
146379699|NCT03799627|527889606|FG003|Overall Study|Lack of Efficacy|1|||
146379700|NCT03799627|527889607|FG004|Overall Study|Lack of Efficacy|0|||
146379701|NCT03799627|527889608|FG005|Overall Study|Lack of Efficacy|0|||
146379702|NCT03799627|527889609|FG006|Overall Study|Lack of Efficacy|0|||
146379703|NCT03799627|527889610|FG007|Overall Study|Lack of Efficacy|0|||
146379704|NCT03799627|527889611|FG008|Overall Study|Lack of Efficacy|0|||
146379705|NCT03799627|527889603|FG000|Overall Study|Lost to Follow-up|0|||
146379706|NCT03799627|527889604|FG001|Overall Study|Lost to Follow-up|0|||
146379707|NCT03799627|527889605|FG002|Overall Study|Lost to Follow-up|0|||
146379708|NCT03799627|527889606|FG003|Overall Study|Lost to Follow-up|0|||
146379709|NCT03799627|527889607|FG004|Overall Study|Lost to Follow-up|0|||
146379710|NCT03799627|527889608|FG005|Overall Study|Lost to Follow-up|0|||
146379711|NCT03799627|527889609|FG006|Overall Study|Lost to Follow-up|1|||
146379712|NCT03799627|527889610|FG007|Overall Study|Lost to Follow-up|0|||
146379713|NCT03799627|527889611|FG008|Overall Study|Lost to Follow-up|1|||
146379714|NCT03799627|527889603|FG000|Overall Study|Death|0|||
146379715|NCT03799627|527889604|FG001|Overall Study|Death|0|||
146379716|NCT03799627|527889605|FG002|Overall Study|Death|0|||
146379717|NCT03799627|527889606|FG003|Overall Study|Death|1|||
146379718|NCT03799627|527889607|FG004|Overall Study|Death|0|||
146379719|NCT03799627|527889608|FG005|Overall Study|Death|0|||
146379720|NCT03799627|527889609|FG006|Overall Study|Death|0|||
146379721|NCT03799627|527889610|FG007|Overall Study|Death|0|||
146379722|NCT03799627|527889611|FG008|Overall Study|Death|0|||
146379723|NCT03799627|527889603|FG000|Overall Study|Study Drug Put on Hold|1|||
146379724|NCT03799627|527889604|FG001|Overall Study|Study Drug Put on Hold|0|||
146379725|NCT03799627|527889605|FG002|Overall Study|Study Drug Put on Hold|0|||
146379726|NCT03799627|527889606|FG003|Overall Study|Study Drug Put on Hold|0|||
146379727|NCT03799627|527889607|FG004|Overall Study|Study Drug Put on Hold|0|||
146379728|NCT03799627|527889608|FG005|Overall Study|Study Drug Put on Hold|0|||
146379729|NCT03799627|527889609|FG006|Overall Study|Study Drug Put on Hold|0|||
146379730|NCT03799627|527889610|FG007|Overall Study|Study Drug Put on Hold|0|||
146379731|NCT03799627|527889611|FG008|Overall Study|Study Drug Put on Hold|0|||
146379732|NCT03799627|527889603|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
146379733|NCT03799627|527889604|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
146379734|NCT03799627|527889605|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
146379735|NCT03799627|527889606|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
146379736|NCT03799627|527889607|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
146379737|NCT03799627|527889608|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
146379738|NCT03799627|527889609|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
146379739|NCT03799627|527889610|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
146379740|NCT03799627|527889611|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
146379741|NCT03799627|527889603|FG000|Overall Study|Kidney Transplantation|1|||
146379742|NCT03799627|527889604|FG001|Overall Study|Kidney Transplantation|0|||
146379743|NCT03799627|527889605|FG002|Overall Study|Kidney Transplantation|0|||
146379744|NCT03799627|527889606|FG003|Overall Study|Kidney Transplantation|1|||
146379745|NCT03799627|527889607|FG004|Overall Study|Kidney Transplantation|1|||
146379746|NCT03799627|527889608|FG005|Overall Study|Kidney Transplantation|0|||
146379747|NCT03799627|527889609|FG006|Overall Study|Kidney Transplantation|0|||
146379748|NCT03799627|527889610|FG007|Overall Study|Kidney Transplantation|0|||
146379749|NCT03799627|527889611|FG008|Overall Study|Kidney Transplantation|0|||
146379750|NCT03799627|527889603|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
146379751|NCT03799627|527889604|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
146379752|NCT03799627|527889605|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
146379753|NCT03799627|527889606|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
146379754|NCT03799627|527889607|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
146379755|NCT03799627|527889608|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
146379756|NCT03799627|527889609|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
146379757|NCT03799627|527889610|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
146379758|NCT03799627|527889611|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
146379759|NCT03799627|527889603|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379760|NCT03799627|527889604|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
146379761|NCT03799627|527889605|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379762|NCT03799627|527889606|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379763|NCT03799627|527889607|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379764|NCT03799627|527889608|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379765|NCT03799627|527889609|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379766|NCT03799627|527889610|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379767|NCT03799627|527889611|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
146379768|NCT03799627|527889603|FG000|Overall Study|Met Exclusion Criteria|0|||
146379769|NCT03799627|527889604|FG001|Overall Study|Met Exclusion Criteria|0|||
146379770|NCT03799627|527889605|FG002|Overall Study|Met Exclusion Criteria|0|||
146379771|NCT03799627|527889606|FG003|Overall Study|Met Exclusion Criteria|1|||
146379772|NCT03799627|527889607|FG004|Overall Study|Met Exclusion Criteria|0|||
146379773|NCT03799627|527889608|FG005|Overall Study|Met Exclusion Criteria|0|||
146379774|NCT03799627|527889609|FG006|Overall Study|Met Exclusion Criteria|0|||
146379775|NCT03799627|527889610|FG007|Overall Study|Met Exclusion Criteria|0|||
146379776|NCT03799627|527889611|FG008|Overall Study|Met Exclusion Criteria|0|||
146379777|NCT03799627|527889603|FG000|Overall Study|Investigational Product Noncompliance|0|||
146379778|NCT03799627|527889604|FG001|Overall Study|Investigational Product Noncompliance|0|||
146379779|NCT03799627|527889605|FG002|Overall Study|Investigational Product Noncompliance|0|||
146379780|NCT03799627|527889606|FG003|Overall Study|Investigational Product Noncompliance|1|||
146379781|NCT03799627|527889607|FG004|Overall Study|Investigational Product Noncompliance|0|||
146379782|NCT03799627|527889608|FG005|Overall Study|Investigational Product Noncompliance|0|||
146379783|NCT03799627|527889609|FG006|Overall Study|Investigational Product Noncompliance|0|||
146379784|NCT03799627|527889610|FG007|Overall Study|Investigational Product Noncompliance|0|||
146379785|NCT03799627|527889611|FG008|Overall Study|Investigational Product Noncompliance|0|||
146379786|NCT03799627|527889603|FG000|Overall Study|Participant Relocation|0|||
146379787|NCT03799627|527889604|FG001|Overall Study|Participant Relocation|0|||
146379788|NCT03799627|527889605|FG002|Overall Study|Participant Relocation|0|||
146379789|NCT03799627|527889606|FG003|Overall Study|Participant Relocation|1|||
146379790|NCT03799627|527889607|FG004|Overall Study|Participant Relocation|0|||
146379791|NCT03799627|527889608|FG005|Overall Study|Participant Relocation|1|||
146379792|NCT03799627|527889609|FG006|Overall Study|Participant Relocation|0|||
146379793|NCT03799627|527889610|FG007|Overall Study|Participant Relocation|0|||
146379794|NCT03799627|527889611|FG008|Overall Study|Participant Relocation|0|||
146379795|NCT03799627|527889603|FG000|Overall Study|Eurofin Issue|0|||
146379796|NCT03799627|527889604|FG001|Overall Study|Eurofin Issue|0|||
146379797|NCT03799627|527889605|FG002|Overall Study|Eurofin Issue|0|||
146379798|NCT03799627|527889606|FG003|Overall Study|Eurofin Issue|0|||
146379799|NCT03799627|527889607|FG004|Overall Study|Eurofin Issue|1|||
146379800|NCT03799627|527889608|FG005|Overall Study|Eurofin Issue|0|||
146379801|NCT03799627|527889609|FG006|Overall Study|Eurofin Issue|0|||
146379802|NCT03799627|527889610|FG007|Overall Study|Eurofin Issue|0|||
146379803|NCT03799627|527889611|FG008|Overall Study|Eurofin Issue|0|||
146379804|NCT03799627|527889603|FG000|Overall Study|Noncompliance with Site Instructions|0|||
146379805|NCT03799627|527889604|FG001|Overall Study|Noncompliance with Site Instructions|0|||
146379806|NCT03799627|527889605|FG002|Overall Study|Noncompliance with Site Instructions|0|||
146379807|NCT03799627|527889606|FG003|Overall Study|Noncompliance with Site Instructions|0|||
146379808|NCT03799627|527889607|FG004|Overall Study|Noncompliance with Site Instructions|1|||
146379809|NCT03799627|527889608|FG005|Overall Study|Noncompliance with Site Instructions|0|||
146379810|NCT03799627|527889609|FG006|Overall Study|Noncompliance with Site Instructions|0|||
146379811|NCT03799627|527889610|FG007|Overall Study|Noncompliance with Site Instructions|0|||
146379812|NCT03799627|527889611|FG008|Overall Study|Noncompliance with Site Instructions|0|||
146379813|NCT03799627|527889603|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379814|NCT03799627|527889604|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379815|NCT03799627|527889605|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379816|NCT03799627|527889606|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379817|NCT03799627|527889607|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
146379818|NCT03799627|527889608|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379819|NCT03799627|527889609|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379820|NCT03799627|527889610|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379821|NCT03799627|527889611|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
146379822|NCT03799627|527889603|FG000|Overall Study|Changes In Hemoglobin Values|1|||
146379823|NCT03799627|527889604|FG001|Overall Study|Changes In Hemoglobin Values|2|||
146379824|NCT03799627|527889605|FG002|Overall Study|Changes In Hemoglobin Values|1|||
146379825|NCT03799627|527889606|FG003|Overall Study|Changes In Hemoglobin Values|0|||
146379826|NCT03799627|527889607|FG004|Overall Study|Changes In Hemoglobin Values|0|||
146379827|NCT03799627|527889608|FG005|Overall Study|Changes In Hemoglobin Values|2|||
146379828|NCT03799627|527889609|FG006|Overall Study|Changes In Hemoglobin Values|1|||
146379829|NCT03799627|527889610|FG007|Overall Study|Changes In Hemoglobin Values|0|||
146379830|NCT03799627|527889611|FG008|Overall Study|Changes In Hemoglobin Values|1|||
146379831|NCT01474889|527889616|FG000|Overall Study|Physician Decision|1|||
146379832|NCT01474889|527889617|FG001|Overall Study|Physician Decision|0|||
146379833|NCT01474889|527889618|FG002|Overall Study|Physician Decision|0|||
146379834|NCT01474889|527889616|FG000|Overall Study|Did not meet inclusion|1|||
146379835|NCT01474889|527889617|FG001|Overall Study|Did not meet inclusion|0|||
146379836|NCT01474889|527889618|FG002|Overall Study|Did not meet inclusion|0|||
146379837|NCT01474889|527889616|FG000|Overall Study|Withdrawal by Subject|0|||
146379838|NCT01474889|527889617|FG001|Overall Study|Withdrawal by Subject|1|||
146379839|NCT01474889|527889618|FG002|Overall Study|Withdrawal by Subject|0|||
146379840|NCT02569398|527889622|FG000|Overall Study|Adverse Event|0|||
146379841|NCT02569398|527889623|FG001|Overall Study|Adverse Event|1|||
146379842|NCT02569398|527889624|FG002|Overall Study|Adverse Event|6|||
146379843|NCT02569398|527889622|FG000|Overall Study|Withdrawal by Subject|43|||
146379844|NCT02569398|527889623|FG001|Overall Study|Withdrawal by Subject|43|||
146379845|NCT02569398|527889624|FG002|Overall Study|Withdrawal by Subject|30|||
146379846|NCT02569398|527889622|FG000|Overall Study|Study terminated by sponsor|130|||
146379847|NCT02569398|527889623|FG001|Overall Study|Study terminated by sponsor|131|||
146379848|NCT02569398|527889624|FG002|Overall Study|Study terminated by sponsor|134|||
146379849|NCT02569398|527889622|FG000|Overall Study|Other|12|||
146379850|NCT02569398|527889623|FG001|Overall Study|Other|14|||
146379851|NCT02569398|527889624|FG002|Overall Study|Other|13|||
146379852|NCT03559192|527889625|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
146379853|NCT03559192|527889626|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
146379854|NCT03559192|527889627|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
146379855|NCT03559192|527889625|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
146379856|NCT03559192|527889626|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
146379857|NCT03559192|527889627|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
146379858|NCT03559192|527889625|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
146379859|NCT03559192|527889626|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
146379860|NCT03559192|527889627|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
146379861|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
146379862|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
146379863|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
146379864|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
146379865|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
146379866|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
146379867|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
146379868|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
146379869|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
146379870|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
146379871|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
146379872|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
146379873|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
146379874|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
146379875|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
146379876|NCT03559192|527889625|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
146379877|NCT03559192|527889626|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
146379878|NCT03559192|527889627|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
146379879|NCT04888507|527891222|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
146379880|NCT00636155|527891223|FG000|Overall Study|Adverse Event|8|||
146379881|NCT00636155|527891223|FG000|Overall Study|Lack of Efficacy|1|||
146379882|NCT00636155|527891223|FG000|Overall Study|Withdrawal by Subject|3|||
146379883|NCT00636155|527891223|FG000|Overall Study|Stem cell transplant|1|||
146379884|NCT00636155|527891223|FG000|Overall Study|Physician Decision|5|||
146379885|NCT00766142|527891224|FG000|Overall Study|Protocol Violation|4|||
146379886|NCT00400946|527891225|FG000|Overall Study|Ineligible|0|||
146379887|NCT00400946|527891226|FG001|Overall Study|Ineligible|0|||
146379888|NCT00400946|527891227|FG002|Overall Study|Ineligible|0|||
146379889|NCT00400946|527891228|FG003|Overall Study|Ineligible|5|||
146379890|NCT00400946|527891229|FG004|Overall Study|Ineligible|1|||
146379891|NCT00400946|527891225|FG000|Overall Study|Induction Failure|0|||
146379892|NCT00400946|527891226|FG001|Overall Study|Induction Failure|0|||
146379893|NCT00400946|527891227|FG002|Overall Study|Induction Failure|0|||
146379894|NCT00400946|527891228|FG003|Overall Study|Induction Failure|11|||
146379895|NCT00400946|527891229|FG004|Overall Study|Induction Failure|8|||
146379896|NCT00400946|527891225|FG000|Overall Study|Induction Death|0|||
146379897|NCT00400946|527891226|FG001|Overall Study|Induction Death|0|||
146379898|NCT00400946|527891227|FG002|Overall Study|Induction Death|0|||
146379899|NCT00400946|527891228|FG003|Overall Study|Induction Death|13|||
146379900|NCT00400946|527891229|FG004|Overall Study|Induction Death|3|||
146379901|NCT00400946|527891225|FG000|Overall Study|Lost to Follow-up|1|||
146379902|NCT00400946|527891226|FG001|Overall Study|Lost to Follow-up|1|||
146379903|NCT00400946|527891227|FG002|Overall Study|Lost to Follow-up|0|||
146379904|NCT00400946|527891228|FG003|Overall Study|Lost to Follow-up|0|||
146379905|NCT00400946|527891229|FG004|Overall Study|Lost to Follow-up|1|||
146379906|NCT00400946|527891225|FG000|Overall Study|Remission Death|1|||
146379907|NCT00400946|527891226|FG001|Overall Study|Remission Death|1|||
146379908|NCT00400946|527891227|FG002|Overall Study|Remission Death|0|||
146379909|NCT00400946|527891228|FG003|Overall Study|Remission Death|0|||
146379910|NCT00400946|527891229|FG004|Overall Study|Remission Death|1|||
146379911|NCT00400946|527891225|FG000|Overall Study|Relapse|9|||
146379912|NCT00400946|527891226|FG001|Overall Study|Relapse|2|||
146379913|NCT00400946|527891227|FG002|Overall Study|Relapse|1|||
146379914|NCT00400946|527891228|FG003|Overall Study|Relapse|1|||
146379915|NCT00400946|527891229|FG004|Overall Study|Relapse|5|||
146379916|NCT00400946|527891225|FG000|Overall Study|Transplant in CR1|0|||
146379917|NCT00400946|527891226|FG001|Overall Study|Transplant in CR1|0|||
146379918|NCT00400946|527891227|FG002|Overall Study|Transplant in CR1|0|||
146379919|NCT00400946|527891228|FG003|Overall Study|Transplant in CR1|10|||
146379920|NCT00400946|527891229|FG004|Overall Study|Transplant in CR1|1|||
146379921|NCT00400946|527891225|FG000|Overall Study|Withdrawal by Subject|2|||
146379922|NCT00400946|527891226|FG001|Overall Study|Withdrawal by Subject|5|||
146379923|NCT00400946|527891227|FG002|Overall Study|Withdrawal by Subject|1|||
146379924|NCT00400946|527891228|FG003|Overall Study|Withdrawal by Subject|5|||
146379925|NCT00400946|527891229|FG004|Overall Study|Withdrawal by Subject|8|||
146379926|NCT00400946|527891225|FG000|Overall Study|Clinical|1|||
146379927|NCT00400946|527891226|FG001|Overall Study|Clinical|2|||
146379928|NCT00400946|527891227|FG002|Overall Study|Clinical|0|||
146379929|NCT00400946|527891228|FG003|Overall Study|Clinical|2|||
146379930|NCT00400946|527891229|FG004|Overall Study|Clinical|9|||
146379931|NCT00400946|527891225|FG000|Overall Study|Other|0|||
146379932|NCT00400946|527891226|FG001|Overall Study|Other|0|||
146379933|NCT00400946|527891227|FG002|Overall Study|Other|0|||
146379934|NCT00400946|527891228|FG003|Overall Study|Other|0|||
146379935|NCT00400946|527891229|FG004|Overall Study|Other|1|||
146379936|NCT05643170|527891235|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
146379937|NCT05643170|527891235|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
146379938|NCT02358863|527891240|FG000|Overall Study|Physician Decision|3|||
146379939|NCT01673373|527891250|FG000|Overall Study|Death|2|||
146379940|NCT02632344|527891251|FG000|Overall Study|Adverse Event|3|||
146379941|NCT02632344|527891251|FG000|Overall Study|Lack of Efficacy|3|||
146379942|NCT02632344|527891251|FG000|Overall Study|Withdrawal by Subject|2|||
146379943|NCT05426460|527891252|FG000|Overall Study|Protocol Violation|1|||
146379944|NCT05426460|527891253|FG001|Overall Study|Protocol Violation|1|||
146379945|NCT05426460|527891254|FG002|Overall Study|Protocol Violation|1|||
146379946|NCT05426460|527891255|FG003|Overall Study|Protocol Violation|0|||
146379947|NCT04924114|527891261|FG000|Overall Study|Withdrawal by Subject|0|||
146379948|NCT04924114|527891262|FG001|Overall Study|Withdrawal by Subject|2|||
146379949|NCT04924114|527891263|FG002|Overall Study|Withdrawal by Subject|2|||
146379950|NCT04924114|527891264|FG003|Overall Study|Withdrawal by Subject|0|||
146379951|NCT04924114|527891265|FG004|Overall Study|Withdrawal by Subject|2|||
146379952|NCT03671148|527891267|FG000|Overall Study|Adverse Event|3|||
146379953|NCT03671148|527891268|FG001|Overall Study|Adverse Event|2|||
146379954|NCT03671148|527891267|FG000|Overall Study|Withdrawal by Subject|8|||
146379955|NCT03671148|527891268|FG001|Overall Study|Withdrawal by Subject|2|||
146379956|NCT03671148|527891267|FG000|Overall Study|Lost to Follow-up|1|||
146379957|NCT03671148|527891268|FG001|Overall Study|Lost to Follow-up|2|||
146379958|NCT03671148|527891267|FG000|Overall Study|Lack of Efficacy|7|||
146379959|NCT03671148|527891268|FG001|Overall Study|Lack of Efficacy|2|||
146379960|NCT03671148|527891267|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
146379961|NCT03671148|527891268|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
146379962|NCT03671148|527891267|FG000|Overall Study|Other|1|||
146379963|NCT03671148|527891268|FG001|Overall Study|Other|0|||
146379964|NCT03671148|527891267|FG000|Overall Study|Incomplete Randomization Visit|1|||
146379965|NCT03671148|527891268|FG001|Overall Study|Incomplete Randomization Visit|0|||
146379966|NCT03878160|527891272|FG000|Overall Study|Lost to Follow-up|1|||
146379967|NCT03878160|527891273|FG001|Overall Study|Lost to Follow-up|1|||
146379968|NCT03878160|527891274|FG002|Overall Study|Lost to Follow-up|1|||
146379969|NCT03878160|527891272|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
146379970|NCT03878160|527891273|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
146379971|NCT03878160|527891274|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
146379972|NCT03887052|527891276|FG000|Overall Study|Adverse Event|2|||
146379973|NCT03887052|527891276|FG000|Overall Study|Physician Decision|2|||
146379974|NCT03887052|527891276|FG000|Overall Study|Withdrawal by Subject|3|||
146379975|NCT03887052|527891276|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
146379976|NCT03887052|527891276|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
146379977|NCT02365506|527891277|FG000|Overall Study|Investigator's Discretion|0|||
146379978|NCT02365506|527891278|FG001|Overall Study|Investigator's Discretion|0|||
146379979|NCT02365506|527891279|FG002|Overall Study|Investigator's Discretion|1|||
146379980|NCT00413777|527891282|FG000|Fixed-dose Period|Lost to Follow-up|1|||
146379981|NCT00413777|527891283|FG001|Fixed-dose Period|Lost to Follow-up|1|||
146379982|NCT00413777|527891282|FG000|Fixed-dose Period|Adverse Event|2|||
146379983|NCT00413777|527891283|FG001|Fixed-dose Period|Adverse Event|1|||
146379984|NCT00413777|527891282|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
146379985|NCT00413777|527891283|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
146379986|NCT00413777|527891282|FG000|Fixed-dose Period|Withdrew Consent|0|||
146379987|NCT00413777|527891283|FG001|Fixed-dose Period|Withdrew Consent|1|||
146379988|NCT03287830|527891284|FG000|Overall Study|Withdrawal by Subject|1|||
146379989|NCT03287830|527891285|FG001|Overall Study|Withdrawal by Subject|1|||
146379990|NCT03287830|527891284|FG000|Overall Study|not meeting inclusion criteria|5|||
146379991|NCT03287830|527891285|FG001|Overall Study|not meeting inclusion criteria|12|||
146379992|NCT05505734|527891286|FG000|Overall Study|Withdrawal by Subject|51|||
146379993|NCT05505734|527891287|FG001|Overall Study|Withdrawal by Subject|64|||
146379994|NCT05505734|527891286|FG000|Overall Study|Adverse Event|6|||
146379995|NCT05505734|527891287|FG001|Overall Study|Adverse Event|20|||
146379996|NCT05505734|527891286|FG000|Overall Study|Protocol Violation|8|||
146379997|NCT05505734|527891287|FG001|Overall Study|Protocol Violation|15|||
146379998|NCT05505734|527891286|FG000|Overall Study|Lack of therapeutic response|0|||
146379999|NCT05505734|527891287|FG001|Overall Study|Lack of therapeutic response|1|||
146380000|NCT05505734|527891286|FG000|Overall Study|Lost to Follow-up|247|||
146380001|NCT05505734|527891287|FG001|Overall Study|Lost to Follow-up|237|||
146380002|NCT05505734|527891286|FG000|Overall Study|Physician Decision|22|||
146380003|NCT05505734|527891287|FG001|Overall Study|Physician Decision|13|||
146380004|NCT05505734|527891286|FG000|Overall Study|Death|2|||
146380005|NCT05505734|527891287|FG001|Overall Study|Death|1|||
146380006|NCT05505734|527891286|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146380007|NCT05505734|527891287|FG001|Overall Study|Withdrawal by parent/guardian|1|||
146380008|NCT05505734|527891286|FG000|Overall Study|Pregnancy|1|||
146380009|NCT05505734|527891287|FG001|Overall Study|Pregnancy|0|||
146380010|NCT05505734|527891286|FG000|Overall Study|Other|17|||
146380011|NCT05505734|527891287|FG001|Overall Study|Other|13|||
146380012|NCT01058395|527891292|FG000|Overall Study|Death|2|||
146380013|NCT01058395|527891293|FG001|Overall Study|Death|1|||
146380014|NCT01058395|527891292|FG000|Overall Study|Lost to Follow-up|1|||
146380015|NCT01058395|527891293|FG001|Overall Study|Lost to Follow-up|0|||
146380016|NCT01266876|527891294|FG000|Overall Study|Adverse Event|0|||
146380017|NCT01266876|527891295|FG001|Overall Study|Adverse Event|0|||
146380018|NCT01266876|527891296|FG002|Overall Study|Adverse Event|0|||
146380019|NCT01266876|527891297|FG003|Overall Study|Adverse Event|1|||
146380020|NCT01266876|527891298|FG004|Overall Study|Adverse Event|0|||
146380021|NCT02768103|527891301|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
146380022|NCT00372489|527891303|FG000|Overall Study|Adverse Event|18|||
146380023|NCT00372489|527891303|FG000|Overall Study|Lack of Efficacy|1|||
146380024|NCT00372489|527891303|FG000|Overall Study|Lost to Follow-up|3|||
146380025|NCT00372489|527891303|FG000|Overall Study|Physician Decision|3|||
146380026|NCT00372489|527891303|FG000|Overall Study|Withdrawal by Subject|5|||
146380027|NCT00372489|527891303|FG000|Overall Study|Patient Relocation|2|||
146380028|NCT00372489|527891303|FG000|Overall Study|Renal transplant|6|||
146380029|NCT00372489|527891303|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
146380030|NCT04476108|527891304|FG000|Overall Study|Adverse Event|4|||
146380031|NCT04476108|527891305|FG001|Overall Study|Adverse Event|1|||
146380032|NCT04476108|527891304|FG000|Overall Study|Lost to Follow-up|1|||
146380033|NCT04476108|527891305|FG001|Overall Study|Lost to Follow-up|0|||
146380034|NCT04476108|527891304|FG000|Overall Study|Inadvertent Enrollment|1|||
146380035|NCT04476108|527891305|FG001|Overall Study|Inadvertent Enrollment|0|||
146380036|NCT04476108|527891304|FG000|Overall Study|Protocol Violation|1|||
146380037|NCT04476108|527891305|FG001|Overall Study|Protocol Violation|1|||
146380038|NCT04476108|527891304|FG000|Overall Study|Withdrawal by Subject|1|||
146380039|NCT04476108|527891305|FG001|Overall Study|Withdrawal by Subject|1|||
146380040|NCT00085644|527891306|FG000|Double-Blind Period|Adverse Event|5|||
146380041|NCT00085644|527891307|FG001|Double-Blind Period|Adverse Event|2|||
146380042|NCT00085644|527891308|FG002|Double-Blind Period|Adverse Event|0|||
146380043|NCT00085644|527891306|FG000|Double-Blind Period|Withdrawal by Subject|3|||
146380044|NCT00085644|527891307|FG001|Double-Blind Period|Withdrawal by Subject|0|||
146380045|NCT00085644|527891308|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146380046|NCT00085644|527891306|FG000|Double-Blind Period|Lost to Follow-up|2|||
146380047|NCT00085644|527891307|FG001|Double-Blind Period|Lost to Follow-up|1|||
146380048|NCT00085644|527891308|FG002|Double-Blind Period|Lost to Follow-up|0|||
146380049|NCT00085644|527891306|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
146380050|NCT00085644|527891307|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
146380051|NCT00085644|527891308|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
146380052|NCT00085644|527891306|FG000|Double-Blind Period|Contemplating pregnancy|1|||
146380053|NCT00085644|527891307|FG001|Double-Blind Period|Contemplating pregnancy|0|||
146380054|NCT00085644|527891308|FG002|Double-Blind Period|Contemplating pregnancy|0|||
146380055|NCT00085644|527891306|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
146380056|NCT00085644|527891307|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
146380057|NCT00085644|527891308|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
146380058|NCT00085644|527891306|FG000|Open-Label Period|Adverse Event|0|||
146380059|NCT00085644|527891307|FG001|Open-Label Period|Adverse Event|0|||
146380060|NCT00085644|527891308|FG002|Open-Label Period|Adverse Event|38|||
146380061|NCT00085644|527891306|FG000|Open-Label Period|Withdrawal by Subject|0|||
146380062|NCT00085644|527891307|FG001|Open-Label Period|Withdrawal by Subject|0|||
146380063|NCT00085644|527891308|FG002|Open-Label Period|Withdrawal by Subject|29|||
146380064|NCT00085644|527891306|FG000|Open-Label Period|Lost to Follow-up|0|||
146380065|NCT00085644|527891307|FG001|Open-Label Period|Lost to Follow-up|0|||
146380066|NCT00085644|527891308|FG002|Open-Label Period|Lost to Follow-up|13|||
146380067|NCT00085644|527891306|FG000|Open-Label Period|Lack of Efficacy|0|||
146380068|NCT00085644|527891307|FG001|Open-Label Period|Lack of Efficacy|0|||
146380069|NCT00085644|527891308|FG002|Open-Label Period|Lack of Efficacy|15|||
146380070|NCT00085644|527891306|FG000|Open-Label Period|Pregnancy|0|||
146380071|NCT00085644|527891307|FG001|Open-Label Period|Pregnancy|0|||
146380072|NCT00085644|527891308|FG002|Open-Label Period|Pregnancy|3|||
146380073|NCT00085644|527891306|FG000|Open-Label Period|Contemplating pregnancy|0|||
146380074|NCT00085644|527891307|FG001|Open-Label Period|Contemplating pregnancy|0|||
146380075|NCT00085644|527891308|FG002|Open-Label Period|Contemplating pregnancy|3|||
146380076|NCT00085644|527891306|FG000|Open-Label Period|Protocol Violation|0|||
146380077|NCT00085644|527891307|FG001|Open-Label Period|Protocol Violation|0|||
146380078|NCT00085644|527891308|FG002|Open-Label Period|Protocol Violation|4|||
146380079|NCT00085644|527891306|FG000|Open-Label Period|Personal reason|0|||
146380080|NCT00085644|527891307|FG001|Open-Label Period|Personal reason|0|||
146380081|NCT00085644|527891308|FG002|Open-Label Period|Personal reason|4|||
146380082|NCT04259346|527891309|FG000|Overall Study|Lost to Follow-up|1|||
146380083|NCT04259346|527891310|FG001|Overall Study|Lost to Follow-up|3|||
146380084|NCT04259346|527891309|FG000|Overall Study|Protocol Violation|1|||
146380085|NCT04259346|527891310|FG001|Overall Study|Protocol Violation|0|||
146380086|NCT04259346|527891309|FG000|Overall Study|Withdrawal by Subject|1|||
146380087|NCT04259346|527891310|FG001|Overall Study|Withdrawal by Subject|0|||
146380088|NCT04259346|527891309|FG000|Overall Study|Adverse Event|1|||
146380089|NCT04259346|527891310|FG001|Overall Study|Adverse Event|1|||
146380090|NCT03330106|527891311|FG000|Part A|Withdrawal by Subject|1|||
146380091|NCT03330106|527891312|FG001|Part A|Withdrawal by Subject|1|||
146380092|NCT03330106|527891313|FG002|Part A|Withdrawal by Subject|0|||
146380093|NCT03330106|527891314|FG003|Part A|Withdrawal by Subject|0|||
146380094|NCT03330106|527891311|FG000|Part A|Death|2|||
146380095|NCT03330106|527891312|FG001|Part A|Death|1|||
146380096|NCT03330106|527891313|FG002|Part A|Death|0|||
146380097|NCT03330106|527891314|FG003|Part A|Death|0|||
146380098|NCT03330106|527891311|FG000|Part A|Adverse Event|0|||
146380099|NCT03330106|527891312|FG001|Part A|Adverse Event|1|||
146380100|NCT03330106|527891313|FG002|Part A|Adverse Event|0|||
146380101|NCT03330106|527891314|FG003|Part A|Adverse Event|0|||
146380102|NCT03330106|527891311|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146380103|NCT03330106|527891312|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
146380104|NCT03330106|527891313|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146380105|NCT03330106|527891314|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
146380106|NCT03330106|527891311|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
146380107|NCT03330106|527891312|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146380108|NCT03330106|527891313|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146380109|NCT03330106|527891314|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
146380110|NCT03330106|527891311|FG000|Part A|Progressive Disease|0|||
146380111|NCT03330106|527891312|FG001|Part A|Progressive Disease|1|||
146380112|NCT03330106|527891313|FG002|Part A|Progressive Disease|0|||
146380113|NCT03330106|527891314|FG003|Part A|Progressive Disease|0|||
146380114|NCT03330106|527891311|FG000|Part B|Lost to Follow-up|0|||
146380115|NCT03330106|527891312|FG001|Part B|Lost to Follow-up|0|||
146380116|NCT03330106|527891313|FG002|Part B|Lost to Follow-up|0|||
146380117|NCT03330106|527891314|FG003|Part B|Lost to Follow-up|1|||
146380118|NCT03330106|527891311|FG000|Part B|Withdrawal by Subject|0|||
146380119|NCT03330106|527891312|FG001|Part B|Withdrawal by Subject|0|||
146380120|NCT03330106|527891313|FG002|Part B|Withdrawal by Subject|4|||
146380121|NCT03330106|527891314|FG003|Part B|Withdrawal by Subject|0|||
146380122|NCT03330106|527891311|FG000|Part B|Death|0|||
146380123|NCT03330106|527891312|FG001|Part B|Death|0|||
146380124|NCT03330106|527891313|FG002|Part B|Death|2|||
146380125|NCT03330106|527891314|FG003|Part B|Death|0|||
146380126|NCT03330106|527891311|FG000|Part B|Clinical Progression|0|||
146380127|NCT03330106|527891312|FG001|Part B|Clinical Progression|0|||
146380128|NCT03330106|527891313|FG002|Part B|Clinical Progression|1|||
146380129|NCT03330106|527891314|FG003|Part B|Clinical Progression|1|||
146380130|NCT03330106|527891311|FG000|Part B|Symptomatic Deterioration|0|||
146380131|NCT03330106|527891312|FG001|Part B|Symptomatic Deterioration|0|||
146380132|NCT03330106|527891313|FG002|Part B|Symptomatic Deterioration|0|||
146380133|NCT03330106|527891314|FG003|Part B|Symptomatic Deterioration|1|||
146380134|NCT03330106|527891311|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146380135|NCT03330106|527891312|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146380136|NCT03330106|527891313|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
146380137|NCT03330106|527891314|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
146380138|NCT03330106|527891311|FG000|Part B|Progressive Disease|0|||
146380139|NCT03330106|527891312|FG001|Part B|Progressive Disease|0|||
146380140|NCT03330106|527891313|FG002|Part B|Progressive Disease|11|||
146380141|NCT03330106|527891314|FG003|Part B|Progressive Disease|4|||
146380142|NCT00486889|527891315|FG000|Overall Study|Death|3|||
146380143|NCT00486889|527891315|FG000|Overall Study|Non-compliant|2|||
146380144|NCT00486889|527891315|FG000|Overall Study|Withdrawal by Subject|6|||
146380145|NCT00899678|527891320|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
146380146|NCT00899678|527891321|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
146380147|NCT00899678|527891322|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
146380148|NCT00899678|527891320|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
146380149|NCT00899678|527891321|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
146380150|NCT00899678|527891322|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
146380151|NCT00899678|527891320|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
146380152|NCT00899678|527891321|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
146380153|NCT00899678|527891322|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
146380154|NCT00899678|527891320|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
146380155|NCT00899678|527891321|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
146380156|NCT00899678|527891322|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
146380157|NCT00899678|527891320|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
146380158|NCT00899678|527891321|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
146380159|NCT00899678|527891322|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
146380160|NCT00899678|527891320|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
146380161|NCT00899678|527891321|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
146380162|NCT00899678|527891322|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
146380163|NCT00899678|527891320|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
146380164|NCT00899678|527891321|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
146380165|NCT00899678|527891322|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
146380166|NCT00899678|527891320|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
146380167|NCT00899678|527891321|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
146380168|NCT00899678|527891322|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
146380169|NCT00899678|527891320|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
146380170|NCT00899678|527891321|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
146380171|NCT00899678|527891322|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
146380172|NCT02699125|527891325|FG000|Placebo|Lost to Follow-up|2|||
146380173|NCT02699125|527891326|FG001|Placebo|Lost to Follow-up|0|||
146380174|NCT02699125|527891325|FG000|Placebo|Protocol Violation|1|||
146380175|NCT02699125|527891326|FG001|Placebo|Protocol Violation|0|||
146380176|NCT02699125|527891325|FG000|Placebo|Withdrawal by Subject|0|||
146380177|NCT02699125|527891326|FG001|Placebo|Withdrawal by Subject|4|||
146380178|NCT02699125|527891325|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
146380179|NCT02699125|527891326|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
146380180|NCT04445051|527891329|FG000|Overall Study|Adverse Event|0|||
146380181|NCT04445051|527891330|FG001|Overall Study|Adverse Event|0|||
146380182|NCT04445051|527891331|FG002|Overall Study|Adverse Event|1|||
146380183|NCT04445051|527891332|FG003|Overall Study|Adverse Event|0|||
146380184|NCT04445051|527891333|FG004|Overall Study|Adverse Event|0|||
146380185|NCT04445051|527891334|FG005|Overall Study|Adverse Event|0|||
146380186|NCT02092324|527891342|FG000|Overall Study|Adverse Event|1|||
146380187|NCT02092324|527891342|FG000|Overall Study|Lack of Efficacy|6|||
146380188|NCT02092324|527891342|FG000|Overall Study|Proceed to Transplant|3|||
146380189|NCT02092324|527891342|FG000|Overall Study|Physician Decision|7|||
146380190|NCT02092324|527891342|FG000|Overall Study|Misdiagnosis|2|||
146380191|NCT00398138|527891345|FG000|Overall Study|Adverse Event|2|||
146380192|NCT04973085|527891350|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
146380193|NCT04973085|527891351|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
146380194|NCT03924427|527891357|FG000|Overall Study|Adverse Event|4|||
146380195|NCT03924427|527891357|FG000|Overall Study|Lack of Efficacy|1|||
146380196|NCT03924427|527891357|FG000|Overall Study|Withdrawal by Subject|1|||
146380197|NCT01316380|527891365|FG000|Overall Study|Adverse Event|0|||
146380198|NCT01316380|527891366|FG001|Overall Study|Adverse Event|2|||
146380199|NCT01316380|527891367|FG002|Overall Study|Adverse Event|1|||
146380200|NCT01316380|527891365|FG000|Overall Study|Protocol Violation|0|||
146380201|NCT01316380|527891366|FG001|Overall Study|Protocol Violation|0|||
146380202|NCT01316380|527891367|FG002|Overall Study|Protocol Violation|1|||
146380203|NCT01316380|527891365|FG000|Overall Study|Withdrawal by Subject|1|||
146380204|NCT01316380|527891366|FG001|Overall Study|Withdrawal by Subject|2|||
146380205|NCT01316380|527891367|FG002|Overall Study|Withdrawal by Subject|0|||
146380206|NCT01316380|527891365|FG000|Overall Study|Other|0|||
146380207|NCT01316380|527891366|FG001|Overall Study|Other|1|||
146380208|NCT01316380|527891367|FG002|Overall Study|Other|1|||
146380209|NCT01316380|527891365|FG000|Overall Study|Not treated|1|||
146380210|NCT01316380|527891366|FG001|Overall Study|Not treated|0|||
146380211|NCT01316380|527891367|FG002|Overall Study|Not treated|0|||
146380212|NCT00149890|527891368|FG000|Overall Study|Adverse Event|1|||
146380213|NCT00149890|527891369|FG001|Overall Study|Adverse Event|8|||
146380214|NCT00149890|527891368|FG000|Overall Study|Lack of Efficacy|8|||
146380215|NCT00149890|527891369|FG001|Overall Study|Lack of Efficacy|9|||
146380216|NCT00149890|527891368|FG000|Overall Study|Protocol Violation|1|||
146380217|NCT00149890|527891369|FG001|Overall Study|Protocol Violation|0|||
146380218|NCT00149890|527891368|FG000|Overall Study|Lost to Follow-up|1|||
146380219|NCT00149890|527891369|FG001|Overall Study|Lost to Follow-up|0|||
146380220|NCT00149890|527891368|FG000|Overall Study|Graft Loss|2|||
146380221|NCT00149890|527891369|FG001|Overall Study|Graft Loss|1|||
146380222|NCT01387594|527891370|FG000|Overall Study|Withdrawal by Subject|0|||
146380223|NCT01387594|527891371|FG001|Overall Study|Withdrawal by Subject|2|||
146380224|NCT01387594|527891370|FG000|Overall Study|Lost to Follow-up|0|||
146380225|NCT01387594|527891371|FG001|Overall Study|Lost to Follow-up|1|||
146380226|NCT01365091|527891372|FG000|Period 1|Adverse Event|1|||
146380227|NCT01365091|527891373|FG001|Period 1|Adverse Event|0|||
146380228|NCT01365091|527891374|FG002|Period 1|Adverse Event|2|||
146380229|NCT01365091|527891375|FG003|Period 1|Adverse Event|3|||
146380230|NCT01365091|527891372|FG000|Period 1|Positive test result for drugs of abuse|1|||
146380231|NCT01365091|527891373|FG001|Period 1|Positive test result for drugs of abuse|0|||
146380232|NCT01365091|527891374|FG002|Period 1|Positive test result for drugs of abuse|0|||
146380233|NCT01365091|527891375|FG003|Period 1|Positive test result for drugs of abuse|0|||
146380234|NCT01365091|527891372|FG000|Period 1|No longer met study criteria|0|||
146380235|NCT01365091|527891373|FG001|Period 1|No longer met study criteria|1|||
146380236|NCT01365091|527891374|FG002|Period 1|No longer met study criteria|0|||
146380237|NCT01365091|527891375|FG003|Period 1|No longer met study criteria|0|||
146380238|NCT01365091|527891372|FG000|Period 1|Withdrawal by Subject|0|||
146380239|NCT01365091|527891373|FG001|Period 1|Withdrawal by Subject|1|||
146380240|NCT01365091|527891374|FG002|Period 1|Withdrawal by Subject|0|||
146380241|NCT01365091|527891375|FG003|Period 1|Withdrawal by Subject|0|||
146380242|NCT01365091|527891372|FG000|Period 1|Personal reasons|0|||
146380243|NCT01365091|527891373|FG001|Period 1|Personal reasons|0|||
146380244|NCT01365091|527891374|FG002|Period 1|Personal reasons|1|||
146380245|NCT01365091|527891375|FG003|Period 1|Personal reasons|0|||
146380246|NCT01365091|527891372|FG000|Period 2|Withdrawal by Subject|1|||
146380247|NCT01365091|527891373|FG001|Period 2|Withdrawal by Subject|0|||
146380248|NCT01365091|527891374|FG002|Period 2|Withdrawal by Subject|0|||
146380249|NCT01365091|527891375|FG003|Period 2|Withdrawal by Subject|0|||
146380250|NCT01365091|527891372|FG000|Period 2|Adverse Event|0|||
146380251|NCT01365091|527891373|FG001|Period 2|Adverse Event|0|||
146380252|NCT01365091|527891374|FG002|Period 2|Adverse Event|1|||
146380253|NCT01365091|527891375|FG003|Period 2|Adverse Event|0|||
146380254|NCT05116683|527891377|FG000|Overall Study|Physician Decision|4|||
146380255|NCT04964557|527891378|FG000|Overall Study|Withdrawal by Subject|3|||
146380256|NCT04964557|527891379|FG001|Overall Study|Withdrawal by Subject|2|||
146380257|NCT04964557|527891378|FG000|Overall Study|Lost to Follow-up|1|||
146380258|NCT04964557|527891379|FG001|Overall Study|Lost to Follow-up|2|||
146380259|NCT04964557|527891378|FG000|Overall Study|Physician Decision|2|||
146380260|NCT04964557|527891379|FG001|Overall Study|Physician Decision|0|||
146380261|NCT04964557|527891378|FG000|Overall Study|Death|3|||
146380262|NCT04964557|527891379|FG001|Overall Study|Death|0|||
146380263|NCT04964557|527891378|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
146380264|NCT04964557|527891379|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
146380265|NCT02531633|527893840|FG000|Part A (52 Weeks)|Sponsor request|24|||
146380266|NCT02531633|527893841|FG001|Part A (52 Weeks)|Sponsor request|24|||
146380267|NCT02531633|527893842|FG002|Part A (52 Weeks)|Sponsor request|18|||
146380268|NCT02531633|527893843|FG003|Part A (52 Weeks)|Sponsor request|18|||
146380269|NCT02531633|527893844|FG004|Part A (52 Weeks)|Sponsor request|19|||
146380270|NCT02531633|527893845|FG005|Part A (52 Weeks)|Sponsor request|0|||
146380271|NCT02531633|527893846|FG006|Part A (52 Weeks)|Sponsor request|0|||
146380272|NCT02531633|527893847|FG007|Part A (52 Weeks)|Sponsor request|0|||
146380273|NCT02531633|527893848|FG008|Part A (52 Weeks)|Sponsor request|0|||
146380274|NCT02531633|527893849|FG009|Part A (52 Weeks)|Sponsor request|0|||
146380275|NCT02531633|527893840|FG000|Part A (52 Weeks)|Protocol Violation|1|||
146380276|NCT02531633|527893841|FG001|Part A (52 Weeks)|Protocol Violation|0|||
146380277|NCT02531633|527893842|FG002|Part A (52 Weeks)|Protocol Violation|0|||
146380278|NCT02531633|527893843|FG003|Part A (52 Weeks)|Protocol Violation|0|||
146380279|NCT02531633|527893844|FG004|Part A (52 Weeks)|Protocol Violation|0|||
146380280|NCT02531633|527893845|FG005|Part A (52 Weeks)|Protocol Violation|0|||
146380281|NCT02531633|527893846|FG006|Part A (52 Weeks)|Protocol Violation|0|||
146380282|NCT02531633|527893847|FG007|Part A (52 Weeks)|Protocol Violation|0|||
146380283|NCT02531633|527893848|FG008|Part A (52 Weeks)|Protocol Violation|0|||
146380284|NCT02531633|527893849|FG009|Part A (52 Weeks)|Protocol Violation|0|||
146380285|NCT02531633|527893840|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
146380286|NCT02531633|527893841|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
146380287|NCT02531633|527893842|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
146380288|NCT02531633|527893843|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
146380289|NCT02531633|527893844|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
146380290|NCT02531633|527893845|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
146380291|NCT02531633|527893846|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
146380292|NCT02531633|527893847|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
146380293|NCT02531633|527893848|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
146380294|NCT02531633|527893849|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
146380295|NCT02531633|527893840|FG000|Part A (52 Weeks)|Physician Decision|1|||
146380296|NCT02531633|527893841|FG001|Part A (52 Weeks)|Physician Decision|4|||
146380297|NCT02531633|527893842|FG002|Part A (52 Weeks)|Physician Decision|3|||
146380298|NCT02531633|527893843|FG003|Part A (52 Weeks)|Physician Decision|1|||
146380299|NCT02531633|527893844|FG004|Part A (52 Weeks)|Physician Decision|0|||
146380300|NCT02531633|527893845|FG005|Part A (52 Weeks)|Physician Decision|0|||
146380301|NCT02531633|527893846|FG006|Part A (52 Weeks)|Physician Decision|0|||
146380302|NCT02531633|527893847|FG007|Part A (52 Weeks)|Physician Decision|0|||
146380303|NCT02531633|527893848|FG008|Part A (52 Weeks)|Physician Decision|0|||
146380304|NCT02531633|527893849|FG009|Part A (52 Weeks)|Physician Decision|0|||
146380305|NCT02531633|527893840|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
146380306|NCT02531633|527893841|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
146380307|NCT02531633|527893842|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
146380308|NCT02531633|527893843|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
146380309|NCT02531633|527893844|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
146380310|NCT02531633|527893845|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
146380311|NCT02531633|527893846|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
146380312|NCT02531633|527893847|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
146380313|NCT02531633|527893848|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
146380314|NCT02531633|527893849|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
146380315|NCT02531633|527893840|FG000|Part A (52 Weeks)|Other|2|||
146380316|NCT02531633|527893841|FG001|Part A (52 Weeks)|Other|0|||
146380317|NCT02531633|527893842|FG002|Part A (52 Weeks)|Other|0|||
146380318|NCT02531633|527893843|FG003|Part A (52 Weeks)|Other|0|||
146380319|NCT02531633|527893844|FG004|Part A (52 Weeks)|Other|0|||
146380320|NCT02531633|527893845|FG005|Part A (52 Weeks)|Other|0|||
146380321|NCT02531633|527893846|FG006|Part A (52 Weeks)|Other|0|||
146380322|NCT02531633|527893847|FG007|Part A (52 Weeks)|Other|0|||
146380323|NCT02531633|527893848|FG008|Part A (52 Weeks)|Other|0|||
146380324|NCT02531633|527893849|FG009|Part A (52 Weeks)|Other|0|||
146380325|NCT02531633|527893840|FG000|Part B (104 Weeks)|Sponsor request|0|||
146380326|NCT02531633|527893841|FG001|Part B (104 Weeks)|Sponsor request|0|||
146380327|NCT02531633|527893842|FG002|Part B (104 Weeks)|Sponsor request|0|||
146380328|NCT02531633|527893843|FG003|Part B (104 Weeks)|Sponsor request|0|||
146380329|NCT02531633|527893844|FG004|Part B (104 Weeks)|Sponsor request|0|||
146380330|NCT02531633|527893845|FG005|Part B (104 Weeks)|Sponsor request|8|||
146380331|NCT02531633|527893846|FG006|Part B (104 Weeks)|Sponsor request|5|||
146380332|NCT02531633|527893847|FG007|Part B (104 Weeks)|Sponsor request|3|||
146380333|NCT02531633|527893848|FG008|Part B (104 Weeks)|Sponsor request|5|||
146380334|NCT02531633|527893849|FG009|Part B (104 Weeks)|Sponsor request|4|||
146380335|NCT02531633|527893840|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
146380336|NCT02531633|527893841|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
146380337|NCT02531633|527893842|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
146380338|NCT02531633|527893843|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
146380339|NCT02531633|527893844|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
146380340|NCT02531633|527893845|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
146380341|NCT02531633|527893846|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
146380342|NCT02531633|527893847|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
146380343|NCT02531633|527893848|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
146380344|NCT02531633|527893849|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
146380345|NCT04517253|527893852|FG000|Primary Treatment Period|Adverse Event|1|||
146380346|NCT04517253|527893853|FG001|Primary Treatment Period|Adverse Event|0|||
146380347|NCT04517253|527893854|FG002|Primary Treatment Period|Adverse Event|0|||
146380348|NCT04517253|527893852|FG000|Primary Treatment Period|Death|0|||
146380349|NCT04517253|527893853|FG001|Primary Treatment Period|Death|1|||
146380350|NCT04517253|527893854|FG002|Primary Treatment Period|Death|0|||
146380351|NCT04517253|527893852|FG000|Maintenance Period|Withdrawal by Subject|1|||
146380352|NCT04517253|527893853|FG001|Maintenance Period|Withdrawal by Subject|0|||
146380353|NCT04517253|527893854|FG002|Maintenance Period|Withdrawal by Subject|0|||
146380354|NCT04517253|527893852|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
146380355|NCT04517253|527893853|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
146380356|NCT04517253|527893854|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
146380357|NCT02136134|527893860|FG000|Overall Study|Death|170|||
146380358|NCT02136134|527893861|FG001|Overall Study|Death|148|||
146380359|NCT02136134|527893860|FG000|Overall Study|Withdrawal by Subject|19|||
146380360|NCT02136134|527893861|FG001|Overall Study|Withdrawal by Subject|10|||
146380361|NCT02136134|527893860|FG000|Overall Study|Lost to Follow-up|3|||
146380362|NCT02136134|527893861|FG001|Overall Study|Lost to Follow-up|3|||
146380363|NCT02136134|527893860|FG000|Overall Study|Uspecified|55|||
146380364|NCT02136134|527893861|FG001|Overall Study|Uspecified|90|||
146380365|NCT03070119|527893864|FG000|Overall Study|Adverse Event|0|||
146380366|NCT03070119|527893865|FG001|Overall Study|Adverse Event|0|||
146380367|NCT03070119|527893866|FG002|Overall Study|Adverse Event|1|||
146380368|NCT03070119|527893864|FG000|Overall Study|Lost to Follow-up|0|||
146380369|NCT03070119|527893865|FG001|Overall Study|Lost to Follow-up|1|||
146380370|NCT03070119|527893866|FG002|Overall Study|Lost to Follow-up|0|||
146380371|NCT03070119|527893864|FG000|Overall Study|Consent Withdrawn|6|||
146380372|NCT03070119|527893865|FG001|Overall Study|Consent Withdrawn|5|||
146380373|NCT03070119|527893866|FG002|Overall Study|Consent Withdrawn|3|||
146380374|NCT03070119|527893864|FG000|Overall Study|Investigator Decision|0|||
146380375|NCT03070119|527893865|FG001|Overall Study|Investigator Decision|0|||
146380376|NCT03070119|527893866|FG002|Overall Study|Investigator Decision|1|||
146380377|NCT03070119|527893864|FG000|Overall Study|Death|7|||
146380378|NCT03070119|527893865|FG001|Overall Study|Death|14|||
146380379|NCT03070119|527893866|FG002|Overall Study|Death|5|||
146380380|NCT03070119|527893864|FG000|Overall Study|Disease Progression|5|||
146380381|NCT03070119|527893865|FG001|Overall Study|Disease Progression|7|||
146380382|NCT03070119|527893866|FG002|Overall Study|Disease Progression|7|||
146380383|NCT03070119|527893864|FG000|Overall Study|Reason not Specified|2|||
146380384|NCT03070119|527893865|FG001|Overall Study|Reason not Specified|2|||
146380385|NCT03070119|527893866|FG002|Overall Study|Reason not Specified|1|||
146380386|NCT02974621|527893868|FG000|Overall Study|Didn't receive study treatment|1|||
146380387|NCT02974621|527893869|FG001|Overall Study|Didn't receive study treatment|10|||
146380388|NCT00732472|527893870|FG000|Overall Study|Adverse Event|0|||
146380389|NCT00732472|527893871|FG001|Overall Study|Adverse Event|1|||
146380390|NCT00732472|527893872|FG002|Overall Study|Adverse Event|1|||
146380391|NCT00732472|527893873|FG003|Overall Study|Adverse Event|1|||
146380392|NCT00732472|527893870|FG000|Overall Study|Protocol Violation|0|||
146380393|NCT00732472|527893871|FG001|Overall Study|Protocol Violation|0|||
146380394|NCT00732472|527893872|FG002|Overall Study|Protocol Violation|0|||
146380395|NCT00732472|527893873|FG003|Overall Study|Protocol Violation|1|||
146380396|NCT00732472|527893870|FG000|Overall Study|Withdrawal by Subject|0|||
146380397|NCT00732472|527893871|FG001|Overall Study|Withdrawal by Subject|2|||
146380398|NCT00732472|527893872|FG002|Overall Study|Withdrawal by Subject|0|||
146380399|NCT00732472|527893873|FG003|Overall Study|Withdrawal by Subject|1|||
146380400|NCT02155712|527893875|FG000|Overall Study|Death|12|||
146380401|NCT02155712|527893876|FG001|Overall Study|Death|0|||
146380402|NCT02155712|527893875|FG000|Overall Study|Lost to Follow-up|37|||
146380403|NCT02155712|527893876|FG001|Overall Study|Lost to Follow-up|22|||
146380404|NCT02155712|527893875|FG000|Overall Study|Revision of device|4|||
146380405|NCT02155712|527893876|FG001|Overall Study|Revision of device|3|||
146380406|NCT02155712|527893875|FG000|Overall Study|Withdrawal by Subject|39|||
146380407|NCT02155712|527893876|FG001|Overall Study|Withdrawal by Subject|21|||
146380408|NCT02155712|527893875|FG000|Overall Study|Site termination|77|||
146380409|NCT02155712|527893876|FG001|Overall Study|Site termination|19|||
146380410|NCT02155712|527893875|FG000|Overall Study|Sponsor terminated study early|150|||
146380411|NCT02155712|527893876|FG001|Overall Study|Sponsor terminated study early|0|||
146380412|NCT02155712|527893875|FG000|Overall Study|Missed final 5-year protocol visit|0|||
146380413|NCT02155712|527893876|FG001|Overall Study|Missed final 5-year protocol visit|32|||
146380414|NCT02155712|527893875|FG000|Overall Study|Censored because surgery cancelled|6|||
146380415|NCT02155712|527893876|FG001|Overall Study|Censored because surgery cancelled|10|||
146380416|NCT02155712|527893875|FG000|Overall Study|Censored because study device was not implanted|61|||
146380417|NCT02155712|527893876|FG001|Overall Study|Censored because study device was not implanted|66|||
146380418|NCT02155712|527893875|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
146380419|NCT02155712|527893876|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
146380420|NCT05180721|527893877|FG000|Overall Study|Lost to Follow-up|4|||
146380421|NCT05016037|527893878|FG000|Overall Study|Lost to Follow-up|2|||
146380422|NCT03575351|527893879|FG000|Overall Study|Adverse Event|1|||
146380423|NCT03575351|527893880|FG001|Overall Study|Adverse Event|0|||
146380424|NCT03575351|527893879|FG000|Overall Study|Death|2|||
146380425|NCT03575351|527893880|FG001|Overall Study|Death|2|||
146380426|NCT03575351|527893879|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
146380427|NCT03575351|527893880|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
146380428|NCT03575351|527893879|FG000|Overall Study|Lack of Efficacy|28|||
146380429|NCT03575351|527893880|FG001|Overall Study|Lack of Efficacy|0|||
146380430|NCT03575351|527893879|FG000|Overall Study|Withdrawal by Subject|1|||
146380431|NCT03575351|527893880|FG001|Overall Study|Withdrawal by Subject|1|||
146380432|NCT03575351|527893879|FG000|Overall Study|Physician Decision|3|||
146380433|NCT03575351|527893880|FG001|Overall Study|Physician Decision|0|||
146380434|NCT03575351|527893879|FG000|Overall Study|Disease relapse|15|||
146380435|NCT03575351|527893880|FG001|Overall Study|Disease relapse|6|||
146380436|NCT03575351|527893879|FG000|Overall Study|Study drug manufacturing failure|0|||
146380437|NCT03575351|527893880|FG001|Overall Study|Study drug manufacturing failure|1|||
146380438|NCT03575351|527893879|FG000|Overall Study|other reasons|5|||
146380439|NCT03575351|527893880|FG001|Overall Study|other reasons|0|||
146380440|NCT01688999|527893881|FG000|Overall Study|Withdrawal by Subject|5|||
146380441|NCT01688999|527893882|FG001|Overall Study|Withdrawal by Subject|1|||
146380442|NCT01688999|527893883|FG002|Overall Study|Withdrawal by Subject|1|||
146380443|NCT01688999|527893881|FG000|Overall Study|Adverse Event|2|||
146380444|NCT01688999|527893882|FG001|Overall Study|Adverse Event|0|||
146380445|NCT01688999|527893883|FG002|Overall Study|Adverse Event|2|||
146380446|NCT01688999|527893881|FG000|Overall Study|Ineligible/Not treated|1|||
146380447|NCT01688999|527893882|FG001|Overall Study|Ineligible/Not treated|0|||
146380448|NCT01688999|527893883|FG002|Overall Study|Ineligible/Not treated|0|||
146380449|NCT01855425|527893902|FG000|Overall Study|Physician Decision|20|||
146380450|NCT01025232|527893909|FG000|Overall Study|Study drug no longer available|3|||
146380451|NCT01025232|527893910|FG001|Overall Study|Study drug no longer available|6|||
146380452|NCT01600105|527893911|FG000|Total Participants|Withdrawal by Subject|1|||
146380453|NCT01600105|527893912|FG001|Total Participants|Withdrawal by Subject|0|||
146380454|NCT01600105|527893911|FG000|Total Participants|No images in PACS|10|||
146380455|NCT01600105|527893912|FG001|Total Participants|No images in PACS|0|||
146380456|NCT01600105|527893911|FG000|Total Participants|Insufficient image quality|30|||
146380457|NCT01600105|527893912|FG001|Total Participants|Insufficient image quality|10|||
146380458|NCT01600105|527893911|FG000|Sub Study I|Insufficient image quality|0|||
146380459|NCT01600105|527893912|FG001|Sub Study I|Insufficient image quality|10|||
146380460|NCT01600105|527893911|FG000|Sub Study II|Withdrawal by Subject|1|||
146380461|NCT01600105|527893912|FG001|Sub Study II|Withdrawal by Subject|0|||
146380462|NCT01600105|527893911|FG000|Sub Study II|No images in PACS|1|||
146380463|NCT01600105|527893912|FG001|Sub Study II|No images in PACS|0|||
146380464|NCT01600105|527893911|FG000|Sub Study II|Insufficient image quality|3|||
146380465|NCT01600105|527893912|FG001|Sub Study II|Insufficient image quality|0|||
146380466|NCT01600105|527893911|FG000|Sub Study III|Insufficient image quality|5|||
146380467|NCT01600105|527893912|FG001|Sub Study III|Insufficient image quality|0|||
146380468|NCT01600105|527893911|FG000|Sub Study V|Poor Image Quality|2|||
146380469|NCT01600105|527893912|FG001|Sub Study V|Poor Image Quality|0|||
146380470|NCT01263444|527893913|FG000|Overall Study|Adverse Event|8|||
146380471|NCT01263444|527893913|FG000|Overall Study|Withdrawal by Subject|1|||
146380472|NCT01263444|527893913|FG000|Overall Study|Protocol Violation|1|||
146380473|NCT01899768|527893915|FG000|Part A|Adverse Event|2|||
146380474|NCT01899768|527893915|FG000|Part A|Withdrawal by Subject|1|||
146380475|NCT01899768|527893915|FG000|Part B|Adverse Event|1|||
146380476|NCT01899768|527893915|FG000|Part B|Withdrawal by Subject|1|||
146380477|NCT04043416|527893916|FG000|Washout|Change in health condition|0|||
146380478|NCT04043416|527893917|FG001|Washout|Change in health condition|1|||
146380479|NCT01196091|527893918|FG000|Overall Study|Adverse Event|22|||
146380480|NCT01196091|527893919|FG001|Overall Study|Adverse Event|27|||
146380481|NCT01196091|527893920|FG002|Overall Study|Adverse Event|26|||
146380482|NCT01196091|527893918|FG000|Overall Study|Death|3|||
146380483|NCT01196091|527893919|FG001|Overall Study|Death|2|||
146380484|NCT01196091|527893920|FG002|Overall Study|Death|2|||
146380485|NCT01196091|527893918|FG000|Overall Study|Entry Criteria Not Met|11|||
146380486|NCT01196091|527893919|FG001|Overall Study|Entry Criteria Not Met|11|||
146380487|NCT01196091|527893920|FG002|Overall Study|Entry Criteria Not Met|10|||
146380488|NCT01196091|527893918|FG000|Overall Study|Lack of Efficacy|15|||
146380489|NCT01196091|527893919|FG001|Overall Study|Lack of Efficacy|12|||
146380490|NCT01196091|527893920|FG002|Overall Study|Lack of Efficacy|17|||
146380491|NCT01196091|527893918|FG000|Overall Study|Lost to Follow-up|5|||
146380492|NCT01196091|527893919|FG001|Overall Study|Lost to Follow-up|5|||
146380493|NCT01196091|527893920|FG002|Overall Study|Lost to Follow-up|6|||
146380494|NCT01196091|527893918|FG000|Overall Study|Parent/Caregiver Decision|0|||
146380495|NCT01196091|527893919|FG001|Overall Study|Parent/Caregiver Decision|0|||
146380496|NCT01196091|527893920|FG002|Overall Study|Parent/Caregiver Decision|1|||
146380497|NCT01196091|527893918|FG000|Overall Study|Withdrawal by Subject|16|||
146380498|NCT01196091|527893919|FG001|Overall Study|Withdrawal by Subject|19|||
146380499|NCT01196091|527893920|FG002|Overall Study|Withdrawal by Subject|22|||
146380500|NCT01196091|527893918|FG000|Overall Study|Physician Decision|3|||
146380501|NCT01196091|527893919|FG001|Overall Study|Physician Decision|3|||
146380502|NCT01196091|527893920|FG002|Overall Study|Physician Decision|4|||
146380503|NCT01196091|527893918|FG000|Overall Study|Protocol Violation|1|||
146380504|NCT01196091|527893919|FG001|Overall Study|Protocol Violation|3|||
146380505|NCT01196091|527893920|FG002|Overall Study|Protocol Violation|3|||
146380506|NCT01196091|527893918|FG000|Overall Study|Sponsor Decision|6|||
146380507|NCT01196091|527893919|FG001|Overall Study|Sponsor Decision|5|||
146380508|NCT01196091|527893920|FG002|Overall Study|Sponsor Decision|4|||
146380509|NCT01196091|527893918|FG000|Overall Study|Excluded Site|5|||
146380510|NCT01196091|527893919|FG001|Overall Study|Excluded Site|11|||
146380511|NCT01196091|527893920|FG002|Overall Study|Excluded Site|8|||
146380512|NCT01196091|527893918|FG000|Overall Study|Randomized, No Study Drug Received|1|||
146380513|NCT01196091|527893919|FG001|Overall Study|Randomized, No Study Drug Received|0|||
146380514|NCT01196091|527893920|FG002|Overall Study|Randomized, No Study Drug Received|1|||
146380515|NCT00355615|527893922|FG000|Randomized Double Blind Period|Adverse Event|1|||
146380516|NCT00355615|527893923|FG001|Randomized Double Blind Period|Adverse Event|0|||
146380517|NCT00355615|527893924|FG002|Randomized Double Blind Period|Adverse Event|0|||
146380518|NCT00355615|527893925|FG003|Randomized Double Blind Period|Adverse Event|0|||
146380519|NCT00355615|527893926|FG004|Randomized Double Blind Period|Adverse Event|0|||
146380520|NCT00355615|527893922|FG000|Randomized Double Blind Period|Protocol Violation|0|||
146380521|NCT00355615|527893923|FG001|Randomized Double Blind Period|Protocol Violation|0|||
146380522|NCT00355615|527893924|FG002|Randomized Double Blind Period|Protocol Violation|1|||
146380523|NCT00355615|527893925|FG003|Randomized Double Blind Period|Protocol Violation|1|||
146380524|NCT00355615|527893926|FG004|Randomized Double Blind Period|Protocol Violation|0|||
146380525|NCT00355615|527893922|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146380526|NCT00355615|527893923|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146380527|NCT00355615|527893924|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146380528|NCT00355615|527893925|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
146380529|NCT00355615|527893926|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
146380530|NCT00355615|527893922|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146380531|NCT00355615|527893923|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146380532|NCT00355615|527893924|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146380533|NCT00355615|527893925|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
146380534|NCT00355615|527893926|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
146380535|NCT00355615|527893922|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146380536|NCT00355615|527893923|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146380537|NCT00355615|527893924|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146380538|NCT00355615|527893925|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
146380539|NCT00355615|527893926|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
146380540|NCT00355615|527893922|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146380541|NCT00355615|527893923|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146380542|NCT00355615|527893924|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146380543|NCT00355615|527893925|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
146380544|NCT00355615|527893926|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
146380545|NCT02324049|527893928|FG000|Part C|Study terminated|11|||
146380546|NCT02159365|527893929|FG000|Overall Study|Disease Progression|23|||
146380547|NCT02159365|527893929|FG000|Overall Study|Other reasons|11|||
146380548|NCT02159365|527893929|FG000|Overall Study|Administrative reason by Sponsor|9|||
146380549|NCT02159365|527893929|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
146380550|NCT02159365|527893929|FG000|Overall Study|Study drug toxicity|7|||
146380551|NCT02159365|527893929|FG000|Overall Study|Maximum clinical benefit|3|||
146380552|NCT02159365|527893929|FG000|Overall Study|Subject request to discontinue treatment|3|||
146380553|NCT02159365|527893929|FG000|Overall Study|Subject withdrew consent|3|||
146380554|NCT02159365|527893929|FG000|Overall Study|Death|1|||
146380555|NCT02159365|527893929|FG000|Overall Study|Lost to Follow-up|1|||
146380556|NCT03198728|527893931|FG000|Overall Study|Adverse Event|10|||
146380557|NCT03198728|527893932|FG001|Overall Study|Adverse Event|5|||
146380558|NCT03198728|527893931|FG000|Overall Study|Lost to Follow-up|21|||
146380559|NCT03198728|527893932|FG001|Overall Study|Lost to Follow-up|7|||
146380560|NCT03198728|527893931|FG000|Overall Study|Physician Decision|7|||
146380561|NCT03198728|527893932|FG001|Overall Study|Physician Decision|2|||
146380562|NCT03198728|527893931|FG000|Overall Study|Withdrawal by Subject|14|||
146380563|NCT03198728|527893932|FG001|Overall Study|Withdrawal by Subject|10|||
146380564|NCT04051944|527893934|FG000|Overall Study|Study ending|1|||
146380565|NCT04051944|527893935|FG001|Overall Study|Study ending|1|||
146380566|NCT04051944|527893934|FG000|Overall Study|Early study termination by participant|1|||
146380567|NCT04051944|527893935|FG001|Overall Study|Early study termination by participant|0|||
146380568|NCT04051944|527893934|FG000|Overall Study|Withdrawal by Subject|2|||
146380569|NCT04051944|527893935|FG001|Overall Study|Withdrawal by Subject|2|||
146380570|NCT04051944|527893934|FG000|Overall Study|Lack of Efficacy|3|||
146380571|NCT04051944|527893935|FG001|Overall Study|Lack of Efficacy|0|||
146380572|NCT04051944|527893934|FG000|Overall Study|Adverse event, non- fatal|1|||
146380573|NCT04051944|527893935|FG001|Overall Study|Adverse event, non- fatal|1|||
146380574|NCT03083470|527893936|FG000|Overall Study|Lost to Follow-up|0|||
146380575|NCT03083470|527893937|FG001|Overall Study|Lost to Follow-up|0|||
146380576|NCT03083470|527893938|FG002|Overall Study|Lost to Follow-up|0|||
146380577|NCT03083470|527893939|FG003|Overall Study|Lost to Follow-up|0|||
146380578|NCT03083470|527893940|FG004|Overall Study|Lost to Follow-up|1|||
146380579|NCT03083470|527893936|FG000|Overall Study|Withdrawal by Subject|0|||
146380580|NCT03083470|527893937|FG001|Overall Study|Withdrawal by Subject|0|||
146380581|NCT03083470|527893938|FG002|Overall Study|Withdrawal by Subject|0|||
146380582|NCT03083470|527893939|FG003|Overall Study|Withdrawal by Subject|0|||
146380583|NCT03083470|527893940|FG004|Overall Study|Withdrawal by Subject|1|||
146380584|NCT03077711|527893941|FG000|Overall Study|Lost to Follow-up|2|||
146380585|NCT03077711|527893942|FG001|Overall Study|Lost to Follow-up|2|||
146380586|NCT03077711|527893941|FG000|Overall Study|noncompliant taking medication|2|||
146380587|NCT03077711|527893942|FG001|Overall Study|noncompliant taking medication|0|||
146380588|NCT01526928|527893943|FG000|Overall Study|Progressive Disease|35|||
146380589|NCT01526928|527893944|FG001|Overall Study|Progressive Disease|17|||
146380590|NCT01526928|527893945|FG002|Overall Study|Progressive Disease|150|||
146380591|NCT01526928|527893946|FG003|Overall Study|Progressive Disease|182|||
146380592|NCT01526928|527893947|FG004|Overall Study|Progressive Disease|76|||
146380593|NCT01526928|527893948|FG005|Overall Study|Progressive Disease|4|||
146380594|NCT01526928|527893943|FG000|Overall Study|Adverse Event|2|||
146380595|NCT01526928|527893944|FG001|Overall Study|Adverse Event|1|||
146380596|NCT01526928|527893945|FG002|Overall Study|Adverse Event|29|||
146380597|NCT01526928|527893946|FG003|Overall Study|Adverse Event|40|||
146380598|NCT01526928|527893947|FG004|Overall Study|Adverse Event|13|||
146380599|NCT01526928|527893948|FG005|Overall Study|Adverse Event|2|||
146380600|NCT01526928|527893943|FG000|Overall Study|Death|0|||
146380601|NCT01526928|527893944|FG001|Overall Study|Death|0|||
146380602|NCT01526928|527893945|FG002|Overall Study|Death|3|||
146380603|NCT01526928|527893946|FG003|Overall Study|Death|0|||
146380604|NCT01526928|527893947|FG004|Overall Study|Death|0|||
146380605|NCT01526928|527893948|FG005|Overall Study|Death|0|||
146380606|NCT01526928|527893943|FG000|Overall Study|Withdrawal by Subject|1|||
146380607|NCT01526928|527893944|FG001|Overall Study|Withdrawal by Subject|0|||
146380608|NCT01526928|527893945|FG002|Overall Study|Withdrawal by Subject|13|||
146380609|NCT01526928|527893946|FG003|Overall Study|Withdrawal by Subject|11|||
146380610|NCT01526928|527893947|FG004|Overall Study|Withdrawal by Subject|3|||
146380611|NCT01526928|527893948|FG005|Overall Study|Withdrawal by Subject|0|||
146380612|NCT01526928|527893943|FG000|Overall Study|Physician Decision|0|||
146380613|NCT01526928|527893944|FG001|Overall Study|Physician Decision|0|||
146380614|NCT01526928|527893945|FG002|Overall Study|Physician Decision|2|||
146380615|NCT01526928|527893946|FG003|Overall Study|Physician Decision|5|||
146380616|NCT01526928|527893947|FG004|Overall Study|Physician Decision|0|||
146380617|NCT01526928|527893948|FG005|Overall Study|Physician Decision|0|||
146380618|NCT01526928|527893943|FG000|Overall Study|Other Reason|0|||
146380619|NCT01526928|527893944|FG001|Overall Study|Other Reason|1|||
146380620|NCT01526928|527893945|FG002|Overall Study|Other Reason|11|||
146380621|NCT01526928|527893946|FG003|Overall Study|Other Reason|4|||
146380622|NCT01526928|527893947|FG004|Overall Study|Other Reason|1|||
146380623|NCT01526928|527893948|FG005|Overall Study|Other Reason|0|||
146380624|NCT01526928|527893943|FG000|Overall Study|Lost to Follow-up|0|||
146380625|NCT01526928|527893944|FG001|Overall Study|Lost to Follow-up|0|||
146380626|NCT01526928|527893945|FG002|Overall Study|Lost to Follow-up|0|||
146380627|NCT01526928|527893946|FG003|Overall Study|Lost to Follow-up|1|||
146380628|NCT01526928|527893947|FG004|Overall Study|Lost to Follow-up|0|||
146380629|NCT01526928|527893948|FG005|Overall Study|Lost to Follow-up|0|||
146380630|NCT01526928|527893943|FG000|Overall Study|Protocol Deviation|0|||
146380631|NCT01526928|527893944|FG001|Overall Study|Protocol Deviation|0|||
146380632|NCT01526928|527893945|FG002|Overall Study|Protocol Deviation|0|||
146380633|NCT01526928|527893946|FG003|Overall Study|Protocol Deviation|2|||
146380634|NCT01526928|527893947|FG004|Overall Study|Protocol Deviation|0|||
146380635|NCT01526928|527893948|FG005|Overall Study|Protocol Deviation|0|||
146380636|NCT01526928|527893943|FG000|Overall Study|Missing|0|||
146380637|NCT01526928|527893944|FG001|Overall Study|Missing|0|||
146380638|NCT01526928|527893945|FG002|Overall Study|Missing|1|||
146380639|NCT01526928|527893946|FG003|Overall Study|Missing|0|||
146380640|NCT01526928|527893947|FG004|Overall Study|Missing|2|||
146380641|NCT01526928|527893948|FG005|Overall Study|Missing|0|||
146380642|NCT00736450|527893949|FG000|Overall Study|Not ABC gene eligible|19|||
146380643|NCT00736450|527893949|FG000|Overall Study|Withdrawal by Subject|5|||
146380644|NCT00736450|527893949|FG000|Overall Study|Physician Decision|1|||
146380645|NCT04157751|527893950|FG000|Overall Study|Withdrawal by Subject|12|||
146380646|NCT04157751|527893951|FG001|Overall Study|Withdrawal by Subject|17|||
146380647|NCT04157751|527893950|FG000|Overall Study|Lost to Follow-up|6|||
146380648|NCT04157751|527893951|FG001|Overall Study|Lost to Follow-up|2|||
146380649|NCT04157751|527893950|FG000|Overall Study|Adverse Event|34|||
146380650|NCT04157751|527893951|FG001|Overall Study|Adverse Event|23|||
146380651|NCT04157751|527893950|FG000|Overall Study|Not treated|1|||
146380652|NCT04157751|527893951|FG001|Overall Study|Not treated|5|||
146380653|NCT04157751|527893950|FG000|Overall Study|Other reason not stated above|10|||
146380654|NCT04157751|527893951|FG001|Overall Study|Other reason not stated above|10|||
146380655|NCT03446612|527893954|FG000|Overall Study|Protocol defined stopping criteria|0|||
146380656|NCT03446612|527893955|FG001|Overall Study|Protocol defined stopping criteria|1|||
146380657|NCT00333970|527893956|FG000|Overall Study|Withdrawal by Subject|13|||
146380658|NCT00333970|527893957|FG001|Overall Study|Withdrawal by Subject|7|||
146380659|NCT03148795|527893961|FG000|Overall Study|Progressive Disease|1|||
146380660|NCT04228445|527893969|FG000|Overall Study|Lost to Follow-up|1|||
146380661|NCT04228445|527893970|FG001|Overall Study|Lost to Follow-up|1|||
146380662|NCT04228445|527893969|FG000|Overall Study|Physician Decision|1|||
146380663|NCT04228445|527893970|FG001|Overall Study|Physician Decision|2|||
146380664|NCT04228445|527893969|FG000|Overall Study|Withdrawal by Subject|0|||
146380665|NCT04228445|527893970|FG001|Overall Study|Withdrawal by Subject|1|||
146380666|NCT04228445|527893969|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
146380667|NCT04228445|527893970|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
146380668|NCT03418376|527893971|FG000|Overall Study|Musculoskeletal injury|1|||
146380669|NCT03418376|527893972|FG001|Overall Study|Musculoskeletal injury|2|||
146380670|NCT03418376|527893973|FG002|Overall Study|Musculoskeletal injury|1|||
146380671|NCT03418376|527893974|FG003|Overall Study|Musculoskeletal injury|0|||
146380672|NCT03418376|527893971|FG000|Overall Study|Personal reasons|0|||
146380673|NCT03418376|527893972|FG001|Overall Study|Personal reasons|2|||
146380674|NCT03418376|527893973|FG002|Overall Study|Personal reasons|2|||
146380675|NCT03418376|527893974|FG003|Overall Study|Personal reasons|1|||
146380676|NCT03418376|527893971|FG000|Overall Study|Exacerbation|0|||
146380677|NCT03418376|527893972|FG001|Overall Study|Exacerbation|1|||
146380678|NCT03418376|527893973|FG002|Overall Study|Exacerbation|0|||
146380679|NCT03418376|527893974|FG003|Overall Study|Exacerbation|0|||
146380680|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
146380681|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
146380682|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146380683|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146380684|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
146380685|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
146380686|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
146380687|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146380688|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146380689|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
146380690|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
146380691|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
146380692|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146380693|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146380694|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
146380695|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146380696|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
146380697|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146380698|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146380699|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
146380700|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
146380701|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146380702|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146380703|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146380704|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
146380705|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146380706|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
146380707|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146380708|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146380709|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
146380710|NCT04757376|527893977|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
146380711|NCT04757376|527893978|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
146380712|NCT04757376|527893979|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146380713|NCT04757376|527893980|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146380714|NCT04757376|527893981|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
146380715|NCT04757376|527893977|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146380716|NCT04757376|527893978|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146380717|NCT04757376|527893979|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
146380718|NCT04757376|527893980|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146380719|NCT04757376|527893981|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
146380720|NCT01307046|527893982|FG000|Overall Study|Adverse Event|3|||
146380721|NCT01307046|527893983|FG001|Overall Study|Adverse Event|3|||
146380722|NCT01307046|527893982|FG000|Overall Study|Lack of Efficacy|0|||
146380723|NCT01307046|527893983|FG001|Overall Study|Lack of Efficacy|2|||
146380724|NCT01307046|527893982|FG000|Overall Study|Physician Decision|2|||
146380725|NCT01307046|527893983|FG001|Overall Study|Physician Decision|0|||
146380726|NCT01307046|527893982|FG000|Overall Study|Withdrawal by Subject|1|||
146380727|NCT01307046|527893983|FG001|Overall Study|Withdrawal by Subject|1|||
146380728|NCT01307046|527893982|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
146380729|NCT01307046|527893983|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
146380730|NCT01307046|527893982|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
146380731|NCT01307046|527893983|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
146380732|NCT02574520|527893984|FG000|Overall Study|Not dosed|2|||
146380733|NCT02574520|527893985|FG001|Overall Study|Not dosed|0|||
146380734|NCT02574520|527893986|FG002|Overall Study|Not dosed|5|||
146380735|NCT02574520|527893987|FG003|Overall Study|Not dosed|4|||
146380736|NCT02574520|527893984|FG000|Overall Study|Adverse Event|0|||
146380737|NCT02574520|527893985|FG001|Overall Study|Adverse Event|0|||
146380738|NCT02574520|527893986|FG002|Overall Study|Adverse Event|0|||
146380739|NCT02574520|527893987|FG003|Overall Study|Adverse Event|1|||
146380740|NCT02574520|527893984|FG000|Overall Study|Withdrawal by Subject|0|||
146380741|NCT02574520|527893985|FG001|Overall Study|Withdrawal by Subject|0|||
146380742|NCT02574520|527893986|FG002|Overall Study|Withdrawal by Subject|0|||
146380743|NCT02574520|527893987|FG003|Overall Study|Withdrawal by Subject|1|||
146380744|NCT02574520|527893984|FG000|Overall Study|Other|0|||
146380745|NCT02574520|527893985|FG001|Overall Study|Other|0|||
146380746|NCT02574520|527893986|FG002|Overall Study|Other|0|||
146380747|NCT02574520|527893987|FG003|Overall Study|Other|2|||
146380748|NCT03935594|527893999|FG000|Overall Study|Physician Decision|3|||
146380749|NCT01435122|527894000|FG000|Overall Study|Early withdrawal due to toxicity|8|||
146380750|NCT01190020|527894001|FG000|Overall Study|Adverse Event|2|||
146380751|NCT01190020|527894002|FG001|Overall Study|Adverse Event|0|||
146380752|NCT01190020|527894001|FG000|Overall Study|Lost to Follow-up|2|||
146380753|NCT01190020|527894002|FG001|Overall Study|Lost to Follow-up|0|||
146380754|NCT01190020|527894001|FG000|Overall Study|Withdrawal by Subject|3|||
146380755|NCT01190020|527894002|FG001|Overall Study|Withdrawal by Subject|0|||
146380756|NCT00796224|527894003|FG000|Overall Study|Adverse Event|1|||
146380757|NCT00796224|527894004|FG001|Overall Study|Adverse Event|0|||
146380758|NCT00796224|527894003|FG000|Overall Study|Protocol Violation|0|||
146380759|NCT00796224|527894004|FG001|Overall Study|Protocol Violation|1|||
146380760|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
146380761|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146380762|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
146380763|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
146380764|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
146380765|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
146380766|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146380767|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
146380768|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
146380769|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
146380770|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
146380771|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
146056250|NCT00549640|526721156|FG000|Overall Study|Withdrawal by Subject|6|||
146380772|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
146380773|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146380774|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146380775|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
146380776|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146380777|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146380778|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
146380779|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
146380780|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
146380781|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
146380782|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
146380783|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
146380784|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
146380785|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146380786|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
146380787|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
146380788|NCT03227224|527894007|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
146380789|NCT03227224|527894008|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
146380790|NCT03227224|527894009|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
146380791|NCT03227224|527894010|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
146380792|NCT03227224|527894007|FG000|Follow-up Phase (2 Weeks)|Other|4|||
146380793|NCT03227224|527894008|FG001|Follow-up Phase (2 Weeks)|Other|4|||
146380794|NCT03227224|527894009|FG002|Follow-up Phase (2 Weeks)|Other|6|||
146380795|NCT03227224|527894010|FG003|Follow-up Phase (2 Weeks)|Other|3|||
146380796|NCT04195750|527894011|FG000|Overall Study|Death|245|||
146380797|NCT04195750|527894012|FG001|Overall Study|Death|253|||
146380798|NCT04195750|527894013|FG002|Overall Study|Death|5|||
146380799|NCT04195750|527894011|FG000|Overall Study|Physician Decision|0|||
146380800|NCT04195750|527894012|FG001|Overall Study|Physician Decision|1|||
146380801|NCT04195750|527894013|FG002|Overall Study|Physician Decision|0|||
146380802|NCT04195750|527894011|FG000|Overall Study|Withdrawal by Subject|9|||
146380803|NCT04195750|527894012|FG001|Overall Study|Withdrawal by Subject|8|||
146380804|NCT04195750|527894013|FG002|Overall Study|Withdrawal by Subject|0|||
146380805|NCT04195750|527894011|FG000|Overall Study|Ongoing|120|||
146380806|NCT04195750|527894012|FG001|Overall Study|Ongoing|110|||
146380807|NCT04195750|527894013|FG002|Overall Study|Ongoing|4|||
146380808|NCT02406027|527894014|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146380809|NCT02406027|527894015|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
146380810|NCT02406027|527894016|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
146380811|NCT02406027|527894017|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146380812|NCT02406027|527894018|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146380813|NCT02406027|527894019|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146380814|NCT02406027|527894020|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
146380815|NCT02406027|527894014|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
146380816|NCT02406027|527894015|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146380817|NCT02406027|527894016|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
146380818|NCT02406027|527894017|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146380819|NCT02406027|527894018|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146380820|NCT02406027|527894019|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146380821|NCT02406027|527894020|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
146380822|NCT02406027|527894014|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
146380823|NCT02406027|527894015|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
146380824|NCT02406027|527894016|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
146380825|NCT02406027|527894017|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146380826|NCT02406027|527894018|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146380827|NCT02406027|527894019|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146380828|NCT02406027|527894020|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
146380829|NCT02406027|527894014|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
146380830|NCT02406027|527894015|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146380831|NCT02406027|527894016|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
146380832|NCT02406027|527894017|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146380833|NCT02406027|527894018|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146380834|NCT02406027|527894019|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146380835|NCT02406027|527894020|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
146380836|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
146380837|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
146380838|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
146380839|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
146380840|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
146380841|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
146380842|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
146380843|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
146380844|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
146380845|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
146380846|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
146380847|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
146380848|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
146380849|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
146380850|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146380851|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146380852|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146380853|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
146380854|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
146380855|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
146380856|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
146380857|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146380858|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146380859|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
146380860|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
146380861|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
146380862|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
146380863|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
146380864|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380865|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380866|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380867|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380868|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380869|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
146380870|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
146380871|NCT02406027|527894014|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380872|NCT02406027|527894015|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380873|NCT02406027|527894016|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380874|NCT02406027|527894017|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380875|NCT02406027|527894018|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
146380876|NCT02406027|527894019|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380877|NCT02406027|527894020|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
146380878|NCT03782376|527894021|FG000|Overall Study|Lost to Follow-up|2|||
146380879|NCT03782376|527894022|FG001|Overall Study|Lost to Follow-up|2|||
146380880|NCT03782376|527894021|FG000|Overall Study|Withdrawal by Subject|7|||
146380881|NCT03782376|527894022|FG001|Overall Study|Withdrawal by Subject|11|||
146380882|NCT03782376|527894021|FG000|Overall Study|Death|1|||
146380883|NCT03782376|527894022|FG001|Overall Study|Death|0|||
146380884|NCT03782376|527894021|FG000|Overall Study|Other|16|||
146380885|NCT03782376|527894022|FG001|Overall Study|Other|17|||
146380886|NCT03277794|527894025|FG000|Overall Study|Lost to Follow-up|2|||
146380887|NCT03277794|527894026|FG001|Overall Study|Lost to Follow-up|4|||
146380888|NCT03277794|527894025|FG000|Overall Study|Withdrew due to high acuity|1|||
146380889|NCT03277794|527894026|FG001|Overall Study|Withdrew due to high acuity|0|||
146380890|NCT02254304|527894028|FG000|Overall Study|Adverse Event|2|||
146380891|NCT02254304|527894029|FG001|Overall Study|Adverse Event|1|||
146380892|NCT02254304|527894028|FG000|Overall Study|Lost to Follow-up|2|||
146380893|NCT02254304|527894029|FG001|Overall Study|Lost to Follow-up|2|||
146380894|NCT02254304|527894028|FG000|Overall Study|Protocol Violation|1|||
146380895|NCT02254304|527894029|FG001|Overall Study|Protocol Violation|0|||
146380896|NCT02254304|527894028|FG000|Overall Study|Withdrawal by Subject|3|||
146380897|NCT02254304|527894029|FG001|Overall Study|Withdrawal by Subject|0|||
146380898|NCT02254304|527894028|FG000|Overall Study|Injection site pain and Injection fear|1|||
146380899|NCT02254304|527894029|FG001|Overall Study|Injection site pain and Injection fear|0|||
146380900|NCT02254304|527894028|FG000|Overall Study|Personal causes|4|||
146380901|NCT02254304|527894029|FG001|Overall Study|Personal causes|1|||
146380902|NCT02254304|527894028|FG000|Overall Study|Personal decision|1|||
146380903|NCT02254304|527894029|FG001|Overall Study|Personal decision|0|||
146380904|NCT05166603|527894030|FG000|Overall Study|Withdrawal by Subject|68|||
146380905|NCT05166603|527894031|FG001|Overall Study|Withdrawal by Subject|0|||
146380906|NCT02903966|527895626|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
146380907|NCT02903966|527895627|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
146380908|NCT02903966|527895626|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
146380909|NCT02903966|527895627|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
146380910|NCT02903966|527895626|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
146380911|NCT02903966|527895627|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
146380912|NCT03715205|527895629|FG000|Overall Study|Death|13|||
146380913|NCT03715205|527895629|FG000|Overall Study|Lost to Follow-up|2|||
146380914|NCT03715205|527895629|FG000|Overall Study|Physician Decision|93|||
146380915|NCT03715205|527895629|FG000|Overall Study|Withdrawal by Subject|26|||
146380916|NCT03342404|527895630|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
146380917|NCT03342404|527895631|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
146380918|NCT03342404|527895630|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
146380919|NCT03342404|527895631|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
146380920|NCT03342404|527895630|FG000|Blinded Treatment Phase|Adverse Event|5|||
146380921|NCT03342404|527895631|FG001|Blinded Treatment Phase|Adverse Event|4|||
146380922|NCT03342404|527895630|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
146380923|NCT03342404|527895631|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
146380924|NCT03342404|527895630|FG000|Blinded Treatment Phase|Other reasons|1|||
146380925|NCT03342404|527895631|FG001|Blinded Treatment Phase|Other reasons|0|||
146380926|NCT03342404|527895630|FG000|Blinded Treatment Phase|Physician Decision|1|||
146380927|NCT03342404|527895631|FG001|Blinded Treatment Phase|Physician Decision|0|||
146380928|NCT03342404|527895630|FG000|Blinded Treatment Phase|Death|1|||
146380929|NCT03342404|527895631|FG001|Blinded Treatment Phase|Death|0|||
146380930|NCT03342404|527895630|FG000|Open-Label Phase|Lost to Follow-up|0|||
146380931|NCT03342404|527895631|FG001|Open-Label Phase|Lost to Follow-up|1|||
146380932|NCT03342404|527895630|FG000|Open-Label Phase|Other reasons|0|||
146380933|NCT03342404|527895631|FG001|Open-Label Phase|Other reasons|1|||
146380934|NCT03342404|527895630|FG000|Open-Label Phase|Adverse Event|0|||
146380935|NCT03342404|527895631|FG001|Open-Label Phase|Adverse Event|3|||
146380936|NCT03342404|527895630|FG000|Open-Label Phase|Withdrawal by Subject|0|||
146380937|NCT03342404|527895631|FG001|Open-Label Phase|Withdrawal by Subject|6|||
146380938|NCT03733249|527895632|FG000|Overall Study|Death|7|||
146380939|NCT03733249|527895632|FG000|Overall Study|Disease relapse|16|||
146380940|NCT03733249|527895632|FG000|Overall Study|Lost to Follow-up|4|||
146380941|NCT03733249|527895632|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
146380942|NCT03733249|527895632|FG000|Overall Study|Withdrawal by Subject|1|||
146380943|NCT00850135|527895633|FG000|Overall Study|Physician Decision|1|||
146380944|NCT02253992|527895634|FG000|Overall Study|Study drug toxicity|1|||
146380945|NCT02253992|527895635|FG001|Overall Study|Study drug toxicity|0|||
146380946|NCT02253992|527895636|FG002|Overall Study|Study drug toxicity|10|||
146380947|NCT02253992|527895634|FG000|Overall Study|Disease progression|4|||
146380948|NCT02253992|527895635|FG001|Overall Study|Disease progression|3|||
146380949|NCT02253992|527895636|FG002|Overall Study|Disease progression|98|||
146380950|NCT02253992|527895634|FG000|Overall Study|Withdrawal by Subject|0|||
146380951|NCT02253992|527895635|FG001|Overall Study|Withdrawal by Subject|0|||
146380952|NCT02253992|527895636|FG002|Overall Study|Withdrawal by Subject|3|||
146380953|NCT02253992|527895634|FG000|Overall Study|Adverse Event|0|||
146380954|NCT02253992|527895635|FG001|Overall Study|Adverse Event|0|||
146380955|NCT02253992|527895636|FG002|Overall Study|Adverse Event|8|||
146380956|NCT02253992|527895634|FG000|Overall Study|Death|0|||
146380957|NCT02253992|527895635|FG001|Overall Study|Death|0|||
146380958|NCT02253992|527895636|FG002|Overall Study|Death|1|||
146380959|NCT02253992|527895634|FG000|Overall Study|Subject discontinued study drug|1|||
146380960|NCT02253992|527895635|FG001|Overall Study|Subject discontinued study drug|0|||
146380961|NCT02253992|527895636|FG002|Overall Study|Subject discontinued study drug|1|||
146380962|NCT02253992|527895634|FG000|Overall Study|Completed treatment as per protocol|0|||
146380963|NCT02253992|527895635|FG001|Overall Study|Completed treatment as per protocol|1|||
146380964|NCT02253992|527895636|FG002|Overall Study|Completed treatment as per protocol|22|||
146380965|NCT02253992|527895634|FG000|Overall Study|Other|0|||
146380966|NCT02253992|527895635|FG001|Overall Study|Other|0|||
146380967|NCT02253992|527895636|FG002|Overall Study|Other|1|||
146380968|NCT00772889|527895637|FG000|Overall Study|Adverse Event|7|||
146380969|NCT00772889|527895638|FG001|Overall Study|Adverse Event|4|||
146380970|NCT00772889|527895639|FG002|Overall Study|Adverse Event|0|||
146380971|NCT00772889|527895637|FG000|Overall Study|Withdrawal by Subject|9|||
146380972|NCT00772889|527895638|FG001|Overall Study|Withdrawal by Subject|8|||
146380973|NCT00772889|527895639|FG002|Overall Study|Withdrawal by Subject|9|||
146380974|NCT00772889|527895637|FG000|Overall Study|Lost to Follow-up|6|||
146380975|NCT00772889|527895638|FG001|Overall Study|Lost to Follow-up|6|||
146380976|NCT00772889|527895639|FG002|Overall Study|Lost to Follow-up|7|||
146380977|NCT03323086|527895640|FG000|Overall Study|Lost to Follow-up|3|||
146380978|NCT03323086|527895641|FG001|Overall Study|Lost to Follow-up|2|||
146380979|NCT00796549|527895653|FG000|Overall Study|Adverse Event|11|||
146380980|NCT00796549|527895653|FG000|Overall Study|not entered|149|||
146380981|NCT00796549|527895653|FG000|Overall Study|Other|2|||
146380982|NCT00796549|527895653|FG000|Overall Study|Progressive disease|56|||
146380983|NCT03523715|527895656|FG000|Overall Study|Lost to Follow-up|11|||
146380984|NCT03523715|527895657|FG001|Overall Study|Lost to Follow-up|14|||
146380985|NCT03523715|527895656|FG000|Overall Study|Did not meet inclusion criteria|1|||
146380986|NCT03523715|527895657|FG001|Overall Study|Did not meet inclusion criteria|0|||
146380987|NCT03523715|527895656|FG000|Overall Study|Internally inconsistent reporting|0|||
146380988|NCT03523715|527895657|FG001|Overall Study|Internally inconsistent reporting|2|||
146380989|NCT00606229|527895658|FG000|Overall Study|Adverse Event|11|||
146380990|NCT00606229|527895658|FG000|Overall Study|Lack of Efficacy|1|||
146380991|NCT00606229|527895658|FG000|Overall Study|Withdrawal by Subject|4|||
146380992|NCT00606229|527895658|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
146380993|NCT00606229|527895658|FG000|Overall Study|change of residence or other commitments|2|||
146380994|NCT01332851|527895659|FG000|Overall Study|Withdrawal by Subject|4|||
146380995|NCT01332851|527895660|FG001|Overall Study|Withdrawal by Subject|2|||
146380996|NCT01332851|527895659|FG000|Overall Study|Lost to Follow-up|7|||
146380997|NCT01332851|527895660|FG001|Overall Study|Lost to Follow-up|11|||
146380998|NCT03299166|527895661|FG000|Overall Study|Adverse Event|9|||
146380999|NCT03299166|527895662|FG001|Overall Study|Adverse Event|4|||
146381000|NCT03299166|527895661|FG000|Overall Study|Withdrawal by Subject|6|||
146381001|NCT03299166|527895662|FG001|Overall Study|Withdrawal by Subject|5|||
146381002|NCT03299166|527895661|FG000|Overall Study|Physician Decision|1|||
146381003|NCT03299166|527895662|FG001|Overall Study|Physician Decision|1|||
146381004|NCT03299166|527895661|FG000|Overall Study|Sponsor Decision|3|||
146381005|NCT03299166|527895662|FG001|Overall Study|Sponsor Decision|0|||
146381006|NCT03299166|527895661|FG000|Overall Study|Lost to Follow-up|2|||
146381007|NCT03299166|527895662|FG001|Overall Study|Lost to Follow-up|4|||
146381008|NCT03299166|527895661|FG000|Overall Study|Randomization Error|0|||
146381009|NCT03299166|527895662|FG001|Overall Study|Randomization Error|1|||
146381010|NCT03299166|527895661|FG000|Overall Study|Subject unable to return due to COVID|1|||
146381011|NCT03299166|527895662|FG001|Overall Study|Subject unable to return due to COVID|0|||
146381012|NCT03299166|527895661|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
146381013|NCT03299166|527895662|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
146381014|NCT01302691|527895665|FG000|Overall Study|Adverse Event|2|||
146381015|NCT01302691|527895666|FG001|Overall Study|Adverse Event|0|||
146381016|NCT01302691|527895665|FG000|Overall Study|Death|0|||
146381017|NCT01302691|527895666|FG001|Overall Study|Death|1|||
146381018|NCT01302691|527895665|FG000|Overall Study|Lost to Follow-up|1|||
146381019|NCT01302691|527895666|FG001|Overall Study|Lost to Follow-up|0|||
146381020|NCT01302691|527895665|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
146381021|NCT01302691|527895666|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
146381022|NCT01302691|527895665|FG000|Overall Study|Physician Decision|0|||
146381023|NCT01302691|527895666|FG001|Overall Study|Physician Decision|1|||
146381024|NCT01302691|527895665|FG000|Overall Study|Protocol Violation|1|||
146381025|NCT01302691|527895666|FG001|Overall Study|Protocol Violation|0|||
146381026|NCT02829775|527895667|FG000|Overall Study|Death|1|||
146381027|NCT02829775|527895667|FG000|Overall Study|Withdrawal by Subject|3|||
146381028|NCT02829775|527895667|FG000|Overall Study|Disease remission|1|||
146381029|NCT03796195|527895668|FG000|Overall Study|Study closed early|1|||
146381030|NCT00062647|527895669|FG000|Overall Study|Death|2|||
146381031|NCT00062647|527895670|FG001|Overall Study|Death|2|||
146381032|NCT00062647|527895669|FG000|Overall Study|Adverse Event|1|||
146381033|NCT00062647|527895670|FG001|Overall Study|Adverse Event|1|||
146381034|NCT00062647|527895669|FG000|Overall Study|Withdrawal by Subject|2|||
146381035|NCT00062647|527895670|FG001|Overall Study|Withdrawal by Subject|1|||
146381036|NCT00062647|527895669|FG000|Overall Study|Protocol Violation|1|||
146381037|NCT00062647|527895670|FG001|Overall Study|Protocol Violation|0|||
146381038|NCT00062647|527895669|FG000|Overall Study|Lost to Follow-up|1|||
146381039|NCT00062647|527895670|FG001|Overall Study|Lost to Follow-up|2|||
146381040|NCT00062647|527895669|FG000|Overall Study|Failed continuation criteria|4|||
146381041|NCT00062647|527895670|FG001|Overall Study|Failed continuation criteria|2|||
146381042|NCT00062647|527895669|FG000|Overall Study|Other|4|||
146381043|NCT00062647|527895670|FG001|Overall Study|Other|4|||
146381044|NCT00062647|527895669|FG000|Overall Study|Never received study treatment|1|||
146381045|NCT00062647|527895670|FG001|Overall Study|Never received study treatment|1|||
146381046|NCT02392468|527895676|FG000|Overall Study|Adverse Event|0|||
146381047|NCT02392468|527895677|FG001|Overall Study|Adverse Event|1|||
146381048|NCT02392468|527895678|FG002|Overall Study|Adverse Event|0|||
146381049|NCT02392468|527895679|FG003|Overall Study|Adverse Event|0|||
146381050|NCT02392468|527895680|FG004|Overall Study|Adverse Event|0|||
146381051|NCT02392468|527895681|FG005|Overall Study|Adverse Event|1|||
146381052|NCT01039428|527895682|FG000|Overall Study|Protocol Violation|1|||
146381053|NCT01039428|527895683|FG001|Overall Study|Protocol Violation|0|||
146381054|NCT01039428|527895682|FG000|Overall Study|Withdrawal by Subject|1|||
146381055|NCT01039428|527895683|FG001|Overall Study|Withdrawal by Subject|0|||
146381056|NCT01313039|527895684|FG000|Overall Study|Physician Decision|1|||
146381057|NCT01313039|527895684|FG000|Overall Study|Adverse Event|1|||
146381058|NCT01678560|527895687|FG000|Overall Study|Physician Decision|4|||
146381059|NCT01678560|527895688|FG001|Overall Study|Physician Decision|4|||
146381060|NCT01678560|527895687|FG000|Overall Study|Death|0|||
146381061|NCT01678560|527895688|FG001|Overall Study|Death|1|||
146381062|NCT01678560|527895687|FG000|Overall Study|Withdrawal by Subject|0|||
146381063|NCT01678560|527895688|FG001|Overall Study|Withdrawal by Subject|1|||
146381064|NCT02201472|527895689|FG000|Overall Study|Lack of Efficacy|2|||
146381065|NCT01300767|527895690|FG000|Overall Study|Discomfort|2|||
146381066|NCT01300767|527895690|FG000|Overall Study|Biomicroscopy|1|||
146381067|NCT01300767|527895690|FG000|Overall Study|Unacceptable fit|1|||
146381068|NCT00117572|527895691|FG000|Overall Study|Site withdrew before starting treatment|2|||
146381069|NCT00117572|527895692|FG001|Overall Study|Site withdrew before starting treatment|3|||
146381070|NCT00117572|527895691|FG000|Overall Study|Withdrawal by Subject|3|||
146381071|NCT00117572|527895692|FG001|Overall Study|Withdrawal by Subject|3|||
146381072|NCT00117572|527895691|FG000|Overall Study|Protocol Violation|1|||
146381073|NCT00117572|527895692|FG001|Overall Study|Protocol Violation|0|||
146381074|NCT01188811|527895695|FG000|Overall Study|Withdrawal by Subject|0|||
146381075|NCT01188811|527895696|FG001|Overall Study|Withdrawal by Subject|2|||
146381076|NCT01188811|527895695|FG000|Overall Study|Adverse Event|6|||
146381077|NCT01188811|527895696|FG001|Overall Study|Adverse Event|0|||
146381078|NCT00654368|527895697|FG000|Overall Study|Ineligibility determined|6|||
146381079|NCT00654368|527895698|FG001|Overall Study|Ineligibility determined|0|||
146381080|NCT00654368|527895699|FG002|Overall Study|Ineligibility determined|0|||
146381081|NCT00654368|527895697|FG000|Overall Study|Protocol deviation|3|||
146381082|NCT00654368|527895698|FG001|Overall Study|Protocol deviation|2|||
146381083|NCT00654368|527895699|FG002|Overall Study|Protocol deviation|1|||
146381084|NCT00654368|527895697|FG000|Overall Study|Non-compliance|2|||
146381085|NCT00654368|527895698|FG001|Overall Study|Non-compliance|1|||
146381086|NCT00654368|527895699|FG002|Overall Study|Non-compliance|2|||
146381087|NCT00654368|527895697|FG000|Overall Study|Withdrawal by Subject|5|||
146381088|NCT00654368|527895698|FG001|Overall Study|Withdrawal by Subject|2|||
146381089|NCT00654368|527895699|FG002|Overall Study|Withdrawal by Subject|2|||
146381090|NCT00654368|527895697|FG000|Overall Study|Disease progression|21|||
146381091|NCT00654368|527895698|FG001|Overall Study|Disease progression|31|||
146381092|NCT00654368|527895699|FG002|Overall Study|Disease progression|13|||
146381093|NCT00654368|527895697|FG000|Overall Study|Requirement for alternative therapy|1|||
146381094|NCT00654368|527895698|FG001|Overall Study|Requirement for alternative therapy|1|||
146381095|NCT00654368|527895699|FG002|Overall Study|Requirement for alternative therapy|1|||
146381096|NCT00654368|527895697|FG000|Overall Study|Physician Decision|0|||
146381097|NCT00654368|527895698|FG001|Overall Study|Physician Decision|0|||
146381098|NCT00654368|527895699|FG002|Overall Study|Physician Decision|2|||
146381099|NCT00654368|527895697|FG000|Overall Study|Death|1|||
146381100|NCT00654368|527895698|FG001|Overall Study|Death|0|||
146381101|NCT00654368|527895699|FG002|Overall Study|Death|0|||
146381102|NCT00654368|527895697|FG000|Overall Study|Pregnancy|0|||
146381103|NCT00654368|527895698|FG001|Overall Study|Pregnancy|0|||
146381104|NCT00654368|527895699|FG002|Overall Study|Pregnancy|2|||
146381105|NCT00654368|527895697|FG000|Overall Study|Other|0|||
146381106|NCT00654368|527895698|FG001|Overall Study|Other|2|||
146381107|NCT00654368|527895699|FG002|Overall Study|Other|3|||
146381108|NCT00654368|527895697|FG000|Overall Study|Adverse Event|14|||
146381109|NCT00654368|527895698|FG001|Overall Study|Adverse Event|9|||
146381110|NCT00654368|527895699|FG002|Overall Study|Adverse Event|6|||
146381111|NCT01602744|527895700|FG000|Overall Study|Death|17|||
146381112|NCT01602744|527895701|FG001|Overall Study|Death|15|||
146381113|NCT01602744|527895700|FG000|Overall Study|Lost to Follow-up|13|||
146381114|NCT01602744|527895701|FG001|Overall Study|Lost to Follow-up|8|||
146381115|NCT00606294|527895705|FG000|Overall Study|Withdrawal by Subject|36|||
146381116|NCT00606294|527895706|FG001|Overall Study|Withdrawal by Subject|0|||
146381117|NCT01976624|527895707|FG000|Overall Study|Participants contraindicated|2|||
146381118|NCT01976624|527895707|FG000|Overall Study|Participants age less than 19 years|12|||
146381119|NCT02774291|527895708|FG000|Overall Study|Lost to Follow-up|1|||
146381126|NCT03325010|527895711|FG000|Overall Study|Adverse Event|3|||
146381127|NCT03325010|527895712|FG001|Overall Study|Adverse Event|8|||
146381128|NCT03325010|527895711|FG000|Overall Study|Protocol Violation|1|||
146381129|NCT03325010|527895712|FG001|Overall Study|Protocol Violation|8|||
146381130|NCT03325010|527895711|FG000|Overall Study|Withdrawal by Subject|1|||
146381131|NCT03325010|527895712|FG001|Overall Study|Withdrawal by Subject|3|||
146381132|NCT03325010|527895711|FG000|Overall Study|Lost to Follow-up|1|||
146381133|NCT03325010|527895712|FG001|Overall Study|Lost to Follow-up|0|||
146381134|NCT03325010|527895711|FG000|Overall Study|Physician Decision|1|||
146381135|NCT03325010|527895712|FG001|Overall Study|Physician Decision|1|||
146381136|NCT03325010|527895711|FG000|Overall Study|Lack of Efficacy|2|||
146381137|NCT03325010|527895712|FG001|Overall Study|Lack of Efficacy|0|||
146381138|NCT00471315|527895715|FG000|Overall Study|Adverse Event|7|||
146381139|NCT00471315|527895715|FG000|Overall Study|Withdrawal by Subject|1|||
146381140|NCT00113555|527895721|FG000|Overall Study|Baseline Failure|59|||
146381141|NCT00113555|527895721|FG000|Overall Study|Permanently Explanted|7|||
146381142|NCT00113555|527895721|FG000|Overall Study|Death|1|||
146381143|NCT00113555|527895721|FG000|Overall Study|Missed Followup|4|||
146381144|NCT00113555|527895721|FG000|Overall Study|Lost to Follow-up|8|||
146381145|NCT00609167|527895722|FG000|Overall Study|Withdrawal by Subject|1|||
146381146|NCT00609167|527895723|FG001|Overall Study|Withdrawal by Subject|0|||
146381147|NCT00609167|527895722|FG000|Overall Study|Lack of Efficacy|1|||
146381148|NCT00609167|527895723|FG001|Overall Study|Lack of Efficacy|0|||
146381149|NCT00609167|527895722|FG000|Overall Study|Adverse Event|5|||
146381150|NCT00609167|527895723|FG001|Overall Study|Adverse Event|1|||
146381151|NCT00609167|527895722|FG000|Overall Study|Disease Progression|1|||
146381152|NCT00609167|527895723|FG001|Overall Study|Disease Progression|0|||
146381153|NCT00609167|527895722|FG000|Overall Study|Stem Cell Transplant|0|||
146381154|NCT00609167|527895723|FG001|Overall Study|Stem Cell Transplant|6|||
146381155|NCT03898323|527895724|FG000|Overall Study|Physician Decision|1|||
146381156|NCT00712270|527895726|FG000|Overall Study|Withdrawal by Subject|11|||
146381157|NCT00712270|527895726|FG000|Overall Study|Screen Failure|3|||
146381158|NCT03954704|527895737|FG000|Overall Study|Death|1|||
146381159|NCT03954704|527895738|FG001|Overall Study|Death|1|||
146381160|NCT03954704|527895739|FG002|Overall Study|Death|1|||
146381161|NCT03954704|527895740|FG003|Overall Study|Death|3|||
146381162|NCT03954704|527895741|FG004|Overall Study|Death|2|||
146381163|NCT03954704|527895742|FG005|Overall Study|Death|2|||
146381164|NCT03954704|527895743|FG006|Overall Study|Death|0|||
146381165|NCT03954704|527895737|FG000|Overall Study|Withdrew Consent|0|||
146381166|NCT03954704|527895738|FG001|Overall Study|Withdrew Consent|0|||
146381167|NCT03954704|527895739|FG002|Overall Study|Withdrew Consent|1|||
146381168|NCT03954704|527895740|FG003|Overall Study|Withdrew Consent|0|||
146381169|NCT03954704|527895741|FG004|Overall Study|Withdrew Consent|0|||
146381170|NCT03954704|527895742|FG005|Overall Study|Withdrew Consent|1|||
146381171|NCT03954704|527895743|FG006|Overall Study|Withdrew Consent|0|||
146381172|NCT03954704|527895737|FG000|Overall Study|Lost to Follow-up|0|||
146381173|NCT03954704|527895738|FG001|Overall Study|Lost to Follow-up|0|||
146381174|NCT03954704|527895739|FG002|Overall Study|Lost to Follow-up|0|||
146381175|NCT03954704|527895740|FG003|Overall Study|Lost to Follow-up|0|||
146381176|NCT03954704|527895741|FG004|Overall Study|Lost to Follow-up|0|||
146381177|NCT03954704|527895742|FG005|Overall Study|Lost to Follow-up|0|||
146381178|NCT03954704|527895743|FG006|Overall Study|Lost to Follow-up|1|||
146381179|NCT03954704|527895737|FG000|Overall Study|Study Terminated by Sponsor|0|||
146381180|NCT03954704|527895738|FG001|Overall Study|Study Terminated by Sponsor|0|||
146381181|NCT03954704|527895739|FG002|Overall Study|Study Terminated by Sponsor|1|||
146381182|NCT03954704|527895740|FG003|Overall Study|Study Terminated by Sponsor|0|||
146381183|NCT03954704|527895741|FG004|Overall Study|Study Terminated by Sponsor|1|||
146381184|NCT03954704|527895742|FG005|Overall Study|Study Terminated by Sponsor|4|||
146381185|NCT03954704|527895743|FG006|Overall Study|Study Terminated by Sponsor|2|||
146381186|NCT03954704|527895737|FG000|Overall Study|Enrolled but not Treated|0|||
146381187|NCT03954704|527895738|FG001|Overall Study|Enrolled but not Treated|0|||
146381188|NCT03954704|527895739|FG002|Overall Study|Enrolled but not Treated|0|||
146381189|NCT03954704|527895740|FG003|Overall Study|Enrolled but not Treated|0|||
146381190|NCT03954704|527895741|FG004|Overall Study|Enrolled but not Treated|0|||
146381191|NCT03954704|527895742|FG005|Overall Study|Enrolled but not Treated|1|||
146381192|NCT03954704|527895743|FG006|Overall Study|Enrolled but not Treated|0|||
146381193|NCT03864627|527895745|FG000|Overall Study|Adverse Event|0|||
146381194|NCT03864627|527895746|FG001|Overall Study|Adverse Event|1|||
146381195|NCT03864627|527895745|FG000|Overall Study|Lack of Efficacy|0|||
146381196|NCT03864627|527895746|FG001|Overall Study|Lack of Efficacy|1|||
146381197|NCT03864627|527895745|FG000|Overall Study|Lost to Follow-up|0|||
146381198|NCT03864627|527895746|FG001|Overall Study|Lost to Follow-up|1|||
146381199|NCT03864627|527895745|FG000|Overall Study|Withdrawal by Subject|4|||
146381200|NCT03864627|527895746|FG001|Overall Study|Withdrawal by Subject|8|||
146381201|NCT03864627|527895745|FG000|Overall Study|Study terminated by sponsor|0|||
146381202|NCT03864627|527895746|FG001|Overall Study|Study terminated by sponsor|1|||
146381203|NCT01388491|527895747|FG000|Overall Study|Adverse Event|10|||
146381204|NCT01388491|527895748|FG001|Overall Study|Adverse Event|9|||
146381205|NCT01388491|527895747|FG000|Overall Study|Sponsor Request|9|||
146381206|NCT01388491|527895748|FG001|Overall Study|Sponsor Request|7|||
146381207|NCT01388491|527895747|FG000|Overall Study|Withdrawal by Subject|6|||
146381208|NCT01388491|527895748|FG001|Overall Study|Withdrawal by Subject|10|||
146381209|NCT01388491|527895747|FG000|Overall Study|Lost to Follow-up|4|||
146381210|NCT01388491|527895748|FG001|Overall Study|Lost to Follow-up|3|||
146381211|NCT01388491|527895747|FG000|Overall Study|Protocol Violation|2|||
146381212|NCT01388491|527895748|FG001|Overall Study|Protocol Violation|0|||
146381213|NCT01388491|527895747|FG000|Overall Study|Noncompliance|2|||
146381214|NCT01388491|527895748|FG001|Overall Study|Noncompliance|0|||
146056251|NCT00549640|526721157|FG001|Overall Study|Withdrawal by Subject|12|||
146381215|NCT01388491|527895747|FG000|Overall Study|Pregnancy|1|||
146381216|NCT01388491|527895748|FG001|Overall Study|Pregnancy|0|||
146381217|NCT04035473|527895749|FG000|Screening/Baseline|Death|0|||
146381218|NCT04035473|527895750|FG001|Screening/Baseline|Death|1|||
146381219|NCT04035473|527895749|FG000|Screening/Baseline|Adverse Event|0|||
146381220|NCT04035473|527895750|FG001|Screening/Baseline|Adverse Event|1|||
146381221|NCT04035473|527895749|FG000|Follow-up Period|Adverse Event|2|||
146381222|NCT04035473|527895750|FG001|Follow-up Period|Adverse Event|0|||
146381223|NCT00112840|527895751|FG000|Overall Study|Physician Decision|1|||
146381224|NCT00112840|527895752|FG001|Overall Study|Physician Decision|0|||
146381225|NCT00112840|527895753|FG002|Overall Study|Physician Decision|0|||
146381226|NCT00112840|527895751|FG000|Overall Study|Withdrawal by Subject|1|||
146381227|NCT00112840|527895752|FG001|Overall Study|Withdrawal by Subject|0|||
146381228|NCT00112840|527895753|FG002|Overall Study|Withdrawal by Subject|1|||
146381229|NCT00112840|527895751|FG000|Overall Study|Protocol Violation|0|||
146381230|NCT00112840|527895752|FG001|Overall Study|Protocol Violation|0|||
146381231|NCT00112840|527895753|FG002|Overall Study|Protocol Violation|5|||
146381232|NCT03595176|527895754|FG000|Overall Study|Death|0|||
146381233|NCT03595176|527895755|FG001|Overall Study|Death|2|||
146381234|NCT03595176|527895754|FG000|Overall Study|Lost to Follow-up|0|||
146381235|NCT03595176|527895755|FG001|Overall Study|Lost to Follow-up|1|||
146381236|NCT02735044|527895757|FG000|Overall Study|Adverse Event|3|||
146381237|NCT02735044|527895758|FG001|Overall Study|Adverse Event|3|||
146381238|NCT02735044|527895757|FG000|Overall Study|Lack of Efficacy|1|||
146381239|NCT02735044|527895758|FG001|Overall Study|Lack of Efficacy|0|||
146381240|NCT02735044|527895757|FG000|Overall Study|Poor compliance to protocol|7|||
146381241|NCT02735044|527895758|FG001|Overall Study|Poor compliance to protocol|7|||
146381242|NCT02735044|527895757|FG000|Overall Study|Randomized and not treated|0|||
146381243|NCT02735044|527895758|FG001|Overall Study|Randomized and not treated|2|||
146381244|NCT02735044|527895757|FG000|Overall Study|Other, not specified above|5|||
146381245|NCT02735044|527895758|FG001|Overall Study|Other, not specified above|11|||
146381246|NCT01682759|527895760|FG000|Overall Study|Death|2|||
146381247|NCT01682759|527895761|FG001|Overall Study|Death|1|||
146381248|NCT01682759|527895760|FG000|Overall Study|Lost to Follow-up|10|||
146381249|NCT01682759|527895761|FG001|Overall Study|Lost to Follow-up|13|||
146381250|NCT01682759|527895760|FG000|Overall Study|Physician Decision|1|||
146381251|NCT01682759|527895761|FG001|Overall Study|Physician Decision|1|||
146381252|NCT01682759|527895760|FG000|Overall Study|Withdrawal by Subject|56|||
146381253|NCT01682759|527895761|FG001|Overall Study|Withdrawal by Subject|55|||
146381254|NCT00397891|527895762|FG000|Overall Study|Withdrawal by Subject|1|||
146381255|NCT00397891|527895763|FG001|Overall Study|Withdrawal by Subject|0|||
146381256|NCT00397891|527895764|FG002|Overall Study|Withdrawal by Subject|0|||
146381257|NCT00397891|527895765|FG003|Overall Study|Withdrawal by Subject|0|||
146381258|NCT00397891|527895766|FG004|Overall Study|Withdrawal by Subject|1|||
146381259|NCT00412113|527895767|FG000|Overall Study|Adverse Event|11|||
146381260|NCT00412113|527895768|FG001|Overall Study|Adverse Event|15|||
146381261|NCT00412113|527895767|FG000|Overall Study|did not receive treatment|1|||
146381262|NCT00412113|527895768|FG001|Overall Study|did not receive treatment|0|||
146381263|NCT01226472|527895776|FG000|Overall Study|Progressive Disease|1|||
146381264|NCT03661983|527897703|FG000|Open Label Stabilization Phase|Adverse Event|5|||
146381265|NCT03661983|527897704|FG001|Open Label Stabilization Phase|Adverse Event|0|||
146381266|NCT03661983|527897705|FG002|Open Label Stabilization Phase|Adverse Event|0|||
146381267|NCT03661983|527897706|FG003|Open Label Stabilization Phase|Adverse Event|0|||
146381268|NCT03661983|527897703|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
146381269|NCT03661983|527897704|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
146381270|NCT03661983|527897705|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
146381271|NCT03661983|527897706|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
146381272|NCT03661983|527897703|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
146381273|NCT03661983|527897704|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146381274|NCT03661983|527897705|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146381275|NCT03661983|527897706|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
146381276|NCT03661983|527897703|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
146381277|NCT03661983|527897704|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146381278|NCT03661983|527897705|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146381279|NCT03661983|527897706|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
146381280|NCT03661983|527897703|FG000|Double-blind Randomized Phase|Adverse Event|0|||
146381281|NCT03661983|527897704|FG001|Double-blind Randomized Phase|Adverse Event|1|||
146381282|NCT03661983|527897705|FG002|Double-blind Randomized Phase|Adverse Event|0|||
146381283|NCT03661983|527897706|FG003|Double-blind Randomized Phase|Adverse Event|0|||
146381284|NCT03661983|527897703|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
146381285|NCT03661983|527897704|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
146381286|NCT03661983|527897705|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
146381287|NCT03661983|527897706|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
146381288|NCT03661983|527897703|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146381289|NCT03661983|527897704|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146381290|NCT03661983|527897705|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
146381291|NCT03661983|527897706|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
146381292|NCT03661983|527897703|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
146381293|NCT03661983|527897704|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146381294|NCT03661983|527897705|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146381295|NCT03661983|527897706|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
146381296|NCT01320033|527897707|FG000|Overall Study|Lack of Efficacy|0|||
146381297|NCT01320033|527897708|FG001|Overall Study|Lack of Efficacy|0|||
146381298|NCT01320033|527897709|FG002|Overall Study|Lack of Efficacy|1|||
146381299|NCT01320033|527897707|FG000|Overall Study|Adverse Event|9|||
146381300|NCT01320033|527897708|FG001|Overall Study|Adverse Event|7|||
146381301|NCT01320033|527897709|FG002|Overall Study|Adverse Event|8|||
146381302|NCT01320033|527897707|FG000|Overall Study|Withdrawal by Subject|22|||
146381303|NCT01320033|527897708|FG001|Overall Study|Withdrawal by Subject|23|||
146381304|NCT01320033|527897709|FG002|Overall Study|Withdrawal by Subject|23|||
146381305|NCT01320033|527897707|FG000|Overall Study|Protocol Violation|3|||
146381306|NCT01320033|527897708|FG001|Overall Study|Protocol Violation|5|||
146381307|NCT01320033|527897709|FG002|Overall Study|Protocol Violation|3|||
146381308|NCT01320033|527897707|FG000|Overall Study|Lost to Follow-up|22|||
146381309|NCT01320033|527897708|FG001|Overall Study|Lost to Follow-up|26|||
146381310|NCT01320033|527897709|FG002|Overall Study|Lost to Follow-up|17|||
146381311|NCT01320033|527897707|FG000|Overall Study|Other|2|||
146381312|NCT01320033|527897708|FG001|Overall Study|Other|3|||
146381313|NCT01320033|527897709|FG002|Overall Study|Other|1|||
146381314|NCT02045979|527897710|FG000|Overall Study|Informed Consent Withdrawn|2|||
146381315|NCT02045979|527897711|FG001|Overall Study|Informed Consent Withdrawn|0|||
146381316|NCT02045979|527897712|FG002|Overall Study|Informed Consent Withdrawn|1|||
146381317|NCT02045979|527897710|FG000|Overall Study|not specified above|0|||
146381318|NCT02045979|527897711|FG001|Overall Study|not specified above|1|||
146381319|NCT02045979|527897712|FG002|Overall Study|not specified above|0|||
146381320|NCT00963469|527897713|FG000|Overall Study|Adverse Event|15|||
146381321|NCT00963469|527897714|FG001|Overall Study|Adverse Event|11|||
146381322|NCT00963469|527897715|FG002|Overall Study|Adverse Event|1|||
146381323|NCT00963469|527897713|FG000|Overall Study|Lack of Efficacy|10|||
146381324|NCT00963469|527897714|FG001|Overall Study|Lack of Efficacy|7|||
146381325|NCT00963469|527897715|FG002|Overall Study|Lack of Efficacy|2|||
146381326|NCT00963469|527897713|FG000|Overall Study|Lost to Follow-up|1|||
146381327|NCT00963469|527897714|FG001|Overall Study|Lost to Follow-up|1|||
146381328|NCT00963469|527897715|FG002|Overall Study|Lost to Follow-up|0|||
146381329|NCT00963469|527897713|FG000|Overall Study|Protocol Violation|5|||
146381330|NCT00963469|527897714|FG001|Overall Study|Protocol Violation|5|||
146381331|NCT00963469|527897715|FG002|Overall Study|Protocol Violation|3|||
146381332|NCT00963469|527897713|FG000|Overall Study|Withdrawal by Subject|4|||
146381333|NCT00963469|527897714|FG001|Overall Study|Withdrawal by Subject|1|||
146381334|NCT00963469|527897715|FG002|Overall Study|Withdrawal by Subject|1|||
146381335|NCT00963469|527897713|FG000|Overall Study|Pre-randomization Adverse Event|1|||
146381336|NCT00963469|527897714|FG001|Overall Study|Pre-randomization Adverse Event|2|||
146381337|NCT00963469|527897715|FG002|Overall Study|Pre-randomization Adverse Event|0|||
146381338|NCT00963469|527897713|FG000|Overall Study|Moved|1|||
146381339|NCT00963469|527897714|FG001|Overall Study|Moved|0|||
146381340|NCT00963469|527897715|FG002|Overall Study|Moved|0|||
146381341|NCT00963469|527897713|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
146381342|NCT00963469|527897714|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
146381343|NCT00963469|527897715|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
146381344|NCT00378534|527897724|FG000|Overall Study|Participants did not receive transplant|3|||
146381345|NCT00378534|527897725|FG001|Overall Study|Participants did not receive transplant|0|||
146381346|NCT04969900|527897726|FG000|Overall Study|Physician Decision|1|||
146381347|NCT04969900|527897727|FG001|Overall Study|Physician Decision|1|||
146381348|NCT04969900|527897726|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
146381349|NCT04969900|527897727|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
146381350|NCT04423718|527897733|FG000|Main Study|Adverse Event|9|||
146381351|NCT04423718|527897734|FG001|Main Study|Adverse Event|5|||
146381352|NCT04423718|527897735|FG002|Main Study|Adverse Event|8|||
146381353|NCT04423718|527897733|FG000|Main Study|Physician Decision|3|||
146381354|NCT04423718|527897734|FG001|Main Study|Physician Decision|3|||
146381355|NCT04423718|527897735|FG002|Main Study|Physician Decision|2|||
146381356|NCT04423718|527897733|FG000|Main Study|Protocol Violation|0|||
146381357|NCT04423718|527897734|FG001|Main Study|Protocol Violation|0|||
146381358|NCT04423718|527897735|FG002|Main Study|Protocol Violation|1|||
146381359|NCT04423718|527897733|FG000|Main Study|Lost to Follow-up|3|||
146381360|NCT04423718|527897734|FG001|Main Study|Lost to Follow-up|3|||
146381361|NCT04423718|527897735|FG002|Main Study|Lost to Follow-up|4|||
146381362|NCT04423718|527897733|FG000|Main Study|Lack of Efficacy|2|||
146381363|NCT04423718|527897734|FG001|Main Study|Lack of Efficacy|1|||
146381364|NCT04423718|527897735|FG002|Main Study|Lack of Efficacy|0|||
146381365|NCT04423718|527897733|FG000|Main Study|Withdrawal by Subject|14|||
146381366|NCT04423718|527897734|FG001|Main Study|Withdrawal by Subject|20|||
146381367|NCT04423718|527897735|FG002|Main Study|Withdrawal by Subject|20|||
146381368|NCT04423718|527897733|FG000|Main Study|Death|10|||
146381369|NCT04423718|527897734|FG001|Main Study|Death|7|||
146381370|NCT04423718|527897735|FG002|Main Study|Death|7|||
146381371|NCT04423718|527897733|FG000|Main Study|COVID-19 pandemic|2|||
146381372|NCT04423718|527897734|FG001|Main Study|COVID-19 pandemic|2|||
146381373|NCT04423718|527897735|FG002|Main Study|COVID-19 pandemic|2|||
146381374|NCT04423718|527897733|FG000|Main Study|Other|7|||
146381375|NCT04423718|527897734|FG001|Main Study|Other|3|||
146381376|NCT04423718|527897735|FG002|Main Study|Other|2|||
146381377|NCT04423718|527897733|FG000|Extension Phase|Other|1|||
146381378|NCT04423718|527897734|FG001|Extension Phase|Other|0|||
146381379|NCT04423718|527897735|FG002|Extension Phase|Other|0|||
146381380|NCT04423718|527897733|FG000|Extension Phase|Logistical problems|0|||
146381381|NCT04423718|527897734|FG001|Extension Phase|Logistical problems|1|||
146381382|NCT04423718|527897735|FG002|Extension Phase|Logistical problems|1|||
146381383|NCT04423718|527897733|FG000|Extension Phase|Physician Decision|1|||
146381384|NCT04423718|527897734|FG001|Extension Phase|Physician Decision|0|||
146381385|NCT04423718|527897735|FG002|Extension Phase|Physician Decision|1|||
146381386|NCT04423718|527897733|FG000|Extension Phase|Lack of Efficacy|2|||
146381387|NCT04423718|527897734|FG001|Extension Phase|Lack of Efficacy|0|||
146381388|NCT04423718|527897735|FG002|Extension Phase|Lack of Efficacy|1|||
146381389|NCT04423718|527897733|FG000|Extension Phase|Lost to Follow-up|0|||
146381390|NCT04423718|527897734|FG001|Extension Phase|Lost to Follow-up|2|||
146381391|NCT04423718|527897735|FG002|Extension Phase|Lost to Follow-up|3|||
146381392|NCT04423718|527897733|FG000|Extension Phase|Adverse Event|2|||
146381393|NCT04423718|527897734|FG001|Extension Phase|Adverse Event|3|||
146381394|NCT04423718|527897735|FG002|Extension Phase|Adverse Event|1|||
146381395|NCT04423718|527897733|FG000|Extension Phase|Death|4|||
146381396|NCT04423718|527897734|FG001|Extension Phase|Death|7|||
146381397|NCT04423718|527897735|FG002|Extension Phase|Death|2|||
146381398|NCT04423718|527897733|FG000|Extension Phase|Withdrawal by Subject|11|||
146381399|NCT04423718|527897734|FG001|Extension Phase|Withdrawal by Subject|11|||
146381400|NCT04423718|527897735|FG002|Extension Phase|Withdrawal by Subject|7|||
146381401|NCT00425945|527897736|FG000|Overall Study|Concern about Supplement|2|||
146381402|NCT00425945|527897737|FG001|Overall Study|Concern about Supplement|0|||
146381403|NCT00425945|527897736|FG000|Overall Study|Inconvenience|0|||
146381404|NCT00425945|527897737|FG001|Overall Study|Inconvenience|2|||
146381405|NCT00425945|527897736|FG000|Overall Study|Lost to Follow-up|0|||
146381406|NCT00425945|527897737|FG001|Overall Study|Lost to Follow-up|2|||
146381407|NCT00425945|527897736|FG000|Overall Study|Began hypertension medication|1|||
146381408|NCT00425945|527897737|FG001|Overall Study|Began hypertension medication|0|||
146381409|NCT00425945|527897736|FG000|Overall Study|Began cancer treatments|1|||
146381410|NCT00425945|527897737|FG001|Overall Study|Began cancer treatments|0|||
146381411|NCT00425945|527897736|FG000|Overall Study|Moved from area|0|||
146381412|NCT00425945|527897737|FG001|Overall Study|Moved from area|1|||
146381413|NCT05618808|527897738|FG000|Overall Study|Withdrawal by Subject|3|||
146381414|NCT05618808|527897739|FG001|Overall Study|Withdrawal by Subject|1|||
146381415|NCT05618808|527897740|FG002|Overall Study|Withdrawal by Subject|3|||
146381416|NCT03381274|527897741|FG000|Overall Study|Death|2|||
146381417|NCT03381274|527897742|FG001|Overall Study|Death|9|||
146381418|NCT03381274|527897743|FG002|Overall Study|Death|3|||
146381419|NCT03381274|527897744|FG003|Overall Study|Death|2|||
146381420|NCT03381274|527897745|FG004|Overall Study|Death|3|||
146381421|NCT03381274|527897741|FG000|Overall Study|Lost to Follow-up|0|||
146381422|NCT03381274|527897742|FG001|Overall Study|Lost to Follow-up|0|||
146381423|NCT03381274|527897743|FG002|Overall Study|Lost to Follow-up|0|||
146381424|NCT03381274|527897744|FG003|Overall Study|Lost to Follow-up|1|||
146381425|NCT03381274|527897745|FG004|Overall Study|Lost to Follow-up|0|||
146381426|NCT03381274|527897741|FG000|Overall Study|Withdrawal by Subject|2|||
146381427|NCT03381274|527897742|FG001|Overall Study|Withdrawal by Subject|1|||
146381428|NCT03381274|527897743|FG002|Overall Study|Withdrawal by Subject|3|||
146381429|NCT03381274|527897744|FG003|Overall Study|Withdrawal by Subject|1|||
146381430|NCT03381274|527897745|FG004|Overall Study|Withdrawal by Subject|0|||
146381431|NCT03381274|527897741|FG000|Overall Study|Other|1|||
146381432|NCT03381274|527897742|FG001|Overall Study|Other|11|||
146381433|NCT03381274|527897743|FG002|Overall Study|Other|0|||
146381434|NCT03381274|527897744|FG003|Overall Study|Other|2|||
146381435|NCT03381274|527897745|FG004|Overall Study|Other|2|||
146381436|NCT01874353|527897746|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
146381437|NCT01874353|527897747|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146381438|NCT01874353|527897748|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146381439|NCT01874353|527897749|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
146381440|NCT01874353|527897746|FG000|Overall Study|Lost to Follow-up|2|||
146381441|NCT01874353|527897747|FG001|Overall Study|Lost to Follow-up|2|||
146381442|NCT01874353|527897748|FG002|Overall Study|Lost to Follow-up|2|||
146381443|NCT01874353|527897749|FG003|Overall Study|Lost to Follow-up|0|||
146381444|NCT01874353|527897746|FG000|Overall Study|Death|110|||
146381445|NCT01874353|527897747|FG001|Overall Study|Death|60|||
146381446|NCT01874353|527897748|FG002|Overall Study|Death|13|||
146381447|NCT01874353|527897749|FG003|Overall Study|Death|7|||
146381448|NCT01874353|527897746|FG000|Overall Study|Withdrawal by Subject|13|||
146381449|NCT01874353|527897747|FG001|Overall Study|Withdrawal by Subject|11|||
146381450|NCT01874353|527897748|FG002|Overall Study|Withdrawal by Subject|0|||
146381451|NCT01874353|527897749|FG003|Overall Study|Withdrawal by Subject|0|||
146381452|NCT04992507|527897758|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
146381453|NCT04992507|527897759|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
146381454|NCT04992507|527897758|FG000|Overall Study|Death|0|||
146381455|NCT04992507|527897759|FG001|Overall Study|Death|1|||
146381456|NCT01852591|527897760|FG000|Overall Study|Withdrawal by Subject|2|||
146381457|NCT01852591|527897760|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
146381458|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
146381459|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
146381460|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Death|1|||
146381461|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Death|1|||
146381462|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
146381463|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
146381464|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
146381465|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
146381466|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
146381467|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
146381468|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
146381469|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
146381470|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
146381471|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
146381472|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
146381473|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
146381474|NCT03728881|527897763|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
146381475|NCT03728881|527897764|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
146381476|NCT03728881|527897763|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
146381477|NCT03728881|527897764|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
146381478|NCT03728881|527897763|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
146381479|NCT03728881|527897764|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
146381480|NCT04651777|527897769|FG000|Overall Study|Adverse Event|1|||
146381481|NCT04651777|527897769|FG000|Overall Study|Withdrawal by Subject|2|||
146381482|NCT06048367|527897770|FG000|Overall Study|Withdrawal by Subject|0|||
146381483|NCT06048367|527897771|FG001|Overall Study|Withdrawal by Subject|1|||
146381484|NCT06048367|527897772|FG002|Overall Study|Withdrawal by Subject|0|||
146381485|NCT06048367|527897773|FG003|Overall Study|Withdrawal by Subject|0|||
146381486|NCT06048367|527897774|FG004|Overall Study|Withdrawal by Subject|0|||
146381487|NCT06048367|527897770|FG000|Overall Study|Withdrawal by Subject|0|||
146381488|NCT06048367|527897771|FG001|Overall Study|Withdrawal by Subject|0|||
146381489|NCT06048367|527897772|FG002|Overall Study|Withdrawal by Subject|1|||
146381490|NCT06048367|527897773|FG003|Overall Study|Withdrawal by Subject|0|||
146381491|NCT06048367|527897774|FG004|Overall Study|Withdrawal by Subject|0|||
146381492|NCT06048367|527897770|FG000|Overall Study|Withdrawal by Subject|0|||
146381493|NCT06048367|527897771|FG001|Overall Study|Withdrawal by Subject|0|||
146381494|NCT06048367|527897772|FG002|Overall Study|Withdrawal by Subject|0|||
146381495|NCT06048367|527897773|FG003|Overall Study|Withdrawal by Subject|1|||
146381496|NCT06048367|527897774|FG004|Overall Study|Withdrawal by Subject|0|||
146381497|NCT06048367|527897770|FG000|Overall Study|Withdrawal by Subject|0|||
146381498|NCT06048367|527897771|FG001|Overall Study|Withdrawal by Subject|0|||
146381499|NCT06048367|527897772|FG002|Overall Study|Withdrawal by Subject|0|||
146381500|NCT06048367|527897773|FG003|Overall Study|Withdrawal by Subject|1|||
146381501|NCT06048367|527897774|FG004|Overall Study|Withdrawal by Subject|0|||
146381502|NCT04088331|527897775|FG000|Overall Study|Lost to Follow-up|3|||
146381503|NCT04088331|527897775|FG000|Overall Study|Withdrawal by Subject|7|||
146381504|NCT04088331|527897775|FG000|Overall Study|Adverse Event|4|||
146381505|NCT03233308|527897776|FG000|Overall Study|Adverse Event|1|||
146381506|NCT03233308|527897776|FG000|Overall Study|Protocol Violation|1|||
146381507|NCT02756845|527897777|FG000|Overall Study|Death|12|||
146381508|NCT02756845|527897778|FG001|Overall Study|Death|2|||
146381509|NCT02756845|527897777|FG000|Overall Study|Withdrawal by Subject|1|||
146381510|NCT02756845|527897778|FG001|Overall Study|Withdrawal by Subject|0|||
146381511|NCT02139280|527897780|FG000|Overall Study|No longer eligible|2|||
146381512|NCT02139280|527897781|FG001|Overall Study|No longer eligible|0|||
146381513|NCT05559203|527897782|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
146381514|NCT00422903|527897784|FG000|Overall Study|Disease Progression|3|||
146381515|NCT00422903|527897785|FG001|Overall Study|Disease Progression|1|||
146381516|NCT00422903|527897784|FG000|Overall Study|Adverse Event|0|||
146056252|NCT00549640|526721156|FG000|Overall Study|Adverse Event|5|||
146381517|NCT00422903|527897785|FG001|Overall Study|Adverse Event|2|||
146381518|NCT00422903|527897784|FG000|Overall Study|Informed Consent Withdrawn|1|||
146381519|NCT00422903|527897785|FG001|Overall Study|Informed Consent Withdrawn|2|||
146381520|NCT01947894|527897790|FG000|Overall Study|Other|3|||
146381521|NCT01947894|527897791|FG001|Overall Study|Other|4|||
146381522|NCT01947894|527897792|FG002|Overall Study|Other|3|||
146381523|NCT01947894|527897790|FG000|Overall Study|Withdrawal by Subject|12|||
146381524|NCT01947894|527897791|FG001|Overall Study|Withdrawal by Subject|4|||
146381525|NCT01947894|527897792|FG002|Overall Study|Withdrawal by Subject|1|||
146381526|NCT01947894|527897790|FG000|Overall Study|Death|12|||
146381527|NCT01947894|527897791|FG001|Overall Study|Death|1|||
146381528|NCT01947894|527897792|FG002|Overall Study|Death|0|||
146381529|NCT01947894|527897790|FG000|Overall Study|Physician Decision|2|||
146381530|NCT01947894|527897791|FG001|Overall Study|Physician Decision|0|||
146381531|NCT01947894|527897792|FG002|Overall Study|Physician Decision|0|||
146381532|NCT01947894|527897790|FG000|Overall Study|Adverse Event|5|||
146381533|NCT01947894|527897791|FG001|Overall Study|Adverse Event|1|||
146381534|NCT01947894|527897792|FG002|Overall Study|Adverse Event|0|||
146381535|NCT01947894|527897790|FG000|Overall Study|Switched to other growth hormone brand|53|||
146381536|NCT01947894|527897791|FG001|Overall Study|Switched to other growth hormone brand|8|||
146381537|NCT01947894|527897792|FG002|Overall Study|Switched to other growth hormone brand|23|||
146381538|NCT01249157|527897793|FG000|Overall Study|Withdrawal by Subject|1|||
146381539|NCT03630016|527897794|FG000|Overall Study|Poor Sensor Placement|1|||
146381540|NCT02470429|527897795|FG000|Overall Study|Adverse Event|1|||
146381541|NCT02470429|527897796|FG001|Overall Study|Adverse Event|0|||
146381542|NCT02470429|527897795|FG000|Overall Study|Withdrawal by Subject|1|||
146381543|NCT02470429|527897796|FG001|Overall Study|Withdrawal by Subject|0|||
146381544|NCT00090766|527897797|FG000|Overall Study|Nephrectomy Planned|0|||
146381545|NCT00090766|527897798|FG001|Overall Study|Nephrectomy Planned|0|||
146381546|NCT00090766|527897799|FG002|Overall Study|Nephrectomy Planned|1|||
146381547|NCT00090766|527897797|FG000|Overall Study|Death|1|||
146381548|NCT00090766|527897798|FG001|Overall Study|Death|0|||
146381549|NCT00090766|527897799|FG002|Overall Study|Death|0|||
146381550|NCT00090766|527897797|FG000|Overall Study|Admin|0|||
146381551|NCT00090766|527897798|FG001|Overall Study|Admin|2|||
146381552|NCT00090766|527897799|FG002|Overall Study|Admin|0|||
146381553|NCT00090766|527897797|FG000|Overall Study|Lost to Follow-up|2|||
146381554|NCT00090766|527897798|FG001|Overall Study|Lost to Follow-up|0|||
146381555|NCT00090766|527897799|FG002|Overall Study|Lost to Follow-up|2|||
146381556|NCT00804986|527897800|FG000|Overall Study|Adverse Event|0|||
146381557|NCT00804986|527897801|FG001|Overall Study|Adverse Event|1|||
146381558|NCT00804986|527897802|FG002|Overall Study|Adverse Event|2|||
146381559|NCT00804986|527897803|FG003|Overall Study|Adverse Event|1|||
146381560|NCT00804986|527897804|FG004|Overall Study|Adverse Event|3|||
146381561|NCT00804986|527897805|FG005|Overall Study|Adverse Event|0|||
146381562|NCT00804986|527897800|FG000|Overall Study|Lack of Efficacy|0|||
146381563|NCT00804986|527897801|FG001|Overall Study|Lack of Efficacy|0|||
146381564|NCT00804986|527897802|FG002|Overall Study|Lack of Efficacy|0|||
146381565|NCT00804986|527897803|FG003|Overall Study|Lack of Efficacy|1|||
146381566|NCT00804986|527897804|FG004|Overall Study|Lack of Efficacy|0|||
146381567|NCT00804986|527897805|FG005|Overall Study|Lack of Efficacy|3|||
146381568|NCT00804986|527897800|FG000|Overall Study|Lost to Follow-up|0|||
146381569|NCT00804986|527897801|FG001|Overall Study|Lost to Follow-up|0|||
146381570|NCT00804986|527897802|FG002|Overall Study|Lost to Follow-up|0|||
146381571|NCT00804986|527897803|FG003|Overall Study|Lost to Follow-up|1|||
146381572|NCT00804986|527897804|FG004|Overall Study|Lost to Follow-up|1|||
146381573|NCT00804986|527897805|FG005|Overall Study|Lost to Follow-up|3|||
146381574|NCT00804986|527897800|FG000|Overall Study|Protocol Violation|0|||
146381575|NCT00804986|527897801|FG001|Overall Study|Protocol Violation|1|||
146381576|NCT00804986|527897802|FG002|Overall Study|Protocol Violation|0|||
146381577|NCT00804986|527897803|FG003|Overall Study|Protocol Violation|1|||
146381578|NCT00804986|527897804|FG004|Overall Study|Protocol Violation|0|||
146381579|NCT00804986|527897805|FG005|Overall Study|Protocol Violation|0|||
146381580|NCT00804986|527897800|FG000|Overall Study|Withdrawal by Subject|0|||
146381581|NCT00804986|527897801|FG001|Overall Study|Withdrawal by Subject|3|||
146381582|NCT00804986|527897802|FG002|Overall Study|Withdrawal by Subject|0|||
146381583|NCT00804986|527897803|FG003|Overall Study|Withdrawal by Subject|3|||
146381584|NCT00804986|527897804|FG004|Overall Study|Withdrawal by Subject|5|||
146381585|NCT00804986|527897805|FG005|Overall Study|Withdrawal by Subject|3|||
146381586|NCT00804986|527897800|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
146381587|NCT00804986|527897801|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
146381588|NCT00804986|527897802|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
146381589|NCT00804986|527897803|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
146381590|NCT00804986|527897804|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
146381591|NCT00804986|527897805|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
146381592|NCT00804986|527897800|FG000|Overall Study|Sponsor Decision|0|||
146381593|NCT00804986|527897801|FG001|Overall Study|Sponsor Decision|1|||
146381594|NCT00804986|527897802|FG002|Overall Study|Sponsor Decision|0|||
146381595|NCT00804986|527897803|FG003|Overall Study|Sponsor Decision|0|||
146381596|NCT00804986|527897804|FG004|Overall Study|Sponsor Decision|0|||
146381597|NCT00804986|527897805|FG005|Overall Study|Sponsor Decision|0|||
146381598|NCT00804986|527897800|FG000|Overall Study|Physician Decision|1|||
146381599|NCT00804986|527897801|FG001|Overall Study|Physician Decision|0|||
146381600|NCT00804986|527897802|FG002|Overall Study|Physician Decision|0|||
146381601|NCT00804986|527897803|FG003|Overall Study|Physician Decision|0|||
146381602|NCT00804986|527897804|FG004|Overall Study|Physician Decision|0|||
146381603|NCT00804986|527897805|FG005|Overall Study|Physician Decision|0|||
146381604|NCT00959699|527897806|FG000|Treatment Period|Adverse Event|3|||
146381605|NCT00959699|527897807|FG001|Treatment Period|Adverse Event|13|||
146381606|NCT00959699|527897806|FG000|Treatment Period|Lack of Efficacy|15|||
146381607|NCT00959699|527897807|FG001|Treatment Period|Lack of Efficacy|6|||
146381608|NCT00959699|527897806|FG000|Treatment Period|Lost to Follow-up|0|||
146381609|NCT00959699|527897807|FG001|Treatment Period|Lost to Follow-up|1|||
146381610|NCT00959699|527897806|FG000|Treatment Period|Withdrawal by Subject|1|||
146381611|NCT00959699|527897807|FG001|Treatment Period|Withdrawal by Subject|3|||
146381612|NCT00959699|527897806|FG000|Treatment Period|Non-Compliance with Protocol|0|||
146381613|NCT00959699|527897807|FG001|Treatment Period|Non-Compliance with Protocol|1|||
146381614|NCT00959699|527897806|FG000|Treatment Period|Did not receive treatment|0|||
146381615|NCT00959699|527897807|FG001|Treatment Period|Did not receive treatment|1|||
146381616|NCT00959699|527897806|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
146381617|NCT00959699|527897807|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
146381618|NCT00959699|527897806|FG000|Follow-up Period|Lost to Follow-up|3|||
146381619|NCT00959699|527897807|FG001|Follow-up Period|Lost to Follow-up|2|||
146381620|NCT00959699|527897806|FG000|Follow-up Period|Withdrawal by Subject|3|||
146381621|NCT00959699|527897807|FG001|Follow-up Period|Withdrawal by Subject|4|||
146381622|NCT01885104|527897809|FG000|Overall Study|Withdrawal of Consent|1|||
146381623|NCT01885104|527897810|FG001|Overall Study|Withdrawal of Consent|0|||
146381624|NCT01885104|527897809|FG000|Overall Study|Lost to Follow-up|0|||
146381625|NCT01885104|527897810|FG001|Overall Study|Lost to Follow-up|1|||
146381626|NCT01885104|527897809|FG000|Overall Study|Physician Decision|1|||
146381627|NCT01885104|527897810|FG001|Overall Study|Physician Decision|0|||
146381628|NCT00126425|527897813|FG000|Overall Study|Withdrawal by Subject|17|||
146381629|NCT00126425|527897814|FG001|Overall Study|Withdrawal by Subject|1|||
146381630|NCT00126425|527897813|FG000|Overall Study|Lost to Follow-up|8|||
146381631|NCT00126425|527897814|FG001|Overall Study|Lost to Follow-up|4|||
146381632|NCT00126425|527897813|FG000|Overall Study|Protocol Violation|9|||
146381633|NCT00126425|527897814|FG001|Overall Study|Protocol Violation|6|||
146381634|NCT00126425|527897813|FG000|Overall Study|Adverse Event|1|||
146381635|NCT00126425|527897814|FG001|Overall Study|Adverse Event|0|||
146381636|NCT00126425|527897813|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
146381637|NCT00126425|527897814|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
146381638|NCT00126425|527897813|FG000|Overall Study|Other|5|||
146381639|NCT00126425|527897814|FG001|Overall Study|Other|0|||
146381640|NCT01894776|527897815|FG000|Overall Study|Withdrawal by Subject|1|||
146381641|NCT04350372|527897818|FG000|Overall Study|Death|1|||
146381642|NCT02875366|527897819|FG000|Overall Study|Adverse Event|0|||
146381643|NCT02875366|527897820|FG001|Overall Study|Adverse Event|2|||
146381644|NCT02875366|527897819|FG000|Overall Study|Noncompliance|0|||
146381645|NCT02875366|527897820|FG001|Overall Study|Noncompliance|1|||
146381646|NCT00683774|527897821|FG000|Overall Study|Withdrawal by Subject|0|||
146381647|NCT00683774|527897822|FG001|Overall Study|Withdrawal by Subject|1|||
146381648|NCT00683774|527897821|FG000|Overall Study|Physician Decision|3|||
146381649|NCT00683774|527897822|FG001|Overall Study|Physician Decision|0|||
146381650|NCT00691054|527897823|FG000|Overall Study|Withdrawal by Subject|1|||
146381651|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
146381652|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146381653|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146381654|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146381655|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146381656|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
146381657|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
146381658|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146381659|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146381660|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146381661|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146381662|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
146381663|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
146381664|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146381665|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146381666|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146381667|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146381668|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
146381669|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Other|14|||
146381670|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Other|0|||
146381671|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Other|0|||
146381672|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Other|0|||
146381673|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Other|0|||
146381674|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Other|0|||
146395884|NCT02646566|527952399|FG000|Overall Study|Treatment failure|1|||
146381675|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
146381676|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
146381677|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
146381678|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
146381679|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
146381680|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
146381681|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
146381682|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146381683|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146381684|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146381685|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146381686|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
146381687|NCT02141854|527897825|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
146381688|NCT02141854|527897826|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146381689|NCT02141854|527897827|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146381690|NCT02141854|527897828|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146381691|NCT02141854|527897829|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146381692|NCT02141854|527897830|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
146381693|NCT02141854|527897825|FG000|Treatment Period|Protocol Violation|0|||
146381694|NCT02141854|527897826|FG001|Treatment Period|Protocol Violation|1|||
146381695|NCT02141854|527897827|FG002|Treatment Period|Protocol Violation|0|||
146381696|NCT02141854|527897828|FG003|Treatment Period|Protocol Violation|2|||
146381697|NCT02141854|527897829|FG004|Treatment Period|Protocol Violation|2|||
146381698|NCT02141854|527897830|FG005|Treatment Period|Protocol Violation|1|||
146381699|NCT02141854|527897825|FG000|Treatment Period|Noncompliance|0|||
146381700|NCT02141854|527897826|FG001|Treatment Period|Noncompliance|0|||
146381701|NCT02141854|527897827|FG002|Treatment Period|Noncompliance|0|||
146381702|NCT02141854|527897828|FG003|Treatment Period|Noncompliance|1|||
146381703|NCT02141854|527897829|FG004|Treatment Period|Noncompliance|0|||
146381704|NCT02141854|527897830|FG005|Treatment Period|Noncompliance|0|||
146381705|NCT02141854|527897825|FG000|Treatment Period|Lack of Efficacy|0|||
146381706|NCT02141854|527897826|FG001|Treatment Period|Lack of Efficacy|0|||
146381707|NCT02141854|527897827|FG002|Treatment Period|Lack of Efficacy|0|||
146381708|NCT02141854|527897828|FG003|Treatment Period|Lack of Efficacy|1|||
146381709|NCT02141854|527897829|FG004|Treatment Period|Lack of Efficacy|1|||
146381710|NCT02141854|527897830|FG005|Treatment Period|Lack of Efficacy|7|||
146381711|NCT02141854|527897825|FG000|Treatment Period|Pregnancy|0|||
146381712|NCT02141854|527897826|FG001|Treatment Period|Pregnancy|1|||
146381713|NCT02141854|527897827|FG002|Treatment Period|Pregnancy|0|||
146381714|NCT02141854|527897828|FG003|Treatment Period|Pregnancy|0|||
146381715|NCT02141854|527897829|FG004|Treatment Period|Pregnancy|0|||
146381716|NCT02141854|527897830|FG005|Treatment Period|Pregnancy|0|||
146381717|NCT02141854|527897825|FG000|Treatment Period|Other|0|||
146381718|NCT02141854|527897826|FG001|Treatment Period|Other|1|||
146381719|NCT02141854|527897827|FG002|Treatment Period|Other|2|||
146381720|NCT02141854|527897828|FG003|Treatment Period|Other|0|||
146381721|NCT02141854|527897829|FG004|Treatment Period|Other|1|||
146381722|NCT02141854|527897830|FG005|Treatment Period|Other|2|||
146381723|NCT02141854|527897825|FG000|Treatment Period|Adverse Event|0|||
146381724|NCT02141854|527897826|FG001|Treatment Period|Adverse Event|2|||
146381725|NCT02141854|527897827|FG002|Treatment Period|Adverse Event|2|||
146381726|NCT02141854|527897828|FG003|Treatment Period|Adverse Event|0|||
146381727|NCT02141854|527897829|FG004|Treatment Period|Adverse Event|2|||
146381728|NCT02141854|527897830|FG005|Treatment Period|Adverse Event|2|||
146381729|NCT02141854|527897825|FG000|Treatment Period|Withdrawal by Subject|0|||
146381730|NCT02141854|527897826|FG001|Treatment Period|Withdrawal by Subject|2|||
146381731|NCT02141854|527897827|FG002|Treatment Period|Withdrawal by Subject|3|||
146381732|NCT02141854|527897828|FG003|Treatment Period|Withdrawal by Subject|3|||
146381733|NCT02141854|527897829|FG004|Treatment Period|Withdrawal by Subject|4|||
146381734|NCT02141854|527897830|FG005|Treatment Period|Withdrawal by Subject|7|||
146381735|NCT02141854|527897825|FG000|Treatment Period|Disease progression|0|||
146381736|NCT02141854|527897826|FG001|Treatment Period|Disease progression|2|||
146381737|NCT02141854|527897827|FG002|Treatment Period|Disease progression|1|||
146381738|NCT02141854|527897828|FG003|Treatment Period|Disease progression|3|||
146381739|NCT02141854|527897829|FG004|Treatment Period|Disease progression|0|||
146381740|NCT02141854|527897830|FG005|Treatment Period|Disease progression|18|||
146381741|NCT02141854|527897825|FG000|Treatment Period|Lost to Follow-up|0|||
146381742|NCT02141854|527897826|FG001|Treatment Period|Lost to Follow-up|1|||
146381743|NCT02141854|527897827|FG002|Treatment Period|Lost to Follow-up|1|||
146381744|NCT02141854|527897828|FG003|Treatment Period|Lost to Follow-up|1|||
146381745|NCT02141854|527897829|FG004|Treatment Period|Lost to Follow-up|0|||
146381746|NCT02141854|527897830|FG005|Treatment Period|Lost to Follow-up|1|||
146381747|NCT01868594|527897833|FG000|Overall Study|Do not meet inclusion criteria|4|||
146381748|NCT01868594|527897834|FG001|Overall Study|Do not meet inclusion criteria|3|||
146381749|NCT01201967|527897837|FG000|Overall Study|Lost to Follow-up|6|||
146381750|NCT01201967|527897838|FG001|Overall Study|Lost to Follow-up|5|||
146381751|NCT02116361|527897841|FG000|Overall Study|Pregnancy|0|||
146381752|NCT02116361|527897842|FG001|Overall Study|Pregnancy|0|||
146381753|NCT02116361|527897843|FG002|Overall Study|Pregnancy|0|||
146381754|NCT02116361|527897844|FG003|Overall Study|Pregnancy|1|||
146381755|NCT02116361|527897841|FG000|Overall Study|Protocol Violation|1|||
146381756|NCT02116361|527897842|FG001|Overall Study|Protocol Violation|0|||
146381757|NCT02116361|527897843|FG002|Overall Study|Protocol Violation|0|||
146381758|NCT02116361|527897844|FG003|Overall Study|Protocol Violation|2|||
146381759|NCT02116361|527897841|FG000|Overall Study|Physician Decision|2|||
146381760|NCT02116361|527897842|FG001|Overall Study|Physician Decision|3|||
146381761|NCT02116361|527897843|FG002|Overall Study|Physician Decision|0|||
146381762|NCT02116361|527897844|FG003|Overall Study|Physician Decision|0|||
146381763|NCT02116361|527897841|FG000|Overall Study|Adverse Event|1|||
146381764|NCT02116361|527897842|FG001|Overall Study|Adverse Event|0|||
146381765|NCT02116361|527897843|FG002|Overall Study|Adverse Event|0|||
146381766|NCT02116361|527897844|FG003|Overall Study|Adverse Event|3|||
146381767|NCT02116361|527897841|FG000|Overall Study|Other Reasons|3|||
146381768|NCT02116361|527897842|FG001|Overall Study|Other Reasons|3|||
146381769|NCT02116361|527897843|FG002|Overall Study|Other Reasons|3|||
146381770|NCT02116361|527897844|FG003|Overall Study|Other Reasons|3|||
146381771|NCT02116361|527897841|FG000|Overall Study|Lack of Efficacy|5|||
146381772|NCT02116361|527897842|FG001|Overall Study|Lack of Efficacy|7|||
146381773|NCT02116361|527897843|FG002|Overall Study|Lack of Efficacy|4|||
146381774|NCT02116361|527897844|FG003|Overall Study|Lack of Efficacy|3|||
146381775|NCT02116361|527897841|FG000|Overall Study|Lost to Follow-up|4|||
146381776|NCT02116361|527897842|FG001|Overall Study|Lost to Follow-up|5|||
146381777|NCT02116361|527897843|FG002|Overall Study|Lost to Follow-up|7|||
146381778|NCT02116361|527897844|FG003|Overall Study|Lost to Follow-up|5|||
146381779|NCT02116361|527897841|FG000|Overall Study|Personal Reasons|6|||
146381780|NCT02116361|527897842|FG001|Overall Study|Personal Reasons|6|||
146381781|NCT02116361|527897843|FG002|Overall Study|Personal Reasons|4|||
146381782|NCT02116361|527897844|FG003|Overall Study|Personal Reasons|9|||
146381783|NCT02116361|527897841|FG000|Overall Study|Investigator Decision - Relapse|9|||
146381784|NCT02116361|527897842|FG001|Overall Study|Investigator Decision - Relapse|7|||
146381785|NCT02116361|527897843|FG002|Overall Study|Investigator Decision - Relapse|8|||
146381786|NCT02116361|527897844|FG003|Overall Study|Investigator Decision - Relapse|5|||
146381787|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
146381788|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
146381789|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
146381790|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
146381791|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Other|13|||
146381792|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
146381793|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
146381794|NCT02497287|527897845|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
146381795|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
146381796|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
146381797|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
146381798|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
146381799|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
146381800|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
146381801|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
146381802|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
146381803|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
146381804|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
146381805|NCT02497287|527897845|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
146381806|NCT02497287|527897845|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
146381807|NCT02497287|527897845|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
146381808|NCT02497287|527897845|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
146381809|NCT02497287|527897845|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
146381810|NCT02497287|527897845|FG000|Follow-up Phase (4 Week)|Other|1|||
146381811|NCT02659098|527897846|FG000|Overall Study|Withdrawal by Subject|7|||
146381812|NCT04363944|527897847|FG000|Overall Study|Withdrawal by Subject|2|||
146381813|NCT04363944|527897848|FG001|Overall Study|Withdrawal by Subject|0|||
146381814|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
146381815|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
146381816|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Death|0|||
146381817|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Death|4|||
146381818|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
146381819|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
146381820|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
146381821|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
146381822|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
146381823|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
146381824|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
146395885|NCT02646566|527952400|FG001|Overall Study|Treatment failure|0|||
146381825|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
146381826|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
146381827|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
146381828|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Other|4|||
146381829|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Other|3|||
146381830|NCT03517722|527897849|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
146381831|NCT03517722|527897850|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
146381832|NCT03517722|527897849|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
146381833|NCT03517722|527897850|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
146381834|NCT03517722|527897849|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
146381835|NCT03517722|527897850|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
146381836|NCT03517722|527897849|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
146381837|NCT03517722|527897850|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
146381838|NCT03517722|527897849|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
146381839|NCT03517722|527897850|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
146381840|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
146381841|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
146381842|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
146381843|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
146381844|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
146381845|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
146381846|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
146381847|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
146381848|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
146381849|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
146381850|NCT02422186|527897851|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
146381851|NCT02422186|527897852|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
146381852|NCT02422186|527897851|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
146381853|NCT02422186|527897852|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
146381854|NCT02422186|527897851|FG000|Follow-up Phase (2 Weeks)|Other|3|||
146381855|NCT02422186|527897852|FG001|Follow-up Phase (2 Weeks)|Other|0|||
146381856|NCT03074318|527897853|FG000|Overall Study|Adverse Event|0|||
146381857|NCT03074318|527897854|FG001|Overall Study|Adverse Event|1|||
146381858|NCT03074318|527897855|FG002|Overall Study|Adverse Event|1|||
146381859|NCT03074318|527897856|FG003|Overall Study|Adverse Event|1|||
146381860|NCT03074318|527897853|FG000|Overall Study|Death|1|||
146381861|NCT03074318|527897854|FG001|Overall Study|Death|0|||
146381862|NCT03074318|527897855|FG002|Overall Study|Death|0|||
146381863|NCT03074318|527897856|FG003|Overall Study|Death|0|||
146381864|NCT03074318|527897853|FG000|Overall Study|Withdrawal by Subject|1|||
146381865|NCT03074318|527897854|FG001|Overall Study|Withdrawal by Subject|2|||
146381866|NCT03074318|527897855|FG002|Overall Study|Withdrawal by Subject|2|||
146381867|NCT03074318|527897856|FG003|Overall Study|Withdrawal by Subject|4|||
146381868|NCT03074318|527897853|FG000|Overall Study|Trial Closure|2|||
146381869|NCT03074318|527897854|FG001|Overall Study|Trial Closure|2|||
146381870|NCT03074318|527897855|FG002|Overall Study|Trial Closure|3|||
146381871|NCT03074318|527897856|FG003|Overall Study|Trial Closure|11|||
146381872|NCT03573804|527897859|FG000|Overall Study|claustrophobia or MRI table problems|10|||
146381873|NCT00952419|527897860|FG000|Overall Study|Adverse Event|2|||
146381874|NCT00952419|527897861|FG001|Overall Study|Adverse Event|0|||
146381875|NCT00952419|527897862|FG002|Overall Study|Adverse Event|0|||
146381876|NCT00952419|527897860|FG000|Overall Study|Protocol Violation|3|||
146381877|NCT00952419|527897861|FG001|Overall Study|Protocol Violation|7|||
146381878|NCT00952419|527897862|FG002|Overall Study|Protocol Violation|0|||
146381879|NCT00952419|527897860|FG000|Overall Study|Withdrawal by Subject|1|||
146381880|NCT00952419|527897861|FG001|Overall Study|Withdrawal by Subject|3|||
146381881|NCT00952419|527897862|FG002|Overall Study|Withdrawal by Subject|0|||
146381882|NCT01952041|527899363|FG000|Overall Study|Lost to Follow-up|9|||
146381883|NCT01952041|527899364|FG001|Overall Study|Lost to Follow-up|16|||
146381884|NCT01952041|527899363|FG000|Overall Study|Withdrawal by Subject|7|||
146381885|NCT01952041|527899364|FG001|Overall Study|Withdrawal by Subject|5|||
146381886|NCT01952041|527899363|FG000|Overall Study|Death|1|||
146381887|NCT01952041|527899364|FG001|Overall Study|Death|0|||
146381888|NCT01736176|527899365|FG000|Overall Study|Adverse Event|3|||
146381889|NCT01736176|527899365|FG000|Overall Study|Withdrawal by Subject|4|||
146381890|NCT01736176|527899365|FG000|Overall Study|Lack of Efficacy|3|||
146381891|NCT01736176|527899365|FG000|Overall Study|Unable to Complete PEG Placement|1|||
146381892|NCT00186121|527899366|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
146381893|NCT00186121|527899366|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
146381894|NCT00186121|527899366|FG000|Overall Study|Not eligible (no treatment)|1|||
146381895|NCT03650387|527899367|FG000|Overall Study|Withdrawal by Subject|13|||
146381896|NCT03650387|527899367|FG000|Overall Study|Lost to Follow-up|12|||
146381897|NCT03650387|527899367|FG000|Overall Study|Adverse Event (Not related)|1|||
146381898|NCT03650387|527899367|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
146381899|NCT01370499|527899368|FG000|Overall Study|Adverse Event|38|||
146381900|NCT01370499|527899369|FG001|Overall Study|Adverse Event|12|||
146381901|NCT01370499|527899368|FG000|Overall Study|Lack of Efficacy|4|||
146381902|NCT01370499|527899369|FG001|Overall Study|Lack of Efficacy|2|||
146381903|NCT01370499|527899368|FG000|Overall Study|Lost to Follow-up|2|||
146381904|NCT01370499|527899369|FG001|Overall Study|Lost to Follow-up|1|||
146381905|NCT01370499|527899368|FG000|Overall Study|Physician Decision|3|||
146381906|NCT01370499|527899369|FG001|Overall Study|Physician Decision|3|||
146381907|NCT01370499|527899368|FG000|Overall Study|Protocol Violation|5|||
146381908|NCT01370499|527899369|FG001|Overall Study|Protocol Violation|4|||
146381909|NCT01370499|527899368|FG000|Overall Study|Withdrawal by Subject|18|||
146381910|NCT01370499|527899369|FG001|Overall Study|Withdrawal by Subject|7|||
146381911|NCT01370499|527899368|FG000|Overall Study|Sponsor Decision|41|||
146381912|NCT01370499|527899369|FG001|Overall Study|Sponsor Decision|15|||
146381913|NCT00887822|527899370|FG000|Overall Study|Insufficient therapeutic response|53|||
146381914|NCT00887822|527899371|FG001|Overall Study|Insufficient therapeutic response|55|||
146381915|NCT00887822|527899370|FG000|Overall Study|Adverse Event|14|||
146381916|NCT00887822|527899371|FG001|Overall Study|Adverse Event|17|||
146381917|NCT00887822|527899370|FG000|Overall Study|Failure to return|11|||
146381918|NCT00887822|527899371|FG001|Overall Study|Failure to return|11|||
146381919|NCT00887822|527899370|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
146381920|NCT00887822|527899371|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
146381921|NCT00887822|527899370|FG000|Overall Study|Administrative/Other than specified|5|||
146381922|NCT00887822|527899371|FG001|Overall Study|Administrative/Other than specified|4|||
146381923|NCT00887822|527899370|FG000|Overall Study|Death|2|||
146381924|NCT00887822|527899371|FG001|Overall Study|Death|3|||
146381925|NCT00887822|527899370|FG000|Overall Study|Protocol Violation|0|||
146381926|NCT00887822|527899371|FG001|Overall Study|Protocol Violation|1|||
146381927|NCT00887822|527899370|FG000|Overall Study|Randomized but not treated|0|||
146381928|NCT00887822|527899371|FG001|Overall Study|Randomized but not treated|1|||
146381929|NCT05815758|527899372|FG000|Overall Study|Adverse Event|6|||
146381930|NCT05815758|527899373|FG001|Overall Study|Adverse Event|2|||
146381931|NCT05815758|527899372|FG000|Overall Study|Lost to Follow-up|14|||
146381932|NCT05815758|527899373|FG001|Overall Study|Lost to Follow-up|1|||
146381933|NCT05815758|527899372|FG000|Overall Study|Withdrawal by Subject|6|||
146381934|NCT05815758|527899373|FG001|Overall Study|Withdrawal by Subject|6|||
146381935|NCT05815758|527899372|FG000|Overall Study|Protocol Violation|1|||
146381936|NCT05815758|527899373|FG001|Overall Study|Protocol Violation|1|||
146381937|NCT05815758|527899372|FG000|Overall Study|Discontinued|4|||
146381938|NCT05815758|527899373|FG001|Overall Study|Discontinued|4|||
146381939|NCT02881151|527899374|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
146381940|NCT01222767|527899376|FG000|Overall Study|Progressive disease|13|||
146381941|NCT01222767|527899376|FG000|Overall Study|Adverse Event|2|||
146381942|NCT01222767|527899376|FG000|Overall Study|Surgical resection|1|||
146381943|NCT01222767|527899376|FG000|Overall Study|Never treated|1|||
146381944|NCT03258593|527899377|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
146381945|NCT03258593|527899378|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
146381946|NCT03258593|527899379|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
146381947|NCT03258593|527899380|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
146381948|NCT03258593|527899377|FG000|Run-In Maintenance Phase|Disease progression|3|||
146381949|NCT03258593|527899378|FG001|Run-In Maintenance Phase|Disease progression|0|||
146381950|NCT03258593|527899379|FG002|Run-In Maintenance Phase|Disease progression|0|||
146381951|NCT03258593|527899380|FG003|Run-In Maintenance Phase|Disease progression|0|||
146381952|NCT03258593|527899377|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146381953|NCT03258593|527899378|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
146381954|NCT03258593|527899379|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146381955|NCT03258593|527899380|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
146381956|NCT03258593|527899377|FG000|Expansion Maintenance Phase|Physician Decision|0|||
146381957|NCT03258593|527899378|FG001|Expansion Maintenance Phase|Physician Decision|1|||
146381958|NCT03258593|527899379|FG002|Expansion Maintenance Phase|Physician Decision|0|||
146381959|NCT03258593|527899380|FG003|Expansion Maintenance Phase|Physician Decision|0|||
146381960|NCT00723489|527899381|FG000|Overall Study|Physician Decision|0|||
146381961|NCT00723489|527899382|FG001|Overall Study|Physician Decision|1|||
146381962|NCT00723489|527899383|FG002|Overall Study|Physician Decision|0|||
146381963|NCT00723489|527899384|FG003|Overall Study|Physician Decision|0|||
146381964|NCT00723489|527899381|FG000|Overall Study|Pregnancy|0|||
146381965|NCT00723489|527899382|FG001|Overall Study|Pregnancy|0|||
146381966|NCT00723489|527899383|FG002|Overall Study|Pregnancy|0|||
146381967|NCT00723489|527899384|FG003|Overall Study|Pregnancy|1|||
146381968|NCT00723489|527899381|FG000|Overall Study|Withdrawal by Subject|0|||
146381969|NCT00723489|527899382|FG001|Overall Study|Withdrawal by Subject|0|||
146381970|NCT00723489|527899383|FG002|Overall Study|Withdrawal by Subject|0|||
146381971|NCT00723489|527899384|FG003|Overall Study|Withdrawal by Subject|1|||
146381972|NCT00723489|527899381|FG000|Overall Study|Seropositive at baseline|1|||
146381973|NCT00723489|527899382|FG001|Overall Study|Seropositive at baseline|0|||
146381974|NCT00723489|527899383|FG002|Overall Study|Seropositive at baseline|0|||
146381975|NCT00723489|527899384|FG003|Overall Study|Seropositive at baseline|0|||
146381976|NCT00723489|527899381|FG000|Overall Study|Prohibited Medication|0|||
146381977|NCT00723489|527899382|FG001|Overall Study|Prohibited Medication|0|||
146381978|NCT00723489|527899383|FG002|Overall Study|Prohibited Medication|0|||
146381979|NCT00723489|527899384|FG003|Overall Study|Prohibited Medication|1|||
146381980|NCT00723489|527899381|FG000|Overall Study|Samples Collected Out of Window|0|||
146381981|NCT00723489|527899382|FG001|Overall Study|Samples Collected Out of Window|3|||
146381982|NCT00723489|527899383|FG002|Overall Study|Samples Collected Out of Window|0|||
146381983|NCT00723489|527899384|FG003|Overall Study|Samples Collected Out of Window|0|||
146381984|NCT03657576|527899388|FG000|Overall Study|Death|0|||
146381985|NCT03657576|527899389|FG001|Overall Study|Death|1|||
146381986|NCT03657576|527899390|FG002|Overall Study|Death|1|||
146381987|NCT03657576|527899391|FG003|Overall Study|Death|0|||
146381988|NCT03657576|527899392|FG004|Overall Study|Death|0|||
146381989|NCT03657576|527899393|FG005|Overall Study|Death|0|||
146381990|NCT03657576|527899388|FG000|Overall Study|Withdrawal by Subject|0|||
146381991|NCT03657576|527899389|FG001|Overall Study|Withdrawal by Subject|0|||
146381992|NCT03657576|527899390|FG002|Overall Study|Withdrawal by Subject|0|||
146381993|NCT03657576|527899391|FG003|Overall Study|Withdrawal by Subject|1|||
146381994|NCT03657576|527899392|FG004|Overall Study|Withdrawal by Subject|0|||
146381995|NCT03657576|527899393|FG005|Overall Study|Withdrawal by Subject|0|||
146381996|NCT03657576|527899388|FG000|Overall Study|Screen Fail|0|||
146381997|NCT03657576|527899389|FG001|Overall Study|Screen Fail|0|||
146381998|NCT03657576|527899390|FG002|Overall Study|Screen Fail|0|||
146381999|NCT03657576|527899391|FG003|Overall Study|Screen Fail|0|||
146382000|NCT03657576|527899392|FG004|Overall Study|Screen Fail|0|||
146382001|NCT03657576|527899393|FG005|Overall Study|Screen Fail|5|||
146382002|NCT03657576|527899388|FG000|Overall Study|Disease Progression|1|||
146382003|NCT03657576|527899389|FG001|Overall Study|Disease Progression|1|||
146382004|NCT03657576|527899390|FG002|Overall Study|Disease Progression|0|||
146382005|NCT03657576|527899391|FG003|Overall Study|Disease Progression|5|||
146382006|NCT03657576|527899392|FG004|Overall Study|Disease Progression|0|||
146382007|NCT03657576|527899393|FG005|Overall Study|Disease Progression|0|||
146382008|NCT03657576|527899388|FG000|Overall Study|Insurance Coverage|0|||
146382009|NCT03657576|527899389|FG001|Overall Study|Insurance Coverage|0|||
146382010|NCT03657576|527899390|FG002|Overall Study|Insurance Coverage|0|||
146382011|NCT03657576|527899391|FG003|Overall Study|Insurance Coverage|1|||
146382012|NCT03657576|527899392|FG004|Overall Study|Insurance Coverage|0|||
146382013|NCT03657576|527899393|FG005|Overall Study|Insurance Coverage|0|||
146382014|NCT04437511|527899394|FG000|Overall Study|Adverse Event|50|||
146382015|NCT04437511|527899395|FG001|Overall Study|Adverse Event|21|||
146382016|NCT04437511|527899394|FG000|Overall Study|Death|15|||
146382017|NCT04437511|527899395|FG001|Overall Study|Death|10|||
146382018|NCT04437511|527899394|FG000|Overall Study|Lost to Follow-up|11|||
146382019|NCT04437511|527899395|FG001|Overall Study|Lost to Follow-up|11|||
146382020|NCT04437511|527899394|FG000|Overall Study|Physician Decision|19|||
146382021|NCT04437511|527899395|FG001|Overall Study|Physician Decision|10|||
146382022|NCT04437511|527899394|FG000|Overall Study|Progressive Disease|4|||
146382023|NCT04437511|527899395|FG001|Overall Study|Progressive Disease|7|||
146382024|NCT04437511|527899394|FG000|Overall Study|Withdrawal by Subject|111|||
146382025|NCT04437511|527899395|FG001|Overall Study|Withdrawal by Subject|94|||
146382026|NCT04437511|527899394|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
146382027|NCT04437511|527899395|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
146382028|NCT04437511|527899394|FG000|Overall Study|Continuing Study|7|||
146382029|NCT04437511|527899395|FG001|Overall Study|Continuing Study|5|||
146382030|NCT04284787|527899398|FG000|Overall Study|Disease Progression|9|||
146382031|NCT04284787|527899399|FG001|Overall Study|Disease Progression|12|||
146382032|NCT04284787|527899398|FG000|Overall Study|Physician Decision|12|||
146382033|NCT04284787|527899399|FG001|Overall Study|Physician Decision|7|||
146382034|NCT04284787|527899398|FG000|Overall Study|Transplant|5|||
146382035|NCT04284787|527899399|FG001|Overall Study|Transplant|4|||
146382036|NCT04284787|527899398|FG000|Overall Study|Death|1|||
146382037|NCT04284787|527899399|FG001|Overall Study|Death|2|||
146382038|NCT04284787|527899398|FG000|Overall Study|Adverse Event|0|||
146382039|NCT04284787|527899399|FG001|Overall Study|Adverse Event|4|||
146382040|NCT04284787|527899398|FG000|Overall Study|Non-adherence|2|||
146382041|NCT04284787|527899399|FG001|Overall Study|Non-adherence|0|||
146382042|NCT04284787|527899398|FG000|Overall Study|Lack of Efficacy|2|||
146382043|NCT04284787|527899399|FG001|Overall Study|Lack of Efficacy|0|||
146382044|NCT02559115|527899400|FG000|Overall Study|Withdrawal by Subject|3|||
146382045|NCT01996865|527899401|FG000|Induction Period|Protocol Violation|1|||
146382046|NCT01996865|527899402|FG001|Induction Period|Protocol Violation|0|||
146382047|NCT01996865|527899403|FG002|Induction Period|Protocol Violation|0|||
146382048|NCT01996865|527899401|FG000|Induction Period|Progressive Disease|4|||
146382049|NCT01996865|527899402|FG001|Induction Period|Progressive Disease|0|||
146382050|NCT01996865|527899403|FG002|Induction Period|Progressive Disease|0|||
146382051|NCT01996865|527899401|FG000|Induction Period|Lost to Follow-up|10|||
146382052|NCT01996865|527899402|FG001|Induction Period|Lost to Follow-up|0|||
146382053|NCT01996865|527899403|FG002|Induction Period|Lost to Follow-up|0|||
146382054|NCT01996865|527899401|FG000|Induction Period|Other Reasons|13|||
146382055|NCT01996865|527899402|FG001|Induction Period|Other Reasons|0|||
146382056|NCT01996865|527899403|FG002|Induction Period|Other Reasons|0|||
146382057|NCT01996865|527899401|FG000|Induction Period|Adverse Event|20|||
146382058|NCT01996865|527899402|FG001|Induction Period|Adverse Event|0|||
146382059|NCT01996865|527899403|FG002|Induction Period|Adverse Event|0|||
146382060|NCT01996865|527899401|FG000|Induction Period|Withdrawal by Subject|60|||
146382061|NCT01996865|527899402|FG001|Induction Period|Withdrawal by Subject|0|||
146382062|NCT01996865|527899403|FG002|Induction Period|Withdrawal by Subject|0|||
146382063|NCT01996865|527899401|FG000|Induction Period|Death|111|||
146382064|NCT01996865|527899402|FG001|Induction Period|Death|0|||
146382065|NCT01996865|527899403|FG002|Induction Period|Death|0|||
146382066|NCT01996865|527899401|FG000|Maintenance Period|Protocol Violation|0|||
146382067|NCT01996865|527899402|FG001|Maintenance Period|Protocol Violation|1|||
146382068|NCT01996865|527899403|FG002|Maintenance Period|Protocol Violation|1|||
146382069|NCT01996865|527899401|FG000|Maintenance Period|Other reasons|0|||
146382070|NCT01996865|527899402|FG001|Maintenance Period|Other reasons|8|||
146382071|NCT01996865|527899403|FG002|Maintenance Period|Other reasons|5|||
146382072|NCT01996865|527899401|FG000|Maintenance Period|Progressive Disease|0|||
146382073|NCT01996865|527899402|FG001|Maintenance Period|Progressive Disease|6|||
146382074|NCT01996865|527899403|FG002|Maintenance Period|Progressive Disease|23|||
146382075|NCT01996865|527899401|FG000|Maintenance Period|Withdrawal by Subject|0|||
146382076|NCT01996865|527899402|FG001|Maintenance Period|Withdrawal by Subject|18|||
146382077|NCT01996865|527899403|FG002|Maintenance Period|Withdrawal by Subject|4|||
146382078|NCT01996865|527899401|FG000|Maintenance Period|Adverse Event|0|||
146382079|NCT01996865|527899402|FG001|Maintenance Period|Adverse Event|7|||
146382080|NCT01996865|527899403|FG002|Maintenance Period|Adverse Event|7|||
146382081|NCT01996865|527899401|FG000|Maintenance Period|Death|0|||
146382082|NCT01996865|527899402|FG001|Maintenance Period|Death|15|||
146382083|NCT01996865|527899403|FG002|Maintenance Period|Death|3|||
146382084|NCT01996865|527899401|FG000|Maintenance Period|Lost to Follow-up|0|||
146382085|NCT01996865|527899402|FG001|Maintenance Period|Lost to Follow-up|2|||
146382086|NCT01996865|527899403|FG002|Maintenance Period|Lost to Follow-up|0|||
146382087|NCT02354690|527899410|FG000|Overall Study|Physician Decision|1|||
146382088|NCT00515099|527899415|FG000|Overall Study|Lost to Follow-up|0|||
146382089|NCT00515099|527899416|FG001|Overall Study|Lost to Follow-up|4|||
146382090|NCT00515099|527899415|FG000|Overall Study|Withdrawal by Subject|2|||
146382091|NCT00515099|527899416|FG001|Overall Study|Withdrawal by Subject|0|||
146382092|NCT00515099|527899415|FG000|Overall Study|IRB Recommendation|1|||
146382093|NCT00515099|527899416|FG001|Overall Study|IRB Recommendation|0|||
146382094|NCT00592072|527899417|FG000|Wash Out Period|Lost to Follow-up|1|||
146382095|NCT00592072|527899418|FG001|Wash Out Period|Lost to Follow-up|1|||
146382096|NCT03369704|527899419|FG000|Treatment Epoch|technical problems|1|||
146382097|NCT03369704|527899420|FG001|Treatment Epoch|technical problems|0|||
146382098|NCT03369704|527899419|FG000|Treatment Epoch|Protocol Violation|1|||
146382099|NCT03369704|527899420|FG001|Treatment Epoch|Protocol Violation|0|||
146382100|NCT03369704|527899419|FG000|Treatment Epoch|Lost to Follow-up|0|||
146382101|NCT03369704|527899420|FG001|Treatment Epoch|Lost to Follow-up|1|||
146382102|NCT03369704|527899419|FG000|Treatment Epoch|Lack of Efficacy|0|||
146382103|NCT03369704|527899420|FG001|Treatment Epoch|Lack of Efficacy|2|||
146382104|NCT03369704|527899419|FG000|Treatment Epoch|Adverse Event|2|||
146382105|NCT03369704|527899420|FG001|Treatment Epoch|Adverse Event|0|||
146382106|NCT03369704|527899419|FG000|Follow-up Epoch|Lost to Follow-up|1|||
146382107|NCT03369704|527899420|FG001|Follow-up Epoch|Lost to Follow-up|0|||
146382108|NCT05333289|527899422|FG000|Overall Study|Other|1|||
146382109|NCT05333289|527899423|FG001|Overall Study|Other|0|||
146382110|NCT05333289|527899424|FG002|Overall Study|Other|0|||
146382111|NCT05333289|527899425|FG003|Overall Study|Other|1|||
146382112|NCT05333289|527899426|FG004|Overall Study|Other|1|||
146382113|NCT05333289|527899427|FG005|Overall Study|Other|2|||
146382114|NCT05333289|527899428|FG006|Overall Study|Other|2|||
146382115|NCT05333289|527899429|FG007|Overall Study|Other|0|||
146382116|NCT05333289|527899422|FG000|Overall Study|Withdrawal by Subject|1|||
146382117|NCT05333289|527899423|FG001|Overall Study|Withdrawal by Subject|2|||
146382118|NCT05333289|527899424|FG002|Overall Study|Withdrawal by Subject|2|||
146382119|NCT05333289|527899425|FG003|Overall Study|Withdrawal by Subject|1|||
146382120|NCT05333289|527899426|FG004|Overall Study|Withdrawal by Subject|1|||
146382121|NCT05333289|527899427|FG005|Overall Study|Withdrawal by Subject|2|||
146382122|NCT05333289|527899428|FG006|Overall Study|Withdrawal by Subject|1|||
146382123|NCT05333289|527899429|FG007|Overall Study|Withdrawal by Subject|3|||
146382124|NCT05333289|527899422|FG000|Overall Study|Protocol Violation|1|||
146382125|NCT05333289|527899423|FG001|Overall Study|Protocol Violation|0|||
146382126|NCT05333289|527899424|FG002|Overall Study|Protocol Violation|0|||
146382127|NCT05333289|527899425|FG003|Overall Study|Protocol Violation|0|||
146382128|NCT05333289|527899426|FG004|Overall Study|Protocol Violation|0|||
146382129|NCT05333289|527899427|FG005|Overall Study|Protocol Violation|0|||
146382130|NCT05333289|527899428|FG006|Overall Study|Protocol Violation|0|||
146382131|NCT05333289|527899429|FG007|Overall Study|Protocol Violation|0|||
146382132|NCT05333289|527899422|FG000|Overall Study|Physician Decision|0|||
146382133|NCT05333289|527899423|FG001|Overall Study|Physician Decision|0|||
146382134|NCT05333289|527899424|FG002|Overall Study|Physician Decision|1|||
146382135|NCT05333289|527899425|FG003|Overall Study|Physician Decision|0|||
146382136|NCT05333289|527899426|FG004|Overall Study|Physician Decision|0|||
146382137|NCT05333289|527899427|FG005|Overall Study|Physician Decision|2|||
146382138|NCT05333289|527899428|FG006|Overall Study|Physician Decision|0|||
146382139|NCT05333289|527899429|FG007|Overall Study|Physician Decision|0|||
146382140|NCT05333289|527899422|FG000|Overall Study|Lost to Follow-up|6|||
146382141|NCT05333289|527899423|FG001|Overall Study|Lost to Follow-up|0|||
146382142|NCT05333289|527899424|FG002|Overall Study|Lost to Follow-up|1|||
146382143|NCT05333289|527899425|FG003|Overall Study|Lost to Follow-up|6|||
146382144|NCT05333289|527899426|FG004|Overall Study|Lost to Follow-up|3|||
146382145|NCT05333289|527899427|FG005|Overall Study|Lost to Follow-up|3|||
146382146|NCT05333289|527899428|FG006|Overall Study|Lost to Follow-up|2|||
146382147|NCT05333289|527899429|FG007|Overall Study|Lost to Follow-up|1|||
146382148|NCT05333289|527899422|FG000|Overall Study|Death|1|||
146382149|NCT05333289|527899423|FG001|Overall Study|Death|0|||
146382150|NCT05333289|527899424|FG002|Overall Study|Death|0|||
146382151|NCT05333289|527899425|FG003|Overall Study|Death|0|||
146382152|NCT05333289|527899426|FG004|Overall Study|Death|0|||
146382153|NCT05333289|527899427|FG005|Overall Study|Death|0|||
146382154|NCT05333289|527899428|FG006|Overall Study|Death|0|||
146382155|NCT05333289|527899429|FG007|Overall Study|Death|0|||
146382156|NCT02750501|527899430|FG000|Overall Study|Adverse Event|4|||
146382157|NCT02750501|527899430|FG000|Overall Study|Physician Decision|1|||
146382158|NCT02750501|527899430|FG000|Overall Study|Protocol Violation|1|||
146382159|NCT02750501|527899430|FG000|Overall Study|G-tube came out|1|||
146382160|NCT02750501|527899430|FG000|Overall Study|Non-compliant use of PERT|1|||
146382161|NCT03685643|527899431|FG000|Overall Study|Lost to Follow-up|14|||
146382162|NCT03685643|527899432|FG001|Overall Study|Lost to Follow-up|22|||
146382163|NCT03797144|527899433|FG000|Enrollment|Protocol Violation|4|||
146382164|NCT03797144|527899434|FG001|Enrollment|Protocol Violation|1|||
146382165|NCT03797144|527899433|FG000|Surgery|Protocol Violation|1|||
146382166|NCT03797144|527899434|FG001|Surgery|Protocol Violation|0|||
146382167|NCT03797144|527899433|FG000|3 Month|Early termination cut-off date|2|||
146382168|NCT03797144|527899434|FG001|3 Month|Early termination cut-off date|0|||
146382169|NCT03797144|527899433|FG000|12 Month|Early termination cut-off date|8|||
146382170|NCT03797144|527899434|FG001|12 Month|Early termination cut-off date|9|||
146382171|NCT03797144|527899433|FG000|24 Month|Early termination cut-off date|1|||
146382172|NCT03797144|527899434|FG001|24 Month|Early termination cut-off date|1|||
146382173|NCT04430036|527899435|FG000|Safety Run in Phase|Progression of disease|2|||
146382174|NCT00376675|527899436|FG000|Overall Study|Withdrawal by Subject|9|||
146382175|NCT00376675|527899437|FG001|Overall Study|Withdrawal by Subject|2|||
146382176|NCT00376675|527899436|FG000|Overall Study|Adverse Event|10|||
146382177|NCT00376675|527899437|FG001|Overall Study|Adverse Event|5|||
146382178|NCT00376675|527899436|FG000|Overall Study|Other Reason|1|||
146382179|NCT00376675|527899437|FG001|Overall Study|Other Reason|7|||
146382180|NCT00423592|527899445|FG000|Overall Study|Adverse Event (through Week 12)|2|||
146382181|NCT00423592|527899445|FG000|Overall Study|Adverse Event (post Week 12)|5|||
146382182|NCT00255008|527899450|FG000|Overall Study|Adverse Event|1|||
146382183|NCT00255008|527899451|FG001|Overall Study|Adverse Event|1|||
146382184|NCT00255008|527899452|FG002|Overall Study|Adverse Event|2|||
146382185|NCT00255008|527899453|FG003|Overall Study|Adverse Event|0|||
146382186|NCT00255008|527899450|FG000|Overall Study|Lost to Follow-up|1|||
146382187|NCT00255008|527899451|FG001|Overall Study|Lost to Follow-up|0|||
146382188|NCT00255008|527899452|FG002|Overall Study|Lost to Follow-up|1|||
146382189|NCT00255008|527899453|FG003|Overall Study|Lost to Follow-up|2|||
146382190|NCT00255008|527899450|FG000|Overall Study|Did not meet viral reduction criteria|4|||
146382191|NCT00255008|527899451|FG001|Overall Study|Did not meet viral reduction criteria|5|||
146382192|NCT00255008|527899452|FG002|Overall Study|Did not meet viral reduction criteria|0|||
146382193|NCT00255008|527899453|FG003|Overall Study|Did not meet viral reduction criteria|1|||
146382194|NCT00255008|527899450|FG000|Overall Study|Withdrew consent|0|||
146382195|NCT00255008|527899451|FG001|Overall Study|Withdrew consent|0|||
146382196|NCT00255008|527899452|FG002|Overall Study|Withdrew consent|2|||
146382197|NCT00255008|527899453|FG003|Overall Study|Withdrew consent|0|||
146382198|NCT00255008|527899450|FG000|Overall Study|Sponsor request|18|||
146382199|NCT00255008|527899451|FG001|Overall Study|Sponsor request|3|||
146382200|NCT00255008|527899452|FG002|Overall Study|Sponsor request|8|||
146382201|NCT00255008|527899453|FG003|Overall Study|Sponsor request|17|||
146382202|NCT00255008|527899450|FG000|Overall Study|Adverse lab experience|1|||
146382203|NCT00255008|527899451|FG001|Overall Study|Adverse lab experience|0|||
146382204|NCT00255008|527899452|FG002|Overall Study|Adverse lab experience|0|||
146382205|NCT00255008|527899453|FG003|Overall Study|Adverse lab experience|0|||
146382206|NCT00255008|527899450|FG000|Overall Study|Other|7|||
146382207|NCT00255008|527899451|FG001|Overall Study|Other|0|||
146382208|NCT00255008|527899452|FG002|Overall Study|Other|3|||
146382209|NCT00255008|527899453|FG003|Overall Study|Other|2|||
146382210|NCT03457636|527899457|FG000|Overall Study|Lost to Follow-up|2|||
146382211|NCT01833806|527899458|FG000|Overall Study|Alternative treatment|2|||
146382212|NCT01833806|527899458|FG000|Overall Study|Death|5|||
146382213|NCT01833806|527899458|FG000|Overall Study|Physician Decision|1|||
146382214|NCT01833806|527899458|FG000|Overall Study|Lost to Follow-up|1|||
146382215|NCT05083949|527899459|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
146382216|NCT05083949|527899460|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
146382217|NCT05083949|527899459|FG000|Period 1|Adverse Event|1|||
146382218|NCT05083949|527899460|FG001|Period 1|Adverse Event|1|||
146382219|NCT05083949|527899459|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
146382220|NCT05083949|527899460|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
146382221|NCT05083949|527899459|FG000|Period 2|Adverse Event|0|||
146382222|NCT05083949|527899460|FG001|Period 2|Adverse Event|2|||
146382223|NCT00707486|527899463|FG000|Overall Study|Withdrawal by Subject|1|||
146382224|NCT04474366|527899474|FG000|Overall Study|Lost to Follow-up|2|||
146382225|NCT04474366|527899475|FG001|Overall Study|Lost to Follow-up|5|||
146382226|NCT00320190|527899476|FG000|First 12 Months|Completed but did not enter extension|5|||
146382227|NCT00320190|527899477|FG001|First 12 Months|Completed but did not enter extension|3|||
146382228|NCT00320190|527899476|FG000|First 12 Months|Sponsor terminated study|2|||
146382229|NCT00320190|527899477|FG001|First 12 Months|Sponsor terminated study|2|||
146382230|NCT00320190|527899476|FG000|First 12 Months|Lost to Follow-up|0|||
146382231|NCT00320190|527899477|FG001|First 12 Months|Lost to Follow-up|1|||
146382232|NCT00320190|527899476|FG000|First 12 Months|Enrollment failure|0|||
146382233|NCT00320190|527899477|FG001|First 12 Months|Enrollment failure|1|||
146382234|NCT00320190|527899476|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
146382235|NCT00320190|527899477|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
146382236|NCT00320190|527899476|FG000|First 12 Months|Investigator request|0|||
146382237|NCT00320190|527899477|FG001|First 12 Months|Investigator request|1|||
146382238|NCT00320190|527899476|FG000|First 12 Months|Study drug toxicity|0|||
146382239|NCT00320190|527899477|FG001|First 12 Months|Study drug toxicity|1|||
146382240|NCT00320190|527899476|FG000|First 12 Months|Withdrawal by Subject|0|||
146382241|NCT00320190|527899477|FG001|First 12 Months|Withdrawal by Subject|1|||
146382242|NCT00320190|527899476|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
146382243|NCT00320190|527899477|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
146382244|NCT00320190|527899476|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
146382245|NCT00320190|527899477|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
146382246|NCT00320190|527899476|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
146382247|NCT00320190|527899477|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
146382248|NCT05307523|527899479|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
146382249|NCT05307523|527899480|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
146382250|NCT05307523|527899479|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
146382251|NCT05307523|527899480|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
146382252|NCT03858686|527899483|FG000|Period 1|Adverse Event|1|||
146382253|NCT03858686|527899484|FG001|Period 1|Adverse Event|1|||
146382254|NCT03858686|527899483|FG000|Period 1|Lack of compliance|0|||
146382255|NCT03858686|527899484|FG001|Period 1|Lack of compliance|1|||
146382256|NCT03858686|527899483|FG000|Period 1|Adverse Event|0|||
146382257|NCT03858686|527899484|FG001|Period 1|Adverse Event|1|||
146382258|NCT03858686|527899483|FG000|Period 2|Adverse Event|0|||
146382259|NCT03858686|527899484|FG001|Period 2|Adverse Event|1|||
146382260|NCT00102804|527899485|FG000|Overall Study|Progressive Disease (PD)|307|||
146382261|NCT00102804|527899486|FG001|Overall Study|Progressive Disease (PD)|196|||
146382262|NCT00102804|527899485|FG000|Overall Study|Withdrawal by Subject|46|||
146382263|NCT00102804|527899486|FG001|Overall Study|Withdrawal by Subject|7|||
146382264|NCT00102804|527899485|FG000|Overall Study|Adverse Event|37|||
146382265|NCT00102804|527899486|FG001|Overall Study|Adverse Event|3|||
146382266|NCT00102804|527899485|FG000|Overall Study|Physician Decision|24|||
146382267|NCT00102804|527899486|FG001|Overall Study|Physician Decision|6|||
146382268|NCT00102804|527899485|FG000|Overall Study|Death|5|||
146382269|NCT00102804|527899486|FG001|Overall Study|Death|6|||
146382270|NCT00102804|527899485|FG000|Overall Study|Enrollment Criteria Not Met|6|||
146382271|NCT00102804|527899486|FG001|Overall Study|Enrollment Criteria Not Met|0|||
146382272|NCT00102804|527899485|FG000|Overall Study|Lost to Follow-up|4|||
146382273|NCT00102804|527899486|FG001|Overall Study|Lost to Follow-up|1|||
146382274|NCT00102804|527899485|FG000|Overall Study|Protocol Violation|2|||
146382275|NCT00102804|527899486|FG001|Overall Study|Protocol Violation|1|||
146382276|NCT00102804|527899485|FG000|Overall Study|Satisfactory Response|2|||
146382277|NCT00102804|527899486|FG001|Overall Study|Satisfactory Response|0|||
146382278|NCT00102804|527899485|FG000|Overall Study|Sponsor Decision|1|||
146382279|NCT00102804|527899486|FG001|Overall Study|Sponsor Decision|0|||
146382280|NCT00102804|527899485|FG000|Overall Study|Alive, Receiving Treatment|7|||
146382281|NCT00102804|527899486|FG001|Overall Study|Alive, Receiving Treatment|2|||
146382282|NCT04412668|527899487|FG000|Overall Study|Death - multiple comorbidities|2|||
146382283|NCT04412668|527899488|FG001|Overall Study|Death - multiple comorbidities|0|||
146382284|NCT04412668|527899489|FG002|Overall Study|Death - multiple comorbidities|0|||
146382285|NCT04412668|527899487|FG000|Overall Study|Withdrawal by Subject|3|||
146382286|NCT04412668|527899488|FG001|Overall Study|Withdrawal by Subject|0|||
146382287|NCT04412668|527899489|FG002|Overall Study|Withdrawal by Subject|0|||
146382288|NCT04412668|527899487|FG000|Overall Study|Other than Specified|2|||
146382289|NCT04412668|527899488|FG001|Overall Study|Other than Specified|0|||
146382290|NCT04412668|527899489|FG002|Overall Study|Other than Specified|0|||
146382291|NCT02299206|527899496|FG000|Overall Study|Lost to Follow-up|1|||
146382292|NCT02299206|527899496|FG000|Overall Study|Withdrawal by Subject|1|||
146382293|NCT03128307|527899498|FG000|Overall Study|Lost to Follow-up|29|||
146382294|NCT03128307|527899498|FG000|Overall Study|Withdrawal by Subject|5|||
146382295|NCT01592773|527900830|FG000|Overall Study|Study Terminated by Sponsor|582|||
146382296|NCT01592773|527900830|FG000|Overall Study|Withdrawal by Subject|35|||
146382297|NCT01592773|527900830|FG000|Overall Study|Lost to Follow-up|19|||
146382298|NCT01592773|527900830|FG000|Overall Study|Adverse Event|17|||
146382299|NCT01592773|527900830|FG000|Overall Study|Lack of Efficacy|9|||
146382300|NCT01592773|527900830|FG000|Overall Study|Protocol Violation|2|||
146382301|NCT01592773|527900830|FG000|Overall Study|Inclusion/exclusion not meet|1|||
146382302|NCT01592773|527900830|FG000|Overall Study|Other Reason|1|||
146382303|NCT04418427|527900831|FG000|Overall Study|Death|0|||
146382304|NCT04418427|527900832|FG001|Overall Study|Death|1|||
146382305|NCT04418427|527900833|FG002|Overall Study|Death|0|||
146382306|NCT04418427|527900831|FG000|Overall Study|Lost to Follow-up|0|||
146382307|NCT04418427|527900832|FG001|Overall Study|Lost to Follow-up|2|||
146382308|NCT04418427|527900833|FG002|Overall Study|Lost to Follow-up|2|||
146382309|NCT04418427|527900831|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
146382310|NCT04418427|527900832|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
146382311|NCT04418427|527900833|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
146382312|NCT04418427|527900831|FG000|Overall Study|Pre-existing medical condition|0|||
146382313|NCT04418427|527900832|FG001|Overall Study|Pre-existing medical condition|1|||
146382314|NCT04418427|527900833|FG002|Overall Study|Pre-existing medical condition|0|||
146382315|NCT01293123|527900834|FG000|Overall Study|Lost to Follow-up|0|||
146382316|NCT01293123|527900835|FG001|Overall Study|Lost to Follow-up|1|||
146382317|NCT00121485|527900836|FG000|Overall Study|Not implanted|1|||
146382318|NCT00121485|527900837|FG001|Overall Study|Not implanted|5|||
146382319|NCT00121485|527900836|FG000|Overall Study|Crossover|0|||
146382320|NCT00121485|527900837|FG001|Overall Study|Crossover|2|||
146382321|NCT01888965|527900844|FG000|Overall Study|Adverse Event|5|||
146382322|NCT01888965|527900844|FG000|Overall Study|Lack of Efficacy|4|||
146382323|NCT04076579|527900845|FG000|Overall Study|Adverse Event|2|||
146382324|NCT04076579|527900846|FG001|Overall Study|Adverse Event|0|||
146382325|NCT04076579|527900845|FG000|Overall Study|discontinued due to toxicity|1|||
146382326|NCT04076579|527900846|FG001|Overall Study|discontinued due to toxicity|0|||
146382327|NCT04076579|527900845|FG000|Overall Study|Physician Decision|1|||
146382328|NCT04076579|527900846|FG001|Overall Study|Physician Decision|0|||
146382329|NCT04076579|527900845|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
146382330|NCT04076579|527900846|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
146382331|NCT04076579|527900845|FG000|Overall Study|Noncompliance|0|||
146382332|NCT04076579|527900846|FG001|Overall Study|Noncompliance|1|||
146382333|NCT04076579|527900845|FG000|Overall Study|Withdrawal by Subject|0|||
146382334|NCT04076579|527900846|FG001|Overall Study|Withdrawal by Subject|2|||
146382335|NCT00908895|527900847|FG000|Overall Study|Lost to Follow-up|1|||
146382336|NCT00908895|527900848|FG001|Overall Study|Lost to Follow-up|3|||
146382337|NCT00908895|527900847|FG000|Overall Study|algodystrophy|2|||
146382338|NCT00908895|527900848|FG001|Overall Study|algodystrophy|2|||
146382339|NCT00908895|527900847|FG000|Overall Study|Adverse Event|1|||
146382340|NCT00908895|527900848|FG001|Overall Study|Adverse Event|1|||
146382341|NCT03793010|527900849|FG000|Overall Study|Withdrawal by Subject|5|||
146382342|NCT03793010|527900850|FG001|Overall Study|Withdrawal by Subject|7|||
146382343|NCT03793010|527900849|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
146382344|NCT03793010|527900850|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
146382345|NCT03793010|527900849|FG000|Overall Study|Lost to Follow-up|1|||
146382346|NCT03793010|527900850|FG001|Overall Study|Lost to Follow-up|2|||
146382347|NCT03793010|527900849|FG000|Overall Study|Patient couldn't sit still for injection|1|||
146382348|NCT03793010|527900850|FG001|Overall Study|Patient couldn't sit still for injection|0|||
146382349|NCT03793010|527900849|FG000|Overall Study|Withdrew to pursue other treatment|1|||
146382350|NCT03793010|527900850|FG001|Overall Study|Withdrew to pursue other treatment|0|||
146382351|NCT03793010|527900849|FG000|Overall Study|Did not meet eligibility criteria|1|||
146382352|NCT03793010|527900850|FG001|Overall Study|Did not meet eligibility criteria|0|||
146382353|NCT02608099|527900853|FG000|Overall Study|Ablation procedure not initiated|3|||
146382354|NCT02608099|527900854|FG001|Overall Study|Ablation procedure not initiated|2|||
146382355|NCT00417248|527900858|FG000|Overall Study|Study Terminated|6|||
146382356|NCT00417248|527900858|FG000|Overall Study|Death|1|||
146382357|NCT00417248|527900858|FG000|Overall Study|Lack of Efficacy|1|||
146382358|NCT01569568|527900859|FG000|Overall Study|Physician Decision|0|||
146382359|NCT01569568|527900860|FG001|Overall Study|Physician Decision|2|||
146382360|NCT00934791|527900861|FG000|Overall Study|Withdrawal by Subject|1|||
146382361|NCT00934791|527900862|FG001|Overall Study|Withdrawal by Subject|0|||
146382362|NCT02425891|527900864|FG000|Overall Study|Death|333|||
146382363|NCT02425891|527900865|FG001|Overall Study|Death|314|||
146382364|NCT02425891|527900864|FG000|Overall Study|Lost to Follow-up|4|||
146382365|NCT02425891|527900865|FG001|Overall Study|Lost to Follow-up|6|||
146382366|NCT02425891|527900864|FG000|Overall Study|Non-Compliance|1|||
146382367|NCT02425891|527900865|FG001|Overall Study|Non-Compliance|1|||
146382368|NCT02425891|527900864|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
146382369|NCT02425891|527900865|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
146382370|NCT02425891|527900864|FG000|Overall Study|Physician Decision|0|||
146382371|NCT02425891|527900865|FG001|Overall Study|Physician Decision|1|||
146382372|NCT02425891|527900864|FG000|Overall Study|Protocol Violation|1|||
146382373|NCT02425891|527900865|FG001|Overall Study|Protocol Violation|1|||
146382374|NCT02425891|527900864|FG000|Overall Study|Study Terminated By Sponsor|85|||
146382375|NCT02425891|527900865|FG001|Overall Study|Study Terminated By Sponsor|95|||
146382376|NCT02425891|527900864|FG000|Overall Study|Withdrawal by Subject|27|||
146382377|NCT02425891|527900865|FG001|Overall Study|Withdrawal by Subject|32|||
146382378|NCT04124952|527900866|FG000|Overall Study|Lost to Follow-up|1|||
146382379|NCT00166504|527900868|FG000|Overall Study|Adverse Event|3|||
146382380|NCT00166504|527900869|FG001|Overall Study|Adverse Event|3|||
146382381|NCT00166504|527900868|FG000|Overall Study|Lost to Follow-up|1|||
146382382|NCT00166504|527900869|FG001|Overall Study|Lost to Follow-up|1|||
146382383|NCT00166504|527900868|FG000|Overall Study|Withdrawal by Subject|1|||
146382384|NCT00166504|527900869|FG001|Overall Study|Withdrawal by Subject|0|||
146382385|NCT03261037|527900872|FG000|Overall Study|Withdrawal by Subject|2|||
146382386|NCT03261037|527900873|FG001|Overall Study|Withdrawal by Subject|13|||
146382387|NCT03261037|527900874|FG002|Overall Study|Withdrawal by Subject|0|||
146382388|NCT03261037|527900875|FG003|Overall Study|Withdrawal by Subject|18|||
146382389|NCT03261037|527900872|FG000|Overall Study|Non-compliance with study procedures|0|||
146382390|NCT03261037|527900873|FG001|Overall Study|Non-compliance with study procedures|2|||
146382391|NCT03261037|527900874|FG002|Overall Study|Non-compliance with study procedures|0|||
146382392|NCT03261037|527900875|FG003|Overall Study|Non-compliance with study procedures|6|||
146382393|NCT03261037|527900872|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
146382394|NCT03261037|527900873|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
146382395|NCT03261037|527900874|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
146382396|NCT03261037|527900875|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
146382397|NCT03261037|527900872|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
146382398|NCT03261037|527900873|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
146382399|NCT03261037|527900874|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
146382400|NCT03261037|527900875|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
146382401|NCT03261037|527900872|FG000|Overall Study|Diagnosed but protocol deviation|1|||
146382402|NCT03261037|527900873|FG001|Overall Study|Diagnosed but protocol deviation|0|||
146382403|NCT03261037|527900874|FG002|Overall Study|Diagnosed but protocol deviation|0|||
146382404|NCT03261037|527900875|FG003|Overall Study|Diagnosed but protocol deviation|0|||
146382405|NCT03261037|527900872|FG000|Overall Study|Participant did not want to continue the study|0|||
146382406|NCT03261037|527900873|FG001|Overall Study|Participant did not want to continue the study|1|||
146382407|NCT03261037|527900874|FG002|Overall Study|Participant did not want to continue the study|0|||
146382408|NCT03261037|527900875|FG003|Overall Study|Participant did not want to continue the study|0|||
146382409|NCT03261037|527900872|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146382410|NCT03261037|527900873|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146382411|NCT03261037|527900874|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
146382412|NCT03261037|527900875|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
146382413|NCT03261037|527900872|FG000|Overall Study|Participant presented clinical improvement|0|||
146382414|NCT03261037|527900873|FG001|Overall Study|Participant presented clinical improvement|2|||
146382415|NCT03261037|527900874|FG002|Overall Study|Participant presented clinical improvement|0|||
146382416|NCT03261037|527900875|FG003|Overall Study|Participant presented clinical improvement|0|||
146382417|NCT03261037|527900872|FG000|Overall Study|Technical difficulties|0|||
146382418|NCT03261037|527900873|FG001|Overall Study|Technical difficulties|0|||
146382419|NCT03261037|527900874|FG002|Overall Study|Technical difficulties|0|||
146382420|NCT03261037|527900875|FG003|Overall Study|Technical difficulties|1|||
146382421|NCT03261037|527900872|FG000|Overall Study|Equipment failed to work|0|||
146382422|NCT03261037|527900873|FG001|Overall Study|Equipment failed to work|0|||
146382423|NCT03261037|527900874|FG002|Overall Study|Equipment failed to work|0|||
146382424|NCT03261037|527900875|FG003|Overall Study|Equipment failed to work|1|||
146382425|NCT03261037|527900872|FG000|Overall Study|End of study for participant and no follow up|0|||
146382426|NCT03261037|527900873|FG001|Overall Study|End of study for participant and no follow up|0|||
146382427|NCT03261037|527900874|FG002|Overall Study|End of study for participant and no follow up|0|||
146382428|NCT03261037|527900875|FG003|Overall Study|End of study for participant and no follow up|1|||
146382429|NCT03261037|527900872|FG000|Overall Study|Participant was too weak to continue in study|1|||
146382430|NCT03261037|527900873|FG001|Overall Study|Participant was too weak to continue in study|0|||
146382431|NCT03261037|527900874|FG002|Overall Study|Participant was too weak to continue in study|0|||
146382432|NCT03261037|527900875|FG003|Overall Study|Participant was too weak to continue in study|0|||
146382433|NCT01944462|527900880|FG000|PPPP Educational Program|Lost to Follow-up|60|||
146382434|NCT05298774|527900883|FG000|Overall Study|Physician Decision|3|||
146382435|NCT05298774|527900883|FG000|Overall Study|Withdrawal by Subject|2|||
146382436|NCT05298774|527900883|FG000|Overall Study|Lost to Follow-up|3|||
146382437|NCT05298774|527900883|FG000|Overall Study|Screen failure|1|||
146382438|NCT00081263|527900885|FG000|Overall Study|clerical error|1|||
146382439|NCT00081263|527900886|FG001|Overall Study|clerical error|0|||
146382440|NCT00081263|527900885|FG000|Overall Study|wrong cell type|7|||
146382441|NCT00081263|527900886|FG001|Overall Study|wrong cell type|5|||
146382442|NCT00081263|527900885|FG000|Overall Study|improper pre-protocol therapy|0|||
146382443|NCT00081263|527900886|FG001|Overall Study|improper pre-protocol therapy|1|||
146382444|NCT00081263|527900885|FG000|Overall Study|Inadequate pathology|0|||
146382445|NCT00081263|527900886|FG001|Overall Study|Inadequate pathology|1|||
146382446|NCT00081263|527900885|FG000|Overall Study|Never treated|4|||
146382447|NCT00081263|527900886|FG001|Overall Study|Never treated|5|||
146382448|NCT00081263|527900885|FG000|Overall Study|Inadequate data|5|||
146382449|NCT00081263|527900886|FG001|Overall Study|Inadequate data|10|||
146382450|NCT01267955|527900887|FG000|Stage 1 (6 Months)|Death|3|||
146382451|NCT01267955|527900887|FG000|Stage 2 (6 Months)|Death|5|||
146382452|NCT01267955|527900887|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
146382453|NCT03662789|527900888|FG000|Overall Study|Lost to Follow-up|1|||
146382454|NCT03662789|527900889|FG001|Overall Study|Lost to Follow-up|2|||
146382455|NCT03662789|527900888|FG000|Overall Study|Could not perform treadmill test|4|||
146382456|NCT03662789|527900889|FG001|Overall Study|Could not perform treadmill test|4|||
146382457|NCT03662789|527900888|FG000|Overall Study|Death|0|||
146382458|NCT03662789|527900889|FG001|Overall Study|Death|1|||
146382459|NCT03598140|527900890|FG000|Overall Study|enrolled but didn't start|1|||
146382460|NCT03598140|527900891|FG001|Overall Study|enrolled but didn't start|0|||
146382461|NCT05304611|527900892|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382462|NCT05304611|527900893|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382463|NCT05304611|527900894|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382464|NCT05304611|527900895|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382465|NCT05304611|527900896|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382466|NCT05304611|527900897|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382467|NCT05304611|527900898|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
146382468|NCT05304611|527900899|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382469|NCT05304611|527900900|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
146382470|NCT05304611|527900901|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382471|NCT05304611|527900902|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382472|NCT05304611|527900903|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
146382473|NCT05304611|527900892|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
146382474|NCT05304611|527900893|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
146382475|NCT05304611|527900894|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
146382476|NCT05304611|527900895|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
146382477|NCT05304611|527900896|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
146382478|NCT05304611|527900897|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
146382479|NCT05304611|527900898|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
146382480|NCT05304611|527900899|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
146382481|NCT05304611|527900900|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
146382482|NCT05304611|527900901|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
146382483|NCT05304611|527900902|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
146382484|NCT05304611|527900903|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
146382485|NCT05304611|527900892|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
146382486|NCT05304611|527900893|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
146382487|NCT05304611|527900894|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
146382488|NCT05304611|527900895|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
146382489|NCT05304611|527900896|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
146382490|NCT05304611|527900897|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
146382491|NCT05304611|527900898|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
146382492|NCT05304611|527900899|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
146382493|NCT05304611|527900900|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
146382494|NCT05304611|527900901|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
146382495|NCT05304611|527900902|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
146382496|NCT05304611|527900903|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
146382497|NCT00963820|527900904|FG000|Dose Escalation Phase|Progressive Disease|3|||
146382498|NCT00963820|527900905|FG001|Dose Escalation Phase|Progressive Disease|3|||
146382499|NCT00963820|527900906|FG002|Dose Escalation Phase|Progressive Disease|3|||
146382500|NCT00963820|527900907|FG003|Dose Escalation Phase|Progressive Disease|3|||
146382501|NCT00963820|527900908|FG004|Dose Escalation Phase|Progressive Disease|4|||
146382502|NCT00963820|527900909|FG005|Dose Escalation Phase|Progressive Disease|3|||
146382503|NCT00963820|527900910|FG006|Dose Escalation Phase|Progressive Disease|3|||
146382504|NCT00963820|527900911|FG007|Dose Escalation Phase|Progressive Disease|2|||
146382505|NCT00963820|527900912|FG008|Dose Escalation Phase|Progressive Disease|0|||
146382506|NCT00963820|527900913|FG009|Dose Escalation Phase|Progressive Disease|0|||
146382507|NCT00963820|527900914|FG010|Dose Escalation Phase|Progressive Disease|0|||
146382508|NCT00963820|527900915|FG011|Dose Escalation Phase|Progressive Disease|0|||
146382509|NCT00963820|527900904|FG000|Dose Escalation Phase|Adverse Event|0|||
146382510|NCT00963820|527900905|FG001|Dose Escalation Phase|Adverse Event|0|||
146382511|NCT00963820|527900906|FG002|Dose Escalation Phase|Adverse Event|0|||
146382512|NCT00963820|527900907|FG003|Dose Escalation Phase|Adverse Event|0|||
146382513|NCT00963820|527900908|FG004|Dose Escalation Phase|Adverse Event|0|||
146382514|NCT00963820|527900909|FG005|Dose Escalation Phase|Adverse Event|0|||
146382515|NCT00963820|527900910|FG006|Dose Escalation Phase|Adverse Event|3|||
146382516|NCT00963820|527900911|FG007|Dose Escalation Phase|Adverse Event|1|||
146382517|NCT00963820|527900912|FG008|Dose Escalation Phase|Adverse Event|0|||
146382518|NCT00963820|527900913|FG009|Dose Escalation Phase|Adverse Event|0|||
146382519|NCT00963820|527900914|FG010|Dose Escalation Phase|Adverse Event|0|||
146382520|NCT00963820|527900915|FG011|Dose Escalation Phase|Adverse Event|0|||
146382521|NCT00963820|527900904|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
146382522|NCT00963820|527900905|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
146382523|NCT00963820|527900906|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
146382524|NCT00963820|527900907|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
146382525|NCT00963820|527900908|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
146382526|NCT00963820|527900909|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
146382527|NCT00963820|527900910|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
146382528|NCT00963820|527900911|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
146382529|NCT00963820|527900912|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
146382530|NCT00963820|527900913|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
146382531|NCT00963820|527900914|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
146382532|NCT00963820|527900915|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
146382533|NCT00963820|527900904|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382534|NCT00963820|527900905|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382535|NCT00963820|527900906|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382536|NCT00963820|527900907|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382537|NCT00963820|527900908|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382538|NCT00963820|527900909|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382539|NCT00963820|527900910|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
146382540|NCT00963820|527900911|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382541|NCT00963820|527900912|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382542|NCT00963820|527900913|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382543|NCT00963820|527900914|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382544|NCT00963820|527900915|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
146382545|NCT00963820|527900904|FG000|Expansion Phase|Progressive Disease|0|||
146382546|NCT00963820|527900905|FG001|Expansion Phase|Progressive Disease|0|||
146382547|NCT00963820|527900906|FG002|Expansion Phase|Progressive Disease|0|||
146382548|NCT00963820|527900907|FG003|Expansion Phase|Progressive Disease|0|||
146382549|NCT00963820|527900908|FG004|Expansion Phase|Progressive Disease|0|||
146382550|NCT00963820|527900909|FG005|Expansion Phase|Progressive Disease|0|||
146382551|NCT00963820|527900910|FG006|Expansion Phase|Progressive Disease|0|||
146382552|NCT00963820|527900911|FG007|Expansion Phase|Progressive Disease|0|||
146382553|NCT00963820|527900912|FG008|Expansion Phase|Progressive Disease|8|||
146382554|NCT00963820|527900913|FG009|Expansion Phase|Progressive Disease|6|||
146382555|NCT00963820|527900914|FG010|Expansion Phase|Progressive Disease|4|||
146382556|NCT00963820|527900915|FG011|Expansion Phase|Progressive Disease|2|||
146382557|NCT00963820|527900904|FG000|Expansion Phase|Adverse Event|0|||
146382558|NCT00963820|527900905|FG001|Expansion Phase|Adverse Event|0|||
146382559|NCT00963820|527900906|FG002|Expansion Phase|Adverse Event|0|||
146382560|NCT00963820|527900907|FG003|Expansion Phase|Adverse Event|0|||
146382561|NCT00963820|527900908|FG004|Expansion Phase|Adverse Event|0|||
146382562|NCT00963820|527900909|FG005|Expansion Phase|Adverse Event|0|||
146382563|NCT00963820|527900910|FG006|Expansion Phase|Adverse Event|0|||
146382564|NCT00963820|527900911|FG007|Expansion Phase|Adverse Event|0|||
146382565|NCT00963820|527900912|FG008|Expansion Phase|Adverse Event|1|||
146382566|NCT00963820|527900913|FG009|Expansion Phase|Adverse Event|3|||
146382567|NCT00963820|527900914|FG010|Expansion Phase|Adverse Event|0|||
146382568|NCT00963820|527900915|FG011|Expansion Phase|Adverse Event|0|||
146382569|NCT00963820|527900904|FG000|Expansion Phase|Withdrawal by Subject|0|||
146382570|NCT00963820|527900905|FG001|Expansion Phase|Withdrawal by Subject|0|||
146382571|NCT00963820|527900906|FG002|Expansion Phase|Withdrawal by Subject|0|||
146382572|NCT00963820|527900907|FG003|Expansion Phase|Withdrawal by Subject|0|||
146382573|NCT00963820|527900908|FG004|Expansion Phase|Withdrawal by Subject|0|||
146382574|NCT00963820|527900909|FG005|Expansion Phase|Withdrawal by Subject|0|||
146382575|NCT00963820|527900910|FG006|Expansion Phase|Withdrawal by Subject|0|||
146382576|NCT00963820|527900911|FG007|Expansion Phase|Withdrawal by Subject|0|||
146382577|NCT00963820|527900912|FG008|Expansion Phase|Withdrawal by Subject|1|||
146382578|NCT00963820|527900913|FG009|Expansion Phase|Withdrawal by Subject|0|||
146382579|NCT00963820|527900914|FG010|Expansion Phase|Withdrawal by Subject|1|||
146382580|NCT00963820|527900915|FG011|Expansion Phase|Withdrawal by Subject|1|||
146382581|NCT00963820|527900904|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382582|NCT00963820|527900905|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382583|NCT00963820|527900906|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382584|NCT00963820|527900907|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382585|NCT00963820|527900908|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382586|NCT00963820|527900909|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382587|NCT00963820|527900910|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382588|NCT00963820|527900911|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382589|NCT00963820|527900912|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382590|NCT00963820|527900913|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382591|NCT00963820|527900914|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
146382592|NCT00963820|527900915|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
146382593|NCT04556175|527900919|FG000|Overall Study|Study terminated due to COVID-19|8|||
146382594|NCT04556175|527900920|FG001|Overall Study|Study terminated due to COVID-19|8|||
146382595|NCT05549505|527900922|FG000|Overall Study|Lost to Follow-up|2|||
146382596|NCT05549505|527900923|FG001|Overall Study|Lost to Follow-up|0|||
146382597|NCT05549505|527900922|FG000|Overall Study|Withdrawal by Subject|3|||
146382598|NCT05549505|527900923|FG001|Overall Study|Withdrawal by Subject|3|||
146382599|NCT05549505|527900922|FG000|Overall Study|Other: Miscellaneous|3|||
146382600|NCT05549505|527900923|FG001|Overall Study|Other: Miscellaneous|6|||
146382601|NCT05492877|527900926|FG000|Overall Study|Adverse Event|11|||
146382602|NCT05492877|527900927|FG001|Overall Study|Adverse Event|7|||
146382603|NCT05492877|527900926|FG000|Overall Study|Death|1|||
146382604|NCT05492877|527900927|FG001|Overall Study|Death|0|||
146382605|NCT05492877|527900926|FG000|Overall Study|Lost to Follow-up|1|||
146382606|NCT05492877|527900927|FG001|Overall Study|Lost to Follow-up|1|||
146382607|NCT05492877|527900926|FG000|Overall Study|Physician Decision|1|||
146382608|NCT05492877|527900927|FG001|Overall Study|Physician Decision|2|||
146382609|NCT05492877|527900926|FG000|Overall Study|Protocol Violation|1|||
146382610|NCT05492877|527900927|FG001|Overall Study|Protocol Violation|1|||
146382611|NCT05492877|527900926|FG000|Overall Study|Withdrawal by Subject|3|||
146382612|NCT05492877|527900927|FG001|Overall Study|Withdrawal by Subject|7|||
146382613|NCT05492877|527900926|FG000|Overall Study|Reason not specified|6|||
146382614|NCT05492877|527900927|FG001|Overall Study|Reason not specified|4|||
146382615|NCT01842334|527900929|FG000|Overall Study|Withdrawal by Subject|3|||
146382616|NCT01842334|527900930|FG001|Overall Study|Withdrawal by Subject|3|||
146382617|NCT01842334|527900929|FG000|Overall Study|Moved away mid-study|0|||
146382618|NCT01842334|527900930|FG001|Overall Study|Moved away mid-study|1|||
146382619|NCT00942422|527900931|FG000|Overall Study|Withdrawal by Subject|1|||
146382620|NCT00942422|527900931|FG000|Overall Study|Death|1|||
146382621|NCT00942422|527900931|FG000|Overall Study|Progressive diease|1|||
146382622|NCT02943668|527900932|FG000|Overall Study|Disease Progression|1|||
146382623|NCT00572728|527900937|FG000|Overall Study|Withdrawal by Subject|10|||
146382624|NCT00572728|527900937|FG000|Overall Study|Ineligible|3|||
146382625|NCT00572728|527900937|FG000|Overall Study|Enrolled under Amendment 4|5|||
146382626|NCT00572728|527900937|FG000|Overall Study|Offstudy due to complicating disease|1|||
146382627|NCT00572728|527900937|FG000|Overall Study|FLT1 not completed|4|||
146382628|NCT00572728|527900937|FG000|Overall Study|First Chemotherapy not initiated|2|||
146382629|NCT00572728|527900937|FG000|Overall Study|FLT2 not completed|5|||
146382630|NCT00572728|527900937|FG000|Overall Study|Second chemotherapy not initiated|1|||
146382631|NCT00572728|527900937|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
146382632|NCT00572728|527900937|FG000|Overall Study|Pathology missing|1|||
146382633|NCT00002981|527900938|FG000|Overall Study|Inevaluable|6|||
146382634|NCT02724111|527900939|FG000|Overall Study|Protocol Violation|2|||
146382635|NCT02724111|527900940|FG001|Overall Study|Protocol Violation|5|||
146382636|NCT02996500|527900941|FG000|Overall Study|Adverse Event|1|||
146382637|NCT02996500|527900942|FG001|Overall Study|Adverse Event|1|||
146382638|NCT02996500|527900943|FG002|Overall Study|Adverse Event|4|||
146382639|NCT02996500|527900944|FG003|Overall Study|Adverse Event|3|||
146382640|NCT02996500|527900945|FG004|Overall Study|Adverse Event|1|||
146382641|NCT02996500|527900946|FG005|Overall Study|Adverse Event|2|||
146382642|NCT02996500|527900941|FG000|Overall Study|Lack of Efficacy|0|||
146382643|NCT02996500|527900942|FG001|Overall Study|Lack of Efficacy|0|||
146382644|NCT02996500|527900943|FG002|Overall Study|Lack of Efficacy|0|||
146382645|NCT02996500|527900944|FG003|Overall Study|Lack of Efficacy|0|||
146382646|NCT02996500|527900945|FG004|Overall Study|Lack of Efficacy|2|||
146382647|NCT02996500|527900946|FG005|Overall Study|Lack of Efficacy|0|||
146382648|NCT02996500|527900941|FG000|Overall Study|Lost to Follow-up|1|||
146056253|NCT00549640|526721157|FG001|Overall Study|Adverse Event|0|||
146382649|NCT02996500|527900942|FG001|Overall Study|Lost to Follow-up|0|||
146382650|NCT02996500|527900943|FG002|Overall Study|Lost to Follow-up|0|||
146382651|NCT02996500|527900944|FG003|Overall Study|Lost to Follow-up|0|||
146382652|NCT02996500|527900945|FG004|Overall Study|Lost to Follow-up|0|||
146382653|NCT02996500|527900946|FG005|Overall Study|Lost to Follow-up|1|||
146382654|NCT02996500|527900941|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
146382655|NCT02996500|527900942|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
146382656|NCT02996500|527900943|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
146382657|NCT02996500|527900944|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
146382658|NCT02996500|527900945|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
146382659|NCT02996500|527900946|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
146382660|NCT02996500|527900941|FG000|Overall Study|Non-Compliance With Study Drug|0|||
146382661|NCT02996500|527900942|FG001|Overall Study|Non-Compliance With Study Drug|0|||
146382662|NCT02996500|527900943|FG002|Overall Study|Non-Compliance With Study Drug|0|||
146382663|NCT02996500|527900944|FG003|Overall Study|Non-Compliance With Study Drug|0|||
146382664|NCT02996500|527900945|FG004|Overall Study|Non-Compliance With Study Drug|0|||
146382665|NCT02996500|527900946|FG005|Overall Study|Non-Compliance With Study Drug|1|||
146382666|NCT02996500|527900941|FG000|Overall Study|Progressive Disease|1|||
146382667|NCT02996500|527900942|FG001|Overall Study|Progressive Disease|0|||
146382668|NCT02996500|527900943|FG002|Overall Study|Progressive Disease|0|||
146382669|NCT02996500|527900944|FG003|Overall Study|Progressive Disease|0|||
146382670|NCT02996500|527900945|FG004|Overall Study|Progressive Disease|0|||
146382671|NCT02996500|527900946|FG005|Overall Study|Progressive Disease|0|||
146382672|NCT02996500|527900941|FG000|Overall Study|Other|2|||
146382673|NCT02996500|527900942|FG001|Overall Study|Other|0|||
146382674|NCT02996500|527900943|FG002|Overall Study|Other|2|||
146382675|NCT02996500|527900944|FG003|Overall Study|Other|0|||
146382676|NCT02996500|527900945|FG004|Overall Study|Other|0|||
146382677|NCT02996500|527900946|FG005|Overall Study|Other|0|||
146382678|NCT02996500|527900941|FG000|Overall Study|Protocol Violation|0|||
146382679|NCT02996500|527900942|FG001|Overall Study|Protocol Violation|0|||
146382680|NCT02996500|527900943|FG002|Overall Study|Protocol Violation|0|||
146382681|NCT02996500|527900944|FG003|Overall Study|Protocol Violation|1|||
146382682|NCT02996500|527900945|FG004|Overall Study|Protocol Violation|0|||
146382683|NCT02996500|527900946|FG005|Overall Study|Protocol Violation|0|||
146382684|NCT02996500|527900941|FG000|Overall Study|Withdrawal by Subject|3|||
146382685|NCT02996500|527900942|FG001|Overall Study|Withdrawal by Subject|0|||
146382686|NCT02996500|527900943|FG002|Overall Study|Withdrawal by Subject|3|||
146382687|NCT02996500|527900944|FG003|Overall Study|Withdrawal by Subject|0|||
146382688|NCT02996500|527900945|FG004|Overall Study|Withdrawal by Subject|2|||
146382689|NCT02996500|527900946|FG005|Overall Study|Withdrawal by Subject|0|||
146382690|NCT00322387|527900950|FG000|Treatment Period|Adverse Event|0|||
146382691|NCT00322387|527900951|FG001|Treatment Period|Adverse Event|1|||
146382692|NCT00322387|527900950|FG000|Follow-up Period|Final assessment not done|1|||
146382693|NCT00322387|527900951|FG001|Follow-up Period|Final assessment not done|3|||
146382694|NCT00322387|527900950|FG000|Follow-up Period|Death|1|||
146382695|NCT00322387|527900951|FG001|Follow-up Period|Death|0|||
146382696|NCT01855919|527902738|FG000|Overall Study|Adverse Event|16|||
146382697|NCT01855919|527902739|FG001|Overall Study|Adverse Event|8|||
146382698|NCT01855919|527902738|FG000|Overall Study|Lack of Efficacy|1|||
146382699|NCT01855919|527902739|FG001|Overall Study|Lack of Efficacy|3|||
146382700|NCT01855919|527902738|FG000|Overall Study|Withdrawal by Subject|4|||
146382701|NCT01855919|527902739|FG001|Overall Study|Withdrawal by Subject|10|||
146382702|NCT01855919|527902738|FG000|Overall Study|Entry Criteria Not Met|1|||
146382703|NCT01855919|527902739|FG001|Overall Study|Entry Criteria Not Met|1|||
146382704|NCT01855919|527902738|FG000|Overall Study|Protocol Violation|1|||
146382705|NCT01855919|527902739|FG001|Overall Study|Protocol Violation|4|||
146382706|NCT03455530|527902740|FG000|Overall Study|Withdrawal by Subject|9|||
146382707|NCT03455530|527902741|FG001|Overall Study|Withdrawal by Subject|1|||
146382708|NCT03455530|527902742|FG002|Overall Study|Withdrawal by Subject|3|||
146382709|NCT03455530|527902743|FG003|Overall Study|Withdrawal by Subject|3|||
146382710|NCT00740116|527902749|FG000|Overall Study|Withdrawal by Subject|1|||
146382711|NCT00740116|527902750|FG001|Overall Study|Withdrawal by Subject|1|||
146382712|NCT00740116|527902749|FG000|Overall Study|Protocol Violation|1|||
146382713|NCT00740116|527902750|FG001|Overall Study|Protocol Violation|4|||
146382714|NCT01997892|527902751|FG000|Overall Study|Physician Decision|2|||
146382715|NCT01997892|527902751|FG000|Overall Study|Lost to Follow-up|6|||
146382716|NCT01997892|527902751|FG000|Overall Study|Death|14|||
146382717|NCT01997892|527902751|FG000|Overall Study|Renal transplant|8|||
146382718|NCT01997892|527902751|FG000|Overall Study|Other|3|||
146382719|NCT01997892|527902751|FG000|Overall Study|Study completion data not recorded|35|||
146382720|NCT02710422|527902752|FG000|Overall Study|Termination of study|9|||
146382721|NCT02710422|527902753|FG001|Overall Study|Termination of study|9|||
146382722|NCT01654224|527902773|FG000|Overall Study|Lost to Follow-up|2|||
146382723|NCT01654224|527902774|FG001|Overall Study|Lost to Follow-up|2|||
146382724|NCT01654224|527902773|FG000|Overall Study|Did not receive allocation|1|||
146382725|NCT01654224|527902774|FG001|Overall Study|Did not receive allocation|8|||
146382726|NCT01654224|527902773|FG000|Overall Study|Insufficient blood sample|3|||
146382727|NCT01654224|527902774|FG001|Overall Study|Insufficient blood sample|2|||
146382728|NCT03763942|527902775|FG000|Overall Study|Lost to Follow-up|114|||
146382729|NCT03763942|527902776|FG001|Overall Study|Lost to Follow-up|54|||
146382730|NCT03763942|527902775|FG000|Overall Study|Protocol Violation|1|||
146382731|NCT03763942|527902776|FG001|Overall Study|Protocol Violation|0|||
146382732|NCT03763942|527902775|FG000|Overall Study|Withdrawal by Subject|2|||
146382733|NCT03763942|527902776|FG001|Overall Study|Withdrawal by Subject|0|||
146382734|NCT03763942|527902775|FG000|Overall Study|Other|2|||
146382735|NCT03763942|527902776|FG001|Overall Study|Other|3|||
146382736|NCT02145429|527902777|FG000|Overall Study|Death|4|||
146382737|NCT02145429|527902778|FG001|Overall Study|Death|5|||
146382738|NCT02145429|527902777|FG000|Overall Study|Lost to Follow-up|4|||
146382739|NCT02145429|527902778|FG001|Overall Study|Lost to Follow-up|3|||
146382740|NCT02145429|527902777|FG000|Overall Study|Withdrawal by Subject|8|||
146382741|NCT02145429|527902778|FG001|Overall Study|Withdrawal by Subject|3|||
146382742|NCT02200510|527902779|FG000|Overall Study|Death|1|||
146382743|NCT02200510|527902780|FG001|Overall Study|Death|1|||
146382744|NCT02200510|527902779|FG000|Overall Study|Protocol Violation|0|||
146382745|NCT02200510|527902780|FG001|Overall Study|Protocol Violation|1|||
146382746|NCT02200510|527902779|FG000|Overall Study|Lost to Follow-up|7|||
146382747|NCT02200510|527902780|FG001|Overall Study|Lost to Follow-up|1|||
146382748|NCT02200510|527902779|FG000|Overall Study|potential COI - joined study team|1|||
146382749|NCT02200510|527902780|FG001|Overall Study|potential COI - joined study team|0|||
146382750|NCT03345849|527902781|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
146382751|NCT03345849|527902782|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
146382752|NCT03345849|527902783|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
146382753|NCT03345849|527902784|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
146382754|NCT03345849|527902781|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
146382755|NCT03345849|527902782|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
146382756|NCT03345849|527902783|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
146382757|NCT03345849|527902784|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
146382758|NCT03345849|527902781|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146382759|NCT03345849|527902782|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
146382760|NCT03345849|527902783|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146382761|NCT03345849|527902784|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
146382762|NCT03345849|527902781|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
146382763|NCT03345849|527902782|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
146382764|NCT03345849|527902783|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
146382765|NCT03345849|527902784|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
146382766|NCT03345849|527902781|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146382767|NCT03345849|527902782|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
146382768|NCT03345849|527902783|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146382769|NCT03345849|527902784|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
146382770|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
146382771|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
146382772|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
146382773|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
146382774|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
146382775|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
146382776|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
146382777|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
146382778|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
146382779|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
146382780|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
146382781|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
146382782|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146382783|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146382784|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
146382785|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
146382786|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146382787|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146382788|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
146382789|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
146382790|NCT03345849|527902781|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
146382791|NCT03345849|527902782|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
146382792|NCT03345849|527902783|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
146382793|NCT03345849|527902784|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
146382794|NCT02943577|527902785|FG000|Overall Study|Protocol Violation|0|||
146382795|NCT02943577|527902786|FG001|Overall Study|Protocol Violation|1|||
146382796|NCT02943577|527902785|FG000|Overall Study|Adverse Event|3|||
146382797|NCT02943577|527902786|FG001|Overall Study|Adverse Event|2|||
146382798|NCT02943577|527902785|FG000|Overall Study|Lost to Follow-up|0|||
146382799|NCT02943577|527902786|FG001|Overall Study|Lost to Follow-up|1|||
146382800|NCT02943577|527902785|FG000|Overall Study|Withdrawal by Subject|1|||
146382801|NCT02943577|527902786|FG001|Overall Study|Withdrawal by Subject|1|||
146382802|NCT02943577|527902785|FG000|Overall Study|Pregnancy|1|||
146382803|NCT02943577|527902786|FG001|Overall Study|Pregnancy|0|||
146382804|NCT00939055|527902791|FG000|Overall Study|Discontinuation prior to procedure|4|||
146382805|NCT00939055|527902792|FG001|Overall Study|Discontinuation prior to procedure|0|||
146382806|NCT00584987|527902793|FG000|Overall Study|Protocol Violation|1|||
146382807|NCT00584987|527902794|FG001|Overall Study|Protocol Violation|1|||
146382808|NCT00584987|527902795|FG002|Overall Study|Protocol Violation|1|||
146382809|NCT00584987|527902796|FG003|Overall Study|Protocol Violation|0|||
146382810|NCT00584987|527902793|FG000|Overall Study|Adverse Event|0|||
146382811|NCT00584987|527902794|FG001|Overall Study|Adverse Event|0|||
146382812|NCT00584987|527902795|FG002|Overall Study|Adverse Event|0|||
146382813|NCT00584987|527902796|FG003|Overall Study|Adverse Event|1|||
146382814|NCT02274311|527902800|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
146382815|NCT04564027|527902805|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
146382816|NCT04564027|527902806|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
146382817|NCT04564027|527902807|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
146382818|NCT04564027|527902808|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
146382819|NCT05827978|527902811|FG000|Overall Study|Adverse Event|1|||
146382820|NCT05827978|527902812|FG001|Overall Study|Adverse Event|0|||
146382821|NCT05827978|527902813|FG002|Overall Study|Adverse Event|0|||
146382822|NCT05827978|527902814|FG003|Overall Study|Adverse Event|1|||
146382823|NCT05827978|527902815|FG004|Overall Study|Adverse Event|0|||
146382824|NCT05827978|527902816|FG005|Overall Study|Adverse Event|0|||
146382825|NCT05827978|527902811|FG000|Overall Study|Death|1|||
146382826|NCT05827978|527902812|FG001|Overall Study|Death|5|||
146382827|NCT05827978|527902813|FG002|Overall Study|Death|2|||
146382828|NCT05827978|527902814|FG003|Overall Study|Death|3|||
146382829|NCT05827978|527902815|FG004|Overall Study|Death|1|||
146382830|NCT05827978|527902816|FG005|Overall Study|Death|3|||
146382831|NCT05827978|527902811|FG000|Overall Study|Lost to Follow-up|57|||
146382832|NCT05827978|527902812|FG001|Overall Study|Lost to Follow-up|88|||
146382833|NCT05827978|527902813|FG002|Overall Study|Lost to Follow-up|54|||
146382834|NCT05827978|527902814|FG003|Overall Study|Lost to Follow-up|47|||
146382835|NCT05827978|527902815|FG004|Overall Study|Lost to Follow-up|25|||
146382836|NCT05827978|527902816|FG005|Overall Study|Lost to Follow-up|10|||
146382837|NCT05827978|527902811|FG000|Overall Study|Noncompliance with Study Procedures|0|||
146382838|NCT05827978|527902812|FG001|Overall Study|Noncompliance with Study Procedures|1|||
146382839|NCT05827978|527902813|FG002|Overall Study|Noncompliance with Study Procedures|1|||
146382840|NCT05827978|527902814|FG003|Overall Study|Noncompliance with Study Procedures|1|||
146382841|NCT05827978|527902815|FG004|Overall Study|Noncompliance with Study Procedures|1|||
146382842|NCT05827978|527902816|FG005|Overall Study|Noncompliance with Study Procedures|0|||
146382843|NCT05827978|527902811|FG000|Overall Study|Physician Decision|2|||
146382844|NCT05827978|527902812|FG001|Overall Study|Physician Decision|0|||
146382845|NCT05827978|527902813|FG002|Overall Study|Physician Decision|1|||
146382846|NCT05827978|527902814|FG003|Overall Study|Physician Decision|2|||
146382847|NCT05827978|527902815|FG004|Overall Study|Physician Decision|1|||
146382848|NCT05827978|527902816|FG005|Overall Study|Physician Decision|1|||
146382849|NCT05827978|527902811|FG000|Overall Study|Protocol Violation|5|||
146382850|NCT05827978|527902812|FG001|Overall Study|Protocol Violation|2|||
146382851|NCT05827978|527902813|FG002|Overall Study|Protocol Violation|0|||
146382852|NCT05827978|527902814|FG003|Overall Study|Protocol Violation|0|||
146382853|NCT05827978|527902815|FG004|Overall Study|Protocol Violation|0|||
146382854|NCT05827978|527902816|FG005|Overall Study|Protocol Violation|0|||
146382855|NCT05827978|527902811|FG000|Overall Study|Withdrawal by Subject|17|||
146382856|NCT05827978|527902812|FG001|Overall Study|Withdrawal by Subject|16|||
146382857|NCT05827978|527902813|FG002|Overall Study|Withdrawal by Subject|10|||
146382858|NCT05827978|527902814|FG003|Overall Study|Withdrawal by Subject|12|||
146382859|NCT05827978|527902815|FG004|Overall Study|Withdrawal by Subject|10|||
146382860|NCT05827978|527902816|FG005|Overall Study|Withdrawal by Subject|9|||
146382861|NCT05827978|527902811|FG000|Overall Study|Other Than Specified|0|||
146382862|NCT05827978|527902812|FG001|Overall Study|Other Than Specified|0|||
146382863|NCT05827978|527902813|FG002|Overall Study|Other Than Specified|1|||
146382864|NCT05827978|527902814|FG003|Overall Study|Other Than Specified|0|||
146382865|NCT05827978|527902815|FG004|Overall Study|Other Than Specified|2|||
146382866|NCT05827978|527902816|FG005|Overall Study|Other Than Specified|0|||
146382867|NCT05564039|527902817|FG000|Overall Study|Adverse Event|1|||
146382868|NCT05564039|527902818|FG001|Overall Study|Adverse Event|0|||
146382869|NCT05564039|527902817|FG000|Overall Study|Death|1|||
146382870|NCT05564039|527902818|FG001|Overall Study|Death|1|||
146382871|NCT05564039|527902817|FG000|Overall Study|Lost to Follow-up|3|||
146382872|NCT05564039|527902818|FG001|Overall Study|Lost to Follow-up|2|||
146382873|NCT05564039|527902817|FG000|Overall Study|Withdrawal by Subject|2|||
146382874|NCT05564039|527902818|FG001|Overall Study|Withdrawal by Subject|0|||
146382875|NCT05564039|527902817|FG000|Overall Study|Inadvertent enrollment|3|||
146382876|NCT05564039|527902818|FG001|Overall Study|Inadvertent enrollment|6|||
146382877|NCT04785144|527902819|FG000|Overall Study|Withdrawal by Subject|4|||
146382878|NCT04785144|527902820|FG001|Overall Study|Withdrawal by Subject|1|||
146382879|NCT04785144|527902821|FG002|Overall Study|Withdrawal by Subject|0|||
146382880|NCT04785144|527902822|FG003|Overall Study|Withdrawal by Subject|0|||
146382881|NCT04785144|527902823|FG004|Overall Study|Withdrawal by Subject|0|||
146382882|NCT04785144|527902824|FG005|Overall Study|Withdrawal by Subject|2|||
146382883|NCT04785144|527902825|FG006|Overall Study|Withdrawal by Subject|2|||
146382884|NCT04785144|527902826|FG007|Overall Study|Withdrawal by Subject|0|||
146382885|NCT04785144|527902827|FG008|Overall Study|Withdrawal by Subject|1|||
146382886|NCT04785144|527902828|FG009|Overall Study|Withdrawal by Subject|0|||
146382887|NCT04785144|527902819|FG000|Overall Study|Lost to Follow-up|1|||
146382888|NCT04785144|527902820|FG001|Overall Study|Lost to Follow-up|0|||
146382889|NCT04785144|527902821|FG002|Overall Study|Lost to Follow-up|0|||
146382890|NCT04785144|527902822|FG003|Overall Study|Lost to Follow-up|0|||
146382891|NCT04785144|527902823|FG004|Overall Study|Lost to Follow-up|1|||
146382892|NCT04785144|527902824|FG005|Overall Study|Lost to Follow-up|2|||
146382893|NCT04785144|527902825|FG006|Overall Study|Lost to Follow-up|1|||
146382894|NCT04785144|527902826|FG007|Overall Study|Lost to Follow-up|2|||
146382895|NCT04785144|527902827|FG008|Overall Study|Lost to Follow-up|4|||
146382896|NCT04785144|527902828|FG009|Overall Study|Lost to Follow-up|1|||
146382897|NCT04785144|527902819|FG000|Overall Study|Protocol Violation|0|||
146382898|NCT04785144|527902820|FG001|Overall Study|Protocol Violation|0|||
146382899|NCT04785144|527902821|FG002|Overall Study|Protocol Violation|0|||
146382900|NCT04785144|527902822|FG003|Overall Study|Protocol Violation|0|||
146382901|NCT04785144|527902823|FG004|Overall Study|Protocol Violation|0|||
146382902|NCT04785144|527902824|FG005|Overall Study|Protocol Violation|0|||
146382903|NCT04785144|527902825|FG006|Overall Study|Protocol Violation|1|||
146382904|NCT04785144|527902826|FG007|Overall Study|Protocol Violation|0|||
146382905|NCT04785144|527902827|FG008|Overall Study|Protocol Violation|0|||
146382906|NCT04785144|527902828|FG009|Overall Study|Protocol Violation|0|||
146382907|NCT04785144|527902819|FG000|Overall Study|Physician Decision|0|||
146382908|NCT04785144|527902820|FG001|Overall Study|Physician Decision|0|||
146382909|NCT04785144|527902821|FG002|Overall Study|Physician Decision|0|||
146382910|NCT04785144|527902822|FG003|Overall Study|Physician Decision|0|||
146382911|NCT04785144|527902823|FG004|Overall Study|Physician Decision|0|||
146382912|NCT04785144|527902824|FG005|Overall Study|Physician Decision|0|||
146382913|NCT04785144|527902825|FG006|Overall Study|Physician Decision|0|||
146382914|NCT04785144|527902826|FG007|Overall Study|Physician Decision|0|||
146382915|NCT04785144|527902827|FG008|Overall Study|Physician Decision|0|||
146382916|NCT04785144|527902828|FG009|Overall Study|Physician Decision|1|||
146382917|NCT04785144|527902819|FG000|Overall Study|Unable to continue due to work schedule|0|||
146382918|NCT04785144|527902820|FG001|Overall Study|Unable to continue due to work schedule|0|||
146382919|NCT04785144|527902821|FG002|Overall Study|Unable to continue due to work schedule|0|||
146382920|NCT04785144|527902822|FG003|Overall Study|Unable to continue due to work schedule|0|||
146382921|NCT04785144|527902823|FG004|Overall Study|Unable to continue due to work schedule|0|||
146382922|NCT04785144|527902824|FG005|Overall Study|Unable to continue due to work schedule|0|||
146382923|NCT04785144|527902825|FG006|Overall Study|Unable to continue due to work schedule|0|||
146382924|NCT04785144|527902826|FG007|Overall Study|Unable to continue due to work schedule|0|||
146382925|NCT04785144|527902827|FG008|Overall Study|Unable to continue due to work schedule|0|||
146382926|NCT04785144|527902828|FG009|Overall Study|Unable to continue due to work schedule|1|||
146382927|NCT01263470|527902831|FG000|Overall Study|Adverse Event|2|||
146382928|NCT01263470|527902832|FG001|Overall Study|Adverse Event|2|||
146382929|NCT01263470|527902833|FG002|Overall Study|Adverse Event|1|||
146382930|NCT01263470|527902834|FG003|Overall Study|Adverse Event|1|||
146382931|NCT01263470|527902835|FG004|Overall Study|Adverse Event|2|||
146382932|NCT01263470|527902836|FG005|Overall Study|Adverse Event|2|||
146382933|NCT01263470|527902831|FG000|Overall Study|Protocol Violation|0|||
146382934|NCT01263470|527902832|FG001|Overall Study|Protocol Violation|1|||
146382935|NCT01263470|527902833|FG002|Overall Study|Protocol Violation|0|||
146382936|NCT01263470|527902834|FG003|Overall Study|Protocol Violation|0|||
146382937|NCT01263470|527902835|FG004|Overall Study|Protocol Violation|0|||
146382938|NCT01263470|527902836|FG005|Overall Study|Protocol Violation|1|||
146382939|NCT01263470|527902831|FG000|Overall Study|Withdrawal by Subject|0|||
146382940|NCT01263470|527902832|FG001|Overall Study|Withdrawal by Subject|1|||
146382941|NCT01263470|527902833|FG002|Overall Study|Withdrawal by Subject|1|||
146382942|NCT01263470|527902834|FG003|Overall Study|Withdrawal by Subject|2|||
146382943|NCT01263470|527902835|FG004|Overall Study|Withdrawal by Subject|0|||
146382944|NCT01263470|527902836|FG005|Overall Study|Withdrawal by Subject|2|||
146382945|NCT01263470|527902831|FG000|Overall Study|Lack of Efficacy|0|||
146382946|NCT01263470|527902832|FG001|Overall Study|Lack of Efficacy|0|||
146382947|NCT01263470|527902833|FG002|Overall Study|Lack of Efficacy|2|||
146382948|NCT01263470|527902834|FG003|Overall Study|Lack of Efficacy|0|||
146382949|NCT01263470|527902835|FG004|Overall Study|Lack of Efficacy|0|||
146382950|NCT01263470|527902836|FG005|Overall Study|Lack of Efficacy|0|||
146382951|NCT01263470|527902831|FG000|Overall Study|Participant Unavailability|0|||
146382952|NCT01263470|527902832|FG001|Overall Study|Participant Unavailability|1|||
146382953|NCT01263470|527902833|FG002|Overall Study|Participant Unavailability|0|||
146382954|NCT01263470|527902834|FG003|Overall Study|Participant Unavailability|0|||
146382955|NCT01263470|527902835|FG004|Overall Study|Participant Unavailability|0|||
146382956|NCT01263470|527902836|FG005|Overall Study|Participant Unavailability|0|||
146382957|NCT01263470|527902831|FG000|Overall Study|Study Drug Non-compliance|0|||
146382958|NCT01263470|527902832|FG001|Overall Study|Study Drug Non-compliance|0|||
146382959|NCT01263470|527902833|FG002|Overall Study|Study Drug Non-compliance|0|||
146382960|NCT01263470|527902834|FG003|Overall Study|Study Drug Non-compliance|0|||
146382961|NCT01263470|527902835|FG004|Overall Study|Study Drug Non-compliance|1|||
146382962|NCT01263470|527902836|FG005|Overall Study|Study Drug Non-compliance|0|||
146382963|NCT00610714|527902837|FG000|Overall Study|Adverse Event|3|||
146382964|NCT00610714|527902838|FG001|Overall Study|Adverse Event|1|||
146382965|NCT00610714|527902837|FG000|Overall Study|Death|12|||
146382966|NCT00610714|527902838|FG001|Overall Study|Death|18|||
146382967|NCT00610714|527902837|FG000|Overall Study|Withdrawal by Subject|9|||
146382968|NCT00610714|527902838|FG001|Overall Study|Withdrawal by Subject|3|||
146382969|NCT00610714|527902837|FG000|Overall Study|Study completion at 120 PFS events|2|||
146382970|NCT00610714|527902838|FG001|Overall Study|Study completion at 120 PFS events|2|||
146382971|NCT00712712|527902839|FG000|Overall Study|Protocol Violation|11|||
146382972|NCT00712712|527902839|FG000|Overall Study|Radiofrequency not done|3|||
146382973|NCT00712712|527902839|FG000|Overall Study|Death|8|||
146382974|NCT00712712|527902839|FG000|Overall Study|Withdrawal by Subject|1|||
146382975|NCT02060903|527902842|FG000|Overall Study|Lost to Follow-up|4|||
146382976|NCT02060903|527902843|FG001|Overall Study|Lost to Follow-up|0|||
146382977|NCT02060903|527902842|FG000|Overall Study|Withdrawal by Subject|0|||
146382978|NCT02060903|527902843|FG001|Overall Study|Withdrawal by Subject|7|||
146382979|NCT00137267|527902844|FG000|Overall Study|Lost to Follow-up|15|||
146382980|NCT00137267|527902845|FG001|Overall Study|Lost to Follow-up|21|||
146382981|NCT01602822|527902848|FG000|Overall Study|Adverse Event|11|||
146382982|NCT02871791|527902852|FG000|Phase 1b|Death|0|||
146382983|NCT02871791|527902853|FG001|Phase 1b|Death|1|||
146382984|NCT02871791|527902852|FG000|Phase 1b|progressive disease|6|||
146382985|NCT02871791|527902853|FG001|Phase 1b|progressive disease|2|||
146382986|NCT02871791|527902852|FG000|Phase 2|Death|1|||
146382987|NCT02871791|527902853|FG001|Phase 2|Death|0|||
146382988|NCT02871791|527902852|FG000|Phase 2|Lost to Follow-up|2|||
146382989|NCT02871791|527902853|FG001|Phase 2|Lost to Follow-up|0|||
146382990|NCT02010567|527902867|FG000|Overall Study|Adverse Event|0|||
146382991|NCT02010567|527902868|FG001|Overall Study|Adverse Event|0|||
146382992|NCT02010567|527902869|FG002|Overall Study|Adverse Event|1|||
146382993|NCT02010567|527902870|FG003|Overall Study|Adverse Event|0|||
146382994|NCT02010567|527902871|FG004|Overall Study|Adverse Event|1|||
146382995|NCT00118040|527902876|FG000|Overall Study|Adverse Event|0|||
146382996|NCT00118040|527902877|FG001|Overall Study|Adverse Event|1|||
146382997|NCT00118040|527902878|FG002|Overall Study|Adverse Event|0|||
146382998|NCT00118040|527902876|FG000|Overall Study|Withdrawal by Subject|0|||
146382999|NCT00118040|527902877|FG001|Overall Study|Withdrawal by Subject|0|||
146383000|NCT00118040|527902878|FG002|Overall Study|Withdrawal by Subject|2|||
146383001|NCT00118040|527902876|FG000|Overall Study|Medical Contraindication|0|||
146383002|NCT00118040|527902877|FG001|Overall Study|Medical Contraindication|0|||
146383003|NCT00118040|527902878|FG002|Overall Study|Medical Contraindication|1|||
146383004|NCT00118040|527902876|FG000|Overall Study|Non-Compliant Participant|1|||
146383005|NCT00118040|527902877|FG001|Overall Study|Non-Compliant Participant|1|||
146383006|NCT00118040|527902878|FG002|Overall Study|Non-Compliant Participant|2|||
146383007|NCT00118040|527902876|FG000|Overall Study|Other|0|||
146383008|NCT00118040|527902877|FG001|Overall Study|Other|0|||
146383009|NCT00118040|527902878|FG002|Overall Study|Other|1|||
146383010|NCT00397631|527902879|FG000|Overall Study|Adverse Event|5|||
146383011|NCT00397631|527902880|FG001|Overall Study|Adverse Event|6|||
146383012|NCT00397631|527902879|FG000|Overall Study|Lack of Efficacy|7|||
146383013|NCT00397631|527902880|FG001|Overall Study|Lack of Efficacy|10|||
146383014|NCT00397631|527902879|FG000|Overall Study|Lost to Follow-up|8|||
146383015|NCT00397631|527902880|FG001|Overall Study|Lost to Follow-up|9|||
146383016|NCT00397631|527902879|FG000|Overall Study|Physician Decision|2|||
146383017|NCT00397631|527902880|FG001|Overall Study|Physician Decision|0|||
146383018|NCT00397631|527902879|FG000|Overall Study|Protocol Violation|0|||
146383019|NCT00397631|527902880|FG001|Overall Study|Protocol Violation|1|||
146383020|NCT00397631|527902879|FG000|Overall Study|Withdrawal by Subject|7|||
146383021|NCT00397631|527902880|FG001|Overall Study|Withdrawal by Subject|14|||
146383022|NCT00397631|527902879|FG000|Overall Study|protocol discontinuation criteria|1|||
146383023|NCT00397631|527902880|FG001|Overall Study|protocol discontinuation criteria|4|||
146383024|NCT01738594|527902881|FG000|Registration and Treatment Start|Adverse Event|0|||
146383025|NCT01738594|527902882|FG001|Registration and Treatment Start|Adverse Event|1|||
146383026|NCT01738594|527902883|FG002|Registration and Treatment Start|Adverse Event|0|||
146383027|NCT01738594|527902884|FG003|Registration and Treatment Start|Adverse Event|0|||
146383028|NCT01738594|527902885|FG004|Registration and Treatment Start|Adverse Event|0|||
146383029|NCT01738594|527902886|FG005|Registration and Treatment Start|Adverse Event|0|||
146383030|NCT01738594|527902887|FG006|Registration and Treatment Start|Adverse Event|0|||
146383031|NCT01738594|527902888|FG007|Registration and Treatment Start|Adverse Event|0|||
146383032|NCT01738594|527902881|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383033|NCT01738594|527902882|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383034|NCT01738594|527902883|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383035|NCT01738594|527902884|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146395886|NCT02646566|527952401|FG002|Overall Study|Treatment failure|0|||
146383036|NCT01738594|527902885|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383037|NCT01738594|527902886|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
146383038|NCT01738594|527902887|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383039|NCT01738594|527902888|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
146383040|NCT01738594|527902881|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383041|NCT01738594|527902882|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
146383042|NCT01738594|527902883|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383043|NCT01738594|527902884|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383044|NCT01738594|527902885|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383045|NCT01738594|527902886|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383046|NCT01738594|527902887|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383047|NCT01738594|527902888|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
146383048|NCT01738594|527902881|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383049|NCT01738594|527902882|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383050|NCT01738594|527902883|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383051|NCT01738594|527902884|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383052|NCT01738594|527902885|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383053|NCT01738594|527902886|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
146383054|NCT01738594|527902887|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383055|NCT01738594|527902888|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
146383056|NCT01738594|527902881|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383057|NCT01738594|527902882|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383058|NCT01738594|527902883|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383059|NCT01738594|527902884|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383060|NCT01738594|527902885|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383061|NCT01738594|527902886|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
146383062|NCT01738594|527902887|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383063|NCT01738594|527902888|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
146383064|NCT01738594|527902881|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383065|NCT01738594|527902882|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383066|NCT01738594|527902883|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383067|NCT01738594|527902884|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383068|NCT01738594|527902885|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
146383069|NCT01738594|527902886|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383070|NCT01738594|527902887|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383071|NCT01738594|527902888|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
146383072|NCT01738594|527902881|FG000|Follow up for 1 Year|Death|0|||
146383073|NCT01738594|527902882|FG001|Follow up for 1 Year|Death|0|||
146383074|NCT01738594|527902883|FG002|Follow up for 1 Year|Death|0|||
146383075|NCT01738594|527902884|FG003|Follow up for 1 Year|Death|0|||
146383076|NCT01738594|527902885|FG004|Follow up for 1 Year|Death|0|||
146383077|NCT01738594|527902886|FG005|Follow up for 1 Year|Death|1|||
146383078|NCT01738594|527902887|FG006|Follow up for 1 Year|Death|0|||
146383079|NCT01738594|527902888|FG007|Follow up for 1 Year|Death|0|||
146383080|NCT01738594|527902881|FG000|Follow up for 1 Year|Other|0|||
146383081|NCT01738594|527902882|FG001|Follow up for 1 Year|Other|0|||
146383082|NCT01738594|527902883|FG002|Follow up for 1 Year|Other|0|||
146383083|NCT01738594|527902884|FG003|Follow up for 1 Year|Other|0|||
146383084|NCT01738594|527902885|FG004|Follow up for 1 Year|Other|0|||
146383085|NCT01738594|527902886|FG005|Follow up for 1 Year|Other|2|||
146383086|NCT01738594|527902887|FG006|Follow up for 1 Year|Other|0|||
146383087|NCT01738594|527902888|FG007|Follow up for 1 Year|Other|0|||
146383088|NCT00403390|527902890|FG000|Overall Study|Withdrawal by Subject|1|||
146383089|NCT00403390|527902891|FG001|Overall Study|Withdrawal by Subject|0|||
146383090|NCT00403390|527902890|FG000|Overall Study|samples lost|1|||
146383091|NCT00403390|527902891|FG001|Overall Study|samples lost|0|||
146383092|NCT00403390|527902890|FG000|Overall Study|non-compliant|1|||
146383093|NCT00403390|527902891|FG001|Overall Study|non-compliant|0|||
146383094|NCT01878175|527902892|FG000|Overall Study|Developed contraindicated health problem|2|||
146383095|NCT01796106|527902893|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
146383096|NCT01796106|527902894|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
146383097|NCT04107935|527902895|FG000|Overall Study|Death|1|||
146383098|NCT04107935|527902896|FG001|Overall Study|Death|0|||
146383099|NCT01108068|527902897|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
146383100|NCT01108068|527902898|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
146383101|NCT00836953|527902899|FG000|Overall Study|Withdrawal by Subject|1|||
146383102|NCT00836953|527902899|FG000|Overall Study|Lost to Follow-up|1|||
146383103|NCT02201251|527902900|FG000|Overall Study|Adverse Event|1|||
146383104|NCT02201251|527902901|FG001|Overall Study|Adverse Event|1|||
146383105|NCT02201251|527902900|FG000|Overall Study|Protocol Violation|1|||
146383106|NCT02201251|527902901|FG001|Overall Study|Protocol Violation|0|||
146383107|NCT02201251|527902900|FG000|Overall Study|Noncompliance with Study Drug|0|||
146383108|NCT02201251|527902901|FG001|Overall Study|Noncompliance with Study Drug|1|||
146383109|NCT02201251|527902900|FG000|Overall Study|Withdrawal by Subject|2|||
146383110|NCT02201251|527902901|FG001|Overall Study|Withdrawal by Subject|1|||
146383111|NCT02711553|527902904|FG000|Overall Study|Withdrawal by Subject|2|||
146383112|NCT02711553|527902905|FG001|Overall Study|Withdrawal by Subject|1|||
146383113|NCT02711553|527902906|FG002|Overall Study|Withdrawal by Subject|1|||
146383114|NCT02711553|527902907|FG003|Overall Study|Withdrawal by Subject|0|||
146383115|NCT02711553|527902904|FG000|Overall Study|Lost to Follow-up|3|||
146383116|NCT02711553|527902905|FG001|Overall Study|Lost to Follow-up|3|||
146383117|NCT02711553|527902906|FG002|Overall Study|Lost to Follow-up|6|||
146383118|NCT02711553|527902907|FG003|Overall Study|Lost to Follow-up|3|||
146383119|NCT02711553|527902904|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
146383120|NCT02711553|527902905|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
146383121|NCT02711553|527902906|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
146383122|NCT02711553|527902907|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
146383123|NCT01828567|527902910|FG000|Overall Study|Lost to Follow-up|27|||
146383124|NCT01828567|527902911|FG001|Overall Study|Lost to Follow-up|9|||
146383125|NCT01828567|527902910|FG000|Overall Study|Excluded - did not meet criteria|4|||
146383126|NCT01828567|527902911|FG001|Overall Study|Excluded - did not meet criteria|1|||
146383127|NCT02332876|527902912|FG000|Overall Study|Lost to Follow-up|1|||
146383128|NCT02332876|527902913|FG001|Overall Study|Lost to Follow-up|1|||
146383129|NCT02415595|527902914|FG000|Overall Study|Administrative reason by sponsor|39|||
146383130|NCT02415595|527902915|FG001|Overall Study|Administrative reason by sponsor|40|||
146383131|NCT02415595|527902916|FG002|Overall Study|Administrative reason by sponsor|41|||
146383132|NCT02415595|527902917|FG003|Overall Study|Administrative reason by sponsor|39|||
146383133|NCT02415595|527902914|FG000|Overall Study|Adverse Event|1|||
146383134|NCT02415595|527902915|FG001|Overall Study|Adverse Event|3|||
146383135|NCT02415595|527902916|FG002|Overall Study|Adverse Event|5|||
146383136|NCT02415595|527902917|FG003|Overall Study|Adverse Event|10|||
146383137|NCT02415595|527902914|FG000|Overall Study|Lack of Efficacy|4|||
146383138|NCT02415595|527902915|FG001|Overall Study|Lack of Efficacy|4|||
146383139|NCT02415595|527902916|FG002|Overall Study|Lack of Efficacy|0|||
146383140|NCT02415595|527902917|FG003|Overall Study|Lack of Efficacy|0|||
146383141|NCT02415595|527902914|FG000|Overall Study|Lost to Follow-up|1|||
146383142|NCT02415595|527902915|FG001|Overall Study|Lost to Follow-up|3|||
146383143|NCT02415595|527902916|FG002|Overall Study|Lost to Follow-up|1|||
146383144|NCT02415595|527902917|FG003|Overall Study|Lost to Follow-up|1|||
146383145|NCT02415595|527902914|FG000|Overall Study|Poor/Non-compliance|1|||
146383146|NCT02415595|527902915|FG001|Overall Study|Poor/Non-compliance|0|||
146383147|NCT02415595|527902916|FG002|Overall Study|Poor/Non-compliance|1|||
146383148|NCT02415595|527902917|FG003|Overall Study|Poor/Non-compliance|0|||
146383149|NCT02415595|527902914|FG000|Overall Study|Reached stopping criteria|0|||
146383150|NCT02415595|527902915|FG001|Overall Study|Reached stopping criteria|1|||
146383151|NCT02415595|527902916|FG002|Overall Study|Reached stopping criteria|1|||
146383152|NCT02415595|527902917|FG003|Overall Study|Reached stopping criteria|0|||
146383153|NCT02415595|527902914|FG000|Overall Study|Withdrawal by Subject|4|||
146383154|NCT02415595|527902915|FG001|Overall Study|Withdrawal by Subject|0|||
146383155|NCT02415595|527902916|FG002|Overall Study|Withdrawal by Subject|1|||
146383156|NCT02415595|527902917|FG003|Overall Study|Withdrawal by Subject|3|||
146383157|NCT02415595|527902914|FG000|Overall Study|Other|0|||
146383158|NCT02415595|527902915|FG001|Overall Study|Other|1|||
146383159|NCT02415595|527902916|FG002|Overall Study|Other|1|||
146383160|NCT02415595|527902917|FG003|Overall Study|Other|0|||
146383161|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
146383162|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
146383163|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
146383164|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
146383165|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
146383166|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146383167|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146383168|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
146383169|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
146383170|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
146383171|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
146383172|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
146383173|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
146383174|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
146383175|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
146383176|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
146383177|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
146383178|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
146383179|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
146383180|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
146383181|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
146383182|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
146383183|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
146383184|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
146383185|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Screen failure|0|||
146383186|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Screen failure|1|||
146383187|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Screen failure|2|||
146383188|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Screen failure|0|||
146383189|NCT02614261|527902918|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
146383190|NCT02614261|527902919|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
146383191|NCT02614261|527902920|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
146383192|NCT02614261|527902921|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
146383193|NCT02614261|527902918|FG000|Open-Label Extension Phase|Adverse Event|23|||
146383194|NCT02614261|527902919|FG001|Open-Label Extension Phase|Adverse Event|12|||
146383195|NCT02614261|527902920|FG002|Open-Label Extension Phase|Adverse Event|11|||
146383196|NCT02614261|527902921|FG003|Open-Label Extension Phase|Adverse Event|0|||
146383197|NCT02614261|527902918|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
146383198|NCT02614261|527902919|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
146383199|NCT02614261|527902920|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
146383200|NCT02614261|527902921|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
146383201|NCT02614261|527902918|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
146383202|NCT02614261|527902919|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
146383203|NCT02614261|527902920|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
146383204|NCT02614261|527902921|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
146383205|NCT02614261|527902918|FG000|Open-Label Extension Phase|Physician Decision|2|||
146383206|NCT02614261|527902919|FG001|Open-Label Extension Phase|Physician Decision|0|||
146383207|NCT02614261|527902920|FG002|Open-Label Extension Phase|Physician Decision|0|||
146383208|NCT02614261|527902921|FG003|Open-Label Extension Phase|Physician Decision|0|||
146383209|NCT02614261|527902918|FG000|Open-Label Extension Phase|Pregnancy|1|||
146383210|NCT02614261|527902919|FG001|Open-Label Extension Phase|Pregnancy|2|||
146383211|NCT02614261|527902920|FG002|Open-Label Extension Phase|Pregnancy|1|||
146383212|NCT02614261|527902921|FG003|Open-Label Extension Phase|Pregnancy|0|||
146383213|NCT02614261|527902918|FG000|Open-Label Extension Phase|Protocol Violation|3|||
146383214|NCT02614261|527902919|FG001|Open-Label Extension Phase|Protocol Violation|4|||
146383215|NCT02614261|527902920|FG002|Open-Label Extension Phase|Protocol Violation|1|||
146383216|NCT02614261|527902921|FG003|Open-Label Extension Phase|Protocol Violation|0|||
146383217|NCT02614261|527902918|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
146383218|NCT02614261|527902919|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
146383219|NCT02614261|527902920|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
146383220|NCT02614261|527902921|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
146383221|NCT02614261|527902918|FG000|Follow-up Phase|Adverse Event|2|||
146383222|NCT02614261|527902919|FG001|Follow-up Phase|Adverse Event|0|||
146383223|NCT02614261|527902920|FG002|Follow-up Phase|Adverse Event|1|||
146383224|NCT02614261|527902921|FG003|Follow-up Phase|Adverse Event|0|||
146383225|NCT02614261|527902918|FG000|Follow-up Phase|Lost to Follow-up|12|||
146383226|NCT02614261|527902919|FG001|Follow-up Phase|Lost to Follow-up|5|||
146383227|NCT02614261|527902920|FG002|Follow-up Phase|Lost to Follow-up|2|||
146383228|NCT02614261|527902921|FG003|Follow-up Phase|Lost to Follow-up|0|||
146383229|NCT02614261|527902918|FG000|Follow-up Phase|Physician Decision|5|||
146383230|NCT02614261|527902919|FG001|Follow-up Phase|Physician Decision|1|||
146383231|NCT02614261|527902920|FG002|Follow-up Phase|Physician Decision|0|||
146383232|NCT02614261|527902921|FG003|Follow-up Phase|Physician Decision|0|||
146383233|NCT02614261|527902918|FG000|Follow-up Phase|Pregnancy|0|||
146383234|NCT02614261|527902919|FG001|Follow-up Phase|Pregnancy|1|||
146383235|NCT02614261|527902920|FG002|Follow-up Phase|Pregnancy|0|||
146383236|NCT02614261|527902921|FG003|Follow-up Phase|Pregnancy|0|||
146383237|NCT02614261|527902918|FG000|Follow-up Phase|Protocol Violation|1|||
146383238|NCT02614261|527902919|FG001|Follow-up Phase|Protocol Violation|0|||
146056254|NCT00549640|526721156|FG000|Overall Study|Lost to Follow-up|7|||
146056255|NCT00549640|526721157|FG001|Overall Study|Lost to Follow-up|4|||
146056256|NCT00626275|526721160|FG000|Part A - Treatment Period 1|Adverse Event|1|||
146056257|NCT00626275|526721161|FG001|Part A - Treatment Period 1|Adverse Event|0|||
146056258|NCT00626275|526721162|FG002|Part A - Treatment Period 1|Adverse Event|0|||
146056259|NCT00626275|526721163|FG003|Part A - Treatment Period 1|Adverse Event|0|||
146056260|NCT00626275|526721164|FG004|Part A - Treatment Period 1|Adverse Event|0|||
146056261|NCT00626275|526721165|FG005|Part A - Treatment Period 1|Adverse Event|0|||
146056262|NCT00626275|526721166|FG006|Part A - Treatment Period 1|Adverse Event|0|||
146056263|NCT00626275|526721167|FG007|Part A - Treatment Period 1|Adverse Event|0|||
146056264|NCT00626275|526721160|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146056265|NCT00626275|526721161|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146056266|NCT00626275|526721162|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
146056267|NCT00626275|526721163|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146383239|NCT02614261|527902920|FG002|Follow-up Phase|Protocol Violation|0|||
146383240|NCT02614261|527902921|FG003|Follow-up Phase|Protocol Violation|0|||
146383241|NCT02614261|527902918|FG000|Follow-up Phase|Withdrawal by Subject|12|||
146383242|NCT02614261|527902919|FG001|Follow-up Phase|Withdrawal by Subject|4|||
146383243|NCT02614261|527902920|FG002|Follow-up Phase|Withdrawal by Subject|11|||
146383244|NCT02614261|527902921|FG003|Follow-up Phase|Withdrawal by Subject|0|||
146383245|NCT02614261|527902918|FG000|Israel Addendum|Withdrawal by Subject|0|||
146383246|NCT02614261|527902919|FG001|Israel Addendum|Withdrawal by Subject|0|||
146383247|NCT02614261|527902920|FG002|Israel Addendum|Withdrawal by Subject|0|||
146383248|NCT02614261|527902921|FG003|Israel Addendum|Withdrawal by Subject|4|||
146383249|NCT03512275|527902924|FG000|Overall Study|Withdrawal by Subject|1|||
146383250|NCT03512275|527902925|FG001|Overall Study|Withdrawal by Subject|3|||
146383251|NCT03512275|527902924|FG000|Overall Study|Physician Decision|0|||
146383252|NCT03512275|527902925|FG001|Overall Study|Physician Decision|1|||
146383253|NCT03512275|527902924|FG000|Overall Study|Lost to Follow-up|0|||
146383254|NCT03512275|527902925|FG001|Overall Study|Lost to Follow-up|3|||
146383255|NCT03512275|527902924|FG000|Overall Study|Other|1|||
146383256|NCT03512275|527902925|FG001|Overall Study|Other|0|||
146383257|NCT04063865|527902926|FG000|Overall Study|Physician Decision|1|||
146383258|NCT04063865|527902927|FG001|Overall Study|Physician Decision|3|||
146383259|NCT04063865|527902926|FG000|Overall Study|Study Closed Prior to Completion|4|||
146383260|NCT04063865|527902927|FG001|Overall Study|Study Closed Prior to Completion|4|||
146383261|NCT04063865|527902926|FG000|Overall Study|Withdrawal by Subject|1|||
146383262|NCT04063865|527902927|FG001|Overall Study|Withdrawal by Subject|1|||
146383263|NCT03231228|527902929|FG000|Overall Study|Lost to Follow-up|2|||
146383264|NCT03231228|527902930|FG001|Overall Study|Lost to Follow-up|0|||
146383265|NCT03231228|527902929|FG000|Overall Study|Physician Decision|1|||
146383266|NCT03231228|527902930|FG001|Overall Study|Physician Decision|0|||
146383267|NCT03399786|527902936|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
146383268|NCT03399786|527902937|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146383269|NCT03399786|527902938|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146383270|NCT03399786|527902939|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
146383271|NCT03399786|527902936|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146383272|NCT03399786|527902937|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146383273|NCT03399786|527902938|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
146383274|NCT03399786|527902939|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
146383275|NCT03399786|527902936|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146383276|NCT03399786|527902937|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146383277|NCT03399786|527902938|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
146383278|NCT03399786|527902939|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
146383279|NCT03037489|527905032|FG000|Overall Study|Adverse Event|4|||
146383280|NCT03037489|527905033|FG001|Overall Study|Adverse Event|0|||
146383281|NCT03037489|527905032|FG000|Overall Study|Withdrawal by Subject|3|||
146383282|NCT03037489|527905033|FG001|Overall Study|Withdrawal by Subject|0|||
146383283|NCT02499172|527905034|FG000|Overall Study|Financial reason|0|||
146383284|NCT02499172|527905035|FG001|Overall Study|Financial reason|0|||
146383285|NCT02499172|527905036|FG002|Overall Study|Financial reason|523|||
146383286|NCT02499172|527905037|FG003|Overall Study|Financial reason|436|||
146383287|NCT02499172|527905034|FG000|Overall Study|Lost to Follow-up|65|||
146383288|NCT02499172|527905035|FG001|Overall Study|Lost to Follow-up|64|||
146383289|NCT02499172|527905036|FG002|Overall Study|Lost to Follow-up|0|||
146383290|NCT02499172|527905037|FG003|Overall Study|Lost to Follow-up|0|||
146383291|NCT00724243|527905040|FG000|Overall Study|Lack of Efficacy|10|||
146383292|NCT00724243|527905040|FG000|Overall Study|Adverse Event|5|||
146383293|NCT04610827|527905042|FG000|Overall Study|Withdrawal by Subject|1|||
146383294|NCT04610827|527905043|FG001|Overall Study|Withdrawal by Subject|1|||
146383295|NCT04610827|527905044|FG002|Overall Study|Withdrawal by Subject|0|||
146383296|NCT02059174|527905053|FG000|Period 1|Withdrawal by Subject|0|||
146383297|NCT02059174|527905054|FG001|Period 1|Withdrawal by Subject|2|||
146383298|NCT02059174|527905053|FG000|Period 2|Withdrawal by Subject|0|||
146383299|NCT02059174|527905054|FG001|Period 2|Withdrawal by Subject|2|||
146383300|NCT02059174|527905053|FG000|Period 2|Protocol Violation|1|||
146383301|NCT02059174|527905054|FG001|Period 2|Protocol Violation|0|||
146383302|NCT02059174|527905053|FG000|Period 3|Physician Decision|1|||
146383303|NCT02059174|527905054|FG001|Period 3|Physician Decision|0|||
146383304|NCT02306148|527905055|FG000|Overall Study|Adverse Event|12|||
146383305|NCT02306148|527905056|FG001|Overall Study|Adverse Event|6|||
146383306|NCT02306148|527905055|FG000|Overall Study|Lost to Follow-up|1|||
146383307|NCT02306148|527905056|FG001|Overall Study|Lost to Follow-up|4|||
146383308|NCT04167514|527905063|FG000|Overall Study|Adverse event, not serious|0|||
146383309|NCT04167514|527905064|FG001|Overall Study|Adverse event, not serious|1|||
146383310|NCT04167514|527905063|FG000|Overall Study|Lost to Follow-up|1|||
146383311|NCT04167514|527905064|FG001|Overall Study|Lost to Follow-up|0|||
146383312|NCT04167514|527905063|FG000|Overall Study|Participant Decision|2|||
146383313|NCT04167514|527905064|FG001|Overall Study|Participant Decision|4|||
146383314|NCT04167514|527905063|FG000|Overall Study|Physician Decision|3|||
146383315|NCT04167514|527905064|FG001|Overall Study|Physician Decision|2|||
146383316|NCT04167514|527905063|FG000|Overall Study|Death|14|||
146383317|NCT04167514|527905064|FG001|Overall Study|Death|18|||
146383318|NCT04167514|527905063|FG000|Overall Study|Enrolled but treatment not administered|2|||
146383319|NCT04167514|527905064|FG001|Overall Study|Enrolled but treatment not administered|0|||
146383320|NCT04167514|527905063|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
146383321|NCT04167514|527905064|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
146383322|NCT04167514|527905063|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
146383323|NCT04167514|527905064|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
146383324|NCT00290355|527905065|FG000|Overall Study|Serious adverse event|7|||
146383325|NCT00290355|527905066|FG001|Overall Study|Serious adverse event|4|||
146383326|NCT00290355|527905065|FG000|Overall Study|Study product reactogenicity|1|||
146383327|NCT00290355|527905066|FG001|Overall Study|Study product reactogenicity|0|||
146383328|NCT00290355|527905065|FG000|Overall Study|Protocol Violation|1|||
146383329|NCT00290355|527905066|FG001|Overall Study|Protocol Violation|0|||
146383330|NCT00290355|527905065|FG000|Overall Study|Withdrawal by Subject|2|||
146383331|NCT00290355|527905066|FG001|Overall Study|Withdrawal by Subject|0|||
146383332|NCT00290355|527905065|FG000|Overall Study|Migrated / moved from the study area|1|||
146383333|NCT00290355|527905066|FG001|Overall Study|Migrated / moved from the study area|0|||
146383334|NCT00290355|527905065|FG000|Overall Study|Lost to Follow-up|3|||
146383335|NCT00290355|527905066|FG001|Overall Study|Lost to Follow-up|1|||
146383336|NCT00290355|527905065|FG000|Overall Study|Other|2|||
146383337|NCT00290355|527905066|FG001|Overall Study|Other|0|||
146383338|NCT03225833|527905069|FG000|Overall Study|Adverse Event|0|||
146383339|NCT03225833|527905070|FG001|Overall Study|Adverse Event|1|||
146383340|NCT03225833|527905071|FG002|Overall Study|Adverse Event|2|||
146383341|NCT03225833|527905072|FG003|Overall Study|Adverse Event|0|||
146383342|NCT03225833|527905073|FG004|Overall Study|Adverse Event|0|||
146383343|NCT03225833|527905074|FG005|Overall Study|Adverse Event|2|||
146383344|NCT03225833|527905069|FG000|Overall Study|Withdrawal by Subject|1|||
146383345|NCT03225833|527905070|FG001|Overall Study|Withdrawal by Subject|0|||
146383346|NCT03225833|527905071|FG002|Overall Study|Withdrawal by Subject|0|||
146383347|NCT03225833|527905072|FG003|Overall Study|Withdrawal by Subject|0|||
146383348|NCT03225833|527905073|FG004|Overall Study|Withdrawal by Subject|1|||
146383349|NCT03225833|527905074|FG005|Overall Study|Withdrawal by Subject|0|||
146383350|NCT03225833|527905069|FG000|Overall Study|Termination of Study by Sponsor|4|||
146383351|NCT03225833|527905070|FG001|Overall Study|Termination of Study by Sponsor|0|||
146383352|NCT03225833|527905071|FG002|Overall Study|Termination of Study by Sponsor|0|||
146383353|NCT03225833|527905072|FG003|Overall Study|Termination of Study by Sponsor|0|||
146383354|NCT03225833|527905073|FG004|Overall Study|Termination of Study by Sponsor|0|||
146383355|NCT03225833|527905074|FG005|Overall Study|Termination of Study by Sponsor|7|||
146383356|NCT03225833|527905069|FG000|Overall Study|Sponsor Decision|0|||
146383357|NCT03225833|527905070|FG001|Overall Study|Sponsor Decision|0|||
146383358|NCT03225833|527905071|FG002|Overall Study|Sponsor Decision|0|||
146383359|NCT03225833|527905072|FG003|Overall Study|Sponsor Decision|0|||
146383360|NCT03225833|527905073|FG004|Overall Study|Sponsor Decision|0|||
146383361|NCT03225833|527905074|FG005|Overall Study|Sponsor Decision|1|||
146383362|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
146383363|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
146383364|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
146383365|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
146383366|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Other|1|||
146383367|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Other|0|||
146383368|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Other|2|||
146383369|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Other|4|||
146383370|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
146383371|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
146383372|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
146383373|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
146383374|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Adverse Event|0|||
146383375|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Adverse Event|0|||
146383376|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Adverse Event|1|||
146383377|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Adverse Event|2|||
146383378|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
146383379|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
146383380|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
146383381|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
146383382|NCT00808028|527905075|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
146383383|NCT00808028|527905076|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
146383384|NCT00808028|527905077|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
146383385|NCT00808028|527905078|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
146383386|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
146383387|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
146383388|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
146383389|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
146383390|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146383391|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146383392|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
146383393|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
146383394|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
146383395|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
146383396|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
146383397|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
146383398|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
146383399|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
146383400|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
146383401|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
146383402|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
146383403|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
146383404|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
146383405|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
146383406|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
146383407|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
146383408|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
146383409|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
146383410|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146383411|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146383412|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
146383413|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
146383414|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
146383415|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
146383416|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
146383417|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
146383418|NCT00808028|527905075|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146383419|NCT00808028|527905076|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146383420|NCT00808028|527905077|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
146383421|NCT00808028|527905078|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
146383422|NCT00508001|527905088|FG000|Overall Study|Adverse Event|2|||
146383423|NCT00508001|527905089|FG001|Overall Study|Adverse Event|0|||
146383424|NCT00508001|527905090|FG002|Overall Study|Adverse Event|4|||
146383425|NCT00508001|527905088|FG000|Overall Study|condition under investigation worsened|13|||
146383426|NCT00508001|527905089|FG001|Overall Study|condition under investigation worsened|7|||
146383427|NCT00508001|527905090|FG002|Overall Study|condition under investigation worsened|1|||
146383428|NCT00508001|527905088|FG000|Overall Study|Death|0|||
146383429|NCT00508001|527905089|FG001|Overall Study|Death|1|||
146383430|NCT00508001|527905090|FG002|Overall Study|Death|1|||
146383431|NCT00508001|527905088|FG000|Overall Study|Withdrawal by Subject|4|||
146383432|NCT00508001|527905089|FG001|Overall Study|Withdrawal by Subject|4|||
146383433|NCT00508001|527905090|FG002|Overall Study|Withdrawal by Subject|1|||
146383434|NCT01599585|527905091|FG000|Overall Study|Withdrawal by Subject|16|||
146383435|NCT01599585|527905092|FG001|Overall Study|Withdrawal by Subject|9|||
146383436|NCT01599585|527905091|FG000|Overall Study|Lost to Follow-up|3|||
146383437|NCT01599585|527905092|FG001|Overall Study|Lost to Follow-up|5|||
146383438|NCT01599585|527905091|FG000|Overall Study|randomized did not start treatment|3|||
146383439|NCT01599585|527905092|FG001|Overall Study|randomized did not start treatment|3|||
146383440|NCT03093350|527905093|FG000|Overall Study|Death|1|||
146383441|NCT03093350|527905093|FG000|Overall Study|Signed consent, never began treartment|1|||
146383442|NCT00777036|527905096|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
146383443|NCT00777036|527905097|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
146383444|NCT00777036|527905098|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
146383445|NCT00777036|527905099|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
146383446|NCT00777036|527905096|FG000|On Treatment|Administrative Reason By Sponsor|1|||
146383447|NCT00777036|527905097|FG001|On Treatment|Administrative Reason By Sponsor|0|||
146383448|NCT00777036|527905098|FG002|On Treatment|Administrative Reason By Sponsor|9|||
146383449|NCT00777036|527905099|FG003|On Treatment|Administrative Reason By Sponsor|0|||
146383450|NCT00777036|527905096|FG000|On Treatment|Failure to Meet Study Criteria|0|||
146383451|NCT00777036|527905097|FG001|On Treatment|Failure to Meet Study Criteria|1|||
146383452|NCT00777036|527905098|FG002|On Treatment|Failure to Meet Study Criteria|4|||
146383453|NCT00777036|527905099|FG003|On Treatment|Failure to Meet Study Criteria|0|||
146383454|NCT00777036|527905096|FG000|On Treatment|Pregnancy|1|||
146383455|NCT00777036|527905097|FG001|On Treatment|Pregnancy|0|||
146383456|NCT00777036|527905098|FG002|On Treatment|Pregnancy|1|||
146383457|NCT00777036|527905099|FG003|On Treatment|Pregnancy|0|||
146383458|NCT00777036|527905096|FG000|On Treatment|Non-compliance with Study Drug|1|||
146383459|NCT00777036|527905097|FG001|On Treatment|Non-compliance with Study Drug|0|||
146383460|NCT00777036|527905098|FG002|On Treatment|Non-compliance with Study Drug|1|||
146383461|NCT00777036|527905099|FG003|On Treatment|Non-compliance with Study Drug|0|||
146383462|NCT00777036|527905096|FG000|On Treatment|Maximum Clinical Benefit|2|||
146383463|NCT00777036|527905097|FG001|On Treatment|Maximum Clinical Benefit|0|||
146383464|NCT00777036|527905098|FG002|On Treatment|Maximum Clinical Benefit|5|||
146383465|NCT00777036|527905099|FG003|On Treatment|Maximum Clinical Benefit|0|||
146383466|NCT00777036|527905096|FG000|On Treatment|Withdrawal by Subject|0|||
146383467|NCT00777036|527905097|FG001|On Treatment|Withdrawal by Subject|2|||
146383468|NCT00777036|527905098|FG002|On Treatment|Withdrawal by Subject|2|||
146383469|NCT00777036|527905099|FG003|On Treatment|Withdrawal by Subject|0|||
146383470|NCT00777036|527905096|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
146383471|NCT00777036|527905097|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
146383472|NCT00777036|527905098|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
146383473|NCT00777036|527905099|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
146383474|NCT00777036|527905096|FG000|On Treatment|Death|0|||
146383475|NCT00777036|527905097|FG001|On Treatment|Death|2|||
146383476|NCT00777036|527905098|FG002|On Treatment|Death|0|||
146383477|NCT00777036|527905099|FG003|On Treatment|Death|0|||
146383478|NCT00777036|527905096|FG000|On Treatment|Study Drug Toxicity|1|||
146383479|NCT00777036|527905097|FG001|On Treatment|Study Drug Toxicity|0|||
146383480|NCT00777036|527905098|FG002|On Treatment|Study Drug Toxicity|4|||
146383481|NCT00777036|527905099|FG003|On Treatment|Study Drug Toxicity|0|||
146383482|NCT00777036|527905096|FG000|On Treatment|Progressive Disease|6|||
146383483|NCT00777036|527905097|FG001|On Treatment|Progressive Disease|4|||
146383484|NCT00777036|527905098|FG002|On Treatment|Progressive Disease|7|||
146383485|NCT00777036|527905099|FG003|On Treatment|Progressive Disease|0|||
146383486|NCT00777036|527905096|FG000|On Treatment|Not Reported|0|||
146383487|NCT00777036|527905097|FG001|On Treatment|Not Reported|0|||
146383488|NCT00777036|527905098|FG002|On Treatment|Not Reported|2|||
146383489|NCT00777036|527905099|FG003|On Treatment|Not Reported|0|||
146383490|NCT00777036|527905096|FG000|On Treatment|Site Closed|0|||
146383491|NCT00777036|527905097|FG001|On Treatment|Site Closed|1|||
146383492|NCT00777036|527905098|FG002|On Treatment|Site Closed|1|||
146383493|NCT00777036|527905099|FG003|On Treatment|Site Closed|0|||
146383494|NCT00777036|527905096|FG000|Follow-Up|Withdrawal by Subject|0|||
146383495|NCT00777036|527905097|FG001|Follow-Up|Withdrawal by Subject|0|||
146383496|NCT00777036|527905098|FG002|Follow-Up|Withdrawal by Subject|5|||
146383497|NCT00777036|527905099|FG003|Follow-Up|Withdrawal by Subject|0|||
146383498|NCT00777036|527905096|FG000|Follow-Up|Death|1|||
146383499|NCT00777036|527905097|FG001|Follow-Up|Death|9|||
146383500|NCT00777036|527905098|FG002|Follow-Up|Death|0|||
146383501|NCT00777036|527905099|FG003|Follow-Up|Death|0|||
146383502|NCT00777036|527905096|FG000|Follow-Up|Lost to Follow-up|3|||
146383503|NCT00777036|527905097|FG001|Follow-Up|Lost to Follow-up|0|||
146383504|NCT00777036|527905098|FG002|Follow-Up|Lost to Follow-up|0|||
146383505|NCT00777036|527905099|FG003|Follow-Up|Lost to Follow-up|0|||
146383506|NCT00777036|527905096|FG000|Follow-Up|Reason Not Specified|4|||
146383507|NCT00777036|527905097|FG001|Follow-Up|Reason Not Specified|0|||
146383508|NCT00777036|527905098|FG002|Follow-Up|Reason Not Specified|13|||
146383509|NCT00777036|527905099|FG003|Follow-Up|Reason Not Specified|0|||
146383510|NCT00777036|527905096|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
146383511|NCT00777036|527905097|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
146383512|NCT00777036|527905098|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
146383513|NCT00777036|527905099|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
146383514|NCT04566445|527905100|FG000|Overall Study|Death|4|||
146383515|NCT04566445|527905101|FG001|Overall Study|Death|1|||
146383516|NCT04566445|527905102|FG002|Overall Study|Death|1|||
146383517|NCT04566445|527905100|FG000|Overall Study|Lost to Follow-up|3|||
146383518|NCT04566445|527905101|FG001|Overall Study|Lost to Follow-up|1|||
146383519|NCT04566445|527905102|FG002|Overall Study|Lost to Follow-up|1|||
146383520|NCT04566445|527905100|FG000|Overall Study|Study terminated by sponsor|11|||
146383521|NCT04566445|527905101|FG001|Overall Study|Study terminated by sponsor|17|||
146383522|NCT04566445|527905102|FG002|Overall Study|Study terminated by sponsor|32|||
146383523|NCT04566445|527905100|FG000|Overall Study|Withdrawal by Subject|12|||
146383524|NCT04566445|527905101|FG001|Overall Study|Withdrawal by Subject|14|||
146383525|NCT04566445|527905102|FG002|Overall Study|Withdrawal by Subject|13|||
146383526|NCT04566445|527905100|FG000|Overall Study|Randomized but not treated due to AE|2|||
146383527|NCT04566445|527905101|FG001|Overall Study|Randomized but not treated due to AE|1|||
146383528|NCT04566445|527905102|FG002|Overall Study|Randomized but not treated due to AE|0|||
146383529|NCT04566445|527905100|FG000|Overall Study|Adverse Event|1|||
146383530|NCT04566445|527905101|FG001|Overall Study|Adverse Event|1|||
146383531|NCT04566445|527905102|FG002|Overall Study|Adverse Event|0|||
146383532|NCT01327573|527905103|FG000|Overall Study|Physician Decision|3|||
146383533|NCT01327573|527905104|FG001|Overall Study|Physician Decision|1|||
146383534|NCT01108263|527905105|FG000|Overall Study|Adverse Event|0|||
146383535|NCT01108263|527905106|FG001|Overall Study|Adverse Event|1|||
146383536|NCT00729560|527905107|FG000|Overall Study|Withdrawal by Subject|3|||
146383537|NCT00829010|527905110|FG000|Overall Study|Adverse Event|1|||
146383538|NCT00829010|527905111|FG001|Overall Study|Adverse Event|0|||
146383539|NCT00829010|527905112|FG002|Overall Study|Adverse Event|0|||
146383540|NCT00829010|527905113|FG003|Overall Study|Adverse Event|0|||
146383541|NCT00829010|527905114|FG004|Overall Study|Adverse Event|0|||
146383542|NCT00829010|527905110|FG000|Overall Study|Withdrawal by Subject|0|||
146383543|NCT00829010|527905111|FG001|Overall Study|Withdrawal by Subject|1|||
146383544|NCT00829010|527905112|FG002|Overall Study|Withdrawal by Subject|1|||
146383545|NCT00829010|527905113|FG003|Overall Study|Withdrawal by Subject|0|||
146383546|NCT00829010|527905114|FG004|Overall Study|Withdrawal by Subject|2|||
146383547|NCT00829010|527905110|FG000|Overall Study|Lost to Follow-up|1|||
146383548|NCT00829010|527905111|FG001|Overall Study|Lost to Follow-up|0|||
146383549|NCT00829010|527905112|FG002|Overall Study|Lost to Follow-up|2|||
146383550|NCT00829010|527905113|FG003|Overall Study|Lost to Follow-up|0|||
146383551|NCT00829010|527905114|FG004|Overall Study|Lost to Follow-up|0|||
146383552|NCT00829010|527905110|FG000|Overall Study|Fatality|5|||
146383553|NCT00829010|527905111|FG001|Overall Study|Fatality|4|||
146383554|NCT00829010|527905112|FG002|Overall Study|Fatality|0|||
146383555|NCT00829010|527905113|FG003|Overall Study|Fatality|3|||
146383556|NCT00829010|527905114|FG004|Overall Study|Fatality|0|||
146383557|NCT00829010|527905110|FG000|Overall Study|Migrated/Moved from study area|3|||
146383558|NCT00829010|527905111|FG001|Overall Study|Migrated/Moved from study area|4|||
146383559|NCT00829010|527905112|FG002|Overall Study|Migrated/Moved from study area|0|||
146383560|NCT00829010|527905113|FG003|Overall Study|Migrated/Moved from study area|5|||
146383561|NCT00829010|527905114|FG004|Overall Study|Migrated/Moved from study area|0|||
146383562|NCT01029691|527905115|FG000|Continued APAP to Delivery|Death|0|||
146383563|NCT01029691|527905116|FG001|Continued APAP to Delivery|Death|0|||
146383564|NCT01029691|527905117|FG002|Continued APAP to Delivery|Death|1|||
146383565|NCT01023516|527905118|FG000|Overall Study|Voluntary discontinuation|7|||
146383566|NCT01023516|527905119|FG001|Overall Study|Voluntary discontinuation|5|||
146383567|NCT01023516|527905118|FG000|Overall Study|Adverse Event|9|||
146383568|NCT01023516|527905119|FG001|Overall Study|Adverse Event|6|||
146383569|NCT01023516|527905118|FG000|Overall Study|Safety reason|0|||
146383570|NCT01023516|527905119|FG001|Overall Study|Safety reason|3|||
146383571|NCT01023516|527905118|FG000|Overall Study|Study-specific criteria|4|||
146383572|NCT01023516|527905119|FG001|Overall Study|Study-specific criteria|2|||
146383573|NCT01023516|527905118|FG000|Overall Study|Incorrect enrolment|4|||
146383574|NCT01023516|527905119|FG001|Overall Study|Incorrect enrolment|2|||
146383575|NCT00638989|527905123|FG000|Overall Study|Lost to Follow-up|0|||
146383576|NCT00638989|527905124|FG001|Overall Study|Lost to Follow-up|0|||
146383577|NCT00638989|527905125|FG002|Overall Study|Lost to Follow-up|1|||
146383578|NCT05245071|527905126|FG000|Overall Study|Progressive disease|18|||
146383579|NCT05245071|527905126|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
146383580|NCT05245071|527905126|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
146383581|NCT00853112|527905127|FG000|Overall Study|Randomized but not treated|0|||
146383582|NCT00853112|527905128|FG001|Overall Study|Randomized but not treated|1|||
146383583|NCT00853112|527905129|FG002|Overall Study|Randomized but not treated|0|||
146383584|NCT00853112|527905130|FG003|Overall Study|Randomized but not treated|2|||
146383585|NCT00853112|527905131|FG004|Overall Study|Randomized but not treated|0|||
146383586|NCT00853112|527905132|FG005|Overall Study|Randomized but not treated|0|||
146383587|NCT00853112|527905133|FG006|Overall Study|Randomized but not treated|1|||
146383588|NCT01553591|527905134|FG000|Overall Study|Voluntarily withdrew|94|||
146383589|NCT01553591|527905135|FG001|Overall Study|Voluntarily withdrew|79|||
146383590|NCT01553591|527905136|FG002|Overall Study|Voluntarily withdrew|96|||
146383591|NCT01553591|527905134|FG000|Overall Study|Adverse Event|36|||
146383592|NCT01553591|527905135|FG001|Overall Study|Adverse Event|45|||
146383593|NCT01553591|527905136|FG002|Overall Study|Adverse Event|16|||
146383594|NCT01553591|527905134|FG000|Overall Study|Lost to Follow-up|25|||
146383595|NCT01553591|527905135|FG001|Overall Study|Lost to Follow-up|23|||
146383596|NCT01553591|527905136|FG002|Overall Study|Lost to Follow-up|16|||
146383597|NCT01553591|527905134|FG000|Overall Study|Physician decision: other|11|||
146383598|NCT01553591|527905135|FG001|Overall Study|Physician decision: other|14|||
146383599|NCT01553591|527905136|FG002|Overall Study|Physician decision: other|16|||
146383600|NCT01553591|527905134|FG000|Overall Study|Physician decision: lack of efficacy|2|||
146383601|NCT01553591|527905135|FG001|Overall Study|Physician decision: lack of efficacy|3|||
146383602|NCT01553591|527905136|FG002|Overall Study|Physician decision: lack of efficacy|7|||
146383603|NCT01553591|527905134|FG000|Overall Study|Protocol Violation|3|||
146383604|NCT01553591|527905135|FG001|Overall Study|Protocol Violation|4|||
146383605|NCT01553591|527905136|FG002|Overall Study|Protocol Violation|4|||
146383606|NCT01553591|527905134|FG000|Overall Study|Sponsor decision|1|||
146383607|NCT01553591|527905135|FG001|Overall Study|Sponsor decision|0|||
146383608|NCT01553591|527905136|FG002|Overall Study|Sponsor decision|3|||
146383609|NCT01553591|527905134|FG000|Overall Study|Randomized and never dispensed drug|0|||
146383610|NCT01553591|527905135|FG001|Overall Study|Randomized and never dispensed drug|1|||
146383611|NCT01553591|527905136|FG002|Overall Study|Randomized and never dispensed drug|0|||
146383612|NCT01426009|527905137|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
146383613|NCT01426009|527905137|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
146383614|NCT01426009|527905137|FG000|Washout 1|Withdrawal by Subject|1|||
146383615|NCT01426009|527905137|FG000|Washout 1|Personal Reasons|1|||
146383616|NCT01426009|527905137|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
146383617|NCT01426009|527905137|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
146383618|NCT01426009|527905137|FG000|Washout 2|electrive surgery|1|||
146383619|NCT01426009|527905137|FG000|Washout 3|personal reasons|1|||
146383620|NCT01426009|527905137|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
146383621|NCT01426009|527905137|FG000|Washout 4|Lost to Follow-up|1|||
146383622|NCT01021553|527905139|FG000|Overall Study|Adverse Event|1|||
146383623|NCT01021553|527905140|FG001|Overall Study|Adverse Event|0|||
146383624|NCT01021553|527905141|FG002|Overall Study|Adverse Event|0|||
146383625|NCT01021553|527905139|FG000|Overall Study|Lack of Efficacy|2|||
146383626|NCT01021553|527905140|FG001|Overall Study|Lack of Efficacy|2|||
146383627|NCT01021553|527905141|FG002|Overall Study|Lack of Efficacy|0|||
146383628|NCT01021553|527905139|FG000|Overall Study|Protocol Violation|0|||
146383629|NCT01021553|527905140|FG001|Overall Study|Protocol Violation|2|||
146383630|NCT01021553|527905141|FG002|Overall Study|Protocol Violation|2|||
146383631|NCT01021553|527905139|FG000|Overall Study|Lost to Follow-up|0|||
146383632|NCT01021553|527905140|FG001|Overall Study|Lost to Follow-up|0|||
146383633|NCT01021553|527905141|FG002|Overall Study|Lost to Follow-up|1|||
146383634|NCT01021553|527905139|FG000|Overall Study|Withdrawal by Subject|1|||
146383635|NCT01021553|527905140|FG001|Overall Study|Withdrawal by Subject|1|||
146383636|NCT01021553|527905141|FG002|Overall Study|Withdrawal by Subject|0|||
146383637|NCT01950364|527905142|FG000|Overall Study|Adverse Event|3|||
146383638|NCT01950364|527905143|FG001|Overall Study|Adverse Event|0|||
146383639|NCT01950364|527905142|FG000|Overall Study|Stem Cell Transplant|2|||
146383640|NCT01950364|527905143|FG001|Overall Study|Stem Cell Transplant|6|||
146383641|NCT01950364|527905142|FG000|Overall Study|Disease Progression|5|||
146383642|NCT01950364|527905143|FG001|Overall Study|Disease Progression|2|||
146383643|NCT01950364|527905142|FG000|Overall Study|Withdrawal by Subject|0|||
146383644|NCT01950364|527905143|FG001|Overall Study|Withdrawal by Subject|1|||
146383645|NCT01950364|527905142|FG000|Overall Study|Protocol Violation|0|||
146383646|NCT01950364|527905143|FG001|Overall Study|Protocol Violation|1|||
146383647|NCT02877134|527905145|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383648|NCT02877134|527905146|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
146383649|NCT02877134|527905147|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383650|NCT02877134|527905148|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383651|NCT02877134|527905149|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383652|NCT02877134|527905150|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
146383653|NCT02877134|527905151|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383654|NCT02877134|527905152|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383655|NCT02877134|527905153|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383656|NCT02877134|527905154|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383657|NCT02877134|527905155|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383658|NCT02877134|527905156|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
146383659|NCT02877134|527905145|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383660|NCT02877134|527905146|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
146383661|NCT02877134|527905147|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383662|NCT02877134|527905148|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
146383663|NCT02877134|527905149|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383664|NCT02877134|527905150|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383665|NCT02877134|527905151|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
146383666|NCT02877134|527905152|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383667|NCT02877134|527905153|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383668|NCT02877134|527905154|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383669|NCT02877134|527905155|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383670|NCT02877134|527905156|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
146383671|NCT02877134|527905145|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
146383672|NCT02877134|527905146|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
146383673|NCT02877134|527905147|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
146383674|NCT02877134|527905148|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
146383675|NCT02877134|527905149|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
146383676|NCT02877134|527905150|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
146383677|NCT02877134|527905151|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
146383678|NCT02877134|527905152|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146383679|NCT02877134|527905153|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146383680|NCT02877134|527905154|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146383681|NCT02877134|527905155|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146383682|NCT02877134|527905156|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
146383683|NCT02877134|527905145|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
146383684|NCT02877134|527905146|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
146383685|NCT02877134|527905147|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
146383686|NCT02877134|527905148|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
146383687|NCT02877134|527905149|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
146383688|NCT02877134|527905150|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
146383689|NCT02877134|527905151|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
146383690|NCT02877134|527905152|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
146383691|NCT02877134|527905153|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
146383692|NCT02877134|527905154|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
146383693|NCT02877134|527905155|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
146383694|NCT02877134|527905156|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
146383695|NCT02877134|527905145|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383696|NCT02877134|527905146|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383697|NCT02877134|527905147|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383698|NCT02877134|527905148|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383699|NCT02877134|527905149|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383700|NCT02877134|527905150|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383701|NCT02877134|527905151|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383702|NCT02877134|527905152|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383703|NCT02877134|527905153|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
146383704|NCT02877134|527905154|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383705|NCT02877134|527905155|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383706|NCT02877134|527905156|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
146383707|NCT02877134|527905145|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383708|NCT02877134|527905146|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383709|NCT02877134|527905147|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383710|NCT02877134|527905148|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383711|NCT02877134|527905149|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383712|NCT02877134|527905150|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383713|NCT02877134|527905151|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
146383714|NCT02877134|527905152|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
146383715|NCT02877134|527905153|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
146383716|NCT02877134|527905154|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
146383717|NCT02877134|527905155|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
146383718|NCT02877134|527905156|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
146383719|NCT02877134|527905145|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383720|NCT02877134|527905146|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383721|NCT02877134|527905147|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383722|NCT02877134|527905148|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383723|NCT02877134|527905149|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383724|NCT02877134|527905150|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383725|NCT02877134|527905151|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383726|NCT02877134|527905152|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146383727|NCT02877134|527905153|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146383728|NCT02877134|527905154|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
146383729|NCT02877134|527905155|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383730|NCT02877134|527905156|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
146383731|NCT02877134|527905145|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
146383732|NCT02877134|527905146|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
146383733|NCT02877134|527905147|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
146383734|NCT02877134|527905148|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
146383735|NCT02877134|527905149|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
146383736|NCT02877134|527905150|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
146383737|NCT02877134|527905151|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
146383738|NCT02877134|527905152|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
146383739|NCT02877134|527905153|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
146383740|NCT02877134|527905154|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
146383741|NCT02877134|527905155|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
146383742|NCT02877134|527905156|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
146383743|NCT04048876|527905159|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
146383744|NCT04048876|527905160|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
146383745|NCT04048876|527905161|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
146383746|NCT04048876|527905162|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
146383747|NCT04048876|527905159|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
146383748|NCT04048876|527905160|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
146383749|NCT04048876|527905161|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
146383750|NCT04048876|527905162|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
146383751|NCT04048876|527905159|FG000|Placebo Controlled Phase|Adverse Event|0|||
146383752|NCT04048876|527905160|FG001|Placebo Controlled Phase|Adverse Event|1|||
146383753|NCT04048876|527905161|FG002|Placebo Controlled Phase|Adverse Event|0|||
146383754|NCT04048876|527905162|FG003|Placebo Controlled Phase|Adverse Event|0|||
146383755|NCT04048876|527905159|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
146383756|NCT04048876|527905160|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
146383757|NCT04048876|527905161|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
146383758|NCT04048876|527905162|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
146383759|NCT01347840|527905167|FG000|Overall Study|Withdrawal by Subject|1|||
146383760|NCT01700140|527905170|FG000|Overall Study|Use of rescue drugs|3|||
146383761|NCT01700140|527905171|FG001|Overall Study|Use of rescue drugs|3|||
146383762|NCT01700140|527905172|FG002|Overall Study|Use of rescue drugs|1|||
146383763|NCT01700140|527905170|FG000|Overall Study|Discontinuation of radiotherapy|1|||
146383764|NCT01700140|527905171|FG001|Overall Study|Discontinuation of radiotherapy|0|||
146383765|NCT01700140|527905172|FG002|Overall Study|Discontinuation of radiotherapy|0|||
146383766|NCT01700140|527905170|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
146383767|NCT01700140|527905171|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
146383768|NCT01700140|527905172|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
146383769|NCT01700140|527905170|FG000|Overall Study|Aggravation of symptoms|1|||
146383770|NCT01700140|527905171|FG001|Overall Study|Aggravation of symptoms|0|||
146383771|NCT01700140|527905172|FG002|Overall Study|Aggravation of symptoms|0|||
146383772|NCT01700140|527905170|FG000|Overall Study|Adverse Event|0|||
146383773|NCT01700140|527905171|FG001|Overall Study|Adverse Event|1|||
146383774|NCT01700140|527905172|FG002|Overall Study|Adverse Event|0|||
146383775|NCT01700140|527905170|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
146383776|NCT01700140|527905171|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
146383777|NCT01700140|527905172|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
146383778|NCT01060124|527905173|FG000|Overall Study|Other|16|||
146383779|NCT01060124|527905173|FG000|Overall Study|Adverse Event|14|||
146383780|NCT01060124|527905173|FG000|Overall Study|Withdrawal by Subject|7|||
146383781|NCT01708915|527905179|FG000|Overall Study|Adverse Event|1|||
146383782|NCT01708915|527905180|FG001|Overall Study|Adverse Event|0|||
146383783|NCT01708915|527905181|FG002|Overall Study|Adverse Event|9|||
146383784|NCT01708915|527905182|FG003|Overall Study|Adverse Event|13|||
146383785|NCT01708915|527905179|FG000|Overall Study|Lack of Efficacy|84|||
146383786|NCT01708915|527905180|FG001|Overall Study|Lack of Efficacy|60|||
146383787|NCT01708915|527905181|FG002|Overall Study|Lack of Efficacy|35|||
146383788|NCT01708915|527905182|FG003|Overall Study|Lack of Efficacy|15|||
146383789|NCT01708915|527905179|FG000|Overall Study|Protocol Violation|0|||
146383790|NCT01708915|527905180|FG001|Overall Study|Protocol Violation|0|||
146383791|NCT01708915|527905181|FG002|Overall Study|Protocol Violation|0|||
146383792|NCT01708915|527905182|FG003|Overall Study|Protocol Violation|1|||
146383793|NCT01708915|527905179|FG000|Overall Study|Withdrawal by Subject|0|||
146383794|NCT01708915|527905180|FG001|Overall Study|Withdrawal by Subject|1|||
146383795|NCT01708915|527905181|FG002|Overall Study|Withdrawal by Subject|2|||
146383796|NCT01708915|527905182|FG003|Overall Study|Withdrawal by Subject|2|||
146383797|NCT01708915|527905179|FG000|Overall Study|Other reasons than stated above|1|||
146383798|NCT01708915|527905180|FG001|Overall Study|Other reasons than stated above|1|||
146383799|NCT01708915|527905181|FG002|Overall Study|Other reasons than stated above|0|||
146383800|NCT01708915|527905182|FG003|Overall Study|Other reasons than stated above|2|||
146383801|NCT00374127|527905185|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
146383802|NCT00374127|527905185|FG000|Overall Study|Blood could not be drawn.|2|||
146383803|NCT00374127|527905185|FG000|Overall Study|Protocol Violation|5|||
146383804|NCT00374127|527905185|FG000|Overall Study|Pregnancy|1|||
146383805|NCT01222416|527905186|FG000|Overall Study|ineligible;metastasis|3|||
146383806|NCT01222416|527905187|FG001|Overall Study|ineligible;metastasis|0|||
146383807|NCT01222416|527905186|FG000|Overall Study|Adverse Event|4|||
146383808|NCT01222416|527905187|FG001|Overall Study|Adverse Event|0|||
146383809|NCT01222416|527905186|FG000|Overall Study|Withdrawal by Subject|5|||
146383810|NCT01222416|527905187|FG001|Overall Study|Withdrawal by Subject|0|||
146383811|NCT01222416|527905186|FG000|Overall Study|scheduling|6|||
146383812|NCT01222416|527905187|FG001|Overall Study|scheduling|0|||
146383813|NCT01222416|527905186|FG000|Overall Study|missed view/scan|1|||
146383814|NCT01222416|527905187|FG001|Overall Study|missed view/scan|0|||
146383815|NCT01222416|527905186|FG000|Overall Study|Death|1|||
146383816|NCT01222416|527905187|FG001|Overall Study|Death|0|||
146383817|NCT00518336|527905188|FG000|Year 7|Lost to Follow-up|2|||
146383818|NCT00518336|527905189|FG001|Year 7|Lost to Follow-up|0|||
146383819|NCT00518336|527905188|FG000|Year 7|Could not attend in time|0|||
146383820|NCT00518336|527905189|FG001|Year 7|Could not attend in time|3|||
146383821|NCT00518336|527905188|FG000|Year 8|Lost to Follow-up|1|||
146383822|NCT00518336|527905189|FG001|Year 8|Lost to Follow-up|1|||
146383823|NCT00518336|527905188|FG000|Year 8|Could not attend in time|0|||
146056268|NCT00626275|526721164|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146383824|NCT00518336|527905189|FG001|Year 8|Could not attend in time|1|||
146383825|NCT00518336|527905188|FG000|Year 9|Migrated/moved from study area|1|||
146396047|NCT01397409|527952473|FG003|Stage 3|Adverse Event|0|||
146383826|NCT00518336|527905189|FG001|Year 9|Migrated/moved from study area|1|||
146383827|NCT00518336|527905188|FG000|Year 9|Lost to Follow-up|3|||
146383828|NCT00518336|527905189|FG001|Year 9|Lost to Follow-up|0|||
146383829|NCT00518336|527905188|FG000|Year 9|Personal reasons|1|||
146383830|NCT00518336|527905189|FG001|Year 9|Personal reasons|0|||
146383831|NCT04223778|527905190|FG000|Overall Study|Death|1|||
146383832|NCT04223778|527905191|FG001|Overall Study|Death|1|||
146383833|NCT04223778|527905190|FG000|Overall Study|Lost to Follow-up|4|||
146383834|NCT04223778|527905191|FG001|Overall Study|Lost to Follow-up|5|||
146383835|NCT04223778|527905190|FG000|Overall Study|Physician Decision|10|||
146383836|NCT04223778|527905191|FG001|Overall Study|Physician Decision|6|||
146383837|NCT04223778|527905190|FG000|Overall Study|Withdrawal by Subject|35|||
146383838|NCT04223778|527905191|FG001|Overall Study|Withdrawal by Subject|17|||
146383839|NCT04223778|527905190|FG000|Overall Study|Not Reported|7|||
146383840|NCT04223778|527905191|FG001|Overall Study|Not Reported|8|||
146383841|NCT02972658|527906797|FG000|Overall Study|Adverse Event|0|||
146383842|NCT02972658|527906798|FG001|Overall Study|Adverse Event|3|||
146383843|NCT02972658|527906799|FG002|Overall Study|Adverse Event|0|||
146383844|NCT02972658|527906800|FG003|Overall Study|Adverse Event|2|||
146383845|NCT02972658|527906797|FG000|Overall Study|Other-determined by Investigator|1|||
146383846|NCT02972658|527906798|FG001|Overall Study|Other-determined by Investigator|1|||
146383847|NCT02972658|527906799|FG002|Overall Study|Other-determined by Investigator|0|||
146383848|NCT02972658|527906800|FG003|Overall Study|Other-determined by Investigator|0|||
146383849|NCT02972658|527906797|FG000|Overall Study|Death|0|||
146383850|NCT02972658|527906798|FG001|Overall Study|Death|0|||
146383851|NCT02972658|527906799|FG002|Overall Study|Death|0|||
146383852|NCT02972658|527906800|FG003|Overall Study|Death|1|||
146383853|NCT02972658|527906797|FG000|Overall Study|Lost to Follow-up|0|||
146383854|NCT02972658|527906798|FG001|Overall Study|Lost to Follow-up|1|||
146383855|NCT02972658|527906799|FG002|Overall Study|Lost to Follow-up|1|||
146383856|NCT02972658|527906800|FG003|Overall Study|Lost to Follow-up|2|||
146383857|NCT02972658|527906797|FG000|Overall Study|Progressive Disease|0|||
146383858|NCT02972658|527906798|FG001|Overall Study|Progressive Disease|1|||
146383859|NCT02972658|527906799|FG002|Overall Study|Progressive Disease|0|||
146383860|NCT02972658|527906800|FG003|Overall Study|Progressive Disease|1|||
146383861|NCT02972658|527906797|FG000|Overall Study|Withdrawal by Subject|4|||
146383862|NCT02972658|527906798|FG001|Overall Study|Withdrawal by Subject|4|||
146383863|NCT02972658|527906799|FG002|Overall Study|Withdrawal by Subject|1|||
146383864|NCT02972658|527906800|FG003|Overall Study|Withdrawal by Subject|6|||
146383865|NCT02972658|527906797|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146383866|NCT02972658|527906798|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146383867|NCT02972658|527906799|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
146383868|NCT02972658|527906800|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
146383869|NCT02972658|527906797|FG000|Overall Study|Sponsor Decision|70|||
146383870|NCT02972658|527906798|FG001|Overall Study|Sponsor Decision|127|||
146383871|NCT02972658|527906799|FG002|Overall Study|Sponsor Decision|72|||
146383872|NCT02972658|527906800|FG003|Overall Study|Sponsor Decision|119|||
146383873|NCT03958149|527906801|FG000|Overall Study|Withdrawal by Subject|0|||
146383874|NCT03958149|527906802|FG001|Overall Study|Withdrawal by Subject|1|||
146383875|NCT02785588|527906803|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
146383876|NCT02785588|527906803|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
146383877|NCT00621764|527906805|FG000|Overall Study|Protocol Violation|0|||
146383878|NCT00621764|527906806|FG001|Overall Study|Protocol Violation|0|||
146383879|NCT00621764|527906807|FG002|Overall Study|Protocol Violation|0|||
146383880|NCT00621764|527906808|FG003|Overall Study|Protocol Violation|1|||
146383881|NCT03031327|527906813|FG000|Overall Study|Withdrawal by Subject|0|||
146383882|NCT03031327|527906814|FG001|Overall Study|Withdrawal by Subject|1|||
146383883|NCT03031327|527906815|FG002|Overall Study|Withdrawal by Subject|1|||
146383884|NCT00211536|527906816|FG000|Overall Study|Withdrawal by Subject|2|||
146383885|NCT00211536|527906817|FG001|Overall Study|Withdrawal by Subject|2|||
146383886|NCT00211536|527906816|FG000|Overall Study|Physician Decision|0|||
146383887|NCT00211536|527906817|FG001|Overall Study|Physician Decision|5|||
146383888|NCT00211536|527906816|FG000|Overall Study|Adverse Event|2|||
146383889|NCT00211536|527906817|FG001|Overall Study|Adverse Event|0|||
146383890|NCT00669240|527906818|FG000|Overall Study|Lack of Efficacy|33|||
146383891|NCT00669240|527906818|FG000|Overall Study|Withdrawal by Subject|42|||
146383892|NCT00669240|527906818|FG000|Overall Study|Lost to Follow-up|34|||
146383893|NCT00669240|527906818|FG000|Overall Study|Adverse Event|21|||
146383894|NCT00669240|527906818|FG000|Overall Study|Other|19|||
146383895|NCT00669240|527906818|FG000|Overall Study|Enrolled but not treated|15|||
146383896|NCT00669240|527906818|FG000|Overall Study|Enrolled but no dosing record|1|||
146383897|NCT02583399|527906819|FG000|Overall Study|Able to be discharged|3|||
146383898|NCT02583399|527906819|FG000|Overall Study|Wanted to use a restricted medication|3|||
146383899|NCT00003389|527906820|FG000|Overall Study|Disease progression|6|||
146383900|NCT00003389|527906821|FG001|Overall Study|Disease progression|1|||
146383901|NCT00003389|527906820|FG000|Overall Study|Adverse Event|13|||
146383902|NCT00003389|527906821|FG001|Overall Study|Adverse Event|2|||
146383903|NCT00003389|527906820|FG000|Overall Study|Death|0|||
146383904|NCT00003389|527906821|FG001|Overall Study|Death|3|||
146383905|NCT00003389|527906820|FG000|Overall Study|Withdrawal by Subject|12|||
146383906|NCT00003389|527906821|FG001|Overall Study|Withdrawal by Subject|5|||
146383907|NCT00003389|527906820|FG000|Overall Study|Alternative therapy|2|||
146383908|NCT00003389|527906821|FG001|Overall Study|Alternative therapy|1|||
146383909|NCT00003389|527906820|FG000|Overall Study|Complicating disease|1|||
146383910|NCT00003389|527906821|FG001|Overall Study|Complicating disease|0|||
146383911|NCT00003389|527906820|FG000|Overall Study|Off-treatment reason missing|31|||
146383912|NCT00003389|527906821|FG001|Overall Study|Off-treatment reason missing|21|||
146383913|NCT00003389|527906820|FG000|Overall Study|Ineligible|33|||
146383914|NCT00003389|527906821|FG001|Overall Study|Ineligible|27|||
146383915|NCT02554721|527906822|FG000|Overall Study|Adverse Event|1|||
146383916|NCT02554721|527906823|FG001|Overall Study|Adverse Event|0|||
146383917|NCT02554721|527906824|FG002|Overall Study|Adverse Event|0|||
146383918|NCT02554721|527906825|FG003|Overall Study|Adverse Event|0|||
146383919|NCT02554721|527906826|FG004|Overall Study|Adverse Event|1|||
146383920|NCT02554721|527906822|FG000|Overall Study|Noncompliance|0|||
146383921|NCT02554721|527906823|FG001|Overall Study|Noncompliance|0|||
146383922|NCT02554721|527906824|FG002|Overall Study|Noncompliance|0|||
146383923|NCT02554721|527906825|FG003|Overall Study|Noncompliance|0|||
146383924|NCT02554721|527906826|FG004|Overall Study|Noncompliance|1|||
146383925|NCT00686699|527906827|FG000|Treatment Period 1|Adverse Event|0|||
146383926|NCT00686699|527906828|FG001|Treatment Period 1|Adverse Event|2|||
146383927|NCT00364611|527906831|FG000|Overall Study|Did not receive study medication|0|||
146383928|NCT00364611|527906832|FG001|Overall Study|Did not receive study medication|1|||
146383929|NCT00364611|527906831|FG000|Overall Study|Adverse Event|7|||
146383930|NCT00364611|527906832|FG001|Overall Study|Adverse Event|4|||
146383931|NCT00364611|527906831|FG000|Overall Study|Participant's Request|3|||
146383932|NCT00364611|527906832|FG001|Overall Study|Participant's Request|4|||
146383933|NCT00364611|527906831|FG000|Overall Study|Disease Progression|38|||
146383934|NCT00364611|527906832|FG001|Overall Study|Disease Progression|8|||
146383935|NCT00364611|527906831|FG000|Overall Study|Investigator decision|2|||
146383936|NCT00364611|527906832|FG001|Overall Study|Investigator decision|2|||
146383937|NCT00364611|527906831|FG000|Overall Study|Found Ineligible|1|||
146383938|NCT00364611|527906832|FG001|Overall Study|Found Ineligible|0|||
146383939|NCT00364611|527906831|FG000|Overall Study|Presumed CR on Study|0|||
146383940|NCT00364611|527906832|FG001|Overall Study|Presumed CR on Study|1|||
146383941|NCT00364611|527906831|FG000|Overall Study|Receiving Liver Ablation|0|||
146383942|NCT00364611|527906832|FG001|Overall Study|Receiving Liver Ablation|1|||
146383943|NCT04097925|527906837|FG000|Overall Study|Withdrawal by Subject|1|||
146383944|NCT04397757|527906840|FG000|Overall Study|Death|3|||
146383945|NCT04397757|527906841|FG001|Overall Study|Death|11|||
146383946|NCT04397757|527906840|FG000|Overall Study|Withdrawal by Subject|2|||
146383947|NCT04397757|527906841|FG001|Overall Study|Withdrawal by Subject|0|||
146383948|NCT04397757|527906840|FG000|Overall Study|Lost to Follow-up|4|||
146383949|NCT04397757|527906841|FG001|Overall Study|Lost to Follow-up|3|||
146383950|NCT00033514|527906842|FG000|Overall Study|Lost to Follow-up|1|||
146383951|NCT00033514|527906843|FG001|Overall Study|Lost to Follow-up|1|||
146383952|NCT00033514|527906842|FG000|Overall Study|Withdrawal by Subject|0|||
146383953|NCT00033514|527906843|FG001|Overall Study|Withdrawal by Subject|3|||
146383954|NCT02477800|527906846|FG000|Placebo-Controlled Period|Adverse Event|16|||
146383955|NCT02477800|527906847|FG001|Placebo-Controlled Period|Adverse Event|25|||
146383956|NCT02477800|527906848|FG002|Placebo-Controlled Period|Adverse Event|28|||
146383957|NCT02477800|527906849|FG003|Placebo-Controlled Period|Adverse Event|0|||
146383958|NCT02477800|527906850|FG004|Placebo-Controlled Period|Adverse Event|0|||
146383959|NCT02477800|527906851|FG005|Placebo-Controlled Period|Adverse Event|0|||
146383960|NCT02477800|527906852|FG006|Placebo-Controlled Period|Adverse Event|0|||
146383961|NCT02477800|527906846|FG000|Placebo-Controlled Period|Change of Treatment|1|||
146383962|NCT02477800|527906847|FG001|Placebo-Controlled Period|Change of Treatment|2|||
146383963|NCT02477800|527906848|FG002|Placebo-Controlled Period|Change of Treatment|1|||
146383964|NCT02477800|527906849|FG003|Placebo-Controlled Period|Change of Treatment|0|||
146383965|NCT02477800|527906850|FG004|Placebo-Controlled Period|Change of Treatment|0|||
146383966|NCT02477800|527906851|FG005|Placebo-Controlled Period|Change of Treatment|0|||
146383967|NCT02477800|527906852|FG006|Placebo-Controlled Period|Change of Treatment|0|||
146383968|NCT02477800|527906846|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
146383969|NCT02477800|527906847|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
146383970|NCT02477800|527906848|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
146383971|NCT02477800|527906849|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
146383972|NCT02477800|527906850|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
146383973|NCT02477800|527906851|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
146383974|NCT02477800|527906852|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
146383975|NCT02477800|527906846|FG000|Placebo-Controlled Period|Death|0|||
146383976|NCT02477800|527906847|FG001|Placebo-Controlled Period|Death|3|||
146383977|NCT02477800|527906848|FG002|Placebo-Controlled Period|Death|2|||
146383978|NCT02477800|527906849|FG003|Placebo-Controlled Period|Death|0|||
146383979|NCT02477800|527906850|FG004|Placebo-Controlled Period|Death|0|||
146383980|NCT02477800|527906851|FG005|Placebo-Controlled Period|Death|0|||
146383981|NCT02477800|527906852|FG006|Placebo-Controlled Period|Death|0|||
146383982|NCT02477800|527906846|FG000|Placebo-Controlled Period|Disease Progression|1|||
146383983|NCT02477800|527906847|FG001|Placebo-Controlled Period|Disease Progression|0|||
146383984|NCT02477800|527906848|FG002|Placebo-Controlled Period|Disease Progression|1|||
146383985|NCT02477800|527906849|FG003|Placebo-Controlled Period|Disease Progression|0|||
146383986|NCT02477800|527906850|FG004|Placebo-Controlled Period|Disease Progression|0|||
146383987|NCT02477800|527906851|FG005|Placebo-Controlled Period|Disease Progression|0|||
146383988|NCT02477800|527906852|FG006|Placebo-Controlled Period|Disease Progression|0|||
146383989|NCT02477800|527906846|FG000|Placebo-Controlled Period|Investigator Decision|3|||
146383990|NCT02477800|527906847|FG001|Placebo-Controlled Period|Investigator Decision|2|||
146383991|NCT02477800|527906848|FG002|Placebo-Controlled Period|Investigator Decision|1|||
146383992|NCT02477800|527906849|FG003|Placebo-Controlled Period|Investigator Decision|0|||
146383993|NCT02477800|527906850|FG004|Placebo-Controlled Period|Investigator Decision|0|||
146383994|NCT02477800|527906851|FG005|Placebo-Controlled Period|Investigator Decision|0|||
146383995|NCT02477800|527906852|FG006|Placebo-Controlled Period|Investigator Decision|0|||
146383996|NCT02477800|527906846|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
146383997|NCT02477800|527906847|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
146383998|NCT02477800|527906848|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
146383999|NCT02477800|527906849|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
146384000|NCT02477800|527906850|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
146384001|NCT02477800|527906851|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
146384002|NCT02477800|527906852|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
146384003|NCT02477800|527906846|FG000|Placebo-Controlled Period|Relocation|2|||
146384004|NCT02477800|527906847|FG001|Placebo-Controlled Period|Relocation|0|||
146384005|NCT02477800|527906848|FG002|Placebo-Controlled Period|Relocation|0|||
146384006|NCT02477800|527906849|FG003|Placebo-Controlled Period|Relocation|0|||
146384007|NCT02477800|527906850|FG004|Placebo-Controlled Period|Relocation|0|||
146384008|NCT02477800|527906851|FG005|Placebo-Controlled Period|Relocation|0|||
146384009|NCT02477800|527906852|FG006|Placebo-Controlled Period|Relocation|0|||
146384010|NCT02477800|527906846|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146384011|NCT02477800|527906847|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146384012|NCT02477800|527906848|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
146384013|NCT02477800|527906849|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146384014|NCT02477800|527906850|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146384015|NCT02477800|527906851|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146384016|NCT02477800|527906852|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
146384017|NCT02477800|527906846|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
146384018|NCT02477800|527906847|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
146384019|NCT02477800|527906848|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146384020|NCT02477800|527906849|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146384021|NCT02477800|527906850|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146384022|NCT02477800|527906851|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146384023|NCT02477800|527906852|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
146384024|NCT02477800|527906846|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
146384025|NCT02477800|527906847|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
146384026|NCT02477800|527906848|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
146384027|NCT02477800|527906849|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
146384028|NCT02477800|527906850|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
146384029|NCT02477800|527906851|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
146384030|NCT02477800|527906852|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
146384031|NCT02477800|527906846|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
146384032|NCT02477800|527906847|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
146384033|NCT02477800|527906848|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
146384034|NCT02477800|527906849|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146384035|NCT02477800|527906850|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146384036|NCT02477800|527906851|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146384037|NCT02477800|527906852|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
146384038|NCT02477800|527906846|FG000|Placebo-Controlled Period|Reason not Specified|161|||
146384039|NCT02477800|527906847|FG001|Placebo-Controlled Period|Reason not Specified|161|||
146384040|NCT02477800|527906848|FG002|Placebo-Controlled Period|Reason not Specified|189|||
146384041|NCT02477800|527906849|FG003|Placebo-Controlled Period|Reason not Specified|0|||
146384042|NCT02477800|527906850|FG004|Placebo-Controlled Period|Reason not Specified|0|||
146384043|NCT02477800|527906851|FG005|Placebo-Controlled Period|Reason not Specified|0|||
146384044|NCT02477800|527906852|FG006|Placebo-Controlled Period|Reason not Specified|0|||
146384045|NCT02477800|527906846|FG000|Long Term Extension Period|Adverse Event|0|||
146384046|NCT02477800|527906847|FG001|Long Term Extension Period|Adverse Event|0|||
146384047|NCT02477800|527906848|FG002|Long Term Extension Period|Adverse Event|0|||
146384048|NCT02477800|527906849|FG003|Long Term Extension Period|Adverse Event|6|||
146384049|NCT02477800|527906850|FG004|Long Term Extension Period|Adverse Event|2|||
146384050|NCT02477800|527906851|FG005|Long Term Extension Period|Adverse Event|4|||
146384051|NCT02477800|527906852|FG006|Long Term Extension Period|Adverse Event|3|||
146384052|NCT02477800|527906846|FG000|Long Term Extension Period|Death|0|||
146384053|NCT02477800|527906847|FG001|Long Term Extension Period|Death|0|||
146384054|NCT02477800|527906848|FG002|Long Term Extension Period|Death|0|||
146384055|NCT02477800|527906849|FG003|Long Term Extension Period|Death|1|||
146384056|NCT02477800|527906850|FG004|Long Term Extension Period|Death|1|||
146384057|NCT02477800|527906851|FG005|Long Term Extension Period|Death|1|||
146384058|NCT02477800|527906852|FG006|Long Term Extension Period|Death|2|||
146384059|NCT02477800|527906846|FG000|Long Term Extension Period|Consent Withdrawn|0|||
146384060|NCT02477800|527906847|FG001|Long Term Extension Period|Consent Withdrawn|0|||
146384061|NCT02477800|527906848|FG002|Long Term Extension Period|Consent Withdrawn|0|||
146384062|NCT02477800|527906849|FG003|Long Term Extension Period|Consent Withdrawn|10|||
146384063|NCT02477800|527906850|FG004|Long Term Extension Period|Consent Withdrawn|4|||
146384064|NCT02477800|527906851|FG005|Long Term Extension Period|Consent Withdrawn|13|||
146384065|NCT02477800|527906852|FG006|Long Term Extension Period|Consent Withdrawn|16|||
146384066|NCT02477800|527906846|FG000|Long Term Extension Period|Disease Progression|0|||
146384067|NCT02477800|527906847|FG001|Long Term Extension Period|Disease Progression|0|||
146384068|NCT02477800|527906848|FG002|Long Term Extension Period|Disease Progression|0|||
146384069|NCT02477800|527906849|FG003|Long Term Extension Period|Disease Progression|3|||
146384070|NCT02477800|527906850|FG004|Long Term Extension Period|Disease Progression|1|||
146384071|NCT02477800|527906851|FG005|Long Term Extension Period|Disease Progression|1|||
146384072|NCT02477800|527906852|FG006|Long Term Extension Period|Disease Progression|0|||
146384073|NCT02477800|527906846|FG000|Long Term Extension Period|Investigator Decision|0|||
146384074|NCT02477800|527906847|FG001|Long Term Extension Period|Investigator Decision|0|||
146384075|NCT02477800|527906848|FG002|Long Term Extension Period|Investigator Decision|0|||
146384076|NCT02477800|527906849|FG003|Long Term Extension Period|Investigator Decision|0|||
146384077|NCT02477800|527906850|FG004|Long Term Extension Period|Investigator Decision|0|||
146384078|NCT02477800|527906851|FG005|Long Term Extension Period|Investigator Decision|0|||
146384079|NCT02477800|527906852|FG006|Long Term Extension Period|Investigator Decision|2|||
146384080|NCT02477800|527906846|FG000|Long Term Extension Period|Lost to Follow-up|0|||
146384081|NCT02477800|527906847|FG001|Long Term Extension Period|Lost to Follow-up|0|||
146384082|NCT02477800|527906848|FG002|Long Term Extension Period|Lost to Follow-up|0|||
146384083|NCT02477800|527906849|FG003|Long Term Extension Period|Lost to Follow-up|0|||
146384084|NCT02477800|527906850|FG004|Long Term Extension Period|Lost to Follow-up|1|||
146384085|NCT02477800|527906851|FG005|Long Term Extension Period|Lost to Follow-up|3|||
146384086|NCT02477800|527906852|FG006|Long Term Extension Period|Lost to Follow-up|0|||
146384087|NCT02477800|527906846|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
146384088|NCT02477800|527906847|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
146384089|NCT02477800|527906848|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
146384090|NCT02477800|527906849|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
146384091|NCT02477800|527906850|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
146384092|NCT02477800|527906851|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
146384093|NCT02477800|527906852|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
146384094|NCT02477800|527906846|FG000|Long Term Extension Period|Study Visit Burden|0|||
146384095|NCT02477800|527906847|FG001|Long Term Extension Period|Study Visit Burden|0|||
146384096|NCT02477800|527906848|FG002|Long Term Extension Period|Study Visit Burden|0|||
146384097|NCT02477800|527906849|FG003|Long Term Extension Period|Study Visit Burden|3|||
146384098|NCT02477800|527906850|FG004|Long Term Extension Period|Study Visit Burden|0|||
146384099|NCT02477800|527906851|FG005|Long Term Extension Period|Study Visit Burden|2|||
146384100|NCT02477800|527906852|FG006|Long Term Extension Period|Study Visit Burden|2|||
146384101|NCT02477800|527906846|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146384102|NCT02477800|527906847|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146384103|NCT02477800|527906848|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
146384104|NCT02477800|527906849|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
146384105|NCT02477800|527906850|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
146384106|NCT02477800|527906851|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
146384107|NCT02477800|527906852|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
146384108|NCT02477800|527906846|FG000|Long Term Extension Period|Reason not Specified|0|||
146384109|NCT02477800|527906847|FG001|Long Term Extension Period|Reason not Specified|0|||
146384110|NCT02477800|527906848|FG002|Long Term Extension Period|Reason not Specified|0|||
146384111|NCT02477800|527906849|FG003|Long Term Extension Period|Reason not Specified|126|||
146384112|NCT02477800|527906850|FG004|Long Term Extension Period|Reason not Specified|140|||
146384113|NCT02477800|527906851|FG005|Long Term Extension Period|Reason not Specified|270|||
146384114|NCT02477800|527906852|FG006|Long Term Extension Period|Reason not Specified|224|||
146384115|NCT04005755|527906862|FG000|Overall Study|Adverse Event|6|||
146384116|NCT04005755|527906862|FG000|Overall Study|Physician Decision|3|||
146384117|NCT04005755|527906862|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
146384118|NCT04005755|527906862|FG000|Overall Study|Withdrawal by Subject|3|||
146384119|NCT04005755|527906862|FG000|Overall Study|Lost to Follow-up|1|||
146056269|NCT00626275|526721165|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146384120|NCT02289833|527906863|FG000|Overall Study|Study discontinuation|0|||
146384121|NCT02289833|527906864|FG001|Overall Study|Study discontinuation|1|||
146384122|NCT02289833|527906863|FG000|Overall Study|Lost to Follow-up|4|||
146384123|NCT02289833|527906864|FG001|Overall Study|Lost to Follow-up|0|||
146384124|NCT02289833|527906863|FG000|Overall Study|Death|23|||
146384125|NCT02289833|527906864|FG001|Overall Study|Death|16|||
146384126|NCT02723019|527906865|FG000|Overall Study|Death|17|||
146384127|NCT02723019|527906866|FG001|Overall Study|Death|13|||
146384128|NCT02723019|527906865|FG000|Overall Study|Withdrawal by Subject|11|||
146384129|NCT02723019|527906866|FG001|Overall Study|Withdrawal by Subject|7|||
146384130|NCT02723019|527906865|FG000|Overall Study|Lost to Follow-up|57|||
146384131|NCT02723019|527906866|FG001|Overall Study|Lost to Follow-up|70|||
146384132|NCT00958191|527906867|FG000|Overall Study|Death|4|||
146384133|NCT00958191|527906867|FG000|Overall Study|Lost to Follow-up|5|||
146384134|NCT00958191|527906867|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
146384135|NCT00958191|527906867|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
146384136|NCT00958191|527906867|FG000|Overall Study|Revision of study device|4|||
146384137|NCT00958191|527906867|FG000|Overall Study|Site termination|11|||
146384138|NCT00958191|527906867|FG000|Overall Study|No 5 yr x-rays|56|||
146384139|NCT00611767|527906868|FG000|Overall Study|Withdrawal by Subject|4|||
146384140|NCT00611767|527906869|FG001|Overall Study|Withdrawal by Subject|1|||
146384141|NCT00611767|527906868|FG000|Overall Study|Thiopental not available|3|||
146384142|NCT00611767|527906869|FG001|Overall Study|Thiopental not available|0|||
146384143|NCT00611767|527906868|FG000|Overall Study|didn't like the medication|1|||
146384144|NCT00611767|527906869|FG001|Overall Study|didn't like the medication|1|||
146384145|NCT00611767|527906868|FG000|Overall Study|Physician Decision|1|||
146384146|NCT00611767|527906869|FG001|Overall Study|Physician Decision|0|||
146384147|NCT01642004|527906870|FG000|Randomization|Adverse Event unrelated to study drug|1|||
146384148|NCT01642004|527906871|FG001|Randomization|Adverse Event unrelated to study drug|0|||
146384149|NCT01642004|527906870|FG000|Randomization|Participant withdrew consent|1|||
146384150|NCT01642004|527906871|FG001|Randomization|Participant withdrew consent|6|||
146384151|NCT01642004|527906870|FG000|Randomization|No longer meets study criteria|2|||
146384152|NCT01642004|527906871|FG001|Randomization|No longer meets study criteria|2|||
146384153|NCT01642004|527906870|FG000|Treatment|Disease progression|95|||
146384154|NCT01642004|527906871|FG001|Treatment|Disease progression|79|||
146384155|NCT01642004|527906870|FG000|Treatment|Study drug toxicity|10|||
146384156|NCT01642004|527906871|FG001|Treatment|Study drug toxicity|13|||
146384157|NCT01642004|527906870|FG000|Treatment|Death|1|||
146384158|NCT01642004|527906871|FG001|Treatment|Death|1|||
146384159|NCT01642004|527906870|FG000|Treatment|Adverse event unrelated to study drug|9|||
146384160|NCT01642004|527906871|FG001|Treatment|Adverse event unrelated to study drug|13|||
146384161|NCT01642004|527906870|FG000|Treatment|Maximum clinical benefit|1|||
146384162|NCT01642004|527906871|FG001|Treatment|Maximum clinical benefit|9|||
146384163|NCT01642004|527906870|FG000|Treatment|Poor/non-compliance|1|||
146384164|NCT01642004|527906871|FG001|Treatment|Poor/non-compliance|0|||
146384165|NCT01642004|527906870|FG000|Treatment|No longer meets study criteria|1|||
146384166|NCT01642004|527906871|FG001|Treatment|No longer meets study criteria|2|||
146384167|NCT01642004|527906870|FG000|Treatment|Other reasons|2|||
146384168|NCT01642004|527906871|FG001|Treatment|Other reasons|0|||
146384169|NCT01642004|527906870|FG000|Treatment|Not reported|0|||
146384170|NCT01642004|527906871|FG001|Treatment|Not reported|3|||
146384171|NCT01642004|527906870|FG000|Treatment|Participant request to discontinue study treatment|6|||
146384172|NCT01642004|527906871|FG001|Treatment|Participant request to discontinue study treatment|4|||
146384173|NCT01642004|527906870|FG000|Treatment|Participant withdrew consent|5|||
146384174|NCT01642004|527906871|FG001|Treatment|Participant withdrew consent|5|||
146384175|NCT01818765|527906872|FG000|Overall Study|Death|2|||
146384176|NCT02005211|527906875|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384177|NCT02005211|527906876|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384178|NCT02005211|527906877|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384179|NCT02005211|527906878|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384180|NCT02005211|527906879|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
146384181|NCT02005211|527906880|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384182|NCT02005211|527906881|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
146384183|NCT02202161|527906884|FG000|Overall Study|Adverse Event|1|||
146384184|NCT02202161|527906885|FG001|Overall Study|Adverse Event|1|||
146384185|NCT02202161|527906886|FG002|Overall Study|Adverse Event|0|||
146384186|NCT02202161|527906887|FG003|Overall Study|Adverse Event|0|||
146384187|NCT02202161|527906888|FG004|Overall Study|Adverse Event|0|||
146384188|NCT02202161|527906889|FG005|Overall Study|Adverse Event|1|||
146384189|NCT02202161|527906890|FG006|Overall Study|Adverse Event|0|||
146384190|NCT02202161|527906891|FG007|Overall Study|Adverse Event|0|||
146384191|NCT02202161|527906884|FG000|Overall Study|Did not meet continuation criteria|0|||
146384192|NCT02202161|527906885|FG001|Overall Study|Did not meet continuation criteria|0|||
146384193|NCT02202161|527906886|FG002|Overall Study|Did not meet continuation criteria|0|||
146384194|NCT02202161|527906887|FG003|Overall Study|Did not meet continuation criteria|0|||
146396048|NCT01397409|527952474|FG004|Stage 3|Adverse Event|0|||
146384195|NCT02202161|527906888|FG004|Overall Study|Did not meet continuation criteria|0|||
146384196|NCT02202161|527906889|FG005|Overall Study|Did not meet continuation criteria|0|||
146384197|NCT02202161|527906890|FG006|Overall Study|Did not meet continuation criteria|0|||
146384198|NCT02202161|527906891|FG007|Overall Study|Did not meet continuation criteria|3|||
146384199|NCT02202161|527906884|FG000|Overall Study|Physician Decision|0|||
146384200|NCT02202161|527906885|FG001|Overall Study|Physician Decision|0|||
146384201|NCT02202161|527906886|FG002|Overall Study|Physician Decision|0|||
146384202|NCT02202161|527906887|FG003|Overall Study|Physician Decision|0|||
146384203|NCT02202161|527906888|FG004|Overall Study|Physician Decision|0|||
146384204|NCT02202161|527906889|FG005|Overall Study|Physician Decision|0|||
146384205|NCT02202161|527906890|FG006|Overall Study|Physician Decision|0|||
146384206|NCT02202161|527906891|FG007|Overall Study|Physician Decision|3|||
146384207|NCT02202161|527906884|FG000|Overall Study|Withdrawal by Subject|0|||
146384208|NCT02202161|527906885|FG001|Overall Study|Withdrawal by Subject|0|||
146384209|NCT02202161|527906886|FG002|Overall Study|Withdrawal by Subject|0|||
146384210|NCT02202161|527906887|FG003|Overall Study|Withdrawal by Subject|0|||
146384211|NCT02202161|527906888|FG004|Overall Study|Withdrawal by Subject|1|||
146384212|NCT02202161|527906889|FG005|Overall Study|Withdrawal by Subject|0|||
146384213|NCT02202161|527906890|FG006|Overall Study|Withdrawal by Subject|0|||
146384214|NCT02202161|527906891|FG007|Overall Study|Withdrawal by Subject|0|||
146384215|NCT00832091|527906892|FG000|Overall Study|Adverse Event|1|||
146384216|NCT00832091|527906893|FG001|Overall Study|Adverse Event|1|||
146384217|NCT00832091|527906892|FG000|Overall Study|Protocol Violation|1|||
146384218|NCT00832091|527906893|FG001|Overall Study|Protocol Violation|0|||
146384219|NCT00832091|527906892|FG000|Overall Study|Withdrawal by Subject|2|||
146384220|NCT00832091|527906893|FG001|Overall Study|Withdrawal by Subject|1|||
146384221|NCT00832091|527906892|FG000|Overall Study|Prohibited Medication|1|||
146384222|NCT00832091|527906893|FG001|Overall Study|Prohibited Medication|0|||
146384223|NCT00952588|527906894|FG000|Overall Study|Death|28|||
146384224|NCT00952588|527906895|FG001|Overall Study|Death|13|||
146384225|NCT00952588|527906894|FG000|Overall Study|Withdrawal by Subject|2|||
146384226|NCT00952588|527906895|FG001|Overall Study|Withdrawal by Subject|5|||
146384227|NCT00952588|527906894|FG000|Overall Study|Adverse Event|2|||
146384228|NCT00952588|527906895|FG001|Overall Study|Adverse Event|3|||
146384229|NCT00952588|527906894|FG000|Overall Study|Lost to Follow-up|2|||
146384230|NCT00952588|527906895|FG001|Overall Study|Lost to Follow-up|0|||
146384231|NCT00952588|527906894|FG000|Overall Study|Physician Decision|0|||
146384232|NCT00952588|527906895|FG001|Overall Study|Physician Decision|1|||
146384233|NCT00952588|527906894|FG000|Overall Study|Lack of Efficacy|2|||
146384234|NCT00952588|527906895|FG001|Overall Study|Lack of Efficacy|2|||
146384235|NCT04554394|527906896|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
146384236|NCT04554394|527906897|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
146384237|NCT04554394|527906896|FG000|Overall Study|Withdrawal by Subject|2|||
146384238|NCT04554394|527906897|FG001|Overall Study|Withdrawal by Subject|2|||
146384239|NCT04554394|527906896|FG000|Overall Study|Lost to Follow-up|2|||
146384240|NCT04554394|527906897|FG001|Overall Study|Lost to Follow-up|2|||
146384241|NCT04554394|527906896|FG000|Overall Study|Physician Decision|1|||
146384242|NCT04554394|527906897|FG001|Overall Study|Physician Decision|1|||
146384243|NCT01766401|527906898|FG000|Overall Study|Adverse Event|7|||
146384244|NCT01766401|527906899|FG001|Overall Study|Adverse Event|22|||
146384245|NCT01766401|527906898|FG000|Overall Study|Lack of Efficacy|1|||
146384246|NCT01766401|527906899|FG001|Overall Study|Lack of Efficacy|2|||
146384247|NCT01766401|527906898|FG000|Overall Study|Protocol Violation|3|||
146384248|NCT01766401|527906899|FG001|Overall Study|Protocol Violation|8|||
146384249|NCT01766401|527906898|FG000|Overall Study|Withdrawal by Subject|15|||
146384250|NCT01766401|527906899|FG001|Overall Study|Withdrawal by Subject|12|||
146384251|NCT01766401|527906898|FG000|Overall Study|Lost to Follow-up|10|||
146384252|NCT01766401|527906899|FG001|Overall Study|Lost to Follow-up|11|||
146384253|NCT01766401|527906898|FG000|Overall Study|Pregnancy|1|||
146384254|NCT01766401|527906899|FG001|Overall Study|Pregnancy|1|||
146384255|NCT00935701|527906900|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
146384256|NCT01197794|527906901|FG000|Overall Study|Adverse Event|3|||
146384257|NCT01197794|527906902|FG001|Overall Study|Adverse Event|2|||
146384258|NCT01197794|527906903|FG002|Overall Study|Adverse Event|4|||
146384259|NCT01197794|527906904|FG003|Overall Study|Adverse Event|4|||
146384260|NCT01197794|527906905|FG004|Overall Study|Adverse Event|4|||
146384261|NCT01197794|527906906|FG005|Overall Study|Adverse Event|2|||
146384262|NCT01197794|527906907|FG006|Overall Study|Adverse Event|3|||
146384263|NCT01197794|527906901|FG000|Overall Study|Protocol Violation|0|||
146384264|NCT01197794|527906902|FG001|Overall Study|Protocol Violation|0|||
146384265|NCT01197794|527906903|FG002|Overall Study|Protocol Violation|0|||
146384266|NCT01197794|527906904|FG003|Overall Study|Protocol Violation|0|||
146384267|NCT01197794|527906905|FG004|Overall Study|Protocol Violation|2|||
146384268|NCT01197794|527906906|FG005|Overall Study|Protocol Violation|0|||
146384269|NCT01197794|527906907|FG006|Overall Study|Protocol Violation|1|||
146384270|NCT01197794|527906901|FG000|Overall Study|Development of study withdrawal criteria|3|||
146384271|NCT01197794|527906902|FG001|Overall Study|Development of study withdrawal criteria|0|||
146384272|NCT01197794|527906903|FG002|Overall Study|Development of study withdrawal criteria|0|||
146384273|NCT01197794|527906904|FG003|Overall Study|Development of study withdrawal criteria|1|||
146384274|NCT01197794|527906905|FG004|Overall Study|Development of study withdrawal criteria|0|||
146384275|NCT01197794|527906906|FG005|Overall Study|Development of study withdrawal criteria|0|||
146384276|NCT01197794|527906907|FG006|Overall Study|Development of study withdrawal criteria|1|||
146384277|NCT01197794|527906901|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
146384278|NCT01197794|527906902|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
146384279|NCT01197794|527906903|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
146384280|NCT01197794|527906904|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
146384281|NCT01197794|527906905|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
146384282|NCT01197794|527906906|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
146384283|NCT01197794|527906907|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
146384284|NCT01197794|527906901|FG000|Overall Study|Withdrawal by Subject|3|||
146384285|NCT01197794|527906902|FG001|Overall Study|Withdrawal by Subject|3|||
146384286|NCT01197794|527906903|FG002|Overall Study|Withdrawal by Subject|4|||
146384287|NCT01197794|527906904|FG003|Overall Study|Withdrawal by Subject|1|||
146384288|NCT01197794|527906905|FG004|Overall Study|Withdrawal by Subject|1|||
146384289|NCT01197794|527906906|FG005|Overall Study|Withdrawal by Subject|5|||
146384290|NCT01197794|527906907|FG006|Overall Study|Withdrawal by Subject|6|||
146384291|NCT01197794|527906901|FG000|Overall Study|Lost to Follow-up|1|||
146384292|NCT01197794|527906902|FG001|Overall Study|Lost to Follow-up|1|||
146384293|NCT01197794|527906903|FG002|Overall Study|Lost to Follow-up|0|||
146384294|NCT01197794|527906904|FG003|Overall Study|Lost to Follow-up|1|||
146384295|NCT01197794|527906905|FG004|Overall Study|Lost to Follow-up|0|||
146384296|NCT01197794|527906906|FG005|Overall Study|Lost to Follow-up|1|||
146384297|NCT01197794|527906907|FG006|Overall Study|Lost to Follow-up|0|||
146384298|NCT01197794|527906901|FG000|Overall Study|Other|1|||
146384299|NCT01197794|527906902|FG001|Overall Study|Other|1|||
146384300|NCT01197794|527906903|FG002|Overall Study|Other|3|||
146384301|NCT01197794|527906904|FG003|Overall Study|Other|0|||
146384302|NCT01197794|527906905|FG004|Overall Study|Other|2|||
146384303|NCT01197794|527906906|FG005|Overall Study|Other|2|||
146384304|NCT01197794|527906907|FG006|Overall Study|Other|4|||
146384305|NCT01055457|527906908|FG000|Overall Study|Lost to Follow-up|0|||
146384306|NCT01055457|527906909|FG001|Overall Study|Lost to Follow-up|1|||
146384307|NCT01055457|527906910|FG002|Overall Study|Lost to Follow-up|0|||
146384308|NCT01055457|527906911|FG003|Overall Study|Lost to Follow-up|0|||
146384309|NCT01055457|527906912|FG004|Overall Study|Lost to Follow-up|0|||
146384310|NCT01055457|527906913|FG005|Overall Study|Lost to Follow-up|1|||
146384311|NCT01055457|527906914|FG006|Overall Study|Lost to Follow-up|0|||
146384312|NCT01055457|527906915|FG007|Overall Study|Lost to Follow-up|0|||
146384313|NCT01055457|527906916|FG008|Overall Study|Lost to Follow-up|0|||
146384314|NCT01055457|527906917|FG009|Overall Study|Lost to Follow-up|0|||
146384315|NCT01055457|527906908|FG000|Overall Study|Protocol Violation|0|||
146384316|NCT01055457|527906909|FG001|Overall Study|Protocol Violation|0|||
146384317|NCT01055457|527906910|FG002|Overall Study|Protocol Violation|1|||
146384318|NCT01055457|527906911|FG003|Overall Study|Protocol Violation|1|||
146384319|NCT01055457|527906912|FG004|Overall Study|Protocol Violation|1|||
146384320|NCT01055457|527906913|FG005|Overall Study|Protocol Violation|2|||
146384321|NCT01055457|527906914|FG006|Overall Study|Protocol Violation|1|||
146384322|NCT01055457|527906915|FG007|Overall Study|Protocol Violation|0|||
146384323|NCT01055457|527906916|FG008|Overall Study|Protocol Violation|0|||
146384324|NCT01055457|527906917|FG009|Overall Study|Protocol Violation|1|||
146384325|NCT01055457|527906908|FG000|Overall Study|Subject Disinterest|0|||
146384326|NCT01055457|527906909|FG001|Overall Study|Subject Disinterest|0|||
146384327|NCT01055457|527906910|FG002|Overall Study|Subject Disinterest|0|||
146384328|NCT01055457|527906911|FG003|Overall Study|Subject Disinterest|0|||
146384329|NCT01055457|527906912|FG004|Overall Study|Subject Disinterest|0|||
146384330|NCT01055457|527906913|FG005|Overall Study|Subject Disinterest|0|||
146384331|NCT01055457|527906914|FG006|Overall Study|Subject Disinterest|0|||
146384332|NCT01055457|527906915|FG007|Overall Study|Subject Disinterest|1|||
146384333|NCT01055457|527906916|FG008|Overall Study|Subject Disinterest|0|||
146384334|NCT01055457|527906917|FG009|Overall Study|Subject Disinterest|0|||
146384335|NCT01055457|527906908|FG000|Overall Study|Subject Ineligible|1|||
146384336|NCT01055457|527906909|FG001|Overall Study|Subject Ineligible|0|||
146384337|NCT01055457|527906910|FG002|Overall Study|Subject Ineligible|1|||
146384338|NCT01055457|527906911|FG003|Overall Study|Subject Ineligible|0|||
146384339|NCT01055457|527906912|FG004|Overall Study|Subject Ineligible|1|||
146384340|NCT01055457|527906913|FG005|Overall Study|Subject Ineligible|0|||
146384341|NCT01055457|527906914|FG006|Overall Study|Subject Ineligible|0|||
146384342|NCT01055457|527906915|FG007|Overall Study|Subject Ineligible|0|||
146384343|NCT01055457|527906916|FG008|Overall Study|Subject Ineligible|0|||
146384344|NCT01055457|527906917|FG009|Overall Study|Subject Ineligible|0|||
146384345|NCT01055457|527906908|FG000|Overall Study|Discomfort|0|||
146384346|NCT01055457|527906909|FG001|Overall Study|Discomfort|0|||
146384347|NCT01055457|527906910|FG002|Overall Study|Discomfort|0|||
146384348|NCT01055457|527906911|FG003|Overall Study|Discomfort|0|||
146384349|NCT01055457|527906912|FG004|Overall Study|Discomfort|1|||
146384350|NCT01055457|527906913|FG005|Overall Study|Discomfort|0|||
146384351|NCT01055457|527906914|FG006|Overall Study|Discomfort|0|||
146384352|NCT01055457|527906915|FG007|Overall Study|Discomfort|0|||
146384353|NCT01055457|527906916|FG008|Overall Study|Discomfort|0|||
146384354|NCT01055457|527906917|FG009|Overall Study|Discomfort|0|||
146384355|NCT01055457|527906908|FG000|Overall Study|Pregnancy|0|||
146384356|NCT01055457|527906909|FG001|Overall Study|Pregnancy|0|||
146384357|NCT01055457|527906910|FG002|Overall Study|Pregnancy|0|||
146384358|NCT01055457|527906911|FG003|Overall Study|Pregnancy|1|||
146384359|NCT01055457|527906912|FG004|Overall Study|Pregnancy|0|||
146384360|NCT01055457|527906913|FG005|Overall Study|Pregnancy|0|||
146384361|NCT01055457|527906914|FG006|Overall Study|Pregnancy|0|||
146384362|NCT01055457|527906915|FG007|Overall Study|Pregnancy|0|||
146384363|NCT01055457|527906916|FG008|Overall Study|Pregnancy|0|||
146384364|NCT01055457|527906917|FG009|Overall Study|Pregnancy|0|||
146384365|NCT01055457|527906908|FG000|Overall Study|Adverse Event|0|||
146384366|NCT01055457|527906909|FG001|Overall Study|Adverse Event|0|||
146384367|NCT01055457|527906910|FG002|Overall Study|Adverse Event|0|||
146384368|NCT01055457|527906911|FG003|Overall Study|Adverse Event|1|||
146384369|NCT01055457|527906912|FG004|Overall Study|Adverse Event|0|||
146384370|NCT01055457|527906913|FG005|Overall Study|Adverse Event|0|||
146384371|NCT01055457|527906914|FG006|Overall Study|Adverse Event|0|||
146384372|NCT01055457|527906915|FG007|Overall Study|Adverse Event|0|||
146384373|NCT01055457|527906916|FG008|Overall Study|Adverse Event|0|||
146384374|NCT01055457|527906917|FG009|Overall Study|Adverse Event|0|||
146384375|NCT04055844|527906918|FG000|Overall Study|Adverse Event|12|||
146384376|NCT04055844|527906918|FG000|Overall Study|Poor Performance|1|||
146384377|NCT04055844|527906918|FG000|Overall Study|Death|1|||
146384378|NCT00703781|527906927|FG000|Overall Study|Withdrawal by Subject|1|||
146384379|NCT00703781|527906928|FG001|Overall Study|Withdrawal by Subject|2|||
146384380|NCT00703781|527906927|FG000|Overall Study|Cancelled surgery|1|||
146384381|NCT00703781|527906928|FG001|Overall Study|Cancelled surgery|0|||
146384382|NCT02683668|527906932|FG000|Period 2|Withdrawal by Subject|0|||
146384383|NCT02683668|527906933|FG001|Period 2|Withdrawal by Subject|1|||
146384384|NCT02683668|527906934|FG002|Period 2|Withdrawal by Subject|0|||
146384385|NCT03893630|527906937|FG000|Overall Study|Lost to Follow-up|5|||
146384386|NCT03893630|527906938|FG001|Overall Study|Lost to Follow-up|4|||
146384387|NCT03893630|527906939|FG002|Overall Study|Lost to Follow-up|2|||
146384388|NCT03893630|527906937|FG000|Overall Study|Withdrawal by Subject|3|||
146384389|NCT03893630|527906938|FG001|Overall Study|Withdrawal by Subject|6|||
146384390|NCT03893630|527906939|FG002|Overall Study|Withdrawal by Subject|3|||
146384391|NCT03893630|527906937|FG000|Overall Study|Discontinued Intervention|0|||
146384392|NCT03893630|527906938|FG001|Overall Study|Discontinued Intervention|4|||
146384393|NCT03893630|527906939|FG002|Overall Study|Discontinued Intervention|2|||
146384394|NCT03053180|527908578|FG000|Overall Study|Failure to Return|1|||
146384395|NCT01004861|527908586|FG000|Overall Study|Disease progression|3|||
146384396|NCT01004861|527908587|FG001|Overall Study|Disease progression|4|||
146384397|NCT01004861|527908588|FG002|Overall Study|Disease progression|5|||
146384398|NCT01004861|527908589|FG003|Overall Study|Disease progression|4|||
146384399|NCT01004861|527908590|FG004|Overall Study|Disease progression|4|||
146384400|NCT01004861|527908591|FG005|Overall Study|Disease progression|4|||
146384401|NCT01004861|527908592|FG006|Overall Study|Disease progression|5|||
146384402|NCT01004861|527908593|FG007|Overall Study|Disease progression|1|||
146384403|NCT01004861|527908594|FG008|Overall Study|Disease progression|4|||
146384404|NCT01004861|527908595|FG009|Overall Study|Disease progression|7|||
146384405|NCT01004861|527908596|FG010|Overall Study|Disease progression|6|||
146384406|NCT01004861|527908597|FG011|Overall Study|Disease progression|3|||
146384407|NCT01004861|527908598|FG012|Overall Study|Disease progression|8|||
146384408|NCT01004861|527908586|FG000|Overall Study|Physician Decision|0|||
146384409|NCT01004861|527908587|FG001|Overall Study|Physician Decision|2|||
146384410|NCT01004861|527908588|FG002|Overall Study|Physician Decision|1|||
146384411|NCT01004861|527908589|FG003|Overall Study|Physician Decision|1|||
146384412|NCT01004861|527908590|FG004|Overall Study|Physician Decision|1|||
146384413|NCT01004861|527908591|FG005|Overall Study|Physician Decision|0|||
146384414|NCT01004861|527908592|FG006|Overall Study|Physician Decision|0|||
146384415|NCT01004861|527908593|FG007|Overall Study|Physician Decision|1|||
146384416|NCT01004861|527908594|FG008|Overall Study|Physician Decision|0|||
146384417|NCT01004861|527908595|FG009|Overall Study|Physician Decision|0|||
146384418|NCT01004861|527908596|FG010|Overall Study|Physician Decision|0|||
146384419|NCT01004861|527908597|FG011|Overall Study|Physician Decision|0|||
146384420|NCT01004861|527908598|FG012|Overall Study|Physician Decision|3|||
146384421|NCT01004861|527908586|FG000|Overall Study|Adverse Event|0|||
146384422|NCT01004861|527908587|FG001|Overall Study|Adverse Event|0|||
146384423|NCT01004861|527908588|FG002|Overall Study|Adverse Event|0|||
146384424|NCT01004861|527908589|FG003|Overall Study|Adverse Event|1|||
146384425|NCT01004861|527908590|FG004|Overall Study|Adverse Event|0|||
146384426|NCT01004861|527908591|FG005|Overall Study|Adverse Event|2|||
146384427|NCT01004861|527908592|FG006|Overall Study|Adverse Event|1|||
146384428|NCT01004861|527908593|FG007|Overall Study|Adverse Event|1|||
146384429|NCT01004861|527908594|FG008|Overall Study|Adverse Event|13|||
146384430|NCT01004861|527908595|FG009|Overall Study|Adverse Event|1|||
146384431|NCT01004861|527908596|FG010|Overall Study|Adverse Event|1|||
146384432|NCT01004861|527908597|FG011|Overall Study|Adverse Event|0|||
146384433|NCT01004861|527908598|FG012|Overall Study|Adverse Event|2|||
146384434|NCT01004861|527908586|FG000|Overall Study|Protocol Violation|0|||
146384435|NCT01004861|527908587|FG001|Overall Study|Protocol Violation|0|||
146384436|NCT01004861|527908588|FG002|Overall Study|Protocol Violation|0|||
146384437|NCT01004861|527908589|FG003|Overall Study|Protocol Violation|0|||
146384438|NCT01004861|527908590|FG004|Overall Study|Protocol Violation|1|||
146384439|NCT01004861|527908591|FG005|Overall Study|Protocol Violation|0|||
146384440|NCT01004861|527908592|FG006|Overall Study|Protocol Violation|0|||
146384441|NCT01004861|527908593|FG007|Overall Study|Protocol Violation|0|||
146384442|NCT01004861|527908594|FG008|Overall Study|Protocol Violation|0|||
146384443|NCT01004861|527908595|FG009|Overall Study|Protocol Violation|0|||
146384444|NCT01004861|527908596|FG010|Overall Study|Protocol Violation|0|||
146384445|NCT01004861|527908597|FG011|Overall Study|Protocol Violation|0|||
146384446|NCT01004861|527908598|FG012|Overall Study|Protocol Violation|0|||
146384447|NCT01004861|527908586|FG000|Overall Study|Lost to Follow-up|0|||
146384448|NCT01004861|527908587|FG001|Overall Study|Lost to Follow-up|0|||
146384449|NCT01004861|527908588|FG002|Overall Study|Lost to Follow-up|0|||
146384450|NCT01004861|527908589|FG003|Overall Study|Lost to Follow-up|0|||
146384451|NCT01004861|527908590|FG004|Overall Study|Lost to Follow-up|0|||
146384452|NCT01004861|527908591|FG005|Overall Study|Lost to Follow-up|0|||
146384453|NCT01004861|527908592|FG006|Overall Study|Lost to Follow-up|0|||
146384454|NCT01004861|527908593|FG007|Overall Study|Lost to Follow-up|1|||
146384455|NCT01004861|527908594|FG008|Overall Study|Lost to Follow-up|3|||
146384456|NCT01004861|527908595|FG009|Overall Study|Lost to Follow-up|0|||
146384457|NCT01004861|527908596|FG010|Overall Study|Lost to Follow-up|0|||
146384458|NCT01004861|527908597|FG011|Overall Study|Lost to Follow-up|1|||
146384459|NCT01004861|527908598|FG012|Overall Study|Lost to Follow-up|0|||
146384460|NCT01004861|527908586|FG000|Overall Study|Non-compliance|0|||
146384461|NCT01004861|527908587|FG001|Overall Study|Non-compliance|0|||
146384462|NCT01004861|527908588|FG002|Overall Study|Non-compliance|0|||
146384463|NCT01004861|527908589|FG003|Overall Study|Non-compliance|0|||
146384464|NCT01004861|527908590|FG004|Overall Study|Non-compliance|0|||
146384465|NCT01004861|527908591|FG005|Overall Study|Non-compliance|0|||
146384466|NCT01004861|527908592|FG006|Overall Study|Non-compliance|0|||
146384467|NCT01004861|527908593|FG007|Overall Study|Non-compliance|0|||
146384468|NCT01004861|527908594|FG008|Overall Study|Non-compliance|5|||
146384469|NCT01004861|527908595|FG009|Overall Study|Non-compliance|0|||
146384470|NCT01004861|527908596|FG010|Overall Study|Non-compliance|0|||
146384471|NCT01004861|527908597|FG011|Overall Study|Non-compliance|0|||
146384472|NCT01004861|527908598|FG012|Overall Study|Non-compliance|1|||
146384473|NCT01004861|527908586|FG000|Overall Study|Other|0|||
146384474|NCT01004861|527908587|FG001|Overall Study|Other|0|||
146384475|NCT01004861|527908588|FG002|Overall Study|Other|0|||
146384476|NCT01004861|527908589|FG003|Overall Study|Other|0|||
146384477|NCT01004861|527908590|FG004|Overall Study|Other|0|||
146384478|NCT01004861|527908591|FG005|Overall Study|Other|0|||
146384479|NCT01004861|527908592|FG006|Overall Study|Other|0|||
146384480|NCT01004861|527908593|FG007|Overall Study|Other|0|||
146384481|NCT01004861|527908594|FG008|Overall Study|Other|0|||
146384482|NCT01004861|527908595|FG009|Overall Study|Other|2|||
146384483|NCT01004861|527908596|FG010|Overall Study|Other|1|||
146384484|NCT01004861|527908597|FG011|Overall Study|Other|2|||
146384485|NCT01004861|527908598|FG012|Overall Study|Other|3|||
146384486|NCT01004861|527908586|FG000|Overall Study|Patient decision|0|||
146384487|NCT01004861|527908587|FG001|Overall Study|Patient decision|0|||
146384488|NCT01004861|527908588|FG002|Overall Study|Patient decision|0|||
146384489|NCT01004861|527908589|FG003|Overall Study|Patient decision|0|||
146384490|NCT01004861|527908590|FG004|Overall Study|Patient decision|1|||
146384491|NCT01004861|527908591|FG005|Overall Study|Patient decision|0|||
146384492|NCT01004861|527908592|FG006|Overall Study|Patient decision|1|||
146384493|NCT01004861|527908593|FG007|Overall Study|Patient decision|0|||
146384494|NCT01004861|527908594|FG008|Overall Study|Patient decision|7|||
146384495|NCT01004861|527908595|FG009|Overall Study|Patient decision|1|||
146384496|NCT01004861|527908596|FG010|Overall Study|Patient decision|1|||
146384497|NCT01004861|527908597|FG011|Overall Study|Patient decision|2|||
146384498|NCT01004861|527908598|FG012|Overall Study|Patient decision|3|||
146384499|NCT01004861|527908586|FG000|Overall Study|Transitioned to Phase 4 study|0|||
146384500|NCT01004861|527908587|FG001|Overall Study|Transitioned to Phase 4 study|0|||
146384501|NCT01004861|527908588|FG002|Overall Study|Transitioned to Phase 4 study|0|||
146384502|NCT01004861|527908589|FG003|Overall Study|Transitioned to Phase 4 study|0|||
146384503|NCT01004861|527908590|FG004|Overall Study|Transitioned to Phase 4 study|0|||
146384504|NCT01004861|527908591|FG005|Overall Study|Transitioned to Phase 4 study|0|||
146384505|NCT01004861|527908592|FG006|Overall Study|Transitioned to Phase 4 study|0|||
146384506|NCT01004861|527908593|FG007|Overall Study|Transitioned to Phase 4 study|0|||
146384507|NCT01004861|527908594|FG008|Overall Study|Transitioned to Phase 4 study|2|||
146384508|NCT01004861|527908595|FG009|Overall Study|Transitioned to Phase 4 study|0|||
146384509|NCT01004861|527908596|FG010|Overall Study|Transitioned to Phase 4 study|0|||
146384510|NCT01004861|527908597|FG011|Overall Study|Transitioned to Phase 4 study|0|||
146384511|NCT01004861|527908598|FG012|Overall Study|Transitioned to Phase 4 study|0|||
146384512|NCT01004861|527908586|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384513|NCT01004861|527908587|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384514|NCT01004861|527908588|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384515|NCT01004861|527908589|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384516|NCT01004861|527908590|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384517|NCT01004861|527908591|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384518|NCT01004861|527908592|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384519|NCT01004861|527908593|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384520|NCT01004861|527908594|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
146384521|NCT01004861|527908595|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384522|NCT01004861|527908596|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384523|NCT01004861|527908597|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384524|NCT01004861|527908598|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
146384525|NCT01004861|527908586|FG000|Overall Study|Patient withdrew|0|||
146384526|NCT01004861|527908587|FG001|Overall Study|Patient withdrew|0|||
146384527|NCT01004861|527908588|FG002|Overall Study|Patient withdrew|0|||
146384528|NCT01004861|527908589|FG003|Overall Study|Patient withdrew|0|||
146384529|NCT01004861|527908590|FG004|Overall Study|Patient withdrew|0|||
146384530|NCT01004861|527908591|FG005|Overall Study|Patient withdrew|0|||
146384531|NCT01004861|527908592|FG006|Overall Study|Patient withdrew|0|||
146384532|NCT01004861|527908593|FG007|Overall Study|Patient withdrew|0|||
146384533|NCT01004861|527908594|FG008|Overall Study|Patient withdrew|1|||
146384534|NCT01004861|527908595|FG009|Overall Study|Patient withdrew|0|||
146384535|NCT01004861|527908596|FG010|Overall Study|Patient withdrew|0|||
146384536|NCT01004861|527908597|FG011|Overall Study|Patient withdrew|0|||
146384537|NCT01004861|527908598|FG012|Overall Study|Patient withdrew|0|||
146384538|NCT01004861|527908586|FG000|Overall Study|Surgical resection|0|||
146384539|NCT01004861|527908587|FG001|Overall Study|Surgical resection|0|||
146384540|NCT01004861|527908588|FG002|Overall Study|Surgical resection|0|||
146384541|NCT01004861|527908589|FG003|Overall Study|Surgical resection|0|||
146384542|NCT01004861|527908590|FG004|Overall Study|Surgical resection|0|||
146384543|NCT01004861|527908591|FG005|Overall Study|Surgical resection|0|||
146384544|NCT01004861|527908592|FG006|Overall Study|Surgical resection|0|||
146384545|NCT01004861|527908593|FG007|Overall Study|Surgical resection|0|||
146384546|NCT01004861|527908594|FG008|Overall Study|Surgical resection|1|||
146384547|NCT01004861|527908595|FG009|Overall Study|Surgical resection|0|||
146384548|NCT01004861|527908596|FG010|Overall Study|Surgical resection|0|||
146384549|NCT01004861|527908597|FG011|Overall Study|Surgical resection|0|||
146384550|NCT01004861|527908598|FG012|Overall Study|Surgical resection|0|||
146384551|NCT01004861|527908586|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384552|NCT01004861|527908587|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384553|NCT01004861|527908588|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384554|NCT01004861|527908589|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384555|NCT01004861|527908590|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384556|NCT01004861|527908591|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384557|NCT01004861|527908592|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384558|NCT01004861|527908593|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384559|NCT01004861|527908594|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
146384560|NCT01004861|527908595|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384561|NCT01004861|527908596|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384562|NCT01004861|527908597|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384563|NCT01004861|527908598|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
146384564|NCT01004861|527908586|FG000|Overall Study|Study termination by Sponsor|0|||
146384565|NCT01004861|527908587|FG001|Overall Study|Study termination by Sponsor|0|||
146384566|NCT01004861|527908588|FG002|Overall Study|Study termination by Sponsor|0|||
146384567|NCT01004861|527908589|FG003|Overall Study|Study termination by Sponsor|0|||
146384568|NCT01004861|527908590|FG004|Overall Study|Study termination by Sponsor|0|||
146384569|NCT01004861|527908591|FG005|Overall Study|Study termination by Sponsor|0|||
146384570|NCT01004861|527908592|FG006|Overall Study|Study termination by Sponsor|0|||
146384571|NCT01004861|527908593|FG007|Overall Study|Study termination by Sponsor|0|||
146384572|NCT01004861|527908594|FG008|Overall Study|Study termination by Sponsor|1|||
146384573|NCT01004861|527908595|FG009|Overall Study|Study termination by Sponsor|0|||
146384574|NCT01004861|527908596|FG010|Overall Study|Study termination by Sponsor|0|||
146384575|NCT01004861|527908597|FG011|Overall Study|Study termination by Sponsor|0|||
146384576|NCT01004861|527908598|FG012|Overall Study|Study termination by Sponsor|0|||
146384577|NCT01693562|527908599|FG000|Escalation Phase|Withdrawal by Subject|0|||
146384578|NCT01693562|527908600|FG001|Escalation Phase|Withdrawal by Subject|1|||
146384579|NCT01693562|527908601|FG002|Escalation Phase|Withdrawal by Subject|0|||
146384580|NCT01693562|527908602|FG003|Escalation Phase|Withdrawal by Subject|0|||
146384581|NCT01693562|527908603|FG004|Escalation Phase|Withdrawal by Subject|0|||
146384582|NCT01693562|527908604|FG005|Escalation Phase|Withdrawal by Subject|2|||
146384583|NCT01693562|527908605|FG006|Escalation Phase|Withdrawal by Subject|0|||
146384584|NCT01693562|527908606|FG007|Escalation Phase|Withdrawal by Subject|0|||
146384585|NCT01693562|527908607|FG008|Escalation Phase|Withdrawal by Subject|0|||
146384586|NCT01693562|527908608|FG009|Escalation Phase|Withdrawal by Subject|0|||
146384587|NCT01693562|527908609|FG010|Escalation Phase|Withdrawal by Subject|0|||
146384588|NCT01693562|527908610|FG011|Escalation Phase|Withdrawal by Subject|0|||
146384589|NCT01693562|527908611|FG012|Escalation Phase|Withdrawal by Subject|0|||
146384590|NCT01693562|527908612|FG013|Escalation Phase|Withdrawal by Subject|0|||
146384591|NCT01693562|527908613|FG014|Escalation Phase|Withdrawal by Subject|0|||
146384592|NCT01693562|527908614|FG015|Escalation Phase|Withdrawal by Subject|0|||
146384593|NCT01693562|527908615|FG016|Escalation Phase|Withdrawal by Subject|0|||
146384594|NCT01693562|527908616|FG017|Escalation Phase|Withdrawal by Subject|0|||
146384595|NCT01693562|527908617|FG018|Escalation Phase|Withdrawal by Subject|0|||
146384596|NCT01693562|527908618|FG019|Escalation Phase|Withdrawal by Subject|0|||
146384597|NCT01693562|527908619|FG020|Escalation Phase|Withdrawal by Subject|0|||
146384598|NCT01693562|527908620|FG021|Escalation Phase|Withdrawal by Subject|0|||
146384599|NCT01693562|527908621|FG022|Escalation Phase|Withdrawal by Subject|0|||
146384600|NCT01693562|527908599|FG000|Escalation Phase|Death|4|||
146384601|NCT01693562|527908600|FG001|Escalation Phase|Death|2|||
146384602|NCT01693562|527908601|FG002|Escalation Phase|Death|0|||
146384603|NCT01693562|527908602|FG003|Escalation Phase|Death|3|||
146384604|NCT01693562|527908603|FG004|Escalation Phase|Death|6|||
146384605|NCT01693562|527908604|FG005|Escalation Phase|Death|4|||
146384606|NCT01693562|527908605|FG006|Escalation Phase|Death|0|||
146384607|NCT01693562|527908606|FG007|Escalation Phase|Death|0|||
146384608|NCT01693562|527908607|FG008|Escalation Phase|Death|0|||
146384609|NCT01693562|527908608|FG009|Escalation Phase|Death|0|||
146384610|NCT01693562|527908609|FG010|Escalation Phase|Death|0|||
146384611|NCT01693562|527908610|FG011|Escalation Phase|Death|0|||
146384612|NCT01693562|527908611|FG012|Escalation Phase|Death|0|||
146384613|NCT01693562|527908612|FG013|Escalation Phase|Death|0|||
146384614|NCT01693562|527908613|FG014|Escalation Phase|Death|0|||
146384615|NCT01693562|527908614|FG015|Escalation Phase|Death|0|||
146384616|NCT01693562|527908615|FG016|Escalation Phase|Death|0|||
146384617|NCT01693562|527908616|FG017|Escalation Phase|Death|0|||
146384618|NCT01693562|527908617|FG018|Escalation Phase|Death|0|||
146384619|NCT01693562|527908618|FG019|Escalation Phase|Death|0|||
146384620|NCT01693562|527908619|FG020|Escalation Phase|Death|0|||
146384621|NCT01693562|527908620|FG021|Escalation Phase|Death|0|||
146384622|NCT01693562|527908621|FG022|Escalation Phase|Death|0|||
146384623|NCT01693562|527908599|FG000|Escalation Phase|Lost to Follow-up|0|||
146384624|NCT01693562|527908600|FG001|Escalation Phase|Lost to Follow-up|1|||
146384625|NCT01693562|527908601|FG002|Escalation Phase|Lost to Follow-up|1|||
146384626|NCT01693562|527908602|FG003|Escalation Phase|Lost to Follow-up|0|||
146384627|NCT01693562|527908603|FG004|Escalation Phase|Lost to Follow-up|0|||
146384628|NCT01693562|527908604|FG005|Escalation Phase|Lost to Follow-up|0|||
146384629|NCT01693562|527908605|FG006|Escalation Phase|Lost to Follow-up|0|||
146384630|NCT01693562|527908606|FG007|Escalation Phase|Lost to Follow-up|0|||
146384631|NCT01693562|527908607|FG008|Escalation Phase|Lost to Follow-up|0|||
146384632|NCT01693562|527908608|FG009|Escalation Phase|Lost to Follow-up|0|||
146384633|NCT01693562|527908609|FG010|Escalation Phase|Lost to Follow-up|0|||
146384634|NCT01693562|527908610|FG011|Escalation Phase|Lost to Follow-up|0|||
146384635|NCT01693562|527908611|FG012|Escalation Phase|Lost to Follow-up|0|||
146384636|NCT01693562|527908612|FG013|Escalation Phase|Lost to Follow-up|0|||
146384637|NCT01693562|527908613|FG014|Escalation Phase|Lost to Follow-up|0|||
146384638|NCT01693562|527908614|FG015|Escalation Phase|Lost to Follow-up|0|||
146384639|NCT01693562|527908615|FG016|Escalation Phase|Lost to Follow-up|0|||
146384640|NCT01693562|527908616|FG017|Escalation Phase|Lost to Follow-up|0|||
146384641|NCT01693562|527908617|FG018|Escalation Phase|Lost to Follow-up|0|||
146384642|NCT01693562|527908618|FG019|Escalation Phase|Lost to Follow-up|0|||
146384643|NCT01693562|527908619|FG020|Escalation Phase|Lost to Follow-up|0|||
146384644|NCT01693562|527908620|FG021|Escalation Phase|Lost to Follow-up|0|||
146384645|NCT01693562|527908621|FG022|Escalation Phase|Lost to Follow-up|0|||
146384646|NCT01693562|527908599|FG000|Escalation Phase|Other|0|||
146384647|NCT01693562|527908600|FG001|Escalation Phase|Other|0|||
146384648|NCT01693562|527908601|FG002|Escalation Phase|Other|2|||
146384649|NCT01693562|527908602|FG003|Escalation Phase|Other|0|||
146384650|NCT01693562|527908603|FG004|Escalation Phase|Other|0|||
146384651|NCT01693562|527908604|FG005|Escalation Phase|Other|1|||
146384652|NCT01693562|527908605|FG006|Escalation Phase|Other|0|||
146384653|NCT01693562|527908606|FG007|Escalation Phase|Other|0|||
146384654|NCT01693562|527908607|FG008|Escalation Phase|Other|0|||
146384655|NCT01693562|527908608|FG009|Escalation Phase|Other|0|||
146384656|NCT01693562|527908609|FG010|Escalation Phase|Other|0|||
146384657|NCT01693562|527908610|FG011|Escalation Phase|Other|0|||
146384658|NCT01693562|527908611|FG012|Escalation Phase|Other|0|||
146384659|NCT01693562|527908612|FG013|Escalation Phase|Other|0|||
146384660|NCT01693562|527908613|FG014|Escalation Phase|Other|0|||
146384661|NCT01693562|527908614|FG015|Escalation Phase|Other|0|||
146384662|NCT01693562|527908615|FG016|Escalation Phase|Other|0|||
146384663|NCT01693562|527908616|FG017|Escalation Phase|Other|0|||
146384664|NCT01693562|527908617|FG018|Escalation Phase|Other|0|||
146384665|NCT01693562|527908618|FG019|Escalation Phase|Other|0|||
146384666|NCT01693562|527908619|FG020|Escalation Phase|Other|0|||
146384667|NCT01693562|527908620|FG021|Escalation Phase|Other|0|||
146384668|NCT01693562|527908621|FG022|Escalation Phase|Other|0|||
146384669|NCT01693562|527908599|FG000|Exploration Phase|Withdrawal by Subject|0|||
146384670|NCT01693562|527908600|FG001|Exploration Phase|Withdrawal by Subject|0|||
146384671|NCT01693562|527908601|FG002|Exploration Phase|Withdrawal by Subject|0|||
146384672|NCT01693562|527908602|FG003|Exploration Phase|Withdrawal by Subject|0|||
146384673|NCT01693562|527908603|FG004|Exploration Phase|Withdrawal by Subject|0|||
146384674|NCT01693562|527908604|FG005|Exploration Phase|Withdrawal by Subject|0|||
146384675|NCT01693562|527908605|FG006|Exploration Phase|Withdrawal by Subject|2|||
146384676|NCT01693562|527908606|FG007|Exploration Phase|Withdrawal by Subject|0|||
146384677|NCT01693562|527908607|FG008|Exploration Phase|Withdrawal by Subject|0|||
146384678|NCT01693562|527908608|FG009|Exploration Phase|Withdrawal by Subject|0|||
146384679|NCT01693562|527908609|FG010|Exploration Phase|Withdrawal by Subject|0|||
146384680|NCT01693562|527908610|FG011|Exploration Phase|Withdrawal by Subject|0|||
146384681|NCT01693562|527908611|FG012|Exploration Phase|Withdrawal by Subject|0|||
146384682|NCT01693562|527908612|FG013|Exploration Phase|Withdrawal by Subject|0|||
146384683|NCT01693562|527908613|FG014|Exploration Phase|Withdrawal by Subject|0|||
146384684|NCT01693562|527908614|FG015|Exploration Phase|Withdrawal by Subject|0|||
146384685|NCT01693562|527908615|FG016|Exploration Phase|Withdrawal by Subject|0|||
146384686|NCT01693562|527908616|FG017|Exploration Phase|Withdrawal by Subject|0|||
146384687|NCT01693562|527908617|FG018|Exploration Phase|Withdrawal by Subject|0|||
146384688|NCT01693562|527908618|FG019|Exploration Phase|Withdrawal by Subject|0|||
146384689|NCT01693562|527908619|FG020|Exploration Phase|Withdrawal by Subject|0|||
146384690|NCT01693562|527908620|FG021|Exploration Phase|Withdrawal by Subject|0|||
146384691|NCT01693562|527908621|FG022|Exploration Phase|Withdrawal by Subject|0|||
146384692|NCT01693562|527908599|FG000|Exploration Phase|Death|0|||
146384693|NCT01693562|527908600|FG001|Exploration Phase|Death|0|||
146384694|NCT01693562|527908601|FG002|Exploration Phase|Death|0|||
146384695|NCT01693562|527908602|FG003|Exploration Phase|Death|0|||
146384696|NCT01693562|527908603|FG004|Exploration Phase|Death|0|||
146384697|NCT01693562|527908604|FG005|Exploration Phase|Death|0|||
146384698|NCT01693562|527908605|FG006|Exploration Phase|Death|17|||
146384699|NCT01693562|527908606|FG007|Exploration Phase|Death|0|||
146384700|NCT01693562|527908607|FG008|Exploration Phase|Death|0|||
146384701|NCT01693562|527908608|FG009|Exploration Phase|Death|0|||
146384702|NCT01693562|527908609|FG010|Exploration Phase|Death|0|||
146384703|NCT01693562|527908610|FG011|Exploration Phase|Death|0|||
146384704|NCT01693562|527908611|FG012|Exploration Phase|Death|0|||
146384705|NCT01693562|527908612|FG013|Exploration Phase|Death|0|||
146384706|NCT01693562|527908613|FG014|Exploration Phase|Death|0|||
146384707|NCT01693562|527908614|FG015|Exploration Phase|Death|0|||
146384708|NCT01693562|527908615|FG016|Exploration Phase|Death|0|||
146384709|NCT01693562|527908616|FG017|Exploration Phase|Death|0|||
146384710|NCT01693562|527908617|FG018|Exploration Phase|Death|0|||
146384711|NCT01693562|527908618|FG019|Exploration Phase|Death|0|||
146384712|NCT01693562|527908619|FG020|Exploration Phase|Death|0|||
146384713|NCT01693562|527908620|FG021|Exploration Phase|Death|0|||
146384714|NCT01693562|527908621|FG022|Exploration Phase|Death|0|||
146384715|NCT01693562|527908599|FG000|Exploration Phase|Other|0|||
146384716|NCT01693562|527908600|FG001|Exploration Phase|Other|0|||
146384717|NCT01693562|527908601|FG002|Exploration Phase|Other|0|||
146384718|NCT01693562|527908602|FG003|Exploration Phase|Other|0|||
146384719|NCT01693562|527908603|FG004|Exploration Phase|Other|0|||
146384720|NCT01693562|527908604|FG005|Exploration Phase|Other|0|||
146384721|NCT01693562|527908605|FG006|Exploration Phase|Other|2|||
146384722|NCT01693562|527908606|FG007|Exploration Phase|Other|0|||
146384723|NCT01693562|527908607|FG008|Exploration Phase|Other|0|||
146384724|NCT01693562|527908608|FG009|Exploration Phase|Other|0|||
146384725|NCT01693562|527908609|FG010|Exploration Phase|Other|0|||
146384726|NCT01693562|527908610|FG011|Exploration Phase|Other|0|||
146384727|NCT01693562|527908611|FG012|Exploration Phase|Other|0|||
146384728|NCT01693562|527908612|FG013|Exploration Phase|Other|0|||
146384729|NCT01693562|527908613|FG014|Exploration Phase|Other|0|||
146384730|NCT01693562|527908614|FG015|Exploration Phase|Other|0|||
146384731|NCT01693562|527908615|FG016|Exploration Phase|Other|0|||
146384732|NCT01693562|527908616|FG017|Exploration Phase|Other|0|||
146384733|NCT01693562|527908617|FG018|Exploration Phase|Other|0|||
146384734|NCT01693562|527908618|FG019|Exploration Phase|Other|0|||
146384735|NCT01693562|527908619|FG020|Exploration Phase|Other|0|||
146384736|NCT01693562|527908620|FG021|Exploration Phase|Other|0|||
146384737|NCT01693562|527908621|FG022|Exploration Phase|Other|0|||
146384738|NCT01693562|527908599|FG000|Expansion Phase|Withdrawal by Subject|0|||
146384739|NCT01693562|527908600|FG001|Expansion Phase|Withdrawal by Subject|0|||
146384740|NCT01693562|527908601|FG002|Expansion Phase|Withdrawal by Subject|0|||
146384741|NCT01693562|527908602|FG003|Expansion Phase|Withdrawal by Subject|0|||
146384742|NCT01693562|527908603|FG004|Expansion Phase|Withdrawal by Subject|0|||
146384743|NCT01693562|527908604|FG005|Expansion Phase|Withdrawal by Subject|0|||
146384744|NCT01693562|527908605|FG006|Expansion Phase|Withdrawal by Subject|0|||
146384745|NCT01693562|527908606|FG007|Expansion Phase|Withdrawal by Subject|16|||
146384746|NCT01693562|527908607|FG008|Expansion Phase|Withdrawal by Subject|2|||
146384747|NCT01693562|527908608|FG009|Expansion Phase|Withdrawal by Subject|54|||
146384748|NCT01693562|527908609|FG010|Expansion Phase|Withdrawal by Subject|2|||
146384749|NCT01693562|527908610|FG011|Expansion Phase|Withdrawal by Subject|2|||
146384750|NCT01693562|527908611|FG012|Expansion Phase|Withdrawal by Subject|3|||
146384751|NCT01693562|527908612|FG013|Expansion Phase|Withdrawal by Subject|5|||
146384752|NCT01693562|527908613|FG014|Expansion Phase|Withdrawal by Subject|16|||
146384753|NCT01693562|527908614|FG015|Expansion Phase|Withdrawal by Subject|7|||
146384754|NCT01693562|527908615|FG016|Expansion Phase|Withdrawal by Subject|40|||
146384755|NCT01693562|527908616|FG017|Expansion Phase|Withdrawal by Subject|4|||
146384756|NCT01693562|527908617|FG018|Expansion Phase|Withdrawal by Subject|8|||
146384757|NCT01693562|527908618|FG019|Expansion Phase|Withdrawal by Subject|3|||
146384758|NCT01693562|527908619|FG020|Expansion Phase|Withdrawal by Subject|1|||
146384759|NCT01693562|527908620|FG021|Expansion Phase|Withdrawal by Subject|8|||
146384760|NCT01693562|527908621|FG022|Expansion Phase|Withdrawal by Subject|1|||
146384761|NCT01693562|527908599|FG000|Expansion Phase|Death|0|||
146384762|NCT01693562|527908600|FG001|Expansion Phase|Death|0|||
146384763|NCT01693562|527908601|FG002|Expansion Phase|Death|0|||
146384764|NCT01693562|527908602|FG003|Expansion Phase|Death|0|||
146384765|NCT01693562|527908603|FG004|Expansion Phase|Death|0|||
146384766|NCT01693562|527908604|FG005|Expansion Phase|Death|0|||
146384767|NCT01693562|527908605|FG006|Expansion Phase|Death|0|||
146384768|NCT01693562|527908606|FG007|Expansion Phase|Death|42|||
146384769|NCT01693562|527908607|FG008|Expansion Phase|Death|17|||
146384770|NCT01693562|527908608|FG009|Expansion Phase|Death|208|||
146384771|NCT01693562|527908609|FG010|Expansion Phase|Death|30|||
146384772|NCT01693562|527908610|FG011|Expansion Phase|Death|8|||
146384773|NCT01693562|527908611|FG012|Expansion Phase|Death|19|||
146384774|NCT01693562|527908612|FG013|Expansion Phase|Death|42|||
146384775|NCT01693562|527908613|FG014|Expansion Phase|Death|23|||
146384776|NCT01693562|527908614|FG015|Expansion Phase|Death|23|||
146384777|NCT01693562|527908615|FG016|Expansion Phase|Death|128|||
146384778|NCT01693562|527908616|FG017|Expansion Phase|Death|16|||
146384779|NCT01693562|527908617|FG018|Expansion Phase|Death|36|||
146384780|NCT01693562|527908618|FG019|Expansion Phase|Death|16|||
146384781|NCT01693562|527908619|FG020|Expansion Phase|Death|17|||
146384782|NCT01693562|527908620|FG021|Expansion Phase|Death|35|||
146384783|NCT01693562|527908621|FG022|Expansion Phase|Death|7|||
146384784|NCT01693562|527908599|FG000|Expansion Phase|Lost to Follow-up|0|||
146384785|NCT01693562|527908600|FG001|Expansion Phase|Lost to Follow-up|0|||
146384786|NCT01693562|527908601|FG002|Expansion Phase|Lost to Follow-up|0|||
146384787|NCT01693562|527908602|FG003|Expansion Phase|Lost to Follow-up|0|||
146384788|NCT01693562|527908603|FG004|Expansion Phase|Lost to Follow-up|0|||
146384789|NCT01693562|527908604|FG005|Expansion Phase|Lost to Follow-up|0|||
146384790|NCT01693562|527908605|FG006|Expansion Phase|Lost to Follow-up|0|||
146384791|NCT01693562|527908606|FG007|Expansion Phase|Lost to Follow-up|1|||
146384792|NCT01693562|527908607|FG008|Expansion Phase|Lost to Follow-up|2|||
146384793|NCT01693562|527908608|FG009|Expansion Phase|Lost to Follow-up|10|||
146384794|NCT01693562|527908609|FG010|Expansion Phase|Lost to Follow-up|4|||
146384795|NCT01693562|527908610|FG011|Expansion Phase|Lost to Follow-up|4|||
146384796|NCT01693562|527908611|FG012|Expansion Phase|Lost to Follow-up|1|||
146384797|NCT01693562|527908612|FG013|Expansion Phase|Lost to Follow-up|3|||
146384798|NCT01693562|527908613|FG014|Expansion Phase|Lost to Follow-up|0|||
146384799|NCT01693562|527908614|FG015|Expansion Phase|Lost to Follow-up|1|||
146384800|NCT01693562|527908615|FG016|Expansion Phase|Lost to Follow-up|1|||
146384801|NCT01693562|527908616|FG017|Expansion Phase|Lost to Follow-up|0|||
146384802|NCT01693562|527908617|FG018|Expansion Phase|Lost to Follow-up|2|||
146384803|NCT01693562|527908618|FG019|Expansion Phase|Lost to Follow-up|1|||
146384804|NCT01693562|527908619|FG020|Expansion Phase|Lost to Follow-up|2|||
146384805|NCT01693562|527908620|FG021|Expansion Phase|Lost to Follow-up|2|||
146384806|NCT01693562|527908621|FG022|Expansion Phase|Lost to Follow-up|1|||
146384807|NCT01693562|527908599|FG000|Expansion Phase|Other|0|||
146384808|NCT01693562|527908600|FG001|Expansion Phase|Other|0|||
146384809|NCT01693562|527908601|FG002|Expansion Phase|Other|0|||
146384810|NCT01693562|527908602|FG003|Expansion Phase|Other|0|||
146384811|NCT01693562|527908603|FG004|Expansion Phase|Other|0|||
146384812|NCT01693562|527908604|FG005|Expansion Phase|Other|0|||
146384813|NCT01693562|527908605|FG006|Expansion Phase|Other|0|||
146384814|NCT01693562|527908606|FG007|Expansion Phase|Other|3|||
146384815|NCT01693562|527908607|FG008|Expansion Phase|Other|1|||
146384816|NCT01693562|527908608|FG009|Expansion Phase|Other|28|||
146384817|NCT01693562|527908609|FG010|Expansion Phase|Other|4|||
146384818|NCT01693562|527908610|FG011|Expansion Phase|Other|7|||
146384819|NCT01693562|527908611|FG012|Expansion Phase|Other|0|||
146384820|NCT01693562|527908612|FG013|Expansion Phase|Other|1|||
146384821|NCT01693562|527908613|FG014|Expansion Phase|Other|1|||
146384822|NCT01693562|527908614|FG015|Expansion Phase|Other|0|||
146384823|NCT01693562|527908615|FG016|Expansion Phase|Other|28|||
146384824|NCT01693562|527908616|FG017|Expansion Phase|Other|0|||
146384825|NCT01693562|527908617|FG018|Expansion Phase|Other|1|||
146384826|NCT01693562|527908618|FG019|Expansion Phase|Other|0|||
146384827|NCT01693562|527908619|FG020|Expansion Phase|Other|1|||
146384828|NCT01693562|527908620|FG021|Expansion Phase|Other|17|||
146384829|NCT01693562|527908621|FG022|Expansion Phase|Other|1|||
146384830|NCT02759939|527908622|FG000|Overall Study|Missing data on first outcome assessed|11|||
146384831|NCT02759939|527908623|FG001|Overall Study|Missing data on first outcome assessed|2|||
146384832|NCT02759939|527908624|FG002|Overall Study|Missing data on first outcome assessed|5|||
146384833|NCT02759939|527908625|FG003|Overall Study|Missing data on first outcome assessed|2|||
146384834|NCT02759939|527908622|FG000|Overall Study|Ineligible for T2 and T3|310|||
146384835|NCT02759939|527908623|FG001|Overall Study|Ineligible for T2 and T3|179|||
146384836|NCT02759939|527908624|FG002|Overall Study|Ineligible for T2 and T3|366|||
146384837|NCT02759939|527908625|FG003|Overall Study|Ineligible for T2 and T3|391|||
146384838|NCT02759939|527908622|FG000|Overall Study|Lost to Follow-up|735|||
146384839|NCT02759939|527908623|FG001|Overall Study|Lost to Follow-up|791|||
146384840|NCT02759939|527908624|FG002|Overall Study|Lost to Follow-up|783|||
146384841|NCT02759939|527908625|FG003|Overall Study|Lost to Follow-up|650|||
146384842|NCT00087594|527908626|FG000|Overall Study|Adverse Event|2|||
146384843|NCT00087594|527908627|FG001|Overall Study|Adverse Event|3|||
146384844|NCT00087594|527908626|FG000|Overall Study|Lost to Follow-up|0|||
146384845|NCT00087594|527908627|FG001|Overall Study|Lost to Follow-up|2|||
146384846|NCT00087594|527908626|FG000|Overall Study|Withdrawal by Subject|4|||
146384847|NCT00087594|527908627|FG001|Overall Study|Withdrawal by Subject|2|||
146384848|NCT00087594|527908626|FG000|Overall Study|Lack of Efficacy|2|||
146384849|NCT00087594|527908627|FG001|Overall Study|Lack of Efficacy|5|||
146384850|NCT04657003|527908628|FG000|Overall Study|Adverse Event|5|||
146384851|NCT04657003|527908629|FG001|Overall Study|Adverse Event|1|||
146384852|NCT04657003|527908630|FG002|Overall Study|Adverse Event|5|||
146384853|NCT04657003|527908628|FG000|Overall Study|Death|0|||
146384854|NCT04657003|527908629|FG001|Overall Study|Death|2|||
146384855|NCT04657003|527908630|FG002|Overall Study|Death|0|||
146384856|NCT04657003|527908628|FG000|Overall Study|Lost to Follow-up|8|||
146384857|NCT04657003|527908629|FG001|Overall Study|Lost to Follow-up|4|||
146384858|NCT04657003|527908630|FG002|Overall Study|Lost to Follow-up|10|||
146384859|NCT04657003|527908628|FG000|Overall Study|Other - As Reported by Investigator|3|||
146384860|NCT04657003|527908629|FG001|Overall Study|Other - As Reported by Investigator|2|||
146384861|NCT04657003|527908630|FG002|Overall Study|Other - As Reported by Investigator|2|||
146384862|NCT04657003|527908628|FG000|Overall Study|Pregnancy|2|||
146384863|NCT04657003|527908629|FG001|Overall Study|Pregnancy|0|||
146384864|NCT04657003|527908630|FG002|Overall Study|Pregnancy|2|||
146384865|NCT04657003|527908628|FG000|Overall Study|Withdrawal by Subject|16|||
146384866|NCT04657003|527908629|FG001|Overall Study|Withdrawal by Subject|7|||
146384867|NCT04657003|527908630|FG002|Overall Study|Withdrawal by Subject|10|||
146384868|NCT00768040|527908633|FG000|Overall Study|Adverse Event|3|||
146384869|NCT00768040|527908634|FG001|Overall Study|Adverse Event|2|||
146384870|NCT00768040|527908633|FG000|Overall Study|Abnormal laboratory value|1|||
146384871|NCT00768040|527908634|FG001|Overall Study|Abnormal laboratory value|1|||
146384872|NCT01823991|527908635|FG000|Overall Study|Withdrawal by Subject|8|||
146384873|NCT01823991|527908636|FG001|Overall Study|Withdrawal by Subject|5|||
146384874|NCT02185040|527908641|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
146384875|NCT02185040|527908642|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
146384876|NCT02185040|527908643|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
146384877|NCT02185040|527908644|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
146384878|NCT02185040|527908645|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
146384879|NCT02185040|527908646|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
146384880|NCT02185040|527908647|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
146384881|NCT02185040|527908641|FG000|Part 1 Treatment Phase|Adverse Event|1|||
146384882|NCT02185040|527908642|FG001|Part 1 Treatment Phase|Adverse Event|0|||
146384883|NCT02185040|527908643|FG002|Part 1 Treatment Phase|Adverse Event|0|||
146384884|NCT02185040|527908644|FG003|Part 1 Treatment Phase|Adverse Event|2|||
146384885|NCT02185040|527908645|FG004|Part 1 Treatment Phase|Adverse Event|3|||
146384886|NCT02185040|527908646|FG005|Part 1 Treatment Phase|Adverse Event|0|||
146384887|NCT02185040|527908647|FG006|Part 1 Treatment Phase|Adverse Event|0|||
146384888|NCT02185040|527908641|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384889|NCT02185040|527908642|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
146384890|NCT02185040|527908643|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384891|NCT02185040|527908644|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384892|NCT02185040|527908645|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384893|NCT02185040|527908646|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384894|NCT02185040|527908647|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
146384895|NCT02185040|527908641|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384896|NCT02185040|527908642|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
146384897|NCT02185040|527908643|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384898|NCT02185040|527908644|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384899|NCT02185040|527908645|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384900|NCT02185040|527908646|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384901|NCT02185040|527908647|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
146384902|NCT02185040|527908641|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
146384903|NCT02185040|527908642|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
146384904|NCT02185040|527908643|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
146384905|NCT02185040|527908644|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
146384906|NCT02185040|527908645|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
146384907|NCT02185040|527908646|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
146384908|NCT02185040|527908647|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
146384909|NCT02185040|527908641|FG000|Active Treatment Extension Phase|Adverse Event|0|||
146384910|NCT02185040|527908642|FG001|Active Treatment Extension Phase|Adverse Event|0|||
146384911|NCT02185040|527908643|FG002|Active Treatment Extension Phase|Adverse Event|0|||
146384912|NCT02185040|527908644|FG003|Active Treatment Extension Phase|Adverse Event|0|||
146384913|NCT02185040|527908645|FG004|Active Treatment Extension Phase|Adverse Event|0|||
146384914|NCT02185040|527908646|FG005|Active Treatment Extension Phase|Adverse Event|1|||
146384915|NCT02185040|527908647|FG006|Active Treatment Extension Phase|Adverse Event|4|||
146384916|NCT02185040|527908641|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146384917|NCT02185040|527908642|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146384918|NCT02185040|527908643|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146384919|NCT02185040|527908644|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146384920|NCT02185040|527908645|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
146384921|NCT02185040|527908646|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
146384922|NCT02185040|527908647|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
146384923|NCT02185040|527908641|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384924|NCT02185040|527908642|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384925|NCT02185040|527908643|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384926|NCT02185040|527908644|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384927|NCT02185040|527908645|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384928|NCT02185040|527908646|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
146384929|NCT02185040|527908647|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
146384930|NCT03347279|527908648|FG000|Overall Study|Withdrawal by Subject|8|||
146384931|NCT03347279|527908649|FG001|Overall Study|Withdrawal by Subject|15|||
146384932|NCT03347279|527908648|FG000|Overall Study|Death|0|||
146384933|NCT03347279|527908649|FG001|Overall Study|Death|2|||
146384934|NCT03347279|527908648|FG000|Overall Study|Lost to Follow-up|5|||
146384935|NCT03347279|527908649|FG001|Overall Study|Lost to Follow-up|2|||
146384936|NCT03347279|527908648|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
146384937|NCT03347279|527908649|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
146384938|NCT02987205|527908653|FG000|Overall Study|Adverse Event|1|||
146384939|NCT02987205|527908653|FG000|Overall Study|Withdrawal by Subject|3|||
146384940|NCT03558503|527908654|FG000|Overall Study|Adverse Event|1|||
146384941|NCT03558503|527908654|FG000|Overall Study|Death|1|||
146384942|NCT03558503|527908654|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
146384943|NCT02094612|527908655|FG000|Overall Study|Lost to Follow-up|47|||
146384944|NCT02094612|527908656|FG001|Overall Study|Lost to Follow-up|47|||
146384945|NCT02094612|527908655|FG000|Overall Study|Never started ADHD medication|32|||
146384946|NCT02094612|527908656|FG001|Overall Study|Never started ADHD medication|23|||
146384947|NCT01542632|527908657|FG000|Overall Study|Withdrawal of Consent|0|||
146384948|NCT01542632|527908658|FG001|Overall Study|Withdrawal of Consent|0|||
146384949|NCT01542632|527908659|FG002|Overall Study|Withdrawal of Consent|0|||
146384950|NCT01542632|527908660|FG003|Overall Study|Withdrawal of Consent|2|||
146384951|NCT01542632|527908661|FG004|Overall Study|Withdrawal of Consent|3|||
146384952|NCT01542632|527908662|FG005|Overall Study|Withdrawal of Consent|0|||
146384953|NCT01542632|527908657|FG000|Overall Study|Adverse Event|0|||
146384954|NCT01542632|527908658|FG001|Overall Study|Adverse Event|0|||
146384955|NCT01542632|527908659|FG002|Overall Study|Adverse Event|1|||
146384956|NCT01542632|527908660|FG003|Overall Study|Adverse Event|0|||
146384957|NCT01542632|527908661|FG004|Overall Study|Adverse Event|0|||
146384958|NCT01542632|527908662|FG005|Overall Study|Adverse Event|0|||
146384959|NCT01542632|527908657|FG000|Overall Study|Lost to Follow-up|0|||
146384960|NCT01542632|527908658|FG001|Overall Study|Lost to Follow-up|1|||
146384961|NCT01542632|527908659|FG002|Overall Study|Lost to Follow-up|0|||
146384962|NCT01542632|527908660|FG003|Overall Study|Lost to Follow-up|0|||
146384963|NCT01542632|527908661|FG004|Overall Study|Lost to Follow-up|0|||
146384964|NCT01542632|527908662|FG005|Overall Study|Lost to Follow-up|0|||
146384965|NCT01542632|527908657|FG000|Overall Study|Sponsor/Investigator Decision|0|||
146384966|NCT01542632|527908658|FG001|Overall Study|Sponsor/Investigator Decision|0|||
146384967|NCT01542632|527908659|FG002|Overall Study|Sponsor/Investigator Decision|0|||
146384968|NCT01542632|527908660|FG003|Overall Study|Sponsor/Investigator Decision|0|||
146384969|NCT01542632|527908661|FG004|Overall Study|Sponsor/Investigator Decision|1|||
146384970|NCT01542632|527908662|FG005|Overall Study|Sponsor/Investigator Decision|0|||
146384971|NCT03991936|527908663|FG000|Overall Study|Lost to Follow-up|1|||
146384972|NCT03991936|527908664|FG001|Overall Study|Lost to Follow-up|1|||
146384973|NCT03991936|527908665|FG002|Overall Study|Lost to Follow-up|1|||
146056270|NCT00626275|526721166|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146384974|NCT03991936|527908666|FG003|Overall Study|Lost to Follow-up|1|||
146384975|NCT03991936|527908667|FG004|Overall Study|Lost to Follow-up|1|||
146384976|NCT02773849|527908669|FG000|Overall Study|Lost to Follow-up|11|||
146384977|NCT02773849|527908669|FG000|Overall Study|Death|26|||
146384978|NCT02773849|527908669|FG000|Overall Study|Withdrawal by Subject|5|||
146384979|NCT02773849|527908669|FG000|Overall Study|Withdrawal of Consent|9|||
146384980|NCT02773849|527908669|FG000|Overall Study|Other: not due to lack of tolerability|11|||
146384981|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
146384982|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
146384983|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
146384984|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
146384985|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Death|38|||
146384986|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Death|10|||
146384987|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
146384988|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
146384989|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
146384990|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
146384991|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
146384992|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
146384993|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
146384994|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
146384995|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
146384996|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
146384997|NCT02421939|527908682|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
146384998|NCT02421939|527908683|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
146384999|NCT02421939|527908682|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
146385000|NCT02421939|527908683|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
146385001|NCT02421939|527908682|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
146385002|NCT02421939|527908683|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
146385003|NCT02421939|527908682|FG000|Long Term Follow up: up to 3 Years|Death|118|||
146385004|NCT02421939|527908683|FG001|Long Term Follow up: up to 3 Years|Death|65|||
146385005|NCT02421939|527908682|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
146385006|NCT02421939|527908683|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
146385007|NCT01685372|527908684|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
146385008|NCT01685372|527908685|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
146385009|NCT00129376|527908686|FG000|Overall Study|Adverse Event|1|||
146385010|NCT00129376|527908686|FG000|Overall Study|Lack of Efficacy|1|||
146385011|NCT02061540|527908687|FG000|Overall Study|Adverse Event|2|||
146385012|NCT02061540|527908687|FG000|Overall Study|Withdrawal by Subject|2|||
146385013|NCT02561273|527908694|FG000|Overall Study|Protocol Violation|1|||
146385014|NCT02561273|527908695|FG001|Overall Study|Protocol Violation|0|||
146385015|NCT02718625|527908697|FG000|Overall Study|Adverse Event|0|||
146385016|NCT02718625|527908698|FG001|Overall Study|Adverse Event|1|||
146385017|NCT02718625|527908697|FG000|Overall Study|Termination of Study by Sponsor|0|||
146385018|NCT02718625|527908698|FG001|Overall Study|Termination of Study by Sponsor|1|||
146385019|NCT01603628|527908705|FG000|Overall Study|Personal Reasons|1|||
146385020|NCT01603628|527908706|FG001|Overall Study|Personal Reasons|1|||
146385021|NCT01603628|527908707|FG002|Overall Study|Personal Reasons|2|||
146385022|NCT01603628|527908705|FG000|Overall Study|Protocol Violation|1|||
146385023|NCT01603628|527908706|FG001|Overall Study|Protocol Violation|1|||
146385024|NCT01603628|527908707|FG002|Overall Study|Protocol Violation|0|||
146385025|NCT01603628|527908705|FG000|Overall Study|Lost to Follow-up|0|||
146385026|NCT01603628|527908706|FG001|Overall Study|Lost to Follow-up|1|||
146385027|NCT01603628|527908707|FG002|Overall Study|Lost to Follow-up|0|||
146385028|NCT01603628|527908705|FG000|Overall Study|Other Miscellaneous Reason|1|||
146385029|NCT01603628|527908706|FG001|Overall Study|Other Miscellaneous Reason|0|||
146385030|NCT01603628|527908707|FG002|Overall Study|Other Miscellaneous Reason|0|||
146385031|NCT01969565|527908708|FG000|Overall Study|Withdrawal by Subject|1|||
146385032|NCT02187224|527908713|FG000|Overall Study|Did not show up for test day|1|||
146385033|NCT02187224|527908714|FG001|Overall Study|Did not show up for test day|0|||
146385034|NCT01010776|527908718|FG000|Main Phase|Withdrawal by Subject|14|||
146385035|NCT01010776|527908718|FG000|Main Phase|Lack of Efficacy|8|||
146385036|NCT01010776|527908718|FG000|Main Phase|Adverse Event|7|||
146385037|NCT01010776|527908718|FG000|Main Phase|Lost to Follow-up|6|||
146385038|NCT01010776|527908718|FG000|Main Phase|Non-compliance to study medication|5|||
146385039|NCT01010776|527908718|FG000|Main Phase|Selection failure|2|||
146385040|NCT01010776|527908718|FG000|Main Phase|Inform consent withdrawal|1|||
146385041|NCT01010776|527908718|FG000|Main Phase|Other|1|||
146385042|NCT01010776|527908718|FG000|Main Phase|Did not received study medication|5|||
146385043|NCT01010776|527908718|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
146385044|NCT01010776|527908718|FG000|Extension Phase|Other|3|||
146385045|NCT03267576|527908724|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
146385046|NCT03267576|527908725|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
146396049|NCT01397409|527952475|FG005|Stage 3|Adverse Event|0|||
146385047|NCT03267576|527908724|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
146385048|NCT03267576|527908725|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
146385049|NCT01268514|527908726|FG000|Overall Study|Adverse Event|20|||
146385050|NCT01268514|527908726|FG000|Overall Study|Death|8|||
146385051|NCT01268514|527908726|FG000|Overall Study|Lost to Follow-up|5|||
146385052|NCT01268514|527908726|FG000|Overall Study|Withdrawal by Subject|3|||
146385053|NCT01268514|527908726|FG000|Overall Study|Withdrawal by Surgeon|5|||
146385054|NCT01846208|527908727|FG000|Overall Study|Withdrew prior to treatment|1|||
146385055|NCT01846208|527908728|FG001|Overall Study|Withdrew prior to treatment|1|||
146385056|NCT01846208|527908729|FG002|Overall Study|Withdrew prior to treatment|1|||
146385057|NCT01846208|527908727|FG000|Overall Study|Dosing Symptoms|1|||
146385058|NCT01846208|527908728|FG001|Overall Study|Dosing Symptoms|2|||
146385059|NCT01846208|527908729|FG002|Overall Study|Dosing Symptoms|6|||
146385060|NCT01846208|527908727|FG000|Overall Study|Withdrawal by Subject|5|||
146385061|NCT01846208|527908728|FG001|Overall Study|Withdrawal by Subject|0|||
146385062|NCT01846208|527908729|FG002|Overall Study|Withdrawal by Subject|0|||
146385063|NCT01846208|527908727|FG000|Overall Study|Non-compliance|1|||
146385064|NCT01846208|527908728|FG001|Overall Study|Non-compliance|1|||
146385065|NCT01846208|527908729|FG002|Overall Study|Non-compliance|0|||
146385066|NCT01846208|527908727|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
146385067|NCT01846208|527908728|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
146385068|NCT01846208|527908729|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
146385069|NCT01846208|527908727|FG000|Overall Study|Refused SU OFC|0|||
146385070|NCT01846208|527908728|FG001|Overall Study|Refused SU OFC|0|||
146385071|NCT01846208|527908729|FG002|Overall Study|Refused SU OFC|1|||
146385072|NCT01424306|527908730|FG000|Overall Study|Protocol Violation|0|||
146385073|NCT01424306|527908731|FG001|Overall Study|Protocol Violation|0|||
146385074|NCT01424306|527908732|FG002|Overall Study|Protocol Violation|0|||
146385075|NCT01424306|527908733|FG003|Overall Study|Protocol Violation|0|||
146385076|NCT01424306|527908734|FG004|Overall Study|Protocol Violation|1|||
146385077|NCT01424306|527908735|FG005|Overall Study|Protocol Violation|0|||
146385078|NCT01432938|527908736|FG000|First Intervention|Protocol Violation|1|||
146385079|NCT01432938|527908737|FG001|First Intervention|Protocol Violation|0|||
146385080|NCT01432938|527908736|FG000|First Intervention|Physician Decision|1|||
146385081|NCT01432938|527908737|FG001|First Intervention|Physician Decision|0|||
146385082|NCT01432938|527908736|FG000|Second Intervention|Adverse Event|1|||
146385083|NCT01432938|527908737|FG001|Second Intervention|Adverse Event|0|||
146385084|NCT01875874|527908741|FG000|Overall Study|Death|3|||
146385085|NCT03344562|527908744|FG000|Overall Study|Withdrawal by Subject|2|||
146385086|NCT03344562|527908745|FG001|Overall Study|Withdrawal by Subject|0|||
146385087|NCT02736474|527908746|FG000|Overall Study|Lost to Follow-up|0|||
146385088|NCT02736474|527908747|FG001|Overall Study|Lost to Follow-up|1|||
146385089|NCT02463331|527908748|FG000|Overall Study|Adverse Event|4|||
146385090|NCT02463331|527908749|FG001|Overall Study|Adverse Event|2|||
146385091|NCT02463331|527908748|FG000|Overall Study|Lost to Follow-up|1|||
146385092|NCT02463331|527908749|FG001|Overall Study|Lost to Follow-up|1|||
146385093|NCT02463331|527908748|FG000|Overall Study|Pregnancy|2|||
146385094|NCT02463331|527908749|FG001|Overall Study|Pregnancy|3|||
146385095|NCT02463331|527908748|FG000|Overall Study|Lack of Efficacy|6|||
146385096|NCT02463331|527908749|FG001|Overall Study|Lack of Efficacy|0|||
146385097|NCT02463331|527908748|FG000|Overall Study|Physician Decision|3|||
146385098|NCT02463331|527908749|FG001|Overall Study|Physician Decision|0|||
146385099|NCT02382276|527908750|FG000|Overall Study|Withdrawal by Subject|4|||
146385100|NCT02382276|527908751|FG001|Overall Study|Withdrawal by Subject|8|||
146385101|NCT02382276|527908752|FG002|Overall Study|Withdrawal by Subject|5|||
146385102|NCT02382276|527908750|FG000|Overall Study|Adverse Event|7|||
146385103|NCT02382276|527908751|FG001|Overall Study|Adverse Event|2|||
146385104|NCT02382276|527908752|FG002|Overall Study|Adverse Event|32|||
146385105|NCT02382276|527908750|FG000|Overall Study|Physician Decision|0|||
146385106|NCT02382276|527908751|FG001|Overall Study|Physician Decision|0|||
146385107|NCT02382276|527908752|FG002|Overall Study|Physician Decision|2|||
146385108|NCT04191096|527908757|FG000|Overall Study|Death|102|||
146385109|NCT04191096|527908758|FG001|Overall Study|Death|89|||
146385110|NCT04191096|527908757|FG000|Overall Study|Lost to Follow-up|1|||
146385111|NCT04191096|527908758|FG001|Overall Study|Lost to Follow-up|1|||
146385112|NCT04191096|527908757|FG000|Overall Study|Withdrawal by Subject|5|||
146385113|NCT04191096|527908758|FG001|Overall Study|Withdrawal by Subject|5|||
146385114|NCT04191096|527908757|FG000|Overall Study|Participants Ongoing|518|||
146385115|NCT04191096|527908758|FG001|Overall Study|Participants Ongoing|530|||
146385116|NCT01465958|527910676|FG000|Run-in Phase|Protocol Violation|1|||
146385117|NCT01465958|527910677|FG001|Run-in Phase|Protocol Violation|0|||
146385118|NCT01465958|527910676|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
146385119|NCT01465958|527910677|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
146385120|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146385121|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146385122|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
146385123|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
146385124|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
146385125|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
146385126|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
146385127|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
146385128|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Death|0|||
146385129|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Death|0|||
146385130|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Death|0|||
146385131|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Death|1|||
146385132|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Death|1|||
146385133|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Death|0|||
146385134|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Death|2|||
146385135|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Death|0|||
146385136|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385137|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385138|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385139|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
146385140|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385141|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385142|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385143|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
146385144|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385145|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385146|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385147|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
146385148|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385149|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385150|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385151|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
146385152|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146385153|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146385154|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146385155|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
146385156|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146385157|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
146385158|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
146385159|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
146385160|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146385161|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146385162|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146385163|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
146385164|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146385165|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
146385166|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
146385167|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
146385168|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146385169|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146385170|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146385171|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146385172|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
146385173|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
146385174|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
146385175|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
146385176|NCT02442765|527910678|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385177|NCT02442765|527910679|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385178|NCT02442765|527910680|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385179|NCT02442765|527910681|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385180|NCT02442765|527910682|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
146385181|NCT02442765|527910683|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385182|NCT02442765|527910684|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
146385183|NCT02442765|527910685|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
146385184|NCT05158244|527910686|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
146385185|NCT05158244|527910687|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146385186|NCT05158244|527910688|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146385187|NCT05158244|527910689|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146385188|NCT05158244|527910690|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
146385189|NCT05158244|527910686|FG000|Overall Study|Withdrawal by Subject|0|||
146385190|NCT05158244|527910687|FG001|Overall Study|Withdrawal by Subject|0|||
146385191|NCT05158244|527910688|FG002|Overall Study|Withdrawal by Subject|1|||
146385192|NCT05158244|527910689|FG003|Overall Study|Withdrawal by Subject|0|||
146385193|NCT05158244|527910690|FG004|Overall Study|Withdrawal by Subject|0|||
146385194|NCT03818399|527910694|FG000|Overall Study|Lost to Follow-up|11|||
146385195|NCT03818399|527910694|FG000|Overall Study|Withdrawal by Subject|1|||
146385196|NCT03818399|527910694|FG000|Overall Study|Protocol Violation|2|||
146385197|NCT00141297|527910695|FG000|Overall Study|Adverse Event|0|||
146385198|NCT00141297|527910696|FG001|Overall Study|Adverse Event|0|||
146385199|NCT00141297|527910697|FG002|Overall Study|Adverse Event|1|||
146385200|NCT00141297|527910698|FG003|Overall Study|Adverse Event|0|||
146385201|NCT00141297|527910699|FG004|Overall Study|Adverse Event|1|||
146385202|NCT00141297|527910700|FG005|Overall Study|Adverse Event|1|||
146385203|NCT00141297|527910701|FG006|Overall Study|Adverse Event|0|||
146385204|NCT00141297|527910702|FG007|Overall Study|Adverse Event|1|||
146385205|NCT00141297|527910703|FG008|Overall Study|Adverse Event|1|||
146385206|NCT00141297|527910704|FG009|Overall Study|Adverse Event|0|||
146385207|NCT00141297|527910695|FG000|Overall Study|Death|1|||
146385208|NCT00141297|527910696|FG001|Overall Study|Death|0|||
146385209|NCT00141297|527910697|FG002|Overall Study|Death|0|||
146385210|NCT00141297|527910698|FG003|Overall Study|Death|0|||
146385211|NCT00141297|527910699|FG004|Overall Study|Death|0|||
146385212|NCT00141297|527910700|FG005|Overall Study|Death|0|||
146385213|NCT00141297|527910701|FG006|Overall Study|Death|0|||
146385214|NCT00141297|527910702|FG007|Overall Study|Death|0|||
146385215|NCT00141297|527910703|FG008|Overall Study|Death|1|||
146385216|NCT00141297|527910704|FG009|Overall Study|Death|0|||
146385217|NCT00141297|527910695|FG000|Overall Study|Withdrawal by Subject|0|||
146385218|NCT00141297|527910696|FG001|Overall Study|Withdrawal by Subject|0|||
146385219|NCT00141297|527910697|FG002|Overall Study|Withdrawal by Subject|0|||
146385220|NCT00141297|527910698|FG003|Overall Study|Withdrawal by Subject|0|||
146385221|NCT00141297|527910699|FG004|Overall Study|Withdrawal by Subject|0|||
146385222|NCT00141297|527910700|FG005|Overall Study|Withdrawal by Subject|0|||
146385223|NCT00141297|527910701|FG006|Overall Study|Withdrawal by Subject|0|||
146385224|NCT00141297|527910702|FG007|Overall Study|Withdrawal by Subject|0|||
146385225|NCT00141297|527910703|FG008|Overall Study|Withdrawal by Subject|1|||
146385226|NCT00141297|527910704|FG009|Overall Study|Withdrawal by Subject|0|||
146385227|NCT00141297|527910695|FG000|Overall Study|Other|0|||
146385228|NCT00141297|527910696|FG001|Overall Study|Other|0|||
146385229|NCT00141297|527910697|FG002|Overall Study|Other|0|||
146385230|NCT00141297|527910698|FG003|Overall Study|Other|1|||
146385231|NCT00141297|527910699|FG004|Overall Study|Other|5|||
146385232|NCT00141297|527910700|FG005|Overall Study|Other|0|||
146385233|NCT00141297|527910701|FG006|Overall Study|Other|0|||
146385234|NCT00141297|527910702|FG007|Overall Study|Other|0|||
146385235|NCT00141297|527910703|FG008|Overall Study|Other|2|||
146385236|NCT00141297|527910704|FG009|Overall Study|Other|0|||
146385237|NCT00141297|527910695|FG000|Overall Study|Progressive Disease|2|||
146385238|NCT00141297|527910696|FG001|Overall Study|Progressive Disease|3|||
146385239|NCT00141297|527910697|FG002|Overall Study|Progressive Disease|6|||
146385240|NCT00141297|527910698|FG003|Overall Study|Progressive Disease|2|||
146385241|NCT00141297|527910699|FG004|Overall Study|Progressive Disease|15|||
146385242|NCT00141297|527910700|FG005|Overall Study|Progressive Disease|2|||
146385243|NCT00141297|527910701|FG006|Overall Study|Progressive Disease|3|||
146385244|NCT00141297|527910702|FG007|Overall Study|Progressive Disease|3|||
146385245|NCT00141297|527910703|FG008|Overall Study|Progressive Disease|15|||
146385246|NCT00141297|527910704|FG009|Overall Study|Progressive Disease|6|||
146385247|NCT00141297|527910695|FG000|Overall Study|Transitioned|0|||
146385248|NCT00141297|527910696|FG001|Overall Study|Transitioned|0|||
146385249|NCT00141297|527910697|FG002|Overall Study|Transitioned|0|||
146385250|NCT00141297|527910698|FG003|Overall Study|Transitioned|0|||
146385251|NCT00141297|527910699|FG004|Overall Study|Transitioned|1|||
146385252|NCT00141297|527910700|FG005|Overall Study|Transitioned|0|||
146385253|NCT00141297|527910701|FG006|Overall Study|Transitioned|0|||
146385254|NCT00141297|527910702|FG007|Overall Study|Transitioned|0|||
146385255|NCT00141297|527910703|FG008|Overall Study|Transitioned|0|||
146385256|NCT00141297|527910704|FG009|Overall Study|Transitioned|0|||
146385257|NCT02646891|527910705|FG000|Overall Study|Adverse Event|0|||
146385258|NCT02646891|527910706|FG001|Overall Study|Adverse Event|1|||
146385259|NCT02646891|527910707|FG002|Overall Study|Adverse Event|0|||
146385260|NCT02646891|527910708|FG003|Overall Study|Adverse Event|0|||
146385261|NCT02646891|527910709|FG004|Overall Study|Adverse Event|0|||
146385262|NCT02646891|527910710|FG005|Overall Study|Adverse Event|0|||
146385263|NCT02646891|527910711|FG006|Overall Study|Adverse Event|0|||
146385264|NCT02646891|527910712|FG007|Overall Study|Adverse Event|0|||
146385265|NCT02646891|527910713|FG008|Overall Study|Adverse Event|0|||
146385266|NCT02646891|527910714|FG009|Overall Study|Adverse Event|0|||
146385267|NCT02646891|527910705|FG000|Overall Study|Lost to Follow-up|0|||
146385268|NCT02646891|527910706|FG001|Overall Study|Lost to Follow-up|0|||
146385269|NCT02646891|527910707|FG002|Overall Study|Lost to Follow-up|0|||
146385270|NCT02646891|527910708|FG003|Overall Study|Lost to Follow-up|0|||
146385271|NCT02646891|527910709|FG004|Overall Study|Lost to Follow-up|0|||
146385272|NCT02646891|527910710|FG005|Overall Study|Lost to Follow-up|0|||
146385273|NCT02646891|527910711|FG006|Overall Study|Lost to Follow-up|2|||
146385274|NCT02646891|527910712|FG007|Overall Study|Lost to Follow-up|2|||
146385275|NCT02646891|527910713|FG008|Overall Study|Lost to Follow-up|2|||
146385276|NCT02646891|527910714|FG009|Overall Study|Lost to Follow-up|2|||
146385277|NCT02646891|527910705|FG000|Overall Study|Protocol Violation|0|||
146385278|NCT02646891|527910706|FG001|Overall Study|Protocol Violation|0|||
146385279|NCT02646891|527910707|FG002|Overall Study|Protocol Violation|0|||
146385280|NCT02646891|527910708|FG003|Overall Study|Protocol Violation|0|||
146385281|NCT02646891|527910709|FG004|Overall Study|Protocol Violation|0|||
146385282|NCT02646891|527910710|FG005|Overall Study|Protocol Violation|0|||
146385283|NCT02646891|527910711|FG006|Overall Study|Protocol Violation|1|||
146385284|NCT02646891|527910712|FG007|Overall Study|Protocol Violation|1|||
146385285|NCT02646891|527910713|FG008|Overall Study|Protocol Violation|0|||
146385286|NCT02646891|527910714|FG009|Overall Study|Protocol Violation|0|||
146385287|NCT02646891|527910705|FG000|Overall Study|Withdrawal by Subject|2|||
146385288|NCT02646891|527910706|FG001|Overall Study|Withdrawal by Subject|0|||
146385289|NCT02646891|527910707|FG002|Overall Study|Withdrawal by Subject|1|||
146385290|NCT02646891|527910708|FG003|Overall Study|Withdrawal by Subject|0|||
146385291|NCT02646891|527910709|FG004|Overall Study|Withdrawal by Subject|0|||
146385292|NCT02646891|527910710|FG005|Overall Study|Withdrawal by Subject|0|||
146385293|NCT02646891|527910711|FG006|Overall Study|Withdrawal by Subject|5|||
146385294|NCT02646891|527910712|FG007|Overall Study|Withdrawal by Subject|9|||
146385295|NCT02646891|527910713|FG008|Overall Study|Withdrawal by Subject|7|||
146385296|NCT02646891|527910714|FG009|Overall Study|Withdrawal by Subject|3|||
146385297|NCT02646891|527910705|FG000|Overall Study|Death|0|||
146385298|NCT02646891|527910706|FG001|Overall Study|Death|0|||
146385299|NCT02646891|527910707|FG002|Overall Study|Death|0|||
146385300|NCT02646891|527910708|FG003|Overall Study|Death|0|||
146385301|NCT02646891|527910709|FG004|Overall Study|Death|0|||
146385302|NCT02646891|527910710|FG005|Overall Study|Death|0|||
146385303|NCT02646891|527910711|FG006|Overall Study|Death|1|||
146385304|NCT02646891|527910712|FG007|Overall Study|Death|1|||
146385305|NCT02646891|527910713|FG008|Overall Study|Death|1|||
146385306|NCT02646891|527910714|FG009|Overall Study|Death|0|||
146385307|NCT00103207|527910715|FG000|Overall Study|Adverse Event|3|||
146385308|NCT00103207|527910715|FG000|Overall Study|Death|1|||
146385309|NCT00103207|527910715|FG000|Overall Study|Withdrawal by Subject|2|||
146385310|NCT00103207|527910715|FG000|Overall Study|Other complicating disease|1|||
146385311|NCT00103207|527910715|FG000|Overall Study|Ineligible|4|||
146385312|NCT00103207|527910715|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
146385313|NCT03442595|527910716|FG000|Overall Study|Lost to Follow-up|94|||
146385314|NCT03442595|527910717|FG001|Overall Study|Lost to Follow-up|0|||
146385315|NCT00811395|527910718|FG000|Extension Treatment|Adverse Event|1|||
146385316|NCT00811395|527910719|FG001|Extension Treatment|Adverse Event|2|||
146385317|NCT00811395|527910720|FG002|Extension Treatment|Adverse Event|2|||
146385318|NCT00811395|527910721|FG003|Extension Treatment|Adverse Event|2|||
146385319|NCT00811395|527910722|FG004|Extension Treatment|Adverse Event|0|||
146385320|NCT00811395|527910723|FG005|Extension Treatment|Adverse Event|1|||
146385321|NCT00811395|527910718|FG000|Extension Treatment|Progressive disease|1|||
146385322|NCT00811395|527910719|FG001|Extension Treatment|Progressive disease|1|||
146385323|NCT00811395|527910720|FG002|Extension Treatment|Progressive disease|0|||
146385324|NCT00811395|527910721|FG003|Extension Treatment|Progressive disease|0|||
146385325|NCT00811395|527910722|FG004|Extension Treatment|Progressive disease|0|||
146385326|NCT00811395|527910723|FG005|Extension Treatment|Progressive disease|0|||
146385327|NCT00811395|527910718|FG000|Extension Treatment|Participant did not wish to continue|0|||
146385328|NCT00811395|527910719|FG001|Extension Treatment|Participant did not wish to continue|3|||
146385329|NCT00811395|527910720|FG002|Extension Treatment|Participant did not wish to continue|0|||
146385330|NCT00811395|527910721|FG003|Extension Treatment|Participant did not wish to continue|1|||
146385331|NCT00811395|527910722|FG004|Extension Treatment|Participant did not wish to continue|0|||
146385332|NCT00811395|527910723|FG005|Extension Treatment|Participant did not wish to continue|1|||
146385333|NCT00811395|527910718|FG000|Extension Treatment|Other than above|0|||
146385334|NCT00811395|527910719|FG001|Extension Treatment|Other than above|0|||
146385335|NCT00811395|527910720|FG002|Extension Treatment|Other than above|1|||
146385336|NCT00811395|527910721|FG003|Extension Treatment|Other than above|0|||
146385337|NCT00811395|527910722|FG004|Extension Treatment|Other than above|0|||
146385338|NCT00811395|527910723|FG005|Extension Treatment|Other than above|0|||
146385339|NCT01562327|527910726|FG000|Overall Study|Adverse Event|2|||
146385340|NCT01562327|527910726|FG000|Overall Study|Lack of Efficacy|1|||
146385341|NCT01562327|527910726|FG000|Overall Study|Participant drop-out|1|||
146385342|NCT01562327|527910726|FG000|Overall Study|Infusion not received at 6 month window|4|||
146385343|NCT01947127|527910727|FG000|Overall Study|Protocol Violation|18|||
146385344|NCT01947127|527910728|FG001|Overall Study|Protocol Violation|38|||
146385345|NCT01947127|527910727|FG000|Overall Study|Withdrawal by Subject|1|||
146385346|NCT01947127|527910728|FG001|Overall Study|Withdrawal by Subject|1|||
146385347|NCT01947127|527910727|FG000|Overall Study|Data loss|4|||
146385348|NCT01947127|527910728|FG001|Overall Study|Data loss|4|||
146385349|NCT00170846|527910729|FG000|Overall Study|Subject withdrew Informed Consent|5|||
146385350|NCT00170846|527910730|FG001|Overall Study|Subject withdrew Informed Consent|12|||
146385351|NCT00170846|527910731|FG002|Overall Study|Subject withdrew Informed Consent|8|||
146385352|NCT00170846|527910729|FG000|Overall Study|Lost to Follow-up|6|||
146385353|NCT00170846|527910730|FG001|Overall Study|Lost to Follow-up|3|||
146385354|NCT00170846|527910731|FG002|Overall Study|Lost to Follow-up|2|||
146385355|NCT00170846|527910729|FG000|Overall Study|Death|0|||
146385356|NCT00170846|527910730|FG001|Overall Study|Death|3|||
146385357|NCT00170846|527910731|FG002|Overall Study|Death|3|||
146385358|NCT00170846|527910729|FG000|Overall Study|Reason Missing|0|||
146385359|NCT00170846|527910730|FG001|Overall Study|Reason Missing|1|||
146385360|NCT00170846|527910731|FG002|Overall Study|Reason Missing|0|||
146385361|NCT00528840|527910734|FG000|Overall Study|Lost to Follow-up|10|||
146385362|NCT00528840|527910734|FG000|Overall Study|Adverse Event|1|||
146385363|NCT00528840|527910734|FG000|Overall Study|Withdrawal by Subject|17|||
146385364|NCT00528840|527910734|FG000|Overall Study|Death|2|||
146385365|NCT00528840|527910734|FG000|Overall Study|Administrative Reasons|1|||
146385366|NCT00528840|527910734|FG000|Overall Study|Other|2|||
146385367|NCT02447952|527910735|FG000|Overall Study|Adverse Event|2|||
146385368|NCT02447952|527910735|FG000|Overall Study|Physician Decision|1|||
146385369|NCT02447952|527910735|FG000|Overall Study|Withdrawal by Subject|4|||
146385370|NCT01756833|527910741|FG000|Overall Study|Withdrawal by Subject|4|||
146385371|NCT01756833|527910742|FG001|Overall Study|Withdrawal by Subject|3|||
146385372|NCT00808132|527910746|FG000|Overall Study|Adverse Event|34|||
146385373|NCT00808132|527910747|FG001|Overall Study|Adverse Event|33|||
146385374|NCT00808132|527910748|FG002|Overall Study|Adverse Event|16|||
146385375|NCT00808132|527910749|FG003|Overall Study|Adverse Event|31|||
146385376|NCT00808132|527910750|FG004|Overall Study|Adverse Event|33|||
146385377|NCT00808132|527910746|FG000|Overall Study|Death|0|||
146385378|NCT00808132|527910747|FG001|Overall Study|Death|0|||
146385379|NCT00808132|527910748|FG002|Overall Study|Death|0|||
146385380|NCT00808132|527910749|FG003|Overall Study|Death|0|||
146385381|NCT00808132|527910750|FG004|Overall Study|Death|1|||
146385382|NCT00808132|527910746|FG000|Overall Study|Physician Decision|0|||
146385383|NCT00808132|527910747|FG001|Overall Study|Physician Decision|1|||
146385384|NCT00808132|527910748|FG002|Overall Study|Physician Decision|0|||
146385385|NCT00808132|527910749|FG003|Overall Study|Physician Decision|0|||
146385386|NCT00808132|527910750|FG004|Overall Study|Physician Decision|0|||
146385387|NCT00808132|527910746|FG000|Overall Study|Lost to Follow-up|8|||
146385388|NCT00808132|527910747|FG001|Overall Study|Lost to Follow-up|10|||
146385389|NCT00808132|527910748|FG002|Overall Study|Lost to Follow-up|11|||
146385390|NCT00808132|527910749|FG003|Overall Study|Lost to Follow-up|8|||
146385391|NCT00808132|527910750|FG004|Overall Study|Lost to Follow-up|9|||
146385392|NCT00808132|527910746|FG000|Overall Study|Protocol Violation|8|||
146385393|NCT00808132|527910747|FG001|Overall Study|Protocol Violation|9|||
146385394|NCT00808132|527910748|FG002|Overall Study|Protocol Violation|4|||
146385395|NCT00808132|527910749|FG003|Overall Study|Protocol Violation|9|||
146385396|NCT00808132|527910750|FG004|Overall Study|Protocol Violation|5|||
146385397|NCT00808132|527910746|FG000|Overall Study|Withdrawal by Subject|27|||
146385398|NCT00808132|527910747|FG001|Overall Study|Withdrawal by Subject|18|||
146385399|NCT00808132|527910748|FG002|Overall Study|Withdrawal by Subject|2|||
146385400|NCT00808132|527910749|FG003|Overall Study|Withdrawal by Subject|7|||
146385401|NCT00808132|527910750|FG004|Overall Study|Withdrawal by Subject|16|||
146385402|NCT00808132|527910746|FG000|Overall Study|Other|6|||
146385403|NCT00808132|527910747|FG001|Overall Study|Other|4|||
146385404|NCT00808132|527910748|FG002|Overall Study|Other|6|||
146385405|NCT00808132|527910749|FG003|Overall Study|Other|2|||
146385406|NCT00808132|527910750|FG004|Overall Study|Other|15|||
146385407|NCT00808132|527910746|FG000|Overall Study|Randomized, but not treated|10|||
146385408|NCT00808132|527910747|FG001|Overall Study|Randomized, but not treated|7|||
146385409|NCT00808132|527910748|FG002|Overall Study|Randomized, but not treated|9|||
146385410|NCT00808132|527910749|FG003|Overall Study|Randomized, but not treated|8|||
146385411|NCT00808132|527910750|FG004|Overall Study|Randomized, but not treated|9|||
146385412|NCT00808132|527910746|FG000|Overall Study|Unsatisfactory response|5|||
146385413|NCT00808132|527910747|FG001|Overall Study|Unsatisfactory response|6|||
146385414|NCT00808132|527910748|FG002|Overall Study|Unsatisfactory response|6|||
146385415|NCT00808132|527910749|FG003|Overall Study|Unsatisfactory response|4|||
146385416|NCT00808132|527910750|FG004|Overall Study|Unsatisfactory response|12|||
146385417|NCT02795182|527910751|FG000|Overall Study|Death|5|||
146385418|NCT02795182|527910752|FG001|Overall Study|Death|4|||
146385419|NCT02795182|527910753|FG002|Overall Study|Death|4|||
146385420|NCT02795182|527910754|FG003|Overall Study|Death|18|||
146385421|NCT02795182|527910751|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146385422|NCT02795182|527910752|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146385423|NCT02795182|527910753|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
146385424|NCT02795182|527910754|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
146385425|NCT02795182|527910751|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146385426|NCT02795182|527910752|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146385427|NCT02795182|527910753|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
146385428|NCT02795182|527910754|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
146385429|NCT02795182|527910751|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
146396050|NCT01397409|527952476|FG006|Stage 3|Adverse Event|0|||
146385430|NCT02795182|527910752|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
146385431|NCT02795182|527910753|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
146385432|NCT02795182|527910754|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
146385433|NCT02795182|527910751|FG000|Overall Study|Withdrawal by Subject|4|||
146385434|NCT02795182|527910752|FG001|Overall Study|Withdrawal by Subject|0|||
146385435|NCT02795182|527910753|FG002|Overall Study|Withdrawal by Subject|0|||
146385436|NCT02795182|527910754|FG003|Overall Study|Withdrawal by Subject|3|||
146385437|NCT02795182|527910751|FG000|Overall Study|Lost to Follow-up|0|||
146385438|NCT02795182|527910752|FG001|Overall Study|Lost to Follow-up|0|||
146385439|NCT02795182|527910753|FG002|Overall Study|Lost to Follow-up|1|||
146385440|NCT02795182|527910754|FG003|Overall Study|Lost to Follow-up|1|||
146385441|NCT02795182|527910751|FG000|Overall Study|Roll Over to Long Term Extension|3|||
146385442|NCT02795182|527910752|FG001|Overall Study|Roll Over to Long Term Extension|3|||
146385443|NCT02795182|527910753|FG002|Overall Study|Roll Over to Long Term Extension|2|||
146385444|NCT02795182|527910754|FG003|Overall Study|Roll Over to Long Term Extension|5|||
146385445|NCT02795182|527910751|FG000|Overall Study|Progressive Disease|0|||
146385446|NCT02795182|527910752|FG001|Overall Study|Progressive Disease|1|||
146385447|NCT02795182|527910753|FG002|Overall Study|Progressive Disease|0|||
146385448|NCT02795182|527910754|FG003|Overall Study|Progressive Disease|4|||
146385449|NCT02795182|527910751|FG000|Overall Study|Physician Decision|0|||
146385450|NCT02795182|527910752|FG001|Overall Study|Physician Decision|0|||
146385451|NCT02795182|527910753|FG002|Overall Study|Physician Decision|0|||
146385452|NCT02795182|527910754|FG003|Overall Study|Physician Decision|1|||
146385453|NCT00398086|527910757|FG000|Overall Study|Unacceptable Toxicity|2|||
146385454|NCT00398086|527910758|FG001|Overall Study|Unacceptable Toxicity|8|||
146385455|NCT00398086|527910759|FG002|Overall Study|Unacceptable Toxicity|2|||
146385456|NCT00398086|527910757|FG000|Overall Study|Adverse Event|1|||
146385457|NCT00398086|527910758|FG001|Overall Study|Adverse Event|4|||
146385458|NCT00398086|527910759|FG002|Overall Study|Adverse Event|0|||
146385459|NCT00398086|527910757|FG000|Overall Study|Physician Decision|1|||
146385460|NCT00398086|527910758|FG001|Overall Study|Physician Decision|4|||
146385461|NCT00398086|527910759|FG002|Overall Study|Physician Decision|0|||
146385462|NCT00398086|527910757|FG000|Overall Study|Withdrawal by Subject|5|||
146385463|NCT00398086|527910758|FG001|Overall Study|Withdrawal by Subject|7|||
146385464|NCT00398086|527910759|FG002|Overall Study|Withdrawal by Subject|0|||
146385465|NCT00696774|527910760|FG000|Period II|Adverse Event|0|||
146385466|NCT00696774|527910761|FG001|Period II|Adverse Event|0|||
146385467|NCT00696774|527910762|FG002|Period II|Adverse Event|15|||
146385468|NCT00696774|527910760|FG000|Period II|Lost to Follow-up|0|||
146385469|NCT00696774|527910761|FG001|Period II|Lost to Follow-up|0|||
146385470|NCT00696774|527910762|FG002|Period II|Lost to Follow-up|4|||
146385471|NCT00696774|527910760|FG000|Period II|Protocol Violation|0|||
146385472|NCT00696774|527910761|FG001|Period II|Protocol Violation|0|||
146385473|NCT00696774|527910762|FG002|Period II|Protocol Violation|11|||
146385474|NCT00696774|527910760|FG000|Period II|Withdrawal by Subject|0|||
146385475|NCT00696774|527910761|FG001|Period II|Withdrawal by Subject|0|||
146385476|NCT00696774|527910762|FG002|Period II|Withdrawal by Subject|4|||
146385477|NCT00696774|527910760|FG000|Period II|Sponsor Decision|0|||
146385478|NCT00696774|527910761|FG001|Period II|Sponsor Decision|0|||
146385479|NCT00696774|527910762|FG002|Period II|Sponsor Decision|0|||
146385480|NCT00696774|527910760|FG000|Period II|Lack of Efficacy|0|||
146385481|NCT00696774|527910761|FG001|Period II|Lack of Efficacy|0|||
146385482|NCT00696774|527910762|FG002|Period II|Lack of Efficacy|2|||
146385483|NCT00696774|527910760|FG000|Period III|Adverse Event|1|||
146385484|NCT00696774|527910761|FG001|Period III|Adverse Event|1|||
146385485|NCT00696774|527910762|FG002|Period III|Adverse Event|0|||
146385486|NCT00696774|527910760|FG000|Period III|Lost to Follow-up|2|||
146385487|NCT00696774|527910761|FG001|Period III|Lost to Follow-up|1|||
146385488|NCT00696774|527910762|FG002|Period III|Lost to Follow-up|0|||
146385489|NCT00696774|527910760|FG000|Period III|Protocol Violation|1|||
146385490|NCT00696774|527910761|FG001|Period III|Protocol Violation|1|||
146385491|NCT00696774|527910762|FG002|Period III|Protocol Violation|0|||
146385492|NCT00696774|527910760|FG000|Period III|Withdrawal by Subject|1|||
146385493|NCT00696774|527910761|FG001|Period III|Withdrawal by Subject|2|||
146385494|NCT00696774|527910762|FG002|Period III|Withdrawal by Subject|0|||
146385495|NCT00696774|527910760|FG000|Period III|Sponsor Decision|2|||
146385496|NCT00696774|527910761|FG001|Period III|Sponsor Decision|0|||
146385497|NCT00696774|527910762|FG002|Period III|Sponsor Decision|0|||
146385498|NCT00696774|527910760|FG000|Period III|Lack of Efficacy|0|||
146385499|NCT00696774|527910761|FG001|Period III|Lack of Efficacy|2|||
146385500|NCT00696774|527910762|FG002|Period III|Lack of Efficacy|0|||
146385501|NCT00890201|527910763|FG000|Overall Study|Protocol Violation|5|||
146385502|NCT00890201|527910764|FG001|Overall Study|Protocol Violation|56|||
146385503|NCT00033293|527910765|FG000|Overall Study|Death|0|||
146385504|NCT00033293|527910766|FG001|Overall Study|Death|1|||
146385505|NCT00033293|527910765|FG000|Overall Study|Lack of Efficacy|5|||
146385506|NCT00033293|527910766|FG001|Overall Study|Lack of Efficacy|8|||
146385507|NCT00033293|527910765|FG000|Overall Study|Lost to Follow-up|0|||
146385508|NCT00033293|527910766|FG001|Overall Study|Lost to Follow-up|1|||
146385509|NCT00033293|527910765|FG000|Overall Study|Physician Decision|3|||
146385510|NCT00033293|527910766|FG001|Overall Study|Physician Decision|1|||
146385511|NCT00033293|527910765|FG000|Overall Study|Withdrawal by Subject|1|||
146385512|NCT00033293|527910766|FG001|Overall Study|Withdrawal by Subject|0|||
146385513|NCT00033293|527910765|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
146385514|NCT00033293|527910766|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
146385515|NCT00033293|527910765|FG000|Overall Study|Treatment refused|0|||
146385516|NCT00033293|527910766|FG001|Overall Study|Treatment refused|6|||
146385517|NCT02087241|527910767|FG000|Overall Study|Death|2|||
146385518|NCT02087241|527910768|FG001|Overall Study|Death|1|||
146385519|NCT02087241|527910769|FG002|Overall Study|Death|1|||
146385520|NCT02087241|527910770|FG003|Overall Study|Death|1|||
146385521|NCT02087241|527910767|FG000|Overall Study|Withdrawal by Subject|1|||
146385522|NCT02087241|527910768|FG001|Overall Study|Withdrawal by Subject|0|||
146385523|NCT02087241|527910769|FG002|Overall Study|Withdrawal by Subject|0|||
146385524|NCT02087241|527910770|FG003|Overall Study|Withdrawal by Subject|1|||
146385525|NCT02087241|527910767|FG000|Overall Study|Progressive Disease|0|||
146385526|NCT02087241|527910768|FG001|Overall Study|Progressive Disease|0|||
146385527|NCT02087241|527910769|FG002|Overall Study|Progressive Disease|0|||
146385528|NCT02087241|527910770|FG003|Overall Study|Progressive Disease|1|||
146385529|NCT02087241|527910767|FG000|Overall Study|Study Terminated by Sponsor|0|||
146385530|NCT02087241|527910768|FG001|Overall Study|Study Terminated by Sponsor|2|||
146385531|NCT02087241|527910769|FG002|Overall Study|Study Terminated by Sponsor|0|||
146385532|NCT02087241|527910770|FG003|Overall Study|Study Terminated by Sponsor|4|||
146385533|NCT02181504|527910771|FG000|Overall Study|Adverse Event|1|||
146385534|NCT02181504|527910772|FG001|Overall Study|Adverse Event|1|||
146385535|NCT02181504|527910773|FG002|Overall Study|Adverse Event|1|||
146385536|NCT00887913|527910776|FG000|Overall Study|Withdrawal by Subject|6|||
146385537|NCT00598585|527910777|FG000|Overall Study|Lost to Follow-up|1|||
146385538|NCT00598585|527910778|FG001|Overall Study|Lost to Follow-up|0|||
146385539|NCT01200758|527910779|FG000|Stage I|Death|0|||
146385540|NCT01200758|527910780|FG001|Stage I|Death|1|||
146385541|NCT01200758|527910781|FG002|Stage I|Death|0|||
146385542|NCT01200758|527910782|FG003|Stage I|Death|0|||
146385543|NCT01200758|527910779|FG000|Stage I|Physician Decision|1|||
146385544|NCT01200758|527910780|FG001|Stage I|Physician Decision|1|||
146385545|NCT01200758|527910781|FG002|Stage I|Physician Decision|0|||
146385546|NCT01200758|527910782|FG003|Stage I|Physician Decision|0|||
146385547|NCT01200758|527910779|FG000|Stage I|Lack of Efficacy|2|||
146385548|NCT01200758|527910780|FG001|Stage I|Lack of Efficacy|1|||
146385549|NCT01200758|527910781|FG002|Stage I|Lack of Efficacy|0|||
146385550|NCT01200758|527910782|FG003|Stage I|Lack of Efficacy|0|||
146385551|NCT01200758|527910779|FG000|Stage I|Adverse Event|5|||
146385552|NCT01200758|527910780|FG001|Stage I|Adverse Event|5|||
146385553|NCT01200758|527910781|FG002|Stage I|Adverse Event|0|||
146385554|NCT01200758|527910782|FG003|Stage I|Adverse Event|0|||
146385555|NCT01200758|527910779|FG000|Stage I|Withdrawal by Subject|1|||
146385556|NCT01200758|527910780|FG001|Stage I|Withdrawal by Subject|2|||
146385557|NCT01200758|527910781|FG002|Stage I|Withdrawal by Subject|0|||
146385558|NCT01200758|527910782|FG003|Stage I|Withdrawal by Subject|0|||
146385559|NCT01200758|527910779|FG000|Stage I|Disease Progression|9|||
146385560|NCT01200758|527910780|FG001|Stage I|Disease Progression|7|||
146385561|NCT01200758|527910781|FG002|Stage I|Disease Progression|0|||
146385562|NCT01200758|527910782|FG003|Stage I|Disease Progression|0|||
146385563|NCT01200758|527910779|FG000|Stage 2|Disease Progression|0|||
146385564|NCT01200758|527910780|FG001|Stage 2|Disease Progression|0|||
146385565|NCT01200758|527910781|FG002|Stage 2|Disease Progression|16|||
146385566|NCT01200758|527910782|FG003|Stage 2|Disease Progression|21|||
146385567|NCT01200758|527910779|FG000|Stage 2|Lack of Efficacy|0|||
146385568|NCT01200758|527910780|FG001|Stage 2|Lack of Efficacy|0|||
146385569|NCT01200758|527910781|FG002|Stage 2|Lack of Efficacy|4|||
146385570|NCT01200758|527910782|FG003|Stage 2|Lack of Efficacy|2|||
146385571|NCT01200758|527910779|FG000|Stage 2|Physician Decision|0|||
146385572|NCT01200758|527910780|FG001|Stage 2|Physician Decision|0|||
146385573|NCT01200758|527910781|FG002|Stage 2|Physician Decision|5|||
146385574|NCT01200758|527910782|FG003|Stage 2|Physician Decision|7|||
146385575|NCT01200758|527910779|FG000|Stage 2|Adverse Event|0|||
146385576|NCT01200758|527910780|FG001|Stage 2|Adverse Event|0|||
146385577|NCT01200758|527910781|FG002|Stage 2|Adverse Event|5|||
146385578|NCT01200758|527910782|FG003|Stage 2|Adverse Event|9|||
146385579|NCT01200758|527910779|FG000|Stage 2|Withdrawal by Subject|0|||
146385580|NCT01200758|527910780|FG001|Stage 2|Withdrawal by Subject|0|||
146385581|NCT01200758|527910781|FG002|Stage 2|Withdrawal by Subject|4|||
146385582|NCT01200758|527910782|FG003|Stage 2|Withdrawal by Subject|1|||
146385583|NCT01200758|527910779|FG000|Stage 2|Lost to Follow-up|0|||
146385584|NCT01200758|527910780|FG001|Stage 2|Lost to Follow-up|0|||
146385585|NCT01200758|527910781|FG002|Stage 2|Lost to Follow-up|3|||
146385586|NCT01200758|527910782|FG003|Stage 2|Lost to Follow-up|1|||
146385587|NCT01200758|527910779|FG000|Stage 2|Protocol Violation|0|||
146385588|NCT01200758|527910780|FG001|Stage 2|Protocol Violation|0|||
146385589|NCT01200758|527910781|FG002|Stage 2|Protocol Violation|1|||
146385590|NCT01200758|527910782|FG003|Stage 2|Protocol Violation|4|||
146385591|NCT01200758|527910779|FG000|Stage 2|Death|0|||
146385592|NCT01200758|527910780|FG001|Stage 2|Death|0|||
146385593|NCT01200758|527910781|FG002|Stage 2|Death|3|||
146385594|NCT01200758|527910782|FG003|Stage 2|Death|5|||
146385595|NCT00461552|527910785|FG000|Overall Study|Drug Dispensing error|0|||
146385596|NCT00461552|527910786|FG001|Overall Study|Drug Dispensing error|2|||
146385597|NCT01289028|527910787|FG000|Overall Study|Progressive Disease|49|||
146385598|NCT01289028|527910787|FG000|Overall Study|Adverse Event|14|||
146385599|NCT01289028|527910787|FG000|Overall Study|Withdrawal by Subject|6|||
146385600|NCT01289028|527910787|FG000|Overall Study|Death|4|||
146385601|NCT01289028|527910787|FG000|Overall Study|Lack of Efficacy|2|||
146385602|NCT01289028|527910787|FG000|Overall Study|No longer required|2|||
146385603|NCT01289028|527910787|FG000|Overall Study|Lost to Follow-up|2|||
146385604|NCT01289028|527910787|FG000|Overall Study|New Cancer Therapy|2|||
146385605|NCT01289028|527910787|FG000|Overall Study|Abnormal Lab Value|1|||
146385606|NCT01289028|527910787|FG000|Overall Study|Missing reason for discon|1|||
146385607|NCT00998985|527910794|FG000|Overall Study|Withdrawal by Subject|0|||
146385608|NCT00998985|527910795|FG001|Overall Study|Withdrawal by Subject|0|||
146385609|NCT00998985|527910796|FG002|Overall Study|Withdrawal by Subject|0|||
146385610|NCT00998985|527910797|FG003|Overall Study|Withdrawal by Subject|0|||
146385611|NCT00998985|527910798|FG004|Overall Study|Withdrawal by Subject|0|||
146385612|NCT00998985|527910799|FG005|Overall Study|Withdrawal by Subject|0|||
146385613|NCT00998985|527910800|FG006|Overall Study|Withdrawal by Subject|0|||
146385614|NCT00998985|527910801|FG007|Overall Study|Withdrawal by Subject|0|||
146385615|NCT00998985|527910802|FG008|Overall Study|Withdrawal by Subject|1|||
146385616|NCT00998985|527910803|FG009|Overall Study|Withdrawal by Subject|0|||
146385617|NCT00998985|527910804|FG010|Overall Study|Withdrawal by Subject|0|||
146385618|NCT00998985|527910805|FG011|Overall Study|Withdrawal by Subject|0|||
146385619|NCT00998985|527910806|FG012|Overall Study|Withdrawal by Subject|0|||
146385620|NCT00998985|527910807|FG013|Overall Study|Withdrawal by Subject|0|||
146385621|NCT00998985|527910794|FG000|Overall Study|Protocol Violation|0|||
146385622|NCT00998985|527910795|FG001|Overall Study|Protocol Violation|0|||
146385623|NCT00998985|527910796|FG002|Overall Study|Protocol Violation|0|||
146385624|NCT00998985|527910797|FG003|Overall Study|Protocol Violation|0|||
146385625|NCT00998985|527910798|FG004|Overall Study|Protocol Violation|0|||
146385626|NCT00998985|527910799|FG005|Overall Study|Protocol Violation|1|||
146385627|NCT00998985|527910800|FG006|Overall Study|Protocol Violation|0|||
146385628|NCT00998985|527910801|FG007|Overall Study|Protocol Violation|0|||
146385629|NCT00998985|527910802|FG008|Overall Study|Protocol Violation|0|||
146385630|NCT00998985|527910803|FG009|Overall Study|Protocol Violation|0|||
146385631|NCT00998985|527910804|FG010|Overall Study|Protocol Violation|0|||
146385632|NCT00998985|527910805|FG011|Overall Study|Protocol Violation|0|||
146385633|NCT00998985|527910806|FG012|Overall Study|Protocol Violation|0|||
146385634|NCT00998985|527910807|FG013|Overall Study|Protocol Violation|0|||
146385635|NCT01040728|527910809|FG000|Overall Study|Adverse Event|4|||
146385636|NCT01040728|527910810|FG001|Overall Study|Adverse Event|8|||
146385637|NCT01040728|527910811|FG002|Overall Study|Adverse Event|0|||
146385638|NCT01040728|527910812|FG003|Overall Study|Adverse Event|4|||
146385639|NCT01040728|527910809|FG000|Overall Study|Withdrawal by Subject|0|||
146385640|NCT01040728|527910810|FG001|Overall Study|Withdrawal by Subject|1|||
146385641|NCT01040728|527910811|FG002|Overall Study|Withdrawal by Subject|1|||
146385642|NCT01040728|527910812|FG003|Overall Study|Withdrawal by Subject|0|||
146385643|NCT01040728|527910809|FG000|Overall Study|Protocol Violation|0|||
146385644|NCT01040728|527910810|FG001|Overall Study|Protocol Violation|0|||
146385645|NCT01040728|527910811|FG002|Overall Study|Protocol Violation|0|||
146385646|NCT01040728|527910812|FG003|Overall Study|Protocol Violation|1|||
146385647|NCT01040728|527910809|FG000|Overall Study|Lack of Efficacy|0|||
146385648|NCT01040728|527910810|FG001|Overall Study|Lack of Efficacy|1|||
146385649|NCT01040728|527910811|FG002|Overall Study|Lack of Efficacy|0|||
146385650|NCT01040728|527910812|FG003|Overall Study|Lack of Efficacy|1|||
146385651|NCT01040728|527910809|FG000|Overall Study|Other reasons not listed above|0|||
146385652|NCT01040728|527910810|FG001|Overall Study|Other reasons not listed above|1|||
146385653|NCT01040728|527910811|FG002|Overall Study|Other reasons not listed above|0|||
146385654|NCT01040728|527910812|FG003|Overall Study|Other reasons not listed above|0|||
146385655|NCT02583711|527910815|FG000|Overall Study|Withdrawal by Subject|0|||
146385656|NCT02583711|527910816|FG001|Overall Study|Withdrawal by Subject|10|||
146385657|NCT02583711|527910817|FG002|Overall Study|Withdrawal by Subject|0|||
146385658|NCT01012037|527910818|FG000|Overall Study|Adverse Event|0|||
146385659|NCT01012037|527910819|FG001|Overall Study|Adverse Event|8|||
146385660|NCT01012037|527910820|FG002|Overall Study|Adverse Event|3|||
146385661|NCT01012037|527910818|FG000|Overall Study|Protocol Violation|0|||
146385662|NCT01012037|527910819|FG001|Overall Study|Protocol Violation|3|||
146385663|NCT01012037|527910820|FG002|Overall Study|Protocol Violation|5|||
146385664|NCT01012037|527910818|FG000|Overall Study|Withdrawal by Subject|0|||
146385665|NCT01012037|527910819|FG001|Overall Study|Withdrawal by Subject|4|||
146385666|NCT01012037|527910820|FG002|Overall Study|Withdrawal by Subject|1|||
146385667|NCT01012037|527910818|FG000|Overall Study|Other reason (not specified)|1|||
146385668|NCT01012037|527910819|FG001|Overall Study|Other reason (not specified)|1|||
146385669|NCT01012037|527910820|FG002|Overall Study|Other reason (not specified)|1|||
146385670|NCT00415623|527910824|FG000|Overall Study|Adverse Event|3|||
146385671|NCT00415623|527910825|FG001|Overall Study|Adverse Event|4|||
146385672|NCT00415623|527910824|FG000|Overall Study|Death|1|||
146385673|NCT00415623|527910825|FG001|Overall Study|Death|0|||
146385674|NCT00415623|527910824|FG000|Overall Study|Withdrawal by Subject|1|||
146385675|NCT00415623|527910825|FG001|Overall Study|Withdrawal by Subject|1|||
146385676|NCT01369069|527910826|FG000|Overall Study|Lost to Follow-up|8|||
146385677|NCT01369069|527910827|FG001|Overall Study|Lost to Follow-up|9|||
146385678|NCT01369069|527910826|FG000|Overall Study|Withdrawal by Subject|9|||
146385679|NCT01369069|527910827|FG001|Overall Study|Withdrawal by Subject|7|||
146385680|NCT02573012|527910828|FG000|Overall Study|Adverse Event|5|||
146385681|NCT02573012|527910829|FG001|Overall Study|Adverse Event|5|||
146385682|NCT02573012|527910828|FG000|Overall Study|Lack of Efficacy|5|||
146385683|NCT02573012|527910829|FG001|Overall Study|Lack of Efficacy|4|||
146385684|NCT02573012|527910828|FG000|Overall Study|Non-compliance|1|||
146385685|NCT02573012|527910829|FG001|Overall Study|Non-compliance|2|||
146385686|NCT02573012|527910828|FG000|Overall Study|Withdrawal by Subject|2|||
146385687|NCT02573012|527910829|FG001|Overall Study|Withdrawal by Subject|2|||
146385688|NCT02573012|527910828|FG000|Overall Study|Study Ended per Protocol|1|||
146385689|NCT02573012|527910829|FG001|Overall Study|Study Ended per Protocol|0|||
146385690|NCT02573012|527910828|FG000|Overall Study|Physician Decision|1|||
146385691|NCT02573012|527910829|FG001|Overall Study|Physician Decision|2|||
146385692|NCT00882362|527910830|FG000|Overall Study|Adverse Event|13|||
146385693|NCT00882362|527910831|FG001|Overall Study|Adverse Event|10|||
146385694|NCT00882362|527910830|FG000|Overall Study|Withdrawal by Subject|13|||
146385695|NCT00882362|527910831|FG001|Overall Study|Withdrawal by Subject|10|||
146385696|NCT00882362|527910830|FG000|Overall Study|Lack of Efficacy|3|||
146385697|NCT00882362|527910831|FG001|Overall Study|Lack of Efficacy|0|||
146385698|NCT00882362|527910830|FG000|Overall Study|Protocol Violation|7|||
146385699|NCT00882362|527910831|FG001|Overall Study|Protocol Violation|2|||
146385700|NCT00882362|527910830|FG000|Overall Study|Pregnancy|1|||
146385701|NCT00882362|527910831|FG001|Overall Study|Pregnancy|0|||
146385702|NCT00882362|527910830|FG000|Overall Study|Physician Decision|5|||
146385703|NCT00882362|527910831|FG001|Overall Study|Physician Decision|1|||
146385704|NCT00882362|527910830|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
146385705|NCT00882362|527910831|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
146385706|NCT00882362|527910830|FG000|Overall Study|change of residence or other commitments|5|||
146385707|NCT00882362|527910831|FG001|Overall Study|change of residence or other commitments|0|||
146385708|NCT02096471|527910832|FG000|Overall Study|Adverse Event|1|||
146385709|NCT02096471|527910832|FG000|Overall Study|Lack of Efficacy|7|||
146385710|NCT02096471|527910832|FG000|Overall Study|Withdrawal by Subject|3|||
146385711|NCT02096471|527910832|FG000|Overall Study|Non-Compliant|2|||
146385712|NCT01809327|527910833|FG000|Overall Study|Lost to Follow-up|5|||
146385713|NCT01809327|527910834|FG001|Overall Study|Lost to Follow-up|2|||
146385714|NCT01809327|527910835|FG002|Overall Study|Lost to Follow-up|4|||
146385715|NCT01809327|527910836|FG003|Overall Study|Lost to Follow-up|2|||
146385716|NCT01809327|527910837|FG004|Overall Study|Lost to Follow-up|3|||
146385717|NCT01809327|527910833|FG000|Overall Study|Withdrawal by Subject|6|||
146385718|NCT01809327|527910834|FG001|Overall Study|Withdrawal by Subject|4|||
146385719|NCT01809327|527910835|FG002|Overall Study|Withdrawal by Subject|4|||
146385720|NCT01809327|527910836|FG003|Overall Study|Withdrawal by Subject|2|||
146385721|NCT01809327|527910837|FG004|Overall Study|Withdrawal by Subject|5|||
146385722|NCT01809327|527910833|FG000|Overall Study|Adverse Event|4|||
146385723|NCT01809327|527910834|FG001|Overall Study|Adverse Event|3|||
146385724|NCT01809327|527910835|FG002|Overall Study|Adverse Event|7|||
146385725|NCT01809327|527910836|FG003|Overall Study|Adverse Event|4|||
146385726|NCT01809327|527910837|FG004|Overall Study|Adverse Event|8|||
146385727|NCT01809327|527910833|FG000|Overall Study|Death|1|||
146385728|NCT01809327|527910834|FG001|Overall Study|Death|0|||
146385729|NCT01809327|527910835|FG002|Overall Study|Death|0|||
146385730|NCT01809327|527910836|FG003|Overall Study|Death|0|||
146385731|NCT01809327|527910837|FG004|Overall Study|Death|0|||
146385732|NCT01809327|527910833|FG000|Overall Study|Protocol Violation|0|||
146385733|NCT01809327|527910834|FG001|Overall Study|Protocol Violation|1|||
146385734|NCT01809327|527910835|FG002|Overall Study|Protocol Violation|0|||
146385735|NCT01809327|527910836|FG003|Overall Study|Protocol Violation|0|||
146385736|NCT01809327|527910837|FG004|Overall Study|Protocol Violation|0|||
146385737|NCT01809327|527910833|FG000|Overall Study|Physician Decision|1|||
146385738|NCT01809327|527910834|FG001|Overall Study|Physician Decision|1|||
146385739|NCT01809327|527910835|FG002|Overall Study|Physician Decision|0|||
146385740|NCT01809327|527910836|FG003|Overall Study|Physician Decision|0|||
146385741|NCT01809327|527910837|FG004|Overall Study|Physician Decision|0|||
146385742|NCT01809327|527910833|FG000|Overall Study|Pregnancy|1|||
146385743|NCT01809327|527910834|FG001|Overall Study|Pregnancy|0|||
146385744|NCT01809327|527910835|FG002|Overall Study|Pregnancy|0|||
146385745|NCT01809327|527910836|FG003|Overall Study|Pregnancy|0|||
146385746|NCT01809327|527910837|FG004|Overall Study|Pregnancy|0|||
146385747|NCT01809327|527910833|FG000|Overall Study|Other|14|||
146385748|NCT01809327|527910834|FG001|Overall Study|Other|15|||
146385749|NCT01809327|527910835|FG002|Overall Study|Other|7|||
146385750|NCT01809327|527910836|FG003|Overall Study|Other|4|||
146385751|NCT01809327|527910837|FG004|Overall Study|Other|9|||
146385752|NCT02545049|527910838|FG000|Overall Study|Withdrawal by Subject|1|||
146385753|NCT02545049|527910839|FG001|Overall Study|Withdrawal by Subject|7|||
146385754|NCT02545049|527910838|FG000|Overall Study|Lost to Follow-up|4|||
146385755|NCT02545049|527910839|FG001|Overall Study|Lost to Follow-up|6|||
146385756|NCT02545049|527910838|FG000|Overall Study|GCP violations|37|||
146385757|NCT02545049|527910839|FG001|Overall Study|GCP violations|48|||
146385758|NCT02985684|527910840|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
146385759|NCT02985684|527910840|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
146385760|NCT02985684|527910840|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
146385761|NCT04652102|527911862|FG000|Overall Study|Adverse Event|14|||
146385762|NCT04652102|527911863|FG001|Overall Study|Adverse Event|13|||
146385763|NCT04652102|527911862|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
146385764|NCT04652102|527911863|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
146385765|NCT04652102|527911862|FG000|Overall Study|Physician Decision|78|||
146385766|NCT04652102|527911863|FG001|Overall Study|Physician Decision|40|||
146385767|NCT04652102|527911862|FG000|Overall Study|Study Ended by Sponsor|64|||
146385768|NCT04652102|527911863|FG001|Overall Study|Study Ended by Sponsor|17|||
146385769|NCT04652102|527911862|FG000|Overall Study|Withdrawal by Subject|4625|||
146385770|NCT04652102|527911863|FG001|Overall Study|Withdrawal by Subject|5594|||
146385771|NCT04652102|527911862|FG000|Overall Study|Lost to Follow-up|2019|||
146385772|NCT04652102|527911863|FG001|Overall Study|Lost to Follow-up|1082|||
146385773|NCT04652102|527911862|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
146385774|NCT04652102|527911863|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
146385775|NCT04652102|527911862|FG000|Overall Study|Miscellaneous|80|||
146385776|NCT04652102|527911863|FG001|Overall Study|Miscellaneous|64|||
146385777|NCT02405091|527911866|FG000|Overall Study|Adverse Event|16|||
146385778|NCT02405091|527911867|FG001|Overall Study|Adverse Event|10|||
146385779|NCT02405091|527911868|FG002|Overall Study|Adverse Event|0|||
146385780|NCT02405091|527911866|FG000|Overall Study|Protocol Violation|1|||
146385781|NCT02405091|527911867|FG001|Overall Study|Protocol Violation|0|||
146385782|NCT02405091|527911868|FG002|Overall Study|Protocol Violation|0|||
146385783|NCT02405091|527911866|FG000|Overall Study|Noncompliance|1|||
146385784|NCT02405091|527911867|FG001|Overall Study|Noncompliance|6|||
146385785|NCT02405091|527911868|FG002|Overall Study|Noncompliance|2|||
146385786|NCT02405091|527911866|FG000|Overall Study|Withdrawal by Subject|4|||
146385787|NCT02405091|527911867|FG001|Overall Study|Withdrawal by Subject|8|||
146385788|NCT02405091|527911868|FG002|Overall Study|Withdrawal by Subject|0|||
146385789|NCT02405091|527911866|FG000|Overall Study|Death|0|||
146385790|NCT02405091|527911867|FG001|Overall Study|Death|1|||
146385791|NCT02405091|527911868|FG002|Overall Study|Death|0|||
146385792|NCT02405091|527911866|FG000|Overall Study|Lost to Follow-up|5|||
146385793|NCT02405091|527911867|FG001|Overall Study|Lost to Follow-up|6|||
146385794|NCT02405091|527911868|FG002|Overall Study|Lost to Follow-up|0|||
146385795|NCT02405091|527911866|FG000|Overall Study|Physician Decision|2|||
146385796|NCT02405091|527911867|FG001|Overall Study|Physician Decision|2|||
146385797|NCT02405091|527911868|FG002|Overall Study|Physician Decision|0|||
146385798|NCT00247962|527911877|FG000|Overall Study|Adverse Event|15|||
146385799|NCT00247962|527911878|FG001|Overall Study|Adverse Event|12|||
146385800|NCT00247962|527911877|FG000|Overall Study|Lost to Follow-up|3|||
146385801|NCT00247962|527911878|FG001|Overall Study|Lost to Follow-up|1|||
146385802|NCT00247962|527911877|FG000|Overall Study|Physician Decision|0|||
146385803|NCT00247962|527911878|FG001|Overall Study|Physician Decision|1|||
146385804|NCT00247962|527911877|FG000|Overall Study|Protocol Violation|1|||
146385805|NCT00247962|527911878|FG001|Overall Study|Protocol Violation|1|||
146385806|NCT00247962|527911877|FG000|Overall Study|Withdrawal by Subject|3|||
146385807|NCT00247962|527911878|FG001|Overall Study|Withdrawal by Subject|2|||
146385808|NCT00247962|527911877|FG000|Overall Study|Lack of Efficacy|4|||
146385809|NCT00247962|527911878|FG001|Overall Study|Lack of Efficacy|2|||
146385810|NCT01469637|527911883|FG000|First Intervention|Unacceptable behavior|0|||
146385811|NCT01469637|527911884|FG001|First Intervention|Unacceptable behavior|1|||
146385812|NCT01469637|527911883|FG000|Second Intervention|Incarcerated|1|||
146385813|NCT01469637|527911884|FG001|Second Intervention|Incarcerated|0|||
146385814|NCT01371721|527911885|FG000|Overall Study|Adverse Event|5|||
146385815|NCT01371721|527911886|FG001|Overall Study|Adverse Event|4|||
146385816|NCT01371721|527911887|FG002|Overall Study|Adverse Event|5|||
146385817|NCT01371721|527911885|FG000|Overall Study|Protocol Violation|6|||
146385818|NCT01371721|527911886|FG001|Overall Study|Protocol Violation|4|||
146385819|NCT01371721|527911887|FG002|Overall Study|Protocol Violation|5|||
146385820|NCT01371721|527911885|FG000|Overall Study|Lost to Follow-up|8|||
146385821|NCT01371721|527911886|FG001|Overall Study|Lost to Follow-up|2|||
146385822|NCT01371721|527911887|FG002|Overall Study|Lost to Follow-up|6|||
146385823|NCT01371721|527911885|FG000|Overall Study|Withdrawal by Subject|5|||
146385824|NCT01371721|527911886|FG001|Overall Study|Withdrawal by Subject|7|||
146385825|NCT01371721|527911887|FG002|Overall Study|Withdrawal by Subject|11|||
146385826|NCT01371721|527911885|FG000|Overall Study|Other|2|||
146385827|NCT01371721|527911886|FG001|Overall Study|Other|3|||
146385828|NCT01371721|527911887|FG002|Overall Study|Other|0|||
146385829|NCT01371721|527911885|FG000|Overall Study|Lack of Efficacy|2|||
146385830|NCT01371721|527911886|FG001|Overall Study|Lack of Efficacy|4|||
146385831|NCT01371721|527911887|FG002|Overall Study|Lack of Efficacy|3|||
146385832|NCT01371721|527911885|FG000|Overall Study|Randomized but not treated|1|||
146385833|NCT01371721|527911886|FG001|Overall Study|Randomized but not treated|0|||
146385834|NCT01371721|527911887|FG002|Overall Study|Randomized but not treated|0|||
146385835|NCT00545584|527911888|FG000|Overall Study|Only one reason for discontinuation|62|||
146385836|NCT00545584|527911889|FG001|Overall Study|Only one reason for discontinuation|61|||
146385837|NCT00545584|527911890|FG002|Overall Study|Only one reason for discontinuation|48|||
146385838|NCT00545584|527911888|FG000|Overall Study|Two or more reasons for discontinuation|17|||
146385839|NCT00545584|527911889|FG001|Overall Study|Two or more reasons for discontinuation|19|||
146385840|NCT00545584|527911890|FG002|Overall Study|Two or more reasons for discontinuation|8|||
146385841|NCT03525613|527911893|FG000|Overall Study|Adverse Event|11|||
146385842|NCT03525613|527911894|FG001|Overall Study|Adverse Event|8|||
146385843|NCT03525613|527911895|FG002|Overall Study|Adverse Event|3|||
146385844|NCT03525613|527911896|FG003|Overall Study|Adverse Event|3|||
146385845|NCT03525613|527911893|FG000|Overall Study|Lost to Follow-up|4|||
146385846|NCT03525613|527911894|FG001|Overall Study|Lost to Follow-up|5|||
146385847|NCT03525613|527911895|FG002|Overall Study|Lost to Follow-up|3|||
146385848|NCT03525613|527911896|FG003|Overall Study|Lost to Follow-up|2|||
146385849|NCT03525613|527911893|FG000|Overall Study|Physician Decision|0|||
146385850|NCT03525613|527911894|FG001|Overall Study|Physician Decision|1|||
146385851|NCT03525613|527911895|FG002|Overall Study|Physician Decision|0|||
146385852|NCT03525613|527911896|FG003|Overall Study|Physician Decision|1|||
146385853|NCT03525613|527911893|FG000|Overall Study|Consent Withdrawal|25|||
146385854|NCT03525613|527911894|FG001|Overall Study|Consent Withdrawal|16|||
146385855|NCT03525613|527911895|FG002|Overall Study|Consent Withdrawal|12|||
146385856|NCT03525613|527911896|FG003|Overall Study|Consent Withdrawal|9|||
146385857|NCT03525613|527911893|FG000|Overall Study|Death|20|||
146385858|NCT03525613|527911894|FG001|Overall Study|Death|9|||
146385859|NCT03525613|527911895|FG002|Overall Study|Death|7|||
146385860|NCT03525613|527911896|FG003|Overall Study|Death|1|||
146385861|NCT03525613|527911893|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
146385862|NCT03525613|527911894|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
146385863|NCT03525613|527911895|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
146385864|NCT03525613|527911896|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
146385865|NCT00135694|527911900|FG000|Overall Study|Adverse Event|17|||
146385866|NCT00135694|527911901|FG001|Overall Study|Adverse Event|4|||
146385867|NCT00135694|527911902|FG002|Overall Study|Adverse Event|0|||
146385868|NCT00135694|527911900|FG000|Overall Study|Death|14|||
146385869|NCT00135694|527911901|FG001|Overall Study|Death|1|||
146385870|NCT00135694|527911902|FG002|Overall Study|Death|2|||
146385871|NCT00135694|527911900|FG000|Overall Study|Lost to Follow-up|8|||
146385872|NCT00135694|527911901|FG001|Overall Study|Lost to Follow-up|7|||
146385873|NCT00135694|527911902|FG002|Overall Study|Lost to Follow-up|1|||
146385874|NCT00135694|527911900|FG000|Overall Study|Withdrawal by Subject|41|||
146385875|NCT00135694|527911901|FG001|Overall Study|Withdrawal by Subject|7|||
146385876|NCT00135694|527911902|FG002|Overall Study|Withdrawal by Subject|4|||
146385877|NCT00135694|527911900|FG000|Overall Study|Protocol Violation|19|||
146385878|NCT00135694|527911901|FG001|Overall Study|Protocol Violation|1|||
146385879|NCT00135694|527911902|FG002|Overall Study|Protocol Violation|0|||
146385880|NCT00135694|527911900|FG000|Overall Study|Hepatitis C related reasons|39|||
146385881|NCT00135694|527911901|FG001|Overall Study|Hepatitis C related reasons|1|||
146385882|NCT00135694|527911902|FG002|Overall Study|Hepatitis C related reasons|0|||
146385883|NCT00135694|527911900|FG000|Overall Study|Ineligible for Random assignment|42|||
146385884|NCT00135694|527911901|FG001|Overall Study|Ineligible for Random assignment|0|||
146385885|NCT00135694|527911902|FG002|Overall Study|Ineligible for Random assignment|0|||
146385886|NCT02584660|527911903|FG000|Overall Study|Adverse Event|4|||
146385887|NCT02584660|527911904|FG001|Overall Study|Adverse Event|0|||
146385888|NCT02584660|527911903|FG000|Overall Study|Lost to Follow-up|3|||
146385889|NCT02584660|527911904|FG001|Overall Study|Lost to Follow-up|4|||
146385890|NCT02584660|527911903|FG000|Overall Study|Protocol Violation|0|||
146385891|NCT02584660|527911904|FG001|Overall Study|Protocol Violation|1|||
146385892|NCT02584660|527911903|FG000|Overall Study|Withdrawal by Subject|0|||
146385893|NCT02584660|527911904|FG001|Overall Study|Withdrawal by Subject|2|||
146385894|NCT02584660|527911903|FG000|Overall Study|Other|0|||
146385895|NCT02584660|527911904|FG001|Overall Study|Other|1|||
146385896|NCT00374452|527911905|FG000|Overall Study|Left clinic before intervention started|4|||
146385897|NCT00374452|527911906|FG001|Overall Study|Left clinic before intervention started|1|||
146385898|NCT00374452|527911905|FG000|Overall Study|Change in job role before intervention|0|||
146385899|NCT00374452|527911906|FG001|Overall Study|Change in job role before intervention|1|||
146385900|NCT00374452|527911905|FG000|Overall Study|Left clinic after intervention started|1|||
146385901|NCT00374452|527911906|FG001|Overall Study|Left clinic after intervention started|1|||
146385902|NCT00374452|527911905|FG000|Overall Study|Withdrawal by Subject|0|||
146385903|NCT00374452|527911906|FG001|Overall Study|Withdrawal by Subject|2|||
146385904|NCT02120469|527911910|FG000|Overall Study|HER-2/neu-amplified|1|||
146385905|NCT02120469|527911911|FG001|Overall Study|HER-2/neu-amplified|0|||
146385906|NCT02120469|527911912|FG002|Overall Study|HER-2/neu-amplified|1|||
146385907|NCT01601873|527911913|FG000|Overall Study|Lost to Follow-up|2|||
146385908|NCT01601873|527911914|FG001|Overall Study|Lost to Follow-up|3|||
146385909|NCT03196973|527911915|FG000|Overall Study|Adverse Event|1|||
146385910|NCT03196973|527911916|FG001|Overall Study|Adverse Event|1|||
146385911|NCT03196973|527911917|FG002|Overall Study|Adverse Event|2|||
146385912|NCT03196973|527911915|FG000|Overall Study|Lack of Efficacy|2|||
146385913|NCT03196973|527911916|FG001|Overall Study|Lack of Efficacy|6|||
146385914|NCT03196973|527911917|FG002|Overall Study|Lack of Efficacy|1|||
146385915|NCT03196973|527911915|FG000|Overall Study|Lost to Follow-up|4|||
146385916|NCT03196973|527911916|FG001|Overall Study|Lost to Follow-up|3|||
146385917|NCT03196973|527911917|FG002|Overall Study|Lost to Follow-up|2|||
146385918|NCT03196973|527911915|FG000|Overall Study|Consent withdrawn|2|||
146385919|NCT03196973|527911916|FG001|Overall Study|Consent withdrawn|1|||
146385920|NCT03196973|527911917|FG002|Overall Study|Consent withdrawn|0|||
146385921|NCT03196973|527911915|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
146385922|NCT03196973|527911916|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
146385923|NCT03196973|527911917|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
146385924|NCT02520141|527911930|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
146385925|NCT02168816|527911935|FG000|Overall Study|Lost to Follow-up|2|||
146385926|NCT02168816|527911936|FG001|Overall Study|Lost to Follow-up|2|||
146385927|NCT01066546|527911941|FG000|Overall Study|Study terminated by sponsor|5|||
146385928|NCT03258762|527911946|FG000|Overall Study|Lost to Follow-up|0|||
146385929|NCT03258762|527911947|FG001|Overall Study|Lost to Follow-up|1|||
146385930|NCT00125268|527911948|FG000|Overall Study|Withdrawal by Subject|1|||
146385931|NCT00125268|527911949|FG001|Overall Study|Withdrawal by Subject|1|||
146385932|NCT00805142|527911950|FG000|Titration Period|Adverse Event|3|||
146385933|NCT00805142|527911951|FG001|Titration Period|Adverse Event|3|||
146385934|NCT00805142|527911950|FG000|Titration Period|Lack of Efficacy|1|||
146385935|NCT00805142|527911951|FG001|Titration Period|Lack of Efficacy|1|||
146385936|NCT00805142|527911950|FG000|Titration Period|Lost to Follow-up|0|||
146385937|NCT00805142|527911951|FG001|Titration Period|Lost to Follow-up|1|||
146385938|NCT00805142|527911950|FG000|Titration Period|Disease Progression|2|||
146385939|NCT00805142|527911951|FG001|Titration Period|Disease Progression|1|||
146385940|NCT00805142|527911950|FG000|Titration Period|Withdrawal of consent|0|||
146385941|NCT00805142|527911951|FG001|Titration Period|Withdrawal of consent|1|||
146385942|NCT00805142|527911950|FG000|Titration Period|Other|0|||
146385943|NCT00805142|527911951|FG001|Titration Period|Other|3|||
146385944|NCT00805142|527911950|FG000|Maintenance Period|Adverse Event|0|||
146385945|NCT00805142|527911951|FG001|Maintenance Period|Adverse Event|1|||
146385946|NCT00805142|527911950|FG000|Maintenance Period|Other|0|||
146385947|NCT00805142|527911951|FG001|Maintenance Period|Other|1|||
146385948|NCT00424463|527911955|FG000|Overall Study|Adverse Event|2|||
146385949|NCT00424463|527911956|FG001|Overall Study|Adverse Event|3|||
146385950|NCT00424463|527911957|FG002|Overall Study|Adverse Event|2|||
146385951|NCT00424463|527911955|FG000|Overall Study|Physician Decision|0|||
146385952|NCT00424463|527911956|FG001|Overall Study|Physician Decision|2|||
146385953|NCT00424463|527911957|FG002|Overall Study|Physician Decision|2|||
146385954|NCT00424463|527911955|FG000|Overall Study|Withdrawal by Subject|4|||
146385955|NCT00424463|527911956|FG001|Overall Study|Withdrawal by Subject|2|||
146385956|NCT00424463|527911957|FG002|Overall Study|Withdrawal by Subject|5|||
146385957|NCT00424463|527911955|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
146385958|NCT00424463|527911956|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
146385959|NCT00424463|527911957|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
146385960|NCT00424463|527911955|FG000|Overall Study|Patient's convenience|0|||
146385961|NCT00424463|527911956|FG001|Overall Study|Patient's convenience|0|||
146385962|NCT00424463|527911957|FG002|Overall Study|Patient's convenience|1|||
146385963|NCT02449915|527911958|FG000|Overall Study|Exclusion criteria - drug use|1|||
146385964|NCT02449915|527911959|FG001|Overall Study|Exclusion criteria - drug use|0|||
146385965|NCT02449915|527911958|FG000|Overall Study|Withdrawal by Subject|0|||
146385966|NCT02449915|527911959|FG001|Overall Study|Withdrawal by Subject|2|||
146385967|NCT02449915|527911958|FG000|Overall Study|Intraoperative surgical findings|1|||
146385968|NCT02449915|527911959|FG001|Overall Study|Intraoperative surgical findings|1|||
146385969|NCT02449915|527911958|FG000|Overall Study|Abnormal preop lab|0|||
146385970|NCT02449915|527911959|FG001|Overall Study|Abnormal preop lab|1|||
146385971|NCT01436357|527911960|FG000|Overall Study|Death|5|||
146385972|NCT01436357|527911961|FG001|Overall Study|Death|1|||
146385973|NCT01436357|527911960|FG000|Overall Study|Enrolled but not vaccinated|1|||
146385974|NCT01436357|527911961|FG001|Overall Study|Enrolled but not vaccinated|1|||
146385975|NCT01436357|527911960|FG000|Overall Study|Incarceration|18|||
146385976|NCT01436357|527911961|FG001|Overall Study|Incarceration|20|||
146385977|NCT01436357|527911960|FG000|Overall Study|Lost to Follow-up|67|||
146385978|NCT01436357|527911961|FG001|Overall Study|Lost to Follow-up|61|||
146385979|NCT01436357|527911960|FG000|Overall Study|Protocol Violation|1|||
146385980|NCT01436357|527911961|FG001|Overall Study|Protocol Violation|0|||
146385981|NCT01436357|527911960|FG000|Overall Study|Withdrawal by Subject|26|||
146385982|NCT01436357|527911961|FG001|Overall Study|Withdrawal by Subject|38|||
146385983|NCT01436357|527911960|FG000|Overall Study|Physician Decision|3|||
146385984|NCT01436357|527911961|FG001|Overall Study|Physician Decision|4|||
146385985|NCT01436357|527911960|FG000|Overall Study|Moved out of area|1|||
146385986|NCT01436357|527911961|FG001|Overall Study|Moved out of area|2|||
146385987|NCT01436357|527911960|FG000|Overall Study|Subject in rehab|0|||
146385988|NCT01436357|527911961|FG001|Overall Study|Subject in rehab|1|||
146385989|NCT00656799|527911963|FG000|Overall Study|Death|2|||
146385990|NCT04144140|527913767|FG000|Overall Study|Other|0|||
146385991|NCT04144140|527913768|FG001|Overall Study|Other|0|||
146385992|NCT04144140|527913769|FG002|Overall Study|Other|0|||
146385993|NCT04144140|527913770|FG003|Overall Study|Other|0|||
146385994|NCT04144140|527913771|FG004|Overall Study|Other|0|||
146385995|NCT04144140|527913772|FG005|Overall Study|Other|1|||
146385996|NCT04144140|527913773|FG006|Overall Study|Other|0|||
146385997|NCT04735432|527913776|FG000|Overall Study|Other - due to personal reason|1|||
146385998|NCT04735432|527913777|FG001|Overall Study|Other - due to personal reason|0|||
146385999|NCT04735432|527913776|FG000|Overall Study|Adverse Event|2|||
146386000|NCT04735432|527913777|FG001|Overall Study|Adverse Event|0|||
146386001|NCT01066819|527913778|FG000|Overall Study|Adverse Event|18|||
146386002|NCT01066819|527913779|FG001|Overall Study|Adverse Event|1|||
146386003|NCT01066819|527913780|FG002|Overall Study|Adverse Event|6|||
146386004|NCT01066819|527913781|FG003|Overall Study|Adverse Event|0|||
146386005|NCT01066819|527913782|FG004|Overall Study|Adverse Event|0|||
146386006|NCT01066819|527913783|FG005|Overall Study|Adverse Event|0|||
146386007|NCT01066819|527913778|FG000|Overall Study|Death|5|||
146386008|NCT01066819|527913779|FG001|Overall Study|Death|0|||
146386009|NCT01066819|527913780|FG002|Overall Study|Death|1|||
146386010|NCT01066819|527913781|FG003|Overall Study|Death|0|||
146386011|NCT01066819|527913782|FG004|Overall Study|Death|0|||
146386012|NCT01066819|527913783|FG005|Overall Study|Death|0|||
146386013|NCT01066819|527913778|FG000|Overall Study|Lack of Efficacy|22|||
146386014|NCT01066819|527913779|FG001|Overall Study|Lack of Efficacy|1|||
146386015|NCT01066819|527913780|FG002|Overall Study|Lack of Efficacy|2|||
146386016|NCT01066819|527913781|FG003|Overall Study|Lack of Efficacy|1|||
146386017|NCT01066819|527913782|FG004|Overall Study|Lack of Efficacy|0|||
146386018|NCT01066819|527913783|FG005|Overall Study|Lack of Efficacy|0|||
146386019|NCT01066819|527913778|FG000|Overall Study|Physician Decision|6|||
146386020|NCT01066819|527913779|FG001|Overall Study|Physician Decision|2|||
146386021|NCT01066819|527913780|FG002|Overall Study|Physician Decision|3|||
146386022|NCT01066819|527913781|FG003|Overall Study|Physician Decision|0|||
146386023|NCT01066819|527913782|FG004|Overall Study|Physician Decision|0|||
146386024|NCT01066819|527913783|FG005|Overall Study|Physician Decision|0|||
146386025|NCT01066819|527913778|FG000|Overall Study|Protocol Violation|12|||
146386026|NCT01066819|527913779|FG001|Overall Study|Protocol Violation|6|||
146386027|NCT01066819|527913780|FG002|Overall Study|Protocol Violation|0|||
146386028|NCT01066819|527913781|FG003|Overall Study|Protocol Violation|0|||
146386029|NCT01066819|527913782|FG004|Overall Study|Protocol Violation|0|||
146386030|NCT01066819|527913783|FG005|Overall Study|Protocol Violation|0|||
146386031|NCT01066819|527913778|FG000|Overall Study|Withdrawal by Subject|29|||
146386032|NCT01066819|527913779|FG001|Overall Study|Withdrawal by Subject|11|||
146386033|NCT01066819|527913780|FG002|Overall Study|Withdrawal by Subject|6|||
146386034|NCT01066819|527913781|FG003|Overall Study|Withdrawal by Subject|0|||
146386035|NCT01066819|527913782|FG004|Overall Study|Withdrawal by Subject|0|||
146386036|NCT01066819|527913783|FG005|Overall Study|Withdrawal by Subject|0|||
146386037|NCT01066819|527913778|FG000|Overall Study|Administrative|6|||
146386038|NCT01066819|527913779|FG001|Overall Study|Administrative|4|||
146386039|NCT01066819|527913780|FG002|Overall Study|Administrative|2|||
146386040|NCT01066819|527913781|FG003|Overall Study|Administrative|0|||
146386041|NCT01066819|527913782|FG004|Overall Study|Administrative|0|||
146386042|NCT01066819|527913783|FG005|Overall Study|Administrative|0|||
146386043|NCT01066819|527913778|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
146386044|NCT01066819|527913779|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
146386045|NCT01066819|527913780|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
146386046|NCT01066819|527913781|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
146386047|NCT01066819|527913782|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
146386048|NCT01066819|527913783|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
146386049|NCT01066819|527913778|FG000|Overall Study|Early termination|2|||
146386050|NCT01066819|527913779|FG001|Overall Study|Early termination|0|||
146386051|NCT01066819|527913780|FG002|Overall Study|Early termination|0|||
146386052|NCT01066819|527913781|FG003|Overall Study|Early termination|0|||
146386053|NCT01066819|527913782|FG004|Overall Study|Early termination|0|||
146386054|NCT01066819|527913783|FG005|Overall Study|Early termination|0|||
146386055|NCT01066819|527913778|FG000|Overall Study|Failed to return|298|||
146386056|NCT01066819|527913779|FG001|Overall Study|Failed to return|107|||
146386057|NCT01066819|527913780|FG002|Overall Study|Failed to return|68|||
146386058|NCT01066819|527913781|FG003|Overall Study|Failed to return|7|||
146386059|NCT01066819|527913782|FG004|Overall Study|Failed to return|2|||
146386060|NCT01066819|527913783|FG005|Overall Study|Failed to return|3|||
146386061|NCT01066819|527913778|FG000|Overall Study|Lab test not done|9|||
146386062|NCT01066819|527913779|FG001|Overall Study|Lab test not done|0|||
146386063|NCT01066819|527913780|FG002|Overall Study|Lab test not done|2|||
146386064|NCT01066819|527913781|FG003|Overall Study|Lab test not done|1|||
146386065|NCT01066819|527913782|FG004|Overall Study|Lab test not done|0|||
146386066|NCT01066819|527913783|FG005|Overall Study|Lab test not done|0|||
146386067|NCT01066819|527913778|FG000|Overall Study|Miscellaneous|28|||
146386068|NCT01066819|527913779|FG001|Overall Study|Miscellaneous|10|||
146386069|NCT01066819|527913780|FG002|Overall Study|Miscellaneous|18|||
146386070|NCT01066819|527913781|FG003|Overall Study|Miscellaneous|1|||
146386071|NCT01066819|527913782|FG004|Overall Study|Miscellaneous|0|||
146386072|NCT01066819|527913783|FG005|Overall Study|Miscellaneous|0|||
146386073|NCT01066819|527913778|FG000|Overall Study|Non responders|123|||
146386074|NCT01066819|527913779|FG001|Overall Study|Non responders|2|||
146386075|NCT01066819|527913780|FG002|Overall Study|Non responders|7|||
146386076|NCT01066819|527913781|FG003|Overall Study|Non responders|2|||
146386077|NCT01066819|527913782|FG004|Overall Study|Non responders|0|||
146386078|NCT01066819|527913783|FG005|Overall Study|Non responders|1|||
146386079|NCT01066819|527913778|FG000|Overall Study|Not categorised|9|||
146386080|NCT01066819|527913779|FG001|Overall Study|Not categorised|2|||
146386081|NCT01066819|527913780|FG002|Overall Study|Not categorised|6|||
146386082|NCT01066819|527913781|FG003|Overall Study|Not categorised|1|||
146386083|NCT01066819|527913782|FG004|Overall Study|Not categorised|0|||
146386084|NCT01066819|527913783|FG005|Overall Study|Not categorised|0|||
146386085|NCT01066819|527913778|FG000|Overall Study|Relapse|16|||
146386086|NCT01066819|527913779|FG001|Overall Study|Relapse|4|||
146386087|NCT01066819|527913780|FG002|Overall Study|Relapse|3|||
146386088|NCT01066819|527913781|FG003|Overall Study|Relapse|0|||
146386089|NCT01066819|527913782|FG004|Overall Study|Relapse|0|||
146386090|NCT01066819|527913783|FG005|Overall Study|Relapse|0|||
146386091|NCT01066819|527913778|FG000|Overall Study|Results not available|1|||
146386092|NCT01066819|527913779|FG001|Overall Study|Results not available|0|||
146386093|NCT01066819|527913780|FG002|Overall Study|Results not available|0|||
146386094|NCT01066819|527913781|FG003|Overall Study|Results not available|0|||
146386095|NCT01066819|527913782|FG004|Overall Study|Results not available|0|||
146386096|NCT01066819|527913783|FG005|Overall Study|Results not available|0|||
146386097|NCT01066819|527913778|FG000|Overall Study|Screen failure|1|||
146386098|NCT01066819|527913779|FG001|Overall Study|Screen failure|0|||
146386099|NCT01066819|527913780|FG002|Overall Study|Screen failure|0|||
146386100|NCT01066819|527913781|FG003|Overall Study|Screen failure|0|||
146386101|NCT01066819|527913782|FG004|Overall Study|Screen failure|0|||
146386102|NCT01066819|527913783|FG005|Overall Study|Screen failure|0|||
146386103|NCT01066819|527913778|FG000|Overall Study|Spontaneous cure|1|||
146386104|NCT01066819|527913779|FG001|Overall Study|Spontaneous cure|0|||
146386105|NCT01066819|527913780|FG002|Overall Study|Spontaneous cure|0|||
146386106|NCT01066819|527913781|FG003|Overall Study|Spontaneous cure|0|||
146386107|NCT01066819|527913782|FG004|Overall Study|Spontaneous cure|0|||
146386108|NCT01066819|527913783|FG005|Overall Study|Spontaneous cure|0|||
146386109|NCT01066819|527913778|FG000|Overall Study|Treatment never started|85|||
146386110|NCT01066819|527913779|FG001|Overall Study|Treatment never started|19|||
146386111|NCT01066819|527913780|FG002|Overall Study|Treatment never started|19|||
146386112|NCT01066819|527913781|FG003|Overall Study|Treatment never started|3|||
146386113|NCT01066819|527913782|FG004|Overall Study|Treatment never started|2|||
146386114|NCT01066819|527913783|FG005|Overall Study|Treatment never started|2|||
146386115|NCT01066819|527913778|FG000|Overall Study|Treatment stopped|12|||
146386116|NCT01066819|527913779|FG001|Overall Study|Treatment stopped|1|||
146386117|NCT01066819|527913780|FG002|Overall Study|Treatment stopped|2|||
146386118|NCT01066819|527913781|FG003|Overall Study|Treatment stopped|1|||
146386119|NCT01066819|527913782|FG004|Overall Study|Treatment stopped|0|||
146386120|NCT01066819|527913783|FG005|Overall Study|Treatment stopped|0|||
146386121|NCT01066819|527913778|FG000|Overall Study|Other|5|||
146386122|NCT01066819|527913779|FG001|Overall Study|Other|1|||
146386123|NCT01066819|527913780|FG002|Overall Study|Other|1|||
146386124|NCT01066819|527913781|FG003|Overall Study|Other|0|||
146386125|NCT01066819|527913782|FG004|Overall Study|Other|0|||
146386126|NCT01066819|527913783|FG005|Overall Study|Other|0|||
146386127|NCT02408016|527913784|FG000|Overall Study|Death|6|||
146386128|NCT02408016|527913785|FG001|Overall Study|Death|1|||
146386129|NCT02408016|527913786|FG002|Overall Study|Death|0|||
146386130|NCT02408016|527913784|FG000|Overall Study|Physician Decision|0|||
146386131|NCT02408016|527913785|FG001|Overall Study|Physician Decision|2|||
146386132|NCT02408016|527913786|FG002|Overall Study|Physician Decision|0|||
146386133|NCT00718887|527913788|FG000|Overall Study|Withdrawal by Subject|3|||
146386134|NCT00718887|527913789|FG001|Overall Study|Withdrawal by Subject|2|||
146386135|NCT00718887|527913788|FG000|Overall Study|Not identified|2|||
146386136|NCT00718887|527913789|FG001|Overall Study|Not identified|7|||
146386137|NCT00775138|527913790|FG000|Overall Study|Withdrawal by Subject|0|||
146386138|NCT00775138|527913791|FG001|Overall Study|Withdrawal by Subject|0|||
146386139|NCT00775138|527913792|FG002|Overall Study|Withdrawal by Subject|2|||
146386140|NCT00775138|527913793|FG003|Overall Study|Withdrawal by Subject|2|||
146386141|NCT00775138|527913790|FG000|Overall Study|Adverse Event|0|||
146386142|NCT00775138|527913791|FG001|Overall Study|Adverse Event|0|||
146386143|NCT00775138|527913792|FG002|Overall Study|Adverse Event|1|||
146386144|NCT00775138|527913793|FG003|Overall Study|Adverse Event|0|||
146386145|NCT03557801|527913794|FG000|Overall Study|Protocol Violation|1|||
146386146|NCT03557801|527913795|FG001|Overall Study|Protocol Violation|0|||
146386147|NCT03557801|527913796|FG002|Overall Study|Protocol Violation|0|||
146386148|NCT03557801|527913794|FG000|Overall Study|Withdrawal by Subject|1|||
146386149|NCT03557801|527913795|FG001|Overall Study|Withdrawal by Subject|0|||
146386150|NCT03557801|527913796|FG002|Overall Study|Withdrawal by Subject|3|||
146386151|NCT03557801|527913794|FG000|Overall Study|Lost to Follow-up|0|||
146386152|NCT03557801|527913795|FG001|Overall Study|Lost to Follow-up|1|||
146386153|NCT03557801|527913796|FG002|Overall Study|Lost to Follow-up|0|||
146386154|NCT00535236|527913797|FG000|Overall Study|Adverse Event|1|||
146386155|NCT00535236|527913798|FG001|Overall Study|Adverse Event|0|||
146386156|NCT00535236|527913799|FG002|Overall Study|Adverse Event|9|||
146386157|NCT00535236|527913800|FG003|Overall Study|Adverse Event|3|||
146386158|NCT00535236|527913801|FG004|Overall Study|Adverse Event|3|||
146386159|NCT00535236|527913802|FG005|Overall Study|Adverse Event|0|||
146386160|NCT00535236|527913803|FG006|Overall Study|Adverse Event|5|||
146386161|NCT00535236|527913804|FG007|Overall Study|Adverse Event|1|||
146386162|NCT00535236|527913805|FG008|Overall Study|Adverse Event|2|||
146386163|NCT00535236|527913806|FG009|Overall Study|Adverse Event|1|||
146386164|NCT00535236|527913797|FG000|Overall Study|Lost to Follow-up|1|||
146386165|NCT00535236|527913798|FG001|Overall Study|Lost to Follow-up|2|||
146386166|NCT00535236|527913799|FG002|Overall Study|Lost to Follow-up|0|||
146386167|NCT00535236|527913800|FG003|Overall Study|Lost to Follow-up|0|||
146386168|NCT00535236|527913801|FG004|Overall Study|Lost to Follow-up|2|||
146386169|NCT00535236|527913802|FG005|Overall Study|Lost to Follow-up|0|||
146386170|NCT00535236|527913803|FG006|Overall Study|Lost to Follow-up|0|||
146386171|NCT00535236|527913804|FG007|Overall Study|Lost to Follow-up|0|||
146386172|NCT00535236|527913805|FG008|Overall Study|Lost to Follow-up|6|||
146386173|NCT00535236|527913806|FG009|Overall Study|Lost to Follow-up|1|||
146386174|NCT00535236|527913797|FG000|Overall Study|Physician Decision|0|||
146386175|NCT00535236|527913798|FG001|Overall Study|Physician Decision|0|||
146386176|NCT00535236|527913799|FG002|Overall Study|Physician Decision|0|||
146386177|NCT00535236|527913800|FG003|Overall Study|Physician Decision|0|||
146386178|NCT00535236|527913801|FG004|Overall Study|Physician Decision|1|||
146386179|NCT00535236|527913802|FG005|Overall Study|Physician Decision|0|||
146386180|NCT00535236|527913803|FG006|Overall Study|Physician Decision|1|||
146386181|NCT00535236|527913804|FG007|Overall Study|Physician Decision|0|||
146386182|NCT00535236|527913805|FG008|Overall Study|Physician Decision|0|||
146386183|NCT00535236|527913806|FG009|Overall Study|Physician Decision|0|||
146386184|NCT00535236|527913797|FG000|Overall Study|Protocol Violation|2|||
146386185|NCT00535236|527913798|FG001|Overall Study|Protocol Violation|0|||
146386186|NCT00535236|527913799|FG002|Overall Study|Protocol Violation|1|||
146386187|NCT00535236|527913800|FG003|Overall Study|Protocol Violation|0|||
146386188|NCT00535236|527913801|FG004|Overall Study|Protocol Violation|0|||
146386189|NCT00535236|527913802|FG005|Overall Study|Protocol Violation|0|||
146386190|NCT00535236|527913803|FG006|Overall Study|Protocol Violation|0|||
146386191|NCT00535236|527913804|FG007|Overall Study|Protocol Violation|0|||
146386192|NCT00535236|527913805|FG008|Overall Study|Protocol Violation|1|||
146386193|NCT00535236|527913806|FG009|Overall Study|Protocol Violation|0|||
146386194|NCT00535236|527913797|FG000|Overall Study|Withdrawal by Subject|3|||
146386195|NCT00535236|527913798|FG001|Overall Study|Withdrawal by Subject|0|||
146386196|NCT00535236|527913799|FG002|Overall Study|Withdrawal by Subject|2|||
146386197|NCT00535236|527913800|FG003|Overall Study|Withdrawal by Subject|1|||
146386198|NCT00535236|527913801|FG004|Overall Study|Withdrawal by Subject|6|||
146386199|NCT00535236|527913802|FG005|Overall Study|Withdrawal by Subject|1|||
146386200|NCT00535236|527913803|FG006|Overall Study|Withdrawal by Subject|5|||
146386201|NCT00535236|527913804|FG007|Overall Study|Withdrawal by Subject|0|||
146386202|NCT00535236|527913805|FG008|Overall Study|Withdrawal by Subject|4|||
146386203|NCT00535236|527913806|FG009|Overall Study|Withdrawal by Subject|2|||
146386204|NCT04880642|527913807|FG000|Randomization|Withdrawal by Subject|2|||
146386205|NCT04880642|527913808|FG001|Randomization|Withdrawal by Subject|3|||
146386206|NCT04880642|527913807|FG000|Treatment Period|Adverse Event|0|||
146386207|NCT04880642|527913808|FG001|Treatment Period|Adverse Event|1|||
146386208|NCT04880642|527913807|FG000|Treatment Period|Death|6|||
146386209|NCT04880642|527913808|FG001|Treatment Period|Death|6|||
146386210|NCT04880642|527913807|FG000|Treatment Period|Lost to Follow-up|1|||
146386211|NCT04880642|527913808|FG001|Treatment Period|Lost to Follow-up|0|||
146386212|NCT04880642|527913807|FG000|Treatment Period|Protocol Violation|0|||
146386213|NCT04880642|527913808|FG001|Treatment Period|Protocol Violation|1|||
146386214|NCT04880642|527913807|FG000|Treatment Period|Withdrawal by Subject|5|||
146386215|NCT04880642|527913808|FG001|Treatment Period|Withdrawal by Subject|3|||
146386216|NCT04880642|527913807|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
146386217|NCT04880642|527913808|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
146386218|NCT04880642|527913807|FG000|Follow-up|Death|4|||
146386219|NCT04880642|527913808|FG001|Follow-up|Death|3|||
146386220|NCT04880642|527913807|FG000|Follow-up|Withdrawal by Subject|1|||
146386221|NCT04880642|527913808|FG001|Follow-up|Withdrawal by Subject|0|||
146386222|NCT02275052|527913811|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146386223|NCT02275052|527913812|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
146386224|NCT02275052|527913813|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146386225|NCT02275052|527913814|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
146386226|NCT02275052|527913811|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146386227|NCT02275052|527913812|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
146386228|NCT02275052|527913813|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146386229|NCT02275052|527913814|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
146386230|NCT02275052|527913811|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
146386231|NCT02275052|527913812|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
146386232|NCT02275052|527913813|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146386233|NCT02275052|527913814|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
146386234|NCT02275052|527913811|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
146386235|NCT02275052|527913812|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146386236|NCT02275052|527913813|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146386237|NCT02275052|527913814|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
146386238|NCT02275052|527913811|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
146386239|NCT02275052|527913812|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146386240|NCT02275052|527913813|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146386241|NCT02275052|527913814|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
146386242|NCT02275052|527913811|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
146386243|NCT02275052|527913812|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146386244|NCT02275052|527913813|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146386245|NCT02275052|527913814|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
146386246|NCT02275052|527913811|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
146386247|NCT02275052|527913812|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146386248|NCT02275052|527913813|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146386249|NCT02275052|527913814|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
146386250|NCT02275052|527913811|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146386251|NCT02275052|527913812|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
146386252|NCT02275052|527913813|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
146386253|NCT02275052|527913814|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
146386254|NCT02275052|527913811|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146386255|NCT02275052|527913812|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
146386256|NCT02275052|527913813|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
146386257|NCT02275052|527913814|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
146386258|NCT02275052|527913811|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146386259|NCT02275052|527913812|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
146386260|NCT02275052|527913813|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
146386261|NCT02275052|527913814|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
146386262|NCT02275052|527913811|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146386263|NCT02275052|527913812|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146386264|NCT02275052|527913813|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
146386265|NCT02275052|527913814|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
146386266|NCT00561795|527913815|FG000|Overall Study|Adverse Event|3|||
146386267|NCT00561795|527913816|FG001|Overall Study|Adverse Event|3|||
146386268|NCT00561795|527913817|FG002|Overall Study|Adverse Event|0|||
146386269|NCT00561795|527913818|FG003|Overall Study|Adverse Event|0|||
146386270|NCT00561795|527913815|FG000|Overall Study|Study Closed/Terminated|0|||
146386271|NCT00561795|527913816|FG001|Overall Study|Study Closed/Terminated|3|||
146386272|NCT00561795|527913817|FG002|Overall Study|Study Closed/Terminated|0|||
146386273|NCT00561795|527913818|FG003|Overall Study|Study Closed/Terminated|0|||
146386274|NCT00561795|527913815|FG000|Overall Study|Physician Decision|1|||
146386275|NCT00561795|527913816|FG001|Overall Study|Physician Decision|0|||
146386276|NCT00561795|527913817|FG002|Overall Study|Physician Decision|0|||
146386277|NCT00561795|527913818|FG003|Overall Study|Physician Decision|0|||
146386278|NCT02807376|527913819|FG000|Overall Study|Intra-operative exclusion criteria|3|||
146386279|NCT02807376|527913820|FG001|Overall Study|Intra-operative exclusion criteria|0|||
146386280|NCT02807376|527913819|FG000|Overall Study|Lost to Follow-up|0|||
146386281|NCT02807376|527913820|FG001|Overall Study|Lost to Follow-up|1|||
146386282|NCT00846027|527913821|FG000|Overall Study|Death|3|||
146386283|NCT00846027|527913821|FG000|Overall Study|Disease Progression|30|||
146386284|NCT00846027|527913821|FG000|Overall Study|Toxicity|12|||
146386285|NCT00846027|527913821|FG000|Overall Study|Patient Decision|7|||
146386286|NCT00846027|527913821|FG000|Overall Study|Investigator Discretion|29|||
146386287|NCT00846027|527913821|FG000|Overall Study|Protocol Violation|2|||
146386288|NCT00846027|527913821|FG000|Overall Study|Subject Not Treated|7|||
146386289|NCT03228836|527913826|FG000|Overall Study|Adverse Event|3|||
146386290|NCT03228836|527913826|FG000|Overall Study|Withdrawal by Subject|1|||
146386291|NCT03228836|527913826|FG000|Overall Study|Death|1|||
146386292|NCT03228836|527913826|FG000|Overall Study|Physician Decision|1|||
146386293|NCT03228836|527913826|FG000|Overall Study|Disease Progression|7|||
146386294|NCT03228836|527913826|FG000|Overall Study|Other|4|||
146386295|NCT00948389|527913827|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
146386296|NCT00948389|527913828|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
146386297|NCT00948389|527913829|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
146386298|NCT00948389|527913830|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
146386299|NCT00948389|527913831|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
146386300|NCT00948389|527913827|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
146386301|NCT00948389|527913828|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
146386302|NCT00948389|527913829|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
146386303|NCT00948389|527913830|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
146386304|NCT00948389|527913831|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
146386305|NCT00948389|527913827|FG000|Overall Study|Both Progression and Toxicity|1|||
146386306|NCT00948389|527913828|FG001|Overall Study|Both Progression and Toxicity|0|||
146386307|NCT00948389|527913829|FG002|Overall Study|Both Progression and Toxicity|0|||
146386308|NCT00948389|527913830|FG003|Overall Study|Both Progression and Toxicity|0|||
146386309|NCT00948389|527913831|FG004|Overall Study|Both Progression and Toxicity|0|||
146386310|NCT02967562|527913834|FG000|Overall Study|Consent not obtained|1|||
146386311|NCT02967562|527913835|FG001|Overall Study|Consent not obtained|0|||
146386312|NCT02967562|527913834|FG000|Overall Study|High leak precluding analysis|1|||
146386313|NCT02967562|527913835|FG001|Overall Study|High leak precluding analysis|1|||
146386314|NCT02908841|527913836|FG000|Overall Study|Physician Decision|4|||
146386315|NCT02908841|527913837|FG001|Overall Study|Physician Decision|0|||
146386316|NCT03798366|527913838|FG000|Overall Study|Lost to Follow-up|0|||
146386317|NCT03798366|527913839|FG001|Overall Study|Lost to Follow-up|1|||
146386318|NCT02192190|527913842|FG000|Overall Study|Adverse Event|1|||
146386319|NCT02192190|527913843|FG001|Overall Study|Adverse Event|1|||
146386320|NCT02192190|527913844|FG002|Overall Study|Adverse Event|0|||
146386321|NCT02192190|527913845|FG003|Overall Study|Adverse Event|0|||
146386322|NCT02192190|527913846|FG004|Overall Study|Adverse Event|0|||
146386323|NCT02192190|527913847|FG005|Overall Study|Adverse Event|0|||
146386324|NCT02192190|527913842|FG000|Overall Study|Lost to Follow-up|3|||
146386325|NCT02192190|527913843|FG001|Overall Study|Lost to Follow-up|3|||
146386326|NCT02192190|527913844|FG002|Overall Study|Lost to Follow-up|2|||
146386327|NCT02192190|527913845|FG003|Overall Study|Lost to Follow-up|1|||
146386328|NCT02192190|527913846|FG004|Overall Study|Lost to Follow-up|4|||
146386329|NCT02192190|527913847|FG005|Overall Study|Lost to Follow-up|3|||
146386330|NCT02192190|527913842|FG000|Overall Study|Physician Decision|2|||
146386331|NCT02192190|527913843|FG001|Overall Study|Physician Decision|0|||
146386332|NCT02192190|527913844|FG002|Overall Study|Physician Decision|0|||
146386333|NCT02192190|527913845|FG003|Overall Study|Physician Decision|0|||
146386334|NCT02192190|527913846|FG004|Overall Study|Physician Decision|0|||
146386335|NCT02192190|527913847|FG005|Overall Study|Physician Decision|0|||
146386336|NCT02192190|527913842|FG000|Overall Study|Terminated by Sponsor|43|||
146386337|NCT02192190|527913843|FG001|Overall Study|Terminated by Sponsor|23|||
146386338|NCT02192190|527913844|FG002|Overall Study|Terminated by Sponsor|20|||
146386339|NCT02192190|527913845|FG003|Overall Study|Terminated by Sponsor|23|||
146386340|NCT02192190|527913846|FG004|Overall Study|Terminated by Sponsor|21|||
146386341|NCT02192190|527913847|FG005|Overall Study|Terminated by Sponsor|23|||
146386342|NCT02192190|527913842|FG000|Overall Study|Withdrawal by Subject|4|||
146386343|NCT02192190|527913843|FG001|Overall Study|Withdrawal by Subject|1|||
146386344|NCT02192190|527913844|FG002|Overall Study|Withdrawal by Subject|2|||
146386345|NCT02192190|527913845|FG003|Overall Study|Withdrawal by Subject|1|||
146386346|NCT02192190|527913846|FG004|Overall Study|Withdrawal by Subject|5|||
146386347|NCT02192190|527913847|FG005|Overall Study|Withdrawal by Subject|3|||
146386348|NCT02192190|527913842|FG000|Overall Study|Could not Keep Visit Schedule|1|||
146386349|NCT02192190|527913843|FG001|Overall Study|Could not Keep Visit Schedule|0|||
146386350|NCT02192190|527913844|FG002|Overall Study|Could not Keep Visit Schedule|0|||
146386351|NCT02192190|527913845|FG003|Overall Study|Could not Keep Visit Schedule|0|||
146386352|NCT02192190|527913846|FG004|Overall Study|Could not Keep Visit Schedule|0|||
146386353|NCT02192190|527913847|FG005|Overall Study|Could not Keep Visit Schedule|0|||
146386354|NCT02192190|527913842|FG000|Overall Study|Positive Drug Screen|0|||
146386355|NCT02192190|527913843|FG001|Overall Study|Positive Drug Screen|0|||
146386356|NCT02192190|527913844|FG002|Overall Study|Positive Drug Screen|0|||
146386357|NCT02192190|527913845|FG003|Overall Study|Positive Drug Screen|1|||
146386358|NCT02192190|527913846|FG004|Overall Study|Positive Drug Screen|0|||
146386359|NCT02192190|527913847|FG005|Overall Study|Positive Drug Screen|0|||
146386360|NCT02192190|527913842|FG000|Overall Study|Inadequate Pain Relief|0|||
146386361|NCT02192190|527913843|FG001|Overall Study|Inadequate Pain Relief|1|||
146386362|NCT02192190|527913844|FG002|Overall Study|Inadequate Pain Relief|1|||
146386363|NCT02192190|527913845|FG003|Overall Study|Inadequate Pain Relief|0|||
146386364|NCT02192190|527913846|FG004|Overall Study|Inadequate Pain Relief|0|||
146386365|NCT02192190|527913847|FG005|Overall Study|Inadequate Pain Relief|0|||
146386366|NCT02607865|527913848|FG000|Overall Study|Lost to Follow-up|9|||
146386367|NCT02607865|527913849|FG001|Overall Study|Lost to Follow-up|7|||
146386368|NCT02607865|527913850|FG002|Overall Study|Lost to Follow-up|7|||
146386369|NCT02607865|527913851|FG003|Overall Study|Lost to Follow-up|5|||
146386370|NCT02607865|527913848|FG000|Overall Study|Withdrawal by Subject|18|||
146386371|NCT02607865|527913849|FG001|Overall Study|Withdrawal by Subject|18|||
146386372|NCT02607865|527913850|FG002|Overall Study|Withdrawal by Subject|17|||
146386373|NCT02607865|527913851|FG003|Overall Study|Withdrawal by Subject|8|||
146386374|NCT02607865|527913848|FG000|Overall Study|Death|5|||
146386375|NCT02607865|527913849|FG001|Overall Study|Death|4|||
146386376|NCT02607865|527913850|FG002|Overall Study|Death|1|||
146386377|NCT02607865|527913851|FG003|Overall Study|Death|3|||
146386378|NCT02607865|527913848|FG000|Overall Study|Unclassified|1|||
146386379|NCT02607865|527913849|FG001|Overall Study|Unclassified|1|||
146386380|NCT02607865|527913850|FG002|Overall Study|Unclassified|2|||
146386381|NCT02607865|527913851|FG003|Overall Study|Unclassified|0|||
146386382|NCT03227692|527913852|FG000|Overall Study|Protocol Violation|1|||
146386383|NCT03227692|527913853|FG001|Overall Study|Protocol Violation|1|||
146386384|NCT03227692|527913852|FG000|Overall Study|Lost to Follow-up|4|||
146386385|NCT03227692|527913853|FG001|Overall Study|Lost to Follow-up|2|||
146386386|NCT03227692|527913852|FG000|Overall Study|Adverse Event|0|||
146386387|NCT03227692|527913853|FG001|Overall Study|Adverse Event|2|||
146386388|NCT00381706|527913854|FG000|Overall Study|Never treated|7|||
146386389|NCT00381706|527913855|FG001|Overall Study|Never treated|2|||
146386390|NCT00381706|527913856|FG002|Overall Study|Never treated|1|||
146386391|NCT00203294|527913857|FG000|Overall Study|Withdrawal by Subject|8|||
146386392|NCT00203294|527913858|FG001|Overall Study|Withdrawal by Subject|13|||
146386393|NCT00886587|527913859|FG000|Overall Study|Adverse Event|2|||
146386394|NCT00886587|527913860|FG001|Overall Study|Adverse Event|1|||
146386395|NCT00886587|527913859|FG000|Overall Study|Protocol Violation|2|||
146386396|NCT00886587|527913860|FG001|Overall Study|Protocol Violation|0|||
146386397|NCT00886587|527913859|FG000|Overall Study|Withdrawal by Subject|0|||
146386398|NCT00886587|527913860|FG001|Overall Study|Withdrawal by Subject|1|||
146386399|NCT00550615|527913864|FG000|Overall Study|Withdrawal by Subject|0|||
146386400|NCT00550615|527913865|FG001|Overall Study|Withdrawal by Subject|0|||
146386401|NCT00550615|527913866|FG002|Overall Study|Withdrawal by Subject|2|||
146386402|NCT00550615|527913867|FG003|Overall Study|Withdrawal by Subject|3|||
146386403|NCT00550615|527913864|FG000|Overall Study|Not evaluable|0|||
146386404|NCT00550615|527913865|FG001|Overall Study|Not evaluable|0|||
146386405|NCT00550615|527913866|FG002|Overall Study|Not evaluable|2|||
146386406|NCT00550615|527913867|FG003|Overall Study|Not evaluable|7|||
146386407|NCT01948791|527913875|FG000|Overall Study|Adverse Event|12|||
146386408|NCT01948791|527913875|FG000|Overall Study|Lack of Efficacy|3|||
146386409|NCT01948791|527913875|FG000|Overall Study|Protocol Violation|2|||
146386410|NCT01948791|527913875|FG000|Overall Study|Withdrawal by Subject|5|||
146386411|NCT01948791|527913875|FG000|Overall Study|Lost to Follow-up|6|||
146386412|NCT01948791|527913875|FG000|Overall Study|Management issues|1|||
146386413|NCT01948791|527913875|FG000|Overall Study|Others|7|||
146386414|NCT01948791|527913875|FG000|Overall Study|Screening failure|35|||
146386415|NCT01955005|527913879|FG000|Overall Study|Withdrawal by Subject|3|||
146386416|NCT01955005|527913880|FG001|Overall Study|Withdrawal by Subject|5|||
146386417|NCT03117309|527913881|FG000|Overall Study|Not meeting inclusion criteria|0|||
146386418|NCT03117309|527913882|FG001|Overall Study|Not meeting inclusion criteria|1|||
146386419|NCT01610414|527913885|FG000|Study Start - Month 13|Serious Adverse Event|65|||
146386420|NCT01610414|527913886|FG001|Study Start - Month 13|Serious Adverse Event|67|||
146386421|NCT01610414|527913885|FG000|Study Start - Month 13|Adverse Event|14|||
146386422|NCT01610414|527913886|FG001|Study Start - Month 13|Adverse Event|14|||
146386423|NCT01610414|527913885|FG000|Study Start - Month 13|Protocol Violation|3|||
146386424|NCT01610414|527913886|FG001|Study Start - Month 13|Protocol Violation|1|||
146386425|NCT01610414|527913885|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
146386426|NCT01610414|527913886|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
146386427|NCT01610414|527913885|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
146386428|NCT01610414|527913886|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
146386429|NCT01610414|527913885|FG000|Study Start - Month 13|Lost to Follow-up|4|||
146386430|NCT01610414|527913886|FG001|Study Start - Month 13|Lost to Follow-up|6|||
146386431|NCT01610414|527913885|FG000|Study Start - Month 13|Suspected HZ episode|1|||
146386432|NCT01610414|527913886|FG001|Study Start - Month 13|Suspected HZ episode|3|||
146386433|NCT01610414|527913885|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
146386434|NCT01610414|527913886|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
146386435|NCT01610414|527913885|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
146386436|NCT01610414|527913886|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
146386437|NCT01610414|527913885|FG000|Month 13 - Month 25|Adverse Event|8|||
146386438|NCT01610414|527913886|FG001|Month 13 - Month 25|Adverse Event|4|||
146386439|NCT01610414|527913885|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
146386440|NCT01610414|527913886|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
146386441|NCT01610414|527913885|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
146386442|NCT01610414|527913886|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
146386443|NCT01610414|527913885|FG000|Month 13 - Month 25|Protocol Violation|0|||
146386444|NCT01610414|527913886|FG001|Month 13 - Month 25|Protocol Violation|2|||
146386445|NCT01610414|527913885|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
146386446|NCT01610414|527913886|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
146386447|NCT01610414|527913885|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
146386448|NCT01610414|527913886|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
146386449|NCT01610414|527913885|FG000|After Month 25|Study end not reached|48|||
146386450|NCT01610414|527913886|FG001|After Month 25|Study end not reached|53|||
146386451|NCT02483611|527913893|FG000|Overall Study|Protocol Violation|0|||
146386452|NCT02483611|527913894|FG001|Overall Study|Protocol Violation|0|||
146386453|NCT02483611|527913895|FG002|Overall Study|Protocol Violation|1|||
146386454|NCT02036476|527913898|FG000|Overall Study|Withdrawal by Subject|2|||
146386455|NCT02036476|527913898|FG000|Overall Study|Progressive Disease|4|||
146386456|NCT02036476|527913898|FG000|Overall Study|Unacceptable Toxicity|2|||
146386457|NCT01984294|527913899|FG000|Overall Study|Randomized but Never Treated|0|||
146386458|NCT01984294|527913900|FG001|Overall Study|Randomized but Never Treated|0|||
146386459|NCT01984294|527913901|FG002|Overall Study|Randomized but Never Treated|1|||
146386460|NCT01984294|527913899|FG000|Overall Study|Lack of Efficacy|4|||
146386461|NCT01984294|527913900|FG001|Overall Study|Lack of Efficacy|2|||
146386462|NCT01984294|527913901|FG002|Overall Study|Lack of Efficacy|6|||
146386463|NCT01984294|527913899|FG000|Overall Study|Adverse Event|0|||
146386464|NCT01984294|527913900|FG001|Overall Study|Adverse Event|1|||
146386465|NCT01984294|527913901|FG002|Overall Study|Adverse Event|0|||
146386466|NCT03452397|527913902|FG000|Overall Study|Adverse Event|1|||
146386467|NCT03452397|527913903|FG001|Overall Study|Adverse Event|0|||
146386468|NCT03452397|527913904|FG002|Overall Study|Adverse Event|0|||
146386469|NCT03452397|527913905|FG003|Overall Study|Adverse Event|0|||
146386470|NCT03452397|527913902|FG000|Overall Study|Administrative reason|0|||
146386471|NCT03452397|527913903|FG001|Overall Study|Administrative reason|0|||
146386472|NCT03452397|527913904|FG002|Overall Study|Administrative reason|1|||
146386473|NCT03452397|527913905|FG003|Overall Study|Administrative reason|1|||
146386474|NCT03452397|527913902|FG000|Overall Study|Withdrawal by Subject|0|||
146386475|NCT03452397|527913903|FG001|Overall Study|Withdrawal by Subject|0|||
146386476|NCT03452397|527913904|FG002|Overall Study|Withdrawal by Subject|1|||
146386477|NCT03452397|527913905|FG003|Overall Study|Withdrawal by Subject|0|||
146386478|NCT01711359|527913906|FG000|Treatment Period|Withdrawal by Subject|18|||
146386479|NCT01711359|527913907|FG001|Treatment Period|Withdrawal by Subject|7|||
146386480|NCT01711359|527913908|FG002|Treatment Period|Withdrawal by Subject|13|||
146386481|NCT01711359|527913906|FG000|Treatment Period|Lack of Efficacy|13|||
146386482|NCT01711359|527913907|FG001|Treatment Period|Lack of Efficacy|2|||
146386483|NCT01711359|527913908|FG002|Treatment Period|Lack of Efficacy|2|||
146386484|NCT01711359|527913906|FG000|Treatment Period|Adverse Event|8|||
146386485|NCT01711359|527913907|FG001|Treatment Period|Adverse Event|10|||
146386486|NCT01711359|527913908|FG002|Treatment Period|Adverse Event|24|||
146386487|NCT01711359|527913906|FG000|Treatment Period|Physician Decision|4|||
146386488|NCT01711359|527913907|FG001|Treatment Period|Physician Decision|3|||
146386489|NCT01711359|527913908|FG002|Treatment Period|Physician Decision|2|||
146386490|NCT01711359|527913906|FG000|Treatment Period|Death|3|||
146386491|NCT01711359|527913907|FG001|Treatment Period|Death|0|||
146386492|NCT01711359|527913908|FG002|Treatment Period|Death|0|||
146386493|NCT01711359|527913906|FG000|Treatment Period|Entry Criteria Not Met|1|||
146386494|NCT01711359|527913907|FG001|Treatment Period|Entry Criteria Not Met|0|||
146386495|NCT01711359|527913908|FG002|Treatment Period|Entry Criteria Not Met|0|||
146386496|NCT01711359|527913906|FG000|Treatment Period|Sponsor Decision|1|||
146386497|NCT01711359|527913907|FG001|Treatment Period|Sponsor Decision|0|||
146386498|NCT01711359|527913908|FG002|Treatment Period|Sponsor Decision|0|||
146386499|NCT01711359|527913906|FG000|Treatment Period|Lost to Follow-up|1|||
146386500|NCT01711359|527913907|FG001|Treatment Period|Lost to Follow-up|1|||
146386501|NCT01711359|527913908|FG002|Treatment Period|Lost to Follow-up|1|||
146386502|NCT01711359|527913906|FG000|Treatment Period|Randomized, Not Treated|3|||
146386503|NCT01711359|527913907|FG001|Treatment Period|Randomized, Not Treated|1|||
146386504|NCT01711359|527913908|FG002|Treatment Period|Randomized, Not Treated|0|||
146386505|NCT02698176|527913909|FG000|Overall Study|Progressive disease|4|||
146386506|NCT02698176|527913910|FG001|Overall Study|Progressive disease|3|||
146386507|NCT02698176|527913911|FG002|Overall Study|Progressive disease|1|||
146386508|NCT02698176|527913912|FG003|Overall Study|Progressive disease|0|||
146386509|NCT02698176|527913909|FG000|Overall Study|Adverse Event|2|||
146386510|NCT02698176|527913910|FG001|Overall Study|Adverse Event|0|||
146386511|NCT02698176|527913911|FG002|Overall Study|Adverse Event|0|||
146386512|NCT02698176|527913912|FG003|Overall Study|Adverse Event|0|||
146386513|NCT02698176|527913909|FG000|Overall Study|Clinical progression|3|||
146386514|NCT02698176|527913910|FG001|Overall Study|Clinical progression|0|||
146386515|NCT02698176|527913911|FG002|Overall Study|Clinical progression|0|||
146386516|NCT02698176|527913912|FG003|Overall Study|Clinical progression|0|||
146386517|NCT00925522|527913913|FG000|Overall Study|study closed -- business decision|20|||
146386518|NCT02561572|527913914|FG000|Overall Study|Inadequate time before surgery|2|||
146386519|NCT02561572|527913915|FG001|Overall Study|Inadequate time before surgery|1|||
146386520|NCT02561572|527913914|FG000|Overall Study|Protocol Violation|0|||
146386521|NCT02561572|527913915|FG001|Overall Study|Protocol Violation|1|||
146386522|NCT00410514|527913916|FG000|Overall Study|Adverse Event|2|||
146386523|NCT00410514|527913917|FG001|Overall Study|Adverse Event|2|||
146386524|NCT00410514|527913918|FG002|Overall Study|Adverse Event|2|||
146386525|NCT00410514|527913916|FG000|Overall Study|Protocol Violation|0|||
146386526|NCT00410514|527913917|FG001|Overall Study|Protocol Violation|1|||
146386527|NCT00410514|527913918|FG002|Overall Study|Protocol Violation|1|||
146386528|NCT00410514|527913916|FG000|Overall Study|Lost to Follow-up|0|||
146386529|NCT00410514|527913917|FG001|Overall Study|Lost to Follow-up|0|||
146386530|NCT00410514|527913918|FG002|Overall Study|Lost to Follow-up|2|||
146386531|NCT00410514|527913916|FG000|Overall Study|Non-compliant with study procedures|0|||
146386532|NCT00410514|527913917|FG001|Overall Study|Non-compliant with study procedures|0|||
146386533|NCT00410514|527913918|FG002|Overall Study|Non-compliant with study procedures|2|||
146386534|NCT02691468|527913920|FG000|Overall Study|Bronchial blocker use|2|||
146386535|NCT02691468|527913921|FG001|Overall Study|Bronchial blocker use|1|||
146386536|NCT02691468|527913920|FG000|Overall Study|Lost to Follow-up|2|||
146386537|NCT02691468|527913921|FG001|Overall Study|Lost to Follow-up|1|||
146386538|NCT02691468|527913920|FG000|Overall Study|Failure to advance FOB|2|||
146386539|NCT02691468|527913921|FG001|Overall Study|Failure to advance FOB|0|||
146386540|NCT01021423|527913924|FG000|Overall Study|Study terminated|4|||
146386541|NCT01021423|527913925|FG001|Overall Study|Study terminated|5|||
146386542|NCT00394654|527913926|FG000|Overall Study|Lost to Follow-up|1|||
146386543|NCT00394654|527913927|FG001|Overall Study|Lost to Follow-up|0|||
146386544|NCT00394654|527913926|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
146386545|NCT00394654|527913927|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
146386546|NCT02886338|527913928|FG000|Overall Study|Withdrawal by Subject|1|||
146386547|NCT03756285|527913929|FG000|Overall Study|Lost to Follow-up|0|||
146386548|NCT03756285|527913930|FG001|Overall Study|Lost to Follow-up|1|||
146386549|NCT03756285|527913929|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
146386550|NCT03756285|527913930|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
146386551|NCT03756285|527913929|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
146386552|NCT03756285|527913930|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
146386553|NCT00286156|527913935|FG000|Overall Study|Missed 12 month visit|0|||
146386554|NCT00286156|527913936|FG001|Overall Study|Missed 12 month visit|0|||
146386555|NCT00286156|527913937|FG002|Overall Study|Missed 12 month visit|1|||
146386556|NCT00286156|527913935|FG000|Overall Study|AE: pulmonary embolus|0|||
146386557|NCT00286156|527913936|FG001|Overall Study|AE: pulmonary embolus|1|||
146386558|NCT00286156|527913937|FG002|Overall Study|AE: pulmonary embolus|0|||
146386559|NCT00286156|527913935|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
146386560|NCT00286156|527913936|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
146386561|NCT00286156|527913937|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
146386562|NCT00286156|527913935|FG000|Overall Study|AE: pneumonia|1|||
146386563|NCT00286156|527913936|FG001|Overall Study|AE: pneumonia|0|||
146386564|NCT00286156|527913937|FG002|Overall Study|AE: pneumonia|0|||
146386565|NCT06334055|527913938|FG000|Overall Study|Adverse Event|4|||
146386566|NCT06334055|527913938|FG000|Overall Study|Disqualified|72|||
146386567|NCT05281094|527913939|FG000|Overall Study|Adverse Event|1|||
146386568|NCT05281094|527913940|FG001|Overall Study|Adverse Event|0|||
146386569|NCT05281094|527913939|FG000|Overall Study|Lost to Follow-up|29|||
146386570|NCT05281094|527913940|FG001|Overall Study|Lost to Follow-up|22|||
146386571|NCT05281094|527913939|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
146386572|NCT05281094|527913940|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
146386573|NCT05281094|527913939|FG000|Overall Study|Death|1|||
146386574|NCT05281094|527913940|FG001|Overall Study|Death|2|||
146386575|NCT05281094|527913939|FG000|Overall Study|Not pre-specified reason|8|||
146386576|NCT05281094|527913940|FG001|Overall Study|Not pre-specified reason|5|||
146386577|NCT00631969|527913941|FG000|Overall Study|Adverse Event|3|||
146386578|NCT00631969|527913942|FG001|Overall Study|Adverse Event|1|||
146386579|NCT00631969|527913941|FG000|Overall Study|Lack of Efficacy|2|||
146386580|NCT00631969|527913942|FG001|Overall Study|Lack of Efficacy|8|||
146386581|NCT00631969|527913941|FG000|Overall Study|Lost to Follow-up|2|||
146386582|NCT00631969|527913942|FG001|Overall Study|Lost to Follow-up|1|||
146386583|NCT00631969|527913941|FG000|Overall Study|Protocol Violation|1|||
146386584|NCT00631969|527913942|FG001|Overall Study|Protocol Violation|1|||
146386585|NCT00631969|527913941|FG000|Overall Study|Consent Withdrawn|5|||
146386586|NCT00631969|527913942|FG001|Overall Study|Consent Withdrawn|7|||
146386587|NCT00631969|527913941|FG000|Overall Study|Noncompliant With Study Medication|0|||
146386588|NCT00631969|527913942|FG001|Overall Study|Noncompliant With Study Medication|1|||
146386589|NCT00631969|527913941|FG000|Overall Study|No Drug Exposure|2|||
146386590|NCT00631969|527913942|FG001|Overall Study|No Drug Exposure|2|||
146386591|NCT00957034|527913943|FG000|Overall Study|Adverse Event|0|||
146386592|NCT00957034|527913944|FG001|Overall Study|Adverse Event|1|||
146386593|NCT00957034|527913945|FG002|Overall Study|Adverse Event|1|||
146386594|NCT00957034|527913943|FG000|Overall Study|Sponsor Terminated Study|6|||
146386595|NCT00957034|527913944|FG001|Overall Study|Sponsor Terminated Study|1|||
146386596|NCT00957034|527913945|FG002|Overall Study|Sponsor Terminated Study|5|||
146386597|NCT00957034|527913943|FG000|Overall Study|Withdrawal by Subject|0|||
146386598|NCT00957034|527913944|FG001|Overall Study|Withdrawal by Subject|2|||
146386599|NCT00957034|527913945|FG002|Overall Study|Withdrawal by Subject|0|||
146386600|NCT02390167|527916384|FG000|Overall Study|Lost to Follow-up|1|||
146386601|NCT00027027|527916385|FG000|Overall Study|Adverse Event|0|||
146386602|NCT00027027|527916386|FG001|Overall Study|Adverse Event|0|||
146386603|NCT00027027|527916387|FG002|Overall Study|Adverse Event|1|||
146386604|NCT00027027|527916388|FG003|Overall Study|Adverse Event|0|||
146386605|NCT00027027|527916389|FG004|Overall Study|Adverse Event|1|||
146386606|NCT00027027|527916385|FG000|Overall Study|Admitted for Signs of PD|0|||
146386607|NCT00027027|527916386|FG001|Overall Study|Admitted for Signs of PD|0|||
146386608|NCT00027027|527916387|FG002|Overall Study|Admitted for Signs of PD|0|||
146386609|NCT00027027|527916388|FG003|Overall Study|Admitted for Signs of PD|0|||
146386610|NCT00027027|527916389|FG004|Overall Study|Admitted for Signs of PD|1|||
146386611|NCT00027027|527916385|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
146386612|NCT00027027|527916386|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
146386613|NCT00027027|527916387|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
146386614|NCT00027027|527916388|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
146386615|NCT00027027|527916389|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
146386616|NCT00027027|527916385|FG000|Overall Study|PD Requiring Surgery|0|||
146386617|NCT00027027|527916386|FG001|Overall Study|PD Requiring Surgery|0|||
146386618|NCT00027027|527916387|FG002|Overall Study|PD Requiring Surgery|1|||
146386619|NCT00027027|527916388|FG003|Overall Study|PD Requiring Surgery|0|||
146386620|NCT00027027|527916389|FG004|Overall Study|PD Requiring Surgery|0|||
146386621|NCT00027027|527916385|FG000|Overall Study|Physician Decision Due To PD|2|||
146386622|NCT00027027|527916386|FG001|Overall Study|Physician Decision Due To PD|3|||
146386623|NCT00027027|527916387|FG002|Overall Study|Physician Decision Due To PD|2|||
146386624|NCT00027027|527916388|FG003|Overall Study|Physician Decision Due To PD|3|||
146386625|NCT00027027|527916389|FG004|Overall Study|Physician Decision Due To PD|5|||
146386626|NCT00027027|527916385|FG000|Overall Study|Withdrawal by Subject|0|||
146386627|NCT00027027|527916386|FG001|Overall Study|Withdrawal by Subject|0|||
146386628|NCT00027027|527916387|FG002|Overall Study|Withdrawal by Subject|0|||
146386629|NCT00027027|527916388|FG003|Overall Study|Withdrawal by Subject|0|||
146386630|NCT00027027|527916389|FG004|Overall Study|Withdrawal by Subject|1|||
146386631|NCT01967134|527916393|FG000|Overall Study|Lost to Follow-up|0|||
146386632|NCT01967134|527916394|FG001|Overall Study|Lost to Follow-up|1|||
146386633|NCT01967134|527916395|FG002|Overall Study|Lost to Follow-up|0|||
146386634|NCT00945945|527916397|FG000|Overall Study|Adverse Event|15|||
146386635|NCT00945945|527916398|FG001|Overall Study|Adverse Event|35|||
146386636|NCT00945945|527916397|FG000|Overall Study|Withdrawal by Subject|7|||
146386637|NCT00945945|527916398|FG001|Overall Study|Withdrawal by Subject|10|||
146386638|NCT00945945|527916397|FG000|Overall Study|Lost to Follow-up|4|||
146386639|NCT00945945|527916398|FG001|Overall Study|Lost to Follow-up|5|||
146386640|NCT00945945|527916397|FG000|Overall Study|Lack of Efficacy|6|||
146386641|NCT00945945|527916398|FG001|Overall Study|Lack of Efficacy|2|||
146386642|NCT00945945|527916397|FG000|Overall Study|Protocol Violation|4|||
146386643|NCT00945945|527916398|FG001|Overall Study|Protocol Violation|2|||
146386644|NCT00945945|527916397|FG000|Overall Study|Entry Criteria Not Met|0|||
146386645|NCT00945945|527916398|FG001|Overall Study|Entry Criteria Not Met|1|||
146386646|NCT00805194|527916399|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
146386647|NCT00805194|527916400|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
146386648|NCT00805194|527916399|FG000|Overall Study|Worsening or AE of underlying disease|64|||
146386649|NCT00805194|527916400|FG001|Overall Study|Worsening or AE of underlying disease|70|||
146386650|NCT00805194|527916399|FG000|Overall Study|Other AE|84|||
146386651|NCT00805194|527916400|FG001|Overall Study|Other AE|73|||
146386652|NCT00805194|527916399|FG000|Overall Study|Protocol Violation|9|||
146386653|NCT00805194|527916400|FG001|Overall Study|Protocol Violation|9|||
146386654|NCT00805194|527916399|FG000|Overall Study|Lost to Follow-up|5|||
146386655|NCT00805194|527916400|FG001|Overall Study|Lost to Follow-up|5|||
146386656|NCT00805194|527916399|FG000|Overall Study|Withdrawal by Subject|60|||
146386657|NCT00805194|527916400|FG001|Overall Study|Withdrawal by Subject|42|||
146386658|NCT00805194|527916399|FG000|Overall Study|Not treated|3|||
146386659|NCT00805194|527916400|FG001|Overall Study|Not treated|4|||
146386660|NCT00805194|527916399|FG000|Overall Study|Reasons other than stated above|20|||
146386661|NCT00805194|527916400|FG001|Overall Study|Reasons other than stated above|16|||
146386662|NCT00568399|527916405|FG000|Overall Study|Death|2|||
146386663|NCT00568399|527916405|FG000|Overall Study|Adverse Event|5|||
146386664|NCT00568399|527916405|FG000|Overall Study|Withdrawal by Subject|8|||
146386665|NCT01488994|527916408|FG000|Overall Study|Withdrawal by Subject|0|||
146386666|NCT01488994|527916409|FG001|Overall Study|Withdrawal by Subject|1|||
146386667|NCT01072500|527916410|FG000|Overall Study|Death|2|||
146386668|NCT01072500|527916411|FG001|Overall Study|Death|2|||
146386669|NCT01072500|527916410|FG000|Overall Study|Lost to Follow-up|5|||
146386670|NCT01072500|527916411|FG001|Overall Study|Lost to Follow-up|2|||
146386671|NCT01072500|527916410|FG000|Overall Study|Withdrawal by Subject|17|||
146386672|NCT01072500|527916411|FG001|Overall Study|Withdrawal by Subject|10|||
146386673|NCT01611558|527916412|FG000|Induction Phase|Study drug toxicity|15|||
146386674|NCT01611558|527916412|FG000|Induction Phase|Disease progression|18|||
146386675|NCT01611558|527916412|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
146386676|NCT01611558|527916412|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
146386677|NCT01611558|527916412|FG000|Induction Phase|Death|1|||
146386678|NCT01611558|527916412|FG000|Maintenance Phase|Withdrawal by Subject|1|||
146386679|NCT01611558|527916412|FG000|Maintenance Phase|Elevated Uric acid|1|||
146386680|NCT04005885|527916427|FG000|First Intervention|Withdrawal by Subject|1|||
146386681|NCT04005885|527916428|FG001|First Intervention|Withdrawal by Subject|1|||
146386682|NCT04005885|527916427|FG000|Second Intervention|Withdrawal by Subject|0|||
146386683|NCT04005885|527916428|FG001|Second Intervention|Withdrawal by Subject|2|||
146386684|NCT01412333|527916430|FG000|Overall Study|Adverse Event|40|||
146386685|NCT01412333|527916431|FG001|Overall Study|Adverse Event|42|||
146386686|NCT01412333|527916430|FG000|Overall Study|Death|5|||
146386687|NCT01412333|527916431|FG001|Overall Study|Death|6|||
146386688|NCT01412333|527916430|FG000|Overall Study|Lack of Efficacy|22|||
146386689|NCT01412333|527916431|FG001|Overall Study|Lack of Efficacy|10|||
146386690|NCT01412333|527916430|FG000|Overall Study|Lost to Follow-up|15|||
146386691|NCT01412333|527916431|FG001|Overall Study|Lost to Follow-up|12|||
146386692|NCT01412333|527916430|FG000|Overall Study|Non-Compliance|3|||
146386693|NCT01412333|527916431|FG001|Overall Study|Non-Compliance|7|||
146386694|NCT01412333|527916430|FG000|Overall Study|Non-Compliance With Study Drug|1|||
146386695|NCT01412333|527916431|FG001|Overall Study|Non-Compliance With Study Drug|1|||
146386696|NCT01412333|527916430|FG000|Overall Study|Other|30|||
146386697|NCT01412333|527916431|FG001|Overall Study|Other|33|||
146386698|NCT01412333|527916430|FG000|Overall Study|Physician Decision|11|||
146386699|NCT01412333|527916431|FG001|Overall Study|Physician Decision|16|||
146386700|NCT01412333|527916430|FG000|Overall Study|Pregnancy|6|||
146386701|NCT01412333|527916431|FG001|Overall Study|Pregnancy|4|||
146386702|NCT01412333|527916430|FG000|Overall Study|Protocol Violation|1|||
146386703|NCT01412333|527916431|FG001|Overall Study|Protocol Violation|2|||
146386704|NCT01412333|527916430|FG000|Overall Study|Study Terminated By Sponsor|3|||
146386705|NCT01412333|527916431|FG001|Overall Study|Study Terminated By Sponsor|2|||
146386706|NCT01412333|527916430|FG000|Overall Study|Withdrawal by Subject|51|||
146386707|NCT01412333|527916431|FG001|Overall Study|Withdrawal by Subject|54|||
146386708|NCT01412333|527916430|FG000|Overall Study|Missing|1|||
146386709|NCT01412333|527916431|FG001|Overall Study|Missing|3|||
146386710|NCT00750867|527916432|FG000|Overall Study|Adverse Event|2|||
146386711|NCT00474539|527916433|FG000|Infant Series|Withdrawal by Subject|3|||
146386712|NCT00474539|527916434|FG001|Infant Series|Withdrawal by Subject|4|||
146386713|NCT00474539|527916433|FG000|Infant Series|Randomization error|5|||
146386714|NCT00474539|527916434|FG001|Infant Series|Randomization error|0|||
146386715|NCT00474539|527916433|FG000|Infant Series|Lost to Follow-up|2|||
146386716|NCT00474539|527916434|FG001|Infant Series|Lost to Follow-up|1|||
146386717|NCT00474539|527916433|FG000|Infant Series|Protocol Violation|0|||
146386718|NCT00474539|527916434|FG001|Infant Series|Protocol Violation|1|||
146386719|NCT00474539|527916433|FG000|After Infant Series|Lost to Follow-up|3|||
146386720|NCT00474539|527916434|FG001|After Infant Series|Lost to Follow-up|0|||
146386721|NCT00474539|527916433|FG000|After Infant Series|Withdrawal by Subject|1|||
146386722|NCT00474539|527916434|FG001|After Infant Series|Withdrawal by Subject|0|||
146386723|NCT00474539|527916433|FG000|Toddler Dose|Protocol Violation|1|||
146386724|NCT00474539|527916434|FG001|Toddler Dose|Protocol Violation|0|||
146386725|NCT03018340|527916435|FG000|Overall Study|Adverse Event|1|||
146386726|NCT03018340|527916436|FG001|Overall Study|Adverse Event|2|||
146386727|NCT03018340|527916435|FG000|Overall Study|Withdrawal by Subject|0|||
146386728|NCT03018340|527916436|FG001|Overall Study|Withdrawal by Subject|8|||
146386729|NCT03018340|527916435|FG000|Overall Study|Lack of Efficacy|0|||
146386730|NCT03018340|527916436|FG001|Overall Study|Lack of Efficacy|1|||
146386731|NCT03018340|527916435|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
146386732|NCT03018340|527916436|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
146386733|NCT03018340|527916435|FG000|Overall Study|Lost to Follow-up|1|||
146386734|NCT03018340|527916436|FG001|Overall Study|Lost to Follow-up|7|||
146386735|NCT03018340|527916435|FG000|Overall Study|Protocol Violation|3|||
146386736|NCT03018340|527916436|FG001|Overall Study|Protocol Violation|7|||
146386737|NCT03018340|527916435|FG000|Overall Study|Not further specified|0|||
146386738|NCT03018340|527916436|FG001|Overall Study|Not further specified|1|||
146386739|NCT01836549|527916437|FG000|Overall Study|Did not receive study drug|0|||
146386740|NCT01836549|527916438|FG001|Overall Study|Did not receive study drug|0|||
146386741|NCT01836549|527916439|FG002|Overall Study|Did not receive study drug|1|||
146386742|NCT01836549|527916440|FG003|Overall Study|Did not receive study drug|0|||
146386743|NCT01836549|527916441|FG004|Overall Study|Did not receive study drug|0|||
146386744|NCT01836549|527916442|FG005|Overall Study|Did not receive study drug|0|||
146386745|NCT01836549|527916443|FG006|Overall Study|Did not receive study drug|0|||
146386746|NCT01836549|527916437|FG000|Overall Study|Patient declared ineligible|0|||
146386747|NCT01836549|527916438|FG001|Overall Study|Patient declared ineligible|0|||
146386748|NCT01836549|527916439|FG002|Overall Study|Patient declared ineligible|0|||
146386749|NCT01836549|527916440|FG003|Overall Study|Patient declared ineligible|1|||
146386750|NCT01836549|527916441|FG004|Overall Study|Patient declared ineligible|0|||
146386751|NCT01836549|527916442|FG005|Overall Study|Patient declared ineligible|0|||
146386752|NCT01836549|527916443|FG006|Overall Study|Patient declared ineligible|0|||
146386753|NCT01836549|527916437|FG000|Overall Study|Patient inevaluable to start therapy|0|||
146386754|NCT01836549|527916438|FG001|Overall Study|Patient inevaluable to start therapy|0|||
146386755|NCT01836549|527916439|FG002|Overall Study|Patient inevaluable to start therapy|0|||
146386756|NCT01836549|527916440|FG003|Overall Study|Patient inevaluable to start therapy|0|||
146386757|NCT01836549|527916441|FG004|Overall Study|Patient inevaluable to start therapy|0|||
146386758|NCT01836549|527916442|FG005|Overall Study|Patient inevaluable to start therapy|0|||
146386759|NCT01836549|527916443|FG006|Overall Study|Patient inevaluable to start therapy|1|||
146386760|NCT01657253|527916446|FG000|Overall Study|Lost to Follow-up|6|||
146386761|NCT01657253|527916447|FG001|Overall Study|Lost to Follow-up|5|||
146386762|NCT01657253|527916446|FG000|Overall Study|Withdrawal by Subject|11|||
146386763|NCT01657253|527916447|FG001|Overall Study|Withdrawal by Subject|12|||
146386764|NCT01657253|527916446|FG000|Overall Study|Adverse Event|0|||
146386765|NCT01657253|527916447|FG001|Overall Study|Adverse Event|1|||
146386766|NCT01970540|527916448|FG000|Overall Study|Non-treatment-related AE|0|||
146386767|NCT01970540|527916449|FG001|Overall Study|Non-treatment-related AE|0|||
146386768|NCT01970540|527916450|FG002|Overall Study|Non-treatment-related AE|1|||
146386769|NCT01970540|527916448|FG000|Overall Study|Progressive disease|55|||
146386770|NCT01970540|527916449|FG001|Overall Study|Progressive disease|23|||
146386771|NCT01970540|527916450|FG002|Overall Study|Progressive disease|10|||
146386772|NCT01970540|527916448|FG000|Overall Study|Treatment delay over protocol|0|||
146386773|NCT01970540|527916449|FG001|Overall Study|Treatment delay over protocol|0|||
146386774|NCT01970540|527916450|FG002|Overall Study|Treatment delay over protocol|1|||
146386775|NCT01970540|527916448|FG000|Overall Study|Physician Decision|7|||
146386776|NCT01970540|527916449|FG001|Overall Study|Physician Decision|2|||
146386777|NCT01970540|527916450|FG002|Overall Study|Physician Decision|0|||
146386778|NCT01970540|527916448|FG000|Overall Study|Clinical progression|0|||
146386779|NCT01970540|527916449|FG001|Overall Study|Clinical progression|1|||
146386780|NCT01970540|527916450|FG002|Overall Study|Clinical progression|1|||
146386781|NCT01970540|527916448|FG000|Overall Study|End of study|2|||
146386782|NCT01970540|527916449|FG001|Overall Study|End of study|0|||
146386783|NCT01970540|527916450|FG002|Overall Study|End of study|2|||
146386784|NCT01970540|527916448|FG000|Overall Study|Adverse Event|0|||
146386785|NCT01970540|527916449|FG001|Overall Study|Adverse Event|2|||
146386786|NCT01970540|527916450|FG002|Overall Study|Adverse Event|1|||
146386787|NCT01970540|527916448|FG000|Overall Study|Treatment-related AE|4|||
146386788|NCT01970540|527916449|FG001|Overall Study|Treatment-related AE|0|||
146386789|NCT01970540|527916450|FG002|Overall Study|Treatment-related AE|2|||
146386790|NCT01970540|527916448|FG000|Overall Study|Withdrawal by Subject|4|||
146386791|NCT01970540|527916449|FG001|Overall Study|Withdrawal by Subject|0|||
146386792|NCT01970540|527916450|FG002|Overall Study|Withdrawal by Subject|1|||
146386793|NCT01970540|527916448|FG000|Overall Study|Clinical deterioration|1|||
146386794|NCT01970540|527916449|FG001|Overall Study|Clinical deterioration|0|||
146386795|NCT01970540|527916450|FG002|Overall Study|Clinical deterioration|0|||
146386796|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Adverse Event|30|||
146386797|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Adverse Event|25|||
146386798|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Adverse Event|23|||
146386799|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Adverse Event|14|||
146386800|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Death|0|||
146386801|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Death|0|||
146386802|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Death|1|||
146386803|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Death|0|||
146386804|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Physician Decision|0|||
146386805|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Physician Decision|1|||
146386806|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Physician Decision|0|||
146386807|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Physician Decision|1|||
146386808|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
146386809|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
146386810|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
146386811|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
146386812|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Other|6|||
146386813|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Other|1|||
146386814|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Other|0|||
146386815|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Other|2|||
146386816|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
146386817|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
146386818|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
146386819|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
146386820|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
146386821|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
146386822|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
146386823|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
146396051|NCT01397409|527952477|FG007|Stage 3|Adverse Event|1|||
146386824|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
146386825|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
146386826|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
146386827|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
146386828|NCT00242710|527916451|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
146386829|NCT00242710|527916452|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
146386830|NCT00242710|527916453|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
146386831|NCT00242710|527916454|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
146386832|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Adverse Event|2|||
146386833|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Adverse Event|3|||
146386834|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Adverse Event|5|||
146386835|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Adverse Event|2|||
146386836|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Physician Decision|1|||
146386837|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Physician Decision|1|||
146386838|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Physician Decision|0|||
146386839|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Physician Decision|0|||
146386840|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Other|24|||
146386841|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Other|24|||
146386842|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Other|9|||
146386843|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Other|11|||
146386844|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Extension not Available|17|||
146386845|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Extension not Available|21|||
146386846|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Extension not Available|8|||
146386847|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Extension not Available|7|||
146386848|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
146386849|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
146386850|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
146386851|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
146386852|NCT00242710|527916451|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
146386853|NCT00242710|527916452|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
146386854|NCT00242710|527916453|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
146386855|NCT00242710|527916454|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
146386856|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
146386857|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
146386858|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
146386859|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
146386860|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Death|0|||
146386861|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Death|0|||
146386862|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Death|0|||
146386863|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Death|1|||
146386864|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
146386865|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
146386866|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
146386867|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
146386868|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Other|3|||
146386869|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Other|5|||
146386870|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Other|4|||
146386871|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Other|3|||
146386872|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
146386873|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
146386874|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
146386875|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
146386876|NCT00242710|527916451|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
146386877|NCT00242710|527916452|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
146386878|NCT00242710|527916453|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
146386879|NCT00242710|527916454|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
146386880|NCT00579527|527916455|FG000|Overall Study|Death|4|||
146386881|NCT02364999|527916456|FG000|Overall Study|Death|136|||
146386882|NCT02364999|527916457|FG001|Overall Study|Death|138|||
146386883|NCT02364999|527916456|FG000|Overall Study|Lost to Follow-up|10|||
146386884|NCT02364999|527916457|FG001|Overall Study|Lost to Follow-up|15|||
146386885|NCT02364999|527916456|FG000|Overall Study|Protocol Violation|3|||
146386886|NCT02364999|527916457|FG001|Overall Study|Protocol Violation|2|||
146386887|NCT02364999|527916456|FG000|Overall Study|Withdrawal by Subject|14|||
146386888|NCT02364999|527916457|FG001|Overall Study|Withdrawal by Subject|14|||
146386889|NCT02364999|527916456|FG000|Overall Study|Other|0|||
146386890|NCT02364999|527916457|FG001|Overall Study|Other|1|||
146386891|NCT02364999|527916456|FG000|Overall Study|Randomized but did not receive treatment|2|||
146386892|NCT02364999|527916457|FG001|Overall Study|Randomized but did not receive treatment|3|||
146386893|NCT02555722|527916458|FG000|Week 2|Adverse Event|0|||
146386894|NCT02555722|527916459|FG001|Week 2|Adverse Event|1|||
146386895|NCT02555722|527916458|FG000|Week 2|Withdrawal by Subject|1|||
146386896|NCT02555722|527916459|FG001|Week 2|Withdrawal by Subject|0|||
146386897|NCT02555722|527916458|FG000|Month 1|Lens Discomfort|1|||
146386898|NCT02555722|527916459|FG001|Month 1|Lens Discomfort|0|||
146386899|NCT02555722|527916458|FG000|Month 2|Withdrawal by Subject|3|||
146386900|NCT02555722|527916459|FG001|Month 2|Withdrawal by Subject|0|||
146386901|NCT02555722|527916458|FG000|Month 2|Lost to Follow-up|1|||
146386902|NCT02555722|527916459|FG001|Month 2|Lost to Follow-up|0|||
146386903|NCT00702949|527916460|FG000|Overall Study|Refusal|3|||
146386904|NCT00702949|527916461|FG001|Overall Study|Refusal|2|||
146386905|NCT00702949|527916462|FG002|Overall Study|Refusal|2|||
146386906|NCT00702949|527916460|FG000|Overall Study|Adverse Event|1|||
146386907|NCT00702949|527916461|FG001|Overall Study|Adverse Event|6|||
146386908|NCT00702949|527916462|FG002|Overall Study|Adverse Event|3|||
146386909|NCT00702949|527916460|FG000|Overall Study|Other Medical Reason/unknown|1|||
146386910|NCT00702949|527916461|FG001|Overall Study|Other Medical Reason/unknown|1|||
146386911|NCT00702949|527916462|FG002|Overall Study|Other Medical Reason/unknown|3|||
146386912|NCT00523744|527916467|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
146386913|NCT00523744|527916467|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
146386914|NCT00523744|527916467|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
146386915|NCT00523744|527916467|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
146386916|NCT00523744|527916467|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
146386917|NCT00523744|527916467|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
146386918|NCT00542425|527916471|FG000|Initial 24 Weeks|Administrative reasons|0|||
146386919|NCT00542425|527916472|FG001|Initial 24 Weeks|Administrative reasons|0|||
146386920|NCT00542425|527916473|FG002|Initial 24 Weeks|Administrative reasons|1|||
146386921|NCT00542425|527916474|FG003|Initial 24 Weeks|Administrative reasons|1|||
146386922|NCT00542425|527916475|FG004|Initial 24 Weeks|Administrative reasons|0|||
146386923|NCT00542425|527916471|FG000|Initial 24 Weeks|Adverse Event|0|||
146386924|NCT00542425|527916472|FG001|Initial 24 Weeks|Adverse Event|1|||
146386925|NCT00542425|527916473|FG002|Initial 24 Weeks|Adverse Event|1|||
146386926|NCT00542425|527916474|FG003|Initial 24 Weeks|Adverse Event|3|||
146386927|NCT00542425|527916475|FG004|Initial 24 Weeks|Adverse Event|2|||
146386928|NCT00542425|527916471|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
146386929|NCT00542425|527916472|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
146386930|NCT00542425|527916473|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
146386931|NCT00542425|527916474|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
146386932|NCT00542425|527916475|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
146386933|NCT00542425|527916471|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
146386934|NCT00542425|527916472|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
146386935|NCT00542425|527916473|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
146386936|NCT00542425|527916474|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
146386937|NCT00542425|527916475|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
146386938|NCT00542425|527916471|FG000|Initial 24 Weeks|Non-compliance|0|||
146386939|NCT00542425|527916472|FG001|Initial 24 Weeks|Non-compliance|0|||
146386940|NCT00542425|527916473|FG002|Initial 24 Weeks|Non-compliance|0|||
146386941|NCT00542425|527916474|FG003|Initial 24 Weeks|Non-compliance|1|||
146386942|NCT00542425|527916475|FG004|Initial 24 Weeks|Non-compliance|1|||
146386943|NCT00542425|527916471|FG000|Initial 24 Weeks|Protocol Violation|0|||
146386944|NCT00542425|527916472|FG001|Initial 24 Weeks|Protocol Violation|0|||
146386945|NCT00542425|527916473|FG002|Initial 24 Weeks|Protocol Violation|0|||
146386946|NCT00542425|527916474|FG003|Initial 24 Weeks|Protocol Violation|1|||
146386947|NCT00542425|527916475|FG004|Initial 24 Weeks|Protocol Violation|0|||
146386948|NCT00542425|527916471|FG000|Initial 24 Weeks|Refusal of treatment|2|||
146386949|NCT00542425|527916472|FG001|Initial 24 Weeks|Refusal of treatment|2|||
146386950|NCT00542425|527916473|FG002|Initial 24 Weeks|Refusal of treatment|1|||
146386951|NCT00542425|527916474|FG003|Initial 24 Weeks|Refusal of treatment|4|||
146386952|NCT00542425|527916475|FG004|Initial 24 Weeks|Refusal of treatment|1|||
146386953|NCT00542425|527916471|FG000|Initial 24 Weeks|Other|0|||
146386954|NCT00542425|527916472|FG001|Initial 24 Weeks|Other|2|||
146386955|NCT00542425|527916473|FG002|Initial 24 Weeks|Other|1|||
146386956|NCT00542425|527916474|FG003|Initial 24 Weeks|Other|0|||
146386957|NCT00542425|527916475|FG004|Initial 24 Weeks|Other|0|||
146386958|NCT00542425|527916471|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
146386959|NCT00542425|527916472|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
146386960|NCT00542425|527916473|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
146386961|NCT00542425|527916474|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
146386962|NCT00542425|527916475|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
146386963|NCT00542425|527916471|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146386964|NCT00542425|527916472|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146386965|NCT00542425|527916473|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
146386966|NCT00542425|527916474|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146386967|NCT00542425|527916475|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
146386968|NCT00542425|527916471|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146386969|NCT00542425|527916472|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
146386970|NCT00542425|527916473|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146386971|NCT00542425|527916474|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146386972|NCT00542425|527916475|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
146386973|NCT00542425|527916471|FG000|Extended 24 Weeks of Treatment|Other|1|||
146386974|NCT00542425|527916472|FG001|Extended 24 Weeks of Treatment|Other|1|||
146386975|NCT00542425|527916473|FG002|Extended 24 Weeks of Treatment|Other|0|||
146386976|NCT00542425|527916474|FG003|Extended 24 Weeks of Treatment|Other|0|||
146386977|NCT00542425|527916475|FG004|Extended 24 Weeks of Treatment|Other|1|||
146386978|NCT00590031|527916478|FG000|Overall Study|Adverse Event|3|||
146386979|NCT00590031|527916478|FG000|Overall Study|Withdrawal by Subject|1|||
146386980|NCT00590031|527916478|FG000|Overall Study|Metastatic Disease|1|||
146386981|NCT00590031|527916478|FG000|Overall Study|Admin Hold|1|||
146386982|NCT00826540|527916485|FG000|Overall Study|ineligible|3|||
146386983|NCT00826540|527916485|FG000|Overall Study|Withdrawal by Subject|1|||
146386984|NCT01166386|527916486|FG000|Overall Study|Withdrawal by Subject|3|||
146386985|NCT01166386|527916487|FG001|Overall Study|Withdrawal by Subject|5|||
146386986|NCT02802735|527916488|FG000|Overall Study|Withdrawal by Subject|0|||
146386987|NCT02802735|527916489|FG001|Overall Study|Withdrawal by Subject|1|||
146386988|NCT02802735|527916490|FG002|Overall Study|Withdrawal by Subject|0|||
146386989|NCT02802735|527916491|FG003|Overall Study|Withdrawal by Subject|0|||
146386990|NCT02802735|527916492|FG004|Overall Study|Withdrawal by Subject|0|||
146386991|NCT03922711|527916495|FG000|Overall Study|Adverse Event|3|||
146386992|NCT03922711|527916496|FG001|Overall Study|Adverse Event|2|||
146386993|NCT03922711|527916497|FG002|Overall Study|Adverse Event|2|||
146386994|NCT03922711|527916495|FG000|Overall Study|Protocol Violation|1|||
146386995|NCT03922711|527916496|FG001|Overall Study|Protocol Violation|0|||
146386996|NCT03922711|527916497|FG002|Overall Study|Protocol Violation|0|||
146386997|NCT03922711|527916495|FG000|Overall Study|Withdrawal by Subject|0|||
146386998|NCT03922711|527916496|FG001|Overall Study|Withdrawal by Subject|3|||
146386999|NCT03922711|527916497|FG002|Overall Study|Withdrawal by Subject|1|||
146387000|NCT03922711|527916495|FG000|Overall Study|Not further specified|0|||
146387001|NCT03922711|527916496|FG001|Overall Study|Not further specified|0|||
146387002|NCT03922711|527916497|FG002|Overall Study|Not further specified|1|||
146387003|NCT02390362|527916500|FG000|Overall Study|Withdrawal by Subject|0|||
146387004|NCT02390362|527916501|FG001|Overall Study|Withdrawal by Subject|1|||
146387005|NCT04009824|527916502|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
146387006|NCT04009824|527916503|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
146387007|NCT04009824|527916504|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
146387008|NCT04009824|527916505|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
146387009|NCT04009824|527916506|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
146387010|NCT03147495|527916507|FG000|Overall Study|Physician Decision|0|||
146387011|NCT03147495|527916508|FG001|Overall Study|Physician Decision|6|||
146387012|NCT01024946|527916509|FG000|Overall Study|Screen Failure|3|||
146387013|NCT01024946|527916509|FG000|Overall Study|Withdrawal by Subject|1|||
146387014|NCT01024946|527916509|FG000|Overall Study|Adverse Event|1|||
146387015|NCT01142791|527916519|FG000|Overall Study|Alternative Treatment|1|||
146387016|NCT01142791|527916520|FG001|Overall Study|Alternative Treatment|0|||
146387017|NCT01142791|527916519|FG000|Overall Study|Lost to Follow-up|1|||
146387018|NCT01142791|527916520|FG001|Overall Study|Lost to Follow-up|0|||
146387019|NCT01142791|527916519|FG000|Overall Study|Withdrawal by Subject|5|||
146387020|NCT01142791|527916520|FG001|Overall Study|Withdrawal by Subject|0|||
146387021|NCT01142791|527916519|FG000|Overall Study|Received only 1 sonication|0|||
146387022|NCT01142791|527916520|FG001|Overall Study|Received only 1 sonication|6|||
146387023|NCT02608892|527916521|FG000|Overall Study|Lost to Follow-up|1|||
146387024|NCT02608892|527916522|FG001|Overall Study|Lost to Follow-up|0|||
146387025|NCT03032523|527916523|FG000|Overall Study|Withdrawal by Subject|2|||
146387026|NCT03032523|527916524|FG001|Overall Study|Withdrawal by Subject|2|||
146387027|NCT03032523|527916523|FG000|Overall Study|Physician Decision|1|||
146387028|NCT03032523|527916524|FG001|Overall Study|Physician Decision|0|||
146387029|NCT02590406|527916527|FG000|Overall Study|Adverse Event|1|||
146387030|NCT02590406|527916528|FG001|Overall Study|Adverse Event|0|||
146387031|NCT02590406|527916527|FG000|Overall Study|Saturometer malfunction|0|||
146387032|NCT02590406|527916528|FG001|Overall Study|Saturometer malfunction|1|||
146387033|NCT00957723|527916529|FG000|Overall Study|Death|3|||
146387034|NCT00957723|527916529|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
146387035|NCT00957723|527916529|FG000|Overall Study|Lost to Follow-up|8|||
146387036|NCT00957723|527916529|FG000|Overall Study|Withdrawal by Subject|24|||
146387037|NCT00957723|527916529|FG000|Overall Study|Investigative Site Terminated|61|||
146387038|NCT00957723|527916529|FG000|Overall Study|Intercurrent Illness|2|||
146387039|NCT00957723|527916529|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
146387040|NCT00877890|527916530|FG000|Overall Study|Adverse Event|6|||
146387041|NCT00877890|527916531|FG001|Overall Study|Adverse Event|6|||
146387042|NCT00877890|527916530|FG000|Overall Study|Lost to Follow-up|5|||
146387043|NCT00877890|527916531|FG001|Overall Study|Lost to Follow-up|5|||
146387044|NCT00877890|527916530|FG000|Overall Study|Protocol Violation|0|||
146387045|NCT00877890|527916531|FG001|Overall Study|Protocol Violation|1|||
146387046|NCT00877890|527916530|FG000|Overall Study|Withdrawal of Consent|6|||
146387047|NCT00877890|527916531|FG001|Overall Study|Withdrawal of Consent|12|||
146387048|NCT00877890|527916530|FG000|Overall Study|Investigator Decision|0|||
146387049|NCT00877890|527916531|FG001|Overall Study|Investigator Decision|2|||
146387050|NCT00877890|527916530|FG000|Overall Study|Loss of Glucose Control|3|||
146387051|NCT00877890|527916531|FG001|Overall Study|Loss of Glucose Control|4|||
146387052|NCT00984009|527916532|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
146387053|NCT00281528|527916533|FG000|Overall Study|Progressive Disease|28|||
146387054|NCT00281528|527916534|FG001|Overall Study|Progressive Disease|18|||
146387055|NCT00281528|527916535|FG002|Overall Study|Progressive Disease|27|||
146387056|NCT00281528|527916533|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
146387057|NCT00281528|527916534|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
146387058|NCT00281528|527916535|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
146387059|NCT00281528|527916533|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
146387060|NCT00281528|527916534|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
146387061|NCT00281528|527916535|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
146387062|NCT00281528|527916533|FG000|Overall Study|Physician Decision|11|||
146387063|NCT00281528|527916534|FG001|Overall Study|Physician Decision|4|||
146387064|NCT00281528|527916535|FG002|Overall Study|Physician Decision|5|||
146387065|NCT00281528|527916533|FG000|Overall Study|Protocol Violation|1|||
146387066|NCT00281528|527916534|FG001|Overall Study|Protocol Violation|0|||
146387067|NCT00281528|527916535|FG002|Overall Study|Protocol Violation|1|||
146387068|NCT00281528|527916533|FG000|Overall Study|Withdrawal by Subject|5|||
146387069|NCT00281528|527916534|FG001|Overall Study|Withdrawal by Subject|5|||
146387070|NCT00281528|527916535|FG002|Overall Study|Withdrawal by Subject|7|||
146387071|NCT00281528|527916533|FG000|Overall Study|Other|6|||
146387072|NCT00281528|527916534|FG001|Overall Study|Other|3|||
146387073|NCT00281528|527916535|FG002|Overall Study|Other|5|||
146387074|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
146387075|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
146387076|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
146387077|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
146387078|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
146387079|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
146387080|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
146387081|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
146387082|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
146387083|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
146387084|NCT02178592|527916536|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
146387085|NCT02178592|527916537|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
146387086|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
146387087|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
146387088|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
146387089|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
146387090|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
146387091|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
146387092|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
146387093|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
146387094|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
146387095|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
146387096|NCT02178592|527916536|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
146387097|NCT02178592|527916537|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
146387098|NCT01225211|527916539|FG000|Overall Study|Adverse Event|0|||
146387099|NCT01225211|527916540|FG001|Overall Study|Adverse Event|0|||
146387100|NCT01225211|527916541|FG002|Overall Study|Adverse Event|1|||
146387101|NCT01225211|527916542|FG003|Overall Study|Adverse Event|0|||
146387102|NCT01225211|527916543|FG004|Overall Study|Adverse Event|0|||
146387103|NCT01225211|527916544|FG005|Overall Study|Adverse Event|0|||
146387104|NCT01225211|527916545|FG006|Overall Study|Adverse Event|0|||
146387105|NCT01225211|527916546|FG007|Overall Study|Adverse Event|0|||
146387106|NCT01225211|527916547|FG008|Overall Study|Adverse Event|0|||
146387107|NCT01225211|527916548|FG009|Overall Study|Adverse Event|1|||
146387108|NCT01225211|527916539|FG000|Overall Study|Withdrawal by Subject|0|||
146387109|NCT01225211|527916540|FG001|Overall Study|Withdrawal by Subject|0|||
146387110|NCT01225211|527916541|FG002|Overall Study|Withdrawal by Subject|0|||
146387111|NCT01225211|527916542|FG003|Overall Study|Withdrawal by Subject|0|||
146387112|NCT01225211|527916543|FG004|Overall Study|Withdrawal by Subject|0|||
146387113|NCT01225211|527916544|FG005|Overall Study|Withdrawal by Subject|0|||
146387114|NCT01225211|527916545|FG006|Overall Study|Withdrawal by Subject|1|||
146387115|NCT01225211|527916546|FG007|Overall Study|Withdrawal by Subject|0|||
146387116|NCT01225211|527916547|FG008|Overall Study|Withdrawal by Subject|1|||
146387117|NCT01225211|527916548|FG009|Overall Study|Withdrawal by Subject|3|||
146387118|NCT01225211|527916539|FG000|Overall Study|Other|0|||
146387119|NCT01225211|527916540|FG001|Overall Study|Other|0|||
146387120|NCT01225211|527916541|FG002|Overall Study|Other|0|||
146387121|NCT01225211|527916542|FG003|Overall Study|Other|0|||
146387122|NCT01225211|527916543|FG004|Overall Study|Other|0|||
146387123|NCT01225211|527916544|FG005|Overall Study|Other|0|||
146387124|NCT01225211|527916545|FG006|Overall Study|Other|0|||
146387125|NCT01225211|527916546|FG007|Overall Study|Other|0|||
146387126|NCT01225211|527916547|FG008|Overall Study|Other|0|||
146387127|NCT01225211|527916548|FG009|Overall Study|Other|1|||
146387128|NCT03049852|527916558|FG000|Overall Study|Lost to Follow-up|0|||
146387129|NCT03049852|527916559|FG001|Overall Study|Lost to Follow-up|1|||
146387130|NCT03049852|527916560|FG002|Overall Study|Lost to Follow-up|0|||
146387131|NCT02610231|527916566|FG000|Overall Study|Withdrawal by Subject|27|||
146387132|NCT02610231|527916566|FG000|Overall Study|Adverse Event|20|||
146387133|NCT02610231|527916566|FG000|Overall Study|Death|5|||
146387134|NCT02610231|527916566|FG000|Overall Study|Surgery|2|||
146387135|NCT02610231|527916566|FG000|Overall Study|Physician Decision|1|||
146387136|NCT02610231|527916566|FG000|Overall Study|Non Compliance|2|||
146387137|NCT02610231|527916566|FG000|Overall Study|Other|3|||
146387138|NCT02140762|527916571|FG000|Overall Study|Adverse Event|1|||
146387139|NCT02140762|527916572|FG001|Overall Study|Adverse Event|1|||
146387140|NCT02140762|527916571|FG000|Overall Study|Lost to Follow-up|9|||
146387141|NCT02140762|527916572|FG001|Overall Study|Lost to Follow-up|5|||
146387142|NCT02140762|527916571|FG000|Overall Study|Protocol Violation|1|||
146387143|NCT02140762|527916572|FG001|Overall Study|Protocol Violation|1|||
146387144|NCT02140762|527916571|FG000|Overall Study|Withdrawal by Subject|6|||
146387145|NCT02140762|527916572|FG001|Overall Study|Withdrawal by Subject|4|||
146387146|NCT02140762|527916571|FG000|Overall Study|Other|0|||
146387147|NCT02140762|527916572|FG001|Overall Study|Other|1|||
146387148|NCT02709889|527916573|FG000|Overall Study|Withdrawal by Subject|11|||
146387149|NCT02709889|527916574|FG001|Overall Study|Withdrawal by Subject|10|||
146387150|NCT02709889|527916575|FG002|Overall Study|Withdrawal by Subject|2|||
146387151|NCT02709889|527916576|FG003|Overall Study|Withdrawal by Subject|12|||
146387152|NCT02709889|527916573|FG000|Overall Study|Death|25|||
146387153|NCT02709889|527916574|FG001|Overall Study|Death|38|||
146387154|NCT02709889|527916575|FG002|Overall Study|Death|4|||
146387155|NCT02709889|527916576|FG003|Overall Study|Death|44|||
146387156|NCT02709889|527916573|FG000|Overall Study|Physician Decision|1|||
146387157|NCT02709889|527916574|FG001|Overall Study|Physician Decision|2|||
146387158|NCT02709889|527916575|FG002|Overall Study|Physician Decision|3|||
146387159|NCT02709889|527916576|FG003|Overall Study|Physician Decision|5|||
146387160|NCT02709889|527916573|FG000|Overall Study|Lost to Follow-up|2|||
146387161|NCT02709889|527916574|FG001|Overall Study|Lost to Follow-up|0|||
146387162|NCT02709889|527916575|FG002|Overall Study|Lost to Follow-up|0|||
146387163|NCT02709889|527916576|FG003|Overall Study|Lost to Follow-up|4|||
146387164|NCT02709889|527916573|FG000|Overall Study|Study Terminated by Sponsor|4|||
146387165|NCT02709889|527916574|FG001|Overall Study|Study Terminated by Sponsor|6|||
146387166|NCT02709889|527916575|FG002|Overall Study|Study Terminated by Sponsor|2|||
146387167|NCT02709889|527916576|FG003|Overall Study|Study Terminated by Sponsor|17|||
146387168|NCT02709889|527916573|FG000|Overall Study|Other, Not Specified|0|||
146387169|NCT02709889|527916574|FG001|Overall Study|Other, Not Specified|1|||
146387170|NCT02709889|527916575|FG002|Overall Study|Other, Not Specified|1|||
146387171|NCT02709889|527916576|FG003|Overall Study|Other, Not Specified|6|||
146387172|NCT00537810|527916577|FG000|Overall Study|Withdrawal by Subject|4|||
146387173|NCT00537810|527916578|FG001|Overall Study|Withdrawal by Subject|11|||
146387174|NCT00537810|527916579|FG002|Overall Study|Withdrawal by Subject|4|||
146387175|NCT00537810|527916580|FG003|Overall Study|Withdrawal by Subject|3|||
146387176|NCT00537810|527916577|FG000|Overall Study|Medically withdrawn|2|||
146387177|NCT00537810|527916578|FG001|Overall Study|Medically withdrawn|2|||
146387178|NCT00537810|527916579|FG002|Overall Study|Medically withdrawn|0|||
146387179|NCT00537810|527916580|FG003|Overall Study|Medically withdrawn|1|||
146387180|NCT00554840|527916587|FG000|Overall Study|Physician Decision|0|||
146387181|NCT00554840|527916588|FG001|Overall Study|Physician Decision|1|||
146387182|NCT00795717|527916593|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
146387183|NCT00795717|527916594|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
146387184|NCT00795717|527916593|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
146387185|NCT00795717|527916594|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
146387186|NCT00795717|527916593|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
146387187|NCT00795717|527916594|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
146387188|NCT00795717|527916593|FG000|Phase II|too busy|0|||
146387189|NCT00795717|527916594|FG001|Phase II|too busy|1|||
146387190|NCT04728815|527916597|FG000|Overall Study|Lost to Follow-up|3|||
146387191|NCT04728815|527916598|FG001|Overall Study|Lost to Follow-up|0|||
146387192|NCT04728815|527916599|FG002|Overall Study|Lost to Follow-up|0|||
146387193|NCT04728815|527916600|FG003|Overall Study|Lost to Follow-up|1|||
146387194|NCT04728815|527916601|FG004|Overall Study|Lost to Follow-up|1|||
146387195|NCT04728815|527916602|FG005|Overall Study|Lost to Follow-up|0|||
146387196|NCT04728815|527916603|FG006|Overall Study|Lost to Follow-up|2|||
146387197|NCT04728815|527916604|FG007|Overall Study|Lost to Follow-up|0|||
146387198|NCT04728815|527916597|FG000|Overall Study|Physician Decision|0|||
146387199|NCT04728815|527916598|FG001|Overall Study|Physician Decision|0|||
146387200|NCT04728815|527916599|FG002|Overall Study|Physician Decision|1|||
146387201|NCT04728815|527916600|FG003|Overall Study|Physician Decision|0|||
146387202|NCT04728815|527916601|FG004|Overall Study|Physician Decision|0|||
146387203|NCT04728815|527916602|FG005|Overall Study|Physician Decision|0|||
146387204|NCT04728815|527916603|FG006|Overall Study|Physician Decision|0|||
146387205|NCT04728815|527916604|FG007|Overall Study|Physician Decision|0|||
146387206|NCT04728815|527916597|FG000|Overall Study|Treatment drop|0|||
146387207|NCT04728815|527916598|FG001|Overall Study|Treatment drop|2|||
146387208|NCT04728815|527916599|FG002|Overall Study|Treatment drop|1|||
146387209|NCT04728815|527916600|FG003|Overall Study|Treatment drop|0|||
146387210|NCT04728815|527916601|FG004|Overall Study|Treatment drop|3|||
146387211|NCT04728815|527916602|FG005|Overall Study|Treatment drop|1|||
146387212|NCT04728815|527916603|FG006|Overall Study|Treatment drop|3|||
146387213|NCT04728815|527916604|FG007|Overall Study|Treatment drop|0|||
146387214|NCT04728815|527916597|FG000|Overall Study|Study drop|0|||
146387215|NCT04728815|527916598|FG001|Overall Study|Study drop|3|||
146387216|NCT04728815|527916599|FG002|Overall Study|Study drop|3|||
146387217|NCT04728815|527916600|FG003|Overall Study|Study drop|0|||
146387218|NCT04728815|527916601|FG004|Overall Study|Study drop|0|||
146387219|NCT04728815|527916602|FG005|Overall Study|Study drop|0|||
146387220|NCT04728815|527916603|FG006|Overall Study|Study drop|7|||
146387221|NCT04728815|527916604|FG007|Overall Study|Study drop|0|||
146387222|NCT05315297|527916605|FG000|Overall Study|Lost to Follow-up|6|||
146387223|NCT05315297|527916606|FG001|Overall Study|Lost to Follow-up|4|||
146387224|NCT05315297|527916605|FG000|Overall Study|Withdrawal by Subject|0|||
146387225|NCT05315297|527916606|FG001|Overall Study|Withdrawal by Subject|1|||
146387226|NCT01265719|527917889|FG000|Overall Study|Does not meet entrance criteria|0|||
146387227|NCT01265719|527917890|FG001|Overall Study|Does not meet entrance criteria|3|||
146387228|NCT01265719|527917889|FG000|Overall Study|Other reasons|2|||
146387229|NCT01265719|527917890|FG001|Overall Study|Other reasons|0|||
146387230|NCT01265719|527917889|FG000|Overall Study|Withdrawal by Subject|8|||
146387231|NCT01265719|527917890|FG001|Overall Study|Withdrawal by Subject|3|||
146387232|NCT01265719|527917889|FG000|Overall Study|Lost to Follow-up|2|||
146387233|NCT01265719|527917890|FG001|Overall Study|Lost to Follow-up|7|||
146387234|NCT01265719|527917889|FG000|Overall Study|Adverse Event|2|||
146387235|NCT01265719|527917890|FG001|Overall Study|Adverse Event|0|||
146387236|NCT02039687|527917892|FG000|Overall Study|Adverse Event|0|||
146387237|NCT02039687|527917893|FG001|Overall Study|Adverse Event|0|||
146387238|NCT02039687|527917894|FG002|Overall Study|Adverse Event|1|||
146387239|NCT02039687|527917895|FG003|Overall Study|Adverse Event|0|||
146387240|NCT02039687|527917892|FG000|Overall Study|Withdrawal by Subject|0|||
146387241|NCT02039687|527917893|FG001|Overall Study|Withdrawal by Subject|1|||
146387242|NCT02039687|527917894|FG002|Overall Study|Withdrawal by Subject|0|||
146387243|NCT02039687|527917895|FG003|Overall Study|Withdrawal by Subject|0|||
146387244|NCT02039687|527917892|FG000|Overall Study|treatment assignment could not be confir|0|||
146387245|NCT02039687|527917893|FG001|Overall Study|treatment assignment could not be confir|0|||
146387246|NCT02039687|527917894|FG002|Overall Study|treatment assignment could not be confir|2|||
146387247|NCT02039687|527917895|FG003|Overall Study|treatment assignment could not be confir|0|||
146387248|NCT00959192|527917900|FG000|Overall Study|Adverse Event|1|||
146387249|NCT00959192|527917901|FG001|Overall Study|Adverse Event|1|||
146387250|NCT00959192|527917902|FG002|Overall Study|Adverse Event|1|||
146387251|NCT00959192|527917903|FG003|Overall Study|Adverse Event|0|||
146387252|NCT00959192|527917900|FG000|Overall Study|Investigator Request|1|||
146387253|NCT00959192|527917901|FG001|Overall Study|Investigator Request|0|||
146387254|NCT00959192|527917902|FG002|Overall Study|Investigator Request|0|||
146387255|NCT00959192|527917903|FG003|Overall Study|Investigator Request|0|||
146387256|NCT00959192|527917900|FG000|Overall Study|Caregiver Request|0|||
146387257|NCT00959192|527917901|FG001|Overall Study|Caregiver Request|0|||
146387258|NCT00959192|527917902|FG002|Overall Study|Caregiver Request|2|||
146387259|NCT00959192|527917903|FG003|Overall Study|Caregiver Request|1|||
146387260|NCT00532441|527917904|FG000|Overall Study|Death|1|||
146387261|NCT00532441|527917905|FG001|Overall Study|Death|0|||
146387262|NCT05466240|527917906|FG000|Overall Study|Adverse Event|1|||
146387263|NCT05466240|527917907|FG001|Overall Study|Adverse Event|0|||
146387264|NCT05466240|527917906|FG000|Overall Study|Withdrawal by Subject|1|||
146387265|NCT05466240|527917907|FG001|Overall Study|Withdrawal by Subject|0|||
146387266|NCT00305773|527917908|FG000|Overall Study|Death|3|||
146387267|NCT00305773|527917909|FG001|Overall Study|Death|2|||
146387268|NCT00305773|527917908|FG000|Overall Study|Adverse Event|1|||
146387269|NCT00305773|527917909|FG001|Overall Study|Adverse Event|2|||
146387270|NCT00305773|527917908|FG000|Overall Study|Alternative Treatment|4|||
146387271|NCT00305773|527917909|FG001|Overall Study|Alternative Treatment|4|||
146387272|NCT00305773|527917908|FG000|Overall Study|Physician Decision|1|||
146387273|NCT00305773|527917909|FG001|Overall Study|Physician Decision|1|||
146387274|NCT00305773|527917908|FG000|Overall Study|Withdrawal by Subject|1|||
146387275|NCT00305773|527917909|FG001|Overall Study|Withdrawal by Subject|4|||
146387276|NCT00305773|527917908|FG000|Overall Study|Disease Progression|1|||
146387277|NCT00305773|527917909|FG001|Overall Study|Disease Progression|3|||
146387278|NCT00305773|527917908|FG000|Overall Study|All other reasons|3|||
146387279|NCT00305773|527917909|FG001|Overall Study|All other reasons|2|||
146387280|NCT02679222|527917910|FG000|Overall Study|No time for project|1|||
146387281|NCT00303329|527917911|FG000|Overall Study|Adverse Event|7|||
146387282|NCT00303329|527917912|FG001|Overall Study|Adverse Event|14|||
146387283|NCT00303329|527917911|FG000|Overall Study|Abnormal Laboratory Values|0|||
146387284|NCT00303329|527917912|FG001|Overall Study|Abnormal Laboratory Values|1|||
146387285|NCT00303329|527917911|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
146387286|NCT00303329|527917912|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
146387287|NCT00303329|527917911|FG000|Overall Study|Condition no longer requires study drug|0|||
146387288|NCT00303329|527917912|FG001|Overall Study|Condition no longer requires study drug|8|||
146387289|NCT00303329|527917911|FG000|Overall Study|Protocol Violation|3|||
146387290|NCT00303329|527917912|FG001|Overall Study|Protocol Violation|0|||
146387291|NCT00303329|527917911|FG000|Overall Study|Withdrawal by Subject|9|||
146387292|NCT00303329|527917912|FG001|Overall Study|Withdrawal by Subject|15|||
146387293|NCT00303329|527917911|FG000|Overall Study|Lost to Follow-up|0|||
146387294|NCT00303329|527917912|FG001|Overall Study|Lost to Follow-up|1|||
146387295|NCT00303329|527917911|FG000|Overall Study|Administrative problems|1|||
146387296|NCT00303329|527917912|FG001|Overall Study|Administrative problems|0|||
146387297|NCT00303329|527917911|FG000|Overall Study|Death|2|||
146387298|NCT00303329|527917912|FG001|Overall Study|Death|12|||
146387299|NCT00303329|527917911|FG000|Overall Study|Stopped at end of core|3|||
146387300|NCT00303329|527917912|FG001|Overall Study|Stopped at end of core|9|||
146387301|NCT00303329|527917911|FG000|Overall Study|Stopped at end of extension 1|1|||
146387302|NCT00303329|527917912|FG001|Overall Study|Stopped at end of extension 1|0|||
146387303|NCT00626327|527917915|FG000|Overall Study|Withdrawal by Subject|21|||
146387304|NCT00626327|527917916|FG001|Overall Study|Withdrawal by Subject|29|||
146387305|NCT00626327|527917917|FG002|Overall Study|Withdrawal by Subject|30|||
146387306|NCT00626327|527917915|FG000|Overall Study|Adverse Event|1|||
146387307|NCT00626327|527917916|FG001|Overall Study|Adverse Event|0|||
146387308|NCT00626327|527917917|FG002|Overall Study|Adverse Event|0|||
146387309|NCT00626327|527917915|FG000|Overall Study|Lost to Follow-up|24|||
146387310|NCT00626327|527917916|FG001|Overall Study|Lost to Follow-up|21|||
146387311|NCT00626327|527917917|FG002|Overall Study|Lost to Follow-up|23|||
146387312|NCT00626327|527917915|FG000|Overall Study|Inappropriate enrollment|4|||
146387313|NCT00626327|527917916|FG001|Overall Study|Inappropriate enrollment|5|||
146387314|NCT00626327|527917917|FG002|Overall Study|Inappropriate enrollment|3|||
146387315|NCT00626327|527917915|FG000|Overall Study|Administrative Reason|2|||
146387316|NCT00626327|527917916|FG001|Overall Study|Administrative Reason|0|||
146387317|NCT00626327|527917917|FG002|Overall Study|Administrative Reason|6|||
146387318|NCT00626327|527917915|FG000|Overall Study|Protocol Violation|26|||
146387319|NCT00626327|527917916|FG001|Overall Study|Protocol Violation|4|||
146387320|NCT00626327|527917917|FG002|Overall Study|Protocol Violation|26|||
146387321|NCT01716585|527917920|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
146387322|NCT01716585|527917921|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
146387323|NCT01716585|527917920|FG000|Double-blind Treatment|Adverse Event|2|||
146387324|NCT01716585|527917921|FG001|Double-blind Treatment|Adverse Event|1|||
146387325|NCT01716585|527917920|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
146387326|NCT01716585|527917921|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
146387327|NCT01716585|527917920|FG000|Double-blind Treatment|Lost to Follow-up|2|||
146387328|NCT01716585|527917921|FG001|Double-blind Treatment|Lost to Follow-up|0|||
146387329|NCT01716585|527917920|FG000|Double-blind Treatment|Subject Noncompliant|1|||
146387330|NCT01716585|527917921|FG001|Double-blind Treatment|Subject Noncompliant|0|||
146387331|NCT01716585|527917920|FG000|Double-blind Treatment|Other|1|||
146387332|NCT01716585|527917921|FG001|Double-blind Treatment|Other|0|||
146387333|NCT01716585|527917920|FG000|Open-label Treatment|Adverse Event|0|||
146387334|NCT01716585|527917921|FG001|Open-label Treatment|Adverse Event|2|||
146387335|NCT01716585|527917920|FG000|Open-label Treatment|Virologic Failure|0|||
146387336|NCT01716585|527917921|FG001|Open-label Treatment|Virologic Failure|2|||
146387337|NCT01716585|527917920|FG000|Open-label Treatment|Withdrawal by Subject|0|||
146387338|NCT01716585|527917921|FG001|Open-label Treatment|Withdrawal by Subject|3|||
146387339|NCT05102734|527917924|FG000|Overall Study|Did not require vasopressors|1|||
146387340|NCT05102734|527917925|FG001|Overall Study|Did not require vasopressors|0|||
146387341|NCT05102734|527917924|FG000|Overall Study|Did not have functioning PA catheter|1|||
146387342|NCT05102734|527917925|FG001|Overall Study|Did not have functioning PA catheter|0|||
146387343|NCT05102734|527917924|FG000|Overall Study|Inadequate video quality|2|||
146387344|NCT05102734|527917925|FG001|Overall Study|Inadequate video quality|0|||
146387345|NCT03288987|527917926|FG000|Overall Study|Protocol Violation|10|||
146387346|NCT03288987|527917927|FG001|Overall Study|Protocol Violation|4|||
146387347|NCT04235959|527917928|FG000|Overall Study|Protocol Violation|0|||
146387348|NCT04235959|527917929|FG001|Overall Study|Protocol Violation|1|||
146387349|NCT04235959|527917930|FG002|Overall Study|Protocol Violation|0|||
146387350|NCT04235959|527917928|FG000|Overall Study|Adverse Event|1|||
146387351|NCT04235959|527917929|FG001|Overall Study|Adverse Event|0|||
146387352|NCT04235959|527917930|FG002|Overall Study|Adverse Event|0|||
146387353|NCT03055806|527917933|FG000|Overall Study|Adverse Event|0|||
146387354|NCT03055806|527917934|FG001|Overall Study|Adverse Event|0|||
146387355|NCT03055806|527917935|FG002|Overall Study|Adverse Event|1|||
146387356|NCT03055806|527917936|FG003|Overall Study|Adverse Event|1|||
146387357|NCT03055806|527917933|FG000|Overall Study|Lost to Follow-up|0|||
146387358|NCT03055806|527917934|FG001|Overall Study|Lost to Follow-up|3|||
146387359|NCT03055806|527917935|FG002|Overall Study|Lost to Follow-up|6|||
146387360|NCT03055806|527917936|FG003|Overall Study|Lost to Follow-up|7|||
146387361|NCT03055806|527917933|FG000|Overall Study|Physician Decision|1|||
146387362|NCT03055806|527917934|FG001|Overall Study|Physician Decision|0|||
146387363|NCT03055806|527917935|FG002|Overall Study|Physician Decision|0|||
146387364|NCT03055806|527917936|FG003|Overall Study|Physician Decision|1|||
146387365|NCT03055806|527917933|FG000|Overall Study|Protocol Violation|1|||
146387366|NCT03055806|527917934|FG001|Overall Study|Protocol Violation|0|||
146387367|NCT03055806|527917935|FG002|Overall Study|Protocol Violation|0|||
146387368|NCT03055806|527917936|FG003|Overall Study|Protocol Violation|0|||
146387369|NCT03055806|527917933|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
146387370|NCT03055806|527917934|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
146387371|NCT03055806|527917935|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
146387372|NCT03055806|527917936|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
146387373|NCT03055806|527917933|FG000|Overall Study|Withdrawal of consent to continue study|2|||
146387374|NCT03055806|527917934|FG001|Overall Study|Withdrawal of consent to continue study|3|||
146387375|NCT03055806|527917935|FG002|Overall Study|Withdrawal of consent to continue study|4|||
146387376|NCT03055806|527917936|FG003|Overall Study|Withdrawal of consent to continue study|6|||
146387377|NCT03055806|527917933|FG000|Overall Study|Partner not willing to try intercourse|1|||
146387378|NCT03055806|527917934|FG001|Overall Study|Partner not willing to try intercourse|0|||
146387379|NCT03055806|527917935|FG002|Overall Study|Partner not willing to try intercourse|0|||
146387380|NCT03055806|527917936|FG003|Overall Study|Partner not willing to try intercourse|0|||
146387381|NCT04601194|527917937|FG000|Overall Study|Lost to Follow-up|7|||
146387382|NCT04905563|527917938|FG000|Overall Study|Withdrawal by Subject|1|||
146387383|NCT04905563|527917939|FG001|Overall Study|Withdrawal by Subject|0|||
146387384|NCT04905563|527917938|FG000|Overall Study|Standard of care orders entered by resident|1|||
146387385|NCT04905563|527917939|FG001|Overall Study|Standard of care orders entered by resident|0|||
146387386|NCT04905563|527917938|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
146387387|NCT04905563|527917939|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
146387388|NCT04905563|527917938|FG000|Overall Study|Withdrawal by Subject|0|||
146387389|NCT04905563|527917939|FG001|Overall Study|Withdrawal by Subject|1|||
146387390|NCT01797302|527917940|FG000|Overall Study|Lost to Follow-up|16|||
146387391|NCT01797302|527917941|FG001|Overall Study|Lost to Follow-up|23|||
146387392|NCT01797302|527917942|FG002|Overall Study|Lost to Follow-up|22|||
146387393|NCT01797302|527917940|FG000|Overall Study|Withdrawal by Subject|1|||
146387394|NCT01797302|527917941|FG001|Overall Study|Withdrawal by Subject|3|||
146387395|NCT01797302|527917942|FG002|Overall Study|Withdrawal by Subject|4|||
146387396|NCT02870348|527917947|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
146387397|NCT00672139|527917948|FG000|Overall Study|Death|14|||
146387398|NCT00672139|527917949|FG001|Overall Study|Death|23|||
146387399|NCT00672139|527917948|FG000|Overall Study|Withdrawal by Subject|2|||
146387400|NCT00672139|527917949|FG001|Overall Study|Withdrawal by Subject|11|||
146387401|NCT00672139|527917948|FG000|Overall Study|Adverse Event|4|||
146387402|NCT00672139|527917949|FG001|Overall Study|Adverse Event|7|||
146387403|NCT00672139|527917948|FG000|Overall Study|Physician Decision|2|||
146387404|NCT00672139|527917949|FG001|Overall Study|Physician Decision|0|||
146387405|NCT00672139|527917948|FG000|Overall Study|Lack of Efficacy|4|||
146387406|NCT00672139|527917949|FG001|Overall Study|Lack of Efficacy|1|||
146387407|NCT00672139|527917948|FG000|Overall Study|Protocol Violation|1|||
146387408|NCT00672139|527917949|FG001|Overall Study|Protocol Violation|1|||
146387409|NCT00672139|527917948|FG000|Overall Study|hospice discharge, caregiver requests|3|||
146387410|NCT00672139|527917949|FG001|Overall Study|hospice discharge, caregiver requests|2|||
146387411|NCT01051856|527917950|FG000|Overall Study|Withdrawal by Subject|1|||
146387412|NCT01051856|527917951|FG001|Overall Study|Withdrawal by Subject|0|||
146387413|NCT02381795|527917952|FG000|Overall Study|Withdrawal by Subject|1|||
146387414|NCT02381795|527917952|FG000|Overall Study|Study Terminated|2|||
146387415|NCT02176226|527917953|FG000|Overall Study|Lost to Follow-up|3|||
146387416|NCT02176226|527917953|FG000|Overall Study|Withdrew prior to treatment|6|||
146387417|NCT01038635|527917960|FG000|Overall Study|Disease Progression|2|||
146387418|NCT01038635|527917961|FG001|Overall Study|Disease Progression|0|||
146387419|NCT01038635|527917962|FG002|Overall Study|Disease Progression|0|||
146387420|NCT01038635|527917963|FG003|Overall Study|Disease Progression|0|||
146387421|NCT01038635|527917964|FG004|Overall Study|Disease Progression|0|||
146387422|NCT01038635|527917965|FG005|Overall Study|Disease Progression|0|||
146387423|NCT01038635|527917966|FG006|Overall Study|Disease Progression|1|||
146387424|NCT01038635|527917967|FG007|Overall Study|Disease Progression|4|||
146387425|NCT01038635|527917968|FG008|Overall Study|Disease Progression|0|||
146387426|NCT01038635|527917960|FG000|Overall Study|Death|0|||
146387427|NCT01038635|527917961|FG001|Overall Study|Death|0|||
146387428|NCT01038635|527917962|FG002|Overall Study|Death|0|||
146387429|NCT01038635|527917963|FG003|Overall Study|Death|0|||
146387430|NCT01038635|527917964|FG004|Overall Study|Death|1|||
146387431|NCT01038635|527917965|FG005|Overall Study|Death|0|||
146387432|NCT01038635|527917966|FG006|Overall Study|Death|1|||
146387433|NCT01038635|527917967|FG007|Overall Study|Death|1|||
146387434|NCT01038635|527917968|FG008|Overall Study|Death|2|||
146387435|NCT01227252|527917969|FG000|Overall Study|Sponsor Decision|0|||
146387436|NCT01227252|527917970|FG001|Overall Study|Sponsor Decision|1|||
146387437|NCT01227252|527917971|FG002|Overall Study|Sponsor Decision|0|||
146387438|NCT01227252|527917972|FG003|Overall Study|Sponsor Decision|0|||
146387439|NCT01227252|527917969|FG000|Overall Study|Lost to Follow-up|0|||
146387440|NCT01227252|527917970|FG001|Overall Study|Lost to Follow-up|1|||
146387441|NCT01227252|527917971|FG002|Overall Study|Lost to Follow-up|0|||
146387442|NCT01227252|527917972|FG003|Overall Study|Lost to Follow-up|0|||
146387443|NCT01227252|527917969|FG000|Overall Study|Withdrawal by Subject|0|||
146387444|NCT01227252|527917970|FG001|Overall Study|Withdrawal by Subject|1|||
146387445|NCT01227252|527917971|FG002|Overall Study|Withdrawal by Subject|0|||
146387446|NCT01227252|527917972|FG003|Overall Study|Withdrawal by Subject|0|||
146387447|NCT01034709|527917974|FG000|Overall Study|Protocol Violation|9|||
146387448|NCT01034709|527917975|FG001|Overall Study|Protocol Violation|16|||
146387449|NCT01060150|527917978|FG000|Overall Study|Adverse Event|6|||
146387450|NCT01060150|527917978|FG000|Overall Study|Lost to Follow-up|1|||
146387451|NCT01060150|527917978|FG000|Overall Study|Protocol Violation|6|||
146387452|NCT01060150|527917978|FG000|Overall Study|Withdrawal by Subject|8|||
146387453|NCT01060150|527917978|FG000|Overall Study|Enrolled, but not treated|2|||
146387454|NCT02516306|527917979|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
146387455|NCT02516306|527917980|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
146387456|NCT01566981|527917982|FG000|Overall Study|Lost to Follow-up|5|||
146387457|NCT01566981|527917983|FG001|Overall Study|Lost to Follow-up|8|||
146387458|NCT01351415|527917984|FG000|Overall Study|Withdrawal by Subject|15|||
146387459|NCT01351415|527917985|FG001|Overall Study|Withdrawal by Subject|17|||
146387460|NCT01351415|527917984|FG000|Overall Study|Trial termination by the Sponsor|28|||
146387461|NCT01351415|527917985|FG001|Overall Study|Trial termination by the Sponsor|19|||
146387462|NCT01351415|527917984|FG000|Overall Study|Lost to Follow-up|5|||
146387463|NCT01351415|527917985|FG001|Overall Study|Lost to Follow-up|7|||
146387464|NCT01351415|527917984|FG000|Overall Study|Death|190|||
146387465|NCT01351415|527917985|FG001|Overall Study|Death|187|||
146387466|NCT01351415|527917984|FG000|Overall Study|Physician Decision|2|||
146387467|NCT01351415|527917985|FG001|Overall Study|Physician Decision|3|||
146387468|NCT01351415|527917984|FG000|Overall Study|Reason unknown|0|||
146387469|NCT01351415|527917985|FG001|Overall Study|Reason unknown|2|||
146387470|NCT01351415|527917984|FG000|Overall Study|Never Started|5|||
146387471|NCT01351415|527917985|FG001|Overall Study|Never Started|5|||
146387472|NCT03480360|527917987|FG000|Overall Study|Death|2|||
146387473|NCT00472043|527917990|FG000|Overall Study|Withdrawal by Subject|1|||
146387474|NCT00472043|527917991|FG001|Overall Study|Withdrawal by Subject|0|||
146387475|NCT00472043|527917990|FG000|Overall Study|Death|1|||
146387476|NCT00472043|527917991|FG001|Overall Study|Death|0|||
146387477|NCT05375838|527917993|FG000|Overall Study|Other|0|||
146387478|NCT05375838|527917994|FG001|Overall Study|Other|0|||
146387479|NCT05375838|527917995|FG002|Overall Study|Other|0|||
146387480|NCT05375838|527917996|FG003|Overall Study|Other|1|||
146387481|NCT05375838|527917997|FG004|Overall Study|Other|1|||
146387482|NCT05375838|527917998|FG005|Overall Study|Other|0|||
146387483|NCT05375838|527917993|FG000|Overall Study|Withdrawal by Subject|2|||
146387484|NCT05375838|527917994|FG001|Overall Study|Withdrawal by Subject|1|||
146387485|NCT05375838|527917995|FG002|Overall Study|Withdrawal by Subject|3|||
146387486|NCT05375838|527917996|FG003|Overall Study|Withdrawal by Subject|2|||
146387487|NCT05375838|527917997|FG004|Overall Study|Withdrawal by Subject|2|||
146387488|NCT05375838|527917998|FG005|Overall Study|Withdrawal by Subject|0|||
146387489|NCT05375838|527917993|FG000|Overall Study|Protocol Violation|0|||
146387490|NCT05375838|527917994|FG001|Overall Study|Protocol Violation|0|||
146387491|NCT05375838|527917995|FG002|Overall Study|Protocol Violation|0|||
146387492|NCT05375838|527917996|FG003|Overall Study|Protocol Violation|0|||
146387493|NCT05375838|527917997|FG004|Overall Study|Protocol Violation|1|||
146387494|NCT05375838|527917998|FG005|Overall Study|Protocol Violation|0|||
146387495|NCT05375838|527917993|FG000|Overall Study|Physician Decision|0|||
146387496|NCT05375838|527917994|FG001|Overall Study|Physician Decision|1|||
146387497|NCT05375838|527917995|FG002|Overall Study|Physician Decision|0|||
146387498|NCT05375838|527917996|FG003|Overall Study|Physician Decision|0|||
146387499|NCT05375838|527917997|FG004|Overall Study|Physician Decision|0|||
146387500|NCT05375838|527917998|FG005|Overall Study|Physician Decision|1|||
146387501|NCT05375838|527917993|FG000|Overall Study|Lost to Follow-up|2|||
146387502|NCT05375838|527917994|FG001|Overall Study|Lost to Follow-up|7|||
146387503|NCT05375838|527917995|FG002|Overall Study|Lost to Follow-up|0|||
146387504|NCT05375838|527917996|FG003|Overall Study|Lost to Follow-up|4|||
146387505|NCT05375838|527917997|FG004|Overall Study|Lost to Follow-up|2|||
146387506|NCT05375838|527917998|FG005|Overall Study|Lost to Follow-up|3|||
146387507|NCT02975206|527917999|FG000|Overall Study|Withdrawal by Subject|14|||
146387508|NCT02975206|527918000|FG001|Overall Study|Withdrawal by Subject|11|||
146387509|NCT02975206|527918001|FG002|Overall Study|Withdrawal by Subject|11|||
146387510|NCT02975206|527917999|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
146387511|NCT02975206|527918000|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
146387512|NCT02975206|527918001|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
146387513|NCT01981096|527918002|FG000|Overall Study|Parent illness|1|||
146387514|NCT01981096|527918003|FG001|Overall Study|Parent illness|0|||
146387515|NCT01981096|527918002|FG000|Overall Study|Withdrawal by Subject|0|||
146387516|NCT01981096|527918003|FG001|Overall Study|Withdrawal by Subject|1|||
146387517|NCT01981096|527918002|FG000|Overall Study|Lost to Follow-up|2|||
146387518|NCT01981096|527918003|FG001|Overall Study|Lost to Follow-up|0|||
146387519|NCT00866606|527918004|FG000|Overall Study|Lost to Follow-up|3|||
146387520|NCT00866606|527918004|FG000|Overall Study|Adverse Event|1|||
146387521|NCT00392210|527918021|FG000|First Voiding Trial|Physician Decision|2|||
146387522|NCT00392210|527918022|FG001|First Voiding Trial|Physician Decision|2|||
146387523|NCT02067104|527918023|FG000|Overall Study|Study termination due to low accrual|4|||
146387524|NCT02067104|527918024|FG001|Overall Study|Study termination due to low accrual|5|||
146387525|NCT01987609|527918025|FG000|Overall Study|Adverse Event|1|||
146387526|NCT00806494|527918026|FG000|Overall Study|Adverse Event|29|||
146387527|NCT00806494|527918026|FG000|Overall Study|Lack of Efficacy|6|||
146387528|NCT00806494|527918026|FG000|Overall Study|Lost to Follow-up|10|||
146387529|NCT00806494|527918026|FG000|Overall Study|Other|30|||
146387530|NCT00806494|527918026|FG000|Overall Study|Withdrawal by Subject|5|||
146387531|NCT01279954|527918029|FG000|Overall Study|Lack of Efficacy|3|||
146387532|NCT01279954|527918030|FG001|Overall Study|Lack of Efficacy|4|||
146387533|NCT00122317|527918034|FG000|Overall Study|Death|3|||
146387534|NCT00122317|527918034|FG000|Overall Study|Adverse Event|4|||
146387535|NCT00122317|527918034|FG000|Overall Study|Physician Decision|2|||
146387536|NCT00122317|527918034|FG000|Overall Study|patient non-compliance|1|||
146387537|NCT00122317|527918034|FG000|Overall Study|Withdrawal by Subject|1|||
146387538|NCT03458234|527918035|FG000|Overall Study|Withdrawal by Subject|1|||
146387539|NCT01021293|527918040|FG000|Overall Study|Serious Adverse Event|2|||
146387540|NCT01021293|527918041|FG001|Overall Study|Serious Adverse Event|1|||
146387541|NCT01021293|527918040|FG000|Overall Study|Adverse Event|2|||
146387542|NCT01021293|527918041|FG001|Overall Study|Adverse Event|1|||
146387543|NCT01021293|527918040|FG000|Overall Study|Withdrawal by Subject|1|||
146387544|NCT01021293|527918041|FG001|Overall Study|Withdrawal by Subject|3|||
146387545|NCT01021293|527918040|FG000|Overall Study|Migrated/moved from study area|6|||
146387546|NCT01021293|527918041|FG001|Overall Study|Migrated/moved from study area|18|||
146387547|NCT01021293|527918040|FG000|Overall Study|Lost to Follow-up|1|||
146387548|NCT01021293|527918041|FG001|Overall Study|Lost to Follow-up|1|||
146387549|NCT02033369|527919993|FG000|Overall Study|Physician Decision|1|||
146387550|NCT02033369|527919994|FG001|Overall Study|Physician Decision|2|||
146387551|NCT02033369|527919993|FG000|Overall Study|Not a good demographic match|0|||
146387552|NCT02033369|527919994|FG001|Overall Study|Not a good demographic match|2|||
146387553|NCT02033369|527919993|FG000|Overall Study|Withdrawal by Subject|1|||
146387554|NCT02033369|527919994|FG001|Overall Study|Withdrawal by Subject|1|||
146387555|NCT02033369|527919993|FG000|Overall Study|Lost to Follow-up|1|||
146387556|NCT02033369|527919994|FG001|Overall Study|Lost to Follow-up|0|||
146387557|NCT02033369|527919993|FG000|Overall Study|Protocol Violation|2|||
146387558|NCT02033369|527919994|FG001|Overall Study|Protocol Violation|0|||
146387559|NCT01503229|527919995|FG000|Overall Study|Withdrew consent|1|||
146387560|NCT04335929|527919996|FG000|Overall Study|Lost to Follow-up|10|||
146387561|NCT02534324|527920001|FG000|Overall Study|Protocol Violation|4|||
146387562|NCT02534324|527920002|FG001|Overall Study|Protocol Violation|1|||
146387563|NCT02534324|527920001|FG000|Overall Study|Lost to Follow-up|20|||
146387564|NCT02534324|527920002|FG001|Overall Study|Lost to Follow-up|7|||
146387565|NCT02534324|527920001|FG000|Overall Study|Adverse Event|1|||
146387566|NCT02534324|527920002|FG001|Overall Study|Adverse Event|0|||
146387567|NCT05604781|527920005|FG000|Overall Study|Lost to Follow-up|3|||
146387568|NCT05604781|527920005|FG000|Overall Study|Adverse Event|1|||
146387569|NCT02889861|527920016|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
146387570|NCT01864746|527920019|FG000|Overall Study|Disease recurrence|25|||
146387571|NCT01864746|527920020|FG001|Overall Study|Disease recurrence|40|||
146387572|NCT01864746|527920019|FG000|Overall Study|Second primary invasive nonbreast|2|||
146387573|NCT01864746|527920020|FG001|Overall Study|Second primary invasive nonbreast|3|||
146387574|NCT01864746|527920019|FG000|Overall Study|Death|2|||
146387575|NCT01864746|527920020|FG001|Overall Study|Death|1|||
146387576|NCT01864746|527920019|FG000|Overall Study|Adverse Event|33|||
146387577|NCT01864746|527920020|FG001|Overall Study|Adverse Event|5|||
146387578|NCT01864746|527920019|FG000|Overall Study|Withdrawal by Subject|56|||
146387579|NCT01864746|527920020|FG001|Overall Study|Withdrawal by Subject|41|||
146387580|NCT01864746|527920019|FG000|Overall Study|Physician Decision|5|||
146387581|NCT01864746|527920020|FG001|Overall Study|Physician Decision|6|||
146387582|NCT01005966|527920021|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
146387583|NCT01005966|527920022|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
146387584|NCT01005966|527920023|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
146387585|NCT01005966|527920024|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
146387586|NCT01005966|527920025|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
146387587|NCT01005966|527920021|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
146387588|NCT01005966|527920022|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146387589|NCT01005966|527920023|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
146387590|NCT01005966|527920024|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146387591|NCT01005966|527920025|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
146387592|NCT01005966|527920021|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146387593|NCT01005966|527920022|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146387594|NCT01005966|527920023|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146387595|NCT01005966|527920024|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
146387596|NCT01005966|527920025|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
146387597|NCT01005966|527920021|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
146387598|NCT01005966|527920022|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
146387599|NCT01005966|527920023|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
146387600|NCT01005966|527920024|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
146387601|NCT01005966|527920025|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
146387602|NCT01005966|527920021|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146387603|NCT01005966|527920022|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146387604|NCT01005966|527920023|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146387605|NCT01005966|527920024|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
146387606|NCT01005966|527920025|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
146387607|NCT01005966|527920021|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146387608|NCT01005966|527920022|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146387609|NCT01005966|527920023|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
146387610|NCT01005966|527920024|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146387611|NCT01005966|527920025|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
146387612|NCT01005966|527920021|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146387613|NCT01005966|527920022|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
146387614|NCT01005966|527920023|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146387615|NCT01005966|527920024|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
146387616|NCT01005966|527920025|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
146387617|NCT01005966|527920021|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146387618|NCT01005966|527920022|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
146387619|NCT01005966|527920023|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146387620|NCT01005966|527920024|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146387621|NCT01005966|527920025|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
146387622|NCT01005966|527920021|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
146387623|NCT01005966|527920022|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
146387624|NCT01005966|527920023|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
146387625|NCT01005966|527920024|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
146387626|NCT01005966|527920025|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
146387627|NCT01451203|527920026|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
146387628|NCT01451203|527920027|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
146387629|NCT01451203|527920026|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
146387630|NCT01451203|527920027|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
146387631|NCT01451203|527920026|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
146387632|NCT01451203|527920027|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
146387633|NCT01451203|527920026|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
146387634|NCT01451203|527920027|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
146387635|NCT01451203|527920026|FG000|Double-blind Treatment Period|Adverse Event|6|||
146387636|NCT01451203|527920027|FG001|Double-blind Treatment Period|Adverse Event|9|||
146387637|NCT01451203|527920026|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
146387638|NCT01451203|527920027|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
146387639|NCT01451203|527920026|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
146387640|NCT01451203|527920027|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
146387641|NCT01451203|527920026|FG000|Double-blind Treatment Period|Investigator decision|2|||
146387642|NCT01451203|527920027|FG001|Double-blind Treatment Period|Investigator decision|0|||
146387643|NCT01451203|527920026|FG000|Post-treatment Period|Consent withdrawn|2|||
146387644|NCT01451203|527920027|FG001|Post-treatment Period|Consent withdrawn|4|||
146387645|NCT01451203|527920026|FG000|Post-treatment Period|Lack of Efficacy|12|||
146387646|NCT01451203|527920027|FG001|Post-treatment Period|Lack of Efficacy|28|||
146387647|NCT01451203|527920026|FG000|Post-treatment Period|Adverse Event|0|||
146387648|NCT01451203|527920027|FG001|Post-treatment Period|Adverse Event|1|||
146387649|NCT01451203|527920026|FG000|Post-treatment Period|Investigator decision|0|||
146387650|NCT01451203|527920027|FG001|Post-treatment Period|Investigator decision|1|||
146387651|NCT01041027|527920028|FG000|Overall Study|Withdrawal by Subject|2|||
146387652|NCT01041027|527920028|FG000|Overall Study|Protocol Violation|1|||
146387653|NCT01041027|527920028|FG000|Overall Study|Delayed Radiation Therapy|1|||
146387654|NCT01041027|527920028|FG000|Overall Study|Adverse Event|4|||
146396052|NCT01397409|527952478|FG008|Stage 3|Adverse Event|0|||
146387655|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
146387656|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
146387657|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
146387658|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
146387659|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
146387660|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
146387661|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
146387662|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
146387663|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
146387664|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
146387665|NCT02528643|527920029|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
146387666|NCT02528643|527920030|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
146387667|NCT02528643|527920029|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
146387668|NCT02528643|527920030|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
146387669|NCT02146274|527920032|FG000|Overall Study|Protocol Violation|73|||
146387670|NCT00443534|527920043|FG000|Overall Study|Lack of Efficacy|67|||
146387671|NCT00443534|527920043|FG000|Overall Study|Adverse Event|16|||
146387672|NCT00443534|527920043|FG000|Overall Study|Death|9|||
146387673|NCT00443534|527920043|FG000|Overall Study|Withdrawal by Subject|8|||
146387674|NCT00443534|527920043|FG000|Overall Study|Study Terminated by Sponsor|12|||
146387675|NCT00443534|527920043|FG000|Overall Study|Other|10|||
146387676|NCT00443534|527920043|FG000|Overall Study|Enrolled, Not Treated|1|||
146387677|NCT00413231|527920044|FG000|0 to 30-day Post Treatment|Death|5|||
146387678|NCT00413231|527920044|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
146387679|NCT00413231|527920044|FG000|30-day to 365-day Post Treatment|Death|13|||
146387680|NCT00413231|527920044|FG000|365-day to 60-month Post Treatment|Death|36|||
146387681|NCT00413231|527920044|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
146387682|NCT00413231|527920044|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
146387683|NCT00413231|527920044|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
146387684|NCT04450394|527920049|FG000|Overall Study|Adverse Event|2|||
146387685|NCT04450394|527920050|FG001|Overall Study|Adverse Event|0|||
146387686|NCT04450394|527920051|FG002|Overall Study|Adverse Event|0|||
146387687|NCT04450394|527920049|FG000|Overall Study|Death|0|||
146387688|NCT04450394|527920050|FG001|Overall Study|Death|1|||
146387689|NCT04450394|527920051|FG002|Overall Study|Death|0|||
146387690|NCT04450394|527920049|FG000|Overall Study|Lost to Follow-up|0|||
146387691|NCT04450394|527920050|FG001|Overall Study|Lost to Follow-up|3|||
146387692|NCT04450394|527920051|FG002|Overall Study|Lost to Follow-up|0|||
146387693|NCT04450394|527920049|FG000|Overall Study|Physician Decision|0|||
146387694|NCT04450394|527920050|FG001|Overall Study|Physician Decision|1|||
146387695|NCT04450394|527920051|FG002|Overall Study|Physician Decision|0|||
146387696|NCT04450394|527920049|FG000|Overall Study|Protocol Violation|2|||
146387697|NCT04450394|527920050|FG001|Overall Study|Protocol Violation|0|||
146387698|NCT04450394|527920051|FG002|Overall Study|Protocol Violation|0|||
146387699|NCT04450394|527920049|FG000|Overall Study|Withdrawal by Subject|6|||
146387700|NCT04450394|527920050|FG001|Overall Study|Withdrawal by Subject|9|||
146387701|NCT04450394|527920051|FG002|Overall Study|Withdrawal by Subject|0|||
146387702|NCT03812224|527920059|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
146387703|NCT03812224|527920060|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
146387704|NCT03812224|527920059|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
146387705|NCT03812224|527920060|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
146387706|NCT03812224|527920059|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
146387707|NCT03812224|527920060|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
146387708|NCT03812224|527920059|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
146387709|NCT03812224|527920060|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
146387710|NCT00303719|527920061|FG000|Overall Study|Not evaluable, prior therapies|0|||
146387711|NCT00303719|527920062|FG001|Overall Study|Not evaluable, prior therapies|30|||
146387712|NCT00303719|527920061|FG000|Overall Study|Lost to Follow-up|0|||
146387713|NCT00303719|527920062|FG001|Overall Study|Lost to Follow-up|7|||
146387714|NCT01641952|527920063|FG000|Overall Study|Lost to Follow-up|28|||
146387715|NCT01641952|527920063|FG000|Overall Study|Adverse Event|6|||
146387716|NCT02516605|527920064|FG000|Overall Study|Protocol Violation|0|||
146387717|NCT02516605|527920065|FG001|Overall Study|Protocol Violation|0|||
146387718|NCT02516605|527920066|FG002|Overall Study|Protocol Violation|0|||
146387719|NCT02516605|527920067|FG003|Overall Study|Protocol Violation|0|||
146387720|NCT02516605|527920068|FG004|Overall Study|Protocol Violation|1|||
146387721|NCT02516605|527920064|FG000|Overall Study|Withdrawal by Subject|0|||
146387722|NCT02516605|527920065|FG001|Overall Study|Withdrawal by Subject|0|||
146387723|NCT02516605|527920066|FG002|Overall Study|Withdrawal by Subject|0|||
146387724|NCT02516605|527920067|FG003|Overall Study|Withdrawal by Subject|1|||
146387725|NCT02516605|527920068|FG004|Overall Study|Withdrawal by Subject|0|||
146387726|NCT02643420|527920069|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
146387727|NCT02643420|527920070|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
146387728|NCT02643420|527920069|FG000|Overall Study|Withdrawal by Subject|25|||
146387729|NCT02643420|527920070|FG001|Overall Study|Withdrawal by Subject|19|||
146387730|NCT02643420|527920069|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
146387731|NCT02643420|527920070|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
146387732|NCT02643420|527920069|FG000|Overall Study|Lost to Follow-up|6|||
146387733|NCT02643420|527920070|FG001|Overall Study|Lost to Follow-up|10|||
146387734|NCT02643420|527920069|FG000|Overall Study|Investigator Decision|2|||
146387735|NCT02643420|527920070|FG001|Overall Study|Investigator Decision|4|||
146387736|NCT02643420|527920069|FG000|Overall Study|Sponsor decision|1|||
146387737|NCT02643420|527920070|FG001|Overall Study|Sponsor decision|1|||
146387738|NCT02643420|527920069|FG000|Overall Study|Death|0|||
146387739|NCT02643420|527920070|FG001|Overall Study|Death|2|||
146387740|NCT02643420|527920069|FG000|Overall Study|Reason not Specified|8|||
146387741|NCT02643420|527920070|FG001|Overall Study|Reason not Specified|7|||
146387742|NCT02127970|527920071|FG000|Overall Study|Adverse Event|2|||
146387743|NCT02127970|527920072|FG001|Overall Study|Adverse Event|1|||
146387744|NCT02127970|527920071|FG000|Overall Study|Death|1|||
146387745|NCT02127970|527920072|FG001|Overall Study|Death|1|||
146387746|NCT02127970|527920071|FG000|Overall Study|Lost to Follow-up|14|||
146387747|NCT02127970|527920072|FG001|Overall Study|Lost to Follow-up|14|||
146387748|NCT02127970|527920071|FG000|Overall Study|Reason not Specified|4|||
146387749|NCT02127970|527920072|FG001|Overall Study|Reason not Specified|7|||
146387750|NCT02127970|527920071|FG000|Overall Study|Pregnancy|0|||
146387751|NCT02127970|527920072|FG001|Overall Study|Pregnancy|1|||
146387752|NCT02127970|527920071|FG000|Overall Study|Subject Withdrew Consent|5|||
146387753|NCT02127970|527920072|FG001|Overall Study|Subject Withdrew Consent|3|||
146387754|NCT01710709|527920073|FG000|Overall Study|Lost to Follow-up|29|||
146387755|NCT01710709|527920073|FG000|Overall Study|Adverse Event|48|||
146387756|NCT01710709|527920073|FG000|Overall Study|Participant met withdrawal criteria|33|||
146387757|NCT01710709|527920073|FG000|Overall Study|Participant withdrawn by investigator|2|||
146387758|NCT01710709|527920073|FG000|Overall Study|Withdrawal by Subject|53|||
146387759|NCT01710709|527920073|FG000|Overall Study|Protocol Violation|5|||
146387760|NCT01710709|527920073|FG000|Overall Study|Lack of Efficacy|3|||
146387761|NCT00542321|527920075|FG000|Overall Study|Death|0|||
146387762|NCT00542321|527920076|FG001|Overall Study|Death|1|||
146387763|NCT02988115|527920083|FG000|Overall Study|Adverse Event|6|||
146387764|NCT02988115|527920084|FG001|Overall Study|Adverse Event|1|||
146387765|NCT02988115|527920083|FG000|Overall Study|Sponsor Decision|5|||
146387766|NCT02988115|527920084|FG001|Overall Study|Sponsor Decision|2|||
146387767|NCT02988115|527920083|FG000|Overall Study|Withdrawal by Subject|1|||
146387768|NCT02988115|527920084|FG001|Overall Study|Withdrawal by Subject|1|||
146387769|NCT02988115|527920083|FG000|Overall Study|Withdrawn by Mistake|1|||
146387770|NCT02988115|527920084|FG001|Overall Study|Withdrawn by Mistake|0|||
146387771|NCT02988115|527920083|FG000|Overall Study|Lost to Follow-up|1|||
146387772|NCT02988115|527920084|FG001|Overall Study|Lost to Follow-up|0|||
146387773|NCT01731951|527920085|FG000|Overall Study|Documented Disease Progression|1|||
146387774|NCT01731951|527920086|FG001|Overall Study|Documented Disease Progression|0|||
146387775|NCT01731951|527920087|FG002|Overall Study|Documented Disease Progression|0|||
146387776|NCT01731951|527920088|FG003|Overall Study|Documented Disease Progression|0|||
146387777|NCT01731951|527920089|FG004|Overall Study|Documented Disease Progression|0|||
146387778|NCT01731951|527920090|FG005|Overall Study|Documented Disease Progression|0|||
146387779|NCT01731951|527920085|FG000|Overall Study|Lost to Follow-up|2|||
146387780|NCT01731951|527920086|FG001|Overall Study|Lost to Follow-up|0|||
146387781|NCT01731951|527920087|FG002|Overall Study|Lost to Follow-up|0|||
146387782|NCT01731951|527920088|FG003|Overall Study|Lost to Follow-up|1|||
146387783|NCT01731951|527920089|FG004|Overall Study|Lost to Follow-up|3|||
146387784|NCT01731951|527920090|FG005|Overall Study|Lost to Follow-up|1|||
146387785|NCT01731951|527920085|FG000|Overall Study|Withdrawal of Consent|1|||
146387786|NCT01731951|527920086|FG001|Overall Study|Withdrawal of Consent|0|||
146387787|NCT01731951|527920087|FG002|Overall Study|Withdrawal of Consent|0|||
146387788|NCT01731951|527920088|FG003|Overall Study|Withdrawal of Consent|0|||
146387789|NCT01731951|527920089|FG004|Overall Study|Withdrawal of Consent|0|||
146387790|NCT01731951|527920090|FG005|Overall Study|Withdrawal of Consent|2|||
146387791|NCT01731951|527920085|FG000|Overall Study|Death|13|||
146387792|NCT01731951|527920086|FG001|Overall Study|Death|15|||
146387793|NCT01731951|527920087|FG002|Overall Study|Death|9|||
146387794|NCT01731951|527920088|FG003|Overall Study|Death|8|||
146387795|NCT01731951|527920089|FG004|Overall Study|Death|9|||
146387796|NCT01731951|527920090|FG005|Overall Study|Death|6|||
146387797|NCT00253747|527920091|FG000|Overall Study|Lost to Follow-up|13|||
146387798|NCT00253747|527920092|FG001|Overall Study|Lost to Follow-up|14|||
146387799|NCT00253747|527920091|FG000|Overall Study|Withdrawal by Subject|10|||
146387800|NCT00253747|527920092|FG001|Overall Study|Withdrawal by Subject|11|||
146387801|NCT00253747|527920091|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
146387802|NCT00253747|527920092|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
146387803|NCT00104299|527920093|FG000|Overall Study|Adverse Event|3|||
146387804|NCT00104299|527920094|FG001|Overall Study|Adverse Event|1|||
146387805|NCT00104299|527920093|FG000|Overall Study|Death|2|||
146387806|NCT00104299|527920094|FG001|Overall Study|Death|2|||
146387807|NCT00104299|527920093|FG000|Overall Study|Withdrawal by Subject|2|||
146387808|NCT00104299|527920094|FG001|Overall Study|Withdrawal by Subject|6|||
146387809|NCT00104299|527920093|FG000|Overall Study|Physician Decision|1|||
146387810|NCT00104299|527920094|FG001|Overall Study|Physician Decision|1|||
146387811|NCT00104299|527920093|FG000|Overall Study|To have renal transplant|1|||
146387812|NCT00104299|527920094|FG001|Overall Study|To have renal transplant|0|||
146387813|NCT02452034|527920095|FG000|Overall Study|Adverse Event|0|||
146387814|NCT02452034|527920096|FG001|Overall Study|Adverse Event|0|||
146387815|NCT02452034|527920097|FG002|Overall Study|Adverse Event|0|||
146387816|NCT02452034|527920098|FG003|Overall Study|Adverse Event|0|||
146387817|NCT02452034|527920099|FG004|Overall Study|Adverse Event|0|||
146387818|NCT02452034|527920100|FG005|Overall Study|Adverse Event|1|||
146387819|NCT02452034|527920095|FG000|Overall Study|Death|0|||
146387820|NCT02452034|527920096|FG001|Overall Study|Death|0|||
146387821|NCT02452034|527920097|FG002|Overall Study|Death|0|||
146387822|NCT02452034|527920098|FG003|Overall Study|Death|0|||
146387823|NCT02452034|527920099|FG004|Overall Study|Death|1|||
146387824|NCT02452034|527920100|FG005|Overall Study|Death|1|||
146387825|NCT02452034|527920095|FG000|Overall Study|Physician Decision|0|||
146387826|NCT02452034|527920096|FG001|Overall Study|Physician Decision|1|||
146387827|NCT02452034|527920097|FG002|Overall Study|Physician Decision|1|||
146387828|NCT02452034|527920098|FG003|Overall Study|Physician Decision|0|||
146387829|NCT02452034|527920099|FG004|Overall Study|Physician Decision|0|||
146387830|NCT02452034|527920100|FG005|Overall Study|Physician Decision|0|||
146387831|NCT02452034|527920095|FG000|Overall Study|Protocol Violation|0|||
146387832|NCT02452034|527920096|FG001|Overall Study|Protocol Violation|0|||
146387833|NCT02452034|527920097|FG002|Overall Study|Protocol Violation|0|||
146387834|NCT02452034|527920098|FG003|Overall Study|Protocol Violation|0|||
146387835|NCT02452034|527920099|FG004|Overall Study|Protocol Violation|0|||
146387836|NCT02452034|527920100|FG005|Overall Study|Protocol Violation|1|||
146387837|NCT02452034|527920095|FG000|Overall Study|Screen Failure|1|||
146387838|NCT02452034|527920096|FG001|Overall Study|Screen Failure|0|||
146387839|NCT02452034|527920097|FG002|Overall Study|Screen Failure|0|||
146387840|NCT02452034|527920098|FG003|Overall Study|Screen Failure|1|||
146387841|NCT02452034|527920099|FG004|Overall Study|Screen Failure|0|||
146387842|NCT02452034|527920100|FG005|Overall Study|Screen Failure|0|||
146387843|NCT02452034|527920095|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
146387844|NCT02452034|527920096|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
146387845|NCT02452034|527920097|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
146387846|NCT02452034|527920098|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
146387847|NCT02452034|527920099|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
146387848|NCT02452034|527920100|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
146387849|NCT02630459|527920104|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387850|NCT02630459|527920105|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
146387851|NCT02630459|527920106|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387852|NCT02630459|527920107|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
146387853|NCT02630459|527920108|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387854|NCT02630459|527920109|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387855|NCT02630459|527920110|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387856|NCT02630459|527920111|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
146387857|NCT02630459|527920104|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387858|NCT02630459|527920105|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387859|NCT02630459|527920106|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
146387860|NCT02630459|527920107|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387861|NCT02630459|527920108|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387862|NCT02630459|527920109|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387863|NCT02630459|527920110|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387864|NCT02630459|527920111|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
146387865|NCT02630459|527920104|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
146387866|NCT02630459|527920105|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
146387867|NCT02630459|527920106|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
146387868|NCT02630459|527920107|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
146387869|NCT02630459|527920108|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146387870|NCT02630459|527920109|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146387871|NCT02630459|527920110|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146387872|NCT02630459|527920111|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
146387873|NCT02630459|527920104|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
146387874|NCT02630459|527920105|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387875|NCT02630459|527920106|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387876|NCT02630459|527920107|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387877|NCT02630459|527920108|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387878|NCT02630459|527920109|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387879|NCT02630459|527920110|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387880|NCT02630459|527920111|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
146387881|NCT02630459|527920104|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387882|NCT02630459|527920105|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387883|NCT02630459|527920106|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387884|NCT02630459|527920107|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387885|NCT02630459|527920108|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
146387886|NCT02630459|527920109|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
146387887|NCT02630459|527920110|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387888|NCT02630459|527920111|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
146387889|NCT02630459|527920104|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387890|NCT02630459|527920105|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387891|NCT02630459|527920106|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387892|NCT02630459|527920107|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387893|NCT02630459|527920108|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
146387894|NCT02630459|527920109|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
146387895|NCT02630459|527920110|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387896|NCT02630459|527920111|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
146387897|NCT02630459|527920104|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387898|NCT02630459|527920105|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387899|NCT02630459|527920106|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387900|NCT02630459|527920107|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387901|NCT02630459|527920108|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
146387902|NCT02630459|527920109|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387903|NCT02630459|527920110|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387904|NCT02630459|527920111|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
146387905|NCT00125138|527920112|FG000|Overall Study|Adverse Event|1|||
146387906|NCT00125138|527920113|FG001|Overall Study|Adverse Event|0|||
146387907|NCT00125138|527920114|FG002|Overall Study|Adverse Event|3|||
146387908|NCT00125138|527920115|FG003|Overall Study|Adverse Event|2|||
146387909|NCT00125138|527920112|FG000|Overall Study|Withdrawal by Subject|2|||
146387910|NCT00125138|527920113|FG001|Overall Study|Withdrawal by Subject|3|||
146387911|NCT00125138|527920114|FG002|Overall Study|Withdrawal by Subject|1|||
146387912|NCT00125138|527920115|FG003|Overall Study|Withdrawal by Subject|1|||
146387913|NCT00125138|527920112|FG000|Overall Study|Lack of Efficacy|0|||
146387914|NCT00125138|527920113|FG001|Overall Study|Lack of Efficacy|0|||
146387915|NCT00125138|527920114|FG002|Overall Study|Lack of Efficacy|0|||
146387916|NCT00125138|527920115|FG003|Overall Study|Lack of Efficacy|1|||
146387917|NCT00125138|527920112|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
146387918|NCT00125138|527920113|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
146387919|NCT00125138|527920114|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
146387920|NCT00125138|527920115|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
146387921|NCT00348686|527920118|FG000|Overall Study|Withdrawal by Subject|45|||
146387922|NCT00348686|527920118|FG000|Overall Study|Adverse Event|5|||
146387923|NCT00348686|527920118|FG000|Overall Study|Protocol Violation|6|||
146387924|NCT00348686|527920118|FG000|Overall Study|Lost to Follow-up|2|||
146387925|NCT00348686|527920118|FG000|Overall Study|Multiple Reasons|8|||
146387926|NCT01258738|527920121|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
146387927|NCT01258738|527920122|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
146387928|NCT01258738|527920121|FG000|Double-blind Period|Withdrawal by Subject|2|||
146387929|NCT01258738|527920122|FG001|Double-blind Period|Withdrawal by Subject|2|||
146387930|NCT01258738|527920121|FG000|Double-blind Period|Protocol Violation|1|||
146387931|NCT01258738|527920122|FG001|Double-blind Period|Protocol Violation|1|||
146387932|NCT01258738|527920121|FG000|Double-blind Period|Adverse Event|3|||
146387933|NCT01258738|527920122|FG001|Double-blind Period|Adverse Event|1|||
146387934|NCT01258738|527920121|FG000|Open-label Period|Did not meet inclusion criteria|0|||
146387935|NCT01258738|527920122|FG001|Open-label Period|Did not meet inclusion criteria|1|||
146387936|NCT01258738|527920121|FG000|Open-label Period|Insufficient clinical response|5|||
146387937|NCT01258738|527920122|FG001|Open-label Period|Insufficient clinical response|3|||
146387938|NCT01258738|527920121|FG000|Open-label Period|Lost to Follow-up|0|||
146387939|NCT01258738|527920122|FG001|Open-label Period|Lost to Follow-up|2|||
146387940|NCT01258738|527920121|FG000|Open-label Period|Withdrawal by Subject|5|||
146387941|NCT01258738|527920122|FG001|Open-label Period|Withdrawal by Subject|6|||
146387942|NCT01258738|527920121|FG000|Open-label Period|Protocol Violation|2|||
146387943|NCT01258738|527920122|FG001|Open-label Period|Protocol Violation|2|||
146387944|NCT01258738|527920121|FG000|Open-label Period|Adverse Event|4|||
146387945|NCT01258738|527920122|FG001|Open-label Period|Adverse Event|5|||
146387946|NCT01258738|527920121|FG000|Open-label Period|Other Reasons|0|||
146387947|NCT01258738|527920122|FG001|Open-label Period|Other Reasons|1|||
146387948|NCT01258738|527920121|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
146387949|NCT01258738|527920122|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
146387950|NCT02418000|527920123|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
146387951|NCT02418000|527920124|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387952|NCT02418000|527920125|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387953|NCT02418000|527920126|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387954|NCT02418000|527920127|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387955|NCT02418000|527920123|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
146387956|NCT02418000|527920124|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146387957|NCT02418000|527920125|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146387958|NCT02418000|527920126|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146387959|NCT02418000|527920127|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
146387960|NCT02418000|527920123|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
146387961|NCT02418000|527920124|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146387962|NCT02418000|527920125|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146387963|NCT02418000|527920126|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146387964|NCT02418000|527920127|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
146387965|NCT02418000|527920123|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387966|NCT02418000|527920124|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
146387967|NCT02418000|527920125|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387968|NCT02418000|527920126|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387969|NCT02418000|527920127|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
146387970|NCT02418000|527920123|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146387971|NCT02418000|527920124|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
146387972|NCT02418000|527920125|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146387973|NCT02418000|527920126|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146387974|NCT02418000|527920127|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
146387975|NCT02418000|527920123|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387976|NCT02418000|527920124|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387977|NCT02418000|527920125|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146387978|NCT02418000|527920126|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387979|NCT02418000|527920127|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387980|NCT02418000|527920123|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387981|NCT02418000|527920124|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387982|NCT02418000|527920125|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387983|NCT02418000|527920126|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146387984|NCT02418000|527920127|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387985|NCT02418000|527920123|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146387986|NCT02418000|527920124|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146387987|NCT02418000|527920125|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146387988|NCT02418000|527920126|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
146387989|NCT02418000|527920127|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
146387990|NCT02418000|527920123|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387991|NCT02418000|527920124|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387992|NCT02418000|527920125|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387993|NCT02418000|527920126|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
146387994|NCT02418000|527920127|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
146387995|NCT00689611|527920128|FG000|Overall Study|Death|6|||
146387996|NCT00689611|527920129|FG001|Overall Study|Death|9|||
146387997|NCT00689611|527920128|FG000|Overall Study|Withdrawal by Subject|8|||
146387998|NCT00689611|527920129|FG001|Overall Study|Withdrawal by Subject|9|||
146387999|NCT00689611|527920128|FG000|Overall Study|Lost to Follow-up|27|||
146388000|NCT00689611|527920129|FG001|Overall Study|Lost to Follow-up|28|||
146388001|NCT00490815|527920130|FG000|Overall Study|Adverse Event|2|||
146388002|NCT00490815|527920131|FG001|Overall Study|Adverse Event|3|||
146388003|NCT00490815|527920130|FG000|Overall Study|Withdrawal by Subject|4|||
146388004|NCT00490815|527920131|FG001|Overall Study|Withdrawal by Subject|0|||
146388005|NCT00490815|527920130|FG000|Overall Study|Lost to Follow-up|1|||
146388006|NCT00490815|527920131|FG001|Overall Study|Lost to Follow-up|3|||
146388007|NCT00490815|527920130|FG000|Overall Study|Death|1|||
146388008|NCT00490815|527920131|FG001|Overall Study|Death|3|||
146388009|NCT00732199|527920144|FG000|Overall Study|Withdrawal by Subject|25|||
146388010|NCT00732199|527920145|FG001|Overall Study|Withdrawal by Subject|18|||
146388011|NCT00732199|527920144|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
146388012|NCT00732199|527920145|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
146388013|NCT03644173|527920156|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
146388014|NCT03644173|527920156|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
146388015|NCT03644173|527920156|FG000|Participants at the 1-month Follow up|Death|2|||
146388016|NCT03644173|527920156|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
146388017|NCT03500419|527920159|FG000|Overall Study|Withdrawal by Subject|2|||
146388018|NCT03500419|527920160|FG001|Overall Study|Withdrawal by Subject|25|||
146388019|NCT00256204|527920173|FG000|Overall Study|Adverse Event|10|||
146388020|NCT00256204|527920174|FG001|Overall Study|Adverse Event|14|||
146388021|NCT00256204|527920175|FG002|Overall Study|Adverse Event|16|||
146388022|NCT00256204|527920176|FG003|Overall Study|Adverse Event|14|||
146388023|NCT00256204|527920173|FG000|Overall Study|Death|0|||
146388024|NCT00256204|527920174|FG001|Overall Study|Death|1|||
146388025|NCT00256204|527920175|FG002|Overall Study|Death|0|||
146388026|NCT00256204|527920176|FG003|Overall Study|Death|0|||
146388027|NCT00256204|527920173|FG000|Overall Study|Lost to Follow-up|1|||
146388028|NCT00256204|527920174|FG001|Overall Study|Lost to Follow-up|1|||
146388029|NCT00256204|527920175|FG002|Overall Study|Lost to Follow-up|1|||
146388030|NCT00256204|527920176|FG003|Overall Study|Lost to Follow-up|2|||
146388031|NCT00256204|527920173|FG000|Overall Study|Protocol Violation|1|||
146388032|NCT00256204|527920174|FG001|Overall Study|Protocol Violation|0|||
146388033|NCT00256204|527920175|FG002|Overall Study|Protocol Violation|2|||
146388034|NCT00256204|527920176|FG003|Overall Study|Protocol Violation|1|||
146388035|NCT00256204|527920173|FG000|Overall Study|Physician Decision|0|||
146388036|NCT00256204|527920174|FG001|Overall Study|Physician Decision|0|||
146388037|NCT00256204|527920175|FG002|Overall Study|Physician Decision|1|||
146388038|NCT00256204|527920176|FG003|Overall Study|Physician Decision|2|||
146388039|NCT00256204|527920173|FG000|Overall Study|Withdrawal by Subject|17|||
146388040|NCT00256204|527920174|FG001|Overall Study|Withdrawal by Subject|6|||
146388041|NCT00256204|527920175|FG002|Overall Study|Withdrawal by Subject|7|||
146388042|NCT00256204|527920176|FG003|Overall Study|Withdrawal by Subject|5|||
146388043|NCT00256204|527920173|FG000|Overall Study|Need for additional prohibited treatment|38|||
146388044|NCT00256204|527920174|FG001|Overall Study|Need for additional prohibited treatment|28|||
146388045|NCT00256204|527920175|FG002|Overall Study|Need for additional prohibited treatment|27|||
146388046|NCT00256204|527920176|FG003|Overall Study|Need for additional prohibited treatment|25|||
146388047|NCT02177942|527920181|FG000|Overall Study|Adverse Event|1|||
146388048|NCT02177942|527920182|FG001|Overall Study|Adverse Event|0|||
146388049|NCT02177942|527920181|FG000|Overall Study|Lost to Follow-up|1|||
146388050|NCT02177942|527920182|FG001|Overall Study|Lost to Follow-up|1|||
146388051|NCT02177942|527920181|FG000|Overall Study|Protocol Violation|4|||
146388052|NCT02177942|527920182|FG001|Overall Study|Protocol Violation|6|||
146388053|NCT02177942|527920181|FG000|Overall Study|Withdrawal by Subject|71|||
146388054|NCT02177942|527920182|FG001|Overall Study|Withdrawal by Subject|81|||
146388055|NCT01234337|527920183|FG000|Overall Study|Adverse Event|58|||
146388056|NCT01234337|527920184|FG001|Overall Study|Adverse Event|21|||
146388057|NCT01234337|527920183|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
146388058|NCT01234337|527920184|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
146388059|NCT01234337|527920183|FG000|Overall Study|Investi. decision not protocol driven|5|||
146388060|NCT01234337|527920184|FG001|Overall Study|Investi. decision not protocol driven|6|||
146388061|NCT01234337|527920183|FG000|Overall Study|Non-compliant with study medication|3|||
146388062|NCT01234337|527920184|FG001|Overall Study|Non-compliant with study medication|2|||
146388063|NCT01234337|527920183|FG000|Overall Study|Randomized but not treated|6|||
146388064|NCT01234337|527920184|FG001|Overall Study|Randomized but not treated|4|||
146388065|NCT01234337|527920183|FG000|Overall Study|Lost to Follow-up|0|||
146388066|NCT01234337|527920184|FG001|Overall Study|Lost to Follow-up|1|||
146388067|NCT01234337|527920183|FG000|Overall Study|Protocol Violation|2|||
146388068|NCT01234337|527920184|FG001|Overall Study|Protocol Violation|3|||
146388069|NCT01234337|527920183|FG000|Overall Study|Withdrawal by Subject|11|||
146388070|NCT01234337|527920184|FG001|Overall Study|Withdrawal by Subject|9|||
146388071|NCT01234337|527920183|FG000|Overall Study|Death|0|||
146388072|NCT01234337|527920184|FG001|Overall Study|Death|1|||
146388073|NCT01234337|527920183|FG000|Overall Study|Switch to commercial drug|0|||
146388074|NCT01234337|527920184|FG001|Overall Study|Switch to commercial drug|1|||
146388075|NCT03490734|527920185|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
146388076|NCT03490734|527920186|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
146388077|NCT03490734|527920187|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
146388078|NCT03490734|527920188|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
146388079|NCT03490734|527920185|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146388080|NCT03490734|527920186|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146388081|NCT03490734|527920187|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
146388082|NCT03490734|527920188|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
146388083|NCT03490734|527920185|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146388084|NCT03490734|527920186|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146388085|NCT03490734|527920187|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
146388086|NCT03490734|527920188|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
146388087|NCT03490734|527920185|FG000|Post-intervention Scan Visit|Adverse Event|2|||
146388088|NCT03490734|527920186|FG001|Post-intervention Scan Visit|Adverse Event|0|||
146388089|NCT03490734|527920187|FG002|Post-intervention Scan Visit|Adverse Event|0|||
146388090|NCT03490734|527920188|FG003|Post-intervention Scan Visit|Adverse Event|0|||
146388091|NCT03490734|527920185|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
146388092|NCT03490734|527920186|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
146388093|NCT03490734|527920187|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
146388094|NCT03490734|527920188|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
146388095|NCT03490734|527920185|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
146388096|NCT03490734|527920186|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
146388097|NCT03490734|527920187|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
146388098|NCT03490734|527920188|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
146388099|NCT01277666|527920194|FG000|Overall Study|Adverse Event|26|||
146388100|NCT01277666|527920195|FG001|Overall Study|Adverse Event|25|||
146388101|NCT01277666|527920196|FG002|Overall Study|Adverse Event|20|||
146388102|NCT01277666|527920194|FG000|Overall Study|Lack of Efficacy|8|||
146388103|NCT01277666|527920195|FG001|Overall Study|Lack of Efficacy|20|||
146388104|NCT01277666|527920196|FG002|Overall Study|Lack of Efficacy|12|||
146388105|NCT01277666|527920194|FG000|Overall Study|Protocol Violation|2|||
146388106|NCT01277666|527920195|FG001|Overall Study|Protocol Violation|3|||
146388107|NCT01277666|527920196|FG002|Overall Study|Protocol Violation|2|||
146388108|NCT01277666|527920194|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
146388109|NCT01277666|527920195|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
146388110|NCT01277666|527920196|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
146388111|NCT01277666|527920194|FG000|Overall Study|Lost to Follow-up|1|||
146388112|NCT01277666|527920195|FG001|Overall Study|Lost to Follow-up|1|||
146388113|NCT01277666|527920196|FG002|Overall Study|Lost to Follow-up|2|||
146388114|NCT01277666|527920194|FG000|Overall Study|Withdrawal by Subject|7|||
146388115|NCT01277666|527920195|FG001|Overall Study|Withdrawal by Subject|8|||
146388116|NCT01277666|527920196|FG002|Overall Study|Withdrawal by Subject|6|||
146388117|NCT01277666|527920194|FG000|Overall Study|Death|0|||
146388118|NCT01277666|527920195|FG001|Overall Study|Death|0|||
146388119|NCT01277666|527920196|FG002|Overall Study|Death|1|||
146388120|NCT01385098|527920197|FG000|Overall Study|Adverse Event|10|||
146388121|NCT01385098|527920197|FG000|Overall Study|Lost to Follow-up|4|||
146388122|NCT01084096|527922406|FG000|Overall Study|Lost to Follow-up|1501|||
146388123|NCT01084096|527922407|FG001|Overall Study|Lost to Follow-up|1833|||
146388124|NCT01084096|527922406|FG000|Overall Study|Withdrawal by Subject|3|||
146388125|NCT01084096|527922407|FG001|Overall Study|Withdrawal by Subject|0|||
146388126|NCT01084096|527922406|FG000|Overall Study|Woman had a miscarriage|21|||
146388127|NCT01084096|527922407|FG001|Overall Study|Woman had a miscarriage|17|||
146388128|NCT00027846|527922408|FG000|Overall Study|Lost to Follow-up|0|||
146388129|NCT00027846|527922409|FG001|Overall Study|Lost to Follow-up|41|||
146388130|NCT00027846|527922410|FG002|Overall Study|Lost to Follow-up|9|||
146388131|NCT00027846|527922408|FG000|Overall Study|Withdrawal by Subject|0|||
146388132|NCT00027846|527922409|FG001|Overall Study|Withdrawal by Subject|14|||
146388133|NCT00027846|527922410|FG002|Overall Study|Withdrawal by Subject|7|||
146388134|NCT00027846|527922408|FG000|Overall Study|Ineligible for study|2|||
146388135|NCT00027846|527922409|FG001|Overall Study|Ineligible for study|6|||
146388136|NCT00027846|527922410|FG002|Overall Study|Ineligible for study|14|||
146388137|NCT00027846|527922408|FG000|Overall Study|Entry into another COG therapeutic study|0|||
146388138|NCT00027846|527922409|FG001|Overall Study|Entry into another COG therapeutic study|5|||
146388139|NCT00027846|527922410|FG002|Overall Study|Entry into another COG therapeutic study|2|||
146388140|NCT00027846|527922408|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
146388141|NCT00027846|527922409|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
146388142|NCT00027846|527922410|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
146388143|NCT01354964|527922411|FG000|Overall Study|Lost to Follow-up|2|||
146388144|NCT01354964|527922412|FG001|Overall Study|Lost to Follow-up|0|||
146388145|NCT01354964|527922411|FG000|Overall Study|IV access issues|1|||
146388146|NCT01354964|527922412|FG001|Overall Study|IV access issues|1|||
146388147|NCT01354964|527922411|FG000|Overall Study|Physician Decision|1|||
146388148|NCT01354964|527922412|FG001|Overall Study|Physician Decision|0|||
146388149|NCT04067310|527922414|FG000|Overall Study|Physician Decision|2|||
146388150|NCT04067310|527922415|FG001|Overall Study|Physician Decision|6|||
146388151|NCT04067310|527922414|FG000|Overall Study|Lost to Follow-up|0|||
146388152|NCT04067310|527922415|FG001|Overall Study|Lost to Follow-up|1|||
146388153|NCT04067310|527922414|FG000|Overall Study|Withdrawal by Subject|3|||
146388154|NCT04067310|527922415|FG001|Overall Study|Withdrawal by Subject|0|||
146388155|NCT01249404|527922416|FG000|Overall Study|Study treatment not received|0|||
146388156|NCT01249404|527922417|FG001|Overall Study|Study treatment not received|1|||
146388157|NCT01249404|527922418|FG002|Overall Study|Study treatment not received|2|||
146388158|NCT01249404|527922416|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
146388159|NCT01249404|527922417|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
146388160|NCT01249404|527922418|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
146388161|NCT01249404|527922416|FG000|Overall Study|Adverse Event|2|||
146388162|NCT01249404|527922417|FG001|Overall Study|Adverse Event|2|||
146388163|NCT01249404|527922418|FG002|Overall Study|Adverse Event|2|||
146388164|NCT01249404|527922416|FG000|Overall Study|Withdrawal by Subject|2|||
146388165|NCT01249404|527922417|FG001|Overall Study|Withdrawal by Subject|2|||
146388166|NCT01249404|527922418|FG002|Overall Study|Withdrawal by Subject|0|||
146388167|NCT01249404|527922416|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
146388168|NCT01249404|527922417|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
146388169|NCT01249404|527922418|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
146388170|NCT01249404|527922416|FG000|Overall Study|Non compliance to visit schedule|0|||
146388171|NCT01249404|527922417|FG001|Overall Study|Non compliance to visit schedule|1|||
146388172|NCT01249404|527922418|FG002|Overall Study|Non compliance to visit schedule|0|||
146388173|NCT02493712|527922419|FG000|Overall Study|Withdrawal by Subject|1|||
146388174|NCT02493712|527922420|FG001|Overall Study|Withdrawal by Subject|0|||
146388175|NCT02493712|527922421|FG002|Overall Study|Withdrawal by Subject|2|||
146388176|NCT02493712|527922419|FG000|Overall Study|Protocol Violation|0|||
146388177|NCT02493712|527922420|FG001|Overall Study|Protocol Violation|0|||
146388178|NCT02493712|527922421|FG002|Overall Study|Protocol Violation|1|||
146388179|NCT02493712|527922419|FG000|Overall Study|Lost to Follow-up|1|||
146388180|NCT02493712|527922420|FG001|Overall Study|Lost to Follow-up|0|||
146388181|NCT02493712|527922421|FG002|Overall Study|Lost to Follow-up|0|||
146388182|NCT02493712|527922419|FG000|Overall Study|Physician Decision|0|||
146388183|NCT02493712|527922420|FG001|Overall Study|Physician Decision|1|||
146388184|NCT02493712|527922421|FG002|Overall Study|Physician Decision|0|||
146388185|NCT02493712|527922419|FG000|Overall Study|Lack of Efficacy|0|||
146388186|NCT02493712|527922420|FG001|Overall Study|Lack of Efficacy|5|||
146388187|NCT02493712|527922421|FG002|Overall Study|Lack of Efficacy|3|||
146388188|NCT03890731|527922422|FG000|Overall Study|Progressive disease|1|||
146388189|NCT03890731|527922422|FG000|Overall Study|Patient's decision|1|||
146388190|NCT03890731|527922422|FG000|Overall Study|Adverse Event|4|||
146388191|NCT02058940|527922423|FG000|Overall Study|Discharged from Critical Care Unit|1|||
146388192|NCT01640353|527922434|FG000|Overall Study|Withdrew prior to treatment|10|||
146388193|NCT01640353|527922434|FG000|Overall Study|Withdrawn from analysis at term site|12|||
146388194|NCT01640353|527922434|FG000|Overall Study|Withdrawal by Subject|5|||
146388195|NCT01640353|527922434|FG000|Overall Study|Death|2|||
146388196|NCT01640353|527922434|FG000|Overall Study|Early site termination|3|||
146388197|NCT01640353|527922434|FG000|Overall Study|Lost to Follow-up|12|||
146388198|NCT01640353|527922434|FG000|Overall Study|Physician Decision|1|||
146388199|NCT01524900|527922435|FG000|Overall Study|Lost to Follow-up|3|||
146388200|NCT01524900|527922436|FG001|Overall Study|Lost to Follow-up|12|||
146388201|NCT01524900|527922437|FG002|Overall Study|Lost to Follow-up|1|||
146388202|NCT01524900|527922438|FG003|Overall Study|Lost to Follow-up|0|||
146388203|NCT01524900|527922439|FG004|Overall Study|Lost to Follow-up|0|||
146388204|NCT01524900|527922435|FG000|Overall Study|Other reason than stated above|1|||
146388205|NCT01524900|527922436|FG001|Overall Study|Other reason than stated above|1|||
146388206|NCT01524900|527922437|FG002|Overall Study|Other reason than stated above|0|||
146388207|NCT01524900|527922438|FG003|Overall Study|Other reason than stated above|0|||
146388208|NCT01524900|527922439|FG004|Overall Study|Other reason than stated above|0|||
146388209|NCT01524900|527922435|FG000|Overall Study|No reason documented|2|||
146388210|NCT01524900|527922436|FG001|Overall Study|No reason documented|1|||
146388211|NCT01524900|527922437|FG002|Overall Study|No reason documented|0|||
146388212|NCT01524900|527922438|FG003|Overall Study|No reason documented|1|||
146388213|NCT01524900|527922439|FG004|Overall Study|No reason documented|0|||
146388214|NCT03758612|527922440|FG000|Washout Period|Withdrawal by Subject|0|||
146388215|NCT03758612|527922441|FG001|Washout Period|Withdrawal by Subject|0|||
146388216|NCT03758612|527922442|FG002|Washout Period|Withdrawal by Subject|2|||
146388217|NCT03758612|527922443|FG003|Washout Period|Withdrawal by Subject|0|||
146388218|NCT03758612|527922444|FG004|Washout Period|Withdrawal by Subject|0|||
146388219|NCT03758612|527922445|FG005|Washout Period|Withdrawal by Subject|0|||
146388220|NCT03758612|527922446|FG006|Washout Period|Withdrawal by Subject|0|||
146388221|NCT03758612|527922447|FG007|Washout Period|Withdrawal by Subject|0|||
146388222|NCT03758612|527922448|FG008|Washout Period|Withdrawal by Subject|0|||
146388223|NCT03758612|527922449|FG009|Washout Period|Withdrawal by Subject|0|||
146388224|NCT03758612|527922450|FG010|Washout Period|Withdrawal by Subject|0|||
146388225|NCT03758612|527922451|FG011|Washout Period|Withdrawal by Subject|0|||
146388226|NCT03758612|527922440|FG000|Period 2|Protocol Violation|0|||
146388227|NCT03758612|527922441|FG001|Period 2|Protocol Violation|0|||
146388228|NCT03758612|527922442|FG002|Period 2|Protocol Violation|0|||
146388229|NCT03758612|527922443|FG003|Period 2|Protocol Violation|0|||
146388230|NCT03758612|527922444|FG004|Period 2|Protocol Violation|1|||
146388231|NCT03758612|527922445|FG005|Period 2|Protocol Violation|0|||
146388232|NCT03758612|527922446|FG006|Period 2|Protocol Violation|0|||
146388233|NCT03758612|527922447|FG007|Period 2|Protocol Violation|0|||
146388234|NCT03758612|527922448|FG008|Period 2|Protocol Violation|0|||
146388235|NCT03758612|527922449|FG009|Period 2|Protocol Violation|0|||
146388236|NCT03758612|527922450|FG010|Period 2|Protocol Violation|0|||
146388237|NCT03758612|527922451|FG011|Period 2|Protocol Violation|0|||
146388238|NCT02500901|527922454|FG000|Overall Study|Disease ProgressionDD|2|||
146388239|NCT03633461|527922468|FG000|Overall Study|Lost to Follow-up|0|||
146388240|NCT03633461|527922469|FG001|Overall Study|Lost to Follow-up|1|||
146388241|NCT03938857|527922476|FG000|Overall Study|Physician Decision|1|||
146388242|NCT03938857|527922477|FG001|Overall Study|Physician Decision|0|||
146388243|NCT03938857|527922478|FG002|Overall Study|Physician Decision|0|||
146388244|NCT03938857|527922479|FG003|Overall Study|Physician Decision|0|||
146388245|NCT01904760|527922484|FG000|Overall Study|Protocol Violation|1|||
146388246|NCT01904760|527922485|FG001|Overall Study|Protocol Violation|0|||
146388247|NCT04249076|527922495|FG000|Overall Study|Adverse Event|1|||
146388248|NCT04249076|527922496|FG001|Overall Study|Adverse Event|1|||
146388249|NCT04249076|527922495|FG000|Overall Study|Protocol Violation|1|||
146388250|NCT04249076|527922496|FG001|Overall Study|Protocol Violation|2|||
146388251|NCT04249076|527922495|FG000|Overall Study|Lack of Efficacy|0|||
146388252|NCT04249076|527922496|FG001|Overall Study|Lack of Efficacy|1|||
146388253|NCT04249076|527922495|FG000|Overall Study|Withdrawal by Subject|0|||
146388254|NCT04249076|527922496|FG001|Overall Study|Withdrawal by Subject|1|||
146388255|NCT00783263|527922497|FG000|Overall Study|Adverse Event|3|||
146388256|NCT00783263|527922498|FG001|Overall Study|Adverse Event|0|||
146388257|NCT00783263|527922499|FG002|Overall Study|Adverse Event|2|||
146388258|NCT00783263|527922500|FG003|Overall Study|Adverse Event|1|||
146388259|NCT00783263|527922497|FG000|Overall Study|Lost to Follow-up|1|||
146388260|NCT00783263|527922498|FG001|Overall Study|Lost to Follow-up|1|||
146388261|NCT00783263|527922499|FG002|Overall Study|Lost to Follow-up|0|||
146388262|NCT00783263|527922500|FG003|Overall Study|Lost to Follow-up|0|||
146388263|NCT00783263|527922497|FG000|Overall Study|Withdrawal by Subject|0|||
146388264|NCT00783263|527922498|FG001|Overall Study|Withdrawal by Subject|1|||
146388265|NCT00783263|527922499|FG002|Overall Study|Withdrawal by Subject|1|||
146388266|NCT00783263|527922500|FG003|Overall Study|Withdrawal by Subject|2|||
146388267|NCT00106626|527922501|FG000|Overall Study|Adverse Event|5|||
146388268|NCT00106626|527922502|FG001|Overall Study|Adverse Event|4|||
146388269|NCT00106626|527922503|FG002|Overall Study|Adverse Event|3|||
146388270|NCT00106626|527922504|FG003|Overall Study|Adverse Event|3|||
146388271|NCT00106626|527922501|FG000|Overall Study|Progressive Disease|4|||
146388272|NCT00106626|527922502|FG001|Overall Study|Progressive Disease|1|||
146388273|NCT00106626|527922503|FG002|Overall Study|Progressive Disease|9|||
146388274|NCT00106626|527922504|FG003|Overall Study|Progressive Disease|10|||
146388275|NCT00106626|527922501|FG000|Overall Study|Received radiation on new therapy|1|||
146388276|NCT00106626|527922502|FG001|Overall Study|Received radiation on new therapy|0|||
146388277|NCT00106626|527922503|FG002|Overall Study|Received radiation on new therapy|0|||
146388278|NCT00106626|527922504|FG003|Overall Study|Received radiation on new therapy|0|||
146388279|NCT00106626|527922501|FG000|Overall Study|> 14 day delay in therapy start|0|||
146388280|NCT00106626|527922502|FG001|Overall Study|> 14 day delay in therapy start|1|||
146388281|NCT00106626|527922503|FG002|Overall Study|> 14 day delay in therapy start|0|||
146388282|NCT00106626|527922504|FG003|Overall Study|> 14 day delay in therapy start|0|||
146388283|NCT00405756|527922509|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
146388284|NCT00405756|527922510|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
146388285|NCT00405756|527922511|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
146388286|NCT00405756|527922509|FG000|Double-blind Treatment|Adverse Event|31|||
146388287|NCT00405756|527922510|FG001|Double-blind Treatment|Adverse Event|27|||
146388288|NCT00405756|527922511|FG002|Double-blind Treatment|Adverse Event|12|||
146388289|NCT00405756|527922509|FG000|Double-blind Treatment|Disease Progression|47|||
146388290|NCT00405756|527922510|FG001|Double-blind Treatment|Disease Progression|81|||
146388291|NCT00405756|527922511|FG002|Double-blind Treatment|Disease Progression|102|||
146388292|NCT00405756|527922509|FG000|Double-blind Treatment|Lack of Efficacy|1|||
146388293|NCT00405756|527922510|FG001|Double-blind Treatment|Lack of Efficacy|4|||
146388294|NCT00405756|527922511|FG002|Double-blind Treatment|Lack of Efficacy|2|||
146388295|NCT00405756|527922509|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
146388296|NCT00405756|527922510|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
146388297|NCT00405756|527922511|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
146388298|NCT00405756|527922509|FG000|Double-blind Treatment|Lost to Follow-up|1|||
146388299|NCT00405756|527922510|FG001|Double-blind Treatment|Lost to Follow-up|0|||
146388300|NCT00405756|527922511|FG002|Double-blind Treatment|Lost to Follow-up|0|||
146388301|NCT00405756|527922509|FG000|Double-blind Treatment|Death|4|||
146388302|NCT00405756|527922510|FG001|Double-blind Treatment|Death|4|||
146388303|NCT00405756|527922511|FG002|Double-blind Treatment|Death|4|||
146388304|NCT00405756|527922509|FG000|Double-blind Treatment|Protocol Violation|1|||
146388305|NCT00405756|527922510|FG001|Double-blind Treatment|Protocol Violation|0|||
146388306|NCT00405756|527922511|FG002|Double-blind Treatment|Protocol Violation|2|||
146388307|NCT00405756|527922509|FG000|Double-blind Treatment|Other|7|||
146388308|NCT00405756|527922510|FG001|Double-blind Treatment|Other|4|||
146388309|NCT00405756|527922511|FG002|Double-blind Treatment|Other|4|||
146388310|NCT00405756|527922509|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
146388311|NCT00405756|527922510|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
146388312|NCT00405756|527922511|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
146388313|NCT00405756|527922509|FG000|Open-label Extension|Adverse Event|1|||
146388314|NCT00405756|527922510|FG001|Open-label Extension|Adverse Event|3|||
146388315|NCT00405756|527922511|FG002|Open-label Extension|Adverse Event|7|||
146388316|NCT00405756|527922509|FG000|Open-label Extension|Disease Progression|8|||
146388317|NCT00405756|527922510|FG001|Open-label Extension|Disease Progression|23|||
146388318|NCT00405756|527922511|FG002|Open-label Extension|Disease Progression|26|||
146388319|NCT00405756|527922509|FG000|Open-label Extension|Withdrawal by Subject|2|||
146388320|NCT00405756|527922510|FG001|Open-label Extension|Withdrawal by Subject|3|||
146388321|NCT00405756|527922511|FG002|Open-label Extension|Withdrawal by Subject|3|||
146388322|NCT00405756|527922509|FG000|Open-label Extension|Death|1|||
146388323|NCT00405756|527922510|FG001|Open-label Extension|Death|2|||
146388324|NCT00405756|527922511|FG002|Open-label Extension|Death|4|||
146388325|NCT00405756|527922509|FG000|Open-label Extension|Other|0|||
146388326|NCT00405756|527922510|FG001|Open-label Extension|Other|1|||
146388327|NCT00405756|527922511|FG002|Open-label Extension|Other|7|||
146388328|NCT00405756|527922509|FG000|Follow-up|Ongoing in Follow-up Period|52|||
146388329|NCT00405756|527922510|FG001|Follow-up|Ongoing in Follow-up Period|51|||
146388330|NCT00405756|527922511|FG002|Follow-up|Ongoing in Follow-up Period|60|||
146388331|NCT00405756|527922509|FG000|Follow-up|Death|21|||
146388332|NCT00405756|527922510|FG001|Follow-up|Death|31|||
146388333|NCT00405756|527922511|FG002|Follow-up|Death|24|||
146388334|NCT00405756|527922509|FG000|Follow-up|Lost to Follow-up|2|||
146388335|NCT00405756|527922510|FG001|Follow-up|Lost to Follow-up|8|||
146388336|NCT00405756|527922511|FG002|Follow-up|Lost to Follow-up|4|||
146388337|NCT01117428|527922513|FG000|Overall Study|Lack of Efficacy|1|||
146388338|NCT01117428|527922514|FG001|Overall Study|Lack of Efficacy|0|||
146388339|NCT01117428|527922515|FG002|Overall Study|Lack of Efficacy|0|||
146388340|NCT01117428|527922516|FG003|Overall Study|Lack of Efficacy|0|||
146388341|NCT01117428|527922517|FG004|Overall Study|Lack of Efficacy|0|||
146388342|NCT01117428|527922518|FG005|Overall Study|Lack of Efficacy|0|||
146388343|NCT01117428|527922513|FG000|Overall Study|Adverse Event|4|||
146388344|NCT01117428|527922514|FG001|Overall Study|Adverse Event|0|||
146388345|NCT01117428|527922515|FG002|Overall Study|Adverse Event|0|||
146388346|NCT01117428|527922516|FG003|Overall Study|Adverse Event|0|||
146388347|NCT01117428|527922517|FG004|Overall Study|Adverse Event|1|||
146388348|NCT01117428|527922518|FG005|Overall Study|Adverse Event|2|||
146388349|NCT01117428|527922513|FG000|Overall Study|Death|0|||
146388350|NCT01117428|527922514|FG001|Overall Study|Death|1|||
146388351|NCT01117428|527922515|FG002|Overall Study|Death|2|||
146388352|NCT01117428|527922516|FG003|Overall Study|Death|0|||
146388353|NCT01117428|527922517|FG004|Overall Study|Death|0|||
146388354|NCT01117428|527922518|FG005|Overall Study|Death|1|||
146388355|NCT01117428|527922513|FG000|Overall Study|Physician Decision|0|||
146388356|NCT01117428|527922514|FG001|Overall Study|Physician Decision|1|||
146388357|NCT01117428|527922515|FG002|Overall Study|Physician Decision|0|||
146388358|NCT01117428|527922516|FG003|Overall Study|Physician Decision|0|||
146388359|NCT01117428|527922517|FG004|Overall Study|Physician Decision|0|||
146388360|NCT01117428|527922518|FG005|Overall Study|Physician Decision|0|||
146388361|NCT01117428|527922513|FG000|Overall Study|Withdrawal by Subject|0|||
146388362|NCT01117428|527922514|FG001|Overall Study|Withdrawal by Subject|0|||
146388363|NCT01117428|527922515|FG002|Overall Study|Withdrawal by Subject|1|||
146388364|NCT01117428|527922516|FG003|Overall Study|Withdrawal by Subject|0|||
146388365|NCT01117428|527922517|FG004|Overall Study|Withdrawal by Subject|0|||
146388366|NCT01117428|527922518|FG005|Overall Study|Withdrawal by Subject|0|||
146388367|NCT01117428|527922513|FG000|Overall Study|Progressive disease|15|||
146388368|NCT01117428|527922514|FG001|Overall Study|Progressive disease|27|||
146388369|NCT01117428|527922515|FG002|Overall Study|Progressive disease|10|||
146388370|NCT01117428|527922516|FG003|Overall Study|Progressive disease|12|||
146388371|NCT01117428|527922517|FG004|Overall Study|Progressive disease|16|||
146388372|NCT01117428|527922518|FG005|Overall Study|Progressive disease|17|||
146388373|NCT02519777|527922519|FG000|Overall Study|Death|1|||
146388374|NCT02519777|527922520|FG001|Overall Study|Death|0|||
146388375|NCT02519777|527922521|FG002|Overall Study|Death|0|||
146388376|NCT02519777|527922519|FG000|Overall Study|Lost to Follow-up|0|||
146388377|NCT02519777|527922520|FG001|Overall Study|Lost to Follow-up|4|||
146388378|NCT02519777|527922521|FG002|Overall Study|Lost to Follow-up|2|||
146388379|NCT02519777|527922519|FG000|Overall Study|Withdrawal by Subject|3|||
146388380|NCT02519777|527922520|FG001|Overall Study|Withdrawal by Subject|1|||
146388381|NCT02519777|527922521|FG002|Overall Study|Withdrawal by Subject|0|||
146388382|NCT02519777|527922519|FG000|Overall Study|Severe Debilitation|1|||
146388383|NCT02519777|527922520|FG001|Overall Study|Severe Debilitation|1|||
146388384|NCT02519777|527922521|FG002|Overall Study|Severe Debilitation|1|||
146388385|NCT02519777|527922519|FG000|Overall Study|Not able to get to clinic|1|||
146388386|NCT02519777|527922520|FG001|Overall Study|Not able to get to clinic|2|||
146388387|NCT02519777|527922521|FG002|Overall Study|Not able to get to clinic|1|||
146388388|NCT02195531|527922522|FG000|Overall Study|Withdrawal by Subject|1|||
146388389|NCT02195531|527922523|FG001|Overall Study|Withdrawal by Subject|1|||
146388390|NCT02195531|527922524|FG002|Overall Study|Withdrawal by Subject|1|||
145943497|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146388391|NCT01284127|527922528|FG000|Overall Study|Adverse Event|2|||
146388392|NCT01284127|527922528|FG000|Overall Study|Withdrawal by Subject|4|||
146388393|NCT01284127|527922528|FG000|Overall Study|Physician Decision|1|||
146388394|NCT01683058|527922532|FG000|Overall Study|Lost to Follow-up|9|||
146388395|NCT01683058|527922532|FG000|Overall Study|Adverse Event|6|||
146388396|NCT01683058|527922532|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
146388397|NCT01683058|527922532|FG000|Overall Study|Withdrawal by Subject|7|||
146388398|NCT01683058|527922532|FG000|Overall Study|Lack of Efficacy|2|||
146388399|NCT04062240|527922536|FG000|Overall Study|equipment malfunction|1|||
146388400|NCT01957111|527922537|FG000|Overall Study|Withdrawal by Subject|1|||
146388401|NCT01957111|527922538|FG001|Overall Study|Withdrawal by Subject|1|||
146388402|NCT01057394|527922539|FG000|Overall Study|Not eligible|0|||
146388403|NCT01057394|527922540|FG001|Overall Study|Not eligible|2|||
146388404|NCT01195636|527922541|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
146388405|NCT01195636|527922542|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
146388406|NCT01195636|527922541|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
146388407|NCT01195636|527922542|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
146388408|NCT01195636|527922541|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146388409|NCT01195636|527922542|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
146388410|NCT01195636|527922541|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
146388411|NCT01195636|527922542|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
146388412|NCT01195636|527922541|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
146388413|NCT01195636|527922542|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
146388414|NCT01195636|527922541|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
146388415|NCT01195636|527922542|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
146388416|NCT01195636|527922541|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
146388417|NCT01195636|527922542|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
146388418|NCT01195636|527922541|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
146388419|NCT01195636|527922542|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
146388420|NCT03961529|527922543|FG000|Overall Study|Adverse Event|13|||
146388421|NCT03961529|527922544|FG001|Overall Study|Adverse Event|5|||
146388422|NCT03961529|527922545|FG002|Overall Study|Adverse Event|2|||
146388423|NCT03961529|527922543|FG000|Overall Study|Withdrawal by Subject|17|||
146388424|NCT03961529|527922544|FG001|Overall Study|Withdrawal by Subject|2|||
146388425|NCT03961529|527922545|FG002|Overall Study|Withdrawal by Subject|1|||
146388426|NCT03961529|527922543|FG000|Overall Study|Withdrawal by parent/guardian|0|||
146388427|NCT03961529|527922544|FG001|Overall Study|Withdrawal by parent/guardian|7|||
146388428|NCT03961529|527922545|FG002|Overall Study|Withdrawal by parent/guardian|0|||
146388429|NCT03961529|527922543|FG000|Overall Study|Physician Decision|2|||
146388430|NCT03961529|527922544|FG001|Overall Study|Physician Decision|1|||
146388431|NCT03961529|527922545|FG002|Overall Study|Physician Decision|1|||
146388432|NCT03961529|527922543|FG000|Overall Study|Lost to Follow-up|2|||
146388433|NCT03961529|527922544|FG001|Overall Study|Lost to Follow-up|1|||
146388434|NCT03961529|527922545|FG002|Overall Study|Lost to Follow-up|0|||
146388435|NCT03961529|527922543|FG000|Overall Study|Lack of Efficacy|2|||
146388436|NCT03961529|527922544|FG001|Overall Study|Lack of Efficacy|0|||
146388437|NCT03961529|527922545|FG002|Overall Study|Lack of Efficacy|1|||
146388438|NCT03961529|527922543|FG000|Overall Study|Other|6|||
146388439|NCT03961529|527922544|FG001|Overall Study|Other|1|||
146388440|NCT03961529|527922545|FG002|Overall Study|Other|0|||
146388441|NCT00082628|527922547|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146388442|NCT00082628|527922548|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
146388443|NCT00082628|527922549|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146388444|NCT00082628|527922550|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146388445|NCT00082628|527922551|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
146388446|NCT00082628|527922547|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
146388447|NCT00082628|527922548|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
146388448|NCT00082628|527922549|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146388449|NCT00082628|527922550|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146388450|NCT00082628|527922551|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
146388451|NCT00082628|527922547|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
146388452|NCT00082628|527922548|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
146388453|NCT00082628|527922549|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146388454|NCT00082628|527922550|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146388455|NCT00082628|527922551|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
146388456|NCT00082628|527922547|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
146388457|NCT00082628|527922548|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
146388458|NCT00082628|527922549|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146388459|NCT00082628|527922550|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146388460|NCT00082628|527922551|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
146388461|NCT00082628|527922547|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146388462|NCT00082628|527922548|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146388463|NCT00082628|527922549|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146388464|NCT00082628|527922550|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
146388465|NCT00082628|527922551|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
146388466|NCT00082628|527922547|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146396053|NCT01397409|527952479|FG009|Stage 3|Adverse Event|0|||
146388467|NCT00082628|527922548|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146388468|NCT00082628|527922549|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146388469|NCT00082628|527922550|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
146388470|NCT00082628|527922551|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
146388471|NCT00082628|527922547|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
146388472|NCT00082628|527922548|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
146388473|NCT00082628|527922549|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
146388474|NCT00082628|527922550|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
146388475|NCT00082628|527922551|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
146388476|NCT03481634|527922555|FG000|Overall Study|Withdrawal by Subject|16|||
146388477|NCT03481634|527922556|FG001|Overall Study|Withdrawal by Subject|19|||
146388478|NCT03481634|527922557|FG002|Overall Study|Withdrawal by Subject|14|||
146388479|NCT03481634|527922555|FG000|Overall Study|Protocol Violation|1|||
146388480|NCT03481634|527922556|FG001|Overall Study|Protocol Violation|0|||
146388481|NCT03481634|527922557|FG002|Overall Study|Protocol Violation|1|||
146388482|NCT03481634|527922555|FG000|Overall Study|Progressive disease|0|||
146388483|NCT03481634|527922556|FG001|Overall Study|Progressive disease|1|||
146388484|NCT03481634|527922557|FG002|Overall Study|Progressive disease|0|||
146388485|NCT03481634|527922555|FG000|Overall Study|Physician Decision|3|||
146388486|NCT03481634|527922556|FG001|Overall Study|Physician Decision|0|||
146388487|NCT03481634|527922557|FG002|Overall Study|Physician Decision|1|||
146388488|NCT03481634|527922555|FG000|Overall Study|Lost to Follow-up|3|||
146388489|NCT03481634|527922556|FG001|Overall Study|Lost to Follow-up|4|||
146388490|NCT03481634|527922557|FG002|Overall Study|Lost to Follow-up|4|||
146388491|NCT03481634|527922555|FG000|Overall Study|Death|4|||
146388492|NCT03481634|527922556|FG001|Overall Study|Death|8|||
146388493|NCT03481634|527922557|FG002|Overall Study|Death|7|||
146388494|NCT03481634|527922555|FG000|Overall Study|Adverse Event|6|||
146388495|NCT03481634|527922556|FG001|Overall Study|Adverse Event|3|||
146388496|NCT03481634|527922557|FG002|Overall Study|Adverse Event|7|||
146388497|NCT00994890|527922565|FG000|Overall Study|Adverse Event|13|||
146388498|NCT00994890|527922566|FG001|Overall Study|Adverse Event|9|||
146388499|NCT00994890|527922567|FG002|Overall Study|Adverse Event|11|||
146388500|NCT00994890|527922565|FG000|Overall Study|Lack of Efficacy|0|||
146388501|NCT00994890|527922566|FG001|Overall Study|Lack of Efficacy|0|||
146388502|NCT00994890|527922567|FG002|Overall Study|Lack of Efficacy|1|||
146388503|NCT00994890|527922565|FG000|Overall Study|Lost to Follow-up|6|||
146388504|NCT00994890|527922566|FG001|Overall Study|Lost to Follow-up|1|||
146388505|NCT00994890|527922567|FG002|Overall Study|Lost to Follow-up|3|||
146388506|NCT00994890|527922565|FG000|Overall Study|No longer willing to participate|8|||
146388507|NCT00994890|527922566|FG001|Overall Study|No longer willing to participate|5|||
146388508|NCT00994890|527922567|FG002|Overall Study|No longer willing to participate|13|||
146388509|NCT00994890|527922565|FG000|Overall Study|Protocol Violation|2|||
146388510|NCT00994890|527922566|FG001|Overall Study|Protocol Violation|4|||
146388511|NCT00994890|527922567|FG002|Overall Study|Protocol Violation|0|||
146388512|NCT00994890|527922565|FG000|Overall Study|Study terminated by sponsor|199|||
146388513|NCT00994890|527922566|FG001|Overall Study|Study terminated by sponsor|201|||
146388514|NCT00994890|527922567|FG002|Overall Study|Study terminated by sponsor|197|||
146388515|NCT00994890|527922565|FG000|Overall Study|Randomized, but not treated|1|||
146388516|NCT00994890|527922566|FG001|Overall Study|Randomized, but not treated|0|||
146388517|NCT00994890|527922567|FG002|Overall Study|Randomized, but not treated|0|||
146388518|NCT00994890|527922565|FG000|Overall Study|Other|2|||
146388519|NCT00994890|527922566|FG001|Overall Study|Other|2|||
146388520|NCT00994890|527922567|FG002|Overall Study|Other|1|||
146388521|NCT03323385|527922574|FG000|Overall Study|Withdrawal by Subject|1|||
146388522|NCT03323385|527922575|FG001|Overall Study|Withdrawal by Subject|2|||
146388523|NCT03323385|527922574|FG000|Overall Study|Noncompliance|0|||
146388524|NCT03323385|527922575|FG001|Overall Study|Noncompliance|1|||
146388525|NCT01849289|527922576|FG000|Overall Study|Adverse Event|3|||
146388526|NCT01849289|527922577|FG001|Overall Study|Adverse Event|3|||
146388527|NCT01849289|527922576|FG000|Overall Study|Protocol Violation|3|||
146388528|NCT01849289|527922577|FG001|Overall Study|Protocol Violation|3|||
146388529|NCT01849289|527922576|FG000|Overall Study|Withdrawal criteria|1|||
146388530|NCT01849289|527922577|FG001|Overall Study|Withdrawal criteria|0|||
146388531|NCT01849289|527922576|FG000|Overall Study|Unclassified|25|||
146388532|NCT01849289|527922577|FG001|Overall Study|Unclassified|18|||
146388533|NCT00352027|527922578|FG000|Overall Study|Progressive disease|3|||
146388534|NCT04491591|527922579|FG000|Overall Study|Accidently randomized|3|||
146388535|NCT04491591|527922580|FG001|Overall Study|Accidently randomized|1|||
146388536|NCT04491591|527922581|FG002|Overall Study|Accidently randomized|0|||
146388537|NCT04491591|527922579|FG000|Overall Study|Did not complete survey|28|||
146388538|NCT04491591|527922580|FG001|Overall Study|Did not complete survey|20|||
146388539|NCT04491591|527922581|FG002|Overall Study|Did not complete survey|3|||
146388540|NCT00660816|527922582|FG000|Overall Study|Adverse Event|1|||
146388541|NCT00660816|527922583|FG001|Overall Study|Adverse Event|2|||
146388542|NCT00660816|527922582|FG000|Overall Study|Withdrawal by Subject|1|||
146388543|NCT00660816|527922583|FG001|Overall Study|Withdrawal by Subject|0|||
146388544|NCT00660816|527922582|FG000|Overall Study|Death|0|||
146388545|NCT00660816|527922583|FG001|Overall Study|Death|2|||
146388546|NCT00660816|527922582|FG000|Overall Study|Lack of Efficacy|1|||
146388547|NCT00660816|527922583|FG001|Overall Study|Lack of Efficacy|0|||
146388548|NCT00660816|527922582|FG000|Overall Study|Physician Decision|0|||
146388549|NCT00660816|527922583|FG001|Overall Study|Physician Decision|2|||
146388550|NCT00660816|527922582|FG000|Overall Study|Protocol Violation|1|||
146388551|NCT00660816|527922583|FG001|Overall Study|Protocol Violation|0|||
146388552|NCT00660816|527922582|FG000|Overall Study|Disease Progression|16|||
146388553|NCT00660816|527922583|FG001|Overall Study|Disease Progression|12|||
146388554|NCT00660816|527922582|FG000|Overall Study|Complicating Disease|0|||
146388555|NCT00660816|527922583|FG001|Overall Study|Complicating Disease|1|||
146388556|NCT02607735|527922586|FG000|Primary Study|Randomized but Never Treated|1|||
146388557|NCT02607735|527922587|FG001|Primary Study|Randomized but Never Treated|0|||
146388558|NCT02607735|527922588|FG002|Primary Study|Randomized but Never Treated|0|||
146388559|NCT02607735|527922586|FG000|Primary Study|Lost to Follow-up|4|||
146388560|NCT02607735|527922587|FG001|Primary Study|Lost to Follow-up|0|||
146388561|NCT02607735|527922588|FG002|Primary Study|Lost to Follow-up|0|||
146388562|NCT02607735|527922586|FG000|Primary Study|Withdrew Consent|2|||
146388563|NCT02607735|527922587|FG001|Primary Study|Withdrew Consent|0|||
146388564|NCT02607735|527922588|FG002|Primary Study|Withdrew Consent|0|||
146388565|NCT02607735|527922586|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
146388566|NCT02607735|527922587|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
146388567|NCT02607735|527922588|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
146388568|NCT02607735|527922586|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
146388569|NCT02607735|527922587|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
146388570|NCT02607735|527922588|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
146388571|NCT01058356|527922591|FG000|Overall Study|Adverse Event|5|||
146388572|NCT01058356|527922591|FG000|Overall Study|Administration of contraindicated drugs|12|||
146388573|NCT01058356|527922591|FG000|Overall Study|Withdrawal by Subject|21|||
146388574|NCT01058356|527922591|FG000|Overall Study|Lost to Follow-up|4|||
146388575|NCT02993783|527922592|FG000|Overall Study|Reason not Specified|6|||
146388576|NCT02993783|527922593|FG001|Overall Study|Reason not Specified|9|||
146388577|NCT00606021|527922594|FG000|Induction Phase|Death|73|||
146388578|NCT00606021|527922595|FG001|Induction Phase|Death|0|||
146388579|NCT00606021|527922596|FG002|Induction Phase|Death|0|||
146388580|NCT00606021|527922594|FG000|Induction Phase|Physician Decision|2|||
146388581|NCT00606021|527922595|FG001|Induction Phase|Physician Decision|0|||
146388582|NCT00606021|527922596|FG002|Induction Phase|Physician Decision|0|||
146388583|NCT00606021|527922594|FG000|Induction Phase|Withdrawal by Subject|2|||
146388584|NCT00606021|527922595|FG001|Induction Phase|Withdrawal by Subject|0|||
146388585|NCT00606021|527922596|FG002|Induction Phase|Withdrawal by Subject|0|||
146388586|NCT00606021|527922594|FG000|Induction Phase|Lost to Follow-up|10|||
146388587|NCT00606021|527922595|FG001|Induction Phase|Lost to Follow-up|0|||
146388588|NCT00606021|527922596|FG002|Induction Phase|Lost to Follow-up|0|||
146388589|NCT00606021|527922594|FG000|Maintenance Phase|Death|0|||
146388590|NCT00606021|527922595|FG001|Maintenance Phase|Death|17|||
146388591|NCT00606021|527922596|FG002|Maintenance Phase|Death|15|||
146388592|NCT00606021|527922594|FG000|Maintenance Phase|Physician Decision|0|||
146388593|NCT00606021|527922595|FG001|Maintenance Phase|Physician Decision|1|||
146388594|NCT00606021|527922596|FG002|Maintenance Phase|Physician Decision|0|||
146388595|NCT00606021|527922594|FG000|Maintenance Phase|Lost to Follow-up|0|||
146388596|NCT00606021|527922595|FG001|Maintenance Phase|Lost to Follow-up|5|||
146388597|NCT00606021|527922596|FG002|Maintenance Phase|Lost to Follow-up|2|||
146388598|NCT01899729|527922604|FG000|Overall Study|Adverse Event|1|||
146388599|NCT01899729|527922605|FG001|Overall Study|Adverse Event|0|||
146388600|NCT01899729|527922606|FG002|Overall Study|Adverse Event|0|||
146388601|NCT01899729|527922607|FG003|Overall Study|Adverse Event|0|||
146388602|NCT01899729|527922608|FG004|Overall Study|Adverse Event|1|||
146388603|NCT01899729|527922604|FG000|Overall Study|Withdrawal by Subject|1|||
146388604|NCT01899729|527922605|FG001|Overall Study|Withdrawal by Subject|2|||
146388605|NCT01899729|527922606|FG002|Overall Study|Withdrawal by Subject|0|||
146388606|NCT01899729|527922607|FG003|Overall Study|Withdrawal by Subject|0|||
146388607|NCT01899729|527922608|FG004|Overall Study|Withdrawal by Subject|0|||
146388608|NCT01899729|527922604|FG000|Overall Study|Lack of Efficacy|0|||
146388609|NCT01899729|527922605|FG001|Overall Study|Lack of Efficacy|0|||
146388610|NCT01899729|527922606|FG002|Overall Study|Lack of Efficacy|2|||
146388611|NCT01899729|527922607|FG003|Overall Study|Lack of Efficacy|0|||
146388612|NCT01899729|527922608|FG004|Overall Study|Lack of Efficacy|1|||
146388613|NCT01454531|527922609|FG000|Overall Study|Adverse Event|14|||
146388614|NCT01454531|527922609|FG000|Overall Study|Withdrawal by Subject|5|||
146388615|NCT01454531|527922609|FG000|Overall Study|Lost to Follow-up|1|||
146388616|NCT01454531|527922609|FG000|Overall Study|Physician Decision|1|||
146388617|NCT01454531|527922609|FG000|Overall Study|Delay in IMP administration|1|||
146388618|NCT01454531|527922609|FG000|Overall Study|Other|1|||
146388619|NCT01230827|527922612|FG000|Overall Study|Lost to Follow-up|0|||
146388620|NCT01230827|527922613|FG001|Overall Study|Lost to Follow-up|0|||
146388621|NCT01230827|527922614|FG002|Overall Study|Lost to Follow-up|1|||
146388622|NCT01230827|527922615|FG003|Overall Study|Lost to Follow-up|3|||
146388623|NCT01230827|527922612|FG000|Overall Study|Withdrawal by Subject|1|||
146388624|NCT01230827|527922613|FG001|Overall Study|Withdrawal by Subject|0|||
146388625|NCT01230827|527922614|FG002|Overall Study|Withdrawal by Subject|3|||
146388626|NCT01230827|527922615|FG003|Overall Study|Withdrawal by Subject|2|||
146388627|NCT01230827|527922612|FG000|Overall Study|Lack of Efficacy|14|||
146388628|NCT01230827|527922613|FG001|Overall Study|Lack of Efficacy|1|||
146388629|NCT01230827|527922614|FG002|Overall Study|Lack of Efficacy|2|||
146388630|NCT01230827|527922615|FG003|Overall Study|Lack of Efficacy|3|||
146388631|NCT01230827|527922612|FG000|Overall Study|Adverse Event|4|||
146388632|NCT01230827|527922613|FG001|Overall Study|Adverse Event|2|||
146388633|NCT01230827|527922614|FG002|Overall Study|Adverse Event|3|||
146388634|NCT01230827|527922615|FG003|Overall Study|Adverse Event|7|||
146388635|NCT01230827|527922612|FG000|Overall Study|Recovery|0|||
146388636|NCT01230827|527922613|FG001|Overall Study|Recovery|6|||
146388637|NCT01230827|527922614|FG002|Overall Study|Recovery|0|||
146388638|NCT01230827|527922615|FG003|Overall Study|Recovery|0|||
146388639|NCT01230827|527922612|FG000|Overall Study|Study terminated by Sponsor|0|||
146388640|NCT01230827|527922613|FG001|Overall Study|Study terminated by Sponsor|2|||
146388641|NCT01230827|527922614|FG002|Overall Study|Study terminated by Sponsor|56|||
146388642|NCT01230827|527922615|FG003|Overall Study|Study terminated by Sponsor|63|||
146388643|NCT00711009|527925009|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
146388644|NCT00711009|527925010|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
146388645|NCT00711009|527925009|FG000|Overall Study|Withdrawal by Subject|4|||
146388646|NCT00711009|527925010|FG001|Overall Study|Withdrawal by Subject|2|||
146388647|NCT00711009|527925009|FG000|Overall Study|Lost to Follow-up|3|||
146388648|NCT00711009|527925010|FG001|Overall Study|Lost to Follow-up|9|||
146388649|NCT00711009|527925009|FG000|Overall Study|Participant Noncompliant|0|||
146388650|NCT00711009|527925010|FG001|Overall Study|Participant Noncompliant|1|||
146388651|NCT00711009|527925009|FG000|Overall Study|Virologic Failure|2|||
146388652|NCT00711009|527925010|FG001|Overall Study|Virologic Failure|1|||
146388653|NCT00711009|527925009|FG000|Overall Study|Pregnancy|1|||
146388654|NCT00711009|527925010|FG001|Overall Study|Pregnancy|0|||
146388655|NCT00711009|527925009|FG000|Overall Study|Site closing|0|||
146388656|NCT00711009|527925010|FG001|Overall Study|Site closing|1|||
146388657|NCT00711009|527925009|FG000|Overall Study|Dose adjustment|1|||
146388658|NCT00711009|527925010|FG001|Overall Study|Dose adjustment|0|||
146388659|NCT01459016|527925012|FG000|Overall Study|Withdrawal by Subject|11|||
146388660|NCT01459016|527925012|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
146388661|NCT00303602|527925016|FG000|Overall Study|Adverse Event|2|||
146388662|NCT00303602|527925017|FG001|Overall Study|Adverse Event|2|||
146388663|NCT00303602|527925016|FG000|Overall Study|Withdrawal by Subject|5|||
146388664|NCT00303602|527925017|FG001|Overall Study|Withdrawal by Subject|6|||
146388665|NCT00303602|527925016|FG000|Overall Study|Lost to Follow-up|5|||
146388666|NCT00303602|527925017|FG001|Overall Study|Lost to Follow-up|2|||
146388667|NCT00303602|527925016|FG000|Overall Study|Protocol entry criteria not met|2|||
146388668|NCT00303602|527925017|FG001|Overall Study|Protocol entry criteria not met|2|||
146388669|NCT00303602|527925016|FG000|Overall Study|Physician Decision|2|||
146388670|NCT00303602|527925017|FG001|Overall Study|Physician Decision|1|||
146388671|NCT00303602|527925016|FG000|Overall Study|Noncompliance|2|||
146388672|NCT00303602|527925017|FG001|Overall Study|Noncompliance|2|||
146388673|NCT00303602|527925016|FG000|Overall Study|Protocol Violation|1|||
146388674|NCT00303602|527925017|FG001|Overall Study|Protocol Violation|0|||
146388675|NCT02551874|527925024|FG000|Overall Study|Lost to Follow-up|0|||
146388676|NCT02551874|527925025|FG001|Overall Study|Lost to Follow-up|2|||
146388677|NCT02551874|527925024|FG000|Overall Study|Pregnancy|0|||
146388678|NCT02551874|527925025|FG001|Overall Study|Pregnancy|1|||
146388679|NCT02551874|527925024|FG000|Overall Study|Reason not reported|10|||
146388680|NCT02551874|527925025|FG001|Overall Study|Reason not reported|4|||
146388681|NCT02551874|527925024|FG000|Overall Study|Did not receive randomized treatment|0|||
146388682|NCT02551874|527925025|FG001|Overall Study|Did not receive randomized treatment|7|||
146388683|NCT02551874|527925024|FG000|Overall Study|Did not enter long-term study|18|||
146388684|NCT02551874|527925025|FG001|Overall Study|Did not enter long-term study|25|||
146388685|NCT00313716|527925026|FG000|Overall Study|Death|3|||
146388686|NCT00313716|527925027|FG001|Overall Study|Death|2|||
146388687|NCT00313716|527925028|FG002|Overall Study|Death|9|||
146388688|NCT00313716|527925029|FG003|Overall Study|Death|3|||
146388689|NCT00313716|527925030|FG004|Overall Study|Death|5|||
146388690|NCT00313716|527925031|FG005|Overall Study|Death|9|||
146388691|NCT00313716|527925026|FG000|Overall Study|Lost to Follow-up|2|||
146388692|NCT00313716|527925027|FG001|Overall Study|Lost to Follow-up|5|||
146388693|NCT00313716|527925028|FG002|Overall Study|Lost to Follow-up|2|||
146388694|NCT00313716|527925029|FG003|Overall Study|Lost to Follow-up|1|||
146388695|NCT00313716|527925030|FG004|Overall Study|Lost to Follow-up|0|||
146388696|NCT00313716|527925031|FG005|Overall Study|Lost to Follow-up|4|||
146388697|NCT00313716|527925026|FG000|Overall Study|Withdrawal by Subject|0|||
146388698|NCT00313716|527925027|FG001|Overall Study|Withdrawal by Subject|1|||
146388699|NCT00313716|527925028|FG002|Overall Study|Withdrawal by Subject|1|||
146388700|NCT00313716|527925029|FG003|Overall Study|Withdrawal by Subject|0|||
146388701|NCT00313716|527925030|FG004|Overall Study|Withdrawal by Subject|1|||
146388702|NCT00313716|527925031|FG005|Overall Study|Withdrawal by Subject|0|||
146388703|NCT02491463|527925032|FG000|Overall Study|Withdrawal by Subject|1|||
146388704|NCT02491463|527925033|FG001|Overall Study|Withdrawal by Subject|2|||
146388705|NCT02491463|527925034|FG002|Overall Study|Withdrawal by Subject|0|||
146388706|NCT02491463|527925035|FG003|Overall Study|Withdrawal by Subject|0|||
146388707|NCT02491463|527925032|FG000|Overall Study|Migrated/moved from study area|1|||
146388708|NCT02491463|527925033|FG001|Overall Study|Migrated/moved from study area|5|||
146388709|NCT02491463|527925034|FG002|Overall Study|Migrated/moved from study area|1|||
146388710|NCT02491463|527925035|FG003|Overall Study|Migrated/moved from study area|1|||
146388711|NCT02491463|527925032|FG000|Overall Study|Lost to Follow-up|0|||
146388712|NCT02491463|527925033|FG001|Overall Study|Lost to Follow-up|3|||
146388713|NCT02491463|527925034|FG002|Overall Study|Lost to Follow-up|3|||
146388714|NCT02491463|527925035|FG003|Overall Study|Lost to Follow-up|0|||
146388715|NCT01491802|527925036|FG000|Overall Study|Adverse Event|1|||
146388716|NCT01491802|527925037|FG001|Overall Study|Adverse Event|1|||
146388717|NCT01491802|527925036|FG000|Overall Study|Withdrawal by Subject|0|||
146388718|NCT01491802|527925037|FG001|Overall Study|Withdrawal by Subject|1|||
146388719|NCT00663208|527925038|FG000|Treatment Period|Lost to Follow-up|0|||
146388720|NCT00663208|527925039|FG001|Treatment Period|Lost to Follow-up|1|||
146388721|NCT00663208|527925040|FG002|Treatment Period|Lost to Follow-up|0|||
146388722|NCT00663208|527925041|FG003|Treatment Period|Lost to Follow-up|0|||
146388723|NCT00663208|527925042|FG004|Treatment Period|Lost to Follow-up|0|||
146388724|NCT00663208|527925043|FG005|Treatment Period|Lost to Follow-up|0|||
146388725|NCT00663208|527925044|FG006|Treatment Period|Lost to Follow-up|0|||
146388726|NCT00663208|527925038|FG000|Follow-up Period|Lost to Follow-up|2|||
146388727|NCT00663208|527925039|FG001|Follow-up Period|Lost to Follow-up|0|||
146388728|NCT00663208|527925040|FG002|Follow-up Period|Lost to Follow-up|3|||
146388729|NCT00663208|527925041|FG003|Follow-up Period|Lost to Follow-up|2|||
146388730|NCT00663208|527925042|FG004|Follow-up Period|Lost to Follow-up|0|||
146388731|NCT00663208|527925043|FG005|Follow-up Period|Lost to Follow-up|0|||
146388732|NCT00663208|527925044|FG006|Follow-up Period|Lost to Follow-up|0|||
146388733|NCT00663208|527925038|FG000|Follow-up Period|Other reason|1|||
146388734|NCT00663208|527925039|FG001|Follow-up Period|Other reason|0|||
146388735|NCT00663208|527925040|FG002|Follow-up Period|Other reason|0|||
146388736|NCT00663208|527925041|FG003|Follow-up Period|Other reason|0|||
146388737|NCT00663208|527925042|FG004|Follow-up Period|Other reason|0|||
146388738|NCT00663208|527925043|FG005|Follow-up Period|Other reason|0|||
146388739|NCT00663208|527925044|FG006|Follow-up Period|Other reason|1|||
146388740|NCT00039377|527925046|FG000|Initial Registration|Adverse Event|2|||
146388741|NCT00039377|527925047|FG001|Initial Registration|Adverse Event|0|||
146388742|NCT00039377|527925048|FG002|Initial Registration|Adverse Event|0|||
146388743|NCT00039377|527925049|FG003|Initial Registration|Adverse Event|0|||
146388744|NCT00039377|527925046|FG000|Initial Registration|Relapsed|6|||
146388745|NCT00039377|527925047|FG001|Initial Registration|Relapsed|0|||
146388746|NCT00039377|527925048|FG002|Initial Registration|Relapsed|0|||
146388747|NCT00039377|527925049|FG003|Initial Registration|Relapsed|0|||
146388748|NCT00039377|527925046|FG000|Initial Registration|Received non-protocol therapy|11|||
146388749|NCT00039377|527925047|FG001|Initial Registration|Received non-protocol therapy|0|||
146388750|NCT00039377|527925048|FG002|Initial Registration|Received non-protocol therapy|0|||
146388751|NCT00039377|527925049|FG003|Initial Registration|Received non-protocol therapy|0|||
146388752|NCT00039377|527925046|FG000|Initial Registration|Withdrawal by Subject|3|||
146388753|NCT00039377|527925047|FG001|Initial Registration|Withdrawal by Subject|0|||
146388754|NCT00039377|527925048|FG002|Initial Registration|Withdrawal by Subject|0|||
146388755|NCT00039377|527925049|FG003|Initial Registration|Withdrawal by Subject|0|||
146388756|NCT01347931|527925053|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
146388757|NCT01603615|527925055|FG000|Overall Study|Did not Receive Treatment|7|||
146388758|NCT01603615|527925055|FG000|Overall Study|Lost to Follow-up|9|||
146388759|NCT01603615|527925055|FG000|Overall Study|Personal Reasons|17|||
146388760|NCT01603615|527925055|FG000|Overall Study|Other Miscellaneous|1|||
146388761|NCT01539720|527925059|FG000|Overall Study|Screen Fail|15|||
146388762|NCT01539720|527925060|FG001|Overall Study|Screen Fail|3|||
146388763|NCT01539720|527925059|FG000|Overall Study|Lost to Follow-up|14|||
146388764|NCT01539720|527925060|FG001|Overall Study|Lost to Follow-up|7|||
146388765|NCT00298766|527925061|FG000|Overall Study|Adverse Event|18|||
146388766|NCT00298766|527925061|FG000|Overall Study|Death|2|||
146388767|NCT00298766|527925061|FG000|Overall Study|Withdrawal by Subject|9|||
146388768|NCT00298766|527925061|FG000|Overall Study|Treatment ongoing|4|||
146388769|NCT00298766|527925061|FG000|Overall Study|Progression of amyloid markers|4|||
146388770|NCT00298766|527925061|FG000|Overall Study|Deterioration in KPS and organ function|1|||
146388771|NCT00298766|527925061|FG000|Overall Study|Subjects overall condition deterioration|4|||
146388772|NCT00298766|527925061|FG000|Overall Study|Other|4|||
146388773|NCT00656136|527925064|FG000|Overall Study|Progressive disease|177|||
146388774|NCT00656136|527925065|FG001|Overall Study|Progressive disease|322|||
146388775|NCT00656136|527925064|FG000|Overall Study|Other Adverse Event|5|||
146388776|NCT00656136|527925065|FG001|Overall Study|Other Adverse Event|51|||
146388777|NCT00656136|527925064|FG000|Overall Study|Protocol Violation|2|||
146388778|NCT00656136|527925065|FG001|Overall Study|Protocol Violation|3|||
146388779|NCT00656136|527925064|FG000|Overall Study|Patient refused to take study medication|7|||
146388780|NCT00656136|527925065|FG001|Overall Study|Patient refused to take study medication|10|||
146388781|NCT00656136|527925064|FG000|Overall Study|Unknown and others|4|||
146388782|NCT00656136|527925065|FG001|Overall Study|Unknown and others|4|||
146388783|NCT01345162|527925071|FG000|Overall Study|Protocol Violation|2|||
146388784|NCT01345162|527925072|FG001|Overall Study|Protocol Violation|4|||
146388785|NCT02242305|527925073|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
146388786|NCT02242305|527925074|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
146388787|NCT02242305|527925073|FG000|Overall Study|Adverse Event|1|||
146388788|NCT02242305|527925074|FG001|Overall Study|Adverse Event|0|||
146388789|NCT02242305|527925073|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
146388790|NCT02242305|527925074|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
146388791|NCT02242305|527925073|FG000|Overall Study|Subject withdraws inform consent|0|||
146388792|NCT02242305|527925074|FG001|Overall Study|Subject withdraws inform consent|4|||
146388793|NCT02242305|527925073|FG000|Overall Study|Lost to Follow-up|2|||
146388794|NCT02242305|527925074|FG001|Overall Study|Lost to Follow-up|0|||
146388795|NCT03018028|527925077|FG000|Overall Study|Withdrawal by Subject|3|||
146388796|NCT03018028|527925078|FG001|Overall Study|Withdrawal by Subject|0|||
146388797|NCT03018028|527925079|FG002|Overall Study|Withdrawal by Subject|1|||
146388798|NCT03018028|527925080|FG003|Overall Study|Withdrawal by Subject|2|||
146388799|NCT03018028|527925081|FG004|Overall Study|Withdrawal by Subject|0|||
146388800|NCT00699582|527925092|FG000|Overall Study|Adverse Event|4|||
146388801|NCT00699582|527925093|FG001|Overall Study|Adverse Event|11|||
146388802|NCT00699582|527925094|FG002|Overall Study|Adverse Event|23|||
146388803|NCT00699582|527925092|FG000|Overall Study|Withdrawal by Subject|6|||
146388804|NCT00699582|527925093|FG001|Overall Study|Withdrawal by Subject|7|||
146388805|NCT00699582|527925094|FG002|Overall Study|Withdrawal by Subject|4|||
146388806|NCT00699582|527925092|FG000|Overall Study|Lack of Efficacy|1|||
146388807|NCT00699582|527925093|FG001|Overall Study|Lack of Efficacy|0|||
146388808|NCT00699582|527925094|FG002|Overall Study|Lack of Efficacy|1|||
146388809|NCT00699582|527925092|FG000|Overall Study|Progressive Disease|1|||
146388810|NCT00699582|527925093|FG001|Overall Study|Progressive Disease|0|||
146388811|NCT00699582|527925094|FG002|Overall Study|Progressive Disease|0|||
146388812|NCT00699582|527925092|FG000|Overall Study|Administrative/Other|4|||
146388813|NCT00699582|527925093|FG001|Overall Study|Administrative/Other|3|||
146388814|NCT00699582|527925094|FG002|Overall Study|Administrative/Other|0|||
146388815|NCT00699582|527925092|FG000|Overall Study|Randomized, Not Treated|2|||
146388816|NCT00699582|527925093|FG001|Overall Study|Randomized, Not Treated|1|||
146388817|NCT00699582|527925094|FG002|Overall Study|Randomized, Not Treated|0|||
146388818|NCT03099304|527925100|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
146388819|NCT03099304|527925101|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
146388820|NCT03099304|527925102|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
146388821|NCT03099304|527925103|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
146388822|NCT03099304|527925104|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
146388823|NCT03099304|527925105|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
146388824|NCT03099304|527925100|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
146388825|NCT03099304|527925101|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
146388826|NCT03099304|527925102|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146388827|NCT03099304|527925103|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146388828|NCT03099304|527925104|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146388829|NCT03099304|527925105|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
146388830|NCT03099304|527925100|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
146388831|NCT03099304|527925101|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
146388832|NCT03099304|527925102|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
146388833|NCT03099304|527925103|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
146388834|NCT03099304|527925104|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
146388835|NCT03099304|527925105|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
146388836|NCT03099304|527925100|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
146388837|NCT03099304|527925101|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
146388838|NCT03099304|527925102|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
146388839|NCT03099304|527925103|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
146388840|NCT03099304|527925104|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
146388841|NCT03099304|527925105|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
146388842|NCT03099304|527925100|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146388843|NCT03099304|527925101|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146388844|NCT03099304|527925102|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
146388845|NCT03099304|527925103|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
146388846|NCT03099304|527925104|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146388847|NCT03099304|527925105|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
146388848|NCT03099304|527925100|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146388849|NCT03099304|527925101|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146388850|NCT03099304|527925102|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
146388851|NCT03099304|527925103|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146388852|NCT03099304|527925104|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146388853|NCT03099304|527925105|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
146388854|NCT03099304|527925100|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146388855|NCT03099304|527925101|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146388856|NCT03099304|527925102|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146388857|NCT03099304|527925103|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
146388858|NCT03099304|527925104|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146388859|NCT03099304|527925105|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
146388860|NCT03099304|527925100|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
146388861|NCT03099304|527925101|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
146388862|NCT03099304|527925102|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
146388863|NCT03099304|527925103|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
146388864|NCT03099304|527925104|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
146388865|NCT03099304|527925105|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
146388866|NCT03099304|527925100|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146388867|NCT03099304|527925101|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146388868|NCT03099304|527925102|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146388869|NCT03099304|527925103|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
146388870|NCT03099304|527925104|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
146388871|NCT03099304|527925105|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
146388872|NCT03099304|527925100|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
146388873|NCT03099304|527925101|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
146388874|NCT03099304|527925102|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
146388875|NCT03099304|527925103|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
146388876|NCT03099304|527925104|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
146388877|NCT03099304|527925105|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
146388878|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
146388879|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
146388880|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
146388881|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
146388882|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
146388883|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
146388884|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
146388885|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
146388886|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
146388887|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
146388888|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
146388889|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
146388890|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
146388891|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
146388892|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
146388893|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
146388894|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
146388895|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
146388896|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
146388897|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
146388898|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
146388899|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
146388900|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
146388901|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
146388902|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
146388903|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
146388904|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
146388905|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
146388906|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
146388907|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
146388908|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
146388909|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
146388910|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
146388911|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
146388912|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
146388913|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
146388914|NCT03099304|527925100|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
146388915|NCT03099304|527925101|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
146388916|NCT03099304|527925102|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
146396129|NCT01241591|527954455|FG003|Overall Study|Lack of Efficacy|3|||
146388917|NCT03099304|527925103|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
146388918|NCT03099304|527925104|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
146388919|NCT03099304|527925105|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
146388920|NCT02692560|527925106|FG000|Overall Study|Withdrawal by Subject|0|||
146388921|NCT02692560|527925107|FG001|Overall Study|Withdrawal by Subject|6|||
146388922|NCT00715949|527925110|FG000|Overall Study|could not finish first test|4|||
146388923|NCT00420212|527925111|FG000|Overall Study|Adverse Event|22|||
146388924|NCT00420212|527925112|FG001|Overall Study|Adverse Event|40|||
146388925|NCT00420212|527925113|FG002|Overall Study|Adverse Event|36|||
146388926|NCT00420212|527925111|FG000|Overall Study|Lost to Follow-up|9|||
146388927|NCT00420212|527925112|FG001|Overall Study|Lost to Follow-up|11|||
146388928|NCT00420212|527925113|FG002|Overall Study|Lost to Follow-up|11|||
146388929|NCT00420212|527925111|FG000|Overall Study|Withdrawal by Subject|31|||
146388930|NCT00420212|527925112|FG001|Overall Study|Withdrawal by Subject|22|||
146388931|NCT00420212|527925113|FG002|Overall Study|Withdrawal by Subject|19|||
146388932|NCT00420212|527925111|FG000|Overall Study|Physician Decision|4|||
146388933|NCT00420212|527925112|FG001|Overall Study|Physician Decision|4|||
146388934|NCT00420212|527925113|FG002|Overall Study|Physician Decision|3|||
146388935|NCT00420212|527925111|FG000|Overall Study|Protocol Violation|4|||
146388936|NCT00420212|527925112|FG001|Overall Study|Protocol Violation|4|||
146388937|NCT00420212|527925113|FG002|Overall Study|Protocol Violation|8|||
146388938|NCT00420212|527925111|FG000|Overall Study|Death|0|||
146388939|NCT00420212|527925112|FG001|Overall Study|Death|0|||
146388940|NCT00420212|527925113|FG002|Overall Study|Death|1|||
146388941|NCT00420212|527925111|FG000|Overall Study|Other-Unspecified|21|||
146388942|NCT00420212|527925112|FG001|Overall Study|Other-Unspecified|14|||
146388943|NCT00420212|527925113|FG002|Overall Study|Other-Unspecified|18|||
146388944|NCT01326910|527925114|FG000|Overall Study|Withdrawal by Subject|3|||
146388945|NCT01326910|527925115|FG001|Overall Study|Withdrawal by Subject|2|||
146388946|NCT01326910|527925114|FG000|Overall Study|Protocol Violation|1|||
146388947|NCT01326910|527925115|FG001|Overall Study|Protocol Violation|1|||
146388948|NCT02274766|527925118|FG000|Overall Study|Withdrawal by Subject|3|||
146388949|NCT02274766|527925119|FG001|Overall Study|Withdrawal by Subject|6|||
146388950|NCT02274766|527925118|FG000|Overall Study|Did Not Receive Study Drug|1|||
146388951|NCT02274766|527925119|FG001|Overall Study|Did Not Receive Study Drug|1|||
146388952|NCT02274766|527925118|FG000|Overall Study|Subject Unwilling to Proceed|0|||
146388953|NCT02274766|527925119|FG001|Overall Study|Subject Unwilling to Proceed|1|||
146388954|NCT02274766|527925118|FG000|Overall Study|Adverse Event|0|||
146388955|NCT02274766|527925119|FG001|Overall Study|Adverse Event|1|||
146388956|NCT01681836|527925124|FG000|Second Intervention|Withdrawal by Subject|0|||
146388957|NCT01681836|527925125|FG001|Second Intervention|Withdrawal by Subject|1|||
146388958|NCT02394028|527925126|FG000|Induction Phase|Adverse Event|2|||
146388959|NCT02394028|527925127|FG001|Induction Phase|Adverse Event|4|||
146388960|NCT02394028|527925128|FG002|Induction Phase|Adverse Event|1|||
146388961|NCT02394028|527925129|FG003|Induction Phase|Adverse Event|2|||
146388962|NCT02394028|527925130|FG004|Induction Phase|Adverse Event|5|||
146388963|NCT02394028|527925131|FG005|Induction Phase|Adverse Event|2|||
146388964|NCT02394028|527925132|FG006|Induction Phase|Adverse Event|0|||
146388965|NCT02394028|527925133|FG007|Induction Phase|Adverse Event|0|||
146388966|NCT02394028|527925134|FG008|Induction Phase|Adverse Event|0|||
146388967|NCT02394028|527925135|FG009|Induction Phase|Adverse Event|0|||
146388968|NCT02394028|527925136|FG010|Induction Phase|Adverse Event|0|||
146388969|NCT02394028|527925126|FG000|Induction Phase|Lack of Efficacy|3|||
146388970|NCT02394028|527925127|FG001|Induction Phase|Lack of Efficacy|6|||
146388971|NCT02394028|527925128|FG002|Induction Phase|Lack of Efficacy|2|||
146388972|NCT02394028|527925129|FG003|Induction Phase|Lack of Efficacy|17|||
146388973|NCT02394028|527925130|FG004|Induction Phase|Lack of Efficacy|14|||
146388974|NCT02394028|527925131|FG005|Induction Phase|Lack of Efficacy|8|||
146388975|NCT02394028|527925132|FG006|Induction Phase|Lack of Efficacy|17|||
146388976|NCT02394028|527925133|FG007|Induction Phase|Lack of Efficacy|23|||
146388977|NCT02394028|527925134|FG008|Induction Phase|Lack of Efficacy|0|||
146388978|NCT02394028|527925135|FG009|Induction Phase|Lack of Efficacy|0|||
146388979|NCT02394028|527925136|FG010|Induction Phase|Lack of Efficacy|0|||
146388980|NCT02394028|527925126|FG000|Induction Phase|Lost to Follow-up|1|||
146388981|NCT02394028|527925127|FG001|Induction Phase|Lost to Follow-up|0|||
146388982|NCT02394028|527925128|FG002|Induction Phase|Lost to Follow-up|0|||
146388983|NCT02394028|527925129|FG003|Induction Phase|Lost to Follow-up|1|||
146388984|NCT02394028|527925130|FG004|Induction Phase|Lost to Follow-up|0|||
146388985|NCT02394028|527925131|FG005|Induction Phase|Lost to Follow-up|0|||
146388986|NCT02394028|527925132|FG006|Induction Phase|Lost to Follow-up|1|||
146388987|NCT02394028|527925133|FG007|Induction Phase|Lost to Follow-up|0|||
146388988|NCT02394028|527925134|FG008|Induction Phase|Lost to Follow-up|0|||
146388989|NCT02394028|527925135|FG009|Induction Phase|Lost to Follow-up|0|||
146388990|NCT02394028|527925136|FG010|Induction Phase|Lost to Follow-up|0|||
146388991|NCT02394028|527925126|FG000|Induction Phase|Non-compliance|0|||
146388992|NCT02394028|527925127|FG001|Induction Phase|Non-compliance|1|||
146388993|NCT02394028|527925128|FG002|Induction Phase|Non-compliance|3|||
146388994|NCT02394028|527925129|FG003|Induction Phase|Non-compliance|1|||
146388995|NCT02394028|527925130|FG004|Induction Phase|Non-compliance|3|||
146388996|NCT02394028|527925131|FG005|Induction Phase|Non-compliance|0|||
146388997|NCT02394028|527925132|FG006|Induction Phase|Non-compliance|1|||
146388998|NCT02394028|527925133|FG007|Induction Phase|Non-compliance|1|||
146388999|NCT02394028|527925134|FG008|Induction Phase|Non-compliance|0|||
146389000|NCT02394028|527925135|FG009|Induction Phase|Non-compliance|0|||
146389001|NCT02394028|527925136|FG010|Induction Phase|Non-compliance|0|||
146389002|NCT02394028|527925126|FG000|Induction Phase|Physician Decision|0|||
146389003|NCT02394028|527925127|FG001|Induction Phase|Physician Decision|0|||
146389004|NCT02394028|527925128|FG002|Induction Phase|Physician Decision|1|||
146389005|NCT02394028|527925129|FG003|Induction Phase|Physician Decision|4|||
146389006|NCT02394028|527925130|FG004|Induction Phase|Physician Decision|0|||
146389007|NCT02394028|527925131|FG005|Induction Phase|Physician Decision|2|||
146389008|NCT02394028|527925132|FG006|Induction Phase|Physician Decision|1|||
146389009|NCT02394028|527925133|FG007|Induction Phase|Physician Decision|0|||
146389010|NCT02394028|527925134|FG008|Induction Phase|Physician Decision|0|||
146389011|NCT02394028|527925135|FG009|Induction Phase|Physician Decision|0|||
146389012|NCT02394028|527925136|FG010|Induction Phase|Physician Decision|0|||
146389013|NCT02394028|527925126|FG000|Induction Phase|Protocol Violation|0|||
146389014|NCT02394028|527925127|FG001|Induction Phase|Protocol Violation|2|||
146389015|NCT02394028|527925128|FG002|Induction Phase|Protocol Violation|0|||
146389016|NCT02394028|527925129|FG003|Induction Phase|Protocol Violation|3|||
146389017|NCT02394028|527925130|FG004|Induction Phase|Protocol Violation|0|||
146389018|NCT02394028|527925131|FG005|Induction Phase|Protocol Violation|1|||
146389019|NCT02394028|527925132|FG006|Induction Phase|Protocol Violation|1|||
146389020|NCT02394028|527925133|FG007|Induction Phase|Protocol Violation|0|||
146389021|NCT02394028|527925134|FG008|Induction Phase|Protocol Violation|0|||
146389022|NCT02394028|527925135|FG009|Induction Phase|Protocol Violation|0|||
146389023|NCT02394028|527925136|FG010|Induction Phase|Protocol Violation|0|||
146389024|NCT02394028|527925126|FG000|Induction Phase|Withdrawal by Subject|1|||
146389025|NCT02394028|527925127|FG001|Induction Phase|Withdrawal by Subject|2|||
146389026|NCT02394028|527925128|FG002|Induction Phase|Withdrawal by Subject|4|||
146389027|NCT02394028|527925129|FG003|Induction Phase|Withdrawal by Subject|6|||
146389028|NCT02394028|527925130|FG004|Induction Phase|Withdrawal by Subject|7|||
146389029|NCT02394028|527925131|FG005|Induction Phase|Withdrawal by Subject|4|||
146389030|NCT02394028|527925132|FG006|Induction Phase|Withdrawal by Subject|3|||
146389031|NCT02394028|527925133|FG007|Induction Phase|Withdrawal by Subject|6|||
146389032|NCT02394028|527925134|FG008|Induction Phase|Withdrawal by Subject|0|||
146389033|NCT02394028|527925135|FG009|Induction Phase|Withdrawal by Subject|0|||
146389034|NCT02394028|527925136|FG010|Induction Phase|Withdrawal by Subject|0|||
146389035|NCT02394028|527925126|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389036|NCT02394028|527925127|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389037|NCT02394028|527925128|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389038|NCT02394028|527925129|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389039|NCT02394028|527925130|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389040|NCT02394028|527925131|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389041|NCT02394028|527925132|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
146389042|NCT02394028|527925133|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389043|NCT02394028|527925134|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389044|NCT02394028|527925135|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389045|NCT02394028|527925136|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
146389046|NCT02394028|527925126|FG000|Induction Phase|Sponsor decision|0|||
146389047|NCT02394028|527925127|FG001|Induction Phase|Sponsor decision|1|||
146389048|NCT02394028|527925128|FG002|Induction Phase|Sponsor decision|2|||
146389049|NCT02394028|527925129|FG003|Induction Phase|Sponsor decision|0|||
146389050|NCT02394028|527925130|FG004|Induction Phase|Sponsor decision|0|||
146389051|NCT02394028|527925131|FG005|Induction Phase|Sponsor decision|0|||
146389052|NCT02394028|527925132|FG006|Induction Phase|Sponsor decision|0|||
146389053|NCT02394028|527925133|FG007|Induction Phase|Sponsor decision|0|||
146389054|NCT02394028|527925134|FG008|Induction Phase|Sponsor decision|0|||
146389055|NCT02394028|527925135|FG009|Induction Phase|Sponsor decision|0|||
146389056|NCT02394028|527925136|FG010|Induction Phase|Sponsor decision|0|||
146389057|NCT02394028|527925126|FG000|Induction Phase|Technical reason|0|||
146389058|NCT02394028|527925127|FG001|Induction Phase|Technical reason|0|||
146389059|NCT02394028|527925128|FG002|Induction Phase|Technical reason|0|||
146389060|NCT02394028|527925129|FG003|Induction Phase|Technical reason|1|||
146389061|NCT02394028|527925130|FG004|Induction Phase|Technical reason|0|||
146389062|NCT02394028|527925131|FG005|Induction Phase|Technical reason|0|||
146389063|NCT02394028|527925132|FG006|Induction Phase|Technical reason|0|||
146389064|NCT02394028|527925133|FG007|Induction Phase|Technical reason|0|||
146389065|NCT02394028|527925134|FG008|Induction Phase|Technical reason|0|||
146389066|NCT02394028|527925135|FG009|Induction Phase|Technical reason|0|||
146389067|NCT02394028|527925136|FG010|Induction Phase|Technical reason|0|||
146389068|NCT02394028|527925126|FG000|Induction Phase|:ack of calculation|0|||
146389069|NCT02394028|527925127|FG001|Induction Phase|:ack of calculation|0|||
146389070|NCT02394028|527925128|FG002|Induction Phase|:ack of calculation|0|||
146389071|NCT02394028|527925129|FG003|Induction Phase|:ack of calculation|0|||
146389072|NCT02394028|527925130|FG004|Induction Phase|:ack of calculation|0|||
146389073|NCT02394028|527925131|FG005|Induction Phase|:ack of calculation|0|||
146389074|NCT02394028|527925132|FG006|Induction Phase|:ack of calculation|0|||
146389075|NCT02394028|527925133|FG007|Induction Phase|:ack of calculation|1|||
146389076|NCT02394028|527925134|FG008|Induction Phase|:ack of calculation|0|||
146389077|NCT02394028|527925135|FG009|Induction Phase|:ack of calculation|0|||
146389078|NCT02394028|527925136|FG010|Induction Phase|:ack of calculation|0|||
146389079|NCT02394028|527925126|FG000|Maintenance Phase|Protocol Violation|0|||
146389080|NCT02394028|527925127|FG001|Maintenance Phase|Protocol Violation|0|||
146389081|NCT02394028|527925128|FG002|Maintenance Phase|Protocol Violation|0|||
146389082|NCT02394028|527925129|FG003|Maintenance Phase|Protocol Violation|0|||
146389083|NCT02394028|527925130|FG004|Maintenance Phase|Protocol Violation|0|||
146389084|NCT02394028|527925131|FG005|Maintenance Phase|Protocol Violation|0|||
146389085|NCT02394028|527925132|FG006|Maintenance Phase|Protocol Violation|0|||
146389086|NCT02394028|527925133|FG007|Maintenance Phase|Protocol Violation|0|||
146389087|NCT02394028|527925134|FG008|Maintenance Phase|Protocol Violation|0|||
146389088|NCT02394028|527925135|FG009|Maintenance Phase|Protocol Violation|0|||
146389089|NCT02394028|527925136|FG010|Maintenance Phase|Protocol Violation|1|||
146389090|NCT02394028|527925126|FG000|Maintenance Phase|Physician Decision|0|||
146389091|NCT02394028|527925127|FG001|Maintenance Phase|Physician Decision|0|||
146389092|NCT02394028|527925128|FG002|Maintenance Phase|Physician Decision|0|||
146389093|NCT02394028|527925129|FG003|Maintenance Phase|Physician Decision|0|||
146389094|NCT02394028|527925130|FG004|Maintenance Phase|Physician Decision|0|||
146389095|NCT02394028|527925131|FG005|Maintenance Phase|Physician Decision|0|||
146389096|NCT02394028|527925132|FG006|Maintenance Phase|Physician Decision|0|||
146389097|NCT02394028|527925133|FG007|Maintenance Phase|Physician Decision|0|||
146389098|NCT02394028|527925134|FG008|Maintenance Phase|Physician Decision|1|||
146389099|NCT02394028|527925135|FG009|Maintenance Phase|Physician Decision|3|||
146389100|NCT02394028|527925136|FG010|Maintenance Phase|Physician Decision|2|||
146389101|NCT02394028|527925126|FG000|Maintenance Phase|Lack of Efficacy|0|||
146389102|NCT02394028|527925127|FG001|Maintenance Phase|Lack of Efficacy|0|||
146389103|NCT02394028|527925128|FG002|Maintenance Phase|Lack of Efficacy|0|||
146389104|NCT02394028|527925129|FG003|Maintenance Phase|Lack of Efficacy|0|||
146389105|NCT02394028|527925130|FG004|Maintenance Phase|Lack of Efficacy|0|||
146389106|NCT02394028|527925131|FG005|Maintenance Phase|Lack of Efficacy|0|||
146389107|NCT02394028|527925132|FG006|Maintenance Phase|Lack of Efficacy|0|||
146389108|NCT02394028|527925133|FG007|Maintenance Phase|Lack of Efficacy|0|||
146389109|NCT02394028|527925134|FG008|Maintenance Phase|Lack of Efficacy|7|||
146389110|NCT02394028|527925135|FG009|Maintenance Phase|Lack of Efficacy|25|||
146389111|NCT02394028|527925136|FG010|Maintenance Phase|Lack of Efficacy|33|||
146389112|NCT02394028|527925126|FG000|Maintenance Phase|Death|0|||
146389113|NCT02394028|527925127|FG001|Maintenance Phase|Death|0|||
146389114|NCT02394028|527925128|FG002|Maintenance Phase|Death|0|||
146389115|NCT02394028|527925129|FG003|Maintenance Phase|Death|0|||
146389116|NCT02394028|527925130|FG004|Maintenance Phase|Death|0|||
146389117|NCT02394028|527925131|FG005|Maintenance Phase|Death|0|||
146389118|NCT02394028|527925132|FG006|Maintenance Phase|Death|0|||
146389119|NCT02394028|527925133|FG007|Maintenance Phase|Death|0|||
146389120|NCT02394028|527925134|FG008|Maintenance Phase|Death|0|||
146389121|NCT02394028|527925135|FG009|Maintenance Phase|Death|0|||
146389122|NCT02394028|527925136|FG010|Maintenance Phase|Death|1|||
146389123|NCT02394028|527925126|FG000|Maintenance Phase|Adverse Event|0|||
146389124|NCT02394028|527925127|FG001|Maintenance Phase|Adverse Event|0|||
146389125|NCT02394028|527925128|FG002|Maintenance Phase|Adverse Event|0|||
146389126|NCT02394028|527925129|FG003|Maintenance Phase|Adverse Event|0|||
146389127|NCT02394028|527925130|FG004|Maintenance Phase|Adverse Event|0|||
146389128|NCT02394028|527925131|FG005|Maintenance Phase|Adverse Event|0|||
146389129|NCT02394028|527925132|FG006|Maintenance Phase|Adverse Event|0|||
146389130|NCT02394028|527925133|FG007|Maintenance Phase|Adverse Event|0|||
146389131|NCT02394028|527925134|FG008|Maintenance Phase|Adverse Event|1|||
146389132|NCT02394028|527925135|FG009|Maintenance Phase|Adverse Event|1|||
146389133|NCT02394028|527925136|FG010|Maintenance Phase|Adverse Event|3|||
146389134|NCT02394028|527925126|FG000|Maintenance Phase|Site closure|0|||
146389135|NCT02394028|527925127|FG001|Maintenance Phase|Site closure|0|||
146389136|NCT02394028|527925128|FG002|Maintenance Phase|Site closure|0|||
146389137|NCT02394028|527925129|FG003|Maintenance Phase|Site closure|0|||
146389138|NCT02394028|527925130|FG004|Maintenance Phase|Site closure|0|||
146389139|NCT02394028|527925131|FG005|Maintenance Phase|Site closure|0|||
146389140|NCT02394028|527925132|FG006|Maintenance Phase|Site closure|0|||
146389141|NCT02394028|527925133|FG007|Maintenance Phase|Site closure|0|||
146389142|NCT02394028|527925134|FG008|Maintenance Phase|Site closure|0|||
146389143|NCT02394028|527925135|FG009|Maintenance Phase|Site closure|1|||
146389144|NCT02394028|527925136|FG010|Maintenance Phase|Site closure|0|||
146389145|NCT02394028|527925126|FG000|Maintenance Phase|Withdrawal by Subject|0|||
146389146|NCT02394028|527925127|FG001|Maintenance Phase|Withdrawal by Subject|0|||
146389147|NCT02394028|527925128|FG002|Maintenance Phase|Withdrawal by Subject|0|||
146389148|NCT02394028|527925129|FG003|Maintenance Phase|Withdrawal by Subject|0|||
146389149|NCT02394028|527925130|FG004|Maintenance Phase|Withdrawal by Subject|0|||
146389150|NCT02394028|527925131|FG005|Maintenance Phase|Withdrawal by Subject|0|||
146389151|NCT02394028|527925132|FG006|Maintenance Phase|Withdrawal by Subject|0|||
146389152|NCT02394028|527925133|FG007|Maintenance Phase|Withdrawal by Subject|0|||
146389153|NCT02394028|527925134|FG008|Maintenance Phase|Withdrawal by Subject|3|||
146389154|NCT02394028|527925135|FG009|Maintenance Phase|Withdrawal by Subject|12|||
146389155|NCT02394028|527925136|FG010|Maintenance Phase|Withdrawal by Subject|12|||
146389156|NCT00742391|527925137|FG000|Overall Study|Adverse Event|2|||
146389157|NCT00742391|527925138|FG001|Overall Study|Adverse Event|1|||
146389158|NCT00742391|527925137|FG000|Overall Study|Lost to Follow-up|1|||
146389159|NCT00742391|527925138|FG001|Overall Study|Lost to Follow-up|0|||
146389160|NCT00742391|527925137|FG000|Overall Study|Protocol Violation|1|||
146389161|NCT00742391|527925138|FG001|Overall Study|Protocol Violation|0|||
146389162|NCT04815291|527925152|FG000|Overall Study|Lost to Follow-up|1|||
146389163|NCT04815291|527925152|FG000|Overall Study|Physician Decision|4|||
146389164|NCT04815291|527925152|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
146389165|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
146389166|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
146389167|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
146389168|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146389169|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
146389170|NCT00989664|527925153|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
146389171|NCT00989664|527925153|FG000|Long-Term Follow-Up|Death|3|||
146389172|NCT02363322|527925154|FG000|Overall Study|Lost to Follow-up|1|||
146389173|NCT02363322|527925155|FG001|Overall Study|Lost to Follow-up|0|||
146389174|NCT00983827|527925156|FG000|Overall Study|Withdrawal by Subject|1|||
146389175|NCT01854918|527925157|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
146389176|NCT01854918|527925158|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
146389177|NCT01854918|527925157|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
146389178|NCT01854918|527925158|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
146389179|NCT01854918|527925157|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
146389180|NCT01854918|527925158|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
146389181|NCT01854918|527925157|FG000|SOC-controlled Period (Year 1)|Death|5|||
146389182|NCT01854918|527925158|FG001|SOC-controlled Period (Year 1)|Death|5|||
146389183|NCT01854918|527925157|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
146389184|NCT01854918|527925158|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
146389185|NCT01854918|527925157|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
146389186|NCT01854918|527925158|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
146389187|NCT01854918|527925157|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
146389188|NCT01854918|527925158|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
146389189|NCT01854918|527925157|FG000|All-IP Period (Years 2 and 3)|Death|5|||
146389190|NCT01854918|527925158|FG001|All-IP Period (Years 2 and 3)|Death|16|||
146389191|NCT03091920|527925165|FG000|Overall Study|Adverse Event|0|||
146389192|NCT03091920|527925166|FG001|Overall Study|Adverse Event|1|||
146389193|NCT03091920|527925167|FG002|Overall Study|Adverse Event|0|||
146389194|NCT03922945|527927155|FG000|Overall Study|Adverse Event|1|||
146389195|NCT03922945|527927156|FG001|Overall Study|Adverse Event|1|||
146389196|NCT03922945|527927157|FG002|Overall Study|Adverse Event|2|||
146389197|NCT03922945|527927155|FG000|Overall Study|Lost to Follow-up|13|||
146389198|NCT03922945|527927156|FG001|Overall Study|Lost to Follow-up|9|||
146389199|NCT03922945|527927157|FG002|Overall Study|Lost to Follow-up|20|||
146389200|NCT03922945|527927155|FG000|Overall Study|Lack of Efficacy|2|||
146389201|NCT03922945|527927156|FG001|Overall Study|Lack of Efficacy|0|||
146389202|NCT03922945|527927157|FG002|Overall Study|Lack of Efficacy|1|||
146389203|NCT03922945|527927155|FG000|Overall Study|Protocol Non-Compliance|0|||
146389204|NCT03922945|527927156|FG001|Overall Study|Protocol Non-Compliance|0|||
146389205|NCT03922945|527927157|FG002|Overall Study|Protocol Non-Compliance|1|||
146389206|NCT03922945|527927155|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
146389207|NCT03922945|527927156|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
146389208|NCT03922945|527927157|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
146389209|NCT03922945|527927155|FG000|Overall Study|All Other Personal Reasons|1|||
146389210|NCT03922945|527927156|FG001|Overall Study|All Other Personal Reasons|1|||
146389211|NCT03922945|527927157|FG002|Overall Study|All Other Personal Reasons|2|||
146389212|NCT02719028|527927167|FG000|Overall Study|Adverse Event|2|||
146389213|NCT02719028|527927168|FG001|Overall Study|Adverse Event|1|||
146389214|NCT02719028|527927169|FG002|Overall Study|Adverse Event|4|||
146389215|NCT02719028|527927170|FG003|Overall Study|Adverse Event|8|||
146389216|NCT02719028|527927167|FG000|Overall Study|Physician Decision|0|||
146389217|NCT02719028|527927168|FG001|Overall Study|Physician Decision|1|||
146389218|NCT02719028|527927169|FG002|Overall Study|Physician Decision|1|||
146389219|NCT02719028|527927170|FG003|Overall Study|Physician Decision|1|||
146389220|NCT02719028|527927167|FG000|Overall Study|Use of prohibited medication|0|||
146389221|NCT02719028|527927168|FG001|Overall Study|Use of prohibited medication|0|||
146389222|NCT02719028|527927169|FG002|Overall Study|Use of prohibited medication|1|||
146389223|NCT02719028|527927170|FG003|Overall Study|Use of prohibited medication|0|||
146389224|NCT02719028|527927167|FG000|Overall Study|Protocol Violation|0|||
146389225|NCT02719028|527927168|FG001|Overall Study|Protocol Violation|0|||
146389226|NCT02719028|527927169|FG002|Overall Study|Protocol Violation|0|||
146389227|NCT02719028|527927170|FG003|Overall Study|Protocol Violation|1|||
146389228|NCT03287960|527927171|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
146389229|NCT03287960|527927171|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
146389230|NCT01191190|527927172|FG000|Overall Study|Withdrawal by Subject|1|||
146389231|NCT01398176|527927173|FG000|Overall Study|Lost to Follow-up|1|||
146389232|NCT01398176|527927174|FG001|Overall Study|Lost to Follow-up|3|||
146389233|NCT01398176|527927173|FG000|Overall Study|Physician Decision|2|||
146389234|NCT01398176|527927174|FG001|Overall Study|Physician Decision|3|||
146389235|NCT01871870|527927175|FG000|Overall Study|Hardware issues|7|||
146389236|NCT01871870|527927175|FG000|Overall Study|hyperglycemia|2|||
146389237|NCT01977651|527927179|FG000|4 Month Treatment Period|Adverse Event|34|||
146389238|NCT01977651|527927179|FG000|4 Month Treatment Period|Death|3|||
146389239|NCT01977651|527927179|FG000|4 Month Treatment Period|Progressive Disease|43|||
146389240|NCT01977651|527927179|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
146389241|NCT01977651|527927179|FG000|4 Month Treatment Period|Physician Decision|4|||
146389242|NCT01977651|527927179|FG000|1 Year Extension Period|Adverse Event|14|||
146389243|NCT01977651|527927179|FG000|1 Year Extension Period|Death|10|||
146389244|NCT01977651|527927179|FG000|1 Year Extension Period|Lost to Follow-up|2|||
146389245|NCT01977651|527927179|FG000|1 Year Extension Period|Progressive Disease|86|||
146389246|NCT01977651|527927179|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
146389247|NCT01977651|527927179|FG000|1 Year Extension Period|Physician Decision|6|||
146389248|NCT01977651|527927179|FG000|1 Year Extension Period|Miscellaneous|1|||
146389249|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Adverse Event|5|||
146389250|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Death|13|||
146389251|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
146389252|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
146389253|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Physician Decision|4|||
146389254|NCT01977651|527927179|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
146389255|NCT03287089|527927180|FG000|Overall Study|Lost to Follow-up|0|||
146389256|NCT03287089|527927181|FG001|Overall Study|Lost to Follow-up|2|||
146389257|NCT03287089|527927180|FG000|Overall Study|Physician Decision|0|||
146389258|NCT03287089|527927181|FG001|Overall Study|Physician Decision|2|||
146389259|NCT03287089|527927180|FG000|Overall Study|Withdrawal by Subject|0|||
146389260|NCT03287089|527927181|FG001|Overall Study|Withdrawal by Subject|2|||
146389261|NCT02543801|527927184|FG000|Overall Study|Protocol Violation|1|||
146389262|NCT02543801|527927185|FG001|Overall Study|Protocol Violation|2|||
146389263|NCT02543801|527927186|FG002|Overall Study|Protocol Violation|0|||
146389264|NCT02543801|527927187|FG003|Overall Study|Protocol Violation|0|||
146389265|NCT04118127|527927188|FG000|Overall Study|Trial terminated by sponsor|0|||
146389266|NCT04118127|527927189|FG001|Overall Study|Trial terminated by sponsor|12|||
146389267|NCT04118127|527927188|FG000|Overall Study|Adverse Event|1|||
146389268|NCT04118127|527927189|FG001|Overall Study|Adverse Event|2|||
146389269|NCT04118127|527927188|FG000|Overall Study|Physician Decision|0|||
146389270|NCT04118127|527927189|FG001|Overall Study|Physician Decision|1|||
146389271|NCT04118127|527927188|FG000|Overall Study|Withdrawal by Subject|2|||
146389272|NCT04118127|527927189|FG001|Overall Study|Withdrawal by Subject|1|||
146389273|NCT01646255|527927190|FG000|Overall Study|Adverse Event|7|||
146389274|NCT01646255|527927191|FG001|Overall Study|Adverse Event|8|||
146389275|NCT01646255|527927190|FG000|Overall Study|Lack of Efficacy|2|||
146389276|NCT01646255|527927191|FG001|Overall Study|Lack of Efficacy|0|||
146389277|NCT01646255|527927190|FG000|Overall Study|Withdrawal by Subject|10|||
146389278|NCT01646255|527927191|FG001|Overall Study|Withdrawal by Subject|6|||
146389279|NCT01646255|527927190|FG000|Overall Study|Compliance is not well|1|||
146389280|NCT01646255|527927191|FG001|Overall Study|Compliance is not well|0|||
146389281|NCT01646255|527927190|FG000|Overall Study|Inclusion Criteria Deviation|1|||
146389282|NCT01646255|527927191|FG001|Overall Study|Inclusion Criteria Deviation|0|||
146389283|NCT01376908|527927192|FG000|Overall Study|Protocol Violation|1|||
146389284|NCT01376908|527927193|FG001|Overall Study|Protocol Violation|1|||
146389285|NCT01376908|527927192|FG000|Overall Study|Withdrawal by Subject|1|||
146389286|NCT01376908|527927193|FG001|Overall Study|Withdrawal by Subject|2|||
146389287|NCT02142712|527927194|FG000|Overall Study|Lost to Follow-up|1|||
146389288|NCT02142712|527927195|FG001|Overall Study|Lost to Follow-up|1|||
146389289|NCT02142712|527927196|FG002|Overall Study|Lost to Follow-up|1|||
146389290|NCT02142712|527927197|FG003|Overall Study|Lost to Follow-up|0|||
146389291|NCT01241318|527927198|FG000|Overall Study|Woman: false pregnancies|27|||
146389292|NCT01241318|527927199|FG001|Overall Study|Woman: false pregnancies|15|||
146389293|NCT01241318|527927198|FG000|Overall Study|Woman: miscarriage/abortion|46|||
146389294|NCT01241318|527927199|FG001|Overall Study|Woman: miscarriage/abortion|38|||
146389295|NCT01241318|527927198|FG000|Overall Study|Withdrawal by Subject|175|||
146389296|NCT01241318|527927199|FG001|Overall Study|Withdrawal by Subject|46|||
146389297|NCT01241318|527927198|FG000|Overall Study|Lost to Follow-up|740|||
146389298|NCT01241318|527927199|FG001|Overall Study|Lost to Follow-up|455|||
146389299|NCT01241318|527927198|FG000|Overall Study|Death|2|||
146389300|NCT01241318|527927199|FG001|Overall Study|Death|4|||
146389301|NCT01241318|527927198|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
146389302|NCT01241318|527927199|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
146389303|NCT01241318|527927198|FG000|Overall Study|Woman: Stillborn infant|129|||
146389304|NCT01241318|527927199|FG001|Overall Study|Woman: Stillborn infant|146|||
146389305|NCT02355665|527927200|FG000|Overall Study|Adverse Event|16|||
146389306|NCT02355665|527927201|FG001|Overall Study|Adverse Event|24|||
146389307|NCT02355665|527927200|FG000|Overall Study|Protocol Violation|2|||
146389308|NCT02355665|527927201|FG001|Overall Study|Protocol Violation|0|||
146389309|NCT02355665|527927200|FG000|Overall Study|Withdrawal by Subject|90|||
146389310|NCT02355665|527927201|FG001|Overall Study|Withdrawal by Subject|100|||
146389311|NCT02355665|527927200|FG000|Overall Study|Lost to Follow-up|131|||
146389312|NCT02355665|527927201|FG001|Overall Study|Lost to Follow-up|103|||
146389313|NCT02355665|527927200|FG000|Overall Study|Death|4|||
146389314|NCT02355665|527927201|FG001|Overall Study|Death|2|||
146389315|NCT02355665|527927200|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
146389316|NCT02355665|527927201|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
146389317|NCT04129242|527927202|FG000|Overall Study|Physician Decision|1|||
146389318|NCT04129242|527927203|FG001|Overall Study|Physician Decision|1|||
146389319|NCT04129242|527927202|FG000|Overall Study|Protocol Violation|0|||
146389320|NCT04129242|527927203|FG001|Overall Study|Protocol Violation|1|||
146389321|NCT03480841|527927204|FG000|Overall Study|Lost to Follow-up|2|||
146389322|NCT01362049|527927205|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
146389323|NCT01362049|527927206|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
146389324|NCT01362049|527927207|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
146389325|NCT01362049|527927208|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
146389326|NCT01362049|527927205|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
146389327|NCT01362049|527927206|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
146389328|NCT01362049|527927207|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
146389329|NCT01362049|527927208|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
146389330|NCT02417935|527927209|FG000|Treatment Period|Adverse Event|12|||
146389331|NCT02417935|527927210|FG001|Treatment Period|Adverse Event|10|||
146389332|NCT02417935|527927209|FG000|Treatment Period|Lost to Follow-up|1|||
146389333|NCT02417935|527927210|FG001|Treatment Period|Lost to Follow-up|0|||
146389334|NCT02417935|527927209|FG000|Treatment Period|Entry Criteria not met|0|||
146389335|NCT02417935|527927210|FG001|Treatment Period|Entry Criteria not met|1|||
146389336|NCT02417935|527927209|FG000|Treatment Period|Protocol Violation|2|||
146389337|NCT02417935|527927210|FG001|Treatment Period|Protocol Violation|1|||
146389338|NCT02417935|527927209|FG000|Treatment Period|Withdrawal by Subject|3|||
146389339|NCT02417935|527927210|FG001|Treatment Period|Withdrawal by Subject|3|||
146389340|NCT02417935|527927209|FG000|Treatment Period|Physician Decision|3|||
146389341|NCT02417935|527927210|FG001|Treatment Period|Physician Decision|1|||
146389342|NCT02850276|527927213|FG000|Overall Study|screen failure|43|||
146389343|NCT02850276|527927213|FG000|Overall Study|Withdrawal by Subject|14|||
146389344|NCT02850276|527927213|FG000|Overall Study|Physician Decision|2|||
146389345|NCT02850276|527927213|FG000|Overall Study|Lost to Follow-up|2|||
146389346|NCT00095836|527927217|FG000|Overall Study|Lost to Follow-up|1|||
146389347|NCT00095836|527927217|FG000|Overall Study|Adverse Event|1|||
146389348|NCT00095836|527927217|FG000|Overall Study|Death|2|||
146389349|NCT00962780|527927218|FG000|Overall Study|Death|0|||
146389350|NCT00962780|527927219|FG001|Overall Study|Death|1|||
146389351|NCT00962780|527927218|FG000|Overall Study|Protocol Violation|9|||
146389352|NCT00962780|527927219|FG001|Overall Study|Protocol Violation|4|||
146389353|NCT00962780|527927218|FG000|Overall Study|Withdrawal by Subject|1|||
146389354|NCT00962780|527927219|FG001|Overall Study|Withdrawal by Subject|8|||
146389355|NCT00962780|527927218|FG000|Overall Study|Other|0|||
146389356|NCT00962780|527927219|FG001|Overall Study|Other|1|||
146389357|NCT02853318|527927222|FG000|Overall Study|Withdrawal by Subject|1|||
146389358|NCT02269709|527927223|FG000|Time of Enrollment|Withdrawal by Subject|3|||
146389359|NCT02269709|527927223|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
146389360|NCT02269709|527927223|FG000|Six Month Follow-up|Lost to Follow-up|12|||
146389361|NCT02909504|527927224|FG000|Overall Study|Adverse Event|2|||
146389362|NCT02909504|527927224|FG000|Overall Study|Lack of Efficacy|3|||
146389363|NCT02909504|527927224|FG000|Overall Study|Withdrawal by Subject|4|||
146389364|NCT02909504|527927224|FG000|Overall Study|Pregnancy|1|||
146389365|NCT02909504|527927224|FG000|Overall Study|Subject moved|1|||
146389366|NCT02909504|527927224|FG000|Overall Study|Lost to Follow-up|1|||
146389367|NCT02055976|527927225|FG000|Overall Study|Other|0|||
146389368|NCT02055976|527927226|FG001|Overall Study|Other|0|||
146389369|NCT02055976|527927227|FG002|Overall Study|Other|1|||
146389370|NCT02055976|527927228|FG003|Overall Study|Other|0|||
146389371|NCT02055976|527927229|FG004|Overall Study|Other|0|||
146389372|NCT02055976|527927230|FG005|Overall Study|Other|0|||
146389373|NCT02055976|527927231|FG006|Overall Study|Other|0|||
146389374|NCT02055976|527927232|FG007|Overall Study|Other|0|||
146389375|NCT02055976|527927233|FG008|Overall Study|Other|0|||
146389376|NCT02055976|527927225|FG000|Overall Study|Adverse Event|0|||
146389377|NCT02055976|527927226|FG001|Overall Study|Adverse Event|0|||
146389378|NCT02055976|527927227|FG002|Overall Study|Adverse Event|0|||
146389379|NCT02055976|527927228|FG003|Overall Study|Adverse Event|0|||
146389380|NCT02055976|527927229|FG004|Overall Study|Adverse Event|0|||
146389381|NCT02055976|527927230|FG005|Overall Study|Adverse Event|1|||
146389382|NCT02055976|527927231|FG006|Overall Study|Adverse Event|1|||
146389383|NCT02055976|527927232|FG007|Overall Study|Adverse Event|0|||
146389384|NCT02055976|527927233|FG008|Overall Study|Adverse Event|0|||
146389385|NCT02055976|527927225|FG000|Overall Study|Does not meet entrance criteria|0|||
146389386|NCT02055976|527927226|FG001|Overall Study|Does not meet entrance criteria|0|||
146389387|NCT02055976|527927227|FG002|Overall Study|Does not meet entrance criteria|0|||
146389388|NCT02055976|527927228|FG003|Overall Study|Does not meet entrance criteria|0|||
146389389|NCT02055976|527927229|FG004|Overall Study|Does not meet entrance criteria|0|||
146389390|NCT02055976|527927230|FG005|Overall Study|Does not meet entrance criteria|0|||
146389391|NCT02055976|527927231|FG006|Overall Study|Does not meet entrance criteria|1|||
146389392|NCT02055976|527927232|FG007|Overall Study|Does not meet entrance criteria|0|||
146389393|NCT02055976|527927233|FG008|Overall Study|Does not meet entrance criteria|0|||
146389394|NCT02055976|527927225|FG000|Overall Study|Lost to Follow-up|0|||
146389395|NCT02055976|527927226|FG001|Overall Study|Lost to Follow-up|0|||
146389396|NCT02055976|527927227|FG002|Overall Study|Lost to Follow-up|0|||
146389397|NCT02055976|527927228|FG003|Overall Study|Lost to Follow-up|1|||
146389398|NCT02055976|527927229|FG004|Overall Study|Lost to Follow-up|0|||
146389399|NCT02055976|527927230|FG005|Overall Study|Lost to Follow-up|0|||
146389400|NCT02055976|527927231|FG006|Overall Study|Lost to Follow-up|0|||
146389401|NCT02055976|527927232|FG007|Overall Study|Lost to Follow-up|0|||
146389402|NCT02055976|527927233|FG008|Overall Study|Lost to Follow-up|0|||
146389403|NCT04411472|527927236|FG000|Overall Study|Adverse Event|5|||
146389404|NCT04411472|527927237|FG001|Overall Study|Adverse Event|10|||
146389405|NCT04411472|527927238|FG002|Overall Study|Adverse Event|1|||
146389406|NCT04411472|527927239|FG003|Overall Study|Adverse Event|0|||
146389407|NCT04411472|527927240|FG004|Overall Study|Adverse Event|0|||
146389408|NCT04411472|527927241|FG005|Overall Study|Adverse Event|0|||
146389409|NCT04411472|527927236|FG000|Overall Study|Protocol Violation|1|||
146389410|NCT04411472|527927237|FG001|Overall Study|Protocol Violation|0|||
146389411|NCT04411472|527927238|FG002|Overall Study|Protocol Violation|0|||
146389412|NCT04411472|527927239|FG003|Overall Study|Protocol Violation|0|||
146389413|NCT04411472|527927240|FG004|Overall Study|Protocol Violation|0|||
146389414|NCT04411472|527927241|FG005|Overall Study|Protocol Violation|0|||
146389415|NCT04411472|527927236|FG000|Overall Study|Withdrawal by Subject|0|||
146389416|NCT04411472|527927237|FG001|Overall Study|Withdrawal by Subject|1|||
146389417|NCT04411472|527927238|FG002|Overall Study|Withdrawal by Subject|0|||
146389418|NCT04411472|527927239|FG003|Overall Study|Withdrawal by Subject|1|||
146389419|NCT04411472|527927240|FG004|Overall Study|Withdrawal by Subject|0|||
146389420|NCT04411472|527927241|FG005|Overall Study|Withdrawal by Subject|0|||
146389421|NCT04411472|527927236|FG000|Overall Study|Physician Decision|1|||
146389422|NCT04411472|527927237|FG001|Overall Study|Physician Decision|0|||
146389423|NCT04411472|527927238|FG002|Overall Study|Physician Decision|0|||
146389424|NCT04411472|527927239|FG003|Overall Study|Physician Decision|0|||
146389425|NCT04411472|527927240|FG004|Overall Study|Physician Decision|0|||
146389426|NCT04411472|527927241|FG005|Overall Study|Physician Decision|0|||
146389427|NCT04411472|527927236|FG000|Overall Study|Study terminated by sponsor|17|||
146389428|NCT04411472|527927237|FG001|Overall Study|Study terminated by sponsor|20|||
146389429|NCT04411472|527927238|FG002|Overall Study|Study terminated by sponsor|3|||
146389430|NCT04411472|527927239|FG003|Overall Study|Study terminated by sponsor|0|||
146389431|NCT04411472|527927240|FG004|Overall Study|Study terminated by sponsor|0|||
146389432|NCT04411472|527927241|FG005|Overall Study|Study terminated by sponsor|0|||
146389433|NCT02504424|527927243|FG000|Overall Study|Withdrawal by Subject|2|||
146389434|NCT00440232|527927246|FG000|Overall Study|Lost to Follow-up|1|||
146389435|NCT00440232|527927247|FG001|Overall Study|Lost to Follow-up|1|||
146389436|NCT00440232|527927246|FG000|Overall Study|Unable to treat within allowed time|0|||
146389437|NCT00440232|527927247|FG001|Overall Study|Unable to treat within allowed time|1|||
146389438|NCT00440232|527927246|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
146389439|NCT00440232|527927247|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
146389440|NCT05060003|527927248|FG000|Overall Study|ctDNA negative|7|||
146389441|NCT00362297|527927249|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
146389442|NCT00362297|527927250|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
146389443|NCT00426842|527927251|FG000|Overall Study|Lost to Follow-up|1|||
146389444|NCT00982111|527927258|FG000|Overall Study|Adverse Event|1|||
146389445|NCT00982111|527927259|FG001|Overall Study|Adverse Event|1|||
146389446|NCT00982111|527927258|FG000|Overall Study|Progressive Disease|46|||
146389447|NCT00982111|527927259|FG001|Overall Study|Progressive Disease|39|||
146389448|NCT00982111|527927258|FG000|Overall Study|Lost to Follow-up|9|||
146389449|NCT00982111|527927259|FG001|Overall Study|Lost to Follow-up|6|||
146389450|NCT00982111|527927258|FG000|Overall Study|New Anti-Cancer Therapy|5|||
146389451|NCT00982111|527927259|FG001|Overall Study|New Anti-Cancer Therapy|5|||
146389452|NCT00982111|527927258|FG000|Overall Study|Medical Decision|1|||
146389453|NCT00982111|527927259|FG001|Overall Study|Medical Decision|0|||
146389454|NCT00982111|527927258|FG000|Overall Study|Withdrawal by Subject|17|||
146389455|NCT00982111|527927259|FG001|Overall Study|Withdrawal by Subject|19|||
146389456|NCT00982111|527927258|FG000|Overall Study|Global Study End|0|||
146389457|NCT00982111|527927259|FG001|Overall Study|Global Study End|1|||
146389458|NCT00982111|527927258|FG000|Overall Study|Sponsor's Decision|0|||
146389459|NCT00982111|527927259|FG001|Overall Study|Sponsor's Decision|1|||
146389460|NCT03769753|527927260|FG000|Overall Study|Not Treated|6|||
146389461|NCT03769753|527927260|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
146389462|NCT01070381|527927261|FG000|Period 2, 1 Week of Wear|Handling|0|||
146389463|NCT01070381|527927262|FG001|Period 2, 1 Week of Wear|Handling|1|||
146389464|NCT01070381|527927261|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
146389465|NCT01070381|527927262|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
146389466|NCT00684073|527927263|FG000|Selection|Selection/non-selection criteria|3|||
146389467|NCT00684073|527927263|FG000|Selection|Death|1|||
146389468|NCT00684073|527927263|FG000|Selection|noncompliance|1|||
146389469|NCT00684073|527927263|FG000|Selection|Lost to Follow-up|1|||
146389470|NCT00684073|527927263|FG000|Selection|request of the sponsor|1|||
146389471|NCT00684073|527927263|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
146389472|NCT01657903|527927265|FG000|Overall Study|Lost to Follow-up|1|||
146389473|NCT01657903|527927265|FG000|Overall Study|Withdrawal by Subject|1|||
146389474|NCT03512028|527927267|FG000|Overall Study|Withdrawal by Subject|2|||
146389475|NCT03512028|527927268|FG001|Overall Study|Withdrawal by Subject|0|||
146389476|NCT03512028|527927267|FG000|Overall Study|Protocol Violation|2|||
146389477|NCT03512028|527927268|FG001|Overall Study|Protocol Violation|0|||
146389478|NCT01259388|527927269|FG000|Overall Study|Adverse Event|3|||
146389479|NCT01259388|527927270|FG001|Overall Study|Adverse Event|0|||
146389480|NCT01259388|527927269|FG000|Overall Study|Withdrawal by Subject|1|||
146389481|NCT01259388|527927270|FG001|Overall Study|Withdrawal by Subject|1|||
146389482|NCT01259388|527927269|FG000|Overall Study|Physician Decision|1|||
146389483|NCT01259388|527927270|FG001|Overall Study|Physician Decision|0|||
146389484|NCT03529162|527927271|FG000|Overall Study|Lost to Follow-up|2|||
146389485|NCT03529162|527927272|FG001|Overall Study|Lost to Follow-up|2|||
146389486|NCT02728804|527927278|FG000|Overall Study|Ineligible|3|||
146389487|NCT02728804|527927278|FG000|Overall Study|Did not complete baseline questionnaire|9|||
146389488|NCT02728804|527927278|FG000|Overall Study|Death|99|||
146389489|NCT02146352|527927279|FG000|Overall Study|Death|1|||
146389490|NCT02146352|527927279|FG000|Overall Study|Patient entered hospice care|1|||
146389491|NCT02918006|527927280|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
146389492|NCT02918006|527927281|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
146389493|NCT02918006|527927282|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
146389494|NCT02918006|527927280|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
146389495|NCT02918006|527927281|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
146389496|NCT02918006|527927282|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
146389497|NCT02918006|527927280|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
146389498|NCT02918006|527927281|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
146389499|NCT02918006|527927282|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
146389500|NCT02918006|527927280|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
146389501|NCT02918006|527927281|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
146389502|NCT02918006|527927282|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
146389503|NCT02918006|527927280|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
146389504|NCT02918006|527927281|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
146389505|NCT02918006|527927282|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
146389506|NCT02918006|527927280|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
146389507|NCT02918006|527927281|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
146389508|NCT02918006|527927282|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
146389509|NCT02918006|527927280|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
146389510|NCT02918006|527927281|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
146389511|NCT02918006|527927282|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
146389512|NCT02918006|527927280|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
146389513|NCT02918006|527927281|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
146389514|NCT02918006|527927282|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
146389515|NCT02918006|527927280|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
146389516|NCT02918006|527927281|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
146389517|NCT02918006|527927282|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
146389518|NCT00453349|527927285|FG000|Randomized|Adverse Event|12|||
146389519|NCT00453349|527927286|FG001|Randomized|Adverse Event|11|||
146389520|NCT00453349|527927285|FG000|Randomized|Lack of Efficacy|2|||
146389521|NCT00453349|527927286|FG001|Randomized|Lack of Efficacy|1|||
146389522|NCT00453349|527927285|FG000|Randomized|Lost to Follow-up|7|||
146389523|NCT00453349|527927286|FG001|Randomized|Lost to Follow-up|5|||
146389524|NCT00453349|527927285|FG000|Randomized|Protocol Violation|1|||
146389525|NCT00453349|527927286|FG001|Randomized|Protocol Violation|1|||
146389526|NCT00453349|527927285|FG000|Randomized|Withdrawal by Subject|3|||
146389527|NCT00453349|527927286|FG001|Randomized|Withdrawal by Subject|5|||
146396130|NCT01241591|527954452|FG000|Overall Study|Protocol Violation|5|||
146389528|NCT00453349|527927285|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
146389529|NCT00453349|527927286|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
146389530|NCT00453349|527927285|FG000|Completed Study|Adverse Event|12|||
146389531|NCT00453349|527927286|FG001|Completed Study|Adverse Event|11|||
146389532|NCT00453349|527927285|FG000|Completed Study|Lack of Efficacy|2|||
146389533|NCT00453349|527927286|FG001|Completed Study|Lack of Efficacy|1|||
146389534|NCT00453349|527927285|FG000|Completed Study|Lost to Follow-up|7|||
146389535|NCT00453349|527927286|FG001|Completed Study|Lost to Follow-up|5|||
146389536|NCT00453349|527927285|FG000|Completed Study|Protocol Violation|1|||
146389537|NCT00453349|527927286|FG001|Completed Study|Protocol Violation|1|||
146389538|NCT00453349|527927285|FG000|Completed Study|Withdrawal by Subject|3|||
146389539|NCT00453349|527927286|FG001|Completed Study|Withdrawal by Subject|5|||
146389540|NCT00453349|527927285|FG000|Completed Study|Lost to follow up after study treatment|2|||
146389541|NCT00453349|527927286|FG001|Completed Study|Lost to follow up after study treatment|11|||
146389542|NCT01513460|527927288|FG000|Overall Study|Death|0|||
146389543|NCT01513460|527927289|FG001|Overall Study|Death|0|||
146389544|NCT01513460|527927290|FG002|Overall Study|Death|1|||
146389545|NCT01513460|527927288|FG000|Overall Study|Lost to Follow-up|0|||
146389546|NCT01513460|527927289|FG001|Overall Study|Lost to Follow-up|0|||
146389547|NCT01513460|527927290|FG002|Overall Study|Lost to Follow-up|2|||
146389548|NCT01513460|527927288|FG000|Overall Study|Abnormal laboratory value|1|||
146389549|NCT01513460|527927289|FG001|Overall Study|Abnormal laboratory value|0|||
146389550|NCT01513460|527927290|FG002|Overall Study|Abnormal laboratory value|1|||
146389551|NCT01513460|527927288|FG000|Overall Study|Lack of Efficacy|1|||
146389552|NCT01513460|527927289|FG001|Overall Study|Lack of Efficacy|2|||
146389553|NCT01513460|527927290|FG002|Overall Study|Lack of Efficacy|5|||
146389554|NCT01513460|527927288|FG000|Overall Study|Protocol deviations|3|||
146389555|NCT01513460|527927289|FG001|Overall Study|Protocol deviations|4|||
146389556|NCT01513460|527927290|FG002|Overall Study|Protocol deviations|3|||
146389557|NCT01513460|527927288|FG000|Overall Study|Withdrawal by Subject|7|||
146389558|NCT01513460|527927289|FG001|Overall Study|Withdrawal by Subject|8|||
146389559|NCT01513460|527927290|FG002|Overall Study|Withdrawal by Subject|21|||
146389560|NCT01513460|527927288|FG000|Overall Study|Adverse Event|16|||
146389561|NCT01513460|527927289|FG001|Overall Study|Adverse Event|18|||
146389562|NCT01513460|527927290|FG002|Overall Study|Adverse Event|23|||
146389563|NCT01513460|527927288|FG000|Overall Study|Abnormal test procedure|1|||
146389564|NCT01513460|527927289|FG001|Overall Study|Abnormal test procedure|0|||
146389565|NCT01513460|527927290|FG002|Overall Study|Abnormal test procedure|0|||
146389566|NCT00489216|527927294|FG000|Overall Study|Adverse Event|1|||
146389567|NCT02828982|527927297|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146389568|NCT02828982|527927298|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
146389569|NCT02312934|527927299|FG000|Overall Study|Lost to Follow-up|1|||
146389570|NCT02312934|527927300|FG001|Overall Study|Lost to Follow-up|0|||
146389571|NCT02312934|527927299|FG000|Overall Study|Physician Decision|1|||
146389572|NCT02312934|527927300|FG001|Overall Study|Physician Decision|0|||
146389573|NCT00701064|527927301|FG000|Overall Study|Protocol Violation|1|||
146389574|NCT00701064|527927302|FG001|Overall Study|Protocol Violation|1|||
146389575|NCT00701064|527927301|FG000|Overall Study|Withdrawal by Subject|1|||
146389576|NCT00701064|527927302|FG001|Overall Study|Withdrawal by Subject|1|||
146389577|NCT00701064|527927301|FG000|Overall Study|initiated other PTSD treatment|2|||
146389578|NCT00701064|527927302|FG001|Overall Study|initiated other PTSD treatment|2|||
146389579|NCT02098733|527927303|FG000|Overall Study|Data Not Available|5|||
146389580|NCT02098733|527927303|FG000|Overall Study|Lost to Follow-up|5|||
146389581|NCT02475564|527927304|FG000|Overall Study|Withdrawal by Subject|1|||
146389582|NCT02475564|527927305|FG001|Overall Study|Withdrawal by Subject|0|||
146389583|NCT02475564|527927304|FG000|Overall Study|Lost to Follow-up|2|||
146389584|NCT02475564|527927305|FG001|Overall Study|Lost to Follow-up|1|||
146389585|NCT02475564|527927304|FG000|Overall Study|Intense Menstrual bleeding|1|||
146389586|NCT02475564|527927305|FG001|Overall Study|Intense Menstrual bleeding|0|||
146389587|NCT03395704|527927306|FG000|Overall Study|Adverse Event|2|||
146389588|NCT03395704|527927307|FG001|Overall Study|Adverse Event|1|||
146389589|NCT03395704|527927306|FG000|Overall Study|Withdrawal by Subject|2|||
146389590|NCT03395704|527927307|FG001|Overall Study|Withdrawal by Subject|1|||
146389591|NCT03395704|527927306|FG000|Overall Study|Physician Decision|0|||
146389592|NCT03395704|527927307|FG001|Overall Study|Physician Decision|1|||
146389593|NCT01156012|527927308|FG000|Overall Study|Adverse Event|3|||
146389594|NCT01156012|527927309|FG001|Overall Study|Adverse Event|1|||
146389595|NCT01156012|527927308|FG000|Overall Study|Lost to Follow-up|1|||
146389596|NCT01156012|527927309|FG001|Overall Study|Lost to Follow-up|0|||
146389597|NCT01156012|527927308|FG000|Overall Study|Withdrawal by Subject|1|||
146389598|NCT01156012|527927309|FG001|Overall Study|Withdrawal by Subject|0|||
146389599|NCT01156012|527927308|FG000|Overall Study|use of commercial drug instead of study|0|||
146389600|NCT01156012|527927309|FG001|Overall Study|use of commercial drug instead of study|1|||
146389601|NCT01156012|527927308|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
146389602|NCT01156012|527927309|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
146389603|NCT02927990|527929089|FG000|Overall Study|Protocol Violation|4|||
146389604|NCT02927990|527929089|FG000|Overall Study|Physician Decision|9|||
146389605|NCT02927990|527929089|FG000|Overall Study|Room switched and therefore no study device available|15|||
146389606|NCT02927990|527929089|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
146389607|NCT00772031|527929090|FG000|Overall Study|Early termination of trial|12|||
146389608|NCT00772031|527929091|FG001|Overall Study|Early termination of trial|10|||
146389609|NCT00772031|527929090|FG000|Overall Study|Lost to Follow-up|20|||
146389610|NCT00772031|527929091|FG001|Overall Study|Lost to Follow-up|33|||
146389611|NCT03419741|527929092|FG000|Overall Study|Adverse Event|1|||
146389612|NCT03419741|527929093|FG001|Overall Study|Adverse Event|0|||
146389613|NCT03419741|527929092|FG000|Overall Study|Withdrawal by Subject|1|||
146389614|NCT03419741|527929093|FG001|Overall Study|Withdrawal by Subject|2|||
146389615|NCT04354870|527929094|FG000|Overall Study|Lost to Follow-up|32|||
146389616|NCT04354870|527929095|FG001|Overall Study|Lost to Follow-up|12|||
146389617|NCT04354870|527929094|FG000|Overall Study|Withdrawal by Subject|10|||
146389618|NCT04354870|527929095|FG001|Overall Study|Withdrawal by Subject|16|||
146389619|NCT04354870|527929094|FG000|Overall Study|Did not complete all study visits|6|||
146389620|NCT04354870|527929095|FG001|Overall Study|Did not complete all study visits|5|||
146389621|NCT03384316|527929096|FG000|Overall Study|Screen failure|0|||
146389622|NCT03384316|527929097|FG001|Overall Study|Screen failure|1|||
146389623|NCT02194699|527929102|FG000|Randomised|Did not receive treatment|1|||
146389624|NCT02194699|527929103|FG001|Randomised|Did not receive treatment|5|||
146389625|NCT02194699|527929102|FG000|Randomised|Without potential for 52 weeks of IP|5|||
146389626|NCT02194699|527929103|FG001|Randomised|Without potential for 52 weeks of IP|5|||
146389627|NCT02194699|527929102|FG000|Randomised|Duplicate patient|2|||
146389628|NCT02194699|527929103|FG001|Randomised|Duplicate patient|1|||
146389629|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
146389630|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
146389631|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
146389632|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
146389633|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
146389634|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
146389635|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
146389636|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
146389637|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
146389638|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
146389639|NCT02194699|527929102|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
146389640|NCT02194699|527929103|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
146389641|NCT01667731|527929105|FG000|Overall Study|Enrolled but not treated|0|||
146389642|NCT01667731|527929106|FG001|Overall Study|Enrolled but not treated|0|||
146389643|NCT01667731|527929107|FG002|Overall Study|Enrolled but not treated|0|||
146389644|NCT01667731|527929108|FG003|Overall Study|Enrolled but not treated|0|||
146389645|NCT01667731|527929109|FG004|Overall Study|Enrolled but not treated|1|||
146389646|NCT01667731|527929105|FG000|Overall Study|Efficacy Failure|1|||
146389647|NCT01667731|527929106|FG001|Overall Study|Efficacy Failure|12|||
146389648|NCT01667731|527929107|FG002|Overall Study|Efficacy Failure|0|||
146389649|NCT01667731|527929108|FG003|Overall Study|Efficacy Failure|1|||
146389650|NCT01667731|527929109|FG004|Overall Study|Efficacy Failure|24|||
146389651|NCT01667731|527929105|FG000|Overall Study|Lost to Follow-up|2|||
146389652|NCT01667731|527929106|FG001|Overall Study|Lost to Follow-up|3|||
146389653|NCT01667731|527929107|FG002|Overall Study|Lost to Follow-up|1|||
146389654|NCT01667731|527929108|FG003|Overall Study|Lost to Follow-up|1|||
146389655|NCT01667731|527929109|FG004|Overall Study|Lost to Follow-up|2|||
146389656|NCT01667731|527929105|FG000|Overall Study|Subject Withdrew Consent|2|||
146389657|NCT01667731|527929106|FG001|Overall Study|Subject Withdrew Consent|0|||
146389658|NCT01667731|527929107|FG002|Overall Study|Subject Withdrew Consent|1|||
146389659|NCT01667731|527929108|FG003|Overall Study|Subject Withdrew Consent|0|||
146389660|NCT01667731|527929109|FG004|Overall Study|Subject Withdrew Consent|1|||
146389661|NCT01667731|527929105|FG000|Overall Study|Death|0|||
146389662|NCT01667731|527929106|FG001|Overall Study|Death|1|||
146389663|NCT01667731|527929107|FG002|Overall Study|Death|0|||
146389664|NCT01667731|527929108|FG003|Overall Study|Death|0|||
146389665|NCT01667731|527929109|FG004|Overall Study|Death|0|||
146389666|NCT00561912|527929110|FG000|Overall Study|ineligible|1|||
146389667|NCT00577382|527929111|FG000|Overall Study|Adverse Event|0|||
146389668|NCT00577382|527929112|FG001|Overall Study|Adverse Event|6|||
146389669|NCT00577382|527929111|FG000|Overall Study|Withdrawal by Subject|0|||
146389670|NCT00577382|527929112|FG001|Overall Study|Withdrawal by Subject|1|||
146389671|NCT00577382|527929111|FG000|Overall Study|Progressive Disease|17|||
146389672|NCT00577382|527929112|FG001|Overall Study|Progressive Disease|19|||
146389673|NCT00577382|527929111|FG000|Overall Study|Intercurrent Illness|1|||
146389674|NCT00577382|527929112|FG001|Overall Study|Intercurrent Illness|2|||
146389675|NCT00577382|527929111|FG000|Overall Study|Death|1|||
146389676|NCT00577382|527929112|FG001|Overall Study|Death|1|||
146389677|NCT00577382|527929111|FG000|Overall Study|Lost to Follow-up|2|||
146389678|NCT00577382|527929112|FG001|Overall Study|Lost to Follow-up|2|||
146389679|NCT03007472|527929113|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
146389680|NCT03007472|527929113|FG000|Overall Study|Death|2|||
146389681|NCT03007472|527929113|FG000|Overall Study|Loss to Follow Up|1|||
146389682|NCT00649220|527929114|FG000|Overall Study|Adverse Event|2|||
146389683|NCT00649220|527929114|FG000|Overall Study|Withdrawal by Subject|1|||
146389684|NCT00525499|527929115|FG000|Overall Study|Lost to Follow-up|2|||
146389685|NCT00525499|527929116|FG001|Overall Study|Lost to Follow-up|4|||
146389686|NCT00525499|527929117|FG002|Overall Study|Lost to Follow-up|1|||
146389687|NCT00525499|527929118|FG003|Overall Study|Lost to Follow-up|4|||
146389688|NCT00525499|527929115|FG000|Overall Study|Adverse Event|0|||
146389689|NCT00525499|527929116|FG001|Overall Study|Adverse Event|1|||
146389690|NCT00525499|527929117|FG002|Overall Study|Adverse Event|0|||
146389691|NCT00525499|527929118|FG003|Overall Study|Adverse Event|1|||
146389692|NCT00525499|527929115|FG000|Overall Study|Withdrawal by Subject|5|||
146389693|NCT00525499|527929116|FG001|Overall Study|Withdrawal by Subject|1|||
146389694|NCT00525499|527929117|FG002|Overall Study|Withdrawal by Subject|5|||
146389695|NCT00525499|527929118|FG003|Overall Study|Withdrawal by Subject|2|||
146389696|NCT00525499|527929115|FG000|Overall Study|Protocol Violation|0|||
146389697|NCT00525499|527929116|FG001|Overall Study|Protocol Violation|1|||
146389698|NCT00525499|527929117|FG002|Overall Study|Protocol Violation|1|||
146389699|NCT00525499|527929118|FG003|Overall Study|Protocol Violation|0|||
146389700|NCT01729559|527929123|FG000|Overall Study|Protocol Violation|31|||
146389701|NCT01729559|527929124|FG001|Overall Study|Protocol Violation|28|||
146389702|NCT02906644|527929129|FG000|First 2 Weeks|Withdrawal by Subject|0|||
146389703|NCT02906644|527929130|FG001|First 2 Weeks|Withdrawal by Subject|2|||
146389704|NCT02906644|527929129|FG000|First 2 Weeks|Physician Decision|1|||
146389705|NCT02906644|527929130|FG001|First 2 Weeks|Physician Decision|1|||
146389706|NCT02906644|527929129|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
146389707|NCT02906644|527929130|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
146389708|NCT02906644|527929129|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
146389709|NCT02906644|527929130|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
146389710|NCT03672006|527929133|FG000|Overall Study|exclusion criteria met|0|||
146389711|NCT03672006|527929134|FG001|Overall Study|exclusion criteria met|1|||
146389712|NCT00608426|527929135|FG000|Overall Study|Death|32|||
146389713|NCT00608426|527929136|FG001|Overall Study|Death|36|||
146389714|NCT00608426|527929135|FG000|Overall Study|Lost to Follow-up|485|||
146389715|NCT00608426|527929136|FG001|Overall Study|Lost to Follow-up|521|||
146389716|NCT00608426|527929135|FG000|Overall Study|refused, health issues, wrong address|319|||
146389717|NCT00608426|527929136|FG001|Overall Study|refused, health issues, wrong address|348|||
146389718|NCT00761891|527929137|FG000|Overall Study|Withdrawal by Subject|10|||
146389719|NCT01707667|527929138|FG000|Period 1|expulsion of colonic sensor catheter|1|||
146389720|NCT01707667|527929139|FG001|Period 1|expulsion of colonic sensor catheter|0|||
146389721|NCT01453439|527929143|FG000|Treatment Phase|Withdrawal by Subject|13|||
146389722|NCT01453439|527929144|FG001|Treatment Phase|Withdrawal by Subject|10|||
146389723|NCT01453439|527929143|FG000|Treatment Phase|Suicidal Ideation|2|||
146389724|NCT01453439|527929144|FG001|Treatment Phase|Suicidal Ideation|0|||
146389725|NCT01453439|527929143|FG000|Treatment Phase|Need for higher level of care|1|||
146389726|NCT01453439|527929144|FG001|Treatment Phase|Need for higher level of care|1|||
146389727|NCT01453439|527929143|FG000|Treatment Phase|Therapist conflict of interest|1|||
146389728|NCT01453439|527929144|FG001|Treatment Phase|Therapist conflict of interest|0|||
146389729|NCT01453439|527929143|FG000|Follow-up|Withdrawal by Subject|0|||
146389730|NCT01453439|527929144|FG001|Follow-up|Withdrawal by Subject|1|||
146389731|NCT01453439|527929143|FG000|Follow-up|Lost to Follow-up|5|||
146389732|NCT01453439|527929144|FG001|Follow-up|Lost to Follow-up|10|||
146389733|NCT01014442|527929145|FG000|Overall Study|Adverse Event|0|||
146389734|NCT01014442|527929146|FG001|Overall Study|Adverse Event|8|||
146389735|NCT01014442|527929145|FG000|Overall Study|Withdrawal by Subject|4|||
146389736|NCT01014442|527929146|FG001|Overall Study|Withdrawal by Subject|4|||
146389737|NCT01014442|527929145|FG000|Overall Study|Protocol Violation|2|||
146389738|NCT01014442|527929146|FG001|Overall Study|Protocol Violation|5|||
146389739|NCT01014442|527929145|FG000|Overall Study|Lack of Compliance|0|||
146389740|NCT01014442|527929146|FG001|Overall Study|Lack of Compliance|1|||
146389741|NCT01014442|527929145|FG000|Overall Study|Unspecified Reason|1|||
146389742|NCT01014442|527929146|FG001|Overall Study|Unspecified Reason|1|||
146389743|NCT02074059|527929147|FG000|Overall Study|Death|0|||
146389744|NCT02074059|527929148|FG001|Overall Study|Death|0|||
146389745|NCT02074059|527929149|FG002|Overall Study|Death|0|||
146389746|NCT02074059|527929150|FG003|Overall Study|Death|0|||
146389747|NCT02074059|527929151|FG004|Overall Study|Death|1|||
146389748|NCT02074059|527929152|FG005|Overall Study|Death|1|||
146389749|NCT02764229|527929158|FG000|Overall Study|Withdrawal by Subject|15|||
146389750|NCT02764229|527929158|FG000|Overall Study|Adverse Event|9|||
146389751|NCT02764229|527929158|FG000|Overall Study|Physician Decision|5|||
146389752|NCT02764229|527929158|FG000|Overall Study|Lost to Follow-up|3|||
146389753|NCT02764229|527929158|FG000|Overall Study|Lack of Efficacy|1|||
146389754|NCT02764229|527929158|FG000|Overall Study|Study Stopped by Sponsor|69|||
146389755|NCT02135848|527929162|FG000|Overall Study|Adverse Event|2|||
146389756|NCT02135848|527929163|FG001|Overall Study|Adverse Event|0|||
146389757|NCT02135848|527929162|FG000|Overall Study|Withdrawal by Subject|1|||
146389758|NCT02135848|527929163|FG001|Overall Study|Withdrawal by Subject|1|||
146389759|NCT02030067|527929167|FG000|Overall Study|Disease Progression|1|||
146389760|NCT02030067|527929168|FG001|Overall Study|Disease Progression|1|||
146389761|NCT02030067|527929169|FG002|Overall Study|Disease Progression|2|||
146389762|NCT02030067|527929170|FG003|Overall Study|Disease Progression|2|||
146389763|NCT02030067|527929171|FG004|Overall Study|Disease Progression|3|||
146389764|NCT02030067|527929172|FG005|Overall Study|Disease Progression|2|||
146389765|NCT02030067|527929173|FG006|Overall Study|Disease Progression|3|||
146389766|NCT02030067|527929174|FG007|Overall Study|Disease Progression|3|||
146389767|NCT02030067|527929175|FG008|Overall Study|Disease Progression|4|||
146389768|NCT02030067|527929176|FG009|Overall Study|Disease Progression|3|||
146389769|NCT02030067|527929177|FG010|Overall Study|Disease Progression|7|||
146389770|NCT02030067|527929178|FG011|Overall Study|Disease Progression|2|||
146389771|NCT02030067|527929179|FG012|Overall Study|Disease Progression|59|||
146389772|NCT02030067|527929167|FG000|Overall Study|Withdrawal by Subject|0|||
146389773|NCT02030067|527929168|FG001|Overall Study|Withdrawal by Subject|0|||
146389774|NCT02030067|527929169|FG002|Overall Study|Withdrawal by Subject|0|||
146389775|NCT02030067|527929170|FG003|Overall Study|Withdrawal by Subject|1|||
146389776|NCT02030067|527929171|FG004|Overall Study|Withdrawal by Subject|0|||
146389777|NCT02030067|527929172|FG005|Overall Study|Withdrawal by Subject|0|||
146389778|NCT02030067|527929173|FG006|Overall Study|Withdrawal by Subject|0|||
146389779|NCT02030067|527929174|FG007|Overall Study|Withdrawal by Subject|1|||
146389780|NCT02030067|527929175|FG008|Overall Study|Withdrawal by Subject|0|||
146389781|NCT02030067|527929176|FG009|Overall Study|Withdrawal by Subject|0|||
146389782|NCT02030067|527929177|FG010|Overall Study|Withdrawal by Subject|3|||
146389783|NCT02030067|527929178|FG011|Overall Study|Withdrawal by Subject|0|||
146389784|NCT02030067|527929179|FG012|Overall Study|Withdrawal by Subject|6|||
146389785|NCT02030067|527929167|FG000|Overall Study|Physician Decision|0|||
146389786|NCT02030067|527929168|FG001|Overall Study|Physician Decision|0|||
146389787|NCT02030067|527929169|FG002|Overall Study|Physician Decision|0|||
146389788|NCT02030067|527929170|FG003|Overall Study|Physician Decision|0|||
146389789|NCT02030067|527929171|FG004|Overall Study|Physician Decision|0|||
146389790|NCT02030067|527929172|FG005|Overall Study|Physician Decision|0|||
146389791|NCT02030067|527929173|FG006|Overall Study|Physician Decision|0|||
146389792|NCT02030067|527929174|FG007|Overall Study|Physician Decision|0|||
146389793|NCT02030067|527929175|FG008|Overall Study|Physician Decision|0|||
146389794|NCT02030067|527929176|FG009|Overall Study|Physician Decision|0|||
146389795|NCT02030067|527929177|FG010|Overall Study|Physician Decision|1|||
146389796|NCT02030067|527929178|FG011|Overall Study|Physician Decision|0|||
146389797|NCT02030067|527929179|FG012|Overall Study|Physician Decision|3|||
146389798|NCT02030067|527929167|FG000|Overall Study|other reasons|0|||
146389799|NCT02030067|527929168|FG001|Overall Study|other reasons|0|||
146389800|NCT02030067|527929169|FG002|Overall Study|other reasons|0|||
146389801|NCT02030067|527929170|FG003|Overall Study|other reasons|0|||
146389802|NCT02030067|527929171|FG004|Overall Study|other reasons|0|||
146389803|NCT02030067|527929172|FG005|Overall Study|other reasons|1|||
146389804|NCT02030067|527929173|FG006|Overall Study|other reasons|0|||
146389805|NCT02030067|527929174|FG007|Overall Study|other reasons|0|||
146389806|NCT02030067|527929175|FG008|Overall Study|other reasons|2|||
146389807|NCT02030067|527929176|FG009|Overall Study|other reasons|0|||
146389808|NCT02030067|527929177|FG010|Overall Study|other reasons|0|||
146389809|NCT02030067|527929178|FG011|Overall Study|other reasons|0|||
146389810|NCT02030067|527929179|FG012|Overall Study|other reasons|4|||
146389811|NCT02030067|527929167|FG000|Overall Study|Adverse Event|0|||
146389812|NCT02030067|527929168|FG001|Overall Study|Adverse Event|0|||
146389813|NCT02030067|527929169|FG002|Overall Study|Adverse Event|0|||
146389814|NCT02030067|527929170|FG003|Overall Study|Adverse Event|0|||
146389815|NCT02030067|527929171|FG004|Overall Study|Adverse Event|0|||
146389816|NCT02030067|527929172|FG005|Overall Study|Adverse Event|0|||
146389817|NCT02030067|527929173|FG006|Overall Study|Adverse Event|0|||
146389818|NCT02030067|527929174|FG007|Overall Study|Adverse Event|0|||
146389819|NCT02030067|527929175|FG008|Overall Study|Adverse Event|0|||
146389820|NCT02030067|527929176|FG009|Overall Study|Adverse Event|0|||
146389821|NCT02030067|527929177|FG010|Overall Study|Adverse Event|0|||
146389822|NCT02030067|527929178|FG011|Overall Study|Adverse Event|1|||
146389823|NCT02030067|527929179|FG012|Overall Study|Adverse Event|8|||
146389824|NCT00265382|527929180|FG000|Overall Study|Adverse Event|21|||
146389825|NCT00265382|527929180|FG000|Overall Study|Laboratory Abnormality|1|||
146389826|NCT00265382|527929180|FG000|Overall Study|Lost to Follow-up|3|||
146389827|NCT00265382|527929180|FG000|Overall Study|Lack of Efficacy|6|||
146389828|NCT00265382|527929180|FG000|Overall Study|Miscellaneous|6|||
146389829|NCT00265382|527929180|FG000|Overall Study|Withdrawal by Subject|13|||
146389830|NCT00265382|527929180|FG000|Overall Study|Study terminated by sponsor|94|||
146389831|NCT00265382|527929180|FG000|Overall Study|Death|1|||
146389832|NCT03258710|527929183|FG000|Overall Study|Adverse Event|1|||
146389833|NCT03258710|527929183|FG000|Overall Study|Protocol-defined stopping criteria|1|||
146389834|NCT03258710|527929183|FG000|Overall Study|Physician Decision|1|||
146389835|NCT03451630|527929184|FG000|Overall Study|Death|15|||
146389836|NCT03451630|527929185|FG001|Overall Study|Death|16|||
146389837|NCT03451630|527929186|FG002|Overall Study|Death|11|||
146389838|NCT03451630|527929184|FG000|Overall Study|Lost to Follow-up|9|||
146389839|NCT03451630|527929185|FG001|Overall Study|Lost to Follow-up|0|||
146389840|NCT03451630|527929186|FG002|Overall Study|Lost to Follow-up|4|||
146389841|NCT03451630|527929184|FG000|Overall Study|Withdrawal by Subject|0|||
146389842|NCT03451630|527929185|FG001|Overall Study|Withdrawal by Subject|3|||
146389843|NCT03451630|527929186|FG002|Overall Study|Withdrawal by Subject|0|||
146389844|NCT03451630|527929184|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
146389845|NCT03451630|527929185|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
146389846|NCT03451630|527929186|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
146389847|NCT00089505|527929187|FG000|Overall Study|Death|4|||
146389848|NCT00089505|527929188|FG001|Overall Study|Death|1|||
146389849|NCT00089505|527929189|FG002|Overall Study|Death|5|||
146389850|NCT00089505|527929190|FG003|Overall Study|Death|8|||
146389851|NCT00089505|527929187|FG000|Overall Study|Withdrawal by Subject|3|||
146389852|NCT00089505|527929188|FG001|Overall Study|Withdrawal by Subject|0|||
146389853|NCT00089505|527929189|FG002|Overall Study|Withdrawal by Subject|6|||
146389854|NCT00089505|527929190|FG003|Overall Study|Withdrawal by Subject|6|||
146389855|NCT00089505|527929187|FG000|Overall Study|Lost to Follow-up|1|||
146389856|NCT00089505|527929188|FG001|Overall Study|Lost to Follow-up|1|||
146389857|NCT00089505|527929189|FG002|Overall Study|Lost to Follow-up|9|||
146389858|NCT00089505|527929190|FG003|Overall Study|Lost to Follow-up|7|||
146389859|NCT00089505|527929187|FG000|Overall Study|Physician Decision|1|||
146389860|NCT00089505|527929188|FG001|Overall Study|Physician Decision|0|||
146389861|NCT00089505|527929189|FG002|Overall Study|Physician Decision|0|||
146389862|NCT00089505|527929190|FG003|Overall Study|Physician Decision|0|||
146389863|NCT00089505|527929187|FG000|Overall Study|Protocol Violation|0|||
146389864|NCT00089505|527929188|FG001|Overall Study|Protocol Violation|0|||
146389865|NCT00089505|527929189|FG002|Overall Study|Protocol Violation|1|||
146389866|NCT00089505|527929190|FG003|Overall Study|Protocol Violation|0|||
146389867|NCT01724021|527929191|FG000|Overall Study|Adverse Event|11|||
146389868|NCT01724021|527929192|FG001|Overall Study|Adverse Event|6|||
146389869|NCT01724021|527929191|FG000|Overall Study|Death|46|||
146389870|NCT01724021|527929192|FG001|Overall Study|Death|58|||
146389871|NCT01724021|527929191|FG000|Overall Study|Participant request/ Withdrew consent|18|||
146389872|NCT01724021|527929192|FG001|Overall Study|Participant request/ Withdrew consent|14|||
146389873|NCT01724021|527929191|FG000|Overall Study|Lost to Follow-up|15|||
146389874|NCT01724021|527929192|FG001|Overall Study|Lost to Follow-up|15|||
146389875|NCT01724021|527929191|FG000|Overall Study|Reason Not Specified|36|||
146389876|NCT01724021|527929192|FG001|Overall Study|Reason Not Specified|39|||
146389877|NCT01724021|527929191|FG000|Overall Study|Missing|1|||
146389878|NCT01724021|527929192|FG001|Overall Study|Missing|1|||
146389879|NCT02041533|527929195|FG000|Pre-Treatment Period|Disease Progression|1|||
146389880|NCT02041533|527929196|FG001|Pre-Treatment Period|Disease Progression|1|||
146389881|NCT02041533|527929195|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
146389882|NCT02041533|527929196|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
146389883|NCT02041533|527929195|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
146389884|NCT02041533|527929196|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
146389885|NCT02041533|527929195|FG000|Treatment Period|Disease progression|189|||
146389886|NCT02041533|527929196|FG001|Treatment Period|Disease progression|146|||
146389887|NCT02041533|527929195|FG000|Treatment Period|Study drug toxicity|30|||
146389888|NCT02041533|527929196|FG001|Treatment Period|Study drug toxicity|34|||
146389889|NCT02041533|527929195|FG000|Treatment Period|Death|1|||
146389890|NCT02041533|527929196|FG001|Treatment Period|Death|0|||
146389891|NCT02041533|527929195|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
146389892|NCT02041533|527929196|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
146389893|NCT02041533|527929195|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
146389894|NCT02041533|527929196|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
146389895|NCT02041533|527929195|FG000|Treatment Period|Participant withdrew consent|2|||
146389896|NCT02041533|527929196|FG001|Treatment Period|Participant withdrew consent|2|||
146389897|NCT02041533|527929195|FG000|Treatment Period|Maximum clinical benefit|0|||
146389898|NCT02041533|527929196|FG001|Treatment Period|Maximum clinical benefit|18|||
146389899|NCT02041533|527929195|FG000|Treatment Period|Poor/Non-compliance|1|||
146389900|NCT02041533|527929196|FG001|Treatment Period|Poor/Non-compliance|0|||
146389901|NCT02041533|527929195|FG000|Treatment Period|Administrative reason by sponsor|1|||
146389902|NCT02041533|527929196|FG001|Treatment Period|Administrative reason by sponsor|0|||
146389903|NCT02041533|527929195|FG000|Treatment Period|Other reasons|9|||
146389904|NCT02041533|527929196|FG001|Treatment Period|Other reasons|2|||
146056271|NCT00626275|526721167|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
146389905|NCT02041533|527929195|FG000|Treatment Period|Not Reported|0|||
146389906|NCT02041533|527929196|FG001|Treatment Period|Not Reported|1|||
146389907|NCT01756846|527929197|FG000|Overall Study|Lost to Follow-up|5|||
146389908|NCT01756846|527929198|FG001|Overall Study|Lost to Follow-up|10|||
146389909|NCT01756846|527929197|FG000|Overall Study|Withdrawal by Subject|1|||
146389910|NCT01756846|527929198|FG001|Overall Study|Withdrawal by Subject|2|||
146389911|NCT00565721|527929201|FG000|Overall Study|Screen Failure|2|||
146389912|NCT00565721|527929201|FG000|Overall Study|Lost to Follow-up|6|||
146389913|NCT00565721|527929201|FG000|Overall Study|Technical Problems|1|||
146389914|NCT00565721|527929201|FG000|Overall Study|Physician Decision|2|||
146389915|NCT00565721|527929201|FG000|Overall Study|Other reasons|6|||
146389916|NCT02813681|527929202|FG000|Overall Study|Physician Decision|5|||
146389917|NCT02813681|527929203|FG001|Overall Study|Physician Decision|5|||
146389918|NCT02813681|527929204|FG002|Overall Study|Physician Decision|0|||
146389919|NCT02813681|527929202|FG000|Overall Study|Lost to Follow-up|0|||
146389920|NCT02813681|527929203|FG001|Overall Study|Lost to Follow-up|1|||
146389921|NCT02813681|527929204|FG002|Overall Study|Lost to Follow-up|0|||
146389922|NCT00529152|527929205|FG000|Overall Study|Adverse Event|2|||
146389923|NCT00529152|527929205|FG000|Overall Study|Withdrawal by Subject|2|||
146389924|NCT00529152|527929205|FG000|Overall Study|Lost to Follow-up|1|||
146389925|NCT01497899|527929206|FG000|Double-Blind Phase|Randomized but not Treated|1|||
146389926|NCT01497899|527929207|FG001|Double-Blind Phase|Randomized but not Treated|0|||
146389927|NCT01497899|527929208|FG002|Double-Blind Phase|Randomized but not Treated|0|||
146389928|NCT01497899|527929209|FG003|Double-Blind Phase|Randomized but not Treated|0|||
146389929|NCT01497899|527929206|FG000|Double-Blind Phase|Adverse Event|1|||
146389930|NCT01497899|527929207|FG001|Double-Blind Phase|Adverse Event|0|||
146389931|NCT01497899|527929208|FG002|Double-Blind Phase|Adverse Event|0|||
146389932|NCT01497899|527929209|FG003|Double-Blind Phase|Adverse Event|0|||
146389933|NCT01497899|527929206|FG000|Double-Blind Phase|Lack of Efficacy|0|||
146389934|NCT01497899|527929207|FG001|Double-Blind Phase|Lack of Efficacy|1|||
146389935|NCT01497899|527929208|FG002|Double-Blind Phase|Lack of Efficacy|0|||
146389936|NCT01497899|527929209|FG003|Double-Blind Phase|Lack of Efficacy|0|||
146389937|NCT01497899|527929206|FG000|Double-Blind Phase|Investigator's Discretion|1|||
146389938|NCT01497899|527929207|FG001|Double-Blind Phase|Investigator's Discretion|0|||
146389939|NCT01497899|527929208|FG002|Double-Blind Phase|Investigator's Discretion|0|||
146389940|NCT01497899|527929209|FG003|Double-Blind Phase|Investigator's Discretion|0|||
146389941|NCT01497899|527929206|FG000|Double-Blind Phase|Withdrew Consent|0|||
146389942|NCT01497899|527929207|FG001|Double-Blind Phase|Withdrew Consent|1|||
146389943|NCT01497899|527929208|FG002|Double-Blind Phase|Withdrew Consent|0|||
146389944|NCT01497899|527929209|FG003|Double-Blind Phase|Withdrew Consent|0|||
146389945|NCT01497899|527929206|FG000|Double-Blind Phase|Lost to Follow-up|3|||
146389946|NCT01497899|527929207|FG001|Double-Blind Phase|Lost to Follow-up|2|||
146389947|NCT01497899|527929208|FG002|Double-Blind Phase|Lost to Follow-up|0|||
146389948|NCT01497899|527929209|FG003|Double-Blind Phase|Lost to Follow-up|0|||
146389949|NCT01497899|527929206|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
146389950|NCT01497899|527929207|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
146389951|NCT01497899|527929208|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
146389952|NCT01497899|527929209|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
146389953|NCT01497899|527929206|FG000|Open-Label Extension Phase|Adverse Event|1|||
146389954|NCT01497899|527929207|FG001|Open-Label Extension Phase|Adverse Event|0|||
146389955|NCT01497899|527929208|FG002|Open-Label Extension Phase|Adverse Event|0|||
146389956|NCT01497899|527929209|FG003|Open-Label Extension Phase|Adverse Event|0|||
146389957|NCT01497899|527929206|FG000|Open-Label Extension Phase|Death|1|||
146389958|NCT01497899|527929207|FG001|Open-Label Extension Phase|Death|0|||
146389959|NCT01497899|527929208|FG002|Open-Label Extension Phase|Death|0|||
146389960|NCT01497899|527929209|FG003|Open-Label Extension Phase|Death|0|||
146389961|NCT01497899|527929206|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
146389962|NCT01497899|527929207|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
146389963|NCT01497899|527929208|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
146389964|NCT01497899|527929209|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
146389965|NCT01497899|527929206|FG000|Open-Label Extension Phase|Pregnancy|0|||
146389966|NCT01497899|527929207|FG001|Open-Label Extension Phase|Pregnancy|1|||
146389967|NCT01497899|527929208|FG002|Open-Label Extension Phase|Pregnancy|1|||
146389968|NCT01497899|527929209|FG003|Open-Label Extension Phase|Pregnancy|0|||
146389969|NCT01497899|527929206|FG000|Open-Label Extension Phase|Protocol Violation|0|||
146389970|NCT01497899|527929207|FG001|Open-Label Extension Phase|Protocol Violation|0|||
146389971|NCT01497899|527929208|FG002|Open-Label Extension Phase|Protocol Violation|1|||
146389972|NCT01497899|527929209|FG003|Open-Label Extension Phase|Protocol Violation|0|||
146389973|NCT01497899|527929206|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
146389974|NCT01497899|527929207|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
146389975|NCT01497899|527929208|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
146389976|NCT01497899|527929209|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
146389977|NCT02646332|527929222|FG000|Overall Study|Lost to Follow-up|0|||
146389978|NCT02646332|527929223|FG001|Overall Study|Lost to Follow-up|3|||
146389979|NCT01882439|527929226|FG000|Overall Study|Adverse event related to study drug|3|||
146389980|NCT01882439|527929227|FG001|Overall Study|Adverse event related to study drug|8|||
146389981|NCT01882439|527929228|FG002|Overall Study|Adverse event related to study drug|1|||
146389982|NCT01882439|527929229|FG003|Overall Study|Adverse event related to study drug|2|||
146389983|NCT01882439|527929226|FG000|Overall Study|Pregnancy|0|||
146389984|NCT01882439|527929227|FG001|Overall Study|Pregnancy|1|||
146389985|NCT01882439|527929228|FG002|Overall Study|Pregnancy|0|||
145943498|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
146389986|NCT01882439|527929229|FG003|Overall Study|Pregnancy|0|||
146389987|NCT01882439|527929226|FG000|Overall Study|Protocol Violation|2|||
146389988|NCT01882439|527929227|FG001|Overall Study|Protocol Violation|2|||
146389989|NCT01882439|527929228|FG002|Overall Study|Protocol Violation|0|||
146389990|NCT01882439|527929229|FG003|Overall Study|Protocol Violation|1|||
146389991|NCT01882439|527929226|FG000|Overall Study|No longer willing to participate|1|||
146389992|NCT01882439|527929227|FG001|Overall Study|No longer willing to participate|4|||
146389993|NCT01882439|527929228|FG002|Overall Study|No longer willing to participate|2|||
146389994|NCT01882439|527929229|FG003|Overall Study|No longer willing to participate|3|||
146389995|NCT01882439|527929226|FG000|Overall Study|Medication error with no associated AE|0|||
146389996|NCT01882439|527929227|FG001|Overall Study|Medication error with no associated AE|0|||
146389997|NCT01882439|527929228|FG002|Overall Study|Medication error with no associated AE|2|||
146389998|NCT01882439|527929229|FG003|Overall Study|Medication error with no associated AE|0|||
146389999|NCT01882439|527929226|FG000|Overall Study|Insufficient clinical response|1|||
146390000|NCT01882439|527929227|FG001|Overall Study|Insufficient clinical response|4|||
146390001|NCT01882439|527929228|FG002|Overall Study|Insufficient clinical response|4|||
146390002|NCT01882439|527929229|FG003|Overall Study|Insufficient clinical response|2|||
146390003|NCT01882439|527929226|FG000|Overall Study|Adverse event unrelated to study drug|2|||
146390004|NCT01882439|527929227|FG001|Overall Study|Adverse event unrelated to study drug|2|||
146390005|NCT01882439|527929228|FG002|Overall Study|Adverse event unrelated to study drug|1|||
146390006|NCT01882439|527929229|FG003|Overall Study|Adverse event unrelated to study drug|1|||
146390007|NCT03125902|527929230|FG000|Overall Study|Adverse Event|0|||
146390008|NCT03125902|527929231|FG001|Overall Study|Adverse Event|1|||
146390009|NCT03125902|527929230|FG000|Overall Study|Death|119|||
146390010|NCT03125902|527929231|FG001|Overall Study|Death|229|||
146390011|NCT03125902|527929230|FG000|Overall Study|Lost to Follow-up|4|||
146390012|NCT03125902|527929231|FG001|Overall Study|Lost to Follow-up|13|||
146390013|NCT03125902|527929230|FG000|Overall Study|Other|0|||
146390014|NCT03125902|527929231|FG001|Overall Study|Other|4|||
146390015|NCT03125902|527929230|FG000|Overall Study|Physician Decision|2|||
146390016|NCT03125902|527929231|FG001|Overall Study|Physician Decision|1|||
146390017|NCT03125902|527929230|FG000|Overall Study|Progressive Disease|0|||
146390018|NCT03125902|527929231|FG001|Overall Study|Progressive Disease|3|||
146390019|NCT03125902|527929230|FG000|Overall Study|Study Terminated By Sponsor|74|||
146390020|NCT03125902|527929231|FG001|Overall Study|Study Terminated By Sponsor|143|||
146390021|NCT03125902|527929230|FG000|Overall Study|Withdrawal by Subject|21|||
146390022|NCT03125902|527929231|FG001|Overall Study|Withdrawal by Subject|37|||
146390023|NCT01775995|527929232|FG000|Overall Study|Lost to Follow-up|1|||
146390024|NCT01775995|527929233|FG001|Overall Study|Lost to Follow-up|1|||
146390025|NCT01997333|527929234|FG000|Randomization and Treatment|Disease Progression|70|||
146390026|NCT01997333|527929235|FG001|Randomization and Treatment|Disease Progression|159|||
146390027|NCT01997333|527929234|FG000|Randomization and Treatment|Adverse Event|10|||
146390028|NCT01997333|527929235|FG001|Randomization and Treatment|Adverse Event|32|||
146390029|NCT01997333|527929234|FG000|Randomization and Treatment|Physician Decision|0|||
146390030|NCT01997333|527929235|FG001|Randomization and Treatment|Physician Decision|4|||
146390031|NCT01997333|527929234|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
146390032|NCT01997333|527929235|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
146390033|NCT01997333|527929234|FG000|Randomization and Treatment|Did not receive treatment|17|||
146390034|NCT01997333|527929235|FG001|Randomization and Treatment|Did not receive treatment|5|||
146390035|NCT01997333|527929234|FG000|Survival Follow up|Withdrawal by Subject|15|||
146390036|NCT01997333|527929235|FG001|Survival Follow up|Withdrawal by Subject|6|||
146390037|NCT01997333|527929234|FG000|Survival Follow up|Lost to Follow-up|0|||
146390038|NCT01997333|527929235|FG001|Survival Follow up|Lost to Follow-up|6|||
146390039|NCT01997333|527929234|FG000|Survival Follow up|Various|1|||
146390040|NCT01997333|527929235|FG001|Survival Follow up|Various|2|||
146390041|NCT01747655|527929236|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
146390042|NCT01747655|527929237|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
146390043|NCT01747655|527929236|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
146390044|NCT01747655|527929237|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
146390045|NCT01747655|527929236|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
146390046|NCT01747655|527929237|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
146390047|NCT01906489|527929241|FG000|Overall Study|Adverse Event|10|||
146390048|NCT01906489|527929242|FG001|Overall Study|Adverse Event|3|||
146390049|NCT01906489|527929241|FG000|Overall Study|Worsening of CKD|6|||
146390050|NCT01906489|527929242|FG001|Overall Study|Worsening of CKD|4|||
146390051|NCT01906489|527929241|FG000|Overall Study|Withdrawal by Subject|5|||
146390052|NCT01906489|527929242|FG001|Overall Study|Withdrawal by Subject|0|||
146390053|NCT01906489|527929241|FG000|Overall Study|Worsening of Anemia|1|||
146390054|NCT01906489|527929242|FG001|Overall Study|Worsening of Anemia|0|||
146390055|NCT01906489|527929241|FG000|Overall Study|Protocol Violation|0|||
146390056|NCT01906489|527929242|FG001|Overall Study|Protocol Violation|1|||
146390057|NCT01906489|527929241|FG000|Overall Study|Non- Compliance|1|||
146390058|NCT01906489|527929242|FG001|Overall Study|Non- Compliance|0|||
146390059|NCT01906489|527929241|FG000|Overall Study|Sponsor Decision|1|||
146390060|NCT01906489|527929242|FG001|Overall Study|Sponsor Decision|0|||
146390061|NCT01906489|527929241|FG000|Overall Study|Lost to Follow-up|1|||
146390062|NCT01906489|527929242|FG001|Overall Study|Lost to Follow-up|1|||
146390063|NCT01906489|527929241|FG000|Overall Study|Other|1|||
146390064|NCT01906489|527929242|FG001|Overall Study|Other|0|||
146390065|NCT01078389|527931255|FG000|Overall Study|Adverse Event|10|||
146390066|NCT01078389|527931256|FG001|Overall Study|Adverse Event|6|||
146390067|NCT01078389|527931255|FG000|Overall Study|Major Protocol Deviation|2|||
146390068|NCT01078389|527931256|FG001|Overall Study|Major Protocol Deviation|0|||
146390069|NCT01078389|527931255|FG000|Overall Study|Lost to Follow-up|23|||
146390070|NCT01078389|527931256|FG001|Overall Study|Lost to Follow-up|23|||
146390071|NCT01078389|527931255|FG000|Overall Study|Voluntary Withdrawal|20|||
146390072|NCT01078389|527931256|FG001|Overall Study|Voluntary Withdrawal|36|||
146390073|NCT01078389|527931255|FG000|Overall Study|Other|9|||
146390074|NCT01078389|527931256|FG001|Overall Study|Other|2|||
146390075|NCT04823494|527931257|FG000|Overall Study|Programming software malfunction.|1|||
146390076|NCT04823494|527931258|FG001|Overall Study|Programming software malfunction.|0|||
146390077|NCT04823494|527931257|FG000|Overall Study|Withdrawal by Subject|1|||
146390078|NCT04823494|527931258|FG001|Overall Study|Withdrawal by Subject|0|||
146390079|NCT04823494|527931257|FG000|Overall Study|Devices lost|0|||
146390080|NCT04823494|527931258|FG001|Overall Study|Devices lost|1|||
146390081|NCT03691831|527931259|FG000|Overall Study|Lost to Follow-up|16|||
146390082|NCT03691831|527931260|FG001|Overall Study|Lost to Follow-up|12|||
146390083|NCT03691831|527931259|FG000|Overall Study|Withdrawal by Subject|9|||
146390084|NCT03691831|527931260|FG001|Overall Study|Withdrawal by Subject|17|||
146390085|NCT03691831|527931259|FG000|Overall Study|Investigator Decision|2|||
146390086|NCT03691831|527931260|FG001|Overall Study|Investigator Decision|2|||
146390087|NCT02198040|527931261|FG000|Overall Study|Work reasons|0|||
146390088|NCT02198040|527931262|FG001|Overall Study|Work reasons|1|||
146390089|NCT02198040|527931263|FG002|Overall Study|Work reasons|0|||
146390090|NCT02198040|527931261|FG000|Overall Study|Withdrawal by Subject|0|||
146390091|NCT02198040|527931262|FG001|Overall Study|Withdrawal by Subject|0|||
146390092|NCT02198040|527931263|FG002|Overall Study|Withdrawal by Subject|1|||
146390093|NCT04524663|527931264|FG000|Overall Study|Withdrawal by Subject|0|||
146390094|NCT04524663|527931265|FG001|Overall Study|Withdrawal by Subject|2|||
146390095|NCT01884675|527931266|FG000|Overall Study|Study closed/terminated|3|||
146390096|NCT01884675|527931267|FG001|Overall Study|Study closed/terminated|2|||
146390097|NCT02361307|527931268|FG000|Overall Study|Unstable medical condition.|0|||
146390098|NCT02361307|527931269|FG001|Overall Study|Unstable medical condition.|1|||
146390099|NCT03359811|527931270|FG000|Overall Study|Protocol Violation|2|||
146390100|NCT03359811|527931271|FG001|Overall Study|Protocol Violation|0|||
146390101|NCT01189201|527931276|FG000|Overall Study|Adverse Event|1|||
146390102|NCT01682876|527931277|FG000|Overall Study|Administrative reason|4|||
146390103|NCT01682876|527931278|FG001|Overall Study|Administrative reason|4|||
146390104|NCT01682876|527931279|FG002|Overall Study|Administrative reason|0|||
146390105|NCT01682876|527931280|FG003|Overall Study|Administrative reason|3|||
146390106|NCT01682876|527931277|FG000|Overall Study|Adverse Event|0|||
146390107|NCT01682876|527931278|FG001|Overall Study|Adverse Event|0|||
146390108|NCT01682876|527931279|FG002|Overall Study|Adverse Event|0|||
146390109|NCT01682876|527931280|FG003|Overall Study|Adverse Event|1|||
146390110|NCT01682876|527931277|FG000|Overall Study|Lost to Follow-up|11|||
146390111|NCT01682876|527931278|FG001|Overall Study|Lost to Follow-up|15|||
146390112|NCT01682876|527931279|FG002|Overall Study|Lost to Follow-up|9|||
146390113|NCT01682876|527931280|FG003|Overall Study|Lost to Follow-up|11|||
146390114|NCT01682876|527931277|FG000|Overall Study|Protocol Violation|1|||
146390115|NCT01682876|527931278|FG001|Overall Study|Protocol Violation|1|||
146390116|NCT01682876|527931279|FG002|Overall Study|Protocol Violation|1|||
146390117|NCT01682876|527931280|FG003|Overall Study|Protocol Violation|1|||
146390118|NCT01682876|527931277|FG000|Overall Study|Withdrawal by Subject|4|||
146390119|NCT01682876|527931278|FG001|Overall Study|Withdrawal by Subject|0|||
146390120|NCT01682876|527931279|FG002|Overall Study|Withdrawal by Subject|0|||
146390121|NCT01682876|527931280|FG003|Overall Study|Withdrawal by Subject|2|||
146390122|NCT01682876|527931277|FG000|Overall Study|Other|1|||
146390123|NCT01682876|527931278|FG001|Overall Study|Other|0|||
146390124|NCT01682876|527931279|FG002|Overall Study|Other|1|||
146390125|NCT01682876|527931280|FG003|Overall Study|Other|1|||
146390126|NCT00911508|527931284|FG000|Overall Study|Lost to Follow-up|27|||
146390127|NCT00911508|527931285|FG001|Overall Study|Lost to Follow-up|18|||
146390128|NCT00911508|527931284|FG000|Overall Study|Withdrawal by Subject|79|||
146390129|NCT00911508|527931285|FG001|Overall Study|Withdrawal by Subject|112|||
146390130|NCT00240331|527931288|FG000|Overall Study|Withdrawal by Subject|125|||
146390131|NCT00240331|527931289|FG001|Overall Study|Withdrawal by Subject|132|||
146390132|NCT00240331|527931288|FG000|Overall Study|Option selected by investigator|1|||
146390133|NCT00240331|527931289|FG001|Overall Study|Option selected by investigator|2|||
146390134|NCT01409382|527931290|FG000|Overall Study|Lost to Follow-up|1|||
146390135|NCT01409382|527931291|FG001|Overall Study|Lost to Follow-up|1|||
146390136|NCT01409382|527931290|FG000|Overall Study|Protocol Violation|0|||
146390137|NCT01409382|527931291|FG001|Overall Study|Protocol Violation|3|||
146390138|NCT01409382|527931290|FG000|Overall Study|Multiple pregnancy|2|||
146390139|NCT01409382|527931291|FG001|Overall Study|Multiple pregnancy|4|||
146390140|NCT01409382|527931290|FG000|Overall Study|Still pregnant when study ended|13|||
146390141|NCT01409382|527931291|FG001|Overall Study|Still pregnant when study ended|2|||
146390142|NCT01409382|527931290|FG000|Overall Study|Did not manage to get pregnant|64|||
146390143|NCT01409382|527931291|FG001|Overall Study|Did not manage to get pregnant|70|||
146390144|NCT01409382|527931290|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
146390145|NCT01409382|527931291|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
146390146|NCT01233076|527931292|FG000|Period 2, One Week|Lost to Follow-up|1|||
146390147|NCT01233076|527931293|FG001|Period 2, One Week|Lost to Follow-up|0|||
146390148|NCT04308668|527931294|FG000|Overall Study|Lost to Follow-up|32|||
146390149|NCT04308668|527931295|FG001|Overall Study|Lost to Follow-up|38|||
146390150|NCT04308668|527931294|FG000|Overall Study|Withdrawal by Subject|4|||
146390151|NCT04308668|527931295|FG001|Overall Study|Withdrawal by Subject|4|||
146390152|NCT01266967|527931296|FG000|Overall Study|Death|69|||
146390153|NCT01266967|527931297|FG001|Overall Study|Death|61|||
146390154|NCT01266967|527931296|FG000|Overall Study|Study Closed/Terminated|15|||
146390155|NCT01266967|527931297|FG001|Overall Study|Study Closed/Terminated|17|||
146390156|NCT01266967|527931296|FG000|Overall Study|Lost to Follow-up|2|||
146390157|NCT01266967|527931297|FG001|Overall Study|Lost to Follow-up|1|||
146390158|NCT01266967|527931296|FG000|Overall Study|Physician Decision|0|||
146390159|NCT01266967|527931297|FG001|Overall Study|Physician Decision|1|||
146390160|NCT01266967|527931296|FG000|Overall Study|Withdrawal by Subject|3|||
146390161|NCT01266967|527931297|FG001|Overall Study|Withdrawal by Subject|3|||
146390162|NCT04563845|527931298|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390163|NCT04563845|527931299|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390164|NCT04563845|527931300|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390165|NCT04563845|527931301|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390166|NCT04563845|527931302|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390167|NCT04563845|527931303|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390168|NCT04563845|527931304|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390169|NCT04563845|527931305|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
146390170|NCT04563845|527931306|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390171|NCT04563845|527931307|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390172|NCT04563845|527931308|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390173|NCT04563845|527931309|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390174|NCT04563845|527931310|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390175|NCT04563845|527931311|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
146390176|NCT04563845|527931298|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390177|NCT04563845|527931299|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390178|NCT04563845|527931300|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390179|NCT04563845|527931301|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390180|NCT04563845|527931302|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
146390181|NCT04563845|527931303|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390182|NCT04563845|527931304|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390183|NCT04563845|527931305|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390184|NCT04563845|527931306|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390185|NCT04563845|527931307|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390186|NCT04563845|527931308|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390187|NCT04563845|527931309|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390188|NCT04563845|527931310|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390189|NCT04563845|527931311|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
146390190|NCT01020812|527931312|FG000|Overall Study|Physician Decision|1|||
146390191|NCT01020812|527931312|FG000|Overall Study|Withdrawal by Subject|1|||
146390192|NCT01020812|527931312|FG000|Overall Study|Protocol Violation|1|||
146390193|NCT01519700|527931313|FG000|Overall Study|Death|1|||
146390194|NCT01519700|527931314|FG001|Overall Study|Death|0|||
146390195|NCT01519700|527931315|FG002|Overall Study|Death|0|||
146390196|NCT01519700|527931316|FG003|Overall Study|Death|0|||
146390197|NCT01519700|527931313|FG000|Overall Study|Lost to Follow-up|0|||
146390198|NCT01519700|527931314|FG001|Overall Study|Lost to Follow-up|0|||
146390199|NCT01519700|527931315|FG002|Overall Study|Lost to Follow-up|1|||
146390200|NCT01519700|527931316|FG003|Overall Study|Lost to Follow-up|1|||
146390201|NCT01519700|527931313|FG000|Overall Study|Physician Decision|1|||
146390202|NCT01519700|527931314|FG001|Overall Study|Physician Decision|1|||
146390203|NCT01519700|527931315|FG002|Overall Study|Physician Decision|3|||
146390204|NCT01519700|527931316|FG003|Overall Study|Physician Decision|0|||
146390205|NCT01519700|527931313|FG000|Overall Study|Withdrawal by Subject|5|||
146390206|NCT01519700|527931314|FG001|Overall Study|Withdrawal by Subject|3|||
146390207|NCT01519700|527931315|FG002|Overall Study|Withdrawal by Subject|3|||
146390208|NCT01519700|527931316|FG003|Overall Study|Withdrawal by Subject|2|||
146390209|NCT01519700|527931313|FG000|Overall Study|Other Reason|2|||
146390210|NCT01519700|527931314|FG001|Overall Study|Other Reason|2|||
146390211|NCT01519700|527931315|FG002|Overall Study|Other Reason|0|||
146390212|NCT01519700|527931316|FG003|Overall Study|Other Reason|4|||
146390213|NCT00960323|527931320|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
146390214|NCT03824704|527931330|FG000|Overall Study|Study Terminated by Sponsor|1|||
146390215|NCT02155660|527931333|FG000|Overall Study|Other Reason|8|||
146390216|NCT02155660|527931334|FG001|Overall Study|Other Reason|6|||
146390217|NCT02155660|527931335|FG002|Overall Study|Other Reason|10|||
146390218|NCT02155660|527931336|FG003|Overall Study|Other Reason|10|||
146390219|NCT02155660|527931333|FG000|Overall Study|Study-specific withdrawal criteria|0|||
146390220|NCT02155660|527931334|FG001|Overall Study|Study-specific withdrawal criteria|1|||
146390221|NCT02155660|527931335|FG002|Overall Study|Study-specific withdrawal criteria|1|||
146390222|NCT02155660|527931336|FG003|Overall Study|Study-specific withdrawal criteria|1|||
146390223|NCT02155660|527931333|FG000|Overall Study|Severe non-compliance|0|||
146390224|NCT02155660|527931334|FG001|Overall Study|Severe non-compliance|4|||
146390225|NCT02155660|527931335|FG002|Overall Study|Severe non-compliance|0|||
146390226|NCT02155660|527931336|FG003|Overall Study|Severe non-compliance|1|||
146390227|NCT02155660|527931333|FG000|Overall Study|Adverse Event|2|||
146390228|NCT02155660|527931334|FG001|Overall Study|Adverse Event|6|||
146390229|NCT02155660|527931335|FG002|Overall Study|Adverse Event|3|||
146390230|NCT02155660|527931336|FG003|Overall Study|Adverse Event|1|||
146390231|NCT02155660|527931333|FG000|Overall Study|Lost to Follow-up|3|||
146390232|NCT02155660|527931334|FG001|Overall Study|Lost to Follow-up|6|||
146390233|NCT02155660|527931335|FG002|Overall Study|Lost to Follow-up|5|||
146390234|NCT02155660|527931336|FG003|Overall Study|Lost to Follow-up|8|||
146390235|NCT02155660|527931333|FG000|Overall Study|Death|17|||
146390236|NCT02155660|527931334|FG001|Overall Study|Death|19|||
146390237|NCT02155660|527931335|FG002|Overall Study|Death|17|||
146390238|NCT02155660|527931336|FG003|Overall Study|Death|19|||
146390239|NCT02155660|527931333|FG000|Overall Study|Withdrawal by Subject|28|||
146390240|NCT02155660|527931334|FG001|Overall Study|Withdrawal by Subject|31|||
146390241|NCT02155660|527931335|FG002|Overall Study|Withdrawal by Subject|24|||
146390242|NCT02155660|527931336|FG003|Overall Study|Withdrawal by Subject|21|||
146390243|NCT03730987|527931337|FG000|Overall Study|Lost to Follow-up|2|||
146390244|NCT03730987|527931338|FG001|Overall Study|Lost to Follow-up|0|||
146390245|NCT03730987|527931339|FG002|Overall Study|Lost to Follow-up|2|||
146390246|NCT03730987|527931340|FG003|Overall Study|Lost to Follow-up|0|||
146390247|NCT02505945|527931341|FG000|Overall Study|Withdrawal by Subject|13|||
146390248|NCT02505945|527931342|FG001|Overall Study|Withdrawal by Subject|2|||
146390249|NCT02505945|527931341|FG000|Overall Study|Adverse Event|1|||
146390250|NCT02505945|527931342|FG001|Overall Study|Adverse Event|0|||
146390251|NCT02505945|527931341|FG000|Overall Study|Physician Decision|2|||
146390252|NCT02505945|527931342|FG001|Overall Study|Physician Decision|1|||
146390253|NCT02505945|527931341|FG000|Overall Study|Lost to Follow-up|6|||
146390254|NCT02505945|527931342|FG001|Overall Study|Lost to Follow-up|1|||
146390255|NCT00386152|527931343|FG000|Overall Study|Adverse Event|6|||
146390256|NCT00386152|527931344|FG001|Overall Study|Adverse Event|5|||
146390257|NCT00386152|527931345|FG002|Overall Study|Adverse Event|4|||
146390258|NCT00386152|527931343|FG000|Overall Study|Chang from original chemo stratification|4|||
146390259|NCT00386152|527931344|FG001|Overall Study|Chang from original chemo stratification|5|||
146390260|NCT00386152|527931345|FG002|Overall Study|Chang from original chemo stratification|6|||
146390261|NCT00386152|527931343|FG000|Overall Study|Death|3|||
146390262|NCT00386152|527931344|FG001|Overall Study|Death|0|||
146390263|NCT00386152|527931345|FG002|Overall Study|Death|1|||
146390264|NCT00386152|527931343|FG000|Overall Study|Disease progression|7|||
146390265|NCT00386152|527931344|FG001|Overall Study|Disease progression|4|||
146390266|NCT00386152|527931345|FG002|Overall Study|Disease progression|5|||
146390267|NCT00386152|527931343|FG000|Overall Study|Physician Decision|13|||
146390268|NCT00386152|527931344|FG001|Overall Study|Physician Decision|10|||
146390269|NCT00386152|527931345|FG002|Overall Study|Physician Decision|4|||
146390270|NCT00386152|527931343|FG000|Overall Study|Lost to Follow-up|1|||
146390271|NCT00386152|527931344|FG001|Overall Study|Lost to Follow-up|0|||
146390272|NCT00386152|527931345|FG002|Overall Study|Lost to Follow-up|0|||
146390273|NCT00386152|527931343|FG000|Overall Study|Completed chemotherapy|4|||
146390274|NCT00386152|527931344|FG001|Overall Study|Completed chemotherapy|5|||
146390275|NCT00386152|527931345|FG002|Overall Study|Completed chemotherapy|1|||
146390276|NCT00386152|527931343|FG000|Overall Study|Protocol Violation|3|||
146390277|NCT00386152|527931344|FG001|Overall Study|Protocol Violation|5|||
146390278|NCT00386152|527931345|FG002|Overall Study|Protocol Violation|2|||
146390279|NCT00386152|527931343|FG000|Overall Study|Withdrawal by Subject|3|||
146390280|NCT00386152|527931344|FG001|Overall Study|Withdrawal by Subject|6|||
146390281|NCT00386152|527931345|FG002|Overall Study|Withdrawal by Subject|10|||
146390282|NCT02577107|527931349|FG000|Overall Study|Protocol deviation|0|||
146390283|NCT02577107|527931350|FG001|Overall Study|Protocol deviation|1|||
146390284|NCT02452892|527931351|FG000|Week 1 Initial Randommization|Adverse Event|1|||
146390285|NCT02452892|527931352|FG001|Week 1 Initial Randommization|Adverse Event|0|||
146390286|NCT02452892|527931353|FG002|Week 1 Initial Randommization|Adverse Event|0|||
146390287|NCT02452892|527931354|FG003|Week 1 Initial Randommization|Adverse Event|0|||
146390288|NCT02452892|527931351|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
146390289|NCT02452892|527931352|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
146390290|NCT02452892|527931353|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
146390291|NCT02452892|527931354|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
146390292|NCT02452892|527931351|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146390293|NCT02452892|527931352|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146390294|NCT02452892|527931353|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
146390295|NCT02452892|527931354|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
146390296|NCT02452892|527931351|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
146390297|NCT02452892|527931352|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146390298|NCT02452892|527931353|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146390299|NCT02452892|527931354|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
146390300|NCT02452892|527931351|FG000|Follow-up|Withdrawal by Subject|0|||
146390301|NCT02452892|527931352|FG001|Follow-up|Withdrawal by Subject|0|||
146390302|NCT02452892|527931353|FG002|Follow-up|Withdrawal by Subject|0|||
146390303|NCT02452892|527931354|FG003|Follow-up|Withdrawal by Subject|1|||
146390304|NCT02452892|527931351|FG000|Follow-up|Subject left town on Day 42|1|||
146390305|NCT02452892|527931352|FG001|Follow-up|Subject left town on Day 42|0|||
146390306|NCT02452892|527931353|FG002|Follow-up|Subject left town on Day 42|0|||
146390307|NCT02452892|527931354|FG003|Follow-up|Subject left town on Day 42|0|||
146390308|NCT00545740|527931358|FG000|Overall Study|Lack of Efficacy|34|||
146390309|NCT00545740|527931359|FG001|Overall Study|Lack of Efficacy|35|||
146390310|NCT00545740|527931360|FG002|Overall Study|Lack of Efficacy|47|||
146390311|NCT00545740|527931361|FG003|Overall Study|Lack of Efficacy|36|||
146390312|NCT00545740|527931358|FG000|Overall Study|Withdrawal by Subject|17|||
146390313|NCT00545740|527931359|FG001|Overall Study|Withdrawal by Subject|15|||
146390314|NCT00545740|527931360|FG002|Overall Study|Withdrawal by Subject|16|||
146390315|NCT00545740|527931361|FG003|Overall Study|Withdrawal by Subject|18|||
146390316|NCT00545740|527931358|FG000|Overall Study|Adverse Event|10|||
146390317|NCT00545740|527931359|FG001|Overall Study|Adverse Event|18|||
146390318|NCT00545740|527931360|FG002|Overall Study|Adverse Event|19|||
146390319|NCT00545740|527931361|FG003|Overall Study|Adverse Event|9|||
146390320|NCT00545740|527931358|FG000|Overall Study|Lost to Follow-up|7|||
146390321|NCT00545740|527931359|FG001|Overall Study|Lost to Follow-up|5|||
146390322|NCT00545740|527931360|FG002|Overall Study|Lost to Follow-up|5|||
146390323|NCT00545740|527931361|FG003|Overall Study|Lost to Follow-up|6|||
146390324|NCT00545740|527931358|FG000|Overall Study|Protocol Violation|1|||
146390325|NCT00545740|527931359|FG001|Overall Study|Protocol Violation|3|||
146390326|NCT00545740|527931360|FG002|Overall Study|Protocol Violation|1|||
146390327|NCT00545740|527931361|FG003|Overall Study|Protocol Violation|0|||
146390328|NCT00545740|527931358|FG000|Overall Study|Non-compliance|0|||
146390329|NCT00545740|527931359|FG001|Overall Study|Non-compliance|2|||
146390330|NCT00545740|527931360|FG002|Overall Study|Non-compliance|1|||
146390331|NCT00545740|527931361|FG003|Overall Study|Non-compliance|0|||
146390332|NCT00545740|527931358|FG000|Overall Study|Moved|2|||
146390333|NCT00545740|527931359|FG001|Overall Study|Moved|0|||
146390334|NCT00545740|527931360|FG002|Overall Study|Moved|1|||
146390335|NCT00545740|527931361|FG003|Overall Study|Moved|0|||
146390336|NCT00545740|527931358|FG000|Overall Study|Diverticulitis attack|0|||
146390337|NCT00545740|527931359|FG001|Overall Study|Diverticulitis attack|0|||
146390338|NCT00545740|527931360|FG002|Overall Study|Diverticulitis attack|1|||
146390339|NCT00545740|527931361|FG003|Overall Study|Diverticulitis attack|1|||
146390340|NCT00545740|527931358|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
146390341|NCT00545740|527931359|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
146390342|NCT00545740|527931360|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
146390343|NCT00545740|527931361|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
146390344|NCT00545740|527931358|FG000|Overall Study|Site closure|1|||
146390345|NCT00545740|527931359|FG001|Overall Study|Site closure|0|||
146390346|NCT00545740|527931360|FG002|Overall Study|Site closure|0|||
146390347|NCT00545740|527931361|FG003|Overall Study|Site closure|0|||
146390348|NCT00545740|527931358|FG000|Overall Study|Missed visit|1|||
146390349|NCT00545740|527931359|FG001|Overall Study|Missed visit|0|||
146390350|NCT00545740|527931360|FG002|Overall Study|Missed visit|0|||
146390351|NCT00545740|527931361|FG003|Overall Study|Missed visit|0|||
146390352|NCT00545740|527931358|FG000|Overall Study|Physician Decision|0|||
146390353|NCT00545740|527931359|FG001|Overall Study|Physician Decision|0|||
146390354|NCT00545740|527931360|FG002|Overall Study|Physician Decision|3|||
146390355|NCT00545740|527931361|FG003|Overall Study|Physician Decision|0|||
146390356|NCT00545740|527931358|FG000|Overall Study|Accepted only monthly telephone calls|1|||
146390357|NCT00545740|527931359|FG001|Overall Study|Accepted only monthly telephone calls|0|||
146390358|NCT00545740|527931360|FG002|Overall Study|Accepted only monthly telephone calls|0|||
146056272|NCT00626275|526721160|FG000|Part B|Lost to Follow-up|0|||
146056273|NCT00626275|526721161|FG001|Part B|Lost to Follow-up|0|||
146056274|NCT00626275|526721162|FG002|Part B|Lost to Follow-up|0|||
146390359|NCT00545740|527931361|FG003|Overall Study|Accepted only monthly telephone calls|0|||
146390360|NCT00545740|527931358|FG000|Overall Study|Sponsor decision|0|||
146390361|NCT00545740|527931359|FG001|Overall Study|Sponsor decision|1|||
146390362|NCT00545740|527931360|FG002|Overall Study|Sponsor decision|0|||
146390363|NCT00545740|527931361|FG003|Overall Study|Sponsor decision|0|||
146390364|NCT00545740|527931358|FG000|Overall Study|Lack of time|0|||
146390365|NCT00545740|527931359|FG001|Overall Study|Lack of time|1|||
146390366|NCT00545740|527931360|FG002|Overall Study|Lack of time|0|||
146390367|NCT00545740|527931361|FG003|Overall Study|Lack of time|0|||
146390368|NCT00545740|527931358|FG000|Overall Study|Non-adherence to visits|0|||
146390369|NCT00545740|527931359|FG001|Overall Study|Non-adherence to visits|1|||
146390370|NCT00545740|527931360|FG002|Overall Study|Non-adherence to visits|0|||
146390371|NCT00545740|527931361|FG003|Overall Study|Non-adherence to visits|0|||
146390372|NCT00545740|527931358|FG000|Overall Study|Patient difficulties|0|||
146390373|NCT00545740|527931359|FG001|Overall Study|Patient difficulties|1|||
146390374|NCT00545740|527931360|FG002|Overall Study|Patient difficulties|0|||
146390375|NCT00545740|527931361|FG003|Overall Study|Patient difficulties|0|||
146390376|NCT00545740|527931358|FG000|Overall Study|Husband against study|0|||
146390377|NCT00545740|527931359|FG001|Overall Study|Husband against study|0|||
146390378|NCT00545740|527931360|FG002|Overall Study|Husband against study|1|||
146390379|NCT00545740|527931361|FG003|Overall Study|Husband against study|0|||
146390380|NCT02117024|527931362|FG000|Overall Study|Progressive Disease|26|||
146390381|NCT02117024|527931363|FG001|Overall Study|Progressive Disease|9|||
146390382|NCT02117024|527931362|FG000|Overall Study|Significant Clinical Progression|7|||
146390383|NCT02117024|527931363|FG001|Overall Study|Significant Clinical Progression|4|||
146390384|NCT02117024|527931362|FG000|Overall Study|Death|5|||
146390385|NCT02117024|527931363|FG001|Overall Study|Death|0|||
146390386|NCT02117024|527931362|FG000|Overall Study|Withdrawal by Subject|3|||
146390387|NCT02117024|527931363|FG001|Overall Study|Withdrawal by Subject|1|||
146390388|NCT02117024|527931362|FG000|Overall Study|Protocol Violation|1|||
146390389|NCT02117024|527931363|FG001|Overall Study|Protocol Violation|0|||
146390390|NCT02117024|527931362|FG000|Overall Study|Adverse Event|1|||
146390391|NCT02117024|527931363|FG001|Overall Study|Adverse Event|2|||
146390392|NCT02117024|527931362|FG000|Overall Study|Randomized in Error|1|||
146390393|NCT02117024|527931363|FG001|Overall Study|Randomized in Error|0|||
146390394|NCT02117024|527931362|FG000|Overall Study|Patient returned to primary oncologist|0|||
146390395|NCT02117024|527931363|FG001|Overall Study|Patient returned to primary oncologist|1|||
146390396|NCT02117024|527931362|FG000|Overall Study|Patient took treatment break|0|||
146390397|NCT02117024|527931363|FG001|Overall Study|Patient took treatment break|1|||
146390398|NCT02117024|527931362|FG000|Overall Study|Physician Decision|0|||
146390399|NCT02117024|527931363|FG001|Overall Study|Physician Decision|2|||
146390400|NCT02500706|527931364|FG000|Overall Study|Adverse Event|0|||
146390401|NCT02500706|527931365|FG001|Overall Study|Adverse Event|0|||
146390402|NCT02500706|527931366|FG002|Overall Study|Adverse Event|1|||
146390403|NCT02500706|527931364|FG000|Overall Study|Lost to Follow-up|0|||
146390404|NCT02500706|527931365|FG001|Overall Study|Lost to Follow-up|1|||
146390405|NCT02500706|527931366|FG002|Overall Study|Lost to Follow-up|1|||
146390406|NCT02500706|527931364|FG000|Overall Study|Withdrawal by Subject|4|||
146390407|NCT02500706|527931365|FG001|Overall Study|Withdrawal by Subject|6|||
146390408|NCT02500706|527931366|FG002|Overall Study|Withdrawal by Subject|4|||
146390409|NCT02500706|527931364|FG000|Overall Study|Unclassified|0|||
146390410|NCT02500706|527931365|FG001|Overall Study|Unclassified|0|||
146390411|NCT02500706|527931366|FG002|Overall Study|Unclassified|1|||
146390412|NCT01874288|527931368|FG000|Overall Study|Withdrawal by Subject|1|||
146390413|NCT01874288|527931369|FG001|Overall Study|Withdrawal by Subject|0|||
146390414|NCT01874288|527931370|FG002|Overall Study|Withdrawal by Subject|2|||
146390415|NCT01874288|527931371|FG003|Overall Study|Withdrawal by Subject|1|||
146390416|NCT01874288|527931372|FG004|Overall Study|Withdrawal by Subject|1|||
146390417|NCT01874288|527931368|FG000|Overall Study|Physician Decision|0|||
146390418|NCT01874288|527931369|FG001|Overall Study|Physician Decision|0|||
146390419|NCT01874288|527931370|FG002|Overall Study|Physician Decision|0|||
146390420|NCT01874288|527931371|FG003|Overall Study|Physician Decision|1|||
146390421|NCT01874288|527931372|FG004|Overall Study|Physician Decision|0|||
146390422|NCT01874288|527931368|FG000|Overall Study|Progressive disease|2|||
146390423|NCT01874288|527931369|FG001|Overall Study|Progressive disease|0|||
146390424|NCT01874288|527931370|FG002|Overall Study|Progressive disease|3|||
146390425|NCT01874288|527931371|FG003|Overall Study|Progressive disease|5|||
146390426|NCT01874288|527931372|FG004|Overall Study|Progressive disease|1|||
146390427|NCT04212221|527931373|FG000|Overall Study|Remained on Treatment|0|||
146390428|NCT04212221|527931374|FG001|Overall Study|Remained on Treatment|0|||
146390429|NCT04212221|527931375|FG002|Overall Study|Remained on Treatment|0|||
146390430|NCT04212221|527931376|FG003|Overall Study|Remained on Treatment|1|||
146390431|NCT04212221|527931377|FG004|Overall Study|Remained on Treatment|0|||
146390432|NCT04212221|527931378|FG005|Overall Study|Remained on Treatment|0|||
146390433|NCT04212221|527931379|FG006|Overall Study|Remained on Treatment|3|||
146390434|NCT04212221|527931380|FG007|Overall Study|Remained on Treatment|9|||
146390435|NCT04212221|527931373|FG000|Overall Study|Adverse Event|0|||
146390436|NCT04212221|527931374|FG001|Overall Study|Adverse Event|0|||
146390437|NCT04212221|527931375|FG002|Overall Study|Adverse Event|0|||
146390438|NCT04212221|527931376|FG003|Overall Study|Adverse Event|0|||
146390439|NCT04212221|527931377|FG004|Overall Study|Adverse Event|0|||
146390440|NCT04212221|527931378|FG005|Overall Study|Adverse Event|0|||
146390441|NCT04212221|527931379|FG006|Overall Study|Adverse Event|2|||
146390442|NCT04212221|527931380|FG007|Overall Study|Adverse Event|3|||
146390443|NCT04212221|527931373|FG000|Overall Study|Death|0|||
146390444|NCT04212221|527931374|FG001|Overall Study|Death|0|||
146390445|NCT04212221|527931375|FG002|Overall Study|Death|0|||
146390446|NCT04212221|527931376|FG003|Overall Study|Death|0|||
146390447|NCT04212221|527931377|FG004|Overall Study|Death|0|||
146390448|NCT04212221|527931378|FG005|Overall Study|Death|0|||
146390449|NCT04212221|527931379|FG006|Overall Study|Death|0|||
146390450|NCT04212221|527931380|FG007|Overall Study|Death|2|||
146390451|NCT04212221|527931373|FG000|Overall Study|Disease progression according to irRECIST|1|||
146390452|NCT04212221|527931374|FG001|Overall Study|Disease progression according to irRECIST|2|||
146390453|NCT04212221|527931375|FG002|Overall Study|Disease progression according to irRECIST|3|||
146390454|NCT04212221|527931376|FG003|Overall Study|Disease progression according to irRECIST|3|||
146390455|NCT04212221|527931377|FG004|Overall Study|Disease progression according to irRECIST|2|||
146390456|NCT04212221|527931378|FG005|Overall Study|Disease progression according to irRECIST|2|||
146390457|NCT04212221|527931379|FG006|Overall Study|Disease progression according to irRECIST|21|||
146390458|NCT04212221|527931380|FG007|Overall Study|Disease progression according to irRECIST|17|||
146390459|NCT04212221|527931373|FG000|Overall Study|Global Deterioration of Health Status|0|||
146390460|NCT04212221|527931374|FG001|Overall Study|Global Deterioration of Health Status|0|||
146390461|NCT04212221|527931375|FG002|Overall Study|Global Deterioration of Health Status|0|||
146390462|NCT04212221|527931376|FG003|Overall Study|Global Deterioration of Health Status|0|||
146390463|NCT04212221|527931377|FG004|Overall Study|Global Deterioration of Health Status|0|||
146390464|NCT04212221|527931378|FG005|Overall Study|Global Deterioration of Health Status|0|||
146390465|NCT04212221|527931379|FG006|Overall Study|Global Deterioration of Health Status|0|||
146390466|NCT04212221|527931380|FG007|Overall Study|Global Deterioration of Health Status|2|||
146390467|NCT04212221|527931373|FG000|Overall Study|Investigator's Decision|0|||
146390468|NCT04212221|527931374|FG001|Overall Study|Investigator's Decision|0|||
146390469|NCT04212221|527931375|FG002|Overall Study|Investigator's Decision|0|||
146390470|NCT04212221|527931376|FG003|Overall Study|Investigator's Decision|1|||
146390471|NCT04212221|527931377|FG004|Overall Study|Investigator's Decision|0|||
146390472|NCT04212221|527931378|FG005|Overall Study|Investigator's Decision|0|||
146390473|NCT04212221|527931379|FG006|Overall Study|Investigator's Decision|3|||
146390474|NCT04212221|527931380|FG007|Overall Study|Investigator's Decision|0|||
146390475|NCT04212221|527931373|FG000|Overall Study|Participant refused to continue treatment|0|||
146390476|NCT04212221|527931374|FG001|Overall Study|Participant refused to continue treatment|1|||
146390477|NCT04212221|527931375|FG002|Overall Study|Participant refused to continue treatment|0|||
146390478|NCT04212221|527931376|FG003|Overall Study|Participant refused to continue treatment|1|||
146390479|NCT04212221|527931377|FG004|Overall Study|Participant refused to continue treatment|1|||
146390480|NCT04212221|527931378|FG005|Overall Study|Participant refused to continue treatment|2|||
146390481|NCT04212221|527931379|FG006|Overall Study|Participant refused to continue treatment|4|||
146390482|NCT04212221|527931380|FG007|Overall Study|Participant refused to continue treatment|2|||
146390483|NCT04212221|527931373|FG000|Overall Study|Protocol Violation|0|||
146390484|NCT04212221|527931374|FG001|Overall Study|Protocol Violation|0|||
146390485|NCT04212221|527931375|FG002|Overall Study|Protocol Violation|0|||
146390486|NCT04212221|527931376|FG003|Overall Study|Protocol Violation|0|||
146390487|NCT04212221|527931377|FG004|Overall Study|Protocol Violation|0|||
146390488|NCT04212221|527931378|FG005|Overall Study|Protocol Violation|0|||
146390489|NCT04212221|527931379|FG006|Overall Study|Protocol Violation|0|||
146390490|NCT04212221|527931380|FG007|Overall Study|Protocol Violation|1|||
146390491|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
146390492|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
146390493|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
146390494|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
146390495|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
146390496|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
146390497|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Death|1|||
146390498|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Death|1|||
146390499|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Death|1|||
146390500|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Death|0|||
146390501|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Death|0|||
146390502|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Death|0|||
146390503|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
146390504|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
146390505|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146390506|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146390507|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146390508|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
146390509|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146390510|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146390511|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
146390512|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146390513|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146390514|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
146390515|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146390516|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
146390517|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146390518|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146390519|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146390520|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
146390521|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
146390522|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
146390523|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
146390524|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146390525|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146390526|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
146390527|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
146390528|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
146390529|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
146390530|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
146390531|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
146390532|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
146390533|NCT03370133|527931388|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
146390534|NCT03370133|527931389|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
146390535|NCT03370133|527931390|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
146390536|NCT03370133|527931391|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
146390537|NCT03370133|527931392|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
146390538|NCT03370133|527931393|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
146390539|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146390540|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146390541|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
146390542|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
146390543|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
146390544|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
146390545|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146390546|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146390547|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146390548|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
146390549|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
146390550|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
146390551|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146390552|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146390553|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146390554|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
146390555|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
146390556|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
146390557|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146390558|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146390559|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146390560|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
146390561|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
146390562|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
146390563|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146390564|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146390565|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
146390566|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
146390567|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
146390568|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
146390569|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146390570|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146390571|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146390572|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146390573|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
146390574|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
146390575|NCT03370133|527931388|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146390576|NCT03370133|527931389|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146396131|NCT01241591|527954453|FG001|Overall Study|Protocol Violation|2|||
146390577|NCT03370133|527931390|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146390578|NCT03370133|527931391|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146390579|NCT03370133|527931392|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
146390580|NCT03370133|527931393|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
146390581|NCT00636506|527931394|FG000|Overall Study|Lost to Follow-up|8|||
146390582|NCT00636506|527931394|FG000|Overall Study|Explanted|1|||
146390583|NCT00636506|527931394|FG000|Overall Study|Withdrawal by Subject|6|||
146390584|NCT00636506|527931394|FG000|Overall Study|Procedure aborted|1|||
146390585|NCT03742271|527931395|FG000|Overall Study|Unsatisfactory Visual Response|1|||
146390586|NCT03742271|527931395|FG000|Overall Study|Withdrawal by Subject|3|||
146390587|NCT03742271|527931395|FG000|Overall Study|Lost to Follow-up|4|||
146390588|NCT03742271|527931395|FG000|Overall Study|Failed Insertion & removal|3|||
146390589|NCT03742271|527931395|FG000|Overall Study|Protocol Violation|1|||
146390590|NCT01624974|527931396|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
146390591|NCT01624974|527931397|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
146390592|NCT01624974|527931396|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
146390593|NCT01624974|527931397|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
146390594|NCT01624974|527931396|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
146390595|NCT01624974|527931397|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
146390596|NCT01624974|527931396|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
146390597|NCT01624974|527931397|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
146390598|NCT01624974|527931396|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
146390599|NCT01624974|527931397|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
146390600|NCT01624974|527931396|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
146390601|NCT01624974|527931397|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
146390602|NCT01624974|527931396|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
146390603|NCT01624974|527931397|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
146390604|NCT01624974|527931396|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
146390605|NCT01624974|527931397|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
146390606|NCT01624974|527931396|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
146390607|NCT01624974|527931397|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
146390608|NCT01624974|527931396|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
146390609|NCT01624974|527931397|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
146390610|NCT01624974|527931396|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
146390611|NCT01624974|527931397|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
146390612|NCT01624974|527931396|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
146390613|NCT01624974|527931397|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
146390614|NCT02380703|527931400|FG000|Overall Study|Withdrawal by Subject|12|||
146390615|NCT02380703|527931401|FG001|Overall Study|Withdrawal by Subject|9|||
146390616|NCT02380703|527931400|FG000|Overall Study|Lost to Follow-up|12|||
146390617|NCT02380703|527931401|FG001|Overall Study|Lost to Follow-up|12|||
146390618|NCT02380703|527931400|FG000|Overall Study|Caregiver death|1|||
146390619|NCT02380703|527931401|FG001|Overall Study|Caregiver death|0|||
146390620|NCT02380703|527931400|FG000|Overall Study|Person with dementia (PWD) death|7|||
146390621|NCT02380703|527931401|FG001|Overall Study|Person with dementia (PWD) death|8|||
146390622|NCT02380703|527931400|FG000|Overall Study|Entered Long-term Care|4|||
146390623|NCT02380703|527931401|FG001|Overall Study|Entered Long-term Care|7|||
146390624|NCT00266695|527931402|FG000|Overall Study|Adverse Event|1|||
146390625|NCT00266695|527931402|FG000|Overall Study|Death|9|||
146390626|NCT00266695|527931402|FG000|Overall Study|Physician Decision|1|||
146390627|NCT00266695|527931402|FG000|Overall Study|Lost to Follow-up|3|||
146390628|NCT00266695|527931402|FG000|Overall Study|Withdrawal by Subject|15|||
146390629|NCT03607994|527931403|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
146390630|NCT03607994|527931404|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
146390631|NCT00620815|527931407|FG000|Overall Study|Adverse Event|1|||
146390632|NCT00620815|527931408|FG001|Overall Study|Adverse Event|1|||
146390633|NCT00620815|527931409|FG002|Overall Study|Adverse Event|2|||
146390634|NCT00620815|527931407|FG000|Overall Study|Withdrawal by Subject|1|||
146390635|NCT00620815|527931408|FG001|Overall Study|Withdrawal by Subject|2|||
146390636|NCT00620815|527931409|FG002|Overall Study|Withdrawal by Subject|0|||
146390637|NCT00620815|527931407|FG000|Overall Study|Lost to Follow-up|1|||
146390638|NCT00620815|527931408|FG001|Overall Study|Lost to Follow-up|6|||
146390639|NCT00620815|527931409|FG002|Overall Study|Lost to Follow-up|3|||
146390640|NCT00620815|527931407|FG000|Overall Study|Inappropriate enrolment|0|||
146390641|NCT00620815|527931408|FG001|Overall Study|Inappropriate enrolment|0|||
146390642|NCT00620815|527931409|FG002|Overall Study|Inappropriate enrolment|1|||
146390643|NCT00620815|527931407|FG000|Overall Study|Protocol Violation|1|||
146390644|NCT00620815|527931408|FG001|Overall Study|Protocol Violation|2|||
146390645|NCT00620815|527931409|FG002|Overall Study|Protocol Violation|1|||
146390646|NCT01888367|527931410|FG000|Overall Study|Physician Decision|3|||
146390647|NCT01888367|527931411|FG001|Overall Study|Physician Decision|4|||
146390648|NCT01888367|527931412|FG002|Overall Study|Physician Decision|2|||
146390649|NCT01888367|527931410|FG000|Overall Study|Death|2|||
146390650|NCT01888367|527931411|FG001|Overall Study|Death|0|||
146390651|NCT01888367|527931412|FG002|Overall Study|Death|1|||
146390652|NCT01888367|527931410|FG000|Overall Study|Withdrawal by Subject|1|||
146390653|NCT01888367|527931411|FG001|Overall Study|Withdrawal by Subject|0|||
146390654|NCT01888367|527931412|FG002|Overall Study|Withdrawal by Subject|1|||
146390655|NCT01888367|527931410|FG000|Overall Study|Lost to Follow-up|1|||
146390656|NCT01888367|527931411|FG001|Overall Study|Lost to Follow-up|1|||
146390657|NCT01888367|527931412|FG002|Overall Study|Lost to Follow-up|0|||
146390658|NCT01888367|527931410|FG000|Overall Study|Protocol Violation|0|||
146390659|NCT01888367|527931411|FG001|Overall Study|Protocol Violation|0|||
146390660|NCT01888367|527931412|FG002|Overall Study|Protocol Violation|1|||
146390661|NCT01888367|527931410|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
146390662|NCT01888367|527931411|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
146390663|NCT01888367|527931412|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
146390664|NCT00591786|527931413|FG000|Overall Study|Withdrawal of Informed Consent|0|||
146390665|NCT00591786|527931414|FG001|Overall Study|Withdrawal of Informed Consent|0|||
146390666|NCT00591786|527931415|FG002|Overall Study|Withdrawal of Informed Consent|1|||
146390667|NCT00591786|527931416|FG003|Overall Study|Withdrawal of Informed Consent|0|||
146390668|NCT00591786|527931417|FG004|Overall Study|Withdrawal of Informed Consent|0|||
146390669|NCT00591786|527931418|FG005|Overall Study|Withdrawal of Informed Consent|0|||
146390670|NCT00591786|527931419|FG006|Overall Study|Withdrawal of Informed Consent|0|||
146390671|NCT00591786|527931420|FG007|Overall Study|Withdrawal of Informed Consent|0|||
146390672|NCT00591786|527931421|FG008|Overall Study|Withdrawal of Informed Consent|0|||
146390673|NCT00591786|527931422|FG009|Overall Study|Withdrawal of Informed Consent|0|||
146390674|NCT03969589|527931423|FG000|Overall Study|Lost to Follow-up|3|||
146390675|NCT03969589|527931424|FG001|Overall Study|Lost to Follow-up|2|||
146390676|NCT03969589|527931423|FG000|Overall Study|Declined Follow-Up|0|||
146390677|NCT03969589|527931424|FG001|Overall Study|Declined Follow-Up|1|||
146390678|NCT00517634|527931425|FG000|Second Treatment Period|Withdrawal by Subject|0|||
146390679|NCT00517634|527931426|FG001|Second Treatment Period|Withdrawal by Subject|0|||
146390680|NCT00517634|527931427|FG002|Second Treatment Period|Withdrawal by Subject|0|||
146390681|NCT00517634|527931428|FG003|Second Treatment Period|Withdrawal by Subject|0|||
146390682|NCT00517634|527931429|FG004|Second Treatment Period|Withdrawal by Subject|1|||
146390683|NCT00517634|527931430|FG005|Second Treatment Period|Withdrawal by Subject|0|||
146390684|NCT03143855|527931431|FG000|Overall Study|Withdrawal by Subject|4|||
146390685|NCT03143855|527931432|FG001|Overall Study|Withdrawal by Subject|3|||
146390686|NCT03143855|527931431|FG000|Overall Study|Protocol Violation|1|||
146390687|NCT03143855|527931432|FG001|Overall Study|Protocol Violation|0|||
146390688|NCT03143855|527931431|FG000|Overall Study|Participant experienced withdrawal|0|||
146390689|NCT03143855|527931432|FG001|Overall Study|Participant experienced withdrawal|1|||
146390690|NCT03417999|527931433|FG000|Overall Study|Withdrawal by Subject|1|||
146390691|NCT03417999|527931434|FG001|Overall Study|Withdrawal by Subject|0|||
146390692|NCT03417999|527931435|FG002|Overall Study|Withdrawal by Subject|0|||
146390693|NCT03417999|527931433|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
146390694|NCT03417999|527931434|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
146390695|NCT03417999|527931435|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
146390696|NCT03417999|527931433|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
146390697|NCT03417999|527931434|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
146390698|NCT03417999|527931435|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
146390699|NCT03417999|527931433|FG000|Overall Study|Inadequate study staff available to process samples|0|||
146390700|NCT03417999|527931434|FG001|Overall Study|Inadequate study staff available to process samples|0|||
146390701|NCT03417999|527931435|FG002|Overall Study|Inadequate study staff available to process samples|1|||
146390702|NCT00422942|527931440|FG000|Overall Study|Study terminated by Sponsor|3|||
146390703|NCT00695318|527931442|FG000|Overall Study|Lost to Follow-up|1|||
146390704|NCT00695318|527931443|FG001|Overall Study|Lost to Follow-up|0|||
146390705|NCT00695318|527931442|FG000|Overall Study|Withdrawal by Subject|2|||
146390706|NCT00695318|527931443|FG001|Overall Study|Withdrawal by Subject|0|||
146390707|NCT00695318|527931442|FG000|Overall Study|Death|1|||
146390708|NCT00695318|527931443|FG001|Overall Study|Death|1|||
146390709|NCT00695318|527931442|FG000|Overall Study|Study Terminated|1|||
146390710|NCT00695318|527931443|FG001|Overall Study|Study Terminated|0|||
146390711|NCT02705755|527931444|FG000|Part A (6 Days)|Adverse Event|1|||
146390712|NCT02705755|527931445|FG001|Part A (6 Days)|Adverse Event|0|||
146390713|NCT02705755|527931446|FG002|Part A (6 Days)|Adverse Event|0|||
146390714|NCT02705755|527931447|FG003|Part A (6 Days)|Adverse Event|0|||
146390715|NCT02705755|527931444|FG000|Part A (6 Days)|Physician Decision|3|||
146390716|NCT02705755|527931445|FG001|Part A (6 Days)|Physician Decision|0|||
146390717|NCT02705755|527931446|FG002|Part A (6 Days)|Physician Decision|0|||
146390718|NCT02705755|527931447|FG003|Part A (6 Days)|Physician Decision|0|||
146390719|NCT02705755|527931444|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
146390720|NCT02705755|527931445|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
146390721|NCT02705755|527931446|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
146390722|NCT02705755|527931447|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
146390723|NCT02705755|527931444|FG000|Part C (20 Weeks)|Physician Decision|0|||
146390724|NCT02705755|527931445|FG001|Part C (20 Weeks)|Physician Decision|0|||
146390725|NCT02705755|527931446|FG002|Part C (20 Weeks)|Physician Decision|0|||
146390726|NCT02705755|527931447|FG003|Part C (20 Weeks)|Physician Decision|2|||
146390727|NCT02705755|527931444|FG000|Part C (20 Weeks)|Adverse Event|0|||
146390728|NCT02705755|527931445|FG001|Part C (20 Weeks)|Adverse Event|0|||
146390729|NCT02705755|527931446|FG002|Part C (20 Weeks)|Adverse Event|0|||
146390730|NCT02705755|527931447|FG003|Part C (20 Weeks)|Adverse Event|6|||
146390731|NCT02705755|527931444|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
146390732|NCT02705755|527931445|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
146390733|NCT02705755|527931446|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
146390734|NCT02705755|527931447|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
146390735|NCT00939094|527931448|FG000|Overall Study|Adverse Event|9|||
146390736|NCT00939094|527931449|FG001|Overall Study|Adverse Event|0|||
146390737|NCT00939094|527931448|FG000|Overall Study|Withdrawal by Subject|1|||
146390738|NCT00939094|527931449|FG001|Overall Study|Withdrawal by Subject|6|||
146390739|NCT00939094|527931448|FG000|Overall Study|Lost to Follow-up|1|||
146390740|NCT00939094|527931449|FG001|Overall Study|Lost to Follow-up|1|||
146390741|NCT00939094|527931448|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
146390742|NCT00939094|527931449|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
146390743|NCT00939094|527931448|FG000|Overall Study|Severe non-compliance to protocol|0|||
146390744|NCT00939094|527931449|FG001|Overall Study|Severe non-compliance to protocol|1|||
146390745|NCT00939094|527931448|FG000|Overall Study|Study stopped by sponsor|0|||
146390746|NCT00939094|527931449|FG001|Overall Study|Study stopped by sponsor|2|||
146390747|NCT00939094|527931448|FG000|Overall Study|Abnormal ECG findings|1|||
146390748|NCT00939094|527931449|FG001|Overall Study|Abnormal ECG findings|0|||
146390749|NCT00134563|527933623|FG000|Overall Study|Not treated due to protocol violation|0|||
146390750|NCT00134563|527933624|FG001|Overall Study|Not treated due to protocol violation|1|||
146390751|NCT00134563|527933625|FG002|Overall Study|Not treated due to protocol violation|1|||
146390752|NCT00134563|527933623|FG000|Overall Study|Adverse Event|29|||
146390753|NCT00134563|527933624|FG001|Overall Study|Adverse Event|37|||
146390754|NCT00134563|527933625|FG002|Overall Study|Adverse Event|38|||
146390755|NCT00134563|527933623|FG000|Overall Study|Lack of Efficacy|24|||
146390756|NCT00134563|527933624|FG001|Overall Study|Lack of Efficacy|14|||
146390757|NCT00134563|527933625|FG002|Overall Study|Lack of Efficacy|17|||
146390758|NCT00134563|527933623|FG000|Overall Study|Protocol Violation|3|||
146390759|NCT00134563|527933624|FG001|Overall Study|Protocol Violation|2|||
146390760|NCT00134563|527933625|FG002|Overall Study|Protocol Violation|5|||
146390761|NCT00134563|527933623|FG000|Overall Study|Lost to Follow-up|4|||
146390762|NCT00134563|527933624|FG001|Overall Study|Lost to Follow-up|0|||
146390763|NCT00134563|527933625|FG002|Overall Study|Lost to Follow-up|2|||
146390764|NCT00134563|527933623|FG000|Overall Study|progressive disease|11|||
146390765|NCT00134563|527933624|FG001|Overall Study|progressive disease|4|||
146390766|NCT00134563|527933625|FG002|Overall Study|progressive disease|2|||
146390767|NCT00134563|527933623|FG000|Overall Study|did not wish to continue|33|||
146390768|NCT00134563|527933624|FG001|Overall Study|did not wish to continue|32|||
146390769|NCT00134563|527933625|FG002|Overall Study|did not wish to continue|26|||
146390770|NCT00134563|527933623|FG000|Overall Study|Reason other than above|0|||
146390771|NCT00134563|527933624|FG001|Overall Study|Reason other than above|2|||
146390772|NCT00134563|527933625|FG002|Overall Study|Reason other than above|5|||
146390773|NCT02406586|527933626|FG000|Overall Study|Lost to Follow-up|0|||
146390774|NCT02406586|527933627|FG001|Overall Study|Lost to Follow-up|4|||
146390775|NCT02406586|527933628|FG002|Overall Study|Lost to Follow-up|2|||
146390776|NCT02406586|527933626|FG000|Overall Study|Withdrawal by Subject|1|||
146390777|NCT02406586|527933627|FG001|Overall Study|Withdrawal by Subject|0|||
146390778|NCT02406586|527933628|FG002|Overall Study|Withdrawal by Subject|0|||
146390779|NCT02839330|527933629|FG000|Overall Study|Adverse Event|0|||
146390780|NCT02839330|527933630|FG001|Overall Study|Adverse Event|1|||
146390781|NCT02839330|527933631|FG002|Overall Study|Adverse Event|2|||
146390782|NCT02839330|527933632|FG003|Overall Study|Adverse Event|2|||
146390783|NCT02839330|527933629|FG000|Overall Study|Death|4|||
146390784|NCT02839330|527933630|FG001|Overall Study|Death|6|||
146390785|NCT02839330|527933631|FG002|Overall Study|Death|1|||
146390786|NCT02839330|527933632|FG003|Overall Study|Death|1|||
146390787|NCT02839330|527933629|FG000|Overall Study|Withdrawal by Subject|27|||
146390788|NCT02839330|527933630|FG001|Overall Study|Withdrawal by Subject|19|||
146390789|NCT02839330|527933631|FG002|Overall Study|Withdrawal by Subject|11|||
146390790|NCT02839330|527933632|FG003|Overall Study|Withdrawal by Subject|13|||
146390791|NCT02839330|527933629|FG000|Overall Study|Lost to Follow-up|22|||
146390792|NCT02839330|527933630|FG001|Overall Study|Lost to Follow-up|27|||
146390793|NCT02839330|527933631|FG002|Overall Study|Lost to Follow-up|29|||
146390794|NCT02839330|527933632|FG003|Overall Study|Lost to Follow-up|25|||
146056275|NCT00626275|526721163|FG003|Part B|Lost to Follow-up|0|||
146056276|NCT00626275|526721164|FG004|Part B|Lost to Follow-up|0|||
146056277|NCT00626275|526721165|FG005|Part B|Lost to Follow-up|0|||
146056278|NCT00626275|526721166|FG006|Part B|Lost to Follow-up|1|||
146390795|NCT02839330|527933629|FG000|Overall Study|Administrative Reason|0|||
146390796|NCT02839330|527933630|FG001|Overall Study|Administrative Reason|0|||
146390797|NCT02839330|527933631|FG002|Overall Study|Administrative Reason|0|||
146390798|NCT02839330|527933632|FG003|Overall Study|Administrative Reason|1|||
146390799|NCT02839330|527933629|FG000|Overall Study|Protocol Violation|1|||
146390800|NCT02839330|527933630|FG001|Overall Study|Protocol Violation|2|||
146390801|NCT02839330|527933631|FG002|Overall Study|Protocol Violation|2|||
146390802|NCT02839330|527933632|FG003|Overall Study|Protocol Violation|3|||
146390803|NCT02839330|527933629|FG000|Overall Study|Other reason, not specified|4|||
146390804|NCT02839330|527933630|FG001|Overall Study|Other reason, not specified|3|||
146390805|NCT02839330|527933631|FG002|Overall Study|Other reason, not specified|3|||
146390806|NCT02839330|527933632|FG003|Overall Study|Other reason, not specified|6|||
146390807|NCT00883896|527933635|FG000|Overall Study|Lost to Follow-up|0|||
146390808|NCT00883896|527933636|FG001|Overall Study|Lost to Follow-up|0|||
146390809|NCT00883896|527933637|FG002|Overall Study|Lost to Follow-up|0|||
146390810|NCT00883896|527933638|FG003|Overall Study|Lost to Follow-up|2|||
146390811|NCT00883896|527933635|FG000|Overall Study|Withdrawal by Subject|5|||
146390812|NCT00883896|527933636|FG001|Overall Study|Withdrawal by Subject|0|||
146390813|NCT00883896|527933637|FG002|Overall Study|Withdrawal by Subject|1|||
146390814|NCT00883896|527933638|FG003|Overall Study|Withdrawal by Subject|3|||
146390815|NCT00883896|527933635|FG000|Overall Study|Lack of Efficacy|0|||
146390816|NCT00883896|527933636|FG001|Overall Study|Lack of Efficacy|0|||
146390817|NCT00883896|527933637|FG002|Overall Study|Lack of Efficacy|0|||
146390818|NCT00883896|527933638|FG003|Overall Study|Lack of Efficacy|2|||
146390819|NCT00883896|527933635|FG000|Overall Study|Other|1|||
146390820|NCT00883896|527933636|FG001|Overall Study|Other|0|||
146390821|NCT00883896|527933637|FG002|Overall Study|Other|0|||
146390822|NCT00883896|527933638|FG003|Overall Study|Other|0|||
146390823|NCT03380091|527933650|FG000|Overall Study|Withdrawal by Subject|2|||
146390824|NCT03380091|527933651|FG001|Overall Study|Withdrawal by Subject|1|||
146390825|NCT01980056|527933653|FG000|Overall Study|Death|1|||
146390826|NCT01980056|527933654|FG001|Overall Study|Death|1|||
146390827|NCT01980056|527933655|FG002|Overall Study|Death|0|||
146390828|NCT00661362|527933656|FG000|Overall Study|Adverse Event|5|||
146390829|NCT00661362|527933657|FG001|Overall Study|Adverse Event|4|||
146390830|NCT00661362|527933656|FG000|Overall Study|Incorrect enrollment|2|||
146390831|NCT00661362|527933657|FG001|Overall Study|Incorrect enrollment|0|||
146390832|NCT00661362|527933656|FG000|Overall Study|Study specific discontinuation criteria|4|||
146390833|NCT00661362|527933657|FG001|Overall Study|Study specific discontinuation criteria|11|||
146390834|NCT00661362|527933656|FG000|Overall Study|Withdrawal by Subject|13|||
146390835|NCT00661362|527933657|FG001|Overall Study|Withdrawal by Subject|23|||
146390836|NCT00661362|527933656|FG000|Overall Study|Lost to Follow-up|3|||
146390837|NCT00661362|527933657|FG001|Overall Study|Lost to Follow-up|1|||
146390838|NCT00661362|527933656|FG000|Overall Study|Severe non-compliance to protocol|0|||
146390839|NCT00661362|527933657|FG001|Overall Study|Severe non-compliance to protocol|1|||
146390840|NCT00661362|527933656|FG000|Overall Study|Safety reasons|1|||
146390841|NCT00661362|527933657|FG001|Overall Study|Safety reasons|0|||
146390842|NCT00661362|527933656|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
146390843|NCT00661362|527933657|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
146390844|NCT00535262|527933658|FG000|Overall Study|No funding|3|||
146390845|NCT03802331|527933660|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
146390846|NCT03802331|527933661|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
146390847|NCT00368069|527933663|FG000|Overall Study|Adverse Event|5|||
146390848|NCT00368069|527933664|FG001|Overall Study|Adverse Event|2|||
146390849|NCT00368069|527933663|FG000|Overall Study|Lack of Efficacy|0|||
146390850|NCT00368069|527933664|FG001|Overall Study|Lack of Efficacy|1|||
146390851|NCT00368069|527933663|FG000|Overall Study|Lost to Follow-up|1|||
146390852|NCT00368069|527933664|FG001|Overall Study|Lost to Follow-up|0|||
146390853|NCT00368069|527933663|FG000|Overall Study|Protocol Violation|0|||
146390854|NCT00368069|527933664|FG001|Overall Study|Protocol Violation|2|||
146390855|NCT00368069|527933663|FG000|Overall Study|Withdrawal of Consent|2|||
146390856|NCT00368069|527933664|FG001|Overall Study|Withdrawal of Consent|1|||
146390857|NCT00368069|527933663|FG000|Overall Study|no blood sampling possible|0|||
146390858|NCT00368069|527933664|FG001|Overall Study|no blood sampling possible|1|||
146390859|NCT01220024|527933670|FG000|Overall Study|Lost to Follow-up|1|||
146390860|NCT01220024|527933671|FG001|Overall Study|Lost to Follow-up|1|||
146390861|NCT00174460|527933674|FG000|Overall Study|Withdrawal by Subject|0|||
146390862|NCT00174460|527933675|FG001|Overall Study|Withdrawal by Subject|1|||
146390863|NCT00579059|527933676|FG000|Overall Study|Study Canceled at 1 Year|21|||
146390864|NCT00579059|527933677|FG001|Overall Study|Study Canceled at 1 Year|10|||
146390865|NCT00779506|527933678|FG000|Overall Study|Screening Failed|2|||
146390866|NCT00779506|527933678|FG000|Overall Study|Adverse Event|4|||
146390867|NCT00779506|527933678|FG000|Overall Study|Lack of Efficacy|11|||
146390868|NCT00779506|527933678|FG000|Overall Study|Protocol Violation|5|||
146390869|NCT00779506|527933678|FG000|Overall Study|Withdrawal by Subject|6|||
146390870|NCT00779506|527933678|FG000|Overall Study|Lost to Follow-up|1|||
146390871|NCT03982069|527933679|FG000|Overall Study|Lost to Follow-up|5|||
146390872|NCT03982069|527933680|FG001|Overall Study|Lost to Follow-up|5|||
146390873|NCT03982069|527933681|FG002|Overall Study|Lost to Follow-up|3|||
146390874|NCT03982069|527933682|FG003|Overall Study|Lost to Follow-up|5|||
146390875|NCT03982069|527933679|FG000|Overall Study|Physician Decision|0|||
146390876|NCT03982069|527933680|FG001|Overall Study|Physician Decision|1|||
146390877|NCT03982069|527933681|FG002|Overall Study|Physician Decision|0|||
146390878|NCT03982069|527933682|FG003|Overall Study|Physician Decision|0|||
146390879|NCT03982069|527933679|FG000|Overall Study|Withdrawal by Subject|2|||
146390880|NCT03982069|527933680|FG001|Overall Study|Withdrawal by Subject|1|||
146390881|NCT03982069|527933681|FG002|Overall Study|Withdrawal by Subject|5|||
146390882|NCT03982069|527933682|FG003|Overall Study|Withdrawal by Subject|2|||
146390883|NCT03982069|527933679|FG000|Overall Study|Specimen loss|3|||
146390884|NCT03982069|527933680|FG001|Overall Study|Specimen loss|3|||
146390885|NCT03982069|527933681|FG002|Overall Study|Specimen loss|1|||
146390886|NCT03982069|527933682|FG003|Overall Study|Specimen loss|1|||
146390887|NCT01218477|527933683|FG000|Overall Study|Disease progression|2|||
146390888|NCT01218477|527933684|FG001|Overall Study|Disease progression|3|||
146390889|NCT01218477|527933685|FG002|Overall Study|Disease progression|6|||
146390890|NCT01218477|527933686|FG003|Overall Study|Disease progression|2|||
146390891|NCT01218477|527933683|FG000|Overall Study|Study drug toxicity|0|||
146390892|NCT01218477|527933684|FG001|Overall Study|Study drug toxicity|2|||
146390893|NCT01218477|527933685|FG002|Overall Study|Study drug toxicity|5|||
146390894|NCT01218477|527933686|FG003|Overall Study|Study drug toxicity|0|||
146390895|NCT01218477|527933683|FG000|Overall Study|No longer meets study criteria|1|||
146390896|NCT01218477|527933684|FG001|Overall Study|No longer meets study criteria|0|||
146390897|NCT01218477|527933685|FG002|Overall Study|No longer meets study criteria|0|||
146390898|NCT01218477|527933686|FG003|Overall Study|No longer meets study criteria|0|||
146390899|NCT01218477|527933683|FG000|Overall Study|Withdrawal by Subject|0|||
146390900|NCT01218477|527933684|FG001|Overall Study|Withdrawal by Subject|0|||
146390901|NCT01218477|527933685|FG002|Overall Study|Withdrawal by Subject|1|||
146390902|NCT01218477|527933686|FG003|Overall Study|Withdrawal by Subject|0|||
146390903|NCT01218477|527933683|FG000|Overall Study|Prepared for cell transplantation|0|||
146390904|NCT01218477|527933684|FG001|Overall Study|Prepared for cell transplantation|1|||
146390905|NCT01218477|527933685|FG002|Overall Study|Prepared for cell transplantation|1|||
146390906|NCT01218477|527933686|FG003|Overall Study|Prepared for cell transplantation|0|||
146390907|NCT01218477|527933683|FG000|Overall Study|Administrative reason by sponsor|0|||
146390908|NCT01218477|527933684|FG001|Overall Study|Administrative reason by sponsor|0|||
146390909|NCT01218477|527933685|FG002|Overall Study|Administrative reason by sponsor|1|||
146390910|NCT01218477|527933686|FG003|Overall Study|Administrative reason by sponsor|0|||
146390911|NCT01218477|527933683|FG000|Overall Study|Maximum clinical benefit|0|||
146390912|NCT01218477|527933684|FG001|Overall Study|Maximum clinical benefit|2|||
146390913|NCT01218477|527933685|FG002|Overall Study|Maximum clinical benefit|0|||
146390914|NCT01218477|527933686|FG003|Overall Study|Maximum clinical benefit|0|||
146390915|NCT00787527|527933687|FG000|Overall Study|Toxicity|3|||
146390916|NCT03137433|527933690|FG000|Overall Study|Withdrawal by Subject|11|||
146390917|NCT03137433|527933691|FG001|Overall Study|Withdrawal by Subject|11|||
146390918|NCT03137433|527933690|FG000|Overall Study|Lost to Follow-up|5|||
146390919|NCT03137433|527933691|FG001|Overall Study|Lost to Follow-up|6|||
146390920|NCT03137433|527933690|FG000|Overall Study|Physician Decision|2|||
146390921|NCT03137433|527933691|FG001|Overall Study|Physician Decision|0|||
146390922|NCT03137433|527933690|FG000|Overall Study|Moved out of study area|1|||
146390923|NCT03137433|527933691|FG001|Overall Study|Moved out of study area|0|||
146390924|NCT03137433|527933690|FG000|Overall Study|Too far out of window due to COVID|0|||
146390925|NCT03137433|527933691|FG001|Overall Study|Too far out of window due to COVID|1|||
146390926|NCT00083616|527933692|FG000|Overall Study|Disease Progression|16|||
146390927|NCT00083616|527933692|FG000|Overall Study|Lost to Follow-up|1|||
146390928|NCT00083616|527933692|FG000|Overall Study|Physician Decision|2|||
146390929|NCT00083616|527933692|FG000|Overall Study|Withdrawal by Subject|3|||
146390930|NCT00083616|527933692|FG000|Overall Study|Ineligibility determined|2|||
146390931|NCT00083616|527933692|FG000|Overall Study|Non-compliance|1|||
146390932|NCT00083616|527933692|FG000|Overall Study|Other|6|||
146390933|NCT01474993|527933698|FG000|Overall Study|Lost to Follow-up|1|||
146390934|NCT01474993|527933699|FG001|Overall Study|Lost to Follow-up|2|||
146390935|NCT01474993|527933698|FG000|Overall Study|Adverse Event|0|||
146390936|NCT01474993|527933699|FG001|Overall Study|Adverse Event|1|||
146390937|NCT01853397|527933700|FG000|Overall Study|Withdrawal by Subject|0|||
146390938|NCT01853397|527933701|FG001|Overall Study|Withdrawal by Subject|0|||
146390939|NCT01853397|527933702|FG002|Overall Study|Withdrawal by Subject|0|||
146390940|NCT01853397|527933703|FG003|Overall Study|Withdrawal by Subject|1|||
146390941|NCT01853397|527933700|FG000|Overall Study|Subject Noncompliance|0|||
146390942|NCT01853397|527933701|FG001|Overall Study|Subject Noncompliance|0|||
146390943|NCT01853397|527933702|FG002|Overall Study|Subject Noncompliance|0|||
146390944|NCT01853397|527933703|FG003|Overall Study|Subject Noncompliance|1|||
146390945|NCT02132312|527933704|FG000|Overall Study|Adverse Event|2|||
146390946|NCT02132312|527933705|FG001|Overall Study|Adverse Event|0|||
146390947|NCT02132312|527933704|FG000|Overall Study|Physician Decision|1|||
146390948|NCT02132312|527933705|FG001|Overall Study|Physician Decision|1|||
146390949|NCT02132312|527933704|FG000|Overall Study|Protocol Violation|0|||
146390950|NCT02132312|527933705|FG001|Overall Study|Protocol Violation|1|||
146390951|NCT02132312|527933704|FG000|Overall Study|Withdrawal by Subject|1|||
146390952|NCT02132312|527933705|FG001|Overall Study|Withdrawal by Subject|0|||
146390953|NCT02132312|527933704|FG000|Overall Study|Lost to Follow-up|2|||
146390954|NCT02132312|527933705|FG001|Overall Study|Lost to Follow-up|1|||
146390955|NCT01632345|527933706|FG000|Treatment: Part I|Adverse Event|1|||
146390956|NCT01632345|527933707|FG001|Treatment: Part I|Adverse Event|4|||
146390957|NCT01632345|527933708|FG002|Treatment: Part I|Adverse Event|2|||
146390958|NCT01632345|527933709|FG003|Treatment: Part I|Adverse Event|1|||
146390959|NCT01632345|527933710|FG004|Treatment: Part I|Adverse Event|3|||
146390960|NCT01632345|527933711|FG005|Treatment: Part I|Adverse Event|0|||
146390961|NCT01632345|527933712|FG006|Treatment: Part I|Adverse Event|0|||
146390962|NCT01632345|527933706|FG000|Treatment: Part I|Lack of Efficacy|0|||
146390963|NCT01632345|527933707|FG001|Treatment: Part I|Lack of Efficacy|1|||
146390964|NCT01632345|527933708|FG002|Treatment: Part I|Lack of Efficacy|0|||
146390965|NCT01632345|527933709|FG003|Treatment: Part I|Lack of Efficacy|1|||
146390966|NCT01632345|527933710|FG004|Treatment: Part I|Lack of Efficacy|1|||
146390967|NCT01632345|527933711|FG005|Treatment: Part I|Lack of Efficacy|0|||
146390968|NCT01632345|527933712|FG006|Treatment: Part I|Lack of Efficacy|0|||
146390969|NCT01632345|527933706|FG000|Treatment: Part I|Lost to Follow-up|3|||
146390970|NCT01632345|527933707|FG001|Treatment: Part I|Lost to Follow-up|2|||
146390971|NCT01632345|527933708|FG002|Treatment: Part I|Lost to Follow-up|1|||
146390972|NCT01632345|527933709|FG003|Treatment: Part I|Lost to Follow-up|3|||
146390973|NCT01632345|527933710|FG004|Treatment: Part I|Lost to Follow-up|4|||
146390974|NCT01632345|527933711|FG005|Treatment: Part I|Lost to Follow-up|0|||
146390975|NCT01632345|527933712|FG006|Treatment: Part I|Lost to Follow-up|0|||
146390976|NCT01632345|527933706|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
146390977|NCT01632345|527933707|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
146390978|NCT01632345|527933708|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
146390979|NCT01632345|527933709|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
146390980|NCT01632345|527933710|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
146390981|NCT01632345|527933711|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
146390982|NCT01632345|527933712|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
146390983|NCT01632345|527933706|FG000|Treatment: Part I|Physician Decision|2|||
146390984|NCT01632345|527933707|FG001|Treatment: Part I|Physician Decision|1|||
146390985|NCT01632345|527933708|FG002|Treatment: Part I|Physician Decision|0|||
146390986|NCT01632345|527933709|FG003|Treatment: Part I|Physician Decision|0|||
146390987|NCT01632345|527933710|FG004|Treatment: Part I|Physician Decision|1|||
146390988|NCT01632345|527933711|FG005|Treatment: Part I|Physician Decision|0|||
146390989|NCT01632345|527933712|FG006|Treatment: Part I|Physician Decision|0|||
146390990|NCT01632345|527933706|FG000|Treatment: Part I|Pregnancy|0|||
146390991|NCT01632345|527933707|FG001|Treatment: Part I|Pregnancy|1|||
146390992|NCT01632345|527933708|FG002|Treatment: Part I|Pregnancy|0|||
146390993|NCT01632345|527933709|FG003|Treatment: Part I|Pregnancy|0|||
146390994|NCT01632345|527933710|FG004|Treatment: Part I|Pregnancy|0|||
146390995|NCT01632345|527933711|FG005|Treatment: Part I|Pregnancy|0|||
146390996|NCT01632345|527933712|FG006|Treatment: Part I|Pregnancy|0|||
146390997|NCT01632345|527933706|FG000|Treatment: Part I|Protocol Deviation|0|||
146390998|NCT01632345|527933707|FG001|Treatment: Part I|Protocol Deviation|0|||
146390999|NCT01632345|527933708|FG002|Treatment: Part I|Protocol Deviation|1|||
146391000|NCT01632345|527933709|FG003|Treatment: Part I|Protocol Deviation|1|||
146391001|NCT01632345|527933710|FG004|Treatment: Part I|Protocol Deviation|0|||
146391002|NCT01632345|527933711|FG005|Treatment: Part I|Protocol Deviation|0|||
146391003|NCT01632345|527933712|FG006|Treatment: Part I|Protocol Deviation|0|||
146391004|NCT01632345|527933706|FG000|Treatment: Part I|Withdrawal by Subject|3|||
146391005|NCT01632345|527933707|FG001|Treatment: Part I|Withdrawal by Subject|4|||
146391006|NCT01632345|527933708|FG002|Treatment: Part I|Withdrawal by Subject|4|||
146391007|NCT01632345|527933709|FG003|Treatment: Part I|Withdrawal by Subject|1|||
146391008|NCT01632345|527933710|FG004|Treatment: Part I|Withdrawal by Subject|4|||
146391009|NCT01632345|527933711|FG005|Treatment: Part I|Withdrawal by Subject|0|||
146391010|NCT01632345|527933712|FG006|Treatment: Part I|Withdrawal by Subject|0|||
146391011|NCT01632345|527933706|FG000|Treatment: Part II|Adverse Event|0|||
146391012|NCT01632345|527933707|FG001|Treatment: Part II|Adverse Event|0|||
146391013|NCT01632345|527933708|FG002|Treatment: Part II|Adverse Event|0|||
146391014|NCT01632345|527933709|FG003|Treatment: Part II|Adverse Event|0|||
146391015|NCT01632345|527933710|FG004|Treatment: Part II|Adverse Event|0|||
146391016|NCT01632345|527933711|FG005|Treatment: Part II|Adverse Event|3|||
146391017|NCT01632345|527933712|FG006|Treatment: Part II|Adverse Event|8|||
146391018|NCT01632345|527933706|FG000|Treatment: Part II|Lost to Follow-up|0|||
146391019|NCT01632345|527933707|FG001|Treatment: Part II|Lost to Follow-up|0|||
146391020|NCT01632345|527933708|FG002|Treatment: Part II|Lost to Follow-up|0|||
146391021|NCT01632345|527933709|FG003|Treatment: Part II|Lost to Follow-up|0|||
146391022|NCT01632345|527933710|FG004|Treatment: Part II|Lost to Follow-up|0|||
146391023|NCT01632345|527933711|FG005|Treatment: Part II|Lost to Follow-up|3|||
146391024|NCT01632345|527933712|FG006|Treatment: Part II|Lost to Follow-up|1|||
146391025|NCT01632345|527933706|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391026|NCT01632345|527933707|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391027|NCT01632345|527933708|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391028|NCT01632345|527933709|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391029|NCT01632345|527933710|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391030|NCT01632345|527933711|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
146391031|NCT01632345|527933712|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
146391032|NCT01632345|527933706|FG000|Treatment: Part II|Withdrawal by Subject|0|||
146391033|NCT01632345|527933707|FG001|Treatment: Part II|Withdrawal by Subject|0|||
146391034|NCT01632345|527933708|FG002|Treatment: Part II|Withdrawal by Subject|0|||
146391035|NCT01632345|527933709|FG003|Treatment: Part II|Withdrawal by Subject|0|||
146391036|NCT01632345|527933710|FG004|Treatment: Part II|Withdrawal by Subject|0|||
146391037|NCT01632345|527933711|FG005|Treatment: Part II|Withdrawal by Subject|2|||
146391038|NCT01632345|527933712|FG006|Treatment: Part II|Withdrawal by Subject|2|||
146391039|NCT02543918|527933713|FG000|Overall Study|Never treated|0|||
146391040|NCT02543918|527933714|FG001|Overall Study|Never treated|1|||
146391041|NCT02543918|527933713|FG000|Overall Study|Lost to Follow-up|1|||
146391042|NCT02543918|527933714|FG001|Overall Study|Lost to Follow-up|1|||
146391043|NCT02543918|527933713|FG000|Overall Study|Withdrawal by Subject|1|||
146391044|NCT02543918|527933714|FG001|Overall Study|Withdrawal by Subject|1|||
146391045|NCT02543918|527933713|FG000|Overall Study|Adverse Event|1|||
146391046|NCT02543918|527933714|FG001|Overall Study|Adverse Event|1|||
146391047|NCT04490499|527933715|FG000|Overall Study|Withdrawal by Subject|2|||
146391048|NCT01843933|527933718|FG000|Overall Study|Data lost|6|||
146391049|NCT01843933|527933719|FG001|Overall Study|Data lost|4|||
146391050|NCT00819052|527933720|FG000|Overall Study|Adverse Event|0|||
146391051|NCT00819052|527933721|FG001|Overall Study|Adverse Event|5|||
146391052|NCT00819052|527933720|FG000|Overall Study|Protocol Violation|1|||
146391053|NCT00819052|527933721|FG001|Overall Study|Protocol Violation|2|||
146391054|NCT00819052|527933720|FG000|Overall Study|Lost to Follow-up|1|||
146391055|NCT00819052|527933721|FG001|Overall Study|Lost to Follow-up|2|||
146391056|NCT00819052|527933720|FG000|Overall Study|Withdrawal by Subject|1|||
146391057|NCT00819052|527933721|FG001|Overall Study|Withdrawal by Subject|2|||
146391058|NCT00819052|527933720|FG000|Overall Study|Lack of Efficacy|1|||
146391059|NCT00819052|527933721|FG001|Overall Study|Lack of Efficacy|1|||
146391060|NCT00819052|527933720|FG000|Overall Study|Pregnancy|1|||
146391061|NCT00819052|527933721|FG001|Overall Study|Pregnancy|2|||
146391062|NCT00819052|527933720|FG000|Overall Study|Death or events leading to death|1|||
146391063|NCT00819052|527933721|FG001|Overall Study|Death or events leading to death|0|||
146391064|NCT03524664|527933722|FG000|Overall Study|Withdrawal by Subject|1|||
146391065|NCT03524664|527933723|FG001|Overall Study|Withdrawal by Subject|2|||
146391066|NCT03524664|527933722|FG000|Overall Study|Lost to Follow-up|4|||
146391067|NCT03524664|527933723|FG001|Overall Study|Lost to Follow-up|13|||
146391068|NCT01373294|527933724|FG000|Overall Study|Adverse Event|1|||
146391069|NCT01373294|527933725|FG001|Overall Study|Adverse Event|0|||
146391070|NCT01920061|527933733|FG000|Overall Study|Death|1|||
146391071|NCT01920061|527933734|FG001|Overall Study|Death|1|||
146391072|NCT01920061|527933735|FG002|Overall Study|Death|0|||
146391073|NCT01920061|527933736|FG003|Overall Study|Death|1|||
146391074|NCT01920061|527933737|FG004|Overall Study|Death|1|||
146391075|NCT01920061|527933738|FG005|Overall Study|Death|0|||
146391076|NCT01920061|527933739|FG006|Overall Study|Death|0|||
146391077|NCT01920061|527933740|FG007|Overall Study|Death|1|||
146391078|NCT01920061|527933741|FG008|Overall Study|Death|0|||
146391079|NCT01920061|527933742|FG009|Overall Study|Death|1|||
146391080|NCT01920061|527933743|FG010|Overall Study|Death|0|||
146391081|NCT01920061|527933744|FG011|Overall Study|Death|1|||
146391082|NCT01920061|527933745|FG012|Overall Study|Death|0|||
146391083|NCT01920061|527933746|FG013|Overall Study|Death|2|||
146391084|NCT01920061|527933747|FG014|Overall Study|Death|0|||
146391085|NCT01920061|527933748|FG015|Overall Study|Death|0|||
146391086|NCT01920061|527933749|FG016|Overall Study|Death|0|||
146391087|NCT01920061|527933750|FG017|Overall Study|Death|0|||
146391088|NCT01920061|527933751|FG018|Overall Study|Death|1|||
146391089|NCT01920061|527933752|FG019|Overall Study|Death|0|||
146391090|NCT01920061|527933733|FG000|Overall Study|Lost to Follow-up|0|||
146391091|NCT01920061|527933734|FG001|Overall Study|Lost to Follow-up|2|||
146391092|NCT01920061|527933735|FG002|Overall Study|Lost to Follow-up|0|||
146391093|NCT01920061|527933736|FG003|Overall Study|Lost to Follow-up|0|||
146391094|NCT01920061|527933737|FG004|Overall Study|Lost to Follow-up|0|||
146391095|NCT01920061|527933738|FG005|Overall Study|Lost to Follow-up|0|||
146391096|NCT01920061|527933739|FG006|Overall Study|Lost to Follow-up|1|||
146391097|NCT01920061|527933740|FG007|Overall Study|Lost to Follow-up|0|||
146391098|NCT01920061|527933741|FG008|Overall Study|Lost to Follow-up|0|||
146391099|NCT01920061|527933742|FG009|Overall Study|Lost to Follow-up|0|||
146391100|NCT01920061|527933743|FG010|Overall Study|Lost to Follow-up|3|||
146391101|NCT01920061|527933744|FG011|Overall Study|Lost to Follow-up|0|||
146391102|NCT01920061|527933745|FG012|Overall Study|Lost to Follow-up|0|||
146391103|NCT01920061|527933746|FG013|Overall Study|Lost to Follow-up|0|||
146391104|NCT01920061|527933747|FG014|Overall Study|Lost to Follow-up|0|||
146391105|NCT01920061|527933748|FG015|Overall Study|Lost to Follow-up|0|||
146391106|NCT01920061|527933749|FG016|Overall Study|Lost to Follow-up|0|||
146391107|NCT01920061|527933750|FG017|Overall Study|Lost to Follow-up|1|||
146391108|NCT01920061|527933751|FG018|Overall Study|Lost to Follow-up|4|||
146391109|NCT01920061|527933752|FG019|Overall Study|Lost to Follow-up|3|||
146391110|NCT01920061|527933733|FG000|Overall Study|Other|1|||
146391111|NCT01920061|527933734|FG001|Overall Study|Other|1|||
146391112|NCT01920061|527933735|FG002|Overall Study|Other|2|||
146391113|NCT01920061|527933736|FG003|Overall Study|Other|1|||
146391114|NCT01920061|527933737|FG004|Overall Study|Other|0|||
146391115|NCT01920061|527933738|FG005|Overall Study|Other|1|||
146391116|NCT01920061|527933739|FG006|Overall Study|Other|0|||
146391117|NCT01920061|527933740|FG007|Overall Study|Other|0|||
146391118|NCT01920061|527933741|FG008|Overall Study|Other|0|||
146391119|NCT01920061|527933742|FG009|Overall Study|Other|1|||
146391120|NCT01920061|527933743|FG010|Overall Study|Other|1|||
146391121|NCT01920061|527933744|FG011|Overall Study|Other|2|||
146391122|NCT01920061|527933745|FG012|Overall Study|Other|1|||
146391123|NCT01920061|527933746|FG013|Overall Study|Other|4|||
146391124|NCT01920061|527933747|FG014|Overall Study|Other|0|||
146391125|NCT01920061|527933748|FG015|Overall Study|Other|1|||
146391126|NCT01920061|527933749|FG016|Overall Study|Other|1|||
146391127|NCT01920061|527933750|FG017|Overall Study|Other|0|||
146391128|NCT01920061|527933751|FG018|Overall Study|Other|1|||
146391129|NCT01920061|527933752|FG019|Overall Study|Other|1|||
146391130|NCT01920061|527933733|FG000|Overall Study|Participant refused further follow-up|0|||
146391131|NCT01920061|527933734|FG001|Overall Study|Participant refused further follow-up|0|||
146391132|NCT01920061|527933735|FG002|Overall Study|Participant refused further follow-up|0|||
146391133|NCT01920061|527933736|FG003|Overall Study|Participant refused further follow-up|0|||
146391134|NCT01920061|527933737|FG004|Overall Study|Participant refused further follow-up|1|||
146391135|NCT01920061|527933738|FG005|Overall Study|Participant refused further follow-up|1|||
146391136|NCT01920061|527933739|FG006|Overall Study|Participant refused further follow-up|0|||
146391137|NCT01920061|527933740|FG007|Overall Study|Participant refused further follow-up|0|||
146391138|NCT01920061|527933741|FG008|Overall Study|Participant refused further follow-up|1|||
146391139|NCT01920061|527933742|FG009|Overall Study|Participant refused further follow-up|0|||
146391140|NCT01920061|527933743|FG010|Overall Study|Participant refused further follow-up|1|||
146391141|NCT01920061|527933744|FG011|Overall Study|Participant refused further follow-up|0|||
146391142|NCT01920061|527933745|FG012|Overall Study|Participant refused further follow-up|1|||
146391143|NCT01920061|527933746|FG013|Overall Study|Participant refused further follow-up|0|||
146391144|NCT01920061|527933747|FG014|Overall Study|Participant refused further follow-up|1|||
146391145|NCT01920061|527933748|FG015|Overall Study|Participant refused further follow-up|2|||
146391146|NCT01920061|527933749|FG016|Overall Study|Participant refused further follow-up|1|||
146391147|NCT01920061|527933750|FG017|Overall Study|Participant refused further follow-up|1|||
146391148|NCT01920061|527933751|FG018|Overall Study|Participant refused further follow-up|0|||
146391149|NCT01920061|527933752|FG019|Overall Study|Participant refused further follow-up|0|||
146391150|NCT00877929|527933753|FG000|Overall Study|Adverse Event|11|||
146391151|NCT00877929|527933754|FG001|Overall Study|Adverse Event|20|||
146391152|NCT00877929|527933753|FG000|Overall Study|Protocol Violation|3|||
146391153|NCT00877929|527933754|FG001|Overall Study|Protocol Violation|3|||
146391154|NCT00877929|527933753|FG000|Overall Study|Lost to Follow-up|0|||
146391155|NCT00877929|527933754|FG001|Overall Study|Lost to Follow-up|1|||
146391156|NCT00877929|527933753|FG000|Overall Study|Withdrawal by Subject|4|||
146391157|NCT00877929|527933754|FG001|Overall Study|Withdrawal by Subject|4|||
146391158|NCT00877929|527933753|FG000|Overall Study|Lack of Efficacy|0|||
146391159|NCT00877929|527933754|FG001|Overall Study|Lack of Efficacy|1|||
146391160|NCT00877929|527933753|FG000|Overall Study|Other reason (not specified)|2|||
146391161|NCT00877929|527933754|FG001|Overall Study|Other reason (not specified)|6|||
146391162|NCT01140646|527933755|FG000|Overall Study|Adverse Event|4|||
146391163|NCT01140646|527933755|FG000|Overall Study|Refused Further Treatment|5|||
146391164|NCT02612194|527933766|FG000|Overall Study|Death|5|||
146391165|NCT02612194|527933767|FG001|Overall Study|Death|0|||
146391166|NCT02612194|527933768|FG002|Overall Study|Death|2|||
146391167|NCT02612194|527933766|FG000|Overall Study|Early Study Termination|1|||
146391168|NCT02612194|527933767|FG001|Overall Study|Early Study Termination|0|||
146391169|NCT02612194|527933768|FG002|Overall Study|Early Study Termination|0|||
146391170|NCT02539160|527933769|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
146391171|NCT02539160|527933770|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
146391172|NCT02539160|527933771|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
146391173|NCT02539160|527933772|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
146391174|NCT02539160|527933769|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
146391175|NCT02539160|527933770|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
146391176|NCT02539160|527933771|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
146391177|NCT02539160|527933772|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
146391178|NCT02539160|527933769|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
146391179|NCT02539160|527933770|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
146391180|NCT02539160|527933771|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
146391181|NCT02539160|527933772|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
146391182|NCT01681004|527933773|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
146391183|NCT01681004|527933774|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
146391184|NCT01681004|527933773|FG000|Study Completion|Lost to Follow-up|8|||
146391185|NCT01681004|527933774|FG001|Study Completion|Lost to Follow-up|3|||
146391186|NCT01681004|527933773|FG000|Study Completion|Physician Decision|1|||
146391187|NCT01681004|527933774|FG001|Study Completion|Physician Decision|3|||
146391188|NCT01681004|527933773|FG000|Study Completion|Site Termination|2|||
146391189|NCT01681004|527933774|FG001|Study Completion|Site Termination|1|||
146391190|NCT01681004|527933773|FG000|Study Completion|Death|1|||
146391191|NCT01681004|527933774|FG001|Study Completion|Death|1|||
146391192|NCT00372905|527933775|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
146391193|NCT00372905|527933776|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146391194|NCT00372905|527933777|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146391195|NCT00372905|527933778|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
146391196|NCT00372905|527933775|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146391197|NCT00372905|527933776|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146391198|NCT00372905|527933777|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
146391199|NCT00372905|527933778|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
146391200|NCT00372905|527933775|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146391201|NCT00372905|527933776|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146391202|NCT00372905|527933777|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
146391203|NCT00372905|527933778|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
146391204|NCT00372905|527933775|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146391205|NCT00372905|527933776|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146391206|NCT00372905|527933777|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
146391207|NCT00372905|527933778|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
146391208|NCT00372905|527933775|FG000|Follow up Until Relapse or Progression|Study closed|0|||
146391209|NCT00372905|527933776|FG001|Follow up Until Relapse or Progression|Study closed|0|||
146391210|NCT00372905|527933777|FG002|Follow up Until Relapse or Progression|Study closed|0|||
146391211|NCT00372905|527933778|FG003|Follow up Until Relapse or Progression|Study closed|3|||
146391212|NCT00372905|527933775|FG000|Follow up Until Relapse or Progression|Other|0|||
146391213|NCT00372905|527933776|FG001|Follow up Until Relapse or Progression|Other|1|||
146391214|NCT00372905|527933777|FG002|Follow up Until Relapse or Progression|Other|0|||
146391215|NCT00372905|527933778|FG003|Follow up Until Relapse or Progression|Other|0|||
146391216|NCT03726320|527935122|FG000|Overall Study|Lost to Follow-up|2|||
146391217|NCT03726320|527935123|FG001|Overall Study|Lost to Follow-up|4|||
146391218|NCT03726320|527935124|FG002|Overall Study|Lost to Follow-up|0|||
146391219|NCT03726320|527935122|FG000|Overall Study|Time Constraints|4|||
146391220|NCT03726320|527935123|FG001|Overall Study|Time Constraints|1|||
146391221|NCT03726320|527935124|FG002|Overall Study|Time Constraints|0|||
146391222|NCT03726320|527935122|FG000|Overall Study|Ineligible after enrollment|3|||
146391223|NCT03726320|527935123|FG001|Overall Study|Ineligible after enrollment|3|||
146391224|NCT03726320|527935124|FG002|Overall Study|Ineligible after enrollment|0|||
146391225|NCT03726320|527935122|FG000|Overall Study|Clinic / insurance issue|2|||
146391226|NCT03726320|527935123|FG001|Overall Study|Clinic / insurance issue|0|||
146391227|NCT03726320|527935124|FG002|Overall Study|Clinic / insurance issue|0|||
146391228|NCT03726320|527935122|FG000|Overall Study|Language barrier|1|||
146391229|NCT03726320|527935123|FG001|Overall Study|Language barrier|0|||
146391230|NCT03726320|527935124|FG002|Overall Study|Language barrier|0|||
146391231|NCT03726320|527935122|FG000|Overall Study|Provider left the clinic|0|||
146391232|NCT03726320|527935123|FG001|Overall Study|Provider left the clinic|0|||
146391233|NCT03726320|527935124|FG002|Overall Study|Provider left the clinic|1|||
146391234|NCT02028182|527935127|FG000|Overall Study|Protocol Violation|2|||
146391235|NCT01684930|527935130|FG000|Overall Study|Withdrawal by Subject|3|||
146391236|NCT01684930|527935131|FG001|Overall Study|Withdrawal by Subject|1|||
146391237|NCT00337935|527935132|FG000|Overall Study|Adverse Event|2|||
146391238|NCT00337935|527935133|FG001|Overall Study|Adverse Event|5|||
146391239|NCT00337935|527935132|FG000|Overall Study|Death|2|||
146391240|NCT00337935|527935133|FG001|Overall Study|Death|8|||
146391241|NCT00337935|527935132|FG000|Overall Study|Physician Decision|1|||
146391242|NCT00337935|527935133|FG001|Overall Study|Physician Decision|1|||
146391243|NCT00337935|527935132|FG000|Overall Study|Lost to Follow-up|0|||
146391244|NCT00337935|527935133|FG001|Overall Study|Lost to Follow-up|1|||
146391245|NCT00337935|527935132|FG000|Overall Study|Protocol Violation|4|||
146391246|NCT00337935|527935133|FG001|Overall Study|Protocol Violation|3|||
146391247|NCT00337935|527935132|FG000|Overall Study|Withdrawal by Subject|1|||
146391248|NCT00337935|527935133|FG001|Overall Study|Withdrawal by Subject|7|||
146391249|NCT00337935|527935132|FG000|Overall Study|Other|0|||
146391250|NCT00337935|527935133|FG001|Overall Study|Other|1|||
146391251|NCT00337935|527935132|FG000|Overall Study|Lack of Efficacy|0|||
146391252|NCT00337935|527935133|FG001|Overall Study|Lack of Efficacy|1|||
146391253|NCT01336647|527935136|FG000|Overall Study|Lost to Follow-up|4|||
146391254|NCT01336647|527935137|FG001|Overall Study|Lost to Follow-up|1|||
146391255|NCT01336647|527935138|FG002|Overall Study|Lost to Follow-up|3|||
146391256|NCT01786707|527935143|FG000|Overall Study|Lost to Follow-up|1|||
146391257|NCT01786707|527935144|FG001|Overall Study|Lost to Follow-up|1|||
146391258|NCT00965458|527935149|FG000|Overall Study|Adverse Event|1|||
146391259|NCT00965458|527935150|FG001|Overall Study|Adverse Event|0|||
146391260|NCT00965458|527935149|FG000|Overall Study|Lost to Follow-up|1|||
146391261|NCT00965458|527935150|FG001|Overall Study|Lost to Follow-up|3|||
146391262|NCT00965458|527935149|FG000|Overall Study|Withdrawal by Subject|0|||
146391263|NCT00965458|527935150|FG001|Overall Study|Withdrawal by Subject|1|||
146391264|NCT00594958|527935153|FG000|Overall Study|Withdrawal by Subject|1|||
146391265|NCT00594958|527935154|FG001|Overall Study|Withdrawal by Subject|0|||
146391266|NCT00594958|527935155|FG002|Overall Study|Withdrawal by Subject|1|||
146391267|NCT00594958|527935153|FG000|Overall Study|Adverse Event|4|||
146391268|NCT00594958|527935154|FG001|Overall Study|Adverse Event|1|||
146391269|NCT00594958|527935155|FG002|Overall Study|Adverse Event|2|||
146391270|NCT00594958|527935153|FG000|Overall Study|Pregnancy|0|||
146391271|NCT00594958|527935154|FG001|Overall Study|Pregnancy|2|||
146391272|NCT00594958|527935155|FG002|Overall Study|Pregnancy|0|||
146391273|NCT00594958|527935153|FG000|Overall Study|Protocol Violation|1|||
146391274|NCT00594958|527935154|FG001|Overall Study|Protocol Violation|0|||
146391275|NCT00594958|527935155|FG002|Overall Study|Protocol Violation|2|||
146391276|NCT00594958|527935153|FG000|Overall Study|Lost to Follow-up|5|||
146391277|NCT00594958|527935154|FG001|Overall Study|Lost to Follow-up|0|||
146391278|NCT00594958|527935155|FG002|Overall Study|Lost to Follow-up|3|||
146391279|NCT00594958|527935153|FG000|Overall Study|administrative|3|||
146391280|NCT00594958|527935154|FG001|Overall Study|administrative|0|||
146391281|NCT00594958|527935155|FG002|Overall Study|administrative|2|||
146391282|NCT03233009|527935156|FG000|Overall Study|Lost to Follow-up|1|||
146391283|NCT02079077|527935157|FG000|Overall Study|Lost to Follow-up|5|||
146391284|NCT02079077|527935158|FG001|Overall Study|Lost to Follow-up|7|||
146391285|NCT02079077|527935157|FG000|Overall Study|Became STIs Positive|1|||
146391286|NCT02079077|527935158|FG001|Overall Study|Became STIs Positive|2|||
146391287|NCT01425268|527935159|FG000|Overall Study|Withdrawal by Subject|2|||
146391288|NCT01425268|527935160|FG001|Overall Study|Withdrawal by Subject|0|||
146391289|NCT01425268|527935159|FG000|Overall Study|Sponsor Decision|5|||
146391290|NCT01425268|527935160|FG001|Overall Study|Sponsor Decision|0|||
146391291|NCT01425268|527935159|FG000|Overall Study|Physician Decision|1|||
146391292|NCT01425268|527935160|FG001|Overall Study|Physician Decision|0|||
146391293|NCT01101321|527935161|FG000|Period 1|Withdrawal by Subject|1|||
146391294|NCT01101321|527935162|FG001|Period 1|Withdrawal by Subject|1|||
146391295|NCT01101321|527935161|FG000|Period 1|Adverse Event|3|||
146391296|NCT01101321|527935162|FG001|Period 1|Adverse Event|3|||
146391297|NCT00719706|527935163|FG000|Overall Study|Adverse Event|5|||
146391298|NCT00719706|527935164|FG001|Overall Study|Adverse Event|4|||
146391299|NCT00719706|527935163|FG000|Overall Study|Withdrawal by Subject|1|||
146391300|NCT00719706|527935164|FG001|Overall Study|Withdrawal by Subject|2|||
146391301|NCT00719706|527935163|FG000|Overall Study|Protocol Violation|3|||
146391302|NCT00719706|527935164|FG001|Overall Study|Protocol Violation|0|||
146391303|NCT00682539|527935165|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
146391304|NCT00682539|527935166|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
146391305|NCT00682539|527935167|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
146391306|NCT00682539|527935165|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
146391307|NCT00682539|527935166|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
146391308|NCT00682539|527935167|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
146391309|NCT00508872|527935175|FG000|Overall Study|Lost to Follow-up|1|||
146391310|NCT00508872|527935175|FG000|Overall Study|Physician Decision|1|||
146391311|NCT03339999|527935185|FG000|Overall Study|Adverse Event|1|||
146391312|NCT03339999|527935186|FG001|Overall Study|Adverse Event|2|||
146391313|NCT03339999|527935187|FG002|Overall Study|Adverse Event|2|||
146391314|NCT03339999|527935188|FG003|Overall Study|Adverse Event|1|||
146391315|NCT03339999|527935185|FG000|Overall Study|Lack of Efficacy|0|||
146391316|NCT03339999|527935186|FG001|Overall Study|Lack of Efficacy|1|||
146391317|NCT03339999|527935187|FG002|Overall Study|Lack of Efficacy|0|||
146391318|NCT03339999|527935188|FG003|Overall Study|Lack of Efficacy|0|||
146391319|NCT03339999|527935185|FG000|Overall Study|Lost to Follow-up|0|||
146391320|NCT03339999|527935186|FG001|Overall Study|Lost to Follow-up|0|||
146391321|NCT03339999|527935187|FG002|Overall Study|Lost to Follow-up|0|||
146391322|NCT03339999|527935188|FG003|Overall Study|Lost to Follow-up|1|||
146391323|NCT03339999|527935185|FG000|Overall Study|Study Terminated by Sponsor|6|||
146391324|NCT03339999|527935186|FG001|Overall Study|Study Terminated by Sponsor|3|||
146391325|NCT03339999|527935187|FG002|Overall Study|Study Terminated by Sponsor|4|||
146391326|NCT03339999|527935188|FG003|Overall Study|Study Terminated by Sponsor|3|||
146391327|NCT01856920|527935189|FG000|Overall Study|Disease Progression On Study|3|||
146391328|NCT01856920|527935190|FG001|Overall Study|Disease Progression On Study|4|||
146391329|NCT01856920|527935189|FG000|Overall Study|Disease Progression before Treatment|1|||
146391330|NCT01856920|527935190|FG001|Overall Study|Disease Progression before Treatment|0|||
146391331|NCT01856920|527935189|FG000|Overall Study|Ineligible|0|||
146391332|NCT01856920|527935190|FG001|Overall Study|Ineligible|1|||
146391333|NCT01856920|527935189|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
146391334|NCT01856920|527935190|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
146391335|NCT01856920|527935189|FG000|Overall Study|Refused further Treatment|5|||
146391336|NCT01856920|527935190|FG001|Overall Study|Refused further Treatment|1|||
146391337|NCT01856920|527935189|FG000|Overall Study|Other Reasons|0|||
146391338|NCT01856920|527935190|FG001|Overall Study|Other Reasons|1|||
146391339|NCT01856920|527935189|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
146391340|NCT01856920|527935190|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
146391341|NCT02545270|527935192|FG000|Overall Study|technical difficulties|0|||
146391342|NCT02545270|527935193|FG001|Overall Study|technical difficulties|1|||
146391343|NCT02545270|527935194|FG002|Overall Study|technical difficulties|0|||
146391344|NCT02545270|527935192|FG000|Overall Study|Videos being too similar to other|0|||
146391345|NCT02545270|527935193|FG001|Overall Study|Videos being too similar to other|0|||
146391346|NCT02545270|527935194|FG002|Overall Study|Videos being too similar to other|2|||
146391347|NCT04594213|527935200|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
146391348|NCT04594213|527935201|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
146391349|NCT04594213|527935202|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
146391350|NCT04594213|527935203|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146391351|NCT04594213|527935204|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146391352|NCT04594213|527935205|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
146391353|NCT04594213|527935200|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146391354|NCT04594213|527935201|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
146391355|NCT04594213|527935202|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146391356|NCT04594213|527935203|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146391357|NCT04594213|527935204|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146391358|NCT04594213|527935205|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
146391359|NCT04594213|527935200|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146391360|NCT04594213|527935201|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146391361|NCT04594213|527935202|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
146391362|NCT04594213|527935203|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146391363|NCT04594213|527935204|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146391364|NCT04594213|527935205|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
146391365|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146391366|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146391367|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146391368|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146391369|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
146391370|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
146391371|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146391372|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146391373|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
146391374|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
146391375|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
146391376|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
146391377|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146391378|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146391379|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146391380|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146391381|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
146391382|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
146391383|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146391384|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146391385|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146391386|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
146391387|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146391388|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
146391389|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146391390|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146391391|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146391392|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
146391393|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146391394|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
146391395|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146391396|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146391397|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
146391398|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
146391399|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
146391400|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
146391401|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146391402|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146391403|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
146391404|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
146056279|NCT00626275|526721167|FG007|Part B|Lost to Follow-up|0|||
146391405|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
146391406|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
146391407|NCT04594213|527935200|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
146391408|NCT04594213|527935201|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
146391409|NCT04594213|527935202|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
146391410|NCT04594213|527935203|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
146391411|NCT04594213|527935204|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
146391412|NCT04594213|527935205|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
146391413|NCT03764813|527935206|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
146391414|NCT03764813|527935207|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
146391415|NCT03764813|527935208|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
146391416|NCT03764813|527935209|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
146391417|NCT01654666|527935212|FG000|Overall Study|Protocol Violation|7|||
146391418|NCT01654666|527935213|FG001|Overall Study|Protocol Violation|4|||
146391419|NCT01654666|527935214|FG002|Overall Study|Protocol Violation|8|||
146391420|NCT01654666|527935212|FG000|Overall Study|Lost to Follow-up|4|||
146391421|NCT01654666|527935213|FG001|Overall Study|Lost to Follow-up|5|||
146391422|NCT01654666|527935214|FG002|Overall Study|Lost to Follow-up|5|||
146391423|NCT01654666|527935212|FG000|Overall Study|Withdrawal by Subject|4|||
146391424|NCT01654666|527935213|FG001|Overall Study|Withdrawal by Subject|4|||
146391425|NCT01654666|527935214|FG002|Overall Study|Withdrawal by Subject|1|||
146391426|NCT02898662|527935215|FG000|Overall Study|Adverse Event|1|||
146391427|NCT02898662|527935216|FG001|Overall Study|Adverse Event|0|||
146391428|NCT02898662|527935215|FG000|Overall Study|Loss of asthma control|23|||
146391429|NCT02898662|527935216|FG001|Overall Study|Loss of asthma control|24|||
146391430|NCT02898662|527935215|FG000|Overall Study|Withdrawal by Subject|4|||
146391431|NCT02898662|527935216|FG001|Overall Study|Withdrawal by Subject|1|||
146391432|NCT02898662|527935215|FG000|Overall Study|Technical issue|0|||
146391433|NCT02898662|527935216|FG001|Overall Study|Technical issue|1|||
146391434|NCT02898662|527935215|FG000|Overall Study|Randomized in error|0|||
146391435|NCT02898662|527935216|FG001|Overall Study|Randomized in error|1|||
146391436|NCT02898662|527935215|FG000|Overall Study|Subject decision|1|||
146391437|NCT02898662|527935216|FG001|Overall Study|Subject decision|0|||
146391438|NCT02898662|527935215|FG000|Overall Study|Other|0|||
146391439|NCT02898662|527935216|FG001|Overall Study|Other|1|||
146391440|NCT03432819|527935219|FG000|Overall Study|Lost to Follow-up|2|||
146391441|NCT03432819|527935220|FG001|Overall Study|Lost to Follow-up|2|||
146391442|NCT03432819|527935219|FG000|Overall Study|Withdrawal by Subject|5|||
146391443|NCT03432819|527935220|FG001|Overall Study|Withdrawal by Subject|3|||
146391444|NCT04382066|527935221|FG000|Overall Study|Adverse Event|1|||
146391445|NCT04382066|527935222|FG001|Overall Study|Adverse Event|0|||
146391446|NCT04382066|527935223|FG002|Overall Study|Adverse Event|0|||
146391447|NCT04382066|527935221|FG000|Overall Study|Death|1|||
146391448|NCT04382066|527935222|FG001|Overall Study|Death|0|||
146391449|NCT04382066|527935223|FG002|Overall Study|Death|1|||
146391450|NCT01430559|527935224|FG000|Overall Study|Adverse Event|7|||
146391451|NCT01430559|527935225|FG001|Overall Study|Adverse Event|3|||
146391452|NCT01430559|527935224|FG000|Overall Study|Entry criteria not met|1|||
146391453|NCT01430559|527935225|FG001|Overall Study|Entry criteria not met|1|||
146391454|NCT01430559|527935224|FG000|Overall Study|Lost to Follow-up|1|||
146391455|NCT01430559|527935225|FG001|Overall Study|Lost to Follow-up|0|||
146391456|NCT01430559|527935224|FG000|Overall Study|Medication error|1|||
146391457|NCT01430559|527935225|FG001|Overall Study|Medication error|0|||
146391458|NCT01430559|527935224|FG000|Overall Study|Withdrawal by Subject|3|||
146391459|NCT01430559|527935225|FG001|Overall Study|Withdrawal by Subject|2|||
146391460|NCT01430559|527935224|FG000|Overall Study|Protocol Violation|1|||
146391461|NCT01430559|527935225|FG001|Overall Study|Protocol Violation|0|||
146391462|NCT01430559|527935224|FG000|Overall Study|Other|3|||
146391463|NCT01430559|527935225|FG001|Overall Study|Other|3|||
146391464|NCT01430559|527935224|FG000|Overall Study|Randomized, Not Treated|3|||
146391465|NCT01430559|527935225|FG001|Overall Study|Randomized, Not Treated|3|||
146391466|NCT04225026|527935226|FG000|Overall Study|Withdrawal by Subject|4|||
146391467|NCT04225026|527935226|FG000|Overall Study|Adverse Event|1|||
146391468|NCT04225026|527935226|FG000|Overall Study|Other|1|||
146391469|NCT04225026|527935226|FG000|Overall Study|Death|11|||
146391470|NCT04225026|527935226|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
146391471|NCT00779142|527935227|FG000|Overall Study|Screen Failures|3|||
146391472|NCT00672490|527935228|FG000|Overall Study|Withdrawal by Subject|8|||
146391473|NCT00672490|527935229|FG001|Overall Study|Withdrawal by Subject|8|||
146391474|NCT00672490|527935228|FG000|Overall Study|Lack of Compliance|2|||
146391475|NCT00672490|527935229|FG001|Overall Study|Lack of Compliance|7|||
146391476|NCT00672490|527935228|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
146391477|NCT00672490|527935229|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
146391478|NCT00672490|527935228|FG000|Overall Study|Adverse Event|5|||
146391479|NCT00672490|527935229|FG001|Overall Study|Adverse Event|8|||
146391480|NCT00672490|527935228|FG000|Overall Study|Violation of Concomitant Medicine|1|||
146391481|NCT00672490|527935229|FG001|Overall Study|Violation of Concomitant Medicine|0|||
146391482|NCT00672490|527935228|FG000|Overall Study|Intolerance|0|||
146391483|NCT00672490|527935229|FG001|Overall Study|Intolerance|2|||
146391484|NCT00672490|527935228|FG000|Overall Study|Lost to Follow-up|1|||
146391485|NCT00672490|527935229|FG001|Overall Study|Lost to Follow-up|5|||
146391486|NCT00672490|527935228|FG000|Overall Study|No reason was provided|6|||
146391487|NCT00672490|527935229|FG001|Overall Study|No reason was provided|2|||
146391488|NCT04047472|527935230|FG000|Overall Study|Adverse Event|3|||
146391489|NCT04047472|527935231|FG001|Overall Study|Adverse Event|3|||
146391490|NCT04047472|527935230|FG000|Overall Study|Death|0|||
146391491|NCT04047472|527935231|FG001|Overall Study|Death|1|||
146391492|NCT04047472|527935230|FG000|Overall Study|Lost to Follow-up|1|||
146391493|NCT04047472|527935231|FG001|Overall Study|Lost to Follow-up|0|||
146391494|NCT04047472|527935230|FG000|Overall Study|Physician Decision|1|||
146391495|NCT04047472|527935231|FG001|Overall Study|Physician Decision|2|||
146391496|NCT04047472|527935230|FG000|Overall Study|Protocol Violation|1|||
146391497|NCT04047472|527935231|FG001|Overall Study|Protocol Violation|0|||
146391498|NCT04047472|527935230|FG000|Overall Study|Withdrawal by Subject|10|||
146391499|NCT04047472|527935231|FG001|Overall Study|Withdrawal by Subject|10|||
146391500|NCT01288911|527935232|FG000|Double-blind Period|Death|11|||
146391501|NCT01288911|527935233|FG001|Double-blind Period|Death|7|||
146391502|NCT01288911|527935232|FG000|Double-blind Period|Lost to Follow-up|0|||
146391503|NCT01288911|527935233|FG001|Double-blind Period|Lost to Follow-up|2|||
146391504|NCT01288911|527935232|FG000|Double-blind Period|Progressive Disease|75|||
146391505|NCT01288911|527935233|FG001|Double-blind Period|Progressive Disease|103|||
146391506|NCT01288911|527935232|FG000|Double-blind Period|Protocol Violation|1|||
146391507|NCT01288911|527935233|FG001|Double-blind Period|Protocol Violation|0|||
146391508|NCT01288911|527935232|FG000|Double-blind Period|Withdrawal by Subject|25|||
146391509|NCT01288911|527935233|FG001|Double-blind Period|Withdrawal by Subject|26|||
146391510|NCT01288911|527935232|FG000|Double-blind Period|Miscellaneous Reason|29|||
146391511|NCT01288911|527935233|FG001|Double-blind Period|Miscellaneous Reason|42|||
146391512|NCT01288911|527935232|FG000|Double-blind Period|Randomized but never received study drug|1|||
146391513|NCT01288911|527935233|FG001|Double-blind Period|Randomized but never received study drug|2|||
146391514|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Death|0|||
146391515|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Death|1|||
146391516|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
146391517|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
146391518|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
146391519|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
146391520|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
146391521|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
146391522|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
146391523|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
146391524|NCT01288911|527935232|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
146391525|NCT01288911|527935233|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
146391526|NCT00486720|527935234|FG000|Overall Study|Adverse Event|1|||
146391527|NCT00486720|527935235|FG001|Overall Study|Adverse Event|2|||
146391528|NCT00486720|527935234|FG000|Overall Study|Lack of Efficacy|4|||
146391529|NCT00486720|527935235|FG001|Overall Study|Lack of Efficacy|6|||
146391530|NCT00486720|527935234|FG000|Overall Study|Physician Decision|1|||
146391531|NCT00486720|527935235|FG001|Overall Study|Physician Decision|2|||
146391532|NCT00486720|527935234|FG000|Overall Study|Protocol Violation|1|||
146391533|NCT00486720|527935235|FG001|Overall Study|Protocol Violation|0|||
146391534|NCT00486720|527935234|FG000|Overall Study|Withdrawal by Subject|3|||
146391535|NCT00486720|527935235|FG001|Overall Study|Withdrawal by Subject|1|||
146391536|NCT00486720|527935234|FG000|Overall Study|Progressive Disease|0|||
146391537|NCT00486720|527935235|FG001|Overall Study|Progressive Disease|1|||
146391538|NCT01005875|527935236|FG000|Overall Study|Death|3|||
146391539|NCT00606931|527935239|FG000|Overall Study|Withdrawal by Subject|3|||
146391540|NCT00286234|527935241|FG000|Overall Study|Protocol Violation|1|||
146391541|NCT00286234|527935242|FG001|Overall Study|Protocol Violation|2|||
146391542|NCT00286234|527935243|FG002|Overall Study|Protocol Violation|0|||
146391543|NCT00286234|527935244|FG003|Overall Study|Protocol Violation|1|||
146391544|NCT00286234|527935241|FG000|Overall Study|Physician Decision|1|||
146391545|NCT00286234|527935242|FG001|Overall Study|Physician Decision|0|||
146391546|NCT00286234|527935243|FG002|Overall Study|Physician Decision|0|||
146391547|NCT00286234|527935244|FG003|Overall Study|Physician Decision|1|||
146391548|NCT00286234|527935241|FG000|Overall Study|Adverse Event|0|||
146391549|NCT00286234|527935242|FG001|Overall Study|Adverse Event|0|||
146391550|NCT00286234|527935243|FG002|Overall Study|Adverse Event|0|||
146391551|NCT00286234|527935244|FG003|Overall Study|Adverse Event|1|||
146391552|NCT00286234|527935241|FG000|Overall Study|Adverse Event|0|||
146391553|NCT00286234|527935242|FG001|Overall Study|Adverse Event|0|||
146391554|NCT00286234|527935243|FG002|Overall Study|Adverse Event|0|||
146391555|NCT00286234|527935244|FG003|Overall Study|Adverse Event|1|||
146391556|NCT01000311|527935251|FG000|Overall Study|Adverse Event|2|||
146391557|NCT01000311|527935252|FG001|Overall Study|Adverse Event|5|||
146391558|NCT01000311|527935251|FG000|Overall Study|Withdrawal by Subject|16|||
146391559|NCT01000311|527935252|FG001|Overall Study|Withdrawal by Subject|24|||
146391560|NCT01000311|527935251|FG000|Overall Study|Lost to Follow-up|15|||
146391561|NCT01000311|527935252|FG001|Overall Study|Lost to Follow-up|24|||
146391562|NCT01000311|527935251|FG000|Overall Study|Protocol Violation|1|||
146391563|NCT01000311|527935252|FG001|Overall Study|Protocol Violation|2|||
146391564|NCT01000311|527935251|FG000|Overall Study|Inappropriate enrollment|2|||
146391565|NCT01000311|527935252|FG001|Overall Study|Inappropriate enrollment|0|||
146391566|NCT01000311|527935251|FG000|Overall Study|Administrative reason|9|||
146391567|NCT01000311|527935252|FG001|Overall Study|Administrative reason|15|||
146391568|NCT01468844|527935253|FG000|Overall Study|Adverse Event|1|||
146391569|NCT01468844|527935254|FG001|Overall Study|Adverse Event|0|||
146391570|NCT01468844|527935253|FG000|Overall Study|Withdrawal by Subject|1|||
146391571|NCT01468844|527935254|FG001|Overall Study|Withdrawal by Subject|0|||
146391572|NCT02694562|527935255|FG000|Overall Study|Death|8|||
146391573|NCT02694562|527935255|FG000|Overall Study|Protocol Violation|4|||
146391574|NCT02694562|527935255|FG000|Overall Study|Lost to Follow-up|3|||
146391575|NCT02694562|527935255|FG000|Overall Study|Screen Failure|2|||
146391576|NCT02694562|527935255|FG000|Overall Study|Physician Decision|1|||
146391577|NCT03702166|527935256|FG000|Overall Study|Lost to Follow-up|1|||
146391578|NCT03702166|527935256|FG000|Overall Study|Withdrawal by Subject|1|||
146391579|NCT01333865|527935257|FG000|Overall Study|Adverse Event|2|||
146391580|NCT01521494|527935260|FG000|Overall Study|Adverse Event|1|||
146391581|NCT01521494|527935261|FG001|Overall Study|Adverse Event|2|||
146391582|NCT01521494|527935262|FG002|Overall Study|Adverse Event|9|||
146391583|NCT01521494|527935263|FG003|Overall Study|Adverse Event|6|||
146391584|NCT01521494|527935264|FG004|Overall Study|Adverse Event|2|||
146391585|NCT01521494|527935260|FG000|Overall Study|Lack of Efficacy|0|||
146391586|NCT01521494|527935261|FG001|Overall Study|Lack of Efficacy|0|||
146391587|NCT01521494|527935262|FG002|Overall Study|Lack of Efficacy|0|||
146391588|NCT01521494|527935263|FG003|Overall Study|Lack of Efficacy|0|||
146391589|NCT01521494|527935264|FG004|Overall Study|Lack of Efficacy|2|||
146391590|NCT01521494|527935260|FG000|Overall Study|Withdrawal by Subject|1|||
146391591|NCT01521494|527935261|FG001|Overall Study|Withdrawal by Subject|1|||
146391592|NCT01521494|527935262|FG002|Overall Study|Withdrawal by Subject|0|||
146391593|NCT01521494|527935263|FG003|Overall Study|Withdrawal by Subject|2|||
146391594|NCT01521494|527935264|FG004|Overall Study|Withdrawal by Subject|0|||
146391595|NCT01521494|527935260|FG000|Overall Study|Decrease in serum phosphate|0|||
146391596|NCT01521494|527935261|FG001|Overall Study|Decrease in serum phosphate|2|||
146391597|NCT01521494|527935262|FG002|Overall Study|Decrease in serum phosphate|3|||
146391598|NCT01521494|527935263|FG003|Overall Study|Decrease in serum phosphate|12|||
146391599|NCT01521494|527935264|FG004|Overall Study|Decrease in serum phosphate|0|||
146391600|NCT01521494|527935260|FG000|Overall Study|Decrease in serum calcium|0|||
146391601|NCT01521494|527935261|FG001|Overall Study|Decrease in serum calcium|0|||
146391602|NCT01521494|527935262|FG002|Overall Study|Decrease in serum calcium|0|||
146391603|NCT01521494|527935263|FG003|Overall Study|Decrease in serum calcium|1|||
146391604|NCT01521494|527935264|FG004|Overall Study|Decrease in serum calcium|1|||
146391605|NCT01521494|527935260|FG000|Overall Study|Physician Decision|0|||
146391606|NCT01521494|527935261|FG001|Overall Study|Physician Decision|0|||
146391607|NCT01521494|527935262|FG002|Overall Study|Physician Decision|0|||
146391608|NCT01521494|527935263|FG003|Overall Study|Physician Decision|0|||
146391609|NCT01521494|527935264|FG004|Overall Study|Physician Decision|2|||
146391610|NCT00554229|527935265|FG000|Overall Study|Lost to Follow-up|3|||
146391611|NCT00554229|527935266|FG001|Overall Study|Lost to Follow-up|6|||
146391612|NCT00554229|527935265|FG000|Overall Study|Withdrawal by Subject|29|||
146391613|NCT00554229|527935266|FG001|Overall Study|Withdrawal by Subject|37|||
146391614|NCT00554229|527935265|FG000|Overall Study|Adverse Event|71|||
146391615|NCT00554229|527935266|FG001|Overall Study|Adverse Event|39|||
146391616|NCT00554229|527935265|FG000|Overall Study|Protocol Violation|3|||
146391617|NCT00554229|527935266|FG001|Overall Study|Protocol Violation|3|||
146391618|NCT00554229|527935265|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
146391619|NCT00554229|527935266|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
146391620|NCT00554229|527935265|FG000|Overall Study|Randomised but no treatment received|1|||
146391621|NCT00554229|527935266|FG001|Overall Study|Randomised but no treatment received|0|||
146391622|NCT00689299|527935267|FG000|Overall Study|Adverse Event|2|||
146391623|NCT00689299|527935268|FG001|Overall Study|Adverse Event|1|||
146391624|NCT00689299|527935269|FG002|Overall Study|Adverse Event|1|||
146056280|NCT00626275|526721160|FG000|Part B|Withdrawal by Subject|0|||
146391625|NCT00689299|527935267|FG000|Overall Study|Lost to Follow-up|0|||
146391626|NCT00689299|527935268|FG001|Overall Study|Lost to Follow-up|1|||
146391627|NCT00689299|527935269|FG002|Overall Study|Lost to Follow-up|1|||
146391628|NCT00689299|527935267|FG000|Overall Study|Withdrawal by Subject|4|||
146391629|NCT00689299|527935268|FG001|Overall Study|Withdrawal by Subject|1|||
146391630|NCT00689299|527935269|FG002|Overall Study|Withdrawal by Subject|3|||
146391631|NCT00689299|527935267|FG000|Overall Study|Protocol Violation|1|||
146391632|NCT00689299|527935268|FG001|Overall Study|Protocol Violation|0|||
146391633|NCT00689299|527935269|FG002|Overall Study|Protocol Violation|0|||
146391634|NCT02613910|527935270|FG000|Overall Study|Termination of study|1|||
146391635|NCT00434876|527935271|FG000|Overall Study|Lost to Follow-up|1|||
146391636|NCT00434876|527935272|FG001|Overall Study|Lost to Follow-up|1|||
146391637|NCT00758394|527935273|FG000|2nd Intervention Order|Lost to Follow-up|0|||
146391638|NCT00758394|527935274|FG001|2nd Intervention Order|Lost to Follow-up|1|||
146391639|NCT00758394|527935275|FG002|2nd Intervention Order|Lost to Follow-up|0|||
146391640|NCT00758394|527935276|FG003|2nd Intervention Order|Lost to Follow-up|0|||
146391641|NCT00758394|527935273|FG000|3rd Intervention|Lost to Follow-up|1|||
146391642|NCT00758394|527935274|FG001|3rd Intervention|Lost to Follow-up|0|||
146391643|NCT00758394|527935275|FG002|3rd Intervention|Lost to Follow-up|0|||
146391644|NCT00758394|527935276|FG003|3rd Intervention|Lost to Follow-up|1|||
146391645|NCT01277757|527936804|FG000|Overall Study|Disease Progression|1|||
146391646|NCT01277757|527936804|FG000|Overall Study|Withdrawal by Subject|1|||
146391647|NCT03808298|527936805|FG000|Overall Study|Adverse Event|3|||
146391648|NCT03808298|527936805|FG000|Overall Study|Physician Decision|1|||
146391649|NCT03808298|527936805|FG000|Overall Study|Withdrawal by Subject|1|||
146391650|NCT03808298|527936805|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
146391651|NCT01004822|527936806|FG000|Overall Study|Objective progression or relapse|3|||
146391652|NCT01004822|527936807|FG001|Overall Study|Objective progression or relapse|3|||
146391653|NCT01004822|527936808|FG002|Overall Study|Objective progression or relapse|0|||
146391654|NCT01004822|527936809|FG003|Overall Study|Objective progression or relapse|1|||
146391655|NCT01004822|527936810|FG004|Overall Study|Objective progression or relapse|2|||
146391656|NCT01004822|527936811|FG005|Overall Study|Objective progression or relapse|2|||
146391657|NCT01004822|527936812|FG006|Overall Study|Objective progression or relapse|1|||
146391658|NCT01004822|527936813|FG007|Overall Study|Objective progression or relapse|4|||
146391659|NCT01004822|527936806|FG000|Overall Study|Global deterioration of health status|0|||
146391660|NCT01004822|527936807|FG001|Overall Study|Global deterioration of health status|0|||
146391661|NCT01004822|527936808|FG002|Overall Study|Global deterioration of health status|0|||
146391662|NCT01004822|527936809|FG003|Overall Study|Global deterioration of health status|1|||
146391663|NCT01004822|527936810|FG004|Overall Study|Global deterioration of health status|0|||
146391664|NCT01004822|527936811|FG005|Overall Study|Global deterioration of health status|0|||
146391665|NCT01004822|527936812|FG006|Overall Study|Global deterioration of health status|1|||
146391666|NCT01004822|527936813|FG007|Overall Study|Global deterioration of health status|0|||
146391667|NCT01004822|527936806|FG000|Overall Study|No longer willing to continue|0|||
146391668|NCT01004822|527936807|FG001|Overall Study|No longer willing to continue|0|||
146391669|NCT01004822|527936808|FG002|Overall Study|No longer willing to continue|0|||
146391670|NCT01004822|527936809|FG003|Overall Study|No longer willing to continue|1|||
146391671|NCT01004822|527936810|FG004|Overall Study|No longer willing to continue|2|||
146391672|NCT01004822|527936811|FG005|Overall Study|No longer willing to continue|1|||
146391673|NCT01004822|527936812|FG006|Overall Study|No longer willing to continue|1|||
146391674|NCT01004822|527936813|FG007|Overall Study|No longer willing to continue|0|||
146391675|NCT01004822|527936806|FG000|Overall Study|Adverse Event|0|||
146391676|NCT01004822|527936807|FG001|Overall Study|Adverse Event|0|||
146391677|NCT01004822|527936808|FG002|Overall Study|Adverse Event|0|||
146391678|NCT01004822|527936809|FG003|Overall Study|Adverse Event|0|||
146391679|NCT01004822|527936810|FG004|Overall Study|Adverse Event|0|||
146391680|NCT01004822|527936811|FG005|Overall Study|Adverse Event|0|||
146391681|NCT01004822|527936812|FG006|Overall Study|Adverse Event|1|||
146391682|NCT01004822|527936813|FG007|Overall Study|Adverse Event|1|||
146391683|NCT01004822|527936806|FG000|Overall Study|Other|0|||
146391684|NCT01004822|527936807|FG001|Overall Study|Other|0|||
146391685|NCT01004822|527936808|FG002|Overall Study|Other|4|||
146391686|NCT01004822|527936809|FG003|Overall Study|Other|1|||
146391687|NCT01004822|527936810|FG004|Overall Study|Other|0|||
146391688|NCT01004822|527936811|FG005|Overall Study|Other|1|||
146391689|NCT01004822|527936812|FG006|Overall Study|Other|0|||
146391690|NCT01004822|527936813|FG007|Overall Study|Other|0|||
146391691|NCT01858701|527936814|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
146391692|NCT01858701|527936815|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
146391693|NCT01858701|527936814|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
146391694|NCT01858701|527936815|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
146391695|NCT01858701|527936814|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
146391696|NCT01858701|527936815|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
146391697|NCT01858701|527936814|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
146391698|NCT01858701|527936815|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
146391699|NCT01801475|527936818|FG000|Overall Study|Withdrawal by Subject|0|||
146391700|NCT01801475|527936819|FG001|Overall Study|Withdrawal by Subject|0|||
146391701|NCT01801475|527936820|FG002|Overall Study|Withdrawal by Subject|0|||
146391702|NCT01801475|527936821|FG003|Overall Study|Withdrawal by Subject|0|||
146391703|NCT01801475|527936822|FG004|Overall Study|Withdrawal by Subject|1|||
146391704|NCT00421928|527936823|FG000|Overall Study|Adverse Event|61|||
146391705|NCT00421928|527936824|FG001|Overall Study|Adverse Event|140|||
146391706|NCT00421928|527936825|FG002|Overall Study|Adverse Event|22|||
146391707|NCT00421928|527936823|FG000|Overall Study|Lost to Follow-up|5|||
146391708|NCT00421928|527936824|FG001|Overall Study|Lost to Follow-up|0|||
146391709|NCT00421928|527936825|FG002|Overall Study|Lost to Follow-up|3|||
146391710|NCT00421928|527936823|FG000|Overall Study|Withdrawal by Subject|50|||
146391711|NCT00421928|527936824|FG001|Overall Study|Withdrawal by Subject|48|||
146391712|NCT00421928|527936825|FG002|Overall Study|Withdrawal by Subject|43|||
146391713|NCT00421928|527936823|FG000|Overall Study|Lack of Efficacy|15|||
146391714|NCT00421928|527936824|FG001|Overall Study|Lack of Efficacy|7|||
146391715|NCT00421928|527936825|FG002|Overall Study|Lack of Efficacy|35|||
146391716|NCT00421928|527936823|FG000|Overall Study|Study drug non-compliant|6|||
146391717|NCT00421928|527936824|FG001|Overall Study|Study drug non-compliant|7|||
146391718|NCT00421928|527936825|FG002|Overall Study|Study drug non-compliant|4|||
146391719|NCT00421928|527936823|FG000|Overall Study|All other|26|||
146391720|NCT00421928|527936824|FG001|Overall Study|All other|21|||
146391721|NCT00421928|527936825|FG002|Overall Study|All other|27|||
146391722|NCT00421928|527936823|FG000|Overall Study|Death|0|||
146391723|NCT00421928|527936824|FG001|Overall Study|Death|1|||
146391724|NCT00421928|527936825|FG002|Overall Study|Death|0|||
146391725|NCT04120116|527936839|FG000|Overall Study|Lost to Follow-up|0|||
146391726|NCT04120116|527936840|FG001|Overall Study|Lost to Follow-up|1|||
146391727|NCT04120116|527936841|FG002|Overall Study|Lost to Follow-up|0|||
146391728|NCT04120116|527936842|FG003|Overall Study|Lost to Follow-up|2|||
146391729|NCT04120116|527936839|FG000|Overall Study|Withdrawal by Subject|1|||
146391730|NCT04120116|527936840|FG001|Overall Study|Withdrawal by Subject|0|||
146391731|NCT04120116|527936841|FG002|Overall Study|Withdrawal by Subject|1|||
146391732|NCT04120116|527936842|FG003|Overall Study|Withdrawal by Subject|1|||
146391733|NCT04120116|527936839|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146391734|NCT04120116|527936840|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146391735|NCT04120116|527936841|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
146391736|NCT04120116|527936842|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
146391737|NCT05111548|527936844|FG000|Overall Study|Withdrawal by Subject|2|||
146391738|NCT05111548|527936845|FG001|Overall Study|Withdrawal by Subject|1|||
146391739|NCT05111548|527936844|FG000|Overall Study|Adverse Event|1|||
146391740|NCT05111548|527936845|FG001|Overall Study|Adverse Event|0|||
146391741|NCT01846039|527936846|FG000|Overall Study|Protocol Violation|1|||
146391742|NCT01846039|527936846|FG000|Overall Study|Subject Withdrew Consent|1|||
146391743|NCT01855607|527936857|FG000|Overall Study|Withdrawal by Subject|1|||
146391744|NCT01855607|527936857|FG000|Overall Study|Study was terminated|11|||
146391745|NCT02181634|527936858|FG000|Overall Study|Lack of Efficacy|33|||
146391746|NCT02181634|527936858|FG000|Overall Study|Adverse Event|17|||
146391747|NCT02181634|527936858|FG000|Overall Study|Physician Decision|8|||
146391748|NCT02181634|527936858|FG000|Overall Study|Withdrawal by Subject|5|||
146391749|NCT02181634|527936858|FG000|Overall Study|Death|2|||
146391750|NCT02181634|527936858|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
146391751|NCT02181634|527936858|FG000|Overall Study|Ineligible|1|||
146391752|NCT02181634|527936858|FG000|Overall Study|Max number of dose reduction|1|||
146391753|NCT02181634|527936858|FG000|Overall Study|Symptomatic progression|1|||
146391754|NCT02181634|527936858|FG000|Overall Study|Patient opted to proceed to surgery|1|||
146391755|NCT02528331|527936859|FG000|Overall Study|Withdrawal by Subject|2|||
146391756|NCT02392078|527936860|FG000|Overall Study|Did not have procedure|32|||
146391757|NCT02392078|527936861|FG001|Overall Study|Did not have procedure|43|||
146391758|NCT02392078|527936862|FG002|Overall Study|Did not have procedure|20|||
146391759|NCT02392078|527936863|FG003|Overall Study|Did not have procedure|1|||
146391760|NCT02087085|527936865|FG000|Overall Study|Adverse Event|10|||
146391761|NCT02087085|527936866|FG001|Overall Study|Adverse Event|14|||
146391762|NCT02087085|527936865|FG000|Overall Study|Lack of Efficacy|4|||
146391763|NCT02087085|527936866|FG001|Overall Study|Lack of Efficacy|3|||
146391764|NCT02087085|527936865|FG000|Overall Study|Lost to Follow-up|6|||
146391765|NCT02087085|527936866|FG001|Overall Study|Lost to Follow-up|4|||
146391766|NCT02087085|527936865|FG000|Overall Study|Withdrawal by Subject|9|||
146391767|NCT02087085|527936866|FG001|Overall Study|Withdrawal by Subject|11|||
146391768|NCT02087085|527936865|FG000|Overall Study|Protocol Violation|1|||
146391769|NCT02087085|527936866|FG001|Overall Study|Protocol Violation|0|||
146391770|NCT02087085|527936865|FG000|Overall Study|Study Terminated by Sponsor|87|||
146391771|NCT02087085|527936866|FG001|Overall Study|Study Terminated by Sponsor|80|||
146391772|NCT02087085|527936865|FG000|Overall Study|Other Miscellaneous Reasons|3|||
146391773|NCT02087085|527936866|FG001|Overall Study|Other Miscellaneous Reasons|4|||
146391774|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
146391775|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
146391776|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
146391777|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
146391778|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
146391779|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
146391780|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
146391781|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
146396132|NCT01241591|527954454|FG002|Overall Study|Protocol Violation|3|||
146391782|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
146391783|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
146391784|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
146391785|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
146391786|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
146391787|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
146391788|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
146391789|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|Other|6|||
146391790|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|Other|6|||
146391791|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|Other|7|||
146391792|NCT02681094|527936867|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
146391793|NCT02681094|527936868|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
146391794|NCT02681094|527936869|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
146391795|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Participant decision|7|||
146391796|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Participant decision|10|||
146391797|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Participant decision|9|||
146391798|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
146391799|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
146391800|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
146391801|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
146391802|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
146391803|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
146391804|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
146391805|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
146391806|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
146391807|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
146391808|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
146391809|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
146391810|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|Other|6|||
146391811|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|Other|6|||
146391812|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|Other|7|||
146391813|NCT02681094|527936867|FG000|2 - Enrolled Participants Set|No treatment given|0|||
146391814|NCT02681094|527936868|FG001|2 - Enrolled Participants Set|No treatment given|1|||
146391815|NCT02681094|527936869|FG002|2 - Enrolled Participants Set|No treatment given|1|||
146391816|NCT01270139|527936870|FG000|Overall Study|Adverse Event|8|||
146391817|NCT01270139|527936871|FG001|Overall Study|Adverse Event|17|||
146391818|NCT01270139|527936872|FG002|Overall Study|Adverse Event|18|||
146391819|NCT01270139|527936870|FG000|Overall Study|Lost to Follow-up|10|||
146391820|NCT01270139|527936871|FG001|Overall Study|Lost to Follow-up|9|||
146391821|NCT01270139|527936872|FG002|Overall Study|Lost to Follow-up|2|||
146391822|NCT01072175|527936873|FG000|Part A (Drug-Drug Interaction)|Death|1|||
146391823|NCT01072175|527936874|FG001|Part A (Drug-Drug Interaction)|Death|0|||
146391824|NCT01072175|527936875|FG002|Part A (Drug-Drug Interaction)|Death|0|||
146391825|NCT01072175|527936876|FG003|Part A (Drug-Drug Interaction)|Death|0|||
146391826|NCT01072175|527936877|FG004|Part A (Drug-Drug Interaction)|Death|0|||
146391827|NCT01072175|527936878|FG005|Part A (Drug-Drug Interaction)|Death|0|||
146391828|NCT01072175|527936879|FG006|Part A (Drug-Drug Interaction)|Death|0|||
146391829|NCT01072175|527936880|FG007|Part A (Drug-Drug Interaction)|Death|0|||
146391830|NCT01072175|527936881|FG008|Part A (Drug-Drug Interaction)|Death|0|||
146391831|NCT01072175|527936882|FG009|Part A (Drug-Drug Interaction)|Death|0|||
146391832|NCT01072175|527936883|FG010|Part A (Drug-Drug Interaction)|Death|0|||
146391833|NCT01072175|527936884|FG011|Part A (Drug-Drug Interaction)|Death|0|||
146391834|NCT01072175|527936885|FG012|Part A (Drug-Drug Interaction)|Death|0|||
146391835|NCT01072175|527936873|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
146391836|NCT01072175|527936874|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391837|NCT01072175|527936875|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391838|NCT01072175|527936876|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391839|NCT01072175|527936877|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391840|NCT01072175|527936878|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391841|NCT01072175|527936879|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391842|NCT01072175|527936880|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391843|NCT01072175|527936881|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391844|NCT01072175|527936882|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391845|NCT01072175|527936883|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391846|NCT01072175|527936884|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391847|NCT01072175|527936885|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
146391848|NCT01072175|527936873|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
146391849|NCT01072175|527936874|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391850|NCT01072175|527936875|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391851|NCT01072175|527936876|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391852|NCT01072175|527936877|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391853|NCT01072175|527936878|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391854|NCT01072175|527936879|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391855|NCT01072175|527936880|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391856|NCT01072175|527936881|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391857|NCT01072175|527936882|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391858|NCT01072175|527936883|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391859|NCT01072175|527936884|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391860|NCT01072175|527936885|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
146391861|NCT01072175|527936873|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
146391862|NCT01072175|527936874|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
146391863|NCT01072175|527936875|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
146391864|NCT01072175|527936876|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
146391865|NCT01072175|527936877|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
146391866|NCT01072175|527936878|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
146391867|NCT01072175|527936879|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
146391868|NCT01072175|527936880|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
146391869|NCT01072175|527936881|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
146391870|NCT01072175|527936882|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
146391871|NCT01072175|527936883|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
146391872|NCT01072175|527936884|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
146391873|NCT01072175|527936885|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
146391874|NCT01072175|527936873|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391875|NCT01072175|527936874|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391876|NCT01072175|527936875|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
146391877|NCT01072175|527936876|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391878|NCT01072175|527936877|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
146391879|NCT01072175|527936878|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391880|NCT01072175|527936879|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391881|NCT01072175|527936880|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391882|NCT01072175|527936881|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391883|NCT01072175|527936882|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391884|NCT01072175|527936883|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391885|NCT01072175|527936884|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391886|NCT01072175|527936885|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
146391887|NCT01072175|527936873|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391888|NCT01072175|527936874|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
146391889|NCT01072175|527936875|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391890|NCT01072175|527936876|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
146391891|NCT01072175|527936877|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
146391892|NCT01072175|527936878|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391893|NCT01072175|527936879|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391894|NCT01072175|527936880|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391895|NCT01072175|527936881|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391896|NCT01072175|527936882|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391897|NCT01072175|527936883|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391898|NCT01072175|527936884|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391899|NCT01072175|527936885|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
146391900|NCT01072175|527936873|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391901|NCT01072175|527936874|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391902|NCT01072175|527936875|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
146391903|NCT01072175|527936876|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
146391904|NCT01072175|527936877|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
146391905|NCT01072175|527936878|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391906|NCT01072175|527936879|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391907|NCT01072175|527936880|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391908|NCT01072175|527936881|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391909|NCT01072175|527936882|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391910|NCT01072175|527936883|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391911|NCT01072175|527936884|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391912|NCT01072175|527936885|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
146391913|NCT01072175|527936873|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391914|NCT01072175|527936874|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
146391915|NCT01072175|527936875|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391916|NCT01072175|527936876|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
146391917|NCT01072175|527936877|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
146391918|NCT01072175|527936878|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391919|NCT01072175|527936879|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391920|NCT01072175|527936880|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391921|NCT01072175|527936881|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391922|NCT01072175|527936882|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391923|NCT01072175|527936883|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391924|NCT01072175|527936884|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391925|NCT01072175|527936885|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
146391926|NCT01072175|527936873|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
146391927|NCT01072175|527936874|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
146391928|NCT01072175|527936875|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
146391929|NCT01072175|527936876|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
146391930|NCT01072175|527936877|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
146391931|NCT01072175|527936878|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
146391932|NCT01072175|527936879|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
146391933|NCT01072175|527936880|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
146391934|NCT01072175|527936881|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
146391935|NCT01072175|527936882|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
146391936|NCT01072175|527936883|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
146391937|NCT01072175|527936884|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
146391938|NCT01072175|527936885|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
146391939|NCT01072175|527936873|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391940|NCT01072175|527936874|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391941|NCT01072175|527936875|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391942|NCT01072175|527936876|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391943|NCT01072175|527936877|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391944|NCT01072175|527936878|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146391945|NCT01072175|527936879|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146391946|NCT01072175|527936880|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
146391947|NCT01072175|527936881|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391948|NCT01072175|527936882|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391949|NCT01072175|527936883|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391950|NCT01072175|527936884|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391951|NCT01072175|527936885|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
146391952|NCT01072175|527936873|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391953|NCT01072175|527936874|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391954|NCT01072175|527936875|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391955|NCT01072175|527936876|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391956|NCT01072175|527936877|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391957|NCT01072175|527936878|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391958|NCT01072175|527936879|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
146391959|NCT01072175|527936880|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
146391960|NCT01072175|527936881|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391961|NCT01072175|527936882|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391962|NCT01072175|527936883|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391963|NCT01072175|527936884|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391964|NCT01072175|527936885|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
146391965|NCT01072175|527936873|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391966|NCT01072175|527936874|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391967|NCT01072175|527936875|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391968|NCT01072175|527936876|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391969|NCT01072175|527936877|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391970|NCT01072175|527936878|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
146391971|NCT01072175|527936879|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
146391972|NCT01072175|527936880|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
146391973|NCT01072175|527936881|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391974|NCT01072175|527936882|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391975|NCT01072175|527936883|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391976|NCT01072175|527936884|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391977|NCT01072175|527936885|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
146391978|NCT01072175|527936873|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391979|NCT01072175|527936874|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391980|NCT01072175|527936875|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391981|NCT01072175|527936876|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391982|NCT01072175|527936877|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391983|NCT01072175|527936878|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
146391984|NCT01072175|527936879|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
146391985|NCT01072175|527936880|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391986|NCT01072175|527936881|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391987|NCT01072175|527936882|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391988|NCT01072175|527936883|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391989|NCT01072175|527936884|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391990|NCT01072175|527936885|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
146391991|NCT01072175|527936873|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391992|NCT01072175|527936874|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391993|NCT01072175|527936875|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391994|NCT01072175|527936876|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391995|NCT01072175|527936877|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391996|NCT01072175|527936878|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391997|NCT01072175|527936879|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391998|NCT01072175|527936880|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146391999|NCT01072175|527936881|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
146392000|NCT01072175|527936882|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146392001|NCT01072175|527936883|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146392002|NCT01072175|527936884|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146392003|NCT01072175|527936885|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
146392004|NCT01072175|527936873|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392005|NCT01072175|527936874|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392006|NCT01072175|527936875|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392007|NCT01072175|527936876|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392008|NCT01072175|527936877|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392009|NCT01072175|527936878|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392010|NCT01072175|527936879|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392011|NCT01072175|527936880|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392012|NCT01072175|527936881|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
146392013|NCT01072175|527936882|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392014|NCT01072175|527936883|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392015|NCT01072175|527936884|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392016|NCT01072175|527936885|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
146392017|NCT01072175|527936873|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392018|NCT01072175|527936874|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392019|NCT01072175|527936875|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392020|NCT01072175|527936876|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392021|NCT01072175|527936877|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392022|NCT01072175|527936878|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392023|NCT01072175|527936879|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392024|NCT01072175|527936880|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392025|NCT01072175|527936881|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
146392026|NCT01072175|527936882|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392027|NCT01072175|527936883|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392028|NCT01072175|527936884|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392029|NCT01072175|527936885|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
146392030|NCT01072175|527936873|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392031|NCT01072175|527936874|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392032|NCT01072175|527936875|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392033|NCT01072175|527936876|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392034|NCT01072175|527936877|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392035|NCT01072175|527936878|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392036|NCT01072175|527936879|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392037|NCT01072175|527936880|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392038|NCT01072175|527936881|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
146392039|NCT01072175|527936882|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392040|NCT01072175|527936883|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392041|NCT01072175|527936884|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392042|NCT01072175|527936885|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
146392043|NCT01072175|527936873|FG000|Part D (HPMC Capsules)|Death|0|||
146392044|NCT01072175|527936874|FG001|Part D (HPMC Capsules)|Death|0|||
146392045|NCT01072175|527936875|FG002|Part D (HPMC Capsules)|Death|0|||
146392046|NCT01072175|527936876|FG003|Part D (HPMC Capsules)|Death|0|||
146392047|NCT01072175|527936877|FG004|Part D (HPMC Capsules)|Death|0|||
146392048|NCT01072175|527936878|FG005|Part D (HPMC Capsules)|Death|0|||
146392049|NCT01072175|527936879|FG006|Part D (HPMC Capsules)|Death|0|||
146392050|NCT01072175|527936880|FG007|Part D (HPMC Capsules)|Death|0|||
146392051|NCT01072175|527936881|FG008|Part D (HPMC Capsules)|Death|0|||
146392052|NCT01072175|527936882|FG009|Part D (HPMC Capsules)|Death|10|||
146392053|NCT01072175|527936883|FG010|Part D (HPMC Capsules)|Death|12|||
146392054|NCT01072175|527936884|FG011|Part D (HPMC Capsules)|Death|28|||
146392055|NCT01072175|527936885|FG012|Part D (HPMC Capsules)|Death|26|||
146392056|NCT01072175|527936873|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
146392057|NCT01072175|527936874|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
146392058|NCT01072175|527936875|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
146392059|NCT01072175|527936876|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
146392060|NCT01072175|527936877|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
146392061|NCT01072175|527936878|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
146392062|NCT01072175|527936879|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
146392063|NCT01072175|527936880|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
146392064|NCT01072175|527936881|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
146392065|NCT01072175|527936882|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
146392066|NCT01072175|527936883|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
146392067|NCT01072175|527936884|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
146392068|NCT01072175|527936885|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
146392069|NCT01072175|527936873|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392070|NCT01072175|527936874|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392071|NCT01072175|527936875|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392072|NCT01072175|527936876|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392073|NCT01072175|527936877|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392074|NCT01072175|527936878|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392075|NCT01072175|527936879|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392076|NCT01072175|527936880|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392077|NCT01072175|527936881|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392078|NCT01072175|527936882|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
146392079|NCT01072175|527936883|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
146392080|NCT01072175|527936884|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
146392081|NCT01072175|527936885|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
146392082|NCT01072175|527936873|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392083|NCT01072175|527936874|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392084|NCT01072175|527936875|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392085|NCT01072175|527936876|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392086|NCT01072175|527936877|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392087|NCT01072175|527936878|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392088|NCT01072175|527936879|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392089|NCT01072175|527936880|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392090|NCT01072175|527936881|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
146392091|NCT01072175|527936882|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
146392092|NCT01072175|527936883|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
146392093|NCT01072175|527936884|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
146392094|NCT01072175|527936885|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
146392095|NCT01072175|527936873|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392096|NCT01072175|527936874|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392097|NCT01072175|527936875|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392098|NCT01072175|527936876|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392099|NCT01072175|527936877|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392100|NCT01072175|527936878|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392101|NCT01072175|527936879|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392102|NCT01072175|527936880|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392103|NCT01072175|527936881|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392104|NCT01072175|527936882|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392105|NCT01072175|527936883|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
146392106|NCT01072175|527936884|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
146392107|NCT01072175|527936885|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
146392108|NCT02477215|527936886|FG000|Dose Escalation Phase|Physician Decision|1|||
146392109|NCT02477215|527936887|FG001|Dose Escalation Phase|Physician Decision|2|||
146392110|NCT02477215|527936888|FG002|Dose Escalation Phase|Physician Decision|0|||
146392111|NCT02477215|527936886|FG000|Fixed Dose Phase|Physician Decision|0|||
146392112|NCT02477215|527936887|FG001|Fixed Dose Phase|Physician Decision|7|||
146392113|NCT02477215|527936888|FG002|Fixed Dose Phase|Physician Decision|0|||
146392114|NCT02210559|527936889|FG000|Overall Study|Progressive Disease|3|||
146392115|NCT02210559|527936890|FG001|Overall Study|Progressive Disease|2|||
146392116|NCT02210559|527936889|FG000|Overall Study|Adverse Event|2|||
146392117|NCT02210559|527936890|FG001|Overall Study|Adverse Event|2|||
146392118|NCT02210559|527936889|FG000|Overall Study|Physician Decision|1|||
146392119|NCT02210559|527936890|FG001|Overall Study|Physician Decision|0|||
146392120|NCT02210559|527936889|FG000|Overall Study|Withdrawal by Subject|0|||
146392121|NCT02210559|527936890|FG001|Overall Study|Withdrawal by Subject|1|||
146392122|NCT02210559|527936889|FG000|Overall Study|Other than specified|0|||
146392123|NCT02210559|527936890|FG001|Overall Study|Other than specified|1|||
146392124|NCT02546193|527936891|FG000|Overall Study|Withdrawal by Subject|2|||
146392125|NCT02546193|527936892|FG001|Overall Study|Withdrawal by Subject|0|||
146392126|NCT02546193|527936893|FG002|Overall Study|Withdrawal by Subject|1|||
146392127|NCT02546193|527936894|FG003|Overall Study|Withdrawal by Subject|0|||
146392128|NCT02546193|527936891|FG000|Overall Study|Not eligible at time of induction|4|||
146392129|NCT02546193|527936892|FG001|Overall Study|Not eligible at time of induction|6|||
146392130|NCT02546193|527936893|FG002|Overall Study|Not eligible at time of induction|1|||
146392131|NCT02546193|527936894|FG003|Overall Study|Not eligible at time of induction|0|||
146392132|NCT00917553|527936895|FG000|Overall Study|Lost to Follow-up|2|||
146392133|NCT00917553|527936896|FG001|Overall Study|Lost to Follow-up|1|||
146392134|NCT01616173|527936897|FG000|Overall Study|Lost to Follow-up|0|||
146392135|NCT01616173|527936898|FG001|Overall Study|Lost to Follow-up|2|||
146392136|NCT01616173|527936899|FG002|Overall Study|Lost to Follow-up|0|||
146392137|NCT01177943|527936902|FG000|First Intervention|Withdrawal by Subject|2|||
146392138|NCT01177943|527936903|FG001|First Intervention|Withdrawal by Subject|0|||
146392139|NCT04738123|527936910|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
146392140|NCT04738123|527936911|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
146392141|NCT04738123|527936910|FG000|Overall Study|Progressive Disease|0|||
146392142|NCT04738123|527936911|FG001|Overall Study|Progressive Disease|4|||
146392143|NCT04738123|527936910|FG000|Overall Study|Adverse Event|8|||
146392144|NCT04738123|527936911|FG001|Overall Study|Adverse Event|7|||
146392145|NCT04738123|527936910|FG000|Overall Study|Other Reasons|0|||
146392146|NCT04738123|527936911|FG001|Overall Study|Other Reasons|1|||
146392147|NCT04738123|527936910|FG000|Overall Study|Suicidal or assaultive behavior|0|||
146392148|NCT04738123|527936911|FG001|Overall Study|Suicidal or assaultive behavior|2|||
146392149|NCT04738123|527936910|FG000|Overall Study|Protocol Violation|2|||
146392150|NCT04738123|527936911|FG001|Overall Study|Protocol Violation|2|||
146392151|NCT04738123|527936910|FG000|Overall Study|Consent Withdrawn|35|||
146392152|NCT04738123|527936911|FG001|Overall Study|Consent Withdrawn|22|||
146392153|NCT05047601|527936912|FG000|Overall Study|Lost to Follow-up|9|||
146392154|NCT05047601|527936913|FG001|Overall Study|Lost to Follow-up|11|||
146392155|NCT05047601|527936914|FG002|Overall Study|Lost to Follow-up|7|||
146392156|NCT05047601|527936912|FG000|Overall Study|Withdrawal by Subject|25|||
146392157|NCT05047601|527936913|FG001|Overall Study|Withdrawal by Subject|36|||
146392158|NCT05047601|527936914|FG002|Overall Study|Withdrawal by Subject|23|||
146392159|NCT05047601|527936912|FG000|Overall Study|Other|10|||
146392160|NCT05047601|527936913|FG001|Overall Study|Other|6|||
146392161|NCT05047601|527936914|FG002|Overall Study|Other|5|||
146392162|NCT00302731|527936926|FG000|Overall Study|Lost to Follow-up|1|||
146392163|NCT00302731|527936927|FG001|Overall Study|Lost to Follow-up|2|||
146392164|NCT00302731|527936928|FG002|Overall Study|Lost to Follow-up|0|||
146392165|NCT00302731|527936929|FG003|Overall Study|Lost to Follow-up|0|||
146392166|NCT00302731|527936926|FG000|Overall Study|Adverse Event|0|||
146392167|NCT00302731|527936927|FG001|Overall Study|Adverse Event|2|||
146392168|NCT00302731|527936928|FG002|Overall Study|Adverse Event|2|||
146392169|NCT00302731|527936929|FG003|Overall Study|Adverse Event|0|||
146392170|NCT00302731|527936926|FG000|Overall Study|Withdrawal by Subject|1|||
146392171|NCT00302731|527936927|FG001|Overall Study|Withdrawal by Subject|1|||
146392172|NCT00302731|527936928|FG002|Overall Study|Withdrawal by Subject|0|||
146392173|NCT00302731|527936929|FG003|Overall Study|Withdrawal by Subject|0|||
146392174|NCT00302731|527936926|FG000|Overall Study|Protocol Violation|1|||
146392175|NCT00302731|527936927|FG001|Overall Study|Protocol Violation|0|||
146392176|NCT00302731|527936928|FG002|Overall Study|Protocol Violation|0|||
146392177|NCT00302731|527936929|FG003|Overall Study|Protocol Violation|0|||
146392178|NCT00302731|527936926|FG000|Overall Study|cancer unrelated to study discovered|1|||
146392179|NCT00302731|527936927|FG001|Overall Study|cancer unrelated to study discovered|0|||
146392180|NCT00302731|527936928|FG002|Overall Study|cancer unrelated to study discovered|1|||
146392181|NCT00302731|527936929|FG003|Overall Study|cancer unrelated to study discovered|0|||
146392182|NCT01610752|527936932|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
146392183|NCT01610752|527936933|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
146392184|NCT01610752|527936934|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
146392185|NCT00283062|527936938|FG000|Overall Study|Did not receive any study medication|5|||
146392186|NCT00283062|527936939|FG001|Overall Study|Did not receive any study medication|4|||
146392187|NCT00283062|527936940|FG002|Overall Study|Did not receive any study medication|36|||
146392188|NCT00283062|527936941|FG003|Overall Study|Did not receive any study medication|45|||
146392189|NCT00283062|527936938|FG000|Overall Study|Adverse Event|2|||
146392190|NCT00283062|527936939|FG001|Overall Study|Adverse Event|0|||
146392191|NCT00283062|527936940|FG002|Overall Study|Adverse Event|1|||
146392192|NCT00283062|527936941|FG003|Overall Study|Adverse Event|0|||
146392193|NCT00283062|527936938|FG000|Overall Study|Lost to Follow-up|1|||
146392194|NCT00283062|527936939|FG001|Overall Study|Lost to Follow-up|0|||
146392195|NCT00283062|527936940|FG002|Overall Study|Lost to Follow-up|1|||
146392196|NCT00283062|527936941|FG003|Overall Study|Lost to Follow-up|0|||
146392197|NCT00283062|527936938|FG000|Overall Study|Progressive disease|0|||
146392198|NCT00283062|527936939|FG001|Overall Study|Progressive disease|0|||
146392199|NCT00283062|527936940|FG002|Overall Study|Progressive disease|1|||
146392200|NCT00283062|527936941|FG003|Overall Study|Progressive disease|0|||
146392201|NCT00283062|527936938|FG000|Overall Study|Participant did not wish to continue|3|||
146392202|NCT00283062|527936939|FG001|Overall Study|Participant did not wish to continue|2|||
146392203|NCT00283062|527936940|FG002|Overall Study|Participant did not wish to continue|1|||
146392204|NCT00283062|527936941|FG003|Overall Study|Participant did not wish to continue|0|||
146392205|NCT00283062|527936938|FG000|Overall Study|Undefined|0|||
146392206|NCT00283062|527936939|FG001|Overall Study|Undefined|1|||
146392207|NCT00283062|527936940|FG002|Overall Study|Undefined|1|||
146392208|NCT00283062|527936941|FG003|Overall Study|Undefined|4|||
146392209|NCT00283062|527936938|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
146392210|NCT00283062|527936939|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
146392211|NCT00283062|527936940|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
146392212|NCT00283062|527936941|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
146392213|NCT00252499|527936942|FG000|Overall Study|Lost to Follow-up|1|||
146392214|NCT00252499|527936943|FG001|Overall Study|Lost to Follow-up|0|||
146392215|NCT00252499|527936944|FG002|Overall Study|Lost to Follow-up|0|||
146392216|NCT01535638|527936945|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
146392217|NCT01535638|527936946|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
146392218|NCT01535638|527936947|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
146392219|NCT01535638|527936948|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
146392220|NCT01535638|527936949|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
146392221|NCT01535638|527936950|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
146392222|NCT01535638|527936945|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
146392223|NCT01535638|527936946|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
146392224|NCT01535638|527936947|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
146392225|NCT01535638|527936948|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
146392226|NCT01535638|527936949|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
146392227|NCT01535638|527936950|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
146392228|NCT01482598|527936951|FG000|Overall Study|Death|7|||
146392229|NCT01482598|527936952|FG001|Overall Study|Death|10|||
146392230|NCT01482598|527936951|FG000|Overall Study|Physician Decision|0|||
146392231|NCT01482598|527936952|FG001|Overall Study|Physician Decision|3|||
146392232|NCT01482598|527936951|FG000|Overall Study|Withdrawal by Subject|4|||
146392233|NCT01482598|527936952|FG001|Overall Study|Withdrawal by Subject|5|||
146392234|NCT01482598|527936951|FG000|Overall Study|Lost to Follow-up|5|||
146392235|NCT01482598|527936952|FG001|Overall Study|Lost to Follow-up|4|||
146392236|NCT00423267|527936953|FG000|Period A|Withdrawal by Subject|0|||
146392237|NCT00423267|527936954|FG001|Period A|Withdrawal by Subject|1|||
146392238|NCT00423267|527936953|FG000|Period A|Non-compliance with protocol|1|||
146392239|NCT00423267|527936954|FG001|Period A|Non-compliance with protocol|0|||
146392240|NCT00423267|527936953|FG000|Period A|Administrative|1|||
146392241|NCT00423267|527936954|FG001|Period A|Administrative|0|||
146392242|NCT00827112|527936955|FG000|Overall Study|Adverse Event|2|||
146392243|NCT00827112|527936956|FG001|Overall Study|Adverse Event|0|||
146392244|NCT00827112|527936955|FG000|Overall Study|Lack of Efficacy|2|||
146392245|NCT00827112|527936956|FG001|Overall Study|Lack of Efficacy|0|||
146392246|NCT00827112|527936955|FG000|Overall Study|Lost to Follow-up|3|||
146392247|NCT00827112|527936956|FG001|Overall Study|Lost to Follow-up|2|||
146392248|NCT00827112|527936955|FG000|Overall Study|Pregnancy|0|||
146392249|NCT00827112|527936956|FG001|Overall Study|Pregnancy|1|||
146392250|NCT00827112|527936955|FG000|Overall Study|Protocol Violation|0|||
146392251|NCT00827112|527936956|FG001|Overall Study|Protocol Violation|2|||
146392252|NCT00827112|527936955|FG000|Overall Study|Withdrawal by Subject|2|||
146392253|NCT00827112|527936956|FG001|Overall Study|Withdrawal by Subject|1|||
146392254|NCT00827112|527936955|FG000|Overall Study|Randomized but not treated|5|||
146392255|NCT00827112|527936956|FG001|Overall Study|Randomized but not treated|3|||
146392256|NCT00827112|527936955|FG000|Overall Study|Other|1|||
146392257|NCT00827112|527936956|FG001|Overall Study|Other|3|||
146392258|NCT00689728|527936959|FG000|Double-Blind Treatment|Adverse Event|1|||
146392259|NCT00689728|527936960|FG001|Double-Blind Treatment|Adverse Event|0|||
146392260|NCT00689728|527936961|FG002|Double-Blind Treatment|Adverse Event|0|||
146392261|NCT00689728|527936959|FG000|Double-Blind Treatment|Protocol Violation|0|||
146392262|NCT00689728|527936960|FG001|Double-Blind Treatment|Protocol Violation|0|||
146392263|NCT00689728|527936961|FG002|Double-Blind Treatment|Protocol Violation|1|||
146392264|NCT00689728|527936959|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
146392265|NCT00689728|527936960|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
146392266|NCT00689728|527936961|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
146392267|NCT00689728|527936959|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
146392268|NCT00689728|527936960|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
146392269|NCT00689728|527936961|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
146392270|NCT00689728|527936959|FG000|Rescue|Adverse Event|0|||
146392271|NCT00689728|527936960|FG001|Rescue|Adverse Event|1|||
146392272|NCT00689728|527936961|FG002|Rescue|Adverse Event|0|||
146392273|NCT00689728|527936959|FG000|Rescue|Withdrawal by Subject|1|||
146392274|NCT00689728|527936960|FG001|Rescue|Withdrawal by Subject|1|||
146392275|NCT00689728|527936961|FG002|Rescue|Withdrawal by Subject|1|||
146392276|NCT00689728|527936959|FG000|Optional Follow-Up|Adverse Event|1|||
146392277|NCT00689728|527936960|FG001|Optional Follow-Up|Adverse Event|0|||
146392278|NCT00689728|527936961|FG002|Optional Follow-Up|Adverse Event|0|||
146392279|NCT00689728|527936959|FG000|Optional Follow-Up|Lack of Efficacy|0|||
146392280|NCT00689728|527936960|FG001|Optional Follow-Up|Lack of Efficacy|1|||
146392281|NCT00689728|527936961|FG002|Optional Follow-Up|Lack of Efficacy|1|||
146392282|NCT00689728|527936959|FG000|Optional Follow-Up|Lost to Follow-up|0|||
146392283|NCT00689728|527936960|FG001|Optional Follow-Up|Lost to Follow-up|1|||
146392284|NCT00689728|527936961|FG002|Optional Follow-Up|Lost to Follow-up|1|||
146392285|NCT00689728|527936959|FG000|Optional Follow-Up|Protocol Violation|0|||
146392286|NCT00689728|527936960|FG001|Optional Follow-Up|Protocol Violation|0|||
146392287|NCT00689728|527936961|FG002|Optional Follow-Up|Protocol Violation|1|||
146392288|NCT00689728|527936959|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
146392289|NCT00689728|527936960|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
146392290|NCT00689728|527936961|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
146392291|NCT00784836|527936962|FG000|Overall Study|Early Study Termination|3|||
146392292|NCT00635804|527938719|FG000|Overall Study|Adverse Event|0|||
146392293|NCT00635804|527938720|FG001|Overall Study|Adverse Event|0|||
146392294|NCT00635804|527938721|FG002|Overall Study|Adverse Event|0|||
146392295|NCT00635804|527938722|FG003|Overall Study|Adverse Event|0|||
146392296|NCT00635804|527938723|FG004|Overall Study|Adverse Event|0|||
146392297|NCT00635804|527938724|FG005|Overall Study|Adverse Event|1|||
146392298|NCT00635804|527938725|FG006|Overall Study|Adverse Event|0|||
146392299|NCT00635804|527938726|FG007|Overall Study|Adverse Event|0|||
146392300|NCT00635804|527938719|FG000|Overall Study|Withdrawal by Subject|1|||
146392301|NCT00635804|527938720|FG001|Overall Study|Withdrawal by Subject|0|||
146392302|NCT00635804|527938721|FG002|Overall Study|Withdrawal by Subject|0|||
146392303|NCT00635804|527938722|FG003|Overall Study|Withdrawal by Subject|0|||
146392304|NCT00635804|527938723|FG004|Overall Study|Withdrawal by Subject|0|||
146392305|NCT00635804|527938724|FG005|Overall Study|Withdrawal by Subject|0|||
146392306|NCT00635804|527938725|FG006|Overall Study|Withdrawal by Subject|0|||
146392307|NCT00635804|527938726|FG007|Overall Study|Withdrawal by Subject|0|||
146392308|NCT02452320|527938736|FG000|Overall Study|Adverse Event|0|||
146392309|NCT02452320|527938737|FG001|Overall Study|Adverse Event|1|||
146392310|NCT03382639|527938738|FG000|Overall Study|Adverse Event|2|||
146392311|NCT03382639|527938739|FG001|Overall Study|Adverse Event|0|||
146392312|NCT03382639|527938740|FG002|Overall Study|Adverse Event|1|||
146392313|NCT03382639|527938741|FG003|Overall Study|Adverse Event|1|||
146392314|NCT03382639|527938738|FG000|Overall Study|Lost to Follow-up|1|||
146392315|NCT03382639|527938739|FG001|Overall Study|Lost to Follow-up|0|||
146392316|NCT03382639|527938740|FG002|Overall Study|Lost to Follow-up|0|||
146392317|NCT03382639|527938741|FG003|Overall Study|Lost to Follow-up|0|||
146392318|NCT03382639|527938738|FG000|Overall Study|Withdrawal by Subject|4|||
146392319|NCT03382639|527938739|FG001|Overall Study|Withdrawal by Subject|3|||
146392320|NCT03382639|527938740|FG002|Overall Study|Withdrawal by Subject|2|||
146392321|NCT03382639|527938741|FG003|Overall Study|Withdrawal by Subject|3|||
146392322|NCT03382639|527938738|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
146392323|NCT03382639|527938739|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
146392324|NCT03382639|527938740|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
146392325|NCT03382639|527938741|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
146392326|NCT03382639|527938738|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
146392327|NCT03382639|527938739|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
146392328|NCT03382639|527938740|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
146392329|NCT03382639|527938741|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
146392330|NCT03382639|527938738|FG000|Overall Study|Other|2|||
146392331|NCT03382639|527938739|FG001|Overall Study|Other|0|||
146392332|NCT03382639|527938740|FG002|Overall Study|Other|0|||
146392333|NCT03382639|527938741|FG003|Overall Study|Other|3|||
146392334|NCT00310440|527938744|FG000|Overall Study|Lost to Follow-up|17|||
146392335|NCT00310440|527938745|FG001|Overall Study|Lost to Follow-up|8|||
146392336|NCT00310440|527938744|FG000|Overall Study|Withdrawal by Subject|2|||
146392337|NCT00310440|527938745|FG001|Overall Study|Withdrawal by Subject|1|||
146392338|NCT00310440|527938744|FG000|Overall Study|Missed 12 Month Visit|7|||
146392339|NCT00310440|527938745|FG001|Overall Study|Missed 12 Month Visit|4|||
146392340|NCT01287403|527938746|FG000|1st Intervention (1 Day)|Adverse Event|1|||
146392341|NCT00148109|527938747|FG000|Overall Study|Lack of Efficacy|10|||
146392342|NCT00148109|527938748|FG001|Overall Study|Lack of Efficacy|18|||
146392343|NCT00148109|527938747|FG000|Overall Study|Adverse Event|0|||
146392344|NCT00148109|527938748|FG001|Overall Study|Adverse Event|2|||
146392345|NCT00148109|527938747|FG000|Overall Study|Withdrawal by Subject|2|||
146392346|NCT00148109|527938748|FG001|Overall Study|Withdrawal by Subject|0|||
146392347|NCT01098266|527938749|FG000|Overall Study|Physician Decision|1|||
146392348|NCT01098266|527938750|FG001|Overall Study|Physician Decision|0|||
146392349|NCT01098266|527938749|FG000|Overall Study|Death|3|||
146392350|NCT01098266|527938750|FG001|Overall Study|Death|2|||
146392351|NCT01098266|527938749|FG000|Overall Study|Withdrawal by Subject|3|||
146392352|NCT01098266|527938750|FG001|Overall Study|Withdrawal by Subject|5|||
146392353|NCT00438815|527938751|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
146392354|NCT00438815|527938751|FG000|Overall Study|3-month follow-up no longer required|12|||
146392355|NCT00438815|527938751|FG000|Overall Study|Noncompliance with protocol requirements|9|||
146392356|NCT00438815|527938751|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
146392357|NCT00438815|527938751|FG000|Overall Study|Lost to Follow-up|6|||
146392358|NCT00438815|527938751|FG000|Overall Study|Withdrawal by Subject|6|||
146392359|NCT00438815|527938751|FG000|Overall Study|Death|1|||
146392360|NCT01733758|527938752|FG000|Overall Study|Adverse Event|5|||
146392361|NCT01733758|527938753|FG001|Overall Study|Adverse Event|7|||
146392362|NCT01733758|527938754|FG002|Overall Study|Adverse Event|8|||
146392363|NCT01733758|527938755|FG003|Overall Study|Adverse Event|1|||
146392364|NCT01733758|527938752|FG000|Overall Study|Withdrawal by Subject|1|||
146392365|NCT01733758|527938753|FG001|Overall Study|Withdrawal by Subject|1|||
146392366|NCT01733758|527938754|FG002|Overall Study|Withdrawal by Subject|5|||
146392367|NCT01733758|527938755|FG003|Overall Study|Withdrawal by Subject|3|||
146392368|NCT01733758|527938752|FG000|Overall Study|Persistent Hyperglycemia|3|||
146392369|NCT01733758|527938753|FG001|Overall Study|Persistent Hyperglycemia|2|||
146392370|NCT01733758|527938754|FG002|Overall Study|Persistent Hyperglycemia|0|||
146392371|NCT01733758|527938755|FG003|Overall Study|Persistent Hyperglycemia|0|||
146392372|NCT01733758|527938752|FG000|Overall Study|Protocol Violation|0|||
146392373|NCT01733758|527938753|FG001|Overall Study|Protocol Violation|1|||
146392374|NCT01733758|527938754|FG002|Overall Study|Protocol Violation|2|||
146392375|NCT01733758|527938755|FG003|Overall Study|Protocol Violation|2|||
146392376|NCT01733758|527938752|FG000|Overall Study|Non-compliance|1|||
146392377|NCT01733758|527938753|FG001|Overall Study|Non-compliance|0|||
146392378|NCT01733758|527938754|FG002|Overall Study|Non-compliance|0|||
146392379|NCT01733758|527938755|FG003|Overall Study|Non-compliance|0|||
146392380|NCT01733758|527938752|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
146392381|NCT01733758|527938753|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
146392382|NCT01733758|527938754|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
146392383|NCT01733758|527938755|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
146392384|NCT01733758|527938752|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
146392385|NCT01733758|527938753|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
146392386|NCT01733758|527938754|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
146392387|NCT01733758|527938755|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
146392388|NCT02557308|527938758|FG000|Overall Study|Withdrawal by Subject|11|||
146392389|NCT02557308|527938759|FG001|Overall Study|Withdrawal by Subject|3|||
146392390|NCT02557308|527938760|FG002|Overall Study|Withdrawal by Subject|2|||
146392391|NCT02557308|527938761|FG003|Overall Study|Withdrawal by Subject|0|||
146392392|NCT02557308|527938762|FG004|Overall Study|Withdrawal by Subject|1|||
146392393|NCT02557308|527938763|FG005|Overall Study|Withdrawal by Subject|0|||
146392394|NCT02557308|527938764|FG006|Overall Study|Withdrawal by Subject|10|||
146392395|NCT02557308|527938765|FG007|Overall Study|Withdrawal by Subject|1|||
146392396|NCT02557308|527938758|FG000|Overall Study|Disease Progression|0|||
146392397|NCT02557308|527938759|FG001|Overall Study|Disease Progression|1|||
146392398|NCT02557308|527938760|FG002|Overall Study|Disease Progression|0|||
146392399|NCT02557308|527938761|FG003|Overall Study|Disease Progression|0|||
146392400|NCT02557308|527938762|FG004|Overall Study|Disease Progression|0|||
146392401|NCT02557308|527938763|FG005|Overall Study|Disease Progression|0|||
146392402|NCT02557308|527938764|FG006|Overall Study|Disease Progression|0|||
146392403|NCT02557308|527938765|FG007|Overall Study|Disease Progression|0|||
146392404|NCT02557308|527938758|FG000|Overall Study|Lack of Efficacy|3|||
146392405|NCT02557308|527938759|FG001|Overall Study|Lack of Efficacy|0|||
146392406|NCT02557308|527938760|FG002|Overall Study|Lack of Efficacy|0|||
146392407|NCT02557308|527938761|FG003|Overall Study|Lack of Efficacy|0|||
146392408|NCT02557308|527938762|FG004|Overall Study|Lack of Efficacy|0|||
146392409|NCT02557308|527938763|FG005|Overall Study|Lack of Efficacy|0|||
146392410|NCT02557308|527938764|FG006|Overall Study|Lack of Efficacy|1|||
146392411|NCT02557308|527938765|FG007|Overall Study|Lack of Efficacy|0|||
146392412|NCT02557308|527938758|FG000|Overall Study|Adverse Event|4|||
146392413|NCT02557308|527938759|FG001|Overall Study|Adverse Event|1|||
146392414|NCT02557308|527938760|FG002|Overall Study|Adverse Event|2|||
146392415|NCT02557308|527938761|FG003|Overall Study|Adverse Event|0|||
146392416|NCT02557308|527938762|FG004|Overall Study|Adverse Event|0|||
146392417|NCT02557308|527938763|FG005|Overall Study|Adverse Event|0|||
146392418|NCT02557308|527938764|FG006|Overall Study|Adverse Event|4|||
146392419|NCT02557308|527938765|FG007|Overall Study|Adverse Event|1|||
146392420|NCT02557308|527938758|FG000|Overall Study|Lost to Follow-up|2|||
146392421|NCT02557308|527938759|FG001|Overall Study|Lost to Follow-up|0|||
146392422|NCT02557308|527938760|FG002|Overall Study|Lost to Follow-up|1|||
146392423|NCT02557308|527938761|FG003|Overall Study|Lost to Follow-up|0|||
146392424|NCT02557308|527938762|FG004|Overall Study|Lost to Follow-up|0|||
146392425|NCT02557308|527938763|FG005|Overall Study|Lost to Follow-up|0|||
146392426|NCT02557308|527938764|FG006|Overall Study|Lost to Follow-up|2|||
146392427|NCT02557308|527938765|FG007|Overall Study|Lost to Follow-up|0|||
146392428|NCT02557308|527938758|FG000|Overall Study|Death|1|||
146392429|NCT02557308|527938759|FG001|Overall Study|Death|0|||
146392430|NCT02557308|527938760|FG002|Overall Study|Death|0|||
146392431|NCT02557308|527938761|FG003|Overall Study|Death|0|||
146392432|NCT02557308|527938762|FG004|Overall Study|Death|0|||
146392433|NCT02557308|527938763|FG005|Overall Study|Death|0|||
146392434|NCT02557308|527938764|FG006|Overall Study|Death|0|||
146392435|NCT02557308|527938765|FG007|Overall Study|Death|0|||
146392436|NCT02557308|527938758|FG000|Overall Study|Study Close|98|||
146392437|NCT02557308|527938759|FG001|Overall Study|Study Close|18|||
146392438|NCT02557308|527938760|FG002|Overall Study|Study Close|5|||
146392439|NCT02557308|527938761|FG003|Overall Study|Study Close|3|||
146392440|NCT02557308|527938762|FG004|Overall Study|Study Close|1|||
146392441|NCT02557308|527938763|FG005|Overall Study|Study Close|0|||
146392442|NCT02557308|527938764|FG006|Overall Study|Study Close|123|||
146392443|NCT02557308|527938765|FG007|Overall Study|Study Close|5|||
146392444|NCT02557308|527938758|FG000|Overall Study|Except for study close|5|||
146392445|NCT02557308|527938759|FG001|Overall Study|Except for study close|0|||
146392446|NCT02557308|527938760|FG002|Overall Study|Except for study close|0|||
146392447|NCT02557308|527938761|FG003|Overall Study|Except for study close|0|||
146392448|NCT02557308|527938762|FG004|Overall Study|Except for study close|3|||
146392449|NCT02557308|527938763|FG005|Overall Study|Except for study close|0|||
146392450|NCT02557308|527938764|FG006|Overall Study|Except for study close|6|||
146392451|NCT02557308|527938765|FG007|Overall Study|Except for study close|10|||
146392452|NCT03911401|527938768|FG000|Overall Study|Adverse Event|1|||
146392453|NCT03911401|527938769|FG001|Overall Study|Adverse Event|2|||
146392454|NCT03911401|527938770|FG002|Overall Study|Adverse Event|5|||
146392455|NCT03911401|527938768|FG000|Overall Study|Lack of Efficacy|1|||
146392456|NCT03911401|527938769|FG001|Overall Study|Lack of Efficacy|1|||
146392457|NCT03911401|527938770|FG002|Overall Study|Lack of Efficacy|8|||
146392458|NCT03911401|527938768|FG000|Overall Study|Physician Decision|0|||
146392459|NCT03911401|527938769|FG001|Overall Study|Physician Decision|0|||
146392460|NCT03911401|527938770|FG002|Overall Study|Physician Decision|1|||
146392461|NCT03911401|527938768|FG000|Overall Study|Withdrawal by Subject|1|||
146392462|NCT03911401|527938769|FG001|Overall Study|Withdrawal by Subject|2|||
146392463|NCT03911401|527938770|FG002|Overall Study|Withdrawal by Subject|0|||
146392464|NCT03911401|527938768|FG000|Overall Study|Withdrawal by parent/guardian|4|||
146392465|NCT03911401|527938769|FG001|Overall Study|Withdrawal by parent/guardian|4|||
146392466|NCT03911401|527938770|FG002|Overall Study|Withdrawal by parent/guardian|11|||
146392467|NCT06104423|527938773|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
146392468|NCT06104423|527938774|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
146392469|NCT06104423|527938775|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
146392470|NCT06104423|527938773|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
146392471|NCT06104423|527938774|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
146392472|NCT06104423|527938775|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
146392473|NCT02918968|527938776|FG000|1st Line AAT|Progressive disease|9|||
146392474|NCT02918968|527938777|FG001|1st Line AAT|Progressive disease|4|||
146392475|NCT02918968|527938776|FG000|1st Line AAT|Adverse Event|12|||
146392476|NCT02918968|527938777|FG001|1st Line AAT|Adverse Event|3|||
146392477|NCT02918968|527938776|FG000|1st Line AAT|Physician Decision|4|||
146392478|NCT02918968|527938777|FG001|1st Line AAT|Physician Decision|2|||
146392479|NCT02918968|527938776|FG000|1st Line AAT|Withdrawal by Subject|2|||
146392480|NCT02918968|527938777|FG001|1st Line AAT|Withdrawal by Subject|1|||
146392481|NCT02918968|527938776|FG000|1st Line AAT|Lost to Follow-up|0|||
146392482|NCT02918968|527938777|FG001|1st Line AAT|Lost to Follow-up|1|||
146392483|NCT02918968|527938776|FG000|1st Line AAT|Death|1|||
146392484|NCT02918968|527938777|FG001|1st Line AAT|Death|0|||
146392485|NCT02918968|527938776|FG000|1st Line AAT|Miscellaneous|1|||
146392486|NCT02918968|527938777|FG001|1st Line AAT|Miscellaneous|0|||
146392487|NCT02918968|527938776|FG000|2nd Line AAT|Progressive disease|21|||
146392488|NCT02918968|527938777|FG001|2nd Line AAT|Progressive disease|3|||
146392489|NCT02918968|527938776|FG000|2nd Line AAT|Adverse Event|2|||
146392490|NCT02918968|527938777|FG001|2nd Line AAT|Adverse Event|5|||
146392491|NCT02918968|527938776|FG000|2nd Line AAT|Physician Decision|0|||
146392492|NCT02918968|527938777|FG001|2nd Line AAT|Physician Decision|1|||
146392493|NCT02918968|527938776|FG000|2nd Line AAT|Withdrawal by Subject|2|||
146392494|NCT02918968|527938777|FG001|2nd Line AAT|Withdrawal by Subject|2|||
146392495|NCT02918968|527938776|FG000|2nd Line AAT|Death|0|||
146392496|NCT02918968|527938777|FG001|2nd Line AAT|Death|1|||
146392497|NCT01589185|527938778|FG000|Overall Study|Death|1|||
146392498|NCT01589185|527938779|FG001|Overall Study|Death|2|||
146392499|NCT01589185|527938780|FG002|Overall Study|Death|2|||
146392500|NCT01589185|527938781|FG003|Overall Study|Death|0|||
146392501|NCT01589185|527938782|FG004|Overall Study|Death|1|||
146392502|NCT01589185|527938778|FG000|Overall Study|Lost to Follow-up|1|||
146392503|NCT01589185|527938779|FG001|Overall Study|Lost to Follow-up|0|||
146392504|NCT01589185|527938780|FG002|Overall Study|Lost to Follow-up|2|||
146392505|NCT01589185|527938781|FG003|Overall Study|Lost to Follow-up|3|||
146392506|NCT01589185|527938782|FG004|Overall Study|Lost to Follow-up|0|||
146392507|NCT03172026|527938785|FG000|Overall Study|Withdrawal by Subject|1|||
146392508|NCT03172026|527938786|FG001|Overall Study|Withdrawal by Subject|0|||
146392509|NCT03172026|527938785|FG000|Overall Study|COVID restrictions|1|||
146392510|NCT03172026|527938786|FG001|Overall Study|COVID restrictions|0|||
146392511|NCT00504595|527938790|FG000|Overall Study|Lack of Efficacy|1|||
146392512|NCT00504595|527938791|FG001|Overall Study|Lack of Efficacy|0|||
146392513|NCT00504595|527938792|FG002|Overall Study|Lack of Efficacy|0|||
146392514|NCT00504595|527938793|FG003|Overall Study|Lack of Efficacy|0|||
146392515|NCT00504595|527938790|FG000|Overall Study|Other|0|||
146392516|NCT00504595|527938791|FG001|Overall Study|Other|0|||
146392517|NCT00504595|527938792|FG002|Overall Study|Other|2|||
146392518|NCT00504595|527938793|FG003|Overall Study|Other|0|||
146392519|NCT01258803|527938794|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146392520|NCT01258803|527938795|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146392521|NCT01258803|527938796|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146392522|NCT01258803|527938797|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146392523|NCT01258803|527938798|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
146392524|NCT01258803|527938799|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
146392525|NCT01258803|527938794|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146392526|NCT01258803|527938795|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
146392527|NCT01258803|527938796|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146392528|NCT01258803|527938797|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146392529|NCT01258803|527938798|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146392530|NCT01258803|527938799|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
146392531|NCT01258803|527938794|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146392532|NCT01258803|527938795|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146392533|NCT01258803|527938796|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
146392534|NCT01258803|527938797|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146392535|NCT01258803|527938798|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146392536|NCT01258803|527938799|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
146392537|NCT04652245|527938801|FG000|Wash-Out Period|Adverse Event|0|||
146392538|NCT04652245|527938802|FG001|Wash-Out Period|Adverse Event|2|||
146392539|NCT04652245|527938801|FG000|Wash-Out Period|Withdrawal by Subject|0|||
146392540|NCT04652245|527938802|FG001|Wash-Out Period|Withdrawal by Subject|2|||
146392541|NCT01552408|527938803|FG000|Overall Study|Lost to Follow-up|2|||
146392542|NCT01552408|527938804|FG001|Overall Study|Lost to Follow-up|0|||
146392543|NCT01552408|527938803|FG000|Overall Study|Relocation|0|||
146392544|NCT01552408|527938804|FG001|Overall Study|Relocation|1|||
146392545|NCT01552408|527938803|FG000|Overall Study|Withdrawal by Subject|2|||
146392546|NCT01552408|527938804|FG001|Overall Study|Withdrawal by Subject|1|||
146392547|NCT00851721|527938805|FG000|Overall Study|planned surgery|1|||
146392548|NCT00851721|527938806|FG001|Overall Study|planned surgery|0|||
146392549|NCT00851721|527938805|FG000|Overall Study|Death|1|||
146392550|NCT00851721|527938806|FG001|Overall Study|Death|0|||
146392551|NCT00851721|527938805|FG000|Overall Study|Adverse Event|0|||
146392552|NCT00851721|527938806|FG001|Overall Study|Adverse Event|1|||
146392553|NCT03604159|527938807|FG000|Overall Study|Lost to Follow-up|6|||
146392554|NCT03604159|527938808|FG001|Overall Study|Lost to Follow-up|7|||
146392555|NCT01303159|527938820|FG000|Overall Study|Death|16|||
146392556|NCT01303159|527938820|FG000|Overall Study|Study Termination|7|||
146392557|NCT01016912|527938821|FG000|End of Treatment Period|Lack of Efficacy|0|||
146392558|NCT01016912|527938822|FG001|End of Treatment Period|Lack of Efficacy|1|||
146392559|NCT01016912|527938823|FG002|End of Treatment Period|Lack of Efficacy|0|||
146392560|NCT01016912|527938824|FG003|End of Treatment Period|Lack of Efficacy|4|||
146392561|NCT01016912|527938825|FG004|End of Treatment Period|Lack of Efficacy|4|||
146392562|NCT01016912|527938821|FG000|End of Treatment Period|Adverse Event|0|||
146392563|NCT01016912|527938822|FG001|End of Treatment Period|Adverse Event|1|||
146392564|NCT01016912|527938823|FG002|End of Treatment Period|Adverse Event|1|||
146392565|NCT01016912|527938824|FG003|End of Treatment Period|Adverse Event|0|||
146392566|NCT01016912|527938825|FG004|End of Treatment Period|Adverse Event|0|||
146392567|NCT01016912|527938821|FG000|End of Treatment Period|Completed double-blind period only|0|||
146392568|NCT01016912|527938822|FG001|End of Treatment Period|Completed double-blind period only|1|||
146392569|NCT01016912|527938823|FG002|End of Treatment Period|Completed double-blind period only|0|||
146392570|NCT01016912|527938824|FG003|End of Treatment Period|Completed double-blind period only|0|||
146392571|NCT01016912|527938825|FG004|End of Treatment Period|Completed double-blind period only|0|||
146392572|NCT01016912|527938821|FG000|Follow-up Period|Other reason|0|||
146392573|NCT01016912|527938822|FG001|Follow-up Period|Other reason|0|||
146392574|NCT01016912|527938823|FG002|Follow-up Period|Other reason|1|||
146392575|NCT01016912|527938824|FG003|Follow-up Period|Other reason|1|||
146392576|NCT01016912|527938825|FG004|Follow-up Period|Other reason|0|||
146392577|NCT00914940|527938829|FG000|D0 to D100 Post-transplant|Death|2|||
146392578|NCT00914940|527938829|FG000|D101 to 2 Years Post-transplant|Death|8|||
146392579|NCT00914940|527938829|FG000|2 Years to 5 Years Post-transplant|Death|3|||
146392580|NCT00496782|527938830|FG000|Overall Study|Protocol Violation|1|||
146392581|NCT00496782|527938831|FG001|Overall Study|Protocol Violation|2|||
146392582|NCT00760994|527938836|FG000|Overall Study|Lost to Follow-up|4|||
146392583|NCT00760994|527938837|FG001|Overall Study|Lost to Follow-up|4|||
146392584|NCT00760994|527938838|FG002|Overall Study|Lost to Follow-up|3|||
146392585|NCT02431559|527938839|FG000|Overall Study|Adverse Event|0|||
146392586|NCT02431559|527938840|FG001|Overall Study|Adverse Event|1|||
146392587|NCT02431559|527938841|FG002|Overall Study|Adverse Event|0|||
146392588|NCT02431559|527938842|FG003|Overall Study|Adverse Event|4|||
146392589|NCT02431559|527938839|FG000|Overall Study|Progressive disease|2|||
146392590|NCT02431559|527938840|FG001|Overall Study|Progressive disease|1|||
146392591|NCT02431559|527938841|FG002|Overall Study|Progressive disease|4|||
146392592|NCT02431559|527938842|FG003|Overall Study|Progressive disease|22|||
146392593|NCT02431559|527938839|FG000|Overall Study|Withdrawal by Subject|0|||
146392594|NCT02431559|527938840|FG001|Overall Study|Withdrawal by Subject|1|||
146392595|NCT02431559|527938841|FG002|Overall Study|Withdrawal by Subject|0|||
146392596|NCT02431559|527938842|FG003|Overall Study|Withdrawal by Subject|4|||
146392597|NCT02431559|527938839|FG000|Overall Study|Physician Decision|0|||
146392598|NCT02431559|527938840|FG001|Overall Study|Physician Decision|0|||
146392599|NCT02431559|527938841|FG002|Overall Study|Physician Decision|0|||
146392600|NCT02431559|527938842|FG003|Overall Study|Physician Decision|1|||
146392601|NCT00955682|527938848|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
146392602|NCT00955682|527938849|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
146392603|NCT02260791|527938856|FG000|Overall Study|Lost to Follow-up|4|||
146392604|NCT02260791|527938857|FG001|Overall Study|Lost to Follow-up|4|||
146392605|NCT02260791|527938856|FG000|Overall Study|Lack of Efficacy|2|||
146392606|NCT02260791|527938857|FG001|Overall Study|Lack of Efficacy|1|||
146392607|NCT02260791|527938856|FG000|Overall Study|Adverse Event|13|||
146392608|NCT02260791|527938857|FG001|Overall Study|Adverse Event|9|||
146392609|NCT02260791|527938856|FG000|Overall Study|Death|1|||
146392610|NCT02260791|527938857|FG001|Overall Study|Death|0|||
146392611|NCT02260791|527938856|FG000|Overall Study|Withdrawal by Subject|11|||
146392612|NCT02260791|527938857|FG001|Overall Study|Withdrawal by Subject|16|||
146392613|NCT02260791|527938856|FG000|Overall Study|Screen failure|0|||
146392614|NCT02260791|527938857|FG001|Overall Study|Screen failure|1|||
146392615|NCT02260791|527938856|FG000|Overall Study|Protocol deviation|2|||
146392616|NCT02260791|527938857|FG001|Overall Study|Protocol deviation|3|||
146392617|NCT02924129|527938858|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
146392618|NCT02924129|527938859|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
146392619|NCT02924129|527938858|FG000|Overall Study|Withdrawal by Subject|2|||
146392620|NCT02924129|527938859|FG001|Overall Study|Withdrawal by Subject|2|||
146392621|NCT02924129|527938858|FG000|Overall Study|Physician Decision|1|||
146392622|NCT02924129|527938859|FG001|Overall Study|Physician Decision|0|||
146392623|NCT02924129|527938858|FG000|Overall Study|Missed Visit|0|||
146392624|NCT02924129|527938859|FG001|Overall Study|Missed Visit|1|||
146392625|NCT01348828|527938866|FG000|Overall Study|Death|20|||
146392626|NCT01348828|527938866|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
146392627|NCT01348828|527938866|FG000|Overall Study|Conversion|2|||
146392628|NCT01348828|527938866|FG000|Overall Study|missed visit|1|||
146392629|NCT02442284|527938869|FG000|Overall Study|Adverse Event|1|||
146392630|NCT02442284|527938869|FG000|Overall Study|Withdrew Consent|2|||
146392631|NCT02442284|527938869|FG000|Overall Study|Lost to Follow-up|3|||
146392632|NCT02442284|527938869|FG000|Overall Study|Other|1|||
146392633|NCT02815670|527938870|FG000|Overall Study|Prematurely discontinued of the trial|1|||
146392634|NCT03137173|527938871|FG000|Overall Study|Withdrawal by Subject|8|||
146392635|NCT03137173|527938872|FG001|Overall Study|Withdrawal by Subject|13|||
146392636|NCT03137173|527938871|FG000|Overall Study|Death|1|||
146392637|NCT03137173|527938872|FG001|Overall Study|Death|3|||
146392638|NCT03137173|527938871|FG000|Overall Study|Physician Decision|1|||
146392639|NCT03137173|527938872|FG001|Overall Study|Physician Decision|0|||
146392640|NCT03137173|527938871|FG000|Overall Study|Lost to Follow-up|13|||
146392641|NCT03137173|527938872|FG001|Overall Study|Lost to Follow-up|18|||
146392642|NCT03137173|527938871|FG000|Overall Study|Other reasons|3|||
146392643|NCT03137173|527938872|FG001|Overall Study|Other reasons|2|||
146392644|NCT01365468|527938873|FG000|Overall Study|Physician Decision|1|||
146392645|NCT01365468|527938874|FG001|Overall Study|Physician Decision|0|||
146392646|NCT01365468|527938873|FG000|Overall Study|Disease progression|1|||
146392647|NCT01365468|527938874|FG001|Overall Study|Disease progression|0|||
146392648|NCT01365468|527938873|FG000|Overall Study|Lost to Follow-up|2|||
146392649|NCT01365468|527938874|FG001|Overall Study|Lost to Follow-up|0|||
146392650|NCT00842829|527938875|FG000|Dose Titration Period|Adverse Event|11|||
146392651|NCT00842829|527938876|FG001|Dose Titration Period|Adverse Event|10|||
146392652|NCT00842829|527938877|FG002|Dose Titration Period|Adverse Event|0|||
146392653|NCT00842829|527938875|FG000|Dose Titration Period|Lack of Efficacy|4|||
146392654|NCT00842829|527938876|FG001|Dose Titration Period|Lack of Efficacy|1|||
146392655|NCT00842829|527938877|FG002|Dose Titration Period|Lack of Efficacy|0|||
146392656|NCT00842829|527938875|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
146392657|NCT00842829|527938876|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
146392658|NCT00842829|527938877|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
146392659|NCT00842829|527938875|FG000|Dose Titration Period|Withdrawal by Subject|2|||
146392660|NCT00842829|527938876|FG001|Dose Titration Period|Withdrawal by Subject|6|||
146392661|NCT00842829|527938877|FG002|Dose Titration Period|Withdrawal by Subject|0|||
146392662|NCT00842829|527938875|FG000|Dose Titration Period|Other|5|||
146392663|NCT00842829|527938876|FG001|Dose Titration Period|Other|4|||
146392664|NCT00842829|527938877|FG002|Dose Titration Period|Other|0|||
146392665|NCT00842829|527938875|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
146392666|NCT00842829|527938876|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
146392667|NCT00842829|527938877|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
146392668|NCT00842829|527938875|FG000|Dose Titration Period|Non-compliance to study drug|2|||
146392669|NCT00842829|527938876|FG001|Dose Titration Period|Non-compliance to study drug|1|||
146392670|NCT00842829|527938877|FG002|Dose Titration Period|Non-compliance to study drug|0|||
146392671|NCT00842829|527938875|FG000|Treatment Period|Adverse Event|0|||
146392672|NCT00842829|527938876|FG001|Treatment Period|Adverse Event|0|||
146392673|NCT00842829|527938877|FG002|Treatment Period|Adverse Event|15|||
146392674|NCT00842829|527938875|FG000|Treatment Period|Lack of Efficacy|0|||
146392675|NCT00842829|527938876|FG001|Treatment Period|Lack of Efficacy|0|||
146392676|NCT00842829|527938877|FG002|Treatment Period|Lack of Efficacy|6|||
146392677|NCT00842829|527938875|FG000|Treatment Period|Unstable persistent cancer pain|0|||
146392678|NCT00842829|527938876|FG001|Treatment Period|Unstable persistent cancer pain|0|||
146392679|NCT00842829|527938877|FG002|Treatment Period|Unstable persistent cancer pain|5|||
146392680|NCT00842829|527938875|FG000|Treatment Period|Withdrawal by Subject|0|||
146392681|NCT00842829|527938876|FG001|Treatment Period|Withdrawal by Subject|0|||
146392682|NCT00842829|527938877|FG002|Treatment Period|Withdrawal by Subject|11|||
146392683|NCT00842829|527938875|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
146392684|NCT00842829|527938876|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
146392685|NCT00842829|527938877|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
146392686|NCT00842829|527938875|FG000|Treatment Period|Protocol Violation|0|||
146392687|NCT00842829|527938876|FG001|Treatment Period|Protocol Violation|0|||
146392688|NCT00842829|527938877|FG002|Treatment Period|Protocol Violation|2|||
146392689|NCT00842829|527938875|FG000|Treatment Period|Other|0|||
146392690|NCT00842829|527938876|FG001|Treatment Period|Other|0|||
146392691|NCT00842829|527938877|FG002|Treatment Period|Other|18|||
146392692|NCT00842829|527938875|FG000|Treatment Period|Non-compliance to study procedures|0|||
146392693|NCT00842829|527938876|FG001|Treatment Period|Non-compliance to study procedures|0|||
146392694|NCT00842829|527938877|FG002|Treatment Period|Non-compliance to study procedures|4|||
146392695|NCT00842829|527938875|FG000|Treatment Period|Unclear completion status|0|||
146392696|NCT00842829|527938876|FG001|Treatment Period|Unclear completion status|0|||
146392697|NCT00842829|527938877|FG002|Treatment Period|Unclear completion status|1|||
146392698|NCT00842829|527938875|FG000|Continuation Period|Adverse Event|0|||
146392699|NCT00842829|527938876|FG001|Continuation Period|Adverse Event|0|||
146392700|NCT00842829|527938877|FG002|Continuation Period|Adverse Event|32|||
146392701|NCT00842829|527938875|FG000|Continuation Period|Lack of Efficacy|0|||
146392702|NCT00842829|527938876|FG001|Continuation Period|Lack of Efficacy|0|||
146392703|NCT00842829|527938877|FG002|Continuation Period|Lack of Efficacy|6|||
146392704|NCT00842829|527938875|FG000|Continuation Period|Unstable persistent cancer pain|0|||
146392705|NCT00842829|527938876|FG001|Continuation Period|Unstable persistent cancer pain|0|||
146392706|NCT00842829|527938877|FG002|Continuation Period|Unstable persistent cancer pain|3|||
146392707|NCT00842829|527938875|FG000|Continuation Period|Withdrawal by Subject|0|||
146392708|NCT00842829|527938876|FG001|Continuation Period|Withdrawal by Subject|0|||
146392709|NCT00842829|527938877|FG002|Continuation Period|Withdrawal by Subject|10|||
146392710|NCT00842829|527938875|FG000|Continuation Period|Other|0|||
146392711|NCT00842829|527938876|FG001|Continuation Period|Other|0|||
146392712|NCT00842829|527938877|FG002|Continuation Period|Other|7|||
146392713|NCT00842829|527938875|FG000|Continuation Period|Non-compliance to study procedures|0|||
146392714|NCT00842829|527938876|FG001|Continuation Period|Non-compliance to study procedures|0|||
146392715|NCT00842829|527938877|FG002|Continuation Period|Non-compliance to study procedures|2|||
146392716|NCT00842829|527938875|FG000|Continuation Period|Non-compliance to study drug|0|||
146392717|NCT00842829|527938876|FG001|Continuation Period|Non-compliance to study drug|0|||
146392718|NCT00842829|527938877|FG002|Continuation Period|Non-compliance to study drug|1|||
146392719|NCT01002573|527941194|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
146392720|NCT01002573|527941195|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
146392721|NCT00690612|527941201|FG000|Overall Study|Adverse Event|1|||
146392722|NCT00690612|527941201|FG000|Overall Study|Withdrawal by Subject|2|||
146392723|NCT02926833|527941202|FG000|Overall Study|Death|1|||
146392724|NCT02926833|527941203|FG001|Overall Study|Death|1|||
146392725|NCT02926833|527941204|FG002|Overall Study|Death|2|||
146392726|NCT02926833|527941205|FG003|Overall Study|Death|13|||
146392727|NCT02926833|527941202|FG000|Overall Study|Lost to Follow-up|1|||
146392728|NCT02926833|527941203|FG001|Overall Study|Lost to Follow-up|2|||
146392729|NCT02926833|527941204|FG002|Overall Study|Lost to Follow-up|0|||
146392730|NCT02926833|527941205|FG003|Overall Study|Lost to Follow-up|3|||
146392731|NCT02926833|527941202|FG000|Overall Study|Full Consent Withdrawal|0|||
146392732|NCT02926833|527941203|FG001|Overall Study|Full Consent Withdrawal|0|||
146392733|NCT02926833|527941204|FG002|Overall Study|Full Consent Withdrawal|0|||
146392734|NCT02926833|527941205|FG003|Overall Study|Full Consent Withdrawal|2|||
146392735|NCT02926833|527941202|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
146392736|NCT02926833|527941203|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
146392737|NCT02926833|527941204|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
146392738|NCT02926833|527941205|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
146392739|NCT02926833|527941202|FG000|Overall Study|Investigator Decision|0|||
146392740|NCT02926833|527941203|FG001|Overall Study|Investigator Decision|1|||
146392741|NCT02926833|527941204|FG002|Overall Study|Investigator Decision|0|||
146392742|NCT02926833|527941205|FG003|Overall Study|Investigator Decision|0|||
146392743|NCT02926833|527941202|FG000|Overall Study|Adverse Event|0|||
146392744|NCT02926833|527941203|FG001|Overall Study|Adverse Event|0|||
146392745|NCT02926833|527941204|FG002|Overall Study|Adverse Event|1|||
146392746|NCT02926833|527941205|FG003|Overall Study|Adverse Event|0|||
146392747|NCT02926833|527941202|FG000|Overall Study|Partial Withdrawal of Consent|0|||
146392748|NCT02926833|527941203|FG001|Overall Study|Partial Withdrawal of Consent|0|||
146392749|NCT02926833|527941204|FG002|Overall Study|Partial Withdrawal of Consent|0|||
146392750|NCT02926833|527941205|FG003|Overall Study|Partial Withdrawal of Consent|1|||
146392751|NCT01945866|527941206|FG000|Overall Study|Eyes did not complete or were dropped|2|||
146392752|NCT01945866|527941207|FG001|Overall Study|Eyes did not complete or were dropped|0|||
146392753|NCT00346775|527941212|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
146392754|NCT00346775|527941213|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
146392755|NCT00346775|527941212|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
146392756|NCT00346775|527941213|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
146392757|NCT00346775|527941212|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
146392758|NCT00346775|527941213|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
146392759|NCT02946515|527941214|FG000|Overall Study|Lost to Follow-up|2|||
146392760|NCT02946515|527941215|FG001|Overall Study|Lost to Follow-up|1|||
146392761|NCT03410693|527941218|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
146392762|NCT03410693|527941219|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
146392763|NCT03410693|527941218|FG000|Overall Study|Disc trt: Lost to follow up|0|||
146392764|NCT03410693|527941219|FG001|Overall Study|Disc trt: Lost to follow up|1|||
146392765|NCT03410693|527941218|FG000|Overall Study|Disc trt: radiological progression|58|||
146392766|NCT03410693|527941219|FG001|Overall Study|Disc trt: radiological progression|50|||
146392767|NCT03410693|527941218|FG000|Overall Study|Disc trt: Other|1|||
146392768|NCT03410693|527941219|FG001|Overall Study|Disc trt: Other|0|||
146392769|NCT03410693|527941218|FG000|Overall Study|Study drug never administered|1|||
146392770|NCT03410693|527941219|FG001|Overall Study|Study drug never administered|6|||
146392771|NCT03410693|527941218|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
146392772|NCT03410693|527941219|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
146392773|NCT03410693|527941218|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
146392774|NCT03410693|527941219|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
146392775|NCT03410693|527941218|FG000|Overall Study|Disc trt: Physician decision|0|||
146392776|NCT03410693|527941219|FG001|Overall Study|Disc trt: Physician decision|5|||
146392777|NCT03410693|527941218|FG000|Overall Study|Disc trt: clinical progression|1|||
146392778|NCT03410693|527941219|FG001|Overall Study|Disc trt: clinical progression|5|||
146392779|NCT03410693|527941218|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
146392780|NCT03410693|527941219|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
146392781|NCT01789476|527941220|FG000|Overall Study|Lack of Efficacy|6|||
146392782|NCT01789476|527941221|FG001|Overall Study|Lack of Efficacy|2|||
146392783|NCT01789476|527941220|FG000|Overall Study|Adverse Event|1|||
146392784|NCT01789476|527941221|FG001|Overall Study|Adverse Event|0|||
146392785|NCT01789476|527941220|FG000|Overall Study|Unable to get IV access|1|||
146392786|NCT01789476|527941221|FG001|Overall Study|Unable to get IV access|0|||
146392787|NCT00953576|527941222|FG000|Overall Study|Adverse Event|0|||
146392788|NCT00953576|527941223|FG001|Overall Study|Adverse Event|1|||
146392789|NCT00953576|527941222|FG000|Overall Study|Ineligible after Consent|2|||
146392790|NCT00953576|527941223|FG001|Overall Study|Ineligible after Consent|0|||
146392791|NCT00501969|527941224|FG000|Overall Study|Major Protocol Violation|4|||
146392792|NCT00501969|527941224|FG000|Overall Study|Lack of Efficacy|29|||
146392793|NCT00501969|527941224|FG000|Overall Study|Adverse Event|76|||
146392794|NCT00501969|527941224|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
146392795|NCT00501969|527941224|FG000|Overall Study|Subject withdrew consent|51|||
146392796|NCT00501969|527941224|FG000|Overall Study|Lost to Follow-up|4|||
146392797|NCT00501969|527941224|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
146392798|NCT00501969|527941224|FG000|Overall Study|Other: Sponsors Request|10|||
146392799|NCT00501969|527941224|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
146392800|NCT00501969|527941224|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
146392801|NCT00501969|527941224|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
146392802|NCT00501969|527941224|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
146392803|NCT00501969|527941224|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
146392804|NCT00501969|527941224|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
146392805|NCT00501969|527941224|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
146392806|NCT00501969|527941224|FG000|Overall Study|Other: As Required by Local EC|2|||
146392807|NCT00501969|527941224|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
146392808|NCT00501969|527941224|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
146392809|NCT00665366|527941227|FG000|Overall Study|Lack of Efficacy|11|||
146392810|NCT00665366|527941228|FG001|Overall Study|Lack of Efficacy|10|||
146392811|NCT00665366|527941227|FG000|Overall Study|Adverse Event|25|||
146392812|NCT00665366|527941228|FG001|Overall Study|Adverse Event|23|||
146392813|NCT00665366|527941227|FG000|Overall Study|Withdrawal by Subject|11|||
146392814|NCT00665366|527941228|FG001|Overall Study|Withdrawal by Subject|14|||
146392815|NCT00665366|527941227|FG000|Overall Study|Lost to Follow-up|3|||
146392816|NCT00665366|527941228|FG001|Overall Study|Lost to Follow-up|5|||
146392817|NCT00665366|527941227|FG000|Overall Study|Poor compliance/noncompliance|3|||
146392818|NCT00665366|527941228|FG001|Overall Study|Poor compliance/noncompliance|5|||
146392819|NCT00665366|527941227|FG000|Overall Study|Pregnancy|1|||
146392820|NCT00665366|527941228|FG001|Overall Study|Pregnancy|0|||
146392821|NCT00665366|527941227|FG000|Overall Study|No longer meets study criteria|0|||
146392822|NCT00665366|527941228|FG001|Overall Study|No longer meets study criteria|1|||
146392823|NCT00665366|527941227|FG000|Overall Study|Other reasons|4|||
146392824|NCT00665366|527941228|FG001|Overall Study|Other reasons|1|||
146392825|NCT03039686|527941234|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
146392826|NCT03039686|527941235|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
146392827|NCT03039686|527941236|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
146392828|NCT03039686|527941234|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
146392829|NCT03039686|527941235|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
146392830|NCT03039686|527941236|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
146392831|NCT03039686|527941234|FG000|Double-blind Period|Withdrawal by Subject|2|||
146392832|NCT03039686|527941235|FG001|Double-blind Period|Withdrawal by Subject|2|||
146392833|NCT03039686|527941236|FG002|Double-blind Period|Withdrawal by Subject|1|||
146392834|NCT03039686|527941234|FG000|Double-blind Period|Death|0|||
146392835|NCT03039686|527941235|FG001|Double-blind Period|Death|0|||
146392836|NCT03039686|527941236|FG002|Double-blind Period|Death|1|||
146392837|NCT03039686|527941234|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
146392838|NCT03039686|527941235|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
146392839|NCT03039686|527941236|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
146392840|NCT03039686|527941234|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
146392841|NCT03039686|527941235|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
146392842|NCT03039686|527941236|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
146392843|NCT03039686|527941234|FG000|Open Label Period|Withdrawal by Subject|0|||
146392844|NCT03039686|527941235|FG001|Open Label Period|Withdrawal by Subject|3|||
146392845|NCT03039686|527941236|FG002|Open Label Period|Withdrawal by Subject|1|||
146392846|NCT00285857|527941240|FG000|Overall Study|Withdrawal by Subject|2|||
146392847|NCT00285857|527941240|FG000|Overall Study|Inadequate initial breast cytology|1|||
146392848|NCT00285857|527941240|FG000|Overall Study|Adverse Event|1|||
146392849|NCT05602818|527941241|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
146392850|NCT05602818|527941242|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
146392851|NCT05602818|527941243|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
146392852|NCT05602818|527941244|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
146392853|NCT05602818|527941245|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
146392854|NCT05602818|527941246|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
146392855|NCT05602818|527941247|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
146392856|NCT05602818|527941248|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
146392857|NCT05602818|527941249|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
146392858|NCT05602818|527941250|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
146392859|NCT05602818|527941251|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
146392860|NCT05602818|527941252|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
146392861|NCT05602818|527941241|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
146392862|NCT05602818|527941242|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
146392863|NCT05602818|527941243|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392864|NCT05602818|527941244|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392865|NCT05602818|527941245|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392866|NCT05602818|527941246|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392867|NCT05602818|527941247|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146056281|NCT00626275|526721161|FG001|Part B|Withdrawal by Subject|0|||
146392868|NCT05602818|527941248|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392869|NCT05602818|527941249|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392870|NCT05602818|527941250|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392871|NCT05602818|527941251|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392872|NCT05602818|527941252|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
146392873|NCT05602818|527941241|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
146392874|NCT05602818|527941242|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392875|NCT05602818|527941243|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392876|NCT05602818|527941244|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392877|NCT05602818|527941245|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392878|NCT05602818|527941246|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392879|NCT05602818|527941247|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392880|NCT05602818|527941248|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392881|NCT05602818|527941249|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392882|NCT05602818|527941250|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392883|NCT05602818|527941251|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392884|NCT05602818|527941252|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
146392885|NCT05602818|527941241|FG000|Qualification Phase (3 Days)|Other|1|||
146392886|NCT05602818|527941242|FG001|Qualification Phase (3 Days)|Other|0|||
146392887|NCT05602818|527941243|FG002|Qualification Phase (3 Days)|Other|0|||
146392888|NCT05602818|527941244|FG003|Qualification Phase (3 Days)|Other|0|||
146392889|NCT05602818|527941245|FG004|Qualification Phase (3 Days)|Other|0|||
146392890|NCT05602818|527941246|FG005|Qualification Phase (3 Days)|Other|0|||
146392891|NCT05602818|527941247|FG006|Qualification Phase (3 Days)|Other|0|||
146392892|NCT05602818|527941248|FG007|Qualification Phase (3 Days)|Other|0|||
146392893|NCT05602818|527941249|FG008|Qualification Phase (3 Days)|Other|0|||
146392894|NCT05602818|527941250|FG009|Qualification Phase (3 Days)|Other|0|||
146392895|NCT05602818|527941251|FG010|Qualification Phase (3 Days)|Other|0|||
146392896|NCT05602818|527941252|FG011|Qualification Phase (3 Days)|Other|0|||
146392897|NCT05602818|527941241|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392898|NCT05602818|527941242|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
146392899|NCT05602818|527941243|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392900|NCT05602818|527941244|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392901|NCT05602818|527941245|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392902|NCT05602818|527941246|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392903|NCT05602818|527941247|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392904|NCT05602818|527941248|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392905|NCT05602818|527941249|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392906|NCT05602818|527941250|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392907|NCT05602818|527941251|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392908|NCT05602818|527941252|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
146392909|NCT05602818|527941241|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
146392910|NCT05602818|527941242|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
146392911|NCT05602818|527941243|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
146392912|NCT05602818|527941244|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
146392913|NCT05602818|527941245|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
146392914|NCT05602818|527941246|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
146392915|NCT05602818|527941247|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
146392916|NCT05602818|527941248|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
146392917|NCT05602818|527941249|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
146392918|NCT05602818|527941250|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
146392919|NCT05602818|527941251|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
146392920|NCT05602818|527941252|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
146392921|NCT05602818|527941241|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392922|NCT05602818|527941242|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392923|NCT05602818|527941243|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392924|NCT05602818|527941244|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392925|NCT05602818|527941245|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392926|NCT05602818|527941246|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392927|NCT05602818|527941247|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392928|NCT05602818|527941248|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392929|NCT05602818|527941249|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392930|NCT05602818|527941250|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
146392931|NCT05602818|527941251|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
146392932|NCT05602818|527941252|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
146392933|NCT05602818|527941241|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
146392934|NCT05602818|527941242|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
146392935|NCT05602818|527941243|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
146392936|NCT05602818|527941244|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
146056282|NCT00626275|526721162|FG002|Part B|Withdrawal by Subject|0|||
146392937|NCT05602818|527941245|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
146392938|NCT05602818|527941246|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
146392939|NCT05602818|527941247|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
146392940|NCT05602818|527941248|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
146392941|NCT05602818|527941249|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
146392942|NCT05602818|527941250|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
146392943|NCT05602818|527941251|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
146392944|NCT05602818|527941252|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
146392945|NCT00727246|527941253|FG000|Overall Study|could not complete MRI|0|||
146392946|NCT00727246|527941254|FG001|Overall Study|could not complete MRI|1|||
146392947|NCT00727246|527941255|FG002|Overall Study|could not complete MRI|0|||
146392948|NCT00727246|527941256|FG003|Overall Study|could not complete MRI|1|||
146392949|NCT00727246|527941253|FG000|Overall Study|incidental finding|0|||
146392950|NCT00727246|527941254|FG001|Overall Study|incidental finding|0|||
146392951|NCT00727246|527941255|FG002|Overall Study|incidental finding|0|||
146392952|NCT00727246|527941256|FG003|Overall Study|incidental finding|1|||
146392953|NCT00727246|527941253|FG000|Overall Study|withdrawn|0|||
146392954|NCT00727246|527941254|FG001|Overall Study|withdrawn|0|||
146392955|NCT00727246|527941255|FG002|Overall Study|withdrawn|1|||
146392956|NCT00727246|527941256|FG003|Overall Study|withdrawn|0|||
146392957|NCT03814499|527941257|FG000|Overall Study|Lost to Follow-up|3|||
146392958|NCT00351611|527941258|FG000|Overall Study|Adverse Event|11|||
146392959|NCT00351611|527941259|FG001|Overall Study|Adverse Event|3|||
146392960|NCT00351611|527941258|FG000|Overall Study|Death|1|||
146392961|NCT00351611|527941259|FG001|Overall Study|Death|0|||
146392962|NCT00351611|527941258|FG000|Overall Study|Lost to Follow-up|1|||
146392963|NCT00351611|527941259|FG001|Overall Study|Lost to Follow-up|0|||
146392964|NCT00351611|527941258|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
146392965|NCT00351611|527941259|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
146392966|NCT00351611|527941258|FG000|Overall Study|Other|1|||
146392967|NCT00351611|527941259|FG001|Overall Study|Other|0|||
146392968|NCT00351611|527941258|FG000|Overall Study|Protocol Violation|0|||
146392969|NCT00351611|527941259|FG001|Overall Study|Protocol Violation|2|||
146392970|NCT02046993|527941260|FG000|Overall Study|Withdrawal by Subject|2|||
146392971|NCT02046993|527941261|FG001|Overall Study|Withdrawal by Subject|10|||
146392972|NCT02046993|527941260|FG000|Overall Study|Lost to Follow-up|1|||
146392973|NCT02046993|527941261|FG001|Overall Study|Lost to Follow-up|1|||
146392974|NCT00598442|527941262|FG000|Overall Study|Adverse Event|3|||
146392975|NCT00598442|527941263|FG001|Overall Study|Adverse Event|0|||
146392976|NCT00598442|527941264|FG002|Overall Study|Adverse Event|0|||
146392977|NCT00598442|527941262|FG000|Overall Study|Death|19|||
146392978|NCT00598442|527941263|FG001|Overall Study|Death|11|||
146392979|NCT00598442|527941264|FG002|Overall Study|Death|11|||
146392980|NCT00598442|527941262|FG000|Overall Study|Lost to Follow-up|4|||
146392981|NCT00598442|527941263|FG001|Overall Study|Lost to Follow-up|3|||
146392982|NCT00598442|527941264|FG002|Overall Study|Lost to Follow-up|3|||
146392983|NCT00598442|527941262|FG000|Overall Study|Physician Decision|2|||
146392984|NCT00598442|527941263|FG001|Overall Study|Physician Decision|1|||
146392985|NCT00598442|527941264|FG002|Overall Study|Physician Decision|1|||
146392986|NCT00598442|527941262|FG000|Overall Study|Withdrawal by Subject|8|||
146392987|NCT00598442|527941263|FG001|Overall Study|Withdrawal by Subject|16|||
146392988|NCT00598442|527941264|FG002|Overall Study|Withdrawal by Subject|6|||
146392989|NCT00598442|527941262|FG000|Overall Study|Noncompliance|0|||
146392990|NCT00598442|527941263|FG001|Overall Study|Noncompliance|2|||
146392991|NCT00598442|527941264|FG002|Overall Study|Noncompliance|1|||
146392992|NCT00598442|527941262|FG000|Overall Study|Relocation|1|||
146392993|NCT00598442|527941263|FG001|Overall Study|Relocation|4|||
146392994|NCT00598442|527941264|FG002|Overall Study|Relocation|0|||
146392995|NCT00598442|527941262|FG000|Overall Study|Renal transplant|0|||
146392996|NCT00598442|527941263|FG001|Overall Study|Renal transplant|0|||
146392997|NCT00598442|527941264|FG002|Overall Study|Renal transplant|1|||
146392998|NCT00598442|527941262|FG000|Overall Study|Site closed by sponsor|5|||
146392999|NCT00598442|527941263|FG001|Overall Study|Site closed by sponsor|2|||
146393000|NCT00598442|527941264|FG002|Overall Study|Site closed by sponsor|1|||
146393001|NCT00598442|527941262|FG000|Overall Study|Started dialysis|1|||
146393002|NCT00598442|527941263|FG001|Overall Study|Started dialysis|0|||
146393003|NCT00598442|527941264|FG002|Overall Study|Started dialysis|0|||
146393004|NCT00462501|527941275|FG000|Overall Study|Not treated|3|||
146393005|NCT00462501|527941275|FG000|Overall Study|Adverse Event|2|||
146393006|NCT00267202|527941284|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
146393007|NCT00267202|527941285|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
146393008|NCT00267202|527941284|FG000|Overall Study|Withdrawal by Subject|12|||
146393009|NCT00267202|527941285|FG001|Overall Study|Withdrawal by Subject|15|||
146393010|NCT00267202|527941284|FG000|Overall Study|Adverse Event|13|||
146393011|NCT00267202|527941285|FG001|Overall Study|Adverse Event|7|||
146393012|NCT00267202|527941284|FG000|Overall Study|Protocol Violation|2|||
146393013|NCT00267202|527941285|FG001|Overall Study|Protocol Violation|3|||
146393014|NCT00267202|527941284|FG000|Overall Study|Administrative problems|2|||
146393015|NCT00267202|527941285|FG001|Overall Study|Administrative problems|1|||
146393016|NCT00267202|527941284|FG000|Overall Study|Lost to Follow-up|3|||
146393017|NCT00267202|527941285|FG001|Overall Study|Lost to Follow-up|0|||
146393018|NCT00399542|527941286|FG000|Overall Study|Adverse Event|18|||
146393019|NCT00399542|527941287|FG001|Overall Study|Adverse Event|15|||
146393020|NCT00399542|527941286|FG000|Overall Study|Protocol Violation|13|||
146393021|NCT00399542|527941287|FG001|Overall Study|Protocol Violation|3|||
146393022|NCT00399542|527941286|FG000|Overall Study|Withdrawal by Subject|28|||
146393023|NCT00399542|527941287|FG001|Overall Study|Withdrawal by Subject|10|||
146393024|NCT00399542|527941286|FG000|Overall Study|Lack of Efficacy|18|||
146393025|NCT00399542|527941287|FG001|Overall Study|Lack of Efficacy|8|||
146393026|NCT00399542|527941286|FG000|Overall Study|Lost to Follow-up|6|||
146393027|NCT00399542|527941287|FG001|Overall Study|Lost to Follow-up|6|||
146393028|NCT00399542|527941286|FG000|Overall Study|Other|1|||
146393029|NCT00399542|527941287|FG001|Overall Study|Other|0|||
146393030|NCT00399542|527941286|FG000|Overall Study|Physician Decision|0|||
146393031|NCT00399542|527941287|FG001|Overall Study|Physician Decision|1|||
146393032|NCT00612456|527941288|FG000|Overall Study|Adverse Event|1|||
146393033|NCT00612456|527941289|FG001|Overall Study|Adverse Event|0|||
146393034|NCT00612456|527941290|FG002|Overall Study|Adverse Event|0|||
146393035|NCT00612456|527941288|FG000|Overall Study|Lack of Efficacy|1|||
146393036|NCT00612456|527941289|FG001|Overall Study|Lack of Efficacy|1|||
146393037|NCT00612456|527941290|FG002|Overall Study|Lack of Efficacy|0|||
146393038|NCT00612456|527941288|FG000|Overall Study|Withdrawal by Subject|0|||
146393039|NCT00612456|527941289|FG001|Overall Study|Withdrawal by Subject|1|||
146393040|NCT00612456|527941290|FG002|Overall Study|Withdrawal by Subject|0|||
146393041|NCT00334893|527941291|FG000|Overall Study|Not Treated|1|||
146393042|NCT00334893|527941292|FG001|Overall Study|Not Treated|0|||
146393043|NCT00383292|527941297|FG000|Overall Study|Adverse Event|4|||
146393044|NCT00383292|527941298|FG001|Overall Study|Adverse Event|1|||
146393045|NCT00383292|527941299|FG002|Overall Study|Adverse Event|2|||
146393046|NCT00383292|527941297|FG000|Overall Study|Death|3|||
146393047|NCT00383292|527941298|FG001|Overall Study|Death|3|||
146393048|NCT00383292|527941299|FG002|Overall Study|Death|3|||
146393049|NCT00383292|527941297|FG000|Overall Study|Physician Decision|4|||
146393050|NCT00383292|527941298|FG001|Overall Study|Physician Decision|0|||
146393051|NCT00383292|527941299|FG002|Overall Study|Physician Decision|1|||
146393052|NCT00383292|527941297|FG000|Overall Study|Withdrawal by Subject|3|||
146393053|NCT00383292|527941298|FG001|Overall Study|Withdrawal by Subject|2|||
146393054|NCT00383292|527941299|FG002|Overall Study|Withdrawal by Subject|2|||
146393055|NCT00383292|527941297|FG000|Overall Study|Other|1|||
146393056|NCT00383292|527941298|FG001|Overall Study|Other|0|||
146393057|NCT00383292|527941299|FG002|Overall Study|Other|0|||
146393058|NCT04533204|527941300|FG000|Overall Study|Unable to understand training instructions|1|||
146393059|NCT04533204|527941301|FG001|Overall Study|Unable to understand training instructions|1|||
146393060|NCT00660829|527941302|FG000|Overall Study|Adverse Event|3|||
146393061|NCT00660829|527941303|FG001|Overall Study|Adverse Event|4|||
146393062|NCT00660829|527941302|FG000|Overall Study|Lack of Efficacy|2|||
146393063|NCT00660829|527941303|FG001|Overall Study|Lack of Efficacy|3|||
146393064|NCT00660829|527941302|FG000|Overall Study|Non-Compliance|0|||
146393065|NCT00660829|527941303|FG001|Overall Study|Non-Compliance|4|||
146393066|NCT00660829|527941302|FG000|Overall Study|Withdrawal by Subject|1|||
146393067|NCT00660829|527941303|FG001|Overall Study|Withdrawal by Subject|2|||
146393068|NCT00660829|527941302|FG000|Overall Study|Lost to Follow-up|3|||
146393069|NCT00660829|527941303|FG001|Overall Study|Lost to Follow-up|2|||
146393070|NCT00660829|527941302|FG000|Overall Study|Other|9|||
146393071|NCT00660829|527941303|FG001|Overall Study|Other|4|||
146393072|NCT03590613|527941304|FG000|Period 2, 4 Days|Physician Decision|0|||
146393073|NCT03590613|527941305|FG001|Period 2, 4 Days|Physician Decision|0|||
146393074|NCT03590613|527941306|FG002|Period 2, 4 Days|Physician Decision|0|||
146393075|NCT03590613|527941307|FG003|Period 2, 4 Days|Physician Decision|1|||
146393076|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Death|2|||
146393077|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Death|0|||
146393078|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Adverse Event|33|||
146393079|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Adverse Event|31|||
146393080|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
146393081|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
146393082|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
146393083|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
146393084|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
146393085|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
146393086|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Other|7|||
146393087|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Other|8|||
146393088|NCT00280059|527941308|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
146393089|NCT00280059|527941309|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
146393090|NCT04369742|527941310|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
146393091|NCT04369742|527941311|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
146393092|NCT04369742|527941310|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
146393093|NCT04369742|527941311|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
146393094|NCT02127931|527941314|FG000|Overall Study|Glitch in Game|1|||
146393095|NCT01130831|527941315|FG000|Overall Study|Withdrawal by Subject|7|||
146393096|NCT01130831|527941315|FG000|Overall Study|Death|4|||
146393097|NCT01130831|527941315|FG000|Overall Study|Information was missing|3|||
146393098|NCT00951912|527941316|FG000|Overall Study|Lack of Efficacy|1|||
146393099|NCT00951912|527941317|FG001|Overall Study|Lack of Efficacy|0|||
146393100|NCT00951912|527941318|FG002|Overall Study|Lack of Efficacy|0|||
146393101|NCT00951912|527941316|FG000|Overall Study|Adverse Event|0|||
146393102|NCT00951912|527941317|FG001|Overall Study|Adverse Event|1|||
146393103|NCT00951912|527941318|FG002|Overall Study|Adverse Event|1|||
146393104|NCT00951912|527941316|FG000|Overall Study|Lost to Follow-up|2|||
146393105|NCT00951912|527941317|FG001|Overall Study|Lost to Follow-up|2|||
146393106|NCT00951912|527941318|FG002|Overall Study|Lost to Follow-up|0|||
146393107|NCT00951912|527941316|FG000|Overall Study|Physician Decision|1|||
146393108|NCT00951912|527941317|FG001|Overall Study|Physician Decision|0|||
146393109|NCT00951912|527941318|FG002|Overall Study|Physician Decision|1|||
146393110|NCT00951912|527941316|FG000|Overall Study|Withdrawal by Subject|1|||
146393111|NCT00951912|527941317|FG001|Overall Study|Withdrawal by Subject|1|||
146393112|NCT00951912|527941318|FG002|Overall Study|Withdrawal by Subject|0|||
146393113|NCT00951912|527941316|FG000|Overall Study|Other:Depression|1|||
146393114|NCT00951912|527941317|FG001|Overall Study|Other:Depression|0|||
146393115|NCT00951912|527941318|FG002|Overall Study|Other:Depression|0|||
146393116|NCT00951912|527941316|FG000|Overall Study|Other: Colon cancer|1|||
146393117|NCT00951912|527941317|FG001|Overall Study|Other: Colon cancer|0|||
146393118|NCT00951912|527941318|FG002|Overall Study|Other: Colon cancer|0|||
146393119|NCT00951912|527941316|FG000|Overall Study|Other: Stroke|0|||
146393120|NCT00951912|527941317|FG001|Overall Study|Other: Stroke|1|||
146393121|NCT00951912|527941318|FG002|Overall Study|Other: Stroke|0|||
146393122|NCT01377194|527941320|FG000|Overall Study|Adverse Event|3|||
146393123|NCT01377194|527941321|FG001|Overall Study|Adverse Event|12|||
146393124|NCT01377194|527941322|FG002|Overall Study|Adverse Event|19|||
146393125|NCT01377194|527941320|FG000|Overall Study|Lack of Efficacy|3|||
146393126|NCT01377194|527941321|FG001|Overall Study|Lack of Efficacy|3|||
146393127|NCT01377194|527941322|FG002|Overall Study|Lack of Efficacy|3|||
146393128|NCT01377194|527941320|FG000|Overall Study|Protocol Violation|4|||
146393129|NCT01377194|527941321|FG001|Overall Study|Protocol Violation|10|||
146393130|NCT01377194|527941322|FG002|Overall Study|Protocol Violation|6|||
146393131|NCT01377194|527941320|FG000|Overall Study|Withdrawal by Subject|8|||
146393132|NCT01377194|527941321|FG001|Overall Study|Withdrawal by Subject|10|||
146393133|NCT01377194|527941322|FG002|Overall Study|Withdrawal by Subject|7|||
146393134|NCT01377194|527941320|FG000|Overall Study|Lost to Follow-up|14|||
146393135|NCT01377194|527941321|FG001|Overall Study|Lost to Follow-up|8|||
146393136|NCT01377194|527941322|FG002|Overall Study|Lost to Follow-up|11|||
146393137|NCT01728454|527941323|FG000|Stage 1 and 2|Pregnancy|1|||
146393138|NCT01728454|527941324|FG001|Stage 1 and 2|Pregnancy|0|||
146393139|NCT01728454|527941325|FG002|Stage 1 and 2|Pregnancy|0|||
146393140|NCT01728454|527941323|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
146393141|NCT01728454|527941324|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
146393142|NCT01728454|527941325|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
146393143|NCT01728454|527941323|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
146393144|NCT01728454|527941324|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
146393145|NCT01728454|527941325|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
146393146|NCT01728454|527941323|FG000|Stage 1 and 2|Lost to Follow-up|1|||
146393147|NCT01728454|527941324|FG001|Stage 1 and 2|Lost to Follow-up|1|||
146393148|NCT01728454|527941325|FG002|Stage 1 and 2|Lost to Follow-up|0|||
146393149|NCT01728454|527941323|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
146393150|NCT01728454|527941324|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
146393151|NCT01728454|527941325|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
146393152|NCT01728454|527941323|FG000|Stage 3|Reason Missing|0|||
146393153|NCT01728454|527941324|FG001|Stage 3|Reason Missing|0|||
146393154|NCT01728454|527941325|FG002|Stage 3|Reason Missing|1|||
146393155|NCT01728454|527941323|FG000|Stage 3|Subject Required Other Treatment|0|||
146393156|NCT01728454|527941324|FG001|Stage 3|Subject Required Other Treatment|1|||
146393157|NCT01728454|527941325|FG002|Stage 3|Subject Required Other Treatment|0|||
146393158|NCT01728454|527941323|FG000|Stage 3|Pregnancy|1|||
146393159|NCT01728454|527941324|FG001|Stage 3|Pregnancy|0|||
146393160|NCT01728454|527941325|FG002|Stage 3|Pregnancy|0|||
146393161|NCT01728454|527941323|FG000|Stage 3|Withdrew Consent|1|||
146393162|NCT01728454|527941324|FG001|Stage 3|Withdrew Consent|0|||
146393163|NCT01728454|527941325|FG002|Stage 3|Withdrew Consent|1|||
146393164|NCT01728454|527941323|FG000|Stage 3|Non-compliance with Protocol|0|||
146393165|NCT01728454|527941324|FG001|Stage 3|Non-compliance with Protocol|0|||
146393166|NCT01728454|527941325|FG002|Stage 3|Non-compliance with Protocol|1|||
146393167|NCT01728454|527941323|FG000|Stage 3|Lost to Follow-up|0|||
146393168|NCT01728454|527941324|FG001|Stage 3|Lost to Follow-up|3|||
146393169|NCT01728454|527941325|FG002|Stage 3|Lost to Follow-up|1|||
146393170|NCT01728454|527941323|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
146393171|NCT01728454|527941324|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
146393172|NCT01728454|527941325|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
146393173|NCT01190839|527941328|FG000|Overall Study|Adverse Event|32|||
146393174|NCT01190839|527941329|FG001|Overall Study|Adverse Event|41|||
146393175|NCT01190839|527941328|FG000|Overall Study|Protocol Violation|2|||
146393176|NCT01190839|527941329|FG001|Overall Study|Protocol Violation|2|||
146393177|NCT01190839|527941328|FG000|Overall Study|Lost to Follow-up|7|||
146393178|NCT01190839|527941329|FG001|Overall Study|Lost to Follow-up|1|||
146393179|NCT01190839|527941328|FG000|Overall Study|Death|1|||
146393180|NCT01190839|527941329|FG001|Overall Study|Death|0|||
146393181|NCT01190839|527941328|FG000|Overall Study|Trial stopped by Sponsor|71|||
146393182|NCT01190839|527941329|FG001|Overall Study|Trial stopped by Sponsor|68|||
146393183|NCT01190839|527941328|FG000|Overall Study|Undefined|35|||
146393184|NCT01190839|527941329|FG001|Overall Study|Undefined|31|||
146393185|NCT01190839|527941328|FG000|Overall Study|Randomized but not treated|2|||
146393186|NCT01190839|527941329|FG001|Overall Study|Randomized but not treated|4|||
146393187|NCT00765726|527941334|FG000|Overall Study|Withdrawal by Subject|1|||
146393188|NCT00765726|527941334|FG000|Overall Study|Discontinuation of study by sponsor|8|||
146393189|NCT02993731|527941335|FG000|Overall Study|Study Termination|101|||
146393190|NCT02993731|527941336|FG001|Overall Study|Study Termination|105|||
146393191|NCT00323479|527941337|FG000|Overall Study|Adverse Event|2|||
146393192|NCT00323479|527941337|FG000|Overall Study|Withdrawal by Subject|2|||
146393193|NCT00323479|527941337|FG000|Overall Study|Protocol Violation|3|||
146393194|NCT00323479|527941337|FG000|Overall Study|house moving|1|||
146393195|NCT01362062|527941338|FG000|Overall Study|Adverse Event|1|||
146393196|NCT01362062|527941339|FG001|Overall Study|Adverse Event|0|||
146393197|NCT01362062|527941338|FG000|Overall Study|Lost to Follow-up|11|||
146393198|NCT01362062|527941339|FG001|Overall Study|Lost to Follow-up|0|||
146393199|NCT01362062|527941338|FG000|Overall Study|Withdrawal by Subject|2|||
146393200|NCT01362062|527941339|FG001|Overall Study|Withdrawal by Subject|0|||
146393201|NCT01362062|527941338|FG000|Overall Study|Non-compliant participant|2|||
146393202|NCT01362062|527941339|FG001|Overall Study|Non-compliant participant|0|||
146393203|NCT01362062|527941338|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
146393204|NCT01362062|527941339|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
146393205|NCT01362062|527941338|FG000|Overall Study|Had significant improvement|9|||
146393206|NCT01362062|527941339|FG001|Overall Study|Had significant improvement|0|||
146393207|NCT02545504|527941341|FG000|Overall Study|Death|174|||
146393208|NCT02545504|527941342|FG001|Overall Study|Death|168|||
146393209|NCT02545504|527941341|FG000|Overall Study|Unknown reason|30|||
146393210|NCT02545504|527941342|FG001|Overall Study|Unknown reason|32|||
146393211|NCT02545504|527941341|FG000|Overall Study|Withdrew consent|9|||
146393212|NCT02545504|527941342|FG001|Overall Study|Withdrew consent|11|||
146393213|NCT02545504|527941341|FG000|Overall Study|Investigator's discretion|3|||
146393214|NCT02545504|527941342|FG001|Overall Study|Investigator's discretion|1|||
146393215|NCT02545504|527941341|FG000|Overall Study|Lost to Follow-up|2|||
146393216|NCT02545504|527941342|FG001|Overall Study|Lost to Follow-up|2|||
146393217|NCT00967343|527941343|FG000|Overall Study|Study termination by sponsor|12|||
146393218|NCT00967343|527941343|FG000|Overall Study|Death|24|||
146393219|NCT00967343|527941343|FG000|Overall Study|Relapse|1|||
146393220|NCT00967343|527941343|FG000|Overall Study|Lost to Follow-up|1|||
146393221|NCT03044730|527941344|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
146393222|NCT03044730|527941344|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
146393223|NCT03044730|527941344|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
146393224|NCT03044730|527941344|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
146393225|NCT03044730|527941344|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
146393226|NCT03044730|527941344|FG000|Cycles 4 and Beyond|Adverse Event|1|||
146393227|NCT03044730|527941344|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
146393228|NCT03044730|527941344|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
146393229|NCT03044730|527941344|FG000|On Follow-up for 2 Years|Death|17|||
146393230|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
146393231|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
146393232|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
146393233|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
146393234|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
146393235|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
146393236|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
146393237|NCT00950755|527941345|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
146393238|NCT00950755|527941345|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
146393239|NCT00950755|527941345|FG000|Long-Term Follow-Up|Death|8|||
146393240|NCT00508820|527941347|FG000|Overall Study|Adverse Event|6|||
146393241|NCT00508820|527941348|FG001|Overall Study|Adverse Event|10|||
146393242|NCT00508820|527941347|FG000|Overall Study|Death|6|||
146393243|NCT00508820|527941348|FG001|Overall Study|Death|8|||
146393244|NCT00508820|527941347|FG000|Overall Study|Lost to Follow-up|1|||
146393245|NCT00508820|527941348|FG001|Overall Study|Lost to Follow-up|1|||
146393246|NCT00508820|527941347|FG000|Overall Study|Physician Decision|8|||
146393247|NCT00508820|527941348|FG001|Overall Study|Physician Decision|2|||
146393248|NCT00508820|527941347|FG000|Overall Study|Pregnancy|0|||
146393249|NCT00508820|527941348|FG001|Overall Study|Pregnancy|2|||
146393250|NCT00508820|527941347|FG000|Overall Study|Protocol Violation|2|||
146393251|NCT00508820|527941348|FG001|Overall Study|Protocol Violation|0|||
146393252|NCT00508820|527941347|FG000|Overall Study|Withdrawal by Subject|10|||
146393253|NCT00508820|527941348|FG001|Overall Study|Withdrawal by Subject|12|||
146393254|NCT00508820|527941347|FG000|Overall Study|Other|11|||
146393255|NCT00508820|527941348|FG001|Overall Study|Other|2|||
146393256|NCT00508820|527941347|FG000|Overall Study|Noncompliance|1|||
146393257|NCT00508820|527941348|FG001|Overall Study|Noncompliance|0|||
146393258|NCT00508820|527941347|FG000|Overall Study|Requirement for alternative therapy|7|||
146393259|NCT00508820|527941348|FG001|Overall Study|Requirement for alternative therapy|15|||
146393260|NCT00508820|527941347|FG000|Overall Study|Protocol-specified Criteria|3|||
146393261|NCT00508820|527941348|FG001|Overall Study|Protocol-specified Criteria|12|||
146393262|NCT04398030|527943120|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
146393263|NCT04398030|527943121|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
146393264|NCT04398030|527943120|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
146393265|NCT04398030|527943121|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
146393266|NCT01674010|527943122|FG000|Open Treatment Phase 1|Adverse Event|10|||
146393267|NCT01674010|527943123|FG001|Open Treatment Phase 1|Adverse Event|0|||
146393268|NCT01674010|527943124|FG002|Open Treatment Phase 1|Adverse Event|0|||
146393269|NCT01674010|527943122|FG000|Open Treatment Phase 1|Death|1|||
146393270|NCT01674010|527943123|FG001|Open Treatment Phase 1|Death|0|||
146393271|NCT01674010|527943124|FG002|Open Treatment Phase 1|Death|0|||
146393272|NCT01674010|527943122|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
146393273|NCT01674010|527943123|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
146393274|NCT01674010|527943124|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
146393275|NCT01674010|527943122|FG000|Open Treatment Phase 1|Physician Decision|9|||
146393276|NCT01674010|527943123|FG001|Open Treatment Phase 1|Physician Decision|0|||
146393277|NCT01674010|527943124|FG002|Open Treatment Phase 1|Physician Decision|0|||
146393278|NCT01674010|527943122|FG000|Open Treatment Phase 1|Protocol Violation|7|||
146393279|NCT01674010|527943123|FG001|Open Treatment Phase 1|Protocol Violation|0|||
146393280|NCT01674010|527943124|FG002|Open Treatment Phase 1|Protocol Violation|0|||
146393281|NCT01674010|527943122|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
146393282|NCT01674010|527943123|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
146393283|NCT01674010|527943124|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
146393284|NCT01674010|527943122|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
146393285|NCT01674010|527943123|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
146393286|NCT01674010|527943124|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
146393287|NCT01674010|527943122|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
146393288|NCT01674010|527943123|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
146393289|NCT01674010|527943124|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
146393290|NCT01674010|527943122|FG000|Randomization Phase 2|Adverse Event|0|||
146393291|NCT01674010|527943123|FG001|Randomization Phase 2|Adverse Event|1|||
146393292|NCT01674010|527943124|FG002|Randomization Phase 2|Adverse Event|1|||
146393293|NCT01674010|527943122|FG000|Randomization Phase 2|Lost to Follow-up|0|||
146393294|NCT01674010|527943123|FG001|Randomization Phase 2|Lost to Follow-up|1|||
146393295|NCT01674010|527943124|FG002|Randomization Phase 2|Lost to Follow-up|2|||
146393296|NCT01674010|527943122|FG000|Randomization Phase 2|Mood episode recurrence|0|||
146393297|NCT01674010|527943123|FG001|Randomization Phase 2|Mood episode recurrence|8|||
146393298|NCT01674010|527943124|FG002|Randomization Phase 2|Mood episode recurrence|2|||
146393299|NCT01674010|527943122|FG000|Randomization Phase 2|Physician Decision|0|||
146393300|NCT01674010|527943123|FG001|Randomization Phase 2|Physician Decision|0|||
146393301|NCT01674010|527943124|FG002|Randomization Phase 2|Physician Decision|2|||
146393302|NCT01674010|527943122|FG000|Randomization Phase 2|Pregnancy|0|||
146393303|NCT01674010|527943123|FG001|Randomization Phase 2|Pregnancy|1|||
146393304|NCT01674010|527943124|FG002|Randomization Phase 2|Pregnancy|1|||
146393305|NCT01674010|527943122|FG000|Randomization Phase 2|Protocol Violation|0|||
146393306|NCT01674010|527943123|FG001|Randomization Phase 2|Protocol Violation|1|||
146393307|NCT01674010|527943124|FG002|Randomization Phase 2|Protocol Violation|1|||
146393308|NCT01674010|527943122|FG000|Randomization Phase 2|Sponsor Decision|0|||
146393309|NCT01674010|527943123|FG001|Randomization Phase 2|Sponsor Decision|42|||
146393310|NCT01674010|527943124|FG002|Randomization Phase 2|Sponsor Decision|45|||
146393311|NCT01674010|527943122|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
146393312|NCT01674010|527943123|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
146393313|NCT01674010|527943124|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
146393314|NCT03159455|527943125|FG000|Overall Study|Adverse Event|0|||
146393315|NCT03159455|527943126|FG001|Overall Study|Adverse Event|0|||
146393316|NCT03159455|527943127|FG002|Overall Study|Adverse Event|0|||
146393317|NCT03159455|527943128|FG003|Overall Study|Adverse Event|0|||
146393318|NCT03159455|527943129|FG004|Overall Study|Adverse Event|0|||
146393319|NCT03159455|527943130|FG005|Overall Study|Adverse Event|1|||
146393320|NCT02713490|527943133|FG000|Overall Study|Withdrawal by Subject|2|||
146393321|NCT02713490|527943134|FG001|Overall Study|Withdrawal by Subject|1|||
146393322|NCT02713490|527943133|FG000|Overall Study|Did not receive study drug|1|||
146393323|NCT02713490|527943134|FG001|Overall Study|Did not receive study drug|0|||
146393324|NCT02713490|527943133|FG000|Overall Study|Met exclusion criteria|0|||
146393325|NCT02713490|527943134|FG001|Overall Study|Met exclusion criteria|1|||
146393326|NCT00548340|527943137|FG000|Overall Study|Protocol Violation|2|||
146393327|NCT00548340|527943138|FG001|Overall Study|Protocol Violation|3|||
146393328|NCT00548340|527943139|FG002|Overall Study|Protocol Violation|3|||
146393329|NCT00548340|527943137|FG000|Overall Study|Adverse Event|2|||
146393330|NCT00548340|527943138|FG001|Overall Study|Adverse Event|2|||
146393331|NCT00548340|527943139|FG002|Overall Study|Adverse Event|2|||
146393332|NCT00548340|527943137|FG000|Overall Study|Lost to Follow-up|1|||
146393333|NCT00548340|527943138|FG001|Overall Study|Lost to Follow-up|1|||
146393334|NCT00548340|527943139|FG002|Overall Study|Lost to Follow-up|0|||
146393335|NCT00548340|527943137|FG000|Overall Study|Withdrawal by Subject|2|||
146393336|NCT00548340|527943138|FG001|Overall Study|Withdrawal by Subject|4|||
146393337|NCT00548340|527943139|FG002|Overall Study|Withdrawal by Subject|3|||
146393338|NCT00548340|527943137|FG000|Overall Study|Other|1|||
146393339|NCT00548340|527943138|FG001|Overall Study|Other|1|||
146393340|NCT00548340|527943139|FG002|Overall Study|Other|1|||
146393341|NCT01096017|527943140|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
146393342|NCT01096017|527943141|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
146393343|NCT02600559|527943145|FG000|Overall Study|Withdrawal by Subject|3|||
146393344|NCT02600559|527943145|FG000|Overall Study|Lost to Follow-up|20|||
146393345|NCT03778021|527943151|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
146393346|NCT03778021|527943152|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
146393347|NCT01545375|527943153|FG000|Overall Study|Adverse Event|2|||
146393348|NCT01545375|527943154|FG001|Overall Study|Adverse Event|1|||
146393349|NCT01545375|527943153|FG000|Overall Study|Lost to Follow-up|34|||
146393350|NCT01545375|527943154|FG001|Overall Study|Lost to Follow-up|31|||
146393351|NCT01545375|527943153|FG000|Overall Study|Protocol Violation|3|||
146393352|NCT01545375|527943154|FG001|Overall Study|Protocol Violation|3|||
146393353|NCT01545375|527943153|FG000|Overall Study|Withdrawal by Subject|58|||
146393354|NCT01545375|527943154|FG001|Overall Study|Withdrawal by Subject|55|||
146393355|NCT00679042|527943155|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
146393356|NCT00679042|527943155|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
146393357|NCT00679042|527943155|FG000|5-Year Follow Up|Death|1|||
146393358|NCT00679042|527943155|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
146393359|NCT00679042|527943155|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
146393360|NCT02687815|527943156|FG000|Overall Study|Lost to Follow-up|2|||
146393361|NCT02687815|527943157|FG001|Overall Study|Lost to Follow-up|4|||
146393362|NCT02687815|527943156|FG000|Overall Study|Withdrawal by Subject|2|||
146393363|NCT02687815|527943157|FG001|Overall Study|Withdrawal by Subject|4|||
146393364|NCT04177862|527943158|FG000|Overall Study|Protocol Violation|2|||
146393365|NCT04177862|527943159|FG001|Overall Study|Protocol Violation|7|||
146393366|NCT05637515|527943164|FG000|Overall Study|Withdrawal by Subject|17|||
146393367|NCT05637515|527943165|FG001|Overall Study|Withdrawal by Subject|17|||
146393368|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
146393369|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
146393370|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393371|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393372|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393373|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393374|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393375|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393376|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393377|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393378|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393379|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
146393380|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146393381|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393382|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393383|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393384|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393385|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393386|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146393387|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393388|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393389|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393390|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
146393391|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
146393392|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393393|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
146393394|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393395|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393396|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393397|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393398|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393399|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393400|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393401|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393402|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393403|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
146393404|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
146393405|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
146393406|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
146393407|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
146393408|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
146393409|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
146393410|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
146393411|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
146393412|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
146393413|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
146393414|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
146393415|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
146393416|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393417|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393418|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393419|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393420|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393421|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
146393422|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393423|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393424|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393425|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393426|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393427|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
146393428|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393429|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393430|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393431|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393432|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393433|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
146393434|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393435|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393436|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393437|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393438|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393439|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
146393440|NCT00151775|527943166|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393441|NCT00151775|527943167|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393442|NCT00151775|527943168|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393443|NCT00151775|527943169|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393444|NCT00151775|527943170|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393445|NCT00151775|527943171|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393446|NCT00151775|527943172|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
146393447|NCT00151775|527943173|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393448|NCT00151775|527943174|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393449|NCT00151775|527943175|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393450|NCT00151775|527943176|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393451|NCT00151775|527943177|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
146393452|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393453|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393454|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393455|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393456|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393457|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
146393458|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393459|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393460|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393461|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393462|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393463|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
146393464|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
146393465|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
146393466|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
146393467|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
146393468|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
146393469|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
146393470|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
146393471|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
146393472|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
146393473|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
146393474|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
146393475|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
146393476|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393477|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393478|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393479|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393480|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393481|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393482|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
146393483|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393484|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393485|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393486|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393487|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
146393488|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393489|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393490|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
146393491|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393492|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393493|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393494|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393495|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393496|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393497|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393498|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393499|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
146393500|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393501|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393502|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
146393503|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393504|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393505|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393506|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393507|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393508|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393509|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393510|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393511|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
146393512|NCT00151775|527943166|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393513|NCT00151775|527943167|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393514|NCT00151775|527943168|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393515|NCT00151775|527943169|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393516|NCT00151775|527943170|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393517|NCT00151775|527943171|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393518|NCT00151775|527943172|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393519|NCT00151775|527943173|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393520|NCT00151775|527943174|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393521|NCT00151775|527943175|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393522|NCT00151775|527943176|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
146393523|NCT00151775|527943177|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
146393524|NCT00151775|527943166|FG000|Period 4: Open Label|Increased blood pressure|0|||
146393525|NCT00151775|527943167|FG001|Period 4: Open Label|Increased blood pressure|0|||
146393526|NCT00151775|527943168|FG002|Period 4: Open Label|Increased blood pressure|0|||
146393527|NCT00151775|527943169|FG003|Period 4: Open Label|Increased blood pressure|0|||
146393528|NCT00151775|527943170|FG004|Period 4: Open Label|Increased blood pressure|1|||
146393529|NCT00151775|527943171|FG005|Period 4: Open Label|Increased blood pressure|0|||
146393530|NCT00151775|527943172|FG006|Period 4: Open Label|Increased blood pressure|0|||
146393531|NCT00151775|527943173|FG007|Period 4: Open Label|Increased blood pressure|0|||
146393532|NCT00151775|527943174|FG008|Period 4: Open Label|Increased blood pressure|0|||
146393533|NCT00151775|527943175|FG009|Period 4: Open Label|Increased blood pressure|1|||
146393534|NCT00151775|527943176|FG010|Period 4: Open Label|Increased blood pressure|0|||
146393535|NCT00151775|527943177|FG011|Period 4: Open Label|Increased blood pressure|0|||
146393536|NCT00151775|527943166|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
146393537|NCT00151775|527943167|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
146393538|NCT00151775|527943168|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
146393539|NCT00151775|527943169|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
146393540|NCT00151775|527943170|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
146393541|NCT00151775|527943171|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
146393542|NCT00151775|527943172|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
146393543|NCT00151775|527943173|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
146393544|NCT00151775|527943174|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
146393545|NCT00151775|527943175|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
146393546|NCT00151775|527943176|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
146393547|NCT00151775|527943177|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
146393548|NCT00151775|527943166|FG000|Period 4: Open Label|Adverse Event|0|||
146393549|NCT00151775|527943167|FG001|Period 4: Open Label|Adverse Event|0|||
146393550|NCT00151775|527943168|FG002|Period 4: Open Label|Adverse Event|0|||
146393551|NCT00151775|527943169|FG003|Period 4: Open Label|Adverse Event|0|||
146393552|NCT00151775|527943170|FG004|Period 4: Open Label|Adverse Event|1|||
146393553|NCT00151775|527943171|FG005|Period 4: Open Label|Adverse Event|0|||
146393554|NCT00151775|527943172|FG006|Period 4: Open Label|Adverse Event|0|||
146393555|NCT00151775|527943173|FG007|Period 4: Open Label|Adverse Event|0|||
146393556|NCT00151775|527943174|FG008|Period 4: Open Label|Adverse Event|0|||
146393557|NCT00151775|527943175|FG009|Period 4: Open Label|Adverse Event|2|||
146393558|NCT00151775|527943176|FG010|Period 4: Open Label|Adverse Event|0|||
146393559|NCT00151775|527943177|FG011|Period 4: Open Label|Adverse Event|0|||
146393560|NCT00151775|527943166|FG000|Period 4: Open Label|Lost to Follow-up|0|||
146393561|NCT00151775|527943167|FG001|Period 4: Open Label|Lost to Follow-up|0|||
146393562|NCT00151775|527943168|FG002|Period 4: Open Label|Lost to Follow-up|0|||
146393563|NCT00151775|527943169|FG003|Period 4: Open Label|Lost to Follow-up|0|||
146393564|NCT00151775|527943170|FG004|Period 4: Open Label|Lost to Follow-up|17|||
146393565|NCT00151775|527943171|FG005|Period 4: Open Label|Lost to Follow-up|0|||
146393566|NCT00151775|527943172|FG006|Period 4: Open Label|Lost to Follow-up|0|||
146393567|NCT00151775|527943173|FG007|Period 4: Open Label|Lost to Follow-up|0|||
146393568|NCT00151775|527943174|FG008|Period 4: Open Label|Lost to Follow-up|0|||
146393569|NCT00151775|527943175|FG009|Period 4: Open Label|Lost to Follow-up|7|||
146393570|NCT00151775|527943176|FG010|Period 4: Open Label|Lost to Follow-up|0|||
146393571|NCT00151775|527943177|FG011|Period 4: Open Label|Lost to Follow-up|0|||
146393572|NCT00151775|527943166|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
146393573|NCT00151775|527943167|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
146393574|NCT00151775|527943168|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
146393575|NCT00151775|527943169|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
146393576|NCT00151775|527943170|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
146393577|NCT00151775|527943171|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
146393578|NCT00151775|527943172|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
146393579|NCT00151775|527943173|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
146393580|NCT00151775|527943174|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
146393581|NCT00151775|527943175|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
146393582|NCT00151775|527943176|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
146393583|NCT00151775|527943177|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
146393584|NCT00151775|527943166|FG000|Period 4: Open Label|Other|0|||
146393585|NCT00151775|527943167|FG001|Period 4: Open Label|Other|0|||
146393586|NCT00151775|527943168|FG002|Period 4: Open Label|Other|0|||
146393587|NCT00151775|527943169|FG003|Period 4: Open Label|Other|0|||
146393588|NCT00151775|527943170|FG004|Period 4: Open Label|Other|1|||
146393589|NCT00151775|527943171|FG005|Period 4: Open Label|Other|0|||
146393590|NCT00151775|527943172|FG006|Period 4: Open Label|Other|0|||
146393591|NCT00151775|527943173|FG007|Period 4: Open Label|Other|0|||
146393592|NCT00151775|527943174|FG008|Period 4: Open Label|Other|0|||
146393593|NCT00151775|527943175|FG009|Period 4: Open Label|Other|3|||
146393594|NCT00151775|527943176|FG010|Period 4: Open Label|Other|0|||
146393595|NCT00151775|527943177|FG011|Period 4: Open Label|Other|0|||
146393596|NCT00151775|527943166|FG000|Period 4: Open Label|Physician Decision|0|||
146393597|NCT00151775|527943167|FG001|Period 4: Open Label|Physician Decision|0|||
146393598|NCT00151775|527943168|FG002|Period 4: Open Label|Physician Decision|0|||
146393599|NCT00151775|527943169|FG003|Period 4: Open Label|Physician Decision|0|||
146393600|NCT00151775|527943170|FG004|Period 4: Open Label|Physician Decision|0|||
146393601|NCT00151775|527943171|FG005|Period 4: Open Label|Physician Decision|0|||
146393602|NCT00151775|527943172|FG006|Period 4: Open Label|Physician Decision|0|||
146393603|NCT00151775|527943173|FG007|Period 4: Open Label|Physician Decision|0|||
146393604|NCT00151775|527943174|FG008|Period 4: Open Label|Physician Decision|0|||
146393605|NCT00151775|527943175|FG009|Period 4: Open Label|Physician Decision|2|||
146393606|NCT00151775|527943176|FG010|Period 4: Open Label|Physician Decision|0|||
146393607|NCT00151775|527943177|FG011|Period 4: Open Label|Physician Decision|0|||
146393608|NCT00151775|527943166|FG000|Period 4: Open Label|Protocol Violation|0|||
146393609|NCT00151775|527943167|FG001|Period 4: Open Label|Protocol Violation|0|||
146393610|NCT00151775|527943168|FG002|Period 4: Open Label|Protocol Violation|0|||
146393611|NCT00151775|527943169|FG003|Period 4: Open Label|Protocol Violation|0|||
146393612|NCT00151775|527943170|FG004|Period 4: Open Label|Protocol Violation|1|||
146393613|NCT00151775|527943171|FG005|Period 4: Open Label|Protocol Violation|0|||
146393614|NCT00151775|527943172|FG006|Period 4: Open Label|Protocol Violation|0|||
146393615|NCT00151775|527943173|FG007|Period 4: Open Label|Protocol Violation|0|||
146393616|NCT00151775|527943174|FG008|Period 4: Open Label|Protocol Violation|0|||
146393617|NCT00151775|527943175|FG009|Period 4: Open Label|Protocol Violation|0|||
146393618|NCT00151775|527943176|FG010|Period 4: Open Label|Protocol Violation|0|||
146393619|NCT00151775|527943177|FG011|Period 4: Open Label|Protocol Violation|0|||
146393620|NCT04516291|527943178|FG000|Treatment Period (24 Weeks)|Other|1|||
146393621|NCT04516291|527943179|FG001|Treatment Period (24 Weeks)|Other|0|||
146393622|NCT04516291|527943180|FG002|Treatment Period (24 Weeks)|Other|0|||
146393623|NCT04516291|527943181|FG003|Treatment Period (24 Weeks)|Other|2|||
146393624|NCT04516291|527943182|FG004|Treatment Period (24 Weeks)|Other|2|||
146393625|NCT04516291|527943183|FG005|Treatment Period (24 Weeks)|Other|4|||
146393626|NCT04516291|527943184|FG006|Treatment Period (24 Weeks)|Other|2|||
146393627|NCT04516291|527943185|FG007|Treatment Period (24 Weeks)|Other|0|||
146393628|NCT04516291|527943178|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146393629|NCT04516291|527943179|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
146393630|NCT04516291|527943180|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146393631|NCT04516291|527943181|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146393632|NCT04516291|527943182|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
146393633|NCT04516291|527943183|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146393634|NCT04516291|527943184|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146393635|NCT04516291|527943185|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
146393636|NCT04516291|527943178|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393637|NCT04516291|527943179|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393638|NCT04516291|527943180|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393639|NCT04516291|527943181|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
146393640|NCT04516291|527943182|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393641|NCT04516291|527943183|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393642|NCT04516291|527943184|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393643|NCT04516291|527943185|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
146393644|NCT04516291|527943178|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393645|NCT04516291|527943179|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
146393646|NCT04516291|527943180|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393647|NCT04516291|527943181|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393648|NCT04516291|527943182|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393649|NCT04516291|527943183|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393650|NCT04516291|527943184|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393651|NCT04516291|527943185|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
146393652|NCT04516291|527943178|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
146393653|NCT04516291|527943179|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
146393654|NCT04516291|527943180|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
146393655|NCT04516291|527943181|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
146393656|NCT04516291|527943182|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
146393657|NCT04516291|527943183|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
146393658|NCT04516291|527943184|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
146393659|NCT04516291|527943185|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
146393660|NCT04516291|527943178|FG000|Follow-up Period (12 Weeks)|Other|0|||
146393661|NCT04516291|527943179|FG001|Follow-up Period (12 Weeks)|Other|1|||
146393662|NCT04516291|527943180|FG002|Follow-up Period (12 Weeks)|Other|0|||
146393663|NCT04516291|527943181|FG003|Follow-up Period (12 Weeks)|Other|2|||
146393664|NCT04516291|527943182|FG004|Follow-up Period (12 Weeks)|Other|0|||
146393665|NCT04516291|527943183|FG005|Follow-up Period (12 Weeks)|Other|0|||
146393666|NCT04516291|527943184|FG006|Follow-up Period (12 Weeks)|Other|0|||
146393667|NCT04516291|527943185|FG007|Follow-up Period (12 Weeks)|Other|0|||
146393668|NCT04516291|527943178|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393669|NCT04516291|527943179|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393670|NCT04516291|527943180|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393671|NCT04516291|527943181|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393672|NCT04516291|527943182|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
146393673|NCT04516291|527943183|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393674|NCT04516291|527943184|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393675|NCT04516291|527943185|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
146393676|NCT04516291|527943178|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
146393677|NCT04516291|527943179|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
146056283|NCT00626275|526721163|FG003|Part B|Withdrawal by Subject|0|||
146393678|NCT04516291|527943180|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
146393679|NCT04516291|527943181|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
146393680|NCT04516291|527943182|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
146393681|NCT04516291|527943183|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
146393682|NCT04516291|527943184|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
146393683|NCT04516291|527943185|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
146393684|NCT02158949|527943186|FG000|Overall Study|Withdrawal by Subject|1|||
146393685|NCT02158949|527943187|FG001|Overall Study|Withdrawal by Subject|0|||
146393686|NCT02158949|527943186|FG000|Overall Study|Lost to Follow-up|5|||
146393687|NCT02158949|527943187|FG001|Overall Study|Lost to Follow-up|11|||
146393688|NCT01161173|527943200|FG000|Overall Study|Protocol Violation|13|||
146393689|NCT01161173|527943200|FG000|Overall Study|Lost to Follow-up|7|||
146393690|NCT01161173|527943200|FG000|Overall Study|Progressive Disease|82|||
146393691|NCT01161173|527943200|FG000|Overall Study|Withdrawal of Consent|5|||
146393692|NCT01161173|527943200|FG000|Overall Study|Unacceptable Toxicity|21|||
146393693|NCT01161173|527943200|FG000|Overall Study|Death|194|||
146393694|NCT01161173|527943200|FG000|Overall Study|End of Study|2|||
146393695|NCT01161173|527943200|FG000|Overall Study|Reasons Not Specified|23|||
146393696|NCT00792467|527943201|FG000|Overall Study|progression of disease|17|||
146393697|NCT00792467|527943201|FG000|Overall Study|Adverse Event|1|||
146393698|NCT00792467|527943201|FG000|Overall Study|patient request|1|||
146393699|NCT00792467|527943201|FG000|Overall Study|Lost to Follow-up|1|||
146393700|NCT00792467|527943201|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
146393701|NCT00792467|527943201|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
146393702|NCT03781167|527943203|FG000|Overall Study|Adverse Event|23|||
146393703|NCT03781167|527943204|FG001|Overall Study|Adverse Event|25|||
146393704|NCT03781167|527943203|FG000|Overall Study|Withdrew consent|16|||
146393705|NCT03781167|527943204|FG001|Overall Study|Withdrew consent|12|||
146393706|NCT03781167|527943203|FG000|Overall Study|Lost to Follow-up|0|||
146393707|NCT03781167|527943204|FG001|Overall Study|Lost to Follow-up|1|||
146393708|NCT03781167|527943203|FG000|Overall Study|Lack of Efficacy|4|||
146393709|NCT03781167|527943204|FG001|Overall Study|Lack of Efficacy|5|||
146393710|NCT03781167|527943203|FG000|Overall Study|Difficulty with drug delivery system|2|||
146393711|NCT03781167|527943204|FG001|Overall Study|Difficulty with drug delivery system|3|||
146393712|NCT03781167|527943203|FG000|Overall Study|Other, not specified|2|||
146393713|NCT03781167|527943204|FG001|Overall Study|Other, not specified|2|||
146393714|NCT00679354|527943207|FG000|Overall Study|Death|3|||
146393715|NCT00679354|527943207|FG000|Overall Study|Lack of Efficacy|22|||
146393716|NCT00679354|527943207|FG000|Overall Study|Physician Decision|4|||
146393717|NCT00679354|527943207|FG000|Overall Study|Ineligible|1|||
146393718|NCT01590628|527943208|FG000|Overall Study|Death|2|||
146393719|NCT01590628|527943209|FG001|Overall Study|Death|0|||
146393720|NCT00408408|527943210|FG000|Overall Study|No follow up data|2|||
146393721|NCT00408408|527943211|FG001|Overall Study|No follow up data|3|||
146393722|NCT00408408|527943212|FG002|Overall Study|No follow up data|0|||
146393723|NCT00408408|527943213|FG003|Overall Study|No follow up data|7|||
146393724|NCT00408408|527943214|FG004|Overall Study|No follow up data|5|||
146393725|NCT00408408|527943215|FG005|Overall Study|No follow up data|3|||
146393726|NCT03907072|527943216|FG000|Overall Study|Study Terminated by Sponsor|2|||
146393727|NCT03907072|527943217|FG001|Overall Study|Study Terminated by Sponsor|2|||
146393728|NCT03907072|527943218|FG002|Overall Study|Study Terminated by Sponsor|2|||
146393729|NCT02463097|527943219|FG000|Overall Study|Withdrawal by Subject|1|||
146393730|NCT00808665|527943220|FG000|Overall Study|Withdrawal by Subject|1|||
146393731|NCT00808665|527943221|FG001|Overall Study|Withdrawal by Subject|0|||
146393732|NCT00808665|527943220|FG000|Overall Study|only required minimally invasive surgery|1|||
146393733|NCT00808665|527943221|FG001|Overall Study|only required minimally invasive surgery|0|||
146393734|NCT00808665|527943220|FG000|Overall Study|surgery cancelled|1|||
146393735|NCT00808665|527943221|FG001|Overall Study|surgery cancelled|0|||
146393736|NCT00808665|527943220|FG000|Overall Study|required an additional procedure|0|||
146393737|NCT00808665|527943221|FG001|Overall Study|required an additional procedure|1|||
146393738|NCT00808665|527943220|FG000|Overall Study|Physician Decision|3|||
146393739|NCT00808665|527943221|FG001|Overall Study|Physician Decision|1|||
146393740|NCT00808665|527943220|FG000|Overall Study|Medication stopped by resident|0|||
146393741|NCT00808665|527943221|FG001|Overall Study|Medication stopped by resident|1|||
146393742|NCT03326323|527943222|FG000|Overall Study|Unable to receive ANH protocol|3|||
146393743|NCT01757821|527943223|FG000|Overall Study|Adverse Event|1|||
146393744|NCT03831282|527943224|FG000|Overall Study|Could not place sensor|1|||
146393745|NCT00920582|527943225|FG000|Overall Study|Lost to Follow-up|5|||
146393746|NCT00920582|527943226|FG001|Overall Study|Lost to Follow-up|1|||
146393747|NCT00920582|527943227|FG002|Overall Study|Lost to Follow-up|2|||
146393748|NCT00920582|527943228|FG003|Overall Study|Lost to Follow-up|0|||
146393749|NCT00920582|527943225|FG000|Overall Study|Withdrawal by Subject|5|||
146393750|NCT00920582|527943226|FG001|Overall Study|Withdrawal by Subject|4|||
146393751|NCT00920582|527943227|FG002|Overall Study|Withdrawal by Subject|6|||
146393752|NCT00920582|527943228|FG003|Overall Study|Withdrawal by Subject|3|||
146393753|NCT00920582|527943225|FG000|Overall Study|Protocol Violation|1|||
146393754|NCT00920582|527943226|FG001|Overall Study|Protocol Violation|0|||
146393755|NCT00920582|527943227|FG002|Overall Study|Protocol Violation|0|||
146393756|NCT00920582|527943228|FG003|Overall Study|Protocol Violation|0|||
146393757|NCT00920582|527943225|FG000|Overall Study|Other|2|||
146393758|NCT00920582|527943226|FG001|Overall Study|Other|1|||
146393759|NCT00920582|527943227|FG002|Overall Study|Other|3|||
146393760|NCT00920582|527943228|FG003|Overall Study|Other|2|||
146393761|NCT05146999|527943230|FG000|Overall Study|Withdrew consent|6|||
146393762|NCT05146999|527943231|FG001|Overall Study|Withdrew consent|1|||
146393763|NCT05146999|527943230|FG000|Overall Study|Lost to Follow-up|3|||
146393764|NCT05146999|527943231|FG001|Overall Study|Lost to Follow-up|2|||
146393765|NCT05146999|527943230|FG000|Overall Study|Other|1|||
146393766|NCT05146999|527943231|FG001|Overall Study|Other|3|||
146393767|NCT03319160|527943232|FG000|Overall Study|Data not available.|7|||
146393768|NCT00665002|527943233|FG000|Overall Study|Progression/relapse during treatment|11|||
146393769|NCT00665002|527943233|FG000|Overall Study|Cytogenetic resistance|1|||
146393770|NCT00697255|527943234|FG000|Stage 1a|Insufficient ovarian response|1|||
146393771|NCT00697255|527943235|FG001|Stage 1a|Insufficient ovarian response|0|||
146393772|NCT00697255|527943234|FG000|Stage 1a|Multifollicular growth|1|||
146393773|NCT00697255|527943235|FG001|Stage 1a|Multifollicular growth|0|||
146393774|NCT00697255|527943234|FG000|Stage 1a|Not growing of dominant follicle|1|||
146393775|NCT00697255|527943235|FG001|Stage 1a|Not growing of dominant follicle|0|||
146393776|NCT00697255|527943234|FG000|Stage 1b|Not growing of dominant follicle|0|||
146393777|NCT00697255|527943235|FG001|Stage 1b|Not growing of dominant follicle|1|||
146393778|NCT00697255|527943234|FG000|Stage 1b|Insufficient ovarian response|0|||
146393779|NCT00697255|527943235|FG001|Stage 1b|Insufficient ovarian response|1|||
146393780|NCT01333501|527943240|FG000|Overall Study|Adverse Event|3|||
146393781|NCT01333501|527943241|FG001|Overall Study|Adverse Event|1|||
146393782|NCT01333501|527943240|FG000|Overall Study|Abnormal laboratory value|2|||
146393783|NCT01333501|527943241|FG001|Overall Study|Abnormal laboratory value|1|||
146393784|NCT01333501|527943240|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
146393785|NCT01333501|527943241|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
146393786|NCT01333501|527943240|FG000|Overall Study|Withdrawn consent|3|||
146393787|NCT01333501|527943241|FG001|Overall Study|Withdrawn consent|12|||
146393788|NCT02243306|527943242|FG000|Overall Study|Adverse Event|0|||
146393789|NCT02243306|527943243|FG001|Overall Study|Adverse Event|1|||
146393790|NCT02243306|527943242|FG000|Overall Study|Other: Reached stopping criteria|0|||
146393791|NCT02243306|527943243|FG001|Overall Study|Other: Reached stopping criteria|1|||
146393792|NCT02243306|527943242|FG000|Overall Study|Physician Decision|0|||
146393793|NCT02243306|527943243|FG001|Overall Study|Physician Decision|1|||
146393794|NCT02221882|527943244|FG000|Overall Study|Withdrawal by Subject|0|||
146393795|NCT02221882|527943245|FG001|Overall Study|Withdrawal by Subject|0|||
146393796|NCT02221882|527943246|FG002|Overall Study|Withdrawal by Subject|4|||
146393797|NCT02221882|527943247|FG003|Overall Study|Withdrawal by Subject|2|||
146393798|NCT02221882|527943248|FG004|Overall Study|Withdrawal by Subject|2|||
146393799|NCT02221882|527943249|FG005|Overall Study|Withdrawal by Subject|2|||
146393800|NCT02221882|527943244|FG000|Overall Study|Death|0|||
146393801|NCT02221882|527943245|FG001|Overall Study|Death|1|||
146393802|NCT02221882|527943246|FG002|Overall Study|Death|0|||
146393803|NCT02221882|527943247|FG003|Overall Study|Death|0|||
146393804|NCT02221882|527943248|FG004|Overall Study|Death|0|||
146393805|NCT02221882|527943249|FG005|Overall Study|Death|0|||
146393806|NCT00796367|527943250|FG000|Overall Study|Adverse Event|6|||
146393807|NCT00796367|527943251|FG001|Overall Study|Adverse Event|4|||
146393808|NCT00796367|527943252|FG002|Overall Study|Adverse Event|7|||
146393809|NCT00796367|527943250|FG000|Overall Study|Lost to Follow-up|5|||
146393810|NCT00796367|527943251|FG001|Overall Study|Lost to Follow-up|4|||
146393811|NCT00796367|527943252|FG002|Overall Study|Lost to Follow-up|21|||
146393812|NCT00796367|527943250|FG000|Overall Study|Withdrawal by Subject|9|||
146393813|NCT00796367|527943251|FG001|Overall Study|Withdrawal by Subject|11|||
146393814|NCT00796367|527943252|FG002|Overall Study|Withdrawal by Subject|12|||
146393815|NCT00796367|527943250|FG000|Overall Study|Lack of Efficacy|2|||
146393816|NCT00796367|527943251|FG001|Overall Study|Lack of Efficacy|1|||
146393817|NCT00796367|527943252|FG002|Overall Study|Lack of Efficacy|0|||
146393818|NCT00796367|527943250|FG000|Overall Study|non compliance|3|||
146393819|NCT00796367|527943251|FG001|Overall Study|non compliance|1|||
146393820|NCT00796367|527943252|FG002|Overall Study|non compliance|1|||
146393821|NCT00796367|527943250|FG000|Overall Study|Pregnancy|1|||
146393822|NCT00796367|527943251|FG001|Overall Study|Pregnancy|0|||
146393823|NCT00796367|527943252|FG002|Overall Study|Pregnancy|1|||
146393824|NCT00796367|527943250|FG000|Overall Study|Requirement for restricted medication|2|||
146393825|NCT00796367|527943251|FG001|Overall Study|Requirement for restricted medication|0|||
146393826|NCT00796367|527943252|FG002|Overall Study|Requirement for restricted medication|2|||
146393827|NCT00796367|527943250|FG000|Overall Study|other|2|||
146393828|NCT00796367|527943251|FG001|Overall Study|other|4|||
146393829|NCT00796367|527943252|FG002|Overall Study|other|3|||
146393830|NCT04246996|527943253|FG000|Overall Study|Physician Decision|1|||
146393831|NCT04246996|527943254|FG001|Overall Study|Physician Decision|1|||
146393832|NCT04246996|527943253|FG000|Overall Study|Did not meet eligibility criteria|1|||
146393833|NCT04246996|527943254|FG001|Overall Study|Did not meet eligibility criteria|4|||
146393834|NCT01815099|527943255|FG000|Overall Study|Lack of Efficacy|1|||
146393835|NCT01815099|527943255|FG000|Overall Study|unable to attend study visits|1|||
146393836|NCT01475214|527943256|FG000|Overall Study|Lost to Follow-up|1|||
146393837|NCT01475214|527943257|FG001|Overall Study|Lost to Follow-up|0|||
146393838|NCT01475214|527943258|FG002|Overall Study|Lost to Follow-up|1|||
146393839|NCT01475214|527943256|FG000|Overall Study|Physician Decision|2|||
146393840|NCT01475214|527943257|FG001|Overall Study|Physician Decision|0|||
146393841|NCT01475214|527943258|FG002|Overall Study|Physician Decision|0|||
146393842|NCT01475214|527943256|FG000|Overall Study|Withdrawal by Subject|2|||
146393843|NCT01475214|527943257|FG001|Overall Study|Withdrawal by Subject|4|||
146393844|NCT01475214|527943258|FG002|Overall Study|Withdrawal by Subject|1|||
146393845|NCT00643851|527943259|FG000|Overall Study|Death|0|||
146393846|NCT00643851|527943260|FG001|Overall Study|Death|1|||
146393847|NCT00643851|527943261|FG002|Overall Study|Death|0|||
146393848|NCT00643851|527943259|FG000|Overall Study|Lack of Efficacy|0|||
146393849|NCT00643851|527943260|FG001|Overall Study|Lack of Efficacy|1|||
146393850|NCT00643851|527943261|FG002|Overall Study|Lack of Efficacy|0|||
146393851|NCT00643851|527943259|FG000|Overall Study|Adverse Event|2|||
146393852|NCT00643851|527943260|FG001|Overall Study|Adverse Event|6|||
146393853|NCT00643851|527943261|FG002|Overall Study|Adverse Event|6|||
146393854|NCT00643851|527943259|FG000|Overall Study|Lost to Follow-up|4|||
146393855|NCT00643851|527943260|FG001|Overall Study|Lost to Follow-up|6|||
146393856|NCT00643851|527943261|FG002|Overall Study|Lost to Follow-up|9|||
146393857|NCT00643851|527943259|FG000|Overall Study|Withdrawal by Subject|8|||
146393858|NCT00643851|527943260|FG001|Overall Study|Withdrawal by Subject|15|||
146393859|NCT00643851|527943261|FG002|Overall Study|Withdrawal by Subject|9|||
146393860|NCT00643851|527943259|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
146393861|NCT00643851|527943260|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
146393862|NCT00643851|527943261|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
146393863|NCT02354599|527943264|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
146393864|NCT02354599|527943265|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
146393865|NCT02354599|527943266|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
146393866|NCT02354599|527943267|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
146393867|NCT02354599|527943268|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
146393868|NCT02354599|527943269|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
146393869|NCT02354599|527943264|FG000|Overall Study|Withdrawal by Subject|1|||
146393870|NCT02354599|527943265|FG001|Overall Study|Withdrawal by Subject|1|||
146393871|NCT02354599|527943266|FG002|Overall Study|Withdrawal by Subject|0|||
146393872|NCT02354599|527943267|FG003|Overall Study|Withdrawal by Subject|0|||
146393873|NCT02354599|527943268|FG004|Overall Study|Withdrawal by Subject|0|||
146393874|NCT02354599|527943269|FG005|Overall Study|Withdrawal by Subject|0|||
146393875|NCT04806334|527943270|FG000|Overall Study|Withdrawal by Subject|1|||
146393876|NCT00495794|527943271|FG000|Overall Study|Pharmacist did not activate patient|522|||
146393877|NCT00495794|527943272|FG001|Overall Study|Pharmacist did not activate patient|0|||
146393878|NCT00465894|527943273|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
146393879|NCT00465894|527943274|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
146393880|NCT00465894|527943273|FG000|Treatment For 12 Weeks|Family Issues|1|||
146393881|NCT00465894|527943274|FG001|Treatment For 12 Weeks|Family Issues|1|||
146393882|NCT00465894|527943273|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
146393883|NCT00465894|527943274|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
146393884|NCT01636076|527943275|FG000|Overall Study|Terminated by sponsor|1|||
146393885|NCT01636076|527943276|FG001|Overall Study|Terminated by sponsor|1|||
146393886|NCT01636076|527943275|FG000|Overall Study|Lack of Efficacy|0|||
146393887|NCT01636076|527943276|FG001|Overall Study|Lack of Efficacy|1|||
146393888|NCT01636076|527943275|FG000|Overall Study|Lost to Follow-up|1|||
146393889|NCT01636076|527943276|FG001|Overall Study|Lost to Follow-up|0|||
146393890|NCT01636076|527943275|FG000|Overall Study|Physician Decision|1|||
146393891|NCT01636076|527943276|FG001|Overall Study|Physician Decision|1|||
146393892|NCT01636076|527943275|FG000|Overall Study|Non-compliance with study treatment|1|||
146393893|NCT01636076|527943276|FG001|Overall Study|Non-compliance with study treatment|1|||
146393894|NCT01636076|527943275|FG000|Overall Study|Adverse Event|6|||
146393895|NCT01636076|527943276|FG001|Overall Study|Adverse Event|11|||
146393896|NCT01636076|527943275|FG000|Overall Study|Withdrawal by Subject|7|||
146393897|NCT01636076|527943276|FG001|Overall Study|Withdrawal by Subject|10|||
146393898|NCT01159665|527943277|FG000|Overall Study|Withdrawal by Subject|0|||
146393899|NCT01159665|527943278|FG001|Overall Study|Withdrawal by Subject|1|||
146393900|NCT01159665|527943279|FG002|Overall Study|Withdrawal by Subject|0|||
146393901|NCT01159665|527943280|FG003|Overall Study|Withdrawal by Subject|0|||
146393902|NCT01159665|527943281|FG004|Overall Study|Withdrawal by Subject|0|||
146393903|NCT01159665|527943282|FG005|Overall Study|Withdrawal by Subject|0|||
146393904|NCT02173158|527943283|FG000|Efficacy Phase|Adverse Event|1|||
146056284|NCT00626275|526721164|FG004|Part B|Withdrawal by Subject|0|||
146056285|NCT00626275|526721165|FG005|Part B|Withdrawal by Subject|0|||
146393905|NCT03077646|527943284|FG000|Overall Study|Lost to Follow-up|29|||
146393906|NCT03077646|527943285|FG001|Overall Study|Lost to Follow-up|30|||
146393907|NCT03077646|527943286|FG002|Overall Study|Lost to Follow-up|31|||
146393908|NCT02058966|527943287|FG000|Open-Label Methamphetamine|Adverse Event|1|||
146393909|NCT02058966|527943287|FG000|First Intervention|Withdrawal by Subject|1|||
146393910|NCT01265511|527943288|FG000|Overall Study|Lack of Efficacy|2|||
146393911|NCT01265511|527943289|FG001|Overall Study|Lack of Efficacy|1|||
146393912|NCT01265511|527943288|FG000|Overall Study|Met stopping rules|0|||
146393913|NCT01265511|527943289|FG001|Overall Study|Met stopping rules|2|||
146393914|NCT01018680|527945146|FG000|Overall Study|Adverse Event|23|||
146393915|NCT01018680|527945147|FG001|Overall Study|Adverse Event|40|||
146393916|NCT01018680|527945146|FG000|Overall Study|Withdrawal by Subject|10|||
146393917|NCT01018680|527945147|FG001|Overall Study|Withdrawal by Subject|10|||
146393918|NCT01018680|527945146|FG000|Overall Study|Protocol Violation|5|||
146393919|NCT01018680|527945147|FG001|Overall Study|Protocol Violation|8|||
146393920|NCT01018680|527945146|FG000|Overall Study|Sponsor Decision|6|||
146393921|NCT01018680|527945147|FG001|Overall Study|Sponsor Decision|7|||
146393922|NCT01018680|527945146|FG000|Overall Study|Lack of Efficacy|8|||
146393923|NCT01018680|527945147|FG001|Overall Study|Lack of Efficacy|2|||
146393924|NCT01018680|527945146|FG000|Overall Study|Lost to Follow-up|5|||
146393925|NCT01018680|527945147|FG001|Overall Study|Lost to Follow-up|3|||
146393926|NCT01018680|527945146|FG000|Overall Study|Entry Criteria Not Met|1|||
146393927|NCT01018680|527945147|FG001|Overall Study|Entry Criteria Not Met|4|||
146393928|NCT01018680|527945146|FG000|Overall Study|Physician Decision|3|||
146393929|NCT01018680|527945147|FG001|Overall Study|Physician Decision|1|||
146393930|NCT02930889|527945148|FG000|Overall Study|Lost to Follow-up|2|||
146393931|NCT02930889|527945148|FG000|Overall Study|Withdrawal by Subject|6|||
146393932|NCT02930889|527945148|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
146393933|NCT05056311|527945151|FG000|Overall Study|Lost to Follow-up|14|||
146393934|NCT05056311|527945151|FG000|Overall Study|Withdrawal by Subject|1|||
146393935|NCT05056311|527945151|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
146393936|NCT03799198|527945153|FG000|Overall Study|Lost to Follow-up|4|||
146393937|NCT03799198|527945154|FG001|Overall Study|Lost to Follow-up|8|||
146393938|NCT03799198|527945153|FG000|Overall Study|Death|0|||
146393939|NCT03799198|527945154|FG001|Overall Study|Death|1|||
146393940|NCT00960869|527945155|FG000|Overall Study|Adverse Event|17|||
146393941|NCT00960869|527945156|FG001|Overall Study|Adverse Event|26|||
146393942|NCT00960869|527945155|FG000|Overall Study|Withdrawal by Subject|16|||
146393943|NCT00960869|527945156|FG001|Overall Study|Withdrawal by Subject|14|||
146393944|NCT00960869|527945155|FG000|Overall Study|Lost to Follow-up|1|||
146393945|NCT00960869|527945156|FG001|Overall Study|Lost to Follow-up|4|||
146393946|NCT00960869|527945155|FG000|Overall Study|Misc|19|||
146393947|NCT00960869|527945156|FG001|Overall Study|Misc|18|||
146393948|NCT01714726|527945157|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
146393949|NCT01714726|527945158|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
146393950|NCT01714726|527945159|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
146393951|NCT01714726|527945160|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
146393952|NCT01714726|527945157|FG000|Double-Blinded Induction Period|Adverse Event|0|||
146393953|NCT01714726|527945158|FG001|Double-Blinded Induction Period|Adverse Event|1|||
146393954|NCT01714726|527945159|FG002|Double-Blinded Induction Period|Adverse Event|0|||
146393955|NCT01714726|527945160|FG003|Double-Blinded Induction Period|Adverse Event|0|||
146393956|NCT01714726|527945157|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
146393957|NCT01714726|527945158|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
146393958|NCT01714726|527945159|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
146393959|NCT01714726|527945160|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
146393960|NCT01714726|527945157|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
146393961|NCT01714726|527945158|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
146393962|NCT01714726|527945159|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
146393963|NCT01714726|527945160|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
146393964|NCT01714726|527945157|FG000|Open-Label Period|Other|0|||
146393965|NCT01714726|527945158|FG001|Open-Label Period|Other|0|||
146393966|NCT01714726|527945159|FG002|Open-Label Period|Other|1|||
146393967|NCT01714726|527945160|FG003|Open-Label Period|Other|3|||
146393968|NCT01714726|527945157|FG000|Open-Label Period|Adverse Event|0|||
146393969|NCT01714726|527945158|FG001|Open-Label Period|Adverse Event|0|||
146393970|NCT01714726|527945159|FG002|Open-Label Period|Adverse Event|1|||
146393971|NCT01714726|527945160|FG003|Open-Label Period|Adverse Event|0|||
146393972|NCT01714726|527945157|FG000|Open-Label Period|Withdrawal by Subject|0|||
146393973|NCT01714726|527945158|FG001|Open-Label Period|Withdrawal by Subject|0|||
146393974|NCT01714726|527945159|FG002|Open-Label Period|Withdrawal by Subject|9|||
146393975|NCT01714726|527945160|FG003|Open-Label Period|Withdrawal by Subject|19|||
146393976|NCT01714726|527945157|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
146393977|NCT01714726|527945158|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
146393978|NCT01714726|527945159|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
146393979|NCT01714726|527945160|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
146393980|NCT01714726|527945157|FG000|Open-Label Period|Lost to Follow-up|0|||
146393981|NCT01714726|527945158|FG001|Open-Label Period|Lost to Follow-up|0|||
146393982|NCT01714726|527945159|FG002|Open-Label Period|Lost to Follow-up|3|||
146393983|NCT01714726|527945160|FG003|Open-Label Period|Lost to Follow-up|4|||
146393984|NCT02501642|527945161|FG000|Overall Study|Lost to Follow-up|7|||
146393985|NCT02501642|527945162|FG001|Overall Study|Lost to Follow-up|11|||
146393986|NCT01846442|527945163|FG000|Overall Study|Adverse Event|2|||
146393987|NCT01846442|527945164|FG001|Overall Study|Adverse Event|4|||
146393988|NCT01846442|527945165|FG002|Overall Study|Adverse Event|2|||
146393989|NCT01846442|527945166|FG003|Overall Study|Adverse Event|1|||
146393990|NCT01846442|527945163|FG000|Overall Study|Lost to Follow-up|0|||
146393991|NCT01846442|527945164|FG001|Overall Study|Lost to Follow-up|0|||
146393992|NCT01846442|527945165|FG002|Overall Study|Lost to Follow-up|1|||
146393993|NCT01846442|527945166|FG003|Overall Study|Lost to Follow-up|0|||
146393994|NCT01846442|527945163|FG000|Overall Study|Withdrawal by Subject|3|||
146393995|NCT01846442|527945164|FG001|Overall Study|Withdrawal by Subject|2|||
146393996|NCT01846442|527945165|FG002|Overall Study|Withdrawal by Subject|0|||
146393997|NCT01846442|527945166|FG003|Overall Study|Withdrawal by Subject|1|||
146393998|NCT01846442|527945163|FG000|Overall Study|Left the city/Lost medication|1|||
146393999|NCT01846442|527945164|FG001|Overall Study|Left the city/Lost medication|0|||
146394000|NCT01846442|527945165|FG002|Overall Study|Left the city/Lost medication|1|||
146394001|NCT01846442|527945166|FG003|Overall Study|Left the city/Lost medication|1|||
146394002|NCT01153971|527945173|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
146394003|NCT01153971|527945173|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
146394004|NCT01153971|527945173|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
146394005|NCT01153971|527945173|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
146394006|NCT01153971|527945173|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
146394007|NCT01153971|527945173|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
146394008|NCT01153971|527945173|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
146394009|NCT03628781|527945174|FG000|Overall Study|Lost to Follow-up|16|||
146394010|NCT03628781|527945175|FG001|Overall Study|Lost to Follow-up|8|||
146394011|NCT03628781|527945174|FG000|Overall Study|Withdrawal by Subject|16|||
146394012|NCT03628781|527945175|FG001|Overall Study|Withdrawal by Subject|1|||
146394013|NCT00379639|527945176|FG000|Overall Study|Disease Progression|3|||
146394014|NCT00379639|527945177|FG001|Overall Study|Disease Progression|3|||
146394015|NCT00379639|527945178|FG002|Overall Study|Disease Progression|3|||
146394016|NCT00379639|527945179|FG003|Overall Study|Disease Progression|4|||
146394017|NCT00379639|527945180|FG004|Overall Study|Disease Progression|4|||
146394018|NCT00379639|527945176|FG000|Overall Study|Physician Decision|0|||
146394019|NCT00379639|527945177|FG001|Overall Study|Physician Decision|2|||
146394020|NCT00379639|527945178|FG002|Overall Study|Physician Decision|1|||
146394021|NCT00379639|527945179|FG003|Overall Study|Physician Decision|1|||
146394022|NCT00379639|527945180|FG004|Overall Study|Physician Decision|0|||
146394023|NCT00379639|527945176|FG000|Overall Study|Symptomatic Deterioration|0|||
146394024|NCT00379639|527945177|FG001|Overall Study|Symptomatic Deterioration|0|||
146394025|NCT00379639|527945178|FG002|Overall Study|Symptomatic Deterioration|1|||
146394026|NCT00379639|527945179|FG003|Overall Study|Symptomatic Deterioration|0|||
146394027|NCT00379639|527945180|FG004|Overall Study|Symptomatic Deterioration|1|||
146394028|NCT00379639|527945176|FG000|Overall Study|Adverse Event|0|||
146394029|NCT00379639|527945177|FG001|Overall Study|Adverse Event|0|||
146394030|NCT00379639|527945178|FG002|Overall Study|Adverse Event|1|||
146394031|NCT00379639|527945179|FG003|Overall Study|Adverse Event|0|||
146394032|NCT00379639|527945180|FG004|Overall Study|Adverse Event|1|||
146394033|NCT00379639|527945176|FG000|Overall Study|Lost to Follow-up|0|||
146394034|NCT00379639|527945177|FG001|Overall Study|Lost to Follow-up|0|||
146394035|NCT00379639|527945178|FG002|Overall Study|Lost to Follow-up|0|||
146394036|NCT00379639|527945179|FG003|Overall Study|Lost to Follow-up|1|||
146394037|NCT00379639|527945180|FG004|Overall Study|Lost to Follow-up|0|||
146394038|NCT00379639|527945176|FG000|Overall Study|Other|0|||
146394039|NCT00379639|527945177|FG001|Overall Study|Other|0|||
146394040|NCT00379639|527945178|FG002|Overall Study|Other|3|||
146394041|NCT00379639|527945179|FG003|Overall Study|Other|0|||
146394042|NCT00379639|527945180|FG004|Overall Study|Other|0|||
146394043|NCT03053102|527945181|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
146394044|NCT03053102|527945181|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
146394045|NCT01798056|527945182|FG000|Overall Study|Serious Adverse Event|13|||
146394046|NCT01798056|527945183|FG001|Overall Study|Serious Adverse Event|12|||
146394047|NCT01798056|527945182|FG000|Overall Study|Withdrawal by Subject|12|||
146394048|NCT01798056|527945183|FG001|Overall Study|Withdrawal by Subject|9|||
146394049|NCT01798056|527945182|FG000|Overall Study|Migrated/moved from study area|1|||
146394050|NCT01798056|527945183|FG001|Overall Study|Migrated/moved from study area|1|||
146394051|NCT01798056|527945182|FG000|Overall Study|Lost to Follow-up|1|||
146394052|NCT01798056|527945183|FG001|Overall Study|Lost to Follow-up|1|||
146394053|NCT01798056|527945182|FG000|Overall Study|Other|0|||
146394054|NCT01798056|527945183|FG001|Overall Study|Other|2|||
146394055|NCT01238861|527945186|FG000|Overall Study|Lost to Follow-up|4|||
146394056|NCT01238861|527945187|FG001|Overall Study|Lost to Follow-up|2|||
146394057|NCT01238861|527945188|FG002|Overall Study|Lost to Follow-up|3|||
146394058|NCT01238861|527945189|FG003|Overall Study|Lost to Follow-up|1|||
146394059|NCT01238861|527945190|FG004|Overall Study|Lost to Follow-up|1|||
146394060|NCT01238861|527945191|FG005|Overall Study|Lost to Follow-up|2|||
146394061|NCT01238861|527945186|FG000|Overall Study|Unplanned surgery|1|||
146394062|NCT01238861|527945187|FG001|Overall Study|Unplanned surgery|0|||
146394063|NCT01238861|527945188|FG002|Overall Study|Unplanned surgery|0|||
146394064|NCT01238861|527945189|FG003|Overall Study|Unplanned surgery|0|||
146394065|NCT01238861|527945190|FG004|Overall Study|Unplanned surgery|0|||
146394066|NCT01238861|527945191|FG005|Overall Study|Unplanned surgery|0|||
146394067|NCT01238861|527945186|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146394068|NCT01238861|527945187|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146394069|NCT01238861|527945188|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146394070|NCT01238861|527945189|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
146394071|NCT01238861|527945190|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146394072|NCT01238861|527945191|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
146394073|NCT01238861|527945186|FG000|Overall Study|Incorrect enrollment/randomization|0|||
146394074|NCT01238861|527945187|FG001|Overall Study|Incorrect enrollment/randomization|0|||
146394075|NCT01238861|527945188|FG002|Overall Study|Incorrect enrollment/randomization|1|||
146394076|NCT01238861|527945189|FG003|Overall Study|Incorrect enrollment/randomization|0|||
146394077|NCT01238861|527945190|FG004|Overall Study|Incorrect enrollment/randomization|1|||
146394078|NCT01238861|527945191|FG005|Overall Study|Incorrect enrollment/randomization|0|||
146394079|NCT01238861|527945186|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
146394080|NCT01238861|527945187|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
146394081|NCT01238861|527945188|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
146394082|NCT01238861|527945189|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
146394083|NCT01238861|527945190|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
146394084|NCT01238861|527945191|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
146394085|NCT01238861|527945186|FG000|Overall Study|Subject moved out of state/area|0|||
146394086|NCT01238861|527945187|FG001|Overall Study|Subject moved out of state/area|0|||
146394087|NCT01238861|527945188|FG002|Overall Study|Subject moved out of state/area|1|||
146394088|NCT01238861|527945189|FG003|Overall Study|Subject moved out of state/area|1|||
146394089|NCT01238861|527945190|FG004|Overall Study|Subject moved out of state/area|0|||
146394090|NCT01238861|527945191|FG005|Overall Study|Subject moved out of state/area|0|||
146394091|NCT01238861|527945186|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
146394092|NCT01238861|527945187|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
146394093|NCT01238861|527945188|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
146394094|NCT01238861|527945189|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
146394095|NCT01238861|527945190|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
146394096|NCT01238861|527945191|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
146394097|NCT01238861|527945186|FG000|Overall Study|Personal problems|0|||
146394098|NCT01238861|527945187|FG001|Overall Study|Personal problems|0|||
146394099|NCT01238861|527945188|FG002|Overall Study|Personal problems|0|||
146394100|NCT01238861|527945189|FG003|Overall Study|Personal problems|1|||
146394101|NCT01238861|527945190|FG004|Overall Study|Personal problems|0|||
146394102|NCT01238861|527945191|FG005|Overall Study|Personal problems|0|||
146394103|NCT01238861|527945186|FG000|Overall Study|Unable to continue visits|0|||
146394104|NCT01238861|527945187|FG001|Overall Study|Unable to continue visits|0|||
146394105|NCT01238861|527945188|FG002|Overall Study|Unable to continue visits|0|||
146394106|NCT01238861|527945189|FG003|Overall Study|Unable to continue visits|1|||
146394107|NCT01238861|527945190|FG004|Overall Study|Unable to continue visits|0|||
146394108|NCT01238861|527945191|FG005|Overall Study|Unable to continue visits|1|||
146394109|NCT01238861|527945186|FG000|Overall Study|Serious adverse event|0|||
146394110|NCT01238861|527945187|FG001|Overall Study|Serious adverse event|0|||
146394111|NCT01238861|527945188|FG002|Overall Study|Serious adverse event|0|||
146394112|NCT01238861|527945189|FG003|Overall Study|Serious adverse event|0|||
146394113|NCT01238861|527945190|FG004|Overall Study|Serious adverse event|0|||
146394114|NCT01238861|527945191|FG005|Overall Study|Serious adverse event|1|||
146394115|NCT01238861|527945186|FG000|Overall Study|Lack of compliance|0|||
146394116|NCT01238861|527945187|FG001|Overall Study|Lack of compliance|0|||
146394117|NCT01238861|527945188|FG002|Overall Study|Lack of compliance|0|||
146394118|NCT01238861|527945189|FG003|Overall Study|Lack of compliance|0|||
146394119|NCT01238861|527945190|FG004|Overall Study|Lack of compliance|0|||
146394120|NCT01238861|527945191|FG005|Overall Study|Lack of compliance|1|||
146394121|NCT01238861|527945186|FG000|Overall Study|Adverse Event|0|||
146394122|NCT01238861|527945187|FG001|Overall Study|Adverse Event|1|||
146394123|NCT01238861|527945188|FG002|Overall Study|Adverse Event|0|||
146394124|NCT01238861|527945189|FG003|Overall Study|Adverse Event|0|||
146394125|NCT01238861|527945190|FG004|Overall Study|Adverse Event|0|||
146394126|NCT01238861|527945191|FG005|Overall Study|Adverse Event|0|||
146394127|NCT01238861|527945186|FG000|Overall Study|Withdrawal by Subject|6|||
146394128|NCT01238861|527945187|FG001|Overall Study|Withdrawal by Subject|5|||
146394129|NCT01238861|527945188|FG002|Overall Study|Withdrawal by Subject|4|||
146394130|NCT01238861|527945189|FG003|Overall Study|Withdrawal by Subject|8|||
146394131|NCT01238861|527945190|FG004|Overall Study|Withdrawal by Subject|10|||
146394132|NCT01238861|527945191|FG005|Overall Study|Withdrawal by Subject|9|||
146394133|NCT01269346|527945192|FG000|Treatment Phase|Disease progression|3|||
146394134|NCT01269346|527945192|FG000|Treatment Phase|Adverse Event|3|||
146394135|NCT01269346|527945192|FG000|Treatment Phase|Withdrawal by Subject|1|||
146394136|NCT01269346|527945192|FG000|Treatment Phase|Other|2|||
146394137|NCT01269346|527945192|FG000|Extension Phase|Adverse Event|6|||
146394138|NCT01269346|527945192|FG000|Extension Phase|Withdrawal by Subject|4|||
146394139|NCT01269346|527945192|FG000|Extension Phase|Disease progression|22|||
146394140|NCT01269346|527945192|FG000|Extension Phase|Physician decision or participant choice|9|||
146394141|NCT01269346|527945192|FG000|Extension Phase|Clinical progression|1|||
146394142|NCT01269346|527945192|FG000|Extension Phase|Started a prohibited con med|1|||
146394143|NCT00247416|527945193|FG000|Overall Study|3 patients were found to be ineligible|1|||
146394144|NCT00247416|527945194|FG001|Overall Study|3 patients were found to be ineligible|2|||
146394145|NCT04963231|527945196|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
146394146|NCT04963231|527945197|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
146394147|NCT04963231|527945198|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
146394148|NCT04963231|527945196|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
146394149|NCT04963231|527945197|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
146394150|NCT04963231|527945198|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
146394151|NCT04963231|527945196|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
146394152|NCT04963231|527945197|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
146394153|NCT04963231|527945198|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
146394154|NCT04963231|527945196|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
146394155|NCT04963231|527945197|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
146394156|NCT04963231|527945198|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
146394157|NCT04963231|527945196|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
146394158|NCT04963231|527945197|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
146394159|NCT04963231|527945198|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
146394160|NCT04963231|527945196|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
146394161|NCT04963231|527945197|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
146394162|NCT04963231|527945198|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
146394163|NCT04963231|527945196|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
146394164|NCT04963231|527945197|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
146394165|NCT04963231|527945198|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
146394166|NCT01059175|527945199|FG000|Overall Study|Death|17|||
146394167|NCT01059175|527945200|FG001|Overall Study|Death|17|||
146394168|NCT01059175|527945199|FG000|Overall Study|Adverse Event|4|||
146394169|NCT01059175|527945200|FG001|Overall Study|Adverse Event|2|||
146394170|NCT01059175|527945199|FG000|Overall Study|Lost to Follow-up|0|||
146394171|NCT01059175|527945200|FG001|Overall Study|Lost to Follow-up|1|||
146394172|NCT02957149|527945201|FG000|Overall Study|Withdrawal by Subject|5|||
146394173|NCT01928758|527945207|FG000|Overall Study|Lost to Follow-up|14|||
146394174|NCT01928758|527945208|FG001|Overall Study|Lost to Follow-up|9|||
146394175|NCT01928758|527945207|FG000|Overall Study|Withdrawal by Subject|5|||
146394176|NCT01928758|527945208|FG001|Overall Study|Withdrawal by Subject|2|||
146394177|NCT01928758|527945207|FG000|Overall Study|Adverse Event|3|||
146394178|NCT01928758|527945208|FG001|Overall Study|Adverse Event|5|||
146394179|NCT01928758|527945207|FG000|Overall Study|Protocol Violation|3|||
146394180|NCT01928758|527945208|FG001|Overall Study|Protocol Violation|4|||
146394181|NCT02718131|527945209|FG000|Overall Study|Withdrawal by Subject|1|||
146394182|NCT02718131|527945210|FG001|Overall Study|Withdrawal by Subject|0|||
146394183|NCT02718131|527945209|FG000|Overall Study|Adverse Event|1|||
146394184|NCT02718131|527945210|FG001|Overall Study|Adverse Event|0|||
146394185|NCT02718131|527945209|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
146394186|NCT02718131|527945210|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
146394187|NCT01097057|527945211|FG000|Overall Study|Physician Decision|3|||
146394188|NCT03198559|527945215|FG000|Overall Study|Adverse Event|2|||
146394189|NCT03737812|527945216|FG000|Overall Study|Withdrawal by Subject|1|||
146394190|NCT03737812|527945217|FG001|Overall Study|Withdrawal by Subject|2|||
146394191|NCT03737812|527945218|FG002|Overall Study|Withdrawal by Subject|1|||
146394192|NCT03737812|527945216|FG000|Overall Study|Sponsor Discontinued the Study|4|||
146394193|NCT03737812|527945217|FG001|Overall Study|Sponsor Discontinued the Study|3|||
146394194|NCT03737812|527945218|FG002|Overall Study|Sponsor Discontinued the Study|2|||
146394195|NCT03737812|527945216|FG000|Overall Study|Adverse Event|0|||
146394196|NCT03737812|527945217|FG001|Overall Study|Adverse Event|1|||
146394197|NCT03737812|527945218|FG002|Overall Study|Adverse Event|0|||
146394198|NCT03737812|527945216|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
146394199|NCT03737812|527945217|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
146394200|NCT03737812|527945218|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
146394201|NCT02624713|527945219|FG000|Overall Study|Lost to Follow-up|14|||
146394202|NCT02624713|527945220|FG001|Overall Study|Lost to Follow-up|0|||
146394203|NCT01911546|527945224|FG000|Overall Study|Lost to Follow-up|1|||
146394204|NCT01911546|527945224|FG000|Overall Study|Everolimus was discontinued|5|||
146394205|NCT01474291|527945229|FG000|Overall Study|Not Evaluable for Efficacy|26|||
146056286|NCT00626275|526721166|FG006|Part B|Withdrawal by Subject|0|||
146394206|NCT01474291|527945229|FG000|Overall Study|Lack of Treatment Efficacy|88|||
146394207|NCT01474291|527945229|FG000|Overall Study|Adverse Event|53|||
146394208|NCT01474291|527945229|FG000|Overall Study|Lost to Follow-up|29|||
146396133|NCT01241591|527954455|FG003|Overall Study|Protocol Violation|0|||
146394209|NCT01474291|527945229|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
146394210|NCT01474291|527945229|FG000|Overall Study|No Reason Reported|10|||
146394211|NCT01474291|527945229|FG000|Overall Study|Death|2|||
146394212|NCT03471507|527945230|FG000|Overall Study|Lost to Follow-up|1|||
146394213|NCT03471507|527945231|FG001|Overall Study|Lost to Follow-up|3|||
146394214|NCT03471507|527945230|FG000|Overall Study|Physician Decision|0|||
146394215|NCT03471507|527945231|FG001|Overall Study|Physician Decision|1|||
146394216|NCT03471507|527945230|FG000|Overall Study|Withdrawal by Subject|2|||
146394217|NCT03471507|527945231|FG001|Overall Study|Withdrawal by Subject|1|||
146394218|NCT02213666|527945232|FG000|Overall Study|Withdrawal by Subject|1|||
146394219|NCT01399619|527945233|FG000|Overall Study|Adverse Event|10|||
146394220|NCT01399619|527945234|FG001|Overall Study|Adverse Event|0|||
146394221|NCT01399619|527945235|FG002|Overall Study|Adverse Event|4|||
146394222|NCT01399619|527945236|FG003|Overall Study|Adverse Event|10|||
146394223|NCT01399619|527945233|FG000|Overall Study|Lack of Efficacy|9|||
146394224|NCT01399619|527945234|FG001|Overall Study|Lack of Efficacy|0|||
146394225|NCT01399619|527945235|FG002|Overall Study|Lack of Efficacy|5|||
146394226|NCT01399619|527945236|FG003|Overall Study|Lack of Efficacy|0|||
146394227|NCT01399619|527945233|FG000|Overall Study|Withdrawal by Subject|6|||
146394228|NCT01399619|527945234|FG001|Overall Study|Withdrawal by Subject|0|||
146394229|NCT01399619|527945235|FG002|Overall Study|Withdrawal by Subject|3|||
146394230|NCT01399619|527945236|FG003|Overall Study|Withdrawal by Subject|4|||
146394231|NCT01399619|527945233|FG000|Overall Study|Protocol Violation|0|||
146394232|NCT01399619|527945234|FG001|Overall Study|Protocol Violation|0|||
146394233|NCT01399619|527945235|FG002|Overall Study|Protocol Violation|0|||
146394234|NCT01399619|527945236|FG003|Overall Study|Protocol Violation|1|||
146394235|NCT01399619|527945233|FG000|Overall Study|Not treated|0|||
146394236|NCT01399619|527945234|FG001|Overall Study|Not treated|0|||
146394237|NCT01399619|527945235|FG002|Overall Study|Not treated|0|||
146394238|NCT01399619|527945236|FG003|Overall Study|Not treated|2|||
146394239|NCT00750061|527945237|FG000|Overall Study|Adverse Event|2|||
146394240|NCT00750061|527945238|FG001|Overall Study|Adverse Event|0|||
146394241|NCT00750061|527945237|FG000|Overall Study|Withdrawal by Subject|0|||
146394242|NCT00750061|527945238|FG001|Overall Study|Withdrawal by Subject|1|||
146394243|NCT00750061|527945237|FG000|Overall Study|Physician Decision|0|||
146394244|NCT00750061|527945238|FG001|Overall Study|Physician Decision|1|||
146394245|NCT00229931|527945261|FG000|Overall Study|Death|1|||
146394246|NCT00229931|527945262|FG001|Overall Study|Death|0|||
146394247|NCT00229931|527945261|FG000|Overall Study|Lost to Follow-up|3|||
146394248|NCT00229931|527945262|FG001|Overall Study|Lost to Follow-up|2|||
146394249|NCT00475657|527945263|FG000|Overall Study|Death|1|||
146394250|NCT00475657|527945263|FG000|Overall Study|Sponsor's Decision|3|||
146394251|NCT02992743|527945264|FG000|Overall Study|Withdrawal by Subject|1|||
146394252|NCT02992743|527945265|FG001|Overall Study|Withdrawal by Subject|1|||
146394253|NCT02992743|527945264|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
146394254|NCT02992743|527945265|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
146394255|NCT02992743|527945264|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
146394256|NCT02992743|527945265|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
146394257|NCT02992743|527945264|FG000|Overall Study|No measurable disease|1|||
146394258|NCT02992743|527945265|FG001|Overall Study|No measurable disease|0|||
146394259|NCT02992743|527945264|FG000|Overall Study|Lost to Follow-up|0|||
146394260|NCT02992743|527945265|FG001|Overall Study|Lost to Follow-up|1|||
146394261|NCT00998166|527945268|FG000|Overall Study|Early Study Termination|8|||
146394262|NCT04585906|527945281|FG000|Overall Study|Lost to Follow-up|8|||
146394263|NCT04585906|527945282|FG001|Overall Study|Lost to Follow-up|5|||
146394264|NCT03289676|527945286|FG000|Overall Study|Withdrawal by Subject|2|||
146394265|NCT03289676|527945287|FG001|Overall Study|Withdrawal by Subject|0|||
146394266|NCT03289676|527945286|FG000|Overall Study|Protocol Violation|2|||
146394267|NCT03289676|527945287|FG001|Overall Study|Protocol Violation|0|||
146394268|NCT03289676|527945286|FG000|Overall Study|Lost to Follow-up|0|||
146394269|NCT03289676|527945287|FG001|Overall Study|Lost to Follow-up|1|||
146394270|NCT02576652|527945288|FG000|Overall Study|Withdrawal by Subject|2|||
146394271|NCT04557189|527945297|FG000|Overall Study|Adverse Event|0|||
146394272|NCT04557189|527945298|FG001|Overall Study|Adverse Event|1|||
146394273|NCT04557189|527945297|FG000|Overall Study|Lost to Follow-up|1|||
146394274|NCT04557189|527945298|FG001|Overall Study|Lost to Follow-up|1|||
146394275|NCT04557189|527945297|FG000|Overall Study|Withdrawal by Subject|2|||
146394276|NCT04557189|527945298|FG001|Overall Study|Withdrawal by Subject|1|||
146394277|NCT04557189|527945297|FG000|Overall Study|Reason not Specified|3|||
146394278|NCT04557189|527945298|FG001|Overall Study|Reason not Specified|6|||
146394279|NCT01087944|527945312|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
146394280|NCT01087944|527945313|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
146394281|NCT01087944|527945312|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
146394282|NCT01087944|527945313|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
146394283|NCT00540228|527945314|FG000|Overall Study|Adverse Event|2|||
146394284|NCT00540228|527945315|FG001|Overall Study|Adverse Event|0|||
146394285|NCT00540228|527945316|FG002|Overall Study|Adverse Event|0|||
146394286|NCT00540228|527945317|FG003|Overall Study|Adverse Event|0|||
146394287|NCT00540228|527945318|FG004|Overall Study|Adverse Event|0|||
146394288|NCT00540228|527945314|FG000|Overall Study|Lost to Follow-up|1|||
146394289|NCT00540228|527945315|FG001|Overall Study|Lost to Follow-up|1|||
146394290|NCT00540228|527945316|FG002|Overall Study|Lost to Follow-up|0|||
146394291|NCT00540228|527945317|FG003|Overall Study|Lost to Follow-up|0|||
146394292|NCT00540228|527945318|FG004|Overall Study|Lost to Follow-up|0|||
146394293|NCT02451137|527945319|FG000|Overall Study|Randomized but not treated|19|||
146394294|NCT02451137|527945320|FG001|Overall Study|Randomized but not treated|27|||
146394295|NCT02451137|527945319|FG000|Overall Study|Adverse Event|43|||
146394296|NCT02451137|527945320|FG001|Overall Study|Adverse Event|42|||
146394297|NCT02451137|527945319|FG000|Overall Study|Lack of Efficacy|4|||
146394298|NCT02451137|527945320|FG001|Overall Study|Lack of Efficacy|9|||
146394299|NCT02451137|527945319|FG000|Overall Study|Participant decision:discontinue insulin|41|||
146394300|NCT02451137|527945320|FG001|Overall Study|Participant decision:discontinue insulin|43|||
146394301|NCT02451137|527945319|FG000|Overall Study|Hypoglycemia|2|||
146394302|NCT02451137|527945320|FG001|Overall Study|Hypoglycemia|1|||
146394303|NCT02451137|527945319|FG000|Overall Study|Investigator's decision|23|||
146394304|NCT02451137|527945320|FG001|Overall Study|Investigator's decision|19|||
146394305|NCT02451137|527945319|FG000|Overall Study|Lost to Follow-up|53|||
146394306|NCT02451137|527945320|FG001|Overall Study|Lost to Follow-up|61|||
146394307|NCT02451137|527945319|FG000|Overall Study|Physician Decision|6|||
146394308|NCT02451137|527945320|FG001|Overall Study|Physician Decision|5|||
146394309|NCT02451137|527945319|FG000|Overall Study|Sponsor decision|13|||
146394310|NCT02451137|527945320|FG001|Overall Study|Sponsor decision|25|||
146394311|NCT02451137|527945319|FG000|Overall Study|Withdrawal by Subject|40|||
146394312|NCT02451137|527945320|FG001|Overall Study|Withdrawal by Subject|63|||
146394313|NCT02451137|527945319|FG000|Overall Study|Other than specified above|2|||
146394314|NCT02451137|527945320|FG001|Overall Study|Other than specified above|3|||
146394315|NCT01977573|527945321|FG000|Overall Study|Adverse Event|7|||
146394316|NCT01977573|527945322|FG001|Overall Study|Adverse Event|0|||
146394317|NCT01977573|527945323|FG002|Overall Study|Adverse Event|2|||
146394318|NCT01977573|527945324|FG003|Overall Study|Adverse Event|1|||
146394319|NCT01977573|527945321|FG000|Overall Study|Lost to Follow-up|1|||
146394320|NCT01977573|527945322|FG001|Overall Study|Lost to Follow-up|0|||
146394321|NCT01977573|527945323|FG002|Overall Study|Lost to Follow-up|0|||
146394322|NCT01977573|527945324|FG003|Overall Study|Lost to Follow-up|1|||
146394323|NCT01977573|527945321|FG000|Overall Study|Physician Decision|1|||
146394324|NCT01977573|527945322|FG001|Overall Study|Physician Decision|0|||
146394325|NCT01977573|527945323|FG002|Overall Study|Physician Decision|0|||
146394326|NCT01977573|527945324|FG003|Overall Study|Physician Decision|0|||
146394327|NCT01977573|527945321|FG000|Overall Study|Protocol Violation|3|||
146394328|NCT01977573|527945322|FG001|Overall Study|Protocol Violation|1|||
146394329|NCT01977573|527945323|FG002|Overall Study|Protocol Violation|0|||
146394330|NCT01977573|527945324|FG003|Overall Study|Protocol Violation|0|||
146394331|NCT01977573|527945321|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
146394332|NCT01977573|527945322|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
146394333|NCT01977573|527945323|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
146394334|NCT01977573|527945324|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
146394335|NCT01977573|527945321|FG000|Overall Study|Withdrawal by Subject|6|||
146394336|NCT01977573|527945322|FG001|Overall Study|Withdrawal by Subject|1|||
146394337|NCT01977573|527945323|FG002|Overall Study|Withdrawal by Subject|1|||
146394338|NCT01977573|527945324|FG003|Overall Study|Withdrawal by Subject|1|||
146394339|NCT00198107|527946899|FG000|Double-Blind Period|Adverse Event|1|||
146394340|NCT00198107|527946900|FG001|Double-Blind Period|Adverse Event|1|||
146394341|NCT00198107|527946901|FG002|Double-Blind Period|Adverse Event|0|||
146394342|NCT00198107|527946899|FG000|Double-Blind Period|Lack of Efficacy|2|||
146394343|NCT00198107|527946900|FG001|Double-Blind Period|Lack of Efficacy|0|||
146394344|NCT00198107|527946901|FG002|Double-Blind Period|Lack of Efficacy|0|||
146394345|NCT00198107|527946899|FG000|Double-Blind Period|Lost to Follow-up|2|||
146394346|NCT00198107|527946900|FG001|Double-Blind Period|Lost to Follow-up|1|||
146394347|NCT00198107|527946901|FG002|Double-Blind Period|Lost to Follow-up|0|||
146394348|NCT00198107|527946899|FG000|Double-Blind Period|Physician Decision|1|||
146394349|NCT00198107|527946900|FG001|Double-Blind Period|Physician Decision|0|||
146394350|NCT00198107|527946901|FG002|Double-Blind Period|Physician Decision|0|||
146394351|NCT00198107|527946899|FG000|Double-Blind Period|Withdrawal by Subject|0|||
146394352|NCT00198107|527946900|FG001|Double-Blind Period|Withdrawal by Subject|1|||
146394353|NCT00198107|527946901|FG002|Double-Blind Period|Withdrawal by Subject|0|||
146394354|NCT00198107|527946899|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
146394355|NCT00198107|527946900|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
146394356|NCT00198107|527946901|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
146394357|NCT02513732|527946902|FG000|Overall Study|Lost to Follow-up|11|||
146394358|NCT02513732|527946902|FG000|Overall Study|Death|9|||
146394359|NCT02513732|527946902|FG000|Overall Study|Changing hospital|2|||
146394360|NCT00934661|527946903|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
146394361|NCT00934661|527946904|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
146394362|NCT02660489|527946913|FG000|Overall Study|Lost to Follow-up|1|||
146394363|NCT02660489|527946914|FG001|Overall Study|Lost to Follow-up|1|||
146394364|NCT02660489|527946913|FG000|Overall Study|Adverse Event|1|||
146394365|NCT02660489|527946914|FG001|Overall Study|Adverse Event|3|||
146394366|NCT02660489|527946913|FG000|Overall Study|no rhinovirus infection|4|||
146394367|NCT02660489|527946914|FG001|Overall Study|no rhinovirus infection|4|||
146394368|NCT00474994|527946915|FG000|Overall Study|Patient Not treated|1|||
146394369|NCT00474994|527946915|FG000|Overall Study|Patient evaluable for toxicity only|3|||
146394370|NCT00474994|527946915|FG000|Overall Study|Patient found to be ineligible|1|||
146394371|NCT00278473|527946916|FG000|Overall Study|drop out|4|||
146394372|NCT00278473|527946917|FG001|Overall Study|drop out|3|||
146394373|NCT00761761|527946921|FG000|Overall Study|Lost to Follow-up|3|||
146394374|NCT00761761|527946922|FG001|Overall Study|Lost to Follow-up|1|||
146394375|NCT00761761|527946921|FG000|Overall Study|Withdrawal by Subject|3|||
146394376|NCT00761761|527946922|FG001|Overall Study|Withdrawal by Subject|0|||
146394377|NCT03472586|527946929|FG000|Overall Study|Physician Decision|6|||
146394378|NCT03472586|527946929|FG000|Overall Study|Death|6|||
146394379|NCT03472586|527946929|FG000|Overall Study|Adverse Event|1|||
146394380|NCT02706327|527946930|FG000|Overall Study|Lost to Follow-up|1|||
146394381|NCT02706327|527946931|FG001|Overall Study|Lost to Follow-up|1|||
146394382|NCT02706327|527946932|FG002|Overall Study|Lost to Follow-up|2|||
146394383|NCT02652793|527946935|FG000|Overall Study|Adverse Event|1|||
146394384|NCT02652793|527946935|FG000|Overall Study|Lost to Follow-up|2|||
146394385|NCT02652793|527946935|FG000|Overall Study|Withdrawal by Subject|1|||
146394386|NCT03868410|527946938|FG000|Overall Study|Physician Decision|0|||
146394387|NCT03868410|527946939|FG001|Overall Study|Physician Decision|1|||
146394388|NCT06045026|527946940|FG000|Overall Study|Lost to Follow-up|60|||
146394389|NCT06045026|527946940|FG000|Overall Study|Adverse Event|12|||
146394390|NCT06045026|527946940|FG000|Overall Study|Withdrawal by Subject|3|||
146394391|NCT06045026|527946940|FG000|Overall Study|Enrollment closed|1|||
146394392|NCT04511533|527946941|FG000|Treatment|Other|2|||
146394393|NCT04511533|527946941|FG000|Treatment|Withdrawal by Subject|11|||
146394394|NCT04511533|527946941|FG000|Treatment|Death|5|||
146394395|NCT04511533|527946941|FG000|Treatment|Physician Decision|1|||
146394396|NCT04511533|527946941|FG000|Treatment|Progressive Disease|61|||
146394397|NCT04511533|527946941|FG000|Follow-Up|Other|7|||
146394398|NCT04511533|527946941|FG000|Follow-Up|Withdrawal by Subject|5|||
146394399|NCT04511533|527946941|FG000|Follow-Up|Lost to Follow-up|2|||
146394400|NCT04511533|527946941|FG000|Follow-Up|Death|4|||
146394401|NCT01224171|527946942|FG000|Overall Study|Adverse Event|8|||
146394402|NCT01224171|527946943|FG001|Overall Study|Adverse Event|4|||
146394403|NCT01224171|527946942|FG000|Overall Study|Protocol Violation|0|||
146394404|NCT01224171|527946943|FG001|Overall Study|Protocol Violation|1|||
146394405|NCT01224171|527946942|FG000|Overall Study|Lack of Efficacy|5|||
146394406|NCT01224171|527946943|FG001|Overall Study|Lack of Efficacy|1|||
146394407|NCT01224171|527946942|FG000|Overall Study|Withdrawal of Consent|2|||
146394408|NCT01224171|527946943|FG001|Overall Study|Withdrawal of Consent|4|||
146394409|NCT01224171|527946942|FG000|Overall Study|Lost to Follow-up|0|||
146394410|NCT01224171|527946943|FG001|Overall Study|Lost to Follow-up|3|||
146394411|NCT03417245|527946945|FG000|Overall Study|Adverse Event|1|||
146394412|NCT03417245|527946946|FG001|Overall Study|Adverse Event|0|||
146394413|NCT03417245|527946945|FG000|Overall Study|Protocol Violation|1|||
146394414|NCT03417245|527946946|FG001|Overall Study|Protocol Violation|0|||
146394415|NCT03417245|527946945|FG000|Overall Study|Withdrawal by Subject|1|||
146394416|NCT03417245|527946946|FG001|Overall Study|Withdrawal by Subject|1|||
146394417|NCT02708524|527946947|FG000|Overall Study|Adverse Event|0|||
146394418|NCT02708524|527946948|FG001|Overall Study|Adverse Event|1|||
146394419|NCT02708524|527946949|FG002|Overall Study|Adverse Event|0|||
146394420|NCT02708524|527946950|FG003|Overall Study|Adverse Event|0|||
146394421|NCT02708524|527946947|FG000|Overall Study|Lens Discomfort|1|||
146394422|NCT02708524|527946948|FG001|Overall Study|Lens Discomfort|0|||
146394423|NCT02708524|527946949|FG002|Overall Study|Lens Discomfort|1|||
146394424|NCT02708524|527946950|FG003|Overall Study|Lens Discomfort|0|||
146394425|NCT02708524|527946947|FG000|Overall Study|Lost to Follow-up|1|||
146394426|NCT02708524|527946948|FG001|Overall Study|Lost to Follow-up|1|||
146394427|NCT02708524|527946949|FG002|Overall Study|Lost to Follow-up|1|||
146394428|NCT02708524|527946950|FG003|Overall Study|Lost to Follow-up|0|||
146394429|NCT02708524|527946947|FG000|Overall Study|Protocol Violation|0|||
146394430|NCT02708524|527946948|FG001|Overall Study|Protocol Violation|1|||
146394431|NCT02708524|527946949|FG002|Overall Study|Protocol Violation|0|||
146394432|NCT02708524|527946950|FG003|Overall Study|Protocol Violation|0|||
146394433|NCT02708524|527946947|FG000|Overall Study|Withdrawal by Subject|1|||
146394434|NCT02708524|527946948|FG001|Overall Study|Withdrawal by Subject|1|||
146394435|NCT02708524|527946949|FG002|Overall Study|Withdrawal by Subject|0|||
146394436|NCT02708524|527946950|FG003|Overall Study|Withdrawal by Subject|0|||
146394437|NCT02708524|527946947|FG000|Overall Study|Dispensed incorrect study lens|0|||
146056287|NCT00626275|526721167|FG007|Part B|Withdrawal by Subject|1|||
146394438|NCT02708524|527946948|FG001|Overall Study|Dispensed incorrect study lens|1|||
146394439|NCT02708524|527946949|FG002|Overall Study|Dispensed incorrect study lens|1|||
146394440|NCT02708524|527946950|FG003|Overall Study|Dispensed incorrect study lens|0|||
146394441|NCT02708524|527946947|FG000|Overall Study|Did not wear lens at final visit|0|||
146394442|NCT02708524|527946948|FG001|Overall Study|Did not wear lens at final visit|1|||
146394443|NCT02708524|527946949|FG002|Overall Study|Did not wear lens at final visit|0|||
145943499|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943500|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943501|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943502|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943503|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943504|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145943505|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
145943506|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
145943507|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145943508|NCT02326298|526300464|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943509|NCT02326298|526300465|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943510|NCT02326298|526300466|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943511|NCT02326298|526300467|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943512|NCT02326298|526300468|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943513|NCT02326298|526300469|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943514|NCT02326298|526300470|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943515|NCT02326298|526300471|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943516|NCT02326298|526300472|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943517|NCT02326298|526300473|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943518|NCT02326298|526300474|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145943519|NCT02326298|526300475|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
145943520|NCT02326298|526300476|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
145943521|NCT02326298|526300477|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
145943522|NCT03191864|526300479|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
145943523|NCT03191864|526300480|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
145943524|NCT03191864|526300481|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
145943525|NCT03191864|526300482|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
145943526|NCT03191864|526300483|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
145943527|NCT03191864|526300484|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
145943528|NCT03191864|526300479|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145943529|NCT03191864|526300480|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145943530|NCT03191864|526300481|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145943531|NCT03191864|526300482|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145943532|NCT03191864|526300483|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145943533|NCT03191864|526300484|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
145943534|NCT03191864|526300479|FG000|Baseline Symptom Assessment|Adverse Event|0|||
145943535|NCT03191864|526300480|FG001|Baseline Symptom Assessment|Adverse Event|0|||
145943536|NCT03191864|526300481|FG002|Baseline Symptom Assessment|Adverse Event|0|||
145943537|NCT03191864|526300482|FG003|Baseline Symptom Assessment|Adverse Event|0|||
145943538|NCT03191864|526300483|FG004|Baseline Symptom Assessment|Adverse Event|0|||
145943539|NCT03191864|526300484|FG005|Baseline Symptom Assessment|Adverse Event|2|||
145943540|NCT03191864|526300479|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145943541|NCT03191864|526300480|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145943542|NCT03191864|526300481|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145943543|NCT03191864|526300482|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145943544|NCT03191864|526300483|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145943545|NCT03191864|526300484|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
145943546|NCT03191864|526300479|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145943547|NCT03191864|526300480|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145943548|NCT03191864|526300481|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145943549|NCT03191864|526300482|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145943550|NCT03191864|526300483|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145943551|NCT03191864|526300484|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
145943552|NCT03191864|526300479|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145943553|NCT03191864|526300480|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145943554|NCT03191864|526300481|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
145943555|NCT03191864|526300482|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145943556|NCT03191864|526300483|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145943557|NCT03191864|526300484|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
145943558|NCT03191864|526300479|FG000|Part 1 - Induction|Adverse Event|0|||
145943559|NCT03191864|526300480|FG001|Part 1 - Induction|Adverse Event|2|||
145943560|NCT03191864|526300481|FG002|Part 1 - Induction|Adverse Event|0|||
145943561|NCT03191864|526300482|FG003|Part 1 - Induction|Adverse Event|1|||
145943562|NCT03191864|526300483|FG004|Part 1 - Induction|Adverse Event|0|||
145943563|NCT03191864|526300484|FG005|Part 1 - Induction|Adverse Event|2|||
145943564|NCT03191864|526300479|FG000|Part 1 - Induction|Randomized but never dosed|0|||
145943565|NCT03191864|526300480|FG001|Part 1 - Induction|Randomized but never dosed|0|||
145943566|NCT03191864|526300481|FG002|Part 1 - Induction|Randomized but never dosed|1|||
145943567|NCT03191864|526300482|FG003|Part 1 - Induction|Randomized but never dosed|0|||
145943568|NCT03191864|526300483|FG004|Part 1 - Induction|Randomized but never dosed|0|||
145943569|NCT03191864|526300484|FG005|Part 1 - Induction|Randomized but never dosed|0|||
145943570|NCT03191864|526300479|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
145943571|NCT03191864|526300480|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
145943572|NCT03191864|526300481|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
145943573|NCT03191864|526300482|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
145943574|NCT03191864|526300483|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
145943575|NCT03191864|526300484|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
145943576|NCT03191864|526300479|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145943577|NCT03191864|526300480|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145943578|NCT03191864|526300481|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
145943579|NCT03191864|526300482|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145943580|NCT03191864|526300483|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145943581|NCT03191864|526300484|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145943582|NCT03191864|526300479|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
145943583|NCT03191864|526300480|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145943584|NCT03191864|526300481|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145943585|NCT03191864|526300482|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145943586|NCT03191864|526300483|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145943587|NCT03191864|526300484|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145943588|NCT03191864|526300479|FG000|Part 2 - Maintenance|Physician Decision|1|||
145943589|NCT03191864|526300480|FG001|Part 2 - Maintenance|Physician Decision|0|||
145943590|NCT03191864|526300481|FG002|Part 2 - Maintenance|Physician Decision|0|||
145943591|NCT03191864|526300482|FG003|Part 2 - Maintenance|Physician Decision|0|||
145943592|NCT03191864|526300483|FG004|Part 2 - Maintenance|Physician Decision|0|||
145943593|NCT03191864|526300484|FG005|Part 2 - Maintenance|Physician Decision|0|||
145943594|NCT03191864|526300479|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
145943595|NCT03191864|526300480|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
145943596|NCT03191864|526300481|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
145943597|NCT03191864|526300482|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
145943598|NCT03191864|526300483|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
145943599|NCT03191864|526300484|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
145943600|NCT03191864|526300479|FG000|Part 2 - Maintenance|Adverse Event|0|||
145943601|NCT03191864|526300480|FG001|Part 2 - Maintenance|Adverse Event|0|||
145943602|NCT03191864|526300481|FG002|Part 2 - Maintenance|Adverse Event|0|||
145943603|NCT03191864|526300482|FG003|Part 2 - Maintenance|Adverse Event|0|||
145943604|NCT03191864|526300483|FG004|Part 2 - Maintenance|Adverse Event|1|||
145943605|NCT03191864|526300484|FG005|Part 2 - Maintenance|Adverse Event|0|||
146394444|NCT02708524|527946950|FG003|Overall Study|Did not wear lens at final visit|0|||
146394445|NCT02708524|527946947|FG000|Overall Study|Subject lost study lens|1|||
146394446|NCT02708524|527946948|FG001|Overall Study|Subject lost study lens|0|||
146394447|NCT02708524|527946949|FG002|Overall Study|Subject lost study lens|0|||
146394448|NCT02708524|527946950|FG003|Overall Study|Subject lost study lens|0|||
146394449|NCT00761735|527946955|FG000|Overall Study|Lost to Follow-up|6|||
146394450|NCT00761735|527946955|FG000|Overall Study|Withdrawal by Subject|6|||
146394451|NCT00761735|527946955|FG000|Overall Study|Non-compliance with protocol|1|||
146394452|NCT00761735|527946955|FG000|Overall Study|Administrative|1|||
146394453|NCT03290131|527946956|FG000|Overall Study|Adverse Event|22|||
146394454|NCT03290131|527946957|FG001|Overall Study|Adverse Event|57|||
146394455|NCT03290131|527946958|FG002|Overall Study|Adverse Event|11|||
146394456|NCT03290131|527946956|FG000|Overall Study|Withdrawal by Subject|18|||
146394457|NCT03290131|527946957|FG001|Overall Study|Withdrawal by Subject|13|||
146394458|NCT03290131|527946958|FG002|Overall Study|Withdrawal by Subject|8|||
146394459|NCT03290131|527946956|FG000|Overall Study|MS Relapse|2|||
146394460|NCT03290131|527946957|FG001|Overall Study|MS Relapse|1|||
146394461|NCT03290131|527946958|FG002|Overall Study|MS Relapse|0|||
146394462|NCT03290131|527946956|FG000|Overall Study|Unknown reason|0|||
146394463|NCT03290131|527946957|FG001|Overall Study|Unknown reason|1|||
146394464|NCT03290131|527946958|FG002|Overall Study|Unknown reason|0|||
146394465|NCT00381680|527946959|FG000|Overall Study|Adverse Event|9|||
146394466|NCT00381680|527946960|FG001|Overall Study|Adverse Event|3|||
146394467|NCT00381680|527946959|FG000|Overall Study|Death|10|||
146394468|NCT00381680|527946960|FG001|Overall Study|Death|7|||
146394469|NCT00381680|527946959|FG000|Overall Study|Lost to Follow-up|3|||
146394470|NCT00381680|527946960|FG001|Overall Study|Lost to Follow-up|2|||
146394471|NCT00381680|527946959|FG000|Overall Study|Physician Decision|25|||
146394472|NCT00381680|527946960|FG001|Overall Study|Physician Decision|6|||
146394473|NCT00381680|527946959|FG000|Overall Study|Withdrawal by Subject|3|||
146394474|NCT00381680|527946960|FG001|Overall Study|Withdrawal by Subject|1|||
146394475|NCT00381680|527946959|FG000|Overall Study|Entry onto another COG Trial|1|||
146394476|NCT00381680|527946960|FG001|Overall Study|Entry onto another COG Trial|2|||
146394477|NCT00381680|527946959|FG000|Overall Study|Alternative Therapy|11|||
146394478|NCT00381680|527946960|FG001|Overall Study|Alternative Therapy|5|||
146394479|NCT00381680|527946959|FG000|Overall Study|Secondary Malignancy|3|||
146394480|NCT00381680|527946960|FG001|Overall Study|Secondary Malignancy|0|||
146394481|NCT00381680|527946959|FG000|Overall Study|Delay initiation|1|||
146394482|NCT00381680|527946960|FG001|Overall Study|Delay initiation|0|||
146394483|NCT00381680|527946959|FG000|Overall Study|Stem Cell Transplant|26|||
146394484|NCT00381680|527946960|FG001|Overall Study|Stem Cell Transplant|10|||
146394485|NCT00381680|527946959|FG000|Overall Study|Relapse|18|||
146394486|NCT00381680|527946960|FG001|Overall Study|Relapse|9|||
146394487|NCT00381680|527946959|FG000|Overall Study|Induction Failure|4|||
146394488|NCT00381680|527946960|FG001|Overall Study|Induction Failure|1|||
146394489|NCT00381680|527946959|FG000|Overall Study|Progression|1|||
146394490|NCT00381680|527946960|FG001|Overall Study|Progression|1|||
146394491|NCT00381680|527946959|FG000|Overall Study|Other not otherwise specified|7|||
146394492|NCT00381680|527946960|FG001|Overall Study|Other not otherwise specified|2|||
146394493|NCT00381680|527946959|FG000|Overall Study|Ineligible|3|||
146394494|NCT00381680|527946960|FG001|Overall Study|Ineligible|1|||
146394495|NCT00361504|527946963|FG000|Overall Study|Withdrawal by Subject|94|||
146394496|NCT00361504|527946964|FG001|Overall Study|Withdrawal by Subject|31|||
146394497|NCT00361504|527946963|FG000|Overall Study|Lost to Follow-up|40|||
146394498|NCT00361504|527946964|FG001|Overall Study|Lost to Follow-up|7|||
146394499|NCT00361504|527946963|FG000|Overall Study|Adverse Event|203|||
146394500|NCT00361504|527946964|FG001|Overall Study|Adverse Event|82|||
146394501|NCT00361504|527946963|FG000|Overall Study|Lack of Efficacy|72|||
146394502|NCT00361504|527946964|FG001|Overall Study|Lack of Efficacy|7|||
146394503|NCT00361504|527946963|FG000|Overall Study|Resolution of Pain|2|||
146394504|NCT00361504|527946964|FG001|Overall Study|Resolution of Pain|0|||
146394505|NCT00361504|527946963|FG000|Overall Study|Study medication non compliant|42|||
146394506|NCT00361504|527946964|FG001|Overall Study|Study medication non compliant|15|||
146394507|NCT00361504|527946963|FG000|Overall Study|All other|28|||
146394508|NCT00361504|527946964|FG001|Overall Study|All other|3|||
146394509|NCT01374516|527946970|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
146394510|NCT01374516|527946971|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
146394511|NCT01374516|527946970|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
146394512|NCT01374516|527946971|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
146394513|NCT01374516|527946970|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
146394514|NCT01374516|527946971|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
146394515|NCT01374516|527946970|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
146394516|NCT01374516|527946971|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
146394517|NCT01374516|527946970|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
146394518|NCT01374516|527946971|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
146394519|NCT01374516|527946970|FG000|Surveillance Expansion Period|Protocol Violation|386|||
146394520|NCT01374516|527946971|FG001|Surveillance Expansion Period|Protocol Violation|217|||
146394521|NCT01374516|527946970|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
146394522|NCT01374516|527946971|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
146394523|NCT01374516|527946970|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
146394524|NCT01374516|527946971|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
146394525|NCT01374516|527946970|FG000|Surveillance Expansion Period|Serious adverse event|20|||
146394526|NCT01374516|527946971|FG001|Surveillance Expansion Period|Serious adverse event|5|||
146394527|NCT00450814|527946973|FG000|Overall Study|Failed to complete the initial therapy|0|||
146394528|NCT00450814|527946974|FG001|Overall Study|Failed to complete the initial therapy|0|||
146394529|NCT00450814|527946975|FG002|Overall Study|Failed to complete the initial therapy|0|||
146394530|NCT00450814|527946976|FG003|Overall Study|Failed to complete the initial therapy|1|||
146394531|NCT00450814|527946977|FG004|Overall Study|Failed to complete the initial therapy|1|||
146394532|NCT00450814|527946978|FG005|Overall Study|Failed to complete the initial therapy|1|||
146394533|NCT00450814|527946979|FG006|Overall Study|Failed to complete the initial therapy|0|||
146394534|NCT00450814|527946980|FG007|Overall Study|Failed to complete the initial therapy|0|||
146394535|NCT00450814|527946981|FG008|Overall Study|Failed to complete the initial therapy|0|||
146394536|NCT00450814|527946982|FG009|Overall Study|Failed to complete the initial therapy|0|||
146394537|NCT00450814|527946983|FG010|Overall Study|Failed to complete the initial therapy|0|||
146394538|NCT00450814|527946973|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
146394539|NCT00450814|527946974|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
146394540|NCT00450814|527946975|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
146394541|NCT00450814|527946976|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
146394542|NCT00450814|527946977|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
146394543|NCT00450814|527946978|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
146394544|NCT00450814|527946979|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
146394545|NCT00450814|527946980|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
146394546|NCT00450814|527946981|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
146394547|NCT00450814|527946982|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
146394548|NCT00450814|527946983|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
146394549|NCT04145531|527946984|FG000|Part A|Adverse Event|2|||
146394550|NCT04145531|527946985|FG001|Part A|Adverse Event|12|||
146394551|NCT04145531|527946986|FG002|Part A|Adverse Event|6|||
146394552|NCT04145531|527946987|FG003|Part A|Adverse Event|0|||
146394553|NCT04145531|527946984|FG000|Part A|Death|1|||
146394554|NCT04145531|527946985|FG001|Part A|Death|2|||
146394555|NCT04145531|527946986|FG002|Part A|Death|0|||
146394556|NCT04145531|527946987|FG003|Part A|Death|0|||
146394557|NCT04145531|527946984|FG000|Part A|Physician Decision|2|||
146394558|NCT04145531|527946985|FG001|Part A|Physician Decision|5|||
146394559|NCT04145531|527946986|FG002|Part A|Physician Decision|2|||
146394560|NCT04145531|527946987|FG003|Part A|Physician Decision|0|||
146394561|NCT04145531|527946984|FG000|Part A|Progressive disease|0|||
146394562|NCT04145531|527946985|FG001|Part A|Progressive disease|2|||
146394563|NCT04145531|527946986|FG002|Part A|Progressive disease|1|||
146394564|NCT04145531|527946987|FG003|Part A|Progressive disease|0|||
146394565|NCT04145531|527946984|FG000|Part A|Protocol deviation|0|||
146394566|NCT04145531|527946985|FG001|Part A|Protocol deviation|0|||
146394567|NCT04145531|527946986|FG002|Part A|Protocol deviation|1|||
146394568|NCT04145531|527946987|FG003|Part A|Protocol deviation|0|||
146394569|NCT04145531|527946984|FG000|Part A|Withdrawal by parent or guardian|1|||
146394570|NCT04145531|527946985|FG001|Part A|Withdrawal by parent or guardian|0|||
146394571|NCT04145531|527946986|FG002|Part A|Withdrawal by parent or guardian|0|||
146394572|NCT04145531|527946987|FG003|Part A|Withdrawal by parent or guardian|0|||
146394573|NCT04145531|527946984|FG000|Part A|Withdrawal by participant|0|||
146394574|NCT04145531|527946985|FG001|Part A|Withdrawal by participant|0|||
146394575|NCT04145531|527946986|FG002|Part A|Withdrawal by participant|1|||
146394576|NCT04145531|527946987|FG003|Part A|Withdrawal by participant|0|||
146394577|NCT04145531|527946984|FG000|Part A|Other|0|||
146394578|NCT04145531|527946985|FG001|Part A|Other|0|||
146394579|NCT04145531|527946986|FG002|Part A|Other|1|||
146394580|NCT04145531|527946987|FG003|Part A|Other|0|||
146394581|NCT04145531|527946984|FG000|Part B|Adverse Event|0|||
146394582|NCT04145531|527946985|FG001|Part B|Adverse Event|0|||
146394583|NCT04145531|527946986|FG002|Part B|Adverse Event|0|||
146394584|NCT04145531|527946987|FG003|Part B|Adverse Event|21|||
146394585|NCT04145531|527946984|FG000|Part B|Physician Decision|0|||
146394586|NCT04145531|527946985|FG001|Part B|Physician Decision|0|||
146394587|NCT04145531|527946986|FG002|Part B|Physician Decision|0|||
146394588|NCT04145531|527946987|FG003|Part B|Physician Decision|7|||
146394589|NCT04145531|527946984|FG000|Part B|Progressive disease|0|||
146394590|NCT04145531|527946985|FG001|Part B|Progressive disease|0|||
146394591|NCT04145531|527946986|FG002|Part B|Progressive disease|0|||
146394592|NCT04145531|527946987|FG003|Part B|Progressive disease|1|||
146394593|NCT04145531|527946984|FG000|Part B|Recurrent disease|0|||
146394594|NCT04145531|527946985|FG001|Part B|Recurrent disease|0|||
146394595|NCT04145531|527946986|FG002|Part B|Recurrent disease|0|||
146394596|NCT04145531|527946987|FG003|Part B|Recurrent disease|1|||
146394597|NCT04145531|527946984|FG000|Part B|Withdrawal by parent or guardian|0|||
146394598|NCT04145531|527946985|FG001|Part B|Withdrawal by parent or guardian|0|||
146394599|NCT04145531|527946986|FG002|Part B|Withdrawal by parent or guardian|0|||
146394600|NCT04145531|527946987|FG003|Part B|Withdrawal by parent or guardian|3|||
146394601|NCT04145531|527946984|FG000|Part B|Withdrawal by participant|0|||
146394602|NCT04145531|527946985|FG001|Part B|Withdrawal by participant|0|||
146394603|NCT04145531|527946986|FG002|Part B|Withdrawal by participant|0|||
146394604|NCT04145531|527946987|FG003|Part B|Withdrawal by participant|1|||
146394605|NCT04145531|527946984|FG000|Part B|Other|0|||
146394606|NCT04145531|527946985|FG001|Part B|Other|0|||
146394607|NCT04145531|527946986|FG002|Part B|Other|0|||
146394608|NCT04145531|527946987|FG003|Part B|Other|1|||
146394609|NCT04988035|527946988|FG000|Overall Study|Death|19|||
146394610|NCT04988035|527946989|FG001|Overall Study|Death|13|||
146394611|NCT04988035|527946988|FG000|Overall Study|Lost to Follow-up|12|||
146394612|NCT04988035|527946989|FG001|Overall Study|Lost to Follow-up|6|||
146394613|NCT04988035|527946988|FG000|Overall Study|Protocol Violation|0|||
146394614|NCT04988035|527946989|FG001|Overall Study|Protocol Violation|1|||
146394615|NCT04988035|527946988|FG000|Overall Study|Withdrawal by Subject|2|||
146394616|NCT04988035|527946989|FG001|Overall Study|Withdrawal by Subject|4|||
146394617|NCT04988035|527946988|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
146394618|NCT04988035|527946989|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
146394619|NCT03602976|527946990|FG000|Overall Study|Withdrawal by Subject|1|||
146394620|NCT03732534|527946991|FG000|Overall Study|Study terminated by Sponsor|6|||
146394621|NCT02190604|527946992|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394622|NCT02190604|527946993|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394623|NCT02190604|527946994|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394624|NCT02190604|527946995|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394625|NCT02190604|527946996|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394626|NCT02190604|527946997|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394627|NCT02190604|527946998|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394628|NCT02190604|527946999|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394629|NCT02190604|527947000|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394630|NCT02190604|527947001|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394631|NCT02190604|527947002|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394632|NCT02190604|527947003|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394633|NCT02190604|527947004|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394634|NCT02190604|527947005|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394635|NCT02190604|527947006|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
146394636|NCT02190604|527947007|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394637|NCT02190604|527947008|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394638|NCT02190604|527947009|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394639|NCT02190604|527947010|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
146394640|NCT02190604|527946992|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394641|NCT02190604|527946993|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394642|NCT02190604|527946994|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394643|NCT02190604|527946995|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394644|NCT02190604|527946996|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394645|NCT02190604|527946997|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394646|NCT02190604|527946998|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394647|NCT02190604|527946999|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394648|NCT02190604|527947000|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394649|NCT02190604|527947001|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394650|NCT02190604|527947002|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394651|NCT02190604|527947003|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394652|NCT02190604|527947004|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394653|NCT02190604|527947005|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
146394654|NCT02190604|527947006|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394655|NCT02190604|527947007|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394656|NCT02190604|527947008|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394657|NCT02190604|527947009|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394658|NCT02190604|527947010|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
146394659|NCT02797951|527947011|FG000|Overall Study|Adverse Event|4|||
146394660|NCT02797951|527947011|FG000|Overall Study|Death|1|||
146394661|NCT02797951|527947011|FG000|Overall Study|Lack of Efficacy|19|||
146394662|NCT02797951|527947011|FG000|Overall Study|Lost to Follow-up|4|||
146394663|NCT02797951|527947011|FG000|Overall Study|Physician Decision|6|||
146394664|NCT02797951|527947011|FG000|Overall Study|Withdrawal by Subject|15|||
146394665|NCT03735849|527947012|FG000|Overall Study|Lost to Follow-up|1|||
146394666|NCT03735849|527947013|FG001|Overall Study|Lost to Follow-up|0|||
146394667|NCT03735849|527947014|FG002|Overall Study|Lost to Follow-up|0|||
146394668|NCT03735849|527947012|FG000|Overall Study|Participant unable to adhere to visit|1|||
146394669|NCT03735849|527947013|FG001|Overall Study|Participant unable to adhere to visit|0|||
146394670|NCT03735849|527947014|FG002|Overall Study|Participant unable to adhere to visit|0|||
146394671|NCT03735849|527947012|FG000|Overall Study|Not Randomized|0|||
146394672|NCT03735849|527947013|FG001|Overall Study|Not Randomized|0|||
146394673|NCT03735849|527947014|FG002|Overall Study|Not Randomized|4|||
146394674|NCT04626947|527947017|FG000|Overall Study|Study terminated|14|||
146394675|NCT03556202|527947026|FG000|Extension Treatment Period|Adverse Event|18|||
146394676|NCT03556202|527947027|FG001|Extension Treatment Period|Adverse Event|14|||
146394677|NCT03556202|527947028|FG002|Extension Treatment Period|Adverse Event|9|||
146394678|NCT03556202|527947026|FG000|Extension Treatment Period|Death|2|||
146394679|NCT03556202|527947027|FG001|Extension Treatment Period|Death|6|||
146394680|NCT03556202|527947028|FG002|Extension Treatment Period|Death|0|||
146394681|NCT03556202|527947026|FG000|Extension Treatment Period|Lack of Efficacy|5|||
146394682|NCT03556202|527947027|FG001|Extension Treatment Period|Lack of Efficacy|12|||
146394683|NCT03556202|527947028|FG002|Extension Treatment Period|Lack of Efficacy|18|||
146394684|NCT03556202|527947026|FG000|Extension Treatment Period|Lost to Follow-up|9|||
146394685|NCT03556202|527947027|FG001|Extension Treatment Period|Lost to Follow-up|20|||
146394686|NCT03556202|527947028|FG002|Extension Treatment Period|Lost to Follow-up|2|||
146394687|NCT03556202|527947026|FG000|Extension Treatment Period|Pregnancy|2|||
146394688|NCT03556202|527947027|FG001|Extension Treatment Period|Pregnancy|4|||
146394689|NCT03556202|527947028|FG002|Extension Treatment Period|Pregnancy|3|||
146394690|NCT03556202|527947026|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
146394691|NCT03556202|527947027|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
146394692|NCT03556202|527947028|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
146394693|NCT03556202|527947026|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
146394694|NCT03556202|527947027|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
146394695|NCT03556202|527947028|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
146394696|NCT03556202|527947026|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
146394697|NCT03556202|527947027|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
146394698|NCT03556202|527947028|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
146394699|NCT03556202|527947026|FG000|Extension Treatment Period|Physician Decision|0|||
146394700|NCT03556202|527947027|FG001|Extension Treatment Period|Physician Decision|8|||
146394701|NCT03556202|527947028|FG002|Extension Treatment Period|Physician Decision|2|||
146394702|NCT03556202|527947026|FG000|Extension Treatment Period|Protocol Violation|0|||
146394703|NCT03556202|527947027|FG001|Extension Treatment Period|Protocol Violation|1|||
146394704|NCT03556202|527947028|FG002|Extension Treatment Period|Protocol Violation|1|||
146394705|NCT03556202|527947026|FG000|Extension Treatment Period|Sponsor Decision|0|||
146394706|NCT03556202|527947027|FG001|Extension Treatment Period|Sponsor Decision|1|||
146394707|NCT03556202|527947028|FG002|Extension Treatment Period|Sponsor Decision|0|||
146394708|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
146394709|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
146394710|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
146394711|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Death|1|||
146394712|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Death|0|||
146394713|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Death|0|||
146394714|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
146394715|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
146394716|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
146394717|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
146394718|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
146394719|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
146394720|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
146394721|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
146394722|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
146394723|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
146394724|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
146394725|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
146394726|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
146394727|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
146394728|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
146394729|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
146394730|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
146394731|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
146394732|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
146394733|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
146394734|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
146394735|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
146394736|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
146394737|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
146394738|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
146394739|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
146394740|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
146394741|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
146394742|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
146394743|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
146394744|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
146394745|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
146394746|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
146394747|NCT03556202|527947026|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
146394748|NCT03556202|527947027|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
146394749|NCT03556202|527947028|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
146394750|NCT04034225|527947039|FG000|Overall Study|Death|3|||
146394751|NCT04034225|527947039|FG000|Overall Study|Withdrawal by Subject|2|||
146394752|NCT04034225|527947039|FG000|Overall Study|Study termination by Sponsor|18|||
146394753|NCT04034225|527947039|FG000|Overall Study|Physician Decision|1|||
146394754|NCT04034225|527947039|FG000|Overall Study|Lack of Efficacy|1|||
146394755|NCT00307736|527947043|FG000|Overall Study|Adverse Event|0|||
146394756|NCT00307736|527947044|FG001|Overall Study|Adverse Event|0|||
146394757|NCT00307736|527947045|FG002|Overall Study|Adverse Event|1|||
146394758|NCT00307736|527947046|FG003|Overall Study|Adverse Event|3|||
146394759|NCT00307736|527947043|FG000|Overall Study|Withdrawal by Subject|0|||
146394760|NCT00307736|527947044|FG001|Overall Study|Withdrawal by Subject|0|||
146394761|NCT00307736|527947045|FG002|Overall Study|Withdrawal by Subject|2|||
146394762|NCT00307736|527947046|FG003|Overall Study|Withdrawal by Subject|0|||
146394763|NCT01365182|527947048|FG000|Overall Study|Withdrawal by Subject|10|||
146394764|NCT01365182|527947049|FG001|Overall Study|Withdrawal by Subject|13|||
146394765|NCT01365182|527947050|FG002|Overall Study|Withdrawal by Subject|12|||
146394766|NCT04604015|527947053|FG000|Overall Study|Incomplete Data Collection|33|||
146394767|NCT02811640|527947056|FG000|Overall Study|Technology malfunction|2|||
146394768|NCT01883362|527947059|FG000|Treatment|Adverse Event|1|||
146394769|NCT01883362|527947060|FG001|Treatment|Adverse Event|8|||
146394770|NCT01883362|527947059|FG000|Treatment|Withdrawal by Subject|6|||
146394771|NCT01883362|527947060|FG001|Treatment|Withdrawal by Subject|2|||
146394772|NCT01883362|527947059|FG000|Treatment|Administrative problems|4|||
146394773|NCT01883362|527947060|FG001|Treatment|Administrative problems|1|||
146394774|NCT01883362|527947059|FG000|Treatment|Relapse|4|||
146394775|NCT01883362|527947060|FG001|Treatment|Relapse|2|||
146394776|NCT01883362|527947059|FG000|Treatment|Randomized, not treated|1|||
146394777|NCT01883362|527947060|FG001|Treatment|Randomized, not treated|1|||
146394778|NCT01883362|527947059|FG000|Post Treatment Follow-up|Protocol Violation|0|||
146394779|NCT01883362|527947060|FG001|Post Treatment Follow-up|Protocol Violation|1|||
146394780|NCT01883362|527947059|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
146394781|NCT01883362|527947060|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
146394782|NCT01883362|527947059|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
146394783|NCT01883362|527947060|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
146394784|NCT01883362|527947059|FG000|Post Treatment Follow-up|Administrative problems|2|||
146394785|NCT01883362|527947060|FG001|Post Treatment Follow-up|Administrative problems|0|||
146394786|NCT01883362|527947059|FG000|Post Treatment Follow-up|Death|8|||
146394787|NCT01883362|527947060|FG001|Post Treatment Follow-up|Death|4|||
146394788|NCT01883362|527947059|FG000|Post Treatment Follow-up|Relapse|1|||
146394789|NCT01883362|527947060|FG001|Post Treatment Follow-up|Relapse|2|||
146394790|NCT01230489|527947061|FG000|Overall Study|Death|2|||
146394791|NCT01230489|527947061|FG000|Overall Study|Adverse Event|2|||
146394792|NCT01230489|527947061|FG000|Overall Study|Treatment modality changed|1|||
146394793|NCT03996694|527948514|FG000|First Washout (7 Days)|positive urine drug screen|0|||
146394794|NCT03996694|527948515|FG001|First Washout (7 Days)|positive urine drug screen|0|||
146394795|NCT03996694|527948516|FG002|First Washout (7 Days)|positive urine drug screen|1|||
146394796|NCT03996694|527948517|FG003|First Washout (7 Days)|positive urine drug screen|0|||
146394797|NCT03996694|527948518|FG004|First Washout (7 Days)|positive urine drug screen|0|||
146394798|NCT03996694|527948519|FG005|First Washout (7 Days)|positive urine drug screen|0|||
146394799|NCT03996694|527948514|FG000|First Washout (7 Days)|Adverse Event|0|||
146394800|NCT03996694|527948515|FG001|First Washout (7 Days)|Adverse Event|1|||
146394801|NCT03996694|527948516|FG002|First Washout (7 Days)|Adverse Event|0|||
146394802|NCT03996694|527948517|FG003|First Washout (7 Days)|Adverse Event|0|||
146394803|NCT03996694|527948518|FG004|First Washout (7 Days)|Adverse Event|0|||
146394804|NCT03996694|527948519|FG005|First Washout (7 Days)|Adverse Event|0|||
146394805|NCT03996694|527948514|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
146394806|NCT03996694|527948515|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
146394807|NCT03996694|527948516|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
146394808|NCT03996694|527948517|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
146394809|NCT03996694|527948518|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
146394810|NCT03996694|527948519|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
146394811|NCT03996694|527948514|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
146394812|NCT03996694|527948515|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
146394813|NCT03996694|527948516|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
146394814|NCT03996694|527948517|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
146394815|NCT03996694|527948518|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
146394816|NCT03996694|527948519|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
146394817|NCT00656669|527948526|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
146394818|NCT00656669|527948526|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
146394819|NCT00656669|527948526|FG000|AC (Cycles 6-9)|Adverse Event|1|||
146394820|NCT00656669|527948526|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
146394821|NCT02777554|527948529|FG000|Overall Study|Adverse Event|4|||
146394822|NCT02777554|527948530|FG001|Overall Study|Adverse Event|4|||
146394823|NCT02777554|527948531|FG002|Overall Study|Adverse Event|0|||
146394824|NCT02777554|527948532|FG003|Overall Study|Adverse Event|1|||
146394825|NCT02777554|527948533|FG004|Overall Study|Adverse Event|0|||
146394826|NCT02777554|527948534|FG005|Overall Study|Adverse Event|0|||
146394827|NCT02777554|527948529|FG000|Overall Study|Withdrawal by Subject|3|||
146394828|NCT02777554|527948530|FG001|Overall Study|Withdrawal by Subject|1|||
146394829|NCT02777554|527948531|FG002|Overall Study|Withdrawal by Subject|1|||
146394830|NCT02777554|527948532|FG003|Overall Study|Withdrawal by Subject|0|||
146394831|NCT02777554|527948533|FG004|Overall Study|Withdrawal by Subject|0|||
146394832|NCT02777554|527948534|FG005|Overall Study|Withdrawal by Subject|0|||
146394833|NCT02777554|527948529|FG000|Overall Study|Discharged early due to hurricane|22|||
146394834|NCT02777554|527948530|FG001|Overall Study|Discharged early due to hurricane|20|||
146394835|NCT02777554|527948531|FG002|Overall Study|Discharged early due to hurricane|0|||
146394836|NCT02777554|527948532|FG003|Overall Study|Discharged early due to hurricane|0|||
146394837|NCT02777554|527948533|FG004|Overall Study|Discharged early due to hurricane|0|||
146394838|NCT02777554|527948534|FG005|Overall Study|Discharged early due to hurricane|0|||
146394839|NCT02777554|527948529|FG000|Overall Study|Other - Miscellaneous|1|||
146394840|NCT02777554|527948530|FG001|Overall Study|Other - Miscellaneous|0|||
146394841|NCT02777554|527948531|FG002|Overall Study|Other - Miscellaneous|0|||
146394842|NCT02777554|527948532|FG003|Overall Study|Other - Miscellaneous|0|||
146394843|NCT02777554|527948533|FG004|Overall Study|Other - Miscellaneous|0|||
146394844|NCT02777554|527948534|FG005|Overall Study|Other - Miscellaneous|0|||
146394845|NCT00066573|527948535|FG000|Overall Study|Did not received protocol treatment|28|||
146394846|NCT00066573|527948536|FG001|Overall Study|Did not received protocol treatment|28|||
146394847|NCT01013207|527948537|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
146394848|NCT01541644|527948542|FG000|Overall Study|Withdrawal by Subject|3|||
146394849|NCT01458535|527948545|FG000|Overall Study|Other|0|||
146394850|NCT01458535|527948546|FG001|Overall Study|Other|0|||
146394851|NCT01458535|527948547|FG002|Overall Study|Other|0|||
146394852|NCT01458535|527948548|FG003|Overall Study|Other|0|||
146394853|NCT01458535|527948549|FG004|Overall Study|Other|1|||
146394854|NCT01458535|527948550|FG005|Overall Study|Other|1|||
146394855|NCT01458535|527948545|FG000|Overall Study|Withdrawal by Subject|0|||
146394856|NCT01458535|527948546|FG001|Overall Study|Withdrawal by Subject|0|||
146394857|NCT01458535|527948547|FG002|Overall Study|Withdrawal by Subject|2|||
146394858|NCT01458535|527948548|FG003|Overall Study|Withdrawal by Subject|0|||
146394859|NCT01458535|527948549|FG004|Overall Study|Withdrawal by Subject|1|||
146394860|NCT01458535|527948550|FG005|Overall Study|Withdrawal by Subject|1|||
146394861|NCT01458535|527948545|FG000|Overall Study|Lost to Follow-up|0|||
146394862|NCT01458535|527948546|FG001|Overall Study|Lost to Follow-up|2|||
146394863|NCT01458535|527948547|FG002|Overall Study|Lost to Follow-up|0|||
146394864|NCT01458535|527948548|FG003|Overall Study|Lost to Follow-up|3|||
146394865|NCT01458535|527948549|FG004|Overall Study|Lost to Follow-up|2|||
146394866|NCT01458535|527948550|FG005|Overall Study|Lost to Follow-up|2|||
146394867|NCT01458535|527948545|FG000|Overall Study|Adverse Event|0|||
146394868|NCT01458535|527948546|FG001|Overall Study|Adverse Event|0|||
146394869|NCT01458535|527948547|FG002|Overall Study|Adverse Event|0|||
146394870|NCT01458535|527948548|FG003|Overall Study|Adverse Event|1|||
146394871|NCT01458535|527948549|FG004|Overall Study|Adverse Event|0|||
146394872|NCT01458535|527948550|FG005|Overall Study|Adverse Event|0|||
146394873|NCT02842736|527948551|FG000|Overall Study|Lost to Follow-up|13|||
146394874|NCT02842736|527948551|FG000|Overall Study|Intervention for menstrual bleeding|17|||
146394875|NCT02842736|527948551|FG000|Overall Study|Withdrawal by Subject|4|||
146394876|NCT02842736|527948551|FG000|Overall Study|Pregnancy|3|||
146394877|NCT02842736|527948551|FG000|Overall Study|Hysterectomy for fibroids|2|||
146394878|NCT02842736|527948551|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
146394879|NCT02842736|527948551|FG000|Overall Study|IUD: Mirena|1|||
146394880|NCT00344968|527948555|FG000|Overall Study|Adverse Event|5|||
146394881|NCT00344968|527948556|FG001|Overall Study|Adverse Event|4|||
146394882|NCT00344968|527948557|FG002|Overall Study|Adverse Event|15|||
146394883|NCT00344968|527948555|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
146394884|NCT00344968|527948556|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
146394885|NCT00344968|527948557|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
146394886|NCT00344968|527948555|FG000|Overall Study|Protocol Violation|2|||
146394887|NCT00344968|527948556|FG001|Overall Study|Protocol Violation|2|||
146394888|NCT00344968|527948557|FG002|Overall Study|Protocol Violation|5|||
146394889|NCT00344968|527948555|FG000|Overall Study|Withdrawal by Subject|14|||
146394890|NCT00344968|527948556|FG001|Overall Study|Withdrawal by Subject|31|||
146394891|NCT00344968|527948557|FG002|Overall Study|Withdrawal by Subject|27|||
146394892|NCT00344968|527948555|FG000|Overall Study|Lost to Follow-up|24|||
146394893|NCT00344968|527948556|FG001|Overall Study|Lost to Follow-up|37|||
146394894|NCT00344968|527948557|FG002|Overall Study|Lost to Follow-up|37|||
146394895|NCT00344968|527948555|FG000|Overall Study|Death|11|||
146394896|NCT00344968|527948556|FG001|Overall Study|Death|27|||
146394897|NCT00344968|527948557|FG002|Overall Study|Death|31|||
146394898|NCT00344968|527948555|FG000|Overall Study|Other|0|||
146394899|NCT00344968|527948556|FG001|Overall Study|Other|1|||
146394900|NCT00344968|527948557|FG002|Overall Study|Other|0|||
146394901|NCT03735680|527948558|FG000|Overall Study|Withdrawal by Subject|0|||
146394902|NCT03735680|527948559|FG001|Overall Study|Withdrawal by Subject|1|||
146394903|NCT03735680|527948560|FG002|Overall Study|Withdrawal by Subject|0|||
146394904|NCT03735680|527948561|FG003|Overall Study|Withdrawal by Subject|0|||
146394905|NCT03735680|527948562|FG004|Overall Study|Withdrawal by Subject|0|||
146394906|NCT03735680|527948563|FG005|Overall Study|Withdrawal by Subject|1|||
146394907|NCT03735680|527948558|FG000|Overall Study|Patient unable or unwilling to continue|0|||
146394908|NCT03735680|527948559|FG001|Overall Study|Patient unable or unwilling to continue|0|||
146394909|NCT03735680|527948560|FG002|Overall Study|Patient unable or unwilling to continue|1|||
146394910|NCT03735680|527948561|FG003|Overall Study|Patient unable or unwilling to continue|0|||
146394911|NCT03735680|527948562|FG004|Overall Study|Patient unable or unwilling to continue|0|||
146394912|NCT03735680|527948563|FG005|Overall Study|Patient unable or unwilling to continue|0|||
146394913|NCT04001790|527948564|FG000|Overall Study|Withdrawal by Subject|1|||
146394914|NCT04001790|527948565|FG001|Overall Study|Withdrawal by Subject|2|||
146394915|NCT05028816|527948567|FG000|Overall Study|Lost to Follow-up|5|||
146394916|NCT05028816|527948568|FG001|Overall Study|Lost to Follow-up|3|||
146394917|NCT05028816|527948567|FG000|Overall Study|Withdrawal by Subject|4|||
146394918|NCT05028816|527948568|FG001|Overall Study|Withdrawal by Subject|1|||
146394919|NCT05028816|527948567|FG000|Overall Study|Physician Decision|1|||
146394920|NCT05028816|527948568|FG001|Overall Study|Physician Decision|0|||
146394921|NCT05064436|527948569|FG000|Overall Study|Other Reasons|1|||
146394922|NCT05064436|527948570|FG001|Overall Study|Other Reasons|0|||
146394923|NCT01711736|527948571|FG000|Overall Study|Lost to Follow-up|4|||
146394924|NCT01711736|527948572|FG001|Overall Study|Lost to Follow-up|1|||
146394925|NCT01711736|527948571|FG000|Overall Study|Withdrawal by Subject|6|||
146394926|NCT01711736|527948572|FG001|Overall Study|Withdrawal by Subject|6|||
146394927|NCT01711736|527948571|FG000|Overall Study|Migrated/moved from study area|2|||
146394928|NCT01711736|527948572|FG001|Overall Study|Migrated/moved from study area|1|||
146394929|NCT01342445|527948573|FG000|Overall Study|Experienced side effects|0|||
146394930|NCT01342445|527948574|FG001|Overall Study|Experienced side effects|2|||
146394931|NCT05450198|527948579|FG000|Overall Study|Withdrawal by Subject|1|||
146394932|NCT05450198|527948580|FG001|Overall Study|Withdrawal by Subject|1|||
146394933|NCT05450198|527948581|FG002|Overall Study|Withdrawal by Subject|2|||
146394934|NCT05450198|527948582|FG003|Overall Study|Withdrawal by Subject|0|||
146394935|NCT05450198|527948579|FG000|Overall Study|Lost to Follow-up|1|||
146394936|NCT05450198|527948580|FG001|Overall Study|Lost to Follow-up|0|||
146394937|NCT05450198|527948581|FG002|Overall Study|Lost to Follow-up|2|||
146394938|NCT05450198|527948582|FG003|Overall Study|Lost to Follow-up|1|||
146394939|NCT01319422|527948583|FG000|Overall Study|Withdrawal by Subject|1|||
146394940|NCT01319422|527948584|FG001|Overall Study|Withdrawal by Subject|0|||
146394941|NCT00933543|527948586|FG000|Overall Study|Adverse Event|2|||
146394942|NCT00933543|527948587|FG001|Overall Study|Adverse Event|1|||
146394943|NCT00933543|527948586|FG000|Overall Study|Lost to Follow-up|0|||
146394944|NCT00933543|527948587|FG001|Overall Study|Lost to Follow-up|1|||
146394945|NCT00933543|527948586|FG000|Overall Study|Withdrawal by Subject|0|||
146394946|NCT00933543|527948587|FG001|Overall Study|Withdrawal by Subject|1|||
146394947|NCT00933543|527948586|FG000|Overall Study|Lack of Efficacy|0|||
146394948|NCT00933543|527948587|FG001|Overall Study|Lack of Efficacy|3|||
146394949|NCT00933543|527948586|FG000|Overall Study|Other|1|||
146394950|NCT00933543|527948587|FG001|Overall Study|Other|1|||
146394951|NCT04837807|527948590|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
146394952|NCT04837807|527948591|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
146394953|NCT04629534|527948592|FG000|Overall Study|Physician Decision|1|||
146394954|NCT04629534|527948593|FG001|Overall Study|Physician Decision|0|||
146394955|NCT04629534|527948592|FG000|Overall Study|Protocol Violation|0|||
146394956|NCT04629534|527948593|FG001|Overall Study|Protocol Violation|2|||
146394957|NCT00308555|527948594|FG000|Overall Study|Withdrawal by Subject|1|||
146394958|NCT00308555|527948595|FG001|Overall Study|Withdrawal by Subject|0|||
146394959|NCT00308555|527948594|FG000|Overall Study|Physician Decision|2|||
146394960|NCT00308555|527948595|FG001|Overall Study|Physician Decision|0|||
146394961|NCT00814502|527948596|FG000|Overall Study|Adverse Event|1|||
146394962|NCT00814502|527948597|FG001|Overall Study|Adverse Event|0|||
146394963|NCT00814502|527948596|FG000|Overall Study|Withdrawal by Subject|0|||
146394964|NCT00814502|527948597|FG001|Overall Study|Withdrawal by Subject|2|||
146394965|NCT04246593|527948604|FG000|Overall Study|Withdrawal by Subject|14|||
146394966|NCT04246593|527948605|FG001|Overall Study|Withdrawal by Subject|13|||
146394967|NCT04246593|527948604|FG000|Overall Study|Lost to Follow-up|124|||
146394968|NCT04246593|527948605|FG001|Overall Study|Lost to Follow-up|71|||
146394969|NCT04246593|527948604|FG000|Overall Study|Moved out of area/became ineligible|3|||
146394970|NCT04246593|527948605|FG001|Overall Study|Moved out of area/became ineligible|1|||
146394971|NCT04246593|527948604|FG000|Overall Study|Reason unknown|4|||
146394972|NCT04246593|527948605|FG001|Overall Study|Reason unknown|2|||
146394973|NCT00265109|527948606|FG000|Overall Study|Withdrawal by Subject|5|||
146394974|NCT00265109|527948606|FG000|Overall Study|Adverse Event|1|||
146394975|NCT01049360|527948611|FG000|Period 1|Adverse Event|0|||
146394976|NCT01049360|527948612|FG001|Period 1|Adverse Event|1|||
146394977|NCT01049360|527948613|FG002|Period 1|Adverse Event|0|||
146394978|NCT01049360|527948614|FG003|Period 1|Adverse Event|1|||
146394979|NCT01049360|527948615|FG004|Period 1|Adverse Event|0|||
146394980|NCT01049360|527948616|FG005|Period 1|Adverse Event|0|||
145943606|NCT03191864|526300479|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
145943607|NCT03191864|526300480|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
145943608|NCT03191864|526300481|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
145943609|NCT03191864|526300482|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
145943610|NCT03191864|526300483|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
145943611|NCT03191864|526300484|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
145943612|NCT03191864|526300479|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145943613|NCT03191864|526300480|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
146394981|NCT01049360|527948617|FG006|Period 1|Adverse Event|0|||
146394982|NCT01049360|527948618|FG007|Period 1|Adverse Event|1|||
146394983|NCT01049360|527948619|FG008|Period 1|Adverse Event|0|||
146394984|NCT01049360|527948620|FG009|Period 1|Adverse Event|0|||
146394985|NCT01049360|527948621|FG010|Period 1|Adverse Event|0|||
146394986|NCT01049360|527948622|FG011|Period 1|Adverse Event|0|||
146394987|NCT01049360|527948623|FG012|Period 1|Adverse Event|1|||
146394988|NCT01049360|527948624|FG013|Period 1|Adverse Event|1|||
146394989|NCT01049360|527948625|FG014|Period 1|Adverse Event|0|||
146394990|NCT01049360|527948626|FG015|Period 1|Adverse Event|0|||
146394991|NCT01049360|527948627|FG016|Period 1|Adverse Event|1|||
146394992|NCT01049360|527948628|FG017|Period 1|Adverse Event|0|||
145943614|NCT03191864|526300481|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145943615|NCT03191864|526300482|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145943616|NCT03191864|526300483|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
145943617|NCT03191864|526300484|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145943618|NCT02044874|526300485|FG000|Overall Study|Adverse Event|5|||
145943619|NCT02044874|526300486|FG001|Overall Study|Adverse Event|6|||
145943620|NCT02044874|526300487|FG002|Overall Study|Adverse Event|6|||
145943621|NCT02044874|526300485|FG000|Overall Study|Withdrawal by Subject|8|||
145943622|NCT02044874|526300486|FG001|Overall Study|Withdrawal by Subject|16|||
145943623|NCT02044874|526300487|FG002|Overall Study|Withdrawal by Subject|23|||
145943624|NCT02044874|526300485|FG000|Overall Study|Physician Decision|0|||
145943625|NCT02044874|526300486|FG001|Overall Study|Physician Decision|2|||
145943626|NCT02044874|526300487|FG002|Overall Study|Physician Decision|1|||
145943627|NCT02044874|526300485|FG000|Overall Study|Lost to Follow-up|10|||
145943628|NCT02044874|526300486|FG001|Overall Study|Lost to Follow-up|27|||
145943629|NCT02044874|526300487|FG002|Overall Study|Lost to Follow-up|21|||
145943630|NCT02044874|526300485|FG000|Overall Study|Sponsor Decision|0|||
145943631|NCT02044874|526300486|FG001|Overall Study|Sponsor Decision|1|||
145943632|NCT02044874|526300487|FG002|Overall Study|Sponsor Decision|1|||
145943633|NCT02044874|526300485|FG000|Overall Study|Other|7|||
145943634|NCT02044874|526300486|FG001|Overall Study|Other|3|||
145943635|NCT02044874|526300487|FG002|Overall Study|Other|8|||
145943636|NCT02889835|526300488|FG000|Overall Study|Lost to Follow-up|13|||
145943637|NCT02889835|526300489|FG001|Overall Study|Lost to Follow-up|13|||
145943638|NCT02889835|526300490|FG002|Overall Study|Lost to Follow-up|13|||
145943639|NCT02889835|526300488|FG000|Overall Study|Withdrawal by Subject|2|||
145943640|NCT02889835|526300489|FG001|Overall Study|Withdrawal by Subject|2|||
145943641|NCT02889835|526300490|FG002|Overall Study|Withdrawal by Subject|2|||
145943642|NCT02889835|526300488|FG000|Overall Study|Protocol Violation|1|||
145943643|NCT02889835|526300489|FG001|Overall Study|Protocol Violation|1|||
145943644|NCT02889835|526300490|FG002|Overall Study|Protocol Violation|1|||
145943645|NCT02889835|526300488|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
145943646|NCT02889835|526300489|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
145943647|NCT02889835|526300490|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
145943648|NCT02889835|526300488|FG000|Overall Study|Death|1|||
145943649|NCT02889835|526300489|FG001|Overall Study|Death|1|||
145943650|NCT02889835|526300490|FG002|Overall Study|Death|1|||
145943651|NCT05072964|526300491|FG000|Overall Study|Withdrawal by Subject|4|||
145943652|NCT05072964|526300491|FG000|Overall Study|Death|1|||
145943653|NCT02342548|526300492|FG000|Overall Study|Adverse Event|12|||
145943654|NCT02342548|526300493|FG001|Overall Study|Adverse Event|17|||
145943655|NCT02342548|526300494|FG002|Overall Study|Adverse Event|13|||
145943656|NCT02342548|526300492|FG000|Overall Study|Lost to Follow-up|0|||
145943657|NCT02342548|526300493|FG001|Overall Study|Lost to Follow-up|1|||
145943658|NCT02342548|526300494|FG002|Overall Study|Lost to Follow-up|0|||
145943659|NCT02342548|526300492|FG000|Overall Study|Study terminated by sponsor|20|||
145943660|NCT02342548|526300493|FG001|Overall Study|Study terminated by sponsor|39|||
145943661|NCT02342548|526300494|FG002|Overall Study|Study terminated by sponsor|25|||
145943662|NCT02342548|526300492|FG000|Overall Study|Protocol Violation|0|||
145943663|NCT02342548|526300493|FG001|Overall Study|Protocol Violation|1|||
145943664|NCT02342548|526300494|FG002|Overall Study|Protocol Violation|0|||
145943665|NCT02342548|526300492|FG000|Overall Study|Withdrawal by Subject|1|||
145943666|NCT02342548|526300493|FG001|Overall Study|Withdrawal by Subject|3|||
145943667|NCT02342548|526300494|FG002|Overall Study|Withdrawal by Subject|4|||
145943668|NCT02342548|526300492|FG000|Overall Study|Other|1|||
145943669|NCT02342548|526300493|FG001|Overall Study|Other|1|||
145943670|NCT02342548|526300494|FG002|Overall Study|Other|1|||
145943671|NCT02987972|526300495|FG000|Overall Study|Adverse Event|1|||
145943672|NCT02987972|526300496|FG001|Overall Study|Adverse Event|1|||
145943673|NCT02987972|526300497|FG002|Overall Study|Adverse Event|0|||
145943674|NCT02987972|526300495|FG000|Overall Study|Death|1|||
145943675|NCT02987972|526300496|FG001|Overall Study|Death|0|||
145943676|NCT02987972|526300497|FG002|Overall Study|Death|0|||
145943677|NCT02987972|526300495|FG000|Overall Study|Lack of Efficacy|9|||
145943678|NCT02987972|526300496|FG001|Overall Study|Lack of Efficacy|12|||
145943679|NCT02987972|526300497|FG002|Overall Study|Lack of Efficacy|12|||
145943680|NCT02987972|526300495|FG000|Overall Study|Lost to Follow-up|7|||
145943681|NCT02987972|526300496|FG001|Overall Study|Lost to Follow-up|8|||
145943682|NCT02987972|526300497|FG002|Overall Study|Lost to Follow-up|4|||
145943683|NCT02987972|526300495|FG000|Overall Study|Physician Decision|1|||
145943684|NCT02987972|526300496|FG001|Overall Study|Physician Decision|6|||
145943685|NCT02987972|526300497|FG002|Overall Study|Physician Decision|0|||
145943686|NCT02987972|526300495|FG000|Overall Study|Protocol Violation|2|||
145943687|NCT02987972|526300496|FG001|Overall Study|Protocol Violation|1|||
145943688|NCT02987972|526300497|FG002|Overall Study|Protocol Violation|5|||
145943689|NCT02987972|526300495|FG000|Overall Study|Withdrawal by Subject|22|||
145943690|NCT02987972|526300496|FG001|Overall Study|Withdrawal by Subject|17|||
145943691|NCT02987972|526300497|FG002|Overall Study|Withdrawal by Subject|21|||
145943692|NCT01047332|526300500|FG000|Overall Study|SEMS Obstruction|11|||
145943693|NCT01047332|526300501|FG001|Overall Study|SEMS Obstruction|20|||
145943694|NCT01047332|526300500|FG000|Overall Study|Died Unobstructed|38|||
145943695|NCT01047332|526300501|FG001|Overall Study|Died Unobstructed|41|||
145943696|NCT01047332|526300500|FG000|Overall Study|Lost to Follow-up|8|||
145943697|NCT01047332|526300501|FG001|Overall Study|Lost to Follow-up|3|||
145943698|NCT03521817|526300506|FG000|Overall Study|Protocol Violation|0|||
145943699|NCT03521817|526300507|FG001|Overall Study|Protocol Violation|1|||
145943700|NCT00073983|526300509|FG000|Overall Study|not evaluable|1|||
145943701|NCT03800836|526300511|FG000|Overall Study|Other|2|||
145943702|NCT03800836|526300512|FG001|Overall Study|Other|1|||
145943703|NCT03800836|526300513|FG002|Overall Study|Other|0|||
145943704|NCT03800836|526300514|FG003|Overall Study|Other|2|||
145943705|NCT03800836|526300515|FG004|Overall Study|Other|0|||
145943706|NCT03800836|526300516|FG005|Overall Study|Other|1|||
145943707|NCT03800836|526300511|FG000|Overall Study|Lost to Follow-up|2|||
145943708|NCT03800836|526300512|FG001|Overall Study|Lost to Follow-up|0|||
145943709|NCT03800836|526300513|FG002|Overall Study|Lost to Follow-up|1|||
145943710|NCT03800836|526300514|FG003|Overall Study|Lost to Follow-up|1|||
145943711|NCT03800836|526300515|FG004|Overall Study|Lost to Follow-up|3|||
145943712|NCT03800836|526300516|FG005|Overall Study|Lost to Follow-up|0|||
145943713|NCT03800836|526300511|FG000|Overall Study|Withdrawal by Subject|1|||
145943714|NCT03800836|526300512|FG001|Overall Study|Withdrawal by Subject|0|||
145943715|NCT03800836|526300513|FG002|Overall Study|Withdrawal by Subject|0|||
146394993|NCT01049360|527948629|FG018|Period 1|Adverse Event|1|||
146394994|NCT01049360|527948630|FG019|Period 1|Adverse Event|0|||
145943716|NCT03800836|526300514|FG003|Overall Study|Withdrawal by Subject|0|||
145943717|NCT03800836|526300515|FG004|Overall Study|Withdrawal by Subject|0|||
145943718|NCT03800836|526300516|FG005|Overall Study|Withdrawal by Subject|0|||
145943719|NCT03800836|526300511|FG000|Overall Study|Physician Decision|31|||
145943720|NCT03800836|526300512|FG001|Overall Study|Physician Decision|3|||
145943721|NCT03800836|526300513|FG002|Overall Study|Physician Decision|6|||
145943722|NCT03800836|526300514|FG003|Overall Study|Physician Decision|4|||
145943723|NCT03800836|526300515|FG004|Overall Study|Physician Decision|4|||
146394995|NCT01049360|527948611|FG000|Period 1|Did not meet inc/exc criteria|0|||
146394996|NCT01049360|527948612|FG001|Period 1|Did not meet inc/exc criteria|0|||
146394997|NCT01049360|527948613|FG002|Period 1|Did not meet inc/exc criteria|0|||
146394998|NCT01049360|527948614|FG003|Period 1|Did not meet inc/exc criteria|0|||
146394999|NCT01049360|527948615|FG004|Period 1|Did not meet inc/exc criteria|0|||
146395000|NCT01049360|527948616|FG005|Period 1|Did not meet inc/exc criteria|0|||
146395001|NCT01049360|527948617|FG006|Period 1|Did not meet inc/exc criteria|0|||
146395002|NCT01049360|527948618|FG007|Period 1|Did not meet inc/exc criteria|1|||
145943724|NCT03800836|526300516|FG005|Overall Study|Physician Decision|5|||
145943725|NCT03800836|526300511|FG000|Overall Study|Death|34|||
145943726|NCT03800836|526300512|FG001|Overall Study|Death|16|||
145943727|NCT03800836|526300513|FG002|Overall Study|Death|5|||
145943728|NCT03800836|526300514|FG003|Overall Study|Death|5|||
145943729|NCT03800836|526300515|FG004|Overall Study|Death|10|||
146395003|NCT01049360|527948619|FG008|Period 1|Did not meet inc/exc criteria|1|||
146395004|NCT01049360|527948620|FG009|Period 1|Did not meet inc/exc criteria|0|||
146395005|NCT01049360|527948621|FG010|Period 1|Did not meet inc/exc criteria|0|||
146395006|NCT01049360|527948622|FG011|Period 1|Did not meet inc/exc criteria|0|||
146395007|NCT01049360|527948623|FG012|Period 1|Did not meet inc/exc criteria|0|||
146395008|NCT01049360|527948624|FG013|Period 1|Did not meet inc/exc criteria|0|||
146395009|NCT01049360|527948625|FG014|Period 1|Did not meet inc/exc criteria|0|||
146395010|NCT01049360|527948626|FG015|Period 1|Did not meet inc/exc criteria|0|||
146395011|NCT01049360|527948627|FG016|Period 1|Did not meet inc/exc criteria|0|||
146395012|NCT01049360|527948628|FG017|Period 1|Did not meet inc/exc criteria|0|||
146395013|NCT01049360|527948629|FG018|Period 1|Did not meet inc/exc criteria|0|||
146395014|NCT01049360|527948630|FG019|Period 1|Did not meet inc/exc criteria|0|||
146395015|NCT01049360|527948611|FG000|Period 1|Withdrawal by Subject|0|||
146395016|NCT01049360|527948612|FG001|Period 1|Withdrawal by Subject|0|||
146395017|NCT01049360|527948613|FG002|Period 1|Withdrawal by Subject|0|||
146395018|NCT01049360|527948614|FG003|Period 1|Withdrawal by Subject|0|||
146395019|NCT01049360|527948615|FG004|Period 1|Withdrawal by Subject|0|||
146395020|NCT01049360|527948616|FG005|Period 1|Withdrawal by Subject|0|||
145943730|NCT03800836|526300516|FG005|Overall Study|Death|0|||
145943731|NCT03800836|526300511|FG000|Overall Study|Symptomatic Deterioration|1|||
145943732|NCT03800836|526300512|FG001|Overall Study|Symptomatic Deterioration|0|||
145943733|NCT03800836|526300513|FG002|Overall Study|Symptomatic Deterioration|1|||
145943734|NCT03800836|526300514|FG003|Overall Study|Symptomatic Deterioration|0|||
145943735|NCT03800836|526300515|FG004|Overall Study|Symptomatic Deterioration|0|||
145943736|NCT03800836|526300516|FG005|Overall Study|Symptomatic Deterioration|0|||
145943737|NCT00908596|526303148|FG000|Overall Study|Other reasons|46|||
146395021|NCT01049360|527948617|FG006|Period 1|Withdrawal by Subject|0|||
146395022|NCT01049360|527948618|FG007|Period 1|Withdrawal by Subject|0|||
146395023|NCT01049360|527948619|FG008|Period 1|Withdrawal by Subject|1|||
146395024|NCT01049360|527948620|FG009|Period 1|Withdrawal by Subject|0|||
146395025|NCT01049360|527948621|FG010|Period 1|Withdrawal by Subject|1|||
145943738|NCT00908596|526303149|FG001|Overall Study|Other reasons|6|||
146395026|NCT01049360|527948622|FG011|Period 1|Withdrawal by Subject|0|||
145943739|NCT00908596|526303150|FG002|Overall Study|Other reasons|2|||
145943740|NCT00908596|526303151|FG003|Overall Study|Other reasons|0|||
145943741|NCT00908596|526303148|FG000|Overall Study|Lost to Follow-up|0|||
145943742|NCT00908596|526303149|FG001|Overall Study|Lost to Follow-up|1|||
145943743|NCT00908596|526303150|FG002|Overall Study|Lost to Follow-up|12|||
145943744|NCT00908596|526303151|FG003|Overall Study|Lost to Follow-up|4|||
145943745|NCT00908596|526303148|FG000|Overall Study|Death|0|||
145943746|NCT00908596|526303149|FG001|Overall Study|Death|5|||
145943747|NCT00908596|526303150|FG002|Overall Study|Death|57|||
145943748|NCT00908596|526303151|FG003|Overall Study|Death|32|||
145943749|NCT00908596|526303148|FG000|Overall Study|Protocol Violation|1|||
145943750|NCT00908596|526303149|FG001|Overall Study|Protocol Violation|0|||
145943751|NCT00908596|526303150|FG002|Overall Study|Protocol Violation|0|||
145943752|NCT00908596|526303151|FG003|Overall Study|Protocol Violation|0|||
145943753|NCT00908596|526303148|FG000|Overall Study|Withdrawal by Subject|0|||
145943754|NCT00908596|526303149|FG001|Overall Study|Withdrawal by Subject|1|||
145943755|NCT00908596|526303150|FG002|Overall Study|Withdrawal by Subject|3|||
145943756|NCT00908596|526303151|FG003|Overall Study|Withdrawal by Subject|1|||
145943757|NCT02609724|526303156|FG000|Overall Study|Death|2|||
145943758|NCT02609724|526303157|FG001|Overall Study|Death|0|||
145943759|NCT02609724|526303158|FG002|Overall Study|Death|1|||
145943760|NCT02609724|526303156|FG000|Overall Study|Withdrawal by Subject|1|||
145943761|NCT02609724|526303157|FG001|Overall Study|Withdrawal by Subject|2|||
145943762|NCT02609724|526303158|FG002|Overall Study|Withdrawal by Subject|3|||
145943763|NCT02609724|526303156|FG000|Overall Study|Illness|2|||
145943764|NCT02609724|526303157|FG001|Overall Study|Illness|1|||
146395027|NCT01049360|527948623|FG012|Period 1|Withdrawal by Subject|1|||
146395028|NCT01049360|527948624|FG013|Period 1|Withdrawal by Subject|0|||
145943765|NCT02609724|526303158|FG002|Overall Study|Illness|0|||
145943766|NCT03077659|526303159|FG000|Overall Study|Withdrawal by Subject|0|||
145943767|NCT03077659|526303160|FG001|Overall Study|Withdrawal by Subject|0|||
145943768|NCT03077659|526303161|FG002|Overall Study|Withdrawal by Subject|1|||
145943769|NCT00980018|526303166|FG000|Overall Study|Adverse Event|8|||
145943770|NCT00980018|526303166|FG000|Overall Study|Patient withdrew consent|3|||
145943771|NCT00980018|526303166|FG000|Overall Study|Lost to Follow-up|1|||
145943772|NCT00087126|526303170|FG000|Overall Study|Ineligible - second primary|1|||
145943773|NCT00087126|526303170|FG000|Overall Study|Never treated|1|||
145943774|NCT01432275|526303171|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
145943775|NCT01432275|526303172|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
145943776|NCT01432275|526303171|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
145943777|NCT01432275|526303172|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
145943778|NCT01432275|526303171|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
146395029|NCT01049360|527948625|FG014|Period 1|Withdrawal by Subject|0|||
146395030|NCT01049360|527948626|FG015|Period 1|Withdrawal by Subject|0|||
146395031|NCT01049360|527948627|FG016|Period 1|Withdrawal by Subject|0|||
146395032|NCT01049360|527948628|FG017|Period 1|Withdrawal by Subject|0|||
146395033|NCT01049360|527948629|FG018|Period 1|Withdrawal by Subject|0|||
146395034|NCT01049360|527948630|FG019|Period 1|Withdrawal by Subject|0|||
146395035|NCT01049360|527948611|FG000|Period 2|Protocol Violation|0|||
146395036|NCT01049360|527948612|FG001|Period 2|Protocol Violation|0|||
146395037|NCT01049360|527948613|FG002|Period 2|Protocol Violation|0|||
146395038|NCT01049360|527948614|FG003|Period 2|Protocol Violation|1|||
146395039|NCT01049360|527948615|FG004|Period 2|Protocol Violation|0|||
146395040|NCT01049360|527948616|FG005|Period 2|Protocol Violation|0|||
146395041|NCT01049360|527948617|FG006|Period 2|Protocol Violation|0|||
146395042|NCT01049360|527948618|FG007|Period 2|Protocol Violation|0|||
146395043|NCT01049360|527948619|FG008|Period 2|Protocol Violation|0|||
146395044|NCT01049360|527948620|FG009|Period 2|Protocol Violation|0|||
146395045|NCT01049360|527948621|FG010|Period 2|Protocol Violation|0|||
146395046|NCT01049360|527948622|FG011|Period 2|Protocol Violation|0|||
146395047|NCT01049360|527948623|FG012|Period 2|Protocol Violation|0|||
146395048|NCT01049360|527948624|FG013|Period 2|Protocol Violation|0|||
146395049|NCT01049360|527948625|FG014|Period 2|Protocol Violation|1|||
146395050|NCT01049360|527948626|FG015|Period 2|Protocol Violation|1|||
146395051|NCT01049360|527948627|FG016|Period 2|Protocol Violation|0|||
146395052|NCT01049360|527948628|FG017|Period 2|Protocol Violation|0|||
146395053|NCT01049360|527948629|FG018|Period 2|Protocol Violation|0|||
146395054|NCT01049360|527948630|FG019|Period 2|Protocol Violation|0|||
146395055|NCT01049360|527948611|FG000|Period 2|Adverse Event|0|||
146395056|NCT01049360|527948612|FG001|Period 2|Adverse Event|1|||
146395057|NCT01049360|527948613|FG002|Period 2|Adverse Event|0|||
146395058|NCT01049360|527948614|FG003|Period 2|Adverse Event|0|||
146395059|NCT01049360|527948615|FG004|Period 2|Adverse Event|0|||
146395060|NCT01049360|527948616|FG005|Period 2|Adverse Event|0|||
146395061|NCT01049360|527948617|FG006|Period 2|Adverse Event|0|||
146395062|NCT01049360|527948618|FG007|Period 2|Adverse Event|0|||
146395063|NCT01049360|527948619|FG008|Period 2|Adverse Event|1|||
146395064|NCT01049360|527948620|FG009|Period 2|Adverse Event|0|||
146395065|NCT01049360|527948621|FG010|Period 2|Adverse Event|0|||
146395066|NCT01049360|527948622|FG011|Period 2|Adverse Event|0|||
146395067|NCT01049360|527948623|FG012|Period 2|Adverse Event|0|||
145943779|NCT01432275|526303172|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
145943780|NCT01432275|526303171|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
145943781|NCT01432275|526303172|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
145943782|NCT01432275|526303171|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
145943783|NCT01432275|526303172|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
145943784|NCT01432275|526303171|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
145943785|NCT01432275|526303172|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
145943786|NCT01432275|526303171|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
145943787|NCT01432275|526303172|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
145943788|NCT01432275|526303171|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
145943789|NCT01432275|526303172|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
145943790|NCT01432275|526303171|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
145943791|NCT01432275|526303172|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
145943792|NCT02565706|526303173|FG000|Overall Study|Withdrawal by Subject|5|||
145943793|NCT02565706|526303174|FG001|Overall Study|Withdrawal by Subject|7|||
145943794|NCT02565706|526303175|FG002|Overall Study|Withdrawal by Subject|7|||
145943795|NCT02565706|526303176|FG003|Overall Study|Withdrawal by Subject|11|||
145943796|NCT02565706|526303173|FG000|Overall Study|Lost to Follow-up|72|||
145943797|NCT02565706|526303174|FG001|Overall Study|Lost to Follow-up|75|||
145943798|NCT02565706|526303175|FG002|Overall Study|Lost to Follow-up|82|||
145943799|NCT02565706|526303176|FG003|Overall Study|Lost to Follow-up|74|||
145943800|NCT00934856|526303177|FG000|Feasibility Part|Progressive disease|4|||
145943801|NCT00934856|526303178|FG001|Feasibility Part|Progressive disease|4|||
145943802|NCT00934856|526303179|FG002|Feasibility Part|Progressive disease|2|||
145943803|NCT00934856|526303180|FG003|Feasibility Part|Progressive disease|3|||
145943804|NCT00934856|526303181|FG004|Feasibility Part|Progressive disease|0|||
145943805|NCT00934856|526303182|FG005|Feasibility Part|Progressive disease|0|||
145943806|NCT00934856|526303177|FG000|Feasibility Part|Physician Decision|0|||
145943807|NCT00934856|526303178|FG001|Feasibility Part|Physician Decision|0|||
145943808|NCT00934856|526303179|FG002|Feasibility Part|Physician Decision|1|||
145943809|NCT00934856|526303180|FG003|Feasibility Part|Physician Decision|0|||
145943810|NCT00934856|526303181|FG004|Feasibility Part|Physician Decision|0|||
145943811|NCT00934856|526303182|FG005|Feasibility Part|Physician Decision|0|||
145943812|NCT00934856|526303177|FG000|Feasibility Part|Adverse Event|1|||
145943813|NCT00934856|526303178|FG001|Feasibility Part|Adverse Event|1|||
145943814|NCT00934856|526303179|FG002|Feasibility Part|Adverse Event|0|||
145943815|NCT00934856|526303180|FG003|Feasibility Part|Adverse Event|1|||
145943816|NCT00934856|526303181|FG004|Feasibility Part|Adverse Event|0|||
145943817|NCT00934856|526303182|FG005|Feasibility Part|Adverse Event|2|||
145943818|NCT00934856|526303177|FG000|Feasibility Part|Withdrawal by Subject|0|||
145943819|NCT00934856|526303178|FG001|Feasibility Part|Withdrawal by Subject|0|||
145943820|NCT00934856|526303179|FG002|Feasibility Part|Withdrawal by Subject|0|||
145943821|NCT00934856|526303180|FG003|Feasibility Part|Withdrawal by Subject|1|||
145943822|NCT00934856|526303181|FG004|Feasibility Part|Withdrawal by Subject|0|||
145943823|NCT00934856|526303182|FG005|Feasibility Part|Withdrawal by Subject|1|||
145943824|NCT00934856|526303177|FG000|Extension Part|Adverse Event|0|||
145943825|NCT00934856|526303178|FG001|Extension Part|Adverse Event|0|||
145943826|NCT00934856|526303179|FG002|Extension Part|Adverse Event|0|||
145943827|NCT00934856|526303180|FG003|Extension Part|Adverse Event|1|||
145943828|NCT00934856|526303181|FG004|Extension Part|Adverse Event|4|||
145943829|NCT00934856|526303182|FG005|Extension Part|Adverse Event|4|||
145943830|NCT00934856|526303177|FG000|Extension Part|Progressive disease|0|||
145943831|NCT00934856|526303178|FG001|Extension Part|Progressive disease|0|||
145943832|NCT00934856|526303179|FG002|Extension Part|Progressive disease|0|||
145943833|NCT00934856|526303180|FG003|Extension Part|Progressive disease|1|||
145943834|NCT00934856|526303181|FG004|Extension Part|Progressive disease|0|||
145943835|NCT00934856|526303182|FG005|Extension Part|Progressive disease|0|||
145943836|NCT00934856|526303177|FG000|Extension Part|Non-compliance with drug|0|||
145943837|NCT00934856|526303178|FG001|Extension Part|Non-compliance with drug|0|||
145943838|NCT00934856|526303179|FG002|Extension Part|Non-compliance with drug|0|||
145943839|NCT00934856|526303180|FG003|Extension Part|Non-compliance with drug|0|||
145943840|NCT00934856|526303181|FG004|Extension Part|Non-compliance with drug|0|||
145943841|NCT00934856|526303182|FG005|Extension Part|Non-compliance with drug|1|||
145943842|NCT00772005|526303187|FG000|Overall Study|Adverse Event|9|||
145943843|NCT00772005|526303188|FG001|Overall Study|Adverse Event|14|||
145943844|NCT00772005|526303189|FG002|Overall Study|Adverse Event|10|||
145943845|NCT00772005|526303190|FG003|Overall Study|Adverse Event|13|||
145943846|NCT00772005|526303187|FG000|Overall Study|Lack of Efficacy|0|||
145943847|NCT00772005|526303188|FG001|Overall Study|Lack of Efficacy|1|||
145943848|NCT00772005|526303189|FG002|Overall Study|Lack of Efficacy|0|||
145943849|NCT00772005|526303190|FG003|Overall Study|Lack of Efficacy|0|||
145943850|NCT00772005|526303187|FG000|Overall Study|Withdrawal by Subject|3|||
145943851|NCT00772005|526303188|FG001|Overall Study|Withdrawal by Subject|7|||
145943852|NCT00772005|526303189|FG002|Overall Study|Withdrawal by Subject|10|||
145943853|NCT00772005|526303190|FG003|Overall Study|Withdrawal by Subject|2|||
145943854|NCT00772005|526303187|FG000|Overall Study|Protocol Violation|2|||
145943855|NCT00772005|526303188|FG001|Overall Study|Protocol Violation|4|||
145943856|NCT00772005|526303189|FG002|Overall Study|Protocol Violation|1|||
145943857|NCT00772005|526303190|FG003|Overall Study|Protocol Violation|6|||
145943858|NCT00772005|526303187|FG000|Overall Study|Lost to Follow-up|7|||
145943859|NCT00772005|526303188|FG001|Overall Study|Lost to Follow-up|3|||
145943860|NCT00772005|526303189|FG002|Overall Study|Lost to Follow-up|6|||
145943861|NCT00772005|526303190|FG003|Overall Study|Lost to Follow-up|3|||
145943862|NCT00772005|526303187|FG000|Overall Study|Non-compliance with study procedures|1|||
145943863|NCT00772005|526303188|FG001|Overall Study|Non-compliance with study procedures|1|||
145943864|NCT00772005|526303189|FG002|Overall Study|Non-compliance with study procedures|0|||
145943865|NCT00772005|526303190|FG003|Overall Study|Non-compliance with study procedures|1|||
145943866|NCT00772005|526303187|FG000|Overall Study|Non-compliance with drug administration|3|||
145943867|NCT00772005|526303188|FG001|Overall Study|Non-compliance with drug administration|0|||
145943868|NCT00772005|526303189|FG002|Overall Study|Non-compliance with drug administration|1|||
145943869|NCT00772005|526303190|FG003|Overall Study|Non-compliance with drug administration|1|||
145943870|NCT03887117|526303203|FG000|Overall Study|Discontinued prematurely|0|||
145943871|NCT03887117|526303204|FG001|Overall Study|Discontinued prematurely|1|||
145943872|NCT03887117|526303205|FG002|Overall Study|Discontinued prematurely|1|||
145943873|NCT03887117|526303206|FG003|Overall Study|Discontinued prematurely|2|||
145943874|NCT02584959|526303207|FG000|Period 1|Withdrawn from study|3|||
145943875|NCT02584959|526303208|FG001|Period 1|Withdrawn from study|4|||
145943876|NCT02584959|526303209|FG002|Period 1|Withdrawn from study|0|||
145943877|NCT02584959|526303207|FG000|Period 2|Withdrawn from study|6|||
145943878|NCT02584959|526303208|FG001|Period 2|Withdrawn from study|1|||
145943879|NCT02584959|526303209|FG002|Period 2|Withdrawn from study|2|||
145943880|NCT01162122|526303212|FG000|Overall Study|Withdrawal by Subject|52|||
145943881|NCT01162122|526303213|FG001|Overall Study|Withdrawal by Subject|43|||
145943882|NCT01162122|526303212|FG000|Overall Study|Lost to Follow-up|73|||
145943883|NCT01162122|526303213|FG001|Overall Study|Lost to Follow-up|91|||
145943884|NCT01162122|526303212|FG000|Overall Study|Adverse Event|3|||
145943885|NCT01162122|526303213|FG001|Overall Study|Adverse Event|2|||
145943886|NCT01162122|526303212|FG000|Overall Study|Death|51|||
145943887|NCT01162122|526303213|FG001|Overall Study|Death|46|||
145943888|NCT01162122|526303212|FG000|Overall Study|Protocol Violation|2|||
145943889|NCT01162122|526303213|FG001|Overall Study|Protocol Violation|2|||
145943890|NCT01162122|526303212|FG000|Overall Study|Inappropriate enrollment|5|||
145943891|NCT01162122|526303213|FG001|Overall Study|Inappropriate enrollment|4|||
145943892|NCT01162122|526303212|FG000|Overall Study|Administrative reason|1|||
145943893|NCT01162122|526303213|FG001|Overall Study|Administrative reason|1|||
145943894|NCT01162122|526303212|FG000|Overall Study|Unable to classify|3|||
145943895|NCT01162122|526303213|FG001|Overall Study|Unable to classify|7|||
145943896|NCT01162122|526303212|FG000|Overall Study|Missing primary reason|1|||
145943897|NCT01162122|526303213|FG001|Overall Study|Missing primary reason|0|||
145943898|NCT00926536|526303224|FG000|Overall Study|Physician Decision|1|||
145943899|NCT00926536|526303225|FG001|Overall Study|Physician Decision|2|||
145943900|NCT05087966|526303226|FG000|Overall Study|Lost to Follow-up|1|||
145943901|NCT05087966|526303226|FG000|Overall Study|Withdrawal by Subject|5|||
145943902|NCT01267201|526303227|FG000|First Intervention Period|Withdrawal by Subject|1|||
145943903|NCT01267201|526303228|FG001|First Intervention Period|Withdrawal by Subject|0|||
145943904|NCT01267201|526303229|FG002|First Intervention Period|Withdrawal by Subject|0|||
145943905|NCT01267201|526303230|FG003|First Intervention Period|Withdrawal by Subject|0|||
145943906|NCT01267201|526303231|FG004|First Intervention Period|Withdrawal by Subject|0|||
145943907|NCT01267201|526303232|FG005|First Intervention Period|Withdrawal by Subject|0|||
145943908|NCT01267201|526303227|FG000|Second Intervention Period|Withdrawal by Subject|0|||
145943909|NCT01267201|526303228|FG001|Second Intervention Period|Withdrawal by Subject|1|||
145943910|NCT01267201|526303229|FG002|Second Intervention Period|Withdrawal by Subject|0|||
145943911|NCT01267201|526303230|FG003|Second Intervention Period|Withdrawal by Subject|0|||
145943912|NCT01267201|526303231|FG004|Second Intervention Period|Withdrawal by Subject|0|||
145943913|NCT01267201|526303232|FG005|Second Intervention Period|Withdrawal by Subject|0|||
145943914|NCT02124759|526303233|FG000|Overall Study|Withdrawal by Subject|3|||
145943915|NCT02124759|526303234|FG001|Overall Study|Withdrawal by Subject|1|||
145943916|NCT02124759|526303235|FG002|Overall Study|Withdrawal by Subject|1|||
145943917|NCT02124759|526303233|FG000|Overall Study|Screen Fail|2|||
145943918|NCT02124759|526303234|FG001|Overall Study|Screen Fail|2|||
145943919|NCT02124759|526303235|FG002|Overall Study|Screen Fail|3|||
145943920|NCT03689543|526303238|FG000|Overall Study|Adverse Event|0|||
145943921|NCT03689543|526303239|FG001|Overall Study|Adverse Event|0|||
145943922|NCT03689543|526303240|FG002|Overall Study|Adverse Event|1|||
145943923|NCT00932451|526303251|FG000|Overall Study|Withdrawal by Subject|69|||
145943924|NCT00932451|526303251|FG000|Overall Study|Lost to Follow-up|22|||
145943925|NCT00932451|526303251|FG000|Overall Study|Death|726|||
145943926|NCT00932451|526303251|FG000|Overall Study|Other reasons|5|||
145943927|NCT01634659|526303259|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
145943928|NCT01634659|526303260|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
145943929|NCT01634659|526303259|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
145943930|NCT01634659|526303260|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
145943931|NCT03627416|526303261|FG000|Overall Study|Adverse Event|0|||
145943932|NCT03627416|526303262|FG001|Overall Study|Adverse Event|1|||
145943933|NCT02968433|526303263|FG000|Overall Study|Withdrawal by Subject|1|||
145943934|NCT01294371|526303264|FG000|Overall Study|Adverse Event|1|||
145943935|NCT01294371|526303264|FG000|Overall Study|Withdrawal by Subject|12|||
145943936|NCT01294371|526303264|FG000|Overall Study|Lost to Follow-up|6|||
145943937|NCT01294371|526303264|FG000|Overall Study|Administrative Reason|1|||
145943938|NCT01294371|526303264|FG000|Overall Study|Other|14|||
145943939|NCT05619536|526303265|FG000|Overall Study|Withdrawal by Subject|0|||
145943940|NCT05619536|526303266|FG001|Overall Study|Withdrawal by Subject|1|||
145943941|NCT05619536|526303267|FG002|Overall Study|Withdrawal by Subject|0|||
145943942|NCT05619536|526303268|FG003|Overall Study|Withdrawal by Subject|1|||
145943943|NCT05619536|526303265|FG000|Overall Study|Lost to Follow-up|0|||
145943944|NCT05619536|526303266|FG001|Overall Study|Lost to Follow-up|1|||
145943945|NCT05619536|526303267|FG002|Overall Study|Lost to Follow-up|1|||
145943946|NCT05619536|526303268|FG003|Overall Study|Lost to Follow-up|0|||
145943947|NCT00875433|526303269|FG000|Overall Study|Progressive disease|41|||
145943948|NCT00875433|526303269|FG000|Overall Study|Other Adverse Event|14|||
145943949|NCT00875433|526303269|FG000|Overall Study|Withdrawal by Subject|2|||
145943950|NCT00875433|526303269|FG000|Overall Study|Other|3|||
145943951|NCT04272606|526303270|FG000|Overall Study|Protocol Violation|1|||
145943952|NCT04272606|526303271|FG001|Overall Study|Protocol Violation|1|||
145943953|NCT04272606|526303270|FG000|Overall Study|Physician Decision|0|||
145943954|NCT04272606|526303271|FG001|Overall Study|Physician Decision|1|||
145943955|NCT00725101|526303272|FG000|Overall Study|Death|3|||
145943956|NCT00725101|526303272|FG000|Overall Study|Lost to Follow-up|353|||
145943957|NCT00725101|526303272|FG000|Overall Study|Protocol Violation|1|||
145943958|NCT00725101|526303272|FG000|Overall Study|Withdrawal by Subject|127|||
145943959|NCT00725101|526303272|FG000|Overall Study|not specified/no reason given|11|||
145943960|NCT00622336|526303273|FG000|Treatment Phase|Progression of Disease|181|||
145943961|NCT00622336|526303273|FG000|Treatment Phase|Adverse Event|46|||
145943962|NCT00622336|526303273|FG000|Treatment Phase|Other|40|||
145943963|NCT00622336|526303273|FG000|Treatment Phase|Death|14|||
145943964|NCT00622336|526303273|FG000|Treatment Phase|Lack of therapeutic effect|13|||
145943965|NCT00622336|526303273|FG000|Treatment Phase|Withdrawal by Subject|13|||
145943966|NCT00622336|526303273|FG000|Treatment Phase|Lost to Follow-up|2|||
145943967|NCT00622336|526303273|FG000|Extension Phase|Adverse Event|2|||
145943968|NCT00622336|526303273|FG000|Extension Phase|Progressive Disease|6|||
145943969|NCT00622336|526303273|FG000|Extension Phase|Lack of therapeutic effect|2|||
145943970|NCT00622336|526303273|FG000|Extension Phase|Withdrawal by Subject|1|||
145943971|NCT00622336|526303273|FG000|Extension Phase|Lost to Follow-up|1|||
145943972|NCT00622336|526303273|FG000|Extension Phase|Other|9|||
145943973|NCT02923245|526303274|FG000|Overall Study|ultrasound order was cancelled|2|||
145943974|NCT02923245|526303275|FG001|Overall Study|ultrasound order was cancelled|1|||
145943975|NCT03912428|526303276|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145943976|NCT03912428|526303277|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
145943977|NCT03912428|526303278|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145943978|NCT03912428|526303279|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145943979|NCT03912428|526303276|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
145943980|NCT03912428|526303277|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
145943981|NCT03912428|526303278|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
145943982|NCT03912428|526303279|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
145943983|NCT03912428|526303276|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145943984|NCT03912428|526303277|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145943985|NCT03912428|526303278|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145943986|NCT03912428|526303279|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
145943987|NCT03233204|526303280|FG000|Overall Study|Adverse Event|1|||
145943988|NCT03233204|526303280|FG000|Overall Study|Death|1|||
145943989|NCT03233204|526303280|FG000|Overall Study|Withdrawal by Subject|1|||
145943990|NCT03233204|526303280|FG000|Overall Study|Progressive Disease|3|||
145943991|NCT02520427|526303282|FG000|Overall Study|Decision by sponsor|0|||
145943992|NCT02520427|526303283|FG001|Overall Study|Decision by sponsor|0|||
145943993|NCT02520427|526303284|FG002|Overall Study|Decision by sponsor|0|||
145943994|NCT02520427|526303285|FG003|Overall Study|Decision by sponsor|0|||
145943995|NCT02520427|526303286|FG004|Overall Study|Decision by sponsor|0|||
145943996|NCT02520427|526303287|FG005|Overall Study|Decision by sponsor|0|||
145943997|NCT02520427|526303288|FG006|Overall Study|Decision by sponsor|0|||
145943998|NCT02520427|526303289|FG007|Overall Study|Decision by sponsor|0|||
145943999|NCT02520427|526303290|FG008|Overall Study|Decision by sponsor|1|||
145944000|NCT02520427|526303291|FG009|Overall Study|Decision by sponsor|1|||
145944001|NCT02520427|526303292|FG010|Overall Study|Decision by sponsor|0|||
145944002|NCT02520427|526303293|FG011|Overall Study|Decision by sponsor|0|||
145944003|NCT02520427|526303294|FG012|Overall Study|Decision by sponsor|0|||
145944004|NCT02520427|526303295|FG013|Overall Study|Decision by sponsor|0|||
145944005|NCT02520427|526303296|FG014|Overall Study|Decision by sponsor|0|||
145944006|NCT02520427|526303297|FG015|Overall Study|Decision by sponsor|0|||
145944007|NCT02520427|526303298|FG016|Overall Study|Decision by sponsor|0|||
145944008|NCT02520427|526303299|FG017|Overall Study|Decision by sponsor|0|||
145944009|NCT02520427|526303300|FG018|Overall Study|Decision by sponsor|0|||
145944010|NCT02520427|526303301|FG019|Overall Study|Decision by sponsor|0|||
145944011|NCT02520427|526303302|FG020|Overall Study|Decision by sponsor|0|||
145944012|NCT02520427|526303303|FG021|Overall Study|Decision by sponsor|0|||
145944013|NCT02520427|526303304|FG022|Overall Study|Decision by sponsor|0|||
145944014|NCT02520427|526303305|FG023|Overall Study|Decision by sponsor|0|||
145944015|NCT02520427|526303306|FG024|Overall Study|Decision by sponsor|0|||
145944016|NCT02520427|526303307|FG025|Overall Study|Decision by sponsor|0|||
145944017|NCT02520427|526303282|FG000|Overall Study|Withdrawal by Subject|0|||
145944018|NCT02520427|526303283|FG001|Overall Study|Withdrawal by Subject|0|||
145944019|NCT02520427|526303284|FG002|Overall Study|Withdrawal by Subject|1|||
145944020|NCT02520427|526303285|FG003|Overall Study|Withdrawal by Subject|0|||
145944021|NCT02520427|526303286|FG004|Overall Study|Withdrawal by Subject|0|||
145944022|NCT02520427|526303287|FG005|Overall Study|Withdrawal by Subject|0|||
145944023|NCT02520427|526303288|FG006|Overall Study|Withdrawal by Subject|0|||
145944024|NCT02520427|526303289|FG007|Overall Study|Withdrawal by Subject|0|||
145944025|NCT02520427|526303290|FG008|Overall Study|Withdrawal by Subject|0|||
145944026|NCT02520427|526303291|FG009|Overall Study|Withdrawal by Subject|0|||
145944027|NCT02520427|526303292|FG010|Overall Study|Withdrawal by Subject|0|||
145944028|NCT02520427|526303293|FG011|Overall Study|Withdrawal by Subject|0|||
145944029|NCT02520427|526303294|FG012|Overall Study|Withdrawal by Subject|1|||
145944030|NCT02520427|526303295|FG013|Overall Study|Withdrawal by Subject|1|||
145944031|NCT02520427|526303296|FG014|Overall Study|Withdrawal by Subject|1|||
145944032|NCT02520427|526303297|FG015|Overall Study|Withdrawal by Subject|0|||
145944033|NCT02520427|526303298|FG016|Overall Study|Withdrawal by Subject|1|||
145944034|NCT02520427|526303299|FG017|Overall Study|Withdrawal by Subject|0|||
145944035|NCT02520427|526303300|FG018|Overall Study|Withdrawal by Subject|0|||
145944036|NCT02520427|526303301|FG019|Overall Study|Withdrawal by Subject|3|||
145944037|NCT02520427|526303302|FG020|Overall Study|Withdrawal by Subject|2|||
145944038|NCT02520427|526303303|FG021|Overall Study|Withdrawal by Subject|0|||
145944039|NCT02520427|526303304|FG022|Overall Study|Withdrawal by Subject|0|||
145944040|NCT02520427|526303305|FG023|Overall Study|Withdrawal by Subject|0|||
145944041|NCT02520427|526303306|FG024|Overall Study|Withdrawal by Subject|0|||
145944042|NCT02520427|526303307|FG025|Overall Study|Withdrawal by Subject|0|||
145944043|NCT02520427|526303282|FG000|Overall Study|Death|1|||
145944044|NCT02520427|526303283|FG001|Overall Study|Death|0|||
145944045|NCT02520427|526303284|FG002|Overall Study|Death|0|||
145944046|NCT02520427|526303285|FG003|Overall Study|Death|0|||
145944047|NCT02520427|526303286|FG004|Overall Study|Death|0|||
145944048|NCT02520427|526303287|FG005|Overall Study|Death|0|||
145944049|NCT02520427|526303288|FG006|Overall Study|Death|0|||
145944050|NCT02520427|526303289|FG007|Overall Study|Death|0|||
145944051|NCT02520427|526303290|FG008|Overall Study|Death|0|||
145944052|NCT02520427|526303291|FG009|Overall Study|Death|0|||
145944053|NCT02520427|526303292|FG010|Overall Study|Death|0|||
145944054|NCT02520427|526303293|FG011|Overall Study|Death|0|||
145944055|NCT02520427|526303294|FG012|Overall Study|Death|0|||
145944056|NCT02520427|526303295|FG013|Overall Study|Death|0|||
145944057|NCT02520427|526303296|FG014|Overall Study|Death|0|||
145944058|NCT02520427|526303297|FG015|Overall Study|Death|0|||
145944059|NCT02520427|526303298|FG016|Overall Study|Death|2|||
145944060|NCT02520427|526303299|FG017|Overall Study|Death|1|||
145944061|NCT02520427|526303300|FG018|Overall Study|Death|3|||
145944062|NCT02520427|526303301|FG019|Overall Study|Death|2|||
145944063|NCT02520427|526303302|FG020|Overall Study|Death|0|||
145944064|NCT02520427|526303303|FG021|Overall Study|Death|0|||
145944065|NCT02520427|526303304|FG022|Overall Study|Death|1|||
145944066|NCT02520427|526303305|FG023|Overall Study|Death|0|||
145944067|NCT02520427|526303306|FG024|Overall Study|Death|1|||
145944068|NCT02520427|526303307|FG025|Overall Study|Death|0|||
145944069|NCT00793624|526303308|FG000|Overall Study|Adverse Event|18|||
145944070|NCT00793624|526303309|FG001|Overall Study|Adverse Event|16|||
145944071|NCT00793624|526303310|FG002|Overall Study|Adverse Event|15|||
145944072|NCT00793624|526303311|FG003|Overall Study|Adverse Event|20|||
145944073|NCT00793624|526303308|FG000|Overall Study|Lost to Follow-up|2|||
145944074|NCT00793624|526303309|FG001|Overall Study|Lost to Follow-up|2|||
145944075|NCT00793624|526303310|FG002|Overall Study|Lost to Follow-up|4|||
145944076|NCT00793624|526303311|FG003|Overall Study|Lost to Follow-up|0|||
145944077|NCT00793624|526303308|FG000|Overall Study|Withdrawal by Subject|20|||
145944078|NCT00793624|526303309|FG001|Overall Study|Withdrawal by Subject|9|||
145944079|NCT00793624|526303310|FG002|Overall Study|Withdrawal by Subject|11|||
145944080|NCT00793624|526303311|FG003|Overall Study|Withdrawal by Subject|14|||
145944081|NCT00793624|526303308|FG000|Overall Study|Lack of Efficacy|9|||
145944082|NCT00793624|526303309|FG001|Overall Study|Lack of Efficacy|2|||
145944083|NCT00793624|526303310|FG002|Overall Study|Lack of Efficacy|1|||
145944084|NCT00793624|526303311|FG003|Overall Study|Lack of Efficacy|3|||
145944085|NCT00793624|526303308|FG000|Overall Study|Non compliance with protocol|2|||
145944086|NCT00793624|526303309|FG001|Overall Study|Non compliance with protocol|3|||
145944087|NCT00793624|526303310|FG002|Overall Study|Non compliance with protocol|2|||
146056288|NCT01362348|526721168|FG000|Overall Study|Protocol-defined stopping criteria|9|||
146056289|NCT01362348|526721168|FG000|Overall Study|Study closed/terminated|5|||
146056290|NCT02675907|526721169|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
146056291|NCT02675907|526721170|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
146056292|NCT02675907|526721169|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
146056293|NCT02675907|526721170|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
146056294|NCT02675907|526721169|FG000|Study Overall|Lack of Efficacy|1|||
146056295|NCT02675907|526721170|FG001|Study Overall|Lack of Efficacy|0|||
146056296|NCT02675907|526721169|FG000|Study Overall|Withdrawal by Subject|2|||
146056297|NCT02675907|526721170|FG001|Study Overall|Withdrawal by Subject|2|||
146056298|NCT02675907|526721169|FG000|Study Overall|Lost to Follow-up|0|||
146056299|NCT02675907|526721170|FG001|Study Overall|Lost to Follow-up|2|||
146056300|NCT01611792|526721171|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
146056301|NCT01611792|526721172|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
146056302|NCT01611792|526721171|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
146056303|NCT01611792|526721172|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
146056304|NCT03289208|526721177|FG000|Overall Study|Adverse Event|1|||
146056305|NCT03289208|526721178|FG001|Overall Study|Adverse Event|0|||
146056306|NCT03289208|526721179|FG002|Overall Study|Adverse Event|0|||
146056307|NCT00647296|526721180|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146056308|NCT00647296|526721181|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146056309|NCT00647296|526721182|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
146056310|NCT00647296|526721183|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
146056311|NCT00647296|526721180|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
146056312|NCT00647296|526721181|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
146056313|NCT00647296|526721182|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
146056314|NCT00647296|526721183|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
146056315|NCT00647296|526721180|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146056316|NCT00647296|526721181|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
146056317|NCT00647296|526721182|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146056318|NCT00647296|526721183|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
146056319|NCT00647296|526721180|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
146056320|NCT00647296|526721181|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146056321|NCT00647296|526721182|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146056322|NCT00647296|526721183|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
146056323|NCT00647296|526721180|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
146056324|NCT00647296|526721181|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146056325|NCT00647296|526721182|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146056326|NCT00647296|526721183|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
146056327|NCT00647296|526721180|FG000|Part 2: 4-week Placebo Washout|Death|3|||
146056328|NCT00647296|526721181|FG001|Part 2: 4-week Placebo Washout|Death|0|||
146056329|NCT00647296|526721182|FG002|Part 2: 4-week Placebo Washout|Death|0|||
146056330|NCT00647296|526721183|FG003|Part 2: 4-week Placebo Washout|Death|0|||
146056331|NCT00647296|526721180|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
146056332|NCT00647296|526721181|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
146056333|NCT00647296|526721182|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
146056334|NCT00647296|526721183|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
146056335|NCT00647296|526721180|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
146056336|NCT00647296|526721181|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
146056337|NCT00647296|526721182|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
146056338|NCT00647296|526721183|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
146056339|NCT00647296|526721180|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146056340|NCT00647296|526721181|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
146056341|NCT00647296|526721182|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146056342|NCT00647296|526721183|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
146056343|NCT00647296|526721180|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
146056344|NCT00647296|526721181|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
146056345|NCT00647296|526721182|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
146056346|NCT00647296|526721183|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
146056347|NCT00647296|526721180|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
146056348|NCT00647296|526721181|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
146056349|NCT00647296|526721182|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
146056350|NCT00647296|526721183|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
146056351|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
146056352|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
146056353|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
146056354|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
146056355|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
146056356|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
146056357|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
146056358|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
145944088|NCT00793624|526303311|FG003|Overall Study|Non compliance with protocol|3|||
145944089|NCT00793624|526303308|FG000|Overall Study|Other reason not described above|6|||
145944090|NCT00793624|526303309|FG001|Overall Study|Other reason not described above|4|||
145944091|NCT00793624|526303310|FG002|Overall Study|Other reason not described above|6|||
145944092|NCT00793624|526303311|FG003|Overall Study|Other reason not described above|3|||
146056359|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
146056360|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
146056361|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
146056362|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
146056363|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
146056364|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
146056365|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
146056366|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
146056367|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
146056368|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
146056369|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
146056370|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
146056371|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
146056372|NCT00550407|526721184|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
146056373|NCT00550407|526721185|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
146056374|NCT00550407|526721186|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
146056375|NCT00550407|526721184|FG000|26-Week Randomized Phase|Adverse Event|0|||
146056376|NCT00550407|526721185|FG001|26-Week Randomized Phase|Adverse Event|5|||
146056377|NCT00550407|526721186|FG002|26-Week Randomized Phase|Adverse Event|2|||
146056378|NCT00550407|526721184|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
146056379|NCT00550407|526721185|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
146056380|NCT00550407|526721186|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
146056381|NCT00550407|526721184|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
146056382|NCT00550407|526721185|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
146056383|NCT00550407|526721186|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
146056384|NCT00550407|526721184|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
146056385|NCT00550407|526721185|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
146056386|NCT00550407|526721186|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
146056387|NCT00584415|526721187|FG000|Overall Study|Adverse Event|7|||
146056388|NCT00556894|526721188|FG000|Overall Study|Adverse Event|2|||
146056389|NCT00556894|526721189|FG001|Overall Study|Adverse Event|3|||
146056390|NCT00556894|526721190|FG002|Overall Study|Adverse Event|3|||
146056391|NCT00556894|526721188|FG000|Overall Study|Death|1|||
146056392|NCT00556894|526721189|FG001|Overall Study|Death|0|||
146056393|NCT00556894|526721190|FG002|Overall Study|Death|0|||
146056394|NCT00556894|526721188|FG000|Overall Study|regulatory decision in Bulgaria|10|||
146056395|NCT00556894|526721189|FG001|Overall Study|regulatory decision in Bulgaria|14|||
146056396|NCT00556894|526721190|FG002|Overall Study|regulatory decision in Bulgaria|13|||
146056397|NCT00556894|526721188|FG000|Overall Study|Change in therapy|2|||
146056398|NCT00556894|526721189|FG001|Overall Study|Change in therapy|1|||
146056399|NCT00556894|526721190|FG002|Overall Study|Change in therapy|2|||
146056400|NCT00556894|526721188|FG000|Overall Study|Withdrawal by Subject|1|||
146056401|NCT00556894|526721189|FG001|Overall Study|Withdrawal by Subject|1|||
146056402|NCT00556894|526721190|FG002|Overall Study|Withdrawal by Subject|1|||
146056403|NCT03883581|526721191|FG000|Overall Study|Withdrawal by Subject|4|||
146056404|NCT04750642|526721195|FG000|Overall Study|Adverse Event|1|||
146056405|NCT04750642|526721196|FG001|Overall Study|Adverse Event|0|||
146056406|NCT04750642|526721195|FG000|Overall Study|Withdrawal by Subject|0|||
146056407|NCT04750642|526721196|FG001|Overall Study|Withdrawal by Subject|1|||
146056408|NCT04750642|526721195|FG000|Overall Study|Protocol Violation|0|||
146056409|NCT04750642|526721196|FG001|Overall Study|Protocol Violation|1|||
146056410|NCT00410956|526721197|FG000|Overall Study|Adverse Event|1|||
146056411|NCT00410956|526721197|FG000|Overall Study|Death|2|||
146056412|NCT00410956|526721197|FG000|Overall Study|Lack of Efficacy|10|||
146056413|NCT00410956|526721197|FG000|Overall Study|Physician Decision|6|||
146056414|NCT01650194|526721199|FG000|Overall Study|Progressive Disease (PD)|35|||
146056415|NCT01650194|526721199|FG000|Overall Study|Withdrawal by Subject|2|||
146056416|NCT01650194|526721199|FG000|Overall Study|Miscellaneous|10|||
146056417|NCT00740220|526722620|FG000|Overall Study|screen failures (non-COPD patients)|9|||
146056418|NCT01908426|526722625|FG000|Overall Study|Adverse Event|98|||
146056419|NCT01908426|526722626|FG001|Overall Study|Adverse Event|11|||
146056420|NCT01908426|526722625|FG000|Overall Study|Clinical Deterioration|72|||
146056421|NCT01908426|526722626|FG001|Overall Study|Clinical Deterioration|38|||
146056422|NCT01908426|526722625|FG000|Overall Study|Lack of Efficacy|3|||
146056423|NCT01908426|526722626|FG001|Overall Study|Lack of Efficacy|0|||
146056424|NCT01908426|526722625|FG000|Overall Study|Lost to Follow-up|0|||
146056425|NCT01908426|526722626|FG001|Overall Study|Lost to Follow-up|1|||
146056426|NCT01908426|526722625|FG000|Overall Study|Physician Decision|3|||
146056427|NCT01908426|526722626|FG001|Overall Study|Physician Decision|3|||
146056428|NCT01908426|526722625|FG000|Overall Study|Withdrawal by Subject|11|||
146056429|NCT01908426|526722626|FG001|Overall Study|Withdrawal by Subject|6|||
146056430|NCT01908426|526722625|FG000|Overall Study|Progressive Disease|206|||
146056431|NCT01908426|526722626|FG001|Overall Study|Progressive Disease|152|||
146056432|NCT01908426|526722625|FG000|Overall Study|Protocol Violation|1|||
146056433|NCT01908426|526722626|FG001|Overall Study|Protocol Violation|0|||
146056434|NCT01908426|526722625|FG000|Overall Study|No Study Treatment Given|3|||
146056435|NCT01908426|526722626|FG001|Overall Study|No Study Treatment Given|0|||
146056436|NCT03346434|526722627|FG000|Overall Study|Randomized in Error|0|||
146056437|NCT03346434|526722628|FG001|Overall Study|Randomized in Error|0|||
146056438|NCT03346434|526722629|FG002|Overall Study|Randomized in Error|0|||
146056439|NCT03346434|526722630|FG003|Overall Study|Randomized in Error|0|||
146056440|NCT03346434|526722631|FG004|Overall Study|Randomized in Error|1|||
146056441|NCT03346434|526722632|FG005|Overall Study|Randomized in Error|0|||
146056442|NCT03346434|526722627|FG000|Overall Study|Withdrawal by Subject|0|||
146056443|NCT03346434|526722628|FG001|Overall Study|Withdrawal by Subject|0|||
146056444|NCT03346434|526722629|FG002|Overall Study|Withdrawal by Subject|1|||
146056445|NCT03346434|526722630|FG003|Overall Study|Withdrawal by Subject|0|||
146056446|NCT03346434|526722631|FG004|Overall Study|Withdrawal by Subject|1|||
146056447|NCT03346434|526722632|FG005|Overall Study|Withdrawal by Subject|0|||
146056448|NCT03346434|526722627|FG000|Overall Study|Lost to Follow-up|0|||
146056449|NCT03346434|526722628|FG001|Overall Study|Lost to Follow-up|0|||
146056450|NCT03346434|526722629|FG002|Overall Study|Lost to Follow-up|0|||
146056451|NCT03346434|526722630|FG003|Overall Study|Lost to Follow-up|0|||
146056452|NCT03346434|526722631|FG004|Overall Study|Lost to Follow-up|1|||
146056453|NCT03346434|526722632|FG005|Overall Study|Lost to Follow-up|1|||
146056454|NCT03346434|526722627|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146056455|NCT03346434|526722628|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146056456|NCT03346434|526722629|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146056457|NCT03346434|526722630|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
146056458|NCT03346434|526722631|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
146056459|NCT03346434|526722632|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
146056460|NCT04416204|526722636|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146056461|NCT04416204|526722637|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
146056462|NCT04416204|526722638|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146056463|NCT04416204|526722639|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
146056464|NCT00812708|526722640|FG000|Overall Study|Device could not be implanted|2|||
146056465|NCT00812708|526722640|FG000|Overall Study|Lack of medical insurance|1|||
146056466|NCT00812708|526722640|FG000|Overall Study|Switched to another study|1|||
146056467|NCT00812708|526722640|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
146056468|NCT00812708|526722640|FG000|Overall Study|Signed consent but later withdrew|3|||
146056469|NCT03224130|526722646|FG000|Overall Study|consent issue|0|||
146056470|NCT03224130|526722647|FG001|Overall Study|consent issue|1|||
146056471|NCT02587520|526722650|FG000|Overall Study|Protocol Violation|2|||
146056472|NCT02587520|526722651|FG001|Overall Study|Protocol Violation|0|||
146056473|NCT02587520|526722652|FG002|Overall Study|Protocol Violation|0|||
146056474|NCT02587520|526722653|FG003|Overall Study|Protocol Violation|2|||
146056475|NCT02587520|526722654|FG004|Overall Study|Protocol Violation|0|||
146056476|NCT02587520|526722655|FG005|Overall Study|Protocol Violation|1|||
146056477|NCT02587520|526722656|FG006|Overall Study|Protocol Violation|1|||
146056478|NCT02587520|526722657|FG007|Overall Study|Protocol Violation|1|||
146056479|NCT02587520|526722658|FG008|Overall Study|Protocol Violation|3|||
146056480|NCT02587520|526722659|FG009|Overall Study|Protocol Violation|3|||
146056481|NCT02587520|526722660|FG010|Overall Study|Protocol Violation|1|||
146056482|NCT02587520|526722661|FG011|Overall Study|Protocol Violation|2|||
146056483|NCT02587520|526722662|FG012|Overall Study|Protocol Violation|0|||
146056484|NCT02587520|526722663|FG013|Overall Study|Protocol Violation|0|||
146056485|NCT02587520|526722664|FG014|Overall Study|Protocol Violation|0|||
146056486|NCT02587520|526722665|FG015|Overall Study|Protocol Violation|0|||
146056487|NCT02587520|526722666|FG016|Overall Study|Protocol Violation|0|||
146056488|NCT02587520|526722667|FG017|Overall Study|Protocol Violation|0|||
146056489|NCT02587520|526722650|FG000|Overall Study|Adverse Event|0|||
146056490|NCT02587520|526722651|FG001|Overall Study|Adverse Event|0|||
146056491|NCT02587520|526722652|FG002|Overall Study|Adverse Event|0|||
146056492|NCT02587520|526722653|FG003|Overall Study|Adverse Event|0|||
146056493|NCT02587520|526722654|FG004|Overall Study|Adverse Event|0|||
146056494|NCT02587520|526722655|FG005|Overall Study|Adverse Event|0|||
146056495|NCT02587520|526722656|FG006|Overall Study|Adverse Event|0|||
146056496|NCT02587520|526722657|FG007|Overall Study|Adverse Event|0|||
146056497|NCT02587520|526722658|FG008|Overall Study|Adverse Event|0|||
146056498|NCT02587520|526722659|FG009|Overall Study|Adverse Event|0|||
146056499|NCT02587520|526722660|FG010|Overall Study|Adverse Event|0|||
146056500|NCT02587520|526722661|FG011|Overall Study|Adverse Event|1|||
146056501|NCT02587520|526722662|FG012|Overall Study|Adverse Event|0|||
146056502|NCT02587520|526722663|FG013|Overall Study|Adverse Event|0|||
146056503|NCT02587520|526722664|FG014|Overall Study|Adverse Event|0|||
146056504|NCT02587520|526722665|FG015|Overall Study|Adverse Event|0|||
146056505|NCT02587520|526722666|FG016|Overall Study|Adverse Event|0|||
146056506|NCT02587520|526722667|FG017|Overall Study|Adverse Event|0|||
146056507|NCT02587520|526722650|FG000|Overall Study|Withdrawal by Subject|0|||
146056508|NCT02587520|526722651|FG001|Overall Study|Withdrawal by Subject|0|||
146056509|NCT02587520|526722652|FG002|Overall Study|Withdrawal by Subject|1|||
146056510|NCT02587520|526722653|FG003|Overall Study|Withdrawal by Subject|1|||
146056511|NCT02587520|526722654|FG004|Overall Study|Withdrawal by Subject|0|||
146056512|NCT02587520|526722655|FG005|Overall Study|Withdrawal by Subject|1|||
146056513|NCT02587520|526722656|FG006|Overall Study|Withdrawal by Subject|1|||
146056514|NCT02587520|526722657|FG007|Overall Study|Withdrawal by Subject|0|||
146056515|NCT02587520|526722658|FG008|Overall Study|Withdrawal by Subject|0|||
146056516|NCT02587520|526722659|FG009|Overall Study|Withdrawal by Subject|0|||
146056517|NCT02587520|526722660|FG010|Overall Study|Withdrawal by Subject|0|||
146056518|NCT02587520|526722661|FG011|Overall Study|Withdrawal by Subject|0|||
146056519|NCT02587520|526722662|FG012|Overall Study|Withdrawal by Subject|0|||
146056520|NCT02587520|526722663|FG013|Overall Study|Withdrawal by Subject|1|||
146056521|NCT02587520|526722664|FG014|Overall Study|Withdrawal by Subject|0|||
146056522|NCT02587520|526722665|FG015|Overall Study|Withdrawal by Subject|0|||
146056523|NCT02587520|526722666|FG016|Overall Study|Withdrawal by Subject|0|||
146056524|NCT02587520|526722667|FG017|Overall Study|Withdrawal by Subject|0|||
146056525|NCT02587520|526722650|FG000|Overall Study|Lost to Follow-up|0|||
146056526|NCT02587520|526722651|FG001|Overall Study|Lost to Follow-up|2|||
146056527|NCT02587520|526722652|FG002|Overall Study|Lost to Follow-up|0|||
146056528|NCT02587520|526722653|FG003|Overall Study|Lost to Follow-up|2|||
146056529|NCT02587520|526722654|FG004|Overall Study|Lost to Follow-up|0|||
146056530|NCT02587520|526722655|FG005|Overall Study|Lost to Follow-up|1|||
146056531|NCT02587520|526722656|FG006|Overall Study|Lost to Follow-up|1|||
146056532|NCT02587520|526722657|FG007|Overall Study|Lost to Follow-up|1|||
146056533|NCT02587520|526722658|FG008|Overall Study|Lost to Follow-up|0|||
146056534|NCT02587520|526722659|FG009|Overall Study|Lost to Follow-up|2|||
146056535|NCT02587520|526722660|FG010|Overall Study|Lost to Follow-up|2|||
146056536|NCT02587520|526722661|FG011|Overall Study|Lost to Follow-up|1|||
146056537|NCT02587520|526722662|FG012|Overall Study|Lost to Follow-up|0|||
146056538|NCT02587520|526722663|FG013|Overall Study|Lost to Follow-up|0|||
146056539|NCT02587520|526722664|FG014|Overall Study|Lost to Follow-up|0|||
146056540|NCT02587520|526722665|FG015|Overall Study|Lost to Follow-up|0|||
146056541|NCT02587520|526722666|FG016|Overall Study|Lost to Follow-up|0|||
146056542|NCT02587520|526722667|FG017|Overall Study|Lost to Follow-up|0|||
146056543|NCT04516746|526722668|FG000|Overall Study|Randomized but not Treated|51|||
146056544|NCT04516746|526722669|FG001|Overall Study|Randomized but not Treated|19|||
146056545|NCT04516746|526722668|FG000|Overall Study|Adverse Event|0|||
146056546|NCT04516746|526722669|FG001|Overall Study|Adverse Event|1|||
146056547|NCT04516746|526722668|FG000|Overall Study|Death|62|||
146056548|NCT04516746|526722669|FG001|Overall Study|Death|32|||
146056549|NCT04516746|526722668|FG000|Overall Study|Lost to Follow-up|3431|||
146056550|NCT04516746|526722669|FG001|Overall Study|Lost to Follow-up|1831|||
146056551|NCT04516746|526722668|FG000|Overall Study|Withdrawal by Subject|1946|||
146056552|NCT04516746|526722669|FG001|Overall Study|Withdrawal by Subject|1696|||
146056553|NCT04516746|526722668|FG000|Overall Study|Physician Decision|10|||
146056554|NCT04516746|526722669|FG001|Overall Study|Physician Decision|8|||
146056555|NCT04516746|526722668|FG000|Overall Study|Other|35|||
146056556|NCT04516746|526722669|FG001|Overall Study|Other|16|||
146056557|NCT00435409|526722672|FG000|Overall Study|Protocol Violation|1|||
146056558|NCT00435409|526722673|FG001|Overall Study|Protocol Violation|2|||
146056559|NCT00435409|526722674|FG002|Overall Study|Protocol Violation|0|||
146056560|NCT00435409|526722672|FG000|Overall Study|Lost to Follow-up|1|||
146056561|NCT00435409|526722673|FG001|Overall Study|Lost to Follow-up|2|||
146056562|NCT00435409|526722674|FG002|Overall Study|Lost to Follow-up|0|||
146056563|NCT00435409|526722672|FG000|Overall Study|Death|8|||
146056564|NCT00435409|526722673|FG001|Overall Study|Death|6|||
146056565|NCT00435409|526722674|FG002|Overall Study|Death|6|||
146056566|NCT00435409|526722672|FG000|Overall Study|Objective progression or relapse|158|||
146056567|NCT00435409|526722673|FG001|Overall Study|Objective progression or relapse|93|||
146056568|NCT00435409|526722674|FG002|Overall Study|Objective progression or relapse|58|||
146056569|NCT00435409|526722672|FG000|Overall Study|Global deterioration of health status|0|||
146056570|NCT00435409|526722673|FG001|Overall Study|Global deterioration of health status|0|||
146056571|NCT00435409|526722674|FG002|Overall Study|Global deterioration of health status|4|||
146056572|NCT00435409|526722672|FG000|Overall Study|Withdrawal by Subject|8|||
146056573|NCT00435409|526722673|FG001|Overall Study|Withdrawal by Subject|7|||
146056574|NCT00435409|526722674|FG002|Overall Study|Withdrawal by Subject|1|||
146056575|NCT00435409|526722672|FG000|Overall Study|Other|45|||
146056576|NCT00435409|526722673|FG001|Overall Study|Other|30|||
146056577|NCT00435409|526722674|FG002|Overall Study|Other|1|||
146056578|NCT00435409|526722672|FG000|Overall Study|Adverse Event|0|||
146056579|NCT00435409|526722673|FG001|Overall Study|Adverse Event|0|||
146056580|NCT00435409|526722674|FG002|Overall Study|Adverse Event|8|||
146056581|NCT00435409|526722672|FG000|Overall Study|Sponsor decision|0|||
146056582|NCT00435409|526722673|FG001|Overall Study|Sponsor decision|3|||
146056583|NCT00435409|526722674|FG002|Overall Study|Sponsor decision|0|||
146056584|NCT03661723|526722679|FG000|Overall Study|Disease Progression|4|||
146056585|NCT03661723|526722680|FG001|Overall Study|Disease Progression|24|||
146056586|NCT03661723|526722681|FG002|Overall Study|Disease Progression|4|||
146056587|NCT03661723|526722682|FG003|Overall Study|Disease Progression|19|||
146056588|NCT03661723|526722679|FG000|Overall Study|Withdrawal by Subject|1|||
146056589|NCT03661723|526722680|FG001|Overall Study|Withdrawal by Subject|0|||
146056590|NCT03661723|526722681|FG002|Overall Study|Withdrawal by Subject|2|||
146056591|NCT03661723|526722682|FG003|Overall Study|Withdrawal by Subject|4|||
146056592|NCT03661723|526722679|FG000|Overall Study|Physician Decision|1|||
146056593|NCT03661723|526722680|FG001|Overall Study|Physician Decision|0|||
146056594|NCT03661723|526722681|FG002|Overall Study|Physician Decision|0|||
146056595|NCT03661723|526722682|FG003|Overall Study|Physician Decision|0|||
146056596|NCT03661723|526722679|FG000|Overall Study|Clinical Deterioration|0|||
146056597|NCT03661723|526722680|FG001|Overall Study|Clinical Deterioration|0|||
146056598|NCT03661723|526722681|FG002|Overall Study|Clinical Deterioration|0|||
146056599|NCT03661723|526722682|FG003|Overall Study|Clinical Deterioration|1|||
146056600|NCT03562195|526722685|FG000|Overall Study|Adverse Event|0|||
146056601|NCT03562195|526722686|FG001|Overall Study|Adverse Event|6|||
146056602|NCT03562195|526722685|FG000|Overall Study|Lack of Efficacy|0|||
146056603|NCT03562195|526722686|FG001|Overall Study|Lack of Efficacy|5|||
146056604|NCT03562195|526722685|FG000|Overall Study|Protocol Violation|0|||
146056605|NCT03562195|526722686|FG001|Overall Study|Protocol Violation|1|||
146056606|NCT03562195|526722685|FG000|Overall Study|Lost to Follow-up|0|||
146056607|NCT03562195|526722686|FG001|Overall Study|Lost to Follow-up|1|||
146056608|NCT03562195|526722685|FG000|Overall Study|Physician Decision|1|||
146056609|NCT03562195|526722686|FG001|Overall Study|Physician Decision|0|||
146056610|NCT03562195|526722685|FG000|Overall Study|Withdrawal by Subject|3|||
146056611|NCT03562195|526722686|FG001|Overall Study|Withdrawal by Subject|0|||
146056612|NCT02529852|526722687|FG000|Overall Study|Withdrawal by Subject|2|||
146056613|NCT00614575|526722689|FG000|Overall Study|Adverse Event|106|||
146056614|NCT00614575|526722689|FG000|Overall Study|Lost to Follow-up|55|||
146056615|NCT00614575|526722689|FG000|Overall Study|Lack of Efficacy|14|||
146056616|NCT00614575|526722689|FG000|Overall Study|Withdrawal by Subject|6|||
146056617|NCT00614575|526722689|FG000|Overall Study|Death|3|||
146056618|NCT00614575|526722689|FG000|Overall Study|Physician Decision|2|||
146056619|NCT00614575|526722689|FG000|Overall Study|No data were collected.|18|||
146056620|NCT00614575|526722689|FG000|Overall Study|Irregularly enrolled patients|23|||
146056621|NCT00614575|526722689|FG000|Overall Study|No treatment|1|||
146056622|NCT00524485|526722693|FG000|Overall Study|Withdrawal by Subject|5|||
146056623|NCT00300755|526722698|FG000|Overall Study|Adverse Event|1|||
146056624|NCT00300755|526722699|FG001|Overall Study|Adverse Event|2|||
146056625|NCT00300755|526722700|FG002|Overall Study|Adverse Event|1|||
146056626|NCT00300755|526722698|FG000|Overall Study|Withdrawal by Subject|0|||
146056627|NCT00300755|526722699|FG001|Overall Study|Withdrawal by Subject|2|||
146056628|NCT00300755|526722700|FG002|Overall Study|Withdrawal by Subject|0|||
146056629|NCT00300755|526722698|FG000|Overall Study|Protocol Violation|0|||
146056630|NCT00300755|526722699|FG001|Overall Study|Protocol Violation|0|||
146056631|NCT00300755|526722700|FG002|Overall Study|Protocol Violation|1|||
146056632|NCT04571944|526722701|FG000|Overall Study|Death|1|||
146056633|NCT04571944|526722702|FG001|Overall Study|Death|0|||
146056634|NCT04571944|526722701|FG000|Overall Study|Withdrawal by Subject|3|||
146056635|NCT04571944|526722702|FG001|Overall Study|Withdrawal by Subject|0|||
146056636|NCT04571944|526722701|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
146056637|NCT04571944|526722702|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
146056638|NCT04079296|526722705|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146056639|NCT04079296|526722706|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146056640|NCT04079296|526722707|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
146056641|NCT04079296|526722708|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
146056642|NCT04079296|526722709|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
146056643|NCT04079296|526722705|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146056644|NCT04079296|526722706|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146056645|NCT04079296|526722707|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
146056646|NCT04079296|526722708|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
146056647|NCT04079296|526722709|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
146056648|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146056649|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146056650|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146056651|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
146395068|NCT01049360|527948624|FG013|Period 2|Adverse Event|0|||
146056652|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
146056653|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146056654|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146056655|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146056656|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
146056657|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
146056658|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146056659|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146056660|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146056661|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
146056662|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
146056663|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146056664|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146056665|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
146056666|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
146056667|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
146056668|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146056669|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146056670|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
146056671|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
146056672|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
146056673|NCT04079296|526722705|FG000|Dose Expansion Phase (168 Days)|Death|0|||
146056674|NCT04079296|526722706|FG001|Dose Expansion Phase (168 Days)|Death|0|||
146056675|NCT04079296|526722707|FG002|Dose Expansion Phase (168 Days)|Death|0|||
146056676|NCT04079296|526722708|FG003|Dose Expansion Phase (168 Days)|Death|1|||
146056677|NCT04079296|526722709|FG004|Dose Expansion Phase (168 Days)|Death|0|||
146056678|NCT01919229|526722711|FG000|Overall Study|Subject/guardian decision|0|||
146056679|NCT01919229|526722712|FG001|Overall Study|Subject/guardian decision|0|||
146056680|NCT01919229|526722713|FG002|Overall Study|Subject/guardian decision|1|||
146056681|NCT01011673|526722714|FG000|Randomized|Secondary headache|2|||
146056682|NCT01011673|526722715|FG001|Randomized|Secondary headache|1|||
146056683|NCT01011673|526722714|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
146056684|NCT01011673|526722715|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
146056685|NCT03261336|526722717|FG000|Overall Study|Adverse Event|1|||
146056686|NCT00292942|526722719|FG000|Overall Study|Withdrawal by Subject|0|||
146056687|NCT00292942|526722720|FG001|Overall Study|Withdrawal by Subject|0|||
146056688|NCT00292942|526722721|FG002|Overall Study|Withdrawal by Subject|1|||
146056689|NCT00292942|526722722|FG003|Overall Study|Withdrawal by Subject|0|||
146056690|NCT00292942|526722719|FG000|Overall Study|Adverse Event|0|||
146056691|NCT00292942|526722720|FG001|Overall Study|Adverse Event|0|||
146056692|NCT00292942|526722721|FG002|Overall Study|Adverse Event|0|||
146056693|NCT00292942|526722722|FG003|Overall Study|Adverse Event|1|||
146056694|NCT00644358|526722723|FG000|Overall Study|Adverse Event|124|||
146056695|NCT00644358|526722723|FG000|Overall Study|Lost to Follow-up|105|||
146056696|NCT00644358|526722723|FG000|Overall Study|Consent Withdrawal|64|||
146056697|NCT00644358|526722723|FG000|Overall Study|Lack of Effectiveness|39|||
146056698|NCT00644358|526722723|FG000|Overall Study|Protocol Violation|5|||
146056699|NCT00644358|526722723|FG000|Overall Study|Noncompliance|14|||
146056700|NCT00644358|526722723|FG000|Overall Study|Other Unspecified|11|||
146056701|NCT00651924|526722729|FG000|Overall Study|Withdrawal by PI|0|||
146056702|NCT00651924|526722730|FG001|Overall Study|Withdrawal by PI|2|||
146056703|NCT00651924|526722729|FG000|Overall Study|Withdrawal by Subject|0|||
146056704|NCT00651924|526722730|FG001|Overall Study|Withdrawal by Subject|5|||
146056705|NCT00758771|526722731|FG000|Overall Study|Withdrawal by Subject|1|||
146056706|NCT00758771|526722732|FG001|Overall Study|Withdrawal by Subject|1|||
146056707|NCT00758771|526722731|FG000|Overall Study|Did not meet eligibility criteria|2|||
146056708|NCT00758771|526722732|FG001|Overall Study|Did not meet eligibility criteria|4|||
146056709|NCT00960063|526722733|FG000|Overall Study|Adverse Event|1|||
146056710|NCT00960063|526722734|FG001|Overall Study|Adverse Event|0|||
146056711|NCT00960063|526722735|FG002|Overall Study|Adverse Event|0|||
146056712|NCT00960063|526722733|FG000|Overall Study|Progression of Disease|0|||
146056713|NCT00960063|526722734|FG001|Overall Study|Progression of Disease|0|||
146056714|NCT00960063|526722735|FG002|Overall Study|Progression of Disease|3|||
146056715|NCT01759420|526722736|FG000|Overall Study|Screen failure|5|||
146056716|NCT01759420|526722736|FG000|Overall Study|Inaccurate EKG machine readings|1|||
146056717|NCT01129622|526722737|FG000|Overall Study|Withdrawal by Subject|2|||
146056718|NCT02051764|526722738|FG000|Overall Study|Study terminated by sponsor|0|||
146056719|NCT02051764|526722739|FG001|Overall Study|Study terminated by sponsor|7|||
146056720|NCT00591006|526722740|FG000|Overall Study|Withdrawal by Subject|0|||
146056721|NCT00591006|526722741|FG001|Overall Study|Withdrawal by Subject|0|||
146056722|NCT00591006|526722742|FG002|Overall Study|Withdrawal by Subject|0|||
146056723|NCT00591006|526722743|FG003|Overall Study|Withdrawal by Subject|0|||
146056724|NCT00591006|526722744|FG004|Overall Study|Withdrawal by Subject|0|||
146056725|NCT00591006|526722745|FG005|Overall Study|Withdrawal by Subject|0|||
146056726|NCT00591006|526722746|FG006|Overall Study|Withdrawal by Subject|0|||
146056727|NCT00591006|526722747|FG007|Overall Study|Withdrawal by Subject|0|||
146056728|NCT00591006|526722748|FG008|Overall Study|Withdrawal by Subject|0|||
146056729|NCT00591006|526722749|FG009|Overall Study|Withdrawal by Subject|0|||
146056730|NCT00591006|526722750|FG010|Overall Study|Withdrawal by Subject|0|||
146056731|NCT00591006|526722751|FG011|Overall Study|Withdrawal by Subject|0|||
146056732|NCT00591006|526722752|FG012|Overall Study|Withdrawal by Subject|0|||
146056733|NCT00591006|526722753|FG013|Overall Study|Withdrawal by Subject|0|||
146056734|NCT00591006|526722754|FG014|Overall Study|Withdrawal by Subject|0|||
146056735|NCT00591006|526722755|FG015|Overall Study|Withdrawal by Subject|1|||
146056736|NCT00591006|526722756|FG016|Overall Study|Withdrawal by Subject|0|||
146056737|NCT00591006|526722757|FG017|Overall Study|Withdrawal by Subject|0|||
146056738|NCT00591006|526722758|FG018|Overall Study|Withdrawal by Subject|0|||
146056739|NCT00591006|526722759|FG019|Overall Study|Withdrawal by Subject|0|||
146056740|NCT00591006|526722760|FG020|Overall Study|Withdrawal by Subject|0|||
146056741|NCT00591006|526722761|FG021|Overall Study|Withdrawal by Subject|0|||
146056742|NCT00591006|526722762|FG022|Overall Study|Withdrawal by Subject|0|||
146056743|NCT00591006|526722763|FG023|Overall Study|Withdrawal by Subject|1|||
146056744|NCT00591006|526722740|FG000|Overall Study|Adverse Event|0|||
146056745|NCT00591006|526722741|FG001|Overall Study|Adverse Event|0|||
146056746|NCT00591006|526722742|FG002|Overall Study|Adverse Event|0|||
146056747|NCT00591006|526722743|FG003|Overall Study|Adverse Event|0|||
146056748|NCT00591006|526722744|FG004|Overall Study|Adverse Event|0|||
146056749|NCT00591006|526722745|FG005|Overall Study|Adverse Event|0|||
146056750|NCT00591006|526722746|FG006|Overall Study|Adverse Event|0|||
146056751|NCT00591006|526722747|FG007|Overall Study|Adverse Event|0|||
146056752|NCT00591006|526722748|FG008|Overall Study|Adverse Event|0|||
146056753|NCT00591006|526722749|FG009|Overall Study|Adverse Event|0|||
146056754|NCT00591006|526722750|FG010|Overall Study|Adverse Event|0|||
146056755|NCT00591006|526722751|FG011|Overall Study|Adverse Event|0|||
146056756|NCT00591006|526722752|FG012|Overall Study|Adverse Event|0|||
146056757|NCT00591006|526722753|FG013|Overall Study|Adverse Event|0|||
146056758|NCT00591006|526722754|FG014|Overall Study|Adverse Event|0|||
146056759|NCT00591006|526722755|FG015|Overall Study|Adverse Event|0|||
146056760|NCT00591006|526722756|FG016|Overall Study|Adverse Event|0|||
146056761|NCT00591006|526722757|FG017|Overall Study|Adverse Event|0|||
146056762|NCT00591006|526722758|FG018|Overall Study|Adverse Event|0|||
146056763|NCT00591006|526722759|FG019|Overall Study|Adverse Event|0|||
146056764|NCT00591006|526722760|FG020|Overall Study|Adverse Event|0|||
146056765|NCT00591006|526722761|FG021|Overall Study|Adverse Event|0|||
146056766|NCT00591006|526722762|FG022|Overall Study|Adverse Event|1|||
146056767|NCT00591006|526722763|FG023|Overall Study|Adverse Event|0|||
146056768|NCT05190120|526722766|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146056769|NCT05190120|526722767|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146056770|NCT05190120|526722768|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
146056771|NCT05190120|526722769|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
146056772|NCT05190120|526722766|FG000|Overall Study|Lost to Follow-up|5|||
146056773|NCT05190120|526722767|FG001|Overall Study|Lost to Follow-up|0|||
146056774|NCT05190120|526722768|FG002|Overall Study|Lost to Follow-up|2|||
146056775|NCT05190120|526722769|FG003|Overall Study|Lost to Follow-up|3|||
146056776|NCT03062358|526722771|FG000|Overall Study|Death|269|||
146056777|NCT03062358|526722772|FG001|Overall Study|Death|145|||
146056778|NCT03062358|526722771|FG000|Overall Study|Withdrawal by Subject|2|||
146056779|NCT03062358|526722772|FG001|Overall Study|Withdrawal by Subject|1|||
146056780|NCT03062358|526722771|FG000|Overall Study|Sponsor Decision|29|||
146056781|NCT03062358|526722772|FG001|Overall Study|Sponsor Decision|7|||
146056782|NCT00880698|526722777|FG000|Overall Study|Death|0|||
146056783|NCT00880698|526722778|FG001|Overall Study|Death|0|||
146056784|NCT00880698|526722779|FG002|Overall Study|Death|1|||
146056785|NCT00880698|526722780|FG003|Overall Study|Death|2|||
146056786|NCT00880698|526722777|FG000|Overall Study|Lost to Follow-up|1|||
146056787|NCT00880698|526722778|FG001|Overall Study|Lost to Follow-up|3|||
146056788|NCT00880698|526722779|FG002|Overall Study|Lost to Follow-up|0|||
146056789|NCT00880698|526722780|FG003|Overall Study|Lost to Follow-up|1|||
146056790|NCT04972162|526722781|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
146056791|NCT04972162|526722782|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
146395069|NCT01049360|527948625|FG014|Period 2|Adverse Event|0|||
146395070|NCT01049360|527948626|FG015|Period 2|Adverse Event|0|||
146395071|NCT01049360|527948627|FG016|Period 2|Adverse Event|0|||
146395072|NCT01049360|527948628|FG017|Period 2|Adverse Event|0|||
146395073|NCT01049360|527948629|FG018|Period 2|Adverse Event|0|||
146395074|NCT01049360|527948630|FG019|Period 2|Adverse Event|1|||
146395075|NCT01049360|527948611|FG000|Period 2|Withdrawal by Subject|0|||
146395076|NCT01049360|527948612|FG001|Period 2|Withdrawal by Subject|0|||
146395077|NCT01049360|527948613|FG002|Period 2|Withdrawal by Subject|0|||
146395078|NCT01049360|527948614|FG003|Period 2|Withdrawal by Subject|1|||
146395079|NCT01049360|527948615|FG004|Period 2|Withdrawal by Subject|0|||
146395080|NCT01049360|527948616|FG005|Period 2|Withdrawal by Subject|0|||
146395081|NCT01049360|527948617|FG006|Period 2|Withdrawal by Subject|0|||
146395082|NCT01049360|527948618|FG007|Period 2|Withdrawal by Subject|0|||
146395083|NCT01049360|527948619|FG008|Period 2|Withdrawal by Subject|0|||
146395084|NCT01049360|527948620|FG009|Period 2|Withdrawal by Subject|0|||
146395085|NCT01049360|527948621|FG010|Period 2|Withdrawal by Subject|0|||
146395086|NCT01049360|527948622|FG011|Period 2|Withdrawal by Subject|0|||
146395087|NCT01049360|527948623|FG012|Period 2|Withdrawal by Subject|0|||
146395088|NCT01049360|527948624|FG013|Period 2|Withdrawal by Subject|0|||
146395089|NCT01049360|527948625|FG014|Period 2|Withdrawal by Subject|1|||
146395090|NCT01049360|527948626|FG015|Period 2|Withdrawal by Subject|0|||
146395091|NCT01049360|527948627|FG016|Period 2|Withdrawal by Subject|0|||
146395092|NCT01049360|527948628|FG017|Period 2|Withdrawal by Subject|0|||
146395093|NCT01049360|527948629|FG018|Period 2|Withdrawal by Subject|0|||
146395094|NCT01049360|527948630|FG019|Period 2|Withdrawal by Subject|1|||
146395095|NCT01049360|527948611|FG000|Period 2|Lack of Efficacy|0|||
146395096|NCT01049360|527948612|FG001|Period 2|Lack of Efficacy|0|||
146395097|NCT01049360|527948613|FG002|Period 2|Lack of Efficacy|0|||
146395098|NCT01049360|527948614|FG003|Period 2|Lack of Efficacy|0|||
146395099|NCT01049360|527948615|FG004|Period 2|Lack of Efficacy|0|||
146395100|NCT01049360|527948616|FG005|Period 2|Lack of Efficacy|1|||
146395101|NCT01049360|527948617|FG006|Period 2|Lack of Efficacy|0|||
146395102|NCT01049360|527948618|FG007|Period 2|Lack of Efficacy|0|||
146395103|NCT01049360|527948619|FG008|Period 2|Lack of Efficacy|0|||
146395104|NCT01049360|527948620|FG009|Period 2|Lack of Efficacy|0|||
146395105|NCT01049360|527948621|FG010|Period 2|Lack of Efficacy|0|||
146395106|NCT01049360|527948622|FG011|Period 2|Lack of Efficacy|0|||
146395107|NCT01049360|527948623|FG012|Period 2|Lack of Efficacy|0|||
146395108|NCT01049360|527948624|FG013|Period 2|Lack of Efficacy|0|||
146395109|NCT01049360|527948625|FG014|Period 2|Lack of Efficacy|0|||
146395110|NCT01049360|527948626|FG015|Period 2|Lack of Efficacy|0|||
146395111|NCT01049360|527948627|FG016|Period 2|Lack of Efficacy|0|||
146395112|NCT01049360|527948628|FG017|Period 2|Lack of Efficacy|0|||
146395113|NCT01049360|527948629|FG018|Period 2|Lack of Efficacy|0|||
146395114|NCT01049360|527948630|FG019|Period 2|Lack of Efficacy|0|||
146395115|NCT01049360|527948611|FG000|Period 4|Protocol Violation|0|||
146395116|NCT01049360|527948612|FG001|Period 4|Protocol Violation|0|||
146395117|NCT01049360|527948613|FG002|Period 4|Protocol Violation|0|||
146395118|NCT01049360|527948614|FG003|Period 4|Protocol Violation|0|||
146395119|NCT01049360|527948615|FG004|Period 4|Protocol Violation|0|||
146395120|NCT01049360|527948616|FG005|Period 4|Protocol Violation|0|||
146395121|NCT01049360|527948617|FG006|Period 4|Protocol Violation|0|||
146395122|NCT01049360|527948618|FG007|Period 4|Protocol Violation|0|||
146395123|NCT01049360|527948619|FG008|Period 4|Protocol Violation|0|||
146395124|NCT01049360|527948620|FG009|Period 4|Protocol Violation|0|||
146395125|NCT01049360|527948621|FG010|Period 4|Protocol Violation|0|||
146395126|NCT01049360|527948622|FG011|Period 4|Protocol Violation|0|||
146395127|NCT01049360|527948623|FG012|Period 4|Protocol Violation|0|||
146395128|NCT01049360|527948624|FG013|Period 4|Protocol Violation|0|||
146395129|NCT01049360|527948625|FG014|Period 4|Protocol Violation|0|||
146395130|NCT01049360|527948626|FG015|Period 4|Protocol Violation|0|||
146395131|NCT01049360|527948627|FG016|Period 4|Protocol Violation|0|||
146395132|NCT01049360|527948628|FG017|Period 4|Protocol Violation|1|||
146395133|NCT01049360|527948629|FG018|Period 4|Protocol Violation|0|||
146395134|NCT01049360|527948630|FG019|Period 4|Protocol Violation|0|||
146395135|NCT01049360|527948611|FG000|Period 4|Withdrawal by Subject|0|||
146395136|NCT01049360|527948612|FG001|Period 4|Withdrawal by Subject|0|||
146395137|NCT01049360|527948613|FG002|Period 4|Withdrawal by Subject|0|||
146395138|NCT01049360|527948614|FG003|Period 4|Withdrawal by Subject|1|||
146395139|NCT01049360|527948615|FG004|Period 4|Withdrawal by Subject|0|||
146395140|NCT01049360|527948616|FG005|Period 4|Withdrawal by Subject|0|||
146395141|NCT01049360|527948617|FG006|Period 4|Withdrawal by Subject|0|||
146395142|NCT01049360|527948618|FG007|Period 4|Withdrawal by Subject|0|||
146395143|NCT01049360|527948619|FG008|Period 4|Withdrawal by Subject|0|||
146395144|NCT01049360|527948620|FG009|Period 4|Withdrawal by Subject|0|||
146395145|NCT01049360|527948621|FG010|Period 4|Withdrawal by Subject|0|||
146395146|NCT01049360|527948622|FG011|Period 4|Withdrawal by Subject|0|||
146395147|NCT01049360|527948623|FG012|Period 4|Withdrawal by Subject|0|||
146395148|NCT01049360|527948624|FG013|Period 4|Withdrawal by Subject|0|||
146395149|NCT01049360|527948625|FG014|Period 4|Withdrawal by Subject|0|||
146395150|NCT01049360|527948626|FG015|Period 4|Withdrawal by Subject|0|||
146395151|NCT01049360|527948627|FG016|Period 4|Withdrawal by Subject|0|||
146395152|NCT01049360|527948628|FG017|Period 4|Withdrawal by Subject|0|||
146395153|NCT01049360|527948629|FG018|Period 4|Withdrawal by Subject|0|||
146395154|NCT01049360|527948630|FG019|Period 4|Withdrawal by Subject|0|||
146395155|NCT00429026|527948631|FG000|Overall Study|Inevaluable for response.|40|||
146395156|NCT01012765|527948634|FG000|Treatment Period 1|Adverse Event|1|||
146395157|NCT01012765|527948635|FG001|Treatment Period 1|Adverse Event|0|||
146395158|NCT01012765|527948636|FG002|Treatment Period 1|Adverse Event|1|||
146395159|NCT01012765|527948637|FG003|Treatment Period 1|Adverse Event|0|||
146395160|NCT01012765|527948638|FG004|Treatment Period 1|Adverse Event|0|||
146395161|NCT01012765|527948639|FG005|Treatment Period 1|Adverse Event|0|||
146395162|NCT01012765|527948634|FG000|Treatment Period 1|Withdrawal by Subject|2|||
146395163|NCT01012765|527948635|FG001|Treatment Period 1|Withdrawal by Subject|0|||
146395164|NCT01012765|527948636|FG002|Treatment Period 1|Withdrawal by Subject|0|||
146395165|NCT01012765|527948637|FG003|Treatment Period 1|Withdrawal by Subject|0|||
146395166|NCT01012765|527948638|FG004|Treatment Period 1|Withdrawal by Subject|0|||
146395167|NCT01012765|527948639|FG005|Treatment Period 1|Withdrawal by Subject|0|||
146395168|NCT01012765|527948634|FG000|Treatment Period 1|Administrative problems|0|||
146395169|NCT01012765|527948635|FG001|Treatment Period 1|Administrative problems|0|||
146395170|NCT01012765|527948636|FG002|Treatment Period 1|Administrative problems|1|||
146395171|NCT01012765|527948637|FG003|Treatment Period 1|Administrative problems|1|||
146395172|NCT01012765|527948638|FG004|Treatment Period 1|Administrative problems|1|||
146395173|NCT01012765|527948639|FG005|Treatment Period 1|Administrative problems|0|||
146395174|NCT01012765|527948634|FG000|Treatment Period 1|Protocol Violation|0|||
146395175|NCT01012765|527948635|FG001|Treatment Period 1|Protocol Violation|0|||
146395176|NCT01012765|527948636|FG002|Treatment Period 1|Protocol Violation|0|||
146395177|NCT01012765|527948637|FG003|Treatment Period 1|Protocol Violation|2|||
146395178|NCT01012765|527948638|FG004|Treatment Period 1|Protocol Violation|1|||
146395179|NCT01012765|527948639|FG005|Treatment Period 1|Protocol Violation|0|||
146395180|NCT01012765|527948634|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146395181|NCT01012765|527948635|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146395182|NCT01012765|527948636|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146395183|NCT01012765|527948637|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146395184|NCT01012765|527948638|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
146395185|NCT01012765|527948639|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
146395186|NCT01012765|527948634|FG000|Treatment Period 2|Withdrawal by Subject|1|||
146395187|NCT01012765|527948635|FG001|Treatment Period 2|Withdrawal by Subject|0|||
146395188|NCT01012765|527948636|FG002|Treatment Period 2|Withdrawal by Subject|1|||
146395189|NCT01012765|527948637|FG003|Treatment Period 2|Withdrawal by Subject|0|||
146395190|NCT01012765|527948638|FG004|Treatment Period 2|Withdrawal by Subject|1|||
146395191|NCT01012765|527948639|FG005|Treatment Period 2|Withdrawal by Subject|0|||
146395192|NCT01012765|527948634|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
146395193|NCT01012765|527948635|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
146395194|NCT01012765|527948636|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
146395195|NCT01012765|527948637|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
146395196|NCT01012765|527948638|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
146395197|NCT01012765|527948639|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
146395198|NCT01012765|527948634|FG000|Treatment Period 2|Adverse Event|0|||
146395199|NCT01012765|527948635|FG001|Treatment Period 2|Adverse Event|1|||
146395200|NCT01012765|527948636|FG002|Treatment Period 2|Adverse Event|1|||
146395201|NCT01012765|527948637|FG003|Treatment Period 2|Adverse Event|0|||
146395202|NCT01012765|527948638|FG004|Treatment Period 2|Adverse Event|0|||
146395203|NCT01012765|527948639|FG005|Treatment Period 2|Adverse Event|0|||
146395204|NCT01012765|527948634|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146395205|NCT01012765|527948635|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
146395206|NCT01012765|527948636|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
146395207|NCT01012765|527948637|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146395208|NCT01012765|527948638|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146395209|NCT01012765|527948639|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
146395210|NCT01326312|527948640|FG000|Overall Study|Adverse Event|11|||
146395211|NCT01326312|527948641|FG001|Overall Study|Adverse Event|11|||
146395212|NCT01326312|527948642|FG002|Overall Study|Adverse Event|1|||
146395213|NCT01326312|527948640|FG000|Overall Study|Withdrawal by Subject|1|||
146395214|NCT01326312|527948641|FG001|Overall Study|Withdrawal by Subject|2|||
146395215|NCT01326312|527948642|FG002|Overall Study|Withdrawal by Subject|1|||
146395216|NCT01326312|527948640|FG000|Overall Study|Protocol Violation|0|||
146395217|NCT01326312|527948641|FG001|Overall Study|Protocol Violation|1|||
146395218|NCT01326312|527948642|FG002|Overall Study|Protocol Violation|0|||
146395219|NCT01326312|527948640|FG000|Overall Study|Lack of Efficacy|13|||
146395220|NCT01326312|527948641|FG001|Overall Study|Lack of Efficacy|7|||
146395221|NCT01326312|527948642|FG002|Overall Study|Lack of Efficacy|1|||
146395222|NCT01326312|527948640|FG000|Overall Study|Death|1|||
146395223|NCT01326312|527948641|FG001|Overall Study|Death|0|||
146395224|NCT01326312|527948642|FG002|Overall Study|Death|1|||
146395225|NCT01326312|527948640|FG000|Overall Study|progressive disease|0|||
146395226|NCT01326312|527948641|FG001|Overall Study|progressive disease|1|||
146395227|NCT01326312|527948642|FG002|Overall Study|progressive disease|1|||
146395228|NCT01326312|527948640|FG000|Overall Study|Study terminated by Sponsor|8|||
146395229|NCT01326312|527948641|FG001|Overall Study|Study terminated by Sponsor|32|||
146395230|NCT01326312|527948642|FG002|Overall Study|Study terminated by Sponsor|46|||
146395231|NCT01326312|527948640|FG000|Overall Study|Treatment arm terminated|19|||
146395232|NCT01326312|527948641|FG001|Overall Study|Treatment arm terminated|0|||
146395233|NCT01326312|527948642|FG002|Overall Study|Treatment arm terminated|0|||
146395234|NCT01326312|527948640|FG000|Overall Study|QTc > 500|0|||
146395235|NCT01326312|527948641|FG001|Overall Study|QTc > 500|1|||
146395236|NCT01326312|527948642|FG002|Overall Study|QTc > 500|0|||
146395237|NCT00499694|527948653|FG000|Overall Study|Patient never received treatment.|1|||
146395238|NCT02370173|527948654|FG000|Overall Study|Protocol Violation|1|||
146395239|NCT02370173|527948655|FG001|Overall Study|Protocol Violation|1|||
146395240|NCT02370173|527948654|FG000|Overall Study|Withdrawal by Subject|2|||
146395241|NCT02370173|527948655|FG001|Overall Study|Withdrawal by Subject|2|||
146395242|NCT00736840|527948658|FG000|Overall Study|Lost to Follow-up|13|||
146395243|NCT01411917|527948659|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
146395244|NCT01411917|527948660|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
146395245|NCT01728194|527948665|FG000|Overall Study|Lost to Follow-up|4|||
146395246|NCT01728194|527948666|FG001|Overall Study|Lost to Follow-up|3|||
146395247|NCT01728194|527948665|FG000|Overall Study|Physician Decision|4|||
146395248|NCT01728194|527948666|FG001|Overall Study|Physician Decision|0|||
146395249|NCT01728194|527948665|FG000|Overall Study|Withdrawal by Subject|7|||
146395250|NCT01728194|527948666|FG001|Overall Study|Withdrawal by Subject|3|||
146395251|NCT01728194|527948665|FG000|Overall Study|Perceived Medication Side Effects|4|||
146395252|NCT01728194|527948666|FG001|Overall Study|Perceived Medication Side Effects|0|||
146395253|NCT01728194|527948665|FG000|Overall Study|Family Member Request|1|||
146395254|NCT01728194|527948666|FG001|Overall Study|Family Member Request|0|||
146395255|NCT02309372|527948669|FG000|Overall Study|Lost to Follow-up|3|||
146395256|NCT02309372|527948670|FG001|Overall Study|Lost to Follow-up|2|||
146395257|NCT00242658|527948671|FG000|Overall Study|Lost to Follow-up|22|||
146395258|NCT00242658|527948672|FG001|Overall Study|Lost to Follow-up|19|||
146395259|NCT00553319|527948676|FG000|Overall Study|Lost to Follow-up|10|||
146395260|NCT00553319|527948677|FG001|Overall Study|Lost to Follow-up|9|||
146395261|NCT00553319|527948678|FG002|Overall Study|Lost to Follow-up|5|||
146395262|NCT00553319|527948676|FG000|Overall Study|wanted treatment elsewhere|2|||
146395263|NCT00553319|527948677|FG001|Overall Study|wanted treatment elsewhere|1|||
146395264|NCT00553319|527948678|FG002|Overall Study|wanted treatment elsewhere|1|||
146395265|NCT00553319|527948676|FG000|Overall Study|non-compliance|0|||
146395266|NCT00553319|527948677|FG001|Overall Study|non-compliance|0|||
146395267|NCT00553319|527948678|FG002|Overall Study|non-compliance|2|||
146395268|NCT00553319|527948676|FG000|Overall Study|incarceration|1|||
146395269|NCT00553319|527948677|FG001|Overall Study|incarceration|0|||
146395270|NCT00553319|527948678|FG002|Overall Study|incarceration|0|||
146395271|NCT00553319|527948676|FG000|Overall Study|moved|1|||
146395272|NCT00553319|527948677|FG001|Overall Study|moved|0|||
146395273|NCT00553319|527948678|FG002|Overall Study|moved|1|||
146395274|NCT01731600|527948684|FG000|Overall Study|Adverse Event|2|||
146395275|NCT01731600|527948685|FG001|Overall Study|Adverse Event|0|||
146395276|NCT01731600|527948684|FG000|Overall Study|Withdrawal criteria|1|||
146395277|NCT01731600|527948685|FG001|Overall Study|Withdrawal criteria|0|||
146395278|NCT01731600|527948684|FG000|Overall Study|Other reasons|3|||
146395279|NCT01731600|527948685|FG001|Overall Study|Other reasons|0|||
146395280|NCT03575975|527948686|FG000|Overall Study|Lost to Follow-up|1|||
146395281|NCT03575975|527948687|FG001|Overall Study|Lost to Follow-up|0|||
146395282|NCT03575975|527948688|FG002|Overall Study|Lost to Follow-up|0|||
146395283|NCT00129220|527948691|FG000|Study Period II|Adverse Event|9|||
146395284|NCT00129220|527948692|FG001|Study Period II|Adverse Event|5|||
146395285|NCT00129220|527948693|FG002|Study Period II|Adverse Event|7|||
146395286|NCT00129220|527948691|FG000|Study Period II|Lack of Efficacy|15|||
146395287|NCT00129220|527948692|FG001|Study Period II|Lack of Efficacy|1|||
146395288|NCT00129220|527948693|FG002|Study Period II|Lack of Efficacy|28|||
146395289|NCT00129220|527948691|FG000|Study Period II|Entry Criteria Not Met|2|||
146395290|NCT00129220|527948692|FG001|Study Period II|Entry Criteria Not Met|0|||
146395291|NCT00129220|527948693|FG002|Study Period II|Entry Criteria Not Met|2|||
146395292|NCT00129220|527948691|FG000|Study Period II|Protocol Violation|4|||
146395293|NCT00129220|527948692|FG001|Study Period II|Protocol Violation|2|||
146395294|NCT00129220|527948693|FG002|Study Period II|Protocol Violation|1|||
146395295|NCT00129220|527948691|FG000|Study Period II|Physician Decision|0|||
146395296|NCT00129220|527948692|FG001|Study Period II|Physician Decision|1|||
146395297|NCT00129220|527948693|FG002|Study Period II|Physician Decision|0|||
146395298|NCT00129220|527948691|FG000|Study Period II|Withdrawal by Subject|1|||
146395299|NCT00129220|527948692|FG001|Study Period II|Withdrawal by Subject|3|||
146395300|NCT00129220|527948693|FG002|Study Period II|Withdrawal by Subject|4|||
146395301|NCT00129220|527948691|FG000|Study Period II|Reason Not Specified|2|||
146395302|NCT00129220|527948692|FG001|Study Period II|Reason Not Specified|0|||
146395303|NCT00129220|527948693|FG002|Study Period II|Reason Not Specified|5|||
146395304|NCT00129220|527948691|FG000|Study Period III|Adverse Event|1|||
146395305|NCT00129220|527948692|FG001|Study Period III|Adverse Event|0|||
146395306|NCT00129220|527948693|FG002|Study Period III|Adverse Event|3|||
146395307|NCT00129220|527948691|FG000|Study Period III|Protocol Violation|1|||
146395308|NCT00129220|527948692|FG001|Study Period III|Protocol Violation|1|||
146395309|NCT00129220|527948693|FG002|Study Period III|Protocol Violation|2|||
146395310|NCT00129220|527948691|FG000|Study Period III|Withdrawal by Subject|1|||
146395311|NCT00129220|527948692|FG001|Study Period III|Withdrawal by Subject|0|||
146395312|NCT00129220|527948693|FG002|Study Period III|Withdrawal by Subject|3|||
146395313|NCT00129220|527948691|FG000|Study Period III|Sponsor Decision|1|||
146395314|NCT00129220|527948692|FG001|Study Period III|Sponsor Decision|0|||
146395315|NCT00129220|527948693|FG002|Study Period III|Sponsor Decision|0|||
146395316|NCT00129220|527948691|FG000|Study Period III|Reason Not Specified|9|||
146395317|NCT00129220|527948692|FG001|Study Period III|Reason Not Specified|0|||
146395318|NCT00129220|527948693|FG002|Study Period III|Reason Not Specified|2|||
146395319|NCT02147132|527950789|FG000|Overall Study|Lost to Follow-up|1|||
146395320|NCT02147132|527950790|FG001|Overall Study|Lost to Follow-up|0|||
146395321|NCT02147132|527950791|FG002|Overall Study|Lost to Follow-up|0|||
146395322|NCT02147132|527950792|FG003|Overall Study|Lost to Follow-up|0|||
146395323|NCT02064231|527950793|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
146395324|NCT02064231|527950794|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
146395325|NCT02064231|527950795|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
146395326|NCT02064231|527950796|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
146395327|NCT02064231|527950793|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
146395328|NCT02064231|527950794|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
146395329|NCT02064231|527950795|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
146395330|NCT02064231|527950796|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
146395331|NCT02064231|527950793|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
146395332|NCT02064231|527950794|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
146395333|NCT02064231|527950795|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
146395334|NCT02064231|527950796|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
146395335|NCT02064231|527950793|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
146395336|NCT02064231|527950794|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
146395337|NCT02064231|527950795|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
146395338|NCT02064231|527950796|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
146395339|NCT04854421|527950798|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
146395340|NCT04854421|527950799|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
146395341|NCT02322866|527950800|FG000|Overall Study|Adverse Event|6|||
146395342|NCT02322866|527950801|FG001|Overall Study|Adverse Event|11|||
146395343|NCT02322866|527950800|FG000|Overall Study|Withdrawal of Consent|16|||
146395344|NCT02322866|527950801|FG001|Overall Study|Withdrawal of Consent|25|||
146395345|NCT02322866|527950800|FG000|Overall Study|Lost to Follow-up|36|||
146395346|NCT02322866|527950801|FG001|Overall Study|Lost to Follow-up|39|||
146395347|NCT02322866|527950800|FG000|Overall Study|Protocol Violation|1|||
146395348|NCT02322866|527950801|FG001|Overall Study|Protocol Violation|0|||
146395349|NCT02322866|527950800|FG000|Overall Study|Noncompliance with Treatment|3|||
146395350|NCT02322866|527950801|FG001|Overall Study|Noncompliance with Treatment|4|||
146395351|NCT02322866|527950800|FG000|Overall Study|Lack of Efficacy|3|||
146395352|NCT02322866|527950801|FG001|Overall Study|Lack of Efficacy|1|||
146395353|NCT02322866|527950800|FG000|Overall Study|Other Miscellaneous Reasons|6|||
146395354|NCT02322866|527950801|FG001|Overall Study|Other Miscellaneous Reasons|6|||
146395355|NCT00718809|527950802|FG000|Overall Study|Disease progression|9|||
146395356|NCT00718809|527950803|FG001|Overall Study|Disease progression|7|||
146395357|NCT00718809|527950802|FG000|Overall Study|Adverse Event|1|||
146395358|NCT00718809|527950803|FG001|Overall Study|Adverse Event|1|||
146395359|NCT00718809|527950802|FG000|Overall Study|Withdrawal by Subject|0|||
146395360|NCT00718809|527950803|FG001|Overall Study|Withdrawal by Subject|1|||
146395361|NCT00718809|527950802|FG000|Overall Study|Lost to Follow-up|1|||
146395362|NCT00718809|527950803|FG001|Overall Study|Lost to Follow-up|0|||
146395363|NCT00718809|527950802|FG000|Overall Study|Noncompliance|1|||
146395364|NCT00718809|527950803|FG001|Overall Study|Noncompliance|0|||
146395365|NCT00463385|527950804|FG000|Overall Study|Other|4|||
146395366|NCT00463385|527950805|FG001|Overall Study|Other|3|||
146395367|NCT00463385|527950806|FG002|Overall Study|Other|6|||
146395368|NCT00463385|527950807|FG003|Overall Study|Other|4|||
146395369|NCT00463385|527950804|FG000|Overall Study|Adverse Event|5|||
146395370|NCT00463385|527950805|FG001|Overall Study|Adverse Event|8|||
146395371|NCT00463385|527950806|FG002|Overall Study|Adverse Event|4|||
146395372|NCT00463385|527950807|FG003|Overall Study|Adverse Event|2|||
146395373|NCT00463385|527950804|FG000|Overall Study|Lack of Efficacy|6|||
146395374|NCT00463385|527950805|FG001|Overall Study|Lack of Efficacy|6|||
146395375|NCT00463385|527950806|FG002|Overall Study|Lack of Efficacy|7|||
146395376|NCT00463385|527950807|FG003|Overall Study|Lack of Efficacy|9|||
146395377|NCT00463385|527950804|FG000|Overall Study|Withdrawal by Subject|3|||
146395378|NCT00463385|527950805|FG001|Overall Study|Withdrawal by Subject|3|||
146395379|NCT00463385|527950806|FG002|Overall Study|Withdrawal by Subject|3|||
146395380|NCT00463385|527950807|FG003|Overall Study|Withdrawal by Subject|4|||
146395381|NCT00463385|527950804|FG000|Overall Study|Lost to Follow-up|0|||
146395382|NCT00463385|527950805|FG001|Overall Study|Lost to Follow-up|0|||
146395383|NCT00463385|527950806|FG002|Overall Study|Lost to Follow-up|0|||
146395384|NCT00463385|527950807|FG003|Overall Study|Lost to Follow-up|1|||
146395385|NCT00463385|527950804|FG000|Overall Study|Death|2|||
146395386|NCT00463385|527950805|FG001|Overall Study|Death|1|||
146395387|NCT00463385|527950806|FG002|Overall Study|Death|2|||
146395388|NCT00463385|527950807|FG003|Overall Study|Death|0|||
146395389|NCT00463385|527950804|FG000|Overall Study|Missing|2|||
146395390|NCT00463385|527950805|FG001|Overall Study|Missing|0|||
146395391|NCT00463385|527950806|FG002|Overall Study|Missing|0|||
146395392|NCT00463385|527950807|FG003|Overall Study|Missing|2|||
146395393|NCT00463385|527950804|FG000|Overall Study|1 participant received commercial drug|0|||
146395394|NCT00463385|527950805|FG001|Overall Study|1 participant received commercial drug|1|||
146395395|NCT00463385|527950806|FG002|Overall Study|1 participant received commercial drug|0|||
146395396|NCT00463385|527950807|FG003|Overall Study|1 participant received commercial drug|0|||
146395397|NCT00798161|527950808|FG000|Overall Study|Adverse Event|3|||
146395398|NCT00798161|527950809|FG001|Overall Study|Adverse Event|4|||
146395399|NCT00798161|527950810|FG002|Overall Study|Adverse Event|6|||
146395400|NCT00798161|527950811|FG003|Overall Study|Adverse Event|6|||
146395401|NCT00798161|527950812|FG004|Overall Study|Adverse Event|5|||
146395402|NCT00798161|527950813|FG005|Overall Study|Adverse Event|2|||
146395403|NCT00798161|527950814|FG006|Overall Study|Adverse Event|4|||
146395404|NCT00798161|527950808|FG000|Overall Study|Protocol Violation|2|||
146395405|NCT00798161|527950809|FG001|Overall Study|Protocol Violation|1|||
146395406|NCT00798161|527950810|FG002|Overall Study|Protocol Violation|3|||
146395407|NCT00798161|527950811|FG003|Overall Study|Protocol Violation|3|||
146395408|NCT00798161|527950812|FG004|Overall Study|Protocol Violation|3|||
146395409|NCT00798161|527950813|FG005|Overall Study|Protocol Violation|2|||
146395410|NCT00798161|527950814|FG006|Overall Study|Protocol Violation|0|||
146395411|NCT00798161|527950808|FG000|Overall Study|Lost to Follow-up|1|||
146395412|NCT00798161|527950809|FG001|Overall Study|Lost to Follow-up|3|||
146395413|NCT00798161|527950810|FG002|Overall Study|Lost to Follow-up|4|||
146395414|NCT00798161|527950811|FG003|Overall Study|Lost to Follow-up|3|||
146395415|NCT00798161|527950812|FG004|Overall Study|Lost to Follow-up|4|||
146395416|NCT00798161|527950813|FG005|Overall Study|Lost to Follow-up|0|||
146395417|NCT00798161|527950814|FG006|Overall Study|Lost to Follow-up|0|||
146395418|NCT00798161|527950808|FG000|Overall Study|Withdrawal by Subject|5|||
146395419|NCT00798161|527950809|FG001|Overall Study|Withdrawal by Subject|4|||
146395420|NCT00798161|527950810|FG002|Overall Study|Withdrawal by Subject|5|||
146395421|NCT00798161|527950811|FG003|Overall Study|Withdrawal by Subject|4|||
146395422|NCT00798161|527950812|FG004|Overall Study|Withdrawal by Subject|2|||
146395423|NCT00798161|527950813|FG005|Overall Study|Withdrawal by Subject|3|||
146395424|NCT00798161|527950814|FG006|Overall Study|Withdrawal by Subject|1|||
146395425|NCT00798161|527950808|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
146395426|NCT00798161|527950809|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
146395427|NCT00798161|527950810|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
146395428|NCT00798161|527950811|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
146395429|NCT00798161|527950812|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
146395430|NCT00798161|527950813|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
146395431|NCT00798161|527950814|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
146395432|NCT00503035|527950828|FG000|Overall Study|Lost to Follow-up|2|||
146395433|NCT00503035|527950828|FG000|Overall Study|Physician Decision|3|||
146395434|NCT00503035|527950828|FG000|Overall Study|Ineligible|15|||
146395435|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Adverse Event|4|||
146395436|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Adverse Event|3|||
146395437|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Adverse Event|0|||
146395438|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Adverse Event|0|||
146395439|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Death|24|||
146395440|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Death|9|||
146395441|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Death|0|||
146395442|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Death|0|||
146395443|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
146395444|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
146395445|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
146395446|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
146395447|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Physician Decision|4|||
146395448|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Physician Decision|1|||
146395449|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Physician Decision|0|||
146395450|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Physician Decision|0|||
146395451|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Progressive disease|1|||
146395452|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Progressive disease|0|||
146395453|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Progressive disease|0|||
146395454|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Progressive disease|0|||
146395455|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
146395456|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
146395457|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
146395458|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
146395459|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
146395460|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
146395461|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
146395462|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
146395463|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
146395464|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
146395465|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
146395466|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
146395467|NCT04579666|527950830|FG000|RTP (Up to Week 52)|Other|2|||
146395468|NCT04579666|527950831|FG001|RTP (Up to Week 52)|Other|0|||
146395469|NCT04579666|527950832|FG002|RTP (Up to Week 52)|Other|0|||
146395470|NCT04579666|527950833|FG003|RTP (Up to Week 52)|Other|0|||
146395471|NCT04579666|527950830|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146395472|NCT04579666|527950831|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146395473|NCT04579666|527950832|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
146395474|NCT04579666|527950833|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
146395475|NCT04579666|527950830|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
146395476|NCT04579666|527950831|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
146395477|NCT04579666|527950832|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
146395478|NCT04579666|527950833|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
146395479|NCT04579666|527950830|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
146395480|NCT04579666|527950831|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
146395481|NCT04579666|527950832|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
146395482|NCT04579666|527950833|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
146395483|NCT04579666|527950830|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
146395484|NCT04579666|527950831|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
146395485|NCT04579666|527950832|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
146395486|NCT04579666|527950833|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
146395487|NCT04579666|527950830|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
146395488|NCT04579666|527950831|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
146395489|NCT04579666|527950832|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
146395490|NCT04579666|527950833|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
146395491|NCT01982942|527950834|FG000|Overall Study|Adverse Event|10|||
146395492|NCT01982942|527950835|FG001|Overall Study|Adverse Event|5|||
146395493|NCT01982942|527950834|FG000|Overall Study|Lost to Follow-up|4|||
146395494|NCT01982942|527950835|FG001|Overall Study|Lost to Follow-up|3|||
146395495|NCT01982942|527950834|FG000|Overall Study|Multiple sclerosis progression|3|||
146395496|NCT01982942|527950835|FG001|Overall Study|Multiple sclerosis progression|2|||
146395497|NCT01982942|527950834|FG000|Overall Study|Wanted to try therapy not permitted|1|||
146395498|NCT01982942|527950835|FG001|Overall Study|Wanted to try therapy not permitted|0|||
146395499|NCT01982942|527950834|FG000|Overall Study|Subject declined future visits|0|||
146395500|NCT01982942|527950835|FG001|Overall Study|Subject declined future visits|1|||
146395501|NCT01982942|527950834|FG000|Overall Study|Left geographical area|2|||
146395502|NCT01982942|527950835|FG001|Overall Study|Left geographical area|0|||
146395503|NCT01982942|527950834|FG000|Overall Study|Too many pills|1|||
146395504|NCT01982942|527950835|FG001|Overall Study|Too many pills|0|||
146395505|NCT01982942|527950834|FG000|Overall Study|MS Relapse|0|||
146395506|NCT01982942|527950835|FG001|Overall Study|MS Relapse|1|||
146395507|NCT01982942|527950834|FG000|Overall Study|Chose to join a stem cell trial|0|||
146395508|NCT01982942|527950835|FG001|Overall Study|Chose to join a stem cell trial|1|||
146395509|NCT01982942|527950834|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
146395510|NCT01982942|527950835|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
146395511|NCT04576702|527950836|FG000|Overall Study|Death|1|||
146395512|NCT04576702|527950837|FG001|Overall Study|Death|0|||
146395513|NCT04576702|527950838|FG002|Overall Study|Death|0|||
146395514|NCT04576702|527950839|FG003|Overall Study|Death|0|||
146395515|NCT04576702|527950836|FG000|Overall Study|Withdrawal by Subject|0|||
146395516|NCT04576702|527950837|FG001|Overall Study|Withdrawal by Subject|2|||
146395517|NCT04576702|527950838|FG002|Overall Study|Withdrawal by Subject|1|||
146395518|NCT04576702|527950839|FG003|Overall Study|Withdrawal by Subject|0|||
146395519|NCT04576702|527950836|FG000|Overall Study|Lost to Follow-up|3|||
146395520|NCT04576702|527950837|FG001|Overall Study|Lost to Follow-up|3|||
146395521|NCT04576702|527950838|FG002|Overall Study|Lost to Follow-up|3|||
146395522|NCT04576702|527950839|FG003|Overall Study|Lost to Follow-up|4|||
146395523|NCT02985996|527950846|FG000|Overall Study|Withdrawal by Subject|0|||
146395524|NCT02985996|527950847|FG001|Overall Study|Withdrawal by Subject|0|||
146395525|NCT02985996|527950848|FG002|Overall Study|Withdrawal by Subject|1|||
146395526|NCT02985996|527950849|FG003|Overall Study|Withdrawal by Subject|0|||
146395527|NCT02985996|527950850|FG004|Overall Study|Withdrawal by Subject|0|||
146395528|NCT02985996|527950846|FG000|Overall Study|Protocol Violation|0|||
146395529|NCT02985996|527950847|FG001|Overall Study|Protocol Violation|1|||
146395530|NCT02985996|527950848|FG002|Overall Study|Protocol Violation|0|||
146395531|NCT02985996|527950849|FG003|Overall Study|Protocol Violation|0|||
146395532|NCT02985996|527950850|FG004|Overall Study|Protocol Violation|0|||
146395533|NCT00401726|527950851|FG000|Overall Study|Adverse Event|34|||
146395534|NCT00401726|527950852|FG001|Overall Study|Adverse Event|45|||
146395535|NCT00401726|527950851|FG000|Overall Study|Death|0|||
146395536|NCT00401726|527950852|FG001|Overall Study|Death|3|||
146395537|NCT00401726|527950851|FG000|Overall Study|Sponsor Request|0|||
146395538|NCT00401726|527950852|FG001|Overall Study|Sponsor Request|1|||
146395539|NCT00401726|527950851|FG000|Overall Study|Physician Decision|3|||
146395540|NCT00401726|527950852|FG001|Overall Study|Physician Decision|6|||
146395541|NCT00401726|527950851|FG000|Overall Study|Lost to Follow-up|23|||
146395542|NCT00401726|527950852|FG001|Overall Study|Lost to Follow-up|20|||
146395543|NCT00401726|527950851|FG000|Overall Study|Protocol Violation|6|||
146395544|NCT00401726|527950852|FG001|Overall Study|Protocol Violation|3|||
146395545|NCT00401726|527950851|FG000|Overall Study|Withdrawal by Subject|18|||
146395546|NCT00401726|527950852|FG001|Overall Study|Withdrawal by Subject|24|||
146395547|NCT00401726|527950851|FG000|Overall Study|Lack of Efficacy|4|||
146395548|NCT00401726|527950852|FG001|Overall Study|Lack of Efficacy|6|||
146395549|NCT00401726|527950851|FG000|Overall Study|Protocol Deviation|9|||
146395550|NCT00401726|527950852|FG001|Overall Study|Protocol Deviation|4|||
146395551|NCT02067728|527950853|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
146395552|NCT02067728|527950854|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
146395553|NCT02067728|527950853|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
146395554|NCT02067728|527950854|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
146395555|NCT02067728|527950853|FG000|6 Month Measurements|Unable to attend|114|||
146395556|NCT02067728|527950854|FG001|6 Month Measurements|Unable to attend|97|||
146395557|NCT03532048|527950856|FG000|Overall Study|Lost to Follow-up|12|||
146395558|NCT03532048|527950857|FG001|Overall Study|Lost to Follow-up|17|||
146395559|NCT03532048|527950856|FG000|Overall Study|Withdrawal by Subject|7|||
146395560|NCT03532048|527950857|FG001|Overall Study|Withdrawal by Subject|0|||
146395561|NCT01901393|527950858|FG000|Overall Study|Adverse Event|1|||
146395562|NCT01901393|527950859|FG001|Overall Study|Adverse Event|0|||
146395563|NCT04113746|527950864|FG000|Overall Study|Lost to Follow-up|4|||
146395564|NCT04113746|527950865|FG001|Overall Study|Lost to Follow-up|4|||
146395565|NCT03125382|527950866|FG000|Randomization|screening failure|1|||
146395566|NCT03125382|527950867|FG001|Randomization|screening failure|4|||
146395567|NCT03125382|527950868|FG002|Randomization|screening failure|2|||
146395568|NCT03125382|527950869|FG003|Randomization|screening failure|0|||
146395569|NCT03125382|527950866|FG000|Follow-up|Death|1|||
146395570|NCT03125382|527950867|FG001|Follow-up|Death|2|||
146395571|NCT03125382|527950868|FG002|Follow-up|Death|1|||
146395572|NCT03125382|527950869|FG003|Follow-up|Death|2|||
146395573|NCT03125382|527950866|FG000|Follow-up|Lost to Follow-up|1|||
146395574|NCT03125382|527950867|FG001|Follow-up|Lost to Follow-up|4|||
146395575|NCT03125382|527950868|FG002|Follow-up|Lost to Follow-up|3|||
146395576|NCT03125382|527950869|FG003|Follow-up|Lost to Follow-up|1|||
146395577|NCT01050998|527950871|FG000|Overall Study|Adverse Event|1|||
146395578|NCT01050998|527950872|FG001|Overall Study|Adverse Event|0|||
146395579|NCT01050998|527950873|FG002|Overall Study|Adverse Event|1|||
146395580|NCT01050998|527950874|FG003|Overall Study|Adverse Event|0|||
146395581|NCT01050998|527950875|FG004|Overall Study|Adverse Event|2|||
146395582|NCT01050998|527950871|FG000|Overall Study|Withdrawal by Subject|0|||
146395583|NCT01050998|527950872|FG001|Overall Study|Withdrawal by Subject|0|||
146395584|NCT01050998|527950873|FG002|Overall Study|Withdrawal by Subject|0|||
146395585|NCT01050998|527950874|FG003|Overall Study|Withdrawal by Subject|1|||
146395586|NCT01050998|527950875|FG004|Overall Study|Withdrawal by Subject|3|||
146395587|NCT01050998|527950871|FG000|Overall Study|Other|3|||
146395588|NCT01050998|527950872|FG001|Overall Study|Other|2|||
146395589|NCT01050998|527950873|FG002|Overall Study|Other|1|||
146395590|NCT01050998|527950874|FG003|Overall Study|Other|1|||
146395591|NCT01050998|527950875|FG004|Overall Study|Other|5|||
146395592|NCT01050998|527950871|FG000|Overall Study|Data integrity issues|0|||
146395593|NCT01050998|527950872|FG001|Overall Study|Data integrity issues|0|||
146395594|NCT01050998|527950873|FG002|Overall Study|Data integrity issues|1|||
146395595|NCT01050998|527950874|FG003|Overall Study|Data integrity issues|1|||
146395596|NCT01050998|527950875|FG004|Overall Study|Data integrity issues|4|||
146395597|NCT00234533|527950880|FG000|Overall Study|Withdrawal by Subject|6|||
146395598|NCT00234533|527950880|FG000|Overall Study|Adverse Event|2|||
146395599|NCT00234533|527950880|FG000|Overall Study|Enrolled but not treated|3|||
146395600|NCT04338685|527950881|FG000|Overall Study|Death|3|||
146395601|NCT04338685|527950882|FG001|Overall Study|Death|4|||
146395602|NCT04338685|527950883|FG002|Overall Study|Death|2|||
146395603|NCT04338685|527950884|FG003|Overall Study|Death|4|||
146395604|NCT04338685|527950885|FG004|Overall Study|Death|4|||
146395605|NCT04338685|527950886|FG005|Overall Study|Death|8|||
146395606|NCT04338685|527950887|FG006|Overall Study|Death|1|||
146395607|NCT04338685|527950888|FG007|Overall Study|Death|0|||
146395608|NCT04338685|527950889|FG008|Overall Study|Death|0|||
146395609|NCT04338685|527950881|FG000|Overall Study|Study terminated by Sponsor|0|||
146395610|NCT04338685|527950882|FG001|Overall Study|Study terminated by Sponsor|0|||
146395611|NCT04338685|527950883|FG002|Overall Study|Study terminated by Sponsor|1|||
146395612|NCT04338685|527950884|FG003|Overall Study|Study terminated by Sponsor|4|||
146395613|NCT04338685|527950885|FG004|Overall Study|Study terminated by Sponsor|0|||
146395614|NCT04338685|527950886|FG005|Overall Study|Study terminated by Sponsor|5|||
146395615|NCT04338685|527950887|FG006|Overall Study|Study terminated by Sponsor|2|||
146395616|NCT04338685|527950888|FG007|Overall Study|Study terminated by Sponsor|4|||
146395617|NCT04338685|527950889|FG008|Overall Study|Study terminated by Sponsor|1|||
146395618|NCT04338685|527950881|FG000|Overall Study|Withdrawal by Subject|1|||
146395619|NCT04338685|527950882|FG001|Overall Study|Withdrawal by Subject|2|||
146395620|NCT04338685|527950883|FG002|Overall Study|Withdrawal by Subject|0|||
146395621|NCT04338685|527950884|FG003|Overall Study|Withdrawal by Subject|2|||
146395622|NCT04338685|527950885|FG004|Overall Study|Withdrawal by Subject|0|||
146395623|NCT04338685|527950886|FG005|Overall Study|Withdrawal by Subject|5|||
146395624|NCT04338685|527950887|FG006|Overall Study|Withdrawal by Subject|1|||
146395625|NCT04338685|527950888|FG007|Overall Study|Withdrawal by Subject|1|||
146395626|NCT04338685|527950889|FG008|Overall Study|Withdrawal by Subject|0|||
146395627|NCT02967055|527950890|FG000|Overall Study|Excluded|40|||
146395628|NCT02967055|527950890|FG000|Overall Study|Screen fail|3|||
146395629|NCT02967055|527950890|FG000|Overall Study|Lost to Follow-up|2|||
146395630|NCT02967055|527950890|FG000|Overall Study|Stopped due to side effects|3|||
146395631|NCT02967055|527950890|FG000|Overall Study|Stopped due to drug cost|1|||
146395632|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
146395633|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
146395634|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
146395635|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
146395636|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
146395637|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
146395638|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
146395639|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
146395640|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
146395641|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
146395642|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
146395643|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
146395644|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
146395645|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
146395646|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
146395647|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
146395648|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
146395649|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
146395650|NCT00570492|527950891|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
146395651|NCT00570492|527950892|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
146395652|NCT00570492|527950893|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
146395653|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
146395654|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
146395655|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
146395656|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
146395657|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
146395658|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
146395659|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
146395660|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
146395661|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
146395662|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
146395663|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
146395664|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
146395665|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
146395666|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
146395667|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
146395668|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146395669|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
146395670|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
146395671|NCT00570492|527950891|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
146395672|NCT00570492|527950892|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
146395673|NCT00570492|527950893|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
146395674|NCT00976989|527950894|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
146395675|NCT00976989|527950895|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
146395676|NCT00976989|527950896|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
146395677|NCT00976989|527950894|FG000|Overall Study|Death|5|||
146395678|NCT00976989|527950895|FG001|Overall Study|Death|7|||
146395679|NCT00976989|527950896|FG002|Overall Study|Death|10|||
146395680|NCT00976989|527950894|FG000|Overall Study|Refused Treatment|4|||
146395681|NCT00976989|527950895|FG001|Overall Study|Refused Treatment|3|||
146395682|NCT00976989|527950896|FG002|Overall Study|Refused Treatment|5|||
146395683|NCT00976989|527950894|FG000|Overall Study|Failure to Return|2|||
146395684|NCT00976989|527950895|FG001|Overall Study|Failure to Return|1|||
146395685|NCT00976989|527950896|FG002|Overall Study|Failure to Return|0|||
146395686|NCT00976989|527950894|FG000|Overall Study|Recurrence of Disease|0|||
146395687|NCT00976989|527950895|FG001|Overall Study|Recurrence of Disease|1|||
146395688|NCT00976989|527950896|FG002|Overall Study|Recurrence of Disease|0|||
146395689|NCT00976989|527950894|FG000|Overall Study|Other|1|||
146395690|NCT00976989|527950895|FG001|Overall Study|Other|0|||
146395722|NCT00903357|527950901|FG000|First Intervention|Withdrawal by Subject|5|||
146395723|NCT00903357|527950902|FG001|First Intervention|Withdrawal by Subject|3|||
146395724|NCT00903357|527950901|FG000|First Intervention|Flu|0|||
146395725|NCT00903357|527950902|FG001|First Intervention|Flu|1|||
146395726|NCT00903357|527950901|FG000|Wash Out Period of 2 Weeks|Flu|0|||
146395727|NCT00903357|527950902|FG001|Wash Out Period of 2 Weeks|Flu|1|||
146395728|NCT00903357|527950901|FG000|Second Intervention|Lost to Follow-up|1|||
146395729|NCT00903357|527950902|FG001|Second Intervention|Lost to Follow-up|0|||
146395730|NCT00678652|527950905|FG000|Overall Study|Protocol Violation|2|||
146395731|NCT00678652|527950906|FG001|Overall Study|Protocol Violation|0|||
146395732|NCT00678652|527950907|FG002|Overall Study|Protocol Violation|0|||
146395733|NCT00678652|527950908|FG003|Overall Study|Protocol Violation|0|||
146395734|NCT00678652|527950905|FG000|Overall Study|Pregnancy|0|||
146395735|NCT00678652|527950906|FG001|Overall Study|Pregnancy|0|||
146395736|NCT00678652|527950907|FG002|Overall Study|Pregnancy|1|||
146395737|NCT00678652|527950908|FG003|Overall Study|Pregnancy|0|||
146395738|NCT00678652|527950905|FG000|Overall Study|Relocation|1|||
146395739|NCT00678652|527950906|FG001|Overall Study|Relocation|0|||
146395740|NCT00678652|527950907|FG002|Overall Study|Relocation|0|||
146395741|NCT00678652|527950908|FG003|Overall Study|Relocation|0|||
146395742|NCT03958045|527950911|FG000|Overall Study|Withdrawal by Subject|1|||
146395743|NCT00674440|527950916|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
146395744|NCT00674440|527950916|FG000|Overall Study|did not have surgery, so unevaluable|7|||
146395745|NCT00674440|527950916|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
146395746|NCT03457701|527950917|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146395747|NCT03457701|527950918|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146395748|NCT03457701|527950917|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
146395749|NCT03457701|527950918|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
146395750|NCT03329404|527950919|FG000|Overall Study|The study was suspended.|1|||
146395751|NCT03329404|527950920|FG001|Overall Study|The study was suspended.|4|||
146395752|NCT05664672|527950924|FG000|Overall Study|Adverse Event|0|||
146395753|NCT05664672|527950925|FG001|Overall Study|Adverse Event|0|||
146395754|NCT05664672|527950926|FG002|Overall Study|Adverse Event|0|||
146395755|NCT05664672|527950927|FG003|Overall Study|Adverse Event|0|||
146395756|NCT05664672|527950928|FG004|Overall Study|Adverse Event|0|||
146395757|NCT05664672|527950929|FG005|Overall Study|Adverse Event|1|||
146395758|NCT05664672|527950924|FG000|Overall Study|Withdrawal by Subject|0|||
146395759|NCT05664672|527950925|FG001|Overall Study|Withdrawal by Subject|1|||
146395760|NCT05664672|527950926|FG002|Overall Study|Withdrawal by Subject|3|||
146395761|NCT05664672|527950927|FG003|Overall Study|Withdrawal by Subject|0|||
146395762|NCT05664672|527950928|FG004|Overall Study|Withdrawal by Subject|5|||
146395763|NCT05664672|527950929|FG005|Overall Study|Withdrawal by Subject|6|||
146395764|NCT05664672|527950924|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
146395765|NCT05664672|527950925|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
146395766|NCT05664672|527950926|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
146395767|NCT05664672|527950927|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
146395768|NCT05664672|527950928|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
146395769|NCT05664672|527950929|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
146395770|NCT05664672|527950924|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
146395771|NCT05664672|527950925|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146395772|NCT05664672|527950926|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146395773|NCT05664672|527950927|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146395774|NCT05664672|527950928|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146395775|NCT05664672|527950929|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
146395776|NCT04095039|527950932|FG000|Overall Study|Withdrawal by Subject|2|||
146395777|NCT04095039|527950933|FG001|Overall Study|Withdrawal by Subject|16|||
146395778|NCT04095039|527950932|FG000|Overall Study|Transplanted|21|||
146395779|NCT04095039|527950933|FG001|Overall Study|Transplanted|24|||
146395780|NCT04095039|527950932|FG000|Overall Study|Transferred to Non-study Facility|47|||
146395781|NCT04095039|527950933|FG001|Overall Study|Transferred to Non-study Facility|44|||
146395782|NCT04095039|527950932|FG000|Overall Study|Withdrawal from internvention target|0|||
146395783|NCT04095039|527950933|FG001|Overall Study|Withdrawal from internvention target|2|||
146395784|NCT04095039|527950932|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
146395785|NCT04095039|527950933|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
146395786|NCT04095039|527950932|FG000|Overall Study|Cacliphylaxis|0|||
146395787|NCT04095039|527950933|FG001|Overall Study|Cacliphylaxis|1|||
146395788|NCT04095039|527950932|FG000|Overall Study|Pregnancy|1|||
146395789|NCT04095039|527950933|FG001|Overall Study|Pregnancy|0|||
146395790|NCT04236986|527950934|FG000|Overall Study|Withdrawal by Subject|3|||
146395791|NCT04236986|527950935|FG001|Overall Study|Withdrawal by Subject|1|||
146395792|NCT01326481|527950938|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
146395793|NCT01990339|527950943|FG000|Overall Study|Data Not Available|49|||
146395794|NCT01990339|527950943|FG000|Overall Study|Voluntary Withdrawal|1402|||
146395800|NCT01314261|527950944|FG000|Overall Study|Withdrawal by Subject|0|||
146395801|NCT01314261|527950945|FG001|Overall Study|Withdrawal by Subject|3|||
146395802|NCT01314261|527950946|FG002|Overall Study|Withdrawal by Subject|1|||
146395803|NCT01314261|527950947|FG003|Overall Study|Withdrawal by Subject|0|||
146395804|NCT01314261|527950944|FG000|Overall Study|Lost to Follow-up|1|||
146395805|NCT01314261|527950945|FG001|Overall Study|Lost to Follow-up|0|||
146395806|NCT01314261|527950946|FG002|Overall Study|Lost to Follow-up|2|||
146395807|NCT01314261|527950947|FG003|Overall Study|Lost to Follow-up|2|||
146395808|NCT01314261|527950944|FG000|Overall Study|Virologic Failure|0|||
146395809|NCT01314261|527950945|FG001|Overall Study|Virologic Failure|1|||
146395810|NCT01314261|527950946|FG002|Overall Study|Virologic Failure|0|||
146395811|NCT01314261|527950947|FG003|Overall Study|Virologic Failure|1|||
146395812|NCT02129192|527950948|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
146395813|NCT02129192|527950949|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
146395814|NCT01231620|527950950|FG000|Overall Study|Physician Decision|3|||
146395815|NCT01231620|527950951|FG001|Overall Study|Physician Decision|5|||
146395816|NCT01231620|527950952|FG002|Overall Study|Physician Decision|10|||
146395817|NCT01231620|527950950|FG000|Overall Study|Death|12|||
146395818|NCT01231620|527950951|FG001|Overall Study|Death|14|||
146395819|NCT01231620|527950952|FG002|Overall Study|Death|11|||
146395820|NCT01231620|527950950|FG000|Overall Study|Adverse Event|2|||
146395821|NCT01231620|527950951|FG001|Overall Study|Adverse Event|2|||
146395822|NCT01231620|527950952|FG002|Overall Study|Adverse Event|1|||
146395823|NCT01231620|527950950|FG000|Overall Study|Withdrawal by Subject|6|||
146395824|NCT01231620|527950951|FG001|Overall Study|Withdrawal by Subject|6|||
146395825|NCT01231620|527950952|FG002|Overall Study|Withdrawal by Subject|8|||
146395826|NCT01231620|527950950|FG000|Overall Study|Lost to Follow-up|3|||
146395827|NCT01231620|527950951|FG001|Overall Study|Lost to Follow-up|4|||
146395828|NCT01231620|527950952|FG002|Overall Study|Lost to Follow-up|9|||
146395829|NCT04524507|527950953|FG000|Overall Study|Lost to Follow-up|2|||
146395830|NCT04524507|527950954|FG001|Overall Study|Lost to Follow-up|4|||
146395831|NCT04524507|527950953|FG000|Overall Study|Withdrawal by Subject|2|||
146395832|NCT04524507|527950954|FG001|Overall Study|Withdrawal by Subject|9|||
146395833|NCT04524507|527950953|FG000|Overall Study|Death|2|||
146395834|NCT04524507|527950954|FG001|Overall Study|Death|10|||
146395835|NCT02441517|527950960|FG000|Overall Study|Lost to Follow-up|1|||
146395836|NCT02441517|527950960|FG000|Overall Study|Withdrawal by Subject|2|||
146395837|NCT02441517|527950960|FG000|Overall Study|Study Terminated by Sponsor|1|||
146395838|NCT01393444|527950961|FG000|Overall Study|Withdrawal by Subject|1|||
146395839|NCT01393444|527950961|FG000|Overall Study|Determined ineligible during screening.|2|||
146395840|NCT03039699|527950962|FG000|Overall Study|Incorrect inclusion|5|||
146395841|NCT03039699|527950963|FG001|Overall Study|Incorrect inclusion|4|||
146395842|NCT03039699|527950962|FG000|Overall Study|Lack of data to assess study endpoint|5|||
146395843|NCT03039699|527950963|FG001|Overall Study|Lack of data to assess study endpoint|3|||
146395844|NCT03039699|527950962|FG000|Overall Study|Bacterial infection|12|||
146395845|NCT03039699|527950963|FG001|Overall Study|Bacterial infection|28|||
146395846|NCT01302366|527952370|FG000|Overall Study|patient choice or noncompliance|5|||
146395847|NCT00467051|527952371|FG000|Overall Study|Adverse Event|2|||
146395848|NCT01740297|527952372|FG000|Overall Study|Withdrawal by Subject|4|||
146395849|NCT01740297|527952373|FG001|Overall Study|Withdrawal by Subject|16|||
146395850|NCT01740297|527952374|FG002|Overall Study|Withdrawal by Subject|17|||
146395851|NCT01740297|527952372|FG000|Overall Study|Death|8|||
146395852|NCT01740297|527952373|FG001|Overall Study|Death|46|||
146395853|NCT01740297|527952374|FG002|Overall Study|Death|40|||
146395854|NCT01740297|527952372|FG000|Overall Study|Lost to Follow-up|1|||
146395855|NCT01740297|527952373|FG001|Overall Study|Lost to Follow-up|2|||
146395856|NCT01740297|527952374|FG002|Overall Study|Lost to Follow-up|4|||
146395857|NCT00761462|527952375|FG000|Treatment|Subjects never received study medication|23|||
146395858|NCT00761462|527952376|FG001|Treatment|Subjects never received study medication|12|||
146395859|NCT00761462|527952375|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
146395860|NCT00761462|527952376|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
146395861|NCT00761462|527952375|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
146395862|NCT00761462|527952376|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
146395863|NCT00761462|527952375|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
146395864|NCT00761462|527952376|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
146395865|NCT02383966|527952380|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
146395866|NCT02383966|527952381|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
146395867|NCT02383966|527952380|FG000|Overall Study|Randomized, but not treated|1|||
146395868|NCT02383966|527952381|FG001|Overall Study|Randomized, but not treated|3|||
146395869|NCT03575806|527952388|FG000|Overall Study|Withdrawal by Subject|0|||
146395870|NCT03575806|527952389|FG001|Overall Study|Withdrawal by Subject|2|||
146395871|NCT03575806|527952388|FG000|Overall Study|Protocol Violation|0|||
146395872|NCT03575806|527952389|FG001|Overall Study|Protocol Violation|2|||
146395873|NCT00270205|527952390|FG000|Overall Study|Lost to Follow-up|1|||
146395874|NCT00270205|527952391|FG001|Overall Study|Lost to Follow-up|0|||
146395875|NCT00270205|527952392|FG002|Overall Study|Lost to Follow-up|0|||
146395876|NCT00270205|527952393|FG003|Overall Study|Lost to Follow-up|1|||
146395887|NCT00465101|527952407|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
146395888|NCT00465101|527952407|FG000|Overall Study|Change in health precluded follow up|4|||
146395889|NCT00465101|527952407|FG000|Overall Study|Did not meet study criteria|4|||
146395890|NCT00465101|527952407|FG000|Overall Study|Lost to Follow-up|5|||
146395891|NCT00465101|527952407|FG000|Overall Study|Other|6|||
146395892|NCT00465101|527952407|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
146395893|NCT00465101|527952407|FG000|Overall Study|Patient postponed procedure|1|||
146395894|NCT00465101|527952407|FG000|Overall Study|Site closed due to IRB expiration|1|||
146395895|NCT00465101|527952407|FG000|Overall Study|Unable to obtain IRB approval|1|||
146395896|NCT00465101|527952407|FG000|Overall Study|Death|3|||
146395897|NCT00465101|527952407|FG000|Overall Study|Withdrawal by Subject|25|||
146395898|NCT00465101|527952407|FG000|Overall Study|Physician Decision|1|||
146395899|NCT00465101|527952407|FG000|Overall Study|Withdrew consent prior to procedure|3|||
146395900|NCT03099096|527952408|FG000|Overall Study|Adverse Event|1|||
146395901|NCT03099096|527952408|FG000|Overall Study|Physician Decision|1|||
146395902|NCT03219372|527952410|FG000|Overall Study|Withdrawal by Subject|1|||
146395903|NCT03219372|527952411|FG001|Overall Study|Withdrawal by Subject|0|||
146395904|NCT01428882|527952412|FG000|Overall Study|Lack of Efficacy|2|||
146395905|NCT01428882|527952413|FG001|Overall Study|Lack of Efficacy|7|||
146395906|NCT01428882|527952412|FG000|Overall Study|Protocol Violation|4|||
146395907|NCT01428882|527952413|FG001|Overall Study|Protocol Violation|3|||
146395908|NCT02304484|527952414|FG000|Overall Study|Death|9|||
146395909|NCT02304484|527952414|FG000|Overall Study|Withdrawal by Subject|14|||
146395910|NCT02304484|527952414|FG000|Overall Study|Lost to Follow-up|2|||
146395911|NCT00752206|527952415|FG000|Overall Study|Disease progression|8|||
146395912|NCT00752206|527952416|FG001|Overall Study|Disease progression|11|||
146395913|NCT00752206|527952415|FG000|Overall Study|Pregnancy|1|||
146395914|NCT00752206|527952416|FG001|Overall Study|Pregnancy|0|||
146395915|NCT01539512|527952417|FG000|Overall Study|Adverse Event|9|||
146395916|NCT01539512|527952418|FG001|Overall Study|Adverse Event|7|||
146395917|NCT01539512|527952417|FG000|Overall Study|Physician Decision|1|||
146395918|NCT01539512|527952418|FG001|Overall Study|Physician Decision|1|||
146395919|NCT01539512|527952417|FG000|Overall Study|Withdrawal by Subject|12|||
146395920|NCT01539512|527952418|FG001|Overall Study|Withdrawal by Subject|5|||
146395921|NCT01539512|527952417|FG000|Overall Study|Richter's Transformation|1|||
146395922|NCT01539512|527952418|FG001|Overall Study|Richter's Transformation|0|||
146395923|NCT01484691|527952419|FG000|Overall Study|Withdrawal by Subject|1|||
146395924|NCT01484691|527952420|FG001|Overall Study|Withdrawal by Subject|1|||
146395925|NCT01484691|527952421|FG002|Overall Study|Withdrawal by Subject|1|||
146395926|NCT01484691|527952419|FG000|Overall Study|Physician Decision|0|||
146395927|NCT01484691|527952420|FG001|Overall Study|Physician Decision|2|||
146395928|NCT01484691|527952421|FG002|Overall Study|Physician Decision|1|||
146395929|NCT04668157|527952424|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
146395930|NCT04668157|527952425|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
146395931|NCT04668157|527952424|FG000|Treatment Period (52 Weeks)|Other|0|||
146395932|NCT04668157|527952425|FG001|Treatment Period (52 Weeks)|Other|2|||
146395933|NCT04768881|527952430|FG000|Overall Study|Completed Study Follow-up|0|||
146395934|NCT04768881|527952431|FG001|Overall Study|Completed Study Follow-up|2|||
146395935|NCT04768881|527952430|FG000|Overall Study|Death|3|||
146395936|NCT04768881|527952431|FG001|Overall Study|Death|2|||
146395937|NCT04768881|527952430|FG000|Overall Study|Study Terminated by Sponsor|2|||
146395938|NCT04768881|527952431|FG001|Overall Study|Study Terminated by Sponsor|2|||
146395939|NCT04768881|527952430|FG000|Overall Study|Withdrawal by Subject|2|||
146395940|NCT04768881|527952431|FG001|Overall Study|Withdrawal by Subject|0|||
146395941|NCT04768881|527952430|FG000|Overall Study|Other|2|||
146395942|NCT04768881|527952431|FG001|Overall Study|Other|0|||
146395943|NCT00945815|527952433|FG000|Overall Study|Death|3|||
146395944|NCT00945815|527952433|FG000|Overall Study|Not protocol specified|1|||
146395945|NCT00945815|527952433|FG000|Overall Study|Ineligible|3|||
146395946|NCT00945815|527952433|FG000|Overall Study|Did not begin protocol therapy|1|||
146395947|NCT01038609|527952438|FG000|Overall Study|Adverse Event|0|||
146395948|NCT01038609|527952439|FG001|Overall Study|Adverse Event|0|||
146395949|NCT01038609|527952440|FG002|Overall Study|Adverse Event|1|||
146395950|NCT01038609|527952441|FG003|Overall Study|Adverse Event|0|||
146395951|NCT01038609|527952442|FG004|Overall Study|Adverse Event|0|||
146395952|NCT01038609|527952438|FG000|Overall Study|Dosing Error|0|||
146395953|NCT01038609|527952439|FG001|Overall Study|Dosing Error|0|||
146395954|NCT01038609|527952440|FG002|Overall Study|Dosing Error|0|||
146395955|NCT01038609|527952441|FG003|Overall Study|Dosing Error|1|||
146395956|NCT01038609|527952442|FG004|Overall Study|Dosing Error|1|||
146395957|NCT01038609|527952438|FG000|Overall Study|Death in the Family|1|||
146395958|NCT01038609|527952439|FG001|Overall Study|Death in the Family|0|||
146395959|NCT01038609|527952440|FG002|Overall Study|Death in the Family|0|||
146395960|NCT01038609|527952441|FG003|Overall Study|Death in the Family|0|||
146395961|NCT01038609|527952442|FG004|Overall Study|Death in the Family|0|||
146395962|NCT01038609|527952438|FG000|Overall Study|Refusal of Blood Draws|0|||
146395963|NCT01038609|527952439|FG001|Overall Study|Refusal of Blood Draws|1|||
146395964|NCT01038609|527952440|FG002|Overall Study|Refusal of Blood Draws|0|||
146396134|NCT01241591|527954452|FG000|Overall Study|Lost to Follow-up|1|||
146395965|NCT01038609|527952441|FG003|Overall Study|Refusal of Blood Draws|0|||
146395966|NCT01038609|527952442|FG004|Overall Study|Refusal of Blood Draws|0|||
146395967|NCT01590810|527952443|FG000|Overall Study|Physician Decision|0|||
146395968|NCT01590810|527952444|FG001|Overall Study|Physician Decision|1|||
146395969|NCT01590810|527952445|FG002|Overall Study|Physician Decision|1|||
146395970|NCT01590810|527952446|FG003|Overall Study|Physician Decision|0|||
146395971|NCT01590810|527952447|FG004|Overall Study|Physician Decision|0|||
146395972|NCT02400281|527952449|FG000|Overall Study|Adverse Event|0|||
146395973|NCT02400281|527952450|FG001|Overall Study|Adverse Event|0|||
146395974|NCT02400281|527952451|FG002|Overall Study|Adverse Event|1|||
146395975|NCT02400281|527952452|FG003|Overall Study|Adverse Event|0|||
146395976|NCT02400281|527952453|FG004|Overall Study|Adverse Event|1|||
146395977|NCT02400281|527952454|FG005|Overall Study|Adverse Event|0|||
146395978|NCT02400281|527952449|FG000|Overall Study|Physician Decision|0|||
146395979|NCT02400281|527952450|FG001|Overall Study|Physician Decision|0|||
146395980|NCT02400281|527952451|FG002|Overall Study|Physician Decision|1|||
146395981|NCT02400281|527952452|FG003|Overall Study|Physician Decision|0|||
146395982|NCT02400281|527952453|FG004|Overall Study|Physician Decision|0|||
146395983|NCT02400281|527952454|FG005|Overall Study|Physician Decision|0|||
146395984|NCT00412360|527952455|FG000|Overall Study|Lost to Follow-up|0|||
146395985|NCT00412360|527952456|FG001|Overall Study|Lost to Follow-up|1|||
146395986|NCT00412360|527952455|FG000|Overall Study|Not Transplanted|1|||
146395987|NCT00412360|527952456|FG001|Overall Study|Not Transplanted|2|||
146395988|NCT03655951|527952460|FG000|Overall Study|Lost to Follow-up|39|||
146395989|NCT03655951|527952461|FG001|Overall Study|Lost to Follow-up|20|||
146395990|NCT03655951|527952460|FG000|Overall Study|Withdrawal by Subject|0|||
146395991|NCT03655951|527952461|FG001|Overall Study|Withdrawal by Subject|1|||
146395992|NCT01078974|527952464|FG000|Overall Study|Adverse Event|3|||
146395993|NCT02569996|527952465|FG000|Overall Study|Adverse Event|6|||
146395994|NCT02569996|527952465|FG000|Overall Study|Physician Decision|3|||
146395995|NCT02569996|527952465|FG000|Overall Study|Progression of the disease|18|||
146395996|NCT02569996|527952465|FG000|Overall Study|New anti-lymphoma treatment|1|||
146395997|NCT02569996|527952465|FG000|Overall Study|Non-compliance|9|||
146395998|NCT02569996|527952465|FG000|Overall Study|Withdrawal by Subject|5|||
146395999|NCT02569996|527952465|FG000|Overall Study|Lost to Follow-up|5|||
146396000|NCT02569996|527952465|FG000|Overall Study|Complete remission|7|||
146396001|NCT02569996|527952465|FG000|Overall Study|Unknown reason|1|||
146396002|NCT01349816|527952466|FG000|Overall Study|Withdrawal by Subject|4|||
146396003|NCT01349816|527952466|FG000|Overall Study|Physician Decision|1|||
146396004|NCT01349816|527952466|FG000|Overall Study|Adverse Event|14|||
146396005|NCT01349816|527952466|FG000|Overall Study|Lost to Follow-up|2|||
146396006|NCT01349816|527952466|FG000|Overall Study|Protocol Violation|1|||
146396007|NCT01349816|527952466|FG000|Overall Study|Protocol-specified criteria|8|||
146396008|NCT01383317|527952467|FG000|Overall Study|Lost to Follow-up|2|||
146396009|NCT01383317|527952468|FG001|Overall Study|Lost to Follow-up|1|||
146396010|NCT01383317|527952467|FG000|Overall Study|Death|1|||
146396011|NCT01383317|527952468|FG001|Overall Study|Death|0|||
146396012|NCT01383317|527952467|FG000|Overall Study|Adverse Event|0|||
146396013|NCT01383317|527952468|FG001|Overall Study|Adverse Event|1|||
146396014|NCT01397409|527952470|FG000|Stage 2|Adverse Event|0|||
146396015|NCT01397409|527952471|FG001|Stage 2|Adverse Event|0|||
146396016|NCT01397409|527952472|FG002|Stage 2|Adverse Event|0|||
146396017|NCT01397409|527952473|FG003|Stage 2|Adverse Event|0|||
146396018|NCT01397409|527952474|FG004|Stage 2|Adverse Event|6|||
146396019|NCT01397409|527952475|FG005|Stage 2|Adverse Event|3|||
146396020|NCT01397409|527952476|FG006|Stage 2|Adverse Event|0|||
146396021|NCT01397409|527952477|FG007|Stage 2|Adverse Event|0|||
146396022|NCT01397409|527952478|FG008|Stage 2|Adverse Event|0|||
146396023|NCT01397409|527952479|FG009|Stage 2|Adverse Event|0|||
146396024|NCT01397409|527952470|FG000|Stage 2|Personal Reasons|0|||
146396025|NCT01397409|527952471|FG001|Stage 2|Personal Reasons|0|||
146396026|NCT01397409|527952472|FG002|Stage 2|Personal Reasons|0|||
146396027|NCT01397409|527952473|FG003|Stage 2|Personal Reasons|0|||
146396028|NCT01397409|527952474|FG004|Stage 2|Personal Reasons|1|||
146396029|NCT01397409|527952475|FG005|Stage 2|Personal Reasons|0|||
146396030|NCT01397409|527952476|FG006|Stage 2|Personal Reasons|0|||
146396031|NCT01397409|527952477|FG007|Stage 2|Personal Reasons|0|||
146396032|NCT01397409|527952478|FG008|Stage 2|Personal Reasons|0|||
146396033|NCT01397409|527952479|FG009|Stage 2|Personal Reasons|0|||
146396034|NCT01397409|527952470|FG000|Stage 2|Other Miscellaneous Reasons|0|||
146396035|NCT01397409|527952471|FG001|Stage 2|Other Miscellaneous Reasons|0|||
146396036|NCT01397409|527952472|FG002|Stage 2|Other Miscellaneous Reasons|0|||
146396037|NCT01397409|527952473|FG003|Stage 2|Other Miscellaneous Reasons|0|||
146396038|NCT01397409|527952474|FG004|Stage 2|Other Miscellaneous Reasons|1|||
146396039|NCT01397409|527952475|FG005|Stage 2|Other Miscellaneous Reasons|1|||
146396040|NCT01397409|527952476|FG006|Stage 2|Other Miscellaneous Reasons|0|||
146396041|NCT01397409|527952477|FG007|Stage 2|Other Miscellaneous Reasons|0|||
146396042|NCT01397409|527952478|FG008|Stage 2|Other Miscellaneous Reasons|0|||
146396043|NCT01397409|527952479|FG009|Stage 2|Other Miscellaneous Reasons|0|||
146396044|NCT01397409|527952470|FG000|Stage 3|Adverse Event|0|||
146396045|NCT01397409|527952471|FG001|Stage 3|Adverse Event|0|||
146396046|NCT01397409|527952472|FG002|Stage 3|Adverse Event|0|||
146396054|NCT01397409|527952470|FG000|Stage 3|Other Miscellaneous Reasons|0|||
146396055|NCT01397409|527952471|FG001|Stage 3|Other Miscellaneous Reasons|0|||
146396056|NCT01397409|527952472|FG002|Stage 3|Other Miscellaneous Reasons|0|||
146396057|NCT01397409|527952473|FG003|Stage 3|Other Miscellaneous Reasons|0|||
146396058|NCT01397409|527952474|FG004|Stage 3|Other Miscellaneous Reasons|0|||
146396059|NCT01397409|527952475|FG005|Stage 3|Other Miscellaneous Reasons|0|||
146396060|NCT01397409|527952476|FG006|Stage 3|Other Miscellaneous Reasons|0|||
146396061|NCT01397409|527952477|FG007|Stage 3|Other Miscellaneous Reasons|1|||
146396062|NCT01397409|527952478|FG008|Stage 3|Other Miscellaneous Reasons|0|||
146396063|NCT01397409|527952479|FG009|Stage 3|Other Miscellaneous Reasons|0|||
146396064|NCT02911285|527952480|FG000|Overall Study|Lost to Follow-up|8|||
146396065|NCT02911285|527952481|FG001|Overall Study|Lost to Follow-up|5|||
146396066|NCT02911285|527952480|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
146396067|NCT02911285|527952481|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
146396068|NCT00422227|527952482|FG000|Overall Study|Adverse Event|3|||
146396069|NCT00422227|527952483|FG001|Overall Study|Adverse Event|8|||
146396070|NCT00422227|527952482|FG000|Overall Study|Lost to Follow-up|1|||
146396071|NCT00422227|527952483|FG001|Overall Study|Lost to Follow-up|3|||
146396072|NCT00422227|527952482|FG000|Overall Study|Withdrawal by Subject|0|||
146396073|NCT00422227|527952483|FG001|Overall Study|Withdrawal by Subject|4|||
146396074|NCT01207427|527952484|FG000|Double-blind Treatment Period|Adverse Event|0|||
146396075|NCT01207427|527952485|FG001|Double-blind Treatment Period|Adverse Event|1|||
146396076|NCT01207427|527952486|FG002|Double-blind Treatment Period|Adverse Event|0|||
146396077|NCT01207427|527952484|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
146396078|NCT01207427|527952485|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
146396079|NCT01207427|527952486|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
146396080|NCT01207427|527952484|FG000|Double-blind Treatment Period|Protocol Violation|2|||
146396081|NCT01207427|527952485|FG001|Double-blind Treatment Period|Protocol Violation|1|||
146396082|NCT01207427|527952486|FG002|Double-blind Treatment Period|Protocol Violation|1|||
146396083|NCT01207427|527952484|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
146396084|NCT01207427|527952485|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
146396085|NCT01207427|527952486|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
146396086|NCT03418727|527952487|FG000|Overall Study|Adverse Event|1|||
146396087|NCT03418727|527952488|FG001|Overall Study|Adverse Event|2|||
146396088|NCT03418727|527952489|FG002|Overall Study|Adverse Event|0|||
146396089|NCT03418727|527952487|FG000|Overall Study|Withdrawal by Subject|0|||
146396090|NCT03418727|527952488|FG001|Overall Study|Withdrawal by Subject|0|||
146396091|NCT03418727|527952489|FG002|Overall Study|Withdrawal by Subject|2|||
146396092|NCT00686894|527952491|FG000|Overall Study|Relapse|2|||
146396093|NCT00686894|527952491|FG000|Overall Study|Protocol Violation|4|||
146396094|NCT01791543|527952492|FG000|Overall Study|Lost to Follow-up|1|||
146396095|NCT01791543|527952492|FG000|Overall Study|Adverse Event|1|||
146396096|NCT01790633|527952497|FG000|Overall Study|Protocol Violation|1|||
146396097|NCT01790633|527952498|FG001|Overall Study|Protocol Violation|2|||
146396098|NCT01790633|527952497|FG000|Overall Study|Did not have serology performed|47|||
146396099|NCT01790633|527952498|FG001|Overall Study|Did not have serology performed|0|||
146396100|NCT01790633|527952497|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
146396101|NCT01790633|527952498|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
146396102|NCT02985541|527954427|FG000|Overall Study|Withdrawal by Subject|33|||
146396103|NCT02985541|527954427|FG000|Overall Study|Lost to Follow-up|26|||
146396104|NCT02985541|527954427|FG000|Overall Study|Adverse Event|27|||
146396105|NCT02985541|527954427|FG000|Overall Study|Physician Decision|2|||
146396106|NCT02985541|527954427|FG000|Overall Study|Pregnancy|2|||
146396107|NCT02985541|527954427|FG000|Overall Study|Wish for pregnancy|44|||
146396108|NCT02985541|527954427|FG000|Overall Study|Other reason|5|||
146396109|NCT02985541|527954427|FG000|Overall Study|Not valid for analysis|2|||
146396110|NCT02163759|527954428|FG000|Overall Study|Withdrawal by Subject|1|||
146396111|NCT02163759|527954429|FG001|Overall Study|Withdrawal by Subject|5|||
146396112|NCT02163759|527954430|FG002|Overall Study|Withdrawal by Subject|1|||
146396113|NCT02163759|527954428|FG000|Overall Study|Adverse Event|0|||
146396114|NCT02163759|527954429|FG001|Overall Study|Adverse Event|0|||
146396115|NCT02163759|527954430|FG002|Overall Study|Adverse Event|1|||
146396116|NCT02163759|527954428|FG000|Overall Study|Death|0|||
146396117|NCT02163759|527954429|FG001|Overall Study|Death|0|||
146396118|NCT02163759|527954430|FG002|Overall Study|Death|1|||
146396119|NCT01479777|527954437|FG000|Overall Study|Physician Decision|2|||
146396120|NCT00451191|527954441|FG000|Overall Study|withdrawal or received alternate tx|15|||
146396121|NCT00451191|527954442|FG001|Overall Study|withdrawal or received alternate tx|11|||
146396122|NCT00219349|527954450|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
146396123|NCT00219349|527954450|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
146396124|NCT00219349|527954450|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
146396125|NCT00219349|527954450|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
146396126|NCT01241591|527954452|FG000|Overall Study|Lack of Efficacy|5|||
146396127|NCT01241591|527954453|FG001|Overall Study|Lack of Efficacy|2|||
146396128|NCT01241591|527954454|FG002|Overall Study|Lack of Efficacy|2|||
146396142|NCT01241591|527954452|FG000|Overall Study|Withdrawal by Subject|6|||
146396143|NCT01241591|527954453|FG001|Overall Study|Withdrawal by Subject|4|||
146396144|NCT01241591|527954454|FG002|Overall Study|Withdrawal by Subject|2|||
146396145|NCT01241591|527954455|FG003|Overall Study|Withdrawal by Subject|2|||
146396146|NCT01241591|527954452|FG000|Overall Study|Other|0|||
146396147|NCT01241591|527954453|FG001|Overall Study|Other|1|||
146396148|NCT01241591|527954454|FG002|Overall Study|Other|0|||
146396149|NCT01241591|527954455|FG003|Overall Study|Other|1|||
146396150|NCT01241591|527954452|FG000|Overall Study|Adverse Event|3|||
146396151|NCT01241591|527954453|FG001|Overall Study|Adverse Event|11|||
146396152|NCT01241591|527954454|FG002|Overall Study|Adverse Event|12|||
146396153|NCT01241591|527954455|FG003|Overall Study|Adverse Event|4|||
146396154|NCT01945034|527954456|FG000|Overall Study|Medication Error|0|||
146396155|NCT01945034|527954457|FG001|Overall Study|Medication Error|1|||
146396156|NCT01945034|527954458|FG002|Overall Study|Medication Error|0|||
146396157|NCT01945034|527954456|FG000|Overall Study|Withdrawal by Subject|0|||
146396158|NCT01945034|527954457|FG001|Overall Study|Withdrawal by Subject|3|||
146396159|NCT01945034|527954458|FG002|Overall Study|Withdrawal by Subject|1|||
146396160|NCT01945034|527954456|FG000|Overall Study|Other|0|||
146396161|NCT01945034|527954457|FG001|Overall Study|Other|1|||
146396162|NCT01945034|527954458|FG002|Overall Study|Other|3|||
146396163|NCT01945034|527954456|FG000|Overall Study|Lost to Follow-up|0|||
146396164|NCT01945034|527954457|FG001|Overall Study|Lost to Follow-up|0|||
146396165|NCT01945034|527954458|FG002|Overall Study|Lost to Follow-up|2|||
146396166|NCT01945034|527954456|FG000|Overall Study|Protocol Violation|1|||
146396167|NCT01945034|527954457|FG001|Overall Study|Protocol Violation|0|||
146396168|NCT01945034|527954458|FG002|Overall Study|Protocol Violation|1|||
146396169|NCT02389621|527954461|FG000|Treatment Period|Withdrawal by Subject|1|||
146396170|NCT02389621|527954462|FG001|Treatment Period|Withdrawal by Subject|1|||
146396171|NCT02389621|527954461|FG000|Posttreatment Period|Adverse Event|3|||
146396172|NCT02389621|527954462|FG001|Posttreatment Period|Adverse Event|1|||
146396173|NCT02389621|527954461|FG000|Posttreatment Period|Withdrawal by Subject|3|||
146396174|NCT02389621|527954462|FG001|Posttreatment Period|Withdrawal by Subject|2|||
146396175|NCT02389621|527954461|FG000|Posttreatment Period|Lost to Follow-up|1|||
146396176|NCT02389621|527954462|FG001|Posttreatment Period|Lost to Follow-up|1|||
146396177|NCT02389621|527954461|FG000|Posttreatment Period|Other - Miscellaneous|2|||
146396178|NCT02389621|527954462|FG001|Posttreatment Period|Other - Miscellaneous|0|||
146396179|NCT03323034|527954465|FG000|Overall Study|Lack of Efficacy|5|||
146396180|NCT03323034|527954466|FG001|Overall Study|Lack of Efficacy|5|||
146396181|NCT03323034|527954467|FG002|Overall Study|Lack of Efficacy|6|||
146396182|NCT03323034|527954468|FG003|Overall Study|Lack of Efficacy|5|||
146396183|NCT03323034|527954469|FG004|Overall Study|Lack of Efficacy|5|||
146396184|NCT03323034|527954465|FG000|Overall Study|Physician Decision|0|||
146396185|NCT03323034|527954466|FG001|Overall Study|Physician Decision|0|||
146396186|NCT03323034|527954467|FG002|Overall Study|Physician Decision|0|||
146396187|NCT03323034|527954468|FG003|Overall Study|Physician Decision|0|||
146396188|NCT03323034|527954469|FG004|Overall Study|Physician Decision|1|||
146396189|NCT03323034|527954465|FG000|Overall Study|Withdrawal by Subject|1|||
146396190|NCT03323034|527954466|FG001|Overall Study|Withdrawal by Subject|1|||
146396191|NCT03323034|527954467|FG002|Overall Study|Withdrawal by Subject|0|||
146396192|NCT03323034|527954468|FG003|Overall Study|Withdrawal by Subject|1|||
146396193|NCT03323034|527954469|FG004|Overall Study|Withdrawal by Subject|0|||
146396194|NCT02815540|527954473|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
146396195|NCT02222246|527954474|FG000|Overall Study|No Emergency Department Visits|27|||
146396196|NCT02222246|527954475|FG001|Overall Study|No Emergency Department Visits|26|||
146396197|NCT02222246|527954474|FG000|Overall Study|Physician Decision|0|||
146396198|NCT02222246|527954475|FG001|Overall Study|Physician Decision|1|||
146396199|NCT04887922|527954483|FG000|1st Randomization|Decided not to have surgery|0|||
146396200|NCT04887922|527954484|FG001|1st Randomization|Decided not to have surgery|1|||
146396201|NCT04887922|527954485|FG002|1st Randomization|Decided not to have surgery|0|||
146396202|NCT04887922|527954486|FG003|1st Randomization|Decided not to have surgery|0|||
146396203|NCT04887922|527954487|FG004|1st Randomization|Decided not to have surgery|0|||
146396204|NCT00953017|527954488|FG000|Overall Study|DId not show up for colonoscopy|4|||
146396205|NCT00953017|527954489|FG001|Overall Study|DId not show up for colonoscopy|4|||
146396206|NCT00953017|527954490|FG002|Overall Study|DId not show up for colonoscopy|5|||
146396207|NCT00953017|527954491|FG003|Overall Study|DId not show up for colonoscopy|4|||
146396208|NCT00953017|527954488|FG000|Overall Study|Incomplete data|1|||
146396209|NCT00953017|527954489|FG001|Overall Study|Incomplete data|1|||
146396210|NCT00953017|527954490|FG002|Overall Study|Incomplete data|0|||
146396211|NCT00953017|527954491|FG003|Overall Study|Incomplete data|0|||
146396212|NCT00953017|527954488|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
146396213|NCT00953017|527954489|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
146396214|NCT00953017|527954490|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
146396215|NCT00953017|527954491|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
146396216|NCT00953017|527954488|FG000|Overall Study|Brown stool prior to procedure|0|||
146396217|NCT00953017|527954489|FG001|Overall Study|Brown stool prior to procedure|0|||
146396218|NCT00953017|527954490|FG002|Overall Study|Brown stool prior to procedure|1|||
146396219|NCT00953017|527954491|FG003|Overall Study|Brown stool prior to procedure|0|||
146396220|NCT01300741|527954492|FG000|Overall Study|Lens deposits|1|||
146396221|NCT01300741|527954492|FG000|Overall Study|Lost to Follow-up|1|||
146396222|NCT01300741|527954492|FG000|Overall Study|Discomfort|1|||
146396223|NCT01548573|527954495|FG000|Overall Study|Death|3|||
146396224|NCT01548573|527954495|FG000|Overall Study|Withdrawal by Subject|2|||
146396225|NCT00290511|527954503|FG000|Overall Study|Adverse Event|1|||
146396226|NCT00290511|527954503|FG000|Overall Study|Death|1|||
146396227|NCT00290511|527954503|FG000|Overall Study|Physician Decision|1|||
146396228|NCT00290511|527954503|FG000|Overall Study|Withdrawal by Subject|1|||
146396229|NCT00558831|527954504|FG000|Overall Study|Lost to Follow-up|1|||
146396230|NCT00447265|527954505|FG000|Overall Study|Physician Decision|1|||
146396231|NCT00447265|527954506|FG001|Overall Study|Physician Decision|0|||
146396232|NCT02204449|527954507|FG000|Overall Study|Lost to Follow-up|7|||
146396233|NCT02204449|527954508|FG001|Overall Study|Lost to Follow-up|9|||
146396234|NCT02204449|527954507|FG000|Overall Study|Death|0|||
146396235|NCT02204449|527954508|FG001|Overall Study|Death|1|||
146396236|NCT02204449|527954507|FG000|Overall Study|Withdrawal by Subject|0|||
146396237|NCT02204449|527954508|FG001|Overall Study|Withdrawal by Subject|1|||
146396238|NCT04311411|527954511|FG000|Overall Study|Adverse Event|2|||
146396239|NCT04311411|527954512|FG001|Overall Study|Adverse Event|3|||
146396240|NCT04311411|527954513|FG002|Overall Study|Adverse Event|2|||
146396241|NCT04311411|527954511|FG000|Overall Study|Withdrawal by Subject|3|||
146396242|NCT04311411|527954512|FG001|Overall Study|Withdrawal by Subject|3|||
146396243|NCT04311411|527954513|FG002|Overall Study|Withdrawal by Subject|0|||
146396244|NCT01976663|527954517|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
146396245|NCT01976663|527954517|FG000|Overall Study|Personal Reasons|6|||
146396246|NCT01976663|527954517|FG000|Overall Study|Withdrawal by Subject|4|||
146396247|NCT01976663|527954517|FG000|Overall Study|Screen Failure|3|||
146396248|NCT01976663|527954517|FG000|Overall Study|Adverse Event|2|||
146396249|NCT01976663|527954517|FG000|Overall Study|Lost to Follow-up|3|||
146396250|NCT01151085|527954520|FG000|Overall Study|Lost to Follow-up|31|||
146396251|NCT01151085|527954520|FG000|Overall Study|Protocol Violation|25|||
146396252|NCT00489411|527954521|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
146396253|NCT00489411|527954522|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
146396254|NCT00489411|527954521|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
146396255|NCT00489411|527954522|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
146396256|NCT00489411|527954521|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
146396257|NCT00489411|527954522|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
146396258|NCT00489411|527954521|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
146396259|NCT00489411|527954522|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
146396260|NCT00489411|527954521|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
146396261|NCT00489411|527954522|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
146396262|NCT01748162|527954523|FG000|Overall Study|no additional croup episodes to evaluate|2|||
146396263|NCT01748162|527954524|FG001|Overall Study|no additional croup episodes to evaluate|2|||
146396264|NCT01748162|527954523|FG000|Overall Study|participant consented but did not begin|0|||
146396265|NCT01748162|527954524|FG001|Overall Study|participant consented but did not begin|1|||
146396266|NCT01748162|527954523|FG000|Overall Study|reasons not available|3|||
146396267|NCT01748162|527954524|FG001|Overall Study|reasons not available|2|||
146396268|NCT03841331|527954525|FG000|Overall Study|Withdrawal by Subject|4|||
146396269|NCT03841331|527954526|FG001|Overall Study|Withdrawal by Subject|9|||
146396270|NCT03841331|527954525|FG000|Overall Study|Lost to Follow-up|5|||
146396271|NCT03841331|527954526|FG001|Overall Study|Lost to Follow-up|1|||
146396272|NCT00779857|527954527|FG000|Overall Study|Death|1|||
146396273|NCT00779857|527954527|FG000|Overall Study|Withdrawal by Subject|3|||
146396274|NCT00779857|527954527|FG000|Overall Study|Missed Visit|2|||
146396275|NCT04640168|527954528|FG000|Overall Study|Withdrawal by Subject|8|||
146396276|NCT04640168|527954529|FG001|Overall Study|Withdrawal by Subject|7|||
146396277|NCT04640168|527954528|FG000|Overall Study|Lost to Follow-up|1|||
146396278|NCT04640168|527954529|FG001|Overall Study|Lost to Follow-up|0|||
146396279|NCT04640168|527954528|FG000|Overall Study|Enrolled but not treated|12|||
146396280|NCT04640168|527954529|FG001|Overall Study|Enrolled but not treated|12|||
146396281|NCT00442572|527954537|FG000|Overall Study|Relapse|8|||
146396282|NCT00442572|527954538|FG001|Overall Study|Relapse|1|||
146396283|NCT00442572|527954537|FG000|Overall Study|Lost to Follow-up|0|||
146396284|NCT00442572|527954538|FG001|Overall Study|Lost to Follow-up|1|||
146396285|NCT00442572|527954537|FG000|Overall Study|Withdrawal by Subject|0|||
146396286|NCT00442572|527954538|FG001|Overall Study|Withdrawal by Subject|1|||
146396287|NCT03557775|527954539|FG000|Overall Study|Withdrawal by Subject|1|||
146396288|NCT03557775|527954540|FG001|Overall Study|Withdrawal by Subject|2|||
146396289|NCT03557775|527954541|FG002|Overall Study|Withdrawal by Subject|4|||
146396290|NCT03557775|527954539|FG000|Overall Study|Physician Decision|0|||
146396291|NCT03557775|527954540|FG001|Overall Study|Physician Decision|1|||
146396292|NCT03557775|527954541|FG002|Overall Study|Physician Decision|0|||
146396305|NCT02219477|527954551|FG000|Overall Study|Withdrawal by Subject|0|||
146396306|NCT02219477|527954552|FG001|Overall Study|Withdrawal by Subject|1|||
146396307|NCT02219477|527954553|FG002|Overall Study|Withdrawal by Subject|0|||
146396308|NCT02283411|527954556|FG000|Overall Study|Withdrawal by Subject|3|||
146396309|NCT02283411|527954556|FG000|Overall Study|Screen Failed|28|||
146396310|NCT01683565|527954557|FG000|Overall Study|Lost to Follow-up|2|||
146396311|NCT01683565|527954558|FG001|Overall Study|Lost to Follow-up|0|||
146396312|NCT01683565|527954557|FG000|Overall Study|Discontinued Intervention|1|||
146396313|NCT01683565|527954558|FG001|Overall Study|Discontinued Intervention|1|||
146396314|NCT04479358|527954559|FG000|Overall Study|Withdrawal by Subject|0|||
146396315|NCT04479358|527954560|FG001|Overall Study|Withdrawal by Subject|0|||
146396316|NCT04479358|527954561|FG002|Overall Study|Withdrawal by Subject|1|||
146396317|NCT04479358|527954562|FG003|Overall Study|Withdrawal by Subject|0|||
146396318|NCT04479358|527954563|FG004|Overall Study|Withdrawal by Subject|0|||
146396319|NCT04479358|527954564|FG005|Overall Study|Withdrawal by Subject|1|||
146396320|NCT05437211|527954573|FG000|Overall Study|Patient's decision|1|||
146396321|NCT05437211|527954574|FG001|Overall Study|Patient's decision|1|||
146396322|NCT04410991|527954576|FG000|Overall Study|Poor compliance to protocol|5|||
146396323|NCT04410991|527954577|FG001|Overall Study|Poor compliance to protocol|4|||
146396324|NCT04410991|527954576|FG000|Overall Study|Withdrawal by Subject|59|||
146396325|NCT04410991|527954577|FG001|Overall Study|Withdrawal by Subject|55|||
146396326|NCT04410991|527954576|FG000|Overall Study|Other|10|||
146396327|NCT04410991|527954577|FG001|Overall Study|Other|4|||
146396328|NCT03282123|527954578|FG000|Overall Study|Withdrawal by Subject|5|||
146396329|NCT00764465|527954579|FG000|Overall Study|Adverse Event|2|||
146396330|NCT00764465|527954580|FG001|Overall Study|Adverse Event|0|||
146396331|NCT00764465|527954581|FG002|Overall Study|Adverse Event|0|||
146396332|NCT00764465|527954582|FG003|Overall Study|Adverse Event|1|||
146396333|NCT00764465|527954583|FG004|Overall Study|Adverse Event|1|||
146396334|NCT00764465|527954584|FG005|Overall Study|Adverse Event|1|||
146396335|NCT00764465|527954579|FG000|Overall Study|Withdrawal by Subject|0|||
146396336|NCT00764465|527954580|FG001|Overall Study|Withdrawal by Subject|1|||
146396337|NCT00764465|527954581|FG002|Overall Study|Withdrawal by Subject|1|||
146396338|NCT00764465|527954582|FG003|Overall Study|Withdrawal by Subject|0|||
146396339|NCT00764465|527954583|FG004|Overall Study|Withdrawal by Subject|0|||
146396340|NCT00764465|527954584|FG005|Overall Study|Withdrawal by Subject|0|||
146396341|NCT01195662|527954586|FG000|Double Blind Treatment Period|Adverse Event|4|||
146396342|NCT01195662|527954587|FG001|Double Blind Treatment Period|Adverse Event|1|||
146396343|NCT01195662|527954588|FG002|Double Blind Treatment Period|Adverse Event|2|||
146396344|NCT01195662|527954586|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
146396345|NCT01195662|527954587|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
146396346|NCT01195662|527954588|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
146396347|NCT01195662|527954586|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
146396348|NCT01195662|527954587|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
146396349|NCT01195662|527954588|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
146396350|NCT01195662|527954586|FG000|Double Blind Treatment Period|Administrative reason|2|||
146396351|NCT01195662|527954587|FG001|Double Blind Treatment Period|Administrative reason|1|||
146396352|NCT01195662|527954588|FG002|Double Blind Treatment Period|Administrative reason|1|||
146396353|NCT01195662|527954586|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
146396354|NCT01195662|527954587|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
146396355|NCT01195662|527954588|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
146396356|NCT01195662|527954586|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
146396357|NCT01195662|527954587|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
146396358|NCT01195662|527954588|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
146396359|NCT01195662|527954586|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
146396360|NCT01195662|527954587|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
146396361|NCT01195662|527954588|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
146396362|NCT01195662|527954586|FG000|Double Blind Treatment Period|Non-specified|3|||
146396363|NCT01195662|527954587|FG001|Double Blind Treatment Period|Non-specified|0|||
146396364|NCT01195662|527954588|FG002|Double Blind Treatment Period|Non-specified|0|||
146396365|NCT01195662|527954586|FG000|Double Blind Treatment Period|Missing disposition information|0|||
146396366|NCT01195662|527954587|FG001|Double Blind Treatment Period|Missing disposition information|1|||
146396367|NCT01195662|527954588|FG002|Double Blind Treatment Period|Missing disposition information|1|||
146396368|NCT01195662|527954586|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
146396369|NCT01195662|527954587|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
146396370|NCT01195662|527954588|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
146396371|NCT01195662|527954586|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
146396372|NCT01195662|527954587|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
146396373|NCT01195662|527954588|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
146396374|NCT01463631|527954592|FG000|Overall Study|Withdrawal by Subject|0|||
146396375|NCT01463631|527954593|FG001|Overall Study|Withdrawal by Subject|0|||
146396376|NCT01463631|527954594|FG002|Overall Study|Withdrawal by Subject|0|||
146396377|NCT01463631|527954595|FG003|Overall Study|Withdrawal by Subject|1|||
146396378|NCT01463631|527954592|FG000|Overall Study|Death|0|||
146396379|NCT01463631|527954593|FG001|Overall Study|Death|0|||
146396380|NCT01463631|527954594|FG002|Overall Study|Death|1|||
146396381|NCT01463631|527954595|FG003|Overall Study|Death|0|||
146396382|NCT01463631|527954592|FG000|Overall Study|Progressive Disease|0|||
146396383|NCT01463631|527954593|FG001|Overall Study|Progressive Disease|0|||
146396384|NCT01463631|527954594|FG002|Overall Study|Progressive Disease|0|||
146396385|NCT01463631|527954595|FG003|Overall Study|Progressive Disease|5|||
146396386|NCT05966129|527954598|FG000|Overall Study|Death|1|||
146396387|NCT05966129|527954599|FG001|Overall Study|Death|2|||
146396388|NCT05966129|527954598|FG000|Overall Study|Lost to Follow-up|63|||
146396389|NCT05966129|527954599|FG001|Overall Study|Lost to Follow-up|66|||
146396390|NCT05966129|527954598|FG000|Overall Study|Protocol Violation|1|||
146396391|NCT05966129|527954599|FG001|Overall Study|Protocol Violation|0|||
146396392|NCT05966129|527954598|FG000|Overall Study|Withdrawal by Subject|26|||
146396393|NCT05966129|527954599|FG001|Overall Study|Withdrawal by Subject|25|||
146396394|NCT05966129|527954598|FG000|Overall Study|Surgery not completed|63|||
146396395|NCT05966129|527954599|FG001|Overall Study|Surgery not completed|69|||
146396396|NCT05966129|527954598|FG000|Overall Study|Surgery logistics issue|2|||
146396397|NCT05966129|527954599|FG001|Overall Study|Surgery logistics issue|1|||
146396398|NCT01298323|527954600|FG000|Overall Study|Adverse Event|2|||
146396399|NCT01298323|527954601|FG001|Overall Study|Adverse Event|4|||
146396400|NCT01298323|527954600|FG000|Overall Study|Death|11|||
146396401|NCT01298323|527954601|FG001|Overall Study|Death|16|||
146396402|NCT01298323|527954600|FG000|Overall Study|Lost to Follow-up|1|||
146396403|NCT01298323|527954601|FG001|Overall Study|Lost to Follow-up|0|||
146396404|NCT01298323|527954600|FG000|Overall Study|Withdrawal by Subject|6|||
146396405|NCT01298323|527954601|FG001|Overall Study|Withdrawal by Subject|3|||
146396406|NCT01298323|527954600|FG000|Overall Study|Protocol Violation|1|||
146396407|NCT01298323|527954601|FG001|Overall Study|Protocol Violation|0|||
146396408|NCT01298323|527954600|FG000|Overall Study|Other|10|||
146396409|NCT01298323|527954601|FG001|Overall Study|Other|9|||
146396410|NCT01298323|527954600|FG000|Overall Study|Ongoing|55|||
146396411|NCT01298323|527954601|FG001|Overall Study|Ongoing|55|||
146396412|NCT01298323|527954600|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
146396413|NCT01298323|527954601|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
